id|nct_id|mesh_term|downcase_mesh_term|mesh_type
1944266|NCT00718315|Erythromycin|erythromycin|mesh-list
1944267|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
1944268|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
1944269|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
1944270|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
1944271|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1944272|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944273|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1944274|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944275|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944276|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1944277|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944278|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1944279|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1944280|NCT00718328|Simvastatin|simvastatin|mesh-list
1944281|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1944282|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1944283|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
1944284|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944285|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1944286|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1944287|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944288|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1944289|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
1944290|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944291|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
1944292|NCT00718549|Rituximab|rituximab|mesh-list
1944293|NCT00718549|Cladribine|cladribine|mesh-list
1944294|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1944295|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
1944296|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944297|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1944298|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1944299|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
1944300|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944301|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944302|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1944303|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1944304|NCT00718718|Methotrexate|methotrexate|mesh-list
1944305|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1944306|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1944307|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
1944308|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1944309|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944310|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1944311|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
1944312|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944313|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944314|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
1944315|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944316|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1944317|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1944318|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
1944319|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1944320|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1944321|NCT00718770|Bexarotene|bexarotene|mesh-list
1944322|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944323|NCT00718809|Saracatinib|saracatinib|mesh-list
1944324|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944325|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944326|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944327|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
1944328|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1944329|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944330|NCT00718887|Entecavir|entecavir|mesh-list
1944331|NCT00718887|Adefovir|adefovir|mesh-list
1944332|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
1944333|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944334|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1944335|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1944336|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944337|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944338|NCT00719043|Vaccines|vaccines|mesh-list
1944339|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
1944340|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944341|NCT00719134|Rizatriptan|rizatriptan|mesh-list
1944342|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1944343|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
1944344|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944345|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944346|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944347|NCT00719160|Esomeprazole|esomeprazole|mesh-list
1944348|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1944349|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1944350|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1944351|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944352|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944353|NCT00719186|Letrozole|letrozole|mesh-list
1944354|NCT00719186|Clomiphene|clomiphene|mesh-list
1944355|NCT00719186|Enclomiphene|enclomiphene|mesh-list
1944356|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
1944357|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944358|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944359|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1944360|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1944361|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944362|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1944363|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
1944364|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1944365|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944366|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1944367|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
1944368|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1944369|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1944370|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1944371|NCT00719264|Interferons|interferons|mesh-list
1944372|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
1944373|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
1944374|NCT00719264|Bevacizumab|bevacizumab|mesh-list
1944375|NCT00719264|Everolimus|everolimus|mesh-list
1944376|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1944377|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944378|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1944379|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1944380|NCT00719264|Growth Substances|growth substances|mesh-ancestor
1944381|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944382|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
1944383|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
1944384|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944385|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1944386|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
1944387|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
1944388|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1944389|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944390|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
1944391|NCT00719472|Antipyretics|antipyretics|mesh-list
1944392|NCT00719472|Prednisone|prednisone|mesh-list
1944393|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
1944394|NCT00719472|Rituximab|rituximab|mesh-list
1944395|NCT00719472|Doxorubicin|doxorubicin|mesh-list
1944396|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1944397|NCT00719472|Vincristine|vincristine|mesh-list
1944398|NCT00719472|Analgesics|analgesics|mesh-list
1944399|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
1944400|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
1944401|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1944402|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
1944403|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944404|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1944405|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1944406|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
1944407|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944408|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944409|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1944410|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1944411|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1944412|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1944413|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1944414|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944415|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1944416|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
1944417|NCT00719472|Hormones|hormones|mesh-ancestor
1944418|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1944419|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1944420|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1944421|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
1944422|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
1944423|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
1944424|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
1944425|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944426|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
1944427|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944428|NCT00719537|Aspirin|aspirin|mesh-list
1944429|NCT00719537|Progesterone|progesterone|mesh-list
1944430|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1944431|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1944432|NCT00719537|Analgesics|analgesics|mesh-ancestor
1944433|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
1944434|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944435|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944436|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1944437|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1944438|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1944439|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1944440|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944441|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1944442|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1944443|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944444|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
1944445|NCT00719537|Progestins|progestins|mesh-ancestor
1944446|NCT00719537|Hormones|hormones|mesh-ancestor
1944447|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1944448|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
1944449|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
1944450|NCT00719706|Vitamins|vitamins|mesh-ancestor
1944451|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
1944452|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944453|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
1944454|NCT00719810|Tigecycline|tigecycline|mesh-list
1944455|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
1944456|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1944457|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944458|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1944459|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944460|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944461|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1944462|NCT00719849|Cyclosporine|cyclosporine|mesh-list
1944463|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
1944464|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
1944465|NCT00719849|Fludarabine|fludarabine|mesh-list
1944466|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
1944467|NCT00719849|Cyclosporins|cyclosporins|mesh-list
1944468|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1944469|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1944470|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
1944471|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944472|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1944473|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1944474|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
1944475|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944476|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944477|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1944478|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1944479|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
1944480|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944481|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
1944482|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944483|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
1944484|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1944485|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1944486|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1944487|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
1944488|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1944489|NCT00719862|Azelastine|azelastine|mesh-list
1944490|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1944491|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
1944492|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944493|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944494|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1944495|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
1944496|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1944497|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944498|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944499|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1944500|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1944501|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1944502|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
1944503|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
1944504|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944505|NCT00719901|Bortezomib|bortezomib|mesh-list
1944506|NCT00719901|Obatoclax|obatoclax|mesh-list
1944507|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944508|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944509|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944510|NCT00720057|Naproxen|naproxen|mesh-list
1944511|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1944512|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1944513|NCT00720057|Analgesics|analgesics|mesh-ancestor
1944514|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
1944515|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944516|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944517|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1944518|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1944519|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
1944520|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1944521|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944522|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944523|NCT00720096|Doxorubicin|doxorubicin|mesh-list
1944524|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1944525|NCT00720096|Topotecan|topotecan|mesh-list
1944526|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1944527|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944528|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1944529|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1944530|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944531|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944532|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1944533|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
1944534|NCT00720109|Leucovorin|leucovorin|mesh-list
1944535|NCT00720109|Folic Acid|folic acid|mesh-list
1944536|NCT00720109|Cytarabine|cytarabine|mesh-list
1944537|NCT00720109|Dexamethasone|dexamethasone|mesh-list
1944538|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
1944539|NCT00720109|Prednisone|prednisone|mesh-list
1944540|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
1944541|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1944542|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1944543|NCT00720109|Prednisolone|prednisolone|mesh-list
1944544|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
1944545|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
1944546|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1944547|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1944548|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1944549|NCT00720109|Cortisone|cortisone|mesh-list
1944550|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
1944551|NCT00720109|Ifosfamide|ifosfamide|mesh-list
1944552|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
1944553|NCT00720109|Methotrexate|methotrexate|mesh-list
1944554|NCT00720109|Etoposide|etoposide|mesh-list
1944555|NCT00720109|Vincristine|vincristine|mesh-list
1944556|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
1944557|NCT00720109|Daunorubicin|daunorubicin|mesh-list
1944558|NCT00720109|Asparaginase|asparaginase|mesh-list
1944559|NCT00720109|Dasatinib|dasatinib|mesh-list
1944560|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
1944561|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
1944562|NCT00720109|Pegaspargase|pegaspargase|mesh-list
1944563|NCT00720109|Lenograstim|lenograstim|mesh-list
1944564|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1944565|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
1944566|NCT00720109|BB 1101|bb 1101|mesh-list
1944567|NCT00720109|Calcium|calcium|mesh-list
1944568|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
1944569|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1944570|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
1944571|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944572|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1944573|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1944574|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
1944575|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944576|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944577|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1944578|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1944579|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
1944580|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
1944581|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944582|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1944583|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
1944584|NCT00720109|Hormones|hormones|mesh-ancestor
1944585|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1944586|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1944587|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
1944588|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944589|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1944590|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1944591|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1944592|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
1944593|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1944594|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1944595|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
1944596|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
1944597|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1944598|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1944599|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1944600|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1944601|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1944602|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1944603|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
1944604|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944605|NCT00720109|Antidotes|antidotes|mesh-ancestor
1944606|NCT00720109|Protective Agents|protective agents|mesh-ancestor
1944607|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
1944608|NCT00720109|Vitamins|vitamins|mesh-ancestor
1944609|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
1944610|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
1944611|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
1944612|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
1944613|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1944614|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1944615|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1944616|NCT00720109|Hematinics|hematinics|mesh-ancestor
1944617|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
1944618|NCT00720122|Insulin|insulin|mesh-list
1944619|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1944620|NCT00720122|Mitogens|mitogens|mesh-list
1944621|NCT00720122|Mecasermin|mecasermin|mesh-list
1944622|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1944623|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944624|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
1944625|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944626|NCT00720122|Growth Substances|growth substances|mesh-ancestor
1944627|NCT00720226|Losartan|losartan|mesh-list
1944628|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1944629|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1944630|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1944631|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1944632|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944633|NCT00720278|Azelastine|azelastine|mesh-list
1944634|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1944635|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
1944636|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944637|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944638|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1944639|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
1944640|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1944641|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944642|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944643|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1944644|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1944645|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1944646|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
1944647|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
1944648|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944649|NCT00720330|Lidocaine|lidocaine|mesh-list
1944650|NCT00720330|Ketamine|ketamine|mesh-list
1944651|NCT00720330|Ropivacaine|ropivacaine|mesh-list
1944652|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
1944653|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
1944654|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1944655|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944656|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
1944657|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944658|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1944659|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1944660|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1944661|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1944662|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944663|NCT00720330|Analgesics|analgesics|mesh-ancestor
1944664|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1944665|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1944666|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
1944667|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1944668|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1944669|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944670|NCT00720356|Bevacizumab|bevacizumab|mesh-list
1944671|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1944672|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1944673|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944674|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1944675|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1944676|NCT00720356|Growth Substances|growth substances|mesh-ancestor
1944677|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944678|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
1944679|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1944680|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944681|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944682|NCT00720369|Ubiquinone|ubiquinone|mesh-list
1944683|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
1944684|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
1944685|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944686|NCT00720369|Vitamins|vitamins|mesh-ancestor
1944687|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
1944688|NCT00720382|Azelastine|azelastine|mesh-list
1944689|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1944690|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
1944691|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1944692|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1944693|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
1944694|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944695|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944696|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1944697|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
1944698|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1944699|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944700|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944701|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1944702|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1944703|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
1944704|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
1944705|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944706|NCT00720473|Lamotrigine|lamotrigine|mesh-list
1944707|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
1944708|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1944709|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1944710|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944711|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1944712|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944713|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1944714|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1944715|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1944716|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1944717|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1944718|NCT00720499|Bromides|bromides|mesh-list
1944719|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
1944720|NCT00720499|Olodaterol|olodaterol|mesh-list
1944721|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1944722|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
1944723|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944724|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944725|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1944726|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
1944727|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
1944728|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1944729|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
1944730|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944731|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944732|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
1944733|NCT00720629|Methotrexate|methotrexate|mesh-list
1944734|NCT00720629|Tacrolimus|tacrolimus|mesh-list
1944735|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
1944736|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1944737|NCT00720629|Visilizumab|visilizumab|mesh-list
1944738|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1944739|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
1944740|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1944741|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944742|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1944743|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
1944744|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944745|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944746|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
1944747|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944748|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1944749|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1944750|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
1944751|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1944752|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1944753|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1944754|NCT00720759|Cycloserine|cycloserine|mesh-list
1944755|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1944756|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944757|NCT00720759|Renal Agents|renal agents|mesh-ancestor
1944758|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1944759|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
1944760|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1944761|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
1944762|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944763|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1944764|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
1944765|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
1944766|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1944767|NCT00720798|Analgesics|analgesics|mesh-ancestor
1944768|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
1944769|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944770|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944771|NCT00720876|Rituximab|rituximab|mesh-list
1944772|NCT00720876|Vorinostat|vorinostat|mesh-list
1944773|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1944774|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944775|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
1944776|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944777|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1944778|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1944779|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944780|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944781|NCT00720941|Sunitinib|sunitinib|mesh-list
1944782|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944783|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1944784|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1944785|NCT00720941|Growth Substances|growth substances|mesh-ancestor
1944786|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944787|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
1944788|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1944789|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944790|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944791|NCT00721110|Lidocaine|lidocaine|mesh-list
1944792|NCT00721110|Ketamine|ketamine|mesh-list
1944793|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
1944794|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
1944795|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1944796|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944797|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
1944798|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1944799|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1944800|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1944801|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1944802|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1944803|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944804|NCT00721110|Analgesics|analgesics|mesh-ancestor
1944805|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1944806|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1944807|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
1944808|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1944809|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1944810|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944811|NCT00721136|Heparin|heparin|mesh-list
1944812|NCT00721136|Warfarin|warfarin|mesh-list
1944813|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
1944814|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1944815|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1944816|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944817|NCT00721162|Ramucirumab|ramucirumab|mesh-list
1944818|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944819|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
1944820|NCT00721188|Hematinics|hematinics|mesh-ancestor
1944821|NCT00721214|Azacitidine|azacitidine|mesh-list
1944822|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1944823|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
1944824|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944825|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944826|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944827|NCT00721279|Pramipexole|pramipexole|mesh-list
1944828|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
1944829|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944830|NCT00721279|Protective Agents|protective agents|mesh-ancestor
1944831|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944832|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1944833|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1944834|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
1944835|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
1944836|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944837|NCT00721396|Vaccines|vaccines|mesh-list
1944838|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1944839|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
1944840|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944841|NCT00721409|Letrozole|letrozole|mesh-list
1944842|NCT00721409|Palbociclib|palbociclib|mesh-list
1944843|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944844|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1944845|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1944846|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944847|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944848|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1944849|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
1944850|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1944851|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944852|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1944853|NCT00721513|Docetaxel|docetaxel|mesh-list
1944854|NCT00721513|Fluorouracil|fluorouracil|mesh-list
1944855|NCT00721513|Cetuximab|cetuximab|mesh-list
1944856|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944857|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
1944858|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
1944859|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
1944860|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944861|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
1944862|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1944863|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1944864|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
1944865|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944866|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1944867|NCT00721578|Voriconazole|voriconazole|mesh-list
1944868|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
1944869|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1944870|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1944871|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1944872|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944873|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944874|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1944875|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
1944876|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1944877|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944878|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1944879|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1944880|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1944881|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1944882|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1944883|NCT00721630|Capecitabine|capecitabine|mesh-list
1944884|NCT00721630|Lapatinib|lapatinib|mesh-list
1944885|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1944886|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
1944887|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944888|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944889|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1944890|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944891|NCT00721955|Loxapine|loxapine|mesh-list
1944892|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1944893|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1944894|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1944895|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944896|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1944897|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1944898|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
1944899|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1944900|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944901|NCT00722072|Sorafenib|sorafenib|mesh-list
1944902|NCT00722072|Fulvestrant|fulvestrant|mesh-list
1944903|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944904|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1944905|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944906|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944907|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1944908|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1944909|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1944910|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
1944911|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1944912|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944913|NCT00722137|Prednisone|prednisone|mesh-list
1944914|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
1944915|NCT00722137|Rituximab|rituximab|mesh-list
1944916|NCT00722137|Doxorubicin|doxorubicin|mesh-list
1944917|NCT00722137|Vincristine|vincristine|mesh-list
1944918|NCT00722137|Bortezomib|bortezomib|mesh-list
1944919|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1944920|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
1944921|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944922|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1944923|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1944924|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
1944925|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944926|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944927|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1944928|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1944929|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1944930|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1944931|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1944932|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944933|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1944934|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
1944935|NCT00722137|Hormones|hormones|mesh-ancestor
1944936|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1944937|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1944938|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1944939|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
1944940|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
1944941|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
1944942|NCT00722371|Metformin|metformin|mesh-list
1944943|NCT00722371|Pioglitazone|pioglitazone|mesh-list
1944944|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1944945|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1944946|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944947|NCT00722371|Incretins|incretins|mesh-ancestor
1944948|NCT00722371|Hormones|hormones|mesh-ancestor
1944949|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1944950|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1944951|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
1944952|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944953|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944954|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
1944955|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1944956|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1944957|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944958|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
1944959|NCT00722436|Coagulants|coagulants|mesh-ancestor
1944960|NCT00722553|Vitamins|vitamins|mesh-list
1944961|NCT00722553|Folic Acid|folic acid|mesh-list
1944962|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
1944963|NCT00722553|Hydroxocobalamin|hydroxocobalamin|mesh-list
1944964|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
1944965|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
1944966|NCT00722553|Aminopterin|aminopterin|mesh-list
1944967|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
1944968|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944969|NCT00722553|Hematinics|hematinics|mesh-ancestor
1944970|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1944971|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1944972|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1944973|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944974|NCT00722566|Bortezomib|bortezomib|mesh-list
1944975|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944976|NCT00722722|Bortezomib|bortezomib|mesh-list
1944977|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1944978|NCT00722761|Drospirenone|drospirenone|mesh-list
1944979|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1944980|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
1944981|NCT00722761|Estradiol|estradiol|mesh-list
1944982|NCT00722761|Estrogens|estrogens|mesh-ancestor
1944983|NCT00722761|Hormones|hormones|mesh-ancestor
1944984|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1944985|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1944986|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1944987|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
1944988|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1944989|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1944990|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1944991|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1944992|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1944993|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
1944994|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1944995|NCT00722761|Diuretics|diuretics|mesh-ancestor
1944996|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
1944997|NCT00722800|Drospirenone|drospirenone|mesh-list
1944998|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1944999|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
1945000|NCT00722800|Estradiol|estradiol|mesh-list
1945001|NCT00722800|Estrogens|estrogens|mesh-ancestor
1945002|NCT00722800|Hormones|hormones|mesh-ancestor
1945003|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1945004|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945005|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1945006|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
1945007|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1945008|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1945009|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1945010|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1945011|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1945012|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
1945013|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1945014|NCT00722800|Diuretics|diuretics|mesh-ancestor
1945015|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
1945016|NCT00722865|Bevacizumab|bevacizumab|mesh-list
1945017|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1945018|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945019|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1945020|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1945021|NCT00722865|Growth Substances|growth substances|mesh-ancestor
1945022|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945023|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
1945024|NCT00723021|Zileuton|zileuton|mesh-list
1945025|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1945026|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1945027|NCT00723021|Analgesics|analgesics|mesh-ancestor
1945028|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
1945029|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945030|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945031|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1945032|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945033|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1945034|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945035|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945036|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1945037|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
1945038|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1945039|NCT00723099|Cyclosporine|cyclosporine|mesh-list
1945040|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
1945041|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
1945042|NCT00723099|Fludarabine|fludarabine|mesh-list
1945043|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
1945044|NCT00723099|Cyclosporins|cyclosporins|mesh-list
1945045|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1945046|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
1945047|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945048|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945049|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1945050|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
1945051|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945052|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945053|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1945054|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1945055|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
1945056|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945057|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
1945058|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945059|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
1945060|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1945061|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1945062|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1945063|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
1945064|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1945065|NCT00723125|Paclitaxel|paclitaxel|mesh-list
1945066|NCT00723125|Bevacizumab|bevacizumab|mesh-list
1945067|NCT00723125|Carboplatin|carboplatin|mesh-list
1945068|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1945069|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1945070|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945071|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
1945072|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
1945073|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
1945074|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945075|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1945076|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1945077|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1945078|NCT00723125|Growth Substances|growth substances|mesh-ancestor
1945079|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945080|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
1945081|NCT00723177|Ibudilast|ibudilast|mesh-list
1945082|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1945083|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
1945084|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945085|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945086|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1945087|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
1945088|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1945089|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945090|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945091|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1945092|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
1945093|NCT00723190|Clonidine|clonidine|mesh-list
1945094|NCT00723190|Analgesics|analgesics|mesh-ancestor
1945095|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
1945096|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945097|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945098|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1945099|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
1945100|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
1945101|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1945102|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1945103|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1945104|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
1945105|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1945106|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945107|NCT00723203|Panobinostat|panobinostat|mesh-list
1945108|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945109|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1945110|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945111|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945112|NCT00723229|Acyclovir|acyclovir|mesh-list
1945113|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
1945114|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945115|NCT00723255|Sirolimus|sirolimus|mesh-list
1945116|NCT00723255|Bevacizumab|bevacizumab|mesh-list
1945117|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1945118|NCT00723255|Antibodies|antibodies|mesh-list
1945119|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
1945120|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1945121|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945122|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1945123|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1945124|NCT00723255|Growth Substances|growth substances|mesh-ancestor
1945125|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945126|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
1945127|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
1945128|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1945129|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945130|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1945131|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
1945132|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1945133|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
1945134|NCT00723398|Pitavastatin|pitavastatin|mesh-list
1945135|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1945136|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1945137|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1945138|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
1945139|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945140|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945141|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1945142|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1945143|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
1945144|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1945145|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945146|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1945147|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1945148|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1945149|NCT00723450|Lamotrigine|lamotrigine|mesh-list
1945150|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
1945151|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1945152|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1945153|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945154|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1945155|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945156|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1945157|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1945158|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1945159|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1945160|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1945161|NCT00723528|Ustekinumab|ustekinumab|mesh-list
1945162|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
1945163|NCT00723554|Iloprost|iloprost|mesh-list
1945164|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1945165|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
1945166|NCT00723580|Risperidone|risperidone|mesh-list
1945167|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1945168|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
1945169|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1945170|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945171|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945172|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1945173|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1945174|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1945175|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1945176|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1945177|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
1945178|NCT00723606|Haloperidol|haloperidol|mesh-list
1945179|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
1945180|NCT00723606|Ziprasidone|ziprasidone|mesh-list
1945181|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
1945182|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
1945183|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945184|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945185|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945186|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1945187|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1945188|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1945189|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1945190|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1945191|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
1945192|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1945193|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945194|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1945195|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1945196|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
1945197|NCT00723632|Ribavirin|ribavirin|mesh-list
1945198|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945199|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
1945200|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945201|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
1945202|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945203|NCT00723697|Buprenorphine|buprenorphine|mesh-list
1945204|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1945205|NCT00723697|Narcotics|narcotics|mesh-ancestor
1945206|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1945207|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945208|NCT00723697|Analgesics|analgesics|mesh-ancestor
1945209|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
1945210|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945211|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1945212|NCT00723710|Interferons|interferons|mesh-list
1945213|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
1945214|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
1945215|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945216|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
1945217|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945218|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
1945219|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945220|NCT00723736|Desloratadine|desloratadine|mesh-list
1945221|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1945222|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
1945223|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1945224|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945225|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945226|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1945227|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1945228|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
1945229|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
1945230|NCT00723749|Buprenorphine|buprenorphine|mesh-list
1945231|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1945232|NCT00723749|Naloxone|naloxone|mesh-list
1945233|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1945234|NCT00723749|Narcotics|narcotics|mesh-ancestor
1945235|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1945236|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945237|NCT00723749|Analgesics|analgesics|mesh-ancestor
1945238|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
1945239|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945240|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1945241|NCT00723801|Losartan|losartan|mesh-list
1945242|NCT00723801|Atenolol|atenolol|mesh-list
1945243|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1945244|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1945245|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2079327|NCT02057393|Methylene Blue|methylene blue|mesh-list
1945246|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1945247|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945248|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
1945249|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
1945250|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945251|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945252|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1945253|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1945254|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1945255|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
1945256|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1945257|NCT00723827|Temozolomide|temozolomide|mesh-list
1945258|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1945259|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
1945260|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945261|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945262|NCT00723892|Ribavirin|ribavirin|mesh-list
1945263|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945264|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
1945265|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
1945266|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945267|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
1945268|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945269|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
1945270|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945271|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945272|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
1945273|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945274|NCT00723944|Ethanol|ethanol|mesh-list
1945275|NCT00723944|Povidone-Iodine|povidone-iodine|mesh-list
1945276|NCT00723944|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1945277|NCT00723944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945278|NCT00723944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1945279|NCT00723944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945280|NCT00723957|Paclitaxel|paclitaxel|mesh-list
1945281|NCT00723957|Carboplatin|carboplatin|mesh-list
1945282|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1945283|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945284|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
1945285|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
1945286|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
1945287|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945288|NCT00724009|Clofarabine|clofarabine|mesh-list
1945289|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1945290|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
1945291|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945292|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945293|NCT00724061|Interferons|interferons|mesh-list
1945294|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
1945295|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
1945296|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945297|NCT00724061|Furocoumarins|furocoumarins|mesh-list
1945298|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945299|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
1945300|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945301|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
1945302|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945303|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
1945304|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1945305|NCT00724126|Rifaximin|rifaximin|mesh-list
1945306|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1945307|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945308|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945309|NCT00724243|Infliximab|infliximab|mesh-list
1945310|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
1945311|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945312|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945313|NCT00724373|Ribavirin|ribavirin|mesh-list
1945314|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945315|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
1945316|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945317|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
1945318|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945319|NCT00724451|Ribavirin|ribavirin|mesh-list
1945320|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1945321|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945322|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
1945323|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945324|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
1945325|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945326|NCT00724464|Interferons|interferons|mesh-list
1945327|NCT00724464|Ribavirin|ribavirin|mesh-list
1945328|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
1945329|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
1945330|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945331|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945332|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
1945333|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945334|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
1945335|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945336|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
1945337|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945338|NCT00724568|Dexamethasone|dexamethasone|mesh-list
1945339|NCT00724568|Lenalidomide|lenalidomide|mesh-list
1945340|NCT00724568|Bortezomib|bortezomib|mesh-list
1945341|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1945342|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
1945343|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
1945344|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945345|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945346|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945347|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
1945348|NCT00724568|Hormones|hormones|mesh-ancestor
1945349|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1945350|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1945351|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945352|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
1945353|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1945354|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1945355|NCT00724568|Growth Substances|growth substances|mesh-ancestor
1945356|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
1945357|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
1945358|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1945359|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
1945360|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945361|NCT00724594|Expectorants|expectorants|mesh-ancestor
1945362|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
1945363|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1945364|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
1945365|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945366|NCT00724594|Protective Agents|protective agents|mesh-ancestor
1945367|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945368|NCT00724594|Antidotes|antidotes|mesh-ancestor
1945369|NCT00724698|Desloratadine|desloratadine|mesh-list
1945370|NCT00724698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1945371|NCT00724698|Cholinergic Agents|cholinergic agents|mesh-ancestor
1945372|NCT00724698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1945373|NCT00724698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945374|NCT00724698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945375|NCT00724698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1945376|NCT00724698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1945377|NCT00724698|Histamine Antagonists|histamine antagonists|mesh-ancestor
1945378|NCT00724698|Histamine Agents|histamine agents|mesh-ancestor
1945379|NCT00724711|Tenofovir|tenofovir|mesh-list
1945380|NCT00724711|Lamivudine|lamivudine|mesh-list
1945381|NCT00724711|Emtricitabine|emtricitabine|mesh-list
1945382|NCT00724711|Abacavir|abacavir|mesh-list
1945383|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
1945384|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945385|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1945386|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1945387|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945388|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945389|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1945390|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1945391|NCT00724815|Sumatriptan|sumatriptan|mesh-list
1945392|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1945393|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1945394|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1945395|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
1945396|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1945397|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945398|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945399|NCT00724854|Ribavirin|ribavirin|mesh-list
1945400|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945401|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
1945402|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
1945403|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945404|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
1945405|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945406|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
1945407|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945408|NCT00724867|Belimumab|belimumab|mesh-list
1945409|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1945410|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
1945411|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945412|NCT00724893|Interferons|interferons|mesh-list
1945413|NCT00724893|Ribavirin|ribavirin|mesh-list
1945414|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
1945415|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
1945416|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945417|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945418|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
1945419|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945420|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
1945421|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945422|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
1945423|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945424|NCT00724932|Atropine|atropine|mesh-list
1945425|NCT00724932|Bromides|bromides|mesh-list
1945426|NCT00724932|Rocuronium|rocuronium|mesh-list
1945427|NCT00724932|Neostigmine|neostigmine|mesh-list
1945428|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
1945429|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1945430|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1945431|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1945432|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945433|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945434|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1945435|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1945436|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1945437|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
1945438|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1945439|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
1945440|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
1945441|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
1945442|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1945443|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1945444|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
1945445|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1945446|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945447|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1945448|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945449|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1945450|NCT00724958|Infliximab|infliximab|mesh-list
1945451|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
1945452|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945453|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945454|NCT00724971|Rituximab|rituximab|mesh-list
1945455|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
1945456|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1945457|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945458|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
1945459|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945460|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945461|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1945462|NCT00724984|Abexinostat|abexinostat|mesh-list
1945463|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1945464|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945465|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945466|NCT00725010|Temozolomide|temozolomide|mesh-list
1945467|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1945468|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
1945469|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945470|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945471|NCT00725205|Ribavirin|ribavirin|mesh-list
1945472|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945473|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
1945474|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
1945475|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945476|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
1945477|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945478|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
1945479|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945480|NCT00725270|Mifepristone|mifepristone|mesh-list
1945481|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1945482|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
1945483|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1945484|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945485|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1945486|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1945487|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1945488|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
1945489|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1945490|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1945491|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
1945492|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1945493|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
1945494|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1945495|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1945496|NCT00725296|Infliximab|infliximab|mesh-list
1945497|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
1945498|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945499|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945500|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
1945501|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1945502|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1945503|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1945504|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1945505|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945506|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
1945507|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1945508|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945509|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1945510|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945511|NCT00725361|Ambrisentan|ambrisentan|mesh-list
1945512|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1945513|NCT00725452|Infliximab|infliximab|mesh-list
1945514|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
1945515|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945516|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945517|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1945518|NCT00725491|Ganirelix|ganirelix|mesh-list
1945519|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
1945520|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1945521|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
1945522|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1945523|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945524|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1945525|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1945526|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945527|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
1945528|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1945529|NCT00725504|Lidocaine|lidocaine|mesh-list
1945530|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
1945531|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
1945532|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1945533|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945534|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
1945535|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945536|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1945537|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1945538|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1945539|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1945540|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945541|NCT00725543|Infliximab|infliximab|mesh-list
1945542|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
1945543|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945544|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945545|NCT00725608|Buprenorphine|buprenorphine|mesh-list
1945546|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1945547|NCT00725608|Naloxone|naloxone|mesh-list
1945548|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1945549|NCT00725608|Narcotics|narcotics|mesh-ancestor
1945550|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1945551|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945552|NCT00725608|Analgesics|analgesics|mesh-ancestor
1945553|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
1945554|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945555|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1945556|NCT00725621|Infliximab|infliximab|mesh-list
1945557|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
1945558|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945559|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945560|NCT00725751|Interferons|interferons|mesh-list
1945561|NCT00725751|Ribavirin|ribavirin|mesh-list
1945562|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
1945563|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
1945564|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945565|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945566|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
1945567|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945568|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
1945569|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945570|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
1945571|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945572|NCT00725842|Ribavirin|ribavirin|mesh-list
1945573|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
1945574|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945575|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
1945576|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945577|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
1945578|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945579|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945580|NCT00725920|Topiramate|topiramate|mesh-list
1945581|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
1945582|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1945583|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475507|NCT01084408|Paclitaxel|paclitaxel|mesh-list
2475508|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2475509|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2475510|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475511|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
1945589|NCT00726375|Etanercept|etanercept|mesh-list
1945590|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1945591|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1945592|NCT00726375|Analgesics|analgesics|mesh-ancestor
1945593|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
1945594|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945595|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945596|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1945597|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945598|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945599|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1945600|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
1945601|NCT00726388|Diclofenac|diclofenac|mesh-list
1945602|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1945603|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1945604|NCT00726388|Analgesics|analgesics|mesh-ancestor
1945605|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
1945606|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945607|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945608|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1945609|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945610|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1945611|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945612|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945613|NCT00726414|Quinine|quinine|mesh-list
1945614|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
1945615|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1945616|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1945617|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945618|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1945619|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945620|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1945621|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945622|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1945623|NCT00726414|Analgesics|analgesics|mesh-ancestor
1945624|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
1945625|NCT00726557|Interferons|interferons|mesh-list
1945626|NCT00726557|Ribavirin|ribavirin|mesh-list
1945627|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
1945628|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
1945629|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945630|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945631|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
1945632|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945633|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
1945634|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945635|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
1945636|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945637|NCT00726609|Posaconazole|posaconazole|mesh-list
1945638|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
1945639|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945640|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1945641|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1945642|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1945643|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1945644|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1945645|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945646|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945647|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1945648|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
1945649|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1945650|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945651|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
1945652|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
1945653|NCT00726713|Vitamins|vitamins|mesh-ancestor
1945654|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
1945655|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945656|NCT00726739|Aldesleukin|aldesleukin|mesh-list
1945657|NCT00726739|Interleukin-2|interleukin-2|mesh-list
1945658|NCT00726739|Vaccines|vaccines|mesh-list
1945659|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
1945660|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945661|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945662|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1945663|NCT00726739|Analgesics|analgesics|mesh-ancestor
1945664|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
1945665|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945666|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1945667|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1945668|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
1945669|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945670|NCT00726752|Axitinib|axitinib|mesh-list
1945671|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945672|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1945673|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945674|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945675|NCT00726895|Quinine|quinine|mesh-list
1945676|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
1945677|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1945678|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1945679|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945680|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1945681|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945682|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1945683|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945684|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1945685|NCT00726895|Analgesics|analgesics|mesh-ancestor
1945686|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
1945687|NCT00726986|Etoposide|etoposide|mesh-list
1945688|NCT00726986|Sorafenib|sorafenib|mesh-list
1945689|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945690|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1945691|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1945692|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1945693|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945694|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945695|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1945696|NCT00726999|Morphine|morphine|mesh-list
1945697|NCT00726999|Gabapentin|gabapentin|mesh-list
1945698|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1945699|NCT00726999|Narcotics|narcotics|mesh-ancestor
1945700|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1945701|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945702|NCT00726999|Analgesics|analgesics|mesh-ancestor
1945703|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
1945704|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945705|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
1945706|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1945707|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1945708|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1945709|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1945710|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1945711|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1945712|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945713|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
1945714|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1945715|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1945716|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1945717|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1945718|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1945719|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945720|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1945721|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945722|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1945723|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
1945724|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1945725|NCT00727090|Conivaptan|conivaptan|mesh-list
1945726|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1945727|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945728|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
1945729|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945730|NCT00727194|Eculizumab|eculizumab|mesh-list
1945731|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1945732|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1945733|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
1945734|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945735|NCT00727246|Choline|choline|mesh-list
1945736|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
1945737|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
1945738|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1945739|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
1945740|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945741|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945742|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1945743|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
1945744|NCT00727259|Ribavirin|ribavirin|mesh-list
1945745|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945746|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
1945747|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945748|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
1945749|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945750|NCT00727272|Quinine|quinine|mesh-list
1945751|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
1945752|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1945753|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1945754|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945755|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1945756|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945757|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1945758|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945759|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1945760|NCT00727272|Analgesics|analgesics|mesh-ancestor
1945761|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
1945762|NCT00727298|Infliximab|infliximab|mesh-list
1945763|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
1945764|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945765|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945766|NCT00727311|Ribavirin|ribavirin|mesh-list
1945767|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945768|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
1945769|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
1945770|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945771|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
1945772|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945773|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
1945774|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945775|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
1945776|NCT00727415|Fludarabine|fludarabine|mesh-list
1945777|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
1945778|NCT00727415|Lenalidomide|lenalidomide|mesh-list
1945779|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1945780|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
1945781|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945782|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945783|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1945784|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
1945785|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945786|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945787|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1945788|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1945789|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
1945790|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1945791|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1945792|NCT00727415|Growth Substances|growth substances|mesh-ancestor
1945793|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
1945794|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
1945795|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1945796|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
1945797|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945798|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945799|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1945800|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
1945801|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945802|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945803|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1945804|NCT00727506|Afatinib|afatinib|mesh-list
1945805|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945806|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1945807|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945808|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945809|NCT00727532|Sorafenib|sorafenib|mesh-list
1945810|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945811|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1945812|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945813|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945814|NCT00727597|Efavirenz|efavirenz|mesh-list
1945815|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
1945816|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1945817|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1945818|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945819|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945820|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
1945821|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945822|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1945823|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1945824|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1945825|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1945826|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1945827|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1945828|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1945829|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1945830|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
1945831|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1945832|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1945833|NCT00727636|Vaccines|vaccines|mesh-list
1945834|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
1945835|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945836|NCT00727649|Loperamide|loperamide|mesh-list
1945837|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
1945838|NCT00727649|Psyllium|psyllium|mesh-list
1945839|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945840|NCT00727649|Cathartics|cathartics|mesh-ancestor
1945841|NCT00727740|Indomethacin|indomethacin|mesh-list
1945842|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1945843|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1945844|NCT00727740|Analgesics|analgesics|mesh-ancestor
1945845|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
1945846|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945847|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945848|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1945849|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1945850|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
1945851|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
1945852|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1945853|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1945854|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945855|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945856|NCT00727844|Linezolid|linezolid|mesh-list
1945857|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1945858|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945859|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1945860|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945861|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945862|NCT00727857|Metformin|metformin|mesh-list
1945863|NCT00727857|Pioglitazone|pioglitazone|mesh-list
1945864|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1945865|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945866|NCT00727961|Doxorubicin|doxorubicin|mesh-list
1945867|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1945868|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1945869|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945870|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1945871|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1945872|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945873|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945874|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
1945875|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1945876|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
1945877|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1945878|NCT00728481|Budesonide|budesonide|mesh-list
1945879|NCT00728481|Esomeprazole|esomeprazole|mesh-list
1945880|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1945881|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1945882|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
1945883|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1945884|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945885|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1945886|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
1945887|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
1945888|NCT00728481|Hormones|hormones|mesh-ancestor
1945889|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1945890|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1945891|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1945892|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1945893|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945894|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945895|NCT00728494|Ribavirin|ribavirin|mesh-list
1945896|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1945897|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
1945898|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
1945899|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945900|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
1945901|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945902|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
1945903|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945904|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
1945905|NCT00728507|Rifampin|rifampin|mesh-list
1945906|NCT00728507|Isoniazid|isoniazid|mesh-list
1945907|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
1945908|NCT00728507|Ethambutol|ethambutol|mesh-list
1945909|NCT00728507|Rifapentine|rifapentine|mesh-list
1945910|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1945911|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945912|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1945913|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1945914|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945915|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945916|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945917|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1945918|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
1945919|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
1945920|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1945921|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1945922|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1945923|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1945924|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1945925|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1945926|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1945927|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1945928|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1945929|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
1945930|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1945931|NCT00728754|Ethanol|ethanol|mesh-list
1945932|NCT00728754|Povidone-Iodine|povidone-iodine|mesh-list
1945933|NCT00728754|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1945934|NCT00728754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945935|NCT00728754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1945936|NCT00728754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945937|NCT00728910|Niacin|niacin|mesh-list
1945938|NCT00728910|Atorvastatin|atorvastatin|mesh-list
1945939|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1945940|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1945941|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
1945942|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945943|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1945944|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1945945|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945946|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
1945947|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
1945948|NCT00728910|Vitamins|vitamins|mesh-ancestor
1945949|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
1945950|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945951|NCT00728949|Tamoxifen|tamoxifen|mesh-list
1945952|NCT00728949|Letrozole|letrozole|mesh-list
1945953|NCT00728949|Fulvestrant|fulvestrant|mesh-list
1945954|NCT00728949|Anastrozole|anastrozole|mesh-list
1945955|NCT00728949|Exemestane|exemestane|mesh-list
1945956|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1945957|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945958|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1945959|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1945960|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945961|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945962|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1945963|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
1945964|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1945965|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945966|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1945967|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1945968|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1945969|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1945970|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1945971|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
1945972|NCT00728988|Atorvastatin|atorvastatin|mesh-list
1945973|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1945974|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1945975|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
1945976|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945977|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1945978|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1945979|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1945980|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
1945981|NCT00729157|Aflibercept|aflibercept|mesh-list
1945982|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
1945983|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1945984|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1945985|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1945986|NCT00729157|Growth Substances|growth substances|mesh-ancestor
1945987|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1945988|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
1945989|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1945990|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1945991|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1945992|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
1945993|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
1945994|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1945995|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
1945996|NCT00729183|Vitamin D|vitamin d|mesh-list
1945997|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
1945998|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
1945999|NCT00729183|Calcium|calcium|mesh-list
1946000|NCT00729183|Vitamins|vitamins|mesh-ancestor
1946001|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
1946002|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946003|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1946004|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1946005|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946006|NCT00729183|Antacids|antacids|mesh-ancestor
1946007|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1946008|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1946009|NCT00729326|Exenatide|exenatide|mesh-list
1946010|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1946011|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946012|NCT00729326|Incretins|incretins|mesh-ancestor
1946013|NCT00729326|Hormones|hormones|mesh-ancestor
1946014|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1946015|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1946016|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
1946017|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946018|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946019|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1946020|NCT00729482|Everolimus|everolimus|mesh-list
1946021|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946022|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1946023|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
1946024|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946025|NCT00729586|Tamoxifen|tamoxifen|mesh-list
1946026|NCT00729586|Sirolimus|sirolimus|mesh-list
1946027|NCT00729586|Megestrol|megestrol|mesh-list
1946028|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
1946029|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1946030|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946031|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1946032|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946033|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
1946034|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1946035|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
1946036|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946037|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1946038|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
1946039|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1946040|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1946041|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1946042|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1946043|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1946044|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1946045|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1946046|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1946047|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
1946048|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1946049|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1946050|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1946051|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
1946052|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1946053|NCT00729612|Paclitaxel|paclitaxel|mesh-list
1946054|NCT00729612|Carboplatin|carboplatin|mesh-list
1946055|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1946056|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1946057|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946058|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
1946059|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
1946060|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
1946061|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946062|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
1946063|NCT00729651|Alendronate|alendronate|mesh-list
1946064|NCT00729651|Calcium|calcium|mesh-list
1946065|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1946066|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946067|NCT00729651|Vitamins|vitamins|mesh-ancestor
1946068|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
1946069|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1946070|NCT00729690|Pregabalin|pregabalin|mesh-list
1946071|NCT00729690|Analgesics|analgesics|mesh-ancestor
1946072|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
1946073|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1946074|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946075|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
1946076|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1946077|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1946078|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946079|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1946080|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1946081|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1946082|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1946083|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1946084|NCT00729807|Pentamidine|pentamidine|mesh-list
1946085|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
1946086|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946087|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1946088|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1946089|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1946090|NCT00729833|Sunitinib|sunitinib|mesh-list
1946091|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946092|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1946093|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1946094|NCT00729833|Growth Substances|growth substances|mesh-ancestor
1946095|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946096|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
1946097|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1946098|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946099|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946100|NCT00729846|Bevacizumab|bevacizumab|mesh-list
1946101|NCT00729846|Verteporfin|verteporfin|mesh-list
1946102|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1946103|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946104|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1946105|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1946106|NCT00729846|Growth Substances|growth substances|mesh-ancestor
1946107|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946108|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
1946109|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1946110|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
1946111|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
1946112|NCT00729859|Anastrozole|anastrozole|mesh-list
1946113|NCT00729859|Testosterone|testosterone|mesh-list
1946114|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
1946115|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
1946116|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1946117|NCT00729859|Acyline|acyline|mesh-list
1946118|NCT00729859|Androgens|androgens|mesh-ancestor
1946119|NCT00729859|Hormones|hormones|mesh-ancestor
1946120|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1946121|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946122|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1946123|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946124|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
1946125|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1946126|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1946127|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946128|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946129|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1946130|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
1946131|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
1946132|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1946133|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1946134|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
1946135|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946136|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1946137|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1946138|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946139|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946140|NCT00729937|Clindamycin|clindamycin|mesh-list
1946141|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
1946142|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
1946143|NCT00729937|Cephalexin|cephalexin|mesh-list
1946144|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1946145|NCT00729937|Trimethoprim|trimethoprim|mesh-list
1946146|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
1946147|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1946148|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946149|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1946150|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946151|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946152|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1946153|NCT00729937|Renal Agents|renal agents|mesh-ancestor
1946154|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
1946155|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1946156|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2079328|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946157|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1946158|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1946159|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1946160|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1946161|NCT00730015|Linaclotide|linaclotide|mesh-list
1946162|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
1946163|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
1946164|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946165|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1946166|NCT00730028|Clindamycin|clindamycin|mesh-list
1946167|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
1946168|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
1946169|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1946170|NCT00730028|Trimethoprim|trimethoprim|mesh-list
1946171|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
1946172|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1946173|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946174|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1946175|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946176|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946177|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1946178|NCT00730028|Renal Agents|renal agents|mesh-ancestor
1946179|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
1946180|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1946181|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1946182|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1946183|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1946184|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1946185|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1946186|NCT00730132|Ezetimibe|ezetimibe|mesh-list
1946187|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1946188|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1946189|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
1946190|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946191|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1946192|NCT00730158|Irinotecan|irinotecan|mesh-list
1946193|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1946194|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1946195|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946196|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946197|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946198|NCT00730171|Linaclotide|linaclotide|mesh-list
1946199|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
1946200|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
1946201|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946202|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1946203|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1946204|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1946205|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946206|NCT00730275|Incretins|incretins|mesh-ancestor
1946207|NCT00730275|Hormones|hormones|mesh-ancestor
1946208|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1946209|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1946210|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
1946211|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946212|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946213|NCT00730353|Paclitaxel|paclitaxel|mesh-list
1946214|NCT00730353|Sunitinib|sunitinib|mesh-list
1946215|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1946216|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946217|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
1946218|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
1946219|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
1946220|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946221|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1946222|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1946223|NCT00730353|Growth Substances|growth substances|mesh-ancestor
1946224|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946225|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
1946226|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1946227|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946228|NCT00730405|Albaconazole|albaconazole|mesh-list
1946229|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
1946230|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946231|NCT00730483|Doxorubicin|doxorubicin|mesh-list
1946232|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1946233|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1946234|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946235|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1946236|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1946237|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946238|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946239|NCT00730522|Vigabatrin|vigabatrin|mesh-list
1946240|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
1946241|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946242|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946243|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
1946244|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946245|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745535|NCT02979977|Cetuximab|cetuximab|mesh-list
2745536|NCT02979977|Afatinib|afatinib|mesh-list
2745537|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745538|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745539|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1946251|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1946252|NCT00730691|Vortioxetine|vortioxetine|mesh-list
1946253|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1946254|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1946255|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1946256|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946257|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946258|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946259|NCT00730691|Analgesics|analgesics|mesh-ancestor
1946260|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
1946261|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1946262|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
1946263|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1946264|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
1946265|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1946266|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1946267|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1946268|NCT00730691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1946269|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
1946270|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1946271|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1946272|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1946273|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1946274|NCT00730756|Fluticasone|fluticasone|mesh-list
1946275|NCT00730756|Xhance|xhance|mesh-list
1946276|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1946277|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1946278|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
1946279|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1946280|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946281|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1946282|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
1946283|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
1946284|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1946285|NCT00730847|Vaccines|vaccines|mesh-list
1946286|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
1946287|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946288|NCT00730912|Loratadine|loratadine|mesh-list
1946289|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
1946290|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
1946291|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1946292|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1946293|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1946294|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
1946295|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
1946296|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946297|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946298|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946299|NCT00730925|Paclitaxel|paclitaxel|mesh-list
1946300|NCT00730925|Afatinib|afatinib|mesh-list
1946301|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1946302|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946303|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
1946304|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
2745540|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946305|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
1946306|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946307|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1946308|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946309|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1946310|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1946311|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946312|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
1946313|NCT00731055|Varenicline|varenicline|mesh-list
1946314|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1946315|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1946316|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
1946317|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946318|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946319|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946320|NCT00731120|Vortioxetine|vortioxetine|mesh-list
1946321|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
1946322|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1946323|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1946324|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1946325|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1946326|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946327|NCT00731120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1946328|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1946329|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1946330|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946331|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946332|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
1946333|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1946334|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1946335|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1946336|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1946337|NCT00731133|Disulfiram|disulfiram|mesh-list
1946338|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1946339|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
1946340|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946341|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946342|NCT00731198|Drotaverin|drotaverin|mesh-list
1946343|NCT00731198|Scopolamine|scopolamine|mesh-list
1946344|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
1946345|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1946346|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
1946347|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
1946348|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1946349|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946350|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1946351|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
1946352|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1946353|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
1946354|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946355|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946356|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1946357|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
1946358|NCT00731198|Analgesics|analgesics|mesh-ancestor
1946359|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
1946360|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
1946361|NCT00731549|Aripiprazole|aripiprazole|mesh-list
1946362|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
1946363|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1946364|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1946365|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1946366|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1946367|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946368|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
1946369|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
1946370|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946371|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946372|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1946373|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1946374|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
1946375|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1946376|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1946377|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1946378|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1946379|NCT00731588|Biotin|biotin|mesh-list
1946380|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
1946381|NCT00731588|Vitamins|vitamins|mesh-ancestor
1946382|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
1946383|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946384|NCT00731679|Rifaximin|rifaximin|mesh-list
1946385|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1946386|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946387|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1946388|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1946389|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1946390|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946391|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1946392|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
1946393|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946394|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
1946395|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1946396|NCT00731783|Mupirocin|mupirocin|mesh-list
1946397|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1946398|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946399|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
1946400|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
1946401|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1946402|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1946403|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946404|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946405|NCT00731874|Tacrolimus|tacrolimus|mesh-list
1946406|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1946407|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
1946408|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946409|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1946410|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946411|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946412|NCT00732069|Valsartan|valsartan|mesh-list
1946413|NCT00732069|Ramipril|ramipril|mesh-list
1946414|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1946415|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1946416|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1946417|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946418|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1946419|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
1946420|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946421|NCT00732212|Hemostatics|hemostatics|mesh-list
1946422|NCT00732212|Coagulants|coagulants|mesh-ancestor
1946423|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
1946424|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1946425|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
1946426|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946427|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
1946428|NCT00732225|Protective Agents|protective agents|mesh-ancestor
1946429|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1946430|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946431|NCT00732251|Allopurinol|allopurinol|mesh-list
1946432|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
1946433|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946434|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946435|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
1946436|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1946437|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1946438|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
1946439|NCT00732251|Protective Agents|protective agents|mesh-ancestor
1946440|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946441|NCT00732303|Pemetrexed|pemetrexed|mesh-list
1946442|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946443|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946444|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946445|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1946446|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1946447|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
1946448|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1946449|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
1946450|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1946451|NCT00732498|Cytarabine|cytarabine|mesh-list
1946452|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
1946453|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2209025|NCT00012857|Acetaminophen|acetaminophen|mesh-list
1946454|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1946455|NCT00732498|Prednisolone|prednisolone|mesh-list
1946456|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
1946457|NCT00732498|Rituximab|rituximab|mesh-list
1946458|NCT00732498|Etoposide|etoposide|mesh-list
1946459|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1946460|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1946461|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
1946462|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946463|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1946464|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
1946465|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946466|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1946467|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1946468|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1946469|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1946470|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946471|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946472|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1946473|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
1946474|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
1946475|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946476|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1946477|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1946478|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
1946479|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
1946480|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1946481|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1946482|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
1946483|NCT00732498|Hormones|hormones|mesh-ancestor
1946484|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1946485|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1946486|NCT00732498|Protective Agents|protective agents|mesh-ancestor
1946487|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1946488|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
1946489|NCT00732654|Caseins|caseins|mesh-list
1946490|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946491|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
1946492|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
1946493|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946494|NCT00732758|Vitamin D|vitamin d|mesh-list
1946495|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
1946496|NCT00732758|Vitamins|vitamins|mesh-ancestor
1946497|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
1946498|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946499|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1946500|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1946501|NCT00732875|Methotrexate|methotrexate|mesh-list
1946502|NCT00732875|Infliximab|infliximab|mesh-list
1946503|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1946504|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
1946505|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1946506|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946507|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1946508|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
1946509|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946510|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946511|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
1946512|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946513|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1946514|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1946515|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
1946516|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1946517|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1946518|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1946519|NCT00732901|Citalopram|citalopram|mesh-list
1946520|NCT00732901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1946521|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1946522|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1946523|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946524|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946525|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
1946526|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946527|NCT00732901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1946528|NCT00732901|Antidepressive Agents|antidepressive agents|mesh-ancestor
1946529|NCT00732901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1946530|NCT00732940|Belimumab|belimumab|mesh-list
1946531|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1946532|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
1946533|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946534|NCT00732992|Pemetrexed|pemetrexed|mesh-list
1946535|NCT00732992|Sunitinib|sunitinib|mesh-list
1946536|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946537|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946538|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946539|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1946540|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1946541|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1946542|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1946543|NCT00732992|Growth Substances|growth substances|mesh-ancestor
1946544|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946545|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
1946546|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1946547|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
1946548|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1946549|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
1946550|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1946551|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
1946552|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1946553|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1946554|NCT00733096|Prednisolone|prednisolone|mesh-list
1946555|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
1946556|NCT00733096|Etanercept|etanercept|mesh-list
1946557|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1946558|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
1946559|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1946560|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
1946561|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
1946562|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1946563|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946564|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1946565|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
1946566|NCT00733096|Hormones|hormones|mesh-ancestor
1946567|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1946568|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1946569|NCT00733096|Protective Agents|protective agents|mesh-ancestor
1946570|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1946571|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946572|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1946573|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1946574|NCT00733096|Analgesics|analgesics|mesh-ancestor
1946575|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
1946576|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1946577|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1946578|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
1946579|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
1946580|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1946581|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
1946582|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946583|NCT00733278|Copper|copper|mesh-list
1946584|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
1946585|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1946586|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946587|NCT00733278|Trace Elements|trace elements|mesh-ancestor
1946588|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
1946589|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1946590|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1946591|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1946592|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946593|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1946594|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1946595|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1946596|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946597|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
1946598|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946599|NCT00733408|Paclitaxel|paclitaxel|mesh-list
1946600|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1946601|NCT00733408|Bevacizumab|bevacizumab|mesh-list
1946602|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1946603|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1946604|NCT00733408|Antibodies|antibodies|mesh-list
1946605|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
1946606|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1946607|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1946608|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946609|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
1946610|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
1946611|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
1946612|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946613|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1946614|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1946615|NCT00733408|Growth Substances|growth substances|mesh-ancestor
1946616|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946617|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
1946618|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
1946619|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1946620|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946621|NCT00733421|Etoricoxib|etoricoxib|mesh-list
1946622|NCT00733421|Tramadol|tramadol|mesh-list
1946623|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1946624|NCT00733421|Narcotics|narcotics|mesh-ancestor
1946625|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1946626|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946627|NCT00733421|Analgesics|analgesics|mesh-ancestor
1946628|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
1946629|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1946630|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1946631|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1946632|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1946633|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1946634|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1946635|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1946636|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946637|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946638|NCT00733746|Gemcitabine|gemcitabine|mesh-list
1946639|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1946640|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1946641|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
1946642|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946643|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946644|NCT00733746|Antiviral Agents|antiviral agents|mesh-ancestor
1946645|NCT00733746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946646|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946647|NCT00733746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1946648|NCT00733746|Immunologic Factors|immunologic factors|mesh-ancestor
1946649|NCT00733746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946650|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1946651|NCT00733824|Plerixafor|plerixafor|mesh-list
1946652|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1946653|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1946654|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
1946655|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946656|NCT00733902|Tanezumab|tanezumab|mesh-list
1946657|NCT00733902|Analgesics|analgesics|mesh-ancestor
1946658|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
1946659|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1946660|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946661|NCT00733954|Clobetasol|clobetasol|mesh-list
1946662|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1946663|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
1946664|NCT00733954|Hormones|hormones|mesh-ancestor
1946665|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1946666|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946667|NCT00733993|Caffeine|caffeine|mesh-list
1946668|NCT00733993|Amphetamine|amphetamine|mesh-list
1946669|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1946670|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946671|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1946672|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946673|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946674|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1946675|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1946676|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
1946677|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946678|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
1946679|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
1946680|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1946681|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
1946682|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
1946683|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1946684|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1946685|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1946686|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1946687|NCT00734032|Darapladib|darapladib|mesh-list
1946688|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
1946689|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946690|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946691|NCT00734071|Vortioxetine|vortioxetine|mesh-list
1946692|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
1946693|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1946694|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1946695|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1946696|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1946697|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946698|NCT00734071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1946699|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1946700|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1946701|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946702|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946703|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
1946704|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1946705|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1946706|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1946707|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1946708|NCT00734097|Esomeprazole|esomeprazole|mesh-list
1946709|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1946710|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1946711|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1946712|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946713|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946714|NCT00734149|Prednisone|prednisone|mesh-list
1946715|NCT00734149|Bortezomib|bortezomib|mesh-list
1946716|NCT00734149|Melphalan|melphalan|mesh-list
1946717|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1946718|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
1946719|NCT00734149|Hormones|hormones|mesh-ancestor
1946720|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1946721|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946722|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1946723|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946724|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1946725|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
1946726|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946727|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1946728|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1946729|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
1946730|NCT00734162|Tenofovir|tenofovir|mesh-list
1946731|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
1946732|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946733|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1946734|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1946735|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946736|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946737|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1946738|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1946739|NCT00734344|Tenofovir|tenofovir|mesh-list
1946740|NCT00734344|Efavirenz|efavirenz|mesh-list
1946741|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
1946742|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
1946743|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946744|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1946745|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1946746|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946747|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946748|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1946749|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1946750|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1946751|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1946752|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1946753|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1946754|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1946755|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1946756|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1946757|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1946758|NCT00734474|Metformin|metformin|mesh-list
1946759|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1946760|NCT00734474|Dulaglutide|dulaglutide|mesh-list
1946761|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1946762|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946763|NCT00734474|Incretins|incretins|mesh-ancestor
1946764|NCT00734474|Hormones|hormones|mesh-ancestor
1946765|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1946766|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1946767|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
1946768|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946769|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946770|NCT00734500|Anidulafungin|anidulafungin|mesh-list
1946771|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
1946772|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946773|NCT00734539|Fluconazole|fluconazole|mesh-list
1946774|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
1946775|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946776|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1946777|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1946778|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946779|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946780|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1946781|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
1946782|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1946783|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946784|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1946785|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1946786|NCT00734578|Guanfacine|guanfacine|mesh-list
1946787|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1946788|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1946789|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1946790|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1946791|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
1946792|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946793|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946794|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946795|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
1946796|NCT00734604|Tadalafil|tadalafil|mesh-list
1946797|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946798|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
1946799|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1946800|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1946801|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946802|NCT00734604|Urological Agents|urological agents|mesh-ancestor
1946803|NCT00734617|Nicotine|nicotine|mesh-list
1946804|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1946805|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
1946806|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1946807|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946808|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1946809|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1946810|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
1946811|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946812|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946813|NCT00734630|Losartan|losartan|mesh-list
1946814|NCT00734630|Lisinopril|lisinopril|mesh-list
1946815|NCT00734630|Nebivolol|nebivolol|mesh-list
1946816|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1946817|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1946818|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1946819|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1946820|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946821|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1946822|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
1946823|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946824|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1946825|NCT00734630|Protective Agents|protective agents|mesh-ancestor
1946826|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946827|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
1946828|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1946829|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1946830|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1946831|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
1946832|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946833|NCT00734656|Ethanol|ethanol|mesh-list
1946834|NCT00734656|Dutasteride|dutasteride|mesh-list
1946835|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1946836|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946837|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1946838|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946839|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1946840|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1946841|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946842|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946843|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
1946844|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1946845|NCT00734851|Docetaxel|docetaxel|mesh-list
1946846|NCT00734851|Sunitinib|sunitinib|mesh-list
1946847|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946848|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
1946849|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
1946850|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
1946851|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946852|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1946853|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1946854|NCT00734851|Growth Substances|growth substances|mesh-ancestor
1946855|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946856|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
1946857|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1946858|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946859|NCT00734929|Dexamethasone|dexamethasone|mesh-list
1946860|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
1946861|NCT00734929|Ondansetron|ondansetron|mesh-list
1946862|NCT00734929|Aprepitant|aprepitant|mesh-list
1946863|NCT00734929|BB 1101|bb 1101|mesh-list
1946864|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1946865|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
1946866|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
1946867|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1946868|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946869|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1946870|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
1946871|NCT00734929|Hormones|hormones|mesh-ancestor
1946872|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1946873|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1946874|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946875|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
1946876|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946877|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946878|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
1946879|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
1946880|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1946881|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
1946882|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946883|NCT00734929|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1946884|NCT00734929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1946885|NCT00734929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1946886|NCT00734929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1946887|NCT00734929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1946888|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1946889|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
1946890|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1946891|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946892|NCT00734968|Renal Agents|renal agents|mesh-ancestor
1946893|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1946894|NCT00734994|Mitomycins|mitomycins|mesh-list
1946895|NCT00734994|Mitomycin|mitomycin|mesh-list
1946896|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1946897|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946898|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
1946899|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946900|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1946901|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946902|NCT00735072|Maraviroc|maraviroc|mesh-list
1946903|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1946904|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1946905|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946906|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1946907|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1946908|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
1946909|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1946910|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1946911|NCT00735306|Bevacizumab|bevacizumab|mesh-list
1946912|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1946913|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1946914|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946915|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1946916|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1946917|NCT00735306|Growth Substances|growth substances|mesh-ancestor
1946918|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946919|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
1946920|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1946921|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946922|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946923|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1946924|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1946925|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946926|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1946927|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1946928|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1946929|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946930|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
1946931|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946932|NCT00735436|Bevacizumab|bevacizumab|mesh-list
1946933|NCT00735436|Irinotecan|irinotecan|mesh-list
1946934|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1946935|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946936|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1946937|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1946938|NCT00735436|Growth Substances|growth substances|mesh-ancestor
1946939|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946940|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
1946941|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1946942|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1946943|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946944|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946945|NCT00735449|Timolol|timolol|mesh-list
1946946|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1946947|NCT00735449|Latanoprost|latanoprost|mesh-list
1946948|NCT00735449|Maleic acid|maleic acid|mesh-list
1946949|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1946950|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1946951|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
1946952|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946953|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946954|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946955|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1946956|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1946957|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1946958|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1946959|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1946960|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1946961|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1946962|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1946963|NCT00735462|Imiquimod|imiquimod|mesh-list
1946964|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1946965|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
1946966|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946967|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946968|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
1946969|NCT00735475|Vaccines|vaccines|mesh-list
1946970|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
1946971|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946972|NCT00735644|Vaccines|vaccines|mesh-list
1946973|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
1946974|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946975|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1946976|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1946977|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1946978|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1946979|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946980|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1946981|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1946982|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1946983|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
1946984|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1946985|NCT00735696|Paclitaxel|paclitaxel|mesh-list
1946986|NCT00735696|Carboplatin|carboplatin|mesh-list
1946987|NCT00735696|Ramucirumab|ramucirumab|mesh-list
1946988|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1946989|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1946990|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
1946991|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
1946992|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
1946993|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1946994|NCT00735709|Vortioxetine|vortioxetine|mesh-list
1946995|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
1946996|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1946997|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1946998|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1946999|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1947000|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947001|NCT00735709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1947002|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1947003|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1947004|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947005|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947006|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
1947007|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1947008|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1947009|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1947010|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1947011|NCT00735787|Adalimumab|adalimumab|mesh-list
1947012|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1947013|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1947014|NCT00735826|Vorinostat|vorinostat|mesh-list
1947015|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947016|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1947017|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947018|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947019|NCT00735878|Carboplatin|carboplatin|mesh-list
1947020|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947021|NCT00735904|Gemcitabine|gemcitabine|mesh-list
1947022|NCT00735904|Axitinib|axitinib|mesh-list
1947023|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947024|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1947025|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
1947026|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947027|NCT00735904|Antiviral Agents|antiviral agents|mesh-ancestor
1947028|NCT00735904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947029|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947030|NCT00735904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1947031|NCT00735904|Immunologic Factors|immunologic factors|mesh-ancestor
1947032|NCT00735904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947033|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1947034|NCT00735917|Saracatinib|saracatinib|mesh-list
1947035|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1947036|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1947037|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947038|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947039|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947040|NCT00735969|Ribavirin|ribavirin|mesh-list
1947041|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
1947042|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947043|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
1947044|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947045|NCT00736073|Aprepitant|aprepitant|mesh-list
1947046|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
1947047|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
1947048|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947049|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947050|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1947051|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1947052|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947053|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947054|NCT00736099|Pioglitazone|pioglitazone|mesh-list
1947055|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1947056|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947057|NCT00736190|Tenofovir|tenofovir|mesh-list
1947058|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
1947059|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947060|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1947061|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1947062|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947063|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947064|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1947065|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1947066|NCT00736229|Exenatide|exenatide|mesh-list
1947067|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1947068|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947069|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1947070|NCT00736229|Incretins|incretins|mesh-ancestor
1947071|NCT00736229|Hormones|hormones|mesh-ancestor
1947072|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1947073|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1947074|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
1947075|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
1947076|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947077|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947078|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1947079|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
1947080|NCT00736255|Nicotine|nicotine|mesh-list
1947081|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1947082|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
1947083|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947084|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947085|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1947086|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1947087|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
1947088|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947089|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947090|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1947091|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1947092|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1947093|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1947094|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
1947095|NCT00736333|Doxorubicin|doxorubicin|mesh-list
1947096|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1947097|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1947098|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947099|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1947100|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1947101|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947102|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947103|NCT00736450|Prednisone|prednisone|mesh-list
1947104|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
1947105|NCT00736450|Rituximab|rituximab|mesh-list
1947106|NCT00736450|Doxorubicin|doxorubicin|mesh-list
1947107|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1947108|NCT00736450|Vincristine|vincristine|mesh-list
1947109|NCT00736450|Oblimersen|oblimersen|mesh-list
1947110|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1947111|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
1947112|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947113|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1947114|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1947115|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
1947116|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947117|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947118|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1947119|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1947120|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1947121|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1947122|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1947123|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947124|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1947125|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
1947126|NCT00736450|Hormones|hormones|mesh-ancestor
1947127|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1947128|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1947129|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1947130|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
1947131|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
1947132|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
1947133|NCT00736476|Vaccines|vaccines|mesh-list
1947134|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
1947135|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947136|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
1947137|NCT00736489|AZD-3199|azd-3199|mesh-list
1947138|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1947139|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
1947140|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947141|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947142|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1947143|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
1947144|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1947145|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1947146|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1947147|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
1947148|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947149|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947150|NCT00736632|Vitamin D|vitamin d|mesh-list
1947151|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
1947152|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
1947153|NCT00736632|Vitamins|vitamins|mesh-list
1947154|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
1947155|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947156|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1947157|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1947158|NCT00736645|Selenium|selenium|mesh-list
1947159|NCT00736645|Finasteride|finasteride|mesh-list
1947160|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1947161|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1947162|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947163|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947164|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
1947165|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1947166|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947167|NCT00736645|Urological Agents|urological agents|mesh-ancestor
1947168|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
1947169|NCT00736645|Protective Agents|protective agents|mesh-ancestor
1947170|NCT00736645|Trace Elements|trace elements|mesh-ancestor
1947171|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
1947172|NCT00736853|Acetaminophen|acetaminophen|mesh-list
1947173|NCT00736853|Tramadol|tramadol|mesh-list
1947174|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1947175|NCT00736853|Analgesics|analgesics|mesh-ancestor
1947176|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
1947177|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947178|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947179|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
1947180|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1947181|NCT00736853|Narcotics|narcotics|mesh-ancestor
1947182|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1947183|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
1947184|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1947185|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947186|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1947187|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947188|NCT00736944|Cisplatin|cisplatin|mesh-list
1947189|NCT00736944|Cetuximab|cetuximab|mesh-list
1947190|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1947191|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947192|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1947193|NCT00736957|Acetaminophen|acetaminophen|mesh-list
1947194|NCT00736957|Tramadol|tramadol|mesh-list
1947195|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1947196|NCT00736957|Analgesics|analgesics|mesh-ancestor
1947197|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
1947198|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947199|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947200|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
1947201|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1947202|NCT00736957|Narcotics|narcotics|mesh-ancestor
1947203|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1947204|NCT00736996|Pioglitazone|pioglitazone|mesh-list
1947205|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1947206|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947207|NCT00737048|Acetaminophen|acetaminophen|mesh-list
1947208|NCT00737048|Tramadol|tramadol|mesh-list
1947209|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1947210|NCT00737048|Analgesics|analgesics|mesh-ancestor
1947211|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
1947212|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947213|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947214|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
1947215|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1947216|NCT00737048|Narcotics|narcotics|mesh-ancestor
1947217|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1947218|NCT00737100|Bromides|bromides|mesh-list
1947219|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
1947220|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1947221|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
1947222|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947223|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947224|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1947225|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
1947226|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
1947227|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1947228|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
1947229|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947230|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947231|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
1947232|NCT00737178|Copper|copper|mesh-list
1947233|NCT00737178|Trace Elements|trace elements|mesh-ancestor
1947234|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
1947235|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947236|NCT00737204|Modafinil|modafinil|mesh-list
1947237|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1947238|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947239|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1947240|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1947241|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1947242|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947243|NCT00737243|Paclitaxel|paclitaxel|mesh-list
1947244|NCT00737243|Bevacizumab|bevacizumab|mesh-list
1947245|NCT00737243|Carboplatin|carboplatin|mesh-list
1947246|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1947247|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1947248|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947249|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
1947250|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
1947251|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
1947252|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947253|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1947254|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1947255|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1947256|NCT00737243|Growth Substances|growth substances|mesh-ancestor
1947257|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947258|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
1947259|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1947260|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947261|NCT00737438|Bevacizumab|bevacizumab|mesh-list
1947262|NCT00737438|Docetaxel|docetaxel|mesh-list
1947263|NCT00737438|Capecitabine|capecitabine|mesh-list
1947264|NCT00737438|Irinotecan|irinotecan|mesh-list
1947265|NCT00737438|Epirubicin|epirubicin|mesh-list
1947266|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1947267|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947268|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1947269|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1947270|NCT00737438|Growth Substances|growth substances|mesh-ancestor
1947271|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947272|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
1947273|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
1947274|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
1947275|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
1947276|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947277|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1947278|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
1947279|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1947280|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1947281|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947282|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1947283|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1947284|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
1947285|NCT00737464|Hematinics|hematinics|mesh-ancestor
1947286|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
1947287|NCT00737477|Hematinics|hematinics|mesh-ancestor
1947288|NCT00737529|Lenalidomide|lenalidomide|mesh-list
1947289|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
1947290|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947291|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1947292|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1947293|NCT00737529|Growth Substances|growth substances|mesh-ancestor
1947294|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
1947295|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947296|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1947297|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1947298|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1947299|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947300|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947301|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
1947302|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947303|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1947304|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1947305|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
1947306|NCT00737711|Hematinics|hematinics|mesh-ancestor
1947307|NCT00737737|Morphine|morphine|mesh-list
1947308|NCT00737737|Oxycodone|oxycodone|mesh-list
1947309|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1947310|NCT00737737|Narcotics|narcotics|mesh-ancestor
1947311|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1947312|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947313|NCT00737737|Analgesics|analgesics|mesh-ancestor
1947314|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
1947315|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947316|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
1947317|NCT00737893|Hematinics|hematinics|mesh-ancestor
1947318|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
1947319|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1947320|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1947321|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947322|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1947323|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1947324|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1947325|NCT00738049|Darusentan|darusentan|mesh-list
1947326|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1947327|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947328|NCT00738062|Droxidopa|droxidopa|mesh-list
1947329|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1947330|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1947331|NCT00738361|Paclitaxel|paclitaxel|mesh-list
1947332|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1947333|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1947334|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947335|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
1947336|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
1947337|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
1947338|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947339|NCT00738374|Rituximab|rituximab|mesh-list
1947340|NCT00738374|Chlorambucil|chlorambucil|mesh-list
1947341|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1947342|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947343|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
1947344|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947345|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1947346|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1947347|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
1947348|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947349|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
1947350|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
2475512|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
1947351|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1947352|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1947353|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947354|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947355|NCT00738400|Urological Agents|urological agents|mesh-ancestor
1947356|NCT00738530|Interferons|interferons|mesh-list
1947357|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
1947358|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
1947359|NCT00738530|Bevacizumab|bevacizumab|mesh-list
1947360|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1947361|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947362|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1947363|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1947364|NCT00738530|Growth Substances|growth substances|mesh-ancestor
1947365|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947366|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
1947367|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
1947368|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947369|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
1947370|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
1947371|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1947372|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947373|NCT00738699|Paclitaxel|paclitaxel|mesh-list
1947374|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1947375|NCT00738699|Farletuzumab|farletuzumab|mesh-list
1947376|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1947377|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947378|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
1947379|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
1947380|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
1947381|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947382|NCT00738881|Pemetrexed|pemetrexed|mesh-list
1947383|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1947384|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947385|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947386|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947387|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1947388|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1947389|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1947390|NCT00738894|Aspirin|aspirin|mesh-list
1947391|NCT00738894|Dipyridamole|dipyridamole|mesh-list
1947392|NCT00738894|Clopidogrel|clopidogrel|mesh-list
1947393|NCT00738894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1947394|NCT00738894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1947395|NCT00738894|Analgesics|analgesics|mesh-ancestor
1947396|NCT00738894|Sensory System Agents|sensory system agents|mesh-ancestor
1947397|NCT00738894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947398|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947399|NCT00738894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1947400|NCT00738894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1947401|NCT00738894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1947402|NCT00738894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1947403|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947404|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1947405|NCT00738894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1947406|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947407|NCT00738894|Antipyretics|antipyretics|mesh-ancestor
1947408|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1947409|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1947410|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1947411|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
1947412|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947413|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1947414|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
1947415|NCT00739297|Montelukast|montelukast|mesh-list
1947416|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1947417|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
1947418|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1947419|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
1947420|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1947421|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947422|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1947423|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2209026|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1947424|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947425|NCT00739596|Amlodipine|amlodipine|mesh-list
1947426|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1947427|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1947428|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1947429|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1947430|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947431|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1947432|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947433|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
1947434|NCT00739596|Diuretics|diuretics|mesh-ancestor
1947435|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
1947436|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1947437|NCT00739648|Levofloxacin|levofloxacin|mesh-list
1947438|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1947439|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947440|NCT00739648|Renal Agents|renal agents|mesh-ancestor
1947441|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1947442|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1947443|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1947444|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947445|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947446|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947447|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1947448|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1947449|NCT00739674|Losartan|losartan|mesh-list
1947450|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1947451|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
1947452|NCT00739674|Calcium|calcium|mesh-list
1947453|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1947454|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947455|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1947456|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1947457|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1947458|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1947459|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947460|NCT00739674|Diuretics|diuretics|mesh-ancestor
1947461|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
1947462|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1947463|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1947464|NCT00739934|Voriconazole|voriconazole|mesh-list
1947465|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
1947466|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947467|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1947468|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1947469|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947470|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947471|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1947472|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
1947473|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1947474|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947475|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1947476|NCT00739960|Abatacept|abatacept|mesh-list
1947477|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1947478|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947479|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947480|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1947481|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
1947482|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947483|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1947484|NCT00739973|Amlodipine|amlodipine|mesh-list
1947485|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1947486|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1947487|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1947488|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947489|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1947490|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947491|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
1947492|NCT00739999|Atorvastatin|atorvastatin|mesh-list
1947493|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1947494|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1947495|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
1947496|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947497|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1947498|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1947499|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947500|NCT00740051|Glimepiride|glimepiride|mesh-list
1947501|NCT00740051|Linagliptin|linagliptin|mesh-list
1947502|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1947503|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1947504|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947505|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1947506|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
1947507|NCT00740051|Incretins|incretins|mesh-ancestor
1947508|NCT00740051|Hormones|hormones|mesh-ancestor
1947509|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1947510|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1947511|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
1947512|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947513|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947514|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
1947515|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1947516|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947517|NCT00740636|Temozolomide|temozolomide|mesh-list
1947518|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1947519|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
1947520|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947521|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947522|NCT00740714|Vitamins|vitamins|mesh-list
1947523|NCT00740714|Vitamin E|vitamin e|mesh-list
1947524|NCT00740714|Tocopherols|tocopherols|mesh-list
1947525|NCT00740714|Tocotrienols|tocotrienols|mesh-list
1947526|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
1947527|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
1947528|NCT00740714|Ubiquinone|ubiquinone|mesh-list
1947529|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
1947530|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947531|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
1947532|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947533|NCT00740714|Protective Agents|protective agents|mesh-ancestor
1947534|NCT00740779|Silodosin|silodosin|mesh-list
1947535|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1947536|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1947537|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1947538|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
1947539|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947540|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947541|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947542|NCT00740779|Urological Agents|urological agents|mesh-ancestor
1947543|NCT00740792|Fluticasone|fluticasone|mesh-list
1947544|NCT00740792|Xhance|xhance|mesh-list
1947545|NCT00740792|Azelastine|azelastine|mesh-list
1947546|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1947547|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1947548|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
1947549|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947550|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947551|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1947552|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
1947553|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
1947554|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1947555|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1947556|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947557|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947558|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1947559|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1947560|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
1947561|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
1947562|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947563|NCT00740831|Leuprolide|leuprolide|mesh-list
1947564|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
1947565|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1947566|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
1947567|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1947568|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947569|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1947570|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947571|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1947572|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
1947573|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1947574|NCT00740857|Ibuprofen|ibuprofen|mesh-list
1947575|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1947576|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1947577|NCT00740857|Analgesics|analgesics|mesh-ancestor
1947578|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
1947579|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947580|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947581|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1947582|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1947583|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1947584|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947585|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947586|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
1947587|NCT00741013|Protein C|protein c|mesh-list
1947588|NCT00741013|Lovastatin|lovastatin|mesh-list
1947589|NCT00741013|L 647318|l 647318|mesh-list
1947590|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
1947591|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1947592|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1947593|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
1947594|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947595|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1947596|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1947597|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947598|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
1947599|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1947600|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1947601|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947602|NCT00741026|Olanzapine|olanzapine|mesh-list
1947603|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
1947604|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
1947605|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947606|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947607|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1947608|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1947609|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1947610|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1947611|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1947612|NCT00741026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1947613|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1947614|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1947615|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947616|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947617|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
1947618|NCT00741039|Vaccines|vaccines|mesh-list
1947619|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1947620|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
1947621|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947622|NCT00741104|Infliximab|infliximab|mesh-list
1947623|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
1947624|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1947625|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1947626|NCT00741156|Enalaprilat|enalaprilat|mesh-list
1947627|NCT00741156|Enalapril|enalapril|mesh-list
1947628|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1947629|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
1947630|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947631|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947632|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1947633|NCT00741260|Capecitabine|capecitabine|mesh-list
1947634|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1947635|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
1947636|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947637|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947638|NCT00741286|Aspirin|aspirin|mesh-list
1947639|NCT00741286|Cilostazol|cilostazol|mesh-list
1947640|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1947641|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1947642|NCT00741286|Analgesics|analgesics|mesh-ancestor
1947643|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
1947644|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947645|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947646|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1947647|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1947648|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1947649|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1947650|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947651|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1947652|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1947653|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947654|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
1947655|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1947656|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
1947657|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1947658|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
1947659|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
1947660|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1947661|NCT00741286|Protective Agents|protective agents|mesh-ancestor
1947662|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1947663|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1947664|NCT00741338|Cyclosporine|cyclosporine|mesh-list
1947665|NCT00741338|Azathioprine|azathioprine|mesh-list
1947666|NCT00741338|Cyclosporins|cyclosporins|mesh-list
1947667|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947668|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947669|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1947670|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
1947671|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947672|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
1947673|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947674|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
1947675|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1947676|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1947677|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
1947678|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1947679|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947680|NCT00741455|Cyclosporine|cyclosporine|mesh-list
1947681|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
1947682|NCT00741455|Methotrexate|methotrexate|mesh-list
1947683|NCT00741455|Fludarabine|fludarabine|mesh-list
1947684|NCT00741455|Cyclosporins|cyclosporins|mesh-list
1947685|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1947686|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
1947687|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947688|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1947689|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1947690|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
1947691|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947692|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947693|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1947694|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1947695|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
1947696|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1947697|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1947698|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
1947699|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
1947700|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947701|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1947702|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1947703|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
1947704|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947705|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1947706|NCT00741468|Tolbutamide|tolbutamide|mesh-list
1947707|NCT00741468|Midazolam|midazolam|mesh-list
1947708|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
1947709|NCT00741468|Caffeine|caffeine|mesh-list
1947710|NCT00741468|Omeprazole|omeprazole|mesh-list
1947711|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1947712|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1947713|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1947714|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947715|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1947716|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1947717|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1947718|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1947719|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
1947720|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
1947721|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
1947722|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
1947723|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947724|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947725|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1947726|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1947727|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1947728|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947729|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1947730|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1947731|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1947732|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1947733|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
1947734|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
1947735|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
1947736|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1947737|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1947738|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1947739|NCT00741598|Galantamine|galantamine|mesh-list
1947740|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1947741|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947742|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947743|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
1947744|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947745|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947746|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1947747|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
1947748|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947749|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
1947750|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
1947751|NCT00741819|Treprostinil|treprostinil|mesh-list
1947752|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1947753|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1947754|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1947755|NCT00741858|Estradiol|estradiol|mesh-list
1947756|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1947757|NCT00741858|Estrogens|estrogens|mesh-ancestor
1947758|NCT00741858|Hormones|hormones|mesh-ancestor
1947759|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1947760|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947761|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1947762|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
1947763|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1947764|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2745541|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745542|NCT02975492|Vitamin D|vitamin d|mesh-list
2745543|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
2745544|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
2745545|NCT02975492|Vitamins|vitamins|mesh-list
2745546|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
2745547|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745548|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2745549|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1947774|NCT00742027|Panobinostat|panobinostat|mesh-list
1947775|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947776|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1947777|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947778|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947779|NCT00742079|Cycloserine|cycloserine|mesh-list
1947780|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1947781|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947782|NCT00742079|Renal Agents|renal agents|mesh-ancestor
1947783|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1947784|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
1947785|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1947786|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
1947787|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947788|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
1947789|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1947790|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947791|NCT00742235|Vitamin D|vitamin d|mesh-list
1947792|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
1947793|NCT00742235|Vitamins|vitamins|mesh-ancestor
1947794|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
1947795|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947796|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1947797|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1947798|NCT00742313|Hemostatics|hemostatics|mesh-list
1947799|NCT00742313|Coagulants|coagulants|mesh-ancestor
1947800|NCT00742326|Pioglitazone|pioglitazone|mesh-list
1947801|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1947802|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947803|NCT00742469|Rifaximin|rifaximin|mesh-list
1947804|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1947805|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947806|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1947807|NCT00742508|Carvedilol|carvedilol|mesh-list
1947808|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1947809|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1947810|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
1947811|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947812|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947813|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947814|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1947815|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
1947816|NCT00742508|Protective Agents|protective agents|mesh-ancestor
1947817|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1947818|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1947819|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1947820|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
1947821|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1947822|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1947823|NCT00742560|Dexamethasone|dexamethasone|mesh-list
1947824|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
1947825|NCT00742560|Lenalidomide|lenalidomide|mesh-list
1947826|NCT00742560|Elotuzumab|elotuzumab|mesh-list
1947827|NCT00742560|BB 1101|bb 1101|mesh-list
1947828|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1947829|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
1947830|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
1947831|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947832|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947833|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1947834|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
1947835|NCT00742560|Hormones|hormones|mesh-ancestor
1947836|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1947837|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1947838|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947839|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
1947840|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947841|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947842|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
1947843|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1947844|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1947845|NCT00742560|Growth Substances|growth substances|mesh-ancestor
1947846|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
1947847|NCT00742573|Bupropion|bupropion|mesh-list
1947848|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
1947849|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1947850|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1947851|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947852|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947853|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947854|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1947855|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1947856|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
1947857|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1947858|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1947859|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1947860|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947861|NCT00742625|Cytarabine|cytarabine|mesh-list
1947862|NCT00742625|Bortezomib|bortezomib|mesh-list
1947863|NCT00742625|Daunorubicin|daunorubicin|mesh-list
1947864|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1947865|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
1947866|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947867|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947868|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
1947869|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947870|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1947871|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
1947872|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947873|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1947874|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1947875|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1947876|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947877|NCT00742781|Vitamin D|vitamin d|mesh-list
1947878|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
1947879|NCT00742781|Vitamins|vitamins|mesh-ancestor
1947880|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
1947881|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947882|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1947883|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1947884|NCT00742859|Warfarin|warfarin|mesh-list
1947885|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
1947886|NCT00742859|Betrixaban|betrixaban|mesh-list
1947887|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
1947888|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1947889|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
1947890|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1947891|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
1947892|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947893|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947894|NCT00742872|Mosapride|mosapride|mesh-list
1947895|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947896|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1947897|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1947898|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
1947899|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947900|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947901|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
1947902|NCT00742924|Leucovorin|leucovorin|mesh-list
1947903|NCT00742924|Cisplatin|cisplatin|mesh-list
1947904|NCT00742924|Doxorubicin|doxorubicin|mesh-list
1947905|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1947906|NCT00742924|Methotrexate|methotrexate|mesh-list
1947907|NCT00742924|Etoposide|etoposide|mesh-list
1947908|NCT00742924|Ifosfamide|ifosfamide|mesh-list
1947909|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
1947910|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
1947911|NCT00742924|Razoxane|razoxane|mesh-list
1947912|NCT00742924|Imidazole|imidazole|mesh-list
1947913|NCT00742924|Lenograstim|lenograstim|mesh-list
1947914|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
1947915|NCT00742924|Mesna|mesna|mesh-list
1947916|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947917|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1947918|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1947919|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1947920|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947921|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947922|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947923|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1947924|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
1947925|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1947926|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1947927|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
1947928|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
1947929|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1947930|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1947931|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
1947932|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1947933|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1947934|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1947935|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1947936|NCT00742924|Antidotes|antidotes|mesh-ancestor
1947937|NCT00742924|Protective Agents|protective agents|mesh-ancestor
1947938|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
1947939|NCT00742924|Vitamins|vitamins|mesh-ancestor
1947940|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
1947941|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1947942|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
1947943|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1947944|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1947945|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
1947946|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
1947947|NCT00743093|Acetaminophen|acetaminophen|mesh-list
1947948|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1947949|NCT00743093|Analgesics|analgesics|mesh-ancestor
1947950|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
2209027|NCT00012857|Analgesics|analgesics|mesh-ancestor
1947951|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947952|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947953|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
1947954|NCT00743106|Fenoldopam|fenoldopam|mesh-list
1947955|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1947956|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
1947957|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
1947958|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
1947959|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947960|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947961|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947962|NCT00743119|Dronabinol|dronabinol|mesh-list
1947963|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
1947964|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947965|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1947966|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1947967|NCT00743119|Analgesics|analgesics|mesh-ancestor
1947968|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
1947969|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947970|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1947971|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1947972|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1947973|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947974|NCT00743119|Hormones|hormones|mesh-ancestor
1947975|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1947976|NCT00743145|Naltrexone|naltrexone|mesh-list
1947977|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1947978|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1947979|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947980|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
1947981|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1947982|NCT00743288|Melphalan|melphalan|mesh-list
1947983|NCT00743288|Panobinostat|panobinostat|mesh-list
1947984|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1947985|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
1947986|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1947987|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1947988|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1947989|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1947990|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
1947991|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1947992|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1947993|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1947994|NCT00743340|Emtricitabine|emtricitabine|mesh-list
1947995|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
1947996|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1947997|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1947998|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1947999|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948000|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948001|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1948002|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1948003|NCT00743366|Riboflavin|riboflavin|mesh-list
1948004|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1948005|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
1948006|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948007|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1948008|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1948009|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948010|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948011|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
1948012|NCT00743366|Vitamins|vitamins|mesh-ancestor
1948013|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
1948014|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1948015|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
1948016|NCT00743431|Doxorubicin|doxorubicin|mesh-list
1948017|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1948018|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948019|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1948020|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1948021|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948022|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948023|NCT00743444|Lesogaberan|lesogaberan|mesh-list
1948024|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1948025|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1948026|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
1948027|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
1948028|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948029|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948030|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948031|NCT00743509|Sirolimus|sirolimus|mesh-list
1948032|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
1948033|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1948034|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
1948035|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948036|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1948037|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1948038|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
1948039|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948040|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948041|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1948042|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1948043|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1948044|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1948045|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
1948046|NCT00743574|Vitamin D|vitamin d|mesh-list
1948047|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
1948048|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
1948049|NCT00743574|Vitamins|vitamins|mesh-list
1948050|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1948051|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
1948052|NCT00743574|Calcium|calcium|mesh-list
1948053|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
1948054|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948055|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1948056|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1948057|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1948058|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1948059|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1948060|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
1948061|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1948062|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1948063|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1948064|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1948065|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1948066|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948067|NCT00743652|Vaccines|vaccines|mesh-list
1948068|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1948069|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
1948070|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948071|NCT00743717|Cobalt|cobalt|mesh-list
1948072|NCT00743717|Trace Elements|trace elements|mesh-ancestor
1948073|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
1948074|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948075|NCT00743730|Morphine|morphine|mesh-list
1948076|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1948077|NCT00743730|Narcotics|narcotics|mesh-ancestor
1948078|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948079|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948080|NCT00743730|Analgesics|analgesics|mesh-ancestor
1948081|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
1948082|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948083|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
1948084|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
1948085|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948086|NCT00744055|Prazosin|prazosin|mesh-list
1948087|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1948088|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1948089|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1948090|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1948091|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
1948092|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948093|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948094|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948095|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
1948096|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1948097|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948098|NCT00744237|Metoprolol|metoprolol|mesh-list
1948099|NCT00744237|Nebivolol|nebivolol|mesh-list
1948100|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1948101|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1948102|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
1948103|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
1948104|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948105|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948106|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1948107|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1948108|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1948109|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
1948110|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948111|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948112|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
1948113|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1948114|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1948115|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1948116|NCT00744263|Vaccines|vaccines|mesh-list
1948117|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1948118|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
1948119|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948120|NCT00744328|Sertraline|sertraline|mesh-list
1948121|NCT00744328|Estradiol|estradiol|mesh-list
1948122|NCT00744328|Estrogens|estrogens|mesh-ancestor
1948123|NCT00744328|Hormones|hormones|mesh-ancestor
1948124|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1948125|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948126|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
1948127|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948128|NCT00744328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1948129|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1948130|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1948131|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948132|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948133|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
1948134|NCT00744380|Midazolam|midazolam|mesh-list
1948135|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
1948136|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1948137|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948138|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948139|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1948140|NCT00744380|Analgesics|analgesics|mesh-ancestor
1948141|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
1948142|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948143|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1948144|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1948145|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1948146|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
1948147|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948148|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948149|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1948150|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1948151|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1948152|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948153|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1948154|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
1948155|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
1948156|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
1948157|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
1948158|NCT00744471|Tanezumab|tanezumab|mesh-list
1948159|NCT00744471|Analgesics|analgesics|mesh-ancestor
1948160|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
1948161|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948162|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948163|NCT00744497|Prednisone|prednisone|mesh-list
1948164|NCT00744497|Docetaxel|docetaxel|mesh-list
1948165|NCT00744497|Dasatinib|dasatinib|mesh-list
1948166|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948167|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
1948168|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
1948169|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
1948170|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948171|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1948172|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
1948173|NCT00744497|Hormones|hormones|mesh-ancestor
1948174|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1948175|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948176|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1948177|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1948178|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948179|NCT00744627|Vortioxetine|vortioxetine|mesh-list
1948180|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
1948181|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948182|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1948183|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1948184|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948185|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948186|NCT00744627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1948187|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1948188|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1948189|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948190|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948191|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
1948192|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1948193|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1948194|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1948195|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1948196|NCT00744653|Bleomycin|bleomycin|mesh-list
1948197|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1948198|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948199|NCT00744692|Fludarabine|fludarabine|mesh-list
1948200|NCT00744692|Melphalan|melphalan|mesh-list
1948201|NCT00744692|Thiotepa|thiotepa|mesh-list
1948202|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
1948203|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948204|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948205|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1948206|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
1948207|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948208|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1948209|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
1948210|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1948211|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
1948212|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948213|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1948214|NCT00744757|Decitabine|decitabine|mesh-list
1948215|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1948216|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
1948217|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948218|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948219|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948220|NCT00744848|Epinephrine|epinephrine|mesh-list
1948221|NCT00744848|Bupivacaine|bupivacaine|mesh-list
1948222|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
1948223|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
1948224|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948225|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948226|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
1948227|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948228|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1948229|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1948230|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
1948231|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948232|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948233|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1948234|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1948235|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
1948236|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1948237|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
1948238|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
1948239|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
1948240|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1948241|NCT00744965|Glyburide|glyburide|mesh-list
1948242|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1948243|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948244|NCT00744978|Varenicline|varenicline|mesh-list
1948245|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1948246|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1948247|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
1948248|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948249|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948250|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948251|NCT00745095|Neostigmine|neostigmine|mesh-list
1948252|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1948253|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948254|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948255|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
1948256|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948257|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948258|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1948259|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
1948260|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948261|NCT00745290|Bupivacaine|bupivacaine|mesh-list
1948262|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
1948263|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
1948264|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948265|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948266|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
1948267|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948268|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
1948269|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1948270|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1948271|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
1948272|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1948273|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1948274|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1948275|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948276|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948277|NCT00745498|Bevacizumab|bevacizumab|mesh-list
1948278|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1948279|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948280|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1948281|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1948282|NCT00745498|Growth Substances|growth substances|mesh-ancestor
1948283|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948284|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
1948285|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
1948286|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1948287|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1948288|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1948289|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
1948290|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1948291|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1948292|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1948293|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948294|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948295|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1948296|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1948297|NCT00745849|Esomeprazole|esomeprazole|mesh-list
1948298|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1948299|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1948300|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1948301|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948302|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948303|NCT00745875|Pemetrexed|pemetrexed|mesh-list
1948304|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948305|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948306|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948307|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1948308|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1948309|NCT00745901|Drospirenone|drospirenone|mesh-list
1948310|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1948311|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1948312|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1948313|NCT00745901|Norgestimate|norgestimate|mesh-list
1948314|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
1948315|NCT00745901|Estradiol|estradiol|mesh-list
1948316|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1948317|NCT00745901|Estrogens|estrogens|mesh-ancestor
1948318|NCT00745901|Hormones|hormones|mesh-ancestor
1948319|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1948320|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948321|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1948322|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
1948323|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2475513|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
1948324|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1948325|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1948326|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1948327|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1948328|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
1948329|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1948330|NCT00745901|Diuretics|diuretics|mesh-ancestor
1948331|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
1948332|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1948333|NCT00746252|Risperidone|risperidone|mesh-list
1948334|NCT00746252|Aripiprazole|aripiprazole|mesh-list
1948335|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1948336|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
1948337|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948338|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948339|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948340|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1948341|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1948342|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948343|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948344|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1948345|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
1948346|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
1948347|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
1948348|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1948349|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1948350|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1948351|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1948352|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
1948353|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
1948354|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1948355|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
1948356|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948357|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948358|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1948359|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
1948360|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1948361|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1948362|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1948363|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
1948364|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948365|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948366|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1948367|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
1948368|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1948369|NCT00746395|Lubiprostone|lubiprostone|mesh-list
1948370|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1948371|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1948372|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948373|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1948374|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
1948375|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948376|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1948377|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1948378|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948379|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948380|NCT00746512|Prednisone|prednisone|mesh-list
1948381|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1948382|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
1948383|NCT00746512|Hormones|hormones|mesh-ancestor
1948384|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1948385|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948386|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1948387|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948388|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
1948389|NCT00746551|Hematinics|hematinics|mesh-ancestor
1948390|NCT00746590|Tretazicar|tretazicar|mesh-list
1948391|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948392|NCT00746733|Amphetamine|amphetamine|mesh-list
1948393|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1948394|NCT00746733|Adderall|adderall|mesh-list
1948395|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1948396|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948397|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
1948398|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
1948399|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948400|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
1948401|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948402|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948403|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
1948404|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1948405|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1948406|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1948407|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1948408|NCT00746785|Olanzapine|olanzapine|mesh-list
1948409|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
1948410|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
1948411|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948412|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948413|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1948414|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1948415|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1948416|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948417|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948418|NCT00746785|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1948419|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1948420|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1948421|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948422|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948423|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
1948424|NCT00746798|Vaccines|vaccines|mesh-list
1948425|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
1948426|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948427|NCT00746863|Bupivacaine|bupivacaine|mesh-list
1948428|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
1948429|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
1948430|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948431|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948432|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
1948433|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948434|NCT00746889|Triamcinolone|triamcinolone|mesh-list
1948435|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1948436|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1948437|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1948438|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1948439|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
1948440|NCT00746889|Hormones|hormones|mesh-ancestor
1948441|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1948442|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948443|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1948444|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
1948445|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948446|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948447|NCT00746941|Mefloquine|mefloquine|mesh-list
1948448|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
1948449|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1948450|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1948451|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1948452|NCT00746954|Acetazolamide|acetazolamide|mesh-list
1948453|NCT00746954|Buspirone|buspirone|mesh-list
1948454|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
1948455|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1948456|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948457|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948458|NCT00746954|Diuretics|diuretics|mesh-ancestor
1948459|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
1948460|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948461|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1948462|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1948463|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948464|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948465|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1948466|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
1948467|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948468|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
1948469|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1948470|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948471|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1948472|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1948473|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1948474|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
1948475|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948476|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1948477|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1948478|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948479|NCT00747214|Prednisolone|prednisolone|mesh-list
1948480|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
1948481|NCT00747214|Dipyridamole|dipyridamole|mesh-list
1948482|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1948483|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
1948484|NCT00747214|Hormones|hormones|mesh-ancestor
1948485|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1948486|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948487|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1948488|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948489|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1948490|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948491|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948492|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1948493|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
1948494|NCT00747344|Ustekinumab|ustekinumab|mesh-list
1948495|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
1948496|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1948497|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1948498|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948499|NCT00747643|Varenicline|varenicline|mesh-list
1948500|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1948501|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1948502|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
1948503|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948504|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948505|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948506|NCT00748072|Vasopressins|vasopressins|mesh-list
1948507|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
1948508|NCT00748072|Coagulants|coagulants|mesh-ancestor
1948509|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1948510|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1948511|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
1948512|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948513|NCT00748098|Gabapentin|gabapentin|mesh-list
1948514|NCT00748098|Analgesics|analgesics|mesh-ancestor
1948515|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
1948516|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948517|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948518|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
1948519|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1948520|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1948521|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948522|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948523|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1948524|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1948525|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948526|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948527|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
1948528|NCT00748189|Ofatumumab|ofatumumab|mesh-list
1948529|NCT00748189|Chlorambucil|chlorambucil|mesh-list
1948530|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948531|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1948532|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
1948533|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948534|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
1948535|NCT00748215|Loperamide|loperamide|mesh-list
1948536|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
1948537|NCT00748215|Calcium|calcium|mesh-list
1948538|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1948539|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948540|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1948541|NCT00748553|Paclitaxel|paclitaxel|mesh-list
1948542|NCT00748553|Azacitidine|azacitidine|mesh-list
1948543|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1948544|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1948545|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948546|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
1948547|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
1948548|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
1948549|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948550|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1948551|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
1948552|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948553|NCT00748566|Ziprasidone|ziprasidone|mesh-list
1948554|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1948555|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
1948556|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948557|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948558|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948559|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1948560|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1948561|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948562|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948563|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1948564|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
1948565|NCT00748657|Bevacizumab|bevacizumab|mesh-list
1948566|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1948567|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
1948568|NCT00748657|Antibodies|antibodies|mesh-list
1948569|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
1948570|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1948571|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
1948572|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948573|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1948574|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1948575|NCT00748657|Growth Substances|growth substances|mesh-ancestor
1948576|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948577|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
1948578|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
1948579|NCT00748709|Afatinib|afatinib|mesh-list
1948580|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948581|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1948582|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948583|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948584|NCT00748826|Infliximab|infliximab|mesh-list
1948585|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
1948586|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1948587|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1948588|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1948589|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
1948590|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1948591|NCT00749125|Citalopram|citalopram|mesh-list
1948592|NCT00749125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1948593|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1948594|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1948595|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948596|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948597|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
1948598|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948599|NCT00749125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1948600|NCT00749125|Antidepressive Agents|antidepressive agents|mesh-ancestor
1948601|NCT00749125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948602|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1948603|NCT00749190|Empagliflozin|empagliflozin|mesh-list
1948604|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1948605|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948606|NCT00749190|Incretins|incretins|mesh-ancestor
1948607|NCT00749190|Hormones|hormones|mesh-ancestor
1948608|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1948609|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1948610|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
1948611|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948612|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948613|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1948614|NCT00749203|Midazolam|midazolam|mesh-list
1948615|NCT00749203|Ketamine|ketamine|mesh-list
1948616|NCT00749203|Analgesics|analgesics|mesh-ancestor
1948617|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
1948618|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948619|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948620|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1948621|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1948622|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
1948623|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
1948624|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948625|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1948626|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1948627|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948628|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948629|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1948630|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1948631|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1948632|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1948633|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948634|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
1948635|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
1948636|NCT00749398|Infliximab|infliximab|mesh-list
1948637|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
1948638|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1948639|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1948640|NCT00749463|Nicotine|nicotine|mesh-list
1948641|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1948642|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
1948643|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948644|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948645|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1948646|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1948647|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
1948648|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948649|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948650|NCT00749515|Deferasirox|deferasirox|mesh-list
1948651|NCT00749515|Deferoxamine|deferoxamine|mesh-list
1948652|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1948653|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
1948654|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
1948655|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948656|NCT00749515|Siderophores|siderophores|mesh-ancestor
1948657|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
1948658|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1948659|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1948660|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
1948661|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1948662|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1948663|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1948664|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948665|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948666|NCT00749684|Interferons|interferons|mesh-list
1948667|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948668|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
1948669|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1948670|NCT00749749|Bupivacaine|bupivacaine|mesh-list
1948671|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
1948672|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
1948673|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948674|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948675|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
1948676|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948677|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1948678|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948679|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1948680|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948681|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948682|NCT00749944|Varenicline|varenicline|mesh-list
1948683|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1948684|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1948685|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
1948686|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948687|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948688|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948689|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
1948690|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
1948691|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948692|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948693|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948694|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
1948695|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1948696|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948697|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948698|NCT00750308|Ramipril|ramipril|mesh-list
1948699|NCT00750308|Tadalafil|tadalafil|mesh-list
1948700|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
1948701|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1948702|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1948703|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948704|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948705|NCT00750308|Urological Agents|urological agents|mesh-ancestor
1948706|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1948707|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
1948708|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1948709|NCT00750737|Amphotericin B|amphotericin b|mesh-list
1948710|NCT00750737|Posaconazole|posaconazole|mesh-list
1948711|NCT00750737|Amebicides|amebicides|mesh-ancestor
1948712|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1948713|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1948714|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1948715|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1948716|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
1948717|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1948718|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1948719|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1948720|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948721|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948722|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1948723|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
1948724|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1948725|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948726|NCT00750815|Dexamethasone|dexamethasone|mesh-list
1948727|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
1948728|NCT00750815|Doxorubicin|doxorubicin|mesh-list
1948729|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1948730|NCT00750815|Bortezomib|bortezomib|mesh-list
1948731|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1948732|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
1948733|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948734|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1948735|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1948736|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
1948737|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948738|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948739|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1948740|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1948741|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
1948742|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
1948743|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948744|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1948745|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
1948746|NCT00750815|Hormones|hormones|mesh-ancestor
1948747|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1948748|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1948749|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1948750|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1948751|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1948752|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948753|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
1948754|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1948755|NCT00750867|Antibodies|antibodies|mesh-list
1948756|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
1948757|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1948758|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
1948759|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948760|NCT00750919|Mirtazapine|mirtazapine|mesh-list
1948761|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
1948762|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1948763|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1948764|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
1948765|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
1948766|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948767|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948768|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948769|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1948770|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1948771|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1948772|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1948773|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1948774|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1948775|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
1948776|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1948777|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1948778|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
1948779|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1948780|NCT00751023|Modafinil|modafinil|mesh-list
1948781|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1948782|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948783|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1948784|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1948785|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1948786|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948787|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
1948788|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948789|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1948790|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948791|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948792|NCT00751101|Nicotine|nicotine|mesh-list
1948793|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1948794|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
1948795|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948796|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948797|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1948798|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1948799|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
1948800|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948801|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948802|NCT00751114|Metformin|metformin|mesh-list
1948803|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
1948804|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1948805|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1948806|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948807|NCT00751114|Incretins|incretins|mesh-ancestor
1948808|NCT00751114|Hormones|hormones|mesh-ancestor
1948809|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1948810|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1948811|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
1948812|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948813|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948814|NCT00751179|Bromides|bromides|mesh-list
1948815|NCT00751179|Rocuronium|rocuronium|mesh-list
1948816|NCT00751179|Succinylcholine|succinylcholine|mesh-list
1948817|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
1948818|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1948819|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1948820|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1948821|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948822|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948823|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
1948824|NCT00751296|Lenalidomide|lenalidomide|mesh-list
1948825|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
1948826|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948827|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1948828|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1948829|NCT00751296|Growth Substances|growth substances|mesh-ancestor
1948830|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
1948831|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948832|NCT00751400|Naproxen|naproxen|mesh-list
1948833|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1948834|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1948835|NCT00751400|Analgesics|analgesics|mesh-ancestor
1948836|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
1948837|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948838|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948839|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1948840|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1948841|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
1948842|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1948843|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948844|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948845|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
1948846|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1948847|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1948848|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
1948849|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1948850|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1948851|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1948852|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948853|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948854|NCT00751777|Vaccines|vaccines|mesh-list
1948855|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
1948856|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948857|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1948858|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
1948859|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1948860|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
1948861|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1948862|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948863|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1948864|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1948865|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948866|NCT00751881|Teriflunomide|teriflunomide|mesh-list
1948867|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1948868|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1948869|NCT00751881|Analgesics|analgesics|mesh-ancestor
1948870|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
1948871|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1948872|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948873|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1948874|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1948875|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1948876|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
1948877|NCT00752102|Calcitriol|calcitriol|mesh-list
1948878|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1948879|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948880|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1948881|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1948882|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948883|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1948884|NCT00752102|Vitamins|vitamins|mesh-ancestor
1948885|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
1948886|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1948887|NCT00752206|Saracatinib|saracatinib|mesh-list
1948888|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948889|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948890|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948891|NCT00752219|Metronidazole|metronidazole|mesh-list
1948892|NCT00752219|Meropenem|meropenem|mesh-list
1948893|NCT00752219|Ceftazidime|ceftazidime|mesh-list
1948894|NCT00752219|Avibactam|avibactam|mesh-list
1948895|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1948896|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1948897|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1948898|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1948899|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1948900|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948901|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948902|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
1948903|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1948904|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
1948905|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948906|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
1948907|NCT00752557|Vitamin D|vitamin d|mesh-list
1948908|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
1948909|NCT00752557|Diphosphonates|diphosphonates|mesh-list
1948910|NCT00752557|Vitamins|vitamins|mesh-list
1948911|NCT00752557|Calcium|calcium|mesh-list
1948912|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
1948913|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948914|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1948915|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1948916|NCT00752622|Infliximab|infliximab|mesh-list
1948917|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
1948918|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1948919|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1948920|NCT00752726|Orlistat|orlistat|mesh-list
1948921|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948922|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948923|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1948924|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1948925|NCT00752856|Ritonavir|ritonavir|mesh-list
1948926|NCT00752856|Lopinavir|lopinavir|mesh-list
1948927|NCT00752856|Tenofovir|tenofovir|mesh-list
1948928|NCT00752856|Emtricitabine|emtricitabine|mesh-list
1948929|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
1948930|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1948931|NCT00752856|Efavirenz|efavirenz|mesh-list
1948932|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1948933|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1948934|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
1948935|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948936|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948937|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1948938|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1948939|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
1948940|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1948941|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1948942|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1948943|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1948944|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1948945|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1948946|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1948947|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1948948|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1948949|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1948950|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1948951|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1948952|NCT00752973|Malathion|malathion|mesh-list
1948953|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1948954|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1948955|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948956|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
1948957|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948958|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948959|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1948960|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1948961|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948962|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1948963|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1948964|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1948965|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948966|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
1948967|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1948968|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1948969|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1948970|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1948971|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1948972|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
1948973|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1948974|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
1948975|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948976|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1948977|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1948978|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
1948979|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1948980|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1948981|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1948982|NCT00753337|Cobalt|cobalt|mesh-list
1948983|NCT00753337|Trace Elements|trace elements|mesh-ancestor
1948984|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
1948985|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948986|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
1948987|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1948988|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
1948989|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1948990|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1948991|NCT00753506|Artemisinins|artemisinins|mesh-list
1948992|NCT00753506|Artemisinin|artemisinin|mesh-list
1948993|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
1948994|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1948995|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1948996|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1948997|NCT00753545|Olaparib|olaparib|mesh-list
1948998|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1948999|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949000|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949001|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949002|NCT00753636|Isradipine|isradipine|mesh-list
1949003|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1949004|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1949005|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1949006|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949007|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1949008|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949009|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
1949010|NCT00753675|Gemcitabine|gemcitabine|mesh-list
1949011|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1949012|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
1949013|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949014|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949015|NCT00753675|Antiviral Agents|antiviral agents|mesh-ancestor
1949016|NCT00753675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949017|NCT00753675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949018|NCT00753675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1949019|NCT00753675|Immunologic Factors|immunologic factors|mesh-ancestor
1949020|NCT00753675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949021|NCT00753714|Gemcitabine|gemcitabine|mesh-list
1949022|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1949023|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
1949024|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949025|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949026|NCT00753714|Antiviral Agents|antiviral agents|mesh-ancestor
1949027|NCT00753714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949028|NCT00753714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949029|NCT00753714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1949030|NCT00753714|Immunologic Factors|immunologic factors|mesh-ancestor
1949031|NCT00753714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949032|NCT00753896|Exenatide|exenatide|mesh-list
1949033|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1949034|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949035|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1949036|NCT00753896|Incretins|incretins|mesh-ancestor
1949037|NCT00753896|Hormones|hormones|mesh-ancestor
1949038|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1949039|NCT00753935|Aspirin|aspirin|mesh-list
1949040|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1949041|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1949042|NCT00753935|Analgesics|analgesics|mesh-ancestor
1949043|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
1949044|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949045|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949046|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1949047|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949048|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1949049|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1949050|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949051|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1949052|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1949053|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949054|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
1949055|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
1949056|NCT00754065|Dienogest|dienogest|mesh-list
1949057|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1949058|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1949059|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1949060|NCT00754065|Estradiol|estradiol|mesh-list
1949061|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1949062|NCT00754065|Estrogens|estrogens|mesh-ancestor
1949063|NCT00754065|Hormones|hormones|mesh-ancestor
1949064|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1949065|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949066|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1949067|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
1949068|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1949069|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1949070|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1949071|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1949072|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1949073|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
1949074|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1949075|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949076|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1949077|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1949078|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949079|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1949080|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1949081|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949082|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949083|NCT00754208|Methylphenidate|methylphenidate|mesh-list
1949084|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1949085|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949086|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1949087|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1949088|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1949089|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949090|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
1949091|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949092|NCT00754247|Vitamin E|vitamin e|mesh-list
1949093|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
1949094|NCT00754247|Vitamins|vitamins|mesh-ancestor
1949095|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
1949096|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949097|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1949098|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
1949099|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949100|NCT00754247|Protective Agents|protective agents|mesh-ancestor
1949101|NCT00754325|Dasatinib|dasatinib|mesh-list
1949102|NCT00754325|Fulvestrant|fulvestrant|mesh-list
1949103|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949104|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1949105|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949106|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949107|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1949108|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1949109|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1949110|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
1949111|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1949112|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949113|NCT00754338|Dipivefrin|dipivefrin|mesh-list
1949114|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1949115|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
1949116|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949117|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949118|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949119|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
1949120|NCT00754390|Calcium|calcium|mesh-list
1949121|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1949122|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949123|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1949124|NCT00754442|Teriparatide|teriparatide|mesh-list
1949125|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1949126|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949127|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1949128|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1949129|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949130|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1949131|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949132|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949133|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
1949134|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1949135|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
1949136|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949137|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949138|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1949139|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
1949140|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1949141|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1949142|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1949143|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
1949144|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949145|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949146|NCT00754572|Methotrexate|methotrexate|mesh-list
1949147|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1949148|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
1949149|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1949150|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949151|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1949152|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
1949153|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949154|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949155|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
1949156|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949157|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1949158|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1949159|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
1949160|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949161|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1949162|NCT00754624|Insulin|insulin|mesh-list
1949163|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1949164|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949165|NCT00754650|Bevacizumab|bevacizumab|mesh-list
1949166|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1949167|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949168|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1949169|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1949170|NCT00754650|Growth Substances|growth substances|mesh-ancestor
1949171|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949172|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
1949173|NCT00754845|Letrozole|letrozole|mesh-list
1949174|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949175|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1949176|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1949177|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949178|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949179|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1949180|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
1949181|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1949182|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949183|NCT00754923|Sorafenib|sorafenib|mesh-list
1949184|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949185|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1949186|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949187|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949188|NCT00754936|Citalopram|citalopram|mesh-list
1949189|NCT00754936|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1949190|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1949191|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1949192|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949193|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949194|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
1949195|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949196|NCT00754936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1949197|NCT00754936|Antidepressive Agents|antidepressive agents|mesh-ancestor
1949198|NCT00754936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1949199|NCT00755040|Cyclosporine|cyclosporine|mesh-list
1949200|NCT00755040|Cyclosporins|cyclosporins|mesh-list
1949201|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949202|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949203|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1949204|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
1949205|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949206|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
1949207|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949208|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
1949209|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949210|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1949211|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
1949212|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
1949213|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949214|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949215|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949216|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
1949217|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1949218|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1949219|NCT00755183|Testosterone|testosterone|mesh-list
1949220|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
1949221|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
1949222|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1949223|NCT00755183|Androgens|androgens|mesh-ancestor
1949224|NCT00755183|Hormones|hormones|mesh-ancestor
1949225|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1949226|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949227|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1949228|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949229|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
1949230|NCT00755274|Vaccines|vaccines|mesh-list
1949231|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
1949232|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949233|NCT00755417|Gabapentin|gabapentin|mesh-list
1949234|NCT00755417|Analgesics|analgesics|mesh-ancestor
1949235|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
1949236|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949237|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949238|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
1949239|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1949240|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1949241|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1949242|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1949243|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1949244|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1949245|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949246|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949247|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
1949248|NCT00755716|Topiramate|topiramate|mesh-list
1949249|NCT00755716|Nicotine|nicotine|mesh-list
1949250|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1949251|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
1949252|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949253|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949254|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1949255|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1949256|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
1949257|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949258|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949259|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
1949260|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1949261|NCT00755755|Iron|iron|mesh-list
1949262|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
1949263|NCT00755755|Trace Elements|trace elements|mesh-ancestor
1949264|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
1949265|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949266|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1949267|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
1949268|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1949269|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1949270|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1949271|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1949272|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1949273|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1949274|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949275|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949276|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949277|NCT00755807|Analgesics|analgesics|mesh-ancestor
1949278|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
1949279|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949280|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
1949281|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1949282|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
1949283|NCT00755846|Alogliptin|alogliptin|mesh-list
1949284|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1949285|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949286|NCT00755846|Incretins|incretins|mesh-ancestor
1949287|NCT00755846|Hormones|hormones|mesh-ancestor
1949288|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1949289|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1949290|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
1949291|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949292|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949293|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
1949294|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
1949295|NCT00755911|Coagulants|coagulants|mesh-ancestor
1949296|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1949297|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
1949298|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1949299|NCT00756106|Temozolomide|temozolomide|mesh-list
1949300|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1949301|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
1949302|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949303|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949304|NCT00756236|Metoprolol|metoprolol|mesh-list
1949305|NCT00756236|Esmolol|esmolol|mesh-list
1949306|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1949307|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1949308|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
1949309|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
1949310|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949311|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949312|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1949313|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1949314|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1949315|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
1949316|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949317|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949318|NCT00756275|Nicotine|nicotine|mesh-list
1949319|NCT00756275|Varenicline|varenicline|mesh-list
1949320|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1949321|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
1949322|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949323|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949324|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1949325|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1949326|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
1949327|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949328|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949329|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
1949330|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1949331|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949332|NCT00756444|Panitumumab|panitumumab|mesh-list
1949333|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949334|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1949335|NCT00756470|Paclitaxel|paclitaxel|mesh-list
1949336|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
1949337|NCT00756470|Fluorouracil|fluorouracil|mesh-list
1949338|NCT00756470|Epirubicin|epirubicin|mesh-list
1949339|NCT00756470|Lapatinib|lapatinib|mesh-list
1949340|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1949341|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949342|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
1949343|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
1949344|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
1949345|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949346|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1949347|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
1949348|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949349|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949350|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1949351|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
1949352|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1949353|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
1949354|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1949355|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1949356|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1949357|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1949358|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949359|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1949360|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
1949361|NCT00756548|Laxatives|laxatives|mesh-ancestor
1949362|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1949363|NCT00756600|Anesthetics|anesthetics|mesh-list
1949364|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1949365|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949366|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1949367|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
1949368|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1949369|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1949370|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1949371|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1949372|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
1949373|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949374|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949375|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1949376|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1949377|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
1949378|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949379|NCT00756886|Atorvastatin|atorvastatin|mesh-list
1949380|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1949381|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1949382|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
1949383|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949384|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1949385|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1949386|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949387|NCT00756938|Losartan|losartan|mesh-list
1949388|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1949389|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1949390|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1949391|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1949392|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949393|NCT00756964|Rasburicase|rasburicase|mesh-list
1949394|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
1949395|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949396|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
1949397|NCT00756977|Laxatives|laxatives|mesh-ancestor
1949398|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1949399|NCT00757172|Docetaxel|docetaxel|mesh-list
1949400|NCT00757172|Panitumumab|panitumumab|mesh-list
1949401|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949402|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
1949403|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
1949404|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
1949405|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949406|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1949407|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1949408|NCT00757237|Tobramycin|tobramycin|mesh-list
1949409|NCT00757237|Aztreonam|aztreonam|mesh-list
1949410|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1949411|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1949412|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949413|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
1949414|NCT00757588|Insulin|insulin|mesh-list
1949415|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1949416|NCT00757588|Saxagliptin|saxagliptin|mesh-list
1949417|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1949418|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949419|NCT00757588|Incretins|incretins|mesh-ancestor
1949420|NCT00757588|Hormones|hormones|mesh-ancestor
1949421|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1949422|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1949423|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
1949424|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949425|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949426|NCT00757627|Etoricoxib|etoricoxib|mesh-list
1949427|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1949428|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1949429|NCT00757627|Analgesics|analgesics|mesh-ancestor
1949430|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
1949431|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949432|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949433|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1949434|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949435|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1949436|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1949437|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949438|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949439|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1949440|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1949441|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1949442|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1949443|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949444|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1949445|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1949446|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1949447|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
1949448|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949449|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949450|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1949451|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1949452|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
1949453|NCT00757783|Ritonavir|ritonavir|mesh-list
1949454|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1949455|NCT00757783|Darunavir|darunavir|mesh-list
1949456|NCT00757783|Tenofovir|tenofovir|mesh-list
1949457|NCT00757783|Emtricitabine|emtricitabine|mesh-list
1949458|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1949459|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1949460|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
1949461|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949462|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949463|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1949464|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1949465|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
1949466|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949467|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1949468|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1949469|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1949470|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1949471|NCT00757822|Dronabinol|dronabinol|mesh-list
1949472|NCT00757822|Ondansetron|ondansetron|mesh-list
1949473|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
1949474|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
1949475|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949476|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949477|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1949478|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
1949479|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
1949480|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1949481|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
1949482|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949483|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949484|NCT00757822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1949485|NCT00757822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1949486|NCT00757822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1949487|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1949488|NCT00757822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1949489|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
1949490|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1949491|NCT00757822|Analgesics|analgesics|mesh-ancestor
1949492|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
1949493|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1949494|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1949495|NCT00757822|Hormones|hormones|mesh-ancestor
1949496|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1949497|NCT00758043|Ribavirin|ribavirin|mesh-list
1949498|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1949499|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
1949500|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949501|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
1949502|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949503|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1949504|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1949505|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949506|NCT00758069|Incretins|incretins|mesh-ancestor
1949507|NCT00758069|Hormones|hormones|mesh-ancestor
1949508|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1949509|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1949510|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
1949511|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949512|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949513|NCT00758160|Methylphenidate|methylphenidate|mesh-list
1949514|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1949515|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949516|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1949517|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1949518|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1949519|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949520|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
1949521|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949522|NCT00758264|Vaccines|vaccines|mesh-list
1949523|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1949524|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
1949525|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949526|NCT00758290|Triclosan|triclosan|mesh-list
1949527|NCT00758290|Fluorides|fluorides|mesh-list
1949528|NCT00758290|Cariostatic Agents|cariostatic agents|mesh-ancestor
1949529|NCT00758290|Protective Agents|protective agents|mesh-ancestor
1949530|NCT00758290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949531|NCT00758290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1949532|NCT00758290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949533|NCT00758290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1949534|NCT00758290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1949535|NCT00758290|Antimetabolites|antimetabolites|mesh-ancestor
1949536|NCT00758290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949537|NCT00758290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1949538|NCT00758342|Travoprost|travoprost|mesh-list
1949539|NCT00758342|Brinzolamide|brinzolamide|mesh-list
1949540|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1949541|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1949542|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949543|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949544|NCT00758394|Listerine|listerine|mesh-list
1949545|NCT00758394|Triclosan|triclosan|mesh-list
1949546|NCT00758394|Fluorides|fluorides|mesh-list
1949547|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
1949548|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
1949549|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
1949550|NCT00758394|Protective Agents|protective agents|mesh-ancestor
1949551|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949552|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1949553|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949554|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1949555|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1949556|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
1949557|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949558|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1949559|NCT00758420|Polidocanol|polidocanol|mesh-list
1949560|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
1949561|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1949562|NCT00758498|Modafinil|modafinil|mesh-list
1949563|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1949564|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949565|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1949566|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1949567|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1949568|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949569|NCT00758524|Eplerenone|eplerenone|mesh-list
1949570|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1949571|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
1949572|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1949573|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949574|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1949575|NCT00758524|Diuretics|diuretics|mesh-ancestor
1949576|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
1949577|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1949578|NCT00758563|Triclosan|triclosan|mesh-list
1949579|NCT00758563|Fluorides|fluorides|mesh-list
1949580|NCT00758563|Cariostatic Agents|cariostatic agents|mesh-ancestor
1949581|NCT00758563|Protective Agents|protective agents|mesh-ancestor
1949582|NCT00758563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949583|NCT00758563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1949584|NCT00758563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949585|NCT00758563|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1949586|NCT00758563|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1949587|NCT00758563|Antimetabolites|antimetabolites|mesh-ancestor
1949588|NCT00758563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949589|NCT00758563|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1949590|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
1949591|NCT00758602|Tacrolimus|tacrolimus|mesh-list
1949592|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1949593|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
1949594|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949595|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1949596|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949597|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949598|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1949599|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949600|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1949601|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
1949602|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1949603|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949604|NCT00758667|Mesna|mesna|mesh-list
1949605|NCT00758667|Protective Agents|protective agents|mesh-ancestor
1949606|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949607|NCT00758784|Bromfenac|bromfenac|mesh-list
1949608|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1949609|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1949610|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1949611|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1949612|NCT00758784|Analgesics|analgesics|mesh-ancestor
1949613|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
1949614|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949615|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949616|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1949617|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949618|NCT00758836|Acetaminophen|acetaminophen|mesh-list
1949619|NCT00758836|Ibuprofen|ibuprofen|mesh-list
1949620|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1949621|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1949622|NCT00758836|Analgesics|analgesics|mesh-ancestor
1949623|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
1949624|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949625|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949626|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1949627|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949628|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1949629|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949630|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949631|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
1949632|NCT00759031|Listerine|listerine|mesh-list
1949633|NCT00759031|Triclosan|triclosan|mesh-list
1949634|NCT00759031|Fluorides|fluorides|mesh-list
1949635|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
1949636|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
1949637|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
1949638|NCT00759031|Protective Agents|protective agents|mesh-ancestor
1949639|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949640|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1949641|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949642|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1949643|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1949644|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
1949645|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949646|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1949647|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1949648|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
1949649|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949650|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
1949651|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1949652|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1949653|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1949654|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1949655|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949656|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1949657|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1949658|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949659|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949660|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949661|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1949662|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
1949663|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1949664|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949665|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1949666|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1949667|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1949668|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
1949669|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1949670|NCT00759187|Triclosan|triclosan|mesh-list
1949671|NCT00759187|Fluorides|fluorides|mesh-list
1949672|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
1949673|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
1949674|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
1949675|NCT00759187|Protective Agents|protective agents|mesh-ancestor
1949676|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949677|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1949678|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949679|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
1949680|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
1949681|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1949682|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1949683|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
1949684|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949685|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1949686|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
1949687|NCT00759330|Analgesics|analgesics|mesh-ancestor
1949688|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
1949689|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949690|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949691|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1949692|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1949693|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1949694|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949695|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1949696|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949697|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949698|NCT00759356|Morphine|morphine|mesh-list
1949699|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1949700|NCT00759356|Narcotics|narcotics|mesh-ancestor
1949701|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1949702|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949703|NCT00759356|Analgesics|analgesics|mesh-ancestor
1949704|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
1949705|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949706|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
1949707|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1949708|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1949709|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949710|NCT00759473|Cycloserine|cycloserine|mesh-list
1949711|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1949712|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949713|NCT00759473|Renal Agents|renal agents|mesh-ancestor
1949714|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1949715|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
1949716|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1949717|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
1949718|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949719|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
1949720|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1949721|NCT00759564|Lactams|lactams|mesh-list
1949722|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1949723|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949724|NCT00759603|Rituximab|rituximab|mesh-list
1949725|NCT00759603|Lenalidomide|lenalidomide|mesh-list
1949726|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1949727|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949728|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
1949729|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949730|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949731|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1949732|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1949733|NCT00759603|Growth Substances|growth substances|mesh-ancestor
1949734|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
1949735|NCT00759642|Lapatinib|lapatinib|mesh-list
1949736|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949737|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1949738|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209028|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
1949739|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949740|NCT00759655|Factor VIII|factor viii|mesh-list
1949741|NCT00759655|Coagulants|coagulants|mesh-ancestor
1949742|NCT00759681|Thrombin|thrombin|mesh-list
1949743|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
1949744|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
1949745|NCT00759681|Coagulants|coagulants|mesh-ancestor
1949746|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
1949747|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949748|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949749|NCT00759759|Morphine|morphine|mesh-list
1949750|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1949751|NCT00759759|Narcotics|narcotics|mesh-ancestor
1949752|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1949753|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949754|NCT00759759|Analgesics|analgesics|mesh-ancestor
1949755|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
1949756|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949757|NCT00759772|Teriparatide|teriparatide|mesh-list
1949758|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1949759|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949760|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1949761|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1949762|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
1949763|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949764|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
1949765|NCT00759798|Rituximab|rituximab|mesh-list
1949766|NCT00759798|Fludarabine|fludarabine|mesh-list
1949767|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1949768|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
1949769|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949770|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949771|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1949772|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
1949773|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949774|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949775|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1949776|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1949777|NCT00759811|Methotrexate|methotrexate|mesh-list
1949778|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1949779|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
1949780|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1949781|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949782|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1949783|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
1949784|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949785|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949786|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
1949787|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949788|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1949789|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1949790|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
1949791|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949792|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1949793|NCT00759902|Morphine|morphine|mesh-list
1949794|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1949795|NCT00759902|Narcotics|narcotics|mesh-ancestor
1949796|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1949797|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949798|NCT00759902|Analgesics|analgesics|mesh-ancestor
1949799|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
1949800|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949801|NCT00759915|Morphine|morphine|mesh-list
1949802|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1949803|NCT00759915|Narcotics|narcotics|mesh-ancestor
1949804|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1949805|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949806|NCT00759915|Analgesics|analgesics|mesh-ancestor
1949807|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
1949808|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949809|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1949810|NCT00759941|Latanoprost|latanoprost|mesh-list
1949811|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1949812|NCT00759941|Brinzolamide|brinzolamide|mesh-list
1949813|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1949814|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949815|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949816|NCT00759954|Morphine|morphine|mesh-list
1949817|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1949818|NCT00759954|Narcotics|narcotics|mesh-ancestor
1949819|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1949820|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949821|NCT00759954|Analgesics|analgesics|mesh-ancestor
1949822|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
1949823|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949824|NCT00760006|Ampicillin|ampicillin|mesh-list
1949825|NCT00760006|Sulbactam|sulbactam|mesh-list
1949826|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1949827|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1949828|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949829|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1949830|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949831|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949832|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
1949833|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1949834|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1949835|NCT00760019|Analgesics|analgesics|mesh-ancestor
1949836|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
1949837|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949838|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949839|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1949840|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949841|NCT00760084|Decitabine|decitabine|mesh-list
1949842|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1949843|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
1949844|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949845|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949846|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949847|NCT00760214|Ramipril|ramipril|mesh-list
1949848|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1949849|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1949850|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
1949851|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949852|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949853|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1949854|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1949855|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1949856|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1949857|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1949858|NCT00760266|Diuretics|diuretics|mesh-ancestor
1949859|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
1949860|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949861|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1949862|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1949863|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949864|NCT00760435|Infliximab|infliximab|mesh-list
1949865|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
1949866|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1949867|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949868|NCT00760474|Pregabalin|pregabalin|mesh-list
1949869|NCT00760474|Analgesics|analgesics|mesh-ancestor
1949870|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
1949871|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949872|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949873|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
1949874|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1949875|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1949876|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949877|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1949878|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1949879|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1949880|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1949881|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1949882|NCT00760578|Pioglitazone|pioglitazone|mesh-list
1949883|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1949884|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949885|NCT00760669|Methotrexate|methotrexate|mesh-list
1949886|NCT00760669|Infliximab|infliximab|mesh-list
1949887|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1949888|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
1949889|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1949890|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949891|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1949892|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
1949893|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949894|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949895|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
1949896|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949897|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1949898|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1949899|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
1949900|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1949901|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1949902|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1949903|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1949904|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1949905|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1949906|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1949907|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949908|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
1949909|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949910|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949911|NCT00760838|Azithromycin|azithromycin|mesh-list
1949912|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1949913|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949914|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
1949915|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949916|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1949917|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949918|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949919|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1949920|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1949921|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1949922|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1949923|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949924|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949925|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
1949926|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949927|NCT00761085|Morphine|morphine|mesh-list
1949928|NCT00761085|Methadone|methadone|mesh-list
1949929|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1949930|NCT00761085|Narcotics|narcotics|mesh-ancestor
1949931|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1949932|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949933|NCT00761085|Analgesics|analgesics|mesh-ancestor
1949934|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
1949935|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949936|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
1949937|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
1949938|NCT00761137|Tropicamide|tropicamide|mesh-list
1949939|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
1949940|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
1949941|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949942|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949943|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1949944|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1949945|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
1949946|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949947|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949948|NCT00761150|Acetaminophen|acetaminophen|mesh-list
1949949|NCT00761150|Hydrocodone|hydrocodone|mesh-list
1949950|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1949951|NCT00761150|Analgesics|analgesics|mesh-ancestor
1949952|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
1949953|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1949954|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949955|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
1949956|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1949957|NCT00761150|Narcotics|narcotics|mesh-ancestor
1949958|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1949959|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
1949960|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
1949961|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1949962|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1949963|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1949964|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1949965|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949966|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1949967|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1949968|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1949969|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
1949970|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1949971|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949972|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1949973|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1949974|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
1949975|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1949976|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
1949977|NCT00761202|Glycerol|glycerol|mesh-list
1949978|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1949979|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
1949980|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1949981|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
1949982|NCT00761202|Protective Agents|protective agents|mesh-ancestor
1949983|NCT00761202|Laxatives|laxatives|mesh-ancestor
1949984|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1949985|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1949986|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
1949987|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1949988|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949989|NCT00761267|Fluconazole|fluconazole|mesh-list
1949990|NCT00761267|Anidulafungin|anidulafungin|mesh-list
1949991|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
1949992|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1949993|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1949994|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1949995|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1949996|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1949997|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1949998|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
1949999|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1950000|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950001|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1950002|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1950003|NCT00761280|Temozolomide|temozolomide|mesh-list
1950004|NCT00761280|Carmustine|carmustine|mesh-list
1950005|NCT00761280|Lomustine|lomustine|mesh-list
1950006|NCT00761280|Trabedersen|trabedersen|mesh-list
1950007|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1950008|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
1950009|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950010|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950011|NCT00761306|Vortioxetine|vortioxetine|mesh-list
1950012|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
1950013|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1950014|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1950015|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1950016|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1950017|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950018|NCT00761306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1950019|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1950020|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1950021|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950022|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950023|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
1950024|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1950025|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1950026|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1950027|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1950028|NCT00761319|Travoprost|travoprost|mesh-list
1950029|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1950030|NCT00761319|Latanoprost|latanoprost|mesh-list
1950031|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1950032|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1950033|NCT00761345|Gemcitabine|gemcitabine|mesh-list
1950034|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1950035|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1950036|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
1950037|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950038|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950039|NCT00761345|Antiviral Agents|antiviral agents|mesh-ancestor
1950040|NCT00761345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950041|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950042|NCT00761345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1950043|NCT00761345|Immunologic Factors|immunologic factors|mesh-ancestor
1950044|NCT00761345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950045|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1950046|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1950047|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
1950048|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950049|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1950050|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1950051|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950052|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950053|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950054|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1950055|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1950056|NCT00761514|Adalimumab|adalimumab|mesh-list
1950057|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1950058|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1950059|NCT00761527|Desloratadine|desloratadine|mesh-list
1950060|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1950061|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
1950062|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950063|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950064|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950065|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1950066|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1950067|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
1950068|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
1950069|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1950070|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1950071|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1950072|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1950073|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950074|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1950075|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1950076|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1950077|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
1950078|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950079|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950080|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1950081|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1950082|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
1950083|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
1950084|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1950085|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1950086|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1950087|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1950088|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950089|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
1950090|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950091|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950092|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1950093|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950094|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1950095|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1950096|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1950097|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1950098|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950099|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1950100|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1950101|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1950102|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
1950103|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950104|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950105|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1950106|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1950107|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
1950108|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1950109|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
1950110|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950111|NCT00761735|Ribavirin|ribavirin|mesh-list
1950112|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1950113|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
1950114|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950115|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
1950116|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950117|NCT00761774|Brivaracetam|brivaracetam|mesh-list
1950118|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
1950119|NCT00761891|Aspirin|aspirin|mesh-list
1950120|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1950121|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1950122|NCT00761891|Analgesics|analgesics|mesh-ancestor
1950123|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
1950124|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950125|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950126|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1950127|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1950128|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1950129|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1950130|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950131|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1950132|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1950133|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950134|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
1950135|NCT00761930|Listerine|listerine|mesh-list
1950136|NCT00761930|Triclosan|triclosan|mesh-list
1950137|NCT00761930|Fluorides|fluorides|mesh-list
1950138|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
1950139|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
1950140|NCT00761930|Protective Agents|protective agents|mesh-ancestor
1950141|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950142|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1950143|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950144|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1950145|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950146|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
1950147|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950148|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950149|NCT00762034|Paclitaxel|paclitaxel|mesh-list
1950150|NCT00762034|Bevacizumab|bevacizumab|mesh-list
1950151|NCT00762034|Carboplatin|carboplatin|mesh-list
1950152|NCT00762034|Pemetrexed|pemetrexed|mesh-list
1950153|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1950154|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950155|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
1950156|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
1950157|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
1950158|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950159|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1950160|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1950161|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1950162|NCT00762034|Growth Substances|growth substances|mesh-ancestor
1950163|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950164|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
1950165|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950166|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1950167|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1950168|NCT00762073|Budesonide|budesonide|mesh-list
1950169|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1950170|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1950171|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
1950172|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950173|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950174|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1950175|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
1950176|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
1950177|NCT00762073|Hormones|hormones|mesh-ancestor
1950178|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1950179|NCT00762164|Simvastatin|simvastatin|mesh-list
1950180|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
1950181|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1950182|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950183|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
1950184|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950185|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950186|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1950187|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950188|NCT00762177|Triclosan|triclosan|mesh-list
1950189|NCT00762177|Fluorides|fluorides|mesh-list
1950190|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
1950191|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
1950192|NCT00762177|Protective Agents|protective agents|mesh-ancestor
1950193|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950194|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1950195|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950196|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1950197|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950198|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
1950199|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950200|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950201|NCT00762229|Ezetimibe|ezetimibe|mesh-list
1950202|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1950203|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950204|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
1950205|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950206|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950207|NCT00762320|Ritonavir|ritonavir|mesh-list
1950208|NCT00762320|Lopinavir|lopinavir|mesh-list
1950209|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1950210|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1950211|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
1950212|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950213|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950214|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1950215|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1950216|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
1950217|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950218|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1950219|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1950220|NCT00762359|Lansoprazole|lansoprazole|mesh-list
1950221|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
1950222|NCT00762359|Gefarnate|gefarnate|mesh-list
1950223|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1950224|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1950225|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1950226|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950227|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950228|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
1950229|NCT00762372|Sevoflurane|sevoflurane|mesh-list
1950230|NCT00762372|Desflurane|desflurane|mesh-list
1950231|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1950232|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1950233|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
1950234|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
1950235|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1950236|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950237|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1950238|NCT00762372|Analgesics|analgesics|mesh-ancestor
1950239|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
1950240|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950241|NCT00762450|Triclosan|triclosan|mesh-list
1950242|NCT00762450|Fluorides|fluorides|mesh-list
1950243|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
1950244|NCT00762450|Protective Agents|protective agents|mesh-ancestor
1950245|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950246|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1950247|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950248|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1950249|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950250|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
1950251|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950252|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950253|NCT00762463|Celecoxib|celecoxib|mesh-list
1950254|NCT00762463|Diclofenac|diclofenac|mesh-list
1950255|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1950256|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1950257|NCT00762463|Analgesics|analgesics|mesh-ancestor
1950258|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
1950259|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950260|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950261|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1950262|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1950263|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1950264|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1950265|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950266|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950267|NCT00762515|Triclosan|triclosan|mesh-list
1950268|NCT00762515|Fluorides|fluorides|mesh-list
1950269|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
1950270|NCT00762515|Protective Agents|protective agents|mesh-ancestor
1950271|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950272|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1950273|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950274|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1950275|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950276|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
1950277|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950278|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950279|NCT00762528|Triclosan|triclosan|mesh-list
1950280|NCT00762528|Fluorides|fluorides|mesh-list
1950281|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
1950282|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
1950283|NCT00762528|Protective Agents|protective agents|mesh-ancestor
1950284|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950285|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1950286|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950287|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1950288|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950289|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
1950290|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950291|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950292|NCT00762619|Triclosan|triclosan|mesh-list
1950293|NCT00762619|Fluorides|fluorides|mesh-list
1950294|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
1950295|NCT00762619|Protective Agents|protective agents|mesh-ancestor
1950296|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950297|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1950298|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950299|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1950300|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950301|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
1950302|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950303|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950304|NCT00762645|Travoprost|travoprost|mesh-list
1950305|NCT00762645|Pilocarpine|pilocarpine|mesh-list
1950306|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1950307|NCT00762645|Miotics|miotics|mesh-ancestor
1950308|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
1950309|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950310|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950311|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
1950312|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1950313|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
1950314|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950315|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950316|NCT00762710|Prazosin|prazosin|mesh-list
1950317|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1950318|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1950319|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1950320|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1950321|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
1950322|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950323|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950324|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950325|NCT00762762|Triclosan|triclosan|mesh-list
1950326|NCT00762762|Fluorides|fluorides|mesh-list
1950327|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
1950328|NCT00762762|Protective Agents|protective agents|mesh-ancestor
1950329|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950330|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1950331|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950332|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1950333|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950334|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
1950335|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950336|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950337|NCT00762853|Triclosan|triclosan|mesh-list
1950338|NCT00762853|Fluorides|fluorides|mesh-list
1950339|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
1950340|NCT00762853|Protective Agents|protective agents|mesh-ancestor
1950341|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950342|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1950343|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950344|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1950345|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950346|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
1950347|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950348|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950349|NCT00762892|Tenofovir|tenofovir|mesh-list
1950350|NCT00762892|Emtricitabine|emtricitabine|mesh-list
1950351|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
1950352|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1950353|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1950354|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
1950355|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950356|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1950357|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1950358|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950359|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950360|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1950361|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1950362|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1950363|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1950364|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1950365|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1950366|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
1950367|NCT00763035|Dobutamine|dobutamine|mesh-list
1950368|NCT00763035|Regadenoson|regadenoson|mesh-list
1950369|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1950370|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
1950371|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
1950372|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950373|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950374|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1950375|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1950376|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1950377|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
1950378|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950379|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950380|NCT00763035|Protective Agents|protective agents|mesh-ancestor
1950381|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1950382|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1950383|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
1950384|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
1950385|NCT00763048|Triclosan|triclosan|mesh-list
1950386|NCT00763048|Fluorides|fluorides|mesh-list
1950387|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
1950388|NCT00763048|Protective Agents|protective agents|mesh-ancestor
1950389|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950390|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1950391|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950392|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1950393|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950394|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
1950395|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950396|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950397|NCT00763061|Timolol|timolol|mesh-list
1950398|NCT00763061|Travoprost|travoprost|mesh-list
1950399|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1950400|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1950401|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1950402|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1950403|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
1950404|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950405|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950406|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950407|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1950408|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1950409|NCT00763139|Pioglitazone|pioglitazone|mesh-list
1950410|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1950411|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950412|NCT00763256|Triclosan|triclosan|mesh-list
1950413|NCT00763256|Fluorides|fluorides|mesh-list
1950414|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
1950415|NCT00763256|Protective Agents|protective agents|mesh-ancestor
1950416|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950417|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1950418|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950419|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1950420|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950421|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
1950422|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950423|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950424|NCT00763269|Silicon|silicon|mesh-list
1950425|NCT00763269|Triclosan|triclosan|mesh-list
1950426|NCT00763269|Fluorides|fluorides|mesh-list
1950427|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
1950428|NCT00763269|Protective Agents|protective agents|mesh-ancestor
1950429|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950430|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1950431|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950432|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1950433|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950434|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
1950435|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950436|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950437|NCT00763269|Trace Elements|trace elements|mesh-ancestor
1950438|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
1950439|NCT00763321|Acetaminophen|acetaminophen|mesh-list
1950440|NCT00763321|Hydrocodone|hydrocodone|mesh-list
1950441|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1950442|NCT00763321|Analgesics|analgesics|mesh-ancestor
1950443|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
1950444|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950445|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950446|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
1950447|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1950448|NCT00763321|Narcotics|narcotics|mesh-ancestor
1950449|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1950450|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
1950451|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
1950452|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
1950453|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1950454|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
1950455|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950456|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
1950457|NCT00763360|Protective Agents|protective agents|mesh-ancestor
1950458|NCT00763412|Repaglinide|repaglinide|mesh-list
1950459|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1950460|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950461|NCT00763451|Metformin|metformin|mesh-list
1950462|NCT00763451|Lixisenatide|lixisenatide|mesh-list
1950463|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1950464|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950465|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
1950466|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1950467|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950468|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1950469|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
1950470|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1950471|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950472|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950473|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950474|NCT00763815|Metformin|metformin|mesh-list
1950475|NCT00763815|Pioglitazone|pioglitazone|mesh-list
1950476|NCT00763815|Lixisenatide|lixisenatide|mesh-list
1950477|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1950478|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950479|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
1950480|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
1950481|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1950482|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1950483|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950484|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950485|NCT00763867|Urological Agents|urological agents|mesh-ancestor
1950486|NCT00763958|Buprenorphine|buprenorphine|mesh-list
1950487|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1950488|NCT00763958|Narcotics|narcotics|mesh-ancestor
1950489|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1950490|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950491|NCT00763958|Analgesics|analgesics|mesh-ancestor
1950492|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
1950493|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950494|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1950495|NCT00763971|Methylphenidate|methylphenidate|mesh-list
1950496|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1950497|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1950498|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950499|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1950500|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1950501|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1950502|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950503|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
1950504|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950505|NCT00764309|Dasatinib|dasatinib|mesh-list
1950506|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950507|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1950508|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950509|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950510|NCT00764322|Tamoxifen|tamoxifen|mesh-list
1950511|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1950512|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
1950513|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1950514|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950515|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1950516|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950517|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1950518|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1950519|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1950520|NCT00764361|Doxycycline|doxycycline|mesh-list
1950521|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1950522|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950523|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
1950524|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1950525|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1950526|NCT00764465|Ritonavir|ritonavir|mesh-list
1950527|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
1950528|NCT00764465|Maraviroc|maraviroc|mesh-list
1950529|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1950530|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1950531|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
1950532|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950533|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950534|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1950535|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1950536|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
1950537|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950538|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1950539|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1950540|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1950541|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1950542|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1950543|NCT00764478|Asenapine|asenapine|mesh-list
1950544|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1950545|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1950546|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1950547|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950548|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1950549|NCT00764517|Rituximab|rituximab|mesh-list
1950550|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1950551|NCT00764517|Vorinostat|vorinostat|mesh-list
1950552|NCT00764517|Cladribine|cladribine|mesh-list
1950553|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
1950554|NCT00764517|Antibodies|antibodies|mesh-list
1950555|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
1950556|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1950557|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
1950558|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950559|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950560|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1950561|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1950562|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950563|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950564|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1950565|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1950566|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
1950567|NCT00764738|Ranibizumab|ranibizumab|mesh-list
1950568|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1950569|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1950570|NCT00764738|Growth Substances|growth substances|mesh-ancestor
1950571|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950572|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
1950573|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950574|NCT00764751|Calcipotriene|calcipotriene|mesh-list
1950575|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
1950576|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1950577|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1950578|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950579|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1950580|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1950581|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1950582|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950583|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
1950584|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950585|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
1950586|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
1950587|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1950588|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
1950589|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1950590|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950591|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1950592|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1950593|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1950594|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1950595|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1950596|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
1950597|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1950598|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1950599|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
1950600|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1950601|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1950602|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
1950603|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950604|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1950605|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1950606|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950607|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950608|NCT00765063|Dalteparin|dalteparin|mesh-list
1950609|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
1950610|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1950611|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1950612|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950613|NCT00765102|Bortezomib|bortezomib|mesh-list
1950614|NCT00765102|Romidepsin|romidepsin|mesh-list
1950615|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950616|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1950617|NCT00765128|Ketorolac|ketorolac|mesh-list
1950618|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1950619|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1950620|NCT00765128|Analgesics|analgesics|mesh-ancestor
1950621|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
1950622|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950623|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950624|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1950625|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1950626|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1950627|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950628|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950629|NCT00765206|Omeprazole|omeprazole|mesh-list
1950630|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1950631|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1950632|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1950633|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950634|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950635|NCT00765232|Ketorolac|ketorolac|mesh-list
1950636|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1950637|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1950638|NCT00765232|Analgesics|analgesics|mesh-ancestor
1950639|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
1950640|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950641|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950642|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1950643|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1950644|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1950645|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950646|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950647|NCT00765245|Rituximab|rituximab|mesh-list
1950648|NCT00765245|Lenalidomide|lenalidomide|mesh-list
1950649|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1950650|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950651|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
1950652|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950653|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1950654|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1950655|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1950656|NCT00765245|Growth Substances|growth substances|mesh-ancestor
1950657|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
1950658|NCT00765336|Minocycline|minocycline|mesh-list
1950659|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1950660|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950661|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
1950662|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1950663|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1950664|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1950665|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1950666|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950667|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
1950668|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950669|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950670|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1950671|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950672|NCT00765648|Labetalol|labetalol|mesh-list
1950673|NCT00765648|Nicardipine|nicardipine|mesh-list
1950674|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1950675|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1950676|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
1950677|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950678|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950679|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950680|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1950681|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
1950682|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
1950683|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950684|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1950685|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1950686|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1950687|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1950688|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1950689|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
1950690|NCT00765661|Tacrolimus|tacrolimus|mesh-list
1950691|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1950692|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
1950693|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950694|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1950695|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950696|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950697|NCT00765674|Amlodipine|amlodipine|mesh-list
1950698|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1950699|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1950700|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1950701|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1950702|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950703|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1950704|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950705|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
1950706|NCT00765674|Diuretics|diuretics|mesh-ancestor
1950707|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
1950708|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1950709|NCT00765726|Factor VIII|factor viii|mesh-list
1950710|NCT00765726|Coagulants|coagulants|mesh-ancestor
1950711|NCT00765817|Exenatide|exenatide|mesh-list
1950712|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1950713|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950714|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1950715|NCT00765817|Incretins|incretins|mesh-ancestor
1950716|NCT00765817|Hormones|hormones|mesh-ancestor
1950717|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1950718|NCT00765856|Oxymorphone|oxymorphone|mesh-list
1950719|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1950720|NCT00765856|Narcotics|narcotics|mesh-ancestor
1950721|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1950722|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950723|NCT00765856|Analgesics|analgesics|mesh-ancestor
1950724|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
1950725|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950726|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1950727|NCT00765882|Linaclotide|linaclotide|mesh-list
1950728|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
1950729|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
1950730|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950731|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1950732|NCT00765895|Nortriptyline|nortriptyline|mesh-list
1950733|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1950734|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
1950735|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1950736|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1950737|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1950738|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1950739|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950740|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
1950741|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950742|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950743|NCT00765947|Amlodipine|amlodipine|mesh-list
1950744|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1950745|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1950746|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1950747|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1950748|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950749|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1950750|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950751|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
1950752|NCT00765947|Diuretics|diuretics|mesh-ancestor
1950753|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
1950754|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1950755|NCT00765999|Linaclotide|linaclotide|mesh-list
1950756|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
1950757|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
1950758|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950759|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1950760|NCT00766038|Hormones|hormones|mesh-list
1950761|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1950762|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950763|NCT00766116|Azacitidine|azacitidine|mesh-list
1950764|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
1950765|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1950766|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
1950767|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950768|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950769|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950770|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1950771|NCT00766142|Leucovorin|leucovorin|mesh-list
1950772|NCT00766142|Fluorouracil|fluorouracil|mesh-list
1950773|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
1950774|NCT00766142|Cetuximab|cetuximab|mesh-list
1950775|NCT00766142|Calcium|calcium|mesh-list
1950776|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
1950777|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1950778|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950779|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
1950780|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950781|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1950782|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950783|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1950784|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
1950785|NCT00766142|Antidotes|antidotes|mesh-ancestor
1950786|NCT00766142|Protective Agents|protective agents|mesh-ancestor
1950787|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
1950788|NCT00766142|Vitamins|vitamins|mesh-ancestor
1950789|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
1950790|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1950791|NCT00766363|Rivastigmine|rivastigmine|mesh-list
1950792|NCT00766363|Donepezil|donepezil|mesh-list
1950793|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1950794|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950795|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950796|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
1950797|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950798|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950799|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
1950800|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1950801|NCT00766363|Protective Agents|protective agents|mesh-ancestor
1950802|NCT00766467|Modafinil|modafinil|mesh-list
1950803|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1950804|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950805|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1950806|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1950807|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1950808|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950809|NCT00766506|Fentanyl|fentanyl|mesh-list
1950810|NCT00766506|Morphine|morphine|mesh-list
1950811|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1950812|NCT00766506|Narcotics|narcotics|mesh-ancestor
1950813|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1950814|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950815|NCT00766506|Analgesics|analgesics|mesh-ancestor
1950816|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
1950817|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950818|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1950819|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1950820|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
1950821|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
1950822|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1950823|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1950824|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950825|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950826|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1950827|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
1950828|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1950829|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950830|NCT00766649|Sirolimus|sirolimus|mesh-list
1950831|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1950832|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950833|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1950834|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950835|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
1950836|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1950837|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
1950838|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950839|NCT00766675|Acetaminophen|acetaminophen|mesh-list
1950840|NCT00766675|Tramadol|tramadol|mesh-list
1950841|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1950842|NCT00766675|Analgesics|analgesics|mesh-ancestor
1950843|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
1950844|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950845|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950846|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
1950847|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1950848|NCT00766675|Narcotics|narcotics|mesh-ancestor
1950849|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1950850|NCT00766753|Vaccines|vaccines|mesh-list
1950851|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
1950852|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950853|NCT00766831|Hydromorphone|hydromorphone|mesh-list
1950854|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1950855|NCT00766831|Narcotics|narcotics|mesh-ancestor
1950856|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1950857|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950858|NCT00766831|Analgesics|analgesics|mesh-ancestor
1950859|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
1950860|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950861|NCT00767000|Metformin|metformin|mesh-list
1950862|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
1950863|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1950864|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950865|NCT00767039|Poractant alfa|poractant alfa|mesh-list
1950866|NCT00767039|Beractant|beractant|mesh-list
1950867|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
1950868|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
1950869|NCT00767325|Methotrexate|methotrexate|mesh-list
1950870|NCT00767325|Abatacept|abatacept|mesh-list
1950871|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1950872|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
1950873|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1950874|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950875|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1950876|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
1950877|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950878|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950879|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
1950880|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950881|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1950882|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1950883|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
1950884|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1950885|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1950886|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1950887|NCT00767364|Vaccines|vaccines|mesh-list
1950888|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
1950889|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950890|NCT00767507|Cangrelor|cangrelor|mesh-list
1950891|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1950892|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1950893|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1950894|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1950895|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
1950896|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950897|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950898|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950899|NCT00767520|Dasatinib|dasatinib|mesh-list
1950900|NCT00767520|Exemestane|exemestane|mesh-list
1950901|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950902|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1950903|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950904|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950905|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1950906|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1950907|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1950908|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
1950909|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1950910|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950911|NCT00767572|Atorvastatin|atorvastatin|mesh-list
1950912|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1950913|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950914|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
1950915|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950916|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950917|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1950918|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950919|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
1950920|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1950921|NCT00767767|Thiopental|thiopental|mesh-list
1950922|NCT00767767|Propofol|propofol|mesh-list
1950923|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1950924|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1950925|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950926|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1950927|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
1950928|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
1950929|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
1950930|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
1950931|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
1950932|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950933|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950934|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1950935|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1950936|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1950937|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1950938|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950939|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1950940|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950941|NCT00767806|Analgesics|analgesics|mesh-ancestor
1950942|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
1950943|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950944|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
1950945|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1950946|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
1950947|NCT00767819|Everolimus|everolimus|mesh-list
1950948|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950949|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1950950|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
1950951|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950952|NCT00768053|Etanercept|etanercept|mesh-list
1950953|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1950954|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1950955|NCT00768053|Analgesics|analgesics|mesh-ancestor
1950956|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
1950957|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950958|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950959|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1950960|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1950961|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1950962|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1950963|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
1950964|NCT00768079|Benralizumab|benralizumab|mesh-list
1950965|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1950966|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
1950967|NCT00768118|Curcumin|curcumin|mesh-list
1950968|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1950969|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1950970|NCT00768118|Analgesics|analgesics|mesh-ancestor
1950971|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
1950972|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1950973|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950974|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1950975|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1950976|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950977|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950978|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950979|NCT00768144|Sunitinib|sunitinib|mesh-list
1950980|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1950981|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1950982|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1950983|NCT00768144|Growth Substances|growth substances|mesh-ancestor
1950984|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1950985|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
1950986|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1950987|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1950988|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950989|NCT00768222|Triclosan|triclosan|mesh-list
1950990|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1950991|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1950992|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1950993|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1950994|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
1950995|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1950996|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1950997|NCT00768261|Memantine|memantine|mesh-list
1950998|NCT00768261|Donepezil|donepezil|mesh-list
1950999|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1951000|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951001|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951002|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
1951003|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951004|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951005|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
1951006|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1951007|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1951008|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
1951009|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1951010|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1951011|NCT00768300|Ambrisentan|ambrisentan|mesh-list
1951012|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1951013|NCT00768430|Midazolam|midazolam|mesh-list
1951014|NCT00768430|Ketamine|ketamine|mesh-list
1951015|NCT00768430|Analgesics|analgesics|mesh-ancestor
1951016|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
1951017|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951018|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951019|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1951020|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1951021|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
1951022|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
1951023|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1951024|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1951025|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1951026|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951027|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951028|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1951029|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1951030|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1951031|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1951032|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1951033|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
1951034|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
1951035|NCT00768469|Paclitaxel|paclitaxel|mesh-list
1951036|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1951037|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951038|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
1951039|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
1951040|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
1951041|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951042|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
1951043|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1951044|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1951045|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
1951046|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951047|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951048|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951049|NCT00768521|Urological Agents|urological agents|mesh-ancestor
1951050|NCT00768560|Nifedipine|nifedipine|mesh-list
1951051|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1951052|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1951053|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951054|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1951055|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951056|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
1951057|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
1951058|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1951059|NCT00768599|Econazole|econazole|mesh-list
1951060|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
1951061|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951062|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1951063|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1951064|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951065|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951066|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1951067|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
1951068|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951069|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951070|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1951071|NCT00768651|Pantoprazole|pantoprazole|mesh-list
1951072|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1951073|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951074|NCT00768651|Incretins|incretins|mesh-ancestor
1951075|NCT00768651|Hormones|hormones|mesh-ancestor
1951076|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951077|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1951078|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
1951079|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951080|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951081|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1951082|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1951083|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1951084|NCT00768716|Acetaminophen|acetaminophen|mesh-list
1951085|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1951086|NCT00768716|Analgesics|analgesics|mesh-ancestor
1951087|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
1951088|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951089|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951090|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
1951091|NCT00768755|Pemetrexed|pemetrexed|mesh-list
1951092|NCT00768755|Axitinib|axitinib|mesh-list
1951093|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951094|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951095|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951096|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1951097|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1951098|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1951099|NCT00768989|Ritonavir|ritonavir|mesh-list
1951100|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1951101|NCT00768989|Tenofovir|tenofovir|mesh-list
1951102|NCT00768989|Emtricitabine|emtricitabine|mesh-list
1951103|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
1951104|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1951105|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1951106|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
1951107|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951108|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951109|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1951110|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1951111|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
1951112|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951113|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1951114|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1951115|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1951116|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1951117|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1951118|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1951119|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1951120|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951121|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1951122|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951123|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951124|NCT00769132|Niacin|niacin|mesh-list
1951125|NCT00769132|Niacinamide|niacinamide|mesh-list
1951126|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
1951127|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1951128|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
1951129|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951130|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1951131|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
1951132|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
1951133|NCT00769132|Vitamins|vitamins|mesh-ancestor
1951134|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
1951135|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951136|NCT00769184|Clobetasol|clobetasol|mesh-list
1951137|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951138|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
1951139|NCT00769184|Hormones|hormones|mesh-ancestor
1951140|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951141|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951142|NCT00769314|Acyclovir|acyclovir|mesh-list
1951143|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
1951144|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951145|NCT00769392|Lidocaine|lidocaine|mesh-list
1951146|NCT00769392|Tetracaine|tetracaine|mesh-list
1951147|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
1951148|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
1951149|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
1951150|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1951151|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951152|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
1951153|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951154|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1951155|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1951156|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1951157|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1951158|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951159|NCT00769483|Gemcitabine|gemcitabine|mesh-list
1951160|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1951161|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1951162|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
1951163|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951164|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951165|NCT00769483|Antiviral Agents|antiviral agents|mesh-ancestor
1951166|NCT00769483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951167|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951168|NCT00769483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1951169|NCT00769483|Immunologic Factors|immunologic factors|mesh-ancestor
1951170|NCT00769483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951171|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1951172|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
1951173|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951174|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
1951175|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
1951176|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
1951177|NCT00769600|Itraconazole|itraconazole|mesh-list
1951178|NCT00769600|Pemetrexed|pemetrexed|mesh-list
1951179|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951180|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951181|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951182|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1951183|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1951184|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
1951185|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951186|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1951187|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1951188|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1951189|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
1951190|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951191|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951192|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1951193|NCT00769704|Molgramostim|molgramostim|mesh-list
1951194|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
1951195|NCT00769704|Sargramostim|sargramostim|mesh-list
1951196|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
1951197|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951198|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951199|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1951200|NCT00769886|Ketotifen|ketotifen|mesh-list
1951201|NCT00769886|Naphazoline|naphazoline|mesh-list
1951202|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
1951203|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
1951204|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1951205|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
1951206|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
1951207|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951208|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951209|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951210|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1951211|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1951212|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1951213|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
1951214|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
1951215|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1951216|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
1951217|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
1951218|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1951219|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1951220|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1951221|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1951222|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1951223|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951224|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
1951225|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951226|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951227|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1951228|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951229|NCT00770120|Everolimus|everolimus|mesh-list
1951230|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951231|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1951232|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
1951233|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951234|NCT00770133|Ketotifen|ketotifen|mesh-list
1951235|NCT00770133|Naphazoline|naphazoline|mesh-list
1951236|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
1951237|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
1951238|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1951239|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
1951240|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
1951241|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951242|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951243|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951244|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1951245|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1951246|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1951247|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
1951248|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
1951249|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1951250|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
1951251|NCT00770146|Mipomersen|mipomersen|mesh-list
1951252|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1951253|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1951254|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
1951255|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951256|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1951257|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
1951258|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1951259|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1951260|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1951261|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1951262|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1951263|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951264|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
1951265|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951266|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951267|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1951268|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951269|NCT00770224|Prednisone|prednisone|mesh-list
1951270|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
1951271|NCT00770224|Rituximab|rituximab|mesh-list
1951272|NCT00770224|Doxorubicin|doxorubicin|mesh-list
1951273|NCT00770224|Vincristine|vincristine|mesh-list
1951274|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
1951275|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1951276|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
1951277|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951278|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1951279|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1951280|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
1951281|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951282|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951283|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1951284|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1951285|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1951286|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1951287|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1951288|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951289|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951290|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
1951291|NCT00770224|Hormones|hormones|mesh-ancestor
1951292|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951293|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1951294|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1951295|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
1951296|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
1951297|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
1951298|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
1951299|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1951300|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951301|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951302|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1951303|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1951304|NCT00770328|Protective Agents|protective agents|mesh-ancestor
1951305|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951306|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
1951307|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1951308|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
1951309|NCT00770341|Vancomycin|vancomycin|mesh-list
1951310|NCT00770341|Daptomycin|daptomycin|mesh-list
1951311|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1951312|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951313|NCT00770367|Pioglitazone|pioglitazone|mesh-list
1951314|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1951315|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951316|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
1951317|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1951318|NCT00770432|Laxatives|laxatives|mesh-ancestor
1951319|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1951320|NCT00770484|Propranolol|propranolol|mesh-list
1951321|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1951322|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1951323|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
1951324|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951325|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951326|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951327|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1951328|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1951329|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
1951330|NCT00770510|Zolpidem|zolpidem|mesh-list
1951331|NCT00770510|Eszopiclone|eszopiclone|mesh-list
1951332|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1951333|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1951334|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1951335|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951336|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1951337|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
1951338|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
1951339|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951340|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951341|NCT00770562|Dexamethasone|dexamethasone|mesh-list
1951342|NCT00770562|Rituximab|rituximab|mesh-list
1951343|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951344|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
1951345|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
1951346|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951347|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951348|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1951349|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
1951350|NCT00770562|Hormones|hormones|mesh-ancestor
1951351|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951352|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1951353|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951354|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1951355|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
1951356|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1951357|NCT00770588|Gefitinib|gefitinib|mesh-list
1951358|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951359|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1951360|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951361|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951362|NCT00770653|Metformin|metformin|mesh-list
1951363|NCT00770653|Pioglitazone|pioglitazone|mesh-list
1951364|NCT00770653|Glimepiride|glimepiride|mesh-list
1951365|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1951366|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951367|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1951368|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1951369|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
1951370|NCT00770679|Atorvastatin|atorvastatin|mesh-list
1951371|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1951372|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1951373|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
1951374|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951375|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1951376|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1951377|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951378|NCT00770692|Eszopiclone|eszopiclone|mesh-list
1951379|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1951380|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1951381|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951382|NCT00770757|Pomalidomide|pomalidomide|mesh-list
1951383|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
1951384|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951385|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1951386|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1951387|NCT00770757|Growth Substances|growth substances|mesh-ancestor
1951388|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
1951389|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951390|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
1951391|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951392|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
1951393|NCT00770770|Hormones|hormones|mesh-ancestor
1951394|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951395|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951396|NCT00770809|Paclitaxel|paclitaxel|mesh-list
1951397|NCT00770809|Trastuzumab|trastuzumab|mesh-list
1951398|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1951399|NCT00770809|Lapatinib|lapatinib|mesh-list
1951400|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
1951401|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1951402|NCT00770809|Antibodies|antibodies|mesh-list
1951403|NCT00770809|Immunoglobulins|immunoglobulins|mesh-list
1951404|NCT00770809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1951405|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1951406|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951407|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
1951408|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
1951409|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
1951410|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951411|NCT00770809|Immunologic Factors|immunologic factors|mesh-ancestor
1951412|NCT00770809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951413|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1951414|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951415|NCT00770861|Nebivolol|nebivolol|mesh-list
1951416|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1951417|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
1951418|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1951419|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1951420|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1951421|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
1951422|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951423|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951424|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951425|NCT00770874|Cisplatin|cisplatin|mesh-list
1951426|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951427|NCT00770913|Rabeprazole|rabeprazole|mesh-list
1951428|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1951429|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1951430|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1951431|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951432|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951433|NCT00771030|Brodalumab|brodalumab|mesh-list
1951434|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
1951435|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
1951436|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
1951437|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1951438|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1951439|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951440|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951441|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951442|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1951443|NCT00771472|Vorinostat|vorinostat|mesh-list
1951444|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951445|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1951446|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951447|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951448|NCT00771667|Ustekinumab|ustekinumab|mesh-list
1951449|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
1951450|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
1951451|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1951452|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
1951453|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951454|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1951455|NCT00771758|Oxycodone|oxycodone|mesh-list
1951456|NCT00771758|Tapentadol|tapentadol|mesh-list
1951457|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1951458|NCT00771758|Narcotics|narcotics|mesh-ancestor
1951459|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1951460|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951461|NCT00771758|Analgesics|analgesics|mesh-ancestor
1951462|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
1951463|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951464|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1951465|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1951466|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1951467|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951468|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
1951469|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951470|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
1951471|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1951472|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
1951473|NCT00771875|Acetaminophen|acetaminophen|mesh-list
1951474|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
1951475|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
1951476|NCT00771875|Rituximab|rituximab|mesh-list
1951477|NCT00771875|Bortezomib|bortezomib|mesh-list
1951478|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
1951479|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1951480|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
1951481|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
1951482|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1951483|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951484|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
1951485|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951486|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1951487|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1951488|NCT00771875|Analgesics|analgesics|mesh-ancestor
1951489|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
1951490|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951491|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
1951492|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951493|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
1951494|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
1951495|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1951496|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
1951497|NCT00771875|Hormones|hormones|mesh-ancestor
1951498|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951499|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1951500|NCT00771875|Protective Agents|protective agents|mesh-ancestor
1951501|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1951502|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1951503|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1951504|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1951505|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
1951506|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
1951507|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
1951508|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951509|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951510|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1951511|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
1951512|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
1951513|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951514|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
1951515|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951516|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1951517|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1951518|NCT00771914|Aspirin|aspirin|mesh-list
1951519|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1951520|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1951521|NCT00771914|Analgesics|analgesics|mesh-ancestor
1951522|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
1951523|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951524|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951525|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951526|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1951527|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1951528|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1951529|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951530|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1951531|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1951532|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951533|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
1951534|NCT00771927|Lacosamide|lacosamide|mesh-list
1951535|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
1951536|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1951537|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1951538|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1951539|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951540|NCT00771953|Docetaxel|docetaxel|mesh-list
1951541|NCT00771953|Pemetrexed|pemetrexed|mesh-list
1951542|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951543|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
1951544|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
1951545|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
1951546|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951547|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951548|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1951549|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1951550|NCT00772005|Modafinil|modafinil|mesh-list
1951551|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1951552|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951553|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1951554|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1951555|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1951556|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951557|NCT00772031|Topiramate|topiramate|mesh-list
1951558|NCT00772031|Propranolol|propranolol|mesh-list
1951559|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1951560|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1951561|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
1951562|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951563|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951564|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951565|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1951566|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1951567|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
1951568|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
1951569|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1951570|NCT00772070|Vaccines|vaccines|mesh-list
1951571|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
1951572|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951573|NCT00772109|Vaccines|vaccines|mesh-list
1951574|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
1951575|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951576|NCT00772148|Tacrolimus|tacrolimus|mesh-list
1951577|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1951578|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
1951579|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951580|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1951581|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951582|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951583|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1951584|NCT00772304|Azelastine|azelastine|mesh-list
1951585|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1951586|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1951587|NCT00772304|Analgesics|analgesics|mesh-ancestor
1951588|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
1951589|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951590|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951591|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951592|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1951593|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1951594|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1951595|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1951596|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
1951597|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
1951598|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951599|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951600|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1951601|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
1951602|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1951603|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
1951604|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1951605|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951606|NCT00772447|Vancomycin|vancomycin|mesh-list
1951607|NCT00772447|Daptomycin|daptomycin|mesh-list
1951608|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1951609|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951610|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
1951611|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1951612|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
1951613|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951614|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951615|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1951616|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
1951617|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
1951618|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1951619|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
1951620|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951621|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951622|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1951623|NCT00772577|Ramipril|ramipril|mesh-list
1951624|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1951625|NCT00772577|Diuretics|diuretics|mesh-ancestor
1951626|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
1951627|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951628|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1951629|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1951630|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951631|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1951632|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
1951633|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951634|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
1951635|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1951636|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1951637|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
1951638|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951639|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1951640|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1951641|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951642|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951643|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
1951644|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
1951645|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1951646|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1951647|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1951648|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951649|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1951650|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1951651|NCT00772668|Prednisone|prednisone|mesh-list
1951652|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
1951653|NCT00772668|Rituximab|rituximab|mesh-list
1951654|NCT00772668|Bortezomib|bortezomib|mesh-list
1951655|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1951656|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
1951657|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951658|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1951659|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1951660|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
1951661|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951662|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951663|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1951664|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1951665|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951666|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
1951667|NCT00772668|Hormones|hormones|mesh-ancestor
1951668|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951669|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1951670|NCT00772772|Vitamin D|vitamin d|mesh-list
1951671|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
1951672|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
1951673|NCT00772772|Vitamins|vitamins|mesh-list
1951674|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
1951675|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951676|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1951677|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1951678|NCT00772915|Dexamethasone|dexamethasone|mesh-list
1951679|NCT00772915|Lenalidomide|lenalidomide|mesh-list
1951680|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951681|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
1951682|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
1951683|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951684|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951685|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1951686|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
1951687|NCT00772915|Hormones|hormones|mesh-ancestor
1951688|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951689|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1951690|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951691|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
1951692|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1951693|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1951694|NCT00772915|Growth Substances|growth substances|mesh-ancestor
1951695|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
1951696|NCT00772928|Vaccines|vaccines|mesh-list
1951697|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1951698|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
1951699|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951700|NCT00772941|Varenicline|varenicline|mesh-list
1951701|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1951702|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1951703|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
1951704|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951705|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951706|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951707|NCT00772954|Vaccines|vaccines|mesh-list
1951708|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
1951709|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951710|NCT00772967|Naproxen|naproxen|mesh-list
1951711|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1951712|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1951713|NCT00772967|Analgesics|analgesics|mesh-ancestor
1951714|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
1951715|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951716|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951717|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951718|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1951719|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
1951720|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1951721|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951722|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951723|NCT00773097|Poly ICLC|poly iclc|mesh-list
1951724|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
1951725|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
1951726|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951727|NCT00773136|Bimatoprost|bimatoprost|mesh-list
1951728|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1951729|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
1951730|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1951731|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1951732|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1951733|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1951734|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951735|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
1951736|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951737|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951738|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1951739|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951740|NCT00773292|Cyclosporine|cyclosporine|mesh-list
1951741|NCT00773292|Cyclosporins|cyclosporins|mesh-list
1951742|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951743|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951744|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1951745|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
1951746|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951747|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
1951748|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951749|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
1951750|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1951751|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1951752|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1951753|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951754|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1951755|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951756|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951757|NCT00773422|Naltrexone|naltrexone|mesh-list
1951758|NCT00773422|Varenicline|varenicline|mesh-list
1951759|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1951760|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1951761|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951762|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
1951763|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951764|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1951765|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1951766|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
1951767|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951768|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951769|NCT00773474|Lonafarnib|lonafarnib|mesh-list
1951770|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951771|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951772|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
1951773|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
1951774|NCT00773513|Hematinics|hematinics|mesh-ancestor
1951775|NCT00773734|Thalidomide|thalidomide|mesh-list
1951776|NCT00773734|Apremilast|apremilast|mesh-list
1951777|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1951778|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1951779|NCT00773734|Analgesics|analgesics|mesh-ancestor
1951780|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
1951781|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951782|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951783|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951784|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1951785|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1951786|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1951787|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951788|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951789|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1951790|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
1951791|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
1951792|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1951793|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951794|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1951795|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1951796|NCT00773734|Growth Substances|growth substances|mesh-ancestor
1951797|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
1951798|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951799|NCT00773747|Bortezomib|bortezomib|mesh-list
1951800|NCT00773747|Vorinostat|vorinostat|mesh-list
1951801|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951802|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1951803|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951804|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951805|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
1951806|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1951807|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
1951808|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951809|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951810|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1951811|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
1951812|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1951813|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1951814|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1951815|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
1951816|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951817|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951818|NCT00773838|Dexamethasone|dexamethasone|mesh-list
1951819|NCT00773838|Bortezomib|bortezomib|mesh-list
1951820|NCT00773838|Vorinostat|vorinostat|mesh-list
1951821|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951822|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
1951823|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
1951824|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951825|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951826|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1951827|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
1951828|NCT00773838|Hormones|hormones|mesh-ancestor
1951829|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951830|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1951831|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951832|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1951833|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951834|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951835|NCT00773955|Acetic Acid|acetic acid|mesh-list
1951836|NCT00773955|Retinol acetate|retinol acetate|mesh-list
1951837|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
1951838|NCT00773955|Gossypol|gossypol|mesh-list
1951839|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1951840|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951841|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1951842|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
1951843|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951844|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1951845|NCT00773955|Protective Agents|protective agents|mesh-ancestor
1951846|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951847|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1951848|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
1951849|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1951850|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1951851|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1951852|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
1951853|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
1951854|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
1951855|NCT00773968|Hematinics|hematinics|mesh-ancestor
1951856|NCT00774046|Cytarabine|cytarabine|mesh-list
1951857|NCT00774046|Etoposide|etoposide|mesh-list
1951858|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
1951859|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1951860|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951861|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1951862|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1951863|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1951864|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951865|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1951866|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
1951867|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
1951868|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951869|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1951870|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
1951871|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951872|NCT00774046|Analgesics|analgesics|mesh-ancestor
1951873|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
1951874|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951875|NCT00774202|Prednisone|prednisone|mesh-list
1951876|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
1951877|NCT00774202|Rituximab|rituximab|mesh-list
1951878|NCT00774202|Vincristine|vincristine|mesh-list
1951879|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1951880|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
1951881|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951882|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1951883|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1951884|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
1951885|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951886|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951887|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1951888|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1951889|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951890|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
1951891|NCT00774202|Hormones|hormones|mesh-ancestor
1951892|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951893|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1951894|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1951895|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
1951896|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
1951897|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
1951898|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
1951899|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1951900|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
1951901|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951902|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951903|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1951904|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1951905|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1951906|NCT00774787|Imiquimod|imiquimod|mesh-list
1951907|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1951908|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
1951909|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951910|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951911|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
1951912|NCT00774800|Insulin|insulin|mesh-list
1951913|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1951914|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
1951915|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1951916|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951917|NCT00774852|Prednisone|prednisone|mesh-list
1951918|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
1951919|NCT00774852|Abatacept|abatacept|mesh-list
1951920|NCT00774852|Azathioprine|azathioprine|mesh-list
1951921|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1951922|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
1951923|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951924|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1951925|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1951926|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
1951927|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951928|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951929|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1951930|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951931|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
1951932|NCT00774852|Hormones|hormones|mesh-ancestor
1951933|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951934|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1951935|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1951936|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
1951937|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1951938|NCT00774930|Lanreotide|lanreotide|mesh-list
1951939|NCT00774930|Somatostatin|somatostatin|mesh-list
1951940|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951941|NCT00774930|Hormones|hormones|mesh-ancestor
1951942|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951943|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951944|NCT00775138|Amikacin|amikacin|mesh-list
1951945|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1951946|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1951947|NCT00775203|Trazodone|trazodone|mesh-list
1951948|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1951949|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1951950|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1951951|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951952|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1951953|NCT00775203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1951954|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1951955|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1951956|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951957|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1951958|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
1951959|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1951960|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
1951961|NCT00775229|Naltrexone|naltrexone|mesh-list
1951962|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1951963|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1951964|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951965|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
1951966|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951967|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1951968|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1951969|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1951970|NCT00775411|Dexamethasone|dexamethasone|mesh-list
1951971|NCT00775411|Ranibizumab|ranibizumab|mesh-list
1951972|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951973|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
1951974|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
1951975|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1951976|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951977|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1951978|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
1951979|NCT00775411|Hormones|hormones|mesh-ancestor
1951980|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1951981|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1951982|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1951983|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1951984|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1951985|NCT00775411|Growth Substances|growth substances|mesh-ancestor
1951986|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
1951987|NCT00775437|Adalimumab|adalimumab|mesh-list
1951988|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1951989|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1951990|NCT00775450|Vaccines|vaccines|mesh-list
1951991|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
1951992|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1951993|NCT00775463|Treprostinil|treprostinil|mesh-list
1951994|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1951995|NCT00775528|Pancrelipase|pancrelipase|mesh-list
1951996|NCT00775528|Pancreatin|pancreatin|mesh-list
1951997|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1951998|NCT00775593|Sirolimus|sirolimus|mesh-list
1951999|NCT00775593|Clofarabine|clofarabine|mesh-list
1952000|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1952001|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952002|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1952003|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952004|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
1952005|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952006|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
1952007|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952008|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1952009|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
1952010|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952011|NCT00775606|Ritonavir|ritonavir|mesh-list
1952012|NCT00775606|Lopinavir|lopinavir|mesh-list
1952013|NCT00775606|Efavirenz|efavirenz|mesh-list
1952014|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1952015|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1952016|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
1952017|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952018|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952019|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1952020|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1952021|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
1952022|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952023|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1952024|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1952025|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1952026|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1952027|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1952028|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1952029|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1952030|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1952031|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1952032|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
1952033|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
1952034|NCT00775645|Vitamins|vitamins|mesh-ancestor
1952035|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
1952036|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952037|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
1952038|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1952039|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1952040|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1952041|NCT00775658|Analgesics|analgesics|mesh-ancestor
1952042|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
1952043|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952044|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952045|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1952046|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1952047|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1952048|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1952049|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1952050|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
1952051|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
1952052|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952053|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952054|NCT00775671|Metoprolol|metoprolol|mesh-list
1952055|NCT00775671|Nebivolol|nebivolol|mesh-list
1952056|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1952057|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1952058|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
1952059|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
1952060|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952061|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952062|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1952063|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1952064|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1952065|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
1952066|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952067|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952068|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
1952069|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1952070|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1952071|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1952072|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1952073|NCT00775684|Exenatide|exenatide|mesh-list
1952074|NCT00775684|Glimepiride|glimepiride|mesh-list
1952075|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1952076|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952077|NCT00775684|Incretins|incretins|mesh-ancestor
1952078|NCT00775684|Hormones|hormones|mesh-ancestor
1952079|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1952080|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1952081|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
1952082|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952083|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952084|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1952085|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1952086|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952087|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
1952088|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
1952089|NCT00775931|Busulfan|busulfan|mesh-list
1952090|NCT00775931|Fludarabine|fludarabine|mesh-list
1952091|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
1952092|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
1952093|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952094|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
1952095|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952096|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1952097|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1952098|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
1952099|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952100|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952101|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1952102|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1952103|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
1952104|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1952105|NCT00775944|Nicotine|nicotine|mesh-list
1952106|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1952107|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
1952108|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952109|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952110|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1952111|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1952112|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
1952113|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952114|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952115|NCT00776009|Methylphenidate|methylphenidate|mesh-list
1952116|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
1952117|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1952118|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952119|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1952120|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1952121|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1952122|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952123|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
1952124|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952125|NCT00776230|Vaccines|vaccines|mesh-list
1952126|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
1952127|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952128|NCT00776594|Bevacizumab|bevacizumab|mesh-list
1952129|NCT00776594|Bicalutamide|bicalutamide|mesh-list
1952130|NCT00776594|Androgens|androgens|mesh-list
1952131|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1952132|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952133|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1952134|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1952135|NCT00776594|Growth Substances|growth substances|mesh-ancestor
1952136|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952137|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
1952138|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
1952139|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
1952140|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1952141|NCT00776594|Hormones|hormones|mesh-ancestor
1952142|NCT00776659|Exemestane|exemestane|mesh-list
1952143|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952144|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1952145|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1952146|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952147|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952148|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1952149|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
1952150|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1952151|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952152|NCT00776919|Clindamycin|clindamycin|mesh-list
1952153|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
1952154|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
1952155|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1952156|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1952157|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952158|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1952159|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952160|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952161|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
1952162|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
1952163|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1952164|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
1952165|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952166|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952167|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1952168|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
1952169|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
1952170|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1952171|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
1952172|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952173|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952174|NCT00777023|Gabapentin|gabapentin|mesh-list
1952175|NCT00777023|Analgesics|analgesics|mesh-ancestor
1952176|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
1952177|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952178|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952179|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
1952180|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1952181|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1952182|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1952183|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1952184|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1952185|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1952186|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952187|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952188|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
1952189|NCT00777036|Dasatinib|dasatinib|mesh-list
1952190|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952191|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1952192|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952193|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952194|NCT00777049|Panobinostat|panobinostat|mesh-list
1952195|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952196|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1952197|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952198|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952199|NCT00777062|Naltrexone|naltrexone|mesh-list
1952200|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1952201|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1952202|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952203|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
1952204|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952205|NCT00777101|Capecitabine|capecitabine|mesh-list
1952206|NCT00777101|Lapatinib|lapatinib|mesh-list
1952207|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1952208|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
1952209|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952210|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952211|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1952212|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952213|NCT00777153|Cediranib|cediranib|mesh-list
1952214|NCT00777153|Lomustine|lomustine|mesh-list
1952215|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952216|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1952217|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952218|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952219|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1952220|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
1952221|NCT00777296|Amikacin|amikacin|mesh-list
1952222|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1952223|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952224|NCT00777335|Panobinostat|panobinostat|mesh-list
1952225|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952226|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1952227|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952228|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952229|NCT00777491|Gemcitabine|gemcitabine|mesh-list
1952230|NCT00777491|Cisplatin|cisplatin|mesh-list
1952231|NCT00777491|Fluorouracil|fluorouracil|mesh-list
1952232|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952233|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1952234|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
1952235|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952236|NCT00777491|Antiviral Agents|antiviral agents|mesh-ancestor
1952237|NCT00777491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952238|NCT00777491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952239|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952240|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
1952241|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952242|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
1952243|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1952244|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
1952245|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1952246|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952247|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1952248|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1952249|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1952250|NCT00777608|Donepezil|donepezil|mesh-list
1952251|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1952252|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952253|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952254|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
1952255|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952256|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952257|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
1952258|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
1952259|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1952260|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1952261|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1952262|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1952263|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1952264|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952265|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
1952266|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952267|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952268|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1952269|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952270|NCT00777829|Zolpidem|zolpidem|mesh-list
1952271|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1952272|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1952273|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1952274|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952275|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1952276|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
1952277|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
1952278|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952279|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952280|NCT00777855|Rifampin|rifampin|mesh-list
1952281|NCT00777855|Warfarin|warfarin|mesh-list
1952282|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
1952283|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1952284|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
1952285|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1952286|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952287|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
1952288|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1952289|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952290|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952291|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1952292|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1952293|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1952294|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1952295|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1952296|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1952297|NCT00777920|Ambrisentan|ambrisentan|mesh-list
1952298|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1952299|NCT00777946|Amlodipine|amlodipine|mesh-list
1952300|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1952301|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1952302|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1952303|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952304|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1952305|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952306|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
1952307|NCT00778102|Leucovorin|leucovorin|mesh-list
1952308|NCT00778102|Bevacizumab|bevacizumab|mesh-list
1952309|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
1952310|NCT00778102|Irinotecan|irinotecan|mesh-list
1952311|NCT00778102|Fluorouracil|fluorouracil|mesh-list
1952312|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
1952313|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1952314|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952315|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1952316|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1952317|NCT00778102|Growth Substances|growth substances|mesh-ancestor
1952318|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952319|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
1952320|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1952321|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1952322|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952323|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952324|NCT00778102|Antidotes|antidotes|mesh-ancestor
1952325|NCT00778102|Protective Agents|protective agents|mesh-ancestor
1952326|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
1952327|NCT00778102|Vitamins|vitamins|mesh-ancestor
1952328|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
1952329|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
1952330|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1952331|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952332|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
1952333|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1952334|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1952335|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952336|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1952337|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952338|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952339|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
1952340|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952341|NCT00778310|Methylphenidate|methylphenidate|mesh-list
1952342|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1952343|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952344|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1952345|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1952346|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1952347|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952348|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
1952349|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952350|NCT00778375|Cytarabine|cytarabine|mesh-list
1952351|NCT00778375|Decitabine|decitabine|mesh-list
1952352|NCT00778375|Clofarabine|clofarabine|mesh-list
1952353|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1952354|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
1952355|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952356|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952357|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
1952358|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952359|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952360|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
1952361|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952362|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952363|NCT00778622|Metformin|metformin|mesh-list
1952364|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1952365|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952366|NCT00778817|Mitotane|mitotane|mesh-list
1952367|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1952368|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952369|NCT00778830|Cetuximab|cetuximab|mesh-list
1952370|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1952371|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952372|NCT00778869|Infliximab|infliximab|mesh-list
1952373|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
1952374|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1952375|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1952376|NCT00778921|Amlodipine|amlodipine|mesh-list
1952377|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1952378|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1952379|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1952380|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952381|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1952382|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952383|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
1952384|NCT00778999|Desogestrel|desogestrel|mesh-list
1952385|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1952386|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1952387|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1952388|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
1952389|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1952390|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952391|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1952392|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1952393|NCT00778999|Progestins|progestins|mesh-ancestor
1952394|NCT00778999|Hormones|hormones|mesh-ancestor
1952395|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1952396|NCT00779116|Cetirizine|cetirizine|mesh-list
1952397|NCT00779116|Desloratadine|desloratadine|mesh-list
1952398|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1952399|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1952400|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1952401|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
1952402|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
1952403|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952404|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952405|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952406|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1952407|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
1952408|NCT00779142|Methotrexate|methotrexate|mesh-list
1952409|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1952410|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
1952411|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1952412|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952413|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1952414|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
1952415|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952416|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952417|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
1952418|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952419|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1952420|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952421|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
1952422|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1952423|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1952424|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
1952425|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1952426|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1952427|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952428|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
1952429|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
1952430|NCT00779259|Quinine|quinine|mesh-list
1952431|NCT00779259|Theophylline|theophylline|mesh-list
1952432|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1952433|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
1952434|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952435|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952436|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1952437|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
1952438|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1952439|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952440|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952441|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
1952442|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1952443|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1952444|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
1952445|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952446|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
1952447|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1952448|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1952449|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952450|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1952451|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1952452|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1952453|NCT00779259|Analgesics|analgesics|mesh-ancestor
1952454|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
1952455|NCT00779285|Doxorubicin|doxorubicin|mesh-list
1952456|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1952457|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1952458|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952459|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1952460|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1952461|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952462|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952463|NCT00779311|Bevacizumab|bevacizumab|mesh-list
1952464|NCT00779311|Sorafenib|sorafenib|mesh-list
1952465|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1952466|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952467|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1952468|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1952469|NCT00779311|Growth Substances|growth substances|mesh-ancestor
1952470|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952471|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
1952472|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1952473|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952474|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952475|NCT00779324|Amantadine|amantadine|mesh-list
1952476|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1952477|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1952478|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
1952479|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952480|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
1952481|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952482|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952483|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952484|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1952485|NCT00779324|Analgesics|analgesics|mesh-ancestor
1952486|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
1952487|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952488|NCT00779467|Fentanyl|fentanyl|mesh-list
1952489|NCT00779467|Bupivacaine|bupivacaine|mesh-list
1952490|NCT00779467|Neostigmine|neostigmine|mesh-list
1952491|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
1952492|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
1952493|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1952494|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952495|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
1952496|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952497|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1952498|NCT00779467|Narcotics|narcotics|mesh-ancestor
1952499|NCT00779467|Analgesics|analgesics|mesh-ancestor
1952500|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1952501|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1952502|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
1952503|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1952504|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952505|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952506|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
1952507|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952508|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1952509|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
1952510|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1952511|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
1952512|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1952513|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1952514|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1952515|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1952516|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952517|NCT00779558|Heparin|heparin|mesh-list
1952518|NCT00779558|Calcium heparin|calcium heparin|mesh-list
1952519|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
1952520|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1952521|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1952522|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952523|NCT00779584|Gemcitabine|gemcitabine|mesh-list
1952524|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1952525|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
1952526|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952527|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952528|NCT00779584|Antiviral Agents|antiviral agents|mesh-ancestor
1952529|NCT00779584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952530|NCT00779584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952531|NCT00779584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952532|NCT00779584|Immunologic Factors|immunologic factors|mesh-ancestor
1952533|NCT00779584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952534|NCT00779675|Infliximab|infliximab|mesh-list
1952535|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
1952536|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1952537|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1952538|NCT00779701|Insulin|insulin|mesh-list
1952539|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1952540|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952541|NCT00779909|Vitamin D|vitamin d|mesh-list
1952542|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
1952543|NCT00779909|Vitamins|vitamins|mesh-ancestor
1952544|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
1952545|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952546|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1952547|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1952548|NCT00780026|Insulin|insulin|mesh-list
1952549|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1952550|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952551|NCT00780143|Cytarabine|cytarabine|mesh-list
1952552|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1952553|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
1952554|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952555|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952556|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
1952557|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952558|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952559|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
1952560|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952561|NCT00780208|Methylphenidate|methylphenidate|mesh-list
1952562|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1952563|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952564|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1952565|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1952566|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1952567|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952568|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
1952569|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952570|NCT00780234|Pioglitazone|pioglitazone|mesh-list
1952571|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1952572|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952573|NCT00780273|Cimetidine|cimetidine|mesh-list
1952574|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1952575|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1952576|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1952577|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
1952578|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
1952579|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952580|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952581|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952582|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1952583|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1952584|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952585|NCT00780403|Cetirizine|cetirizine|mesh-list
1952586|NCT00780403|Desloratadine|desloratadine|mesh-list
1952587|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1952588|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1952589|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1952590|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
1952591|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
1952592|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952593|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952594|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952595|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1952596|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
1952597|NCT00780416|Ribavirin|ribavirin|mesh-list
1952598|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1952599|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
1952600|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
1952601|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952602|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
1952603|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952604|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
1952605|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952606|NCT00780442|Cycloserine|cycloserine|mesh-list
1952607|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1952608|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952609|NCT00780442|Renal Agents|renal agents|mesh-ancestor
1952610|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1952611|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
1952612|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1952613|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
1952614|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952615|NCT00780494|Bevacizumab|bevacizumab|mesh-list
1952616|NCT00780494|Carboplatin|carboplatin|mesh-list
1952617|NCT00780494|Capecitabine|capecitabine|mesh-list
1952618|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1952619|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952620|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1952621|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1952622|NCT00780494|Growth Substances|growth substances|mesh-ancestor
1952623|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952624|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
1952625|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1952626|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
1952627|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952628|NCT00780676|Dasatinib|dasatinib|mesh-list
1952629|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952630|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1952631|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952632|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952633|NCT00780715|Metformin|metformin|mesh-list
1952634|NCT00780715|Pioglitazone|pioglitazone|mesh-list
1952635|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1952636|NCT00780715|Gliclazide|gliclazide|mesh-list
1952637|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1952638|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952639|NCT00780715|Incretins|incretins|mesh-ancestor
1952640|NCT00780715|Hormones|hormones|mesh-ancestor
1952641|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1952642|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1952643|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
1952644|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952645|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952646|NCT00780910|Ribavirin|ribavirin|mesh-list
1952647|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1952648|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
1952649|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952650|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
1952651|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952652|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
1952653|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1952654|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
1952655|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952656|NCT00780962|Expectorants|expectorants|mesh-ancestor
1952657|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
1952658|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1952659|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
1952660|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952661|NCT00780962|Protective Agents|protective agents|mesh-ancestor
1952662|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952663|NCT00780962|Antidotes|antidotes|mesh-ancestor
1952664|NCT00781274|Ribavirin|ribavirin|mesh-list
1952665|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1952666|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
1952667|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952668|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
1952669|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952670|NCT00781326|Nimodipine|nimodipine|mesh-list
1952671|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1952672|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1952673|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1952674|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952675|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1952676|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952677|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
1952678|NCT00781391|Warfarin|warfarin|mesh-list
1952679|NCT00781391|Edoxaban|edoxaban|mesh-list
1952680|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
1952681|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1952682|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
1952683|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1952684|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
1952685|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952686|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952687|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
1952688|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
1952689|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
1952690|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1952691|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952692|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1952693|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1952694|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1952695|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
1952696|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
1952697|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1952698|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1952699|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952700|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952701|NCT00781508|Urological Agents|urological agents|mesh-ancestor
1952702|NCT00781599|Varenicline|varenicline|mesh-list
1952703|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1952704|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1952705|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
1952706|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952707|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952708|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952709|NCT00781768|Ondansetron|ondansetron|mesh-list
1952710|NCT00781768|Aprepitant|aprepitant|mesh-list
1952711|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
1952712|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
1952713|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952714|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952715|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1952716|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
1952717|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
1952718|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1952719|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
1952720|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952721|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952722|NCT00781768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1952723|NCT00781768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1952724|NCT00781768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1952725|NCT00781768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1952726|NCT00781768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1952727|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1952728|NCT00781859|Plasminogen|plasminogen|mesh-list
1952729|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1952730|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1952731|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952732|NCT00781885|Beraprost|beraprost|mesh-list
1952733|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1952734|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
1952735|NCT00781898|Naltrexone|naltrexone|mesh-list
1952736|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1952737|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1952738|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952739|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
1952740|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952741|NCT00781911|Octreotide|octreotide|mesh-list
1952742|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1952743|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1952744|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952745|NCT00781937|Liraglutide|liraglutide|mesh-list
1952746|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1952747|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952748|NCT00781937|Incretins|incretins|mesh-ancestor
1952749|NCT00781937|Hormones|hormones|mesh-ancestor
1952750|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1952751|NCT00782067|Midostaurin|midostaurin|mesh-list
1952752|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952753|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1952754|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952755|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952756|NCT00782184|Atorvastatin|atorvastatin|mesh-list
1952757|NCT00782184|Simvastatin|simvastatin|mesh-list
1952758|NCT00782184|Ezetimibe|ezetimibe|mesh-list
1952759|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
1952760|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1952761|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1952762|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
1952763|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952764|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1952765|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1952766|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952767|NCT00782210|Olodaterol|olodaterol|mesh-list
1952768|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1952769|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
1952770|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952771|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952772|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1952773|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
1952774|NCT00782275|Sirolimus|sirolimus|mesh-list
1952775|NCT00782275|Bevacizumab|bevacizumab|mesh-list
1952776|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1952777|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952778|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1952779|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1952780|NCT00782275|Growth Substances|growth substances|mesh-ancestor
1952781|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952782|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
1952783|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1952784|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952785|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1952786|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
1952787|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952788|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
1952789|NCT00782288|Digitoxin|digitoxin|mesh-list
1952790|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1952791|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1952792|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952793|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952794|NCT00782288|Protective Agents|protective agents|mesh-ancestor
1952795|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952796|NCT00782340|Droxidopa|droxidopa|mesh-list
1952797|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1952798|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1952799|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
1952800|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
1952801|NCT00782379|Busulfan|busulfan|mesh-list
1952802|NCT00782379|Fludarabine|fludarabine|mesh-list
1952803|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
1952804|NCT00782379|Tacrolimus|tacrolimus|mesh-list
1952805|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952806|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
1952807|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952808|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1952809|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1952810|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
1952811|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952812|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952813|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1952814|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1952815|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
1952816|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1952817|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952818|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1952819|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1952820|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
1952821|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1952822|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952823|NCT00782418|Exenatide|exenatide|mesh-list
1952824|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1952825|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952826|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1952827|NCT00782418|Incretins|incretins|mesh-ancestor
1952828|NCT00782418|Hormones|hormones|mesh-ancestor
1952829|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1952830|NCT00782509|Olodaterol|olodaterol|mesh-list
1952831|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1952832|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
1952833|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952834|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952835|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1952836|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
1952837|NCT00782626|Everolimus|everolimus|mesh-list
1952838|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952839|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952840|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
1952841|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952842|NCT00782717|Prednisolone|prednisolone|mesh-list
1952843|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1952844|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
1952845|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1952846|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
1952847|NCT00782717|Nepafenac|nepafenac|mesh-list
1952848|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1952849|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
1952850|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1952851|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
1952852|NCT00782717|Hormones|hormones|mesh-ancestor
1952853|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1952854|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952855|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1952856|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952857|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
1952858|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
1952859|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952860|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1952861|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1952862|NCT00782717|Protective Agents|protective agents|mesh-ancestor
1952863|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1952864|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1952865|NCT00782717|Analgesics|analgesics|mesh-ancestor
1952866|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
1952867|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1952868|NCT00782756|Bevacizumab|bevacizumab|mesh-list
1952869|NCT00782756|Temozolomide|temozolomide|mesh-list
1952870|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1952871|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952872|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1952873|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1952874|NCT00782756|Growth Substances|growth substances|mesh-ancestor
1952875|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952876|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
1952877|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1952878|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
1952879|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952880|NCT00782795|Pioglitazone|pioglitazone|mesh-list
1952881|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1952882|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952883|NCT00782821|Rituximab|rituximab|mesh-list
1952884|NCT00782821|Bortezomib|bortezomib|mesh-list
1952885|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
1952886|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1952887|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1952888|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952889|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
1952890|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952891|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1952892|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952893|NCT00783094|Tadalafil|tadalafil|mesh-list
1952894|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
1952895|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1952896|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1952897|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952898|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952899|NCT00783094|Urological Agents|urological agents|mesh-ancestor
1952900|NCT00783224|Fluticasone|fluticasone|mesh-list
1952901|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
1952902|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1952903|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1952904|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
1952905|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952906|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952907|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1952908|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
1952909|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
1952910|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1952911|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1952912|NCT00783263|Ezetimibe|ezetimibe|mesh-list
1952913|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1952914|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1952915|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
1952916|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952917|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1952918|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1952919|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952920|NCT00783289|Benralizumab|benralizumab|mesh-list
1952921|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1952922|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
1952923|NCT00783367|Dexamethasone|dexamethasone|mesh-list
1952924|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
1952925|NCT00783367|Rituximab|rituximab|mesh-list
1952926|NCT00783367|Lenalidomide|lenalidomide|mesh-list
1952927|NCT00783367|BB 1101|bb 1101|mesh-list
1952928|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1952929|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
1952930|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
1952931|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952932|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952933|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1952934|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
1952935|NCT00783367|Hormones|hormones|mesh-ancestor
1952936|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1952937|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1952938|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952939|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
1952940|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952941|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952942|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1952943|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
1952944|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1952945|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1952946|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1952947|NCT00783367|Growth Substances|growth substances|mesh-ancestor
1952948|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
1952949|NCT00783432|Azelastine|azelastine|mesh-list
1952950|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1952951|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
1952952|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952953|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952954|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1952955|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
1952956|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1952957|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952958|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952959|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1952960|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1952961|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1952962|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
1952963|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
1952964|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1952965|NCT00783614|Aspirin|aspirin|mesh-list
1952966|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1952967|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1952968|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1952969|NCT00783614|Analgesics|analgesics|mesh-ancestor
1952970|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
1952971|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1952972|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952973|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1952974|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1952975|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1952976|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1952977|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1952978|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1952979|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1952980|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1952981|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
1952982|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
1952983|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1952984|NCT00783692|Vedolizumab|vedolizumab|mesh-list
1952985|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1952986|NCT00783705|Inositol|inositol|mesh-list
1952987|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
1952988|NCT00783705|Vitamins|vitamins|mesh-ancestor
1952989|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
1952990|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952991|NCT00783718|Vedolizumab|vedolizumab|mesh-list
1952992|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1952993|NCT00783796|Everolimus|everolimus|mesh-list
1952994|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1952995|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1952996|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
1952997|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1952998|NCT00783835|Methylphenidate|methylphenidate|mesh-list
1952999|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1953000|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953001|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1953002|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1953003|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1953004|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953005|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
1953006|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953007|NCT00783965|Tazarotene|tazarotene|mesh-list
1953008|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
1953009|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
1953010|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1953011|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1953012|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1953013|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953014|NCT00784147|Ibalizumab|ibalizumab|mesh-list
1953015|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1953016|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1953017|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1953018|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
1953019|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953020|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
1953021|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953022|NCT00784225|Vitamins|vitamins|mesh-list
1953023|NCT00784225|Vitamin E|vitamin e|mesh-list
1953024|NCT00784225|Tocopherols|tocopherols|mesh-list
1953025|NCT00784225|Tocotrienols|tocotrienols|mesh-list
1953026|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
1953027|NCT00784225|Selenium|selenium|mesh-list
1953028|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
1953029|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953030|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
1953031|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953032|NCT00784225|Protective Agents|protective agents|mesh-ancestor
1953033|NCT00784225|Trace Elements|trace elements|mesh-ancestor
1953034|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1953035|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1953036|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1953037|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953038|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953039|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1953040|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1953041|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1953042|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
1953043|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953044|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953045|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1953046|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1953047|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
1953048|NCT00784277|Oxycodone|oxycodone|mesh-list
1953049|NCT00784277|Tapentadol|tapentadol|mesh-list
1953050|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1953051|NCT00784277|Narcotics|narcotics|mesh-ancestor
1953052|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953053|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953054|NCT00784277|Analgesics|analgesics|mesh-ancestor
1953055|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
1953056|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953057|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1953058|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1953059|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1953060|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953061|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
1953062|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953063|NCT00784303|Lenvatinib|lenvatinib|mesh-list
1953064|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953065|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1953066|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953067|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953068|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1953069|NCT00784459|Abatacept|abatacept|mesh-list
1953070|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1953071|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953072|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953073|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953074|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
1953075|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953076|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1953077|NCT00784524|Aldesleukin|aldesleukin|mesh-list
1953078|NCT00784524|Interleukin-2|interleukin-2|mesh-list
1953079|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953080|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1953081|NCT00784524|Analgesics|analgesics|mesh-ancestor
1953082|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
1953083|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953084|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953085|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1953086|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1953087|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
1953088|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953089|NCT00784550|Fluticasone|fluticasone|mesh-list
1953090|NCT00784550|Xhance|xhance|mesh-list
1953091|NCT00784550|Bromides|bromides|mesh-list
1953092|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
1953093|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1953094|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1953095|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1953096|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
1953097|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953098|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953099|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1953100|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
1953101|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
1953102|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1953103|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
1953104|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1953105|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
1953106|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953107|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953108|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1953109|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1953110|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1953111|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
1953112|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
1953113|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1953114|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1953115|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953116|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1953117|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1953118|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1953119|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953120|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
1953121|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953122|NCT00784693|Tanezumab|tanezumab|mesh-list
1953123|NCT00784693|Analgesics|analgesics|mesh-ancestor
1953124|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
1953125|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953126|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953127|NCT00784719|Cyclosporine|cyclosporine|mesh-list
1953128|NCT00784719|Cyclosporins|cyclosporins|mesh-list
1953129|NCT00784719|Tofacitinib|tofacitinib|mesh-list
1953130|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953131|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953132|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953133|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
1953134|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953135|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
1953136|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953137|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
1953138|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1953139|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1953140|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1953141|NCT00784784|Zanamivir|zanamivir|mesh-list
1953142|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
1953143|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953144|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953145|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953146|NCT00784810|Acetaminophen|acetaminophen|mesh-list
1953147|NCT00784810|Oxycodone|oxycodone|mesh-list
1953148|NCT00784810|Codeine|codeine|mesh-list
1953149|NCT00784810|Naloxone|naloxone|mesh-list
1953150|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1953151|NCT00784810|Analgesics|analgesics|mesh-ancestor
1953152|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
1953153|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953154|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953155|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
1953156|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1953157|NCT00784810|Narcotics|narcotics|mesh-ancestor
1953158|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953159|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1953160|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
1953161|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
1953162|NCT00784836|Interferons|interferons|mesh-list
1953163|NCT00784836|Interferon-beta|interferon-beta|mesh-list
1953164|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
1953165|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953166|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
1953167|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953168|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
1953169|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953170|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1953171|NCT00784849|Methylene Blue|methylene blue|mesh-list
1953172|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953173|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953174|NCT00784875|Zolpidem|zolpidem|mesh-list
1953175|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1953176|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1953177|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953178|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953179|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1953180|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
1953181|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
1953182|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953183|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953184|NCT00784927|Dexamethasone|dexamethasone|mesh-list
1953185|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
1953186|NCT00784927|Rituximab|rituximab|mesh-list
1953187|NCT00784927|Lenalidomide|lenalidomide|mesh-list
1953188|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953189|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
1953190|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953191|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1953192|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1953193|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
1953194|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953195|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953196|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1953197|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1953198|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
1953199|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
1953200|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953201|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1953202|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
1953203|NCT00784927|Hormones|hormones|mesh-ancestor
1953204|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1953205|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1953206|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1953207|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1953208|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1953209|NCT00784927|Growth Substances|growth substances|mesh-ancestor
1953210|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
1953211|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
1953212|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
1953213|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953214|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
1953215|NCT00785213|Quinine|quinine|mesh-list
1953216|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1953217|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953218|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
1953219|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1953220|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1953221|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953222|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1953223|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1953224|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953225|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1953226|NCT00785213|Analgesics|analgesics|mesh-ancestor
1953227|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
1953228|NCT00785291|Paclitaxel|paclitaxel|mesh-list
1953229|NCT00785291|Epothilones|epothilones|mesh-list
1953230|NCT00785291|Epothilone B|epothilone b|mesh-list
1953231|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1953232|NCT00785291|Bevacizumab|bevacizumab|mesh-list
1953233|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1953234|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
1953235|NCT00785291|Antibodies|antibodies|mesh-list
1953236|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
1953237|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1953238|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
1953239|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1953240|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953241|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
1953242|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
1953243|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
1953244|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953245|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1953246|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1953247|NCT00785291|Growth Substances|growth substances|mesh-ancestor
1953248|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953249|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
1953250|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
1953251|NCT00785486|Quinine|quinine|mesh-list
1953252|NCT00785486|Midazolam|midazolam|mesh-list
1953253|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1953254|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1953255|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953256|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953257|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1953258|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1953259|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1953260|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1953261|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
1953262|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
1953263|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
1953264|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
1953265|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953266|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953267|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
1953268|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1953269|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1953270|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953271|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1953272|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1953273|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953274|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1953275|NCT00785486|Analgesics|analgesics|mesh-ancestor
1953276|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
1953277|NCT00785512|Nebivolol|nebivolol|mesh-list
1953278|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1953279|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
1953280|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1953281|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1953282|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1953283|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
1953284|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953285|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953286|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953287|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1953288|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
1953289|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953290|NCT00785577|Pregabalin|pregabalin|mesh-list
1953291|NCT00785577|Analgesics|analgesics|mesh-ancestor
1953292|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
1953293|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953294|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953295|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
1953296|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1953297|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1953298|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953299|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1953300|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1953301|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1953302|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953303|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1953304|NCT00785629|Calcium|calcium|mesh-list
1953305|NCT00785629|Sevelamer|sevelamer|mesh-list
1953306|NCT00785629|Calcium acetate|calcium acetate|mesh-list
1953307|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1953308|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953309|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
1953310|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
1953311|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953312|NCT00785772|Gabapentin|gabapentin|mesh-list
1953313|NCT00785772|Analgesics|analgesics|mesh-ancestor
1953314|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
1953315|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953316|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953317|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
1953318|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1953319|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1953320|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953321|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1953322|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1953323|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1953324|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953325|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953326|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
1953327|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
1953328|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953329|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1953330|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953331|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953332|NCT00785798|Doxorubicin|doxorubicin|mesh-list
1953333|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1953334|NCT00785798|Vorinostat|vorinostat|mesh-list
1953335|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1953336|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953337|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1953338|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1953339|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953340|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953341|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1953342|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
1953343|NCT00785980|Quinine|quinine|mesh-list
1953344|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1953345|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953346|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1953347|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1953348|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953349|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953350|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953351|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1953352|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1953353|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
1953354|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1953355|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1953356|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1953357|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953358|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1953359|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953360|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1953361|NCT00785980|Analgesics|analgesics|mesh-ancestor
1953362|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
1953363|NCT00786019|Vitamins|vitamins|mesh-list
1953364|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
1953365|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
1953366|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953367|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
1953368|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953369|NCT00786019|Protective Agents|protective agents|mesh-ancestor
1953370|NCT00786188|Paroxetine|paroxetine|mesh-list
1953371|NCT00786188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1953372|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1953373|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1953374|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953375|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953376|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
1953377|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953378|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1953379|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
1953380|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1953381|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1953382|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1953383|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953384|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
1953385|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1953386|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
1953387|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1953388|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
1953389|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953390|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953391|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
1953392|NCT00786474|Dalteparin|dalteparin|mesh-list
1953393|NCT00786474|Tinzaparin|tinzaparin|mesh-list
1953394|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1953395|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
1953396|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1953397|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1953398|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953399|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1953400|NCT00786487|Glycerol|glycerol|mesh-list
1953401|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1953402|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1953403|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1953404|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1953405|NCT00786487|Protective Agents|protective agents|mesh-ancestor
1953406|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953407|NCT00786643|Leucovorin|leucovorin|mesh-list
1953408|NCT00786643|Interferons|interferons|mesh-list
1953409|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
1953410|NCT00786643|Bevacizumab|bevacizumab|mesh-list
1953411|NCT00786643|Fluorouracil|fluorouracil|mesh-list
1953412|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
1953413|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1953414|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953415|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1953416|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1953417|NCT00786643|Growth Substances|growth substances|mesh-ancestor
1953418|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953419|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
1953420|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
1953421|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953422|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1953423|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953424|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
1953425|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
1953426|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953427|NCT00786643|Antidotes|antidotes|mesh-ancestor
1953428|NCT00786643|Protective Agents|protective agents|mesh-ancestor
1953429|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
1953430|NCT00786643|Vitamins|vitamins|mesh-ancestor
1953431|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
1953432|NCT00786825|Somatostatin|somatostatin|mesh-list
1953433|NCT00786825|Hormones|hormones|mesh-ancestor
1953434|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1953435|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953436|NCT00786838|Trabectedin|trabectedin|mesh-list
1953437|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1953438|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
1953439|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953440|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953441|NCT00786916|Lidocaine|lidocaine|mesh-list
1953442|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
1953443|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
1953444|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953445|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953446|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
1953447|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953448|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1953449|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1953450|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1953451|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1953452|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953453|NCT00786994|Petrolatum|petrolatum|mesh-list
1953454|NCT00786994|Emollients|emollients|mesh-ancestor
1953455|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
1953456|NCT00787150|Warfarin|warfarin|mesh-list
1953457|NCT00787150|Apixaban|apixaban|mesh-list
1953458|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
1953459|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1953460|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
1953461|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1953462|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
1953463|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953464|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953465|NCT00787254|Lansoprazole|lansoprazole|mesh-list
1953466|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
1953467|NCT00787254|Gefarnate|gefarnate|mesh-list
1953468|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1953469|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1953470|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1953471|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953472|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953473|NCT00787267|Dasatinib|dasatinib|mesh-list
1953474|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953475|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1953476|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953477|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953478|NCT00787332|Desirudin|desirudin|mesh-list
1953479|NCT00787332|Argatroban|argatroban|mesh-list
1953480|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
1953481|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1953482|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
1953483|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953484|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953485|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
1953486|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1953487|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1953488|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1953489|NCT00787527|Prednisone|prednisone|mesh-list
1953490|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
1953491|NCT00787527|Doxorubicin|doxorubicin|mesh-list
1953492|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1953493|NCT00787527|Vincristine|vincristine|mesh-list
1953494|NCT00787527|Vorinostat|vorinostat|mesh-list
1953495|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953496|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
1953497|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953498|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1953499|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1953500|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
1953501|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953502|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953503|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1953504|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1953505|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1953506|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1953507|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953508|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1953509|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
1953510|NCT00787527|Hormones|hormones|mesh-ancestor
1953511|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1953512|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1953513|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1953514|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
1953515|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
1953516|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
1953517|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1953518|NCT00787566|Granisetron|granisetron|mesh-list
1953519|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
1953520|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
1953521|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953522|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953523|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1953524|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1953525|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
1953526|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953527|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953528|NCT00787605|Amlodipine|amlodipine|mesh-list
1953529|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1953530|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1953531|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1953532|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1953533|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953534|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1953535|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953536|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
1953537|NCT00787605|Diuretics|diuretics|mesh-ancestor
1953538|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
1953539|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1953540|NCT00787644|Pioglitazone|pioglitazone|mesh-list
1953541|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1953542|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953543|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
1953544|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1953545|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1953546|NCT00787722|Prednisolone|prednisolone|mesh-list
1953547|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
1953548|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
1953549|NCT00787722|Rituximab|rituximab|mesh-list
1953550|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
1953551|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1953552|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1953553|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
1953554|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953555|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
1953556|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953557|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1953558|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1953559|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
1953560|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953561|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953562|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1953563|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1953564|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1953565|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
1953566|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
1953567|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953568|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1953569|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
1953570|NCT00787722|Hormones|hormones|mesh-ancestor
1953571|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1953572|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1953573|NCT00787722|Protective Agents|protective agents|mesh-ancestor
1953574|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1953575|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
1953576|NCT00787761|Busulfan|busulfan|mesh-list
1953577|NCT00787761|Methotrexate|methotrexate|mesh-list
1953578|NCT00787761|Fludarabine|fludarabine|mesh-list
1953579|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
1953580|NCT00787761|Tacrolimus|tacrolimus|mesh-list
1953581|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
1953582|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1953583|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953584|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
1953585|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953586|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1953587|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1953588|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
1953589|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953590|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953591|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1953592|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1953593|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
1953594|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1953595|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1953596|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
1953597|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
1953598|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953599|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1953600|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1953601|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1953602|NCT00787787|Capecitabine|capecitabine|mesh-list
1953603|NCT00787787|Sunitinib|sunitinib|mesh-list
1953604|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1953605|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
1953606|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953607|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953608|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1953609|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1953610|NCT00787787|Growth Substances|growth substances|mesh-ancestor
1953611|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953612|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
1953613|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1953614|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953615|NCT00787852|Paclitaxel|paclitaxel|mesh-list
1953616|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1953617|NCT00787852|Dasatinib|dasatinib|mesh-list
1953618|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1953619|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953620|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
1953621|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
1953622|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
1953623|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953624|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1953625|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953626|NCT00787891|Rabeprazole|rabeprazole|mesh-list
1953627|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1953628|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1953629|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1953630|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953631|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953632|NCT00787930|Valproic Acid|valproic acid|mesh-list
1953633|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
1953634|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953635|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953636|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
1953637|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953638|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953639|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
1953640|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1953641|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953642|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1953643|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1953644|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
1953645|NCT00788008|Propofol|propofol|mesh-list
1953646|NCT00788008|Isoflurane|isoflurane|mesh-list
1953647|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
1953648|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953649|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953650|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1953651|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1953652|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
1953653|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1953654|NCT00788151|Vaccines|vaccines|mesh-list
1953655|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1953656|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
1953657|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953658|NCT00788255|Oxytocin|oxytocin|mesh-list
1953659|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
1953660|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1953661|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953662|NCT00788372|Fentanyl|fentanyl|mesh-list
1953663|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1953664|NCT00788372|Narcotics|narcotics|mesh-ancestor
1953665|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953666|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953667|NCT00788372|Analgesics|analgesics|mesh-ancestor
1953668|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
1953669|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953670|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1953671|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1953672|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
1953673|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
1953674|NCT00788593|Pancreatin|pancreatin|mesh-list
1953675|NCT00788593|Pancrelipase|pancrelipase|mesh-list
1953676|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1953677|NCT00788710|Etoricoxib|etoricoxib|mesh-list
1953678|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1953679|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1953680|NCT00788710|Analgesics|analgesics|mesh-ancestor
1953681|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
1953682|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953683|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953684|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1953685|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1953686|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1953687|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1953688|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953689|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953690|NCT00788892|Cytarabine|cytarabine|mesh-list
1953691|NCT00788892|Daunorubicin|daunorubicin|mesh-list
1953692|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1953693|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
1953694|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953695|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953696|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
1953697|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953698|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953699|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
1953700|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953701|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1953702|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1953703|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1953704|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953705|NCT00788957|Panitumumab|panitumumab|mesh-list
1953706|NCT00788957|Rilotumumab|rilotumumab|mesh-list
1953707|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1953708|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953709|NCT00789035|Metformin|metformin|mesh-list
1953710|NCT00789035|Empagliflozin|empagliflozin|mesh-list
1953711|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1953712|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953713|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1953714|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953715|NCT00789074|Varenicline|varenicline|mesh-list
1953716|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1953717|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1953718|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
1953719|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953720|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953721|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953722|NCT00789113|Lamotrigine|lamotrigine|mesh-list
1953723|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
1953724|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1953725|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1953726|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953727|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1953728|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953729|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1953730|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1953731|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953732|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1953733|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1953734|NCT00789191|Metformin|metformin|mesh-list
1953735|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1953736|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
1953737|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1953738|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953739|NCT00789191|Incretins|incretins|mesh-ancestor
1953740|NCT00789191|Hormones|hormones|mesh-ancestor
1953741|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1953742|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1953743|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
1953744|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953745|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953746|NCT00789256|Bortezomib|bortezomib|mesh-list
1953747|NCT00789256|Melphalan|melphalan|mesh-list
1953748|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953749|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1953750|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
1953751|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953752|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1953753|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953754|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
1953755|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953756|NCT00789321|Amlodipine|amlodipine|mesh-list
1953757|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1953758|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1953759|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1953760|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953761|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1953762|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953763|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
1953764|NCT00789360|Loxapine|loxapine|mesh-list
1953765|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1953766|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1953767|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953768|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953769|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1953770|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1953771|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
1953772|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953773|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953774|NCT00789373|Pemetrexed|pemetrexed|mesh-list
1953775|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953776|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953777|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953778|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1953779|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1953780|NCT00789477|Aflibercept|aflibercept|mesh-list
1953781|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1953782|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1953783|NCT00789477|Growth Substances|growth substances|mesh-ancestor
1953784|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953785|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
1953786|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953787|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1953788|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1953789|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1953790|NCT00789555|Analgesics|analgesics|mesh-ancestor
1953791|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
1953792|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953793|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953794|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1953795|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1953796|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1953797|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1953798|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1953799|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
1953800|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
1953801|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953802|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953803|NCT00789581|Paclitaxel|paclitaxel|mesh-list
1953804|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
1953805|NCT00789581|Doxorubicin|doxorubicin|mesh-list
1953806|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1953807|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1953808|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953809|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
1953810|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
1953811|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
1953812|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953813|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953814|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
1953815|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953816|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1953817|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1953818|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
1953819|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1953820|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1953821|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1953822|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1953823|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953824|NCT00789672|Levodopa|levodopa|mesh-list
1953825|NCT00789672|Carbidopa|carbidopa|mesh-list
1953826|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1953827|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1953828|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
1953829|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953830|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953831|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953832|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1953833|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953834|NCT00789685|Interferons|interferons|mesh-list
1953835|NCT00789685|Interferon-beta|interferon-beta|mesh-list
1953836|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953837|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
1953838|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953839|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
1953840|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953841|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1953842|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1953843|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
1953844|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1953845|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1953846|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1953847|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953848|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953849|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1953850|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1953851|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1953852|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
1953853|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953854|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953855|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1953856|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1953857|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
1953858|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1953859|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1953860|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
1953861|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1953862|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1953863|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1953864|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1953865|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1953866|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
1953867|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953868|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1953869|NCT00789750|Pioglitazone|pioglitazone|mesh-list
1953870|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1953871|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1953872|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953873|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1953874|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1953875|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
1953876|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953877|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1953878|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
1953879|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
1953880|NCT00789776|Fludarabine|fludarabine|mesh-list
1953881|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
1953882|NCT00789776|Tacrolimus|tacrolimus|mesh-list
1953883|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953884|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
1953885|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953886|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1953887|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1953888|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
1953889|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953890|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953891|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1953892|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1953893|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
1953894|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1953895|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953896|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1953897|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1953898|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
1953899|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1953900|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953901|NCT00789802|Naproxen|naproxen|mesh-list
1953902|NCT00789802|Estradiol|estradiol|mesh-list
1953903|NCT00789802|Estrogens|estrogens|mesh-ancestor
1953904|NCT00789802|Hormones|hormones|mesh-ancestor
1953905|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1953906|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953907|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1953908|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1953909|NCT00789802|Analgesics|analgesics|mesh-ancestor
1953910|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
1953911|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953912|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1953913|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1953914|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
1953915|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1953916|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953917|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953918|NCT00789815|Midazolam|midazolam|mesh-list
1953919|NCT00789815|Propofol|propofol|mesh-list
1953920|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1953921|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953922|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953923|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1953924|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
1953925|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
1953926|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1953927|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1953928|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1953929|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1953930|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
1953931|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
1953932|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953933|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953934|NCT00789828|Everolimus|everolimus|mesh-list
1953935|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953936|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953937|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
1953938|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953939|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1953940|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
1953941|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1953942|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
1953943|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1953944|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1953945|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1953946|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1953947|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953948|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953949|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953950|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
1953951|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1953952|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1953953|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1953954|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1953955|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1953956|NCT00789880|Vitamin D|vitamin d|mesh-list
1953957|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
1953958|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
1953959|NCT00789880|Vitamins|vitamins|mesh-list
1953960|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
1953961|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953962|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1953963|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1953964|NCT00789958|Gemcitabine|gemcitabine|mesh-list
1953965|NCT00789958|Capecitabine|capecitabine|mesh-list
1953966|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1953967|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
1953968|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1953969|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953970|NCT00789958|Antiviral Agents|antiviral agents|mesh-ancestor
1953971|NCT00789958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953972|NCT00789958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1953973|NCT00789958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953974|NCT00789958|Immunologic Factors|immunologic factors|mesh-ancestor
1953975|NCT00789958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953976|NCT00789997|Levofloxacin|levofloxacin|mesh-list
1953977|NCT00789997|Ofloxacin|ofloxacin|mesh-list
1953978|NCT00789997|Prednisone|prednisone|mesh-list
1953979|NCT00789997|Etanercept|etanercept|mesh-list
1953980|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1953981|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
1953982|NCT00789997|Hormones|hormones|mesh-ancestor
1953983|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1953984|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1953985|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1953986|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1953987|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1953988|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1953989|NCT00789997|Analgesics|analgesics|mesh-ancestor
1953990|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
1953991|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1953992|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1953993|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1953994|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1953995|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
1953996|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1953997|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1953998|NCT00789997|Renal Agents|renal agents|mesh-ancestor
1953999|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1954000|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1954001|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1954002|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954003|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954004|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1954005|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1954006|NCT00790023|Ciclesonide|ciclesonide|mesh-list
1954007|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
1954008|NCT00790023|Hormones|hormones|mesh-ancestor
1954009|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1954010|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954011|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1954012|NCT00790036|Everolimus|everolimus|mesh-list
1954013|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954014|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954015|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
1954016|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954017|NCT00790062|Oxytocin|oxytocin|mesh-list
1954018|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
1954019|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1954020|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954021|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1954022|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1954023|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
1954024|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1954025|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1954026|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1954027|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1954028|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954029|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1954030|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1954031|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1954032|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
1954033|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954034|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954035|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1954036|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1954037|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
1954038|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1954039|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1954040|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
1954041|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1954042|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1954043|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954044|NCT00790205|Incretins|incretins|mesh-ancestor
1954045|NCT00790205|Hormones|hormones|mesh-ancestor
1954046|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1954047|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1954048|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
1954049|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954050|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954051|NCT00790218|Adenosine|adenosine|mesh-list
1954052|NCT00790218|Analgesics|analgesics|mesh-ancestor
1954053|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
1954054|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954055|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954056|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1954057|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
1954058|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1954059|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
1954060|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
1954061|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954062|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954063|NCT00790270|Ibuprofen|ibuprofen|mesh-list
1954064|NCT00790270|Amitriptyline|amitriptyline|mesh-list
1954065|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
1954066|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1954067|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1954068|NCT00790270|Analgesics|analgesics|mesh-ancestor
1954069|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
1954070|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954071|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954072|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1954073|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954074|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1954075|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954076|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954077|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1954078|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
1954079|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1954080|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1954081|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1954082|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1954083|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1954084|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1954085|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1954086|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1954087|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
1954088|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954089|NCT00790296|Hormones|hormones|mesh-list
1954090|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
1954091|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1954092|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954093|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1954094|NCT00790335|Plasminogen|plasminogen|mesh-list
1954095|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1954096|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1954097|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954098|NCT00790400|Everolimus|everolimus|mesh-list
1954099|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954100|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954101|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
1954102|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954103|NCT00790569|Nicotine|nicotine|mesh-list
1954104|NCT00790569|Varenicline|varenicline|mesh-list
1954105|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1954106|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
1954107|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954108|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954109|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1954110|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1954111|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
1954112|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954113|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954114|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
1954115|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
1954116|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1954117|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954118|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954119|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
1954120|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1954121|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1954122|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954123|NCT00790647|Bortezomib|bortezomib|mesh-list
1954124|NCT00790647|Melphalan|melphalan|mesh-list
1954125|NCT00790647|Sargramostim|sargramostim|mesh-list
1954126|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
1954127|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954128|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954129|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1954130|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
1954131|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954132|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1954133|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954134|NCT00790842|Aspirin|aspirin|mesh-list
1954135|NCT00790842|Dexamethasone|dexamethasone|mesh-list
1954136|NCT00790842|Lenalidomide|lenalidomide|mesh-list
1954137|NCT00790842|Heparin|heparin|mesh-list
1954138|NCT00790842|Calcium heparin|calcium heparin|mesh-list
1954139|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1954140|NCT00790842|Tinzaparin|tinzaparin|mesh-list
1954141|NCT00790842|Dalteparin|dalteparin|mesh-list
1954142|NCT00790842|Anticoagulants|anticoagulants|mesh-list
1954143|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1954144|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
1954145|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
1954146|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954147|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954148|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1954149|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
1954150|NCT00790842|Hormones|hormones|mesh-ancestor
1954151|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1954152|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1954153|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954154|NCT00790842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1954155|NCT00790842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1954156|NCT00790842|Analgesics|analgesics|mesh-ancestor
1954157|NCT00790842|Sensory System Agents|sensory system agents|mesh-ancestor
1954158|NCT00790842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954159|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1954160|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1954161|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954162|NCT00790842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1954163|NCT00790842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1954164|NCT00790842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954165|NCT00790842|Antipyretics|antipyretics|mesh-ancestor
1954166|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
1954167|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1954168|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1954169|NCT00790842|Growth Substances|growth substances|mesh-ancestor
1954170|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
1954171|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1954172|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1954173|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
1954174|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954175|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954176|NCT00790868|Cycloserine|cycloserine|mesh-list
1954177|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1954178|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954179|NCT00790868|Renal Agents|renal agents|mesh-ancestor
1954180|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1954181|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
1954182|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1954183|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
1954184|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954185|NCT00790907|Heparin|heparin|mesh-list
1954186|NCT00790907|PENTA|penta|mesh-list
1954187|NCT00790907|Fondaparinux|fondaparinux|mesh-list
1954188|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
1954189|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1954190|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1954191|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954192|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1954193|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
1954194|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1954195|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
1954196|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954197|NCT00790933|Vedolizumab|vedolizumab|mesh-list
1954198|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1954199|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
1954200|NCT00791037|Sargramostim|sargramostim|mesh-list
1954201|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954202|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
1954203|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954204|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954205|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1954206|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
1954207|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954208|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954209|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1954210|NCT00791219|Itraconazole|itraconazole|mesh-list
1954211|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
1954212|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
1954213|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954214|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1954215|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1954216|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954217|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954218|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1954219|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
1954220|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1954221|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954222|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1954223|NCT00791258|Amlodipine|amlodipine|mesh-list
1954224|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1954225|NCT00791258|Olmesartan|olmesartan|mesh-list
1954226|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1954227|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1954228|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1954229|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1954230|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954231|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1954232|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954233|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
1954234|NCT00791258|Diuretics|diuretics|mesh-ancestor
1954235|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
1954236|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1954237|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1954238|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1954239|NCT00791323|Ketorolac|ketorolac|mesh-list
1954240|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1954241|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
1954242|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1954243|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1954244|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1954245|NCT00791323|Analgesics|analgesics|mesh-ancestor
1954246|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
1954247|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954248|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954249|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1954250|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954251|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1954252|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954253|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954254|NCT00791479|Dulaglutide|dulaglutide|mesh-list
1954255|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1954256|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954257|NCT00791557|Infliximab|infliximab|mesh-list
1954258|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
1954259|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1954260|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954261|NCT00791648|Atorvastatin|atorvastatin|mesh-list
1954262|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1954263|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1954264|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
1954265|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954266|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1954267|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1954268|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954269|NCT00791700|Maraviroc|maraviroc|mesh-list
1954270|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1954271|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1954272|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954273|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1954274|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1954275|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
1954276|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954277|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1954278|NCT00791765|Etanercept|etanercept|mesh-list
1954279|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1954280|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1954281|NCT00791765|Analgesics|analgesics|mesh-ancestor
1954282|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
1954283|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954284|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954285|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1954286|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954287|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1954288|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954289|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
1954290|NCT00791778|Sorafenib|sorafenib|mesh-list
1954291|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954292|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1954293|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954294|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954295|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
1954296|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954297|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
1954298|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954299|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954300|NCT00791973|Fluticasone|fluticasone|mesh-list
1954301|NCT00791973|Xhance|xhance|mesh-list
1954302|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1954303|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1954304|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
1954305|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954306|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954307|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1954308|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
1954309|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
1954310|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1954311|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
1954312|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954313|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
1954314|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954315|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954316|NCT00792077|Lenalidomide|lenalidomide|mesh-list
1954317|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
1954318|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954319|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1954320|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1954321|NCT00792077|Growth Substances|growth substances|mesh-ancestor
1954322|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
1954323|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954324|NCT00792142|Thalidomide|thalidomide|mesh-list
1954325|NCT00792142|Dexamethasone|dexamethasone|mesh-list
1954326|NCT00792142|Bortezomib|bortezomib|mesh-list
1954327|NCT00792142|Melphalan|melphalan|mesh-list
1954328|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1954329|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
1954330|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
1954331|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954332|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954333|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1954334|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
1954335|NCT00792142|Hormones|hormones|mesh-ancestor
1954336|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1954337|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1954338|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954339|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1954340|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
1954341|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954342|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1954343|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954344|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
1954345|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
1954346|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1954347|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954348|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1954349|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1954350|NCT00792142|Growth Substances|growth substances|mesh-ancestor
1954351|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
1954352|NCT00792298|Suvorexant|suvorexant|mesh-list
1954353|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1954354|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1954355|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1954356|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954357|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1954358|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954359|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954360|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
1954361|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
1954362|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954363|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954364|NCT00792571|Epoprostenol|epoprostenol|mesh-list
1954365|NCT00792571|Beraprost|beraprost|mesh-list
1954366|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1954367|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
1954368|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1954369|NCT00792636|Naproxen|naproxen|mesh-list
1954370|NCT00792636|Sumatriptan|sumatriptan|mesh-list
1954371|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1954372|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1954373|NCT00792636|Analgesics|analgesics|mesh-ancestor
1954374|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
1954375|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954376|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954377|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1954378|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954379|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
1954380|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1954381|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954382|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954383|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1954384|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1954385|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1954386|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
1954387|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954388|NCT00792701|Gemcitabine|gemcitabine|mesh-list
1954389|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954390|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1954391|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
1954392|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954393|NCT00792701|Antiviral Agents|antiviral agents|mesh-ancestor
1954394|NCT00792701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954395|NCT00792701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954396|NCT00792701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954397|NCT00792701|Immunologic Factors|immunologic factors|mesh-ancestor
1954398|NCT00792701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954399|NCT00792909|Vaccines|vaccines|mesh-list
1954400|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1954401|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
1954402|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954403|NCT00792922|Azithromycin|azithromycin|mesh-list
1954404|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1954405|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954406|NCT00792935|Metformin|metformin|mesh-list
1954407|NCT00792935|Glimepiride|glimepiride|mesh-list
1954408|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1954409|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954410|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1954411|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954412|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
1954495|NCT00793546|Exemestane|exemestane|mesh-list
1954496|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954497|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1954498|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1954499|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954500|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954501|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1954502|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
1954503|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1954504|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954505|NCT00793572|Cyclosporine|cyclosporine|mesh-list
1954506|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
1954507|NCT00793572|Fludarabine|fludarabine|mesh-list
1954508|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
1954509|NCT00793572|Bortezomib|bortezomib|mesh-list
1954510|NCT00793572|Melphalan|melphalan|mesh-list
1954511|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
1954512|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1954513|NCT00793572|Cyclosporins|cyclosporins|mesh-list
1954514|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954515|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1954516|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
1954517|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954518|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954519|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
1954520|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954521|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954522|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
1954523|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954524|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
1954525|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954526|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1954527|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1954528|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1954529|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
1954530|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1954531|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1954532|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
1954533|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1954534|NCT00793585|Allopurinol|allopurinol|mesh-list
1954535|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
1954536|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954537|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954538|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
1954539|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954540|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1954541|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
1954542|NCT00793585|Protective Agents|protective agents|mesh-ancestor
1954543|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954544|NCT00793598|Brincidofovir|brincidofovir|mesh-list
1954545|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
1954546|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954547|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
1954548|NCT00793624|Olodaterol|olodaterol|mesh-list
1954549|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1954550|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
1954551|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954552|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954553|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1954554|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
1954555|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1954556|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1954557|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1954558|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
1954559|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954560|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954561|NCT00793650|Bortezomib|bortezomib|mesh-list
1954562|NCT00793650|Melphalan|melphalan|mesh-list
1954563|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954564|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1954565|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
1954566|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954567|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1954568|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954569|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
1954570|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954571|NCT00793780|Naltrexone|naltrexone|mesh-list
1954572|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1954573|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1954574|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954575|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
1954576|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954577|NCT00793819|Silodosin|silodosin|mesh-list
1954578|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1954579|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1954580|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1954581|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
1954582|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954583|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954584|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954585|NCT00793819|Urological Agents|urological agents|mesh-ancestor
1954586|NCT00793871|Sunitinib|sunitinib|mesh-list
1954587|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954588|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1954589|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1954590|NCT00793871|Growth Substances|growth substances|mesh-ancestor
1954591|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954592|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
1954593|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1954594|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954595|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954596|NCT00793910|Gabapentin|gabapentin|mesh-list
1954597|NCT00793910|Analgesics|analgesics|mesh-ancestor
1954598|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
1954599|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954600|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954601|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
1954602|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1954603|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1954604|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1954605|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1954606|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1954607|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1954608|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954609|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954610|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
1954611|NCT00794040|Methylphenidate|methylphenidate|mesh-list
1954612|NCT00794040|Citalopram|citalopram|mesh-list
1954613|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1954614|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954615|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1954616|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1954617|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1954618|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954619|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
1954620|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954621|NCT00794040|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1954622|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
1954623|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1954624|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
1954625|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1954626|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1954627|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1954628|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1954629|NCT00794144|Analgesics|analgesics|mesh-ancestor
1954630|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
1954631|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954632|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954633|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1954634|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954635|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1954636|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1954637|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1954638|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
1954639|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
1954640|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954641|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954642|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
1954643|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1954644|NCT00794313|Topiramate|topiramate|mesh-list
1954645|NCT00794313|Amantadine|amantadine|mesh-list
1954646|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
1954647|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1954648|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954649|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1954650|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1954651|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
1954652|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954653|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
1954654|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954655|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954656|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1954657|NCT00794313|Analgesics|analgesics|mesh-ancestor
1954658|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
1954659|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954660|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1954661|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1954662|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954663|NCT00794365|Varenicline|varenicline|mesh-list
1954664|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1954665|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1954666|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
1954667|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954668|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954669|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954670|NCT00794417|Pemetrexed|pemetrexed|mesh-list
1954671|NCT00794417|Aflibercept|aflibercept|mesh-list
1954672|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954673|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954674|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954675|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1954676|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1954677|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1954678|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1954679|NCT00794417|Growth Substances|growth substances|mesh-ancestor
1954680|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954681|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
1954682|NCT00794547|Calcitriol|calcitriol|mesh-list
1954683|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1954684|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954685|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1954686|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1954687|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954688|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1954689|NCT00794547|Vitamins|vitamins|mesh-ancestor
1954690|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
1954691|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1954692|NCT00794573|Varenicline|varenicline|mesh-list
1954693|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1954694|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1954695|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
1954696|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954697|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954698|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954699|NCT00794664|Mipomersen|mipomersen|mesh-list
1954700|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1954701|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1954702|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
1954703|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954704|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1954705|NCT00794677|Ezetimibe|ezetimibe|mesh-list
1954706|NCT00794677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1954707|NCT00794677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1954708|NCT00794677|Antimetabolites|antimetabolites|mesh-ancestor
1954709|NCT00794677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954710|NCT00794677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1954711|NCT00794820|Vidarabine|vidarabine|mesh-list
1954712|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
1954713|NCT00794820|Rituximab|rituximab|mesh-list
1954714|NCT00794820|Fludarabine|fludarabine|mesh-list
1954715|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
1954716|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954717|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
1954718|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954719|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954720|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1954721|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
1954722|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954723|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954724|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1954725|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1954726|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1954727|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
1954728|NCT00794820|Antiviral Agents|antiviral agents|mesh-ancestor
1954729|NCT00794820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954730|NCT00794950|Sunitinib|sunitinib|mesh-list
1954731|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954732|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1954733|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1954734|NCT00794950|Growth Substances|growth substances|mesh-ancestor
1954735|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954736|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
1954737|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1954738|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954739|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954740|NCT00794963|Metformin|metformin|mesh-list
1954741|NCT00794963|Orlistat|orlistat|mesh-list
1954742|NCT00794963|Irbesartan|irbesartan|mesh-list
1954743|NCT00794963|Fenofibrate|fenofibrate|mesh-list
1954744|NCT00794963|Pravastatin|pravastatin|mesh-list
1954745|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1954746|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954747|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1954748|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
1954749|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954750|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1954751|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1954752|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1954753|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954754|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1954755|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1954756|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1954757|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1954758|NCT00795002|Cytarabine|cytarabine|mesh-list
1954759|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
1954760|NCT00795002|Alvocidib|alvocidib|mesh-list
1954761|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1954762|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
1954763|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954764|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954765|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
1954766|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954767|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954768|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
1954769|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954770|NCT00795002|Analgesics|analgesics|mesh-ancestor
1954771|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
1954772|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954773|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1954774|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1954775|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954776|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
1954777|NCT00795002|Growth Substances|growth substances|mesh-ancestor
1954778|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1954779|NCT00795132|Cyclosporine|cyclosporine|mesh-list
1954780|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
1954781|NCT00795132|Fludarabine|fludarabine|mesh-list
1954782|NCT00795132|Busulfan|busulfan|mesh-list
1954783|NCT00795132|Cyclosporins|cyclosporins|mesh-list
1954784|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
1954785|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1954786|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954787|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954788|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954789|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
1954790|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954791|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954792|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
1954793|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954794|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
1954795|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954796|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1954797|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1954798|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1954799|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
1954800|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1954801|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
1954802|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1954803|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1954804|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
1954805|NCT00795145|Linezolid|linezolid|mesh-list
1954806|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1954807|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954808|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1954809|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1954810|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954811|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954812|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954813|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1954814|NCT00795210|Hormones|hormones|mesh-list
1954815|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
1954816|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1954817|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954818|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1954819|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1954820|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954821|NCT00795275|Incretins|incretins|mesh-ancestor
1954822|NCT00795275|Hormones|hormones|mesh-ancestor
1954823|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1954824|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1954825|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
1954826|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954827|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954828|NCT00795288|Simvastatin|simvastatin|mesh-list
1954829|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1954830|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1954831|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
1954832|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954833|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1954834|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1954835|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954836|NCT00795340|Paclitaxel|paclitaxel|mesh-list
1954837|NCT00795340|Carboplatin|carboplatin|mesh-list
1954838|NCT00795340|Cediranib|cediranib|mesh-list
1954839|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1954840|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954841|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
1954842|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
1954843|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
1954844|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954845|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954846|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1954847|NCT00795366|Vasopressins|vasopressins|mesh-list
1954848|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
1954849|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
1954850|NCT00795366|Coagulants|coagulants|mesh-ancestor
1954851|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1954852|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1954853|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
1954854|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954855|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
1954856|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1954857|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1954858|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
1954859|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954860|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954861|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954862|NCT00795509|Urological Agents|urological agents|mesh-ancestor
1954863|NCT00795600|Insulin|insulin|mesh-list
1954864|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1954865|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
1954866|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
1954867|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
1954868|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
1954869|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1954870|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954871|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
1954872|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1954873|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954874|NCT00795769|Ondansetron|ondansetron|mesh-list
1954875|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
1954876|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
1954877|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954878|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954879|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1954880|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
1954881|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
1954882|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1954883|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
1954884|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954885|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954886|NCT00795769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1954887|NCT00795769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1954888|NCT00795769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1954889|NCT00795769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1954890|NCT00795769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1954891|NCT00795886|Sirolimus|sirolimus|mesh-list
1954892|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1954893|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954894|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1954895|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954896|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
1954897|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954898|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
1954899|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954900|NCT00796003|Decitabine|decitabine|mesh-list
1954901|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1954902|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
1954903|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954904|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954905|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954906|NCT00796120|Doxorubicin|doxorubicin|mesh-list
1954907|NCT00796120|Ifosfamide|ifosfamide|mesh-list
1954908|NCT00796120|Trabectedin|trabectedin|mesh-list
1954909|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1954910|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954911|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1954912|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1954913|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954914|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954915|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1954916|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
1954917|NCT00796224|Azithromycin|azithromycin|mesh-list
1954918|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1954919|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1954920|NCT00796302|Risperidone|risperidone|mesh-list
1954921|NCT00796302|Methylphenidate|methylphenidate|mesh-list
1954922|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1954923|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
1954924|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954925|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954926|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954927|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1954928|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1954929|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1954930|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1954931|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1954932|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
1954933|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1954934|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1954935|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1954936|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1954937|NCT00796315|Doxylamine|doxylamine|mesh-list
1954938|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
1954939|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1954940|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
1954941|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
1954942|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954943|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954944|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954945|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
1954946|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
1954947|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954948|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1954949|NCT00796328|Phenylephrine|phenylephrine|mesh-list
1954950|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
1954951|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1954952|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
1954953|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
1954954|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1954955|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954956|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
1954957|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1954958|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
1954959|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
1954960|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1954961|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1954962|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1954963|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
1954964|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954965|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954966|NCT00796328|Protective Agents|protective agents|mesh-ancestor
1954967|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
1954968|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
1954969|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
1954970|NCT00796549|Afatinib|afatinib|mesh-list
1954971|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954972|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1954973|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1954974|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954975|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
1954976|NCT00796562|Busulfan|busulfan|mesh-list
1954977|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1954978|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
1954979|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954980|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1954981|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1954982|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
1954983|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954984|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1954985|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1954986|NCT00796614|Tamsulosin|tamsulosin|mesh-list
1954987|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1954988|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1954989|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1954990|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
1954991|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1954992|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1954993|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1954994|NCT00796614|Urological Agents|urological agents|mesh-ancestor
1954995|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
1954996|NCT00796653|Olodaterol|olodaterol|mesh-list
1954997|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1954998|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
1954999|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955000|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955001|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1955002|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
1955003|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1955004|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1955005|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1955006|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
1955007|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955008|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955009|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
1955010|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
1955011|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
1955012|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1955013|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1955014|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955015|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955016|NCT00796666|Urological Agents|urological agents|mesh-ancestor
1955017|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1955018|NCT00796705|Adalimumab|adalimumab|mesh-list
1955019|NCT00796705|Etanercept|etanercept|mesh-list
1955020|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1955021|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1955022|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1955023|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1955024|NCT00796705|Analgesics|analgesics|mesh-ancestor
1955025|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
1955026|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955027|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955028|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1955029|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1955030|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
1955031|NCT00796718|Capecitabine|capecitabine|mesh-list
1955032|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1955033|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
1955034|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955035|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955036|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
1955037|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1955038|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
1955039|NCT00796757|Interferons|interferons|mesh-list
1955040|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
1955041|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
1955042|NCT00796757|Bevacizumab|bevacizumab|mesh-list
1955043|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1955044|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955045|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1955046|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1955047|NCT00796757|Growth Substances|growth substances|mesh-ancestor
1955048|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955049|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
1955050|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
1955051|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955052|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
1955053|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
1955054|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1955055|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955056|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955057|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1955058|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1955059|NCT00796822|Protective Agents|protective agents|mesh-ancestor
1955060|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955061|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
1955062|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1955063|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
1955064|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1955065|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1955066|NCT00796978|Trastuzumab|trastuzumab|mesh-list
1955067|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1955068|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955069|NCT00796991|Paclitaxel|paclitaxel|mesh-list
1955070|NCT00796991|Carboplatin|carboplatin|mesh-list
1955071|NCT00796991|Ipilimumab|ipilimumab|mesh-list
1955072|NCT00796991|Dacarbazine|dacarbazine|mesh-list
1955073|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1955074|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955075|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
1955076|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
1955077|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
1955078|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955079|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1955080|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1955081|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1955082|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
1955083|NCT00797108|Amoxicillin|amoxicillin|mesh-list
1955084|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
1955085|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
1955086|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
1955087|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1955088|NCT00797108|Lactams|lactams|mesh-list
1955089|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1955090|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955091|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1955092|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955093|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955094|NCT00797225|Leuprolide|leuprolide|mesh-list
1955095|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1955096|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
1955097|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1955098|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955099|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1955100|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955101|NCT00797277|Lorazepam|lorazepam|mesh-list
1955102|NCT00797277|Haloperidol|haloperidol|mesh-list
1955103|NCT00797277|Olanzapine|olanzapine|mesh-list
1955104|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
1955105|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
1955106|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
1955107|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955108|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955109|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1955110|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1955111|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1955112|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1955113|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1955114|NCT00797277|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1955115|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1955116|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955117|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955118|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955119|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
1955120|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1955121|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
1955122|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1955123|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
1955124|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1955125|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1955126|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
1955127|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
1955128|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1955129|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1955130|NCT00797316|Diuretics|diuretics|mesh-ancestor
1955131|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
1955132|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955133|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1955134|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955135|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955136|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
1955137|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1955138|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
1955139|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955140|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
1955141|NCT00797459|Protective Agents|protective agents|mesh-ancestor
1955142|NCT00797797|Milnacipran|milnacipran|mesh-list
1955143|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
1955144|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1955145|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1955146|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955147|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955148|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955149|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955150|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1955151|NCT00797797|Analgesics|analgesics|mesh-ancestor
1955152|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
1955153|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955154|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
1955155|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1955156|NCT00797823|Insulin|insulin|mesh-list
1955157|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1955158|NCT00797823|Glucagon|glucagon|mesh-list
1955159|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1955160|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955161|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1955162|NCT00797823|Hormones|hormones|mesh-ancestor
1955163|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955164|NCT00797862|Amlodipine|amlodipine|mesh-list
1955165|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1955166|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1955167|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1955168|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955169|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955170|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1955171|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955172|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
1955173|NCT00797862|Diuretics|diuretics|mesh-ancestor
1955174|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
1955175|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1955176|NCT00797966|Citalopram|citalopram|mesh-list
1955177|NCT00797966|Fluoxetine|fluoxetine|mesh-list
1955178|NCT00797966|Paroxetine|paroxetine|mesh-list
1955179|NCT00797966|Sertraline|sertraline|mesh-list
1955180|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1955181|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
1955182|NCT00797966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1955183|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1955184|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955185|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955186|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955187|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
1955188|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955189|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1955190|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
1955191|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1955192|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1955193|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1955194|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955195|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1955196|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
1955197|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
1955198|NCT00798018|Lidocaine|lidocaine|mesh-list
1955199|NCT00798018|Tetracaine|tetracaine|mesh-list
1955200|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
1955201|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
1955202|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1955203|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955204|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
1955205|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955206|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1955207|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1955208|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1955209|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955210|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955211|NCT00798135|Itraconazole|itraconazole|mesh-list
1955212|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
1955213|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955214|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1955215|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1955216|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955217|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955218|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1955219|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
1955220|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955221|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955222|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1955223|NCT00798161|Metformin|metformin|mesh-list
1955224|NCT00798161|Linagliptin|linagliptin|mesh-list
1955225|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1955226|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955227|NCT00798161|Incretins|incretins|mesh-ancestor
1955228|NCT00798161|Hormones|hormones|mesh-ancestor
1955229|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955230|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1955231|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
1955232|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955233|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955234|NCT00798304|Vaccines|vaccines|mesh-list
1955235|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
1955236|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955237|NCT00798317|Plasminogen|plasminogen|mesh-list
1955238|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1955239|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1955240|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955241|NCT00798369|Triamcinolone|triamcinolone|mesh-list
1955242|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1955243|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1955244|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1955245|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1955246|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1955247|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
1955248|NCT00798369|Hormones|hormones|mesh-ancestor
1955249|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955250|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955251|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1955252|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
1955253|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955254|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955255|NCT00798434|Fesoterodine|fesoterodine|mesh-list
1955256|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1955257|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1955258|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
1955259|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955260|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955261|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955262|NCT00798434|Urological Agents|urological agents|mesh-ancestor
1955263|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1955264|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1955265|NCT00798603|Bevacizumab|bevacizumab|mesh-list
1955266|NCT00798603|Carboplatin|carboplatin|mesh-list
1955267|NCT00798603|Pemetrexed|pemetrexed|mesh-list
1955268|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1955269|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955270|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1955271|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1955272|NCT00798603|Growth Substances|growth substances|mesh-ancestor
1955273|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955274|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
1955275|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955276|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955277|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1955278|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1955279|NCT00798655|Cisplatin|cisplatin|mesh-list
1955280|NCT00798655|Panitumumab|panitumumab|mesh-list
1955281|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955282|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1955283|NCT00798694|Travoprost|travoprost|mesh-list
1955284|NCT00798694|Latanoprost|latanoprost|mesh-list
1955285|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1955286|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1955287|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1955288|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1955289|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1955290|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1955291|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955292|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955293|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955294|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955295|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
1955296|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1955297|NCT00798720|Bortezomib|bortezomib|mesh-list
1955298|NCT00798720|Vorinostat|vorinostat|mesh-list
1955299|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955300|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1955301|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955302|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955303|NCT00798759|Travoprost|travoprost|mesh-list
1955304|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1955305|NCT00798759|Latanoprost|latanoprost|mesh-list
1955306|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1955307|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1955308|NCT00798889|Sunitinib|sunitinib|mesh-list
1955309|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955310|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1955311|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1955312|NCT00798889|Growth Substances|growth substances|mesh-ancestor
1955313|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955314|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
1955315|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1955316|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955317|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955318|NCT00798967|Teduglutide|teduglutide|mesh-list
1955319|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1955320|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1955321|NCT00798967|Protective Agents|protective agents|mesh-ancestor
1955322|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955323|NCT00799227|Dexamethasone|dexamethasone|mesh-list
1955324|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1955325|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
1955326|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
1955327|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955328|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955329|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1955330|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
1955331|NCT00799227|Hormones|hormones|mesh-ancestor
1955332|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955333|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1955334|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475514|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475515|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
2475516|NCT01084473|Morphine|morphine|mesh-list
1955338|NCT00799292|Vasopressins|vasopressins|mesh-list
1955339|NCT00799292|Arginine Vasopressin|arginine vasopressin|mesh-list
1955340|NCT00799292|Hemostatics|hemostatics|mesh-ancestor
1955341|NCT00799292|Coagulants|coagulants|mesh-ancestor
1955342|NCT00799292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1955343|NCT00799292|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1955344|NCT00799292|Natriuretic Agents|natriuretic agents|mesh-ancestor
1955345|NCT00799292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955346|NCT00799383|Vitamin D|vitamin d|mesh-list
1955347|NCT00799383|Calcium|calcium|mesh-list
1955348|NCT00799383|Vitamins|vitamins|mesh-ancestor
1955349|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
1955350|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955351|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1955352|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1955353|NCT00799396|Aspirin|aspirin|mesh-list
1955354|NCT00799396|Clopidogrel|clopidogrel|mesh-list
1955355|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1955356|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1955357|NCT00799396|Analgesics|analgesics|mesh-ancestor
1955358|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
1955359|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955360|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955361|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1955362|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1955363|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1955364|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1955365|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955366|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1955367|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1955368|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955369|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
1955370|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1955371|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1955372|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1955373|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
1955374|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955375|NCT00799409|Methylphenidate|methylphenidate|mesh-list
1955376|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1955377|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955378|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1955379|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1955380|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955381|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955382|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
1955383|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955384|NCT00799435|Exenatide|exenatide|mesh-list
1955385|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1955386|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955387|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1955388|NCT00799435|Incretins|incretins|mesh-ancestor
1955389|NCT00799435|Hormones|hormones|mesh-ancestor
1955390|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955391|NCT00799487|Methylphenidate|methylphenidate|mesh-list
1955392|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1955393|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955394|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1955395|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1955396|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955397|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955398|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
1955399|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955400|NCT00799578|Cysteamine|cysteamine|mesh-list
1955401|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
1955402|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955403|NCT00799604|Clevidipine|clevidipine|mesh-list
1955404|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1955405|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955406|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955407|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1955408|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955409|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
1955410|NCT00799617|Testosterone|testosterone|mesh-list
1955411|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
1955412|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
1955413|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1955414|NCT00799617|Androgens|androgens|mesh-ancestor
1955415|NCT00799617|Hormones|hormones|mesh-ancestor
1955416|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955417|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955418|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1955419|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955420|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
1955421|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
1955422|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
1955423|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1955424|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1955425|NCT00799643|Analgesics|analgesics|mesh-ancestor
1955426|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
1955427|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955428|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955429|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1955430|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1955431|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1955432|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955433|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955434|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1955435|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1955436|NCT00799708|Estradiol|estradiol|mesh-list
1955437|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1955438|NCT00799708|Estrogens|estrogens|mesh-ancestor
1955439|NCT00799708|Hormones|hormones|mesh-ancestor
1955440|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955441|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955442|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1955443|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
1955444|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1955445|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1955446|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1955447|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1955448|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955449|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
1955450|NCT00799903|Darapladib|darapladib|mesh-list
1955451|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
1955452|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955453|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955454|NCT00800202|Paclitaxel|paclitaxel|mesh-list
1955455|NCT00800202|Bevacizumab|bevacizumab|mesh-list
1955456|NCT00800202|Carboplatin|carboplatin|mesh-list
1955457|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1955458|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1955459|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955460|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
1955461|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
1955462|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
1955463|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955464|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1955465|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1955466|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1955467|NCT00800202|Growth Substances|growth substances|mesh-ancestor
1955468|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955469|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
1955470|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1955471|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955472|NCT00800345|Topotecan|topotecan|mesh-list
1955473|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1955474|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1955475|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955476|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955477|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955478|NCT00800436|Trastuzumab|trastuzumab|mesh-list
1955479|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1955480|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955481|NCT00800540|Timolol|timolol|mesh-list
1955482|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1955483|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1955484|NCT00800540|Brinzolamide|brinzolamide|mesh-list
1955485|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1955486|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1955487|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1955488|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
1955489|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955490|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955491|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955492|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1955493|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1955494|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1955495|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1955496|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1955497|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1955498|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955499|NCT00800683|Linagliptin|linagliptin|mesh-list
1955500|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1955501|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955502|NCT00800683|Incretins|incretins|mesh-ancestor
1955503|NCT00800683|Hormones|hormones|mesh-ancestor
1955504|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955505|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1955506|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
1955507|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955508|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955509|NCT00800735|Interferons|interferons|mesh-list
1955510|NCT00800735|Ribavirin|ribavirin|mesh-list
1955511|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
1955512|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
1955513|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1955514|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955515|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
1955516|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955517|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
1955518|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955519|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
1955520|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955521|NCT00800839|Vidarabine|vidarabine|mesh-list
1955522|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
1955523|NCT00800839|Busulfan|busulfan|mesh-list
1955524|NCT00800839|Fludarabine|fludarabine|mesh-list
1955525|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
1955526|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1955527|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
1955528|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955529|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1955530|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1955531|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
1955532|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955533|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955534|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1955535|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1955536|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
1955537|NCT00800839|Antiviral Agents|antiviral agents|mesh-ancestor
1955538|NCT00800839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955539|NCT00800982|Etanercept|etanercept|mesh-list
1955540|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1955541|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1955542|NCT00800982|Analgesics|analgesics|mesh-ancestor
1955543|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
1955544|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955545|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955546|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1955547|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1955548|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1955549|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1955550|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
1955551|NCT00801099|Amoxicillin|amoxicillin|mesh-list
1955552|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1955553|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
1955554|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
1955555|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1955556|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955557|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1955558|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955559|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955560|NCT00801138|Dexamethasone|dexamethasone|mesh-list
1955561|NCT00801138|Bupivacaine|bupivacaine|mesh-list
1955562|NCT00801138|Ropivacaine|ropivacaine|mesh-list
1955563|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1955564|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
1955565|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
1955566|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955567|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955568|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1955569|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
1955570|NCT00801138|Hormones|hormones|mesh-ancestor
1955571|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955572|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1955573|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955574|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
1955575|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
1955576|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1955577|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
1955578|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1955579|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1955580|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955581|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1955582|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1955583|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955584|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955585|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
1955586|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955587|NCT00801398|Oxymorphone|oxymorphone|mesh-list
1955588|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1955589|NCT00801398|Narcotics|narcotics|mesh-ancestor
1955590|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1955591|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955592|NCT00801398|Analgesics|analgesics|mesh-ancestor
1955593|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
1955594|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955595|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1955596|NCT00801632|Prednisone|prednisone|mesh-list
1955597|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
1955598|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
1955599|NCT00801632|Rituximab|rituximab|mesh-list
1955600|NCT00801632|Tacrolimus|tacrolimus|mesh-list
1955601|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1955602|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
1955603|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955604|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1955605|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1955606|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
1955607|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955608|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955609|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1955610|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1955611|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1955612|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
1955613|NCT00801632|Hormones|hormones|mesh-ancestor
1955614|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955615|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1955616|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1955617|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955618|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
1955619|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
1955620|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955621|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1955622|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1955623|NCT00801632|Protective Agents|protective agents|mesh-ancestor
1955624|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1955625|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
1955626|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1955627|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
1955628|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955629|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955630|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1955631|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
1955632|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1955633|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1955634|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1955635|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
1955636|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955637|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955638|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
1955639|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1955640|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
1955641|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1955642|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1955643|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1955644|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955645|NCT00801723|Budesonide|budesonide|mesh-list
1955646|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1955647|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1955648|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
1955649|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955650|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955651|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1955652|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
1955653|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
1955654|NCT00801723|Hormones|hormones|mesh-ancestor
1955655|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955656|NCT00801801|Docetaxel|docetaxel|mesh-list
1955657|NCT00801801|Sorafenib|sorafenib|mesh-list
1955658|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955659|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
1955660|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
1955661|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
1955662|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955663|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1955664|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955665|NCT00801827|Fallypride|fallypride|mesh-list
1955666|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1955667|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1955668|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
1955669|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955670|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955671|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955672|NCT00802074|Ritonavir|ritonavir|mesh-list
1955673|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
1955674|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
1955675|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1955676|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1955677|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
1955678|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955679|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955680|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1955681|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1955682|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
1955683|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955684|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1955685|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1955686|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1955687|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1955688|NCT00802100|Metformin|metformin|mesh-list
1955689|NCT00802100|Benztropine|benztropine|mesh-list
1955690|NCT00802100|Olanzapine|olanzapine|mesh-list
1955691|NCT00802100|Aripiprazole|aripiprazole|mesh-list
1955692|NCT00802100|Perphenazine|perphenazine|mesh-list
1955693|NCT00802100|Simvastatin|simvastatin|mesh-list
1955694|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1955695|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955696|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1955697|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1955698|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
1955699|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955700|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1955701|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1955702|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955703|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
1955704|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
1955705|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955706|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1955707|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1955708|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1955709|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1955710|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1955711|NCT00802100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1955712|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1955713|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955714|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955715|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
1955716|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
1955717|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
1955718|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
1955719|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1955720|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1955721|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1955722|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1955723|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1955724|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1955725|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1955726|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1955727|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
1955728|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1955729|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1955730|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
1955731|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1955732|NCT00802113|Fludarabine|fludarabine|mesh-list
1955733|NCT00802113|Busulfan|busulfan|mesh-list
1955734|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1955735|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955736|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955737|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1955738|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
1955739|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955740|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
1955741|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1955742|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1955743|NCT00802360|Menotropins|menotropins|mesh-list
1955744|NCT00802360|Progesterone|progesterone|mesh-list
1955745|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1955746|NCT00802360|Ganirelix|ganirelix|mesh-list
1955747|NCT00802360|Progestins|progestins|mesh-ancestor
1955748|NCT00802360|Hormones|hormones|mesh-ancestor
1955749|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955750|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955751|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
1955752|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1955753|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
1955754|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1955755|NCT00802412|Topiramate|topiramate|mesh-list
1955756|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
1955757|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1955758|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955759|NCT00802529|Gentamicins|gentamicins|mesh-list
1955760|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
1955761|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1955762|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1955763|NCT00802529|Prednisolone|prednisolone|mesh-list
1955764|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
1955765|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1955766|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
1955767|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1955768|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
1955769|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
1955770|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955771|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955772|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1955773|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
1955774|NCT00802529|Hormones|hormones|mesh-ancestor
1955775|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1955776|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1955777|NCT00802529|Protective Agents|protective agents|mesh-ancestor
1955778|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1955779|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955780|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1955781|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955782|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1955783|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955784|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955785|NCT00802672|Ciclopirox|ciclopirox|mesh-list
1955786|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
1955787|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955788|NCT00802685|Ibuprofen|ibuprofen|mesh-list
1955789|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1955790|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1955791|NCT00802685|Analgesics|analgesics|mesh-ancestor
1955792|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
1955793|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955794|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955795|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1955796|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1955797|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1955798|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955799|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955800|NCT00802737|Ofatumumab|ofatumumab|mesh-list
1955801|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955802|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
1955803|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955804|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1955805|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955806|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955807|NCT00802880|Dacarbazine|dacarbazine|mesh-list
1955808|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1955809|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
1955810|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955811|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955812|NCT00802919|Varenicline|varenicline|mesh-list
1955813|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1955814|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1955815|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
1955816|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955817|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955818|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955819|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
1955820|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955821|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1955822|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1955823|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955824|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955825|NCT00803010|Sirolimus|sirolimus|mesh-list
1955826|NCT00803010|Methotrexate|methotrexate|mesh-list
1955827|NCT00803010|Tacrolimus|tacrolimus|mesh-list
1955828|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1955829|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
1955830|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1955831|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955832|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1955833|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
1955834|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955835|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955836|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
1955837|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955838|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1955839|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1955840|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
1955841|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1955842|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1955843|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1955844|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1955845|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955846|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1955847|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
1955848|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
1955849|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1955850|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1955851|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
1955852|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
1955853|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1955854|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955855|NCT00803049|Teriflunomide|teriflunomide|mesh-list
1955856|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1955857|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1955858|NCT00803049|Analgesics|analgesics|mesh-ancestor
1955859|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
1955860|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955861|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955862|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1955863|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1955864|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1955865|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
1955866|NCT00803062|Paclitaxel|paclitaxel|mesh-list
1955867|NCT00803062|Bevacizumab|bevacizumab|mesh-list
1955868|NCT00803062|Cisplatin|cisplatin|mesh-list
1955869|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1955870|NCT00803062|Topotecan|topotecan|mesh-list
1955871|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1955872|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
1955873|NCT00803062|Antibodies|antibodies|mesh-list
1955874|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
1955875|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1955876|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
1955877|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1955878|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955879|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
1955880|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
1955881|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
1955882|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955883|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1955884|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1955885|NCT00803062|Growth Substances|growth substances|mesh-ancestor
1955886|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955887|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
1955888|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
1955889|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1955890|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1955891|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955892|NCT00803101|Protein C|protein c|mesh-list
1955893|NCT00803101|Protein S|protein s|mesh-list
1955894|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
1955895|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1955896|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1955897|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955898|NCT00803114|Morphine|morphine|mesh-list
1955899|NCT00803114|Narcotics|narcotics|mesh-list
1955900|NCT00803114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1955901|NCT00803114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1955902|NCT00803114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955903|NCT00803114|Analgesics|analgesics|mesh-ancestor
1955904|NCT00803114|Sensory System Agents|sensory system agents|mesh-ancestor
1955905|NCT00803114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955906|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1955907|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1955908|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1955909|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955910|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955911|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955912|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955913|NCT00803361|Analgesics|analgesics|mesh-ancestor
1955914|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
1955915|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1955916|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
1955917|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1955918|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
1955919|NCT00803400|Alprazolam|alprazolam|mesh-list
1955920|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1955921|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1955922|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955923|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1955924|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1955925|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1955926|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
1955927|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
1955928|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1955929|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955930|NCT00803452|Azithromycin|azithromycin|mesh-list
1955931|NCT00803452|Doxycycline|doxycycline|mesh-list
1955932|NCT00803452|Minocycline|minocycline|mesh-list
1955933|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1955934|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955935|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
1955936|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1955937|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1955938|NCT00803543|Valacyclovir|valacyclovir|mesh-list
1955939|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
1955940|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955941|NCT00803569|Sargramostim|sargramostim|mesh-list
1955942|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
1955943|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955944|NCT00803595|Oseltamivir|oseltamivir|mesh-list
1955945|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
1955946|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1955947|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1955948|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955949|NCT00803634|Diltiazem|diltiazem|mesh-list
1955950|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
1955951|NCT00803634|Nitroprusside|nitroprusside|mesh-list
1955952|NCT00803634|Nicardipine|nicardipine|mesh-list
1955953|NCT00803634|Clevidipine|clevidipine|mesh-list
1955954|NCT00803634|Isosorbide|isosorbide|mesh-list
1955955|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
1955956|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
1955957|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
1955958|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1955959|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1955960|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955961|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1955962|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955963|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1955964|NCT00803634|Diuretics|diuretics|mesh-ancestor
1955965|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
1955966|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
1955967|NCT00803647|Leucovorin|leucovorin|mesh-list
1955968|NCT00803647|Fluorouracil|fluorouracil|mesh-list
1955969|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
1955970|NCT00803647|Cetuximab|cetuximab|mesh-list
1955971|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
1955972|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1955973|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1955974|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1955975|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1955976|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
1955977|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955978|NCT00803647|Antidotes|antidotes|mesh-ancestor
1955979|NCT00803647|Protective Agents|protective agents|mesh-ancestor
1955980|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
1955981|NCT00803647|Vitamins|vitamins|mesh-ancestor
1955982|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
1955983|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1955984|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
1955985|NCT00803686|Calcitonin|calcitonin|mesh-list
1955986|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1955987|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955988|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1955989|NCT00803712|Vitamin D|vitamin d|mesh-list
1955990|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
1955991|NCT00803712|Vitamins|vitamins|mesh-list
1955992|NCT00803712|Cinacalcet|cinacalcet|mesh-list
1955993|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
1955994|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1955995|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1955996|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1955997|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1955998|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
1955999|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1956000|NCT00803738|Terconazole|terconazole|mesh-list
1956001|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
1956002|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956003|NCT00803790|Vitamin D|vitamin d|mesh-list
1956004|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
1956005|NCT00803790|Alendronate|alendronate|mesh-list
1956006|NCT00803790|Vitamins|vitamins|mesh-list
1956007|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
1956008|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956009|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1956010|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1956011|NCT00804141|Bromides|bromides|mesh-list
1956012|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
1956013|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
1956014|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1956015|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956016|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
1956017|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956018|NCT00804193|Ciclopirox|ciclopirox|mesh-list
1956019|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
1956020|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956021|NCT00804609|Lidocaine|lidocaine|mesh-list
1956022|NCT00804609|Morphine|morphine|mesh-list
1956023|NCT00804609|Anesthetics|anesthetics|mesh-list
1956024|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
1956025|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1956026|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956027|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
1956028|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956029|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1956030|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1956031|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1956032|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1956033|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956034|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1956035|NCT00804609|Narcotics|narcotics|mesh-ancestor
1956036|NCT00804609|Analgesics|analgesics|mesh-ancestor
1956037|NCT00804648|Timolol|timolol|mesh-list
1956038|NCT00804648|Maleic acid|maleic acid|mesh-list
1956039|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1956040|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1956041|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
1956042|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956043|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956044|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956045|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1956046|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1956047|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956048|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
1956049|NCT00804687|Ephedrine|ephedrine|mesh-list
1956050|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1956051|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
1956052|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956053|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956054|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1956055|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
1956056|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
1956057|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1956058|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1956059|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
1956060|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
1956061|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956062|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956063|NCT00804843|Niacin|niacin|mesh-list
1956064|NCT00804843|Atorvastatin|atorvastatin|mesh-list
1956065|NCT00804843|Simvastatin|simvastatin|mesh-list
1956066|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1956067|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1956068|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
1956069|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956070|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1956071|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1956072|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956073|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
1956074|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
1956075|NCT00804843|Vitamins|vitamins|mesh-ancestor
1956076|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
1956077|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956078|NCT00804908|Temozolomide|temozolomide|mesh-list
1956079|NCT00804908|Veliparib|veliparib|mesh-list
1956080|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1956081|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
1956082|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956083|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956084|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1956085|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956086|NCT00804973|Sumatriptan|sumatriptan|mesh-list
1956087|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1956088|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1956089|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1956090|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
1956091|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956092|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956093|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956094|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1956095|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1956096|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956097|NCT00805142|Tapentadol|tapentadol|mesh-list
1956098|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1956099|NCT00805142|Narcotics|narcotics|mesh-ancestor
1956100|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1956101|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956102|NCT00805142|Analgesics|analgesics|mesh-ancestor
1956103|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
1956104|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956105|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1956106|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1956107|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1956108|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956109|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
1956110|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956111|NCT00805194|Docetaxel|docetaxel|mesh-list
1956112|NCT00805194|Nintedanib|nintedanib|mesh-list
1956113|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956114|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
1956115|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
1956116|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
1956117|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956118|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1956119|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956120|NCT00805207|Estradiol|estradiol|mesh-list
1956121|NCT00805207|Estrogens|estrogens|mesh-list
1956122|NCT00805207|Testosterone|testosterone|mesh-list
1956123|NCT00805207|Progesterone|progesterone|mesh-list
1956124|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
1956125|NCT00805207|Hormones|hormones|mesh-ancestor
2209029|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956126|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1956127|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956128|NCT00805207|Androgens|androgens|mesh-ancestor
1956129|NCT00805207|Progestins|progestins|mesh-ancestor
1956130|NCT00805285|Budesonide|budesonide|mesh-list
1956131|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
1956132|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1956133|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1956134|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
1956135|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956136|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956137|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1956138|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
1956139|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
1956140|NCT00805285|Hormones|hormones|mesh-ancestor
1956141|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1956142|NCT00805493|Riluzole|riluzole|mesh-list
1956143|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
1956144|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1956145|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1956146|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956147|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956148|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956149|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1956150|NCT00805493|Protective Agents|protective agents|mesh-ancestor
1956151|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1956152|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1956153|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956154|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
1956155|NCT00805675|Tenofovir|tenofovir|mesh-list
1956156|NCT00805675|Telbivudine|telbivudine|mesh-list
1956157|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
1956158|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956159|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1956160|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1956161|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956162|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956163|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1956164|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1956165|NCT00805740|Caspofungin|caspofungin|mesh-list
1956166|NCT00805740|Anidulafungin|anidulafungin|mesh-list
1956167|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
1956168|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956169|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956170|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956171|NCT00805766|Infliximab|infliximab|mesh-list
1956172|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
1956173|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1956174|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1956175|NCT00805792|Donepezil|donepezil|mesh-list
1956176|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1956177|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956178|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956179|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
1956180|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956181|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956182|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
1956183|NCT00805935|Leuprolide|leuprolide|mesh-list
1956184|NCT00805935|Menotropins|menotropins|mesh-list
1956185|NCT00805935|Progesterone|progesterone|mesh-list
1956186|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1956187|NCT00805935|Progestins|progestins|mesh-ancestor
1956188|NCT00805935|Hormones|hormones|mesh-ancestor
1956189|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1956190|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956191|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1956192|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
1956193|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1956194|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1956195|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956211|NCT00806026|Pregabalin|pregabalin|mesh-list
1956212|NCT00806026|Pramipexole|pramipexole|mesh-list
1956213|NCT00806026|Analgesics|analgesics|mesh-ancestor
1956214|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
1956215|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956216|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956217|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
1956218|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1956219|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1956220|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956221|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1956222|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1956223|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1956224|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1956225|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1956226|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
1956227|NCT00806026|Protective Agents|protective agents|mesh-ancestor
1956228|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1956229|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1956230|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
1956231|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
1956232|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956233|NCT00806078|Quinine|quinine|mesh-list
1956234|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
1956235|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1956236|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1956237|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956238|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1956239|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956240|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1956241|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956242|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1956243|NCT00806078|Analgesics|analgesics|mesh-ancestor
1956244|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
1956245|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
1956246|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956247|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1956248|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1956249|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956250|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956251|NCT00806195|Vaccines|vaccines|mesh-list
1956252|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1956253|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
1956254|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956255|NCT00806221|Emollients|emollients|mesh-list
1956256|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
1956257|NCT00806234|Metformin|metformin|mesh-list
1956258|NCT00806234|Olanzapine|olanzapine|mesh-list
1956259|NCT00806234|Risperidone|risperidone|mesh-list
1956260|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1956261|NCT00806234|Aripiprazole|aripiprazole|mesh-list
1956262|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1956263|NCT00806234|Ziprasidone|ziprasidone|mesh-list
1956264|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1956265|NCT00806234|Asenapine|asenapine|mesh-list
1956266|NCT00806234|Iloperidone|iloperidone|mesh-list
1956267|NCT00806234|Perphenazine|perphenazine|mesh-list
1956268|NCT00806234|Fluoxetine|fluoxetine|mesh-list
1956269|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1956270|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956271|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1956272|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
1956273|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956274|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956275|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1956276|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1956277|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1956278|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2745574|NCT02866682|Tacrolimus|tacrolimus|mesh-list
1956279|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1956280|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
1956281|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
1956282|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
1956283|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956284|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1956285|NCT00806234|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1956286|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1956287|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1956288|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
1956289|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
1956290|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1956291|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1956292|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1956293|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1956294|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1956295|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1956296|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1956297|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956298|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1956299|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1956300|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1956301|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
1956302|NCT00806260|Ethanol|ethanol|mesh-list
1956303|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1956304|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956305|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1956306|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956307|NCT00806286|Paclitaxel|paclitaxel|mesh-list
1956308|NCT00806286|Carboplatin|carboplatin|mesh-list
1956309|NCT00806286|Efatutazone|efatutazone|mesh-list
1956310|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1956311|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956312|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
1956313|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
1956314|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
1956315|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956316|NCT00806351|Caspofungin|caspofungin|mesh-list
1956317|NCT00806351|Anidulafungin|anidulafungin|mesh-list
1956318|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
1956319|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956320|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956321|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956322|NCT00806403|Reteplase|reteplase|mesh-list
1956323|NCT00806403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1956324|NCT00806403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1956325|NCT00806403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956326|NCT00806416|Vitamin D|vitamin d|mesh-list
1956327|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
1956328|NCT00806416|Alendronate|alendronate|mesh-list
1956329|NCT00806416|Vitamins|vitamins|mesh-ancestor
1956330|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
1956331|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956332|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1956333|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1956334|NCT00806442|Borage oil|borage oil|mesh-list
1956335|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1956336|NCT00806494|Fesoterodine|fesoterodine|mesh-list
1956337|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1956338|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1956339|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
1956340|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956341|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956342|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956343|NCT00806494|Urological Agents|urological agents|mesh-ancestor
1956344|NCT00806598|Cyclosporine|cyclosporine|mesh-list
1956345|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
1956346|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1956347|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1956348|NCT00806598|Prednisolone|prednisolone|mesh-list
1956349|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
1956350|NCT00806598|Cyclosporins|cyclosporins|mesh-list
1956351|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
1956352|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1956353|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1956354|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
1956355|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956356|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956357|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1956358|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
1956359|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956360|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
1956361|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956362|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
1956363|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1956364|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1956365|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1956366|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
1956367|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
1956368|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956369|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1956370|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
1956371|NCT00806598|Hormones|hormones|mesh-ancestor
1956372|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1956373|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1956374|NCT00806598|Protective Agents|protective agents|mesh-ancestor
1956375|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1956376|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956377|NCT00806624|Warfarin|warfarin|mesh-list
1956378|NCT00806624|Edoxaban|edoxaban|mesh-list
1956379|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
1956380|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1956381|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
1956382|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1956383|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
1956384|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956385|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956386|NCT00806676|Vaccines|vaccines|mesh-list
1956387|NCT00806676|Immunologic Factors|immunologic factors|mesh-ancestor
1956388|NCT00806676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956389|NCT00806819|Folic Acid|folic acid|mesh-list
1956390|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
1956391|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
1956392|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
1956393|NCT00806819|Dexamethasone|dexamethasone|mesh-list
1956394|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
1956395|NCT00806819|Pemetrexed|pemetrexed|mesh-list
1956396|NCT00806819|Nintedanib|nintedanib|mesh-list
1956397|NCT00806819|BB 1101|bb 1101|mesh-list
1956398|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1956399|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
1956400|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
1956401|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956402|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956403|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1956404|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
1956405|NCT00806819|Hormones|hormones|mesh-ancestor
1956406|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1956407|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1956408|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956409|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
1956410|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956411|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956412|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1956413|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1956414|NCT00806819|Hematinics|hematinics|mesh-ancestor
1956415|NCT00806819|Vitamins|vitamins|mesh-ancestor
1956416|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
1956417|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1956418|NCT00807014|Adapalene|adapalene|mesh-list
1956419|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1956420|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1956421|NCT00807014|Analgesics|analgesics|mesh-ancestor
1956422|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
1956423|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956424|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956425|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1956426|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1956427|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
1956428|NCT00807092|Insulin|insulin|mesh-list
1956429|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1956430|NCT00807092|Metformin|metformin|mesh-list
1956431|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
1956432|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
1956433|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
1956434|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1956435|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956436|NCT00807144|Tacrolimus|tacrolimus|mesh-list
1956437|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1956438|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
1956439|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956440|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1956441|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956442|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956443|NCT00807209|Fentanyl|fentanyl|mesh-list
1956444|NCT00807209|Bupivacaine|bupivacaine|mesh-list
1956445|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
1956446|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
1956447|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1956448|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956449|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
1956450|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956451|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1956452|NCT00807209|Narcotics|narcotics|mesh-ancestor
1956453|NCT00807209|Analgesics|analgesics|mesh-ancestor
1956454|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1956455|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1956456|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
1956457|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1956458|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
1956459|NCT00807248|Gaboxadol|gaboxadol|mesh-list
1956460|NCT00807248|Dexetimide|dexetimide|mesh-list
1956461|NCT00807248|Citalopram|citalopram|mesh-list
1956462|NCT00807248|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1956463|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1956464|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1956465|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956466|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956467|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
1956468|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956469|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1956470|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
1956471|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1956472|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1956473|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1956474|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
1956475|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
1956476|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956477|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1956478|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1956479|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
1956480|NCT00807248|Analgesics|analgesics|mesh-ancestor
1956481|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
1956482|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
1956483|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
1956484|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
1956485|NCT00807573|Paclitaxel|paclitaxel|mesh-list
1956486|NCT00807573|Bevacizumab|bevacizumab|mesh-list
1956487|NCT00807573|Pemetrexed|pemetrexed|mesh-list
1956488|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1956489|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956490|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
1956491|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
1956492|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
1956493|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956494|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1956495|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1956496|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1956497|NCT00807573|Growth Substances|growth substances|mesh-ancestor
1956498|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956499|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
1956500|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956501|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1956502|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1956503|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1956504|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1956505|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
1956506|NCT00807586|Prednisolone|prednisolone|mesh-list
1956507|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
1956508|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1956509|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
1956510|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1956511|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
1956512|NCT00807586|Hormones|hormones|mesh-ancestor
1956513|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1956514|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956515|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1956516|NCT00807586|Protective Agents|protective agents|mesh-ancestor
1956517|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1956518|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956519|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
1956520|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
1956521|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956522|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1956523|NCT00807599|Dexamethasone|dexamethasone|mesh-list
1956524|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
1956525|NCT00807599|Lenalidomide|lenalidomide|mesh-list
1956526|NCT00807599|Melphalan|melphalan|mesh-list
1956527|NCT00807599|BB 1101|bb 1101|mesh-list
1956528|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1956529|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
1956530|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
1956531|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956532|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956533|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1956534|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
1956535|NCT00807599|Hormones|hormones|mesh-ancestor
1956536|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1956537|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1956538|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956539|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
1956540|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956541|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956542|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
1956543|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1956544|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1956545|NCT00807599|Growth Substances|growth substances|mesh-ancestor
1956546|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
1956547|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1956548|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
1956549|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1956550|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1956551|NCT00807742|Nicotine|nicotine|mesh-list
1956552|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1956553|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
1956554|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956555|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956556|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1956557|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1956558|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
1956559|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956560|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956561|NCT00807768|Paclitaxel|paclitaxel|mesh-list
1956562|NCT00807768|Carboplatin|carboplatin|mesh-list
1956563|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1956564|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1956565|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956566|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
1956567|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
1956568|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
1956569|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956570|NCT00807846|Celecoxib|celecoxib|mesh-list
1956571|NCT00807846|Naproxen|naproxen|mesh-list
1956572|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1956573|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1956574|NCT00807846|Analgesics|analgesics|mesh-ancestor
1956575|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
1956576|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956577|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956578|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1956579|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1956580|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1956581|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1956582|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956583|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956584|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
1956585|NCT00807937|Lorazepam|lorazepam|mesh-list
1956586|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
1956587|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
1956588|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
1956589|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956590|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956591|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1956592|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1956593|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1956594|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1956595|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1956596|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1956597|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
1956598|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
1956599|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956600|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956601|NCT00807989|Lamotrigine|lamotrigine|mesh-list
1956602|NCT00807989|Carbamazepine|carbamazepine|mesh-list
1956603|NCT00807989|Valproic Acid|valproic acid|mesh-list
1956604|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
1956605|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1956606|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1956607|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956608|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1956609|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956610|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1956611|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1956612|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1956613|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1956614|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1956615|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956616|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
1956617|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956618|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
1956619|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1956620|NCT00807989|Analgesics|analgesics|mesh-ancestor
1956621|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
1956622|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956623|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1956624|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1956625|NCT00808015|Varenicline|varenicline|mesh-list
1956626|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1956627|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1956628|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
1956629|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956630|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956631|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956632|NCT00808028|Vaccines|vaccines|mesh-list
1956633|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
1956634|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956635|NCT00808067|Dabigatran|dabigatran|mesh-list
1956636|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
1956637|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1956638|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
1956639|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956640|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956641|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
1956642|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
1956643|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1956644|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
1956645|NCT00808132|Estrogens|estrogens|mesh-list
1956646|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1956647|NCT00808132|Hormones|hormones|mesh-ancestor
1956648|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1956649|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956650|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1956651|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1956652|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1956653|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
1956654|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1956655|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1956656|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1956657|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1956658|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1956659|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956660|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1956661|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1956662|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
1956663|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1956664|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
1956665|NCT00808210|Methotrexate|methotrexate|mesh-list
1956666|NCT00808210|Infliximab|infliximab|mesh-list
1956667|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
1956668|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1956669|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
1956670|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1956671|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956672|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1956673|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
1956674|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956675|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956676|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
1956677|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956678|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1956679|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1956680|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
1956681|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1956682|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1956683|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1956684|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
1956685|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
1956686|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956687|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1956688|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
1956689|NCT00808210|Hormones|hormones|mesh-ancestor
1956690|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1956691|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1956692|NCT00808210|Protective Agents|protective agents|mesh-ancestor
1956693|NCT00808405|Acyclovir|acyclovir|mesh-list
1956694|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
1956695|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956696|NCT00808444|Vaccines|vaccines|mesh-list
1956697|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1956698|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
1956699|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956700|NCT00808470|Ascorbic Acid|ascorbic acid|mesh-list
1956701|NCT00808470|Beta Carotene|beta carotene|mesh-list
1956702|NCT00808470|Carotenoids|carotenoids|mesh-list
1956703|NCT00808470|Vitamins|vitamins|mesh-ancestor
1956704|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
1956705|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956706|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
1956707|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956708|NCT00808470|Protective Agents|protective agents|mesh-ancestor
1956709|NCT00808470|Provitamins|provitamins|mesh-ancestor
1956710|NCT00808509|Adalimumab|adalimumab|mesh-list
1956711|NCT00808509|Methotrexate|methotrexate|mesh-list
1956712|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1956713|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
1956714|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1956715|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956716|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1956717|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
1956718|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956719|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956720|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
1956721|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956722|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1956723|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1956724|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
1956725|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1956726|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1956727|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1956728|NCT00808639|Doxorubicin|doxorubicin|mesh-list
1956729|NCT00808639|Methotrexate|methotrexate|mesh-list
1956730|NCT00808639|Vinblastine|vinblastine|mesh-list
1956731|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956732|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1956733|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1956734|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1956735|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956736|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956737|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1956738|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
1956739|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1956740|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956741|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1956742|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
1956743|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
1956744|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1956745|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1956746|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
1956747|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1956748|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1956749|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1956750|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
1956751|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
1956752|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
1956753|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
1956754|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1956755|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1956756|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956757|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1956758|NCT00808665|Analgesics|analgesics|mesh-ancestor
1956759|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
1956760|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956761|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1956762|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1956763|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1956764|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
1956765|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956766|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956767|NCT00809055|Caffeine|caffeine|mesh-list
1956768|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
1956769|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956770|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1956771|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956772|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1956773|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956774|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1956775|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1956776|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
1956777|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956778|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
1956779|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1956780|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
1956781|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956782|NCT00809094|Expectorants|expectorants|mesh-ancestor
1956783|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
1956784|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1956785|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
1956786|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956787|NCT00809094|Protective Agents|protective agents|mesh-ancestor
1956788|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956789|NCT00809094|Antidotes|antidotes|mesh-ancestor
1956790|NCT00809133|Paclitaxel|paclitaxel|mesh-list
1956791|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1956792|NCT00809133|Bevacizumab|bevacizumab|mesh-list
1956793|NCT00809133|Carboplatin|carboplatin|mesh-list
1956794|NCT00809133|Afatinib|afatinib|mesh-list
1956795|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1956796|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956797|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
1956798|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
1956799|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
1956800|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956801|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1956802|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1956803|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1956804|NCT00809133|Growth Substances|growth substances|mesh-ancestor
1956805|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956806|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
1956807|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1956808|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956809|NCT00809185|Everolimus|everolimus|mesh-list
1956810|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956811|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1956812|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
1956813|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956814|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
1956815|NCT00809276|Busulfan|busulfan|mesh-list
1956816|NCT00809276|Fludarabine|fludarabine|mesh-list
1956817|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1956818|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
1956819|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956820|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1956821|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1956822|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
1956823|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956824|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956825|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1956826|NCT00809328|Azithromycin|azithromycin|mesh-list
1956827|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1956828|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956829|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
1956830|NCT00809354|Tanezumab|tanezumab|mesh-list
1956831|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1956832|NCT00809354|Analgesics|analgesics|mesh-ancestor
1956833|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
1956834|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956835|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956836|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1956837|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1956838|NCT00809757|Albuterol|albuterol|mesh-list
1956839|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1956840|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
1956841|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956842|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956843|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1956844|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
1956845|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
1956846|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1956847|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1956848|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1956849|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1956850|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
1956851|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956852|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956853|NCT00809783|Tanezumab|tanezumab|mesh-list
1956854|NCT00809783|Analgesics|analgesics|mesh-ancestor
1956855|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
1956856|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956857|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956858|NCT00809809|Zinc|zinc|mesh-list
1956859|NCT00809809|Trace Elements|trace elements|mesh-ancestor
1956860|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
1956861|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956862|NCT00809835|Galantamine|galantamine|mesh-list
1956863|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1956864|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956865|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956866|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
1956867|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956868|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956869|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1956870|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
1956871|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956872|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
1956873|NCT00809848|Bimatoprost|bimatoprost|mesh-list
1956874|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1956875|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1956876|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1956877|NCT00809926|Valsartan|valsartan|mesh-list
1956878|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1956879|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1956880|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1956881|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956882|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
1956883|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1956884|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
1956885|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1956886|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
1956887|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956888|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956889|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
1956890|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1956891|NCT00810069|Citalopram|citalopram|mesh-list
1956892|NCT00810069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1956893|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1956894|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1956895|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956896|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1956897|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
1956898|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956899|NCT00810069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1956900|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
1956901|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1956902|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1956903|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1956904|NCT00810069|Analgesics|analgesics|mesh-ancestor
1956905|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
1956906|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
1956907|NCT00810108|Ritonavir|ritonavir|mesh-list
1956908|NCT00810108|Lopinavir|lopinavir|mesh-list
1956909|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1956910|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1956911|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
1956912|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956913|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956914|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1956915|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1956916|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
1956917|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956918|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1956919|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1956920|NCT00810199|Methotrexate|methotrexate|mesh-list
1956921|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1956922|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
1956923|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1956924|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956925|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1956926|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
1956927|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956928|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956929|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
1956930|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956931|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1956932|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1956933|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
1956934|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1956935|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1956936|NCT00810303|Efavirenz|efavirenz|mesh-list
1956937|NCT00810303|Ezetimibe|ezetimibe|mesh-list
1956938|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1956939|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1956940|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
1956941|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956942|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1956943|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1956944|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1956945|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956946|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
1956947|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956948|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1956949|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1956950|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1956951|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1956952|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1956953|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1956954|NCT00810394|Sorafenib|sorafenib|mesh-list
1956955|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956956|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1956957|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209030|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956958|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956959|NCT00810407|Rifabutin|rifabutin|mesh-list
1956960|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1956961|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956962|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1956963|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
2475517|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2475518|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475519|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475520|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2475521|NCT01084473|Analgesics|analgesics|mesh-ancestor
1956969|NCT00810576|Bortezomib|bortezomib|mesh-list
1956970|NCT00810576|Vorinostat|vorinostat|mesh-list
1956971|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956972|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1956973|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956974|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956975|NCT00810602|Vorinostat|vorinostat|mesh-list
1956976|NCT00810602|Tacrolimus|tacrolimus|mesh-list
1956977|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1956978|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
1956979|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1956980|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1956981|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956982|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956983|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956984|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1956985|NCT00810693|Riociguat|riociguat|mesh-list
1956986|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
1956987|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956988|NCT00810719|Gemcitabine|gemcitabine|mesh-list
1956989|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1956990|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1956991|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
1956992|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1956993|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1956994|NCT00810719|Antiviral Agents|antiviral agents|mesh-ancestor
1956995|NCT00810719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1956996|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1956997|NCT00810719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1956998|NCT00810719|Immunologic Factors|immunologic factors|mesh-ancestor
1956999|NCT00810719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957000|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1957001|NCT00810797|Exemestane|exemestane|mesh-list
1957002|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957003|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1957004|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1957005|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957006|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957007|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1957008|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
1957009|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957010|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957011|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
1957012|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1957013|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957014|NCT00811057|Indomethacin|indomethacin|mesh-list
1957015|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
1957016|NCT00811057|Nifedipine|nifedipine|mesh-list
1957017|NCT00811057|Analgesics|analgesics|mesh-ancestor
1957018|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
1957019|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957020|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957021|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
1957022|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1957023|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1957024|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
1957025|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1957026|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1957027|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957028|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1957029|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
1957030|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1957031|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
1957032|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1957033|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1957034|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957035|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1957036|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
1957037|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1957038|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957039|NCT00811135|Bevacizumab|bevacizumab|mesh-list
1957040|NCT00811135|Trastuzumab|trastuzumab|mesh-list
1957041|NCT00811135|Capecitabine|capecitabine|mesh-list
1957042|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1957043|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957044|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1957045|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1957046|NCT00811135|Growth Substances|growth substances|mesh-ancestor
1957047|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957048|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
1957049|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1957050|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
1957051|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957052|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
1957053|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1957054|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1957055|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
1957056|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957057|NCT00811187|Lidocaine|lidocaine|mesh-list
1957058|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
1957059|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
1957060|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1957061|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957062|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
1957063|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957064|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1957065|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1957066|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1957067|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1957068|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957069|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1957070|NCT00811252|Vortioxetine|vortioxetine|mesh-list
1957071|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1957072|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1957073|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1957074|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957075|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957076|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957077|NCT00811252|Analgesics|analgesics|mesh-ancestor
1957078|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
1957079|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957080|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
1957081|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1957082|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
1957083|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1957084|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1957085|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1957086|NCT00811252|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1957087|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
1957088|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1957089|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1957090|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1957091|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1957092|NCT00811395|Interferons|interferons|mesh-list
1957093|NCT00811395|Interferon-beta|interferon-beta|mesh-list
1957094|NCT00811395|Teriflunomide|teriflunomide|mesh-list
1957095|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
1957096|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
1957097|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
1957098|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957099|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
1957100|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1957101|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1957102|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
1957103|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957104|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1957105|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1957106|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1957107|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1957108|NCT00811395|Analgesics|analgesics|mesh-ancestor
1957109|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
1957110|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957111|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957112|NCT00811434|Lactulose|lactulose|mesh-list
1957113|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1957114|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1957115|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
1957116|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1957117|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1957118|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1957119|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1957120|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957121|NCT00811564|Timolol|timolol|mesh-list
1957122|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1957123|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1957124|NCT00811564|Latanoprost|latanoprost|mesh-list
1957125|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1957126|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1957127|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1957128|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
1957129|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957130|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957131|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957132|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1957133|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1957134|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1957135|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1957136|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1957137|NCT00811642|Posaconazole|posaconazole|mesh-list
1957138|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
1957139|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1957140|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1957141|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1957142|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1957143|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1957144|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1957145|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957146|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957147|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1957148|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
1957149|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957150|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957151|NCT00811720|Nalmefene|nalmefene|mesh-list
1957152|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1957153|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957154|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
1957155|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957156|NCT00811733|Ofatumumab|ofatumumab|mesh-list
1957157|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957158|NCT00811850|Timolol|timolol|mesh-list
1957159|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1957160|NCT00811850|Dorzolamide|dorzolamide|mesh-list
1957161|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1957162|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1957163|NCT00811850|Maleic acid|maleic acid|mesh-list
1957164|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1957165|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1957166|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
1957167|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957168|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957169|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957170|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1957171|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1957172|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957173|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1957174|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1957175|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1957176|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1957177|NCT00811928|Fluconazole|fluconazole|mesh-list
1957178|NCT00811928|Posaconazole|posaconazole|mesh-list
1957179|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
1957180|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1957181|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1957182|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1957183|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957184|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957185|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1957186|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
1957187|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957188|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957189|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1957190|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1957191|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1957192|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1957193|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1957194|NCT00811941|Nalmefene|nalmefene|mesh-list
1957195|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1957196|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957197|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
1957198|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957199|NCT00811954|Ritonavir|ritonavir|mesh-list
1957200|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1957201|NCT00811954|Darunavir|darunavir|mesh-list
1957202|NCT00811954|Tenofovir|tenofovir|mesh-list
1957203|NCT00811954|Emtricitabine|emtricitabine|mesh-list
1957204|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
1957205|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1957206|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1957207|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1957208|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
1957209|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957210|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957211|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1957212|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1957213|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
1957214|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1957215|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1957216|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1957217|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1957218|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1957219|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1957220|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1957221|NCT00812006|Rizatriptan|rizatriptan|mesh-list
1957222|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1957223|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
1957224|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957225|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957226|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957227|NCT00812253|Insulin|insulin|mesh-list
1957228|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1957229|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1957230|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957231|NCT00812331|Simeprevir|simeprevir|mesh-list
1957232|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
1957233|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1957234|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
1957235|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957236|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957237|NCT00812461|Nalmefene|nalmefene|mesh-list
1957238|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1957239|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957240|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
1957241|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957242|NCT00812487|Insulin|insulin|mesh-list
1957243|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1957244|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1957245|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957246|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
1957247|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1957248|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1957249|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
1957250|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957251|NCT00812604|Analgesics|analgesics|mesh-list
1957252|NCT00812604|Petrolatum|petrolatum|mesh-list
1957253|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
1957254|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957255|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957256|NCT00812604|Emollients|emollients|mesh-ancestor
1957257|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
1957258|NCT00812812|Paroxetine|paroxetine|mesh-list
1957259|NCT00812812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1957260|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1957261|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1957262|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957263|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957264|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
1957265|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957266|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1957267|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
1957268|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1957269|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1957270|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1957271|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957272|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
1957273|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1957274|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1957275|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1957276|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1957277|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957278|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
1957279|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957280|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957281|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1957282|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957283|NCT00812877|Calcium|calcium|mesh-list
1957284|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1957285|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957286|NCT00812955|Simvastatin|simvastatin|mesh-list
1957287|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1957288|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1957289|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
1957290|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957291|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1957292|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1957293|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957294|NCT00812968|Lenalidomide|lenalidomide|mesh-list
1957295|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
1957296|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957297|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1957298|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1957299|NCT00812968|Growth Substances|growth substances|mesh-ancestor
1957300|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
1957301|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957302|NCT00813111|Epinephrine|epinephrine|mesh-list
1957303|NCT00813111|Bupivacaine|bupivacaine|mesh-list
1957304|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
1957305|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
1957306|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1957307|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957308|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
1957309|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957310|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1957311|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1957312|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
1957313|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957314|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957315|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1957316|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1957317|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
1957318|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1957319|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
1957320|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
1957321|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
1957322|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1957323|NCT00813124|Vidarabine|vidarabine|mesh-list
1957324|NCT00813124|Fludarabine|fludarabine|mesh-list
1957325|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
1957326|NCT00813124|Azacitidine|azacitidine|mesh-list
1957327|NCT00813124|Busulfan|busulfan|mesh-list
1957328|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
1957329|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1957330|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957331|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1957332|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
1957333|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957334|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1957335|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
1957336|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957337|NCT00813124|Antiviral Agents|antiviral agents|mesh-ancestor
1957338|NCT00813124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1957339|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957340|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
1957341|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1957342|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1957343|NCT00813150|Dexamethasone|dexamethasone|mesh-list
1957344|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
1957345|NCT00813150|Bortezomib|bortezomib|mesh-list
1957346|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1957347|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
1957348|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957349|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1957350|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1957351|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
1957352|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957353|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957354|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1957355|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957356|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
1957357|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
1957358|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957359|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1957360|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
1957361|NCT00813150|Hormones|hormones|mesh-ancestor
1957362|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957363|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1957364|NCT00813293|Sorafenib|sorafenib|mesh-list
1957365|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957366|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1957367|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957368|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957369|NCT00813488|Fentanyl|fentanyl|mesh-list
1957370|NCT00813488|Oxycodone|oxycodone|mesh-list
1957371|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1957372|NCT00813488|Narcotics|narcotics|mesh-ancestor
1957373|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1957374|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957375|NCT00813488|Analgesics|analgesics|mesh-ancestor
1957376|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
1957377|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957378|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1957379|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1957380|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
1957381|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
1957382|NCT00813592|Pasireotide|pasireotide|mesh-list
1957383|NCT00813592|Hormones|hormones|mesh-ancestor
1957384|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957385|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957386|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
1957387|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1957388|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
1957389|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957390|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957391|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
1957392|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1957393|NCT00813748|Omalizumab|omalizumab|mesh-list
1957394|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1957395|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1957396|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
1957397|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1957398|NCT00813800|Varenicline|varenicline|mesh-list
1957399|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1957400|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1957401|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
1957402|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957403|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957404|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957405|NCT00813917|Varenicline|varenicline|mesh-list
1957406|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1957407|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1957408|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
1957409|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957410|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957411|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957412|NCT00813943|Temozolomide|temozolomide|mesh-list
1957413|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1957414|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
1957415|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957416|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957417|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1957418|NCT00813995|Metformin|metformin|mesh-list
1957419|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1957420|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957421|NCT00813995|Incretins|incretins|mesh-ancestor
1957422|NCT00813995|Hormones|hormones|mesh-ancestor
1957423|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957424|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1957425|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
1957426|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957427|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957428|NCT00814138|Methotrexate|methotrexate|mesh-list
1957429|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1957430|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
1957431|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1957432|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957433|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1957434|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
1957435|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957436|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957437|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
1957438|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957439|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1957440|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1957441|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
1957442|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1957443|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1957444|NCT00814164|Daunorubicin|daunorubicin|mesh-list
1957445|NCT00814164|Clofarabine|clofarabine|mesh-list
1957446|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1957447|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957448|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1957449|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1957450|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957451|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957452|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1957453|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
1957454|NCT00814177|Warfarin|warfarin|mesh-list
1957455|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
1957456|NCT00814255|Adalimumab|adalimumab|mesh-list
1957457|NCT00814255|Losartan|losartan|mesh-list
1957458|NCT00814255|Lisinopril|lisinopril|mesh-list
1957459|NCT00814255|Atorvastatin|atorvastatin|mesh-list
1957460|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1957461|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1957462|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
1957463|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957464|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1957465|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1957466|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957467|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957468|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1957469|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1957470|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1957471|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1957472|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1957473|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1957474|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
1957475|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1957476|NCT00814255|Protective Agents|protective agents|mesh-ancestor
1957477|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957478|NCT00814307|Tofacitinib|tofacitinib|mesh-list
1957479|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1957480|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957481|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957482|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
1957483|NCT00814320|Antibodies|antibodies|mesh-list
1957484|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
1957485|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1957486|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1957487|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
1957488|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
1957489|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957490|NCT00814502|Zolpidem|zolpidem|mesh-list
1957491|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1957492|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1957493|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1957494|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957495|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1957496|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
1957497|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
1957498|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957499|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957500|NCT00814580|Oxycodone|oxycodone|mesh-list
1957501|NCT00814580|Tapentadol|tapentadol|mesh-list
1957502|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1957503|NCT00814580|Narcotics|narcotics|mesh-ancestor
1957504|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1957505|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957506|NCT00814580|Analgesics|analgesics|mesh-ancestor
1957507|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
1957508|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957509|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1957510|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1957511|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1957512|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957513|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
1957514|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957515|NCT00814632|Apremilast|apremilast|mesh-list
1957516|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1957517|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1957518|NCT00814632|Analgesics|analgesics|mesh-ancestor
1957519|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
1957520|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957521|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957522|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957523|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1957524|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1957525|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1957526|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957527|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957528|NCT00814658|Nimodipine|nimodipine|mesh-list
1957529|NCT00814658|Galantamine|galantamine|mesh-list
1957530|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1957531|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957532|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957533|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
1957534|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957535|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957536|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1957537|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
1957538|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957539|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
1957540|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1957541|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1957542|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1957543|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1957544|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
1957545|NCT00814671|Rifampin|rifampin|mesh-list
1957546|NCT00814671|Rifapentine|rifapentine|mesh-list
1957547|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1957548|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
1957549|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1957550|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1957551|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
1957552|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1957553|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209031|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
1957554|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957555|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1957556|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1957557|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1957558|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1957559|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1957560|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1957561|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1957562|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
1957563|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957564|NCT00814788|Everolimus|everolimus|mesh-list
1957565|NCT00814788|Bicalutamide|bicalutamide|mesh-list
1957566|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957567|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1957568|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
1957569|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957570|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
1957571|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
1957572|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957573|NCT00814801|Galantamine|galantamine|mesh-list
1957574|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1957575|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957576|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957577|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
1957578|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957579|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957580|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1957581|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
1957582|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957583|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
1957584|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
1957585|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1957586|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1957587|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1957588|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
1957589|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1957590|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1957591|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1957592|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957593|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957594|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1957595|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1957596|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
1957597|NCT00815295|Cetuximab|cetuximab|mesh-list
1957598|NCT00815295|Sorafenib|sorafenib|mesh-list
1957599|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1957600|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957601|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1957602|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957603|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957604|NCT00815308|Paclitaxel|paclitaxel|mesh-list
1957605|NCT00815308|Cetuximab|cetuximab|mesh-list
1957606|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1957607|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957608|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
1957609|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
1957610|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
1957611|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957612|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1957613|NCT00815347|Bosentan|bosentan|mesh-list
1957614|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1957615|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1957616|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957617|NCT00815360|Triamcinolone|triamcinolone|mesh-list
1957618|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1957619|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1957620|NCT00815360|Ranibizumab|ranibizumab|mesh-list
1957621|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1957622|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1957623|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1957624|NCT00815360|Growth Substances|growth substances|mesh-ancestor
1957625|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957626|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
1957627|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957628|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957629|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
1957630|NCT00815360|Hormones|hormones|mesh-ancestor
1957631|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957632|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1957633|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
1957634|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957635|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957636|NCT00815516|Amphotericin B|amphotericin b|mesh-list
1957637|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
1957638|NCT00815516|Micafungin|micafungin|mesh-list
1957639|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
1957640|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
1957641|NCT00815516|Amebicides|amebicides|mesh-ancestor
1957642|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1957643|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1957644|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1957645|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1957646|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
1957647|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1957648|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1957649|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1957650|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1957651|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1957652|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
1957653|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957654|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1957655|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1957656|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957657|NCT00815919|Prednisone|prednisone|mesh-list
1957658|NCT00815919|Bortezomib|bortezomib|mesh-list
1957659|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957660|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
1957661|NCT00815919|Hormones|hormones|mesh-ancestor
1957662|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957663|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957664|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1957665|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957666|NCT00816023|Ecallantide|ecallantide|mesh-list
1957667|NCT00816023|Analgesics|analgesics|mesh-ancestor
1957668|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
1957669|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957670|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957671|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1957672|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1957673|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957674|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1957675|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
1957676|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1957677|NCT00816166|Aspirin|aspirin|mesh-list
1957678|NCT00816166|Clopidogrel|clopidogrel|mesh-list
1957679|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1957680|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1957681|NCT00816166|Analgesics|analgesics|mesh-ancestor
1957682|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
1957683|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957684|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957685|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957686|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1957687|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1957688|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1957689|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957690|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1957691|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1957692|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957693|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
1957694|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1957695|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1957696|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1957697|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
1957698|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957699|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1957700|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1957701|NCT00816556|Estradiol|estradiol|mesh-list
1957702|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1957703|NCT00816556|Estrogens|estrogens|mesh-ancestor
1957704|NCT00816556|Hormones|hormones|mesh-ancestor
1957705|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957706|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957707|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1957708|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
1957709|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1957710|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1957711|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
1957712|NCT00816595|Bevacizumab|bevacizumab|mesh-list
1957713|NCT00816595|Rituximab|rituximab|mesh-list
1957714|NCT00816595|Pentostatin|pentostatin|mesh-list
1957715|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1957716|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
1957717|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957718|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1957719|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1957720|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
1957721|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957722|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957723|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1957724|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1957725|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1957726|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1957727|NCT00816595|Growth Substances|growth substances|mesh-ancestor
1957728|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
1957729|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1957730|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957731|NCT00816751|Lidocaine|lidocaine|mesh-list
1957732|NCT00816751|Vasopressins|vasopressins|mesh-list
1957733|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
1957734|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
1957735|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
1957736|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1957737|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957738|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
1957739|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957740|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1957741|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1957742|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1957743|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1957744|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957745|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
1957746|NCT00816751|Coagulants|coagulants|mesh-ancestor
1957747|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1957748|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1957749|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
1957750|NCT00816829|Fenofibrate|fenofibrate|mesh-list
1957751|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1957752|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
1957753|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957754|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1957755|NCT00816907|Metformin|metformin|mesh-list
1957756|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1957757|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957758|NCT00817063|Alitretinoin|alitretinoin|mesh-list
1957759|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957760|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
1957761|NCT00817089|Naltrexone|naltrexone|mesh-list
1957762|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1957763|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1957764|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957765|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
1957766|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957767|NCT00817206|Tacrolimus|tacrolimus|mesh-list
1957768|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1957769|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
1957770|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957771|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1957772|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957773|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957774|NCT00817219|Betamethasone|betamethasone|mesh-list
1957775|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
1957776|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
1957777|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
1957778|NCT00817219|Calcipotriene|calcipotriene|mesh-list
1957779|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
1957780|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957781|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
1957782|NCT00817219|Hormones|hormones|mesh-ancestor
1957783|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957784|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957785|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1957786|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
1957787|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
1957788|NCT00817479|Dexamethasone|dexamethasone|mesh-list
1957789|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957790|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
1957791|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
1957792|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957793|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957794|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1957795|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
1957796|NCT00817479|Hormones|hormones|mesh-ancestor
1957797|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957798|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1957799|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957800|NCT00817531|Dasatinib|dasatinib|mesh-list
1957801|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957802|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1957803|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957804|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957805|NCT00817635|Eplerenone|eplerenone|mesh-list
1957806|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1957807|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
1957808|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957809|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957810|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1957811|NCT00817635|Diuretics|diuretics|mesh-ancestor
1957812|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
1957813|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1957814|NCT00817843|Simvastatin|simvastatin|mesh-list
1957815|NCT00817843|Ezetimibe|ezetimibe|mesh-list
1957816|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1957817|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1957818|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
1957819|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957820|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1957821|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1957822|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957823|NCT00817999|Clopidogrel|clopidogrel|mesh-list
1957824|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1957825|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1957826|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1957827|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1957828|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
1957829|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957830|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957831|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957832|NCT00818168|Infliximab|infliximab|mesh-list
1957833|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
1957834|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1957835|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1957836|NCT00818259|Dexamethasone|dexamethasone|mesh-list
1957837|NCT00818259|Ondansetron|ondansetron|mesh-list
1957838|NCT00818259|Aprepitant|aprepitant|mesh-list
1957839|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
1957840|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957841|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
1957842|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
1957843|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957844|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957845|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1957846|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
1957847|NCT00818259|Hormones|hormones|mesh-ancestor
1957848|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957849|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1957850|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957851|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
1957852|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
1957853|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1957854|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
1957855|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957856|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957857|NCT00818259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1957858|NCT00818259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1957859|NCT00818259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1957860|NCT00818259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1957861|NCT00818259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1957862|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1957863|NCT00818272|Infliximab|infliximab|mesh-list
1957864|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
1957865|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1957866|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1957867|NCT00818324|Rebamipide|rebamipide|mesh-list
1957868|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1957869|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1957870|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
1957871|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957872|NCT00818324|Protective Agents|protective agents|mesh-ancestor
1957873|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957874|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957875|NCT00818337|Aspirin|aspirin|mesh-list
1957876|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1957877|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1957878|NCT00818337|Analgesics|analgesics|mesh-ancestor
1957879|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
1957880|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957881|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957882|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957883|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1957884|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1957885|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1957886|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957887|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1957888|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1957889|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957890|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
1957891|NCT00818363|Bupivacaine|bupivacaine|mesh-list
1957892|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
1957893|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
1957894|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1957895|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957896|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
1957897|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957898|NCT00818389|Riluzole|riluzole|mesh-list
1957899|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
1957900|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
1957901|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1957902|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957903|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957904|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
1957905|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1957906|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1957907|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957908|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
1957909|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1957910|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1957911|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957912|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1957913|NCT00818389|Protective Agents|protective agents|mesh-ancestor
1957914|NCT00818454|Albuterol|albuterol|mesh-list
1957915|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1957916|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
1957917|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957918|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957919|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1957920|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
1957921|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
1957922|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1957923|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1957924|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1957925|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1957926|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
1957927|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957928|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957929|NCT00818519|Drospirenone|drospirenone|mesh-list
1957930|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1957931|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
1957932|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1957933|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957934|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1957935|NCT00818519|Diuretics|diuretics|mesh-ancestor
1957936|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
1957937|NCT00818649|Bortezomib|bortezomib|mesh-list
1957938|NCT00818649|Vorinostat|vorinostat|mesh-list
1957939|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1957940|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1957941|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957942|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957943|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1957944|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
1957945|NCT00818662|Antibodies|antibodies|mesh-list
1957946|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
1957947|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1957948|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1957949|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
1957950|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
1957951|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957952|NCT00818753|Heparin|heparin|mesh-list
1957953|NCT00818753|Calcium heparin|calcium heparin|mesh-list
1957954|NCT00818753|Dabigatran|dabigatran|mesh-list
1957955|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
1957956|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1957957|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1957958|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957959|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
1957960|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1957961|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
1957962|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1957963|NCT00818766|Vancomycin|vancomycin|mesh-list
1957964|NCT00818766|Cefazolin|cefazolin|mesh-list
1957965|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1957966|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1957967|NCT00818779|Amlodipine|amlodipine|mesh-list
1957968|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1957969|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1957970|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1957971|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957972|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1957973|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957974|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
1957975|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1957976|NCT00818805|Tranilast|tranilast|mesh-list
1957977|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1957978|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1957979|NCT00818805|Analgesics|analgesics|mesh-ancestor
1957980|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
1957981|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1957982|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1957983|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1957984|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1957985|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1957986|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1957987|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1957988|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
1957989|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
1957990|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1957991|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1957992|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1957993|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1957994|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1957995|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1957996|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1957997|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
1957998|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1957999|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1958000|NCT00818883|Diuretics|diuretics|mesh-ancestor
1958001|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
1958002|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958003|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1958004|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1958005|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958006|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1958007|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1958008|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
1958009|NCT00818961|Busulfan|busulfan|mesh-list
1958010|NCT00818961|Rituximab|rituximab|mesh-list
1958011|NCT00818961|Methotrexate|methotrexate|mesh-list
1958012|NCT00818961|Fludarabine|fludarabine|mesh-list
1958013|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
1958014|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
1958015|NCT00818961|Tacrolimus|tacrolimus|mesh-list
1958016|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1958017|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
1958018|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958019|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1958020|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1958021|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
1958022|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958023|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958024|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1958025|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1958026|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1958027|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
1958028|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1958029|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1958030|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
1958031|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
1958032|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958033|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1958034|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1958035|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1958036|NCT00819013|Vaccines|vaccines|mesh-list
1958037|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
1958038|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958039|NCT00819039|Ondansetron|ondansetron|mesh-list
1958040|NCT00819039|Aprepitant|aprepitant|mesh-list
1958041|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
1958042|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
1958043|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958044|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958045|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1958046|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
1958047|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
1958048|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1958049|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
1958050|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958051|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958052|NCT00819039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1958053|NCT00819039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1958054|NCT00819039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1958055|NCT00819039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1958056|NCT00819039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1958057|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1958058|NCT00819052|Nevirapine|nevirapine|mesh-list
1958059|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1958060|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1958061|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958062|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958063|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
1958064|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958065|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1958066|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1958067|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1958068|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1958069|NCT00819091|Linagliptin|linagliptin|mesh-list
1958070|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1958071|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958072|NCT00819091|Incretins|incretins|mesh-ancestor
1958073|NCT00819091|Hormones|hormones|mesh-ancestor
1958074|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1958075|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1958076|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
1958077|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958078|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958079|NCT00819234|Pramlintide|pramlintide|mesh-list
1958080|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1958081|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958082|NCT00819390|Chloroquine|chloroquine|mesh-list
1958083|NCT00819390|Amebicides|amebicides|mesh-ancestor
1958084|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1958085|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1958086|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958087|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
1958088|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1958089|NCT00819403|Simvastatin|simvastatin|mesh-list
1958090|NCT00819403|Ezetimibe|ezetimibe|mesh-list
1958091|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
1958092|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1958093|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1958094|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
1958095|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958096|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1958097|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1958098|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958099|NCT00819507|Fluocinonide|fluocinonide|mesh-list
1958100|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1958101|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
1958102|NCT00819507|Hormones|hormones|mesh-ancestor
1958103|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1958104|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958105|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1958106|NCT00819585|Colchicine|colchicine|mesh-list
1958107|NCT00819585|Allopurinol|allopurinol|mesh-list
1958108|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1958109|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
1958110|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1958111|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
1958112|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
1958113|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
1958114|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958115|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958116|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
1958117|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958118|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1958119|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
1958120|NCT00819585|Protective Agents|protective agents|mesh-ancestor
1958121|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958122|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
1958123|NCT00819637|Albuterol|albuterol|mesh-list
1958124|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
1958125|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1958126|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
1958127|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958128|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958129|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1958130|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
1958131|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1958132|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1958133|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1958134|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
1958135|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958136|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958137|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
1958138|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1958139|NCT00819741|Metformin|metformin|mesh-list
1958140|NCT00819741|Repaglinide|repaglinide|mesh-list
1958141|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1958142|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958143|NCT00819767|Valsartan|valsartan|mesh-list
1958144|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1958145|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1958146|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1958147|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958148|NCT00819780|Bevacizumab|bevacizumab|mesh-list
1958149|NCT00819780|Panitumumab|panitumumab|mesh-list
1958150|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1958151|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958152|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1958153|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1958154|NCT00819780|Growth Substances|growth substances|mesh-ancestor
1958155|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958156|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
1958157|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
1958158|NCT00819910|Fenofibrate|fenofibrate|mesh-list
1958159|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1958160|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958161|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1958162|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
1958163|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958164|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1958165|NCT00820027|Ibuprofen|ibuprofen|mesh-list
1958166|NCT00820027|Etoricoxib|etoricoxib|mesh-list
1958167|NCT00820027|Morphine|morphine|mesh-list
1958168|NCT00820027|Oxycodone|oxycodone|mesh-list
1958169|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1958170|NCT00820027|Narcotics|narcotics|mesh-ancestor
1958171|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1958172|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958173|NCT00820027|Analgesics|analgesics|mesh-ancestor
1958174|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
1958175|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958176|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1958177|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1958178|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1958179|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1958180|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1958181|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958182|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958183|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1958184|NCT00820170|Paclitaxel|paclitaxel|mesh-list
1958185|NCT00820170|Dasatinib|dasatinib|mesh-list
1958186|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1958187|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958188|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
1958189|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
1958190|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
1958191|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958192|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1958193|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958194|NCT00820222|Capecitabine|capecitabine|mesh-list
1958195|NCT00820222|Trastuzumab|trastuzumab|mesh-list
1958196|NCT00820222|Lapatinib|lapatinib|mesh-list
1958197|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1958198|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
1958199|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958200|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958201|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1958202|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1958203|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958204|NCT00820248|Panitumumab|panitumumab|mesh-list
1958205|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958206|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1958207|NCT00820534|Penciclovir|penciclovir|mesh-list
1958208|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
1958209|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958210|NCT00820573|Metformin|metformin|mesh-list
1958211|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1958212|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1958213|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958214|NCT00820573|Incretins|incretins|mesh-ancestor
1958215|NCT00820573|Hormones|hormones|mesh-ancestor
1958216|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1958217|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1958218|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
1958219|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958220|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958221|NCT00820612|Indomethacin|indomethacin|mesh-list
1958222|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1958223|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1958224|NCT00820612|Analgesics|analgesics|mesh-ancestor
1958225|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
1958226|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958227|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958228|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1958229|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1958230|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
1958231|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
1958232|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1958233|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1958234|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958235|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958236|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1958237|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1958238|NCT00820664|Estradiol|estradiol|mesh-list
1958239|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1958240|NCT00820664|Estrogens|estrogens|mesh-ancestor
1958241|NCT00820664|Hormones|hormones|mesh-ancestor
1958242|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1958243|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958244|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1958245|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
1958246|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1958247|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1958248|NCT00820755|Cetuximab|cetuximab|mesh-list
1958249|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1958250|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958251|NCT00820872|Carboplatin|carboplatin|mesh-list
1958252|NCT00820872|Docetaxel|docetaxel|mesh-list
1958253|NCT00820872|Trastuzumab|trastuzumab|mesh-list
1958254|NCT00820872|Lapatinib|lapatinib|mesh-list
1958255|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958256|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
1958257|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
1958258|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
1958259|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958260|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1958261|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1958262|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958263|NCT00820898|Gemcitabine|gemcitabine|mesh-list
1958264|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1958265|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
1958266|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958267|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958268|NCT00820898|Antiviral Agents|antiviral agents|mesh-ancestor
1958269|NCT00820898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958270|NCT00820898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958271|NCT00820898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1958272|NCT00820898|Immunologic Factors|immunologic factors|mesh-ancestor
1958273|NCT00820898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958274|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1958275|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1958276|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
1958277|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958278|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958279|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1958280|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
1958281|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1958282|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1958283|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1958284|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
1958285|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958286|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958287|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
1958288|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1958289|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1958290|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
1958291|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958292|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958293|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958294|NCT00821184|Urological Agents|urological agents|mesh-ancestor
1958295|NCT00821327|Gemcitabine|gemcitabine|mesh-list
1958296|NCT00821327|Sunitinib|sunitinib|mesh-list
1958297|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958298|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1958299|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
1958300|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958301|NCT00821327|Antiviral Agents|antiviral agents|mesh-ancestor
1958302|NCT00821327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958303|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958304|NCT00821327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1958305|NCT00821327|Immunologic Factors|immunologic factors|mesh-ancestor
1958306|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958307|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1958308|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1958309|NCT00821327|Growth Substances|growth substances|mesh-ancestor
1958310|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
1958311|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1958312|NCT00821509|Disinfectants|disinfectants|mesh-list
1958313|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958314|NCT00821587|Cyclosporine|cyclosporine|mesh-list
1958315|NCT00821587|Tacrolimus|tacrolimus|mesh-list
1958316|NCT00821587|Cyclosporins|cyclosporins|mesh-list
1958317|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1958318|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
1958319|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958320|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1958321|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958322|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958323|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
1958324|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958325|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
1958326|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1958327|NCT00821795|Insulin|insulin|mesh-list
1958328|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
1958329|NCT00821795|Protamines|protamines|mesh-list
1958330|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1958331|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958332|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
1958333|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958334|NCT00821795|Coagulants|coagulants|mesh-ancestor
1958335|NCT00821821|Edaravone|edaravone|mesh-list
1958336|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1958337|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
1958338|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958339|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1958340|NCT00821821|Protective Agents|protective agents|mesh-ancestor
1958341|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958342|NCT00821886|Carboplatin|carboplatin|mesh-list
1958343|NCT00821886|Trastuzumab|trastuzumab|mesh-list
1958344|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958345|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1958346|NCT00821951|Vorinostat|vorinostat|mesh-list
1958347|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958348|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1958349|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958350|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958351|NCT00821964|Paclitaxel|paclitaxel|mesh-list
1958352|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1958353|NCT00821964|Imiquimod|imiquimod|mesh-list
1958354|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1958355|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958356|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
1958357|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
1958358|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
1958359|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958360|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1958361|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
1958362|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958363|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
1958364|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1958365|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1958366|NCT00822107|Diuretics|diuretics|mesh-ancestor
1958367|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
1958368|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958369|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1958370|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1958371|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958404|NCT00822172|Cilostazol|cilostazol|mesh-list
1958405|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1958406|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
1958407|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958408|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958409|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1958410|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
1958411|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1958412|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1958413|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958414|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1958415|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
1958416|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1958417|NCT00822172|Protective Agents|protective agents|mesh-ancestor
1958418|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1958419|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1958420|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958421|NCT00822237|Vaccines|vaccines|mesh-list
1958422|NCT00822237|Immunoglobulins|immunoglobulins|mesh-list
1958423|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
1958424|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958425|NCT00822354|Tadalafil|tadalafil|mesh-list
1958426|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
1958427|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1958428|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1958429|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958430|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958431|NCT00822354|Urological Agents|urological agents|mesh-ancestor
1958432|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
1958433|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1958434|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1958435|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1958436|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1958437|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958438|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
1958439|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958440|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958441|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1958442|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958443|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1958444|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1958445|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958446|NCT00822692|Renal Agents|renal agents|mesh-ancestor
1958447|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1958448|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
1958449|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1958450|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1958451|NCT00822770|Vidarabine|vidarabine|mesh-list
1958452|NCT00822770|Plerixafor|plerixafor|mesh-list
1958453|NCT00822770|Fludarabine|fludarabine|mesh-list
1958454|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
1958455|NCT00822770|Busulfan|busulfan|mesh-list
1958456|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
1958457|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1958458|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958459|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1958460|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
1958461|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958462|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1958463|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
1958464|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958465|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
1958466|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958467|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
1958468|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1958469|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1958470|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1958471|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1958472|NCT00822900|Progesterone|progesterone|mesh-list
1958473|NCT00822900|Progestins|progestins|mesh-ancestor
1958474|NCT00822900|Hormones|hormones|mesh-ancestor
1958475|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1958476|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958477|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
1958478|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1958479|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1958480|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1958481|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1958482|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958483|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
1958484|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958485|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958486|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1958487|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958488|NCT00823043|Timolol|timolol|mesh-list
1958489|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1958490|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1958491|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
1958492|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958493|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958494|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958495|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1958496|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1958497|NCT00823082|Antithrombins|antithrombins|mesh-list
1958498|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
1958499|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1958500|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
1958501|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958502|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958503|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
1958504|NCT00823212|Aspirin|aspirin|mesh-list
1958505|NCT00823212|Ticlopidine|ticlopidine|mesh-list
1958506|NCT00823212|Clopidogrel|clopidogrel|mesh-list
1958507|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1958508|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1958509|NCT00823212|Analgesics|analgesics|mesh-ancestor
1958510|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
1958511|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958512|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958513|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1958514|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1958515|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1958516|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1958517|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958518|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1958519|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1958520|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958521|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
1958522|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1958523|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1958524|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1958525|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
1958526|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958527|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1958528|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1958529|NCT00823264|Charcoal|charcoal|mesh-list
1958530|NCT00823264|Antidotes|antidotes|mesh-ancestor
1958531|NCT00823264|Protective Agents|protective agents|mesh-ancestor
1958532|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958533|NCT00823303|Calcitriol|calcitriol|mesh-list
1958534|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1958535|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958536|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1958537|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1958538|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958539|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1958540|NCT00823303|Vitamins|vitamins|mesh-ancestor
1958541|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
1958542|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1958543|NCT00823459|Everolimus|everolimus|mesh-list
1958544|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958545|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1958546|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
1958547|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958548|NCT00823472|Ganirelix|ganirelix|mesh-list
1958549|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
1958550|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1958551|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958552|NCT00823719|Ofatumumab|ofatumumab|mesh-list
1958553|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1958554|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958555|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
1958556|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958557|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1958558|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1958559|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
1958560|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958561|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958562|NCT00823823|Calpastatin|calpastatin|mesh-list
1958563|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
1958564|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
1958565|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958566|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958567|NCT00823836|Ropinirole|ropinirole|mesh-list
1958568|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1958569|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1958570|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
1958571|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
1958572|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958573|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958574|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958575|NCT00823901|Clindamycin|clindamycin|mesh-list
1958576|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
1958577|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
1958578|NCT00823901|Tretinoin|tretinoin|mesh-list
1958579|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1958580|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958581|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1958582|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958583|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958584|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958585|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
1958586|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
1958587|NCT00823966|Delavirdine|delavirdine|mesh-list
1958588|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1958589|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1958590|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958591|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958592|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
1958593|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958594|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1958595|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1958596|NCT00823979|Etravirine|etravirine|mesh-list
1958597|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1958598|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1958599|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958600|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958601|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
1958602|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958603|NCT00824044|Citalopram|citalopram|mesh-list
1958604|NCT00824044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1958605|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1958606|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1958607|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958608|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958609|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
1958610|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958611|NCT00824044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1958612|NCT00824044|Antidepressive Agents|antidepressive agents|mesh-ancestor
1958613|NCT00824044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1958614|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
1958615|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
1958616|NCT00824070|Besifloxacin|besifloxacin|mesh-list
1958617|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1958618|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1958619|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958620|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1958621|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1958622|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958623|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958624|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958625|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1958626|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
1958627|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1958628|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958629|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1958630|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1958631|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1958632|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1958633|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1958634|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1958635|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1958636|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1958637|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1958638|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958639|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958640|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958641|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
1958642|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1958643|NCT00824382|Olodaterol|olodaterol|mesh-list
1958644|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1958645|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
1958646|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958647|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958648|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1958649|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
1958650|NCT00824408|Pemetrexed|pemetrexed|mesh-list
1958651|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958652|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958653|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958654|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1958655|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1958656|NCT00824460|Iron|iron|mesh-list
1958657|NCT00824460|Sevelamer|sevelamer|mesh-list
1958658|NCT00824460|Trace Elements|trace elements|mesh-ancestor
1958659|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
1958660|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958661|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
1958662|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
1958663|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958664|NCT00824473|Azelastine|azelastine|mesh-list
1958665|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1958666|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
1958667|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958668|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958669|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1958670|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
1958671|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1958672|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958673|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958674|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1958675|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1958676|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1958677|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
1958678|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
1958679|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958680|NCT00824538|Sunitinib|sunitinib|mesh-list
1958681|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958682|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1958683|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1958684|NCT00824538|Growth Substances|growth substances|mesh-ancestor
1958685|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958686|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
1958687|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1958688|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958689|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958690|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
1958691|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1958692|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1958693|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958694|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
1958695|NCT00824564|Coagulants|coagulants|mesh-ancestor
1958696|NCT00824616|Insulin|insulin|mesh-list
1958697|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1958698|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958699|NCT00824733|Trastuzumab|trastuzumab|mesh-list
1958700|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1958701|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958702|NCT00824746|Gefitinib|gefitinib|mesh-list
1958703|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958704|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1958705|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958706|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958707|NCT00824824|Timolol|timolol|mesh-list
1958708|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1958709|NCT00824824|Dorzolamide|dorzolamide|mesh-list
1958710|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1958711|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1958712|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
1958713|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958714|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958715|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958716|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1958717|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1958718|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1958719|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1958720|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1958721|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1958722|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958723|NCT00824850|Vaccines|vaccines|mesh-list
1958724|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1958725|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
1958726|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958727|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
1958728|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958729|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1958730|NCT00825162|Vaccines|vaccines|mesh-list
1958731|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
1958732|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958733|NCT00825266|Pioglitazone|pioglitazone|mesh-list
1958734|NCT00825266|Bosentan|bosentan|mesh-list
1958735|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1958736|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958737|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1958738|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1958739|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958740|NCT00825305|Vaccines|vaccines|mesh-list
1958741|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
1958742|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958743|NCT00825344|Etanercept|etanercept|mesh-list
1958744|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1958745|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1958746|NCT00825344|Analgesics|analgesics|mesh-ancestor
1958747|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
1958748|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958749|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958750|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1958751|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1958752|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1958753|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1958754|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
1958755|NCT00825370|Hydromorphone|hydromorphone|mesh-list
1958756|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1958757|NCT00825370|Narcotics|narcotics|mesh-ancestor
1958758|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1958759|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958760|NCT00825370|Analgesics|analgesics|mesh-ancestor
1958761|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
1958762|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958763|NCT00825500|Loxapine|loxapine|mesh-list
1958764|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1958765|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1958766|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1958767|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958768|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1958769|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1958770|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
1958771|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958772|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958773|NCT00825565|Allantoin|allantoin|mesh-list
1958774|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
1958775|NCT00825630|Esomeprazole|esomeprazole|mesh-list
1958776|NCT00825630|Pantoprazole|pantoprazole|mesh-list
1958777|NCT00825630|Lansoprazole|lansoprazole|mesh-list
1958778|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
1958779|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1958780|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1958781|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1958782|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958783|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958784|NCT00825734|Sorafenib|sorafenib|mesh-list
1958785|NCT00825734|Epothilones|epothilones|mesh-list
1958786|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958787|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1958788|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958789|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958790|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
1958791|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
1958792|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
1958793|NCT00825786|Ropivacaine|ropivacaine|mesh-list
1958794|NCT00825786|Mepivacaine|mepivacaine|mesh-list
1958795|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
1958796|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
1958797|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1958798|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958799|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
1958800|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958801|NCT00825812|Atropine|atropine|mesh-list
1958802|NCT00825812|Neostigmine|neostigmine|mesh-list
1958803|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1958804|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1958805|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1958806|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
1958807|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958808|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958809|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1958810|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
1958811|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
1958812|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
1958813|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1958814|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1958815|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
1958816|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958817|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958818|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1958819|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958820|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1958821|NCT00825825|Citalopram|citalopram|mesh-list
1958822|NCT00825825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1958823|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1958824|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1958825|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958826|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958827|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
1958828|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958829|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1958830|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
1958831|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1958832|NCT00826111|Eszopiclone|eszopiclone|mesh-list
1958833|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1958834|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1958835|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958836|NCT00826228|Teriparatide|teriparatide|mesh-list
1958837|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1958838|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958839|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1958840|NCT00826241|Temozolomide|temozolomide|mesh-list
1958841|NCT00826241|Lapatinib|lapatinib|mesh-list
1958842|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1958843|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
1958844|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958845|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958846|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1958847|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958848|NCT00826267|Trastuzumab|trastuzumab|mesh-list
1958849|NCT00826267|Lapatinib|lapatinib|mesh-list
1958850|NCT00826267|Afatinib|afatinib|mesh-list
1958851|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1958852|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958853|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1958854|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958855|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958856|NCT00826280|Caffeine|caffeine|mesh-list
1958857|NCT00826280|Regadenoson|regadenoson|mesh-list
1958858|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1958859|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958860|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1958861|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958862|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958863|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1958864|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1958865|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
1958866|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958867|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1958868|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1958869|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
1958870|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1958871|NCT00826449|Dasatinib|dasatinib|mesh-list
1958872|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958873|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1958874|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958875|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958876|NCT00826514|Tanezumab|tanezumab|mesh-list
1958877|NCT00826514|Analgesics|analgesics|mesh-ancestor
1958878|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
1958879|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958880|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958881|NCT00826540|Bevacizumab|bevacizumab|mesh-list
1958882|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1958883|NCT00826540|Sorafenib|sorafenib|mesh-list
1958884|NCT00826540|Antibodies|antibodies|mesh-list
1958885|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
1958886|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1958887|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958888|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1958889|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1958890|NCT00826540|Growth Substances|growth substances|mesh-ancestor
1958891|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958892|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
1958893|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
1958894|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1958895|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958896|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958897|NCT00826618|Ranibizumab|ranibizumab|mesh-list
1958898|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1958899|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1958900|NCT00826618|Growth Substances|growth substances|mesh-ancestor
1958901|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958902|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
1958903|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958904|NCT00826748|Beclomethasone|beclomethasone|mesh-list
1958905|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1958906|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
1958907|NCT00826748|Hormones|hormones|mesh-ancestor
1958908|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1958909|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958910|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1958911|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
1958912|NCT00826800|Bevacizumab|bevacizumab|mesh-list
1958913|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1958914|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958915|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1958916|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1958917|NCT00826800|Growth Substances|growth substances|mesh-ancestor
1958918|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958919|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
1958920|NCT00826943|Cetirizine|cetirizine|mesh-list
1958921|NCT00826943|Levocetirizine|levocetirizine|mesh-list
1958922|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1958923|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1958924|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1958925|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
1958926|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
1958927|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1958928|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958929|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958930|NCT00827073|Lidocaine|lidocaine|mesh-list
1958931|NCT00827073|Tetracaine|tetracaine|mesh-list
1958932|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
1958933|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
1958934|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1958935|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958936|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
1958937|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1958938|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1958939|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1958940|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1958941|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1958942|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958943|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
1958944|NCT00827099|Fludarabine|fludarabine|mesh-list
1958945|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
1958946|NCT00827099|Melphalan|melphalan|mesh-list
1958947|NCT00827099|Tacrolimus|tacrolimus|mesh-list
1958948|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1958949|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1958950|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1958951|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
1958952|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958953|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1958954|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
1958955|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1958956|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1958957|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958958|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1958959|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1958960|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
1958961|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1958962|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958963|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1958964|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
1958965|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1958966|NCT00827112|Ritonavir|ritonavir|mesh-list
1958967|NCT00827112|Lopinavir|lopinavir|mesh-list
1958968|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1958969|NCT00827112|Darunavir|darunavir|mesh-list
1958970|NCT00827112|Tenofovir|tenofovir|mesh-list
1958971|NCT00827112|Emtricitabine|emtricitabine|mesh-list
1958972|NCT00827112|Maraviroc|maraviroc|mesh-list
1958973|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1958974|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1958975|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
1958976|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958977|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958978|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1958979|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1958980|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
1958981|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1958982|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1958983|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1958984|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1958985|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1958986|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1958987|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1958988|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1958989|NCT00827242|Tadalafil|tadalafil|mesh-list
1958990|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
1958991|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1958992|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1958993|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958994|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1958995|NCT00827242|Urological Agents|urological agents|mesh-ancestor
1958996|NCT00827255|Cyclosporine|cyclosporine|mesh-list
1958997|NCT00827255|Cyclosporins|cyclosporins|mesh-list
1958998|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1958999|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959000|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1959001|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
1959002|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959003|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
1959004|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959005|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
1959006|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1959007|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1959008|NCT00827359|Everolimus|everolimus|mesh-list
1959009|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959010|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1959011|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
1959012|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959013|NCT00827541|Tigecycline|tigecycline|mesh-list
1959014|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1959015|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959016|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1959017|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959018|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959019|NCT00827606|Atorvastatin|atorvastatin|mesh-list
1959020|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1959021|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1959022|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
1959023|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959024|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1959025|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1959026|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959027|NCT00827775|Carvedilol|carvedilol|mesh-list
1959028|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1959029|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1959030|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
1959031|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959032|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959033|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959034|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1959035|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
1959036|NCT00827775|Protective Agents|protective agents|mesh-ancestor
1959037|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1959038|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1959039|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1959040|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
1959041|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1959042|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1959043|NCT00827918|Olanzapine|olanzapine|mesh-list
1959044|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
1959045|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
1959046|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1959047|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959048|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1959049|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1959050|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1959051|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1959052|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1959053|NCT00827918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1959054|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1959055|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1959056|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959057|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959058|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
1959059|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
1959060|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1959061|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1959062|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959063|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
1959064|NCT00827931|Coagulants|coagulants|mesh-ancestor
1959065|NCT00827983|Progesterone|progesterone|mesh-list
1959066|NCT00827983|Progestins|progestins|mesh-ancestor
1959067|NCT00827983|Hormones|hormones|mesh-ancestor
1959068|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959069|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959070|NCT00828009|Paclitaxel|paclitaxel|mesh-list
1959071|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
1959072|NCT00828009|Bevacizumab|bevacizumab|mesh-list
1959073|NCT00828009|Carboplatin|carboplatin|mesh-list
1959074|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1959075|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959076|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
1959077|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
1959078|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
1959079|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959080|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1959081|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
1959082|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959083|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1959084|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1959085|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
1959086|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1959087|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1959088|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1959089|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1959090|NCT00828009|Growth Substances|growth substances|mesh-ancestor
1959091|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
1959092|NCT00828061|Prednisone|prednisone|mesh-list
1959093|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1959094|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
1959095|NCT00828061|Hormones|hormones|mesh-ancestor
1959096|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959097|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959098|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1959099|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959100|NCT00828074|Sorafenib|sorafenib|mesh-list
1959101|NCT00828074|Vinorelbine|vinorelbine|mesh-list
1959102|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959103|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1959104|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959105|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959106|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1959107|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
1959108|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
1959109|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
1959110|NCT00828113|Varenicline|varenicline|mesh-list
1959111|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1959112|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1959113|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
1959114|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959115|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959116|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959117|NCT00828139|Aflibercept|aflibercept|mesh-list
1959118|NCT00828139|Topotecan|topotecan|mesh-list
1959119|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
1959120|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1959121|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1959122|NCT00828139|Growth Substances|growth substances|mesh-ancestor
1959123|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959124|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
1959125|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959126|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1959127|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1959128|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959129|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959130|NCT00828191|Progesterone|progesterone|mesh-list
1959131|NCT00828191|Progestins|progestins|mesh-ancestor
1959132|NCT00828191|Hormones|hormones|mesh-ancestor
1959133|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959134|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959135|NCT00828204|Interferons|interferons|mesh-list
1959136|NCT00828204|Interferon-beta|interferon-beta|mesh-list
1959137|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
1959138|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959139|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
1959140|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959141|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
1959142|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959143|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1959144|NCT00828295|Palonosetron|palonosetron|mesh-list
1959145|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
1959146|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
1959147|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1959148|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959149|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1959150|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1959151|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1959152|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
1959153|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959154|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959155|NCT00828321|Ramipril|ramipril|mesh-list
1959156|NCT00828321|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1959157|NCT00828321|Protease Inhibitors|protease inhibitors|mesh-ancestor
1959158|NCT00828321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959159|NCT00828321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959160|NCT00828321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1959161|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
1959162|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
1959163|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1959164|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959165|NCT00828347|Vitamins|vitamins|mesh-ancestor
1959166|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
1959167|NCT00828412|Desonide|desonide|mesh-list
1959168|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1959169|NCT00828464|Clobetasol|clobetasol|mesh-list
1959170|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1959171|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
1959172|NCT00828464|Hormones|hormones|mesh-ancestor
1959173|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959174|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959175|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1959176|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
1959177|NCT00828542|Desogestrel|desogestrel|mesh-list
1959178|NCT00828542|Etonogestrel|etonogestrel|mesh-list
1959179|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1959180|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1959181|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1959182|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
1959183|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1959184|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959185|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1959186|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1959187|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1959188|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1959189|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959190|NCT00828542|Progestins|progestins|mesh-ancestor
1959191|NCT00828542|Hormones|hormones|mesh-ancestor
1959192|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959193|NCT00828568|Imiquimod|imiquimod|mesh-list
1959194|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1959195|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
1959196|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959197|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959198|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
1959199|NCT00828672|Bevacizumab|bevacizumab|mesh-list
1959200|NCT00828672|Capecitabine|capecitabine|mesh-list
1959201|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
1959202|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1959203|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959204|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1959205|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1959206|NCT00828672|Growth Substances|growth substances|mesh-ancestor
1959207|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959208|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
1959209|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1959210|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
1959211|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959212|NCT00828841|Gemcitabine|gemcitabine|mesh-list
1959213|NCT00828841|Paclitaxel|paclitaxel|mesh-list
1959214|NCT00828841|Carboplatin|carboplatin|mesh-list
1959215|NCT00828841|Cetuximab|cetuximab|mesh-list
1959216|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1959217|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959218|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
1959219|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
1959220|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
1959221|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959222|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1959223|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
1959224|NCT00828841|Antiviral Agents|antiviral agents|mesh-ancestor
1959225|NCT00828841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959226|NCT00828841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959227|NCT00828841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1959228|NCT00828841|Immunologic Factors|immunologic factors|mesh-ancestor
1959229|NCT00828841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959230|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1959231|NCT00828984|Laxatives|laxatives|mesh-list
1959232|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
1959233|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1959234|NCT00829010|Vaccines|vaccines|mesh-list
1959235|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1959236|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
1959237|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959238|NCT00829049|Adapalene|adapalene|mesh-list
1959239|NCT00829049|Tazarotene|tazarotene|mesh-list
1959240|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1959241|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1959242|NCT00829049|Analgesics|analgesics|mesh-ancestor
1959243|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
1959244|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1959245|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959246|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1959247|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1959248|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
1959249|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
1959250|NCT00829166|Capecitabine|capecitabine|mesh-list
1959251|NCT00829166|Trastuzumab|trastuzumab|mesh-list
1959252|NCT00829166|Lapatinib|lapatinib|mesh-list
1959253|NCT00829166|Maytansine|maytansine|mesh-list
1959254|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1959255|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1959256|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
1959257|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959258|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959259|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1959260|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1959261|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959262|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1959263|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
1959264|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
1959265|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
1959266|NCT00829179|Omalizumab|omalizumab|mesh-list
1959267|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1959268|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1959269|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
1959270|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1959271|NCT00829244|Hormones|hormones|mesh-ancestor
1959272|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959273|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959274|NCT00829283|Orlistat|orlistat|mesh-list
1959275|NCT00829283|Sibutramine|sibutramine|mesh-list
1959276|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959277|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959278|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1959279|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1959280|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
1959281|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1959282|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
1959283|NCT00829296|Metoprolol|metoprolol|mesh-list
1959284|NCT00829296|Nebivolol|nebivolol|mesh-list
1959285|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1959286|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1959287|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
1959288|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
1959289|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1959290|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959291|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1959292|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1959293|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1959294|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
1959295|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959296|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959297|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
1959298|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1959299|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1959300|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1959301|NCT00829309|Pravastatin|pravastatin|mesh-list
1959302|NCT00829309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1959303|NCT00829309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1959304|NCT00829309|Antimetabolites|antimetabolites|mesh-ancestor
1959305|NCT00829309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959306|NCT00829309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1959307|NCT00829309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1959308|NCT00829309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959309|NCT00829426|Alprazolam|alprazolam|mesh-list
1959310|NCT00829426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1959311|NCT00829426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1959312|NCT00829426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959313|NCT00829426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1959314|NCT00829426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1959315|NCT00829426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1959316|NCT00829426|GABA Modulators|gaba modulators|mesh-ancestor
1959317|NCT00829426|GABA Agents|gaba agents|mesh-ancestor
1959318|NCT00829426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959319|NCT00829426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959320|NCT00829439|Levodopa|levodopa|mesh-list
1959321|NCT00829439|Carbidopa|carbidopa|mesh-list
1959322|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1959323|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1959324|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
1959325|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959326|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959327|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959328|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1959329|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959330|NCT00829452|Ramipril|ramipril|mesh-list
1959331|NCT00829452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1959332|NCT00829452|Protease Inhibitors|protease inhibitors|mesh-ancestor
1959333|NCT00829452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959334|NCT00829452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959335|NCT00829452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1959336|NCT00829504|Ropinirole|ropinirole|mesh-list
1959337|NCT00829504|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1959338|NCT00829504|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1959339|NCT00829504|Dopamine Agonists|dopamine agonists|mesh-ancestor
1959340|NCT00829504|Dopamine Agents|dopamine agents|mesh-ancestor
1959341|NCT00829504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959342|NCT00829504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959343|NCT00829504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959344|NCT00829530|Ramipril|ramipril|mesh-list
1959345|NCT00829530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1959346|NCT00829530|Protease Inhibitors|protease inhibitors|mesh-ancestor
1959347|NCT00829530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959348|NCT00829530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959349|NCT00829530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1959350|NCT00829673|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
1959351|NCT00829673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1959352|NCT00829673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959353|NCT00829673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1959354|NCT00829673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1959355|NCT00829673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1959356|NCT00829673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959357|NCT00829673|Dopamine Agents|dopamine agents|mesh-ancestor
1959358|NCT00829673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959359|NCT00829686|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1959360|NCT00829686|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1959361|NCT00829686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959362|NCT00829686|Renal Agents|renal agents|mesh-ancestor
1959363|NCT00829686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1959364|NCT00829686|Antimalarials|antimalarials|mesh-ancestor
1959365|NCT00829686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1959366|NCT00829686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1959367|NCT00829712|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
1959368|NCT00829712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1959369|NCT00829712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959370|NCT00829712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1959371|NCT00829712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1959372|NCT00829712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1959373|NCT00829712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959374|NCT00829712|Dopamine Agents|dopamine agents|mesh-ancestor
1959375|NCT00829712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959376|NCT00829738|Pantoprazole|pantoprazole|mesh-list
1959377|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1959378|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1959379|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1959380|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959381|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959382|NCT00829764|Doxycycline|doxycycline|mesh-list
1959383|NCT00829764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1959384|NCT00829764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959385|NCT00829764|Antimalarials|antimalarials|mesh-ancestor
1959386|NCT00829764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1959387|NCT00829764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1959388|NCT00829790|Doxycycline|doxycycline|mesh-list
1959389|NCT00829790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1959390|NCT00829790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959391|NCT00829790|Antimalarials|antimalarials|mesh-ancestor
1959392|NCT00829790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1959393|NCT00829790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1959394|NCT00829829|Rilonacept|rilonacept|mesh-list
1959395|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1959396|NCT00829868|Zaleplon|zaleplon|mesh-list
1959397|NCT00829868|Anticonvulsants|anticonvulsants|mesh-ancestor
1959398|NCT00829868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1959399|NCT00829868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1959400|NCT00829868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959401|NCT00829868|GABA Modulators|gaba modulators|mesh-ancestor
1959402|NCT00829868|GABA Agents|gaba agents|mesh-ancestor
1959403|NCT00829868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959404|NCT00829868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959405|NCT00829933|Warfarin|warfarin|mesh-list
1959406|NCT00829933|Edoxaban|edoxaban|mesh-list
1959407|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
1959408|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1959409|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
1959410|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1959411|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
1959412|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959413|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959414|NCT00829998|Zaleplon|zaleplon|mesh-list
1959415|NCT00829998|Anticonvulsants|anticonvulsants|mesh-ancestor
1959416|NCT00829998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1959417|NCT00829998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1959418|NCT00829998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959419|NCT00829998|GABA Modulators|gaba modulators|mesh-ancestor
1959420|NCT00829998|GABA Agents|gaba agents|mesh-ancestor
1959421|NCT00829998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959422|NCT00829998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959423|NCT00830024|Alprazolam|alprazolam|mesh-list
1959424|NCT00830024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1959425|NCT00830024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1959426|NCT00830024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959427|NCT00830024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1959428|NCT00830024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1959429|NCT00830024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1959430|NCT00830024|GABA Modulators|gaba modulators|mesh-ancestor
1959431|NCT00830024|GABA Agents|gaba agents|mesh-ancestor
1959432|NCT00830024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959433|NCT00830024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959434|NCT00830063|Naproxen|naproxen|mesh-list
1959435|NCT00830063|Tanezumab|tanezumab|mesh-list
1959436|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1959437|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1959438|NCT00830063|Analgesics|analgesics|mesh-ancestor
1959439|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
1959440|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1959441|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959442|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1959443|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1959444|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
1959445|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1959446|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959447|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959448|NCT00830076|Metformin|metformin|mesh-list
1959449|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1959450|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1959451|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959452|NCT00830076|Incretins|incretins|mesh-ancestor
1959453|NCT00830076|Hormones|hormones|mesh-ancestor
1959454|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959455|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1959456|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
1959457|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959458|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959459|NCT00830115|Pantoprazole|pantoprazole|mesh-list
1959460|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1959461|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1959462|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1959463|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959464|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959465|NCT00830128|Pregabalin|pregabalin|mesh-list
1959466|NCT00830128|Analgesics|analgesics|mesh-ancestor
1959467|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
1959468|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1959469|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959470|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
1959471|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1959472|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1959473|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959474|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1959475|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1959476|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1959477|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1959478|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1959479|NCT00830167|Pregabalin|pregabalin|mesh-list
1959480|NCT00830167|Analgesics|analgesics|mesh-ancestor
1959481|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
1959482|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1959483|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959484|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
1959485|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1959486|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1959487|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959488|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1959489|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1959490|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1959491|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1959492|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1959493|NCT00830206|Azithromycin|azithromycin|mesh-list
1959494|NCT00830206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1959495|NCT00830206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959496|NCT00830219|Ropinirole|ropinirole|mesh-list
1959497|NCT00830219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1959498|NCT00830219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1959499|NCT00830219|Dopamine Agonists|dopamine agonists|mesh-ancestor
1959500|NCT00830219|Dopamine Agents|dopamine agents|mesh-ancestor
1959501|NCT00830219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209032|NCT00012909|Hormones|hormones|mesh-list
1959502|NCT00830219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959503|NCT00830219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959504|NCT00830258|Pravastatin|pravastatin|mesh-list
1959505|NCT00830258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1959506|NCT00830258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1959507|NCT00830258|Antimetabolites|antimetabolites|mesh-ancestor
1959508|NCT00830258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959509|NCT00830258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1959510|NCT00830258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1959511|NCT00830258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959512|NCT00830336|Azithromycin|azithromycin|mesh-list
1959513|NCT00830336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1959514|NCT00830336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959515|NCT00830362|Propranolol|propranolol|mesh-list
1959516|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1959517|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1959518|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
1959519|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959520|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959521|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959522|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1959523|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1959524|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
1959525|NCT00830375|Memantine|memantine|mesh-list
1959526|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1959527|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1959528|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
1959529|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959530|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959531|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959532|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1959533|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1959534|NCT00830388|Ketoconazole|ketoconazole|mesh-list
1959535|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
1959536|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959537|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1959538|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1959539|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959540|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959541|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1959542|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
1959543|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959544|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959545|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1959546|NCT00830765|Progesterone|progesterone|mesh-list
1959547|NCT00830765|Progestins|progestins|mesh-ancestor
1959548|NCT00830765|Hormones|hormones|mesh-ancestor
1959549|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959550|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959551|NCT00830804|Ritonavir|ritonavir|mesh-list
1959552|NCT00830804|Darunavir|darunavir|mesh-list
1959553|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
1959554|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1959555|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1959556|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
1959557|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959558|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959559|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1959560|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1959561|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
1959562|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959563|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1959564|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1959565|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1959566|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1959567|NCT00830869|Ixazomib|ixazomib|mesh-list
1959568|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959569|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
1959570|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959571|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959572|NCT00830960|Clopidogrel|clopidogrel|mesh-list
1959573|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1959574|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1959575|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1959576|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1959577|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1959578|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
1959579|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959580|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959581|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959582|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
1959583|NCT00831129|Simvastatin|simvastatin|mesh-list
1959584|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1959585|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1959586|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
1959587|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959588|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1959589|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1959590|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959591|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1959592|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959593|NCT00831181|Leucovorin|leucovorin|mesh-list
1959594|NCT00831181|Fluorouracil|fluorouracil|mesh-list
1959595|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
1959596|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
1959597|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959598|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1959599|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959600|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1959601|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
1959602|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959603|NCT00831181|Antidotes|antidotes|mesh-ancestor
1959604|NCT00831181|Protective Agents|protective agents|mesh-ancestor
1959605|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
1959606|NCT00831181|Vitamins|vitamins|mesh-ancestor
1959607|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
1959608|NCT00831233|Goserelin|goserelin|mesh-list
1959609|NCT00831233|Bicalutamide|bicalutamide|mesh-list
1959610|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1959611|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959612|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
1959613|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
1959614|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959615|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959616|NCT00831272|Naltrexone|naltrexone|mesh-list
1959617|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1959618|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1959619|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959620|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
1959621|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1959622|NCT00831311|Vaccines|vaccines|mesh-list
1959623|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
1959624|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959625|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1959626|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1959627|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1959628|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1959629|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959630|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959631|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959632|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
1959633|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1959634|NCT00831441|Apixaban|apixaban|mesh-list
1959635|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1959636|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
1959637|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1959638|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
1959639|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959640|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959641|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
1959642|NCT00831480|Everolimus|everolimus|mesh-list
1959643|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959644|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1959645|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
1959646|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959647|NCT00831493|Vorinostat|vorinostat|mesh-list
1959648|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959649|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1959650|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959651|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959652|NCT00831675|Vaccines|vaccines|mesh-list
1959653|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
1959654|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959655|NCT00831701|Tamsulosin|tamsulosin|mesh-list
1959656|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1959657|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1959658|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1959659|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
1959660|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959661|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959662|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959663|NCT00831701|Urological Agents|urological agents|mesh-ancestor
1959664|NCT00831766|Cytarabine|cytarabine|mesh-list
1959665|NCT00831766|Lenalidomide|lenalidomide|mesh-list
1959666|NCT00831766|Idarubicin|idarubicin|mesh-list
1959667|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
1959668|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1959669|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
1959670|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959671|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
1959672|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959673|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1959674|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
1959675|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959676|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1959677|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1959678|NCT00831766|Growth Substances|growth substances|mesh-ancestor
1959679|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
1959680|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1959681|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1959682|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1959683|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959684|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
1959685|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1959686|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959687|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1959688|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959689|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1959690|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
1959691|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959692|NCT00831987|Vaccines|vaccines|mesh-list
1959693|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
1959694|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959695|NCT00832000|Mexiletine|mexiletine|mesh-list
1959696|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1959697|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1959698|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1959699|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1959700|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959701|NCT00832117|Cisplatin|cisplatin|mesh-list
1959702|NCT00832117|Epothilones|epothilones|mesh-list
1959703|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959704|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
1959705|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
1959706|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
1959707|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959708|NCT00832338|Dexamethasone|dexamethasone|mesh-list
1959709|NCT00832338|Docetaxel|docetaxel|mesh-list
1959710|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
1959711|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1959712|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
1959713|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
1959714|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1959715|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959716|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1959717|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
1959718|NCT00832338|Hormones|hormones|mesh-ancestor
1959719|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959720|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1959721|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959722|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
1959723|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
1959724|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
1959725|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959726|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1959727|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
1959728|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1959729|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1959730|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
1959731|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1959732|NCT00832377|Timolol|timolol|mesh-list
1959733|NCT00832377|Dorzolamide|dorzolamide|mesh-list
1959734|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1959735|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1959736|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
1959737|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959738|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959739|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959740|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1959741|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1959742|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1959743|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959744|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1959745|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1959746|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959747|NCT00832390|Incretins|incretins|mesh-ancestor
1959748|NCT00832390|Hormones|hormones|mesh-ancestor
1959749|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959750|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1959751|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
1959752|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959753|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959754|NCT00832416|Tramadol|tramadol|mesh-list
1959755|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1959756|NCT00832416|Narcotics|narcotics|mesh-ancestor
1959757|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1959758|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959759|NCT00832416|Analgesics|analgesics|mesh-ancestor
1959760|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
1959761|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1959762|NCT00832455|Montelukast|montelukast|mesh-list
1959763|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1959764|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
1959765|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1959766|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
1959767|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959768|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959769|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1959770|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1959771|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959772|NCT00832585|Alefacept|alefacept|mesh-list
1959773|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
1959774|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
1959775|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959776|NCT00832637|Gemcitabine|gemcitabine|mesh-list
1959777|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1959778|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959779|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1959780|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
1959781|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959782|NCT00832637|Antiviral Agents|antiviral agents|mesh-ancestor
1959783|NCT00832637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959784|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959785|NCT00832637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1959786|NCT00832637|Immunologic Factors|immunologic factors|mesh-ancestor
1959787|NCT00832637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959788|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1959789|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
1959790|NCT00832650|Fesoterodine|fesoterodine|mesh-list
1959791|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1959792|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1959793|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
1959794|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959795|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959796|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959797|NCT00832650|Urological Agents|urological agents|mesh-ancestor
1959798|NCT00832819|Paclitaxel|paclitaxel|mesh-list
1959799|NCT00832819|Carboplatin|carboplatin|mesh-list
1959800|NCT00832819|Lenvatinib|lenvatinib|mesh-list
1959801|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1959802|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959803|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
1959804|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
1959805|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
1959806|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959807|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1959808|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959809|NCT00832871|Mifepristone|mifepristone|mesh-list
1959810|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1959811|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
1959812|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1959813|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959814|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1959815|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1959816|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1959817|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
1959818|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1959819|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1959820|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
1959821|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959822|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
1959823|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1959824|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1959825|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1959826|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1959827|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959828|NCT00833027|Incretins|incretins|mesh-ancestor
1959829|NCT00833027|Hormones|hormones|mesh-ancestor
1959830|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959831|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1959832|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
1959833|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959834|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959835|NCT00833040|Sufentanil|sufentanil|mesh-list
1959836|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1959837|NCT00833040|Narcotics|narcotics|mesh-ancestor
1959838|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1959839|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959840|NCT00833040|Analgesics|analgesics|mesh-ancestor
1959841|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
1959842|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1959843|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1959844|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1959845|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
1959846|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
1959847|NCT00833053|Methotrexate|methotrexate|mesh-list
1959848|NCT00833053|Infliximab|infliximab|mesh-list
1959849|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1959850|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
1959851|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1959852|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959853|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1959854|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
1959855|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959856|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959857|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
1959858|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959859|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1959860|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1959861|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
1959862|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1959863|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1959864|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1959865|NCT00833248|Goserelin|goserelin|mesh-list
1959866|NCT00833248|Bicalutamide|bicalutamide|mesh-list
1959867|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1959868|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959869|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
1959870|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
1959871|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959872|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959873|NCT00833261|Paclitaxel|paclitaxel|mesh-list
1959874|NCT00833261|Cetuximab|cetuximab|mesh-list
1959875|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1959876|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959877|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
1959878|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
1959879|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
1959880|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959881|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1959882|NCT00833365|Ibuprofen|ibuprofen|mesh-list
1959883|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1959884|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1959885|NCT00833365|Analgesics|analgesics|mesh-ancestor
1959886|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
1959887|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1959888|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959889|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1959890|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1959891|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1959892|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959893|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959894|NCT00833443|Bupropion|bupropion|mesh-list
1959895|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1959896|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
1959897|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1959898|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1959899|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1959900|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1959901|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959902|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
1959903|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959904|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959905|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1959906|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1959907|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959908|NCT00833469|Citalopram|citalopram|mesh-list
1959909|NCT00833469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1959910|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1959911|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1959912|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959913|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959914|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
1959915|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959916|NCT00833469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1959917|NCT00833469|Antidepressive Agents|antidepressive agents|mesh-ancestor
1959918|NCT00833469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1959919|NCT00833482|Ritonavir|ritonavir|mesh-list
1959920|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1959921|NCT00833482|Voriconazole|voriconazole|mesh-list
1959922|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1959923|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1959924|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
1959925|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959926|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959927|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1959928|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1959929|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
1959930|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959931|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1959932|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1959933|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
1959934|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1959935|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1959936|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
1959937|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959938|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959939|NCT00833521|Zolpidem|zolpidem|mesh-list
1959940|NCT00833521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1959941|NCT00833521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1959942|NCT00833521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1959943|NCT00833521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959944|NCT00833521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1959945|NCT00833521|GABA Agonists|gaba agonists|mesh-ancestor
1959946|NCT00833521|GABA Agents|gaba agents|mesh-ancestor
1959947|NCT00833521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959948|NCT00833521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959949|NCT00833547|Eszopiclone|eszopiclone|mesh-list
1959950|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1959951|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1959952|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959953|NCT00833560|Dexamethasone|dexamethasone|mesh-list
1959954|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
1959955|NCT00833560|Bortezomib|bortezomib|mesh-list
1959956|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1959957|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
1959958|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1959959|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1959960|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1959961|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
1959962|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959963|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1959964|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1959965|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1959966|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
1959967|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
1959968|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1959969|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1959970|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
1959971|NCT00833560|Hormones|hormones|mesh-ancestor
1959972|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1959973|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1959974|NCT00833586|Terbinafine|terbinafine|mesh-list
1959975|NCT00833586|Antifungal Agents|antifungal agents|mesh-ancestor
1959976|NCT00833586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959977|NCT00833586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959978|NCT00833586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959979|NCT00833638|Tadalafil|tadalafil|mesh-list
1959980|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
1959981|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1959982|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1959983|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959984|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959985|NCT00833638|Urological Agents|urological agents|mesh-ancestor
1959986|NCT00833664|Terbinafine|terbinafine|mesh-list
1959987|NCT00833664|Antifungal Agents|antifungal agents|mesh-ancestor
1959988|NCT00833664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1959989|NCT00833664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1959990|NCT00833664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959991|NCT00833703|Clopidogrel|clopidogrel|mesh-list
1959992|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1959993|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1959994|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1959995|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1959996|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
1959997|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1959998|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1959999|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960000|NCT00833755|Ketamine|ketamine|mesh-list
1960001|NCT00833755|Analgesics|analgesics|mesh-ancestor
1960002|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
1960003|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960004|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960005|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1960006|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1960007|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
1960008|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
1960009|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960010|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1960011|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1960012|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960013|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960014|NCT00833794|Tramadol|tramadol|mesh-list
1960015|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1960016|NCT00833794|Narcotics|narcotics|mesh-ancestor
1960017|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960018|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960019|NCT00833794|Analgesics|analgesics|mesh-ancestor
1960020|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
1960021|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960022|NCT00833833|Aspirin|aspirin|mesh-list
1960023|NCT00833833|Dexamethasone|dexamethasone|mesh-list
1960024|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
1960025|NCT00833833|Pomalidomide|pomalidomide|mesh-list
1960026|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1960027|NCT00833833|BB 1101|bb 1101|mesh-list
1960028|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1960029|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
1960030|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
1960031|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960032|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960033|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1960034|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
1960035|NCT00833833|Hormones|hormones|mesh-ancestor
1960036|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1960037|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1960038|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960039|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
1960040|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960041|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960042|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1960043|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1960044|NCT00833833|Analgesics|analgesics|mesh-ancestor
1960045|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
1960046|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1960047|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1960048|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1960049|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1960050|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1960051|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
1960052|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
1960053|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1960054|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1960055|NCT00833833|Growth Substances|growth substances|mesh-ancestor
1960056|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
1960057|NCT00833911|Tramadol|tramadol|mesh-list
1960058|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1960059|NCT00833911|Narcotics|narcotics|mesh-ancestor
1960060|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960061|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960062|NCT00833911|Analgesics|analgesics|mesh-ancestor
1960063|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
1960064|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960065|NCT00833937|Zolpidem|zolpidem|mesh-list
1960066|NCT00833937|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1960067|NCT00833937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1960068|NCT00833937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960069|NCT00833937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960070|NCT00833937|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1960071|NCT00833937|GABA Agonists|gaba agonists|mesh-ancestor
1960072|NCT00833937|GABA Agents|gaba agents|mesh-ancestor
1960073|NCT00833937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960074|NCT00833937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960075|NCT00834067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1960076|NCT00834067|Moexipril|moexipril|mesh-list
1960077|NCT00834067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1960078|NCT00834067|Diuretics|diuretics|mesh-ancestor
1960079|NCT00834067|Natriuretic Agents|natriuretic agents|mesh-ancestor
1960080|NCT00834067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960081|NCT00834067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1960082|NCT00834067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960083|NCT00834067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960084|NCT00834067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1960085|NCT00834067|Protease Inhibitors|protease inhibitors|mesh-ancestor
1960086|NCT00834067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960087|NCT00834080|Naltrexone|naltrexone|mesh-list
1960088|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1960089|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1960090|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960091|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
1960092|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960093|NCT00834132|Azithromycin|azithromycin|mesh-list
1960094|NCT00834132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960095|NCT00834132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960096|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
1960097|NCT00834171|Tobramycin|tobramycin|mesh-list
1960098|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960099|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960100|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1960101|NCT00834197|Mirtazapine|mirtazapine|mesh-list
1960102|NCT00834197|Antidepressive Agents|antidepressive agents|mesh-ancestor
1960103|NCT00834197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1960104|NCT00834197|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1960105|NCT00834197|Histamine Antagonists|histamine antagonists|mesh-ancestor
1960106|NCT00834197|Histamine Agents|histamine agents|mesh-ancestor
1960107|NCT00834197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960108|NCT00834197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960109|NCT00834197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960110|NCT00834197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1960111|NCT00834197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1960112|NCT00834197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960113|NCT00834197|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1960114|NCT00834197|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1960115|NCT00834197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1960116|NCT00834197|Adrenergic Agents|adrenergic agents|mesh-ancestor
1960117|NCT00834197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1960118|NCT00834197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1960119|NCT00834197|Serotonin Agents|serotonin agents|mesh-ancestor
1960120|NCT00834197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1960121|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
1960122|NCT00834210|Dapsone|dapsone|mesh-list
1960123|NCT00834210|Tazarotene|tazarotene|mesh-list
1960124|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960125|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
1960126|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1960127|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1960128|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1960129|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960130|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960131|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
1960132|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960133|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
1960134|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
1960135|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
1960136|NCT00834210|Vitamins|vitamins|mesh-ancestor
1960137|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
1960138|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960139|NCT00834249|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1960140|NCT00834249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1960141|NCT00834249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1960142|NCT00834249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960143|NCT00834249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960144|NCT00834249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960145|NCT00834249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960146|NCT00834249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1960147|NCT00834249|Antidepressive Agents|antidepressive agents|mesh-ancestor
1960148|NCT00834249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1960149|NCT00834275|Cefadroxil|cefadroxil|mesh-list
1960150|NCT00834275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960151|NCT00834275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960152|NCT00834288|Tramadol|tramadol|mesh-list
1960153|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1960154|NCT00834288|Narcotics|narcotics|mesh-ancestor
1960155|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960156|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960157|NCT00834288|Analgesics|analgesics|mesh-ancestor
1960158|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
1960159|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960160|NCT00834340|Glimepiride|glimepiride|mesh-list
1960161|NCT00834340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1960162|NCT00834340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960163|NCT00834340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960164|NCT00834340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1960165|NCT00834340|Immunologic Factors|immunologic factors|mesh-ancestor
1960166|NCT00834366|Tramadol|tramadol|mesh-list
1960167|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1960168|NCT00834366|Narcotics|narcotics|mesh-ancestor
1960169|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960170|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960171|NCT00834366|Analgesics|analgesics|mesh-ancestor
1960172|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
1960173|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960174|NCT00834405|Leflunomide|leflunomide|mesh-list
1960175|NCT00834405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960176|NCT00834405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960177|NCT00834405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1960178|NCT00834405|Immunologic Factors|immunologic factors|mesh-ancestor
1960179|NCT00834405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960180|NCT00834418|Leflunomide|leflunomide|mesh-list
1960181|NCT00834418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960182|NCT00834418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960183|NCT00834418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1960184|NCT00834418|Immunologic Factors|immunologic factors|mesh-ancestor
1960185|NCT00834418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960186|NCT00834431|Famciclovir|famciclovir|mesh-list
1960187|NCT00834431|Antiviral Agents|antiviral agents|mesh-ancestor
1960188|NCT00834431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960189|NCT00834431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1960190|NCT00834431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960191|NCT00834431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960192|NCT00834444|Famciclovir|famciclovir|mesh-list
1960193|NCT00834444|Antiviral Agents|antiviral agents|mesh-ancestor
1960194|NCT00834444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960195|NCT00834444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1960196|NCT00834444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960197|NCT00834444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960198|NCT00834522|Granisetron|granisetron|mesh-list
1960199|NCT00834522|Antiemetics|antiemetics|mesh-ancestor
1960200|NCT00834522|Autonomic Agents|autonomic agents|mesh-ancestor
1960201|NCT00834522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960202|NCT00834522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960203|NCT00834522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1960204|NCT00834522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1960205|NCT00834522|Serotonin Agents|serotonin agents|mesh-ancestor
1960206|NCT00834522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960207|NCT00834522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960208|NCT00834535|Cefdinir|cefdinir|mesh-list
1960209|NCT00834535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960210|NCT00834535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960211|NCT00834561|Lamotrigine|lamotrigine|mesh-list
1960212|NCT00834561|Anticonvulsants|anticonvulsants|mesh-ancestor
1960213|NCT00834561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1960214|NCT00834561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960215|NCT00834561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960216|NCT00834561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1960217|NCT00834561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960218|NCT00834561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1960219|NCT00834561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1960220|NCT00834561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960221|NCT00834561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1960222|NCT00834561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1960223|NCT00834574|Cefdinir|cefdinir|mesh-list
1960224|NCT00834574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960225|NCT00834574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960226|NCT00834587|Metformin|metformin|mesh-list
1960227|NCT00834587|Glipizide|glipizide|mesh-list
1960228|NCT00834587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960229|NCT00834587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960230|NCT00834613|Metformin|metformin|mesh-list
1960231|NCT00834613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960232|NCT00834613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960233|NCT00834639|Valproic Acid|valproic acid|mesh-list
1960234|NCT00834639|Anticonvulsants|anticonvulsants|mesh-ancestor
1960235|NCT00834639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960236|NCT00834639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960237|NCT00834639|GABA Agents|gaba agents|mesh-ancestor
1960238|NCT00834639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960239|NCT00834639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960240|NCT00834639|Antimanic Agents|antimanic agents|mesh-ancestor
1960241|NCT00834639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1960242|NCT00834639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960243|NCT00834639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1960244|NCT00834652|Metformin|metformin|mesh-list
1960245|NCT00834652|Sertraline|sertraline|mesh-list
1960246|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960247|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960248|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
1960249|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1960250|NCT00834652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1960251|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1960252|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960253|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960254|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960255|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
1960256|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1960257|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1960258|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960259|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1960260|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960261|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960262|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1960263|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
1960264|NCT00834717|Granisetron|granisetron|mesh-list
1960265|NCT00834717|Antiemetics|antiemetics|mesh-ancestor
1960266|NCT00834717|Autonomic Agents|autonomic agents|mesh-ancestor
1960267|NCT00834717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960268|NCT00834717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960269|NCT00834717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1960270|NCT00834717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1960271|NCT00834717|Serotonin Agents|serotonin agents|mesh-ancestor
1960272|NCT00834717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960273|NCT00834717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960274|NCT00834743|Metformin|metformin|mesh-list
1960275|NCT00834743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960276|NCT00834743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960277|NCT00834756|Azithromycin|azithromycin|mesh-list
1960278|NCT00834756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960279|NCT00834756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960280|NCT00834795|Carvedilol|carvedilol|mesh-list
1960281|NCT00834795|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1960282|NCT00834795|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1960283|NCT00834795|Adrenergic Agents|adrenergic agents|mesh-ancestor
1960284|NCT00834795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960285|NCT00834795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960286|NCT00834795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960287|NCT00834795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1960288|NCT00834795|Antioxidants|antioxidants|mesh-ancestor
1960289|NCT00834795|Protective Agents|protective agents|mesh-ancestor
1960290|NCT00834795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1960291|NCT00834795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960292|NCT00834795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1960293|NCT00834795|Vasodilator Agents|vasodilator agents|mesh-ancestor
1960294|NCT00834795|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1960295|NCT00834795|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1960296|NCT00834808|Tramadol|tramadol|mesh-list
1960297|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1960298|NCT00834808|Narcotics|narcotics|mesh-ancestor
1960299|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960300|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960301|NCT00834808|Analgesics|analgesics|mesh-ancestor
1960302|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
1960303|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960304|NCT00834834|Fluoxetine|fluoxetine|mesh-list
1960305|NCT00834834|Citalopram|citalopram|mesh-list
1960306|NCT00834834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1960307|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1960308|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960309|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960310|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960311|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
1960312|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960313|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1960314|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
1960315|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1960316|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1960317|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1960318|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960319|NCT00834873|Carvedilol|carvedilol|mesh-list
1960320|NCT00834873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1960321|NCT00834873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1960322|NCT00834873|Adrenergic Agents|adrenergic agents|mesh-ancestor
1960323|NCT00834873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960324|NCT00834873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960325|NCT00834873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960326|NCT00834873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1960327|NCT00834873|Antioxidants|antioxidants|mesh-ancestor
1960328|NCT00834873|Protective Agents|protective agents|mesh-ancestor
1960329|NCT00834873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1960330|NCT00834873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960331|NCT00834873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1960332|NCT00834873|Vasodilator Agents|vasodilator agents|mesh-ancestor
1960333|NCT00834873|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1960334|NCT00834873|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1960335|NCT00834886|Melatonin|melatonin|mesh-list
1960336|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
1960337|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960338|NCT00834886|Protective Agents|protective agents|mesh-ancestor
1960339|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960340|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960341|NCT00834899|Eptifibatide|eptifibatide|mesh-list
1960342|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1960343|NCT00834912|Tramadol|tramadol|mesh-list
1960344|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1960345|NCT00834912|Narcotics|narcotics|mesh-ancestor
1960346|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960347|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960348|NCT00834912|Analgesics|analgesics|mesh-ancestor
1960349|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
1960350|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960351|NCT00834964|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1960352|NCT00834964|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1960353|NCT00834964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1960354|NCT00834964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960355|NCT00834964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960356|NCT00834964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960357|NCT00834964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960358|NCT00834964|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1960359|NCT00834964|Antidepressive Agents|antidepressive agents|mesh-ancestor
1960360|NCT00834964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1960361|NCT00834977|Amlodipine|amlodipine|mesh-list
1960362|NCT00834977|Benazepril|benazepril|mesh-list
1960363|NCT00834977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1960364|NCT00834977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1960365|NCT00834977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960366|NCT00834977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960367|NCT00834977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1960368|NCT00834977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960369|NCT00834977|Vasodilator Agents|vasodilator agents|mesh-ancestor
1960370|NCT00834977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1960371|NCT00834977|Protease Inhibitors|protease inhibitors|mesh-ancestor
1960372|NCT00834977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960373|NCT00834990|Valproic Acid|valproic acid|mesh-list
1960374|NCT00834990|Anticonvulsants|anticonvulsants|mesh-ancestor
1960375|NCT00834990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960376|NCT00834990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960377|NCT00834990|GABA Agents|gaba agents|mesh-ancestor
1960378|NCT00834990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960379|NCT00834990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960380|NCT00834990|Antimanic Agents|antimanic agents|mesh-ancestor
1960381|NCT00834990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1960382|NCT00834990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960383|NCT00834990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1960384|NCT00835042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1960385|NCT00835042|Moexipril|moexipril|mesh-list
1960386|NCT00835042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1960387|NCT00835042|Diuretics|diuretics|mesh-ancestor
1960388|NCT00835042|Natriuretic Agents|natriuretic agents|mesh-ancestor
1960389|NCT00835042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960390|NCT00835042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1960391|NCT00835042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960392|NCT00835042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960393|NCT00835042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1960394|NCT00835042|Protease Inhibitors|protease inhibitors|mesh-ancestor
1960395|NCT00835042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960396|NCT00835081|Cefadroxil|cefadroxil|mesh-list
1960397|NCT00835081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960398|NCT00835081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960399|NCT00835120|Pioglitazone|pioglitazone|mesh-list
1960400|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960401|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960402|NCT00835146|Ribavirin|ribavirin|mesh-list
1960403|NCT00835146|Antimetabolites|antimetabolites|mesh-ancestor
1960404|NCT00835146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960405|NCT00835146|Antiviral Agents|antiviral agents|mesh-ancestor
1960406|NCT00835146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960407|NCT00835159|Rivastigmine|rivastigmine|mesh-list
1960408|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1960409|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960410|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960411|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
1960412|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960413|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960414|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1960415|NCT00835159|Protective Agents|protective agents|mesh-ancestor
1960416|NCT00835172|Glimepiride|glimepiride|mesh-list
1960417|NCT00835172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1960418|NCT00835172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960419|NCT00835172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960420|NCT00835172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1960421|NCT00835172|Immunologic Factors|immunologic factors|mesh-ancestor
1960422|NCT00835185|Leucovorin|leucovorin|mesh-list
1960423|NCT00835185|Folic Acid|folic acid|mesh-list
1960424|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
1960425|NCT00835185|Necitumumab|necitumumab|mesh-list
1960426|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
1960427|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1960428|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960429|NCT00835185|Antidotes|antidotes|mesh-ancestor
1960430|NCT00835185|Protective Agents|protective agents|mesh-ancestor
1960431|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960432|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
1960433|NCT00835185|Vitamins|vitamins|mesh-ancestor
1960434|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
1960435|NCT00835185|Hematinics|hematinics|mesh-ancestor
1960436|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1960437|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
1960438|NCT00835198|Dapsone|dapsone|mesh-list
1960439|NCT00835198|Tretinoin|tretinoin|mesh-list
1960440|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960441|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
1960442|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
1960443|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960444|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
1960445|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1960446|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1960447|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1960448|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960449|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960450|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
1960451|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960452|NCT00835211|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
1960453|NCT00835211|Hemostatics|hemostatics|mesh-ancestor
1960454|NCT00835211|Coagulants|coagulants|mesh-ancestor
1960455|NCT00835211|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1960456|NCT00835211|Natriuretic Agents|natriuretic agents|mesh-ancestor
1960457|NCT00835211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960458|NCT00835224|Midodrine|midodrine|mesh-list
1960459|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
1960460|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
1960461|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960462|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960463|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1960464|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1960465|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1960466|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1960467|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
1960468|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960469|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960470|NCT00835263|Lamotrigine|lamotrigine|mesh-list
1960471|NCT00835263|Anticonvulsants|anticonvulsants|mesh-ancestor
1960472|NCT00835263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1960473|NCT00835263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960474|NCT00835263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960475|NCT00835263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1960476|NCT00835263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960477|NCT00835263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1960478|NCT00835263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1960479|NCT00835263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960480|NCT00835263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1960481|NCT00835263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1960482|NCT00835276|Fexofenadine|fexofenadine|mesh-list
1960483|NCT00835276|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1960484|NCT00835276|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1960485|NCT00835276|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1960486|NCT00835276|Histamine Antagonists|histamine antagonists|mesh-ancestor
1960487|NCT00835276|Histamine Agents|histamine agents|mesh-ancestor
1960488|NCT00835276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960489|NCT00835276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960490|NCT00835276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960491|NCT00835354|Cefprozil|cefprozil|mesh-list
1960492|NCT00835354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960493|NCT00835354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960494|NCT00835367|Amlodipine|amlodipine|mesh-list
1960495|NCT00835367|Benazepril|benazepril|mesh-list
1960496|NCT00835367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1960497|NCT00835367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1960498|NCT00835367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960499|NCT00835367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960500|NCT00835367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1960501|NCT00835367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960502|NCT00835367|Vasodilator Agents|vasodilator agents|mesh-ancestor
1960503|NCT00835367|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1960504|NCT00835367|Protease Inhibitors|protease inhibitors|mesh-ancestor
1960505|NCT00835367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960506|NCT00835406|Alendronate|alendronate|mesh-list
1960507|NCT00835406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1960508|NCT00835406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960509|NCT00835484|Cefdinir|cefdinir|mesh-list
1960510|NCT00835484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960511|NCT00835484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960512|NCT00835497|Metformin|metformin|mesh-list
1960513|NCT00835497|Glipizide|glipizide|mesh-list
1960514|NCT00835497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960515|NCT00835497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960516|NCT00835510|Butenafine|butenafine|mesh-list
1960517|NCT00835510|Clotrimazole|clotrimazole|mesh-list
1960518|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
1960519|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960520|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1960521|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1960522|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1960523|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960524|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960525|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1960526|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
1960527|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1960528|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960529|NCT00835536|Ribavirin|ribavirin|mesh-list
1960530|NCT00835536|Antimetabolites|antimetabolites|mesh-ancestor
1960531|NCT00835536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960532|NCT00835536|Antiviral Agents|antiviral agents|mesh-ancestor
1960533|NCT00835536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960534|NCT00835549|Cefdinir|cefdinir|mesh-list
1960535|NCT00835549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960536|NCT00835549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960537|NCT00835575|Mirtazapine|mirtazapine|mesh-list
1960538|NCT00835575|Antidepressive Agents|antidepressive agents|mesh-ancestor
1960539|NCT00835575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1960540|NCT00835575|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1960541|NCT00835575|Histamine Antagonists|histamine antagonists|mesh-ancestor
1960542|NCT00835575|Histamine Agents|histamine agents|mesh-ancestor
1960543|NCT00835575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960544|NCT00835575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960545|NCT00835575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960546|NCT00835575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1960547|NCT00835575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1960548|NCT00835575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960549|NCT00835575|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1960550|NCT00835575|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1960551|NCT00835575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1960552|NCT00835575|Adrenergic Agents|adrenergic agents|mesh-ancestor
1960553|NCT00835575|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1960554|NCT00835575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1960555|NCT00835575|Serotonin Agents|serotonin agents|mesh-ancestor
1960556|NCT00835575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1960557|NCT00835588|Pantoprazole|pantoprazole|mesh-list
1960558|NCT00835588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1960559|NCT00835588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1960560|NCT00835588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1960561|NCT00835588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960562|NCT00835588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960563|NCT00835614|Cefprozil|cefprozil|mesh-list
1960564|NCT00835614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960565|NCT00835614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960566|NCT00835640|Fexofenadine|fexofenadine|mesh-list
1960567|NCT00835640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1960568|NCT00835640|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1960569|NCT00835640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1960570|NCT00835640|Histamine Antagonists|histamine antagonists|mesh-ancestor
1960571|NCT00835640|Histamine Agents|histamine agents|mesh-ancestor
1960572|NCT00835640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960573|NCT00835640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960574|NCT00835640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960575|NCT00835666|Finasteride|finasteride|mesh-list
1960576|NCT00835666|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1960577|NCT00835666|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1960578|NCT00835666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960579|NCT00835666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960580|NCT00835666|Hormone Antagonists|hormone antagonists|mesh-ancestor
1960581|NCT00835666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1960582|NCT00835666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960583|NCT00835666|Urological Agents|urological agents|mesh-ancestor
1960584|NCT00835692|Clarithromycin|clarithromycin|mesh-list
1960585|NCT00835692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960586|NCT00835692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960587|NCT00835692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1960588|NCT00835692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960589|NCT00835692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960590|NCT00835692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1960591|NCT00835692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1960592|NCT00835705|Amoxicillin|amoxicillin|mesh-list
1960593|NCT00835705|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1960594|NCT00835705|Clavulanic Acids|clavulanic acids|mesh-list
1960595|NCT00835705|Clavulanic Acid|clavulanic acid|mesh-list
1960596|NCT00835705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960597|NCT00835705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960598|NCT00835705|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1960599|NCT00835705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960600|NCT00835705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960601|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
1960602|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
1960603|NCT00835731|Misoprostol|misoprostol|mesh-list
1960604|NCT00835731|Vitamins|vitamins|mesh-ancestor
1960605|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
1960606|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960607|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1960608|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
1960609|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1960610|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1960611|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1960612|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
1960613|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
1960614|NCT00835731|Hematinics|hematinics|mesh-ancestor
1960615|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
1960616|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
1960617|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1960618|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
1960619|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960620|NCT00835796|Finasteride|finasteride|mesh-list
1960621|NCT00835796|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1960622|NCT00835796|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1960623|NCT00835796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960624|NCT00835796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960625|NCT00835796|Hormone Antagonists|hormone antagonists|mesh-ancestor
1960626|NCT00835796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1960627|NCT00835796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960628|NCT00835796|Urological Agents|urological agents|mesh-ancestor
1960629|NCT00835861|Insulin|insulin|mesh-list
1960630|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1960631|NCT00835861|Metformin|metformin|mesh-list
1960632|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
1960633|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
1960634|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960635|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960636|NCT00835900|Varenicline|varenicline|mesh-list
1960637|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1960638|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1960639|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
1960640|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960641|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960642|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960643|NCT00835926|Vaccines|vaccines|mesh-list
1960644|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
1960645|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960646|NCT00835978|Axitinib|axitinib|mesh-list
1960647|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960648|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1960649|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960650|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960651|NCT00835991|Metformin|metformin|mesh-list
1960652|NCT00835991|Glyburide|glyburide|mesh-list
1960653|NCT00835991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960654|NCT00835991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960655|NCT00836004|Clindamycin|clindamycin|mesh-list
1960656|NCT00836004|Clindamycin palmitate|clindamycin palmitate|mesh-list
1960657|NCT00836004|Clindamycin phosphate|clindamycin phosphate|mesh-list
1960658|NCT00836004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960659|NCT00836004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960660|NCT00836004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1960661|NCT00836004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960662|NCT00836004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960663|NCT00836056|Clindamycin|clindamycin|mesh-list
1960664|NCT00836056|Clindamycin palmitate|clindamycin palmitate|mesh-list
1960665|NCT00836056|Clindamycin phosphate|clindamycin phosphate|mesh-list
1960666|NCT00836056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960667|NCT00836056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960668|NCT00836056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1960669|NCT00836056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960670|NCT00836056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960671|NCT00836277|Irinotecan|irinotecan|mesh-list
1960672|NCT00836277|Panitumumab|panitumumab|mesh-list
1960673|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1960674|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1960675|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960676|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960677|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960678|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1960679|NCT00836407|Ipilimumab|ipilimumab|mesh-list
1960680|NCT00836407|Vaccines|vaccines|mesh-list
1960681|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
1960682|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960683|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1960684|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960685|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1960686|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960687|NCT00836472|Metformin|metformin|mesh-list
1960688|NCT00836472|Glyburide|glyburide|mesh-list
1960689|NCT00836472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960690|NCT00836472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960691|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1960692|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
1960693|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960694|NCT00836693|Tadalafil|tadalafil|mesh-list
1960695|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
1960696|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1960697|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1960698|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960699|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960700|NCT00836693|Urological Agents|urological agents|mesh-ancestor
1960701|NCT00836706|Clarithromycin|clarithromycin|mesh-list
1960702|NCT00836706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960703|NCT00836706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960704|NCT00836706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1960705|NCT00836706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960706|NCT00836706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960707|NCT00836706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1960708|NCT00836706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1960709|NCT00836810|Prednisone|prednisone|mesh-list
1960710|NCT00836810|Prednisolone|prednisolone|mesh-list
1960711|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1960712|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
1960713|NCT00836810|Hormones|hormones|mesh-ancestor
1960714|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1960715|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960716|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1960717|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960718|NCT00836875|Voriconazole|voriconazole|mesh-list
1960719|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
1960720|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960721|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1960722|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1960723|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960724|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960725|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1960726|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
1960727|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1960728|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960729|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1960730|NCT00836888|Nivolumab|nivolumab|mesh-list
1960731|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1960732|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960733|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1960734|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960735|NCT00836901|Amoxicillin|amoxicillin|mesh-list
1960736|NCT00836901|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1960737|NCT00836901|Clavulanic Acids|clavulanic acids|mesh-list
1960738|NCT00836901|Clavulanic Acid|clavulanic acid|mesh-list
1960739|NCT00836901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960740|NCT00836901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960741|NCT00836901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1960742|NCT00836901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960743|NCT00836901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960744|NCT00836927|Sirolimus|sirolimus|mesh-list
1960745|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960746|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960747|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1960748|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960749|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
1960750|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1960751|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
1960752|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960753|NCT00837031|Gemcitabine|gemcitabine|mesh-list
1960754|NCT00837031|Lenalidomide|lenalidomide|mesh-list
1960755|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1960756|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
1960757|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960758|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960759|NCT00837031|Antiviral Agents|antiviral agents|mesh-ancestor
1960760|NCT00837031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960761|NCT00837031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960762|NCT00837031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1960763|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
1960764|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960765|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1960766|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1960767|NCT00837031|Growth Substances|growth substances|mesh-ancestor
1960768|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
1960769|NCT00837148|Sorafenib|sorafenib|mesh-list
1960770|NCT00837148|Dacarbazine|dacarbazine|mesh-list
1960771|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960772|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1960773|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960774|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960775|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1960776|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
1960777|NCT00837200|Doxorubicin|doxorubicin|mesh-list
1960778|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1960779|NCT00837200|Asparaginase|asparaginase|mesh-list
1960780|NCT00837200|Pegaspargase|pegaspargase|mesh-list
1960781|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1960782|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960783|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1960784|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1960785|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960786|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960787|NCT00837213|Doxycycline|doxycycline|mesh-list
1960788|NCT00837213|Clindamycin|clindamycin|mesh-list
1960789|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
1960790|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
1960791|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1960792|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960793|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960794|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
1960795|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1960796|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1960797|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1960798|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960799|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960800|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
1960801|NCT00837252|Finasteride|finasteride|mesh-list
1960802|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1960803|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1960804|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960805|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960806|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
1960807|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1960808|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960809|NCT00837252|Urological Agents|urological agents|mesh-ancestor
1960810|NCT00837330|Ranibizumab|ranibizumab|mesh-list
1960811|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1960812|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1960813|NCT00837330|Growth Substances|growth substances|mesh-ancestor
1960814|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960815|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
1960816|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960817|NCT00837434|Adalimumab|adalimumab|mesh-list
1960818|NCT00837434|Etanercept|etanercept|mesh-list
1960819|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1960820|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1960821|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1960822|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1960823|NCT00837434|Analgesics|analgesics|mesh-ancestor
1960824|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
1960825|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960826|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960827|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1960828|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1960829|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
1960830|NCT00837512|Insulin|insulin|mesh-list
1960831|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1960832|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960833|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960834|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1960835|NCT00837577|Voglibose|voglibose|mesh-list
1960836|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960837|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960838|NCT00837577|Incretins|incretins|mesh-ancestor
1960839|NCT00837577|Hormones|hormones|mesh-ancestor
1960840|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1960841|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1960842|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
1960843|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960844|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960845|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
1960846|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
1960847|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
1960848|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1960849|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1960850|NCT00837590|Analgesics|analgesics|mesh-ancestor
1960851|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
1960852|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960853|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960854|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1960855|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1960856|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1960857|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960858|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960859|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1960860|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1960861|NCT00837616|Estradiol|estradiol|mesh-list
1960862|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1960863|NCT00837616|Estrogens|estrogens|mesh-ancestor
1960864|NCT00837616|Hormones|hormones|mesh-ancestor
1960865|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1960866|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960867|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1960868|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
1960869|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1960870|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1960871|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1960872|NCT00837759|Lansoprazole|lansoprazole|mesh-list
1960873|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
1960874|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1960875|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960876|NCT00837759|Incretins|incretins|mesh-ancestor
1960877|NCT00837759|Hormones|hormones|mesh-ancestor
1960878|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1960879|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1960880|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
1960881|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960882|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960883|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1960884|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1960885|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1960886|NCT00837876|Sorafenib|sorafenib|mesh-list
1960887|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960888|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1960889|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960890|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960891|NCT00837902|Atenolol|atenolol|mesh-list
1960892|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1960893|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1960894|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
1960895|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
1960896|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960897|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960898|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1960899|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1960900|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1960901|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
1960902|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960903|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960904|NCT00837967|Terbutaline|terbutaline|mesh-list
1960905|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1960906|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1960907|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
1960908|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1960909|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
1960910|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1960911|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960912|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
1960913|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
1960914|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1960915|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1960916|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1960917|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1960918|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
1960919|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960920|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960921|NCT00838136|Lamotrigine|lamotrigine|mesh-list
1960922|NCT00838136|Anticonvulsants|anticonvulsants|mesh-ancestor
1960923|NCT00838136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1960924|NCT00838136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960925|NCT00838136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960926|NCT00838136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1960927|NCT00838136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960928|NCT00838136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1960929|NCT00838136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1960930|NCT00838136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960931|NCT00838136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1960932|NCT00838136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1960933|NCT00838162|Ritonavir|ritonavir|mesh-list
1960934|NCT00838162|TMC-310911|tmc-310911|mesh-list
1960935|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1960936|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1960937|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
1960938|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960939|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960940|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1960941|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1960942|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
1960943|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960944|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1960945|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1960946|NCT00838201|Denosumab|denosumab|mesh-list
1960947|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1960948|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960949|NCT00838279|Lamotrigine|lamotrigine|mesh-list
1960950|NCT00838279|Anticonvulsants|anticonvulsants|mesh-ancestor
1960951|NCT00838279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1960952|NCT00838279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960953|NCT00838279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960954|NCT00838279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1960955|NCT00838279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960956|NCT00838279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1960957|NCT00838279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1960958|NCT00838279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1960959|NCT00838279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1960960|NCT00838279|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1960961|NCT00838435|Verapamil|verapamil|mesh-list
1960962|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1960963|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1960964|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1960965|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960966|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1960967|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960968|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
1960969|NCT00838513|Eculizumab|eculizumab|mesh-list
1960970|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1960971|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1960972|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
1960973|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960974|NCT00838526|Rabeprazole|rabeprazole|mesh-list
1960975|NCT00838526|Ranitidine|ranitidine|mesh-list
1960976|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
1960977|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1960978|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1960979|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1960980|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1960981|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1960982|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1960983|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
1960984|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
1960985|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1960986|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960987|NCT00838539|Sirolimus|sirolimus|mesh-list
1960988|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1960989|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1960990|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1960991|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1960992|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
1960993|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1960994|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
1960995|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1960996|NCT00838578|Irinotecan|irinotecan|mesh-list
1960997|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1960998|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1960999|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961000|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961001|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961002|NCT00838630|Cilostazol|cilostazol|mesh-list
1961003|NCT00838630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1961004|NCT00838630|Autonomic Agents|autonomic agents|mesh-ancestor
1961005|NCT00838630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961006|NCT00838630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961007|NCT00838630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1961008|NCT00838630|Respiratory System Agents|respiratory system agents|mesh-ancestor
1961009|NCT00838630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1961010|NCT00838630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1961011|NCT00838630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961012|NCT00838630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1961013|NCT00838630|Vasodilator Agents|vasodilator agents|mesh-ancestor
1961014|NCT00838630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1961015|NCT00838630|Protective Agents|protective agents|mesh-ancestor
1961016|NCT00838630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1961017|NCT00838630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1961018|NCT00838630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961019|NCT00838682|Omeprazole|omeprazole|mesh-list
1961020|NCT00838682|Rabeprazole|rabeprazole|mesh-list
1961021|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1961022|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1961023|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1961024|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961025|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961026|NCT00838695|Phenylephrine|phenylephrine|mesh-list
1961027|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
1961028|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1961029|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
1961030|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
1961031|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961032|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961033|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
1961034|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1961035|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
1961036|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
1961037|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1961038|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1961039|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1961040|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
1961041|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961042|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961043|NCT00838695|Protective Agents|protective agents|mesh-ancestor
1961044|NCT00838903|Metformin|metformin|mesh-list
1961045|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1961046|NCT00838903|Glimepiride|glimepiride|mesh-list
1961047|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
1961048|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
1961049|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1961050|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961051|NCT00838903|Incretins|incretins|mesh-ancestor
1961052|NCT00838903|Hormones|hormones|mesh-ancestor
1961053|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1961054|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1961055|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
1961056|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961057|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961058|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1961059|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961060|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
1961061|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
1961062|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
1961063|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1961064|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961065|NCT00838916|Incretins|incretins|mesh-ancestor
1961066|NCT00838916|Hormones|hormones|mesh-ancestor
1961067|NCT00838916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1961068|NCT00838929|Vorinostat|vorinostat|mesh-list
1961069|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961070|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1961071|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961072|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745575|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2745576|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
2745577|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745578|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2745579|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745580|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745581|NCT02864251|Carboplatin|carboplatin|mesh-list
2745582|NCT02864251|Nivolumab|nivolumab|mesh-list
2745583|NCT02864251|Pemetrexed|pemetrexed|mesh-list
2745584|NCT02864251|Ipilimumab|ipilimumab|mesh-list
2745585|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745586|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745587|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2745588|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745589|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745590|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1961089|NCT00839072|Trazodone|trazodone|mesh-list
1961090|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1961091|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1961092|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1961093|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961094|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1961095|NCT00839072|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1961096|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1961097|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961098|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961099|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961100|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
1961101|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1961102|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
1961103|NCT00839254|Vaccines|vaccines|mesh-list
1961104|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1961105|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
1961106|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961107|NCT00839306|Rabeprazole|rabeprazole|mesh-list
1961108|NCT00839306|Ranitidine|ranitidine|mesh-list
1961109|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
1961110|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1961111|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1961112|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1961113|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961114|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961115|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1961116|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
1961117|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
1961118|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961119|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961120|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1961121|NCT00839319|Testosterone|testosterone|mesh-list
1961122|NCT00839319|Acyline|acyline|mesh-list
1961123|NCT00839319|Androgens|androgens|mesh-ancestor
1961124|NCT00839319|Hormones|hormones|mesh-ancestor
1961125|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1961126|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961127|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1961128|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
1961129|NCT00839332|Gemcitabine|gemcitabine|mesh-list
1961130|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1961131|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
1961132|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961133|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961134|NCT00839332|Antiviral Agents|antiviral agents|mesh-ancestor
1961135|NCT00839332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961136|NCT00839332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961137|NCT00839332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961138|NCT00839332|Immunologic Factors|immunologic factors|mesh-ancestor
1961139|NCT00839332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961140|NCT00839423|Vortioxetine|vortioxetine|mesh-list
1961141|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1961142|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1961143|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1961144|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961145|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961146|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961147|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961148|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1961149|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
1961150|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1961151|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1961152|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1961153|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1961154|NCT00839423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1961155|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
1961156|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1961157|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1961158|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1961159|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1961160|NCT00839527|Metformin|metformin|mesh-list
1961161|NCT00839527|Pioglitazone|pioglitazone|mesh-list
1961162|NCT00839527|Glimepiride|glimepiride|mesh-list
1961163|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
1961164|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
1961165|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1961166|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961167|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1961168|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961169|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
1961170|NCT00839527|Incretins|incretins|mesh-ancestor
1961171|NCT00839527|Hormones|hormones|mesh-ancestor
1961172|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1961173|NCT00839540|Caspofungin|caspofungin|mesh-list
1961174|NCT00839540|Micafungin|micafungin|mesh-list
1961175|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
1961176|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961177|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961178|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961179|NCT00839800|Terbutaline|terbutaline|mesh-list
1961180|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1961181|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1961182|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
1961183|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1961184|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
1961185|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961186|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961187|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
1961188|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
1961189|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1961190|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1961191|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1961192|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1961193|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
1961194|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961195|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961196|NCT00839852|Cariprazine|cariprazine|mesh-list
1961197|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1961198|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1961199|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1961200|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961201|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1961202|NCT00839930|Cilostazol|cilostazol|mesh-list
1961203|NCT00839930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1961204|NCT00839930|Autonomic Agents|autonomic agents|mesh-ancestor
1961205|NCT00839930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961206|NCT00839930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961207|NCT00839930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1961208|NCT00839930|Respiratory System Agents|respiratory system agents|mesh-ancestor
1961209|NCT00839930|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1961210|NCT00839930|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1961211|NCT00839930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961212|NCT00839930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1961213|NCT00839930|Vasodilator Agents|vasodilator agents|mesh-ancestor
1961214|NCT00839930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1961215|NCT00839930|Protective Agents|protective agents|mesh-ancestor
1961216|NCT00839930|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1961217|NCT00839930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1961218|NCT00839930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961219|NCT00839956|Bortezomib|bortezomib|mesh-list
1961220|NCT00839956|Vorinostat|vorinostat|mesh-list
1961221|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961222|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1961223|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961224|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961225|NCT00839982|Cytarabine|cytarabine|mesh-list
1961226|NCT00839982|Clofarabine|clofarabine|mesh-list
1961227|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1961228|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
1961229|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961230|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961231|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
1961232|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961233|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961234|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
1961235|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961236|NCT00840073|Trandolapril|trandolapril|mesh-list
1961237|NCT00840073|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1961238|NCT00840073|Protease Inhibitors|protease inhibitors|mesh-ancestor
1961239|NCT00840073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961240|NCT00840073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961241|NCT00840073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1961242|NCT00840099|Amoxicillin|amoxicillin|mesh-list
1961243|NCT00840099|Clavulanic Acid|clavulanic acid|mesh-list
1961244|NCT00840099|Clavulanic Acids|clavulanic acids|mesh-list
1961245|NCT00840099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1961246|NCT00840099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1961247|NCT00840099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961248|NCT00840099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1961249|NCT00840099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961250|NCT00840099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961251|NCT00840177|Cytarabine|cytarabine|mesh-list
1961252|NCT00840177|Idarubicin|idarubicin|mesh-list
1961253|NCT00840177|Pravastatin|pravastatin|mesh-list
1961254|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1961255|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
1961256|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961257|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961258|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
1961259|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961260|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961261|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
1961262|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961263|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1961264|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1961265|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1961266|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961267|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1961268|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1961269|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1961270|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1961271|NCT00840203|Mesalamine|mesalamine|mesh-list
1961272|NCT00840203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1961273|NCT00840203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1961274|NCT00840203|Analgesics|analgesics|mesh-ancestor
1961275|NCT00840203|Sensory System Agents|sensory system agents|mesh-ancestor
1961276|NCT00840203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961277|NCT00840203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961278|NCT00840203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1961279|NCT00840203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1961280|NCT00840216|Clarithromycin|clarithromycin|mesh-list
1961281|NCT00840216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1961282|NCT00840216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961283|NCT00840216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1961284|NCT00840216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961285|NCT00840216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961286|NCT00840216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1961287|NCT00840216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1961288|NCT00840281|Cefprozil|cefprozil|mesh-list
1961289|NCT00840281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1961290|NCT00840281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961291|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
1961292|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1961293|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961294|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1961295|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1961296|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961297|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961298|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961299|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1961300|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1961301|NCT00840411|Clarithromycin|clarithromycin|mesh-list
1961302|NCT00840411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1961303|NCT00840411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961304|NCT00840411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1961305|NCT00840411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961306|NCT00840411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961307|NCT00840411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1961308|NCT00840411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1961309|NCT00840450|Paclitaxel|paclitaxel|mesh-list
1961310|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1961311|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
1961312|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1961313|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961314|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
1961315|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
1961316|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
1961317|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961318|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1961319|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961320|NCT00840463|Ambrisentan|ambrisentan|mesh-list
1961321|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1961322|NCT00840476|Meloxicam|meloxicam|mesh-list
1961323|NCT00840476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1961324|NCT00840476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1961325|NCT00840476|Analgesics|analgesics|mesh-ancestor
1961326|NCT00840476|Sensory System Agents|sensory system agents|mesh-ancestor
1961327|NCT00840476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961328|NCT00840476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961329|NCT00840476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1961330|NCT00840476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1961331|NCT00840476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1961332|NCT00840476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1961333|NCT00840476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961334|NCT00840476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961335|NCT00840632|Trandolapril|trandolapril|mesh-list
1961336|NCT00840632|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1961337|NCT00840632|Protease Inhibitors|protease inhibitors|mesh-ancestor
1961338|NCT00840632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961339|NCT00840632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961340|NCT00840632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1961341|NCT00840840|Amoxicillin|amoxicillin|mesh-list
1961342|NCT00840840|Clavulanic Acid|clavulanic acid|mesh-list
1961343|NCT00840840|Clavulanic Acids|clavulanic acids|mesh-list
1961344|NCT00840840|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1961345|NCT00840840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1961346|NCT00840840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961347|NCT00840840|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1961348|NCT00840840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961349|NCT00840840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961350|NCT00840866|Cefprozil|cefprozil|mesh-list
1961351|NCT00840866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1961352|NCT00840866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961353|NCT00840879|Meloxicam|meloxicam|mesh-list
1961354|NCT00840879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1961355|NCT00840879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1961356|NCT00840879|Analgesics|analgesics|mesh-ancestor
1961357|NCT00840879|Sensory System Agents|sensory system agents|mesh-ancestor
1961358|NCT00840879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961359|NCT00840879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961360|NCT00840879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1961361|NCT00840879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1961362|NCT00840879|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1961363|NCT00840879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1961364|NCT00840879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961365|NCT00840879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961366|NCT00840996|Lidocaine|lidocaine|mesh-list
1961367|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
1961368|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
1961369|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1961370|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961371|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
1961372|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961373|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1961374|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1961375|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1961376|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961377|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961378|NCT00841087|Insulin|insulin|mesh-list
1961379|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1961380|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
1961381|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
1961382|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1961383|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961384|NCT00841204|Sulindac|sulindac|mesh-list
1961385|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1961386|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1961387|NCT00841204|Analgesics|analgesics|mesh-ancestor
1961388|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
1961389|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961390|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961391|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1961392|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1961393|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961394|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1961395|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961396|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961397|NCT00841542|Amlodipine|amlodipine|mesh-list
1961398|NCT00841542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1961399|NCT00841542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1961400|NCT00841542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961401|NCT00841542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961402|NCT00841542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1961403|NCT00841542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961404|NCT00841542|Vasodilator Agents|vasodilator agents|mesh-ancestor
1961405|NCT00841555|Temozolomide|temozolomide|mesh-list
1961406|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1961407|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
1961408|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961409|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961410|NCT00841568|Tolvaptan|tolvaptan|mesh-list
1961411|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1961412|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961413|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
1961414|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961415|NCT00841659|Paroxetine|paroxetine|mesh-list
1961416|NCT00841659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1961417|NCT00841659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1961418|NCT00841659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961419|NCT00841659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961420|NCT00841659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961421|NCT00841659|Serotonin Agents|serotonin agents|mesh-ancestor
1961422|NCT00841659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961423|NCT00841659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1961424|NCT00841659|Antidepressive Agents|antidepressive agents|mesh-ancestor
1961425|NCT00841659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1961426|NCT00841659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1961427|NCT00841659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1961428|NCT00841659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961429|NCT00841672|Amlodipine|amlodipine|mesh-list
1961430|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1961431|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1961432|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961433|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961434|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1961435|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961436|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
1961437|NCT00841698|Paroxetine|paroxetine|mesh-list
1961438|NCT00841698|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1961439|NCT00841698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1961440|NCT00841698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961441|NCT00841698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961442|NCT00841698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961443|NCT00841698|Serotonin Agents|serotonin agents|mesh-ancestor
1961444|NCT00841698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961445|NCT00841698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1961446|NCT00841698|Antidepressive Agents|antidepressive agents|mesh-ancestor
1961447|NCT00841698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1961448|NCT00841698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1961449|NCT00841698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1961450|NCT00841698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961451|NCT00841763|Vaccines|vaccines|mesh-list
1961452|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
1961453|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961454|NCT00841815|Amlodipine|amlodipine|mesh-list
1961455|NCT00841815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1961456|NCT00841815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1961457|NCT00841815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961458|NCT00841815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961459|NCT00841815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1961460|NCT00841815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961461|NCT00841815|Vasodilator Agents|vasodilator agents|mesh-ancestor
1961462|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
1961463|NCT00841828|Docetaxel|docetaxel|mesh-list
1961464|NCT00841828|Trastuzumab|trastuzumab|mesh-list
1961465|NCT00841828|Epirubicin|epirubicin|mesh-list
1961466|NCT00841828|Lapatinib|lapatinib|mesh-list
1961467|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961468|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
1961469|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961470|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1961471|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1961472|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
1961473|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961474|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961475|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1961476|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
1961477|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
1961478|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
1961479|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1961480|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1961481|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1961482|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1961483|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961484|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1961485|NCT00841971|Fluconazole|fluconazole|mesh-list
1961486|NCT00841971|Anidulafungin|anidulafungin|mesh-list
1961487|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
1961488|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961489|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1961490|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1961491|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961492|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961493|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1961494|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
1961495|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1961496|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961497|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1961498|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1961499|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1961500|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
1961501|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
1961502|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
1961503|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961504|NCT00842075|Pramlintide|pramlintide|mesh-list
1961505|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1961506|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961507|NCT00842153|Clobetasol|clobetasol|mesh-list
1961508|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1961509|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
1961510|NCT00842153|Hormones|hormones|mesh-ancestor
1961511|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1961512|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961513|NCT00842244|Capecitabine|capecitabine|mesh-list
1961514|NCT00842244|Axitinib|axitinib|mesh-list
1961515|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961516|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1961517|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
1961518|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961519|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1961520|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961521|NCT00842257|Panitumumab|panitumumab|mesh-list
1961522|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1961523|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961524|NCT00842309|Cycloserine|cycloserine|mesh-list
1961525|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1961526|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961527|NCT00842309|Renal Agents|renal agents|mesh-ancestor
1961528|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1961529|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
1961530|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1961531|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
1961532|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961533|NCT00842348|Lanreotide|lanreotide|mesh-list
1961534|NCT00842348|Somatostatin|somatostatin|mesh-list
1961535|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961536|NCT00842348|Hormones|hormones|mesh-ancestor
1961537|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1961538|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961539|NCT00842361|Insulin|insulin|mesh-list
1961540|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1961541|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
1961542|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
1961543|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1961544|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
1961545|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
1961546|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1961547|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961548|NCT00842530|Vaccines|vaccines|mesh-list
1961549|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
1961550|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961551|NCT00842608|Haloperidol|haloperidol|mesh-list
1961552|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
1961553|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
1961554|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
1961555|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
1961556|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961557|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961558|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1961559|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1961560|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1961561|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1961562|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1961563|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1961564|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
1961565|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961566|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961567|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1961568|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
1961569|NCT00842712|Gemcitabine|gemcitabine|mesh-list
1961570|NCT00842712|Cisplatin|cisplatin|mesh-list
1961571|NCT00842712|Cetuximab|cetuximab|mesh-list
1961572|NCT00842712|Vinorelbine|vinorelbine|mesh-list
1961573|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961574|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1961575|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
1961576|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961577|NCT00842712|Antiviral Agents|antiviral agents|mesh-ancestor
1961578|NCT00842712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961579|NCT00842712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961580|NCT00842712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961581|NCT00842712|Immunologic Factors|immunologic factors|mesh-ancestor
1961582|NCT00842712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961583|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1961584|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1961585|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
1961586|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
1961587|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
1961588|NCT00842751|Finasteride|finasteride|mesh-list
1961589|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1961590|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1961591|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961592|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961593|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
1961594|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1961595|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961596|NCT00842751|Urological Agents|urological agents|mesh-ancestor
1961597|NCT00842829|Fentanyl|fentanyl|mesh-list
1961598|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1961599|NCT00842829|Narcotics|narcotics|mesh-ancestor
1961600|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1961601|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961602|NCT00842829|Analgesics|analgesics|mesh-ancestor
1961603|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
1961604|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961605|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1961606|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1961607|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
1961608|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
1961609|NCT00842985|Dronabinol|dronabinol|mesh-list
1961610|NCT00842985|Modafinil|modafinil|mesh-list
1961611|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1961612|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961613|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1961614|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1961615|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1961616|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961617|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
1961618|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1961619|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1961620|NCT00842985|Analgesics|analgesics|mesh-ancestor
1961621|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
1961622|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961623|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1961624|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1961625|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961626|NCT00842985|Hormones|hormones|mesh-ancestor
1961627|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1961628|NCT00843024|Naproxen|naproxen|mesh-list
1961629|NCT00843024|Sumatriptan|sumatriptan|mesh-list
1961630|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1961631|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1961632|NCT00843024|Analgesics|analgesics|mesh-ancestor
1961633|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
1961634|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961635|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961636|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1961637|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1961638|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
1961639|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1961640|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961641|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961642|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1961643|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1961644|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1961645|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
1961646|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961647|NCT00843115|Donepezil|donepezil|mesh-list
1961648|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1961649|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961650|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961651|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
1961652|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961653|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961654|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
1961655|NCT00843193|Fluticasone|fluticasone|mesh-list
1961656|NCT00843193|Xhance|xhance|mesh-list
1961657|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1961658|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1961659|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
1961660|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961661|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961662|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1961663|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
1961664|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
1961665|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1961666|NCT00843284|Pregabalin|pregabalin|mesh-list
1961667|NCT00843284|Analgesics|analgesics|mesh-ancestor
1961668|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
1961669|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961670|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961671|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
1961672|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1961673|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961674|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961675|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1961676|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1961677|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1961678|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1961679|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1961680|NCT00843492|PENTA|penta|mesh-list
1961681|NCT00843492|Nadroparin|nadroparin|mesh-list
1961682|NCT00843492|Fondaparinux|fondaparinux|mesh-list
1961683|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1961684|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
1961685|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1961686|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
1961687|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961688|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961689|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
1961690|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1961691|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1961692|NCT00843531|Everolimus|everolimus|mesh-list
1961693|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1961694|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961695|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961696|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
1961697|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961698|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1961699|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961700|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961701|NCT00843635|Tadalafil|tadalafil|mesh-list
1961702|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
1961703|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1961704|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1961705|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961706|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961707|NCT00843635|Urological Agents|urological agents|mesh-ancestor
1961708|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
1961709|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1961710|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1961711|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
1961712|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961713|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1961714|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1961715|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961716|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961717|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
1961718|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961719|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
1961720|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961721|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1961722|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
1961723|NCT00843856|Tacrolimus|tacrolimus|mesh-list
1961724|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961725|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
1961726|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961727|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1961728|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961729|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961730|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1961731|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961732|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1961733|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
1961734|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1961735|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961746|NCT00844051|Vaccines|vaccines|mesh-list
1961747|NCT00844051|Immunologic Factors|immunologic factors|mesh-ancestor
1961748|NCT00844051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961749|NCT00844090|Methylphenidate|methylphenidate|mesh-list
1961750|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1961751|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961752|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1961753|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1961754|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961755|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961756|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
1961757|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961758|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1961759|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1961760|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1961761|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961762|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961763|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961764|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961765|NCT00844194|Analgesics|analgesics|mesh-ancestor
1961766|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
1961767|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961768|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
1961769|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1961770|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
1961771|NCT00844298|Cytarabine|cytarabine|mesh-list
1961772|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1961773|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
1961774|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961775|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961776|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
1961777|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961778|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961779|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
1961780|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961781|NCT00844376|Atorvastatin|atorvastatin|mesh-list
1961782|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1961783|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1961784|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
1961785|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961786|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1961787|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1961788|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961789|NCT00844415|Dabigatran|dabigatran|mesh-list
1961790|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
1961791|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1961792|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
1961793|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961794|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961795|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
1961796|NCT00844428|Eculizumab|eculizumab|mesh-list
1961797|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1961798|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961799|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
1961800|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475522|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
2475523|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475524|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1961804|NCT00844519|Maraviroc|maraviroc|mesh-list
1961805|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1961806|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1961807|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961808|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1961809|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1961810|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
1961811|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961812|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1961813|NCT00844545|Eculizumab|eculizumab|mesh-list
1961814|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1961815|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961816|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
1961817|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961818|NCT00844649|Gemcitabine|gemcitabine|mesh-list
1961819|NCT00844649|Paclitaxel|paclitaxel|mesh-list
1961820|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1961821|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1961822|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961823|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
1961824|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
1961825|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
1961826|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961827|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1961828|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
1961829|NCT00844649|Antiviral Agents|antiviral agents|mesh-ancestor
1961830|NCT00844649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961831|NCT00844649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961832|NCT00844649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961833|NCT00844649|Immunologic Factors|immunologic factors|mesh-ancestor
1961834|NCT00844649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961835|NCT00844714|Rituximab|rituximab|mesh-list
1961836|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1961837|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961838|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
1961839|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961840|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1961841|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1961842|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1961843|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1961844|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961845|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961846|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
1961847|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961848|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961849|NCT00844805|Naproxen|naproxen|mesh-list
1961850|NCT00844805|Infliximab|infliximab|mesh-list
1961851|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
1961852|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1961853|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1961854|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1961855|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1961856|NCT00844805|Analgesics|analgesics|mesh-ancestor
1961857|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
1961858|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961859|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961860|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1961861|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
1961862|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1961863|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961864|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961865|NCT00844831|Lubiprostone|lubiprostone|mesh-list
1961866|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1961867|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961868|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961869|NCT00844844|Eculizumab|eculizumab|mesh-list
1961870|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1961871|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1961872|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
1961873|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961874|NCT00844857|Olanzapine|olanzapine|mesh-list
1961875|NCT00844857|Fluoxetine|fluoxetine|mesh-list
1961876|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
1961877|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
1961878|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961879|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961880|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1961881|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1961882|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1961883|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1961884|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1961885|NCT00844857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1961886|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1961887|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961888|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961889|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961890|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
1961891|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1961892|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
1961893|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1961894|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1961895|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961896|NCT00844883|Sorafenib|sorafenib|mesh-list
1961897|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961898|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1961899|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961900|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961901|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
1961902|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961903|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961904|NCT00845000|Levodopa|levodopa|mesh-list
1961905|NCT00845000|Carbidopa|carbidopa|mesh-list
1961906|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1961907|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1961908|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
1961909|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961910|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961911|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961912|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1961913|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961914|NCT00845039|Irinotecan|irinotecan|mesh-list
1961915|NCT00845039|Cetuximab|cetuximab|mesh-list
1961916|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1961917|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1961918|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1961919|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961920|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961921|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1961922|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1961923|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
1961924|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961925|NCT00845065|Ribavirin|ribavirin|mesh-list
1961926|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1961927|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
1961928|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961929|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
1961930|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1961931|NCT00845130|Vitamins|vitamins|mesh-list
1961932|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
1961933|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
1961934|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961935|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
1961936|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961937|NCT00845130|Protective Agents|protective agents|mesh-ancestor
1961938|NCT00845182|Pioglitazone|pioglitazone|mesh-list
1961939|NCT00845182|Exenatide|exenatide|mesh-list
1961940|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1961941|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961942|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1961943|NCT00845182|Incretins|incretins|mesh-ancestor
1961944|NCT00845182|Hormones|hormones|mesh-ancestor
1961945|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1961946|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1961947|NCT00845195|Azelastine|azelastine|mesh-list
1961948|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1961949|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1961950|NCT00845195|Analgesics|analgesics|mesh-ancestor
1961951|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
1961952|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1961953|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961954|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1961955|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1961956|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1961957|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1961958|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1961959|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
1961960|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
1961961|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1961962|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961963|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1961964|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
1961965|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1961966|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
1961967|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1961968|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1961969|NCT00845429|Vaccines|vaccines|mesh-list
1961970|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
1961971|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961972|NCT00845481|Calcitriol|calcitriol|mesh-list
1961973|NCT00845481|Betamethasone|betamethasone|mesh-list
1961974|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1961975|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
1961976|NCT00845481|Hormones|hormones|mesh-ancestor
1961977|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1961978|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961979|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1961980|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
1961981|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1961982|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1961983|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1961984|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1961985|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1961986|NCT00845481|Vitamins|vitamins|mesh-ancestor
1961987|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
1961988|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1961989|NCT00845507|Exenatide|exenatide|mesh-list
1961990|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1961991|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1961992|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1961993|NCT00845507|Incretins|incretins|mesh-ancestor
1961994|NCT00845507|Hormones|hormones|mesh-ancestor
1961995|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1961996|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
1961997|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
1961998|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1961999|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1962000|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
1962001|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962002|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
1962003|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1962004|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
1962005|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962006|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1962007|NCT00845676|Interferons|interferons|mesh-list
1962008|NCT00845676|Ribavirin|ribavirin|mesh-list
1962009|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
1962010|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
1962011|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1962012|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962013|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
1962014|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1962015|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
1962016|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962017|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
1962018|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962019|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
1962020|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1962021|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
1962022|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962023|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962024|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1962025|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
1962026|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
1962027|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1962028|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
1962029|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962030|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962031|NCT00845832|Rituximab|rituximab|mesh-list
1962032|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1962033|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962034|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
1962035|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962036|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1962037|NCT00845858|Metoclopramide|metoclopramide|mesh-list
1962038|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
1962039|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
1962040|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962041|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962042|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1962043|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1962044|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1962045|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
1962046|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962047|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962048|NCT00845871|Deferasirox|deferasirox|mesh-list
1962049|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1962050|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
1962051|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
1962052|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962053|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
1962054|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1962055|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1962056|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962057|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
1962058|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962059|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962060|NCT00846027|Gemcitabine|gemcitabine|mesh-list
1962061|NCT00846027|Paclitaxel|paclitaxel|mesh-list
1962062|NCT00846027|Bevacizumab|bevacizumab|mesh-list
1962063|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1962064|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962065|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
1962066|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
1962067|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
1962068|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962069|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1962070|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1962071|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1962072|NCT00846027|Growth Substances|growth substances|mesh-ancestor
1962073|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962074|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
1962075|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1962076|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
1962077|NCT00846027|Antiviral Agents|antiviral agents|mesh-ancestor
1962078|NCT00846027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1962079|NCT00846027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962080|NCT00846027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1962081|NCT00846027|Immunologic Factors|immunologic factors|mesh-ancestor
1962082|NCT00846040|Fallypride|fallypride|mesh-list
1962083|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1962084|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1962085|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
1962086|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962087|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962088|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962089|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1962090|NCT00846365|Olmesartan|olmesartan|mesh-list
1962091|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1962092|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
1962093|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1962094|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1962095|NCT00846365|Diuretics|diuretics|mesh-ancestor
1962096|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
1962097|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962098|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1962099|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1962100|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962101|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1962102|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1962103|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
1962104|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962105|NCT00846495|Topiramate|topiramate|mesh-list
1962106|NCT00846495|Frovatriptan|frovatriptan|mesh-list
1962107|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
1962108|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1962109|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962110|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1962111|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
1962112|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962113|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962114|NCT00846521|Acarbose|acarbose|mesh-list
1962115|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
1962116|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962117|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962118|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1962119|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962120|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
1962121|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1962122|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
1962123|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962124|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962125|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1962126|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
1962127|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
1962128|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1962129|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
1962130|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962131|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962132|NCT00846651|Phenylephrine|phenylephrine|mesh-list
1962133|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
1962134|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1962135|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
1962136|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
1962137|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962138|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962139|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
1962140|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1962141|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
1962142|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
1962143|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1962144|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1962145|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1962146|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
1962147|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962148|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962149|NCT00846651|Protective Agents|protective agents|mesh-ancestor
1962150|NCT00846768|Olodaterol|olodaterol|mesh-list
1962151|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1962152|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
1962153|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962154|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962155|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1962156|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
1962157|NCT00846885|Sumatriptan|sumatriptan|mesh-list
1962158|NCT00846885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1962159|NCT00846885|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1962160|NCT00846885|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1962161|NCT00846885|Serotonin Agents|serotonin agents|mesh-ancestor
1962162|NCT00846885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962163|NCT00846885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962164|NCT00846885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962165|NCT00847015|Gemcitabine|gemcitabine|mesh-list
1962166|NCT00847015|Sunitinib|sunitinib|mesh-list
1962167|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962168|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1962169|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
1962170|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962171|NCT00847015|Antiviral Agents|antiviral agents|mesh-ancestor
1962172|NCT00847015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1962173|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962174|NCT00847015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1962175|NCT00847015|Immunologic Factors|immunologic factors|mesh-ancestor
1962176|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962177|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1962178|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1962179|NCT00847015|Growth Substances|growth substances|mesh-ancestor
1962180|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
1962181|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1962182|NCT00847145|Vaccines|vaccines|mesh-list
1962183|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
1962184|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962185|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
1962186|NCT00847171|Trastuzumab|trastuzumab|mesh-list
1962187|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1962188|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
1962189|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962190|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1962191|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1962192|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
1962193|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962194|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962195|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1962196|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1962197|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
1962198|NCT00847210|Lansoprazole|lansoprazole|mesh-list
1962199|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1962200|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1962201|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1962202|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962203|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962204|NCT00847405|Sumatriptan|sumatriptan|mesh-list
1962205|NCT00847405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1962206|NCT00847405|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1962207|NCT00847405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1962208|NCT00847405|Serotonin Agents|serotonin agents|mesh-ancestor
1962209|NCT00847405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962210|NCT00847405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962211|NCT00847405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962212|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
1962213|NCT00847587|Etonogestrel|etonogestrel|mesh-list
1962214|NCT00847587|Desogestrel|desogestrel|mesh-list
1962215|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1962216|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962217|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1962218|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1962219|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1962220|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1962221|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1962222|NCT00847587|Progestins|progestins|mesh-ancestor
1962223|NCT00847587|Hormones|hormones|mesh-ancestor
1962224|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1962225|NCT00847613|Tofacitinib|tofacitinib|mesh-list
1962226|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1962227|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962228|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962229|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
1962230|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1962231|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1962232|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1962233|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962234|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1962235|NCT00847626|Diuretics|diuretics|mesh-ancestor
1962236|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
1962237|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962238|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1962239|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1962240|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
1962241|NCT00847808|Lansoprazole|lansoprazole|mesh-list
1962242|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1962243|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1962244|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1962245|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962246|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962247|NCT00847886|Methotrexate|methotrexate|mesh-list
1962248|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1962249|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
1962250|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1962251|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962252|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1962253|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
1962254|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962255|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962256|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
1962257|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962258|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1962259|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1962260|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
1962261|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1962262|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1962263|NCT00847912|Fluorouracil|fluorouracil|mesh-list
1962264|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
1962265|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962266|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1962267|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962268|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1962269|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
1962270|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962271|NCT00847938|Neostigmine|neostigmine|mesh-list
1962272|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1962273|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962274|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962275|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
1962276|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962277|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962278|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1962279|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
1962280|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962281|NCT00848016|Acetic Acid|acetic acid|mesh-list
1962282|NCT00848016|Retinol acetate|retinol acetate|mesh-list
1962283|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
1962284|NCT00848016|Gossypol|gossypol|mesh-list
1962285|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1962286|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1962287|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1962288|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
1962289|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962290|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1962291|NCT00848016|Protective Agents|protective agents|mesh-ancestor
1962292|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962293|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1962294|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
1962295|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1962296|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1962297|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1962298|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
1962299|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
1962300|NCT00848081|Tadalafil|tadalafil|mesh-list
1962301|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
1962302|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1962303|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1962304|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962305|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962306|NCT00848081|Urological Agents|urological agents|mesh-ancestor
1962307|NCT00848107|Treprostinil|treprostinil|mesh-list
1962308|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1962309|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1962310|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
1962311|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
1962312|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962313|NCT00848354|Etanercept|etanercept|mesh-list
1962314|NCT00848354|Methotrexate|methotrexate|mesh-list
1962315|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1962316|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
1962317|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1962318|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962319|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1962320|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
1962321|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962322|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962323|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
1962324|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962325|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1962326|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1962327|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
1962328|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1962329|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1962330|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1962331|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1962332|NCT00848354|Analgesics|analgesics|mesh-ancestor
1962333|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
1962334|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962335|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1962336|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1962337|NCT00848393|Fentanyl|fentanyl|mesh-list
1962338|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
1962339|NCT00848393|Citric Acid|citric acid|mesh-list
1962340|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
1962341|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1962342|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1962343|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962344|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1962345|NCT00848393|Analgesics|analgesics|mesh-ancestor
1962346|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
1962347|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962348|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1962349|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1962350|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1962351|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
1962352|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962353|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962354|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1962355|NCT00848393|Narcotics|narcotics|mesh-ancestor
1962356|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1962357|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1962358|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
1962359|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
1962360|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
1962361|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1962362|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
1962363|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
1962364|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
1962365|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
1962366|NCT00848497|Testosterone|testosterone|mesh-list
1962367|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
1962368|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
1962369|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1962370|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962371|NCT00848497|Androgens|androgens|mesh-ancestor
1962372|NCT00848497|Hormones|hormones|mesh-ancestor
1962373|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1962374|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962375|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1962376|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962377|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
1962378|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
1962379|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1962380|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1962381|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962382|NCT00848497|Urological Agents|urological agents|mesh-ancestor
1962383|NCT00848536|Travoprost|travoprost|mesh-list
1962384|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1962385|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1962386|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1962387|NCT00848549|Carbamazepine|carbamazepine|mesh-list
1962388|NCT00848549|Zonisamide|zonisamide|mesh-list
1962389|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
1962390|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
1962391|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1962392|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1962393|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962394|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1962395|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1962396|NCT00848549|Analgesics|analgesics|mesh-ancestor
1962397|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
1962398|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962399|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1962400|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1962401|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962402|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1962403|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1962404|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1962405|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1962406|NCT00848718|Paclitaxel|paclitaxel|mesh-list
1962407|NCT00848718|Docetaxel|docetaxel|mesh-list
1962408|NCT00848718|Carboplatin|carboplatin|mesh-list
1962409|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1962410|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1962411|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962412|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
1962413|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
1962414|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
1962415|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962416|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1962417|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962418|NCT00848783|Capecitabine|capecitabine|mesh-list
1962419|NCT00848783|Irinotecan|irinotecan|mesh-list
1962420|NCT00848783|Floxuridine|floxuridine|mesh-list
1962421|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962422|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1962423|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
1962424|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962425|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1962426|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1962427|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962428|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1962429|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1962430|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962431|NCT00848965|Fluticasone|fluticasone|mesh-list
1962432|NCT00848965|Xhance|xhance|mesh-list
1962433|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1962434|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1962435|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
1962436|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962437|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962438|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1962439|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
1962440|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
1962441|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1962442|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
1962443|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
1962444|NCT00849017|Incretins|incretins|mesh-ancestor
1962445|NCT00849017|Hormones|hormones|mesh-ancestor
1962446|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1962447|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962448|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
1962449|NCT00849056|Incretins|incretins|mesh-ancestor
1962450|NCT00849056|Hormones|hormones|mesh-ancestor
1962451|NCT00849056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1962452|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962453|NCT00849121|Vaccines|vaccines|mesh-list
1962454|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
1962455|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962456|NCT00849186|Sunitinib|sunitinib|mesh-list
1962457|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962458|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1962459|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1962460|NCT00849186|Growth Substances|growth substances|mesh-ancestor
1962461|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962462|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
1962463|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1962464|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962465|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962466|NCT00849251|Dexamethasone|dexamethasone|mesh-list
1962467|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
1962468|NCT00849251|Doxorubicin|doxorubicin|mesh-list
1962469|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1962470|NCT00849251|Bortezomib|bortezomib|mesh-list
1962471|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1962472|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
1962473|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962474|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1962475|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1962476|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
1962477|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962478|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962479|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1962480|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1962481|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
1962482|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
1962483|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962484|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1962485|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
1962486|NCT00849251|Hormones|hormones|mesh-ancestor
1962487|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1962488|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1962489|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1962490|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1962491|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1962492|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962493|NCT00849472|Paclitaxel|paclitaxel|mesh-list
1962494|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
1962495|NCT00849472|Doxorubicin|doxorubicin|mesh-list
1962496|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1962497|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962498|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
1962499|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
1962500|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
1962501|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962502|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1962503|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
1962504|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962505|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1962506|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1962507|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
1962508|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1962509|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1962510|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1962511|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1962512|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962513|NCT00849485|Levetiracetam|levetiracetam|mesh-list
1962514|NCT00849485|Anticonvulsants|anticonvulsants|mesh-ancestor
1962515|NCT00849485|Nootropic Agents|nootropic agents|mesh-ancestor
1962516|NCT00849680|Vaccines|vaccines|mesh-list
1962517|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
1962518|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962519|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1962520|NCT00849693|Fluoxetine|fluoxetine|mesh-list
1962521|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1962522|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1962523|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1962524|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962525|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962526|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962527|NCT00849693|Analgesics|analgesics|mesh-ancestor
1962528|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
1962529|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962530|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
1962531|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1962532|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
1962533|NCT00849693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1962534|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
1962535|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1962536|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1962537|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1962538|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962539|NCT00849797|Oxcarbazepine|oxcarbazepine|mesh-list
1962540|NCT00849797|Anticonvulsants|anticonvulsants|mesh-ancestor
1962541|NCT00849797|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1962542|NCT00849797|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1962543|NCT00849797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1962544|NCT00849797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962545|NCT00849797|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1962546|NCT00849797|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1962547|NCT00849810|Metoprolol|metoprolol|mesh-list
1962548|NCT00849810|Nebivolol|nebivolol|mesh-list
1962549|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1962550|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1962551|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
1962552|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
1962553|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962554|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962555|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1962556|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1962557|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1962558|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
1962559|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962560|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962561|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
1962562|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1962563|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1962564|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1962565|NCT00849862|Levetiracetam|levetiracetam|mesh-list
1962566|NCT00849862|Anticonvulsants|anticonvulsants|mesh-ancestor
1962567|NCT00849862|Nootropic Agents|nootropic agents|mesh-ancestor
1962568|NCT00849875|Dacarbazine|dacarbazine|mesh-list
1962569|NCT00849875|Imidazole|imidazole|mesh-list
1962570|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1962571|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
1962572|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962573|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962574|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962575|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1962576|NCT00849901|Fluoxetine|fluoxetine|mesh-list
1962577|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1962578|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1962579|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1962580|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962581|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962582|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962583|NCT00849901|Analgesics|analgesics|mesh-ancestor
1962584|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
1962585|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962586|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
1962587|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1962588|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
1962589|NCT00849901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1962590|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
1962591|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1962592|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1962593|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1962594|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962595|NCT00850096|Insulin|insulin|mesh-list
1962596|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1962597|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962598|NCT00850174|Oxcarbazepine|oxcarbazepine|mesh-list
1962599|NCT00850174|Anticonvulsants|anticonvulsants|mesh-ancestor
1962600|NCT00850174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1962601|NCT00850174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1962602|NCT00850174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1962603|NCT00850174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962604|NCT00850174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1962605|NCT00850174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1962606|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
1962607|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1962608|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
1962609|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962610|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1962611|NCT00850395|Maraviroc|maraviroc|mesh-list
1962612|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1962613|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2217890|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962614|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962615|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1962616|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1962617|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
1962618|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1962619|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1962620|NCT00850460|Atorvastatin|atorvastatin|mesh-list
1962621|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1962622|NCT00850460|Simvastatin|simvastatin|mesh-list
1962623|NCT00850460|Pravastatin|pravastatin|mesh-list
1962624|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1962625|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1962626|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
1962627|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962628|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1962629|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1962630|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962631|NCT00850499|Rituximab|rituximab|mesh-list
1962632|NCT00850499|Fludarabine|fludarabine|mesh-list
1962633|NCT00850499|Bortezomib|bortezomib|mesh-list
1962634|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1962635|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962636|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
1962637|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962638|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1962639|NCT00850564|Hormones|hormones|mesh-list
1962640|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
1962641|NCT00850564|Tesamorelin|tesamorelin|mesh-list
1962642|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1962643|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962644|NCT00850564|Growth Substances|growth substances|mesh-ancestor
1962645|NCT00850889|Lidocaine|lidocaine|mesh-list
1962646|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
1962647|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
1962648|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
1962649|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1962650|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962651|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
1962652|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962653|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1962654|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1962655|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1962656|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1962657|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962658|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1962659|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
1962660|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
1962661|NCT00850889|Protective Agents|protective agents|mesh-ancestor
1962662|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
1962663|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962664|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962665|NCT00851084|Leucovorin|leucovorin|mesh-list
1962666|NCT00851084|Folic Acid|folic acid|mesh-list
1962667|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
1962668|NCT00851084|Aflibercept|aflibercept|mesh-list
1962669|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
1962670|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962671|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1962672|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1962673|NCT00851084|Growth Substances|growth substances|mesh-ancestor
1962674|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962675|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
1962676|NCT00851084|Antidotes|antidotes|mesh-ancestor
1962677|NCT00851084|Protective Agents|protective agents|mesh-ancestor
1962678|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
1962679|NCT00851084|Vitamins|vitamins|mesh-ancestor
1962680|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
1962681|NCT00851084|Hematinics|hematinics|mesh-ancestor
1962682|NCT00851318|Methotrexate|methotrexate|mesh-list
1962683|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
1962684|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1962685|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
1962686|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1962687|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962688|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1962689|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
2217891|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962690|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962691|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962692|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
1962693|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962694|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1962695|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1962696|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
1962697|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1962698|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1962699|NCT00851357|Nicotine|nicotine|mesh-list
1962700|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1962701|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
1962702|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962703|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962704|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1962705|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1962706|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
1962707|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962708|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962709|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1962710|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1962711|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1962712|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
1962713|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962714|NCT00851630|Lamivudine|lamivudine|mesh-list
1962715|NCT00851630|Zidovudine|zidovudine|mesh-list
1962716|NCT00851630|Abacavir|abacavir|mesh-list
1962717|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1962718|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1962719|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962720|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962721|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
1962722|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1962723|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1962724|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1962725|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
1962726|NCT00851721|Factor VIII|factor viii|mesh-list
1962727|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
1962728|NCT00851721|Coagulants|coagulants|mesh-ancestor
1962729|NCT00851799|Ritonavir|ritonavir|mesh-list
1962730|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1962731|NCT00851799|Darunavir|darunavir|mesh-list
1962732|NCT00851799|Tenofovir|tenofovir|mesh-list
1962733|NCT00851799|Emtricitabine|emtricitabine|mesh-list
1962734|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
1962735|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1962736|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1962737|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1962738|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
1962739|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962740|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962741|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1962742|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1962743|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
1962744|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1962745|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1962746|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1962747|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1962748|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1962749|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1962750|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1962751|NCT00851877|Paclitaxel|paclitaxel|mesh-list
1962752|NCT00851877|Cetuximab|cetuximab|mesh-list
1962753|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1962754|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962755|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
1962756|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
1962757|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
1962758|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962759|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1962760|NCT00851890|Interferons|interferons|mesh-list
1962761|NCT00851890|Ribavirin|ribavirin|mesh-list
1962762|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962763|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
1962764|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1962765|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
1962766|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962767|NCT00851903|Metformin|metformin|mesh-list
1962768|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
1962769|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1962770|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1962771|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962772|NCT00851903|Incretins|incretins|mesh-ancestor
1962773|NCT00851903|Hormones|hormones|mesh-ancestor
1962774|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1962775|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1962776|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
1962777|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962778|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962779|NCT00852202|Cariprazine|cariprazine|mesh-list
1962780|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1962781|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1962782|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1962783|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962784|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1962785|NCT00852397|Apixaban|apixaban|mesh-list
1962786|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1962787|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
1962788|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1962789|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
1962790|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962791|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962792|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
1962793|NCT00852540|Linezolid|linezolid|mesh-list
1962794|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1962795|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1962796|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1962797|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962798|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962799|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1962800|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
1962801|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1962802|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1962803|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1962804|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1962805|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962806|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1962807|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1962808|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962809|NCT00852761|Clobetasol|clobetasol|mesh-list
1962810|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1962811|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
1962812|NCT00852761|Hormones|hormones|mesh-ancestor
1962813|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1962814|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962815|NCT00852917|Tramadol|tramadol|mesh-list
1962816|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1962817|NCT00852917|Narcotics|narcotics|mesh-ancestor
1962818|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1962819|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962820|NCT00852917|Analgesics|analgesics|mesh-ancestor
1962821|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
1962822|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962823|NCT00852969|Niacin|niacin|mesh-list
1962824|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1962825|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
1962826|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962827|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1962828|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
1962829|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
1962830|NCT00852969|Vitamins|vitamins|mesh-ancestor
1962831|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
1962832|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962833|NCT00853021|Aldesleukin|aldesleukin|mesh-list
1962834|NCT00853021|Bevacizumab|bevacizumab|mesh-list
1962835|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1962836|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962837|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1962838|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1962839|NCT00853021|Growth Substances|growth substances|mesh-ancestor
1962840|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962841|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
1962842|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1962843|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1962844|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
1962845|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1962846|NCT00853047|Octreotide|octreotide|mesh-list
1962847|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1962848|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1962849|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962850|NCT00853073|Bevacizumab|bevacizumab|mesh-list
1962851|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1962852|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962853|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1962854|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1962855|NCT00853073|Growth Substances|growth substances|mesh-ancestor
1962856|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962857|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
1962858|NCT00853099|Adalimumab|adalimumab|mesh-list
1962859|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1962860|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1962861|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
1962862|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
1962863|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1962864|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1962865|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962866|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962867|NCT00853112|Urological Agents|urological agents|mesh-ancestor
1962868|NCT00853125|Sunitinib|sunitinib|mesh-list
1962869|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962870|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1962871|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1962872|NCT00853125|Growth Substances|growth substances|mesh-ancestor
1962873|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962874|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
1962875|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1962876|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962877|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962878|NCT00853242|Sevelamer|sevelamer|mesh-list
1962879|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
1962880|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
1962881|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962882|NCT00853333|Midazolam|midazolam|mesh-list
1962883|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
1962884|NCT00853333|Propofol|propofol|mesh-list
1962885|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1962886|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1962887|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962888|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1962889|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
1962890|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
1962891|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1962892|NCT00853333|Analgesics|analgesics|mesh-ancestor
1962893|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
1962894|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962895|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1962896|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1962897|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1962898|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
1962899|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962900|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962901|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1962902|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1962903|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1962904|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1962905|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
1962906|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
1962907|NCT00853372|Sunitinib|sunitinib|mesh-list
1962908|NCT00853372|Trebananib|trebananib|mesh-list
1962909|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
1962910|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1962911|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1962912|NCT00853372|Growth Substances|growth substances|mesh-ancestor
1962913|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962914|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
1962915|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1962916|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217892|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1962917|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962918|NCT00853385|Adalimumab|adalimumab|mesh-list
1962919|NCT00853385|Tofacitinib|tofacitinib|mesh-list
1962920|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1962921|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1962922|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1962923|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962924|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962925|NCT00853580|Lovastatin|lovastatin|mesh-list
1962926|NCT00853580|L 647318|l 647318|mesh-list
1962927|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
1962928|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1962929|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1962930|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
1962931|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962932|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1962933|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1962934|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962935|NCT00853658|Enalapril|enalapril|mesh-list
1962936|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1962937|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
1962938|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962939|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962940|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1962941|NCT00853671|Adenosine|adenosine|mesh-list
1962942|NCT00853671|Analgesics|analgesics|mesh-ancestor
1962943|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
1962944|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1962945|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962946|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1962947|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
1962948|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1962949|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
1962950|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
1962951|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1962952|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962953|NCT00853723|Teriparatide|teriparatide|mesh-list
1962954|NCT00853723|Hormones|hormones|mesh-list
1962955|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
1962956|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
1962957|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1962958|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962959|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1962960|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1962961|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1962962|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
1962963|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962964|NCT00853840|Maraviroc|maraviroc|mesh-list
1962965|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
1962966|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1962967|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1962968|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962969|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1962970|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1962971|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
1962972|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1962973|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1962974|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
1962975|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1962976|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1962977|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962978|NCT00853840|Urological Agents|urological agents|mesh-ancestor
1962979|NCT00853905|Triamcinolone|triamcinolone|mesh-list
1962980|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1962981|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1962982|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1962983|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1962984|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1962985|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
1962986|NCT00853905|Hormones|hormones|mesh-ancestor
1962987|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1962988|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1962989|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1962990|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
1962991|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1962992|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962993|NCT00853957|Amlodipine|amlodipine|mesh-list
1962994|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1962995|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1962996|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1962997|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1962998|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1962999|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963000|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
1963001|NCT00853970|Bromfenac|bromfenac|mesh-list
1963002|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1963003|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1963004|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1963005|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1963006|NCT00853970|Analgesics|analgesics|mesh-ancestor
1963007|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
1963008|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1963009|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963010|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1963011|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1963012|NCT00854061|Prednisone|prednisone|mesh-list
1963013|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
1963014|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1963015|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
1963016|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1963017|NCT00854061|Prednisolone|prednisolone|mesh-list
1963018|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1963019|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
1963020|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1963021|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
1963022|NCT00854061|Hormones|hormones|mesh-ancestor
1963023|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963024|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963025|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1963026|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963027|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
1963028|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
1963029|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1963030|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1963031|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1963032|NCT00854061|Protective Agents|protective agents|mesh-ancestor
1963033|NCT00854100|Cariprazine|cariprazine|mesh-list
1963034|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
1963035|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1963036|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1963037|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1963038|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1963039|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963040|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
1963041|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963042|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1963043|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963044|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1963045|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963046|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1963047|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963048|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963049|NCT00854360|Beclomethasone|beclomethasone|mesh-list
1963050|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1963051|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
1963052|NCT00854360|Hormones|hormones|mesh-ancestor
1963053|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963054|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963055|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1963056|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
1963057|NCT00854373|Hormones|hormones|mesh-list
1963058|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1963059|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963060|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963061|NCT00854581|Interferons|interferons|mesh-list
1963062|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
1963063|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
1963064|NCT00854581|Zidovudine|zidovudine|mesh-list
1963065|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1963066|NCT00854581|Valproic Acid|valproic acid|mesh-list
1963067|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963068|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
1963069|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963070|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
1963071|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963072|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
1963073|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963074|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1963075|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1963076|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963077|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1963078|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1963079|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
1963080|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
1963081|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963082|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
1963083|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1963084|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1963085|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1963086|NCT00854620|Sorafenib|sorafenib|mesh-list
1963087|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963088|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1963089|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963090|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963091|NCT00854724|Puerarin|puerarin|mesh-list
1963092|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
1963093|NCT00855010|Pioglitazone|pioglitazone|mesh-list
1963094|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1963095|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963096|NCT00855062|Minocycline|minocycline|mesh-list
1963097|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1963098|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963099|NCT00855166|Metformin|metformin|mesh-list
1963100|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1963101|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
1963102|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1963103|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963104|NCT00855166|Incretins|incretins|mesh-ancestor
1963105|NCT00855166|Hormones|hormones|mesh-ancestor
1963106|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963107|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1963108|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
1963109|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963110|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963111|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1963112|NCT00855218|Sorafenib|sorafenib|mesh-list
1963113|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963114|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1963115|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963116|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963117|NCT00855309|Acyclovir|acyclovir|mesh-list
1963118|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
1963119|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963120|NCT00855335|Ritonavir|ritonavir|mesh-list
1963121|NCT00855335|Darunavir|darunavir|mesh-list
1963122|NCT00855335|Cobicistat|cobicistat|mesh-list
1963123|NCT00855335|Rilpivirine|rilpivirine|mesh-list
1963124|NCT00855335|Etravirine|etravirine|mesh-list
1963125|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1963126|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1963127|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
1963128|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963129|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963130|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1963131|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1963132|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
1963133|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963134|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1963135|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1963136|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1963137|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1963138|NCT00855413|Ritonavir|ritonavir|mesh-list
1963139|NCT00855413|Darunavir|darunavir|mesh-list
1963140|NCT00855413|Etravirine|etravirine|mesh-list
1963141|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1963142|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1963143|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
1963144|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963145|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963146|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1963147|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1963148|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
1963149|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963150|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1963151|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1963152|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1963153|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1963154|NCT00855439|Exenatide|exenatide|mesh-list
1963155|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1963156|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963157|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1963158|NCT00855439|Incretins|incretins|mesh-ancestor
1963159|NCT00855439|Hormones|hormones|mesh-ancestor
1963160|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963161|NCT00855465|Riociguat|riociguat|mesh-list
1963162|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
1963163|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963164|NCT00855582|Tadalafil|tadalafil|mesh-list
1963165|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
1963166|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1963167|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1963168|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963169|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963170|NCT00855582|Urological Agents|urological agents|mesh-ancestor
1963171|NCT00855595|Metronidazole|metronidazole|mesh-list
1963172|NCT00855595|Doxycycline|doxycycline|mesh-list
1963173|NCT00855595|Azelaic acid|azelaic acid|mesh-list
1963174|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963175|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1963176|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1963177|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1963178|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
1963179|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963180|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
1963181|NCT00855738|Topiramate|topiramate|mesh-list
1963182|NCT00855738|Pregabalin|pregabalin|mesh-list
1963183|NCT00855738|Lamotrigine|lamotrigine|mesh-list
1963184|NCT00855738|Zonisamide|zonisamide|mesh-list
1963185|NCT00855738|Gabapentin|gabapentin|mesh-list
1963186|NCT00855738|Levetiracetam|levetiracetam|mesh-list
1963187|NCT00855738|Tiagabine|tiagabine|mesh-list
1963188|NCT00855738|Analgesics|analgesics|mesh-ancestor
1963189|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
1963190|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1963191|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963192|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
1963193|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1963194|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1963195|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963196|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1963197|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1963198|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1963199|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1963200|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1963201|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1963202|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1963203|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963204|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
1963205|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1963206|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
1963207|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1963208|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1963209|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
1963210|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1963211|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
1963212|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1963213|NCT00855894|Pertuzumab|pertuzumab|mesh-list
1963214|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963215|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1963216|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217893|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1963217|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963218|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1963219|NCT00855920|Indomethacin|indomethacin|mesh-list
1963220|NCT00855920|Rilonacept|rilonacept|mesh-list
1963221|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1963222|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1963223|NCT00855920|Analgesics|analgesics|mesh-ancestor
1963224|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
1963225|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1963226|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963227|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1963228|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1963229|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
1963230|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
1963231|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1963232|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1963233|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963234|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963235|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
1963236|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1963237|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963238|NCT00855959|Budesonide|budesonide|mesh-list
1963239|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1963240|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1963241|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
1963242|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1963243|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963244|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1963245|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
1963246|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
1963247|NCT00855959|Hormones|hormones|mesh-ancestor
1963248|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963249|NCT00856024|Ribavirin|ribavirin|mesh-list
1963250|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1963251|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
1963252|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963253|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
1963254|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963255|NCT00856050|Letrozole|letrozole|mesh-list
1963256|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963257|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1963258|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1963259|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963260|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963261|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1963262|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
1963263|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963264|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963265|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
1963266|NCT00856180|Bevacizumab|bevacizumab|mesh-list
1963267|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963268|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
1963269|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963270|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1963271|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1963272|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
1963273|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963274|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963275|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1963276|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1963277|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1963278|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1963279|NCT00856180|Growth Substances|growth substances|mesh-ancestor
1963280|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
1963281|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
1963282|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1963283|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1963284|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1963285|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
1963286|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963287|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963288|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963289|NCT00856206|Rilonacept|rilonacept|mesh-list
2217894|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
1963290|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1963291|NCT00856245|Rituximab|rituximab|mesh-list
1963292|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1963293|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963294|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
1963295|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963296|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1963297|NCT00856284|Metformin|metformin|mesh-list
1963298|NCT00856284|Alogliptin|alogliptin|mesh-list
1963299|NCT00856284|Glipizide|glipizide|mesh-list
1963300|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1963301|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963302|NCT00856284|Incretins|incretins|mesh-ancestor
1963303|NCT00856284|Hormones|hormones|mesh-ancestor
1963304|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963305|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1963306|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
1963307|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963308|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963309|NCT00856297|Vaccines|vaccines|mesh-list
1963310|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
1963311|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963312|NCT00856323|Tenofovir|tenofovir|mesh-list
1963313|NCT00856323|Emtricitabine|emtricitabine|mesh-list
1963314|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1963315|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
1963316|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963317|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1963318|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1963319|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963320|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963321|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1963322|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1963323|NCT00856375|Irinotecan|irinotecan|mesh-list
1963324|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
1963325|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1963326|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1963327|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963328|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963329|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963330|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1963331|NCT00856388|Fludarabine|fludarabine|mesh-list
1963332|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
1963333|NCT00856388|Melphalan|melphalan|mesh-list
1963334|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
1963335|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1963336|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
1963337|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963338|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1963339|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
1963340|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963341|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963342|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
1963343|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963344|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1963345|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
1963346|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1963347|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
1963348|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1963349|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1963350|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1963351|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1963352|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963353|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
1963354|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963355|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963356|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1963357|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1963358|NCT00856492|Paclitaxel|paclitaxel|mesh-list
1963359|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
1963360|NCT00856492|Bevacizumab|bevacizumab|mesh-list
1963361|NCT00856492|Doxorubicin|doxorubicin|mesh-list
1963362|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1963363|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1963364|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1963365|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963366|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
1963367|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
1963368|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
1963369|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963370|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963371|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
1963372|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963373|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1963374|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1963375|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
1963376|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1963377|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1963378|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1963379|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1963380|NCT00856492|Growth Substances|growth substances|mesh-ancestor
1963381|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
1963382|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1963383|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1963384|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1963385|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963386|NCT00856544|Tofacitinib|tofacitinib|mesh-list
1963387|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1963388|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963389|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963390|NCT00856583|Risperidone|risperidone|mesh-list
1963391|NCT00856583|Sertindole|sertindole|mesh-list
1963392|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1963393|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
1963394|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963395|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963396|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963397|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1963398|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1963399|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1963400|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1963401|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1963402|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
1963403|NCT00856609|Exenatide|exenatide|mesh-list
1963404|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1963405|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963406|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1963407|NCT00856609|Incretins|incretins|mesh-ancestor
1963408|NCT00856609|Hormones|hormones|mesh-ancestor
1963409|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963410|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
1963411|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
1963412|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1963413|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
1963414|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963415|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963416|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1963417|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
1963418|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1963419|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1963420|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963421|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
1963422|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1963423|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963424|NCT00856791|ON 01910|on 01910|mesh-list
1963425|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963426|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1963427|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963428|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963429|NCT00856830|Carboplatin|carboplatin|mesh-list
1963430|NCT00856830|Irinotecan|irinotecan|mesh-list
1963431|NCT00856830|Etoposide|etoposide|mesh-list
1963432|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1963433|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963434|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1963435|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1963436|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963437|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963438|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1963439|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1963440|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1963441|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
1963442|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
1963443|NCT00856843|Laxatives|laxatives|mesh-ancestor
1963444|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1963445|NCT00856856|Everolimus|everolimus|mesh-list
1963446|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963447|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963448|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
1963449|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963450|NCT00856973|Eszopiclone|eszopiclone|mesh-list
1963451|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1963452|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1963453|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963454|NCT00856986|Metformin|metformin|mesh-list
1963455|NCT00856986|Liraglutide|liraglutide|mesh-list
1963456|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
1963457|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1963458|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963459|NCT00856986|Incretins|incretins|mesh-ancestor
1963460|NCT00856986|Hormones|hormones|mesh-ancestor
1963461|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963462|NCT00857220|Eszopiclone|eszopiclone|mesh-list
1963463|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1963464|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1963465|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963466|NCT00857233|Memantine|memantine|mesh-list
1963467|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1963468|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1963469|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
1963470|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963471|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963472|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963473|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1963474|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1963475|NCT00857246|Irinotecan|irinotecan|mesh-list
1963476|NCT00857246|Cetuximab|cetuximab|mesh-list
1963477|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963478|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1963479|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1963480|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963481|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963482|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1963483|NCT00857259|Everolimus|everolimus|mesh-list
1963484|NCT00857259|Ranibizumab|ranibizumab|mesh-list
1963485|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963486|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963487|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
1963488|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963489|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1963490|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1963491|NCT00857259|Growth Substances|growth substances|mesh-ancestor
1963492|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
1963493|NCT00857272|Bisacodyl|bisacodyl|mesh-list
1963494|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1963495|NCT00857272|Cathartics|cathartics|mesh-ancestor
1963496|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1963497|NCT00857272|Laxatives|laxatives|mesh-ancestor
1963498|NCT00857285|Losartan|losartan|mesh-list
1963499|NCT00857285|Olmesartan|olmesartan|mesh-list
1963500|NCT00857285|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1963501|NCT00857285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1963502|NCT00857285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1963503|NCT00857285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1963504|NCT00857285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1963505|NCT00857285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963506|NCT00857311|Vaccines|vaccines|mesh-list
1963507|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
1963508|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963509|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
1963510|NCT00857389|Busulfan|busulfan|mesh-list
1963511|NCT00857389|Thiotepa|thiotepa|mesh-list
1963512|NCT00857389|Methotrexate|methotrexate|mesh-list
1963513|NCT00857389|Clofarabine|clofarabine|mesh-list
1963514|NCT00857389|Tacrolimus|tacrolimus|mesh-list
1963515|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
1963516|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1963517|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963518|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
1963519|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963520|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1963521|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1963522|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
1963523|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963524|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963525|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1963526|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1963527|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
1963528|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1963529|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1963530|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
1963531|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
1963532|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963533|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1963534|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1963535|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1963536|NCT00857454|Testosterone|testosterone|mesh-list
1963537|NCT00857454|Androgens|androgens|mesh-ancestor
1963538|NCT00857454|Hormones|hormones|mesh-ancestor
1963539|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963540|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963541|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
1963542|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
1963543|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963544|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1963545|NCT00857584|Sertraline|sertraline|mesh-list
1963546|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
1963547|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1963548|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1963549|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1963550|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1963551|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963552|NCT00857584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1963553|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1963554|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1963555|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963556|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963557|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
1963558|NCT00857649|Memantine|memantine|mesh-list
1963559|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1963560|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1963561|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
1963562|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963563|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963564|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963565|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1963566|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1963567|NCT00857714|Lapatinib|lapatinib|mesh-list
1963568|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963569|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1963570|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963571|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963572|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
1963573|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1963574|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1963575|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963576|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1963577|NCT00857727|Analgesics|analgesics|mesh-ancestor
1963578|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
1963579|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1963580|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1963581|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1963582|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1963583|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
1963584|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963585|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963586|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1963587|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1963588|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
1963589|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1963590|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963591|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1963592|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
1963593|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
1963594|NCT00857766|Hormones|hormones|mesh-ancestor
1963595|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963596|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
1963597|NCT00857792|Regadenoson|regadenoson|mesh-list
1963598|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1963599|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1963600|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
1963601|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
1963602|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963603|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963604|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963605|NCT00857818|Risperidone|risperidone|mesh-list
1963606|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1963607|NCT00857818|Aripiprazole|aripiprazole|mesh-list
1963608|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1963609|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
1963610|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963611|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963612|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963613|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1963614|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1963615|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1963616|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1963617|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1963618|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
1963619|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
1963620|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
1963621|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1963622|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1963623|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1963624|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1963625|NCT00857896|Fesoterodine|fesoterodine|mesh-list
1963626|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1963627|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1963628|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
1963629|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963630|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963631|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963632|NCT00857896|Urological Agents|urological agents|mesh-ancestor
1963633|NCT00857948|Ivermectin|ivermectin|mesh-list
1963634|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1963635|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963636|NCT00857961|Testosterone|testosterone|mesh-list
1963637|NCT00857961|Androgens|androgens|mesh-ancestor
1963638|NCT00857961|Hormones|hormones|mesh-ancestor
1963639|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963640|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963641|NCT00858013|Glimepiride|glimepiride|mesh-list
1963642|NCT00858013|Nateglinide|nateglinide|mesh-list
1963643|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1963644|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1963645|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963646|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963647|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
1963648|NCT00858117|Rituximab|rituximab|mesh-list
1963649|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
1963650|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1963651|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963652|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
1963653|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963654|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1963655|NCT00858234|Bortezomib|bortezomib|mesh-list
1963656|NCT00858234|Vorinostat|vorinostat|mesh-list
1963657|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963658|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1963659|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963660|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963661|NCT00858247|Vitamin D|vitamin d|mesh-list
1963662|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
1963663|NCT00858247|Vitamins|vitamins|mesh-ancestor
1963664|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
1963665|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963666|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1963667|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1963668|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
1963669|NCT00858364|Hematinics|hematinics|mesh-ancestor
1963670|NCT00858403|Dasatinib|dasatinib|mesh-list
1963671|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963672|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1963673|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963674|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963675|NCT00858468|Vaccines|vaccines|mesh-list
1963676|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
1963677|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963678|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
1963679|NCT00858637|Simvastatin|simvastatin|mesh-list
1963680|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1963681|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1963682|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
1963683|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963684|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1963685|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1963686|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963687|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1963688|NCT00858689|Minocycline|minocycline|mesh-list
1963689|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1963690|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963691|NCT00858702|Olmesartan|olmesartan|mesh-list
1963692|NCT00858702|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1963693|NCT00858702|Diuretics|diuretics|mesh-list
1963694|NCT00858702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1963695|NCT00858702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1963696|NCT00858702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1963697|NCT00858702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963698|NCT00858702|Natriuretic Agents|natriuretic agents|mesh-ancestor
1963699|NCT00858702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963700|NCT00858780|Etanercept|etanercept|mesh-list
1963701|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1963702|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1963703|NCT00858780|Analgesics|analgesics|mesh-ancestor
1963704|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
1963705|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1963706|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963707|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1963708|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1963709|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1963710|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963711|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
1963712|NCT00858832|Methylergonovine|methylergonovine|mesh-list
1963713|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
1963714|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1963715|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963716|NCT00858845|Clonidine|clonidine|mesh-list
1963717|NCT00858845|Analgesics|analgesics|mesh-ancestor
1963718|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
1963719|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1963720|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963721|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1963722|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
1963723|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
1963724|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1963725|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1963726|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1963727|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
1963728|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963729|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963730|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1963731|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1963732|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1963733|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
1963734|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1963735|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1963736|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
1963737|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963738|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1963739|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1963740|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963741|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963742|NCT00858988|Rifaximin|rifaximin|mesh-list
1963743|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1963744|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963745|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1963746|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
1963747|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
1963748|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1963749|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1963750|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963751|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1963752|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963753|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1963754|NCT00859040|Pasireotide|pasireotide|mesh-list
1963755|NCT00859040|Hormones|hormones|mesh-ancestor
1963756|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963757|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963758|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
1963759|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1963760|NCT00859131|Daclizumab|daclizumab|mesh-list
1963761|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
1963762|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963763|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963764|NCT00859222|Bevacizumab|bevacizumab|mesh-list
1963765|NCT00859222|Panobinostat|panobinostat|mesh-list
1963766|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1963767|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963768|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1963769|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1963770|NCT00859222|Growth Substances|growth substances|mesh-ancestor
1963771|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963772|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
1963773|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1963774|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963775|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963776|NCT00859313|Sufentanil|sufentanil|mesh-list
1963777|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1963778|NCT00859313|Narcotics|narcotics|mesh-ancestor
1963779|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1963780|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963781|NCT00859313|Analgesics|analgesics|mesh-ancestor
1963782|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
1963783|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1963784|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1963785|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1963786|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
1963787|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
1963788|NCT00859339|Gemcitabine|gemcitabine|mesh-list
1963789|NCT00859339|Sunitinib|sunitinib|mesh-list
1963790|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963791|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1963792|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
1963793|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963794|NCT00859339|Antiviral Agents|antiviral agents|mesh-ancestor
1963795|NCT00859339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963796|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963797|NCT00859339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963798|NCT00859339|Immunologic Factors|immunologic factors|mesh-ancestor
1963799|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963800|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1963801|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1963802|NCT00859339|Growth Substances|growth substances|mesh-ancestor
1963803|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
1963804|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1963805|NCT00859430|Levetiracetam|levetiracetam|mesh-list
1963806|NCT00859430|Anticonvulsants|anticonvulsants|mesh-ancestor
1963807|NCT00859430|Nootropic Agents|nootropic agents|mesh-ancestor
1963808|NCT00859456|Sunitinib|sunitinib|mesh-list
1963809|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963810|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1963811|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1963812|NCT00859456|Growth Substances|growth substances|mesh-ancestor
1963813|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963814|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
1963815|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1963816|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963817|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963818|NCT00859469|Gemcitabine|gemcitabine|mesh-list
1963819|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
1963820|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1963821|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
1963822|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963823|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963824|NCT00859469|Antiviral Agents|antiviral agents|mesh-ancestor
1963825|NCT00859469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963826|NCT00859469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963827|NCT00859469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963828|NCT00859469|Immunologic Factors|immunologic factors|mesh-ancestor
1963829|NCT00859469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963830|NCT00859495|Doxorubicin|doxorubicin|mesh-list
1963831|NCT00859495|Pemetrexed|pemetrexed|mesh-list
1963832|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963833|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1963834|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1963835|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1963836|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963837|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963838|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1963839|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1963840|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1963841|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1963842|NCT00859508|Estradiol|estradiol|mesh-list
1963843|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1963844|NCT00859508|Estrogens|estrogens|mesh-ancestor
1963845|NCT00859508|Hormones|hormones|mesh-ancestor
1963846|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1963847|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963848|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1963849|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
1963850|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1963851|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1963852|NCT00859521|Levetiracetam|levetiracetam|mesh-list
1963853|NCT00859521|Anticonvulsants|anticonvulsants|mesh-ancestor
1963854|NCT00859521|Nootropic Agents|nootropic agents|mesh-ancestor
1963855|NCT00859573|Modafinil|modafinil|mesh-list
1963856|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1963857|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963858|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1963859|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1963860|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1963861|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963862|NCT00859651|Vitamin D|vitamin d|mesh-list
1963863|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
1963864|NCT00859651|Vitamins|vitamins|mesh-ancestor
1963865|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
1963866|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963867|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1963868|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1963869|NCT00859833|Adenosine|adenosine|mesh-list
1963870|NCT00859833|Regadenoson|regadenoson|mesh-list
1963871|NCT00859833|Analgesics|analgesics|mesh-ancestor
1963872|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
1963873|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1963874|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963875|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1963876|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
1963877|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1963878|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
1963879|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
1963880|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963881|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963882|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1963883|NCT00859898|Metformin|metformin|mesh-list
1963884|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
1963885|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1963886|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963887|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1963888|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963889|NCT00859937|Dasatinib|dasatinib|mesh-list
1963890|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963891|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1963892|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963893|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963894|NCT00860015|Gemcitabine|gemcitabine|mesh-list
1963895|NCT00860015|Pemetrexed|pemetrexed|mesh-list
1963896|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1963897|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
1963898|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963899|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963900|NCT00860015|Antiviral Agents|antiviral agents|mesh-ancestor
1963901|NCT00860015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963902|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963903|NCT00860015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963904|NCT00860015|Immunologic Factors|immunologic factors|mesh-ancestor
1963905|NCT00860015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963906|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1963907|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1963908|NCT00860028|Varenicline|varenicline|mesh-list
1963909|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1963910|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1963911|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
1963912|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1963913|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963914|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963915|NCT00860171|Iodine|iodine|mesh-list
1963916|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
1963917|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1963918|NCT00860171|Antibodies|antibodies|mesh-list
1963919|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
1963920|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1963921|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
1963922|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963923|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963924|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1963925|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1963926|NCT00860171|Trace Elements|trace elements|mesh-ancestor
1963927|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
1963928|NCT00860262|Amlodipine|amlodipine|mesh-list
1963929|NCT00860262|Telmisartan|telmisartan|mesh-list
1963930|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
1963931|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1963932|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1963933|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1963934|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963935|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1963936|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963937|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
1963938|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1963939|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1963940|NCT00860379|Selenium|selenium|mesh-list
1963941|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
1963942|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963943|NCT00860379|Protective Agents|protective agents|mesh-ancestor
1963944|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963945|NCT00860379|Trace Elements|trace elements|mesh-ancestor
1963946|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
1963947|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
1963948|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
1963949|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
1963950|NCT00860457|Rituximab|rituximab|mesh-list
1963951|NCT00860457|Fludarabine|fludarabine|mesh-list
1963952|NCT00860457|Lenalidomide|lenalidomide|mesh-list
1963953|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1963954|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963955|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
1963956|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963957|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1963958|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1963959|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1963960|NCT00860457|Growth Substances|growth substances|mesh-ancestor
1963961|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
1963962|NCT00860470|Iron|iron|mesh-list
1963963|NCT00860470|Trace Elements|trace elements|mesh-list
1963964|NCT00860470|Folic Acid|folic acid|mesh-list
1963965|NCT00860470|Micronutrients|micronutrients|mesh-list
1963966|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963967|NCT00860470|Hematinics|hematinics|mesh-ancestor
1963968|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
1963969|NCT00860470|Vitamins|vitamins|mesh-ancestor
1963970|NCT00860574|Methotrexate|methotrexate|mesh-list
1963971|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
1963972|NCT00860574|Fludarabine|fludarabine|mesh-list
1963973|NCT00860574|Treosulfan|treosulfan|mesh-list
1963974|NCT00860574|Tacrolimus|tacrolimus|mesh-list
1963975|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1963976|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
1963977|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1963978|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963979|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1963980|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
1963981|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963982|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1963983|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
1963984|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1963985|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1963986|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1963987|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
1963988|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1963989|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1963990|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1963991|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1963992|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
1963993|NCT00860743|Antioxidants|antioxidants|mesh-list
1963994|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1963995|NCT00860743|Protective Agents|protective agents|mesh-ancestor
1963996|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1963997|NCT00860847|Ubiquinone|ubiquinone|mesh-list
1963998|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
1963999|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
1964000|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964001|NCT00860847|Vitamins|vitamins|mesh-ancestor
1964002|NCT00860938|Budesonide|budesonide|mesh-list
1964003|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1964004|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1964005|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
1964006|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964007|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964008|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1964009|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
1964010|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
1964011|NCT00860938|Hormones|hormones|mesh-ancestor
1964012|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1964013|NCT00861341|Aspirin|aspirin|mesh-list
1964014|NCT00861341|Pioglitazone|pioglitazone|mesh-list
1964015|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1964016|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1964017|NCT00861341|Analgesics|analgesics|mesh-ancestor
1964018|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
1964019|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964020|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964021|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1964022|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1964023|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1964024|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1964025|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964026|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1964027|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1964028|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964029|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
1964030|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1964031|NCT00861380|Vaccines|vaccines|mesh-list
1964032|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1964033|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
1964034|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964035|NCT00861471|Docetaxel|docetaxel|mesh-list
1964036|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
1964037|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964038|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
1964039|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
1964040|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
1964041|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964042|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1964043|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964044|NCT00861614|Ipilimumab|ipilimumab|mesh-list
1964045|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1964046|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964047|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1964048|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964049|NCT00861692|Argatroban|argatroban|mesh-list
1964050|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
1964051|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1964052|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
1964053|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964054|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964055|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
1964056|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2745591|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2745592|NCT02855229|Methylphenidate|methylphenidate|mesh-list
2745593|NCT02855229|Modafinil|modafinil|mesh-list
2745594|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2745595|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745596|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2745597|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2745598|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2745599|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745600|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
2745601|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2745602|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2745603|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2745604|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2745605|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2745606|NCT02827526|Ketamine|ketamine|mesh-list
2745607|NCT02827526|Analgesics|analgesics|mesh-ancestor
2745608|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
2745609|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2745610|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745611|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2745612|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2745613|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
2745614|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
2745615|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2745616|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2745617|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2745618|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2745619|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964091|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1964092|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
1964093|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964094|NCT00861757|Tadalafil|tadalafil|mesh-list
1964095|NCT00861757|Tamsulosin|tamsulosin|mesh-list
1964096|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
1964097|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1964098|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1964099|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964100|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964101|NCT00861757|Urological Agents|urological agents|mesh-ancestor
1964102|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1964103|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1964104|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1964105|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
1964106|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1964107|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964108|NCT00862082|Sorafenib|sorafenib|mesh-list
1964109|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1964110|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964111|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1964112|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964113|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964114|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1964115|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
1964116|NCT00862121|Mesalamine|mesalamine|mesh-list
1964117|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1964118|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1964119|NCT00862121|Analgesics|analgesics|mesh-ancestor
1964120|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
1964121|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964122|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964123|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1964124|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1964125|NCT00862134|Docetaxel|docetaxel|mesh-list
1964126|NCT00862134|Sargramostim|sargramostim|mesh-list
1964127|NCT00862134|Lenograstim|lenograstim|mesh-list
1964128|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964129|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
1964130|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
1964131|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
1964132|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964133|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
1964134|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964135|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1964136|NCT00862251|Atorvastatin|atorvastatin|mesh-list
1964137|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1964138|NCT00862251|Simvastatin|simvastatin|mesh-list
1964139|NCT00862251|Ezetimibe|ezetimibe|mesh-list
1964140|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1964141|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1964142|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
1964143|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964144|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1964145|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1964146|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964147|NCT00862563|Topiramate|topiramate|mesh-list
1964148|NCT00862563|Zonisamide|zonisamide|mesh-list
1964149|NCT00862563|Levetiracetam|levetiracetam|mesh-list
1964150|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
1964151|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1964152|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964153|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
1964154|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1964155|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1964156|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964157|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1964158|NCT00862641|Regadenoson|regadenoson|mesh-list
1964159|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1964160|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1964161|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
1964162|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
1964163|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1964164|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964165|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964166|NCT00862654|Ketoconazole|ketoconazole|mesh-list
1964167|NCT00862654|Clobetasol|clobetasol|mesh-list
1964168|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
1964169|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964170|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1964171|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1964172|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964173|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964174|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1964175|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
1964176|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1964177|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964178|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1964179|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1964180|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
1964181|NCT00862654|Hormones|hormones|mesh-ancestor
1964182|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1964183|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1964184|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964185|NCT00862719|Incretins|incretins|mesh-ancestor
1964186|NCT00862719|Hormones|hormones|mesh-ancestor
1964187|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1964188|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1964189|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
1964190|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964191|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964192|NCT00862745|Fesoterodine|fesoterodine|mesh-list
1964193|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1964194|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1964195|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
1964196|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1964197|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964198|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964199|NCT00862745|Urological Agents|urological agents|mesh-ancestor
1964200|NCT00862784|Leucovorin|leucovorin|mesh-list
1964201|NCT00862784|Folic Acid|folic acid|mesh-list
1964202|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
1964203|NCT00862784|Fluorouracil|fluorouracil|mesh-list
1964204|NCT00862784|Ramucirumab|ramucirumab|mesh-list
1964205|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1964206|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
1964207|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964208|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
1964209|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964210|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1964211|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1964212|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
1964213|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964214|NCT00862784|Antidotes|antidotes|mesh-ancestor
1964215|NCT00862784|Protective Agents|protective agents|mesh-ancestor
1964216|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
1964217|NCT00862784|Vitamins|vitamins|mesh-ancestor
1964218|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
1964219|NCT00862784|Hematinics|hematinics|mesh-ancestor
1964220|NCT00862810|Vaccines|vaccines|mesh-list
1964221|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
1964222|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964223|NCT00862823|Tenofovir|tenofovir|mesh-list
1964224|NCT00862823|Emtricitabine|emtricitabine|mesh-list
1964225|NCT00862823|Efavirenz|efavirenz|mesh-list
1964226|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
1964227|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964228|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1964229|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1964230|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964231|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964232|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1964233|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1964234|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1964235|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1964236|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1964237|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1964238|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1964239|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1964240|NCT00862849|Insulin|insulin|mesh-list
1964241|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1964242|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
1964243|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1964244|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964245|NCT00862940|Memantine|memantine|mesh-list
1964246|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1964247|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1964248|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
1964249|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1964250|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964251|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964252|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1964253|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1964254|NCT00862979|Cyclosporine|cyclosporine|mesh-list
1964255|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
1964256|NCT00862979|Everolimus|everolimus|mesh-list
1964257|NCT00862979|Tacrolimus|tacrolimus|mesh-list
1964258|NCT00862979|Cyclosporins|cyclosporins|mesh-list
1964259|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1964260|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
1964261|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964262|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1964263|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964264|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964265|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
1964266|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964267|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
1964268|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1964269|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964270|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1964271|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1964272|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
1964273|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1964274|NCT00862992|Cariprazine|cariprazine|mesh-list
1964275|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1964276|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1964277|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1964278|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964279|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1964280|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1964281|NCT00863057|Methadone|methadone|mesh-list
1964282|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1964283|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1964284|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1964285|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964286|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1964287|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964288|NCT00863057|Analgesics|analgesics|mesh-ancestor
1964289|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
1964290|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964291|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
1964292|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1964293|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
1964294|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1964295|NCT00863057|Narcotics|narcotics|mesh-ancestor
1964296|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1964297|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
1964298|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
1964299|NCT00863109|Ribavirin|ribavirin|mesh-list
1964300|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1964301|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
1964302|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964303|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
1964304|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964305|NCT00863122|Lapatinib|lapatinib|mesh-list
1964306|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964307|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1964308|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964309|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964310|NCT00863265|Ezetimibe|ezetimibe|mesh-list
1964311|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1964312|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1964313|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
1964314|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964315|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1964316|NCT00863304|Naproxen|naproxen|mesh-list
1964317|NCT00863304|Tanezumab|tanezumab|mesh-list
1964318|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1964319|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1964320|NCT00863304|Analgesics|analgesics|mesh-ancestor
1964321|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
1964322|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964323|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964324|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1964325|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1964326|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
1964327|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1964328|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964329|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964330|NCT00863317|Montelukast|montelukast|mesh-list
1964331|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1964332|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
1964333|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1964334|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
1964335|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1964336|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964337|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1964338|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1964339|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964340|NCT00863356|Hemostatics|hemostatics|mesh-list
1964341|NCT00863356|Chitosan|chitosan|mesh-list
1964342|NCT00863356|Coagulants|coagulants|mesh-ancestor
1964343|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1964344|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1964345|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
1964346|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964347|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1964348|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
1964349|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
1964350|NCT00863434|Cytarabine|cytarabine|mesh-list
1964351|NCT00863434|Clofarabine|clofarabine|mesh-list
1964352|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
1964353|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964354|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1964355|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
1964356|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964357|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964358|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
1964359|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964360|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1964361|NCT00863551|Trospium chloride|trospium chloride|mesh-list
1964362|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
1964363|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
1964364|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964365|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964366|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1964367|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1964368|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
1964369|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1964370|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964371|NCT00863551|Urological Agents|urological agents|mesh-ancestor
1964372|NCT00863655|Everolimus|everolimus|mesh-list
1964373|NCT00863655|Exemestane|exemestane|mesh-list
1964374|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964375|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1964376|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
1964377|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964378|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1964379|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1964380|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964381|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964382|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1964383|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
1964384|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1964385|NCT00863681|Riociguat|riociguat|mesh-list
1964386|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
1964387|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964388|NCT00863707|Regadenoson|regadenoson|mesh-list
1964389|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1964390|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1964391|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
1964392|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
1964393|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1964394|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964395|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964396|NCT00863746|Sorafenib|sorafenib|mesh-list
1964397|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964398|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1964399|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964400|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964401|NCT00863772|Tanezumab|tanezumab|mesh-list
1964402|NCT00863772|Analgesics|analgesics|mesh-ancestor
1964403|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
1964404|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964405|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964406|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1964407|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1964408|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1964409|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1964410|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964411|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1964412|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964413|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
1964414|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1964415|NCT00864032|Sorafenib|sorafenib|mesh-list
1964416|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964417|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1964418|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964419|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964420|NCT00864097|Diclofenac|diclofenac|mesh-list
1964421|NCT00864097|Tanezumab|tanezumab|mesh-list
1964422|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1964423|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1964424|NCT00864097|Analgesics|analgesics|mesh-ancestor
1964425|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
1964426|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964427|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964428|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1964429|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1964430|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1964431|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964432|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964433|NCT00864123|Cycloserine|cycloserine|mesh-list
1964434|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1964435|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964436|NCT00864123|Renal Agents|renal agents|mesh-ancestor
1964437|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1964438|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
1964439|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1964440|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
1964441|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964442|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1964443|NCT00864253|Dacarbazine|dacarbazine|mesh-list
1964444|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964445|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1964446|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
1964447|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964448|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
1964449|NCT00864383|Rifampin|rifampin|mesh-list
1964450|NCT00864383|Isoniazid|isoniazid|mesh-list
1964451|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
1964452|NCT00864383|Ethambutol|ethambutol|mesh-list
1964453|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1964454|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964455|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1964456|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1964457|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964458|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964459|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964460|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1964461|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
1964462|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
1964463|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1964464|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1964465|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1964466|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1964467|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1964468|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1964469|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1964470|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1964471|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1964472|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
1964473|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2475525|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2475526|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2475527|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
2475528|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475529|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475530|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2475531|NCT01084473|Narcotics|narcotics|mesh-ancestor
2475532|NCT01084486|Metformin|metformin|mesh-list
2475533|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1964483|NCT00864513|Pemetrexed|pemetrexed|mesh-list
1964484|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964485|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964486|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964487|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1964488|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1964489|NCT00864539|Vitamin D|vitamin d|mesh-list
1964490|NCT00864539|Calcium|calcium|mesh-list
1964491|NCT00864539|Vitamins|vitamins|mesh-ancestor
1964492|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
1964493|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964494|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1964495|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1964496|NCT00864682|Lidocaine|lidocaine|mesh-list
1964497|NCT00864682|Propofol|propofol|mesh-list
1964498|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
1964499|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
1964500|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1964501|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964502|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
1964503|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964504|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1964505|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1964506|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1964507|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1964508|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964509|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1964510|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1964511|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
1964512|NCT00864721|Sunitinib|sunitinib|mesh-list
1964513|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964514|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1964515|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1964516|NCT00864721|Growth Substances|growth substances|mesh-ancestor
1964517|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964518|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
1964519|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1964520|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964521|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964522|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1964523|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
1964524|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
1964525|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964526|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1964527|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964528|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964529|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1964530|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1964531|NCT00864916|Protective Agents|protective agents|mesh-ancestor
1964532|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964533|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
1964534|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1964535|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
1964536|NCT00865020|Telmisartan|telmisartan|mesh-list
1964537|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1964538|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1964539|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1964540|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964541|NCT00865098|Cetuximab|cetuximab|mesh-list
1964542|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1964543|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964544|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1964545|NCT00865124|Spironolactone|spironolactone|mesh-list
1964546|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1964547|NCT00865124|Diuretics|diuretics|mesh-ancestor
1964548|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
1964549|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964550|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1964551|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1964552|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964553|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1964554|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
1964555|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1964556|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1964557|NCT00865189|Leucovorin|leucovorin|mesh-list
1964558|NCT00865189|Folic Acid|folic acid|mesh-list
1964559|NCT00865189|Bevacizumab|bevacizumab|mesh-list
1964560|NCT00865189|Fluorouracil|fluorouracil|mesh-list
1964561|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
1964562|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
1964563|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1964564|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964565|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1964566|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1964567|NCT00865189|Growth Substances|growth substances|mesh-ancestor
1964568|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964569|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
1964570|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
1964571|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964572|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1964573|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1964574|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
1964575|NCT00865189|Antidotes|antidotes|mesh-ancestor
1964576|NCT00865189|Protective Agents|protective agents|mesh-ancestor
1964577|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
1964578|NCT00865189|Vitamins|vitamins|mesh-ancestor
1964579|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
1964580|NCT00865189|Hematinics|hematinics|mesh-ancestor
1964581|NCT00865202|Tryptophan|tryptophan|mesh-list
1964582|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1964583|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
1964584|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1964585|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
1964586|NCT00865280|Linezolid|linezolid|mesh-list
1964587|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1964588|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964589|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1964590|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1964591|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964592|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964593|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964594|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1964595|NCT00865566|Vaccines|vaccines|mesh-list
1964596|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
1964597|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964598|NCT00865709|Leucovorin|leucovorin|mesh-list
1964599|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
1964600|NCT00865709|Fluorouracil|fluorouracil|mesh-list
1964601|NCT00865709|Sorafenib|sorafenib|mesh-list
1964602|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
1964603|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964604|NCT00865709|Antidotes|antidotes|mesh-ancestor
1964605|NCT00865709|Protective Agents|protective agents|mesh-ancestor
1964606|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964607|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
1964608|NCT00865709|Vitamins|vitamins|mesh-ancestor
1964609|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
1964610|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
1964611|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964612|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1964613|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1964614|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
1964615|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1964616|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964617|NCT00865969|Belinostat|belinostat|mesh-list
1964618|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964619|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1964620|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964621|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964622|NCT00866034|Cetrorelix|cetrorelix|mesh-list
1964623|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1964624|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
1964625|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1964626|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964627|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
1964628|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1964629|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1964630|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1964631|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964632|NCT00866281|Midostaurin|midostaurin|mesh-list
1964633|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964634|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1964635|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964636|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964637|NCT00866294|Paroxetine|paroxetine|mesh-list
1964638|NCT00866294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1964639|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1964640|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1964641|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964642|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1964643|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
1964644|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964645|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1964646|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
1964647|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1964648|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1964649|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1964650|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964651|NCT00866307|Cytarabine|cytarabine|mesh-list
1964652|NCT00866307|Dexamethasone|dexamethasone|mesh-list
1964653|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
1964654|NCT00866307|Prednisone|prednisone|mesh-list
1964655|NCT00866307|Cortisone|cortisone|mesh-list
1964656|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
1964657|NCT00866307|Doxorubicin|doxorubicin|mesh-list
1964658|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1964659|NCT00866307|Methotrexate|methotrexate|mesh-list
1964660|NCT00866307|Vincristine|vincristine|mesh-list
1964661|NCT00866307|Daunorubicin|daunorubicin|mesh-list
1964662|NCT00866307|Asparaginase|asparaginase|mesh-list
1964663|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
1964664|NCT00866307|Pegaspargase|pegaspargase|mesh-list
1964665|NCT00866307|Thioguanine|thioguanine|mesh-list
1964666|NCT00866307|BB 1101|bb 1101|mesh-list
1964667|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
1964668|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1964669|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
1964670|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964671|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1964672|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1964673|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
1964674|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964675|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964676|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1964677|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1964678|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
1964679|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
1964680|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964681|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1964682|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
1964683|NCT00866307|Hormones|hormones|mesh-ancestor
1964684|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1964685|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1964686|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
1964687|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964688|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1964689|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1964690|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1964691|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1964692|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
1964693|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1964694|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1964695|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
1964696|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
1964697|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1964698|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1964699|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
1964700|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964701|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1964702|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
1964703|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
1964704|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
1964705|NCT00866320|Sorafenib|sorafenib|mesh-list
1964706|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964707|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1964708|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964709|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964710|NCT00866333|Entinostat|entinostat|mesh-list
1964711|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964712|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1964713|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964714|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964715|NCT00866359|Apremilast|apremilast|mesh-list
1964716|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1964717|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1964718|NCT00866359|Analgesics|analgesics|mesh-ancestor
1964719|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
1964720|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964721|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964722|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1964723|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1964724|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1964725|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1964726|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964727|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964728|NCT00866619|Vaccines|vaccines|mesh-list
1964729|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
1964730|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964731|NCT00866658|Lixisenatide|lixisenatide|mesh-list
1964732|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1964733|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964734|NCT00866723|Bevacizumab|bevacizumab|mesh-list
1964735|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1964736|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964737|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1964738|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1964739|NCT00866723|Growth Substances|growth substances|mesh-ancestor
1964740|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964741|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
1964742|NCT00866749|Cytarabine|cytarabine|mesh-list
1964743|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
1964744|NCT00866749|Doxorubicin|doxorubicin|mesh-list
1964745|NCT00866749|Methotrexate|methotrexate|mesh-list
1964746|NCT00866749|Vincristine|vincristine|mesh-list
1964747|NCT00866749|Daunorubicin|daunorubicin|mesh-list
1964748|NCT00866749|Asparaginase|asparaginase|mesh-list
1964749|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
1964750|NCT00866749|Thioguanine|thioguanine|mesh-list
1964751|NCT00866749|Pegaspargase|pegaspargase|mesh-list
1964752|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1964753|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
1964754|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964755|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1964756|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1964757|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
1964758|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964759|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964760|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1964761|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1964762|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1964763|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1964764|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964765|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1964766|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
1964767|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1964768|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1964769|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
1964770|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
1964771|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1964772|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1964773|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
1964774|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964775|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1964776|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
1964777|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
1964778|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
1964779|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1964780|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
1964781|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1964782|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1964783|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1964784|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964785|NCT00866788|Omalizumab|omalizumab|mesh-list
1964786|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
1964787|NCT00866788|Promethazine|promethazine|mesh-list
1964788|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
1964789|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
1964790|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1964791|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1964792|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
1964793|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1964794|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1964795|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1964796|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964797|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
1964798|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
1964799|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
1964800|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964801|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
1964802|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
1964803|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1964804|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
1964805|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1964806|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964807|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
1964808|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
1964809|NCT00866879|Sirolimus|sirolimus|mesh-list
1964810|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1964811|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964812|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1964813|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964814|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
1964815|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1964816|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
1964817|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964818|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
1964819|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1964820|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
1964821|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964822|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1964823|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1964824|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
1964825|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964826|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964827|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1964828|NCT00866918|Cytarabine|cytarabine|mesh-list
1964829|NCT00866918|Methotrexate|methotrexate|mesh-list
1964830|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
1964831|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
1964832|NCT00866918|Idarubicin|idarubicin|mesh-list
1964833|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
1964834|NCT00866918|Tretinoin|tretinoin|mesh-list
1964835|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1964836|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
1964837|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1964838|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964839|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1964840|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
1964841|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964842|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964843|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
1964844|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964845|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1964846|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1964847|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
1964848|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1964849|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1964850|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
1964851|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964852|NCT00866918|Analgesics|analgesics|mesh-ancestor
1964853|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
1964854|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964855|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1964856|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1964857|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1964858|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
1964859|NCT00867009|Pemetrexed|pemetrexed|mesh-list
1964860|NCT00867009|Cetuximab|cetuximab|mesh-list
1964861|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964862|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964863|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964864|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1964865|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1964866|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1964867|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
1964868|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1964869|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
1964870|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1964871|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964872|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
1964873|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
1964874|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
1964875|NCT00867087|Rituximab|rituximab|mesh-list
1964876|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
1964877|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1964878|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964879|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
1964880|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964881|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1964882|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1964883|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
1964884|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964885|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1964886|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964887|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964888|NCT00867139|Oseltamivir|oseltamivir|mesh-list
1964889|NCT00867139|Ribavirin|ribavirin|mesh-list
1964890|NCT00867139|Zanamivir|zanamivir|mesh-list
1964891|NCT00867139|Amantadine|amantadine|mesh-list
1964892|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
1964893|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
1964894|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1964895|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964896|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964897|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
1964898|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1964899|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1964900|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
1964901|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1964902|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964903|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1964904|NCT00867139|Analgesics|analgesics|mesh-ancestor
1964905|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
1964906|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1964907|NCT00867165|Ezetimibe|ezetimibe|mesh-list
1964908|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1964909|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1964910|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
1964911|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964912|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1964913|NCT00867217|Vitamin D|vitamin d|mesh-list
1964914|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
1964915|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
1964916|NCT00867217|Vitamins|vitamins|mesh-list
1964917|NCT00867217|Letrozole|letrozole|mesh-list
1964918|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
1964919|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964920|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1964921|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1964922|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964923|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1964924|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1964925|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964926|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964927|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1964928|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
1964929|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1964930|NCT00867308|Lenalidomide|lenalidomide|mesh-list
1964931|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
1964932|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964933|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1964934|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1964935|NCT00867308|Growth Substances|growth substances|mesh-ancestor
1964936|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
1964937|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964938|NCT00867321|Bevacizumab|bevacizumab|mesh-list
1964939|NCT00867321|Sorafenib|sorafenib|mesh-list
1964940|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1964941|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964942|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1964943|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1964944|NCT00867321|Growth Substances|growth substances|mesh-ancestor
1964945|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964946|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
1964947|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1964948|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964949|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964950|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
1964951|NCT00867334|Panitumumab|panitumumab|mesh-list
1964952|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964953|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1964954|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1964955|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964956|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1964957|NCT00867360|Mifepristone|mifepristone|mesh-list
1964958|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1964959|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
1964960|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1964961|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964962|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1964963|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1964964|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1964965|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
1964966|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1964967|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1964968|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
1964969|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1964970|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
1964971|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1964972|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1964973|NCT00867451|Melatonin|melatonin|mesh-list
1964974|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
1964975|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964976|NCT00867451|Protective Agents|protective agents|mesh-ancestor
1964977|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964978|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1964979|NCT00867490|Amlodipine|amlodipine|mesh-list
1964980|NCT00867490|Candesartan|candesartan|mesh-list
1964981|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1964982|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1964983|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1964984|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1964985|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964986|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1964987|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1964988|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
1964989|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1964990|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1964991|NCT00867490|Diuretics|diuretics|mesh-ancestor
1964992|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
1964993|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1964994|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1964995|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1964996|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
1964997|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1964998|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1964999|NCT00867529|Rituximab|rituximab|mesh-list
1965000|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1965001|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965002|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
1965003|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965004|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1965005|NCT00867659|Cetrorelix|cetrorelix|mesh-list
1965006|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1965007|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
1965008|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1965009|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965010|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
1965011|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1965012|NCT00867789|Trimethoprim|trimethoprim|mesh-list
1965013|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1965014|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
1965015|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1965016|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965017|NCT00867789|Renal Agents|renal agents|mesh-ancestor
1965018|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
1965019|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1965020|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1965021|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1965022|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965023|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965024|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1965025|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1965026|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1965027|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1965028|NCT00867932|Eculizumab|eculizumab|mesh-list
1965029|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1965030|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1965031|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
1965032|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965033|NCT00868140|Pioglitazone|pioglitazone|mesh-list
1965034|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1965035|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965036|NCT00868166|Riluzole|riluzole|mesh-list
1965037|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
1965038|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1965039|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1965040|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965041|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965042|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965043|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1965044|NCT00868166|Protective Agents|protective agents|mesh-ancestor
1965045|NCT00868192|Bevacizumab|bevacizumab|mesh-list
1965046|NCT00868192|Pemetrexed|pemetrexed|mesh-list
1965047|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1965048|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965049|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1965050|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1965051|NCT00868192|Growth Substances|growth substances|mesh-ancestor
1965052|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965053|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
1965054|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965055|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965056|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1965057|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1965058|NCT00868231|Bromides|bromides|mesh-list
1965059|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
1965060|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1965061|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
1965062|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1965063|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965064|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1965065|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
1965066|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
1965067|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1965068|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
1965069|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965070|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965071|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
1965072|NCT00868296|Pantoprazole|pantoprazole|mesh-list
1965073|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1965074|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1965075|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1965076|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965077|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965078|NCT00868309|Antivenins|antivenins|mesh-list
1965079|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
1965080|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965081|NCT00868348|Ketorolac|ketorolac|mesh-list
1965082|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1965083|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1965084|NCT00868348|Analgesics|analgesics|mesh-ancestor
1965085|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
1965086|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1965087|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965088|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1965089|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1965090|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1965091|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965092|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965093|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1965094|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
1965095|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1965096|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1965097|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1965098|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1965099|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965100|NCT00868452|Valproic Acid|valproic acid|mesh-list
1965101|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
1965102|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1965103|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
1965104|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1965105|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965106|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965107|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
1965108|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1965109|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1965110|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965111|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
1965112|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
1965113|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965114|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1965115|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1965116|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1965117|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1965118|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
1965119|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1965120|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1965121|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
1965122|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1965123|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1965124|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
1965125|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
1965126|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1965127|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965128|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1965129|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1965130|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1965131|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1965132|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1965133|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965134|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1965135|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1965136|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1965137|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1965138|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
1965139|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965140|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965141|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1965142|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1965143|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
1965144|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1965145|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1965146|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
1965147|NCT00868790|Metformin|metformin|mesh-list
1965148|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1965149|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965150|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1965151|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1965152|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1965153|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1965154|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965155|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1965156|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1965157|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1965158|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1965159|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
1965160|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965161|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965162|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1965163|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1965164|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
1965165|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1965166|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1965167|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
1965168|NCT00869050|Capecitabine|capecitabine|mesh-list
1965169|NCT00869050|Temozolomide|temozolomide|mesh-list
1965170|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1965171|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
1965172|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965173|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965174|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1965175|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
1965176|NCT00869089|Apremilast|apremilast|mesh-list
1965177|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1965178|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1965179|NCT00869089|Analgesics|analgesics|mesh-ancestor
1965180|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
1965181|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1965182|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965183|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1965184|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1965185|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1965186|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1965187|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965188|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965189|NCT00869128|Melatonin|melatonin|mesh-list
1965190|NCT00869128|Antioxidants|antioxidants|mesh-ancestor
1965191|NCT00869128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965192|NCT00869128|Protective Agents|protective agents|mesh-ancestor
1965193|NCT00869128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965194|NCT00869128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1965195|NCT00869141|Timolol|timolol|mesh-list
1965196|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1965197|NCT00869141|Dorzolamide|dorzolamide|mesh-list
1965198|NCT00869141|Brinzolamide|brinzolamide|mesh-list
1965199|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1965200|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1965201|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
1965202|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965203|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965204|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965205|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1965206|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1965207|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1965208|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1965209|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1965210|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1965211|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965212|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
1965213|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1965214|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965215|NCT00869323|Rituximab|rituximab|mesh-list
1965216|NCT00869323|Bortezomib|bortezomib|mesh-list
1965217|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1965218|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965219|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
1965220|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965221|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1965222|NCT00869401|Temozolomide|temozolomide|mesh-list
1965223|NCT00869401|Dasatinib|dasatinib|mesh-list
1965224|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1965225|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
1965226|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965227|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965228|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1965229|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965230|NCT00869440|Midazolam|midazolam|mesh-list
1965231|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1965232|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1965233|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1965234|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965235|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1965236|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1965237|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1965238|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1965239|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
1965240|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
1965241|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
1965242|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
1965243|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965244|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965245|NCT00869518|Trimethoprim|trimethoprim|mesh-list
1965246|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1965247|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
1965248|NCT00869518|Rifabutin|rifabutin|mesh-list
1965249|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1965250|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965251|NCT00869518|Renal Agents|renal agents|mesh-ancestor
1965252|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
1965253|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1965254|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1965255|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1965256|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965257|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965258|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1965259|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1965260|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1965261|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1965262|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1965263|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
1965264|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1965265|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1965266|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1965267|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1965268|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965269|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965270|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
1965271|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965272|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1965273|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1965274|NCT00869622|Vitamin D|vitamin d|mesh-list
1965275|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
1965276|NCT00869622|Calcium|calcium|mesh-list
1965277|NCT00869622|Vitamins|vitamins|mesh-ancestor
1965278|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
1965279|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965280|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1965281|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1965282|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1965283|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1965284|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965285|NCT00869778|Vaccines|vaccines|mesh-list
1965286|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
1965287|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965288|NCT00869791|Levodopa|levodopa|mesh-list
1965289|NCT00869791|Carbidopa|carbidopa|mesh-list
1965290|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1965291|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1965292|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1965293|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
1965294|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965295|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965296|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965297|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1965298|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965299|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1965300|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
1965301|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
1965302|NCT00869960|Ritonavir|ritonavir|mesh-list
1965303|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1965304|NCT00869960|Tenofovir|tenofovir|mesh-list
1965305|NCT00869960|Emtricitabine|emtricitabine|mesh-list
1965306|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1965307|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1965308|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
1965309|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965310|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965311|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1965312|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1965313|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
1965314|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965315|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1965316|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1965317|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1965318|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1965319|NCT00869999|Rituximab|rituximab|mesh-list
1965320|NCT00869999|Everolimus|everolimus|mesh-list
1965321|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1965322|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965323|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
1965324|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965325|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1965326|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1965327|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
1965328|NCT00870103|Dexamethasone|dexamethasone|mesh-list
1965329|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1965330|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1965331|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
1965332|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
1965333|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1965334|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965335|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1965336|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
1965337|NCT00870103|Hormones|hormones|mesh-ancestor
1965338|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1965339|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1965340|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965341|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1965342|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965343|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1965344|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1965345|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965346|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965347|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1965348|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1965349|NCT00870194|Exenatide|exenatide|mesh-list
1965350|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1965351|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965352|NCT00870194|Incretins|incretins|mesh-ancestor
1965353|NCT00870194|Hormones|hormones|mesh-ancestor
1965354|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1965355|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1965356|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
1965357|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965358|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965359|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1965360|NCT00870363|Efavirenz|efavirenz|mesh-list
1965361|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
1965362|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
1965363|NCT00870363|Maraviroc|maraviroc|mesh-list
1965364|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1965365|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965366|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965367|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
1965368|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965369|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1965370|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1965371|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1965372|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1965373|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1965374|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1965375|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1965376|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1965377|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1965378|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1965379|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1965380|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1965381|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1965382|NCT00870467|Adalimumab|adalimumab|mesh-list
1965383|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1965384|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1965385|NCT00870584|Omalizumab|omalizumab|mesh-list
1965386|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1965387|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1965388|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
1965389|NCT00870688|Valproic Acid|valproic acid|mesh-list
1965390|NCT00870688|Anticonvulsants|anticonvulsants|mesh-ancestor
1965391|NCT00870688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965392|NCT00870688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965393|NCT00870688|GABA Agents|gaba agents|mesh-ancestor
1965394|NCT00870688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965395|NCT00870688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965396|NCT00870688|Antimanic Agents|antimanic agents|mesh-ancestor
1965397|NCT00870688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1965398|NCT00870688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1965399|NCT00870688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1965400|NCT00870727|Aripiprazole|aripiprazole|mesh-list
1965401|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
1965402|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1965403|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1965404|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1965405|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1965406|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965407|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
1965408|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
1965409|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965410|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965411|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1965412|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1965413|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
1965414|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1965415|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1965416|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1965417|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1965418|NCT00870740|Daclizumab|daclizumab|mesh-list
1965419|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1965420|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
1965421|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965422|NCT00870870|Gemcitabine|gemcitabine|mesh-list
1965423|NCT00870870|Carboplatin|carboplatin|mesh-list
1965424|NCT00870870|Cetuximab|cetuximab|mesh-list
1965425|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1965426|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965427|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1965428|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
1965429|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965430|NCT00870870|Antiviral Agents|antiviral agents|mesh-ancestor
1965431|NCT00870870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965432|NCT00870870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965433|NCT00870870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1965434|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
1965435|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965436|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1965437|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
1965438|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1965439|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
1965440|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1965441|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965442|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1965443|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
1965444|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
1965445|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1965446|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
1965447|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965448|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965449|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
1965450|NCT00871000|Antidotes|antidotes|mesh-ancestor
1965451|NCT00871000|Protective Agents|protective agents|mesh-ancestor
1965452|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965453|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
1965454|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
1965455|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965456|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1965457|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
1965458|NCT00871169|Irinotecan|irinotecan|mesh-list
1965459|NCT00871169|Cetuximab|cetuximab|mesh-list
1965460|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965461|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1965462|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1965463|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965464|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965465|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1965466|NCT00871234|Etravirine|etravirine|mesh-list
1965467|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1965468|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1965469|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965470|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965471|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
1965472|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965473|NCT00871260|Regadenoson|regadenoson|mesh-list
1965474|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1965475|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1965476|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
1965477|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
1965478|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965479|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965480|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965481|NCT00871338|Vaccines|vaccines|mesh-list
1965482|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1965483|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
1965484|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965485|NCT00871351|Atorvastatin|atorvastatin|mesh-list
1965486|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1965487|NCT00871351|Ezetimibe|ezetimibe|mesh-list
1965488|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1965489|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1965490|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
1965491|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965492|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1965493|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1965494|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965495|NCT00871403|Pemetrexed|pemetrexed|mesh-list
1965496|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965497|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965498|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965499|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1965500|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1965501|NCT00871494|Azithromycin|azithromycin|mesh-list
1965502|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1965503|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965504|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
1965505|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1965506|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1965507|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965508|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1965509|NCT00871624|Analgesics|analgesics|mesh-ancestor
1965510|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
1965511|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1965512|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1965513|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1965514|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1965515|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
1965516|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965517|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965518|NCT00871689|Vidarabine|vidarabine|mesh-list
1965519|NCT00871689|Aldesleukin|aldesleukin|mesh-list
1965520|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
1965521|NCT00871689|Fludarabine|fludarabine|mesh-list
1965522|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
1965523|NCT00871689|Interleukin-2|interleukin-2|mesh-list
1965524|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1965525|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
1965526|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965527|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1965528|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1965529|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
1965530|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965531|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965532|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1965533|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1965534|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
1965535|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
1965536|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965537|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1965538|NCT00871689|Analgesics|analgesics|mesh-ancestor
1965539|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
1965540|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1965541|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1965542|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1965543|NCT00871728|Itraconazole|itraconazole|mesh-list
1965544|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
1965545|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965546|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1965547|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1965548|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965549|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965550|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1965551|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
1965552|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1965553|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965554|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1965555|NCT00871780|Natalizumab|natalizumab|mesh-list
1965556|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
1965557|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965558|NCT00871858|Fulvestrant|fulvestrant|mesh-list
1965559|NCT00871858|Anastrozole|anastrozole|mesh-list
1965560|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1965561|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965562|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1965563|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1965564|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
1965565|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1965566|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965567|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1965568|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1965569|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965570|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965571|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1965572|NCT00871871|Isosorbide|isosorbide|mesh-list
1965573|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
1965574|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
1965575|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1965576|NCT00871871|Diuretics|diuretics|mesh-ancestor
1965577|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
1965578|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965579|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1965580|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1965581|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965582|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1965583|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
1965584|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
1965585|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1965586|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965587|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1965588|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965589|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965590|NCT00872027|Citalopram|citalopram|mesh-list
1965591|NCT00872027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1965592|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1965593|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1965594|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965595|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965596|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
1965597|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965598|NCT00872027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1965599|NCT00872027|Antidepressive Agents|antidepressive agents|mesh-ancestor
1965600|NCT00872027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1965601|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
1965602|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
1965603|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1965604|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1965605|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965606|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965607|NCT00872170|Urological Agents|urological agents|mesh-ancestor
1965608|NCT00872430|Laxatives|laxatives|mesh-list
1965609|NCT00872430|Cathartics|cathartics|mesh-list
1965610|NCT00872430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1965611|NCT00872534|Aspirin|aspirin|mesh-list
1965612|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1965613|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1965614|NCT00872534|Analgesics|analgesics|mesh-ancestor
1965615|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
1965616|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1965617|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965618|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1965619|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1965620|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1965621|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1965622|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965623|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1965624|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1965625|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965626|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
1965627|NCT00872599|Fenofibrate|fenofibrate|mesh-list
1965628|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1965629|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
1965630|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965631|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1965632|NCT00872729|Cysteamine|cysteamine|mesh-list
1965633|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
1965634|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965635|NCT00872898|Memantine|memantine|mesh-list
1965636|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1965637|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1965638|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
1965639|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965640|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965641|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965642|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1965643|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1965644|NCT00872989|Docetaxel|docetaxel|mesh-list
1965645|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965646|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
1965647|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
1965648|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
1965649|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965650|NCT00873041|Deferasirox|deferasirox|mesh-list
1965651|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1965652|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
1965653|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
1965654|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965655|NCT00873093|Leucovorin|leucovorin|mesh-list
1965656|NCT00873093|Cytarabine|cytarabine|mesh-list
1965657|NCT00873093|Prednisone|prednisone|mesh-list
1965658|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
1965659|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1965660|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1965661|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1965662|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
1965663|NCT00873093|Doxorubicin|doxorubicin|mesh-list
1965664|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1965665|NCT00873093|Methotrexate|methotrexate|mesh-list
1965666|NCT00873093|Etoposide|etoposide|mesh-list
1965667|NCT00873093|Vincristine|vincristine|mesh-list
1965668|NCT00873093|Bortezomib|bortezomib|mesh-list
1965669|NCT00873093|Asparaginase|asparaginase|mesh-list
1965670|NCT00873093|Pegaspargase|pegaspargase|mesh-list
1965671|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
1965672|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
1965673|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1965674|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
1965675|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965676|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1965677|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1965678|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
1965679|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965680|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965681|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1965682|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1965683|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1965684|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1965685|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965686|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1965687|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
1965688|NCT00873093|Hormones|hormones|mesh-ancestor
1965689|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1965690|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1965691|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1965692|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
1965693|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1965694|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1965695|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
1965696|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
1965697|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1965698|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1965699|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1965700|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
1965701|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965702|NCT00873093|Antidotes|antidotes|mesh-ancestor
1965703|NCT00873093|Protective Agents|protective agents|mesh-ancestor
1965704|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
1965705|NCT00873093|Vitamins|vitamins|mesh-ancestor
1965706|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
1965707|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
1965708|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
1965709|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
1965710|NCT00873119|Paclitaxel|paclitaxel|mesh-list
1965711|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1965712|NCT00873119|Carboplatin|carboplatin|mesh-list
1965713|NCT00873119|Belinostat|belinostat|mesh-list
1965714|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1965715|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965716|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
1965717|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
1965718|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
1965719|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965720|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1965721|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965722|NCT00873327|Tazobactam|tazobactam|mesh-list
1965723|NCT00873327|Piperacillin|piperacillin|mesh-list
1965724|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
1965725|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1965726|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965727|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1965728|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965729|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475534|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475535|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2475536|NCT01084577|Laxatives|laxatives|mesh-ancestor
2475537|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2475538|NCT01084720|V0034CR|v0034cr|mesh-list
2475539|NCT01084720|Emollients|emollients|mesh-ancestor
2475540|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
2475541|NCT01084824|Cantharidin|cantharidin|mesh-list
2475542|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475543|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475544|NCT01084837|Bortezomib|bortezomib|mesh-list
2475545|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475546|NCT01084863|Paclitaxel|paclitaxel|mesh-list
2475547|NCT01084863|Trastuzumab|trastuzumab|mesh-list
2475548|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2475549|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475550|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
1965747|NCT00873730|Etanercept|etanercept|mesh-list
1965748|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1965749|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1965750|NCT00873730|Analgesics|analgesics|mesh-ancestor
1965751|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
1965752|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1965753|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965754|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1965755|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2475551|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
2475552|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
1965756|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1965757|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1965758|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
1965759|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1965760|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
1965761|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965762|NCT00874120|Phenylephrine|phenylephrine|mesh-list
1965763|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
1965764|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1965765|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
1965766|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
1965767|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1965768|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965769|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
1965770|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1965771|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
1965772|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
1965773|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1965774|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1965775|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1965776|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
1965777|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965778|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965779|NCT00874120|Protective Agents|protective agents|mesh-ancestor
1965780|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
1965781|NCT00874237|Loxapine|loxapine|mesh-list
1965782|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1965783|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965784|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1965785|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1965786|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965787|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965788|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965789|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965790|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1965791|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1965792|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1965793|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1965794|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1965795|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
1965796|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965797|NCT00874432|Lisinopril|lisinopril|mesh-list
1965798|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1965799|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
1965800|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
1965801|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965802|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1965803|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1965804|NCT00874432|Protective Agents|protective agents|mesh-ancestor
1965805|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965806|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
1965807|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965808|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965809|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965810|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1965811|NCT00874731|Sirolimus|sirolimus|mesh-list
1965812|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1965813|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965814|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1965815|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965816|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
1965817|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1965818|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
1965819|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965820|NCT00874770|Ribavirin|ribavirin|mesh-list
1965821|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1965822|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
1965823|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965824|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
1965825|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965826|NCT00874848|Paclitaxel|paclitaxel|mesh-list
1965827|NCT00874848|Carboplatin|carboplatin|mesh-list
1965828|NCT00874848|Cetuximab|cetuximab|mesh-list
1965829|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1965830|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1965831|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965832|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
1965833|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
1965834|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
1965835|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965836|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1965837|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
1965838|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
1965839|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1965840|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1965841|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1965842|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1965843|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1965844|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1965845|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965846|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965847|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965848|NCT00875017|Sevelamer|sevelamer|mesh-list
1965849|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
1965850|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
1965851|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965852|NCT00875056|Vorinostat|vorinostat|mesh-list
1965853|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965854|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1965855|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965856|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965857|NCT00875212|Calcium|calcium|mesh-list
1965858|NCT00875212|Fluorides|fluorides|mesh-list
1965859|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
1965860|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1965861|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965862|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
1965863|NCT00875212|Protective Agents|protective agents|mesh-ancestor
1965864|NCT00875277|Betamethasone|betamethasone|mesh-list
1965865|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
1965866|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
1965867|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
1965868|NCT00875277|Calcipotriene|calcipotriene|mesh-list
1965869|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
1965870|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1965871|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
1965872|NCT00875277|Hormones|hormones|mesh-ancestor
1965873|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1965874|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965875|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1965876|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
1965877|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
1965878|NCT00875433|Afatinib|afatinib|mesh-list
1965879|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965880|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1965881|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965882|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965883|NCT00875524|Vaccines|vaccines|mesh-list
1965884|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
1965885|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965886|NCT00875550|Fentanyl|fentanyl|mesh-list
1965887|NCT00875550|Midazolam|midazolam|mesh-list
1965888|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
1965889|NCT00875550|Morphine|morphine|mesh-list
1965890|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1965891|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1965892|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965893|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1965894|NCT00875550|Analgesics|analgesics|mesh-ancestor
1965895|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
1965896|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1965897|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1965898|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1965899|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1965900|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
1965901|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965902|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965903|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1965904|NCT00875550|Narcotics|narcotics|mesh-ancestor
1965905|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1965906|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1965907|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
1965908|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
1965909|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1965910|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1965911|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1965912|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
1965913|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
1965914|NCT00875615|Carboplatin|carboplatin|mesh-list
1965915|NCT00875615|Sorafenib|sorafenib|mesh-list
1965916|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965917|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1965918|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965919|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965920|NCT00875667|Fludarabine|fludarabine|mesh-list
1965921|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
1965922|NCT00875667|Lenalidomide|lenalidomide|mesh-list
1965923|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965924|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1965925|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
1965926|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965927|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1965928|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
1965929|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965930|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1965931|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1965932|NCT00875667|Growth Substances|growth substances|mesh-ancestor
1965933|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
1965934|NCT00875836|Buspirone|buspirone|mesh-list
1965935|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1965936|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1965937|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1965938|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965939|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1965940|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1965941|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
1965942|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965943|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965944|NCT00875979|Trastuzumab|trastuzumab|mesh-list
1965945|NCT00875979|Pertuzumab|pertuzumab|mesh-list
1965946|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1965947|NCT00875979|Maytansine|maytansine|mesh-list
1965948|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1965949|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965950|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1965951|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
1965952|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
1965953|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
1965954|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965955|NCT00876187|Naproxen|naproxen|mesh-list
1965956|NCT00876187|Tanezumab|tanezumab|mesh-list
1965957|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1965958|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1965959|NCT00876187|Analgesics|analgesics|mesh-ancestor
1965960|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
1965961|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1965962|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965963|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1965964|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1965965|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
1965966|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1965967|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1965968|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965969|NCT00876200|Minoxidil|minoxidil|mesh-list
1965970|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1965971|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
1965972|NCT00876343|Aripiprazole|aripiprazole|mesh-list
1965973|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
1965974|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1965975|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1965976|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1965977|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1965978|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1965979|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
1965980|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
1965981|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1965982|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965983|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1965984|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1965985|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
1965986|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1965987|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1965988|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1965989|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1965990|NCT00876395|Paclitaxel|paclitaxel|mesh-list
1965991|NCT00876395|Trastuzumab|trastuzumab|mesh-list
1965992|NCT00876395|Everolimus|everolimus|mesh-list
1965993|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1965994|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1965995|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
1965996|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
1965997|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
1965998|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1965999|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1966000|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1966001|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
1966002|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966003|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
1966004|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1966005|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1966006|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1966007|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1966008|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966009|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
1966010|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966011|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966012|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1966013|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966014|NCT00876460|Docetaxel|docetaxel|mesh-list
1966015|NCT00876460|Nintedanib|nintedanib|mesh-list
1966016|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966017|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
1966018|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
1966019|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
1966020|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966021|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1966022|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966023|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1966024|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1966025|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
1966026|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966027|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966028|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1966029|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
1966030|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1966031|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1966032|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1966033|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
1966034|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966035|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966036|NCT00876915|Dalteparin|dalteparin|mesh-list
1966037|NCT00876915|Tinzaparin|tinzaparin|mesh-list
1966038|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1966039|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
1966040|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1966041|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1966042|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966043|NCT00876928|Vitamin D|vitamin d|mesh-list
1966044|NCT00876928|Vitamins|vitamins|mesh-ancestor
1966045|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
1966046|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966047|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1966048|NCT00876993|Bevacizumab|bevacizumab|mesh-list
1966049|NCT00876993|Irinotecan|irinotecan|mesh-list
1966050|NCT00876993|Temozolomide|temozolomide|mesh-list
1966051|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1966052|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966053|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1966054|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1966055|NCT00876993|Growth Substances|growth substances|mesh-ancestor
1966056|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966057|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
1966058|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1966059|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1966060|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966061|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966062|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1966063|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
1966064|NCT00877006|Prednisone|prednisone|mesh-list
1966065|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
1966066|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1966067|NCT00877006|Rituximab|rituximab|mesh-list
1966068|NCT00877006|Doxorubicin|doxorubicin|mesh-list
1966069|NCT00877006|Vincristine|vincristine|mesh-list
1966070|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1966071|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
1966072|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966073|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1966074|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1966075|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
1966076|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966077|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966078|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1966079|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1966080|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1966081|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1966082|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1966083|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966084|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1966085|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
1966086|NCT00877006|Hormones|hormones|mesh-ancestor
1966087|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1966088|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1966089|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1966090|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
1966091|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
1966092|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
1966093|NCT00877370|Ertapenem|ertapenem|mesh-list
1966094|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1966095|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966096|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
1966097|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1966098|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
1966099|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966100|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966101|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1966102|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
1966103|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
1966104|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1966105|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
1966106|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966107|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966108|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1966109|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1966110|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966111|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1966112|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1966113|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1966114|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966115|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
1966116|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966117|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
1966118|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1966119|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1966120|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
1966121|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966122|NCT00877773|Sirolimus|sirolimus|mesh-list
1966123|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1966124|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966125|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1966126|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966127|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
1966128|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1966129|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
1966130|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966131|NCT00877890|Exenatide|exenatide|mesh-list
1966132|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1966133|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966134|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1966135|NCT00877890|Incretins|incretins|mesh-ancestor
1966136|NCT00877890|Hormones|hormones|mesh-ancestor
1966137|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1966138|NCT00877929|Amlodipine|amlodipine|mesh-list
1966139|NCT00877929|Telmisartan|telmisartan|mesh-list
1966140|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1966141|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1966142|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1966143|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966144|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1966145|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966146|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
1966147|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1966148|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1966149|NCT00878072|Famciclovir|famciclovir|mesh-list
1966150|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
1966151|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966152|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1966153|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966154|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966155|NCT00878215|Liver Extracts|liver extracts|mesh-list
1966156|NCT00878215|Hematinics|hematinics|mesh-ancestor
1966157|NCT00878228|Ondansetron|ondansetron|mesh-list
1966158|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
1966159|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
1966160|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966161|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966162|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1966163|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
1966164|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
1966165|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1966166|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
1966167|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966168|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966169|NCT00878228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1966170|NCT00878228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1966171|NCT00878228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1966172|NCT00878228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1966173|NCT00878228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1966174|NCT00878436|Bicalutamide|bicalutamide|mesh-list
1966175|NCT00878436|Panobinostat|panobinostat|mesh-list
1966176|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
1966177|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
1966178|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1966179|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966180|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966181|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1966182|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966183|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966184|NCT00878553|Zaleplon|zaleplon|mesh-list
1966185|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
1966186|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1966187|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1966188|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966189|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
1966190|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
1966191|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966192|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966193|NCT00878722|Idarubicin|idarubicin|mesh-list
1966194|NCT00878722|Belinostat|belinostat|mesh-list
1966195|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1966196|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966197|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1966198|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1966199|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966200|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966201|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1966202|NCT00878800|Doxorubicin|doxorubicin|mesh-list
1966203|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1966204|NCT00878800|Belinostat|belinostat|mesh-list
1966205|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1966206|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966207|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1966208|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1966209|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966210|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966211|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1966212|NCT00878826|Enoxaparin|enoxaparin|mesh-list
1966213|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
1966214|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1966215|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1966216|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966217|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
1966218|NCT00878995|Testosterone|testosterone|mesh-list
1966219|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
1966220|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
1966221|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1966222|NCT00878995|Androgens|androgens|mesh-ancestor
1966223|NCT00878995|Hormones|hormones|mesh-ancestor
1966224|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1966225|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966226|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1966227|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966228|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
1966229|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
1966230|NCT00879034|Pravastatin|pravastatin|mesh-list
1966231|NCT00879034|Lonafarnib|lonafarnib|mesh-list
1966232|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1966233|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966234|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1966235|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1966236|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
1966237|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966238|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1966239|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1966240|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966241|NCT00879060|Spironolactone|spironolactone|mesh-list
1966242|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1966243|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
1966244|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1966245|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966246|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1966247|NCT00879060|Diuretics|diuretics|mesh-ancestor
1966248|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
1966249|NCT00879190|Gentamicins|gentamicins|mesh-list
1966250|NCT00879190|Ampicillin|ampicillin|mesh-list
1966251|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1966252|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966253|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1966254|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966255|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966256|NCT00879229|Ambrisentan|ambrisentan|mesh-list
1966257|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1966258|NCT00879333|Everolimus|everolimus|mesh-list
1966259|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966260|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1966261|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
1966262|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966263|NCT00879359|Paclitaxel|paclitaxel|mesh-list
1966264|NCT00879359|Bevacizumab|bevacizumab|mesh-list
1966265|NCT00879359|Carboplatin|carboplatin|mesh-list
1966266|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1966267|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966268|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
1966269|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
1966270|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
1966271|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966272|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1966273|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1966274|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1966275|NCT00879359|Growth Substances|growth substances|mesh-ancestor
1966276|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966277|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
1966278|NCT00879398|Fesoterodine|fesoterodine|mesh-list
1966279|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1966280|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1966281|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
1966282|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966283|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966284|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966285|NCT00879398|Urological Agents|urological agents|mesh-ancestor
1966286|NCT00879411|Telmisartan|telmisartan|mesh-list
1966287|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1966288|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1966289|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1966290|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966291|NCT00879437|Bevacizumab|bevacizumab|mesh-list
1966292|NCT00879437|Valproic Acid|valproic acid|mesh-list
1966293|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1966294|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966295|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1966296|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1966297|NCT00879437|Growth Substances|growth substances|mesh-ancestor
1966298|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966299|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
1966300|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
1966301|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966302|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966303|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
1966304|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966305|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
1966306|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1966307|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1966308|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1966309|NCT00879658|Siponimod|siponimod|mesh-list
1966310|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1966311|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966312|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1966313|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
1966314|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966315|NCT00879710|Simvastatin|simvastatin|mesh-list
1966316|NCT00879710|Ezetimibe|ezetimibe|mesh-list
1966317|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1966318|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1966319|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
1966320|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966321|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1966322|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1966323|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966324|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
1966325|NCT00879775|Caffeine|caffeine|mesh-list
1966326|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1966327|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966328|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1966329|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966330|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966331|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1966332|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1966333|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
1966334|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966335|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
1966336|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966337|NCT00879814|Vaccines|vaccines|mesh-list
1966338|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
1966339|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966340|NCT00879879|Losartan|losartan|mesh-list
1966341|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1966342|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1966343|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1966344|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1966345|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966346|NCT00879970|Vitamin D|vitamin d|mesh-list
1966347|NCT00879970|Pioglitazone|pioglitazone|mesh-list
1966348|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
1966349|NCT00879970|Vitamins|vitamins|mesh-ancestor
1966350|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
1966351|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966352|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1966353|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1966354|NCT00879996|Buprenorphine|buprenorphine|mesh-list
1966355|NCT00879996|Methadone|methadone|mesh-list
1966356|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1966357|NCT00879996|Naloxone|naloxone|mesh-list
1966358|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1966359|NCT00879996|Narcotics|narcotics|mesh-ancestor
1966360|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1966361|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966362|NCT00879996|Analgesics|analgesics|mesh-ancestor
1966363|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
1966364|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966365|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1966366|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
1966367|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
1966368|NCT00880009|Letrozole|letrozole|mesh-list
1966369|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966370|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1966371|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1966372|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966373|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966374|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1966375|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
1966376|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1966377|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966378|NCT00880100|Pancrelipase|pancrelipase|mesh-list
1966379|NCT00880100|Pancreatin|pancreatin|mesh-list
1966380|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1966381|NCT00880191|Dexamethasone|dexamethasone|mesh-list
1966382|NCT00880191|Gabapentin|gabapentin|mesh-list
1966383|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1966384|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
1966385|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
1966386|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966387|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966388|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1966389|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
1966390|NCT00880191|Hormones|hormones|mesh-ancestor
1966391|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1966392|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1966393|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966394|NCT00880191|Analgesics|analgesics|mesh-ancestor
1966395|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
1966396|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
1966397|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1966398|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1966399|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1966400|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1966401|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1966402|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1966403|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966404|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966405|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
1966406|NCT00880269|Panobinostat|panobinostat|mesh-list
1966407|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966408|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1966409|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966410|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966411|NCT00880334|Docetaxel|docetaxel|mesh-list
1966412|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966413|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
1966414|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
1966415|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
1966416|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966417|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
1966418|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966419|NCT00880607|Morphine|morphine|mesh-list
1966420|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1966421|NCT00880607|Narcotics|narcotics|mesh-ancestor
1966422|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1966423|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966424|NCT00880607|Analgesics|analgesics|mesh-ancestor
1966425|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
1966426|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966427|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1966428|NCT00880620|Carbidopa|carbidopa|mesh-list
1966429|NCT00880620|Levodopa|levodopa|mesh-list
1966430|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1966431|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
1966432|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966433|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1966434|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1966435|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
1966436|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
1966437|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966438|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966439|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1966440|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966441|NCT00880685|Memantine|memantine|mesh-list
1966442|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1966443|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1966444|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
1966445|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966446|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966447|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966448|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1966449|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1966450|NCT00880763|Interferons|interferons|mesh-list
1966451|NCT00880763|Ribavirin|ribavirin|mesh-list
1966452|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966453|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
1966454|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966455|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
1966456|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966457|NCT00880893|Vaccines|vaccines|mesh-list
1966458|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
1966459|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966460|NCT00880906|Fluticasone|fluticasone|mesh-list
1966461|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
1966462|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1966463|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1966464|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
1966465|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966466|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966467|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1966468|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
1966469|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
1966470|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1966471|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966472|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966473|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1966474|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
1966475|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1966476|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1966477|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1966478|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1966479|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966480|NCT00880997|Doxazosin|doxazosin|mesh-list
1966481|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1966482|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1966483|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1966484|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1966485|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
1966486|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966487|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966488|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966489|NCT00881504|Bevacizumab|bevacizumab|mesh-list
1966490|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1966491|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966492|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1966493|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1966494|NCT00881504|Growth Substances|growth substances|mesh-ancestor
1966495|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966496|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
1966497|NCT00881530|Metformin|metformin|mesh-list
1966498|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1966499|NCT00881530|Empagliflozin|empagliflozin|mesh-list
1966500|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1966501|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966502|NCT00881530|Incretins|incretins|mesh-ancestor
1966503|NCT00881530|Hormones|hormones|mesh-ancestor
1966504|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1966505|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1966506|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
1966507|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966508|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966509|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1966510|NCT00881569|Efatutazone|efatutazone|mesh-list
1966511|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966512|NCT00881621|Capecitabine|capecitabine|mesh-list
1966513|NCT00881621|Lapatinib|lapatinib|mesh-list
1966514|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1966515|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
1966516|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966517|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966518|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1966519|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966520|NCT00881751|Bevacizumab|bevacizumab|mesh-list
1966521|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1966522|NCT00881751|Sorafenib|sorafenib|mesh-list
1966523|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1966524|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966525|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1966526|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1966527|NCT00881751|Growth Substances|growth substances|mesh-ancestor
1966528|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966529|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
1966530|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1966531|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966532|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966533|NCT00881868|Clobetasol|clobetasol|mesh-list
1966534|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1966535|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
1966536|NCT00881868|Hormones|hormones|mesh-ancestor
1966537|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1966538|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966539|NCT00881894|Rotigotine|rotigotine|mesh-list
1966540|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
1966541|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
1966542|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966543|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966544|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966545|NCT00882102|Decitabine|decitabine|mesh-list
1966546|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
1966547|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1966548|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
1966549|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966550|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966551|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966552|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1966553|NCT00882115|Sulforaphane|sulforaphane|mesh-list
1966554|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1966555|NCT00882115|Protective Agents|protective agents|mesh-ancestor
1966556|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966557|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966558|NCT00882206|Cytarabine|cytarabine|mesh-list
1966559|NCT00882206|Prednisone|prednisone|mesh-list
1966560|NCT00882206|Doxorubicin|doxorubicin|mesh-list
1966561|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1966562|NCT00882206|Methotrexate|methotrexate|mesh-list
1966563|NCT00882206|Vincristine|vincristine|mesh-list
1966564|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
1966565|NCT00882206|Decitabine|decitabine|mesh-list
1966566|NCT00882206|Asparaginase|asparaginase|mesh-list
1966567|NCT00882206|Vorinostat|vorinostat|mesh-list
1966568|NCT00882206|Pegaspargase|pegaspargase|mesh-list
1966569|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1966570|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966571|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1966572|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1966573|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966574|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966575|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1966576|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
1966577|NCT00882206|Hormones|hormones|mesh-ancestor
1966578|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1966579|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966580|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1966581|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1966582|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
1966583|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1966584|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1966585|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
1966586|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
1966587|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1966588|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1966589|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
1966590|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1966591|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1966592|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
1966593|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966594|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1966595|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
1966596|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
1966597|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
1966598|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1966599|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1966600|NCT00882362|Aripiprazole|aripiprazole|mesh-list
1966601|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
1966602|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1966603|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1966604|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1966605|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1966606|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966607|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
1966608|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
1966609|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966610|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966611|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1966612|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1966613|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
1966614|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1966615|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1966616|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1966617|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1966618|NCT00882440|Losartan|losartan|mesh-list
1966619|NCT00882440|Enalapril|enalapril|mesh-list
1966620|NCT00882440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1966621|NCT00882440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1966622|NCT00882440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1966623|NCT00882440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1966624|NCT00882440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966625|NCT00882440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1966626|NCT00882440|Protease Inhibitors|protease inhibitors|mesh-ancestor
1966627|NCT00882440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966628|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
1966629|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1966630|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
1966631|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1966632|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1966633|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1966634|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1966635|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966636|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
1966637|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
1966638|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966639|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1966640|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1966641|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
1966642|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966643|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966644|NCT00882557|Daptomycin|daptomycin|mesh-list
1966645|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1966646|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966647|NCT00882583|Cisplatin|cisplatin|mesh-list
1966648|NCT00882583|Cetuximab|cetuximab|mesh-list
1966649|NCT00882583|Dasatinib|dasatinib|mesh-list
1966650|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966651|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1966652|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1966653|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966654|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966655|NCT00882687|Lifitegrast|lifitegrast|mesh-list
1966656|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1966657|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1966658|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
1966659|NCT00882713|Hematinics|hematinics|mesh-ancestor
1966660|NCT00882908|Ribavirin|ribavirin|mesh-list
1966661|NCT00882908|Simeprevir|simeprevir|mesh-list
1966662|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
1966663|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966664|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
1966665|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966666|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
1966667|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966668|NCT00883051|Lasmiditan|lasmiditan|mesh-list
1966669|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1966670|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
1966671|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966672|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966673|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966674|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
1966675|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1966676|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1966677|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966678|NCT00883103|Lidocaine|lidocaine|mesh-list
1966679|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
1966680|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
1966681|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1966682|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966683|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
1966684|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966685|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1966686|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1966687|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1966688|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1966689|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966690|NCT00883116|Paclitaxel|paclitaxel|mesh-list
1966691|NCT00883116|Doxorubicin|doxorubicin|mesh-list
1966692|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1966693|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1966694|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966695|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
1966696|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
1966697|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
1966698|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966699|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1966700|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1966701|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1966702|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966703|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
1966704|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
1966705|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1966706|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
1966707|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966708|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1966709|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1966710|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
1966711|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966712|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966713|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1966714|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1966715|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1966716|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
1966717|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1966718|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966719|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966720|NCT00883168|Fluticasone|fluticasone|mesh-list
1966721|NCT00883168|Xhance|xhance|mesh-list
1966722|NCT00883168|Azelastine|azelastine|mesh-list
1966723|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1966724|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1966725|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
1966726|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966727|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966728|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1966729|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
1966730|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
1966731|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1966732|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1966733|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966734|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966735|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1966736|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1966737|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
1966738|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
1966739|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966740|NCT00883233|Adapalene|adapalene|mesh-list
1966741|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1966742|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1966743|NCT00883233|Analgesics|analgesics|mesh-ancestor
1966744|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
1966745|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966746|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966747|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1966748|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1966749|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
1966750|NCT00883337|Interferons|interferons|mesh-list
1966751|NCT00883337|Interferon-beta|interferon-beta|mesh-list
1966752|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
1966753|NCT00883337|Teriflunomide|teriflunomide|mesh-list
1966754|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966755|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
1966756|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966757|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1966758|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1966759|NCT00883337|Analgesics|analgesics|mesh-ancestor
1966760|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
1966761|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966762|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966763|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1966764|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1966765|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1966766|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
1966767|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1966768|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
1966769|NCT00883415|Hematinics|hematinics|mesh-ancestor
1966770|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1966771|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
1966772|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
1966773|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1966774|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1966775|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1966776|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1966777|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966778|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966779|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966780|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
1966781|NCT00883558|Insulin|insulin|mesh-list
1966782|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1966783|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
1966784|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
1966785|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1966786|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966787|NCT00883675|Carboplatin|carboplatin|mesh-list
1966788|NCT00883675|Docetaxel|docetaxel|mesh-list
1966789|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966790|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
1966791|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
1966792|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
1966793|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966794|NCT00883688|Bevacizumab|bevacizumab|mesh-list
1966795|NCT00883688|Lapatinib|lapatinib|mesh-list
1966796|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1966797|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966798|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1966799|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1966800|NCT00883688|Growth Substances|growth substances|mesh-ancestor
1966801|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966802|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
1966803|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1966804|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966805|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966806|NCT00883740|Pregabalin|pregabalin|mesh-list
1966807|NCT00883740|Analgesics|analgesics|mesh-ancestor
1966808|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
1966809|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966810|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966811|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
1966812|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1966813|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1966814|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966815|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1966816|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1966817|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1966818|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1966819|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1966820|NCT00883779|Gemcitabine|gemcitabine|mesh-list
1966821|NCT00883779|Carboplatin|carboplatin|mesh-list
1966822|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1966823|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966824|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1966825|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
1966826|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966827|NCT00883779|Antiviral Agents|antiviral agents|mesh-ancestor
1966828|NCT00883779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966829|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966830|NCT00883779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1966831|NCT00883779|Immunologic Factors|immunologic factors|mesh-ancestor
1966832|NCT00883779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966833|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1966834|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
1966835|NCT00884039|Anecortave|anecortave|mesh-list
1966836|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1966837|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1966838|NCT00884039|Growth Substances|growth substances|mesh-ancestor
1966839|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966840|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
1966841|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966842|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1966843|NCT00884052|Levetiracetam|levetiracetam|mesh-list
1966844|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
1966845|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
1966846|NCT00884117|Oseltamivir|oseltamivir|mesh-list
1966847|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
1966848|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966849|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966850|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966851|NCT00884221|Menotropins|menotropins|mesh-list
1966852|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1966853|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
1966854|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1966855|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966856|NCT00884273|Goserelin|goserelin|mesh-list
1966857|NCT00884273|Bicalutamide|bicalutamide|mesh-list
1966858|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1966859|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966860|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
1966861|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
1966862|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1966863|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966864|NCT00884325|Levocetirizine|levocetirizine|mesh-list
1966865|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1966866|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1966867|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
1966868|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
1966869|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966870|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966871|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966872|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
1966873|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1966874|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1966875|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966876|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
1966877|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1966878|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
1966879|NCT00884390|Factor VIII|factor viii|mesh-list
1966880|NCT00884390|Coagulants|coagulants|mesh-ancestor
1966881|NCT00884585|Cyclosporine|cyclosporine|mesh-list
1966882|NCT00884585|Cyclosporins|cyclosporins|mesh-list
1966883|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966884|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966885|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1966886|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
1966887|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966888|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
1966889|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966890|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
1966891|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1966892|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1966893|NCT00884650|Analgesics|analgesics|mesh-list
1966894|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
1966895|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966896|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966897|NCT00884741|Bevacizumab|bevacizumab|mesh-list
1966898|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1966899|NCT00884741|Temozolomide|temozolomide|mesh-list
1966900|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
1966901|NCT00884741|Antibodies|antibodies|mesh-list
1966902|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
1966903|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1966904|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
1966905|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1966906|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1966907|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1966908|NCT00884741|Growth Substances|growth substances|mesh-ancestor
1966909|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966910|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
1966911|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
1966912|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1966913|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
1966914|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966915|NCT00884793|Ritonavir|ritonavir|mesh-list
1966916|NCT00884793|Lopinavir|lopinavir|mesh-list
1966917|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1966918|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
1966919|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
1966920|NCT00884793|Efavirenz|efavirenz|mesh-list
1966921|NCT00884793|Etravirine|etravirine|mesh-list
1966922|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1966923|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1966924|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
1966925|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966926|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966927|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1966928|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1966929|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
1966930|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1966931|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1966932|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1966933|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1966934|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1966935|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1966936|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1966937|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1966938|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1966939|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1966940|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1966941|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1966942|NCT00884832|Clonidine|clonidine|mesh-list
1966943|NCT00884832|Analgesics|analgesics|mesh-ancestor
1966944|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
1966945|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1966946|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966947|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1966948|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
1966949|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
1966950|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1966951|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1966952|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1966953|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
1966954|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1966955|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966956|NCT00884897|Oxytocin|oxytocin|mesh-list
1966957|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
1966958|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1966959|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966960|NCT00885079|Rebamipide|rebamipide|mesh-list
1966961|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1966962|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1966963|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1966964|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1966965|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
1966966|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966967|NCT00885079|Protective Agents|protective agents|mesh-ancestor
1966968|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966969|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966970|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1966971|NCT00885105|Vaccines|vaccines|mesh-list
1966972|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
1966973|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966974|NCT00885118|Empagliflozin|empagliflozin|mesh-list
1966975|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1966976|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1966977|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1966978|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966979|NCT00885170|Vitamin D|vitamin d|mesh-list
1966980|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
1966981|NCT00885170|Calcium|calcium|mesh-list
1966982|NCT00885170|Vitamins|vitamins|mesh-ancestor
1966983|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
1966984|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966985|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1966986|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1966987|NCT00885352|Metformin|metformin|mesh-list
1966988|NCT00885352|Pioglitazone|pioglitazone|mesh-list
1966989|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1966990|NCT00885352|Glipizide|glipizide|mesh-list
1966991|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1966992|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1966993|NCT00885352|Incretins|incretins|mesh-ancestor
1966994|NCT00885352|Hormones|hormones|mesh-ancestor
1966995|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1966996|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1966997|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
1966998|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1966999|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967000|NCT00885365|Tobramycin|tobramycin|mesh-list
1967001|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1967002|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1967003|NCT00885378|Metformin|metformin|mesh-list
1967004|NCT00885378|Saxagliptin|saxagliptin|mesh-list
1967005|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1967006|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967007|NCT00885378|Incretins|incretins|mesh-ancestor
1967008|NCT00885378|Hormones|hormones|mesh-ancestor
1967009|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1967010|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1967011|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
1967012|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967013|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967014|NCT00885482|Ritonavir|ritonavir|mesh-list
1967015|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1967016|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1967017|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1967018|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
1967019|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967020|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967021|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1967022|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1967023|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
1967024|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1967025|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1967026|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1967027|NCT00885534|Temozolomide|temozolomide|mesh-list
1967028|NCT00885534|Vinblastine|vinblastine|mesh-list
1967029|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967030|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1967031|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
1967032|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967033|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1967034|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
1967035|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
1967036|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
1967037|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1967038|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1967039|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967040|NCT00885638|Incretins|incretins|mesh-ancestor
1967041|NCT00885638|Hormones|hormones|mesh-ancestor
1967042|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1967043|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1967044|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
1967045|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967046|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967047|NCT00885703|Fluconazole|fluconazole|mesh-list
1967048|NCT00885703|Amphotericin B|amphotericin b|mesh-list
1967049|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
1967050|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
1967051|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
1967052|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
1967053|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1967054|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1967055|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1967056|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967057|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967058|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1967059|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
1967060|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1967061|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967062|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1967063|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1967064|NCT00885703|Amebicides|amebicides|mesh-ancestor
1967065|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1967066|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1967067|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1967068|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1967069|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1967070|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
1967071|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1967072|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1967073|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967074|NCT00885755|Capecitabine|capecitabine|mesh-list
1967075|NCT00885755|Trastuzumab|trastuzumab|mesh-list
1967076|NCT00885755|Taxane|taxane|mesh-list
1967077|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1967078|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
1967079|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967080|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967081|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1967082|NCT00886236|Gabapentin|gabapentin|mesh-list
1967083|NCT00886236|Analgesics|analgesics|mesh-ancestor
1967084|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
1967085|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967086|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967087|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
1967088|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1967089|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1967090|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1967091|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1967092|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1967093|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1967094|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967095|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967096|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
1967097|NCT00886262|Vasopressins|vasopressins|mesh-list
1967098|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
1967099|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
1967100|NCT00886262|Coagulants|coagulants|mesh-ancestor
1967101|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1967102|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1967103|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
1967104|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967105|NCT00886379|Vitamin D|vitamin d|mesh-list
1967106|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
1967107|NCT00886379|Vitamins|vitamins|mesh-list
1967108|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
1967109|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967110|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1967111|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1967112|NCT00886600|Losartan|losartan|mesh-list
1967113|NCT00886600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1967114|NCT00886600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1967115|NCT00886600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1967116|NCT00886600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1967117|NCT00886600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1967118|NCT00886600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967119|NCT00886600|Diuretics|diuretics|mesh-ancestor
1967120|NCT00886600|Natriuretic Agents|natriuretic agents|mesh-ancestor
1967121|NCT00886600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967122|NCT00886600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1967123|NCT00886600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1967124|NCT00886613|Vaccines|vaccines|mesh-list
1967125|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
1967126|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967127|NCT00886626|Exenatide|exenatide|mesh-list
1967128|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1967129|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967130|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1967131|NCT00886626|Incretins|incretins|mesh-ancestor
1967132|NCT00886626|Hormones|hormones|mesh-ancestor
1967133|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1967134|NCT00886691|Bevacizumab|bevacizumab|mesh-list
1967135|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1967136|NCT00886691|Everolimus|everolimus|mesh-list
1967137|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
1967138|NCT00886691|Antibodies|antibodies|mesh-list
1967139|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
1967140|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1967141|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
1967142|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967143|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1967144|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1967145|NCT00886691|Growth Substances|growth substances|mesh-ancestor
1967146|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967147|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
1967148|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
1967149|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1967150|NCT00886743|Oprelvekin|oprelvekin|mesh-list
1967151|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967152|NCT00886795|Abatacept|abatacept|mesh-list
1967153|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1967154|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967155|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967156|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1967157|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
1967158|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967159|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1967160|NCT00886834|Misoprostol|misoprostol|mesh-list
1967161|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1967162|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
1967163|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1967164|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967165|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1967166|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1967167|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
1967168|NCT00887068|Azacitidine|azacitidine|mesh-list
1967169|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1967170|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
1967171|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967172|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967173|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967174|NCT00887159|Cisplatin|cisplatin|mesh-list
1967175|NCT00887159|Etoposide|etoposide|mesh-list
1967176|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
1967177|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
1967178|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1967179|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967180|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1967181|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1967182|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1967183|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217895|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967184|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967185|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
1967186|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
1967187|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
1967188|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
1967189|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
1967190|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
1967191|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967192|NCT00887198|Prednisone|prednisone|mesh-list
1967193|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
1967194|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1967195|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
1967196|NCT00887198|Hormones|hormones|mesh-ancestor
1967197|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1967198|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967199|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1967200|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967201|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1967202|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967203|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967204|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
1967205|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1967206|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1967207|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1967208|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1967209|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1967210|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967211|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967212|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967213|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
1967214|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1967215|NCT00887250|Losartan|losartan|mesh-list
1967216|NCT00887250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1967217|NCT00887250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1967218|NCT00887250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1967219|NCT00887250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1967220|NCT00887250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967221|NCT00887354|Vitamin D|vitamin d|mesh-list
1967222|NCT00887354|Teriparatide|teriparatide|mesh-list
1967223|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
1967224|NCT00887354|Calcium|calcium|mesh-list
1967225|NCT00887354|Vitamins|vitamins|mesh-ancestor
1967226|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
1967227|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967228|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1967229|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1967230|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1967231|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1967232|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967233|NCT00887432|Vitamin D|vitamin d|mesh-list
1967234|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
1967235|NCT00887432|Vitamins|vitamins|mesh-ancestor
1967236|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
1967237|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967238|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1967239|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1967240|NCT00887458|Itraconazole|itraconazole|mesh-list
1967241|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
1967242|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
1967243|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1967244|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1967245|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1967246|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967247|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967248|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1967249|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
1967250|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1967251|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967252|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1967253|NCT00887484|Clindamycin|clindamycin|mesh-list
1967254|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
1967255|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
1967256|NCT00887484|Adapalene|adapalene|mesh-list
1967257|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1967258|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1967259|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1967260|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1967261|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967262|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967263|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
1967264|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1967265|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1967266|NCT00887484|Analgesics|analgesics|mesh-ancestor
1967267|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
1967268|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967269|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967270|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1967271|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1967272|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1967273|NCT00887510|Trandolapril|trandolapril|mesh-list
1967274|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1967275|NCT00887510|Diuretics|diuretics|mesh-ancestor
1967276|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
1967277|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967278|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1967279|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1967280|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967281|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1967282|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
1967283|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967284|NCT00887549|Pemetrexed|pemetrexed|mesh-list
1967285|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967286|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967287|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967288|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1967289|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1967290|NCT00887562|Ubiquinone|ubiquinone|mesh-list
1967291|NCT00887562|Idebenone|idebenone|mesh-list
1967292|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
1967293|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967294|NCT00887562|Protective Agents|protective agents|mesh-ancestor
1967295|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967296|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
1967297|NCT00887575|Paclitaxel|paclitaxel|mesh-list
1967298|NCT00887575|Carboplatin|carboplatin|mesh-list
1967299|NCT00887575|Sunitinib|sunitinib|mesh-list
1967300|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1967301|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967302|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
1967303|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
1967304|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
1967305|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967306|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1967307|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1967308|NCT00887575|Growth Substances|growth substances|mesh-ancestor
1967309|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967310|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
1967311|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1967312|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967313|NCT00887588|Valsartan|valsartan|mesh-list
1967314|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1967315|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1967316|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1967317|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1967318|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967319|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
1967320|NCT00887640|Promethazine|promethazine|mesh-list
1967321|NCT00887640|Sirolimus|sirolimus|mesh-list
1967322|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1967323|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1967324|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1967325|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967326|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
1967327|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1967328|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
1967329|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967330|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1967331|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1967332|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1967333|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
1967334|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
1967335|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
1967336|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967337|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
1967338|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
1967339|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1967340|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1967341|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
1967342|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
1967343|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967344|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967345|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1967346|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
1967347|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
1967348|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
1967349|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1967350|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1967351|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
1967352|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1967353|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1967354|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1967355|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967356|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967357|NCT00887679|Citalopram|citalopram|mesh-list
1967358|NCT00887679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1967359|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1967360|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1967361|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967362|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967363|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
1967364|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967365|NCT00887679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1967366|NCT00887679|Antidepressive Agents|antidepressive agents|mesh-ancestor
1967367|NCT00887679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1967368|NCT00887783|Vinorelbine|vinorelbine|mesh-list
1967369|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1967370|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967371|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
1967372|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
1967373|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
1967374|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967375|NCT00887809|Gemcitabine|gemcitabine|mesh-list
1967376|NCT00887809|Bevacizumab|bevacizumab|mesh-list
1967377|NCT00887809|Docetaxel|docetaxel|mesh-list
1967378|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1967379|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967380|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1967381|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1967382|NCT00887809|Growth Substances|growth substances|mesh-ancestor
1967383|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967384|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
1967385|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1967386|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
1967387|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967388|NCT00887809|Antiviral Agents|antiviral agents|mesh-ancestor
1967389|NCT00887809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1967390|NCT00887809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967391|NCT00887809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1967392|NCT00887809|Immunologic Factors|immunologic factors|mesh-ancestor
1967393|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
1967394|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
1967395|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
1967396|NCT00887822|Bevacizumab|bevacizumab|mesh-list
1967397|NCT00887822|Capecitabine|capecitabine|mesh-list
1967398|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1967399|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967400|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1967401|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1967402|NCT00887822|Growth Substances|growth substances|mesh-ancestor
1967403|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967404|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
1967405|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1967406|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
1967407|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967408|NCT00887965|Denosumab|denosumab|mesh-list
1967409|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1967410|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967411|NCT00887978|Treprostinil|treprostinil|mesh-list
1967412|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1967413|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1967414|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1967415|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967416|NCT00888238|Incretins|incretins|mesh-ancestor
1967417|NCT00888238|Hormones|hormones|mesh-ancestor
1967418|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1967419|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1967420|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
1967421|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967422|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967423|NCT00888329|Aprepitant|aprepitant|mesh-list
1967424|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
1967425|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
1967426|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967427|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967428|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1967429|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1967430|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967431|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967432|NCT00888355|Losartan|losartan|mesh-list
1967433|NCT00888355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1967434|NCT00888355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1967435|NCT00888355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1967436|NCT00888355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1967437|NCT00888355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967438|NCT00888381|Vaccines|vaccines|mesh-list
1967439|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
1967440|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967441|NCT00888459|Nicotine|nicotine|mesh-list
1967442|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1967443|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
1967444|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967445|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967446|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1967447|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1967448|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
1967449|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967450|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967451|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1967452|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967453|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1967454|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967455|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967456|NCT00888615|Paclitaxel|paclitaxel|mesh-list
1967457|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1967458|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1967459|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967460|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
1967461|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
1967462|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
1967463|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967464|NCT00888628|Etanercept|etanercept|mesh-list
1967465|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1967466|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1967467|NCT00888628|Analgesics|analgesics|mesh-ancestor
1967468|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
1967469|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967470|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967471|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1967472|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1967473|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1967474|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1967475|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
1967476|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
1967477|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1967478|NCT00888654|Protective Agents|protective agents|mesh-ancestor
1967479|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967480|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967481|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
1967482|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967483|NCT00888940|Ecallantide|ecallantide|mesh-list
1967484|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
1967485|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1967486|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1967487|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967488|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
1967489|NCT00888940|Coagulants|coagulants|mesh-ancestor
1967490|NCT00888940|Analgesics|analgesics|mesh-ancestor
1967491|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
1967492|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967493|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967494|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1967495|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1967496|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1967497|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1967498|NCT00888979|Nicotine|nicotine|mesh-list
1967499|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1967500|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
1967501|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967502|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967503|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1967504|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1967505|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
1967506|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967507|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967508|NCT00889187|Capecitabine|capecitabine|mesh-list
1967509|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1967510|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
1967511|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967512|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967513|NCT00889200|Eszopiclone|eszopiclone|mesh-list
1967514|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1967515|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1967516|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967517|NCT00889226|Atorvastatin|atorvastatin|mesh-list
1967518|NCT00889226|Pitavastatin|pitavastatin|mesh-list
1967519|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1967520|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1967521|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
1967522|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967523|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1967524|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1967525|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967526|NCT00889252|Ketotifen|ketotifen|mesh-list
1967527|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
1967528|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
1967529|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1967530|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
1967531|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
1967532|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967533|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967534|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967535|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1967536|NCT00889330|Alcaftadine|alcaftadine|mesh-list
1967537|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1967538|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
1967539|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
1967540|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967541|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967542|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967543|NCT00889603|Donepezil|donepezil|mesh-list
1967544|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1967545|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967546|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967547|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
1967548|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967549|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967550|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
1967551|NCT00889720|Varenicline|varenicline|mesh-list
1967552|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1967553|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1967554|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
1967555|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967556|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967557|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967558|NCT00889915|Methylphenidate|methylphenidate|mesh-list
1967559|NCT00889915|Amphetamine|amphetamine|mesh-list
1967560|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1967561|NCT00889915|Adderall|adderall|mesh-list
1967562|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1967563|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967564|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1967565|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1967566|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1967567|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967568|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
1967569|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967570|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
1967571|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
1967572|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967573|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
1967574|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1967575|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1967576|NCT00890084|Telmisartan|telmisartan|mesh-list
1967577|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
1967578|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1967579|NCT00890084|Diuretics|diuretics|mesh-ancestor
1967580|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
1967581|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967582|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1967583|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1967584|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967585|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1967586|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1967587|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1967588|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1967589|NCT00890162|Omalizumab|omalizumab|mesh-list
1967590|NCT00890162|Epinephrine|epinephrine|mesh-list
1967591|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1967592|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1967593|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
1967594|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967595|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967596|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967597|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1967598|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1967599|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
1967600|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967601|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1967602|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
1967603|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
1967604|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
1967605|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1967606|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1967607|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
1967608|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967609|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
1967610|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967611|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967612|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1967613|NCT00890552|Dexamethasone|dexamethasone|mesh-list
1967614|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
1967615|NCT00890552|Lenalidomide|lenalidomide|mesh-list
1967616|NCT00890552|Melphalan|melphalan|mesh-list
1967617|NCT00890552|BB 1101|bb 1101|mesh-list
1967618|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1967619|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
1967620|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
1967621|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967622|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967623|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1967624|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
1967625|NCT00890552|Hormones|hormones|mesh-ancestor
1967626|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1967627|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1967628|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967629|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
1967630|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967631|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967632|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
1967633|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1967634|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1967635|NCT00890552|Growth Substances|growth substances|mesh-ancestor
1967636|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
1967637|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1967638|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
1967639|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1967640|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1967641|NCT00890591|Amlodipine|amlodipine|mesh-list
1967642|NCT00890591|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1967643|NCT00890591|Olmesartan|olmesartan|mesh-list
1967644|NCT00890591|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1967645|NCT00890591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1967646|NCT00890591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1967647|NCT00890591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1967648|NCT00890591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967649|NCT00890591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1967650|NCT00890591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967651|NCT00890591|Vasodilator Agents|vasodilator agents|mesh-ancestor
1967652|NCT00890591|Diuretics|diuretics|mesh-ancestor
1967653|NCT00890591|Natriuretic Agents|natriuretic agents|mesh-ancestor
1967654|NCT00890591|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1967655|NCT00890591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1967656|NCT00890591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1967657|NCT00890617|Prednisone|prednisone|mesh-list
1967658|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1967659|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
1967660|NCT00890617|Hormones|hormones|mesh-ancestor
1967661|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1967662|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967663|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1967664|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967665|NCT00890656|Dexamethasone|dexamethasone|mesh-list
1967666|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
1967667|NCT00890656|Doxorubicin|doxorubicin|mesh-list
1967668|NCT00890656|Methotrexate|methotrexate|mesh-list
1967669|NCT00890656|Vincristine|vincristine|mesh-list
1967670|NCT00890656|Asparaginase|asparaginase|mesh-list
1967671|NCT00890656|Pegaspargase|pegaspargase|mesh-list
1967672|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1967673|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
1967674|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967675|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1967676|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1967677|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
1967678|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967679|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967680|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1967681|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1967682|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
1967683|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
1967684|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967685|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1967686|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
1967687|NCT00890656|Hormones|hormones|mesh-ancestor
1967688|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1967689|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1967690|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967691|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1967692|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1967693|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1967694|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1967695|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
1967696|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1967697|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1967698|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
1967699|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
1967700|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1967701|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1967702|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1967703|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
1967704|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
1967705|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
1967706|NCT00890825|Docetaxel|docetaxel|mesh-list
1967707|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967708|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
1967709|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
1967710|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
1967711|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967712|NCT00890929|Lenalidomide|lenalidomide|mesh-list
1967713|NCT00890929|Azacitidine|azacitidine|mesh-list
1967714|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
1967715|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967716|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1967717|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1967718|NCT00890929|Growth Substances|growth substances|mesh-ancestor
1967719|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
1967720|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967721|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1967722|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
1967723|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967724|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967725|NCT00890981|Denosumab|denosumab|mesh-list
1967726|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1967727|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967728|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1967729|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
1967730|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967731|NCT00891202|Eliglustat|eliglustat|mesh-list
1967732|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967733|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967734|NCT00891228|ST 1435|st 1435|mesh-list
1967735|NCT00891228|Testosterone|testosterone|mesh-list
1967736|NCT00891228|Androgens|androgens|mesh-ancestor
1967737|NCT00891228|Hormones|hormones|mesh-ancestor
1967738|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1967739|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967740|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1967741|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
1967742|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1967743|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1967744|NCT00891293|Fenofibrate|fenofibrate|mesh-list
1967745|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1967746|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
1967747|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967748|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1967749|NCT00891371|Lanreotide|lanreotide|mesh-list
1967750|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967751|NCT00891436|Fluticasone|fluticasone|mesh-list
1967752|NCT00891436|Xhance|xhance|mesh-list
1967753|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1967754|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1967755|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
1967756|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967757|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967758|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1967759|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
1967760|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
1967761|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1967762|NCT00891462|Bromides|bromides|mesh-list
1967763|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
1967764|NCT00891527|Bevacizumab|bevacizumab|mesh-list
1967765|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
1967766|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1967767|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967768|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1967769|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1967770|NCT00891527|Growth Substances|growth substances|mesh-ancestor
1967771|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967772|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
1967773|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1967774|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967775|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967776|NCT00891735|Ranibizumab|ranibizumab|mesh-list
1967777|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1967778|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1967779|NCT00891735|Growth Substances|growth substances|mesh-ancestor
1967780|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967781|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
1967782|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967783|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
1967784|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1967785|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967786|NCT00891813|Vitamins|vitamins|mesh-ancestor
1967787|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
1967788|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1967789|NCT00891839|Rituximab|rituximab|mesh-list
1967790|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1967791|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1967792|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967793|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
1967794|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967795|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1967796|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1967797|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
1967798|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967799|NCT00891878|Capecitabine|capecitabine|mesh-list
1967800|NCT00891878|Sunitinib|sunitinib|mesh-list
1967801|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1967802|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
1967803|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967804|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967805|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1967806|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1967807|NCT00891878|Growth Substances|growth substances|mesh-ancestor
1967808|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967809|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
1967810|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1967811|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967812|NCT00891930|Irinotecan|irinotecan|mesh-list
1967813|NCT00891930|Panitumumab|panitumumab|mesh-list
1967814|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1967815|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1967816|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967817|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967818|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967819|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1967820|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
1967821|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
1967822|NCT00891995|Insulin|insulin|mesh-list
1967823|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1967824|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967825|NCT00892008|Pregabalin|pregabalin|mesh-list
1967826|NCT00892008|Analgesics|analgesics|mesh-ancestor
1967827|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
1967828|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967829|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967830|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
1967831|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1967832|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1967833|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967834|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1967835|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1967836|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1967837|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1967838|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1967839|NCT00892047|Aripiprazole|aripiprazole|mesh-list
1967840|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1967841|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
1967842|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1967843|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1967844|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1967845|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1967846|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967847|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
1967848|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
1967849|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967850|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967851|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1967852|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1967853|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
1967854|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1967855|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1967856|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1967857|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1967858|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1967859|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1967860|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1967861|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1967862|NCT00892099|Vitamin D|vitamin d|mesh-list
1967863|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
1967864|NCT00892099|Vitamins|vitamins|mesh-list
1967865|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
1967866|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967867|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1967868|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1967869|NCT00892177|Bevacizumab|bevacizumab|mesh-list
1967870|NCT00892177|Dasatinib|dasatinib|mesh-list
1967871|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1967872|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967873|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1967874|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1967875|NCT00892177|Growth Substances|growth substances|mesh-ancestor
1967876|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967877|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
1967878|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1967879|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967880|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967881|NCT00892281|Doxycycline|doxycycline|mesh-list
1967882|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1967883|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1967884|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
1967885|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1967886|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1967887|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1967888|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1967889|NCT00892437|Cobicistat|cobicistat|mesh-list
1967890|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1967891|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1967892|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967893|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967894|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
1967895|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1967896|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1967897|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1967898|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1967899|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1967900|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
1967901|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1967902|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1967903|NCT00892606|Morphine|morphine|mesh-list
1967904|NCT00892606|Methadone|methadone|mesh-list
1967905|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1967906|NCT00892606|Narcotics|narcotics|mesh-ancestor
1967907|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1967908|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967909|NCT00892606|Analgesics|analgesics|mesh-ancestor
1967910|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
1967911|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967912|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
1967913|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
1967914|NCT00892697|Ribavirin|ribavirin|mesh-list
1967915|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1967916|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
1967917|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967918|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
1967919|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1967920|NCT00892710|Bevacizumab|bevacizumab|mesh-list
1967921|NCT00892710|Carboplatin|carboplatin|mesh-list
1967922|NCT00892710|Pemetrexed|pemetrexed|mesh-list
1967923|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1967924|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967925|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1967926|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1967927|NCT00892710|Growth Substances|growth substances|mesh-ancestor
1967928|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967929|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
1967930|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967931|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967932|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1967933|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1967934|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
1967935|NCT00892957|Thrombin|thrombin|mesh-list
1967936|NCT00892957|Aprotinin|aprotinin|mesh-list
1967937|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
1967938|NCT00892957|Coagulants|coagulants|mesh-ancestor
1967939|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1967940|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1967941|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
1967942|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967943|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967944|NCT00893074|Dronabinol|dronabinol|mesh-list
1967945|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
1967946|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967947|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1967948|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1967949|NCT00893074|Analgesics|analgesics|mesh-ancestor
1967950|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
1967951|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967952|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1967953|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1967954|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967955|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967956|NCT00893074|Hormones|hormones|mesh-ancestor
1967957|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1967958|NCT00893113|Alfuzosin|alfuzosin|mesh-list
1967959|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1967960|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1967961|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1967962|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
1967963|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967964|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967965|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967966|NCT00893113|Urological Agents|urological agents|mesh-ancestor
1967967|NCT00893464|Ixazomib|ixazomib|mesh-list
1967968|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1967969|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
1967970|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967971|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967972|NCT00893737|Naproxen|naproxen|mesh-list
1967973|NCT00893737|Sumatriptan|sumatriptan|mesh-list
1967974|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1967975|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1967976|NCT00893737|Analgesics|analgesics|mesh-ancestor
1967977|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
1967978|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1967979|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1967980|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1967981|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1967982|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
1967983|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1967984|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1967985|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1967986|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1967987|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1967988|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1967989|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
1967990|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1967998|NCT00893984|Nebivolol|nebivolol|mesh-list
1967999|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1968000|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
1968001|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1968002|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1968003|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1968004|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
1968005|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968006|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968007|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968008|NCT00893997|Vaccines|vaccines|mesh-list
1968009|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
1968010|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968011|NCT00894166|Bupropion|bupropion|mesh-list
1968012|NCT00894166|Nicotine|nicotine|mesh-list
1968013|NCT00894166|Varenicline|varenicline|mesh-list
1968014|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1968015|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
1968016|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968017|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968018|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1968019|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1968020|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
1968021|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968022|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968023|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1968024|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
1968025|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1968026|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1968027|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1968028|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968029|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
1968030|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1968031|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1968032|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968033|NCT00894322|Exenatide|exenatide|mesh-list
1968034|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1968035|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968036|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1968037|NCT00894322|Incretins|incretins|mesh-ancestor
1968038|NCT00894322|Hormones|hormones|mesh-ancestor
1968039|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1968040|NCT00894413|Tadalafil|tadalafil|mesh-list
1968041|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
1968042|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1968043|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1968044|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968045|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968046|NCT00894413|Urological Agents|urological agents|mesh-ancestor
1968047|NCT00894465|Midazolam|midazolam|mesh-list
1968048|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1968049|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1968050|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1968051|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968052|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1968053|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1968054|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1968055|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1968056|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
1968057|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
1968058|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
1968059|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
1968060|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968061|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968062|NCT00894504|Gemcitabine|gemcitabine|mesh-list
1968063|NCT00894504|Carboplatin|carboplatin|mesh-list
1968064|NCT00894504|Panitumumab|panitumumab|mesh-list
1968065|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968066|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1968067|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
1968068|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968069|NCT00894504|Antiviral Agents|antiviral agents|mesh-ancestor
1968070|NCT00894504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1968071|NCT00894504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968072|NCT00894504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1968073|NCT00894504|Immunologic Factors|immunologic factors|mesh-ancestor
1968074|NCT00894504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968075|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1968076|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
1968077|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1968078|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1968079|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1968080|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968081|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968082|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
1968083|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968084|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968085|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1968086|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968087|NCT00894543|Citalopram|citalopram|mesh-list
1968088|NCT00894543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1968089|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1968090|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968091|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968092|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968093|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
1968094|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968095|NCT00894543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1968096|NCT00894543|Antidepressive Agents|antidepressive agents|mesh-ancestor
1968097|NCT00894543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1968098|NCT00894556|Sumatriptan|sumatriptan|mesh-list
1968099|NCT00894556|Rizatriptan|rizatriptan|mesh-list
1968100|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1968101|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1968102|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1968103|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
1968104|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968105|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968106|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968107|NCT00894647|Imiquimod|imiquimod|mesh-list
1968108|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1968109|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
1968110|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968111|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968112|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
1968113|NCT00894699|Sufentanil|sufentanil|mesh-list
1968114|NCT00894699|Triazolam|triazolam|mesh-list
1968115|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1968116|NCT00894699|Narcotics|narcotics|mesh-ancestor
1968117|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1968118|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968119|NCT00894699|Analgesics|analgesics|mesh-ancestor
1968120|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
1968121|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968122|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1968123|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1968124|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
1968125|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
1968126|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1968127|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1968128|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1968129|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
1968130|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
1968131|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968132|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968133|NCT00894803|Eptifibatide|eptifibatide|mesh-list
1968134|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1968135|NCT00895037|Factor VIII|factor viii|mesh-list
1968136|NCT00895037|Coagulants|coagulants|mesh-ancestor
1968137|NCT00895180|Ramucirumab|ramucirumab|mesh-list
1968138|NCT00895180|Olaratumab|olaratumab|mesh-list
1968139|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968140|NCT00895193|Aspirin|aspirin|mesh-list
1968141|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1968142|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1968143|NCT00895193|Analgesics|analgesics|mesh-ancestor
1968144|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
1968145|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968146|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968147|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1968148|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1968149|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1968150|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1968151|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968152|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1968153|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1968154|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968155|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
1968156|NCT00895232|Iron|iron|mesh-list
1968157|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
1968158|NCT00895232|Trace Elements|trace elements|mesh-ancestor
1968159|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
1968160|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968161|NCT00895232|Hematinics|hematinics|mesh-ancestor
1968162|NCT00895245|Dexamethasone|dexamethasone|mesh-list
1968163|NCT00895245|Palonosetron|palonosetron|mesh-list
1968164|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
1968165|NCT00895245|Aprepitant|aprepitant|mesh-list
1968166|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968167|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1968168|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
1968169|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
1968170|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968171|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968172|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1968173|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
1968174|NCT00895245|Hormones|hormones|mesh-ancestor
1968175|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1968176|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1968177|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1968178|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1968179|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
1968180|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968181|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968182|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1968183|NCT00895310|Ketoconazole|ketoconazole|mesh-list
1968184|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
1968185|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1968186|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
1968187|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1968188|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1968189|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1968190|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968191|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968192|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1968193|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
1968194|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1968195|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968196|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1968197|NCT00895414|Doxorubicin|doxorubicin|mesh-list
1968198|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1968199|NCT00895414|Enalapril|enalapril|mesh-list
1968200|NCT00895414|Enalaprilat|enalaprilat|mesh-list
1968201|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1968202|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968203|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1968204|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1968205|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968206|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968207|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1968208|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
1968209|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1968210|NCT00895453|Iron|iron|mesh-list
1968211|NCT00895453|Itraconazole|itraconazole|mesh-list
1968212|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
1968213|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1968214|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1968215|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1968216|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968217|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968218|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1968219|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
1968220|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1968221|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968222|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1968223|NCT00895453|Trace Elements|trace elements|mesh-ancestor
1968224|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
1968225|NCT00895531|Morphine|morphine|mesh-list
1968226|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1968227|NCT00895531|Narcotics|narcotics|mesh-ancestor
1968228|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1968229|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968230|NCT00895531|Analgesics|analgesics|mesh-ancestor
1968231|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
1968232|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968233|NCT00895583|Sirolimus|sirolimus|mesh-list
1968234|NCT00895583|Tacrolimus|tacrolimus|mesh-list
1968235|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1968236|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
1968237|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968238|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1968239|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968240|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968241|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1968242|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1968243|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1968244|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968245|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
1968246|NCT00895661|Rituximab|rituximab|mesh-list
1968247|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1968248|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968249|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
1968250|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968251|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1968252|NCT00895752|Riluzole|riluzole|mesh-list
1968253|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
1968254|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1968255|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1968256|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968257|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968258|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968259|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1968260|NCT00895752|Protective Agents|protective agents|mesh-ancestor
1968261|NCT00895817|Fluticasone|fluticasone|mesh-list
1968262|NCT00895817|Esomeprazole|esomeprazole|mesh-list
1968263|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1968264|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1968265|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
1968266|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968267|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968268|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1968269|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
1968270|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
1968271|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1968272|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1968273|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1968274|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1968275|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968276|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968277|NCT00895843|Ibuprofen|ibuprofen|mesh-list
1968278|NCT00895843|Epinephrine|epinephrine|mesh-list
1968279|NCT00895843|Bupivacaine|bupivacaine|mesh-list
1968280|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
1968281|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
1968282|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1968283|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968284|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
1968285|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968286|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1968287|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1968288|NCT00895843|Analgesics|analgesics|mesh-ancestor
1968289|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1968290|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1968291|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1968292|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968293|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968294|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1968295|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1968296|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
1968297|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968298|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1968299|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1968300|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
1968301|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1968302|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
1968303|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
1968304|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
1968305|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1968306|NCT00895895|Donepezil|donepezil|mesh-list
1968307|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1968308|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968309|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968310|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
1968311|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968312|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968313|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
1968314|NCT00895921|Olanzapine|olanzapine|mesh-list
1968315|NCT00895921|Aripiprazole|aripiprazole|mesh-list
1968316|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
1968317|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
1968318|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968319|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968320|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1968321|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1968322|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1968323|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1968324|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1968325|NCT00895921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1968326|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1968327|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968328|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968329|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968330|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
1968331|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
1968332|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
1968333|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
1968334|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1968335|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1968336|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1968337|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1968338|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1968339|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1968340|NCT00895934|Azacitidine|azacitidine|mesh-list
1968341|NCT00895934|Vorinostat|vorinostat|mesh-list
1968342|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
1968343|NCT00895934|Calicheamicins|calicheamicins|mesh-list
1968344|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1968345|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
1968346|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968347|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968348|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968349|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1968350|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1968351|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1968352|NCT00895947|Interferons|interferons|mesh-list
1968353|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
1968354|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968355|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
1968356|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1968357|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
1968358|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968359|NCT00896012|Sirolimus|sirolimus|mesh-list
1968360|NCT00896012|Tacrolimus|tacrolimus|mesh-list
1968361|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1968362|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
1968363|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968364|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1968365|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968366|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968367|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1968368|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1968369|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1968370|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968371|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
1968372|NCT00896038|Aprepitant|aprepitant|mesh-list
1968373|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
1968374|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
1968375|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968376|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968377|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1968378|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1968379|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968380|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968381|NCT00896051|Ritonavir|ritonavir|mesh-list
1968382|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1968383|NCT00896051|Tenofovir|tenofovir|mesh-list
1968384|NCT00896051|Etravirine|etravirine|mesh-list
1968385|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
1968386|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1968387|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1968388|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
1968389|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968390|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968391|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1968392|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1968393|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
1968394|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1968395|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1968396|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1968397|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1968398|NCT00896064|Vaccines|vaccines|mesh-list
1968399|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1968400|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
1968401|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968402|NCT00896168|Methotrexate|methotrexate|mesh-list
1968403|NCT00896168|Infliximab|infliximab|mesh-list
1968404|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1968405|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
1968406|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1968407|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968408|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1968409|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
1968410|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968411|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968412|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
1968413|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968414|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1968415|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1968416|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
1968417|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1968418|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1968419|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1968420|NCT00896181|Carboplatin|carboplatin|mesh-list
1968421|NCT00896181|Docetaxel|docetaxel|mesh-list
1968422|NCT00896181|Fluorouracil|fluorouracil|mesh-list
1968423|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968424|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
1968425|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
1968426|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
1968427|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968428|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
1968429|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1968430|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1968431|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
1968432|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968433|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1968434|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1968435|NCT00896389|Diuretics|diuretics|mesh-ancestor
1968436|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
1968437|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968438|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1968439|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968440|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968441|NCT00896441|Citalopram|citalopram|mesh-list
1968442|NCT00896441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1968443|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1968444|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968445|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968446|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968447|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
1968448|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968449|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1968450|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
1968451|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1968452|NCT00896454|Denosumab|denosumab|mesh-list
1968453|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1968454|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968455|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
1968456|NCT00896532|Denosumab|denosumab|mesh-list
1968457|NCT00896532|Alendronate|alendronate|mesh-list
1968458|NCT00896532|Teriparatide|teriparatide|mesh-list
1968459|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1968460|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1968461|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968462|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1968463|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
1968464|NCT00896779|Ranibizumab|ranibizumab|mesh-list
1968465|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1968466|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1968467|NCT00896779|Growth Substances|growth substances|mesh-ancestor
1968468|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968469|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
1968470|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968471|NCT00897104|Sumatriptan|sumatriptan|mesh-list
1968472|NCT00897104|Rizatriptan|rizatriptan|mesh-list
1968473|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1968474|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1968475|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1968476|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
1968477|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968478|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968479|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968480|NCT00897390|Metformin|metformin|mesh-list
1968481|NCT00897390|Saxagliptin|saxagliptin|mesh-list
1968482|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1968483|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968484|NCT00897390|Incretins|incretins|mesh-ancestor
1968485|NCT00897390|Hormones|hormones|mesh-ancestor
1968486|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1968487|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1968488|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
1968489|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968490|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968491|NCT00897715|Rilonacept|rilonacept|mesh-list
1968492|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1968493|NCT00897949|Rizatriptan|rizatriptan|mesh-list
1968494|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1968495|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
1968496|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968497|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968498|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968499|NCT00898222|Aspirin|aspirin|mesh-list
1968500|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1968501|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1968502|NCT00898222|Analgesics|analgesics|mesh-ancestor
1968503|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
1968504|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968505|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968506|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1968507|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1968508|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1968509|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1968510|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968511|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1968512|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1968513|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968514|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
1968515|NCT00898443|Anesthetics|anesthetics|mesh-list
1968516|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1968517|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968518|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1968519|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
1968520|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1968521|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1968522|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968523|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968524|NCT00898677|Sumatriptan|sumatriptan|mesh-list
1968525|NCT00898677|Rizatriptan|rizatriptan|mesh-list
1968526|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1968527|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1968528|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1968529|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
1968530|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968531|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968532|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968533|NCT00898807|Citalopram|citalopram|mesh-list
1968534|NCT00898807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1968535|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1968536|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968537|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968538|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968539|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
1968540|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968541|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1968542|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
1968543|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1968544|NCT00899379|Rizatriptan|rizatriptan|mesh-list
1968545|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1968546|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
1968547|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968548|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968549|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968550|NCT00899431|Vidarabine|vidarabine|mesh-list
1968551|NCT00899431|Rituximab|rituximab|mesh-list
1968552|NCT00899431|Fludarabine|fludarabine|mesh-list
1968553|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
1968554|NCT00899431|Lenalidomide|lenalidomide|mesh-list
1968555|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1968556|NCT00899431|Allopurinol|allopurinol|mesh-list
1968557|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
1968558|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1968559|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1968560|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968561|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
1968562|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968563|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1968564|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1968565|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
1968566|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968567|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1968568|NCT00899431|Antiviral Agents|antiviral agents|mesh-ancestor
1968569|NCT00899431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1968570|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1968571|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1968572|NCT00899431|Growth Substances|growth substances|mesh-ancestor
1968573|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
1968574|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1968575|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
1968576|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968577|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
1968578|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1968579|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
1968580|NCT00899431|Protective Agents|protective agents|mesh-ancestor
1968581|NCT00899470|Metformin|metformin|mesh-list
1968582|NCT00899470|Saxagliptin|saxagliptin|mesh-list
1968583|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1968584|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968585|NCT00899470|Incretins|incretins|mesh-ancestor
1968586|NCT00899470|Hormones|hormones|mesh-ancestor
1968587|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1968588|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1968589|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
1968590|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968591|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968592|NCT00899574|Imiquimod|imiquimod|mesh-list
1968593|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1968594|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
1968595|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968596|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968597|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
1968598|NCT00899600|Ketamine|ketamine|mesh-list
1968599|NCT00899600|Analgesics|analgesics|mesh-ancestor
1968600|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
1968601|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968602|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968603|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1968604|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1968605|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
1968606|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
1968607|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1968608|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1968609|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1968610|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968611|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968612|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
1968613|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1968614|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
1968615|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968616|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1968617|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
1968618|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1968619|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
1968620|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
1968621|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
1968622|NCT00899847|Acetaminophen|acetaminophen|mesh-list
1968623|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
1968624|NCT00899847|Promethazine|promethazine|mesh-list
1968625|NCT00899847|Cyclosporine|cyclosporine|mesh-list
1968626|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
1968627|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
1968628|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1968629|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
1968630|NCT00899847|Melphalan|melphalan|mesh-list
1968631|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
1968632|NCT00899847|Cyclosporins|cyclosporins|mesh-list
1968633|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
1968634|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1968635|NCT00899847|Lenograstim|lenograstim|mesh-list
1968636|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1968637|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
1968638|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968639|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1968640|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1968641|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
1968642|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968643|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968644|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1968645|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1968646|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968647|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
1968648|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1968649|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
1968650|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1968651|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1968652|NCT00899847|Analgesics|analgesics|mesh-ancestor
1968653|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
1968654|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968655|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
1968656|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1968657|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1968658|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
1968659|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1968660|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1968661|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1968662|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1968663|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1968664|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
1968665|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
1968666|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
1968667|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
1968668|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1968669|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1968670|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
1968671|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
1968672|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968673|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1968674|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
1968675|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
1968676|NCT00899847|Hormones|hormones|mesh-ancestor
1968677|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1968678|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1968679|NCT00899847|Protective Agents|protective agents|mesh-ancestor
1968680|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1968681|NCT00900146|Metformin|metformin|mesh-list
1968682|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1968683|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968684|NCT00900159|Eszopiclone|eszopiclone|mesh-list
1968685|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1968686|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1968687|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968688|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1968689|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
1968690|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
1968691|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1968692|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1968693|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968694|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968695|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1968696|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1968697|NCT00900627|Paclitaxel|paclitaxel|mesh-list
1968698|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1968699|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968700|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
1968701|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
1968702|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
1968703|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968704|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
1968705|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1968706|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1968707|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1968708|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968709|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968710|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
1968711|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968712|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968713|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1968714|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968715|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
1968716|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1968717|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
1968718|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968719|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968720|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1968721|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
1968722|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
1968723|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1968724|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
1968725|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968726|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968727|NCT00900757|Palonosetron|palonosetron|mesh-list
1968728|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
1968729|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
1968730|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968731|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968732|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1968733|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1968734|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1968735|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
1968736|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968737|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968738|NCT00901186|Ranibizumab|ranibizumab|mesh-list
1968739|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1968740|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1968741|NCT00901186|Growth Substances|growth substances|mesh-ancestor
1968742|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968743|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
1968744|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968745|NCT00901199|Deferasirox|deferasirox|mesh-list
1968746|NCT00901199|Deferoxamine|deferoxamine|mesh-list
1968747|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1968748|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
1968749|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
1968750|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968751|NCT00901199|Siderophores|siderophores|mesh-ancestor
1968752|NCT00901225|Plerixafor|plerixafor|mesh-list
1968753|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1968754|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1968755|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
1968756|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1968757|NCT00901394|Folic Acid|folic acid|mesh-list
1968758|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
1968759|NCT00901394|Hematinics|hematinics|mesh-ancestor
1968760|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
1968761|NCT00901394|Vitamins|vitamins|mesh-ancestor
1968762|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
1968763|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968764|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1968765|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
1968766|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
1968767|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1968768|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1968769|NCT00901394|Analgesics|analgesics|mesh-ancestor
1968770|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
1968771|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968772|NCT00901576|Methylphenidate|methylphenidate|mesh-list
1968773|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1968774|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968775|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1968776|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1968777|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968778|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968779|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
1968780|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968781|NCT00901628|Cefuroxime|cefuroxime|mesh-list
1968782|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
1968783|NCT00901628|Ketorolac|ketorolac|mesh-list
1968784|NCT00901628|Epinephrine|epinephrine|mesh-list
1968785|NCT00901628|Morphine|morphine|mesh-list
1968786|NCT00901628|Ropivacaine|ropivacaine|mesh-list
1968787|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1968788|NCT00901628|Narcotics|narcotics|mesh-ancestor
1968789|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1968790|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968791|NCT00901628|Analgesics|analgesics|mesh-ancestor
1968792|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
1968793|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968794|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
1968795|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
1968796|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1968797|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1968798|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
1968799|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968800|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968801|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1968802|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1968803|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
1968804|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1968805|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
1968806|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
1968807|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
1968808|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1968809|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1968810|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1968811|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1968812|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1968813|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1968814|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968815|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1968816|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1968817|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1968818|NCT00901901|Sorafenib|sorafenib|mesh-list
1968819|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968820|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1968821|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968822|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968823|NCT00901927|Rituximab|rituximab|mesh-list
1968824|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1968825|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
1968826|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1968827|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968828|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
1968829|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968830|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1968831|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1968832|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
1968833|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968834|NCT00901927|Analgesics|analgesics|mesh-ancestor
1968835|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
1968836|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1968837|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1968838|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1968839|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968840|NCT00902161|Propranolol|propranolol|mesh-list
1968841|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1968842|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1968843|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
1968844|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968845|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968846|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968847|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1968848|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1968849|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
1968850|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
1968851|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968852|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1968853|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968854|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968855|NCT00902226|Citalopram|citalopram|mesh-list
1968856|NCT00902226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1968857|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1968858|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968859|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968860|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968861|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
1968862|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968863|NCT00902226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1968864|NCT00902226|Antidepressive Agents|antidepressive agents|mesh-ancestor
1968865|NCT00902226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1968866|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
1968867|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
1968868|NCT00902265|Coagulants|coagulants|mesh-ancestor
1968869|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1968870|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
1968871|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968872|NCT00902304|Amlodipine|amlodipine|mesh-list
1968873|NCT00902304|Valsartan|valsartan|mesh-list
1968874|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1968875|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
1968876|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1968877|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1968878|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968879|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968880|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1968881|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968882|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
1968883|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1968884|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1968885|NCT00902304|Diuretics|diuretics|mesh-ancestor
1968886|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
1968887|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1968888|NCT00902538|Amlodipine|amlodipine|mesh-list
1968889|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1968890|NCT00902538|Olmesartan|olmesartan|mesh-list
1968891|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1968892|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1968893|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1968894|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968895|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968896|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1968897|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968898|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
1968899|NCT00902538|Diuretics|diuretics|mesh-ancestor
1968900|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
1968901|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1968902|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1968903|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1968904|NCT00902564|Citalopram|citalopram|mesh-list
1968905|NCT00902564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1968906|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1968907|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1968908|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968909|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1968910|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
1968911|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968912|NCT00902564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1968913|NCT00902564|Antidepressive Agents|antidepressive agents|mesh-ancestor
1968914|NCT00902564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1968915|NCT00902577|Misonidazole|misonidazole|mesh-list
1968916|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968917|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1968918|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1968919|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1968920|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
1968921|NCT00903162|Letrozole|letrozole|mesh-list
1968922|NCT00903162|Leuprolide|leuprolide|mesh-list
1968923|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968924|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1968925|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1968926|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968927|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968928|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1968929|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
1968930|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1968931|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968932|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1968933|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1968934|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
1968935|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1968936|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1968937|NCT00903175|Everolimus|everolimus|mesh-list
1968938|NCT00903175|Sunitinib|sunitinib|mesh-list
1968939|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1968940|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1968941|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
1968942|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968943|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1968944|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1968945|NCT00903175|Growth Substances|growth substances|mesh-ancestor
1968946|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
1968947|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1968948|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968949|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968950|NCT00903331|Macitentan|macitentan|mesh-list
1968951|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
1968952|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1968953|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968954|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
1968955|NCT00903344|Vitamin D|vitamin d|mesh-list
1968956|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
1968957|NCT00903344|Vitamins|vitamins|mesh-ancestor
1968958|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
1968959|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968960|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1968961|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1968962|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
1968963|NCT00903357|Montelukast|montelukast|mesh-list
1968964|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1968965|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
1968966|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1968967|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
1968968|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1968969|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1968970|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1968971|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1968972|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968973|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
1968974|NCT00903357|Protective Agents|protective agents|mesh-ancestor
1968975|NCT00903357|Vitamins|vitamins|mesh-ancestor
1968976|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
1968977|NCT00903409|Simvastatin|simvastatin|mesh-list
1968978|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1968979|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1968980|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
1968981|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968982|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1968983|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1968984|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968985|NCT00903448|Omeprazole|omeprazole|mesh-list
1968986|NCT00903448|Lansoprazole|lansoprazole|mesh-list
1968987|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1968988|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1968989|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1968990|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1968991|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968992|NCT00903617|Niacin|niacin|mesh-list
1968993|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
1968994|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1968995|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
1968996|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1968997|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1968998|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
1968999|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
1969000|NCT00903617|Vitamins|vitamins|mesh-ancestor
1969001|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
1969002|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969003|NCT00903630|Doxorubicin|doxorubicin|mesh-list
1969004|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1969005|NCT00903630|Lenalidomide|lenalidomide|mesh-list
1969006|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1969007|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969008|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1969009|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1969010|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969011|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969012|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
1969013|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969014|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1969015|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1969016|NCT00903630|Growth Substances|growth substances|mesh-ancestor
1969017|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
1969018|NCT00903682|Efavirenz|efavirenz|mesh-list
1969019|NCT00903682|Etravirine|etravirine|mesh-list
1969020|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1969021|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1969022|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969023|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969024|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
1969025|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969026|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1969027|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1969028|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1969029|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1969030|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1969031|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1969032|NCT00903760|Decitabine|decitabine|mesh-list
1969033|NCT00903760|Clofarabine|clofarabine|mesh-list
1969034|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1969035|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
1969036|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969037|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969038|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969039|NCT00903968|Plerixafor|plerixafor|mesh-list
1969040|NCT00903968|Dexamethasone|dexamethasone|mesh-list
1969041|NCT00903968|Bortezomib|bortezomib|mesh-list
1969042|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1969043|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
1969044|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
1969045|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969046|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969047|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1969048|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
1969049|NCT00903968|Hormones|hormones|mesh-ancestor
1969050|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1969051|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1969052|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969053|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1969054|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1969055|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
1969056|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969057|NCT00904033|Calcitriol|calcitriol|mesh-list
1969058|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1969059|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969060|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1969061|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969062|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969063|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1969064|NCT00904033|Vitamins|vitamins|mesh-ancestor
1969065|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
1969066|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1969067|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1969068|NCT00904215|Telmisartan|telmisartan|mesh-list
1969069|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1969070|NCT00904215|Diuretics|diuretics|mesh-ancestor
1969071|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
1969072|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969073|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1969074|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969075|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969076|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1969077|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1969078|NCT00904345|Cetuximab|cetuximab|mesh-list
1969079|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1969080|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969081|NCT00904488|Metolazone|metolazone|mesh-list
1969082|NCT00904488|Furosemide|furosemide|mesh-list
1969083|NCT00904488|Diuretics|diuretics|mesh-ancestor
1969084|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
1969085|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969086|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1969087|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969088|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969089|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1969090|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1969091|NCT00904618|Lidocaine|lidocaine|mesh-list
1969092|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
1969093|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
1969094|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1969095|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969096|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
1969097|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969098|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1969099|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1969100|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1969101|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969102|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969103|NCT00904670|Methylphenidate|methylphenidate|mesh-list
1969104|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1969105|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969106|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1969107|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1969108|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969109|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969110|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
1969111|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1969112|NCT00904722|Rituximab|rituximab|mesh-list
1969113|NCT00904722|Pidilizumab|pidilizumab|mesh-list
1969114|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1969115|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969116|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
1969117|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969118|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1969119|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
1969120|NCT00904748|Citric Acid|citric acid|mesh-list
1969121|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
1969122|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
1969123|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1969124|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
1969125|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
1969126|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969127|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
1969128|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1969129|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1969130|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969131|NCT00904748|Urological Agents|urological agents|mesh-ancestor
1969132|NCT00904826|Eculizumab|eculizumab|mesh-list
1969133|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1969134|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1969135|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
1969136|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969137|NCT00904839|Bevacizumab|bevacizumab|mesh-list
1969138|NCT00904839|Nintedanib|nintedanib|mesh-list
1969139|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1969140|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969141|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1969142|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1969143|NCT00904839|Growth Substances|growth substances|mesh-ancestor
1969144|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969145|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
1969146|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1969147|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969148|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969149|NCT00904943|Topiramate|topiramate|mesh-list
1969150|NCT00904943|Anticonvulsants|anticonvulsants|mesh-ancestor
1969151|NCT00904943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1969152|NCT00904943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969153|NCT00904995|Voriconazole|voriconazole|mesh-list
1969154|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
1969155|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969156|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1969157|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1969158|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969159|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969160|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1969161|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
1969162|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1969163|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969164|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1969165|NCT00905021|Sunitinib|sunitinib|mesh-list
1969166|NCT00905021|Exemestane|exemestane|mesh-list
1969167|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969168|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1969169|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1969170|NCT00905021|Growth Substances|growth substances|mesh-ancestor
1969171|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969172|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
1969173|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1969174|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969175|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969176|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1969177|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1969178|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1969179|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
1969180|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1969181|NCT00905034|Dexamethasone|dexamethasone|mesh-list
1969182|NCT00905034|Rituximab|rituximab|mesh-list
1969183|NCT00905034|Methotrexate|methotrexate|mesh-list
1969184|NCT00905034|Vincristine|vincristine|mesh-list
1969185|NCT00905034|Asparaginase|asparaginase|mesh-list
1969186|NCT00905034|Pegaspargase|pegaspargase|mesh-list
1969187|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1969188|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
1969189|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
1969190|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969191|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969192|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1969193|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
1969194|NCT00905034|Hormones|hormones|mesh-ancestor
1969195|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1969196|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1969197|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969198|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1969199|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
1969200|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1969201|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1969202|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
1969203|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1969204|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1969205|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
1969206|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969207|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
1969208|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969209|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1969210|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1969211|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1969212|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1969213|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
1969214|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
1969215|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
1969216|NCT00905060|Temozolomide|temozolomide|mesh-list
1969217|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1969218|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
1969219|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969220|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969221|NCT00905164|Topiramate|topiramate|mesh-list
1969222|NCT00905164|Anticonvulsants|anticonvulsants|mesh-ancestor
1969223|NCT00905164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1969224|NCT00905164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969225|NCT00905255|Lixisenatide|lixisenatide|mesh-list
1969226|NCT00905255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1969227|NCT00905255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969228|NCT00905268|Idebenone|idebenone|mesh-list
1969229|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
1969230|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969231|NCT00905268|Protective Agents|protective agents|mesh-ancestor
1969232|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969233|NCT00905307|Aripiprazole|aripiprazole|mesh-list
1969234|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
1969235|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1969236|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1969237|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1969238|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1969239|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969240|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
1969241|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
1969242|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1969243|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969244|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1969245|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1969246|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
1969247|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1969248|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1969249|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1969250|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1969251|NCT00905346|Topiramate|topiramate|mesh-list
1969252|NCT00905346|Anticonvulsants|anticonvulsants|mesh-ancestor
1969253|NCT00905346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1969254|NCT00905346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969255|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1969256|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
1969257|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1969258|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1969259|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969260|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1969261|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1969262|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969263|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969264|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
1969265|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1969266|NCT00905437|Pregabalin|pregabalin|mesh-list
1969267|NCT00905437|Analgesics|analgesics|mesh-ancestor
1969268|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
1969269|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969270|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969271|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
1969272|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1969273|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969274|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969275|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1969276|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1969277|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1969278|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1969279|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1969280|NCT00905489|Nevirapine|nevirapine|mesh-list
1969281|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1969282|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1969283|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969284|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969285|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
1969286|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969287|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1969288|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1969289|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1969290|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1969291|NCT00905515|Cyclosporine|cyclosporine|mesh-list
1969292|NCT00905515|Tacrolimus|tacrolimus|mesh-list
1969293|NCT00905515|Cyclosporins|cyclosporins|mesh-list
1969294|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1969295|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
1969296|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969297|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1969298|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969299|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969300|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
1969301|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969302|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
1969303|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1969304|NCT00905567|Topiramate|topiramate|mesh-list
1969305|NCT00905567|Anticonvulsants|anticonvulsants|mesh-ancestor
1969306|NCT00905567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1969307|NCT00905567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969308|NCT00905580|Pregabalin|pregabalin|mesh-list
1969309|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969310|NCT00905580|Analgesics|analgesics|mesh-ancestor
1969311|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
1969312|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969313|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
1969314|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1969315|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969316|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969317|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1969318|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1969319|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1969320|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1969321|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1969322|NCT00905606|Topiramate|topiramate|mesh-list
1969323|NCT00905606|Anticonvulsants|anticonvulsants|mesh-ancestor
1969324|NCT00905606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1969325|NCT00905606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969326|NCT00906087|Timolol|timolol|mesh-list
1969327|NCT00906087|Dorzolamide|dorzolamide|mesh-list
1969328|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1969329|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1969330|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1969331|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
1969332|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1969333|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969334|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969335|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1969336|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1969337|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1969338|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969339|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1969340|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
1969341|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1969342|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
1969343|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969344|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1969345|NCT00906282|Carboplatin|carboplatin|mesh-list
1969346|NCT00906282|Pemetrexed|pemetrexed|mesh-list
1969347|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969348|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969349|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969350|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1969351|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1969352|NCT00906347|Misoprostol|misoprostol|mesh-list
1969353|NCT00906347|Oxytocin|oxytocin|mesh-list
1969354|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
1969355|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1969356|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969357|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1969358|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
1969359|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1969360|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1969361|NCT00906373|Sorafenib|sorafenib|mesh-list
1969362|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1969363|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969364|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1969365|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969366|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969367|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
1969368|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969369|NCT00906399|Interferons|interferons|mesh-list
1969370|NCT00906399|Interferon-beta|interferon-beta|mesh-list
1969371|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
1969372|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969373|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
1969374|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969375|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
1969376|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969377|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1969378|NCT00906503|Dexamethasone|dexamethasone|mesh-list
1969379|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1969380|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1969381|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
1969382|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
1969383|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969384|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969385|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1969386|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
1969387|NCT00906503|Hormones|hormones|mesh-ancestor
1969388|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1969389|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1969390|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969391|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1969392|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969393|NCT00906698|Vinorelbine|vinorelbine|mesh-list
1969394|NCT00906698|Afatinib|afatinib|mesh-list
1969395|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1969396|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969397|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
1969398|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
1969399|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
1969400|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969401|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1969402|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969403|NCT00906945|Cytarabine|cytarabine|mesh-list
1969404|NCT00906945|Plerixafor|plerixafor|mesh-list
1969405|NCT00906945|Etoposide|etoposide|mesh-list
1969406|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
1969407|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1969408|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969409|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1969410|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1969411|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969412|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969413|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
1969414|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969415|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1969416|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
1969417|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
1969418|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969419|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1969420|NCT00906945|Analgesics|analgesics|mesh-ancestor
1969421|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
1969422|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969423|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1969424|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1969425|NCT00907101|Adapalene|adapalene|mesh-list
1969426|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
1969427|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1969428|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
1969429|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1969430|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1969431|NCT00907101|Analgesics|analgesics|mesh-ancestor
1969432|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
1969433|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969434|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969435|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1969436|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1969437|NCT00907153|Vitamin D|vitamin d|mesh-list
1969438|NCT00907153|Vitamins|vitamins|mesh-ancestor
1969439|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
1969440|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969441|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1969442|NCT00907257|Tretinoin|tretinoin|mesh-list
1969443|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1969444|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
1969445|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969446|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
1969447|NCT00907335|Tretinoin|tretinoin|mesh-list
1969448|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1969449|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969450|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
1969451|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
1969452|NCT00907374|Benazepril|benazepril|mesh-list
1969453|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1969454|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
1969455|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969456|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969457|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1969458|NCT00907426|Bimatoprost|bimatoprost|mesh-list
1969459|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1969460|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1969461|NCT00907517|Cytarabine|cytarabine|mesh-list
1969462|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1969463|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
1969464|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969465|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969466|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
1969467|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969468|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1969469|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
1969470|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969471|NCT00907738|Vorinostat|vorinostat|mesh-list
1969472|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969473|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1969474|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969475|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969476|NCT00907777|Vaccines|vaccines|mesh-list
1969477|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1969478|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
1969479|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969480|NCT00907907|Mycophenolic Acid|mycophenolic acid|mesh-list
1969481|NCT00907907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1969482|NCT00907907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969483|NCT00907907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1969484|NCT00907907|Antitubercular Agents|antitubercular agents|mesh-ancestor
1969485|NCT00907907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1969486|NCT00907907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969487|NCT00907907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969488|NCT00907907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969489|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1969490|NCT00908011|Ezetimibe|ezetimibe|mesh-list
1969491|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1969492|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1969493|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
1969494|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969495|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1969496|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1969497|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969498|NCT00908076|Lubiprostone|lubiprostone|mesh-list
1969499|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1969500|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969501|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969502|NCT00908128|Mycophenolic Acid|mycophenolic acid|mesh-list
1969503|NCT00908128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1969504|NCT00908128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969505|NCT00908128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1969506|NCT00908128|Antitubercular Agents|antitubercular agents|mesh-ancestor
1969507|NCT00908128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1969508|NCT00908128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969509|NCT00908128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969510|NCT00908128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969511|NCT00908141|Sargramostim|sargramostim|mesh-list
1969512|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
1969513|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969514|NCT00908232|Dexamethasone|dexamethasone|mesh-list
1969515|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
1969516|NCT00908232|Lenalidomide|lenalidomide|mesh-list
1969517|NCT00908232|Bortezomib|bortezomib|mesh-list
1969518|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1969519|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
1969520|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969521|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1969522|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1969523|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
1969524|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969525|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969526|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1969527|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1969528|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
1969529|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
1969530|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969531|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1969532|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
1969533|NCT00908232|Hormones|hormones|mesh-ancestor
1969534|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1969535|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1969536|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1969537|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1969538|NCT00908232|Growth Substances|growth substances|mesh-ancestor
1969539|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
1969540|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
1969541|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
1969542|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1969543|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1969544|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969545|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969546|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1969547|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1969548|NCT00908375|Pregabalin|pregabalin|mesh-list
1969549|NCT00908375|Analgesics|analgesics|mesh-ancestor
1969550|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
1969551|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969552|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969553|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
1969554|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1969555|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969556|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969557|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1969558|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1969559|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1969560|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1969561|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1969562|NCT00908466|Sirolimus|sirolimus|mesh-list
1969563|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1969564|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969565|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1969566|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969567|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
1969568|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1969569|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
1969570|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969571|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
1969572|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1969573|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1969574|NCT00908583|Prednisolone|prednisolone|mesh-list
1969575|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
1969576|NCT00908583|Rituximab|rituximab|mesh-list
1969577|NCT00908583|Bortezomib|bortezomib|mesh-list
1969578|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1969579|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
1969580|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1969581|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969582|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
1969583|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969584|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1969585|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1969586|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
1969587|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
1969588|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969589|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1969590|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
1969591|NCT00908583|Hormones|hormones|mesh-ancestor
1969592|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1969593|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1969594|NCT00908583|Protective Agents|protective agents|mesh-ancestor
1969595|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1969596|NCT00908960|Enoxaparin|enoxaparin|mesh-list
1969597|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
1969598|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1969599|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1969600|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969601|NCT00909064|PENTA|penta|mesh-list
1969602|NCT00909064|Fondaparinux|fondaparinux|mesh-list
1969603|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1969604|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
1969605|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1969606|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
1969607|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969608|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969609|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
1969610|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1969611|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1969612|NCT00909155|Fluoxetine|fluoxetine|mesh-list
1969613|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1969614|NCT00909155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1969615|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1969616|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969617|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969618|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1969619|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
1969620|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969621|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1969622|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
1969623|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1969624|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1969625|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1969626|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969627|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1969628|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
1969629|NCT00909181|Oxybutynin|oxybutynin|mesh-list
1969630|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
1969631|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
1969632|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969633|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969634|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1969635|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1969636|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
1969637|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1969638|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969639|NCT00909181|Urological Agents|urological agents|mesh-ancestor
1969640|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1969641|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969642|NCT00909181|Renal Agents|renal agents|mesh-ancestor
1969643|NCT00909389|Simvastatin|simvastatin|mesh-list
1969644|NCT00909389|Ezetimibe|ezetimibe|mesh-list
1969645|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
1969646|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1969647|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1969648|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
1969649|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969650|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1969651|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1969652|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969653|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
1969654|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1969655|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1969656|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
1969657|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1969658|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969659|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969660|NCT00909428|Urological Agents|urological agents|mesh-ancestor
1969661|NCT00909480|Insulin|insulin|mesh-list
1969662|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1969663|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
1969664|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
1969665|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1969666|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969667|NCT00909532|Ivacaftor|ivacaftor|mesh-list
1969668|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1969669|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969670|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969671|NCT00909545|Isradipine|isradipine|mesh-list
1969672|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1969673|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1969674|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969675|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969676|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1969677|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969678|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
1969679|NCT00909610|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1969680|NCT00909610|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1969681|NCT00909610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1969682|NCT00909649|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
1969683|NCT00909649|Hemostatics|hemostatics|mesh-ancestor
1969684|NCT00909649|Coagulants|coagulants|mesh-ancestor
1969685|NCT00909727|Ivacaftor|ivacaftor|mesh-list
1969686|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1969687|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969688|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969689|NCT00909753|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1969690|NCT00909753|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1969691|NCT00909753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1969692|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
1969693|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1969694|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
1969695|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969696|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969697|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1969698|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
1969699|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1969700|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1969701|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1969702|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
1969703|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1969704|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969705|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1969706|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
1969707|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1969708|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
1969709|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1969710|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969711|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1969712|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1969713|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969714|NCT00909857|Dienogest|dienogest|mesh-list
1969715|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1969716|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1969717|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
1969718|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1969719|NCT00909857|Estradiol|estradiol|mesh-list
1969720|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1969721|NCT00909857|Estrogens|estrogens|mesh-ancestor
1969722|NCT00909857|Hormones|hormones|mesh-ancestor
1969723|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1969724|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969725|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1969726|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
1969727|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1969728|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1969729|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1969730|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1969731|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1969732|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1969733|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
1969734|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1969735|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969736|NCT00910000|Gemcitabine|gemcitabine|mesh-list
1969737|NCT00910000|Carboplatin|carboplatin|mesh-list
1969738|NCT00910000|Vorinostat|vorinostat|mesh-list
1969739|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969740|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1969741|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
1969742|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969743|NCT00910000|Antiviral Agents|antiviral agents|mesh-ancestor
1969744|NCT00910000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969745|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969746|NCT00910000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1969747|NCT00910000|Immunologic Factors|immunologic factors|mesh-ancestor
1969748|NCT00910000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969749|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1969750|NCT00910039|Sunitinib|sunitinib|mesh-list
1969751|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969752|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1969753|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1969754|NCT00910039|Growth Substances|growth substances|mesh-ancestor
1969755|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969756|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
1969757|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1969758|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969759|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969760|NCT00910091|Megestrol|megestrol|mesh-list
1969761|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
1969762|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1969763|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1969764|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1969765|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
1969766|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1969767|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969768|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1969769|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1969770|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1969771|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969772|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
1969773|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1969774|NCT00910208|Morphine|morphine|mesh-list
1969775|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1969776|NCT00910208|Narcotics|narcotics|mesh-ancestor
1969777|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1969778|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969779|NCT00910208|Analgesics|analgesics|mesh-ancestor
1969780|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
1969781|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969782|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1969783|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
1969784|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1969785|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1969786|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969787|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969788|NCT00910273|Etanercept|etanercept|mesh-list
1969789|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1969790|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1969791|NCT00910273|Analgesics|analgesics|mesh-ancestor
1969792|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
1969793|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969794|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969795|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1969796|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1969797|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1969798|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1969799|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
1969800|NCT00910299|Clopidogrel|clopidogrel|mesh-list
1969801|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1969802|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1969803|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1969804|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1969805|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1969806|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
1969807|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1969808|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969809|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969810|NCT00910429|Riociguat|riociguat|mesh-list
1969811|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
1969812|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969813|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
1969814|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1969815|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1969816|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1969817|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969818|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969819|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
1969820|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1969821|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969822|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1969823|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969824|NCT00910624|Ribavirin|ribavirin|mesh-list
1969825|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1969826|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
1969827|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969828|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
1969829|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2745642|NCT02757872|Vitamin D|vitamin d|mesh-list
1969842|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
1969843|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1969844|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969845|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1969846|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
1969847|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1969848|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969849|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969850|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969851|NCT00910689|Propranolol|propranolol|mesh-list
1969852|NCT00910689|Nadolol|nadolol|mesh-list
1969853|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1969854|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1969855|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
1969856|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1969857|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969858|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969859|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1969860|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1969861|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
1969862|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
1969863|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
1969864|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969865|NCT00910715|Doxycycline|doxycycline|mesh-list
1969866|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1969867|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969868|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
1969869|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1969870|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1969871|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
1969872|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1969873|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1969874|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1969875|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969876|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969877|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
1969878|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1969879|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969880|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1969881|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969882|NCT00910858|Lenalidomide|lenalidomide|mesh-list
1969883|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
1969884|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
1969885|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969886|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1969887|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1969888|NCT00910858|Growth Substances|growth substances|mesh-ancestor
1969889|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
1969890|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969891|NCT00910858|Hematinics|hematinics|mesh-ancestor
1969892|NCT00910871|Bedaquiline|bedaquiline|mesh-list
1969893|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
1969894|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1969895|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969896|NCT00910910|Lenalidomide|lenalidomide|mesh-list
1969897|NCT00910910|Chlorambucil|chlorambucil|mesh-list
1969898|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
1969899|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969900|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1969901|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1969902|NCT00910910|Growth Substances|growth substances|mesh-ancestor
1969903|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
1969904|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969905|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1969906|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
1969907|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969908|NCT00910988|Olanzapine|olanzapine|mesh-list
1969909|NCT00910988|Ziprasidone|ziprasidone|mesh-list
1969910|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
1969911|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
1969912|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1969913|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969914|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1969915|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1969916|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1969917|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1969918|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1969919|NCT00910988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1969920|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1969921|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1969922|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969923|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1969924|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
1969925|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1969926|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1969927|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
1969928|NCT00911144|Vaccines|vaccines|mesh-list
1969929|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1969930|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
1969931|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969932|NCT00911157|Heparin|heparin|mesh-list
1969933|NCT00911157|Calcium heparin|calcium heparin|mesh-list
1969934|NCT00911157|PENTA|penta|mesh-list
1969935|NCT00911157|Fondaparinux|fondaparinux|mesh-list
1969936|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
1969937|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1969938|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2745643|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
1969939|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969940|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1969941|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
1969942|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1969943|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
1969944|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969945|NCT00911170|Bevacizumab|bevacizumab|mesh-list
1969946|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1969947|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969948|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1969949|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1969950|NCT00911170|Growth Substances|growth substances|mesh-ancestor
1969951|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969952|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
1969953|NCT00911274|Mycophenolic Acid|mycophenolic acid|mesh-list
1969954|NCT00911274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1969955|NCT00911274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969956|NCT00911274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1969957|NCT00911274|Antitubercular Agents|antitubercular agents|mesh-ancestor
1969958|NCT00911274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1969959|NCT00911274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969960|NCT00911274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969961|NCT00911274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969962|NCT00911300|Vitamin K|vitamin k|mesh-list
1969963|NCT00911300|Heparin|heparin|mesh-list
1969964|NCT00911300|Calcium heparin|calcium heparin|mesh-list
1969965|NCT00911300|PENTA|penta|mesh-list
1969966|NCT00911300|Fondaparinux|fondaparinux|mesh-list
1969967|NCT00911300|Vitamins|vitamins|mesh-ancestor
1969968|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
1969969|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1969970|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
1969971|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1969972|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1969973|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969974|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1969975|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
1969976|NCT00911300|Coagulants|coagulants|mesh-ancestor
1969977|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1969978|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
1969979|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1969980|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
1969981|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1969982|NCT00911326|Dextrans|dextrans|mesh-list
1969983|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
1969984|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
1969985|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
1969986|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
1969987|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
1969988|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
1969989|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1969990|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1969991|NCT00911443|Interferons|interferons|mesh-list
1969992|NCT00911443|Interferon-alpha|interferon-alpha|mesh-list
1969993|NCT00911443|Interferon alpha-2|interferon alpha-2|mesh-list
1969994|NCT00911443|Dacarbazine|dacarbazine|mesh-list
1969995|NCT00911443|Thymalfasin|thymalfasin|mesh-list
1969996|NCT00911443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1969997|NCT00911443|Antiviral Agents|antiviral agents|mesh-ancestor
1969998|NCT00911443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1969999|NCT00911443|Immunologic Factors|immunologic factors|mesh-ancestor
1970000|NCT00911443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970001|NCT00911443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1970002|NCT00911443|Alkylating Agents|alkylating agents|mesh-ancestor
1970003|NCT00911443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970004|NCT00911443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1970005|NCT00911534|Rabeprazole|rabeprazole|mesh-list
1970006|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1970007|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1970008|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1970009|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970010|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970011|NCT00911547|Beclomethasone|beclomethasone|mesh-list
1970012|NCT00911547|Montelukast|montelukast|mesh-list
1970013|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1970014|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
1970015|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1970016|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
1970017|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1970018|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970019|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1970020|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1970021|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970022|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1970023|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
1970024|NCT00911547|Hormones|hormones|mesh-ancestor
1970025|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
1970026|NCT00911586|Testosterone|testosterone|mesh-list
1970027|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
1970028|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
1970029|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1970030|NCT00911586|Androgens|androgens|mesh-ancestor
1970031|NCT00911586|Hormones|hormones|mesh-ancestor
1970032|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1970033|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970034|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1970035|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970036|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
1970037|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1970038|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1970039|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1970040|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
1970041|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970042|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1970043|NCT00911625|Insulin|insulin|mesh-list
1970044|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1970045|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
1970046|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
1970047|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1970048|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970049|NCT00911742|Tramadol|tramadol|mesh-list
1970050|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1970051|NCT00911742|Narcotics|narcotics|mesh-ancestor
1970052|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1970053|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970054|NCT00911742|Analgesics|analgesics|mesh-ancestor
1970055|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
1970056|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970057|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
1970058|NCT00911807|Donepezil|donepezil|mesh-list
1970059|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1970060|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970061|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970062|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
1970063|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970064|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970065|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
1970066|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1970067|NCT00911807|Protective Agents|protective agents|mesh-ancestor
1970068|NCT00911820|Bevacizumab|bevacizumab|mesh-list
1970069|NCT00911820|Cisplatin|cisplatin|mesh-list
1970070|NCT00911820|Docetaxel|docetaxel|mesh-list
1970071|NCT00911820|Irinotecan|irinotecan|mesh-list
1970072|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1970073|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970074|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1970075|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1970076|NCT00911820|Growth Substances|growth substances|mesh-ancestor
1970077|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970078|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
1970079|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
1970080|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
1970081|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
1970082|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970083|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1970084|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1970085|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970086|NCT00911859|Prednisone|prednisone|mesh-list
1970087|NCT00911859|Bortezomib|bortezomib|mesh-list
1970088|NCT00911859|Melphalan|melphalan|mesh-list
1970089|NCT00911859|Siltuximab|siltuximab|mesh-list
1970090|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1970091|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1970092|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
1970093|NCT00911859|Hormones|hormones|mesh-ancestor
1970094|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1970095|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970096|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1970097|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970098|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1970099|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
1970100|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970101|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1970102|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970103|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
1970104|NCT00911937|Fesoterodine|fesoterodine|mesh-list
1970105|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1970106|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1970107|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
1970108|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970109|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970110|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970111|NCT00911937|Urological Agents|urological agents|mesh-ancestor
1970112|NCT00912015|Tramadol|tramadol|mesh-list
1970113|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1970114|NCT00912015|Narcotics|narcotics|mesh-ancestor
1970115|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1970116|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970117|NCT00912015|Analgesics|analgesics|mesh-ancestor
1970118|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
1970119|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970120|NCT00912093|Icatibant|icatibant|mesh-list
1970121|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1970122|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1970123|NCT00912093|Analgesics|analgesics|mesh-ancestor
1970124|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
1970125|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970126|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970127|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1970128|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1970129|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
1970130|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
1970131|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970132|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1970133|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970134|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
1970135|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
1970136|NCT00912301|Cathartics|cathartics|mesh-ancestor
1970137|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1970138|NCT00912340|Trastuzumab|trastuzumab|mesh-list
1970139|NCT00912340|Everolimus|everolimus|mesh-list
1970140|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1970141|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970142|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970143|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
1970144|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970145|NCT00912509|Riboflavin|riboflavin|mesh-list
1970146|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
1970147|NCT00912509|Vitamins|vitamins|mesh-ancestor
1970148|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
1970149|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970150|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1970151|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
1970152|NCT00912743|Olaparib|olaparib|mesh-list
1970153|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1970154|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970155|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970156|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970157|NCT00912782|Vitamin D|vitamin d|mesh-list
1970158|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
1970159|NCT00912782|Vitamins|vitamins|mesh-ancestor
1970160|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
1970161|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970162|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1970163|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1970164|NCT00912808|Donepezil|donepezil|mesh-list
1970165|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1970166|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970167|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970168|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
1970169|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970170|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970171|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
1970172|NCT00912873|Ropivacaine|ropivacaine|mesh-list
1970173|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
1970174|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
1970175|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1970176|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970177|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
1970178|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970179|NCT00912912|Sunitinib|sunitinib|mesh-list
1970180|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970181|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1970182|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1970183|NCT00912912|Growth Substances|growth substances|mesh-ancestor
1970184|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970185|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
1970186|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1970187|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970188|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970189|NCT00912964|Mirabegron|mirabegron|mesh-list
1970190|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
1970191|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1970192|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1970193|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
1970194|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970195|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970196|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970197|NCT00912964|Urological Agents|urological agents|mesh-ancestor
1970198|NCT00912990|Cisatracurium|cisatracurium|mesh-list
1970199|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1970200|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1970201|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970202|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970203|NCT00913003|Lidocaine|lidocaine|mesh-list
1970204|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
1970205|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
1970206|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1970207|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970208|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
1970209|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970210|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1970211|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1970212|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1970213|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1970214|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970215|NCT00913068|Lidocaine|lidocaine|mesh-list
1970216|NCT00913068|Ropivacaine|ropivacaine|mesh-list
1970217|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
1970218|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
1970219|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1970220|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970221|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
1970222|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970223|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1970224|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1970225|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1970226|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1970227|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970228|NCT00913081|Quercetin|quercetin|mesh-list
1970229|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
1970230|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970231|NCT00913081|Protective Agents|protective agents|mesh-ancestor
1970232|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970233|NCT00913133|Desirudin|desirudin|mesh-list
1970234|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
1970235|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1970236|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1970237|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970238|NCT00913263|Flutamide|flutamide|mesh-list
1970239|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
1970240|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
1970241|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
1970242|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1970243|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970244|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1970245|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970246|NCT00913458|Etanercept|etanercept|mesh-list
1970247|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1970248|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1970249|NCT00913458|Analgesics|analgesics|mesh-ancestor
1970250|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
1970251|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970252|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970253|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1970254|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1970255|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1970256|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970257|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
1970258|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
1970259|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
1970260|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970261|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970262|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970263|NCT00913627|Ibuprofen|ibuprofen|mesh-list
1970264|NCT00913627|Naproxen|naproxen|mesh-list
1970265|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1970266|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1970267|NCT00913627|Analgesics|analgesics|mesh-ancestor
1970268|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
1970269|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970270|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970271|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1970272|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1970273|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1970274|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970275|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970276|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
1970277|NCT00913770|Buprenorphine|buprenorphine|mesh-list
1970278|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1970279|NCT00913770|Narcotics|narcotics|mesh-ancestor
1970280|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1970281|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970282|NCT00913770|Analgesics|analgesics|mesh-ancestor
1970283|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
1970284|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970285|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1970286|NCT00913835|Doxorubicin|doxorubicin|mesh-list
1970287|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1970288|NCT00913835|Olaratumab|olaratumab|mesh-list
1970289|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1970290|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970291|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1970292|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1970293|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970294|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970295|NCT00913913|Bevacizumab|bevacizumab|mesh-list
1970296|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1970297|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970298|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1970299|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1970300|NCT00913913|Growth Substances|growth substances|mesh-ancestor
1970301|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970302|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
1970303|NCT00914316|Ranolazine|ranolazine|mesh-list
1970304|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1970305|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1970306|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970307|NCT00914459|Factor VIII|factor viii|mesh-list
1970308|NCT00914459|Coagulants|coagulants|mesh-ancestor
1970309|NCT00914732|Vaccines|vaccines|mesh-list
1970310|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
1970311|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970312|NCT00914810|Vitamin D|vitamin d|mesh-list
1970313|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
1970314|NCT00914810|Vitamins|vitamins|mesh-ancestor
1970315|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
1970316|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970317|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1970318|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1970319|NCT00914849|Plerixafor|plerixafor|mesh-list
1970320|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1970321|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1970322|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
1970323|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970324|NCT00914940|Fludarabine|fludarabine|mesh-list
1970325|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
1970326|NCT00914940|Thiotepa|thiotepa|mesh-list
1970327|NCT00914940|Tacrolimus|tacrolimus|mesh-list
1970328|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970329|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1970330|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
1970331|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970332|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970333|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
1970334|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970335|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1970336|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970337|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1970338|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
1970339|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1970340|NCT00914966|Complement C1s|complement c1s|mesh-list
1970341|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1970342|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
1970343|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
1970344|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970345|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1970346|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970347|NCT00915005|Paclitaxel|paclitaxel|mesh-list
1970348|NCT00915005|Carboplatin|carboplatin|mesh-list
1970349|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1970350|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970351|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
1970352|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
1970353|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
1970354|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970355|NCT00915018|Paclitaxel|paclitaxel|mesh-list
1970356|NCT00915018|Trastuzumab|trastuzumab|mesh-list
1970357|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1970358|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1970359|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970360|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
1970361|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
1970362|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
1970363|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970364|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1970365|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
1970366|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1970367|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1970368|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1970369|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1970370|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
1970371|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1970372|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1970373|NCT00915473|Prednisolone|prednisolone|mesh-list
1970374|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
1970375|NCT00915473|Lidocaine|lidocaine|mesh-list
1970376|NCT00915473|Bupivacaine|bupivacaine|mesh-list
1970377|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1970378|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
1970379|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
1970380|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
1970381|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1970382|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970383|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
1970384|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970385|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1970386|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1970387|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1970388|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1970389|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970390|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1970391|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
1970392|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
1970393|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1970394|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
1970395|NCT00915473|Hormones|hormones|mesh-ancestor
1970396|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1970397|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1970398|NCT00915473|Protective Agents|protective agents|mesh-ancestor
1970399|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1970400|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970401|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
1970402|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1970403|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1970404|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1970405|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1970406|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970407|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
1970408|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970409|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970410|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1970411|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970412|NCT00915538|Budesonide|budesonide|mesh-list
1970413|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1970414|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1970415|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1970416|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
1970417|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970418|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970419|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1970420|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
1970421|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
1970422|NCT00915538|Hormones|hormones|mesh-ancestor
1970423|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1970424|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1970425|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1970426|NCT00915603|Paclitaxel|paclitaxel|mesh-list
1970427|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1970428|NCT00915603|Bevacizumab|bevacizumab|mesh-list
1970429|NCT00915603|Everolimus|everolimus|mesh-list
1970430|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1970431|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970432|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
1970433|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
1970434|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
1970435|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970436|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1970437|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1970438|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1970439|NCT00915603|Growth Substances|growth substances|mesh-ancestor
1970440|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970441|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
1970442|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970443|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
1970444|NCT00915655|Ritonavir|ritonavir|mesh-list
1970445|NCT00915655|Darunavir|darunavir|mesh-list
1970446|NCT00915655|Lamivudine|lamivudine|mesh-list
1970447|NCT00915655|Zidovudine|zidovudine|mesh-list
1970448|NCT00915655|Abacavir|abacavir|mesh-list
1970449|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1970450|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1970451|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
1970452|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970453|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970454|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1970455|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1970456|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
1970457|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970458|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1970459|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1970460|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1970461|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1970462|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
1970463|NCT00915772|Metformin|metformin|mesh-list
1970464|NCT00915772|Linagliptin|linagliptin|mesh-list
1970465|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1970466|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970467|NCT00915772|Incretins|incretins|mesh-ancestor
1970468|NCT00915772|Hormones|hormones|mesh-ancestor
1970469|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1970470|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1970471|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
1970472|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970473|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970474|NCT00915928|Perindopril|perindopril|mesh-list
1970475|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1970476|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
1970477|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970478|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970479|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1970480|NCT00915967|Vancomycin|vancomycin|mesh-list
1970481|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1970482|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970483|NCT00916032|Factor VIII|factor viii|mesh-list
1970484|NCT00916032|Coagulants|coagulants|mesh-ancestor
1970485|NCT00916058|Melphalan|melphalan|mesh-list
1970486|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1970487|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1970488|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
1970489|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970490|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970491|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1970492|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970493|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
1970494|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970495|NCT00916149|Lamotrigine|lamotrigine|mesh-list
1970496|NCT00916149|Levetiracetam|levetiracetam|mesh-list
1970497|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
1970498|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
1970499|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1970500|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1970501|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970502|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1970503|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970504|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1970505|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1970506|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1970507|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1970508|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1970509|NCT00916279|Paclitaxel|paclitaxel|mesh-list
1970510|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1970511|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970512|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
1970513|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
1970514|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
1970515|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970516|NCT00916357|Insulin|insulin|mesh-list
1970517|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1970518|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
1970519|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1970520|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970521|NCT00916383|Donepezil|donepezil|mesh-list
1970522|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1970523|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970524|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970525|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
1970526|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970527|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970528|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
1970529|NCT00916539|Calpastatin|calpastatin|mesh-list
1970530|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
1970531|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
1970532|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970533|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970534|NCT00916578|Capecitabine|capecitabine|mesh-list
1970535|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1970536|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
1970537|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970538|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970539|NCT00916721|Propranolol|propranolol|mesh-list
1970540|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1970541|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1970542|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
1970543|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970544|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970545|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970546|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1970547|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1970548|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
1970549|NCT00917267|Exenatide|exenatide|mesh-list
1970550|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1970551|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970552|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1970553|NCT00917267|Incretins|incretins|mesh-ancestor
1970554|NCT00917267|Hormones|hormones|mesh-ancestor
1970555|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1970556|NCT00917384|Ramucirumab|ramucirumab|mesh-list
1970557|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970558|NCT00917462|Sorafenib|sorafenib|mesh-list
1970559|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970560|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1970561|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970562|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970563|NCT00917553|Doxycycline|doxycycline|mesh-list
1970564|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1970565|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970566|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
1970567|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1970568|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1970569|NCT00917579|Atorvastatin|atorvastatin|mesh-list
1970570|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1970571|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1970572|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
1970573|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970574|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1970575|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1970576|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970577|NCT00917644|Atorvastatin|atorvastatin|mesh-list
1970578|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1970579|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1970580|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
1970581|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970582|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1970583|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1970584|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970585|NCT00918138|Metformin|metformin|mesh-list
1970586|NCT00918138|Saxagliptin|saxagliptin|mesh-list
1970587|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1970588|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970589|NCT00918138|Incretins|incretins|mesh-ancestor
1970590|NCT00918138|Hormones|hormones|mesh-ancestor
1970591|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1970592|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1970593|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
1970594|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970595|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970596|NCT00918203|Paclitaxel|paclitaxel|mesh-list
1970597|NCT00918203|Carboplatin|carboplatin|mesh-list
1970598|NCT00918203|Olaratumab|olaratumab|mesh-list
1970599|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1970600|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970601|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
1970602|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
1970603|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
1970604|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970605|NCT00918255|Adalimumab|adalimumab|mesh-list
1970606|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1970607|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1970608|NCT00918333|Everolimus|everolimus|mesh-list
1970609|NCT00918333|Panobinostat|panobinostat|mesh-list
1970610|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
1970611|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970612|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970613|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
1970614|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970615|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745644|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
1970616|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970617|NCT00918385|Dasatinib|dasatinib|mesh-list
1970618|NCT00918385|Nilutamide|nilutamide|mesh-list
1970619|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970620|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1970621|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970622|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970623|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
1970624|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
1970625|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1970626|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970627|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1970628|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1970629|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1970630|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1970631|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970632|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
1970633|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970634|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970635|NCT00918684|Citalopram|citalopram|mesh-list
1970636|NCT00918684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1970637|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1970638|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1970639|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970640|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970641|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
1970642|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970643|NCT00918684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1970644|NCT00918684|Antidepressive Agents|antidepressive agents|mesh-ancestor
1970645|NCT00918684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1970646|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
1970647|NCT00918723|Rituximab|rituximab|mesh-list
1970648|NCT00918723|Fludarabine|fludarabine|mesh-list
1970649|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
1970650|NCT00918723|Vorinostat|vorinostat|mesh-list
1970651|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970652|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
1970653|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970654|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1970655|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1970656|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
1970657|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970658|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970659|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1970660|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1970661|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1970662|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
1970663|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1970664|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970665|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
1970666|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1970667|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
1970668|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970669|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
1970670|NCT00918736|Protective Agents|protective agents|mesh-ancestor
1970671|NCT00918879|Saxagliptin|saxagliptin|mesh-list
1970672|NCT00918879|Incretins|incretins|mesh-ancestor
1970673|NCT00918879|Hormones|hormones|mesh-ancestor
1970674|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1970675|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970676|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1970677|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
1970678|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970679|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970680|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1970681|NCT00918931|Obatoclax|obatoclax|mesh-list
1970682|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970683|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970684|NCT00918957|Tobramycin|tobramycin|mesh-list
1970685|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1970686|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970687|NCT00919035|Sirolimus|sirolimus|mesh-list
1970688|NCT00919035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1970689|NCT00919035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970690|NCT00919035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1970691|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970692|NCT00919035|Antifungal Agents|antifungal agents|mesh-ancestor
1970693|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970694|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
1970695|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970696|NCT00919061|Gemcitabine|gemcitabine|mesh-list
1970697|NCT00919061|Sorafenib|sorafenib|mesh-list
1970698|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970699|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1970700|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
1970701|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970702|NCT00919061|Antiviral Agents|antiviral agents|mesh-ancestor
1970703|NCT00919061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970704|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970705|NCT00919061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970706|NCT00919061|Immunologic Factors|immunologic factors|mesh-ancestor
1970707|NCT00919061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970708|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1970709|NCT00919126|Xenon|xenon|mesh-list
1970710|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1970711|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
1970712|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
1970713|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1970714|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970715|NCT00919191|Adapalene|adapalene|mesh-list
1970716|NCT00919191|Tretinoin|tretinoin|mesh-list
1970717|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1970718|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
1970719|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1970720|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1970721|NCT00919191|Analgesics|analgesics|mesh-ancestor
1970722|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
1970723|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970724|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970725|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1970726|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1970727|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970728|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
1970729|NCT00919503|Cyclosporine|cyclosporine|mesh-list
1970730|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
1970731|NCT00919503|Methotrexate|methotrexate|mesh-list
1970732|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
1970733|NCT00919503|Fludarabine|fludarabine|mesh-list
1970734|NCT00919503|Treosulfan|treosulfan|mesh-list
1970735|NCT00919503|Busulfan|busulfan|mesh-list
1970736|NCT00919503|Tacrolimus|tacrolimus|mesh-list
1970737|NCT00919503|Cyclosporins|cyclosporins|mesh-list
1970738|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
1970739|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1970740|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1970741|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
1970742|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1970743|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970744|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1970745|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
1970746|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970747|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970748|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
1970749|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970750|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1970751|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970752|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
1970753|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1970754|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1970755|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1970756|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
1970757|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970758|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1970759|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1970760|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
1970761|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1970762|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1970763|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
1970764|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1970765|NCT00919633|Interferons|interferons|mesh-list
1970766|NCT00919633|Ribavirin|ribavirin|mesh-list
1970767|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
1970768|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
1970769|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1970770|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970771|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970772|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
1970773|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970774|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
1970775|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970776|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
1970777|NCT00919711|Denosumab|denosumab|mesh-list
1970778|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
1970779|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1970780|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970781|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1970782|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1970783|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970784|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1970785|NCT00919802|Oxytocin|oxytocin|mesh-list
1970786|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
1970787|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1970788|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970789|NCT00919854|Ritonavir|ritonavir|mesh-list
1970790|NCT00919854|Darunavir|darunavir|mesh-list
1970791|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1970792|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1970793|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
1970794|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970795|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970796|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1970797|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1970798|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
1970799|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970800|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1970801|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1970802|NCT00919867|Guanfacine|guanfacine|mesh-list
1970803|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1970804|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1970805|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970806|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1970807|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1970808|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1970809|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970810|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
1970811|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970812|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1970813|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1970814|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1970815|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1970816|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
1970817|NCT00920075|Alendronate|alendronate|mesh-list
1970818|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1970819|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970820|NCT00920140|Trametinib|trametinib|mesh-list
1970821|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970822|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1970823|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970824|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970825|NCT00920218|Vaccines|vaccines|mesh-list
1970826|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
1970827|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970828|NCT00920426|Cabotegravir|cabotegravir|mesh-list
1970829|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1970830|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1970831|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970832|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970833|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1970834|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1970835|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
1970836|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970837|NCT00920556|Bortezomib|bortezomib|mesh-list
1970838|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970839|NCT00920621|Vitamin D|vitamin d|mesh-list
1970840|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
1970841|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
1970842|NCT00920621|Vitamins|vitamins|mesh-list
1970843|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
1970844|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970845|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1970846|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1970847|NCT00920686|Sumatriptan|sumatriptan|mesh-list
1970848|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1970849|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1970850|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1970851|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
1970852|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970853|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970854|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970855|NCT00920699|Ubiquinone|ubiquinone|mesh-list
1970856|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
1970857|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
1970858|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970859|NCT00920699|Vitamins|vitamins|mesh-ancestor
1970860|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
1970861|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970862|NCT00920816|Sorafenib|sorafenib|mesh-list
1970863|NCT00920816|Axitinib|axitinib|mesh-list
1970864|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970865|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1970866|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970867|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970868|NCT00920829|Naltrexone|naltrexone|mesh-list
1970869|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1970870|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1970871|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970872|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
1970873|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970874|NCT00920855|Bortezomib|bortezomib|mesh-list
1970875|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1970876|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970877|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1970878|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
1970879|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970880|NCT00920907|Ipilimumab|ipilimumab|mesh-list
1970881|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1970882|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970883|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1970884|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970885|NCT00921024|Ceftazidime|ceftazidime|mesh-list
1970886|NCT00921024|Ceftolozane|ceftolozane|mesh-list
1970887|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1970888|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970889|NCT00921115|Fulvestrant|fulvestrant|mesh-list
1970890|NCT00921115|Anastrozole|anastrozole|mesh-list
1970891|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1970892|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970893|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1970894|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1970895|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
1970896|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1970897|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970898|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1970899|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1970900|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970901|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970902|NCT00921310|Sirolimus|sirolimus|mesh-list
1970903|NCT00921310|Pemetrexed|pemetrexed|mesh-list
1970904|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1970905|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970906|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970907|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1970908|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1970909|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1970910|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970911|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1970912|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
1970913|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1970914|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
1970915|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970916|NCT00921557|Vitamin D|vitamin d|mesh-list
1970917|NCT00921557|Alendronate|alendronate|mesh-list
1970918|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
1970919|NCT00921557|Calcium|calcium|mesh-list
1970920|NCT00921557|Vitamins|vitamins|mesh-ancestor
1970921|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
1970922|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970923|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1970924|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1970925|NCT00921557|Antacids|antacids|mesh-ancestor
1970926|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970927|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1970928|NCT00921843|Methadone|methadone|mesh-list
1970929|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1970930|NCT00921843|Narcotics|narcotics|mesh-ancestor
1970931|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1970932|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970933|NCT00921843|Analgesics|analgesics|mesh-ancestor
1970934|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
1970935|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1970936|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
1970937|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
1970938|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
1970939|NCT00922116|Hematinics|hematinics|mesh-ancestor
1970940|NCT00922194|Metformin|metformin|mesh-list
1970941|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1970942|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970943|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1970944|NCT00922207|Entecavir|entecavir|mesh-list
1970945|NCT00922207|Adefovir|adefovir|mesh-list
1970946|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
1970947|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1970948|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1970949|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1970950|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1970951|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970952|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
1970953|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1970954|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
1970955|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1970956|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970957|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1970958|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1970959|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1970960|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1970961|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1970962|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970963|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1970964|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1970965|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1970966|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970967|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
1970968|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970969|NCT00922441|Valsartan|valsartan|mesh-list
1970970|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1970971|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1970972|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1970973|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970974|NCT00922480|Losartan|losartan|mesh-list
1970975|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1970976|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1970977|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1970978|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1970979|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970980|NCT00922636|Methylphenidate|methylphenidate|mesh-list
1970981|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1970982|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1970983|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1970984|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1970985|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1970986|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970987|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
1970988|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1970989|NCT00922766|Dalteparin|dalteparin|mesh-list
1970990|NCT00922766|Tinzaparin|tinzaparin|mesh-list
1970991|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1970992|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
1970993|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1970994|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1970995|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1970996|NCT00922779|Ribavirin|ribavirin|mesh-list
1970997|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1970998|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
1970999|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971000|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
1971001|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971002|NCT00922987|Pregabalin|pregabalin|mesh-list
1971003|NCT00922987|Analgesics|analgesics|mesh-ancestor
1971004|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
1971005|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971006|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971007|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
1971008|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1971009|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1971010|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971011|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1971012|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1971013|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1971014|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1971015|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1971016|NCT00923091|Amlodipine|amlodipine|mesh-list
1971017|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1971018|NCT00923091|Olmesartan|olmesartan|mesh-list
1971019|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1971020|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
1971021|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1971022|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1971023|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1971024|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971025|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1971026|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971027|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
1971028|NCT00923091|Diuretics|diuretics|mesh-ancestor
1971029|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
1971030|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1971031|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1971032|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1971033|NCT00923117|Sunitinib|sunitinib|mesh-list
1971034|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971035|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1971036|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1971037|NCT00923117|Growth Substances|growth substances|mesh-ancestor
1971038|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971039|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
1971040|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1971041|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971042|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971043|NCT00923130|Bevacizumab|bevacizumab|mesh-list
1971044|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1971045|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971046|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1971047|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1971048|NCT00923130|Growth Substances|growth substances|mesh-ancestor
1971049|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971050|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
1971051|NCT00923156|Ramipril|ramipril|mesh-list
1971052|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1971053|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
1971054|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971055|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971056|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1971057|NCT00923195|Aldesleukin|aldesleukin|mesh-list
1971058|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
1971059|NCT00923195|Fludarabine|fludarabine|mesh-list
1971060|NCT00923195|Interleukin-2|interleukin-2|mesh-list
1971061|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1971062|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
1971063|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971064|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1971065|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1971066|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
1971067|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971068|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971069|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1971070|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1971071|NCT00923195|Analgesics|analgesics|mesh-ancestor
1971072|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
1971073|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971074|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1971075|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1971076|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
1971077|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475553|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971080|NCT00923273|Folic Acid|folic acid|mesh-list
1971081|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
1971082|NCT00923273|Hydroxocobalamin|hydroxocobalamin|mesh-list
1971083|NCT00923273|Sirolimus|sirolimus|mesh-list
1971084|NCT00923273|Dexamethasone|dexamethasone|mesh-list
1971085|NCT00923273|Pemetrexed|pemetrexed|mesh-list
1971086|NCT00923273|Vitamins|vitamins|mesh-ancestor
1971087|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
1971088|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971089|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1971090|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
1971091|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
1971092|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971093|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1971094|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
1971095|NCT00923273|Hormones|hormones|mesh-ancestor
1971096|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1971097|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1971098|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971099|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971100|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971101|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1971102|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1971103|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1971104|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971105|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1971106|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
1971107|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1971108|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
1971109|NCT00923273|Hematinics|hematinics|mesh-ancestor
1971110|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
1971111|NCT00923351|Vaccines|vaccines|mesh-list
1971112|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
1971113|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971114|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
1971115|NCT00923364|Fludarabine|fludarabine|mesh-list
1971116|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
1971117|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1971118|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1971119|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
1971120|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971121|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1971122|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1971123|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
1971124|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971125|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971126|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1971127|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1971128|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
1971129|NCT00923845|Sirolimus|sirolimus|mesh-list
1971130|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
1971131|NCT00923845|Pentostatin|pentostatin|mesh-list
1971132|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1971133|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
1971134|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971135|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1971136|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1971137|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
1971138|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971139|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971140|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1971141|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1971142|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971143|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1971144|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
1971145|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1971146|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971147|NCT00923910|Acetaminophen|acetaminophen|mesh-list
1971148|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
1971149|NCT00923910|Promethazine|promethazine|mesh-list
1971150|NCT00923910|Interleukin-4|interleukin-4|mesh-list
1971151|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
1971152|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1971153|NCT00923910|Analgesics|analgesics|mesh-ancestor
1971154|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
1971155|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971156|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971157|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
1971158|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1971159|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1971160|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1971161|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
1971162|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
1971163|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
1971164|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
1971165|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1971166|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1971167|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
1971168|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
1971169|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1971170|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971171|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1971172|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
1971173|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
1971174|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1971175|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
1971176|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971177|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1971178|NCT00923936|Bevacizumab|bevacizumab|mesh-list
1971179|NCT00923936|Doxorubicin|doxorubicin|mesh-list
1971180|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1971181|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1971182|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971183|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1971184|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1971185|NCT00923936|Growth Substances|growth substances|mesh-ancestor
1971186|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971187|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
1971188|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1971189|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1971190|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1971191|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971192|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971193|NCT00923949|Pioglitazone|pioglitazone|mesh-list
1971194|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1971195|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971196|NCT00924001|Aldesleukin|aldesleukin|mesh-list
1971197|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
1971198|NCT00924001|Fludarabine|fludarabine|mesh-list
1971199|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1971200|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
1971201|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971202|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1971203|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1971204|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
1971205|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971206|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971207|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1971208|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1971209|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1971210|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
1971211|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971212|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
1971213|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971214|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1971215|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971216|NCT00924066|Epothilones|epothilones|mesh-list
1971217|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
1971218|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
1971219|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
1971220|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971221|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971222|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
1971223|NCT00924170|Fludarabine|fludarabine|mesh-list
1971224|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1971225|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
1971226|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971227|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1971228|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1971229|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
1971230|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971231|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971232|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1971233|NCT00924209|Gemcitabine|gemcitabine|mesh-list
1971234|NCT00924209|Bevacizumab|bevacizumab|mesh-list
1971235|NCT00924209|Etoposide|etoposide|mesh-list
1971236|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1971237|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971238|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1971239|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1971240|NCT00924209|Growth Substances|growth substances|mesh-ancestor
1971241|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971242|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
1971243|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1971244|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
1971245|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971246|NCT00924209|Antiviral Agents|antiviral agents|mesh-ancestor
1971247|NCT00924209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971248|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971249|NCT00924209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1971250|NCT00924209|Immunologic Factors|immunologic factors|mesh-ancestor
1971251|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1971252|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1971253|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1971254|NCT00924287|Aldesleukin|aldesleukin|mesh-list
1971255|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
1971256|NCT00924287|Fludarabine|fludarabine|mesh-list
1971257|NCT00924287|Interleukin-2|interleukin-2|mesh-list
1971258|NCT00924287|Mesna|mesna|mesh-list
1971259|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1971260|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
1971261|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971262|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1971263|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1971264|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
1971265|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971266|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971267|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1971268|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1971269|NCT00924287|Analgesics|analgesics|mesh-ancestor
1971270|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
1971271|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971272|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1971273|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1971274|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
1971275|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971276|NCT00924287|Protective Agents|protective agents|mesh-ancestor
1971302|NCT00924352|Dasatinib|dasatinib|mesh-list
1971303|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971304|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1971305|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971306|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971307|NCT00924443|Clofarabine|clofarabine|mesh-list
1971308|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1971309|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
1971310|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971311|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971312|NCT00924469|Prednisone|prednisone|mesh-list
1971313|NCT00924469|Leuprolide|leuprolide|mesh-list
1971314|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1971315|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
1971316|NCT00924469|Hormones|hormones|mesh-ancestor
1971317|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1971318|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971319|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1971320|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971321|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1971322|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
1971323|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1971324|NCT00924508|Triamcinolone|triamcinolone|mesh-list
1971325|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1971326|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1971327|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1971328|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1971329|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
1971330|NCT00924508|Hormones|hormones|mesh-ancestor
1971331|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1971332|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971333|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1971334|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
1971335|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971336|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971337|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1971338|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1971339|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
1971340|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1971341|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
1971342|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
1971343|NCT00924560|Estradiol|estradiol|mesh-list
1971344|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1971345|NCT00924560|Estrogens|estrogens|mesh-ancestor
1971346|NCT00924560|Hormones|hormones|mesh-ancestor
1971347|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1971348|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971349|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1971350|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1971351|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1971352|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1971353|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1971354|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
1971355|NCT00924612|Testosterone|testosterone|mesh-list
1971356|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
1971357|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
1971358|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1971359|NCT00924612|Androgens|androgens|mesh-ancestor
1971360|NCT00924612|Hormones|hormones|mesh-ancestor
1971361|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1971362|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971363|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1971364|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971365|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
1971366|NCT00924664|Tanezumab|tanezumab|mesh-list
1971367|NCT00924664|Analgesics|analgesics|mesh-ancestor
1971368|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
1971369|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971370|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971371|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
1971372|NCT00924729|Besifloxacin|besifloxacin|mesh-list
1971373|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1971374|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1971375|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1971376|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971377|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1971378|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1971379|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971380|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971381|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971382|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
1971383|NCT00924781|Hematinics|hematinics|mesh-ancestor
1971384|NCT00924820|Bevacizumab|bevacizumab|mesh-list
1971385|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1971386|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971387|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1971388|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1971389|NCT00924820|Growth Substances|growth substances|mesh-ancestor
1971390|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971391|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
1971392|NCT00924833|Carvedilol|carvedilol|mesh-list
1971393|NCT00924833|Nebivolol|nebivolol|mesh-list
1971394|NCT00924833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1971395|NCT00924833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1971396|NCT00924833|Adrenergic Agents|adrenergic agents|mesh-ancestor
1971397|NCT00924833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1971398|NCT00924833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971399|NCT00924833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971400|NCT00924833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1971401|NCT00924833|Antioxidants|antioxidants|mesh-ancestor
1971402|NCT00924833|Protective Agents|protective agents|mesh-ancestor
1971403|NCT00924833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1971404|NCT00924833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1971405|NCT00924833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1971406|NCT00924833|Vasodilator Agents|vasodilator agents|mesh-ancestor
1971407|NCT00924833|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1971408|NCT00924833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1971409|NCT00924833|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1971410|NCT00924833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1971411|NCT00924833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1971412|NCT00924898|Tenofovir|tenofovir|mesh-list
1971413|NCT00924898|Emtricitabine|emtricitabine|mesh-list
1971414|NCT00924898|Efavirenz|efavirenz|mesh-list
1971415|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
1971416|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971417|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1971418|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1971419|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971420|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971421|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1971422|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1971423|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1971424|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1971425|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1971426|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1971427|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1971428|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1971429|NCT00924950|Calcitriol|calcitriol|mesh-list
1971430|NCT00924950|Betamethasone|betamethasone|mesh-list
1971431|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1971432|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
1971433|NCT00924950|Hormones|hormones|mesh-ancestor
1971434|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1971435|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971436|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1971437|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
1971438|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1971439|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1971440|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1971441|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971442|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1971443|NCT00924950|Vitamins|vitamins|mesh-ancestor
1971444|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
1971445|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1971446|NCT00925015|Irinotecan|irinotecan|mesh-list
1971447|NCT00925015|Cetuximab|cetuximab|mesh-list
1971448|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1971449|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1971450|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1971451|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971452|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971453|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971454|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1971455|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
1971456|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971457|NCT00925119|Atenolol|atenolol|mesh-list
1971458|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1971459|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1971460|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
1971461|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
1971462|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971463|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971464|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1971465|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1971466|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1971467|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
1971468|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1971469|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971470|NCT00925132|Temozolomide|temozolomide|mesh-list
1971471|NCT00925132|Decitabine|decitabine|mesh-list
1971472|NCT00925132|Panobinostat|panobinostat|mesh-list
1971473|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1971474|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
1971475|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971476|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971477|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1971478|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
1971479|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971480|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1971481|NCT00925288|Vaccines|vaccines|mesh-list
1971482|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
1971483|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971484|NCT00925353|Lidocaine|lidocaine|mesh-list
1971485|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
1971486|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
1971487|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1971488|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971489|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
1971490|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971491|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1971492|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1971493|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1971494|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1971495|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971496|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
1971497|NCT00925587|Hematinics|hematinics|mesh-ancestor
1971498|NCT00925600|Denosumab|denosumab|mesh-list
1971499|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1971500|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971501|NCT00925704|Calcitriol|calcitriol|mesh-list
1971502|NCT00925704|Sevelamer|sevelamer|mesh-list
1971503|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1971504|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971505|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1971506|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1971507|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971508|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1971509|NCT00925704|Vitamins|vitamins|mesh-ancestor
1971510|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
1971511|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1971512|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
1971513|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
1971514|NCT00925756|Maraviroc|maraviroc|mesh-list
1971515|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1971516|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1971517|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971518|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1971519|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1971520|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
1971521|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971522|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1971523|NCT00925769|Bevacizumab|bevacizumab|mesh-list
1971524|NCT00925769|Capecitabine|capecitabine|mesh-list
1971525|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1971526|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1971527|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971528|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1971529|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1971530|NCT00925769|Growth Substances|growth substances|mesh-ancestor
1971531|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971532|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
1971533|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1971534|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
1971535|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971536|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1971537|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971538|NCT00925782|Melphalan|melphalan|mesh-list
1971539|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1971540|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
1971541|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971542|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971543|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1971544|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1971545|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
1971546|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971547|NCT00925899|Melatonin|melatonin|mesh-list
1971548|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
1971549|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971550|NCT00925899|Protective Agents|protective agents|mesh-ancestor
1971551|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971552|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1971553|NCT00925938|Misoprostol|misoprostol|mesh-list
1971554|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1971555|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
1971556|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1971557|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971558|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1971559|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1971560|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
1971561|NCT00925990|Ribavirin|ribavirin|mesh-list
1971562|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
1971563|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971564|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
1971565|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971566|NCT00926029|Listerine|listerine|mesh-list
1971567|NCT00926029|Triclosan|triclosan|mesh-list
1971568|NCT00926029|Fluorides|fluorides|mesh-list
1971569|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
1971570|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
1971571|NCT00926029|Protective Agents|protective agents|mesh-ancestor
1971572|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971573|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1971574|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971575|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1971576|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1971577|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
1971578|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971579|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1971580|NCT00926185|Lifitegrast|lifitegrast|mesh-list
1971581|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1971582|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1971583|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
1971584|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1971585|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1971586|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971587|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1971588|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1971589|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971590|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971591|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971592|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971593|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
1971594|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1971595|NCT00926289|Telmisartan|telmisartan|mesh-list
1971596|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1971597|NCT00926289|Diuretics|diuretics|mesh-ancestor
1971598|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
1971599|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971600|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1971601|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1971602|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971603|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1971604|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1971605|NCT00926328|Triclosan|triclosan|mesh-list
1971606|NCT00926328|Fluorides|fluorides|mesh-list
1971607|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
1971608|NCT00926328|Protective Agents|protective agents|mesh-ancestor
1971609|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971610|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1971611|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971612|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1971613|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1971614|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
1971615|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971616|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1971617|NCT00926367|Clindamycin|clindamycin|mesh-list
1971618|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
1971619|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
1971620|NCT00926367|Adapalene|adapalene|mesh-list
1971621|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1971622|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1971623|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971624|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1971625|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971626|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971627|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
1971628|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1971629|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1971630|NCT00926367|Analgesics|analgesics|mesh-ancestor
1971631|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
1971632|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971633|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971634|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1971635|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1971636|NCT00926380|Denosumab|denosumab|mesh-list
1971637|NCT00926380|Teriparatide|teriparatide|mesh-list
1971638|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1971639|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971640|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1971641|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1971642|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
1971643|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1971644|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1971645|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1971646|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1971647|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971648|NCT00926588|Analgesics|analgesics|mesh-list
1971649|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
1971650|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971651|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971652|NCT00926796|Azithromycin|azithromycin|mesh-list
1971653|NCT00926796|Gentamicins|gentamicins|mesh-list
1971654|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
1971655|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1971656|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971657|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1971658|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971659|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971660|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1971661|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1971662|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971663|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
1971664|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1971665|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
1971666|NCT00927069|Adalimumab|adalimumab|mesh-list
1971667|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1971668|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1971669|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1971670|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
1971671|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971672|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
1971673|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1971674|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971675|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
1971676|NCT00927186|Teriparatide|teriparatide|mesh-list
1971677|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1971678|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971679|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1971680|NCT00927355|Pioglitazone|pioglitazone|mesh-list
1971681|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1971682|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971683|NCT00927394|Valsartan|valsartan|mesh-list
1971684|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1971685|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1971686|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1971687|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971688|NCT00927472|Permethrin|permethrin|mesh-list
1971689|NCT00927472|Malathion|malathion|mesh-list
1971690|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971691|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971692|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1971693|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
1971694|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1971695|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971696|NCT00927485|Curcumin|curcumin|mesh-list
1971697|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1971698|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1971699|NCT00927485|Analgesics|analgesics|mesh-ancestor
1971700|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
1971701|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971702|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971703|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1971704|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1971705|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971706|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971707|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971708|NCT00927563|Tolcapone|tolcapone|mesh-list
1971709|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1971710|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1971711|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1971712|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971713|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971714|NCT00927589|Carboplatin|carboplatin|mesh-list
1971715|NCT00927589|Docetaxel|docetaxel|mesh-list
1971716|NCT00927589|Trastuzumab|trastuzumab|mesh-list
1971717|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971718|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
1971719|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
1971720|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
1971721|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971722|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1971723|NCT00927758|Fluticasone|fluticasone|mesh-list
1971724|NCT00927758|Xhance|xhance|mesh-list
1971725|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1971726|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1971727|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1971728|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1971729|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
1971730|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971731|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971732|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1971733|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
1971734|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
1971735|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1971736|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1971737|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1971738|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1971739|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
1971740|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1971741|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971742|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
1971743|NCT00927758|Hormones|hormones|mesh-ancestor
1971744|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1971745|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
1971746|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
1971747|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
1971748|NCT00927849|Glycerol|glycerol|mesh-list
1971749|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1971750|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1971751|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971752|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
1971753|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1971754|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971755|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1971756|NCT00927849|Protective Agents|protective agents|mesh-ancestor
1971757|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
1971758|NCT00927862|Warfarin|warfarin|mesh-list
1971759|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
1971760|NCT00927888|Bupivacaine|bupivacaine|mesh-list
1971761|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
1971762|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
1971763|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1971764|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971765|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
1971766|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971767|NCT00927901|Maleic acid|maleic acid|mesh-list
1971768|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971769|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971770|NCT00928018|Cyclosporine|cyclosporine|mesh-list
1971771|NCT00928018|Sirolimus|sirolimus|mesh-list
1971772|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
1971773|NCT00928018|Methotrexate|methotrexate|mesh-list
1971774|NCT00928018|Tacrolimus|tacrolimus|mesh-list
1971775|NCT00928018|Cyclosporins|cyclosporins|mesh-list
1971776|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1971777|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
1971778|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1971779|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971780|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1971781|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
1971782|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971783|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971784|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
1971785|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971786|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1971787|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1971788|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
1971789|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1971790|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1971791|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1971792|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
1971793|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971794|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1971795|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1971796|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
1971797|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1971798|NCT00928070|Fesoterodine|fesoterodine|mesh-list
1971799|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1971800|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1971801|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
1971802|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1971803|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971804|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971805|NCT00928070|Urological Agents|urological agents|mesh-ancestor
1971806|NCT00928083|Artefenomel|artefenomel|mesh-list
1971807|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
1971808|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1971809|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1971810|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971811|NCT00928174|Fluorides|fluorides|mesh-list
1971812|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
1971813|NCT00928174|Protective Agents|protective agents|mesh-ancestor
1971814|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971815|NCT00928187|Ritonavir|ritonavir|mesh-list
1971816|NCT00928187|Lopinavir|lopinavir|mesh-list
1971817|NCT00928187|Darunavir|darunavir|mesh-list
1971818|NCT00928187|Tenofovir|tenofovir|mesh-list
1971819|NCT00928187|Emtricitabine|emtricitabine|mesh-list
1971820|NCT00928187|Abacavir|abacavir|mesh-list
1971821|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1971822|NCT00928187|Didanosine|didanosine|mesh-list
1971823|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1971824|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1971825|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
1971826|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971827|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971828|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1971829|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1971830|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
1971831|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971832|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1971833|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1971834|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1971835|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1971836|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
1971837|NCT00928200|Cytarabine|cytarabine|mesh-list
1971838|NCT00928200|Dexamethasone|dexamethasone|mesh-list
1971839|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
1971840|NCT00928200|Doxorubicin|doxorubicin|mesh-list
1971841|NCT00928200|Methotrexate|methotrexate|mesh-list
1971842|NCT00928200|Vincristine|vincristine|mesh-list
1971843|NCT00928200|Asparaginase|asparaginase|mesh-list
1971844|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
1971845|NCT00928200|Razoxane|razoxane|mesh-list
1971846|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1971847|NCT00928200|BB 1101|bb 1101|mesh-list
1971848|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1971849|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
1971850|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
1971851|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971852|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971853|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1971854|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
1971855|NCT00928200|Hormones|hormones|mesh-ancestor
1971856|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1971857|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1971858|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971859|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
1971860|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971861|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971862|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1971863|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1971864|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1971865|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1971866|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
1971867|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1971868|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1971869|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
1971870|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
1971871|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1971872|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1971873|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
1971874|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1971875|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1971876|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
1971877|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971878|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1971879|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
1971880|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
1971881|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
1971882|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1971883|NCT00928200|Protective Agents|protective agents|mesh-ancestor
1971884|NCT00928252|Fluorides|fluorides|mesh-list
1971885|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
1971886|NCT00928252|Protective Agents|protective agents|mesh-ancestor
1971887|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971888|NCT00928408|Cinacalcet|cinacalcet|mesh-list
1971889|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1971890|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971891|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1971892|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
1971893|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1971894|NCT00928421|Polidocanol|polidocanol|mesh-list
1971895|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
1971896|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1971897|NCT00928434|Leuprolide|leuprolide|mesh-list
1971898|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1971899|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
1971900|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1971901|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971902|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1971903|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971904|NCT00928486|Dexamethasone|dexamethasone|mesh-list
1971905|NCT00928486|Lenalidomide|lenalidomide|mesh-list
1971906|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1971907|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
1971908|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
1971909|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971910|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971911|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1971912|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
1971913|NCT00928486|Hormones|hormones|mesh-ancestor
1971914|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1971915|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1971916|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971917|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
1971918|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1971919|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1971920|NCT00928486|Growth Substances|growth substances|mesh-ancestor
1971921|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
1971922|NCT00928564|Anesthetics|anesthetics|mesh-list
1971923|NCT00928564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1971924|NCT00928564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971925|NCT00928642|Gemcitabine|gemcitabine|mesh-list
1971926|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
1971927|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1971928|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
1971929|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971930|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971931|NCT00928642|Antiviral Agents|antiviral agents|mesh-ancestor
1971932|NCT00928642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1971933|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971934|NCT00928642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1971935|NCT00928642|Immunologic Factors|immunologic factors|mesh-ancestor
1971936|NCT00928642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971937|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1971938|NCT00928668|Olodaterol|olodaterol|mesh-list
1971939|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1971940|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
1971941|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971942|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971943|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1971944|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
1971945|NCT00928694|Fenofibrate|fenofibrate|mesh-list
1971946|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1971947|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
1971948|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971949|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1971950|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
1971951|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
1971952|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1971953|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
1971954|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971955|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971956|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1971957|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1971958|NCT00928746|Bromides|bromides|mesh-list
1971959|NCT00928746|Ipratropium|ipratropium|mesh-list
1971960|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
1971961|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1971962|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
1971963|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971964|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971965|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1971966|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
1971967|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1971968|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
1971969|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1971970|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971971|NCT00928772|Midazolam|midazolam|mesh-list
1971972|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1971973|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1971974|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1971975|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971976|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1971977|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1971978|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1971979|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1971980|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
1971981|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
1971982|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
1971983|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
1971984|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1971985|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971986|NCT00928889|Acarbose|acarbose|mesh-list
1971987|NCT00928889|Nateglinide|nateglinide|mesh-list
1971988|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
1971989|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1971990|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1971991|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1971992|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971993|NCT00928954|Gabapentin|gabapentin|mesh-list
1971994|NCT00928954|Memantine|memantine|mesh-list
1971995|NCT00928954|Analgesics|analgesics|mesh-ancestor
1971996|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
1971997|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1971998|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1971999|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
1972000|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1972001|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1972002|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972003|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1972004|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1972005|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1972006|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972007|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972008|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
1972009|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1972010|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1972011|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
1972012|NCT00929071|Lidocaine|lidocaine|mesh-list
1972013|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
1972014|NCT00929071|Anesthetics|anesthetics|mesh-list
1972015|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972016|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972017|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
1972018|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972019|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1972020|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1972021|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1972022|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1972023|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972024|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
1972025|NCT00929110|Bromides|bromides|mesh-list
1972026|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
1972027|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1972028|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
1972029|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972030|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972031|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1972032|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
1972033|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
1972034|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1972035|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
1972036|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972037|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972038|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
1972039|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1972040|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1972041|NCT00929162|Paclitaxel|paclitaxel|mesh-list
1972042|NCT00929162|Carboplatin|carboplatin|mesh-list
1972043|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1972044|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972045|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
1972046|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
1972047|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
1972048|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972049|NCT00929201|Metformin|metformin|mesh-list
1972050|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1972051|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1972052|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972053|NCT00929201|Incretins|incretins|mesh-ancestor
1972054|NCT00929201|Hormones|hormones|mesh-ancestor
1972055|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1972056|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1972057|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
1972058|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972059|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972060|NCT00929240|Bevacizumab|bevacizumab|mesh-list
1972061|NCT00929240|Capecitabine|capecitabine|mesh-list
1972062|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1972063|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972064|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1972065|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1972066|NCT00929240|Growth Substances|growth substances|mesh-ancestor
1972067|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972068|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
1972069|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1972070|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
1972071|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972072|NCT00929344|Pregabalin|pregabalin|mesh-list
1972073|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1972074|NCT00929344|Analgesics|analgesics|mesh-ancestor
1972075|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
1972076|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972077|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972078|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
1972079|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1972080|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1972081|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972082|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1972083|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1972084|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1972085|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972086|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1972087|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1972088|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1972089|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972090|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
1972091|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
1972092|NCT00929383|Hemostatics|hemostatics|mesh-list
1972093|NCT00929383|Coagulants|coagulants|mesh-ancestor
1972094|NCT00929578|Fluphenazine|fluphenazine|mesh-list
1972095|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
1972096|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
1972097|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1972098|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1972099|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972100|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972101|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1972102|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1972103|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
1972104|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972105|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972106|NCT00929669|Pasireotide|pasireotide|mesh-list
1972107|NCT00929669|Hormones|hormones|mesh-ancestor
1972108|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1972109|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972110|NCT00929695|Prednisone|prednisone|mesh-list
1972111|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
1972112|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1972113|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1972114|NCT00929695|Prednisolone|prednisolone|mesh-list
1972115|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
1972116|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1972117|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
1972118|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1972119|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
1972120|NCT00929695|Hormones|hormones|mesh-ancestor
1972121|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1972122|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972123|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1972124|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972125|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
1972126|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
1972127|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972128|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1972129|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1972130|NCT00929695|Protective Agents|protective agents|mesh-ancestor
1972131|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
1972132|NCT00929708|AZD-3199|azd-3199|mesh-list
1972133|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1972134|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
1972135|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972136|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972137|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1972138|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
1972139|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1972140|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1972141|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1972142|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
1972143|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972144|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972145|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1972146|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1972147|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1972148|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1972149|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
1972150|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972151|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1972152|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972153|NCT00929864|Adalimumab|adalimumab|mesh-list
1972154|NCT00929864|Abatacept|abatacept|mesh-list
1972155|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1972156|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1972157|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1972158|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972159|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972160|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1972161|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
1972162|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972163|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
1972164|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1972165|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1972166|NCT00929981|Prednisolone|prednisolone|mesh-list
1972167|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
1972168|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1972169|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
1972170|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1972171|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
1972172|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
1972173|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972174|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972175|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1972176|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
1972177|NCT00929981|Hormones|hormones|mesh-ancestor
1972178|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1972179|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1972180|NCT00929981|Protective Agents|protective agents|mesh-ancestor
1972181|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1972182|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972183|NCT00930046|Ropivacaine|ropivacaine|mesh-list
1972184|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
1972185|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
1972186|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972187|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972188|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
1972189|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972190|NCT00930293|Dexetimide|dexetimide|mesh-list
1972191|NCT00930293|Citalopram|citalopram|mesh-list
1972192|NCT00930293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1972193|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1972194|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1972195|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972196|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972197|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
1972198|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972199|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1972200|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
1972201|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1972202|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1972203|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1972204|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
1972205|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
1972206|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972207|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1972208|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1972209|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
1972210|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
1972211|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1972212|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972213|NCT00930644|Teduglutide|teduglutide|mesh-list
1972214|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1972215|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1972216|NCT00930644|Protective Agents|protective agents|mesh-ancestor
1972217|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475554|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2475555|NCT01084876|Paclitaxel|paclitaxel|mesh-list
2475556|NCT01084876|Trastuzumab|trastuzumab|mesh-list
2475557|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2475558|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475559|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
1972224|NCT00930930|Paclitaxel|paclitaxel|mesh-list
1972225|NCT00930930|Everolimus|everolimus|mesh-list
1972226|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1972227|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972228|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
1972229|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
1972230|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
1972231|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972232|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1972233|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
1972234|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972235|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
1972236|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1972237|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1972238|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1972239|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1972240|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972241|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972242|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972243|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1972244|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1972245|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
1972246|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1972247|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1972248|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
1972249|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
1972250|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972251|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972252|NCT00931242|Thalidomide|thalidomide|mesh-list
1972253|NCT00931242|Apremilast|apremilast|mesh-list
1972254|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1972255|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1972256|NCT00931242|Analgesics|analgesics|mesh-ancestor
1972257|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
1972258|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972259|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972260|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1972261|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1972262|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1972263|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1972264|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972265|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972266|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1972267|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
1972268|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
1972269|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1972270|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1972271|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1972272|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1972273|NCT00931242|Growth Substances|growth substances|mesh-ancestor
1972274|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
1972275|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972276|NCT00931255|Sirolimus|sirolimus|mesh-list
1972277|NCT00931255|Tacrolimus|tacrolimus|mesh-list
1972278|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1972279|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
1972280|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972281|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1972282|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972283|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972284|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1972285|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1972286|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1972287|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972288|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
1972289|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
1972290|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1972291|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
1972292|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972293|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972294|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1972295|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
1972296|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1972297|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1972298|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1972299|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
1972300|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972301|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972302|NCT00931463|Ritonavir|ritonavir|mesh-list
1972303|NCT00931463|Lopinavir|lopinavir|mesh-list
1972304|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
1972305|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1972306|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1972307|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
1972308|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972309|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972310|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1972311|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1972312|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
1972313|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1972314|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1972315|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1972316|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1972317|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1972318|NCT00931489|Ranibizumab|ranibizumab|mesh-list
1972319|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1972320|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1972321|NCT00931489|Growth Substances|growth substances|mesh-ancestor
1972322|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972323|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
1972324|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972325|NCT00931528|Tadalafil|tadalafil|mesh-list
1972326|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
1972327|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1972328|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1972329|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972330|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972331|NCT00931528|Urological Agents|urological agents|mesh-ancestor
1972332|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
1972333|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1972334|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
1972335|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972336|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972337|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1972338|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
1972339|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1972340|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
1972341|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972342|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972343|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1972344|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
1972345|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
1972346|NCT00931632|Protective Agents|protective agents|mesh-ancestor
1972347|NCT00931710|Losartan|losartan|mesh-list
1972348|NCT00931710|Amlodipine|amlodipine|mesh-list
1972349|NCT00931710|Valsartan|valsartan|mesh-list
1972350|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1972351|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1972352|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1972353|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1972354|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972355|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1972356|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972357|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
1972358|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1972359|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1972360|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1972361|NCT00931710|Diuretics|diuretics|mesh-ancestor
1972362|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
1972363|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1972364|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1972365|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
1972366|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1972367|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1972368|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1972369|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972370|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972371|NCT00931762|Panobinostat|panobinostat|mesh-list
1972372|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972373|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1972374|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972375|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972376|NCT00931801|Tenofovir|tenofovir|mesh-list
1972377|NCT00931801|Emtricitabine|emtricitabine|mesh-list
1972378|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
1972379|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1972380|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
1972381|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1972382|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1972383|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1972384|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972385|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972386|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1972387|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1972388|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1972389|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1972390|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1972391|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1972392|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
1972393|NCT00931918|Prednisone|prednisone|mesh-list
1972394|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
1972395|NCT00931918|Rituximab|rituximab|mesh-list
1972396|NCT00931918|Doxorubicin|doxorubicin|mesh-list
1972397|NCT00931918|Vincristine|vincristine|mesh-list
1972398|NCT00931918|Bortezomib|bortezomib|mesh-list
1972399|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1972400|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
1972401|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972402|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1972403|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1972404|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
1972405|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972406|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972407|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1972408|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1972409|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1972410|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1972411|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1972412|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972413|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1972414|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
1972415|NCT00931918|Hormones|hormones|mesh-ancestor
1972416|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1972417|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1972418|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1972419|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
1972420|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
1972421|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
1972422|NCT00931944|Pramipexole|pramipexole|mesh-list
1972423|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
1972424|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972425|NCT00931944|Protective Agents|protective agents|mesh-ancestor
1972426|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972427|NCT00931944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1972428|NCT00931944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1972429|NCT00931944|Dopamine Agonists|dopamine agonists|mesh-ancestor
1972430|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
1972431|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972432|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
1972433|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1972434|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972435|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972436|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1972437|NCT00932022|Trospium chloride|trospium chloride|mesh-list
1972438|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
1972439|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
1972440|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972441|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972442|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1972443|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1972444|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
1972445|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972446|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972447|NCT00932022|Urological Agents|urological agents|mesh-ancestor
1972448|NCT00932113|Folic Acid|folic acid|mesh-list
1972449|NCT00932113|Adalimumab|adalimumab|mesh-list
1972450|NCT00932113|Methotrexate|methotrexate|mesh-list
1972451|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1972452|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
1972453|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1972454|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972455|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1972456|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
1972457|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972458|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972459|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
1972460|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972461|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1972462|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1972463|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
1972464|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1972465|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1972466|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1972467|NCT00932113|Hematinics|hematinics|mesh-ancestor
1972468|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
1972469|NCT00932113|Vitamins|vitamins|mesh-ancestor
1972470|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
1972471|NCT00932165|Exemestane|exemestane|mesh-list
1972472|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972473|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1972474|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1972475|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972476|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972477|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1972478|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
1972479|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1972480|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972481|NCT00932282|Omalizumab|omalizumab|mesh-list
1972482|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1972483|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1972484|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
1972485|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1972486|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1972487|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1972488|NCT00932321|Norethindrone|norethindrone|mesh-list
1972489|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
1972490|NCT00932321|Estradiol|estradiol|mesh-list
1972491|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1972492|NCT00932321|Estrogens|estrogens|mesh-ancestor
1972493|NCT00932321|Hormones|hormones|mesh-ancestor
2475560|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
1972494|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1972495|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972496|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1972497|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
1972498|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1972499|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1972500|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1972501|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1972502|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1972503|NCT00932373|Trastuzumab|trastuzumab|mesh-list
1972504|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1972505|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1972506|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972507|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
1972508|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
1972509|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
1972510|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972511|NCT00932438|Leucovorin|leucovorin|mesh-list
1972512|NCT00932438|Bevacizumab|bevacizumab|mesh-list
1972513|NCT00932438|Fluorouracil|fluorouracil|mesh-list
1972514|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
1972515|NCT00932438|Irinotecan|irinotecan|mesh-list
1972516|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1972517|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972518|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1972519|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1972520|NCT00932438|Growth Substances|growth substances|mesh-ancestor
1972521|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972522|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
1972523|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
1972524|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972525|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1972526|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1972527|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
1972528|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1972529|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1972530|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972531|NCT00932438|Antidotes|antidotes|mesh-ancestor
1972532|NCT00932438|Protective Agents|protective agents|mesh-ancestor
1972533|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
1972534|NCT00932438|Vitamins|vitamins|mesh-ancestor
1972535|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
1972536|NCT00932451|Crizotinib|crizotinib|mesh-list
1972537|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972538|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1972539|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972540|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972541|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1972542|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
1972543|NCT00932477|Glycerol|glycerol|mesh-list
1972544|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1972545|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1972546|NCT00932477|Laxatives|laxatives|mesh-ancestor
1972547|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1972548|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1972549|NCT00932477|Protective Agents|protective agents|mesh-ancestor
1972550|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972551|NCT00932620|Simvastatin|simvastatin|mesh-list
1972552|NCT00932620|Ezetimibe|ezetimibe|mesh-list
1972553|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1972554|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1972555|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
1972556|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972557|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1972558|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1972559|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972560|NCT00932646|Olodaterol|olodaterol|mesh-list
1972561|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
1972562|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1972563|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
1972564|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972565|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972566|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1972567|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
1972568|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1972569|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1972570|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1972571|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
1972572|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972573|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972574|NCT00932698|Ixazomib|ixazomib|mesh-list
1972575|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972576|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
1972577|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972578|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972579|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
1972580|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972581|NCT00932893|Docetaxel|docetaxel|mesh-list
1972582|NCT00932893|Pemetrexed|pemetrexed|mesh-list
1972583|NCT00932893|Crizotinib|crizotinib|mesh-list
1972584|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972585|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
1972586|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
1972587|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
1972588|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972589|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972590|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1972591|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1972592|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1972593|NCT00933244|Vitamin D|vitamin d|mesh-list
1972594|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
1972595|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
1972596|NCT00933244|Vitamins|vitamins|mesh-list
1972597|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
1972598|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972599|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1972600|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1972601|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
1972602|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972603|NCT00933608|Memantine|memantine|mesh-list
1972604|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1972605|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1972606|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
1972607|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972608|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972609|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972610|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1972611|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1972612|NCT00934024|Varenicline|varenicline|mesh-list
1972613|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1972614|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1972615|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
1972616|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972617|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972618|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972619|NCT00934050|Inositol|inositol|mesh-list
1972620|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
1972621|NCT00934050|Vitamins|vitamins|mesh-ancestor
1972622|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
1972623|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972624|NCT00934089|Latanoprost|latanoprost|mesh-list
1972625|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1972626|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1972627|NCT00934180|Ondansetron|ondansetron|mesh-list
1972628|NCT00934180|Antiemetics|antiemetics|mesh-ancestor
1972629|NCT00934180|Autonomic Agents|autonomic agents|mesh-ancestor
1972630|NCT00934180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972631|NCT00934180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972632|NCT00934180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1972633|NCT00934180|Antipruritics|antipruritics|mesh-ancestor
1972634|NCT00934180|Dermatologic Agents|dermatologic agents|mesh-ancestor
1972635|NCT00934180|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1972636|NCT00934180|Serotonin Agents|serotonin agents|mesh-ancestor
1972637|NCT00934180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972638|NCT00934180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972639|NCT00934180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1972640|NCT00934180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1972641|NCT00934180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972642|NCT00934180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1972643|NCT00934180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1972644|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1972645|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
1972646|NCT00934375|Donepezil|donepezil|mesh-list
1972647|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1972648|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972649|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972650|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
1972651|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972652|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972653|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
1972654|NCT00934440|Bevacizumab|bevacizumab|mesh-list
1972655|NCT00934440|Azacitidine|azacitidine|mesh-list
1972656|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1972657|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972658|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1972659|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1972660|NCT00934440|Growth Substances|growth substances|mesh-ancestor
1972661|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972662|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
1972663|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1972664|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
1972665|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972666|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972667|NCT00934635|Risperidone|risperidone|mesh-list
1972668|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1972669|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1972670|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
1972671|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972672|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972673|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972674|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1972675|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1972676|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972677|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1972678|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1972679|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
1972680|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1972681|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1972682|NCT00934648|Rituximab|rituximab|mesh-list
1972683|NCT00934648|Methotrexate|methotrexate|mesh-list
1972684|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1972685|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972686|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
1972687|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972688|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1972689|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1972690|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
1972691|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1972692|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1972693|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
1972694|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972695|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
1972696|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972697|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1972698|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1972699|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1972700|NCT00934661|Morphine|morphine|mesh-list
1972701|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1972702|NCT00934661|Narcotics|narcotics|mesh-ancestor
1972703|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972704|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972705|NCT00934661|Analgesics|analgesics|mesh-ancestor
1972706|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
1972707|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972708|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
1972709|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1972710|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1972711|NCT00934843|Prednisolone|prednisolone|mesh-list
1972712|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
1972713|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1972714|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
1972715|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
1972716|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1972717|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
1972718|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
1972719|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972720|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972721|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1972722|NCT00934843|Hormones|hormones|mesh-ancestor
1972723|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1972724|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1972725|NCT00934843|Protective Agents|protective agents|mesh-ancestor
1972726|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1972727|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972728|NCT00934856|Docetaxel|docetaxel|mesh-list
1972729|NCT00934856|Trastuzumab|trastuzumab|mesh-list
1972730|NCT00934856|Pertuzumab|pertuzumab|mesh-list
1972731|NCT00934856|Maytansine|maytansine|mesh-list
1972732|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1972733|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972734|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
1972735|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
1972736|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
1972737|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972738|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1972739|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1972740|NCT00934921|Ondansetron|ondansetron|mesh-list
1972741|NCT00934921|Antiemetics|antiemetics|mesh-ancestor
1972742|NCT00934921|Autonomic Agents|autonomic agents|mesh-ancestor
1972743|NCT00934921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972744|NCT00934921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972745|NCT00934921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1972746|NCT00934921|Antipruritics|antipruritics|mesh-ancestor
1972747|NCT00934921|Dermatologic Agents|dermatologic agents|mesh-ancestor
1972748|NCT00934921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1972749|NCT00934921|Serotonin Agents|serotonin agents|mesh-ancestor
1972750|NCT00934921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972751|NCT00934921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972752|NCT00934921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1972753|NCT00934921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1972754|NCT00934921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972755|NCT00934921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1972756|NCT00934921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1972757|NCT00934934|Anidulafungin|anidulafungin|mesh-list
1972758|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
1972759|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1972760|NCT00934947|Propranolol|propranolol|mesh-list
1972761|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1972762|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1972763|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
1972764|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972765|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972766|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972767|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1972768|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1972769|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
1972770|NCT00935220|Linagliptin|linagliptin|mesh-list
1972771|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1972772|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972773|NCT00935220|Incretins|incretins|mesh-ancestor
1972774|NCT00935220|Hormones|hormones|mesh-ancestor
1972775|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1972776|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1972777|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
1972778|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972779|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972780|NCT00935259|Simvastatin|simvastatin|mesh-list
1972781|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1972782|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1972783|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
1972784|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972785|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1972786|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1972787|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972788|NCT00935311|Acetaminophen|acetaminophen|mesh-list
1972789|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
1972790|NCT00935311|Hydrocodone|hydrocodone|mesh-list
1972791|NCT00935311|Oxycodone|oxycodone|mesh-list
1972792|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1972793|NCT00935311|Analgesics|analgesics|mesh-ancestor
1972794|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
1972795|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972796|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972797|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
1972798|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1972799|NCT00935311|Narcotics|narcotics|mesh-ancestor
1972800|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972801|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
1972802|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
1972803|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1972804|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1972805|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1972806|NCT00935493|Guanfacine|guanfacine|mesh-list
1972807|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1972808|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1972809|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1972810|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1972811|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
1972812|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972813|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972814|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972815|NCT00935532|Insulin|insulin|mesh-list
1972816|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1972817|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
1972818|NCT00935532|Exenatide|exenatide|mesh-list
1972819|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1972820|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972821|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1972822|NCT00935532|Incretins|incretins|mesh-ancestor
1972823|NCT00935532|Hormones|hormones|mesh-ancestor
1972824|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1972825|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1972826|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
1972827|NCT00935792|Everolimus|everolimus|mesh-list
1972828|NCT00935792|Antibodies|antibodies|mesh-list
1972829|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
1972830|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1972831|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
1972832|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972833|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972834|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1972835|NCT00935818|Bupropion|bupropion|mesh-list
1972836|NCT00935818|Varenicline|varenicline|mesh-list
1972837|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1972838|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
1972839|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1972840|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1972841|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1972842|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1972843|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972844|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
1972845|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972846|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972847|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1972848|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1972849|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972850|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1972851|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1972852|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
1972853|NCT00935883|Eculizumab|eculizumab|mesh-list
1972854|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1972855|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1972856|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
1972857|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972858|NCT00936065|Etanercept|etanercept|mesh-list
1972859|NCT00936065|Acitretin|acitretin|mesh-list
1972860|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1972861|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1972862|NCT00936065|Analgesics|analgesics|mesh-ancestor
1972863|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
1972864|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972865|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972866|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1972867|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1972868|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1972869|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1972870|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
1972871|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
1972872|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
1972873|NCT00936117|Posaconazole|posaconazole|mesh-list
1972874|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
1972875|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1972876|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1972877|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1972878|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1972879|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1972880|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1972881|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972882|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972883|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1972884|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
1972885|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1972886|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972887|NCT00936221|Dacarbazine|dacarbazine|mesh-list
1972888|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1972889|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
1972890|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972891|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972892|NCT00936299|Bupropion|bupropion|mesh-list
1972893|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1972894|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
1972895|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1972896|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1972897|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1972898|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1972899|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972900|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
1972901|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972902|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972903|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1972904|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1972905|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972906|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
1972907|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1972908|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1972909|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972910|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1972911|NCT00936377|Analgesics|analgesics|mesh-ancestor
1972912|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
1972913|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972914|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1972915|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1972916|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1972917|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
1972918|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1972919|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972920|NCT00936611|Panobinostat|panobinostat|mesh-list
1972921|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972922|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1972923|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972924|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972925|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1972926|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1972927|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972928|NCT00936663|Incretins|incretins|mesh-ancestor
1972929|NCT00936663|Hormones|hormones|mesh-ancestor
1972930|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1972931|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1972932|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
1972933|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972934|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972935|NCT00936702|Paclitaxel|paclitaxel|mesh-list
1972936|NCT00936702|Carboplatin|carboplatin|mesh-list
1972937|NCT00936702|Everolimus|everolimus|mesh-list
1972938|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1972939|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972940|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
1972941|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
1972942|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
2475561|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
1972943|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972944|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1972945|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
1972946|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972947|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1972948|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1972949|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1972950|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1972951|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1972952|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
1972953|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1972954|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1972955|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1972956|NCT00936741|Mifepristone|mifepristone|mesh-list
1972957|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1972958|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
1972959|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1972960|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972961|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1972962|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1972963|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1972964|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
1972965|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1972966|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1972967|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
1972968|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1972969|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
1972970|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1972971|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1972972|NCT00936858|Everolimus|everolimus|mesh-list
1972973|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1972974|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1972975|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
1972976|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972977|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
1972978|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1972979|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972980|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
1972981|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1972982|NCT00936897|Denosumab|denosumab|mesh-list
1972983|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
1972984|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1972985|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1972986|NCT00936910|Amphotericin B|amphotericin b|mesh-list
1972987|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
1972988|NCT00936910|Amebicides|amebicides|mesh-ancestor
1972989|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1972990|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1972991|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1972992|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1972993|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
1972994|NCT00936975|Listerine|listerine|mesh-list
1972995|NCT00936975|Fluorides|fluorides|mesh-list
1972996|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
1972997|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
1972998|NCT00936975|Protective Agents|protective agents|mesh-ancestor
1972999|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973000|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1973001|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973002|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
1973003|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
1973004|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1973005|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
1973006|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973007|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973008|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1973009|NCT00937235|Varenicline|varenicline|mesh-list
1973010|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1973011|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1973012|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
1973013|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1973014|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973015|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973016|NCT00937495|Bortezomib|bortezomib|mesh-list
1973017|NCT00937495|Vorinostat|vorinostat|mesh-list
1973018|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973019|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1973020|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973021|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973022|NCT00937521|Antipyretics|antipyretics|mesh-list
1973023|NCT00937521|Vaccines|vaccines|mesh-list
1973024|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
1973025|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973026|NCT00937560|Paclitaxel|paclitaxel|mesh-list
1973027|NCT00937560|Bevacizumab|bevacizumab|mesh-list
1973028|NCT00937560|Carboplatin|carboplatin|mesh-list
1973029|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1973030|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973031|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
1973032|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
1973033|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
1973034|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973035|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1973036|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1973037|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1973038|NCT00937560|Growth Substances|growth substances|mesh-ancestor
1973039|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973040|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
1973041|NCT00937768|Leuprolide|leuprolide|mesh-list
1973042|NCT00937768|Goserelin|goserelin|mesh-list
1973043|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1973044|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
1973045|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1973046|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973047|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1973048|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973049|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
1973050|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973051|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
1973052|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1973053|NCT00938314|Hematinics|hematinics|mesh-ancestor
1973054|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1973055|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973056|NCT00938366|Cladribine|cladribine|mesh-list
1973057|NCT00938366|Pantoprazole|pantoprazole|mesh-list
1973058|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1973059|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1973060|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1973061|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973062|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973063|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973064|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973065|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
1973066|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973067|NCT00938392|Vaccines|vaccines|mesh-list
1973068|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
1973069|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973070|NCT00938431|Lacosamide|lacosamide|mesh-list
1973071|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
1973072|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1973073|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1973074|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1973075|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973076|NCT00938470|Docetaxel|docetaxel|mesh-list
1973077|NCT00938470|Fluorouracil|fluorouracil|mesh-list
1973078|NCT00938470|Capecitabine|capecitabine|mesh-list
1973079|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
1973080|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973081|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
1973082|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
1973083|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
1973084|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973085|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
1973086|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1973087|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973088|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
1973089|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973090|NCT00938548|Pregabalin|pregabalin|mesh-list
1973091|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973092|NCT00938548|Analgesics|analgesics|mesh-ancestor
1973093|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
1973094|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1973095|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
1973096|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1973097|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1973098|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973099|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1973100|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1973101|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1973102|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1973103|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1973104|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1973105|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
1973106|NCT00938704|Glycerol|glycerol|mesh-list
1973107|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1973108|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
1973109|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973110|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
1973111|NCT00938704|Protective Agents|protective agents|mesh-ancestor
1973112|NCT00938704|Laxatives|laxatives|mesh-ancestor
1973113|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1973114|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1973115|NCT00938717|Linaclotide|linaclotide|mesh-list
1973116|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
1973117|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
1973118|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973119|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1973120|NCT00938860|Cyclosporine|cyclosporine|mesh-list
1973121|NCT00938860|Tacrolimus|tacrolimus|mesh-list
1973122|NCT00938860|Cyclosporins|cyclosporins|mesh-list
1973123|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973124|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
1973125|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973126|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1973127|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973128|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973129|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
1973130|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973131|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
1973132|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1973133|NCT00938886|Naltrexone|naltrexone|mesh-list
1973134|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1973135|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1973136|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973137|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
1973138|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1973139|NCT00938964|Lidocaine|lidocaine|mesh-list
1973140|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
1973141|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
1973142|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1973143|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973144|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
1973145|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1973146|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1973147|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1973148|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1973149|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1973150|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973151|NCT00939003|Adalimumab|adalimumab|mesh-list
1973152|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1973153|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1973154|NCT00939029|Nicotine|nicotine|mesh-list
1973155|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1973156|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
1973157|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1973158|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973159|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1973160|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1973161|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
1973162|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1973163|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973164|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
1973165|NCT00939120|Dutasteride|dutasteride|mesh-list
1973166|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1973167|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1973168|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973169|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973170|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
1973171|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1973172|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973173|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1973174|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1973175|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
1973176|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1973177|NCT00939120|Urological Agents|urological agents|mesh-ancestor
1973178|NCT00939159|Panobinostat|panobinostat|mesh-list
1973179|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973180|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1973181|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973182|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973183|NCT00939185|Azithromycin|azithromycin|mesh-list
1973184|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1973185|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973186|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
1973187|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1973188|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
1973189|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1973190|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973191|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1973192|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
1973193|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
1973194|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1973195|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
1973196|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1973197|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973198|NCT00939341|Budesonide|budesonide|mesh-list
1973199|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
1973200|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1973201|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1973202|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1973203|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
1973204|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1973205|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973206|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1973207|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
1973208|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
1973209|NCT00939341|Hormones|hormones|mesh-ancestor
1973210|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1973211|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1973212|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1973213|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1973214|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
1973215|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1973216|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973217|NCT00939367|Zolpidem|zolpidem|mesh-list
1973218|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1973219|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1973220|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1973221|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973222|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1973223|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
1973224|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
1973225|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1973226|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973227|NCT00939510|Lenalidomide|lenalidomide|mesh-list
1973228|NCT00939510|Sargramostim|sargramostim|mesh-list
1973229|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
1973230|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973231|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1973232|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1973233|NCT00939510|Growth Substances|growth substances|mesh-ancestor
1973234|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
1973235|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973236|NCT00939523|Lapatinib|lapatinib|mesh-list
1973237|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973238|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1973239|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973240|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973241|NCT00939536|Zolpidem|zolpidem|mesh-list
1973242|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1973243|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1973244|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1973245|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973246|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1973247|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
1973248|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
1973249|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1973250|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973251|NCT00939562|Doxycycline|doxycycline|mesh-list
1973252|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1973253|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973254|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
1973255|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1973256|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1973257|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1973258|NCT00939627|Cetuximab|cetuximab|mesh-list
1973259|NCT00939627|Sorafenib|sorafenib|mesh-list
1973260|NCT00939627|Antibodies|antibodies|mesh-list
1973261|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
1973262|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1973263|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
1973264|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973265|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973266|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1973267|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973268|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973269|NCT00939653|Cytarabine|cytarabine|mesh-list
1973270|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
1973271|NCT00939653|Etoposide|etoposide|mesh-list
1973272|NCT00939653|Clofarabine|clofarabine|mesh-list
1973273|NCT00939653|Lenograstim|lenograstim|mesh-list
1973274|NCT00939653|Sargramostim|sargramostim|mesh-list
1973275|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973276|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
1973277|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973278|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1973279|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1973280|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
1973281|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973282|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973283|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1973284|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1973285|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1973286|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1973287|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973288|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1973289|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1973290|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
1973291|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
1973292|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973293|NCT00939692|Topiramate|topiramate|mesh-list
1973294|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
1973295|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1973296|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973297|NCT00939705|Topiramate|topiramate|mesh-list
1973298|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
1973299|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1973300|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973301|NCT00939731|Crizotinib|crizotinib|mesh-list
1973302|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973303|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1973304|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973305|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973306|NCT00939770|Crizotinib|crizotinib|mesh-list
1973307|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973308|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1973309|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973310|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973311|NCT00939822|Simvastatin|simvastatin|mesh-list
1973312|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1973313|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1973314|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
1973315|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973316|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1973317|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1973318|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973319|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
1973320|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1973321|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1973322|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
1973323|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973324|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1973325|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1973326|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973327|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973328|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
1973329|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1973330|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973331|NCT00939952|Ertapenem|ertapenem|mesh-list
1973332|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1973333|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973334|NCT00939991|Bevacizumab|bevacizumab|mesh-list
1973335|NCT00939991|Temozolomide|temozolomide|mesh-list
1973336|NCT00939991|Vorinostat|vorinostat|mesh-list
1973337|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1973338|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973339|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1973340|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1973341|NCT00939991|Growth Substances|growth substances|mesh-ancestor
1973342|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973343|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
1973344|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1973345|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
1973346|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973347|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1973348|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973349|NCT00940017|Voriconazole|voriconazole|mesh-list
1973350|NCT00940017|Anidulafungin|anidulafungin|mesh-list
1973351|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
1973352|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973353|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1973354|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1973355|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973356|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973357|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1973358|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
1973359|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1973360|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973361|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1973362|NCT00940316|Irinotecan|irinotecan|mesh-list
1973363|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1973364|NCT00940316|Panitumumab|panitumumab|mesh-list
1973365|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1973366|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1973367|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973368|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973369|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973370|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1973371|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1973372|NCT00940342|Rituximab|rituximab|mesh-list
1973373|NCT00940342|Molgramostim|molgramostim|mesh-list
1973374|NCT00940342|Sargramostim|sargramostim|mesh-list
1973375|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1973376|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973377|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
1973378|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973379|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1973380|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1973381|NCT00940485|Entecavir|entecavir|mesh-list
1973382|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
1973383|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475562|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475563|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2475564|NCT01084902|Latanoprost|latanoprost|mesh-list
2475565|NCT01084902|Brinzolamide|brinzolamide|mesh-list
1973388|NCT00940589|Melatonin|melatonin|mesh-list
1973389|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
1973390|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973391|NCT00940589|Protective Agents|protective agents|mesh-ancestor
1973392|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475566|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1973393|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1973394|NCT00940602|Deferasirox|deferasirox|mesh-list
1973395|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1973396|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
1973397|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
1973398|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973399|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1973400|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1973401|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1973402|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
1973403|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973404|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973405|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1973406|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1973407|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
1973408|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973409|NCT00940875|Gemcitabine|gemcitabine|mesh-list
1973410|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1973411|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1973412|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
1973413|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973414|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973415|NCT00940875|Antiviral Agents|antiviral agents|mesh-ancestor
1973416|NCT00940875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973417|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973418|NCT00940875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973419|NCT00940875|Immunologic Factors|immunologic factors|mesh-ancestor
1973420|NCT00940875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973421|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1973422|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
1973423|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
1973424|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1973425|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1973426|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973427|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973428|NCT00940901|Urological Agents|urological agents|mesh-ancestor
1973429|NCT00940927|Albuterol|albuterol|mesh-list
1973430|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1973431|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
1973432|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1973433|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973434|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1973435|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
1973436|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
1973437|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1973438|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1973439|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1973440|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1973441|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
1973442|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1973443|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973444|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1973445|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
1973446|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973447|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1973448|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1973449|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973450|NCT00941304|Oxycodone|oxycodone|mesh-list
1973451|NCT00941304|Buprenorphine|buprenorphine|mesh-list
1973452|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1973453|NCT00941304|Narcotics|narcotics|mesh-ancestor
1973454|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1973455|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973456|NCT00941304|Analgesics|analgesics|mesh-ancestor
1973457|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
1973458|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1973459|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1973460|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
1973461|NCT00941330|Docetaxel|docetaxel|mesh-list
1973462|NCT00941330|Exemestane|exemestane|mesh-list
1973463|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973464|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
1973465|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973466|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1973467|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1973468|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
1973469|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973470|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973471|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1973472|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
1973473|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
1973474|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
1973475|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1973476|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1973477|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973478|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1973479|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
1973480|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1973481|NCT00941655|Leucovorin|leucovorin|mesh-list
1973482|NCT00941655|Fluorouracil|fluorouracil|mesh-list
1973483|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
1973484|NCT00941655|Irinotecan|irinotecan|mesh-list
1973485|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
1973486|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973487|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1973488|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973489|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973490|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
1973491|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973492|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1973493|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1973494|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973495|NCT00941655|Antidotes|antidotes|mesh-ancestor
1973496|NCT00941655|Protective Agents|protective agents|mesh-ancestor
1973497|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
1973498|NCT00941655|Vitamins|vitamins|mesh-ancestor
1973499|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
1973500|NCT00941668|Triclosan|triclosan|mesh-list
1973501|NCT00941668|Fluorides|fluorides|mesh-list
1973502|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
1973503|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
1973504|NCT00941668|Protective Agents|protective agents|mesh-ancestor
1973505|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973506|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1973507|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973508|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1973509|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1973510|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
1973511|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973512|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1973513|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
1973514|NCT00941720|Busulfan|busulfan|mesh-list
1973515|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973516|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
1973517|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973518|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1973519|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1973520|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
1973521|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973522|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973523|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1973524|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
1973525|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1973526|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
1973527|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1973528|NCT00941863|Sorafenib|sorafenib|mesh-list
1973529|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973530|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1973531|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973532|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973533|NCT00942084|Acyclovir|acyclovir|mesh-list
1973534|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
1973535|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973536|NCT00942149|Daptomycin|daptomycin|mesh-list
1973537|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1973538|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973539|NCT00942175|Esomeprazole|esomeprazole|mesh-list
1973540|NCT00942175|Omeprazole|omeprazole|mesh-list
1973541|NCT00942175|Lansoprazole|lansoprazole|mesh-list
1973542|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
1973543|NCT00942175|Clopidogrel|clopidogrel|mesh-list
1973544|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1973545|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1973546|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1973547|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1973548|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
1973549|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1973550|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973551|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973552|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1973553|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1973554|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1973555|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973556|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
1973557|NCT00942266|Leucovorin|leucovorin|mesh-list
1973558|NCT00942266|Fluorouracil|fluorouracil|mesh-list
1973559|NCT00942266|Vorinostat|vorinostat|mesh-list
1973560|NCT00942266|Calcium|calcium|mesh-list
1973561|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
1973562|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1973563|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973564|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1973565|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
1973566|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973567|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1973568|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973569|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973570|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
1973571|NCT00942266|Antidotes|antidotes|mesh-ancestor
1973572|NCT00942266|Protective Agents|protective agents|mesh-ancestor
1973573|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
1973574|NCT00942266|Vitamins|vitamins|mesh-ancestor
1973575|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
1973576|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1973577|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973578|NCT00942305|Brincidofovir|brincidofovir|mesh-list
1973579|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
1973580|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973581|NCT00942331|Gemcitabine|gemcitabine|mesh-list
1973582|NCT00942331|Bevacizumab|bevacizumab|mesh-list
1973583|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1973584|NCT00942331|Cisplatin|cisplatin|mesh-list
1973585|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
1973586|NCT00942331|Antibodies|antibodies|mesh-list
1973587|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
1973588|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1973589|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
1973590|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973591|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1973592|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1973593|NCT00942331|Growth Substances|growth substances|mesh-ancestor
1973594|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973595|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
1973596|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
1973597|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1973598|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
1973599|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973600|NCT00942331|Antiviral Agents|antiviral agents|mesh-ancestor
1973601|NCT00942331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973602|NCT00942331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973603|NCT00942331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973604|NCT00942357|Paclitaxel|paclitaxel|mesh-list
1973605|NCT00942357|Cisplatin|cisplatin|mesh-list
1973606|NCT00942357|Carboplatin|carboplatin|mesh-list
1973607|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1973608|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1973609|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973610|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
1973611|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
1973612|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
1973613|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973614|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
1973615|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
1973616|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973617|NCT00942422|Protective Agents|protective agents|mesh-ancestor
1973618|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973619|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
1973620|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1973621|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973622|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1973623|NCT00942448|Diclofenac|diclofenac|mesh-list
1973624|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1973625|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1973626|NCT00942448|Analgesics|analgesics|mesh-ancestor
1973627|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
1973628|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1973629|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973630|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1973631|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1973632|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1973633|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973634|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973635|NCT00942578|Prednisone|prednisone|mesh-list
1973636|NCT00942578|Bevacizumab|bevacizumab|mesh-list
1973637|NCT00942578|Lenalidomide|lenalidomide|mesh-list
1973638|NCT00942578|Docetaxel|docetaxel|mesh-list
1973639|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1973640|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973641|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1973642|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1973643|NCT00942578|Growth Substances|growth substances|mesh-ancestor
1973644|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973645|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
1973646|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
1973647|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
1973648|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
1973649|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973650|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1973651|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
1973652|NCT00942578|Hormones|hormones|mesh-ancestor
1973653|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1973654|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1973655|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
1973656|NCT00942708|Fluoxetine|fluoxetine|mesh-list
1973657|NCT00942708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1973658|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1973659|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1973660|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973661|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1973662|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
1973663|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973664|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1973665|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
1973666|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1973667|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1973668|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1973669|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973670|NCT00942734|Everolimus|everolimus|mesh-list
1973671|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1973672|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973673|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973674|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
1973675|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973676|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1973677|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973678|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973679|NCT00942825|Cisplatin|cisplatin|mesh-list
1973680|NCT00942825|Pemetrexed|pemetrexed|mesh-list
1973681|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973682|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973683|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973684|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1973685|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1973686|NCT00942877|Cediranib|cediranib|mesh-list
1973687|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973688|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1973689|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973690|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973691|NCT00942968|Dalteparin|dalteparin|mesh-list
1973692|NCT00942968|Tinzaparin|tinzaparin|mesh-list
1973693|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1973694|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
1973695|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1973696|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2475567|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1973697|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973698|NCT00942994|Amlodipine|amlodipine|mesh-list
1973699|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1973700|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1973701|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1973702|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1973703|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973704|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1973705|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973706|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
1973707|NCT00942994|Diuretics|diuretics|mesh-ancestor
1973708|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
1973709|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1973710|NCT00943072|Aflibercept|aflibercept|mesh-list
1973711|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1973712|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1973713|NCT00943072|Growth Substances|growth substances|mesh-ancestor
1973714|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973715|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
1973716|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973717|NCT00943098|Diclofenac|diclofenac|mesh-list
1973718|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1973719|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1973720|NCT00943098|Analgesics|analgesics|mesh-ancestor
1973721|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
1973722|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1973723|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973724|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1973725|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1973726|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1973727|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973728|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973729|NCT00943111|Eliglustat|eliglustat|mesh-list
1973730|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973731|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973732|NCT00943124|Niacin|niacin|mesh-list
1973733|NCT00943124|Niacinamide|niacinamide|mesh-list
1973734|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
1973735|NCT00943124|Simvastatin|simvastatin|mesh-list
1973736|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1973737|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1973738|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
1973739|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973740|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1973741|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1973742|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973743|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
1973744|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
1973745|NCT00943124|Vitamins|vitamins|mesh-ancestor
1973746|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
1973747|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973748|NCT00943202|Vaccines|vaccines|mesh-list
1973749|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
1973750|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973751|NCT00943319|Fludarabine|fludarabine|mesh-list
1973752|NCT00943319|Busulfan|busulfan|mesh-list
1973753|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
1973754|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973755|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973756|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973757|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
1973758|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973759|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
1973760|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1973761|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1973762|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1973763|NCT00943397|Montelukast|montelukast|mesh-list
1973764|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1973765|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
1973766|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1973767|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
1973768|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1973769|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973770|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1973771|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1973772|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973773|NCT00943592|Melphalan|melphalan|mesh-list
1973774|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
1973775|NCT00943592|Clofarabine|clofarabine|mesh-list
1973776|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1973777|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
1973778|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973779|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973780|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1973781|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973782|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
1973783|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973784|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1973785|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1973786|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
2745645|NCT02757872|Vitamins|vitamins|mesh-list
2745646|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
2745647|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745648|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2745649|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2745650|NCT02753998|Paclitaxel|paclitaxel|mesh-list
2745651|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2745652|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745653|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
2745654|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
2745655|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
2745656|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745657|NCT02743923|Paclitaxel|paclitaxel|mesh-list
2745658|NCT02743923|Bevacizumab|bevacizumab|mesh-list
2745659|NCT02743923|Carboplatin|carboplatin|mesh-list
2745660|NCT02743923|Pemetrexed|pemetrexed|mesh-list
2745661|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2745662|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973805|NCT00943670|Trastuzumab|trastuzumab|mesh-list
1973806|NCT00943670|Pertuzumab|pertuzumab|mesh-list
1973807|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1973808|NCT00943670|Maytansine|maytansine|mesh-list
1973809|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1973810|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973811|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1973812|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
1973813|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
1973814|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
1973815|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973816|NCT00943683|Montelukast|montelukast|mesh-list
1973817|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1973818|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
1973819|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1973820|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
1973821|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1973822|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973823|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1973824|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1973825|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973826|NCT00943735|Fesoterodine|fesoterodine|mesh-list
1973827|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1973828|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1973829|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
1973830|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1973831|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973832|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973833|NCT00943735|Urological Agents|urological agents|mesh-ancestor
1973834|NCT00943761|Interferons|interferons|mesh-list
1973835|NCT00943761|Ribavirin|ribavirin|mesh-list
1973836|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973837|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
1973838|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973839|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
1973840|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973841|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
1973842|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973843|NCT00943800|Vidarabine|vidarabine|mesh-list
2745663|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
1973844|NCT00943800|Fludarabine|fludarabine|mesh-list
1973845|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
1973846|NCT00943800|Melphalan|melphalan|mesh-list
1973847|NCT00943800|Busulfan|busulfan|mesh-list
1973848|NCT00943800|Thiotepa|thiotepa|mesh-list
1973849|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1973850|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
1973851|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973852|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1973853|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
1973854|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973855|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973856|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
1973857|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973858|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
1973859|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1973860|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1973861|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
1973862|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1973863|NCT00943826|Bevacizumab|bevacizumab|mesh-list
1973864|NCT00943826|Temozolomide|temozolomide|mesh-list
1973865|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1973866|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973867|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1973868|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1973869|NCT00943826|Growth Substances|growth substances|mesh-ancestor
1973870|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973871|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
1973872|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1973873|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
1973874|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973875|NCT00943852|Losartan|losartan|mesh-list
1973876|NCT00943852|Isosorbide|isosorbide|mesh-list
1973877|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
1973878|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
1973879|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1973880|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1973881|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1973882|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1973883|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973884|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1973885|NCT00943852|Diuretics|diuretics|mesh-ancestor
1973886|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
1973887|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973888|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
1973889|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
1973890|NCT00943878|Vaccines|vaccines|mesh-list
1973891|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
1973892|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973893|NCT00943917|Exenatide|exenatide|mesh-list
1973894|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1973895|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973896|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1973897|NCT00943917|Incretins|incretins|mesh-ancestor
1973898|NCT00943917|Hormones|hormones|mesh-ancestor
1973899|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1973900|NCT00944034|Vaccines|vaccines|mesh-list
1973901|NCT00944034|Immunologic Factors|immunologic factors|mesh-ancestor
1973902|NCT00944034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973903|NCT00944047|Paclitaxel|paclitaxel|mesh-list
1973904|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
1973905|NCT00944047|Doxorubicin|doxorubicin|mesh-list
1973906|NCT00944047|Trastuzumab|trastuzumab|mesh-list
1973907|NCT00944047|Mitogens|mitogens|mesh-list
1973908|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1973909|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1973910|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
1973911|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
1973912|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
1973913|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973914|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1973915|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
1973916|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973917|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1973918|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1973919|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
1973920|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1973921|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1973922|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1973923|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1973924|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973925|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1973926|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1973927|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1973928|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973929|NCT00944450|Incretins|incretins|mesh-ancestor
1973930|NCT00944450|Hormones|hormones|mesh-ancestor
1973931|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1973932|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1973933|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
1973934|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973935|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973936|NCT00944554|Varenicline|varenicline|mesh-list
1973937|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1973938|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1973939|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
1973940|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1973941|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973942|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973943|NCT00944645|Niacin|niacin|mesh-list
1973944|NCT00944645|Niacinamide|niacinamide|mesh-list
1973945|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
1973946|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1973947|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
1973948|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973949|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1973950|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
1973951|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
1973952|NCT00944645|Vitamins|vitamins|mesh-ancestor
1973953|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
1973954|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973955|NCT00944658|Apremilast|apremilast|mesh-list
1973956|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1973957|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1973958|NCT00944658|Analgesics|analgesics|mesh-ancestor
1973959|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
1973960|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1973961|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973962|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1973963|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1973964|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1973965|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1973966|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1973967|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973968|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
1973969|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
1973970|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
1973971|NCT00944671|Famotidine|famotidine|mesh-list
1973972|NCT00944671|Calcium|calcium|mesh-list
1973973|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1973974|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973975|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1973976|NCT00944671|Antacids|antacids|mesh-ancestor
1973977|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1973978|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1973979|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1973980|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1973981|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
1973982|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
1973983|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1973984|NCT00944697|Oxycodone|oxycodone|mesh-list
1973985|NCT00944697|Naloxone|naloxone|mesh-list
1973986|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1973987|NCT00944697|Narcotics|narcotics|mesh-ancestor
1973988|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1973989|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1973990|NCT00944697|Analgesics|analgesics|mesh-ancestor
1973991|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
1973992|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1973993|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1973994|NCT00944710|Atropine|atropine|mesh-list
1973995|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1973996|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1973997|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1973998|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
1973999|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974000|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974001|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1974002|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
1974003|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
1974004|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
1974005|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1974006|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1974007|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
1974008|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974009|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974010|NCT00944749|Cyclosporine|cyclosporine|mesh-list
1974011|NCT00944749|Cyclosporins|cyclosporins|mesh-list
1974012|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974013|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974014|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1974015|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
1974016|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974017|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
1974018|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974019|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
1974020|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1974021|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1974022|NCT00945009|Dactinomycin|dactinomycin|mesh-list
1974023|NCT00945009|Cactinomycin|cactinomycin|mesh-list
1974024|NCT00945009|Doxorubicin|doxorubicin|mesh-list
1974025|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1974026|NCT00945009|Vincristine|vincristine|mesh-list
1974027|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1974028|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974029|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1974030|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1974031|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974032|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974033|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1974034|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
1974035|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
1974036|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
1974037|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1974038|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974039|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1974040|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1974041|NCT00945035|Etoricoxib|etoricoxib|mesh-list
1974042|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1974043|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1974044|NCT00945035|Analgesics|analgesics|mesh-ancestor
1974045|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
1974046|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974047|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974048|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1974049|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1974050|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1974051|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1974052|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974053|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974054|NCT00945139|Bevacizumab|bevacizumab|mesh-list
1974055|NCT00945139|Doxorubicin|doxorubicin|mesh-list
1974056|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1974057|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974058|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1974059|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1974060|NCT00945139|Growth Substances|growth substances|mesh-ancestor
1974061|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974062|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
1974063|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1974064|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1974065|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1974066|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974067|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974068|NCT00945191|Paclitaxel|paclitaxel|mesh-list
1974069|NCT00945191|Carboplatin|carboplatin|mesh-list
1974070|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1974071|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974072|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
1974073|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
1974074|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
1974075|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974076|NCT00945256|Nitroprusside|nitroprusside|mesh-list
1974077|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1974078|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
1974079|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
1974080|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974081|NCT00945282|Ritonavir|ritonavir|mesh-list
1974082|NCT00945282|Lopinavir|lopinavir|mesh-list
1974083|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1974084|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1974085|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
1974086|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974087|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974088|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1974089|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1974090|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
1974091|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974092|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1974093|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1974094|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
1974095|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1974096|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1974097|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1974098|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1974099|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974100|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
1974101|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974102|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974103|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1974104|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974105|NCT00945321|Aprepitant|aprepitant|mesh-list
1974106|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
1974107|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
1974108|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
1974109|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974110|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974111|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1974112|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1974113|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974114|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974115|NCT00945334|Rifaximin|rifaximin|mesh-list
1974116|NCT00945334|Neomycin|neomycin|mesh-list
1974117|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1974118|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974119|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1974120|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1974121|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974122|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974123|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1974124|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974125|NCT00945750|Famotidine|famotidine|mesh-list
1974126|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1974127|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1974128|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1974129|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
1974130|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
1974131|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974132|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974133|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974134|NCT00945815|Cytarabine|cytarabine|mesh-list
1974135|NCT00945815|Clofarabine|clofarabine|mesh-list
1974136|NCT00945815|Epratuzumab|epratuzumab|mesh-list
1974137|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1974138|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
1974139|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974140|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974141|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
1974142|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974143|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1974144|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
1974145|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974146|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1974147|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
1974148|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1974149|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1974150|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974151|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1974152|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1974153|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1974154|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1974155|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974156|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974157|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974158|NCT00945945|Analgesics|analgesics|mesh-ancestor
1974159|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
1974160|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974161|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
1974162|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1974163|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
1974164|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
1974165|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
1974166|NCT00946023|Rituximab|rituximab|mesh-list
1974167|NCT00946023|Fludarabine|fludarabine|mesh-list
1974168|NCT00946023|Tacrolimus|tacrolimus|mesh-list
1974169|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1974170|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
1974171|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974172|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1974173|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1974174|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
1974175|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974176|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974177|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1974178|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1974179|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1974180|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974181|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1974182|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1974183|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
1974184|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1974185|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974186|NCT00946088|Progesterone|progesterone|mesh-list
1974187|NCT00946088|Progestins|progestins|mesh-ancestor
1974188|NCT00946088|Hormones|hormones|mesh-ancestor
1974189|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1974190|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974191|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
1974192|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
1974193|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1974194|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1974195|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974196|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974197|NCT00946114|Urological Agents|urological agents|mesh-ancestor
1974198|NCT00946153|Lenvatinib|lenvatinib|mesh-list
1974199|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974200|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1974201|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974202|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974203|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1974204|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1974205|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1974206|NCT00946192|Desogestrel|desogestrel|mesh-list
1974207|NCT00946192|Estradiol|estradiol|mesh-list
1974208|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1974209|NCT00946192|Progesterone|progesterone|mesh-list
1974210|NCT00946192|Estrogens|estrogens|mesh-ancestor
1974211|NCT00946192|Hormones|hormones|mesh-ancestor
1974212|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1974213|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974214|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1974215|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
1974216|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1974217|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1974218|NCT00946192|Progestins|progestins|mesh-ancestor
1974219|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1974220|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1974221|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1974222|NCT00946270|Thalidomide|thalidomide|mesh-list
1974223|NCT00946270|Prednisone|prednisone|mesh-list
1974224|NCT00946270|Pomalidomide|pomalidomide|mesh-list
1974225|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1974226|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
1974227|NCT00946270|Hormones|hormones|mesh-ancestor
1974228|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1974229|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974230|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1974231|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974232|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
1974233|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1974234|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1974235|NCT00946270|Growth Substances|growth substances|mesh-ancestor
1974236|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
1974237|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1974238|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
1974239|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1974240|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974241|NCT00946309|Sulforaphane|sulforaphane|mesh-list
1974242|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1974243|NCT00946309|Protective Agents|protective agents|mesh-ancestor
1974244|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974245|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974246|NCT00946348|Dronabinol|dronabinol|mesh-list
1974247|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
1974248|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974249|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1974250|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1974251|NCT00946348|Analgesics|analgesics|mesh-ancestor
1974252|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
1974253|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974254|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1974255|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1974256|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974257|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974258|NCT00946348|Hormones|hormones|mesh-ancestor
1974259|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1974260|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
1974261|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1974262|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1974263|NCT00946478|Analgesics|analgesics|mesh-ancestor
1974264|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
1974265|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974266|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974267|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1974268|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1974269|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
1974270|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1974271|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
1974272|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1974273|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974274|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974275|NCT00946647|Azacitidine|azacitidine|mesh-list
1974276|NCT00946647|Panobinostat|panobinostat|mesh-list
1974277|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1974278|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
1974279|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974280|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974281|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974282|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1974283|NCT00946712|Paclitaxel|paclitaxel|mesh-list
1974284|NCT00946712|Bevacizumab|bevacizumab|mesh-list
1974285|NCT00946712|Carboplatin|carboplatin|mesh-list
1974286|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1974287|NCT00946712|Cetuximab|cetuximab|mesh-list
1974288|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1974289|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
1974290|NCT00946712|Antibodies|antibodies|mesh-list
1974291|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
1974292|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1974293|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
1974294|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1974295|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974296|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
1974297|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
1974298|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
1974299|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974300|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1974301|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1974302|NCT00946712|Growth Substances|growth substances|mesh-ancestor
1974303|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974304|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
1974305|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
1974306|NCT00946920|Goserelin|goserelin|mesh-list
1974307|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1974308|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974309|NCT00946998|Sertraline|sertraline|mesh-list
1974310|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
1974311|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1974312|NCT00946998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1974313|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1974314|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1974315|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974316|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974317|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
1974318|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974319|NCT00947154|Aripiprazole|aripiprazole|mesh-list
1974320|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
1974321|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1974322|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1974323|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1974324|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1974325|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974326|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
1974327|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
1974328|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974329|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974330|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1974331|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1974332|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
1974333|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1974334|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1974335|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1974336|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1974337|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1974338|NCT00947167|Pertuzumab|pertuzumab|mesh-list
1974339|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974340|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1974341|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974342|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974343|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1974344|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
1974345|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974346|NCT00947349|Interferons|interferons|mesh-list
1974347|NCT00947349|Ribavirin|ribavirin|mesh-list
1974348|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974349|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
1974350|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974351|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
1974352|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974353|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1974354|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
1974355|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974356|NCT00947518|Chlorhexidine|chlorhexidine|mesh-list
1974357|NCT00947518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1974358|NCT00947518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974359|NCT00947518|Disinfectants|disinfectants|mesh-ancestor
1974360|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
1974361|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1974362|NCT00947531|Protective Agents|protective agents|mesh-ancestor
1974363|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974364|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
1974365|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
1974366|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974367|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
1974368|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
1974369|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1974370|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
1974371|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974372|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1974373|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1974374|NCT00947765|Prednisolone|prednisolone|mesh-list
1974375|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1974376|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
1974377|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1974378|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
1974379|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1974380|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
1974381|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1974382|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
1974383|NCT00947765|Hormones|hormones|mesh-ancestor
1974384|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1974385|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974386|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1974387|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974388|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
1974389|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
1974390|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974391|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1974392|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1974393|NCT00947765|Protective Agents|protective agents|mesh-ancestor
1974394|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1974395|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1974396|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974397|NCT00948064|Azacitidine|azacitidine|mesh-list
1974398|NCT00948064|Vorinostat|vorinostat|mesh-list
1974399|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1974400|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
1974401|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974402|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974403|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974404|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1974405|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
1974406|NCT00948090|Busulfan|busulfan|mesh-list
1974407|NCT00948090|Etoposide|etoposide|mesh-list
1974408|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1974409|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
1974410|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974411|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1974412|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1974413|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
1974414|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974415|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974416|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1974417|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1974418|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1974419|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1974420|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974421|NCT00948155|Varenicline|varenicline|mesh-list
1974422|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1974423|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1974424|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
1974425|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974426|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974427|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974428|NCT00948298|Vitamin D|vitamin d|mesh-list
1974429|NCT00948298|Vitamins|vitamins|mesh-ancestor
1974430|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
1974431|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974432|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1974433|NCT00948389|Dasatinib|dasatinib|mesh-list
1974434|NCT00948389|Lomustine|lomustine|mesh-list
1974435|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974436|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1974437|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974438|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974439|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1974440|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
1974441|NCT00948428|Imiquimod|imiquimod|mesh-list
1974442|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1974443|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
1974444|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974445|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974446|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
1974447|NCT00948441|Ethanol|ethanol|mesh-list
1974448|NCT00948441|Heparin|heparin|mesh-list
1974449|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
1974450|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1974451|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1974452|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974453|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1974454|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974455|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1974456|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974457|NCT00948506|Cidofovir|cidofovir|mesh-list
1974458|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
1974459|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974460|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974461|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974462|NCT00948610|Infliximab|infliximab|mesh-list
1974463|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
1974464|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1974465|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1974466|NCT00948675|Paclitaxel|paclitaxel|mesh-list
1974467|NCT00948675|Bevacizumab|bevacizumab|mesh-list
1974468|NCT00948675|Carboplatin|carboplatin|mesh-list
1974469|NCT00948675|Pemetrexed|pemetrexed|mesh-list
1974470|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1974471|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974472|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
1974473|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
1974474|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
1974475|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974476|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1974477|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1974478|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1974479|NCT00948675|Growth Substances|growth substances|mesh-ancestor
1974480|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974481|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
1974482|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974483|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1974484|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1974485|NCT00948688|Vorinostat|vorinostat|mesh-list
1974486|NCT00948688|Fluorouracil|fluorouracil|mesh-list
1974487|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974488|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1974489|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974490|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974491|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
1974492|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1974493|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1974494|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
1974495|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974496|NCT00948766|Rivastigmine|rivastigmine|mesh-list
1974497|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1974498|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974499|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974500|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
1974501|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974502|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974503|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1974504|NCT00948766|Protective Agents|protective agents|mesh-ancestor
1974505|NCT00948818|Linaclotide|linaclotide|mesh-list
1974506|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
1974507|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
1974508|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974509|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1974510|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
1974511|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1974512|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
1974513|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974514|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
1974515|NCT00948896|Piperaquine|piperaquine|mesh-list
1974516|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
1974517|NCT00948896|Trimethoprim|trimethoprim|mesh-list
1974518|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
1974519|NCT00948896|Artenimol|artenimol|mesh-list
1974520|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1974521|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
1974522|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
1974523|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1974524|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1974525|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974526|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1974527|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974528|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974529|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1974530|NCT00948896|Renal Agents|renal agents|mesh-ancestor
1974531|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1974532|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1974533|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1974534|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1974535|NCT00948922|Fludarabine|fludarabine|mesh-list
1974536|NCT00948922|Bortezomib|bortezomib|mesh-list
1974537|NCT00948922|Melphalan|melphalan|mesh-list
1974538|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974539|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974540|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1974541|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
1974542|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974543|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1974544|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
1974545|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1974546|NCT00948935|Gemcitabine|gemcitabine|mesh-list
1974547|NCT00948935|Irinotecan|irinotecan|mesh-list
1974548|NCT00948935|Panitumumab|panitumumab|mesh-list
1974549|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1974550|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
1974551|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974552|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974553|NCT00948935|Antiviral Agents|antiviral agents|mesh-ancestor
1974554|NCT00948935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974555|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974556|NCT00948935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1974557|NCT00948935|Immunologic Factors|immunologic factors|mesh-ancestor
1974558|NCT00948935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974559|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1974560|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1974561|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1974562|NCT00949078|Omalizumab|omalizumab|mesh-list
1974563|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1974564|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1974565|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
1974566|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
1974567|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
1974568|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
1974569|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1974570|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1974571|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
1974572|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
1974573|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974574|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974575|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974576|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1974577|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
1974578|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1974579|NCT00949234|Ritonavir|ritonavir|mesh-list
1974580|NCT00949234|Lopinavir|lopinavir|mesh-list
1974581|NCT00949234|Tenofovir|tenofovir|mesh-list
1974582|NCT00949234|Emtricitabine|emtricitabine|mesh-list
1974583|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1974584|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1974585|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
1974586|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974587|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974588|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1974589|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1974590|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
1974591|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974592|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1974593|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1974594|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1974595|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1974596|NCT00949325|Sirolimus|sirolimus|mesh-list
1974597|NCT00949325|Doxorubicin|doxorubicin|mesh-list
1974598|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1974599|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1974600|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974601|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1974602|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1974603|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974604|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974605|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1974606|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974607|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
1974608|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1974609|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
1974610|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974611|NCT00949533|Oseltamivir|oseltamivir|mesh-list
1974612|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
1974613|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974614|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974615|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974616|NCT00949650|Pemetrexed|pemetrexed|mesh-list
1974617|NCT00949650|Afatinib|afatinib|mesh-list
1974618|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974619|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974620|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974621|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1974622|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1974623|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1974624|NCT00949702|Vemurafenib|vemurafenib|mesh-list
1974625|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974626|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1974627|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974628|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974629|NCT00949884|Losartan|losartan|mesh-list
1974630|NCT00949884|Olmesartan|olmesartan|mesh-list
1974631|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1974632|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1974633|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1974634|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1974635|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1974636|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974637|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1974638|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974639|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1974640|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974641|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974642|NCT00950170|Factor VIII|factor viii|mesh-list
1974643|NCT00950170|Coagulants|coagulants|mesh-ancestor
1974644|NCT00950248|Idebenone|idebenone|mesh-list
1974645|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
1974646|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974647|NCT00950248|Protective Agents|protective agents|mesh-ancestor
1974648|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974649|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
1974650|NCT00950300|Docetaxel|docetaxel|mesh-list
1974651|NCT00950300|Fluorouracil|fluorouracil|mesh-list
1974652|NCT00950300|Trastuzumab|trastuzumab|mesh-list
1974653|NCT00950300|Epirubicin|epirubicin|mesh-list
1974654|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1974655|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
1974656|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974657|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1974658|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1974659|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
1974660|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974661|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974662|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1974663|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
1974664|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
1974665|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
1974666|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
1974667|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1974668|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1974669|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1974670|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1974671|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1974672|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974673|NCT00950352|Choline|choline|mesh-list
1974674|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
1974675|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
1974676|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1974677|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
1974678|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974679|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1974680|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1974681|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
1974682|NCT00950365|Pemetrexed|pemetrexed|mesh-list
1974683|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1974684|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974685|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974686|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974687|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1974688|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1974689|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1974690|NCT00950599|Saxagliptin|saxagliptin|mesh-list
1974691|NCT00950599|Incretins|incretins|mesh-ancestor
1974692|NCT00950599|Hormones|hormones|mesh-ancestor
1974693|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1974694|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974695|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1974696|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
1974697|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974698|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974699|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1974700|NCT00950651|Tramadol|tramadol|mesh-list
1974701|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1974702|NCT00950651|Narcotics|narcotics|mesh-ancestor
1974703|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1974704|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974705|NCT00950651|Analgesics|analgesics|mesh-ancestor
1974706|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
1974707|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974708|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1974709|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1974710|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1974711|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974712|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974713|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1974714|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1974715|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974716|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
1974717|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974718|NCT00950742|Trastuzumab|trastuzumab|mesh-list
1974719|NCT00950742|Afatinib|afatinib|mesh-list
1974720|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1974721|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974722|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1974723|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974724|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974725|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
1974726|NCT00950755|Antibodies|antibodies|mesh-list
1974727|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
1974728|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974729|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974730|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
1974731|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1974732|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
1974733|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974734|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974735|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1974736|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
1974737|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
1974738|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1974739|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
1974740|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974741|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974742|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1974743|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
1974744|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974745|NCT00950859|Dolutegravir|dolutegravir|mesh-list
1974746|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1974747|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1974748|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974749|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974750|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1974751|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1974752|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
1974753|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974754|NCT00950911|Denosumab|denosumab|mesh-list
1974755|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1974756|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974757|NCT00951015|Efavirenz|efavirenz|mesh-list
1974758|NCT00951015|Dolutegravir|dolutegravir|mesh-list
1974759|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1974760|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1974761|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974762|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974763|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
1974764|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1974765|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1974766|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1974767|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1974768|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1974769|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1974770|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1974771|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1974772|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1974773|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1974774|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1974775|NCT00951041|Vaccines|vaccines|mesh-list
1974776|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
1974777|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974778|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
1974779|NCT00951379|Pioglitazone|pioglitazone|mesh-list
1974780|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1974781|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974782|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1974783|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
1974784|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1974785|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1974786|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1974787|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1974788|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974789|NCT00951496|Paclitaxel|paclitaxel|mesh-list
1974790|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1974791|NCT00951496|Bevacizumab|bevacizumab|mesh-list
1974792|NCT00951496|Cisplatin|cisplatin|mesh-list
1974793|NCT00951496|Carboplatin|carboplatin|mesh-list
1974794|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1974795|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
1974796|NCT00951496|Antibodies|antibodies|mesh-list
1974797|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
1974798|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1974799|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
1974800|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1974801|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974802|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
1974803|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
1974804|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
1974805|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974806|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1974807|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1974808|NCT00951496|Growth Substances|growth substances|mesh-ancestor
1974809|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974810|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
1974811|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
1974812|NCT00951561|Ibuprofen|ibuprofen|mesh-list
1974813|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1974814|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1974815|NCT00951561|Analgesics|analgesics|mesh-ancestor
1974816|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
1974817|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974818|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974819|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1974820|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1974821|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1974822|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974823|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974824|NCT00951665|Paclitaxel|paclitaxel|mesh-list
1974825|NCT00951665|Maytansine|maytansine|mesh-list
1974826|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1974827|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1974828|NCT00951665|Trastuzumab|trastuzumab|mesh-list
1974829|NCT00951665|Pertuzumab|pertuzumab|mesh-list
1974830|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1974831|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974832|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
1974833|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
1974834|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
1974835|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974836|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1974837|NCT00951899|Metformin|metformin|mesh-list
1974838|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1974839|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1974840|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974841|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1974842|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1974843|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
1974844|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974845|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1974846|NCT00951912|Genistein|genistein|mesh-list
1974847|NCT00951912|Daidzein|daidzein|mesh-list
1974848|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1974849|NCT00951912|Protective Agents|protective agents|mesh-ancestor
1974850|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974851|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974852|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1974853|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974854|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974855|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
1974856|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1974857|NCT00951912|Estrogens|estrogens|mesh-ancestor
1974858|NCT00951912|Hormones|hormones|mesh-ancestor
1974859|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1974860|NCT00952068|Tramadol|tramadol|mesh-list
1974861|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1974862|NCT00952068|Narcotics|narcotics|mesh-ancestor
1974863|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1974864|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974865|NCT00952068|Analgesics|analgesics|mesh-ancestor
1974866|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
1974867|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974868|NCT00952081|Clevidipine|clevidipine|mesh-list
1974869|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1974870|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1974871|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974872|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1974873|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974874|NCT00952133|Dexamethasone|dexamethasone|mesh-list
1974875|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
1974876|NCT00952133|Palonosetron|palonosetron|mesh-list
1974877|NCT00952133|BB 1101|bb 1101|mesh-list
1974878|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1974879|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
1974880|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
1974881|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974882|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974883|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1974884|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
1974885|NCT00952133|Hormones|hormones|mesh-ancestor
1974886|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1974887|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1974888|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974889|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
1974890|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974891|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974892|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1974893|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1974894|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
1974895|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974896|NCT00952276|Vaccines|vaccines|mesh-list
1974897|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
1974898|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974899|NCT00952341|Dexamethasone|dexamethasone|mesh-list
1974900|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
1974901|NCT00952341|Aprepitant|aprepitant|mesh-list
1974902|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
1974903|NCT00952341|Granisetron|granisetron|mesh-list
1974904|NCT00952341|BB 1101|bb 1101|mesh-list
1974905|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1974906|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
1974907|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
1974908|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974909|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974910|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1974911|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
1974912|NCT00952341|Hormones|hormones|mesh-ancestor
1974913|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1974914|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1974915|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974916|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
1974917|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1974918|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974919|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1974920|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974921|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1974922|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
1974923|NCT00952380|Dalteparin|dalteparin|mesh-list
1974924|NCT00952380|Tinzaparin|tinzaparin|mesh-list
1974925|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1974926|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
1974927|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1974928|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1974929|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974930|NCT00952419|Vaccines|vaccines|mesh-list
1974931|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
1974932|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974933|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
1974934|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
1974935|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974936|NCT00952523|Adapalene|adapalene|mesh-list
1974937|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
1974938|NCT00952523|Tretinoin|tretinoin|mesh-list
1974939|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1974940|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
1974941|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1974942|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1974943|NCT00952523|Analgesics|analgesics|mesh-ancestor
1974944|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
1974945|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1974946|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974947|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1974948|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1974949|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974950|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
1974951|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
1974952|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1974953|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
1974954|NCT00952614|Hormones|hormones|mesh-ancestor
1974955|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1974956|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974957|NCT00952653|Midazolam|midazolam|mesh-list
1974958|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1974959|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1974960|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1974961|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1974962|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974963|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1974964|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1974965|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1974966|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1974967|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
1974968|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
1974969|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
1974970|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
1974971|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1974972|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974973|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1974974|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1974975|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1974976|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
1974977|NCT00952731|Tamoxifen|tamoxifen|mesh-list
1974978|NCT00952731|Afimoxifene|afimoxifene|mesh-list
1974979|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1974980|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
1974981|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1974982|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1974983|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1974984|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1974985|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1974986|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1974987|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1974988|NCT00952822|Factor VIII|factor viii|mesh-list
1974989|NCT00952822|Coagulants|coagulants|mesh-ancestor
1974990|NCT00953017|Bisacodyl|bisacodyl|mesh-list
1974991|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
1974992|NCT00953017|Lubiprostone|lubiprostone|mesh-list
1974993|NCT00953017|Cathartics|cathartics|mesh-ancestor
1974994|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1974995|NCT00953017|Laxatives|laxatives|mesh-ancestor
1974996|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1974997|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1974998|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1974999|NCT00953043|Lubiprostone|lubiprostone|mesh-list
1975000|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1975001|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975002|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975003|NCT00953056|Vaccines|vaccines|mesh-list
1975004|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
1975005|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975006|NCT00953121|Bevacizumab|bevacizumab|mesh-list
1975007|NCT00953121|Carboplatin|carboplatin|mesh-list
1975008|NCT00953121|Irinotecan|irinotecan|mesh-list
1975009|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1975010|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975011|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1975012|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1975013|NCT00953121|Growth Substances|growth substances|mesh-ancestor
1975014|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975015|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
1975016|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1975017|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1975018|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975019|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975020|NCT00953147|Ciclesonide|ciclesonide|mesh-list
1975021|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
1975022|NCT00953147|Hormones|hormones|mesh-ancestor
1975023|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1975024|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975025|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1975026|NCT00953199|Lidocaine|lidocaine|mesh-list
1975027|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
1975028|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
1975029|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1975030|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975031|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
1975032|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975033|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1975034|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1975035|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1975036|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975037|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975038|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
1975039|NCT00953212|Amiodarone|amiodarone|mesh-list
1975040|NCT00953212|Metoprolol|metoprolol|mesh-list
1975041|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1975042|NCT00953212|Vitamins|vitamins|mesh-ancestor
1975043|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
1975044|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975045|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
1975046|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975047|NCT00953212|Protective Agents|protective agents|mesh-ancestor
1975048|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1975049|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
1975050|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975051|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1975052|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
1975053|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1975054|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975055|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1975056|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1975057|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1975058|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975059|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1975060|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1975061|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1975062|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1975063|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
1975064|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
1975065|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975066|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1975067|NCT00953225|Vitamin D|vitamin d|mesh-list
1975068|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
1975069|NCT00953225|Vitamins|vitamins|mesh-ancestor
1975070|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
1975071|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975072|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1975073|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1975074|NCT00953524|Vaccines|vaccines|mesh-list
1975075|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
1975076|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975077|NCT00953576|Ketoconazole|ketoconazole|mesh-list
1975078|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
1975079|NCT00953576|Lapatinib|lapatinib|mesh-list
1975080|NCT00953576|Dutasteride|dutasteride|mesh-list
1975081|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1975082|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975083|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1975084|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975085|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975086|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
1975087|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1975088|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1975089|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1975090|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1975091|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
1975092|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1975093|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975094|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1975095|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1975096|NCT00953667|Niacin|niacin|mesh-list
1975097|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1975098|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
1975099|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975100|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1975101|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
1975102|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
1975103|NCT00953667|Vitamins|vitamins|mesh-ancestor
1975104|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
1975105|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975106|NCT00953680|Losartan|losartan|mesh-list
1975107|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1975108|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1975109|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1975110|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1975111|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1975112|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975113|NCT00953680|Diuretics|diuretics|mesh-ancestor
1975114|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
1975115|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975116|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1975117|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975118|NCT00953706|Ivacaftor|ivacaftor|mesh-list
1975119|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1975120|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975121|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975122|NCT00953745|Aripiprazole|aripiprazole|mesh-list
1975123|NCT00953745|Citalopram|citalopram|mesh-list
2745664|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
1975124|NCT00953745|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1975125|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1975126|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975127|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975128|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975129|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
1975130|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975131|NCT00953745|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1975132|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
1975133|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1975134|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1975135|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1975136|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1975137|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
1975138|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
1975139|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1975140|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1975141|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1975142|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1975143|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1975144|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1975145|NCT00953849|Calcitriol|calcitriol|mesh-list
1975146|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
1975147|NCT00953849|Vitamin D|vitamin d|mesh-list
1975148|NCT00953849|Celecoxib|celecoxib|mesh-list
1975149|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1975150|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1975151|NCT00953849|Analgesics|analgesics|mesh-ancestor
1975152|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
1975153|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975154|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975155|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1975156|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1975157|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1975158|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1975159|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975160|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975161|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1975162|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1975163|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975164|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1975165|NCT00953849|Vitamins|vitamins|mesh-ancestor
1975166|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
1975167|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1975168|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1975169|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1975170|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1975171|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975172|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975173|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
1975174|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975175|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975176|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1975177|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
1975178|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1975179|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1975180|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1975181|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1975182|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975183|NCT00954174|Paclitaxel|paclitaxel|mesh-list
1975184|NCT00954174|Carboplatin|carboplatin|mesh-list
1975185|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1975186|NCT00954174|Ifosfamide|ifosfamide|mesh-list
1975187|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
1975188|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1975189|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975190|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
1975191|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
1975192|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
1975193|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975194|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1975195|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
1975196|NCT00954447|Linagliptin|linagliptin|mesh-list
1975197|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1975198|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975199|NCT00954447|Incretins|incretins|mesh-ancestor
1975200|NCT00954447|Hormones|hormones|mesh-ancestor
1975201|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1975202|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1975203|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
1975204|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975205|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975206|NCT00954512|Leucovorin|leucovorin|mesh-list
1975207|NCT00954512|Folic Acid|folic acid|mesh-list
1975208|NCT00954512|Gemcitabine|gemcitabine|mesh-list
1975209|NCT00954512|Carboplatin|carboplatin|mesh-list
1975210|NCT00954512|Irinotecan|irinotecan|mesh-list
1975211|NCT00954512|Trastuzumab|trastuzumab|mesh-list
1975212|NCT00954512|Cetuximab|cetuximab|mesh-list
1975213|NCT00954512|Everolimus|everolimus|mesh-list
1975214|NCT00954512|Epirubicin|epirubicin|mesh-list
1975215|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
1975216|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975217|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975218|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1975219|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
1975220|NCT00954512|Antiviral Agents|antiviral agents|mesh-ancestor
1975221|NCT00954512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1975222|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975223|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1975224|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
1975225|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975226|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1975227|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1975228|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1975229|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1975230|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1975231|NCT00954512|Antidotes|antidotes|mesh-ancestor
1975232|NCT00954512|Protective Agents|protective agents|mesh-ancestor
1975233|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
1975234|NCT00954512|Vitamins|vitamins|mesh-ancestor
1975235|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
1975236|NCT00954512|Hematinics|hematinics|mesh-ancestor
1975237|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1975238|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
1975239|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1975240|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1975241|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1975242|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1975243|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975244|NCT00954707|Aspirin|aspirin|mesh-list
1975245|NCT00954707|Clopidogrel|clopidogrel|mesh-list
1975246|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1975247|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1975248|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1975249|NCT00954707|Analgesics|analgesics|mesh-ancestor
1975250|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
1975251|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975252|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975253|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1975254|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1975255|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1975256|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1975257|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975258|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1975259|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1975260|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975261|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
1975262|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1975263|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1975264|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1975265|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
1975266|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975267|NCT00954941|Ondansetron|ondansetron|mesh-list
1975268|NCT00954941|Aprepitant|aprepitant|mesh-list
1975269|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
1975270|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
1975271|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975272|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975273|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1975274|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
1975275|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
1975276|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1975277|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
1975278|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975279|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975280|NCT00954941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1975281|NCT00954941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1975282|NCT00954941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1975283|NCT00954941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1975284|NCT00954941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1975285|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1975286|NCT00955110|Oxymorphone|oxymorphone|mesh-list
1975287|NCT00955110|Oxycodone|oxycodone|mesh-list
1975288|NCT00955110|Hydromorphone|hydromorphone|mesh-list
1975289|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1975290|NCT00955110|Narcotics|narcotics|mesh-ancestor
1975291|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1975292|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975293|NCT00955110|Analgesics|analgesics|mesh-ancestor
1975294|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
1975295|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975296|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1975297|NCT00955253|Guanfacine|guanfacine|mesh-list
1975298|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1975299|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1975300|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1975301|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1975302|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
1975303|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975304|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975305|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975306|NCT00955266|Calcium|calcium|mesh-list
1975307|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1975308|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975309|NCT00955279|Golimumab|golimumab|mesh-list
1975310|NCT00955279|Ustekinumab|ustekinumab|mesh-list
1975311|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
1975312|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1975313|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1975314|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1975315|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
1975316|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975317|NCT00955305|Paclitaxel|paclitaxel|mesh-list
1975318|NCT00955305|Bevacizumab|bevacizumab|mesh-list
1975319|NCT00955305|Carboplatin|carboplatin|mesh-list
1975320|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1975321|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975322|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
1975323|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
1975324|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
1975325|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975326|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1975327|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1975328|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1975329|NCT00955305|Growth Substances|growth substances|mesh-ancestor
1975330|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975331|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
1975332|NCT00955357|Lacosamide|lacosamide|mesh-list
1975333|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
1975334|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1975335|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1975336|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975337|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975338|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
1975339|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1975340|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
1975341|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975342|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1975343|NCT00955474|Citalopram|citalopram|mesh-list
1975344|NCT00955474|Sertraline|sertraline|mesh-list
1975345|NCT00955474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1975346|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1975347|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975348|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975349|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975350|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
1975351|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975352|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1975353|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
1975354|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1975355|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1975356|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1975357|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1975358|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
1975359|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1975360|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
1975361|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975362|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975363|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1975364|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
1975365|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1975366|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
1975367|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975368|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975369|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1975370|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
1975371|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
1975372|NCT00955487|Protective Agents|protective agents|mesh-ancestor
1975373|NCT00955513|Diclofenac|diclofenac|mesh-list
1975374|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1975375|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1975376|NCT00955513|Analgesics|analgesics|mesh-ancestor
1975377|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
1975378|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975379|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975380|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1975381|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1975382|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1975383|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975384|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975385|NCT00955721|Gemcitabine|gemcitabine|mesh-list
1975386|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
1975387|NCT00955721|Sorafenib|sorafenib|mesh-list
1975388|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1975389|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
1975390|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975391|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975392|NCT00955721|Antiviral Agents|antiviral agents|mesh-ancestor
1975393|NCT00955721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1975394|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975395|NCT00955721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1975396|NCT00955721|Immunologic Factors|immunologic factors|mesh-ancestor
1975397|NCT00955721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975398|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1975399|NCT00955747|Tagatose|tagatose|mesh-list
1975400|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1975401|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
1975402|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
1975403|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975404|NCT00955877|Morphine|morphine|mesh-list
1975405|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1975406|NCT00955877|Narcotics|narcotics|mesh-ancestor
1975407|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1975408|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975409|NCT00955877|Analgesics|analgesics|mesh-ancestor
1975410|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
1975411|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975412|NCT00955916|Cytarabine|cytarabine|mesh-list
1975413|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
1975414|NCT00955916|Cladribine|cladribine|mesh-list
1975415|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1975416|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
1975417|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975418|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975419|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
1975420|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1975421|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1975422|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
1975423|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975424|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1975425|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975426|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1975427|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
1975428|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1975429|NCT00956085|Memantine|memantine|mesh-list
1975430|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1975431|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1975432|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
1975433|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975434|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975435|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975436|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1975437|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1975438|NCT00956254|Fentanyl|fentanyl|mesh-list
1975439|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1975440|NCT00956254|Narcotics|narcotics|mesh-ancestor
1975441|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1975442|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975443|NCT00956254|Analgesics|analgesics|mesh-ancestor
1975444|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
1975445|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975446|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1975447|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1975448|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
1975449|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
1975450|NCT00956293|Cyclosporine|cyclosporine|mesh-list
1975451|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
1975452|NCT00956293|Everolimus|everolimus|mesh-list
1975453|NCT00956293|Cyclosporins|cyclosporins|mesh-list
1975454|NCT00956293|Basiliximab|basiliximab|mesh-list
1975455|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975456|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975457|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1975458|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
1975459|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975460|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
1975461|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1975462|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
1975463|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1975464|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1975465|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975466|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1975467|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1975468|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
1975469|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1975470|NCT00956709|Ropivacaine|ropivacaine|mesh-list
1975471|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
1975472|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
1975473|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
1975474|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1975475|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975476|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
1975477|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975478|NCT00956839|Vitamin D|vitamin d|mesh-list
1975479|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
1975480|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
1975481|NCT00956839|Vitamins|vitamins|mesh-list
1975482|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
1975483|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975484|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1975485|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1975486|NCT00956930|Doxorubicin|doxorubicin|mesh-list
1975487|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1975488|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1975489|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975490|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1975491|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1975492|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975493|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975494|NCT00956943|Nicotine|nicotine|mesh-list
1975495|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1975496|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
1975497|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975498|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975499|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1975500|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1975501|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
1975502|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975503|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975504|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1975505|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
1975506|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1975507|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1975508|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975509|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975510|NCT00957242|Warfarin|warfarin|mesh-list
1975511|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
1975512|NCT00957268|Alogliptin|alogliptin|mesh-list
1975513|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1975514|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975515|NCT00957268|Incretins|incretins|mesh-ancestor
1975516|NCT00957268|Hormones|hormones|mesh-ancestor
1975517|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1975518|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1975519|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
1975520|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975521|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975522|NCT00957333|Ketamine|ketamine|mesh-list
1975523|NCT00957333|Analgesics|analgesics|mesh-ancestor
1975524|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
1975525|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975526|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975527|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1975528|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1975529|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
1975530|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
1975531|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1975532|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1975533|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1975534|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975535|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975536|NCT00957359|Niacin|niacin|mesh-list
1975537|NCT00957359|Psilocybin|psilocybin|mesh-list
1975538|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
1975539|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1975540|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
1975541|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975542|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1975543|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
1975544|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
1975545|NCT00957359|Vitamins|vitamins|mesh-ancestor
1975546|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
1975547|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975548|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
1975549|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1975550|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1975551|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
1975552|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975553|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1975554|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1975555|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
1975556|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1975557|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1975558|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975559|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975560|NCT00957424|Nicotine|nicotine|mesh-list
1975561|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1975562|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
1975563|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975564|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975565|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1975566|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1975567|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
1975568|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975569|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975570|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
1975571|NCT00957528|Testosterone|testosterone|mesh-list
1975572|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
1975573|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
1975574|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1975575|NCT00957528|Androgens|androgens|mesh-ancestor
1975576|NCT00957528|Hormones|hormones|mesh-ancestor
1975577|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1975578|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975579|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1975580|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975581|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
1975582|NCT00957580|Niacinamide|niacinamide|mesh-list
1975583|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
1975584|NCT00957580|Vitamins|vitamins|mesh-ancestor
1975585|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
1975586|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975587|NCT00957593|Oxytocin|oxytocin|mesh-list
1975588|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
1975589|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1975590|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975591|NCT00957671|Hormones|hormones|mesh-list
1975592|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1975593|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975594|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1975595|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
1975596|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1975597|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1975598|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975599|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975600|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
1975601|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1975602|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1975603|NCT00957801|Prednisolone|prednisolone|mesh-list
1975604|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
1975605|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
1975606|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1975607|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
1975608|NCT00957801|Testosterone|testosterone|mesh-list
1975609|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
1975610|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
1975611|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1975612|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1975613|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
1975614|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
1975615|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975616|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975617|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1975618|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
1975619|NCT00957801|Hormones|hormones|mesh-ancestor
1975620|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1975621|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1975622|NCT00957801|Protective Agents|protective agents|mesh-ancestor
1975623|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1975624|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975625|NCT00957801|Androgens|androgens|mesh-ancestor
1975626|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
1975627|NCT00957853|Cetuximab|cetuximab|mesh-list
1975628|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1975629|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975630|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
1975631|NCT00957905|Leucovorin|leucovorin|mesh-list
1975632|NCT00957905|Folic Acid|folic acid|mesh-list
1975633|NCT00957905|Fluorouracil|fluorouracil|mesh-list
1975634|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
1975635|NCT00957905|Alvocidib|alvocidib|mesh-list
1975636|NCT00957905|Calcium|calcium|mesh-list
1975637|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
1975638|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1975639|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975640|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1975641|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
1975642|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975643|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1975644|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975645|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1975646|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
1975647|NCT00957905|Antidotes|antidotes|mesh-ancestor
1975648|NCT00957905|Protective Agents|protective agents|mesh-ancestor
1975649|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
1975650|NCT00957905|Vitamins|vitamins|mesh-ancestor
1975651|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
1975652|NCT00957905|Hematinics|hematinics|mesh-ancestor
1975653|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
1975654|NCT00957905|Growth Substances|growth substances|mesh-ancestor
1975655|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1975656|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975657|NCT00957944|Rotigotine|rotigotine|mesh-list
1975658|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
1975659|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
1975660|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975661|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975662|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975663|NCT00957996|Peramivir|peramivir|mesh-list
1975664|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
1975665|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1975666|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975667|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975668|NCT00958035|Bimatoprost|bimatoprost|mesh-list
1975669|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1975670|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1975671|NCT00958074|Vorinostat|vorinostat|mesh-list
1975672|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975673|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1975674|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975675|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975676|NCT00958243|Vaccines|vaccines|mesh-list
1975677|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
1975678|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975679|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
1975680|NCT00958256|Rituximab|rituximab|mesh-list
1975681|NCT00958256|Bortezomib|bortezomib|mesh-list
1975682|NCT00958256|Lenograstim|lenograstim|mesh-list
1975683|NCT00958256|Sargramostim|sargramostim|mesh-list
1975684|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1975685|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
1975686|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975687|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1975688|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1975689|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
1975690|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975691|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975692|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1975693|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1975694|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1975695|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1975696|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1975697|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975698|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1975699|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1975700|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975701|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975702|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
1975703|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975704|NCT00958438|Rilonacept|rilonacept|mesh-list
1975705|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1975706|NCT00958568|Olanzapine|olanzapine|mesh-list
1975707|NCT00958568|Fluoxetine|fluoxetine|mesh-list
1975708|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
1975709|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
1975710|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975711|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975712|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1975713|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1975714|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1975715|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1975716|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1975717|NCT00958568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1975718|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1975719|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975720|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975721|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975722|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
1975723|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1975724|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
1975725|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1975726|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1975727|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975728|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
1975729|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
1975730|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1975731|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1975732|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975733|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
1975734|NCT00958581|Coagulants|coagulants|mesh-ancestor
1975735|NCT00958724|Vinorelbine|vinorelbine|mesh-list
1975736|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1975737|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975738|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
1975739|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
1975740|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
1975741|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975742|NCT00958776|Peramivir|peramivir|mesh-list
1975743|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
1975744|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1975745|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975746|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975747|NCT00958841|Pasireotide|pasireotide|mesh-list
1975748|NCT00958841|Hormones|hormones|mesh-ancestor
1975749|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1975750|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975751|NCT00958880|Yohimbine|yohimbine|mesh-list
1975752|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
1975753|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
1975754|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975755|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975756|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1975757|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1975758|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1975759|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
1975760|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975761|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975762|NCT00958880|Urological Agents|urological agents|mesh-ancestor
1975763|NCT00958919|Naloxone|naloxone|mesh-list
1975764|NCT00958919|Endorphins|endorphins|mesh-list
1975765|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1975766|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975767|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
1975768|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975769|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975770|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975771|NCT00959049|Vaccines|vaccines|mesh-list
1975772|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
1975773|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975774|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
1975775|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1975776|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
1975777|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975778|NCT00959647|Bevacizumab|bevacizumab|mesh-list
1975779|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1975780|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975781|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1975782|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1975783|NCT00959647|Growth Substances|growth substances|mesh-ancestor
1975784|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975785|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
1975786|NCT00959699|Interferons|interferons|mesh-list
1975787|NCT00959699|Ribavirin|ribavirin|mesh-list
1975788|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
1975789|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
1975790|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1975791|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975792|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
1975793|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1975794|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
1975795|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975796|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
1975797|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975798|NCT00959764|Calcitonin|calcitonin|mesh-list
1975799|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
1975800|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
1975801|NCT00959764|Katacalcin|katacalcin|mesh-list
1975802|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1975803|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975804|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1975805|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
1975806|NCT00959894|Tenofovir|tenofovir|mesh-list
1975807|NCT00959894|Emtricitabine|emtricitabine|mesh-list
1975808|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1975809|NCT00959894|Etravirine|etravirine|mesh-list
1975810|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
1975811|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1975812|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1975813|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1975814|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975815|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975816|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1975817|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1975818|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
1975819|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1975820|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1975821|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1975822|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1975823|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1975824|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975825|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
1975826|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975827|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975828|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1975829|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975830|NCT00959946|Capecitabine|capecitabine|mesh-list
1975831|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1975832|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
1975833|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975834|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975835|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
1975836|NCT00960063|Temozolomide|temozolomide|mesh-list
1975837|NCT00960063|Ifosfamide|ifosfamide|mesh-list
1975838|NCT00960063|Doxorubicin|doxorubicin|mesh-list
1975839|NCT00960063|Irinotecan|irinotecan|mesh-list
1975840|NCT00960063|Etoposide|etoposide|mesh-list
1975841|NCT00960063|Vincristine|vincristine|mesh-list
1975842|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1975843|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
1975844|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975845|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1975846|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1975847|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
1975848|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975849|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975850|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1975851|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1975852|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1975853|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1975854|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975855|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1975856|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1975857|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
1975858|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
1975859|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
1975860|NCT00960076|Metformin|metformin|mesh-list
1975861|NCT00960076|Saxagliptin|saxagliptin|mesh-list
1975862|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1975863|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975864|NCT00960076|Incretins|incretins|mesh-ancestor
1975865|NCT00960076|Hormones|hormones|mesh-ancestor
1975866|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1975867|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1975868|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
1975869|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975870|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975871|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
1975872|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
1975873|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975874|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1975875|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1975876|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1975877|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
2475568|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1975878|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975879|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975880|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1975881|NCT00960141|Loratadine|loratadine|mesh-list
1975882|NCT00960141|Montelukast|montelukast|mesh-list
1975883|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1975884|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
1975885|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1975886|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
1975887|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1975888|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975889|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1975890|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1975891|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975892|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
1975893|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
1975894|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1975895|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1975896|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1975897|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
1975898|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
1975899|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975900|NCT00960193|Colchicine|colchicine|mesh-list
1975901|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
1975902|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1975903|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
1975904|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
1975905|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
1975906|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975907|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975908|NCT00960323|Colchicine|colchicine|mesh-list
1975909|NCT00960323|Atorvastatin|atorvastatin|mesh-list
1975910|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1975911|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1975912|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
1975913|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975914|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1975915|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1975916|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975917|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
1975918|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1975919|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
1975920|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
1975921|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
1975922|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1975923|NCT00960440|Tofacitinib|tofacitinib|mesh-list
1975924|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1975925|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975926|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975927|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
1975928|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1975929|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
1975930|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975931|NCT00960570|Efavirenz|efavirenz|mesh-list
1975932|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
1975933|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1975934|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1975935|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975936|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975937|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
1975938|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1975939|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1975940|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1975941|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1975942|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1975943|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1975944|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1975945|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1975946|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1975947|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
1975948|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1975949|NCT00960622|Tenofovir|tenofovir|mesh-list
1975950|NCT00960622|Lamivudine|lamivudine|mesh-list
1975951|NCT00960622|Zidovudine|zidovudine|mesh-list
1975952|NCT00960622|Emtricitabine|emtricitabine|mesh-list
1975953|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1975954|NCT00960622|Abacavir|abacavir|mesh-list
1975955|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
1975956|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
1975957|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
1975958|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1975959|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1975960|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1975961|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1975962|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975963|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1975964|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1975965|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
1975966|NCT00960661|Insulin|insulin|mesh-list
1975967|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1975968|NCT00960661|Metformin|metformin|mesh-list
1975969|NCT00960661|Exenatide|exenatide|mesh-list
1975970|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
1975971|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1975972|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975973|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1975974|NCT00960661|Incretins|incretins|mesh-ancestor
1975975|NCT00960661|Hormones|hormones|mesh-ancestor
1975976|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1975977|NCT00960687|Fenofibrate|fenofibrate|mesh-list
1975978|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
1975979|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1975980|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
1975981|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975982|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1975983|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1975984|NCT00960778|Nicotine|nicotine|mesh-list
1975985|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1975986|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
1975987|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975988|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975989|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1975990|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1975991|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
1975992|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1975993|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1975994|NCT00960804|Tanezumab|tanezumab|mesh-list
1975995|NCT00960804|Analgesics|analgesics|mesh-ancestor
1975996|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
1975997|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1975998|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1975999|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
1976000|NCT00960856|Fenofibrate|fenofibrate|mesh-list
1976001|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1976002|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1976003|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
1976004|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976005|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1976006|NCT00960869|Aspirin|aspirin|mesh-list
1976007|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1976008|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1976009|NCT00960869|Analgesics|analgesics|mesh-ancestor
1976010|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
1976011|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976012|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976013|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1976014|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1976015|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1976016|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1976017|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976018|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1976019|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1976020|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976021|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
1976022|NCT00960934|Vitamin D|vitamin d|mesh-list
1976023|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
1976024|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
1976025|NCT00960934|Calcium|calcium|mesh-list
1976026|NCT00960934|Vitamins|vitamins|mesh-ancestor
1976027|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
1976028|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976029|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1976030|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1976031|NCT00960934|Antacids|antacids|mesh-ancestor
1976032|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976033|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1976034|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1976035|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1976036|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1976037|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1976038|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976039|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976040|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976041|NCT00960986|Analgesics|analgesics|mesh-ancestor
1976042|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
1976043|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976044|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
1976045|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1976046|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
1976047|NCT00961116|Fenofibrate|fenofibrate|mesh-list
1976048|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
1976049|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1976050|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
1976051|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976052|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1976053|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1976054|NCT00961181|Paclitaxel|paclitaxel|mesh-list
1976055|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1976056|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976057|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
1976058|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
1976059|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
1976060|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976061|NCT00961220|Carmustine|carmustine|mesh-list
1976062|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
1976063|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1976064|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
1976065|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976066|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976067|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976068|NCT00961233|Budesonide|budesonide|mesh-list
1976069|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1976070|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1976071|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
1976072|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976073|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976074|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1976075|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
1976076|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
1976077|NCT00961233|Hormones|hormones|mesh-ancestor
1976078|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976079|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
1976080|NCT00961259|Fenofibrate|fenofibrate|mesh-list
1976081|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1976082|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1976083|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
1976084|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976085|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1976086|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1976087|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1976088|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1976089|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1976090|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976091|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976092|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976093|NCT00961298|Analgesics|analgesics|mesh-ancestor
1976094|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
1976095|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976096|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
1976097|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1976098|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
1976099|NCT00961350|Aspirin|aspirin|mesh-list
1976100|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1976101|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1976102|NCT00961350|Analgesics|analgesics|mesh-ancestor
1976103|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
1976104|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976105|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976106|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1976107|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1976108|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1976109|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1976110|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976111|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1976112|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1976113|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976114|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
1976115|NCT00961415|Bevacizumab|bevacizumab|mesh-list
1976116|NCT00961415|Pemetrexed|pemetrexed|mesh-list
1976117|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1976118|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976119|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1976120|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1976121|NCT00961415|Growth Substances|growth substances|mesh-ancestor
1976122|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976123|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
1976124|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976125|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976126|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1976127|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1976128|NCT00961441|Levetiracetam|levetiracetam|mesh-list
1976129|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
1976130|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
1976131|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
1976132|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
1976133|NCT00961532|Coagulants|coagulants|mesh-ancestor
1976134|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1976135|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
1976136|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976137|NCT00961571|Capecitabine|capecitabine|mesh-list
1976138|NCT00961571|Sunitinib|sunitinib|mesh-list
1976139|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1976140|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
1976141|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976142|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976143|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1976144|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1976145|NCT00961571|Growth Substances|growth substances|mesh-ancestor
1976146|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976147|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
1976148|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1976149|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976150|NCT00961636|Niacin|niacin|mesh-list
1976151|NCT00961636|Niacinamide|niacinamide|mesh-list
1976152|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
1976153|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1976154|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
1976155|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976156|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1976157|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
1976158|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
1976159|NCT00961636|Vitamins|vitamins|mesh-ancestor
1976160|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
1976161|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976162|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1976163|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1976164|NCT00961649|Brinzolamide|brinzolamide|mesh-list
1976165|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1976166|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1976167|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1976168|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1976169|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1976170|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
1976171|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976172|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976173|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976174|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1976175|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976176|NCT00961662|Tagatose|tagatose|mesh-list
1976177|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1976178|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
1976179|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
1976180|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976181|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
1976182|NCT00961961|Fluoxetine|fluoxetine|mesh-list
1976183|NCT00961961|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1976184|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1976185|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1976186|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976187|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976188|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
1976189|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976190|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1976191|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
1976192|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1976193|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1976194|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1976195|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976196|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
1976197|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1976198|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1976199|NCT00962039|Citalopram|citalopram|mesh-list
1976200|NCT00962039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1976201|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1976202|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1976203|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976204|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976205|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
1976206|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976207|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1976208|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
1976209|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1976210|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
1976211|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1976212|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976213|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1976214|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976215|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1976216|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1976217|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1976218|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1976219|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976220|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
1976221|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976222|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976223|NCT00962390|Equol|equol|mesh-list
1976224|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
1976225|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1976226|NCT00962390|Estrogens|estrogens|mesh-ancestor
1976227|NCT00962390|Hormones|hormones|mesh-ancestor
1976228|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976229|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976230|NCT00962585|Equol|equol|mesh-list
1976231|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
1976232|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1976233|NCT00962585|Estrogens|estrogens|mesh-ancestor
1976234|NCT00962585|Hormones|hormones|mesh-ancestor
1976235|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976236|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976237|NCT00962741|Etanercept|etanercept|mesh-list
1976238|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1976239|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1976240|NCT00962741|Analgesics|analgesics|mesh-ancestor
1976241|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
1976242|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976243|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976244|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1976245|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1976246|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1976247|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1976248|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
1976249|NCT00962780|Vaccines|vaccines|mesh-list
1976250|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1976251|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
1976252|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976253|NCT00962871|Tenofovir|tenofovir|mesh-list
1976254|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1976255|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
1976256|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1976257|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1976258|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1976259|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976260|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976261|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1976262|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1976263|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
1976264|NCT00962949|Giapreza|giapreza|mesh-list
1976265|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
1976266|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1976267|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1976268|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
1976269|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976270|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976271|NCT00963105|Lenalidomide|lenalidomide|mesh-list
1976272|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
1976273|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976274|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1976275|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1976276|NCT00963105|Growth Substances|growth substances|mesh-ancestor
1976277|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
1976278|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976279|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1976280|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
1976281|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976282|NCT00963469|Loratadine|loratadine|mesh-list
1976283|NCT00963469|Montelukast|montelukast|mesh-list
1976284|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1976285|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
1976286|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1976287|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
1976288|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976289|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976290|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1976291|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1976292|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976293|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
1976294|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
1976295|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1976296|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1976297|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1976298|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
1976299|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
1976300|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976301|NCT00963508|Permethrin|permethrin|mesh-list
1976302|NCT00963508|Malathion|malathion|mesh-list
1976303|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976304|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976305|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1976306|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
1976307|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976308|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976309|NCT00963547|Trastuzumab|trastuzumab|mesh-list
1976310|NCT00963547|Lapatinib|lapatinib|mesh-list
1976311|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1976312|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976313|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1976314|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976315|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976316|NCT00963599|Loratadine|loratadine|mesh-list
1976317|NCT00963599|Montelukast|montelukast|mesh-list
1976318|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1976319|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
1976320|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1976321|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
1976322|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976323|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976324|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1976325|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1976326|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976327|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
1976328|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
1976329|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1976330|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1976331|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1976332|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
1976333|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
1976334|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976335|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
1976336|NCT00963807|Alovudine|alovudine|mesh-list
1976337|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
1976338|NCT00963807|Cisplatin|cisplatin|mesh-list
1976339|NCT00963807|Docetaxel|docetaxel|mesh-list
1976340|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1976341|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976342|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
1976343|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
1976344|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
1976345|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976346|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1976347|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
1976348|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
1976349|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1976350|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1976351|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1976352|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976353|NCT00963820|Ixazomib|ixazomib|mesh-list
1976354|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976355|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976356|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
1976357|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976358|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
1976359|NCT00963872|Fludarabine|fludarabine|mesh-list
1976360|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
1976361|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1976362|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
1976363|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976364|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1976365|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1976366|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
1976367|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976368|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976369|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1976370|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1976371|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
1976372|NCT00963924|Cycloserine|cycloserine|mesh-list
1976373|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1976374|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1976375|NCT00963924|Renal Agents|renal agents|mesh-ancestor
1976376|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1976377|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
1976378|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1976379|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
1976380|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976381|NCT00963937|Sumatriptan|sumatriptan|mesh-list
1976382|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1976383|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1976384|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1976385|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
1976386|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976387|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976388|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976389|NCT00964223|Clindamycin|clindamycin|mesh-list
1976390|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
1976391|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
1976392|NCT00964223|Adapalene|adapalene|mesh-list
1976393|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
1976394|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1976395|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1976396|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1976397|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1976398|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976399|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976400|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
1976401|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1976402|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1976403|NCT00964223|Analgesics|analgesics|mesh-ancestor
1976404|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
1976405|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976406|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976407|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1976408|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1976409|NCT00964353|Warfarin|warfarin|mesh-list
1976410|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
1976411|NCT00964366|Clindamycin|clindamycin|mesh-list
1976412|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
1976413|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
1976414|NCT00964366|Dapsone|dapsone|mesh-list
1976415|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1976416|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1976417|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1976418|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1976419|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976420|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976421|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
1976422|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
1976423|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1976424|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1976425|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1976426|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
1976427|NCT00964431|Celecoxib|celecoxib|mesh-list
1976428|NCT00964431|Indomethacin|indomethacin|mesh-list
1976429|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1976430|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1976431|NCT00964431|Analgesics|analgesics|mesh-ancestor
1976432|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
1976433|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976434|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976435|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1976436|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1976437|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1976438|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1976439|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976440|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976441|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
1976442|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
1976443|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1976444|NCT00964496|Thalidomide|thalidomide|mesh-list
1976445|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
1976446|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1976447|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
1976448|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976449|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
1976450|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1976451|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1976452|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1976453|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1976454|NCT00964496|Growth Substances|growth substances|mesh-ancestor
1976455|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
1976456|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976457|NCT00964496|Hematinics|hematinics|mesh-ancestor
1976458|NCT00964548|Dantrolene|dantrolene|mesh-list
1976459|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1976460|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976461|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1976462|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976463|NCT00964678|Carvedilol|carvedilol|mesh-list
1976464|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1976465|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1976466|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
1976467|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976468|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976469|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976470|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1976471|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
1976472|NCT00964678|Protective Agents|protective agents|mesh-ancestor
1976473|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1976474|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1976475|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1976476|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
1976477|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1976478|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1976479|NCT00964743|Cytarabine|cytarabine|mesh-list
1976480|NCT00964743|Sorafenib|sorafenib|mesh-list
1976481|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1976482|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
1976483|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976484|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976485|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
1976486|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1976487|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1976488|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
1976489|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976490|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1976491|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976492|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
1976493|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
1976494|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1976495|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1976496|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976497|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976498|NCT00964782|Urological Agents|urological agents|mesh-ancestor
1976499|NCT00964795|Aflibercept|aflibercept|mesh-list
1976500|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1976501|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1976502|NCT00964795|Growth Substances|growth substances|mesh-ancestor
1976503|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976504|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
1976505|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976506|NCT00964886|Benztropine|benztropine|mesh-list
1976507|NCT00964886|Desipramine|desipramine|mesh-list
1976508|NCT00964886|Clomipramine|clomipramine|mesh-list
1976509|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1976510|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
1976511|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1976512|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976513|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976514|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1976515|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1976516|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1976517|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
1976518|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976519|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976520|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1976521|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1976522|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
1976523|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
1976524|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976525|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1976526|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1976527|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
1976528|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1976529|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
1976530|NCT00964886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1976531|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
1976532|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1976533|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1976534|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1976535|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1976536|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976537|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976538|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976539|NCT00965081|Analgesics|analgesics|mesh-ancestor
1976540|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
1976541|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976542|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
1976543|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1976544|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
1976545|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
1976546|NCT00965094|Everolimus|everolimus|mesh-list
1976547|NCT00965094|Tacrolimus|tacrolimus|mesh-list
1976548|NCT00965094|Basiliximab|basiliximab|mesh-list
1976549|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1976550|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
1976551|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976552|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1976553|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976554|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976555|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976556|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1976557|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1976558|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
1976559|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1976560|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1976561|NCT00965185|Atorvastatin|atorvastatin|mesh-list
1976562|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1976563|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1976564|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
1976565|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976566|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1976567|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1976568|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976569|NCT00965263|Cocaine|cocaine|mesh-list
1976570|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
1976571|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
1976572|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1976573|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976574|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
1976575|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976576|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1976577|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1976578|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1976579|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1976580|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976581|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
1976582|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976583|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
1976584|NCT00965341|Testosterone|testosterone|mesh-list
1976585|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
1976586|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
1976587|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1976588|NCT00965341|Androgens|androgens|mesh-ancestor
1976589|NCT00965341|Hormones|hormones|mesh-ancestor
1976590|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976591|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976592|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1976593|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976594|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
1976595|NCT00965458|Alefacept|alefacept|mesh-list
1976596|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
1976597|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
1976598|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976599|NCT00965497|Citalopram|citalopram|mesh-list
1976600|NCT00965497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1976601|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1976602|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1976603|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976604|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976605|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
1976606|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976607|NCT00965497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1976608|NCT00965497|Antidepressive Agents|antidepressive agents|mesh-ancestor
1976609|NCT00965497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1976610|NCT00965562|Fluoxetine|fluoxetine|mesh-list
1976611|NCT00965562|Calcium|calcium|mesh-list
1976612|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1976613|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976614|NCT00965562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1976615|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1976616|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1976617|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976618|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976619|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
1976620|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1976621|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
1976622|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1976623|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1976624|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1976625|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976626|NCT00965575|Melatonin|melatonin|mesh-list
1976627|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
1976628|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976629|NCT00965575|Protective Agents|protective agents|mesh-ancestor
1976630|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976631|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1976632|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1976633|NCT00965731|Crizotinib|crizotinib|mesh-list
1976634|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976635|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1976636|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976637|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976638|NCT00965848|Doripenem|doripenem|mesh-list
1976639|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1976640|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1976641|NCT00966277|Dalteparin|dalteparin|mesh-list
1976642|NCT00966277|Tinzaparin|tinzaparin|mesh-list
1976643|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1976644|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
1976645|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1976646|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1976647|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976648|NCT00966355|Octreotide|octreotide|mesh-list
1976649|NCT00966355|Terlipressin|terlipressin|mesh-list
1976650|NCT00966355|Somatostatin|somatostatin|mesh-list
1976651|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1976652|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1976653|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976654|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1976655|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1976656|NCT00966355|Hormones|hormones|mesh-ancestor
1976657|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976658|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976659|NCT00966641|Naproxen|naproxen|mesh-list
1976660|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1976661|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1976662|NCT00966641|Analgesics|analgesics|mesh-ancestor
1976663|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
1976664|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976665|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976666|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1976667|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1976668|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
1976669|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1976670|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976671|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976672|NCT00966693|Thalidomide|thalidomide|mesh-list
1976673|NCT00966693|Dexamethasone|dexamethasone|mesh-list
1976674|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
1976675|NCT00966693|Lenalidomide|lenalidomide|mesh-list
1976676|NCT00966693|Ichthammol|ichthammol|mesh-list
1976677|NCT00966693|BB 1101|bb 1101|mesh-list
1976678|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1976679|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
1976680|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
1976681|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976682|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976683|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1976684|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
1976685|NCT00966693|Hormones|hormones|mesh-ancestor
1976686|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976687|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1976688|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976689|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
1976690|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1976691|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1976692|NCT00966693|Growth Substances|growth substances|mesh-ancestor
1976693|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
1976694|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1976695|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
1976696|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1976697|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1976698|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
1976699|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976700|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976701|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
1976702|NCT00966875|Ixekizumab|ixekizumab|mesh-list
1976703|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
1976704|NCT00966940|Travoprost|travoprost|mesh-list
1976705|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1976706|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1976707|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1976708|NCT00966953|Honokiol|honokiol|mesh-list
1976709|NCT00966953|Triclosan|triclosan|mesh-list
1976710|NCT00966953|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1976711|NCT00966953|Fluorides|fluorides|mesh-list
1976712|NCT00966953|Cariostatic Agents|cariostatic agents|mesh-ancestor
1976713|NCT00966953|Protective Agents|protective agents|mesh-ancestor
1976714|NCT00966953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976715|NCT00966953|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1976716|NCT00966953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1976717|NCT00966953|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1976718|NCT00966953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1976719|NCT00966953|Antimetabolites|antimetabolites|mesh-ancestor
1976720|NCT00966953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976721|NCT00966953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1976722|NCT00966953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1976723|NCT00966953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1976724|NCT00966953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976725|NCT00966953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1976726|NCT00966953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976727|NCT00966953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1976728|NCT00966953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1976729|NCT00966953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1976730|NCT00966953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1976731|NCT00966953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1976732|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
1976733|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1976734|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
1976735|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1976736|NCT00967005|Expectorants|expectorants|mesh-ancestor
1976737|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
1976738|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1976739|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
1976740|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976741|NCT00967005|Protective Agents|protective agents|mesh-ancestor
1976742|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976743|NCT00967005|Antidotes|antidotes|mesh-ancestor
1976744|NCT00967044|Everolimus|everolimus|mesh-list
1976745|NCT00967044|Panobinostat|panobinostat|mesh-list
1976746|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976747|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1976748|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
1976749|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976750|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1976751|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976752|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976753|NCT00967226|Prednisolone|prednisolone|mesh-list
1976754|NCT00967226|Propranolol|propranolol|mesh-list
1976755|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
1976756|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1976757|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
1976758|NCT00967226|Hormones|hormones|mesh-ancestor
1976759|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976760|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976761|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1976762|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976763|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1976764|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1976765|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
1976766|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976767|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976768|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1976769|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1976770|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
1976771|NCT00967330|Bevacizumab|bevacizumab|mesh-list
1976772|NCT00967330|Irinotecan|irinotecan|mesh-list
1976773|NCT00967330|Temozolomide|temozolomide|mesh-list
1976774|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1976775|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976776|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1976777|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1976778|NCT00967330|Growth Substances|growth substances|mesh-ancestor
1976779|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976780|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
1976781|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1976782|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1976783|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976784|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976785|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1976786|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
1976787|NCT00967369|Carboplatin|carboplatin|mesh-list
1976788|NCT00967369|Etoposide|etoposide|mesh-list
1976789|NCT00967369|Bortezomib|bortezomib|mesh-list
1976790|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
1976791|NCT00967369|Ifosfamide|ifosfamide|mesh-list
1976792|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
1976793|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
1976794|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976795|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1976796|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1976797|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1976798|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976799|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976800|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1976801|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
1976802|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
1976803|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
1976804|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
1976805|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
1976806|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
1976807|NCT00967499|Ondansetron|ondansetron|mesh-list
1976808|NCT00967499|Palonosetron|palonosetron|mesh-list
1976809|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
1976810|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
1976811|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976812|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976813|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1976814|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
1976815|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
1976816|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1976817|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
1976818|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976819|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976820|NCT00967499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1976821|NCT00967499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1976822|NCT00967499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1976823|NCT00967499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1976824|NCT00967499|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1976825|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1976826|NCT00967551|Zinc|zinc|mesh-list
1976827|NCT00967551|Trace Elements|trace elements|mesh-list
1976828|NCT00967551|Micronutrients|micronutrients|mesh-list
1976829|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976830|NCT00967616|Leucovorin|leucovorin|mesh-list
1976831|NCT00967616|Fluorouracil|fluorouracil|mesh-list
1976832|NCT00967616|Irinotecan|irinotecan|mesh-list
1976833|NCT00967616|Efatutazone|efatutazone|mesh-list
1976834|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
1976835|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
1976836|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976837|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1976838|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976839|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1976840|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
1976841|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976842|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1976843|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1976844|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976845|NCT00967616|Antidotes|antidotes|mesh-ancestor
1976846|NCT00967616|Protective Agents|protective agents|mesh-ancestor
1976847|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
1976848|NCT00967616|Vitamins|vitamins|mesh-ancestor
1976849|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
1976850|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
1976851|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1976852|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
1976853|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
1976854|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1976855|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976856|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1976857|NCT00967694|Analgesics|analgesics|mesh-ancestor
1976858|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
1976859|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976860|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1976861|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1976862|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976863|NCT00967798|Incretins|incretins|mesh-ancestor
1976864|NCT00967798|Hormones|hormones|mesh-ancestor
1976865|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976866|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1976867|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
1976868|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976869|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976870|NCT00968071|Decitabine|decitabine|mesh-list
1976871|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
1976872|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1976873|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
1976874|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976875|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976876|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976877|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1976878|NCT00968149|Montelukast|montelukast|mesh-list
1976879|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1976880|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
1976881|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1976882|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
1976883|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976884|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976885|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1976886|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1976887|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976888|NCT00968201|Montelukast|montelukast|mesh-list
1976889|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1976890|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
1976891|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1976892|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
1976893|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976894|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976895|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1976896|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1976897|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976898|NCT00968253|Cytarabine|cytarabine|mesh-list
1976899|NCT00968253|Dexamethasone|dexamethasone|mesh-list
1976900|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
1976901|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1976902|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1976903|NCT00968253|Prednisolone|prednisolone|mesh-list
1976904|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
1976905|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
1976906|NCT00968253|Doxorubicin|doxorubicin|mesh-list
1976907|NCT00968253|Methotrexate|methotrexate|mesh-list
1976908|NCT00968253|Vincristine|vincristine|mesh-list
1976909|NCT00968253|Everolimus|everolimus|mesh-list
1976910|NCT00968253|Lenograstim|lenograstim|mesh-list
1976911|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1976912|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
1976913|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1976914|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
1976915|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976916|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1976917|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1976918|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
1976919|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976920|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976921|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1976922|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1976923|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
1976924|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
1976925|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1976926|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1976927|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
1976928|NCT00968253|Hormones|hormones|mesh-ancestor
1976929|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976930|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1976931|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1976932|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1976933|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1976934|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976935|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1976936|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
1976937|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1976938|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1976939|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
1976940|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
1976941|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1976942|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1976943|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1976944|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
1976945|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1976946|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1976947|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
1976948|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
1976949|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
1976950|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1976951|NCT00968253|Protective Agents|protective agents|mesh-ancestor
1976952|NCT00968539|Vaccines|vaccines|mesh-list
1976953|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
1976954|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976955|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
1976956|NCT00968617|Hematinics|hematinics|mesh-ancestor
1976957|NCT00968708|Alogliptin|alogliptin|mesh-list
1976958|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1976959|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976960|NCT00968708|Incretins|incretins|mesh-ancestor
1976961|NCT00968708|Hormones|hormones|mesh-ancestor
1976962|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1976963|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1976964|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
1976965|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976966|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976967|NCT00968799|Cisplatin|cisplatin|mesh-list
1976968|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976969|NCT00968812|Metformin|metformin|mesh-list
1976970|NCT00968812|Glimepiride|glimepiride|mesh-list
1976971|NCT00968812|Canagliflozin|canagliflozin|mesh-list
1976972|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1976973|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976974|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1976975|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1976976|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
1976977|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1976978|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976979|NCT00968890|Vaccines|vaccines|mesh-list
1976980|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
1976981|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976982|NCT00968968|Trastuzumab|trastuzumab|mesh-list
1976983|NCT00968968|Lapatinib|lapatinib|mesh-list
1976984|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1976985|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1976986|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1976987|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1976988|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976989|NCT00969150|Milnacipran|milnacipran|mesh-list
1976990|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
1976991|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1976992|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1976993|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1976994|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1976995|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1976996|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1976997|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
1976998|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1976999|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1977000|NCT00969150|Analgesics|analgesics|mesh-ancestor
1977001|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
1977002|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977003|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1977004|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1977005|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1977006|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1977007|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977008|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
1977009|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977010|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977011|NCT00969709|Milnacipran|milnacipran|mesh-list
1977012|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
1977013|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1977014|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1977015|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1977016|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977017|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977018|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977019|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
1977020|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1977021|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1977022|NCT00969709|Analgesics|analgesics|mesh-ancestor
1977023|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
1977024|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977025|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
1977026|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1977027|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
1977028|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977029|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1977030|NCT00969878|Antacids|antacids|mesh-ancestor
1977031|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977032|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1977033|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
1977034|NCT00970073|Tacrolimus|tacrolimus|mesh-list
1977035|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
1977036|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1977037|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977038|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
1977039|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977040|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1977041|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977042|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977043|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1977044|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977045|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1977046|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
1977047|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1977048|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977049|NCT00970203|Vaccines|vaccines|mesh-list
1977050|NCT00970203|Androgens|androgens|mesh-list
1977051|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
1977052|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977053|NCT00970203|Hormones|hormones|mesh-ancestor
1977054|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977055|NCT00970216|Telbivudine|telbivudine|mesh-list
1977056|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
1977057|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977058|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1977059|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977060|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977061|NCT00970268|Bromides|bromides|mesh-list
1977062|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
1977063|NCT00970281|Olanzapine|olanzapine|mesh-list
1977064|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
1977065|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
1977066|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977067|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977068|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1977069|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1977070|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1977071|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1977072|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1977073|NCT00970281|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1977074|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1977075|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1977076|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977077|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977078|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
1977079|NCT00970307|Vaccines|vaccines|mesh-list
1977080|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1977081|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
1977082|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977083|NCT00970502|Celecoxib|celecoxib|mesh-list
1977084|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1977085|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977086|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1977087|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977088|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977089|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1977090|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1977091|NCT00970502|Analgesics|analgesics|mesh-ancestor
1977092|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
1977093|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977094|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977095|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1977096|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1977097|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1977098|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1977099|NCT00970632|Tadalafil|tadalafil|mesh-list
1977100|NCT00970632|Tamsulosin|tamsulosin|mesh-list
1977101|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
1977102|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1977103|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1977104|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977105|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977106|NCT00970632|Urological Agents|urological agents|mesh-ancestor
1977107|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1977108|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1977109|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1977110|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
1977111|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977112|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977113|NCT00970684|Gemcitabine|gemcitabine|mesh-list
1977114|NCT00970684|Bevacizumab|bevacizumab|mesh-list
1977115|NCT00970684|Docetaxel|docetaxel|mesh-list
1977116|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1977117|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977118|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1977119|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1977120|NCT00970684|Growth Substances|growth substances|mesh-ancestor
1977121|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977122|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
1977123|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1977124|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
1977125|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977126|NCT00970684|Antiviral Agents|antiviral agents|mesh-ancestor
1977127|NCT00970684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977128|NCT00970684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977129|NCT00970684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977130|NCT00970684|Immunologic Factors|immunologic factors|mesh-ancestor
1977131|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
1977132|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
1977133|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
1977134|NCT00970814|Levetiracetam|levetiracetam|mesh-list
1977135|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
1977136|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
1977137|NCT00970944|Amantadine|amantadine|mesh-list
1977138|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1977139|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1977140|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
1977141|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977142|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
1977143|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977144|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977145|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977146|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1977147|NCT00970944|Analgesics|analgesics|mesh-ancestor
1977148|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
1977149|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977150|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
1977151|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1977152|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1977153|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977154|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1977155|NCT00971178|Analgesics|analgesics|mesh-ancestor
1977156|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
1977157|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977158|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1977159|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1977160|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1977161|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
1977162|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977163|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977164|NCT00971243|Metformin|metformin|mesh-list
1977165|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1977166|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977167|NCT00971295|Metformin|metformin|mesh-list
1977168|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1977169|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1977170|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977171|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
1977172|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1977173|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1977174|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1977175|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977176|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
1977177|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1977178|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1977179|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1977180|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1977181|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977182|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
1977183|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977184|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977185|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1977186|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977187|NCT00971633|Ondansetron|ondansetron|mesh-list
1977188|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
1977189|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
1977190|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977191|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977192|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1977193|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
1977194|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
1977195|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1977196|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
1977197|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977198|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977199|NCT00971633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1977200|NCT00971633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1977201|NCT00971633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1977202|NCT00971633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1977203|NCT00971633|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1977204|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
1977205|NCT00971737|Trastuzumab|trastuzumab|mesh-list
1977206|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977207|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
1977208|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977209|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1977210|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1977211|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
1977212|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977213|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977214|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1977215|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1977216|NCT00971789|Sirolimus|sirolimus|mesh-list
1977217|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1977218|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1977219|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977220|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1977221|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977222|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
1977223|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977224|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
1977225|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977226|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1977227|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977228|NCT00971841|Paclitaxel|paclitaxel|mesh-list
1977229|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1977230|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977231|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
1977232|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
1977233|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
1977234|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977235|NCT00971932|Carboplatin|carboplatin|mesh-list
1977236|NCT00971932|Fluorouracil|fluorouracil|mesh-list
1977237|NCT00971932|Cetuximab|cetuximab|mesh-list
1977238|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977239|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
1977240|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977241|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1977242|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977243|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
1977244|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977245|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1977246|NCT00971945|Paclitaxel|paclitaxel|mesh-list
1977247|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1977248|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977249|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
1977250|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
1977251|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
1977252|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977253|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
1977254|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1977255|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977256|NCT00972205|Paclitaxel|paclitaxel|mesh-list
1977257|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
1977258|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1977259|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977260|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
1977261|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
1977262|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
1977263|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977264|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1977265|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
1977266|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1977267|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977268|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1977269|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977270|NCT00972283|Insulin|insulin|mesh-list
1977271|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1977272|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
1977273|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
1977274|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1977275|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977276|NCT00972335|Bevacizumab|bevacizumab|mesh-list
1977277|NCT00972335|Everolimus|everolimus|mesh-list
1977278|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1977279|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977280|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1977281|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1977282|NCT00972335|Growth Substances|growth substances|mesh-ancestor
1977283|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977284|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
1977285|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977286|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
1977287|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1977288|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1977289|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1977290|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1977291|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1977292|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
1977293|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475569|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977294|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977295|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977296|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
1977297|NCT00972439|Norinyl|norinyl|mesh-list
1977298|NCT00972439|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
1977299|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
1977300|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1977301|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977302|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1977303|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1977304|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1977305|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1977306|NCT00972439|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
1977307|NCT00972439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1977308|NCT00972478|Prednisone|prednisone|mesh-list
1977309|NCT00972478|Cortisone|cortisone|mesh-list
1977310|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
1977311|NCT00972478|Rituximab|rituximab|mesh-list
1977312|NCT00972478|Doxorubicin|doxorubicin|mesh-list
1977313|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1977314|NCT00972478|Vincristine|vincristine|mesh-list
1977315|NCT00972478|Vorinostat|vorinostat|mesh-list
1977316|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1977317|NCT00972478|Antibodies|antibodies|mesh-list
1977318|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
1977319|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1977320|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977321|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
1977322|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977323|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1977324|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1977325|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
1977326|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977327|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977328|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1977329|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1977330|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1977331|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1977332|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977333|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1977334|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
1977335|NCT00972478|Hormones|hormones|mesh-ancestor
1977336|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977337|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1977338|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1977339|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
1977340|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
1977341|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
1977342|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1977343|NCT00972504|Cetirizine|cetirizine|mesh-list
1977344|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1977345|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1977346|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1977347|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
1977348|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
1977349|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977350|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977351|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977352|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1977353|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
1977354|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977355|NCT00972595|Ondansetron|ondansetron|mesh-list
1977356|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
1977357|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
1977358|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977359|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977360|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1977361|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
1977362|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
1977363|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1977364|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
1977365|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977366|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977367|NCT00972595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1977368|NCT00972595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1977369|NCT00972595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1977370|NCT00972595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1977371|NCT00972595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1977372|NCT00972725|Chloroquine|chloroquine|mesh-list
1977373|NCT00972725|Amebicides|amebicides|mesh-ancestor
1977374|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1977375|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1977376|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977377|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
1977378|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1977379|NCT00972738|Loratadine|loratadine|mesh-list
1977380|NCT00972738|Montelukast|montelukast|mesh-list
1977381|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1977382|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
1977383|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1977384|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
1977385|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977386|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977387|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1977388|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1977389|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977390|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
1977391|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
1977392|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1977393|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1977394|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1977395|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
1977396|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
1977397|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977398|NCT00972777|Besifloxacin|besifloxacin|mesh-list
1977399|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1977400|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977401|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1977402|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1977403|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977404|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977405|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977406|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
1977407|NCT00972959|Dexamethasone|dexamethasone|mesh-list
1977408|NCT00972959|Bortezomib|bortezomib|mesh-list
1977409|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1977410|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
1977411|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
1977412|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977413|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977414|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1977415|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
1977416|NCT00972959|Hormones|hormones|mesh-ancestor
1977417|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977418|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1977419|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977420|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1977421|NCT00973102|Estrogens|estrogens|mesh-list
1977422|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1977423|NCT00973102|Hormones|hormones|mesh-ancestor
1977424|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977425|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977426|NCT00973479|Golimumab|golimumab|mesh-list
1977427|NCT00973479|Methotrexate|methotrexate|mesh-list
1977428|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1977429|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
1977430|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1977431|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977432|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1977433|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
1977434|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977435|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977436|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
1977437|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977438|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1977439|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977440|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
1977441|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1977442|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1977443|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1977444|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1977445|NCT00973674|Estrogens|estrogens|mesh-list
1977446|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1977447|NCT00973674|Hormones|hormones|mesh-ancestor
1977448|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977449|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977450|NCT00973739|Lapatinib|lapatinib|mesh-list
1977451|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977452|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1977453|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977454|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977455|NCT00973752|Cytarabine|cytarabine|mesh-list
1977456|NCT00973752|Prednisone|prednisone|mesh-list
1977457|NCT00973752|Doxorubicin|doxorubicin|mesh-list
1977458|NCT00973752|Methotrexate|methotrexate|mesh-list
1977459|NCT00973752|Vincristine|vincristine|mesh-list
1977460|NCT00973752|Asparaginase|asparaginase|mesh-list
1977461|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
1977462|NCT00973752|Clofarabine|clofarabine|mesh-list
1977463|NCT00973752|Pegaspargase|pegaspargase|mesh-list
1977464|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1977465|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977466|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1977467|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1977468|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977469|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977470|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1977471|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
1977472|NCT00973752|Hormones|hormones|mesh-ancestor
1977473|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977474|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977475|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1977476|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1977477|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
1977478|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1977479|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1977480|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
1977481|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
1977482|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1977483|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977484|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
1977485|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1977486|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1977487|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
1977488|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977489|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1977490|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
1977491|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
1977492|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
1977493|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1977494|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1977495|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977496|NCT00973765|Renal Agents|renal agents|mesh-ancestor
1977497|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1977498|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
1977499|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1977500|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1977501|NCT00974051|Insulin|insulin|mesh-list
1977502|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1977503|NCT00974051|Terbutaline|terbutaline|mesh-list
1977504|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
1977505|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1977506|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977507|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1977508|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
1977509|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977510|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1977511|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
1977512|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
1977513|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
1977514|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1977515|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1977516|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1977517|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
1977518|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977519|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977520|NCT00974090|Glimepiride|glimepiride|mesh-list
1977521|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1977522|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1977523|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977524|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977525|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
1977526|NCT00974142|Cyclosporine|cyclosporine|mesh-list
1977527|NCT00974142|Cyclosporins|cyclosporins|mesh-list
1977528|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977529|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977530|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977531|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
1977532|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977533|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
1977534|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977535|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
1977536|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1977537|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1977538|NCT00974220|Fentanyl|fentanyl|mesh-list
1977539|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1977540|NCT00974220|Narcotics|narcotics|mesh-ancestor
1977541|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1977542|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977543|NCT00974220|Analgesics|analgesics|mesh-ancestor
1977544|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
1977545|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977546|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1977547|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1977548|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
1977549|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
1977550|NCT00974233|Rituximab|rituximab|mesh-list
1977551|NCT00974233|Lenalidomide|lenalidomide|mesh-list
1977552|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1977553|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1977554|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977555|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
1977556|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977557|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1977558|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1977559|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1977560|NCT00974233|Growth Substances|growth substances|mesh-ancestor
1977561|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
1977562|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1977563|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
1977564|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977565|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1977566|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1977567|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
1977568|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977569|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977570|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1977571|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
1977572|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
1977573|NCT00974246|Hormones|hormones|mesh-ancestor
1977574|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977575|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
1977576|NCT00974350|Bupivacaine|bupivacaine|mesh-list
1977577|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
1977578|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
1977579|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1977580|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977581|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
1977582|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977583|NCT00974376|Gabapentin|gabapentin|mesh-list
1977584|NCT00974376|Analgesics|analgesics|mesh-ancestor
1977585|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
1977586|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977587|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977588|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
1977589|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1977590|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1977591|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1977592|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1977593|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1977594|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1977595|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977596|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977597|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
1977598|NCT00974480|Tretinoin|tretinoin|mesh-list
1977599|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977600|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
1977601|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
1977602|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1977603|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1977604|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977605|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
1977606|NCT00974571|Cetirizine|cetirizine|mesh-list
1977607|NCT00974571|Montelukast|montelukast|mesh-list
1977608|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1977609|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
1977610|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1977611|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
1977612|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977613|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977614|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1977615|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1977616|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977617|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1977618|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1977619|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1977620|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
1977621|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
1977622|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977623|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1977624|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
1977625|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977626|NCT00974818|Mitomycins|mitomycins|mesh-list
1977627|NCT00974818|Mitomycin|mitomycin|mesh-list
1977628|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
1977629|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1977630|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977631|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
1977632|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977633|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1977634|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977635|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1977636|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
1977637|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977638|NCT00974974|Levodopa|levodopa|mesh-list
1977639|NCT00974974|Carbidopa|carbidopa|mesh-list
1977640|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1977641|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1977642|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1977643|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
1977644|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977645|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977646|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977647|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1977648|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977649|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1977650|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
1977651|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
1977652|NCT00975000|Cinacalcet|cinacalcet|mesh-list
1977653|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1977654|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977655|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1977656|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
1977657|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977658|NCT00975130|Golimumab|golimumab|mesh-list
1977659|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1977660|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1977661|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1977662|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977663|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
1977664|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977665|NCT00975143|Isotretinoin|isotretinoin|mesh-list
1977666|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
1977667|NCT00975195|Fluticasone|fluticasone|mesh-list
1977668|NCT00975195|Xhance|xhance|mesh-list
1977669|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
1977670|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1977671|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1977672|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1977673|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
1977674|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977675|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977676|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1977677|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
1977678|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
1977679|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1977680|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
1977681|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1977682|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
1977683|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977684|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977685|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1977686|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1977687|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1977688|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
1977689|NCT00975221|Cinacalcet|cinacalcet|mesh-list
1977690|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1977691|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977692|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1977693|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
1977694|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977695|NCT00975286|Metformin|metformin|mesh-list
1977696|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
1977697|NCT00975286|Lixisenatide|lixisenatide|mesh-list
1977698|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
1977699|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1977700|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977701|NCT00975416|Oxytocin|oxytocin|mesh-list
1977702|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
1977703|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1977704|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977705|NCT00975481|Alprazolam|alprazolam|mesh-list
1977706|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1977707|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1977708|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977709|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1977710|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1977711|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1977712|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
1977713|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
1977714|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977715|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977716|NCT00975637|Brodalumab|brodalumab|mesh-list
1977717|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1977718|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
1977719|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
1977720|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977721|NCT00975650|Testosterone|testosterone|mesh-list
1977722|NCT00975650|Androgens|androgens|mesh-ancestor
1977723|NCT00975650|Hormones|hormones|mesh-ancestor
1977724|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977725|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977726|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
1977727|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1977728|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
1977729|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977730|NCT00975689|Expectorants|expectorants|mesh-ancestor
1977731|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
1977732|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1977733|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
1977734|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977735|NCT00975689|Protective Agents|protective agents|mesh-ancestor
1977736|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977737|NCT00975689|Antidotes|antidotes|mesh-ancestor
1977738|NCT00975806|Lenalidomide|lenalidomide|mesh-list
1977739|NCT00975806|Sunitinib|sunitinib|mesh-list
1977740|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
1977741|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977742|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1977743|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1977744|NCT00975806|Growth Substances|growth substances|mesh-ancestor
1977745|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
1977746|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977747|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1977748|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977749|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977750|NCT00975975|Basiliximab|basiliximab|mesh-list
1977751|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977752|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
1977753|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977754|NCT00976027|Vaccines|vaccines|mesh-list
1977755|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
1977756|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977757|NCT00976183|Vorinostat|vorinostat|mesh-list
1977758|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977759|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1977760|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977761|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977762|NCT00976209|Phenylephrine|phenylephrine|mesh-list
1977763|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
1977764|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1977765|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
1977766|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
1977767|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977768|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977769|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
1977770|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1977771|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
1977772|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
1977773|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1977774|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1977775|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1977776|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
1977777|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1977778|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977779|NCT00976209|Protective Agents|protective agents|mesh-ancestor
1977780|NCT00976248|Everolimus|everolimus|mesh-list
1977781|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977782|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977783|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
1977784|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977785|NCT00976391|Insulin|insulin|mesh-list
1977786|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1977787|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
1977788|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
1977789|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
1977790|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1977791|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977792|NCT00976391|Incretins|incretins|mesh-ancestor
1977793|NCT00976391|Hormones|hormones|mesh-ancestor
1977794|NCT00976391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977795|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
1977796|NCT00976404|Maraviroc|maraviroc|mesh-list
1977797|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1977798|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1977799|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
1977800|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977801|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1977802|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1977803|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977804|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977805|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1977806|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1977807|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1977808|NCT00976456|Bevacizumab|bevacizumab|mesh-list
1977809|NCT00976456|Carboplatin|carboplatin|mesh-list
1977810|NCT00976456|Pemetrexed|pemetrexed|mesh-list
1977811|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1977812|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977813|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1977814|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1977815|NCT00976456|Growth Substances|growth substances|mesh-ancestor
1977816|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977817|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
1977818|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977819|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977820|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1977821|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1977822|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
1977823|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1977824|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1977825|NCT00976495|Diuretics|diuretics|mesh-ancestor
1977826|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
1977827|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977828|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1977829|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1977830|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977831|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1977832|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1977833|NCT00976521|Abciximab|abciximab|mesh-list
1977834|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
1977835|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1977836|NCT00976573|Paclitaxel|paclitaxel|mesh-list
1977837|NCT00976573|Bevacizumab|bevacizumab|mesh-list
1977838|NCT00976573|Carboplatin|carboplatin|mesh-list
1977839|NCT00976573|Everolimus|everolimus|mesh-list
1977840|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1977841|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977842|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
1977843|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
1977844|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
1977845|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977846|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1977847|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1977848|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1977849|NCT00976573|Growth Substances|growth substances|mesh-ancestor
1977850|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977851|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
1977852|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977853|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
1977854|NCT00976599|Methotrexate|methotrexate|mesh-list
1977855|NCT00976599|Tofacitinib|tofacitinib|mesh-list
1977856|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1977857|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
1977858|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1977859|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977860|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1977861|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
1977862|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977863|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977864|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
1977865|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977866|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1977867|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1977868|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
1977869|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1977870|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1977871|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1977872|NCT00976677|Paclitaxel|paclitaxel|mesh-list
1977873|NCT00976677|Bevacizumab|bevacizumab|mesh-list
1977874|NCT00976677|Carboplatin|carboplatin|mesh-list
1977875|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1977876|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1977877|NCT00976677|Antibodies|antibodies|mesh-list
1977878|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
1977879|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1977880|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1977881|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977882|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
1977883|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
1977884|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
1977885|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977886|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1977887|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1977888|NCT00976677|Growth Substances|growth substances|mesh-ancestor
1977889|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977890|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
1977891|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
1977892|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1977893|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977894|NCT00976716|Celecoxib|celecoxib|mesh-list
1977895|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1977896|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1977897|NCT00976716|Analgesics|analgesics|mesh-ancestor
1977898|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
1977899|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977900|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977901|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1977902|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1977903|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1977904|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1977905|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977906|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977907|NCT00976911|Paclitaxel|paclitaxel|mesh-list
1977908|NCT00976911|Bevacizumab|bevacizumab|mesh-list
1977909|NCT00976911|Doxorubicin|doxorubicin|mesh-list
1977910|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1977911|NCT00976911|Topotecan|topotecan|mesh-list
1977912|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1977913|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977914|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
1977915|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
1977916|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
1977917|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977918|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1977919|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1977920|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1977921|NCT00976911|Growth Substances|growth substances|mesh-ancestor
1977922|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977923|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
1977924|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1977925|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1977926|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1977927|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977928|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1977929|NCT00976937|Metformin|metformin|mesh-list
1977930|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1977931|NCT00976937|Lixisenatide|lixisenatide|mesh-list
1977932|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1977933|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977934|NCT00976937|Incretins|incretins|mesh-ancestor
1977935|NCT00976937|Hormones|hormones|mesh-ancestor
1977936|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977937|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1977938|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
1977939|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977940|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977941|NCT00976950|Ritonavir|ritonavir|mesh-list
1977942|NCT00976950|Tipranavir|tipranavir|mesh-list
1977943|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1977944|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1977945|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
1977946|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977947|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977948|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1977949|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1977950|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
1977951|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1977952|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1977953|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1977954|NCT00976989|Docetaxel|docetaxel|mesh-list
1977955|NCT00976989|Trastuzumab|trastuzumab|mesh-list
1977956|NCT00976989|Pertuzumab|pertuzumab|mesh-list
1977957|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977958|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
1977959|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
1977960|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
1977961|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977962|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1977963|NCT00977080|Cinacalcet|cinacalcet|mesh-list
1977964|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1977965|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977966|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1977967|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
1977968|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1977969|NCT00977171|Droxidopa|droxidopa|mesh-list
1977970|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1977971|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1977972|NCT00977197|Pregabalin|pregabalin|mesh-list
1977973|NCT00977197|Analgesics|analgesics|mesh-ancestor
1977974|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
1977975|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1977976|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1977977|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
1977978|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1977979|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1977980|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977981|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1977982|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1977983|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1977984|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1977985|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1977986|NCT00977379|Capecitabine|capecitabine|mesh-list
1977987|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1977988|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
1977989|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977990|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977991|NCT00977431|Temozolomide|temozolomide|mesh-list
1977992|NCT00977431|Afatinib|afatinib|mesh-list
1977993|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1977994|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
1977995|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1977996|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1977997|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1977998|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1977999|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
1978000|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1978001|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978002|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1978003|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978004|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978005|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
1978006|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1978007|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1978008|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978009|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978010|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1978011|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978012|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1978013|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978014|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978015|NCT00977561|Cisplatin|cisplatin|mesh-list
1978016|NCT00977561|Carboplatin|carboplatin|mesh-list
1978017|NCT00977561|Etoposide|etoposide|mesh-list
1978018|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
1978019|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978020|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1978021|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1978022|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1978023|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978024|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978025|NCT00977665|Rasagiline|rasagiline|mesh-list
1978026|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1978027|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978028|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978029|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1978030|NCT00977665|Protective Agents|protective agents|mesh-ancestor
1978031|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978032|NCT00977691|Sirolimus|sirolimus|mesh-list
1978033|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
1978034|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
1978035|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1978036|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
1978037|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978038|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978039|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1978040|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
1978041|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978042|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978043|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1978044|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1978045|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978046|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1978047|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
1978048|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1978049|NCT00977769|Oxytocin|oxytocin|mesh-list
1978050|NCT00977769|Carbetocin|carbetocin|mesh-list
1978051|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
1978052|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1978053|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978054|NCT00977938|Aspirin|aspirin|mesh-list
1978055|NCT00977938|Clopidogrel|clopidogrel|mesh-list
1978056|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1978057|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1978058|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1978059|NCT00977938|Analgesics|analgesics|mesh-ancestor
1978060|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
1978061|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978062|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978063|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1978064|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978065|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1978066|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1978067|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978068|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1978069|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1978070|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978071|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
1978072|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1978073|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1978074|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1978075|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
1978076|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1978077|NCT00978068|Ritonavir|ritonavir|mesh-list
1978078|NCT00978068|Lopinavir|lopinavir|mesh-list
1978079|NCT00978068|Nevirapine|nevirapine|mesh-list
1978080|NCT00978068|Efavirenz|efavirenz|mesh-list
1978081|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
1978082|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1978083|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1978084|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
1978085|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978086|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978087|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1978088|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1978089|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
1978090|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978091|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1978092|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1978093|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1978094|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1978095|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1978096|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1978097|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1978098|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1978099|NCT00978120|Vaccines|vaccines|mesh-list
1978100|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
1978101|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978102|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
1978103|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
1978104|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978105|NCT00978341|Pregabalin|pregabalin|mesh-list
1978106|NCT00978341|Analgesics|analgesics|mesh-ancestor
1978107|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
1978108|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978109|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978110|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
1978111|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1978112|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1978113|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978114|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1978115|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1978116|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1978117|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1978118|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1978119|NCT00978432|Everolimus|everolimus|mesh-list
1978120|NCT00978432|Panobinostat|panobinostat|mesh-list
1978121|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978122|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1978123|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
1978124|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978125|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1978126|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978127|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978128|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1978129|NCT00978562|Hematinics|hematinics|mesh-ancestor
1978130|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1978131|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1978132|NCT00978627|Insulin|insulin|mesh-list
1978133|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1978134|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
1978135|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
1978136|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1978137|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
1978138|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1978139|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978140|NCT00978731|Dasatinib|dasatinib|mesh-list
1978141|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978142|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1978143|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978144|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978145|NCT00978757|Ketamine|ketamine|mesh-list
1978146|NCT00978757|Analgesics|analgesics|mesh-ancestor
1978147|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
1978148|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978149|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978150|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1978151|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1978152|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
1978153|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
1978154|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1978155|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1978156|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1978157|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1978158|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978159|NCT00979017|Bevacizumab|bevacizumab|mesh-list
1978160|NCT00979017|Irinotecan|irinotecan|mesh-list
1978161|NCT00979017|Temozolomide|temozolomide|mesh-list
1978162|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1978163|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978164|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1978165|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1978166|NCT00979017|Growth Substances|growth substances|mesh-ancestor
1978167|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978168|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
1978169|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1978170|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1978171|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978172|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978173|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1978174|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
1978175|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1978176|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1978177|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1978178|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
1978179|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978180|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1978181|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1978182|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978183|NCT00979212|Paclitaxel|paclitaxel|mesh-list
1978184|NCT00979212|Carboplatin|carboplatin|mesh-list
1978185|NCT00979212|Panitumumab|panitumumab|mesh-list
1978186|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1978187|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978188|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
1978189|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
1978190|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
1978191|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978192|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1978193|NCT00979407|Vaccines|vaccines|mesh-list
1978194|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
1978195|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978196|NCT00979576|Pemetrexed|pemetrexed|mesh-list
1978197|NCT00979576|Nintedanib|nintedanib|mesh-list
1978198|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978199|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978200|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978201|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1978202|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1978203|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1978204|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1978205|NCT00979615|Azelastine|azelastine|mesh-list
1978206|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1978207|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1978208|NCT00979615|Analgesics|analgesics|mesh-ancestor
1978209|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
1978210|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978211|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978212|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1978213|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978214|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1978215|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1978216|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1978217|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
1978218|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
1978219|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1978220|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978221|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1978222|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
1978223|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1978224|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
1978225|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1978226|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978227|NCT00979628|Insulin|insulin|mesh-list
1978228|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1978229|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
1978230|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
1978231|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1978232|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978233|NCT00979654|Sifalimumab|sifalimumab|mesh-list
1978234|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
1978235|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978236|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
1978237|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1978238|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978239|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
1978240|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978241|NCT00979732|Protective Agents|protective agents|mesh-ancestor
1978242|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978243|NCT00979745|Afamelanotide|afamelanotide|mesh-list
1978244|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
1978245|NCT00979875|Insulin|insulin|mesh-list
1978246|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1978247|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
1978248|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
1978249|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
1978250|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1978251|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978252|NCT00979901|Loratadine|loratadine|mesh-list
1978253|NCT00979901|Montelukast|montelukast|mesh-list
1978254|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1978255|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
1978256|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1978257|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
1978258|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1978259|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978260|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1978261|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1978262|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978263|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
1978264|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
1978265|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1978266|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1978267|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1978268|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
1978269|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
1978270|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1978271|NCT00979940|Atorvastatin|atorvastatin|mesh-list
1978272|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1978273|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1978274|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
1978275|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978276|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1978277|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1978278|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978279|NCT00979953|Oxycodone|oxycodone|mesh-list
1978280|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1978281|NCT00979953|Narcotics|narcotics|mesh-ancestor
1978282|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1978283|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978284|NCT00979953|Analgesics|analgesics|mesh-ancestor
1978285|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
1978286|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978287|NCT00979992|Sunitinib|sunitinib|mesh-list
1978288|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978289|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1978290|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1978291|NCT00979992|Growth Substances|growth substances|mesh-ancestor
1978292|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978293|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
1978294|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1978295|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978296|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978297|NCT00980044|Tramadol|tramadol|mesh-list
1978298|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1978299|NCT00980044|Narcotics|narcotics|mesh-ancestor
1978300|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1978301|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978302|NCT00980044|Analgesics|analgesics|mesh-ancestor
1978303|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
1978304|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978305|NCT00980148|Azithromycin|azithromycin|mesh-list
1978306|NCT00980148|Doxycycline|doxycycline|mesh-list
1978307|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1978308|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978309|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
1978310|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1978311|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1978312|NCT00980174|Denosumab|denosumab|mesh-list
1978313|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1978314|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978315|NCT00980330|Ribavirin|ribavirin|mesh-list
1978316|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1978317|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
1978318|NCT00980330|Simeprevir|simeprevir|mesh-list
1978319|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
1978320|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978321|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
1978322|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978323|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978324|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
1978325|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978326|NCT00980395|Rituximab|rituximab|mesh-list
1978327|NCT00980395|Bortezomib|bortezomib|mesh-list
1978328|NCT00980395|Cladribine|cladribine|mesh-list
1978329|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1978330|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978331|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
1978332|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978333|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978334|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1978335|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
1978336|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
1978337|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
1978338|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978339|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1978340|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
1978341|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1978342|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1978343|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1978344|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978345|NCT00980785|Ramipril|ramipril|mesh-list
1978346|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1978347|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
1978348|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978349|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978350|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1978351|NCT00980798|Hydromorphone|hydromorphone|mesh-list
1978352|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1978353|NCT00980798|Narcotics|narcotics|mesh-ancestor
1978354|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1978355|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978356|NCT00980798|Analgesics|analgesics|mesh-ancestor
1978357|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
1978358|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978359|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
1978360|NCT00980980|Mupirocin|mupirocin|mesh-list
1978361|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1978362|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978363|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
1978364|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1978365|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1978366|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978367|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978368|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
1978369|NCT00981045|Hematinics|hematinics|mesh-ancestor
1978370|NCT00981058|Gemcitabine|gemcitabine|mesh-list
1978371|NCT00981058|Necitumumab|necitumumab|mesh-list
1978372|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978373|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1978374|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
1978375|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978376|NCT00981058|Antiviral Agents|antiviral agents|mesh-ancestor
1978377|NCT00981058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978378|NCT00981058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978379|NCT00981058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1978380|NCT00981058|Immunologic Factors|immunologic factors|mesh-ancestor
1978381|NCT00981058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978382|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1978383|NCT00981084|Modafinil|modafinil|mesh-list
1978384|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1978385|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978386|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1978387|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1978388|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1978389|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978390|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1978391|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1978392|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1978393|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1978394|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978395|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1978396|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978397|NCT00981149|Analgesics|analgesics|mesh-ancestor
1978398|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
1978399|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978400|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
1978401|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1978402|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
1978403|NCT00981214|Pancrelipase|pancrelipase|mesh-list
1978404|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1978405|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1978406|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
1978407|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1978408|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1978409|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1978410|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978411|NCT00981409|Heparin|heparin|mesh-list
1978412|NCT00981409|Calcium heparin|calcium heparin|mesh-list
1978413|NCT00981409|PENTA|penta|mesh-list
1978414|NCT00981409|Fondaparinux|fondaparinux|mesh-list
1978415|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
1978416|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1978417|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1978418|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978419|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1978420|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
1978421|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1978422|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
1978423|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978424|NCT00981435|Prednisolone|prednisolone|mesh-list
1978425|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
1978426|NCT00981435|Ketorolac|ketorolac|mesh-list
1978427|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
1978428|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1978429|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
1978430|NCT00981435|Hormones|hormones|mesh-ancestor
1978431|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1978432|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978433|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1978434|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978435|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978436|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1978437|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1978438|NCT00981435|Analgesics|analgesics|mesh-ancestor
1978439|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
1978440|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978441|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1978442|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978443|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978444|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1978445|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1978446|NCT00981526|Telmisartan|telmisartan|mesh-list
1978447|NCT00981526|Olanzapine|olanzapine|mesh-list
1978448|NCT00981526|Clozapine|clozapine|mesh-list
1978449|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
1978450|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
1978451|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978452|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978453|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1978454|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1978455|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1978456|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1978457|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1978458|NCT00981526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1978459|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1978460|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1978461|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978462|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1978463|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
1978464|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1978465|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1978466|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1978467|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1978468|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
1978469|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
1978470|NCT00981669|Vaccines|vaccines|mesh-list
1978471|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
1978472|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978473|NCT00981747|Losartan|losartan|mesh-list
1978474|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
1978475|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
1978476|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1978477|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1978478|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978479|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978480|NCT00981747|Urological Agents|urological agents|mesh-ancestor
1978481|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1978482|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1978483|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1978484|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1978485|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
1978486|NCT00981799|Methotrexate|methotrexate|mesh-list
1978487|NCT00981799|Etoposide|etoposide|mesh-list
1978488|NCT00981799|Lenograstim|lenograstim|mesh-list
1978489|NCT00981799|Sargramostim|sargramostim|mesh-list
1978490|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1978491|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
1978492|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978493|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978494|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1978495|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
1978496|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978497|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978498|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1978499|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1978500|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
1978501|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1978502|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1978503|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
1978504|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
1978505|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978506|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1978507|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1978508|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1978509|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1978510|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1978511|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1978512|NCT00981825|Listerine|listerine|mesh-list
1978513|NCT00981825|Triclosan|triclosan|mesh-list
1978514|NCT00981825|Fluorides|fluorides|mesh-list
1978515|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
1978516|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
1978517|NCT00981825|Protective Agents|protective agents|mesh-ancestor
1978518|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978519|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1978520|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978521|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1978522|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1978523|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
1978524|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978525|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1978526|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
1978527|NCT00982007|Hematinics|hematinics|mesh-ancestor
1978528|NCT00982020|Olanzapine|olanzapine|mesh-list
1978529|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
1978530|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
1978531|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978532|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978533|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1978534|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1978535|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1978536|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1978537|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1978538|NCT00982020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1978539|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1978540|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1978541|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978542|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1978543|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
1978544|NCT00982072|Prednisolone|prednisolone|mesh-list
1978545|NCT00982072|Tacrolimus|tacrolimus|mesh-list
1978546|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1978547|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
1978548|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978549|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1978550|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978551|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978552|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1978553|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
1978554|NCT00982072|Hormones|hormones|mesh-ancestor
1978555|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1978556|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1978557|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978566|NCT00982189|Lisinopril|lisinopril|mesh-list
1978567|NCT00982189|Pravastatin|pravastatin|mesh-list
1978568|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1978569|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1978570|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
1978571|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978572|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1978573|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1978574|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978575|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1978576|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
1978577|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1978578|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1978579|NCT00982189|Protective Agents|protective agents|mesh-ancestor
1978580|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978581|NCT00982228|Insulin|insulin|mesh-list
1978582|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1978583|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
1978584|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
1978585|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1978586|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978587|NCT00982280|Tapentadol|tapentadol|mesh-list
1978588|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1978589|NCT00982280|Narcotics|narcotics|mesh-ancestor
1978590|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1978591|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978592|NCT00982280|Analgesics|analgesics|mesh-ancestor
1978593|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
1978594|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978595|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1978596|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1978597|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1978598|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978599|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
1978600|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1978601|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1978602|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
1978603|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1978604|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1978605|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1978606|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1978607|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978608|NCT00982423|Furosemide|furosemide|mesh-list
1978609|NCT00982423|Diuretics|diuretics|mesh-ancestor
1978610|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
1978611|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978612|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1978613|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1978614|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978615|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
1978616|NCT00982488|Dasatinib|dasatinib|mesh-list
1978617|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978618|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1978619|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978620|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978621|NCT00982553|Ribavirin|ribavirin|mesh-list
1978622|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
1978623|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
1978624|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978625|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
1978626|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978627|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1978628|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1978629|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1978630|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1978631|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978632|NCT00982592|Leucovorin|leucovorin|mesh-list
1978633|NCT00982592|Fluorouracil|fluorouracil|mesh-list
1978634|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
1978635|NCT00982592|Calcium|calcium|mesh-list
1978636|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
1978637|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1978638|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978639|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
1978640|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978641|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1978642|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978643|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1978644|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
1978645|NCT00982592|Antidotes|antidotes|mesh-ancestor
1978646|NCT00982592|Protective Agents|protective agents|mesh-ancestor
1978647|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
1978648|NCT00982592|Vitamins|vitamins|mesh-ancestor
1978649|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
1978650|NCT00982644|Insulin|insulin|mesh-list
1978651|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1978652|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
1978653|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1978654|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978655|NCT00982657|Sunitinib|sunitinib|mesh-list
1978656|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978657|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1978658|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1978659|NCT00982657|Growth Substances|growth substances|mesh-ancestor
1978660|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978661|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
1978662|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1978663|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978664|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978665|NCT00982865|Niacinamide|niacinamide|mesh-list
1978666|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
1978667|NCT00982865|Vitamins|vitamins|mesh-ancestor
1978668|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
1978669|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978670|NCT00982878|Maraviroc|maraviroc|mesh-list
1978671|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1978672|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1978673|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978674|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1978675|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1978676|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
1978677|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978678|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1978679|NCT00982930|Tobramycin|tobramycin|mesh-list
1978680|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1978681|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978682|NCT00983073|Tapentadol|tapentadol|mesh-list
1978683|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1978684|NCT00983073|Narcotics|narcotics|mesh-ancestor
1978685|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1978686|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978687|NCT00983073|Analgesics|analgesics|mesh-ancestor
1978688|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
1978689|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978690|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1978691|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1978692|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1978693|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978694|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
1978695|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1978696|NCT00983216|Ketoconazole|ketoconazole|mesh-list
1978697|NCT00983216|Colchicine|colchicine|mesh-list
1978698|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
1978699|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978700|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
1978701|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
1978702|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
1978703|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978704|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978705|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
1978706|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978707|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1978708|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1978709|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978710|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1978711|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
1978712|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1978713|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978714|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1978715|NCT00983242|Colchicine|colchicine|mesh-list
1978716|NCT00983242|Verapamil|verapamil|mesh-list
1978717|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
1978718|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978719|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
1978720|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
1978721|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
1978722|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978723|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978724|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1978725|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1978726|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1978727|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1978728|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978729|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
1978730|NCT00983294|Azithromycin|azithromycin|mesh-list
1978731|NCT00983294|Colchicine|colchicine|mesh-list
1978732|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1978733|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978734|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
1978735|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978736|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
1978737|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
1978738|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
1978739|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978740|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978741|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1978742|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978743|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1978744|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978745|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978746|NCT00983346|Bortezomib|bortezomib|mesh-list
1978747|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978748|NCT00983372|Colchicine|colchicine|mesh-list
1978749|NCT00983372|Diltiazem|diltiazem|mesh-list
1978750|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
1978751|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978752|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
1978753|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
1978754|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
1978755|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978756|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978757|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1978758|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1978759|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1978760|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1978761|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978762|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
1978763|NCT00983385|Tapentadol|tapentadol|mesh-list
1978764|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1978765|NCT00983385|Narcotics|narcotics|mesh-ancestor
1978766|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1978767|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978768|NCT00983385|Analgesics|analgesics|mesh-ancestor
1978769|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
1978770|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978771|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1978772|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1978773|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1978774|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978775|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
1978776|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2745665|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
2745666|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745667|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745668|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2745669|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2745670|NCT02743923|Growth Substances|growth substances|mesh-ancestor
2745671|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978784|NCT00983515|Ritonavir|ritonavir|mesh-list
1978785|NCT00983515|Colchicine|colchicine|mesh-list
1978786|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1978787|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1978788|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
1978789|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978790|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978791|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1978792|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1978793|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
1978794|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2745672|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
1978795|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1978796|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1978797|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
1978798|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978799|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
1978800|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
1978801|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
1978802|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978803|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
1978804|NCT00983528|Clofarabine|clofarabine|mesh-list
1978805|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1978806|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978807|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1978808|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
1978809|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978810|NCT00983541|Gemcitabine|gemcitabine|mesh-list
1978811|NCT00983541|Fluorouracil|fluorouracil|mesh-list
1978812|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1978813|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
1978814|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978815|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978816|NCT00983541|Antiviral Agents|antiviral agents|mesh-ancestor
1978817|NCT00983541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978818|NCT00983541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978819|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1978820|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
1978821|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978822|NCT00983580|Aspirin|aspirin|mesh-list
1978823|NCT00983580|Eflornithine|eflornithine|mesh-list
1978824|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1978825|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1978826|NCT00983580|Analgesics|analgesics|mesh-ancestor
1978827|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
1978828|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978829|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978830|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1978831|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978832|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1978833|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1978834|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978835|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1978836|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1978837|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978838|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
1978839|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978840|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1978841|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1978842|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1978843|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978844|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
1978845|NCT00983619|Rituximab|rituximab|mesh-list
1978846|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1978847|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978848|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
1978849|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978850|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978851|NCT00983853|Ribavirin|ribavirin|mesh-list
1978852|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1978853|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
1978854|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978855|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
1978856|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978857|NCT00983905|Colchicine|colchicine|mesh-list
1978858|NCT00983905|Theophylline|theophylline|mesh-list
1978859|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
1978860|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978861|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
1978862|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
1978863|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
1978864|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978865|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978866|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1978867|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
1978868|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978869|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745673|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978870|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1978871|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
1978872|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1978873|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978874|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
1978875|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1978876|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1978877|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
1978878|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1978879|NCT00983918|Propofol|propofol|mesh-list
1978880|NCT00983918|Sevoflurane|sevoflurane|mesh-list
1978881|NCT00983918|Desflurane|desflurane|mesh-list
1978882|NCT00983918|Isoflurane|isoflurane|mesh-list
1978883|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1978884|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1978885|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978886|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1978887|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
1978888|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
1978889|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1978890|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1978891|NCT00983931|Cyclosporine|cyclosporine|mesh-list
1978892|NCT00983931|Colchicine|colchicine|mesh-list
1978893|NCT00983931|Cyclosporins|cyclosporins|mesh-list
1978894|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978895|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978896|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1978897|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
1978898|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978899|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
1978900|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978901|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
1978902|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978903|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1978904|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
1978905|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
1978906|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
1978907|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
1978908|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978909|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
1978910|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1978911|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1978912|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
1978913|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1978914|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978915|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1978916|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1978917|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1978918|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1978919|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978920|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1978921|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1978922|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978923|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978924|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978925|NCT00984009|Colchicine|colchicine|mesh-list
1978926|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
1978927|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978928|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
1978929|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
1978930|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
1978931|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978932|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978933|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1978934|NCT00984022|Laxatives|laxatives|mesh-ancestor
1978935|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1978936|NCT00984061|Clarithromycin|clarithromycin|mesh-list
1978937|NCT00984061|Colchicine|colchicine|mesh-list
1978938|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1978939|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978940|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1978941|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978942|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978943|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1978944|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1978945|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
1978946|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978947|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
1978948|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
1978949|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
1978950|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978951|NCT00984126|Factor VIII|factor viii|mesh-list
1978952|NCT00984126|Coagulants|coagulants|mesh-ancestor
1978953|NCT00984139|Vaccines|vaccines|mesh-list
1978954|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
1978955|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978956|NCT00984256|Atovaquone|atovaquone|mesh-list
1978957|NCT00984256|Proguanil|proguanil|mesh-list
1978958|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
1978959|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1978960|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
1978961|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1978962|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1978963|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978964|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978965|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
1978966|NCT00984282|Sorafenib|sorafenib|mesh-list
1978967|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978968|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1978969|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1978970|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978971|NCT00984334|Naloxone|naloxone|mesh-list
1978972|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1978973|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978974|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
1978975|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978976|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1978977|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1978978|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
1978979|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978980|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978981|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
1978982|NCT00984568|Prednisolone|prednisolone|mesh-list
1978983|NCT00984568|Mesalamine|mesalamine|mesh-list
1978984|NCT00984568|Azathioprine|azathioprine|mesh-list
1978985|NCT00984568|Infliximab|infliximab|mesh-list
1978986|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1978987|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
1978988|NCT00984568|Hormones|hormones|mesh-ancestor
1978989|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1978990|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1978991|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1978992|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1978993|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1978994|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1978995|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
1978996|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1978997|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
1978998|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1978999|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1979000|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1979001|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
1979002|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
1979003|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1979004|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979005|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1979006|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1979007|NCT00984568|Analgesics|analgesics|mesh-ancestor
1979008|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
1979009|NCT00984620|Interferons|interferons|mesh-list
1979010|NCT00984620|Ribavirin|ribavirin|mesh-list
1979011|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
1979012|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979013|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
1979014|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979015|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
1979016|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979017|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
1979018|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979019|NCT00984659|Fluticasone|fluticasone|mesh-list
1979020|NCT00984659|Xhance|xhance|mesh-list
1979021|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1979022|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1979023|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1979024|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
1979025|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979026|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979027|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1979028|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
1979029|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
1979030|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1979031|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1979032|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1979033|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1979034|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
1979035|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979036|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979037|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
1979038|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1979039|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979040|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1979041|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979042|NCT00985192|Everolimus|everolimus|mesh-list
1979043|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979044|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1979045|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
1979046|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979047|NCT00985426|Vaccines|vaccines|mesh-list
1979048|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
1979049|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979050|NCT00985439|Celecoxib|celecoxib|mesh-list
1979051|NCT00985439|Diclofenac|diclofenac|mesh-list
1979052|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1979053|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1979054|NCT00985439|Analgesics|analgesics|mesh-ancestor
1979055|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
1979056|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979057|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979058|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1979059|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1979060|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1979061|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1979062|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979063|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979064|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1979065|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
1979066|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979067|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1979068|NCT00985504|Citalopram|citalopram|mesh-list
1979069|NCT00985504|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1979070|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1979071|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979072|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979073|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979074|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
1979075|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979076|NCT00985504|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1979077|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
1979078|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1979079|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979080|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1979081|NCT00985504|Analgesics|analgesics|mesh-ancestor
1979082|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
1979083|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
1979084|NCT00985543|Ritonavir|ritonavir|mesh-list
1979085|NCT00985543|Lopinavir|lopinavir|mesh-list
1979086|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1979087|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1979088|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
1979089|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979090|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979091|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1979092|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1979093|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
1979094|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979095|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1979096|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1979097|NCT00985621|Oxycodone|oxycodone|mesh-list
1979098|NCT00985621|Tanezumab|tanezumab|mesh-list
1979099|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1979100|NCT00985621|Narcotics|narcotics|mesh-ancestor
1979101|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1979102|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979103|NCT00985621|Analgesics|analgesics|mesh-ancestor
1979104|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
1979105|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979106|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
1979107|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1979108|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979109|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1979110|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1979111|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979112|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1979113|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1979114|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979115|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979116|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
1979117|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979118|NCT00985751|Vaccines|vaccines|mesh-list
1979119|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1979120|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
1979121|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979122|NCT00985907|Bortezomib|bortezomib|mesh-list
1979123|NCT00985907|Melphalan|melphalan|mesh-list
1979124|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1979125|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979126|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1979127|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
1979128|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979129|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1979130|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1979131|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
1979132|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979133|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1979134|NCT00985946|Panobinostat|panobinostat|mesh-list
1979135|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979136|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1979137|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979138|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979139|NCT00985959|Prednisolone|prednisolone|mesh-list
1979140|NCT00985959|Bortezomib|bortezomib|mesh-list
1979141|NCT00985959|Melphalan|melphalan|mesh-list
1979142|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979143|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1979144|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
1979145|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979146|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1979147|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1979148|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
1979149|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979150|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1979151|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
1979152|NCT00985959|Hormones|hormones|mesh-ancestor
1979153|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1979154|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1979155|NCT00985985|Nicotine|nicotine|mesh-list
1979156|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1979157|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
1979158|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979159|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979160|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1979161|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1979162|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
1979163|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979164|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979165|NCT00986102|Doripenem|doripenem|mesh-list
1979166|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1979167|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979168|NCT00986154|Heparin|heparin|mesh-list
1979169|NCT00986154|Calcium heparin|calcium heparin|mesh-list
1979170|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1979171|NCT00986154|Tinzaparin|tinzaparin|mesh-list
1979172|NCT00986154|Dalteparin|dalteparin|mesh-list
1979173|NCT00986154|Warfarin|warfarin|mesh-list
1979174|NCT00986154|Edoxaban|edoxaban|mesh-list
1979175|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
1979176|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1979177|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1979178|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979179|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1979180|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
1979181|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1979182|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
1979183|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979184|NCT00986180|Oxycodone|oxycodone|mesh-list
1979185|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1979186|NCT00986180|Narcotics|narcotics|mesh-ancestor
1979187|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1979188|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979189|NCT00986180|Analgesics|analgesics|mesh-ancestor
1979190|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
1979191|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979192|NCT00986245|Ropinirole|ropinirole|mesh-list
1979193|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1979194|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1979195|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
1979196|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
1979197|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979198|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979199|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979200|NCT00986258|Tapentadol|tapentadol|mesh-list
1979201|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1979202|NCT00986258|Narcotics|narcotics|mesh-ancestor
1979203|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1979204|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979205|NCT00986258|Analgesics|analgesics|mesh-ancestor
1979206|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
1979207|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979208|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1979209|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1979210|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979211|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979212|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
1979213|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979214|NCT00986401|Metformin|metformin|mesh-list
1979215|NCT00986401|Trospium chloride|trospium chloride|mesh-list
1979216|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1979217|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979218|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
1979219|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
1979220|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979221|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1979222|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1979223|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
1979224|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979225|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979226|NCT00986401|Urological Agents|urological agents|mesh-ancestor
1979227|NCT00986427|Cyclosporine|cyclosporine|mesh-list
1979228|NCT00986427|Cyclosporins|cyclosporins|mesh-list
1979229|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979230|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979231|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1979232|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
1979233|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979234|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
1979235|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979236|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
1979237|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1979238|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1979239|NCT00986440|Efatutazone|efatutazone|mesh-list
1979240|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979241|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
1979242|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1979243|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1979244|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1979245|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979246|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979247|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
1979248|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979249|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979250|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1979251|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979252|NCT00986583|Succinylcholine|succinylcholine|mesh-list
1979253|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
1979254|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1979255|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1979256|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979257|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979258|NCT00986674|Paclitaxel|paclitaxel|mesh-list
1979259|NCT00986674|Carboplatin|carboplatin|mesh-list
1979260|NCT00986674|Cetuximab|cetuximab|mesh-list
1979261|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1979262|NCT00986674|Antibodies|antibodies|mesh-list
1979263|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
1979264|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1979265|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1979266|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979267|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
1979268|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
1979269|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
1979270|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979271|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
1979272|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979273|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
1979274|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1979275|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979276|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1979277|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979278|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979279|NCT00986921|Mifepristone|mifepristone|mesh-list
1979280|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1979281|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
1979282|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1979283|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979284|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1979285|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1979286|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1979287|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
1979288|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1979289|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1979290|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
1979291|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1979292|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
1979293|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1979294|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1979295|NCT00986986|Niacin|niacin|mesh-list
1979296|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1979297|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
1979298|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979299|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1979300|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
1979301|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
1979302|NCT00986986|Vitamins|vitamins|mesh-ancestor
1979303|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
1979304|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979305|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
1979306|NCT00987389|Hormones|hormones|mesh-ancestor
1979307|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1979308|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979309|NCT00987402|Ethanol|ethanol|mesh-list
1979310|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1979311|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979312|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1979313|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979314|NCT00987415|Allopurinol|allopurinol|mesh-list
1979315|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
1979316|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979317|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979318|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
1979319|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1979320|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1979321|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
1979322|NCT00987415|Protective Agents|protective agents|mesh-ancestor
1979323|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979324|NCT00987467|Cyclosporine|cyclosporine|mesh-list
1979325|NCT00987467|Cyclosporins|cyclosporins|mesh-list
1979326|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979327|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979328|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1979329|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
1979330|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979331|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
1979332|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979333|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
1979334|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1979335|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1979336|NCT00987480|Cyclosporine|cyclosporine|mesh-list
1979337|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
1979338|NCT00987480|Busulfan|busulfan|mesh-list
1979339|NCT00987480|Fludarabine|fludarabine|mesh-list
1979340|NCT00987480|Cyclosporins|cyclosporins|mesh-list
1979341|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1979342|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
1979343|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979344|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1979345|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1979346|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
1979347|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979348|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979349|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1979350|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979351|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
1979352|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979353|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
1979354|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1979355|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1979356|NCT00987558|Simvastatin|simvastatin|mesh-list
1979357|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1979358|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1979359|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
1979360|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979361|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1979362|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1979363|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979364|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
1979365|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1979366|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1979367|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979368|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1979369|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
1979370|NCT00987727|Glycerol|glycerol|mesh-list
1979371|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1979372|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
1979373|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979374|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
1979375|NCT00987727|Protective Agents|protective agents|mesh-ancestor
1979376|NCT00987727|Laxatives|laxatives|mesh-ancestor
1979377|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1979378|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1979379|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
1979380|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1979381|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1979382|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
1979383|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
1979384|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979385|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979386|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1979387|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
1979388|NCT00987831|Hormones|hormones|mesh-ancestor
1979389|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1979390|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1979391|NCT00987831|Protective Agents|protective agents|mesh-ancestor
1979392|NCT00987935|Sorafenib|sorafenib|mesh-list
1979393|NCT00987935|Nintedanib|nintedanib|mesh-list
1979394|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979395|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1979396|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979397|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979398|NCT00987948|Maraviroc|maraviroc|mesh-list
1979399|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1979400|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1979401|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979402|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1979403|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1979404|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
1979405|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979406|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1979407|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
1979408|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1979409|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
1979410|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979411|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
1979412|NCT00988091|Protective Agents|protective agents|mesh-ancestor
1979413|NCT00988117|Rivastigmine|rivastigmine|mesh-list
1979414|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1979415|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979416|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979417|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
1979418|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979419|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979420|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1979421|NCT00988117|Protective Agents|protective agents|mesh-ancestor
1979422|NCT00988143|Vaccines|vaccines|mesh-list
1979423|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
1979424|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979425|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1979426|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
1979427|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1979428|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1979429|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979430|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979431|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1979432|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979433|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1979434|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979435|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979436|NCT00988208|Prednisone|prednisone|mesh-list
1979437|NCT00988208|Docetaxel|docetaxel|mesh-list
1979438|NCT00988208|Lenalidomide|lenalidomide|mesh-list
1979439|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979440|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
1979441|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
1979442|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
1979443|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979444|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1979445|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
1979446|NCT00988208|Hormones|hormones|mesh-ancestor
1979447|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1979448|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979449|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1979450|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
1979451|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1979452|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1979453|NCT00988208|Growth Substances|growth substances|mesh-ancestor
1979454|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
2745674|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2745675|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2745676|NCT02735707|Aspirin|aspirin|mesh-list
2745677|NCT02735707|Vitamins|vitamins|mesh-list
2745678|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
2745679|NCT02735707|Interferons|interferons|mesh-list
2745680|NCT02735707|Ritonavir|ritonavir|mesh-list
2745681|NCT02735707|Lopinavir|lopinavir|mesh-list
1979463|NCT00988325|Oseltamivir|oseltamivir|mesh-list
1979464|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
1979465|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979466|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979467|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979468|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1979469|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
1979470|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2745682|NCT02735707|Interferon-beta|interferon-beta|mesh-list
2745683|NCT02735707|Oseltamivir|oseltamivir|mesh-list
1979471|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1979472|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979473|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979474|NCT00988533|Ivermectin|ivermectin|mesh-list
1979475|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1979476|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979477|NCT00988559|Imiquimod|imiquimod|mesh-list
1979478|NCT00988559|Vaccines|vaccines|mesh-list
1979479|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
1979480|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979481|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1979482|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979483|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
1979484|NCT00988637|Calcitriol|calcitriol|mesh-list
1979485|NCT00988637|Clobetasol|clobetasol|mesh-list
1979486|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1979487|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979488|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1979489|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979490|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979491|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1979492|NCT00988637|Vitamins|vitamins|mesh-ancestor
1979493|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
1979494|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1979495|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1979496|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
1979497|NCT00988637|Hormones|hormones|mesh-ancestor
1979498|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1979499|NCT00988832|Infliximab|infliximab|mesh-list
1979500|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
1979501|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1979502|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1979503|NCT00988858|Pemetrexed|pemetrexed|mesh-list
1979504|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979505|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979506|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979507|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1979508|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1979509|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
1979510|NCT00989092|Hematinics|hematinics|mesh-ancestor
1979511|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1979512|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1979513|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1979514|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979515|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979516|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979517|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979518|NCT00989157|Analgesics|analgesics|mesh-ancestor
1979519|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
1979520|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979521|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
1979522|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1979523|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
1979524|NCT00989196|Factor VIII|factor viii|mesh-list
1979525|NCT00989196|Coagulants|coagulants|mesh-ancestor
1979526|NCT00989235|Abatacept|abatacept|mesh-list
1979527|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1979528|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979529|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979530|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1979531|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
1979532|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979533|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1979534|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1979535|NCT00989586|Veltuzumab|veltuzumab|mesh-list
1979536|NCT00989586|Antibodies|antibodies|mesh-list
1979537|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
1979538|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1979539|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
1979540|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979541|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979542|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
1979543|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979544|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
1979545|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1979546|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1979547|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1979548|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979549|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979550|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
1979551|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979552|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979553|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1979554|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979555|NCT00989781|Dexamethasone|dexamethasone|mesh-list
1979556|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1979557|NCT00989781|Hormones|hormones|mesh-list
1979558|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1979559|NCT00989781|Cosyntropin|cosyntropin|mesh-list
1979560|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
1979561|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
1979562|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
1979563|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1979564|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
1979565|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
1979566|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979567|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979568|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1979569|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
1979570|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1979571|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1979572|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979573|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1979574|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979575|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979576|NCT00989833|Budesonide|budesonide|mesh-list
1979577|NCT00989833|Terbutaline|terbutaline|mesh-list
1979578|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
1979579|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1979580|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1979581|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
1979582|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979583|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979584|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1979585|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
1979586|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
1979587|NCT00989833|Hormones|hormones|mesh-ancestor
1979588|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1979589|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1979590|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1979591|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1979592|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
1979593|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979594|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979595|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
1979596|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
1979597|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1979598|NCT00989911|Bosentan|bosentan|mesh-list
1979599|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1979600|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1979601|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979602|NCT00989950|Methylphenidate|methylphenidate|mesh-list
1979603|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1979604|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979605|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1979606|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1979607|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979608|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979609|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
1979610|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979611|NCT00989963|Beraprost|beraprost|mesh-list
1979612|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1979613|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
1979614|NCT00989989|Ranibizumab|ranibizumab|mesh-list
1979615|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1979616|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1979617|NCT00989989|Growth Substances|growth substances|mesh-ancestor
1979618|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979619|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
1979620|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979621|NCT00990106|Prazosin|prazosin|mesh-list
1979622|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1979623|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1979624|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1979625|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1979626|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
1979627|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979628|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979629|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979630|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1979631|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1979632|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1979633|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
1979634|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979635|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1979636|NCT00990236|Enoxaparin|enoxaparin|mesh-list
1979637|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
1979638|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
1979639|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1979640|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1979641|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979642|NCT00990249|Busulfan|busulfan|mesh-list
1979643|NCT00990249|Clofarabine|clofarabine|mesh-list
1979644|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
1979645|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1979646|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
1979647|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979648|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1979649|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
1979650|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979651|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1979652|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979653|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1979654|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1979655|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
1979656|NCT00990288|Thrombin|thrombin|mesh-list
1979657|NCT00990288|Hemostatics|hemostatics|mesh-list
1979658|NCT00990288|Coagulants|coagulants|mesh-ancestor
1979659|NCT00990314|Epoprostenol|epoprostenol|mesh-list
1979660|NCT00990314|Beraprost|beraprost|mesh-list
1979661|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1979662|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
1979663|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1979664|NCT00990561|Clobetasol|clobetasol|mesh-list
1979665|NCT00990561|Halobetasol|halobetasol|mesh-list
1979666|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1979667|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1979668|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
1979669|NCT00990561|Hormones|hormones|mesh-ancestor
1979670|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1979671|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979672|NCT00990652|Temozolomide|temozolomide|mesh-list
1979673|NCT00990652|Bortezomib|bortezomib|mesh-list
1979674|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1979675|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
1979676|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979677|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979678|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
1979679|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1979680|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
1979681|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1979682|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979683|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1979684|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1979685|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1979686|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
1979687|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979688|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
1979689|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1979690|NCT00990704|Protective Agents|protective agents|mesh-ancestor
1979691|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979692|NCT00990769|Anesthetics|anesthetics|mesh-list
1979693|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1979694|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979695|NCT00990821|Midazolam|midazolam|mesh-list
1979696|NCT00990821|Aprepitant|aprepitant|mesh-list
1979697|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
1979698|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1979699|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1979700|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1979701|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979702|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1979703|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1979704|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1979705|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1979706|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
1979707|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
1979708|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
1979709|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
1979710|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979711|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979712|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
1979713|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
1979714|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979715|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1979716|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1979717|NCT00991029|Clopidogrel|clopidogrel|mesh-list
1979718|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1979719|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1979720|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1979721|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1979722|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
1979723|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979724|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979725|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979726|NCT00991081|Bupropion|bupropion|mesh-list
1979727|NCT00991081|Nicotine|nicotine|mesh-list
1979728|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1979729|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
1979730|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979731|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979732|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1979733|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1979734|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
1979735|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979736|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979737|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1979738|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
1979739|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1979740|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1979741|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1979742|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979743|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
1979744|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1979745|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1979746|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979747|NCT00991276|Pregabalin|pregabalin|mesh-list
1979748|NCT00991276|Pramipexole|pramipexole|mesh-list
1979749|NCT00991276|Analgesics|analgesics|mesh-ancestor
1979750|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
1979751|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979752|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979753|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
1979754|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1979755|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979756|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979757|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1979758|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1979759|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1979760|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1979761|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1979762|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
1979763|NCT00991276|Protective Agents|protective agents|mesh-ancestor
1979764|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1979765|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1979766|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
1979767|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
1979768|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979769|NCT00991289|Interferons|interferons|mesh-list
1979770|NCT00991289|Ribavirin|ribavirin|mesh-list
1979771|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
1979772|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
1979773|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1979774|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
1979775|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979776|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
1979777|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979778|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
1979779|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979780|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
1979781|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979782|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1979783|NCT00991458|Cyclosporine|cyclosporine|mesh-list
1979784|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1979785|NCT00991458|Cyclosporins|cyclosporins|mesh-list
1979786|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979787|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979788|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1979789|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
1979790|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979791|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
1979792|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979793|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
1979794|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1979795|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1979796|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1979797|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
1979798|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1979799|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979800|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1979801|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
1979802|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1979803|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979804|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979805|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979806|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
1979807|NCT00991809|Promethazine|promethazine|mesh-list
1979808|NCT00991809|Alfentanil|alfentanil|mesh-list
1979809|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1979810|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1979811|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1979812|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979813|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
1979814|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
1979815|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
1979816|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979817|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
1979818|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
1979819|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1979820|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1979821|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
1979822|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
1979823|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979824|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979825|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1979826|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
1979827|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
1979828|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1979829|NCT00991809|Narcotics|narcotics|mesh-ancestor
1979830|NCT00991809|Analgesics|analgesics|mesh-ancestor
1979831|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1979832|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
1979833|NCT00991939|Dexamethasone|dexamethasone|mesh-list
1979834|NCT00991939|Prednisone|prednisone|mesh-list
1979835|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1979836|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
1979837|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
1979838|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979839|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979840|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1979841|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
1979842|NCT00991939|Hormones|hormones|mesh-ancestor
1979843|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1979844|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1979845|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979846|NCT00991952|Irinotecan|irinotecan|mesh-list
1979847|NCT00991952|Alvocidib|alvocidib|mesh-list
1979848|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1979849|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1979850|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979851|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979852|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979853|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
1979854|NCT00991952|Growth Substances|growth substances|mesh-ancestor
1979855|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979856|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1979857|NCT00992056|Metoprolol|metoprolol|mesh-list
1979858|NCT00992056|Nebivolol|nebivolol|mesh-list
1979859|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1979860|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1979861|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
1979862|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
1979863|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979864|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979865|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1979866|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1979867|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1979868|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
1979869|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979870|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979871|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
1979872|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1979873|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1979874|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1979875|NCT00992108|Lidocaine|lidocaine|mesh-list
1979876|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
1979877|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
1979878|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1979879|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979880|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
1979881|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979882|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1979883|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1979884|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1979885|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1979886|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979887|NCT00992394|Etanercept|etanercept|mesh-list
1979888|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1979889|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1979890|NCT00992394|Analgesics|analgesics|mesh-ancestor
1979891|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
1979892|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1979893|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979894|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1979895|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1979896|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1979897|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1979898|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
1979899|NCT00992407|Risperidone|risperidone|mesh-list
1979900|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1979901|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
1979902|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1979903|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979904|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979905|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1979906|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1979907|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1979908|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1979909|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1979910|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
1979911|NCT00992446|Cytarabine|cytarabine|mesh-list
1979912|NCT00992446|Rituximab|rituximab|mesh-list
1979913|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1979914|NCT00992446|Etoposide|etoposide|mesh-list
1979915|NCT00992446|Bortezomib|bortezomib|mesh-list
1979916|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
1979917|NCT00992446|Melphalan|melphalan|mesh-list
1979918|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
1979919|NCT00992446|Vorinostat|vorinostat|mesh-list
1979920|NCT00992446|Carmustine|carmustine|mesh-list
1979921|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
1979922|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1979923|NCT00992446|Antibodies|antibodies|mesh-list
1979924|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
1979925|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1979926|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
1979927|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979928|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979929|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1979930|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1979931|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1979932|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1979933|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979934|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979935|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1979936|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
1979937|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
1979938|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979939|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1979940|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1979941|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
1979942|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1979943|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1979944|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
1979945|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
1979946|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
1979947|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
1979948|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
1979949|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
1979950|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979951|NCT00992511|Vaccines|vaccines|mesh-list
1979952|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
1979953|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979954|NCT00992589|Rabeprazole|rabeprazole|mesh-list
1979955|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1979956|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1979957|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1979958|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979959|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979960|NCT00992602|Cytarabine|cytarabine|mesh-list
1979961|NCT00992602|Methotrexate|methotrexate|mesh-list
1979962|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1979963|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
1979964|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1979965|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1979966|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1979967|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
1979968|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979969|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979970|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
1979971|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979972|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1979973|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1979974|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
1979975|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1979976|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1979977|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
1979978|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979979|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
1979980|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1979981|NCT00993031|Ritonavir|ritonavir|mesh-list
1979982|NCT00993031|Lopinavir|lopinavir|mesh-list
1979983|NCT00993031|Lamivudine|lamivudine|mesh-list
1979984|NCT00993031|Zidovudine|zidovudine|mesh-list
1979985|NCT00993031|Efavirenz|efavirenz|mesh-list
1979986|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1979987|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1979988|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
1979989|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1979990|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1979991|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1979992|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1979993|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
1979994|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1979995|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1979996|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1979997|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1979998|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1979999|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
1980000|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1980001|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1980002|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1980003|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1980004|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1980005|NCT00993044|Bevacizumab|bevacizumab|mesh-list
1980006|NCT00993044|Irinotecan|irinotecan|mesh-list
1980007|NCT00993044|Vincristine|vincristine|mesh-list
1980008|NCT00993044|Temozolomide|temozolomide|mesh-list
1980009|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1980010|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980011|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1980012|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1980013|NCT00993044|Growth Substances|growth substances|mesh-ancestor
1980014|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980015|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
1980016|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1980017|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1980018|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980019|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980020|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1980021|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
1980022|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
1980023|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
1980024|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1980025|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
1980026|NCT00993148|Ritonavir|ritonavir|mesh-list
1980027|NCT00993148|Darunavir|darunavir|mesh-list
1980028|NCT00993148|Maraviroc|maraviroc|mesh-list
1980029|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1980030|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1980031|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
1980032|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980033|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980034|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1980035|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1980036|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
1980037|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980038|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1980039|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1980040|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1980041|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1980042|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1980043|NCT00993187|Metformin|metformin|mesh-list
1980044|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1980045|NCT00993187|Glimepiride|glimepiride|mesh-list
1980046|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1980047|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980048|NCT00993187|Incretins|incretins|mesh-ancestor
1980049|NCT00993187|Hormones|hormones|mesh-ancestor
1980050|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980051|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1980052|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
1980053|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980054|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980055|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1980056|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1980057|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
1980058|NCT00993200|Warfarin|warfarin|mesh-list
1980059|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
1980060|NCT00993226|Bupivacaine|bupivacaine|mesh-list
1980061|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
1980062|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
1980063|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1980064|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980065|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
1980066|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980067|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
1980068|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1980069|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
1980070|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980071|NCT00993265|Expectorants|expectorants|mesh-ancestor
1980072|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
1980073|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1980074|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
2745684|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
1980075|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980076|NCT00993265|Protective Agents|protective agents|mesh-ancestor
1980077|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980078|NCT00993265|Antidotes|antidotes|mesh-ancestor
1980079|NCT00993317|Methotrexate|methotrexate|mesh-list
1980080|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
1980081|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1980082|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
1980083|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1980084|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980085|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1980086|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
1980087|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980088|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980089|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
1980090|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980091|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1980092|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1980093|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
1980094|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1980095|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1980096|NCT00993421|Sibutramine|sibutramine|mesh-list
1980097|NCT00993421|Metoprolol|metoprolol|mesh-list
1980098|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1980099|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1980100|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
1980101|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
1980102|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980103|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980104|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1980105|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1980106|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1980107|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
1980108|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1980109|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980110|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
1980111|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1980112|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
1980113|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1980114|NCT00993473|Insulin|insulin|mesh-list
1980115|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1980116|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
1980117|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
1980118|NCT00993473|Protamines|protamines|mesh-list
1980119|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1980120|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980121|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
1980122|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980123|NCT00993473|Coagulants|coagulants|mesh-ancestor
1980124|NCT00993499|Sirolimus|sirolimus|mesh-list
1980125|NCT00993499|Afatinib|afatinib|mesh-list
1980126|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1980127|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980128|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1980129|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980130|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
1980131|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1980132|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
1980133|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980134|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1980135|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980136|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980137|NCT00993616|Carboplatin|carboplatin|mesh-list
1980138|NCT00993616|Belinostat|belinostat|mesh-list
1980139|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980140|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1980141|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980142|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980143|NCT00993655|Paclitaxel|paclitaxel|mesh-list
1980144|NCT00993655|Carboplatin|carboplatin|mesh-list
1980145|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1980146|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980147|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
1980148|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
1980149|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
2745685|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
1980150|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980151|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
1980152|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1980153|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
1980154|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980155|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1980156|NCT00993798|Bupivacaine|bupivacaine|mesh-list
1980157|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
1980158|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
1980159|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1980160|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980161|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
1980162|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980163|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1980164|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1980165|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1980166|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
1980167|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980168|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1980169|NCT00993915|Atorvastatin|atorvastatin|mesh-list
1980170|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1980171|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1980172|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
1980173|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980174|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1980175|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1980176|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980177|NCT00993967|Idebenone|idebenone|mesh-list
1980178|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
1980179|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980180|NCT00993967|Protective Agents|protective agents|mesh-ancestor
1980181|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980182|NCT00994110|Pasireotide|pasireotide|mesh-list
1980183|NCT00994110|Hormones|hormones|mesh-ancestor
1980184|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980185|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980186|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1980187|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980188|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1980189|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980190|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980191|NCT00994175|Pioglitazone|pioglitazone|mesh-list
1980192|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1980193|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980194|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
1980195|NCT00994318|Hematinics|hematinics|mesh-ancestor
1980196|NCT00994422|Ivermectin|ivermectin|mesh-list
1980197|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1980198|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980199|NCT00994448|Bupropion|bupropion|mesh-list
1980200|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1980201|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
1980202|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1980203|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1980204|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1980205|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1980206|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980207|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
1980208|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1980209|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980210|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1980211|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1980212|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980213|NCT00994461|Celecoxib|celecoxib|mesh-list
1980214|NCT00994461|Loxoprofen|loxoprofen|mesh-list
1980215|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1980216|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1980217|NCT00994461|Analgesics|analgesics|mesh-ancestor
1980218|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
1980219|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980220|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980221|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1980222|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1980223|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1980224|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1980225|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980226|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980227|NCT00994643|Aldesleukin|aldesleukin|mesh-list
1980228|NCT00994643|Rituximab|rituximab|mesh-list
1980229|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1980230|NCT00994643|Interleukin-2|interleukin-2|mesh-list
1980231|NCT00994643|Antibodies|antibodies|mesh-list
1980232|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
1980233|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1980234|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
1980235|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980236|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980237|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1980238|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1980239|NCT00994643|Analgesics|analgesics|mesh-ancestor
1980240|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
1980241|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980242|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1980243|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1980244|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
1980245|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980246|NCT00994682|Pioglitazone|pioglitazone|mesh-list
1980247|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1980248|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980249|NCT00994760|Fentanyl|fentanyl|mesh-list
1980250|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1980251|NCT00994760|Narcotics|narcotics|mesh-ancestor
1980252|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1980253|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980254|NCT00994760|Analgesics|analgesics|mesh-ancestor
1980255|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
1980256|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980257|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1980258|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1980259|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
1980260|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
1980261|NCT00994890|Tanezumab|tanezumab|mesh-list
1980262|NCT00994890|Analgesics|analgesics|mesh-ancestor
1980263|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
1980264|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980265|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980266|NCT00994929|Oprelvekin|oprelvekin|mesh-list
1980267|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980268|NCT00995007|Carboplatin|carboplatin|mesh-list
1980269|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980270|NCT00995072|Metoprolol|metoprolol|mesh-list
1980271|NCT00995072|Nebivolol|nebivolol|mesh-list
1980272|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1980273|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1980274|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
1980275|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
1980276|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980277|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980278|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1980279|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1980280|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1980281|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
1980282|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1980283|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980284|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
1980285|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1980286|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1980287|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1980288|NCT00995085|Pyridoxine|pyridoxine|mesh-list
1980289|NCT00995085|Metadoxine|metadoxine|mesh-list
1980290|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1980291|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
1980292|NCT00995085|Vitamins|vitamins|mesh-ancestor
1980293|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
1980294|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980295|NCT00995475|Fluticasone|fluticasone|mesh-list
1980296|NCT00995475|Xhance|xhance|mesh-list
1980297|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1980298|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1980299|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
1980300|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980301|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980302|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1980303|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
1980304|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
1980305|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1980306|NCT00995488|Paclitaxel|paclitaxel|mesh-list
1980307|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1980308|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1980309|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980310|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
1980311|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
1980312|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
1980313|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980314|NCT00995501|Insulin|insulin|mesh-list
1980315|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1980316|NCT00995501|Dexamethasone|dexamethasone|mesh-list
1980317|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
1980318|NCT00995501|Anesthetics|anesthetics|mesh-list
1980319|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
1980320|NCT00995501|BB 1101|bb 1101|mesh-list
1980321|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1980322|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980323|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1980324|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
1980325|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
1980326|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980327|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1980328|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
1980329|NCT00995501|Hormones|hormones|mesh-ancestor
1980330|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980331|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1980332|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980333|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
1980334|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980335|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980336|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1980337|NCT00995501|Cathartics|cathartics|mesh-ancestor
1980338|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
1980339|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1980340|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980341|NCT00995670|Ascorbic Acid|ascorbic acid|mesh-list
1980342|NCT00995670|Sevoflurane|sevoflurane|mesh-list
1980343|NCT00995670|Simvastatin|simvastatin|mesh-list
1980344|NCT00995670|Vitamins|vitamins|mesh-ancestor
1980345|NCT00995670|Micronutrients|micronutrients|mesh-ancestor
1980346|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980347|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1980348|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1980349|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
1980350|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980351|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1980352|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1980353|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980354|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1980355|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1980356|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
1980357|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
1980358|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1980359|NCT00995670|Antioxidants|antioxidants|mesh-ancestor
1980360|NCT00995670|Protective Agents|protective agents|mesh-ancestor
1980361|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1980362|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
1980363|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980364|NCT00995722|Prednisone|prednisone|mesh-list
1980365|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1980366|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
1980367|NCT00995722|Hormones|hormones|mesh-ancestor
1980368|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980369|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980370|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1980371|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980372|NCT00995761|Cisplatin|cisplatin|mesh-list
1980373|NCT00995761|Docetaxel|docetaxel|mesh-list
1980374|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980375|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
1980376|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
1980377|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
1980378|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980379|NCT00996034|Nicotine|nicotine|mesh-list
1980380|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980381|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1980382|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
1980383|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980384|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1980385|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1980386|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
1980387|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1980388|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980389|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
1980390|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
1980391|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980392|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1980393|NCT00996281|Olmesartan|olmesartan|mesh-list
1980394|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1980395|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
1980396|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1980397|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1980398|NCT00996281|Diuretics|diuretics|mesh-ancestor
1980399|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
1980400|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980401|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1980402|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1980403|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980404|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1980405|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1980406|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
1980407|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1980408|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
1980409|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980410|NCT00996346|Sirolimus|sirolimus|mesh-list
1980411|NCT00996346|Irinotecan|irinotecan|mesh-list
1980412|NCT00996346|Complement Factor H|complement factor h|mesh-list
1980413|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1980414|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1980415|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980416|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980417|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980418|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1980419|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980420|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1980421|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
1980422|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1980423|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
1980424|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980425|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1980426|NCT00996437|Ranibizumab|ranibizumab|mesh-list
1980427|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1980428|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1980429|NCT00996437|Growth Substances|growth substances|mesh-ancestor
1980430|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980431|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
1980432|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980433|NCT00996476|Simeprevir|simeprevir|mesh-list
1980434|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
1980435|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980436|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
1980437|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980438|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980439|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
1980440|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1980441|NCT00996580|Estradiol|estradiol|mesh-list
1980442|NCT00996580|Estrogens|estrogens|mesh-ancestor
1980443|NCT00996580|Hormones|hormones|mesh-ancestor
1980444|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980445|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980446|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1980447|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
1980448|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1980449|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1980450|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1980451|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1980452|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1980453|NCT00996593|Iodine|iodine|mesh-list
1980454|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
1980455|NCT00996593|Antibodies|antibodies|mesh-list
1980456|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
1980457|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
1980458|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980459|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1980460|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980461|NCT00996593|Trace Elements|trace elements|mesh-ancestor
1980462|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
1980463|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980464|NCT00996658|Linagliptin|linagliptin|mesh-list
1980465|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1980466|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980467|NCT00996658|Incretins|incretins|mesh-ancestor
1980468|NCT00996658|Hormones|hormones|mesh-ancestor
1980469|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980470|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1980471|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
1980472|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980473|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980474|NCT00996736|Voriconazole|voriconazole|mesh-list
1980475|NCT00996736|Natamycin|natamycin|mesh-list
1980476|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
1980477|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980478|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1980479|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1980480|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980481|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980482|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1980483|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
1980484|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980485|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980486|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1980487|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1980488|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1980489|NCT00996801|Vitamin D|vitamin d|mesh-list
1980490|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
1980491|NCT00996801|Alendronate|alendronate|mesh-list
1980492|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
1980493|NCT00996801|Calcium|calcium|mesh-list
1980494|NCT00996801|Vitamins|vitamins|mesh-ancestor
1980495|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
1980496|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980497|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1980498|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1980499|NCT00996801|Antacids|antacids|mesh-ancestor
1980500|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980501|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1980502|NCT00996931|Lenalidomide|lenalidomide|mesh-list
1980503|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
1980504|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980505|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1980506|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1980507|NCT00996931|Growth Substances|growth substances|mesh-ancestor
1980508|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
1980509|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980510|NCT00996944|Ropinirole|ropinirole|mesh-list
1980511|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1980512|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1980513|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
1980514|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
1980515|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1980516|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980517|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980518|NCT00996996|Iodine|iodine|mesh-list
1980519|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
1980520|NCT00996996|Antibodies|antibodies|mesh-list
1980521|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
1980522|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
1980523|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980524|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1980525|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980526|NCT00996996|Trace Elements|trace elements|mesh-ancestor
1980527|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
1980528|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980529|NCT00997035|Voriconazole|voriconazole|mesh-list
1980530|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
1980531|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980532|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1980533|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1980534|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980535|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980536|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1980537|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
1980538|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980539|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980540|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1980541|NCT00997113|Alfentanil|alfentanil|mesh-list
1980542|NCT00997113|Propofol|propofol|mesh-list
1980543|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1980544|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1980545|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980546|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1980547|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
1980548|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
1980549|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1980550|NCT00997113|Narcotics|narcotics|mesh-ancestor
1980551|NCT00997113|Analgesics|analgesics|mesh-ancestor
1980552|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
1980553|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980554|NCT00997126|Alfentanil|alfentanil|mesh-list
1980555|NCT00997126|Propofol|propofol|mesh-list
1980556|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1980557|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1980558|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980559|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1980560|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
1980561|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
1980562|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1980563|NCT00997126|Narcotics|narcotics|mesh-ancestor
1980564|NCT00997126|Analgesics|analgesics|mesh-ancestor
1980565|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
1980566|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980567|NCT00997139|Polymyxins|polymyxins|mesh-list
1980568|NCT00997139|Bacitracin|bacitracin|mesh-list
1980569|NCT00997139|Neomycin|neomycin|mesh-list
1980570|NCT00997139|Polymyxin B|polymyxin b|mesh-list
1980571|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
1980572|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1980573|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980574|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1980575|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1980576|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980577|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980578|NCT00997204|Icatibant|icatibant|mesh-list
1980579|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1980580|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1980581|NCT00997204|Analgesics|analgesics|mesh-ancestor
1980582|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
1980583|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980584|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980585|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1980586|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1980587|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
1980588|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
1980589|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980590|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1980591|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1980592|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
1980593|NCT00997243|Azacitidine|azacitidine|mesh-list
1980594|NCT00997243|Lintuzumab|lintuzumab|mesh-list
1980595|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1980596|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
1980597|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980598|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980599|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980600|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1980601|NCT00997321|Ketamine|ketamine|mesh-list
1980602|NCT00997321|Propofol|propofol|mesh-list
1980603|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1980604|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1980605|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980606|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1980607|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
1980608|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
1980609|NCT00997321|Analgesics|analgesics|mesh-ancestor
1980610|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
1980611|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980612|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1980613|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1980614|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1980615|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1980616|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980617|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1980618|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980619|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1980620|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980621|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980622|NCT00997373|Letrozole|letrozole|mesh-list
1980623|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980624|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1980625|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1980626|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980627|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980628|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1980629|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
1980630|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980631|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980632|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
1980633|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
1980634|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980635|NCT00997438|Protective Agents|protective agents|mesh-ancestor
1980636|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980637|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
1980638|NCT00997438|Vitamins|vitamins|mesh-ancestor
1980639|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
1980640|NCT00997503|Aspirin|aspirin|mesh-list
1980641|NCT00997503|Paclitaxel|paclitaxel|mesh-list
1980642|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1980643|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1980644|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980645|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
1980646|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
1980647|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
1980648|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980649|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1980650|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1980651|NCT00997503|Analgesics|analgesics|mesh-ancestor
1980652|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
1980653|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980654|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980655|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1980656|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1980657|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1980658|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1980659|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1980660|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1980661|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980662|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
1980663|NCT00997620|Fluticasone|fluticasone|mesh-list
1980664|NCT00997620|Xhance|xhance|mesh-list
1980665|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1980666|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1980667|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
1980668|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980669|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980670|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1980671|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
1980672|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
1980673|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1980674|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
1980675|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
1980676|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1980677|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980678|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980679|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
1980680|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1980681|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1980682|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980683|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1980684|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1980685|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1980686|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
1980687|NCT00997893|Estradiol|estradiol|mesh-list
1980688|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1980689|NCT00997893|Estrogens|estrogens|mesh-list
1980690|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
1980691|NCT00997893|Hormones|hormones|mesh-ancestor
1980692|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980693|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980694|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1980695|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
1980696|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1980697|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1980698|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1980699|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1980700|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1980701|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1980702|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1980703|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980704|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1980705|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
1980706|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
1980707|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1980708|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980709|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1980710|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1980711|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1980712|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1980713|NCT00997984|Guanfacine|guanfacine|mesh-list
1980714|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1980715|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1980716|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1980717|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1980718|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
1980719|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1980720|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980721|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980722|NCT00998010|Temozolomide|temozolomide|mesh-list
1980723|NCT00998010|Bortezomib|bortezomib|mesh-list
1980724|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1980725|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
1980726|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980727|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980728|NCT00998049|Plerixafor|plerixafor|mesh-list
1980729|NCT00998049|Lenograstim|lenograstim|mesh-list
1980730|NCT00998049|Sargramostim|sargramostim|mesh-list
1980731|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1980732|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
1980733|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980734|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1980735|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1980736|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
1980737|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980738|NCT00998205|Atropine|atropine|mesh-list
1980739|NCT00998205|Dobutamine|dobutamine|mesh-list
1980740|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1980741|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1980742|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1980743|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
1980744|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980745|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980746|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1980747|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
1980748|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
1980749|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
1980750|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1980751|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1980752|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
1980753|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1980754|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980755|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1980756|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
1980757|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1980758|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1980759|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1980760|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
1980761|NCT00998205|Protective Agents|protective agents|mesh-ancestor
1980762|NCT00998296|Nintedanib|nintedanib|mesh-list
1980763|NCT00998296|Afatinib|afatinib|mesh-list
1980764|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980765|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1980766|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980767|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980768|NCT00998309|Azithromycin|azithromycin|mesh-list
1980769|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1980770|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980771|NCT00998335|Insulin|insulin|mesh-list
1980772|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1980773|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
1980774|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
1980775|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1980776|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
1980777|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1980778|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980779|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
1980780|NCT00998426|Antibodies|antibodies|mesh-list
1980781|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
1980782|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1980783|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1980784|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
1980785|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
1980786|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980787|NCT00998582|Tenofovir|tenofovir|mesh-list
1980788|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
1980789|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980790|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1980791|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1980792|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980793|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980794|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1980795|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1980796|NCT00998946|Vitamins|vitamins|mesh-list
1980797|NCT00998946|Folic Acid|folic acid|mesh-list
1980798|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
1980799|NCT00998946|Hydroxocobalamin|hydroxocobalamin|mesh-list
1980800|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
1980801|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
1980802|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
1980803|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980804|NCT00998946|Hematinics|hematinics|mesh-ancestor
1980805|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980806|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1980807|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980808|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980809|NCT00998985|Grazoprevir|grazoprevir|mesh-list
1980810|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
1980811|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980812|NCT00999037|Sevelamer|sevelamer|mesh-list
1980813|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
1980814|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
1980815|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980816|NCT00999102|Metoprolol|metoprolol|mesh-list
1980817|NCT00999102|Nebivolol|nebivolol|mesh-list
1980818|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1980819|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1980820|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
1980821|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
1980822|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980823|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980824|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1980825|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1980826|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1980827|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
1980828|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1980829|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980830|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
1980831|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1980832|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1980833|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1980834|NCT00999518|Tanezumab|tanezumab|mesh-list
1980835|NCT00999518|Analgesics|analgesics|mesh-ancestor
1980836|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
1980837|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980838|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980839|NCT00999544|Oxycodone|oxycodone|mesh-list
1980840|NCT00999544|Aprepitant|aprepitant|mesh-list
1980841|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
1980842|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1980843|NCT00999544|Narcotics|narcotics|mesh-ancestor
1980844|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1980845|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980846|NCT00999544|Analgesics|analgesics|mesh-ancestor
1980847|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
1980848|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980849|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
1980850|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
1980851|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1980852|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1980853|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1980854|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980855|NCT00999713|Calfactant|calfactant|mesh-list
1980856|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
1980857|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
1980858|NCT00999804|Trastuzumab|trastuzumab|mesh-list
1980859|NCT00999804|Letrozole|letrozole|mesh-list
1980860|NCT00999804|Lapatinib|lapatinib|mesh-list
1980861|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1980862|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980863|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1980864|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1980865|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980866|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980867|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1980868|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
1980869|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980870|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980871|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1980872|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
1980873|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1980874|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
1980875|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980876|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980877|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1980878|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
1980879|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
1980880|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1980881|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
1980882|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1980883|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980884|NCT00999921|Tamoxifen|tamoxifen|mesh-list
1980885|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
1980886|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1980887|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
1980888|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980889|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980890|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1980891|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980892|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1980893|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1980894|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1980895|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1980896|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1980897|NCT00999921|Analgesics|analgesics|mesh-ancestor
1980898|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
1980899|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1980900|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1980901|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1980902|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1980903|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
1980904|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980905|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1980906|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
1980907|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1980908|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1980909|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980910|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1980911|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1980912|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1980913|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980914|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
1980915|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1980916|NCT01000155|Vorinostat|vorinostat|mesh-list
1980917|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980918|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1980919|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980920|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980921|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
1980922|NCT01000285|Prednisone|prednisone|mesh-list
1980923|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
1980924|NCT01000285|Doxorubicin|doxorubicin|mesh-list
1980925|NCT01000285|Etoposide|etoposide|mesh-list
1980926|NCT01000285|Vincristine|vincristine|mesh-list
1980927|NCT01000285|Bortezomib|bortezomib|mesh-list
1980928|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1980929|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
1980930|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980931|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1980932|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1980933|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
1980934|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980935|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980936|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1980937|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1980938|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1980939|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1980940|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980941|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1980942|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
1980943|NCT01000285|Hormones|hormones|mesh-ancestor
1980944|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980945|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1980946|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1980947|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
1980948|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
1980949|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
1980950|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1980951|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1980952|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
1980953|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980954|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1980955|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1980956|NCT01000311|Vaccines|vaccines|mesh-list
1980957|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1980958|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
1980959|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980960|NCT01000337|Propofol|propofol|mesh-list
1980961|NCT01000337|Sevoflurane|sevoflurane|mesh-list
1980962|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1980963|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1980964|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1980965|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1980966|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
1980967|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
1980968|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1980969|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1980970|NCT01000376|Ketoconazole|ketoconazole|mesh-list
1980971|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
1980972|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1980973|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1980974|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1980975|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980976|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980977|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1980978|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
1980979|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1980980|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745686|NCT02735707|Amoxicillin|amoxicillin|mesh-list
1980981|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1980982|NCT01000480|Pemetrexed|pemetrexed|mesh-list
1980983|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980984|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1980985|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1980986|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1980987|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1980988|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
1980989|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1980990|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1980991|NCT01000610|Prednisolone|prednisolone|mesh-list
1980992|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
1980993|NCT01000610|Rituximab|rituximab|mesh-list
1980994|NCT01000610|Methotrexate|methotrexate|mesh-list
1980995|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1980996|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
1980997|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1980998|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1980999|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
1981000|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981001|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981002|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1981003|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
1981004|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1981005|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1981006|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
1981007|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981008|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
1981009|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981010|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1981011|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981012|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1981013|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1981014|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
1981015|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
1981016|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981017|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1981018|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
1981019|NCT01000610|Hormones|hormones|mesh-ancestor
1981020|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1981021|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1981022|NCT01000610|Protective Agents|protective agents|mesh-ancestor
1981023|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1981024|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
1981025|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1981026|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
1981027|NCT01000649|Vasopressins|vasopressins|mesh-list
1981028|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
1981029|NCT01000649|Coagulants|coagulants|mesh-ancestor
1981030|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1981031|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1981032|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
1981033|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079329|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079330|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
2079331|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
2079332|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2079333|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2079334|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079335|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079336|NCT02057458|Urological Agents|urological agents|mesh-ancestor
2079337|NCT02057523|Hormones|hormones|mesh-list
2079338|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2079339|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2079340|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
2079341|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2079342|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079343|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079344|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079345|NCT02057549|Haloperidol|haloperidol|mesh-list
2079346|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
2079347|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
2079348|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
2079349|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981034|NCT01000727|Darapladib|darapladib|mesh-list
1981035|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
1981036|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981037|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981038|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1981039|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1981040|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1981041|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1981042|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981043|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981044|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981045|NCT01000805|Analgesics|analgesics|mesh-ancestor
1981046|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
1981047|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981048|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
1981049|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1981050|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
1981051|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
1981052|NCT01000818|Omeprazole|omeprazole|mesh-list
1981053|NCT01000818|Famotidine|famotidine|mesh-list
1981054|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1981055|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1981056|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1981057|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981058|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981059|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1981060|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1981061|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
1981062|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981063|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1981064|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1981065|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1981066|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
1981067|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
1981068|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981069|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981070|NCT01000961|Cysteamine|cysteamine|mesh-list
1981071|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
1981072|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981073|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1981074|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
1981075|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981076|NCT01000987|Varenicline|varenicline|mesh-list
1981077|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1981078|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1981079|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
1981080|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981081|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981082|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981083|NCT01001052|Colchicine|colchicine|mesh-list
1981084|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
1981085|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981086|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
1981087|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
1981088|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
1981089|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981090|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981091|NCT01001104|Dulaglutide|dulaglutide|mesh-list
1981092|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1981093|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981094|NCT01001195|Bimatoprost|bimatoprost|mesh-list
1981095|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1981096|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1981097|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1981098|NCT01001208|Etanercept|etanercept|mesh-list
1981099|NCT01001208|Methotrexate|methotrexate|mesh-list
1981100|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1981101|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
1981102|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1981103|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981104|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1981105|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
1981106|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981107|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981108|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
1981109|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981110|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1981111|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981112|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
1981113|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981114|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1981115|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1981116|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1981117|NCT01001208|Analgesics|analgesics|mesh-ancestor
1981118|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
1981119|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981120|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1981121|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1981122|NCT01001221|Gemcitabine|gemcitabine|mesh-list
1981123|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1981124|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
1981125|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981126|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981127|NCT01001221|Antiviral Agents|antiviral agents|mesh-ancestor
1981128|NCT01001221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981129|NCT01001221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981130|NCT01001221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981131|NCT01001221|Immunologic Factors|immunologic factors|mesh-ancestor
1981132|NCT01001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981133|NCT01001234|Rizatriptan|rizatriptan|mesh-list
1981134|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1981135|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
1981136|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981137|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981138|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981139|NCT01001377|Cetuximab|cetuximab|mesh-list
1981140|NCT01001377|Panitumumab|panitumumab|mesh-list
1981141|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1981142|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981143|NCT01001403|Nafamostat|nafamostat|mesh-list
1981144|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1981145|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1981146|NCT01001403|Analgesics|analgesics|mesh-ancestor
1981147|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
1981148|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981149|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981150|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1981151|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981152|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
1981153|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
1981154|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981155|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981156|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1981157|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1981158|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1981159|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981160|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
1981161|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
1981162|NCT01001429|Propofol|propofol|mesh-list
1981163|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1981164|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1981165|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981166|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1981167|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
1981168|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
1981169|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1981170|NCT01001429|Analgesics|analgesics|mesh-ancestor
1981171|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
1981172|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981173|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1981174|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1981175|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1981176|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
1981177|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981178|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981179|NCT01001442|Maytansine|maytansine|mesh-list
1981180|NCT01001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1981181|NCT01001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981182|NCT01001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
1981183|NCT01001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
1981184|NCT01001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
1981185|NCT01001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981186|NCT01001494|Bromides|bromides|mesh-list
1981187|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
1981188|NCT01001520|Tolcapone|tolcapone|mesh-list
1981189|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1981190|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1981191|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1981192|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981193|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981194|NCT01001559|Norepinephrine|norepinephrine|mesh-list
1981195|NCT01001559|Serotonin|serotonin|mesh-list
1981196|NCT01001559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1981197|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
1981198|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1981199|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1981200|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
1981201|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981202|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981203|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981204|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
1981205|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
1981206|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981207|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1981208|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1981209|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
1981210|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1981211|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1981212|NCT01001572|Amlodipine|amlodipine|mesh-list
1981213|NCT01001572|Valsartan|valsartan|mesh-list
1981214|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1981215|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1981216|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1981217|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981218|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1981219|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981220|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
1981221|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1981222|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1981223|NCT01001598|Danazol|danazol|mesh-list
1981224|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1981225|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
1981226|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1981227|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981228|NCT01001702|Aripiprazole|aripiprazole|mesh-list
1981229|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
1981230|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1981231|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1981232|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1981233|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1981234|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981235|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
1981236|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
1981237|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981238|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981239|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1981240|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1981241|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
1981242|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1981243|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1981244|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1981245|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1981246|NCT01001806|Ketorolac|ketorolac|mesh-list
1981247|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1981248|NCT01001806|Nepafenac|nepafenac|mesh-list
1981249|NCT01001806|Bromfenac|bromfenac|mesh-list
1981250|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1981251|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1981252|NCT01001806|Analgesics|analgesics|mesh-ancestor
1981253|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
1981254|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981255|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981256|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1981257|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981258|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1981259|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981260|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981261|NCT01001832|Abatacept|abatacept|mesh-list
1981262|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1981263|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981264|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981265|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981266|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
1981267|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981268|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981269|NCT01001910|Carboplatin|carboplatin|mesh-list
1981270|NCT01001910|Pemetrexed|pemetrexed|mesh-list
1981271|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981272|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981273|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981274|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1981275|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1981276|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
1981277|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1981278|NCT01001975|Protective Agents|protective agents|mesh-ancestor
1981279|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981280|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
1981281|NCT01002105|Baclofen|baclofen|mesh-list
1981282|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1981283|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981284|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1981285|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981286|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
1981287|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
1981288|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
1981289|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981290|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981291|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
1981292|NCT01002339|Cyclosporine|cyclosporine|mesh-list
1981293|NCT01002339|Prednisone|prednisone|mesh-list
1981294|NCT01002339|Tacrolimus|tacrolimus|mesh-list
1981295|NCT01002339|Basiliximab|basiliximab|mesh-list
1981296|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981297|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
1981298|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981299|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1981300|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981301|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981302|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1981303|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981304|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1981305|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
1981306|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1981307|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981308|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1981309|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
1981310|NCT01002339|Hormones|hormones|mesh-ancestor
1981311|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1981312|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1981313|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
1981314|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
1981315|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981316|NCT01002547|Vitamins|vitamins|mesh-list
1981317|NCT01002547|Vitamin E|vitamin e|mesh-list
1981318|NCT01002547|Tocopherols|tocopherols|mesh-list
1981319|NCT01002547|Tocotrienols|tocotrienols|mesh-list
1981320|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
1981321|NCT01002547|Pioglitazone|pioglitazone|mesh-list
1981322|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
1981323|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981324|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1981325|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
1981326|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981327|NCT01002547|Protective Agents|protective agents|mesh-ancestor
1981328|NCT01002573|Acetaminophen|acetaminophen|mesh-list
1981329|NCT01002573|Ibuprofen|ibuprofen|mesh-list
1981330|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1981331|NCT01002573|Analgesics|analgesics|mesh-ancestor
1981332|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
1981333|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981334|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981335|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
1981336|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1981337|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1981338|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981339|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1981340|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981341|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981342|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
1981343|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1981344|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981345|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1981346|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
1981347|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1981348|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981349|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981350|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981351|NCT01002755|Lenalidomide|lenalidomide|mesh-list
1981352|NCT01002755|Ofatumumab|ofatumumab|mesh-list
1981353|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1981354|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
1981355|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981356|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1981357|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1981358|NCT01002755|Growth Substances|growth substances|mesh-ancestor
1981359|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
1981360|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981361|NCT01003080|Hemostatics|hemostatics|mesh-list
1981362|NCT01003080|Coagulants|coagulants|mesh-ancestor
1981363|NCT01003106|Ranibizumab|ranibizumab|mesh-list
1981364|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1981365|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1981366|NCT01003106|Growth Substances|growth substances|mesh-ancestor
1981367|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981368|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
1981369|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981370|NCT01003184|Exenatide|exenatide|mesh-list
1981371|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
1981372|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1981373|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981374|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1981375|NCT01003184|Incretins|incretins|mesh-ancestor
1981376|NCT01003184|Hormones|hormones|mesh-ancestor
1981377|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1981378|NCT01003249|Baclofen|baclofen|mesh-list
1981379|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1981380|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981381|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1981382|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981383|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
1981384|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
1981385|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
1981386|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981387|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981388|NCT01003301|Omalizumab|omalizumab|mesh-list
1981389|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1981390|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1981391|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
1981392|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1981393|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
1981394|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981395|NCT01003639|Aspirin|aspirin|mesh-list
1981396|NCT01003639|Acetaminophen|acetaminophen|mesh-list
1981397|NCT01003639|Ibuprofen|ibuprofen|mesh-list
1981398|NCT01003639|Naproxen|naproxen|mesh-list
1981399|NCT01003639|Acetazolamide|acetazolamide|mesh-list
1981400|NCT01003639|Codeine|codeine|mesh-list
1981401|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1981402|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1981403|NCT01003639|Analgesics|analgesics|mesh-ancestor
1981404|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
1981405|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981406|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981407|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1981408|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981409|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1981410|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1981411|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981412|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1981413|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1981414|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981415|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
1981416|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
1981417|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
1981418|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1981419|NCT01003639|Diuretics|diuretics|mesh-ancestor
1981420|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
1981421|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1981422|NCT01003639|Narcotics|narcotics|mesh-ancestor
1981423|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1981424|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
1981425|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
1981426|NCT01003769|Acetic Acid|acetic acid|mesh-list
1981427|NCT01003769|Lenalidomide|lenalidomide|mesh-list
1981428|NCT01003769|Retinol acetate|retinol acetate|mesh-list
1981429|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
1981430|NCT01003769|Gossypol|gossypol|mesh-list
1981431|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
1981432|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981433|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1981434|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1981435|NCT01003769|Growth Substances|growth substances|mesh-ancestor
1981436|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
1981437|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981438|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1981439|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981440|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1981441|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1981442|NCT01003769|Protective Agents|protective agents|mesh-ancestor
1981443|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1981444|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
1981445|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1981446|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1981447|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1981448|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
1981449|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
1981450|NCT01003886|Doxazosin|doxazosin|mesh-list
1981451|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1981452|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1981453|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1981454|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1981455|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
1981456|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981457|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981458|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981459|NCT01003899|Afatinib|afatinib|mesh-list
1981460|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981461|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1981462|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981463|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981464|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1981465|NCT01003938|Topotecan|topotecan|mesh-list
1981466|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981467|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1981468|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981469|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981470|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1981471|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1981472|NCT01003990|Ritonavir|ritonavir|mesh-list
1981473|NCT01003990|Lopinavir|lopinavir|mesh-list
1981474|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1981475|NCT01003990|Tenofovir|tenofovir|mesh-list
1981476|NCT01003990|Emtricitabine|emtricitabine|mesh-list
1981477|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1981478|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1981479|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
1981480|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981481|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981482|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1981483|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1981484|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
1981485|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981486|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1981487|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1981488|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1981489|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1981490|NCT01004003|Sorafenib|sorafenib|mesh-list
1981491|NCT01004003|Nintedanib|nintedanib|mesh-list
1981492|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981493|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1981494|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981495|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981496|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
1981497|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
1981498|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1981499|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
1981500|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1981501|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981502|NCT01004029|Progestins|progestins|mesh-ancestor
1981503|NCT01004029|Hormones|hormones|mesh-ancestor
1981504|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
1981505|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1981506|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1981507|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1981508|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1981509|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981510|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
1981511|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981512|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981513|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1981514|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981515|NCT01004159|Irinotecan|irinotecan|mesh-list
1981516|NCT01004159|Cetuximab|cetuximab|mesh-list
1981517|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1981518|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1981519|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981520|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981521|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981522|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1981523|NCT01004172|Bevacizumab|bevacizumab|mesh-list
1981524|NCT01004172|Trastuzumab|trastuzumab|mesh-list
1981525|NCT01004172|Carboplatin|carboplatin|mesh-list
1981526|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1981527|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981528|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1981529|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1981530|NCT01004172|Growth Substances|growth substances|mesh-ancestor
1981531|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981532|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
1981533|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
1981534|NCT01004185|Mesalamine|mesalamine|mesh-list
1981535|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1981536|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1981537|NCT01004185|Analgesics|analgesics|mesh-ancestor
1981538|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
1981539|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981540|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981541|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1981542|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981543|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
1981544|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1981545|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981546|NCT01004250|Bevacizumab|bevacizumab|mesh-list
1981547|NCT01004250|Pemetrexed|pemetrexed|mesh-list
1981548|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1981549|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981550|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1981551|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1981552|NCT01004250|Growth Substances|growth substances|mesh-ancestor
1981553|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981554|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
1981555|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981556|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981557|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1981558|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1981559|NCT01004263|Rizatriptan|rizatriptan|mesh-list
1981560|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1981561|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
1981562|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981563|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981564|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981565|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
1981566|NCT01004354|Vitamin D|vitamin d|mesh-list
1981567|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1981568|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981569|NCT01004354|Vitamins|vitamins|mesh-ancestor
1981570|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
1981571|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1981572|NCT01004393|Bromides|bromides|mesh-list
1981573|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
1981574|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
1981575|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1981576|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981577|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
1981578|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981579|NCT01004406|Atorvastatin|atorvastatin|mesh-list
1981580|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1981581|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1981582|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1981583|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
1981584|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981585|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1981586|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981587|NCT01004432|Golimumab|golimumab|mesh-list
1981588|NCT01004432|Methotrexate|methotrexate|mesh-list
1981589|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1981590|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1981591|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
1981592|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1981593|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981594|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1981595|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
1981596|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981597|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981598|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
1981599|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981600|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1981601|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981602|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
1981603|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981604|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1981605|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1981606|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1981607|NCT01004614|Amlodipine|amlodipine|mesh-list
1981608|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1981609|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1981610|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1981611|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981612|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1981613|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981614|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
1981615|NCT01004705|Aspirin|aspirin|mesh-list
1981616|NCT01004705|Ramipril|ramipril|mesh-list
1981617|NCT01004705|Simvastatin|simvastatin|mesh-list
1981618|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1981619|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1981620|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
1981621|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981622|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1981623|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1981624|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981625|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1981626|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1981627|NCT01004705|Analgesics|analgesics|mesh-ancestor
1981628|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
1981629|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981630|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981631|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1981632|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981633|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1981634|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1981635|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1981636|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1981637|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
1981638|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1981639|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
1981640|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1981641|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
1981642|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1981643|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1981644|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981645|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
1981646|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
1981647|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981648|NCT01004744|Anastrozole|anastrozole|mesh-list
1981649|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1981650|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981651|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1981652|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1981653|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981654|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981655|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1981656|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
1981657|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1981658|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981659|NCT01004874|Bevacizumab|bevacizumab|mesh-list
1981660|NCT01004874|Temozolomide|temozolomide|mesh-list
1981661|NCT01004874|Topotecan|topotecan|mesh-list
1981662|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1981663|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981664|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1981665|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1981666|NCT01004874|Growth Substances|growth substances|mesh-ancestor
1981667|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981668|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
1981669|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1981670|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
1981671|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981672|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1981673|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1981674|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981675|NCT01004939|PENTA|penta|mesh-list
1981676|NCT01004939|Fondaparinux|fondaparinux|mesh-list
1981677|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1981678|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
1981679|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1981680|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
1981681|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981682|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981683|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
1981684|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1981685|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1981686|NCT01004991|Prednisone|prednisone|mesh-list
1981687|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
1981688|NCT01004991|Rituximab|rituximab|mesh-list
1981689|NCT01004991|Doxorubicin|doxorubicin|mesh-list
1981690|NCT01004991|Vincristine|vincristine|mesh-list
1981691|NCT01004991|Azacitidine|azacitidine|mesh-list
1981692|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981693|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
1981694|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981695|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981696|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1981697|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
1981698|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981699|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981700|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1981701|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1981702|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1981703|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1981704|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1981705|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981706|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1981707|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
1981708|NCT01004991|Hormones|hormones|mesh-ancestor
2745687|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
1981709|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1981710|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1981711|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1981712|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
1981713|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
1981714|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
1981715|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1981716|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
1981717|NCT01005251|Lesogaberan|lesogaberan|mesh-list
1981718|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1981719|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1981720|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
1981721|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
1981722|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981723|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981724|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981725|NCT01005290|Ramipril|ramipril|mesh-list
1981726|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1981727|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
1981728|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981729|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981730|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1981731|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
1981732|NCT01005316|Prednisone|prednisone|mesh-list
1981733|NCT01005316|Tacrolimus|tacrolimus|mesh-list
1981734|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
1981735|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1981736|NCT01005316|Antibodies|antibodies|mesh-list
1981737|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
1981738|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1981739|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1981740|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
1981741|NCT01005316|Hormones|hormones|mesh-ancestor
1981742|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1981743|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981744|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1981745|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981746|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981747|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
1981748|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1981749|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981750|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981751|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1981752|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1981753|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
1981754|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1981755|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981756|NCT01005329|Paclitaxel|paclitaxel|mesh-list
1981757|NCT01005329|Bevacizumab|bevacizumab|mesh-list
1981758|NCT01005329|Cisplatin|cisplatin|mesh-list
1981759|NCT01005329|Carboplatin|carboplatin|mesh-list
1981760|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1981761|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1981762|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
1981763|NCT01005329|Antibodies|antibodies|mesh-list
1981764|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
1981765|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1981766|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
1981767|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1981768|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981769|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
1981770|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
1981771|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
1981772|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981773|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1981774|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1981775|NCT01005329|Growth Substances|growth substances|mesh-ancestor
1981776|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981777|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
1981778|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
1981779|NCT01005355|Ramucirumab|ramucirumab|mesh-list
1981780|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981781|NCT01005407|Vaccines|vaccines|mesh-list
1981782|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
1981783|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981784|NCT01005459|Bupivacaine|bupivacaine|mesh-list
1981785|NCT01005459|Tetracaine|tetracaine|mesh-list
1981786|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
1981787|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
1981788|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1981789|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981790|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
1981791|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981792|NCT01005576|Fludarabine|fludarabine|mesh-list
1981793|NCT01005576|Melphalan|melphalan|mesh-list
1981794|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
1981795|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981796|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981797|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981798|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
1981799|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981800|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1981801|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
1981802|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1981803|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1981804|NCT01005602|Digoxin|digoxin|mesh-list
1981805|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1981806|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1981807|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981808|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981809|NCT01005602|Protective Agents|protective agents|mesh-ancestor
1981810|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981811|NCT01005680|Gemcitabine|gemcitabine|mesh-list
1981812|NCT01005680|Pemetrexed|pemetrexed|mesh-list
1981813|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981814|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1981815|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
1981816|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981817|NCT01005680|Antiviral Agents|antiviral agents|mesh-ancestor
1981818|NCT01005680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981819|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981820|NCT01005680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981821|NCT01005680|Immunologic Factors|immunologic factors|mesh-ancestor
1981822|NCT01005680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981823|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1981824|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1981825|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
1981826|NCT01005706|Sirolimus|sirolimus|mesh-list
1981827|NCT01005706|Tacrolimus|tacrolimus|mesh-list
1981828|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981829|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
1981830|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981831|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1981832|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981833|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981834|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1981835|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981836|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1981837|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
1981838|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1981839|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981840|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
1981841|NCT01005719|Omeprazole|omeprazole|mesh-list
1981842|NCT01005719|Lansoprazole|lansoprazole|mesh-list
1981843|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
1981844|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1981845|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1981846|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1981847|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981848|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981849|NCT01005745|Aldesleukin|aldesleukin|mesh-list
1981850|NCT01005745|Interleukin-2|interleukin-2|mesh-list
1981851|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981852|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1981853|NCT01005745|Analgesics|analgesics|mesh-ancestor
1981854|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
1981855|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981856|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981857|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1981858|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1981859|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
1981860|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981861|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
1981862|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1981863|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
1981864|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981865|NCT01005810|Expectorants|expectorants|mesh-ancestor
1981866|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
1981867|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1981868|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
1981869|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981870|NCT01005810|Protective Agents|protective agents|mesh-ancestor
1981871|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981872|NCT01005810|Antidotes|antidotes|mesh-ancestor
1981873|NCT01005875|Sorafenib|sorafenib|mesh-list
1981874|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981875|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1981876|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981877|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981878|NCT01005888|Complement C1s|complement c1s|mesh-list
1981879|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1981880|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
1981881|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
1981882|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981883|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1981884|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981885|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
1981886|NCT01005901|Bromides|bromides|mesh-list
1981887|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
1981888|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1981889|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1981890|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1981891|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
1981892|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981893|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981894|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981895|NCT01005966|Listerine|listerine|mesh-list
1981896|NCT01005966|Fluorides|fluorides|mesh-list
1981897|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
1981898|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
1981899|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
1981900|NCT01005966|Protective Agents|protective agents|mesh-ancestor
1981901|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981902|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1981903|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981904|NCT01006252|Paclitaxel|paclitaxel|mesh-list
1981905|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1981906|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981907|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
1981908|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
1981909|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
1981910|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981911|NCT01006265|Ponesimod|ponesimod|mesh-list
1981912|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1981913|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981914|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981915|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
1981916|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981917|NCT01006291|Insulin|insulin|mesh-list
1981918|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1981919|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
1981920|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
1981921|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1981922|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981923|NCT01006356|Hydromorphone|hydromorphone|mesh-list
1981924|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1981925|NCT01006356|Narcotics|narcotics|mesh-ancestor
1981926|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1981927|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981928|NCT01006356|Analgesics|analgesics|mesh-ancestor
1981929|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
1981930|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981931|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
1981932|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
1981933|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1981934|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1981935|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981936|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745688|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
1981937|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981938|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1981939|NCT01006538|Ranibizumab|ranibizumab|mesh-list
1981940|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1981941|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1981942|NCT01006538|Growth Substances|growth substances|mesh-ancestor
1981943|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981944|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
1981945|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1981946|NCT01006590|Metformin|metformin|mesh-list
1981947|NCT01006590|Saxagliptin|saxagliptin|mesh-list
1981948|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1981949|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981950|NCT01006590|Incretins|incretins|mesh-ancestor
1981951|NCT01006590|Hormones|hormones|mesh-ancestor
1981952|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1981953|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1981954|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
1981955|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981956|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981957|NCT01006603|Glimepiride|glimepiride|mesh-list
1981958|NCT01006603|Saxagliptin|saxagliptin|mesh-list
1981959|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1981960|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1981961|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981962|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1981963|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
1981964|NCT01006603|Incretins|incretins|mesh-ancestor
1981965|NCT01006603|Hormones|hormones|mesh-ancestor
1981966|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1981967|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1981968|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
1981969|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1981970|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981971|NCT01006629|Palivizumab|palivizumab|mesh-list
1981972|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
1981973|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1981974|NCT01006655|Beclomethasone|beclomethasone|mesh-list
1981975|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1981976|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
1981977|NCT01006655|Hormones|hormones|mesh-ancestor
1981978|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1981979|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981980|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1981981|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
1981982|NCT01006707|Ondansetron|ondansetron|mesh-list
1981983|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
1981984|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
1981985|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1981986|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1981987|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1981988|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
1981989|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
1981990|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1981991|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
1981992|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1981993|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1981994|NCT01006707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1981995|NCT01006707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1981996|NCT01006707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1981997|NCT01006707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1981998|NCT01006707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1981999|NCT01006889|Exenatide|exenatide|mesh-list
1982000|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1982001|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982002|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1982003|NCT01006889|Incretins|incretins|mesh-ancestor
1982004|NCT01006889|Hormones|hormones|mesh-ancestor
1982005|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1982006|NCT01006980|Dacarbazine|dacarbazine|mesh-list
1982007|NCT01006980|Vemurafenib|vemurafenib|mesh-list
1982008|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1982009|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
1982010|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982011|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982012|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1982013|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982014|NCT01007071|Hormones|hormones|mesh-list
1982015|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1982016|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982017|NCT01007149|Omalizumab|omalizumab|mesh-list
1982018|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1982019|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1982020|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
1982021|NCT01007253|Fluticasone|fluticasone|mesh-list
1982022|NCT01007253|Xhance|xhance|mesh-list
1982023|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1982024|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1982025|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1982026|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1982027|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
1982028|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982029|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982030|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1982031|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
1982032|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
1982033|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1982034|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1982035|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1982036|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1982037|NCT01007253|Analgesics|analgesics|mesh-ancestor
1982038|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
1982039|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1982040|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1982041|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1982042|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
1982043|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
1982044|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982045|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982046|NCT01007435|Methotrexate|methotrexate|mesh-list
1982047|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1982048|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
1982049|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1982050|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982051|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1982052|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
1982053|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982054|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982055|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
1982056|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982057|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1982058|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1982059|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
1982060|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1982061|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1982062|NCT01007448|Bexarotene|bexarotene|mesh-list
1982063|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982064|NCT01007552|Gemcitabine|gemcitabine|mesh-list
1982065|NCT01007552|Bevacizumab|bevacizumab|mesh-list
1982066|NCT01007552|Capecitabine|capecitabine|mesh-list
1982067|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1982068|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982069|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1982070|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1982071|NCT01007552|Growth Substances|growth substances|mesh-ancestor
1982072|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982073|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
1982074|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1982075|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
1982076|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982077|NCT01007552|Antiviral Agents|antiviral agents|mesh-ancestor
1982078|NCT01007552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982079|NCT01007552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982080|NCT01007552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1982081|NCT01007552|Immunologic Factors|immunologic factors|mesh-ancestor
1982082|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
1982083|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1982084|NCT01007942|Trastuzumab|trastuzumab|mesh-list
1982085|NCT01007942|Everolimus|everolimus|mesh-list
1982086|NCT01007942|Vinorelbine|vinorelbine|mesh-list
1982087|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1982088|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982089|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1982090|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
1982091|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982092|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1982093|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
1982094|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
1982095|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
1982096|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982097|NCT01007994|Propranolol|propranolol|mesh-list
1982098|NCT01007994|Enalapril|enalapril|mesh-list
1982099|NCT01007994|Isradipine|isradipine|mesh-list
1982100|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1982101|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1982102|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
1982103|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982104|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982105|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982106|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1982107|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1982108|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
1982109|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1982110|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
1982111|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982112|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1982113|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1982114|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1982115|NCT01008059|Alfentanil|alfentanil|mesh-list
1982116|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1982117|NCT01008059|Narcotics|narcotics|mesh-ancestor
1982118|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1982119|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982120|NCT01008059|Analgesics|analgesics|mesh-ancestor
1982121|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
1982122|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982123|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1982124|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
1982125|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
1982126|NCT01008150|Paclitaxel|paclitaxel|mesh-list
1982127|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
1982128|NCT01008150|Doxorubicin|doxorubicin|mesh-list
1982129|NCT01008150|Trastuzumab|trastuzumab|mesh-list
1982130|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1982131|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982132|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
1982133|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
1982134|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
1982135|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982136|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1982137|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
1982138|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982139|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1982140|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1982141|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
1982142|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1982143|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1982144|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1982145|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1982146|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982147|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1982148|NCT01008280|Baclofen|baclofen|mesh-list
1982149|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1982150|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982151|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1982152|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982153|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
1982154|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
1982155|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
1982156|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982157|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982158|NCT01008319|Citric Acid|citric acid|mesh-list
1982159|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
1982160|NCT01008319|Clomiphene|clomiphene|mesh-list
1982161|NCT01008319|Enclomiphene|enclomiphene|mesh-list
1982162|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
1982163|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
1982164|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1982165|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
1982166|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
1982167|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982168|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1982169|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
1982170|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1982171|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982172|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1982173|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
1982174|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1982175|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1982176|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1982177|NCT01008410|Budesonide|budesonide|mesh-list
1982178|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1982179|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1982180|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
1982181|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982182|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982183|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1982184|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
1982185|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
1982186|NCT01008410|Hormones|hormones|mesh-ancestor
1982187|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1982188|NCT01008423|Budesonide|budesonide|mesh-list
1982189|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1982190|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1982191|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
1982192|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982193|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982194|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1982195|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
1982196|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
1982197|NCT01008423|Hormones|hormones|mesh-ancestor
1982198|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1982199|NCT01008462|Cytarabine|cytarabine|mesh-list
1982200|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
1982201|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
1982202|NCT01008462|Melphalan|melphalan|mesh-list
1982203|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
1982204|NCT01008462|Carmustine|carmustine|mesh-list
1982205|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1982206|NCT01008462|Fludarabine|fludarabine|mesh-list
1982207|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
1982208|NCT01008462|Etoposide|etoposide|mesh-list
1982209|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
1982210|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
1982211|NCT01008462|Tacrolimus|tacrolimus|mesh-list
1982212|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1982213|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
1982214|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982215|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1982216|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1982217|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
1982218|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982219|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982220|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1982221|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1982222|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
1982223|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1982224|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1982225|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1982226|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982227|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
1982228|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982229|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1982230|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1982231|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1982232|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
1982233|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1982234|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
1982235|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
1982236|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
1982237|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
1982238|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
1982239|NCT01008475|Irinotecan|irinotecan|mesh-list
1982240|NCT01008475|Cetuximab|cetuximab|mesh-list
1982241|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1982242|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1982243|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982244|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982245|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982246|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1982247|NCT01008553|Fentanyl|fentanyl|mesh-list
1982248|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1982249|NCT01008553|Narcotics|narcotics|mesh-ancestor
1982250|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1982251|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982252|NCT01008553|Analgesics|analgesics|mesh-ancestor
1982253|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
1982254|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982255|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1982256|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1982257|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
1982258|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
1982259|NCT01008618|Fentanyl|fentanyl|mesh-list
1982260|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1982261|NCT01008618|Narcotics|narcotics|mesh-ancestor
1982262|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1982263|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982264|NCT01008618|Analgesics|analgesics|mesh-ancestor
1982265|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
1982266|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982267|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1982268|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1982269|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
1982270|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
1982271|NCT01008696|Rabeprazole|rabeprazole|mesh-list
1982272|NCT01008696|Lansoprazole|lansoprazole|mesh-list
1982273|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
1982274|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1982275|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1982276|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1982277|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982278|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982279|NCT01008748|Nicotine|nicotine|mesh-list
1982280|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1982281|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
1982282|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982283|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982284|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1982285|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1982286|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
1982287|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982288|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982289|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
1982290|NCT01008904|Antacids|antacids|mesh-ancestor
1982291|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982292|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1982293|NCT01008995|Ustekinumab|ustekinumab|mesh-list
1982294|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
1982295|NCT01009047|Aripiprazole|aripiprazole|mesh-list
1982296|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1982297|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
1982298|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1982299|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1982300|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1982301|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1982302|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982303|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
1982304|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
1982305|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982306|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982307|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1982308|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1982309|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
1982310|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1982311|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1982312|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1982313|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1982314|NCT01009086|Ustekinumab|ustekinumab|mesh-list
1982315|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
1982316|NCT01009203|Sirolimus|sirolimus|mesh-list
1982317|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1982318|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982319|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1982320|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982321|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982322|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1982323|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982324|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1982325|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
1982326|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1982327|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
1982328|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982329|NCT01009346|Cisplatin|cisplatin|mesh-list
1982330|NCT01009346|Carboplatin|carboplatin|mesh-list
1982331|NCT01009346|Cetuximab|cetuximab|mesh-list
1982332|NCT01009346|Everolimus|everolimus|mesh-list
1982333|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982334|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1982335|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1982336|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
1982337|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982338|NCT01009515|Paclitaxel|paclitaxel|mesh-list
1982339|NCT01009515|Carboplatin|carboplatin|mesh-list
1982340|NCT01009515|Temozolomide|temozolomide|mesh-list
1982341|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1982342|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982343|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
1982344|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
1982345|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
1982346|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982347|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1982348|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
1982349|NCT01009554|Listerine|listerine|mesh-list
1982350|NCT01009554|Fluorides|fluorides|mesh-list
1982351|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
1982352|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
1982353|NCT01009554|Protective Agents|protective agents|mesh-ancestor
1982354|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982355|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1982356|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982357|NCT01009580|Insulin|insulin|mesh-list
1982358|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1982359|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
1982360|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
1982361|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1982362|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
1982363|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
1982364|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1982365|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982366|NCT01009619|Azithromycin|azithromycin|mesh-list
1982367|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1982368|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982369|NCT01009814|Ritonavir|ritonavir|mesh-list
1982370|NCT01009814|Fostemsavir|fostemsavir|mesh-list
1982371|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1982372|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1982373|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
1982374|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982375|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982376|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1982377|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1982378|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
1982379|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982380|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1982381|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1982382|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1982383|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1982384|NCT01009840|Bortezomib|bortezomib|mesh-list
1982385|NCT01009840|Busulfan|busulfan|mesh-list
1982386|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982387|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
1982388|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982389|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1982390|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
1982391|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982392|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1982393|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1982394|NCT01009918|Carvedilol|carvedilol|mesh-list
1982395|NCT01009918|Lisinopril|lisinopril|mesh-list
1982396|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1982397|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1982398|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
1982399|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982400|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982401|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982402|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1982403|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
1982404|NCT01009918|Protective Agents|protective agents|mesh-ancestor
1982405|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1982406|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1982407|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1982408|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
1982409|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1982410|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1982411|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1982412|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
1982413|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982414|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1982415|NCT01009983|Paclitaxel|paclitaxel|mesh-list
1982416|NCT01009983|Carboplatin|carboplatin|mesh-list
1982417|NCT01009983|Panitumumab|panitumumab|mesh-list
1982418|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1982419|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982420|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
1982421|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
1982422|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
1982423|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982424|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1982425|NCT01010009|Resveratrol|resveratrol|mesh-list
1982426|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
1982427|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982428|NCT01010009|Protective Agents|protective agents|mesh-ancestor
1982429|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982430|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982431|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1982432|NCT01010061|Rituximab|rituximab|mesh-list
1982433|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
1982434|NCT01010061|Chlorambucil|chlorambucil|mesh-list
1982435|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1982436|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982437|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
1982438|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982439|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1982440|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1982441|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
1982442|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982443|NCT01010126|Sirolimus|sirolimus|mesh-list
1982444|NCT01010126|Bevacizumab|bevacizumab|mesh-list
1982445|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1982446|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
1982447|NCT01010126|Antibodies|antibodies|mesh-list
1982448|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
1982449|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1982450|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
1982451|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982452|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1982453|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1982454|NCT01010126|Growth Substances|growth substances|mesh-ancestor
1982455|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982456|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
1982457|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
1982458|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1982459|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982460|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1982461|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
1982462|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1982463|NCT01010204|Varenicline|varenicline|mesh-list
1982464|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1982465|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1982466|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
1982467|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079350|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982468|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982469|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982470|NCT01010217|Vidarabine|vidarabine|mesh-list
1982471|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
1982472|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
1982473|NCT01010217|Melphalan|melphalan|mesh-list
1982474|NCT01010217|Thiotepa|thiotepa|mesh-list
1982475|NCT01010217|Rituximab|rituximab|mesh-list
1982476|NCT01010217|Fludarabine|fludarabine|mesh-list
1982477|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
1982478|NCT01010217|Tacrolimus|tacrolimus|mesh-list
1982479|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1982480|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
1982481|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982482|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1982483|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1982484|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
1982485|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982486|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982487|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1982488|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1982489|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1982490|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
1982491|NCT01010217|Antiviral Agents|antiviral agents|mesh-ancestor
1982492|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982493|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1982494|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982495|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1982496|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1982497|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
1982498|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1982499|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1982500|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
1982501|NCT01010282|Glycerol|glycerol|mesh-list
1982502|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1982503|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1982504|NCT01010282|Laxatives|laxatives|mesh-ancestor
1982505|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1982506|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1982507|NCT01010282|Protective Agents|protective agents|mesh-ancestor
1982508|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982509|NCT01010399|Ritonavir|ritonavir|mesh-list
1982510|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
1982511|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1982512|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1982513|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
1982514|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982515|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982516|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1982517|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1982518|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
1982519|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982520|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1982521|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1982522|NCT01010477|Nicotine|nicotine|mesh-list
1982523|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1982524|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
1982525|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982526|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982527|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1982528|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1982529|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
1982530|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982531|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982532|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1982533|NCT01010568|Ofatumumab|ofatumumab|mesh-list
1982534|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1982535|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1982536|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
1982537|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982538|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982539|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
1982540|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982541|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
1982542|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1982543|NCT01010750|Amphetamine|amphetamine|mesh-list
1982544|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1982545|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1982546|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982547|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
1982548|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
1982549|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982550|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
1982551|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982552|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982553|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
1982554|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1982555|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1982556|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1982557|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1982558|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1982559|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1982560|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1982561|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1982562|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982563|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1982564|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1982565|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1982566|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
1982567|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982568|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982569|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1982570|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1982571|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
1982572|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
1982573|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
1982574|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
1982575|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982576|NCT01010971|Ciclesonide|ciclesonide|mesh-list
1982577|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
1982578|NCT01010971|Hormones|hormones|mesh-ancestor
1982579|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1982580|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982581|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1982582|NCT01010984|Doxorubicin|doxorubicin|mesh-list
1982583|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1982584|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982585|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1982586|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1982587|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982588|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982589|NCT01011049|Vaccines|vaccines|mesh-list
1982590|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
1982591|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982592|NCT01011075|Paclitaxel|paclitaxel|mesh-list
1982593|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
1982594|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1982595|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982596|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
1982597|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
1982598|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
1982599|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982600|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1982601|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982602|NCT01011218|Modafinil|modafinil|mesh-list
1982603|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1982604|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982605|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1982606|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1982607|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1982608|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982609|NCT01011283|Azacitidine|azacitidine|mesh-list
1982610|NCT01011283|Decitabine|decitabine|mesh-list
1982611|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1982612|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
1982613|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982614|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982615|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982616|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
1982617|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1982618|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1982619|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982620|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
1982621|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1982622|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
1982623|NCT01011413|Efavirenz|efavirenz|mesh-list
1982624|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1982625|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1982626|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982627|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982628|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
1982629|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982630|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1982631|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1982632|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1982633|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1982634|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1982635|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1982636|NCT01011439|Maleic acid|maleic acid|mesh-list
1982637|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982638|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982639|NCT01011465|Oxytocin|oxytocin|mesh-list
1982640|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
1982641|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1982642|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982643|NCT01011556|Teriparatide|teriparatide|mesh-list
1982644|NCT01011556|Hormones|hormones|mesh-list
1982645|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
1982646|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1982647|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982648|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1982649|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1982650|NCT01011673|Ketorolac|ketorolac|mesh-list
1982651|NCT01011673|Metoclopramide|metoclopramide|mesh-list
1982652|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1982653|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1982654|NCT01011673|Analgesics|analgesics|mesh-ancestor
1982655|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
1982656|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982657|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982658|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1982659|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1982660|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1982661|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982662|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982663|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
1982664|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
1982665|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1982666|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1982667|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1982668|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
1982669|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982670|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
1982671|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
1982672|NCT01011816|Coagulants|coagulants|mesh-ancestor
1982673|NCT01011829|Varenicline|varenicline|mesh-list
1982674|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1982675|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1982676|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
1982677|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982678|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982679|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982680|NCT01011868|Empagliflozin|empagliflozin|mesh-list
1982681|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1982682|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982683|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1982684|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982685|NCT01011894|Lenalidomide|lenalidomide|mesh-list
1982686|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
1982687|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982688|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1982689|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1982690|NCT01011894|Growth Substances|growth substances|mesh-ancestor
1982691|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
1982692|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982693|NCT01011907|Varenicline|varenicline|mesh-list
1982694|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1982695|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1982696|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
1982697|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982698|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982699|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982700|NCT01012037|Linagliptin|linagliptin|mesh-list
1982701|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1982702|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982703|NCT01012037|Incretins|incretins|mesh-ancestor
1982704|NCT01012037|Hormones|hormones|mesh-ancestor
1982705|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1982706|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1982707|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
1982708|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982709|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982710|NCT01012089|Daptomycin|daptomycin|mesh-list
1982711|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1982712|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982727|NCT01012219|Aspirin|aspirin|mesh-list
1982728|NCT01012219|Niacin|niacin|mesh-list
1982729|NCT01012219|Clopidogrel|clopidogrel|mesh-list
1982730|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1982731|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1982732|NCT01012219|Analgesics|analgesics|mesh-ancestor
1982733|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
1982734|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982735|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982736|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1982737|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1982738|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1982739|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1982740|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982741|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1982742|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1982743|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982744|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
1982745|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1982746|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1982747|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1982748|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
1982749|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982750|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1982751|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
1982752|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1982753|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
1982754|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
1982755|NCT01012219|Vitamins|vitamins|mesh-ancestor
1982756|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
1982757|NCT01012258|Cetuximab|cetuximab|mesh-list
1982758|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1982759|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982760|NCT01012297|Gemcitabine|gemcitabine|mesh-list
1982761|NCT01012297|Bevacizumab|bevacizumab|mesh-list
1982762|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1982763|NCT01012297|Docetaxel|docetaxel|mesh-list
1982764|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
1982765|NCT01012297|Antibodies|antibodies|mesh-list
1982766|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
1982767|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1982768|NCT01012297|Lenograstim|lenograstim|mesh-list
1982769|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
1982770|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982771|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1982772|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1982773|NCT01012297|Growth Substances|growth substances|mesh-ancestor
1982774|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982775|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
1982776|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
1982777|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1982778|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
1982779|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982780|NCT01012297|Antiviral Agents|antiviral agents|mesh-ancestor
1982781|NCT01012297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982782|NCT01012297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982783|NCT01012297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1982784|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
1982785|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
1982786|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
1982787|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1982788|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
1982789|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
1982790|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982791|NCT01012336|Dexamethasone|dexamethasone|mesh-list
1982792|NCT01012336|Aprepitant|aprepitant|mesh-list
1982793|NCT01012336|Ramosetron|ramosetron|mesh-list
1982794|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1982795|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
1982796|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
1982797|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982798|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982799|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1982800|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
1982801|NCT01012336|Hormones|hormones|mesh-ancestor
1982802|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1982803|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1982804|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982805|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1982806|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982807|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982808|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1982809|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
1982810|NCT01012492|Abatacept|abatacept|mesh-list
1982811|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1982812|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982813|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982814|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1982815|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
1982816|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982817|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1982818|NCT01012609|Irinotecan|irinotecan|mesh-list
1982819|NCT01012609|Cetuximab|cetuximab|mesh-list
1982820|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1982821|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1982822|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982823|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982824|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982825|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1982826|NCT01012622|Methylphenidate|methylphenidate|mesh-list
1982827|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1982828|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982829|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1982830|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1982831|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1982832|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982833|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
1982834|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982835|NCT01012661|Lidocaine|lidocaine|mesh-list
1982836|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
1982837|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
1982838|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1982839|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982840|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
2745689|NCT02735707|Levofloxacin|levofloxacin|mesh-list
1982841|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982842|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1982843|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1982844|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1982845|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1982846|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982847|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
1982848|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
1982849|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
1982850|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982851|NCT01012713|Calcitriol|calcitriol|mesh-list
1982852|NCT01012713|Clobetasol|clobetasol|mesh-list
1982853|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1982854|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
1982855|NCT01012713|Hormones|hormones|mesh-ancestor
1982856|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1982857|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982858|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1982859|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1982860|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1982861|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982862|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1982863|NCT01012713|Vitamins|vitamins|mesh-ancestor
1982864|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
1982865|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1982866|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
1982867|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1982868|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
1982869|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982870|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982871|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1982872|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
1982873|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
1982874|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1982875|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
1982876|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982877|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982878|NCT01012973|Aflibercept|aflibercept|mesh-list
1982879|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1982880|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1982881|NCT01012973|Growth Substances|growth substances|mesh-ancestor
1982882|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982883|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
1982884|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982885|NCT01012999|Sufentanil|sufentanil|mesh-list
1982886|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1982887|NCT01012999|Narcotics|narcotics|mesh-ancestor
1982888|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1982889|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982890|NCT01012999|Analgesics|analgesics|mesh-ancestor
1982891|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
1982892|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982893|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1982894|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1982895|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
1982896|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
1982897|NCT01013285|Bevacizumab|bevacizumab|mesh-list
1982898|NCT01013285|Temozolomide|temozolomide|mesh-list
1982899|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1982900|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982901|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1982902|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1982903|NCT01013285|Growth Substances|growth substances|mesh-ancestor
1982904|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982905|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
1982906|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1982907|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
1982908|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982909|NCT01013597|Panobinostat|panobinostat|mesh-list
1982910|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982911|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1982912|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745690|NCT02735707|Ivermectin|ivermectin|mesh-list
1982913|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982914|NCT01013740|Capecitabine|capecitabine|mesh-list
1982915|NCT01013740|Vinorelbine|vinorelbine|mesh-list
1982916|NCT01013740|Lapatinib|lapatinib|mesh-list
1982917|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1982918|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
1982919|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982920|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982921|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1982922|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
1982923|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
1982924|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
1982925|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1982926|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982927|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
1982928|NCT01013753|Olodaterol|olodaterol|mesh-list
1982929|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1982930|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
1982931|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1982932|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982933|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1982934|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
1982935|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1982936|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1982937|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1982938|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
1982939|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1982940|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982941|NCT01013870|Atorvastatin|atorvastatin|mesh-list
1982942|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1982943|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1982944|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
1982945|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982946|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1982947|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1982948|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1982949|NCT01013961|Rituximab|rituximab|mesh-list
1982950|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
1982951|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1982952|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982953|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
1982954|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982955|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1982956|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
1982957|NCT01014013|Ertapenem|ertapenem|mesh-list
1982958|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1982959|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982960|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
1982961|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1982962|NCT01014143|Triclosan|triclosan|mesh-list
1982963|NCT01014143|Fluorides|fluorides|mesh-list
1982964|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
1982965|NCT01014143|Protective Agents|protective agents|mesh-ancestor
1982966|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982967|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1982968|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1982969|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
1982970|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
1982971|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1982972|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1982973|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
1982974|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982975|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1982976|NCT01014208|Rituximab|rituximab|mesh-list
1982977|NCT01014208|Ofatumumab|ofatumumab|mesh-list
1982978|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1982979|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982980|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
1982981|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982982|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1982983|NCT01014351|Paclitaxel|paclitaxel|mesh-list
1982984|NCT01014351|Carboplatin|carboplatin|mesh-list
1982985|NCT01014351|Everolimus|everolimus|mesh-list
1982986|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1982987|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1982988|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
1982989|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
1982990|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
1982991|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1982992|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1982993|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
1982994|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1982995|NCT01014403|Enoxaparin|enoxaparin|mesh-list
1982996|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
1982997|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1982998|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1982999|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983000|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
1983001|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1983002|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983003|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1983004|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
1983005|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983006|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983007|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983008|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983009|NCT01014533|Gabapentin|gabapentin|mesh-list
1983010|NCT01014533|Analgesics|analgesics|mesh-ancestor
1983011|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
1983012|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983013|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983014|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
1983015|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1983016|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1983017|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1983018|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1983019|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1983020|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1983021|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983022|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983023|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
1983024|NCT01014585|Milnacipran|milnacipran|mesh-list
1983025|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
1983026|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1983027|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1983028|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1983029|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983030|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983031|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983032|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1983033|NCT01014585|Analgesics|analgesics|mesh-ancestor
1983034|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
1983035|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983036|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
1983037|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1983038|NCT01014624|Clopidogrel|clopidogrel|mesh-list
1983039|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1983040|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1983041|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1983042|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1983043|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1983044|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
1983045|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983046|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983047|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983048|NCT01014689|Lymecycline|lymecycline|mesh-list
1983049|NCT01014689|Adapalene|adapalene|mesh-list
1983050|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1983051|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1983052|NCT01014689|Analgesics|analgesics|mesh-ancestor
1983053|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
1983054|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983055|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983056|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1983057|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1983058|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
1983059|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983060|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983061|NCT01014728|Propofol|propofol|mesh-list
1983062|NCT01014728|Sevoflurane|sevoflurane|mesh-list
1983063|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1983064|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1983065|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983066|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1983067|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
1983068|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
1983069|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1983070|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1983071|NCT01014741|Ibutilide|ibutilide|mesh-list
1983072|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1983073|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
1983074|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1983075|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1983076|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1983077|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1983078|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983079|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
1983080|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983081|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983082|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1983083|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983084|NCT01014936|Tepotinib|tepotinib|mesh-list
1983085|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983086|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
1983087|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1983088|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1983089|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983090|NCT01014988|Zanamivir|zanamivir|mesh-list
1983091|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
1983092|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983093|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983094|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983095|NCT01015118|Paclitaxel|paclitaxel|mesh-list
1983096|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1983097|NCT01015118|Carboplatin|carboplatin|mesh-list
1983098|NCT01015118|Nintedanib|nintedanib|mesh-list
1983099|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1983100|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983101|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
1983102|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
1983103|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
1983104|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983105|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1983106|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983107|NCT01015131|Alovudine|alovudine|mesh-list
1983108|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
1983109|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983110|NCT01015170|Bupropion|bupropion|mesh-list
1983111|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1983112|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
1983113|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1983114|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1983115|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1983116|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1983117|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983118|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
1983119|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983120|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983121|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1983122|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1983123|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983124|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1983125|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1983126|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
1983127|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1983128|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
1983129|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983130|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1983131|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1983132|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
1983133|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983134|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983135|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1983136|NCT01015534|Temozolomide|temozolomide|mesh-list
1983137|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1983138|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
1983139|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983140|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983141|NCT01015560|Antibodies|antibodies|mesh-list
1983142|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1983143|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
1983144|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983145|NCT01015586|Lamotrigine|lamotrigine|mesh-list
1983146|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
1983147|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1983148|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1983149|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983150|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1983151|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983152|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1983153|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1983154|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1983155|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1983156|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1983157|NCT01015638|Clindamycin|clindamycin|mesh-list
1983158|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
1983159|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
1983160|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1983161|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983162|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983163|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1983164|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983165|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983166|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
1983167|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1983168|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1983169|NCT01015677|Estradiol|estradiol|mesh-list
1983170|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1983171|NCT01015677|Estrogens|estrogens|mesh-ancestor
1983172|NCT01015677|Hormones|hormones|mesh-ancestor
1983173|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1983174|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983175|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1983176|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
1983177|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1983178|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1983179|NCT01015807|Clonidine|clonidine|mesh-list
1983180|NCT01015807|Bupivacaine|bupivacaine|mesh-list
1983181|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
1983182|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
1983183|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1983184|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983185|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
1983186|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983187|NCT01015807|Analgesics|analgesics|mesh-ancestor
1983188|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1983189|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
1983190|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
1983191|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1983192|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1983193|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1983194|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
1983195|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983196|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745691|NCT02735707|Tazobactam|tazobactam|mesh-list
2745692|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
2745693|NCT02735707|Piperacillin|piperacillin|mesh-list
2745694|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
2745695|NCT02735707|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2745696|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2745697|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2745698|NCT02735707|Apremilast|apremilast|mesh-list
2745699|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
2745700|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1983207|NCT01016015|Sirolimus|sirolimus|mesh-list
1983208|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1983209|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983210|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983211|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1983212|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983213|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
1983214|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1983215|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
1983216|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983217|NCT01016262|Mesalamine|mesalamine|mesh-list
1983218|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1983219|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1983220|NCT01016262|Analgesics|analgesics|mesh-ancestor
1983221|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
1983222|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983223|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983224|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1983225|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1983226|NCT01016483|Gemcitabine|gemcitabine|mesh-list
1983227|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1983228|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
1983229|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983230|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983231|NCT01016483|Antiviral Agents|antiviral agents|mesh-ancestor
1983232|NCT01016483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983233|NCT01016483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983234|NCT01016483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1983235|NCT01016483|Immunologic Factors|immunologic factors|mesh-ancestor
1983236|NCT01016483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983237|NCT01016600|Lenalidomide|lenalidomide|mesh-list
1983238|NCT01016600|Azacitidine|azacitidine|mesh-list
1983239|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
1983240|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983241|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1983242|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1983243|NCT01016600|Growth Substances|growth substances|mesh-ancestor
1983244|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
1983245|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983246|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1983247|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
1983248|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983249|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983250|NCT01016678|Naproxen|naproxen|mesh-list
1983251|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1983252|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1983253|NCT01016678|Analgesics|analgesics|mesh-ancestor
1983254|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
1983255|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983256|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983257|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1983258|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1983259|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
1983260|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1983261|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983262|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983263|NCT01016691|Bimatoprost|bimatoprost|mesh-list
1983264|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1983265|NCT01016769|Sirolimus|sirolimus|mesh-list
1983266|NCT01016769|Paclitaxel|paclitaxel|mesh-list
1983267|NCT01016769|Carboplatin|carboplatin|mesh-list
1983268|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1983269|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983270|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
1983271|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
1983272|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
1983273|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983274|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983275|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983276|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1983277|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
1983278|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1983279|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
1983280|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983281|NCT01016834|Sumatriptan|sumatriptan|mesh-list
1983282|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1983283|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1983284|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1983285|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
1983286|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983287|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983288|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983289|NCT01016912|Ribavirin|ribavirin|mesh-list
1983290|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1983291|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
1983292|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983293|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
1983294|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983295|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
1983296|NCT01016977|Clindamycin|clindamycin|mesh-list
1983297|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
1983298|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
1983299|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1983300|NCT01016977|Tazarotene|tazarotene|mesh-list
1983301|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983302|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983303|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1983304|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983305|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983306|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
1983307|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
1983308|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
1983309|NCT01016977|Vitamins|vitamins|mesh-ancestor
1983310|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
1983311|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983312|NCT01017003|Colchicine|colchicine|mesh-list
1983313|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
1983314|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1983315|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
1983316|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
1983317|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
1983318|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983319|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983320|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
1983321|NCT01017029|Everolimus|everolimus|mesh-list
1983322|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983323|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1983324|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
1983325|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983326|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1983327|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1983328|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
1983329|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983330|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983331|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983332|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983333|NCT01017042|Colchicine|colchicine|mesh-list
1983334|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
1983335|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1983336|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
1983337|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
1983338|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
1983339|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983340|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983341|NCT01017120|Tazarotene|tazarotene|mesh-list
1983342|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
1983343|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
1983344|NCT01017146|Tazarotene|tazarotene|mesh-list
1983345|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
1983346|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
1983347|NCT01017237|Midazolam|midazolam|mesh-list
1983348|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
1983349|NCT01017237|Ketamine|ketamine|mesh-list
1983350|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1983351|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1983352|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983353|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1983354|NCT01017237|Analgesics|analgesics|mesh-ancestor
1983355|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
1983356|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983357|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1983358|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1983359|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1983360|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
1983361|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983362|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983363|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1983364|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1983365|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
1983366|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
1983367|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1983368|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1983369|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1983370|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1983371|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1983372|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1983373|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
1983374|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
1983375|NCT01017250|Bevacizumab|bevacizumab|mesh-list
1983376|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1983377|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983378|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1983379|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1983380|NCT01017250|Growth Substances|growth substances|mesh-ancestor
1983381|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983382|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
1983383|NCT01017575|Ribavirin|ribavirin|mesh-list
1983384|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1983385|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
1983386|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983387|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
1983388|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983389|NCT01017653|Irinotecan|irinotecan|mesh-list
1983390|NCT01017653|Panitumumab|panitumumab|mesh-list
1983391|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1983392|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1983393|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983394|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983395|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983396|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1983397|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
1983398|NCT01017731|Promethazine|promethazine|mesh-list
1983399|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
1983400|NCT01017731|Ramucirumab|ramucirumab|mesh-list
1983401|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983402|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983403|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1983404|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1983405|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983406|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983407|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983408|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983409|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1983410|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1983411|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1983412|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
1983413|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
1983414|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
1983415|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983416|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
1983417|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
1983418|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1983419|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1983420|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
1983421|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
1983422|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983423|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1983424|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
1983425|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
1983426|NCT01017874|Pemetrexed|pemetrexed|mesh-list
1983427|NCT01017874|Gefitinib|gefitinib|mesh-list
1983428|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983429|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983430|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983431|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1983432|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1983433|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1983434|NCT01018056|Riluzole|riluzole|mesh-list
1983435|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
1983436|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1983437|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1983438|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983439|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983440|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983441|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1983442|NCT01018056|Protective Agents|protective agents|mesh-ancestor
1983443|NCT01018095|Metronidazole|metronidazole|mesh-list
1983444|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983445|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983446|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1983447|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1983448|NCT01018134|Desoximetasone|desoximetasone|mesh-list
1983449|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1983450|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
1983451|NCT01018134|Hormones|hormones|mesh-ancestor
1983452|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1983453|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983454|NCT01018186|Fluticasone|fluticasone|mesh-list
1983455|NCT01018186|Xhance|xhance|mesh-list
1983456|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1983457|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1983458|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
1983459|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983460|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983461|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1983462|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
1983463|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
1983464|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1983465|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
1983466|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1983467|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1983468|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
1983469|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983470|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983471|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983472|NCT01018264|Urological Agents|urological agents|mesh-ancestor
1983473|NCT01018394|Nicotine|nicotine|mesh-list
1983474|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1983475|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
1983476|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983477|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983478|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1983479|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1983480|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
1983481|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983482|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983483|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
1983484|NCT01018420|Colchicine|colchicine|mesh-list
1983485|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983486|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983487|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1983488|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1983489|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983490|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983491|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983492|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
1983493|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1983494|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
1983495|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
1983496|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
1983497|NCT01018511|Tamsulosin|tamsulosin|mesh-list
1983498|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
1983499|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1983500|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1983501|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1983502|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
1983503|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983504|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983505|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983506|NCT01018511|Urological Agents|urological agents|mesh-ancestor
1983507|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1983508|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1983509|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
1983510|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1983511|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1983512|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1983513|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2745701|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1983514|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983515|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983516|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983517|NCT01018680|Analgesics|analgesics|mesh-ancestor
1983518|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
1983519|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983520|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
1983521|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1983522|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
1983523|NCT01018732|Lactitol|lactitol|mesh-list
1983524|NCT01018732|Cathartics|cathartics|mesh-ancestor
1983525|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1983526|NCT01018862|Azelastine|azelastine|mesh-list
1983527|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1983528|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
1983529|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983530|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983531|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1983532|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
1983533|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1983534|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983535|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983536|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1983537|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1983538|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1983539|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
1983540|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
1983541|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983542|NCT01019317|Vidarabine|vidarabine|mesh-list
1983543|NCT01019317|Cytarabine|cytarabine|mesh-list
1983544|NCT01019317|Fludarabine|fludarabine|mesh-list
1983545|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
1983546|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983547|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1983548|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
1983549|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983550|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1983551|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
1983552|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983553|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
1983554|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983555|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1983556|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
1983557|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1983558|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1983559|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1983560|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
1983561|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1983562|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983563|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1983564|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1983565|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1983566|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1983567|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983568|NCT01019486|Regadenoson|regadenoson|mesh-list
1983569|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
1983570|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1983571|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1983572|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
1983573|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
1983574|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983575|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983576|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983577|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1983578|NCT01019694|Albuterol|albuterol|mesh-list
1983579|NCT01019694|Ipratropium|ipratropium|mesh-list
1983580|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1983581|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
1983582|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983583|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983584|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1983585|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
1983586|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
1983587|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1983588|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1983589|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1983590|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1983591|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
1983592|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983593|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983594|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1983595|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
1983596|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1983597|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1983598|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1983599|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1983600|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983601|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
1983602|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983603|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983604|NCT01020006|Gemcitabine|gemcitabine|mesh-list
1983605|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1983606|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
1983607|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983608|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983609|NCT01020006|Antiviral Agents|antiviral agents|mesh-ancestor
1983610|NCT01020006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983611|NCT01020006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983612|NCT01020006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1983613|NCT01020006|Immunologic Factors|immunologic factors|mesh-ancestor
1983614|NCT01020006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983615|NCT01020019|Lofexidine|lofexidine|mesh-list
1983616|NCT01020019|Dronabinol|dronabinol|mesh-list
1983617|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
1983618|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983619|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1983620|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1983621|NCT01020019|Analgesics|analgesics|mesh-ancestor
1983622|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
1983623|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983624|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1983625|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1983626|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983627|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983628|NCT01020019|Hormones|hormones|mesh-ancestor
1983629|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1983630|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1983631|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1983632|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1983633|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1983634|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1983635|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
1983636|NCT01020123|Glipizide|glipizide|mesh-list
1983637|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1983638|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983639|NCT01020305|Sirolimus|sirolimus|mesh-list
1983640|NCT01020305|Bicalutamide|bicalutamide|mesh-list
1983641|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983642|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983643|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1983644|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983645|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
1983646|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1983647|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
1983648|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983649|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
1983650|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
1983651|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1983652|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1983653|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
1983654|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1983655|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
1983656|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1983657|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983658|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1983659|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1983660|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983661|NCT01020474|Pregabalin|pregabalin|mesh-list
1983662|NCT01020474|Analgesics|analgesics|mesh-ancestor
1983663|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
1983664|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983665|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983666|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
1983667|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1983668|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1983669|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983670|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1983671|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1983672|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1983673|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1983674|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1983675|NCT01020526|Pregabalin|pregabalin|mesh-list
1983676|NCT01020526|Analgesics|analgesics|mesh-ancestor
1983677|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
1983678|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983679|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983680|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
1983681|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1983682|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1983683|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983684|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1983685|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1983686|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1983687|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1983688|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1983689|NCT01020747|Bevacizumab|bevacizumab|mesh-list
1983690|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1983691|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983692|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1983693|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1983694|NCT01020747|Growth Substances|growth substances|mesh-ancestor
1983695|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983696|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
1983697|NCT01020786|Carboplatin|carboplatin|mesh-list
1983698|NCT01020786|Pemetrexed|pemetrexed|mesh-list
1983699|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983700|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983701|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983702|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1983703|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1983704|NCT01020799|Citalopram|citalopram|mesh-list
1983705|NCT01020799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1983706|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1983707|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1983708|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983709|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983710|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
1983711|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983712|NCT01020799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1983713|NCT01020799|Antidepressive Agents|antidepressive agents|mesh-ancestor
1983714|NCT01020799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1983715|NCT01020877|Metronidazole|metronidazole|mesh-list
1983716|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983717|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983718|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1983719|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1983720|NCT01021020|Colchicine|colchicine|mesh-list
1983721|NCT01021020|Probenecid|probenecid|mesh-list
1983722|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
1983723|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1983724|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
1983725|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
1983726|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
1983727|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983728|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983729|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
1983730|NCT01021020|Renal Agents|renal agents|mesh-ancestor
1983731|NCT01021215|Celecoxib|celecoxib|mesh-list
1983732|NCT01021215|Zileuton|zileuton|mesh-list
1983733|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1983734|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1983735|NCT01021215|Analgesics|analgesics|mesh-ancestor
1983736|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
1983737|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983738|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983739|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1983740|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1983741|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1983742|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1983743|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983744|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983745|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1983746|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1983747|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
1983748|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1983749|NCT01021332|Tamsulosin|tamsulosin|mesh-list
1983750|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
1983751|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1983752|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1983753|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1983754|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
1983755|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983756|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983757|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983758|NCT01021332|Urological Agents|urological agents|mesh-ancestor
1983759|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1983760|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1983761|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
1983762|NCT01021423|Lenalidomide|lenalidomide|mesh-list
1983763|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
1983764|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983765|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1983766|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1983767|NCT01021423|Growth Substances|growth substances|mesh-ancestor
1983768|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
1983769|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983770|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
1983771|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983772|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983773|NCT01021618|Dipyridamole|dipyridamole|mesh-list
1983774|NCT01021618|Regadenoson|regadenoson|mesh-list
1983775|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1983776|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1983777|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
1983778|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
1983779|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983780|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983781|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983782|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1983783|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983784|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1983785|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
1983786|NCT01021683|Itraconazole|itraconazole|mesh-list
1983787|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
1983788|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983789|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1983790|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1983791|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983792|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983793|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1983794|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
1983795|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1983796|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983797|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1983798|NCT01021761|Ketorolac|ketorolac|mesh-list
1983799|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1983800|NCT01021761|Nepafenac|nepafenac|mesh-list
1983801|NCT01021761|Bromfenac|bromfenac|mesh-list
1983802|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1983803|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1983804|NCT01021761|Analgesics|analgesics|mesh-ancestor
1983805|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
1983806|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983807|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983808|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1983809|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1983810|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1983811|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983812|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983813|NCT01021813|Suvorexant|suvorexant|mesh-list
1983814|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1983815|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1983816|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1983817|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983818|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1983819|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983820|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983821|NCT01021878|Icodextrin|icodextrin|mesh-list
1983822|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
1983823|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1983824|NCT01022190|Etoricoxib|etoricoxib|mesh-list
1983825|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1983826|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1983827|NCT01022190|Analgesics|analgesics|mesh-ancestor
1983828|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
1983829|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983830|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983831|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1983832|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1983833|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1983834|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1983835|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983836|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983837|NCT01022424|Tolvaptan|tolvaptan|mesh-list
1983838|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1983839|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983840|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
1983841|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983842|NCT01022567|Ertapenem|ertapenem|mesh-list
1983843|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1983844|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983845|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1983846|NCT01022580|Calfactant|calfactant|mesh-list
1983847|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
1983848|NCT01022762|Repaglinide|repaglinide|mesh-list
1983849|NCT01022762|Gliclazide|gliclazide|mesh-list
1983850|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1983851|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983852|NCT01022853|Nintedanib|nintedanib|mesh-list
1983853|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983854|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1983855|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983856|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983857|NCT01022996|Everolimus|everolimus|mesh-list
1983858|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983859|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1983860|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
1983861|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983862|NCT01023035|Ribavirin|ribavirin|mesh-list
1983863|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1983864|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
1983865|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
1983866|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983867|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
1983868|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983869|NCT01023035|Hematinics|hematinics|mesh-ancestor
1983870|NCT01023061|Prednisone|prednisone|mesh-list
1983871|NCT01023061|Leuprolide|leuprolide|mesh-list
1983872|NCT01023061|Goserelin|goserelin|mesh-list
1983873|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
1983874|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1983875|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
1983876|NCT01023061|Hormones|hormones|mesh-ancestor
1983877|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1983878|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983879|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1983880|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983881|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1983882|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
1983883|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1983884|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1983885|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983886|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983887|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
1983888|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1983889|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1983890|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1983891|NCT01023178|Estradiol|estradiol|mesh-list
1983892|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1983893|NCT01023178|Estrogens|estrogens|mesh-list
1983894|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1983895|NCT01023178|Progesterone|progesterone|mesh-list
1983896|NCT01023178|Hormones|hormones|mesh-ancestor
1983897|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1983898|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983899|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1983900|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
1983901|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1983902|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1983903|NCT01023178|Progestins|progestins|mesh-ancestor
1983904|NCT01023217|Lamivudine|lamivudine|mesh-list
1983905|NCT01023217|Adefovir|adefovir|mesh-list
1983906|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1983907|NCT01023217|Entecavir|entecavir|mesh-list
1983908|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1983909|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1983910|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983911|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983912|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
1983913|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983914|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1983915|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1983916|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1983917|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
1983918|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983919|NCT01023308|Dexamethasone|dexamethasone|mesh-list
1983920|NCT01023308|Bortezomib|bortezomib|mesh-list
1983921|NCT01023308|Panobinostat|panobinostat|mesh-list
1983922|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1983923|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
1983924|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
1983925|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983926|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983927|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1983928|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
1983929|NCT01023308|Hormones|hormones|mesh-ancestor
1983930|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1983931|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1983932|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1983933|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1983934|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983935|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983936|NCT01023477|Chloroquine|chloroquine|mesh-list
1983937|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
1983938|NCT01023477|Amebicides|amebicides|mesh-ancestor
1983939|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1983940|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1983941|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1983942|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
1983943|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1983944|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1983945|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1983946|NCT01023477|Analgesics|analgesics|mesh-ancestor
1983947|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
1983948|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1983949|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983950|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1983951|NCT01023477|Filaricides|filaricides|mesh-ancestor
1983952|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
1983953|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
1983954|NCT01023581|Metformin|metformin|mesh-list
1983955|NCT01023581|Alogliptin|alogliptin|mesh-list
1983956|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1983957|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983958|NCT01023581|Incretins|incretins|mesh-ancestor
1983959|NCT01023581|Hormones|hormones|mesh-ancestor
1983960|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1983961|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1983962|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
1983963|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983964|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983965|NCT01023659|Bupropion|bupropion|mesh-list
1983966|NCT01023659|Varenicline|varenicline|mesh-list
1983967|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1983968|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
1983969|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1983970|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1983971|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1983972|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1983973|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983974|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
1983975|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1983976|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983977|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1983978|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1983979|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1983980|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1983981|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1983982|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
1983983|NCT01023672|Modafinil|modafinil|mesh-list
1983984|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1983985|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983986|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1983987|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1983988|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1983989|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1983990|NCT01023711|Vaccines|vaccines|mesh-list
1983991|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
1983992|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1983993|NCT01023724|Ketorolac|ketorolac|mesh-list
1983994|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1983995|NCT01023724|Bromfenac|bromfenac|mesh-list
1983996|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1983997|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1983998|NCT01023724|Analgesics|analgesics|mesh-ancestor
1983999|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
1984000|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984001|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984002|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1984003|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1984004|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1984005|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984006|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984007|NCT01023776|Vaccines|vaccines|mesh-list
1984008|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
1984009|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984010|NCT01023815|Cyclosporine|cyclosporine|mesh-list
1984011|NCT01023815|Everolimus|everolimus|mesh-list
1984012|NCT01023815|Cyclosporins|cyclosporins|mesh-list
1984013|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984014|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984015|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984016|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
1984017|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984018|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
1984019|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984020|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
1984021|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1984022|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1984023|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984024|NCT01023841|Bimatoprost|bimatoprost|mesh-list
1984025|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1984026|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1984027|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1984028|NCT01024010|Vidarabine|vidarabine|mesh-list
1984029|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
1984030|NCT01024010|Ofatumumab|ofatumumab|mesh-list
1984031|NCT01024010|Pentostatin|pentostatin|mesh-list
1984032|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1984033|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984034|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
1984035|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984036|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1984037|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1984038|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
1984039|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984040|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984041|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1984042|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
1984043|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984044|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
1984045|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
1984046|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984047|NCT01024036|Siltuximab|siltuximab|mesh-list
1984048|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984049|NCT01024231|Nivolumab|nivolumab|mesh-list
1984050|NCT01024231|Ipilimumab|ipilimumab|mesh-list
1984051|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1984052|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984053|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1984054|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984055|NCT01024335|Naltrexone|naltrexone|mesh-list
1984056|NCT01024335|Dronabinol|dronabinol|mesh-list
1984057|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1984058|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1984059|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984060|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
1984061|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984062|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
1984063|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1984064|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1984065|NCT01024335|Analgesics|analgesics|mesh-ancestor
1984066|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1984067|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1984068|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984069|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984070|NCT01024335|Hormones|hormones|mesh-ancestor
1984071|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2745702|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2745703|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2745704|NCT02735707|Losartan|losartan|mesh-list
2745705|NCT02735707|Valsartan|valsartan|mesh-list
2745706|NCT02735707|Telmisartan|telmisartan|mesh-list
2745707|NCT02735707|Candesartan|candesartan|mesh-list
2745708|NCT02735707|Ramipril|ramipril|mesh-list
2745709|NCT02735707|Olmesartan|olmesartan|mesh-list
1984080|NCT01024686|Vaccines|vaccines|mesh-list
1984081|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
1984082|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984083|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
1984084|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1984085|NCT01024738|Triclosan|triclosan|mesh-list
1984086|NCT01024738|Fluorides|fluorides|mesh-list
1984087|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
1984088|NCT01024738|Protective Agents|protective agents|mesh-ancestor
1984089|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984090|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1984091|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984092|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
1984093|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
1984094|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1984095|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1984096|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
1984097|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984098|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1984099|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1984100|NCT01024920|Sunitinib|sunitinib|mesh-list
1984101|NCT01024920|Nintedanib|nintedanib|mesh-list
1984102|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984103|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1984104|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1984105|NCT01024920|Growth Substances|growth substances|mesh-ancestor
1984106|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984107|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
1984108|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1984109|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984110|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984111|NCT01024946|Everolimus|everolimus|mesh-list
1984112|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745710|NCT02735707|Enalapril|enalapril|mesh-list
2745711|NCT02735707|Lisinopril|lisinopril|mesh-list
1984113|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984114|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
1984115|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984116|NCT01024972|Mannitol|mannitol|mesh-list
1984117|NCT01024972|Dantrolene|dantrolene|mesh-list
1984118|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1984119|NCT01024972|Diuretics|diuretics|mesh-ancestor
1984120|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
1984121|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984122|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1984123|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1984124|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984125|NCT01025154|Cytarabine|cytarabine|mesh-list
1984126|NCT01025154|Clofarabine|clofarabine|mesh-list
1984127|NCT01025154|Idarubicin|idarubicin|mesh-list
1984128|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1984129|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
1984130|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984131|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984132|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
1984133|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984134|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984135|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
1984136|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984137|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1984138|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1984139|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1984140|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984141|NCT01025193|Belimumab|belimumab|mesh-list
1984142|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984143|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
1984144|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984145|NCT01025232|Ranibizumab|ranibizumab|mesh-list
1984146|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1984147|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1984148|NCT01025232|Growth Substances|growth substances|mesh-ancestor
1984149|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984150|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
1984151|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984152|NCT01025284|Sargramostim|sargramostim|mesh-list
1984153|NCT01025284|Lenograstim|lenograstim|mesh-list
1984154|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
1984155|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984156|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1984157|NCT01025427|Tenofovir|tenofovir|mesh-list
1984158|NCT01025427|Emtricitabine|emtricitabine|mesh-list
1984159|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
1984160|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
1984161|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984162|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1984163|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1984164|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984165|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984166|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1984167|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1984168|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1984169|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1984170|NCT01025453|Sirolimus|sirolimus|mesh-list
1984171|NCT01025453|Sorafenib|sorafenib|mesh-list
1984172|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984173|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1984174|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984175|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984176|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1984177|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984178|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1984179|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
1984180|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984181|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
1984182|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984183|NCT01025635|Azelaic acid|azelaic acid|mesh-list
1984184|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984185|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
1984186|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
1984187|NCT01025817|Everolimus|everolimus|mesh-list
1984188|NCT01025817|Tacrolimus|tacrolimus|mesh-list
1984189|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984190|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
1984191|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984192|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1984193|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984194|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984195|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984196|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1984197|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1984198|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
1984199|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1984200|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984201|NCT01025830|Lamivudine|lamivudine|mesh-list
1984202|NCT01025830|Nevirapine|nevirapine|mesh-list
1984203|NCT01025830|Stavudine|stavudine|mesh-list
1984204|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
1984205|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1984206|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1984207|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984208|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984209|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
1984210|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984211|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1984212|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1984213|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1984214|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1984215|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
1984216|NCT01025843|Candesartan|candesartan|mesh-list
1984217|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
1984218|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1984219|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1984220|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1984221|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984222|NCT01026012|Regadenoson|regadenoson|mesh-list
1984223|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1984224|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1984225|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
1984226|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
1984227|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984228|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984229|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984230|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1984231|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
1984232|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984233|NCT01026142|Capecitabine|capecitabine|mesh-list
1984234|NCT01026142|Trastuzumab|trastuzumab|mesh-list
1984235|NCT01026142|Pertuzumab|pertuzumab|mesh-list
1984236|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1984237|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
1984238|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984239|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984240|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1984241|NCT01026194|Pioglitazone|pioglitazone|mesh-list
1984242|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1984243|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745712|NCT02735707|Irbesartan|irbesartan|mesh-list
2745713|NCT02735707|Perindopril|perindopril|mesh-list
2745714|NCT02735707|Captopril|captopril|mesh-list
2745715|NCT02735707|Trandolapril|trandolapril|mesh-list
2745716|NCT02735707|Clopidogrel|clopidogrel|mesh-list
2745717|NCT02735707|Ticagrelor|ticagrelor|mesh-list
2745718|NCT02735707|Simvastatin|simvastatin|mesh-list
2745719|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2745720|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
2745721|NCT02735707|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2745722|NCT02735707|Antibodies|antibodies|mesh-list
2745723|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2745724|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2745725|NCT02735707|Cysteamine|cysteamine|mesh-list
2745726|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
2745727|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745728|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745729|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2745730|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2745731|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2745732|NCT02735707|Analgesics|analgesics|mesh-ancestor
2745733|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
2745734|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2745735|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2745736|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2745737|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2745738|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2745739|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745740|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2745741|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2745742|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
2745743|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1984276|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
1984277|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1984278|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984279|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984280|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
1984281|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
1984282|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
1984283|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984284|NCT01026454|Valacyclovir|valacyclovir|mesh-list
1984285|NCT01026454|Acyclovir|acyclovir|mesh-list
1984286|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
1984287|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984288|NCT01026493|Temozolomide|temozolomide|mesh-list
1984289|NCT01026493|Veliparib|veliparib|mesh-list
1984290|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1984291|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
1984292|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984293|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984294|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1984295|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984296|NCT01026623|Sirolimus|sirolimus|mesh-list
1984297|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1984298|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1984299|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984300|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1984301|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984302|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
1984303|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984304|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
1984305|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984306|NCT01026792|Sirolimus|sirolimus|mesh-list
1984307|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1984308|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984309|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1984310|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984311|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
1984312|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984313|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
1984314|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984315|NCT01026818|Tadalafil|tadalafil|mesh-list
1984316|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
1984317|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1984318|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1984319|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984320|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984321|NCT01026818|Urological Agents|urological agents|mesh-ancestor
1984322|NCT01026831|Timolol|timolol|mesh-list
1984323|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1984324|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1984325|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
1984326|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984327|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984328|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984329|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1984330|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1984331|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
1984332|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1984333|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984334|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1984335|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984336|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984337|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
1984338|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1984339|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1984340|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984341|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1984342|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1984343|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1984344|NCT01026948|Dinoprostone|dinoprostone|mesh-list
1984345|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
1984346|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1984347|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984348|NCT01027000|Sirolimus|sirolimus|mesh-list
1984349|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
1984350|NCT01027000|Busulfan|busulfan|mesh-list
1984351|NCT01027000|Rituximab|rituximab|mesh-list
1984352|NCT01027000|Methotrexate|methotrexate|mesh-list
1984353|NCT01027000|Fludarabine|fludarabine|mesh-list
1984354|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
1984355|NCT01027000|Tacrolimus|tacrolimus|mesh-list
1984356|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984357|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
1984358|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984359|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1984360|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1984361|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
1984362|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984363|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984364|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1984365|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1984366|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1984367|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
1984368|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1984369|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1984370|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
1984371|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
1984372|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984373|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1984374|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1984375|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1984376|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1984377|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984378|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1984379|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
1984380|NCT01027351|Vaccines|vaccines|mesh-list
1984381|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
1984382|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984383|NCT01027416|Tamoxifen|tamoxifen|mesh-list
1984384|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1984385|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
1984386|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1984387|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984388|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1984389|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984390|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1984391|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1984392|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1984393|NCT01027468|Bevacizumab|bevacizumab|mesh-list
1984394|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1984395|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984396|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1984397|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1984398|NCT01027468|Growth Substances|growth substances|mesh-ancestor
1984399|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984400|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
1984401|NCT01027559|Sertraline|sertraline|mesh-list
1984402|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
1984403|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1984404|NCT01027559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1984405|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1984406|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1984407|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984408|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984409|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
1984410|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984411|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1984412|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984413|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1984414|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984415|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984416|NCT01027650|Dexamethasone|dexamethasone|mesh-list
1984417|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1984418|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
1984419|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
1984420|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984421|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984422|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1984423|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
1984424|NCT01027650|Hormones|hormones|mesh-ancestor
1984425|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1984426|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1984427|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984428|NCT01027754|Varenicline|varenicline|mesh-list
1984429|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1984430|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1984431|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
1984432|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984433|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984434|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984435|NCT01027793|Tretinoin|tretinoin|mesh-list
1984436|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984437|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
1984438|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
1984439|NCT01027806|Montelukast|montelukast|mesh-list
1984440|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1984441|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
1984442|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1984443|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
1984444|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1984445|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984446|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1984447|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1984448|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984449|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1984450|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
1984451|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984452|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
1984453|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1984454|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984455|NCT01027884|Idebenone|idebenone|mesh-list
1984456|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
1984457|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984458|NCT01027884|Protective Agents|protective agents|mesh-ancestor
1984459|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984460|NCT01027897|Doripenem|doripenem|mesh-list
1984461|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1984462|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984463|NCT01027910|Doxorubicin|doxorubicin|mesh-list
1984464|NCT01027910|Abexinostat|abexinostat|mesh-list
1984465|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1984466|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984467|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1984468|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1984469|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984470|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984471|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1984472|NCT01027949|Treprostinil|treprostinil|mesh-list
1984473|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1984474|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
1984475|NCT01028014|Ephedrine|ephedrine|mesh-list
1984476|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
1984477|NCT01028014|Imipramine|imipramine|mesh-list
1984478|NCT01028014|Tamsulosin|tamsulosin|mesh-list
1984479|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
1984480|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1984481|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1984482|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1984483|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
1984484|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984485|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984486|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984487|NCT01028014|Urological Agents|urological agents|mesh-ancestor
1984488|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1984489|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1984490|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
1984491|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1984492|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
1984493|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984494|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1984495|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
1984496|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
1984497|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1984498|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1984499|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
1984500|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1984501|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
1984502|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1984503|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1984504|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1984505|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1984506|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1984507|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1984508|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1984509|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1984510|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
1984511|NCT01028027|Tobramycin|tobramycin|mesh-list
1984512|NCT01028027|Dexamethasone|dexamethasone|mesh-list
1984513|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1984514|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
1984515|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
1984516|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984517|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984518|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1984519|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
1984520|NCT01028027|Hormones|hormones|mesh-ancestor
1984521|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1984522|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1984523|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984524|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1984525|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984526|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1984527|NCT01028053|Flutemetamol|flutemetamol|mesh-list
1984528|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1984529|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984530|NCT01028222|Dacarbazine|dacarbazine|mesh-list
1984531|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1984532|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
1984533|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984534|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984535|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1984536|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1984537|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1984538|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1984539|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984540|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984541|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984542|NCT01028352|Analgesics|analgesics|mesh-ancestor
1984543|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
1984544|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984545|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
1984546|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1984547|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
1984548|NCT01028391|Metformin|metformin|mesh-list
1984549|NCT01028391|Pioglitazone|pioglitazone|mesh-list
1984550|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1984551|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1984552|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984553|NCT01028391|Incretins|incretins|mesh-ancestor
1984554|NCT01028391|Hormones|hormones|mesh-ancestor
1984555|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1984556|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1984557|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
1984558|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984559|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984560|NCT01028651|Treprostinil|treprostinil|mesh-list
1984561|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1984562|NCT01028677|Oxytocin|oxytocin|mesh-list
1984563|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
1984564|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1984565|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984566|NCT01028820|Aripiprazole|aripiprazole|mesh-list
1984567|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
1984568|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1984569|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1984570|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1984571|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1984572|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984573|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
1984574|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
1984575|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984576|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984577|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1984578|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1984579|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
1984580|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1984581|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1984582|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1984583|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1984584|NCT01029054|Dexamethasone|dexamethasone|mesh-list
1984585|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
1984586|NCT01029054|Lenalidomide|lenalidomide|mesh-list
1984587|NCT01029054|BB 1101|bb 1101|mesh-list
1984588|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1984589|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
1984590|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
1984591|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984592|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984593|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1984594|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
1984595|NCT01029054|Hormones|hormones|mesh-ancestor
1984596|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1984597|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1984598|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984599|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
1984600|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984601|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984602|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
1984603|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1984604|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1984605|NCT01029054|Growth Substances|growth substances|mesh-ancestor
1984606|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
1984607|NCT01029262|Lenalidomide|lenalidomide|mesh-list
1984608|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
1984609|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984610|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1984611|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1984612|NCT01029262|Growth Substances|growth substances|mesh-ancestor
1984613|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
1984614|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984615|NCT01029340|Factor VIII|factor viii|mesh-list
1984616|NCT01029340|Coagulants|coagulants|mesh-ancestor
1984617|NCT01029392|Vitamin D|vitamin d|mesh-list
1984618|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
1984619|NCT01029392|Vitamins|vitamins|mesh-ancestor
1984620|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
1984621|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984622|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1984623|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1984624|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
1984625|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1984626|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
1984627|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984628|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
1984629|NCT01029535|Protective Agents|protective agents|mesh-ancestor
1984630|NCT01029587|Eculizumab|eculizumab|mesh-list
1984631|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1984632|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984633|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
1984634|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984635|NCT01029652|Triamcinolone|triamcinolone|mesh-list
1984636|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1984637|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1984638|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1984639|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1984640|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1984641|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
1984642|NCT01029652|Hormones|hormones|mesh-ancestor
1984643|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1984644|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984645|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984646|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
1984647|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984648|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984649|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
1984650|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984651|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1984652|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984653|NCT01029730|Rituximab|rituximab|mesh-list
1984654|NCT01029730|Bortezomib|bortezomib|mesh-list
1984655|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1984656|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1984657|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984658|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
1984659|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984660|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1984661|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1984662|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
1984663|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984664|NCT01029782|Cefazolin|cefazolin|mesh-list
1984665|NCT01029782|Cephalexin|cephalexin|mesh-list
1984666|NCT01029782|Probenecid|probenecid|mesh-list
1984667|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1984668|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984669|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
1984670|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
1984671|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1984672|NCT01029782|Renal Agents|renal agents|mesh-ancestor
1984673|NCT01029795|Glyburide|glyburide|mesh-list
1984674|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1984675|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984676|NCT01029886|Liraglutide|liraglutide|mesh-list
1984677|NCT01029886|Exenatide|exenatide|mesh-list
1984678|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1984679|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984680|NCT01029886|Incretins|incretins|mesh-ancestor
1984681|NCT01029886|Hormones|hormones|mesh-ancestor
1984682|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1984683|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1984684|NCT01030341|Insulin|insulin|mesh-list
1984685|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1984686|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1984687|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984688|NCT01030458|Amlodipine|amlodipine|mesh-list
1984689|NCT01030458|Valsartan|valsartan|mesh-list
1984690|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1984691|NCT01030458|Bisoprolol|bisoprolol|mesh-list
1984692|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1984693|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1984694|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1984695|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984696|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1984697|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984698|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
1984699|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1984700|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1984701|NCT01030458|Diuretics|diuretics|mesh-ancestor
1984702|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
1984703|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1984704|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
1984705|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
1984706|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984707|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1984708|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1984709|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1984710|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
1984711|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984712|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
1984713|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984714|NCT01030575|Inositol|inositol|mesh-list
1984715|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
1984716|NCT01030575|Vitamins|vitamins|mesh-ancestor
1984717|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
1984718|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984719|NCT01030653|Voriconazole|voriconazole|mesh-list
1984720|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
1984721|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984722|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1984723|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1984724|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984725|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984726|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1984727|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
1984728|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1984729|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984730|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1984731|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
1984732|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1984733|NCT01030666|Doxycycline|doxycycline|mesh-list
1984734|NCT01030666|Ibuprofen|ibuprofen|mesh-list
1984735|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1984736|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1984737|NCT01030666|Analgesics|analgesics|mesh-ancestor
1984738|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
1984739|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984740|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984741|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1984742|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1984743|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1984744|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984745|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984746|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1984747|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984748|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
1984749|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
1984750|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1984751|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
1984752|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1984753|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1984754|NCT01030718|Dasatinib|dasatinib|mesh-list
1984755|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984756|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1984757|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984758|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984759|NCT01030783|Sorafenib|sorafenib|mesh-list
1984760|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984761|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1984762|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984763|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984764|NCT01030822|Vaccines|vaccines|mesh-list
1984765|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1984766|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
1984767|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984768|NCT01030952|Acarbose|acarbose|mesh-list
1984769|NCT01030952|Nateglinide|nateglinide|mesh-list
1984770|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
1984771|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984772|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984773|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1984774|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984775|NCT01031043|Bethanechol|bethanechol|mesh-list
1984776|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1984777|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
1984778|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984779|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984780|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
1984781|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1984782|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
1984783|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984784|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984785|NCT01031069|Vaccines|vaccines|mesh-list
1984786|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
1984787|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984788|NCT01031381|Bevacizumab|bevacizumab|mesh-list
1984789|NCT01031381|Everolimus|everolimus|mesh-list
1984790|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1984791|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984792|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1984793|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1984794|NCT01031381|Growth Substances|growth substances|mesh-ancestor
1984795|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984796|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
1984797|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984798|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
1984799|NCT01031420|Doxorubicin|doxorubicin|mesh-list
1984800|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1984801|NCT01031420|Methotrexate|methotrexate|mesh-list
1984802|NCT01031420|Vinblastine|vinblastine|mesh-list
1984803|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1984804|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984805|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1984806|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1984807|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984808|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984809|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1984810|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
1984811|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1984812|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984813|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1984814|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
1984815|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
1984816|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1984817|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984818|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
1984819|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1984820|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1984821|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1984822|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
1984823|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
1984824|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
1984825|NCT01031446|Paclitaxel|paclitaxel|mesh-list
1984826|NCT01031446|Everolimus|everolimus|mesh-list
1984827|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1984828|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984829|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
1984830|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
1984831|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
1984832|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984833|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1984834|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
1984835|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984836|NCT01031498|Ondansetron|ondansetron|mesh-list
1984837|NCT01031498|Palonosetron|palonosetron|mesh-list
1984838|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
1984839|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
1984840|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984841|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984842|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1984843|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
1984844|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
1984845|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1984846|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
1984847|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984848|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984849|NCT01031498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1984850|NCT01031498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1984851|NCT01031498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1984852|NCT01031498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1984853|NCT01031498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1984854|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1984855|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
1984856|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1984857|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984858|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1984859|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984860|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
1984861|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
1984862|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1984863|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1984864|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984865|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984866|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1984867|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1984868|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1984869|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984870|NCT01031836|Sifalimumab|sifalimumab|mesh-list
1984871|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1984872|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
1984873|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984874|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
1984875|NCT01031953|Aprepitant|aprepitant|mesh-list
1984876|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
1984877|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
1984878|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984879|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984880|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1984881|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1984882|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984883|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984884|NCT01031979|Yohimbine|yohimbine|mesh-list
1984885|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
1984886|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
1984887|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984888|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984889|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1984890|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1984891|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1984892|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
1984893|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984894|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984895|NCT01031979|Urological Agents|urological agents|mesh-ancestor
1984896|NCT01032018|Bupropion|bupropion|mesh-list
1984897|NCT01032018|Citalopram|citalopram|mesh-list
1984898|NCT01032018|Sertraline|sertraline|mesh-list
1984899|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1984900|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
1984901|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1984902|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1984903|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1984904|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1984905|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984906|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
1984907|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984908|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984909|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1984910|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1984911|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984912|NCT01032018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1984913|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
1984914|NCT01032070|Etoposide|etoposide|mesh-list
1984915|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1984916|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1984917|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984918|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1984919|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1984920|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984921|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984922|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1984923|NCT01032174|Azithromycin|azithromycin|mesh-list
1984924|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1984925|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984926|NCT01032200|Modafinil|modafinil|mesh-list
1984927|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1984928|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984929|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1984930|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1984931|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1984932|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984933|NCT01032239|Baclofen|baclofen|mesh-list
1984934|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1984935|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984936|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1984937|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1984938|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
1984939|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
1984940|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
1984941|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984942|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984943|NCT01032291|Lenalidomide|lenalidomide|mesh-list
1984944|NCT01032291|Cetuximab|cetuximab|mesh-list
1984945|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
1984946|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984947|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1984948|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1984949|NCT01032291|Growth Substances|growth substances|mesh-ancestor
1984950|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
1984951|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984952|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1984953|NCT01032382|Gentamicins|gentamicins|mesh-list
1984954|NCT01032382|Paromomycin|paromomycin|mesh-list
1984955|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1984956|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984957|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1984958|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984959|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984960|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1984961|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1984962|NCT01032629|Canagliflozin|canagliflozin|mesh-list
1984963|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1984964|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984965|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1984966|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984967|NCT01032694|Azithromycin|azithromycin|mesh-list
1984968|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1984969|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984970|NCT01032759|Memantine|memantine|mesh-list
1984971|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1984972|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1984973|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
1984974|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1984975|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984976|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984977|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1984978|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1984979|NCT01032837|Oseltamivir|oseltamivir|mesh-list
1984980|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
1984981|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1984982|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984983|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984984|NCT01032850|Capecitabine|capecitabine|mesh-list
1984985|NCT01032850|Sorafenib|sorafenib|mesh-list
1984986|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1984987|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
1984988|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1984989|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1984990|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1984991|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1984992|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
1984993|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1984994|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1984995|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1984996|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
1984997|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1984998|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
1984999|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1985000|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1985001|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985002|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
1985003|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985004|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985005|NCT01032993|Ubiquinone|ubiquinone|mesh-list
1985006|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
1985007|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
1985008|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985009|NCT01032993|Vitamins|vitamins|mesh-ancestor
1985010|NCT01033032|Amrubicin|amrubicin|mesh-list
1985011|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985012|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1985013|NCT01033071|Olmesartan|olmesartan|mesh-list
1985014|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1985015|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
1985016|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1985017|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1985018|NCT01033071|Diuretics|diuretics|mesh-ancestor
1985019|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
1985020|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985021|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1985022|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1985023|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985024|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1985025|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1985026|NCT01033240|Sorafenib|sorafenib|mesh-list
1985027|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985028|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1985029|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985030|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985031|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1985032|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
1985033|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985034|NCT01033565|Melatonin|melatonin|mesh-list
1985035|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
1985036|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985037|NCT01033565|Protective Agents|protective agents|mesh-ancestor
1985038|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985039|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1985040|NCT01033734|Oseltamivir|oseltamivir|mesh-list
1985041|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
1985042|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985043|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985044|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985045|NCT01033747|Deferasirox|deferasirox|mesh-list
1985046|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1985047|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
1985048|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
1985049|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985050|NCT01033773|Metformin|metformin|mesh-list
1985051|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
1985052|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985053|NCT01033825|Ciclesonide|ciclesonide|mesh-list
1985054|NCT01033825|Dexamethasone|dexamethasone|mesh-list
1985055|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
1985056|NCT01033825|BB 1101|bb 1101|mesh-list
1985057|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1985058|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
1985059|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
1985060|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985061|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985062|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1985063|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
1985064|NCT01033825|Hormones|hormones|mesh-ancestor
1985065|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1985066|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1985067|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985068|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
1985069|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985070|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985071|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1985072|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
1985073|NCT01033864|Prednisone|prednisone|mesh-list
1985074|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1985075|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
1985076|NCT01033864|Hormones|hormones|mesh-ancestor
1985077|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1985078|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985079|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1985080|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985081|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1985082|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1985083|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
1985084|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1985085|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985086|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985087|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985088|NCT01033942|Tenofovir|tenofovir|mesh-list
1985089|NCT01033942|Emtricitabine|emtricitabine|mesh-list
1985090|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
1985091|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985092|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1985093|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1985094|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985095|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985096|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1985097|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1985098|NCT01034111|Metformin|metformin|mesh-list
1985099|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1985100|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1985101|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985102|NCT01034111|Incretins|incretins|mesh-ancestor
1985103|NCT01034111|Hormones|hormones|mesh-ancestor
1985104|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1985105|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1985106|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
1985107|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985108|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985109|NCT01034137|Methotrexate|methotrexate|mesh-list
1985110|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1985111|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
1985112|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1985113|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985114|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1985115|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
1985116|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985117|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985118|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
1985119|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985120|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1985121|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1985122|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
1985123|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1985124|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1985125|NCT01034163|Panobinostat|panobinostat|mesh-list
1985126|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985127|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1985128|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985129|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985130|NCT01034176|Levofloxacin|levofloxacin|mesh-list
1985131|NCT01034176|Ofloxacin|ofloxacin|mesh-list
1985132|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1985133|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985134|NCT01034176|Renal Agents|renal agents|mesh-ancestor
1985135|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1985136|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1985137|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1985138|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985139|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985140|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985141|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1985142|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1985143|NCT01034462|Milnacipran|milnacipran|mesh-list
1985144|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
1985145|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1985146|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1985147|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1985148|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985149|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985150|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985151|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
1985152|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1985153|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1985154|NCT01034462|Analgesics|analgesics|mesh-ancestor
1985155|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
1985156|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985157|NCT01034553|Bortezomib|bortezomib|mesh-list
1985158|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985159|NCT01034592|Lenalidomide|lenalidomide|mesh-list
1985160|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
1985161|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985162|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1985163|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1985164|NCT01034592|Growth Substances|growth substances|mesh-ancestor
1985165|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
1985166|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985167|NCT01034631|Everolimus|everolimus|mesh-list
1985168|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985169|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1985170|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
1985171|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985172|NCT01034657|Panobinostat|panobinostat|mesh-list
1985173|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
1985174|NCT01034657|Hematinics|hematinics|mesh-ancestor
1985175|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985176|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1985177|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985178|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985179|NCT01035099|Letrozole|letrozole|mesh-list
1985180|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985181|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1985182|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1985183|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985184|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985185|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1985186|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
1985187|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1985188|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985189|NCT01035229|Everolimus|everolimus|mesh-list
1985190|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985191|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1985192|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
1985193|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985194|NCT01035255|Enalapril|enalapril|mesh-list
1985195|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1985196|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1985197|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
1985198|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985199|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985200|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1985201|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1985202|NCT01035333|Orlistat|orlistat|mesh-list
1985203|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985204|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985205|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1985206|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1985207|NCT01035346|Ibuprofen|ibuprofen|mesh-list
1985208|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1985209|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1985210|NCT01035346|Analgesics|analgesics|mesh-ancestor
1985211|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
1985212|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985213|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985214|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1985215|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1985216|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1985217|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985218|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985219|NCT01035463|Cytarabine|cytarabine|mesh-list
1985220|NCT01035463|Rituximab|rituximab|mesh-list
1985221|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1985222|NCT01035463|Etoposide|etoposide|mesh-list
1985223|NCT01035463|Lenalidomide|lenalidomide|mesh-list
1985224|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
1985225|NCT01035463|Melphalan|melphalan|mesh-list
1985226|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
1985227|NCT01035463|Carmustine|carmustine|mesh-list
1985228|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
1985229|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1985230|NCT01035463|Antibodies|antibodies|mesh-list
1985231|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
1985232|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1985233|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
1985234|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985235|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985236|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1985237|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1985238|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1985239|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1985240|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985241|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985242|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1985243|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
1985244|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
1985245|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985246|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1985247|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1985248|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1985249|NCT01035463|Growth Substances|growth substances|mesh-ancestor
1985250|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
1985251|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1985252|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
1985253|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1985254|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
1985255|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
1985256|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
1985257|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
1985258|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
1985259|NCT01035658|Doxorubicin|doxorubicin|mesh-list
1985260|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1985261|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1985262|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985263|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1985264|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1985265|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985266|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985267|NCT01035749|Vaccines|vaccines|mesh-list
1985268|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
1985269|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985270|NCT01036594|Ketoconazole|ketoconazole|mesh-list
1985271|NCT01036594|Dexamethasone|dexamethasone|mesh-list
1985272|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
1985273|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
1985274|NCT01036594|BB 1101|bb 1101|mesh-list
1985275|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1985276|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
1985277|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
1985278|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985279|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985280|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1985281|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
1985282|NCT01036594|Hormones|hormones|mesh-ancestor
1985283|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1985284|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1985285|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985286|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
1985287|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985288|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985289|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
1985290|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985291|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1985292|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1985293|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1985294|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
1985295|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1985296|NCT01036802|Warfarin|warfarin|mesh-list
1985297|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
1985298|NCT01037127|Trametinib|trametinib|mesh-list
1985299|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985300|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1985301|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985302|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985303|NCT01037192|Vancomycin|vancomycin|mesh-list
1985304|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1985305|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985306|NCT01037218|Udenafil|udenafil|mesh-list
1985307|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1985308|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1985309|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985310|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985311|NCT01037244|Udenafil|udenafil|mesh-list
1985312|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1985313|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1985314|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985315|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985316|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
1985317|NCT01037452|Lansoprazole|lansoprazole|mesh-list
1985318|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
1985319|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
1985320|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
1985321|NCT01037452|Calcium|calcium|mesh-list
1985322|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1985323|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985324|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1985325|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1985326|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1985327|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1985328|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985329|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985330|NCT01037452|Antacids|antacids|mesh-ancestor
1985331|NCT01037790|Palbociclib|palbociclib|mesh-list
1985332|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985333|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1985334|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985335|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985336|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
1985337|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1985338|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1985339|NCT01037881|Analgesics|analgesics|mesh-ancestor
1985340|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
1985341|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985342|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985343|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1985344|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1985345|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
1985346|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1985347|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
1985348|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1985349|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985350|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985351|NCT01038128|Memantine|memantine|mesh-list
1985352|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1985353|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1985354|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
1985355|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985356|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985357|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985358|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1985359|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1985360|NCT01038323|Milnacipran|milnacipran|mesh-list
1985361|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
1985362|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1985363|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1985364|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1985365|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985366|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985367|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985368|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1985369|NCT01038323|Analgesics|analgesics|mesh-ancestor
1985370|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
1985371|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985372|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
1985373|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1985374|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
1985375|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1985376|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
1985377|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1985378|NCT01038609|Acetaminophen|acetaminophen|mesh-list
1985379|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
1985380|NCT01038609|Morphine|morphine|mesh-list
1985381|NCT01038609|Hydrocodone|hydrocodone|mesh-list
1985382|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1985383|NCT01038609|Narcotics|narcotics|mesh-ancestor
1985384|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1985385|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985386|NCT01038609|Analgesics|analgesics|mesh-ancestor
1985387|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
1985388|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985389|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1985390|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
1985391|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
1985392|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
1985393|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1985394|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1985395|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1985396|NCT01038635|Lenalidomide|lenalidomide|mesh-list
1985397|NCT01038635|Azacitidine|azacitidine|mesh-list
1985398|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
1985399|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985400|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1985401|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1985402|NCT01038635|Growth Substances|growth substances|mesh-ancestor
1985403|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
1985404|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985405|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1985406|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
1985407|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985408|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985409|NCT01038778|Aldesleukin|aldesleukin|mesh-list
1985410|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
1985411|NCT01038778|Interleukin-2|interleukin-2|mesh-list
1985412|NCT01038778|Entinostat|entinostat|mesh-list
1985413|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1985414|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
1985415|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985416|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1985417|NCT01038778|Analgesics|analgesics|mesh-ancestor
1985418|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
1985419|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985420|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985421|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1985422|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1985423|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
1985424|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985425|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1985426|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985427|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985428|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
1985429|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1985430|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985431|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1985432|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985433|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985434|NCT01038869|Azelaic acid|azelaic acid|mesh-list
1985435|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985436|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
1985437|NCT01038921|Melatonin|melatonin|mesh-list
1985438|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
1985439|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985440|NCT01038921|Protective Agents|protective agents|mesh-ancestor
1985441|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985442|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1985443|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1985444|NCT01039207|Rilotumumab|rilotumumab|mesh-list
1985445|NCT01039207|Antibodies|antibodies|mesh-list
1985446|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
1985447|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1985448|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
1985449|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985450|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985451|NCT01039376|Ofatumumab|ofatumumab|mesh-list
1985452|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985453|NCT01039584|Butoconazole|butoconazole|mesh-list
1985454|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
1985455|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985456|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
1985457|NCT01039688|Tofacitinib|tofacitinib|mesh-list
1985458|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1985459|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985460|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985461|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
1985462|NCT01039792|Vitamins|vitamins|mesh-ancestor
1985463|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
1985464|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985465|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
1985466|NCT01040130|Olodaterol|olodaterol|mesh-list
1985467|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1985468|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
1985469|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985470|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985471|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1985472|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
1985473|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
1985474|NCT01040169|Calcium|calcium|mesh-list
1985475|NCT01040169|Fluorides|fluorides|mesh-list
1985476|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1985477|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985478|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
1985479|NCT01040169|Protective Agents|protective agents|mesh-ancestor
1985480|NCT01040169|Antacids|antacids|mesh-ancestor
1985481|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985482|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1985483|NCT01040260|Nicotine|nicotine|mesh-list
1985484|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1985485|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
1985486|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985487|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985488|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1985489|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1985490|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
1985491|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985492|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985493|NCT01040403|Bromides|bromides|mesh-list
1985494|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
1985495|NCT01040403|Olodaterol|olodaterol|mesh-list
1985496|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1985497|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
1985498|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985499|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985500|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1985501|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
1985502|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
1985503|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1985504|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
1985505|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985506|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985507|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
1985508|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
1985509|NCT01040689|Olodaterol|olodaterol|mesh-list
1985510|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1985511|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
1985512|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985513|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985514|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1985515|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
1985516|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
1985517|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1985518|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
1985519|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985520|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985521|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
1985522|NCT01040728|Olodaterol|olodaterol|mesh-list
1985523|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1985524|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
1985525|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985526|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985527|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1985528|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
1985529|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
1985530|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1985531|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
1985532|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985533|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985534|NCT01040780|Gefitinib|gefitinib|mesh-list
1985535|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985536|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1985537|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985538|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985539|NCT01040793|Olodaterol|olodaterol|mesh-list
1985540|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1985541|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
1985542|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985543|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985544|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1985545|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
1985546|NCT01040819|Pioglitazone|pioglitazone|mesh-list
1985547|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1985548|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985549|NCT01040832|Cetuximab|cetuximab|mesh-list
1985550|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1985551|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985552|NCT01040845|Colchicine|colchicine|mesh-list
1985553|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1985554|NCT01040845|Norethindrone|norethindrone|mesh-list
1985555|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
1985556|NCT01040845|Estradiol|estradiol|mesh-list
1985557|NCT01040845|Estrogens|estrogens|mesh-ancestor
1985558|NCT01040845|Hormones|hormones|mesh-ancestor
1985559|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1985560|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985561|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1985562|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
1985563|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1985564|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1985565|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
1985566|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1985567|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
1985568|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
1985569|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
1985570|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985571|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985572|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1985573|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1985574|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1985575|NCT01040871|Prednisone|prednisone|mesh-list
1985576|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
1985577|NCT01040871|Rituximab|rituximab|mesh-list
1985578|NCT01040871|Doxorubicin|doxorubicin|mesh-list
1985579|NCT01040871|Vincristine|vincristine|mesh-list
1985580|NCT01040871|Bortezomib|bortezomib|mesh-list
1985581|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1985582|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
1985583|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985584|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1985585|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1985586|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
1985587|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985588|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985589|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1985590|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1985591|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1985592|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1985593|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1985594|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985595|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1985596|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
1985597|NCT01040871|Hormones|hormones|mesh-ancestor
1985598|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1985599|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1985600|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1985601|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
1985602|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
1985603|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
1985604|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1985605|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985606|NCT01041274|Citalopram|citalopram|mesh-list
1985607|NCT01041274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1985608|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1985609|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1985610|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985611|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985612|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
1985613|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985614|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1985615|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
1985616|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1985617|NCT01041287|Metoprolol|metoprolol|mesh-list
1985618|NCT01041287|Nebivolol|nebivolol|mesh-list
1985619|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1985620|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1985621|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
1985622|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
1985623|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985624|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985625|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1985626|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1985627|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1985628|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
1985629|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985630|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985631|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
1985632|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1985633|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1985634|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1985635|NCT01041404|Fluorouracil|fluorouracil|mesh-list
1985636|NCT01041404|Capecitabine|capecitabine|mesh-list
1985637|NCT01041404|Trastuzumab|trastuzumab|mesh-list
1985638|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985639|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
1985640|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985641|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1985642|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1985643|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
1985644|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985645|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1985646|NCT01041417|Molgramostim|molgramostim|mesh-list
1985647|NCT01041417|Sargramostim|sargramostim|mesh-list
1985648|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
1985649|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985650|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985651|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
1985652|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1985653|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
1985654|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1985655|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1985656|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985657|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1985658|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985659|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1985660|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1985661|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1985662|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
1985663|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985664|NCT01041638|Vitamin A|vitamin a|mesh-list
1985665|NCT01041638|Aldesleukin|aldesleukin|mesh-list
1985666|NCT01041638|Interleukin-2|interleukin-2|mesh-list
1985667|NCT01041638|Tretinoin|tretinoin|mesh-list
1985668|NCT01041638|Dinutuximab|dinutuximab|mesh-list
1985669|NCT01041638|Isotretinoin|isotretinoin|mesh-list
1985670|NCT01041638|Sargramostim|sargramostim|mesh-list
1985671|NCT01041638|Vitamins|vitamins|mesh-ancestor
1985672|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
1985673|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985674|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985675|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1985676|NCT01041638|Analgesics|analgesics|mesh-ancestor
1985677|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
1985678|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985679|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
1985680|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1985681|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1985682|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
1985683|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985684|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
1985685|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
1985686|NCT01041781|Gemcitabine|gemcitabine|mesh-list
1985687|NCT01041781|Celecoxib|celecoxib|mesh-list
1985688|NCT01041781|Carboplatin|carboplatin|mesh-list
1985689|NCT01041781|Pemetrexed|pemetrexed|mesh-list
1985690|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985691|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1985692|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
1985693|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985694|NCT01041781|Antiviral Agents|antiviral agents|mesh-ancestor
1985695|NCT01041781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985696|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985697|NCT01041781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1985698|NCT01041781|Immunologic Factors|immunologic factors|mesh-ancestor
1985699|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985700|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1985701|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1985702|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1985703|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1985704|NCT01041781|Analgesics|analgesics|mesh-ancestor
1985705|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
1985706|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985707|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1985708|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1985709|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1985710|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1985711|NCT01041859|Tapentadol|tapentadol|mesh-list
1985712|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1985713|NCT01041859|Narcotics|narcotics|mesh-ancestor
1985714|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1985715|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985716|NCT01041859|Analgesics|analgesics|mesh-ancestor
1985717|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
1985718|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985719|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1985720|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1985721|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1985722|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985723|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
1985724|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985725|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1985726|NCT01042093|Clonidine|clonidine|mesh-list
1985727|NCT01042093|Epinephrine|epinephrine|mesh-list
1985728|NCT01042093|Ropivacaine|ropivacaine|mesh-list
1985729|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
1985730|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
1985731|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1985732|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985733|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
1985734|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985735|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1985736|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1985737|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
1985738|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985739|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985740|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1985741|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1985742|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
1985743|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1985744|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
1985745|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
1985746|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
1985747|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1985748|NCT01042093|Analgesics|analgesics|mesh-ancestor
1985749|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1985750|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
1985751|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1985752|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1985753|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1985754|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1985755|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1985756|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1985757|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985758|NCT01042145|Dexamethasone|dexamethasone|mesh-list
1985759|NCT01042145|Prednisone|prednisone|mesh-list
1985760|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1985761|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
1985762|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
1985763|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985764|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985765|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1985766|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
1985767|NCT01042145|Hormones|hormones|mesh-ancestor
1985768|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1985769|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1985770|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985771|NCT01042158|Ambrisentan|ambrisentan|mesh-list
1985772|NCT01042158|Tadalafil|tadalafil|mesh-list
1985773|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
1985774|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1985775|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1985776|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985777|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985778|NCT01042158|Urological Agents|urological agents|mesh-ancestor
1985779|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1985780|NCT01042236|Fesoterodine|fesoterodine|mesh-list
1985781|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1985782|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1985783|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
1985784|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985785|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985786|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985787|NCT01042236|Urological Agents|urological agents|mesh-ancestor
1985788|NCT01042288|Carboplatin|carboplatin|mesh-list
1985789|NCT01042288|Pemetrexed|pemetrexed|mesh-list
1985790|NCT01042288|Panitumumab|panitumumab|mesh-list
1985791|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985792|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985793|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985794|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1985795|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1985796|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1985797|NCT01042366|Vaccines|vaccines|mesh-list
1985798|NCT01042366|Immunologic Factors|immunologic factors|mesh-ancestor
1985799|NCT01042366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985800|NCT01042392|Ramipril|ramipril|mesh-list
1985801|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1985802|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
1985803|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985804|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985805|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1985806|NCT01042496|Lamotrigine|lamotrigine|mesh-list
1985807|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
1985808|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1985809|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1985810|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985811|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1985812|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985813|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1985814|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1985815|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1985816|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1985817|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1985818|NCT01042509|Rituximab|rituximab|mesh-list
1985819|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
1985820|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1985821|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985822|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
1985823|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985824|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1985825|NCT01042535|Tryptophan|tryptophan|mesh-list
1985826|NCT01042535|Vaccines|vaccines|mesh-list
1985827|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
1985828|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985829|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1985830|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
1985831|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1985832|NCT01042795|Sunitinib|sunitinib|mesh-list
1985833|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985834|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1985835|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1985836|NCT01042795|Growth Substances|growth substances|mesh-ancestor
1985837|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985838|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
1985839|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1985840|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985841|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985842|NCT01042938|Curcumin|curcumin|mesh-list
1985843|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1985844|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1985845|NCT01042938|Analgesics|analgesics|mesh-ancestor
1985846|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
1985847|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985848|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985849|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1985850|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1985851|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985852|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985853|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985854|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
1985855|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1985856|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985857|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1985858|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985859|NCT01043094|Pitavastatin|pitavastatin|mesh-list
1985860|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1985861|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1985862|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1985863|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
1985864|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985865|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985866|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1985867|NCT01043185|Lesogaberan|lesogaberan|mesh-list
1985868|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1985869|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1985870|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
1985871|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
1985872|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985873|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985874|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985875|NCT01043393|Desoximetasone|desoximetasone|mesh-list
1985876|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1985877|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
1985878|NCT01043393|Hormones|hormones|mesh-ancestor
1985879|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1985880|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985881|NCT01043640|Cyclosporine|cyclosporine|mesh-list
1985882|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
1985883|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
1985884|NCT01043640|Busulfan|busulfan|mesh-list
1985885|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
1985886|NCT01043640|Cyclosporins|cyclosporins|mesh-list
1985887|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1985888|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
1985889|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985890|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1985891|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1985892|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
1985893|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985894|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985895|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1985896|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985897|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
1985898|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985899|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
1985900|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1985901|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1985902|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1985903|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
1985904|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1985905|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1985906|NCT01043926|Suvorexant|suvorexant|mesh-list
1985907|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1985908|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1985909|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1985910|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985911|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1985912|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985913|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985914|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
1985915|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
1985916|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1985917|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
1985918|NCT01044056|NuvaRing|nuvaring|mesh-list
1985919|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
1985920|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1985921|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985922|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1985923|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1985924|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1985925|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1985926|NCT01044056|Estrogens|estrogens|mesh-ancestor
1985927|NCT01044056|Hormones|hormones|mesh-ancestor
1985928|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1985929|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1985930|NCT01044212|Psyllium|psyllium|mesh-list
1985931|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
1985932|NCT01044212|Cathartics|cathartics|mesh-ancestor
1985933|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1985934|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
1985935|NCT01044264|Clindamycin|clindamycin|mesh-list
1985936|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
1985937|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
1985938|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1985939|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1985940|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985941|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1985942|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985943|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985944|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
1985945|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
1985946|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1985947|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985948|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1985949|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
1985950|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1985951|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1985952|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985953|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985954|NCT01044433|Capecitabine|capecitabine|mesh-list
1985955|NCT01044433|Lapatinib|lapatinib|mesh-list
1985956|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1985957|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
1985958|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985959|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1985960|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1985961|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985962|NCT01044459|Bromides|bromides|mesh-list
1985963|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
1985964|NCT01044498|Norinyl|norinyl|mesh-list
1985965|NCT01044498|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
1985966|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1985967|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1985968|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1985969|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
1985970|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1985971|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985972|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1985973|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1985974|NCT01044498|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
1985975|NCT01044498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1985976|NCT01044693|Metoprolol|metoprolol|mesh-list
1985977|NCT01044693|Nebivolol|nebivolol|mesh-list
1985978|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
1985979|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
1985980|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1985981|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1985982|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1985983|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1985984|NCT01044693|Urological Agents|urological agents|mesh-ancestor
1985985|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1985986|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1985987|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
1985988|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
1985989|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1985990|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1985991|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1985992|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1985993|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1985994|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
1985995|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1985996|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1985997|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1985998|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1985999|NCT01044706|Bicalutamide|bicalutamide|mesh-list
1986000|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
1986001|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
1986002|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986003|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986004|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986005|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
1986006|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
1986007|NCT01044745|Busulfan|busulfan|mesh-list
1986008|NCT01044745|Rituximab|rituximab|mesh-list
1986009|NCT01044745|Fludarabine|fludarabine|mesh-list
1986010|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
1986011|NCT01044745|Tacrolimus|tacrolimus|mesh-list
1986012|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
1986013|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1986014|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
1986015|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
1986016|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986017|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986018|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1986019|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
1986020|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986021|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986022|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1986023|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1986024|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1986025|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
1986026|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1986027|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986028|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1986029|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1986030|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
1986031|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1986032|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986033|NCT01044758|Levetiracetam|levetiracetam|mesh-list
1986034|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
1986035|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
1986036|NCT01044771|Tenofovir|tenofovir|mesh-list
1986037|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
1986038|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
1986039|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986040|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1986041|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1986042|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986043|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986044|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1986045|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1986046|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1986047|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1986048|NCT01044862|Letrozole|letrozole|mesh-list
1986049|NCT01044862|Clomiphene|clomiphene|mesh-list
1986050|NCT01044862|Enclomiphene|enclomiphene|mesh-list
1986051|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
1986052|NCT01044862|Hormones|hormones|mesh-list
1986053|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1986054|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1986055|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986056|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986057|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986058|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986059|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1986060|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986061|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1986062|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
1986063|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1986064|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
1986065|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1986066|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1986067|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1986068|NCT01044966|Temozolomide|temozolomide|mesh-list
1986069|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1986070|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
1986071|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986072|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986073|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
1986074|NCT01045096|Lansoprazole|lansoprazole|mesh-list
1986075|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1986076|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1986077|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1986078|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986079|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986080|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
1986081|NCT01045122|Propofol|propofol|mesh-list
1986082|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1986083|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1986084|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986085|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1986086|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
1986087|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
1986088|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1986089|NCT01045122|Analgesics|analgesics|mesh-ancestor
1986090|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
1986091|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986092|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1986093|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1986094|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1986095|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
1986096|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986097|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986098|NCT01045161|Bromides|bromides|mesh-list
1986099|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
1986100|NCT01045447|Insulin|insulin|mesh-list
1986101|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1986102|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
1986103|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
1986104|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1986105|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986106|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
1986107|NCT01045460|Melphalan|melphalan|mesh-list
1986108|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1986109|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
1986110|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986111|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986112|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1986113|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
1986114|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986115|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986116|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1986117|NCT01045551|Apremilast|apremilast|mesh-list
1986118|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1986119|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1986120|NCT01045551|Analgesics|analgesics|mesh-ancestor
1986121|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
1986122|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986123|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986124|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986125|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986126|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1986127|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1986128|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986129|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986130|NCT01045707|Insulin|insulin|mesh-list
1986131|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1986132|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
1986133|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
1986134|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1986135|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986136|NCT01045798|Caspofungin|caspofungin|mesh-list
1986137|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
1986138|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986139|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986140|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986141|NCT01045967|Lansoprazole|lansoprazole|mesh-list
1986142|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
1986143|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1986144|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1986145|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1986146|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986147|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986148|NCT01045993|Analgesics|analgesics|mesh-list
1986149|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
1986150|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986151|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986152|NCT01046084|Lansoprazole|lansoprazole|mesh-list
1986153|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
1986154|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1986155|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1986156|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1986157|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986158|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986159|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1986160|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1986161|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986162|NCT01046110|Incretins|incretins|mesh-ancestor
1986163|NCT01046110|Hormones|hormones|mesh-ancestor
1986164|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986165|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1986166|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
1986167|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986168|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986169|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
1986170|NCT01046136|Guaifenesin|guaifenesin|mesh-list
1986171|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
1986172|NCT01046136|Expectorants|expectorants|mesh-ancestor
1986173|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
1986174|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1986175|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1986176|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
1986177|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986178|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986179|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986180|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
1986181|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1986182|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
1986183|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
1986184|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986185|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
1986186|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1986187|NCT01046253|Lansoprazole|lansoprazole|mesh-list
1986188|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
1986189|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1986190|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1986191|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1986192|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986193|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986194|NCT01046396|Adapalene|adapalene|mesh-list
1986195|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1986196|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1986197|NCT01046396|Analgesics|analgesics|mesh-ancestor
1986198|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
1986199|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986200|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986201|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986202|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986203|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
1986204|NCT01046565|Adapalene|adapalene|mesh-list
1986205|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1986206|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1986207|NCT01046565|Analgesics|analgesics|mesh-ancestor
1986208|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
1986209|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986210|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986211|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986212|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986213|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
1986214|NCT01046643|Estradiol|estradiol|mesh-list
1986215|NCT01046643|Progesterone|progesterone|mesh-list
1986216|NCT01046643|Estrogens|estrogens|mesh-ancestor
1986217|NCT01046643|Hormones|hormones|mesh-ancestor
1986218|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986219|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986220|NCT01046643|Progestins|progestins|mesh-ancestor
1986221|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
1986222|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1986223|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1986224|NCT01046682|Analgesics|analgesics|mesh-ancestor
1986225|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
1986226|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986227|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986228|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986229|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986230|NCT01046903|Dalteparin|dalteparin|mesh-list
1986231|NCT01046903|Tinzaparin|tinzaparin|mesh-list
1986232|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1986233|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
1986234|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1986235|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1986236|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986237|NCT01047007|Cisplatin|cisplatin|mesh-list
1986238|NCT01047007|Adavosertib|adavosertib|mesh-list
1986239|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986240|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986241|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986242|NCT01047189|Clindamycin|clindamycin|mesh-list
1986243|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
1986244|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
1986245|NCT01047189|Tretinoin|tretinoin|mesh-list
1986246|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1986247|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986248|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1986249|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986250|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986251|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986252|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
1986253|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
1986254|NCT01047241|Sufentanil|sufentanil|mesh-list
1986255|NCT01047241|Ketamine|ketamine|mesh-list
1986256|NCT01047241|Analgesics|analgesics|mesh-ancestor
1986257|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
1986258|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986259|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986260|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1986261|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1986262|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
1986263|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
1986264|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1986265|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1986266|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1986267|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986268|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986269|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1986270|NCT01047241|Narcotics|narcotics|mesh-ancestor
1986271|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1986272|NCT01047293|Leucovorin|leucovorin|mesh-list
1986273|NCT01047293|Bevacizumab|bevacizumab|mesh-list
1986274|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
1986275|NCT01047293|Everolimus|everolimus|mesh-list
1986276|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1986277|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986278|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1986279|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1986280|NCT01047293|Growth Substances|growth substances|mesh-ancestor
1986281|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986282|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
1986283|NCT01047293|Antidotes|antidotes|mesh-ancestor
1986284|NCT01047293|Protective Agents|protective agents|mesh-ancestor
1986285|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
1986286|NCT01047293|Vitamins|vitamins|mesh-ancestor
1986287|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
1986288|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1986289|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
1986290|NCT01047358|Exemestane|exemestane|mesh-list
1986291|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986292|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1986293|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1986294|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986295|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986296|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1986297|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
1986298|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986299|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986300|NCT01047436|Artemether|artemether|mesh-list
1986301|NCT01047436|Quinine|quinine|mesh-list
1986302|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
1986303|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1986304|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1986305|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986306|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1986307|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986308|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1986309|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986310|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1986311|NCT01047436|Analgesics|analgesics|mesh-ancestor
1986312|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
1986313|NCT01047527|Nicotine|nicotine|mesh-list
1986314|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1986315|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
1986316|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986317|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986318|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1986319|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1986320|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
1986321|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986322|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986323|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
1986324|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1986325|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
1986326|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986327|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986328|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1986329|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
1986330|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1986331|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1986332|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1986333|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
1986334|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986335|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986336|NCT01048099|Trastuzumab|trastuzumab|mesh-list
1986337|NCT01048099|Pertuzumab|pertuzumab|mesh-list
1986338|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1986339|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986340|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
1986341|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1986342|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1986343|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
1986344|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986345|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986346|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1986347|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
1986348|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1986349|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1986350|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1986351|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
1986352|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986353|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986354|NCT01048502|Fenofibrate|fenofibrate|mesh-list
1986355|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1986356|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
1986357|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986358|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1986359|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
1986360|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1986361|NCT01048606|Estrogens|estrogens|mesh-ancestor
1986362|NCT01048606|Hormones|hormones|mesh-ancestor
1986363|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986364|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986365|NCT01048658|Sevoflurane|sevoflurane|mesh-list
1986366|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1986367|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1986368|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
1986369|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
1986370|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1986371|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986372|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
1986373|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1986374|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1986375|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
1986376|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986377|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1986378|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1986379|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986380|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986381|NCT01048697|Ethambutol|ethambutol|mesh-list
1986382|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
1986383|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1986384|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986385|NCT01048788|Tolvaptan|tolvaptan|mesh-list
1986386|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1986387|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986388|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
1986389|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986390|NCT01048866|Acetaminophen|acetaminophen|mesh-list
1986391|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
1986392|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1986393|NCT01048866|Analgesics|analgesics|mesh-ancestor
1986394|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
1986395|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986396|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986397|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
1986398|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1986399|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986400|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986401|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1986402|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986403|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986404|NCT01048879|Oseltamivir|oseltamivir|mesh-list
1986405|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
1986406|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1986407|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
1986408|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986409|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986410|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986411|NCT01048944|Bupropion|bupropion|mesh-list
1986412|NCT01048944|Nicotine|nicotine|mesh-list
1986413|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1986414|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
1986415|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986416|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986417|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1986418|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1986419|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
1986420|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986421|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986422|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1986423|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
1986424|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1986425|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1986426|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1986427|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1986428|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
1986429|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1986430|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1986431|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986432|NCT01049009|Metoprolol|metoprolol|mesh-list
1986433|NCT01049009|Nebivolol|nebivolol|mesh-list
1986434|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1986435|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1986436|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
1986437|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
1986438|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986439|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986440|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1986441|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1986442|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1986443|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
1986444|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986445|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986446|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
1986447|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1986448|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1986449|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2475570|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475571|NCT01084980|Tacrolimus|tacrolimus|mesh-list
2475572|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2475573|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
2475574|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986455|NCT01049217|Pregabalin|pregabalin|mesh-list
1986456|NCT01049217|Analgesics|analgesics|mesh-ancestor
1986457|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
1986458|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986459|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986460|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
1986461|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1986462|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1986463|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986464|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1986465|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1986466|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1986467|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1986468|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1986469|NCT01049243|Fluocinonide|fluocinonide|mesh-list
1986470|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986471|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
1986472|NCT01049243|Hormones|hormones|mesh-ancestor
1986473|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986474|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986475|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1986476|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
1986477|NCT01049334|Analgesics|analgesics|mesh-ancestor
1986478|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
1986479|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986480|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986481|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1986482|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1986483|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986484|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986485|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1986486|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986487|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986488|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
1986489|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1986490|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
1986491|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986492|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986493|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1986494|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
1986495|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1986496|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1986497|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1986498|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
1986499|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986500|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986501|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
1986502|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1986503|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986504|NCT01049503|Fluorides|fluorides|mesh-list
1986505|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
1986506|NCT01049503|Protective Agents|protective agents|mesh-ancestor
1986507|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986508|NCT01049945|Dexamethasone|dexamethasone|mesh-list
1986509|NCT01049945|Lenalidomide|lenalidomide|mesh-list
1986510|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1986511|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986512|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
1986513|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
1986514|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986515|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986516|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1986517|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
1986518|NCT01049945|Hormones|hormones|mesh-ancestor
1986519|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986520|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1986521|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986522|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
1986523|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1986524|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1986525|NCT01049945|Growth Substances|growth substances|mesh-ancestor
1986526|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
1986527|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1986528|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
1986529|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986530|NCT01049984|Rasagiline|rasagiline|mesh-list
1986531|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1986532|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986533|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986534|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1986535|NCT01049984|Protective Agents|protective agents|mesh-ancestor
1986536|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986537|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1986538|NCT01050062|Telmisartan|telmisartan|mesh-list
1986539|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1986540|NCT01050062|Diuretics|diuretics|mesh-ancestor
1986541|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
1986542|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986543|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1986544|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1986545|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986546|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1986547|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1986548|NCT01050153|Aspirin|aspirin|mesh-list
1986549|NCT01050153|Dalteparin|dalteparin|mesh-list
1986550|NCT01050153|Tinzaparin|tinzaparin|mesh-list
1986551|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1986552|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1986553|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1986554|NCT01050153|Analgesics|analgesics|mesh-ancestor
1986555|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
1986556|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986557|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986558|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986559|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986560|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1986561|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1986562|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986563|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1986564|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1986565|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986566|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
1986567|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
1986568|NCT01050257|Oseltamivir|oseltamivir|mesh-list
1986569|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
1986570|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986571|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986572|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986573|NCT01050530|Tolvaptan|tolvaptan|mesh-list
1986574|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1986575|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986576|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
1986577|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986578|NCT01050543|Neostigmine|neostigmine|mesh-list
1986579|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1986580|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986581|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986582|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
1986583|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986584|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986585|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1986586|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
1986587|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986588|NCT01050569|Nicotine|nicotine|mesh-list
1986589|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1986590|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
1986591|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986592|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986593|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1986594|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1986595|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
1986596|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986597|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986598|NCT01050582|Risperidone|risperidone|mesh-list
1986599|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
1986600|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1986601|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
1986602|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986603|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986604|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986605|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1986606|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1986607|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1986608|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1986609|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
1986610|NCT01050634|Exemestane|exemestane|mesh-list
1986611|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986612|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1986613|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1986614|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986615|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986616|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1986617|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
1986618|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986619|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986620|NCT01050647|Castor Oil|castor oil|mesh-list
1986621|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
1986622|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
1986623|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1986624|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
1986625|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986626|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986627|NCT01050647|Progestins|progestins|mesh-ancestor
1986628|NCT01050647|Hormones|hormones|mesh-ancestor
1986629|NCT01050647|Cathartics|cathartics|mesh-ancestor
1986630|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1986631|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1986632|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
1986633|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1986634|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1986635|NCT01050764|Vidarabine|vidarabine|mesh-list
1986636|NCT01050764|Fludarabine|fludarabine|mesh-list
1986637|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
1986638|NCT01050764|Melphalan|melphalan|mesh-list
1986639|NCT01050764|Thiotepa|thiotepa|mesh-list
1986640|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
1986641|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1986642|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986643|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1986644|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
1986645|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986646|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1986647|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
1986648|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986649|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
1986650|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986651|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1986652|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
1986653|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1986654|NCT01050790|Lenalidomide|lenalidomide|mesh-list
1986655|NCT01050790|Azacitidine|azacitidine|mesh-list
1986656|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
1986657|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986658|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1986659|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1986660|NCT01050790|Growth Substances|growth substances|mesh-ancestor
1986661|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
1986662|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986663|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1986664|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
1986665|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986666|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986667|NCT01050907|Miltefosine|miltefosine|mesh-list
1986668|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
1986669|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986670|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986671|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1986672|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1986673|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
1986674|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1986675|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986676|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
1986677|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986678|NCT01051349|Daclizumab|daclizumab|mesh-list
1986679|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1986680|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
1986681|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986682|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1986683|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1986684|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986685|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1986686|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1986687|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1986688|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986689|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
1986690|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986691|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1986692|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1986693|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1986694|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1986695|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986696|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986697|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986698|NCT01051466|Analgesics|analgesics|mesh-ancestor
1986699|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
1986700|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986701|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
1986702|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1986703|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
1986704|NCT01051557|Sirolimus|sirolimus|mesh-list
1986705|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1986706|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986707|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1986708|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986709|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
1986710|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1986711|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
1986712|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986713|NCT01051570|Prednisone|prednisone|mesh-list
1986714|NCT01051570|Carboplatin|carboplatin|mesh-list
1986715|NCT01051570|Everolimus|everolimus|mesh-list
1986716|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986717|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986718|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
1986719|NCT01051570|Hormones|hormones|mesh-ancestor
1986720|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986721|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986722|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1986723|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1986724|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
1986725|NCT01051596|Temozolomide|temozolomide|mesh-list
1986726|NCT01051596|Veliparib|veliparib|mesh-list
1986727|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1986728|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
1986729|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986730|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986731|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1986732|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986733|NCT01051661|Vaccines|vaccines|mesh-list
1986734|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
1986735|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986736|NCT01051778|Aspirin|aspirin|mesh-list
1986737|NCT01051778|Heparin|heparin|mesh-list
1986738|NCT01051778|Enoxaparin|enoxaparin|mesh-list
1986739|NCT01051778|Calcium heparin|calcium heparin|mesh-list
1986740|NCT01051778|Calcium|calcium|mesh-list
1986741|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1986742|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986743|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1986744|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1986745|NCT01051778|Analgesics|analgesics|mesh-ancestor
1986746|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
1986747|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986748|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986749|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986750|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1986751|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1986752|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986753|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1986754|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1986755|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986756|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
1986757|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
1986758|NCT01051791|Everolimus|everolimus|mesh-list
1986759|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986760|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1986761|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
1986762|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986763|NCT01051960|Ambrisentan|ambrisentan|mesh-list
1986764|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1986765|NCT01052012|Bupivacaine|bupivacaine|mesh-list
1986766|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
1986767|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
1986768|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1986769|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986770|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
1986771|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986772|NCT01052038|Dexamethasone|dexamethasone|mesh-list
1986773|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
1986774|NCT01052038|BB 1101|bb 1101|mesh-list
1986775|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986776|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
1986777|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
1986778|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986779|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986780|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1986781|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
1986782|NCT01052038|Hormones|hormones|mesh-ancestor
1986783|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986784|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1986785|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1986786|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
1986787|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986788|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986789|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
1986790|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1986791|NCT01052103|Olanzapine|olanzapine|mesh-list
1986792|NCT01052103|Antiemetics|antiemetics|mesh-ancestor
1986793|NCT01052103|Autonomic Agents|autonomic agents|mesh-ancestor
1986794|NCT01052103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986795|NCT01052103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986796|NCT01052103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1986797|NCT01052103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1986798|NCT01052103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1986799|NCT01052103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1986800|NCT01052103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1986801|NCT01052103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1986802|NCT01052103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1986803|NCT01052103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1986804|NCT01052103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986805|NCT01052103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986806|NCT01052103|Serotonin Agents|serotonin agents|mesh-ancestor
1986807|NCT01052272|Allopurinol|allopurinol|mesh-list
1986808|NCT01052272|Candesartan|candesartan|mesh-list
1986809|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
1986810|NCT01052272|Ramipril|ramipril|mesh-list
1986811|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1986812|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1986813|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1986814|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986815|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1986816|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
1986817|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986818|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
1986819|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
1986820|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986821|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1986822|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
1986823|NCT01052272|Protective Agents|protective agents|mesh-ancestor
1986824|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986825|NCT01052428|Metoprolol|metoprolol|mesh-list
1986826|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1986827|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1986828|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
1986829|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
1986830|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986831|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986832|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1986833|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1986834|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1986835|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
1986836|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986837|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986838|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
1986839|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1986840|NCT01052493|Hormones|hormones|mesh-ancestor
1986841|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986842|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986843|NCT01052662|Memantine|memantine|mesh-list
1986844|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1986845|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1986846|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
1986847|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986848|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986849|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986850|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1986851|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1986852|NCT01052701|Ribavirin|ribavirin|mesh-list
1986853|NCT01052701|Abacavir|abacavir|mesh-list
1986854|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
1986855|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986856|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
1986857|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986858|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1986859|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1986860|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986861|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1986862|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1986863|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1986864|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
1986865|NCT01052779|Hematinics|hematinics|mesh-ancestor
1986866|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1986867|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1986868|NCT01052831|Naltrexone|naltrexone|mesh-list
1986869|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1986870|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1986871|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986872|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
1986873|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986874|NCT01052844|Gabapentin|gabapentin|mesh-list
1986875|NCT01052844|Analgesics|analgesics|mesh-ancestor
1986876|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
1986877|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986878|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986879|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
1986880|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1986881|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1986882|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1986883|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1986884|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1986885|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1986886|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986887|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986888|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
1986889|NCT01053000|Tazarotene|tazarotene|mesh-list
1986890|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
1986891|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
1986892|NCT01053078|Naltrexone|naltrexone|mesh-list
1986893|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1986894|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1986895|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986896|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
1986897|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986898|NCT01053156|Minocycline|minocycline|mesh-list
1986899|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1986900|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986901|NCT01053247|Tacrolimus|tacrolimus|mesh-list
1986902|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1986903|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
1986904|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986905|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1986906|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986907|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986908|NCT01053312|Flutemetamol|flutemetamol|mesh-list
1986909|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1986910|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986911|NCT01053429|Ziprasidone|ziprasidone|mesh-list
1986912|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1986913|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
1986914|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1986915|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986916|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986917|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1986918|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1986919|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1986920|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1986921|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1986922|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
1986923|NCT01053507|Naproxen|naproxen|mesh-list
1986924|NCT01053507|Sumatriptan|sumatriptan|mesh-list
1986925|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1986926|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1986927|NCT01053507|Analgesics|analgesics|mesh-ancestor
1986928|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
1986929|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986930|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986931|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986932|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986933|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
1986934|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1986935|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986936|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986937|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1986938|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1986939|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1986940|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
1986941|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475575|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2475576|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475577|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475578|NCT01084993|Heparin|heparin|mesh-list
2475579|NCT01084993|Bivalirudin|bivalirudin|mesh-list
2475580|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
2475581|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2475582|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2475583|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475584|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
2475585|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2475586|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
2475587|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475588|NCT01085032|Nicotine|nicotine|mesh-list
2475589|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2475590|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
2475591|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986959|NCT01053663|Oseltamivir|oseltamivir|mesh-list
1986960|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
1986961|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1986962|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1986963|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986964|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
1986965|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1986966|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1986967|NCT01053819|Etanercept|etanercept|mesh-list
1986968|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1986969|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1986970|NCT01053819|Analgesics|analgesics|mesh-ancestor
1986971|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
1986972|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986973|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986974|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986975|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1986976|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1986977|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1986978|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
1986979|NCT01053962|Plecanatide|plecanatide|mesh-list
1986980|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
1986981|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
1986982|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1986983|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1986984|NCT01054079|Cinacalcet|cinacalcet|mesh-list
1986985|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1986986|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986987|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1986988|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
1986989|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1986990|NCT01054144|Dexamethasone|dexamethasone|mesh-list
1986991|NCT01054144|Prednisone|prednisone|mesh-list
1986992|NCT01054144|Lenalidomide|lenalidomide|mesh-list
1986993|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1986994|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
1986995|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
1986996|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1986997|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1986998|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1986999|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
1987000|NCT01054144|Hormones|hormones|mesh-ancestor
1987001|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1987002|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1987003|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987004|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
1987005|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1987006|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1987007|NCT01054144|Growth Substances|growth substances|mesh-ancestor
1987008|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
1987009|NCT01054222|Fesoterodine|fesoterodine|mesh-list
1987010|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1987011|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1987012|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
1987013|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987014|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987015|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987016|NCT01054222|Urological Agents|urological agents|mesh-ancestor
1987017|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
1987018|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1987019|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987020|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1987021|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987022|NCT01054404|Furosemide|furosemide|mesh-list
1987023|NCT01054404|Diuretics|diuretics|mesh-ancestor
1987024|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
1987025|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987026|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1987027|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1987028|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987029|NCT01054573|Interferons|interferons|mesh-list
1987030|NCT01054573|Ribavirin|ribavirin|mesh-list
1987031|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987032|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
1987033|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987034|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
1987035|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987036|NCT01054599|Memantine|memantine|mesh-list
1987037|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1987038|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1987039|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
1987040|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987041|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987042|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987043|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1987044|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1987045|NCT01054625|Zalutumumab|zalutumumab|mesh-list
1987046|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1987047|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987048|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
1987049|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
1987050|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987051|NCT01054742|Ribavirin|ribavirin|mesh-list
1987052|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1987053|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
1987054|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987055|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
1987056|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987057|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
1987058|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
1987059|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
1987060|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987061|NCT01054768|Protective Agents|protective agents|mesh-ancestor
1987062|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987063|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
1987064|NCT01054768|Vitamins|vitamins|mesh-ancestor
1987065|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
1987066|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
1987067|NCT01054820|Diclofenac|diclofenac|mesh-list
1987068|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
1987069|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1987070|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1987071|NCT01054820|Analgesics|analgesics|mesh-ancestor
1987072|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
1987073|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987074|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987075|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1987076|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1987077|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1987078|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987079|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987080|NCT01054911|Sunitinib|sunitinib|mesh-list
1987081|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987082|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1987083|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1987084|NCT01054911|Growth Substances|growth substances|mesh-ancestor
1987085|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987086|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
1987087|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1987088|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987089|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987090|NCT01054976|Galantamine|galantamine|mesh-list
1987091|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1987092|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987093|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987094|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
1987095|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987096|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987097|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1987098|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
1987099|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987100|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
1987101|NCT01055028|Paclitaxel|paclitaxel|mesh-list
1987102|NCT01055028|Bevacizumab|bevacizumab|mesh-list
1987103|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1987104|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987105|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
1987106|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
1987107|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
1987108|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987109|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1987110|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1987111|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1987112|NCT01055028|Growth Substances|growth substances|mesh-ancestor
1987113|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987114|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
1987115|NCT01055171|Propranolol|propranolol|mesh-list
1987116|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1987117|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1987118|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
1987119|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987120|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987121|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987122|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1987123|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1987124|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
1987125|NCT01055184|Vaccines|vaccines|mesh-list
1987126|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
1987127|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987128|NCT01055223|Troglitazone|troglitazone|mesh-list
1987129|NCT01055223|Amiloride|amiloride|mesh-list
1987130|NCT01055223|Spironolactone|spironolactone|mesh-list
1987131|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1987132|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
1987133|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1987134|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987135|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1987136|NCT01055223|Diuretics|diuretics|mesh-ancestor
1987137|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
1987138|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
1987139|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1987140|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1987141|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987142|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
1987143|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1987144|NCT01055314|Dactinomycin|dactinomycin|mesh-list
1987145|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
1987146|NCT01055314|Temozolomide|temozolomide|mesh-list
1987147|NCT01055314|Ifosfamide|ifosfamide|mesh-list
1987148|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
1987149|NCT01055314|Doxorubicin|doxorubicin|mesh-list
1987150|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1987151|NCT01055314|Irinotecan|irinotecan|mesh-list
1987152|NCT01055314|Etoposide|etoposide|mesh-list
1987153|NCT01055314|Vincristine|vincristine|mesh-list
1987154|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
1987155|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
1987156|NCT01055314|Camptothecin|camptothecin|mesh-list
1987157|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1987158|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987159|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
1987160|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987161|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1987162|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1987163|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
1987164|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987165|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987166|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1987167|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1987168|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1987169|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1987170|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987171|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1987172|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1987173|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
1987174|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
1987175|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
1987176|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
1987177|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
1987178|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1987179|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987180|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1987181|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1987182|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1987183|NCT01055496|Gemcitabine|gemcitabine|mesh-list
1987184|NCT01055496|Dexamethasone|dexamethasone|mesh-list
1987185|NCT01055496|Prednisone|prednisone|mesh-list
1987186|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
1987187|NCT01055496|Rituximab|rituximab|mesh-list
1987188|NCT01055496|Vincristine|vincristine|mesh-list
1987189|NCT01055496|Cisplatin|cisplatin|mesh-list
1987190|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
1987191|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987192|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
1987193|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987194|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1987195|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1987196|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
1987197|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987198|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987199|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1987200|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1987201|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
1987202|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
1987203|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987204|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1987205|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
1987206|NCT01055496|Hormones|hormones|mesh-ancestor
1987207|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1987208|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1987209|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1987210|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1987211|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
1987212|NCT01055496|Antiviral Agents|antiviral agents|mesh-ancestor
1987213|NCT01055496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987214|NCT01055496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987215|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1987216|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
1987217|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
1987218|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
1987219|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1987220|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1987221|NCT01055704|Naltrexone|naltrexone|mesh-list
1987222|NCT01055704|Codeine|codeine|mesh-list
1987223|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
1987224|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1987225|NCT01055704|Narcotics|narcotics|mesh-ancestor
1987226|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1987227|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987228|NCT01055704|Analgesics|analgesics|mesh-ancestor
1987229|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
1987230|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987231|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
1987232|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
1987233|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1987234|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1987235|NCT01055769|Linezolid|linezolid|mesh-list
1987236|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1987237|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987238|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1987239|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987240|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987241|NCT01055834|Eszopiclone|eszopiclone|mesh-list
1987242|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1987243|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1987244|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987245|NCT01055886|Nicotine|nicotine|mesh-list
1987246|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1987247|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
1987248|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987249|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987250|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1987251|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1987252|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
1987253|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987254|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987255|NCT01056107|Glucagon|glucagon|mesh-list
1987256|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
1987257|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1987258|NCT01056107|Hormones|hormones|mesh-ancestor
1987259|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1987260|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987261|NCT01056107|Incretins|incretins|mesh-ancestor
1987262|NCT01056263|Axitinib|axitinib|mesh-list
1987263|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987264|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1987265|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987266|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987267|NCT01056276|Dexamethasone|dexamethasone|mesh-list
1987268|NCT01056276|Bortezomib|bortezomib|mesh-list
1987269|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1987270|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1987271|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
1987272|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
1987273|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987274|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987275|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1987276|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
1987277|NCT01056276|Hormones|hormones|mesh-ancestor
1987278|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1987279|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1987280|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987281|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1987282|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
1987283|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987284|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1987285|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1987286|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1987287|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1987288|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987289|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987290|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987291|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
1987292|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1987293|NCT01056341|Propranolol|propranolol|mesh-list
1987294|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1987295|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1987296|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
1987297|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987298|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987299|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987300|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1987301|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1987302|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
1987303|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
1987304|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1987305|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987306|NCT01056510|Rituximab|rituximab|mesh-list
1987307|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1987308|NCT01056510|Chlorambucil|chlorambucil|mesh-list
1987309|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1987310|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987311|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
1987312|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987313|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1987314|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1987315|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
1987316|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987317|NCT01056523|Cytarabine|cytarabine|mesh-list
1987318|NCT01056523|Ribavirin|ribavirin|mesh-list
1987319|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1987320|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
1987321|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987322|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987323|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
1987324|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987325|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987326|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
1987327|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987328|NCT01056601|Bortezomib|bortezomib|mesh-list
1987329|NCT01056601|Panobinostat|panobinostat|mesh-list
1987330|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987331|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1987332|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987333|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987334|NCT01056718|Nebivolol|nebivolol|mesh-list
1987335|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1987336|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
1987337|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1987338|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1987339|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1987340|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
1987341|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987342|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987343|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987344|NCT01057017|Panitumumab|panitumumab|mesh-list
1987345|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1987346|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987347|NCT01057121|Lenalidomide|lenalidomide|mesh-list
1987348|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
1987349|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987350|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1987351|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1987352|NCT01057121|Growth Substances|growth substances|mesh-ancestor
1987353|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
1987354|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987355|NCT01057225|Thalidomide|thalidomide|mesh-list
1987356|NCT01057225|Dexamethasone|dexamethasone|mesh-list
1987357|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
1987358|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987359|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
1987360|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987361|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1987362|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1987363|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
1987364|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987365|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987366|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1987367|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1987368|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
1987369|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
1987370|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987371|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1987372|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
1987373|NCT01057225|Hormones|hormones|mesh-ancestor
1987374|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1987375|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1987376|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
1987377|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1987378|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987379|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1987380|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1987381|NCT01057225|Growth Substances|growth substances|mesh-ancestor
1987382|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
1987383|NCT01057251|Nebivolol|nebivolol|mesh-list
1987384|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1987385|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
1987386|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1987387|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1987388|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1987389|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
1987390|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987391|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987392|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987393|NCT01057277|Everolimus|everolimus|mesh-list
1987394|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987395|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987396|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
1987397|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987398|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
1987399|NCT01057381|Morphine|morphine|mesh-list
1987400|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1987401|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1987402|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987403|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1987404|NCT01057381|Analgesics|analgesics|mesh-ancestor
1987405|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
1987406|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987407|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1987408|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1987409|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1987410|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
1987411|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987412|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987413|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1987414|NCT01057381|Narcotics|narcotics|mesh-ancestor
1987415|NCT01057433|Ritonavir|ritonavir|mesh-list
1987416|NCT01057433|Lopinavir|lopinavir|mesh-list
1987417|NCT01057433|Pitavastatin|pitavastatin|mesh-list
1987418|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1987419|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1987420|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
1987421|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987422|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987423|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1987424|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1987425|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
1987426|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987427|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1987428|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1987429|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1987430|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1987431|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1987432|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
1987433|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1987434|NCT01057589|Folic Acid|folic acid|mesh-list
1987435|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
1987436|NCT01057589|Hydroxocobalamin|hydroxocobalamin|mesh-list
1987437|NCT01057589|Pemetrexed|pemetrexed|mesh-list
1987438|NCT01057589|Cetuximab|cetuximab|mesh-list
1987439|NCT01057589|Vitamins|vitamins|mesh-ancestor
1987440|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
1987441|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987442|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987443|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987444|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987445|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1987446|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1987447|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1987448|NCT01057589|Hematinics|hematinics|mesh-ancestor
1987449|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
1987450|NCT01057693|Pregabalin|pregabalin|mesh-list
1987451|NCT01057693|Analgesics|analgesics|mesh-ancestor
1987452|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
1987453|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987454|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987455|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
1987456|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1987457|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1987458|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987459|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1987460|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1987461|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1987462|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1987463|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1987464|NCT01057810|Ipilimumab|ipilimumab|mesh-list
1987465|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1987466|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987467|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1987468|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987469|NCT01057862|Naltrexone|naltrexone|mesh-list
1987470|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1987471|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1987472|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987473|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
1987474|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987475|NCT01058005|Interferons|interferons|mesh-list
1987476|NCT01058005|Interferon-beta|interferon-beta|mesh-list
1987477|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
1987478|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
1987479|NCT01058005|Natalizumab|natalizumab|mesh-list
1987480|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
1987481|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987482|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
1987483|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987484|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
1987485|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987486|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1987487|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987488|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1987489|NCT01058096|Cariprazine|cariprazine|mesh-list
1987490|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1987491|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1987492|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1987493|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987494|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1987495|NCT01058239|Rituximab|rituximab|mesh-list
1987496|NCT01058239|Bortezomib|bortezomib|mesh-list
1987497|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1987498|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987499|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
1987500|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987501|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1987502|NCT01058395|Minocycline|minocycline|mesh-list
1987503|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1987504|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987505|NCT01058655|Everolimus|everolimus|mesh-list
1987506|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987507|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987508|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
1987509|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987510|NCT01058668|Cariprazine|cariprazine|mesh-list
1987511|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1987512|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1987513|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1987514|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987515|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1987516|NCT01058863|Albuterol|albuterol|mesh-list
1987517|NCT01058863|Procaterol|procaterol|mesh-list
1987518|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1987519|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
1987520|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987521|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987522|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1987523|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
1987524|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
1987525|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1987526|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1987527|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1987528|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1987529|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
1987530|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987531|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987532|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
1987533|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
1987534|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
1987535|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987536|NCT01058941|Protective Agents|protective agents|mesh-ancestor
1987537|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987538|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
1987539|NCT01058941|Vitamins|vitamins|mesh-ancestor
1987540|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
1987541|NCT01058993|Plerixafor|plerixafor|mesh-list
1987542|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1987543|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1987544|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
1987545|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987546|NCT01059071|Eflornithine|eflornithine|mesh-list
1987547|NCT01059071|Etoposide|etoposide|mesh-list
1987548|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1987549|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987550|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1987551|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1987552|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987553|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987554|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1987555|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1987556|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1987557|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987558|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
1987559|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1987560|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987561|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1987562|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987563|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987564|NCT01059318|Everolimus|everolimus|mesh-list
1987565|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987566|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987567|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
1987568|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987569|NCT01059526|Ecallantide|ecallantide|mesh-list
1987570|NCT01059526|Analgesics|analgesics|mesh-ancestor
1987571|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
1987572|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987573|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987574|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1987575|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1987576|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1987577|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1987578|NCT01059539|Cariprazine|cariprazine|mesh-list
1987579|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1987580|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1987581|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1987582|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987583|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1987584|NCT01059617|Vaccines|vaccines|mesh-list
1987585|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
1987586|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987587|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1987588|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
1987589|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1987590|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
1987591|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987592|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987593|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1987594|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
1987595|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1987596|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1987597|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
1987598|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987599|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1987600|NCT01059773|Methotrexate|methotrexate|mesh-list
1987601|NCT01059773|Ustekinumab|ustekinumab|mesh-list
1987602|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1987603|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
1987604|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1987605|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987606|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1987607|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
1987608|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987609|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987610|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
1987611|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987612|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1987613|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987614|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
1987615|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1987616|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1987617|NCT01059799|Insulin|insulin|mesh-list
1987618|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1987619|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
1987620|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1987621|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987622|NCT01059812|Insulin|insulin|mesh-list
1987623|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1987624|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
1987625|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
1987626|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1987627|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
1987628|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
1987629|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1987630|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987631|NCT01059825|Metformin|metformin|mesh-list
1987632|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1987633|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
1987634|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1987635|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987636|NCT01059825|Incretins|incretins|mesh-ancestor
1987637|NCT01059825|Hormones|hormones|mesh-ancestor
1987638|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1987639|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1987640|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
1987641|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987642|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987643|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1987644|NCT01059851|Suvorexant|suvorexant|mesh-list
1987645|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1987646|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1987647|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1987648|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987649|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1987650|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987651|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987652|NCT01059864|Atorvastatin|atorvastatin|mesh-list
1987653|NCT01059864|Tofacitinib|tofacitinib|mesh-list
1987654|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1987655|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1987656|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
1987657|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987658|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1987659|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1987660|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987661|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1987662|NCT01059903|Rotigotine|rotigotine|mesh-list
1987663|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
1987664|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
1987665|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987666|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987667|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987668|NCT01059929|Fentanyl|fentanyl|mesh-list
1987669|NCT01059929|Midazolam|midazolam|mesh-list
1987670|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
1987671|NCT01059929|Propofol|propofol|mesh-list
1987672|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1987673|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1987674|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987675|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1987676|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
1987677|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
1987678|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1987679|NCT01059929|Analgesics|analgesics|mesh-ancestor
1987680|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
1987681|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987682|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1987683|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1987684|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1987685|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
1987686|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987687|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987688|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1987689|NCT01059929|Narcotics|narcotics|mesh-ancestor
1987690|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1987691|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1987692|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1987693|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1987694|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
1987695|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
1987696|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
1987697|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
1987698|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1987699|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1987700|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987701|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987702|NCT01059994|Urological Agents|urological agents|mesh-ancestor
1987703|NCT01060007|Leucovorin|leucovorin|mesh-list
1987704|NCT01060007|Fluorouracil|fluorouracil|mesh-list
1987705|NCT01060007|Capecitabine|capecitabine|mesh-list
1987706|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
1987707|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
1987708|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987709|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1987710|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987711|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987712|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
1987713|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987714|NCT01060007|Antidotes|antidotes|mesh-ancestor
1987715|NCT01060007|Protective Agents|protective agents|mesh-ancestor
1987716|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
1987717|NCT01060007|Vitamins|vitamins|mesh-ancestor
1987718|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
1987719|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
1987720|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
1987721|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1987722|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1987723|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987724|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987725|NCT01060020|Urological Agents|urological agents|mesh-ancestor
1987726|NCT01060059|Exenatide|exenatide|mesh-list
1987727|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1987728|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987729|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1987730|NCT01060059|Incretins|incretins|mesh-ancestor
1987731|NCT01060059|Hormones|hormones|mesh-ancestor
1987732|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1987733|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
1987734|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1987735|NCT01060098|Adalimumab|adalimumab|mesh-list
1987736|NCT01060098|Etanercept|etanercept|mesh-list
1987737|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1987738|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1987739|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1987740|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1987741|NCT01060098|Analgesics|analgesics|mesh-ancestor
1987742|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
1987743|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987744|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987745|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1987746|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987747|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
1987748|NCT01060111|Topiramate|topiramate|mesh-list
1987749|NCT01060111|Propranolol|propranolol|mesh-list
1987750|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1987751|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1987752|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
1987753|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987754|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987755|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987756|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1987757|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1987758|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
1987759|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
1987760|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1987761|NCT01060124|Fentanyl|fentanyl|mesh-list
1987762|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1987763|NCT01060124|Narcotics|narcotics|mesh-ancestor
1987764|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1987765|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987766|NCT01060124|Analgesics|analgesics|mesh-ancestor
1987767|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
1987768|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987769|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1987770|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1987771|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
1987772|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
1987773|NCT01060150|Methylphenidate|methylphenidate|mesh-list
1987774|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1987775|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987776|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1987777|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1987778|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1987779|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987780|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
1987781|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987782|NCT01060384|Lenalidomide|lenalidomide|mesh-list
1987783|NCT01060384|Ofatumumab|ofatumumab|mesh-list
1987784|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
1987785|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987786|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1987787|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1987788|NCT01060384|Growth Substances|growth substances|mesh-ancestor
1987789|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
1987790|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987791|NCT01061034|Aspirin|aspirin|mesh-list
1987792|NCT01061034|Omeprazole|omeprazole|mesh-list
1987793|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1987794|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1987795|NCT01061034|Analgesics|analgesics|mesh-ancestor
1987796|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
1987797|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987798|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987799|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1987800|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1987801|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1987802|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1987803|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987804|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1987805|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1987806|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987807|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
1987808|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1987809|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1987810|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1987811|NCT01061151|Ritonavir|ritonavir|mesh-list
1987812|NCT01061151|Lopinavir|lopinavir|mesh-list
1987813|NCT01061151|Tenofovir|tenofovir|mesh-list
1987814|NCT01061151|Lamivudine|lamivudine|mesh-list
1987815|NCT01061151|Zidovudine|zidovudine|mesh-list
1987816|NCT01061151|Emtricitabine|emtricitabine|mesh-list
1987817|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1987818|NCT01061151|Nevirapine|nevirapine|mesh-list
1987819|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
1987820|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1987821|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1987822|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
1987823|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987824|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987825|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1987826|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1987827|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
1987828|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987829|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1987830|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1987831|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1987832|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1987833|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
1987834|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1987835|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1987836|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
1987837|NCT01061333|Nedocromil|nedocromil|mesh-list
1987838|NCT01061333|Montelukast|montelukast|mesh-list
1987839|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1987840|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
1987841|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1987842|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
1987843|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1987844|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987845|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1987846|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1987847|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987848|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1987849|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
1987850|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1987851|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
1987852|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
1987853|NCT01061359|Epirubicin|epirubicin|mesh-list
1987854|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1987855|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987856|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1987857|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1987858|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987859|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987860|NCT01061528|Nicotine|nicotine|mesh-list
1987861|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1987862|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
1987863|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987864|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987865|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1987866|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1987867|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
1987868|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987869|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987870|NCT01061606|Sirolimus|sirolimus|mesh-list
1987871|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1987872|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987873|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1987874|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987875|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
1987876|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987877|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
1987878|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987879|NCT01061671|Simvastatin|simvastatin|mesh-list
1987880|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1987881|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1987882|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
1987883|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987884|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1987885|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1987886|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987887|NCT01061710|Varenicline|varenicline|mesh-list
1987888|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1987889|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1987890|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
1987891|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987892|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987893|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987894|NCT01061736|Folic Acid|folic acid|mesh-list
1987895|NCT01061736|Methotrexate|methotrexate|mesh-list
1987896|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1987897|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
1987898|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1987899|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987900|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1987901|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
1987902|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987903|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987904|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
1987905|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987906|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1987907|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987908|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
1987909|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1987910|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1987911|NCT01061736|Hematinics|hematinics|mesh-ancestor
1987912|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
1987913|NCT01061736|Vitamins|vitamins|mesh-ancestor
1987914|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
1987915|NCT01061775|Exenatide|exenatide|mesh-list
1987916|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1987917|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987918|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1987919|NCT01061775|Incretins|incretins|mesh-ancestor
1987920|NCT01061775|Hormones|hormones|mesh-ancestor
1987921|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1987922|NCT01061866|Thalidomide|thalidomide|mesh-list
1987923|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987924|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
1987925|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987926|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
1987927|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1987928|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987929|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1987930|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1987931|NCT01061866|Growth Substances|growth substances|mesh-ancestor
1987932|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
1987933|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987934|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
1987935|NCT01062009|Astringents|astringents|mesh-ancestor
1987936|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987937|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
1987938|NCT01062113|Celecoxib|celecoxib|mesh-list
1987939|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1987940|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1987941|NCT01062113|Analgesics|analgesics|mesh-ancestor
1987942|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
1987943|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987944|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987945|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1987946|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1987947|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1987948|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1987949|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987950|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987951|NCT01062165|Caspofungin|caspofungin|mesh-list
1987952|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
1987953|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1987954|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1987955|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987956|NCT01062230|Bortezomib|bortezomib|mesh-list
1987957|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987958|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
1987959|NCT01062256|Guaifenesin|guaifenesin|mesh-list
1987960|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
1987961|NCT01062256|Expectorants|expectorants|mesh-ancestor
1987962|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
1987963|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1987964|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1987965|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
1987966|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1987967|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987968|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987969|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
1987970|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1987971|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
1987972|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
1987973|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1987974|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
1987975|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1987976|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
1987977|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1987978|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1987979|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
1987980|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1987981|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1987982|NCT01062399|Everolimus|everolimus|mesh-list
1987983|NCT01062399|Temozolomide|temozolomide|mesh-list
1987984|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1987985|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1987986|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
1987987|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1987988|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1987989|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
1987990|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745744|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2745745|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
2745746|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2745747|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2745748|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2745749|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2745750|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2745751|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1988000|NCT01062555|Cyclosporine|cyclosporine|mesh-list
1988001|NCT01062555|Sirolimus|sirolimus|mesh-list
1988002|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
1988003|NCT01062555|Tacrolimus|tacrolimus|mesh-list
1988004|NCT01062555|Cyclosporins|cyclosporins|mesh-list
1988005|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1988006|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
1988007|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988008|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1988009|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988010|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988011|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
1988012|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988013|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
1988014|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1988015|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1988016|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988017|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1988018|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
1988019|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1988020|NCT01062568|Dexamethasone|dexamethasone|mesh-list
1988021|NCT01062568|Cosyntropin|cosyntropin|mesh-list
1988022|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
1988023|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
1988024|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
1988025|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1988026|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
1988027|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
1988028|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988029|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988030|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1988031|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
1988032|NCT01062568|Hormones|hormones|mesh-ancestor
1988033|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988034|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1988035|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988036|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988037|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988038|NCT01062763|Spironolactone|spironolactone|mesh-list
1988039|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1988040|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
1988041|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988042|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988043|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1988044|NCT01062763|Diuretics|diuretics|mesh-ancestor
1988045|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
1988046|NCT01062971|Timolol|timolol|mesh-list
1988047|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1988048|NCT01062971|Dorzolamide|dorzolamide|mesh-list
1988049|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1988050|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1988051|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
1988052|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988053|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988054|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988055|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1988056|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1988057|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1988058|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1988059|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1988060|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1988061|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988062|NCT01063036|Tenofovir|tenofovir|mesh-list
1988063|NCT01063036|Entecavir|entecavir|mesh-list
1988064|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
1988065|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988066|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1988067|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1988068|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988069|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988070|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1988071|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1988072|NCT01063049|Bisacodyl|bisacodyl|mesh-list
1988073|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
1988074|NCT01063049|Cathartics|cathartics|mesh-ancestor
1988075|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1988076|NCT01063049|Laxatives|laxatives|mesh-ancestor
1988077|NCT01063062|Methotrexate|methotrexate|mesh-list
1988078|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1988079|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
1988080|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1988081|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988082|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1988083|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
1988084|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988085|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988086|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
1988087|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988088|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1988089|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1988090|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
1988091|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1988092|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1988093|NCT01063075|Carboplatin|carboplatin|mesh-list
1988094|NCT01063075|Cetuximab|cetuximab|mesh-list
1988095|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988096|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1988097|NCT01063153|Methylphenidate|methylphenidate|mesh-list
1988098|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1988099|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988100|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1988101|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1988102|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1988103|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988104|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
1988105|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988106|NCT01063283|Bevacizumab|bevacizumab|mesh-list
1988107|NCT01063283|Carboplatin|carboplatin|mesh-list
1988108|NCT01063283|Pemetrexed|pemetrexed|mesh-list
1988109|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1988110|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988111|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1988112|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1988113|NCT01063283|Growth Substances|growth substances|mesh-ancestor
1988114|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988115|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
1988116|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988117|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988118|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1988119|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1988120|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
1988121|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1988122|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
1988123|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988124|NCT01063348|Expectorants|expectorants|mesh-ancestor
1988125|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
1988126|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1988127|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
1988128|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988129|NCT01063348|Protective Agents|protective agents|mesh-ancestor
1988130|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988131|NCT01063348|Antidotes|antidotes|mesh-ancestor
1988142|NCT01063764|Levetiracetam|levetiracetam|mesh-list
1988143|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
1988144|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
1988145|NCT01063829|Letermovir|letermovir|mesh-list
1988146|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1988147|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988148|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988149|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988150|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
1988151|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988152|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
1988153|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1988154|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988155|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988156|NCT01063868|Oxycodone|oxycodone|mesh-list
1988157|NCT01063868|Tapentadol|tapentadol|mesh-list
1988158|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1988159|NCT01063868|Narcotics|narcotics|mesh-ancestor
1988160|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1988161|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988162|NCT01063868|Analgesics|analgesics|mesh-ancestor
1988163|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
1988164|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988165|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1988166|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1988167|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1988168|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988169|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
1988170|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988171|NCT01063907|Bortezomib|bortezomib|mesh-list
1988172|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988173|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
1988174|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1988175|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1988176|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988177|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
1988178|NCT01064167|Coagulants|coagulants|mesh-ancestor
1988179|NCT01064284|Factor VIII|factor viii|mesh-list
1988180|NCT01064284|Coagulants|coagulants|mesh-ancestor
1988181|NCT01064297|Lamotrigine|lamotrigine|mesh-list
1988182|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
1988183|NCT01064297|Valproic Acid|valproic acid|mesh-list
1988184|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1988185|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1988186|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988187|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1988188|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988189|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1988190|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1988191|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1988192|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1988193|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1988194|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988195|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
1988196|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988197|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
1988198|NCT01064310|Sunitinib|sunitinib|mesh-list
1988199|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988200|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1988201|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1988202|NCT01064310|Growth Substances|growth substances|mesh-ancestor
1988203|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988204|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
1988205|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1988206|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988207|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988208|NCT01064362|Heparin|heparin|mesh-list
1988209|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1988210|NCT01064362|Tinzaparin|tinzaparin|mesh-list
1988211|NCT01064362|Dalteparin|dalteparin|mesh-list
1988212|NCT01064362|PENTA|penta|mesh-list
1988213|NCT01064362|Fondaparinux|fondaparinux|mesh-list
1988214|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
1988215|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1988216|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1988217|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988218|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1988219|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
1988220|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1988221|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
1988222|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988223|NCT01064401|Interferons|interferons|mesh-list
1988224|NCT01064401|Interferon-beta|interferon-beta|mesh-list
1988225|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
1988226|NCT01064401|Daclizumab|daclizumab|mesh-list
1988227|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988228|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
1988229|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988230|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
1988231|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988232|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1988233|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1988234|NCT01064414|Canagliflozin|canagliflozin|mesh-list
1988235|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1988236|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988237|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1988238|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988239|NCT01064622|Gemcitabine|gemcitabine|mesh-list
1988240|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
1988241|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1988242|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
1988243|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988244|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988245|NCT01064622|Antiviral Agents|antiviral agents|mesh-ancestor
1988246|NCT01064622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988247|NCT01064622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988248|NCT01064622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1988249|NCT01064622|Immunologic Factors|immunologic factors|mesh-ancestor
1988250|NCT01064622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988251|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1988262|NCT01064687|Metformin|metformin|mesh-list
1988263|NCT01064687|Pioglitazone|pioglitazone|mesh-list
1988264|NCT01064687|Exenatide|exenatide|mesh-list
1988265|NCT01064687|Dulaglutide|dulaglutide|mesh-list
1988266|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1988267|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988268|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1988269|NCT01064687|Incretins|incretins|mesh-ancestor
1988270|NCT01064687|Hormones|hormones|mesh-ancestor
1988271|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988272|NCT01064830|Cyclosporine|cyclosporine|mesh-list
1988273|NCT01064830|Cyclosporins|cyclosporins|mesh-list
1988274|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988275|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988276|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1988277|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
1988278|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988279|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
1988280|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988281|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
1988282|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1988283|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1988284|NCT01064856|Adalimumab|adalimumab|mesh-list
1988285|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1988286|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1988287|NCT01064882|Bimatoprost|bimatoprost|mesh-list
1988288|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1988289|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1988290|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1988291|NCT01064947|Retapamulin|retapamulin|mesh-list
1988292|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1988293|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988294|NCT01065350|Ketamine|ketamine|mesh-list
1988295|NCT01065350|Propofol|propofol|mesh-list
1988296|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1988297|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1988298|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988299|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1988300|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
1988301|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
1988302|NCT01065350|Analgesics|analgesics|mesh-ancestor
1988303|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
1988304|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988305|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1988306|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1988307|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1988308|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988309|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745752|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2745753|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
2745754|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988313|NCT01065506|Nicotine|nicotine|mesh-list
1988314|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1988315|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
1988316|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988317|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988318|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1988319|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1988320|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
1988321|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079351|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1988322|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988323|NCT01065558|Ecopipam|ecopipam|mesh-list
1988324|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1988325|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1988326|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1988327|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988328|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1988329|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1988330|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
1988331|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988332|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988333|NCT01065766|Metformin|metformin|mesh-list
1988334|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1988335|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1988336|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988337|NCT01065766|Incretins|incretins|mesh-ancestor
1988338|NCT01065766|Hormones|hormones|mesh-ancestor
1988339|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988340|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1988341|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
1988342|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988343|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988344|NCT01065779|Alendronate|alendronate|mesh-list
1988345|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1988346|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988347|NCT01065844|Nelfinavir|nelfinavir|mesh-list
1988348|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1988349|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1988350|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
1988351|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988352|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988353|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1988354|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1988355|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
1988356|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988357|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
1988358|NCT01066000|Hematinics|hematinics|mesh-ancestor
1988359|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
1988360|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1988361|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
1988362|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988363|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
1988364|NCT01066026|Protective Agents|protective agents|mesh-ancestor
1988365|NCT01066039|Bisoprolol|bisoprolol|mesh-list
1988366|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1988367|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
1988368|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
1988369|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988370|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988371|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1988372|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1988373|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1988374|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
1988375|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988376|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988377|NCT01066104|Omalizumab|omalizumab|mesh-list
1988378|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1988379|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1988380|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1988381|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
1988382|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
1988383|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988384|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1988385|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
1988386|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1988387|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1988388|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1988389|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1988390|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988391|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1988392|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
1988393|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1988394|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1988395|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1988396|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1988397|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988398|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1988399|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1988400|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1988401|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
1988402|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988403|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1988404|NCT01066520|Diclofenac|diclofenac|mesh-list
1988405|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1988406|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1988407|NCT01066520|Analgesics|analgesics|mesh-ancestor
1988408|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
1988409|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988410|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988411|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1988412|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1988413|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1988414|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988415|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988416|NCT01066585|Ivermectin|ivermectin|mesh-list
1988417|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1988418|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988419|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1988420|NCT01066624|Calcium|calcium|mesh-list
1988421|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1988422|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988423|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1988424|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1988425|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
1988426|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988427|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1988428|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1988429|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
1988430|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988431|NCT01066897|Pramipexole|pramipexole|mesh-list
1988432|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
1988433|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988434|NCT01066897|Protective Agents|protective agents|mesh-ancestor
1988435|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988436|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1988437|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1988438|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
1988439|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
1988440|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988441|NCT01066923|Aspirin|aspirin|mesh-list
1988442|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1988443|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1988444|NCT01066923|Analgesics|analgesics|mesh-ancestor
1988445|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
1988446|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988447|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988448|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1988449|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1988450|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1988451|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1988452|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988453|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1988454|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1988455|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988456|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
1988457|NCT01067105|Ciclesonide|ciclesonide|mesh-list
1988458|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
1988459|NCT01067105|Hormones|hormones|mesh-ancestor
1988460|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988461|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988462|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1988463|NCT01067144|Gabapentin|gabapentin|mesh-list
1988464|NCT01067144|Lorazepam|lorazepam|mesh-list
1988465|NCT01067144|Analgesics|analgesics|mesh-ancestor
1988466|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
1988467|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988468|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988469|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
1988470|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1988471|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1988472|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1988473|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1988474|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1988475|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1988476|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988477|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988478|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
1988479|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
1988480|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
1988481|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1988482|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1988483|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
1988484|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
1988485|NCT01067339|Darapladib|darapladib|mesh-list
1988486|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
1988487|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988488|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988489|NCT01067352|Hormones|hormones|mesh-list
1988490|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988491|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988492|NCT01067469|Bevacizumab|bevacizumab|mesh-list
1988493|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1988494|NCT01067469|Lomustine|lomustine|mesh-list
1988495|NCT01067469|Antibodies|antibodies|mesh-list
1988496|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
1988497|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1988498|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988499|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1988500|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1988501|NCT01067469|Growth Substances|growth substances|mesh-ancestor
1988502|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988503|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
1988504|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
1988505|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1988506|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
1988507|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745755|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2745756|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2745757|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2745758|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
2745759|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2745760|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1988515|NCT01067846|Cycloserine|cycloserine|mesh-list
1988516|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1988517|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988518|NCT01067846|Renal Agents|renal agents|mesh-ancestor
1988519|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1988520|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
1988521|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1988522|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
1988523|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988524|NCT01068158|Ivermectin|ivermectin|mesh-list
1988525|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1988526|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988527|NCT01068418|Vitamin D|vitamin d|mesh-list
1988528|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
1988529|NCT01068418|Vitamins|vitamins|mesh-ancestor
1988530|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
1988531|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988532|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1988533|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1988534|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1988535|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1988536|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1988537|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
1988538|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988539|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1988540|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1988541|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988542|NCT01068652|Insulin|insulin|mesh-list
1988543|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1988544|NCT01068652|Metformin|metformin|mesh-list
1988545|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
1988546|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
1988547|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1988548|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
1988549|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
1988550|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
1988551|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1988552|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988553|NCT01068665|Insulin|insulin|mesh-list
1988554|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1988555|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
1988556|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1988557|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988558|NCT01068678|Insulin|insulin|mesh-list
1988559|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1988560|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
1988561|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1988562|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988563|NCT01068717|Metformin|metformin|mesh-list
1988564|NCT01068717|Saxagliptin|saxagliptin|mesh-list
1988565|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1988566|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988567|NCT01068717|Incretins|incretins|mesh-ancestor
1988568|NCT01068717|Hormones|hormones|mesh-ancestor
1988569|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988570|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1988571|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
1988572|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988573|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988574|NCT01068730|Metformin|metformin|mesh-list
1988575|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1988576|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988577|NCT01068743|Metformin|metformin|mesh-list
1988578|NCT01068743|Saxagliptin|saxagliptin|mesh-list
1988579|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1988580|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988581|NCT01068743|Incretins|incretins|mesh-ancestor
1988582|NCT01068743|Hormones|hormones|mesh-ancestor
1988583|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988584|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1988585|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
1988586|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988587|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988588|NCT01068860|Insulin|insulin|mesh-list
1988589|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1988590|NCT01068860|Metformin|metformin|mesh-list
1988591|NCT01068860|Glimepiride|glimepiride|mesh-list
1988592|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
1988593|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
1988594|NCT01068860|Glyburide|glyburide|mesh-list
1988595|NCT01068860|Glipizide|glipizide|mesh-list
1988596|NCT01068860|Troglitazone|troglitazone|mesh-list
1988597|NCT01068860|Tolbutamide|tolbutamide|mesh-list
1988598|NCT01068860|Acetohexamide|acetohexamide|mesh-list
1988599|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
1988600|NCT01068860|Tolazamide|tolazamide|mesh-list
1988601|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
1988602|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1988603|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1988604|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988605|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1988606|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1988607|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
1988608|NCT01068873|Ritonavir|ritonavir|mesh-list
1988609|NCT01068873|Lopinavir|lopinavir|mesh-list
1988610|NCT01068873|Maraviroc|maraviroc|mesh-list
1988611|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1988612|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1988613|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
1988614|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988615|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988616|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1988617|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1988618|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
1988619|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988620|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1988621|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1988622|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1988623|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1988624|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1988625|NCT01068912|Favipiravir|favipiravir|mesh-list
1988626|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
1988627|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988628|NCT01068964|Timolol|timolol|mesh-list
1988629|NCT01068964|Bimatoprost|bimatoprost|mesh-list
1988630|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1988631|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1988632|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1988633|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1988634|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
1988635|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988636|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988637|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988638|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1988639|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1988640|NCT01069172|Dipivefrin|dipivefrin|mesh-list
1988641|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1988642|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
1988643|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988644|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988645|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988646|NCT01069289|Budesonide|budesonide|mesh-list
1988647|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
1988648|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1988649|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1988650|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1988651|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
1988652|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988653|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988654|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1988655|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
1988656|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
1988657|NCT01069289|Hormones|hormones|mesh-ancestor
1988658|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988659|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1988660|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1988661|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1988662|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
1988663|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988664|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988665|NCT01069341|Ranibizumab|ranibizumab|mesh-list
1988666|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1988667|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1988668|NCT01069341|Growth Substances|growth substances|mesh-ancestor
1988669|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988670|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
1988671|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988672|NCT01069354|Lidocaine|lidocaine|mesh-list
1988673|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
1988674|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
1988675|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1988676|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988677|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
1988678|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988679|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1988680|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1988681|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1988682|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1988683|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988684|NCT01069510|Spironolactone|spironolactone|mesh-list
1988685|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1988686|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
1988687|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988688|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988689|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1988690|NCT01069510|Diuretics|diuretics|mesh-ancestor
1988691|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
1988692|NCT01069523|Guanfacine|guanfacine|mesh-list
1988693|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1988694|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1988695|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1988696|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1988697|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
1988698|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988699|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988700|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988701|NCT01069627|Bevacizumab|bevacizumab|mesh-list
1988702|NCT01069627|Fotemustine|fotemustine|mesh-list
1988703|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1988704|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988705|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1988706|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1988707|NCT01069627|Growth Substances|growth substances|mesh-ancestor
1988708|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988709|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
1988710|NCT01069705|Tobramycin|tobramycin|mesh-list
1988711|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1988712|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988713|NCT01069900|Amoxicillin|amoxicillin|mesh-list
1988714|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
1988715|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
1988716|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
1988717|NCT01069900|Ertapenem|ertapenem|mesh-list
1988718|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1988719|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1988720|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1988721|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988722|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1988723|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1988724|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988725|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988726|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988727|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1988728|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
1988729|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1988730|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988731|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1988732|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1988733|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1988734|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1988735|NCT01069939|Esomeprazole|esomeprazole|mesh-list
1988736|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1988737|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1988738|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1988739|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988740|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988741|NCT01070043|Amlodipine|amlodipine|mesh-list
1988742|NCT01070043|Valsartan|valsartan|mesh-list
1988743|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1988744|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1988745|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1988746|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988747|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1988748|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988749|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
1988750|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1988751|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1988752|NCT01070303|Adalimumab|adalimumab|mesh-list
1988753|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1988754|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1988755|NCT01070316|Everolimus|everolimus|mesh-list
1988756|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988757|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1988758|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
1988759|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988760|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1988761|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1988762|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1988763|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1988764|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988765|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988766|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988767|NCT01070329|Analgesics|analgesics|mesh-ancestor
1988768|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
1988769|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988770|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
1988771|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1988772|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
1988773|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1988774|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1988775|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988776|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1988777|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1988778|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1988779|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988780|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
1988781|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988782|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1988783|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
1988784|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988785|NCT01070784|Budesonide|budesonide|mesh-list
1988786|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
1988787|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1988788|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1988789|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1988790|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
1988791|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988792|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988793|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1988794|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
1988795|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
1988796|NCT01070784|Hormones|hormones|mesh-ancestor
1988797|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988798|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1988799|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1988800|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1988801|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
1988802|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988803|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988804|NCT01070810|Thiamine|thiamine|mesh-list
1988805|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
1988806|NCT01070810|Vitamins|vitamins|mesh-ancestor
1988807|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
1988808|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988809|NCT01070888|Budesonide|budesonide|mesh-list
1988810|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
1988811|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1988812|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1988813|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
1988814|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988815|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988816|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1988817|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
1988818|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
1988819|NCT01070888|Hormones|hormones|mesh-ancestor
1988820|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988821|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1988822|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1988823|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1988824|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
1988825|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988826|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988827|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1988828|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1988829|NCT01070979|Estradiol|estradiol|mesh-list
1988830|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1988831|NCT01070979|Estrogens|estrogens|mesh-list
1988832|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1988833|NCT01070979|Hormones|hormones|mesh-ancestor
1988834|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988835|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988836|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1988837|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
1988838|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1988839|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1988840|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1988841|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1988842|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988843|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1988844|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1988845|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1988846|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988847|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
1988848|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988849|NCT01071083|Interferons|interferons|mesh-list
1988850|NCT01071083|Interferon-beta|interferon-beta|mesh-list
1988851|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
1988852|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
1988853|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
1988854|NCT01071083|Natalizumab|natalizumab|mesh-list
1988855|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
1988856|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988857|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
1988858|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988859|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1988860|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
1988861|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
1988862|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988863|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988864|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1988865|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
1988866|NCT01071083|Hormones|hormones|mesh-ancestor
1988867|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988868|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1988869|NCT01071083|Protective Agents|protective agents|mesh-ancestor
1988870|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
1988871|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1988872|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1988873|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1988874|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
1988875|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1988876|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1988877|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1988878|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1988879|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988880|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
1988881|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988882|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988883|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1988884|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988885|NCT01071200|Hormones|hormones|mesh-list
1988886|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1988887|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1988888|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988889|NCT01071317|Naproxen|naproxen|mesh-list
1988890|NCT01071317|Sumatriptan|sumatriptan|mesh-list
1988891|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1988892|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1988893|NCT01071317|Analgesics|analgesics|mesh-ancestor
1988894|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
1988895|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988896|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988897|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1988898|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1988899|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
1988900|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1988901|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1988902|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988903|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1988904|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1988905|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1988906|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
1988907|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988908|NCT01071395|Amantadine|amantadine|mesh-list
1988909|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1988910|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1988911|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
1988912|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988913|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
1988914|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1988915|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988916|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988917|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1988918|NCT01071395|Analgesics|analgesics|mesh-ancestor
1988919|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
1988920|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988921|NCT01071512|Natalizumab|natalizumab|mesh-list
1988922|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
1988923|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988924|NCT01071538|Buprenorphine|buprenorphine|mesh-list
1988925|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1988926|NCT01071538|Narcotics|narcotics|mesh-ancestor
1988927|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1988928|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988929|NCT01071538|Analgesics|analgesics|mesh-ancestor
1988930|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
1988931|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988932|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1988933|NCT01071798|Rituximab|rituximab|mesh-list
1988934|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1988935|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988936|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
1988937|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988938|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1988939|NCT01072136|Azithromycin|azithromycin|mesh-list
1988940|NCT01072136|Cefixime|cefixime|mesh-list
1988941|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1988942|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988943|NCT01072149|Fluticasone|fluticasone|mesh-list
1988944|NCT01072149|Xhance|xhance|mesh-list
1988945|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1988946|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1988947|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
1988948|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988949|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988950|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1988951|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
1988952|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
1988953|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2475592|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475593|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2475594|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2475595|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
2475596|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475597|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988960|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
1988961|NCT01072188|Calcium|calcium|mesh-list
1988962|NCT01072188|Fluorides|fluorides|mesh-list
1988963|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1988964|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988965|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
1988966|NCT01072188|Protective Agents|protective agents|mesh-ancestor
1988967|NCT01072188|Antacids|antacids|mesh-ancestor
1988968|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988969|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1988970|NCT01072201|Triclosan|triclosan|mesh-list
1988971|NCT01072201|Fluorides|fluorides|mesh-list
1988972|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
1988973|NCT01072201|Protective Agents|protective agents|mesh-ancestor
1988974|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988975|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1988976|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1988977|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1988978|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1988979|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
1988980|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1988981|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1988982|NCT01072357|Bevacizumab|bevacizumab|mesh-list
1988983|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1988984|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1988985|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1988986|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1988987|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1988988|NCT01072357|Growth Substances|growth substances|mesh-ancestor
1988989|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988990|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
1988991|NCT01072357|Laxatives|laxatives|mesh-ancestor
1988992|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1988993|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
1988994|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1988995|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
1988996|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1988997|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1988998|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1988999|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
1989000|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
1989001|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1989002|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
1989003|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989004|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989005|NCT01072539|Tigecycline|tigecycline|mesh-list
1989006|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1989007|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989008|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1989009|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989010|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989011|NCT01072630|Modafinil|modafinil|mesh-list
1989012|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1989013|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989014|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1989015|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1989016|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1989017|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989018|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
1989019|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1989020|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1989021|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989022|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1989023|NCT01072643|Analgesics|analgesics|mesh-ancestor
1989024|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
1989025|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989026|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1989027|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1989028|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1989029|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
1989030|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989031|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989032|NCT01072669|Ambrisentan|ambrisentan|mesh-list
1989033|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1989034|NCT01072773|Dexamethasone|dexamethasone|mesh-list
1989035|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
1989036|NCT01072773|Bortezomib|bortezomib|mesh-list
1989037|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1989038|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
1989039|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989040|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1989041|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1989042|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
1989043|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989044|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989045|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1989046|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1989047|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
1989048|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
1989049|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989050|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1989051|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
1989052|NCT01072773|Hormones|hormones|mesh-ancestor
1989053|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989054|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1989055|NCT01072877|Polidocanol|polidocanol|mesh-list
1989056|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
1989057|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1989058|NCT01072929|Modafinil|modafinil|mesh-list
1989059|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1989060|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989061|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1989062|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1989063|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1989064|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989065|NCT01073163|Rituximab|rituximab|mesh-list
1989066|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1989067|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1989068|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989069|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
1989070|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989071|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1989072|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1989073|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
1989074|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989075|NCT01073566|Insulin|insulin|mesh-list
1989076|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1989077|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1989078|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989079|NCT01073618|Voriconazole|voriconazole|mesh-list
1989080|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
1989081|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989082|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1989083|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1989084|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989085|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989086|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1989087|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
1989088|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989089|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989090|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1989091|NCT01073631|Voriconazole|voriconazole|mesh-list
1989092|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
1989093|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989094|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1989095|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1989096|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989097|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989098|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1989099|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
1989100|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989101|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989102|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1989103|NCT01073865|Goserelin|goserelin|mesh-list
1989104|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1989105|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989106|NCT01073930|Bisacodyl|bisacodyl|mesh-list
1989107|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
1989108|NCT01073930|Cathartics|cathartics|mesh-ancestor
1989109|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1989110|NCT01073930|Laxatives|laxatives|mesh-ancestor
1989111|NCT01073943|Bisacodyl|bisacodyl|mesh-list
1989112|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
1989113|NCT01073943|Cathartics|cathartics|mesh-ancestor
1989114|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1989115|NCT01073943|Laxatives|laxatives|mesh-ancestor
1989116|NCT01074008|Ritonavir|ritonavir|mesh-list
1989117|NCT01074008|Ribavirin|ribavirin|mesh-list
1989118|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1989119|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1989120|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1989121|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
1989122|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989123|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989124|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1989125|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1989126|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
1989127|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989128|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1989129|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1989130|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
1989131|NCT01074047|Azacitidine|azacitidine|mesh-list
1989132|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1989133|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
1989134|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989135|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989136|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989137|NCT01074177|Afatinib|afatinib|mesh-list
1989138|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989139|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1989140|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989141|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989142|NCT01074216|Vitamin D|vitamin d|mesh-list
1989143|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
1989144|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
1989145|NCT01074216|Vitamins|vitamins|mesh-list
1989146|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
1989147|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989148|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1989149|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1989150|NCT01074229|Ropivacaine|ropivacaine|mesh-list
1989151|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
1989152|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
1989153|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1989154|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989155|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
1989156|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989157|NCT01074255|Aprepitant|aprepitant|mesh-list
1989158|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
1989159|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
1989160|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989161|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989162|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1989163|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1989164|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989165|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989166|NCT01074268|Insulin|insulin|mesh-list
1989167|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1989168|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
1989169|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
1989170|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1989171|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989172|NCT01074307|Bisoprolol|bisoprolol|mesh-list
1989173|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1989174|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
1989175|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
1989176|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989177|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989178|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1989179|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1989180|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1989181|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
1989182|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989183|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989184|NCT01074450|Pramipexole|pramipexole|mesh-list
1989185|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
1989186|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989187|NCT01074450|Protective Agents|protective agents|mesh-ancestor
1989188|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989189|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1989190|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1989191|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
1989192|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
1989193|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989194|NCT01074463|Pramipexole|pramipexole|mesh-list
1989195|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
1989196|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989197|NCT01074463|Protective Agents|protective agents|mesh-ancestor
1989198|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989199|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1989200|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1989201|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
1989202|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
1989203|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989204|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1989205|NCT01074554|Azithromycin|azithromycin|mesh-list
1989206|NCT01074554|Levofloxacin|levofloxacin|mesh-list
1989207|NCT01074554|Rifampin|rifampin|mesh-list
1989208|NCT01074554|Ethambutol|ethambutol|mesh-list
1989209|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989210|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1989211|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
1989212|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1989213|NCT01074554|Renal Agents|renal agents|mesh-ancestor
1989214|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1989215|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1989216|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989217|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989218|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989219|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1989220|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1989221|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
1989222|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1989223|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1989224|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1989225|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1989226|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1989227|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1989228|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1989229|NCT01074931|Ritonavir|ritonavir|mesh-list
1989230|NCT01074931|Lopinavir|lopinavir|mesh-list
1989231|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1989232|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1989233|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
1989234|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989235|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989236|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1989237|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1989238|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
1989239|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989240|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1989241|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1989242|NCT01074944|Eliglustat|eliglustat|mesh-list
1989243|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989244|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989245|NCT01075048|Irinotecan|irinotecan|mesh-list
1989246|NCT01075048|Cetuximab|cetuximab|mesh-list
1989247|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1989248|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1989249|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989250|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989251|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989252|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1989253|NCT01075087|Ropivacaine|ropivacaine|mesh-list
1989254|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
1989255|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
1989256|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1989257|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989258|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
1989259|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989260|NCT01075100|Carboplatin|carboplatin|mesh-list
1989261|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989262|NCT01075152|Lamivudine|lamivudine|mesh-list
1989263|NCT01075152|Zidovudine|zidovudine|mesh-list
1989264|NCT01075152|Efavirenz|efavirenz|mesh-list
1989265|NCT01075152|Stavudine|stavudine|mesh-list
1989266|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1989267|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1989268|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989269|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989270|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
1989271|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989272|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1989273|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1989274|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
1989275|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1989276|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1989277|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1989278|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1989279|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1989280|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1989281|NCT01075204|Clarithromycin|clarithromycin|mesh-list
1989282|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1989283|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989284|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1989285|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989286|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989287|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1989288|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1989289|NCT01075243|Acetaminophen|acetaminophen|mesh-list
1989290|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1989291|NCT01075243|Analgesics|analgesics|mesh-ancestor
1989292|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
1989293|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989294|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989295|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
1989296|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
1989297|NCT01075256|Calcium|calcium|mesh-list
1989298|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1989299|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989300|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1989301|NCT01075282|Metformin|metformin|mesh-list
1989302|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
1989303|NCT01075282|Glimepiride|glimepiride|mesh-list
1989304|NCT01075282|Dulaglutide|dulaglutide|mesh-list
1989305|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1989306|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989307|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1989308|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1989309|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
1989310|NCT01075321|Lenalidomide|lenalidomide|mesh-list
1989311|NCT01075321|Everolimus|everolimus|mesh-list
1989312|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
1989313|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989314|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1989315|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1989316|NCT01075321|Growth Substances|growth substances|mesh-ancestor
1989317|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
1989318|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989319|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1989320|NCT01075399|Imidazole|imidazole|mesh-list
1989321|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989322|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989323|NCT01075646|Ropivacaine|ropivacaine|mesh-list
1989324|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1989325|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
1989326|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
1989327|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1989328|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989329|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
1989330|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989331|NCT01075763|Interferons|interferons|mesh-list
1989332|NCT01075763|Interferon-beta|interferon-beta|mesh-list
1989333|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
1989334|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989335|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
1989336|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989337|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
1989338|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989339|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1989340|NCT01075815|Hormones|hormones|mesh-list
1989341|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1989342|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989343|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989344|NCT01075971|Buprenorphine|buprenorphine|mesh-list
1989345|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1989346|NCT01075971|Narcotics|narcotics|mesh-ancestor
1989347|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1989348|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989349|NCT01075971|Analgesics|analgesics|mesh-ancestor
1989350|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
1989351|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989352|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1989353|NCT01075984|Posaconazole|posaconazole|mesh-list
1989354|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
1989355|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989356|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1989357|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1989358|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1989359|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1989360|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1989361|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989362|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989363|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1989364|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
1989365|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989366|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989367|NCT01076010|Sorafenib|sorafenib|mesh-list
1989368|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989369|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1989370|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989371|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989372|NCT01076075|Metformin|metformin|mesh-list
1989373|NCT01076075|Pioglitazone|pioglitazone|mesh-list
1989374|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1989375|NCT01076075|Glimepiride|glimepiride|mesh-list
1989376|NCT01076075|Gliclazide|gliclazide|mesh-list
1989377|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1989378|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989379|NCT01076075|Incretins|incretins|mesh-ancestor
1989380|NCT01076075|Hormones|hormones|mesh-ancestor
1989381|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989382|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1989383|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
1989384|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989385|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989386|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1989387|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1989388|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
1989389|NCT01076088|Metformin|metformin|mesh-list
1989390|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1989391|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1989392|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989393|NCT01076088|Incretins|incretins|mesh-ancestor
1989394|NCT01076088|Hormones|hormones|mesh-ancestor
1989395|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989396|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1989397|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
1989398|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989399|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989400|NCT01076153|Clarithromycin|clarithromycin|mesh-list
1989401|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1989402|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989403|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1989404|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989405|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989406|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1989407|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1989408|NCT01076166|Clarithromycin|clarithromycin|mesh-list
1989409|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1989410|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989411|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1989412|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989413|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989414|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1989415|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1989416|NCT01076231|Etoposide|etoposide|mesh-list
1989417|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
1989418|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
1989419|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989420|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1989421|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1989422|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1989423|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989424|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989425|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
1989426|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
1989427|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
1989428|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
1989429|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
1989430|NCT01076270|Plerixafor|plerixafor|mesh-list
1989431|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1989432|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1989433|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
1989434|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989435|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
1989436|NCT01076283|Baclofen|baclofen|mesh-list
1989437|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1989438|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989439|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1989440|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989441|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
1989442|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
1989443|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
1989444|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989445|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989446|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
1989447|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
1989448|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1989449|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1989450|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
1989451|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
1989452|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1989453|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
1989454|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1989455|NCT01076335|Docetaxel|docetaxel|mesh-list
1989456|NCT01076335|Leuprolide|leuprolide|mesh-list
1989457|NCT01076335|Goserelin|goserelin|mesh-list
1989458|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989459|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
1989460|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
1989461|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
1989462|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989463|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1989464|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
1989465|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1989466|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989467|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1989468|NCT01076400|Topotecan|topotecan|mesh-list
1989469|NCT01076400|Adavosertib|adavosertib|mesh-list
1989470|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989471|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1989472|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1989473|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989474|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989475|NCT01076504|Carboplatin|carboplatin|mesh-list
1989476|NCT01076504|Amrubicin|amrubicin|mesh-list
1989477|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989478|NCT01076543|Sirolimus|sirolimus|mesh-list
1989479|NCT01076543|Lenalidomide|lenalidomide|mesh-list
1989480|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
1989481|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989482|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1989483|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1989484|NCT01076543|Growth Substances|growth substances|mesh-ancestor
1989485|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
1989486|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989487|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1989488|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989489|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1989490|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
1989491|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1989492|NCT01076647|Insulin|insulin|mesh-list
1989493|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1989494|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
1989495|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1989496|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989497|NCT01076972|Ritonavir|ritonavir|mesh-list
1989498|NCT01076972|Lopinavir|lopinavir|mesh-list
1989499|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1989500|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1989501|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
1989502|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989503|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989504|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1989505|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1989506|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
1989507|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989508|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1989509|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1989510|NCT01076985|Ritonavir|ritonavir|mesh-list
1989511|NCT01076985|Lopinavir|lopinavir|mesh-list
1989512|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1989513|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1989514|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
1989515|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989516|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989517|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1989518|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1989519|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
1989520|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989521|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1989522|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1989523|NCT01077076|Omeprazole|omeprazole|mesh-list
1989524|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
1989525|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1989526|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1989527|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1989528|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989529|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989530|NCT01077154|Denosumab|denosumab|mesh-list
1989531|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1989532|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989533|NCT01077284|Allopurinol|allopurinol|mesh-list
1989534|NCT01077284|Febuxostat|febuxostat|mesh-list
1989535|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
1989536|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989537|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989538|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
1989539|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1989540|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1989541|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
1989542|NCT01077284|Protective Agents|protective agents|mesh-ancestor
1989543|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989544|NCT01077310|Naltrexone|naltrexone|mesh-list
1989545|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1989546|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1989547|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989548|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
1989549|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989550|NCT01077323|Exenatide|exenatide|mesh-list
1989551|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
1989552|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989553|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1989554|NCT01077323|Incretins|incretins|mesh-ancestor
1989555|NCT01077323|Hormones|hormones|mesh-ancestor
1989556|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989557|NCT01077362|Ustekinumab|ustekinumab|mesh-list
1989558|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
1989559|NCT01077375|Milnacipran|milnacipran|mesh-list
1989560|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
1989561|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1989562|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1989563|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1989564|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989565|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989566|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989567|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1989568|NCT01077375|Analgesics|analgesics|mesh-ancestor
1989569|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
1989570|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989571|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
1989572|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1989573|NCT01077401|Ranibizumab|ranibizumab|mesh-list
1989574|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1989575|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1989576|NCT01077401|Growth Substances|growth substances|mesh-ancestor
1989577|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989578|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
1989579|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989580|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1989581|NCT01077518|Ofatumumab|ofatumumab|mesh-list
1989582|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1989583|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1989584|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
1989585|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989586|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989587|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
1989588|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989589|NCT01077596|Bupropion|bupropion|mesh-list
1989590|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
1989591|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
1989592|NCT01077596|Serotonin|serotonin|mesh-list
1989593|NCT01077596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1989594|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1989595|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1989596|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1989597|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1989598|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1989599|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989600|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
1989601|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989602|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989603|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1989604|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1989605|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989606|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1989607|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
1989608|NCT01077622|Ofatumumab|ofatumumab|mesh-list
1989609|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989610|NCT01077713|Gemcitabine|gemcitabine|mesh-list
1989611|NCT01077713|Bevacizumab|bevacizumab|mesh-list
1989612|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1989613|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989614|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1989615|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1989616|NCT01077713|Growth Substances|growth substances|mesh-ancestor
1989617|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989618|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
1989619|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1989620|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
1989621|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989622|NCT01077713|Antiviral Agents|antiviral agents|mesh-ancestor
1989623|NCT01077713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989624|NCT01077713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989625|NCT01077713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1989626|NCT01077713|Immunologic Factors|immunologic factors|mesh-ancestor
1989627|NCT01077739|Leucovorin|leucovorin|mesh-list
1989628|NCT01077739|Bevacizumab|bevacizumab|mesh-list
1989629|NCT01077739|Fluorouracil|fluorouracil|mesh-list
1989630|NCT01077739|Capecitabine|capecitabine|mesh-list
1989631|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
1989632|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1989633|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989634|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1989635|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1989636|NCT01077739|Growth Substances|growth substances|mesh-ancestor
1989637|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989638|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
1989639|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
1989640|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989641|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1989642|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1989643|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
1989644|NCT01077739|Antidotes|antidotes|mesh-ancestor
1989645|NCT01077739|Protective Agents|protective agents|mesh-ancestor
1989646|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
1989647|NCT01077739|Vitamins|vitamins|mesh-ancestor
1989648|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
1989649|NCT01077817|Alendronate|alendronate|mesh-list
1989650|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
1989651|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
1989652|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
1989653|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
1989654|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1989655|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989656|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1989657|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1989658|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989659|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1989660|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1989661|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
1989662|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989663|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1989664|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1989665|NCT01077921|Propranolol|propranolol|mesh-list
1989666|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1989667|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1989668|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
1989669|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989670|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989671|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989672|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1989673|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1989674|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
1989675|NCT01077960|Hormones|hormones|mesh-list
1989676|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989677|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989678|NCT01077973|Ibuprofen|ibuprofen|mesh-list
1989679|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1989680|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1989681|NCT01077973|Analgesics|analgesics|mesh-ancestor
1989682|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
1989683|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989684|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989685|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1989686|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1989687|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1989688|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989689|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989690|NCT01078168|Acitretin|acitretin|mesh-list
1989691|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
1989692|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
1989693|NCT01078298|Varenicline|varenicline|mesh-list
1989694|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1989695|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1989696|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
1989697|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989698|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989699|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989700|NCT01078363|Ramipril|ramipril|mesh-list
1989701|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1989702|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
1989703|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989704|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989705|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1989706|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1989707|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1989708|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1989709|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989710|NCT01078389|Febuxostat|febuxostat|mesh-list
1989711|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
1989712|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1989713|NCT01078441|Dexamethasone|dexamethasone|mesh-list
1989714|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
1989715|NCT01078441|Doxorubicin|doxorubicin|mesh-list
1989716|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1989717|NCT01078441|Bortezomib|bortezomib|mesh-list
1989718|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1989719|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
1989720|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989721|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1989722|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1989723|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
1989724|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989725|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989726|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1989727|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1989728|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
1989729|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
1989730|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989731|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1989732|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
1989733|NCT01078441|Hormones|hormones|mesh-ancestor
1989734|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989735|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1989736|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1989737|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1989738|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1989739|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989760|NCT01078545|Leuprolide|leuprolide|mesh-list
1989761|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1989762|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
1989763|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1989764|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989765|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1989766|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989767|NCT01078571|Adalimumab|adalimumab|mesh-list
1989768|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1989769|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1989770|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
1989771|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1989772|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
1989773|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989774|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989775|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1989776|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
1989777|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1989778|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1989779|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1989780|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
1989781|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989782|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989783|NCT01078662|Olaparib|olaparib|mesh-list
1989784|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1989785|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989786|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989787|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989788|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
1989789|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1989790|NCT01078675|Calcium|calcium|mesh-list
1989791|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1989792|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989793|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1989794|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1989795|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1989796|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
1989797|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989798|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1989799|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1989800|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989801|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
1989802|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
1989803|NCT01078753|Coagulants|coagulants|mesh-ancestor
1989804|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1989805|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
1989806|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989807|NCT01078805|Teriparatide|teriparatide|mesh-list
1989808|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1989809|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989810|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1989811|NCT01078922|Ofatumumab|ofatumumab|mesh-list
1989812|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989813|NCT01078974|Dexamethasone|dexamethasone|mesh-list
1989814|NCT01078974|Rituximab|rituximab|mesh-list
1989815|NCT01078974|Pomalidomide|pomalidomide|mesh-list
1989816|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1989817|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
1989818|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
1989819|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989820|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989821|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1989822|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
1989823|NCT01078974|Hormones|hormones|mesh-ancestor
1989824|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989825|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1989826|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989827|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1989828|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
1989829|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1989830|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1989831|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1989832|NCT01078974|Growth Substances|growth substances|mesh-ancestor
1989833|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
1989834|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1989835|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1989836|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
1989837|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989838|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989839|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1989840|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
1989841|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1989842|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1989843|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1989844|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
1989845|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989846|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989847|NCT01079143|Cyclosporine|cyclosporine|mesh-list
1989848|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
1989849|NCT01079143|Everolimus|everolimus|mesh-list
1989850|NCT01079143|Cyclosporins|cyclosporins|mesh-list
1989851|NCT01079143|Basiliximab|basiliximab|mesh-list
1989852|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989853|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989854|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1989855|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
1989856|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989857|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
1989858|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989859|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
1989860|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1989861|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1989862|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989863|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1989864|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1989865|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
1989866|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1989867|NCT01079234|Insulin|insulin|mesh-list
1989868|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1989869|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
1989870|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
1989871|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1989872|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989873|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
1989874|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1989875|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989876|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
1989877|NCT01079741|Poly I-C|poly i-c|mesh-list
1989878|NCT01079741|Mineral Oil|mineral oil|mesh-list
1989879|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1989880|NCT01079741|Poly ICLC|poly iclc|mesh-list
1989881|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
1989882|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
1989883|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
1989884|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989885|NCT01079741|Laxatives|laxatives|mesh-ancestor
1989886|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1989887|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
1989888|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989889|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1989890|NCT01079741|Emollients|emollients|mesh-ancestor
1989891|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
1989892|NCT01079806|Entecavir|entecavir|mesh-list
1989893|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
1989894|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989895|NCT01079936|Lenalidomide|lenalidomide|mesh-list
1989896|NCT01079936|Melphalan|melphalan|mesh-list
1989897|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
1989898|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989899|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1989900|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1989901|NCT01079936|Growth Substances|growth substances|mesh-ancestor
1989902|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
1989903|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989904|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1989905|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
1989906|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989907|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1989908|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1989909|NCT01079949|Cetrorelix|cetrorelix|mesh-list
1989910|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1989911|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1989912|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
1989913|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1989914|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989915|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
1989916|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989917|NCT01079962|Atenolol|atenolol|mesh-list
1989918|NCT01079962|Bisoprolol|bisoprolol|mesh-list
1989919|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1989920|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1989921|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
1989922|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
1989923|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989924|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989925|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1989926|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1989927|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1989928|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
1989929|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989930|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989931|NCT01079988|Cyclosporine|cyclosporine|mesh-list
1989932|NCT01079988|Methotrexate|methotrexate|mesh-list
1989933|NCT01079988|Cyclosporins|cyclosporins|mesh-list
1989934|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1989935|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
1989936|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1989937|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989938|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1989939|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
1989940|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989941|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989942|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
1989943|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989944|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1989945|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1989946|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
1989947|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1989948|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1989949|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
1989950|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989951|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1989952|NCT01080131|Triamcinolone|triamcinolone|mesh-list
1989953|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1989954|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1989955|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1989956|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1989957|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1989958|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
1989959|NCT01080131|Hormones|hormones|mesh-ancestor
1989960|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1989961|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989962|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1989963|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
1989964|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989965|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989966|NCT01080248|Gemcitabine|gemcitabine|mesh-list
1989967|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1989968|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
1989969|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989970|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1989971|NCT01080248|Antiviral Agents|antiviral agents|mesh-ancestor
1989972|NCT01080248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1989973|NCT01080248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1989974|NCT01080248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1989975|NCT01080248|Immunologic Factors|immunologic factors|mesh-ancestor
1989976|NCT01080248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989977|NCT01080300|Gabapentin|gabapentin|mesh-list
1989978|NCT01080300|Analgesics|analgesics|mesh-ancestor
1989979|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
1989980|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989981|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989982|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
1989983|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1989984|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1989985|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1989986|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1989987|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1989988|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1989989|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1989990|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1989991|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
1989992|NCT01080391|Dexamethasone|dexamethasone|mesh-list
1989993|NCT01080391|Lenalidomide|lenalidomide|mesh-list
1989994|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1989995|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
1989996|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
1989997|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1989998|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1989999|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1990000|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
1990001|NCT01080391|Hormones|hormones|mesh-ancestor
1990002|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990003|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1990004|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990005|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
1990006|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1990007|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1990008|NCT01080391|Growth Substances|growth substances|mesh-ancestor
1990009|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
1990010|NCT01080625|Phenylephrine|phenylephrine|mesh-list
1990011|NCT01080625|Epinephrine|epinephrine|mesh-list
1990012|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
1990013|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1990014|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1990015|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
1990016|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990017|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990018|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990019|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1990020|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1990021|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
1990022|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990023|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1990024|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
1990025|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
1990026|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
1990027|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1990028|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1990029|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
1990030|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1990031|NCT01080625|Protective Agents|protective agents|mesh-ancestor
1990032|NCT01080677|Propranolol|propranolol|mesh-list
1990033|NCT01080677|Caffeine|caffeine|mesh-list
1990034|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1990035|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990036|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1990037|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990038|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990039|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1990040|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1990041|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
1990042|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990043|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1990044|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1990045|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
1990046|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1990047|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1990048|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
1990049|NCT01080716|Vaccines|vaccines|mesh-list
1990050|NCT01080716|Complement Factor H|complement factor h|mesh-list
1990051|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
1990052|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990053|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1990054|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1990055|NCT01080807|Modafinil|modafinil|mesh-list
1990056|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1990057|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990058|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1990059|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1990060|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1990061|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990062|NCT01081041|Carboplatin|carboplatin|mesh-list
1990063|NCT01081041|Fluorouracil|fluorouracil|mesh-list
1990064|NCT01081041|Cetuximab|cetuximab|mesh-list
1990065|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990066|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
1990067|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990068|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1990069|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1990070|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
1990071|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990072|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1990073|NCT01081132|Guanfacine|guanfacine|mesh-list
1990074|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1990075|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1990076|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1990077|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1990078|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
1990079|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990080|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990081|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990082|NCT01081145|Guanfacine|guanfacine|mesh-list
1990083|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1990084|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1990085|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1990086|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1990087|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
1990088|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990089|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990090|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990091|NCT01081249|Oxytocin|oxytocin|mesh-list
1990092|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
1990093|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1990094|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745761|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2745762|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2745763|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
2745764|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2745765|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2745766|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
2745767|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2745768|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2745769|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2745770|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
2745771|NCT02735707|Protective Agents|protective agents|mesh-ancestor
2745772|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2745773|NCT02735707|Renal Agents|renal agents|mesh-ancestor
2745774|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2745775|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2745776|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2745777|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2745778|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2745779|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2745780|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2745781|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
2745782|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
1990121|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1990122|NCT01081626|Hormones|hormones|mesh-ancestor
1990123|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990124|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990125|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1990126|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
1990127|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1990128|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1990129|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990130|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1990131|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1990132|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1990133|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
1990134|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990135|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990136|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1990137|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1990138|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
1990139|NCT01081795|Topiramate|topiramate|mesh-list
1990140|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
1990141|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1990142|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990143|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1990144|NCT01081834|Canagliflozin|canagliflozin|mesh-list
1990145|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1990146|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990147|NCT01081834|Incretins|incretins|mesh-ancestor
1990148|NCT01081834|Hormones|hormones|mesh-ancestor
1990149|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990150|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1990151|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
1990152|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990153|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990154|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1990155|NCT01081873|Leuprolide|leuprolide|mesh-list
1990156|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1990157|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
1990158|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1990159|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990160|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1990161|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990162|NCT01081912|Hydrocodone|hydrocodone|mesh-list
1990163|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1990164|NCT01081912|Narcotics|narcotics|mesh-ancestor
1990165|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1990166|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990167|NCT01081912|Analgesics|analgesics|mesh-ancestor
1990168|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
1990169|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990170|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
1990171|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
1990172|NCT01081951|Paclitaxel|paclitaxel|mesh-list
1990173|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1990174|NCT01081951|Carboplatin|carboplatin|mesh-list
1990175|NCT01081951|Olaparib|olaparib|mesh-list
1990176|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1990177|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990178|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
1990179|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
1990180|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
1990181|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990182|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1990183|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990184|NCT01082081|Acetaminophen|acetaminophen|mesh-list
1990185|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1990186|NCT01082081|Analgesics|analgesics|mesh-ancestor
1990187|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
1990188|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990189|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990190|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
1990191|NCT01082380|Crizotinib|crizotinib|mesh-list
1990192|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990193|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1990194|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990195|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990196|NCT01082588|Pravastatin|pravastatin|mesh-list
1990197|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1990198|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1990199|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
1990200|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990201|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1990202|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1990203|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990204|NCT01082640|Febuxostat|febuxostat|mesh-list
1990205|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
1990206|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1990207|NCT01082874|Aspirin|aspirin|mesh-list
1990208|NCT01082874|Clonidine|clonidine|mesh-list
1990209|NCT01082874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1990210|NCT01082874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1990211|NCT01082874|Analgesics|analgesics|mesh-ancestor
1990212|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
1990213|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990214|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990215|NCT01082874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1990216|NCT01082874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1990217|NCT01082874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1990218|NCT01082874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1990219|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990220|NCT01082874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1990221|NCT01082874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1990222|NCT01082874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990223|NCT01082874|Antipyretics|antipyretics|mesh-ancestor
1990224|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1990225|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
1990226|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
1990227|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1990228|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1990229|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1990230|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
1990231|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990232|NCT01082939|Vidarabine|vidarabine|mesh-list
1990233|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
1990234|NCT01082939|Rituximab|rituximab|mesh-list
1990235|NCT01082939|Fludarabine|fludarabine|mesh-list
1990236|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
1990237|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
1990238|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1990239|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
1990240|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990241|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1990242|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1990243|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
1990244|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990245|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990246|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1990247|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1990248|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1990249|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
1990250|NCT01082939|Antiviral Agents|antiviral agents|mesh-ancestor
1990251|NCT01082939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1990252|NCT01082965|Donepezil|donepezil|mesh-list
1990253|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1990254|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990255|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990256|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
1990257|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990258|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990259|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
1990260|NCT01083316|Dexamethasone|dexamethasone|mesh-list
1990261|NCT01083316|Bortezomib|bortezomib|mesh-list
1990262|NCT01083316|Melphalan|melphalan|mesh-list
1990263|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1990264|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
1990265|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
1990266|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990267|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990268|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1990269|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
1990270|NCT01083316|Hormones|hormones|mesh-ancestor
1990271|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990272|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1990273|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990274|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1990275|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
1990276|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990277|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1990278|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1990279|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
1990280|NCT01083368|Sirolimus|sirolimus|mesh-list
1990281|NCT01083368|Bevacizumab|bevacizumab|mesh-list
1990282|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1990283|NCT01083368|Antibodies|antibodies|mesh-list
1990284|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
1990285|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1990286|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990287|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1990288|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1990289|NCT01083368|Growth Substances|growth substances|mesh-ancestor
1990290|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990291|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
1990292|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
1990293|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1990294|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1990295|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1990296|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
1990297|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1990298|NCT01083485|Oxycodone|oxycodone|mesh-list
1990299|NCT01083485|Naloxone|naloxone|mesh-list
1990300|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1990301|NCT01083485|Narcotics|narcotics|mesh-ancestor
1990302|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1990303|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990304|NCT01083485|Analgesics|analgesics|mesh-ancestor
1990305|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
1990306|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990307|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1990308|NCT01083576|Gentamicins|gentamicins|mesh-list
1990309|NCT01083576|Paromomycin|paromomycin|mesh-list
1990310|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1990311|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1990312|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1990313|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990314|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990315|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1990316|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1990317|NCT01083602|Dexamethasone|dexamethasone|mesh-list
1990318|NCT01083602|Bortezomib|bortezomib|mesh-list
1990319|NCT01083602|Panobinostat|panobinostat|mesh-list
1990320|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1990321|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
1990322|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
1990323|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990324|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990325|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1990326|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
1990327|NCT01083602|Hormones|hormones|mesh-ancestor
1990328|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990329|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1990330|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990331|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1990332|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990333|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990334|NCT01083641|Estradiol|estradiol|mesh-list
1990335|NCT01083641|Estrogens|estrogens|mesh-ancestor
1990336|NCT01083641|Hormones|hormones|mesh-ancestor
1990337|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990338|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990339|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
1990340|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
1990341|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1990342|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1990343|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1990344|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1990345|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990346|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990347|NCT01083706|Azacitidine|azacitidine|mesh-list
1990348|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1990349|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
1990350|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990351|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990352|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990353|NCT01083732|Dabigatran|dabigatran|mesh-list
1990354|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
1990355|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1990356|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
1990357|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990358|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990359|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
1990360|NCT01083810|Ritonavir|ritonavir|mesh-list
1990361|NCT01083810|Lopinavir|lopinavir|mesh-list
1990362|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1990363|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1990364|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
1990365|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990366|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990367|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1990368|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1990369|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
1990370|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1990371|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1990372|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1990373|NCT01084005|Linagliptin|linagliptin|mesh-list
1990374|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1990375|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990376|NCT01084005|Incretins|incretins|mesh-ancestor
1990377|NCT01084005|Hormones|hormones|mesh-ancestor
1990378|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990379|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1990380|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
1990381|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990382|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990383|NCT01084083|Paclitaxel|paclitaxel|mesh-list
1990384|NCT01084083|Cetuximab|cetuximab|mesh-list
1990385|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1990386|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990387|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
1990388|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
1990389|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
1990390|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990391|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1990392|NCT01084135|Rivastigmine|rivastigmine|mesh-list
1990393|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1990394|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990395|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990396|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
1990397|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990398|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990399|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1990400|NCT01084135|Protective Agents|protective agents|mesh-ancestor
1990401|NCT01084148|V0034CR|v0034cr|mesh-list
1990402|NCT01084148|Emollients|emollients|mesh-ancestor
1990403|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
1990404|NCT01084252|Dexamethasone|dexamethasone|mesh-list
1990405|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
1990406|NCT01084252|BB 1101|bb 1101|mesh-list
1990407|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1990408|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
1990409|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
1990410|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990411|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990412|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1990413|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
1990414|NCT01084252|Hormones|hormones|mesh-ancestor
1990415|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990416|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1990417|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990418|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
1990419|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990420|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990421|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1990422|NCT01084265|Hormones|hormones|mesh-list
1990423|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1990424|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990425|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990426|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1990427|NCT01084278|Colchicine|colchicine|mesh-list
1990428|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
1990429|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1990430|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
1990431|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
1990432|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
1990433|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990434|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990435|NCT01084499|Letrozole|letrozole|mesh-list
1990436|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990437|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1990438|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1990439|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990440|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990441|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1990442|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
1990443|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990444|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990445|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
1990446|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1990447|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990448|NCT01084538|Vitamins|vitamins|mesh-ancestor
1990449|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
1990450|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1990451|NCT01084603|Nicotine|nicotine|mesh-list
1990452|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1990453|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
1990454|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990455|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990456|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1990457|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1990458|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
1990459|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990460|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990461|NCT01084655|Prednisone|prednisone|mesh-list
1990462|NCT01084655|Docetaxel|docetaxel|mesh-list
1990463|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990464|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
1990465|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
1990466|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
1990467|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990468|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1990469|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
1990470|NCT01084655|Hormones|hormones|mesh-ancestor
1990471|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990472|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990473|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1990474|NCT01084707|Nicotine|nicotine|mesh-list
1990475|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1990476|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
1990477|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990478|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990479|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1990480|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1990481|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
1990482|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990483|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990484|NCT01084759|Etoposide|etoposide|mesh-list
1990485|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
1990486|NCT01084759|Testosterone|testosterone|mesh-list
1990487|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
1990488|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
1990489|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1990490|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1990491|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990492|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1990493|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1990494|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990495|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990496|NCT01084759|Androgens|androgens|mesh-ancestor
1990497|NCT01084759|Hormones|hormones|mesh-ancestor
1990498|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990499|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990500|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1990501|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
1990502|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
1990503|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1990504|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1990505|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990506|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
1990507|NCT01085006|Coagulants|coagulants|mesh-ancestor
1990508|NCT01085045|Bromides|bromides|mesh-list
1990509|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
1990510|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
1990511|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1990512|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
1990513|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990514|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990515|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1990516|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
1990517|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1990518|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1990519|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1990520|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
1990521|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990522|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990523|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
1990524|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1990525|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
1990526|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
1990527|NCT01085136|Afatinib|afatinib|mesh-list
1990528|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990529|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1990530|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990531|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990532|NCT01085201|Regadenoson|regadenoson|mesh-list
1990533|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1990534|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1990535|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
1990536|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
1990537|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990538|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990539|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990540|NCT01085344|Factor VIII|factor viii|mesh-list
1990541|NCT01085344|Coagulants|coagulants|mesh-ancestor
1990542|NCT01085591|Vancomycin|vancomycin|mesh-list
1990543|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1990544|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1990545|NCT01085630|Pemetrexed|pemetrexed|mesh-list
1990546|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990547|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990548|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990549|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1990550|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1990551|NCT01085734|Bevacizumab|bevacizumab|mesh-list
1990552|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1990553|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990554|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1990555|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1990556|NCT01085734|Growth Substances|growth substances|mesh-ancestor
1990557|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990558|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
1990559|NCT01085760|Metronidazole|metronidazole|mesh-list
1990560|NCT01085760|Vancomycin|vancomycin|mesh-list
1990561|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1990562|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1990563|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1990564|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1990565|NCT01085786|Amoxicillin|amoxicillin|mesh-list
1990566|NCT01085786|Metronidazole|metronidazole|mesh-list
1990567|NCT01085786|Clarithromycin|clarithromycin|mesh-list
1990568|NCT01085786|Esomeprazole|esomeprazole|mesh-list
1990569|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1990570|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1990571|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1990572|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1990573|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1990574|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1990575|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1990576|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990577|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990578|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1990579|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1990580|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1990581|NCT01085812|Milnacipran|milnacipran|mesh-list
1990582|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
1990583|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1990584|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1990585|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1990586|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990587|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990588|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990589|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
1990590|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1990591|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1990592|NCT01085812|Analgesics|analgesics|mesh-ancestor
1990593|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
1990594|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990595|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
1990596|NCT01085903|Modafinil|modafinil|mesh-list
1990597|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1990598|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990599|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1990600|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1990601|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1990602|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990603|NCT01086150|Lidocaine|lidocaine|mesh-list
1990604|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
1990605|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
1990606|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1990607|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990608|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
1990609|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990610|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1990611|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1990612|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1990613|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1990614|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990615|NCT01086358|Naproxen|naproxen|mesh-list
1990616|NCT01086358|Sumatriptan|sumatriptan|mesh-list
1990617|NCT01086358|Naratriptan|naratriptan|mesh-list
1990618|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
1990619|NCT01086358|Rizatriptan|rizatriptan|mesh-list
1990620|NCT01086358|Eletriptan|eletriptan|mesh-list
1990621|NCT01086358|Almotriptan|almotriptan|mesh-list
1990622|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1990623|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1990624|NCT01086358|Analgesics|analgesics|mesh-ancestor
1990625|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
1990626|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990627|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990628|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1990629|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1990630|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
1990631|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1990632|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990633|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990634|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1990635|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1990636|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1990637|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
1990638|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990639|NCT01086384|Fluticasone|fluticasone|mesh-list
1990640|NCT01086384|Xhance|xhance|mesh-list
1990641|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1990642|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1990643|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
1990644|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990645|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990646|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1990647|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
1990648|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
1990649|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1990650|NCT01086410|Fluticasone|fluticasone|mesh-list
1990651|NCT01086410|Xhance|xhance|mesh-list
1990652|NCT01086410|Prednisolone|prednisolone|mesh-list
1990653|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1990654|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1990655|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
1990656|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990657|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990658|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1990659|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
1990660|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
1990661|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1990662|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
1990663|NCT01086410|Hormones|hormones|mesh-ancestor
1990664|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990665|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1990666|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990667|NCT01086475|Cycloserine|cycloserine|mesh-list
1990668|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1990669|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1990670|NCT01086475|Renal Agents|renal agents|mesh-ancestor
1990671|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1990672|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
1990673|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1990674|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
1990675|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990676|NCT01086540|Acetaminophen|acetaminophen|mesh-list
1990677|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
1990678|NCT01086540|Promethazine|promethazine|mesh-list
1990679|NCT01086540|Prednisone|prednisone|mesh-list
1990680|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
1990681|NCT01086540|Rituximab|rituximab|mesh-list
1990682|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1990683|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990684|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
1990685|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990686|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1990687|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1990688|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
1990689|NCT01086540|Hormones|hormones|mesh-ancestor
1990690|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990691|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1990692|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1990693|NCT01086540|Analgesics|analgesics|mesh-ancestor
1990694|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
1990695|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990696|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
1990697|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
1990698|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
1990699|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1990700|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1990701|NCT01086540|Protective Agents|protective agents|mesh-ancestor
1990702|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1990703|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1990704|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1990705|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
1990706|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
1990707|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1990708|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
1990709|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
1990710|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990711|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990712|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1990713|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
1990714|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
1990715|NCT01086605|Pixantrone|pixantrone|mesh-list
1990716|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1990717|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1990718|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990719|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990720|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990726|NCT01087489|Lidocaine|lidocaine|mesh-list
1990727|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
1990728|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
1990729|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1990730|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990731|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
1990732|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990733|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1990734|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1990735|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1990736|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1990737|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990738|NCT01087502|Glimepiride|glimepiride|mesh-list
1990739|NCT01087502|Linagliptin|linagliptin|mesh-list
1990740|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1990741|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1990742|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990743|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1990744|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
1990745|NCT01087502|Incretins|incretins|mesh-ancestor
1990746|NCT01087502|Hormones|hormones|mesh-ancestor
1990747|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990748|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1990749|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
1990750|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990751|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990752|NCT01087723|Heparin|heparin|mesh-list
1990753|NCT01087723|Bivalirudin|bivalirudin|mesh-list
1990754|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
1990755|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1990756|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1990757|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990758|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
1990759|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1990760|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
1990761|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990762|NCT01087736|Topiramate|topiramate|mesh-list
1990763|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
1990764|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1990765|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990766|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
1990767|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1990768|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
1990769|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990770|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1990771|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
1990772|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1990773|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
1990774|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990775|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1990776|NCT01087814|Efavirenz|efavirenz|mesh-list
1990777|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1990778|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1990779|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990780|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990781|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
1990782|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1990783|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1990784|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1990785|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1990786|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1990787|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1990788|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1990789|NCT01087905|Nicotine|nicotine|mesh-list
1990790|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1990791|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
1990792|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990793|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990794|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1990795|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1990796|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
1990797|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990798|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990799|NCT01087931|Bupivacaine|bupivacaine|mesh-list
1990800|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
1990801|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
1990802|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1990803|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990804|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
1990805|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990806|NCT01087970|Carboplatin|carboplatin|mesh-list
1990807|NCT01087970|Pemetrexed|pemetrexed|mesh-list
1990808|NCT01087970|Cetuximab|cetuximab|mesh-list
1990809|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990810|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990811|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990812|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1990813|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1990814|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1990815|NCT01088048|Rituximab|rituximab|mesh-list
1990816|NCT01088048|Fludarabine|fludarabine|mesh-list
1990817|NCT01088048|Lenalidomide|lenalidomide|mesh-list
1990818|NCT01088048|Everolimus|everolimus|mesh-list
1990819|NCT01088048|Bortezomib|bortezomib|mesh-list
1990820|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1990821|NCT01088048|Ofatumumab|ofatumumab|mesh-list
1990822|NCT01088048|Idelalisib|idelalisib|mesh-list
1990823|NCT01088048|Chlorambucil|chlorambucil|mesh-list
1990824|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1990825|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990826|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
1990827|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990828|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1990829|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990830|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1990831|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1990832|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1990833|NCT01088048|Growth Substances|growth substances|mesh-ancestor
1990834|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
1990835|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1990836|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
1990837|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990838|NCT01088243|Mesalamine|mesalamine|mesh-list
1990839|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1990840|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1990841|NCT01088243|Analgesics|analgesics|mesh-ancestor
1990842|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
1990843|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990844|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990845|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1990846|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1990847|NCT01088295|Telmisartan|telmisartan|mesh-list
1990848|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1990849|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1990850|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1990851|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990852|NCT01088464|Necitumumab|necitumumab|mesh-list
1990853|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1990854|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1990855|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990856|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
1990857|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990858|NCT01088529|Prednisone|prednisone|mesh-list
1990859|NCT01088529|Leuprolide|leuprolide|mesh-list
1990860|NCT01088529|Goserelin|goserelin|mesh-list
1990861|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
1990862|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1990863|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
1990864|NCT01088529|Hormones|hormones|mesh-ancestor
1990865|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1990866|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990867|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1990868|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990869|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1990870|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
1990871|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1990872|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1990873|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990874|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990875|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
1990876|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1990893|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1990894|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1990895|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
1990896|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990897|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990898|NCT01088997|Milrinone|milrinone|mesh-list
1990899|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1990900|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1990901|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
1990902|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1990903|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1990904|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990905|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990906|NCT01088997|Protective Agents|protective agents|mesh-ancestor
1990907|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990908|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
1990909|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1990910|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
1990911|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
1990912|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990913|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990914|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990915|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1990916|NCT01089062|Analgesics|analgesics|mesh-ancestor
1990917|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
1990918|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990919|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1990920|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1990921|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
1990922|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990923|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990924|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1990925|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
1990926|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1990927|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1990928|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1990929|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
1990930|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990931|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990932|NCT01089361|Ketamine|ketamine|mesh-list
1990933|NCT01089361|Analgesics|analgesics|mesh-ancestor
1990934|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
1990935|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990936|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990937|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1990938|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1990939|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
1990940|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
1990941|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1990942|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1990943|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1990944|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990945|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990946|NCT01089413|Bevacizumab|bevacizumab|mesh-list
1990947|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1990948|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990949|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1990950|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1990951|NCT01089413|Growth Substances|growth substances|mesh-ancestor
1990952|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990953|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
1990954|NCT01089504|Phenobarbital|phenobarbital|mesh-list
1990955|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
1990956|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1990957|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1990958|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990959|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1990960|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1990961|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990962|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990963|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
1990964|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
1990965|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1990966|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1990967|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1990968|NCT01089517|Ranibizumab|ranibizumab|mesh-list
1990969|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1990970|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1990971|NCT01089517|Growth Substances|growth substances|mesh-ancestor
1990972|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990973|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
1990974|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1990975|NCT01089543|Rabeprazole|rabeprazole|mesh-list
1990976|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1990977|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1990978|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1990979|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1990980|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990981|NCT01089556|Pregabalin|pregabalin|mesh-list
1990982|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1990983|NCT01089556|Analgesics|analgesics|mesh-ancestor
1990984|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
1990985|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1990986|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1990987|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
1990988|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1990989|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1990990|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1990991|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1990992|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1990993|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1990994|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1990995|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1990996|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1990997|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1990998|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1990999|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
1991000|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
1991001|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
1991002|NCT01089569|Exenatide|exenatide|mesh-list
1991003|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1991004|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991005|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1991006|NCT01089569|Incretins|incretins|mesh-ancestor
1991007|NCT01089569|Hormones|hormones|mesh-ancestor
1991008|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1991009|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
1991010|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991011|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1991012|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991013|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991014|NCT01089608|Azithromycin|azithromycin|mesh-list
1991015|NCT01089608|Povidone|povidone|mesh-list
1991016|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1991017|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991018|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
1991019|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
1991020|NCT01089647|Budesonide|budesonide|mesh-list
1991021|NCT01089647|Montelukast|montelukast|mesh-list
1991022|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1991023|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1991024|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
1991025|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991026|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991027|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1991028|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
1991029|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
1991030|NCT01089647|Hormones|hormones|mesh-ancestor
1991031|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1991032|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1991033|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
1991034|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1991035|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1991036|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991037|NCT01089725|Tanezumab|tanezumab|mesh-list
1991038|NCT01089725|Analgesics|analgesics|mesh-ancestor
1991039|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
1991040|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991041|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991042|NCT01089751|Trospium chloride|trospium chloride|mesh-list
1991043|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
1991044|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
1991045|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991046|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991047|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1991048|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1991049|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
1991050|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991051|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991052|NCT01089751|Urological Agents|urological agents|mesh-ancestor
1991053|NCT01090011|Cetuximab|cetuximab|mesh-list
1991054|NCT01090011|Afatinib|afatinib|mesh-list
1991055|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1991056|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991057|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1991058|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991059|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991060|NCT01090050|Naproxen|naproxen|mesh-list
1991061|NCT01090050|Sumatriptan|sumatriptan|mesh-list
1991062|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1991063|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1991064|NCT01090050|Analgesics|analgesics|mesh-ancestor
1991065|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
1991066|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991067|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991068|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1991069|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1991070|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
1991071|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1991072|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991073|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991074|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1991075|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1991076|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1991077|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
1991078|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991079|NCT01090063|Ustekinumab|ustekinumab|mesh-list
1991080|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
1991081|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
1991082|NCT01090102|Mesalamine|mesalamine|mesh-list
1991083|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1991084|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1991085|NCT01090102|Analgesics|analgesics|mesh-ancestor
1991086|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
1991087|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991088|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991089|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1991090|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1991091|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
1991092|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1991093|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991094|NCT01090180|Dexamethasone|dexamethasone|mesh-list
1991095|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1991096|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
1991097|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
1991098|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991099|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991100|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1991101|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
1991102|NCT01090180|Hormones|hormones|mesh-ancestor
1991103|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1991104|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1991105|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991106|NCT01090323|Deferasirox|deferasirox|mesh-list
1991107|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1991108|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
1991109|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
1991110|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991111|NCT01090414|Idelalisib|idelalisib|mesh-list
1991112|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991113|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991114|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991115|NCT01090427|Ustekinumab|ustekinumab|mesh-list
1991116|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
1991117|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1991118|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
1991119|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991120|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
1991121|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1991122|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991123|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
1991124|NCT01090752|Metformin|metformin|mesh-list
1991125|NCT01090752|Pioglitazone|pioglitazone|mesh-list
1991126|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1991127|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991128|NCT01090921|Bortezomib|bortezomib|mesh-list
1991129|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991130|NCT01090973|Panobinostat|panobinostat|mesh-list
1991131|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
1991132|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991133|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991134|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991135|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
1991136|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
1991137|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
1991138|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991139|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1991140|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1991141|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
1991142|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991143|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
1991144|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991145|NCT01091259|Bevacizumab|bevacizumab|mesh-list
1991146|NCT01091259|Irinotecan|irinotecan|mesh-list
1991147|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1991148|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991149|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1991150|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1991151|NCT01091259|Growth Substances|growth substances|mesh-ancestor
1991152|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991153|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
1991154|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1991155|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1991156|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991157|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991158|NCT01091428|Paclitaxel|paclitaxel|mesh-list
1991159|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1991160|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991161|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
1991162|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
1991163|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
1991164|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991165|NCT01091454|Cisplatin|cisplatin|mesh-list
1991166|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991167|NCT01091519|Fesoterodine|fesoterodine|mesh-list
1991168|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1991169|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1991170|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
1991171|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991172|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991173|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991174|NCT01091519|Urological Agents|urological agents|mesh-ancestor
1991175|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1991176|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
1991177|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1991178|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1991179|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1991180|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991181|NCT01091675|Etoricoxib|etoricoxib|mesh-list
1991182|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1991183|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1991184|NCT01091675|Analgesics|analgesics|mesh-ancestor
1991185|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
1991186|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991187|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991188|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1991189|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1991190|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1991191|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1991192|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991193|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991194|NCT01091974|Modafinil|modafinil|mesh-list
1991195|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1991196|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991197|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1991198|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1991199|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1991200|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991201|NCT01092182|Prednisone|prednisone|mesh-list
1991202|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
1991203|NCT01092182|Rituximab|rituximab|mesh-list
1991204|NCT01092182|Doxorubicin|doxorubicin|mesh-list
1991205|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1991206|NCT01092182|Etoposide|etoposide|mesh-list
1991207|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
1991208|NCT01092182|Vincristine|vincristine|mesh-list
1991209|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1991210|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
1991211|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991212|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1991213|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1991214|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
1991215|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991216|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991217|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1991218|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1991219|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1991220|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1991221|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1991222|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991223|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1991224|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
1991225|NCT01092182|Hormones|hormones|mesh-ancestor
1991226|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1991227|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1991228|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1991229|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
1991230|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
1991231|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
1991232|NCT01092338|Vitamin D|vitamin d|mesh-list
1991233|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
1991234|NCT01092338|Vitamins|vitamins|mesh-ancestor
1991235|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
1991236|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991237|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1991238|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1991239|NCT01092507|Vaccines|vaccines|mesh-list
1991240|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
1991241|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991242|NCT01092546|Flutemetamol|flutemetamol|mesh-list
1991243|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2079352|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1991244|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991245|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
1991246|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1991247|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
1991248|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991249|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991250|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1991251|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
1991252|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1991253|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
1991254|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991255|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991256|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1991257|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
1991258|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
1991259|NCT01092559|Protective Agents|protective agents|mesh-ancestor
1991260|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1991261|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1991262|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1991263|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991264|NCT01092663|Incretins|incretins|mesh-ancestor
1991265|NCT01092663|Hormones|hormones|mesh-ancestor
1991266|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1991267|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1991268|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
1991269|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991270|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991271|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1991272|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1991273|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
1991274|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1991275|NCT01092676|Ibuprofen|ibuprofen|mesh-list
1991276|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1991277|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1991278|NCT01092676|Analgesics|analgesics|mesh-ancestor
1991279|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
1991280|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991281|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991282|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1991283|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1991284|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1991285|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991286|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991287|NCT01092702|Varenicline|varenicline|mesh-list
1991288|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1991289|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1991290|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
1991291|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991292|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991293|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991294|NCT01092728|Dasatinib|dasatinib|mesh-list
1991295|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991296|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1991297|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991298|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991299|NCT01092780|Modafinil|modafinil|mesh-list
1991300|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1991301|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991302|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1991303|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1991304|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1991305|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991306|NCT01092832|Voriconazole|voriconazole|mesh-list
1991307|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
1991308|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991309|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1991310|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1991311|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991312|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991313|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1991314|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
2079353|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1991315|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1991316|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991317|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1991318|NCT01092923|Sevoflurane|sevoflurane|mesh-list
1991319|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1991320|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1991321|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
1991322|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
1991323|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1991324|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991325|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
1991326|NCT01093183|Lenalidomide|lenalidomide|mesh-list
1991327|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1991328|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
1991329|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991330|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1991331|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1991332|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
1991333|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991334|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991335|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1991336|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1991337|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1991338|NCT01093183|Growth Substances|growth substances|mesh-ancestor
1991339|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
1991340|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1991341|NCT01093222|Sorafenib|sorafenib|mesh-list
1991342|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991343|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1991344|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991345|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991346|NCT01093417|Vitamin D|vitamin d|mesh-list
1991347|NCT01093417|Vitamins|vitamins|mesh-ancestor
1991348|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
1991349|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991350|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1991351|NCT01093469|Decanoic acid|decanoic acid|mesh-list
1991352|NCT01093469|Petrolatum|petrolatum|mesh-list
1991353|NCT01093469|Emollients|emollients|mesh-ancestor
1991354|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
1991355|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
1991356|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991357|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
1991358|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1991359|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991360|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991361|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
1991362|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1991363|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1991364|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
1991365|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991366|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991367|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991368|NCT01093534|Urological Agents|urological agents|mesh-ancestor
1991369|NCT01093573|Azacitidine|azacitidine|mesh-list
1991370|NCT01093573|Midostaurin|midostaurin|mesh-list
1991371|NCT01093573|Staurosporine|staurosporine|mesh-list
1991372|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1991373|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
1991374|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991375|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991376|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991377|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1991378|NCT01093586|Cyclosporine|cyclosporine|mesh-list
1991379|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
1991380|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
1991381|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1991382|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1991383|NCT01093586|Prednisolone|prednisolone|mesh-list
1991384|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
1991385|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
1991386|NCT01093586|Busulfan|busulfan|mesh-list
1991387|NCT01093586|Cyclosporins|cyclosporins|mesh-list
1991388|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
1991389|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1991390|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1991391|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
1991392|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1991393|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
1991394|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991395|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1991396|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1991397|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
1991398|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991399|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991400|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1991401|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991402|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
1991403|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991404|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
1991405|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1991406|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1991407|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1991408|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
1991409|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1991410|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1991411|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
1991412|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
1991413|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991414|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1991415|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
1991416|NCT01093586|Hormones|hormones|mesh-ancestor
1991417|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1991418|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1991419|NCT01093586|Protective Agents|protective agents|mesh-ancestor
1991420|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1991421|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1991422|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1991423|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991424|NCT01093651|Incretins|incretins|mesh-ancestor
1991425|NCT01093651|Hormones|hormones|mesh-ancestor
1991426|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1991427|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1991428|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
1991429|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991430|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991431|NCT01093690|Metoclopramide|metoclopramide|mesh-list
1991432|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
1991433|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
1991434|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991435|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991436|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1991437|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1991438|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1991439|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
1991440|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991441|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991442|NCT01093755|Omeprazole|omeprazole|mesh-list
1991443|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
1991444|NCT01093755|Lansoprazole|lansoprazole|mesh-list
1991445|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1991446|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1991447|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1991448|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991449|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991450|NCT01093794|Metformin|metformin|mesh-list
1991451|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1991452|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1991453|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991454|NCT01093794|Incretins|incretins|mesh-ancestor
1991455|NCT01093794|Hormones|hormones|mesh-ancestor
1991456|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1991457|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1991458|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
1991459|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991460|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991461|NCT01093885|Ambrisentan|ambrisentan|mesh-list
1991462|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1991463|NCT01093976|Dronabinol|dronabinol|mesh-list
1991464|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
1991465|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991466|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1991467|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1991468|NCT01093976|Analgesics|analgesics|mesh-ancestor
1991469|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
1991470|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991471|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1991472|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1991473|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991474|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991475|NCT01093976|Hormones|hormones|mesh-ancestor
1991476|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1991477|NCT01094106|Ropivacaine|ropivacaine|mesh-list
1991478|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
1991479|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
1991480|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1991481|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991482|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
1991483|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991484|NCT01094184|Paclitaxel|paclitaxel|mesh-list
1991485|NCT01094184|Docetaxel|docetaxel|mesh-list
1991486|NCT01094184|Bevacizumab|bevacizumab|mesh-list
1991487|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1991488|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991489|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
1991490|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
1991491|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
1991492|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991493|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1991494|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1991495|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1991496|NCT01094184|Growth Substances|growth substances|mesh-ancestor
1991497|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991498|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
1991499|NCT01094288|Docetaxel|docetaxel|mesh-list
1991500|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991501|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
1991502|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
1991503|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
1991504|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991505|NCT01094522|Morphine|morphine|mesh-list
1991506|NCT01094522|Methadone|methadone|mesh-list
1991507|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1991508|NCT01094522|Narcotics|narcotics|mesh-ancestor
1991509|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1991510|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991511|NCT01094522|Analgesics|analgesics|mesh-ancestor
1991512|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
1991513|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991514|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
1991515|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
1991516|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
1991517|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1991518|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
1991519|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991520|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1991521|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1991522|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
1991523|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991524|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991525|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1991526|NCT01094574|Propranolol|propranolol|mesh-list
1991527|NCT01094574|Alfentanil|alfentanil|mesh-list
1991528|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1991529|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1991530|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
1991531|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991532|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991533|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991534|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1991535|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1991536|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
1991537|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1991538|NCT01094574|Narcotics|narcotics|mesh-ancestor
1991539|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1991540|NCT01094574|Analgesics|analgesics|mesh-ancestor
1991541|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
1991542|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991543|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1991544|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
1991545|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
1991546|NCT01094717|Tazarotene|tazarotene|mesh-list
1991547|NCT01094717|Acitretin|acitretin|mesh-list
1991548|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
1991549|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
1991550|NCT01094808|Pregabalin|pregabalin|mesh-list
1991551|NCT01094808|Analgesics|analgesics|mesh-ancestor
1991552|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
1991553|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991554|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991555|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
1991556|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1991557|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1991558|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991559|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1991560|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1991561|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1991562|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1991563|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1991564|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
1991565|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1991566|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
1991567|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1991568|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
1991569|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991570|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991571|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
1991572|NCT01095003|Capecitabine|capecitabine|mesh-list
1991573|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1991574|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
1991575|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991576|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991577|NCT01095094|Ritonavir|ritonavir|mesh-list
1991578|NCT01095094|Lopinavir|lopinavir|mesh-list
1991579|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1991580|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1991581|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
1991582|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991583|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991584|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1991585|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1991586|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
1991587|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991588|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1991589|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1991590|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1991591|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1991592|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1991593|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
1991594|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991595|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1991596|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1991597|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1991598|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
1991599|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991600|NCT01095653|Metformin|metformin|mesh-list
1991601|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
1991602|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1991603|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991604|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1991605|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991606|NCT01095666|Metformin|metformin|mesh-list
1991607|NCT01095666|Pioglitazone|pioglitazone|mesh-list
1991608|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
1991609|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1991610|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991611|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1991612|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991613|NCT01095757|Plerixafor|plerixafor|mesh-list
1991614|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1991615|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1991616|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
1991617|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991618|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1991619|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1991620|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1991621|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1991622|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991623|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991624|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
1991625|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991626|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1991627|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1991628|NCT01095835|Interferons|interferons|mesh-list
1991629|NCT01095835|Lamivudine|lamivudine|mesh-list
1991630|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1991631|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
1991632|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991633|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
1991634|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991635|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1991636|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1991637|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991638|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991639|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1991640|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1991641|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
1991642|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991643|NCT01095887|Eculizumab|eculizumab|mesh-list
1991644|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1991645|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1991646|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
1991647|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991648|NCT01095978|Clarithromycin|clarithromycin|mesh-list
1991649|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1991650|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991651|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1991652|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991653|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991654|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1991655|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1991656|NCT01096017|Albuterol|albuterol|mesh-list
1991657|NCT01096017|Terbutaline|terbutaline|mesh-list
1991658|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1991659|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
1991660|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991661|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991662|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1991663|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
1991664|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
1991665|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1991666|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1991667|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1991668|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1991669|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
1991670|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991671|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991672|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
1991673|NCT01096056|Vaccines|vaccines|mesh-list
1991674|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
1991675|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991676|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1991677|NCT01096186|Carbidopa|carbidopa|mesh-list
1991678|NCT01096186|Levodopa|levodopa|mesh-list
1991679|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1991680|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
1991681|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991682|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1991683|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1991684|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
1991685|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
1991686|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991687|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079354|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1991688|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1991689|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991690|NCT01096290|Lubiprostone|lubiprostone|mesh-list
1991691|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1991692|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1991693|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991694|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
1991695|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1991696|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991697|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991698|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1991699|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
1991700|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1991701|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1991702|NCT01096589|Monensin|monensin|mesh-list
1991703|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
1991704|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991705|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1991706|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1991707|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
1991708|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
1991709|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
1991710|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991711|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991712|NCT01096589|Ionophores|ionophores|mesh-ancestor
1991713|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1991714|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
1991715|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
1991716|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1991717|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1991718|NCT01096667|Diuretics|diuretics|mesh-ancestor
1991719|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
1991720|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991721|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1991722|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1991723|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991724|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1991725|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1991726|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1991727|NCT01096680|Modafinil|modafinil|mesh-list
1991728|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1991729|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991730|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1991731|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1991732|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1991733|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991734|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
1991735|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991736|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1991737|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1991738|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1991739|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1991740|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1991741|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1991742|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1991743|NCT01096784|Mecasermin|mecasermin|mesh-list
1991744|NCT01096784|Growth Substances|growth substances|mesh-ancestor
1991745|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991746|NCT01096849|Levofloxacin|levofloxacin|mesh-list
1991747|NCT01096849|Ofloxacin|ofloxacin|mesh-list
1991748|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1991749|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991750|NCT01096849|Renal Agents|renal agents|mesh-ancestor
1991751|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1991752|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1991753|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1991754|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991755|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991756|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991757|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1991758|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1991759|NCT01096875|Atorvastatin|atorvastatin|mesh-list
1991760|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1991761|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1991762|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
1991763|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991764|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1991765|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1991766|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991767|NCT01096992|Vidarabine|vidarabine|mesh-list
1991768|NCT01096992|Rituximab|rituximab|mesh-list
1991769|NCT01096992|Fludarabine|fludarabine|mesh-list
1991770|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
1991771|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1991772|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1991773|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991774|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
1991775|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991776|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1991777|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1991778|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
1991779|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991780|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1991781|NCT01096992|Antiviral Agents|antiviral agents|mesh-ancestor
1991782|NCT01096992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991783|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1991784|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
1991785|NCT01097044|Afamelanotide|afamelanotide|mesh-list
1991786|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
1991787|NCT01097057|Plerixafor|plerixafor|mesh-list
1991788|NCT01097057|Rituximab|rituximab|mesh-list
1991789|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1991790|NCT01097057|Carboplatin|carboplatin|mesh-list
1991791|NCT01097057|Etoposide|etoposide|mesh-list
1991792|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
1991793|NCT01097057|Ifosfamide|ifosfamide|mesh-list
1991794|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
1991795|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
1991796|NCT01097057|Antibodies|antibodies|mesh-list
1991797|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
1991798|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1991799|NCT01097057|Lenograstim|lenograstim|mesh-list
1991800|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
1991801|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991802|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991803|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1991804|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1991805|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1991806|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1991807|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991808|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991809|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1991810|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1991811|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
1991812|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1991813|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1991814|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
1991815|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991816|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
1991817|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
1991818|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
1991819|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
1991820|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
1991821|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1991822|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1991823|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1991824|NCT01097330|Amiodarone|amiodarone|mesh-list
1991825|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1991826|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
1991827|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1991828|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1991829|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991830|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1991831|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1991832|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1991833|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991834|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1991835|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1991836|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1991837|NCT01097343|Clopidogrel|clopidogrel|mesh-list
1991838|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1991839|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1991840|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1991841|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1991842|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
1991843|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991844|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991845|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991846|NCT01097395|Ribavirin|ribavirin|mesh-list
1991847|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
1991848|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991849|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
1991850|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991851|NCT01097421|Pramipexole|pramipexole|mesh-list
1991852|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
1991853|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991854|NCT01097421|Protective Agents|protective agents|mesh-ancestor
1991855|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991856|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1991857|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1991858|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
1991859|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
1991860|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991861|NCT01097460|Trastuzumab|trastuzumab|mesh-list
1991862|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1991863|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991864|NCT01097577|Pregabalin|pregabalin|mesh-list
1991865|NCT01097577|Analgesics|analgesics|mesh-ancestor
1991866|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
1991867|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991868|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991869|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
1991870|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1991871|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1991872|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991873|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1991874|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1991875|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1991876|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1991877|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1991878|NCT01097616|Suvorexant|suvorexant|mesh-list
1991879|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1991880|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1991881|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1991882|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991883|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1991884|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991885|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991886|NCT01097629|Suvorexant|suvorexant|mesh-list
1991887|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1991888|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1991889|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1991890|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991891|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1991892|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991893|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991894|NCT01097642|Cetuximab|cetuximab|mesh-list
1991895|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1991896|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991897|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
1991898|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991899|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1991900|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991901|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991902|NCT01097785|Simvastatin|simvastatin|mesh-list
1991903|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1991904|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1991905|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
1991906|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991907|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1991908|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1991909|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991910|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
1991911|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
1991912|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991913|NCT01098032|Expectorants|expectorants|mesh-ancestor
1991914|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
1991915|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1991916|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
1991917|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991918|NCT01098032|Protective Agents|protective agents|mesh-ancestor
1991919|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991920|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
1991921|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1991922|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
1991923|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1991924|NCT01098097|Ribavirin|ribavirin|mesh-list
1991925|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
1991926|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991927|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
1991928|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1991929|NCT01098110|Asenapine|asenapine|mesh-list
1991930|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1991931|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1991932|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1991933|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991934|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1991935|NCT01098305|Varenicline|varenicline|mesh-list
1991936|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1991937|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1991938|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
1991939|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991940|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991941|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991942|NCT01098318|Sertraline|sertraline|mesh-list
1991943|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
1991944|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1991945|NCT01098318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1991946|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1991947|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1991948|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991949|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1991950|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
1991951|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991952|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
1991953|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
1991954|NCT01098461|Incretins|incretins|mesh-ancestor
1991955|NCT01098461|Hormones|hormones|mesh-ancestor
1991956|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1991957|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991958|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1991959|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
1991960|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991961|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1991962|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
1991963|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1991964|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991965|NCT01098539|Incretins|incretins|mesh-ancestor
1991966|NCT01098539|Hormones|hormones|mesh-ancestor
1991967|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1991968|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1991969|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
1991970|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991971|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991972|NCT01098747|Ibuprofen|ibuprofen|mesh-list
1991973|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1991974|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1991975|NCT01098747|Analgesics|analgesics|mesh-ancestor
1991976|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
1991977|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1991978|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991979|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1991980|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1991981|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1991982|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1991983|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991984|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
1991985|NCT01099202|Hematinics|hematinics|mesh-ancestor
1991986|NCT01099358|Fluorouracil|fluorouracil|mesh-list
1991987|NCT01099358|Cetuximab|cetuximab|mesh-list
1991988|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1991989|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
1991990|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1991991|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1991992|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1991993|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
1991994|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1991995|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1991996|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
1991997|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
1991998|NCT01099449|Calcium|calcium|mesh-list
1991999|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1992000|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992001|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992002|NCT01099449|Analgesics|analgesics|mesh-ancestor
1992003|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
1992004|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992005|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
1992006|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992007|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1992008|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
1992009|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1992010|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1992011|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992012|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
1992013|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1992014|NCT01099579|Ritonavir|ritonavir|mesh-list
1992015|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1992016|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1992017|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1992018|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
1992019|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992020|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992021|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1992022|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1992023|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
1992024|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992025|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1992026|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1992027|NCT01099618|Metformin|metformin|mesh-list
1992028|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1992029|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1992030|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992031|NCT01099618|Incretins|incretins|mesh-ancestor
1992032|NCT01099618|Hormones|hormones|mesh-ancestor
1992033|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992034|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1992035|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
1992036|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992037|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992038|NCT01099709|Oxycodone|oxycodone|mesh-list
1992039|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1992040|NCT01099709|Narcotics|narcotics|mesh-ancestor
1992041|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992042|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992043|NCT01099709|Analgesics|analgesics|mesh-ancestor
1992044|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
1992045|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992046|NCT01099774|Bimatoprost|bimatoprost|mesh-list
1992047|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1992048|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1992049|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1992050|NCT01100034|Etanercept|etanercept|mesh-list
1992051|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1992052|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1992053|NCT01100034|Analgesics|analgesics|mesh-ancestor
1992054|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
1992055|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992056|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992057|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1992058|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1992059|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1992060|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1992061|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
1992062|NCT01100086|Oxycodone|oxycodone|mesh-list
1992063|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1992064|NCT01100086|Narcotics|narcotics|mesh-ancestor
1992065|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992066|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992067|NCT01100086|Analgesics|analgesics|mesh-ancestor
1992068|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
1992069|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992070|NCT01100112|Budesonide|budesonide|mesh-list
1992071|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1992072|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1992073|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
1992074|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992075|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992076|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1992077|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
1992078|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
1992079|NCT01100112|Hormones|hormones|mesh-ancestor
1992080|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992081|NCT01100242|Bortezomib|bortezomib|mesh-list
1992082|NCT01100242|Sorafenib|sorafenib|mesh-list
1992083|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992084|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1992085|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992086|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992087|NCT01100255|Ketamine|ketamine|mesh-list
1992088|NCT01100255|Analgesics|analgesics|mesh-ancestor
1992089|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
1992090|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992091|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992092|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1992093|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1992094|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
1992095|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
1992096|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992097|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1992098|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1992099|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992100|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992101|NCT01100268|Methylphenidate|methylphenidate|mesh-list
1992102|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1992103|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992104|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1992105|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1992106|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1992107|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992108|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
1992109|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992110|NCT01100320|Oxycodone|oxycodone|mesh-list
1992111|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1992112|NCT01100320|Narcotics|narcotics|mesh-ancestor
1992113|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992114|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992115|NCT01100320|Analgesics|analgesics|mesh-ancestor
1992116|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
1992117|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992118|NCT01100437|Naltrexone|naltrexone|mesh-list
1992119|NCT01100437|Morphine|morphine|mesh-list
1992120|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1992121|NCT01100437|Narcotics|narcotics|mesh-ancestor
1992122|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992123|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992124|NCT01100437|Analgesics|analgesics|mesh-ancestor
1992125|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
1992126|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992127|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1992128|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1992129|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1992130|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1992131|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992132|NCT01100528|Interferons|interferons|mesh-list
1992133|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
1992134|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
1992135|NCT01100528|Dacarbazine|dacarbazine|mesh-list
1992136|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992137|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
1992138|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992139|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
1992140|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992141|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1992142|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
1992143|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992144|NCT01100606|Pancrelipase|pancrelipase|mesh-list
1992145|NCT01100606|Pancreatin|pancreatin|mesh-list
1992146|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1992147|NCT01100723|Vitamin D|vitamin d|mesh-list
1992148|NCT01100723|Calcitriol|calcitriol|mesh-list
1992149|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
1992150|NCT01100723|Cinacalcet|cinacalcet|mesh-list
1992151|NCT01100723|Vitamins|vitamins|mesh-ancestor
1992152|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
1992153|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992154|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1992155|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1992156|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1992157|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1992158|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992159|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1992160|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1992161|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
1992162|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992163|NCT01100853|Naltrexone|naltrexone|mesh-list
1992164|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1992165|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1992166|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992167|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
1992168|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992169|NCT01100931|Paclitaxel|paclitaxel|mesh-list
1992170|NCT01100931|Carboplatin|carboplatin|mesh-list
1992171|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1992172|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992173|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
1992174|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
1992175|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
1992176|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992177|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
1992178|NCT01100944|Doxorubicin|doxorubicin|mesh-list
1992179|NCT01100944|Belinostat|belinostat|mesh-list
1992180|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1992181|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
1992182|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992183|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1992184|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1992185|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
1992186|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992187|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992188|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1992189|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1992190|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1992191|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1992192|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992193|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1992194|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1992195|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1992196|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992197|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1992198|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1992199|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1992200|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992201|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
1992202|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992203|NCT01101035|Allopurinol|allopurinol|mesh-list
1992204|NCT01101035|Febuxostat|febuxostat|mesh-list
1992205|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
1992206|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992207|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992208|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
1992209|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1992210|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1992211|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
1992212|NCT01101035|Protective Agents|protective agents|mesh-ancestor
1992213|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992214|NCT01101100|Brodalumab|brodalumab|mesh-list
1992215|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
1992216|NCT01101165|Oxycodone|oxycodone|mesh-list
1992217|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1992218|NCT01101165|Narcotics|narcotics|mesh-ancestor
1992219|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992220|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992221|NCT01101165|Analgesics|analgesics|mesh-ancestor
1992222|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
1992223|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992224|NCT01101178|Oxycodone|oxycodone|mesh-list
1992225|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1992226|NCT01101178|Narcotics|narcotics|mesh-ancestor
1992227|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992228|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992229|NCT01101178|Analgesics|analgesics|mesh-ancestor
1992230|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
1992231|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992232|NCT01101191|Oxycodone|oxycodone|mesh-list
1992233|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1992234|NCT01101191|Narcotics|narcotics|mesh-ancestor
1992235|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992236|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992237|NCT01101191|Analgesics|analgesics|mesh-ancestor
1992238|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
1992239|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992240|NCT01101308|Oxycodone|oxycodone|mesh-list
1992241|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1992242|NCT01101308|Narcotics|narcotics|mesh-ancestor
1992243|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992244|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992245|NCT01101308|Analgesics|analgesics|mesh-ancestor
1992246|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
1992247|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992248|NCT01101321|Oxycodone|oxycodone|mesh-list
1992249|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1992250|NCT01101321|Narcotics|narcotics|mesh-ancestor
1992251|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992252|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992253|NCT01101321|Analgesics|analgesics|mesh-ancestor
1992254|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
1992255|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992256|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1992257|NCT01101334|Efatutazone|efatutazone|mesh-list
1992258|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992259|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1992260|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992261|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992262|NCT01101464|Asenapine|asenapine|mesh-list
1992263|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1992264|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1992265|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992266|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992267|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1992268|NCT01101750|Vaccines|vaccines|mesh-list
1992269|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
1992270|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992271|NCT01101841|Paroxetine|paroxetine|mesh-list
1992272|NCT01101841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1992273|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1992274|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1992275|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992276|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992277|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
1992278|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992279|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1992280|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
1992281|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1992282|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2079355|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1992283|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1992284|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992285|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
1992286|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
1992287|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1992288|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1992289|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992290|NCT01101880|Cytarabine|cytarabine|mesh-list
1992291|NCT01101880|Clofarabine|clofarabine|mesh-list
1992292|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
1992293|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992294|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1992295|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
1992296|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992297|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992298|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
1992299|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992300|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1992301|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
1992302|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
1992303|NCT01102218|Hematinics|hematinics|mesh-ancestor
1992304|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1992305|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992306|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992307|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1992308|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1992309|NCT01102218|Protective Agents|protective agents|mesh-ancestor
1992310|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992311|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
1992312|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1992313|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
1992314|NCT01102231|Cetuximab|cetuximab|mesh-list
1992315|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1992316|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992317|NCT01102270|Eszopiclone|eszopiclone|mesh-list
1992318|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1992319|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992320|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992321|NCT01102374|Vitamin D|vitamin d|mesh-list
1992322|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
1992323|NCT01102374|Vitamins|vitamins|mesh-list
1992324|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
1992325|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992326|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1992327|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1992328|NCT01102426|Dexamethasone|dexamethasone|mesh-list
1992329|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1992330|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
1992331|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
1992332|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992333|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992334|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1992335|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
1992336|NCT01102426|Hormones|hormones|mesh-ancestor
1992337|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992338|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1992339|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992340|NCT01102491|Ramosetron|ramosetron|mesh-list
1992341|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
1992342|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
1992343|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992344|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992345|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1992346|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1992347|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
1992348|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992349|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992350|NCT01102803|Cycloserine|cycloserine|mesh-list
1992351|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1992352|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992353|NCT01102803|Renal Agents|renal agents|mesh-ancestor
1992354|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1992355|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
1992356|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1992357|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
2079356|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1992358|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992359|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1992360|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1992361|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1992362|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1992363|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992364|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992365|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
1992366|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992367|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1992368|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1992369|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1992370|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1992371|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
1992372|NCT01103063|Azithromycin|azithromycin|mesh-list
1992373|NCT01103063|Chloroquine|chloroquine|mesh-list
1992374|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
1992375|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
1992376|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
1992377|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1992378|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992379|NCT01103063|Amebicides|amebicides|mesh-ancestor
1992380|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1992381|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1992382|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
1992383|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1992384|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1992385|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992386|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992387|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1992388|NCT01103063|Renal Agents|renal agents|mesh-ancestor
1992389|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1992390|NCT01103245|Spironolactone|spironolactone|mesh-list
1992391|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1992392|NCT01103245|Diuretics|diuretics|mesh-ancestor
1992393|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
1992394|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992395|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1992396|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1992397|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992398|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1992399|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
1992400|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992401|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1992402|NCT01103414|Pioglitazone|pioglitazone|mesh-list
1992403|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1992404|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992405|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
1992406|NCT01103440|Tirofiban|tirofiban|mesh-list
1992407|NCT01103440|Ticlopidine|ticlopidine|mesh-list
1992408|NCT01103440|Abciximab|abciximab|mesh-list
1992409|NCT01103440|Clopidogrel|clopidogrel|mesh-list
1992410|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1992411|NCT01103440|Cangrelor|cangrelor|mesh-list
1992412|NCT01103440|Eptifibatide|eptifibatide|mesh-list
1992413|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1992414|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1992415|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1992416|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1992417|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
1992418|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992419|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992420|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992421|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
1992422|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1992423|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1992424|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1992425|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
1992426|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1992427|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992428|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
1992429|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992430|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
1992431|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1992432|NCT01103440|Protective Agents|protective agents|mesh-ancestor
1992433|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1992434|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1992435|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992436|NCT01103713|Azithromycin|azithromycin|mesh-list
1992437|NCT01103713|Chloroquine|chloroquine|mesh-list
1992438|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1992439|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992440|NCT01103713|Amebicides|amebicides|mesh-ancestor
1992441|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1992442|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1992443|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
1992444|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1992445|NCT01103778|Bortezomib|bortezomib|mesh-list
1992446|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992447|NCT01103934|Vitamin D|vitamin d|mesh-list
1992448|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
1992449|NCT01103934|Fluticasone|fluticasone|mesh-list
1992450|NCT01103934|Xhance|xhance|mesh-list
1992451|NCT01103934|Vitamins|vitamins|mesh-ancestor
1992452|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
1992453|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992454|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1992455|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1992456|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1992457|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
1992458|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992459|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1992460|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
1992461|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
1992462|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1992463|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1992464|NCT01103960|Amlodipine|amlodipine|mesh-list
1992465|NCT01103960|Telmisartan|telmisartan|mesh-list
1992466|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1992467|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1992468|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1992469|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992470|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1992471|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992472|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
1992473|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1992474|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1992475|NCT01104025|Dexamethasone|dexamethasone|mesh-list
1992476|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
1992477|NCT01104025|Methotrexate|methotrexate|mesh-list
1992478|NCT01104025|Etoposide|etoposide|mesh-list
1992479|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
1992480|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1992481|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
1992482|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
1992483|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992484|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992485|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1992486|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
1992487|NCT01104025|Hormones|hormones|mesh-ancestor
1992488|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992489|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1992490|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992491|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1992492|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
1992493|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1992494|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1992495|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
1992496|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992497|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
1992498|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992499|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1992500|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1992501|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
1992502|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1992503|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1992504|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1992505|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1992506|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1992507|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1992508|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992509|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1992510|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992511|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992512|NCT01104246|Testosterone|testosterone|mesh-list
1992513|NCT01104246|Androgens|androgens|mesh-ancestor
1992514|NCT01104246|Hormones|hormones|mesh-ancestor
1992515|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992516|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992517|NCT01104376|Efavirenz|efavirenz|mesh-list
1992518|NCT01104376|Voriconazole|voriconazole|mesh-list
1992519|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1992520|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1992521|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992522|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992523|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
1992524|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992525|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1992526|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1992527|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1992528|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1992529|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1992530|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1992531|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
1992532|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1992533|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1992534|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
1992535|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992536|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992537|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1992538|NCT01104558|Bisoprolol|bisoprolol|mesh-list
1992539|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1992540|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
1992541|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
1992542|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992543|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992544|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1992545|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1992546|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1992547|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
1992548|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992549|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992550|NCT01104636|Varenicline|varenicline|mesh-list
1992551|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1992552|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1992553|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
1992554|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992555|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992556|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992557|NCT01104662|Vancomycin|vancomycin|mesh-list
1992558|NCT01104662|Daptomycin|daptomycin|mesh-list
1992559|NCT01104662|Penicillins|penicillins|mesh-list
1992560|NCT01104662|Cloxacillin|cloxacillin|mesh-list
1992561|NCT01104662|Oxacillin|oxacillin|mesh-list
1992562|NCT01104662|Nafcillin|nafcillin|mesh-list
1992563|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1992564|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992565|NCT01104701|Exenatide|exenatide|mesh-list
1992566|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1992567|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992568|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1992569|NCT01104701|Incretins|incretins|mesh-ancestor
1992570|NCT01104701|Hormones|hormones|mesh-ancestor
1992571|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992572|NCT01104766|Aripiprazole|aripiprazole|mesh-list
1992573|NCT01104766|Cariprazine|cariprazine|mesh-list
1992574|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
1992575|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1992576|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1992577|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1992578|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992579|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992580|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
1992581|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
1992582|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992583|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992584|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1992585|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1992586|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
1992587|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1992588|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1992589|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1992590|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1992591|NCT01104779|Cariprazine|cariprazine|mesh-list
1992592|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1992593|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1992594|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992595|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992596|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1992597|NCT01104792|Cariprazine|cariprazine|mesh-list
1992598|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1992599|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1992600|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992601|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992602|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1992603|NCT01104870|Treprostinil|treprostinil|mesh-list
1992604|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1992605|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1992606|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1992607|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1992608|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1992609|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1992610|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
1992611|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992612|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992613|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992614|NCT01105091|Epoprostenol|epoprostenol|mesh-list
1992615|NCT01105091|Tezosentan|tezosentan|mesh-list
1992616|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1992617|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1992618|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
1992619|NCT01105117|Epoprostenol|epoprostenol|mesh-list
1992620|NCT01105117|Tezosentan|tezosentan|mesh-list
1992621|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1992622|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1992623|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
1992624|NCT01105312|Letrozole|letrozole|mesh-list
1992625|NCT01105312|Panobinostat|panobinostat|mesh-list
1992626|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992627|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1992628|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1992629|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992630|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992631|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1992632|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
1992633|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992634|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992635|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1992636|NCT01105377|Azacitidine|azacitidine|mesh-list
1992637|NCT01105377|Entinostat|entinostat|mesh-list
1992638|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
1992639|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1992640|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
1992641|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992642|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992643|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992644|NCT01105650|Cyclosporine|cyclosporine|mesh-list
1992645|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
1992646|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1992647|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1992648|NCT01105650|Prednisolone|prednisolone|mesh-list
1992649|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
1992650|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
1992651|NCT01105650|Fludarabine|fludarabine|mesh-list
1992652|NCT01105650|Interleukin-2|interleukin-2|mesh-list
1992653|NCT01105650|Cyclosporins|cyclosporins|mesh-list
1992654|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1992655|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
1992656|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1992657|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
1992658|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992659|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1992660|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1992661|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
1992662|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992663|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992664|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1992665|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992666|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
1992667|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992668|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
1992669|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1992670|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1992671|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
1992672|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
1992673|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992674|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1992675|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
1992676|NCT01105650|Hormones|hormones|mesh-ancestor
1992677|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992678|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1992679|NCT01105650|Protective Agents|protective agents|mesh-ancestor
1992680|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1992681|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1992682|NCT01105650|Analgesics|analgesics|mesh-ancestor
1992683|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
1992684|NCT01105702|Bevacizumab|bevacizumab|mesh-list
1992685|NCT01105702|Temozolomide|temozolomide|mesh-list
1992686|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
1992687|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1992688|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992689|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1992690|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1992691|NCT01105702|Growth Substances|growth substances|mesh-ancestor
1992692|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992693|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
1992694|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1992695|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
1992696|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992697|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
1992698|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1992699|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992700|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
1992701|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1992702|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992703|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
1992704|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1992705|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1992706|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992707|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
1992708|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
1992709|NCT01105936|Acetaminophen|acetaminophen|mesh-list
1992710|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1992711|NCT01105936|Analgesics|analgesics|mesh-ancestor
1992712|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
1992713|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992714|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992715|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
1992716|NCT01105975|Atorvastatin|atorvastatin|mesh-list
1992717|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1992718|NCT01105975|Simvastatin|simvastatin|mesh-list
1992719|NCT01105975|Evacetrapib|evacetrapib|mesh-list
1992720|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1992721|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1992722|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
1992723|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992724|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1992725|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1992726|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992727|NCT01106014|Selexipag|selexipag|mesh-list
1992728|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1992729|NCT01106027|Eculizumab|eculizumab|mesh-list
1992730|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1992731|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1992732|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
1992733|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992734|NCT01106092|Vaccines|vaccines|mesh-list
1992735|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
1992736|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992737|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
1992738|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
1992739|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992740|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1992741|NCT01106352|Docetaxel|docetaxel|mesh-list
1992742|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
1992743|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992744|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
1992745|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
1992746|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
1992747|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992748|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1992749|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1992750|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1992751|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1992752|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1992753|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992754|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
1992755|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992756|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992757|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1992758|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1992759|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
1992760|NCT01106586|Ritonavir|ritonavir|mesh-list
1992761|NCT01106586|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1992762|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1992763|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1992764|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1992765|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
1992766|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992767|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992768|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1992769|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1992770|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
1992771|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992772|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1992773|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1992774|NCT01106586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1992775|NCT01106586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1992776|NCT01106625|Metformin|metformin|mesh-list
1992777|NCT01106625|Canagliflozin|canagliflozin|mesh-list
1992778|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1992779|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992780|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1992781|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992782|NCT01106651|Canagliflozin|canagliflozin|mesh-list
1992783|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
1992784|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1992785|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992786|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992787|NCT01106677|Metformin|metformin|mesh-list
1992788|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1992789|NCT01106677|Canagliflozin|canagliflozin|mesh-list
1992790|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1992791|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992792|NCT01106677|Incretins|incretins|mesh-ancestor
1992793|NCT01106677|Hormones|hormones|mesh-ancestor
1992794|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992795|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1992796|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
1992797|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992798|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992799|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1992800|NCT01106690|Metformin|metformin|mesh-list
1992801|NCT01106690|Pioglitazone|pioglitazone|mesh-list
1992802|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1992803|NCT01106690|Canagliflozin|canagliflozin|mesh-list
1992804|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2079357|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
1992805|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992806|NCT01106690|Incretins|incretins|mesh-ancestor
1992807|NCT01106690|Hormones|hormones|mesh-ancestor
1992808|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992809|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1992810|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
1992811|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992812|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992813|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1992814|NCT01106833|Sirolimus|sirolimus|mesh-list
1992815|NCT01106833|Prednisone|prednisone|mesh-list
1992816|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
1992817|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1992818|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
1992819|NCT01106833|Hormones|hormones|mesh-ancestor
1992820|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992821|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992822|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1992823|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992824|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1992825|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992826|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1992827|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
1992828|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1992829|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
1992830|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992831|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992832|NCT01106846|Ketamine|ketamine|mesh-list
1992833|NCT01106846|Analgesics|analgesics|mesh-ancestor
1992834|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
1992835|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992836|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992837|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1992838|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1992839|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
1992840|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
1992841|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992842|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1992843|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1992844|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992845|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992846|NCT01106859|Zolpidem|zolpidem|mesh-list
1992847|NCT01106859|Zopiclone|zopiclone|mesh-list
1992848|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1992849|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1992850|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1992851|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992852|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1992853|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
1992854|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
1992855|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992856|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992857|NCT01106898|Paclitaxel|paclitaxel|mesh-list
1992858|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
1992859|NCT01106898|Trastuzumab|trastuzumab|mesh-list
1992860|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1992861|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992862|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
1992863|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
1992864|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
1992865|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992866|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1992867|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
1992868|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992869|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1992870|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1992871|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
1992872|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1992873|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1992874|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
1992875|NCT01106950|Fludarabine|fludarabine|mesh-list
1992876|NCT01106950|Interleukin-2|interleukin-2|mesh-list
1992877|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
1992878|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1992879|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
1992880|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992881|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1992882|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1992883|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
1992884|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992885|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992886|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1992887|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1992888|NCT01106950|Analgesics|analgesics|mesh-ancestor
1992889|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
1992890|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992891|NCT01107353|Imipramine|imipramine|mesh-list
1992892|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1992893|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
1992894|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1992895|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1992896|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1992897|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1992898|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992899|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
1992900|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992901|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992902|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
1992903|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1992904|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1992905|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1992906|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1992907|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992908|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
1992909|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992910|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992911|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1992912|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1992913|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
1992914|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1992915|NCT01107444|Docetaxel|docetaxel|mesh-list
1992916|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992917|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
1992918|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
1992919|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
1992920|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992921|NCT01107457|Ixekizumab|ixekizumab|mesh-list
1992922|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
1992923|NCT01107535|Palivizumab|palivizumab|mesh-list
1992924|NCT01107535|Antibodies|antibodies|mesh-list
1992925|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1992926|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
1992927|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992928|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
1992929|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1992930|NCT01107626|Paclitaxel|paclitaxel|mesh-list
1992931|NCT01107626|Bevacizumab|bevacizumab|mesh-list
1992932|NCT01107626|Carboplatin|carboplatin|mesh-list
1992933|NCT01107626|Pemetrexed|pemetrexed|mesh-list
1992934|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1992935|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992936|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
1992937|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
1992938|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
1992939|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992940|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1992941|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1992942|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1992943|NCT01107626|Growth Substances|growth substances|mesh-ancestor
1992944|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992945|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
1992946|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992947|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1992948|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1992949|NCT01107665|Paclitaxel|paclitaxel|mesh-list
1992950|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1992951|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1992952|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
1992953|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
1992954|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
1992955|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992956|NCT01107730|Ascorbic Acid|ascorbic acid|mesh-list
1992957|NCT01107730|Vitamins|vitamins|mesh-ancestor
1992958|NCT01107730|Micronutrients|micronutrients|mesh-ancestor
1992959|NCT01107730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992960|NCT01107730|Antioxidants|antioxidants|mesh-ancestor
1992961|NCT01107730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992962|NCT01107730|Protective Agents|protective agents|mesh-ancestor
1992963|NCT01107743|Amlodipine|amlodipine|mesh-list
1992964|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
1992965|NCT01107743|Atorvastatin|atorvastatin|mesh-list
1992966|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1992967|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1992968|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
1992969|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992970|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1992971|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1992972|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992973|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1992974|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1992975|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1992976|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1992977|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992978|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
1992979|NCT01107886|Saxagliptin|saxagliptin|mesh-list
1992980|NCT01107886|Incretins|incretins|mesh-ancestor
1992981|NCT01107886|Hormones|hormones|mesh-ancestor
1992982|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1992983|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992984|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1992985|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
1992986|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1992987|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992988|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1992989|NCT01107899|Clopidogrel|clopidogrel|mesh-list
1992990|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1992991|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1992992|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1992993|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1992994|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1992995|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
1992996|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1992997|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1992998|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1992999|NCT01107912|Clopidogrel|clopidogrel|mesh-list
1993000|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1993001|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1993002|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1993003|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1993004|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1993005|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
1993006|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993007|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993008|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993009|NCT01107925|Clopidogrel|clopidogrel|mesh-list
1993010|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1993011|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1993012|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1993013|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1993014|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1993015|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
1993016|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993017|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993018|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993026|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
1993027|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993028|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
1993029|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1993030|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993031|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
1993032|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1993033|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1993034|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993035|NCT01108094|Itraconazole|itraconazole|mesh-list
1993036|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
1993037|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1993038|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1993039|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1993040|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993041|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993042|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1993043|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
1993044|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1993045|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993046|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1993047|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1993048|NCT01108341|Ofatumumab|ofatumumab|mesh-list
1993049|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1993050|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
1993051|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993052|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993053|NCT01108445|Everolimus|everolimus|mesh-list
1993054|NCT01108445|Sunitinib|sunitinib|mesh-list
1993055|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993056|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1993057|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
1993058|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993059|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1993060|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1993061|NCT01108445|Growth Substances|growth substances|mesh-ancestor
1993062|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
1993063|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1993064|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993065|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993066|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1993067|NCT01108458|Pertuzumab|pertuzumab|mesh-list
1993068|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993069|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1993070|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993071|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993072|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1993073|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1993074|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1993075|NCT01108510|Cobicistat|cobicistat|mesh-list
1993076|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1993077|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1993078|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993079|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993080|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
1993081|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1993082|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1993083|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1993084|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1993085|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1993086|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
1993087|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1993088|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1993089|NCT01108731|Milnacipran|milnacipran|mesh-list
1993090|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
1993091|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1993092|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1993093|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1993094|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993095|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993096|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993097|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1993098|NCT01108731|Analgesics|analgesics|mesh-ancestor
1993099|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
1993100|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993101|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
1993102|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1993103|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1993104|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1993105|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1993106|NCT01108757|Renal Agents|renal agents|mesh-ancestor
1993107|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1993108|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
1993109|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1993110|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1993111|NCT01108809|Telmisartan|telmisartan|mesh-list
1993112|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1993113|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1993114|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1993115|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745820|NCT02431247|Tenofovir|tenofovir|mesh-list
2745821|NCT02431247|Emtricitabine|emtricitabine|mesh-list
2745822|NCT02431247|Darunavir|darunavir|mesh-list
2745823|NCT02431247|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2745824|NCT02431247|Cobicistat|cobicistat|mesh-list
2745825|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2745826|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
2745827|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2745828|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2745829|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2745830|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745831|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745832|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1993135|NCT01109056|Cyclosporine|cyclosporine|mesh-list
1993136|NCT01109056|Cyclosporins|cyclosporins|mesh-list
1993137|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993138|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993139|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1993140|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
1993141|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993142|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
1993143|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1993144|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
1993145|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1993146|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1993147|NCT01109173|Nepafenac|nepafenac|mesh-list
1993148|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1993149|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1993150|NCT01109173|Analgesics|analgesics|mesh-ancestor
1993151|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
1993152|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993153|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993154|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1993155|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1993156|NCT01109316|Insulin|insulin|mesh-list
1993157|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1993158|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
1993159|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
1993160|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1993161|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993162|NCT01109524|Cetuximab|cetuximab|mesh-list
1993163|NCT01109524|Vinorelbine|vinorelbine|mesh-list
1993164|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993165|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1993166|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1993167|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
1993168|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
1993169|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
1993170|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993171|NCT01109849|Methylphenidate|methylphenidate|mesh-list
1993172|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
1993173|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993174|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1993175|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1993176|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1993177|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993178|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
1993179|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993180|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1993181|NCT01109979|Drospirenone|drospirenone|mesh-list
1993182|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1993183|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1993184|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
1993185|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
1993186|NCT01109979|Estradiol|estradiol|mesh-list
1993187|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1993188|NCT01109979|Estrogens|estrogens|mesh-ancestor
1993189|NCT01109979|Hormones|hormones|mesh-ancestor
1993190|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1993191|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993192|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1993193|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
1993194|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1993195|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1993196|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1993197|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1993198|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1993199|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1993200|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1993201|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993202|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1993203|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
1993204|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1993205|NCT01109979|Diuretics|diuretics|mesh-ancestor
1993206|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
1993207|NCT01109992|Regadenoson|regadenoson|mesh-list
1993208|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1993209|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1993210|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
1993211|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
1993212|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993213|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993214|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993215|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1993216|NCT01110135|Dexamethasone|dexamethasone|mesh-list
1993217|NCT01110135|Etoposide|etoposide|mesh-list
1993218|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
1993219|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1993220|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1993221|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
1993222|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
1993223|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993224|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993225|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1993226|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
1993227|NCT01110135|Hormones|hormones|mesh-ancestor
1993228|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1993229|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1993230|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993231|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1993232|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1993233|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1993234|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993235|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993236|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1993237|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
1993238|NCT01110187|Lacosamide|lacosamide|mesh-list
1993239|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
1993240|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
1993241|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1993242|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1993243|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1993244|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993245|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1993246|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1993247|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1993248|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
1993249|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993250|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993251|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1993252|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
1993253|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1993254|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1993255|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1993256|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
1993257|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993258|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993259|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
1993260|NCT01110200|Hormones|hormones|mesh-ancestor
1993261|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1993262|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
1993263|NCT01110330|Ketoconazole|ketoconazole|mesh-list
1993264|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
1993265|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1993266|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1993267|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1993268|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993269|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993270|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1993271|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
1993272|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1993273|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993274|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1993275|NCT01110382|Amoxicillin|amoxicillin|mesh-list
1993276|NCT01110382|Meropenem|meropenem|mesh-list
1993277|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
1993278|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
1993279|NCT01110382|Doripenem|doripenem|mesh-list
1993280|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1993281|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1993282|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1993283|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1993284|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993285|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993286|NCT01110408|Amoxicillin|amoxicillin|mesh-list
1993287|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
1993288|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
1993289|NCT01110408|Cefepime|cefepime|mesh-list
1993290|NCT01110408|Doripenem|doripenem|mesh-list
1993291|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1993292|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1993293|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1993294|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1993295|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993296|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993297|NCT01110421|Amoxicillin|amoxicillin|mesh-list
1993298|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
1993299|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
1993300|NCT01110421|Cefepime|cefepime|mesh-list
1993301|NCT01110421|Doripenem|doripenem|mesh-list
1993302|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1993303|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1993304|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1993305|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1993306|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993307|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993308|NCT01110434|Topiramate|topiramate|mesh-list
1993309|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
1993310|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1993311|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993312|NCT01110499|Bimatoprost|bimatoprost|mesh-list
1993313|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1993314|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1993315|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1993316|NCT01110707|Hormones|hormones|mesh-list
1993317|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1993318|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1993319|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993320|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1993321|NCT01110876|Temozolomide|temozolomide|mesh-list
1993322|NCT01110876|Vorinostat|vorinostat|mesh-list
1993323|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993324|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1993325|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993326|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993327|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1993328|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
1993329|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2745833|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2745834|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2745835|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1993333|NCT01111058|Everolimus|everolimus|mesh-list
1993334|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993335|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1993336|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
1993337|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993338|NCT01111123|Halobetasol|halobetasol|mesh-list
1993339|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1993340|NCT01111149|Bupropion|bupropion|mesh-list
1993341|NCT01111149|Varenicline|varenicline|mesh-list
1993342|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1993343|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
1993344|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1993345|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1993346|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1993347|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1993348|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993349|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
1993350|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993351|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993352|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1993353|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1993354|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993355|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1993356|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1993357|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
1993358|NCT01111162|Vaccines|vaccines|mesh-list
1993359|NCT01111162|Immunologic Factors|immunologic factors|mesh-ancestor
1993360|NCT01111162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993361|NCT01111292|Inositol|inositol|mesh-list
1993362|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
1993363|NCT01111292|Vitamins|vitamins|mesh-ancestor
1993364|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
1993365|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993378|NCT01111318|Empagliflozin|empagliflozin|mesh-list
1993379|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1993380|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993381|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1993382|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993383|NCT01111331|Empagliflozin|empagliflozin|mesh-list
1993384|NCT01111331|Warfarin|warfarin|mesh-list
1993385|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
1993386|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1993387|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993388|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1993389|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993390|NCT01111461|Lenvatinib|lenvatinib|mesh-list
1993391|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745836|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
1993392|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1993393|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993394|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993395|NCT01111526|Panobinostat|panobinostat|mesh-list
1993396|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993397|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1993398|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993399|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993400|NCT01111539|Aripiprazole|aripiprazole|mesh-list
1993401|NCT01111539|Citalopram|citalopram|mesh-list
1993402|NCT01111539|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1993403|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1993404|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1993405|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993406|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993407|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
1993408|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993409|NCT01111539|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1993410|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
1993411|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1993412|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1993413|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1993414|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1993415|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
1993416|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
1993417|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1993418|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1993419|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1993420|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1993421|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1993422|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1993423|NCT01111552|Aripiprazole|aripiprazole|mesh-list
1993424|NCT01111552|Citalopram|citalopram|mesh-list
1993425|NCT01111552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1993426|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1993427|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1993428|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993429|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993430|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
1993431|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993432|NCT01111552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1993433|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
1993434|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1993435|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1993436|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1993437|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1993438|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
1993439|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
1993440|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1993441|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1993442|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1993443|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1993444|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1993445|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1993446|NCT01111604|Ramucirumab|ramucirumab|mesh-list
1993447|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993448|NCT01111825|Sirolimus|sirolimus|mesh-list
1993449|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1993450|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1993451|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1993452|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993453|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
1993454|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1993455|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
1993456|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993457|NCT01111851|Dexamethasone|dexamethasone|mesh-list
1993458|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
1993459|NCT01111851|Ondansetron|ondansetron|mesh-list
1993460|NCT01111851|Aprepitant|aprepitant|mesh-list
1993461|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
1993462|NCT01111851|BB 1101|bb 1101|mesh-list
1993463|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1993464|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
1993465|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
1993466|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993467|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993468|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1993469|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
1993470|NCT01111851|Hormones|hormones|mesh-ancestor
1993471|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1993472|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1993473|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993474|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
1993475|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993476|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993477|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
1993478|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
1993479|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1993480|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
1993481|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993482|NCT01111851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1993483|NCT01111851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1993484|NCT01111851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1993485|NCT01111851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1993486|NCT01111851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1993487|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1993488|NCT01112059|Doxycycline|doxycycline|mesh-list
1993489|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1993490|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1993491|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
1993492|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1993493|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1993494|NCT01112241|Albuterol|albuterol|mesh-list
1993495|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
1993496|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1993497|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
1993498|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993499|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993500|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1993501|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
1993502|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
1993503|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1993504|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
1993505|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993506|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993507|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
1993508|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1993509|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1993510|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1993511|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1993512|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
1993513|NCT01112267|Acetaminophen|acetaminophen|mesh-list
1993514|NCT01112267|Tramadol|tramadol|mesh-list
1993515|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1993516|NCT01112267|Analgesics|analgesics|mesh-ancestor
1993517|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
1993518|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993519|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993520|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
1993521|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1993522|NCT01112267|Narcotics|narcotics|mesh-ancestor
1993523|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1993524|NCT01112358|Cetrorelix|cetrorelix|mesh-list
1993525|NCT01112358|Progesterone|progesterone|mesh-list
1993526|NCT01112358|Progestins|progestins|mesh-ancestor
1993527|NCT01112358|Hormones|hormones|mesh-ancestor
1993528|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1993529|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993530|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1993531|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
1993532|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1993533|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
1993534|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1993535|NCT01112670|Atorvastatin|atorvastatin|mesh-list
1993536|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1993537|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1993538|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
1993539|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993540|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1993541|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1993542|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993543|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1993544|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993545|NCT01112670|Incretins|incretins|mesh-ancestor
1993546|NCT01112670|Hormones|hormones|mesh-ancestor
1993547|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1993548|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1993549|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
1993550|NCT01112683|Memantine|memantine|mesh-list
1993551|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1993552|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1993553|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
1993554|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993555|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993556|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993557|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1993558|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1993559|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
1993560|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
1993561|NCT01112735|Coagulants|coagulants|mesh-ancestor
1993562|NCT01112982|Colchicine|colchicine|mesh-list
1993563|NCT01112982|Febuxostat|febuxostat|mesh-list
1993564|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
1993565|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1993566|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
1993567|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
1993568|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
1993569|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993570|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993571|NCT01113398|Bevacizumab|bevacizumab|mesh-list
1993572|NCT01113398|Rilotumumab|rilotumumab|mesh-list
1993573|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1993574|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993575|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1993576|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1993577|NCT01113398|Growth Substances|growth substances|mesh-ancestor
1993578|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993579|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
1993580|NCT01113541|Ziprasidone|ziprasidone|mesh-list
1993581|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1993582|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
1993583|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993584|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993585|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993586|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1993587|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1993588|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1993589|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1993590|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1993591|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
1993592|NCT01113632|Ofatumumab|ofatumumab|mesh-list
1993593|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993594|NCT01113710|Rotigotine|rotigotine|mesh-list
1993595|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
1993596|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
1993597|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993598|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993599|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993600|NCT01113931|Doxycycline|doxycycline|mesh-list
1993601|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1993602|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1993603|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
1993604|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1993605|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1993606|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1993607|NCT01114139|Hematinics|hematinics|mesh-ancestor
1993608|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1993609|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1993610|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1993611|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
1993612|NCT01114204|Hematinics|hematinics|mesh-ancestor
1993613|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1993614|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1993615|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1993616|NCT01114217|Hematinics|hematinics|mesh-ancestor
1993617|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1993618|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1993619|NCT01114360|Melatonin|melatonin|mesh-list
1993620|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
1993621|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993622|NCT01114360|Protective Agents|protective agents|mesh-ancestor
1993623|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993624|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1993625|NCT01114373|Melatonin|melatonin|mesh-list
1993626|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
1993627|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993628|NCT01114373|Protective Agents|protective agents|mesh-ancestor
1993629|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993630|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1993631|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
1993632|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1993633|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1993634|NCT01114503|Prednisolone|prednisolone|mesh-list
1993635|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
1993636|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1993637|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
1993638|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1993639|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
1993640|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
1993641|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993642|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993643|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1993644|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
1993645|NCT01114503|Hormones|hormones|mesh-ancestor
1993646|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1993647|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1993648|NCT01114503|Protective Agents|protective agents|mesh-ancestor
1993649|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1993650|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993651|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1993652|NCT01114516|Clindamycin|clindamycin|mesh-list
1993653|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
1993654|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
1993655|NCT01114516|Cefazolin|cefazolin|mesh-list
1993656|NCT01114516|Indomethacin|indomethacin|mesh-list
1993657|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1993658|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1993659|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993660|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993661|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1993662|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1993663|NCT01114516|Analgesics|analgesics|mesh-ancestor
1993664|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
1993665|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993666|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993667|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1993668|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1993669|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
1993670|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
1993671|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1993672|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1993673|NCT01114529|Cyclosporine|cyclosporine|mesh-list
1993674|NCT01114529|Everolimus|everolimus|mesh-list
1993675|NCT01114529|Tacrolimus|tacrolimus|mesh-list
1993676|NCT01114529|Cyclosporins|cyclosporins|mesh-list
1993677|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1993678|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
1993679|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993680|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1993681|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993682|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993683|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
1993684|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1993685|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
1993686|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1993687|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993688|NCT01114555|Bevacizumab|bevacizumab|mesh-list
1993689|NCT01114555|Irinotecan|irinotecan|mesh-list
1993690|NCT01114555|Temozolomide|temozolomide|mesh-list
1993691|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1993692|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993693|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1993694|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1993695|NCT01114555|Growth Substances|growth substances|mesh-ancestor
1993696|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993697|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
1993698|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1993699|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1993700|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993701|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993702|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1993703|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
1993704|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
1993705|NCT01114581|Guaifenesin|guaifenesin|mesh-list
1993706|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
1993707|NCT01114581|Expectorants|expectorants|mesh-ancestor
1993708|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
1993709|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1993710|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1993711|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
1993712|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993713|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993714|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993715|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
1993716|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1993717|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
1993718|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
1993719|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993720|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
1993721|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1993722|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
1993723|NCT01114672|Vitamin D|vitamin d|mesh-list
1993724|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1993725|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993726|NCT01114672|Vitamins|vitamins|mesh-ancestor
1993727|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
1993728|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1993729|NCT01114737|Verapamil|verapamil|mesh-list
1993730|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1993731|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1993732|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1993733|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993734|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1993735|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993736|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
1993737|NCT01114828|Tolvaptan|tolvaptan|mesh-list
1993738|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1993739|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993740|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
1993741|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993742|NCT01114880|Adalimumab|adalimumab|mesh-list
1993743|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1993744|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1993745|NCT01114893|Travoprost|travoprost|mesh-list
1993746|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1993747|NCT01114971|Labetalol|labetalol|mesh-list
1993748|NCT01114971|Fentanyl|fentanyl|mesh-list
1993749|NCT01114971|Esmolol|esmolol|mesh-list
1993750|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1993751|NCT01114971|Narcotics|narcotics|mesh-ancestor
1993752|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1993753|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993754|NCT01114971|Analgesics|analgesics|mesh-ancestor
1993755|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
1993756|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993757|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1993758|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1993759|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
1993760|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
1993761|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1993762|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1993763|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1993764|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
1993765|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993766|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993767|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1993768|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
1993769|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
1993770|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1993771|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1993772|NCT01114997|Lidocaine|lidocaine|mesh-list
1993773|NCT01114997|Esmolol|esmolol|mesh-list
1993774|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
1993775|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
1993776|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1993777|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993778|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
1993779|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993780|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1993781|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1993782|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1993783|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1993784|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993785|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1993786|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1993787|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1993788|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
1993789|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993790|NCT01115101|Pirinitramide|pirinitramide|mesh-list
1993791|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1993792|NCT01115101|Narcotics|narcotics|mesh-ancestor
1993793|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1993794|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993795|NCT01115101|Analgesics|analgesics|mesh-ancestor
1993796|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
1993797|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993798|NCT01115491|Bevacizumab|bevacizumab|mesh-list
1993799|NCT01115491|Temozolomide|temozolomide|mesh-list
1993800|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1993801|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993802|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1993803|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1993804|NCT01115491|Growth Substances|growth substances|mesh-ancestor
1993805|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993806|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
1993807|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1993808|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
1993809|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993810|NCT01115517|Bevacizumab|bevacizumab|mesh-list
1993811|NCT01115517|Mitomycins|mitomycins|mesh-list
1993812|NCT01115517|Mitomycin|mitomycin|mesh-list
1993813|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1993814|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993815|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1993816|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1993817|NCT01115517|Growth Substances|growth substances|mesh-ancestor
1993818|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993819|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
1993820|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1993821|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
1993822|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993823|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1993824|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993825|NCT01115556|Ranibizumab|ranibizumab|mesh-list
1993826|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1993827|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1993828|NCT01115556|Growth Substances|growth substances|mesh-ancestor
1993829|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993830|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
1993831|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993832|NCT01115569|Hydrocodone|hydrocodone|mesh-list
1993833|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1993834|NCT01115569|Narcotics|narcotics|mesh-ancestor
1993835|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1993836|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993837|NCT01115569|Analgesics|analgesics|mesh-ancestor
1993838|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
1993839|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993840|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
1993841|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
1993842|NCT01115582|Cholic Acids|cholic acids|mesh-list
1993843|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1993844|NCT01115673|Acetaminophen|acetaminophen|mesh-list
1993845|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1993846|NCT01115673|Analgesics|analgesics|mesh-ancestor
1993847|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
1993848|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993849|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993850|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
1993851|NCT01115738|Clopidogrel|clopidogrel|mesh-list
1993852|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1993853|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1993854|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1993855|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1993856|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1993857|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
1993858|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993859|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993860|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993861|NCT01115803|Everolimus|everolimus|mesh-list
1993862|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1993863|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993864|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1993865|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
1993866|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993867|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1993868|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993869|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993870|NCT01115855|Eplerenone|eplerenone|mesh-list
1993871|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1993872|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
1993873|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1993874|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993875|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1993876|NCT01115855|Diuretics|diuretics|mesh-ancestor
1993877|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
1993878|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1993879|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1993880|NCT01116401|Leuprolide|leuprolide|mesh-list
1993881|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1993882|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
1993883|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1993884|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993885|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1993886|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993887|NCT01116427|Abatacept|abatacept|mesh-list
1993888|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1993889|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993890|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993891|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1993892|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
1993893|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993894|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2745837|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2745838|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2745839|NCT02397226|Anesthetics|anesthetics|mesh-list
2745840|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2745841|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745842|NCT02395666|Eflornithine|eflornithine|mesh-list
2745843|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1993903|NCT01116687|R04929097|r04929097|mesh-list
1993904|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1993905|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993906|NCT01116739|Fluorides|fluorides|mesh-list
1993907|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
1993908|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
1993909|NCT01116739|Protective Agents|protective agents|mesh-ancestor
1993910|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993911|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1993912|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
1993913|NCT01116986|Nicotine|nicotine|mesh-list
1993914|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1993915|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
1993916|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993917|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993918|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1993919|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1993920|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
1993921|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993922|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993923|NCT01117012|Ivacaftor|ivacaftor|mesh-list
1993924|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1993925|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1993926|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993927|NCT01117051|Prucalopride|prucalopride|mesh-list
1993928|NCT01117051|Laxatives|laxatives|mesh-ancestor
1993929|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1993930|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
1993931|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1993932|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
1993933|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993934|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993935|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993936|NCT01117181|Methylphenidate|methylphenidate|mesh-list
1993937|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1993938|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993939|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1993940|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1993941|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1993942|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993943|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
1993944|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993945|NCT01117350|Metformin|metformin|mesh-list
1993946|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
1993947|NCT01117350|Liraglutide|liraglutide|mesh-list
1993948|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1993949|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993950|NCT01117350|Incretins|incretins|mesh-ancestor
1993951|NCT01117350|Hormones|hormones|mesh-ancestor
1993952|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1993953|NCT01117454|Flecainide|flecainide|mesh-list
1993954|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1993955|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1993956|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
1993957|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993958|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993959|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993960|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1993961|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1993962|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1993963|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1993964|NCT01117766|Pregabalin|pregabalin|mesh-list
1993965|NCT01117766|Analgesics|analgesics|mesh-ancestor
1993966|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
1993967|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993968|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993969|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
1993970|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1993971|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1993972|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993973|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1993974|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1993975|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1993976|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1993977|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1993978|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1993979|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1993980|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1993981|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1993982|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1993983|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1993984|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993985|NCT01117857|Analgesics|analgesics|mesh-ancestor
1993986|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
1993987|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993988|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
1993989|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1993990|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
1993991|NCT01117948|Lornoxicam|lornoxicam|mesh-list
1993992|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1993993|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1993994|NCT01117948|Analgesics|analgesics|mesh-ancestor
1993995|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
1993996|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1993997|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1993998|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1993999|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1994000|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
1994001|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994002|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1994003|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994004|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994005|NCT01118091|Aldesleukin|aldesleukin|mesh-list
1994006|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994007|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1994008|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1994009|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
1994010|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1994011|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
1994012|NCT01118273|Promethazine|promethazine|mesh-list
1994013|NCT01118273|Ibuprofen|ibuprofen|mesh-list
1994014|NCT01118273|Naproxen|naproxen|mesh-list
1994015|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994016|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1994017|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1994018|NCT01118273|Analgesics|analgesics|mesh-ancestor
1994019|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
1994020|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994021|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994022|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1994023|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1994024|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1994025|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994026|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
1994027|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1994028|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1994029|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1994030|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
1994031|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
1994032|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
1994033|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
1994034|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1994035|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1994036|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
1994037|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
1994038|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994039|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1994040|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
1994041|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
1994042|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
1994043|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1994044|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
1994045|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1994046|NCT01118325|Clopidogrel|clopidogrel|mesh-list
1994047|NCT01118325|Ticagrelor|ticagrelor|mesh-list
1994048|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1994049|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1994050|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1994051|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1994052|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
1994053|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994054|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994055|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994056|NCT01118351|Sunitinib|sunitinib|mesh-list
1994057|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994058|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1994059|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1994060|NCT01118351|Growth Substances|growth substances|mesh-ancestor
1994061|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994062|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
1994063|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1994064|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994065|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994066|NCT01118377|Capecitabine|capecitabine|mesh-list
1994067|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1994068|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
1994069|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994070|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994071|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
1994072|NCT01118520|Amlodipine|amlodipine|mesh-list
1994073|NCT01118520|Perindopril|perindopril|mesh-list
1994074|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1994075|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1994076|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994077|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994078|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1994079|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994080|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
1994081|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1994082|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
1994083|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994084|NCT01118624|Vitamins|vitamins|mesh-list
1994085|NCT01118624|Folic Acid|folic acid|mesh-list
1994086|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
1994087|NCT01118624|Hydroxocobalamin|hydroxocobalamin|mesh-list
1994088|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
1994089|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
1994090|NCT01118624|Aminopterin|aminopterin|mesh-list
1994091|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
1994092|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994093|NCT01118624|Hematinics|hematinics|mesh-ancestor
1994094|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1994095|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994096|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994097|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994098|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
1994099|NCT01118663|Edetic Acid|edetic acid|mesh-list
1994100|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1994101|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
1994102|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
1994103|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1994104|NCT01118663|Expectorants|expectorants|mesh-ancestor
1994105|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
1994106|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1994107|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
1994108|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994109|NCT01118663|Protective Agents|protective agents|mesh-ancestor
1994110|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994111|NCT01118663|Antidotes|antidotes|mesh-ancestor
1994112|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
1994113|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1994114|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
1994115|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
1994116|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1994117|NCT01118741|Disulfiram|disulfiram|mesh-list
1994118|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1994119|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
1994120|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994121|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994122|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1994123|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1994124|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1994125|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994126|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994127|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994128|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994129|NCT01118780|Analgesics|analgesics|mesh-ancestor
1994130|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
1994131|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994132|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
1994133|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1994134|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
1994135|NCT01118845|Rituximab|rituximab|mesh-list
1994136|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1994137|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1994138|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994139|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
1994140|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994141|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1994142|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1994143|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
1994144|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994145|NCT01118949|Lacosamide|lacosamide|mesh-list
1994146|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
1994147|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1994148|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1994149|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994150|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994151|NCT01118962|Lacosamide|lacosamide|mesh-list
1994152|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
1994153|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1994154|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1994155|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994156|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994157|NCT01118975|Lapatinib|lapatinib|mesh-list
1994158|NCT01118975|Vorinostat|vorinostat|mesh-list
1994159|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994160|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1994161|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994162|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994163|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1994164|NCT01119105|Vancomycin|vancomycin|mesh-list
1994165|NCT01119105|Lefamulin|lefamulin|mesh-list
1994166|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1994167|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1994168|NCT01119131|Vitamin D|vitamin d|mesh-list
1994169|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
1994170|NCT01119131|Calcium|calcium|mesh-list
1994171|NCT01119131|Vitamins|vitamins|mesh-ancestor
1994172|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
1994173|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994174|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1994175|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1994176|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
1994177|NCT01119222|Promethazine|promethazine|mesh-list
1994178|NCT01119222|Morphine|morphine|mesh-list
1994179|NCT01119222|Gabapentin|gabapentin|mesh-list
1994180|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1994181|NCT01119222|Narcotics|narcotics|mesh-ancestor
1994182|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1994183|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994184|NCT01119222|Analgesics|analgesics|mesh-ancestor
1994185|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
1994186|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994187|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
1994188|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1994189|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1994190|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1994191|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1994192|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1994193|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994194|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994195|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
1994196|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1994197|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1994198|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
1994199|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
1994200|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
1994201|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
1994202|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1994203|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1994204|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
1994205|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
1994206|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1994207|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
1994208|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
1994209|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1994210|NCT01119287|Dexamethasone|dexamethasone|mesh-list
1994211|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1994212|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1994213|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
1994214|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
1994215|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994216|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994217|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1994218|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
1994219|NCT01119287|Hormones|hormones|mesh-ancestor
1994220|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1994221|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1994222|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994223|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1994224|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1994225|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1994226|NCT01119287|Analgesics|analgesics|mesh-ancestor
1994227|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
1994228|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1994229|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1994230|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1994231|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1994232|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
1994233|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
1994234|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994235|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994236|NCT01119508|Temozolomide|temozolomide|mesh-list
1994237|NCT01119508|Ipilimumab|ipilimumab|mesh-list
1994238|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1994239|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
1994240|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994241|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994242|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1994243|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1994244|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1994245|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
1994246|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994247|NCT01119703|Vaccines|vaccines|mesh-list
1994248|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
1994249|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994250|NCT01119768|Esomeprazole|esomeprazole|mesh-list
1994251|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1994252|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1994253|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1994254|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994255|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994256|NCT01119794|Bortezomib|bortezomib|mesh-list
1994257|NCT01119794|Ofatumumab|ofatumumab|mesh-list
1994258|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994259|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1994260|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1994261|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994262|NCT01119846|Incretins|incretins|mesh-ancestor
1994263|NCT01119846|Hormones|hormones|mesh-ancestor
1994264|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1994265|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1994266|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
1994267|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994268|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994269|NCT01119859|Adalimumab|adalimumab|mesh-list
1994270|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1994271|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1994272|NCT01119898|Diclofenac|diclofenac|mesh-list
1994273|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1994274|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1994275|NCT01119898|Analgesics|analgesics|mesh-ancestor
1994276|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
1994277|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994278|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994279|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1994280|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1994281|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1994282|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994283|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994284|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
1994285|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
1994286|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1994287|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
1994288|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994289|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994290|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1994291|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
1994292|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
1994293|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1994294|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
1994295|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994296|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994297|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1994298|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1994299|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
1994300|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1994301|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1994302|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1994303|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
1994304|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994305|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994306|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994307|NCT01119963|Castor Oil|castor oil|mesh-list
1994308|NCT01119963|Progesterone|progesterone|mesh-list
1994309|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
1994310|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
1994311|NCT01119963|Progestins|progestins|mesh-ancestor
1994312|NCT01119963|Hormones|hormones|mesh-ancestor
1994313|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1994314|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994315|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1994316|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
1994317|NCT01119963|Cathartics|cathartics|mesh-ancestor
1994318|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1994319|NCT01120028|Sirolimus|sirolimus|mesh-list
1994320|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
1994321|NCT01120028|Tacrolimus|tacrolimus|mesh-list
1994322|NCT01120028|Basiliximab|basiliximab|mesh-list
1994323|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1994324|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
1994325|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994326|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1994327|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994328|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994329|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1994330|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1994331|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1994332|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994333|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
1994334|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1994335|NCT01120093|Bromides|bromides|mesh-list
1994336|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
1994337|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1994338|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
1994339|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994340|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994341|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1994342|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
1994343|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1994344|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1994345|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1994346|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
1994347|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994348|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994349|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
1994350|NCT01120184|Paclitaxel|paclitaxel|mesh-list
1994351|NCT01120184|Maytansine|maytansine|mesh-list
1994352|NCT01120184|Docetaxel|docetaxel|mesh-list
1994353|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1994354|NCT01120184|Trastuzumab|trastuzumab|mesh-list
1994355|NCT01120184|Pertuzumab|pertuzumab|mesh-list
1994356|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1994357|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994358|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
1994359|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
1994360|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
1994361|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994362|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1994363|NCT01120236|Leuprolide|leuprolide|mesh-list
1994364|NCT01120236|Goserelin|goserelin|mesh-list
1994365|NCT01120236|Bicalutamide|bicalutamide|mesh-list
1994366|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1994367|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1994368|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
1994369|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1994370|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994371|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1994372|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994373|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
1994374|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
1994375|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1994376|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
1994377|NCT01120275|R04929097|r04929097|mesh-list
1994378|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994379|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994380|NCT01120405|Sevoflurane|sevoflurane|mesh-list
1994381|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1994382|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1994383|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
1994384|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
1994385|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1994386|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994387|NCT01120600|Vitamin D|vitamin d|mesh-list
1994388|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
1994389|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
1994390|NCT01120600|Calcium|calcium|mesh-list
1994391|NCT01120600|Vitamins|vitamins|mesh-ancestor
1994392|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
1994393|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994394|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1994395|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1994396|NCT01120600|Antacids|antacids|mesh-ancestor
1994397|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994398|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1994399|NCT01120626|Donepezil|donepezil|mesh-list
1994400|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1994401|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994402|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994403|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
1994404|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994405|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994406|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
1994407|NCT01120639|Temozolomide|temozolomide|mesh-list
1994408|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1994409|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
1994410|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994411|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994412|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
1994413|NCT01120691|Albuterol|albuterol|mesh-list
1994414|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
1994415|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1994416|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
1994417|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994418|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994419|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1994420|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
1994421|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
1994422|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1994423|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
1994424|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994425|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994426|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
1994427|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1994428|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1994429|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1994430|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1994431|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
1994432|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1994433|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1994434|NCT01120704|Nicotine|nicotine|mesh-list
1994435|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1994436|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
1994437|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994438|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994439|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1994440|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1994441|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
1994442|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994443|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994444|NCT01120834|Azacitidine|azacitidine|mesh-list
1994445|NCT01120834|Vorinostat|vorinostat|mesh-list
1994446|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1994447|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
1994448|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994449|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994450|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994451|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1994452|NCT01120899|Minocycline|minocycline|mesh-list
1994453|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1994454|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1994455|NCT01121211|Testosterone|testosterone|mesh-list
1994456|NCT01121211|Androgens|androgens|mesh-ancestor
1994457|NCT01121211|Hormones|hormones|mesh-ancestor
1994458|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1994459|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994460|NCT01121224|Clopidogrel|clopidogrel|mesh-list
1994461|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1994462|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1994463|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1994464|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1994465|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
1994466|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994467|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994468|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994469|NCT01121393|Gemcitabine|gemcitabine|mesh-list
1994470|NCT01121393|Afatinib|afatinib|mesh-list
1994471|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994472|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1994473|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
1994474|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994475|NCT01121393|Antiviral Agents|antiviral agents|mesh-ancestor
1994476|NCT01121393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1994477|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994478|NCT01121393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1994479|NCT01121393|Immunologic Factors|immunologic factors|mesh-ancestor
1994480|NCT01121393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994481|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1994482|NCT01121406|Gemcitabine|gemcitabine|mesh-list
1994483|NCT01121406|Paclitaxel|paclitaxel|mesh-list
1994484|NCT01121406|Doxorubicin|doxorubicin|mesh-list
1994485|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1994486|NCT01121406|Topotecan|topotecan|mesh-list
1994487|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1994488|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994489|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
1994490|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
1994491|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
1994492|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994493|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1994494|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
1994495|NCT01121406|Antiviral Agents|antiviral agents|mesh-ancestor
1994496|NCT01121406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1994497|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994498|NCT01121406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1994499|NCT01121406|Immunologic Factors|immunologic factors|mesh-ancestor
1994500|NCT01121406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994501|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1994502|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1994503|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1994504|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1994505|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
1994506|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1994507|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1994508|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994509|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994510|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994511|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994512|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
1994513|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1994514|NCT01121536|Modafinil|modafinil|mesh-list
1994515|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1994516|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994517|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1994518|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1994519|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1994520|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994521|NCT01121549|Exemestane|exemestane|mesh-list
1994522|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994523|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1994524|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1994525|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994526|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994527|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1994528|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
1994529|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1994530|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994531|NCT01121562|Sunitinib|sunitinib|mesh-list
1994532|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994533|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1994534|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1994535|NCT01121562|Growth Substances|growth substances|mesh-ancestor
1994536|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994537|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
1994538|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1994539|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994540|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994541|NCT01121575|Crizotinib|crizotinib|mesh-list
1994542|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994543|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1994544|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994545|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994546|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1994547|NCT01121666|Hormones|hormones|mesh-ancestor
1994548|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1994549|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994550|NCT01121757|Lenalidomide|lenalidomide|mesh-list
1994551|NCT01121757|Azacitidine|azacitidine|mesh-list
1994552|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
1994553|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994554|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1994555|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1994556|NCT01121757|Growth Substances|growth substances|mesh-ancestor
1994557|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
1994558|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994559|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1994560|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
1994561|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994562|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994563|NCT01121900|Trazodone|trazodone|mesh-list
1994564|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1994565|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1994566|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1994567|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994568|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1994569|NCT01121900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1994570|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1994571|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994572|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994573|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994574|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
1994575|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1994576|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
1994577|NCT01121913|Trazodone|trazodone|mesh-list
1994578|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1994579|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1994580|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1994581|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994582|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1994583|NCT01121913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1994584|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1994585|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994586|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994587|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994588|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
1994589|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1994590|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
1994591|NCT01121926|Trazodone|trazodone|mesh-list
1994592|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1994593|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1994594|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1994595|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994596|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1994597|NCT01121926|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1994598|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1994599|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994600|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994601|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994602|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
1994603|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1994604|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
1994605|NCT01121939|Bevacizumab|bevacizumab|mesh-list
1994606|NCT01121939|Pertuzumab|pertuzumab|mesh-list
1994607|NCT01121939|Octreotide|octreotide|mesh-list
1994608|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1994609|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994610|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1994611|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1994612|NCT01121939|Growth Substances|growth substances|mesh-ancestor
1994613|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994614|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
1994615|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1994616|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1994617|NCT01121991|Hormones|hormones|mesh-list
1994618|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1994619|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994620|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
1994621|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
1994622|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1994623|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1994624|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
1994625|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994626|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1994627|NCT01122160|Omeprazole|omeprazole|mesh-list
1994628|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1994629|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1994630|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1994631|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994632|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994633|NCT01122238|Nicotine|nicotine|mesh-list
1994634|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1994635|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
1994636|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994637|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994638|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1994639|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1994640|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
1994641|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994642|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994643|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
1994644|NCT01122264|Tadalafil|tadalafil|mesh-list
1994645|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994646|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
1994647|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1994648|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1994649|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994650|NCT01122264|Urological Agents|urological agents|mesh-ancestor
1994651|NCT01122316|Metformin|metformin|mesh-list
1994652|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1994653|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994654|NCT01122680|Bromides|bromides|mesh-list
1994655|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
1994656|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1994657|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
1994658|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994659|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994660|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1994661|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
1994662|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
1994663|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1994664|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
1994665|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994666|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994667|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
1994668|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
1994669|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1994670|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1994671|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
1994672|NCT01122901|R04929097|r04929097|mesh-list
1994673|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994674|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994675|NCT01122927|Aripiprazole|aripiprazole|mesh-list
1994676|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
1994677|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1994678|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1994679|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1994680|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1994681|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994682|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
1994683|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
1994684|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994685|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994686|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1994687|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1994688|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
1994689|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1994690|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1994691|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1994692|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1994693|NCT01123070|Rituximab|rituximab|mesh-list
1994694|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1994695|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994696|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
1994697|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994698|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1994699|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
1994700|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
1994701|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994702|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1994703|NCT01123356|Lenalidomide|lenalidomide|mesh-list
1994704|NCT01123356|Ofatumumab|ofatumumab|mesh-list
1994705|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
1994706|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994707|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1994708|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1994709|NCT01123356|Growth Substances|growth substances|mesh-ancestor
1994710|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
1994711|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994712|NCT01123395|Colchicine|colchicine|mesh-list
1994713|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
1994714|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1994715|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
1994716|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
1994717|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
1994718|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994719|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994720|NCT01123889|Lidocaine|lidocaine|mesh-list
1994721|NCT01123889|Ropivacaine|ropivacaine|mesh-list
1994722|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
1994723|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
1994724|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1994725|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994726|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
1994727|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994728|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1994729|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1994730|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1994731|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994732|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994733|NCT01123980|Insulin|insulin|mesh-list
1994734|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1994735|NCT01123980|Metformin|metformin|mesh-list
1994736|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
1994737|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
1994738|NCT01123980|Glimepiride|glimepiride|mesh-list
1994739|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
1994740|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
1994741|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1994742|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994743|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1994744|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1994745|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
1994746|NCT01124045|Prednisolone|prednisolone|mesh-list
1994747|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1994748|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
1994749|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1994750|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
1994751|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1994752|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
1994753|NCT01124045|Difluprednate|difluprednate|mesh-list
1994754|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1994755|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
1994756|NCT01124045|Hormones|hormones|mesh-ancestor
1994757|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1994758|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994759|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1994760|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994761|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
1994762|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
1994763|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994764|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1994765|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1994766|NCT01124045|Protective Agents|protective agents|mesh-ancestor
1994767|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1994768|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
1994769|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1994770|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1994771|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994772|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994773|NCT01124149|Mesalamine|mesalamine|mesh-list
1994774|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1994775|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1994776|NCT01124149|Analgesics|analgesics|mesh-ancestor
1994777|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
1994778|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994779|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994780|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1994781|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1994782|NCT01124162|Losartan|losartan|mesh-list
1994783|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1994784|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1994785|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1994786|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1994787|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994788|NCT01124175|Losartan|losartan|mesh-list
1994789|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1994790|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1994791|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1994792|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1994793|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994794|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1994795|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1994796|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1994797|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994798|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994799|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994800|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994801|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1994802|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
1994803|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1994804|NCT01124422|Fluticasone|fluticasone|mesh-list
1994805|NCT01124422|Xhance|xhance|mesh-list
1994806|NCT01124422|Bromides|bromides|mesh-list
1994807|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
1994808|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1994809|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1994810|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1994811|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
1994812|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994813|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994814|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1994815|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
1994816|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
1994817|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1994818|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
1994819|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1994820|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
1994821|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994822|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994823|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1994824|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1994825|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1994826|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
1994827|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
1994828|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
1994829|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
1994830|NCT01124448|Growth Substances|growth substances|mesh-ancestor
1994831|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994832|NCT01124604|Tapentadol|tapentadol|mesh-list
1994833|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1994834|NCT01124604|Narcotics|narcotics|mesh-ancestor
1994835|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1994836|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994837|NCT01124604|Analgesics|analgesics|mesh-ancestor
1994838|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
1994839|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994840|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1994841|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1994842|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994843|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994844|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
1994845|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994846|NCT01124617|Tapentadol|tapentadol|mesh-list
1994847|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1994848|NCT01124617|Narcotics|narcotics|mesh-ancestor
1994849|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1994850|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994851|NCT01124617|Analgesics|analgesics|mesh-ancestor
1994852|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
1994853|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994854|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1994855|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1994856|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994857|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994858|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
1994859|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1994860|NCT01124734|Temozolomide|temozolomide|mesh-list
1994861|NCT01124734|Interleukin-2|interleukin-2|mesh-list
1994862|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1994863|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
1994864|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994865|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994866|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1994867|NCT01124734|Analgesics|analgesics|mesh-ancestor
1994868|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
1994869|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994870|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994871|NCT01124786|Gemcitabine|gemcitabine|mesh-list
1994872|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1994873|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
1994874|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994875|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994876|NCT01124786|Antiviral Agents|antiviral agents|mesh-ancestor
1994877|NCT01124786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1994878|NCT01124786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994879|NCT01124786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1994880|NCT01124786|Immunologic Factors|immunologic factors|mesh-ancestor
1994881|NCT01124786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994882|NCT01124838|Prednisone|prednisone|mesh-list
1994883|NCT01124838|Adalimumab|adalimumab|mesh-list
1994884|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1994885|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
1994886|NCT01124838|Hormones|hormones|mesh-ancestor
1994887|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1994888|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994889|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1994890|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994891|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1994892|NCT01125046|Bevacizumab|bevacizumab|mesh-list
1994893|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1994894|NCT01125046|Antibodies|antibodies|mesh-list
1994895|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
1994896|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1994897|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994898|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1994899|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1994900|NCT01125046|Growth Substances|growth substances|mesh-ancestor
1994901|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994902|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
1994903|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
1994904|NCT01125098|Amoxicillin|amoxicillin|mesh-list
1994905|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
1994906|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1994907|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1994908|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1994909|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1994910|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994911|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994912|NCT01125163|Iron|iron|mesh-list
1994913|NCT01125163|Trace Elements|trace elements|mesh-ancestor
1994914|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
1994915|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994932|NCT01125189|Interferons|interferons|mesh-list
1994933|NCT01125189|Ribavirin|ribavirin|mesh-list
1994934|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
1994935|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
1994936|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1994937|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994938|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
1994939|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1994940|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
1994941|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994942|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
1994943|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994944|NCT01125293|Rituximab|rituximab|mesh-list
1994945|NCT01125293|Everolimus|everolimus|mesh-list
1994946|NCT01125293|Bortezomib|bortezomib|mesh-list
1994947|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1994948|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994949|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
1994950|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994951|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1994952|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1994953|NCT01125514|Furosemide|furosemide|mesh-list
1994954|NCT01125514|Diuretics|diuretics|mesh-ancestor
1994955|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
1994956|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994957|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1994958|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1994959|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994960|NCT01125566|Trastuzumab|trastuzumab|mesh-list
1994961|NCT01125566|Vinorelbine|vinorelbine|mesh-list
1994962|NCT01125566|Afatinib|afatinib|mesh-list
1994963|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1994964|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994965|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1994966|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
1994967|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
1994968|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
1994969|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1994970|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1994971|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1994972|NCT01125748|Omalizumab|omalizumab|mesh-list
1994973|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1994974|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1994975|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
1994976|NCT01125813|Factor VIII|factor viii|mesh-list
1994977|NCT01125813|Coagulants|coagulants|mesh-ancestor
1994978|NCT01125917|Buprenorphine|buprenorphine|mesh-list
1994979|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1994980|NCT01125917|Narcotics|narcotics|mesh-ancestor
1994981|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1994982|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1994983|NCT01125917|Analgesics|analgesics|mesh-ancestor
1994984|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
1994985|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1994986|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1994987|NCT01125930|Tretinoin|tretinoin|mesh-list
1994988|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1994989|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
1994990|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
1994991|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
1994992|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
1994993|NCT01126060|Coagulants|coagulants|mesh-ancestor
1994994|NCT01126099|Prazosin|prazosin|mesh-list
1994995|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1994996|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1994997|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1994998|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1994999|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
1995000|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1995001|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995002|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995003|NCT01126268|Retapamulin|retapamulin|mesh-list
1995004|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1995005|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1995006|NCT01126359|Lidocaine|lidocaine|mesh-list
1995007|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
1995008|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
1995009|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1995010|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995011|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
1995012|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995013|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1995014|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1995015|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1995016|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1995017|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995018|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
1995019|NCT01126424|Oxybutynin|oxybutynin|mesh-list
1995020|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1995021|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1995022|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
1995023|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1995024|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995025|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995026|NCT01126424|Urological Agents|urological agents|mesh-ancestor
1995027|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
1995028|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
1995029|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995030|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
1995031|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1995032|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
1995033|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995034|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995035|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1995036|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
1995037|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
1995038|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1995039|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
1995040|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1995041|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995042|NCT01126541|Rituximab|rituximab|mesh-list
1995043|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1995044|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995045|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
1995046|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995047|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1995048|NCT01126580|Metformin|metformin|mesh-list
1995049|NCT01126580|Dulaglutide|dulaglutide|mesh-list
1995050|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1995051|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995052|NCT01126593|Bupivacaine|bupivacaine|mesh-list
1995053|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
1995054|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
1995055|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1995056|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995057|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
1995058|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995059|NCT01126671|Vitamin D|vitamin d|mesh-list
1995060|NCT01126671|Vitamins|vitamins|mesh-ancestor
1995061|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
1995062|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995063|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1995064|NCT01127165|Zonisamide|zonisamide|mesh-list
1995065|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
1995066|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1995067|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1995068|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995069|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1995070|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995090|NCT01127438|Fospropofol|fospropofol|mesh-list
1995091|NCT01127438|Propofol|propofol|mesh-list
1995092|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1995093|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1995094|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995095|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1995096|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
1995097|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
1995098|NCT01127581|Dinoprostone|dinoprostone|mesh-list
1995099|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
1995100|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1995101|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995102|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1995103|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1995104|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995105|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1995106|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1995107|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1995108|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995109|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
1995110|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1995111|NCT01127646|Methylphenidate|methylphenidate|mesh-list
1995112|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1995113|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1995114|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995115|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1995116|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1995117|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1995118|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995119|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
1995120|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1995121|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1995122|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
1995123|NCT01127659|Testosterone|testosterone|mesh-list
1995124|NCT01127659|Androgens|androgens|mesh-ancestor
1995125|NCT01127659|Hormones|hormones|mesh-ancestor
1995126|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995127|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995128|NCT01127763|Carboplatin|carboplatin|mesh-list
1995129|NCT01127763|Everolimus|everolimus|mesh-list
1995130|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995131|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1995132|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
1995133|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995134|NCT01127893|Tanezumab|tanezumab|mesh-list
1995135|NCT01127893|Analgesics|analgesics|mesh-ancestor
1995136|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
1995137|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995138|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995139|NCT01128153|Saxagliptin|saxagliptin|mesh-list
1995140|NCT01128153|Incretins|incretins|mesh-ancestor
1995141|NCT01128153|Hormones|hormones|mesh-ancestor
1995142|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995143|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995144|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1995145|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
1995146|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995147|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995148|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1995149|NCT01128192|Pasireotide|pasireotide|mesh-list
1995150|NCT01128192|Hormones|hormones|mesh-ancestor
1995151|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995152|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995153|NCT01128244|Pyridoxine|pyridoxine|mesh-list
1995154|NCT01128244|Pyridoxal|pyridoxal|mesh-list
1995155|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
1995156|NCT01128244|Vitamins|vitamins|mesh-ancestor
1995157|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
1995158|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995159|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
1995160|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
1995161|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1995162|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1995163|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995164|NCT01128296|Gemcitabine|gemcitabine|mesh-list
1995165|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
1995166|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1995167|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
1995168|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995169|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995170|NCT01128296|Antiviral Agents|antiviral agents|mesh-ancestor
1995171|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1995172|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995173|NCT01128296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1995174|NCT01128296|Immunologic Factors|immunologic factors|mesh-ancestor
1995175|NCT01128296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995176|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
1995177|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1995178|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1995179|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1995180|NCT01128387|Panitumumab|panitumumab|mesh-list
1995181|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1995182|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995183|NCT01128543|Vinorelbine|vinorelbine|mesh-list
1995184|NCT01128543|Lapatinib|lapatinib|mesh-list
1995185|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1995186|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995187|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
1995188|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
1995189|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
1995190|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995191|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1995192|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995193|NCT01128569|Fluticasone|fluticasone|mesh-list
1995194|NCT01128569|Xhance|xhance|mesh-list
1995195|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1995196|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1995197|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
1995198|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995199|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995200|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1995201|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
1995202|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
1995203|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1995204|NCT01128595|Fluticasone|fluticasone|mesh-list
1995205|NCT01128595|Xhance|xhance|mesh-list
1995206|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1995207|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1995208|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
1995209|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995210|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995211|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1995212|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
1995213|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
1995214|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1995215|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1995216|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1995217|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995218|NCT01128621|Incretins|incretins|mesh-ancestor
1995219|NCT01128621|Hormones|hormones|mesh-ancestor
1995220|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995221|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1995222|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
1995223|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995224|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995225|NCT01128842|Capecitabine|capecitabine|mesh-list
1995226|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1995227|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
1995228|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995229|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995230|NCT01128894|Liraglutide|liraglutide|mesh-list
1995231|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
1995232|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1995233|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995234|NCT01128894|Incretins|incretins|mesh-ancestor
1995235|NCT01128894|Hormones|hormones|mesh-ancestor
1995236|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995237|NCT01128959|Carbamazepine|carbamazepine|mesh-list
1995238|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
1995239|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
1995240|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1995241|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1995242|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995243|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1995244|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1995245|NCT01128959|Analgesics|analgesics|mesh-ancestor
1995246|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
1995247|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995248|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1995249|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1995250|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995251|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1995252|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1995253|NCT01128972|Listerine|listerine|mesh-list
1995254|NCT01128972|Fluorides|fluorides|mesh-list
1995255|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
1995256|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
1995257|NCT01128972|Protective Agents|protective agents|mesh-ancestor
1995258|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995259|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1995260|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1995261|NCT01129011|Naproxen|naproxen|mesh-list
1995262|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1995263|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1995264|NCT01129011|Analgesics|analgesics|mesh-ancestor
1995265|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
1995266|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995267|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995268|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1995269|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1995270|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
1995271|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1995272|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995273|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995274|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
1995275|NCT01129206|Docetaxel|docetaxel|mesh-list
1995276|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1995277|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995278|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
1995279|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
1995280|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
1995281|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995282|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1995283|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
1995284|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
1995285|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1995286|NCT01129245|Celecoxib|celecoxib|mesh-list
1995287|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1995288|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1995289|NCT01129245|Analgesics|analgesics|mesh-ancestor
1995290|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
1995291|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995292|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995293|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1995294|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1995295|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1995296|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1995297|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995298|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995299|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
1995300|NCT01129284|Hormones|hormones|mesh-ancestor
1995301|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995302|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995303|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
1995304|NCT01129336|Diphosphonates|diphosphonates|mesh-list
1995305|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1995306|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995307|NCT01129440|Fluorides|fluorides|mesh-list
1995308|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
1995309|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
1995310|NCT01129440|Protective Agents|protective agents|mesh-ancestor
1995311|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995312|NCT01129557|Valsartan|valsartan|mesh-list
1995313|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1995314|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1995315|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1995316|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995317|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
1995318|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1995319|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1995320|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1995321|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1995322|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995323|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
1995324|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1995325|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995326|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1995327|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995328|NCT01129622|Letrozole|letrozole|mesh-list
1995329|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995330|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1995331|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1995332|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995333|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995334|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1995335|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
1995336|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995337|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995338|NCT01129778|Omeprazole|omeprazole|mesh-list
1995339|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
1995340|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
1995341|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1995342|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1995343|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995344|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995345|NCT01129882|Aripiprazole|aripiprazole|mesh-list
1995346|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
1995347|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1995348|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1995349|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1995350|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1995351|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995352|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
1995353|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
1995354|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1995355|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995356|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1995357|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1995358|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
1995359|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1995360|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1995361|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1995362|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1995363|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
1995364|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
1995365|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1995366|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1995367|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1995368|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995369|NCT01130051|Colchicine|colchicine|mesh-list
1995370|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
1995371|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1995372|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
1995373|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
1995374|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
1995375|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995376|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995377|NCT01130103|Paroxetine|paroxetine|mesh-list
1995378|NCT01130103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1995379|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1995380|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1995381|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995382|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1995383|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
1995384|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995385|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1995386|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
1995387|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1995388|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1995389|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1995390|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995391|NCT01130168|Amlodipine|amlodipine|mesh-list
1995392|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1995393|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1995394|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1995395|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995396|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1995397|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995398|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
1995399|NCT01130272|Eluxadoline|eluxadoline|mesh-list
1995400|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1995401|NCT01130337|Capecitabine|capecitabine|mesh-list
1995402|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
1995403|NCT01130337|Trastuzumab|trastuzumab|mesh-list
1995404|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1995405|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
1995406|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995407|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995408|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1995409|NCT01130493|Levodopa|levodopa|mesh-list
1995410|NCT01130493|Carbidopa|carbidopa|mesh-list
1995411|NCT01130493|Entacapone|entacapone|mesh-list
1995412|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1995413|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1995414|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1995415|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
1995416|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1995417|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995418|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995419|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1995420|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995421|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1995422|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1995423|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
1995424|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
1995425|NCT01130532|Tadalafil|tadalafil|mesh-list
1995426|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
1995427|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1995428|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1995429|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995430|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995431|NCT01130532|Urological Agents|urological agents|mesh-ancestor
1995432|NCT01130597|Spironolactone|spironolactone|mesh-list
1995433|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1995434|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
1995435|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995436|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995437|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1995438|NCT01130597|Diuretics|diuretics|mesh-ancestor
1995439|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
1995440|NCT01130844|Mesalamine|mesalamine|mesh-list
1995441|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1995442|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1995443|NCT01130844|Analgesics|analgesics|mesh-ancestor
1995444|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
1995445|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995446|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995447|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1995448|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1995449|NCT01131052|Insulin|insulin|mesh-list
1995450|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1995451|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
1995452|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
1995453|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1995454|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995455|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
1995456|NCT01131065|Antibodies|antibodies|mesh-list
1995457|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
1995458|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1995459|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1995460|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
1995461|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995462|NCT01131078|Bevacizumab|bevacizumab|mesh-list
1995463|NCT01131078|Capecitabine|capecitabine|mesh-list
1995464|NCT01131078|Irinotecan|irinotecan|mesh-list
1995465|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1995466|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995467|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1995468|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1995469|NCT01131078|Growth Substances|growth substances|mesh-ancestor
1995470|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995471|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
1995472|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1995473|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
1995474|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995475|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1995476|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1995477|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995478|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
1995479|NCT01131104|Tadalafil|tadalafil|mesh-list
1995480|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
1995481|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
1995482|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
1995483|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1995484|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995485|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995486|NCT01131104|Urological Agents|urological agents|mesh-ancestor
1995487|NCT01131182|Metformin|metformin|mesh-list
1995488|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1995489|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1995490|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995491|NCT01131182|Incretins|incretins|mesh-ancestor
1995492|NCT01131182|Hormones|hormones|mesh-ancestor
1995493|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995494|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1995495|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
1995496|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995497|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995498|NCT01131507|Pancrelipase|pancrelipase|mesh-list
1995499|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1995500|NCT01131585|Ranibizumab|ranibizumab|mesh-list
1995501|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1995502|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1995503|NCT01131585|Growth Substances|growth substances|mesh-ancestor
1995504|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995505|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
1995506|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995507|NCT01131676|Empagliflozin|empagliflozin|mesh-list
1995508|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1995509|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995510|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1995511|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995512|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
1995513|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
1995514|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1995515|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1995516|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1995517|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995518|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995519|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1995520|NCT01132313|Ribavirin|ribavirin|mesh-list
1995521|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
1995522|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995523|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
1995524|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1995525|NCT01132326|Droxidopa|droxidopa|mesh-list
1995526|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1995527|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1995528|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
1995529|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
1995530|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1995531|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1995532|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995533|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995534|NCT01132482|Urological Agents|urological agents|mesh-ancestor
1995535|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
1995536|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
1995537|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
1995538|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1995539|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1995540|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
1995541|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
1995542|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1995543|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995544|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995545|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1995546|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
1995547|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1995548|NCT01132664|Capecitabine|capecitabine|mesh-list
1995549|NCT01132664|Trastuzumab|trastuzumab|mesh-list
1995550|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1995551|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
1995552|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995553|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995554|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1995555|NCT01132807|Prednisone|prednisone|mesh-list
1995556|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
1995557|NCT01132807|Dacarbazine|dacarbazine|mesh-list
1995558|NCT01132807|Doxorubicin|doxorubicin|mesh-list
1995559|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1995560|NCT01132807|Etoposide|etoposide|mesh-list
1995561|NCT01132807|Bleomycin|bleomycin|mesh-list
1995562|NCT01132807|Vinblastine|vinblastine|mesh-list
1995563|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
1995564|NCT01132807|Procarbazine|procarbazine|mesh-list
1995565|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1995566|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1995567|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
1995568|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995569|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1995570|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1995571|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
1995572|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995573|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995574|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1995575|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1995576|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1995577|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1995578|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995579|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1995580|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
1995581|NCT01132807|Hormones|hormones|mesh-ancestor
1995582|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995583|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1995584|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1995585|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1995586|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
1995587|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
1995588|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
1995589|NCT01132820|Cediranib|cediranib|mesh-list
1995590|NCT01132820|Maleic acid|maleic acid|mesh-list
1995591|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995592|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995593|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995594|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1995595|NCT01132846|Dopamine|dopamine|mesh-list
1995596|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1995597|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1995598|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
1995599|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
1995600|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995601|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995602|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
1995603|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1995604|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995605|NCT01132846|Protective Agents|protective agents|mesh-ancestor
1995606|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
1995607|NCT01133158|Dexamethasone|dexamethasone|mesh-list
1995608|NCT01133158|Rituximab|rituximab|mesh-list
1995609|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1995610|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
1995611|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1995612|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
1995613|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
1995614|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995615|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995616|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1995617|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
1995618|NCT01133158|Hormones|hormones|mesh-ancestor
1995619|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995620|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1995621|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995622|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1995623|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
1995624|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1995625|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1995626|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
1995627|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995628|NCT01133158|Analgesics|analgesics|mesh-ancestor
1995629|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
1995630|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1995631|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1995632|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995633|NCT01133275|Prednisone|prednisone|mesh-list
1995634|NCT01133275|Lenalidomide|lenalidomide|mesh-list
1995635|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1995636|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
1995637|NCT01133275|Hormones|hormones|mesh-ancestor
1995638|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995639|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995640|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1995641|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995642|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
1995643|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1995644|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1995645|NCT01133275|Growth Substances|growth substances|mesh-ancestor
1995646|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
1995647|NCT01133379|Fluorides|fluorides|mesh-list
1995648|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
1995649|NCT01133379|Protective Agents|protective agents|mesh-ancestor
1995650|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995651|NCT01133392|Insulin|insulin|mesh-list
1995652|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1995653|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
1995654|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1995655|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995656|NCT01133522|Evolocumab|evolocumab|mesh-list
1995657|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1995658|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1995659|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
1995660|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995661|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1995662|NCT01133626|Prednisone|prednisone|mesh-list
1995663|NCT01133626|Beclomethasone|beclomethasone|mesh-list
1995664|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1995665|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
1995666|NCT01133626|Hormones|hormones|mesh-ancestor
1995667|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995668|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995669|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1995670|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995671|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1995672|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
1995673|NCT01133665|Lenalidomide|lenalidomide|mesh-list
1995674|NCT01133665|Cetuximab|cetuximab|mesh-list
1995675|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
1995676|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995677|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1995678|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1995679|NCT01133665|Growth Substances|growth substances|mesh-ancestor
1995680|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
1995681|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995682|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1995683|NCT01133678|Paclitaxel|paclitaxel|mesh-list
1995684|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1995685|NCT01133678|Cisplatin|cisplatin|mesh-list
1995686|NCT01133678|Cetuximab|cetuximab|mesh-list
1995687|NCT01133678|Everolimus|everolimus|mesh-list
1995688|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1995689|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995690|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
1995691|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
1995692|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
1995693|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995694|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1995695|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1995696|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
1995697|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995698|NCT01133756|Gemcitabine|gemcitabine|mesh-list
1995699|NCT01133756|Carboplatin|carboplatin|mesh-list
1995700|NCT01133756|Lenvatinib|lenvatinib|mesh-list
1995701|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995702|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1995703|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
1995704|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995705|NCT01133756|Antiviral Agents|antiviral agents|mesh-ancestor
1995706|NCT01133756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1995707|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995708|NCT01133756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1995709|NCT01133756|Immunologic Factors|immunologic factors|mesh-ancestor
1995710|NCT01133756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995711|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1995712|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1995713|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
1995714|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1995715|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1995716|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1995717|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1995718|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995719|NCT01133847|Guanfacine|guanfacine|mesh-list
1995720|NCT01133847|Methylphenidate|methylphenidate|mesh-list
1995721|NCT01133847|Amphetamine|amphetamine|mesh-list
1995722|NCT01133847|Adderall|adderall|mesh-list
1995723|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1995724|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1995725|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995726|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1995727|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1995728|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1995729|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995730|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
1995731|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1995732|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1995733|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
1995734|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
1995735|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
1995736|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995737|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1995738|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1995739|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1995740|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1995741|NCT01133977|Lenvatinib|lenvatinib|mesh-list
1995742|NCT01133977|Dacarbazine|dacarbazine|mesh-list
1995743|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995744|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1995745|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995746|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995747|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1995748|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
1995749|NCT01134042|Fluticasone|fluticasone|mesh-list
1995750|NCT01134042|Xhance|xhance|mesh-list
1995751|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1995752|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1995753|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
1995754|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995755|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995756|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1995757|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
1995758|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
1995759|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1995760|NCT01134055|Ranibizumab|ranibizumab|mesh-list
1995761|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1995762|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1995763|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1995764|NCT01134055|Growth Substances|growth substances|mesh-ancestor
1995765|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995766|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
1995767|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995768|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1995769|NCT01134107|Insulin|insulin|mesh-list
1995770|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1995771|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
1995772|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
1995773|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1995774|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995775|NCT01134198|Mifepristone|mifepristone|mesh-list
1995776|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1995777|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
1995778|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1995779|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995780|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1995781|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1995782|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1995783|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
1995784|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1995785|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1995786|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
1995787|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995788|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
1995789|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1995790|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1995791|NCT01134263|Vaccines|vaccines|mesh-list
1995792|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
1995793|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995794|NCT01134315|Calcitriol|calcitriol|mesh-list
1995795|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1995796|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995797|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1995798|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1995799|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995800|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1995801|NCT01134315|Vitamins|vitamins|mesh-ancestor
1995802|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
1995803|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1995804|NCT01134393|Amlodipine|amlodipine|mesh-list
1995805|NCT01134393|Telmisartan|telmisartan|mesh-list
1995806|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
1995807|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1995808|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1995809|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1995810|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995811|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1995812|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995813|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
1995814|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1995815|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1995816|NCT01134510|Complement C1s|complement c1s|mesh-list
1995817|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1995818|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
1995819|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
1995820|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995821|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1995822|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1995823|NCT01134575|Rituximab|rituximab|mesh-list
1995824|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
1995825|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1995826|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995827|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
1995828|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995829|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1995830|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1995831|NCT01134614|Ipilimumab|ipilimumab|mesh-list
1995832|NCT01134614|Sargramostim|sargramostim|mesh-list
1995833|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1995834|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995835|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1995836|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995837|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
1995838|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995839|NCT01134627|Minocycline|minocycline|mesh-list
1995840|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1995841|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1995842|NCT01134705|Beclomethasone|beclomethasone|mesh-list
1995843|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1995844|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
1995845|NCT01134705|Hormones|hormones|mesh-ancestor
1995846|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1995847|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995848|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1995849|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
1995850|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1995851|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1995852|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995853|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1995854|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1995855|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995856|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1995857|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1995858|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1995859|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
1995860|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475598|NCT01085058|Lenograstim|lenograstim|mesh-list
1995861|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1995862|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1995863|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
1995864|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
1995865|NCT01134952|Sirolimus|sirolimus|mesh-list
1995866|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1995867|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995868|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1995869|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
1995870|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1995871|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1995872|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995873|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995874|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
1995875|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1995876|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
1995877|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995878|NCT01135017|Dronedarone|dronedarone|mesh-list
1995879|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1995880|NCT01135069|Tretinoin|tretinoin|mesh-list
1995881|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995882|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
1995883|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
1995884|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
1995885|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1995886|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
1995887|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1995888|NCT01135186|Verapamil|verapamil|mesh-list
1995889|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1995890|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1995891|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1995892|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995893|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1995894|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995895|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
1995896|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
1995897|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
1995898|NCT01135329|Busulfan|busulfan|mesh-list
1995899|NCT01135329|Fludarabine|fludarabine|mesh-list
1995900|NCT01135329|Tacrolimus|tacrolimus|mesh-list
1995901|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1995902|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
1995903|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995904|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1995905|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1995906|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
1995907|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995908|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995909|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1995910|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1995911|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995912|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1995913|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1995914|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
1995915|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1995916|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1995917|NCT01135368|Lansoprazole|lansoprazole|mesh-list
1995918|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
1995919|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1995920|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1995921|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1995922|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995923|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995924|NCT01135394|Pioglitazone|pioglitazone|mesh-list
1995925|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1995926|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995927|NCT01135498|Bevacizumab|bevacizumab|mesh-list
1995928|NCT01135498|Capecitabine|capecitabine|mesh-list
1995929|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1995930|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
1995931|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1995932|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995933|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1995934|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1995935|NCT01135498|Growth Substances|growth substances|mesh-ancestor
1995936|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995937|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
1995938|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1995939|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
1995940|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995941|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1995942|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995943|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1995944|NCT01135511|Tofacitinib|tofacitinib|mesh-list
1995945|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
1995946|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1995947|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1995948|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995949|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995950|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1995951|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
1995952|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995953|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
1995954|NCT01135511|Protective Agents|protective agents|mesh-ancestor
1995955|NCT01135524|Buprenorphine|buprenorphine|mesh-list
1995956|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1995957|NCT01135524|Narcotics|narcotics|mesh-ancestor
1995958|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1995959|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995960|NCT01135524|Analgesics|analgesics|mesh-ancestor
1995961|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
1995962|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1995963|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1995964|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
1995965|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1995966|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
1995967|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995968|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1995969|NCT01135914|Ranibizumab|ranibizumab|mesh-list
1995970|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1995971|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1995972|NCT01135914|Growth Substances|growth substances|mesh-ancestor
1995973|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995974|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
1995975|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995976|NCT01135992|Insulin|insulin|mesh-list
1995977|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1995978|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
1995979|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1995980|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995981|NCT01136174|Nintedanib|nintedanib|mesh-list
1995982|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995983|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1995984|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1995985|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1995986|NCT01136226|Leuprolide|leuprolide|mesh-list
1995987|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1995988|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
1995989|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1995990|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995991|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1995992|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1995993|NCT01136356|Morphine|morphine|mesh-list
1995994|NCT01136356|Buprenorphine|buprenorphine|mesh-list
1995995|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1995996|NCT01136356|Narcotics|narcotics|mesh-ancestor
1995997|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1995998|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1995999|NCT01136356|Analgesics|analgesics|mesh-ancestor
1996000|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
1996001|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996002|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1996003|NCT01136382|Budesonide|budesonide|mesh-list
1996004|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1996005|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1996006|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
1996007|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996008|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996009|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1996010|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
1996011|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
1996012|NCT01136382|Hormones|hormones|mesh-ancestor
2079358|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996013|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996014|NCT01136408|Warfarin|warfarin|mesh-list
1996015|NCT01136408|Dabigatran|dabigatran|mesh-list
1996016|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
1996017|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
1996018|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1996019|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
1996020|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996021|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996022|NCT01136655|Budesonide|budesonide|mesh-list
1996023|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
1996024|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1996025|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1996026|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1996027|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
1996028|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996029|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996030|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1996031|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
1996032|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
1996033|NCT01136655|Hormones|hormones|mesh-ancestor
1996034|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996035|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1996036|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1996037|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1996038|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
1996039|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996040|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996041|NCT01136733|Everolimus|everolimus|mesh-list
1996042|NCT01136733|Lenvatinib|lenvatinib|mesh-list
1996043|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996044|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1996045|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
1996046|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996047|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1996048|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996049|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996050|NCT01136746|Insulin|insulin|mesh-list
1996051|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1996052|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
1996053|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
1996054|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1996055|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996056|NCT01136772|Haloperidol|haloperidol|mesh-list
1996057|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1996058|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
1996059|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1996060|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1996061|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1996062|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996063|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1996064|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1996065|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1996066|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
1996067|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996068|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996069|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1996070|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1996071|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
1996072|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
1996073|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
1996074|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996075|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1996076|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1996077|NCT01136798|Exenatide|exenatide|mesh-list
1996078|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1996079|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996080|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1996081|NCT01136798|Incretins|incretins|mesh-ancestor
1996082|NCT01136798|Hormones|hormones|mesh-ancestor
1996083|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996084|NCT01136954|Zonisamide|zonisamide|mesh-list
1996085|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
1996086|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1996087|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1996088|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996089|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1996090|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745844|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2745845|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2745846|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2745847|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2745848|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
1996096|NCT01137071|Antibodies|antibodies|mesh-list
1996097|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1996098|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
1996099|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996100|NCT01137292|Voriconazole|voriconazole|mesh-list
1996101|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
1996102|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1996103|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1996104|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1996105|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996106|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996107|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1996108|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
1996109|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996110|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996111|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1996112|NCT01137396|Modafinil|modafinil|mesh-list
1996113|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1996114|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996115|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1996116|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1996117|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1996118|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996119|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
1996120|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1996121|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996122|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1996123|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996124|NCT01137604|Bevacizumab|bevacizumab|mesh-list
1996125|NCT01137604|Lenvatinib|lenvatinib|mesh-list
1996126|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1996127|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996128|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1996129|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1996130|NCT01137604|Growth Substances|growth substances|mesh-ancestor
1996131|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996132|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
1996133|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1996134|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996135|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996136|NCT01137682|Octreotide|octreotide|mesh-list
1996137|NCT01137682|Lanreotide|lanreotide|mesh-list
1996138|NCT01137682|Pasireotide|pasireotide|mesh-list
1996139|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1996140|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1996141|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996142|NCT01137682|Hormones|hormones|mesh-ancestor
1996143|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996144|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996149|NCT01137812|Metformin|metformin|mesh-list
1996150|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1996151|NCT01137812|Canagliflozin|canagliflozin|mesh-list
1996152|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1996153|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996154|NCT01137812|Incretins|incretins|mesh-ancestor
1996155|NCT01137812|Hormones|hormones|mesh-ancestor
1996156|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996157|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1996158|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
1996159|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996160|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996161|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1996162|NCT01137890|Zonisamide|zonisamide|mesh-list
1996163|NCT01137890|Cocaine|cocaine|mesh-list
1996164|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
1996165|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1996166|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1996167|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996168|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1996169|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996170|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
1996171|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
1996172|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1996173|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
1996174|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996175|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1996176|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1996177|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1996178|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
1996179|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996180|NCT01138046|Paclitaxel|paclitaxel|mesh-list
1996181|NCT01138046|Lapatinib|lapatinib|mesh-list
1996182|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1996183|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996184|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
1996185|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
1996186|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
1996187|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996188|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1996189|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996190|NCT01138124|Gabapentin|gabapentin|mesh-list
1996191|NCT01138124|Analgesics|analgesics|mesh-ancestor
1996192|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
1996193|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996194|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996195|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
1996196|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1996197|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1996198|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1996199|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1996200|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1996201|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1996202|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996203|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996204|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
1996205|NCT01138150|Naproxen|naproxen|mesh-list
1996206|NCT01138150|Sumatriptan|sumatriptan|mesh-list
1996207|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1996208|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1996209|NCT01138150|Analgesics|analgesics|mesh-ancestor
1996210|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
1996211|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996212|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996213|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1996214|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996215|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
1996216|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1996217|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996218|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996219|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1996220|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1996221|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1996222|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
1996223|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996224|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
1996225|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1996226|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996227|NCT01138475|Vitamins|vitamins|mesh-ancestor
1996228|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
1996229|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1996230|NCT01138501|Factor VIII|factor viii|mesh-list
1996231|NCT01138501|Coagulants|coagulants|mesh-ancestor
1996232|NCT01138514|Clindamycin|clindamycin|mesh-list
1996233|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
1996234|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
1996235|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1996236|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1996237|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1996238|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1996239|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996240|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996241|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
1996242|NCT01138657|Prednisone|prednisone|mesh-list
1996243|NCT01138657|Adalimumab|adalimumab|mesh-list
1996244|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1996245|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
1996246|NCT01138657|Hormones|hormones|mesh-ancestor
1996247|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996248|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996249|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1996250|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996251|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996252|NCT01138735|Adapalene|adapalene|mesh-list
1996253|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
1996254|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1996255|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
1996256|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1996257|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1996258|NCT01138735|Analgesics|analgesics|mesh-ancestor
1996259|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
1996260|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996261|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996262|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1996263|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996264|NCT01138826|Amlodipine|amlodipine|mesh-list
1996265|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1996266|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1996267|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1996268|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996269|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1996270|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996271|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
1996272|NCT01138969|Esomeprazole|esomeprazole|mesh-list
1996273|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1996274|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1996275|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1996276|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996277|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996278|NCT01139008|Metronidazole|metronidazole|mesh-list
1996279|NCT01139008|Azelaic acid|azelaic acid|mesh-list
1996280|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1996281|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1996282|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1996283|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1996284|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996285|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
1996286|NCT01139047|Metronidazole|metronidazole|mesh-list
1996287|NCT01139047|Azelaic acid|azelaic acid|mesh-list
1996288|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1996289|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1996290|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1996291|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1996292|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996293|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
1996294|NCT01139190|Naproxen|naproxen|mesh-list
1996295|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1996296|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1996297|NCT01139190|Analgesics|analgesics|mesh-ancestor
1996298|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
1996299|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996300|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996301|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1996302|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996303|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
1996304|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1996305|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996306|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996307|NCT01139450|Tacrolimus|tacrolimus|mesh-list
1996308|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1996309|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
1996310|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996311|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1996312|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996313|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996314|NCT01139515|Eletriptan|eletriptan|mesh-list
1996315|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1996316|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
1996317|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996318|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996319|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996320|NCT01139580|Calcipotriene|calcipotriene|mesh-list
1996321|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
1996322|NCT01139762|Tadalafil|tadalafil|mesh-list
1996323|NCT01139762|Finasteride|finasteride|mesh-list
1996324|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
1996325|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1996326|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1996327|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996328|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996329|NCT01139762|Urological Agents|urological agents|mesh-ancestor
1996330|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1996331|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1996332|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
1996333|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996334|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996335|NCT01139775|Pemetrexed|pemetrexed|mesh-list
1996336|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996337|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996338|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996339|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1996340|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1996341|NCT01139801|Misoprostol|misoprostol|mesh-list
1996342|NCT01139801|Oxytocin|oxytocin|mesh-list
1996343|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
1996344|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1996345|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996346|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1996347|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
1996348|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1996349|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1996350|NCT01140061|MK 0873|mk 0873|mesh-list
1996351|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1996352|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1996353|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996354|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996355|NCT01140191|Gentamicins|gentamicins|mesh-list
1996356|NCT01140191|Paromomycin|paromomycin|mesh-list
1996357|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1996358|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1996359|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1996360|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996361|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996362|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1996363|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1996364|NCT01140347|Ramucirumab|ramucirumab|mesh-list
1996365|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996366|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
1996367|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996368|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1996369|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996370|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996371|NCT01140503|Apremilast|apremilast|mesh-list
1996372|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1996373|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1996374|NCT01140503|Analgesics|analgesics|mesh-ancestor
1996375|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
1996376|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996377|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996378|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1996379|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996380|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1996381|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1996382|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475599|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1996383|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996391|NCT01140880|Tenofovir|tenofovir|mesh-list
1996392|NCT01140880|Emtricitabine|emtricitabine|mesh-list
1996393|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1996394|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
1996395|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1996396|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1996397|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1996398|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996399|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996400|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1996401|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1996402|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1996403|NCT01140906|Vortioxetine|vortioxetine|mesh-list
1996404|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1996405|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1996406|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1996407|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996408|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996409|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996410|NCT01140906|Analgesics|analgesics|mesh-ancestor
1996411|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
1996412|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996413|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
1996414|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1996415|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
1996416|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1996417|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1996418|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1996419|NCT01140906|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1996420|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
1996421|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1996422|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1996423|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1996424|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1996425|NCT01141049|Gabapentin|gabapentin|mesh-list
1996426|NCT01141049|Analgesics|analgesics|mesh-ancestor
1996427|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
1996428|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996429|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996430|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
1996431|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1996432|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1996433|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1996434|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1996435|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1996436|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1996437|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996438|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996439|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
1996440|NCT01141283|Buprenorphine|buprenorphine|mesh-list
1996441|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1996442|NCT01141283|Narcotics|narcotics|mesh-ancestor
1996443|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1996444|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996445|NCT01141283|Analgesics|analgesics|mesh-ancestor
1996446|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
1996447|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996448|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1996449|NCT01141478|Sorafenib|sorafenib|mesh-list
1996450|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996451|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1996452|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996453|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996454|NCT01141491|Vaccines|vaccines|mesh-list
1996455|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
1996456|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
1996457|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996458|NCT01141569|R04929097|r04929097|mesh-list
1996459|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996460|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996461|NCT01141595|Verapamil|verapamil|mesh-list
1996462|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1996463|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1996464|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1996465|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996466|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1996467|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996468|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
1996489|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1996490|NCT01141725|Idarubicin|idarubicin|mesh-list
1996491|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1996492|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
1996493|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996494|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996495|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1996496|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1996497|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1996498|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996499|NCT01142089|Rifamycins|rifamycins|mesh-list
1996500|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
1996501|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1996502|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1996503|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996504|NCT01142193|Topiramate|topiramate|mesh-list
1996505|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
1996506|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1996507|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996508|NCT01142232|Lenalidomide|lenalidomide|mesh-list
1996509|NCT01142232|Melphalan|melphalan|mesh-list
1996510|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
1996511|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996512|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1996513|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1996514|NCT01142232|Growth Substances|growth substances|mesh-ancestor
1996515|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
1996516|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996517|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1996518|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
1996519|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996520|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1996521|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1996522|NCT01142310|Lamotrigine|lamotrigine|mesh-list
1996523|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
1996524|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1996525|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1996526|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996527|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1996528|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996529|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1996530|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1996531|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1996532|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1996533|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1996534|NCT01142323|Fenofibrate|fenofibrate|mesh-list
1996535|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1996536|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
1996537|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996538|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1996539|NCT01142336|Simvastatin|simvastatin|mesh-list
1996540|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1996541|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1996542|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
1996543|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996544|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1996545|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1996546|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996547|NCT01142388|Paclitaxel|paclitaxel|mesh-list
1996548|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1996549|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1996550|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1996551|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996552|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
1996553|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
1996554|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
1996555|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996556|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
1996557|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996558|NCT01142466|Interferons|interferons|mesh-list
1996559|NCT01142466|Interferon-beta|interferon-beta|mesh-list
1996560|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
1996561|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996562|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
1996563|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1996564|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
1996565|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996566|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1996567|NCT01142596|Asenapine|asenapine|mesh-list
1996568|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1996569|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1996570|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1996571|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996572|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1996573|NCT01142726|Methotrexate|methotrexate|mesh-list
1996574|NCT01142726|Abatacept|abatacept|mesh-list
1996575|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1996576|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
1996577|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1996578|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996579|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1996580|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
1996581|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996582|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996583|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
1996584|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996585|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1996586|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1996587|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
1996588|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996589|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1996590|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1996591|NCT01142947|Beclomethasone|beclomethasone|mesh-list
1996592|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1996593|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
1996594|NCT01142947|Hormones|hormones|mesh-ancestor
1996595|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996596|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996597|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1996598|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
1996599|NCT01143051|Epinephrine|epinephrine|mesh-list
1996600|NCT01143051|Racepinephrine|racepinephrine|mesh-list
1996601|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
1996602|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1996603|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1996604|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
1996605|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996606|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996607|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996608|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1996609|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1996610|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
1996611|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996612|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1996613|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
1996614|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
1996615|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
1996616|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1996617|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1996618|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1996619|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1996620|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1996621|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996622|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1996623|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1996624|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1996625|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1996626|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
1996627|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996628|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996629|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1996630|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1996631|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
1996632|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1996633|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1996634|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
1996635|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1996636|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1996637|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1996638|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1996639|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996640|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1996641|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1996642|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1996643|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1996644|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
1996645|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996646|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996647|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1996648|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1996649|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
1996650|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1996651|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1996652|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
1996653|NCT01143181|Brincidofovir|brincidofovir|mesh-list
1996654|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
1996655|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1996656|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1996657|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
1996658|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1996659|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1996660|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1996661|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
1996662|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1996663|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996664|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1996665|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1996666|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1996667|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1996668|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996669|NCT01143259|Alvimopan|alvimopan|mesh-list
1996670|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1996671|NCT01143337|Methotrexate|methotrexate|mesh-list
1996672|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1996673|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
1996674|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1996675|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996676|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1996677|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
2475600|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
1996678|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996679|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996680|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
1996681|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996682|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1996683|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1996684|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
1996685|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996686|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1996687|NCT01143389|Riboflavin|riboflavin|mesh-list
1996688|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
1996689|NCT01143389|Vitamins|vitamins|mesh-ancestor
1996690|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
1996691|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996692|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1996693|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
1996694|NCT01143402|Temozolomide|temozolomide|mesh-list
1996695|NCT01143402|Dacarbazine|dacarbazine|mesh-list
1996696|NCT01143402|Imidazole|imidazole|mesh-list
1996697|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1996698|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
1996699|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996700|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996701|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996702|NCT01143688|Albuterol|albuterol|mesh-list
1996703|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1996704|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
1996705|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996706|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996707|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1996708|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
1996709|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
1996710|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1996711|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1996712|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1996713|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1996714|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
1996715|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996716|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996717|NCT01143714|Petrolatum|petrolatum|mesh-list
1996718|NCT01143714|Emollients|emollients|mesh-ancestor
1996719|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
1996720|NCT01143766|Gabapentin|gabapentin|mesh-list
1996721|NCT01143766|Analgesics|analgesics|mesh-ancestor
1996722|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
1996723|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996724|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996725|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
1996726|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1996727|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1996728|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1996729|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1996730|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1996731|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1996732|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996733|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996734|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
1996735|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
1996736|NCT01143818|Testosterone|testosterone|mesh-list
1996737|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
1996738|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
1996739|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1996740|NCT01143818|Androgens|androgens|mesh-ancestor
1996741|NCT01143818|Hormones|hormones|mesh-ancestor
1996742|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996743|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996744|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1996745|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996746|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
1996747|NCT01144052|Interferons|interferons|mesh-list
1996748|NCT01144052|Interferon-beta|interferon-beta|mesh-list
1996749|NCT01144052|Natalizumab|natalizumab|mesh-list
1996750|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
1996751|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996752|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
1996753|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1996754|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
1996755|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996756|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1996757|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
1996758|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1996759|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1996760|NCT01144143|Prednisolone|prednisolone|mesh-list
1996761|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
1996762|NCT01144143|Infliximab|infliximab|mesh-list
1996763|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1996764|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
1996765|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1996766|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
1996767|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
1996768|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996769|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996770|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1996771|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
1996772|NCT01144143|Hormones|hormones|mesh-ancestor
1996773|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996774|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1996775|NCT01144143|Protective Agents|protective agents|mesh-ancestor
1996776|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1996777|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996778|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
1996779|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996780|NCT01144338|Exenatide|exenatide|mesh-list
1996781|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1996782|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996783|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1996784|NCT01144338|Incretins|incretins|mesh-ancestor
1996785|NCT01144338|Hormones|hormones|mesh-ancestor
1996786|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996787|NCT01144364|Rituximab|rituximab|mesh-list
1996788|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1996789|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996790|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
1996791|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996792|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996793|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
1996794|NCT01144403|Rituximab|rituximab|mesh-list
1996795|NCT01144403|Fludarabine|fludarabine|mesh-list
1996796|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
1996797|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1996798|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
1996799|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996800|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996801|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1996802|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
1996803|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996804|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996805|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1996806|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1996807|NCT01144403|Analgesics|analgesics|mesh-ancestor
1996808|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
1996809|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996810|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1996811|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1996812|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996813|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1996814|NCT01144416|Hormones|hormones|mesh-ancestor
1996815|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996816|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996817|NCT01144442|Paclitaxel|paclitaxel|mesh-list
1996818|NCT01144442|Carboplatin|carboplatin|mesh-list
1996819|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1996820|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996821|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
1996822|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
1996823|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
1996824|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996825|NCT01144455|Gemcitabine|gemcitabine|mesh-list
1996826|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
1996827|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1996828|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
1996829|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996830|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996831|NCT01144455|Antiviral Agents|antiviral agents|mesh-ancestor
1996832|NCT01144455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1996833|NCT01144455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996834|NCT01144455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1996835|NCT01144455|Immunologic Factors|immunologic factors|mesh-ancestor
1996836|NCT01144455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996837|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1996838|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
1996839|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1996840|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
1996841|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1996842|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1996843|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1996844|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1996845|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
1996846|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996847|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996848|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996849|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1996850|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1996851|NCT01144949|Silodosin|silodosin|mesh-list
1996852|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1996853|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1996854|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1996855|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
1996856|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996857|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996858|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996859|NCT01144949|Urological Agents|urological agents|mesh-ancestor
1996860|NCT01145001|Nicotine|nicotine|mesh-list
1996861|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1996862|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
1996863|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996864|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996865|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1996866|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1996867|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
1996868|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996869|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996870|NCT01145066|Borage oil|borage oil|mesh-list
1996871|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996872|NCT01145183|Doxazosin|doxazosin|mesh-list
1996873|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1996874|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1996875|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1996876|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1996877|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
1996878|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996879|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996880|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996881|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
1996882|NCT01145209|Fludarabine|fludarabine|mesh-list
1996883|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
1996884|NCT01145209|Ofatumumab|ofatumumab|mesh-list
1996885|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1996886|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
1996887|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996888|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996889|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1996890|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
1996891|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996892|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996893|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1996894|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1996895|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
1996896|NCT01145222|Midazolam|midazolam|mesh-list
1996897|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1996898|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1996899|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1996900|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996901|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1996902|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1996903|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1996904|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1996905|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
1996906|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
1996907|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
1996908|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
1996909|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996910|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996911|NCT01145352|Etanercept|etanercept|mesh-list
1996912|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1996913|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1996914|NCT01145352|Analgesics|analgesics|mesh-ancestor
1996915|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
1996916|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996917|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996918|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1996919|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1996920|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1996921|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1996922|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
1996923|NCT01145417|Pregabalin|pregabalin|mesh-list
1996924|NCT01145417|Analgesics|analgesics|mesh-ancestor
1996925|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
1996926|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996927|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996928|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
1996929|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1996930|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1996931|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996932|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1996933|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1996934|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1996935|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1996936|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1996937|NCT01145482|Insulin|insulin|mesh-list
1996938|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
1996939|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1996940|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996941|NCT01145508|Metronidazole|metronidazole|mesh-list
1996942|NCT01145508|Prednisone|prednisone|mesh-list
1996943|NCT01145508|Cortisone|cortisone|mesh-list
1996944|NCT01145508|Docetaxel|docetaxel|mesh-list
1996945|NCT01145508|Vaccines|vaccines|mesh-list
1996946|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
1996947|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996948|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1996949|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
1996950|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
1996951|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
1996952|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996953|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1996954|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
1996955|NCT01145508|Hormones|hormones|mesh-ancestor
1996956|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1996957|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1996958|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1996959|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1996960|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1996961|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1996962|NCT01145625|Minoxidil|minoxidil|mesh-list
1996963|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1996964|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
1996965|NCT01145638|Iron|iron|mesh-list
1996966|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
1996967|NCT01145638|Trace Elements|trace elements|mesh-ancestor
1996968|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
1996969|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996970|NCT01145638|Hematinics|hematinics|mesh-ancestor
1996971|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1996972|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1996973|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1996974|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1996975|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996976|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996977|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996978|NCT01145755|Analgesics|analgesics|mesh-ancestor
1996979|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
1996980|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1996981|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
1996982|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1996983|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
1996984|NCT01145898|Timolol|timolol|mesh-list
1996985|NCT01145898|Dorzolamide|dorzolamide|mesh-list
1996986|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1996987|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1996988|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
1996989|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1996990|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1996991|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1996992|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1996993|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1996994|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1996995|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1996996|NCT01146054|Gemcitabine|gemcitabine|mesh-list
1996997|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1996998|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1996999|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
1997000|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997001|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997002|NCT01146054|Antiviral Agents|antiviral agents|mesh-ancestor
1997003|NCT01146054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997004|NCT01146054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997005|NCT01146054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1997006|NCT01146054|Immunologic Factors|immunologic factors|mesh-ancestor
1997007|NCT01146054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997008|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1997009|NCT01146288|Furosemide|furosemide|mesh-list
1997010|NCT01146288|Acetazolamide|acetazolamide|mesh-list
1997011|NCT01146288|Diuretics|diuretics|mesh-ancestor
1997012|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
1997013|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997014|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1997015|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1997016|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997017|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
1997018|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1997019|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997020|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1997021|NCT01146418|Hormones|hormones|mesh-ancestor
1997022|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997023|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997024|NCT01146457|Morphine|morphine|mesh-list
1997025|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1997026|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1997027|NCT01146457|Narcotics|narcotics|mesh-ancestor
1997028|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1997029|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997030|NCT01146457|Analgesics|analgesics|mesh-ancestor
1997031|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
1997032|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997033|NCT01146561|Tanezumab|tanezumab|mesh-list
1997034|NCT01146561|Analgesics|analgesics|mesh-ancestor
1997035|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
1997036|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997037|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997038|NCT01146600|Clarithromycin|clarithromycin|mesh-list
1997039|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1997040|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997041|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1997042|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997043|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997044|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1997045|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1997046|NCT01146613|Varenicline|varenicline|mesh-list
1997047|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1997048|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1997049|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
1997050|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997051|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997052|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997053|NCT01146795|Paclitaxel|paclitaxel|mesh-list
1997054|NCT01146795|Bevacizumab|bevacizumab|mesh-list
1997055|NCT01146795|Carboplatin|carboplatin|mesh-list
1997056|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1997057|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997058|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
1997059|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
1997060|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
1997061|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997062|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1997063|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1997064|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1997065|NCT01146795|Growth Substances|growth substances|mesh-ancestor
1997066|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997067|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
1997068|NCT01146808|Adefovir|adefovir|mesh-list
1997069|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1997070|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
1997071|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997072|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1997073|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1997074|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997075|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997076|NCT01146834|Plerixafor|plerixafor|mesh-list
1997077|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
1997078|NCT01146834|Bortezomib|bortezomib|mesh-list
1997079|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1997080|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
1997081|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997082|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1997083|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1997084|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
1997085|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997086|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997087|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1997088|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1997089|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1997090|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
1997091|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997092|NCT01146873|Ritonavir|ritonavir|mesh-list
1997093|NCT01146873|Lopinavir|lopinavir|mesh-list
1997094|NCT01146873|Abacavir|abacavir|mesh-list
1997095|NCT01146873|Stavudine|stavudine|mesh-list
1997096|NCT01146873|Efavirenz|efavirenz|mesh-list
1997097|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1997098|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1997099|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
1997100|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997101|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997102|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1997103|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1997104|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
1997105|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997106|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1997107|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1997108|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1997109|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1997110|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1997111|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1997112|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1997113|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1997114|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1997115|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
1997116|NCT01146951|Rufinamide|rufinamide|mesh-list
1997117|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
1997118|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1997119|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1997120|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1997121|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997122|NCT01147055|Rifampin|rifampin|mesh-list
1997123|NCT01147055|Crizotinib|crizotinib|mesh-list
1997124|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1997125|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
1997126|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1997127|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997128|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
1997129|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1997130|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997131|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997132|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1997133|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1997134|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1997135|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1997136|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1997137|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1997138|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997139|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1997140|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
1997141|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
1997142|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
1997143|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997144|NCT01147107|Efavirenz|efavirenz|mesh-list
1997145|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
1997146|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1997147|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1997148|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997149|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997150|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
1997151|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997152|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1997153|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1997154|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1997155|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1997156|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1997157|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1997158|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1997159|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1997160|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1997161|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1997162|NCT01147250|Lixisenatide|lixisenatide|mesh-list
1997163|NCT01147250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1997164|NCT01147250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997165|NCT01147302|Complement C1s|complement c1s|mesh-list
1997166|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1997167|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
1997168|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
1997169|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997170|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1997171|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1997172|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
1997173|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1997174|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
1997175|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997176|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1997177|NCT01147380|Vaccines|vaccines|mesh-list
1997178|NCT01147380|Immunologic Factors|immunologic factors|mesh-ancestor
1997179|NCT01147380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997180|NCT01147458|Naproxen|naproxen|mesh-list
1997181|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1997182|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1997183|NCT01147458|Analgesics|analgesics|mesh-ancestor
1997184|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
1997185|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997186|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997187|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1997188|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1997189|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
1997190|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1997191|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997192|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997193|NCT01147497|Misoprostol|misoprostol|mesh-list
1997194|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1997195|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
1997196|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1997197|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997198|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1997199|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1997200|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
1997201|NCT01147601|Timolol|timolol|mesh-list
1997202|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1997203|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1997204|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
1997205|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997206|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997207|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997208|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1997209|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1997210|NCT01147627|Insulin|insulin|mesh-list
1997211|NCT01147627|Pioglitazone|pioglitazone|mesh-list
1997212|NCT01147627|Exenatide|exenatide|mesh-list
1997213|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
1997214|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1997215|NCT01147627|Protamines|protamines|mesh-list
1997216|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1997217|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997218|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1997219|NCT01147627|Incretins|incretins|mesh-ancestor
1997220|NCT01147627|Hormones|hormones|mesh-ancestor
1997221|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997222|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
1997223|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997224|NCT01147627|Coagulants|coagulants|mesh-ancestor
1997225|NCT01147640|Metronidazole|metronidazole|mesh-list
1997226|NCT01147640|Meropenem|meropenem|mesh-list
1997227|NCT01147640|Tazobactam|tazobactam|mesh-list
1997228|NCT01147640|Ceftolozane|ceftolozane|mesh-list
1997229|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997230|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1997231|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1997232|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1997233|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1997234|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997235|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997236|NCT01147744|Fluticasone|fluticasone|mesh-list
1997237|NCT01147744|Xhance|xhance|mesh-list
1997238|NCT01147744|Montelukast|montelukast|mesh-list
1997239|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1997240|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1997241|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
1997242|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997243|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997244|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1997245|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
1997246|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
1997247|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1997248|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1997249|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
1997250|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997251|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1997252|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1997253|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745849|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745850|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745851|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
2745852|NCT02345850|Methotrexate|methotrexate|mesh-list
2745853|NCT02345850|Tacrolimus|tacrolimus|mesh-list
2745854|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2745855|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
2745856|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745857|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2745858|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1997264|NCT01147848|Fluticasone|fluticasone|mesh-list
1997265|NCT01147848|Xhance|xhance|mesh-list
1997266|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1997267|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1997268|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1997269|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
1997270|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997271|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997272|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1997273|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
1997274|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
1997275|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1997276|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1997277|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1997278|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2745859|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
1997279|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
1997280|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997281|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997282|NCT01147926|Prucalopride|prucalopride|mesh-list
1997283|NCT01147926|Laxatives|laxatives|mesh-ancestor
1997284|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1997285|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
1997286|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1997287|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
1997288|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997289|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997290|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997291|NCT01148225|Adalimumab|adalimumab|mesh-list
1997292|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1997293|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1997294|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1997295|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
1997296|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1997297|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1997298|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1997299|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
1997300|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1997301|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997302|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1997303|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1997304|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1997305|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1997306|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997307|NCT01148459|Vaccines|vaccines|mesh-list
1997308|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
1997309|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997310|NCT01148511|Ranibizumab|ranibizumab|mesh-list
1997311|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1997312|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1997313|NCT01148511|Growth Substances|growth substances|mesh-ancestor
1997314|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997315|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
1997316|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997317|NCT01148524|Vaccines|vaccines|mesh-list
1997318|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
1997319|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997320|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
1997321|NCT01148537|Buprenorphine|buprenorphine|mesh-list
1997322|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1997323|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1997324|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997325|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1997326|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1997327|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997328|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997329|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997330|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1997331|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
1997332|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1997333|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997334|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1997335|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1997336|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1997337|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1997338|NCT01148537|Narcotics|narcotics|mesh-ancestor
1997339|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1997340|NCT01148537|Analgesics|analgesics|mesh-ancestor
1997341|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
1997342|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997343|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1997344|NCT01148693|Gentamicins|gentamicins|mesh-list
1997345|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1997346|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997347|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1997348|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997349|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997350|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1997351|NCT01148745|Hematinics|hematinics|mesh-ancestor
1997352|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1997353|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1997354|NCT01148771|Ertapenem|ertapenem|mesh-list
1997355|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1997356|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997357|NCT01148810|Siponimod|siponimod|mesh-list
1997358|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1997359|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997360|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1997361|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
1997362|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997363|NCT01148836|Ubiquinone|ubiquinone|mesh-list
1997364|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
1997365|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
1997366|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997367|NCT01148836|Vitamins|vitamins|mesh-ancestor
1997368|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1997369|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1997370|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997371|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1997372|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1997373|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1997374|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997375|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
1997376|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997377|NCT01149096|Lenograstim|lenograstim|mesh-list
1997378|NCT01149096|Sargramostim|sargramostim|mesh-list
1997379|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1997380|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
1997381|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997382|NCT01149369|Aprepitant|aprepitant|mesh-list
1997383|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
1997384|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
1997385|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997386|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997387|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1997388|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1997389|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997390|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997391|NCT01149421|Dulaglutide|dulaglutide|mesh-list
1997392|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1997393|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997394|NCT01149434|Everolimus|everolimus|mesh-list
1997395|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997396|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1997397|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
1997398|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997399|NCT01149460|Valacyclovir|valacyclovir|mesh-list
1997400|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
1997401|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997402|NCT01149473|Losartan|losartan|mesh-list
1997403|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1997404|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1997405|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1997406|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1997407|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1997408|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997409|NCT01149473|Diuretics|diuretics|mesh-ancestor
1997410|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
1997411|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997412|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1997413|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1997414|NCT01149486|Losartan|losartan|mesh-list
1997415|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1997416|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1997417|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1997418|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1997419|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1997420|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997421|NCT01149486|Diuretics|diuretics|mesh-ancestor
1997422|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
1997423|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997424|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1997425|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1997426|NCT01149538|Choline|choline|mesh-list
1997427|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
1997428|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1997429|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
1997430|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997431|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1997432|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1997433|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
1997434|NCT01149616|Dexamethasone|dexamethasone|mesh-list
1997435|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1997436|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
1997437|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
1997438|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997439|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997440|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1997441|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
1997442|NCT01149616|Hormones|hormones|mesh-ancestor
1997443|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997444|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1997445|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997446|NCT01149655|Aripiprazole|aripiprazole|mesh-list
1997447|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
1997448|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1997449|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1997450|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1997451|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1997452|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997453|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
1997454|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
1997455|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997456|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997457|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1997458|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1997459|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
1997460|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1997461|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1997462|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1997463|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1997464|NCT01149733|Tamsulosin|tamsulosin|mesh-list
1997465|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1997466|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1997467|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1997468|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
1997469|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997470|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997471|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997472|NCT01149733|Urological Agents|urological agents|mesh-ancestor
1997473|NCT01149759|Cyclosporine|cyclosporine|mesh-list
1997474|NCT01149759|Cyclosporins|cyclosporins|mesh-list
1997475|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997476|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997477|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1997478|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
1997479|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997480|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
1997481|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997482|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
1997483|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1997484|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1997485|NCT01149785|Ketoconazole|ketoconazole|mesh-list
1997486|NCT01149785|Crizotinib|crizotinib|mesh-list
1997487|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
1997488|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997489|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1997490|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1997491|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997492|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997493|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1997494|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
1997495|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997496|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997497|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1997498|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997499|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1997500|NCT01149863|Plerixafor|plerixafor|mesh-list
1997501|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1997502|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1997503|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
1997504|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997505|NCT01149876|Tretinoin|tretinoin|mesh-list
1997506|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997507|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
1997508|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
1997509|NCT01150045|Leucovorin|leucovorin|mesh-list
1997510|NCT01150045|Celecoxib|celecoxib|mesh-list
1997511|NCT01150045|Fluorouracil|fluorouracil|mesh-list
1997512|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
1997513|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
1997514|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997515|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1997516|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997517|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1997518|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
1997519|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997520|NCT01150045|Antidotes|antidotes|mesh-ancestor
1997521|NCT01150045|Protective Agents|protective agents|mesh-ancestor
1997522|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
1997523|NCT01150045|Vitamins|vitamins|mesh-ancestor
1997524|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
1997525|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1997526|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1997527|NCT01150045|Analgesics|analgesics|mesh-ancestor
1997528|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
1997529|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997530|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1997531|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1997532|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1997533|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1997534|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997535|NCT01150097|Everolimus|everolimus|mesh-list
1997536|NCT01150097|Tacrolimus|tacrolimus|mesh-list
1997537|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1997538|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
1997539|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997540|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1997541|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997542|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997543|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997544|NCT01150123|Vaccines|vaccines|mesh-list
1997545|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
1997546|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997547|NCT01150461|Losartan|losartan|mesh-list
1997548|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
1997549|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
1997550|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1997551|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1997552|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1997553|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997554|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1997555|NCT01150500|Sirolimus|sirolimus|mesh-list
1997556|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1997557|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997558|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1997559|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997560|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
1997561|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1997562|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
1997563|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997564|NCT01150760|Alvimopan|alvimopan|mesh-list
1997565|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1997566|NCT01150838|Propofol|propofol|mesh-list
1997567|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1997568|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1997569|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997570|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1997571|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
1997572|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
1997573|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
1997574|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1997575|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997576|NCT01151046|Exemestane|exemestane|mesh-list
1997577|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997578|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1997579|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1997580|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997581|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997582|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1997583|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
1997584|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997585|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997586|NCT01151085|Voriconazole|voriconazole|mesh-list
1997587|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
1997588|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997589|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1997590|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1997591|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997592|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997593|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1997594|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
1997595|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997596|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997597|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1997598|NCT01151098|Buprenorphine|buprenorphine|mesh-list
1997599|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1997600|NCT01151098|Narcotics|narcotics|mesh-ancestor
1997601|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1997602|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997603|NCT01151098|Analgesics|analgesics|mesh-ancestor
1997604|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
1997605|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997606|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1997607|NCT01151137|Dronedarone|dronedarone|mesh-list
1997608|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1997609|NCT01151215|Anastrozole|anastrozole|mesh-list
1997610|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1997611|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997612|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1997613|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1997614|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997615|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997616|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1997617|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
1997618|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997619|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997620|NCT01151410|Enalapril|enalapril|mesh-list
1997621|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1997622|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
1997623|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997624|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997625|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1997626|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
1997627|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1997628|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
1997629|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997630|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
1997631|NCT01151436|Protective Agents|protective agents|mesh-ancestor
1997632|NCT01151449|R04929097|r04929097|mesh-list
1997633|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997634|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997635|NCT01151540|Rufinamide|rufinamide|mesh-list
1997636|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
1997637|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1997638|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1997639|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1997640|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997641|NCT01151579|Albuterol|albuterol|mesh-list
1997642|NCT01151579|Ipratropium|ipratropium|mesh-list
1997643|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1997644|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
1997645|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997646|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997647|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1997648|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
1997649|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
1997650|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1997651|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1997652|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1997653|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1997654|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
1997655|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997656|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997657|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1997658|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
1997659|NCT01151761|Gemcitabine|gemcitabine|mesh-list
1997660|NCT01151761|Cisplatin|cisplatin|mesh-list
1997661|NCT01151761|Carboplatin|carboplatin|mesh-list
1997662|NCT01151761|Fluorouracil|fluorouracil|mesh-list
1997663|NCT01151761|Capecitabine|capecitabine|mesh-list
1997664|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997665|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1997666|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
1997667|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997668|NCT01151761|Antiviral Agents|antiviral agents|mesh-ancestor
1997669|NCT01151761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997670|NCT01151761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997671|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1997672|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
1997673|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997674|NCT01151813|Varenicline|varenicline|mesh-list
1997675|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1997676|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1997677|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
1997678|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997679|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997680|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997681|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
1997682|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997683|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1997684|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997685|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997686|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
1997687|NCT01152021|Propofol|propofol|mesh-list
1997688|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1997689|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1997690|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997691|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1997692|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
1997693|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
1997694|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1997695|NCT01152021|Analgesics|analgesics|mesh-ancestor
1997696|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
1997697|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997698|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1997699|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1997700|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1997701|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
1997702|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997703|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997704|NCT01152190|Tadalafil|tadalafil|mesh-list
1997705|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
1997706|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1997707|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1997708|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997709|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997710|NCT01152190|Urological Agents|urological agents|mesh-ancestor
1997711|NCT01152437|Cetuximab|cetuximab|mesh-list
1997712|NCT01152437|Afatinib|afatinib|mesh-list
1997713|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1997714|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997715|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1997716|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997717|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997718|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
1997719|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1997720|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
1997721|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997722|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997723|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1997724|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
1997725|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
1997726|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1997727|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
1997728|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997729|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997730|NCT01152515|Remifentanil|remifentanil|mesh-list
1997731|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1997732|NCT01152515|Narcotics|narcotics|mesh-ancestor
1997733|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1997734|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997735|NCT01152515|Analgesics|analgesics|mesh-ancestor
1997736|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
1997737|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997738|NCT01152580|Melatonin|melatonin|mesh-list
1997739|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
1997740|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997741|NCT01152580|Protective Agents|protective agents|mesh-ancestor
1997742|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997743|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1997744|NCT01152697|Haloperidol|haloperidol|mesh-list
1997745|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
1997746|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
1997747|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
1997748|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997749|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997750|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1997751|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1997752|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1997753|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1997754|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1997755|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1997756|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
1997757|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997758|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997759|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1997760|NCT01152788|Dacarbazine|dacarbazine|mesh-list
1997761|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1997762|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
1997763|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997764|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997765|NCT01152996|Vortioxetine|vortioxetine|mesh-list
1997766|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
1997767|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1997768|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1997769|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1997770|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1997771|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997772|NCT01152996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1997773|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1997774|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1997775|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997776|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997777|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
1997778|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1997779|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1997780|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1997781|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1997782|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1997783|NCT01153009|Vortioxetine|vortioxetine|mesh-list
1997784|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1997785|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1997786|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1997787|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997788|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997789|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997790|NCT01153009|Analgesics|analgesics|mesh-ancestor
1997791|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
1997792|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997793|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
1997794|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1997795|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
1997796|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1997797|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1997798|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1997799|NCT01153009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1997800|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
1997801|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1997802|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1997803|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1997804|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1997805|NCT01153269|Ritonavir|ritonavir|mesh-list
1997806|NCT01153269|Lopinavir|lopinavir|mesh-list
1997807|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1997808|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1997809|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
1997810|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997811|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997812|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1997813|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1997814|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
1997815|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997816|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1997817|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1997818|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
1997819|NCT01153425|Teriparatide|teriparatide|mesh-list
1997820|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1997821|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997822|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1997823|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1997824|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1997825|NCT01153581|Estradiol|estradiol|mesh-list
1997826|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1997827|NCT01153581|Progesterone|progesterone|mesh-list
1997828|NCT01153581|Ganirelix|ganirelix|mesh-list
1997829|NCT01153581|Estrogens|estrogens|mesh-ancestor
1997830|NCT01153581|Hormones|hormones|mesh-ancestor
1997831|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997832|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997833|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1997834|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
1997835|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1997836|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1997837|NCT01153581|Progestins|progestins|mesh-ancestor
1997838|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
1997839|NCT01153620|Polihexanide|polihexanide|mesh-list
1997840|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
1997841|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997842|NCT01153672|Letrozole|letrozole|mesh-list
1997843|NCT01153672|Vorinostat|vorinostat|mesh-list
1997844|NCT01153672|Anastrozole|anastrozole|mesh-list
1997845|NCT01153672|Exemestane|exemestane|mesh-list
1997846|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997847|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1997848|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1997849|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997850|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997851|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1997852|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
1997853|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997854|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997855|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1997856|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1997857|NCT01153698|Dabigatran|dabigatran|mesh-list
1997858|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
1997859|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1997860|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
1997861|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997862|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997863|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
1997864|NCT01153711|Ketoconazole|ketoconazole|mesh-list
1997865|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
1997866|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997867|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1997868|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1997869|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997870|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997871|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1997872|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
1997873|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997874|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997875|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1997876|NCT01153724|Fluconazole|fluconazole|mesh-list
1997877|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
1997878|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997879|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1997880|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1997881|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997882|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997883|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1997884|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
1997885|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997886|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997887|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1997888|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1997889|NCT01153763|Dabrafenib|dabrafenib|mesh-list
1997890|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997891|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1997892|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997893|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997894|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
1997895|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1997896|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1997897|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1997898|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1997899|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997900|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
1997901|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997902|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997903|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1997904|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997905|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1997906|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
1997907|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997908|NCT01153958|Metronidazole|metronidazole|mesh-list
1997909|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
1997910|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1997911|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1997912|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1997913|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1997914|NCT01153971|Rituximab|rituximab|mesh-list
1997915|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1997916|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997917|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
1997918|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997919|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1997920|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1997921|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997922|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1997923|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997924|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997925|NCT01154036|Atorvastatin|atorvastatin|mesh-list
1997926|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1997927|NCT01154036|Ezetimibe|ezetimibe|mesh-list
1997928|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1997929|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1997930|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
1997931|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997932|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1997933|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1997934|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997935|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
1997936|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1997937|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1997938|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1997939|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
1997940|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997941|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997942|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997943|NCT01154153|Loratadine|loratadine|mesh-list
1997944|NCT01154153|Triamcinolone|triamcinolone|mesh-list
1997945|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1997946|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1997947|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1997948|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1997949|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
1997950|NCT01154153|Hormones|hormones|mesh-ancestor
1997951|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997952|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997953|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1997954|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
1997955|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997956|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997957|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
1997958|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
1997959|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1997960|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1997961|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1997962|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
1997963|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
1997964|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997965|NCT01154166|Ropinirole|ropinirole|mesh-list
1997966|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1997967|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1997968|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
1997969|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
1997970|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1997971|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997972|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997973|NCT01154192|Dexamethasone|dexamethasone|mesh-list
1997974|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1997975|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1997976|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
1997977|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
1997978|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1997979|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997980|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1997981|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
1997982|NCT01154192|Hormones|hormones|mesh-ancestor
1997983|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1997984|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1997985|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997986|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1997987|NCT01154218|Crizotinib|crizotinib|mesh-list
1997988|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997989|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1997990|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997991|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1997992|NCT01154335|Everolimus|everolimus|mesh-list
1997993|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1997994|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1997995|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
1997996|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1997997|NCT01154452|R04929097|r04929097|mesh-list
1997998|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1997999|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998000|NCT01154673|Ritonavir|ritonavir|mesh-list
1998001|NCT01154673|Lopinavir|lopinavir|mesh-list
1998002|NCT01154673|Tenofovir|tenofovir|mesh-list
1998003|NCT01154673|Emtricitabine|emtricitabine|mesh-list
1998004|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
1998005|NCT01154673|Maraviroc|maraviroc|mesh-list
1998006|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1998007|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1998008|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
1998009|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998010|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998011|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1998012|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1998013|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
1998014|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998015|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1998016|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1998017|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1998018|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1998019|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1998020|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1998021|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1998022|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1998023|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1998024|NCT01155063|Exemestane|exemestane|mesh-list
1998025|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998026|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1998027|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1998028|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998029|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998030|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1998031|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
1998032|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1998033|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998034|NCT01155154|Clindamycin|clindamycin|mesh-list
1998035|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
1998036|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
1998037|NCT01155154|Cephalexin|cephalexin|mesh-list
1998038|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1998039|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998040|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1998041|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998042|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998043|NCT01155167|Lidocaine|lidocaine|mesh-list
1998044|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
1998045|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
1998046|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
1998047|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1998048|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998049|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
1998050|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998051|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1998052|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1998053|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1998054|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1998055|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998056|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
1998057|NCT01155219|Latanoprost|latanoprost|mesh-list
1998058|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1998059|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1998060|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1998061|NCT01155284|Lansoprazole|lansoprazole|mesh-list
1998062|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
1998063|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1998064|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998065|NCT01155284|Incretins|incretins|mesh-ancestor
1998066|NCT01155284|Hormones|hormones|mesh-ancestor
1998067|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1998068|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1998069|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
1998070|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998071|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998072|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1998073|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1998074|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1998075|NCT01155466|Rasagiline|rasagiline|mesh-list
1998076|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1998077|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998078|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998079|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1998080|NCT01155466|Protective Agents|protective agents|mesh-ancestor
1998081|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998082|NCT01155479|Rasagiline|rasagiline|mesh-list
1998083|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1998084|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998085|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998086|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1998087|NCT01155479|Protective Agents|protective agents|mesh-ancestor
1998088|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998089|NCT01155531|Sertraline|sertraline|mesh-list
1998090|NCT01155531|Telenzepine|telenzepine|mesh-list
1998091|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
1998092|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1998093|NCT01155531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1998094|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1998095|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1998096|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998097|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998098|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
1998099|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998100|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
1998101|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
1998102|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998103|NCT01155583|Dexamethasone|dexamethasone|mesh-list
1998104|NCT01155583|Lenalidomide|lenalidomide|mesh-list
1998105|NCT01155583|Azacitidine|azacitidine|mesh-list
1998106|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1998107|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
1998108|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
1998109|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998110|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998111|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1998112|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
1998113|NCT01155583|Hormones|hormones|mesh-ancestor
1998114|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1998115|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1998116|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998117|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
1998118|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1998119|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1998120|NCT01155583|Growth Substances|growth substances|mesh-ancestor
1998121|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
1998122|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1998123|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
1998124|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998125|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998126|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
1998127|NCT01155661|Serotonin|serotonin|mesh-list
1998128|NCT01155661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1998129|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1998130|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
1998131|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998132|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998133|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998134|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1998135|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1998136|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1998137|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998138|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
1998139|NCT01155869|Naltrexone|naltrexone|mesh-list
1998140|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1998141|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1998142|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998143|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
1998144|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998145|NCT01155999|Tobramycin|tobramycin|mesh-list
1998146|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1998147|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998148|NCT01156051|Guanfacine|guanfacine|mesh-list
1998149|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1998150|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1998151|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1998152|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1998153|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
1998154|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998155|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998156|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998157|NCT01156142|Doxepin|doxepin|mesh-list
1998158|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1998159|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1998160|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1998161|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998162|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1998163|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
1998164|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1998165|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
1998166|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
1998167|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998168|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998169|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
1998170|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
1998171|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1998172|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
1998173|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998174|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
1998175|NCT01156363|Hematinics|hematinics|mesh-ancestor
1998176|NCT01156376|Listerine|listerine|mesh-list
1998177|NCT01156376|Fluorides|fluorides|mesh-list
1998178|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
1998179|NCT01156376|Protective Agents|protective agents|mesh-ancestor
1998180|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998181|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1998182|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998183|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
1998184|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1998185|NCT01156571|Clopidogrel|clopidogrel|mesh-list
1998186|NCT01156571|Cangrelor|cangrelor|mesh-list
1998187|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1998188|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1998189|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1998190|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1998191|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
1998192|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998193|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998194|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998195|NCT01156597|Pioglitazone|pioglitazone|mesh-list
1998196|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1998197|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998198|NCT01156701|Zanamivir|zanamivir|mesh-list
1998199|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
1998200|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998201|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998202|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998203|NCT01156792|Montelukast|montelukast|mesh-list
1998204|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1998205|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
1998206|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1998207|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
1998208|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1998209|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998210|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1998211|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1998212|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998213|NCT01157065|Ranibizumab|ranibizumab|mesh-list
1998214|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1998215|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1998216|NCT01157065|Growth Substances|growth substances|mesh-ancestor
1998217|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998218|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
1998219|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998220|NCT01157117|Omalizumab|omalizumab|mesh-list
1998221|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1998222|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1998223|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1998224|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
1998225|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
1998226|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998227|NCT01157169|Buprenorphine|buprenorphine|mesh-list
1998228|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1998229|NCT01157169|Narcotics|narcotics|mesh-ancestor
1998230|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1998231|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998232|NCT01157169|Analgesics|analgesics|mesh-ancestor
1998233|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
1998234|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998235|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1998236|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1998237|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1998238|NCT01157182|Norethindrone|norethindrone|mesh-list
1998239|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
1998240|NCT01157182|Estradiol|estradiol|mesh-list
1998241|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1998242|NCT01157182|Estrogens|estrogens|mesh-ancestor
1998243|NCT01157182|Hormones|hormones|mesh-ancestor
1998244|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1998245|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998246|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1998247|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
1998248|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1998249|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1998250|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1998251|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1998252|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1998253|NCT01157234|Metoprolol|metoprolol|mesh-list
1998254|NCT01157234|Nebivolol|nebivolol|mesh-list
1998255|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1998256|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1998257|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
1998258|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
1998259|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998260|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998261|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1998262|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1998263|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1998264|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
1998265|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998266|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998267|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
1998268|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1998269|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1998270|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1998271|NCT01157351|Olanzapine|olanzapine|mesh-list
1998272|NCT01157351|Risperidone|risperidone|mesh-list
1998273|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1998274|NCT01157351|Aripiprazole|aripiprazole|mesh-list
1998275|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1998276|NCT01157351|Perphenazine|perphenazine|mesh-list
1998277|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1998278|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
1998279|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998280|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998281|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998282|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1998283|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1998284|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1998285|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1998286|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1998287|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
1998288|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
1998289|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
1998290|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998291|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1998292|NCT01157351|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1998293|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1998294|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1998295|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
1998296|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
1998297|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1998298|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1998299|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1998300|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1998301|NCT01157364|Bimatoprost|bimatoprost|mesh-list
1998302|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1998303|NCT01157416|Cycloserine|cycloserine|mesh-list
1998304|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1998305|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998306|NCT01157416|Renal Agents|renal agents|mesh-ancestor
1998307|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1998308|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
1998309|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1998310|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
1998311|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998312|NCT01157429|Cycloserine|cycloserine|mesh-list
1998313|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1998314|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998315|NCT01157429|Renal Agents|renal agents|mesh-ancestor
1998316|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1998317|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
1998318|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1998319|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
1998320|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998321|NCT01158118|Plerixafor|plerixafor|mesh-list
1998322|NCT01158118|Sargramostim|sargramostim|mesh-list
1998323|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
1998324|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998325|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1998326|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1998327|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
1998328|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998329|NCT01158222|Sunitinib|sunitinib|mesh-list
1998330|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998331|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1998332|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1998333|NCT01158222|Growth Substances|growth substances|mesh-ancestor
1998334|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998335|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
1998336|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1998337|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998338|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998339|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
1998340|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
1998341|NCT01158261|Coagulants|coagulants|mesh-ancestor
1998342|NCT01158534|Interferons|interferons|mesh-list
1998343|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
1998344|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
1998345|NCT01158534|Celecoxib|celecoxib|mesh-list
1998346|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998347|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
1998348|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998349|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
1998350|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998351|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1998352|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1998353|NCT01158534|Analgesics|analgesics|mesh-ancestor
1998354|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
1998355|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998356|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1998357|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1998358|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1998359|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1998360|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998361|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998362|NCT01158651|Everolimus|everolimus|mesh-list
1998363|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998364|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1998365|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
1998366|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998367|NCT01158703|Aspirin|aspirin|mesh-list
1998368|NCT01158703|Clopidogrel|clopidogrel|mesh-list
1998369|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1998370|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1998371|NCT01158703|Analgesics|analgesics|mesh-ancestor
1998372|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
1998373|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998374|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998375|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1998376|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1998377|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1998378|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1998379|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998380|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1998381|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1998382|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998383|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
1998384|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1998385|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1998386|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1998387|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
1998388|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998389|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
1998390|NCT01158820|Fentanyl|fentanyl|mesh-list
1998391|NCT01158820|Midazolam|midazolam|mesh-list
1998392|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
1998393|NCT01158820|Ketamine|ketamine|mesh-list
1998394|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1998395|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1998396|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998397|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1998398|NCT01158820|Analgesics|analgesics|mesh-ancestor
1998399|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
1998400|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998401|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1998402|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1998403|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1998404|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
1998405|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998406|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998407|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1998408|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1998409|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
1998410|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
1998411|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1998412|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1998413|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1998414|NCT01158820|Narcotics|narcotics|mesh-ancestor
1998415|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1998416|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1998417|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1998418|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1998419|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
1998420|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
1998421|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1998422|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
1998423|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
1998424|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
1998425|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1998426|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1998427|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
1998428|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
1998429|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1998430|NCT01158885|Cytarabine|cytarabine|mesh-list
1998431|NCT01158885|Methotrexate|methotrexate|mesh-list
1998432|NCT01158885|Clofarabine|clofarabine|mesh-list
1998433|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1998434|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
1998435|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1998436|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998437|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1998438|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
1998439|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998440|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998441|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
1998442|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998443|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1998444|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1998445|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
1998446|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1998447|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1998448|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
1998449|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998450|NCT01158950|Tolcapone|tolcapone|mesh-list
1998451|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1998452|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1998453|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1998454|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998455|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998456|NCT01159054|Niacin|niacin|mesh-list
1998457|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
1998458|NCT01159054|Niacinamide|niacinamide|mesh-list
1998459|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1998460|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
1998461|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998462|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1998463|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
1998464|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
1998465|NCT01159054|Vitamins|vitamins|mesh-ancestor
1998466|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
1998467|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998468|NCT01159067|Deferasirox|deferasirox|mesh-list
1998469|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1998470|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
1998471|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
1998472|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998473|NCT01159171|Bevacizumab|bevacizumab|mesh-list
1998474|NCT01159171|Capecitabine|capecitabine|mesh-list
1998475|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
1998476|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1998477|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998478|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1998479|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1998480|NCT01159171|Growth Substances|growth substances|mesh-ancestor
1998481|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998482|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
1998483|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1998484|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
1998485|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998486|NCT01159262|Fentanyl|fentanyl|mesh-list
1998487|NCT01159262|Midazolam|midazolam|mesh-list
1998488|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
1998489|NCT01159262|Morphine|morphine|mesh-list
1998490|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1998491|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1998492|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998493|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1998494|NCT01159262|Analgesics|analgesics|mesh-ancestor
1998495|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
1998496|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998497|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1998498|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1998499|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1998500|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
1998501|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998502|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998503|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1998504|NCT01159262|Narcotics|narcotics|mesh-ancestor
1998505|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1998506|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1998507|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
1998508|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
1998509|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1998510|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1998511|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1998512|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
1998513|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
1998514|NCT01159574|Clarithromycin|clarithromycin|mesh-list
1998515|NCT01159574|Dexamethasone|dexamethasone|mesh-list
1998516|NCT01159574|Pomalidomide|pomalidomide|mesh-list
1998517|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1998518|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
1998519|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
1998520|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998521|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998522|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1998523|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
1998524|NCT01159574|Hormones|hormones|mesh-ancestor
1998525|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1998526|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1998527|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998528|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1998529|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998530|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1998531|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998532|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998533|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1998534|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1998535|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
1998536|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1998537|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1998538|NCT01159574|Growth Substances|growth substances|mesh-ancestor
1998539|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
1998540|NCT01159600|Empagliflozin|empagliflozin|mesh-list
1998541|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1998542|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998543|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1998544|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998545|NCT01159665|Plasminogen|plasminogen|mesh-list
1998546|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
1998547|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1998548|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1998549|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998550|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1998551|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1998552|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1998553|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1998554|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1998555|NCT01159769|Analgesics|analgesics|mesh-ancestor
1998556|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
1998557|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998558|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998559|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1998560|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1998561|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1998562|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1998563|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1998564|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
1998565|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
1998566|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998567|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998568|NCT01159912|Fluticasone|fluticasone|mesh-list
1998569|NCT01159912|Xhance|xhance|mesh-list
1998570|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1998571|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1998572|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
1998573|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998574|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998575|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1998576|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
1998577|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
1998578|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1998579|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
1998580|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1998581|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998582|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
1998583|NCT01160198|Chelating Agents|chelating agents|mesh-list
1998584|NCT01160198|Glycine|glycine|mesh-list
1998585|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
1998586|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998587|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
1998588|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998589|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998590|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
1998591|NCT01160198|Protective Agents|protective agents|mesh-ancestor
1998592|NCT01160198|Vitamins|vitamins|mesh-ancestor
1998593|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
1998594|NCT01160211|Trastuzumab|trastuzumab|mesh-list
1998595|NCT01160211|Lapatinib|lapatinib|mesh-list
1998596|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1998597|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1998598|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998599|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1998600|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998601|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998602|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1998603|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1998604|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
1998605|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1998606|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998607|NCT01160289|Tadalafil|tadalafil|mesh-list
1998608|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
1998609|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1998610|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1998611|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998612|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998613|NCT01160289|Urological Agents|urological agents|mesh-ancestor
1998614|NCT01160354|Plerixafor|plerixafor|mesh-list
1998615|NCT01160354|Clofarabine|clofarabine|mesh-list
1998616|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1998617|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
1998618|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998619|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998620|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1998621|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1998622|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
1998623|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998624|NCT01160380|Modafinil|modafinil|mesh-list
1998625|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1998626|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998627|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1998628|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1998629|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1998630|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998631|NCT01160445|Aldesleukin|aldesleukin|mesh-list
1998632|NCT01160445|Zanolimumab|zanolimumab|mesh-list
1998633|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998634|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1998635|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1998636|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
1998637|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998638|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1998639|NCT01160484|Lenalidomide|lenalidomide|mesh-list
1998640|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
1998641|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998642|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1998643|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1998644|NCT01160484|Growth Substances|growth substances|mesh-ancestor
1998645|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
1998646|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998647|NCT01160614|Oxycodone|oxycodone|mesh-list
1998648|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1998649|NCT01160614|Narcotics|narcotics|mesh-ancestor
1998650|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1998651|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998652|NCT01160614|Analgesics|analgesics|mesh-ancestor
1998653|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
1998654|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998655|NCT01160640|Metronidazole|metronidazole|mesh-list
1998656|NCT01160640|Doxycycline|doxycycline|mesh-list
1998657|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
1998658|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998659|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1998660|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1998661|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1998662|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
1998663|NCT01160744|Gemcitabine|gemcitabine|mesh-list
1998664|NCT01160744|Carboplatin|carboplatin|mesh-list
1998665|NCT01160744|Pemetrexed|pemetrexed|mesh-list
1998666|NCT01160744|Ramucirumab|ramucirumab|mesh-list
1998667|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1998668|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998669|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1998670|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
1998671|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998672|NCT01160744|Antiviral Agents|antiviral agents|mesh-ancestor
1998673|NCT01160744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998674|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998675|NCT01160744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1998676|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
1998677|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998678|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1998679|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1998680|NCT01160770|Clobazam|clobazam|mesh-list
1998681|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
1998682|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1998683|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1998684|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1998685|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998686|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1998687|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1998688|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
1998689|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
1998690|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998691|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998692|NCT01160822|Naproxen|naproxen|mesh-list
1998693|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1998694|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1998695|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1998696|NCT01160822|Analgesics|analgesics|mesh-ancestor
1998697|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
1998698|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998699|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998700|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1998701|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1998702|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
1998703|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1998704|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998705|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998706|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
1998707|NCT01160848|Ethanol|ethanol|mesh-list
1998708|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1998709|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998710|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1998711|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998712|NCT01161121|Adenosine|adenosine|mesh-list
1998713|NCT01161121|Regadenoson|regadenoson|mesh-list
1998714|NCT01161121|Analgesics|analgesics|mesh-ancestor
1998715|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
1998716|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998717|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998718|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1998719|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
1998720|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1998721|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
1998722|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
1998723|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998724|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998725|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1998726|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1998727|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998728|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1998729|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998730|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998731|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
1998732|NCT01161407|Calcium|calcium|mesh-list
1998733|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1998734|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998735|NCT01161407|Antacids|antacids|mesh-ancestor
1998736|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998737|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1998738|NCT01161446|Antibodies|antibodies|mesh-list
1998739|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
1998740|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
1998741|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998742|NCT01161472|Alprazolam|alprazolam|mesh-list
1998743|NCT01161472|Fesoterodine|fesoterodine|mesh-list
1998744|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1998745|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1998746|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998747|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1998748|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1998749|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1998750|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
1998751|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
1998752|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998753|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998754|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1998755|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1998756|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
1998757|NCT01161472|Urological Agents|urological agents|mesh-ancestor
1998758|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
1998759|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998760|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1998761|NCT01161537|Ivacaftor|ivacaftor|mesh-list
1998762|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1998763|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1998764|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998765|NCT01161563|Leuprolide|leuprolide|mesh-list
1998766|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1998767|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1998768|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
1998769|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1998770|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998771|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1998772|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998773|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
1998774|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1998775|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
1998776|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1998777|NCT01161628|Rituximab|rituximab|mesh-list
1998778|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1998779|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998780|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
1998781|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998782|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1998783|NCT01161862|Glucagon|glucagon|mesh-list
1998784|NCT01161862|Pancrelipase|pancrelipase|mesh-list
1998785|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998786|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1998787|NCT01161862|Hormones|hormones|mesh-ancestor
1998788|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1998789|NCT01162005|Tacrolimus|tacrolimus|mesh-list
1998790|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1998791|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
1998792|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998793|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1998794|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998795|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998796|NCT01162122|Vaccines|vaccines|mesh-list
1998797|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
1998798|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998799|NCT01162135|Digoxin|digoxin|mesh-list
1998800|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1998801|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1998802|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998803|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998804|NCT01162135|Protective Agents|protective agents|mesh-ancestor
1998805|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998806|NCT01162239|Varenicline|varenicline|mesh-list
1998807|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1998808|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1998809|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
1998810|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998811|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998812|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998813|NCT01162421|Adalimumab|adalimumab|mesh-list
1998814|NCT01162421|Methotrexate|methotrexate|mesh-list
1998815|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1998816|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
1998817|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1998818|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998819|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1998820|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
1998821|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998822|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998823|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
1998824|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998825|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1998826|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1998827|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
1998828|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1998829|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1998830|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1998831|NCT01162473|Caseins|caseins|mesh-list
1998832|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
1998833|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
1998834|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998835|NCT01162486|Rifampin|rifampin|mesh-list
1998836|NCT01162486|Rifapentine|rifapentine|mesh-list
1998837|NCT01162486|Midazolam|midazolam|mesh-list
1998838|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1998839|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1998840|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1998841|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998842|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1998843|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1998844|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1998845|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1998846|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
1998847|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
1998848|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
1998849|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
1998850|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998851|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998852|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1998853|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
1998854|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1998855|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998856|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
1998857|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1998858|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998859|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1998860|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1998861|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1998862|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1998863|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1998864|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1998865|NCT01162551|Sirolimus|sirolimus|mesh-list
1998866|NCT01162551|Methotrexate|methotrexate|mesh-list
1998867|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1998868|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
1998869|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1998870|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998871|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1998872|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
1998873|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998874|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998875|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
1998876|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998877|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1998878|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1998879|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
1998880|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1998881|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1998882|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1998883|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998884|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1998885|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
1998886|NCT01162733|Vancomycin|vancomycin|mesh-list
1998887|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1998888|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1998889|NCT01162863|Lubiprostone|lubiprostone|mesh-list
1998890|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1998891|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1998892|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998893|NCT01163097|Heparin|heparin|mesh-list
1998894|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
1998895|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1998896|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1998897|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998898|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
1998899|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
1998900|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998901|NCT01163214|Ropivacaine|ropivacaine|mesh-list
1998902|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
1998903|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
1998904|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1998905|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998906|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
1998907|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998908|NCT01163253|Tofacitinib|tofacitinib|mesh-list
1998909|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1998910|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998911|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998912|NCT01163266|Vortioxetine|vortioxetine|mesh-list
1998913|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
1998914|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1998915|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1998916|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1998917|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1998918|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998919|NCT01163266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1998920|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1998921|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1998922|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998923|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998924|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
1998925|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1998926|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1998927|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1998928|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1998929|NCT01163604|Aspirin|aspirin|mesh-list
1998930|NCT01163604|Argatroban|argatroban|mesh-list
1998931|NCT01163604|Clopidogrel|clopidogrel|mesh-list
1998932|NCT01163604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1998933|NCT01163604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1998934|NCT01163604|Analgesics|analgesics|mesh-ancestor
1998935|NCT01163604|Sensory System Agents|sensory system agents|mesh-ancestor
1998936|NCT01163604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1998937|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998938|NCT01163604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1998939|NCT01163604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1998940|NCT01163604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1998941|NCT01163604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1998942|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998943|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1998944|NCT01163604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1998945|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998946|NCT01163604|Antipyretics|antipyretics|mesh-ancestor
1998947|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1998948|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1998949|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1998950|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
1998951|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1998952|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
1998953|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1998954|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
1998955|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
1998956|NCT01163617|Adalimumab|adalimumab|mesh-list
1998957|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1998958|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1998959|NCT01163656|Cobalt|cobalt|mesh-list
1998960|NCT01163656|Trace Elements|trace elements|mesh-ancestor
1998961|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
1998962|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998963|NCT01163721|Ranolazine|ranolazine|mesh-list
1998964|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1998965|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1998966|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998967|NCT01163747|Methotrexate|methotrexate|mesh-list
1998968|NCT01163747|Vaccines|vaccines|mesh-list
1998969|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1998970|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
1998971|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1998972|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1998973|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
1998974|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1998975|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1998976|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
1998977|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998978|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998979|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
1998980|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1998981|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1998982|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1998983|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1998984|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1998985|NCT01163786|Bortezomib|bortezomib|mesh-list
1998986|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998987|NCT01163851|Bococizumab|bococizumab|mesh-list
1998988|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1998989|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1998990|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
1998991|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1998992|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1998993|NCT01164007|Bevacizumab|bevacizumab|mesh-list
1998994|NCT01164007|Dacarbazine|dacarbazine|mesh-list
1998995|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1998996|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1998997|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1998998|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1998999|NCT01164007|Growth Substances|growth substances|mesh-ancestor
1999000|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999001|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
1999002|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1999003|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
1999004|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999005|NCT01164098|Rituximab|rituximab|mesh-list
1999006|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1999007|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999008|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
1999009|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999010|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1999028|NCT01164475|Plerixafor|plerixafor|mesh-list
1999029|NCT01164475|Lenograstim|lenograstim|mesh-list
1999030|NCT01164475|Sargramostim|sargramostim|mesh-list
1999031|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1999032|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
1999033|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999034|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1999035|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1999036|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
1999037|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999038|NCT01164501|Empagliflozin|empagliflozin|mesh-list
1999039|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1999040|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999041|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1999042|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999043|NCT01164579|Methotrexate|methotrexate|mesh-list
1999044|NCT01164579|Tofacitinib|tofacitinib|mesh-list
1999045|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1999046|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
1999047|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1999048|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999049|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1999050|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
1999051|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999052|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999053|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
1999054|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999055|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1999056|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1999057|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
1999058|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1999059|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1999060|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1999061|NCT01164956|Methylphenidate|methylphenidate|mesh-list
1999062|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1999063|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999064|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1999065|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1999066|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1999067|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999068|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
1999069|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999070|NCT01165021|Folic Acid|folic acid|mesh-list
1999071|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
1999072|NCT01165021|Hydroxocobalamin|hydroxocobalamin|mesh-list
1999073|NCT01165021|Dexamethasone|dexamethasone|mesh-list
1999074|NCT01165021|Pemetrexed|pemetrexed|mesh-list
1999075|NCT01165021|Vitamins|vitamins|mesh-ancestor
1999076|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
1999077|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999078|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999079|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1999080|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
1999081|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
1999082|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999083|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1999084|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
1999085|NCT01165021|Hormones|hormones|mesh-ancestor
1999086|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1999087|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1999088|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999089|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999090|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1999091|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1999092|NCT01165021|Hematinics|hematinics|mesh-ancestor
1999093|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
1999094|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
1999095|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1999096|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
1999097|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999098|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999099|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1999100|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
1999101|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1999102|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
1999103|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999104|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999105|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1999106|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
1999107|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
1999108|NCT01165047|Protective Agents|protective agents|mesh-ancestor
1999109|NCT01165112|Rituximab|rituximab|mesh-list
1999110|NCT01165112|Carboplatin|carboplatin|mesh-list
1999111|NCT01165112|Etoposide|etoposide|mesh-list
1999112|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1999113|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1999114|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999115|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
1999116|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999117|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1999118|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1999119|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1999120|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1999121|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999122|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999123|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1999124|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
1999125|NCT01165138|Fluticasone|fluticasone|mesh-list
1999126|NCT01165138|Xhance|xhance|mesh-list
1999127|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1999128|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1999129|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
1999130|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999131|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999132|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1999133|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
1999134|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
1999135|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1999136|NCT01165203|Vaccines|vaccines|mesh-list
1999137|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
1999138|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999139|NCT01165216|Paclitaxel|paclitaxel|mesh-list
1999140|NCT01165216|Carboplatin|carboplatin|mesh-list
1999141|NCT01165216|Ipilimumab|ipilimumab|mesh-list
1999142|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1999143|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999144|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
1999145|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
1999146|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
1999147|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999148|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1999149|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1999150|NCT01165281|Oxycodone|oxycodone|mesh-list
1999151|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1999152|NCT01165281|Narcotics|narcotics|mesh-ancestor
1999153|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1999154|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999155|NCT01165281|Analgesics|analgesics|mesh-ancestor
1999156|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
1999157|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999158|NCT01165307|Naproxen|naproxen|mesh-list
1999159|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
1999160|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
1999161|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
1999162|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
1999163|NCT01165307|Estradiol|estradiol|mesh-list
1999164|NCT01165307|Estrogens|estrogens|mesh-ancestor
1999165|NCT01165307|Hormones|hormones|mesh-ancestor
1999166|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1999167|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999168|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1999169|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1999170|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1999171|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1999172|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1999173|NCT01165307|Analgesics|analgesics|mesh-ancestor
1999174|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
1999175|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999176|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1999177|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1999178|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
1999179|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1999180|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999181|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999182|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1999183|NCT01165320|Caspofungin|caspofungin|mesh-list
1999184|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
1999185|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999186|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999187|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999188|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
1999189|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1999190|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
1999191|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1999192|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1999193|NCT01165541|Mirtazapine|mirtazapine|mesh-list
1999194|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
1999195|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1999196|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1999197|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1999198|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1999199|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999200|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1999201|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
1999202|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
1999203|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999204|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999205|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1999206|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1999207|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1999208|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1999209|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
1999210|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1999211|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1999212|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
1999213|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1999214|NCT01165554|Flutemetamol|flutemetamol|mesh-list
1999215|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1999216|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999217|NCT01165684|Insulin|insulin|mesh-list
1999218|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1999219|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
1999220|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
1999221|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1999222|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
1999223|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1999224|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999225|NCT01165840|Dapsone|dapsone|mesh-list
1999226|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999227|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
1999228|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1999229|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1999230|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1999231|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999232|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999233|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
1999234|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1999235|NCT01165996|Decitabine|decitabine|mesh-list
1999236|NCT01165996|Azacitidine|azacitidine|mesh-list
1999237|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1999238|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
1999239|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999240|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999241|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999242|NCT01166126|Sirolimus|sirolimus|mesh-list
1999243|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1999244|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999245|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1999246|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999247|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
1999248|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1999249|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
1999250|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999251|NCT01166282|Adalimumab|adalimumab|mesh-list
1999252|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1999253|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1999254|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
1999255|NCT01166438|Trospium chloride|trospium chloride|mesh-list
1999256|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
1999257|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1999258|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1999259|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1999260|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1999261|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999262|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
1999263|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999264|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999265|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1999266|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999267|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1999268|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1999269|NCT01166438|Urological Agents|urological agents|mesh-ancestor
1999270|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
1999271|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
1999272|NCT01166646|Clobetasol|clobetasol|mesh-list
1999273|NCT01166646|Halobetasol|halobetasol|mesh-list
1999274|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1999275|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1999276|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
1999277|NCT01166646|Hormones|hormones|mesh-ancestor
1999278|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1999279|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999280|NCT01166763|Vitamin D|vitamin d|mesh-list
1999281|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
1999282|NCT01166763|Vitamins|vitamins|mesh-ancestor
1999283|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
1999284|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999285|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1999286|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1999287|NCT01166945|Amoxicillin|amoxicillin|mesh-list
1999288|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
1999289|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
1999290|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1999291|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1999292|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999293|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1999294|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999295|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999296|NCT01166958|Teriparatide|teriparatide|mesh-list
1999297|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
1999298|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1999299|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999300|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1999301|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1999302|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
1999303|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1999304|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1999305|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1999306|NCT01166997|Heparin|heparin|mesh-list
1999307|NCT01166997|Calcium heparin|calcium heparin|mesh-list
1999308|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
1999309|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1999310|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1999311|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999312|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1999313|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1999314|NCT01167153|Amlodipine|amlodipine|mesh-list
1999315|NCT01167153|Valsartan|valsartan|mesh-list
1999316|NCT01167153|Nifedipine|nifedipine|mesh-list
1999317|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1999318|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1999319|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1999320|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999321|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1999322|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999323|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
1999324|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1999325|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1999326|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
1999327|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1999328|NCT01167192|Carboplatin|carboplatin|mesh-list
1999329|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999330|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
1999331|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1999332|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1999333|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1999334|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1999335|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999336|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
1999337|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999338|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999339|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1999340|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999341|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
1999342|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
1999343|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1999344|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
1999345|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999346|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1999347|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1999348|NCT01167452|Trimethoprim|trimethoprim|mesh-list
1999349|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1999350|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
1999351|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1999352|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999353|NCT01167452|Renal Agents|renal agents|mesh-ancestor
1999354|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
1999355|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1999356|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1999357|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1999358|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999359|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999360|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1999361|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1999362|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1999363|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1999364|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
1999365|NCT01167569|Vitamins|vitamins|mesh-ancestor
1999366|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
1999367|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999368|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
1999369|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999370|NCT01167569|Protective Agents|protective agents|mesh-ancestor
1999371|NCT01167712|Paclitaxel|paclitaxel|mesh-list
1999372|NCT01167712|Bevacizumab|bevacizumab|mesh-list
1999373|NCT01167712|Carboplatin|carboplatin|mesh-list
1999374|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1999375|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1999376|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
1999377|NCT01167712|Antibodies|antibodies|mesh-list
1999378|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
1999379|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1999380|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
1999381|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1999382|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999383|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
1999384|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
1999385|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
1999386|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999387|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1999388|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1999389|NCT01167712|Growth Substances|growth substances|mesh-ancestor
1999390|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999391|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
1999392|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
1999393|NCT01167829|Testosterone|testosterone|mesh-list
1999394|NCT01167829|Acyline|acyline|mesh-list
1999395|NCT01167829|Androgens|androgens|mesh-ancestor
1999396|NCT01167829|Hormones|hormones|mesh-ancestor
1999397|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1999398|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999399|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
1999400|NCT01167881|Glimepiride|glimepiride|mesh-list
1999401|NCT01167881|Empagliflozin|empagliflozin|mesh-list
1999402|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1999403|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1999404|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999405|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1999406|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
1999407|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1999408|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999409|NCT01167907|Ropivacaine|ropivacaine|mesh-list
1999410|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
1999411|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
1999412|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1999413|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999414|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
1999415|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2745860|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745861|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745862|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2745863|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2745864|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
2745865|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2745866|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2745867|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
2745868|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
2745869|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745870|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2745871|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2745872|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2745882|NCT02332928|Melatonin|melatonin|mesh-list
2745883|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
2745884|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999442|NCT01168232|Epothilones|epothilones|mesh-list
1999443|NCT01168232|Epothilone B|epothilone b|mesh-list
1999444|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
1999445|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
1999446|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
1999447|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999448|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999449|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
1999450|NCT01168349|Hematinics|hematinics|mesh-ancestor
1999451|NCT01168596|Rasagiline|rasagiline|mesh-list
1999452|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1999453|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999454|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999455|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1999456|NCT01168596|Protective Agents|protective agents|mesh-ancestor
1999457|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999458|NCT01168674|Ziprasidone|ziprasidone|mesh-list
1999459|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1999460|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
1999461|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999462|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999463|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999464|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1999465|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1999466|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1999467|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1999468|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1999469|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
1999470|NCT01168687|Levetiracetam|levetiracetam|mesh-list
1999471|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
1999472|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
1999473|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
1999474|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
1999475|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1999476|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1999477|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999478|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999479|NCT01168908|Urological Agents|urological agents|mesh-ancestor
1999480|NCT01168934|Crizotinib|crizotinib|mesh-list
1999481|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999482|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1999483|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999484|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999485|NCT01168973|Docetaxel|docetaxel|mesh-list
1999486|NCT01168973|Ramucirumab|ramucirumab|mesh-list
1999487|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1999488|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999489|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
1999490|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
1999491|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
1999492|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999493|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
1999494|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999495|NCT01169038|Azithromycin|azithromycin|mesh-list
1999496|NCT01169038|Rifampin|rifampin|mesh-list
1999497|NCT01169038|Ethambutol|ethambutol|mesh-list
1999498|NCT01169038|Levofloxacin|levofloxacin|mesh-list
1999499|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1999500|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999501|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1999502|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
1999503|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
1999504|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1999505|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999506|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999507|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1999508|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1999509|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1999510|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1999511|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1999512|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1999513|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1999514|NCT01169038|Renal Agents|renal agents|mesh-ancestor
1999515|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1999516|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1999517|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999518|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1999519|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1999520|NCT01169103|Hormones|hormones|mesh-list
1999521|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1999522|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999523|NCT01169259|Vitamin D|vitamin d|mesh-list
1999524|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
1999525|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
1999526|NCT01169259|Vitamins|vitamins|mesh-list
1999527|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
1999528|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999529|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1999530|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1999531|NCT01169337|Lenalidomide|lenalidomide|mesh-list
1999532|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
1999533|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999534|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1999535|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1999536|NCT01169337|Growth Substances|growth substances|mesh-ancestor
1999537|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
1999538|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999539|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1999540|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1999541|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999542|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
1999543|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1999544|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1999545|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999546|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1999547|NCT01169467|Analgesics|analgesics|mesh-ancestor
1999548|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
1999549|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999550|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1999551|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1999552|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1999553|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
1999554|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999555|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999556|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
1999557|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
1999558|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1999559|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1999560|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999561|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999562|NCT01169519|Urological Agents|urological agents|mesh-ancestor
1999563|NCT01169532|Vorinostat|vorinostat|mesh-list
1999564|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999565|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1999566|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999567|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999568|NCT01169558|Bevacizumab|bevacizumab|mesh-list
1999569|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1999570|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999571|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1999572|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1999573|NCT01169558|Growth Substances|growth substances|mesh-ancestor
1999574|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999575|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
1999576|NCT01169636|Carboplatin|carboplatin|mesh-list
1999577|NCT01169636|Etoposide|etoposide|mesh-list
1999578|NCT01169636|Ifosfamide|ifosfamide|mesh-list
1999579|NCT01169636|Panobinostat|panobinostat|mesh-list
1999580|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999581|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1999582|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1999583|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1999584|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999585|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999586|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1999587|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
1999588|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1999589|NCT01169675|Pemetrexed|pemetrexed|mesh-list
1999590|NCT01169675|Afatinib|afatinib|mesh-list
1999591|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999592|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999593|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999594|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1999595|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1999596|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1999597|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
1999598|NCT01169701|Everolimus|everolimus|mesh-list
1999599|NCT01169701|Tacrolimus|tacrolimus|mesh-list
1999600|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1999601|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
1999602|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999603|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1999604|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999605|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999606|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999607|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1999608|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1999609|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
1999610|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1999611|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999612|NCT01169779|Metformin|metformin|mesh-list
1999613|NCT01169779|Lixisenatide|lixisenatide|mesh-list
1999614|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1999615|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999616|NCT01170039|Lubiprostone|lubiprostone|mesh-list
1999617|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1999618|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1999619|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999620|NCT01170065|Nintedanib|nintedanib|mesh-list
1999621|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999622|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1999623|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999624|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999625|NCT01170117|Olanzapine|olanzapine|mesh-list
1999626|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
1999627|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
1999628|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999629|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999630|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1999631|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1999632|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1999633|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1999634|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1999635|NCT01170117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1999636|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1999637|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1999638|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999639|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999640|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
1999641|NCT01170208|Insulin|insulin|mesh-list
1999642|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1999643|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999644|NCT01170221|Linezolid|linezolid|mesh-list
1999645|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
1999646|NCT01170221|Tedizolid|tedizolid|mesh-list
1999647|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1999648|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999649|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1999650|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999651|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999652|NCT01170247|Ketamine|ketamine|mesh-list
1999653|NCT01170247|Analgesics|analgesics|mesh-ancestor
1999654|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
1999655|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999656|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999657|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1999658|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1999659|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
1999660|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
1999661|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1999662|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1999663|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1999664|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999665|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999666|NCT01170273|Vitamin D|vitamin d|mesh-list
1999667|NCT01170273|Vitamins|vitamins|mesh-ancestor
1999668|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
1999669|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999670|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1999671|NCT01170364|Sibutramine|sibutramine|mesh-list
1999672|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
1999673|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1999674|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
1999675|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1999676|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1999677|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1999678|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
1999679|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1999680|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
1999681|NCT01170390|Estradiol|estradiol|mesh-list
1999682|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1999683|NCT01170390|Estrogens|estrogens|mesh-ancestor
1999684|NCT01170390|Hormones|hormones|mesh-ancestor
1999685|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1999686|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999687|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1999688|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
1999689|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1999690|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1999691|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1999692|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1999693|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1999694|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1999695|NCT01170533|Omeprazole|omeprazole|mesh-list
1999696|NCT01170533|Pantoprazole|pantoprazole|mesh-list
1999697|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1999698|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1999699|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1999700|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999701|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999702|NCT01170663|Paclitaxel|paclitaxel|mesh-list
1999703|NCT01170663|Ramucirumab|ramucirumab|mesh-list
1999704|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1999705|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999706|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
1999707|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
1999708|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
1999709|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999710|NCT01170715|Etanercept|etanercept|mesh-list
1999711|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1999712|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1999713|NCT01170715|Analgesics|analgesics|mesh-ancestor
1999714|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
1999715|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999716|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999717|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1999718|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1999719|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1999720|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1999721|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
1999722|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
1999723|NCT01170754|Laxatives|laxatives|mesh-ancestor
1999724|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1999725|NCT01170884|Timolol|timolol|mesh-list
1999726|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1999727|NCT01170884|Bimatoprost|bimatoprost|mesh-list
1999728|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1999729|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1999730|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1999731|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1999732|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
1999733|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999734|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999735|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999736|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1999737|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1999738|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1999739|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1999740|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1999741|NCT01170949|Miltefosine|miltefosine|mesh-list
1999742|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
1999743|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999744|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999745|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1999746|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1999747|NCT01170962|Ribavirin|ribavirin|mesh-list
1999748|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1999749|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
1999750|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999751|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
1999752|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999753|NCT01171118|Physostigmine|physostigmine|mesh-list
1999754|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1999755|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999756|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999757|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
1999758|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999759|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999760|NCT01171118|Miotics|miotics|mesh-ancestor
1999761|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
1999762|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999763|NCT01171183|Carvedilol|carvedilol|mesh-list
1999764|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1999765|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1999766|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
1999767|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999768|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999769|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999770|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1999771|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
1999772|NCT01171183|Protective Agents|protective agents|mesh-ancestor
1999773|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1999774|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1999775|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1999776|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
1999777|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1999778|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1999779|NCT01171690|Teriparatide|teriparatide|mesh-list
1999780|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1999781|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999782|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1999783|NCT01171794|Ibuprofen|ibuprofen|mesh-list
1999784|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1999785|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1999786|NCT01171794|Analgesics|analgesics|mesh-ancestor
1999787|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
1999788|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999789|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999790|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1999791|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1999792|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1999793|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999794|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999795|NCT01171963|Vaccines|vaccines|mesh-list
1999796|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
1999797|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999798|NCT01171976|Ranibizumab|ranibizumab|mesh-list
1999799|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1999800|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1999801|NCT01171976|Growth Substances|growth substances|mesh-ancestor
1999802|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999803|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
1999804|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999805|NCT01172145|Modafinil|modafinil|mesh-list
1999806|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1999807|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999808|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1999809|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1999810|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1999811|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999812|NCT01172197|Ropivacaine|ropivacaine|mesh-list
1999813|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
1999814|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
1999815|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
1999816|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1999817|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999818|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
1999819|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999820|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
1999821|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1999822|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
1999823|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999824|NCT01172275|Expectorants|expectorants|mesh-ancestor
1999825|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
1999826|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1999827|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
1999828|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999829|NCT01172275|Protective Agents|protective agents|mesh-ancestor
1999830|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999831|NCT01172275|Antidotes|antidotes|mesh-ancestor
1999832|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
1999833|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1999834|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
1999835|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999836|NCT01172288|Expectorants|expectorants|mesh-ancestor
1999837|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
1999838|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1999839|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
1999840|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999841|NCT01172288|Protective Agents|protective agents|mesh-ancestor
1999842|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999843|NCT01172288|Antidotes|antidotes|mesh-ancestor
1999844|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
1999845|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
1999846|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1999847|NCT01172418|Daclizumab|daclizumab|mesh-list
1999848|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
1999849|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999850|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1999851|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1999852|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999853|NCT01172522|Fexofenadine|fexofenadine|mesh-list
1999854|NCT01172522|Terfenadine|terfenadine|mesh-list
1999855|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1999856|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1999857|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1999858|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
1999859|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
1999860|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999861|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999862|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999863|NCT01172535|Ritonavir|ritonavir|mesh-list
1999864|NCT01172535|Lopinavir|lopinavir|mesh-list
1999865|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1999866|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1999867|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
1999868|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999869|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999870|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1999871|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1999872|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
1999873|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999874|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1999875|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1999876|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
1999877|NCT01172600|Entonox|entonox|mesh-list
1999878|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1999879|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
1999880|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
1999881|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1999882|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999883|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1999884|NCT01172600|Analgesics|analgesics|mesh-ancestor
1999885|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
1999886|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999887|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
1999888|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
1999889|NCT01172639|Prednisone|prednisone|mesh-list
1999890|NCT01172639|Methotrexate|methotrexate|mesh-list
1999891|NCT01172639|Leflunomide|leflunomide|mesh-list
1999892|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1999893|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
1999894|NCT01172639|Hormones|hormones|mesh-ancestor
1999895|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1999896|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999897|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1999898|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999899|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1999900|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
1999901|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1999902|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1999903|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
1999904|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999905|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
1999906|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999907|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1999908|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1999909|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
1999910|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1999911|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1999912|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999913|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1999914|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1999915|NCT01172639|Analgesics|analgesics|mesh-ancestor
1999916|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
1999917|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999918|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1999919|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
1999920|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1999921|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1999922|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
1999923|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999924|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999925|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1999926|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
1999927|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
1999928|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1999929|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
1999930|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999931|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999932|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1999933|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1999934|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1999935|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
1999936|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
1999937|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1999938|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1999939|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
1999940|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999941|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999942|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1999943|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
1999944|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
1999945|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1999946|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
1999947|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1999948|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999949|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1999950|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1999951|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1999952|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
1999953|NCT01172847|Oseltamivir|oseltamivir|mesh-list
1999954|NCT01172847|Rimantadine|rimantadine|mesh-list
1999955|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
1999956|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999957|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999958|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999959|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1999960|NCT01172873|Cycloserine|cycloserine|mesh-list
1999961|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1999962|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999963|NCT01172873|Renal Agents|renal agents|mesh-ancestor
1999964|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1999965|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
1999966|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1999967|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
1999968|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999969|NCT01172938|Thalidomide|thalidomide|mesh-list
1999970|NCT01172938|Apremilast|apremilast|mesh-list
1999971|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1999972|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1999973|NCT01172938|Analgesics|analgesics|mesh-ancestor
1999974|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
1999975|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1999976|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1999977|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1999978|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1999979|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1999980|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1999981|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1999982|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1999983|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1999984|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
1999985|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
1999986|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1999987|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1999988|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1999989|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1999990|NCT01172938|Growth Substances|growth substances|mesh-ancestor
1999991|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
1999992|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1999993|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
1999994|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
1999995|NCT01173029|Diuretics|diuretics|mesh-list
1999996|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1999997|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
1999998|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
1999999|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
2000000|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2000001|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000002|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
2000003|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000004|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
2000005|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000006|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000007|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
2000008|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000009|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2000010|NCT01173055|Milnacipran|milnacipran|mesh-list
2000011|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
2000012|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2000013|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2000014|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000015|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000016|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000017|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000018|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2000019|NCT01173055|Analgesics|analgesics|mesh-ancestor
2000020|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
2000021|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2000022|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
2000023|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2000024|NCT01173120|Abatacept|abatacept|mesh-list
2000025|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2000026|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000027|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000028|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2000029|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
2000030|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000031|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2000032|NCT01173211|Vaccines|vaccines|mesh-list
2000033|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
2000034|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000035|NCT01173471|Niacinamide|niacinamide|mesh-list
2000036|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
2000037|NCT01173471|Vitamins|vitamins|mesh-ancestor
2000038|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
2000039|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000040|NCT01173601|Serotonin|serotonin|mesh-list
2000041|NCT01173601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2000042|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2000043|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
2000044|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2745885|NCT02332928|Protective Agents|protective agents|mesh-ancestor
2000045|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000046|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000047|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2000048|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000049|NCT01173679|Rituximab|rituximab|mesh-list
2000050|NCT01173679|Fludarabine|fludarabine|mesh-list
2000051|NCT01173679|Dasatinib|dasatinib|mesh-list
2000052|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2000053|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000054|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
2000055|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000056|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2000057|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000058|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2000059|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000060|NCT01173692|Minocycline|minocycline|mesh-list
2000061|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2000062|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2000063|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
2000064|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
2000065|NCT01173848|Vitamin D|vitamin d|mesh-list
2000066|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2000067|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000068|NCT01173848|Vitamins|vitamins|mesh-ancestor
2000069|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
2000070|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2000071|NCT01174004|Pimavanserin|pimavanserin|mesh-list
2000072|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2000073|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2000074|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2000075|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2000076|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2000077|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000078|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2000079|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2000080|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2000081|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
2000082|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000083|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000084|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2000085|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000086|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2000087|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000088|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000089|NCT01174082|Vaccines|vaccines|mesh-list
2000090|NCT01174082|Sargramostim|sargramostim|mesh-list
2000091|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
2000092|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000093|NCT01174173|Ranolazine|ranolazine|mesh-list
2000094|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2000095|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000096|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000097|NCT01174186|Adalimumab|adalimumab|mesh-list
2000098|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2000099|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2000100|NCT01174238|Paclitaxel|paclitaxel|mesh-list
2000101|NCT01174238|Carboplatin|carboplatin|mesh-list
2000102|NCT01174238|Axitinib|axitinib|mesh-list
2000103|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2000104|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000105|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
2000106|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
2000107|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
2000108|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000109|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2000110|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745886|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745887|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2745888|NCT02281084|Azacitidine|azacitidine|mesh-list
2745889|NCT02281084|Durvalumab|durvalumab|mesh-list
2745890|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2000116|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
2000117|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2000118|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2000119|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2000120|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2000121|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2000122|NCT01175135|Risperidone|risperidone|mesh-list
2000123|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2000124|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
2000125|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000126|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000127|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000128|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2000129|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2000130|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2000131|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2000132|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2000133|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
2000134|NCT01175148|Atorvastatin|atorvastatin|mesh-list
2000135|NCT01175148|Calcium|calcium|mesh-list
2000136|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2000137|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000138|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2000139|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2000140|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
2000141|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000142|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2000143|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2000144|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000145|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2000146|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
2000147|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2000148|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
2000149|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000150|NCT01175343|R04929097|r04929097|mesh-list
2000151|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000152|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000153|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
2000154|NCT01175356|Melphalan|melphalan|mesh-list
2000155|NCT01175356|Busulfan|busulfan|mesh-list
2000156|NCT01175356|Doxorubicin|doxorubicin|mesh-list
2000157|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2000158|NCT01175356|Etoposide|etoposide|mesh-list
2000159|NCT01175356|Vincristine|vincristine|mesh-list
2000160|NCT01175356|Topotecan|topotecan|mesh-list
2000161|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
2000162|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2000163|NCT01175356|Isotretinoin|isotretinoin|mesh-list
2000164|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2000165|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
2000166|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000167|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2000168|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2000169|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
2000170|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000171|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000172|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2000173|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2000174|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2000175|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2000176|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000177|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2000178|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
2000179|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
2000180|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
2000181|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2000182|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
2000183|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2000184|NCT01175382|Tamsulosin|tamsulosin|mesh-list
2000185|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2000186|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2000187|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2000188|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2000189|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
2000190|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000191|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000192|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000193|NCT01175382|Urological Agents|urological agents|mesh-ancestor
2000194|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2000195|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2000196|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
2000197|NCT01175395|Triamcinolone|triamcinolone|mesh-list
2000198|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2000199|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2000200|NCT01175395|Ranibizumab|ranibizumab|mesh-list
2000201|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2000202|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2000203|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
2000204|NCT01175395|Hormones|hormones|mesh-ancestor
2000205|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000206|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000207|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2000208|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
2000209|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000210|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000211|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2000212|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2000213|NCT01175395|Growth Substances|growth substances|mesh-ancestor
2000214|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
2000215|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000216|NCT01175473|Metformin|metformin|mesh-list
2000217|NCT01175473|Liraglutide|liraglutide|mesh-list
2000218|NCT01175473|Lixisenatide|lixisenatide|mesh-list
2000219|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2000220|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000221|NCT01175473|Incretins|incretins|mesh-ancestor
2000222|NCT01175473|Hormones|hormones|mesh-ancestor
2000223|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000224|NCT01175590|Besifloxacin|besifloxacin|mesh-list
2000225|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2000226|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2000227|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2000228|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2000229|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000230|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000231|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000232|NCT01175668|Clonidine|clonidine|mesh-list
2000233|NCT01175668|Phenobarbital|phenobarbital|mesh-list
2000234|NCT01175668|Analgesics|analgesics|mesh-ancestor
2000235|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
2000236|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2000237|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000238|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2000239|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
2000240|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
2000241|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2000242|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2000243|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2000244|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
2000245|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000246|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000247|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
2000248|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2000249|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2000250|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2000251|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2000252|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
2000253|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
2000254|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2000255|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2000256|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2000257|NCT01175707|Vancomycin|vancomycin|mesh-list
2000258|NCT01175707|Daptomycin|daptomycin|mesh-list
2000259|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2000260|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2000261|NCT01175798|Vitamin D|vitamin d|mesh-list
2000262|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
2000263|NCT01175798|Vitamins|vitamins|mesh-ancestor
2000264|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
2000265|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000266|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2000267|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2000268|NCT01175811|Insulin|insulin|mesh-list
2000269|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2000270|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
2000271|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
2000272|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
2000273|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
2000274|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
2000275|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2000276|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000277|NCT01175824|Insulin|insulin|mesh-list
2000278|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2000279|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
2000280|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
2000281|NCT01175824|Protamines|protamines|mesh-list
2000282|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2000283|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000284|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
2000285|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000286|NCT01175824|Coagulants|coagulants|mesh-ancestor
2000287|NCT01175902|Timolol|timolol|mesh-list
2000288|NCT01175902|Dorzolamide|dorzolamide|mesh-list
2000289|NCT01175902|Latanoprost|latanoprost|mesh-list
2000290|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2000291|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2000292|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
2000293|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000294|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000295|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000296|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2000297|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2000298|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2000299|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2000300|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2000301|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000302|NCT01175980|Vorinostat|vorinostat|mesh-list
2000303|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000304|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2000305|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000306|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000307|NCT01176032|Losartan|losartan|mesh-list
2000308|NCT01176032|Amlodipine|amlodipine|mesh-list
2000309|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2000310|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2000311|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2000312|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000313|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000314|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2000315|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000316|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
2000317|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2000318|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2000319|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2000320|NCT01176032|Diuretics|diuretics|mesh-ancestor
2000321|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
2000322|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2000323|NCT01176058|Fluconazole|fluconazole|mesh-list
2000324|NCT01176058|Anidulafungin|anidulafungin|mesh-list
2000325|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
2000326|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2000327|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2000328|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2000329|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000330|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000331|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2000332|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
2000333|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000334|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000335|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2000336|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2000337|NCT01176240|Mannitol|mannitol|mesh-list
2000338|NCT01176240|Droxidopa|droxidopa|mesh-list
2000339|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2000340|NCT01176240|Diuretics|diuretics|mesh-ancestor
2000341|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
2000342|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000343|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2000344|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2000345|NCT01176435|Levodopa|levodopa|mesh-list
2000346|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2000347|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2000348|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
2000349|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000350|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000351|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000352|NCT01176565|Nicardipine|nicardipine|mesh-list
2000353|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2000354|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2000355|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000356|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000357|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2000358|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000359|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
2000360|NCT01176591|Aprepitant|aprepitant|mesh-list
2000361|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
2000362|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
2000363|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
2000364|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2000365|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000366|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2000367|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2000368|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000369|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000370|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
2000371|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2000372|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
2000373|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000374|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
2000375|NCT01176773|Protective Agents|protective agents|mesh-ancestor
2000376|NCT01176916|Exemestane|exemestane|mesh-list
2000377|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000378|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2000379|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2000380|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000381|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000382|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2000383|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
2000384|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000385|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000386|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2000387|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
2000388|NCT01176968|Eplerenone|eplerenone|mesh-list
2000389|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2000390|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
2000391|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000392|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000393|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2000394|NCT01176968|Diuretics|diuretics|mesh-ancestor
2000395|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
2000396|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2000397|NCT01176981|Methotrexate|methotrexate|mesh-list
2000398|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2000399|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
2000400|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2000401|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000402|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2000403|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
2000404|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000405|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000406|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
2000407|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000408|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2000409|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2000410|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
2000411|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2000412|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2000413|NCT01177098|Timolol|timolol|mesh-list
2000414|NCT01177098|Bimatoprost|bimatoprost|mesh-list
2000415|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2000416|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2000417|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2000418|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2000419|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
2000420|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000421|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000422|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000423|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2000424|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2000425|NCT01177189|Ascorbic Acid|ascorbic acid|mesh-list
2000426|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
2000427|NCT01177189|Vitamins|vitamins|mesh-ancestor
2000428|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
2000429|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000430|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
2000431|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000432|NCT01177189|Protective Agents|protective agents|mesh-ancestor
2000433|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
2000434|NCT01177228|Vedolizumab|vedolizumab|mesh-list
2000435|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2000436|NCT01177293|Amlodipine|amlodipine|mesh-list
2000437|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2000438|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2000439|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000440|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000441|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2000442|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000443|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
2000444|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2000445|NCT01177384|Glimepiride|glimepiride|mesh-list
2000446|NCT01177384|Acarbose|acarbose|mesh-list
2000447|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2000448|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000449|NCT01177384|Incretins|incretins|mesh-ancestor
2000450|NCT01177384|Hormones|hormones|mesh-ancestor
2000451|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000452|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2000453|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
2000454|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000455|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000456|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2000457|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2000458|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
2000459|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2000460|NCT01177410|Mesalamine|mesalamine|mesh-list
2000461|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2000462|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2000463|NCT01177410|Analgesics|analgesics|mesh-ancestor
2000464|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
2000465|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2000466|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000467|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2000468|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2000469|NCT01177709|Metformin|metformin|mesh-list
2000470|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2000471|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000472|NCT01177722|Vaccines|vaccines|mesh-list
2000473|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
2000474|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000475|NCT01177735|Pomalidomide|pomalidomide|mesh-list
2000476|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
2000477|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000478|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2000479|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2000480|NCT01177735|Growth Substances|growth substances|mesh-ancestor
2000481|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
2000482|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000483|NCT01177800|Infliximab|infliximab|mesh-list
2000484|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
2000485|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2000486|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2000487|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2000488|NCT01177813|Empagliflozin|empagliflozin|mesh-list
2000489|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2000490|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000491|NCT01177813|Incretins|incretins|mesh-ancestor
2000492|NCT01177813|Hormones|hormones|mesh-ancestor
2000493|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000494|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2000495|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
2000496|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000497|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000498|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2000499|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2000500|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2000501|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2000502|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000503|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000504|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
2000505|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000506|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000507|NCT01177956|Fluorouracil|fluorouracil|mesh-list
2000508|NCT01177956|Cetuximab|cetuximab|mesh-list
2000509|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000510|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
2000511|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000512|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2000513|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2000514|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
2000515|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000516|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2000517|NCT01178073|Ambrisentan|ambrisentan|mesh-list
2000518|NCT01178073|Tadalafil|tadalafil|mesh-list
2000519|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
2000520|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2000521|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2000522|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000523|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000524|NCT01178073|Urological Agents|urological agents|mesh-ancestor
2000525|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2000526|NCT01178086|Rituximab|rituximab|mesh-list
2000527|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2000528|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000529|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
2000530|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000531|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2000532|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2000533|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2000534|NCT01178138|Prazosin|prazosin|mesh-list
2000535|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2000536|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2000537|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2000538|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2000539|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
2000540|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000541|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000542|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000543|NCT01178216|Rituximab|rituximab|mesh-list
2000544|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2000545|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000546|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
2000547|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000548|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2000549|NCT01178281|Thalidomide|thalidomide|mesh-list
2000550|NCT01178281|Pomalidomide|pomalidomide|mesh-list
2000551|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
2000552|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000553|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2000554|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2000555|NCT01178281|Growth Substances|growth substances|mesh-ancestor
2000556|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
2000557|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000558|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2000559|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
2000560|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2000561|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2000562|NCT01178528|Carvedilol|carvedilol|mesh-list
2000563|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2000564|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2000565|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
2000566|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000567|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000568|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000569|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2000570|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
2000571|NCT01178528|Protective Agents|protective agents|mesh-ancestor
2000572|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2000573|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000574|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2000575|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
2000576|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2000577|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2000578|NCT01178671|Mirtazapine|mirtazapine|mesh-list
2000579|NCT01178671|Sertraline|sertraline|mesh-list
2000580|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
2000581|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2000582|NCT01178671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2000583|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2000584|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000585|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000586|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000587|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
2000588|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000589|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2000590|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
2000591|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
2000592|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2000593|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2000594|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2000595|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2000596|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2000597|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2000598|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
2000599|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2000600|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2000601|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2000602|NCT01178762|Azithromycin|azithromycin|mesh-list
2000603|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2000604|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2000613|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
2000614|NCT01178827|Oxybutynin|oxybutynin|mesh-list
2000615|NCT01178827|Trospium chloride|trospium chloride|mesh-list
2000616|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
2000617|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
2000618|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2000619|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000620|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2000621|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2000622|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
2000623|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000624|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000625|NCT01178827|Urological Agents|urological agents|mesh-ancestor
2000626|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2000627|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2000628|NCT01178827|Renal Agents|renal agents|mesh-ancestor
2000629|NCT01178853|Warfarin|warfarin|mesh-list
2000630|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2000631|NCT01178853|Pitavastatin|pitavastatin|mesh-list
2000632|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2000633|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2000634|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
2000635|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000636|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2000637|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2000638|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000639|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
2000640|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
2000641|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
2000642|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000643|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2000644|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000645|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000646|NCT01179048|Liraglutide|liraglutide|mesh-list
2000647|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2000648|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000649|NCT01179048|Incretins|incretins|mesh-ancestor
2000650|NCT01179048|Hormones|hormones|mesh-ancestor
2000651|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000652|NCT01179113|Esmolol|esmolol|mesh-list
2000653|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2000654|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2000655|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2000656|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
2000657|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000658|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000659|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000660|NCT01179191|Naltrexone|naltrexone|mesh-list
2000661|NCT01179191|Morphine|morphine|mesh-list
2000662|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2000663|NCT01179191|Narcotics|narcotics|mesh-ancestor
2000664|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2000665|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000666|NCT01179191|Analgesics|analgesics|mesh-ancestor
2000667|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
2000668|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2000669|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2000670|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2000671|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
2000672|NCT01179334|Riociguat|riociguat|mesh-list
2000673|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
2000674|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2000675|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2000676|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000677|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000678|NCT01179334|Urological Agents|urological agents|mesh-ancestor
2000679|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
2000680|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
2000681|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2000682|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
2000683|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2000684|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000685|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2000686|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
2000687|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
2000688|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2000689|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
2000690|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000691|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000692|NCT01179490|Prednisolone|prednisolone|mesh-list
2000693|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2000694|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
2000695|NCT01179490|Hormones|hormones|mesh-ancestor
2000696|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000697|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000698|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2000699|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000700|NCT01179516|Vortioxetine|vortioxetine|mesh-list
2000701|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
2000702|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2000703|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2000704|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2000705|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2000706|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000707|NCT01179516|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2000708|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2000709|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000710|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000711|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000712|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
2000713|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2000714|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2000715|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2000716|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2000717|NCT01179568|Citalopram|citalopram|mesh-list
2745891|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
2000718|NCT01179568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2000719|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2000720|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000721|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000722|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000723|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
2000724|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000725|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2000726|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
2000727|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2000728|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2000729|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2000730|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2000731|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000732|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000733|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000734|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000735|NCT01179672|Analgesics|analgesics|mesh-ancestor
2000736|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
2000737|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2000738|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
2000739|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2000740|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
2000741|NCT01179919|Oseltamivir|oseltamivir|mesh-list
2000742|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
2000743|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2000744|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000745|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000746|NCT01180036|Cyclosporine|cyclosporine|mesh-list
2000747|NCT01180036|Rituximab|rituximab|mesh-list
2000748|NCT01180036|Cyclosporins|cyclosporins|mesh-list
2000749|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2000750|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000751|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
2000752|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000753|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2000754|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000755|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000756|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2000757|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
2000758|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2000759|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
2000760|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2000761|NCT01180049|Sirolimus|sirolimus|mesh-list
2000762|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2000763|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2000764|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2000765|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000766|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
2000767|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2000768|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
2000769|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000770|NCT01180296|Progesterone|progesterone|mesh-list
2000771|NCT01180296|Progestins|progestins|mesh-ancestor
2000772|NCT01180296|Hormones|hormones|mesh-ancestor
2000773|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000774|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000775|NCT01180647|Naltrexone|naltrexone|mesh-list
2000776|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2000777|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2000778|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000779|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
2000780|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2000781|NCT01180660|Lidocaine|lidocaine|mesh-list
2000782|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
2000783|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
2000784|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2000785|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000786|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
2000787|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2000788|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2000789|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2000790|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2000791|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000792|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000793|NCT01180790|Interferons|interferons|mesh-list
2000794|NCT01180790|Ribavirin|ribavirin|mesh-list
2000795|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
2000796|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
2000797|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2000798|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000799|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
2000800|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2000801|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
2000802|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000803|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
2000804|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000805|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2000806|NCT01180894|Hematinics|hematinics|mesh-ancestor
2000807|NCT01181011|Amlodipine|amlodipine|mesh-list
2000808|NCT01181011|Telmisartan|telmisartan|mesh-list
2000809|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2000810|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2000811|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2000812|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2000813|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000814|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2000815|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000816|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
2000817|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2000818|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2000819|NCT01181102|Enoxaparin|enoxaparin|mesh-list
2000820|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
2000821|NCT01181102|Edoxaban|edoxaban|mesh-list
2000822|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
2000823|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2000824|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2000825|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000826|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2000827|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
2000828|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2000829|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
2000830|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000831|NCT01181128|Factor VIII|factor viii|mesh-list
2000832|NCT01181128|Coagulants|coagulants|mesh-ancestor
2000833|NCT01181141|Enoxaparin|enoxaparin|mesh-list
2000834|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
2000835|NCT01181141|Edoxaban|edoxaban|mesh-list
2000836|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
2000837|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2000838|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2000839|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000840|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2000841|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
2000842|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2000843|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
2000844|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000845|NCT01181167|Enoxaparin|enoxaparin|mesh-list
2000846|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
2000847|NCT01181167|Edoxaban|edoxaban|mesh-list
2000848|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
2000849|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2000850|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2000851|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000852|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2000853|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
2000854|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2000855|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
2000856|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000857|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
2000858|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
2000859|NCT01181258|Rituximab|rituximab|mesh-list
2000860|NCT01181258|Fludarabine|fludarabine|mesh-list
2000861|NCT01181258|Interleukin-2|interleukin-2|mesh-list
2000862|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2000863|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
2000864|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000865|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2000866|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2000867|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
2000868|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000869|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000870|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2000871|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2000872|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2000873|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
2000874|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
2000875|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2000876|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2000877|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
2000878|NCT01181258|Hormones|hormones|mesh-ancestor
2000879|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000880|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2000881|NCT01181258|Protective Agents|protective agents|mesh-ancestor
2000882|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2000883|NCT01181258|Analgesics|analgesics|mesh-ancestor
2000884|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
2000885|NCT01181271|Sirolimus|sirolimus|mesh-list
2000886|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
2000887|NCT01181271|Busulfan|busulfan|mesh-list
2000888|NCT01181271|Methotrexate|methotrexate|mesh-list
2000889|NCT01181271|Fludarabine|fludarabine|mesh-list
2000890|NCT01181271|Etoposide|etoposide|mesh-list
2000891|NCT01181271|Tacrolimus|tacrolimus|mesh-list
2000892|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2000893|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
2000894|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000895|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2000896|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2000897|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
2000898|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000899|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000900|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2000901|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2000902|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
2000903|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2000904|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2000905|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
2000906|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
2000907|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000908|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2000909|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2000910|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2000911|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2000912|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2000913|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2000914|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2000915|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2000916|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2000917|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
2000918|NCT01181323|Vaccines|vaccines|mesh-list
2000919|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
2000920|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000921|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
2000922|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2000923|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2000924|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000925|NCT01181531|Vitamin D|vitamin d|mesh-list
2000926|NCT01181531|Cinacalcet|cinacalcet|mesh-list
2000927|NCT01181531|Vitamins|vitamins|mesh-ancestor
2000928|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
2000929|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000930|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2000931|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2000932|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2000933|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
2000934|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000935|NCT01181609|Bevacizumab|bevacizumab|mesh-list
2000936|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2000937|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000938|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2000939|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2000940|NCT01181609|Growth Substances|growth substances|mesh-ancestor
2000941|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000942|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
2000943|NCT01181674|Insulin|insulin|mesh-list
2000944|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2000945|NCT01181674|Metformin|metformin|mesh-list
2000946|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
2000947|NCT01181674|Acarbose|acarbose|mesh-list
2000948|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2000949|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000950|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2000951|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000952|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000953|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2000954|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2000955|NCT01181726|Norethindrone|norethindrone|mesh-list
2000956|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
2000957|NCT01181726|Estradiol|estradiol|mesh-list
2000958|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2000959|NCT01181726|Estrogens|estrogens|mesh-ancestor
2000960|NCT01181726|Hormones|hormones|mesh-ancestor
2000961|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000962|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000963|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2000964|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
2000965|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2000966|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2000967|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2000968|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2000969|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2000970|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2000971|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2000972|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
2000973|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2000974|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000975|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2000976|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
2000977|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2000978|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2000979|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2000980|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
2000981|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2000982|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000983|NCT01181986|Exenatide|exenatide|mesh-list
2000984|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2000985|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2000986|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2000987|NCT01181986|Incretins|incretins|mesh-ancestor
2000988|NCT01181986|Hormones|hormones|mesh-ancestor
2000989|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2000990|NCT01182181|Anastrozole|anastrozole|mesh-list
2000991|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2000992|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2000993|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2000994|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2000995|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2000996|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2000997|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2000998|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
2000999|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001000|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001001|NCT01182194|Drospirenone|drospirenone|mesh-list
2001002|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2001003|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2001004|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2001005|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2001006|NCT01182194|Estradiol|estradiol|mesh-list
2001007|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2001008|NCT01182194|Estrogens|estrogens|mesh-ancestor
2001009|NCT01182194|Hormones|hormones|mesh-ancestor
2001010|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001011|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001012|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2001013|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
2001014|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2001015|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2001016|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2001017|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2001018|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2001019|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
2001020|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2001021|NCT01182194|Diuretics|diuretics|mesh-ancestor
2001022|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
2001023|NCT01182207|Drospirenone|drospirenone|mesh-list
2001024|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2001025|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2001026|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2001027|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2001028|NCT01182207|Estradiol|estradiol|mesh-list
2001029|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2001030|NCT01182207|Estrogens|estrogens|mesh-ancestor
2001031|NCT01182207|Hormones|hormones|mesh-ancestor
2001032|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001033|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001034|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2001035|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
2001036|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2001037|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2001038|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2001039|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2001040|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2001041|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
2001042|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2001043|NCT01182207|Diuretics|diuretics|mesh-ancestor
2001044|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
2001045|NCT01182285|Valproic Acid|valproic acid|mesh-list
2001046|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
2001047|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001048|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001049|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
2001050|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001051|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001052|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
2001053|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2001054|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2001055|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2001056|NCT01182350|Bevacizumab|bevacizumab|mesh-list
2001057|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2001058|NCT01182350|Temozolomide|temozolomide|mesh-list
2001059|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2001060|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001061|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2001062|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2001063|NCT01182350|Growth Substances|growth substances|mesh-ancestor
2001064|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001065|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
2001066|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2001067|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001068|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001069|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2001070|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
2001071|NCT01182376|Dronedarone|dronedarone|mesh-list
2001072|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2001073|NCT01182441|Warfarin|warfarin|mesh-list
2001074|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
2001075|NCT01182493|Insulin|insulin|mesh-list
2001076|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2001077|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001078|NCT01182675|Plerixafor|plerixafor|mesh-list
2001079|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
2001080|NCT01182675|Lenograstim|lenograstim|mesh-list
2001081|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2001082|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
2001083|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001084|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2001085|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001086|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2001087|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2001088|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
2001089|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2001090|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2001091|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2001092|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2001093|NCT01182727|Analgesics|analgesics|mesh-ancestor
2001094|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
2001095|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001096|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001097|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2001098|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2001099|NCT01183013|Pioglitazone|pioglitazone|mesh-list
2001100|NCT01183013|Linagliptin|linagliptin|mesh-list
2001101|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2001102|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001103|NCT01183013|Incretins|incretins|mesh-ancestor
2001104|NCT01183013|Hormones|hormones|mesh-ancestor
2001105|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001106|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2001107|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
2001108|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001109|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001110|NCT01183065|Folic Acid|folic acid|mesh-list
2001111|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
2001112|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
2001113|NCT01183065|Vitamins|vitamins|mesh-ancestor
2001114|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
2001115|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001116|NCT01183065|Hematinics|hematinics|mesh-ancestor
2001117|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
2001118|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2001119|NCT01183104|Glimepiride|glimepiride|mesh-list
2001120|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2001121|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001122|NCT01183104|Incretins|incretins|mesh-ancestor
2001123|NCT01183104|Hormones|hormones|mesh-ancestor
2001124|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001125|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2001126|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
2001127|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001128|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001129|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2001130|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001131|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
2001132|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2001133|NCT01183143|Hormones|hormones|mesh-ancestor
2001134|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001135|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001136|NCT01183169|Ribavirin|ribavirin|mesh-list
2001137|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2001138|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
2001139|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001140|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
2001141|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2001142|NCT01183234|Methylphenidate|methylphenidate|mesh-list
2001143|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2001144|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001145|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2001146|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2001147|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2001148|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001149|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
2001150|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001151|NCT01183312|Flumazenil|flumazenil|mesh-list
2001152|NCT01183312|Antidotes|antidotes|mesh-ancestor
2001153|NCT01183312|Protective Agents|protective agents|mesh-ancestor
2001154|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001155|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
2001156|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
2001157|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001158|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001159|NCT01183390|Anastrozole|anastrozole|mesh-list
2001160|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2001161|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001162|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2001163|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2001164|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001165|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001166|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2001167|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
2001168|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001169|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001170|NCT01183481|Aprepitant|aprepitant|mesh-list
2001171|NCT01183481|Granisetron|granisetron|mesh-list
2001172|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
2001173|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
2001174|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001175|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001176|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2001177|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2001178|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001179|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001180|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2001181|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
2001182|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2001183|NCT01183533|Plasminogen|plasminogen|mesh-list
2001184|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2001185|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2001186|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001187|NCT01183559|Paclitaxel|paclitaxel|mesh-list
2001188|NCT01183559|Carboplatin|carboplatin|mesh-list
2001189|NCT01183559|Fluorouracil|fluorouracil|mesh-list
2001190|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2001191|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001192|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
2001193|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
2001194|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
2001195|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001196|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
2001197|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2001198|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001199|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
2001200|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001201|NCT01183650|Tadalafil|tadalafil|mesh-list
2001202|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
2001203|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2001204|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2001205|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001206|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001207|NCT01183650|Urological Agents|urological agents|mesh-ancestor
2001208|NCT01183780|Leucovorin|leucovorin|mesh-list
2001209|NCT01183780|Folic Acid|folic acid|mesh-list
2001210|NCT01183780|Fluorouracil|fluorouracil|mesh-list
2001211|NCT01183780|Irinotecan|irinotecan|mesh-list
2001212|NCT01183780|Ramucirumab|ramucirumab|mesh-list
2001213|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
2001214|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
2001215|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001216|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2001217|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001218|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001219|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
2001220|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001221|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2001222|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2001223|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001224|NCT01183780|Antidotes|antidotes|mesh-ancestor
2001225|NCT01183780|Protective Agents|protective agents|mesh-ancestor
2001226|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
2001227|NCT01183780|Vitamins|vitamins|mesh-ancestor
2001228|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
2001229|NCT01183780|Hematinics|hematinics|mesh-ancestor
2001230|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2001231|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001232|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2001233|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001234|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001235|NCT01184014|Insulin|insulin|mesh-list
2001236|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2001237|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
2001238|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
2001239|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
2001240|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
2001241|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
2001242|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2001243|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001244|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
2001245|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001246|NCT01184079|Vaccines|vaccines|mesh-list
2001247|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
2001248|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001249|NCT01184118|Fluticasone|fluticasone|mesh-list
2001250|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2001251|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2001252|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
2001253|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001254|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001255|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2001256|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
2001257|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
2001258|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2001259|NCT01184326|Everolimus|everolimus|mesh-list
2001260|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001261|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001262|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
2001263|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001264|NCT01184417|Phenobarbital|phenobarbital|mesh-list
2001265|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
2001266|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2001267|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2001268|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001269|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2001270|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2001271|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001272|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001273|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
2001274|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
2001275|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2001276|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2001277|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2001278|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
2001279|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2001280|NCT01184846|Antibodies|antibodies|mesh-list
2001281|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
2001282|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001283|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2001284|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
2001285|NCT01184859|Coagulants|coagulants|mesh-ancestor
2001286|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2001287|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
2001288|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001289|NCT01184872|Vancomycin|vancomycin|mesh-list
2001290|NCT01184872|Daptomycin|daptomycin|mesh-list
2001291|NCT01184872|Penicillins|penicillins|mesh-list
2001292|NCT01184872|Floxacillin|floxacillin|mesh-list
2001293|NCT01184872|Cloxacillin|cloxacillin|mesh-list
2001294|NCT01184872|Oxacillin|oxacillin|mesh-list
2001295|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2001296|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2001297|NCT01184885|Sirolimus|sirolimus|mesh-list
2001298|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
2001299|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2001300|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001301|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001302|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2001303|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2001304|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
2001305|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001306|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
2001307|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001308|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2001309|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2001310|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
2001311|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2001312|NCT01184898|Cytarabine|cytarabine|mesh-list
2001313|NCT01184898|Sirolimus|sirolimus|mesh-list
2001314|NCT01184898|Etoposide|etoposide|mesh-list
2001315|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
2001316|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
2001317|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2001318|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001319|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2001320|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2001321|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001322|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001323|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2001324|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
2001325|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
2001326|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2001327|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001328|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
2001329|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001330|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2001331|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2001332|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
2001333|NCT01184898|Analgesics|analgesics|mesh-ancestor
2001334|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
2001335|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001336|NCT01184989|Dabigatran|dabigatran|mesh-list
2001337|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
2001338|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2001339|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
2001340|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001341|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001342|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
2001343|NCT01185028|Interferons|interferons|mesh-list
2001344|NCT01185028|Ribavirin|ribavirin|mesh-list
2001345|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
2001346|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001347|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
2001348|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2001349|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
2001350|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001351|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2001352|NCT01185080|Adenosine|adenosine|mesh-list
2001353|NCT01185080|Analgesics|analgesics|mesh-ancestor
2001354|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
2001355|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001356|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001357|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2001358|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
2001359|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2001360|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
2001361|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
2001362|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001363|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001364|NCT01185171|Gefitinib|gefitinib|mesh-list
2001365|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001366|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2001367|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001368|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001369|NCT01185288|Adalimumab|adalimumab|mesh-list
2001370|NCT01185288|Methotrexate|methotrexate|mesh-list
2001371|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2001372|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
2001373|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2001374|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001375|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2001376|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
2001377|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001378|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001379|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
2001380|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001381|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2001382|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001383|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
2001384|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2001385|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2001386|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2001387|NCT01185301|Adalimumab|adalimumab|mesh-list
2001388|NCT01185301|Methotrexate|methotrexate|mesh-list
2001389|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2001390|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
2001391|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2001392|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001393|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2001394|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
2001395|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001396|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001397|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
2001398|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001399|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2001400|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001401|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
2001402|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2001403|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2001404|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2001405|NCT01185340|Serotonin|serotonin|mesh-list
2001406|NCT01185340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2001407|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2001408|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
2001409|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001410|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001411|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001412|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2001413|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2001414|NCT01185353|Methotrexate|methotrexate|mesh-list
2001415|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2001416|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
2001417|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2001418|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001419|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2001420|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
2001421|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001422|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001423|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
2001424|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001425|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2001426|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001427|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
2001428|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2001429|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2001430|NCT01185366|Everolimus|everolimus|mesh-list
2001431|NCT01185366|Sunitinib|sunitinib|mesh-list
2001432|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001433|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001434|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
2001435|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001436|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2001437|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2001438|NCT01185366|Growth Substances|growth substances|mesh-ancestor
2001439|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
2001440|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2001441|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001442|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001443|NCT01185509|Trastuzumab|trastuzumab|mesh-list
2001444|NCT01185509|Vinorelbine|vinorelbine|mesh-list
2001445|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2001446|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001447|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2001448|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
2001449|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
2001450|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
2001451|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001452|NCT01185548|Tolbutamide|tolbutamide|mesh-list
2001453|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2001454|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001455|NCT01185704|Cetrorelix|cetrorelix|mesh-list
2001456|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2001457|NCT01185704|Hormones|hormones|mesh-list
2001458|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2001459|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001460|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001461|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2001462|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
2001463|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2001464|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
2001465|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
2001466|NCT01185782|Hormones|hormones|mesh-list
2001467|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2001468|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001469|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001470|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2001471|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
2001472|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2001473|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
2001474|NCT01185821|Siponimod|siponimod|mesh-list
2001475|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2001476|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001477|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001478|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
2001479|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001480|NCT01185964|Doxorubicin|doxorubicin|mesh-list
2001481|NCT01185964|Olaratumab|olaratumab|mesh-list
2001482|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2001483|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001484|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2001485|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2001486|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001487|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001488|NCT01186250|Pioglitazone|pioglitazone|mesh-list
2001489|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2001490|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001491|NCT01186328|Cytarabine|cytarabine|mesh-list
2001492|NCT01186328|Prednisone|prednisone|mesh-list
2001493|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
2001494|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2001495|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2001496|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2001497|NCT01186328|Cortisone|cortisone|mesh-list
2001498|NCT01186328|Doxorubicin|doxorubicin|mesh-list
2001499|NCT01186328|Methotrexate|methotrexate|mesh-list
2001500|NCT01186328|Vincristine|vincristine|mesh-list
2001501|NCT01186328|Asparaginase|asparaginase|mesh-list
2001502|NCT01186328|Pegaspargase|pegaspargase|mesh-list
2001503|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2001504|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001505|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2001506|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2001507|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001508|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001509|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2001510|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
2001511|NCT01186328|Hormones|hormones|mesh-ancestor
2001512|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001513|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001514|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2001515|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2001516|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
2001517|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2001518|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2001519|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
2001520|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
2001521|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2001522|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001523|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
2001524|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2001525|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2001526|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
2001527|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2001528|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2001529|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
2001530|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
2001531|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
2001532|NCT01186406|Bevacizumab|bevacizumab|mesh-list
2001533|NCT01186406|Temozolomide|temozolomide|mesh-list
2001534|NCT01186406|Carmustine|carmustine|mesh-list
2001535|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2001536|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001537|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2001538|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2001539|NCT01186406|Growth Substances|growth substances|mesh-ancestor
2001540|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001541|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
2001542|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2001543|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
2001544|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001545|NCT01186458|Rituximab|rituximab|mesh-list
2001546|NCT01186458|Fludarabine|fludarabine|mesh-list
2001547|NCT01186458|Bortezomib|bortezomib|mesh-list
2001548|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2001549|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001550|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
2001551|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001552|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2001553|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2001554|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2001555|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001556|NCT01186562|Incretins|incretins|mesh-ancestor
2001557|NCT01186562|Hormones|hormones|mesh-ancestor
2001558|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001559|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2001560|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
2001561|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001562|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001563|NCT01186744|Tofacitinib|tofacitinib|mesh-list
2001564|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2001565|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001566|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001567|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
2001568|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2001569|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001570|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
2001571|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001572|NCT01186796|Fulvestrant|fulvestrant|mesh-list
2001573|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2001574|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001575|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2001576|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2001577|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
2001578|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001579|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001580|NCT01186939|Azacitidine|azacitidine|mesh-list
2001581|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2001582|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
2001583|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001584|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001585|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001586|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
2001587|NCT01187017|Fludarabine|fludarabine|mesh-list
2001588|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001589|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
2001590|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001591|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2001592|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2001593|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
2001594|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001595|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001596|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2001597|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2001598|NCT01187381|Trastuzumab|trastuzumab|mesh-list
2001599|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2001600|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001601|NCT01187407|Serotonin|serotonin|mesh-list
2001602|NCT01187407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2001603|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2001604|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
2001605|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001606|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001607|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001608|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2001609|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2001610|NCT01187433|Vaccines|vaccines|mesh-list
2001611|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
2001612|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001613|NCT01187446|Vorinostat|vorinostat|mesh-list
2001614|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001615|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2001616|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001617|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001618|NCT01187498|Oxybutynin|oxybutynin|mesh-list
2001619|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
2001620|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
2001621|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001622|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001623|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2001624|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2001625|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
2001626|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001627|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001628|NCT01187498|Urological Agents|urological agents|mesh-ancestor
2001629|NCT01187550|Hormones|hormones|mesh-list
2001630|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001631|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001632|NCT01187901|Sulindac|sulindac|mesh-list
2001633|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2001634|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001635|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2001636|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001637|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001638|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2001639|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2001640|NCT01187901|Analgesics|analgesics|mesh-ancestor
2001641|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
2001642|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001643|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001644|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2001645|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2001646|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2001647|NCT01187953|Tacrolimus|tacrolimus|mesh-list
2001648|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001649|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
2001650|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001651|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2001652|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001653|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001654|NCT01188109|Gemcitabine|gemcitabine|mesh-list
2001655|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001656|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2001657|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
2001658|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001659|NCT01188109|Antiviral Agents|antiviral agents|mesh-ancestor
2001660|NCT01188109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2001661|NCT01188109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001662|NCT01188109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001663|NCT01188109|Immunologic Factors|immunologic factors|mesh-ancestor
2001664|NCT01188109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001665|NCT01188369|Simendan|simendan|mesh-list
2001666|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2001667|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
2001668|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2001669|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2001670|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001671|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001672|NCT01188369|Protective Agents|protective agents|mesh-ancestor
2001673|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001674|NCT01188421|Clonidine|clonidine|mesh-list
2001675|NCT01188421|Buprenorphine|buprenorphine|mesh-list
2001676|NCT01188421|Tramadol|tramadol|mesh-list
2001677|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2001678|NCT01188421|Naloxone|naloxone|mesh-list
2001679|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2001680|NCT01188421|Narcotics|narcotics|mesh-ancestor
2001681|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2001682|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001683|NCT01188421|Analgesics|analgesics|mesh-ancestor
2001684|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
2001685|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001686|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2001687|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2001688|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
2001689|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
2001690|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2001691|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2001692|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2001693|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
2001694|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001695|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001696|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
2001697|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2001698|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2001699|NCT01188538|Analgesics|analgesics|mesh-ancestor
2001700|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
2001701|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001702|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001703|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2001704|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2001705|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
2001706|NCT01188551|Fentanyl|fentanyl|mesh-list
2001707|NCT01188551|Midazolam|midazolam|mesh-list
2001708|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
2001709|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2001710|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2001711|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001712|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2001713|NCT01188551|Analgesics|analgesics|mesh-ancestor
2001714|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
2001715|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001716|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2001717|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2001718|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2001719|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
2001720|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001721|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001722|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2001723|NCT01188551|Narcotics|narcotics|mesh-ancestor
2001724|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2001725|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2001726|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
2001727|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
2001728|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2001729|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2001730|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2001731|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
2001732|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
2001733|NCT01188577|Epinephrine|epinephrine|mesh-list
2001734|NCT01188577|Racepinephrine|racepinephrine|mesh-list
2001735|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
2001736|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2001737|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2001738|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
2001739|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001740|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001741|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001742|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2001743|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2001744|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
2001745|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001746|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2001747|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
2001748|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
2001749|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
2001750|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2001751|NCT01188655|Etanercept|etanercept|mesh-list
2001752|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2001753|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2001754|NCT01188655|Analgesics|analgesics|mesh-ancestor
2001755|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
2001756|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001757|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001758|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2001759|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2001760|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2001761|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001762|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
2001763|NCT01188668|Aripiprazole|aripiprazole|mesh-list
2001764|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2001765|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
2001766|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2001767|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2001768|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2001769|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2001770|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001771|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
2001772|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
2001773|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001774|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001775|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2001776|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2001777|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
2001778|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2001779|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2001780|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2001781|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2001782|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2001783|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2001784|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2001785|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2001786|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
2001787|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2001788|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
2001789|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001790|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001791|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
2001792|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001793|NCT01188694|Methylene Blue|methylene blue|mesh-list
2001794|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001795|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001796|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
2001797|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
2001798|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2001799|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
2001800|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
2001801|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001802|NCT01188811|Protective Agents|protective agents|mesh-ancestor
2001803|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001804|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
2001805|NCT01188811|Vitamins|vitamins|mesh-ancestor
2001806|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
2001807|NCT01188876|Folic Acid|folic acid|mesh-list
2001808|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
2001809|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
2001810|NCT01188876|Carboplatin|carboplatin|mesh-list
2001811|NCT01188876|Vitamins|vitamins|mesh-ancestor
2001812|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
2001813|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001814|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001815|NCT01188876|Hematinics|hematinics|mesh-ancestor
2001816|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
2001817|NCT01188928|Betamethasone|betamethasone|mesh-list
2001818|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
2001819|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2001820|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
2001821|NCT01188928|Calcipotriene|calcipotriene|mesh-list
2001822|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2001823|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2001824|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
2001825|NCT01188928|Hormones|hormones|mesh-ancestor
2001826|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001827|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001828|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2001829|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
2001830|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
2001831|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2001832|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2001833|NCT01189201|Linagliptin|linagliptin|mesh-list
2001834|NCT01189201|Empagliflozin|empagliflozin|mesh-list
2001835|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2001836|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001837|NCT01189201|Incretins|incretins|mesh-ancestor
2001838|NCT01189201|Hormones|hormones|mesh-ancestor
2001839|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001840|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2001841|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
2001842|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001843|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001844|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2001845|NCT01189240|Bevacizumab|bevacizumab|mesh-list
2001846|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2001847|NCT01189240|Antibodies|antibodies|mesh-list
2001848|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
2001849|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2001850|NCT01189240|R04929097|r04929097|mesh-list
2001851|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001852|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2001853|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2001854|NCT01189240|Growth Substances|growth substances|mesh-ancestor
2001855|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001856|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
2001857|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
2001858|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001859|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001860|NCT01189266|Vorinostat|vorinostat|mesh-list
2001861|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001862|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2001863|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001864|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001865|NCT01189279|Bimatoprost|bimatoprost|mesh-list
2001866|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2001867|NCT01189292|Dexamethasone|dexamethasone|mesh-list
2001868|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2001869|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
2001870|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
2001871|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001872|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001873|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2001874|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
2001875|NCT01189292|Hormones|hormones|mesh-ancestor
2001876|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001877|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2001878|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001879|NCT01189370|Sorafenib|sorafenib|mesh-list
2001880|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001881|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2001882|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001883|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001884|NCT01189409|Sennosides|sennosides|mesh-list
2001885|NCT01189409|Laxatives|laxatives|mesh-ancestor
2001886|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2001887|NCT01189487|Ampicillin|ampicillin|mesh-list
2001888|NCT01189487|Sulbactam|sulbactam|mesh-list
2001889|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2001890|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2001891|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2001892|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001893|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001894|NCT01189500|Tamoxifen|tamoxifen|mesh-list
2001895|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2001896|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2001897|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
2001898|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001899|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001900|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2001901|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2001902|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2001903|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2001904|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2001905|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2001906|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2001907|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2001908|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001909|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001910|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
2001911|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2001912|NCT01189604|Propofol|propofol|mesh-list
2001913|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2001914|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2001915|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001916|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2001917|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
2001918|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
2001919|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2001920|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2001921|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2001922|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001923|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001924|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2001925|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2001926|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001927|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
2001928|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001929|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2001930|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2001931|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2001932|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2001933|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001934|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2001935|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2001936|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001937|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
2001938|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001939|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
2001940|NCT01189812|Citalopram|citalopram|mesh-list
2001941|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
2001942|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2001943|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001944|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001945|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
2001946|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2001947|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2001948|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001949|NCT01189812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2001950|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2001951|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2001952|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2001953|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
2001954|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2001955|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2001956|NCT01189890|Glimepiride|glimepiride|mesh-list
2001957|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2001958|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001959|NCT01189890|Incretins|incretins|mesh-ancestor
2001960|NCT01189890|Hormones|hormones|mesh-ancestor
2001961|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2001962|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2001963|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
2001964|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001965|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001966|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2001967|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2001968|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
2001969|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
2001970|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2001971|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2001972|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
2001973|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001974|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2001975|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2001976|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2001977|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2001978|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2001979|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2001980|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2001981|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2001982|NCT01190020|Lubiprostone|lubiprostone|mesh-list
2001983|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2001984|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2001985|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001986|NCT01190098|Lacosamide|lacosamide|mesh-list
2001987|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
2001988|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2001989|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2001990|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2001991|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001992|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
2001993|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2001994|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2001995|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2001996|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
2001997|NCT01190150|Coagulants|coagulants|mesh-ancestor
2001998|NCT01190228|Vaccines|vaccines|mesh-list
2001999|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
2002000|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002001|NCT01190254|Asenapine|asenapine|mesh-list
2002002|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2002003|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2002004|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2002005|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002006|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2002007|NCT01190267|Asenapine|asenapine|mesh-list
2002008|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2002009|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2002010|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2002011|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002012|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2002013|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
2002014|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002015|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
2002016|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002017|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2002018|NCT01190436|Bisoprolol|bisoprolol|mesh-list
2002019|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2002020|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
2002021|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
2002022|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002023|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002024|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2002025|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2002026|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2002027|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
2002028|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002029|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002030|NCT01190449|Ofatumumab|ofatumumab|mesh-list
2002031|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002032|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2002033|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2002034|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2002035|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2002036|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002037|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002038|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002039|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
2002040|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2002041|NCT01190813|Levodopa|levodopa|mesh-list
2002042|NCT01190813|Carbidopa|carbidopa|mesh-list
2002043|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2002044|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2002045|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
2002046|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002047|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002048|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002049|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2002050|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002051|NCT01190839|Infliximab|infliximab|mesh-list
2002052|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
2002053|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2002054|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2002055|NCT01190878|Bromfenac|bromfenac|mesh-list
2002056|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2002057|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2002058|NCT01190878|Analgesics|analgesics|mesh-ancestor
2002059|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
2002060|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002061|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002062|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2002063|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2002064|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
2002065|NCT01190930|Leucovorin|leucovorin|mesh-list
2002066|NCT01190930|Folic Acid|folic acid|mesh-list
2002067|NCT01190930|Cytarabine|cytarabine|mesh-list
2002068|NCT01190930|Dexamethasone|dexamethasone|mesh-list
2002069|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
2002070|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
2002071|NCT01190930|Doxorubicin|doxorubicin|mesh-list
2002072|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2002073|NCT01190930|Methotrexate|methotrexate|mesh-list
2002074|NCT01190930|Vincristine|vincristine|mesh-list
2002075|NCT01190930|Asparaginase|asparaginase|mesh-list
2002076|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
2002077|NCT01190930|Pegaspargase|pegaspargase|mesh-list
2002078|NCT01190930|Thioguanine|thioguanine|mesh-list
2002079|NCT01190930|BB 1101|bb 1101|mesh-list
2002080|NCT01190930|Calcium|calcium|mesh-list
2002081|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
2002082|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
2002083|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002084|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
2002085|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002086|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2002087|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2002088|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
2002089|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002090|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002091|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2002092|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2002093|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
2002094|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
2002095|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002096|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2002097|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
2002098|NCT01190930|Hormones|hormones|mesh-ancestor
2002099|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002100|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2002101|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
2002102|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002103|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2002104|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2002105|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2002106|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2002107|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2002108|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2002109|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
2002110|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2002111|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2002112|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
2002113|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
2002114|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2002115|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2002116|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
2002117|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002118|NCT01190930|Antidotes|antidotes|mesh-ancestor
2002119|NCT01190930|Protective Agents|protective agents|mesh-ancestor
2002120|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
2002121|NCT01190930|Vitamins|vitamins|mesh-ancestor
2002122|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
2002123|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2002124|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
2002125|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
2002126|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
2002127|NCT01190930|Hematinics|hematinics|mesh-ancestor
2002128|NCT01191008|Timolol|timolol|mesh-list
2002129|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2002130|NCT01191008|Latanoprost|latanoprost|mesh-list
2002131|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2002132|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2002133|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2002134|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
2002135|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002136|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002137|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002138|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2002139|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2002140|NCT01191086|Topiramate|topiramate|mesh-list
2002141|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
2002142|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2002143|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002144|NCT01191190|Ofatumumab|ofatumumab|mesh-list
2002145|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002146|NCT01191255|Sevelamer|sevelamer|mesh-list
2002147|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
2002148|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
2002149|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002150|NCT01191268|Insulin|insulin|mesh-list
2002151|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2002152|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
2002153|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
2002154|NCT01191268|Dulaglutide|dulaglutide|mesh-list
2002155|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2002156|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002157|NCT01191320|Enclomiphene|enclomiphene|mesh-list
2002158|NCT01191320|Clomiphene|clomiphene|mesh-list
2002159|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
2002160|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2002161|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
2002162|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002163|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002164|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2002165|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
2002166|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2002167|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2002168|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2002169|NCT01191398|Atropine|atropine|mesh-list
2002170|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
2002171|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2002172|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2002173|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2002174|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
2002175|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002176|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002177|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2002178|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
2002179|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
2002180|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
2002181|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2002182|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2002183|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
2002184|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002185|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002186|NCT01191476|Propofol|propofol|mesh-list
2002187|NCT01191476|Sevoflurane|sevoflurane|mesh-list
2002188|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2002189|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2002190|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002191|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2002192|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
2002193|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
2002194|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2002195|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2002196|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
2002197|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2002198|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002199|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2002200|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2002201|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002202|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002203|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002204|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
2002205|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2002206|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002207|NCT01191762|Sevelamer|sevelamer|mesh-list
2002208|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
2002209|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
2002210|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002211|NCT01191801|Cytarabine|cytarabine|mesh-list
2002212|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2002213|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
2002214|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002215|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002216|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
2002217|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002218|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002219|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
2002220|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002221|NCT01191840|Vancomycin|vancomycin|mesh-list
2002222|NCT01191840|Cefazolin|cefazolin|mesh-list
2002223|NCT01191840|Daptomycin|daptomycin|mesh-list
2002224|NCT01191840|Cloxacillin|cloxacillin|mesh-list
2002225|NCT01191840|Oxacillin|oxacillin|mesh-list
2002226|NCT01191840|Nafcillin|nafcillin|mesh-list
2002227|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2002228|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002229|NCT01191944|Pramipexole|pramipexole|mesh-list
2002230|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
2002231|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002232|NCT01191944|Protective Agents|protective agents|mesh-ancestor
2002233|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002234|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2002235|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2002236|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
2002237|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
2002238|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002239|NCT01192139|Metformin|metformin|mesh-list
2002240|NCT01192139|Saxagliptin|saxagliptin|mesh-list
2002241|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2002242|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002243|NCT01192139|Incretins|incretins|mesh-ancestor
2002244|NCT01192139|Hormones|hormones|mesh-ancestor
2002245|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002246|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2002247|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
2002248|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002249|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002250|NCT01192152|Metformin|metformin|mesh-list
2002251|NCT01192152|Saxagliptin|saxagliptin|mesh-list
2002252|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2002253|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002254|NCT01192152|Incretins|incretins|mesh-ancestor
2002255|NCT01192152|Hormones|hormones|mesh-ancestor
2002256|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002257|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2002258|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
2002259|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002260|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002261|NCT01192178|Fluticasone|fluticasone|mesh-list
2002262|NCT01192178|Xhance|xhance|mesh-list
2002263|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2002264|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2002265|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2002266|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2002267|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
2002268|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002269|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002270|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2002271|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
2002272|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
2002273|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2002274|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2002275|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2002276|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2002277|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
2002278|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002279|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002280|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
2002281|NCT01192178|Hormones|hormones|mesh-ancestor
2002282|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002283|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
2002284|NCT01192191|Fluticasone|fluticasone|mesh-list
2002285|NCT01192191|Xhance|xhance|mesh-list
2002286|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2002287|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2002288|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
2002289|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002290|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002291|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2002292|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
2002293|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
2002294|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2002295|NCT01192295|Oxycodone|oxycodone|mesh-list
2002296|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2002297|NCT01192295|Narcotics|narcotics|mesh-ancestor
2002298|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2002299|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002300|NCT01192295|Analgesics|analgesics|mesh-ancestor
2002301|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
2002302|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002303|NCT01192399|Eculizumab|eculizumab|mesh-list
2002304|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2002305|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002306|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
2002307|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002308|NCT01192698|Interferons|interferons|mesh-list
2002309|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002310|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
2002311|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002312|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2002313|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002314|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2002315|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002316|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002317|NCT01193049|Prednisone|prednisone|mesh-list
2002318|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2002319|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
2002320|NCT01193049|Hormones|hormones|mesh-ancestor
2002321|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002322|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002323|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2002324|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002325|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2002326|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2002327|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002328|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2002329|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2002330|NCT01193127|Mydriatics|mydriatics|mesh-list
2002331|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
2002332|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002333|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002334|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2002335|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2002336|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2002337|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2002338|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002339|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2002340|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2002341|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2002342|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
2002343|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002344|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002345|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2002346|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2002347|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
2002348|NCT01193218|Empagliflozin|empagliflozin|mesh-list
2002349|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2002350|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002351|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2002352|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002353|NCT01193244|Prednisone|prednisone|mesh-list
2002354|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2002355|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
2002356|NCT01193244|Hormones|hormones|mesh-ancestor
2002357|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002358|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002359|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2002360|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002361|NCT01193257|Prednisone|prednisone|mesh-list
2002362|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2002363|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
2002364|NCT01193257|Hormones|hormones|mesh-ancestor
2002365|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002366|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002367|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2002368|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002369|NCT01193283|Cyclosporine|cyclosporine|mesh-list
2002370|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
2002371|NCT01193283|Cyclosporins|cyclosporins|mesh-list
2002372|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002373|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
2002374|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002375|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2002376|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2002377|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
2002378|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002379|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002380|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2002381|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002382|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
2002383|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002384|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
2002385|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2002386|NCT01193335|Vaccines|vaccines|mesh-list
2002387|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2002388|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
2002389|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002390|NCT01193348|Eculizumab|eculizumab|mesh-list
2002391|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2002392|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002393|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
2002394|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002395|NCT01193517|Capecitabine|capecitabine|mesh-list
2002396|NCT01193517|Azacitidine|azacitidine|mesh-list
2002397|NCT01193517|Decitabine|decitabine|mesh-list
2002398|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
2002399|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2002400|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
2002401|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002402|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002403|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002404|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2002405|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
2002406|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002407|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
2002408|NCT01193660|Hematinics|hematinics|mesh-ancestor
2745892|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745893|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745894|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745895|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745909|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
2745910|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
2745911|NCT02220985|Thiotepa|thiotepa|mesh-list
2745912|NCT02220985|Methotrexate|methotrexate|mesh-list
2745913|NCT02220985|Fludarabine|fludarabine|mesh-list
2745914|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
2745915|NCT02220985|Tacrolimus|tacrolimus|mesh-list
2745916|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2745917|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
2745918|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745919|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2745920|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2745921|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
2745922|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745923|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745924|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2745925|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2745926|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
2745927|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2745928|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2745929|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
2745930|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
2002449|NCT01193868|R04929097|r04929097|mesh-list
2002450|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002451|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002452|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2002453|NCT01193920|Vaccines|vaccines|mesh-list
2002454|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
2002455|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002456|NCT01194089|Nicotine|nicotine|mesh-list
2002457|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2002458|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
2002459|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002460|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002461|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2002462|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2002463|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
2002464|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002465|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002466|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
2002467|NCT01194154|Hematinics|hematinics|mesh-ancestor
2002468|NCT01194219|Apremilast|apremilast|mesh-list
2002469|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2002470|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2002471|NCT01194219|Analgesics|analgesics|mesh-ancestor
2002472|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
2002473|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002474|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002475|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2002476|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2002477|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2002478|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2002479|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002480|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002481|NCT01194245|Insulin|insulin|mesh-list
2002482|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2002483|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
2002484|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
2002485|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
2002486|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
2002487|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2002488|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002489|NCT01194258|Insulin|insulin|mesh-list
2002490|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2002491|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
2002492|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
2002493|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
2002494|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
2002495|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2002496|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002497|NCT01194271|Ipilimumab|ipilimumab|mesh-list
2002498|NCT01194271|Leuprolide|leuprolide|mesh-list
2002499|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2002500|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002501|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2002502|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002503|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2002504|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
2002505|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2002506|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002507|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2002508|NCT01194297|Vaccines|vaccines|mesh-list
2002509|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
2002510|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002511|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
2002512|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
2002513|NCT01194440|Letrozole|letrozole|mesh-list
2002514|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002515|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2002516|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2002517|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002518|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002519|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2002520|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
2002521|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002522|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002523|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2002524|NCT01194453|Folic Acid|folic acid|mesh-list
2002525|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
2002526|NCT01194453|Hydroxocobalamin|hydroxocobalamin|mesh-list
2002527|NCT01194453|Gemcitabine|gemcitabine|mesh-list
2002528|NCT01194453|Dexamethasone|dexamethasone|mesh-list
2002529|NCT01194453|Cisplatin|cisplatin|mesh-list
2002530|NCT01194453|Vitamins|vitamins|mesh-ancestor
2002531|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
2002532|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002533|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002534|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2002535|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
2002536|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
2002537|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002538|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2002539|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
2002540|NCT01194453|Hormones|hormones|mesh-ancestor
2002541|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002542|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2002543|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2002544|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
2002545|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002546|NCT01194453|Antiviral Agents|antiviral agents|mesh-ancestor
2002547|NCT01194453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002548|NCT01194453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002549|NCT01194453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002550|NCT01194453|Immunologic Factors|immunologic factors|mesh-ancestor
2002551|NCT01194453|Hematinics|hematinics|mesh-ancestor
2002552|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
2002553|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
2002554|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2002555|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
2002556|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002557|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002558|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2002559|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
2002560|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2002561|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2002562|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2002563|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
2002564|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002565|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002569|NCT01194674|Plasminogen|plasminogen|mesh-list
2002570|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2002571|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2002572|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002573|NCT01194804|Eculizumab|eculizumab|mesh-list
2002574|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2002575|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002576|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
2002577|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002578|NCT01194830|Linagliptin|linagliptin|mesh-list
2002579|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2002580|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002581|NCT01194830|Incretins|incretins|mesh-ancestor
2002582|NCT01194830|Hormones|hormones|mesh-ancestor
2002583|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002584|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2002585|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
2002586|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002587|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002588|NCT01194869|Paclitaxel|paclitaxel|mesh-list
2002589|NCT01194869|Cisplatin|cisplatin|mesh-list
2002590|NCT01194869|Sorafenib|sorafenib|mesh-list
2002591|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2002592|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002593|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
2002594|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
2002595|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
2002596|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002597|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2002598|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002599|NCT01194973|Eculizumab|eculizumab|mesh-list
2002600|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2002601|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002602|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
2002603|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002604|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2002605|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
2002606|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
2002607|NCT01195090|Pioglitazone|pioglitazone|mesh-list
2002608|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2002609|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2002610|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002611|NCT01195090|Incretins|incretins|mesh-ancestor
2002612|NCT01195090|Hormones|hormones|mesh-ancestor
2002613|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002614|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2002615|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
2002616|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002617|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002618|NCT01195103|Fentanyl|fentanyl|mesh-list
2002619|NCT01195103|Midazolam|midazolam|mesh-list
2002620|NCT01195103|Propofol|propofol|mesh-list
2002621|NCT01195103|Fospropofol|fospropofol|mesh-list
2002622|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2002623|NCT01195103|Narcotics|narcotics|mesh-ancestor
2002624|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2002625|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002626|NCT01195103|Analgesics|analgesics|mesh-ancestor
2002627|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
2002628|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002629|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2002630|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2002631|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
2002632|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
2002633|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2002634|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2002635|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2002636|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2002637|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
2002638|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
2002639|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002640|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002641|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
2002642|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2002643|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2002644|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002645|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2002646|NCT01195116|Analgesics|analgesics|mesh-ancestor
2002647|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
2002648|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002649|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2002650|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2002651|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2002652|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
2002653|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002654|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002655|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2002656|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
2002657|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2002658|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2002659|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2002660|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2002661|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002662|NCT01195415|Gemcitabine|gemcitabine|mesh-list
2002663|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2002664|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
2002665|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002666|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002667|NCT01195415|Antiviral Agents|antiviral agents|mesh-ancestor
2002668|NCT01195415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002669|NCT01195415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002670|NCT01195415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002671|NCT01195415|Immunologic Factors|immunologic factors|mesh-ancestor
2002672|NCT01195415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002673|NCT01195467|Tenofovir|tenofovir|mesh-list
2002674|NCT01195467|Emtricitabine|emtricitabine|mesh-list
2002675|NCT01195467|Efavirenz|efavirenz|mesh-list
2002676|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
2002677|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2002678|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
2002679|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002680|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2002681|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2002682|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002683|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002684|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2002685|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2002686|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2002687|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2002688|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2002689|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2002690|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2002691|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2002692|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2002693|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2002694|NCT01195597|Nicotine|nicotine|mesh-list
2002695|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2002696|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
2002697|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002698|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002699|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2002700|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2002701|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
2002702|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002703|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002704|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
2002705|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2002706|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002707|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2002708|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002709|NCT01195675|Empagliflozin|empagliflozin|mesh-list
2002710|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
2002711|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2002712|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002713|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2002714|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2002715|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002716|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002717|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002718|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002719|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2002720|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2002721|NCT01195779|Vaccines|vaccines|mesh-list
2002722|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
2002723|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002724|NCT01195831|Calcipotriene|calcipotriene|mesh-list
2002725|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
2002726|NCT01195922|Sirolimus|sirolimus|mesh-list
2002727|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2002728|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002729|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2002730|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002731|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
2002732|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002733|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
2002734|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002735|NCT01196052|Trastuzumab|trastuzumab|mesh-list
2002736|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2002737|NCT01196052|Maytansine|maytansine|mesh-list
2002738|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2002739|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002740|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2002741|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
2002742|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
2002743|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
2002744|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002745|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2002746|NCT01196078|Vinorelbine|vinorelbine|mesh-list
2002747|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002748|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2002749|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002750|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002751|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2002752|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
2002753|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
2002754|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
2002755|NCT01196091|Antimalarials|antimalarials|mesh-list
2002756|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2002757|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2002758|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2002759|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2002760|NCT01196091|Analgesics|analgesics|mesh-ancestor
2002761|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
2002762|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002763|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002764|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2002765|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
2002766|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2002767|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2002768|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002769|NCT01196104|Insulin|insulin|mesh-list
2002770|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2002771|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
2002772|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
2002773|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2002774|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002775|NCT01196377|Albuterol|albuterol|mesh-list
2002776|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2002777|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
2002778|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002779|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002780|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2002781|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
2002782|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
2002783|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2002784|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2002785|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2002786|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2002787|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
2002788|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2002789|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745931|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745932|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2745933|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2745934|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2745935|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2745936|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2745937|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
2745938|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2745939|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002807|NCT01196416|Cisplatin|cisplatin|mesh-list
2002808|NCT01196416|Temozolomide|temozolomide|mesh-list
2002809|NCT01196416|Vinblastine|vinblastine|mesh-list
2002810|NCT01196416|R04929097|r04929097|mesh-list
2002811|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002812|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2002813|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
2002814|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002815|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2002816|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
2002817|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
2002818|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
2002819|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002820|NCT01196429|Sirolimus|sirolimus|mesh-list
2002821|NCT01196429|Paclitaxel|paclitaxel|mesh-list
2002822|NCT01196429|Docetaxel|docetaxel|mesh-list
2002823|NCT01196429|Carboplatin|carboplatin|mesh-list
2002824|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2002825|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2002826|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002827|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
2002828|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
2002829|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
2002830|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002831|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2002832|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002833|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2002834|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
2002835|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002836|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
2002837|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002838|NCT01196741|Paclitaxel|paclitaxel|mesh-list
2002839|NCT01196741|Saracatinib|saracatinib|mesh-list
2002840|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2002841|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002842|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
2002843|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
2002844|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
2002845|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002846|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002847|NCT01196936|Tamoxifen|tamoxifen|mesh-list
2002848|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2002849|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
2002850|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002851|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002852|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2002853|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002854|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2002855|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2002856|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2002857|NCT01196975|Vaccines|vaccines|mesh-list
2002858|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
2002859|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002860|NCT01196988|Vaccines|vaccines|mesh-list
2002861|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
2002862|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002863|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
2002864|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2002865|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002866|NCT01197378|Cysteamine|cysteamine|mesh-list
2002867|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2002868|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002869|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
2002870|NCT01197417|Analgesics|analgesics|mesh-ancestor
2002871|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
2002872|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002873|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002874|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
2002875|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2002876|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2002877|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
2002878|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2002879|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2002880|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002881|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2002882|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
2002883|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2002884|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
2002885|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2002886|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
2002887|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002888|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
2002889|NCT01197495|Protective Agents|protective agents|mesh-ancestor
2002890|NCT01197560|Gemcitabine|gemcitabine|mesh-list
2002891|NCT01197560|Rituximab|rituximab|mesh-list
2002892|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
2002893|NCT01197560|Etoposide|etoposide|mesh-list
2002894|NCT01197560|Lenalidomide|lenalidomide|mesh-list
2002895|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2002896|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002897|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
2002898|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002899|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2002900|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2002901|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
2002902|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002903|NCT01197560|Antiviral Agents|antiviral agents|mesh-ancestor
2002904|NCT01197560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002905|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002906|NCT01197560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002907|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2002908|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2002909|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2002910|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2002911|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2002912|NCT01197560|Growth Substances|growth substances|mesh-ancestor
2002913|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
2002914|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2002915|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2002916|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2002917|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002918|NCT01197612|Budesonide|budesonide|mesh-list
2002919|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2002920|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2002921|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
2002922|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002923|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002924|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2002925|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
2002926|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
2002927|NCT01197612|Hormones|hormones|mesh-ancestor
2002928|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2002929|NCT01197833|Polidocanol|polidocanol|mesh-list
2002930|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2002931|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2002932|NCT01198002|Methotrexate|methotrexate|mesh-list
2002933|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2002934|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
2002935|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2002936|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002937|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2002938|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
2002939|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002940|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002941|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
2002942|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002943|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2002944|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002945|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
2002946|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2002947|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2002948|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2002949|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002950|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2002951|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2002952|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2002953|NCT01198132|Vitamin D|vitamin d|mesh-list
2002954|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
2002955|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
2002956|NCT01198132|Vitamins|vitamins|mesh-list
2002957|NCT01198132|Interferons|interferons|mesh-list
2002958|NCT01198132|Interferon-beta|interferon-beta|mesh-list
2002959|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
2002960|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
2002961|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002962|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2002963|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2002964|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002965|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
2002966|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002967|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
2002968|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2002969|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
2002970|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2002971|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2002972|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2002973|NCT01198145|Analgesics|analgesics|mesh-ancestor
2002974|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
2002975|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2002976|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002977|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2002978|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2002979|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2002980|NCT01198158|Bevacizumab|bevacizumab|mesh-list
2002981|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2002982|NCT01198158|Everolimus|everolimus|mesh-list
2002983|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
2002984|NCT01198158|Antibodies|antibodies|mesh-list
2002985|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
2002986|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2002987|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
2002988|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2002989|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2002990|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2002991|NCT01198158|Growth Substances|growth substances|mesh-ancestor
2002992|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2002993|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
2002994|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
2002995|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2002996|NCT01198275|Amiodarone|amiodarone|mesh-list
2002997|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2002998|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
2002999|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2003000|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2003001|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003002|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2003003|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2003004|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2003005|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003006|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2003007|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2003008|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2003009|NCT01198327|Ranibizumab|ranibizumab|mesh-list
2003010|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2003011|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2003012|NCT01198327|Growth Substances|growth substances|mesh-ancestor
2003013|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003014|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
2003015|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003016|NCT01198509|Vancomycin|vancomycin|mesh-list
2003017|NCT01198509|Doxycycline|doxycycline|mesh-list
2003018|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2003019|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2003020|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
2003021|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2003022|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2003023|NCT01198574|Vitamins|vitamins|mesh-list
2003024|NCT01198574|Folic Acid|folic acid|mesh-list
2003025|NCT01198574|Vitamin A|vitamin a|mesh-list
2003026|NCT01198574|Iron|iron|mesh-list
2003027|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
2003028|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
2003029|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003030|NCT01198574|Trace Elements|trace elements|mesh-ancestor
2003031|NCT01198574|Hematinics|hematinics|mesh-ancestor
2003032|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
2003033|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
2003034|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003035|NCT01198574|Protective Agents|protective agents|mesh-ancestor
2003036|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2003037|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003038|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
2003039|NCT01198587|Astringents|astringents|mesh-ancestor
2003040|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003041|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
2003042|NCT01198756|Vaccines|vaccines|mesh-list
2003043|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
2003044|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003045|NCT01198795|Citalopram|citalopram|mesh-list
2003046|NCT01198795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2003047|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2003048|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2003049|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003050|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2003051|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
2003052|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003053|NCT01198795|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2003054|NCT01198795|Antidepressive Agents|antidepressive agents|mesh-ancestor
2003055|NCT01198795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2003056|NCT01198873|Dronedarone|dronedarone|mesh-list
2003057|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2003058|NCT01199055|Paclitaxel|paclitaxel|mesh-list
2003059|NCT01199055|Carboplatin|carboplatin|mesh-list
2003060|NCT01199055|Efatutazone|efatutazone|mesh-list
2003061|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2003062|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003063|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
2003064|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
2003065|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
2003066|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003067|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2003068|NCT01199068|Efatutazone|efatutazone|mesh-list
2003069|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003070|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2003071|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003072|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003073|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
2003074|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003075|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2003076|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003077|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003078|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
2003079|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003080|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003081|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2003082|NCT01199198|Tolvaptan|tolvaptan|mesh-list
2003083|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2003084|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003085|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
2003086|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003087|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
2003088|NCT01199237|Sevoflurane|sevoflurane|mesh-list
2003089|NCT01199237|Desflurane|desflurane|mesh-list
2003090|NCT01199237|Rocuronium|rocuronium|mesh-list
2003091|NCT01199237|Neostigmine|neostigmine|mesh-list
2003092|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2003093|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2003094|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
2003095|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
2003096|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2003097|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003098|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2003099|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2003100|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2003101|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003102|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2003103|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003104|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003105|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
2003106|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2003107|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2003108|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
2003109|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2003110|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2003111|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2003112|NCT01199263|Paclitaxel|paclitaxel|mesh-list
2003113|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2003114|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2003115|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003116|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
2003117|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
2003118|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
2003119|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003120|NCT01199289|Brodalumab|brodalumab|mesh-list
2003121|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
2003122|NCT01199380|Nicotine|nicotine|mesh-list
2003123|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2003124|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
2003125|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003126|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003127|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2003128|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2003129|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
2003130|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2003131|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003132|NCT01199575|Rituximab|rituximab|mesh-list
2003133|NCT01199575|Lenalidomide|lenalidomide|mesh-list
2003134|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2003135|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003136|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
2003137|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003138|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2003139|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2003140|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2003141|NCT01199575|Growth Substances|growth substances|mesh-ancestor
2003142|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
2003143|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
2003144|NCT01199705|Antibodies|antibodies|mesh-list
2003145|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
2003146|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2003147|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2003148|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
2003149|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003150|NCT01199731|Etravirine|etravirine|mesh-list
2003151|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2003152|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2003153|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003154|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003155|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
2003156|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2003157|NCT01199744|Zanamivir|zanamivir|mesh-list
2003158|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
2003159|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2003160|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003161|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003162|NCT01199822|Olaratumab|olaratumab|mesh-list
2003163|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003164|NCT01199861|Vaccines|vaccines|mesh-list
2003165|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2003166|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
2003167|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003168|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2003169|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003170|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2003171|NCT01199926|Vitamin D|vitamin d|mesh-list
2003172|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
2003173|NCT01199926|Vitamins|vitamins|mesh-ancestor
2003174|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
2003175|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003176|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2003177|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2003178|NCT01199939|Ritonavir|ritonavir|mesh-list
2003179|NCT01199939|Darunavir|darunavir|mesh-list
2003180|NCT01199939|Etravirine|etravirine|mesh-list
2003181|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2003182|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2003183|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
2003184|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003185|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003186|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2003187|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2003188|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
2003189|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2003190|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2003191|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2003192|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2003193|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2003194|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
2003195|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2003196|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
2003197|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
2003198|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2003199|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003200|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003201|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2003202|NCT01199965|Analgesics|analgesics|mesh-ancestor
2003203|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
2003204|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003205|NCT01200069|Ibuprofen|ibuprofen|mesh-list
2003206|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2003207|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2003208|NCT01200069|Analgesics|analgesics|mesh-ancestor
2003209|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
2003210|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003211|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003212|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2003213|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2003214|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2003215|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003216|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003217|NCT01200160|Niacin|niacin|mesh-list
2003218|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2003219|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
2003220|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003221|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2003222|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
2003223|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
2003224|NCT01200160|Vitamins|vitamins|mesh-ancestor
2003225|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
2003226|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003227|NCT01200329|Gemcitabine|gemcitabine|mesh-list
2003228|NCT01200329|Melphalan|melphalan|mesh-list
2003229|NCT01200329|Busulfan|busulfan|mesh-list
2003230|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2003231|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
2003232|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003233|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003234|NCT01200329|Antiviral Agents|antiviral agents|mesh-ancestor
2003235|NCT01200329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2003236|NCT01200329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003237|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2003238|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
2003239|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003240|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2003241|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
2003242|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2003243|NCT01200342|Paclitaxel|paclitaxel|mesh-list
2003244|NCT01200342|Carboplatin|carboplatin|mesh-list
2003245|NCT01200342|Oblimersen|oblimersen|mesh-list
2003246|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2003247|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003248|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
2003249|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
2003250|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
2003251|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003252|NCT01200355|Posaconazole|posaconazole|mesh-list
2003253|NCT01200355|Micafungin|micafungin|mesh-list
2003254|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
2003255|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2003256|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2003257|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2003258|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2003259|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2003260|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2003261|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003262|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003263|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2003264|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
2003265|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003266|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003267|NCT01200368|Vaccines|vaccines|mesh-list
2003268|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2003269|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
2003270|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003271|NCT01200407|Amlodipine|amlodipine|mesh-list
2003272|NCT01200407|Olmesartan|olmesartan|mesh-list
2003273|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2003274|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2003275|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2003276|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2003277|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003278|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2003279|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003280|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
2003281|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2003282|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2003283|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
2003284|NCT01200433|Propofol|propofol|mesh-list
2003285|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2003286|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2003287|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003288|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2003289|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
2003290|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
2003291|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2003292|NCT01200433|Analgesics|analgesics|mesh-ancestor
2003293|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
2003294|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003295|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2003296|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2003297|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2003298|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
2003299|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2003300|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003301|NCT01200485|Allopurinol|allopurinol|mesh-list
2003302|NCT01200485|Rasburicase|rasburicase|mesh-list
2003303|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
2003304|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003305|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003306|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
2003307|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2003308|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2003309|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
2003310|NCT01200485|Protective Agents|protective agents|mesh-ancestor
2003311|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003312|NCT01200589|Rituximab|rituximab|mesh-list
2003313|NCT01200589|Ofatumumab|ofatumumab|mesh-list
2003314|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2003315|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2003316|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003317|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
2003318|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003319|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2003320|NCT01200758|Prednisone|prednisone|mesh-list
2003321|NCT01200758|Prednisolone|prednisolone|mesh-list
2003322|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
2003323|NCT01200758|Rituximab|rituximab|mesh-list
2003324|NCT01200758|Doxorubicin|doxorubicin|mesh-list
2003325|NCT01200758|Vincristine|vincristine|mesh-list
2003326|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2003327|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
2003328|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003329|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2003330|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2003331|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
2003332|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003333|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003334|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2003335|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2003336|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2003337|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2003338|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2003339|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003340|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2003341|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
2003342|NCT01200758|Hormones|hormones|mesh-ancestor
2003343|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003344|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2003345|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2003346|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
2003347|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
2003348|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
2003349|NCT01200810|Bicalutamide|bicalutamide|mesh-list
2003350|NCT01200810|R04929097|r04929097|mesh-list
2003351|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
2003352|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
2079359|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003353|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003354|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003355|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003356|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003357|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003358|NCT01200992|Mitomycins|mitomycins|mesh-list
2003359|NCT01200992|Mitomycin|mitomycin|mesh-list
2003360|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2003361|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003362|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
2003363|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003364|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2003365|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003366|NCT01201265|Gemcitabine|gemcitabine|mesh-list
2003367|NCT01201265|Bevacizumab|bevacizumab|mesh-list
2003368|NCT01201265|Carboplatin|carboplatin|mesh-list
2003369|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2003370|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003371|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2003372|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2003373|NCT01201265|Growth Substances|growth substances|mesh-ancestor
2003374|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003375|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
2003376|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2003377|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
2003378|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003379|NCT01201265|Antiviral Agents|antiviral agents|mesh-ancestor
2003380|NCT01201265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2003381|NCT01201265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003382|NCT01201265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2003383|NCT01201265|Immunologic Factors|immunologic factors|mesh-ancestor
2003384|NCT01201343|Interferons|interferons|mesh-list
2003385|NCT01201343|Interferon-beta|interferon-beta|mesh-list
2003386|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
2003387|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003388|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
2003389|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2003390|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
2003391|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003392|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2003393|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2003394|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2003395|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003396|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2003397|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
2003398|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003399|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2003400|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
2003401|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2003402|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2003403|NCT01201759|Analgesics|analgesics|mesh-ancestor
2003404|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
2003405|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003406|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003407|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2003408|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2003409|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2003410|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003411|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003412|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2003413|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2003414|NCT01201785|Aspirin|aspirin|mesh-list
2003415|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2003416|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2003417|NCT01201785|Analgesics|analgesics|mesh-ancestor
2003418|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
2003419|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003420|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003421|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2003422|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2003423|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2003424|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2003425|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003426|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2003427|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2003428|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003429|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
2003430|NCT01201798|Prednisolone|prednisolone|mesh-list
2003431|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2003432|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
2003433|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2003434|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
2003435|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2003436|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
2003437|NCT01201798|Difluprednate|difluprednate|mesh-list
2003438|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2003439|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
2003440|NCT01201798|Hormones|hormones|mesh-ancestor
2003441|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003442|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003443|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2003444|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003445|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
2003446|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
2003447|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003448|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2003449|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2003450|NCT01201798|Protective Agents|protective agents|mesh-ancestor
2003451|NCT01201811|Azacitidine|azacitidine|mesh-list
2003452|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2003453|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
2003454|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003455|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003456|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003457|NCT01201850|Bevacizumab|bevacizumab|mesh-list
2003458|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2003459|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003460|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2003461|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2003462|NCT01201850|Growth Substances|growth substances|mesh-ancestor
2003463|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003464|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
2003465|NCT01201863|Testosterone|testosterone|mesh-list
2003466|NCT01201863|Androgens|androgens|mesh-ancestor
2003467|NCT01201863|Hormones|hormones|mesh-ancestor
2003468|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003469|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003470|NCT01202071|Rabeprazole|rabeprazole|mesh-list
2003471|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2003472|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2003473|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2003474|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003475|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003476|NCT01202162|Sevoflurane|sevoflurane|mesh-list
2003477|NCT01202162|Desflurane|desflurane|mesh-list
2003478|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2003479|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2003480|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
2003481|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
2003482|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2003483|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003484|NCT01202175|Nebivolol|nebivolol|mesh-list
2003485|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2003486|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
2003487|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2003488|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2003489|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2003490|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
2003491|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2003492|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003493|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003494|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
2003495|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
2003496|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2003497|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
2003498|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003499|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003500|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2003501|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
2003502|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
2003503|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2003504|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
2003505|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2003506|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003507|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2003508|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2003509|NCT01202227|Pregabalin|pregabalin|mesh-list
2003510|NCT01202227|Analgesics|analgesics|mesh-ancestor
2003511|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
2003512|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003513|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003514|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
2003515|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2003516|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2003517|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003518|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2003519|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2003520|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2003521|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2003522|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2003523|NCT01202253|Anidulafungin|anidulafungin|mesh-list
2003524|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
2003525|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2003526|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
2003527|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
2003528|NCT01202279|Guaifenesin|guaifenesin|mesh-list
2003529|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2003530|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2003531|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
2003532|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003533|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003534|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2003535|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
2003536|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
2003537|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2003538|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
2003539|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
2003540|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2003541|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003542|NCT01202279|Expectorants|expectorants|mesh-ancestor
2003543|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2003544|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2003545|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
2003546|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2003547|NCT01202409|Panitumumab|panitumumab|mesh-list
2003548|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2003549|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003550|NCT01202591|Fulvestrant|fulvestrant|mesh-list
2003551|NCT01202591|Exemestane|exemestane|mesh-list
2003552|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2003553|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003554|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2003555|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2003556|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
2003557|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003558|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003559|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2003560|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2003561|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003562|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003563|NCT01202643|Lenograstim|lenograstim|mesh-list
2003564|NCT01202643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2003565|NCT01202643|Immunologic Factors|immunologic factors|mesh-ancestor
2003566|NCT01202643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003567|NCT01202656|Lenograstim|lenograstim|mesh-list
2003568|NCT01202656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2003569|NCT01202656|Immunologic Factors|immunologic factors|mesh-ancestor
2003570|NCT01202656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003571|NCT01202721|Atenolol|atenolol|mesh-list
2003572|NCT01202721|Telmisartan|telmisartan|mesh-list
2003573|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2003574|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2003575|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2003576|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003577|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2003578|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
2003579|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
2003580|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003581|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003582|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2003583|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2003584|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2003585|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
2003586|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2003587|NCT01202877|Azacitidine|azacitidine|mesh-list
2003588|NCT01202877|Midostaurin|midostaurin|mesh-list
2003589|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2003590|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
2003591|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003592|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003593|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003594|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2003595|NCT01202903|Omalizumab|omalizumab|mesh-list
2003596|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2003597|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2003598|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
2003599|NCT01202955|Tolcapone|tolcapone|mesh-list
2003600|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2003601|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2003602|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2003603|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003604|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003605|NCT01202994|Flutemetamol|flutemetamol|mesh-list
2003606|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2003607|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003608|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2003609|NCT01203046|Ertapenem|ertapenem|mesh-list
2003610|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2003611|NCT01203072|Edoxaban|edoxaban|mesh-list
2003612|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2003613|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
2003614|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2003615|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
2003616|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003617|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003618|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
2003619|NCT01203098|Enoxaparin|enoxaparin|mesh-list
2003620|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
2003621|NCT01203098|Edoxaban|edoxaban|mesh-list
2003622|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
2003623|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2003624|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2003625|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003626|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2003627|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
2003628|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2003629|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
2003630|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003631|NCT01203189|Ketoconazole|ketoconazole|mesh-list
2003632|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
2003633|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2003634|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2003635|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2003636|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003637|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003638|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2003639|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
2003640|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003641|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003642|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2003643|NCT01203319|Vaccines|vaccines|mesh-list
2003644|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
2003645|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003646|NCT01203644|Bupivacaine|bupivacaine|mesh-list
2003647|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
2003648|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
2003649|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2003650|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003651|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
2003652|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003653|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
2003654|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2003655|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003656|NCT01203787|Sorafenib|sorafenib|mesh-list
2003657|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003658|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2003659|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003660|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003661|NCT01203852|Metoprolol|metoprolol|mesh-list
2003662|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
2003663|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2003664|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2003665|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
2003666|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
2003667|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003668|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003669|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2003670|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2003671|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2003672|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
2003673|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2003674|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003675|NCT01203852|Diuretics|diuretics|mesh-ancestor
2003676|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
2003677|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2003678|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2003679|NCT01203878|Imiquimod|imiquimod|mesh-list
2003680|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2003681|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2003682|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
2003683|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003684|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003685|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
2003686|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2003687|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
2003688|NCT01203917|Gefitinib|gefitinib|mesh-list
2003689|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003690|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2003691|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003692|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003693|NCT01203930|Rituximab|rituximab|mesh-list
2003694|NCT01203930|Idelalisib|idelalisib|mesh-list
2003695|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2003696|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003697|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
2003698|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003699|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2003700|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003701|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003702|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
2003703|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2003704|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003705|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
2003706|NCT01204255|Promethazine|promethazine|mesh-list
2003707|NCT01204255|Lorazepam|lorazepam|mesh-list
2003708|NCT01204255|Haloperidol|haloperidol|mesh-list
2003709|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
2003710|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2003711|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2003712|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2003713|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003714|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
2003715|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
2003716|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
2003717|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003718|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
2003719|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
2003720|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2003721|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2003722|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
2003723|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
2003724|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079360|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2003725|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003726|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2003727|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
2003728|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
2003729|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2003730|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2003731|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2003732|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2003733|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
2003734|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2003735|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
2003736|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2003737|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
2003738|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
2003739|NCT01204294|Metformin|metformin|mesh-list
2003740|NCT01204294|Linagliptin|linagliptin|mesh-list
2003741|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2003742|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003743|NCT01204294|Incretins|incretins|mesh-ancestor
2003744|NCT01204294|Hormones|hormones|mesh-ancestor
2003745|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003746|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2003747|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
2003748|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003749|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003750|NCT01204398|Amlodipine|amlodipine|mesh-list
2003751|NCT01204398|Telmisartan|telmisartan|mesh-list
2003752|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2003753|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2003754|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2003755|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2003756|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003757|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2003758|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003759|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
2003760|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2003761|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2003762|NCT01204658|Vaccines|vaccines|mesh-list
2003763|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2003764|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
2003765|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003766|NCT01204671|Vaccines|vaccines|mesh-list
2003767|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
2003768|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003769|NCT01204697|Docetaxel|docetaxel|mesh-list
2003770|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2003771|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003772|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
2003773|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
2003774|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
2003775|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003776|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2003777|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003778|NCT01204710|Prednisone|prednisone|mesh-list
2003779|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
2003780|NCT01204710|Olaratumab|olaratumab|mesh-list
2003781|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2003782|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
2003783|NCT01204710|Hormones|hormones|mesh-ancestor
2003784|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003785|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003786|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2003787|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003788|NCT01204710|Analgesics|analgesics|mesh-ancestor
2003789|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
2003790|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003791|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2003792|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2003793|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003794|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003795|NCT01204775|Metformin|metformin|mesh-list
2003796|NCT01204775|Saxagliptin|saxagliptin|mesh-list
2003797|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2003798|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003799|NCT01204775|Incretins|incretins|mesh-ancestor
2003800|NCT01204775|Hormones|hormones|mesh-ancestor
2003801|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003802|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2003803|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
2003804|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003805|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003806|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
2003807|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2003808|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003809|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
2003810|NCT01204905|Maraviroc|maraviroc|mesh-list
2003811|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2003812|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2003813|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
2003814|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2003815|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2003816|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2003817|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003818|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003819|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2003820|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2003821|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2003822|NCT01204918|Riluzole|riluzole|mesh-list
2003823|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
2003824|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2003825|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2003826|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2003827|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003828|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003829|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2003830|NCT01204918|Protective Agents|protective agents|mesh-ancestor
2003831|NCT01205035|Ranibizumab|ranibizumab|mesh-list
2003832|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2003833|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2003834|NCT01205035|Growth Substances|growth substances|mesh-ancestor
2003835|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003836|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
2003837|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003838|NCT01205126|Oxycodone|oxycodone|mesh-list
2003839|NCT01205126|Hydromorphone|hydromorphone|mesh-list
2003840|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2003841|NCT01205126|Narcotics|narcotics|mesh-ancestor
2003842|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2003843|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003844|NCT01205126|Analgesics|analgesics|mesh-ancestor
2003845|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
2003846|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003847|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
2003848|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2003849|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2003850|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2003851|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2003852|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003853|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
2003854|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2003855|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003856|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2003857|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003858|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
2003859|NCT01205503|Doxorubicin|doxorubicin|mesh-list
2003860|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2003861|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
2003862|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003863|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2003864|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2003865|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
2003866|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003867|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003868|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2003869|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2003870|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2003871|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2003872|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003873|NCT01205529|Procainamide|procainamide|mesh-list
2003874|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2003875|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2003876|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2003877|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2003878|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003879|NCT01205581|Vaccines|vaccines|mesh-list
2003880|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
2003881|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003882|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
2003883|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2003884|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003885|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2003886|NCT01205685|Letrozole|letrozole|mesh-list
2003887|NCT01205685|Goserelin|goserelin|mesh-list
2003888|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003889|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2003890|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003891|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003892|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2003893|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2003894|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2003895|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
2003896|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003897|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003898|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2003899|NCT01205828|Temozolomide|temozolomide|mesh-list
2003900|NCT01205828|Veliparib|veliparib|mesh-list
2003901|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2003902|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
2003903|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003904|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003905|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2003906|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2003907|NCT01206140|Sirolimus|sirolimus|mesh-list
2003908|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2003909|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2003910|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2003911|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003912|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
2003913|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2003914|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
2003915|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003916|NCT01206322|Insulin|insulin|mesh-list
2003917|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2003918|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003919|NCT01206387|Desoximetasone|desoximetasone|mesh-list
2003920|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2003921|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
2003922|NCT01206387|Hormones|hormones|mesh-ancestor
2003923|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003924|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003925|NCT01206452|Prednisone|prednisone|mesh-list
2003926|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2003927|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
2003928|NCT01206452|Hormones|hormones|mesh-ancestor
2003929|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003930|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003931|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2003932|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003933|NCT01206465|Fluorouracil|fluorouracil|mesh-list
2003934|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
2003935|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003936|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2003937|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003938|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2003939|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
2003940|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003941|NCT01206478|Megestrol|megestrol|mesh-list
2003942|NCT01206478|Amitriptyline|amitriptyline|mesh-list
2003943|NCT01206478|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2003944|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2003945|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
2003946|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2003947|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2003948|NCT01206478|Analgesics|analgesics|mesh-ancestor
2003949|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
2003950|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003951|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003952|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2003953|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2003954|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2003955|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2003956|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
2003957|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2003958|NCT01206478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2003959|NCT01206478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2003960|NCT01206478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2003961|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2003962|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2003963|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2003964|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
2003965|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2003966|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2003967|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2003968|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2003969|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003970|NCT01206517|Asenapine|asenapine|mesh-list
2003971|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2003972|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2003973|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2003974|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003975|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2003976|NCT01206595|Bupivacaine|bupivacaine|mesh-list
2003977|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
2003978|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
2003979|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2003980|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003981|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
2003982|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003983|NCT01206608|Bupivacaine|bupivacaine|mesh-list
2003984|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
2003985|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
2003986|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2003987|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003988|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
2003989|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2003990|NCT01206660|Desoximetasone|desoximetasone|mesh-list
2003991|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2003992|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
2003993|NCT01206660|Hormones|hormones|mesh-ancestor
2003994|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2003995|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2003996|NCT01206764|Everolimus|everolimus|mesh-list
2003997|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2003998|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2003999|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
2004000|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004001|NCT01206777|Rituximab|rituximab|mesh-list
2004002|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2004003|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004004|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
2004005|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004006|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2004007|NCT01206816|Afatinib|afatinib|mesh-list
2004008|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004009|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2004010|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004011|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004012|NCT01207388|Blinatumomab|blinatumomab|mesh-list
2004013|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004014|NCT01207401|Lidocaine|lidocaine|mesh-list
2004015|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
2004016|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
2004017|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2004018|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004019|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
2004020|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004021|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2004022|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2004023|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2004024|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2004025|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004026|NCT01207414|Iloperidone|iloperidone|mesh-list
2004027|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2004028|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2004029|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2004030|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004031|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2004032|NCT01207440|Ponatinib|ponatinib|mesh-list
2004033|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004034|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2004035|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004036|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004037|NCT01207453|Milnacipran|milnacipran|mesh-list
2004038|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
2004039|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2004040|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2004041|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2004042|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004043|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004044|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004045|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2004046|NCT01207453|Analgesics|analgesics|mesh-ancestor
2004047|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
2004048|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004049|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
2004050|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2004051|NCT01207596|Hydromorphone|hydromorphone|mesh-list
2004052|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2004053|NCT01207596|Narcotics|narcotics|mesh-ancestor
2004054|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2004055|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004056|NCT01207596|Analgesics|analgesics|mesh-ancestor
2004057|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
2004058|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004059|NCT01207687|Bevacizumab|bevacizumab|mesh-list
2004060|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2004061|NCT01207687|Antibodies|antibodies|mesh-list
2004062|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
2004063|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2004064|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004065|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2004066|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2004067|NCT01207687|Growth Substances|growth substances|mesh-ancestor
2004068|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004069|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
2004070|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
2004071|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2004072|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
2004073|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2004074|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2004075|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
2004076|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004077|NCT01207908|Mecasermin|mecasermin|mesh-list
2004078|NCT01207908|Growth Substances|growth substances|mesh-ancestor
2004079|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004080|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
2004081|NCT01208038|Testosterone|testosterone|mesh-list
2004082|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
2004083|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
2004084|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2004085|NCT01208038|Androgens|androgens|mesh-ancestor
2004086|NCT01208038|Hormones|hormones|mesh-ancestor
2004087|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2004088|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004089|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2004090|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004091|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
2004092|NCT01208051|Lenalidomide|lenalidomide|mesh-list
2004093|NCT01208051|Cediranib|cediranib|mesh-list
2004094|NCT01208051|Maleic acid|maleic acid|mesh-list
2004095|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
2004096|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004097|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2004098|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2004099|NCT01208051|Growth Substances|growth substances|mesh-ancestor
2004100|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
2004101|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004102|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004103|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004104|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2004105|NCT01208103|Bevacizumab|bevacizumab|mesh-list
2004106|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2004107|NCT01208103|Capecitabine|capecitabine|mesh-list
2004108|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
2004109|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
2004110|NCT01208103|Antibodies|antibodies|mesh-list
2004111|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
2004112|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2004113|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
2004114|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004115|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2004116|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2004117|NCT01208103|Growth Substances|growth substances|mesh-ancestor
2004118|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004119|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
2004120|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
2004121|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2004122|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
2004123|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004124|NCT01208181|Etoricoxib|etoricoxib|mesh-list
2004125|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2004126|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2004127|NCT01208181|Analgesics|analgesics|mesh-ancestor
2004128|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
2004129|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004130|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004131|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2004132|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2004133|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2004134|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2004135|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004136|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004137|NCT01208207|Naproxen|naproxen|mesh-list
2004138|NCT01208207|Etoricoxib|etoricoxib|mesh-list
2004139|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2004140|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2004141|NCT01208207|Analgesics|analgesics|mesh-ancestor
2004142|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
2004143|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004144|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004145|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2004146|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2004147|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
2004148|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2004149|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004150|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004151|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2004152|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
2004153|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2004154|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2004155|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004156|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004157|NCT01208324|Estrogens|estrogens|mesh-list
2004158|NCT01208324|Hormones|hormones|mesh-ancestor
2004159|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2004160|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004161|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
2004162|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2004163|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004164|NCT01208402|Esmolol|esmolol|mesh-list
2004165|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2004166|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2004167|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2004168|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
2004169|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004170|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004171|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004172|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
2004173|NCT01208922|Rifamycins|rifamycins|mesh-list
2004174|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
2004175|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2004176|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004177|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2004178|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2004179|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004180|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004181|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004182|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2004183|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2004184|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2004185|NCT01209078|Linezolid|linezolid|mesh-list
2004186|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2004187|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004188|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2004189|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004190|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004191|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
2004192|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2004193|NCT01209143|Norethindrone|norethindrone|mesh-list
2004194|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
2004195|NCT01209143|Estradiol|estradiol|mesh-list
2004196|NCT01209143|Estrogens|estrogens|mesh-ancestor
2004197|NCT01209143|Hormones|hormones|mesh-ancestor
2004198|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2004199|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004200|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2004201|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
2004202|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2004203|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2004204|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2004205|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2004206|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2004207|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2004208|NCT01209195|Paclitaxel|paclitaxel|mesh-list
2004209|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2004210|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004211|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
2004212|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
2004213|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
2004214|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004215|NCT01209286|Blinatumomab|blinatumomab|mesh-list
2004216|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004217|NCT01209442|Bevacizumab|bevacizumab|mesh-list
2004218|NCT01209442|Temozolomide|temozolomide|mesh-list
2004219|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2004220|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004221|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2004222|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2004223|NCT01209442|Growth Substances|growth substances|mesh-ancestor
2004224|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004225|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
2004226|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2004227|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
2004228|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004229|NCT01209598|Palbociclib|palbociclib|mesh-list
2004230|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004231|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2004232|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004233|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004234|NCT01209832|Midazolam|midazolam|mesh-list
2004235|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2004236|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2004237|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2004238|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004239|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2004240|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2004241|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2004242|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2004243|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
2004244|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
2004245|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
2004246|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
2004247|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004248|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004249|NCT01209949|Adapalene|adapalene|mesh-list
2004250|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2004251|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
2004252|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2004253|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2004254|NCT01209949|Analgesics|analgesics|mesh-ancestor
2004255|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
2004256|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004257|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004258|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2004259|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2004260|NCT01210001|Empagliflozin|empagliflozin|mesh-list
2004261|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2004262|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004263|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2004264|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004265|NCT01210079|Gabapentin|gabapentin|mesh-list
2004266|NCT01210079|Analgesics|analgesics|mesh-ancestor
2004267|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
2004268|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004269|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004270|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
2004271|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2004272|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2004273|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2004274|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2004275|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2004276|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2004277|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004278|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004279|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
2004280|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2004281|NCT01210144|Hormones|hormones|mesh-list
2004282|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2004283|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2004284|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004285|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2004286|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
2004287|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2004288|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
2004289|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2004290|NCT01210222|Trebananib|trebananib|mesh-list
2004291|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2004292|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2004293|NCT01210222|Growth Substances|growth substances|mesh-ancestor
2004294|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004295|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
2004296|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004297|NCT01210352|Oxymorphone|oxymorphone|mesh-list
2004298|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2004299|NCT01210352|Narcotics|narcotics|mesh-ancestor
2004300|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2004301|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004302|NCT01210352|Analgesics|analgesics|mesh-ancestor
2004303|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
2004304|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004305|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2004306|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
2004307|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2004308|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004309|NCT01210495|Axitinib|axitinib|mesh-list
2004310|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004311|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2004312|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004313|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004314|NCT01210560|Tolvaptan|tolvaptan|mesh-list
2004315|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2004316|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004317|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
2004318|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004319|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
2004320|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
2004321|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2004322|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2004323|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
2004324|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004325|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004326|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004327|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004328|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2004329|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004330|NCT01211197|Metformin|metformin|mesh-list
2004331|NCT01211197|Empagliflozin|empagliflozin|mesh-list
2004332|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2004333|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004334|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2004335|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004336|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2004337|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004338|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2004339|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004340|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004341|NCT01211522|Haloperidol|haloperidol|mesh-list
2004342|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
2004343|NCT01211522|Ziprasidone|ziprasidone|mesh-list
2004344|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
2004345|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
2004346|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004347|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004348|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2004349|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2004350|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2004351|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2004352|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2004353|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2004354|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
2004355|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004356|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004357|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2004358|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2004359|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
2004360|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2004361|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
2004362|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2004363|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2004364|NCT01211665|Prednisolone|prednisolone|mesh-list
2004365|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
2004366|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2004367|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
2004368|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2004369|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
2004370|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
2004371|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004372|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004373|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2004374|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
2004375|NCT01211665|Hormones|hormones|mesh-ancestor
2004376|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2004377|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2004378|NCT01211665|Protective Agents|protective agents|mesh-ancestor
2004379|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2004380|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004381|NCT01211730|Insulin|insulin|mesh-list
2004382|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2004383|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2004384|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004385|NCT01211769|Naltrexone|naltrexone|mesh-list
2004386|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2004387|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2004388|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004389|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
2004390|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004391|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2004392|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
2004393|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
2004394|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004395|NCT01212094|Rituximab|rituximab|mesh-list
2004396|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2004397|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004398|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
2004399|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004400|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2004401|NCT01212185|Oxytocin|oxytocin|mesh-list
2004402|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
2004403|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2004404|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004405|NCT01212302|Aspirin|aspirin|mesh-list
2004406|NCT01212302|Clopidogrel|clopidogrel|mesh-list
2004407|NCT01212302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2004408|NCT01212302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2004409|NCT01212302|Analgesics|analgesics|mesh-ancestor
2004410|NCT01212302|Sensory System Agents|sensory system agents|mesh-ancestor
2004411|NCT01212302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004412|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004413|NCT01212302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2004414|NCT01212302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2004415|NCT01212302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2004416|NCT01212302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2004417|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004418|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2004419|NCT01212302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2004420|NCT01212302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004421|NCT01212302|Antipyretics|antipyretics|mesh-ancestor
2004422|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2004423|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2004424|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2004425|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
2004426|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004427|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2004428|NCT01212445|Laxatives|laxatives|mesh-list
2004429|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2004430|NCT01212471|Bromfenac|bromfenac|mesh-list
2004431|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2004432|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2004433|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2004434|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2004435|NCT01212471|Analgesics|analgesics|mesh-ancestor
2004436|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
2004437|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004438|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004439|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2004440|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2004441|NCT01212484|Carbidopa|carbidopa|mesh-list
2004442|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2004443|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2004444|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
2004445|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004446|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004447|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004448|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2004449|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004450|NCT01212588|Mifepristone|mifepristone|mesh-list
2004451|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2004452|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
2004453|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2004454|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004455|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2004456|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2004457|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2004458|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
2004459|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2004460|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2004461|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
2004462|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2004463|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
2004464|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2004465|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2004466|NCT01212757|Thalidomide|thalidomide|mesh-list
2004467|NCT01212757|Apremilast|apremilast|mesh-list
2004468|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2004469|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2004470|NCT01212757|Analgesics|analgesics|mesh-ancestor
2004471|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
2004472|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004473|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004474|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2004475|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2004476|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2004477|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2004478|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004479|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004480|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2004481|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
2004482|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
2004483|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2004484|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004485|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2004486|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2004487|NCT01212757|Growth Substances|growth substances|mesh-ancestor
2004488|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
2004489|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004490|NCT01212770|Thalidomide|thalidomide|mesh-list
2004491|NCT01212770|Apremilast|apremilast|mesh-list
2004492|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2004493|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2004494|NCT01212770|Analgesics|analgesics|mesh-ancestor
2004495|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
2004496|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004497|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004498|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2004499|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2004500|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2004501|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2004502|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004503|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004504|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2004505|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
2004506|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
2004507|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2004508|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004509|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2004510|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2004511|NCT01212770|Growth Substances|growth substances|mesh-ancestor
2004512|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
2004513|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004514|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
2004515|NCT01212874|Esmolol|esmolol|mesh-list
2004516|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
2004517|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2004518|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2004519|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2004520|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
2004521|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004522|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004523|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004524|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2004525|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2004526|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2004527|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
2004528|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004529|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004530|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2004531|NCT01212952|Dexamethasone|dexamethasone|mesh-list
2004532|NCT01212952|Bortezomib|bortezomib|mesh-list
2004533|NCT01212952|Pomalidomide|pomalidomide|mesh-list
2004534|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2004535|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
2004536|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
2004537|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004538|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004539|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2004540|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
2004541|NCT01212952|Hormones|hormones|mesh-ancestor
2004542|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2004543|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2004544|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004545|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
2004546|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2004547|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2004548|NCT01212952|Growth Substances|growth substances|mesh-ancestor
2004549|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
2004550|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
2004551|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2004552|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004553|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004554|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2004555|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2004556|NCT01213082|Bevacizumab|bevacizumab|mesh-list
2004557|NCT01213082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2004558|NCT01213082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004559|NCT01213082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2004560|NCT01213082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2004561|NCT01213082|Growth Substances|growth substances|mesh-ancestor
2004562|NCT01213082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004563|NCT01213082|Growth Inhibitors|growth inhibitors|mesh-ancestor
2004564|NCT01213173|Metoprolol|metoprolol|mesh-list
2004565|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2004566|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2004567|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
2004568|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
2004569|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004570|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004571|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2004572|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2004573|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2004574|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
2004575|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004576|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004577|NCT01213199|Adapalene|adapalene|mesh-list
2004578|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2004579|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2004580|NCT01213199|Analgesics|analgesics|mesh-ancestor
2004581|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
2004582|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004583|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004584|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2004585|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2004586|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
2004587|NCT01213264|Anesthetics|anesthetics|mesh-list
2004588|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2004589|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004590|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
2004591|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2004592|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2004593|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
2004594|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004595|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2004596|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2004597|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004598|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004599|NCT01213524|Nicotine|nicotine|mesh-list
2004600|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2004601|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
2004602|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004603|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004604|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2004605|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2004606|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
2004607|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004608|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004609|NCT01213576|Ivermectin|ivermectin|mesh-list
2004610|NCT01213576|Albendazole|albendazole|mesh-list
2004611|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2004612|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004613|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
2004614|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
2004615|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2004616|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2004617|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
2004618|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
2004619|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
2004620|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004621|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004622|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2004623|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
2004624|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2004625|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2004626|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2004627|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2004628|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004629|NCT01213966|Artefenomel|artefenomel|mesh-list
2004630|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
2004631|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2004632|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2004633|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004634|NCT01214044|Dexetimide|dexetimide|mesh-list
2004635|NCT01214044|Citalopram|citalopram|mesh-list
2004636|NCT01214044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2004637|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2004638|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2004639|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004640|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004641|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
2004642|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004643|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2004644|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
2004645|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2004646|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2004647|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2004648|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
2004649|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
2004650|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004651|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2004652|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2004653|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
2004654|NCT01214057|Remifentanil|remifentanil|mesh-list
2004655|NCT01214057|Propofol|propofol|mesh-list
2004656|NCT01214057|Sevoflurane|sevoflurane|mesh-list
2004657|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2004658|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2004659|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004660|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2004661|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
2004662|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
2004663|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2004664|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2004665|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2004666|NCT01214057|Narcotics|narcotics|mesh-ancestor
2004667|NCT01214057|Analgesics|analgesics|mesh-ancestor
2004668|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
2004669|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004670|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
2004671|NCT01214083|Naltrexone|naltrexone|mesh-list
2004672|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2004673|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2004674|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2004675|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004676|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
2004677|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004678|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
2004679|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004680|NCT01214083|Expectorants|expectorants|mesh-ancestor
2004681|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
2004682|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2004683|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
2004684|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004685|NCT01214083|Protective Agents|protective agents|mesh-ancestor
2004686|NCT01214083|Antidotes|antidotes|mesh-ancestor
2004687|NCT01214109|Pramipexole|pramipexole|mesh-list
2004688|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
2004689|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004690|NCT01214109|Protective Agents|protective agents|mesh-ancestor
2004691|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004692|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2004693|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2004694|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
2004695|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
2004696|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004697|NCT01214161|Lidocaine|lidocaine|mesh-list
2004698|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
2004699|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
2004700|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2004701|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004702|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
2004703|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004704|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2004705|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2004706|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2004707|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2004708|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004709|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
2004710|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
2004711|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004712|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
2004713|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004714|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004715|NCT01214239|Linagliptin|linagliptin|mesh-list
2004716|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2004717|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004718|NCT01214239|Incretins|incretins|mesh-ancestor
2004719|NCT01214239|Hormones|hormones|mesh-ancestor
2004720|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2004721|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2004722|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
2004723|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004724|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004725|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
2004726|NCT01214317|Analgesics|analgesics|mesh-ancestor
2004727|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
2004728|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004729|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004730|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004731|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2004732|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2004733|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004734|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004735|NCT01214356|Vitamin D|vitamin d|mesh-list
2004736|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
2004737|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
2004738|NCT01214356|Vitamins|vitamins|mesh-list
2004739|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
2004740|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004741|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2004742|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2004743|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
2004744|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2004745|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004746|NCT01214421|Tolvaptan|tolvaptan|mesh-list
2004747|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2004748|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004749|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
2004750|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004751|NCT01214434|Emollients|emollients|mesh-list
2004752|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
2004753|NCT01214616|Vinorelbine|vinorelbine|mesh-list
2004754|NCT01214616|Afatinib|afatinib|mesh-list
2004755|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2004756|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004757|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
2004758|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
2004759|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
2004760|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004761|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2004762|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004763|NCT01214668|Doxorubicin|doxorubicin|mesh-list
2004764|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2004765|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2004766|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004767|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2004768|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2004769|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004770|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004771|NCT01214720|Bevacizumab|bevacizumab|mesh-list
2004772|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2004773|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004774|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2004775|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2004776|NCT01214720|Growth Substances|growth substances|mesh-ancestor
2004777|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004778|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
2004779|NCT01214759|Tenofovir|tenofovir|mesh-list
2004780|NCT01214759|Emtricitabine|emtricitabine|mesh-list
2004781|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
2004782|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2004783|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
2004784|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004785|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2004786|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2004787|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004788|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004789|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2004790|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2004791|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2004792|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2004793|NCT01214850|Vaccines|vaccines|mesh-list
2004794|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
2004795|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004796|NCT01214915|Anagrelide|anagrelide|mesh-list
2004797|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2004798|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2004799|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004800|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2004801|NCT01215032|Metformin|metformin|mesh-list
2004802|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2004803|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004804|NCT01215097|Linagliptin|linagliptin|mesh-list
2004805|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2004806|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004807|NCT01215097|Incretins|incretins|mesh-ancestor
2004808|NCT01215097|Hormones|hormones|mesh-ancestor
2004809|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2004810|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2004811|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
2004812|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004813|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004814|NCT01215110|Bedaquiline|bedaquiline|mesh-list
2004815|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
2004816|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2004817|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004818|NCT01215123|Bevacizumab|bevacizumab|mesh-list
2004819|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2004820|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004821|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2004822|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2004823|NCT01215123|Growth Substances|growth substances|mesh-ancestor
2004824|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004825|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
2004826|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2004827|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
2004828|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004829|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2004830|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
2004831|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004832|NCT01215227|Rasagiline|rasagiline|mesh-list
2004833|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2004834|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004835|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004836|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2004837|NCT01215227|Protective Agents|protective agents|mesh-ancestor
2004838|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004839|NCT01215253|Ranolazine|ranolazine|mesh-list
2004840|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2004841|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2004842|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004843|NCT01215292|Ketoconazole|ketoconazole|mesh-list
2004844|NCT01215292|Anastrozole|anastrozole|mesh-list
2004845|NCT01215292|Testosterone|testosterone|mesh-list
2004846|NCT01215292|Dutasteride|dutasteride|mesh-list
2004847|NCT01215292|Acyline|acyline|mesh-list
2004848|NCT01215292|Androgens|androgens|mesh-ancestor
2004849|NCT01215292|Hormones|hormones|mesh-ancestor
2004850|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2004851|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004852|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2004853|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004854|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2004855|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2004856|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004857|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004858|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2004859|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
2004860|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
2004861|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004862|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2004863|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2004864|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2004865|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2004866|NCT01215318|Silicon|silicon|mesh-list
2004867|NCT01215318|Trace Elements|trace elements|mesh-ancestor
2004868|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
2004869|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004870|NCT01215344|Diphosphonates|diphosphonates|mesh-list
2004871|NCT01215344|Dexamethasone|dexamethasone|mesh-list
2004872|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
2004873|NCT01215344|Doxorubicin|doxorubicin|mesh-list
2004874|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2004875|NCT01215344|Lenalidomide|lenalidomide|mesh-list
2004876|NCT01215344|Bortezomib|bortezomib|mesh-list
2004877|NCT01215344|BB 1101|bb 1101|mesh-list
2004878|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2004879|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
2004880|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
2004881|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004882|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004883|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2004884|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
2004885|NCT01215344|Hormones|hormones|mesh-ancestor
2004886|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2004887|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2004888|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004889|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
2004890|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004891|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004892|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2004893|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2004894|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2004895|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
2004896|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2004897|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2004898|NCT01215344|Growth Substances|growth substances|mesh-ancestor
2004899|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
2004900|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2004901|NCT01215357|Ecopipam|ecopipam|mesh-list
2004902|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2004903|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2004904|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2004905|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004906|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2004907|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2004908|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
2004909|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004910|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004911|NCT01215435|Insulin|insulin|mesh-list
2004912|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2004913|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
2004914|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
2004915|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2004916|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
2004917|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2004918|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
2004919|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2004920|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004921|NCT01215643|Ribavirin|ribavirin|mesh-list
2004922|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2004923|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
2004924|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004925|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
2004926|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004927|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
2004928|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2004929|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2004930|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
2004931|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004932|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004933|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004934|NCT01215721|Urological Agents|urological agents|mesh-ancestor
2004935|NCT01215734|Vaccines|vaccines|mesh-list
2004936|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
2004937|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004938|NCT01215786|Timolol|timolol|mesh-list
2004939|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2004940|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2004941|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2004942|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2004943|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
2004944|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004945|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004946|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004947|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2004948|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2004949|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
2004950|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
2004951|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2004952|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2004953|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2004954|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2004955|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004956|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004957|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004958|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
2004959|NCT01215916|Pemetrexed|pemetrexed|mesh-list
2004960|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2004961|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2004962|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004963|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2004964|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2004965|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
2004966|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2004967|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004968|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2004969|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2004970|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2004971|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004972|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
2004973|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2004974|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
2004975|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2004976|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004977|NCT01215968|Dulaglutide|dulaglutide|mesh-list
2004978|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2004979|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004980|NCT01215981|Vaccines|vaccines|mesh-list
2004981|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
2004982|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004983|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2004984|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
2079361|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2004985|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2004986|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2004987|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2004988|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
2004989|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004990|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2004991|NCT01216163|Acetaminophen|acetaminophen|mesh-list
2004992|NCT01216163|Ibuprofen|ibuprofen|mesh-list
2004993|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2004994|NCT01216163|Analgesics|analgesics|mesh-ancestor
2004995|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
2004996|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2004997|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2004998|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
2004999|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2005000|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2005001|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2005002|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2005003|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005004|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005005|NCT01216176|Anastrozole|anastrozole|mesh-list
2005006|NCT01216176|Saracatinib|saracatinib|mesh-list
2005007|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2005008|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005009|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2005010|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2005011|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005012|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005013|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2005014|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
2005015|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2005016|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005017|NCT01216241|Daptomycin|daptomycin|mesh-list
2005018|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2005019|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2005020|NCT01216332|Vaccines|vaccines|mesh-list
2005021|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
2005022|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005023|NCT01216397|Metformin|metformin|mesh-list
2005024|NCT01216397|Linagliptin|linagliptin|mesh-list
2005025|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2005026|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005027|NCT01216397|Incretins|incretins|mesh-ancestor
2005028|NCT01216397|Hormones|hormones|mesh-ancestor
2005029|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2005030|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2005031|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
2005032|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005033|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005034|NCT01216410|Phenylephrine|phenylephrine|mesh-list
2005035|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
2005036|NCT01216410|Ondansetron|ondansetron|mesh-list
2005037|NCT01216410|Metoclopramide|metoclopramide|mesh-list
2005038|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
2005039|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
2005040|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005041|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005042|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2005043|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
2005044|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
2005045|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2005046|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
2005047|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005048|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005049|NCT01216410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2005050|NCT01216410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2005051|NCT01216410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2005052|NCT01216410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2005053|NCT01216410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2005054|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2005055|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
2005056|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
2005057|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2005058|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
2005059|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
2005060|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2005061|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2005062|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2005063|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
2005064|NCT01216410|Protective Agents|protective agents|mesh-ancestor
2005065|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2005066|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2005067|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
2005068|NCT01216683|Rituximab|rituximab|mesh-list
2005069|NCT01216683|Lenalidomide|lenalidomide|mesh-list
2005070|NCT01216683|Bortezomib|bortezomib|mesh-list
2005071|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2005072|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2005073|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005074|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
2005075|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005076|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2005077|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2005078|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2005079|NCT01216683|Growth Substances|growth substances|mesh-ancestor
2005080|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
2005081|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2005082|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
2005083|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005084|NCT01216735|Fluticasone|fluticasone|mesh-list
2005085|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2005086|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2005087|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
2005088|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005089|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005090|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2005091|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
2005092|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
2005093|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2005094|NCT01216761|Iodine|iodine|mesh-list
2005095|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
2005096|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2005097|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
2005098|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
2005099|NCT01216761|Povidone|povidone|mesh-list
2005100|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2005101|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2005102|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
2005103|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
2005104|NCT01216761|Trace Elements|trace elements|mesh-ancestor
2005105|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
2005106|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005107|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
2005108|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
2005109|NCT01216943|Timolol|timolol|mesh-list
2005110|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2005111|NCT01216943|Bimatoprost|bimatoprost|mesh-list
2005112|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2005113|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2005114|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2005115|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2005116|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
2005117|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005118|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005119|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005120|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2005121|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2005122|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2005123|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2005124|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2005125|NCT01217073|Metformin|metformin|mesh-list
2005126|NCT01217073|Pioglitazone|pioglitazone|mesh-list
2005127|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2005128|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005129|NCT01217112|Cannabidiol|cannabidiol|mesh-list
2005130|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
2005131|NCT01217190|Ondansetron|ondansetron|mesh-list
2005132|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
2005133|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
2005134|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005135|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005136|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2005137|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
2005138|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
2005139|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2005140|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
2005141|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005142|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005143|NCT01217190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2005144|NCT01217190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2005145|NCT01217190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2005146|NCT01217190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2005147|NCT01217190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2005148|NCT01217307|Metformin|metformin|mesh-list
2005149|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2005150|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005151|NCT01217411|R04929097|r04929097|mesh-list
2005152|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005153|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005154|NCT01217437|Bevacizumab|bevacizumab|mesh-list
2005155|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2005156|NCT01217437|Irinotecan|irinotecan|mesh-list
2005157|NCT01217437|Temozolomide|temozolomide|mesh-list
2005158|NCT01217437|Camptothecin|camptothecin|mesh-list
2005159|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
2005160|NCT01217437|Antibodies|antibodies|mesh-list
2005161|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
2005162|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2005163|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
2005164|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005165|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2005166|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2005167|NCT01217437|Growth Substances|growth substances|mesh-ancestor
2005168|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005169|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
2005170|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
2005171|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2005172|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2005173|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005174|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005175|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2005176|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
2005177|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2005178|NCT01217515|Diltiazem|diltiazem|mesh-list
2005179|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2005180|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2005181|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2005182|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005183|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2005184|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005185|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
2005186|NCT01217606|Timolol|timolol|mesh-list
2005187|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2005188|NCT01217606|Bimatoprost|bimatoprost|mesh-list
2005189|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2005190|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2005191|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2005192|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2005193|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
2005194|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005195|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005196|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005197|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2005198|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2005199|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2005200|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2005201|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2005202|NCT01217749|Ofatumumab|ofatumumab|mesh-list
2005203|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005204|NCT01217801|Ondansetron|ondansetron|mesh-list
2005205|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
2005206|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
2005207|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005208|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005209|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2005210|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
2005211|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
2005212|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2005213|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
2005214|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005215|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005216|NCT01217801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2005217|NCT01217801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2005218|NCT01217801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2005219|NCT01217801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2005220|NCT01217801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2005221|NCT01217814|Leucovorin|leucovorin|mesh-list
2005222|NCT01217814|Folic Acid|folic acid|mesh-list
2005223|NCT01217814|Golimumab|golimumab|mesh-list
2005224|NCT01217814|Methotrexate|methotrexate|mesh-list
2005225|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
2005226|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2005227|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
2005228|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2005229|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005230|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2005231|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
2005232|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005233|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005234|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
2005235|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005236|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2005237|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2005238|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
2005239|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2005240|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2005241|NCT01217814|Antidotes|antidotes|mesh-ancestor
2005242|NCT01217814|Protective Agents|protective agents|mesh-ancestor
2005243|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
2005244|NCT01217814|Vitamins|vitamins|mesh-ancestor
2005245|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
2005246|NCT01217814|Hematinics|hematinics|mesh-ancestor
2005247|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2005248|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2005249|NCT01217840|Vitamin D|vitamin d|mesh-list
2005250|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
2005251|NCT01217840|Vitamins|vitamins|mesh-ancestor
2005252|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
2005253|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005254|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2005255|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2005256|NCT01217892|Metformin|metformin|mesh-list
2005257|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
2005258|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2005259|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005260|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2005261|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005262|NCT01217944|Ranibizumab|ranibizumab|mesh-list
2005263|NCT01217944|Verteporfin|verteporfin|mesh-list
2005264|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2005265|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2005266|NCT01217944|Growth Substances|growth substances|mesh-ancestor
2005267|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005268|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
2005269|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005270|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2005271|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
2005272|NCT01217957|Dexamethasone|dexamethasone|mesh-list
2005273|NCT01217957|Lenalidomide|lenalidomide|mesh-list
2005274|NCT01217957|Ixazomib|ixazomib|mesh-list
2005275|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2005276|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
2005277|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
2005278|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005279|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005280|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2005281|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
2005282|NCT01217957|Hormones|hormones|mesh-ancestor
2005283|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2005284|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2005285|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005286|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
2005287|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2005288|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2005289|NCT01217957|Growth Substances|growth substances|mesh-ancestor
2005290|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
2005291|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
2005292|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005293|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005294|NCT01218009|Albuterol|albuterol|mesh-list
2005295|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2005296|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
2005297|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005298|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005299|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2005300|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
2005301|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
2005302|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2005303|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2005304|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2005305|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2005306|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
2005307|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005308|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005309|NCT01218048|Carboplatin|carboplatin|mesh-list
2005310|NCT01218048|Cetuximab|cetuximab|mesh-list
2005311|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005312|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2005313|NCT01218100|Lisinopril|lisinopril|mesh-list
2005314|NCT01218100|Nebivolol|nebivolol|mesh-list
2005315|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2005316|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
2005317|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005318|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005319|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2005320|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2005321|NCT01218100|Protective Agents|protective agents|mesh-ancestor
2005322|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005323|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
2005324|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2005325|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2005326|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2005327|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
2005328|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005329|NCT01218204|Atorvastatin|atorvastatin|mesh-list
2005330|NCT01218204|Ezetimibe|ezetimibe|mesh-list
2005331|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2005332|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2005333|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
2005334|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005335|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2005336|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2005337|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005338|NCT01218308|Vaccines|vaccines|mesh-list
2005339|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
2005340|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005341|NCT01218399|Budesonide|budesonide|mesh-list
2005342|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2005343|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2005344|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2005345|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
2005346|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005347|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005348|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2005349|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
2005350|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
2005351|NCT01218399|Hormones|hormones|mesh-ancestor
2005352|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2005353|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2005354|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
2005355|NCT01218438|Antibodies|antibodies|mesh-list
2005356|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
2005357|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2005358|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2005359|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
2005360|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
2005361|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005362|NCT01218477|Dasatinib|dasatinib|mesh-list
2005363|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005364|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2005365|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005366|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005367|NCT01218516|Paclitaxel|paclitaxel|mesh-list
2005368|NCT01218516|Carboplatin|carboplatin|mesh-list
2005369|NCT01218516|Pemetrexed|pemetrexed|mesh-list
2005370|NCT01218516|Farletuzumab|farletuzumab|mesh-list
2005371|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2005372|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005373|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
2005374|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
2005375|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
2005376|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005377|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005378|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2005379|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2005380|NCT01218594|Endostatins|endostatins|mesh-list
2005381|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2005382|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2005383|NCT01218594|Growth Substances|growth substances|mesh-ancestor
2005384|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005385|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
2005386|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005387|NCT01218646|Vaccines|vaccines|mesh-list
2005388|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
2005389|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005390|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2005391|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2005392|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2005393|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
2005394|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005395|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2005396|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2005397|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005398|NCT01218867|Aldesleukin|aldesleukin|mesh-list
2005399|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
2005400|NCT01218867|Fludarabine|fludarabine|mesh-list
2005401|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2005402|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
2005403|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005404|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2005405|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2005406|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
2005407|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005408|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005409|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2005410|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2005411|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2005412|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
2005413|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2005414|NCT01218958|Naltrexone|naltrexone|mesh-list
2005415|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2005416|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2005417|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005418|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
2005419|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005420|NCT01218971|Naltrexone|naltrexone|mesh-list
2005421|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2005422|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2005423|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005424|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
2005425|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005426|NCT01218984|Naltrexone|naltrexone|mesh-list
2005427|NCT01218984|Hydromorphone|hydromorphone|mesh-list
2005428|NCT01218984|Naloxone|naloxone|mesh-list
2005429|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2005430|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2005431|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005432|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
2005433|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005434|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2005435|NCT01218984|Narcotics|narcotics|mesh-ancestor
2005436|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2005437|NCT01218984|Analgesics|analgesics|mesh-ancestor
2005438|NCT01218997|Naltrexone|naltrexone|mesh-list
2005439|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2005440|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2005441|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005442|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
2005443|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005444|NCT01219738|Budesonide|budesonide|mesh-list
2005445|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2005446|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2005447|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
2005448|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005449|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005450|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2005451|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
2005452|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
2005453|NCT01219738|Hormones|hormones|mesh-ancestor
2005454|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2005455|NCT01219777|Paclitaxel|paclitaxel|mesh-list
2005456|NCT01219777|Bevacizumab|bevacizumab|mesh-list
2005457|NCT01219777|Carboplatin|carboplatin|mesh-list
2005458|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2005459|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005460|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
2005461|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
2005462|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
2005463|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005464|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2005465|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2005466|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2005467|NCT01219777|Growth Substances|growth substances|mesh-ancestor
2005468|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005469|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
2005470|NCT01219881|Sevoflurane|sevoflurane|mesh-list
2005471|NCT01219881|Desflurane|desflurane|mesh-list
2005472|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2005473|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2005474|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
2005475|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
2005476|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2005477|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005478|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
2005479|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2005480|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2005481|NCT01219933|Prednisolone|prednisolone|mesh-list
2005482|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
2005483|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2005484|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
2005485|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2005486|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
2005487|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
2005488|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005489|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005490|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2005491|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
2005492|NCT01219933|Hormones|hormones|mesh-ancestor
2005493|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2005494|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2005495|NCT01219933|Protective Agents|protective agents|mesh-ancestor
2005496|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2005497|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005498|NCT01219959|Icodextrin|icodextrin|mesh-list
2005499|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
2005500|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2005501|NCT01220024|Bupivacaine|bupivacaine|mesh-list
2005502|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
2005503|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
2005504|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2005505|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005506|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
2005507|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005508|NCT01220128|Paclitaxel|paclitaxel|mesh-list
2005509|NCT01220128|Docetaxel|docetaxel|mesh-list
2005510|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
2005511|NCT01220128|Carboplatin|carboplatin|mesh-list
2005512|NCT01220128|Doxorubicin|doxorubicin|mesh-list
2005513|NCT01220128|Fluorouracil|fluorouracil|mesh-list
2005514|NCT01220128|Trastuzumab|trastuzumab|mesh-list
2005515|NCT01220128|Epirubicin|epirubicin|mesh-list
2005516|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2005517|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2005518|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005519|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
2005520|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
2005521|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
2005522|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005523|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2005524|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
2005525|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005526|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2005527|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2005528|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
2005529|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2005530|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2005531|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2005532|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2005533|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005534|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
2005535|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2005536|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2005537|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2005538|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2005539|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
2005540|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2005541|NCT01220167|Ondansetron|ondansetron|mesh-list
2005542|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
2005543|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
2005544|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005545|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005546|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2005547|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
2005548|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
2005549|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2005550|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
2005551|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005552|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005553|NCT01220167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2005554|NCT01220167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2005555|NCT01220167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2005556|NCT01220167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2005557|NCT01220167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2005558|NCT01220180|Pregabalin|pregabalin|mesh-list
2005559|NCT01220180|Analgesics|analgesics|mesh-ancestor
2005560|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
2005561|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005562|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005563|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
2005564|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2005565|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2005566|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005567|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2005568|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2005569|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2005570|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2005571|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2005572|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
2005573|NCT01220297|Sirolimus|sirolimus|mesh-list
2005574|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
2005575|NCT01220297|Carmustine|carmustine|mesh-list
2005576|NCT01220297|Etoposide|etoposide|mesh-list
2005577|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
2005578|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2005579|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
2005580|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005581|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2005582|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2005583|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
2005584|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005585|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005586|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2005587|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2005588|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2005589|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2005590|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005591|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2005592|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2005593|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
2005594|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2005595|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2005596|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
2005597|NCT01220414|Naltrexone|naltrexone|mesh-list
2005598|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2005599|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2005600|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005601|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
2005602|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005603|NCT01220557|Insulin|insulin|mesh-list
2005604|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2005605|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005606|NCT01220609|Epothilones|epothilones|mesh-list
2005607|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
2005608|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
2005609|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
2005610|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005611|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005612|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
2005613|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2005614|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
2005615|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005616|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005617|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2005618|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
2005619|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2005620|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
2005621|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005622|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005623|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2005624|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
2005625|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
2005626|NCT01220687|Protective Agents|protective agents|mesh-ancestor
2005627|NCT01220973|Celecoxib|celecoxib|mesh-list
2005628|NCT01220973|Atorvastatin|atorvastatin|mesh-list
2005629|NCT01220973|Calcium|calcium|mesh-list
2005630|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2005631|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005632|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2005633|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2005634|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
2005635|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005636|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2005637|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2005638|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005639|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2005640|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2005641|NCT01220973|Analgesics|analgesics|mesh-ancestor
2005642|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
2005643|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005644|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2005645|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2005646|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2005647|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2005648|NCT01221181|Eculizumab|eculizumab|mesh-list
2005649|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2005650|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2005651|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
2005652|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005653|NCT01221207|Calpastatin|calpastatin|mesh-list
2005654|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2005655|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
2005656|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005657|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005658|NCT01221272|Ranolazine|ranolazine|mesh-list
2005659|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2005660|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2005661|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005662|NCT01221298|Ritonavir|ritonavir|mesh-list
2005663|NCT01221298|Ribavirin|ribavirin|mesh-list
2005664|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2005665|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2005666|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
2005667|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005668|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005669|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2005670|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2005671|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
2005672|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2005673|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2005674|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2005675|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
2005676|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
2005677|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
2005678|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005679|NCT01221350|Protective Agents|protective agents|mesh-ancestor
2005680|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005681|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
2005682|NCT01221350|Vitamins|vitamins|mesh-ancestor
2005683|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
2005684|NCT01221727|Denosumab|denosumab|mesh-list
2005685|NCT01221727|Midazolam|midazolam|mesh-list
2005686|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2005687|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2005688|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2005689|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005690|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2005691|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2005692|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2005693|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2005694|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
2005695|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
2005696|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
2005697|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
2005698|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005699|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005700|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2005701|NCT01221753|Carboplatin|carboplatin|mesh-list
2005702|NCT01221753|Docetaxel|docetaxel|mesh-list
2005703|NCT01221753|Fluorouracil|fluorouracil|mesh-list
2005704|NCT01221753|Cetuximab|cetuximab|mesh-list
2005705|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005706|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
2005707|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
2005708|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
2005709|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005710|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
2005711|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2005712|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2005713|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
2005714|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005715|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2005716|NCT01222091|Propranolol|propranolol|mesh-list
2005717|NCT01222091|Remifentanil|remifentanil|mesh-list
2005718|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2005719|NCT01222091|Narcotics|narcotics|mesh-ancestor
2005720|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2005721|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005722|NCT01222091|Analgesics|analgesics|mesh-ancestor
2005723|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
2005724|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005725|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2005726|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2005727|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
2005728|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005729|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005730|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2005731|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2005732|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
2005733|NCT01222117|Plasminogen|plasminogen|mesh-list
2005734|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2005735|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
2005736|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2005737|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2005738|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005739|NCT01222195|Lenalidomide|lenalidomide|mesh-list
2005740|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
2005741|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
2005742|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005743|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2005744|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2005745|NCT01222195|Growth Substances|growth substances|mesh-ancestor
2005746|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
2005747|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005748|NCT01222195|Hematinics|hematinics|mesh-ancestor
2005749|NCT01222234|Vitamin D|vitamin d|mesh-list
2005750|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
2005751|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
2005752|NCT01222234|Calcitriol|calcitriol|mesh-list
2005753|NCT01222234|Vitamins|vitamins|mesh-list
2005754|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
2005755|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005756|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2005757|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2005758|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2005759|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2005760|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005761|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2005762|NCT01222247|Betamethasone|betamethasone|mesh-list
2005763|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2005764|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
2005765|NCT01222247|Hormones|hormones|mesh-ancestor
2005766|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2005767|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005768|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2005769|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
2005770|NCT01222260|Dexamethasone|dexamethasone|mesh-list
2005771|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2005772|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2005773|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
2005774|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
2005775|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005776|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005777|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2005778|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
2005779|NCT01222260|Hormones|hormones|mesh-ancestor
2005780|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2005781|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2005782|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005783|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2005784|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
2005785|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005786|NCT01222273|Vitamin D|vitamin d|mesh-list
2005787|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
2005788|NCT01222273|Vitamins|vitamins|mesh-ancestor
2005789|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
2005790|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005791|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2005792|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2005793|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
2005794|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2005795|NCT01222403|Vaccines|vaccines|mesh-list
2005796|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
2005797|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
2005798|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005799|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2005800|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
2005801|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005802|NCT01222520|Amlodipine|amlodipine|mesh-list
2005803|NCT01222520|Telmisartan|telmisartan|mesh-list
2005804|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2005805|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2005806|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2005807|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2005808|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005809|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2005810|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005811|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
2005812|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2005813|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2005814|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
2005815|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2005816|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
2005817|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005818|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005819|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2005820|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
2005821|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
2005822|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2005823|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
2005824|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005825|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005826|NCT01222572|Etoposide|etoposide|mesh-list
2005827|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005828|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2005829|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2005830|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2005831|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005832|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005833|NCT01222585|Metronidazole|metronidazole|mesh-list
2005834|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2005835|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2005836|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2005837|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2005838|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2005839|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005840|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2005841|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005842|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005843|NCT01222715|Sirolimus|sirolimus|mesh-list
2005844|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
2005845|NCT01222715|Bevacizumab|bevacizumab|mesh-list
2005846|NCT01222715|Vinorelbine|vinorelbine|mesh-list
2005847|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2005848|NCT01222715|Antibodies|antibodies|mesh-list
2005849|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
2005850|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2005851|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
2005852|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
2005853|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2005854|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
2005855|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005856|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2005857|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2005858|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
2005859|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005860|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005861|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2005862|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2005863|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2005864|NCT01222715|Growth Substances|growth substances|mesh-ancestor
2005865|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
2005866|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2005867|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2005868|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2005869|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
2005870|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2005871|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
2005872|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
2005873|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
2005874|NCT01222832|Bacitracin|bacitracin|mesh-list
2005875|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2005876|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2005877|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2005878|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2005879|NCT01222884|Hematinics|hematinics|mesh-ancestor
2005880|NCT01223027|Sorafenib|sorafenib|mesh-list
2005881|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005882|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2005883|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005884|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005885|NCT01223196|Pioglitazone|pioglitazone|mesh-list
2005886|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2005887|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005888|NCT01223235|Bevacizumab|bevacizumab|mesh-list
2005889|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2005890|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005891|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2005892|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2005893|NCT01223235|Growth Substances|growth substances|mesh-ancestor
2005894|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005895|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
2005896|NCT01223352|Bosentan|bosentan|mesh-list
2005897|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2005898|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2005899|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005900|NCT01223365|Hydrocodone|hydrocodone|mesh-list
2005901|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2005902|NCT01223365|Narcotics|narcotics|mesh-ancestor
2005903|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2005904|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005905|NCT01223365|Analgesics|analgesics|mesh-ancestor
2005906|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
2005907|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005908|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
2005909|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
2005910|NCT01223378|Latanoprost|latanoprost|mesh-list
2005911|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2005912|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2005913|NCT01223404|Mecamylamine|mecamylamine|mesh-list
2005914|NCT01223404|Nicotine|nicotine|mesh-list
2005915|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2005916|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
2005917|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005918|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005919|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2005920|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2005921|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
2005922|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005923|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005924|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2005925|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2005926|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2005927|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2005928|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2005929|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
2005930|NCT01223937|Coagulants|coagulants|mesh-ancestor
2005931|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2005932|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
2005933|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005934|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2005935|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2005936|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2005937|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005938|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005939|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2005940|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2005941|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005942|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
2005943|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005944|NCT01224145|Bupivacaine|bupivacaine|mesh-list
2005945|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
2005946|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
2005947|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2005948|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005949|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
2005950|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005951|NCT01224171|Vedolizumab|vedolizumab|mesh-list
2005952|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2005953|NCT01224210|Ambrisentan|ambrisentan|mesh-list
2005954|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2005955|NCT01224431|Lidocaine|lidocaine|mesh-list
2005956|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
2005957|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
2005958|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2005959|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005960|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
2005961|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2005962|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2005963|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2005964|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2005965|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2005966|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005967|NCT01224626|Linezolid|linezolid|mesh-list
2005968|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2005969|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2005970|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2005971|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2005972|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005973|NCT01224639|Vaccines|vaccines|mesh-list
2005974|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
2005975|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005976|NCT01224678|Vitamin D|vitamin d|mesh-list
2005977|NCT01224678|Vitamins|vitamins|mesh-ancestor
2005978|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
2005979|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005980|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2005981|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
2005982|NCT01224821|Antibodies|antibodies|mesh-list
2005983|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
2005984|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005985|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2005986|NCT01225055|Teriparatide|teriparatide|mesh-list
2005987|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2005988|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005989|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2005990|NCT01225068|Milnacipran|milnacipran|mesh-list
2005991|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
2005992|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2005993|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2005994|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2005995|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2005996|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2005997|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2005998|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2005999|NCT01225068|Analgesics|analgesics|mesh-ancestor
2006000|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
2006001|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006002|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
2006003|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2006004|NCT01225146|Ranibizumab|ranibizumab|mesh-list
2006005|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2006006|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2006007|NCT01225146|Growth Substances|growth substances|mesh-ancestor
2006008|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006009|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
2006010|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006011|NCT01225172|Letrozole|letrozole|mesh-list
2006012|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006013|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2006014|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2006015|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006016|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006017|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2006018|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
2006019|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2006020|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006021|NCT01225211|Ivacaftor|ivacaftor|mesh-list
2006022|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2006023|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2006024|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006025|NCT01225263|Vitamin D|vitamin d|mesh-list
2006026|NCT01225263|Simvastatin|simvastatin|mesh-list
2006027|NCT01225263|Vitamins|vitamins|mesh-ancestor
2006028|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
2006029|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006030|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2006031|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2006032|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2006033|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
2006034|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006035|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2006036|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2006037|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006038|NCT01225289|Vitamin A|vitamin a|mesh-list
2006039|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
2006040|NCT01225289|Vitamins|vitamins|mesh-ancestor
2006041|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
2006042|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006043|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
2006044|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006045|NCT01225289|Protective Agents|protective agents|mesh-ancestor
2006046|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2006047|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006058|NCT01225354|Calcium|calcium|mesh-list
2006059|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2006060|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006061|NCT01225549|Budesonide|budesonide|mesh-list
2006062|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2006063|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2006064|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
2006065|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006066|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006067|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2006068|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
2006069|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
2006070|NCT01225549|Hormones|hormones|mesh-ancestor
2006071|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2006072|NCT01225562|Ticagrelor|ticagrelor|mesh-list
2006073|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2006074|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2006075|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2006076|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2006077|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
2006078|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2006079|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006080|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006081|NCT01225822|Enoxaparin|enoxaparin|mesh-list
2006082|NCT01225822|Dabigatran|dabigatran|mesh-list
2006083|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
2006084|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2006085|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2006086|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006087|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
2006088|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2006089|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
2006090|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006091|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2006092|NCT01225835|Cetrorelix|cetrorelix|mesh-list
2006093|NCT01225835|Menotropins|menotropins|mesh-list
2006094|NCT01225835|Progesterone|progesterone|mesh-list
2006095|NCT01225835|Progestins|progestins|mesh-ancestor
2006096|NCT01225835|Hormones|hormones|mesh-ancestor
2006097|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2006098|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006099|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2006100|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2006101|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
2006102|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
2006103|NCT01225887|Nintedanib|nintedanib|mesh-list
2006104|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006105|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2006106|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006107|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006108|NCT01225991|Milnacipran|milnacipran|mesh-list
2006109|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
2006110|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2006111|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2006112|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2006113|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006114|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2006115|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006116|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2006117|NCT01225991|Analgesics|analgesics|mesh-ancestor
2006118|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
2079362|NCT02057575|Latanoprost|latanoprost|mesh-list
2006119|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006120|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
2006121|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2006122|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
2006123|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2006124|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006125|NCT01226420|Alefacept|alefacept|mesh-list
2006126|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
2006127|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
2006128|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006129|NCT01226459|Minoxidil|minoxidil|mesh-list
2006130|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2006131|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
2006132|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
2006133|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006134|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2006135|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2006136|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2006137|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2006138|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006139|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2006140|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006141|NCT01226511|Analgesics|analgesics|mesh-ancestor
2006142|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
2006143|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006144|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
2006145|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2006146|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
2006147|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
2006148|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2006149|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2006150|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2006151|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2006152|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006153|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
2006154|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2006155|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006156|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2006157|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006158|NCT01226719|Leucovorin|leucovorin|mesh-list
2006159|NCT01226719|Fluorouracil|fluorouracil|mesh-list
2006160|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
2006161|NCT01226719|Irinotecan|irinotecan|mesh-list
2006162|NCT01226719|Panitumumab|panitumumab|mesh-list
2006163|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
2006164|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006165|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2006166|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006167|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006168|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
2006169|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006170|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2006171|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2006172|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006173|NCT01226719|Antidotes|antidotes|mesh-ancestor
2006174|NCT01226719|Protective Agents|protective agents|mesh-ancestor
2006175|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
2006176|NCT01226719|Vitamins|vitamins|mesh-ancestor
2006177|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
2006178|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2006179|NCT01226732|Capecitabine|capecitabine|mesh-list
2006180|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2006181|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
2006182|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006183|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006184|NCT01226745|Ceralifimod|ceralifimod|mesh-list
2006185|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2006186|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006187|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006188|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
2006189|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006190|NCT01227044|Naltrexone|naltrexone|mesh-list
2006191|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2006192|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2006193|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006194|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
2006195|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006196|NCT01227278|Benralizumab|benralizumab|mesh-list
2006197|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2006198|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
2006199|NCT01227395|Azithromycin|azithromycin|mesh-list
2006200|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2006201|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006202|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
2006203|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2006204|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006205|NCT01227434|Palbociclib|palbociclib|mesh-list
2006206|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006207|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2006208|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006209|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006210|NCT01227512|Tolvaptan|tolvaptan|mesh-list
2006211|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2006212|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006213|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
2006214|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006215|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
2006216|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2006217|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
2006218|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006219|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2006220|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2006221|NCT01227616|Hematinics|hematinics|mesh-ancestor
2006222|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2006223|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2006224|NCT01227629|Warfarin|warfarin|mesh-list
2006225|NCT01227629|Dabigatran|dabigatran|mesh-list
2006226|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
2006227|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
2006228|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2006229|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
2006230|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006231|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006232|NCT01227655|Levodopa|levodopa|mesh-list
2006233|NCT01227655|Carbidopa|carbidopa|mesh-list
2006234|NCT01227655|Opicapone|opicapone|mesh-list
2006235|NCT01227655|Benserazide|benserazide|mesh-list
2006236|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2006237|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2006238|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
2006239|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2006240|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006241|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006242|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2006243|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006244|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2006245|NCT01227668|Aripiprazole|aripiprazole|mesh-list
2006246|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
2006247|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2006248|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2006249|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2006250|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2006251|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006252|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
2006253|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
2006254|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2006255|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006256|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2006257|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2006258|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
2006259|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2006260|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2006261|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2006262|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2006263|NCT01227681|Lenograstim|lenograstim|mesh-list
2006264|NCT01227681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2006265|NCT01227681|Immunologic Factors|immunologic factors|mesh-ancestor
2006266|NCT01227681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006267|NCT01227707|Leucovorin|leucovorin|mesh-list
2006268|NCT01227707|Bevacizumab|bevacizumab|mesh-list
2006269|NCT01227707|Fluorouracil|fluorouracil|mesh-list
2006270|NCT01227707|Capecitabine|capecitabine|mesh-list
2006271|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2006272|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006273|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2006274|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2006275|NCT01227707|Growth Substances|growth substances|mesh-ancestor
2006276|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006277|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
2006278|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
2006279|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006280|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2006281|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006282|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
2006283|NCT01227707|Antidotes|antidotes|mesh-ancestor
2006284|NCT01227707|Protective Agents|protective agents|mesh-ancestor
2006285|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
2006286|NCT01227707|Vitamins|vitamins|mesh-ancestor
2006287|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
2006288|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
2006289|NCT01227824|Dolutegravir|dolutegravir|mesh-list
2006290|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2006291|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2006292|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
2006293|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006294|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2006295|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2006296|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006297|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006298|NCT01227889|Dacarbazine|dacarbazine|mesh-list
2006299|NCT01227889|Dabrafenib|dabrafenib|mesh-list
2006300|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2006301|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
2006302|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006303|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006304|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2006305|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006306|NCT01227902|Ezogabine|ezogabine|mesh-list
2006307|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
2006308|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2006309|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006310|NCT01227967|Ribavirin|ribavirin|mesh-list
2006311|NCT01227967|Oseltamivir|oseltamivir|mesh-list
2006312|NCT01227967|Amantadine|amantadine|mesh-list
2006313|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
2006314|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006315|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
2006316|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006317|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006318|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2006319|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2006320|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
2006321|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2006322|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006323|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2006324|NCT01227967|Analgesics|analgesics|mesh-ancestor
2006325|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
2006326|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006327|NCT01227993|Finasteride|finasteride|mesh-list
2006328|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2006329|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2006330|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006331|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006332|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
2006333|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2006334|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006335|NCT01227993|Urological Agents|urological agents|mesh-ancestor
2006336|NCT01228019|Niacin|niacin|mesh-list
2006337|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2006338|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
2006339|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006340|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2006341|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
2006342|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
2006343|NCT01228019|Vitamins|vitamins|mesh-ancestor
2006344|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
2006345|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006346|NCT01228071|Testosterone|testosterone|mesh-list
2006347|NCT01228071|Androgens|androgens|mesh-ancestor
2006348|NCT01228071|Hormones|hormones|mesh-ancestor
2006349|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2006350|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006351|NCT01228084|Sulforaphane|sulforaphane|mesh-list
2006352|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2006353|NCT01228084|Protective Agents|protective agents|mesh-ancestor
2006354|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006355|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006356|NCT01228149|Acetazolamide|acetazolamide|mesh-list
2006357|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
2006358|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2006359|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006360|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006361|NCT01228149|Diuretics|diuretics|mesh-ancestor
2006362|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
2006363|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006364|NCT01228175|Riboflavin|riboflavin|mesh-list
2006365|NCT01228175|Varenicline|varenicline|mesh-list
2006366|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2006367|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2006368|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
2006369|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2006370|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006371|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006372|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
2006373|NCT01228175|Vitamins|vitamins|mesh-ancestor
2006374|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
2006375|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2006376|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
2006377|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
2006378|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2006379|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006380|NCT01228734|Leucovorin|leucovorin|mesh-list
2006381|NCT01228734|Folic Acid|folic acid|mesh-list
2006382|NCT01228734|Fluorouracil|fluorouracil|mesh-list
2006383|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
2006384|NCT01228734|Cetuximab|cetuximab|mesh-list
2006385|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
2006386|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
2006387|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006388|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2006389|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006390|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006391|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
2006392|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006393|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2006394|NCT01228734|Antidotes|antidotes|mesh-ancestor
2006395|NCT01228734|Protective Agents|protective agents|mesh-ancestor
2006396|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
2006397|NCT01228734|Vitamins|vitamins|mesh-ancestor
2006398|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
2006399|NCT01228734|Hematinics|hematinics|mesh-ancestor
2006400|NCT01228747|Levetiracetam|levetiracetam|mesh-list
2006401|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
2006402|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
2006403|NCT01228903|Allopurinol|allopurinol|mesh-list
2006404|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
2006405|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006406|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006407|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
2006408|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2006409|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2006410|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
2006411|NCT01228903|Protective Agents|protective agents|mesh-ancestor
2006412|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006413|NCT01229111|Leucovorin|leucovorin|mesh-list
2006414|NCT01229111|Fluorouracil|fluorouracil|mesh-list
2006415|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
2006416|NCT01229111|Cediranib|cediranib|mesh-list
2006417|NCT01229111|Calcium|calcium|mesh-list
2006418|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
2006419|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2006420|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006421|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
2006422|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006423|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2006424|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006425|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006426|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
2006427|NCT01229111|Antidotes|antidotes|mesh-ancestor
2006428|NCT01229111|Protective Agents|protective agents|mesh-ancestor
2006429|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
2006430|NCT01229111|Vitamins|vitamins|mesh-ancestor
2006431|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
2006432|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006433|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2006434|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2006435|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006436|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2006437|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006438|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006439|NCT01229176|Vaccines|vaccines|mesh-list
2006440|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2006441|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
2006442|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006443|NCT01229228|Naproxen|naproxen|mesh-list
2006444|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2006445|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2006446|NCT01229228|Analgesics|analgesics|mesh-ancestor
2006447|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
2006448|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006449|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006450|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2006451|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2006452|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
2006453|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2006454|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006455|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006456|NCT01229254|Amiodarone|amiodarone|mesh-list
2006457|NCT01229254|Betrixaban|betrixaban|mesh-list
2006458|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2006459|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
2006460|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2006461|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2006462|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006463|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2006464|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2006465|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2006466|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006467|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2006468|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2006469|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2006470|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2006471|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
2006472|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2006473|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
2006474|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
2006475|NCT01229267|Vaccines|vaccines|mesh-list
2006476|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
2006477|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006478|NCT01229371|Vaccines|vaccines|mesh-list
2006479|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
2006480|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006481|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2006482|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2006483|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2006484|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2006485|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2006486|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
2006487|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2006488|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006489|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006490|NCT01229423|Bimatoprost|bimatoprost|mesh-list
2006491|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2006492|NCT01229449|Acetaminophen|acetaminophen|mesh-list
2006493|NCT01229449|Ibuprofen|ibuprofen|mesh-list
2006494|NCT01229449|Codeine|codeine|mesh-list
2006495|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2006496|NCT01229449|Analgesics|analgesics|mesh-ancestor
2006497|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
2006498|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006499|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006500|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
2006501|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2006502|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2006503|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2006504|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2006505|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006506|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006507|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2006508|NCT01229449|Narcotics|narcotics|mesh-ancestor
2006509|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2006510|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
2006511|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
2006512|NCT01229462|Timolol|timolol|mesh-list
2006513|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2006514|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2006515|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2006516|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2006517|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2006518|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
2006519|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2006520|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006521|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006522|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2006523|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2006524|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2006525|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2006526|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2006527|NCT01229527|Meperidine|meperidine|mesh-list
2006528|NCT01229527|Remifentanil|remifentanil|mesh-list
2006529|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2006530|NCT01229527|Narcotics|narcotics|mesh-ancestor
2006531|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2006532|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006533|NCT01229527|Analgesics|analgesics|mesh-ancestor
2006534|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
2006535|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006536|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2006537|NCT01229735|Topiramate|topiramate|mesh-list
2006538|NCT01229735|Levetiracetam|levetiracetam|mesh-list
2006539|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
2006540|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2006541|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006542|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
2006543|NCT01229891|Vitamin D|vitamin d|mesh-list
2006544|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
2006545|NCT01229891|Vitamins|vitamins|mesh-list
2006546|NCT01229891|Calcium|calcium|mesh-list
2006547|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
2006548|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006549|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2006550|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2006551|NCT01229943|Bevacizumab|bevacizumab|mesh-list
2006552|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2006553|NCT01229943|Everolimus|everolimus|mesh-list
2006554|NCT01229943|Octreotide|octreotide|mesh-list
2006555|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
2006556|NCT01229943|Antibodies|antibodies|mesh-list
2006557|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
2006558|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2006559|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
2006560|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006561|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2006562|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2006563|NCT01229943|Growth Substances|growth substances|mesh-ancestor
2006564|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006565|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
2006566|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
2006567|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006568|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2006569|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2006570|NCT01230177|Etanercept|etanercept|mesh-list
2006571|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2006572|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2006573|NCT01230177|Analgesics|analgesics|mesh-ancestor
2006574|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
2006575|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006576|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006577|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2006578|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2006579|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2006580|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006581|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
2006582|NCT01230424|Triamcinolone|triamcinolone|mesh-list
2006583|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2006584|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2006585|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2006586|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2006587|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
2006588|NCT01230424|Hormones|hormones|mesh-ancestor
2006589|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2006590|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006591|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006592|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
2006593|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006594|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006595|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
2006596|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2006597|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006598|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2006599|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
2006600|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2006601|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006602|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006603|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006604|NCT01230593|Tobramycin|tobramycin|mesh-list
2006605|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
2006606|NCT01230593|Dexamethasone|dexamethasone|mesh-list
2006607|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
2006608|NCT01230593|BB 1101|bb 1101|mesh-list
2006609|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2006610|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
2006611|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
2006612|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006613|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006614|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2006615|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
2006616|NCT01230593|Hormones|hormones|mesh-ancestor
2006617|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2006618|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2006619|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006620|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
2006621|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006622|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006623|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2006624|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006625|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2006626|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2006627|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2006628|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006629|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2006630|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006631|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006632|NCT01230749|Pioglitazone|pioglitazone|mesh-list
2006633|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2006634|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006635|NCT01230814|Metronidazole|metronidazole|mesh-list
2006636|NCT01230814|Miconazole|miconazole|mesh-list
2006637|NCT01230814|Clotrimazole|clotrimazole|mesh-list
2006638|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006639|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2006640|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2006641|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2006642|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
2006643|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2006644|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2006645|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006646|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006647|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2006648|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
2006649|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2006650|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006651|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2006652|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2006653|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2006654|NCT01230827|Golimumab|golimumab|mesh-list
2006655|NCT01230827|Methotrexate|methotrexate|mesh-list
2006656|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2006657|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
2006658|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2006659|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006660|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2006661|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
2006662|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006663|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006664|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
2006665|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006666|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2006667|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006668|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
2006669|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2006670|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2006671|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2006672|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2006673|NCT01230892|Atenolol|atenolol|mesh-list
2006674|NCT01230892|Nebivolol|nebivolol|mesh-list
2006675|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2006676|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2006677|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
2006678|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
2006679|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006680|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006681|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2006682|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2006683|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2006684|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
2006685|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2006686|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006687|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
2006688|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2006689|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2006690|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2006691|NCT01231230|Fluticasone|fluticasone|mesh-list
2006692|NCT01231230|Xhance|xhance|mesh-list
2006693|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2006694|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2006695|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2006696|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2006697|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
2006698|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006699|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006700|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2006701|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
2006702|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
2006703|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2006704|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2006705|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2006706|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2006707|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
2006708|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2006709|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006710|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
2006711|NCT01231230|Hormones|hormones|mesh-ancestor
2006712|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2006713|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
2006714|NCT01231321|Adalimumab|adalimumab|mesh-list
2006715|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2006716|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2006717|NCT01231334|Clindamycin|clindamycin|mesh-list
2006718|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
2006719|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
2006720|NCT01231334|Dapsone|dapsone|mesh-list
2006721|NCT01231334|Adapalene|adapalene|mesh-list
2006722|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2006723|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2006724|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006725|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2006726|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006727|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006728|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
2006729|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2006730|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2006731|NCT01231334|Analgesics|analgesics|mesh-ancestor
2006732|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
2006733|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006734|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006735|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2006736|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2006737|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
2006738|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2006739|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2006740|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2006741|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
2006742|NCT01231373|Polidocanol|polidocanol|mesh-list
2006743|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2006744|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2006745|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
2006746|NCT01231399|Leucovorin|leucovorin|mesh-list
2006747|NCT01231399|Fluorouracil|fluorouracil|mesh-list
2006748|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
2006749|NCT01231399|Everolimus|everolimus|mesh-list
2006750|NCT01231399|Calcium|calcium|mesh-list
2006751|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
2006752|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2006753|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006754|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2006755|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
2006756|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006757|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2006758|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006759|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006760|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
2006761|NCT01231399|Antidotes|antidotes|mesh-ancestor
2006762|NCT01231399|Protective Agents|protective agents|mesh-ancestor
2006763|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
2006764|NCT01231399|Vitamins|vitamins|mesh-ancestor
2006765|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
2006766|NCT01231412|Cyclosporine|cyclosporine|mesh-list
2006767|NCT01231412|Sirolimus|sirolimus|mesh-list
2006768|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
2006769|NCT01231412|Fludarabine|fludarabine|mesh-list
2006770|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
2006771|NCT01231412|Cyclosporins|cyclosporins|mesh-list
2006772|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006773|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2006774|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
2006775|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006776|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006777|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
2006778|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006779|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006780|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
2006781|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006782|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
2006783|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2006784|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2006785|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2006786|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2006787|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
2006788|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2006789|NCT01231464|Fluticasone|fluticasone|mesh-list
2006790|NCT01231464|Xhance|xhance|mesh-list
2006791|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2006792|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2006793|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
2006794|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006795|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006796|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2006797|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
2006798|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
2006799|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2006800|NCT01231503|Vaccines|vaccines|mesh-list
2006801|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
2006802|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006803|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
2006804|NCT01231516|Dolutegravir|dolutegravir|mesh-list
2006805|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2006806|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2006807|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
2006808|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006809|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2006810|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2006811|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006812|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006813|NCT01231555|Efavirenz|efavirenz|mesh-list
2006814|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2006815|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2006816|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006817|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006818|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
2006819|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006820|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2006821|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2006822|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2006823|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2006824|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2006825|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2006826|NCT01231581|Gemcitabine|gemcitabine|mesh-list
2006827|NCT01231581|Trametinib|trametinib|mesh-list
2006828|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2006829|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
2006830|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006831|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006832|NCT01231581|Antiviral Agents|antiviral agents|mesh-ancestor
2006833|NCT01231581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006834|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006835|NCT01231581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006836|NCT01231581|Immunologic Factors|immunologic factors|mesh-ancestor
2006837|NCT01231581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006838|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2006839|NCT01231607|Finasteride|finasteride|mesh-list
2006840|NCT01231607|Dutasteride|dutasteride|mesh-list
2006841|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2006842|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2006843|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006844|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006845|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
2006846|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2006847|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006848|NCT01231607|Urological Agents|urological agents|mesh-ancestor
2006849|NCT01231620|Oseltamivir|oseltamivir|mesh-list
2006850|NCT01231620|Zanamivir|zanamivir|mesh-list
2006851|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
2006852|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006853|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006854|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006855|NCT01231633|Dexamethasone|dexamethasone|mesh-list
2006856|NCT01231633|Bevacizumab|bevacizumab|mesh-list
2006857|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2006858|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006859|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2006860|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2006861|NCT01231633|Growth Substances|growth substances|mesh-ancestor
2006862|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006863|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
2006864|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2006865|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
2006866|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
2006867|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006868|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2006869|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
2006870|NCT01231633|Hormones|hormones|mesh-ancestor
2006871|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2006872|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2006873|NCT01231659|Everolimus|everolimus|mesh-list
2006874|NCT01231659|Letrozole|letrozole|mesh-list
2006875|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006876|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006877|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
2006878|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006879|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2006880|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2006881|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006882|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006883|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2006884|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
2006885|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2006886|NCT01231841|Cyclosporine|cyclosporine|mesh-list
2006887|NCT01231841|Cyclosporins|cyclosporins|mesh-list
2006888|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
2006889|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2006890|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
2006891|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006892|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006893|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006894|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
2006895|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006896|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
2006897|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006898|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
2006899|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2006900|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2006901|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
2006902|NCT01231906|Ifosfamide|ifosfamide|mesh-list
2006903|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
2006904|NCT01231906|Doxorubicin|doxorubicin|mesh-list
2006905|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2006906|NCT01231906|Etoposide|etoposide|mesh-list
2006907|NCT01231906|Vincristine|vincristine|mesh-list
2006908|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
2006909|NCT01231906|Topotecan|topotecan|mesh-list
2006910|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
2006911|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
2006912|NCT01231906|Razoxane|razoxane|mesh-list
2006913|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
2006914|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2006915|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
2006916|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006917|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2006918|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2006919|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
2006920|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006921|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006922|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2006923|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2006924|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2006925|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2006926|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006927|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2006928|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
2006929|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
2006930|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
2006931|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2006932|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
2006933|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
2006934|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2006935|NCT01231906|Protective Agents|protective agents|mesh-ancestor
2006936|NCT01232127|Ritonavir|ritonavir|mesh-list
2006937|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2006938|NCT01232127|Tenofovir|tenofovir|mesh-list
2006939|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2006940|NCT01232127|Famotidine|famotidine|mesh-list
2006941|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2006942|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2006943|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
2006944|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006945|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006946|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2006947|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2006948|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
2006949|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2006950|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2006951|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2006952|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2006953|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2006954|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2006955|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2006956|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
2006957|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
2006958|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2006959|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006960|NCT01232205|Micronutrients|micronutrients|mesh-list
2006961|NCT01232205|Trace Elements|trace elements|mesh-list
2006962|NCT01232205|Antioxidants|antioxidants|mesh-list
2006963|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006964|NCT01232205|Protective Agents|protective agents|mesh-ancestor
2006965|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006966|NCT01232283|Apremilast|apremilast|mesh-list
2006967|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2006968|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2006969|NCT01232283|Analgesics|analgesics|mesh-ancestor
2006970|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
2006971|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2006972|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006973|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2006974|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2006975|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2006976|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2006977|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006978|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006979|NCT01232296|Sorafenib|sorafenib|mesh-list
2006980|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006981|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2006982|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006983|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006984|NCT01232452|Pemetrexed|pemetrexed|mesh-list
2006985|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2006986|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2006987|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2006988|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2006989|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2006990|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
2006991|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2006992|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006993|NCT01232504|Molgramostim|molgramostim|mesh-list
2006994|NCT01232504|Sargramostim|sargramostim|mesh-list
2006995|NCT01232504|Lenograstim|lenograstim|mesh-list
2006996|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
2006997|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2006998|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2006999|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007000|NCT01232556|Gemcitabine|gemcitabine|mesh-list
2007001|NCT01232556|Rituximab|rituximab|mesh-list
2007002|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2007003|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2007004|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2007005|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007006|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
2007007|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007008|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007009|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2007010|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
2007011|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007012|NCT01232556|Antiviral Agents|antiviral agents|mesh-ancestor
2007013|NCT01232556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2007014|NCT01232556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007015|NCT01232556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2007016|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2007017|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
2007018|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2007019|NCT01232738|Rasagiline|rasagiline|mesh-list
2007020|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2007021|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007022|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007023|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2007024|NCT01232738|Protective Agents|protective agents|mesh-ancestor
2007025|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007026|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
2007027|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2007028|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
2007029|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2007030|NCT01232790|Expectorants|expectorants|mesh-ancestor
2007031|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
2007032|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2007033|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
2007034|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007035|NCT01232790|Protective Agents|protective agents|mesh-ancestor
2007036|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007037|NCT01232790|Antidotes|antidotes|mesh-ancestor
2007038|NCT01232829|R04929097|r04929097|mesh-list
2007039|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007040|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007041|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
2007042|NCT01232920|Methotrexate|methotrexate|mesh-list
2007043|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2007044|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
2007045|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2007046|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007047|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2007048|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
2007049|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007050|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007051|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
2007052|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007053|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2007054|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2007055|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
2007056|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007057|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2007058|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2007059|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2007060|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
2007061|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2007062|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2007063|NCT01232946|Insulin|insulin|mesh-list
2007064|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2007065|NCT01232946|Liraglutide|liraglutide|mesh-list
2007066|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
2007067|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2007068|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007069|NCT01232946|Incretins|incretins|mesh-ancestor
2007070|NCT01232946|Hormones|hormones|mesh-ancestor
2007071|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2007072|NCT01233050|Ethanol|ethanol|mesh-list
2007073|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
2007074|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2007075|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2007076|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2007077|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2007078|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007079|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
2007080|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
2007081|NCT01233258|Factor VIII|factor viii|mesh-list
2007082|NCT01233258|Coagulants|coagulants|mesh-ancestor
2007083|NCT01233284|Bromides|bromides|mesh-list
2007084|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
2007085|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2007086|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
2007087|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007088|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007089|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2007090|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
2007091|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
2007092|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2007093|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
2007094|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007095|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007096|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
2007097|NCT01233609|Valproic Acid|valproic acid|mesh-list
2007098|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
2007099|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007100|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007101|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
2007102|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007103|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007104|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
2007105|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2007106|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2007107|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2007108|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2007109|NCT01233687|Rilotumumab|rilotumumab|mesh-list
2007110|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007111|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2007112|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007113|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007114|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2007115|NCT01233921|Mitogens|mitogens|mesh-list
2007116|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
2007117|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007118|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
2007119|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2007120|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2007121|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2007122|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007123|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007124|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
2007125|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007126|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007127|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2007128|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007129|NCT01234337|Capecitabine|capecitabine|mesh-list
2007130|NCT01234337|Sorafenib|sorafenib|mesh-list
2007131|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2007132|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
2007133|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007134|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007135|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2007136|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007137|NCT01234402|Capecitabine|capecitabine|mesh-list
2007138|NCT01234402|Ramucirumab|ramucirumab|mesh-list
2007139|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2007140|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
2007141|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007142|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007143|NCT01234467|Rituximab|rituximab|mesh-list
2007144|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2007145|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2007146|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007147|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
2007148|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007149|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007150|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2007151|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
2007152|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007153|NCT01234649|Metformin|metformin|mesh-list
2007154|NCT01234649|Liraglutide|liraglutide|mesh-list
2007155|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2007156|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007157|NCT01234649|Incretins|incretins|mesh-ancestor
2007158|NCT01234649|Hormones|hormones|mesh-ancestor
2007159|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2007160|NCT01234675|Milnacipran|milnacipran|mesh-list
2007161|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
2007162|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2007163|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2007164|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007165|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007166|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007167|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007168|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2007169|NCT01234675|Analgesics|analgesics|mesh-ancestor
2007170|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
2007171|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007172|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
2007173|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2007174|NCT01234714|Liver Extracts|liver extracts|mesh-list
2007175|NCT01234714|Hematinics|hematinics|mesh-ancestor
2007176|NCT01234766|Rituximab|rituximab|mesh-list
2007177|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2007178|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2007179|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007180|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
2007181|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007182|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007183|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2007184|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
2007185|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007186|NCT01234870|Adenosine|adenosine|mesh-list
2007187|NCT01234870|Analgesics|analgesics|mesh-ancestor
2007188|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
2007189|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007190|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007191|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2007192|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
2007193|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2007194|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
2007195|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
2007196|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007197|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007198|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
2007199|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2007200|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2007201|NCT01234922|Losartan|losartan|mesh-list
2007202|NCT01234922|Ramipril|ramipril|mesh-list
2007203|NCT01234922|Lisinopril|lisinopril|mesh-list
2007204|NCT01234922|Benazepril|benazepril|mesh-list
2007205|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2007206|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2007207|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2007208|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2007209|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007210|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2007211|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
2007212|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007213|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2007214|NCT01234922|Protective Agents|protective agents|mesh-ancestor
2007215|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007216|NCT01235195|Sertraline|sertraline|mesh-list
2007217|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
2007218|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2007219|NCT01235195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2007220|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2007221|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007222|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007223|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007224|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
2007225|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007226|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2007227|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2007228|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2007229|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2007230|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007231|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007232|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007233|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007234|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2007235|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
2007236|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2007237|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2007238|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2007239|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
2007240|NCT01235351|Clopidogrel|clopidogrel|mesh-list
2007241|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2007242|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2007243|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2007244|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2007245|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
2007246|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007247|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007248|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007249|NCT01235403|Lacosamide|lacosamide|mesh-list
2007250|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
2007251|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2079363|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2007252|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2007253|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007254|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007255|NCT01235442|Etanercept|etanercept|mesh-list
2007256|NCT01235442|Clobetasol|clobetasol|mesh-list
2007257|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2007258|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2007259|NCT01235442|Analgesics|analgesics|mesh-ancestor
2007260|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
2007261|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007262|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007263|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2007264|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007265|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2007266|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2007267|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
2007268|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
2007269|NCT01235442|Hormones|hormones|mesh-ancestor
2007270|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2007271|NCT01235507|Methotrexate|methotrexate|mesh-list
2007272|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2007273|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
2007274|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2007275|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007276|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2007277|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
2007278|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007279|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007280|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
2007281|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007282|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2007283|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2007284|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
2007285|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007286|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2007287|NCT01235546|Azithromycin|azithromycin|mesh-list
2007288|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2007289|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2007290|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
2007291|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2007292|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
2007293|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007294|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007295|NCT01235689|Prednisone|prednisone|mesh-list
2007296|NCT01235689|Adalimumab|adalimumab|mesh-list
2007297|NCT01235689|Azathioprine|azathioprine|mesh-list
2007298|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2007299|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
2007300|NCT01235689|Hormones|hormones|mesh-ancestor
2007301|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2007302|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007303|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2007304|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007305|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007306|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
2007307|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007308|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2007309|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2007310|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
2007311|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2007312|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
2007313|NCT01235715|Coagulants|coagulants|mesh-ancestor
2007314|NCT01235728|Calcitriol|calcitriol|mesh-list
2007315|NCT01235728|MK 0873|mk 0873|mesh-list
2007316|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2007317|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007318|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2007319|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007320|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007321|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2007322|NCT01235728|Vitamins|vitamins|mesh-ancestor
2007323|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
2007324|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2007325|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2007326|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2007327|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007328|NCT01235741|Pramlintide|pramlintide|mesh-list
2007329|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2007330|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007331|NCT01235793|Temozolomide|temozolomide|mesh-list
2007332|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2007333|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
2007334|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007335|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007336|NCT01235897|Paclitaxel|paclitaxel|mesh-list
2007337|NCT01235897|Trastuzumab|trastuzumab|mesh-list
2007338|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2007339|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007340|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
2007341|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
2007342|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
2007343|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007344|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2007345|NCT01235910|Cyclosporine|cyclosporine|mesh-list
2007346|NCT01235910|Cyclosporins|cyclosporins|mesh-list
2007347|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007348|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007349|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2007350|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
2007351|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007352|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
2007353|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2007354|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
2007355|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007356|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2007357|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
2007358|NCT01235923|Hematinics|hematinics|mesh-ancestor
2007359|NCT01235949|Acetaminophen|acetaminophen|mesh-list
2007360|NCT01235949|Ibuprofen|ibuprofen|mesh-list
2007361|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2007362|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2007363|NCT01235949|Analgesics|analgesics|mesh-ancestor
2007364|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
2007365|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007366|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007367|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2007368|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007369|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2007370|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007371|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007372|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
2007373|NCT01236001|Lacosamide|lacosamide|mesh-list
2007374|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
2007375|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2007376|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2007377|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007378|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007379|NCT01236053|Gabapentin|gabapentin|mesh-list
2007380|NCT01236053|Analgesics|analgesics|mesh-ancestor
2007381|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
2007382|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007383|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007384|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
2007385|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2007386|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2007387|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2007388|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2007389|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2007390|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2007391|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007392|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007393|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
2007394|NCT01236105|Charcoal|charcoal|mesh-list
2007395|NCT01236105|Antidotes|antidotes|mesh-ancestor
2007396|NCT01236105|Protective Agents|protective agents|mesh-ancestor
2007397|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007398|NCT01236118|Ixekizumab|ixekizumab|mesh-list
2007399|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
2007400|NCT01236365|Atorvastatin|atorvastatin|mesh-list
2007401|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2007402|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2007403|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
2007404|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007405|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2007406|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2007407|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007408|NCT01236378|Sirolimus|sirolimus|mesh-list
2007409|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2007410|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2007411|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2007412|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007413|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
2007414|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2007415|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
2007416|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007417|NCT01236521|Analgesics|analgesics|mesh-list
2007418|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
2007419|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007420|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007421|NCT01236534|Lubiprostone|lubiprostone|mesh-list
2007422|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2007423|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007424|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007425|NCT01236547|Paclitaxel|paclitaxel|mesh-list
2007426|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2007427|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2007428|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007429|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
2007430|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
2007431|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
2007432|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007433|NCT01236560|Bevacizumab|bevacizumab|mesh-list
2007434|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2007435|NCT01236560|Temozolomide|temozolomide|mesh-list
2007436|NCT01236560|Vorinostat|vorinostat|mesh-list
2007437|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
2007438|NCT01236560|Antibodies|antibodies|mesh-list
2007439|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
2007440|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2007441|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
2007442|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007443|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2007444|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2007445|NCT01236560|Growth Substances|growth substances|mesh-ancestor
2007446|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007447|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
2007448|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
2007449|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2007450|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
2007451|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007452|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2007453|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007454|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
2007455|NCT01236573|Fludarabine|fludarabine|mesh-list
2007456|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2007457|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
2007458|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007459|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007460|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2007461|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
2007462|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007463|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007464|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2007465|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
2007466|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
2007467|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
2007468|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2007469|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007470|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2007471|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2007472|NCT01237041|Niacin|niacin|mesh-list
2007473|NCT01237041|Niacinamide|niacinamide|mesh-list
2007474|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
2007475|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2007476|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
2079364|NCT02057640|Dexamethasone|dexamethasone|mesh-list
2007477|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007478|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2007479|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
2007480|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
2007481|NCT01237041|Vitamins|vitamins|mesh-ancestor
2007482|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
2007483|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007484|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2007485|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2007486|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007487|NCT01237197|Exenatide|exenatide|mesh-list
2007488|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2007489|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007490|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2007491|NCT01237197|Incretins|incretins|mesh-ancestor
2007492|NCT01237197|Hormones|hormones|mesh-ancestor
2007493|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2007494|NCT01237223|Amlodipine|amlodipine|mesh-list
2007495|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2007496|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2007497|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007498|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007499|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2007500|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007501|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
2007502|NCT01237327|Exemestane|exemestane|mesh-list
2007503|NCT01237327|Megestrol|megestrol|mesh-list
2007504|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
2007505|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007506|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2007507|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2007508|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007509|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007510|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2007511|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
2007512|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2007513|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007514|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2007515|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2007516|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2007517|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
2007518|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2007519|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2007520|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2007521|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2007522|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
2007523|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2007524|NCT01237353|Rabeprazole|rabeprazole|mesh-list
2007525|NCT01237353|Betaine|betaine|mesh-list
2007526|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2007527|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2007528|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2007529|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007530|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007531|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
2007532|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2007533|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
2007534|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2007535|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2007536|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2007537|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2007538|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007539|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007540|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007541|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007542|NCT01237587|Analgesics|analgesics|mesh-ancestor
2007543|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
2007544|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007545|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
2007546|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2007547|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
2007548|NCT01237678|Carboplatin|carboplatin|mesh-list
2007549|NCT01237678|Etoposide|etoposide|mesh-list
2007550|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
2007551|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007552|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2007553|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2007554|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2007555|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007556|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007557|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2007558|NCT01237899|Eplerenone|eplerenone|mesh-list
2007559|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2007560|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
2007561|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2007562|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007563|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2007564|NCT01237899|Diuretics|diuretics|mesh-ancestor
2007565|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
2007566|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2007567|NCT01237951|Gemcitabine|gemcitabine|mesh-list
2007568|NCT01237951|Dexamethasone|dexamethasone|mesh-list
2007569|NCT01237951|Melphalan|melphalan|mesh-list
2007570|NCT01237951|Busulfan|busulfan|mesh-list
2007571|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2007572|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
2007573|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
2007574|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007575|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007576|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2007577|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
2007578|NCT01237951|Hormones|hormones|mesh-ancestor
2007579|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2007580|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2007581|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007582|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2007583|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
2007584|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007585|NCT01237951|Antiviral Agents|antiviral agents|mesh-ancestor
2007586|NCT01237951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2007587|NCT01237951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007588|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2007589|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
2007590|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2007591|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
2007592|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2007593|NCT01238120|Ibuprofen|ibuprofen|mesh-list
2007594|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2007595|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2007596|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2007597|NCT01238120|Analgesics|analgesics|mesh-ancestor
2007598|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
2007599|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007600|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007601|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007602|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2007603|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007604|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745968|NCT02109081|Dexamethasone|dexamethasone|mesh-list
2745969|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2745970|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
2745971|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
2745972|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2745973|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745974|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2745975|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
2007622|NCT01238471|Propranolol|propranolol|mesh-list
2007623|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2007624|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2007625|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
2007626|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007627|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007628|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007629|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2007630|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2007631|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
2007632|NCT01238536|Dexamethasone|dexamethasone|mesh-list
2007633|NCT01238536|Betamethasone|betamethasone|mesh-list
2007634|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2007635|NCT01238536|Lidocaine|lidocaine|mesh-list
2007636|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
2007637|NCT01238536|Anesthetics|anesthetics|mesh-list
2007638|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2007639|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
2007640|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
2007641|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007642|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007643|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2007644|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
2007645|NCT01238536|Hormones|hormones|mesh-ancestor
2007646|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2007647|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2007648|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007649|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007650|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2007651|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
2007652|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2007653|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2007654|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2007655|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007656|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2007657|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
2007658|NCT01238575|Guanfacine|guanfacine|mesh-list
2007659|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2007660|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2007661|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2007662|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2007663|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
2007664|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007665|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007666|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007667|NCT01238588|Sevelamer|sevelamer|mesh-list
2007668|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
2007669|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
2007670|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007671|NCT01238640|Nicotine|nicotine|mesh-list
2007672|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2007673|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
2007674|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007675|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007676|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2007677|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2007678|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
2007679|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007680|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007681|NCT01238822|Methylphenidate|methylphenidate|mesh-list
2007682|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2007683|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007684|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2007685|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2007686|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007687|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007688|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
2007689|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007690|NCT01238861|Benralizumab|benralizumab|mesh-list
2007691|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2007692|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
2007693|NCT01239212|Levetiracetam|levetiracetam|mesh-list
2007694|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
2007695|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
2007696|NCT01239342|Everolimus|everolimus|mesh-list
2007697|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007698|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2007699|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
2007700|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745976|NCT02109081|Hormones|hormones|mesh-ancestor
2745977|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2745978|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2745979|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007710|NCT01239394|Ofatumumab|ofatumumab|mesh-list
2007711|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007712|NCT01239472|Everolimus|everolimus|mesh-list
2007713|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007714|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2007715|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
2007716|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007717|NCT01239732|Paclitaxel|paclitaxel|mesh-list
2007718|NCT01239732|Bevacizumab|bevacizumab|mesh-list
2007719|NCT01239732|Carboplatin|carboplatin|mesh-list
2007720|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2007721|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007722|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
2007723|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
2007724|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
2007725|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007726|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2007727|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2007728|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2007729|NCT01239732|Growth Substances|growth substances|mesh-ancestor
2007730|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007731|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
2007732|NCT01239745|Exemestane|exemestane|mesh-list
2007733|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007734|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2007735|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2007736|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007737|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007738|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2007739|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
2007740|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2007741|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007742|NCT01239797|Dexamethasone|dexamethasone|mesh-list
2007743|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
2007744|NCT01239797|Lenalidomide|lenalidomide|mesh-list
2007745|NCT01239797|Elotuzumab|elotuzumab|mesh-list
2007746|NCT01239797|BB 1101|bb 1101|mesh-list
2007747|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2007748|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
2007749|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
2007750|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007751|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007752|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2007753|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
2007754|NCT01239797|Hormones|hormones|mesh-ancestor
2007755|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2007756|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2007757|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007758|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
2007759|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007760|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007761|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
2007762|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2007763|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2007764|NCT01239797|Growth Substances|growth substances|mesh-ancestor
2007765|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
2007766|NCT01239992|Niacin|niacin|mesh-list
2007767|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2007768|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
2007769|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007770|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2007771|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
2007772|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
2007773|NCT01239992|Vitamins|vitamins|mesh-ancestor
2007774|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
2007775|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007776|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2007777|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
2007778|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2007779|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007780|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2007781|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2007782|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
2007783|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2007784|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
2007785|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007786|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
2007787|NCT01240382|Protective Agents|protective agents|mesh-ancestor
2007788|NCT01240590|Cisplatin|cisplatin|mesh-list
2007789|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007790|NCT01240746|Vaccines|vaccines|mesh-list
2007791|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
2007792|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007793|NCT01240785|Metformin|metformin|mesh-list
2007794|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2007795|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007796|NCT01240811|Copper|copper|mesh-list
2007797|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
2007798|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2007799|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
2007800|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2007801|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007802|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2007803|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2007804|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2007805|NCT01240811|Trace Elements|trace elements|mesh-ancestor
2007806|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
2007807|NCT01240863|Hydrocodone|hydrocodone|mesh-list
2007808|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2007809|NCT01240863|Narcotics|narcotics|mesh-ancestor
2007810|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2007811|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007812|NCT01240863|Analgesics|analgesics|mesh-ancestor
2007813|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
2007814|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007815|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
2007816|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
2007817|NCT01241240|Timolol|timolol|mesh-list
2007818|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2007819|NCT01241240|Bimatoprost|bimatoprost|mesh-list
2007820|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2007821|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2007822|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2007823|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2007824|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
2007825|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007826|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007827|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007828|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2007829|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2007830|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2007831|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2007832|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2007833|NCT01241292|Elotuzumab|elotuzumab|mesh-list
2007834|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007835|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
2007836|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2007837|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2007838|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2007839|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
2007840|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
2007841|NCT01241344|Brincidofovir|brincidofovir|mesh-list
2007842|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
2007843|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2007844|NCT01241539|Dabigatran|dabigatran|mesh-list
2007845|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
2007846|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2007847|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
2007848|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007849|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007850|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
2007851|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2007852|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
2007853|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007854|NCT01241591|Etanercept|etanercept|mesh-list
2007855|NCT01241591|Tofacitinib|tofacitinib|mesh-list
2007856|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2007857|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2007858|NCT01241591|Analgesics|analgesics|mesh-ancestor
2007859|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
2007860|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007861|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007862|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2007863|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007864|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2007865|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2007866|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
2007867|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2007868|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007869|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007870|NCT01241760|Interferons|interferons|mesh-list
2007871|NCT01241760|Ribavirin|ribavirin|mesh-list
2007872|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
2007873|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
2007874|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2007875|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007876|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
2007877|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2007878|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
2007879|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007880|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
2007881|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007882|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2007883|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2007884|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2007885|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
2007886|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007887|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2007888|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2007889|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007890|NCT01242176|Empagliflozin|empagliflozin|mesh-list
2007891|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2007892|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007893|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2007894|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007895|NCT01242241|Propofol|propofol|mesh-list
2007896|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2007897|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2007898|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007899|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2007900|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
2007901|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
2007902|NCT01242644|Ketorolac|ketorolac|mesh-list
2007903|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2007904|NCT01242644|Morphine|morphine|mesh-list
2007905|NCT01242644|Ropivacaine|ropivacaine|mesh-list
2007906|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2007907|NCT01242644|Narcotics|narcotics|mesh-ancestor
2007908|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2007909|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007910|NCT01242644|Analgesics|analgesics|mesh-ancestor
2007911|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
2007912|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007913|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
2007914|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
2007915|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2007916|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2007917|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2007918|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2007919|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2007920|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007921|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007922|NCT01242748|Goserelin|goserelin|mesh-list
2007923|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2007924|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2007925|NCT01243112|Lidocaine|lidocaine|mesh-list
2007926|NCT01243112|Epinephrine|epinephrine|mesh-list
2007927|NCT01243112|Racepinephrine|racepinephrine|mesh-list
2007928|NCT01243112|Bupivacaine|bupivacaine|mesh-list
2007929|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
2007930|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
2007931|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
2007932|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2007933|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007934|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
2007935|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007936|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2007937|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2007938|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2007939|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007940|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007941|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2007942|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2007943|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
2007944|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2007945|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2007946|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2007947|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
2007948|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2007949|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
2007950|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
2007951|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
2007952|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2007953|NCT01243151|Bococizumab|bococizumab|mesh-list
2007954|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2007955|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2007956|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
2007957|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007958|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2007959|NCT01243177|Lacosamide|lacosamide|mesh-list
2007960|NCT01243177|Carbamazepine|carbamazepine|mesh-list
2007961|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
2007962|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2007963|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2007964|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2007965|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007966|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
2007967|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2007968|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2007969|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2007970|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2007971|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2007972|NCT01243177|Analgesics|analgesics|mesh-ancestor
2007973|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
2007974|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2007975|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2007976|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2007977|NCT01243242|Metadoxine|metadoxine|mesh-list
2007978|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2007979|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2007980|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2007981|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2007982|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2007983|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007984|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
2007985|NCT01243333|Alovudine|alovudine|mesh-list
2007986|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
2007987|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2007988|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2007989|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2007990|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
2007991|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
2007992|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2007993|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2007994|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2007995|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2007996|NCT01243424|Glimepiride|glimepiride|mesh-list
2007997|NCT01243424|Linagliptin|linagliptin|mesh-list
2007998|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2007999|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2008000|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008001|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2008002|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
2008003|NCT01243424|Incretins|incretins|mesh-ancestor
2008004|NCT01243424|Hormones|hormones|mesh-ancestor
2008005|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2008006|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2008007|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
2008008|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008009|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008010|NCT01243450|Tretinoin|tretinoin|mesh-list
2008011|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008012|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
2008013|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
2008014|NCT01243567|Timolol|timolol|mesh-list
2008015|NCT01243567|Bimatoprost|bimatoprost|mesh-list
2008016|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2008017|NCT01243567|Latanoprost|latanoprost|mesh-list
2008018|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2008019|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2008020|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2008021|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
2008022|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008023|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008024|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008025|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2008026|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2008027|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
2008028|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
2008029|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2008030|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
2008031|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2008032|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008033|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2008034|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2008035|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2008036|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2008037|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2008038|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008039|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008040|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008041|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2008042|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2008043|NCT01243593|Anesthetics|anesthetics|mesh-list
2008044|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2008045|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008046|NCT01243671|Adalimumab|adalimumab|mesh-list
2008047|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2008048|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2008049|NCT01243775|Docetaxel|docetaxel|mesh-list
2008050|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
2008051|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008052|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
2008053|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
2008054|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
2008055|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008056|NCT01243944|Lenalidomide|lenalidomide|mesh-list
2008057|NCT01243944|Pomalidomide|pomalidomide|mesh-list
2008058|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
2008059|NCT01243944|Pipobroman|pipobroman|mesh-list
2008060|NCT01243944|Anagrelide|anagrelide|mesh-list
2008061|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
2008062|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008063|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2008064|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2008065|NCT01243944|Growth Substances|growth substances|mesh-ancestor
2008066|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
2008067|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008068|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
2008069|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008070|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008071|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2008072|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2008073|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2008074|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2008075|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2008076|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
2008077|NCT01243957|Fluoxetine|fluoxetine|mesh-list
2008078|NCT01243957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2008079|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2008080|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008081|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008082|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008083|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
2008084|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008085|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2008086|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
2008087|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2008088|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2008089|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2008090|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008091|NCT01244061|Varenicline|varenicline|mesh-list
2008092|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2008093|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2008094|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
2008095|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008096|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008097|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008098|NCT01244126|Fentanyl|fentanyl|mesh-list
2008099|NCT01244126|Morphine|morphine|mesh-list
2008100|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2008101|NCT01244126|Narcotics|narcotics|mesh-ancestor
2008102|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2008103|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008104|NCT01244126|Analgesics|analgesics|mesh-ancestor
2008105|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
2008106|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008107|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2008108|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2008109|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
2008110|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
2008111|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2008112|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008113|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2008114|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008115|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008116|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2008117|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
2008118|NCT01244425|Coagulants|coagulants|mesh-ancestor
2008119|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2008120|NCT01244451|Ofatumumab|ofatumumab|mesh-list
2008121|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2008122|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
2008123|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008124|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008125|NCT01244490|Guanfacine|guanfacine|mesh-list
2008126|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2008127|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2008128|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2008129|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008130|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008131|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
2008132|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008133|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008134|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2008135|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2008136|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2008137|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2008138|NCT01244633|Ecopipam|ecopipam|mesh-list
2008139|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2008140|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2008141|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2008142|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008143|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2008144|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2008145|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
2008146|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008147|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008148|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2008149|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
2008150|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2008151|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2008152|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2008153|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2008154|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008155|NCT01244724|Citalopram|citalopram|mesh-list
2008156|NCT01244724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2008157|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2008158|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008159|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008160|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008161|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
2008162|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008163|NCT01244724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2008164|NCT01244724|Antidepressive Agents|antidepressive agents|mesh-ancestor
2008165|NCT01244724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2008166|NCT01244815|Asenapine|asenapine|mesh-list
2008167|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2008168|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2008169|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2008170|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008171|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2008172|NCT01244828|Asenapine|asenapine|mesh-list
2008173|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2008174|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2008175|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2008176|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008177|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2008178|NCT01244984|Fluticasone|fluticasone|mesh-list
2008179|NCT01244984|Xhance|xhance|mesh-list
2008180|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2008181|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2008182|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
2008183|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008184|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008185|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2008186|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
2008187|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
2008188|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2008189|NCT01245062|Trametinib|trametinib|mesh-list
2008190|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008191|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2008192|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008193|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008194|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
2008195|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2008196|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2008197|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
2008198|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2008199|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2008200|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2008201|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008202|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008203|NCT01245140|Alitretinoin|alitretinoin|mesh-list
2008204|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008205|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
2008206|NCT01245595|Aminophylline|aminophylline|mesh-list
2008207|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2008208|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
2008209|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008210|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008211|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2008212|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
2008213|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2008214|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2008215|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008216|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008217|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2008218|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2008219|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
2008220|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008221|NCT01245595|Protective Agents|protective agents|mesh-ancestor
2008222|NCT01245647|Naltrexone|naltrexone|mesh-list
2008223|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2008224|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2008225|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008226|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
2008227|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008228|NCT01245673|Lenalidomide|lenalidomide|mesh-list
2008229|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2008230|NCT01245673|Poly ICLC|poly iclc|mesh-list
2008231|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
2008232|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008233|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2008234|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2008235|NCT01245673|Growth Substances|growth substances|mesh-ancestor
2008236|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
2008237|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008238|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
2008239|NCT01246063|Dexamethasone|dexamethasone|mesh-list
2008240|NCT01246063|Doxorubicin|doxorubicin|mesh-list
2008241|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2008242|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2008243|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
2008244|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
2008245|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008246|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008247|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2008248|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
2008249|NCT01246063|Hormones|hormones|mesh-ancestor
2008250|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2008251|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2008252|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008253|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2008254|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2008255|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2008256|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008257|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008258|NCT01246076|Lenalidomide|lenalidomide|mesh-list
2008259|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
2008260|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008261|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2008262|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2008263|NCT01246076|Growth Substances|growth substances|mesh-ancestor
2008264|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
2008265|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008266|NCT01246206|Tacrolimus|tacrolimus|mesh-list
2008267|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
2008268|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2008269|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
2008270|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008271|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2008272|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008273|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008274|NCT01246401|Naltrexone|naltrexone|mesh-list
2008275|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2008276|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2008277|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008278|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
2008279|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008280|NCT01246583|Tofacitinib|tofacitinib|mesh-list
2008281|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2008282|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008283|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008284|NCT01246713|Acetaminophen|acetaminophen|mesh-list
2008285|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2008286|NCT01246713|Analgesics|analgesics|mesh-ancestor
2008287|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
2008288|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008289|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008290|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
2008291|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2008292|NCT01246791|Norethindrone|norethindrone|mesh-list
2008293|NCT01246791|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2008294|NCT01246791|Norinyl|norinyl|mesh-list
2008295|NCT01246791|Estradiol|estradiol|mesh-list
2008296|NCT01246791|Estrogens|estrogens|mesh-ancestor
2008297|NCT01246791|Hormones|hormones|mesh-ancestor
2008298|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2008299|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008300|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2008301|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
2008302|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2008303|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2008304|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2008305|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2008306|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2008307|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2008308|NCT01246791|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2008309|NCT01246960|Leucovorin|leucovorin|mesh-list
2008310|NCT01246960|Fluorouracil|fluorouracil|mesh-list
2008311|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
2008312|NCT01246960|Ramucirumab|ramucirumab|mesh-list
2008313|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
2008314|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008315|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2008316|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008317|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2008318|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
2008319|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008320|NCT01246960|Antidotes|antidotes|mesh-ancestor
2008321|NCT01246960|Protective Agents|protective agents|mesh-ancestor
2008322|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
2008323|NCT01246960|Vitamins|vitamins|mesh-ancestor
2008324|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
2008325|NCT01246973|Curcumin|curcumin|mesh-list
2008326|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2008327|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2008328|NCT01246973|Analgesics|analgesics|mesh-ancestor
2008329|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
2008330|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008331|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008332|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2008333|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2008334|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008335|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008336|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008337|NCT01246986|Sorafenib|sorafenib|mesh-list
2008338|NCT01246986|Ramucirumab|ramucirumab|mesh-list
2008339|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008340|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2008341|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008342|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008343|NCT01246999|Vaccines|vaccines|mesh-list
2008344|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
2008345|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008346|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2008347|NCT01247090|Vasopressins|vasopressins|mesh-list
2008348|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
2008349|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
2008350|NCT01247090|Coagulants|coagulants|mesh-ancestor
2008351|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2008352|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2008353|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
2008354|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008355|NCT01247220|Ranibizumab|ranibizumab|mesh-list
2008356|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2008357|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2008358|NCT01247220|Growth Substances|growth substances|mesh-ancestor
2008359|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008360|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
2008361|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008362|NCT01247272|Fluoxetine|fluoxetine|mesh-list
2008363|NCT01247272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2008364|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2008365|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008366|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008367|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008368|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
2008369|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008370|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2008371|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
2008372|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2008373|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2008374|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2008375|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008376|NCT01247285|Fluoxetine|fluoxetine|mesh-list
2008377|NCT01247285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2008378|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2008379|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008380|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008381|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008382|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
2008383|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008384|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2008385|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
2008386|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2008387|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2008388|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2008389|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008400|NCT01247363|Globalagliatin|globalagliatin|mesh-list
2008401|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
2008402|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008403|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2008404|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008405|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2008406|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008407|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008408|NCT01248065|Vitamin D|vitamin d|mesh-list
2008409|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
2008410|NCT01248065|Ciclesonide|ciclesonide|mesh-list
2008411|NCT01248065|Vitamins|vitamins|mesh-ancestor
2008412|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
2008413|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008414|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2008415|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2008416|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
2008417|NCT01248065|Hormones|hormones|mesh-ancestor
2008418|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2008419|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2008420|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
2008421|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
2008422|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2008423|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2008424|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008425|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
2008426|NCT01248104|Coagulants|coagulants|mesh-ancestor
2008427|NCT01248364|Empagliflozin|empagliflozin|mesh-list
2008428|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2008429|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008430|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2008431|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008432|NCT01248416|Letrozole|letrozole|mesh-list
2008433|NCT01248416|Anastrozole|anastrozole|mesh-list
2008434|NCT01248416|Hormones|hormones|mesh-list
2008435|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2008436|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2008437|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008438|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008439|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2008440|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008441|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008442|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2008443|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
2008444|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2008445|NCT01248468|Aspirin|aspirin|mesh-list
2008446|NCT01248468|Acetaminophen|acetaminophen|mesh-list
2008447|NCT01248468|Sumatriptan|sumatriptan|mesh-list
2008448|NCT01248468|Caffeine|caffeine|mesh-list
2008449|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2008450|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2008451|NCT01248468|Analgesics|analgesics|mesh-ancestor
2008452|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
2008453|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008454|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008455|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2008456|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2008457|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2008458|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2008459|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008460|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2008461|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2008462|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008463|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
2008464|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2008465|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2008466|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2008467|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2008468|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
2008469|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008470|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2008471|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2008472|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2008473|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
2008474|NCT01248585|Dexamethasone|dexamethasone|mesh-list
2008475|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2008476|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
2008477|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
2008478|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008479|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008480|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2008481|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
2008482|NCT01248585|Hormones|hormones|mesh-ancestor
2008483|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2008484|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2008485|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008486|NCT01248715|Oseltamivir|oseltamivir|mesh-list
2008487|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
2008488|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2008489|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008490|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008491|NCT01248780|Golimumab|golimumab|mesh-list
2008492|NCT01248780|Methotrexate|methotrexate|mesh-list
2008493|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2008494|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
2008495|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2008496|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008497|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2008498|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
2008499|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008500|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008501|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
2008502|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008503|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2008504|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2008505|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
2008506|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2008507|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2008508|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2008509|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2008510|NCT01248793|Golimumab|golimumab|mesh-list
2008511|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2008512|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2008513|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2008514|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2008515|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
2008516|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008517|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2008518|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
2008519|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008520|NCT01248949|Paclitaxel|paclitaxel|mesh-list
2008521|NCT01248949|Bevacizumab|bevacizumab|mesh-list
2008522|NCT01248949|Carboplatin|carboplatin|mesh-list
2008523|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2008524|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008525|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
2008526|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
2008527|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
2008528|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008529|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2008530|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2008531|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2008532|NCT01248949|Growth Substances|growth substances|mesh-ancestor
2008533|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008534|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
2008535|NCT01248962|Carboplatin|carboplatin|mesh-list
2008536|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008537|NCT01249027|Everolimus|everolimus|mesh-list
2008538|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008539|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2008540|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
2008541|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008542|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
2008543|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2008544|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008545|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008546|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2008547|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2008548|NCT01249092|Protective Agents|protective agents|mesh-ancestor
2008549|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008550|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
2008551|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2008552|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
2008553|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
2008554|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
2008555|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2008556|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008557|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008558|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2008559|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008560|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2008561|NCT01249274|Progesterone|progesterone|mesh-list
2008562|NCT01249274|Progestins|progestins|mesh-ancestor
2008563|NCT01249274|Hormones|hormones|mesh-ancestor
2008564|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2008565|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008566|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
2008567|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2008568|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2008569|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2008570|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008571|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008572|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
2008573|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008574|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008575|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2008576|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008577|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
2008578|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2008579|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2008580|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2008581|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008582|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008583|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
2008584|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008585|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008586|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2008587|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008588|NCT01249651|Esomeprazole|esomeprazole|mesh-list
2008589|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2008590|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2008591|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2008592|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008593|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008594|NCT01249664|Aflibercept|aflibercept|mesh-list
2008595|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2008596|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2008597|NCT01249664|Growth Substances|growth substances|mesh-ancestor
2008598|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008599|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
2008600|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008601|NCT01249833|Oseltamivir|oseltamivir|mesh-list
2008602|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
2008603|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2008604|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008605|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008606|NCT01249872|Morphine|morphine|mesh-list
2008607|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
2008608|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2008609|NCT01249872|Narcotics|narcotics|mesh-ancestor
2008610|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2008611|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008612|NCT01249872|Analgesics|analgesics|mesh-ancestor
2008613|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
2008614|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008615|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
2008616|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
2008617|NCT01250002|Lidocaine|lidocaine|mesh-list
2008618|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
2008619|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
2008620|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2008621|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008622|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
2008623|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008624|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2008625|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2008626|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2008627|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008628|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008629|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2008630|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008631|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2008632|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008633|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008634|NCT01250145|Teriparatide|teriparatide|mesh-list
2008635|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2008636|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008637|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2008638|NCT01250184|Lidocaine|lidocaine|mesh-list
2008639|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
2008640|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
2008641|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2008642|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008643|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
2008644|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008645|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2008646|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2008647|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2008648|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008649|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008650|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
2008651|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2008652|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2008653|NCT01250210|Estradiol|estradiol|mesh-list
2008654|NCT01250210|Estrogens|estrogens|mesh-ancestor
2008655|NCT01250210|Hormones|hormones|mesh-ancestor
2008656|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2008657|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008658|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2008659|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
2008660|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2008661|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2008662|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2008663|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2008664|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2008665|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2008666|NCT01250379|Bevacizumab|bevacizumab|mesh-list
2008667|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2008668|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008669|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2008670|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2008671|NCT01250379|Growth Substances|growth substances|mesh-ancestor
2008672|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008673|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
2008674|NCT01250418|Ketamine|ketamine|mesh-list
2008675|NCT01250418|Analgesics|analgesics|mesh-ancestor
2008676|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
2008677|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008678|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008679|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2008680|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2008681|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
2008682|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
2008683|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2008684|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2008685|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2008686|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008687|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008688|NCT01250717|Dexamethasone|dexamethasone|mesh-list
2008689|NCT01250717|Goserelin|goserelin|mesh-list
2008690|NCT01250717|Estramustine|estramustine|mesh-list
2008691|NCT01250717|Docetaxel|docetaxel|mesh-list
2008692|NCT01250717|Bicalutamide|bicalutamide|mesh-list
2008693|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2008694|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
2008695|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
2008696|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008697|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008698|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2008699|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
2008700|NCT01250717|Hormones|hormones|mesh-ancestor
2008701|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2008702|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2008703|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008704|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
2008705|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
2008706|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
2008707|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008708|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
2008709|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
2008710|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2008711|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
2008712|NCT01250730|Crizotinib|crizotinib|mesh-list
2008713|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008714|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2008715|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008716|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008717|NCT01250756|Vaccines|vaccines|mesh-list
2008718|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2008719|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
2008720|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008721|NCT01250834|Dulaglutide|dulaglutide|mesh-list
2008722|NCT01250834|Atorvastatin|atorvastatin|mesh-list
2008723|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2008724|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2008725|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
2008726|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008727|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2008728|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2008729|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008730|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2008731|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008732|NCT01250873|Sertraline|sertraline|mesh-list
2008733|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
2008734|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2008735|NCT01250873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2008736|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2008737|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008738|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008739|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008740|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
2008741|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008742|NCT01250899|Vitamin D|vitamin d|mesh-list
2008743|NCT01250899|Vitamins|vitamins|mesh-ancestor
2008744|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
2008745|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008746|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2008752|NCT01250977|Donepezil|donepezil|mesh-list
2008753|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2008754|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008755|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008756|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
2008757|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008758|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008759|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
2008760|NCT01250990|Niacin|niacin|mesh-list
2008761|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2008762|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
2008763|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008764|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2008765|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
2008766|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
2008767|NCT01250990|Vitamins|vitamins|mesh-ancestor
2008768|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
2008769|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008770|NCT01251146|Atenolol|atenolol|mesh-list
2008771|NCT01251146|Bisoprolol|bisoprolol|mesh-list
2008772|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2008773|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2008774|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
2008775|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
2008776|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008777|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008778|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2008779|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2008780|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2008781|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
2008782|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008783|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008784|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
2008785|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2008786|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
2008787|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2008788|NCT01251315|Expectorants|expectorants|mesh-ancestor
2008789|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
2008790|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2008791|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
2008792|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008793|NCT01251315|Protective Agents|protective agents|mesh-ancestor
2008794|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008795|NCT01251315|Antidotes|antidotes|mesh-ancestor
2008796|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
2008797|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2008798|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2008799|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2008800|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008801|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008802|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
2008803|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008804|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008805|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2008806|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008807|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
2008808|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2008809|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2008810|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2008811|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008812|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008813|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
2008814|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008815|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008816|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2008817|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008818|NCT01251393|Biperiden|biperiden|mesh-list
2008819|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2008820|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2008821|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
2008822|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
2008823|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008824|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008825|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2008826|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2008827|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
2008828|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2008829|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008830|NCT01251536|Cetuximab|cetuximab|mesh-list
2008831|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2008832|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008833|NCT01251575|Cyclosporine|cyclosporine|mesh-list
2008834|NCT01251575|Sirolimus|sirolimus|mesh-list
2008835|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
2008836|NCT01251575|Fludarabine|fludarabine|mesh-list
2008837|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
2008838|NCT01251575|Cyclosporins|cyclosporins|mesh-list
2008839|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008840|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2008841|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
2008842|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008843|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2008844|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
2008845|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008846|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008847|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
2008848|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2008849|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
2008850|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2008851|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2008852|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2008853|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2008854|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
2008855|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2008856|NCT01251614|Adalimumab|adalimumab|mesh-list
2008857|NCT01251614|Methotrexate|methotrexate|mesh-list
2008858|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2008859|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
2008860|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2008861|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008862|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2008863|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
2008864|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008865|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008866|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
2008867|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008868|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2008869|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2008870|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
2008871|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2008872|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2008873|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2008874|NCT01251653|Gemcitabine|gemcitabine|mesh-list
2008875|NCT01251653|Docetaxel|docetaxel|mesh-list
2008876|NCT01251653|Afatinib|afatinib|mesh-list
2008877|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2008878|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
2008879|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008880|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008881|NCT01251653|Antiviral Agents|antiviral agents|mesh-ancestor
2008882|NCT01251653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2008883|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008884|NCT01251653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2008885|NCT01251653|Immunologic Factors|immunologic factors|mesh-ancestor
2008886|NCT01251653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008887|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
2008888|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
2008889|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
2008890|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2008891|NCT01251861|Bicalutamide|bicalutamide|mesh-list
2008892|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
2008893|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
2008894|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2008895|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008896|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008897|NCT01251978|Ranibizumab|ranibizumab|mesh-list
2008898|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2008899|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2008900|NCT01251978|Growth Substances|growth substances|mesh-ancestor
2008901|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008902|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
2008903|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008904|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2008905|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
2008906|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
2008907|NCT01252186|Desogestrel|desogestrel|mesh-list
2008908|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
2008909|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2008910|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008911|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2008912|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2008913|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2008914|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2008915|NCT01252186|Progestins|progestins|mesh-ancestor
2008916|NCT01252186|Hormones|hormones|mesh-ancestor
2008917|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2008918|NCT01252238|Amlodipine|amlodipine|mesh-list
2008919|NCT01252238|Valsartan|valsartan|mesh-list
2008920|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2008921|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2008922|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008923|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008924|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2008925|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008926|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
2008927|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2008928|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2008929|NCT01252251|Everolimus|everolimus|mesh-list
2008930|NCT01252251|Pasireotide|pasireotide|mesh-list
2008931|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008932|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2008933|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
2008934|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008935|NCT01252251|Hormones|hormones|mesh-ancestor
2008936|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2008937|NCT01252355|Interferons|interferons|mesh-list
2008938|NCT01252355|Interferon-beta|interferon-beta|mesh-list
2008939|NCT01252355|Teriflunomide|teriflunomide|mesh-list
2008940|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008941|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
2008942|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2008943|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
2008944|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008945|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2008946|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2008947|NCT01252355|Analgesics|analgesics|mesh-ancestor
2008948|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
2008949|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2008950|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2008951|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2008952|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2008953|NCT01252563|Amlodipine|amlodipine|mesh-list
2008954|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2008955|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2008956|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2008957|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008958|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2008959|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008960|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
2008961|NCT01252667|Cyclosporine|cyclosporine|mesh-list
2008962|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
2008963|NCT01252667|Clofarabine|clofarabine|mesh-list
2008964|NCT01252667|Cyclosporins|cyclosporins|mesh-list
2008965|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2008966|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2008967|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2008968|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
2008969|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008970|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
2008971|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2008972|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
2008973|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2008974|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2008975|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2008976|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008977|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2008978|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
2008979|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2008980|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2008981|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
2008982|NCT01252732|Vancomycin|vancomycin|mesh-list
2008983|NCT01252732|Oritavancin|oritavancin|mesh-list
2008984|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2008985|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2008986|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
2008987|NCT01252745|Testosterone|testosterone|mesh-list
2008988|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
2008989|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
2008990|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2008991|NCT01252745|Androgens|androgens|mesh-ancestor
2008992|NCT01252745|Hormones|hormones|mesh-ancestor
2008993|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2008994|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2008995|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2008996|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2008997|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
2008998|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
2008999|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
2009000|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009001|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2009002|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2009003|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009004|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009005|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2009006|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2009007|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
2009008|NCT01252953|Anacetrapib|anacetrapib|mesh-list
2009009|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2009010|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2009011|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
2009012|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009013|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2009014|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009015|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2009016|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009017|NCT01253070|Cytarabine|cytarabine|mesh-list
2009018|NCT01253070|Sorafenib|sorafenib|mesh-list
2009019|NCT01253070|Daunorubicin|daunorubicin|mesh-list
2009020|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2009021|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
2009022|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009023|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009024|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
2009025|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009026|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2009027|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
2009028|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009029|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2009030|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009031|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2009032|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2009033|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2009034|NCT01253135|Petrolatum|petrolatum|mesh-list
2009035|NCT01253135|Emollients|emollients|mesh-ancestor
2009036|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
2009037|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
2009038|NCT01253174|Drospirenone|drospirenone|mesh-list
2009039|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2009040|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
2009041|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2009042|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009043|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2009044|NCT01253174|Diuretics|diuretics|mesh-ancestor
2009045|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
2009046|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
2009047|NCT01253174|Vitamins|vitamins|mesh-ancestor
2009048|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
2009049|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
2009050|NCT01253187|Drospirenone|drospirenone|mesh-list
2009051|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2009052|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
2009053|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2009054|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009055|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2009056|NCT01253187|Diuretics|diuretics|mesh-ancestor
2009057|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
2009058|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
2009059|NCT01253187|Vitamins|vitamins|mesh-ancestor
2009060|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
2009061|NCT01253200|Acifluorfen|acifluorfen|mesh-list
2009062|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009063|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009064|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2009065|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
2009066|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009067|NCT01253265|Ixekizumab|ixekizumab|mesh-list
2009068|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
2009069|NCT01253304|Dulaglutide|dulaglutide|mesh-list
2009070|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2009071|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009072|NCT01253317|Mecasermin|mecasermin|mesh-list
2009073|NCT01253317|Growth Substances|growth substances|mesh-ancestor
2009074|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009075|NCT01253408|Dronabinol|dronabinol|mesh-list
2009076|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
2009077|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009078|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2009079|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2009080|NCT01253408|Analgesics|analgesics|mesh-ancestor
2009081|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
2009082|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009083|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2009084|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2009085|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009086|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009087|NCT01253408|Hormones|hormones|mesh-ancestor
2009088|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2009089|NCT01253421|Amisulpride|amisulpride|mesh-list
2009090|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2009091|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2009092|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009093|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009094|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2009095|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2009096|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
2009097|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009098|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009099|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2009100|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
2009101|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
2009102|NCT01253460|Rituximab|rituximab|mesh-list
2009103|NCT01253460|Sapacitabine|sapacitabine|mesh-list
2009104|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2009105|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
2009106|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009107|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2009108|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2009109|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
2009110|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009111|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009112|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2009113|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2009114|NCT01253525|Paclitaxel|paclitaxel|mesh-list
2009115|NCT01253525|Ramucirumab|ramucirumab|mesh-list
2009116|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2009117|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009118|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
2009119|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
2009120|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
2009121|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009122|NCT01253642|Docetaxel|docetaxel|mesh-list
2009123|NCT01253642|Phenelzine|phenelzine|mesh-list
2009124|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009125|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
2009126|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
2009127|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
2009128|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009129|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
2009130|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2009131|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2009132|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009133|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2009134|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2009135|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2009136|NCT01253824|Norethindrone|norethindrone|mesh-list
2009137|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
2009138|NCT01253824|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2009139|NCT01253824|Norinyl|norinyl|mesh-list
2009140|NCT01253824|Mestranol|mestranol|mesh-list
2009141|NCT01253824|Estradiol|estradiol|mesh-list
2009142|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2009143|NCT01253824|Estrogens|estrogens|mesh-ancestor
2009144|NCT01253824|Hormones|hormones|mesh-ancestor
2009145|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2009146|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009147|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2009148|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
2009149|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2009150|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2009151|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2009152|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2009153|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2009154|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2009155|NCT01253824|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2009156|NCT01253902|Bimatoprost|bimatoprost|mesh-list
2009157|NCT01253902|Travoprost|travoprost|mesh-list
2009158|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2009159|NCT01253902|Latanoprost|latanoprost|mesh-list
2009160|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2009161|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2009162|NCT01253980|Amoxicillin|amoxicillin|mesh-list
2009163|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2009164|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009165|NCT01254045|Oxytocin|oxytocin|mesh-list
2009166|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
2009167|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2009168|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009169|NCT01254227|Deferasirox|deferasirox|mesh-list
2009170|NCT01254227|Deferoxamine|deferoxamine|mesh-list
2009171|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2009172|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
2009173|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
2009174|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009175|NCT01254227|Siderophores|siderophores|mesh-ancestor
2009176|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
2009177|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2009178|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
2009179|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2009180|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009181|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2009182|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2009183|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2009184|NCT01254305|Milnacipran|milnacipran|mesh-list
2009185|NCT01254305|Sertraline|sertraline|mesh-list
2009186|NCT01254305|Fluoxetine|fluoxetine|mesh-list
2009187|NCT01254305|Paroxetine|paroxetine|mesh-list
2009188|NCT01254305|Citalopram|citalopram|mesh-list
2009189|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
2009190|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
2009191|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2009192|NCT01254305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2009193|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2009194|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2009195|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009196|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009197|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
2009198|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009199|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2009200|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2009201|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2009202|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009203|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009204|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2009205|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2009206|NCT01254305|Analgesics|analgesics|mesh-ancestor
2009207|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
2009208|NCT01254344|Metronidazole|metronidazole|mesh-list
2009209|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
2009210|NCT01254344|Ertapenem|ertapenem|mesh-list
2009211|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009212|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2009213|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2009214|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2009215|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
2009216|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
2009217|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2009218|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2009219|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009220|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009221|NCT01254396|Urological Agents|urological agents|mesh-ancestor
2009222|NCT01254422|Vaccines|vaccines|mesh-list
2009223|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
2009224|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009225|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2009226|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
2009227|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
2009228|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009229|NCT01254604|Timolol|timolol|mesh-list
2009230|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2009231|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2009232|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
2009233|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009234|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009235|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009236|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2009237|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2009238|NCT01254630|Vaccines|vaccines|mesh-list
2009239|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
2009240|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009241|NCT01254656|Efavirenz|efavirenz|mesh-list
2009242|NCT01254656|Etravirine|etravirine|mesh-list
2009243|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2009244|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2009245|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009246|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009247|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
2009248|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009249|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2009250|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2009251|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2009252|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2009253|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2009254|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2009255|NCT01254669|Vaccines|vaccines|mesh-list
2009256|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
2009257|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009258|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2009259|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
2009260|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2009261|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2009262|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2009263|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009264|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009265|NCT01254877|Ondansetron|ondansetron|mesh-list
2009266|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
2009267|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
2009268|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009269|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009270|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2009271|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
2009272|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
2009273|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2009274|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
2009275|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009276|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009277|NCT01254877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2009278|NCT01254877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2009279|NCT01254877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009280|NCT01254877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2009281|NCT01254877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2009282|NCT01254890|Sorafenib|sorafenib|mesh-list
2009283|NCT01254890|Azacitidine|azacitidine|mesh-list
2009284|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009285|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2009286|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009287|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009288|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2009289|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
2009290|NCT01255137|Axitinib|axitinib|mesh-list
2009291|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009292|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2009293|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009294|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009295|NCT01255163|Exenatide|exenatide|mesh-list
2009296|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2009297|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009298|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2009299|NCT01255163|Incretins|incretins|mesh-ancestor
2009300|NCT01255163|Hormones|hormones|mesh-ancestor
2009301|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2009302|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2009303|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2009304|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2009305|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2009306|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2009307|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
2009308|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009309|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009310|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009311|NCT01255423|Diclofenac|diclofenac|mesh-list
2009312|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2009313|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2009314|NCT01255423|Analgesics|analgesics|mesh-ancestor
2009315|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
2009316|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009317|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009318|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2009319|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2009320|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2009321|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009322|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009323|NCT01255449|Albuterol|albuterol|mesh-list
2009324|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2009325|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
2009326|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009327|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009328|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2009329|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
2009330|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
2009331|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2009332|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2009333|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2009334|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2009335|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
2009336|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009337|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009338|NCT01255670|Metronidazole|metronidazole|mesh-list
2009339|NCT01255670|Penicillins|penicillins|mesh-list
2009340|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009341|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2009342|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2009343|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2009344|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
2009345|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2009346|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
2009347|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009348|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2009349|NCT01255787|Vortioxetine|vortioxetine|mesh-list
2009350|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
2009351|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2009352|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2009353|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2009354|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009355|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009356|NCT01255787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2009357|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2009358|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2009359|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009360|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009361|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
2009362|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2009363|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2009364|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2009365|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2009366|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
2009367|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
2009368|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2009369|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009370|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009371|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2009372|NCT01255904|Analgesics|analgesics|mesh-ancestor
2009373|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
2009374|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009375|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2009376|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2009377|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2009378|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
2009379|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009380|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009381|NCT01256060|Oxytocin|oxytocin|mesh-list
2009382|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
2009383|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2009384|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009385|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
2009386|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2009387|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
2009388|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009389|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009390|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2009391|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
2009392|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2009393|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2009394|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2009395|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
2009396|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009397|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009398|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2009399|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
2009400|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
2009401|NCT01256164|Coagulants|coagulants|mesh-ancestor
2009402|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2009403|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
2009404|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2009405|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2009406|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2009407|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009408|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009409|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2009410|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
2009411|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
2009412|NCT01256190|Coagulants|coagulants|mesh-ancestor
2009413|NCT01256294|Tacrolimus|tacrolimus|mesh-list
2009414|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2009415|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
2009416|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009417|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2009418|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009419|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009420|NCT01256385|Sirolimus|sirolimus|mesh-list
2009421|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2009422|NCT01256385|Cetuximab|cetuximab|mesh-list
2009423|NCT01256385|Antibodies|antibodies|mesh-list
2009424|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
2009425|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2009426|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
2009427|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009428|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009429|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2009430|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009431|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2009432|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
2009433|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2009434|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
2009435|NCT01256398|Leucovorin|leucovorin|mesh-list
2009436|NCT01256398|Folic Acid|folic acid|mesh-list
2009437|NCT01256398|Cytarabine|cytarabine|mesh-list
2009438|NCT01256398|Dexamethasone|dexamethasone|mesh-list
2009439|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
2009440|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
2009441|NCT01256398|Melphalan|melphalan|mesh-list
2009442|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
2009443|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2009444|NCT01256398|Methotrexate|methotrexate|mesh-list
2009445|NCT01256398|Fludarabine|fludarabine|mesh-list
2009446|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
2009447|NCT01256398|Etoposide|etoposide|mesh-list
2009448|NCT01256398|Vincristine|vincristine|mesh-list
2009449|NCT01256398|Daunorubicin|daunorubicin|mesh-list
2009450|NCT01256398|Dasatinib|dasatinib|mesh-list
2009451|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
2009452|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
2009453|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
2009454|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2009455|NCT01256398|Tacrolimus|tacrolimus|mesh-list
2009456|NCT01256398|Antibodies|antibodies|mesh-list
2009457|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
2009458|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2009459|NCT01256398|Lenograstim|lenograstim|mesh-list
2009460|NCT01256398|BB 1101|bb 1101|mesh-list
2009461|NCT01256398|Calcium|calcium|mesh-list
2009462|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
2009463|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2009464|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
2009465|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009466|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2009467|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2009468|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
2009469|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009470|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009471|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2009472|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2009473|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
2009474|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
2009475|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009476|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2009477|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
2009478|NCT01256398|Hormones|hormones|mesh-ancestor
2009479|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2009480|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2009481|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
2009482|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009483|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2009484|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2009485|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2009486|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
2009487|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2009488|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2009489|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
2009490|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
2009491|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2009492|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2009493|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2009494|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2009495|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2009496|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2009497|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
2009498|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009499|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2009500|NCT01256398|Antidotes|antidotes|mesh-ancestor
2009501|NCT01256398|Protective Agents|protective agents|mesh-ancestor
2009502|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
2009503|NCT01256398|Vitamins|vitamins|mesh-ancestor
2009504|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
2009505|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
2009506|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
2009507|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
2009508|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2009509|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2009510|NCT01256398|Hematinics|hematinics|mesh-ancestor
2009511|NCT01256411|Amlodipine|amlodipine|mesh-list
2009512|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2009513|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2009514|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2009515|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2009516|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2009517|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009518|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2009519|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009520|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
2009521|NCT01256411|Diuretics|diuretics|mesh-ancestor
2009522|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
2009523|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2009524|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2009525|NCT01256450|Buprenorphine|buprenorphine|mesh-list
2009526|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2009527|NCT01256450|Narcotics|narcotics|mesh-ancestor
2009528|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009529|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009530|NCT01256450|Analgesics|analgesics|mesh-ancestor
2009531|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
2009532|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009533|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2009534|NCT01256476|Pravastatin|pravastatin|mesh-list
2009535|NCT01256476|Pitavastatin|pitavastatin|mesh-list
2009536|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2009537|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2009538|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
2009539|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009540|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2009541|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2009542|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009543|NCT01256567|Docetaxel|docetaxel|mesh-list
2009544|NCT01256567|Ramucirumab|ramucirumab|mesh-list
2009545|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009546|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
2009547|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
2009548|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
2009549|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009550|NCT01256593|Pregabalin|pregabalin|mesh-list
2009551|NCT01256593|Analgesics|analgesics|mesh-ancestor
2009552|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
2009553|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009554|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009555|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
2009556|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2009557|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2009558|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009559|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2009560|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2009561|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2009562|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009563|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2009564|NCT01256658|Lumefantrine|lumefantrine|mesh-list
2009565|NCT01256658|Artemether|artemether|mesh-list
2009566|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2009567|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
2009568|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2009569|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2009570|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009571|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2009572|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2009573|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
2009574|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009575|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2009576|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2009577|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
2009578|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009579|NCT01256879|Cimetidine|cimetidine|mesh-list
2009580|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2009581|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2009582|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2009583|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
2009584|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
2009585|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009586|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009587|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009588|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2009589|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2009590|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009591|NCT01257087|Insulin|insulin|mesh-list
2009592|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2009593|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
2009594|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2009595|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009596|NCT01257204|Interferons|interferons|mesh-list
2009597|NCT01257204|Ribavirin|ribavirin|mesh-list
2009598|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
2009599|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
2009600|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2009601|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009602|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
2009603|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009604|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
2009605|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009606|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
2009607|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009608|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
2009609|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2009610|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
2009611|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009612|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009613|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2009614|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
2009615|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
2009616|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2009617|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
2009618|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009619|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009620|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2009621|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
2009622|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2009623|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
2009624|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2009625|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009626|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2009627|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2009628|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009629|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
2009630|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
2009631|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
2009632|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2009633|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2009634|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009635|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009636|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009637|NCT01257581|Tamoxifen|tamoxifen|mesh-list
2009638|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2009639|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
2009640|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2009641|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009642|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2009643|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009644|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2009645|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2009646|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2009647|NCT01257698|Timolol|timolol|mesh-list
2009648|NCT01257698|Dorzolamide|dorzolamide|mesh-list
2009649|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2009650|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2009651|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2009652|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
2009653|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009654|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009655|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009656|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2009657|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2009658|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2009659|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009660|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2009661|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2009662|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009663|NCT01257802|Leuprolide|leuprolide|mesh-list
2009664|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2009665|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
2009666|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2009667|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009668|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2009669|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009670|NCT01258049|Artemether|artemether|mesh-list
2009671|NCT01258049|Quinine|quinine|mesh-list
2009672|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
2009673|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2009674|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2009675|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009676|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2009677|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009678|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2009679|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009680|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2009681|NCT01258049|Analgesics|analgesics|mesh-ancestor
2009682|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
2009683|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2009684|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2009685|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2009686|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
2009687|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009688|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2009689|NCT01258101|Ribavirin|ribavirin|mesh-list
2009690|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2009691|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
2009692|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
2009693|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009694|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
2009695|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009696|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
2009697|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009698|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2009699|NCT01258153|MEN 11420|men 11420|mesh-list
2009700|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2009701|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
2009702|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009703|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009704|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2009705|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
2009706|NCT01258348|Sunitinib|sunitinib|mesh-list
2009707|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009708|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2009709|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2009710|NCT01258348|Growth Substances|growth substances|mesh-ancestor
2009711|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009712|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
2009713|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2009714|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009715|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009716|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
2009717|NCT01258374|Darunavir|darunavir|mesh-list
2009718|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2009719|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2009720|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
2009721|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009722|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2009723|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2009724|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009725|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009726|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2009727|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2009728|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
2009729|NCT01258387|Mitogens|mitogens|mesh-list
2009730|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
2009731|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009732|NCT01258595|Vaccines|vaccines|mesh-list
2009733|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
2009734|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009735|NCT01258608|Sorafenib|sorafenib|mesh-list
2009736|NCT01258608|Mapatumumab|mapatumumab|mesh-list
2009737|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009738|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2009739|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009740|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009741|NCT01258660|Folic Acid|folic acid|mesh-list
2009742|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
2009743|NCT01258660|Drospirenone|drospirenone|mesh-list
2009744|NCT01258660|Hematinics|hematinics|mesh-ancestor
2009745|NCT01258660|Vitamins|vitamins|mesh-ancestor
2009746|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
2009747|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009748|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2009749|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
2009750|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2009751|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2009752|NCT01258660|Diuretics|diuretics|mesh-ancestor
2009753|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
2009754|NCT01258738|Etanercept|etanercept|mesh-list
2009755|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2009756|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2009757|NCT01258738|Analgesics|analgesics|mesh-ancestor
2009758|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
2009759|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009760|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009761|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2009762|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2009763|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2009764|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2009765|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
2009766|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
2009767|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
2009768|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2009769|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
2009770|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009771|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009772|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2009773|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
2009774|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2009775|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2009776|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2009777|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
2009778|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009779|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009780|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2009781|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
2009782|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2009783|NCT01258855|Aldesleukin|aldesleukin|mesh-list
2009784|NCT01258855|Aflibercept|aflibercept|mesh-list
2009785|NCT01258855|Interleukin-2|interleukin-2|mesh-list
2009786|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
2009787|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2009788|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2009789|NCT01258855|Growth Substances|growth substances|mesh-ancestor
2009790|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009791|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
2009792|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009793|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2009794|NCT01258855|Analgesics|analgesics|mesh-ancestor
2009795|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
2009796|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009797|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2009798|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2009799|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
2009800|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009801|NCT01259063|Gemcitabine|gemcitabine|mesh-list
2009802|NCT01259063|Everolimus|everolimus|mesh-list
2009803|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2009804|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
2009805|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009806|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009807|NCT01259063|Antiviral Agents|antiviral agents|mesh-ancestor
2009808|NCT01259063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009809|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009810|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2009811|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
2009812|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009813|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2009814|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009815|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2009816|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009817|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009818|NCT01259102|Buprenorphine|buprenorphine|mesh-list
2009819|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2009820|NCT01259102|Narcotics|narcotics|mesh-ancestor
2009821|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009822|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009823|NCT01259102|Analgesics|analgesics|mesh-ancestor
2009824|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
2009825|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009826|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2009827|NCT01259115|Ketoconazole|ketoconazole|mesh-list
2009828|NCT01259115|Buprenorphine|buprenorphine|mesh-list
2009829|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2009830|NCT01259115|Narcotics|narcotics|mesh-ancestor
2009831|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009832|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009833|NCT01259115|Analgesics|analgesics|mesh-ancestor
2009834|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
2009835|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009836|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2009837|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
2009838|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009839|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2009840|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2009841|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009842|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009843|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2009844|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
2009845|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2009846|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2009847|NCT01259297|Amlodipine|amlodipine|mesh-list
2009848|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2009849|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2009850|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2009851|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2009852|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009853|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2009854|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009855|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
2009856|NCT01259297|Diuretics|diuretics|mesh-ancestor
2009857|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
2009858|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2009859|NCT01259375|Amrubicin|amrubicin|mesh-list
2009860|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009861|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
2009862|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
2009863|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2009864|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009865|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009866|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
2009867|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2009868|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009869|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009870|NCT01259466|Nicotine|nicotine|mesh-list
2009871|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2009872|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
2009873|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009874|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009875|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2009876|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2009877|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
2009878|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009879|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009880|NCT01259492|Methylphenidate|methylphenidate|mesh-list
2009881|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2009882|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009883|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2009884|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2009885|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2009886|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009887|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
2009888|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009889|NCT01259713|Amphotericin B|amphotericin b|mesh-list
2009890|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2009891|NCT01259713|Amebicides|amebicides|mesh-ancestor
2009892|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2009893|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2009894|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009895|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2009896|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
2009897|NCT01259856|Aspirin|aspirin|mesh-list
2009898|NCT01259856|Interferons|interferons|mesh-list
2009899|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
2009900|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
2009901|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2009902|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
2009903|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009904|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
2009905|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009906|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2009907|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2009908|NCT01259856|Analgesics|analgesics|mesh-ancestor
2009909|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
2009910|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009911|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009912|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2009913|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2009914|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2009915|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2009916|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009917|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2009918|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2009919|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009920|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
2009921|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
2009922|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
2009923|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2009924|NCT01260142|Propofol|propofol|mesh-list
2009925|NCT01260142|Fospropofol|fospropofol|mesh-list
2009926|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2009927|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009928|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009929|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2009930|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
2009931|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
2009932|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2009933|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009934|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2009935|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2009936|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009937|NCT01260194|Trastuzumab|trastuzumab|mesh-list
2009938|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2009939|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2009940|NCT01260311|Fesoterodine|fesoterodine|mesh-list
2009941|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2009942|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2009943|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
2009944|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009945|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009946|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009947|NCT01260311|Urological Agents|urological agents|mesh-ancestor
2009948|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
2009949|NCT01260350|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2009950|NCT01260350|Ledipasvir|ledipasvir|mesh-list
2009951|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
2009952|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2009953|NCT01260454|Capsaicin|capsaicin|mesh-list
2009954|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
2009955|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
2009956|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
2009957|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009958|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009959|NCT01260467|Memantine|memantine|mesh-list
2009960|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2009961|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2009962|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
2009963|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009964|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009965|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009966|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2009967|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2009968|NCT01260584|Clopidogrel|clopidogrel|mesh-list
2009969|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2009970|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2009971|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2009972|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2009973|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2009974|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
2009975|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009976|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009977|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009978|NCT01260649|Ketamine|ketamine|mesh-list
2009979|NCT01260649|Anesthetics|anesthetics|mesh-list
2009980|NCT01260649|Analgesics|analgesics|mesh-ancestor
2009981|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
2009982|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2009983|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009984|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2009985|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2009986|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
2009987|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009988|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2009989|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2009990|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2009991|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2009992|NCT01260662|Ketamine|ketamine|mesh-list
2009993|NCT01260662|Propofol|propofol|mesh-list
2009994|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2009995|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2009996|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2009997|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2009998|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
2009999|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
2010000|NCT01260662|Analgesics|analgesics|mesh-ancestor
2010001|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
2010002|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010003|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2010004|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2010005|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2010006|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010007|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010008|NCT01260688|Dasatinib|dasatinib|mesh-list
2010009|NCT01260688|Cediranib|cediranib|mesh-list
2010010|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010011|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2010012|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010013|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010014|NCT01260883|Ketorolac|ketorolac|mesh-list
2010015|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2010016|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2010017|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2010018|NCT01260883|Analgesics|analgesics|mesh-ancestor
2010019|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
2010020|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010021|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010022|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2010023|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2010024|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2010025|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010026|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010027|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2010028|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2010029|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2010030|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2010031|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010032|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010033|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010034|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2010035|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
2010036|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2010037|NCT01260922|Donepezil|donepezil|mesh-list
2010038|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2010039|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010040|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010041|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
2010042|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010043|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010044|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
2010045|NCT01260948|Donepezil|donepezil|mesh-list
2010046|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2010047|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010048|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010049|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
2010050|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010051|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010052|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
2010053|NCT01261247|Panobinostat|panobinostat|mesh-list
2010054|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2010055|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010056|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010057|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010058|NCT01261325|Brivaracetam|brivaracetam|mesh-list
2010059|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
2010060|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
2010061|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2010062|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2010063|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
2010064|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010065|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2010066|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
2010067|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2010068|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2010069|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2010070|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2010071|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010072|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
2010073|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010074|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010075|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2010076|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010077|NCT01261793|Epratuzumab|epratuzumab|mesh-list
2010078|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2010079|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010080|NCT01262092|Buprenorphine|buprenorphine|mesh-list
2010081|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2010082|NCT01262092|Narcotics|narcotics|mesh-ancestor
2010083|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010084|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010085|NCT01262092|Analgesics|analgesics|mesh-ancestor
2010086|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
2010087|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010088|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2010089|NCT01262118|Tofacitinib|tofacitinib|mesh-list
2010090|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2010091|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010092|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010093|NCT01262287|Dutasteride|dutasteride|mesh-list
2010094|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2010095|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2010096|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010097|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010098|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
2079365|NCT02057640|Ixazomib|ixazomib|mesh-list
2010099|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010100|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010101|NCT01262352|Ivacaftor|ivacaftor|mesh-list
2010102|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2010103|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2010104|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010105|NCT01262365|Epratuzumab|epratuzumab|mesh-list
2010106|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2010107|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010108|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2010109|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
2010110|NCT01262456|Coagulants|coagulants|mesh-ancestor
2010111|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2010112|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
2010113|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010114|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2010115|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2010116|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
2010117|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010118|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2010119|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010120|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2010121|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010122|NCT01262651|Nabiximols|nabiximols|mesh-list
2010123|NCT01262651|Analgesics|analgesics|mesh-ancestor
2010124|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
2010125|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010126|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010127|NCT01262677|Pregabalin|pregabalin|mesh-list
2010128|NCT01262677|Analgesics|analgesics|mesh-ancestor
2010129|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
2010130|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010131|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010132|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
2010133|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2010134|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2010135|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010136|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2010137|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2010138|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2010139|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010140|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2010141|NCT01262872|Vaccines|vaccines|mesh-list
2010142|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2010143|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
2010144|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010145|NCT01263015|Lamivudine|lamivudine|mesh-list
2010146|NCT01263015|Abacavir|abacavir|mesh-list
2010147|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
2010148|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2010149|NCT01263015|Dolutegravir|dolutegravir|mesh-list
2010150|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2010151|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2010152|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010153|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010154|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
2010155|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2010156|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2010157|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2010158|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
2010159|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2010160|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2010161|NCT01263093|Clopidogrel|clopidogrel|mesh-list
2010162|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2010163|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2010164|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2010165|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2010166|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
2010167|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010168|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010169|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010170|NCT01263106|Theophylline|theophylline|mesh-list
2079366|NCT02057640|Panobinostat|panobinostat|mesh-list
2010171|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2010172|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
2010173|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010174|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010175|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2010176|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
2010177|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2010178|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010179|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010180|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
2010181|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2010182|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2010183|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
2010184|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010185|NCT01263119|Warfarin|warfarin|mesh-list
2010186|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
2010187|NCT01263132|Thiamine|thiamine|mesh-list
2010188|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
2010189|NCT01263132|Gabapentin|gabapentin|mesh-list
2010190|NCT01263132|Analgesics|analgesics|mesh-ancestor
2010191|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
2010192|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010193|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010194|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
2010195|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2010196|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2010197|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010198|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2010199|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2010200|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2010201|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010202|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010203|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
2010204|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
2010205|NCT01263132|Vitamins|vitamins|mesh-ancestor
2010206|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
2010207|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
2010208|NCT01263197|Propranolol|propranolol|mesh-list
2010209|NCT01263197|Albuterol|albuterol|mesh-list
2010210|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2010211|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
2010212|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010213|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010214|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2010215|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
2010216|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
2010217|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2010218|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2010219|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2010220|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2010221|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
2010222|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010223|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010224|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2010225|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2010226|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2010227|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2010228|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
2010229|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2010230|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2010231|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
2010232|NCT01263444|Timolol|timolol|mesh-list
2010233|NCT01263444|Bimatoprost|bimatoprost|mesh-list
2010234|NCT01263444|Travoprost|travoprost|mesh-list
2010235|NCT01263444|Latanoprost|latanoprost|mesh-list
2010236|NCT01263444|Brinzolamide|brinzolamide|mesh-list
2010237|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2010238|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2010239|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
2010240|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010241|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010242|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010243|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2010244|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2010245|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2010246|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2010247|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2010248|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010249|NCT01263470|Alogliptin|alogliptin|mesh-list
2010250|NCT01263470|Voglibose|voglibose|mesh-list
2010251|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2010252|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010253|NCT01263470|Incretins|incretins|mesh-ancestor
2010254|NCT01263470|Hormones|hormones|mesh-ancestor
2010255|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010256|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2010257|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
2010258|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010259|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010260|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2010261|NCT01263483|Inositol|inositol|mesh-list
2010262|NCT01263483|Alogliptin|alogliptin|mesh-list
2010263|NCT01263483|Voglibose|voglibose|mesh-list
2010264|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2010265|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010266|NCT01263483|Incretins|incretins|mesh-ancestor
2010267|NCT01263483|Hormones|hormones|mesh-ancestor
2010268|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010269|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2010270|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
2010271|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010272|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010273|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2010274|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
2010275|NCT01263483|Vitamins|vitamins|mesh-ancestor
2010276|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
2010277|NCT01263496|Alogliptin|alogliptin|mesh-list
2010278|NCT01263496|Voglibose|voglibose|mesh-list
2010279|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2010280|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010281|NCT01263496|Incretins|incretins|mesh-ancestor
2010282|NCT01263496|Hormones|hormones|mesh-ancestor
2010283|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010284|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2010285|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
2010286|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010287|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010288|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2010289|NCT01263509|Inositol|inositol|mesh-list
2010290|NCT01263509|Alogliptin|alogliptin|mesh-list
2010291|NCT01263509|Voglibose|voglibose|mesh-list
2010292|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2010293|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010294|NCT01263509|Incretins|incretins|mesh-ancestor
2010295|NCT01263509|Hormones|hormones|mesh-ancestor
2010296|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010297|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2010298|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
2010299|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010300|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010301|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2010302|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
2010303|NCT01263509|Vitamins|vitamins|mesh-ancestor
2010304|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
2010305|NCT01263691|Vaccines|vaccines|mesh-list
2010306|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
2010307|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010308|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
2010309|NCT01263704|Rituximab|rituximab|mesh-list
2010310|NCT01263704|Fludarabine|fludarabine|mesh-list
2010311|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2010312|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
2010313|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010314|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2010315|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2010316|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
2010317|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010318|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010319|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2010320|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2010321|NCT01263717|Hormones|hormones|mesh-list
2010322|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
2010323|NCT01263717|Tesamorelin|tesamorelin|mesh-list
2010324|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010325|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010326|NCT01263717|Growth Substances|growth substances|mesh-ancestor
2010327|NCT01263782|Bevacizumab|bevacizumab|mesh-list
2010328|NCT01263782|Carboplatin|carboplatin|mesh-list
2010329|NCT01263782|Pemetrexed|pemetrexed|mesh-list
2010330|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2010331|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010332|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2010333|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2010334|NCT01263782|Growth Substances|growth substances|mesh-ancestor
2010335|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010336|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
2010337|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010338|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010339|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2010340|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2010341|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
2010342|NCT01263925|Alprostadil|alprostadil|mesh-list
2010343|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2010344|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010345|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010346|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2010347|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2010348|NCT01263925|Protective Agents|protective agents|mesh-ancestor
2010349|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010350|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
2010351|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2010352|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
2010353|NCT01263925|Urological Agents|urological agents|mesh-ancestor
2010354|NCT01263938|Atorvastatin|atorvastatin|mesh-list
2010355|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2010356|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2010357|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
2010358|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010359|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2010360|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2010361|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010362|NCT01264081|Lapatinib|lapatinib|mesh-list
2010363|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010364|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2010365|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010366|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010367|NCT01264705|Sorafenib|sorafenib|mesh-list
2010368|NCT01264705|Bavituximab|bavituximab|mesh-list
2010369|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2010370|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010371|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2010372|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010373|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010374|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2010375|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
2010376|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010377|NCT01264770|Adalimumab|adalimumab|mesh-list
2010378|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2010379|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2010380|NCT01264887|Tapentadol|tapentadol|mesh-list
2010381|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2010382|NCT01264887|Narcotics|narcotics|mesh-ancestor
2010383|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010384|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010385|NCT01264887|Analgesics|analgesics|mesh-ancestor
2010386|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
2010387|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010388|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2010389|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2010390|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2010391|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010392|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
2010393|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010394|NCT01264939|Omalizumab|omalizumab|mesh-list
2010395|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
2010396|NCT01264939|Promethazine|promethazine|mesh-list
2010397|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
2010398|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2010399|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
2010400|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2010401|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2010402|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
2010403|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2010404|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2010405|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010406|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010407|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
2010408|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
2010409|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
2010410|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010411|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
2010412|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
2010413|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2010414|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
2010415|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010416|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010417|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
2010418|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
2010419|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
2010420|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010421|NCT01265056|Gabapentin|gabapentin|mesh-list
2010422|NCT01265056|Analgesics|analgesics|mesh-ancestor
2010423|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
2010424|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010425|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010426|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
2010427|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2010428|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2010429|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010430|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2010431|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2010432|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2010433|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010434|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010435|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
2010436|NCT01265394|Flutemetamol|flutemetamol|mesh-list
2010437|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2010438|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010439|NCT01265446|Lidocaine|lidocaine|mesh-list
2010440|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
2010441|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
2010442|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010443|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010444|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
2010445|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010446|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2010447|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2010448|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2010449|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2010450|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010451|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2010452|NCT01265498|Cathartics|cathartics|mesh-ancestor
2010453|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2010454|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2010455|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
2010456|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2010457|NCT01265537|Tacrolimus|tacrolimus|mesh-list
2010458|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2010459|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
2010460|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010461|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2010462|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010463|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010464|NCT01265550|Baclofen|baclofen|mesh-list
2010465|NCT01265550|Desipramine|desipramine|mesh-list
2010466|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2010467|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010468|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2010469|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010470|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2010471|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
2010472|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
2010473|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010474|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010475|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2010476|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
2010477|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2010478|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010479|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2010480|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2010481|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2010482|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
2010483|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
2010484|NCT01265563|Silybin|silybin|mesh-list
2010485|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2010486|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
2010487|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2010488|NCT01265563|Expectorants|expectorants|mesh-ancestor
2010489|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
2010490|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2010491|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
2010492|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010493|NCT01265563|Protective Agents|protective agents|mesh-ancestor
2010494|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010495|NCT01265563|Antidotes|antidotes|mesh-ancestor
2010496|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2010497|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010498|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
2010499|NCT01265615|Calcitriol|calcitriol|mesh-list
2010500|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2010501|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010502|NCT01265615|Vitamins|vitamins|mesh-ancestor
2010503|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
2010504|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2010505|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2010506|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2010507|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010508|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2010512|NCT01265823|Adalimumab|adalimumab|mesh-list
2010513|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2010514|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2010515|NCT01265875|Secretin|secretin|mesh-list
2010516|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2010517|NCT01265875|Hormones|hormones|mesh-ancestor
2010518|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010519|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010520|NCT01265953|Sulforaphane|sulforaphane|mesh-list
2010521|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2010522|NCT01265953|Protective Agents|protective agents|mesh-ancestor
2010523|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010524|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745986|NCT01962792|Dexamethasone|dexamethasone|mesh-list
2745987|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2745988|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
2745989|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
2745990|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2745991|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745992|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2745993|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
2745994|NCT01962792|Hormones|hormones|mesh-ancestor
2745995|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2745996|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2010537|NCT01266148|Cyclosporine|cyclosporine|mesh-list
2010538|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
2010539|NCT01266148|Everolimus|everolimus|mesh-list
2010540|NCT01266148|Cyclosporins|cyclosporins|mesh-list
2010541|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2010542|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010543|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010544|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2010545|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
2010546|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010547|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
2010548|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2010549|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
2010550|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2010551|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2010552|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010553|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2010554|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2010555|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
2010556|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2010557|NCT01266161|Ibuprofen|ibuprofen|mesh-list
2010558|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2010559|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2010560|NCT01266161|Analgesics|analgesics|mesh-ancestor
2010561|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
2010562|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010563|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010564|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2010565|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2010566|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2010567|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010568|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010569|NCT01266265|Treprostinil|treprostinil|mesh-list
2010570|NCT01266265|Bosentan|bosentan|mesh-list
2010571|NCT01266265|Ambrisentan|ambrisentan|mesh-list
2010572|NCT01266265|Epoprostenol|epoprostenol|mesh-list
2010573|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
2010574|NCT01266265|Tadalafil|tadalafil|mesh-list
2010575|NCT01266265|Iloprost|iloprost|mesh-list
2010576|NCT01266265|Tezosentan|tezosentan|mesh-list
2010577|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
2010578|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
2010579|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2010580|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010581|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010582|NCT01266265|Urological Agents|urological agents|mesh-ancestor
2010583|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2010584|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2010585|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2010586|NCT01266291|Vigabatrin|vigabatrin|mesh-list
2010587|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
2010588|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010589|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010590|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
2010591|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010592|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010593|NCT01266317|Rituximab|rituximab|mesh-list
2010594|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2010595|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010596|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
2010597|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010598|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2010599|NCT01266447|Topotecan|topotecan|mesh-list
2010600|NCT01266447|Veliparib|veliparib|mesh-list
2010601|NCT01266447|Lenograstim|lenograstim|mesh-list
2010602|NCT01266447|Sargramostim|sargramostim|mesh-list
2010603|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2010604|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
2010605|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010606|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2010607|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2010608|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010609|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010610|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010611|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2010612|NCT01266460|Vaccines|vaccines|mesh-list
2010613|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
2010614|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010615|NCT01266590|Digoxin|digoxin|mesh-list
2010616|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2010617|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2010618|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010619|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010620|NCT01266590|Protective Agents|protective agents|mesh-ancestor
2010621|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010622|NCT01266603|Aldesleukin|aldesleukin|mesh-list
2010623|NCT01266603|Interleukin-2|interleukin-2|mesh-list
2010624|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010625|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2010626|NCT01266603|Analgesics|analgesics|mesh-ancestor
2010627|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
2010628|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010629|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010630|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2010631|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2010632|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
2010633|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2010634|NCT01266902|Rilpivirine|rilpivirine|mesh-list
2010635|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2010636|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2010637|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010638|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010639|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
2010640|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2010641|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2010642|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2010643|NCT01266967|Dabrafenib|dabrafenib|mesh-list
2010644|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010645|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2010646|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010647|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010648|NCT01267136|Acetaminophen|acetaminophen|mesh-list
2010649|NCT01267136|Tramadol|tramadol|mesh-list
2010650|NCT01267136|Codeine|codeine|mesh-list
2010651|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2010652|NCT01267136|Analgesics|analgesics|mesh-ancestor
2010653|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
2010654|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010655|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010656|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
2010657|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2010658|NCT01267136|Narcotics|narcotics|mesh-ancestor
2010659|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010660|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
2010661|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
2010662|NCT01267175|Insulin|insulin|mesh-list
2010663|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2010664|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010665|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
2010666|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2010667|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2010668|NCT01267201|Prednisolone|prednisolone|mesh-list
2010669|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
2010670|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2010671|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
2010672|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2010673|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
2010674|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
2010675|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010676|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010677|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2010678|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
2010679|NCT01267201|Hormones|hormones|mesh-ancestor
2010680|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010681|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2010682|NCT01267201|Protective Agents|protective agents|mesh-ancestor
2010683|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2010684|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010685|NCT01267240|Capecitabine|capecitabine|mesh-list
2010686|NCT01267240|Vorinostat|vorinostat|mesh-list
2010687|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2010688|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
2010689|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010690|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010691|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2010692|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010693|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
2010694|NCT01267266|Saracatinib|saracatinib|mesh-list
2010695|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2010696|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010697|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010698|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010699|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
2010700|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2010701|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010702|NCT01267292|Buspirone|buspirone|mesh-list
2010703|NCT01267292|Methylphenidate|methylphenidate|mesh-list
2010704|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2010705|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010706|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2010707|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2010708|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2010709|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010710|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
2010711|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010712|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2010713|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2010714|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010715|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2010716|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2010717|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
2010718|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2010719|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
2010720|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2010721|NCT01267864|Ketorolac|ketorolac|mesh-list
2010722|NCT01267864|Valproic Acid|valproic acid|mesh-list
2010723|NCT01267864|Metoclopramide|metoclopramide|mesh-list
2010724|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2010725|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2010726|NCT01267864|Analgesics|analgesics|mesh-ancestor
2010727|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
2010728|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010729|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010730|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2010731|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2010732|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2010733|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010734|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010735|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
2010736|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
2010737|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010738|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
2010739|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2010740|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010741|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2010742|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
2010743|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
2010744|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2010745|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2010746|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2010747|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
2010748|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2010749|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2010750|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2010751|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2010752|NCT01268046|Estradiol|estradiol|mesh-list
2010753|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2010754|NCT01268046|Estrogens|estrogens|mesh-list
2010755|NCT01268046|Hormones|hormones|mesh-ancestor
2010756|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010757|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010758|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2010759|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
2010760|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2010761|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2010762|NCT01268059|Paclitaxel|paclitaxel|mesh-list
2010763|NCT01268059|Carboplatin|carboplatin|mesh-list
2010764|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2010765|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010766|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
2010767|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
2010768|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
2010769|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010770|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
2010771|NCT01268111|Vitamin D|vitamin d|mesh-list
2010772|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2010773|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010774|NCT01268111|Vitamins|vitamins|mesh-ancestor
2010775|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
2010776|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2010777|NCT01268293|Lenvatinib|lenvatinib|mesh-list
2010778|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010779|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2010780|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010781|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010782|NCT01268527|Calcipotriene|calcipotriene|mesh-list
2010783|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
2010784|NCT01268553|Treprostinil|treprostinil|mesh-list
2010785|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2010786|NCT01268683|Glyburide|glyburide|mesh-list
2010787|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2010788|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010789|NCT01268891|Rasagiline|rasagiline|mesh-list
2010790|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2010791|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010792|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010793|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2010794|NCT01268891|Protective Agents|protective agents|mesh-ancestor
2010795|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010796|NCT01268943|Capecitabine|capecitabine|mesh-list
2010797|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2010798|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
2010799|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010800|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010801|NCT01269047|Exenatide|exenatide|mesh-list
2010802|NCT01269047|Pramlintide|pramlintide|mesh-list
2010803|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2010804|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010805|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2010806|NCT01269047|Incretins|incretins|mesh-ancestor
2010807|NCT01269047|Hormones|hormones|mesh-ancestor
2010808|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010809|NCT01269125|Leuprolide|leuprolide|mesh-list
2010810|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2010811|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
2010812|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2010813|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010814|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2010815|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010816|NCT01269385|Rituximab|rituximab|mesh-list
2010817|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2010818|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
2010819|NCT01269385|Antibodies|antibodies|mesh-list
2010820|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
2010821|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2010822|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
2010823|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010824|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010825|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2010826|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
2010827|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2010828|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2010829|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2010830|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2010831|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010832|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
2010833|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010834|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010835|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2010836|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010837|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
2010838|NCT01269918|Remifentanil|remifentanil|mesh-list
2010839|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2010840|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010841|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010842|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2010843|NCT01269918|Analgesics|analgesics|mesh-ancestor
2010844|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
2010845|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010846|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2010847|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2010848|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2010849|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
2010850|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010851|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010852|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2010853|NCT01269918|Narcotics|narcotics|mesh-ancestor
2010854|NCT01270256|Budesonide|budesonide|mesh-list
2010855|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2010856|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2010857|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
2010858|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010859|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010860|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2010861|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
2010862|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
2010863|NCT01270256|Hormones|hormones|mesh-ancestor
2010864|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010865|NCT01270321|Everolimus|everolimus|mesh-list
2010866|NCT01270321|Pasireotide|pasireotide|mesh-list
2010867|NCT01270321|Somatostatin|somatostatin|mesh-list
2010868|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010869|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2010870|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
2010871|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010872|NCT01270321|Hormones|hormones|mesh-ancestor
2010873|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010874|NCT01270464|Reslizumab|reslizumab|mesh-list
2010875|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2010876|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
2010877|NCT01270542|Bevacizumab|bevacizumab|mesh-list
2010878|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2010879|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010880|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2010881|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2010882|NCT01270542|Growth Substances|growth substances|mesh-ancestor
2010883|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010884|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
2010885|NCT01270555|Bupropion|bupropion|mesh-list
2010886|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2010887|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
2010888|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2010889|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2010890|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2010891|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2010892|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010893|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
2010894|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2010895|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010896|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2010897|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2010898|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010899|NCT01270620|Propofol|propofol|mesh-list
2010900|NCT01270620|Desflurane|desflurane|mesh-list
2010901|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2010902|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010903|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010904|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2010905|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
2010906|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
2010907|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2010908|NCT01270659|Acetaminophen|acetaminophen|mesh-list
2010909|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2010910|NCT01270659|Fentanyl|fentanyl|mesh-list
2010911|NCT01270659|Oxycodone|oxycodone|mesh-list
2010912|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2010913|NCT01270659|Narcotics|narcotics|mesh-ancestor
2010914|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010915|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010916|NCT01270659|Analgesics|analgesics|mesh-ancestor
2010917|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
2010918|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010919|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2010920|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2010921|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
2010922|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
2010923|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2010924|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
2010925|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2010926|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2010927|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2010928|NCT01270802|Tenofovir|tenofovir|mesh-list
2010929|NCT01270802|Emtricitabine|emtricitabine|mesh-list
2010930|NCT01270802|Efavirenz|efavirenz|mesh-list
2010931|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
2010932|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
2010933|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2010934|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2010935|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2010936|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2010937|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010938|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2010939|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2010940|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2010941|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2010942|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2010943|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2010944|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2010945|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2010946|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2010947|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2010948|NCT01270828|Pregabalin|pregabalin|mesh-list
2010949|NCT01270828|Analgesics|analgesics|mesh-ancestor
2010950|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
2010951|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2010952|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010953|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
2010954|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2010955|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2010956|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010957|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2010958|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2010959|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2010960|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2010961|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2010962|NCT01270841|Enclomiphene|enclomiphene|mesh-list
2010963|NCT01270841|Clomiphene|clomiphene|mesh-list
2010964|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
2010965|NCT01270841|Testosterone|testosterone|mesh-list
2010966|NCT01270841|Androgens|androgens|mesh-ancestor
2010967|NCT01270841|Hormones|hormones|mesh-ancestor
2010968|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2010969|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010970|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2010971|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
2010972|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2010973|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
2010974|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2010975|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2010976|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2010977|NCT01270971|Tavaborole|tavaborole|mesh-list
2010978|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2010979|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
2010980|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2010981|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
2010982|NCT01271010|Rituximab|rituximab|mesh-list
2010983|NCT01271010|Fludarabine|fludarabine|mesh-list
2010984|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2010985|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
2010986|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2010987|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2010988|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2010989|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
2010990|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010991|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2010992|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2010993|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2010994|NCT01271244|Citalopram|citalopram|mesh-list
2010995|NCT01271244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2010996|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2010997|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2010998|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2010999|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2011000|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
2011001|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011002|NCT01271244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2011003|NCT01271244|Antidepressive Agents|antidepressive agents|mesh-ancestor
2011004|NCT01271244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2011005|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
2011006|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2011007|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2011008|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2011009|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2011010|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011011|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
2011012|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2011013|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011014|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2011015|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011016|NCT01271504|Sorafenib|sorafenib|mesh-list
2011017|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011018|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2011019|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011020|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011021|NCT01271686|Bimatoprost|bimatoprost|mesh-list
2011022|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2011023|NCT01271725|Paclitaxel|paclitaxel|mesh-list
2011024|NCT01271725|Vinorelbine|vinorelbine|mesh-list
2011025|NCT01271725|Afatinib|afatinib|mesh-list
2011026|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2011027|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011028|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
2011029|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
2011030|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
2011031|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011032|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2011033|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011034|NCT01271803|Vemurafenib|vemurafenib|mesh-list
2011035|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011036|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2011037|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011038|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011039|NCT01271855|Glycerol|glycerol|mesh-list
2011040|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011041|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2011042|NCT01271855|Protective Agents|protective agents|mesh-ancestor
2011043|NCT01271907|Aldesleukin|aldesleukin|mesh-list
2011044|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
2011045|NCT01271907|Fludarabine|fludarabine|mesh-list
2011046|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2011047|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
2011048|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011049|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011050|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2011051|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
2011052|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011053|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011054|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2011055|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2011056|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2011057|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
2011058|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011059|NCT01271933|Pregabalin|pregabalin|mesh-list
2011060|NCT01271933|Analgesics|analgesics|mesh-ancestor
2011061|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
2011062|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011063|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011064|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
2011065|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2011066|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2011067|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011068|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2011069|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2011070|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2011071|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2011072|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2011073|NCT01272180|Vaccines|vaccines|mesh-list
2011074|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
2011075|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011076|NCT01272193|Insulin|insulin|mesh-list
2011077|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2011078|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
2011079|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
2011080|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2011081|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011082|NCT01272219|Liraglutide|liraglutide|mesh-list
2011083|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2011084|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011085|NCT01272219|Incretins|incretins|mesh-ancestor
2011086|NCT01272219|Hormones|hormones|mesh-ancestor
2011087|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2011088|NCT01272232|Liraglutide|liraglutide|mesh-list
2011089|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2011090|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011091|NCT01272232|Incretins|incretins|mesh-ancestor
2011092|NCT01272232|Hormones|hormones|mesh-ancestor
2011093|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2011094|NCT01272245|Cytarabine|cytarabine|mesh-list
2011095|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
2011096|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2011097|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
2011098|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011099|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011100|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
2011101|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011102|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2011103|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
2011104|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011105|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2011106|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2011107|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011108|NCT01272388|Tadalafil|tadalafil|mesh-list
2011109|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
2011110|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2011111|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2011112|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011113|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011114|NCT01272388|Urological Agents|urological agents|mesh-ancestor
2011115|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2011116|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2011117|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011118|NCT01272583|Incretins|incretins|mesh-ancestor
2011119|NCT01272583|Hormones|hormones|mesh-ancestor
2011120|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2011121|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2011122|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
2011123|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011124|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011125|NCT01272635|Azithromycin|azithromycin|mesh-list
2011126|NCT01272635|Prednisolone|prednisolone|mesh-list
2011127|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2011128|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
2011129|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2011130|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
2011131|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2011132|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
2011133|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2011134|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
2011135|NCT01272635|Hormones|hormones|mesh-ancestor
2011136|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2011137|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011138|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2011139|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011140|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
2011141|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
2011142|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011143|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2011144|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2011145|NCT01272635|Protective Agents|protective agents|mesh-ancestor
2011146|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2011147|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011148|NCT01272908|Rituximab|rituximab|mesh-list
2011149|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2011150|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011151|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
2011152|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011153|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011154|NCT01272921|Bupivacaine|bupivacaine|mesh-list
2011155|NCT01272921|Ropivacaine|ropivacaine|mesh-list
2011156|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
2011157|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
2011158|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2011159|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011160|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
2011161|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011162|NCT01272934|Diclofenac|diclofenac|mesh-list
2011163|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2011164|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2011165|NCT01272934|Analgesics|analgesics|mesh-ancestor
2011166|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
2011167|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011168|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011169|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2011170|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011171|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2011172|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011173|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011174|NCT01272947|Diclofenac|diclofenac|mesh-list
2011175|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2011176|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2011177|NCT01272947|Analgesics|analgesics|mesh-ancestor
2011178|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
2011179|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011180|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011181|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2011182|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011183|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2011184|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011185|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011186|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
2011187|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2011188|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
2011189|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2011190|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011191|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2011192|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2011193|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2011194|NCT01273155|Belinostat|belinostat|mesh-list
2011195|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011196|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2011197|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011198|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011199|NCT01273181|Aldesleukin|aldesleukin|mesh-list
2011200|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
2011201|NCT01273181|Fludarabine|fludarabine|mesh-list
2011202|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2011203|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
2011204|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011205|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011206|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2011207|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
2011208|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011209|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011210|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2011211|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2011212|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2011213|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
2011214|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011215|NCT01273207|Cyclosporine|cyclosporine|mesh-list
2011216|NCT01273207|Cyclosporins|cyclosporins|mesh-list
2011217|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011218|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011219|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2011220|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
2011221|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011222|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
2011223|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011224|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
2011225|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011226|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2011227|NCT01273766|Deferasirox|deferasirox|mesh-list
2011228|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2011229|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
2011230|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
2011231|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011232|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
2011233|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
2011234|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2011235|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2011236|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011237|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011238|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011239|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011240|NCT01273818|Gentamicins|gentamicins|mesh-list
2011241|NCT01273818|Cefazolin|cefazolin|mesh-list
2011242|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2011243|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011244|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2011245|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011246|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011247|NCT01274182|Rituximab|rituximab|mesh-list
2011248|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2011249|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011250|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
2011251|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011252|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011253|NCT01274338|Interferons|interferons|mesh-list
2011254|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
2011255|NCT01274338|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2011256|NCT01274338|Ipilimumab|ipilimumab|mesh-list
2011257|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011258|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
2011259|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011260|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2011261|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2011262|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011263|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
2011264|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745997|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011276|NCT01274637|Dalteparin|dalteparin|mesh-list
2011277|NCT01274637|Tinzaparin|tinzaparin|mesh-list
2011278|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2011279|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
2011280|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2011281|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2011282|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011283|NCT01274897|Lactitol|lactitol|mesh-list
2011284|NCT01274897|Cathartics|cathartics|mesh-ancestor
2011285|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2011286|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
2011287|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2011288|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011289|NCT01275144|Lorazepam|lorazepam|mesh-list
2011290|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
2011291|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
2011292|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
2011293|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011294|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011295|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2011296|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2011297|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2011298|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2011299|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2011300|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2011301|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
2011302|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
2011303|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2011304|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011305|NCT01275170|Imipenem|imipenem|mesh-list
2011306|NCT01275170|Relebactam|relebactam|mesh-list
2011307|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
2011308|NCT01275170|Midazolam|midazolam|mesh-list
2011309|NCT01275170|Caffeine|caffeine|mesh-list
2011310|NCT01275170|Omeprazole|omeprazole|mesh-list
2011311|NCT01275170|Cilastatin|cilastatin|mesh-list
2011312|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2011313|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2011314|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2011315|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011316|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2011317|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2011318|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2011319|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2011320|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
2011321|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
2011322|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
2011323|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
2011324|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2011325|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011326|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2011327|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2011328|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2011329|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011330|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2011331|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2011332|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2011333|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2011334|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
2011335|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2011336|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011337|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
2011338|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2011339|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
2011340|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011341|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2011342|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011343|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011344|NCT01275222|Everolimus|everolimus|mesh-list
2011345|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
2011346|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011347|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2011348|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
2011349|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011350|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2011351|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011352|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011353|NCT01275300|Aspirin|aspirin|mesh-list
2011354|NCT01275300|Niacin|niacin|mesh-list
2011355|NCT01275300|Niacinamide|niacinamide|mesh-list
2011356|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
2011357|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2011358|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2011359|NCT01275300|Analgesics|analgesics|mesh-ancestor
2011360|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
2011361|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011362|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011363|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2011364|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011365|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2011366|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2011367|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011368|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2011369|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2011370|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011371|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
2011372|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2011373|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
2011374|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2011375|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
2011376|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
2011377|NCT01275300|Vitamins|vitamins|mesh-ancestor
2011378|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
2011379|NCT01275339|Tadalafil|tadalafil|mesh-list
2011380|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
2011381|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2011382|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2011383|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011384|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011385|NCT01275339|Urological Agents|urological agents|mesh-ancestor
2011386|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
2011387|NCT01275365|Testosterone|testosterone|mesh-list
2011388|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
2011389|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
2011390|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2011391|NCT01275365|Androgens|androgens|mesh-ancestor
2011392|NCT01275365|Hormones|hormones|mesh-ancestor
2011393|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2011394|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011395|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2011396|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011397|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
2011398|NCT01275625|Maraviroc|maraviroc|mesh-list
2011399|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2011400|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2011401|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011402|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2011403|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2011404|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
2011405|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011406|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2011407|NCT01275664|Dexamethasone|dexamethasone|mesh-list
2011408|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
2011409|NCT01275664|Cisplatin|cisplatin|mesh-list
2011410|NCT01275664|Carboplatin|carboplatin|mesh-list
2011411|NCT01275664|Aprepitant|aprepitant|mesh-list
2011412|NCT01275664|Granisetron|granisetron|mesh-list
2011413|NCT01275664|Ichthammol|ichthammol|mesh-list
2011414|NCT01275664|BB 1101|bb 1101|mesh-list
2011415|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011416|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2011417|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
2011418|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
2011419|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011420|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011421|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2011422|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
2011423|NCT01275664|Hormones|hormones|mesh-ancestor
2011424|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2011425|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2011426|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
2011427|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011428|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011429|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2011430|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2011431|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
2011432|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2011433|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
2746019|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
2746020|NCT01850108|Sirolimus|sirolimus|mesh-list
2746021|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
2746022|NCT01850108|Fludarabine|fludarabine|mesh-list
2746023|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
2746024|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2746025|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
2746026|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746027|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2746028|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2746029|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
2746030|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746031|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746032|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2746033|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2746034|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2746035|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
2746036|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2746037|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2746038|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011464|NCT01276041|Paclitaxel|paclitaxel|mesh-list
2011465|NCT01276041|Trastuzumab|trastuzumab|mesh-list
2011466|NCT01276041|Pertuzumab|pertuzumab|mesh-list
2011467|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2011468|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011469|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
2011470|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
2011471|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
2011472|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011473|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2011474|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
2011475|NCT01276223|Difluprednate|difluprednate|mesh-list
2011476|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
2011477|NCT01276223|Hormones|hormones|mesh-ancestor
2011478|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2011479|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011480|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2011481|NCT01276236|Maraviroc|maraviroc|mesh-list
2011482|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2011483|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2011484|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011485|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2011486|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2011487|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
2011488|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011489|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2011490|NCT01276288|Empagliflozin|empagliflozin|mesh-list
2011491|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2011492|NCT01276288|Torsemide|torsemide|mesh-list
2011493|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2011494|NCT01276288|Diuretics|diuretics|mesh-ancestor
2011495|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
2011496|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011497|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2011498|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2011499|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011500|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2011501|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2011502|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2011503|NCT01276301|Empagliflozin|empagliflozin|mesh-list
2011504|NCT01276301|Verapamil|verapamil|mesh-list
2011505|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2011506|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011507|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2011508|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011509|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2011510|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2011511|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2011512|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2011513|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
2011514|NCT01276314|Prednisolone|prednisolone|mesh-list
2011515|NCT01276314|Etanercept|etanercept|mesh-list
2011516|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2011517|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
2011518|NCT01276314|Hormones|hormones|mesh-ancestor
2011519|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2011520|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011521|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2011522|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011523|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011524|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2011525|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2011526|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2011527|NCT01276314|Analgesics|analgesics|mesh-ancestor
2011528|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
2011529|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011530|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2011531|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
2011532|NCT01276327|Pioglitazone|pioglitazone|mesh-list
2011533|NCT01276327|Linagliptin|linagliptin|mesh-list
2011534|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2011535|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011536|NCT01276327|Incretins|incretins|mesh-ancestor
2011537|NCT01276327|Hormones|hormones|mesh-ancestor
2011538|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2011539|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2011540|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
2011541|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011542|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011543|NCT01276353|Donepezil|donepezil|mesh-list
2011544|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2011545|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011546|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011547|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
2011548|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2011549|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011550|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
2011551|NCT01276379|Leucovorin|leucovorin|mesh-list
2011552|NCT01276379|Folic Acid|folic acid|mesh-list
2011553|NCT01276379|Fluorouracil|fluorouracil|mesh-list
2011554|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
2011555|NCT01276379|Irinotecan|irinotecan|mesh-list
2011556|NCT01276379|Cetuximab|cetuximab|mesh-list
2011557|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
2011558|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
2011559|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011560|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2011561|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011562|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2011563|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
2011564|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011565|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2011566|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2011567|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011568|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2011569|NCT01276379|Antidotes|antidotes|mesh-ancestor
2011570|NCT01276379|Protective Agents|protective agents|mesh-ancestor
2011571|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
2011572|NCT01276379|Vitamins|vitamins|mesh-ancestor
2011573|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
2011574|NCT01276379|Hematinics|hematinics|mesh-ancestor
2011575|NCT01276457|Cyclosporine|cyclosporine|mesh-list
2011576|NCT01276457|Everolimus|everolimus|mesh-list
2011577|NCT01276457|Cyclosporins|cyclosporins|mesh-list
2011578|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011579|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011580|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2011581|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
2011582|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011583|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
2011584|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011585|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
2011586|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011587|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2011588|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011589|NCT01276639|Tofacitinib|tofacitinib|mesh-list
2011590|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2011591|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011592|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011593|NCT01276756|Interferons|interferons|mesh-list
2011594|NCT01276756|Ribavirin|ribavirin|mesh-list
2011595|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
2011596|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
2011597|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2011598|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
2011599|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011600|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
2011601|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011602|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
2011603|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011604|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
2011605|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011606|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2011607|NCT01276821|Epinephrine|epinephrine|mesh-list
2011608|NCT01276821|Racepinephrine|racepinephrine|mesh-list
2011609|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
2011610|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2011611|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2011612|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
2011613|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2011614|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011615|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011616|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2011617|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2011618|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
2011619|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011620|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2011621|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
2011622|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
2011623|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
2011624|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2011625|NCT01276847|Etanercept|etanercept|mesh-list
2011626|NCT01276847|Ustekinumab|ustekinumab|mesh-list
2011627|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2011628|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2011629|NCT01276847|Analgesics|analgesics|mesh-ancestor
2011630|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
2011631|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011632|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011633|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2011634|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011635|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2011636|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2011637|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
2011638|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
2011639|NCT01277081|Acetaminophen|acetaminophen|mesh-list
2011640|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2011641|NCT01277081|Analgesics|analgesics|mesh-ancestor
2011642|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
2011643|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011644|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011645|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
2011646|NCT01277159|Dexamethasone|dexamethasone|mesh-list
2011647|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
2011648|NCT01277159|Buprenorphine|buprenorphine|mesh-list
2011649|NCT01277159|BB 1101|bb 1101|mesh-list
2011650|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2011651|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
2011652|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
2011653|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011654|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011655|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2011656|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
2011657|NCT01277159|Hormones|hormones|mesh-ancestor
2011658|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2011659|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2011660|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011661|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
2011662|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011663|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011664|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2011665|NCT01277159|Narcotics|narcotics|mesh-ancestor
2011666|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2011667|NCT01277159|Analgesics|analgesics|mesh-ancestor
2011668|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
2011669|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2011670|NCT01277211|NuvaRing|nuvaring|mesh-list
2011671|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2011672|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
2011673|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2011674|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011675|NCT01277302|Ranibizumab|ranibizumab|mesh-list
2011676|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2011677|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2011678|NCT01277302|Growth Substances|growth substances|mesh-ancestor
2011679|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011680|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
2011681|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011682|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
2011683|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2011684|NCT01277510|Cinacalcet|cinacalcet|mesh-list
2011685|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2011686|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011687|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2011688|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
2011689|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2011690|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
2011691|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2011692|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
2011693|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011694|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011695|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2011696|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
2011697|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
2011698|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2011699|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
2011700|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2011701|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011702|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2011703|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
2011704|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011705|NCT01277718|Rabeprazole|rabeprazole|mesh-list
2011706|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2011707|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2011708|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2011709|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011710|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011711|NCT01277744|Cisplatin|cisplatin|mesh-list
2011712|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011713|NCT01277822|Losartan|losartan|mesh-list
2011714|NCT01277822|Amlodipine|amlodipine|mesh-list
2011715|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2011716|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2011717|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2011718|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011719|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2011720|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011721|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
2011722|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2011723|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2011724|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2011725|NCT01277861|Fentanyl|fentanyl|mesh-list
2011726|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2011727|NCT01277861|Narcotics|narcotics|mesh-ancestor
2011728|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2011729|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011730|NCT01277861|Analgesics|analgesics|mesh-ancestor
2011731|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
2011732|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011733|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2011734|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2011735|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
2011736|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
2011737|NCT01278160|Insulin|insulin|mesh-list
2011738|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2011739|NCT01278160|Metformin|metformin|mesh-list
2011740|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
2011741|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
2011742|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2011743|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
2011744|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2011745|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
2011746|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2011747|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011748|NCT01278173|Vigabatrin|vigabatrin|mesh-list
2011749|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
2011750|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011751|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011752|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
2011753|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2011754|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011755|NCT01278342|Octreotide|octreotide|mesh-list
2011756|NCT01278342|Cabergoline|cabergoline|mesh-list
2011757|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2011758|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2011759|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011760|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2011761|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2011762|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
2011763|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
2011764|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2011765|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011766|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011767|NCT01278394|Tavaborole|tavaborole|mesh-list
2011768|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
2011769|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011770|NCT01278407|Donepezil|donepezil|mesh-list
2011771|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2011772|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011773|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011774|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
2011775|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2011776|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011777|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
2011778|NCT01278745|Rituximab|rituximab|mesh-list
2011779|NCT01278745|Tacrolimus|tacrolimus|mesh-list
2011780|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2011781|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011782|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
2011783|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011784|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011785|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2011786|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2011787|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011788|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011789|NCT01278797|Amlodipine|amlodipine|mesh-list
2011790|NCT01278797|Telmisartan|telmisartan|mesh-list
2011791|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2011792|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2011793|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2011794|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2011795|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011796|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2011797|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011798|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
2011799|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2011800|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2011801|NCT01279057|Fluticasone|fluticasone|mesh-list
2011802|NCT01279057|Xhance|xhance|mesh-list
2011803|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2011804|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2011805|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
2011806|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011807|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011808|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2011809|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
2011810|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
2011811|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2011812|NCT01279187|Teriparatide|teriparatide|mesh-list
2011813|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2011814|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011815|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2011816|NCT01279317|Acetic Acid|acetic acid|mesh-list
2011817|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2011818|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011819|NCT01279343|Misoprostol|misoprostol|mesh-list
2011820|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2011821|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
2011822|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2011823|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011824|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2011825|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2011826|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
2011827|NCT01279447|Bupivacaine|bupivacaine|mesh-list
2011828|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
2011829|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
2011830|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2011831|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011832|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
2011833|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011834|NCT01279681|Leucovorin|leucovorin|mesh-list
2011835|NCT01279681|Bevacizumab|bevacizumab|mesh-list
2011836|NCT01279681|Fluorouracil|fluorouracil|mesh-list
2011837|NCT01279681|Capecitabine|capecitabine|mesh-list
2011838|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
2011839|NCT01279681|Calcium|calcium|mesh-list
2011840|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
2011841|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2011842|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011843|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2011844|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2011845|NCT01279681|Growth Substances|growth substances|mesh-ancestor
2011846|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011847|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
2011848|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2011849|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
2011850|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011851|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2011852|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2011853|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
2011854|NCT01279681|Antidotes|antidotes|mesh-ancestor
2011855|NCT01279681|Protective Agents|protective agents|mesh-ancestor
2011856|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
2011857|NCT01279681|Vitamins|vitamins|mesh-ancestor
2011858|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
2011859|NCT01279850|Pregabalin|pregabalin|mesh-list
2011860|NCT01279850|Analgesics|analgesics|mesh-ancestor
2011861|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
2011862|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011863|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011864|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
2011865|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2011866|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2011867|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011868|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2011869|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2011870|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2011871|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2011872|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2011873|NCT01279954|Abatacept|abatacept|mesh-list
2011874|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2011875|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011876|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011877|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2011878|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
2011879|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011880|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011881|NCT01280058|Paclitaxel|paclitaxel|mesh-list
2011882|NCT01280058|Carboplatin|carboplatin|mesh-list
2011883|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2011884|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2011885|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011886|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
2011887|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
2011888|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
2011889|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011890|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2011891|NCT01280110|Laxatives|laxatives|mesh-ancestor
2011892|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2011893|NCT01280123|Pioglitazone|pioglitazone|mesh-list
2011894|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2011895|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011896|NCT01280266|Amlodipine|amlodipine|mesh-list
2011897|NCT01280266|Udenafil|udenafil|mesh-list
2011898|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2011899|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2011900|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2011901|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011902|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2011903|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011904|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
2011905|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2011906|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2011907|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011908|NCT01280409|Metformin|metformin|mesh-list
2011909|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2011910|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011911|NCT01280591|Naproxen|naproxen|mesh-list
2011912|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2011913|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2011914|NCT01280591|Analgesics|analgesics|mesh-ancestor
2011915|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
2011916|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011917|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011918|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2011919|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2011920|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
2011921|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2011922|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011923|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011924|NCT01280604|Fenofibrate|fenofibrate|mesh-list
2011925|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2011926|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
2011927|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011928|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2011929|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
2011930|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2011931|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
2011932|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011933|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2011934|NCT01280656|Interferons|interferons|mesh-list
2011935|NCT01280656|Ribavirin|ribavirin|mesh-list
2011936|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2011937|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2011938|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2011939|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
2011940|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011941|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
2011942|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011943|NCT01280695|Pioglitazone|pioglitazone|mesh-list
2011944|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2011945|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011946|NCT01280721|Tolvaptan|tolvaptan|mesh-list
2011947|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2011948|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011949|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
2011950|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011951|NCT01280955|Plerixafor|plerixafor|mesh-list
2011952|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2011953|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2011954|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
2011955|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011956|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2011957|NCT01280968|Vaccines|vaccines|mesh-list
2011958|NCT01280968|Nicotine|nicotine|mesh-list
2011959|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
2011960|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011961|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2011962|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
2011963|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2011964|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2011965|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2011966|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
2011967|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2011968|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011969|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2011970|NCT01280968|Antacids|antacids|mesh-ancestor
2011971|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2011972|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
2011973|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2011974|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2011975|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011976|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
2011977|NCT01280981|Coagulants|coagulants|mesh-ancestor
2011978|NCT01281007|Acyclovir|acyclovir|mesh-list
2011979|NCT01281007|Famciclovir|famciclovir|mesh-list
2011980|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
2011981|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2011982|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2011983|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011984|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011985|NCT01281189|Pramipexole|pramipexole|mesh-list
2011986|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
2011987|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011988|NCT01281189|Protective Agents|protective agents|mesh-ancestor
2011989|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2011990|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2011991|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2011992|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
2011993|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
2011994|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2011995|NCT01281202|Vigabatrin|vigabatrin|mesh-list
2011996|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
2011997|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2011998|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2011999|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
2012000|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012001|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012002|NCT01281306|Valsartan|valsartan|mesh-list
2012003|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2012004|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2012005|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2012006|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2012007|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012008|NCT01281475|Levodopa|levodopa|mesh-list
2012009|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2012010|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2012011|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
2012012|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012013|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012014|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012015|NCT01281501|Scopolamine|scopolamine|mesh-list
2012016|NCT01281501|Pantoprazole|pantoprazole|mesh-list
2012017|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
2012018|NCT01281501|Antacids|antacids|mesh-list
2012019|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2012020|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2012021|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2012022|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012023|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012024|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2012025|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
2012026|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
2012027|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012028|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012029|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
2012030|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2012031|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
2012032|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012033|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2012034|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
2012035|NCT01281839|Ribavirin|ribavirin|mesh-list
2012036|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2012037|NCT01281839|Simeprevir|simeprevir|mesh-list
2012038|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
2012039|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012040|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
2012041|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012042|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
2012043|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012044|NCT01281865|Everolimus|everolimus|mesh-list
2012045|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
2012046|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012047|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2012048|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
2012049|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012050|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2012051|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012052|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012053|NCT01281917|Sirolimus|sirolimus|mesh-list
2012054|NCT01281917|Bortezomib|bortezomib|mesh-list
2012055|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012056|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2012057|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012058|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2012059|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
2012060|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2012061|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
2012062|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012063|NCT01281956|Naluzotan|naluzotan|mesh-list
2012064|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2012065|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2012066|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
2012067|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012068|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012069|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012070|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
2012071|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2012072|NCT01281969|Antibodies|antibodies|mesh-list
2012073|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
2012074|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2012075|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
2012076|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012077|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2012078|NCT01282138|Dextrans|dextrans|mesh-list
2012079|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2012080|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2012081|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2012082|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2012083|NCT01282138|Analgesics|analgesics|mesh-ancestor
2012084|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
2012085|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012086|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012087|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2012088|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2012089|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2012090|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2012091|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2012092|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
2012093|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
2012094|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012095|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012096|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
2012097|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
2012098|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
2012099|NCT01282164|Insulin|insulin|mesh-list
2012100|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2012101|NCT01282164|Glucagon|glucagon|mesh-list
2012102|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2012103|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2012104|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012105|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2012106|NCT01282164|Hormones|hormones|mesh-ancestor
2012107|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2012108|NCT01282164|Incretins|incretins|mesh-ancestor
2012109|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2012110|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2012111|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2012112|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012113|NCT01282424|Idelalisib|idelalisib|mesh-list
2012114|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012115|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012116|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012117|NCT01282463|Docetaxel|docetaxel|mesh-list
2012118|NCT01282463|Ramucirumab|ramucirumab|mesh-list
2012119|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012120|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
2012121|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
2012122|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
2012123|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012124|NCT01282476|Rituximab|rituximab|mesh-list
2012125|NCT01282476|Panobinostat|panobinostat|mesh-list
2012126|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2012127|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012128|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
2012129|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012130|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2012131|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2012132|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012133|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012134|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2012135|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2012136|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2012137|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2012138|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012139|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2746039|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
2012140|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012141|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2012142|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
2012143|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2012144|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2012145|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2012146|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2012147|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2012148|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012149|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012150|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012151|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2012152|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
2012153|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2012154|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
2012155|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2012156|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2012157|NCT01283009|Prednisolone|prednisolone|mesh-list
2012158|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
2012159|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2012160|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
2012161|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2012162|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
2012163|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
2012164|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012165|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012166|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2012167|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
2012168|NCT01283009|Hormones|hormones|mesh-ancestor
2012169|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2012170|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2012171|NCT01283009|Protective Agents|protective agents|mesh-ancestor
2012172|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2012173|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012174|NCT01283139|Sifalimumab|sifalimumab|mesh-list
2012175|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2012176|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
2012177|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012178|NCT01283152|Lactulose|lactulose|mesh-list
2012179|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2012180|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2012181|NCT01283152|Laxatives|laxatives|mesh-ancestor
2012182|NCT01283282|Clopidogrel|clopidogrel|mesh-list
2012183|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2012184|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2012185|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2012186|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2012187|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
2012188|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012189|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012190|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012191|NCT01283334|Carboplatin|carboplatin|mesh-list
2012192|NCT01283334|Cetuximab|cetuximab|mesh-list
2012193|NCT01283334|Everolimus|everolimus|mesh-list
2012194|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012195|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2012196|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2012197|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
2012198|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012199|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
2012200|NCT01283386|Chlorambucil|chlorambucil|mesh-list
2012201|NCT01283386|Rituximab|rituximab|mesh-list
2012202|NCT01283386|Fludarabine|fludarabine|mesh-list
2012203|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2012204|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
2012205|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012206|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2012207|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2012208|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
2012209|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012210|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012211|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2012212|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2012213|NCT01283464|Vitamin A|vitamin a|mesh-list
2012214|NCT01283464|Tretinoin|tretinoin|mesh-list
2012215|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012216|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
2012217|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
2012218|NCT01283464|Vitamins|vitamins|mesh-ancestor
2012219|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
2012220|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012221|NCT01283516|Ceritinib|ceritinib|mesh-list
2012222|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012223|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2012224|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012225|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012226|NCT01283542|Pasireotide|pasireotide|mesh-list
2012227|NCT01283542|Hormones|hormones|mesh-ancestor
2012228|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2012229|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012230|NCT01283555|Tenofovir|tenofovir|mesh-list
2012231|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
2012232|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012233|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2012234|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2012235|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012236|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012237|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2012238|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2012239|NCT01283581|Vancomycin|vancomycin|mesh-list
2012240|NCT01283581|Linezolid|linezolid|mesh-list
2012241|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2012242|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012243|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2012244|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012245|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012246|NCT01283971|Adalimumab|adalimumab|mesh-list
2012247|NCT01283971|Methotrexate|methotrexate|mesh-list
2012248|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2012249|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
2012250|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2012251|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012252|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2012253|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
2012254|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012255|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012256|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
2012257|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012258|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2012259|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2012260|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
2012261|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2012262|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2012263|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2012264|NCT01284296|Lidocaine|lidocaine|mesh-list
2012265|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
2012266|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
2012267|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2012268|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012269|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
2012270|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012271|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2012272|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2012273|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2012274|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2012275|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012276|NCT01284335|Gemcitabine|gemcitabine|mesh-list
2012277|NCT01284335|Docetaxel|docetaxel|mesh-list
2012278|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2012279|NCT01284335|Temozolomide|temozolomide|mesh-list
2012280|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012281|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2012282|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
2012283|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012284|NCT01284335|Antiviral Agents|antiviral agents|mesh-ancestor
2012285|NCT01284335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012286|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012287|NCT01284335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2012288|NCT01284335|Immunologic Factors|immunologic factors|mesh-ancestor
2012289|NCT01284335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012290|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
2012291|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
2012292|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
2012293|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2012294|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2012295|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
2012296|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2012297|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2012298|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2012299|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2012300|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012301|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2012302|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2012303|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2012304|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2012305|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
2012306|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012307|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012308|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2012309|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2012310|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
2012311|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2012312|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2012313|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
2012314|NCT01284621|Empagliflozin|empagliflozin|mesh-list
2012315|NCT01284621|Ramipril|ramipril|mesh-list
2012316|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2012317|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
2012318|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012319|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012320|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2012321|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2012322|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2012323|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012324|NCT01284634|Cannabidiol|cannabidiol|mesh-list
2012325|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
2012326|NCT01284959|Risperidone|risperidone|mesh-list
2012327|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2012328|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2012329|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
2012330|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012331|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012332|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012333|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2012334|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2012335|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2012336|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2012337|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2012338|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
2012339|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2012340|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2012341|NCT01285050|Tenofovir|tenofovir|mesh-list
2012342|NCT01285050|Emtricitabine|emtricitabine|mesh-list
2012343|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
2012344|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2012345|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
2012346|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012347|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2012348|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2012349|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012350|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012351|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2012352|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2012353|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2012354|NCT01285310|Thalidomide|thalidomide|mesh-list
2012355|NCT01285310|Apremilast|apremilast|mesh-list
2012356|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2012357|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2012358|NCT01285310|Analgesics|analgesics|mesh-ancestor
2012359|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
2012360|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012361|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012362|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2012363|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2012364|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2012365|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2012366|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012367|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012368|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2012369|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
2012370|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
2012371|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2012372|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012373|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2012374|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2012375|NCT01285310|Growth Substances|growth substances|mesh-ancestor
2012376|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
2012377|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012378|NCT01285323|Reslizumab|reslizumab|mesh-list
2012379|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2012380|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
2012381|NCT01285401|Interferons|interferons|mesh-list
2012382|NCT01285401|Interferon-beta|interferon-beta|mesh-list
2012383|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
2012384|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012385|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
2012386|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012387|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
2012388|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012389|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2012390|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
2012391|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2012392|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
2012393|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012394|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012395|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2012396|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
2012397|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
2012398|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2012399|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
2012400|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012401|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012402|NCT01285609|Paclitaxel|paclitaxel|mesh-list
2012403|NCT01285609|Carboplatin|carboplatin|mesh-list
2012404|NCT01285609|Ipilimumab|ipilimumab|mesh-list
2012405|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2012406|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012407|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
2012408|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
2012409|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
2012410|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012411|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2012412|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2012413|NCT01285635|Docetaxel|docetaxel|mesh-list
2012414|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012415|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
2012416|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
2012417|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
2012418|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012419|NCT01285908|Norepinephrine|norepinephrine|mesh-list
2012420|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2012421|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2012422|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
2012423|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012424|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012425|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012426|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
2012427|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
2012428|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012429|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2012430|NCT01286077|Bortezomib|bortezomib|mesh-list
2012431|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012432|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
2012433|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2012434|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2012435|NCT01286168|Eusol|eusol|mesh-list
2012436|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2012437|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2012438|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012439|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
2012440|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
2012441|NCT01286207|Rizatriptan|rizatriptan|mesh-list
2012442|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2012443|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
2012444|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012445|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012446|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012447|NCT01286259|Disulfiram|disulfiram|mesh-list
2012448|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2012449|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2012450|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012451|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012452|NCT01286402|Bupropion|bupropion|mesh-list
2012453|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2012454|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
2012455|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2012456|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2012457|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2012458|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2012459|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012460|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
2012461|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012462|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012463|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2012464|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2012465|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012466|NCT01286454|Fesoterodine|fesoterodine|mesh-list
2012467|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2012468|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2012469|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
2012470|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012471|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012472|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012473|NCT01286454|Urological Agents|urological agents|mesh-ancestor
2012474|NCT01286558|Amlodipine|amlodipine|mesh-list
2012475|NCT01286558|Telmisartan|telmisartan|mesh-list
2012476|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2012477|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2012478|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2012479|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012480|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2012481|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012482|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
2012483|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2012484|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2012485|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
2012486|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
2012487|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012488|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2012489|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2012490|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012491|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012492|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2012493|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2012494|NCT01286753|Vemurafenib|vemurafenib|mesh-list
2012495|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012496|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2012497|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012498|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012499|NCT01286805|Bupivacaine|bupivacaine|mesh-list
2012500|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
2012501|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
2012502|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2012503|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012504|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
2012505|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012506|NCT01286818|Leucovorin|leucovorin|mesh-list
2012507|NCT01286818|Fluorouracil|fluorouracil|mesh-list
2012508|NCT01286818|Irinotecan|irinotecan|mesh-list
2012509|NCT01286818|Ramucirumab|ramucirumab|mesh-list
2012510|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2012511|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
2012512|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
2012513|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012514|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2012515|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012516|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2012517|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
2012518|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012519|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2012520|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2012521|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012522|NCT01286818|Antidotes|antidotes|mesh-ancestor
2012523|NCT01286818|Protective Agents|protective agents|mesh-ancestor
2012524|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
2012525|NCT01286818|Vitamins|vitamins|mesh-ancestor
2012526|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
2012527|NCT01286987|Talazoparib|talazoparib|mesh-list
2012528|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2012529|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012530|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012531|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012532|NCT01287039|Reslizumab|reslizumab|mesh-list
2012533|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2012534|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
2012535|NCT01287078|Cyclosporine|cyclosporine|mesh-list
2012536|NCT01287078|Cyclosporins|cyclosporins|mesh-list
2012537|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012538|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012539|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2012540|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
2012541|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012542|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
2012543|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012544|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
2012545|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2012546|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2012547|NCT01287117|Omalizumab|omalizumab|mesh-list
2012548|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2012549|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2012550|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
2012551|NCT01287195|Omeprazole|omeprazole|mesh-list
2012552|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
2012553|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2012554|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2012555|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2012556|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012557|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012558|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
2012559|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012560|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2012561|NCT01287221|Riboflavin|riboflavin|mesh-list
2012562|NCT01287221|Rifampin|rifampin|mesh-list
2012563|NCT01287221|Vitamins|vitamins|mesh-ancestor
2012564|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
2012565|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012566|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
2012567|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2012568|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
2012569|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2012570|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012571|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
2012572|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2012573|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012574|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012575|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2012576|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2012577|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2012578|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2012579|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2012580|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2012581|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2012582|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
2012583|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
2012584|NCT01287364|Ciclesonide|ciclesonide|mesh-list
2012585|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2012586|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
2012587|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2012588|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
2012589|NCT01287364|Hormones|hormones|mesh-ancestor
2012590|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2012591|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012592|NCT01287377|Nicotine|nicotine|mesh-list
2012593|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2012594|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
2012595|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012596|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012597|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2012598|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2012599|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
2012600|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012601|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012602|NCT01287520|Carboplatin|carboplatin|mesh-list
2012603|NCT01287520|Pemetrexed|pemetrexed|mesh-list
2012604|NCT01287520|Ranitidine|ranitidine|mesh-list
2012605|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2012606|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012607|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012608|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012609|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2012610|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2012611|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2012612|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2012613|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2012614|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
2012615|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
2012616|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012617|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746052|NCT01546948|Methadone|methadone|mesh-list
2746053|NCT01546948|Hydromorphone|hydromorphone|mesh-list
2746054|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2746055|NCT01546948|Narcotics|narcotics|mesh-ancestor
2746056|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2746057|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746058|NCT01546948|Analgesics|analgesics|mesh-ancestor
2746059|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
2746060|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2746061|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
2746062|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
2746063|NCT01495676|Gemcitabine|gemcitabine|mesh-list
2746064|NCT01495676|Cisplatin|cisplatin|mesh-list
2746065|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746066|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2746067|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
2746068|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012647|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2012648|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012649|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2012650|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012651|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012652|NCT01287832|Vancomycin|vancomycin|mesh-list
2012653|NCT01287832|Daptomycin|daptomycin|mesh-list
2012654|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2012655|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012656|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2012657|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2012658|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2012659|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2012660|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012661|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2746069|NCT01495676|Antiviral Agents|antiviral agents|mesh-ancestor
2012662|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012663|NCT01288079|Analgesics|analgesics|mesh-ancestor
2012664|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
2012665|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012666|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
2012667|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2012668|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
2012669|NCT01288209|Ribavirin|ribavirin|mesh-list
2012670|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2012671|NCT01288209|Simeprevir|simeprevir|mesh-list
2012672|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
2012673|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012674|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
2012675|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012676|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
2012677|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012678|NCT01288443|Atorvastatin|atorvastatin|mesh-list
2012679|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2012680|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2012681|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2012682|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
2012683|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012684|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2012685|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2012686|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012687|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
2012688|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012689|NCT01288469|Atorvastatin|atorvastatin|mesh-list
2012690|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2012691|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2012692|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2012693|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
2012694|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012695|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2012696|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2012697|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012698|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
2012699|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012700|NCT01288521|Ketoconazole|ketoconazole|mesh-list
2012701|NCT01288521|Tacrolimus|tacrolimus|mesh-list
2012702|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2012703|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
2012704|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012705|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2012706|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012707|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012708|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
2012709|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012710|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2012711|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2012712|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2012713|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
2012714|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2012715|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2012716|NCT01288781|Acetazolamide|acetazolamide|mesh-list
2012717|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
2012718|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2012719|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012720|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012721|NCT01288781|Diuretics|diuretics|mesh-ancestor
2012722|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
2012723|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012724|NCT01288807|Milnacipran|milnacipran|mesh-list
2012725|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2012726|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2012727|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2012728|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012729|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012730|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012731|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2012732|NCT01288807|Analgesics|analgesics|mesh-ancestor
2012733|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
2012734|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012735|NCT01288859|Curcumin|curcumin|mesh-list
2012736|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2012737|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2012738|NCT01288859|Analgesics|analgesics|mesh-ancestor
2012739|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
2012740|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012741|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012742|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2012743|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2012744|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012745|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012746|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012747|NCT01288911|Bicalutamide|bicalutamide|mesh-list
2012748|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
2012749|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
2012750|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2012751|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012752|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012753|NCT01288937|Milnacipran|milnacipran|mesh-list
2012754|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
2012755|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2012756|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2012757|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2012758|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012759|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012760|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012761|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2012762|NCT01288937|Analgesics|analgesics|mesh-ancestor
2012763|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
2012764|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012765|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
2012766|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2012767|NCT01289067|Satraplatin|satraplatin|mesh-list
2012768|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012769|NCT01289119|Metformin|metformin|mesh-list
2012770|NCT01289119|Pioglitazone|pioglitazone|mesh-list
2012771|NCT01289119|Alogliptin|alogliptin|mesh-list
2012772|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2012773|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012774|NCT01289119|Incretins|incretins|mesh-ancestor
2012775|NCT01289119|Hormones|hormones|mesh-ancestor
2012776|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2012777|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2012778|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
2012779|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012780|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012781|NCT01289275|Nicotine|nicotine|mesh-list
2012782|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2012783|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
2012784|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012785|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012786|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2012787|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2012788|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
2012789|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012790|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012791|NCT01289353|Carboplatin|carboplatin|mesh-list
2012792|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012793|NCT01289457|Cytarabine|cytarabine|mesh-list
2012794|NCT01289457|Fludarabine|fludarabine|mesh-list
2012795|NCT01289457|Idarubicin|idarubicin|mesh-list
2012796|NCT01289457|Clofarabine|clofarabine|mesh-list
2012797|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012798|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2012799|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
2012800|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012801|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2012802|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
2012803|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012804|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
2012805|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012806|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2012807|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2012808|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2012809|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012810|NCT01289522|Cetuximab|cetuximab|mesh-list
2012811|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2012812|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012813|NCT01289639|Pioglitazone|pioglitazone|mesh-list
2012814|NCT01289639|Fenofibrate|fenofibrate|mesh-list
2012815|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2012816|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012817|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2012818|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
2012819|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012820|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2012821|NCT01289678|Interleukin-2|interleukin-2|mesh-list
2012822|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012823|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2012824|NCT01289678|Analgesics|analgesics|mesh-ancestor
2012825|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
2012826|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012827|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012828|NCT01289782|Ribavirin|ribavirin|mesh-list
2012829|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2012830|NCT01289782|Simeprevir|simeprevir|mesh-list
2012831|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
2012832|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012833|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
2012834|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012835|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
2012836|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012837|NCT01289821|Leucovorin|leucovorin|mesh-list
2012838|NCT01289821|Folic Acid|folic acid|mesh-list
2012839|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
2012840|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
2012841|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012842|NCT01289821|Antidotes|antidotes|mesh-ancestor
2012843|NCT01289821|Protective Agents|protective agents|mesh-ancestor
2012844|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012845|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
2012846|NCT01289821|Vitamins|vitamins|mesh-ancestor
2012847|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
2012848|NCT01289821|Hematinics|hematinics|mesh-ancestor
2012849|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
2012850|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2012851|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2012852|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
2012853|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012854|NCT01289912|Everolimus|everolimus|mesh-list
2012855|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012856|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2012857|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
2012858|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012859|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2012860|NCT01289990|Empagliflozin|empagliflozin|mesh-list
2012861|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2012862|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012863|NCT01289990|Incretins|incretins|mesh-ancestor
2012864|NCT01289990|Hormones|hormones|mesh-ancestor
2012865|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2012866|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2012867|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
2012868|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012869|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012870|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2012871|NCT01290029|Cinacalcet|cinacalcet|mesh-list
2012872|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2012873|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012874|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2012875|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
2012876|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2012877|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
2012878|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2012879|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012880|NCT01290237|Vancomycin|vancomycin|mesh-list
2012881|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2012882|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012883|NCT01290263|Bevacizumab|bevacizumab|mesh-list
2012884|NCT01290263|Trebananib|trebananib|mesh-list
2012885|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2012886|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012887|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2012888|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2012889|NCT01290263|Growth Substances|growth substances|mesh-ancestor
2012890|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012891|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
2012892|NCT01290315|Dextrans|dextrans|mesh-list
2012893|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2012894|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
2012895|NCT01290315|Hematinics|hematinics|mesh-ancestor
2012896|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
2012897|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
2012898|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
2012899|NCT01290341|Naftifine|naftifine|mesh-list
2012900|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
2012901|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012902|NCT01290445|Varenicline|varenicline|mesh-list
2012903|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2012904|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2012905|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
2012906|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012907|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012908|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012909|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
2012910|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
2012911|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2012912|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2012913|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012914|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012915|NCT01290484|Urological Agents|urological agents|mesh-ancestor
2012916|NCT01290601|Chloroquine|chloroquine|mesh-list
2012917|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2012918|NCT01290601|Primaquine|primaquine|mesh-list
2012919|NCT01290601|Tafenoquine|tafenoquine|mesh-list
2012920|NCT01290601|Amebicides|amebicides|mesh-ancestor
2012921|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2012922|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2012923|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012924|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
2012925|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2012926|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2012927|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2012928|NCT01290601|Analgesics|analgesics|mesh-ancestor
2012929|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
2012930|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012931|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012932|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2012933|NCT01290601|Filaricides|filaricides|mesh-ancestor
2012934|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
2012935|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
2012936|NCT01290679|Ribavirin|ribavirin|mesh-list
2012937|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2012938|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2012939|NCT01290679|Simeprevir|simeprevir|mesh-list
2012940|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
2012941|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012942|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
2012943|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012944|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
2012945|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012946|NCT01290731|Interferons|interferons|mesh-list
2012947|NCT01290731|Ribavirin|ribavirin|mesh-list
2012948|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2012949|NCT01290731|Simeprevir|simeprevir|mesh-list
2012950|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012951|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
2012952|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2012953|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
2012954|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012955|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
2012956|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012957|NCT01290757|Dabigatran|dabigatran|mesh-list
2012958|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
2012959|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2012960|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
2012961|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012962|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012963|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
2012964|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
2012965|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
2012966|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2012967|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2012968|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
2012969|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2012970|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012971|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2012972|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
2012973|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2012974|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2012975|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2012976|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
2012977|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2012978|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012979|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
2012980|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2012981|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
2012982|NCT01290887|Reslizumab|reslizumab|mesh-list
2012983|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2012984|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
2012985|NCT01290913|Omalizumab|omalizumab|mesh-list
2012986|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2012987|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2012988|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
2012989|NCT01291017|Palbociclib|palbociclib|mesh-list
2012990|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2012991|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2012992|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2012993|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2012994|NCT01291056|Clomiphene|clomiphene|mesh-list
2012995|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2012996|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
2012997|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2012998|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2012999|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2013000|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
2013001|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2013002|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2013003|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2013004|NCT01291108|Bimatoprost|bimatoprost|mesh-list
2013005|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2013006|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2013007|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2013008|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013009|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2013010|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2013011|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2013012|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013013|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
2013014|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013015|NCT01291784|Antibodies|antibodies|mesh-list
2013016|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2013017|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
2013018|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013019|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
2013020|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2013021|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013022|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013023|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2013024|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2013025|NCT01292005|Protective Agents|protective agents|mesh-ancestor
2013026|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013027|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
2013028|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2013029|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
2013030|NCT01292057|Aripiprazole|aripiprazole|mesh-list
2013031|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
2013032|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2013033|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2013034|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2013035|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013036|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013037|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
2013038|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
2013039|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013040|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013041|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2013042|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2013043|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
2013044|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2013045|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2013046|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2013047|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2013048|NCT01292187|Calcitonin|calcitonin|mesh-list
2013049|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
2013050|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2013051|NCT01292187|Katacalcin|katacalcin|mesh-list
2013052|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2013053|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013054|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2013055|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
2013056|NCT01292226|Cyclosporine|cyclosporine|mesh-list
2013057|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
2013058|NCT01292226|Antibodies|antibodies|mesh-list
2013059|NCT01292226|Cyclosporins|cyclosporins|mesh-list
2013060|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
2013061|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013062|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013063|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013064|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2013065|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
2013066|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2013067|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
2013068|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2013069|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2013070|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2013071|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013072|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2013073|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
2013074|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2013075|NCT01292239|Ribavirin|ribavirin|mesh-list
2013076|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2013077|NCT01292239|Simeprevir|simeprevir|mesh-list
2013078|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
2013079|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013080|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
2013081|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2013082|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
2013083|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013084|NCT01292252|Teriparatide|teriparatide|mesh-list
2013085|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
2013086|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013087|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2013088|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2013089|NCT01292304|Tolvaptan|tolvaptan|mesh-list
2013090|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2013091|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013092|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
2013093|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013094|NCT01292447|Lidocaine|lidocaine|mesh-list
2013095|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
2013096|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
2013097|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013098|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013099|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
2013100|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013101|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2013102|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2013103|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2013104|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2013105|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013106|NCT01292473|Omalizumab|omalizumab|mesh-list
2013107|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2013108|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2013109|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
2013110|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
2013111|NCT01292603|Rituximab|rituximab|mesh-list
2013112|NCT01292603|Fludarabine|fludarabine|mesh-list
2013113|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2013114|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
2013115|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013116|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2013117|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2013118|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
2013119|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013120|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013121|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2013122|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2013123|NCT01292642|Nicotine|nicotine|mesh-list
2013124|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2013125|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
2013126|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013127|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013128|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2013129|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2013130|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
2013131|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013132|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013133|NCT01292798|Ranibizumab|ranibizumab|mesh-list
2013134|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2013135|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2013136|NCT01292798|Growth Substances|growth substances|mesh-ancestor
2013137|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013138|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
2013139|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013140|NCT01292837|Levetiracetam|levetiracetam|mesh-list
2013141|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
2013142|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
2013143|NCT01293006|Suvorexant|suvorexant|mesh-list
2013144|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2013145|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2013146|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013147|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013148|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2013149|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013150|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013151|NCT01293032|Tamoxifen|tamoxifen|mesh-list
2013152|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2013153|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013154|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2013155|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
2013156|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013157|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013158|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2013159|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013160|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2013161|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2013162|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2013163|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2013164|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013165|NCT01293396|Insulin|insulin|mesh-list
2013166|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2013167|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
2013168|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
2013169|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2013170|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2013171|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2013172|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013173|NCT01293539|Melphalan|melphalan|mesh-list
2013174|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2013175|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
2013176|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013177|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013178|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2013179|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2013180|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
2013181|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013182|NCT01293682|Calcitriol|calcitriol|mesh-list
2013183|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2013184|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013185|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2013186|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2013187|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013188|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2013189|NCT01293682|Vitamins|vitamins|mesh-ancestor
2013190|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
2013191|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2013192|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2013193|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013194|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013195|NCT01293825|Ziprasidone|ziprasidone|mesh-list
2013196|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2013197|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
2013198|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013199|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013200|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013201|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2013202|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2013203|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013204|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2013205|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2013206|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
2013207|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
2013208|NCT01293968|Promethazine|promethazine|mesh-list
2013209|NCT01293968|Ibuprofen|ibuprofen|mesh-list
2013210|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2013211|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2013212|NCT01293968|Analgesics|analgesics|mesh-ancestor
2013213|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
2013214|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013215|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013216|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2013217|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2013218|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2013219|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013220|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013221|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2013222|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2013223|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013224|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
2013225|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
2013226|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
2013227|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
2013228|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2013229|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2013230|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
2013231|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
2013232|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013233|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2013234|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
2013235|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
2013236|NCT01294098|Bupivacaine|bupivacaine|mesh-list
2013237|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
2013238|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
2013239|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013240|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013241|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
2013242|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013243|NCT01294163|Propofol|propofol|mesh-list
2013244|NCT01294163|Sevoflurane|sevoflurane|mesh-list
2013245|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2013246|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013247|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013248|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2013249|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
2013250|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
2013251|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2013252|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2013253|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2013254|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013255|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2013256|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013257|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013258|NCT01294319|Dexamethasone|dexamethasone|mesh-list
2013259|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
2013260|NCT01294319|Spironolactone|spironolactone|mesh-list
2013261|NCT01294319|Mifepristone|mifepristone|mesh-list
2013262|NCT01294319|BB 1101|bb 1101|mesh-list
2013263|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2013264|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
2013265|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
2013266|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013267|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013268|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2013269|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
2013270|NCT01294319|Hormones|hormones|mesh-ancestor
2013271|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013272|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2013273|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013274|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
2013275|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013276|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013277|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2013278|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
2013279|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2013280|NCT01294319|Diuretics|diuretics|mesh-ancestor
2013281|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
2013282|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2013283|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
2013284|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2013285|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2013286|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2013287|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2013288|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
2013289|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2013290|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2013291|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
2013292|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2013293|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2013294|NCT01294358|Gemcitabine|gemcitabine|mesh-list
2013295|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2013296|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
2013297|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013298|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013299|NCT01294358|Antiviral Agents|antiviral agents|mesh-ancestor
2013300|NCT01294358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2013301|NCT01294358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013302|NCT01294358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2013303|NCT01294358|Immunologic Factors|immunologic factors|mesh-ancestor
2013304|NCT01294358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013305|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2013306|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2013307|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2013308|NCT01294384|Laxatives|laxatives|mesh-ancestor
2013309|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2013310|NCT01294397|Denosumab|denosumab|mesh-list
2013311|NCT01294397|Etanercept|etanercept|mesh-list
2013312|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2013313|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2013314|NCT01294397|Analgesics|analgesics|mesh-ancestor
2013315|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
2013316|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013317|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013318|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2013319|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2013320|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2013321|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2013322|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
2013323|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2013324|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
2013325|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2013326|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013327|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2013328|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013329|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
2013330|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2013331|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013332|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2013333|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013334|NCT01294449|Cytarabine|cytarabine|mesh-list
2013335|NCT01294449|Dexamethasone|dexamethasone|mesh-list
2013336|NCT01294449|Methotrexate|methotrexate|mesh-list
2013337|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2013338|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
2013339|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013340|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013341|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
2013342|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2013343|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2013344|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
2013345|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013346|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2013347|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
2013348|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
2013349|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013350|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2013351|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
2013352|NCT01294449|Hormones|hormones|mesh-ancestor
2013353|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013354|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2013355|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2013356|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
2013357|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2013358|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
2013359|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013360|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2013361|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2013362|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2013363|NCT01294462|Aspirin|aspirin|mesh-list
2013364|NCT01294462|Clopidogrel|clopidogrel|mesh-list
2013365|NCT01294462|Ticagrelor|ticagrelor|mesh-list
2013366|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2013367|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2013368|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2013369|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2013370|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
2013371|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013372|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013373|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013374|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2013375|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2013376|NCT01294462|Analgesics|analgesics|mesh-ancestor
2013377|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
2013378|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013379|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2013380|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2013381|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2013382|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2013383|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2013384|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013385|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
2013386|NCT01294553|Metformin|metformin|mesh-list
2013387|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
2013388|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2013389|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013390|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2013391|NCT01294579|Ofatumumab|ofatumumab|mesh-list
2013392|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2013393|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
2013394|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013395|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013396|NCT01294592|Tamsulosin|tamsulosin|mesh-list
2013397|NCT01294592|Dutasteride|dutasteride|mesh-list
2013398|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2013399|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2013400|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2013401|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
2013402|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013403|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013404|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013405|NCT01294592|Urological Agents|urological agents|mesh-ancestor
2013406|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2013407|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2013408|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013409|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
2013410|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013411|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
2013412|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2013413|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2013414|NCT01294683|Niacin|niacin|mesh-list
2013415|NCT01294683|Niacinamide|niacinamide|mesh-list
2013416|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
2013417|NCT01294683|Simvastatin|simvastatin|mesh-list
2013418|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2013419|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2013420|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
2013421|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013422|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2013423|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2013424|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013425|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
2013426|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
2013427|NCT01294683|Vitamins|vitamins|mesh-ancestor
2013428|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
2013429|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013430|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
2013431|NCT01294787|Bromides|bromides|mesh-list
2013432|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
2013433|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2013434|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
2013435|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013436|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013437|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2013438|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
2013439|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
2013440|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2013441|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
2013442|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013443|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013444|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
2013445|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2013446|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2013447|NCT01295034|Vitamin D|vitamin d|mesh-list
2013448|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
2013449|NCT01295034|Vitamins|vitamins|mesh-list
2013450|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
2013451|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013452|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2013453|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2013454|NCT01295112|Dexamethasone|dexamethasone|mesh-list
2013455|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
2013456|NCT01295112|Bevacizumab|bevacizumab|mesh-list
2013457|NCT01295112|BB 1101|bb 1101|mesh-list
2013458|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2013459|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013460|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2013461|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2013462|NCT01295112|Growth Substances|growth substances|mesh-ancestor
2013463|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013464|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
2013465|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2013466|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
2013467|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
2013468|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013469|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2013470|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
2013471|NCT01295112|Hormones|hormones|mesh-ancestor
2013472|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013473|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2013474|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
2013475|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013476|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013477|NCT01295515|Interferons|interferons|mesh-list
2013478|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
2013479|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
2013480|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2013481|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013482|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
2013483|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2013484|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
2013485|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013486|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
2013487|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2013488|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
2013489|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013490|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2013491|NCT01295814|Adalimumab|adalimumab|mesh-list
2013492|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2013493|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2013494|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
2013495|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2013496|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013497|NCT01295879|Vitamin D|vitamin d|mesh-list
2013498|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
2013499|NCT01295879|Vitamins|vitamins|mesh-ancestor
2013500|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
2013501|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013502|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2013503|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2013504|NCT01296035|Panitumumab|panitumumab|mesh-list
2013505|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2013506|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013507|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2013508|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
2013509|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2013510|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2013511|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2013512|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
2013513|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2013514|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013515|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2013516|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2013517|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2013518|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2013519|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013520|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
2013521|NCT01296191|Besifloxacin|besifloxacin|mesh-list
2013522|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2013523|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2013524|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2013525|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2013526|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013527|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013528|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013529|NCT01296347|Ketamine|ketamine|mesh-list
2013530|NCT01296347|Analgesics|analgesics|mesh-ancestor
2013531|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
2013532|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013533|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013534|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2013535|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2013536|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
2013537|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
2013538|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013539|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2013540|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2013541|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013542|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013543|NCT01296412|Metformin|metformin|mesh-list
2013544|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2013545|NCT01296412|Liraglutide|liraglutide|mesh-list
2013546|NCT01296412|Glimepiride|glimepiride|mesh-list
2013547|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2013548|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013549|NCT01296412|Incretins|incretins|mesh-ancestor
2013550|NCT01296412|Hormones|hormones|mesh-ancestor
2013551|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013552|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2013553|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
2013554|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013555|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013556|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2013557|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2013558|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
2013559|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
2013560|NCT01296542|Besifloxacin|besifloxacin|mesh-list
2013561|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2013562|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2013563|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2013564|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2013565|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013566|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013567|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013568|NCT01296568|Gemcitabine|gemcitabine|mesh-list
2013569|NCT01296568|Pemetrexed|pemetrexed|mesh-list
2013570|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2013571|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
2013572|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013573|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013574|NCT01296568|Antiviral Agents|antiviral agents|mesh-ancestor
2013575|NCT01296568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2013576|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013577|NCT01296568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2013578|NCT01296568|Immunologic Factors|immunologic factors|mesh-ancestor
2013579|NCT01296568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013580|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2013581|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2013582|NCT01296646|Naltrexone|naltrexone|mesh-list
2013583|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2013584|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2013585|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013586|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
2013587|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013588|NCT01296672|Finasteride|finasteride|mesh-list
2013589|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2013590|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2013591|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013592|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013593|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
2013594|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013595|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013596|NCT01296672|Urological Agents|urological agents|mesh-ancestor
2013597|NCT01296698|Nicotine|nicotine|mesh-list
2013598|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2013599|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
2013600|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013601|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013602|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2013603|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2013604|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
2013605|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013606|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013607|NCT01296763|Irinotecan|irinotecan|mesh-list
2013608|NCT01296763|Olaparib|olaparib|mesh-list
2013609|NCT01296763|Mitomycins|mitomycins|mesh-list
2013610|NCT01296763|Mitomycin|mitomycin|mesh-list
2013611|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013612|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2013613|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2013614|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013615|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013616|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2013617|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2013618|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
2013619|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2013620|NCT01296815|Bevacizumab|bevacizumab|mesh-list
2013621|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2013622|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013623|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2013624|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2013625|NCT01296815|Growth Substances|growth substances|mesh-ancestor
2013626|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013627|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
2013628|NCT01296932|BI 836826|bi 836826|mesh-list
2013629|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2013630|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013631|NCT01297062|Exenatide|exenatide|mesh-list
2013632|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
2013633|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2013634|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2013635|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2013636|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2013637|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013638|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013639|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013640|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013641|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2013642|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2013643|NCT01297062|Incretins|incretins|mesh-ancestor
2013644|NCT01297062|Hormones|hormones|mesh-ancestor
2013645|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013646|NCT01297335|Clonidine|clonidine|mesh-list
2013647|NCT01297335|Analgesics|analgesics|mesh-ancestor
2013648|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
2013649|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013650|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013651|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2013652|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
2013653|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
2013654|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2013655|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2013656|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2013657|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
2013658|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013659|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013660|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2013661|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2013662|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
2013663|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2013664|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2013665|NCT01297348|Norinyl|norinyl|mesh-list
2013666|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
2013667|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
2013668|NCT01297348|Estradiol|estradiol|mesh-list
2013669|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2013670|NCT01297348|Estrogens|estrogens|mesh-ancestor
2013671|NCT01297348|Hormones|hormones|mesh-ancestor
2013672|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013673|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013674|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2013675|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2013676|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2013677|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2013678|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2013679|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2013680|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2013681|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2013682|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2013683|NCT01297465|Hormones|hormones|mesh-ancestor
2013684|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013685|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013686|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2013687|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2013688|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2013689|NCT01297517|Brinzolamide|brinzolamide|mesh-list
2013690|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2013691|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2013692|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2013693|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2013694|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2013695|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
2013696|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013697|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013698|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013699|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2013700|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013701|NCT01297595|Crizotinib|crizotinib|mesh-list
2013702|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013703|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2013704|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013705|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013706|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2013707|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2013708|NCT01297920|Brinzolamide|brinzolamide|mesh-list
2013709|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2013710|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2013711|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2013712|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2013713|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2013714|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
2013715|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013716|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013717|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013718|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2013719|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013720|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2013721|NCT01298063|Afatinib|afatinib|mesh-list
2013722|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013723|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2013724|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013725|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013726|NCT01298128|NuvaRing|nuvaring|mesh-list
2013727|NCT01298128|Desogestrel|desogestrel|mesh-list
2013728|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2013729|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
2013730|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2013731|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013732|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2013733|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2013734|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2013735|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2013736|NCT01298128|Progestins|progestins|mesh-ancestor
2013737|NCT01298128|Hormones|hormones|mesh-ancestor
2013738|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013739|NCT01298193|Phenothiazine|phenothiazine|mesh-list
2013740|NCT01298193|Droperidol|droperidol|mesh-list
2013741|NCT01298193|Haloperidol|haloperidol|mesh-list
2013742|NCT01298193|Aprepitant|aprepitant|mesh-list
2013743|NCT01298193|Metoclopramide|metoclopramide|mesh-list
2013744|NCT01298193|Domperidone|domperidone|mesh-list
2013745|NCT01298193|Alizapride|alizapride|mesh-list
2013746|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
2013747|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
2013748|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
2013749|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013750|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013751|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2013752|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2013753|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013754|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013755|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2013756|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2013757|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013758|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2013759|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2013760|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
2013761|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2013762|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2013763|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2013764|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2013765|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
2013766|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2013767|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2013768|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2013769|NCT01298219|Lubiprostone|lubiprostone|mesh-list
2013770|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2013771|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2013772|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013773|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2013774|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2013775|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013776|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013777|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2013778|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
2013779|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013780|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013781|NCT01298531|Etanercept|etanercept|mesh-list
2013782|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2013783|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2013784|NCT01298531|Analgesics|analgesics|mesh-ancestor
2013785|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
2013786|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013787|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013788|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2013789|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2013790|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2013791|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2013792|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
2013793|NCT01298570|Leucovorin|leucovorin|mesh-list
2013794|NCT01298570|Fluorouracil|fluorouracil|mesh-list
2013795|NCT01298570|Irinotecan|irinotecan|mesh-list
2013796|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
2013797|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
2013798|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013799|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2013800|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013801|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2013802|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
2013803|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013804|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2013805|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2013806|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013807|NCT01298570|Antidotes|antidotes|mesh-ancestor
2013808|NCT01298570|Protective Agents|protective agents|mesh-ancestor
2013809|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
2013810|NCT01298570|Vitamins|vitamins|mesh-ancestor
2013811|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
2013812|NCT01298700|Bimatoprost|bimatoprost|mesh-list
2013813|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2013814|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2013815|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2013816|NCT01298765|Buprenorphine|buprenorphine|mesh-list
2013817|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2013818|NCT01298765|Narcotics|narcotics|mesh-ancestor
2013819|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013820|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013821|NCT01298765|Analgesics|analgesics|mesh-ancestor
2013822|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
2013823|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013824|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2013825|NCT01298778|Acetaminophen|acetaminophen|mesh-list
2013826|NCT01298778|Morphine|morphine|mesh-list
2013827|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2013828|NCT01298778|Analgesics|analgesics|mesh-ancestor
2013829|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
2013830|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013831|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013832|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
2013833|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2013834|NCT01298778|Narcotics|narcotics|mesh-ancestor
2013835|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013836|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2013837|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2013838|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2013839|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
2013840|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013841|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2013842|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2013843|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013844|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
2013845|NCT01299116|Etonogestrel|etonogestrel|mesh-list
2013846|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
2013847|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2013848|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013849|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2013850|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2013851|NCT01299272|Serotonin|serotonin|mesh-list
2013852|NCT01299272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2013853|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2013854|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
2013855|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013856|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013857|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013858|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2013859|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2013860|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2013861|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2013862|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2013863|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013864|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013865|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2013866|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2013867|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2013868|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
2013869|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013870|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013871|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2013872|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2013873|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
2013874|NCT01299480|Vaccines|vaccines|mesh-list
2013875|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
2013876|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013877|NCT01299571|Dutasteride|dutasteride|mesh-list
2013878|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2013879|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2013880|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013881|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013882|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
2013883|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013884|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013885|NCT01299584|Remifentanil|remifentanil|mesh-list
2013886|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2013887|NCT01299584|Narcotics|narcotics|mesh-ancestor
2013888|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013889|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013890|NCT01299584|Analgesics|analgesics|mesh-ancestor
2013891|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
2013892|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013893|NCT01299805|Vortioxetine|vortioxetine|mesh-list
2013894|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
2013895|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2013896|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2013897|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2013898|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013899|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013900|NCT01299805|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2013901|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2013902|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2013903|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013904|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013905|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
2013906|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2013907|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2013908|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2013909|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2013910|NCT01299896|Bupropion|bupropion|mesh-list
2013911|NCT01299896|Nicotine|nicotine|mesh-list
2013912|NCT01299896|Varenicline|varenicline|mesh-list
2013913|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2013914|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
2013915|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013916|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013917|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2013918|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2013919|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
2013920|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013921|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013922|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2013923|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
2013924|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2013925|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2013926|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2013927|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2013928|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
2013929|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2013930|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2013931|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013932|NCT01299961|Abatacept|abatacept|mesh-list
2013933|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2013934|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013935|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013936|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2013937|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
2013938|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013939|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2013940|NCT01300234|Tenofovir|tenofovir|mesh-list
2013941|NCT01300234|Adefovir|adefovir|mesh-list
2013942|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2013943|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
2013944|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2013945|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2013946|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2013947|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2013948|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013949|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2013950|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2013951|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
2013952|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2013953|NCT01300247|Fludarabine|fludarabine|mesh-list
2013954|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
2013955|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2013956|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
2013957|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013958|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2013959|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2013960|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
2013961|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013962|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013963|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2013964|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2013965|NCT01300260|Dulaglutide|dulaglutide|mesh-list
2013966|NCT01300260|Glucagon|glucagon|mesh-list
2013967|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2013968|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2013969|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013970|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2013971|NCT01300260|Hormones|hormones|mesh-ancestor
2013972|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013973|NCT01300260|Incretins|incretins|mesh-ancestor
2013974|NCT01300351|Fulvestrant|fulvestrant|mesh-list
2013975|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2013976|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2013977|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2013978|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2013979|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
2013980|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2013981|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013982|NCT01300455|Suvorexant|suvorexant|mesh-list
2013983|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2013984|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2013985|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2013986|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013987|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2013988|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2013989|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2013990|NCT01300546|Naproxen|naproxen|mesh-list
2013991|NCT01300546|Sumatriptan|sumatriptan|mesh-list
2013992|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2013993|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2013994|NCT01300546|Analgesics|analgesics|mesh-ancestor
2013995|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
2013996|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2013997|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2013998|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2013999|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2014000|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
2014001|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2014002|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014003|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014004|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2014005|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2014006|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2014007|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
2014008|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014009|NCT01300572|Cyclosporine|cyclosporine|mesh-list
2014010|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
2014011|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2014012|NCT01300572|Fludarabine|fludarabine|mesh-list
2014013|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
2014014|NCT01300572|Antibodies|antibodies|mesh-list
2014015|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
2014016|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2014017|NCT01300572|Cyclosporins|cyclosporins|mesh-list
2014018|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
2014019|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014020|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014021|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2014022|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
2014023|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014024|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2014025|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014026|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
2014027|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014028|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
2014029|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2014030|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2014031|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2014032|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2014033|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
2014034|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2014035|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2014036|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2014037|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
2014038|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
2014039|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014040|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
2014041|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
2014042|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014043|NCT01300819|Rotigotine|rotigotine|mesh-list
2014044|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
2014045|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
2014046|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014047|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014048|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014049|NCT01300923|Acamprosate|acamprosate|mesh-list
2014050|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2014051|NCT01301001|Gabapentin|gabapentin|mesh-list
2014052|NCT01301001|Analgesics|analgesics|mesh-ancestor
2014053|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
2014054|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014055|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014056|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
2014057|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2014058|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2014059|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2014060|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2014061|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2014062|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2014063|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014064|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014065|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
2014066|NCT01301027|Pioglitazone|pioglitazone|mesh-list
2014067|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2014068|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014069|NCT01301066|Pravastatin|pravastatin|mesh-list
2014070|NCT01301066|Pitavastatin|pitavastatin|mesh-list
2014071|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2014072|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2014073|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
2014074|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014075|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2014076|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2014077|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014078|NCT01301079|Ketamine|ketamine|mesh-list
2014079|NCT01301079|Analgesics|analgesics|mesh-ancestor
2014080|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
2014081|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014082|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014083|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2014084|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2014085|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
2014086|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
2014087|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2014088|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2014089|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2014090|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014091|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014092|NCT01301092|Dulaglutide|dulaglutide|mesh-list
2014093|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2014094|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014095|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2014096|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2014097|NCT01301183|Estradiol|estradiol|mesh-list
2014098|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2014099|NCT01301183|Mecasermin|mecasermin|mesh-list
2014100|NCT01301183|Estrogens|estrogens|mesh-ancestor
2014101|NCT01301183|Hormones|hormones|mesh-ancestor
2014102|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2014103|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014104|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2014105|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
2014106|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2014107|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2014108|NCT01301183|Growth Substances|growth substances|mesh-ancestor
2014109|NCT01301391|Maleic acid|maleic acid|mesh-list
2014110|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014111|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014112|NCT01301729|Paclitaxel|paclitaxel|mesh-list
2014113|NCT01301729|Docetaxel|docetaxel|mesh-list
2014114|NCT01301729|Trastuzumab|trastuzumab|mesh-list
2014115|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2014116|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014117|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
2014118|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
2014119|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
2014120|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014121|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2014122|NCT01301742|Empagliflozin|empagliflozin|mesh-list
2014123|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
2014124|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2014125|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014126|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2014127|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014128|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2014129|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
2014130|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2014131|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2014132|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2014133|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014134|NCT01301833|Biguanides|biguanides|mesh-list
2014135|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
2014136|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2014137|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014138|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014139|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014140|NCT01302054|Fesoterodine|fesoterodine|mesh-list
2014141|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2014142|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2014143|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
2014144|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014145|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014146|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014147|NCT01302054|Urological Agents|urological agents|mesh-ancestor
2014148|NCT01302067|Fesoterodine|fesoterodine|mesh-list
2014149|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2014150|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2014151|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
2014152|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014153|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014154|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014155|NCT01302067|Urological Agents|urological agents|mesh-ancestor
2014156|NCT01302080|Sertraline|sertraline|mesh-list
2014157|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
2014158|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2014159|NCT01302080|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2014160|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2014161|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2014162|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014163|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014164|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
2014165|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014166|NCT01302119|Tavaborole|tavaborole|mesh-list
2014167|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2014168|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
2014169|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014170|NCT01302379|Metformin|metformin|mesh-list
2014171|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2014172|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014173|NCT01302483|Lidocaine|lidocaine|mesh-list
2014174|NCT01302483|Phenylephrine|phenylephrine|mesh-list
2014175|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
2014176|NCT01302483|Tetracaine|tetracaine|mesh-list
2014177|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
2014178|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
2014179|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2014180|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014181|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
2014182|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014183|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2014184|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2014185|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2014186|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2014187|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014188|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2014189|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2014190|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
2014191|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014192|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
2014193|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
2014194|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
2014195|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2014196|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
2014197|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2014198|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
2014199|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2014200|NCT01302483|Protective Agents|protective agents|mesh-ancestor
2014201|NCT01302691|Losartan|losartan|mesh-list
2014202|NCT01302691|Amlodipine|amlodipine|mesh-list
2014203|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2014204|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2014205|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2014206|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2014207|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014208|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2014209|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014210|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
2014211|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2014212|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2014213|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2014214|NCT01302691|Diuretics|diuretics|mesh-ancestor
2014215|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
2014216|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2014217|NCT01302743|Metformin|metformin|mesh-list
2014218|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2014219|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014220|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2014221|NCT01302808|Romidepsin|romidepsin|mesh-list
2014222|NCT01302808|Antiemetics|antiemetics|mesh-list
2014223|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014224|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2014225|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014226|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014227|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2014228|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
2014229|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014230|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014231|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2014232|NCT01302834|Cetuximab|cetuximab|mesh-list
2014233|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014234|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2014235|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2014236|NCT01302899|Ramipril|ramipril|mesh-list
2014237|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2014238|NCT01302899|Diuretics|diuretics|mesh-ancestor
2014239|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
2014240|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014241|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2014242|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2014243|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014244|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2014245|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
2014246|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014247|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2014248|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2014249|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2014250|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
2014251|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014252|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014253|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014254|NCT01302938|Urological Agents|urological agents|mesh-ancestor
2014255|NCT01302964|Mirtazapine|mirtazapine|mesh-list
2014256|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
2014257|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2014258|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2014259|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
2014260|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
2014261|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014262|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014263|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014264|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2014265|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2014266|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2014267|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2014268|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2014269|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2014270|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
2014271|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2014272|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2014273|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
2014274|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2014275|NCT01303172|Gemcitabine|gemcitabine|mesh-list
2014276|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2014277|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
2014278|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014279|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014280|NCT01303172|Antiviral Agents|antiviral agents|mesh-ancestor
2014281|NCT01303172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014282|NCT01303172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014283|NCT01303172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2014284|NCT01303172|Immunologic Factors|immunologic factors|mesh-ancestor
2014285|NCT01303172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014286|NCT01303406|Idebenone|idebenone|mesh-list
2014287|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
2014288|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014289|NCT01303406|Protective Agents|protective agents|mesh-ancestor
2014290|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014291|NCT01303445|Omeprazole|omeprazole|mesh-list
2014292|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2014293|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2014294|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2014295|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2014296|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014297|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014298|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2014299|NCT01303627|Remifentanil|remifentanil|mesh-list
2014300|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2014301|NCT01303627|Narcotics|narcotics|mesh-ancestor
2014302|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2014303|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014304|NCT01303627|Analgesics|analgesics|mesh-ancestor
2014305|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
2014306|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014307|NCT01303744|Flurbiprofen|flurbiprofen|mesh-list
2014308|NCT01303744|Analgesics|analgesics|mesh-ancestor
2014309|NCT01303744|Sensory System Agents|sensory system agents|mesh-ancestor
2014310|NCT01303744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014311|NCT01303744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014312|NCT01303744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2014313|NCT01303744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2014314|NCT01303744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2014315|NCT01303744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2014316|NCT01303744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2014317|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014318|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014319|NCT01303835|Naltrexone|naltrexone|mesh-list
2014320|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2014321|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2014322|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014323|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
2014324|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014325|NCT01303861|Bupropion|bupropion|mesh-list
2014326|NCT01303861|Nicotine|nicotine|mesh-list
2014327|NCT01303861|Varenicline|varenicline|mesh-list
2014328|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2014329|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
2014330|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014331|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014332|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2014333|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2014334|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
2014335|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014336|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014337|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2014338|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
2014339|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2014340|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2014341|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2014342|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2014343|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
2014344|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2014345|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2014346|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014347|NCT01303965|Sirolimus|sirolimus|mesh-list
2014348|NCT01303965|Lenalidomide|lenalidomide|mesh-list
2014349|NCT01303965|Tacrolimus|tacrolimus|mesh-list
2014350|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2014351|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
2014352|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014353|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2014354|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014355|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014356|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2014357|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2014358|NCT01303965|Growth Substances|growth substances|mesh-ancestor
2014359|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
2014360|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014361|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2014362|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014363|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2014364|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
2014365|NCT01304082|Lidocaine|lidocaine|mesh-list
2014366|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
2014367|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
2014368|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2014369|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014370|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
2014371|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014372|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2014373|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2014374|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2014375|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2014376|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014377|NCT01304147|Ketamine|ketamine|mesh-list
2014378|NCT01304147|Analgesics|analgesics|mesh-ancestor
2014379|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
2014380|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014381|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014382|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2014383|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2014384|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
2014385|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
2014386|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2014387|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2014388|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2014389|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014390|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014391|NCT01304238|PENTA|penta|mesh-list
2014392|NCT01304238|Lepirudin|lepirudin|mesh-list
2014393|NCT01304238|Danaparoid|danaparoid|mesh-list
2014394|NCT01304238|Fondaparinux|fondaparinux|mesh-list
2014395|NCT01304238|Argatroban|argatroban|mesh-list
2014396|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2014397|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
2014398|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2014399|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
2014400|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014401|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014402|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
2014403|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2014404|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2014405|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2746070|NCT01495676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2746071|NCT01495676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746072|NCT01495676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2746073|NCT01495676|Immunologic Factors|immunologic factors|mesh-ancestor
2746074|NCT01495676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746075|NCT01464164|Prednisone|prednisone|mesh-list
2746076|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2746077|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
2746078|NCT01464164|Hormones|hormones|mesh-ancestor
2746079|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2746080|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746081|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2746082|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746083|NCT01318317|Plerixafor|plerixafor|mesh-list
2746084|NCT01318317|Rituximab|rituximab|mesh-list
2746085|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2746086|NCT01318317|Antibodies|antibodies|mesh-list
2746087|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
2746088|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2746089|NCT01318317|Lenograstim|lenograstim|mesh-list
2746090|NCT01318317|Sargramostim|sargramostim|mesh-list
2746091|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
2746092|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014429|NCT01304329|Empagliflozin|empagliflozin|mesh-list
2014430|NCT01304329|Simvastatin|simvastatin|mesh-list
2014431|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2014432|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2014433|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
2014434|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014435|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2014436|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2014437|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014438|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2014439|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2014440|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014441|NCT01304407|Calcium|calcium|mesh-list
2014442|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2014443|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014444|NCT01304498|Vaccines|vaccines|mesh-list
2014445|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
2014446|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014447|NCT01304589|Milnacipran|milnacipran|mesh-list
2014448|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
2014449|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2014450|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2014451|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2746093|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014452|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014453|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014454|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014455|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2014456|NCT01304589|Analgesics|analgesics|mesh-ancestor
2014457|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
2014458|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014459|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
2014460|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2014461|NCT01304641|Atorvastatin|atorvastatin|mesh-list
2014462|NCT01304641|Simvastatin|simvastatin|mesh-list
2014463|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2014464|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2014465|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
2014466|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014467|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2014468|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2014469|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014470|NCT01304693|Ranibizumab|ranibizumab|mesh-list
2014471|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2014472|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2014473|NCT01304693|Growth Substances|growth substances|mesh-ancestor
2014474|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014475|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
2014476|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014477|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2014478|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2014479|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
2014480|NCT01304706|Hormones|hormones|mesh-ancestor
2014481|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2014482|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014483|NCT01305200|Calcium|calcium|mesh-list
2014484|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2014485|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014486|NCT01305213|Bevacizumab|bevacizumab|mesh-list
2014487|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2014488|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
2014489|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
2014490|NCT01305213|Antibodies|antibodies|mesh-list
2014491|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
2014492|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2014493|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
2014494|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014495|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2014496|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2014497|NCT01305213|Growth Substances|growth substances|mesh-ancestor
2014498|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014499|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
2014500|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
2014501|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2014502|NCT01305239|Exemestane|exemestane|mesh-list
2014503|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014504|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2014505|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2014506|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014507|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014508|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2014509|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
2014510|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2014511|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014512|NCT01305252|Treprostinil|treprostinil|mesh-list
2014513|NCT01305252|Tadalafil|tadalafil|mesh-list
2014514|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
2014515|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2014516|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2014517|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014518|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014519|NCT01305252|Urological Agents|urological agents|mesh-ancestor
2014520|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2014521|NCT01305408|Modafinil|modafinil|mesh-list
2014522|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2014523|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014524|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2014525|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2014526|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2014527|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014528|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
2014529|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2014530|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2014531|NCT01305772|Panitumumab|panitumumab|mesh-list
2014532|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2014533|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014534|NCT01305941|Trastuzumab|trastuzumab|mesh-list
2014535|NCT01305941|Everolimus|everolimus|mesh-list
2014536|NCT01305941|Vinorelbine|vinorelbine|mesh-list
2014537|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2014538|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014539|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2014540|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
2014541|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014542|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2014543|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
2014544|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
2014545|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
2014546|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014547|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
2014548|NCT01306032|Veliparib|veliparib|mesh-list
2014549|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2014550|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
2014551|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014552|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2014553|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2014554|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
2014555|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014556|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014557|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2014558|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2014559|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014560|NCT01306058|Sorafenib|sorafenib|mesh-list
2014561|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014562|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2014563|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014564|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014565|NCT01306162|Dronedarone|dronedarone|mesh-list
2014566|NCT01306162|Dabigatran|dabigatran|mesh-list
2014567|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
2014568|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2014569|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
2014570|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014571|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014572|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
2014573|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2014574|NCT01306175|Empagliflozin|empagliflozin|mesh-list
2014575|NCT01306175|Digoxin|digoxin|mesh-list
2014576|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2014577|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2014578|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014579|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014580|NCT01306175|Protective Agents|protective agents|mesh-ancestor
2014581|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014582|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2014583|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2014584|NCT01306214|Empagliflozin|empagliflozin|mesh-list
2014585|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2014586|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014587|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2014588|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014589|NCT01306331|Nonoxynol|nonoxynol|mesh-list
2014590|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2014591|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2014592|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014593|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2014594|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
2014595|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2014596|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2014597|NCT01306617|Ritonavir|ritonavir|mesh-list
2014598|NCT01306617|Ribavirin|ribavirin|mesh-list
2014599|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2746094|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2014600|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2014601|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
2014602|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014603|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014604|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2014605|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2014606|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
2014607|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014608|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2014609|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2014610|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
2014611|NCT01306643|Idelalisib|idelalisib|mesh-list
2014612|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014613|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014614|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014615|NCT01306656|Vitamin D|vitamin d|mesh-list
2014616|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
2014617|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
2014618|NCT01306656|Vitamins|vitamins|mesh-list
2014619|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
2014620|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014621|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2014622|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2014623|NCT01306942|Paclitaxel|paclitaxel|mesh-list
2014624|NCT01306942|Trastuzumab|trastuzumab|mesh-list
2014625|NCT01306942|Dasatinib|dasatinib|mesh-list
2014626|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2014627|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014628|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
2014629|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
2014630|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
2014631|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014632|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2014633|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2014634|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014635|NCT01307007|Dextrans|dextrans|mesh-list
2014636|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
2014637|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
2014638|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
2014639|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
2014640|NCT01307007|Hematinics|hematinics|mesh-ancestor
2014641|NCT01307020|Ibuprofen|ibuprofen|mesh-list
2014642|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2014643|NCT01307020|Ketoprofen|ketoprofen|mesh-list
2014644|NCT01307020|Tramadol|tramadol|mesh-list
2014645|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2014646|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2014647|NCT01307020|Analgesics|analgesics|mesh-ancestor
2014648|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
2014649|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014650|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014651|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2014652|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2014653|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2014654|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014655|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014656|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2014657|NCT01307020|Narcotics|narcotics|mesh-ancestor
2014658|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2014659|NCT01307033|Losartan|losartan|mesh-list
2014660|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2014661|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2014662|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2014663|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2014664|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014665|NCT01307046|Losartan|losartan|mesh-list
2014666|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2014667|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2014668|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2014669|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2014670|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014671|NCT01307111|Misoprostol|misoprostol|mesh-list
2014672|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2014673|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
2014674|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2014675|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014676|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2014677|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2014678|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
2014679|NCT01307267|Rituximab|rituximab|mesh-list
2014680|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2014681|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
2014682|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2014683|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014684|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
2014685|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014686|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2014687|NCT01307319|Beclomethasone|beclomethasone|mesh-list
2014688|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2014689|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
2014690|NCT01307319|Hormones|hormones|mesh-ancestor
2014691|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2014692|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014693|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2014694|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
2014695|NCT01307397|Vemurafenib|vemurafenib|mesh-list
2014696|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014697|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2014698|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014699|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014700|NCT01307423|Thalidomide|thalidomide|mesh-list
2014701|NCT01307423|Apremilast|apremilast|mesh-list
2014702|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2014703|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2014704|NCT01307423|Analgesics|analgesics|mesh-ancestor
2014705|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
2014706|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014707|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014708|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2014709|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2014710|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2014711|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2014712|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014713|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014714|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2014715|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
2014716|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
2014717|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2014718|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014719|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2014720|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2014721|NCT01307423|Growth Substances|growth substances|mesh-ancestor
2014722|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
2014723|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014724|NCT01307449|Vaccines|vaccines|mesh-list
2014725|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2014726|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
2014727|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014728|NCT01307462|Fluticasone|fluticasone|mesh-list
2014729|NCT01307462|Xhance|xhance|mesh-list
2014730|NCT01307462|Azithromycin|azithromycin|mesh-list
2014731|NCT01307462|Montelukast|montelukast|mesh-list
2014732|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2014733|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2014734|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
2014735|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014736|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014737|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2014738|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
2014739|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
2014740|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2014741|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2014742|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014743|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2014744|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
2014745|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2014746|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2014747|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2014748|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014749|NCT01307579|Fluconazole|fluconazole|mesh-list
2014750|NCT01307579|Caspofungin|caspofungin|mesh-list
2014751|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
2014752|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014753|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2014754|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2014755|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014756|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014757|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2014758|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
2014759|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2014760|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014761|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2014762|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2014763|NCT01307618|Interleukin-12|interleukin-12|mesh-list
2014764|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2014765|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
2014766|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014767|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2014768|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2014769|NCT01307618|Growth Substances|growth substances|mesh-ancestor
2014770|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
2014771|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014772|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2014773|NCT01307891|Paclitaxel|paclitaxel|mesh-list
2014774|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014775|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2014776|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
2014777|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
2014778|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
2014779|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014780|NCT01307930|Anidulafungin|anidulafungin|mesh-list
2014781|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
2014782|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014783|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
2014784|NCT01307956|Leucovorin|leucovorin|mesh-list
2014785|NCT01307956|Folic Acid|folic acid|mesh-list
2014786|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2014787|NCT01307956|Panitumumab|panitumumab|mesh-list
2014788|NCT01307956|Fluorouracil|fluorouracil|mesh-list
2014789|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
2014790|NCT01307956|Antibodies|antibodies|mesh-list
2014791|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
2014792|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2014793|NCT01307956|Calcium|calcium|mesh-list
2014794|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
2014795|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
2014796|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014797|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014798|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2014799|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2014800|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
2014801|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014802|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2014803|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2014804|NCT01307956|Antidotes|antidotes|mesh-ancestor
2014805|NCT01307956|Protective Agents|protective agents|mesh-ancestor
2014806|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
2014807|NCT01307956|Vitamins|vitamins|mesh-ancestor
2014808|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
2014809|NCT01307956|Hematinics|hematinics|mesh-ancestor
2014810|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
2014811|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2014812|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2014813|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2014814|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2014815|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014816|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
2014817|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014818|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014819|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2014820|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014821|NCT01308294|Vaccines|vaccines|mesh-list
2014822|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
2014823|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014824|NCT01308567|Prednisone|prednisone|mesh-list
2014825|NCT01308567|Docetaxel|docetaxel|mesh-list
2014826|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014827|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
2014828|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
2014829|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
2014830|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014831|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2014832|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
2014833|NCT01308567|Hormones|hormones|mesh-ancestor
2014834|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2014835|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014836|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2014837|NCT01308580|Prednisone|prednisone|mesh-list
2014838|NCT01308580|Prednisolone|prednisolone|mesh-list
2014839|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2014840|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
2014841|NCT01308580|Hormones|hormones|mesh-ancestor
2014842|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2014843|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014844|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2014845|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014846|NCT01308619|Doxycycline|doxycycline|mesh-list
2014847|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2014848|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014849|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
2014850|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2014851|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2014852|NCT01308736|Varenicline|varenicline|mesh-list
2014853|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2014854|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2014855|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
2014856|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014857|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014858|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014859|NCT01308749|Oxytocin|oxytocin|mesh-list
2014860|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
2014861|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2014862|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014863|NCT01308814|Estradiol|estradiol|mesh-list
2014864|NCT01308814|Estrogens|estrogens|mesh-ancestor
2014865|NCT01308814|Hormones|hormones|mesh-ancestor
2014866|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2014867|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014868|NCT01308840|Gemcitabine|gemcitabine|mesh-list
2014869|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
2014870|NCT01308840|Panitumumab|panitumumab|mesh-list
2014871|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2014872|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
2014873|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014874|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014875|NCT01308840|Antiviral Agents|antiviral agents|mesh-ancestor
2014876|NCT01308840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014877|NCT01308840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014878|NCT01308840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2014879|NCT01308840|Immunologic Factors|immunologic factors|mesh-ancestor
2014880|NCT01308840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014881|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2014882|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2014883|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2014884|NCT01309204|Brinzolamide|brinzolamide|mesh-list
2014885|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2014886|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2014887|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2014888|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2014889|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2014890|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
2014891|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014892|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014893|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014894|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2014895|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014896|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2014897|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2014898|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2014899|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014900|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014901|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
2014902|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2014903|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2014904|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2014905|NCT01309360|Midazolam|midazolam|mesh-list
2014906|NCT01309360|Prilocaine|prilocaine|mesh-list
2014907|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2014908|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2014909|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2014910|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014911|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2014912|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2014913|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2014914|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2014915|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
2014916|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
2014917|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
2014918|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
2014919|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014920|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014921|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
2014922|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
2014923|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014924|NCT01309386|Morphine|morphine|mesh-list
2014925|NCT01309386|Tapentadol|tapentadol|mesh-list
2014926|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2014927|NCT01309386|Narcotics|narcotics|mesh-ancestor
2014928|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2014929|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014930|NCT01309386|Analgesics|analgesics|mesh-ancestor
2014931|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
2014932|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014933|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2014934|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2014935|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2014936|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014937|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
2014938|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014939|NCT01309451|Dexamethasone|dexamethasone|mesh-list
2014940|NCT01309451|Bevacizumab|bevacizumab|mesh-list
2014941|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2014942|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2014943|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2014944|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2014945|NCT01309451|Growth Substances|growth substances|mesh-ancestor
2014946|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014947|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
2014948|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2014949|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
2014950|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
2014951|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014952|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2014953|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
2014954|NCT01309451|Hormones|hormones|mesh-ancestor
2014955|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2014956|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2014957|NCT01309659|Iron|iron|mesh-list
2014958|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2014959|NCT01309659|Trace Elements|trace elements|mesh-ancestor
2014960|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
2014961|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014962|NCT01309659|Hematinics|hematinics|mesh-ancestor
2014963|NCT01309737|Tofacitinib|tofacitinib|mesh-list
2014964|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2014965|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2014966|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014967|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
2014968|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2014969|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2014970|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2014971|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2014972|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014973|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
2014974|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2014975|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014976|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2014977|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014978|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2014979|NCT01309828|Olmesartan|olmesartan|mesh-list
2014980|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2014981|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
2014982|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2014983|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2014984|NCT01309828|Diuretics|diuretics|mesh-ancestor
2014985|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
2014986|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014987|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2014988|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2014989|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2014990|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2014991|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2014992|NCT01309841|Naloxegol|naloxegol|mesh-list
2014993|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2014994|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2014995|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
2014996|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2014997|NCT01309997|Rituximab|rituximab|mesh-list
2014998|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
2014999|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2015000|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015001|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
2015002|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015003|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015004|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2015005|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015006|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015007|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2015008|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015009|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2015010|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015011|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015012|NCT01310127|Nepafenac|nepafenac|mesh-list
2015013|NCT01310127|Bromfenac|bromfenac|mesh-list
2015014|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2015015|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2015016|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2015017|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2015018|NCT01310127|Analgesics|analgesics|mesh-ancestor
2015019|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
2015020|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015021|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015022|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2015023|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015024|NCT01310179|Fludarabine|fludarabine|mesh-list
2015025|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
2015026|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015027|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2015028|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
2015029|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015030|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015031|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
2015032|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015033|NCT01310231|Metformin|metformin|mesh-list
2015034|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2015035|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015036|NCT01310582|Sevoflurane|sevoflurane|mesh-list
2015037|NCT01310582|Desflurane|desflurane|mesh-list
2015038|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2015039|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2015040|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
2015041|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
2015042|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2015043|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015044|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2015045|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2015046|NCT01310777|Brinzolamide|brinzolamide|mesh-list
2015047|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2015048|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2015049|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2015050|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2015051|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2015052|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
2015053|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015054|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015055|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015056|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2015057|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015058|NCT01310855|Gefitinib|gefitinib|mesh-list
2015059|NCT01310855|Cediranib|cediranib|mesh-list
2015060|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015061|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015062|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015063|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2015064|NCT01310868|Carmustine|carmustine|mesh-list
2015065|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2015066|NCT01310868|Levulinic acid|levulinic acid|mesh-list
2015067|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2015068|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
2015069|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015070|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015071|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2015072|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
2015073|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015074|NCT01311024|Vaccines|vaccines|mesh-list
2015075|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
2015076|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015077|NCT01311102|Lidocaine|lidocaine|mesh-list
2015078|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
2015079|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
2015080|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2015081|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015082|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
2015083|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015084|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2015085|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2015086|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2015087|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2015088|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015089|NCT01311505|Rifampin|rifampin|mesh-list
2015090|NCT01311505|Isoniazid|isoniazid|mesh-list
2015091|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2015092|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
2015093|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2015094|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015095|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
2015096|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2015097|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015098|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015099|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2015100|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2015101|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2015102|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2015103|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2015104|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2015105|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2015106|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2015107|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
2015108|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2015109|NCT01311648|Factor VIII|factor viii|mesh-list
2015110|NCT01311648|Coagulants|coagulants|mesh-ancestor
2015111|NCT01311661|Olodaterol|olodaterol|mesh-list
2015112|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2015113|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
2015114|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015115|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015116|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2015117|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
2015118|NCT01311674|Vaccines|vaccines|mesh-list
2015119|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
2015120|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015121|NCT01311687|Dexamethasone|dexamethasone|mesh-list
2015122|NCT01311687|Pomalidomide|pomalidomide|mesh-list
2015123|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2015124|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
2015125|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
2015126|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015127|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015128|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2015129|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
2015130|NCT01311687|Hormones|hormones|mesh-ancestor
2015131|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2015132|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2015133|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015134|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
2015135|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2015136|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2015137|NCT01311687|Growth Substances|growth substances|mesh-ancestor
2015138|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
2015139|NCT01311895|Hydromorphone|hydromorphone|mesh-list
2015140|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2015141|NCT01311895|Narcotics|narcotics|mesh-ancestor
2015142|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2015143|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015144|NCT01311895|Analgesics|analgesics|mesh-ancestor
2015145|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
2015146|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015147|NCT01312038|Simethicone|simethicone|mesh-list
2015148|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
2015149|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015150|NCT01312038|Emollients|emollients|mesh-ancestor
2015151|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
2015152|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
2015153|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015154|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2015155|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2015156|NCT01312129|Analgesics|analgesics|mesh-ancestor
2015157|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
2015158|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015159|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015160|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2015161|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015162|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2015163|NCT01312272|Oxytocin|oxytocin|mesh-list
2015164|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
2015165|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2015166|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015167|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2015168|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
2015169|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015170|NCT01312467|Metformin|metformin|mesh-list
2015171|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2015172|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015173|NCT01312766|Menotropins|menotropins|mesh-list
2015174|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2015175|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
2015176|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2015177|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015178|NCT01312818|Dexamethasone|dexamethasone|mesh-list
2015179|NCT01312818|Methotrexate|methotrexate|mesh-list
2015180|NCT01312818|Bortezomib|bortezomib|mesh-list
2015181|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
2015182|NCT01312818|Vorinostat|vorinostat|mesh-list
2015183|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2015184|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
2015185|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
2015186|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015187|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015188|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2015189|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
2015190|NCT01312818|Hormones|hormones|mesh-ancestor
2015191|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2015192|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2015193|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015194|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2015195|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
2015196|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2015197|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2015198|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
2015199|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015200|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
2015201|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015202|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2015203|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015204|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
2015205|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015206|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2015207|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2015208|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2015209|NCT01312844|Scopolamine|scopolamine|mesh-list
2015210|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2015211|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2015212|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
2015213|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
2015214|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015215|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015216|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2015217|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
2015218|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2015219|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
2015220|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015221|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015222|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2015223|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
2015224|NCT01312909|Varenicline|varenicline|mesh-list
2015225|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2015226|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2015227|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
2015228|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015229|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015230|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015231|NCT01312961|Fluticasone|fluticasone|mesh-list
2015232|NCT01312961|Xhance|xhance|mesh-list
2015233|NCT01312961|Albuterol|albuterol|mesh-list
2015234|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2015235|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2015236|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2015237|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2015238|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2015239|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
2015240|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015241|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015242|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2015243|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
2015244|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
2015245|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2015246|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2015247|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2015248|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2015249|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
2015250|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015251|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015252|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
2015253|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2015254|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
2015255|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
2015256|NCT01312961|Hormones|hormones|mesh-ancestor
2015257|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2015258|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
2015259|NCT01313078|Asparaginase|asparaginase|mesh-list
2015260|NCT01313078|Pegaspargase|pegaspargase|mesh-list
2015261|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015262|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
2015263|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
2015264|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015265|NCT01313117|Protective Agents|protective agents|mesh-ancestor
2015266|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015267|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
2015268|NCT01313117|Vitamins|vitamins|mesh-ancestor
2015269|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
2015270|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
2015271|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2015272|NCT01313182|Mupirocin|mupirocin|mesh-list
2015273|NCT01313182|Povidone|povidone|mesh-list
2015274|NCT01313182|Calcium|calcium|mesh-list
2015275|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2015276|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015277|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
2015278|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
2015279|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015280|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2015281|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2015282|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015283|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015284|NCT01313208|Etanercept|etanercept|mesh-list
2015285|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2015286|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2015287|NCT01313208|Analgesics|analgesics|mesh-ancestor
2015288|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
2015289|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015290|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015291|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2015292|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015293|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2015294|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015295|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
2015296|NCT01313221|Etanercept|etanercept|mesh-list
2015297|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2015298|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2015299|NCT01313221|Analgesics|analgesics|mesh-ancestor
2015300|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
2015301|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015302|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015303|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2015304|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015305|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2015306|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015307|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
2015308|NCT01313286|Globalagliatin|globalagliatin|mesh-list
2015309|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
2015310|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015311|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
2015312|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2015313|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2015314|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2015315|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2015316|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015317|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
2015318|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015319|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015320|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2015321|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015322|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
2015323|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2015324|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2015325|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2015326|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2015327|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015328|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
2015329|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015330|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015331|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2015332|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015333|NCT01313494|Albuterol|albuterol|mesh-list
2015334|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2015335|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
2015336|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015337|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015338|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2015339|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
2015340|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
2015341|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2015342|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2015343|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2015344|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2015345|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
2015346|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015347|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015348|NCT01313520|Infliximab|infliximab|mesh-list
2015349|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
2015350|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2015351|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015352|NCT01313559|Everolimus|everolimus|mesh-list
2015353|NCT01313559|Pasireotide|pasireotide|mesh-list
2015354|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015355|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015356|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
2015357|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015358|NCT01313559|Hormones|hormones|mesh-ancestor
2015359|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2015360|NCT01313637|Bromides|bromides|mesh-list
2015361|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
2015362|NCT01313663|Pemetrexed|pemetrexed|mesh-list
2015363|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015364|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015365|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015366|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2015367|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2015368|NCT01313676|Fluticasone|fluticasone|mesh-list
2015369|NCT01313676|Xhance|xhance|mesh-list
2015370|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2015371|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2015372|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
2015373|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015374|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015375|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2015376|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
2015377|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
2015378|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2746095|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2746096|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2015381|NCT01313728|Dapsone|dapsone|mesh-list
2015382|NCT01313728|Tretinoin|tretinoin|mesh-list
2015383|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015384|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
2015385|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
2015386|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015387|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
2015388|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2015389|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2015390|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2015391|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015392|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015393|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
2015394|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2015395|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
2015396|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2015397|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2015398|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2015399|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2015400|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015401|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
2015402|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015403|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015404|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2015405|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015406|NCT01313780|Oxycodone|oxycodone|mesh-list
2015407|NCT01313780|Naloxone|naloxone|mesh-list
2015408|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2015409|NCT01313780|Narcotics|narcotics|mesh-ancestor
2015410|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2015411|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015412|NCT01313780|Analgesics|analgesics|mesh-ancestor
2015413|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
2015414|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015415|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2015416|NCT01313858|Golimumab|golimumab|mesh-list
2015417|NCT01313858|Methotrexate|methotrexate|mesh-list
2015418|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2015419|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
2015420|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2015421|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015422|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2015423|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
2015424|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015425|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015426|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
2015427|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015428|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2015429|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015430|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
2015431|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015432|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2015433|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2015434|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2015435|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
2015436|NCT01313884|Temozolomide|temozolomide|mesh-list
2015437|NCT01313884|Doxorubicin|doxorubicin|mesh-list
2015438|NCT01313884|Irinotecan|irinotecan|mesh-list
2015439|NCT01313884|Vincristine|vincristine|mesh-list
2015440|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015441|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
2015442|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015443|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015444|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2015445|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
2015446|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015447|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015448|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2015449|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2015450|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2015451|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2015452|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015453|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2015454|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2015455|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
2015456|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
2015457|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
2015458|NCT01313897|Bortezomib|bortezomib|mesh-list
2015459|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015460|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2015461|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015462|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015463|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015464|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2015465|NCT01314001|Nicotine|nicotine|mesh-list
2015466|NCT01314001|Varenicline|varenicline|mesh-list
2015467|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2015468|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
2015469|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015470|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015471|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2015472|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2015473|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
2015474|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015475|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015476|NCT01314105|Carboplatin|carboplatin|mesh-list
2015477|NCT01314105|Nintedanib|nintedanib|mesh-list
2015478|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015479|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2015480|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015481|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746097|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2746098|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
2746099|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015496|NCT01314261|Interferons|interferons|mesh-list
2015497|NCT01314261|Ribavirin|ribavirin|mesh-list
2015498|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015499|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
2015500|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015501|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
2015502|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015503|NCT01314417|Methotrexate|methotrexate|mesh-list
2015504|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2015505|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
2015506|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2015507|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015508|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2015509|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
2015510|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015511|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015512|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
2015513|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015514|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2015515|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015516|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
2015517|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015518|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2015519|NCT01314443|Vitamin E|vitamin e|mesh-list
2015520|NCT01314443|Tocopherols|tocopherols|mesh-list
2015521|NCT01314443|Tocotrienols|tocotrienols|mesh-list
2015522|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
2015523|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
2015524|NCT01314443|Nicotine|nicotine|mesh-list
2015525|NCT01314443|Vitamins|vitamins|mesh-ancestor
2015526|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
2015527|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015528|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2015529|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
2015530|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015531|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2015532|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2015533|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
2015534|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015535|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015536|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
2015537|NCT01314443|Protective Agents|protective agents|mesh-ancestor
2015538|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2015539|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2015540|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2015541|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
2015542|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015543|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015544|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015545|NCT01314872|Urological Agents|urological agents|mesh-ancestor
2015546|NCT01314911|Oseltamivir|oseltamivir|mesh-list
2015547|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
2015548|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015549|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015550|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015551|NCT01315002|Nicotine|nicotine|mesh-list
2015552|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2015553|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
2015554|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015555|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015556|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2015557|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2015558|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
2015559|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015560|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015561|NCT01315158|Fentanyl|fentanyl|mesh-list
2015562|NCT01315158|Midazolam|midazolam|mesh-list
2015563|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
2015564|NCT01315158|Propofol|propofol|mesh-list
2015565|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2015566|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2015567|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015568|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2015569|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
2015570|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
2015571|NCT01315158|Narcotics|narcotics|mesh-ancestor
2015572|NCT01315158|Analgesics|analgesics|mesh-ancestor
2015573|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
2015574|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015575|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2015576|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2015577|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2015578|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2015579|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
2015580|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
2015581|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015582|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015583|NCT01315236|Amikacin|amikacin|mesh-list
2015584|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2015585|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015586|NCT01315249|Fluticasone|fluticasone|mesh-list
2015587|NCT01315249|Xhance|xhance|mesh-list
2015588|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
2015589|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2015590|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2015591|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2015592|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2015593|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
2015594|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015595|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015596|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2015597|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
2015598|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
2015599|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2015600|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2015601|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2015602|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2015603|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
2015604|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015605|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015606|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2015607|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2015608|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2015609|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
2015610|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
2015611|NCT01315249|Hormones|hormones|mesh-ancestor
2015612|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2015613|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
2015614|NCT01315574|Travoprost|travoprost|mesh-list
2015615|NCT01315574|Latanoprost|latanoprost|mesh-list
2015616|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2015617|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2015618|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2015619|NCT01315665|Sulforaphane|sulforaphane|mesh-list
2015620|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2015621|NCT01315665|Protective Agents|protective agents|mesh-ancestor
2015622|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015623|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015624|NCT01315678|Tobramycin|tobramycin|mesh-list
2015625|NCT01315678|Amikacin|amikacin|mesh-list
2015626|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2015627|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015628|NCT01316042|Metformin|metformin|mesh-list
2015629|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2015630|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015631|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
2015632|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2015633|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2015634|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015635|NCT01316263|Olaratumab|olaratumab|mesh-list
2015636|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015637|NCT01316276|Amikacin|amikacin|mesh-list
2015638|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2015639|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015640|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2015641|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2015642|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2015643|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2015644|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015645|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015646|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015647|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
2015648|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2015649|NCT01316341|Empagliflozin|empagliflozin|mesh-list
2015650|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2015651|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015652|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2015653|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015654|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
2015655|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2015656|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
2015657|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015658|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015659|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2015660|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
2015661|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
2015662|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2015663|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
2015664|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015665|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015666|NCT01316419|Amlodipine|amlodipine|mesh-list
2015667|NCT01316419|Telmisartan|telmisartan|mesh-list
2015668|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2015669|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2015670|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2015671|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015672|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2015673|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015674|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
2015675|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2015676|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2015677|NCT01316770|Dexamethasone|dexamethasone|mesh-list
2015678|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2015679|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
2015680|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
2015681|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015682|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015683|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2015684|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
2015685|NCT01316770|Hormones|hormones|mesh-ancestor
2015686|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2015687|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2015688|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015689|NCT01316900|Bromides|bromides|mesh-list
2015690|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
2015691|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2015692|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
2015693|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015694|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015695|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2015696|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
2015697|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
2015698|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2015699|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
2015700|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015701|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015702|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
2015703|NCT01316913|Bromides|bromides|mesh-list
2015704|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
2015705|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2015706|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
2015707|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015708|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015709|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2015710|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
2015711|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
2015712|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2015713|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
2015714|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015715|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015716|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
2015717|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2015718|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
2015719|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2015720|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015721|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015722|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
2015723|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015724|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2015725|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
2015726|NCT01317472|Lansoprazole|lansoprazole|mesh-list
2015727|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2015728|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2015729|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2015730|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015731|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015732|NCT01317550|Minocycline|minocycline|mesh-list
2015733|NCT01317550|Modafinil|modafinil|mesh-list
2015734|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2015735|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015736|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2015737|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015738|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2015739|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2015740|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2015741|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015742|NCT01317615|Paclitaxel|paclitaxel|mesh-list
2015743|NCT01317615|Carboplatin|carboplatin|mesh-list
2015744|NCT01317615|Everolimus|everolimus|mesh-list
2015745|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2015746|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015747|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
2015748|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
2015749|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
2015750|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015751|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015752|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
2015753|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015754|NCT01317667|Vaccines|vaccines|mesh-list
2015755|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
2015756|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015757|NCT01317901|Rituximab|rituximab|mesh-list
2015758|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2015759|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2015760|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015761|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
2015762|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015763|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015764|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2015765|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
2015766|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015767|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
2015768|NCT01317940|Vitamin D|vitamin d|mesh-list
2015769|NCT01317940|Calcitriol|calcitriol|mesh-list
2015770|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
2015771|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
2015772|NCT01317940|Calcium|calcium|mesh-list
2015773|NCT01317940|Vitamins|vitamins|mesh-ancestor
2015774|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
2015775|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015776|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2015777|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2015778|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015779|NCT01317940|Antacids|antacids|mesh-ancestor
2015780|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2015781|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2015782|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2015783|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2015784|NCT01318070|Pioglitazone|pioglitazone|mesh-list
2015785|NCT01318070|Alogliptin|alogliptin|mesh-list
2015786|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2015787|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015788|NCT01318070|Incretins|incretins|mesh-ancestor
2015789|NCT01318070|Hormones|hormones|mesh-ancestor
2015790|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2015791|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2015792|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
2015793|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015794|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015795|NCT01318083|Glimepiride|glimepiride|mesh-list
2015796|NCT01318083|Alogliptin|alogliptin|mesh-list
2015797|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2015798|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2015799|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015800|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015801|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
2015802|NCT01318083|Incretins|incretins|mesh-ancestor
2015803|NCT01318083|Hormones|hormones|mesh-ancestor
2015804|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2015805|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2015806|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
2015807|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015808|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015809|NCT01318109|Metformin|metformin|mesh-list
2015810|NCT01318109|Alogliptin|alogliptin|mesh-list
2015811|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2015812|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015813|NCT01318109|Incretins|incretins|mesh-ancestor
2015814|NCT01318109|Hormones|hormones|mesh-ancestor
2015815|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2015816|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2015817|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
2015818|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015819|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015820|NCT01318122|Pioglitazone|pioglitazone|mesh-list
2015821|NCT01318122|Alogliptin|alogliptin|mesh-list
2015822|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2015823|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015824|NCT01318122|Incretins|incretins|mesh-ancestor
2015825|NCT01318122|Hormones|hormones|mesh-ancestor
2015826|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2015827|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2015828|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
2015829|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015830|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015831|NCT01318135|Metformin|metformin|mesh-list
2015832|NCT01318135|Glimepiride|glimepiride|mesh-list
2015833|NCT01318135|Alogliptin|alogliptin|mesh-list
2015834|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2015835|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015836|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2015837|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015838|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
2015839|NCT01318135|Incretins|incretins|mesh-ancestor
2015840|NCT01318135|Hormones|hormones|mesh-ancestor
2015841|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2015842|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2015843|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
2015844|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015845|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015846|NCT01318278|Dopamine|dopamine|mesh-list
2015847|NCT01318278|Vasopressins|vasopressins|mesh-list
2015848|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
2015849|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015850|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
2015851|NCT01318278|Coagulants|coagulants|mesh-ancestor
2015852|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2015853|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2015854|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
2015855|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2015856|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
2015857|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
2015858|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015859|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
2015860|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2015861|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015862|NCT01318278|Protective Agents|protective agents|mesh-ancestor
2015863|NCT01318356|Doxycycline|doxycycline|mesh-list
2015864|NCT01318356|Tetracycline|tetracycline|mesh-list
2015865|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2015866|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015867|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
2015868|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2015869|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2015870|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2015871|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015872|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015873|NCT01318408|Levetiracetam|levetiracetam|mesh-list
2015874|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
2015875|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
2015876|NCT01318499|Nepafenac|nepafenac|mesh-list
2015877|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2015878|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2015879|NCT01318499|Analgesics|analgesics|mesh-ancestor
2015880|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
2015881|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015882|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015883|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2015884|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015885|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2015886|NCT01318694|Ribavirin|ribavirin|mesh-list
2015887|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2015888|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
2015889|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015890|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
2015891|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015892|NCT01318811|Heparin|heparin|mesh-list
2015893|NCT01318811|Calcium heparin|calcium heparin|mesh-list
2015894|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
2015895|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2015896|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2015897|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015898|NCT01318902|Dexamethasone|dexamethasone|mesh-list
2015899|NCT01318902|Ixazomib|ixazomib|mesh-list
2015900|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2015901|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
2015902|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
2015903|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2015904|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015905|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2015906|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
2015907|NCT01318902|Hormones|hormones|mesh-ancestor
2015908|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2015909|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2015910|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015911|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
2015912|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015913|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015914|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
2015915|NCT01318915|Sirolimus|sirolimus|mesh-list
2015916|NCT01318915|Rituximab|rituximab|mesh-list
2015917|NCT01318915|Tacrolimus|tacrolimus|mesh-list
2015918|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
2015919|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2015920|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2015921|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015922|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
2015923|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015924|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015925|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015926|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2015927|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015928|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015929|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2015930|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2015931|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
2015932|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2015933|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015934|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
2015935|NCT01318967|Furosemide|furosemide|mesh-list
2015936|NCT01318967|Diuretics|diuretics|mesh-ancestor
2015937|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
2015938|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015939|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2015940|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2015941|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015942|NCT01319045|Iloprost|iloprost|mesh-list
2015943|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2015944|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
2015945|NCT01319110|Ubiquinone|ubiquinone|mesh-list
2015946|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
2015947|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
2015948|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015949|NCT01319110|Vitamins|vitamins|mesh-ancestor
2015950|NCT01319383|Vorinostat|vorinostat|mesh-list
2015951|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015952|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2015953|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015954|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015955|NCT01319422|Pomalidomide|pomalidomide|mesh-list
2015956|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
2015957|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015958|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2015959|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2015960|NCT01319422|Growth Substances|growth substances|mesh-ancestor
2015961|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
2015962|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015963|NCT01319721|Mitomycins|mitomycins|mesh-list
2015964|NCT01319721|Mitomycin|mitomycin|mesh-list
2015965|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2015966|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2015967|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
2015968|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015969|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2015970|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015971|NCT01319773|Cyclosporine|cyclosporine|mesh-list
2015972|NCT01319773|Cyclosporins|cyclosporins|mesh-list
2015973|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2015974|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2015975|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2015976|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
2015977|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015978|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
2015979|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015980|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
2015981|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2015982|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2015983|NCT01319851|Alefacept|alefacept|mesh-list
2015984|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
2015985|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
2015986|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015987|NCT01319994|Metformin|metformin|mesh-list
2015988|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2015989|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2015990|NCT01320033|Doxycycline|doxycycline|mesh-list
2015991|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2015992|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2015993|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
2015994|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2015995|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2015996|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
2015997|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2015998|NCT01320293|Adalimumab|adalimumab|mesh-list
2015999|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2016000|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2016001|NCT01320722|Vitamin D|vitamin d|mesh-list
2016002|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
2016003|NCT01320722|Vitamins|vitamins|mesh-list
2016004|NCT01320722|Allopurinol|allopurinol|mesh-list
2016005|NCT01320722|Probenecid|probenecid|mesh-list
2016006|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
2016007|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016008|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2016009|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2016010|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
2016011|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016012|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016013|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
2016014|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2016015|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2016016|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
2016017|NCT01320722|Protective Agents|protective agents|mesh-ancestor
2016018|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
2016019|NCT01320722|Renal Agents|renal agents|mesh-ancestor
2016020|NCT01321073|Treprostinil|treprostinil|mesh-list
2016021|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2016022|NCT01321151|Resveratrol|resveratrol|mesh-list
2016023|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
2016024|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016025|NCT01321151|Protective Agents|protective agents|mesh-ancestor
2016026|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016027|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016028|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2016029|NCT01321437|Axitinib|axitinib|mesh-list
2016030|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016031|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2016032|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016033|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016034|NCT01321541|Gemcitabine|gemcitabine|mesh-list
2016035|NCT01321541|Rituximab|rituximab|mesh-list
2016036|NCT01321541|Pixantrone|pixantrone|mesh-list
2016037|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2016038|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016039|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
2016040|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016041|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2016042|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2016043|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
2016044|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016045|NCT01321541|Antiviral Agents|antiviral agents|mesh-ancestor
2016046|NCT01321541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016047|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016048|NCT01321541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2016049|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2016050|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2016051|NCT01321554|Lenvatinib|lenvatinib|mesh-list
2016052|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016053|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2016054|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016055|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016056|NCT01321710|Acetaminophen|acetaminophen|mesh-list
2016057|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2016058|NCT01321710|Analgesics|analgesics|mesh-ancestor
2016059|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
2016060|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016061|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016062|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
2016063|NCT01321723|Teriparatide|teriparatide|mesh-list
2016064|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2016065|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016066|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2016067|NCT01321879|Telavancin|telavancin|mesh-list
2016068|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2016069|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016070|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
2016071|NCT01322009|Probenecid|probenecid|mesh-list
2016072|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2016073|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
2016074|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016075|NCT01322009|Expectorants|expectorants|mesh-ancestor
2016076|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
2016077|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2016078|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
2016079|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016080|NCT01322009|Protective Agents|protective agents|mesh-ancestor
2016081|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016082|NCT01322009|Antidotes|antidotes|mesh-ancestor
2016083|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
2016084|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
2016085|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2016086|NCT01322009|Renal Agents|renal agents|mesh-ancestor
2016087|NCT01322048|Propranolol|propranolol|mesh-list
2016088|NCT01322048|Clonidine|clonidine|mesh-list
2016089|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2016090|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2016091|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
2016092|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016093|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016094|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016095|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2016096|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2016097|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
2016098|NCT01322048|Analgesics|analgesics|mesh-ancestor
2016099|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
2016100|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016101|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
2016102|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
2016103|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2016104|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2016105|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2016106|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
2016107|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2016108|NCT01322360|Morphine|morphine|mesh-list
2016109|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2016110|NCT01322360|Narcotics|narcotics|mesh-ancestor
2016111|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2016112|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016113|NCT01322360|Analgesics|analgesics|mesh-ancestor
2016114|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
2016115|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016116|NCT01322386|Vancomycin|vancomycin|mesh-list
2016117|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2016118|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016119|NCT01322490|Molgramostim|molgramostim|mesh-list
2016120|NCT01322490|Sargramostim|sargramostim|mesh-list
2016121|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
2016122|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016123|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016124|NCT01322815|Leucovorin|leucovorin|mesh-list
2016125|NCT01322815|Fluorouracil|fluorouracil|mesh-list
2016126|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
2016127|NCT01322815|Irinotecan|irinotecan|mesh-list
2016128|NCT01322815|Bevacizumab|bevacizumab|mesh-list
2016129|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
2016130|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
2016131|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016132|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2016133|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016134|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2016135|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
2016136|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016137|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2016138|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2016139|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016140|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2016141|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2016142|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2016143|NCT01322815|Growth Substances|growth substances|mesh-ancestor
2016144|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
2016145|NCT01322815|Antidotes|antidotes|mesh-ancestor
2016146|NCT01322815|Protective Agents|protective agents|mesh-ancestor
2016147|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
2016148|NCT01322815|Vitamins|vitamins|mesh-ancestor
2016149|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
2016150|NCT01323010|Albuterol|albuterol|mesh-list
2016151|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2016152|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
2016153|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016154|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016155|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2016156|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
2016157|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
2016158|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2016159|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2016160|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2016161|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2016162|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
2016163|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016164|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016165|NCT01323140|Testosterone|testosterone|mesh-list
2016166|NCT01323140|Androgens|androgens|mesh-ancestor
2016167|NCT01323140|Hormones|hormones|mesh-ancestor
2016168|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2016169|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016170|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
2016171|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2016172|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2016173|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
2016174|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016175|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2016176|NCT01323478|Vortioxetine|vortioxetine|mesh-list
2016177|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
2016178|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2016179|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2016180|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2016181|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2016182|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016183|NCT01323478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2016184|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2016185|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2016186|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016187|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016188|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
2016189|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2016190|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2016191|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2016192|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2016193|NCT01323517|Dactinomycin|dactinomycin|mesh-list
2016194|NCT01323517|Ipilimumab|ipilimumab|mesh-list
2016195|NCT01323517|Melphalan|melphalan|mesh-list
2016196|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2016197|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016198|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2016199|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016200|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2016201|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
2016202|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2016203|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2016204|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
2016205|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016206|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2016207|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016208|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2016209|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2016210|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016211|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2016212|NCT01323530|Capecitabine|capecitabine|mesh-list
2016213|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2016214|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
2016215|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016216|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016217|NCT01323582|Azithromycin|azithromycin|mesh-list
2016218|NCT01323582|Erythromycin|erythromycin|mesh-list
2016219|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
2016220|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2016221|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
2016222|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2016223|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016224|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2016225|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2016226|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016227|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016228|NCT01323595|Celecoxib|celecoxib|mesh-list
2016229|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2016230|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2016231|NCT01323595|Analgesics|analgesics|mesh-ancestor
2016232|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
2016233|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016234|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016235|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2016236|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2016237|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2016238|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2016239|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016240|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016241|NCT01323621|Fluticasone|fluticasone|mesh-list
2016242|NCT01323621|Xhance|xhance|mesh-list
2016243|NCT01323621|Albuterol|albuterol|mesh-list
2016244|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2016245|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2016246|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2016247|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
2016248|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016249|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016250|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2016251|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
2016252|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
2016253|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2016254|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2016255|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2016256|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2016257|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
2016258|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016259|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016260|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
2016261|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2016262|NCT01323634|Fluticasone|fluticasone|mesh-list
2016263|NCT01323634|Xhance|xhance|mesh-list
2016264|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2016265|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2016266|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2016267|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
2016268|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016269|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016270|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2016271|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
2016272|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
2016273|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2016274|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2016275|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2016276|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2016277|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
2016278|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016279|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016280|NCT01323673|Clobetasol|clobetasol|mesh-list
2016281|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2016282|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
2016283|NCT01323673|Hormones|hormones|mesh-ancestor
2016284|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2016285|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016286|NCT01323790|Naloxegol|naloxegol|mesh-list
2016287|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2016288|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016289|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
2016290|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016291|NCT01323920|Methotrexate|methotrexate|mesh-list
2016292|NCT01323920|Bortezomib|bortezomib|mesh-list
2016293|NCT01323920|Tacrolimus|tacrolimus|mesh-list
2016294|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2016295|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
2016296|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2016297|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016298|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2016299|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
2016300|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016301|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016302|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
2016303|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016304|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2016305|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2016306|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
2016307|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2016308|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2016309|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2016310|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2016311|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2016312|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016313|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2016314|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2016315|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2016316|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016317|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
2016318|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016319|NCT01324128|Iron|iron|mesh-list
2016320|NCT01324128|Sevelamer|sevelamer|mesh-list
2016321|NCT01324128|Trace Elements|trace elements|mesh-ancestor
2016322|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
2016323|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016324|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
2016325|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
2016326|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016327|NCT01324141|Fluorouracil|fluorouracil|mesh-list
2016328|NCT01324141|Mitomycins|mitomycins|mesh-list
2016329|NCT01324141|Mitomycin|mitomycin|mesh-list
2016330|NCT01324141|Tempol|tempol|mesh-list
2016331|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
2016332|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016333|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2016334|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016335|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2016336|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
2016337|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016338|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2016339|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
2016340|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2016341|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016342|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
2016343|NCT01324141|Protective Agents|protective agents|mesh-ancestor
2016344|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2016345|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2016346|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2016347|NCT01324232|Quinidine|quinidine|mesh-list
2016348|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
2016349|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
2016350|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
2016351|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2016352|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2016353|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016354|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016355|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016356|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2016357|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2016358|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
2016359|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2016360|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
2016361|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2016362|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2016363|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016364|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016365|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2016366|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2016367|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
2016368|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2016369|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2016370|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2016371|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2016372|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2016373|NCT01324310|Ketoconazole|ketoconazole|mesh-list
2016374|NCT01324310|Romidepsin|romidepsin|mesh-list
2016375|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
2016376|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016377|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2016378|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2016379|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016380|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016381|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2016382|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
2016383|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2016384|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016385|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2016386|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2016387|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016388|NCT01324323|Rifampin|rifampin|mesh-list
2016389|NCT01324323|Romidepsin|romidepsin|mesh-list
2016390|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2016391|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
2016392|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2016393|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016394|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
2016395|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2016396|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016397|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016398|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2016399|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2016400|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2016401|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2016402|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2016403|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2016404|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2016405|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016406|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2016407|NCT01324349|Hemostatics|hemostatics|mesh-list
2016408|NCT01324349|Coagulants|coagulants|mesh-ancestor
2016409|NCT01324388|Dulaglutide|dulaglutide|mesh-list
2016410|NCT01324388|Metoprolol|metoprolol|mesh-list
2016411|NCT01324388|Lisinopril|lisinopril|mesh-list
2016412|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2016413|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2016414|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
2016415|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
2016416|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016417|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016418|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2016419|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2016420|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2016421|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
2016422|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016423|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016424|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2016425|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
2016426|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016427|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2016428|NCT01324388|Protective Agents|protective agents|mesh-ancestor
2016429|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2016430|NCT01324570|Buprenorphine|buprenorphine|mesh-list
2016431|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2016432|NCT01324570|Narcotics|narcotics|mesh-ancestor
2016433|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2016434|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016435|NCT01324570|Analgesics|analgesics|mesh-ancestor
2016436|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
2016437|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016438|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2016439|NCT01324700|Dexetimide|dexetimide|mesh-list
2016440|NCT01324700|Citalopram|citalopram|mesh-list
2016441|NCT01324700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2016442|NCT01324700|Serotonin|serotonin|mesh-list
2016443|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2016444|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2016445|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016446|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016447|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
2016448|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016449|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2016450|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
2016451|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2016452|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2016453|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2016454|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
2016455|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
2016456|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016457|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2016458|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2016459|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
2016460|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2016461|NCT01324947|Pomalidomide|pomalidomide|mesh-list
2016462|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
2016463|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016464|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2016465|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2016466|NCT01324947|Growth Substances|growth substances|mesh-ancestor
2016467|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
2016468|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016469|NCT01324999|Tadalafil|tadalafil|mesh-list
2016470|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
2016471|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2016472|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2016473|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016474|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016475|NCT01324999|Urological Agents|urological agents|mesh-ancestor
2016476|NCT01325181|Ranibizumab|ranibizumab|mesh-list
2016477|NCT01325181|Verteporfin|verteporfin|mesh-list
2016478|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2016479|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2016480|NCT01325181|Growth Substances|growth substances|mesh-ancestor
2016481|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016482|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
2016483|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016484|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2016485|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
2016486|NCT01325207|Trastuzumab|trastuzumab|mesh-list
2016487|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2016488|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016489|NCT01325311|Vitamin D|vitamin d|mesh-list
2016490|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
2016491|NCT01325311|Genistein|genistein|mesh-list
2016492|NCT01325311|Vitamins|vitamins|mesh-ancestor
2016493|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
2016494|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016495|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2016496|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2016497|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2016498|NCT01325311|Protective Agents|protective agents|mesh-ancestor
2016499|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016500|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2016501|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016502|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016503|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
2016504|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2016505|NCT01325311|Estrogens|estrogens|mesh-ancestor
2016506|NCT01325311|Hormones|hormones|mesh-ancestor
2016507|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2016508|NCT01325337|Bimatoprost|bimatoprost|mesh-list
2016509|NCT01325337|Minoxidil|minoxidil|mesh-list
2016510|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2016511|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2016512|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
2016513|NCT01325350|Bimatoprost|bimatoprost|mesh-list
2016514|NCT01325350|Minoxidil|minoxidil|mesh-list
2016515|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2016516|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2016517|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
2016518|NCT01325428|Vinorelbine|vinorelbine|mesh-list
2016519|NCT01325428|Afatinib|afatinib|mesh-list
2016520|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2016521|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016522|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
2016523|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
2016524|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
2016525|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016526|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2016527|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016528|NCT01325493|Ketamine|ketamine|mesh-list
2016529|NCT01325493|Analgesics|analgesics|mesh-ancestor
2016530|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
2016531|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016532|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016533|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2016534|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2016535|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
2016536|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
2016537|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2016538|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2016539|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2016540|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016541|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016542|NCT01326026|Insulin|insulin|mesh-list
2016543|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2016544|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
2016545|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2016546|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016547|NCT01326481|Capecitabine|capecitabine|mesh-list
2016548|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2016549|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
2016550|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016551|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016552|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
2016553|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
2016554|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2016555|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2016556|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016557|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016558|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016559|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2016560|NCT01326546|Entecavir|entecavir|mesh-list
2016561|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
2016562|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016563|NCT01326702|Rituximab|rituximab|mesh-list
2016564|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2016565|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2016566|NCT01326702|Veliparib|veliparib|mesh-list
2016567|NCT01326702|Antibodies|antibodies|mesh-list
2016568|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
2016569|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2016570|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
2016571|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016572|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016573|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2016574|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2016575|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
2016576|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016577|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2016578|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016579|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
2016580|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016581|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
2016582|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
2016583|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
2016584|NCT01327300|Mesalamine|mesalamine|mesh-list
2016585|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2016586|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2016587|NCT01327300|Analgesics|analgesics|mesh-ancestor
2016588|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
2016589|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016590|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016591|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2016592|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2016593|NCT01327339|Ropinirole|ropinirole|mesh-list
2016594|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2016595|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2016596|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
2016597|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
2016598|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016599|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016600|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016601|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
2016602|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2016603|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2016604|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
2016605|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016606|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2016607|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2016608|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016609|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016610|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
2016611|NCT01327495|Testosterone|testosterone|mesh-list
2016612|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
2016613|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
2016614|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2016615|NCT01327495|Acyline|acyline|mesh-list
2016616|NCT01327495|Androgens|androgens|mesh-ancestor
2016617|NCT01327495|Hormones|hormones|mesh-ancestor
2016618|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2016619|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016620|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2016621|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016622|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
2016623|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
2016624|NCT01327547|Maraviroc|maraviroc|mesh-list
2016625|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2016626|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2016627|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016628|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2016629|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2016630|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
2016631|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016632|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2016633|NCT01327573|Eculizumab|eculizumab|mesh-list
2016634|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2016635|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2016636|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
2016637|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016638|NCT01327599|Timolol|timolol|mesh-list
2016639|NCT01327599|Travoprost|travoprost|mesh-list
2016640|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2016641|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2016642|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2016643|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2016644|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
2016645|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016646|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016647|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016648|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2016649|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2016650|NCT01327612|Leucovorin|leucovorin|mesh-list
2016651|NCT01327612|Bevacizumab|bevacizumab|mesh-list
2016652|NCT01327612|Conatumumab|conatumumab|mesh-list
2016653|NCT01327612|Fluorouracil|fluorouracil|mesh-list
2016654|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
2016655|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2016656|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016657|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2016658|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2016659|NCT01327612|Growth Substances|growth substances|mesh-ancestor
2016660|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016661|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
2016662|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
2016663|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016664|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2016665|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2016666|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
2016667|NCT01327612|Antidotes|antidotes|mesh-ancestor
2016668|NCT01327612|Protective Agents|protective agents|mesh-ancestor
2016669|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
2016670|NCT01327612|Vitamins|vitamins|mesh-ancestor
2016671|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
2016672|NCT01327651|Tenofovir|tenofovir|mesh-list
2016673|NCT01327651|Emtricitabine|emtricitabine|mesh-list
2016674|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
2016675|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016676|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2016677|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2016678|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016679|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016680|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2016681|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2016682|NCT01327677|Fentanyl|fentanyl|mesh-list
2016683|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2016684|NCT01327677|Narcotics|narcotics|mesh-ancestor
2016685|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2016686|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016687|NCT01327677|Analgesics|analgesics|mesh-ancestor
2016688|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
2016689|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016690|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2016691|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2016692|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
2016693|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
2016694|NCT01327703|Pancreatin|pancreatin|mesh-list
2016695|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2016696|NCT01327885|Dacarbazine|dacarbazine|mesh-list
2016697|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2016698|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
2016699|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016700|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016701|NCT01328002|Milnacipran|milnacipran|mesh-list
2016702|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
2016703|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2016704|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2016705|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2016706|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016707|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016708|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016709|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2016710|NCT01328002|Analgesics|analgesics|mesh-ancestor
2016711|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
2016712|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016713|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
2016714|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2016715|NCT01328041|Dolutegravir|dolutegravir|mesh-list
2016716|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2016717|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2016718|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016719|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016720|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2016721|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2016722|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
2016723|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016724|NCT01328054|Lapatinib|lapatinib|mesh-list
2016725|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016726|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2016727|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016728|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016729|NCT01328184|Empagliflozin|empagliflozin|mesh-list
2016730|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
2016731|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2016732|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2016733|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2016734|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2016735|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
2016736|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2016737|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016738|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2016739|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2016740|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2016741|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2016742|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016743|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2016744|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2016745|NCT01328184|Estrogens|estrogens|mesh-ancestor
2016746|NCT01328184|Hormones|hormones|mesh-ancestor
2016747|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2016748|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2016749|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2016750|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2016751|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2016752|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
2016753|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2016754|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2016755|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016756|NCT01328535|Temozolomide|temozolomide|mesh-list
2016757|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2016758|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
2016759|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016760|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016761|NCT01328548|Vaccines|vaccines|mesh-list
2016762|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
2016763|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016764|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2016765|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2016766|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016767|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2016768|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2016769|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2016770|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016771|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
2016772|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016773|NCT01328769|Febuxostat|febuxostat|mesh-list
2016774|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
2016775|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2016776|NCT01328782|Acetaminophen|acetaminophen|mesh-list
2016777|NCT01328782|Oxycodone|oxycodone|mesh-list
2016778|NCT01328782|Bupivacaine|bupivacaine|mesh-list
2016779|NCT01328782|Ropivacaine|ropivacaine|mesh-list
2016780|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
2016781|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
2016782|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2016783|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016784|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
2016785|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016786|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2016787|NCT01328782|Analgesics|analgesics|mesh-ancestor
2016788|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
2016789|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2016790|NCT01328782|Narcotics|narcotics|mesh-ancestor
2016791|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2016792|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016793|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2016794|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016795|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016796|NCT01328964|Fluticasone|fluticasone|mesh-list
2016797|NCT01328964|Xhance|xhance|mesh-list
2016798|NCT01328964|Budesonide|budesonide|mesh-list
2016799|NCT01328964|Montelukast|montelukast|mesh-list
2016800|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2016801|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2016802|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
2016803|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016804|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016805|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2016806|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
2016807|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
2016808|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2016809|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
2016810|NCT01328964|Hormones|hormones|mesh-ancestor
2016811|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2016812|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2016813|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
2016814|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2016815|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2016816|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016817|NCT01329185|Valganciclovir|valganciclovir|mesh-list
2016818|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
2016819|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016820|NCT01329263|Menthol|menthol|mesh-list
2016821|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
2016822|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
2016823|NCT01329419|Adefovir|adefovir|mesh-list
2016824|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2016825|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
2016826|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016827|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2016828|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2016829|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016830|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016831|NCT01329562|Naproxen|naproxen|mesh-list
2016832|NCT01329562|Sumatriptan|sumatriptan|mesh-list
2016833|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2016834|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2016835|NCT01329562|Analgesics|analgesics|mesh-ancestor
2016836|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
2016837|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016838|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016839|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2016840|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2016841|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
2016842|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2016843|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016844|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016845|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2016846|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2016847|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2016848|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
2016849|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016850|NCT01329900|Etoposide|etoposide|mesh-list
2016851|NCT01329900|Ifosfamide|ifosfamide|mesh-list
2016852|NCT01329900|Ofatumumab|ofatumumab|mesh-list
2016853|NCT01329900|Lenograstim|lenograstim|mesh-list
2016854|NCT01329900|Sargramostim|sargramostim|mesh-list
2016855|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2016856|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016857|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2016858|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2016859|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016860|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016861|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2016862|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
2016863|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016864|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2016865|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
2016866|NCT01329939|Montelukast|montelukast|mesh-list
2016867|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2016868|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
2016869|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2016870|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
2016871|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2016872|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016873|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2016874|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2016875|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016876|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
2016877|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
2016878|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016879|NCT01330017|Loratadine|loratadine|mesh-list
2016880|NCT01330017|Phenylephrine|phenylephrine|mesh-list
2016881|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
2016882|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2016883|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
2016884|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
2016885|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016886|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016887|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
2016888|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2016889|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
2016890|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
2016891|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2016892|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2016893|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2016894|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
2016895|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016896|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016897|NCT01330017|Protective Agents|protective agents|mesh-ancestor
2016898|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
2016899|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
2016900|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2016901|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2016902|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2016903|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
2016904|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
2016905|NCT01330030|Selegiline|selegiline|mesh-list
2016906|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
2016907|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2016908|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2016909|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2016910|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2016911|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016912|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016913|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2016914|NCT01330030|Protective Agents|protective agents|mesh-ancestor
2016915|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016916|NCT01330043|Bupropion|bupropion|mesh-list
2016917|NCT01330043|Nicotine|nicotine|mesh-list
2016918|NCT01330043|Varenicline|varenicline|mesh-list
2016919|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2016920|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
2016921|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016922|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016923|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2016924|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2016925|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
2016926|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016927|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016928|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2016929|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
2016930|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2016931|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2016932|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2016933|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2016934|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
2016935|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2016936|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2016937|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016938|NCT01330108|Ambrisentan|ambrisentan|mesh-list
2016939|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2016940|NCT01330134|Lidocaine|lidocaine|mesh-list
2016941|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
2016942|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
2016943|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2016944|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016945|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
2016946|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016947|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2016948|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2016949|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2016950|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2016951|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016952|NCT01330290|Rotigotine|rotigotine|mesh-list
2016953|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
2016954|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
2016955|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016956|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016957|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016958|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
2016959|NCT01330355|Besifloxacin|besifloxacin|mesh-list
2016960|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2016961|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2016962|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2016963|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2016964|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2016965|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2016966|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2016967|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016968|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2016969|NCT01330381|Prucalopride|prucalopride|mesh-list
2016970|NCT01330381|Laxatives|laxatives|mesh-ancestor
2016971|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2016972|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2016973|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2016974|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
2016975|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2016976|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016977|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016978|NCT01330459|Acetaminophen|acetaminophen|mesh-list
2016979|NCT01330459|Ibuprofen|ibuprofen|mesh-list
2016980|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2016981|NCT01330459|Lidocaine|lidocaine|mesh-list
2016982|NCT01330459|Hydrocodone|hydrocodone|mesh-list
2016983|NCT01330459|Lorazepam|lorazepam|mesh-list
2016984|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
2016985|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
2016986|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2016987|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2016988|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
2016989|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2016990|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2016991|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2016992|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2016993|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2016994|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2016995|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2016996|NCT01330459|Analgesics|analgesics|mesh-ancestor
2016997|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
2016998|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2016999|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017000|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2017001|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2017002|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017003|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2017004|NCT01330459|Narcotics|narcotics|mesh-ancestor
2017005|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
2017006|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
2017007|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
2017008|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
2017009|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
2017010|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2017011|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2017012|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2017013|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2017014|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2017015|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
2017016|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
2017017|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017018|NCT01331005|Nepafenac|nepafenac|mesh-list
2017019|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2017020|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2017021|NCT01331005|Analgesics|analgesics|mesh-ancestor
2017022|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
2017023|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017024|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017025|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017026|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2017027|NCT01331109|Milnacipran|milnacipran|mesh-list
2017028|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
2017029|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2017030|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2017031|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2017032|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017033|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017034|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017035|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2017036|NCT01331109|Analgesics|analgesics|mesh-ancestor
2017037|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
2017038|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017039|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
2017040|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2017041|NCT01331161|Vaccines|vaccines|mesh-list
2017042|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
2017043|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017044|NCT01331213|Pregabalin|pregabalin|mesh-list
2017045|NCT01331213|Analgesics|analgesics|mesh-ancestor
2017046|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
2017047|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017048|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017049|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
2017050|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2017051|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2017052|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017053|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2017054|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2017055|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2017056|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2017057|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2017058|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2017059|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
2017060|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2017061|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2017062|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2017063|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2017064|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017065|NCT01331681|Aflibercept|aflibercept|mesh-list
2017066|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2017067|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2017068|NCT01331681|Growth Substances|growth substances|mesh-ancestor
2017069|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017070|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
2017071|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017072|NCT01331694|Fluticasone|fluticasone|mesh-list
2017073|NCT01331694|Bromides|bromides|mesh-list
2017074|NCT01331694|Albuterol|albuterol|mesh-list
2017075|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
2017076|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2017077|NCT01331694|Ipratropium|ipratropium|mesh-list
2017078|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2017079|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017080|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2017081|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
2017082|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017083|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017084|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2017085|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
2017086|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
2017087|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2017088|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
2017089|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2017090|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
2017091|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017092|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017093|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2017094|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2017095|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2017096|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
2017097|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
2017098|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
2017099|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2017100|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
2017101|NCT01331694|Hormones|hormones|mesh-ancestor
2017102|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2017103|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
2017104|NCT01331824|Amrubicin|amrubicin|mesh-list
2017105|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017106|NCT01331837|Etanercept|etanercept|mesh-list
2017107|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2017108|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2017109|NCT01331837|Analgesics|analgesics|mesh-ancestor
2017110|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
2017111|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017112|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017113|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017114|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2017115|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2017116|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2017117|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
2017118|NCT01332019|Interferons|interferons|mesh-list
2017119|NCT01332019|Interferon-beta|interferon-beta|mesh-list
2017120|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
2017121|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017122|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
2017123|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2017124|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
2017125|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017126|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2017127|NCT01332071|Metformin|metformin|mesh-list
2017128|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
2017129|NCT01332071|Maleic acid|maleic acid|mesh-list
2017130|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2017131|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017132|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017133|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017134|NCT01332149|Pregabalin|pregabalin|mesh-list
2017135|NCT01332149|Analgesics|analgesics|mesh-ancestor
2017136|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
2017137|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017138|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017139|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
2017140|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2017141|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2017142|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017143|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2017144|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2017145|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2017146|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2017147|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2017148|NCT01332188|Cetirizine|cetirizine|mesh-list
2017149|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2017150|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2017151|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2017152|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
2017153|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
2017154|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017155|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017156|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017157|NCT01332227|Ritonavir|ritonavir|mesh-list
2017158|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2017159|NCT01332227|Tenofovir|tenofovir|mesh-list
2017160|NCT01332227|Emtricitabine|emtricitabine|mesh-list
2017161|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
2017162|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2017163|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2017164|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
2017165|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017166|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017167|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2017168|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2017169|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
2017170|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2017171|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2017172|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2017173|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2017174|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2017175|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2017176|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2017177|NCT01332253|Ibuprofen|ibuprofen|mesh-list
2017178|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2017179|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2017180|NCT01332253|Analgesics|analgesics|mesh-ancestor
2017181|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
2017182|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017183|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017184|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017185|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2017186|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2017187|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017188|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017189|NCT01332292|Fluticasone|fluticasone|mesh-list
2017190|NCT01332292|Xhance|xhance|mesh-list
2017191|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017192|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2017193|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
2017194|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017195|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017196|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2017197|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
2017198|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
2017199|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2017200|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
2017201|NCT01332318|Promethazine|promethazine|mesh-list
2017202|NCT01332318|Gabapentin|gabapentin|mesh-list
2017203|NCT01332318|Analgesics|analgesics|mesh-ancestor
2017204|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
2017205|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017206|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017207|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
2017208|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2017209|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2017210|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2017211|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2017212|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2017213|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2017214|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017215|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017216|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
2017217|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2017218|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2017219|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
2017220|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
2017221|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
2017222|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
2017223|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2017224|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2017225|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
2017226|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
2017227|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2017228|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
2017229|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
2017230|NCT01332331|Ambrisentan|ambrisentan|mesh-list
2017231|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2017232|NCT01332357|Fluticasone|fluticasone|mesh-list
2017233|NCT01332357|Xhance|xhance|mesh-list
2017234|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2017235|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2017236|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017237|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2017238|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
2017239|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017240|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017241|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2017242|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
2017243|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
2017244|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2017245|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2017246|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2017247|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2017248|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
2017249|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017250|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017251|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
2017252|NCT01332357|Hormones|hormones|mesh-ancestor
2017253|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2017254|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
2017255|NCT01332461|Fluticasone|fluticasone|mesh-list
2017256|NCT01332461|Xhance|xhance|mesh-list
2017257|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2017258|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017259|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2017260|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
2017261|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017262|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017263|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2017264|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
2017265|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
2017266|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2017267|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2017268|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2017269|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2017270|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
2017271|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017272|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017273|NCT01332500|Naproxen|naproxen|mesh-list
2017274|NCT01332500|Sumatriptan|sumatriptan|mesh-list
2017275|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2017276|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2017277|NCT01332500|Analgesics|analgesics|mesh-ancestor
2017278|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
2017279|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017280|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017281|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017282|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2017283|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
2017284|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2017285|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017286|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017287|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2017288|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2017289|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2017290|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
2017291|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017292|NCT01332578|Acetaminophen|acetaminophen|mesh-list
2017293|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
2017294|NCT01332578|Phenylephrine|phenylephrine|mesh-list
2017295|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
2017296|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2017297|NCT01332578|Analgesics|analgesics|mesh-ancestor
2017298|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
2017299|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017300|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017301|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
2017302|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
2017303|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017304|NCT01332578|Protective Agents|protective agents|mesh-ancestor
2017305|NCT01332578|Vitamins|vitamins|mesh-ancestor
2017306|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
2017307|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2017308|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
2017309|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
2017310|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
2017311|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2017312|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
2017313|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
2017314|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2017315|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2017316|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2017317|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
2017318|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017319|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
2017320|NCT01332630|Dexamethasone|dexamethasone|mesh-list
2017321|NCT01332630|Ranitidine|ranitidine|mesh-list
2017322|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2017323|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017324|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
2017325|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
2017326|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017327|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017328|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2017329|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
2017330|NCT01332630|Hormones|hormones|mesh-ancestor
2017331|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2017332|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2017333|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017334|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2017335|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2017336|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2017337|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
2017338|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
2017339|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
2017340|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2017341|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
2017342|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
2017343|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017344|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017345|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2017346|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2017347|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2017348|NCT01332721|Bevacizumab|bevacizumab|mesh-list
2017349|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2017350|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017351|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2017352|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2017353|NCT01332721|Growth Substances|growth substances|mesh-ancestor
2017354|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017355|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
2746122|NCT01111565|Aripiprazole|aripiprazole|mesh-list
2746123|NCT01111565|Citalopram|citalopram|mesh-list
2746124|NCT01111565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2746125|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2746126|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2746127|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746128|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2746129|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
2746130|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746131|NCT01111565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2746132|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
2746133|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2746134|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2746135|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2746136|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2746137|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
2746138|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
2746139|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2017386|NCT01332994|Rituximab|rituximab|mesh-list
2017387|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2017388|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017389|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
2017390|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017391|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2017392|NCT01333033|Leucovorin|leucovorin|mesh-list
2017393|NCT01333033|Paclitaxel|paclitaxel|mesh-list
2017394|NCT01333033|Carboplatin|carboplatin|mesh-list
2017395|NCT01333033|Fluorouracil|fluorouracil|mesh-list
2017396|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
2017397|NCT01333033|Calcium|calcium|mesh-list
2017398|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
2017399|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2017400|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017401|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
2017402|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
2017403|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
2017404|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017405|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2017406|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017407|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
2017408|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2017409|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2017410|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
2017411|NCT01333033|Antidotes|antidotes|mesh-ancestor
2017412|NCT01333033|Protective Agents|protective agents|mesh-ancestor
2017413|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
2017414|NCT01333033|Vitamins|vitamins|mesh-ancestor
2017415|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
2017416|NCT01333059|Fentanyl|fentanyl|mesh-list
2017417|NCT01333059|Midazolam|midazolam|mesh-list
2017418|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2017419|NCT01333059|Narcotics|narcotics|mesh-ancestor
2017420|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2017421|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017422|NCT01333059|Analgesics|analgesics|mesh-ancestor
2017423|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
2017424|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017425|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2017426|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2017427|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
2017428|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
2017429|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2017430|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2017431|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2017432|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2017433|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
2017434|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
2017435|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017436|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017437|NCT01333072|Risperidone|risperidone|mesh-list
2017438|NCT01333072|Aripiprazole|aripiprazole|mesh-list
2017439|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2017440|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
2017441|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017442|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017443|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017444|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2017445|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2017446|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2017447|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2017448|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2017449|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
2017450|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
2017451|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
2017452|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2017453|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2017454|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2017455|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2017456|NCT01333098|Mifepristone|mifepristone|mesh-list
2017457|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2017458|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
2017459|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2017460|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017461|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2017462|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2017463|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2017464|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
2017465|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2017466|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2017467|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
2017468|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2017469|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
2017470|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2017471|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2017472|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
2017473|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2017474|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2017475|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2017476|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2017477|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017478|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
2017479|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017480|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017481|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2017482|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017483|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
2017484|NCT01333488|Analgesics|analgesics|mesh-ancestor
2017485|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
2017486|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017487|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017488|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
2017489|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2017490|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2017491|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
2017492|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2017493|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2017494|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017495|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2017496|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
2017497|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2017498|NCT01333501|Interferons|interferons|mesh-list
2017499|NCT01333501|Interferon-beta|interferon-beta|mesh-list
2017500|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2017501|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
2017502|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017503|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
2017504|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2017505|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
2017506|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017507|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2017508|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017509|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2017510|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2017511|NCT01333592|Mitiglinide|mitiglinide|mesh-list
2017512|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2017513|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017514|NCT01333722|Acetaminophen|acetaminophen|mesh-list
2017515|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2017516|NCT01333722|Hydrocodone|hydrocodone|mesh-list
2017517|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2017518|NCT01333722|Analgesics|analgesics|mesh-ancestor
2017519|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
2017520|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017521|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017522|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
2017523|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2017524|NCT01333722|Narcotics|narcotics|mesh-ancestor
2017525|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2017526|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
2017527|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
2017528|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2017529|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017530|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2017531|NCT01333865|Memantine|memantine|mesh-list
2017532|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2017533|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2017534|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
2017535|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017536|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017537|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017538|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2017539|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2017540|NCT01333956|Pregabalin|pregabalin|mesh-list
2017541|NCT01333956|Analgesics|analgesics|mesh-ancestor
2017542|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
2017543|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017544|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017545|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
2017546|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2017547|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2017548|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017549|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2017550|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2017551|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2017552|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2017553|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2017554|NCT01334086|Aprepitant|aprepitant|mesh-list
2017555|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
2017556|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
2017557|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017558|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017559|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2017560|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2017561|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017562|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017563|NCT01334125|Metformin|metformin|mesh-list
2017564|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2017565|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017566|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2017567|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2017568|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017569|NCT01334229|Incretins|incretins|mesh-ancestor
2017570|NCT01334229|Hormones|hormones|mesh-ancestor
2017571|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2017572|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2017573|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
2017574|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017575|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017576|NCT01334515|Isotretinoin|isotretinoin|mesh-list
2017577|NCT01334515|Sargramostim|sargramostim|mesh-list
2017578|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017579|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
2017580|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
2017581|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
2017582|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
2017583|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2017584|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2017585|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017586|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017587|NCT01334554|Urological Agents|urological agents|mesh-ancestor
2017588|NCT01334710|Sorafenib|sorafenib|mesh-list
2017589|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017590|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2017591|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017592|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017593|NCT01334723|Finasteride|finasteride|mesh-list
2017594|NCT01334723|Dutasteride|dutasteride|mesh-list
2017595|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
2017596|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2017597|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017598|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017599|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
2017600|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2017601|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017602|NCT01334723|Urological Agents|urological agents|mesh-ancestor
2017603|NCT01334918|Regadenoson|regadenoson|mesh-list
2017604|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2017605|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2017606|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2017607|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
2017608|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
2017609|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017610|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017611|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017612|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2017613|NCT01334944|Ibuprofen|ibuprofen|mesh-list
2017614|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2017615|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2017616|NCT01334944|Analgesics|analgesics|mesh-ancestor
2017617|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
2017618|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017619|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017620|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017621|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2017622|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2017623|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017624|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017625|NCT01334957|Ibuprofen|ibuprofen|mesh-list
2017626|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2017627|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2017628|NCT01334957|Analgesics|analgesics|mesh-ancestor
2017629|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
2017630|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017631|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017632|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017633|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2017634|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2017635|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017636|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017637|NCT01335009|Antibodies|antibodies|mesh-list
2017638|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2017639|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
2017640|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017641|NCT01335204|Bavituximab|bavituximab|mesh-list
2017642|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2017643|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017644|NCT01335399|Dexamethasone|dexamethasone|mesh-list
2017645|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
2017646|NCT01335399|Lenalidomide|lenalidomide|mesh-list
2017647|NCT01335399|Elotuzumab|elotuzumab|mesh-list
2017648|NCT01335399|BB 1101|bb 1101|mesh-list
2017649|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017650|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
2017651|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
2017652|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017653|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017654|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2017655|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
2017656|NCT01335399|Hormones|hormones|mesh-ancestor
2017657|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2017658|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2017659|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017660|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
2017661|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017662|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017663|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
2017664|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2017665|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2017666|NCT01335399|Growth Substances|growth substances|mesh-ancestor
2017667|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
2017668|NCT01335464|Nintedanib|nintedanib|mesh-list
2017669|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017670|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2017671|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017672|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017673|NCT01335477|Nintedanib|nintedanib|mesh-list
2017674|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017675|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2017676|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017677|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017678|NCT01335620|Tenofovir|tenofovir|mesh-list
2017679|NCT01335620|Emtricitabine|emtricitabine|mesh-list
2017680|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
2017681|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
2017682|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2017683|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2017684|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2017685|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017686|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017687|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2017688|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2017689|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2017690|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2746140|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2746141|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2746142|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2746143|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2746144|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2017709|NCT01335698|Ritonavir|ritonavir|mesh-list
2017710|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2017711|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2017712|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2017713|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
2017714|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017715|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017716|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2017717|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2017718|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
2017719|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2017720|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2017721|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2017722|NCT01335724|Diclofenac|diclofenac|mesh-list
2017723|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2017724|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2017725|NCT01335724|Analgesics|analgesics|mesh-ancestor
2017726|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
2017727|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017728|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017729|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017730|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2017731|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2017732|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017733|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017734|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2017735|NCT01335789|Oxytocin|oxytocin|mesh-list
2017736|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
2017737|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2017738|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017739|NCT01335867|Vigabatrin|vigabatrin|mesh-list
2017740|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
2017741|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017742|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017743|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
2017744|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017745|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017746|NCT01335932|Ganciclovir|ganciclovir|mesh-list
2017747|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2017748|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
2017749|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2017750|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2017751|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017752|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017753|NCT01335971|Sulforaphane|sulforaphane|mesh-list
2017754|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2017755|NCT01335971|Protective Agents|protective agents|mesh-ancestor
2017756|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017757|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017758|NCT01336023|Insulin|insulin|mesh-list
2017759|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2017760|NCT01336023|Liraglutide|liraglutide|mesh-list
2017761|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
2017762|NCT01336023|Xultophy|xultophy|mesh-list
2017763|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2017764|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017765|NCT01336023|Incretins|incretins|mesh-ancestor
2017766|NCT01336023|Hormones|hormones|mesh-ancestor
2017767|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2017768|NCT01336140|Aminophylline|aminophylline|mesh-list
2017769|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2017770|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
2017771|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017772|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017773|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2017774|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
2017775|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2017776|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2017777|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017778|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017779|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2017780|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2017781|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
2017782|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017783|NCT01336140|Protective Agents|protective agents|mesh-ancestor
2017784|NCT01336205|Naloxegol|naloxegol|mesh-list
2017785|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2017786|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017787|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
2017788|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017789|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
2017790|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2017791|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017792|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2017793|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
2017794|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2017795|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2017796|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017797|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017798|NCT01336569|Timolol|timolol|mesh-list
2017799|NCT01336569|Travoprost|travoprost|mesh-list
2017800|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2017801|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2017802|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
2017803|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017804|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017805|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017806|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2017807|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2017808|NCT01336608|Fluticasone|fluticasone|mesh-list
2017809|NCT01336608|Xhance|xhance|mesh-list
2017810|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017811|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2017812|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
2017813|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017814|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017815|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2017816|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
2017817|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
2017818|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2017823|NCT01336634|Trametinib|trametinib|mesh-list
2017824|NCT01336634|Dabrafenib|dabrafenib|mesh-list
2017825|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017826|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2017827|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017828|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017829|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
2017830|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2017831|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
2017832|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2017833|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017834|NCT01336738|Incretins|incretins|mesh-ancestor
2017835|NCT01336738|Hormones|hormones|mesh-ancestor
2017836|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2017837|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2017838|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
2017839|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017840|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017841|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
2017842|NCT01336738|Vitamins|vitamins|mesh-ancestor
2017843|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
2017844|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2017845|NCT01336803|Hematinics|hematinics|mesh-ancestor
2017846|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2017847|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2017848|NCT01336933|Prednisone|prednisone|mesh-list
2017849|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
2017850|NCT01336933|Etoposide|etoposide|mesh-list
2017851|NCT01336933|Vincristine|vincristine|mesh-list
2017852|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
2017853|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2017854|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
2017855|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017856|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2017857|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2017858|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
2017859|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017860|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2017861|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2017862|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017863|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
2017864|NCT01336933|Hormones|hormones|mesh-ancestor
2017865|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2017866|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2017867|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2017868|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2017869|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2017870|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017871|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
2017872|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
2017873|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
2017874|NCT01336972|Tolvaptan|tolvaptan|mesh-list
2017875|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2017876|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017877|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
2017878|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017879|NCT01337089|Nabiximols|nabiximols|mesh-list
2017880|NCT01337089|Analgesics|analgesics|mesh-ancestor
2017881|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
2017882|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017883|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017884|NCT01337115|Ropivacaine|ropivacaine|mesh-list
2017885|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
2017886|NCT01337115|Anesthetics|anesthetics|mesh-list
2017887|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2017888|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017889|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
2017890|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017891|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2017892|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
2017893|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017894|NCT01337336|Fluticasone|fluticasone|mesh-list
2017895|NCT01337336|Xhance|xhance|mesh-list
2017896|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
2017897|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2017898|NCT01337336|Ipratropium|ipratropium|mesh-list
2017899|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2017900|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2017901|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2017902|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
2017903|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017904|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017905|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2017906|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
2017907|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
2017908|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2017909|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
2017910|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
2017911|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017912|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017913|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2017914|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2017915|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2017916|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
2017917|NCT01337635|Vitamin D|vitamin d|mesh-list
2017918|NCT01337635|Vitamins|vitamins|mesh-ancestor
2017919|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
2017920|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017921|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2017922|NCT01337674|Metoprolol|metoprolol|mesh-list
2017923|NCT01337674|Amlodipine|amlodipine|mesh-list
2017924|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2017925|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2017926|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2017927|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017928|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2017929|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017930|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
2017931|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2017932|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
2017933|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
2017934|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017935|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2017936|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2017937|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2017938|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
2017939|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017940|NCT01337687|Oxytocin|oxytocin|mesh-list
2017941|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
2017942|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2017943|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017944|NCT01337700|Milnacipran|milnacipran|mesh-list
2017945|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
2017946|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2017947|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2017948|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2017949|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017950|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017951|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017952|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2017953|NCT01337700|Analgesics|analgesics|mesh-ancestor
2017954|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
2017955|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2017956|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
2017957|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2017958|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
2017959|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2017960|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2017961|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017962|NCT01338025|Lamivudine|lamivudine|mesh-list
2017963|NCT01338025|Emtricitabine|emtricitabine|mesh-list
2017964|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2017965|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2017966|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2017967|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017968|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
2017969|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2017970|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2017971|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2017972|NCT01338298|Aripiprazole|aripiprazole|mesh-list
2017973|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
2017974|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2017975|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2017976|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2017977|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2017978|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2017979|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
2017980|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
2017981|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2017982|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017983|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2017984|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2017985|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
2017986|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2017987|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2017988|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2017989|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2017990|NCT01338415|Bosentan|bosentan|mesh-list
2017991|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2017992|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2017993|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2017994|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2017995|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2017998|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
2017999|NCT01338792|Pemetrexed|pemetrexed|mesh-list
2018000|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018001|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018002|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018003|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2018004|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2018005|NCT01338818|Methylphenidate|methylphenidate|mesh-list
2018006|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2018007|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018008|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2018009|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2018010|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2018011|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018012|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
2018013|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018014|NCT01338857|Sorafenib|sorafenib|mesh-list
2018015|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018016|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2018017|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018018|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018019|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
2018020|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2018021|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
2018022|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2018023|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018024|NCT01338870|Incretins|incretins|mesh-ancestor
2018025|NCT01338870|Hormones|hormones|mesh-ancestor
2018026|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2018027|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2018028|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
2018029|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018030|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018031|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
2018032|NCT01338870|Vitamins|vitamins|mesh-ancestor
2018033|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
2018034|NCT01338987|Alovudine|alovudine|mesh-list
2018035|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
2018036|NCT01338987|Busulfan|busulfan|mesh-list
2018037|NCT01338987|Methotrexate|methotrexate|mesh-list
2018038|NCT01338987|Fludarabine|fludarabine|mesh-list
2018039|NCT01338987|Leuprolide|leuprolide|mesh-list
2018040|NCT01338987|Tacrolimus|tacrolimus|mesh-list
2018041|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2018042|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
2018043|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018044|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2018045|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2018046|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
2018047|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018048|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018049|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2018050|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2018051|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
2018052|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2018053|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2018054|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
2018055|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
2018056|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018057|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2018058|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2018059|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2018060|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2018061|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
2018062|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2018063|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
2018064|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018065|NCT01339000|Vaccines|vaccines|mesh-list
2018066|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2018067|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
2018068|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018069|NCT01339013|Anesthetics|anesthetics|mesh-list
2018070|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2018071|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018072|NCT01339091|Vancomycin|vancomycin|mesh-list
2018073|NCT01339091|Linezolid|linezolid|mesh-list
2018074|NCT01339091|Dalbavancin|dalbavancin|mesh-list
2018075|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2018076|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018077|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2018078|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018079|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018080|NCT01339247|Halofantrine|halofantrine|mesh-list
2018081|NCT01339247|Paroxetine|paroxetine|mesh-list
2018082|NCT01339247|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2018083|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2018084|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2018085|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018086|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018087|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
2018088|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018089|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2018090|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
2018091|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2018092|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2018093|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2018094|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018095|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
2018096|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2018097|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2018098|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018099|NCT01339260|Dexamethasone|dexamethasone|mesh-list
2018100|NCT01339260|Palonosetron|palonosetron|mesh-list
2018101|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2018102|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
2018103|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
2018104|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018105|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018106|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2018107|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
2018108|NCT01339260|Hormones|hormones|mesh-ancestor
2018109|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2018110|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2018111|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018112|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2018113|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2018114|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
2018115|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018116|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018117|NCT01339273|Anesthetics|anesthetics|mesh-list
2018118|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
2018119|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2018120|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018121|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
2018122|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018123|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2018124|NCT01339299|Hormones|hormones|mesh-list
2018125|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2018126|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018127|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2018128|NCT01339559|Brivaracetam|brivaracetam|mesh-list
2018129|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
2018130|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
2018131|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2018132|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
2018133|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018134|NCT01339858|Expectorants|expectorants|mesh-ancestor
2018135|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
2018136|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2018137|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
2018138|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018139|NCT01339858|Protective Agents|protective agents|mesh-ancestor
2018140|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018141|NCT01339858|Antidotes|antidotes|mesh-ancestor
2018142|NCT01339910|Vidarabine|vidarabine|mesh-list
2018143|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
2018144|NCT01339910|Melphalan|melphalan|mesh-list
2018145|NCT01339910|Busulfan|busulfan|mesh-list
2018146|NCT01339910|Fludarabine|fludarabine|mesh-list
2018147|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
2018148|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2018149|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
2018150|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018151|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2018152|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2018153|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
2018154|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018155|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018156|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2018157|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2018158|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
2018159|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
2018160|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018161|NCT01339923|Vaccines|vaccines|mesh-list
2018162|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
2018163|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018164|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2018165|NCT01339936|Glycerol|glycerol|mesh-list
2018166|NCT01339936|Laxatives|laxatives|mesh-ancestor
2018167|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2018168|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2018169|NCT01339936|Protective Agents|protective agents|mesh-ancestor
2018170|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018171|NCT01340014|Timolol|timolol|mesh-list
2018172|NCT01340014|Dorzolamide|dorzolamide|mesh-list
2018173|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2018174|NCT01340014|Brinzolamide|brinzolamide|mesh-list
2018175|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2018176|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2018177|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2018178|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
2018179|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018180|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018181|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018182|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2018183|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2018184|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2018185|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018186|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
2018187|NCT01340027|Mirabegron|mirabegron|mesh-list
2018188|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2018189|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2018190|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
2018191|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018192|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018193|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018194|NCT01340027|Urological Agents|urological agents|mesh-ancestor
2018195|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2018196|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2018197|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2018198|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
2018199|NCT01340196|Tenofovir|tenofovir|mesh-list
2018200|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
2018201|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018202|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2018203|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2018204|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018205|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018206|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2018207|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2018208|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
2018209|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2018210|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
2018211|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018212|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018213|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2018214|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
2018215|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
2018216|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2018217|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
2018218|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018219|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018220|NCT01340300|Metformin|metformin|mesh-list
2018221|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2018222|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018223|NCT01340586|Apixaban|apixaban|mesh-list
2018224|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2018225|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
2018226|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2018227|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
2018228|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018229|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018230|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
2018231|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2018232|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2018233|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2018234|NCT01340625|Norethindrone|norethindrone|mesh-list
2018235|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
2018236|NCT01340625|Estradiol|estradiol|mesh-list
2018237|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2018238|NCT01340625|Estrogens|estrogens|mesh-ancestor
2018239|NCT01340625|Hormones|hormones|mesh-ancestor
2018240|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2018241|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018242|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2018243|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
2018244|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2018245|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2018246|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2018247|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2018248|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2018249|NCT01340664|Metformin|metformin|mesh-list
2018250|NCT01340664|Canagliflozin|canagliflozin|mesh-list
2018251|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2018252|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018253|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2018254|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018255|NCT01340768|Metformin|metformin|mesh-list
2018256|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2018257|NCT01340768|Glimepiride|glimepiride|mesh-list
2018258|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2018259|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018260|NCT01340768|Incretins|incretins|mesh-ancestor
2018261|NCT01340768|Hormones|hormones|mesh-ancestor
2018262|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2018263|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2018264|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
2018265|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018266|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018267|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2018268|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2018269|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
2018270|NCT01340872|Ferric maltol|ferric maltol|mesh-list
2018271|NCT01340872|Hematinics|hematinics|mesh-ancestor
2018272|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2018273|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
2018274|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018275|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
2018276|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
2018277|NCT01341301|Tacrolimus|tacrolimus|mesh-list
2018278|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2018279|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
2018280|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018281|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2018282|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2018283|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
2018284|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018285|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018286|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2018287|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2018288|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018289|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2018290|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2018291|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
2018292|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2018293|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018294|NCT01341457|Gemcitabine|gemcitabine|mesh-list
2018295|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2018296|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
2018297|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018298|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018299|NCT01341457|Antiviral Agents|antiviral agents|mesh-ancestor
2018300|NCT01341457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018301|NCT01341457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018302|NCT01341457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2018303|NCT01341457|Immunologic Factors|immunologic factors|mesh-ancestor
2018304|NCT01341457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018305|NCT01341600|Omeprazole|omeprazole|mesh-list
2018306|NCT01341600|Clopidogrel|clopidogrel|mesh-list
2018307|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2018308|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2018309|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2018310|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2018311|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
2018312|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018313|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018314|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018315|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2018316|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2018317|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2018318|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018319|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2018320|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
2018321|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018322|NCT01341652|Molgramostim|molgramostim|mesh-list
2018323|NCT01341652|Sargramostim|sargramostim|mesh-list
2018324|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
2018325|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018326|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018327|NCT01341730|Pioglitazone|pioglitazone|mesh-list
2018328|NCT01341730|Atorvastatin|atorvastatin|mesh-list
2018329|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2018330|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2018331|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
2018332|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018333|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2018334|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2018335|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018336|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2018337|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018338|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
2018339|NCT01341782|Calcitriol|calcitriol|mesh-list
2018340|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
2018341|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2018342|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018343|NCT01341782|Vitamins|vitamins|mesh-ancestor
2018344|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
2018345|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2018346|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018347|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
2018348|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2018349|NCT01341782|Protective Agents|protective agents|mesh-ancestor
2018350|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2018351|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2018352|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018353|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2018354|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2018355|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2018356|NCT01342029|Ranolazine|ranolazine|mesh-list
2018357|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2018358|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2018359|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018360|NCT01342081|Timolol|timolol|mesh-list
2018361|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2018362|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2018363|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2018364|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2018365|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
2018366|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018367|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018368|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018369|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2018370|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2018371|NCT01342094|Timolol|timolol|mesh-list
2018372|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2018373|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2018374|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2018375|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2018376|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
2018377|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018378|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018379|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018380|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2018381|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2018382|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2018383|NCT01342172|Lenalidomide|lenalidomide|mesh-list
2018384|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
2018385|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018386|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2018387|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2018388|NCT01342172|Growth Substances|growth substances|mesh-ancestor
2018389|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
2018390|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018391|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2018392|NCT01342211|Bococizumab|bococizumab|mesh-list
2018393|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2018394|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2018395|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
2018396|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018397|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018398|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2018399|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
2018400|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2018401|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018402|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2018403|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018404|NCT01342367|Bicalutamide|bicalutamide|mesh-list
2018405|NCT01342367|Finasteride|finasteride|mesh-list
2018406|NCT01342367|Dutasteride|dutasteride|mesh-list
2018407|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
2018408|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
2018409|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2018410|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018411|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018412|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2018413|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2018414|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018415|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018416|NCT01342367|Urological Agents|urological agents|mesh-ancestor
2018417|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2018418|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2018419|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018420|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2018421|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2018422|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2018423|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018424|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
2018425|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018426|NCT01342484|Linagliptin|linagliptin|mesh-list
2018427|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2018428|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018429|NCT01342484|Incretins|incretins|mesh-ancestor
2018430|NCT01342484|Hormones|hormones|mesh-ancestor
2018431|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2018432|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2018433|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
2018434|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018435|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018436|NCT01342510|Lidocaine|lidocaine|mesh-list
2018437|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
2018438|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
2018439|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
2018440|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2018441|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018442|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
2018443|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018444|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2018445|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2018446|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2018447|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2018448|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018449|NCT01342510|Analgesics|analgesics|mesh-ancestor
2018450|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
2018451|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2018452|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2018453|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
2018454|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2018455|NCT01342523|Nicotine|nicotine|mesh-list
2018456|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2018457|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
2018458|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018459|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018460|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2018461|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2018462|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
2018463|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018464|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018465|NCT01342549|Naltrexone|naltrexone|mesh-list
2018466|NCT01342549|Valproic Acid|valproic acid|mesh-list
2018467|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2018468|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2018469|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018470|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
2018471|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018472|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
2018473|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018474|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018475|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
2018476|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018477|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
2018478|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2018479|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2018480|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2018481|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
2018482|NCT01342640|Hematinics|hematinics|mesh-ancestor
2018483|NCT01342757|Temozolomide|temozolomide|mesh-list
2018484|NCT01342757|Vorinostat|vorinostat|mesh-list
2018485|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2018486|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
2018487|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018488|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018489|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2018490|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018491|NCT01342770|Pioglitazone|pioglitazone|mesh-list
2018492|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2018493|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018494|NCT01342796|Vaccines|vaccines|mesh-list
2018495|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
2018496|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018497|NCT01342887|Cyclosporine|cyclosporine|mesh-list
2018498|NCT01342887|Etoposide|etoposide|mesh-list
2018499|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
2018500|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
2018501|NCT01342887|Pravastatin|pravastatin|mesh-list
2018502|NCT01342887|Cyclosporins|cyclosporins|mesh-list
2018503|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2018504|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018505|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2018506|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2018507|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018508|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018509|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2018510|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
2018511|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018512|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
2018513|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018514|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
2018515|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2018516|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2018517|NCT01342887|Analgesics|analgesics|mesh-ancestor
2018518|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
2018519|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018520|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2018521|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2018522|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
2018523|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2018524|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2018525|NCT01342913|Fluticasone|fluticasone|mesh-list
2018526|NCT01342913|Xhance|xhance|mesh-list
2018527|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2018528|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2018529|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2018530|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
2018531|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018532|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018533|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2018534|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
2018535|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
2018536|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2018537|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2018538|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2018539|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2018540|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
2018541|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018542|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018543|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2018544|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018545|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2018546|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018547|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018548|NCT01343004|Teriparatide|teriparatide|mesh-list
2018549|NCT01343004|Abaloparatide|abaloparatide|mesh-list
2018550|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2018551|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018552|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2018553|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
2018554|NCT01343043|Fludarabine|fludarabine|mesh-list
2018555|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2018556|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
2018557|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018558|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2018559|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2018560|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
2018561|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018562|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018563|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2018564|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2018565|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2018566|NCT01343277|Dacarbazine|dacarbazine|mesh-list
2018567|NCT01343277|Trabectedin|trabectedin|mesh-list
2018568|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2018569|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
2018570|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018571|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018572|NCT01343368|Leuprolide|leuprolide|mesh-list
2018573|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2018574|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
2018575|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2018576|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018577|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2018578|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018579|NCT01343823|Ecallantide|ecallantide|mesh-list
2018580|NCT01343823|Analgesics|analgesics|mesh-ancestor
2018581|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
2018582|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018583|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018584|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2018585|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2018586|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2018587|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2018588|NCT01343901|Bevacizumab|bevacizumab|mesh-list
2018589|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2018590|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018591|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2018592|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2018593|NCT01343901|Growth Substances|growth substances|mesh-ancestor
2018594|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018595|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
2018596|NCT01344161|Vitamin D|vitamin d|mesh-list
2018597|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
2018598|NCT01344161|Vitamins|vitamins|mesh-ancestor
2018599|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
2018600|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018601|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2018602|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2018603|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2018604|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2018605|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2018606|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2018607|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2018608|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2018609|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2018610|NCT01344369|Norethindrone|norethindrone|mesh-list
2018611|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
2018612|NCT01344369|Estradiol|estradiol|mesh-list
2018613|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2018614|NCT01344369|Estrogens|estrogens|mesh-ancestor
2018615|NCT01344369|Hormones|hormones|mesh-ancestor
2018616|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2018617|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018618|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2018619|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
2018620|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2018621|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2018622|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2018623|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2018624|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2018625|NCT01344629|Telmisartan|telmisartan|mesh-list
2018626|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2018627|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2018628|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2018629|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018630|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
2018631|NCT01344759|Propofol|propofol|mesh-list
2018632|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2018633|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2018634|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018635|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2018636|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
2018637|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
2018638|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2018639|NCT01344759|Analgesics|analgesics|mesh-ancestor
2018640|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
2018641|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018642|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2018643|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2018644|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2018645|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
2018646|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018647|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018648|NCT01344824|Bevacizumab|bevacizumab|mesh-list
2018649|NCT01344824|Carboplatin|carboplatin|mesh-list
2018650|NCT01344824|Pemetrexed|pemetrexed|mesh-list
2018651|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2018652|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2018653|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018654|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2018655|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2018656|NCT01344824|Growth Substances|growth substances|mesh-ancestor
2018657|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018658|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
2018659|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018660|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018661|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2018662|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2018663|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2018664|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
2018665|NCT01345019|Denosumab|denosumab|mesh-list
2018666|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2018667|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018668|NCT01345058|Lacosamide|lacosamide|mesh-list
2018669|NCT01345058|Levetiracetam|levetiracetam|mesh-list
2018670|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
2018671|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
2018672|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2018673|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2018674|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2018675|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018676|NCT01345162|Ketorolac|ketorolac|mesh-list
2018677|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2018678|NCT01345162|Tramadol|tramadol|mesh-list
2018679|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2018680|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2018681|NCT01345162|Analgesics|analgesics|mesh-ancestor
2018682|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
2018683|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018684|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018685|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2018686|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2018687|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2018688|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018689|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018690|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2018691|NCT01345162|Narcotics|narcotics|mesh-ancestor
2018692|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2018693|NCT01345188|Ranolazine|ranolazine|mesh-list
2018694|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2018695|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2018696|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018700|NCT01345253|Belimumab|belimumab|mesh-list
2018701|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2018702|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
2018703|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018704|NCT01345292|Listerine|listerine|mesh-list
2018705|NCT01345292|Fluorides|fluorides|mesh-list
2018706|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
2018707|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
2018708|NCT01345292|Protective Agents|protective agents|mesh-ancestor
2018709|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018710|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2018711|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018712|NCT01345630|Ritonavir|ritonavir|mesh-list
2018713|NCT01345630|Darunavir|darunavir|mesh-list
2018714|NCT01345630|Tenofovir|tenofovir|mesh-list
2018715|NCT01345630|Emtricitabine|emtricitabine|mesh-list
2018716|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2018717|NCT01345630|Maraviroc|maraviroc|mesh-list
2018718|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2018719|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2018720|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
2018721|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018722|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018723|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2018724|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2018725|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
2018726|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018727|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2018728|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2018729|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2018730|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2018731|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2018732|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2018733|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2018734|NCT01345669|Afatinib|afatinib|mesh-list
2018735|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018736|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2018737|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018738|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018739|NCT01345682|Methotrexate|methotrexate|mesh-list
2018740|NCT01345682|Afatinib|afatinib|mesh-list
2018741|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2018742|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
2018743|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2018744|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018745|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2018746|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
2018747|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018748|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018749|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
2018750|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018751|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2018752|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2018753|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
2018754|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2018755|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2018756|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2018757|NCT01345929|Levofloxacin|levofloxacin|mesh-list
2018758|NCT01345929|Ofloxacin|ofloxacin|mesh-list
2018759|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2018760|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018761|NCT01345929|Renal Agents|renal agents|mesh-ancestor
2018762|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2018763|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2018764|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2018765|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018766|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018767|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018768|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2018769|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2018770|NCT01346059|Vancomycin|vancomycin|mesh-list
2018771|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2018772|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018773|NCT01346072|Tolvaptan|tolvaptan|mesh-list
2018774|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2018775|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018776|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
2018777|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018778|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
2018779|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
2018780|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018781|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2018782|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2018783|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
2018784|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2018785|NCT01346397|Cyclosporine|cyclosporine|mesh-list
2018786|NCT01346397|Tacrolimus|tacrolimus|mesh-list
2018787|NCT01346397|Cyclosporins|cyclosporins|mesh-list
2018788|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2018789|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
2018790|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018791|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2018792|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018793|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018794|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
2018795|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018796|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
2018797|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2018798|NCT01346475|Valacyclovir|valacyclovir|mesh-list
2018799|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
2018800|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018801|NCT01346540|Nintedanib|nintedanib|mesh-list
2018802|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018803|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2018804|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018805|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018806|NCT01346592|Vaccines|vaccines|mesh-list
2018807|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
2018808|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018809|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
2018810|NCT01347008|Citric Acid|citric acid|mesh-list
2018811|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
2018812|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
2018813|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2018814|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
2018815|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
2018816|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018817|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
2018818|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2018819|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2018820|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018821|NCT01347008|Urological Agents|urological agents|mesh-ancestor
2018822|NCT01347060|Fluticasone|fluticasone|mesh-list
2018823|NCT01347060|Xhance|xhance|mesh-list
2018824|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2018825|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2018826|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2018827|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
2018828|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018829|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018830|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2018831|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
2018832|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
2018833|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2018834|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2018835|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2018836|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2018837|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
2018838|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018839|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018840|NCT01347073|Glycerol|glycerol|mesh-list
2018841|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2018842|NCT01347073|Protective Agents|protective agents|mesh-ancestor
2018843|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018844|NCT01347112|Varenicline|varenicline|mesh-list
2018845|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2018846|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2018847|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
2018848|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018849|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018850|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018851|NCT01347255|Betamethasone|betamethasone|mesh-list
2018852|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
2018853|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2018854|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
2018855|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2018856|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2018857|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
2018858|NCT01347255|Hormones|hormones|mesh-ancestor
2018859|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2018860|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018861|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2018862|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
2018863|NCT01347554|Everolimus|everolimus|mesh-list
2018864|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018865|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2018866|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
2018867|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018868|NCT01347580|Ticagrelor|ticagrelor|mesh-list
2018869|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2018870|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2018871|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2018872|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2018873|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
2018874|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018875|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018876|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018877|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2018878|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
2018879|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2018880|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018881|NCT01347762|Nabilone|nabilone|mesh-list
2018882|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
2018883|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
2018884|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018885|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018886|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2018887|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2018888|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2018889|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2018890|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2018891|NCT01347866|Irinotecan|irinotecan|mesh-list
2018892|NCT01347866|Gedatolisib|gedatolisib|mesh-list
2018893|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2018894|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2018895|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018896|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018897|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2018898|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2018899|NCT01348100|Iloperidone|iloperidone|mesh-list
2018900|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2018901|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2018902|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2018903|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018904|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2018905|NCT01348139|AZD-3199|azd-3199|mesh-list
2018906|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2018907|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2018908|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2018909|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
2018910|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018911|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018912|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018913|NCT01348542|Trazodone|trazodone|mesh-list
2018914|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2018915|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2018916|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2018917|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018918|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2018919|NCT01348542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2018920|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2018921|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2018922|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018923|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018924|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
2018925|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2018926|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
2018927|NCT01348607|Methylphenidate|methylphenidate|mesh-list
2018928|NCT01348607|Modafinil|modafinil|mesh-list
2018929|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2018930|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018931|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2018932|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2018933|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2018934|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018935|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
2018936|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2018937|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2018938|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2018939|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2018940|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2018941|NCT01348763|Maraviroc|maraviroc|mesh-list
2018942|NCT01348763|Darunavir|darunavir|mesh-list
2018943|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2018944|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2018945|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018946|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018947|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
2018948|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018949|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2018950|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2018951|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2018952|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2018953|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2018954|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2018955|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2018956|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
2018957|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
2018958|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2018959|NCT01349192|Minocycline|minocycline|mesh-list
2018960|NCT01349192|Rifampin|rifampin|mesh-list
2018961|NCT01349192|Trimethoprim|trimethoprim|mesh-list
2018962|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
2018963|NCT01349192|Mupirocin|mupirocin|mesh-list
2018964|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2018965|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2018966|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
2018967|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
2018968|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2018969|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2018970|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
2018971|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
2018972|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2018973|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2018974|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2018975|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2018976|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2018977|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2018978|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2018979|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2018980|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2018981|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2018982|NCT01349192|Renal Agents|renal agents|mesh-ancestor
2018983|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
2018984|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2018985|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2018986|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2018987|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2018988|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2018989|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2018990|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2018991|NCT01349231|Ketamine|ketamine|mesh-list
2018992|NCT01349231|Analgesics|analgesics|mesh-ancestor
2018993|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
2018994|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2018995|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2018996|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2018997|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2018998|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
2018999|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
2019000|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2019001|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2019002|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2019003|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2019004|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019005|NCT01349491|Ranolazine|ranolazine|mesh-list
2019006|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2019007|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2019008|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019009|NCT01349569|Lenalidomide|lenalidomide|mesh-list
2019010|NCT01349569|Vaccines|vaccines|mesh-list
2019011|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
2019012|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019013|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2019014|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2019015|NCT01349569|Growth Substances|growth substances|mesh-ancestor
2019016|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
2019017|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019018|NCT01349660|Bevacizumab|bevacizumab|mesh-list
2019019|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2019020|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019021|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2019022|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2019023|NCT01349660|Growth Substances|growth substances|mesh-ancestor
2019024|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019025|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
2019026|NCT01349673|Budesonide|budesonide|mesh-list
2019027|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2019028|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2019029|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
2019030|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019031|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019032|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2019033|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
2019034|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
2019035|NCT01349673|Hormones|hormones|mesh-ancestor
2019036|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2019037|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
2019038|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2019039|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
2019040|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019041|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019042|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2019043|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
2019044|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2019045|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2019046|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2019047|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
2019048|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2019049|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019050|NCT01349907|Asenapine|asenapine|mesh-list
2019051|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2019052|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2019053|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2019054|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019055|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2019056|NCT01349920|Infliximab|infliximab|mesh-list
2019057|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
2019058|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2019059|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2746167|NCT00950989|Folic Acid|folic acid|mesh-list
2746168|NCT00950989|Methotrexate|methotrexate|mesh-list
2746169|NCT00950989|Brodalumab|brodalumab|mesh-list
2746170|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2019068|NCT01349972|Cytarabine|cytarabine|mesh-list
2019069|NCT01349972|Daunorubicin|daunorubicin|mesh-list
2019070|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
2019071|NCT01349972|Alvocidib|alvocidib|mesh-list
2019072|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2019073|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
2019074|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019075|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019076|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
2019077|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019078|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2019079|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
2019080|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019081|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2019082|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2019083|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2019084|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019085|NCT01349972|Analgesics|analgesics|mesh-ancestor
2019086|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
2019087|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019088|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
2019089|NCT01349972|Growth Substances|growth substances|mesh-ancestor
2019090|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2019091|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
2019092|NCT01350102|Bacitracin|bacitracin|mesh-list
2019093|NCT01350102|Vitamins|vitamins|mesh-ancestor
2019094|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
2019095|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019096|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
2019097|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019098|NCT01350102|Protective Agents|protective agents|mesh-ancestor
2019099|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2019100|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019101|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2019102|NCT01350128|Bromides|bromides|mesh-list
2019103|NCT01350128|Ipratropium|ipratropium|mesh-list
2019104|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
2019105|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2019106|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
2019107|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019108|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019109|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2019110|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
2019111|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2019112|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
2019113|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079367|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2746171|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
2019114|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019115|NCT01350141|Bococizumab|bococizumab|mesh-list
2019116|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2019117|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2019118|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
2019119|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019120|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2019121|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
2019122|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
2019123|NCT01350245|Tacrolimus|tacrolimus|mesh-list
2019124|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2019125|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
2019126|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019127|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2019128|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2019129|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
2019130|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019131|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019132|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2019133|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2019134|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019135|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2019136|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2019137|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
2019138|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2019139|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019140|NCT01350271|Mebendazole|mebendazole|mesh-list
2019141|NCT01350271|Piperazine|piperazine|mesh-list
2019142|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
2019143|NCT01350271|DMP 777|dmp 777|mesh-list
2019144|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
2019145|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
2019146|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2019147|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019148|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
2019149|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
2019150|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
2019151|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019152|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019153|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019154|NCT01350388|Febuxostat|febuxostat|mesh-list
2019155|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
2019156|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2019157|NCT01350804|Abatacept|abatacept|mesh-list
2019158|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2019159|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019160|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019161|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2019162|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
2019163|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019164|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2019165|NCT01350934|Vitamin D|vitamin d|mesh-list
2019166|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
2019167|NCT01350934|Alendronate|alendronate|mesh-list
2019168|NCT01350934|Calcitriol|calcitriol|mesh-list
2019169|NCT01350934|Calcium|calcium|mesh-list
2019170|NCT01350934|Vitamins|vitamins|mesh-ancestor
2019171|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
2019172|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019173|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2019174|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2019175|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2019176|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2019177|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019178|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2019179|NCT01350947|Azacitidine|azacitidine|mesh-list
2019180|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2019181|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
2019182|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019183|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019184|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019185|NCT01351025|Atorvastatin|atorvastatin|mesh-list
2019186|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2019187|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2019188|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
2019189|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019190|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2019191|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2019192|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019193|NCT01351090|Ketorolac|ketorolac|mesh-list
2019194|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2019195|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2019196|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2019197|NCT01351090|Analgesics|analgesics|mesh-ancestor
2019198|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
2019199|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019200|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019201|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2019202|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2019203|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2019204|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019205|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019206|NCT01351350|Paclitaxel|paclitaxel|mesh-list
2019207|NCT01351350|Trastuzumab|trastuzumab|mesh-list
2019208|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2019209|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019210|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
2019211|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
2019212|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
2019213|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019214|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2019215|NCT01351415|Bevacizumab|bevacizumab|mesh-list
2019216|NCT01351415|Docetaxel|docetaxel|mesh-list
2019217|NCT01351415|Pemetrexed|pemetrexed|mesh-list
2019218|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2019219|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2019220|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019221|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2019222|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2019223|NCT01351415|Growth Substances|growth substances|mesh-ancestor
2019224|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019225|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
2019226|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
2019227|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
2019228|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
2019229|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019230|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019231|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2019232|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2019233|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2019234|NCT01351480|Abatacept|abatacept|mesh-list
2019235|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2019236|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019237|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019238|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2019239|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
2019240|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019241|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2019242|NCT01351740|Ritonavir|ritonavir|mesh-list
2019243|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2019244|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2019245|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2019246|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
2019247|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019248|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019249|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2019250|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2019251|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
2019252|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019253|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2019254|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2019255|NCT01351753|Metformin|metformin|mesh-list
2019256|NCT01351753|Topiramate|topiramate|mesh-list
2019257|NCT01351753|Orlistat|orlistat|mesh-list
2019258|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2019259|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019260|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
2019261|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019262|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019263|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2019264|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2019265|NCT01351766|Nicotine|nicotine|mesh-list
2019266|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2019267|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
2019268|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019269|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019270|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2019271|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2019272|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
2019273|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2019274|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019275|NCT01351805|Vitamin D|vitamin d|mesh-list
2019276|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
2019277|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
2019278|NCT01351805|Vitamins|vitamins|mesh-list
2019279|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
2019280|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019281|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2019282|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2019283|NCT01352117|Tenofovir|tenofovir|mesh-list
2019284|NCT01352117|Emtricitabine|emtricitabine|mesh-list
2019285|NCT01352117|Efavirenz|efavirenz|mesh-list
2019286|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2019287|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2019288|NCT01352117|Etoposide|etoposide|mesh-list
2019289|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2019290|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019291|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2019292|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2019293|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019294|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019295|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
2019296|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019297|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2019298|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2019299|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2019300|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2019301|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2019302|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2019303|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2019304|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2019305|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2019306|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2019307|NCT01352182|Pioglitazone|pioglitazone|mesh-list
2019308|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2019309|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019310|NCT01352221|Ferric maltol|ferric maltol|mesh-list
2019311|NCT01352221|Hematinics|hematinics|mesh-ancestor
2019312|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
2019313|NCT01352507|Tadalafil|tadalafil|mesh-list
2019314|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
2019315|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2019316|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2019317|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019318|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019319|NCT01352507|Urological Agents|urological agents|mesh-ancestor
2019320|NCT01352585|Anagrelide|anagrelide|mesh-list
2019321|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2019322|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2019323|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019324|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2019325|NCT01352637|Cycloserine|cycloserine|mesh-list
2019326|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2019327|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019328|NCT01352637|Renal Agents|renal agents|mesh-ancestor
2019329|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2019330|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
2019331|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2019332|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
2019333|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019334|NCT01352715|Ritonavir|ritonavir|mesh-list
2019335|NCT01352715|Lopinavir|lopinavir|mesh-list
2019336|NCT01352715|Tenofovir|tenofovir|mesh-list
2019337|NCT01352715|Lamivudine|lamivudine|mesh-list
2019338|NCT01352715|Zidovudine|zidovudine|mesh-list
2019339|NCT01352715|Emtricitabine|emtricitabine|mesh-list
2019340|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
2019341|NCT01352715|Abacavir|abacavir|mesh-list
2019342|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2019343|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
2019344|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2019345|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2019346|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
2019347|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019348|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019349|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2019350|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2019351|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
2019352|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019353|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2019354|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2019355|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2019356|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2019357|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
2019358|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2019359|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2019360|NCT01352741|Pregabalin|pregabalin|mesh-list
2019361|NCT01352741|Tapentadol|tapentadol|mesh-list
2019362|NCT01352741|Analgesics|analgesics|mesh-ancestor
2019363|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
2019364|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019365|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019366|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
2019367|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2019368|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2019369|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019370|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2019371|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2019372|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2019373|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2019374|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2019375|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2019376|NCT01352741|Narcotics|narcotics|mesh-ancestor
2019377|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2019378|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2019379|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
2019380|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2019381|NCT01353144|Aspirin|aspirin|mesh-list
2019382|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2019383|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2019384|NCT01353144|Analgesics|analgesics|mesh-ancestor
2019385|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
2019386|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019387|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019388|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2019389|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2019390|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2019391|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2019392|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019393|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2019394|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2019395|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019396|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
2019397|NCT01353508|Valsartan|valsartan|mesh-list
2019398|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2019399|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2019400|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2019401|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2019402|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019403|NCT01353664|Romidepsin|romidepsin|mesh-list
2019404|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2019405|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019406|NCT01353859|Methotrexate|methotrexate|mesh-list
2019407|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2019408|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
2019409|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2019410|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019411|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2019412|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
2019413|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019414|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019415|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
2019416|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019417|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2019418|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2019419|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
2019420|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2019421|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2019422|NCT01353911|Interferons|interferons|mesh-list
2019423|NCT01353911|Ribavirin|ribavirin|mesh-list
2019424|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
2019425|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
2019426|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2019427|NCT01353911|Grazoprevir|grazoprevir|mesh-list
2019428|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019429|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
2019430|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019431|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
2019432|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019433|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
2019434|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019435|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2019436|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2019437|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2019438|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2019439|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019440|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2019441|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019442|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
2019443|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2019444|NCT01353976|Econazole|econazole|mesh-list
2019445|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
2019446|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019447|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2019448|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2019449|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019450|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019451|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2019452|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
2019453|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2019454|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019455|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
2019456|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2019457|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
2019458|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019459|NCT01354132|Expectorants|expectorants|mesh-ancestor
2019460|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
2019461|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2019462|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
2019463|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019464|NCT01354132|Protective Agents|protective agents|mesh-ancestor
2019465|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019466|NCT01354132|Antidotes|antidotes|mesh-ancestor
2019467|NCT01354145|Celecoxib|celecoxib|mesh-list
2019468|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2019469|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2019470|NCT01354145|Analgesics|analgesics|mesh-ancestor
2019471|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
2019472|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019473|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019474|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2019475|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2019476|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2019477|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2019478|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019479|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019480|NCT01354314|Fluconazole|fluconazole|mesh-list
2019481|NCT01354314|Paroxetine|paroxetine|mesh-list
2019482|NCT01354314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2019483|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2019484|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2019485|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019486|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2019487|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
2019488|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019489|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2019490|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
2019491|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2019492|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2019493|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2019494|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019495|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
2019496|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019497|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2019498|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2019499|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
2019500|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2019501|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2019502|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2019503|NCT01354353|Aripiprazole|aripiprazole|mesh-list
2019504|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
2019505|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2019506|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2019507|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2019508|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2019509|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019510|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
2019511|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
2019512|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2019513|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019514|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2019515|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2019516|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
2019517|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2019518|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2019519|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2019520|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2019521|NCT01354431|Nivolumab|nivolumab|mesh-list
2019522|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2019523|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019524|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2019525|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019526|NCT01354444|Carvedilol|carvedilol|mesh-list
2019527|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2019528|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2019529|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
2019530|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2019531|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019532|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019533|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2019534|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
2019535|NCT01354444|Protective Agents|protective agents|mesh-ancestor
2019536|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2019537|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2019538|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2019539|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
2019540|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2019541|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2019542|NCT01354652|Lamivudine|lamivudine|mesh-list
2019543|NCT01354652|Entecavir|entecavir|mesh-list
2019544|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2019545|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2019546|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019547|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019548|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
2019549|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019550|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2019551|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2019552|NCT01354938|Clarithromycin|clarithromycin|mesh-list
2019553|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2019554|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019555|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2019556|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079368|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
2019557|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019558|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2019559|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2019560|NCT01354964|Vitamin D|vitamin d|mesh-list
2019561|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
2019562|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
2019563|NCT01354964|Vitamins|vitamins|mesh-list
2019564|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
2019565|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019566|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2019567|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2019568|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2019569|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2019570|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019571|NCT01354990|Incretins|incretins|mesh-ancestor
2019572|NCT01354990|Hormones|hormones|mesh-ancestor
2019573|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2019574|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2019575|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
2019576|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019577|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019578|NCT01355068|Phenytoin|phenytoin|mesh-list
2019579|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
2019580|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2019581|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2019582|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2019583|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019584|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2019585|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2019586|NCT01355081|Vortioxetine|vortioxetine|mesh-list
2019587|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
2019588|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2019589|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2019590|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2019591|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2019592|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019593|NCT01355081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2019594|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2019595|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2019596|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019597|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2019598|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
2019599|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2019600|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2019601|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2019602|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2019603|NCT01355159|Folic Acid|folic acid|mesh-list
2019604|NCT01355159|Hematinics|hematinics|mesh-ancestor
2019605|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
2019606|NCT01355159|Vitamins|vitamins|mesh-ancestor
2019607|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
2019608|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019609|NCT01355289|Interferons|interferons|mesh-list
2019610|NCT01355289|Ribavirin|ribavirin|mesh-list
2019611|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019612|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
2019613|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019614|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
2019615|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019616|NCT01355302|Capecitabine|capecitabine|mesh-list
2019617|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019618|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2019619|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
2019620|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019621|NCT01355523|Melatonin|melatonin|mesh-list
2019622|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
2019623|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019624|NCT01355523|Protective Agents|protective agents|mesh-ancestor
2019625|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019626|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2019627|NCT01355575|Rifaximin|rifaximin|mesh-list
2019628|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2019629|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019630|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2019631|NCT01355588|Ketorolac|ketorolac|mesh-list
2019632|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2019633|NCT01355588|Lidocaine|lidocaine|mesh-list
2019634|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
2019635|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
2019636|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2019637|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019638|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
2019639|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019640|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2019641|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2019642|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2019643|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2019644|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019645|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2019646|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2019647|NCT01355588|Analgesics|analgesics|mesh-ancestor
2019648|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2019649|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2019650|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2019651|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019652|NCT01355705|Aspirin|aspirin|mesh-list
2019653|NCT01355705|Dexamethasone|dexamethasone|mesh-list
2019654|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
2019655|NCT01355705|Lenalidomide|lenalidomide|mesh-list
2019656|NCT01355705|Amrubicin|amrubicin|mesh-list
2019657|NCT01355705|BB 1101|bb 1101|mesh-list
2019658|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2019659|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
2019660|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
2019661|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019662|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019663|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2019664|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
2019665|NCT01355705|Hormones|hormones|mesh-ancestor
2019666|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2019667|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2019668|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019669|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
2019670|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019671|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019672|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2019673|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2019674|NCT01355705|Analgesics|analgesics|mesh-ancestor
2019675|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
2019676|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2019677|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2019678|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2019679|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2019680|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2019681|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
2019682|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
2019683|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2019684|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2019685|NCT01355705|Growth Substances|growth substances|mesh-ancestor
2019686|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
2019687|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
2019688|NCT01356407|Cathartics|cathartics|mesh-ancestor
2019689|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2019690|NCT01356602|Triamcinolone|triamcinolone|mesh-list
2019691|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2019692|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2019693|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2019694|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2019695|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2019696|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
2019697|NCT01356602|Hormones|hormones|mesh-ancestor
2019698|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2019699|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019700|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2019701|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
2019702|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019703|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019704|NCT01356628|Palbociclib|palbociclib|mesh-list
2019705|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019706|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2019707|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019708|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019709|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
2019710|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2019711|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2019712|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019713|NCT01356966|Folic Acid|folic acid|mesh-list
2019714|NCT01356966|Hematinics|hematinics|mesh-ancestor
2019715|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
2019716|NCT01356966|Vitamins|vitamins|mesh-ancestor
2019717|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
2019718|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019719|NCT01357135|Metformin|metformin|mesh-list
2019720|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2019721|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2019722|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019723|NCT01357135|Incretins|incretins|mesh-ancestor
2019724|NCT01357135|Hormones|hormones|mesh-ancestor
2019725|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2019726|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2019727|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
2019728|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019729|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019730|NCT01357148|Metformin|metformin|mesh-list
2019731|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2019732|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2019733|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019734|NCT01357148|Incretins|incretins|mesh-ancestor
2019735|NCT01357148|Hormones|hormones|mesh-ancestor
2019736|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2019737|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2019738|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
2019739|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019740|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019741|NCT01357161|Paclitaxel|paclitaxel|mesh-list
2019742|NCT01357161|Carboplatin|carboplatin|mesh-list
2019743|NCT01357161|Adavosertib|adavosertib|mesh-list
2019744|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2019745|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019746|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
2019747|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
2019748|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
2019749|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019750|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019751|NCT01357616|Timolol|timolol|mesh-list
2019752|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2019753|NCT01357616|Brinzolamide|brinzolamide|mesh-list
2019754|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2019755|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2019756|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2019757|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
2019758|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2019759|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019760|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019761|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2019762|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2019763|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2019764|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019765|NCT01357655|Dasatinib|dasatinib|mesh-list
2019766|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019767|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2019768|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019769|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019770|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
2019771|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2019772|NCT01357889|Incretins|incretins|mesh-ancestor
2019773|NCT01357889|Hormones|hormones|mesh-ancestor
2019774|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2019775|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019776|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
2019777|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2019778|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2019779|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2019780|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2019781|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019782|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
2019783|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2019784|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019785|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2019786|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019787|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2019788|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
2019789|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019790|NCT01358266|Sirolimus|sirolimus|mesh-list
2019791|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2019792|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019793|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2019794|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019795|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
2019796|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2019797|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
2019798|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019799|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2019800|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2019801|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2019802|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2019803|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019804|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2019805|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2019806|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2019807|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2019808|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
2019809|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2019810|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019811|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2019812|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2019813|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
2019814|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2019815|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2019816|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
2019817|NCT01358526|Oxycodone|oxycodone|mesh-list
2019818|NCT01358526|Naloxone|naloxone|mesh-list
2019819|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2019820|NCT01358526|Narcotics|narcotics|mesh-ancestor
2019821|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2019822|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019823|NCT01358526|Analgesics|analgesics|mesh-ancestor
2019824|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
2019825|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019826|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2019827|NCT01358578|Etanercept|etanercept|mesh-list
2019828|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2019829|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2019830|NCT01358578|Analgesics|analgesics|mesh-ancestor
2019831|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
2019832|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2019833|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019834|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2019835|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2019836|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2019837|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2019838|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
2019839|NCT01358721|Nivolumab|nivolumab|mesh-list
2019840|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2019841|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019842|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2019843|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019844|NCT01358734|Lenalidomide|lenalidomide|mesh-list
2019845|NCT01358734|Azacitidine|azacitidine|mesh-list
2019846|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
2019847|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019848|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2019849|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2019850|NCT01358734|Growth Substances|growth substances|mesh-ancestor
2019851|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
2019852|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019853|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2019854|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
2079369|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
2019855|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019856|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019857|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2019858|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2019859|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
2019860|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019861|NCT01358864|Interferons|interferons|mesh-list
2019862|NCT01358864|Ribavirin|ribavirin|mesh-list
2019863|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
2019864|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019865|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
2019866|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019867|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
2019868|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019869|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
2019870|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019871|NCT01358877|Paclitaxel|paclitaxel|mesh-list
2019872|NCT01358877|Docetaxel|docetaxel|mesh-list
2019873|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
2019874|NCT01358877|Carboplatin|carboplatin|mesh-list
2019875|NCT01358877|Doxorubicin|doxorubicin|mesh-list
2019876|NCT01358877|Fluorouracil|fluorouracil|mesh-list
2019877|NCT01358877|Trastuzumab|trastuzumab|mesh-list
2019878|NCT01358877|Epirubicin|epirubicin|mesh-list
2019879|NCT01358877|Pertuzumab|pertuzumab|mesh-list
2019880|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2019881|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019882|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
2019883|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
2019884|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
2019885|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019886|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2019887|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
2019888|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019889|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2019890|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2019891|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
2019892|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2019893|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2019894|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2019895|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2019896|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019897|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
2019898|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2019899|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2019900|NCT01358968|Gemcitabine|gemcitabine|mesh-list
2019901|NCT01358968|Pemetrexed|pemetrexed|mesh-list
2019902|NCT01358968|Desipramine|desipramine|mesh-list
2019903|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2019904|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
2019905|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019906|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019907|NCT01358968|Antiviral Agents|antiviral agents|mesh-ancestor
2019908|NCT01358968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019909|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019910|NCT01358968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2019911|NCT01358968|Immunologic Factors|immunologic factors|mesh-ancestor
2019912|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019913|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2019914|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2019915|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2019916|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
2019917|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2019918|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2019919|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2019920|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2019921|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
2019922|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2019923|NCT01359007|Leucovorin|leucovorin|mesh-list
2019924|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
2019925|NCT01359007|Irinotecan|irinotecan|mesh-list
2019926|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019927|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2019928|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2019929|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019930|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019931|NCT01359007|Antidotes|antidotes|mesh-ancestor
2019932|NCT01359007|Protective Agents|protective agents|mesh-ancestor
2019933|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019934|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
2019935|NCT01359007|Vitamins|vitamins|mesh-ancestor
2019936|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
2019937|NCT01359150|Tofacitinib|tofacitinib|mesh-list
2019938|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2019939|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019940|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019941|NCT01359592|Prednisone|prednisone|mesh-list
2019942|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
2019943|NCT01359592|Rituximab|rituximab|mesh-list
2019944|NCT01359592|Doxorubicin|doxorubicin|mesh-list
2019945|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2019946|NCT01359592|Vincristine|vincristine|mesh-list
2019947|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2019948|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2019949|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
2019950|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019951|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2019952|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2019953|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
2019954|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019955|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019956|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2019957|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2019958|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2019959|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2019960|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2019961|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2019962|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2019963|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
2019964|NCT01359592|Hormones|hormones|mesh-ancestor
2019965|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2019966|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2019967|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2019968|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
2019969|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
2019970|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
2019971|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2019972|NCT01359644|Ribavirin|ribavirin|mesh-list
2019973|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
2019974|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
2019975|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019976|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
2019977|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019978|NCT01359735|Bacitracin|bacitracin|mesh-list
2019979|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2019980|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019981|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2019982|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
2019983|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2019984|NCT01359956|Interferons|interferons|mesh-list
2019985|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
2019986|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
2019987|NCT01359956|Dacarbazine|dacarbazine|mesh-list
2019988|NCT01359956|Fotemustine|fotemustine|mesh-list
2019989|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2019990|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
2019991|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2019992|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
2019993|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2019994|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2019995|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
2019996|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2019997|NCT01360021|Budesonide|budesonide|mesh-list
2019998|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2019999|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020000|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2020001|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
2020002|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020003|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020004|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2020005|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
2020006|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
2020007|NCT01360021|Hormones|hormones|mesh-ancestor
2079370|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020008|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2020009|NCT01360450|Clonidine|clonidine|mesh-list
2020010|NCT01360450|Analgesics|analgesics|mesh-ancestor
2020011|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
2020012|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020013|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020014|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2020015|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
2020016|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
2020017|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2020018|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2020019|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2020020|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
2020021|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020022|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020023|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2020024|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020025|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2020026|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020027|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020028|NCT01360762|Pentamidine|pentamidine|mesh-list
2020029|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
2020030|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2020031|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2020032|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2020033|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2020034|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2020035|NCT01360866|Citalopram|citalopram|mesh-list
2020036|NCT01360866|Fluoxetine|fluoxetine|mesh-list
2020037|NCT01360866|Paroxetine|paroxetine|mesh-list
2020038|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2020039|NCT01360866|Sertraline|sertraline|mesh-list
2020040|NCT01360866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2020041|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2020042|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2020043|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020044|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020045|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
2020046|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020047|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2020048|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
2020049|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2020050|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020051|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2020052|NCT01360866|Analgesics|analgesics|mesh-ancestor
2020053|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
2020054|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
2020055|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2020056|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2020057|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020058|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
2020059|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
2020060|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2020061|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020062|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2020063|NCT01361009|Pramipexole|pramipexole|mesh-list
2020064|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
2020065|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020066|NCT01361009|Protective Agents|protective agents|mesh-ancestor
2020067|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020068|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2020069|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2020070|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
2020071|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
2020072|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020073|NCT01361048|Metronidazole|metronidazole|mesh-list
2020074|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2020075|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2020076|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2020077|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2020078|NCT01361217|Midazolam|midazolam|mesh-list
2020079|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
2020080|NCT01361217|Caffeine|caffeine|mesh-list
2020081|NCT01361217|Fluoxetine|fluoxetine|mesh-list
2020082|NCT01361217|Omeprazole|omeprazole|mesh-list
2020083|NCT01361217|Lovastatin|lovastatin|mesh-list
2020084|NCT01361217|L 647318|l 647318|mesh-list
2020085|NCT01361217|Dihydromevinolin|dihydromevinolin|mesh-list
2020086|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2020087|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2020088|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2020089|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020090|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2020091|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2020092|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2020093|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2020094|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
2020095|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
2020096|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
2020097|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
2020098|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020099|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020100|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2020101|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2020102|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2020103|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020104|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2020105|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2020106|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2020107|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2020108|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
2020109|NCT01361217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2020110|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2020111|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2020112|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
2020113|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2020114|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
2020115|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2020116|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2020117|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
2020118|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
2020119|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2020120|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2020121|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2020122|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2020123|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
2020124|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2020125|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2020126|NCT01361308|Paroxetine|paroxetine|mesh-list
2020127|NCT01361308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2020128|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2020129|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2020130|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020131|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020132|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
2020133|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020134|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2020135|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
2020136|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2020137|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2020138|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2020139|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020140|NCT01361464|Tipifarnib|tipifarnib|mesh-list
2020141|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020142|NCT01361594|Insulin|insulin|mesh-list
2020143|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2020144|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2020145|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020146|NCT01361607|Nabiximols|nabiximols|mesh-list
2020147|NCT01361607|Analgesics|analgesics|mesh-ancestor
2020148|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
2020149|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020150|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020151|NCT01361620|Aspirin|aspirin|mesh-list
2020152|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2020153|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020154|NCT01361620|Analgesics|analgesics|mesh-ancestor
2020155|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
2020156|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020157|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020158|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020159|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020160|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2020161|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2020162|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020163|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2020164|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2020165|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020166|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
2020167|NCT01361633|Cycloserine|cycloserine|mesh-list
2020168|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2020169|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2020170|NCT01361633|Renal Agents|renal agents|mesh-ancestor
2020171|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2020172|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
2020173|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2020174|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
2020175|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020176|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2020177|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
2020178|NCT01361711|Ofatumumab|ofatumumab|mesh-list
2020179|NCT01361711|Antibodies|antibodies|mesh-list
2020180|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
2020181|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2020182|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
2020183|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020184|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020185|NCT01362127|Cisplatin|cisplatin|mesh-list
2020186|NCT01362127|Carboplatin|carboplatin|mesh-list
2020187|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
2020188|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020189|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
2020190|NCT01362140|Hematinics|hematinics|mesh-ancestor
2020191|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
2020192|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2020193|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2020194|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2020195|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
2020196|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
2020197|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
2020198|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2020199|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2020200|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020201|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020202|NCT01362205|Analgesics|analgesics|mesh-ancestor
2020203|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
2020204|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020205|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2020206|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2020207|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2020208|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
2020209|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020210|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020211|NCT01362296|Docetaxel|docetaxel|mesh-list
2020212|NCT01362296|Trametinib|trametinib|mesh-list
2020213|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020214|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
2020215|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
2020216|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
2020217|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020218|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2020219|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020220|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2020221|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2020222|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2020223|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2020224|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2020225|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2020226|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020227|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2020228|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2020229|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2020230|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
2020231|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020232|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020233|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2020234|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2020235|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
2020236|NCT01362491|Ibuprofen|ibuprofen|mesh-list
2020237|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2020238|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020239|NCT01362491|Analgesics|analgesics|mesh-ancestor
2020240|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
2020241|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020242|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020243|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020244|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020245|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2020246|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020247|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020248|NCT01362530|Ondansetron|ondansetron|mesh-list
2020249|NCT01362530|Aprepitant|aprepitant|mesh-list
2020250|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
2020251|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
2020252|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
2020253|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020254|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020255|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2020256|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
2020257|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
2020258|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2020259|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
2020260|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020261|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020262|NCT01362530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2020263|NCT01362530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2020264|NCT01362530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2020265|NCT01362530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2020266|NCT01362530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2020267|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2020268|NCT01362608|Triamcinolone|triamcinolone|mesh-list
2020269|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2020270|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2020271|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2020272|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020273|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
2020274|NCT01362608|Hormones|hormones|mesh-ancestor
2020275|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2020276|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020277|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2020278|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
2020279|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020280|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020281|NCT01362686|Rivastigmine|rivastigmine|mesh-list
2020282|NCT01362686|Donepezil|donepezil|mesh-list
2020283|NCT01362686|Galantamine|galantamine|mesh-list
2020284|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2020285|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020286|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020287|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
2020288|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020289|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020290|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
2020291|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2020292|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
2020293|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020294|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2020295|NCT01362686|Protective Agents|protective agents|mesh-ancestor
2020296|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
2020297|NCT01362790|Pentostatin|pentostatin|mesh-list
2020298|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2020299|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2020300|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
2020301|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020302|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020303|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2020304|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
2020305|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020306|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020307|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2020308|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2020309|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020310|NCT01362959|Nicotine|nicotine|mesh-list
2020311|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2020312|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
2020313|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020314|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020315|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2020316|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2020317|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
2020318|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020319|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020320|NCT01363011|Darunavir|darunavir|mesh-list
2020321|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2020322|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2020323|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2020324|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
2020325|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020326|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020327|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2020328|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2020329|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
2020330|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2020331|NCT01363050|Ketorolac|ketorolac|mesh-list
2020332|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2020333|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2020334|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020335|NCT01363050|Analgesics|analgesics|mesh-ancestor
2020336|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
2020337|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020338|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020339|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020340|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020341|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2020342|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020343|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020344|NCT01363076|Ketorolac|ketorolac|mesh-list
2020345|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2020346|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2020347|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020348|NCT01363076|Analgesics|analgesics|mesh-ancestor
2020349|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
2020350|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020351|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020352|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020353|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020354|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2020355|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020356|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020357|NCT01363128|Cytarabine|cytarabine|mesh-list
2020358|NCT01363128|Dexamethasone|dexamethasone|mesh-list
2020359|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
2020360|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
2020361|NCT01363128|Doxorubicin|doxorubicin|mesh-list
2020362|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2020363|NCT01363128|Methotrexate|methotrexate|mesh-list
2020364|NCT01363128|Vincristine|vincristine|mesh-list
2020365|NCT01363128|Ofatumumab|ofatumumab|mesh-list
2020366|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2020367|NCT01363128|BB 1101|bb 1101|mesh-list
2020368|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2020369|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
2020370|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020371|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020372|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2020373|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
2020374|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020375|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020376|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2020377|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020378|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
2020379|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
2020380|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020381|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2020382|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
2020383|NCT01363128|Hormones|hormones|mesh-ancestor
2020384|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2020385|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2020386|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2020387|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2020388|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2020389|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020390|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2020391|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
2020392|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2020393|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2020394|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
2020395|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
2020396|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2020397|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2020398|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
2020399|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2020400|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2020401|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
2020402|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
2020403|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
2020404|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
2020405|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2020406|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2020407|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020408|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2020409|NCT01363349|Risperidone|risperidone|mesh-list
2020410|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2020411|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
2020412|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020413|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020414|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020415|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2020416|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2020417|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2020418|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2020419|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2020420|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
2020421|NCT01363440|Aflibercept|aflibercept|mesh-list
2020422|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2020423|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2020424|NCT01363440|Growth Substances|growth substances|mesh-ancestor
2020425|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020426|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
2020427|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020428|NCT01363479|Dexamethasone|dexamethasone|mesh-list
2020429|NCT01363479|Palonosetron|palonosetron|mesh-list
2020430|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020431|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
2020432|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
2020433|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020434|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020435|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2020436|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
2020437|NCT01363479|Hormones|hormones|mesh-ancestor
2020438|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2020439|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2020440|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020441|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2020442|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2020443|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
2020444|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020445|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020446|NCT01363661|Molsidomine|molsidomine|mesh-list
2020447|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
2020448|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2020449|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020450|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2020451|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2020452|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2020453|NCT01363700|Epinastine|epinastine|mesh-list
2020454|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2020455|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020456|NCT01363700|Analgesics|analgesics|mesh-ancestor
2020457|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
2020458|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020459|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020460|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020461|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020462|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2020463|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2020464|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2020465|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
2020466|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
2020467|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020468|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020469|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2020470|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2020471|NCT01363843|Leucovorin|leucovorin|mesh-list
2020472|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
2020473|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020474|NCT01363843|Antidotes|antidotes|mesh-ancestor
2020475|NCT01363843|Protective Agents|protective agents|mesh-ancestor
2020476|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020477|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
2020478|NCT01363843|Vitamins|vitamins|mesh-ancestor
2020479|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
2020480|NCT01363986|Trastuzumab|trastuzumab|mesh-list
2020481|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2020482|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020483|NCT01363999|Atorvastatin|atorvastatin|mesh-list
2020484|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
2020485|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2020486|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2020487|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
2020488|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020489|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2020490|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2020491|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020492|NCT01364090|Interferons|interferons|mesh-list
2020493|NCT01364090|Ribavirin|ribavirin|mesh-list
2020494|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
2020495|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
2020496|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2020497|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020498|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
2020499|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2020500|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
2020501|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020502|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
2020503|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020504|NCT01364259|Amifostine|amifostine|mesh-list
2020505|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2020506|NCT01364259|Protective Agents|protective agents|mesh-ancestor
2020507|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020508|NCT01364298|Pregabalin|pregabalin|mesh-list
2020509|NCT01364298|Gabapentin|gabapentin|mesh-list
2020510|NCT01364298|Analgesics|analgesics|mesh-ancestor
2020511|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
2020512|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020513|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020514|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
2020515|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2020516|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2020517|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020518|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2020519|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2020520|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2020521|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2020522|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2020523|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2020524|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2020525|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020526|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
2020527|NCT01364389|Prednisone|prednisone|mesh-list
2020528|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020529|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
2020530|NCT01364389|Hormones|hormones|mesh-ancestor
2020531|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2020532|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020533|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2020534|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020535|NCT01364428|Insulin|insulin|mesh-list
2020536|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2020537|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
2020538|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2020539|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020540|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
2020541|NCT01364467|Guaifenesin|guaifenesin|mesh-list
2020542|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2020543|NCT01364467|Expectorants|expectorants|mesh-ancestor
2020544|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
2020545|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2020546|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2020547|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
2020548|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020549|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020550|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020551|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
2020552|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2020553|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
2020554|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
2020555|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020556|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
2020557|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2020558|NCT01364558|Diazepam|diazepam|mesh-list
2020559|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2020560|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
2020561|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
2020562|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
2020563|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020564|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020565|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2020566|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2020567|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2020568|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2020569|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2020570|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2020571|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2020572|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2020573|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2020574|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
2020575|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
2020576|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
2020577|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
2020578|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020579|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020580|NCT01364584|Exenatide|exenatide|mesh-list
2020581|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2020582|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020583|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2020584|NCT01364584|Incretins|incretins|mesh-ancestor
2020585|NCT01364584|Hormones|hormones|mesh-ancestor
2020586|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2020587|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
2020588|NCT01364623|Testosterone|testosterone|mesh-list
2020589|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
2020590|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
2020591|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2020592|NCT01364623|Androgens|androgens|mesh-ancestor
2020593|NCT01364623|Hormones|hormones|mesh-ancestor
2020594|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2020595|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020596|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2020597|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020598|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
2020599|NCT01364649|Vortioxetine|vortioxetine|mesh-list
2020600|NCT01364649|Citalopram|citalopram|mesh-list
2020601|NCT01364649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2020602|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2020603|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2020604|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020605|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020606|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
2020607|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020608|NCT01364649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2020609|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
2020610|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2020611|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2020612|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2020613|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2020614|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2020615|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2020616|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2020617|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2020618|NCT01364727|Amrubicin|amrubicin|mesh-list
2020619|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020620|NCT01364922|Acetaminophen|acetaminophen|mesh-list
2020621|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2020622|NCT01364922|Hydrocodone|hydrocodone|mesh-list
2020623|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020624|NCT01364922|Analgesics|analgesics|mesh-ancestor
2020625|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
2020626|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020627|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020628|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
2020629|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2020630|NCT01364922|Narcotics|narcotics|mesh-ancestor
2020631|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2020632|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
2020633|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
2020634|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2020635|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020636|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020637|NCT01365052|Naproxen|naproxen|mesh-list
2020638|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2020639|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020640|NCT01365052|Analgesics|analgesics|mesh-ancestor
2020641|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
2020642|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020643|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020644|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020645|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020646|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
2020647|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2020648|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020649|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020650|NCT01365091|Metformin|metformin|mesh-list
2020651|NCT01365091|Saxagliptin|saxagliptin|mesh-list
2020652|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2020653|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020654|NCT01365091|Incretins|incretins|mesh-ancestor
2020655|NCT01365091|Hormones|hormones|mesh-ancestor
2020656|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2020657|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2020658|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
2020659|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020660|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020661|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2020662|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
2020663|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020664|NCT01365468|Everolimus|everolimus|mesh-list
2020665|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020666|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2020667|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
2020668|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020669|NCT01365481|Amlodipine|amlodipine|mesh-list
2020670|NCT01365481|Valsartan|valsartan|mesh-list
2020671|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2020672|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2020673|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2020674|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2020675|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020676|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2020677|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020678|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
2020679|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2020680|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2020681|NCT01365481|Diuretics|diuretics|mesh-ancestor
2020682|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
2020683|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2020684|NCT01365507|Insulin|insulin|mesh-list
2020685|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
2020686|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2020687|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020688|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
2020689|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020690|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
2020691|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2020692|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2020693|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020694|NCT01365585|Urological Agents|urological agents|mesh-ancestor
2020695|NCT01365611|Fluticasone|fluticasone|mesh-list
2020696|NCT01365611|Xhance|xhance|mesh-list
2020697|NCT01365611|Ketorolac|ketorolac|mesh-list
2020698|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2020699|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020700|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2020701|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
2020702|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020703|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020704|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2020705|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
2020706|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
2020707|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2020708|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2020709|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020710|NCT01365611|Analgesics|analgesics|mesh-ancestor
2020711|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
2020712|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020713|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2020714|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020715|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020716|NCT01365624|Ketorolac|ketorolac|mesh-list
2020717|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2020718|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2020719|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020720|NCT01365624|Analgesics|analgesics|mesh-ancestor
2020721|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
2020722|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020723|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020724|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020725|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020726|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2020727|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020728|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020729|NCT01365650|Fluticasone|fluticasone|mesh-list
2020730|NCT01365650|Xhance|xhance|mesh-list
2020731|NCT01365650|Ketorolac|ketorolac|mesh-list
2020732|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2020733|NCT01365650|Phenylephrine|phenylephrine|mesh-list
2020734|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
2020735|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020736|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2020737|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
2020738|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020739|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020740|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2020741|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
2020742|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
2020743|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2020744|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2020745|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020746|NCT01365650|Analgesics|analgesics|mesh-ancestor
2020747|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
2020748|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020749|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2020750|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020751|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020752|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2020753|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2020754|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
2020755|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020756|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
2020757|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
2020758|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2020759|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2020760|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
2020761|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2020762|NCT01365650|Protective Agents|protective agents|mesh-ancestor
2020763|NCT01365819|Varenicline|varenicline|mesh-list
2020764|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2020765|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2020766|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
2020767|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020768|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020769|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020770|NCT01366092|Interleukin-2|interleukin-2|mesh-list
2020771|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020772|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020773|NCT01366092|Analgesics|analgesics|mesh-ancestor
2020774|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
2020775|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020776|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020777|NCT01366196|Pregabalin|pregabalin|mesh-list
2020778|NCT01366196|Analgesics|analgesics|mesh-ancestor
2020779|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
2020780|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020781|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020782|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
2020783|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2020784|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2020785|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020786|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2020787|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2020788|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2020789|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2020790|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2020791|NCT01366209|Pirfenidone|pirfenidone|mesh-list
2020792|NCT01366209|Analgesics|analgesics|mesh-ancestor
2020793|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
2020794|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020795|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020796|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2020797|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020798|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020799|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020800|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020801|NCT01366534|Vaccines|vaccines|mesh-list
2020802|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
2020803|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020804|NCT01366638|Ribavirin|ribavirin|mesh-list
2020805|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2020806|NCT01366638|Simeprevir|simeprevir|mesh-list
2020807|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
2020808|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020809|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
2020810|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2020811|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
2020812|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020813|NCT01366885|Vitamin D|vitamin d|mesh-list
2020814|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
2020815|NCT01366885|Vitamins|vitamins|mesh-ancestor
2020816|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
2020817|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020818|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2020819|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2020820|NCT01366976|Acetaminophen|acetaminophen|mesh-list
2020821|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020822|NCT01366976|Analgesics|analgesics|mesh-ancestor
2020823|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
2020824|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020825|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020826|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
2020827|NCT01367119|Ketamine|ketamine|mesh-list
2020828|NCT01367119|Methohexital|methohexital|mesh-list
2020829|NCT01367119|Analgesics|analgesics|mesh-ancestor
2020830|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
2020831|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020832|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020833|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2020834|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2020835|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
2020836|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
2020837|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2020838|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2020839|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2020840|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020841|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020842|NCT01367158|Vaccines|vaccines|mesh-list
2020843|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
2020844|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020845|NCT01367249|Bromfenac|bromfenac|mesh-list
2020846|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2020847|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2020848|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2020849|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2020850|NCT01367249|Analgesics|analgesics|mesh-ancestor
2020851|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
2020852|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020853|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020854|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2020855|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2020856|NCT01367275|Irinotecan|irinotecan|mesh-list
2020857|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2020858|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2020859|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020860|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020861|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020862|NCT01367457|Sirolimus|sirolimus|mesh-list
2020863|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2020864|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2020865|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2020866|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020867|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
2020868|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2020869|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
2020870|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020871|NCT01367834|Hormones|hormones|mesh-list
2020872|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2020873|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020874|NCT01367886|Fesoterodine|fesoterodine|mesh-list
2020875|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2020876|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2020877|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
2020878|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020879|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020880|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020881|NCT01367886|Urological Agents|urological agents|mesh-ancestor
2020882|NCT01368081|Metformin|metformin|mesh-list
2020883|NCT01368081|Empagliflozin|empagliflozin|mesh-list
2020884|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2020885|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020886|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2020887|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020888|NCT01368263|Letrozole|letrozole|mesh-list
2020889|NCT01368263|Anastrozole|anastrozole|mesh-list
2020890|NCT01368263|Goserelin|goserelin|mesh-list
2020891|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020892|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2020893|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2020894|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2020895|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020896|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2020897|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
2020898|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2020899|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020900|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2020901|NCT01368276|Molgramostim|molgramostim|mesh-list
2020902|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2020903|NCT01368276|Sargramostim|sargramostim|mesh-list
2020904|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
2020905|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020906|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020907|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2020908|NCT01368432|Citalopram|citalopram|mesh-list
2020909|NCT01368432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2020910|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2020911|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2020912|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020913|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020914|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
2020915|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020916|NCT01368432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2020917|NCT01368432|Antidepressive Agents|antidepressive agents|mesh-ancestor
2020918|NCT01368432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2020919|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2020920|NCT01368497|Entecavir|entecavir|mesh-list
2020921|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
2020922|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2020923|NCT01368536|Amlodipine|amlodipine|mesh-list
2020924|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
2020925|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2020926|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2020927|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2020928|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020929|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2020930|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020931|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
2020932|NCT01368536|Diuretics|diuretics|mesh-ancestor
2020933|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
2020934|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2020935|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
2020936|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2020937|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020938|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
2020939|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020940|NCT01368653|Nicotine|nicotine|mesh-list
2020941|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2020942|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
2020943|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020944|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020945|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2020946|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2020947|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
2020948|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2020949|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020950|NCT01368809|Fentanyl|fentanyl|mesh-list
2020951|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2020952|NCT01368809|Narcotics|narcotics|mesh-ancestor
2020953|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2020954|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020955|NCT01368809|Analgesics|analgesics|mesh-ancestor
2020956|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
2020957|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2020958|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2020959|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2020960|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
2020961|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
2020962|NCT01369069|Insulin|insulin|mesh-list
2020963|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2020964|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2020965|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020966|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2020967|NCT01369199|Entecavir|entecavir|mesh-list
2020968|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
2020969|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2020970|NCT01369329|Ustekinumab|ustekinumab|mesh-list
2020971|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
2020972|NCT01369342|Ustekinumab|ustekinumab|mesh-list
2020973|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
2020974|NCT01369355|Ustekinumab|ustekinumab|mesh-list
2020975|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
2020976|NCT01369433|Sirolimus|sirolimus|mesh-list
2020977|NCT01369433|Paclitaxel|paclitaxel|mesh-list
2020978|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2020979|NCT01369433|Capecitabine|capecitabine|mesh-list
2020980|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2020981|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2020982|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
2020983|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
2020984|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
2020985|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2020986|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2020987|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
2020988|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2020989|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2020990|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2020991|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
2020992|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2020993|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
2020994|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020995|NCT01369485|Caffeine|caffeine|mesh-list
2020996|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2020997|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2020998|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2020999|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021000|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021001|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2021002|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2021003|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
2021004|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021005|NCT01369615|Oxycodone|oxycodone|mesh-list
2021006|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2021007|NCT01369615|Narcotics|narcotics|mesh-ancestor
2021008|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2021009|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021010|NCT01369615|Analgesics|analgesics|mesh-ancestor
2021011|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
2021012|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021013|NCT01369680|Ketamine|ketamine|mesh-list
2021014|NCT01369680|Analgesics|analgesics|mesh-ancestor
2021015|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
2021016|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021017|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021018|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2021019|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2021020|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
2021021|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
2021022|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2021023|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2021024|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2021025|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021026|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021027|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
2021028|NCT01369732|Hematinics|hematinics|mesh-ancestor
2021029|NCT01369745|Prednisone|prednisone|mesh-list
2021030|NCT01369745|Prednisolone|prednisolone|mesh-list
2021031|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2021032|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
2021033|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2021034|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
2021035|NCT01369745|Dipyridamole|dipyridamole|mesh-list
2021036|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2021037|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
2021038|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2021039|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
2021040|NCT01369745|Hormones|hormones|mesh-ancestor
2021041|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021042|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021043|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2021044|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021045|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
2021046|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
2021047|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021048|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2021049|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2021050|NCT01369745|Protective Agents|protective agents|mesh-ancestor
2021051|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2021052|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021053|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021054|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2021055|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
2021056|NCT01369849|Rituximab|rituximab|mesh-list
2021057|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2021058|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2021059|NCT01369849|Antibodies|antibodies|mesh-list
2021060|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
2021061|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2021062|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
2021063|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021064|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021065|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2021066|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2021067|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
2021068|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021069|NCT01369875|Aldesleukin|aldesleukin|mesh-list
2021070|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
2021071|NCT01369875|Fludarabine|fludarabine|mesh-list
2021072|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2021073|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
2021074|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021075|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2021076|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2021077|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
2021078|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021079|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021080|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2021081|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2021082|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2021083|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
2021084|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021085|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
2021086|NCT01369888|Fludarabine|fludarabine|mesh-list
2021087|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2021088|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
2021089|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021090|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2021091|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2021092|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
2021093|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021094|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021095|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2021096|NCT01370005|Empagliflozin|empagliflozin|mesh-list
2021097|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2021098|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021099|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2021100|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021101|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
2021102|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2021103|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021104|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021105|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2021106|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2021107|NCT01370213|Interleukin-2|interleukin-2|mesh-list
2021108|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2021109|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021110|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2021111|NCT01370213|Analgesics|analgesics|mesh-ancestor
2021112|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
2021113|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021114|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021115|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
2021116|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2021117|NCT01370265|Adenosine|adenosine|mesh-list
2021118|NCT01370265|Regadenoson|regadenoson|mesh-list
2021119|NCT01370265|Analgesics|analgesics|mesh-ancestor
2021120|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
2021121|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021122|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021123|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2021124|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
2021125|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2021126|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
2021127|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
2021128|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021129|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021130|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2021131|NCT01370356|Varenicline|varenicline|mesh-list
2021132|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2021133|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2021134|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
2021135|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021136|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021137|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021138|NCT01370369|Testosterone|testosterone|mesh-list
2021139|NCT01370369|Androgens|androgens|mesh-ancestor
2021140|NCT01370369|Hormones|hormones|mesh-ancestor
2021141|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021142|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021143|NCT01370408|Dexamethasone|dexamethasone|mesh-list
2021144|NCT01370408|Ondansetron|ondansetron|mesh-list
2021145|NCT01370408|Palonosetron|palonosetron|mesh-list
2021146|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2021147|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
2021148|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
2021149|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021150|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021151|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2021152|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
2021153|NCT01370408|Hormones|hormones|mesh-ancestor
2021154|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021155|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2021156|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021157|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
2021158|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
2021159|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2021160|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
2021161|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021162|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021163|NCT01370408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2021164|NCT01370408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2021165|NCT01370408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2021166|NCT01370408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2021167|NCT01370408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2021168|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2021169|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
2021170|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2021171|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2021172|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021173|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
2021174|NCT01370460|Coagulants|coagulants|mesh-ancestor
2021175|NCT01370499|Serotonin|serotonin|mesh-list
2021176|NCT01370499|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2021177|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2021178|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
2021179|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021180|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021181|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021182|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2021183|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2021184|NCT01370525|Esomeprazole|esomeprazole|mesh-list
2021185|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2021186|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2021187|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2021188|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021189|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021190|NCT01370538|Esomeprazole|esomeprazole|mesh-list
2021191|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2021192|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2021193|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2021194|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021195|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021196|NCT01370564|Diuretics|diuretics|mesh-list
2021197|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
2021198|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021199|NCT01370590|Atorvastatin|atorvastatin|mesh-list
2021200|NCT01370590|Ezetimibe|ezetimibe|mesh-list
2021201|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2021202|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2021203|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
2021204|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021205|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2021206|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2021207|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021208|NCT01370603|Atorvastatin|atorvastatin|mesh-list
2021209|NCT01370603|Ezetimibe|ezetimibe|mesh-list
2021210|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2021211|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2021212|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
2021213|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021214|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2021215|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2021216|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021217|NCT01370616|Amoxicillin|amoxicillin|mesh-list
2021218|NCT01370616|Tazobactam|tazobactam|mesh-list
2021219|NCT01370616|Piperacillin|piperacillin|mesh-list
2021220|NCT01370616|Ertapenem|ertapenem|mesh-list
2021221|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2021222|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2021223|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021224|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2021225|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021226|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021227|NCT01370642|Ribavirin|ribavirin|mesh-list
2021228|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
2021229|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021230|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
2021231|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021232|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2021233|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2021234|NCT01370655|Diuretics|diuretics|mesh-ancestor
2021235|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
2021236|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021237|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2021238|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2021239|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021240|NCT01370694|Prednisolone|prednisolone|mesh-list
2021241|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
2021242|NCT01370694|Vincristine|vincristine|mesh-list
2021243|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2021244|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
2021245|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021246|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2021247|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2021248|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
2021249|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021250|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021251|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2021252|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2021253|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
2021254|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
2021255|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
2021256|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2021257|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
2021258|NCT01370694|Hormones|hormones|mesh-ancestor
2021259|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021260|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2021261|NCT01371110|Midazolam|midazolam|mesh-list
2021262|NCT01371110|Ketamine|ketamine|mesh-list
2021263|NCT01371110|Analgesics|analgesics|mesh-ancestor
2021264|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
2021265|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021266|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021267|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2021268|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2021269|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
2021270|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
2021271|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2021272|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2021273|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2021274|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021275|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021276|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2021277|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2021278|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2021279|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2021280|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2021281|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
2021282|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
2021283|NCT01371565|Mifepristone|mifepristone|mesh-list
2021284|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2021285|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
2021286|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2021287|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021288|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2021289|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2021290|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2021291|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
2021292|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2021293|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2021294|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
2021295|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021296|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
2021297|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2021298|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2021299|NCT01371643|Octreotide|octreotide|mesh-list
2021300|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2021301|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2021302|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021303|NCT01371656|Levofloxacin|levofloxacin|mesh-list
2021304|NCT01371656|Ofloxacin|ofloxacin|mesh-list
2021305|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2021306|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021307|NCT01371656|Renal Agents|renal agents|mesh-ancestor
2021308|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2021309|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2021310|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2021311|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021312|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021313|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021314|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2021315|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2021316|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2021317|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2021318|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2021319|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2021320|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021321|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021322|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021323|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
2021324|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2021325|NCT01371747|Losartan|losartan|mesh-list
2021326|NCT01371747|Spironolactone|spironolactone|mesh-list
2021327|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2021328|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2021329|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2021330|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2021331|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021332|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2021333|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
2021334|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021335|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021336|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2021337|NCT01371747|Diuretics|diuretics|mesh-ancestor
2021338|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
2021339|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
2021340|NCT01371786|Ciclesonide|ciclesonide|mesh-list
2021341|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2021342|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
2021343|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2021344|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
2021345|NCT01371786|Hormones|hormones|mesh-ancestor
2021346|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021347|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021348|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
2021349|NCT01371838|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2021350|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2021351|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021352|NCT01371851|Doxazosin|doxazosin|mesh-list
2021353|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2021354|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2021355|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2021356|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2021357|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
2021358|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021359|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021360|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021361|NCT01371877|Vitamin D|vitamin d|mesh-list
2021362|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
2021363|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
2021364|NCT01371877|Vitamins|vitamins|mesh-list
2021365|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
2021366|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021367|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2021368|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2021401|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
2021402|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2021403|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2021404|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
2021405|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021406|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021407|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021408|NCT01371994|Urological Agents|urological agents|mesh-ancestor
2021409|NCT01372150|Fluoxetine|fluoxetine|mesh-list
2021410|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2021411|NCT01372150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2021412|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2021413|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2021414|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021415|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021416|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
2021417|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021418|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2021419|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
2021420|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2021421|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2021422|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2021423|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021424|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2021425|NCT01372202|Paclitaxel|paclitaxel|mesh-list
2021426|NCT01372202|Fluorouracil|fluorouracil|mesh-list
2021427|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
2021428|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2021429|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021430|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
2021431|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
2021432|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
2021433|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021434|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
2021435|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2021436|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2021437|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
2021438|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021439|NCT01372254|Nicotine|nicotine|mesh-list
2021440|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2021441|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
2021442|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021443|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021444|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2021445|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2021446|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
2021447|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021448|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021449|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2021450|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021451|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2021452|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021453|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021454|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
2021455|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2021456|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
2021457|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021458|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021459|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2021460|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
2021461|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
2021462|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2021463|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
2021464|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021465|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021466|NCT01372995|Vitamin D|vitamin d|mesh-list
2021467|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
2021468|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
2021469|NCT01372995|Vitamins|vitamins|mesh-list
2021470|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
2021471|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021472|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2021473|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2021474|NCT01373164|Gemcitabine|gemcitabine|mesh-list
2021475|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2021476|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
2021477|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021478|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021479|NCT01373164|Antiviral Agents|antiviral agents|mesh-ancestor
2021480|NCT01373164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021481|NCT01373164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021482|NCT01373164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2021483|NCT01373164|Immunologic Factors|immunologic factors|mesh-ancestor
2021484|NCT01373164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021485|NCT01373229|Plerixafor|plerixafor|mesh-list
2021486|NCT01373229|Rituximab|rituximab|mesh-list
2021487|NCT01373229|Lenalidomide|lenalidomide|mesh-list
2021488|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2021489|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021490|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
2021491|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021492|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2021493|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2021494|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2021495|NCT01373229|Growth Substances|growth substances|mesh-ancestor
2021496|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
2021497|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2021498|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2021499|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
2021500|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021501|NCT01373281|Vaccines|vaccines|mesh-list
2021502|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
2021503|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021504|NCT01373294|Lenalidomide|lenalidomide|mesh-list
2021505|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
2021506|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
2021507|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021508|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2021509|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2021510|NCT01373294|Growth Substances|growth substances|mesh-ancestor
2021511|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
2021512|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021513|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2021514|NCT01373450|Liraglutide|liraglutide|mesh-list
2021515|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2021516|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021517|NCT01373450|Incretins|incretins|mesh-ancestor
2021518|NCT01373450|Hormones|hormones|mesh-ancestor
2021519|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021520|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2021521|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2021522|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2021523|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2021524|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
2021525|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2021526|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2021527|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021528|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2021529|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2021530|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021531|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021532|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021533|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2021534|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
2021535|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2021536|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021537|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2021538|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2021539|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2021540|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2021541|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
2021542|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2021543|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
2021544|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2021545|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021546|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2021547|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2021548|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021549|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
2021550|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2021551|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021552|NCT01374217|Clarithromycin|clarithromycin|mesh-list
2021553|NCT01374217|Dexamethasone|dexamethasone|mesh-list
2021554|NCT01374217|Lenalidomide|lenalidomide|mesh-list
2021555|NCT01374217|Tadalafil|tadalafil|mesh-list
2021556|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2021557|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
2021558|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
2021559|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021560|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021561|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2021562|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
2021563|NCT01374217|Hormones|hormones|mesh-ancestor
2021564|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021565|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2021566|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021567|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
2021568|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2021569|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2021570|NCT01374217|Growth Substances|growth substances|mesh-ancestor
2021571|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
2021572|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2021573|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021574|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2021575|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021576|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021577|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2021578|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2021579|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
2021580|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2021581|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2021582|NCT01374217|Urological Agents|urological agents|mesh-ancestor
2021583|NCT01374269|Acetaminophen|acetaminophen|mesh-list
2021584|NCT01374269|Celecoxib|celecoxib|mesh-list
2021585|NCT01374269|Naproxen|naproxen|mesh-list
2021586|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2021587|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2021588|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2021589|NCT01374269|Analgesics|analgesics|mesh-ancestor
2021590|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
2021591|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021592|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021593|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
2021594|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2021595|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2021596|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2021597|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021598|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021599|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
2021600|NCT01374425|Leucovorin|leucovorin|mesh-list
2021601|NCT01374425|Bevacizumab|bevacizumab|mesh-list
2021602|NCT01374425|Fluorouracil|fluorouracil|mesh-list
2021603|NCT01374425|Capecitabine|capecitabine|mesh-list
2021604|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
2021605|NCT01374425|Irinotecan|irinotecan|mesh-list
2021606|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2021607|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021608|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2021609|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2021610|NCT01374425|Growth Substances|growth substances|mesh-ancestor
2021611|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021612|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
2021613|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
2021614|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021615|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2021616|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2021617|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
2021618|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2021619|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2021620|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021621|NCT01374425|Antidotes|antidotes|mesh-ancestor
2021622|NCT01374425|Protective Agents|protective agents|mesh-ancestor
2021623|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
2021624|NCT01374425|Vitamins|vitamins|mesh-ancestor
2021625|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
2021626|NCT01374451|Everolimus|everolimus|mesh-list
2021627|NCT01374451|Pasireotide|pasireotide|mesh-list
2021628|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021629|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2021630|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
2021631|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021632|NCT01374451|Hormones|hormones|mesh-ancestor
2021633|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021634|NCT01374516|Vaccines|vaccines|mesh-list
2021635|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
2021636|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021637|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2021638|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2021639|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021640|NCT01374568|Incretins|incretins|mesh-ancestor
2021641|NCT01374568|Hormones|hormones|mesh-ancestor
2021642|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021643|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2021644|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
2021645|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021646|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021647|NCT01374802|Ritonavir|ritonavir|mesh-list
2021648|NCT01374802|Darunavir|darunavir|mesh-list
2021649|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2021650|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2021651|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
2021652|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021653|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021654|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2021655|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2021656|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
2021657|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021658|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2021659|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2021660|NCT01374906|Pasireotide|pasireotide|mesh-list
2021661|NCT01374906|Hormones|hormones|mesh-ancestor
2021662|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021663|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021664|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2021665|NCT01374919|Hematinics|hematinics|mesh-ancestor
2021666|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2021667|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2021668|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
2021669|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2021670|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
2021671|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021672|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2021673|NCT01375010|Vitamin D|vitamin d|mesh-list
2021674|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
2021675|NCT01375010|Vitamins|vitamins|mesh-list
2021676|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
2021677|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021678|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2021679|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2021680|NCT01375049|Aztreonam|aztreonam|mesh-list
2021681|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2021682|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021683|NCT01375075|Atorvastatin|atorvastatin|mesh-list
2021684|NCT01375075|Evacetrapib|evacetrapib|mesh-list
2021685|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2021686|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2021687|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
2021688|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021689|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2021690|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2021691|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021692|NCT01375127|Tofacitinib|tofacitinib|mesh-list
2021693|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2021694|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021695|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021696|NCT01375140|Prednisone|prednisone|mesh-list
2021697|NCT01375140|Lenalidomide|lenalidomide|mesh-list
2021698|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2021699|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
2021700|NCT01375140|Hormones|hormones|mesh-ancestor
2021701|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021702|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021703|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2021704|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021705|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
2021706|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2021707|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2021708|NCT01375140|Growth Substances|growth substances|mesh-ancestor
2021709|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
2021710|NCT01375374|Lacosamide|lacosamide|mesh-list
2021711|NCT01375374|Levetiracetam|levetiracetam|mesh-list
2021712|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
2021713|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
2021714|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2021715|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2021716|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2021717|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021718|NCT01375491|Doxycycline|doxycycline|mesh-list
2021719|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2021720|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021721|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
2021722|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2021723|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2021724|NCT01375608|Decitabine|decitabine|mesh-list
2021725|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2021726|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
2021727|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021728|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021729|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021730|NCT01375660|Vitamin D|vitamin d|mesh-list
2021731|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
2021732|NCT01375660|Vitamins|vitamins|mesh-ancestor
2021733|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
2021734|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021735|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2021736|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2021737|NCT01375751|Evolocumab|evolocumab|mesh-list
2021738|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2021739|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2021740|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
2021741|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021742|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2021743|NCT01375764|Ezetimibe|ezetimibe|mesh-list
2021744|NCT01375764|Evolocumab|evolocumab|mesh-list
2021745|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2021746|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2021747|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2021748|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
2021749|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021750|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2021751|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
2021752|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021753|NCT01375777|Ezetimibe|ezetimibe|mesh-list
2021754|NCT01375777|Evolocumab|evolocumab|mesh-list
2021755|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2021756|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2021757|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2021758|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
2021759|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021760|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2021761|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
2021762|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021763|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
2021764|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2021765|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746172|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2746173|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746174|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2746175|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
2746176|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746177|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021773|NCT01376167|Chloroquine|chloroquine|mesh-list
2021774|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2021775|NCT01376167|Primaquine|primaquine|mesh-list
2021776|NCT01376167|Tafenoquine|tafenoquine|mesh-list
2021777|NCT01376167|Amebicides|amebicides|mesh-ancestor
2021778|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2021779|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2021780|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021781|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
2021782|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2021783|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2021784|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2021785|NCT01376167|Analgesics|analgesics|mesh-ancestor
2021786|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
2021787|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021788|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021789|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2021790|NCT01376167|Filaricides|filaricides|mesh-ancestor
2021791|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
2021792|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
2021793|NCT01376245|Fluticasone|fluticasone|mesh-list
2021794|NCT01376245|Xhance|xhance|mesh-list
2021795|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2021796|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2021797|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
2021798|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021799|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021800|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2021801|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
2021802|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
2021803|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2021804|NCT01376297|Dexamethasone|dexamethasone|mesh-list
2021805|NCT01376297|Aprepitant|aprepitant|mesh-list
2021806|NCT01376297|Palonosetron|palonosetron|mesh-list
2021807|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2021808|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
2021809|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
2021810|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021811|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021812|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2021813|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
2021814|NCT01376297|Hormones|hormones|mesh-ancestor
2021815|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021816|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2021817|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021818|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2021819|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021820|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021821|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2021822|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2021823|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
2021824|NCT01376310|Gemcitabine|gemcitabine|mesh-list
2021825|NCT01376310|Paclitaxel|paclitaxel|mesh-list
2021826|NCT01376310|Docetaxel|docetaxel|mesh-list
2021827|NCT01376310|Carboplatin|carboplatin|mesh-list
2021828|NCT01376310|Pemetrexed|pemetrexed|mesh-list
2021829|NCT01376310|Everolimus|everolimus|mesh-list
2021830|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2021831|NCT01376310|Trametinib|trametinib|mesh-list
2021832|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2021833|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021834|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
2021835|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
2021836|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
2021837|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021838|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2021839|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
2021840|NCT01376310|Antiviral Agents|antiviral agents|mesh-ancestor
2021841|NCT01376310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021842|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021843|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2021844|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
2021845|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021846|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2021847|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2021848|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2746178|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
2746179|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746180|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2746181|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2746182|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
2746183|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2746184|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2746185|NCT00950989|Hematinics|hematinics|mesh-ancestor
2746186|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
2746187|NCT00950989|Vitamins|vitamins|mesh-ancestor
2021859|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2021860|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2021861|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
2021862|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021863|NCT01376362|Interferons|interferons|mesh-list
2021864|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
2021865|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021866|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
2021867|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021868|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2021869|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2021870|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021871|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2021872|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021873|NCT01376700|Factor VIII|factor viii|mesh-list
2021874|NCT01376700|Coagulants|coagulants|mesh-ancestor
2021875|NCT01376804|Valganciclovir|valganciclovir|mesh-list
2021876|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
2021877|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021878|NCT01377194|Milnacipran|milnacipran|mesh-list
2021879|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
2021880|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2021881|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2021882|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2021883|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021884|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021885|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746188|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
2021886|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
2021887|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2021888|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2021889|NCT01377194|Analgesics|analgesics|mesh-ancestor
2021890|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
2021891|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021892|NCT01377389|Ipilimumab|ipilimumab|mesh-list
2021893|NCT01377389|Leuprolide|leuprolide|mesh-list
2021894|NCT01377389|Goserelin|goserelin|mesh-list
2021895|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2021896|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2021897|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2021898|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021899|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2021900|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
2021901|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2021902|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021903|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2021904|NCT01377467|Denosumab|denosumab|mesh-list
2021905|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2021906|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021907|NCT01377480|Posaconazole|posaconazole|mesh-list
2021908|NCT01377480|Benzonidazole|benzonidazole|mesh-list
2021909|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
2021910|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021911|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2021912|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2021913|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2021914|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2021915|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2021916|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021917|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021918|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2021919|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
2021920|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021921|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021922|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2021923|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
2021924|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
2021925|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2021926|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2021927|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021928|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2021929|NCT01377623|Analgesics|analgesics|mesh-ancestor
2021930|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
2021931|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021932|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2021933|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2021934|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2021935|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
2021936|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021937|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021938|NCT01377636|Isoproterenol|isoproterenol|mesh-list
2021939|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2021940|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2021941|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
2021942|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2021943|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021944|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021945|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2021946|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
2021947|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021948|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2021949|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
2021950|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2021951|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
2021952|NCT01377636|Protective Agents|protective agents|mesh-ancestor
2021953|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
2021954|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2021955|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021956|NCT01377922|Amifampridine|amifampridine|mesh-list
2021957|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2021958|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2021959|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021960|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2021961|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2021962|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021963|NCT01377987|Acetazolamide|acetazolamide|mesh-list
2021964|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
2021965|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2021966|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021967|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021968|NCT01377987|Diuretics|diuretics|mesh-ancestor
2021969|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
2021970|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021971|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2021972|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
2021973|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
2021974|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2021975|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
2021976|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021977|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
2021978|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2021979|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
2021980|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2021981|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2021982|NCT01378117|Incretins|incretins|mesh-ancestor
2021983|NCT01378117|Hormones|hormones|mesh-ancestor
2021984|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021985|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2021986|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
2021987|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2021988|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2021989|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
2021990|NCT01378273|Hematinics|hematinics|mesh-ancestor
2021991|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
2021992|NCT01378299|Testosterone|testosterone|mesh-list
2021993|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
2021994|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
2021995|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2021996|NCT01378299|Androgens|androgens|mesh-ancestor
2021997|NCT01378299|Hormones|hormones|mesh-ancestor
2021998|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2021999|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022000|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2022001|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022002|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
2022003|NCT01378325|Phenylephrine|phenylephrine|mesh-list
2022004|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
2022005|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2022006|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
2022007|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
2022008|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022009|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022010|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
2022011|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2022012|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
2022013|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
2022014|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2022015|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2022016|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2022017|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
2022018|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022019|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022020|NCT01378325|Protective Agents|protective agents|mesh-ancestor
2022021|NCT01378377|Niacinamide|niacinamide|mesh-list
2022022|NCT01378377|Sirolimus|sirolimus|mesh-list
2022023|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2022024|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022025|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2022026|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022027|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
2022028|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2022029|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
2022030|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022031|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
2022032|NCT01378377|Vitamins|vitamins|mesh-ancestor
2022033|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
2022034|NCT01378416|Decitabine|decitabine|mesh-list
2022035|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2022036|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
2022037|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022038|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022039|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022040|NCT01378429|Ciclesonide|ciclesonide|mesh-list
2022041|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
2022042|NCT01378429|Hormones|hormones|mesh-ancestor
2022043|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022044|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022045|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2022046|NCT01378520|Ketoconazole|ketoconazole|mesh-list
2022047|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
2022048|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022049|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2022050|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2022051|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022052|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022053|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2022054|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
2022055|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022056|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022057|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2022058|NCT01378858|Varenicline|varenicline|mesh-list
2022059|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2022060|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2022061|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
2022062|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022063|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022064|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022065|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2022066|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022067|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2022068|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022069|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022070|NCT01378975|Vemurafenib|vemurafenib|mesh-list
2022071|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022072|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2022073|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022074|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022075|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
2022076|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2022077|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2022078|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022079|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2022080|NCT01378988|Analgesics|analgesics|mesh-ancestor
2022081|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
2022082|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022083|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2022084|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2022085|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2022086|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
2022087|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022088|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022089|NCT01379183|Erythromycin|erythromycin|mesh-list
2022090|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
2022091|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2022092|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
2022093|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2022094|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022095|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2022096|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2022097|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022098|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022099|NCT01379508|Tenofovir|tenofovir|mesh-list
2022100|NCT01379508|Telbivudine|telbivudine|mesh-list
2022101|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
2022102|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022103|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2022104|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2022105|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022106|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022107|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2746189|NCT00904046|Pioglitazone|pioglitazone|mesh-list
2022108|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2022109|NCT01379521|Everolimus|everolimus|mesh-list
2022110|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022111|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2022112|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
2022113|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022114|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
2022115|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
2022116|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2022117|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2022118|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022119|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022120|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022121|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2022122|NCT01379664|Sevoflurane|sevoflurane|mesh-list
2022123|NCT01379664|Isoflurane|isoflurane|mesh-list
2022124|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2022125|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2022126|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
2022127|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
2022128|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2022129|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022130|NCT01379937|Vaccines|vaccines|mesh-list
2022131|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
2022132|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022133|NCT01380080|Efavirenz|efavirenz|mesh-list
2022134|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2022135|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2022136|NCT01380080|Rifampin|rifampin|mesh-list
2022137|NCT01380080|Isoniazid|isoniazid|mesh-list
2022138|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
2022139|NCT01380080|Ethambutol|ethambutol|mesh-list
2022140|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
2022141|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2022142|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2022143|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022144|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022145|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
2022146|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022147|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2022148|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2022149|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2022150|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2022151|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2022152|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2022153|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2022154|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2022155|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2022156|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
2022157|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2022158|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
2022159|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2022160|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2022161|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2022162|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2022163|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2022164|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
2022165|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2022166|NCT01380093|Naltrexone|naltrexone|mesh-list
2022167|NCT01380093|Morphine|morphine|mesh-list
2022168|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2022169|NCT01380093|Narcotics|narcotics|mesh-ancestor
2022170|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2022171|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022172|NCT01380093|Analgesics|analgesics|mesh-ancestor
2022173|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
2022174|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022175|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2022176|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2022177|NCT01380106|Lenalidomide|lenalidomide|mesh-list
2022178|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
2022179|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022180|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2022181|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2022182|NCT01380106|Growth Substances|growth substances|mesh-ancestor
2022183|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
2022184|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022185|NCT01380184|Sirolimus|sirolimus|mesh-list
2022186|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2022187|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022188|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2022189|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022190|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
2022191|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2022192|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
2022193|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022194|NCT01380197|Morphine|morphine|mesh-list
2022195|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2022196|NCT01380197|Narcotics|narcotics|mesh-ancestor
2022197|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2022198|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022199|NCT01380197|Analgesics|analgesics|mesh-ancestor
2022200|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
2022201|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022202|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
2022203|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022204|NCT01380366|Hormones|hormones|mesh-list
2022205|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022206|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022207|NCT01380535|Methoxsalen|methoxsalen|mesh-list
2022208|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2022209|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
2022210|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
2022211|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2022212|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022213|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
2022214|NCT01380730|Evolocumab|evolocumab|mesh-list
2022215|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2022216|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2022217|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2022218|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
2022219|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022220|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2022221|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
2022222|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022223|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
2022224|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
2022225|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022226|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022227|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022228|NCT01380782|Nintedanib|nintedanib|mesh-list
2022229|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022230|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2022231|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022232|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022233|NCT01380990|Busulfan|busulfan|mesh-list
2022234|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
2022235|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022236|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2022237|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
2022238|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022239|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2022240|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022241|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2022242|NCT01381016|Hormones|hormones|mesh-list
2022243|NCT01381016|Estradiol|estradiol|mesh-list
2022244|NCT01381016|Progesterone|progesterone|mesh-list
2022245|NCT01381016|Estrogens|estrogens|mesh-list
2022246|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022247|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022248|NCT01381016|Progestins|progestins|mesh-ancestor
2022249|NCT01381120|Acetaminophen|acetaminophen|mesh-list
2022250|NCT01381120|Oxycodone|oxycodone|mesh-list
2022251|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
2022252|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2022253|NCT01381120|Analgesics|analgesics|mesh-ancestor
2022254|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
2022255|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022256|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022257|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
2022258|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2022259|NCT01381120|Narcotics|narcotics|mesh-ancestor
2022260|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2022261|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2022262|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2022263|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
2022264|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022265|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022266|NCT01381120|Urological Agents|urological agents|mesh-ancestor
2022267|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
2022268|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2022269|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
2022270|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022271|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022272|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2022273|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
2022274|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
2022275|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2022276|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
2022277|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022278|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022279|NCT01381471|Fluticasone|fluticasone|mesh-list
2022280|NCT01381471|Xhance|xhance|mesh-list
2022281|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2022282|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2022283|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2022284|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
2022285|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022286|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022287|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2022288|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
2022289|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
2022290|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2022291|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2022292|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2022293|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2022294|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
2022295|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022296|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022297|NCT01381549|Imipenem|imipenem|mesh-list
2022298|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
2022299|NCT01381549|Cilastatin|cilastatin|mesh-list
2022300|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2022301|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022302|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
2022303|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022304|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022305|NCT01381562|Meropenem|meropenem|mesh-list
2022306|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2022307|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022308|NCT01381679|Ezetimibe|ezetimibe|mesh-list
2022309|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2022310|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2022311|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
2022312|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022313|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2022314|NCT01381692|Sirolimus|sirolimus|mesh-list
2022315|NCT01381692|Dexamethasone|dexamethasone|mesh-list
2022316|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
2022317|NCT01381692|Rituximab|rituximab|mesh-list
2022318|NCT01381692|Bortezomib|bortezomib|mesh-list
2022319|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2022320|NCT01381692|Antibodies|antibodies|mesh-list
2022321|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
2022322|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2022323|NCT01381692|BB 1101|bb 1101|mesh-list
2022324|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
2022325|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022326|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2022327|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
2022328|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
2022329|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022330|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2022331|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
2022332|NCT01381692|Hormones|hormones|mesh-ancestor
2022333|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022334|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2022335|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022336|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
2022337|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022338|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022339|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2022340|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2022341|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022342|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2022343|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
2022344|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2022345|NCT01381718|Modafinil|modafinil|mesh-list
2022346|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2022347|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022348|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2022349|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2022350|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2022351|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022352|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2022353|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
2022354|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022355|NCT01381874|Prednisone|prednisone|mesh-list
2022356|NCT01381874|Prednisolone|prednisolone|mesh-list
2022357|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2022358|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
2022359|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2022360|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
2022361|NCT01381874|Exemestane|exemestane|mesh-list
2022362|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
2022363|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2022364|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
2022365|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2022366|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
2022367|NCT01381874|Hormones|hormones|mesh-ancestor
2022368|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022369|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022370|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2022371|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022372|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
2022373|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
2022374|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022375|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2022376|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2022377|NCT01381874|Protective Agents|protective agents|mesh-ancestor
2022378|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2022379|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2022380|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022381|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022382|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2022383|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
2022384|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2022385|NCT01381900|Metformin|metformin|mesh-list
2022386|NCT01381900|Canagliflozin|canagliflozin|mesh-list
2022387|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2022388|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022389|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2022390|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022391|NCT01381926|Exenatide|exenatide|mesh-list
2022392|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2022393|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022394|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2022395|NCT01381926|Incretins|incretins|mesh-ancestor
2022396|NCT01381926|Hormones|hormones|mesh-ancestor
2022397|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022398|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2022399|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
2022400|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2022401|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2022402|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
2022403|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022404|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
2022405|NCT01382225|Protective Agents|protective agents|mesh-ancestor
2022406|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
2022407|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2022408|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022409|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022410|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2022411|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2022412|NCT01382303|Protective Agents|protective agents|mesh-ancestor
2022413|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022414|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
2022415|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2022416|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
2022417|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
2022418|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2022419|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2022420|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022421|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
2022422|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
2022423|NCT01382940|Acetaminophen|acetaminophen|mesh-list
2022424|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
2022425|NCT01382940|Rituximab|rituximab|mesh-list
2022426|NCT01382940|Methotrexate|methotrexate|mesh-list
2022427|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
2022428|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2022429|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2022430|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022431|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
2022432|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022433|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2022434|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2022435|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
2022436|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2022437|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2022438|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
2022439|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022440|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
2022441|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022442|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2022443|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2022444|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2022445|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2022446|NCT01382940|Analgesics|analgesics|mesh-ancestor
2022447|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
2022448|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022449|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
2022450|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2022451|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
2022452|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
2022453|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2022454|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
2022455|NCT01382940|Hormones|hormones|mesh-ancestor
2022456|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022457|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2022458|NCT01382940|Protective Agents|protective agents|mesh-ancestor
2022459|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
2022460|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022461|NCT01383096|Artefenomel|artefenomel|mesh-list
2022462|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2022463|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
2022464|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2022465|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2022466|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022467|NCT01383161|Curcumin|curcumin|mesh-list
2022468|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2022469|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2022470|NCT01383161|Analgesics|analgesics|mesh-ancestor
2022471|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
2022472|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022473|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022474|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2022475|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2022476|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022477|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022478|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022479|NCT01383200|Lidocaine|lidocaine|mesh-list
2022480|NCT01383200|Tetracaine|tetracaine|mesh-list
2022481|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
2022482|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
2022483|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2022484|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022485|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
2022486|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022487|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2022488|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2022489|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2022490|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2022491|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022492|NCT01383356|Metformin|metformin|mesh-list
2022493|NCT01383356|Linagliptin|linagliptin|mesh-list
2022494|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2022495|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022496|NCT01383356|Incretins|incretins|mesh-ancestor
2022497|NCT01383356|Hormones|hormones|mesh-ancestor
2022498|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022499|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2022500|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
2022501|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022502|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022503|NCT01383486|Naproxen|naproxen|mesh-list
2022504|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2022505|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2022506|NCT01383486|Analgesics|analgesics|mesh-ancestor
2022507|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
2022508|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022509|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022510|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2022511|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2022512|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
2022513|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2022514|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022515|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022516|NCT01383499|Bromides|bromides|mesh-list
2022517|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
2022518|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2022519|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
2022520|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022521|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022522|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2022523|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
2022524|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
2022525|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2022526|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
2022527|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022528|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022529|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
2022530|NCT01383707|Leucovorin|leucovorin|mesh-list
2022531|NCT01383707|Bevacizumab|bevacizumab|mesh-list
2022532|NCT01383707|Fluorouracil|fluorouracil|mesh-list
2022533|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
2022534|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
2022535|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2022536|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022537|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2022538|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2022539|NCT01383707|Growth Substances|growth substances|mesh-ancestor
2022540|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022541|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
2022542|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
2022543|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022544|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2022545|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2022546|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
2022547|NCT01383707|Antidotes|antidotes|mesh-ancestor
2022548|NCT01383707|Protective Agents|protective agents|mesh-ancestor
2022549|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
2022550|NCT01383707|Vitamins|vitamins|mesh-ancestor
2022551|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
2022552|NCT01383759|Dexamethasone|dexamethasone|mesh-list
2022553|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
2022554|NCT01383759|Bortezomib|bortezomib|mesh-list
2022555|NCT01383759|BB 1101|bb 1101|mesh-list
2022556|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2022557|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
2022558|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
2022559|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022560|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022561|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2022562|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
2022563|NCT01383759|Hormones|hormones|mesh-ancestor
2022564|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022565|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2022566|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022567|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
2022568|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022569|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022570|NCT01383928|Dexamethasone|dexamethasone|mesh-list
2022571|NCT01383928|Lenalidomide|lenalidomide|mesh-list
2022572|NCT01383928|Ixazomib|ixazomib|mesh-list
2022573|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2022574|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
2022575|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
2022576|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022577|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022578|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2022579|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
2022580|NCT01383928|Hormones|hormones|mesh-ancestor
2022581|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022582|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2022583|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022584|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
2022585|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2022586|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2022587|NCT01383928|Growth Substances|growth substances|mesh-ancestor
2022588|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
2022589|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
2022590|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022591|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022592|NCT01383954|Diclofenac|diclofenac|mesh-list
2022593|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2022594|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2022595|NCT01383954|Analgesics|analgesics|mesh-ancestor
2022596|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
2022597|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022598|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022599|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2022600|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2022601|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2022602|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022603|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022604|NCT01383993|Voriconazole|voriconazole|mesh-list
2022605|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
2022606|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022607|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2022608|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2022609|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022610|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022611|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2022612|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
2022613|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022614|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022615|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2022616|NCT01384292|Naloxegol|naloxegol|mesh-list
2022617|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2022618|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022619|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
2022620|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022621|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
2022622|NCT01384539|Calcitriol|calcitriol|mesh-list
2022623|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2022624|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022625|NCT01384539|Vitamins|vitamins|mesh-ancestor
2022626|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
2022627|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2022628|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2022629|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2022630|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022631|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2022632|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
2022633|NCT01384591|Losartan|losartan|mesh-list
2022634|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2022635|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2022636|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2022637|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2022638|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2022639|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022640|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
2022641|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022642|NCT01384591|Expectorants|expectorants|mesh-ancestor
2022643|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
2022644|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2022645|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
2022646|NCT01384591|Protective Agents|protective agents|mesh-ancestor
2022647|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022648|NCT01384591|Antidotes|antidotes|mesh-ancestor
2022649|NCT01384734|Ritonavir|ritonavir|mesh-list
2022650|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2022651|NCT01384734|Tenofovir|tenofovir|mesh-list
2022652|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
2022653|NCT01384734|Fostemsavir|fostemsavir|mesh-list
2022654|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2022655|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2022656|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
2022657|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022658|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022659|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2022660|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2022661|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
2022662|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022663|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2022664|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2022665|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2022666|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2022667|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2022668|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2022669|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2022670|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2022671|NCT01384877|Lidocaine|lidocaine|mesh-list
2022672|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
2022673|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
2022674|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2022675|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022676|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
2022677|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022678|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2022679|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2022680|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2022681|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2022682|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022683|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
2022684|NCT01385098|Vitamin D|vitamin d|mesh-list
2022685|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
2022686|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
2022687|NCT01385098|Vitamins|vitamins|mesh-list
2022688|NCT01385098|Calcium|calcium|mesh-list
2022689|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
2022690|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022691|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2022692|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2022693|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2022694|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2022695|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
2022696|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022697|NCT01385189|Antacids|antacids|mesh-ancestor
2022698|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022699|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2022700|NCT01385566|Vaccines|vaccines|mesh-list
2022701|NCT01385566|Immunoglobulins|immunoglobulins|mesh-list
2022702|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
2022703|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022704|NCT01385748|Clonidine|clonidine|mesh-list
2022705|NCT01385748|Analgesics|analgesics|mesh-ancestor
2022706|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
2022707|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022708|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022709|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2022710|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
2022711|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
2022712|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2022713|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2022714|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2022715|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
2022716|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022717|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022718|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
2022719|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2022720|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
2022721|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2022722|NCT01386385|Paclitaxel|paclitaxel|mesh-list
2022723|NCT01386385|Carboplatin|carboplatin|mesh-list
2022724|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2022725|NCT01386385|Veliparib|veliparib|mesh-list
2022726|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2022727|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022728|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
2022729|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
2022730|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
2022731|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022732|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2022733|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022734|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2022735|NCT01386554|Hormones|hormones|mesh-ancestor
2022736|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022737|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022738|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
2022739|NCT01386606|Enclomiphene|enclomiphene|mesh-list
2022740|NCT01386606|Clomiphene|clomiphene|mesh-list
2022741|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
2022742|NCT01386606|Testosterone|testosterone|mesh-list
2022743|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
2022744|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
2022745|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2022746|NCT01386606|Androgens|androgens|mesh-ancestor
2022747|NCT01386606|Hormones|hormones|mesh-ancestor
2022748|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022749|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022750|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2022751|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022752|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
2022753|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2022754|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
2022755|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2022756|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
2022757|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2022758|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2022759|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2022760|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
2022761|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2022762|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
2022763|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022764|NCT01386645|Expectorants|expectorants|mesh-ancestor
2022765|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
2022766|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2022767|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
2022768|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022769|NCT01386645|Protective Agents|protective agents|mesh-ancestor
2022770|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022771|NCT01386645|Antidotes|antidotes|mesh-ancestor
2746190|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2746191|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2746192|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746193|NCT00601900|Tamoxifen|tamoxifen|mesh-list
2746194|NCT00601900|Bevacizumab|bevacizumab|mesh-list
2746195|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2746196|NCT00601900|Letrozole|letrozole|mesh-list
2746197|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
2746198|NCT00601900|Antibodies|antibodies|mesh-list
2746199|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
2746200|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2746201|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
2746202|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746203|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2746204|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2746205|NCT00601900|Growth Substances|growth substances|mesh-ancestor
2746206|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022787|NCT01386970|Lamivudine|lamivudine|mesh-list
2022788|NCT01386970|Zidovudine|zidovudine|mesh-list
2022789|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2022790|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2022791|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2022792|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022793|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022794|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
2022795|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022796|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2022797|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2022798|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
2022799|NCT01386983|Finasteride|finasteride|mesh-list
2022800|NCT01386983|Dutasteride|dutasteride|mesh-list
2022801|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2022802|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2022803|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022804|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022805|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
2022806|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022807|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022808|NCT01386983|Urological Agents|urological agents|mesh-ancestor
2022809|NCT01387022|Tenofovir|tenofovir|mesh-list
2022810|NCT01387022|Lamivudine|lamivudine|mesh-list
2022811|NCT01387022|Efavirenz|efavirenz|mesh-list
2022812|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
2022813|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022814|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2022815|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2022816|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022817|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022818|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2022819|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2022820|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2022821|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2022822|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2022823|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2022824|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2022825|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2022826|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
2022827|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2022828|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2022829|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2022830|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2022831|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022832|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
2022833|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022834|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022835|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2022836|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022837|NCT01387139|Ketamine|ketamine|mesh-list
2022838|NCT01387139|Propofol|propofol|mesh-list
2022839|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2022840|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2022841|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022842|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2022843|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
2022844|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
2022845|NCT01387139|Analgesics|analgesics|mesh-ancestor
2022846|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
2022847|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022848|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2022849|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2022850|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2022851|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022852|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022853|NCT01387178|Fluticasone|fluticasone|mesh-list
2022854|NCT01387178|Xhance|xhance|mesh-list
2022855|NCT01387178|Bromides|bromides|mesh-list
2022856|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
2022857|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2022858|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2022859|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2022860|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
2022861|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022862|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022863|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2022864|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
2022865|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
2022866|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2022867|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
2022868|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2022869|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
2022870|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022871|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022872|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2022873|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2022874|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2022875|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
2022876|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
2022877|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2022878|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2022879|NCT01387464|Bromfenac|bromfenac|mesh-list
2022880|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2022881|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2022882|NCT01387464|Analgesics|analgesics|mesh-ancestor
2022883|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
2022884|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022885|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022886|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2022887|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2022888|NCT01387516|Nicotine|nicotine|mesh-list
2022889|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2022890|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
2022891|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022892|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022893|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2022894|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2022895|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
2022896|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022897|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022898|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2022899|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2022900|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2022901|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2022902|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022903|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2022904|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2022905|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2022906|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
2022907|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2022908|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022909|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2022910|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2022911|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
2022912|NCT01387607|Pregabalin|pregabalin|mesh-list
2022913|NCT01387607|Analgesics|analgesics|mesh-ancestor
2022914|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
2022915|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2022916|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022917|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
2022918|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2022919|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2022920|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022921|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2022922|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2022923|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2022924|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2022925|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2022926|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
2022927|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
2022928|NCT01387815|Adalimumab|adalimumab|mesh-list
2022929|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2022930|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2022931|NCT01387932|Doxorubicin|doxorubicin|mesh-list
2022932|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
2022933|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2022934|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022935|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2022936|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2022937|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022938|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022939|NCT01388335|Warfarin|warfarin|mesh-list
2022940|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
2022941|NCT01388361|Insulin|insulin|mesh-list
2022942|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2022943|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
2022944|NCT01388361|Liraglutide|liraglutide|mesh-list
2022945|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2022946|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022947|NCT01388361|Incretins|incretins|mesh-ancestor
2022948|NCT01388361|Hormones|hormones|mesh-ancestor
2022949|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2022950|NCT01388478|Pramipexole|pramipexole|mesh-list
2022951|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
2022952|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022953|NCT01388478|Protective Agents|protective agents|mesh-ancestor
2022954|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2022955|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2022956|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2022957|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
2022958|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
2022959|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2746207|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
2746208|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
2746209|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746210|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2746211|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2746212|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746213|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2746214|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
2746215|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2746216|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2746217|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2746218|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2746219|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2746220|NCT00489307|Dexamethasone|dexamethasone|mesh-list
2746221|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2746222|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
2746223|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
2022978|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2022979|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2022980|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2022981|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
2022982|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2022983|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2022984|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2022985|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2022986|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
2022987|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2022988|NCT01388647|Carboplatin|carboplatin|mesh-list
2022989|NCT01388647|Trastuzumab|trastuzumab|mesh-list
2022990|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022991|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2022992|NCT01388790|Cetuximab|cetuximab|mesh-list
2022993|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2022994|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2022995|NCT01388946|Ropivacaine|ropivacaine|mesh-list
2022996|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
2022997|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
2022998|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2022999|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023000|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
2023001|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023002|NCT01388985|Vaccines|vaccines|mesh-list
2023003|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
2023004|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023005|NCT01389076|Methotrexate|methotrexate|mesh-list
2023006|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
2023007|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2023008|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
2023009|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2023010|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023011|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2023012|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
2023013|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023014|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023015|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
2023016|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023017|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2023018|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2023019|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
2023020|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2023021|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2023022|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2023023|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2023024|NCT01389102|Estradiol|estradiol|mesh-list
2023025|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2023026|NCT01389102|Estrogens|estrogens|mesh-ancestor
2023027|NCT01389102|Hormones|hormones|mesh-ancestor
2023028|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2023029|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023030|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2023031|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
2023032|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2023033|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2023034|NCT01389284|Naproxen|naproxen|mesh-list
2023035|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2023036|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2023037|NCT01389284|Analgesics|analgesics|mesh-ancestor
2023038|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
2023039|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023040|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023041|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2023042|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2023043|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
2023044|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2023045|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023046|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023047|NCT01389323|Interferons|interferons|mesh-list
2023048|NCT01389323|Ribavirin|ribavirin|mesh-list
2023049|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
2023050|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
2023051|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2023052|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023053|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
2023054|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2023055|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
2023056|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023057|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
2023058|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023059|NCT01389596|Pregabalin|pregabalin|mesh-list
2023060|NCT01389596|Analgesics|analgesics|mesh-ancestor
2023061|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
2023062|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023063|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023064|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
2023065|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2023066|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2023067|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023068|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2023069|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2023070|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2023071|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2023072|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2023073|NCT01389752|Charcoal|charcoal|mesh-list
2023074|NCT01389752|Antidotes|antidotes|mesh-ancestor
2023075|NCT01389752|Protective Agents|protective agents|mesh-ancestor
2023076|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023077|NCT01389856|Bosentan|bosentan|mesh-list
2023078|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2023079|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2023080|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023081|NCT01389973|Ustekinumab|ustekinumab|mesh-list
2023082|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
2023083|NCT01390064|Vaccines|vaccines|mesh-list
2023084|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
2023085|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023086|NCT01390077|Nitisinone|nitisinone|mesh-list
2023087|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023088|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023089|NCT01390220|Midazolam|midazolam|mesh-list
2023090|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2023091|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2023092|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2023093|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023094|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2023095|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2023096|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2023097|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2023098|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
2023099|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
2023100|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
2023101|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
2023102|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023103|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023104|NCT01390233|Dinoprostone|dinoprostone|mesh-list
2023105|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
2023106|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2023107|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023108|NCT01390246|Bupropion|bupropion|mesh-list
2023109|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2023110|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
2023111|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2023112|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2023113|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2023114|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2023115|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023116|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
2023117|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023118|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023119|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2023120|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2023121|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023122|NCT01390389|Ubiquinone|ubiquinone|mesh-list
2023123|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
2023124|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
2023125|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023126|NCT01390389|Vitamins|vitamins|mesh-ancestor
2023127|NCT01390402|Aldesleukin|aldesleukin|mesh-list
2023128|NCT01390402|Methotrexate|methotrexate|mesh-list
2023129|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
2023130|NCT01390402|Fludarabine|fludarabine|mesh-list
2023131|NCT01390402|Busulfan|busulfan|mesh-list
2023132|NCT01390402|Interleukin-2|interleukin-2|mesh-list
2023133|NCT01390402|Tacrolimus|tacrolimus|mesh-list
2023134|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
2023135|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2023136|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2023137|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
2023138|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2023139|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023140|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2023141|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
2023142|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023143|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023144|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
2023145|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023146|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2023147|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2023148|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
2023149|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2023150|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2023151|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
2023152|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2023153|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2023154|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
2023155|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2023156|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2023157|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2023158|NCT01390402|Analgesics|analgesics|mesh-ancestor
2023159|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
2023160|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023161|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2023162|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2023163|NCT01390428|Grazoprevir|grazoprevir|mesh-list
2023164|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
2023165|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2023166|NCT01390441|Acetaminophen|acetaminophen|mesh-list
2023167|NCT01390441|Loratadine|loratadine|mesh-list
2023168|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
2023169|NCT01390441|Rituximab|rituximab|mesh-list
2023170|NCT01390441|Methotrexate|methotrexate|mesh-list
2023171|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2023172|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023173|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
2023174|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023175|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2023176|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2023177|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
2023178|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2023179|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2023180|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
2023181|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023182|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
2023183|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023184|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2023185|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2023186|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2023187|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2023188|NCT01390441|Analgesics|analgesics|mesh-ancestor
2023189|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
2023190|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023191|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
2023192|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2023193|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
2023194|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
2023195|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2023196|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
2023197|NCT01390441|Hormones|hormones|mesh-ancestor
2023198|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2023199|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2023200|NCT01390441|Protective Agents|protective agents|mesh-ancestor
2023201|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
2023202|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2023203|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2023204|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2023205|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
2023206|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
2023207|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023208|NCT01390584|Prednisone|prednisone|mesh-list
2023209|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
2023210|NCT01390584|Dacarbazine|dacarbazine|mesh-list
2023211|NCT01390584|Doxorubicin|doxorubicin|mesh-list
2023212|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2023213|NCT01390584|Etoposide|etoposide|mesh-list
2023214|NCT01390584|Vincristine|vincristine|mesh-list
2023215|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
2023216|NCT01390584|Bleomycin|bleomycin|mesh-list
2023217|NCT01390584|Vinblastine|vinblastine|mesh-list
2023218|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
2023219|NCT01390584|Procarbazine|procarbazine|mesh-list
2023220|NCT01390584|Imidazole|imidazole|mesh-list
2023221|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2023222|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
2023223|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023224|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2023225|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2023226|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
2023227|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023228|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023229|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2023230|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2023231|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2023232|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2023233|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023234|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2023235|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
2023236|NCT01390584|Hormones|hormones|mesh-ancestor
2023237|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2023238|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2023239|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2023240|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
2023241|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
2023242|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
2023243|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
2023244|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
2023245|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2023246|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
2023247|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023248|NCT01390818|Niacinamide|niacinamide|mesh-list
2023249|NCT01390818|Sirolimus|sirolimus|mesh-list
2023250|NCT01390818|Elafin|elafin|mesh-list
2023251|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
2023252|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023253|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023254|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
2023255|NCT01390818|Vitamins|vitamins|mesh-ancestor
2023256|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
2023257|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023258|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2023259|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2023260|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2023261|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023262|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
2023263|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2023264|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
2023265|NCT01390844|Ribavirin|ribavirin|mesh-list
2023266|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2023267|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
2023268|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023269|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
2023270|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2023271|NCT01390857|Valacyclovir|valacyclovir|mesh-list
2023272|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
2023273|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2023274|NCT01390870|Alfuzosin|alfuzosin|mesh-list
2023275|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023276|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023277|NCT01390870|Urological Agents|urological agents|mesh-ancestor
2023278|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2023279|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2023280|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2023281|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
2023282|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023283|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
2023284|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
2023285|NCT01390909|Lactitol|lactitol|mesh-list
2023286|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023287|NCT01390909|Cathartics|cathartics|mesh-ancestor
2023288|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2023289|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2023290|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2023291|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2023292|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2023293|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2023294|NCT01390948|Bevacizumab|bevacizumab|mesh-list
2023295|NCT01390948|Temozolomide|temozolomide|mesh-list
2023296|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2023297|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023298|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2023299|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2023300|NCT01390948|Growth Substances|growth substances|mesh-ancestor
2023301|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023302|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
2023303|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2023304|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
2023305|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023306|NCT01391013|Ritonavir|ritonavir|mesh-list
2023307|NCT01391013|Darunavir|darunavir|mesh-list
2023308|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2023309|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2023310|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2023311|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
2023312|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023313|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023314|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2023315|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2023316|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
2023317|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2023318|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2023319|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2023320|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2023321|NCT01391130|Sunitinib|sunitinib|mesh-list
2023322|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023323|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2023324|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2023325|NCT01391130|Growth Substances|growth substances|mesh-ancestor
2023326|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023327|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
2023328|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2023329|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023330|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023331|NCT01391273|Bimatoprost|bimatoprost|mesh-list
2023332|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2023333|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2023334|NCT01391286|Bimatoprost|bimatoprost|mesh-list
2023335|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2023336|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2023337|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
2023338|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2023339|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2023340|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2023341|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2023342|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023343|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
2023344|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023345|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023346|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2023347|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023348|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
2023349|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2023350|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2023351|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2023352|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2023353|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023354|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
2023355|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023356|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023357|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2023358|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023359|NCT01391325|Allopurinol|allopurinol|mesh-list
2023360|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
2023361|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023362|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023363|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
2023364|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2023365|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2023366|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
2023367|NCT01391325|Protective Agents|protective agents|mesh-ancestor
2023368|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023369|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2023370|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2023371|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
2023372|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2023373|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
2023374|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023375|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023376|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2023377|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
2023378|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2023379|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2023380|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2023381|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
2023382|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023383|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023384|NCT01391663|Alogliptin|alogliptin|mesh-list
2023385|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2023386|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023387|NCT01391663|Incretins|incretins|mesh-ancestor
2023388|NCT01391663|Hormones|hormones|mesh-ancestor
2023389|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2023390|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2023391|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
2023392|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023393|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023394|NCT01391793|Dexamethasone|dexamethasone|mesh-list
2023395|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2023396|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
2023397|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
2023398|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023399|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023400|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2023401|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
2023402|NCT01391793|Hormones|hormones|mesh-ancestor
2023403|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2023404|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2023405|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023406|NCT01391858|Pregabalin|pregabalin|mesh-list
2023407|NCT01391858|Analgesics|analgesics|mesh-ancestor
2023408|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
2023409|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023410|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023411|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
2023412|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2023413|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2023414|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023415|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2023416|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2023417|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2023418|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2023419|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2023420|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
2023421|NCT01392183|Sirolimus|sirolimus|mesh-list
2023422|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2023423|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2023424|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2023425|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023426|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
2023427|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2023428|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
2023429|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023430|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2023431|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2023432|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2023433|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
2023434|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
2023435|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
2023436|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023437|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
2023438|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
2023439|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2023440|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2023441|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
2023442|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
2023443|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023444|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023445|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2023446|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2023447|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2023448|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023449|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023450|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2023451|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2023452|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023453|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
2023454|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023455|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2023456|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
2023457|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023458|NCT01392378|Acetaminophen|acetaminophen|mesh-list
2023459|NCT01392378|Ibuprofen|ibuprofen|mesh-list
2023460|NCT01392378|Vaccines|vaccines|mesh-list
2023461|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2023462|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
2023463|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023464|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2023465|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2023466|NCT01392378|Analgesics|analgesics|mesh-ancestor
2023467|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
2023468|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023469|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2023470|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2023471|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2023472|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023473|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023474|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
2023475|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
2023476|NCT01392469|Bosentan|bosentan|mesh-list
2023477|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
2023478|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023479|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2023480|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023481|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023482|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
2023483|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2023484|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2023485|NCT01392469|Urological Agents|urological agents|mesh-ancestor
2023486|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2023487|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2023488|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
2023489|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023490|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2023491|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023492|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023493|NCT01392560|Empagliflozin|empagliflozin|mesh-list
2023494|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2023495|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023496|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2023497|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023498|NCT01392573|Insulin|insulin|mesh-list
2023499|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2023500|NCT01392573|Liraglutide|liraglutide|mesh-list
2023501|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
2023502|NCT01392573|Xultophy|xultophy|mesh-list
2023503|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2023504|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023505|NCT01392573|Incretins|incretins|mesh-ancestor
2023506|NCT01392573|Hormones|hormones|mesh-ancestor
2023507|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2023508|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
2023509|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2023510|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023511|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2023512|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023513|NCT01392703|Dasatinib|dasatinib|mesh-list
2023514|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023515|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2023516|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023517|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023518|NCT01392859|Levocetirizine|levocetirizine|mesh-list
2023519|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2023520|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2023521|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
2023522|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
2023523|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023524|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023525|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023526|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
2023527|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2023528|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2023529|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2023530|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2023531|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023532|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
2023533|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023534|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023535|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2023536|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023537|NCT01392989|Cyclosporine|cyclosporine|mesh-list
2023538|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
2023539|NCT01392989|Cyclosporins|cyclosporins|mesh-list
2023540|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
2023541|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2023542|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023543|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023544|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2023545|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
2023546|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023547|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
2023548|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2023549|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
2023550|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2023551|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2023552|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2023553|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023554|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2023555|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
2023556|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2023557|NCT01393106|Idelalisib|idelalisib|mesh-list
2023558|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023559|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023560|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023561|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2023562|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2023563|NCT01393158|Apremilast|apremilast|mesh-list
2023564|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2023565|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2023566|NCT01393158|Analgesics|analgesics|mesh-ancestor
2023567|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
2023568|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023569|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023570|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2023571|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2023572|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2023573|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2023574|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023575|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023576|NCT01393392|Methadone|methadone|mesh-list
2023577|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2023578|NCT01393392|Narcotics|narcotics|mesh-ancestor
2023579|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2023580|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023581|NCT01393392|Analgesics|analgesics|mesh-ancestor
2023582|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
2023583|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023584|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
2023585|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
2023586|NCT01393405|Methotrexate|methotrexate|mesh-list
2023587|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2023588|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
2023589|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2023590|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023591|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2023592|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
2023593|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023594|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023595|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
2023596|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023597|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2023598|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2023599|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
2023600|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2023601|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2023602|NCT01393457|Levodopa|levodopa|mesh-list
2023603|NCT01393457|Carbidopa|carbidopa|mesh-list
2023604|NCT01393457|Ropinirole|ropinirole|mesh-list
2023605|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2023606|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2023607|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
2023608|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023609|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023610|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023611|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2023612|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023613|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
2023614|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
2023615|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2023616|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2023617|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2023618|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023619|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
2023620|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023621|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023622|NCT01393626|Tofacitinib|tofacitinib|mesh-list
2023623|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2023624|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023625|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023626|NCT01393704|Vasopressins|vasopressins|mesh-list
2023627|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
2023628|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
2023629|NCT01393704|Coagulants|coagulants|mesh-ancestor
2023630|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2023631|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2023632|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
2023633|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023634|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2023635|NCT01393717|Antibodies|antibodies|mesh-list
2023636|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
2023637|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2023638|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
2023639|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
2023640|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023641|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2023642|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023643|NCT01393730|Prednisone|prednisone|mesh-list
2023644|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
2023645|NCT01393730|Dutasteride|dutasteride|mesh-list
2023646|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2023647|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
2023648|NCT01393730|Hormones|hormones|mesh-ancestor
2023649|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2023650|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023651|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2023652|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023653|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2023654|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023655|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023656|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
2023657|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2023658|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2023659|NCT01393899|Tofacitinib|tofacitinib|mesh-list
2023660|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2023661|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023662|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023663|NCT01393964|Dexamethasone|dexamethasone|mesh-list
2023664|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
2023665|NCT01393964|Lenalidomide|lenalidomide|mesh-list
2023666|NCT01393964|Elotuzumab|elotuzumab|mesh-list
2023667|NCT01393964|BB 1101|bb 1101|mesh-list
2023668|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2023669|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
2023670|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
2023671|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023672|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023673|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2023674|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
2023675|NCT01393964|Hormones|hormones|mesh-ancestor
2023676|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2023677|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2023678|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023679|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
2023680|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023681|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023682|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
2023683|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2023684|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2023685|NCT01393964|Growth Substances|growth substances|mesh-ancestor
2023686|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
2023687|NCT01393990|Tamoxifen|tamoxifen|mesh-list
2023688|NCT01393990|Midazolam|midazolam|mesh-list
2023689|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2023690|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2023691|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2023692|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023693|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2023694|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2023695|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2023696|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2023697|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
2023698|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
2023699|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
2023700|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
2023701|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023702|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023703|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2023704|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
2023705|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2023706|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2023707|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023708|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2023709|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2023710|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2023711|NCT01394185|Dronabinol|dronabinol|mesh-list
2023712|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
2023713|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023714|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2023715|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2023716|NCT01394185|Analgesics|analgesics|mesh-ancestor
2023717|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
2023718|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023719|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2023720|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2023721|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023722|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023723|NCT01394185|Hormones|hormones|mesh-ancestor
2023724|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2023725|NCT01394250|Lidocaine|lidocaine|mesh-list
2023726|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
2023727|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
2023728|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2023729|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023730|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
2023731|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023732|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2023733|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2023734|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2023735|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2023736|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023737|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
2023738|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2023739|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
2023740|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2023741|NCT01394510|Expectorants|expectorants|mesh-ancestor
2023742|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
2023743|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2023744|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
2023745|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023746|NCT01394510|Protective Agents|protective agents|mesh-ancestor
2023747|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023748|NCT01394510|Antidotes|antidotes|mesh-ancestor
2023749|NCT01394523|Bupivacaine|bupivacaine|mesh-list
2023750|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
2023751|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
2023752|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2023753|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023754|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
2023755|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023756|NCT01394614|Vaccines|vaccines|mesh-list
2023757|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
2023758|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023759|NCT01394627|Eplerenone|eplerenone|mesh-list
2023760|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2023761|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
2023762|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2023763|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023764|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2023765|NCT01394627|Diuretics|diuretics|mesh-ancestor
2023766|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
2023767|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2023768|NCT01394718|Acetaminophen|acetaminophen|mesh-list
2023769|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2023770|NCT01394718|Analgesics|analgesics|mesh-ancestor
2023771|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
2023772|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023773|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023774|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
2023775|NCT01394939|Irinotecan|irinotecan|mesh-list
2023776|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2023777|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2023778|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023779|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023780|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023781|NCT01394952|Dulaglutide|dulaglutide|mesh-list
2023782|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2023783|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023784|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
2023785|NCT01394991|Hematinics|hematinics|mesh-ancestor
2023786|NCT01395017|Dasatinib|dasatinib|mesh-list
2023787|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023788|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2023789|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023790|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023791|NCT01395030|Choline|choline|mesh-list
2023792|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
2023793|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2023794|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
2023795|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023796|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2023797|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2023798|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
2023799|NCT01395043|Epinephrine|epinephrine|mesh-list
2023800|NCT01395043|Bupivacaine|bupivacaine|mesh-list
2023801|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
2023802|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
2023803|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2023804|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023805|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
2023806|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023807|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2023808|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2023809|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
2023810|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023811|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023812|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2023813|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2023814|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
2023815|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2023816|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
2023817|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
2023818|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
2023819|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2023820|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
2023821|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2023822|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023823|NCT01395329|Metoprolol|metoprolol|mesh-list
2023824|NCT01395329|Nebivolol|nebivolol|mesh-list
2023825|NCT01395329|Nitroprusside|nitroprusside|mesh-list
2023826|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
2023827|NCT01395329|BQ 788|bq 788|mesh-list
2023828|NCT01395329|Acetylcholine|acetylcholine|mesh-list
2023829|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2023830|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2023831|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
2023832|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
2023833|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023834|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023835|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2023836|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2023837|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2023838|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
2023839|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023840|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023841|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
2023842|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2023843|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2023844|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2023845|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2023846|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2023847|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
2023848|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2023849|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2023850|NCT01395524|Naloxegol|naloxegol|mesh-list
2023851|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2023852|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023853|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
2023854|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023855|NCT01395537|Paclitaxel|paclitaxel|mesh-list
2023856|NCT01395537|Carboplatin|carboplatin|mesh-list
2023857|NCT01395537|Lapatinib|lapatinib|mesh-list
2023858|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2023859|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023860|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
2023861|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
2023862|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
2023863|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023864|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2023865|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023866|NCT01395758|Gemcitabine|gemcitabine|mesh-list
2023867|NCT01395758|Docetaxel|docetaxel|mesh-list
2023868|NCT01395758|Pemetrexed|pemetrexed|mesh-list
2023869|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2023870|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2023871|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
2023872|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023873|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023874|NCT01395758|Antiviral Agents|antiviral agents|mesh-ancestor
2023875|NCT01395758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2023876|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023877|NCT01395758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2023878|NCT01395758|Immunologic Factors|immunologic factors|mesh-ancestor
2023879|NCT01395758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023880|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
2023881|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
2023882|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
2023883|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2023884|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2023885|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2023886|NCT01395784|Pioglitazone|pioglitazone|mesh-list
2023887|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2023888|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023889|NCT01395797|Pioglitazone|pioglitazone|mesh-list
2023890|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2023891|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023892|NCT01395823|Vitamin D|vitamin d|mesh-list
2023893|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
2023894|NCT01395823|Vitamins|vitamins|mesh-ancestor
2023895|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
2023896|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023897|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2023898|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2023899|NCT01395888|Fluticasone|fluticasone|mesh-list
2023900|NCT01395888|Xhance|xhance|mesh-list
2023901|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
2023902|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2023903|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2023904|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
2023905|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023906|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023907|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2023908|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
2023909|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
2023910|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2023911|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
2023912|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2023913|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
2023914|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023915|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023916|NCT01395901|Ondansetron|ondansetron|mesh-list
2023917|NCT01395901|Palonosetron|palonosetron|mesh-list
2023918|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
2023919|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
2023920|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023921|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023922|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2023923|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
2023924|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
2023925|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2023926|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
2023927|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2023928|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023929|NCT01395901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2023930|NCT01395901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2023931|NCT01395901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2023932|NCT01395901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2023933|NCT01395901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2023934|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2023935|NCT01396005|Buprenorphine|buprenorphine|mesh-list
2023936|NCT01396005|Methadone|methadone|mesh-list
2023937|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2023938|NCT01396005|Naloxone|naloxone|mesh-list
2023939|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2023940|NCT01396005|Narcotics|narcotics|mesh-ancestor
2023941|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2023942|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023943|NCT01396005|Analgesics|analgesics|mesh-ancestor
2023944|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
2023945|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023946|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2023947|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
2023948|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
2023949|NCT01396057|Dexamethasone|dexamethasone|mesh-list
2023950|NCT01396057|Ranibizumab|ranibizumab|mesh-list
2023951|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2023952|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
2023953|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
2023954|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023955|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023956|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2023957|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
2023958|NCT01396057|Hormones|hormones|mesh-ancestor
2023959|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2023960|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2023961|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023962|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2023963|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2023964|NCT01396057|Growth Substances|growth substances|mesh-ancestor
2023965|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
2023966|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2023967|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2023968|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023969|NCT01396083|Dexamethasone|dexamethasone|mesh-list
2023970|NCT01396083|Ranibizumab|ranibizumab|mesh-list
2023971|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2023972|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
2023973|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
2023974|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2023975|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023976|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2023977|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
2023978|NCT01396083|Hormones|hormones|mesh-ancestor
2023979|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2023980|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2023981|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023982|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2023983|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2023984|NCT01396083|Growth Substances|growth substances|mesh-ancestor
2023985|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
2023986|NCT01396148|Sunitinib|sunitinib|mesh-list
2023987|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2023988|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2023989|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2023990|NCT01396148|Growth Substances|growth substances|mesh-ancestor
2023991|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2023992|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
2023993|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2023994|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2023995|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2023996|NCT01396265|Rifampin|rifampin|mesh-list
2023997|NCT01396265|Afatinib|afatinib|mesh-list
2023998|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2023999|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
2024000|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2024001|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024002|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
2024003|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2024004|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024005|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024006|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2024007|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2024008|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2024009|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2024010|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2024011|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2024012|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024013|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2024014|NCT01396395|Nicorandil|nicorandil|mesh-list
2024015|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2024016|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2024017|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
2024018|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
2024019|NCT01396395|Vitamins|vitamins|mesh-ancestor
2024020|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
2024021|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024022|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
2024023|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
2024024|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024025|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024026|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024027|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
2024028|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
2024029|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2024030|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
2024031|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024032|NCT01396447|Cariprazine|cariprazine|mesh-list
2024033|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2024034|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2024035|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2024036|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024037|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2024038|NCT01396486|Inositol|inositol|mesh-list
2024039|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
2024040|NCT01396486|Vitamins|vitamins|mesh-ancestor
2024041|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
2024042|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024043|NCT01396512|Vaccines|vaccines|mesh-list
2024044|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
2024045|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024046|NCT01397084|Esomeprazole|esomeprazole|mesh-list
2024047|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2024048|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2024049|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2024050|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024051|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024052|NCT01397409|Ranibizumab|ranibizumab|mesh-list
2024053|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2024054|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2024055|NCT01397409|Growth Substances|growth substances|mesh-ancestor
2024056|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024057|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
2024058|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024059|NCT01397422|Amantadine|amantadine|mesh-list
2024060|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2024061|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2024062|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
2024063|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024064|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
2024065|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024066|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024067|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024068|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2024069|NCT01397422|Analgesics|analgesics|mesh-ancestor
2024070|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
2024071|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024072|NCT01397448|Rabeprazole|rabeprazole|mesh-list
2024073|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2024074|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2024075|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2024076|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024077|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024078|NCT01397461|Retapamulin|retapamulin|mesh-list
2024079|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2024080|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024081|NCT01397591|Bortezomib|bortezomib|mesh-list
2024082|NCT01397591|Ofatumumab|ofatumumab|mesh-list
2024083|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024084|NCT01397825|Rituximab|rituximab|mesh-list
2024085|NCT01397825|Vincristine|vincristine|mesh-list
2024086|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2024087|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024088|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
2024089|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024090|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2024091|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2024092|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
2024093|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
2024094|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
2024095|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024096|NCT01397890|Budesonide|budesonide|mesh-list
2024097|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
2024098|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
2024099|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2024100|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2024101|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2024102|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
2024103|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024104|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024105|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2024106|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
2024107|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
2024108|NCT01397890|Hormones|hormones|mesh-ancestor
2024109|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2024110|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2024111|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2024112|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2024113|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
2024114|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024115|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024116|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
2024117|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2024118|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
2024119|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
2024120|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2024121|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2024122|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024123|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
2024124|NCT01398280|Coagulants|coagulants|mesh-ancestor
2024125|NCT01398410|Rabeprazole|rabeprazole|mesh-list
2024126|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2024127|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2024128|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2024129|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024130|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024131|NCT01398514|Citalopram|citalopram|mesh-list
2024132|NCT01398514|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2024133|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2024134|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2024135|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024136|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024137|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
2024138|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024139|NCT01398514|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2024140|NCT01398514|Antidepressive Agents|antidepressive agents|mesh-ancestor
2024141|NCT01398514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2024142|NCT01398943|Antioxidants|antioxidants|mesh-list
2024143|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024144|NCT01398943|Protective Agents|protective agents|mesh-ancestor
2024145|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024146|NCT01398956|Levetiracetam|levetiracetam|mesh-list
2024147|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
2024148|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
2024149|NCT01398982|Bupivacaine|bupivacaine|mesh-list
2024150|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
2024151|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
2024152|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2024153|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024154|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
2024155|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024156|NCT01399008|Colchicine|colchicine|mesh-list
2024157|NCT01399008|Allopurinol|allopurinol|mesh-list
2024158|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
2024159|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2024160|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
2024161|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
2024162|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
2024163|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024164|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024165|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
2024166|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024167|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2024168|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
2024169|NCT01399008|Protective Agents|protective agents|mesh-ancestor
2024170|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024171|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
2024172|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2024173|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024174|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2024175|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
2024176|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2024177|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024178|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024179|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024180|NCT01399125|Rivastigmine|rivastigmine|mesh-list
2024181|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2024182|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024183|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024184|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
2024185|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024186|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024187|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2024188|NCT01399125|Protective Agents|protective agents|mesh-ancestor
2024189|NCT01399190|Bevacizumab|bevacizumab|mesh-list
2024190|NCT01399190|Capecitabine|capecitabine|mesh-list
2024191|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
2024192|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2024193|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024194|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2024195|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2024196|NCT01399190|Growth Substances|growth substances|mesh-ancestor
2024197|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024198|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
2024199|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2024200|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
2024201|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024202|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
2024203|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2024204|NCT01399372|Cytarabine|cytarabine|mesh-list
2024205|NCT01399372|Rituximab|rituximab|mesh-list
2024206|NCT01399372|Methotrexate|methotrexate|mesh-list
2024207|NCT01399372|Vincristine|vincristine|mesh-list
2024208|NCT01399372|Procarbazine|procarbazine|mesh-list
2024209|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2024210|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024211|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
2024212|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024213|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2024214|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2024215|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
2024216|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2024217|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2024218|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
2024219|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024220|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
2024221|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024222|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2024223|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2024224|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2024225|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
2024226|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024227|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2024228|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
2024229|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
2024230|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
2024231|NCT01399593|Eculizumab|eculizumab|mesh-list
2024232|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2024233|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2024234|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
2024235|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024236|NCT01399697|Methotrexate|methotrexate|mesh-list
2024237|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2024238|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
2024239|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2024240|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024241|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2024242|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
2024243|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024244|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024245|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
2024246|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024247|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2024248|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2024249|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
2024250|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2024251|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2024252|NCT01399723|Amoxicillin|amoxicillin|mesh-list
2024253|NCT01399723|Penicillins|penicillins|mesh-list
2024254|NCT01399723|Penicillin G|penicillin g|mesh-list
2024255|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2024256|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
2024257|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2024258|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024259|NCT01399827|Methylphenidate|methylphenidate|mesh-list
2024260|NCT01399827|Amphetamine|amphetamine|mesh-list
2024261|NCT01399827|Adderall|adderall|mesh-list
2024262|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
2024263|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
2024264|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2024265|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2024266|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024267|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2024268|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2024269|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2024270|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024271|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
2024272|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024273|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2024274|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
2024275|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
2024276|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
2024277|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024278|NCT01399866|Cycloserine|cycloserine|mesh-list
2024279|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2024280|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024281|NCT01399866|Renal Agents|renal agents|mesh-ancestor
2024282|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2024283|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
2024284|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2024285|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
2024286|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024287|NCT01399905|Carbidopa|carbidopa|mesh-list
2024288|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2024289|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2024290|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
2024291|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024292|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024293|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024294|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2024295|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024296|NCT01400113|Asenapine|asenapine|mesh-list
2024297|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2024298|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2024299|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2024300|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024301|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2024302|NCT01400139|Hydrocodone|hydrocodone|mesh-list
2024303|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2024304|NCT01400139|Narcotics|narcotics|mesh-ancestor
2024305|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2024306|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024307|NCT01400139|Analgesics|analgesics|mesh-ancestor
2024308|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
2024309|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024310|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
2024311|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
2024312|NCT01400243|Nicotine|nicotine|mesh-list
2024313|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2024314|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
2024315|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024316|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024317|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2024318|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2024319|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
2024320|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024321|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024322|NCT01400412|Ritonavir|ritonavir|mesh-list
2024323|NCT01400412|Darunavir|darunavir|mesh-list
2024324|NCT01400412|Tenofovir|tenofovir|mesh-list
2024325|NCT01400412|Emtricitabine|emtricitabine|mesh-list
2024326|NCT01400412|Maraviroc|maraviroc|mesh-list
2024327|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2024328|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2024329|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
2024330|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024331|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024332|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2024333|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2024334|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
2024335|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024336|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2024337|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2024338|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2024339|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2024340|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2024341|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2024342|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2024343|NCT01400451|Ipilimumab|ipilimumab|mesh-list
2024344|NCT01400451|Vemurafenib|vemurafenib|mesh-list
2024345|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2024346|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024347|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2024348|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024349|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2024350|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024351|NCT01400503|Siltuximab|siltuximab|mesh-list
2024352|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024353|NCT01400516|Vitamin D|vitamin d|mesh-list
2024354|NCT01400516|Teriparatide|teriparatide|mesh-list
2024355|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
2024356|NCT01400516|Calcium|calcium|mesh-list
2024357|NCT01400516|Vitamins|vitamins|mesh-ancestor
2024358|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
2024359|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024360|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2024361|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2024362|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2024363|NCT01400906|Fluticasone|fluticasone|mesh-list
2024364|NCT01400906|Xhance|xhance|mesh-list
2024365|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2024366|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2024367|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
2024368|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024369|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024370|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2024371|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
2024372|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
2024373|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2024374|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2024375|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
2024376|NCT01400958|Modafinil|modafinil|mesh-list
2024377|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2024378|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024379|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2024380|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2024381|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2024382|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024383|NCT01401010|Doripenem|doripenem|mesh-list
2024384|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2024385|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024386|NCT01401023|Tigecycline|tigecycline|mesh-list
2024387|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2024388|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024389|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2024390|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024391|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024392|NCT01401166|Trastuzumab|trastuzumab|mesh-list
2024393|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2024394|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024395|NCT01401322|Lenalidomide|lenalidomide|mesh-list
2024396|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
2024397|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024398|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2024399|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2024400|NCT01401322|Growth Substances|growth substances|mesh-ancestor
2024401|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
2024402|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024403|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
2024404|NCT01401465|Ciclesonide|ciclesonide|mesh-list
2024405|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2024406|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
2024407|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2024408|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
2024409|NCT01401465|Hormones|hormones|mesh-ancestor
2024410|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2024411|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024412|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
2024413|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024414|NCT01401543|Tadalafil|tadalafil|mesh-list
2024415|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
2024416|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2024417|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2024418|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024419|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024420|NCT01401543|Urological Agents|urological agents|mesh-ancestor
2024421|NCT01401595|Dexetimide|dexetimide|mesh-list
2024422|NCT01401595|Citalopram|citalopram|mesh-list
2024423|NCT01401595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2024424|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2024425|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2024426|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024427|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024428|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
2024429|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024430|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2024431|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
2024432|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2024433|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2024434|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2024435|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
2024436|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
2024437|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024438|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2024439|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2024440|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
2024441|NCT01401647|Lidocaine|lidocaine|mesh-list
2024442|NCT01401647|Amiodarone|amiodarone|mesh-list
2024443|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
2024444|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
2024445|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2024446|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024447|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
2024448|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024449|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2024450|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2024451|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2024452|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2024453|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024454|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
2024455|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2024456|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2024457|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2024458|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024459|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2024460|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2024461|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2024462|NCT01401959|Trastuzumab|trastuzumab|mesh-list
2024463|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2024464|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024465|NCT01402011|Lidocaine|lidocaine|mesh-list
2024466|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
2024467|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
2024468|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2024469|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024470|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
2024471|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024472|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2024473|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2024474|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2024475|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2024476|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024477|NCT01402050|Dinoprostone|dinoprostone|mesh-list
2024478|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
2024479|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2024480|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024481|NCT01402063|Temozolomide|temozolomide|mesh-list
2024482|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2024483|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2024484|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
2024485|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024486|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024487|NCT01402284|Dexamethasone|dexamethasone|mesh-list
2024488|NCT01402284|Lenalidomide|lenalidomide|mesh-list
2024489|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2024490|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
2024491|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
2024492|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024493|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024494|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2024495|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
2024496|NCT01402284|Hormones|hormones|mesh-ancestor
2024497|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2024498|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2024499|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024500|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
2024501|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2024502|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2024503|NCT01402284|Growth Substances|growth substances|mesh-ancestor
2024504|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
2024505|NCT01402375|Acetaminophen|acetaminophen|mesh-list
2024506|NCT01402375|Oxycodone|oxycodone|mesh-list
2024507|NCT01402375|Hydrocodone|hydrocodone|mesh-list
2024508|NCT01402375|Codeine|codeine|mesh-list
2024509|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2024510|NCT01402375|Analgesics|analgesics|mesh-ancestor
2024511|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
2024512|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024513|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024514|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
2024515|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2024516|NCT01402375|Narcotics|narcotics|mesh-ancestor
2024517|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2024518|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
2024519|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
2024520|NCT01402427|Verapamil|verapamil|mesh-list
2024521|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2024522|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2024523|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2024524|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024525|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2024526|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024527|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
2024528|NCT01402492|Naltrexone|naltrexone|mesh-list
2024529|NCT01402492|Buprenorphine|buprenorphine|mesh-list
2024530|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2024531|NCT01402492|Naloxone|naloxone|mesh-list
2024532|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2024533|NCT01402492|Narcotics|narcotics|mesh-ancestor
2024534|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2024535|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024536|NCT01402492|Analgesics|analgesics|mesh-ancestor
2024537|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
2024538|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024539|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2024540|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2024541|NCT01402544|Ranibizumab|ranibizumab|mesh-list
2024542|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2024543|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2024544|NCT01402544|Growth Substances|growth substances|mesh-ancestor
2024545|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024546|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
2024547|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024548|NCT01402817|Sunitinib|sunitinib|mesh-list
2024549|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024550|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2024551|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2024552|NCT01402817|Growth Substances|growth substances|mesh-ancestor
2024553|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024554|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
2024555|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2024556|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024557|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024558|NCT01402869|Lidocaine|lidocaine|mesh-list
2024559|NCT01402869|Epinephrine|epinephrine|mesh-list
2024560|NCT01402869|Prilocaine|prilocaine|mesh-list
2024561|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
2024562|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
2024563|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2024564|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024565|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
2024566|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024567|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2024568|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2024569|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2024570|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2024571|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024572|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2024573|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2024574|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
2024575|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024576|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2024577|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2024578|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
2024579|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2024580|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
2024581|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
2024582|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
2024583|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2024584|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
2024585|NCT01402947|Mesalamine|mesalamine|mesh-list
2024586|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2024587|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024588|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2024589|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2024590|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024591|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024592|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024593|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2024594|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2024595|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2024596|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2024597|NCT01402947|Analgesics|analgesics|mesh-ancestor
2024598|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
2024599|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024600|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024601|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2024602|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2024603|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2024604|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
2024605|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024606|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
2024607|NCT01403051|Vitamin D|vitamin d|mesh-list
2024608|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
2024609|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
2024610|NCT01403051|Vitamins|vitamins|mesh-list
2024611|NCT01403051|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2024612|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
2024613|NCT01403051|Calcium|calcium|mesh-list
2024614|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
2024615|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024616|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2024617|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2024618|NCT01403051|Antacids|antacids|mesh-ancestor
2024619|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024620|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2024621|NCT01403051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2024622|NCT01403051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2024623|NCT01403051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024624|NCT01403051|Antiviral Agents|antiviral agents|mesh-ancestor
2024625|NCT01403051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024626|NCT01403051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2024627|NCT01403051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2024628|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
2024629|NCT01403116|Testosterone|testosterone|mesh-list
2024630|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
2024631|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
2024632|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2024633|NCT01403116|Androgens|androgens|mesh-ancestor
2024634|NCT01403116|Hormones|hormones|mesh-ancestor
2024635|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2024636|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024637|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2024638|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024639|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
2024640|NCT01403246|Lenalidomide|lenalidomide|mesh-list
2024641|NCT01403246|Chlorambucil|chlorambucil|mesh-list
2024642|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
2024643|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024644|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2024645|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2024646|NCT01403246|Growth Substances|growth substances|mesh-ancestor
2024647|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
2024648|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024649|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2024650|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
2024651|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024652|NCT01403376|Interferons|interferons|mesh-list
2024653|NCT01403376|Interferon-beta|interferon-beta|mesh-list
2024654|NCT01403376|Teriflunomide|teriflunomide|mesh-list
2024655|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
2024656|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024657|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
2024658|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024659|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2024660|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
2024661|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024662|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2024663|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2024664|NCT01403376|Analgesics|analgesics|mesh-ancestor
2024665|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
2024666|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024667|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2024668|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2024669|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2024670|NCT01403610|Bevacizumab|bevacizumab|mesh-list
2024671|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
2024672|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2024673|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024674|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2024675|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2024676|NCT01403610|Growth Substances|growth substances|mesh-ancestor
2024677|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024678|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
2024679|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2024680|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
2024681|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024682|NCT01403805|Vaccines|vaccines|mesh-list
2024683|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2024684|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
2024685|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746224|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2746225|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746226|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2024689|NCT01404208|Cycloserine|cycloserine|mesh-list
2024690|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2024691|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024692|NCT01404208|Renal Agents|renal agents|mesh-ancestor
2024693|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2024694|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
2024695|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2024696|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
2024697|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024698|NCT01404260|Gemcitabine|gemcitabine|mesh-list
2024699|NCT01404260|Carboplatin|carboplatin|mesh-list
2024700|NCT01404260|Gefitinib|gefitinib|mesh-list
2024701|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024702|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2024703|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
2024704|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024705|NCT01404260|Antiviral Agents|antiviral agents|mesh-ancestor
2024706|NCT01404260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024707|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024708|NCT01404260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2024709|NCT01404260|Immunologic Factors|immunologic factors|mesh-ancestor
2024710|NCT01404260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024711|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2746227|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
2746228|NCT00489307|Hormones|hormones|mesh-ancestor
2746229|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2746230|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2746231|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746232|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2746233|NCT00072410|Antibodies|antibodies|mesh-list
2746234|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
2746235|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2746236|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
2746237|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746238|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024731|NCT01404325|Everolimus|everolimus|mesh-list
2024732|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024733|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2024734|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
2024735|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024736|NCT01404429|Methotrexate|methotrexate|mesh-list
2024737|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2024738|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
2024739|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2024740|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024741|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2024742|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
2024743|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024744|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024745|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
2024746|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024747|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2024748|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2024749|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
2024750|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2024751|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2024752|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2024753|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2024754|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2024755|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
2024756|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024757|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024758|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2024759|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2024760|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
2024761|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024762|NCT01404832|Lansoprazole|lansoprazole|mesh-list
2024763|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
2024764|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2024765|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2024766|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2024767|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024768|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024769|NCT01404923|Mebeverine|mebeverine|mesh-list
2024770|NCT01404923|Alverine|alverine|mesh-list
2024771|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
2024772|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
2024773|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024774|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024775|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
2024776|NCT01404936|Interferons|interferons|mesh-list
2024777|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
2024778|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
2024779|NCT01404936|Doxorubicin|doxorubicin|mesh-list
2024780|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2024781|NCT01404936|Bleomycin|bleomycin|mesh-list
2024782|NCT01404936|Dacarbazine|dacarbazine|mesh-list
2024783|NCT01404936|Vinblastine|vinblastine|mesh-list
2024784|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2024785|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024786|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2024787|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2024788|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024789|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024790|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
2024791|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024792|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
2024793|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024794|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2024795|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
2024796|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2024797|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
2024798|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
2024799|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
2024800|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
2024801|NCT01404949|Tretinoin|tretinoin|mesh-list
2024802|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024803|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
2024804|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
2024805|NCT01405027|Interferons|interferons|mesh-list
2024806|NCT01405027|Ribavirin|ribavirin|mesh-list
2024807|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
2024808|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
2024809|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2024810|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2024811|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024812|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
2024813|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024814|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
2024815|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024816|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
2024817|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024818|NCT01405053|Rufinamide|rufinamide|mesh-list
2024819|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
2024820|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2024821|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2024822|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2024823|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024824|NCT01405456|Eplerenone|eplerenone|mesh-list
2024825|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2024826|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
2024827|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2024828|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024829|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2024830|NCT01405456|Diuretics|diuretics|mesh-ancestor
2024831|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
2024832|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2024833|NCT01405508|Brivaracetam|brivaracetam|mesh-list
2024834|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
2024835|NCT01405560|Ribavirin|ribavirin|mesh-list
2024836|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
2024837|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024838|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
2024839|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024840|NCT01405742|Factor VIII|factor viii|mesh-list
2024841|NCT01405742|Coagulants|coagulants|mesh-ancestor
2024842|NCT01405768|Lidocaine|lidocaine|mesh-list
2024843|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
2024844|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
2024845|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2024846|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024847|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
2024848|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024849|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2024850|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2024851|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2024852|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2024853|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024854|NCT01405820|Natalizumab|natalizumab|mesh-list
2024855|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
2024856|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024857|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2024858|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2024859|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024860|NCT01405911|Incretins|incretins|mesh-ancestor
2024861|NCT01405911|Hormones|hormones|mesh-ancestor
2024862|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2024863|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2024864|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
2024865|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024866|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024867|NCT01405924|Dexamethasone|dexamethasone|mesh-list
2024868|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
2024869|NCT01405924|Aprepitant|aprepitant|mesh-list
2024870|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2024871|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
2024872|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
2024873|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024874|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024875|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2024876|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
2024877|NCT01405924|Hormones|hormones|mesh-ancestor
2024878|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2024879|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2024880|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024881|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2024882|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024883|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024884|NCT01405937|Ribavirin|ribavirin|mesh-list
2024885|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
2024886|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024887|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
2024888|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2024889|NCT01405950|Clonidine|clonidine|mesh-list
2024890|NCT01405950|Tizanidine|tizanidine|mesh-list
2024891|NCT01405950|Analgesics|analgesics|mesh-ancestor
2024892|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
2024893|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024894|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024895|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
2024896|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2024897|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2024898|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
2024899|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
2024900|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2024901|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2024902|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2024903|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
2024904|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024905|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024906|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2024907|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
2024908|NCT01406015|Spironolactone|spironolactone|mesh-list
2024909|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2024910|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
2024911|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2024912|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024913|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2024914|NCT01406015|Diuretics|diuretics|mesh-ancestor
2024915|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
2024916|NCT01406223|Bupropion|bupropion|mesh-list
2024917|NCT01406223|Nicotine|nicotine|mesh-list
2024918|NCT01406223|Varenicline|varenicline|mesh-list
2024919|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2024920|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
2024921|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024922|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024923|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2024924|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2024925|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
2024926|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024927|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024928|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2024929|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
2024930|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2024931|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2024932|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2024933|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2024934|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
2024935|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2024936|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2024937|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2024938|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
2024939|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2024940|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2024941|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024942|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2024943|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024944|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2024945|NCT01406795|Heparin|heparin|mesh-list
2024946|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
2024947|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2024948|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2024949|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024950|NCT01406873|Mexiletine|mexiletine|mesh-list
2024951|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2024952|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2024953|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2024954|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2024955|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024956|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2024957|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
2024958|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024959|NCT01407094|Sertraline|sertraline|mesh-list
2024960|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
2024961|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2024962|NCT01407094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2024963|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2024964|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2024965|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024966|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2024967|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
2024968|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024969|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
2024970|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
2024971|NCT01407523|Levetiracetam|levetiracetam|mesh-list
2024972|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
2024973|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
2024974|NCT01407575|Buprenorphine|buprenorphine|mesh-list
2024975|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2024976|NCT01407575|Narcotics|narcotics|mesh-ancestor
2024977|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2024978|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024979|NCT01407575|Analgesics|analgesics|mesh-ancestor
2024980|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
2024981|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2024982|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2024983|NCT01408030|Bevacizumab|bevacizumab|mesh-list
2024984|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
2024985|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
2024986|NCT01408030|Estrogens|estrogens|mesh-list
2024987|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2024988|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2024989|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2024990|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2024991|NCT01408030|Growth Substances|growth substances|mesh-ancestor
2024992|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2024993|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
2024994|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2024995|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2024996|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2024997|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
2024998|NCT01408030|Coagulants|coagulants|mesh-ancestor
2024999|NCT01408030|Hormones|hormones|mesh-ancestor
2025000|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2025001|NCT01408043|Plerixafor|plerixafor|mesh-list
2025002|NCT01408043|Etoposide|etoposide|mesh-list
2025003|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
2025004|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2025005|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025006|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2025007|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2025008|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025009|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025010|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2025011|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2025012|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
2025013|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025014|NCT01408563|Fludarabine|fludarabine|mesh-list
2025015|NCT01408563|Melphalan|melphalan|mesh-list
2025016|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025017|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025018|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2025019|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
2025020|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025021|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2025022|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
2025023|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2025024|NCT01408576|Epratuzumab|epratuzumab|mesh-list
2025025|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2025026|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025027|NCT01408628|Insulin|insulin|mesh-list
2025028|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2025029|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025030|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
2025031|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2025032|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2025033|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2025034|NCT01408888|Dulaglutide|dulaglutide|mesh-list
2025035|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2025036|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025037|NCT01408888|Incretins|incretins|mesh-ancestor
2025038|NCT01408888|Hormones|hormones|mesh-ancestor
2025039|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2025040|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2025041|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
2025042|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025043|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025044|NCT01408901|Molgramostim|molgramostim|mesh-list
2025045|NCT01408901|Sargramostim|sargramostim|mesh-list
2025046|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
2025047|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025048|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025049|NCT01408914|Rifampin|rifampin|mesh-list
2025050|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2025051|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
2025052|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2025053|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025054|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
2025055|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2025056|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025057|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025058|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2025059|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2025060|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2025061|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2025062|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2025063|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2025064|NCT01409239|Insulin|insulin|mesh-list
2025065|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2025066|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2025067|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025068|NCT01409564|Cilostazol|cilostazol|mesh-list
2025069|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2025070|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
2025071|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025072|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025073|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2025074|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
2025075|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2025076|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2025077|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025078|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2025079|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
2025080|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2025081|NCT01409564|Protective Agents|protective agents|mesh-ancestor
2025082|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2025083|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2025084|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025085|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
2025086|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2025087|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025088|NCT01409837|Lisinopril|lisinopril|mesh-list
2025089|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2025090|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
2025091|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025092|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025093|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2025094|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2025095|NCT01409837|Protective Agents|protective agents|mesh-ancestor
2025096|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025097|NCT01409915|Molgramostim|molgramostim|mesh-list
2025098|NCT01409915|Sargramostim|sargramostim|mesh-list
2025099|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
2025100|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025101|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025102|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
2025103|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
2025104|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2025105|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2025106|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025107|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025108|NCT01409993|Urological Agents|urological agents|mesh-ancestor
2025109|NCT01410058|Efavirenz|efavirenz|mesh-list
2025110|NCT01410058|Nevirapine|nevirapine|mesh-list
2025111|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2025112|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2025113|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025114|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025115|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
2025116|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025117|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2025118|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2025119|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2025120|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2025121|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2025122|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2025123|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2025124|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2025125|NCT01410084|Vitamin D|vitamin d|mesh-list
2025126|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
2025127|NCT01410084|Vitamins|vitamins|mesh-list
2025128|NCT01410084|Vitamin E|vitamin e|mesh-list
2025129|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
2025130|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025131|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2025132|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2025133|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
2025134|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025135|NCT01410084|Protective Agents|protective agents|mesh-ancestor
2025136|NCT01410227|Factor VIII|factor viii|mesh-list
2025137|NCT01410227|Coagulants|coagulants|mesh-ancestor
2025138|NCT01410240|Hemostatics|hemostatics|mesh-list
2025139|NCT01410240|Coagulants|coagulants|mesh-ancestor
2025140|NCT01410344|Vidarabine|vidarabine|mesh-list
2025141|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
2025142|NCT01410344|Melphalan|melphalan|mesh-list
2025143|NCT01410344|Busulfan|busulfan|mesh-list
2025144|NCT01410344|Fludarabine|fludarabine|mesh-list
2025145|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
2025146|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2025147|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
2025148|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025149|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2025150|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2025151|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
2025152|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025153|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025154|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2025155|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2025156|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
2025157|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
2025158|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025159|NCT01410409|Acetaminophen|acetaminophen|mesh-list
2025160|NCT01410409|Pantoprazole|pantoprazole|mesh-list
2025161|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2025162|NCT01410409|Analgesics|analgesics|mesh-ancestor
2025163|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
2025164|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025165|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025166|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
2025167|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2025168|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2025169|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2025170|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025171|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025172|NCT01410448|Cyclosporine|cyclosporine|mesh-list
2025173|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
2025174|NCT01410448|Everolimus|everolimus|mesh-list
2025175|NCT01410448|Cyclosporins|cyclosporins|mesh-list
2025176|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025177|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025178|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2025179|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
2025180|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025181|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
2025182|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025183|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
2025184|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2025185|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2025186|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025187|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2025188|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2025189|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
2025190|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2025191|NCT01410565|Apaziquone|apaziquone|mesh-list
2025192|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025193|NCT01410604|Metformin|metformin|mesh-list
2025194|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2025195|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025196|NCT01411085|Risperidone|risperidone|mesh-list
2025197|NCT01411085|Desipramine|desipramine|mesh-list
2025198|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2025199|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
2025200|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025201|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025202|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025203|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2025204|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2025205|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2025206|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2025207|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2025208|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
2025209|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2025210|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
2025211|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025212|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2025213|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2025214|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2025215|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
2025216|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2025217|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2025218|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
2025219|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025220|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2025221|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2025222|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
2025223|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
2025224|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025225|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025226|NCT01411215|Etanercept|etanercept|mesh-list
2025227|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2025228|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2025229|NCT01411215|Analgesics|analgesics|mesh-ancestor
2025230|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
2025231|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025232|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025233|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2025234|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2025235|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2025236|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2025237|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
2025238|NCT01411241|Vaccines|vaccines|mesh-list
2025239|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2025240|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
2025241|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025242|NCT01411267|Cytarabine|cytarabine|mesh-list
2025243|NCT01411267|Methotrexate|methotrexate|mesh-list
2025244|NCT01411267|Etoposide|etoposide|mesh-list
2025245|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
2025246|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2025247|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
2025248|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2025249|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025250|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2025251|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
2025252|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025253|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025254|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
2025255|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025256|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2025257|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2025258|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
2025259|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2025260|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2025261|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2025262|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2025263|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2025264|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
2025265|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025266|NCT01411501|Mosapride|mosapride|mesh-list
2025267|NCT01411501|Citric Acid|citric acid|mesh-list
2025268|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
2025269|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
2025270|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2025271|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
2025272|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
2025273|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025274|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2025275|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2025276|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
2025277|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025278|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025279|NCT01411696|Dexamethasone|dexamethasone|mesh-list
2025280|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2025281|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
2025282|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
2025283|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025284|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025285|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2025286|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
2025287|NCT01411696|Hormones|hormones|mesh-ancestor
2025288|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2025289|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2025290|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025291|NCT01411774|Cycloserine|cycloserine|mesh-list
2025292|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2025293|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025294|NCT01411774|Renal Agents|renal agents|mesh-ancestor
2025295|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2025296|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
2025297|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2025298|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
2025299|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025300|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
2025301|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2025302|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025303|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
2025304|NCT01411995|Lidocaine|lidocaine|mesh-list
2025305|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
2025306|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
2025307|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2025308|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025309|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
2025310|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025311|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2025312|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2025313|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2025314|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2025315|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025316|NCT01412060|Cariprazine|cariprazine|mesh-list
2025317|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2025318|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2025319|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2025320|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025321|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2025322|NCT01412164|Sirolimus|sirolimus|mesh-list
2025323|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2025324|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025325|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2025326|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025327|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
2025328|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2025329|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
2025330|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025331|NCT01412229|Paclitaxel|paclitaxel|mesh-list
2025332|NCT01412229|Carboplatin|carboplatin|mesh-list
2025333|NCT01412229|Cetuximab|cetuximab|mesh-list
2025334|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2025335|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025336|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
2025337|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
2025338|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
2025339|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025340|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2025341|NCT01412281|Vaccines|vaccines|mesh-list
2025342|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
2025343|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025354|NCT01412372|Mesalamine|mesalamine|mesh-list
2025355|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2025356|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2025357|NCT01412372|Analgesics|analgesics|mesh-ancestor
2025358|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
2025359|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025360|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025361|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2025362|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2025363|NCT01412424|Octreotide|octreotide|mesh-list
2025364|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2025365|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2025366|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025367|NCT01412710|Vitamin D|vitamin d|mesh-list
2025368|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
2025369|NCT01412710|Vitamins|vitamins|mesh-ancestor
2025370|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
2025371|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025372|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2025373|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2025374|NCT01412879|Leucovorin|leucovorin|mesh-list
2025375|NCT01412879|Cytarabine|cytarabine|mesh-list
2025376|NCT01412879|Dexamethasone|dexamethasone|mesh-list
2025377|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
2025378|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2025379|NCT01412879|Rituximab|rituximab|mesh-list
2025380|NCT01412879|Doxorubicin|doxorubicin|mesh-list
2025381|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2025382|NCT01412879|Methotrexate|methotrexate|mesh-list
2025383|NCT01412879|Vincristine|vincristine|mesh-list
2025384|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
2025385|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2025386|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
2025387|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025388|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2025389|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2025390|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
2025391|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025392|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025393|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2025394|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2025395|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
2025396|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
2025397|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025398|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2025399|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
2025400|NCT01412879|Hormones|hormones|mesh-ancestor
2025401|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2025402|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2025403|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2025404|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2025405|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2025406|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2025407|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025408|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2025409|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
2025410|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2025411|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2025412|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
2025413|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
2025414|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2025415|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2025416|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
2025417|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025418|NCT01412879|Antidotes|antidotes|mesh-ancestor
2025419|NCT01412879|Protective Agents|protective agents|mesh-ancestor
2025420|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
2025421|NCT01412879|Vitamins|vitamins|mesh-ancestor
2025422|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
2025423|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2025424|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
2025425|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
2025426|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
2025427|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2025428|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
2025429|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025430|NCT01412957|Panitumumab|panitumumab|mesh-list
2025431|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2025432|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025433|NCT01413178|Melphalan|melphalan|mesh-list
2025434|NCT01413178|Busulfan|busulfan|mesh-list
2025435|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
2025436|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025437|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2025438|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
2025439|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025440|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025441|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2025442|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2025443|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2025444|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
2025445|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025446|NCT01413360|Vitamins|vitamins|mesh-list
2025447|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
2025448|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
2025449|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025450|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
2025451|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025452|NCT01413360|Protective Agents|protective agents|mesh-ancestor
2025453|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2025454|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025455|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025456|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025457|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2025458|NCT01413516|Varenicline|varenicline|mesh-list
2025459|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2025460|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2025461|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
2025462|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025463|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025464|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025465|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2025466|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2025467|NCT01413542|Enalaprilat|enalaprilat|mesh-list
2025468|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2025469|NCT01413542|Bradykinin|bradykinin|mesh-list
2025470|NCT01413542|Glucagon|glucagon|mesh-list
2025471|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2025472|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2025473|NCT01413542|Substance P|substance p|mesh-list
2025474|NCT01413542|Neurokinin A|neurokinin a|mesh-list
2025475|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2025476|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025477|NCT01413542|Incretins|incretins|mesh-ancestor
2025478|NCT01413542|Hormones|hormones|mesh-ancestor
2025479|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2025480|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
2025481|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025482|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025483|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2025484|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
2025485|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
2025486|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2025487|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025488|NCT01413750|Paclitaxel|paclitaxel|mesh-list
2025489|NCT01413750|Carboplatin|carboplatin|mesh-list
2025490|NCT01413750|Vorinostat|vorinostat|mesh-list
2025491|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2025492|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025493|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
2025494|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
2025495|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
2025496|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025497|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2025498|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025499|NCT01413958|Loratadine|loratadine|mesh-list
2025500|NCT01413958|Phenylephrine|phenylephrine|mesh-list
2025501|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
2025502|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2025503|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
2025504|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
2025505|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025506|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025507|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
2025508|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2025509|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
2025510|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
2025511|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2025512|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2025513|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2025514|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
2025515|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025516|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025517|NCT01413958|Protective Agents|protective agents|mesh-ancestor
2025518|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
2025519|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
2025520|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2025521|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2025522|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2025523|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
2025524|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
2025525|NCT01414010|Amoxicillin|amoxicillin|mesh-list
2025526|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2025527|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025528|NCT01414075|Iron|iron|mesh-list
2025529|NCT01414075|Trace Elements|trace elements|mesh-ancestor
2025530|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
2025531|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025532|NCT01414153|Bevacizumab|bevacizumab|mesh-list
2025533|NCT01414153|Ranibizumab|ranibizumab|mesh-list
2025534|NCT01414153|Aflibercept|aflibercept|mesh-list
2025535|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2025536|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2025537|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025538|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2025539|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2025540|NCT01414153|Growth Substances|growth substances|mesh-ancestor
2025541|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025542|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
2025543|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
2025544|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
2025545|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2025546|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025547|NCT01414257|Methotrexate|methotrexate|mesh-list
2025548|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2025549|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
2025550|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2025551|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025552|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2025553|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
2025554|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025555|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025556|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
2025557|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025558|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2025559|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2025560|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
2025561|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2025562|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2025563|NCT01414855|Prednisone|prednisone|mesh-list
2025564|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
2025565|NCT01414855|Doxorubicin|doxorubicin|mesh-list
2025566|NCT01414855|Vincristine|vincristine|mesh-list
2025567|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
2025568|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2025569|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
2025570|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025571|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2025572|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2025573|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
2025574|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025575|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025576|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2025577|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2025578|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2025579|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2025580|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025581|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2025582|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
2025583|NCT01414855|Hormones|hormones|mesh-ancestor
2025584|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2025585|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2025586|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2025587|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
2025588|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
2025589|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
2025590|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2025591|NCT01415349|Omeprazole|omeprazole|mesh-list
2025592|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2025593|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2025594|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2025595|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025596|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025597|NCT01415401|Timolol|timolol|mesh-list
2025598|NCT01415401|Brinzolamide|brinzolamide|mesh-list
2025599|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2025600|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2025601|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
2025602|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025603|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025604|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025605|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2025606|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2025607|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025608|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2025609|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2025610|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2025611|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025612|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2025613|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2025614|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2025615|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025616|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
2025617|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025618|NCT01415518|Budesonide|budesonide|mesh-list
2025619|NCT01415518|Theophylline|theophylline|mesh-list
2025620|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
2025621|NCT01415518|Ipratropium|ipratropium|mesh-list
2025622|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2025623|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2025624|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2025625|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
2025626|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025627|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025628|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2025629|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
2025630|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
2025631|NCT01415518|Hormones|hormones|mesh-ancestor
2025632|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2025633|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2025634|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2025635|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2025636|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
2025637|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025638|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025639|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2025640|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
2025641|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2025642|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025643|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
2025644|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2025645|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2025646|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
2025647|NCT01415531|Nebivolol|nebivolol|mesh-list
2025648|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2025649|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
2025650|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2025651|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2025652|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2025653|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
2025654|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025655|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025656|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025657|NCT01415583|Dexamethasone|dexamethasone|mesh-list
2025658|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2025659|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
2025660|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
2025661|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025662|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025663|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2025664|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
2025665|NCT01415583|Hormones|hormones|mesh-ancestor
2025666|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2025667|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2025668|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025669|NCT01415921|Bromides|bromides|mesh-list
2025670|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2025671|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
2025672|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2025673|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025674|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025675|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
2025676|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025677|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025678|NCT01415960|Leuprolide|leuprolide|mesh-list
2025679|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2025680|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
2025681|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2025682|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025683|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2025684|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025685|NCT01416155|Natalizumab|natalizumab|mesh-list
2025686|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
2025687|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025688|NCT01416181|Natalizumab|natalizumab|mesh-list
2025689|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
2025690|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025691|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2025692|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
2025693|NCT01416194|Diphosphonates|diphosphonates|mesh-list
2025694|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2025695|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
2025696|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2025697|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025698|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2025699|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2025700|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2025701|NCT01416389|Lenograstim|lenograstim|mesh-list
2025702|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2025703|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
2025704|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025705|NCT01416441|Aripiprazole|aripiprazole|mesh-list
2025706|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
2025707|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2025708|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2025709|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2025710|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2025711|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025712|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
2025713|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
2025714|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025715|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025716|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2025717|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2025718|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
2025719|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2025720|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2025721|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2025722|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2025723|NCT01416584|Methadone|methadone|mesh-list
2025724|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2025725|NCT01416584|Narcotics|narcotics|mesh-ancestor
2025726|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2025727|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025728|NCT01416584|Analgesics|analgesics|mesh-ancestor
2025729|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
2025730|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025731|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
2025732|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
2025733|NCT01416636|Treprostinil|treprostinil|mesh-list
2025734|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2025735|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
2025736|NCT01417000|Pancrelipase|pancrelipase|mesh-list
2025737|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2025738|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
2025739|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025740|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2025741|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2025742|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
2025743|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025744|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025745|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2025746|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2025747|NCT01417026|Oxytocin|oxytocin|mesh-list
2025748|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
2025749|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2025750|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025751|NCT01417078|Diazepam|diazepam|mesh-list
2025752|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2025753|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
2025754|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
2025755|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
2025756|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025757|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025758|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2025759|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2025760|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2025761|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2025762|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2025763|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2025764|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2025765|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2025766|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2025767|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
2025768|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
2025769|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
2025770|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
2025771|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025772|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025773|NCT01417156|Nintedanib|nintedanib|mesh-list
2025774|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025775|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2025776|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025777|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025778|NCT01417195|Menotropins|menotropins|mesh-list
2025779|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2025780|NCT01417195|Hormones|hormones|mesh-ancestor
2025781|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2025782|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025783|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2025784|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
2025785|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2025786|NCT01417481|Glycine|glycine|mesh-list
2025787|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
2025788|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025789|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025790|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025791|NCT01418001|Gemcitabine|gemcitabine|mesh-list
2025792|NCT01418001|Docetaxel|docetaxel|mesh-list
2025793|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2025794|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
2025795|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025796|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025797|NCT01418001|Antiviral Agents|antiviral agents|mesh-ancestor
2025798|NCT01418001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025799|NCT01418001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025800|NCT01418001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2025801|NCT01418001|Immunologic Factors|immunologic factors|mesh-ancestor
2025802|NCT01418001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025803|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
2025804|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
2025805|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
2025806|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2025807|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2025808|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2025809|NCT01418209|Estradiol|estradiol|mesh-list
2025810|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2025811|NCT01418209|Progesterone|progesterone|mesh-list
2025812|NCT01418209|Estrogens|estrogens|mesh-ancestor
2025813|NCT01418209|Hormones|hormones|mesh-ancestor
2025814|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2025815|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025816|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2025817|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
2025818|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2025819|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2025820|NCT01418209|Progestins|progestins|mesh-ancestor
2025821|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2025822|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2025823|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2025824|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025825|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025826|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2025827|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
2025828|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2025829|NCT01418339|Aripiprazole|aripiprazole|mesh-list
2025830|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
2025831|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2025832|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2025833|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2025834|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2025835|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025836|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
2025837|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
2025838|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025839|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025840|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2025841|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2025842|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
2025843|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2025844|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2025845|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2025846|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2025847|NCT01418352|Aripiprazole|aripiprazole|mesh-list
2025848|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
2025849|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2025850|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2025851|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2025852|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2025853|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025854|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
2025855|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
2025856|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2025857|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025858|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2025859|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2025860|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
2025861|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2025862|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2025863|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2025864|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2025865|NCT01418365|Metronidazole|metronidazole|mesh-list
2025866|NCT01418365|Mesalamine|mesalamine|mesh-list
2025867|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025868|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2025869|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2025870|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2025871|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2025872|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2025873|NCT01418365|Analgesics|analgesics|mesh-ancestor
2025874|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
2025875|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025876|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025877|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2025878|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2025879|NCT01419184|Vancomycin|vancomycin|mesh-list
2025880|NCT01419184|Daptomycin|daptomycin|mesh-list
2025881|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2025882|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025883|NCT01419197|Trastuzumab|trastuzumab|mesh-list
2025884|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2025885|NCT01419197|Maytansine|maytansine|mesh-list
2025886|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2025887|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025888|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2025889|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
2025890|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
2025891|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
2025892|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025893|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2025894|NCT01419236|Testosterone|testosterone|mesh-list
2025895|NCT01419236|Androgens|androgens|mesh-ancestor
2025896|NCT01419236|Hormones|hormones|mesh-ancestor
2025897|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2025898|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025899|NCT01419275|Xenon|xenon|mesh-list
2025900|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2025901|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
2025902|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
2025903|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2025904|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025905|NCT01419535|Mifepristone|mifepristone|mesh-list
2025906|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2025907|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
2025908|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2025909|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025910|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2025911|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2025912|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2025913|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
2025914|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2025915|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2025916|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
2025917|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2025918|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
2025919|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2025920|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2025921|NCT01419639|Everolimus|everolimus|mesh-list
2025922|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025923|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2025924|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
2025925|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025926|NCT01419665|Rituximab|rituximab|mesh-list
2025927|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2025928|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025929|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
2025930|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025931|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2025932|NCT01419717|Denosumab|denosumab|mesh-list
2025933|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2025934|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025935|NCT01419795|Rituximab|rituximab|mesh-list
2025936|NCT01419795|Lenalidomide|lenalidomide|mesh-list
2025937|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2025938|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025939|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
2025940|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025941|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2025942|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2025943|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2025944|NCT01419795|Growth Substances|growth substances|mesh-ancestor
2025945|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
2025946|NCT01419977|Dalteparin|dalteparin|mesh-list
2025947|NCT01419977|Tinzaparin|tinzaparin|mesh-list
2025948|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2025949|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
2025950|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2025951|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2025952|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025953|NCT01420081|Gedatolisib|gedatolisib|mesh-list
2025954|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2025955|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025956|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025957|NCT01420146|Trastuzumab|trastuzumab|mesh-list
2025958|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2025959|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025960|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
2025961|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2025962|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
2025963|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
2025964|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
2025965|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2025966|NCT01420549|Simvastatin|simvastatin|mesh-list
2025967|NCT01420549|Ezetimibe|ezetimibe|mesh-list
2025968|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2025969|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2025970|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
2025971|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025972|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2025973|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2025974|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025975|NCT01420653|Acetaminophen|acetaminophen|mesh-list
2025976|NCT01420653|Ibuprofen|ibuprofen|mesh-list
2025977|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2025978|NCT01420653|Analgesics|analgesics|mesh-ancestor
2025979|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
2025980|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2025981|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2025982|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
2025983|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2025984|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2025985|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2025986|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2025987|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025988|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025989|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
2025990|NCT01420679|Aminopterin|aminopterin|mesh-list
2025991|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2025992|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2025993|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2025994|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025995|NCT01420926|Bortezomib|bortezomib|mesh-list
2025996|NCT01420926|Decitabine|decitabine|mesh-list
2025997|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2025998|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2025999|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
2026000|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026001|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026002|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
2026003|NCT01421017|Imiquimod|imiquimod|mesh-list
2026004|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2026005|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
2026006|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026007|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2026008|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2026009|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
2026010|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026011|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026012|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2026013|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2026014|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
2026015|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2026016|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2026017|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2026018|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026019|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026020|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2026021|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2026022|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2026023|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2026024|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
2026025|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026026|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026027|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2026028|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2026029|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
2026030|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2026031|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2026032|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
2026033|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
2026034|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2026035|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026036|NCT01421186|Dexamethasone|dexamethasone|mesh-list
2026037|NCT01421186|Lenalidomide|lenalidomide|mesh-list
2026038|NCT01421186|Pomalidomide|pomalidomide|mesh-list
2026039|NCT01421186|Felzartamab|felzartamab|mesh-list
2026040|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026041|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
2026042|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
2026043|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026044|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026045|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2026046|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
2026047|NCT01421186|Hormones|hormones|mesh-ancestor
2026048|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026049|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2026050|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026051|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
2026052|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2026053|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2026054|NCT01421186|Growth Substances|growth substances|mesh-ancestor
2026055|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
2026056|NCT01421225|Insulin|insulin|mesh-list
2026057|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2026058|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2026059|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026060|NCT01421303|Etanercept|etanercept|mesh-list
2026061|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2026062|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2026063|NCT01421303|Analgesics|analgesics|mesh-ancestor
2026064|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
2026065|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026066|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026067|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026068|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2026069|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2026070|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2026071|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
2026072|NCT01421342|Aripiprazole|aripiprazole|mesh-list
2026073|NCT01421342|Bupropion|bupropion|mesh-list
2026074|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
2026075|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2026076|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2026077|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2026078|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2026079|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2026080|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026081|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
2026082|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026083|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026084|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2026085|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2026086|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026087|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2026088|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2026089|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026090|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
2026091|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2026092|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2026093|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
2026094|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2026095|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2026096|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2026097|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2026098|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2026099|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2026100|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2026101|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
2026102|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026103|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026104|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2026105|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2026106|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
2026107|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026108|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
2026109|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2026110|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026111|NCT01421472|Paclitaxel|paclitaxel|mesh-list
2026112|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2026113|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026114|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
2026115|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
2026116|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
2026117|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026118|NCT01421498|Lifitegrast|lifitegrast|mesh-list
2026119|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2026120|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2026121|NCT01421511|Linezolid|linezolid|mesh-list
2026122|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2026123|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026124|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2026125|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026126|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026127|NCT01421589|Hormones|hormones|mesh-list
2026128|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026129|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026130|NCT01421641|Lidocaine|lidocaine|mesh-list
2026131|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
2026132|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
2026133|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026134|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026135|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
2026136|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026137|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2026138|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2026139|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2026140|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2026141|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026142|NCT01421667|Rituximab|rituximab|mesh-list
2026143|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2026144|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2026145|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026146|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
2026147|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026148|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2026149|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2026150|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2026151|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026152|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026153|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2026154|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2026155|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026156|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
2026157|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026158|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
2026159|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2026160|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026161|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
2026162|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2026163|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2026164|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2026165|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026166|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
2026167|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026168|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026169|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2026170|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026171|NCT01422200|Vaccines|vaccines|mesh-list
2026172|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
2026173|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026174|NCT01422213|Vortioxetine|vortioxetine|mesh-list
2026175|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
2026176|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2026177|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2026178|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2026179|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026180|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026181|NCT01422213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2026182|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2026183|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2026184|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026185|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026186|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
2026187|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2026188|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2026189|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2026190|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2026191|NCT01422226|Alprostadil|alprostadil|mesh-list
2026192|NCT01422226|Misoprostol|misoprostol|mesh-list
2026193|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2026194|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
2026195|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2026196|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026197|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2026198|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2026199|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
2026200|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2026201|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
2026202|NCT01422226|Urological Agents|urological agents|mesh-ancestor
2026203|NCT01422304|Atropine|atropine|mesh-list
2026204|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
2026205|NCT01422304|Neostigmine|neostigmine|mesh-list
2026206|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2026207|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2026208|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2026209|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
2026210|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026211|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026212|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2026213|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
2026214|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
2026215|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
2026216|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2026217|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2026218|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
2026219|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026220|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026221|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2026222|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026223|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2026224|NCT01422369|Ritonavir|ritonavir|mesh-list
2026225|NCT01422369|Darunavir|darunavir|mesh-list
2026226|NCT01422369|Pitavastatin|pitavastatin|mesh-list
2026227|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2026228|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2026229|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
2026230|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026231|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026232|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2026233|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2026234|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
2026235|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026236|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2026237|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2026238|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2026239|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2026240|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2026241|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
2026242|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2026243|NCT01422382|Diltiazem|diltiazem|mesh-list
2026244|NCT01422382|Pitavastatin|pitavastatin|mesh-list
2026245|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2026246|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2026247|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2026248|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026249|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2026250|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026251|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
2026252|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2026253|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2026254|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2026255|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
2026256|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026257|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2026258|NCT01422408|Fluocinonide|fluocinonide|mesh-list
2026259|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026260|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
2026261|NCT01422408|Hormones|hormones|mesh-ancestor
2026262|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026263|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026264|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2026265|NCT01422434|Calcitriol|calcitriol|mesh-list
2026266|NCT01422434|Betamethasone|betamethasone|mesh-list
2026267|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
2026268|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2026269|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
2026270|NCT01422434|Calcipotriene|calcipotriene|mesh-list
2026271|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2026272|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026273|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
2026274|NCT01422434|Hormones|hormones|mesh-ancestor
2026275|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026276|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026277|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2026278|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
2026279|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
2026280|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2026281|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2026282|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2026283|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026284|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2026285|NCT01422434|Vitamins|vitamins|mesh-ancestor
2026286|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
2026287|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2026288|NCT01422538|Mannitol|mannitol|mesh-list
2026289|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2026290|NCT01422538|Diuretics|diuretics|mesh-ancestor
2026291|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
2026292|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026293|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2026294|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
2026295|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2026296|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2026297|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2026298|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026299|NCT01422876|Linagliptin|linagliptin|mesh-list
2026300|NCT01422876|Empagliflozin|empagliflozin|mesh-list
2026301|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2026302|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026303|NCT01422876|Incretins|incretins|mesh-ancestor
2026304|NCT01422876|Hormones|hormones|mesh-ancestor
2026305|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026306|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2026307|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
2026308|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026309|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026310|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2026311|NCT01422915|Colestipol|colestipol|mesh-list
2026312|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2026313|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
2026314|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026315|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2026316|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
2026317|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
2026318|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
2026319|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026320|NCT01423162|Protective Agents|protective agents|mesh-ancestor
2026321|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026322|NCT01423162|Vitamins|vitamins|mesh-ancestor
2026323|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
2026324|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2026325|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2026326|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2026327|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026328|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026329|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2026330|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2026331|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2026332|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2026333|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
2026334|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026335|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026336|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2026337|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2026338|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
2026339|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2026340|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2026341|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
2026342|NCT01423604|Capecitabine|capecitabine|mesh-list
2026343|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2026344|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
2026345|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026346|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026347|NCT01423812|Ritonavir|ritonavir|mesh-list
2026348|NCT01423812|Darunavir|darunavir|mesh-list
2026349|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2026350|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2026351|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
2026352|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026353|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026354|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2026355|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2026356|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
2026357|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026358|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2026359|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2026360|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
2026361|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2026362|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026363|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2026364|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2026365|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026366|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026367|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026368|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
2026369|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2026370|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
2026371|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026372|NCT01424033|Expectorants|expectorants|mesh-ancestor
2026373|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
2026374|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2026375|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
2026376|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026377|NCT01424033|Protective Agents|protective agents|mesh-ancestor
2026378|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026379|NCT01424033|Antidotes|antidotes|mesh-ancestor
2026380|NCT01424228|Prucalopride|prucalopride|mesh-list
2026381|NCT01424228|Laxatives|laxatives|mesh-ancestor
2026382|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2026383|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2026384|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2026385|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
2026386|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026387|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026388|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026389|NCT01424566|Nabiximols|nabiximols|mesh-list
2026390|NCT01424566|Analgesics|analgesics|mesh-ancestor
2026391|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
2026392|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026393|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026394|NCT01424644|Vaccines|vaccines|mesh-list
2026395|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
2026396|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026397|NCT01424813|Albuterol|albuterol|mesh-list
2026398|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2026399|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
2026400|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026401|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026402|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2026403|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
2026404|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
2026405|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2026406|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2026407|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2026408|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2026409|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
2026410|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026411|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026412|NCT01424930|Prednisone|prednisone|mesh-list
2026413|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026414|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
2026415|NCT01424930|Hormones|hormones|mesh-ancestor
2026416|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026417|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026418|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2026419|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026420|NCT01425203|Ribavirin|ribavirin|mesh-list
2026421|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2026422|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
2026423|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026424|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
2026425|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026426|NCT01425229|Bosentan|bosentan|mesh-list
2026427|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2026428|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2026429|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026430|NCT01425281|Everolimus|everolimus|mesh-list
2026431|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026432|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2026433|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
2026434|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026435|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
2026436|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026437|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
2026438|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026439|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026440|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2026441|NCT01425359|Ranolazine|ranolazine|mesh-list
2026442|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2026443|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2026444|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026445|NCT01425463|Glycine|glycine|mesh-list
2026446|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
2026447|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026448|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026449|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026450|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
2026451|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2026452|NCT01425801|Albuterol|albuterol|mesh-list
2026453|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2026454|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
2026455|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026456|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026457|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2026458|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
2026459|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
2026460|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2026461|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2026462|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2026463|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2026464|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
2026465|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026466|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026467|NCT01425853|Celecoxib|celecoxib|mesh-list
2026468|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2026469|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2026470|NCT01425853|Analgesics|analgesics|mesh-ancestor
2026471|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
2026472|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026473|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026474|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026475|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2026476|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2026477|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2026478|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026479|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026480|NCT01426009|Bromides|bromides|mesh-list
2026481|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
2026482|NCT01426009|Ipratropium|ipratropium|mesh-list
2026483|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2026484|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
2026485|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026486|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026487|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2026488|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
2026489|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
2026490|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2026491|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
2026492|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026493|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026494|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
2026495|NCT01426269|Metronidazole|metronidazole|mesh-list
2026496|NCT01426269|Doxycycline|doxycycline|mesh-list
2026497|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026498|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2026499|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2026500|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2026501|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
2026502|NCT01426347|Vitamin D|vitamin d|mesh-list
2026503|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
2026504|NCT01426347|Vitamins|vitamins|mesh-ancestor
2026505|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
2026506|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026507|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2026508|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2026509|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
2026510|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2026511|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2026512|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2026513|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
2026514|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026515|NCT01426438|Aspirin|aspirin|mesh-list
2026516|NCT01426438|Niacin|niacin|mesh-list
2026517|NCT01426438|Fenofibrate|fenofibrate|mesh-list
2026518|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2026519|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2026520|NCT01426438|Analgesics|analgesics|mesh-ancestor
2026521|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
2026522|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026523|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026524|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026525|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2026526|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2026527|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2026528|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026529|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2026530|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2026531|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026532|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
2026533|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2026534|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
2026535|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2026536|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
2026537|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
2026538|NCT01426438|Vitamins|vitamins|mesh-ancestor
2026539|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
2026540|NCT01426763|Complement C1s|complement c1s|mesh-list
2026541|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2026542|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2026543|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
2026544|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026545|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2026546|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2026547|NCT01426854|Nepafenac|nepafenac|mesh-list
2026548|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2026549|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2026550|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2026551|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2026552|NCT01426854|Analgesics|analgesics|mesh-ancestor
2026553|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
2026554|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026555|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026556|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026557|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2026558|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2026559|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2026560|NCT01426867|Brinzolamide|brinzolamide|mesh-list
2026561|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2026562|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2026563|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2026564|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2026565|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2026566|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
2026567|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026568|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026569|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026570|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2026571|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026572|NCT01426958|Ritonavir|ritonavir|mesh-list
2026573|NCT01426958|Afatinib|afatinib|mesh-list
2026574|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2026575|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2026576|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
2026577|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026578|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026579|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2026580|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2026581|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
2026582|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026583|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2026584|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2026585|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026586|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2026587|NCT01427309|Vaccines|vaccines|mesh-list
2026588|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
2026589|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026590|NCT01427504|Etravirine|etravirine|mesh-list
2026591|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2026592|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2026593|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026594|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026595|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
2026596|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026597|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
2026598|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2026599|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
2026600|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026601|NCT01427517|Expectorants|expectorants|mesh-ancestor
2026602|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
2026603|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2026604|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
2026605|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026606|NCT01427517|Protective Agents|protective agents|mesh-ancestor
2026607|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026608|NCT01427517|Antidotes|antidotes|mesh-ancestor
2026609|NCT01427595|Metformin|metformin|mesh-list
2026610|NCT01427595|Progesterone|progesterone|mesh-list
2026611|NCT01427595|Estradiol|estradiol|mesh-list
2026612|NCT01427595|Estrogens|estrogens|mesh-list
2026613|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2026614|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026615|NCT01427595|Progestins|progestins|mesh-ancestor
2026616|NCT01427595|Hormones|hormones|mesh-ancestor
2026617|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026618|NCT01427608|Olanzapine|olanzapine|mesh-list
2026619|NCT01427608|Sertraline|sertraline|mesh-list
2026620|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
2026621|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
2026622|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026623|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026624|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2026625|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2026626|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2026627|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026628|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2026629|NCT01427608|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2026630|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2026631|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2026632|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026633|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026634|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
2026635|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
2026636|NCT01427738|Nystatin|nystatin|mesh-list
2026637|NCT01427738|Gentian Violet|gentian violet|mesh-list
2026638|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2026639|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026640|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
2026641|NCT01427738|Ionophores|ionophores|mesh-ancestor
2026642|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2026643|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026644|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2026645|NCT01427751|Dexamethasone|dexamethasone|mesh-list
2026646|NCT01427751|Ranibizumab|ranibizumab|mesh-list
2026647|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026648|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
2026649|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
2026650|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026651|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026652|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2026653|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
2026654|NCT01427751|Hormones|hormones|mesh-ancestor
2026655|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026656|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2026657|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026658|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2026659|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2026660|NCT01427751|Growth Substances|growth substances|mesh-ancestor
2026661|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
2026662|NCT01427803|Naproxen|naproxen|mesh-list
2026663|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2026664|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2026665|NCT01427803|Analgesics|analgesics|mesh-ancestor
2026666|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
2026667|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026668|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026669|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026670|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2026671|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
2026672|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2026673|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026674|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026675|NCT01427881|Cyclosporine|cyclosporine|mesh-list
2026676|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
2026677|NCT01427881|Busulfan|busulfan|mesh-list
2026678|NCT01427881|Fludarabine|fludarabine|mesh-list
2026679|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
2026680|NCT01427881|Cyclosporins|cyclosporins|mesh-list
2026681|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2026682|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
2026683|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026684|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2026685|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2026686|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
2026687|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026688|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026689|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2026690|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2026691|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
2026692|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026693|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
2026694|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026695|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
2026696|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2026697|NCT01427907|Calcium|calcium|mesh-list
2026698|NCT01427907|Sevelamer|sevelamer|mesh-list
2026699|NCT01427907|Calcium acetate|calcium acetate|mesh-list
2026700|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2026701|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026702|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
2026703|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
2026704|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026705|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
2026706|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
2026707|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2026708|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2026709|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026710|NCT01427933|Ramucirumab|ramucirumab|mesh-list
2026711|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026712|NCT01427972|Eplerenone|eplerenone|mesh-list
2026713|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2026714|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
2026715|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026716|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026717|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2026718|NCT01427972|Diuretics|diuretics|mesh-ancestor
2026719|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
2026720|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2026721|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
2026722|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2026723|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
2026724|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026725|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
2026726|NCT01428024|Protective Agents|protective agents|mesh-ancestor
2026727|NCT01428063|Interferons|interferons|mesh-list
2026728|NCT01428063|Ribavirin|ribavirin|mesh-list
2026729|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
2026730|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
2026731|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2026732|NCT01428063|Asunaprevir|asunaprevir|mesh-list
2026733|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026734|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
2026735|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026736|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
2026737|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026738|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
2026739|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026740|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
2026741|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026742|NCT01428076|Polidocanol|polidocanol|mesh-list
2026743|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2026744|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2026745|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
2026746|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026747|NCT01428193|Flutamide|flutamide|mesh-list
2026748|NCT01428193|Estradiol|estradiol|mesh-list
2026749|NCT01428193|Progesterone|progesterone|mesh-list
2026750|NCT01428193|Estrogens|estrogens|mesh-ancestor
2026751|NCT01428193|Hormones|hormones|mesh-ancestor
2026752|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026753|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026754|NCT01428193|Progestins|progestins|mesh-ancestor
2026755|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
2026756|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
2026757|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2026758|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026759|NCT01428245|Estradiol|estradiol|mesh-list
2026760|NCT01428245|Estrogens|estrogens|mesh-list
2026761|NCT01428245|Progesterone|progesterone|mesh-list
2026762|NCT01428245|Hormones|hormones|mesh-ancestor
2026763|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026764|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026765|NCT01428245|Progestins|progestins|mesh-ancestor
2026766|NCT01428258|Coal Tar|coal tar|mesh-list
2026767|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
2026768|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
2026769|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2026770|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2026771|NCT01428336|Cosyntropin|cosyntropin|mesh-list
2026772|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
2026773|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026774|NCT01428336|Hormones|hormones|mesh-ancestor
2026775|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026776|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026777|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026778|NCT01428583|Naltrexone|naltrexone|mesh-list
2026779|NCT01428583|Oxycodone|oxycodone|mesh-list
2026780|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2026781|NCT01428583|Narcotics|narcotics|mesh-ancestor
2026782|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026783|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026784|NCT01428583|Analgesics|analgesics|mesh-ancestor
2026785|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
2026786|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026787|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2026788|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2026789|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
2026790|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
2026791|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
2026792|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2026793|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2026794|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2026795|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026796|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
2026797|NCT01428713|Coagulants|coagulants|mesh-ancestor
2026798|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2026799|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026800|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2026801|NCT01428882|Midazolam|midazolam|mesh-list
2026802|NCT01428882|Propofol|propofol|mesh-list
2026803|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2026804|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026805|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026806|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2026807|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
2026808|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
2026809|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2026810|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2026811|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2026812|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2026813|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
2026814|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
2026815|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026816|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026817|NCT01429051|Fentanyl|fentanyl|mesh-list
2026818|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2026819|NCT01429051|Narcotics|narcotics|mesh-ancestor
2026820|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026821|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026822|NCT01429051|Analgesics|analgesics|mesh-ancestor
2026823|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
2026824|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026825|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2026826|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2026827|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
2026828|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
2026829|NCT01429077|Levodopa|levodopa|mesh-list
2026830|NCT01429077|Carbidopa|carbidopa|mesh-list
2026831|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2026832|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2026833|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
2026834|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026835|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026836|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026837|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2026838|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026839|NCT01429259|Meropenem|meropenem|mesh-list
2026840|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2026841|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026842|NCT01429272|Aspirin|aspirin|mesh-list
2026843|NCT01429272|Minocycline|minocycline|mesh-list
2026844|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2026845|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2026846|NCT01429272|Analgesics|analgesics|mesh-ancestor
2026847|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
2026848|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026849|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026850|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026851|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2026852|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2026853|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2026854|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026855|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2026856|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2026857|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026858|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
2026859|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2026860|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026861|NCT01429285|Hydromorphone|hydromorphone|mesh-list
2026862|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2026863|NCT01429285|Narcotics|narcotics|mesh-ancestor
2026864|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026865|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026866|NCT01429285|Analgesics|analgesics|mesh-ancestor
2026867|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
2026868|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026869|NCT01429298|Hydromorphone|hydromorphone|mesh-list
2026870|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2026871|NCT01429298|Narcotics|narcotics|mesh-ancestor
2026872|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026873|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026874|NCT01429298|Analgesics|analgesics|mesh-ancestor
2026875|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
2026876|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026877|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2026878|NCT01429350|Plasminogen|plasminogen|mesh-list
2026879|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2026880|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2026881|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026882|NCT01429584|Bupivacaine|bupivacaine|mesh-list
2026883|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
2026884|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
2026885|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026886|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026887|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
2026888|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026889|NCT01429792|Ribavirin|ribavirin|mesh-list
2026890|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2026891|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
2026892|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026893|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
2026894|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2026895|NCT01429987|Plecanatide|plecanatide|mesh-list
2026896|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2026897|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
2026898|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026899|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2026900|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2026901|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2026902|NCT01430104|Teriparatide|teriparatide|mesh-list
2026903|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2026904|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026905|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2026906|NCT01430182|Morphine|morphine|mesh-list
2026907|NCT01430182|Methadone|methadone|mesh-list
2026908|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2026909|NCT01430182|Narcotics|narcotics|mesh-ancestor
2026910|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026911|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026912|NCT01430182|Analgesics|analgesics|mesh-ancestor
2026913|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
2026914|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026915|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
2026916|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
2026917|NCT01430403|Fluticasone|fluticasone|mesh-list
2026918|NCT01430403|Xhance|xhance|mesh-list
2026919|NCT01430403|Omalizumab|omalizumab|mesh-list
2026920|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2026921|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026922|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2026923|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
2026924|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026925|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026926|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2026927|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
2026928|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
2026929|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2026930|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
2026931|NCT01430442|Sumatriptan|sumatriptan|mesh-list
2026932|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2026933|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2026934|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2026935|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
2026936|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2026937|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026938|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026939|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
2026940|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
2026941|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2026942|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2026943|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026944|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026945|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2026946|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2026947|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2026948|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026949|NCT01430559|Meloxicam|meloxicam|mesh-list
2026950|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2026951|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2026952|NCT01430559|Analgesics|analgesics|mesh-ancestor
2026953|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
2026954|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026955|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026956|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026957|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2026958|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2026959|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2026960|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026961|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026962|NCT01430585|Letrozole|letrozole|mesh-list
2026963|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026964|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2026965|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2026966|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026967|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026968|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2026969|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
2026970|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026971|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026972|NCT01430611|Vaccines|vaccines|mesh-list
2026973|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
2026974|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026975|NCT01430819|Vaccines|vaccines|mesh-list
2026976|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
2026977|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026978|NCT01431014|Dexamethasone|dexamethasone|mesh-list
2026979|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
2026980|NCT01431014|BB 1101|bb 1101|mesh-list
2026981|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2026982|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
2026983|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
2026984|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2026985|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2026986|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2026987|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
2026988|NCT01431014|Hormones|hormones|mesh-ancestor
2026989|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2026990|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2026991|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2026992|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
2026993|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2026994|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2026995|NCT01431105|Atorvastatin|atorvastatin|mesh-list
2026996|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2026997|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2026998|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
2026999|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027000|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2027001|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2027002|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027003|NCT01431170|Trimethoprim|trimethoprim|mesh-list
2027004|NCT01431170|Polymyxins|polymyxins|mesh-list
2027005|NCT01431170|Polymyxin B|polymyxin b|mesh-list
2027006|NCT01431170|Besifloxacin|besifloxacin|mesh-list
2027007|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
2027008|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2027009|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027010|NCT01431170|Renal Agents|renal agents|mesh-ancestor
2027011|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
2027012|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2027013|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2027014|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2027015|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027016|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027017|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2027018|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2027019|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2027020|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2027021|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2027022|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2027023|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027024|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2027025|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
2027026|NCT01431274|Olodaterol|olodaterol|mesh-list
2027027|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2027028|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
2027029|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027030|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027031|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2027032|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
2027033|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
2027034|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2027035|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
2027036|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027037|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027038|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
2027039|NCT01431287|Olodaterol|olodaterol|mesh-list
2027040|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2027041|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
2027042|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027043|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027044|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2027045|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
2027046|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
2027047|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2027048|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
2027049|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027050|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027051|NCT01431339|Vancomycin|vancomycin|mesh-list
2027052|NCT01431339|Linezolid|linezolid|mesh-list
2027053|NCT01431339|Dalbavancin|dalbavancin|mesh-list
2027054|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2027055|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027056|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2027057|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027058|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027059|NCT01431391|Leuprolide|leuprolide|mesh-list
2027060|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2027061|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
2027062|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2027063|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027064|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2027065|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027066|NCT01431508|Losartan|losartan|mesh-list
2027067|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2027068|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2027069|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2027070|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2027071|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027072|NCT01431521|Pioglitazone|pioglitazone|mesh-list
2027073|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2027074|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027075|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
2027076|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
2027077|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2027078|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027079|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027080|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
2027081|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2027082|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2027083|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027084|NCT01431716|Epoprostenol|epoprostenol|mesh-list
2027085|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2027086|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2027087|NCT01431755|Lidocaine|lidocaine|mesh-list
2027088|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
2027089|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
2027090|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
2027091|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2027092|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027093|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
2027094|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027095|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2027096|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2027097|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2027098|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027099|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027100|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2027101|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
2027102|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
2027103|NCT01431755|Protective Agents|protective agents|mesh-ancestor
2027104|NCT01431794|Gemcitabine|gemcitabine|mesh-list
2027105|NCT01431794|Paclitaxel|paclitaxel|mesh-list
2027106|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2027107|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027108|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
2027109|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
2027110|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
2027111|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027112|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2027113|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
2027114|NCT01431794|Antiviral Agents|antiviral agents|mesh-ancestor
2027115|NCT01431794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027116|NCT01431794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027117|NCT01431794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2027118|NCT01431794|Immunologic Factors|immunologic factors|mesh-ancestor
2027119|NCT01431794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027120|NCT01431950|Fluticasone|fluticasone|mesh-list
2027121|NCT01431950|Xhance|xhance|mesh-list
2027122|NCT01431950|Albuterol|albuterol|mesh-list
2027123|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2027124|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2027125|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
2027126|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027127|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027128|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2027129|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
2027130|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
2027131|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2027132|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
2027133|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2027134|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2027135|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2027136|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2027137|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
2027138|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027139|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027140|NCT01431963|Lamotrigine|lamotrigine|mesh-list
2027141|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
2027142|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2027143|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027144|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027145|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2027146|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027147|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2027148|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2027149|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2027150|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2027151|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2027152|NCT01431976|Lamotrigine|lamotrigine|mesh-list
2027153|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
2027154|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2027155|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027156|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027157|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2027158|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027159|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2027160|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2027161|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2027162|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2027163|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2027164|NCT01431989|Amoxicillin|amoxicillin|mesh-list
2027165|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2027166|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027167|NCT01432015|Aprepitant|aprepitant|mesh-list
2027168|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
2027169|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
2027170|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
2027171|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027172|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027173|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2027174|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2027175|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027176|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027177|NCT01432145|Methotrexate|methotrexate|mesh-list
2027178|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
2027179|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2027180|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
2027181|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2027182|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027183|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2027184|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
2027185|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027186|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027187|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
2027188|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027189|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2027190|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2027191|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
2027192|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2027193|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2027194|NCT01432171|Lacosamide|lacosamide|mesh-list
2027195|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
2027196|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2027197|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2027198|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027199|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027200|NCT01432236|Pregabalin|pregabalin|mesh-list
2027201|NCT01432236|Analgesics|analgesics|mesh-ancestor
2027202|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
2027203|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027204|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027205|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
2027206|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2027207|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027208|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027209|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2027210|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2027211|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2027212|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2027213|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2027214|NCT01432262|Vaccines|vaccines|mesh-list
2027215|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2027216|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
2027217|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027218|NCT01432275|Insulin|insulin|mesh-list
2027219|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2027220|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027221|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
2027222|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2027223|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2027224|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2027225|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027226|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027227|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
2027228|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027229|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027230|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2027231|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027232|NCT01432405|Pioglitazone|pioglitazone|mesh-list
2027233|NCT01432405|Exenatide|exenatide|mesh-list
2027234|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2027235|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027236|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2027237|NCT01432405|Incretins|incretins|mesh-ancestor
2027238|NCT01432405|Hormones|hormones|mesh-ancestor
2027239|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2027240|NCT01432444|Aripiprazole|aripiprazole|mesh-list
2027241|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
2027242|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2027243|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2027244|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2027245|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2027246|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027247|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
2027248|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
2027249|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027250|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027251|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2027252|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2027253|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
2027254|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2027255|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2027256|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2027257|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2027258|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2027259|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2027260|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2027261|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027262|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027263|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027264|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027265|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
2027266|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2027267|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2027268|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
2027269|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027270|NCT01432561|Cysteamine|cysteamine|mesh-list
2027271|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2027272|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027273|NCT01432574|Vaccines|vaccines|mesh-list
2027274|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
2027275|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027276|NCT01432600|Dexamethasone|dexamethasone|mesh-list
2027277|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
2027278|NCT01432600|Pomalidomide|pomalidomide|mesh-list
2027279|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2027280|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
2027281|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027282|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2027283|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2027284|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
2027285|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027286|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027287|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2027288|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2027289|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
2027290|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
2027291|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027292|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2027293|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
2027294|NCT01432600|Hormones|hormones|mesh-ancestor
2027295|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2027296|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2027297|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2027298|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2027299|NCT01432600|Growth Substances|growth substances|mesh-ancestor
2027300|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
2027301|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2027302|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027303|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027304|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027305|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2027306|NCT01432938|Dulaglutide|dulaglutide|mesh-list
2027307|NCT01432938|Warfarin|warfarin|mesh-list
2027308|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
2027309|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2027310|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027311|NCT01433055|Minocycline|minocycline|mesh-list
2027312|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2027313|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027314|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
2027315|NCT01433081|Analgesics|analgesics|mesh-ancestor
2027316|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
2027317|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027318|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027319|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
2027320|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2027321|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2027322|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
2027323|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2027324|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027325|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027326|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2027327|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
2027328|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2027329|NCT01433107|Terbinafine|terbinafine|mesh-list
2027330|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
2027331|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027332|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027333|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027334|NCT01433172|Vaccines|vaccines|mesh-list
2027335|NCT01433172|Immunologic Factors|immunologic factors|mesh-ancestor
2027336|NCT01433172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027337|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2027338|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
2027339|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027340|NCT01433913|Metformin|metformin|mesh-list
2027341|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2027342|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027343|NCT01433978|Maleic acid|maleic acid|mesh-list
2027344|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027345|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027346|NCT01433991|Lenvatinib|lenvatinib|mesh-list
2027347|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027348|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2027349|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027350|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027351|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
2027352|NCT01434121|Vitamins|vitamins|mesh-ancestor
2027353|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
2027354|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027355|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
2027356|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027357|NCT01434121|Protective Agents|protective agents|mesh-ancestor
2027358|NCT01434186|Metformin|metformin|mesh-list
2027359|NCT01434186|Saxagliptin|saxagliptin|mesh-list
2027360|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2027361|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027362|NCT01434186|Incretins|incretins|mesh-ancestor
2027363|NCT01434186|Hormones|hormones|mesh-ancestor
2027364|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2027365|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2027366|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
2027367|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027368|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027369|NCT01434342|Nicotine|nicotine|mesh-list
2027370|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2027371|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
2027372|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027373|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027374|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2027375|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2027376|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
2027377|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027378|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027379|NCT01434472|Vidarabine|vidarabine|mesh-list
2027380|NCT01434472|Cyclosporine|cyclosporine|mesh-list
2027381|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
2027382|NCT01434472|Rituximab|rituximab|mesh-list
2027383|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2027384|NCT01434472|Fludarabine|fludarabine|mesh-list
2027385|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
2027386|NCT01434472|Antibodies|antibodies|mesh-list
2027387|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
2027388|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2027389|NCT01434472|Cyclosporins|cyclosporins|mesh-list
2027390|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
2027391|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027392|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027393|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2027394|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2027395|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
2027396|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027397|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2027398|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
2027399|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027400|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027401|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
2027402|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
2027403|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2027404|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2027405|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2027406|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
2027407|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2027408|NCT01435018|Tenofovir|tenofovir|mesh-list
2027409|NCT01435018|Emtricitabine|emtricitabine|mesh-list
2027410|NCT01435018|Efavirenz|efavirenz|mesh-list
2027411|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2027412|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2027413|NCT01435018|Paclitaxel|paclitaxel|mesh-list
2027414|NCT01435018|Etoposide|etoposide|mesh-list
2027415|NCT01435018|Vincristine|vincristine|mesh-list
2027416|NCT01435018|Bleomycin|bleomycin|mesh-list
2027417|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2027418|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027419|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
2027420|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
2027421|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
2027422|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027423|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2027424|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2027425|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027426|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
2027427|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027428|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2027429|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2027430|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2027431|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2027432|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2027433|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2027434|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2027435|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2027436|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2027437|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2027438|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2027439|NCT01435122|Axitinib|axitinib|mesh-list
2027440|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027441|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2027442|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027443|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027444|NCT01435174|Ranolazine|ranolazine|mesh-list
2027445|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
2027446|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2027447|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2027448|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027449|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027450|NCT01435382|Bococizumab|bococizumab|mesh-list
2027451|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2027452|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2027453|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
2027454|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027455|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2027456|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2027457|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2027458|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2027459|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2027460|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2027461|NCT01435460|Analgesics|analgesics|mesh-ancestor
2027462|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
2027463|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027464|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027465|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2027466|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2027467|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2027468|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2027469|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
2027470|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
2027471|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027472|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027473|NCT01435577|Tapentadol|tapentadol|mesh-list
2027474|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2027475|NCT01435577|Narcotics|narcotics|mesh-ancestor
2027476|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2027477|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027478|NCT01435577|Analgesics|analgesics|mesh-ancestor
2027479|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
2027480|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027481|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2027482|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2027483|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027484|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027485|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
2027486|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027487|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
2027488|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2027489|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027490|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2027491|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
2027492|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2027493|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2027494|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027495|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2027496|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2027497|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027498|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027499|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
2027500|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027501|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
2027502|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
2027503|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
2027504|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2027505|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2027506|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027507|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027508|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027509|NCT01435824|Amoxicillin|amoxicillin|mesh-list
2027510|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2027511|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027512|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2027513|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2027514|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2027515|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2027516|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027517|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2027518|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2027519|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2027520|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2027521|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
2027522|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027523|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027524|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2027525|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2027526|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
2027527|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2027528|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2027529|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
2027530|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
2027531|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2027532|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027533|NCT01436071|Fluticasone|fluticasone|mesh-list
2027534|NCT01436071|Xhance|xhance|mesh-list
2027535|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2027536|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2027537|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
2027538|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027539|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027540|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2027541|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
2027542|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
2027543|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2027544|NCT01436110|Fluticasone|fluticasone|mesh-list
2027545|NCT01436110|Xhance|xhance|mesh-list
2027546|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2027547|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2027548|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
2027549|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027550|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027551|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2027552|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
2027553|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
2027554|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2027555|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2027556|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2027557|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027558|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2027559|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2027560|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027561|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027562|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
2027563|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027564|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2027565|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
2027566|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2027567|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2027568|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027569|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2027570|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2027571|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027572|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027573|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
2027574|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027575|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2027576|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
2027577|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2027578|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2027579|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027580|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2027581|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2027582|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027583|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027584|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
2027585|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027586|NCT01436201|Dulaglutide|dulaglutide|mesh-list
2027587|NCT01436201|Digoxin|digoxin|mesh-list
2027588|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2027589|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2027590|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027591|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027592|NCT01436201|Protective Agents|protective agents|mesh-ancestor
2027593|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027594|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2027595|NCT01436266|Folic Acid|folic acid|mesh-list
2027596|NCT01436266|Misoprostol|misoprostol|mesh-list
2027597|NCT01436266|Vitamins|vitamins|mesh-ancestor
2027598|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
2027599|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027600|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2027601|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
2027602|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2027603|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2027604|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2027605|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
2027606|NCT01436266|Hematinics|hematinics|mesh-ancestor
2027607|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
2027608|NCT01436279|Mifepristone|mifepristone|mesh-list
2027609|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2027610|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
2027611|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2027612|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027613|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2027614|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2027615|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2027616|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
2027617|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2027618|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2027619|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
2027620|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2027621|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
2027622|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2027623|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2027624|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
2027625|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
2027626|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
2027627|NCT01436305|Abatacept|abatacept|mesh-list
2027628|NCT01436305|Tacrolimus|tacrolimus|mesh-list
2027629|NCT01436305|Basiliximab|basiliximab|mesh-list
2027630|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2027631|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
2027632|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027633|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2027634|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027635|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027636|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2027637|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027638|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2027639|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
2027640|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2027641|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027642|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2027643|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
2027644|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
2027645|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027646|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2027647|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
2027648|NCT01436305|Hormones|hormones|mesh-ancestor
2027649|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2027650|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2027651|NCT01436305|Protective Agents|protective agents|mesh-ancestor
2027652|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2027653|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2027654|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2027655|NCT01436370|Vaccines|vaccines|mesh-list
2027656|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
2027657|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027658|NCT01436396|Vaccines|vaccines|mesh-list
2027659|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
2027660|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027661|NCT01436500|Ifetroban|ifetroban|mesh-list
2027662|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2027663|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
2027664|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2027665|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
2027666|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2027667|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
2027668|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027669|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027670|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
2027671|NCT01436643|Fluoxetine|fluoxetine|mesh-list
2027672|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2027673|NCT01436643|Citalopram|citalopram|mesh-list
2027674|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2027675|NCT01436643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2027676|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2027677|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2027678|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027679|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027680|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
2027681|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027682|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2027683|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
2027684|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2027685|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2027686|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2027687|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027688|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2027689|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2027690|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2027691|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
2027692|NCT01436799|Alfentanil|alfentanil|mesh-list
2027693|NCT01436799|Propofol|propofol|mesh-list
2027694|NCT01436799|Desflurane|desflurane|mesh-list
2027695|NCT01436799|Rocuronium|rocuronium|mesh-list
2027696|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2027697|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2027698|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027699|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2027700|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
2027701|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
2027702|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2027703|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2027704|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2027705|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027706|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2027707|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2027708|NCT01436799|Narcotics|narcotics|mesh-ancestor
2027709|NCT01436799|Analgesics|analgesics|mesh-ancestor
2027710|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
2027711|NCT01437111|Vitamin D|vitamin d|mesh-list
2027712|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
2027713|NCT01437111|Alendronate|alendronate|mesh-list
2027714|NCT01437111|Vitamins|vitamins|mesh-ancestor
2027715|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
2027716|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027717|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2027718|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2027719|NCT01437267|Vaccines|vaccines|mesh-list
2027720|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2027721|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
2027722|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027723|NCT01437397|Bromides|bromides|mesh-list
2027724|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
2027725|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2027726|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
2027727|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027728|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027729|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2027730|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
2027731|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2027732|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2027733|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2027734|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
2027735|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027736|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027737|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
2027738|NCT01437449|Carboplatin|carboplatin|mesh-list
2027739|NCT01437449|Docetaxel|docetaxel|mesh-list
2027740|NCT01437449|Cetuximab|cetuximab|mesh-list
2027741|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027742|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
2027743|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
2027744|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
2027745|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027746|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2027747|NCT01437540|Bromides|bromides|mesh-list
2027748|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
2027749|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2027750|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
2027751|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027752|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027753|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2027754|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
2027755|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2027756|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2027757|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2027758|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
2027759|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027760|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027761|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
2027762|NCT01437605|Poly I-C|poly i-c|mesh-list
2027763|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
2027764|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
2027765|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027766|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
2027767|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027768|NCT01437878|Iloprost|iloprost|mesh-list
2027769|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2027770|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
2027771|NCT01437995|Fluticasone|fluticasone|mesh-list
2027772|NCT01437995|Xhance|xhance|mesh-list
2027773|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2027774|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2027775|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2027776|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2027777|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
2027778|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027779|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027780|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2027781|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
2027782|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
2027783|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2027784|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2027785|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2027786|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2027787|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
2027788|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027789|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027790|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
2027791|NCT01437995|Hormones|hormones|mesh-ancestor
2027792|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2027793|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
2027794|NCT01438060|Aripiprazole|aripiprazole|mesh-list
2027795|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
2027796|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2027797|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2027798|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2027799|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2027800|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027801|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
2027802|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
2027803|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027804|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027805|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2027806|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2027807|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
2027808|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2027809|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2027810|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2027811|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2027812|NCT01438151|Infliximab|infliximab|mesh-list
2027813|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
2027814|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2027815|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2027816|NCT01438177|Chloroquine|chloroquine|mesh-list
2027817|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
2027818|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2027819|NCT01438177|Bortezomib|bortezomib|mesh-list
2027820|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2027821|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
2027822|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027823|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2027824|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2027825|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
2027826|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027827|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027828|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2027829|NCT01438177|Amebicides|amebicides|mesh-ancestor
2027830|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2027831|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2027832|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027833|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
2027834|NCT01438411|Cholic Acids|cholic acids|mesh-list
2027835|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2027836|NCT01438424|Lamivudine|lamivudine|mesh-list
2027837|NCT01438424|Entecavir|entecavir|mesh-list
2027838|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2027839|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2027840|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027841|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027842|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
2027843|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027844|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2027845|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2027846|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2027847|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
2027848|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027849|NCT01438710|Tacrolimus|tacrolimus|mesh-list
2027850|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2027851|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
2027852|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027853|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2027854|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027855|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027856|NCT01438814|Metformin|metformin|mesh-list
2027857|NCT01438814|Linagliptin|linagliptin|mesh-list
2027858|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2027859|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027860|NCT01438814|Incretins|incretins|mesh-ancestor
2027861|NCT01438814|Hormones|hormones|mesh-ancestor
2027862|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2027863|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2027864|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
2027865|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027866|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027867|NCT01438840|Maleic acid|maleic acid|mesh-list
2027868|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027869|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027870|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
2027871|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2027872|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2027873|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027874|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2027875|NCT01438957|Analgesics|analgesics|mesh-ancestor
2027876|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
2027877|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027878|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2027879|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2027880|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2027881|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
2027882|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027883|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027884|NCT01439009|Tolvaptan|tolvaptan|mesh-list
2027885|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2027886|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027887|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
2027888|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027889|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
2027890|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2027891|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2027892|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027893|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2027894|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2027895|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
2027896|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2027897|NCT01439126|Clonidine|clonidine|mesh-list
2027898|NCT01439126|Analgesics|analgesics|mesh-ancestor
2027899|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
2027900|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027901|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027902|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2027903|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
2027904|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
2027905|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2027906|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2027907|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2027908|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
2027909|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2027910|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027911|NCT01439204|Abatacept|abatacept|mesh-list
2027912|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2027913|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027914|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027915|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2027916|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
2027917|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027918|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2027919|NCT01439282|Capecitabine|capecitabine|mesh-list
2027920|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2027921|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
2027922|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027923|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027924|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2027925|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
2027926|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027927|NCT01439373|Interferons|interferons|mesh-list
2027928|NCT01439373|Ribavirin|ribavirin|mesh-list
2027929|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
2027930|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
2027931|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2027932|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027933|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
2027934|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2027935|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
2027936|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027937|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
2027938|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027939|NCT01439555|Simvastatin|simvastatin|mesh-list
2027940|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2027941|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2027942|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
2027943|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027944|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2027945|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2027946|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027947|NCT01439568|Carboplatin|carboplatin|mesh-list
2027948|NCT01439568|Etoposide|etoposide|mesh-list
2027949|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027950|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2027951|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2027952|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2027953|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027954|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027955|NCT01439672|Insulin|insulin|mesh-list
2027956|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2027957|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027958|NCT01439711|Letrozole|letrozole|mesh-list
2027959|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2027960|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2027961|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2027962|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2027963|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027964|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2027965|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
2027966|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2027967|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027968|NCT01439815|Fluticasone|fluticasone|mesh-list
2027969|NCT01439815|Xhance|xhance|mesh-list
2027970|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2027971|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2027972|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
2027973|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2027974|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027975|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2027976|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
2027977|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
2027978|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2027979|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
2027980|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2027981|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027982|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2027983|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027984|NCT01439867|Cinacalcet|cinacalcet|mesh-list
2027985|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2027986|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2027987|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2027988|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
2027989|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2027990|NCT01439880|Evolocumab|evolocumab|mesh-list
2027991|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2027992|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2027993|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
2027994|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027995|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2027996|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
2027997|NCT01439945|Antacids|antacids|mesh-ancestor
2027998|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2027999|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2028000|NCT01440101|Natalizumab|natalizumab|mesh-list
2028001|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
2028002|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028003|NCT01440569|Darunavir|darunavir|mesh-list
2028004|NCT01440569|Cobicistat|cobicistat|mesh-list
2028005|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2028006|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2028007|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
2028008|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028009|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028010|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2028011|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2028012|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
2028013|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028014|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2028015|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2028016|NCT01440764|Furosemide|furosemide|mesh-list
2028017|NCT01440764|Diuretics|diuretics|mesh-ancestor
2028018|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
2028019|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028020|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2028021|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2028022|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028023|NCT01440803|Teriparatide|teriparatide|mesh-list
2028024|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2028025|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028026|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2028027|NCT01440816|Interleukin-12|interleukin-12|mesh-list
2028028|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2028029|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
2028030|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028031|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2028032|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2028033|NCT01440816|Growth Substances|growth substances|mesh-ancestor
2028034|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
2028035|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028036|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2028037|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
2028038|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028039|NCT01441037|Danazol|danazol|mesh-list
2028040|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2028041|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
2028042|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028043|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028044|NCT01441063|Zidovudine|zidovudine|mesh-list
2028045|NCT01441063|Valganciclovir|valganciclovir|mesh-list
2028046|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
2028047|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028048|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2028049|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2028050|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028051|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
2028052|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028053|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2028054|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2028055|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2028056|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2028057|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
2028058|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
2028059|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
2028060|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2028061|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2028062|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2028063|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028064|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028065|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
2028066|NCT01441180|Ribavirin|ribavirin|mesh-list
2028067|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
2028068|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028069|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
2028070|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028071|NCT01441245|Furosemide|furosemide|mesh-list
2028072|NCT01441245|Diuretics|diuretics|mesh-ancestor
2028073|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
2028074|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028075|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2028076|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2028077|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028078|NCT01441401|Gabapentin|gabapentin|mesh-list
2028079|NCT01441401|Analgesics|analgesics|mesh-ancestor
2028080|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
2028081|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028082|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028083|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
2028084|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2028085|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2028086|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2028087|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2028088|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2028089|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2028090|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2028091|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028092|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
2028093|NCT01441414|Axitinib|axitinib|mesh-list
2028094|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028095|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2028096|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028097|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028098|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2028099|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2028100|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2028101|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2028102|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028103|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2028104|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028105|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2028106|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
2028107|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2028108|NCT01441570|Metoprolol|metoprolol|mesh-list
2028109|NCT01441570|Nebivolol|nebivolol|mesh-list
2028110|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2028111|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2028112|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
2028113|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
2028114|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028115|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028116|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2028117|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2028118|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2028119|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
2028120|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2028121|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028122|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
2028123|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2028124|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2028125|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2028126|NCT01441596|Vinorelbine|vinorelbine|mesh-list
2028127|NCT01441596|Afatinib|afatinib|mesh-list
2028128|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2028129|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028130|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
2028131|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
2028132|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
2028133|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028134|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2028135|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028136|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2028137|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2028138|NCT01441635|Norethindrone|norethindrone|mesh-list
2028139|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
2028140|NCT01441635|Estradiol|estradiol|mesh-list
2028141|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2028142|NCT01441635|Progesterone|progesterone|mesh-list
2028143|NCT01441635|Estrogens|estrogens|mesh-ancestor
2028144|NCT01441635|Hormones|hormones|mesh-ancestor
2028145|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028146|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028147|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2028148|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
2028149|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2028150|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2028151|NCT01441635|Progestins|progestins|mesh-ancestor
2028152|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2028153|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2028154|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2028155|NCT01441765|Pidilizumab|pidilizumab|mesh-list
2028156|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2028157|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028158|NCT01441843|Lorazepam|lorazepam|mesh-list
2028159|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
2028160|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
2028161|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
2028162|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028163|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028164|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2028165|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2028166|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2028167|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2028168|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2028169|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2028170|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
2028171|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
2028172|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2028173|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028174|NCT01441882|Dasatinib|dasatinib|mesh-list
2028175|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028176|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2028177|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028178|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028179|NCT01441960|Rocuronium|rocuronium|mesh-list
2028180|NCT01441960|Succinylcholine|succinylcholine|mesh-list
2028181|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2028182|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2028183|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2028184|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028185|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028186|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2028187|NCT01441973|Elotuzumab|elotuzumab|mesh-list
2028188|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028189|NCT01442038|Ranolazine|ranolazine|mesh-list
2028190|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2028191|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2028192|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028193|NCT01442064|Ranibizumab|ranibizumab|mesh-list
2028194|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2028195|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2028196|NCT01442064|Growth Substances|growth substances|mesh-ancestor
2028197|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028198|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
2028199|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028200|NCT01442155|Capecitabine|capecitabine|mesh-list
2028201|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
2028202|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2028203|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
2028204|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028205|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028206|NCT01442376|Ondansetron|ondansetron|mesh-list
2028207|NCT01442376|Palonosetron|palonosetron|mesh-list
2028208|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
2028209|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
2028210|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028211|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028212|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2028213|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
2028214|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
2028215|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2028216|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
2028217|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2028218|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028219|NCT01442376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2028220|NCT01442376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2028221|NCT01442376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2028222|NCT01442376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2028223|NCT01442376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2028224|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2028225|NCT01442493|Methadone|methadone|mesh-list
2028226|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2028227|NCT01442493|Narcotics|narcotics|mesh-ancestor
2028228|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2028229|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028230|NCT01442493|Analgesics|analgesics|mesh-ancestor
2028231|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
2028232|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028233|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
2028234|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
2028235|NCT01442688|Amoxicillin|amoxicillin|mesh-list
2028236|NCT01442688|Mesalamine|mesalamine|mesh-list
2028237|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2028238|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028239|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2028240|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2028241|NCT01442688|Analgesics|analgesics|mesh-ancestor
2028242|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
2028243|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028244|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028245|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2028246|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2028247|NCT01442714|Lenalidomide|lenalidomide|mesh-list
2028248|NCT01442714|Azacitidine|azacitidine|mesh-list
2028249|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
2028250|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028251|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2028252|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2028253|NCT01442714|Growth Substances|growth substances|mesh-ancestor
2028254|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
2028255|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028256|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2028257|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
2028258|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028259|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028260|NCT01442779|Interferons|interferons|mesh-list
2028261|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
2028262|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028263|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
2028264|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028265|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
2028266|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028267|NCT01443026|Lycopene|lycopene|mesh-list
2028268|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2028269|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
2028270|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028271|NCT01443026|Protective Agents|protective agents|mesh-ancestor
2028272|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028273|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2028274|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2028275|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028276|NCT01443078|Gemcitabine|gemcitabine|mesh-list
2028277|NCT01443078|Carboplatin|carboplatin|mesh-list
2028278|NCT01443078|Docetaxel|docetaxel|mesh-list
2028279|NCT01443078|Pemetrexed|pemetrexed|mesh-list
2028280|NCT01443078|Vinorelbine|vinorelbine|mesh-list
2028281|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028282|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2028283|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
2028284|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028285|NCT01443078|Antiviral Agents|antiviral agents|mesh-ancestor
2028286|NCT01443078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028287|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028288|NCT01443078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2028289|NCT01443078|Immunologic Factors|immunologic factors|mesh-ancestor
2028290|NCT01443078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028291|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
2028292|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
2028293|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
2028294|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2028295|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2028296|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2028297|NCT01443130|Chloroquine|chloroquine|mesh-list
2028298|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
2028299|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
2028300|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2028301|NCT01443130|Amebicides|amebicides|mesh-ancestor
2028302|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2028303|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2028304|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028305|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
2028306|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2028307|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2028308|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028309|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028310|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2028311|NCT01443130|Renal Agents|renal agents|mesh-ancestor
2028312|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
2028313|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2028314|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
2028315|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028316|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2028317|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2028318|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
2028319|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2028320|NCT01443546|Leuprolide|leuprolide|mesh-list
2028321|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2028322|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
2028323|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2028324|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028325|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2028326|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028327|NCT01443858|Meclizine|meclizine|mesh-list
2028328|NCT01443858|Nicotine|nicotine|mesh-list
2028329|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2028330|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
2028331|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028332|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028333|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2028334|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2028335|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
2028336|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2028337|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028338|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
2028339|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2028340|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2028341|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
2028342|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
2028343|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2028355|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
2028356|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2028357|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2028358|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028359|NCT01444430|Budesonide|budesonide|mesh-list
2028360|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2028361|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2028362|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2028363|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
2028364|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028365|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028366|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2028367|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
2028368|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
2028369|NCT01444430|Hormones|hormones|mesh-ancestor
2028370|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028371|NCT01444651|Tadalafil|tadalafil|mesh-list
2028372|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
2028373|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2028374|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2028375|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028376|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028377|NCT01444651|Urological Agents|urological agents|mesh-ancestor
2028378|NCT01444716|Ofatumumab|ofatumumab|mesh-list
2028379|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2028380|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028381|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
2028382|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028383|NCT01444742|Cytarabine|cytarabine|mesh-list
2028384|NCT01444742|Clofarabine|clofarabine|mesh-list
2028385|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2028386|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
2028387|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028388|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028389|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
2028390|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028391|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2028392|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
2028393|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028394|NCT01444781|Vaccines|vaccines|mesh-list
2028395|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2028396|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
2028397|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028398|NCT01444898|Exenatide|exenatide|mesh-list
2028399|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2028400|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028401|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2028402|NCT01444898|Incretins|incretins|mesh-ancestor
2028403|NCT01444898|Hormones|hormones|mesh-ancestor
2028404|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028405|NCT01444924|Bupivacaine|bupivacaine|mesh-list
2028406|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
2028407|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
2028408|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2028409|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028410|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
2028411|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028412|NCT01445028|Isotretinoin|isotretinoin|mesh-list
2028413|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
2028414|NCT01445080|Sorafenib|sorafenib|mesh-list
2028415|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028416|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2028417|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028418|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028419|NCT01445535|Prednisone|prednisone|mesh-list
2028420|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
2028421|NCT01445535|Rituximab|rituximab|mesh-list
2028422|NCT01445535|Doxorubicin|doxorubicin|mesh-list
2028423|NCT01445535|Etoposide|etoposide|mesh-list
2028424|NCT01445535|Vincristine|vincristine|mesh-list
2028425|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2028426|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
2028427|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028428|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2028429|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2028430|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
2028431|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028432|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028433|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2028434|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2028435|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2028436|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2028437|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2028438|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028439|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2028440|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
2028441|NCT01445535|Hormones|hormones|mesh-ancestor
2028442|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028443|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2028444|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2028445|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
2028446|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
2028447|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
2028448|NCT01445548|Sirolimus|sirolimus|mesh-list
2028449|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2028450|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028451|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2028452|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028453|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
2028454|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2028455|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
2028456|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028457|NCT01445626|Dexamethasone|dexamethasone|mesh-list
2028458|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2028459|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
2028460|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
2028461|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028462|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028463|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2028464|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
2028465|NCT01445626|Hormones|hormones|mesh-ancestor
2028466|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028467|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2028468|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028469|NCT01445678|Metronidazole|metronidazole|mesh-list
2028470|NCT01445678|Meropenem|meropenem|mesh-list
2028471|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028472|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2028473|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2028474|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2028475|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
2028476|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2028477|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
2028478|NCT01445821|Fludarabine|fludarabine|mesh-list
2028479|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
2028480|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2028481|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
2028482|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028483|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2028484|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2028485|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
2028486|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028487|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028488|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2028489|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2028490|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
2028491|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
2028492|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028493|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2028494|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
2028495|NCT01445821|Hormones|hormones|mesh-ancestor
2028496|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028497|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2028498|NCT01445821|Protective Agents|protective agents|mesh-ancestor
2028499|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2028500|NCT01445847|Lidocaine|lidocaine|mesh-list
2028501|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
2028502|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
2028503|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2028504|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028505|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
2028506|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028507|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2028508|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2028509|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2028510|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2028511|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028512|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
2028513|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2028514|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028515|NCT01445886|Calcitriol|calcitriol|mesh-list
2028516|NCT01445886|Calcipotriene|calcipotriene|mesh-list
2028517|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
2028518|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2028519|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028520|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2028521|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2028522|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028523|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2028524|NCT01445886|Vitamins|vitamins|mesh-ancestor
2028525|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
2028526|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2028527|NCT01445951|Insulin|insulin|mesh-list
2028528|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2028529|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
2028530|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2028531|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028532|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
2028533|NCT01446042|Testosterone|testosterone|mesh-list
2028534|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
2028535|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
2028536|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2028537|NCT01446042|Androgens|androgens|mesh-ancestor
2028538|NCT01446042|Hormones|hormones|mesh-ancestor
2028539|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028540|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028541|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2028542|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028543|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
2028544|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2028545|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2028546|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028547|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028548|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2028549|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
2028550|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028551|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028552|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2028553|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
2028554|NCT01446809|Doxorubicin|doxorubicin|mesh-list
2028555|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2028556|NCT01446809|Ifosfamide|ifosfamide|mesh-list
2028557|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
2028558|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2028559|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028560|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2028561|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2028562|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028563|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028564|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2028565|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
2028566|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
2028567|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2028568|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028569|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
2028570|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
2028571|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2028572|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028573|NCT01447225|Gemcitabine|gemcitabine|mesh-list
2028574|NCT01447225|Carboplatin|carboplatin|mesh-list
2028575|NCT01447225|Pemetrexed|pemetrexed|mesh-list
2028576|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028577|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2028578|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
2028579|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028580|NCT01447225|Antiviral Agents|antiviral agents|mesh-ancestor
2028581|NCT01447225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028582|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028583|NCT01447225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2028584|NCT01447225|Immunologic Factors|immunologic factors|mesh-ancestor
2028585|NCT01447225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028586|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2028587|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2028588|NCT01447407|Vaccines|vaccines|mesh-list
2028589|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
2028590|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
2028591|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028592|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2028593|NCT01447420|Ribavirin|ribavirin|mesh-list
2028594|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2028595|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
2028596|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028597|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
2028598|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028599|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
2028600|NCT01447433|Calcium|calcium|mesh-list
2028601|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2028602|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028603|NCT01447433|Antacids|antacids|mesh-ancestor
2028604|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028605|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2028606|NCT01447446|Ribavirin|ribavirin|mesh-list
2028607|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
2028608|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
2028609|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2028610|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2028611|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2028612|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
2028613|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028614|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
2028615|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028616|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
2028617|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028618|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028619|NCT01447511|Rifampin|rifampin|mesh-list
2028620|NCT01447511|Fluconazole|fluconazole|mesh-list
2028621|NCT01447511|Warfarin|warfarin|mesh-list
2028622|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
2028623|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2028624|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
2028625|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2028626|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028627|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
2028628|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2028629|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028630|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028631|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2028632|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2028633|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2028634|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2028635|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2028636|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2028637|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
2028638|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2028639|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2028640|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2028641|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
2079371|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028642|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028643|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028644|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2028645|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2028646|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
2028647|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2028648|NCT01447706|Paclitaxel|paclitaxel|mesh-list
2028649|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2028650|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028651|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
2028652|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
2028653|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
2028654|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028655|NCT01447849|Lubiprostone|lubiprostone|mesh-list
2028656|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2028657|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2028658|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028659|NCT01447888|Morphine|morphine|mesh-list
2028660|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2028661|NCT01447888|Narcotics|narcotics|mesh-ancestor
2028662|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2028663|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028664|NCT01447888|Analgesics|analgesics|mesh-ancestor
2028665|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
2028666|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028667|NCT01447927|Metformin|metformin|mesh-list
2028668|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2028669|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028670|NCT01448044|Interferons|interferons|mesh-list
2028671|NCT01448044|Ribavirin|ribavirin|mesh-list
2028672|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
2028673|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
2028674|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2028675|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028676|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
2028677|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028678|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
2028679|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028680|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
2028681|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028682|NCT01448057|Acetaminophen|acetaminophen|mesh-list
2028683|NCT01448057|Dimethindene|dimethindene|mesh-list
2028684|NCT01448057|Phenylephrine|phenylephrine|mesh-list
2028685|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
2028686|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2028687|NCT01448057|Analgesics|analgesics|mesh-ancestor
2028688|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
2028689|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028690|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028691|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
2028692|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028693|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2028694|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
2028695|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
2028696|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
2028697|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2028698|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
2028699|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
2028700|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2028701|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2028702|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2028703|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
2028704|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2028705|NCT01448057|Protective Agents|protective agents|mesh-ancestor
2028706|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
2028707|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
2028708|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2028709|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
2028710|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
2028711|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2028712|NCT01448213|Fluorometholone|fluorometholone|mesh-list
2028713|NCT01448213|Prednisolone|prednisolone|mesh-list
2028714|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2028715|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
2028716|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2028717|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
2028718|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2028719|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
2028720|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2028721|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
2028722|NCT01448213|Hormones|hormones|mesh-ancestor
2028723|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028724|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028725|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2028726|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028727|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
2028728|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
2028729|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028730|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2028731|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2028732|NCT01448213|Protective Agents|protective agents|mesh-ancestor
2028733|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2028734|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
2028735|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2028736|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2028737|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
2028738|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028739|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2028740|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2028741|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028742|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028743|NCT01448525|Bimatoprost|bimatoprost|mesh-list
2028744|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2028745|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2028746|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2028747|NCT01448616|Tenofovir|tenofovir|mesh-list
2028748|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
2028749|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028750|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2028751|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2028752|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028753|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028754|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2028755|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2028756|NCT01448707|Ritonavir|ritonavir|mesh-list
2028757|NCT01448707|Darunavir|darunavir|mesh-list
2028758|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2028759|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2028760|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
2028761|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028762|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028763|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2028764|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2028765|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
2028766|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028767|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2028768|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2028769|NCT01448824|Ketoconazole|ketoconazole|mesh-list
2028770|NCT01448824|Evacetrapib|evacetrapib|mesh-list
2028771|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
2028772|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028773|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2028774|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2028775|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028776|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028777|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2028778|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
2028779|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028780|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028781|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2028782|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2028783|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2028784|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
2028785|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2028786|NCT01449006|Maraviroc|maraviroc|mesh-list
2028787|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2028788|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2028789|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028790|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2028791|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2028792|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
2028793|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028794|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2028795|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2028796|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
2028797|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
2028798|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028799|NCT01449279|Ipilimumab|ipilimumab|mesh-list
2028800|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2028801|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028802|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2028803|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028804|NCT01449370|Serabelisib|serabelisib|mesh-list
2028805|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028806|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028807|NCT01449630|Celecoxib|celecoxib|mesh-list
2028808|NCT01449630|LY3031207|ly3031207|mesh-list
2028809|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2028810|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2028811|NCT01449630|Analgesics|analgesics|mesh-ancestor
2028812|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
2028813|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028814|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028815|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2028816|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2028817|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2028818|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2028819|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028820|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028821|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
2028822|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
2028823|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028824|NCT01449682|Dexamethasone|dexamethasone|mesh-list
2028825|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
2028826|NCT01449682|BB 1101|bb 1101|mesh-list
2028827|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2028828|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
2028829|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
2028830|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028831|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028832|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2028833|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
2028834|NCT01449682|Hormones|hormones|mesh-ancestor
2028835|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028836|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2028837|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028838|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
2028839|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028840|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028841|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2028842|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2028843|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028844|NCT01449747|Incretins|incretins|mesh-ancestor
2028845|NCT01449747|Hormones|hormones|mesh-ancestor
2028846|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028847|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2028848|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
2028849|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028850|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028851|NCT01449929|Ritonavir|ritonavir|mesh-list
2028852|NCT01449929|Darunavir|darunavir|mesh-list
2028853|NCT01449929|Dolutegravir|dolutegravir|mesh-list
2028854|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2028855|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2028856|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
2028857|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028858|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028859|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2028860|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2028861|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
2028862|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028863|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2028864|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2028865|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2028866|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2028867|NCT01449955|Sirolimus|sirolimus|mesh-list
2028868|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2028869|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028870|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2028871|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028872|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
2028873|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2028874|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
2028875|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028876|NCT01450007|Dexamethasone|dexamethasone|mesh-list
2028877|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
2028878|NCT01450007|Ropivacaine|ropivacaine|mesh-list
2028879|NCT01450007|BB 1101|bb 1101|mesh-list
2028880|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2028881|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
2028882|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
2028883|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028884|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028885|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2028886|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
2028887|NCT01450007|Hormones|hormones|mesh-ancestor
2028888|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028889|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2028890|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028891|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
2028892|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028893|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028894|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
2028895|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
2028896|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2028897|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
2028898|NCT01450098|Evacetrapib|evacetrapib|mesh-list
2028899|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
2028900|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2028901|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2028902|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
2028903|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028904|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2028905|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
2028906|NCT01450098|Protective Agents|protective agents|mesh-ancestor
2028907|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028908|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
2028909|NCT01450137|Hormones|hormones|mesh-ancestor
2028910|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028911|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028912|NCT01450189|Tenofovir|tenofovir|mesh-list
2028913|NCT01450189|Emtricitabine|emtricitabine|mesh-list
2028914|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
2028915|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2028916|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
2028917|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028918|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2028919|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2028920|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028921|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028922|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2028923|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2028924|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2028925|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2028926|NCT01450306|Cycloserine|cycloserine|mesh-list
2028927|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2028928|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028929|NCT01450306|Renal Agents|renal agents|mesh-ancestor
2028930|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2028931|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
2028932|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2028933|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
2028934|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028935|NCT01450319|Cetuximab|cetuximab|mesh-list
2028936|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2028937|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028938|NCT01450683|Itraconazole|itraconazole|mesh-list
2028939|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
2028940|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028941|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2028942|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2028943|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028944|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028945|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2028946|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
2028947|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2028948|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028949|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2028950|NCT01450696|Capecitabine|capecitabine|mesh-list
2028951|NCT01450696|Trastuzumab|trastuzumab|mesh-list
2028952|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028953|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2028954|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
2028955|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028956|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2028957|NCT01450761|Carboplatin|carboplatin|mesh-list
2028958|NCT01450761|Etoposide|etoposide|mesh-list
2028959|NCT01450761|Ipilimumab|ipilimumab|mesh-list
2028960|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2028961|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2028962|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2028963|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2028964|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2028965|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028966|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2028967|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2028968|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
2028969|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2028970|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2028971|NCT01450800|Renal Agents|renal agents|mesh-ancestor
2028972|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2028973|NCT01450813|Bromides|bromides|mesh-list
2028974|NCT01450813|Rocuronium|rocuronium|mesh-list
2028975|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
2028976|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2028977|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2028978|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2028979|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028980|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028981|NCT01450826|Ondansetron|ondansetron|mesh-list
2028982|NCT01450826|Aprepitant|aprepitant|mesh-list
2028983|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
2028984|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
2028985|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2028986|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2028987|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2028988|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
2028989|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
2028990|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2028991|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
2028992|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2028993|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2028994|NCT01450826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2028995|NCT01450826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2028996|NCT01450826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2028997|NCT01450826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2028998|NCT01450826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2028999|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2029000|NCT01451203|Methotrexate|methotrexate|mesh-list
2029001|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
2029002|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2029003|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
2029004|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2029005|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029006|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2029007|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
2029008|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029009|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029010|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
2029011|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029012|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2029013|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2029014|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
2029015|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2029016|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2029017|NCT01451398|Insulin|insulin|mesh-list
2029018|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2029019|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029020|NCT01451411|Conivaptan|conivaptan|mesh-list
2029021|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2029022|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029023|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
2029024|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029025|NCT01451541|Ciclesonide|ciclesonide|mesh-list
2029026|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
2029027|NCT01451541|Hormones|hormones|mesh-ancestor
2029028|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2029029|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029030|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2029031|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2029032|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2029033|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2029034|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2029035|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029036|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029037|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029038|NCT01451606|Analgesics|analgesics|mesh-ancestor
2029039|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
2029040|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029041|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
2029042|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2029043|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
2029044|NCT01451632|Irinotecan|irinotecan|mesh-list
2029045|NCT01451632|Cetuximab|cetuximab|mesh-list
2029046|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2029047|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2029048|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029049|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029050|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029051|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2029052|NCT01451645|Colchicine|colchicine|mesh-list
2029053|NCT01451645|Allopurinol|allopurinol|mesh-list
2029054|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
2029055|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2029056|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
2029057|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
2029058|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
2029059|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029060|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029061|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
2029062|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029063|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2029064|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
2029065|NCT01451645|Protective Agents|protective agents|mesh-ancestor
2029066|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029067|NCT01451749|Donepezil|donepezil|mesh-list
2029068|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2029069|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029070|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029071|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
2029072|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029073|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029074|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
2029075|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
2029076|NCT01451762|Promethazine|promethazine|mesh-list
2029077|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2029078|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2029079|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2029080|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029081|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
2029082|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
2029083|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
2029084|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029085|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
2029086|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
2029087|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2029088|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2029089|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
2029090|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
2029091|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029092|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029093|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2029094|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
2029095|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
2029096|NCT01451775|Empagliflozin|empagliflozin|mesh-list
2029097|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2029098|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029099|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2029100|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029101|NCT01451814|Nicotine|nicotine|mesh-list
2029102|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2029103|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
2029104|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029105|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029106|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2029107|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2029108|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
2029109|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029110|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029111|NCT01451827|Tolvaptan|tolvaptan|mesh-list
2029112|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2029113|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029114|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
2029115|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029116|NCT01451996|Loratadine|loratadine|mesh-list
2029117|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
2029118|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
2029119|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2029120|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2029121|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2029122|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
2029123|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
2029124|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029125|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029126|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029127|NCT01452126|Ropivacaine|ropivacaine|mesh-list
2029128|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
2029129|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
2029130|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2029131|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029132|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
2029133|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029134|NCT01452152|Clopidogrel|clopidogrel|mesh-list
2029135|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2029136|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2029137|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2029138|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2029139|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2029140|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
2029141|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029142|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029143|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029144|NCT01452347|Warfarin|warfarin|mesh-list
2029145|NCT01452347|Dabigatran|dabigatran|mesh-list
2029146|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
2029147|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
2029148|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2029149|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
2029150|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029151|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029152|NCT01452529|Hydrocodone|hydrocodone|mesh-list
2029153|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2029154|NCT01452529|Narcotics|narcotics|mesh-ancestor
2029155|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2029156|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029157|NCT01452529|Analgesics|analgesics|mesh-ancestor
2029158|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
2029159|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029160|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
2029161|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
2029162|NCT01452789|Morphine|morphine|mesh-list
2029163|NCT01452789|Buprenorphine|buprenorphine|mesh-list
2029164|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2029165|NCT01452789|Narcotics|narcotics|mesh-ancestor
2029166|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2029167|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029168|NCT01452789|Analgesics|analgesics|mesh-ancestor
2029169|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
2029170|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029171|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2029172|NCT01453023|Fluticasone|fluticasone|mesh-list
2029173|NCT01453023|Xhance|xhance|mesh-list
2029174|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2029175|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2029176|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
2029177|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029178|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029179|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2029180|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
2029181|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
2029182|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2029183|NCT01453049|Glimepiride|glimepiride|mesh-list
2029184|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
2029185|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2029186|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2029187|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029188|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2029189|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
2029190|NCT01453075|Valacyclovir|valacyclovir|mesh-list
2029191|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
2029192|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029193|NCT01453153|Gemcitabine|gemcitabine|mesh-list
2029194|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2029195|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
2029196|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029197|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029198|NCT01453153|Antiviral Agents|antiviral agents|mesh-ancestor
2029199|NCT01453153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029200|NCT01453153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029201|NCT01453153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2029202|NCT01453153|Immunologic Factors|immunologic factors|mesh-ancestor
2029203|NCT01453153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029204|NCT01453205|Rituximab|rituximab|mesh-list
2029205|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2029206|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029207|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
2029208|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029209|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2029210|NCT01453348|Vaccines|vaccines|mesh-list
2029211|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
2029212|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029213|NCT01453374|Naltrexone|naltrexone|mesh-list
2029214|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2029215|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2029216|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029217|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
2029218|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029219|NCT01453595|Dactolisib|dactolisib|mesh-list
2029220|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029221|NCT01453725|Golimumab|golimumab|mesh-list
2029222|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2029223|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2029224|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2029225|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
2029226|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029227|NCT01453855|Travoprost|travoprost|mesh-list
2029228|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2029229|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2029230|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2029242|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2029243|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
2029244|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029245|NCT01454076|Clarithromycin|clarithromycin|mesh-list
2029246|NCT01454076|Rifampin|rifampin|mesh-list
2029247|NCT01454076|Ketoconazole|ketoconazole|mesh-list
2029248|NCT01454076|Ixazomib|ixazomib|mesh-list
2029249|NCT01454076|Glycine|glycine|mesh-list
2029250|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2029251|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029252|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2029253|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029254|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029255|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2029256|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2029257|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2029258|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
2029259|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
2029260|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2029261|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2029262|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2029263|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2029264|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2029265|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2029266|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2029267|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
2029268|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2029269|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2029270|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
2029271|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2029272|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029273|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029274|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
2029275|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
2029276|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029277|NCT01454102|Gemcitabine|gemcitabine|mesh-list
2029278|NCT01454102|Paclitaxel|paclitaxel|mesh-list
2029279|NCT01454102|Bevacizumab|bevacizumab|mesh-list
2029280|NCT01454102|Carboplatin|carboplatin|mesh-list
2029281|NCT01454102|Nivolumab|nivolumab|mesh-list
2029282|NCT01454102|Pemetrexed|pemetrexed|mesh-list
2029283|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2029284|NCT01454102|Ipilimumab|ipilimumab|mesh-list
2029285|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2029286|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029287|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
2029288|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
2029289|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
2029290|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029291|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2029292|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2029293|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2029294|NCT01454102|Growth Substances|growth substances|mesh-ancestor
2029295|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029296|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
2029297|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2029298|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
2029299|NCT01454102|Antiviral Agents|antiviral agents|mesh-ancestor
2029300|NCT01454102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029301|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029302|NCT01454102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2029303|NCT01454102|Immunologic Factors|immunologic factors|mesh-ancestor
2029304|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2029305|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2029306|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2029307|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2029308|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
2029309|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2029310|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029311|NCT01454362|Nicotine|nicotine|mesh-list
2029312|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2029313|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
2029314|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029315|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029316|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2029317|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2029318|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
2029319|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029320|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029321|NCT01454414|Permethrin|permethrin|mesh-list
2029322|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029323|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029324|NCT01454596|Aldesleukin|aldesleukin|mesh-list
2029325|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
2029326|NCT01454596|Fludarabine|fludarabine|mesh-list
2029327|NCT01454596|Mitogens|mitogens|mesh-list
2029328|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2029329|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
2029330|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029331|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2029332|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2029333|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
2029334|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029335|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029336|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2029337|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
2029338|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2029339|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2029340|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
2029341|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029342|NCT01454739|Factor VIII|factor viii|mesh-list
2029343|NCT01454739|Coagulants|coagulants|mesh-ancestor
2029344|NCT01454778|Paclitaxel|paclitaxel|mesh-list
2029345|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2029346|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029347|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
2029348|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
2029349|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
2029350|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029351|NCT01454791|Diclofenac|diclofenac|mesh-list
2029352|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2029353|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2029354|NCT01454791|Analgesics|analgesics|mesh-ancestor
2029355|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
2029356|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029357|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029358|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2029359|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2029360|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2029361|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029362|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029363|NCT01454934|Gemcitabine|gemcitabine|mesh-list
2029364|NCT01454934|Docetaxel|docetaxel|mesh-list
2029365|NCT01454934|Pemetrexed|pemetrexed|mesh-list
2029366|NCT01454934|Vinorelbine|vinorelbine|mesh-list
2029367|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2029368|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
2029369|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029370|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029371|NCT01454934|Antiviral Agents|antiviral agents|mesh-ancestor
2029372|NCT01454934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029373|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029374|NCT01454934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2029375|NCT01454934|Immunologic Factors|immunologic factors|mesh-ancestor
2029376|NCT01454934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029377|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
2029378|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
2029379|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
2029380|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2029381|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2029382|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2029383|NCT01455012|Rotigotine|rotigotine|mesh-list
2029384|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
2029385|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
2029386|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029387|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029388|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029389|NCT01455194|Ciclesonide|ciclesonide|mesh-list
2029390|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
2029391|NCT01455194|Hormones|hormones|mesh-ancestor
2029392|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2029393|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029394|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2029395|NCT01455220|Natalizumab|natalizumab|mesh-list
2029396|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
2029397|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029398|NCT01455415|Pregabalin|pregabalin|mesh-list
2029399|NCT01455415|Analgesics|analgesics|mesh-ancestor
2029400|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
2029401|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029402|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029403|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
2029404|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2029405|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2029406|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029407|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2029408|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2029409|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2029410|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2029411|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2029412|NCT01455428|Pregabalin|pregabalin|mesh-list
2029413|NCT01455428|Analgesics|analgesics|mesh-ancestor
2029414|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
2029415|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029416|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029417|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
2029418|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2029419|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2029420|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029421|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2029422|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2029423|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2029424|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2029425|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2029426|NCT01455519|Hydromorphone|hydromorphone|mesh-list
2029427|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2029428|NCT01455519|Narcotics|narcotics|mesh-ancestor
2029429|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2029430|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029431|NCT01455519|Analgesics|analgesics|mesh-ancestor
2029432|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
2029433|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029434|NCT01456039|Romidepsin|romidepsin|mesh-list
2029435|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2029436|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029437|NCT01456130|Alogliptin|alogliptin|mesh-list
2029438|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
2029439|NCT01456130|Secretagogues|secretagogues|mesh-list
2029440|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2029441|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029442|NCT01456130|Incretins|incretins|mesh-ancestor
2029443|NCT01456130|Hormones|hormones|mesh-ancestor
2029444|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2029445|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2029446|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
2029447|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029448|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029449|NCT01456143|Proflavine|proflavine|mesh-list
2029450|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2029451|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029452|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
2029453|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2029454|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2029455|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2029456|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029457|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2029458|NCT01456169|Diuretics|diuretics|mesh-ancestor
2029459|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
2029460|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029461|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2029462|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2029463|NCT01456299|Remifentanil|remifentanil|mesh-list
2029464|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2029465|NCT01456299|Narcotics|narcotics|mesh-ancestor
2029466|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2029467|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029468|NCT01456299|Analgesics|analgesics|mesh-ancestor
2029469|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
2029470|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029471|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2029472|NCT01456780|Tobramycin|tobramycin|mesh-list
2029473|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
2029474|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2029475|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029476|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2029477|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2029478|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2029479|NCT01456936|Bupropion|bupropion|mesh-list
2029480|NCT01456936|Nicotine|nicotine|mesh-list
2029481|NCT01456936|Varenicline|varenicline|mesh-list
2029482|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2029483|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
2029484|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029485|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029486|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2029487|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2029488|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
2029489|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029490|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029491|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2029492|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
2029493|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2029494|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2029495|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2029496|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2029497|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
2029498|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2029499|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2029500|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029501|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
2029502|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029503|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2029504|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2029505|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029506|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029507|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2029508|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2029509|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029510|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2029511|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2029512|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2029513|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029514|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
2029515|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029516|NCT01457430|Icatibant|icatibant|mesh-list
2029517|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2029518|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2029519|NCT01457430|Analgesics|analgesics|mesh-ancestor
2029520|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
2029521|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029522|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029523|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2029524|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2029525|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
2029526|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
2029527|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029528|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2029529|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2029530|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
2029531|NCT01457521|Ibuprofen|ibuprofen|mesh-list
2029532|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2029533|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2029534|NCT01457521|Analgesics|analgesics|mesh-ancestor
2029535|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
2029536|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029537|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029538|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2029539|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2029540|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2029541|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029542|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029543|NCT01457573|Tamsulosin|tamsulosin|mesh-list
2029544|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
2029545|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2029546|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2029547|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2029548|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
2029549|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029550|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029551|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029552|NCT01457573|Urological Agents|urological agents|mesh-ancestor
2029553|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2029554|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2029555|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
2029556|NCT01457703|Letrozole|letrozole|mesh-list
2029557|NCT01457703|Cetrorelix|cetrorelix|mesh-list
2029558|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2029559|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029560|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2029561|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2029562|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029563|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029564|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2029565|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
2029566|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2029567|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029568|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2029569|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
2029570|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2029571|NCT01457703|Hormones|hormones|mesh-ancestor
2029572|NCT01457846|Paclitaxel|paclitaxel|mesh-list
2029573|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2029574|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029575|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
2029576|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
2029577|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
2029578|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029579|NCT01457885|Busulfan|busulfan|mesh-list
2029580|NCT01457885|Clofarabine|clofarabine|mesh-list
2029581|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
2029582|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029583|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2029584|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
2029585|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029586|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2029587|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029588|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2029589|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2029590|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
2029591|NCT01457924|Ofatumumab|ofatumumab|mesh-list
2029592|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2029593|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029594|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
2029595|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029596|NCT01457950|Denosumab|denosumab|mesh-list
2029597|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2029598|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029599|NCT01458106|Factor VIII|factor viii|mesh-list
2029600|NCT01458106|Coagulants|coagulants|mesh-ancestor
2029601|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
2029602|NCT01458171|Antibodies|antibodies|mesh-list
2029603|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
2029604|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2029605|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2029606|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
2029607|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029608|NCT01458210|Dulaglutide|dulaglutide|mesh-list
2029609|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
2029610|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2029611|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2029612|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029613|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2029614|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029615|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2029616|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2029617|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029618|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029619|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029620|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2029621|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
2029622|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2029623|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2029624|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2029625|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2029626|NCT01458275|Ciclesonide|ciclesonide|mesh-list
2029627|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
2029628|NCT01458275|Hormones|hormones|mesh-ancestor
2029629|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2029630|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029631|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2029632|NCT01458366|Carboplatin|carboplatin|mesh-list
2029633|NCT01458366|Etoposide|etoposide|mesh-list
2029634|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
2029635|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2029636|NCT01458366|Ofatumumab|ofatumumab|mesh-list
2029637|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029638|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2029639|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2029640|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2029641|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029642|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029643|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2029644|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
2029645|NCT01458418|Montelukast|montelukast|mesh-list
2029646|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2029647|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
2029648|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2029649|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
2029650|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2029651|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029652|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2029653|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2029654|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029655|NCT01458522|Lacosamide|lacosamide|mesh-list
2029656|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
2029657|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
2029658|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2029659|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2029660|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2029661|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029662|NCT01458535|Ritonavir|ritonavir|mesh-list
2029663|NCT01458535|Ribavirin|ribavirin|mesh-list
2029664|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2029665|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2029666|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
2029667|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029668|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029669|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2029670|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2029671|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
2029672|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029673|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2029674|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2029675|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
2029676|NCT01458561|Thrombin|thrombin|mesh-list
2029677|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
2029678|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
2029679|NCT01458561|Coagulants|coagulants|mesh-ancestor
2029680|NCT01458574|Tofacitinib|tofacitinib|mesh-list
2029681|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2029682|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029683|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029684|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2029685|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2029686|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
2029687|NCT01458639|Xenon|xenon|mesh-list
2029688|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2029689|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
2029690|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
2029691|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2029692|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029693|NCT01458951|Tofacitinib|tofacitinib|mesh-list
2029694|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2029695|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029696|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029697|NCT01458990|Omeprazole|omeprazole|mesh-list
2029698|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2029699|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2029700|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2029701|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029702|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029703|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2029704|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2029705|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
2029706|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2029707|NCT01459588|Laxatives|laxatives|mesh-ancestor
2029708|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2029709|NCT01459614|Gemcitabine|gemcitabine|mesh-list
2029710|NCT01459614|Docetaxel|docetaxel|mesh-list
2029711|NCT01459614|Capecitabine|capecitabine|mesh-list
2029712|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029713|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2029714|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
2029715|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029716|NCT01459614|Antiviral Agents|antiviral agents|mesh-ancestor
2029717|NCT01459614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029718|NCT01459614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029719|NCT01459614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2029720|NCT01459614|Immunologic Factors|immunologic factors|mesh-ancestor
2029721|NCT01459614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029722|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
2029723|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
2029724|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
2029725|NCT01459718|Deferasirox|deferasirox|mesh-list
2029726|NCT01459718|Deferoxamine|deferoxamine|mesh-list
2029727|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2029728|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
2029729|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
2029730|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029731|NCT01459718|Siderophores|siderophores|mesh-ancestor
2029732|NCT01459796|Rilonacept|rilonacept|mesh-list
2029733|NCT01459796|Allopurinol|allopurinol|mesh-list
2029734|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
2029735|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029736|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029737|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
2029738|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2029739|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2029740|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
2029741|NCT01459796|Protective Agents|protective agents|mesh-ancestor
2029742|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029743|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2029744|NCT01459913|Interferons|interferons|mesh-list
2029745|NCT01459913|Ribavirin|ribavirin|mesh-list
2029746|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
2029747|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
2029748|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2029749|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029750|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
2029751|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029752|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
2029753|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029754|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
2029755|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029761|NCT01460225|Lubiprostone|lubiprostone|mesh-list
2029762|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2029763|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2029764|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029765|NCT01460290|Asenapine|asenapine|mesh-list
2029766|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2029767|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2029768|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2029769|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029770|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2029771|NCT01460342|Tadalafil|tadalafil|mesh-list
2029772|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
2029773|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2029774|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2029775|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029776|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029777|NCT01460342|Urological Agents|urological agents|mesh-ancestor
2029778|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
2029779|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2029780|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029781|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2029782|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2029783|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029784|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029785|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029786|NCT01460381|Quinidine|quinidine|mesh-list
2029787|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
2029788|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2029789|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2029790|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
2029791|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029792|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029793|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029794|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2029795|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
2029796|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2029797|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2029798|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029799|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029800|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2029801|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2029802|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
2029803|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2029804|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2029805|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2029806|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2029807|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2029808|NCT01460407|Clarithromycin|clarithromycin|mesh-list
2029809|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2029810|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029811|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2029812|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029813|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029814|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2029815|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2029816|NCT01460628|Modafinil|modafinil|mesh-list
2029817|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2029818|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029819|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2029820|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2029821|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2029822|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029823|NCT01460719|Vaccines|vaccines|mesh-list
2029824|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
2029825|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029826|NCT01460875|Interferons|interferons|mesh-list
2029827|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
2029828|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
2029829|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029830|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
2029831|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029832|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
2029833|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029834|NCT01460940|Lenalidomide|lenalidomide|mesh-list
2029835|NCT01460940|Panobinostat|panobinostat|mesh-list
2029836|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2029837|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
2029838|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029839|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2029840|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2029841|NCT01460940|Growth Substances|growth substances|mesh-ancestor
2029842|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
2029843|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029844|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029845|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029846|NCT01461057|Capecitabine|capecitabine|mesh-list
2029847|NCT01461057|Trastuzumab|trastuzumab|mesh-list
2029848|NCT01461057|Pertuzumab|pertuzumab|mesh-list
2029849|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029850|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2029851|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
2029852|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029853|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2029854|NCT01461096|Vaccines|vaccines|mesh-list
2029855|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
2029856|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029857|NCT01461369|Diclofenac|diclofenac|mesh-list
2029858|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2029859|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2029860|NCT01461369|Analgesics|analgesics|mesh-ancestor
2029861|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
2029862|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029863|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029864|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2029865|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2029866|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2029867|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029868|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029869|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2029870|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029871|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2029872|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2029873|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2029874|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029875|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
2029876|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029877|NCT01461551|Propofol|propofol|mesh-list
2029878|NCT01461551|Sevoflurane|sevoflurane|mesh-list
2029879|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2029880|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2029881|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029882|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2029883|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
2029884|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
2029885|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2029886|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2029887|NCT01461668|Retapamulin|retapamulin|mesh-list
2029888|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2029889|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2029890|NCT01461733|Amiodarone|amiodarone|mesh-list
2029891|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2029892|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
2029893|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2029894|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2029895|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029896|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2029897|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2029898|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2029899|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029900|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2029901|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2029902|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2029903|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2029904|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
2029905|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2029906|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2029907|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2029908|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
2029909|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2029910|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746248|NCT05171400|Insulin|insulin|mesh-list
2029911|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2029912|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2029913|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2029914|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2029915|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029916|NCT01461928|Rituximab|rituximab|mesh-list
2029917|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2029918|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029919|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
2029920|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029921|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2029922|NCT01462227|Naltrexone|naltrexone|mesh-list
2029923|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2029924|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2029925|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029926|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
2029927|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2029928|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
2029929|NCT01462253|Clofarabine|clofarabine|mesh-list
2029930|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2029931|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
2029932|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029933|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2029934|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2029935|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
2029936|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029937|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2029938|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2029939|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2029940|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
2029941|NCT01462266|Metformin|metformin|mesh-list
2029942|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
2029943|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2029944|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2029945|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029946|NCT01462266|Incretins|incretins|mesh-ancestor
2029947|NCT01462266|Hormones|hormones|mesh-ancestor
2029948|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2029949|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2029950|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
2029951|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029952|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029953|NCT01462279|Thiamine|thiamine|mesh-list
2029954|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
2029955|NCT01462279|Vitamins|vitamins|mesh-ancestor
2029956|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
2029957|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029958|NCT01462318|Vitamin K|vitamin k|mesh-list
2029959|NCT01462318|Midazolam|midazolam|mesh-list
2029960|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
2029961|NCT01462318|Caffeine|caffeine|mesh-list
2029962|NCT01462318|Omeprazole|omeprazole|mesh-list
2029963|NCT01462318|Warfarin|warfarin|mesh-list
2029964|NCT01462318|Daclizumab|daclizumab|mesh-list
2029965|NCT01462318|Vitamins|vitamins|mesh-ancestor
2029966|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
2029967|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2029968|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2029969|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2029970|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2029971|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2029972|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2029973|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2029974|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2029975|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
2029976|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
2029977|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
2029978|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
2029979|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2029980|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2029981|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
2029982|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2029983|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2029984|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2029985|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2029986|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2029987|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2746249|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2029988|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2029989|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2029990|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
2029991|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2029992|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2029993|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
2029994|NCT01462318|Coagulants|coagulants|mesh-ancestor
2029995|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
2029996|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
2029997|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2029998|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2029999|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2030000|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
2030001|NCT01462344|Fluticasone|fluticasone|mesh-list
2030002|NCT01462344|Xhance|xhance|mesh-list
2030003|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2030004|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2030005|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
2030006|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030007|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030008|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2030009|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
2030010|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
2030011|NCT01462344|Hormones|hormones|mesh-ancestor
2030012|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2030013|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
2030014|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2030015|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
2030016|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2030017|NCT01462370|Acetaminophen|acetaminophen|mesh-list
2030018|NCT01462370|Ibuprofen|ibuprofen|mesh-list
2030019|NCT01462370|Etoricoxib|etoricoxib|mesh-list
2030020|NCT01462370|Caffeine|caffeine|mesh-list
2030021|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2030022|NCT01462370|Analgesics|analgesics|mesh-ancestor
2030023|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
2030024|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030025|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030026|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
2030027|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2030028|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2030029|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2030030|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2030031|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030032|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030033|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2030034|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2030035|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2030036|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2030037|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
2030038|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030039|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2030040|NCT01462435|Celecoxib|celecoxib|mesh-list
2030041|NCT01462435|Diclofenac|diclofenac|mesh-list
2030042|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2030043|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2030044|NCT01462435|Analgesics|analgesics|mesh-ancestor
2030045|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
2030046|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030047|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030048|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2030049|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2030050|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2030051|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2030052|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030053|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030054|NCT01462565|Epoprostenol|epoprostenol|mesh-list
2030055|NCT01462565|Tezosentan|tezosentan|mesh-list
2030056|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2030057|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2030058|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
2030059|NCT01462695|Sunitinib|sunitinib|mesh-list
2030060|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030061|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2030062|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2030063|NCT01462695|Growth Substances|growth substances|mesh-ancestor
2030064|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030065|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
2030066|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2030067|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030068|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030069|NCT01462773|Interferons|interferons|mesh-list
2030070|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
2030071|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
2030072|NCT01462773|Bortezomib|bortezomib|mesh-list
2030073|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030074|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
2030075|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030076|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
2030077|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030078|NCT01462812|Sumatriptan|sumatriptan|mesh-list
2030079|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2030080|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2030081|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2030082|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
2030083|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030084|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030085|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030086|NCT01462877|Fenofibrate|fenofibrate|mesh-list
2030087|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2030088|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
2030089|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030090|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2030091|NCT01462929|Bromides|bromides|mesh-list
2030092|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
2030093|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2030094|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
2030095|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030096|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030097|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2030098|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
2030099|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
2030100|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2030101|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
2030102|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030103|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030104|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
2030105|NCT01462942|Bromides|bromides|mesh-list
2030106|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
2030107|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2030108|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
2030109|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030110|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030111|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2030112|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
2030113|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2030114|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2030115|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2030116|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
2030117|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030118|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030119|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
2030120|NCT01463033|Levetiracetam|levetiracetam|mesh-list
2030121|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
2030122|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
2030123|NCT01463098|Zolpidem|zolpidem|mesh-list
2030124|NCT01463098|Lemborexant|lemborexant|mesh-list
2030125|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2030126|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2030127|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2030128|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030129|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2030130|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
2030131|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
2030132|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030133|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030134|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2030135|NCT01463111|Lamotrigine|lamotrigine|mesh-list
2030136|NCT01463111|Valproic Acid|valproic acid|mesh-list
2030137|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2030138|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079372|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2030139|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030140|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
2030141|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2030142|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2030143|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030144|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
2030145|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2030146|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2030147|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2030148|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2030149|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2030150|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
2030151|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030152|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2030153|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
2030154|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2030155|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2030156|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2030157|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
2030158|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2030159|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030160|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2030161|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2030162|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2030163|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2030164|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030165|NCT01463306|Pregabalin|pregabalin|mesh-list
2030166|NCT01463306|Analgesics|analgesics|mesh-ancestor
2030167|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
2030168|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030169|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030170|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
2030171|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2030172|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2030173|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030174|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2030175|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2030176|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2030177|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2030178|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2030179|NCT01463384|Minocycline|minocycline|mesh-list
2030180|NCT01463384|Tetracycline|tetracycline|mesh-list
2030181|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2030182|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030183|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2030184|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030185|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030186|NCT01463982|Capecitabine|capecitabine|mesh-list
2030187|NCT01463982|Irinotecan|irinotecan|mesh-list
2030188|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2030189|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
2030190|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030191|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030192|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2030193|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2030194|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030195|NCT01464190|Sevelamer|sevelamer|mesh-list
2030196|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
2030197|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
2030198|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030199|NCT01464229|Iloperidone|iloperidone|mesh-list
2030200|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2030201|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2030202|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2030203|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030204|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2030205|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2030206|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2030207|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030208|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030209|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2030210|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2079373|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
2030211|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030212|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
2030213|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030214|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
2030215|NCT01464359|Busulfan|busulfan|mesh-list
2030216|NCT01464359|Fludarabine|fludarabine|mesh-list
2030217|NCT01464359|Interleukin-2|interleukin-2|mesh-list
2030218|NCT01464359|Allopurinol|allopurinol|mesh-list
2030219|NCT01464359|Levetiracetam|levetiracetam|mesh-list
2030220|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2030221|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
2030222|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030223|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2030224|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2030225|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
2030226|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030227|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030228|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2030229|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
2030230|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2030231|NCT01464359|Analgesics|analgesics|mesh-ancestor
2030232|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
2030233|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030234|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
2030235|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
2030236|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030237|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
2030238|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2030239|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
2030240|NCT01464359|Protective Agents|protective agents|mesh-ancestor
2030241|NCT01464424|Bimatoprost|bimatoprost|mesh-list
2030242|NCT01464424|Travoprost|travoprost|mesh-list
2030243|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2030244|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2030245|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2030246|NCT01464697|Progesterone|progesterone|mesh-list
2030247|NCT01464697|Progestins|progestins|mesh-ancestor
2030248|NCT01464697|Hormones|hormones|mesh-ancestor
2030249|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2030250|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030251|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2030252|NCT01464788|Argatroban|argatroban|mesh-list
2030253|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2030254|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2030255|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030256|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
2030257|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2030258|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
2030259|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030260|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
2030261|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2030262|NCT01464827|Ritonavir|ritonavir|mesh-list
2030263|NCT01464827|Ribavirin|ribavirin|mesh-list
2030264|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2030265|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2030266|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
2030267|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030268|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030269|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2030270|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2030271|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
2030272|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030273|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2030274|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2030275|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
2030276|NCT01464840|Azithromycin|azithromycin|mesh-list
2030277|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2030278|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030279|NCT01464879|Testosterone|testosterone|mesh-list
2030280|NCT01464879|Androgens|androgens|mesh-ancestor
2030281|NCT01464879|Hormones|hormones|mesh-ancestor
2030282|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2030283|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030284|NCT01464931|Denosumab|denosumab|mesh-list
2030285|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2030286|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030287|NCT01465022|Estrogens|estrogens|mesh-list
2030288|NCT01465022|Progestins|progestins|mesh-list
2030289|NCT01465022|Hormones|hormones|mesh-ancestor
2030290|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2030291|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030292|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
2030293|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2030294|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030295|NCT01465178|Vitamins|vitamins|mesh-ancestor
2030296|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
2030297|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2030298|NCT01465191|Morphine|morphine|mesh-list
2030299|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2030300|NCT01465191|Narcotics|narcotics|mesh-ancestor
2030301|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2030302|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030303|NCT01465191|Analgesics|analgesics|mesh-ancestor
2030304|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
2030305|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030306|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
2030307|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2030308|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2030309|NCT01465334|Prednisolone|prednisolone|mesh-list
2030310|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
2030311|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
2030312|NCT01465334|Ofatumumab|ofatumumab|mesh-list
2030313|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2030314|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
2030315|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2030316|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
2030317|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
2030318|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030319|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030320|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2030321|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
2030322|NCT01465334|Hormones|hormones|mesh-ancestor
2030323|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2030324|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2030325|NCT01465334|Protective Agents|protective agents|mesh-ancestor
2030326|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2030327|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030328|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2030329|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
2030330|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
2030331|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030332|NCT01465347|Protective Agents|protective agents|mesh-ancestor
2030333|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030334|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2030335|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030336|NCT01465386|Bortezomib|bortezomib|mesh-list
2030337|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030338|NCT01465412|Adenosine|adenosine|mesh-list
2030339|NCT01465412|Analgesics|analgesics|mesh-ancestor
2030340|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
2030341|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030342|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030343|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2030344|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
2030345|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2030346|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
2030347|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
2030348|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030349|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030350|NCT01465464|Orantinib|orantinib|mesh-list
2030351|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2030352|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030353|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030354|NCT01465659|Temozolomide|temozolomide|mesh-list
2030355|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2030356|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
2030357|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030358|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030359|NCT01465763|Tofacitinib|tofacitinib|mesh-list
2030360|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2030361|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030362|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030363|NCT01465802|Doxycycline|doxycycline|mesh-list
2030364|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
2030365|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2030366|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030367|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
2030368|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2030369|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2030370|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2030371|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
2030372|NCT01465802|Hormones|hormones|mesh-ancestor
2030373|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2030374|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030375|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2030376|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
2030377|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2030378|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
2030379|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
2030380|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030381|NCT01465997|Lacosamide|lacosamide|mesh-list
2030382|NCT01465997|Carbamazepine|carbamazepine|mesh-list
2030383|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
2030384|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2030385|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2030386|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2030387|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030388|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
2030389|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2030390|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2030391|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030392|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2030393|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2030394|NCT01465997|Analgesics|analgesics|mesh-ancestor
2030395|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
2030396|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030397|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2030398|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2030399|NCT01466062|Palivizumab|palivizumab|mesh-list
2030400|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
2030401|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030402|NCT01466127|Oxytocin|oxytocin|mesh-list
2030403|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
2030404|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2030405|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030406|NCT01466153|Rituximab|rituximab|mesh-list
2030407|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2030408|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2030409|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030410|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
2030411|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030412|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2030413|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2030414|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
2030415|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030416|NCT01466179|Blinatumomab|blinatumomab|mesh-list
2030417|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030418|NCT01466192|Ribavirin|ribavirin|mesh-list
2030419|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2030420|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
2030421|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030422|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
2030423|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030424|NCT01466270|Donepezil|donepezil|mesh-list
2030425|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2030426|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030427|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030428|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
2030429|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030430|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030431|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
2030432|NCT01466348|Acetaminophen|acetaminophen|mesh-list
2030433|NCT01466348|Caffeine|caffeine|mesh-list
2030434|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2030435|NCT01466348|Analgesics|analgesics|mesh-ancestor
2030436|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
2030437|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030438|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030439|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
2030440|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2030441|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2030442|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030443|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030444|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2030445|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2030446|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
2030447|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030448|NCT01466361|Nicotine|nicotine|mesh-list
2030449|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2030450|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
2030451|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030452|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030453|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2030454|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2030455|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
2030456|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030457|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030458|NCT01466387|Vaccines|vaccines|mesh-list
2030459|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
2030460|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030461|NCT01466491|Lidocaine|lidocaine|mesh-list
2030462|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
2030463|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
2030464|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2030465|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030466|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
2030467|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030468|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2030469|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2030470|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2030471|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2030472|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030473|NCT01466595|Rifaximin|rifaximin|mesh-list
2030474|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2030475|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030476|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2030477|NCT01466660|Gefitinib|gefitinib|mesh-list
2030478|NCT01466660|Afatinib|afatinib|mesh-list
2030479|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030480|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2030481|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030482|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030483|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
2030484|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2030485|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2030486|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2030487|NCT01466673|Desogestrel|desogestrel|mesh-list
2030488|NCT01466673|Norgestimate|norgestimate|mesh-list
2030489|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2030490|NCT01466673|Estradiol|estradiol|mesh-list
2030491|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2030492|NCT01466673|Estrogens|estrogens|mesh-ancestor
2030493|NCT01466673|Hormones|hormones|mesh-ancestor
2030494|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2030495|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030496|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2030497|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
2030498|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2030499|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2030500|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2030501|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2030502|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2030503|NCT01466673|Progestins|progestins|mesh-ancestor
2030504|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2030505|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030506|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2030507|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2030508|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030509|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030510|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030511|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2030512|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2030513|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2030514|NCT01466790|Ribavirin|ribavirin|mesh-list
2030515|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
2030516|NCT01466790|Simeprevir|simeprevir|mesh-list
2030517|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
2030518|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030519|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
2030520|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030521|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
2030522|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030523|NCT01467076|Alprostadil|alprostadil|mesh-list
2030524|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2030525|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
2030526|NCT01467076|Urological Agents|urological agents|mesh-ancestor
2030527|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
2030528|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2030529|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
2030530|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030531|NCT01467466|Expectorants|expectorants|mesh-ancestor
2030532|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
2030533|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2030534|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
2030535|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030536|NCT01467466|Protective Agents|protective agents|mesh-ancestor
2030537|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030538|NCT01467466|Antidotes|antidotes|mesh-ancestor
2030539|NCT01467479|Interferons|interferons|mesh-list
2030540|NCT01467479|Ribavirin|ribavirin|mesh-list
2030541|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
2030542|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
2030543|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2030544|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2030545|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030546|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
2030547|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030548|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
2030549|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030550|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
2030551|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030552|NCT01467492|Interferons|interferons|mesh-list
2030553|NCT01467492|Ribavirin|ribavirin|mesh-list
2030554|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
2030555|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
2030556|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2030557|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030558|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
2030559|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030560|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
2030561|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030562|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
2030563|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030564|NCT01467505|Interferons|interferons|mesh-list
2030565|NCT01467505|Ribavirin|ribavirin|mesh-list
2030566|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
2030567|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
2030568|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2030569|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2030570|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030571|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
2030572|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030573|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
2030574|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030575|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
2030576|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030577|NCT01467583|PENTA|penta|mesh-list
2030578|NCT01467583|Fondaparinux|fondaparinux|mesh-list
2030579|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2030580|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
2030581|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2030582|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
2030583|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030584|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030585|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
2030586|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2030587|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2030588|NCT01467661|Anagrelide|anagrelide|mesh-list
2030589|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2030590|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2030591|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079374|NCT02057640|Hormones|hormones|mesh-ancestor
2030592|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2030593|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2030594|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
2030595|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2030596|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
2030597|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2030598|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030599|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2030600|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2030601|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030602|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2030603|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2030604|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2030605|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2030606|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
2030607|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030608|NCT01467999|Guanfacine|guanfacine|mesh-list
2030609|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2030610|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2030611|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2030612|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2030613|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
2030614|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030615|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030616|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030617|NCT01468012|Levodopa|levodopa|mesh-list
2030618|NCT01468012|Carbidopa|carbidopa|mesh-list
2030619|NCT01468012|Entacapone|entacapone|mesh-list
2030620|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2030621|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2030622|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2030623|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
2030624|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030625|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030626|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030627|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2030628|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030629|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2030630|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2030631|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
2030632|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
2030633|NCT01468181|Dulaglutide|dulaglutide|mesh-list
2030634|NCT01468181|Biguanides|biguanides|mesh-list
2030635|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2030636|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
2030637|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2030638|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030639|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030640|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030641|NCT01468207|Adalimumab|adalimumab|mesh-list
2030642|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2030643|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2030644|NCT01468233|Adalimumab|adalimumab|mesh-list
2030645|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2030646|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2030647|NCT01468311|Daclizumab|daclizumab|mesh-list
2030648|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2030649|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
2030650|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030651|NCT01468337|Interferons|interferons|mesh-list
2030652|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
2030653|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030654|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
2030655|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030656|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
2030657|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2030658|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2030659|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030660|NCT01468532|Prednisone|prednisone|mesh-list
2030661|NCT01468532|Docetaxel|docetaxel|mesh-list
2030662|NCT01468532|Pasireotide|pasireotide|mesh-list
2030663|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030664|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
2030665|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
2030666|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
2030667|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030668|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2030669|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
2030670|NCT01468532|Hormones|hormones|mesh-ancestor
2030671|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2030672|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030673|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2030674|NCT01468558|Ketoconazole|ketoconazole|mesh-list
2030675|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
2030676|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030677|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2030678|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2030679|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030680|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030681|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2030682|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
2030683|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2030684|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030685|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2030686|NCT01468584|Ribavirin|ribavirin|mesh-list
2030687|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2030688|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
2030689|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030690|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
2030691|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030692|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
2030693|NCT01468818|Fludarabine|fludarabine|mesh-list
2030694|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2030695|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
2030696|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030697|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2030698|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2030699|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
2030700|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030701|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030702|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2030703|NCT01468844|Minocycline|minocycline|mesh-list
2030704|NCT01468844|Bevacizumab|bevacizumab|mesh-list
2030705|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2030706|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030707|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2030708|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2030709|NCT01468844|Growth Substances|growth substances|mesh-ancestor
2030710|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030711|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
2030712|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2030713|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030714|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2030715|NCT01468896|Cetuximab|cetuximab|mesh-list
2030716|NCT01468896|Interleukin-12|interleukin-12|mesh-list
2030717|NCT01468896|Antibodies|antibodies|mesh-list
2030718|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
2030719|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2030720|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
2030721|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030722|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030723|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2030724|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2030725|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2030726|NCT01468896|Growth Substances|growth substances|mesh-ancestor
2030727|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
2030728|NCT01468909|Paclitaxel|paclitaxel|mesh-list
2030729|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2030730|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2030731|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030732|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
2030733|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
2030734|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
2030735|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030736|NCT01468987|Insulin|insulin|mesh-list
2030737|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2030738|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
2030739|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
2030740|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2030741|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030742|NCT01469000|Pemetrexed|pemetrexed|mesh-list
2030743|NCT01469000|Gefitinib|gefitinib|mesh-list
2030744|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030745|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030746|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030747|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2030748|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2030749|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2030750|NCT01469013|Methotrexate|methotrexate|mesh-list
2030751|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2030752|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
2030753|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2030754|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030755|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2030756|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
2030757|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030758|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030759|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
2030760|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030761|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2030762|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2030763|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
2030764|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2030765|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2030766|NCT01469052|Axitinib|axitinib|mesh-list
2030767|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030768|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2030769|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030770|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030771|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
2030772|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
2030773|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030774|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030775|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
2030776|NCT01469065|Vitamins|vitamins|mesh-ancestor
2030777|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
2030778|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030779|NCT01469221|Apaziquone|apaziquone|mesh-list
2030780|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030781|NCT01469234|Loratadine|loratadine|mesh-list
2030782|NCT01469234|Fexofenadine|fexofenadine|mesh-list
2030783|NCT01469234|Terfenadine|terfenadine|mesh-list
2030784|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
2030785|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
2030786|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2030787|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2030788|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2030789|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
2030790|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
2030791|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030792|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030793|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030794|NCT01469364|Aztreonam|aztreonam|mesh-list
2030795|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2030796|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030797|NCT01469377|Cariprazine|cariprazine|mesh-list
2030798|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2030799|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2030800|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2030801|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030802|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2030803|NCT01469546|Axitinib|axitinib|mesh-list
2030804|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030805|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2030806|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030807|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030808|NCT01469585|Doxycycline|doxycycline|mesh-list
2030809|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2030810|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030811|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
2030812|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2030813|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2030814|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
2030815|NCT01469637|Mesalamine|mesalamine|mesh-list
2030816|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030817|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2030818|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2030819|NCT01469637|Analgesics|analgesics|mesh-ancestor
2030820|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
2030821|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030822|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030823|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2030824|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2030825|NCT01469767|Fluocinonide|fluocinonide|mesh-list
2030826|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2030827|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
2030828|NCT01469767|Hormones|hormones|mesh-ancestor
2030829|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2030830|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030831|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2030832|NCT01469819|Lubiprostone|lubiprostone|mesh-list
2030833|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2030834|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2030835|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030836|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
2030837|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2030838|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2030839|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
2030840|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030841|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030842|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030843|NCT01470001|Urological Agents|urological agents|mesh-ancestor
2030844|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
2030845|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2030846|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
2030847|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030848|NCT01470027|Expectorants|expectorants|mesh-ancestor
2030849|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
2030850|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2030851|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
2030852|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030853|NCT01470027|Protective Agents|protective agents|mesh-ancestor
2030854|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030855|NCT01470027|Antidotes|antidotes|mesh-ancestor
2030856|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2030857|NCT01470118|Dextrans|dextrans|mesh-list
2030858|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2030859|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2030860|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
2030861|NCT01470118|Alcaftadine|alcaftadine|mesh-list
2030862|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2030863|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2030864|NCT01470118|Analgesics|analgesics|mesh-ancestor
2030865|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
2030866|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030867|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030868|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2030869|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2030870|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2030871|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2030872|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2030873|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
2030874|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
2030875|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030876|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030877|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
2030878|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
2030879|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
2030880|NCT01470144|Epoprostenol|epoprostenol|mesh-list
2030881|NCT01470144|Tezosentan|tezosentan|mesh-list
2030882|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2030883|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2030884|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
2030885|NCT01470170|Alfentanil|alfentanil|mesh-list
2030886|NCT01470170|Propofol|propofol|mesh-list
2030887|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2030888|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2030889|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030890|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2030891|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
2030892|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
2030893|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2030894|NCT01470170|Narcotics|narcotics|mesh-ancestor
2030895|NCT01470170|Analgesics|analgesics|mesh-ancestor
2030896|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
2030897|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030898|NCT01470196|Dexamethasone|dexamethasone|mesh-list
2030899|NCT01470196|Rituximab|rituximab|mesh-list
2030900|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2030901|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
2030902|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
2030903|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2030904|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030905|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2030906|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
2030907|NCT01470196|Hormones|hormones|mesh-ancestor
2030908|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2030909|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2030910|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030911|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2030912|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
2030913|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2030914|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
2030915|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746250|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746251|NCT05171387|Androgens|androgens|mesh-list
2746252|NCT05171387|Hormones|hormones|mesh-ancestor
2746253|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2746254|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746255|NCT05171374|Trametinib|trametinib|mesh-list
2746256|NCT05171374|Dabrafenib|dabrafenib|mesh-list
2030923|NCT01470417|Gemcitabine|gemcitabine|mesh-list
2030924|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2030925|NCT01470417|Paclitaxel|paclitaxel|mesh-list
2030926|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2030927|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
2030928|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030929|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030930|NCT01470417|Antiviral Agents|antiviral agents|mesh-ancestor
2030931|NCT01470417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2030932|NCT01470417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030933|NCT01470417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2030934|NCT01470417|Immunologic Factors|immunologic factors|mesh-ancestor
2030935|NCT01470417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030936|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2030937|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
2030938|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
2030939|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
2030940|NCT01470469|Guanfacine|guanfacine|mesh-list
2030941|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2030942|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2030943|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2030944|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2030945|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
2030946|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030947|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030948|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030949|NCT01470599|Tofacitinib|tofacitinib|mesh-list
2030950|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2030951|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030952|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030953|NCT01470612|Tofacitinib|tofacitinib|mesh-list
2030954|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2030955|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030956|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030957|NCT01470651|Modafinil|modafinil|mesh-list
2030958|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2030959|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030960|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2030961|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2030962|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2030963|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030964|NCT01470859|Levodopa|levodopa|mesh-list
2746257|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2030965|NCT01470859|Carbidopa|carbidopa|mesh-list
2030966|NCT01470859|Pramipexole|pramipexole|mesh-list
2030967|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2030968|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2030969|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2030970|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
2030971|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2030972|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030973|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030974|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2030975|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030976|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
2030977|NCT01470859|Protective Agents|protective agents|mesh-ancestor
2030978|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
2030979|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2030980|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
2030981|NCT01470989|Triamcinolone|triamcinolone|mesh-list
2030982|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2030983|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2030984|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2030985|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2030986|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
2030987|NCT01470989|Hormones|hormones|mesh-ancestor
2030988|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2030989|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2030990|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2030991|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
2030992|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2030993|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2030994|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
2030995|NCT01471015|Hematinics|hematinics|mesh-ancestor
2030996|NCT01471054|Dexamethasone|dexamethasone|mesh-list
2030997|NCT01471054|Bevacizumab|bevacizumab|mesh-list
2030998|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2030999|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031000|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2031001|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2031002|NCT01471054|Growth Substances|growth substances|mesh-ancestor
2031003|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031004|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
2031005|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2031006|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
2031007|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
2031008|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031009|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2031010|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
2031011|NCT01471054|Hormones|hormones|mesh-ancestor
2031012|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031013|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2031014|NCT01471093|Rebamipide|rebamipide|mesh-list
2031015|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2031016|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2031017|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2031018|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2031019|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
2031020|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031021|NCT01471093|Protective Agents|protective agents|mesh-ancestor
2031022|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031023|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031024|NCT01471171|Bromides|bromides|mesh-list
2031025|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
2031026|NCT01471197|Pemetrexed|pemetrexed|mesh-list
2031027|NCT01471197|Ipilimumab|ipilimumab|mesh-list
2031028|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031029|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031030|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031031|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2031032|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2031033|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2031034|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2031035|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
2031036|NCT01471340|Prednisone|prednisone|mesh-list
2031037|NCT01471340|Prednisolone|prednisolone|mesh-list
2031038|NCT01471340|Albuterol|albuterol|mesh-list
2031039|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
2031040|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
2031041|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2031042|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
2031043|NCT01471340|Hormones|hormones|mesh-ancestor
2031044|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031045|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031046|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2031047|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031048|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
2031049|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031050|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2031051|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2031052|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
2031053|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2031054|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2031055|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2031056|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
2031057|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031058|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031059|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
2031060|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2031061|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
2031062|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2031063|NCT01471353|Capecitabine|capecitabine|mesh-list
2031064|NCT01471353|Sorafenib|sorafenib|mesh-list
2031065|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2031066|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
2031067|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031068|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031069|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2031070|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031071|NCT01471379|Milnacipran|milnacipran|mesh-list
2031072|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
2031073|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2031074|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2031075|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2031076|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031077|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031078|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031079|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2031080|NCT01471379|Analgesics|analgesics|mesh-ancestor
2031081|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
2031082|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031083|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
2031084|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2031085|NCT01471574|Interferons|interferons|mesh-list
2031086|NCT01471574|Ribavirin|ribavirin|mesh-list
2031087|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
2031088|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
2031089|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2031090|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031091|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
2031092|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031093|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
2031094|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031095|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
2031096|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031097|NCT01471639|Ketorolac|ketorolac|mesh-list
2031098|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2031099|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2031100|NCT01471639|Analgesics|analgesics|mesh-ancestor
2031101|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
2031102|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031103|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031104|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2031105|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2031106|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2031107|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031108|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031109|NCT01471691|Ranibizumab|ranibizumab|mesh-list
2031110|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2031111|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2031112|NCT01471691|Growth Substances|growth substances|mesh-ancestor
2031113|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031114|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
2031115|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031116|NCT01471782|Blinatumomab|blinatumomab|mesh-list
2031117|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031118|NCT01472185|Ranolazine|ranolazine|mesh-list
2031119|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2031120|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2031121|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031122|NCT01472380|Efavirenz|efavirenz|mesh-list
2031123|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
2031124|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2031125|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2031126|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031127|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031128|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
2031129|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031130|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2031131|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2031132|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2031133|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2031134|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2031135|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2031136|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2031137|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2031138|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
2031139|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2031140|NCT01472432|Vildagliptin|vildagliptin|mesh-list
2031141|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2031142|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031143|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2031144|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
2031145|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031146|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031147|NCT01472445|Vitamin D|vitamin d|mesh-list
2031148|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
2031149|NCT01472445|Vitamins|vitamins|mesh-ancestor
2031150|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
2031151|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031152|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2031153|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2031154|NCT01472549|Ethanol|ethanol|mesh-list
2031155|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
2031156|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2031157|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031158|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2031159|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031160|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
2031161|NCT01472562|Rituximab|rituximab|mesh-list
2031162|NCT01472562|Lenalidomide|lenalidomide|mesh-list
2031163|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2031164|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031165|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
2031166|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031167|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2031168|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2031169|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2031170|NCT01472562|Growth Substances|growth substances|mesh-ancestor
2031171|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
2031172|NCT01472835|Fentanyl|fentanyl|mesh-list
2031173|NCT01472835|Midazolam|midazolam|mesh-list
2031174|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2031175|NCT01472835|Narcotics|narcotics|mesh-ancestor
2031176|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2031177|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031178|NCT01472835|Analgesics|analgesics|mesh-ancestor
2031179|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
2031180|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031181|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2031182|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2031183|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
2031184|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
2031185|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2031186|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2031187|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2031188|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2031189|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
2031190|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
2031191|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031192|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031193|NCT01472874|Trientine|trientine|mesh-list
2031194|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
2031195|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
2031196|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031197|NCT01472965|Ethanol|ethanol|mesh-list
2031198|NCT01472965|Heparin|heparin|mesh-list
2031199|NCT01472965|Calcium heparin|calcium heparin|mesh-list
2031200|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
2031201|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2031202|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2031203|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031204|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2031205|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031206|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2031207|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031208|NCT01473368|Amoxicillin|amoxicillin|mesh-list
2031209|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
2031210|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
2031211|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2031212|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2031213|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031214|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2031215|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031216|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031217|NCT01473381|Dexetimide|dexetimide|mesh-list
2031218|NCT01473381|Citalopram|citalopram|mesh-list
2031219|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2031220|NCT01473381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2031221|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2031222|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2031223|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031224|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031225|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
2031226|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031227|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2031228|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
2031229|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2031230|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2031231|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2031232|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
2031233|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
2031234|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031235|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2031236|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2031237|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
2031238|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2031239|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2031240|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2031241|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
2031242|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2031243|NCT01473394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2031244|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2031245|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2031246|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031247|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031248|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
2031249|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031250|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2031251|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2031252|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
2031253|NCT01473407|Hematinics|hematinics|mesh-ancestor
2031254|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
2031255|NCT01473420|Hematinics|hematinics|mesh-ancestor
2031256|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2031257|NCT01473524|Cathartics|cathartics|mesh-ancestor
2031258|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2031259|NCT01473563|Pemetrexed|pemetrexed|mesh-list
2031260|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031261|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031262|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031263|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2031264|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2031265|NCT01473589|Vitamin D|vitamin d|mesh-list
2031266|NCT01473589|Teriparatide|teriparatide|mesh-list
2031267|NCT01473589|Calcium|calcium|mesh-list
2031268|NCT01473589|Vitamins|vitamins|mesh-ancestor
2031269|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
2031270|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031271|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2031272|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2031273|NCT01473602|Vitamin D|vitamin d|mesh-list
2031274|NCT01473602|Teriparatide|teriparatide|mesh-list
2031275|NCT01473602|Calcium|calcium|mesh-list
2031276|NCT01473602|Vitamins|vitamins|mesh-ancestor
2031277|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
2031278|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031279|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2031280|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2031281|NCT01473745|Daminozide|daminozide|mesh-list
2031282|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2031283|NCT01473745|Growth Substances|growth substances|mesh-ancestor
2031284|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031285|NCT01473836|Metronidazole|metronidazole|mesh-list
2031286|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
2031287|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031288|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2031289|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2031290|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2031291|NCT01473940|Gemcitabine|gemcitabine|mesh-list
2031292|NCT01473940|Ipilimumab|ipilimumab|mesh-list
2031293|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2031294|NCT01473940|Antibodies|antibodies|mesh-list
2031295|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
2031296|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2031297|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
2031298|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031299|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2031300|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
2031301|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031302|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031303|NCT01473940|Antiviral Agents|antiviral agents|mesh-ancestor
2031304|NCT01473940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031305|NCT01473940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031306|NCT01473940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2031307|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2031308|NCT01473953|Liraglutide|liraglutide|mesh-list
2031309|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2031310|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031311|NCT01473953|Incretins|incretins|mesh-ancestor
2031312|NCT01473953|Hormones|hormones|mesh-ancestor
2031313|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031314|NCT01474018|Bromocriptine|bromocriptine|mesh-list
2031315|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2031316|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2031317|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
2031318|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031319|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031320|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
2031321|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
2031322|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031323|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031324|NCT01474109|Macitentan|macitentan|mesh-list
2031325|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2031326|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2031327|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031328|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2031329|NCT01474122|Macitentan|macitentan|mesh-list
2031330|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2031331|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2031332|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031333|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2031334|NCT01474200|Furosemide|furosemide|mesh-list
2031335|NCT01474200|Diuretics|diuretics|mesh-list
2031336|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
2031337|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
2031338|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031339|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2031340|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031341|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
2031342|NCT01474213|Remifentanil|remifentanil|mesh-list
2031343|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2031344|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2031345|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031346|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2031347|NCT01474213|Analgesics|analgesics|mesh-ancestor
2031348|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
2031349|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031350|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2031351|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2031352|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2031353|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
2031354|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031355|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031356|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2031357|NCT01474213|Narcotics|narcotics|mesh-ancestor
2031358|NCT01474239|Bevacizumab|bevacizumab|mesh-list
2031359|NCT01474239|Fotemustine|fotemustine|mesh-list
2031360|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2031361|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031362|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2031363|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2031364|NCT01474239|Growth Substances|growth substances|mesh-ancestor
2031365|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031366|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
2031367|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
2031368|NCT01474486|Thiamine|thiamine|mesh-list
2031369|NCT01474486|Micronutrients|micronutrients|mesh-list
2031370|NCT01474486|Trace Elements|trace elements|mesh-list
2031371|NCT01474486|Vitamins|vitamins|mesh-ancestor
2031372|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031373|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
2031374|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2031375|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2031376|NCT01474512|Ixekizumab|ixekizumab|mesh-list
2031377|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
2031378|NCT01474538|Insulin|insulin|mesh-list
2031379|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2031380|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
2031381|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
2031382|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2031383|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031384|NCT01474551|Vemurafenib|vemurafenib|mesh-list
2031385|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031386|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2031387|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031388|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031389|NCT01474590|Doxycycline|doxycycline|mesh-list
2031390|NCT01474590|Isotretinoin|isotretinoin|mesh-list
2031391|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2031392|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031393|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
2031394|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2031395|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2031396|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
2031397|NCT01474746|Sertraline|sertraline|mesh-list
2031398|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
2031399|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2031400|NCT01474746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2031401|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2031402|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2031403|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031404|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031405|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
2031406|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031407|NCT01474772|Pregabalin|pregabalin|mesh-list
2031408|NCT01474772|Analgesics|analgesics|mesh-ancestor
2031409|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
2031410|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031411|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031412|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
2031413|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2031414|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2031415|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031416|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2031417|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2031418|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2031419|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2031420|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2031421|NCT01474915|Promethazine|promethazine|mesh-list
2031422|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
2031423|NCT01474915|Dexamethasone|dexamethasone|mesh-list
2031424|NCT01474915|Ondansetron|ondansetron|mesh-list
2031425|NCT01474915|Aprepitant|aprepitant|mesh-list
2031426|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2031427|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
2031428|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
2031429|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031430|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031431|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2031432|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
2031433|NCT01474915|Hormones|hormones|mesh-ancestor
2031434|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031435|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2031436|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031437|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
2031438|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
2031439|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2031440|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
2031441|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031442|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031443|NCT01474915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2031444|NCT01474915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2031445|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2031446|NCT01474915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2031447|NCT01474915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2031448|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2031449|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2031450|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
2031451|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
2031452|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2031453|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2031454|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2031455|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
2031456|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
2031457|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
2031458|NCT01474993|Sulforaphane|sulforaphane|mesh-list
2031459|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2031460|NCT01474993|Protective Agents|protective agents|mesh-ancestor
2031461|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031462|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031463|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2031464|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2031465|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2031466|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
2031467|NCT01475253|Lidocaine|lidocaine|mesh-list
2031468|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
2031469|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
2031470|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2031471|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031472|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
2031473|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031474|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2031475|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2031476|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2031477|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2031478|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031479|NCT01475331|Ethanol|ethanol|mesh-list
2031480|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2031481|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031482|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2031483|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031484|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2031485|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2031486|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031487|NCT01475461|Incretins|incretins|mesh-ancestor
2031488|NCT01475461|Hormones|hormones|mesh-ancestor
2031489|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031490|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2031491|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
2031492|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031493|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031494|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
2031495|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2031496|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2031497|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031498|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2031499|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2031500|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031501|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031502|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031503|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2031504|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
2031505|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2031506|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031507|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2031508|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2031509|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2031510|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2031511|NCT01475643|Prednisolone|prednisolone|mesh-list
2031512|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2031513|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
2031514|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2031515|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
2031516|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2031517|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
2031518|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2031519|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
2031520|NCT01475643|Hormones|hormones|mesh-ancestor
2031521|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031522|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031523|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2031524|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031525|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
2031526|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
2031527|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031528|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2031529|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2031530|NCT01475643|Protective Agents|protective agents|mesh-ancestor
2031531|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2031532|NCT01475721|Fluticasone|fluticasone|mesh-list
2031533|NCT01475721|Xhance|xhance|mesh-list
2031534|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2031535|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2031536|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
2031537|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031538|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031539|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2031540|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
2031541|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
2031542|NCT01475721|Hormones|hormones|mesh-ancestor
2031543|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031544|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
2031545|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2031546|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
2031547|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2031548|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
2031549|NCT01475734|Incretins|incretins|mesh-ancestor
2031550|NCT01475734|Hormones|hormones|mesh-ancestor
2031551|NCT01475734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031552|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031553|NCT01475825|Mipomersen|mipomersen|mesh-list
2031554|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2031555|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2031556|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
2031557|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031558|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2031559|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2031560|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
2031561|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031562|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2031563|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2031564|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2031565|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2031566|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
2031567|NCT01476202|Nicotine|nicotine|mesh-list
2031568|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2031569|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
2031570|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031571|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031572|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2031573|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2031574|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
2031575|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031576|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031577|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
2031578|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2031579|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2031580|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
2031581|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031582|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2031583|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
2031584|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2031585|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031586|NCT01476449|Ranibizumab|ranibizumab|mesh-list
2031587|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2031588|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2031589|NCT01476449|Growth Substances|growth substances|mesh-ancestor
2031590|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031591|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
2031592|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031593|NCT01476475|Insulin|insulin|mesh-list
2031594|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2031595|NCT01476475|Metformin|metformin|mesh-list
2031596|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
2031597|NCT01476475|Lixisenatide|lixisenatide|mesh-list
2031598|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2031599|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031600|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2031601|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2031602|NCT01477320|Pantoprazole|pantoprazole|mesh-list
2031603|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2031604|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2031605|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2031606|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031607|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031608|NCT01477333|Treprostinil|treprostinil|mesh-list
2031609|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2031610|NCT01477463|Vitamin D|vitamin d|mesh-list
2031611|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
2031612|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
2031613|NCT01477463|Vitamins|vitamins|mesh-list
2031614|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
2031615|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031616|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2031617|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2031618|NCT01477762|Dexamethasone|dexamethasone|mesh-list
2031619|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2031620|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
2031621|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
2031622|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031623|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031624|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2031625|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
2031626|NCT01477762|Hormones|hormones|mesh-ancestor
2031627|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031628|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2031629|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031630|NCT01477853|Metformin|metformin|mesh-list
2031631|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2031632|NCT01477853|Glimepiride|glimepiride|mesh-list
2031633|NCT01477853|Atorvastatin|atorvastatin|mesh-list
2031634|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2031635|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031636|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2031637|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2031638|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
2031639|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031640|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2031641|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2031642|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031643|NCT01477853|Incretins|incretins|mesh-ancestor
2031644|NCT01477853|Hormones|hormones|mesh-ancestor
2031645|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031646|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2031647|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
2031648|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2031649|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2031650|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
2031651|NCT01477892|Remifentanil|remifentanil|mesh-list
2031652|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2031653|NCT01477892|Narcotics|narcotics|mesh-ancestor
2031654|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2031655|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031656|NCT01477892|Analgesics|analgesics|mesh-ancestor
2031657|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
2031658|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031659|NCT01478048|Dexamethasone|dexamethasone|mesh-list
2031660|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
2031661|NCT01478048|Bortezomib|bortezomib|mesh-list
2031662|NCT01478048|Elotuzumab|elotuzumab|mesh-list
2031663|NCT01478048|BB 1101|bb 1101|mesh-list
2031664|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2031665|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
2031666|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
2031667|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031668|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031669|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2031670|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
2031671|NCT01478048|Hormones|hormones|mesh-ancestor
2031672|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031673|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2031674|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031675|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
2031676|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031677|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031678|NCT01478256|Erythromycin|erythromycin|mesh-list
2031679|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
2031680|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2031681|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
2031682|NCT01478256|Besifloxacin|besifloxacin|mesh-list
2031683|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2031684|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031685|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2031686|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2031687|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031688|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031689|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2031690|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2031691|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031692|NCT01478321|Bevacizumab|bevacizumab|mesh-list
2031693|NCT01478321|Temozolomide|temozolomide|mesh-list
2031694|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2031695|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031696|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2031697|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2031698|NCT01478321|Growth Substances|growth substances|mesh-ancestor
2031699|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031700|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
2031701|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2031702|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
2031703|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031704|NCT01478581|Dexamethasone|dexamethasone|mesh-list
2031705|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2031706|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
2031707|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
2031708|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031709|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031710|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2031711|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
2031712|NCT01478581|Hormones|hormones|mesh-ancestor
2031713|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031714|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2031715|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031716|NCT01478594|Bevacizumab|bevacizumab|mesh-list
2031717|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2031718|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031719|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2031720|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2031721|NCT01478594|Growth Substances|growth substances|mesh-ancestor
2031722|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031723|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
2031724|NCT01478828|Lovastatin|lovastatin|mesh-list
2031725|NCT01478828|L 647318|l 647318|mesh-list
2031726|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
2031727|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2031728|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2031729|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
2031730|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031731|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2031732|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2031733|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031734|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
2031735|NCT01478971|Hematinics|hematinics|mesh-ancestor
2031736|NCT01479127|Silicon|silicon|mesh-list
2031737|NCT01479127|Levodopa|levodopa|mesh-list
2031738|NCT01479127|Carbidopa|carbidopa|mesh-list
2031739|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2031740|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2031741|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
2031742|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031743|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031744|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031745|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2031746|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031747|NCT01479127|Trace Elements|trace elements|mesh-ancestor
2031748|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
2031749|NCT01479270|Epinephrine|epinephrine|mesh-list
2031750|NCT01479270|Ropivacaine|ropivacaine|mesh-list
2031751|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
2031752|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
2031753|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2031754|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031755|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
2031756|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031757|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2031758|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2031759|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
2031760|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031761|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031762|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2031763|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2031764|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
2031765|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2031766|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
2031767|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
2031768|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
2031769|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2031770|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
2031771|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
2031772|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031773|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2031774|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2031775|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2031776|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2031777|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2031778|NCT01479374|Analgesics|analgesics|mesh-ancestor
2031779|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
2031780|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031781|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031782|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2031783|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2031784|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2031785|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2031786|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2031787|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
2031788|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
2031789|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031790|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031791|NCT01479439|Losartan|losartan|mesh-list
2031792|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2031793|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2031794|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2031795|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2031796|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031797|NCT01479465|Leucovorin|leucovorin|mesh-list
2031798|NCT01479465|Fluorouracil|fluorouracil|mesh-list
2031799|NCT01479465|Irinotecan|irinotecan|mesh-list
2031800|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
2031801|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031802|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2031803|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031804|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2031805|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
2031806|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031807|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2031808|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2031809|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031810|NCT01479465|Antidotes|antidotes|mesh-ancestor
2031811|NCT01479465|Protective Agents|protective agents|mesh-ancestor
2031812|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
2031813|NCT01479465|Vitamins|vitamins|mesh-ancestor
2031814|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
2031815|NCT01479517|Tetracaine|tetracaine|mesh-list
2031816|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
2031817|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
2031818|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2031819|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031820|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
2031821|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031822|NCT01479530|Rasagiline|rasagiline|mesh-list
2031823|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2031824|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031825|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031826|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2031827|NCT01479530|Protective Agents|protective agents|mesh-ancestor
2031828|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031829|NCT01479621|Fluticasone|fluticasone|mesh-list
2031830|NCT01479621|Xhance|xhance|mesh-list
2031831|NCT01479621|Albuterol|albuterol|mesh-list
2031832|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
2031833|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2031834|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2031835|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
2031836|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031837|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031838|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2031839|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
2031840|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
2031841|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2031842|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
2031843|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2031844|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2031845|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2031846|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
2031847|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031848|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031849|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
2031850|NCT01479764|Neostigmine|neostigmine|mesh-list
2031851|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2031852|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031853|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031854|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
2031855|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031856|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031857|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2031858|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
2031859|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031860|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2031861|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2031862|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2031863|NCT01479868|Interferons|interferons|mesh-list
2031864|NCT01479868|Ribavirin|ribavirin|mesh-list
2031865|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
2031866|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
2031867|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2031868|NCT01479868|Simeprevir|simeprevir|mesh-list
2031869|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031870|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
2031871|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031872|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
2031873|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031874|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
2031875|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031876|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
2031877|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031878|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
2031879|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2031880|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2031881|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031882|NCT01480089|Ropivacaine|ropivacaine|mesh-list
2031883|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
2031884|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
2031885|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2031886|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031887|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
2031888|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031889|NCT01480219|Voriconazole|voriconazole|mesh-list
2031890|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
2031891|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2031892|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2031893|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2031894|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031895|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031896|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2031897|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
2031898|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2031899|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031900|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2031901|NCT01480232|Nicotine|nicotine|mesh-list
2031902|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2031903|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
2031904|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031905|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031906|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2031907|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2031908|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
2031909|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031910|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031911|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2031912|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
2031913|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031914|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2031915|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
2031916|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2031917|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2031918|NCT01480297|Analgesics|analgesics|mesh-ancestor
2031919|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
2031920|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031921|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031922|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2031923|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2031924|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2031925|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031926|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031927|NCT01480596|Belimumab|belimumab|mesh-list
2031928|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2031929|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
2031930|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031931|NCT01480674|Trastuzumab|trastuzumab|mesh-list
2031932|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2031933|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031934|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
2031935|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2031936|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031937|NCT01481116|Glimepiride|glimepiride|mesh-list
2031938|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2031939|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2031940|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031941|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2031942|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
2031943|NCT01481545|Leucovorin|leucovorin|mesh-list
2031944|NCT01481545|Bevacizumab|bevacizumab|mesh-list
2031945|NCT01481545|Fluorouracil|fluorouracil|mesh-list
2031946|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
2031947|NCT01481545|Raltitrexed|raltitrexed|mesh-list
2031948|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
2031949|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2031950|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2031951|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2031952|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2031953|NCT01481545|Growth Substances|growth substances|mesh-ancestor
2031954|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031955|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
2031956|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
2031957|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031958|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2031959|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2031960|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
2031961|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2031962|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2031963|NCT01481545|Antidotes|antidotes|mesh-ancestor
2031964|NCT01481545|Protective Agents|protective agents|mesh-ancestor
2031965|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
2031966|NCT01481545|Vitamins|vitamins|mesh-ancestor
2031967|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
2031968|NCT01481740|Phenylephrine|phenylephrine|mesh-list
2031969|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
2031970|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2031971|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
2031972|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
2031973|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031974|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031975|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
2031976|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2031977|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
2031978|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
2031979|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2031980|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2031981|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2031982|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
2031983|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2031984|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2031985|NCT01481740|Protective Agents|protective agents|mesh-ancestor
2031986|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
2031987|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2031988|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031989|NCT01482091|Fentanyl|fentanyl|mesh-list
2031990|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2031991|NCT01482091|Narcotics|narcotics|mesh-ancestor
2031992|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2031993|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2031994|NCT01482091|Analgesics|analgesics|mesh-ancestor
2031995|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
2031996|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2031997|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2031998|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2031999|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
2032000|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
2032001|NCT01482169|Adenosine|adenosine|mesh-list
2032002|NCT01482169|Regadenoson|regadenoson|mesh-list
2032003|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2032004|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2032005|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
2032006|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
2032007|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032008|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032009|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032010|NCT01482169|Analgesics|analgesics|mesh-ancestor
2032011|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
2032012|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032013|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2032014|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
2032015|NCT01482715|Rucaparib|rucaparib|mesh-list
2032016|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2032017|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032018|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032019|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032020|NCT01482767|Interferons|interferons|mesh-list
2032021|NCT01482767|Ribavirin|ribavirin|mesh-list
2032022|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
2032023|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
2032024|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2032025|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032026|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
2032027|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2032028|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
2032029|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032030|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
2032031|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032032|NCT01482910|Aflibercept|aflibercept|mesh-list
2032033|NCT01482910|Verteporfin|verteporfin|mesh-list
2032034|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2032035|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2032036|NCT01482910|Growth Substances|growth substances|mesh-ancestor
2032037|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032038|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
2032039|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032040|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2032041|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
2032042|NCT01482962|Gemcitabine|gemcitabine|mesh-list
2032043|NCT01482962|Romidepsin|romidepsin|mesh-list
2032044|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2032045|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
2032046|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032047|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032048|NCT01482962|Antiviral Agents|antiviral agents|mesh-ancestor
2032049|NCT01482962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2032050|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032051|NCT01482962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2032052|NCT01482962|Immunologic Factors|immunologic factors|mesh-ancestor
2032053|NCT01482962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032054|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2032055|NCT01483144|Eflornithine|eflornithine|mesh-list
2032056|NCT01483144|Sulindac|sulindac|mesh-list
2032057|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032058|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2032059|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2032060|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2032061|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2032062|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2032063|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032064|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032065|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2032066|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2032067|NCT01483144|Analgesics|analgesics|mesh-ancestor
2032068|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
2032069|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032070|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032071|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2032072|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2032073|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2032074|NCT01483560|Metformin|metformin|mesh-list
2032075|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2032076|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032077|NCT01483599|Adalimumab|adalimumab|mesh-list
2032078|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2032079|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2032080|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
2032081|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2032082|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
2032083|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032084|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032085|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2032086|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
2032087|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
2032088|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2032089|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
2032090|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032091|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032092|NCT01483651|Insulin|insulin|mesh-list
2032093|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2032094|NCT01483651|Glucagon|glucagon|mesh-list
2032095|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2032096|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032097|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2032098|NCT01483651|Hormones|hormones|mesh-ancestor
2032099|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032100|NCT01483690|Dexamethasone|dexamethasone|mesh-list
2032101|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
2032102|NCT01483690|Methotrexate|methotrexate|mesh-list
2032103|NCT01483690|Vincristine|vincristine|mesh-list
2032104|NCT01483690|Decitabine|decitabine|mesh-list
2032105|NCT01483690|Asparaginase|asparaginase|mesh-list
2032106|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
2032107|NCT01483690|Vorinostat|vorinostat|mesh-list
2032108|NCT01483690|Pegaspargase|pegaspargase|mesh-list
2032109|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2032110|NCT01483690|BB 1101|bb 1101|mesh-list
2032111|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2032112|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
2032113|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
2032114|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032115|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032116|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2032117|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
2032118|NCT01483690|Hormones|hormones|mesh-ancestor
2032119|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032120|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2032121|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032122|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
2032123|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032124|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032125|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2032126|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
2032127|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2032128|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2032129|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
2032130|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
2032131|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2032132|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2032133|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
2032134|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2032135|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2032136|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2032137|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
2032138|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
2032139|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
2032140|NCT01483690|Analgesics|analgesics|mesh-ancestor
2032141|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
2032142|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2032143|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2032144|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2032145|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2032146|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2032147|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032148|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032149|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2032150|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
2032151|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032152|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032153|NCT01484197|Maleic acid|maleic acid|mesh-list
2032154|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032155|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032156|NCT01484275|Siltuximab|siltuximab|mesh-list
2032157|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032158|NCT01484340|Nicotine|nicotine|mesh-list
2032159|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2032160|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
2032161|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032162|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032163|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2032164|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2032165|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
2032166|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032167|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032168|NCT01484431|Tadalafil|tadalafil|mesh-list
2032169|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
2032170|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2032171|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2032172|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032173|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032174|NCT01484431|Urological Agents|urological agents|mesh-ancestor
2032175|NCT01484496|Belimumab|belimumab|mesh-list
2032176|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2032177|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
2032178|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032179|NCT01484561|Tofacitinib|tofacitinib|mesh-list
2032180|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2032181|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032182|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032183|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2032184|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2032185|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
2032186|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032187|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032188|NCT01484873|Exenatide|exenatide|mesh-list
2032189|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2032190|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032191|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2032192|NCT01484873|Incretins|incretins|mesh-ancestor
2032193|NCT01484873|Hormones|hormones|mesh-ancestor
2032194|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032195|NCT01484951|Timolol|timolol|mesh-list
2032196|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2032197|NCT01484951|Brinzolamide|brinzolamide|mesh-list
2032198|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2032199|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2032200|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2032201|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
2032202|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032203|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032204|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032205|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2032206|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2032207|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2032208|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032209|NCT01484977|Lacosamide|lacosamide|mesh-list
2032210|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
2032211|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2032212|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2032213|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2032214|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032215|NCT01485055|Infliximab|infliximab|mesh-list
2032216|NCT01485055|Basiliximab|basiliximab|mesh-list
2032217|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
2032218|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2032219|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2032220|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2032221|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
2032222|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032223|NCT01485094|Pregabalin|pregabalin|mesh-list
2032224|NCT01485094|Analgesics|analgesics|mesh-ancestor
2032225|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
2032226|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032227|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032228|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
2032229|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2032230|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2032231|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032232|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2032233|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2032234|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2032235|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2032236|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2032237|NCT01485172|Ropinirole|ropinirole|mesh-list
2032238|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2032239|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2032240|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
2032241|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
2032242|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032243|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032244|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032245|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
2032246|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2032247|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2032248|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032249|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2032250|NCT01485380|Analgesics|analgesics|mesh-ancestor
2032251|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
2032252|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032253|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2032254|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2032255|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2032256|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
2032257|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032258|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032259|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
2032260|NCT01485393|Zolpidem|zolpidem|mesh-list
2032261|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2032262|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2032263|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032264|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2032265|NCT01485393|Analgesics|analgesics|mesh-ancestor
2032266|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
2032267|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032268|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2032269|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2032270|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2032271|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
2032272|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032273|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032274|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2032275|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2032276|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
2032277|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
2032278|NCT01485588|Immunoconjugates|immunoconjugates|mesh-list
2032279|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
2032280|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032281|NCT01485614|Metformin|metformin|mesh-list
2032282|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2032283|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2032284|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032285|NCT01485614|Incretins|incretins|mesh-ancestor
2032286|NCT01485614|Hormones|hormones|mesh-ancestor
2032287|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032288|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2032289|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
2032290|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032291|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032292|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2032293|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2032294|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2032295|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2032296|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032297|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2032298|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2032299|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2032300|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2032301|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
2032302|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032303|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032304|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2032305|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2032306|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
2032307|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2032308|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2032309|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
2032310|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
2032311|NCT01485796|Antibodies|antibodies|mesh-list
2032312|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
2032313|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2032314|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2032315|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
2032316|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032317|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2032318|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2032319|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2032320|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2032321|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032322|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032323|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032324|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2032325|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
2032326|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2032327|NCT01485991|Simeprevir|simeprevir|mesh-list
2032328|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
2032329|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2032330|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
2032331|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032332|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032333|NCT01486043|Metformin|metformin|mesh-list
2032334|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2032335|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032336|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
2032337|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2032338|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2032339|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2032340|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2032341|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032342|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
2032343|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032344|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032345|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2032346|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032347|NCT01486615|Melatonin|melatonin|mesh-list
2032348|NCT01486615|Alprazolam|alprazolam|mesh-list
2032349|NCT01486615|Azaperone|azaperone|mesh-list
2032350|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
2032351|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032352|NCT01486615|Protective Agents|protective agents|mesh-ancestor
2032353|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032354|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2032355|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2032356|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2032357|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2032358|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2032359|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
2032360|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
2032361|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032362|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2032363|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2032364|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
2032365|NCT01486758|Azithromycin|azithromycin|mesh-list
2032366|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2032367|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2032368|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2032369|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2032370|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032371|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2032372|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2032373|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2032374|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032375|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
2032376|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032377|NCT01486927|Factor VIII|factor viii|mesh-list
2032378|NCT01486927|Coagulants|coagulants|mesh-ancestor
2032379|NCT01486966|Insulin|insulin|mesh-list
2032380|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2032381|NCT01486966|Metformin|metformin|mesh-list
2032382|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
2032383|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
2032384|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
2032385|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
2032386|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
2032387|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2032388|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032389|NCT01487161|Triamcinolone|triamcinolone|mesh-list
2032390|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2032391|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2032392|NCT01487161|FX006|fx006|mesh-list
2032393|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2032394|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2032395|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
2032396|NCT01487161|Hormones|hormones|mesh-ancestor
2032397|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032398|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032399|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2032400|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
2032401|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032402|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032403|NCT01487200|Triamcinolone|triamcinolone|mesh-list
2032404|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2032405|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2032406|NCT01487200|FX006|fx006|mesh-list
2032407|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2032408|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2032409|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
2032410|NCT01487200|Hormones|hormones|mesh-ancestor
2032411|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032412|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032413|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2032414|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
2032415|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032416|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032417|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2032418|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032419|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2032420|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032421|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032422|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
2032423|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2032424|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032425|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2032426|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
2032427|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2032428|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2032429|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032430|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032431|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
2032432|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032433|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2032434|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032435|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032436|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
2032437|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032438|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032439|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2032440|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
2032441|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2032442|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
2032443|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032444|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032445|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2032446|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
2032447|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2032448|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2032449|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2032450|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
2032451|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032452|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032453|NCT01488071|Vortioxetine|vortioxetine|mesh-list
2032454|NCT01488071|S 20098|s 20098|mesh-list
2032455|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
2032456|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2032457|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2032458|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2032459|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2032460|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032461|NCT01488071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2032462|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2032463|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2032464|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032465|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032466|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
2032467|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2032468|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2032469|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2032470|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2032471|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2032472|NCT01488188|Vaccines|vaccines|mesh-list
2032473|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
2032474|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032475|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2032476|NCT01488279|Dexamethasone|dexamethasone|mesh-list
2032477|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
2032478|NCT01488279|BB 1101|bb 1101|mesh-list
2032479|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2032480|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
2032481|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
2032482|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032483|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032484|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2032485|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
2032486|NCT01488279|Hormones|hormones|mesh-ancestor
2032487|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032488|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2032489|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032490|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
2032491|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032492|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032493|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2032494|NCT01488279|Incretins|incretins|mesh-ancestor
2032495|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2032496|NCT01488318|Cetuximab|cetuximab|mesh-list
2032497|NCT01488318|Dasatinib|dasatinib|mesh-list
2032498|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2032499|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032500|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2032501|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032502|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032503|NCT01488409|Acipimox|acipimox|mesh-list
2032504|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2032505|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
2032506|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032507|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2032508|NCT01488487|Everolimus|everolimus|mesh-list
2032509|NCT01488487|Pasireotide|pasireotide|mesh-list
2032510|NCT01488487|Somatostatin|somatostatin|mesh-list
2032511|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032512|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2032513|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
2032514|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032515|NCT01488487|Hormones|hormones|mesh-ancestor
2032516|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032517|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2032518|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2032519|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2032520|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
2032521|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032522|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032523|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032524|NCT01488578|Urological Agents|urological agents|mesh-ancestor
2032525|NCT01488877|Spironolactone|spironolactone|mesh-list
2032526|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2032527|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
2032528|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032529|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032530|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2032531|NCT01488877|Diuretics|diuretics|mesh-ancestor
2032532|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
2032533|NCT01488890|Vaccines|vaccines|mesh-list
2032534|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
2032535|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032536|NCT01489020|Vaccines|vaccines|mesh-list
2032537|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
2032538|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032539|NCT01489189|Ranibizumab|ranibizumab|mesh-list
2032540|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2032541|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2032542|NCT01489189|Growth Substances|growth substances|mesh-ancestor
2032543|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032544|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
2032545|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032546|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
2032547|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
2032548|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2032549|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
2032550|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032551|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2032552|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2032553|NCT01489670|Bimatoprost|bimatoprost|mesh-list
2032554|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2032555|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2032556|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2032557|NCT01489826|HU 211|hu 211|mesh-list
2032558|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2032559|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
2032560|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
2032561|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032562|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032563|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2032564|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2032565|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2032566|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032567|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032568|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2032569|NCT01489826|Protective Agents|protective agents|mesh-ancestor
2032570|NCT01489891|Lidocaine|lidocaine|mesh-list
2032571|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
2032572|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
2032573|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2032574|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032575|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
2032576|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032577|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2032578|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2032579|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2032580|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2032581|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032582|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
2032583|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2032584|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2032585|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
2032586|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032587|NCT01489969|Melatonin|melatonin|mesh-list
2032588|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
2032589|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032590|NCT01489969|Protective Agents|protective agents|mesh-ancestor
2032591|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032592|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2032593|NCT01490060|Dexamethasone|dexamethasone|mesh-list
2032594|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
2032595|NCT01490060|Doxorubicin|doxorubicin|mesh-list
2032596|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2032597|NCT01490060|Vincristine|vincristine|mesh-list
2032598|NCT01490060|Ifosfamide|ifosfamide|mesh-list
2032599|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
2032600|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
2032601|NCT01490060|Aprepitant|aprepitant|mesh-list
2032602|NCT01490060|BB 1101|bb 1101|mesh-list
2032603|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2032604|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
2032605|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
2032606|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032607|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032608|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2032609|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
2032610|NCT01490060|Hormones|hormones|mesh-ancestor
2032611|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032612|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2032613|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032614|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
2032615|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032616|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032617|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2032618|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2032619|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2032620|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2032621|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
2032622|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
2032623|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
2032624|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2032625|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
2032626|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2032627|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032628|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
2032629|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
2032630|NCT01490086|Aripiprazole|aripiprazole|mesh-list
2032631|NCT01490086|RP5063|rp5063|mesh-list
2032632|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
2032633|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2032634|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2032635|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2032636|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2032637|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032638|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
2032639|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
2032640|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032641|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032642|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2032643|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2032644|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
2032645|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2032646|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2032647|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2032648|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2032649|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
2032650|NCT01490125|Albuterol|albuterol|mesh-list
2032651|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
2032652|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2032653|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
2032654|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032655|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032656|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2032657|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
2032658|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
2032659|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2032660|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
2032661|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032662|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032663|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
2032664|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2032665|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2032666|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2032667|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2032668|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
2032669|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2032670|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2032671|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2032672|NCT01490190|Etonogestrel|etonogestrel|mesh-list
2032673|NCT01490190|NuvaRing|nuvaring|mesh-list
2032674|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2032675|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2032676|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2032677|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
2032678|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2032679|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032680|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2032681|NCT01490190|Estrogens|estrogens|mesh-ancestor
2032682|NCT01490190|Hormones|hormones|mesh-ancestor
2032683|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032684|NCT01490580|Atropine|atropine|mesh-list
2032685|NCT01490580|Sufentanil|sufentanil|mesh-list
2032686|NCT01490580|Propofol|propofol|mesh-list
2032687|NCT01490580|Atracurium|atracurium|mesh-list
2032688|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2032689|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2032690|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032691|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2032692|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
2032693|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
2032694|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2032695|NCT01490580|Narcotics|narcotics|mesh-ancestor
2032696|NCT01490580|Analgesics|analgesics|mesh-ancestor
2032697|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
2032698|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032699|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2032700|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2032701|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2032702|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
2032703|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2032704|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
2032705|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
2032706|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
2032707|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2032708|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2032709|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
2032710|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032711|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032712|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2032713|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2032714|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2032715|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2032716|NCT01490697|Cycloserine|cycloserine|mesh-list
2032717|NCT01490697|Mifepristone|mifepristone|mesh-list
2032718|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2032719|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
2032720|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2032721|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032722|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2032723|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2032724|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2032725|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
2032726|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2032727|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2032728|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
2032729|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032730|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
2032731|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2032732|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2032733|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2032734|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2032735|NCT01490697|Renal Agents|renal agents|mesh-ancestor
2032736|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2032737|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
2032738|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2032739|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
2032740|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032741|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
2032742|NCT01490723|Rituximab|rituximab|mesh-list
2032743|NCT01490723|Methotrexate|methotrexate|mesh-list
2032744|NCT01490723|Fludarabine|fludarabine|mesh-list
2032745|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
2032746|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2032747|NCT01490723|Tacrolimus|tacrolimus|mesh-list
2032748|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
2032749|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2032750|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2032751|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2032752|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032753|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
2032754|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032755|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2032756|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2032757|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
2032758|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2032759|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2032760|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
2032761|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032762|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
2032763|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032764|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2032765|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2032766|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2032767|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2032768|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2032769|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2032770|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2032771|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
2032772|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2032773|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2032774|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
2032775|NCT01490788|Amitriptyline|amitriptyline|mesh-list
2032776|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
2032777|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2032778|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
2032779|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2032780|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2032781|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032782|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2032783|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032784|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2032785|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2032786|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2032787|NCT01490788|Analgesics|analgesics|mesh-ancestor
2032788|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
2032789|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2032790|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2032791|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2032792|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032793|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
2032794|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032795|NCT01490866|Leucovorin|leucovorin|mesh-list
2032796|NCT01490866|Bevacizumab|bevacizumab|mesh-list
2032797|NCT01490866|Fluorouracil|fluorouracil|mesh-list
2032798|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
2032799|NCT01490866|Axitinib|axitinib|mesh-list
2032800|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2032801|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032802|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2032803|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2032804|NCT01490866|Growth Substances|growth substances|mesh-ancestor
2032805|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032806|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
2032807|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
2032808|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032809|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2032810|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2032811|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
2032812|NCT01490866|Antidotes|antidotes|mesh-ancestor
2032813|NCT01490866|Protective Agents|protective agents|mesh-ancestor
2032814|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
2032815|NCT01490866|Vitamins|vitamins|mesh-ancestor
2032816|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
2032817|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2032818|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032819|NCT01490918|Metformin|metformin|mesh-list
2032820|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2032821|NCT01490918|Acarbose|acarbose|mesh-list
2032822|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2032823|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032824|NCT01490918|Incretins|incretins|mesh-ancestor
2032825|NCT01490918|Hormones|hormones|mesh-ancestor
2032826|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032827|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2032828|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
2032829|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032830|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032831|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2032832|NCT01490931|Ketorolac|ketorolac|mesh-list
2032833|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2032834|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2032835|NCT01490931|Analgesics|analgesics|mesh-ancestor
2032836|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
2032837|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032838|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032839|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2032840|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2032841|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2032842|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032843|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032844|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
2032845|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2032846|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2032847|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032848|NCT01491035|Vortioxetine|vortioxetine|mesh-list
2032849|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
2032850|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2032851|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2032852|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2032853|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2032854|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032855|NCT01491035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2032856|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2032857|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2032858|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032859|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2032860|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
2032861|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2032862|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2032863|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2032864|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2032865|NCT01491113|Levetiracetam|levetiracetam|mesh-list
2032866|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
2032867|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
2032868|NCT01491607|Vaccines|vaccines|mesh-list
2032869|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
2032870|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032871|NCT01491633|Dasatinib|dasatinib|mesh-list
2032872|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032873|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2032874|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032875|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032876|NCT01491672|Everolimus|everolimus|mesh-list
2032877|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032878|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2032879|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
2032880|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032881|NCT01491737|Trastuzumab|trastuzumab|mesh-list
2032882|NCT01491737|Pertuzumab|pertuzumab|mesh-list
2032883|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2032884|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2032885|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032886|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2032887|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032888|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032889|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2032890|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
2032891|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032892|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032893|NCT01491841|Rituximab|rituximab|mesh-list
2032894|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2032895|NCT01491841|Pixantrone|pixantrone|mesh-list
2032896|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2032897|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032898|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
2032899|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032900|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2032901|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2032902|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
2032903|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032904|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2032905|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2032906|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032910|NCT01491919|Lisinopril|lisinopril|mesh-list
2032911|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2032912|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
2032913|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032914|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032915|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2032916|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2032917|NCT01491919|Protective Agents|protective agents|mesh-ancestor
2032918|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032919|NCT01491958|Methotrexate|methotrexate|mesh-list
2032920|NCT01491958|Atorvastatin|atorvastatin|mesh-list
2032921|NCT01491958|Tacrolimus|tacrolimus|mesh-list
2032922|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2032923|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
2032924|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2032925|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032926|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2032927|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
2032928|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032929|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032930|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
2032931|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032932|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2032933|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2032934|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
2032935|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2032936|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2032937|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2032938|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2032939|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2032940|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2032941|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2032942|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2032943|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2032944|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032945|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
2032946|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032947|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2032948|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2032949|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032950|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032951|NCT01492400|Dexamethasone|dexamethasone|mesh-list
2032952|NCT01492400|Ranibizumab|ranibizumab|mesh-list
2032953|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2032954|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
2032955|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
2032956|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2032957|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032958|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2032959|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
2032960|NCT01492400|Hormones|hormones|mesh-ancestor
2032961|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2032962|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2032963|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032964|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2032965|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2032966|NCT01492400|Growth Substances|growth substances|mesh-ancestor
2032967|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
2032968|NCT01492426|Ribavirin|ribavirin|mesh-list
2032969|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2032970|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
2032971|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032972|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
2032973|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2032974|NCT01492582|Vaccines|vaccines|mesh-list
2032975|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
2032976|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032977|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
2032978|NCT01492673|Bevacizumab|bevacizumab|mesh-list
2032979|NCT01492673|Topotecan|topotecan|mesh-list
2032980|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2032981|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
2032982|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2032983|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2032984|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2032985|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
2032986|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2032987|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2032988|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2032989|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2032990|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2032991|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2032992|NCT01492673|Growth Substances|growth substances|mesh-ancestor
2032993|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
2032994|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2032995|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2032996|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2032997|NCT01492686|Edaravone|edaravone|mesh-list
2032998|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2032999|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
2033000|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033001|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2033002|NCT01492686|Protective Agents|protective agents|mesh-ancestor
2033003|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033004|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
2033005|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2033006|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033007|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033008|NCT01493180|Rebamipide|rebamipide|mesh-list
2033009|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2033010|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
2033011|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2033012|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2033013|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
2033014|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033015|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
2033016|NCT01493180|Protective Agents|protective agents|mesh-ancestor
2033017|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2033018|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2033019|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
2033020|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033021|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033022|NCT01493427|Travoprost|travoprost|mesh-list
2033023|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2033024|NCT01493531|Allopurinol|allopurinol|mesh-list
2033025|NCT01493531|Lesinurad|lesinurad|mesh-list
2033026|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
2033027|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033028|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033029|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
2033030|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2033031|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2033032|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
2033033|NCT01493531|Protective Agents|protective agents|mesh-ancestor
2033034|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033035|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
2033036|NCT01493531|Renal Agents|renal agents|mesh-ancestor
2033037|NCT01493557|Pantoprazole|pantoprazole|mesh-list
2033038|NCT01493557|Dabigatran|dabigatran|mesh-list
2033039|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
2033040|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2033041|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
2033042|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033043|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033044|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
2033045|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2033046|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2033047|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2033048|NCT01493687|Azelaic acid|azelaic acid|mesh-list
2033049|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033050|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
2033051|NCT01493947|Metronidazole|metronidazole|mesh-list
2033052|NCT01493947|Ivermectin|ivermectin|mesh-list
2033053|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033054|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2033055|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2033056|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2033057|NCT01494038|Isoniazid|isoniazid|mesh-list
2033058|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
2033059|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2033060|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033061|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2033062|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2033063|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
2033064|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033065|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2033066|NCT01494350|Gentamicins|gentamicins|mesh-list
2033067|NCT01494350|Paromomycin|paromomycin|mesh-list
2033068|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2033069|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033070|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2033071|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033072|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033073|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2033074|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2033075|NCT01494467|Azelaic acid|azelaic acid|mesh-list
2033076|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033077|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
2033078|NCT01494506|Leucovorin|leucovorin|mesh-list
2033079|NCT01494506|Fluorouracil|fluorouracil|mesh-list
2033080|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
2033081|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033082|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2033083|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033084|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2033085|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
2033086|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033087|NCT01494506|Antidotes|antidotes|mesh-ancestor
2033088|NCT01494506|Protective Agents|protective agents|mesh-ancestor
2033089|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
2033090|NCT01494506|Vitamins|vitamins|mesh-ancestor
2033091|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
2033092|NCT01494532|Ropinirole|ropinirole|mesh-list
2033093|NCT01494532|Levodopa|levodopa|mesh-list
2033094|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
2033095|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
2033096|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033097|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033098|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033099|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2033100|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2033101|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
2033102|NCT01494584|Ezogabine|ezogabine|mesh-list
2033103|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
2033104|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2033105|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033106|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2033107|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2033108|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
2033109|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033110|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033111|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2033112|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
2033113|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
2033114|NCT01494610|Hormones|hormones|mesh-ancestor
2033115|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2033116|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
2033117|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2033118|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
2033119|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2033120|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2033121|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033122|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
2033123|NCT01494987|Glimepiride|glimepiride|mesh-list
2033124|NCT01494987|Ranolazine|ranolazine|mesh-list
2033125|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2033126|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2033127|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033128|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2033129|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
2033130|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2033131|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2033132|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033133|NCT01495000|Denosumab|denosumab|mesh-list
2033134|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2033135|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033136|NCT01495481|Adenosine|adenosine|mesh-list
2033137|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
2033138|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2033139|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2033140|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033141|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2033142|NCT01495481|Analgesics|analgesics|mesh-ancestor
2033143|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
2033144|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033145|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2033146|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2033147|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2033148|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
2033149|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033150|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033151|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2033152|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
2033153|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2033154|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
2033155|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
2033156|NCT01495572|Aldesleukin|aldesleukin|mesh-list
2033157|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
2033158|NCT01495572|Fludarabine|fludarabine|mesh-list
2033159|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2033160|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
2033161|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033162|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2033163|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2033164|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
2033165|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033166|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033167|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2033168|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2033169|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2033170|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
2033171|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033172|NCT01495585|Lonafarnib|lonafarnib|mesh-list
2033173|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033174|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033175|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2033176|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
2033177|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033178|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2033179|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2033180|NCT01495793|Rotigotine|rotigotine|mesh-list
2033181|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
2033182|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
2033183|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033184|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033185|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033186|NCT01495819|Nicotine|nicotine|mesh-list
2033187|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2033188|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
2033189|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033190|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033191|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2033192|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2033193|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
2033194|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033195|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033196|NCT01495858|Naproxen|naproxen|mesh-list
2033197|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2033198|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2033199|NCT01495858|Analgesics|analgesics|mesh-ancestor
2033200|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
2033201|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033202|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033203|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2033204|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2033205|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
2033206|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2033207|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033208|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033209|NCT01495923|Gabapentin|gabapentin|mesh-list
2033210|NCT01495923|Analgesics|analgesics|mesh-ancestor
2033211|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
2033212|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033213|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033214|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
2033215|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2033216|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2033217|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2033218|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2033219|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2033220|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2033221|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033222|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033223|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
2033224|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
2033225|NCT01496131|Goserelin|goserelin|mesh-list
2033226|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
2033227|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033228|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2033229|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2033230|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2033231|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
2033232|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033233|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033234|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2033235|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2033236|NCT01496183|Olanzapine|olanzapine|mesh-list
2033237|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
2033238|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
2033239|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033240|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033241|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2033242|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2033243|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2033244|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2033245|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2033246|NCT01496183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2033247|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2033248|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2033249|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033250|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033251|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
2033252|NCT01496365|Pregabalin|pregabalin|mesh-list
2033253|NCT01496365|Analgesics|analgesics|mesh-ancestor
2033254|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
2033255|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033256|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033257|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
2033258|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2033259|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2033260|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033261|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2033262|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2033263|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2033264|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2033265|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2033266|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2033267|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2033268|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2033269|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033270|NCT01496469|Febuxostat|febuxostat|mesh-list
2033271|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
2033272|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2033273|NCT01496612|Buspirone|buspirone|mesh-list
2033274|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2033275|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2033276|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2033277|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033278|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2033279|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2033280|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
2033281|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033282|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033283|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2033284|NCT01496807|Ipilimumab|ipilimumab|mesh-list
2033285|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2033286|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033287|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2033288|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033289|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
2033290|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033291|NCT01496846|Lidocaine|lidocaine|mesh-list
2033292|NCT01496846|Carticaine|carticaine|mesh-list
2033293|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
2033294|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
2033295|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2033296|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033297|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
2033298|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033299|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2033300|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2033301|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2033302|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2033303|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033304|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2033305|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2033306|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033307|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2033308|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2033309|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033310|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2033311|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
2033312|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033313|NCT01497275|Rituximab|rituximab|mesh-list
2033314|NCT01497275|Bortezomib|bortezomib|mesh-list
2033315|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2033316|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033317|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
2033318|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033319|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2033320|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
2033321|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
2033322|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033323|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
2033324|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2033325|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2033326|NCT01497496|Prednisolone|prednisolone|mesh-list
2033327|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
2033328|NCT01497496|Lenalidomide|lenalidomide|mesh-list
2033329|NCT01497496|Ofatumumab|ofatumumab|mesh-list
2033330|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2033331|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
2033332|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
2033333|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033334|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2033335|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2033336|NCT01497496|Growth Substances|growth substances|mesh-ancestor
2033337|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
2033338|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033339|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2033340|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
2033341|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
2033342|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033343|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2033344|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
2033345|NCT01497496|Hormones|hormones|mesh-ancestor
2033346|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2033347|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2033348|NCT01497496|Protective Agents|protective agents|mesh-ancestor
2033349|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2033350|NCT01497808|Ipilimumab|ipilimumab|mesh-list
2033351|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2033352|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033353|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2033354|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033355|NCT01497860|Vinorelbine|vinorelbine|mesh-list
2033356|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2033357|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033358|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
2033359|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
2033360|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
2033361|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079375|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2033362|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2033363|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2033364|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2033365|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
2033366|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033367|NCT01497938|Insulin|insulin|mesh-list
2033368|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2033369|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033370|NCT01498068|Interferons|interferons|mesh-list
2033371|NCT01498068|Ribavirin|ribavirin|mesh-list
2033372|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
2033373|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
2033374|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2033375|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033376|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
2033377|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033378|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
2033379|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033380|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
2033381|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033382|NCT01498120|Rotigotine|rotigotine|mesh-list
2033383|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
2033384|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
2033385|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033386|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033387|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033388|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
2033389|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2033390|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033391|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2033392|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033393|NCT01498289|Leucovorin|leucovorin|mesh-list
2033394|NCT01498289|Docetaxel|docetaxel|mesh-list
2033395|NCT01498289|Fluorouracil|fluorouracil|mesh-list
2033396|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
2033397|NCT01498289|Irinotecan|irinotecan|mesh-list
2033398|NCT01498289|Calcium|calcium|mesh-list
2033399|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
2033400|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033401|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
2033402|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
2033403|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
2033404|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033405|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2033406|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033407|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
2033408|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2033409|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2033410|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
2033411|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2033412|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2033413|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033414|NCT01498289|Antidotes|antidotes|mesh-ancestor
2033415|NCT01498289|Protective Agents|protective agents|mesh-ancestor
2033416|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
2033417|NCT01498289|Vitamins|vitamins|mesh-ancestor
2033418|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
2033419|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
2033420|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
2033421|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2033422|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033423|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2033424|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2033425|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033426|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033427|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033428|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
2033429|NCT01498445|Decitabine|decitabine|mesh-list
2033430|NCT01498445|Dasatinib|dasatinib|mesh-list
2033431|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2033432|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
2033433|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033434|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033435|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033436|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2033437|NCT01498458|Capecitabine|capecitabine|mesh-list
2033438|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2033439|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
2033440|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033441|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033442|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2033443|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2033444|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2033445|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2033446|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033447|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
2033448|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033449|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033450|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
2033451|NCT01498588|Doxorubicin|doxorubicin|mesh-list
2033452|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2033453|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
2033454|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033455|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2033456|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2033457|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
2033458|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033459|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033460|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2033461|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2033462|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2033463|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2033464|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033465|NCT01498679|Fluticasone|fluticasone|mesh-list
2033466|NCT01498679|Xhance|xhance|mesh-list
2033467|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2033468|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2033469|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
2033470|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033471|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033472|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2033473|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
2033474|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
2033475|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2033476|NCT01498744|Clindamycin|clindamycin|mesh-list
2033477|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
2033478|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
2033479|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2033480|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033481|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2033482|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033483|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033484|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
2033485|NCT01498822|Levetiracetam|levetiracetam|mesh-list
2033486|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
2033487|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
2033488|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2033489|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2033490|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2033491|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033492|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2033493|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2033494|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2033495|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2033496|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033497|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2033498|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
2033499|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033500|NCT01498952|Sorafenib|sorafenib|mesh-list
2033501|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033502|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2033503|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033504|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033505|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2033506|NCT01498978|Ipilimumab|ipilimumab|mesh-list
2033507|NCT01498978|Antibodies|antibodies|mesh-list
2033508|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
2033509|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2033510|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
2033511|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033512|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033513|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2033514|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033515|NCT01499082|Insulin|insulin|mesh-list
2033516|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2033517|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
2033518|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2033519|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033520|NCT01499095|Insulin|insulin|mesh-list
2033521|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2033522|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
2033523|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2033524|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033525|NCT01499134|Metoprolol|metoprolol|mesh-list
2033526|NCT01499134|Nebivolol|nebivolol|mesh-list
2033527|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2033528|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2033529|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
2033530|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
2033531|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033532|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033533|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2033534|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2033535|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2033536|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
2033537|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033538|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033539|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
2033540|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2033541|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2033542|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2033543|NCT01499147|Vidarabine|vidarabine|mesh-list
2033544|NCT01499147|Fludarabine|fludarabine|mesh-list
2033545|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
2033546|NCT01499147|Melphalan|melphalan|mesh-list
2033547|NCT01499147|Busulfan|busulfan|mesh-list
2033548|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
2033549|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033550|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2033551|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
2033552|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033553|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2033554|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
2033555|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033556|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
2033557|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033558|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2033559|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
2033560|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2033561|NCT01499160|Everolimus|everolimus|mesh-list
2033562|NCT01499160|Letrozole|letrozole|mesh-list
2033563|NCT01499160|Lapatinib|lapatinib|mesh-list
2033564|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033565|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2033566|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
2033567|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033568|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2033569|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2033570|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033571|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033572|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2033573|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
2033574|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2033575|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2033576|NCT01499199|Dolutegravir|dolutegravir|mesh-list
2033577|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2033578|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2033579|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033580|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033581|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2033582|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2033583|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
2033584|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033585|NCT01499277|Vancomycin|vancomycin|mesh-list
2033586|NCT01499277|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2033587|NCT01499277|Aztreonam|aztreonam|mesh-list
2033588|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2033589|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033590|NCT01499290|Metronidazole|metronidazole|mesh-list
2033591|NCT01499290|Meropenem|meropenem|mesh-list
2033592|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033593|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2033594|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2033595|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2033596|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
2033597|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2033598|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033599|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2033600|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
2033601|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2033602|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033603|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033604|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033605|NCT01499368|Omeprazole|omeprazole|mesh-list
2033606|NCT01499368|Famotidine|famotidine|mesh-list
2033607|NCT01499368|Lafutidine|lafutidine|mesh-list
2033608|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2033609|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2033610|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2033611|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033612|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033613|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2033614|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
2033615|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
2033616|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033617|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033618|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
2033619|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
2033620|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2033621|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2033622|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033623|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033624|NCT01499498|Urological Agents|urological agents|mesh-ancestor
2033625|NCT01499576|Acetic Acid|acetic acid|mesh-list
2033626|NCT01499576|Retinol acetate|retinol acetate|mesh-list
2033627|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2033628|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033629|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2033630|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
2033631|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033632|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2033633|NCT01499576|Protective Agents|protective agents|mesh-ancestor
2033634|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033635|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2033636|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2033637|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033638|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2033639|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2033640|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033641|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2033642|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
2033643|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033644|NCT01499849|Dexamethasone|dexamethasone|mesh-list
2033645|NCT01499849|Granisetron|granisetron|mesh-list
2033646|NCT01499849|Rolapitant|rolapitant|mesh-list
2033647|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2033648|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
2033649|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
2033650|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033651|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033652|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2033653|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
2033654|NCT01499849|Hormones|hormones|mesh-ancestor
2033655|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2033656|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2033657|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033658|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2033659|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
2033660|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033661|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033662|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2033663|NCT01499940|Vitamin D|vitamin d|mesh-list
2033664|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
2033665|NCT01499940|Vitamins|vitamins|mesh-ancestor
2033666|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
2033667|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033668|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2033669|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2033670|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2033671|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2033672|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
2033673|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033674|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033675|NCT01500213|Dexamethasone|dexamethasone|mesh-list
2033676|NCT01500213|Granisetron|granisetron|mesh-list
2033677|NCT01500213|Rolapitant|rolapitant|mesh-list
2033678|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2033679|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
2033680|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
2033681|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033682|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033683|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2033684|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
2033685|NCT01500213|Hormones|hormones|mesh-ancestor
2033686|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2033687|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2033688|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033689|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2033690|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
2033691|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033692|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033693|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2033694|NCT01500226|Dexamethasone|dexamethasone|mesh-list
2033695|NCT01500226|Granisetron|granisetron|mesh-list
2033696|NCT01500226|Rolapitant|rolapitant|mesh-list
2033697|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2033698|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
2033699|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
2033700|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033701|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033702|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2033703|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
2033704|NCT01500226|Hormones|hormones|mesh-ancestor
2033705|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2033706|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2033707|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033708|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2033709|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
2033710|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033711|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033712|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2033713|NCT01500278|Adalimumab|adalimumab|mesh-list
2033714|NCT01500278|Methotrexate|methotrexate|mesh-list
2033715|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
2033716|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2033717|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
2033718|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2033719|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033720|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2033721|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
2033722|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033723|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033724|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
2033725|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033726|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2033727|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2033728|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
2033729|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2033730|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2033731|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2033732|NCT01500317|Oxycodone|oxycodone|mesh-list
2033733|NCT01500317|Tapentadol|tapentadol|mesh-list
2033734|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2033735|NCT01500317|Narcotics|narcotics|mesh-ancestor
2033736|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2033737|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033738|NCT01500317|Analgesics|analgesics|mesh-ancestor
2033739|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
2033740|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033741|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2033742|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2033743|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2033744|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033745|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
2033746|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033747|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2033748|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2033749|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033750|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2033751|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2033752|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
2033753|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033754|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033755|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033756|NCT01500382|Urological Agents|urological agents|mesh-ancestor
2033757|NCT01500434|Aspirin|aspirin|mesh-list
2033758|NCT01500434|Ticlopidine|ticlopidine|mesh-list
2033759|NCT01500434|Clopidogrel|clopidogrel|mesh-list
2033760|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2033761|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2033762|NCT01500434|Analgesics|analgesics|mesh-ancestor
2033763|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
2033764|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033765|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033766|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2033767|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2033768|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2033769|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2033770|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033771|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2033772|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2033773|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033774|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
2033775|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2033776|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2033777|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2033778|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
2033779|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033780|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2033781|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2033782|NCT01500694|Guanfacine|guanfacine|mesh-list
2033783|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2033784|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2033785|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2033786|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2033787|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
2033788|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033789|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033790|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033791|NCT01500720|Topotecan|topotecan|mesh-list
2033792|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2033793|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2033794|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033795|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033796|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033797|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
2033798|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2033799|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
2033800|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033801|NCT01501110|Expectorants|expectorants|mesh-ancestor
2033802|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
2033803|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2033804|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
2033805|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033806|NCT01501110|Protective Agents|protective agents|mesh-ancestor
2033807|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033808|NCT01501110|Antidotes|antidotes|mesh-ancestor
2033809|NCT01501162|Ethanol|ethanol|mesh-list
2033810|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2033811|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033812|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2033813|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033814|NCT01501929|Metoprolol|metoprolol|mesh-list
2033815|NCT01501929|Nebivolol|nebivolol|mesh-list
2033816|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2033817|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2033818|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
2033819|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
2033820|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033821|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033822|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2033823|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2033824|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2033825|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
2033826|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033827|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033828|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
2033829|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2033830|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2033831|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2033832|NCT01502072|Ribavirin|ribavirin|mesh-list
2033833|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
2033834|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033835|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
2033836|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2033837|NCT01502228|Sunitinib|sunitinib|mesh-list
2033838|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033839|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2033840|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2033841|NCT01502228|Growth Substances|growth substances|mesh-ancestor
2033842|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033843|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
2033844|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2033845|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033846|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033847|NCT01502293|Interleukin-12|interleukin-12|mesh-list
2033848|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2033849|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
2033850|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033851|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2033852|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2033853|NCT01502293|Growth Substances|growth substances|mesh-ancestor
2033854|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
2033855|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033856|NCT01502306|Nicotine|nicotine|mesh-list
2033857|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2033858|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
2033859|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033860|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033861|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2033862|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2033863|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
2033864|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033865|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033866|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
2033867|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2033868|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
2033869|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2033870|NCT01502410|Sorafenib|sorafenib|mesh-list
2033871|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033872|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2033873|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033874|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033875|NCT01502423|Adalimumab|adalimumab|mesh-list
2033876|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2033877|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2033878|NCT01502644|Morphine|morphine|mesh-list
2033879|NCT01502644|Oxycodone|oxycodone|mesh-list
2033880|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2033881|NCT01502644|Narcotics|narcotics|mesh-ancestor
2033882|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2033883|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033884|NCT01502644|Analgesics|analgesics|mesh-ancestor
2033885|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
2033886|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033887|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
2033888|NCT01502761|Analgesics|analgesics|mesh-ancestor
2033889|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
2033890|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033891|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033892|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
2033893|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2033894|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2033895|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
2033896|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2033897|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2033898|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033899|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2033900|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
2033901|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2033902|NCT01502787|Metoprolol|metoprolol|mesh-list
2033903|NCT01502787|Nebivolol|nebivolol|mesh-list
2033904|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
2033905|NCT01502787|Giapreza|giapreza|mesh-list
2033906|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
2033907|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2033908|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2033909|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
2033910|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
2033911|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033912|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033913|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2033914|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2033915|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2033916|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
2033917|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033918|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033919|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
2033920|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2033921|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2033922|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2033923|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2033924|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2033925|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
2033926|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033927|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2033928|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
2033929|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2033930|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2033931|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033932|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033933|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2033934|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2033935|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033936|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
2033937|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2033938|NCT01503229|Prednisone|prednisone|mesh-list
2033939|NCT01503229|Cortisone|cortisone|mesh-list
2033940|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
2033941|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2033942|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
2033943|NCT01503229|Hormones|hormones|mesh-ancestor
2033944|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2033945|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033946|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2033947|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2033948|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2033949|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2033950|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033951|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
2033952|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2033969|NCT01503749|Lenograstim|lenograstim|mesh-list
2033970|NCT01503749|Sargramostim|sargramostim|mesh-list
2033971|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2033972|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
2033973|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033974|NCT01504204|Adapalene|adapalene|mesh-list
2033975|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
2033976|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2033977|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
2033978|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2033979|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2033980|NCT01504204|Analgesics|analgesics|mesh-ancestor
2033981|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
2033982|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033983|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033984|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2033985|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2033986|NCT01504412|Pregabalin|pregabalin|mesh-list
2033987|NCT01504412|Analgesics|analgesics|mesh-ancestor
2033988|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
2033989|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2033990|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2033991|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
2033992|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2033993|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2033994|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2033995|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2033996|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2033997|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2033998|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2033999|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2034000|NCT01504477|Bortezomib|bortezomib|mesh-list
2034001|NCT01504477|Panitumumab|panitumumab|mesh-list
2034002|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034003|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2034004|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
2034005|NCT01504711|Aprepitant|aprepitant|mesh-list
2034006|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
2034007|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
2034008|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034009|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034010|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2034011|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2034012|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034013|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034014|NCT01504841|Etravirine|etravirine|mesh-list
2034015|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2034016|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2034017|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034018|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034019|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
2034020|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2034021|NCT01504854|Resveratrol|resveratrol|mesh-list
2034022|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
2034023|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034024|NCT01504854|Protective Agents|protective agents|mesh-ancestor
2034025|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034026|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034027|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2034028|NCT01504867|Aspirin|aspirin|mesh-list
2034029|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2034030|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2034031|NCT01504867|Analgesics|analgesics|mesh-ancestor
2034032|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
2034033|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034034|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034035|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2034036|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034037|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2034038|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2034039|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034040|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2034041|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2034042|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034043|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
2034044|NCT01504971|Rabeprazole|rabeprazole|mesh-list
2034045|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2034046|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2034047|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2034048|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034049|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034050|NCT01505114|Tenofovir|tenofovir|mesh-list
2034051|NCT01505114|Emtricitabine|emtricitabine|mesh-list
2034052|NCT01505114|Maraviroc|maraviroc|mesh-list
2034053|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
2034054|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2034055|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2034056|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2034057|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034058|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034059|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2034060|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2034061|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2034062|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2034063|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2034064|NCT01505179|Ranolazine|ranolazine|mesh-list
2034065|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2034066|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2034067|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034068|NCT01505465|Melatonin|melatonin|mesh-list
2034069|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
2034070|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034071|NCT01505465|Protective Agents|protective agents|mesh-ancestor
2034072|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034073|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034074|NCT01505491|Adalimumab|adalimumab|mesh-list
2034075|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2034076|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034077|NCT01505608|Irinotecan|irinotecan|mesh-list
2034078|NCT01505608|Temozolomide|temozolomide|mesh-list
2034079|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2034080|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2034081|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034082|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034083|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034084|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2034085|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
2034086|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
2034087|NCT01505634|Imipenem|imipenem|mesh-list
2034088|NCT01505634|Relebactam|relebactam|mesh-list
2034089|NCT01505634|Cilastatin|cilastatin|mesh-list
2034090|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2034091|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2034092|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2034093|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2034094|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034095|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034096|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034097|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2034098|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2034099|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
2034100|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2034101|NCT01505647|Vaccines|vaccines|mesh-list
2034102|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
2034103|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034104|NCT01505673|Liraglutide|liraglutide|mesh-list
2034105|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2034106|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034107|NCT01505673|Incretins|incretins|mesh-ancestor
2034108|NCT01505673|Hormones|hormones|mesh-ancestor
2034109|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2034110|NCT01505868|Carboplatin|carboplatin|mesh-list
2034111|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034112|NCT01505881|Warfarin|warfarin|mesh-list
2034113|NCT01505881|Dabigatran|dabigatran|mesh-list
2034114|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
2034115|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
2034116|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2034117|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
2034118|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034119|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034120|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
2034121|NCT01505933|Propofol|propofol|mesh-list
2034122|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2034123|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034124|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034125|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2034126|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
2034127|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
2034128|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2034129|NCT01505933|Analgesics|analgesics|mesh-ancestor
2034130|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
2034131|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034132|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2034133|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2034134|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2034135|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
2034136|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034137|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034138|NCT01506193|Vaccines|vaccines|mesh-list
2034139|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
2034140|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034141|NCT01506271|Imipenem|imipenem|mesh-list
2034142|NCT01506271|Relebactam|relebactam|mesh-list
2034143|NCT01506271|Cilastatin|cilastatin|mesh-list
2034144|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2034145|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2034146|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
2034147|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034148|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034149|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2034150|NCT01506453|Gabapentin|gabapentin|mesh-list
2034151|NCT01506453|Analgesics|analgesics|mesh-ancestor
2034152|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
2034153|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034154|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034155|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
2034156|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2034157|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2034158|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034159|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2034160|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2034161|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2034162|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034163|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034164|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
2034165|NCT01506609|Paclitaxel|paclitaxel|mesh-list
2034166|NCT01506609|Carboplatin|carboplatin|mesh-list
2034167|NCT01506609|Temozolomide|temozolomide|mesh-list
2034168|NCT01506609|Veliparib|veliparib|mesh-list
2034169|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2034170|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034171|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
2034172|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
2034173|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
2034174|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034175|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2034176|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
2034177|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2034178|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034179|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
2034180|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2034181|NCT01506726|Salicylates|salicylates|mesh-list
2034182|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2034183|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2034184|NCT01506726|Analgesics|analgesics|mesh-ancestor
2034185|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
2034186|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034187|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034188|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2034189|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034190|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2034191|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034192|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034193|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2034194|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
2034195|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
2034196|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
2034197|NCT01506882|Levetiracetam|levetiracetam|mesh-list
2034198|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
2034199|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
2034200|NCT01506908|Nicotine|nicotine|mesh-list
2034201|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2034202|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
2034203|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034204|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034205|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2034206|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2034207|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
2034208|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034209|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034210|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
2034211|NCT01506947|Hematinics|hematinics|mesh-ancestor
2034212|NCT01507051|Vitamin K|vitamin k|mesh-list
2034213|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
2034214|NCT01507051|Warfarin|warfarin|mesh-list
2034215|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
2034216|NCT01507051|Vitamins|vitamins|mesh-ancestor
2034217|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
2034218|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034219|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
2034220|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2034221|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
2034222|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2034223|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
2034224|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034225|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034226|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2034227|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2034228|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
2034229|NCT01507051|Coagulants|coagulants|mesh-ancestor
2034230|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
2034231|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2034232|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
2034233|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034234|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034235|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2034236|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
2034237|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034238|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034239|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2034240|NCT01507181|Midazolam|midazolam|mesh-list
2034241|NCT01507181|Ketamine|ketamine|mesh-list
2034242|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
2034243|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
2034244|NCT01507181|Analgesics|analgesics|mesh-ancestor
2034245|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
2034246|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034247|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034248|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2034249|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2034250|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
2034251|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
2034252|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034253|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2034254|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034255|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034256|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2034257|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2034258|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2034259|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2034260|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2034261|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
2034262|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
2034263|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2034264|NCT01507220|Morphine|morphine|mesh-list
2034265|NCT01507220|Bupivacaine|bupivacaine|mesh-list
2034266|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
2034267|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
2034268|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034269|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034270|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
2034271|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034272|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2034273|NCT01507220|Narcotics|narcotics|mesh-ancestor
2034274|NCT01507220|Analgesics|analgesics|mesh-ancestor
2034275|NCT01507246|Morphine|morphine|mesh-list
2034276|NCT01507246|Bupivacaine|bupivacaine|mesh-list
2034277|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
2034278|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
2034279|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034280|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034281|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
2034282|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034283|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2034284|NCT01507246|Narcotics|narcotics|mesh-ancestor
2034285|NCT01507246|Analgesics|analgesics|mesh-ancestor
2034286|NCT01507779|Vaccines|vaccines|mesh-list
2034287|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
2034288|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034289|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2034290|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
2034291|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034292|NCT01508117|Axitinib|axitinib|mesh-list
2034293|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034294|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2034295|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034296|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034297|NCT01508325|Metoprolol|metoprolol|mesh-list
2034298|NCT01508325|Bisoprolol|bisoprolol|mesh-list
2034299|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2034300|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2034301|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
2034302|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
2034303|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034304|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034305|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2034306|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2034307|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2034308|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
2034309|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034310|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034311|NCT01508455|Fentanyl|fentanyl|mesh-list
2034312|NCT01508455|Midazolam|midazolam|mesh-list
2034313|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
2034314|NCT01508455|Morphine|morphine|mesh-list
2034315|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2034316|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034317|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034318|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2034319|NCT01508455|Analgesics|analgesics|mesh-ancestor
2034320|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
2034321|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034322|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2034323|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2034324|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2034325|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
2034326|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034327|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034328|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2034329|NCT01508455|Narcotics|narcotics|mesh-ancestor
2034330|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2034331|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2034332|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
2034333|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
2034334|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2034335|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2034336|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2034337|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
2034338|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
2034339|NCT01508676|Diclofenac|diclofenac|mesh-list
2034340|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2034341|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2034342|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2034343|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2034344|NCT01508676|Analgesics|analgesics|mesh-ancestor
2034345|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
2034346|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034347|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034348|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034349|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2034350|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034351|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034352|NCT01508702|Lesinurad|lesinurad|mesh-list
2034353|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
2034354|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034355|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
2034356|NCT01508702|Renal Agents|renal agents|mesh-ancestor
2034357|NCT01508832|Lidocaine|lidocaine|mesh-list
2034358|NCT01508832|Bupivacaine|bupivacaine|mesh-list
2034359|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
2034360|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
2034361|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034362|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034363|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
2034364|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034365|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2034366|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2034367|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2034368|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2034369|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034370|NCT01508936|Reslizumab|reslizumab|mesh-list
2034371|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2034372|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
2034373|NCT01509079|Vitamin D|vitamin d|mesh-list
2034374|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
2034375|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
2034376|NCT01509079|Vitamins|vitamins|mesh-list
2034377|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
2034378|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034379|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2034380|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2034381|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2034382|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
2034383|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034384|NCT01509404|Valganciclovir|valganciclovir|mesh-list
2034385|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
2034386|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2034387|NCT01509547|Varenicline|varenicline|mesh-list
2034388|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2034389|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2034390|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
2034391|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034392|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034393|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034394|NCT01509586|Lobeline|lobeline|mesh-list
2034395|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2034396|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
2034397|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034398|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034399|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2034400|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2034401|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
2034402|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034403|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034404|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
2034405|NCT01509625|Fulvestrant|fulvestrant|mesh-list
2034406|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2034407|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034408|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2034409|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2034410|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
2034411|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2034412|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034413|NCT01509638|Bupivacaine|bupivacaine|mesh-list
2034414|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
2034415|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
2034416|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034417|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034418|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
2034419|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034420|NCT01509807|Morphine|morphine|mesh-list
2034421|NCT01509807|Bupivacaine|bupivacaine|mesh-list
2034422|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
2034423|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
2034424|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034425|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034426|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
2034427|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034428|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2034429|NCT01509807|Narcotics|narcotics|mesh-ancestor
2034430|NCT01509807|Analgesics|analgesics|mesh-ancestor
2034431|NCT01509846|Vaccines|vaccines|mesh-list
2034432|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
2034433|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034434|NCT01510145|Travoprost|travoprost|mesh-list
2034435|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2034436|NCT01510158|Allopurinol|allopurinol|mesh-list
2034437|NCT01510158|Lesinurad|lesinurad|mesh-list
2034438|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
2034439|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034440|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034441|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
2034442|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034443|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2034444|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
2034445|NCT01510158|Protective Agents|protective agents|mesh-ancestor
2034446|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034447|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
2034448|NCT01510158|Renal Agents|renal agents|mesh-ancestor
2034449|NCT01510327|Aspirin|aspirin|mesh-list
2034450|NCT01510327|Everolimus|everolimus|mesh-list
2034451|NCT01510327|Ticlopidine|ticlopidine|mesh-list
2034452|NCT01510327|Clopidogrel|clopidogrel|mesh-list
2034453|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2034454|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2034455|NCT01510327|Analgesics|analgesics|mesh-ancestor
2034456|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
2034457|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034458|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034459|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2034460|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034461|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2034462|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2034463|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034464|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2034465|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2034466|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034467|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
2034468|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034469|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2034470|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
2034471|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2034472|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2034473|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2034474|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
2034475|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034476|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2034477|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2034478|NCT01510379|Promethazine|promethazine|mesh-list
2034479|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
2034480|NCT01510379|Ondansetron|ondansetron|mesh-list
2034481|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
2034482|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
2034483|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034484|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034485|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2034486|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
2034487|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
2034488|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2034489|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
2034490|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034491|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034492|NCT01510379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2034493|NCT01510379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2034494|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034495|NCT01510379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2034496|NCT01510379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2034497|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2034498|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
2034499|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
2034500|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2034501|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2034502|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2034503|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
2034504|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
2034505|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
2034506|NCT01510457|Milnacipran|milnacipran|mesh-list
2034507|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
2034508|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2034509|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2034510|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2034511|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034512|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034513|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034514|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2034515|NCT01510457|Analgesics|analgesics|mesh-ancestor
2034516|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
2034517|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034518|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
2034519|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2034520|NCT01510769|Febuxostat|febuxostat|mesh-list
2034521|NCT01510769|Lesinurad|lesinurad|mesh-list
2034522|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
2034523|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034524|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
2034525|NCT01510769|Renal Agents|renal agents|mesh-ancestor
2034526|NCT01510912|Diclofenac|diclofenac|mesh-list
2034527|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2034528|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2034529|NCT01510912|Analgesics|analgesics|mesh-ancestor
2034530|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
2034531|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034532|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034533|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2034534|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034535|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2034536|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034537|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034538|NCT01511068|Sargramostim|sargramostim|mesh-list
2034539|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
2034540|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034541|NCT01511107|Amoxicillin|amoxicillin|mesh-list
2034542|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
2034543|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
2034544|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2034545|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2034546|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2034547|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2034548|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034549|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034550|NCT01511315|Ustekinumab|ustekinumab|mesh-list
2034551|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
2034552|NCT01511445|Silicon|silicon|mesh-list
2034553|NCT01511445|Trace Elements|trace elements|mesh-ancestor
2034554|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
2034555|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034556|NCT01511536|Prednisone|prednisone|mesh-list
2034557|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
2034558|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2034559|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
2034560|NCT01511536|Hormones|hormones|mesh-ancestor
2034561|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2034562|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034563|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2034564|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034565|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2034566|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034567|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034568|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
2034569|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2034570|NCT01511640|Pregabalin|pregabalin|mesh-list
2034571|NCT01511640|Analgesics|analgesics|mesh-ancestor
2034572|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
2034573|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034574|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034575|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
2034576|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2034577|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2034578|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034579|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2034580|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2034581|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2034582|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034583|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2034584|NCT01511809|Ritonavir|ritonavir|mesh-list
2034585|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2034586|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2034587|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2034588|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
2034589|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034590|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034591|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2034592|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2034593|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
2034594|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2034595|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2034596|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2034597|NCT01511939|Diclofenac|diclofenac|mesh-list
2034598|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2034599|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2034600|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2034601|NCT01511939|Analgesics|analgesics|mesh-ancestor
2034602|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
2034603|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034604|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034605|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034606|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2034607|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034608|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034609|NCT01511978|Amifampridine|amifampridine|mesh-list
2034610|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2034611|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034612|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034613|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2034614|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2034615|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034616|NCT01512108|Liraglutide|liraglutide|mesh-list
2034617|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2034618|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034619|NCT01512108|Incretins|incretins|mesh-ancestor
2034620|NCT01512108|Hormones|hormones|mesh-ancestor
2034621|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2034622|NCT01512160|Ibuprofen|ibuprofen|mesh-list
2034623|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2034624|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2034625|NCT01512160|Analgesics|analgesics|mesh-ancestor
2034626|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
2034627|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034628|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034629|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2034630|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034631|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2034632|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034633|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034634|NCT01512225|Domperidone|domperidone|mesh-list
2034635|NCT01512225|Maleic acid|maleic acid|mesh-list
2034636|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034637|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034638|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
2034639|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
2034640|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034641|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034642|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2034643|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2034644|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
2034645|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034646|NCT01512251|Vemurafenib|vemurafenib|mesh-list
2034647|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034648|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2034649|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034650|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034651|NCT01512446|Alendronate|alendronate|mesh-list
2034652|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2034653|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034654|NCT01512745|Apatinib|apatinib|mesh-list
2034655|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034656|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2034657|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034658|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034659|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2034660|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2034661|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034662|NCT01512797|Incretins|incretins|mesh-ancestor
2034663|NCT01512797|Hormones|hormones|mesh-ancestor
2034664|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2034665|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2034666|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
2034667|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034668|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034669|NCT01512979|Metformin|metformin|mesh-list
2034670|NCT01512979|Linagliptin|linagliptin|mesh-list
2034671|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2034672|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034673|NCT01512979|Incretins|incretins|mesh-ancestor
2034674|NCT01512979|Hormones|hormones|mesh-ancestor
2034675|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2034676|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2034677|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
2034678|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034679|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034680|NCT01513122|Ritonavir|ritonavir|mesh-list
2034681|NCT01513122|Lopinavir|lopinavir|mesh-list
2034682|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
2034683|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2034684|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2034685|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
2034686|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034687|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034688|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2034689|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2034690|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
2034691|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2034692|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2034693|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2034694|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2034695|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2034696|NCT01513317|Siltuximab|siltuximab|mesh-list
2034697|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034698|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
2034699|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
2034700|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2034701|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
2034702|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034703|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034704|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2034705|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
2034706|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
2034707|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2034708|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
2034709|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034710|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034711|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2034712|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2034713|NCT01513473|Insulin|insulin|mesh-list
2034714|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2034715|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
2034716|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
2034717|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2034718|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034719|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2034720|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
2034721|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034722|NCT01513590|Insulin|insulin|mesh-list
2034723|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
2034724|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2034725|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034726|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2034727|NCT01513759|Plasminogen|plasminogen|mesh-list
2034728|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2034729|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2034730|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034731|NCT01513902|Tofacitinib|tofacitinib|mesh-list
2034732|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2034733|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034734|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034735|NCT01514149|Metformin|metformin|mesh-list
2034736|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2034737|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034738|NCT01514201|Temozolomide|temozolomide|mesh-list
2034739|NCT01514201|Veliparib|veliparib|mesh-list
2034740|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2034741|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
2034742|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034743|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034744|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2034745|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034746|NCT01514240|Mesalamine|mesalamine|mesh-list
2034747|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2034748|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2034749|NCT01514240|Analgesics|analgesics|mesh-ancestor
2034750|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
2034751|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034752|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034753|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2034754|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034755|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2034756|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
2034757|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034758|NCT01514370|Interferons|interferons|mesh-list
2034759|NCT01514370|Interferon-beta|interferon-beta|mesh-list
2034760|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
2034761|NCT01514370|Curcumin|curcumin|mesh-list
2034762|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034763|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
2034764|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2034765|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2034766|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2034767|NCT01514370|Analgesics|analgesics|mesh-ancestor
2034768|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
2034769|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034770|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034771|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2034772|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034773|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034774|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034775|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
2034776|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2034777|NCT01514422|Minocycline|minocycline|mesh-list
2034778|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2034779|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2034780|NCT01514448|Everolimus|everolimus|mesh-list
2034781|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034782|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2034783|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
2034784|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034785|NCT01514513|Permethrin|permethrin|mesh-list
2034786|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034787|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034788|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2034789|NCT01514734|Timolol|timolol|mesh-list
2034790|NCT01514734|Brinzolamide|brinzolamide|mesh-list
2034791|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2034792|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2034793|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
2034794|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034795|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034796|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034797|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2034798|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2034799|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034800|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2034801|NCT01514864|Dasatinib|dasatinib|mesh-list
2034802|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034803|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2034804|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034805|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034806|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
2034807|NCT01515046|Gemcitabine|gemcitabine|mesh-list
2034808|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2034809|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
2034810|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034811|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034812|NCT01515046|Antiviral Agents|antiviral agents|mesh-ancestor
2034813|NCT01515046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2034814|NCT01515046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034815|NCT01515046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2034816|NCT01515046|Immunologic Factors|immunologic factors|mesh-ancestor
2034817|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034818|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
2034819|NCT01515046|Protective Agents|protective agents|mesh-ancestor
2034820|NCT01515046|Vitamins|vitamins|mesh-ancestor
2034821|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
2034822|NCT01515176|Ofatumumab|ofatumumab|mesh-list
2034823|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2034824|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034825|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
2034826|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034827|NCT01515189|Ipilimumab|ipilimumab|mesh-list
2034828|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2034829|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034830|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2034831|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034832|NCT01515306|Paclitaxel|paclitaxel|mesh-list
2034833|NCT01515306|Ramucirumab|ramucirumab|mesh-list
2034834|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2034835|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034836|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
2034837|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
2034838|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
2034839|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034840|NCT01515345|Clopidogrel|clopidogrel|mesh-list
2034841|NCT01515345|Ticagrelor|ticagrelor|mesh-list
2034842|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2034843|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2034844|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2034845|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2034846|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2034847|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
2034848|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034849|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034850|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034851|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2034852|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2034853|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
2034854|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034855|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2034856|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2034857|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
2034858|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
2034859|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034860|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034861|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2034862|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2034863|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2034864|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2034865|NCT01515540|Lidocaine|lidocaine|mesh-list
2034866|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
2034867|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
2034868|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034869|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034870|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
2034871|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034872|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2034873|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2034874|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2034875|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2034876|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034877|NCT01515566|Fentanyl|fentanyl|mesh-list
2034878|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2034879|NCT01515566|Narcotics|narcotics|mesh-ancestor
2034880|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034881|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034882|NCT01515566|Analgesics|analgesics|mesh-ancestor
2034883|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
2034884|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034885|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2034886|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2034887|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
2034888|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
2034889|NCT01515657|Aspirin|aspirin|mesh-list
2034890|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2034891|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2034892|NCT01515657|Analgesics|analgesics|mesh-ancestor
2034893|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
2034894|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034895|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034896|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2034897|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2034898|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2034899|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2034900|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034901|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2034902|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2034903|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034904|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
2034905|NCT01515748|Docetaxel|docetaxel|mesh-list
2034906|NCT01515748|Fluorouracil|fluorouracil|mesh-list
2034907|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
2034908|NCT01515748|Tegafur|tegafur|mesh-list
2034909|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2034910|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
2034911|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
2034912|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
2034913|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034914|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
2034915|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2034916|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2034917|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
2034918|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034919|NCT01515865|Midodrine|midodrine|mesh-list
2034920|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
2034921|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
2034922|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034923|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034924|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2034925|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2034926|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2034927|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2034928|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
2034929|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034930|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034931|NCT01515891|Opicapone|opicapone|mesh-list
2034932|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2034933|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2034934|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034935|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2034936|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2034937|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
2034938|NCT01515995|Analgesics|analgesics|mesh-ancestor
2034939|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
2034940|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034941|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034942|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
2034943|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034944|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2034945|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
2034946|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2034947|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2034948|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034949|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2034950|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
2034951|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2034952|NCT01516008|Tapentadol|tapentadol|mesh-list
2034953|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2034954|NCT01516008|Narcotics|narcotics|mesh-ancestor
2034955|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034956|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034957|NCT01516008|Analgesics|analgesics|mesh-ancestor
2034958|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
2034959|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034960|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2034961|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2034962|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2034963|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034964|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
2034965|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034966|NCT01516268|Sufentanil|sufentanil|mesh-list
2034967|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2034968|NCT01516268|Narcotics|narcotics|mesh-ancestor
2034969|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034970|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034971|NCT01516268|Analgesics|analgesics|mesh-ancestor
2034972|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
2034973|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2034974|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2034975|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2034976|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
2034977|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
2034978|NCT01516424|Risperidone|risperidone|mesh-list
2034979|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2034980|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
2034981|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2034982|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2034983|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034984|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2034985|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2034986|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034987|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2034988|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2034989|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
2034990|NCT01516684|Lidocaine|lidocaine|mesh-list
2034991|NCT01516684|Fentanyl|fentanyl|mesh-list
2034992|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
2034993|NCT01516684|Prilocaine|prilocaine|mesh-list
2034994|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2034995|NCT01516684|Propofol|propofol|mesh-list
2034996|NCT01516684|Anesthetics|anesthetics|mesh-list
2034997|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2034998|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2034999|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
2035000|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035001|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2035002|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2035003|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2035004|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2035005|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035006|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2035007|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2035008|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
2035009|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2035010|NCT01516684|Narcotics|narcotics|mesh-ancestor
2035011|NCT01516684|Analgesics|analgesics|mesh-ancestor
2035012|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2035013|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2035014|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2035015|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2035016|NCT01516879|Atorvastatin|atorvastatin|mesh-list
2035017|NCT01516879|Ezetimibe|ezetimibe|mesh-list
2035018|NCT01516879|Evolocumab|evolocumab|mesh-list
2035019|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2035020|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2035021|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
2035022|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035023|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2035024|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2035025|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035026|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
2035027|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2035028|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2035029|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2035030|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2035031|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035032|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
2035033|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035034|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035035|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2035036|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035037|NCT01516957|Brodalumab|brodalumab|mesh-list
2035038|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2035039|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
2035040|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
2035041|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035042|NCT01516970|Ritonavir|ritonavir|mesh-list
2035043|NCT01516970|Lopinavir|lopinavir|mesh-list
2035044|NCT01516970|Darunavir|darunavir|mesh-list
2035045|NCT01516970|Zidovudine|zidovudine|mesh-list
2035046|NCT01516970|Efavirenz|efavirenz|mesh-list
2035047|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2035048|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2035049|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
2035050|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035051|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035052|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2035053|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2035054|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
2035055|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035056|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2035057|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2035058|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
2035059|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2035060|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2035061|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2035062|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2035063|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2035064|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2035065|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2035066|NCT01517074|Sirolimus|sirolimus|mesh-list
2035067|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2035068|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035069|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2035070|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035071|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
2035072|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2035073|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
2035074|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035075|NCT01517295|Hydrocodone|hydrocodone|mesh-list
2035076|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2035077|NCT01517295|Narcotics|narcotics|mesh-ancestor
2035078|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2035079|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035080|NCT01517295|Analgesics|analgesics|mesh-ancestor
2035081|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
2035082|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035083|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
2035084|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
2035085|NCT01517373|Glimepiride|glimepiride|mesh-list
2035086|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2035087|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2035088|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035089|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2035090|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
2035091|NCT01517412|Metformin|metformin|mesh-list
2035092|NCT01517412|Lixisenatide|lixisenatide|mesh-list
2035093|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2035094|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035095|NCT01517750|Immunoconjugates|immunoconjugates|mesh-list
2035096|NCT01517750|Immunologic Factors|immunologic factors|mesh-ancestor
2035097|NCT01517750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035098|NCT01517893|Simvastatin|simvastatin|mesh-list
2035099|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2035100|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2035101|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
2035102|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035103|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2035104|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2035105|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035106|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
2035107|NCT01517984|Prednisone|prednisone|mesh-list
2035108|NCT01517984|Tacrolimus|tacrolimus|mesh-list
2035109|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
2035110|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2035111|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2035112|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2035113|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2035114|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
2035115|NCT01517984|Hormones|hormones|mesh-ancestor
2035116|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2035117|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035118|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2035119|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035120|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
2035121|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035122|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035123|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2035124|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2035125|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
2035126|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2035127|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035128|NCT01518153|Vidarabine|vidarabine|mesh-list
2035129|NCT01518153|Methotrexate|methotrexate|mesh-list
2035130|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
2035131|NCT01518153|Fludarabine|fludarabine|mesh-list
2035132|NCT01518153|Melphalan|melphalan|mesh-list
2035133|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
2035134|NCT01518153|Tacrolimus|tacrolimus|mesh-list
2035135|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2035136|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
2035137|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2035138|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035139|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2035140|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
2035141|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035142|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035143|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
2035144|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035145|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2035146|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2035147|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
2035148|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2035149|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2035150|NCT01518153|Antiviral Agents|antiviral agents|mesh-ancestor
2035151|NCT01518153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035152|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2035153|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2035154|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
2035155|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2035156|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2035157|NCT01518192|Doxycycline|doxycycline|mesh-list
2035158|NCT01518192|Cefuroxime|cefuroxime|mesh-list
2035159|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
2035160|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2035161|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035162|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
2035163|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2035164|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2035165|NCT01518244|Timolol|timolol|mesh-list
2035166|NCT01518244|Brinzolamide|brinzolamide|mesh-list
2035167|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2035168|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2035169|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
2035170|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035171|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035172|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035173|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2035174|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2035175|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035176|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2035177|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
2035178|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2035179|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2035180|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2035181|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2035182|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035183|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
2035184|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035185|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035186|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2035187|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035188|NCT01518309|Pimavanserin|pimavanserin|mesh-list
2035189|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2035190|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2035191|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2035192|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2035193|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2035194|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035195|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2035196|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2035197|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2035198|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
2035199|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035200|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035201|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
2035202|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2035203|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2035204|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035205|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2035206|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2035207|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035208|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035209|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035210|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2035211|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
2035212|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2035213|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035214|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2035215|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2035216|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2035217|NCT01518946|Midodrine|midodrine|mesh-list
2035218|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
2035219|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
2035220|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035221|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035222|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2035223|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2035224|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2035225|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2035226|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
2035227|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035228|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035229|NCT01518972|Prazosin|prazosin|mesh-list
2035230|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2035231|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2035232|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2035233|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2035234|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
2035235|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035236|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035237|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035238|NCT01519063|Naltrexone|naltrexone|mesh-list
2035239|NCT01519063|Memantine|memantine|mesh-list
2035240|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2035241|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2035242|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035243|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
2035244|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035245|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2035246|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2035247|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
2035248|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035249|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035250|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2035251|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2035252|NCT01519089|Tofacitinib|tofacitinib|mesh-list
2035253|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2035254|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035255|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035256|NCT01519167|Fentanyl|fentanyl|mesh-list
2035257|NCT01519167|Midazolam|midazolam|mesh-list
2035258|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
2035259|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2035260|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2035261|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035262|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2035263|NCT01519167|Analgesics|analgesics|mesh-ancestor
2035264|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
2035265|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035266|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2035267|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2035268|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2035269|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
2035270|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035271|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035272|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2035273|NCT01519167|Narcotics|narcotics|mesh-ancestor
2035274|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2035275|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2035276|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
2035277|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
2035278|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2035279|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2035280|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2035281|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
2035282|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
2035283|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
2035284|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2035285|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2035286|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035287|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
2035288|NCT01519245|Coagulants|coagulants|mesh-ancestor
2035289|NCT01519271|Rivastigmine|rivastigmine|mesh-list
2035290|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2035291|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035292|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035293|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
2035294|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035295|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035296|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2035297|NCT01519271|Protective Agents|protective agents|mesh-ancestor
2035298|NCT01519284|Levodopa|levodopa|mesh-list
2035299|NCT01519284|Carbidopa|carbidopa|mesh-list
2035300|NCT01519284|Opicapone|opicapone|mesh-list
2035301|NCT01519284|Entacapone|entacapone|mesh-list
2035302|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2035303|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2035304|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
2035305|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035306|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035307|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035308|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2035309|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035310|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2035311|NCT01519323|Vemurafenib|vemurafenib|mesh-list
2035312|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035313|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2035314|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035315|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035316|NCT01519518|Heparin|heparin|mesh-list
2035317|NCT01519518|Calcium heparin|calcium heparin|mesh-list
2035318|NCT01519518|Bivalirudin|bivalirudin|mesh-list
2035319|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
2035320|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2035321|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2035322|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035323|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
2035324|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2035325|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
2035326|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035327|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2035328|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2035329|NCT01519635|Diuretics|diuretics|mesh-ancestor
2035330|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
2035331|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035332|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2035333|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2035334|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035335|NCT01519674|Insulin|insulin|mesh-list
2035336|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2035337|NCT01519674|Metformin|metformin|mesh-list
2035338|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
2035339|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
2035340|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2035341|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2035342|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
2035343|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2035344|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
2035345|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2035346|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035347|NCT01519674|Incretins|incretins|mesh-ancestor
2035348|NCT01519674|Hormones|hormones|mesh-ancestor
2035349|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2035350|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2035351|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
2035352|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035353|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035354|NCT01519700|Lenograstim|lenograstim|mesh-list
2035355|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2035356|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
2035357|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035358|NCT01519765|Misoprostol|misoprostol|mesh-list
2035359|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2035360|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
2035361|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2035362|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035363|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2035364|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2035365|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
2035366|NCT01519778|Tedizolid|tedizolid|mesh-list
2035367|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2035368|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035369|NCT01519791|Methotrexate|methotrexate|mesh-list
2035370|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
2035371|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2035372|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
2035373|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2035374|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035375|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2035376|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
2035377|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035378|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035379|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
2035380|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035381|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2035382|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2035383|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
2035384|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2035385|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2035386|NCT01519817|Vaccines|vaccines|mesh-list
2035387|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
2035388|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035389|NCT01519882|Rotigotine|rotigotine|mesh-list
2035390|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
2035391|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
2035392|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035393|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035394|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035395|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2035396|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
2035397|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035398|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
2035399|NCT01519947|Hematinics|hematinics|mesh-ancestor
2035406|NCT01520207|Mannitol|mannitol|mesh-list
2035407|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2035408|NCT01520207|Diuretics|diuretics|mesh-ancestor
2035409|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
2035410|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035411|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
2035412|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
2035413|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
2035414|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2035415|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2035416|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035417|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035418|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035419|NCT01520402|Warfarin|warfarin|mesh-list
2035420|NCT01520402|Anticoagulants|anticoagulants|mesh-list
2035421|NCT01520454|Heparin|heparin|mesh-list
2035422|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2035423|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
2035424|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2035425|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2035426|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035427|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2035428|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2035429|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2035430|NCT01520519|Rituximab|rituximab|mesh-list
2035431|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2035432|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035433|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
2035434|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035435|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2035436|NCT01520688|Fluticasone|fluticasone|mesh-list
2035437|NCT01520688|Xhance|xhance|mesh-list
2035438|NCT01520688|Budesonide|budesonide|mesh-list
2035439|NCT01520688|Beclomethasone|beclomethasone|mesh-list
2035440|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2035441|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2035442|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
2035443|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035444|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035445|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2035446|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
2035447|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
2035448|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2035449|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
2035450|NCT01520688|Hormones|hormones|mesh-ancestor
2035451|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2035452|NCT01520727|Opicapone|opicapone|mesh-list
2035453|NCT01520727|Entacapone|entacapone|mesh-list
2035454|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2035455|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035456|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035457|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2035458|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2035459|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2035460|NCT01520922|Ofatumumab|ofatumumab|mesh-list
2035461|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2035462|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
2035463|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035464|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035465|NCT01520987|Opicapone|opicapone|mesh-list
2035466|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2035467|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035468|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035469|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2035470|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2035471|NCT01521117|Donepezil|donepezil|mesh-list
2035472|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2035473|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035474|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035475|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
2035476|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035477|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035478|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
2035479|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
2035480|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2035481|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035482|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
2035483|NCT01521364|Clarithromycin|clarithromycin|mesh-list
2035484|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2035485|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035486|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2035487|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035488|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035489|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2035490|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2035491|NCT01521546|Eplerenone|eplerenone|mesh-list
2035492|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2035493|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
2035494|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2035495|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035496|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2035497|NCT01521546|Diuretics|diuretics|mesh-ancestor
2035498|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
2035499|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2035500|NCT01521559|Aflibercept|aflibercept|mesh-list
2035501|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2035502|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2035503|NCT01521559|Growth Substances|growth substances|mesh-ancestor
2035504|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035505|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
2035506|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035507|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2035508|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
2035509|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035510|NCT01521923|Methotrexate|methotrexate|mesh-list
2035511|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
2035512|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2035513|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
2035514|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2035515|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035516|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2035517|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
2035518|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035519|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035520|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
2035521|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035522|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2035523|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2035524|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
2035525|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2035526|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2035527|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2035528|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
2035529|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2035530|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
2035531|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035532|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2035533|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2035534|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2035535|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2035536|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035537|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
2035538|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035539|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035540|NCT01522417|Tirofiban|tirofiban|mesh-list
2035541|NCT01522417|Eptifibatide|eptifibatide|mesh-list
2035542|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2035543|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2035544|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035545|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2035546|NCT01522443|Prednisone|prednisone|mesh-list
2035547|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
2035548|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2035549|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
2035550|NCT01522443|Hormones|hormones|mesh-ancestor
2035551|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2035552|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035553|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2035554|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035555|NCT01522443|Analgesics|analgesics|mesh-ancestor
2035556|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
2035557|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035558|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2035559|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2035560|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035561|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035562|NCT01522456|Tretinoin|tretinoin|mesh-list
2035563|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
2035564|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035565|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
2035566|NCT01522651|Dronedarone|dronedarone|mesh-list
2035567|NCT01522651|Ranolazine|ranolazine|mesh-list
2035568|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2035569|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2035570|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035571|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2035572|NCT01522950|Atenolol|atenolol|mesh-list
2035573|NCT01522950|Nebivolol|nebivolol|mesh-list
2035574|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2035575|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2035576|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
2035577|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
2035578|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035579|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035580|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2035581|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2035582|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2035583|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
2035584|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035585|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035586|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
2035587|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2035588|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2035589|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2035590|NCT01522963|Nicotine|nicotine|mesh-list
2035591|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2035592|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
2035593|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035594|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035595|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2035596|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2035597|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
2035598|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035599|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035600|NCT01523275|Mitomycins|mitomycins|mesh-list
2035601|NCT01523275|Mitomycin|mitomycin|mesh-list
2035602|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2035603|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035604|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
2035605|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035606|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2035607|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035608|NCT01523301|Rotigotine|rotigotine|mesh-list
2035609|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
2035610|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
2035611|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035612|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035613|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035614|NCT01523366|Clopidogrel|clopidogrel|mesh-list
2035615|NCT01523366|Ticagrelor|ticagrelor|mesh-list
2035616|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2035617|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2035618|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2035619|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2035620|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
2035621|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035622|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035623|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035624|NCT01523392|Clopidogrel|clopidogrel|mesh-list
2035625|NCT01523392|Ticagrelor|ticagrelor|mesh-list
2035626|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2035627|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2035628|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2035629|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2035630|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
2035631|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035632|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035633|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035634|NCT01523457|Folfirinox|folfirinox|mesh-list
2035635|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035636|NCT01523496|Vitamin D|vitamin d|mesh-list
2035637|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
2035638|NCT01523496|Calcifediol|calcifediol|mesh-list
2035639|NCT01523496|Vitamins|vitamins|mesh-list
2035640|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
2035641|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035642|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2035643|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2035644|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2035645|NCT01523587|Afatinib|afatinib|mesh-list
2035646|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035647|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2035648|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035649|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035650|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
2035651|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2035652|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035653|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035654|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2035655|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2035656|NCT01523834|Panobinostat|panobinostat|mesh-list
2035657|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035658|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2035659|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035660|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035661|NCT01523886|Rocuronium|rocuronium|mesh-list
2035662|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2035663|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2035664|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2035665|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035666|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035667|NCT01524133|Sertraline|sertraline|mesh-list
2035668|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
2035669|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2035670|NCT01524133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2035671|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2035672|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2035673|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035674|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035675|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
2035676|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035677|NCT01524198|Budesonide|budesonide|mesh-list
2035678|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2035679|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2035680|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
2035681|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035682|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035683|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2035684|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
2035685|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
2035686|NCT01524198|Hormones|hormones|mesh-ancestor
2035687|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2035688|NCT01524289|Anacetrapib|anacetrapib|mesh-list
2035689|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2035690|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2035691|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
2035692|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035693|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2035694|NCT01524302|Levofloxacin|levofloxacin|mesh-list
2035695|NCT01524302|Ofloxacin|ofloxacin|mesh-list
2035696|NCT01524302|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2035697|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2035698|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035699|NCT01524302|Renal Agents|renal agents|mesh-ancestor
2035700|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2035701|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2035702|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2035703|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035704|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035705|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035706|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2035707|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2035708|NCT01524627|Varenicline|varenicline|mesh-list
2035709|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2035710|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2035711|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
2035712|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035713|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035714|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035715|NCT01524679|Interferons|interferons|mesh-list
2035716|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
2035717|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
2035718|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2035719|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035720|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
2035721|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035722|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
2035723|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035724|NCT01524770|Dulaglutide|dulaglutide|mesh-list
2035725|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2035726|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035727|NCT01524783|Everolimus|everolimus|mesh-list
2035728|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035729|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2035730|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
2035731|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035732|NCT01524796|Pregabalin|pregabalin|mesh-list
2035733|NCT01524796|Analgesics|analgesics|mesh-ancestor
2035734|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
2035735|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035736|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035737|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
2035738|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2035739|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2035740|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035741|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2035742|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2035743|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2035744|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2035745|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2035746|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
2035747|NCT01524887|Antibodies|antibodies|mesh-list
2035748|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
2035749|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2035750|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2035751|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
2035752|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035753|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
2035754|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2035755|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
2035756|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035757|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
2035758|NCT01524913|Protective Agents|protective agents|mesh-ancestor
2035759|NCT01524978|Cetuximab|cetuximab|mesh-list
2035760|NCT01524978|Vemurafenib|vemurafenib|mesh-list
2035761|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2035762|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035763|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2035764|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035765|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035766|NCT01524991|Gemcitabine|gemcitabine|mesh-list
2035767|NCT01524991|Ipilimumab|ipilimumab|mesh-list
2035768|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035769|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2035770|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
2035771|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035772|NCT01524991|Antiviral Agents|antiviral agents|mesh-ancestor
2035773|NCT01524991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035774|NCT01524991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035775|NCT01524991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2035776|NCT01524991|Immunologic Factors|immunologic factors|mesh-ancestor
2035777|NCT01524991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035778|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2035779|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2035780|NCT01525082|Bevacizumab|bevacizumab|mesh-list
2035781|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2035782|NCT01525082|Capecitabine|capecitabine|mesh-list
2035783|NCT01525082|Temozolomide|temozolomide|mesh-list
2035784|NCT01525082|Antibodies|antibodies|mesh-list
2035785|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
2035786|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2035787|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035788|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2035789|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2035790|NCT01525082|Growth Substances|growth substances|mesh-ancestor
2035791|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035792|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
2035793|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
2035794|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2035795|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
2035796|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035797|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2035798|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
2035799|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2035800|NCT01525173|Bimatoprost|bimatoprost|mesh-list
2035801|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2035802|NCT01525173|Latanoprost|latanoprost|mesh-list
2035803|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2035804|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
2035805|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2035806|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2035807|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2035808|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2035809|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
2035810|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035811|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035812|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035813|NCT01525225|Metformin|metformin|mesh-list
2035814|NCT01525225|Saxagliptin|saxagliptin|mesh-list
2035815|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2035816|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035817|NCT01525225|Incretins|incretins|mesh-ancestor
2035818|NCT01525225|Hormones|hormones|mesh-ancestor
2035819|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2035820|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2035821|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
2035822|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035823|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035824|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
2035825|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2035826|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035827|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2035828|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035829|NCT01525329|Fluorouracil|fluorouracil|mesh-list
2035830|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
2035831|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035832|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2035833|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035834|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2035835|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
2035836|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035837|NCT01525407|Atorvastatin|atorvastatin|mesh-list
2035838|NCT01525407|Calcium|calcium|mesh-list
2035839|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2035840|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035841|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2035842|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2035843|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
2035844|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035845|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2035846|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2035847|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035848|NCT01525550|Sunitinib|sunitinib|mesh-list
2035849|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035850|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2035851|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2035852|NCT01525550|Growth Substances|growth substances|mesh-ancestor
2035853|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035854|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
2035855|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2035856|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035857|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035858|NCT01525602|Paclitaxel|paclitaxel|mesh-list
2035859|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2035860|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035861|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
2035862|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
2035863|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
2035864|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035865|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
2035866|NCT01525615|Olodaterol|olodaterol|mesh-list
2035867|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2035868|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
2035869|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2035870|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035871|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2035872|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
2035873|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
2035874|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2035875|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
2035876|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035877|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035878|NCT01525628|Tolbutamide|tolbutamide|mesh-list
2035879|NCT01525628|Interferons|interferons|mesh-list
2035880|NCT01525628|Tenofovir|tenofovir|mesh-list
2035881|NCT01525628|Ribavirin|ribavirin|mesh-list
2035882|NCT01525628|Midazolam|midazolam|mesh-list
2035883|NCT01525628|Caffeine|caffeine|mesh-list
2035884|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035885|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
2035886|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035887|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2035888|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2035889|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2035890|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035891|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2035892|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2035893|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2035894|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2035895|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
2035896|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
2035897|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
2035898|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
2035899|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035900|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035901|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2035902|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2035903|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035904|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2035905|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2035906|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
2035907|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2035908|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2035909|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2035910|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2035911|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
2035912|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2035913|NCT01525641|Pramipexole|pramipexole|mesh-list
2035914|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
2079376|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2035915|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035916|NCT01525641|Protective Agents|protective agents|mesh-ancestor
2035917|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035918|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2035919|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2035920|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
2035921|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
2035922|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035923|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
2035924|NCT01525875|Antacids|antacids|mesh-ancestor
2035925|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035926|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2035927|NCT01526057|Rituximab|rituximab|mesh-list
2035928|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2035929|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035930|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
2035931|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035932|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2035933|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2035934|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
2035935|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
2035936|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2035937|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2035938|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2035939|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2035940|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035941|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2035942|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035943|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
2035944|NCT01526213|Fexofenadine|fexofenadine|mesh-list
2035945|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2035946|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2035947|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2035948|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
2035949|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
2035950|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035951|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035952|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035953|NCT01526356|Sirolimus|sirolimus|mesh-list
2035954|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2035955|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035956|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2035957|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2035958|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
2035959|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2035960|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
2035961|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035962|NCT01526538|Cycloserine|cycloserine|mesh-list
2035963|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2035964|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2035965|NCT01526538|Renal Agents|renal agents|mesh-ancestor
2035966|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2035967|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
2035968|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2035969|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
2035970|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035971|NCT01526551|Vaccines|vaccines|mesh-list
2035972|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
2035973|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035974|NCT01526577|Ticagrelor|ticagrelor|mesh-list
2035975|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2035976|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2035977|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2035978|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2035979|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
2035980|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2035981|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2035982|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035983|NCT01526733|Insulin|insulin|mesh-list
2035984|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2035985|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
2035986|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
2035987|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2035988|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035989|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
2035990|NCT01527045|Cyclosporine|cyclosporine|mesh-list
2035991|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
2035992|NCT01527045|Fludarabine|fludarabine|mesh-list
2035993|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
2035994|NCT01527045|Atorvastatin|atorvastatin|mesh-list
2035995|NCT01527045|Calcium|calcium|mesh-list
2035996|NCT01527045|Cyclosporins|cyclosporins|mesh-list
2035997|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2035998|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2035999|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2036000|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036001|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2036002|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
2036003|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036004|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2036005|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
2036006|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036007|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
2036008|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036009|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
2036010|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2036011|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2036012|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2036013|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2036014|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2036015|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2036016|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2036017|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2036018|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
2036019|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2036020|NCT01527110|Zanamivir|zanamivir|mesh-list
2036021|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
2036022|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036023|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036024|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036025|NCT01527149|Cytarabine|cytarabine|mesh-list
2036026|NCT01527149|Dexamethasone|dexamethasone|mesh-list
2036027|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
2036028|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
2036029|NCT01527149|Doxorubicin|doxorubicin|mesh-list
2036030|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2036031|NCT01527149|Methotrexate|methotrexate|mesh-list
2036032|NCT01527149|Vincristine|vincristine|mesh-list
2036033|NCT01527149|Ofatumumab|ofatumumab|mesh-list
2036034|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2036035|NCT01527149|BB 1101|bb 1101|mesh-list
2036036|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2036037|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
2036038|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036039|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2036040|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2036041|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
2036042|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036043|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036044|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2036045|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2036046|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
2036047|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
2036048|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036049|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2036050|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
2036051|NCT01527149|Hormones|hormones|mesh-ancestor
2036052|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2036053|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2036054|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2036055|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2036056|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2036057|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036058|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2036059|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
2036060|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2036061|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2036062|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
2036063|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
2036064|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2036065|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2036066|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
2036067|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036068|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2036069|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
2036070|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
2036071|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
2036072|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
2036073|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2036074|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
2036075|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
2036076|NCT01527357|Coagulants|coagulants|mesh-ancestor
2036077|NCT01527383|Vaccines|vaccines|mesh-list
2036078|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
2036079|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036080|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
2036081|NCT01527487|Docetaxel|docetaxel|mesh-list
2036082|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2036083|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
2036084|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036085|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2036086|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2036087|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
2036088|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036089|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036090|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2036091|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
2036092|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
2036093|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
2036094|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2036095|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
2036096|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2036097|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2036098|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2036099|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036100|NCT01527682|Dorzolamide|dorzolamide|mesh-list
2036101|NCT01527682|Latanoprost|latanoprost|mesh-list
2036102|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2036103|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2036104|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2036105|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2036106|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036107|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036108|NCT01528254|Metformin|metformin|mesh-list
2036109|NCT01528254|Vildagliptin|vildagliptin|mesh-list
2036110|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2036111|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036112|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2036113|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
2036114|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036115|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036116|NCT01528345|Fulvestrant|fulvestrant|mesh-list
2036117|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2036118|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036119|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2036120|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2036121|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
2036122|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2036123|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036124|NCT01528592|Levodopa|levodopa|mesh-list
2036125|NCT01528592|Carbidopa|carbidopa|mesh-list
2036126|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2036127|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2036128|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2036129|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
2036130|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036131|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036132|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036133|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2036134|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036135|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2036136|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
2036137|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
2036138|NCT01528709|Atorvastatin|atorvastatin|mesh-list
2036139|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2036140|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2036141|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
2036142|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036143|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2036144|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2036145|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036146|NCT01528735|Ribavirin|ribavirin|mesh-list
2036147|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
2036148|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036149|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
2036150|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036151|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2036152|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2036153|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
2036154|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2036155|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2036156|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036157|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2036158|NCT01528891|Analgesics|analgesics|mesh-ancestor
2036159|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
2036160|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036161|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2036162|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2036163|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2036164|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
2036165|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036166|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036167|NCT01528969|Sorbitol|sorbitol|mesh-list
2036168|NCT01528969|Cathartics|cathartics|mesh-ancestor
2036169|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2036170|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2036171|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036172|NCT01529112|Lenvatinib|lenvatinib|mesh-list
2036173|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036174|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2036175|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036176|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036177|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
2036178|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2036179|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2036180|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2036181|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2036182|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036183|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
2036184|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036185|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036186|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2036187|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036188|NCT01529268|Cysteamine|cysteamine|mesh-list
2036189|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2036190|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036191|NCT01529346|Ibuprofen|ibuprofen|mesh-list
2036192|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2036193|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2036194|NCT01529346|Analgesics|analgesics|mesh-ancestor
2036195|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
2036196|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036197|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036198|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2036199|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2036200|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2036201|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036202|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036203|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
2036204|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2036205|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
2036206|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036207|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036208|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2036209|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
2036210|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2036211|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
2036212|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036213|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036214|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2036215|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
2036216|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
2036217|NCT01529502|Protective Agents|protective agents|mesh-ancestor
2036218|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2036219|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2036220|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2036221|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2036222|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
2036223|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2036224|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2036225|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2036226|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
2036227|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036228|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036229|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036230|NCT01529645|Vaccines|vaccines|mesh-list
2036231|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
2036232|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036233|NCT01529749|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2036234|NCT01529749|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2036235|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
2036236|NCT01529749|Losartan|losartan|mesh-list
2036237|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2036238|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2036239|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2036240|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2036241|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036242|NCT01529749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2036243|NCT01529749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2036244|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036245|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
2036246|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036247|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2036248|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2036249|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2036250|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2036251|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
2036252|NCT01529827|Methotrexate|methotrexate|mesh-list
2036253|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
2036254|NCT01529827|Fludarabine|fludarabine|mesh-list
2036255|NCT01529827|Melphalan|melphalan|mesh-list
2036256|NCT01529827|Tacrolimus|tacrolimus|mesh-list
2036257|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2036258|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
2036259|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2036260|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036261|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2036262|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
2036263|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036264|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036265|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
2036266|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036267|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2036268|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2036269|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
2036270|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2036271|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2036272|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2036273|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2036274|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2036275|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
2036276|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2036277|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036278|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2036279|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
2036280|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2036281|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2036282|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2036283|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036284|NCT01530178|Incretins|incretins|mesh-ancestor
2036285|NCT01530178|Hormones|hormones|mesh-ancestor
2036286|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2036287|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2036288|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
2036289|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036290|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036291|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2036292|NCT01530243|Terazosin|terazosin|mesh-list
2036293|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2036294|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2036295|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
2036296|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036297|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036298|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036299|NCT01530243|Urological Agents|urological agents|mesh-ancestor
2036300|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2036301|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2036302|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2036303|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
2036304|NCT01530334|Gefitinib|gefitinib|mesh-list
2036305|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036306|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2036307|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036308|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036309|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
2036310|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2036311|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2036312|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036313|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
2036314|NCT01530399|Coagulants|coagulants|mesh-ancestor
2036315|NCT01530464|Ambrisentan|ambrisentan|mesh-list
2036316|NCT01530464|Aminophylline|aminophylline|mesh-list
2036317|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2036318|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2036319|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
2036320|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036321|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036322|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2036323|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
2036324|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2036325|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2036326|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036327|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036328|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2036329|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2036330|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
2036331|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036332|NCT01530464|Protective Agents|protective agents|mesh-ancestor
2746258|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2746259|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036335|NCT01531153|Galantamine|galantamine|mesh-list
2036336|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2036337|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036338|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036339|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
2036340|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036341|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036342|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2036343|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
2036344|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036345|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
2036346|NCT01531205|Leuprolide|leuprolide|mesh-list
2036347|NCT01531205|Goserelin|goserelin|mesh-list
2036348|NCT01531205|Bicalutamide|bicalutamide|mesh-list
2036349|NCT01531205|Androgens|androgens|mesh-list
2036350|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2036351|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
2036352|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2036353|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036354|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2036355|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036356|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
2036357|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
2036358|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2036359|NCT01531205|Hormones|hormones|mesh-ancestor
2036360|NCT01531439|Naloxone|naloxone|mesh-list
2036361|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2036362|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036363|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
2036364|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036365|NCT01531673|Ivacaftor|ivacaftor|mesh-list
2036366|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2036367|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2036368|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036369|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2036370|NCT01531959|Midodrine|midodrine|mesh-list
2036371|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
2036372|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
2036373|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036374|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036375|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2036376|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2036377|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2036378|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2036379|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
2036380|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036381|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036382|NCT01531998|Dexamethasone|dexamethasone|mesh-list
2036383|NCT01531998|Lenalidomide|lenalidomide|mesh-list
2036384|NCT01531998|Bortezomib|bortezomib|mesh-list
2036385|NCT01531998|Siltuximab|siltuximab|mesh-list
2036386|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2036387|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
2036388|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
2036389|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036390|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036391|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2036392|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
2036393|NCT01531998|Hormones|hormones|mesh-ancestor
2036394|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2036395|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2036396|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036397|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
2036398|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2036399|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2036400|NCT01531998|Growth Substances|growth substances|mesh-ancestor
2036401|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
2036402|NCT01532089|Bevacizumab|bevacizumab|mesh-list
2036403|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2036404|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2036405|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
2036406|NCT01532089|Antibodies|antibodies|mesh-list
2036407|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
2036408|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2036409|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
2036410|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036411|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2036412|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2036413|NCT01532089|Growth Substances|growth substances|mesh-ancestor
2036414|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036415|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
2036416|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
2036417|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2036418|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036419|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036420|NCT01532128|Opicapone|opicapone|mesh-list
2036421|NCT01532128|Rasagiline|rasagiline|mesh-list
2036422|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2036423|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036424|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036425|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2036426|NCT01532128|Protective Agents|protective agents|mesh-ancestor
2036427|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036428|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2036429|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2036430|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2036431|NCT01532141|Opicapone|opicapone|mesh-list
2036432|NCT01532141|Rasagiline|rasagiline|mesh-list
2036433|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2036434|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036435|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036436|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2036437|NCT01532141|Protective Agents|protective agents|mesh-ancestor
2036438|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036439|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2036440|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2036441|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2036442|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
2036443|NCT01532349|Vitamins|vitamins|mesh-ancestor
2036444|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
2036445|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036446|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2036447|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2036448|NCT01532414|Enclomiphene|enclomiphene|mesh-list
2036449|NCT01532414|Clomiphene|clomiphene|mesh-list
2036450|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
2036451|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2036452|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
2036453|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2036454|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036455|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2036456|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
2036457|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2036458|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2036459|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2036460|NCT01532648|Budesonide|budesonide|mesh-list
2036461|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2036462|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2036463|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
2036464|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036465|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036466|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2036467|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
2036468|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
2036469|NCT01532648|Hormones|hormones|mesh-ancestor
2036470|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2036471|NCT01532687|Gemcitabine|gemcitabine|mesh-list
2036472|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2036473|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
2036474|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036475|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036476|NCT01532687|Antiviral Agents|antiviral agents|mesh-ancestor
2036477|NCT01532687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036478|NCT01532687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036479|NCT01532687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2036480|NCT01532687|Immunologic Factors|immunologic factors|mesh-ancestor
2036481|NCT01532687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036482|NCT01532700|Ofatumumab|ofatumumab|mesh-list
2036483|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036484|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
2036485|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
2036486|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036487|NCT01533077|Levodopa|levodopa|mesh-list
2036488|NCT01533077|Carbidopa|carbidopa|mesh-list
2036489|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2036490|NCT01533077|Opicapone|opicapone|mesh-list
2036491|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2036492|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2036493|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
2036494|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036495|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036496|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036497|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2036498|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036499|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2036500|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
2036501|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
2036502|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2036503|NCT01533116|Levodopa|levodopa|mesh-list
2036504|NCT01533116|Carbidopa|carbidopa|mesh-list
2036505|NCT01533116|Opicapone|opicapone|mesh-list
2036506|NCT01533116|Benserazide|benserazide|mesh-list
2036507|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2036508|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2036509|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
2036510|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036511|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036512|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079377|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036513|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2036514|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036515|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2036516|NCT01533181|Topotecan|topotecan|mesh-list
2036517|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2036518|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2036519|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036520|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036521|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036522|NCT01533207|Gemcitabine|gemcitabine|mesh-list
2036523|NCT01533207|Docetaxel|docetaxel|mesh-list
2036524|NCT01533207|Doxorubicin|doxorubicin|mesh-list
2036525|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2036526|NCT01533207|Lenograstim|lenograstim|mesh-list
2036527|NCT01533207|Sargramostim|sargramostim|mesh-list
2036528|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2036529|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
2036530|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036531|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036532|NCT01533207|Antiviral Agents|antiviral agents|mesh-ancestor
2036533|NCT01533207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036534|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036535|NCT01533207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2036536|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
2036537|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036538|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
2036539|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
2036540|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
2036541|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2036542|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2036543|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2036544|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2036545|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2036546|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2036547|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2036548|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
2036549|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036550|NCT01533428|Capsaicin|capsaicin|mesh-list
2036551|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
2036552|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
2036553|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
2036554|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036555|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036556|NCT01533493|Memantine|memantine|mesh-list
2036557|NCT01533493|Methylphenidate|methylphenidate|mesh-list
2036558|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2036559|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036560|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2036561|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2036562|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2036563|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036564|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
2036565|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036566|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2036567|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2036568|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2036569|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2036570|NCT01533597|Tamsulosin|tamsulosin|mesh-list
2036571|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
2036572|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2036573|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2036574|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2036575|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
2036576|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036577|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036578|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036579|NCT01533597|Urological Agents|urological agents|mesh-ancestor
2036580|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2036581|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2036582|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
2036583|NCT01533688|Bisacodyl|bisacodyl|mesh-list
2036584|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2036585|NCT01533688|Cathartics|cathartics|mesh-ancestor
2036586|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2036587|NCT01533688|Laxatives|laxatives|mesh-ancestor
2036588|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
2036589|NCT01533922|Olodaterol|olodaterol|mesh-list
2036590|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2036591|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
2036592|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036593|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036594|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2036595|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
2036596|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
2036597|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2036598|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
2036599|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036600|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036601|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
2036602|NCT01533935|Olodaterol|olodaterol|mesh-list
2036603|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2036604|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
2036605|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036606|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036607|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2036608|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
2036609|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
2036610|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2036611|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
2036612|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036613|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036614|NCT01533948|Axitinib|axitinib|mesh-list
2036615|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036616|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2036617|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036618|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036619|NCT01534013|Insulin|insulin|mesh-list
2036620|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2036621|NCT01534013|Pancrelipase|pancrelipase|mesh-list
2036622|NCT01534013|Pancreatin|pancreatin|mesh-list
2036623|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2036624|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036625|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2036626|NCT01534078|Doxorubicin|doxorubicin|mesh-list
2036627|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2036628|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2036629|NCT01534078|Dacarbazine|dacarbazine|mesh-list
2036630|NCT01534078|Vinblastine|vinblastine|mesh-list
2036631|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2036632|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036633|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2036634|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2036635|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036636|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036637|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2036638|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2036639|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
2036640|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2036641|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
2036642|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
2036643|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
2036644|NCT01534182|Interferons|interferons|mesh-list
2036645|NCT01534182|Interferon-beta|interferon-beta|mesh-list
2036646|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
2036647|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2036648|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
2036649|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036650|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
2036651|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036652|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
2036653|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036654|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2036655|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036656|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2036657|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2036658|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2036659|NCT01534195|Prednisolone|prednisolone|mesh-list
2036660|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2036661|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
2036662|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2036663|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
2036664|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2036665|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2036666|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2036667|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
2036668|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2036669|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
2036670|NCT01534195|Hormones|hormones|mesh-ancestor
2036671|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2036672|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036673|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2036674|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036675|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
2036676|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
2036677|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036678|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2036679|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2036680|NCT01534195|Protective Agents|protective agents|mesh-ancestor
2036681|NCT01534208|Enclomiphene|enclomiphene|mesh-list
2036682|NCT01534208|Clomiphene|clomiphene|mesh-list
2036683|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
2036684|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2036685|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
2036686|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2036687|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036688|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2036689|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
2036690|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2036691|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2036692|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2036693|NCT01534260|Bortezomib|bortezomib|mesh-list
2036694|NCT01534260|Sorafenib|sorafenib|mesh-list
2036695|NCT01534260|Vorinostat|vorinostat|mesh-list
2036696|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036697|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2036698|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036699|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036700|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2036701|NCT01534351|Tamsulosin|tamsulosin|mesh-list
2036702|NCT01534351|Finasteride|finasteride|mesh-list
2036703|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2036704|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2036705|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2036706|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
2036707|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036708|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036709|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036710|NCT01534351|Urological Agents|urological agents|mesh-ancestor
2036711|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2036712|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2036713|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036714|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
2036715|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2036716|NCT01534416|Bupivacaine|bupivacaine|mesh-list
2036717|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
2036718|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
2036719|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2036720|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036721|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
2036722|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036723|NCT01534520|Lidocaine|lidocaine|mesh-list
2036724|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
2036725|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
2036726|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2036727|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036728|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
2036729|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036730|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2036731|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2036732|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2036733|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2036734|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036735|NCT01534637|Gemcitabine|gemcitabine|mesh-list
2036736|NCT01534637|Fluorouracil|fluorouracil|mesh-list
2036737|NCT01534637|Capecitabine|capecitabine|mesh-list
2036738|NCT01534637|Aprepitant|aprepitant|mesh-list
2036739|NCT01534637|Antiemetics|antiemetics|mesh-list
2036740|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2036741|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
2036742|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036743|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036744|NCT01534637|Antiviral Agents|antiviral agents|mesh-ancestor
2036745|NCT01534637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036746|NCT01534637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036747|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2036748|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
2036749|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036750|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
2036751|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036752|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2036753|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2036754|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036755|NCT01534897|Dabrafenib|dabrafenib|mesh-list
2036756|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036757|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2036758|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036759|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036760|NCT01534962|Ranolazine|ranolazine|mesh-list
2036761|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2036762|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2036763|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036764|NCT01535001|Acetaminophen|acetaminophen|mesh-list
2036765|NCT01535001|Pantoprazole|pantoprazole|mesh-list
2036766|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2036767|NCT01535001|Analgesics|analgesics|mesh-ancestor
2036768|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
2036769|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036770|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036771|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
2036772|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2036773|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2036774|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2036775|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036776|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036777|NCT01535040|Memantine|memantine|mesh-list
2036778|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2036779|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2036780|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
2036781|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036782|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036783|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036784|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2036785|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2036786|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
2036787|NCT01535053|Leucovorin|leucovorin|mesh-list
2036788|NCT01535053|Folic Acid|folic acid|mesh-list
2036789|NCT01535053|Dactinomycin|dactinomycin|mesh-list
2036790|NCT01535053|Methotrexate|methotrexate|mesh-list
2036791|NCT01535053|Calcium|calcium|mesh-list
2036792|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
2036793|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2036794|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036795|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2036796|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2036797|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
2036798|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2036799|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2036800|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
2036801|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036802|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036803|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
2036804|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036805|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2036806|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2036807|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
2036808|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2036809|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2036810|NCT01535053|Antidotes|antidotes|mesh-ancestor
2036811|NCT01535053|Protective Agents|protective agents|mesh-ancestor
2036812|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
2036813|NCT01535053|Vitamins|vitamins|mesh-ancestor
2036814|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
2036815|NCT01535053|Hematinics|hematinics|mesh-ancestor
2036816|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2036817|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036818|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2036819|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2036820|NCT01535235|Lisinopril|lisinopril|mesh-list
2036821|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2036822|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
2036823|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036824|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036825|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2036826|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2036827|NCT01535235|Protective Agents|protective agents|mesh-ancestor
2036828|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036829|NCT01535261|Ranibizumab|ranibizumab|mesh-list
2036830|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2036831|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2036832|NCT01535261|Growth Substances|growth substances|mesh-ancestor
2036833|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036834|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
2036835|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036836|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
2036837|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2036838|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2036839|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036840|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2036841|NCT01535287|Analgesics|analgesics|mesh-ancestor
2036842|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
2036843|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036844|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2036845|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2036846|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2036847|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
2036848|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036849|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036850|NCT01535443|Bromfenac|bromfenac|mesh-list
2036851|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2036852|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2036853|NCT01535443|Analgesics|analgesics|mesh-ancestor
2036854|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
2036855|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036856|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036857|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2036858|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2036859|NCT01535573|Dexetimide|dexetimide|mesh-list
2036860|NCT01535573|Citalopram|citalopram|mesh-list
2036861|NCT01535573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2036862|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2036863|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2036864|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036865|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036866|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
2036867|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036868|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2036869|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
2036870|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2036871|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2036872|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2036873|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
2036874|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
2036875|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036876|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2036877|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2036878|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
2036879|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
2036880|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2036881|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2036882|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036883|NCT01535924|Gemcitabine|gemcitabine|mesh-list
2036884|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2036885|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2036886|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
2036887|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036888|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036889|NCT01535924|Antiviral Agents|antiviral agents|mesh-ancestor
2036890|NCT01535924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2036891|NCT01535924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036892|NCT01535924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2036893|NCT01535924|Immunologic Factors|immunologic factors|mesh-ancestor
2036894|NCT01535924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036895|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2036896|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
2036897|NCT01535937|Midazolam|midazolam|mesh-list
2036898|NCT01535937|Ketamine|ketamine|mesh-list
2036899|NCT01535937|Analgesics|analgesics|mesh-ancestor
2036900|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
2036901|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036902|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036903|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2036904|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2036905|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
2036906|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
2036907|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2036908|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2036909|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2036910|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036911|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036912|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2036913|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2036914|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2036915|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2036916|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2036917|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
2036918|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
2036919|NCT01535976|Ketamine|ketamine|mesh-list
2036920|NCT01535976|Analgesics|analgesics|mesh-ancestor
2036921|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
2036922|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036923|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036924|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2036925|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2036926|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
2036927|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
2036928|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2036929|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2036930|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2036931|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036932|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036933|NCT01536067|Bortezomib|bortezomib|mesh-list
2036934|NCT01536067|Ofatumumab|ofatumumab|mesh-list
2036935|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036936|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
2036937|NCT01536262|Olodaterol|olodaterol|mesh-list
2036938|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2036939|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
2036940|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036941|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036942|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2036943|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
2036944|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
2036945|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2036946|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
2036947|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036948|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036949|NCT01536366|Repaglinide|repaglinide|mesh-list
2036950|NCT01536366|Opicapone|opicapone|mesh-list
2036951|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2036952|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036953|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2036954|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2036955|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036956|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2036957|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2036958|NCT01536379|Belimumab|belimumab|mesh-list
2036959|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2036960|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
2036961|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036962|NCT01536392|Ondansetron|ondansetron|mesh-list
2036963|NCT01536392|Granisetron|granisetron|mesh-list
2036964|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
2036965|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
2036966|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036967|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036968|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2036969|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
2036970|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
2036971|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2036972|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
2036973|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2036974|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2036975|NCT01536392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2036976|NCT01536392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2036977|NCT01536392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2036978|NCT01536392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2036979|NCT01536392|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2036980|NCT01536535|Prednisone|prednisone|mesh-list
2036981|NCT01536535|Mesalamine|mesalamine|mesh-list
2036982|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2036983|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
2036984|NCT01536535|Hormones|hormones|mesh-ancestor
2036985|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2036986|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2036987|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2036988|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2036989|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2036990|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2036991|NCT01536535|Analgesics|analgesics|mesh-ancestor
2036992|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
2036993|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2036994|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2036995|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
2036996|NCT01536561|Antibodies|antibodies|mesh-list
2036997|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2036998|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
2036999|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
2037000|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037001|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037002|NCT01536574|Ropinirole|ropinirole|mesh-list
2037003|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2037004|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2037005|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
2037006|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
2037007|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037008|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037009|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037010|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2037011|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2037012|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
2037013|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037014|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037015|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2037016|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
2037017|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2037018|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2037019|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2037020|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
2037021|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037022|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037023|NCT01536704|Nicotine|nicotine|mesh-list
2037024|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2037025|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
2037026|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037027|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037028|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2037029|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2037030|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
2037031|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037032|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037033|NCT01536886|Betamethasone|betamethasone|mesh-list
2037034|NCT01536886|Calcipotriene|calcipotriene|mesh-list
2037035|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037036|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
2037037|NCT01536886|Hormones|hormones|mesh-ancestor
2037038|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037039|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037040|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2037041|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
2037042|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
2037043|NCT01536938|Calcitriol|calcitriol|mesh-list
2037044|NCT01536938|Betamethasone|betamethasone|mesh-list
2037045|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
2037046|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2037047|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
2037048|NCT01536938|Calcipotriene|calcipotriene|mesh-list
2037049|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2037050|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037051|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
2037052|NCT01536938|Hormones|hormones|mesh-ancestor
2037053|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037054|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037055|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2037056|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
2037057|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
2037058|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2037059|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2037060|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2037061|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037062|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2037063|NCT01536938|Vitamins|vitamins|mesh-ancestor
2037064|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
2037065|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2037066|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
2037067|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2037068|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037069|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2037070|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2037071|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037072|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037073|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037074|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
2037075|NCT01537029|Doxorubicin|doxorubicin|mesh-list
2037076|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2037077|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
2037078|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037079|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037080|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2037081|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
2037082|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037083|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037084|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2037085|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2037086|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2037087|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2037088|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037089|NCT01537042|Rotigotine|rotigotine|mesh-list
2037090|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
2037091|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
2037092|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037093|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037094|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037095|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2037096|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2037097|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2037098|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2037099|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037100|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037101|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037102|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
2037103|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2037104|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
2037105|NCT01537081|Guaifenesin|guaifenesin|mesh-list
2037106|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2037107|NCT01537081|Expectorants|expectorants|mesh-ancestor
2037108|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
2037109|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2037110|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2037111|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
2037112|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037113|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037114|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037115|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
2037116|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2037117|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
2037118|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
2037119|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037120|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
2037121|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2037122|NCT01537120|Vildagliptin|vildagliptin|mesh-list
2037123|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2037124|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037125|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2037126|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
2037127|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037128|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037129|NCT01537133|Fluticasone|fluticasone|mesh-list
2037130|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037131|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2037132|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
2037133|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037134|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037135|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2037136|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
2037137|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
2037138|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2037139|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
2037140|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2037141|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
2037142|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037143|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
2037144|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
2037145|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2037146|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2037147|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037148|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037149|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037150|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037151|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
2037152|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
2037153|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
2037154|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037155|NCT01537549|Protective Agents|protective agents|mesh-ancestor
2037156|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037157|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
2037158|NCT01537549|Vitamins|vitamins|mesh-ancestor
2037159|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
2037160|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
2037161|NCT01537666|Vancomycin|vancomycin|mesh-list
2037162|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2037163|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037164|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
2037165|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2037166|NCT01537783|Mupirocin|mupirocin|mesh-list
2037167|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2037168|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037169|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
2037170|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
2037171|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2037172|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2037173|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037174|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037175|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
2037176|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2037177|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
2037178|NCT01537887|Evacetrapib|evacetrapib|mesh-list
2037179|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2037180|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037181|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2037182|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2037183|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037184|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037185|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079378|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
2037186|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2037187|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2037188|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
2037189|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2037190|NCT01537900|Grazoprevir|grazoprevir|mesh-list
2037191|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
2037192|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037193|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
2037194|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2037195|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
2037196|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037197|NCT01537926|Expectorants|expectorants|mesh-ancestor
2037198|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
2037199|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2037200|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
2037201|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037202|NCT01537926|Protective Agents|protective agents|mesh-ancestor
2037203|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037204|NCT01537926|Antidotes|antidotes|mesh-ancestor
2037205|NCT01538472|Cytarabine|cytarabine|mesh-list
2037206|NCT01538472|Rituximab|rituximab|mesh-list
2037207|NCT01538472|Melphalan|melphalan|mesh-list
2037208|NCT01538472|Carmustine|carmustine|mesh-list
2037209|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2037210|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2037211|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037212|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
2037213|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037214|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037215|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2037216|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
2037217|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037218|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
2037219|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037220|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2037221|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2037222|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
2037223|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2037224|NCT01538719|Rilonacept|rilonacept|mesh-list
2037225|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037226|NCT01538745|Morphine|morphine|mesh-list
2037227|NCT01538745|Ketamine|ketamine|mesh-list
2037228|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2037229|NCT01538745|Narcotics|narcotics|mesh-ancestor
2037230|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2037231|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037232|NCT01538745|Analgesics|analgesics|mesh-ancestor
2037233|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
2037234|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037235|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2037236|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2037237|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
2037238|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
2037239|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2037240|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2037241|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037242|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037243|NCT01538862|Sargramostim|sargramostim|mesh-list
2037244|NCT01538862|Lenograstim|lenograstim|mesh-list
2037245|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
2037246|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037247|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2037248|NCT01539083|Thalidomide|thalidomide|mesh-list
2037249|NCT01539083|Dexamethasone|dexamethasone|mesh-list
2037250|NCT01539083|Prednisolone|prednisolone|mesh-list
2037251|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
2037252|NCT01539083|Bortezomib|bortezomib|mesh-list
2037253|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2037254|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
2037255|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037256|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037257|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2037258|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
2037259|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037260|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037261|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2037262|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037263|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
2037264|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
2037265|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037266|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2037267|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
2037268|NCT01539083|Hormones|hormones|mesh-ancestor
2037269|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037270|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2037271|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
2037272|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2037273|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037274|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2037275|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2037276|NCT01539083|Growth Substances|growth substances|mesh-ancestor
2037277|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
2037278|NCT01539135|Methylene Blue|methylene blue|mesh-list
2037279|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037280|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037281|NCT01539291|Idelalisib|idelalisib|mesh-list
2037282|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037283|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037284|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037285|NCT01539317|Lidocaine|lidocaine|mesh-list
2037286|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
2037287|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
2037288|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2037289|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037290|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
2037291|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037292|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2037293|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2037294|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2037295|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2037296|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037297|NCT01539512|Rituximab|rituximab|mesh-list
2037298|NCT01539512|Idelalisib|idelalisib|mesh-list
2037299|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2037300|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037301|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
2037302|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037303|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037304|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037305|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037306|NCT01539538|Sufentanil|sufentanil|mesh-list
2037307|NCT01539538|Morphine|morphine|mesh-list
2037308|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2037309|NCT01539538|Narcotics|narcotics|mesh-ancestor
2037310|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2037311|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037312|NCT01539538|Analgesics|analgesics|mesh-ancestor
2037313|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
2037314|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037315|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2037316|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2037317|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
2037318|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
2037319|NCT01539642|Sufentanil|sufentanil|mesh-list
2037320|NCT01539642|Dsuvia|dsuvia|mesh-list
2037321|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2037322|NCT01539642|Narcotics|narcotics|mesh-ancestor
2037323|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2037324|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037325|NCT01539642|Analgesics|analgesics|mesh-ancestor
2037326|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
2037327|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037328|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2037329|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2037330|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
2037331|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
2037332|NCT01539837|Deferiprone|deferiprone|mesh-list
2037333|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2037334|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
2037335|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
2037336|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037337|NCT01540474|Vaccines|vaccines|mesh-list
2037338|NCT01540474|Immunologic Factors|immunologic factors|mesh-ancestor
2037339|NCT01540474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037340|NCT01540487|Metformin|metformin|mesh-list
2037341|NCT01540487|Linagliptin|linagliptin|mesh-list
2037342|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2037343|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037344|NCT01540487|Incretins|incretins|mesh-ancestor
2037345|NCT01540487|Hormones|hormones|mesh-ancestor
2037346|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037347|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2037348|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
2037349|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037350|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037351|NCT01540565|Veliparib|veliparib|mesh-list
2037352|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2037353|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037354|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037355|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037356|NCT01540838|Acetaminophen|acetaminophen|mesh-list
2037357|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2037358|NCT01540838|Analgesics|analgesics|mesh-ancestor
2037359|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
2037360|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037361|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037362|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
2037363|NCT01541215|Metformin|metformin|mesh-list
2037364|NCT01541215|Liraglutide|liraglutide|mesh-list
2037365|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2037366|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037367|NCT01541215|Incretins|incretins|mesh-ancestor
2037368|NCT01541215|Hormones|hormones|mesh-ancestor
2037369|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037370|NCT01541358|Listerine|listerine|mesh-list
2037371|NCT01541358|Fluorides|fluorides|mesh-list
2037372|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
2037373|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
2037374|NCT01541358|Protective Agents|protective agents|mesh-ancestor
2037375|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037376|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2037377|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037378|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2037379|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2037380|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2037381|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2037382|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037383|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2037384|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2037385|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2037386|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
2037387|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037388|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037389|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2037390|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2037391|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
2037392|NCT01541735|Pantoprazole|pantoprazole|mesh-list
2037393|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2037394|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2037395|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2037396|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037397|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037398|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2037399|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2037400|NCT01541930|Metronidazole|metronidazole|mesh-list
2037401|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037402|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2037403|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2037404|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2037405|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
2037406|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2037407|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2037408|NCT01542125|Lidocaine|lidocaine|mesh-list
2037409|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
2037410|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
2037411|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2037412|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037413|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
2037414|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037415|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2037416|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2037417|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2037418|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2037419|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037420|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
2037421|NCT01542255|Dacarbazine|dacarbazine|mesh-list
2037422|NCT01542255|Vinblastine|vinblastine|mesh-list
2037423|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2037424|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
2037425|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037426|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037427|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2037428|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
2037429|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037430|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037431|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2037432|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2037433|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
2037434|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
2037435|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
2037436|NCT01542372|Prazosin|prazosin|mesh-list
2037437|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2037438|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2037439|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2037440|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2037441|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
2037442|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037443|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037444|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037445|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2037446|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037447|NCT01542541|Rifaximin|rifaximin|mesh-list
2037448|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2037449|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037450|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2037451|NCT01542645|Fentanyl|fentanyl|mesh-list
2037452|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
2037453|NCT01542645|Methadone|methadone|mesh-list
2037454|NCT01542645|Narcotics|narcotics|mesh-ancestor
2037455|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2037456|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037457|NCT01542645|Analgesics|analgesics|mesh-ancestor
2037458|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
2037459|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037460|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2037461|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2037462|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
2037463|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
2037464|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
2037465|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
2037466|NCT01542684|Azacitidine|azacitidine|mesh-list
2037467|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2037468|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
2037469|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037470|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037471|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037472|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
2037473|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
2037474|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037475|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
2037476|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
2037477|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037478|NCT01543074|Protective Agents|protective agents|mesh-ancestor
2037479|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037480|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2037481|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037482|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2037483|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037484|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
2037485|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2037486|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
2037487|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037488|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037489|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2037490|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
2037491|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037492|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037493|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2037494|NCT01543178|Rifaximin|rifaximin|mesh-list
2037495|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2037496|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037497|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2037498|NCT01543204|Etanercept|etanercept|mesh-list
2037499|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2037500|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2037501|NCT01543204|Analgesics|analgesics|mesh-ancestor
2037502|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
2037503|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037504|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037505|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037506|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037507|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2037508|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2037509|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
2037510|NCT01543568|Aflibercept|aflibercept|mesh-list
2037511|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2037512|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2037513|NCT01543568|Growth Substances|growth substances|mesh-ancestor
2037514|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037515|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
2037516|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037517|NCT01543685|Celecoxib|celecoxib|mesh-list
2037518|NCT01543685|Indomethacin|indomethacin|mesh-list
2037519|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2037520|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2037521|NCT01543685|Analgesics|analgesics|mesh-ancestor
2037522|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
2037523|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037524|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037525|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037526|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037527|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2037528|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2037529|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037530|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037531|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
2037532|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
2037533|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2037534|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
2037535|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037536|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2037537|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037538|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037539|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
2037540|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037541|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037542|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2037543|NCT01543958|Sevelamer|sevelamer|mesh-list
2037544|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
2037545|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
2037546|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037547|NCT01544062|Acetaminophen|acetaminophen|mesh-list
2037548|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2037549|NCT01544062|Analgesics|analgesics|mesh-ancestor
2037550|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
2037551|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037552|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037553|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
2037554|NCT01544114|Naproxen|naproxen|mesh-list
2037555|NCT01544114|Esomeprazole|esomeprazole|mesh-list
2037556|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2037557|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2037558|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2037559|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037560|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037561|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2037562|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2037563|NCT01544114|Analgesics|analgesics|mesh-ancestor
2037564|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
2037565|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037566|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037567|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037568|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037569|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
2037570|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2037571|NCT01544153|Nicotine|nicotine|mesh-list
2037572|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2037573|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
2037574|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037575|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037576|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2037577|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2037578|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
2037579|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037580|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037581|NCT01544179|Pemetrexed|pemetrexed|mesh-list
2037582|NCT01544179|Gefitinib|gefitinib|mesh-list
2037583|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037584|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037585|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037586|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2037587|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2037588|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2037589|NCT01544309|Atorvastatin|atorvastatin|mesh-list
2037590|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2037591|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2037592|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2037593|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
2037594|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037595|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2037596|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2037597|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037598|NCT01544348|Omalizumab|omalizumab|mesh-list
2037599|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2037600|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2037601|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
2037602|NCT01544491|Everolimus|everolimus|mesh-list
2037603|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037604|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2037605|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
2037606|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037607|NCT01544920|Interferons|interferons|mesh-list
2037608|NCT01544920|Ribavirin|ribavirin|mesh-list
2037609|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
2037610|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
2037611|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2037612|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037613|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
2037614|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037615|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
2037616|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037617|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
2037618|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037619|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2037620|NCT01544998|Tadalafil|tadalafil|mesh-list
2037621|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
2037622|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2037623|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2037624|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037625|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037626|NCT01544998|Urological Agents|urological agents|mesh-ancestor
2037627|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
2037628|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037629|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
2037630|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
2037631|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037632|NCT01545141|Interferons|interferons|mesh-list
2037633|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
2037634|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
2037635|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2037636|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2037637|NCT01545141|Poly I-C|poly i-c|mesh-list
2037638|NCT01545141|Celecoxib|celecoxib|mesh-list
2037639|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037640|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
2037641|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037642|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
2037643|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037644|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2037645|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2037646|NCT01545141|Analgesics|analgesics|mesh-ancestor
2037647|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
2037648|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037649|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037650|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037651|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2037652|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2037653|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037654|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037655|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
2037656|NCT01545336|Anastrozole|anastrozole|mesh-list
2037657|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2037658|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037659|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2037660|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2037661|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037662|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037663|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2037664|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
2037665|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037666|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037667|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2037668|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
2037669|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037670|NCT01545388|Metformin|metformin|mesh-list
2037671|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2037672|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2037673|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037674|NCT01545388|Incretins|incretins|mesh-ancestor
2037675|NCT01545388|Hormones|hormones|mesh-ancestor
2037676|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037677|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2037678|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
2037679|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037680|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037681|NCT01545700|Dexamethasone|dexamethasone|mesh-list
2037682|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
2037683|NCT01545700|BB 1101|bb 1101|mesh-list
2037684|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037685|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
2037686|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
2037687|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037688|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037689|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2037690|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
2037691|NCT01545700|Hormones|hormones|mesh-ancestor
2037692|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037693|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2037694|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037695|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
2037696|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037697|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037698|NCT01545765|Lidocaine|lidocaine|mesh-list
2037699|NCT01545765|Tetracaine|tetracaine|mesh-list
2037700|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
2037701|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
2037702|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2037703|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037704|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
2037705|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037706|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2037707|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2037708|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2037709|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2037710|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037711|NCT01545817|Everolimus|everolimus|mesh-list
2037712|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037713|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2037714|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
2037715|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037716|NCT01545843|Fluoxetine|fluoxetine|mesh-list
2037717|NCT01545843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2037718|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2037719|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2037720|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037721|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037722|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
2037723|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037724|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2037725|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
2037726|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2037727|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2037728|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2037729|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037730|NCT01546038|Cytarabine|cytarabine|mesh-list
2037731|NCT01546038|Decitabine|decitabine|mesh-list
2037732|NCT01546038|Daunorubicin|daunorubicin|mesh-list
2037733|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2037734|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
2037735|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037736|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037737|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
2037738|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037739|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2037740|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
2037741|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037742|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2037743|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2037744|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2037745|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037746|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
2037747|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2037748|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2037749|NCT01546402|Dexamethasone|dexamethasone|mesh-list
2037750|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
2037751|NCT01546402|BB 1101|bb 1101|mesh-list
2037752|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037753|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
2037754|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
2037755|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037756|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037757|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2037758|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
2037759|NCT01546402|Hormones|hormones|mesh-ancestor
2037760|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037761|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2037762|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037763|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
2037764|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037765|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037766|NCT01546454|Leuprolide|leuprolide|mesh-list
2037767|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2037768|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2037769|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
2037770|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2037771|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2037772|NCT01546454|Estradiol|estradiol|mesh-list
2037773|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2037774|NCT01546454|Progesterone|progesterone|mesh-list
2037775|NCT01546454|Estrogens|estrogens|mesh-ancestor
2037776|NCT01546454|Hormones|hormones|mesh-ancestor
2037777|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037778|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037779|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2037780|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
2037781|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2037782|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2037783|NCT01546454|Progestins|progestins|mesh-ancestor
2037784|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2037785|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
2037786|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2037787|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037788|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2037789|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2037790|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2037791|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2037792|NCT01546623|Leuprolide|leuprolide|mesh-list
2037793|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2037794|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
2037795|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2037796|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037797|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2037798|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037799|NCT01546649|Leuprolide|leuprolide|mesh-list
2037800|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2037801|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
2037802|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2037803|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037804|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2037805|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037806|NCT01546688|Zonisamide|zonisamide|mesh-list
2037807|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
2037808|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2037809|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2037810|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037811|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2037812|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037813|NCT01546857|Gabapentin|gabapentin|mesh-list
2037814|NCT01546857|Analgesics|analgesics|mesh-ancestor
2037815|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
2037816|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037817|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037818|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
2037819|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2037820|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2037821|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2037822|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2037823|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2037824|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2037825|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037826|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037827|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
2037828|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
2037829|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037830|NCT01547000|Guanfacine|guanfacine|mesh-list
2037831|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2037832|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2037833|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2037834|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2037835|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
2037836|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037837|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037838|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037839|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
2037840|NCT01547286|Miotics|miotics|mesh-ancestor
2037841|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
2037842|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037843|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037844|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2037845|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2037846|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
2037847|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2037848|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2037849|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
2037850|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037851|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037852|NCT01547299|Leuprolide|leuprolide|mesh-list
2037853|NCT01547299|Dutasteride|dutasteride|mesh-list
2037854|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2037855|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
2037856|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2037857|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037858|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2037859|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037860|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2037861|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2037862|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037863|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037864|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
2037865|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037866|NCT01547390|Aspirin|aspirin|mesh-list
2037867|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2037868|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2037869|NCT01547390|Analgesics|analgesics|mesh-ancestor
2037870|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
2037871|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037872|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037873|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037874|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037875|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2037876|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2037877|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037878|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2037879|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2037880|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037881|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
2037882|NCT01547598|Timolol|timolol|mesh-list
2037883|NCT01547598|Bimatoprost|bimatoprost|mesh-list
2037884|NCT01547598|Travoprost|travoprost|mesh-list
2037885|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2037886|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2037887|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2037888|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2037889|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
2037890|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037891|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037892|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037893|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2037894|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2037895|NCT01547806|Plerixafor|plerixafor|mesh-list
2037896|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2037897|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2037898|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
2037899|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037900|NCT01548417|Mifepristone|mifepristone|mesh-list
2037901|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2037902|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
2037903|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2037904|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037905|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2037906|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2037907|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2037908|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
2037909|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2037910|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2037911|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
2037912|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037913|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
2037914|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2037915|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2037916|NCT01548573|Thalidomide|thalidomide|mesh-list
2037917|NCT01548573|Dexamethasone|dexamethasone|mesh-list
2037918|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
2037919|NCT01548573|Melphalan|melphalan|mesh-list
2037920|NCT01548573|Doxorubicin|doxorubicin|mesh-list
2037921|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2037922|NCT01548573|Etoposide|etoposide|mesh-list
2037923|NCT01548573|Bortezomib|bortezomib|mesh-list
2037924|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
2037925|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2037926|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
2037927|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037928|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2037929|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2037930|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
2037931|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037932|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037933|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2037934|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037935|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
2037936|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
2037937|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037938|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2037939|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
2037940|NCT01548573|Hormones|hormones|mesh-ancestor
2037941|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2037942|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2037943|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2037944|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2037945|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2037946|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037947|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2037948|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
2037949|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2037950|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2037951|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2037952|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2037953|NCT01548573|Growth Substances|growth substances|mesh-ancestor
2037954|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
2037955|NCT01548638|Galantamine|galantamine|mesh-list
2037956|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2037957|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2037958|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037959|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
2037960|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2037961|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037962|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2037963|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
2037964|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037965|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
2037966|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
2037967|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2037968|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
2037969|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2037970|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2037971|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
2037972|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
2037973|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2037974|NCT01549002|Fentanyl|fentanyl|mesh-list
2037975|NCT01549002|Morphine|morphine|mesh-list
2037976|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2037977|NCT01549002|Narcotics|narcotics|mesh-ancestor
2037978|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2037979|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037980|NCT01549002|Analgesics|analgesics|mesh-ancestor
2037981|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
2037982|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2037983|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2037984|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2037985|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
2037986|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
2037987|NCT01549041|Asenapine|asenapine|mesh-list
2037988|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2037989|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2037990|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2037991|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2037992|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2037993|NCT01549223|Misoprostol|misoprostol|mesh-list
2037994|NCT01549223|Oxytocin|oxytocin|mesh-list
2037995|NCT01549223|Methylergonovine|methylergonovine|mesh-list
2037996|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
2037997|NCT01549223|Carboprost|carboprost|mesh-list
2037998|NCT01549223|Maleic acid|maleic acid|mesh-list
2037999|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
2038000|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2038001|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038002|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2038003|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
2038004|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2038005|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038006|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038007|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038008|NCT01549587|Listerine|listerine|mesh-list
2038009|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
2038010|NCT01549587|Fluorides|fluorides|mesh-list
2038011|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
2038012|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
2038013|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
2038014|NCT01549587|Protective Agents|protective agents|mesh-ancestor
2038015|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038016|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2038017|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2038018|NCT01549613|Vancomycin|vancomycin|mesh-list
2038019|NCT01549613|Daptomycin|daptomycin|mesh-list
2038020|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2038021|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2038022|NCT01549652|Morphine|morphine|mesh-list
2038023|NCT01549652|Ondansetron|ondansetron|mesh-list
2038024|NCT01549652|Naloxone|naloxone|mesh-list
2038025|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2038026|NCT01549652|Narcotics|narcotics|mesh-ancestor
2038027|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2038028|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038029|NCT01549652|Analgesics|analgesics|mesh-ancestor
2038030|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
2038031|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038032|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
2038033|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
2038034|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038035|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
2038036|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
2038037|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2038038|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
2038039|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038040|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038041|NCT01549652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2038042|NCT01549652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2038043|NCT01549652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2038044|NCT01549652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2038045|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2038046|NCT01549873|Propofol|propofol|mesh-list
2038047|NCT01549873|Desflurane|desflurane|mesh-list
2038048|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2038049|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2038050|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038051|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2038052|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
2038053|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
2038054|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2038055|NCT01549886|Rituximab|rituximab|mesh-list
2038056|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2038057|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038058|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
2038059|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038060|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2038061|NCT01549951|Prednisone|prednisone|mesh-list
2038062|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038063|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
2038064|NCT01549951|Hormones|hormones|mesh-ancestor
2038065|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038066|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038067|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2038068|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038069|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2038070|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2038071|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038072|NCT01549964|Incretins|incretins|mesh-ancestor
2038073|NCT01549964|Hormones|hormones|mesh-ancestor
2038074|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038075|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2038076|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
2038077|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038078|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038079|NCT01550224|Temozolomide|temozolomide|mesh-list
2038080|NCT01550224|Vorinostat|vorinostat|mesh-list
2038081|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2038082|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
2038083|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038084|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038085|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2038086|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038087|NCT01550289|Vaccines|vaccines|mesh-list
2038088|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
2038089|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746260|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746261|NCT05171335|Lenvatinib|lenvatinib|mesh-list
2746262|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079379|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746263|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2746264|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746265|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038097|NCT01550341|Buprenorphine|buprenorphine|mesh-list
2038098|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2038099|NCT01550341|Naloxone|naloxone|mesh-list
2038100|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2038101|NCT01550341|Narcotics|narcotics|mesh-ancestor
2038102|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2038103|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038104|NCT01550341|Analgesics|analgesics|mesh-ancestor
2038105|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
2038106|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038107|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2038108|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
2038109|NCT01550367|Aldesleukin|aldesleukin|mesh-list
2038110|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
2038111|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2038112|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2038113|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2038114|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038115|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038116|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2038117|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038118|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2038119|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2038120|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
2038121|NCT01550471|Ciclesonide|ciclesonide|mesh-list
2038122|NCT01550471|Beclomethasone|beclomethasone|mesh-list
2038123|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038124|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
2038125|NCT01550471|Hormones|hormones|mesh-ancestor
2038126|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038127|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038128|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2038129|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
2038130|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2038131|NCT01550705|Isoniazid|isoniazid|mesh-list
2038132|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
2038133|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2038134|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2038135|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2038136|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2038137|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
2038138|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038139|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2038140|NCT01550744|Ustekinumab|ustekinumab|mesh-list
2038141|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
2038142|NCT01550965|Adalimumab|adalimumab|mesh-list
2038143|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038144|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2038145|NCT01551056|Cetirizine|cetirizine|mesh-list
2038146|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2038147|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2038148|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2038149|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
2038150|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
2038151|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038152|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038153|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038154|NCT01551212|Everolimus|everolimus|mesh-list
2038155|NCT01551212|Tacrolimus|tacrolimus|mesh-list
2038156|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2038157|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
2038158|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038159|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2038160|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038161|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038162|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038163|NCT01551303|Oxytocin|oxytocin|mesh-list
2038164|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
2038165|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2038166|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038167|NCT01551745|Bevacizumab|bevacizumab|mesh-list
2038168|NCT01551745|Vaccines|vaccines|mesh-list
2038169|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
2038170|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038171|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2038172|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038173|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2038174|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2038175|NCT01551745|Growth Substances|growth substances|mesh-ancestor
2038176|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
2038177|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
2038178|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2038179|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
2038180|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038181|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038182|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2038183|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
2038184|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2038185|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2038186|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2038187|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
2038188|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038189|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038190|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2038191|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2038192|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2038193|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2038194|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038195|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038196|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038197|NCT01552057|Analgesics|analgesics|mesh-ancestor
2038198|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
2038199|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038200|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
2038201|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2038202|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
2038203|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2038204|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
2038205|NCT01552343|Coagulants|coagulants|mesh-ancestor
2038206|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2038207|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
2038208|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038209|NCT01552369|Valganciclovir|valganciclovir|mesh-list
2038210|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
2038211|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2038212|NCT01552408|Ranibizumab|ranibizumab|mesh-list
2038213|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2038214|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2038215|NCT01552408|Growth Substances|growth substances|mesh-ancestor
2038216|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038217|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
2038218|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038219|NCT01552603|Pancrelipase|pancrelipase|mesh-list
2038220|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038221|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
2038222|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
2038223|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038224|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2038225|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2038226|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038227|NCT01552694|Incretins|incretins|mesh-ancestor
2038228|NCT01552694|Hormones|hormones|mesh-ancestor
2038229|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038230|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2038231|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
2038232|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038233|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038234|NCT01552772|Aripiprazole|aripiprazole|mesh-list
2038235|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
2038236|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2038237|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2038238|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2038239|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2038240|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038241|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
2038242|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
2038243|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475601|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038244|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038245|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2038246|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2038247|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
2038248|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2038249|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2038250|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2038251|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2038252|NCT01552902|Methylphenidate|methylphenidate|mesh-list
2038253|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2038254|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2038255|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038256|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2038257|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2038258|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2038259|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038260|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
2038261|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038262|NCT01552915|Methylphenidate|methylphenidate|mesh-list
2038263|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2038264|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2038265|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038266|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2038267|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2038268|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2038269|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038270|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
2038271|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038272|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
2038273|NCT01552928|Anagrelide|anagrelide|mesh-list
2038274|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2038275|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2038276|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2038277|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2038278|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038279|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038280|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038281|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2038282|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2038283|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2038284|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
2038285|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2038286|NCT01553058|Adalimumab|adalimumab|mesh-list
2038287|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038288|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2038289|NCT01553084|Nicotine|nicotine|mesh-list
2038290|NCT01553084|Varenicline|varenicline|mesh-list
2038291|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2038292|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
2038293|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038294|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038295|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2038296|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2038297|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
2038298|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038299|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038300|NCT01553136|Varenicline|varenicline|mesh-list
2038301|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2038302|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2038303|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
2038304|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038305|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038306|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038307|NCT01553149|Lenalidomide|lenalidomide|mesh-list
2038308|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
2038309|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038310|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2038311|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2038312|NCT01553149|Growth Substances|growth substances|mesh-ancestor
2038313|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
2038314|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038315|NCT01553188|Prednisone|prednisone|mesh-list
2038316|NCT01553188|Trebananib|trebananib|mesh-list
2475602|NCT01085097|Mycophenolic Acid|mycophenolic acid|mesh-list
2038317|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038318|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
2038319|NCT01553188|Hormones|hormones|mesh-ancestor
2038320|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038321|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038322|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2038323|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038324|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2038325|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2038326|NCT01553188|Growth Substances|growth substances|mesh-ancestor
2038327|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
2038328|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
2038329|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2038330|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2038331|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038332|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
2038333|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038334|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038335|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2038336|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
2038337|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038338|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2038339|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
2038340|NCT01553318|Ketotifen|ketotifen|mesh-list
2038341|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
2038342|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
2038343|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2038344|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
2038345|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
2038346|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038347|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038348|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038349|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2038350|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2038351|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2038352|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
2038353|NCT01553591|Eluxadoline|eluxadoline|mesh-list
2038354|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038355|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
2038356|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2038357|NCT01553708|Mitogens|mitogens|mesh-list
2038358|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
2038359|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038360|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2038361|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2038362|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2038363|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2038364|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
2038365|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2038366|NCT01553747|Eluxadoline|eluxadoline|mesh-list
2038367|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038368|NCT01553851|Trametinib|trametinib|mesh-list
2038369|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038370|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2038371|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038372|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038373|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
2038374|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
2038375|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2038376|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038377|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038378|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
2038379|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2038380|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2038381|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038382|NCT01554163|Celecoxib|celecoxib|mesh-list
2038383|NCT01554163|Etoricoxib|etoricoxib|mesh-list
2038384|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2038385|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2038386|NCT01554163|Analgesics|analgesics|mesh-ancestor
2038387|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
2038388|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038389|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038390|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038391|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2038392|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2038393|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2038394|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038395|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038396|NCT01554241|Vitamin D|vitamin d|mesh-list
2038397|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
2038398|NCT01554241|Vitamins|vitamins|mesh-ancestor
2038399|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
2038400|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038401|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2038402|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2038403|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
2038404|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2038405|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
2038406|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038407|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2038408|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2038409|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
2038410|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038411|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038412|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2038413|NCT01554488|Fluticasone|fluticasone|mesh-list
2038414|NCT01554488|Xhance|xhance|mesh-list
2038415|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038416|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2038417|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
2038418|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038419|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038420|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2038421|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
2038422|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
2038423|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2038424|NCT01554514|Rituximab|rituximab|mesh-list
2038425|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2038426|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038427|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
2038428|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038429|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2038430|NCT01554618|Exenatide|exenatide|mesh-list
2038431|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2038432|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038433|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2038434|NCT01554618|Incretins|incretins|mesh-ancestor
2038435|NCT01554618|Hormones|hormones|mesh-ancestor
2038436|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038437|NCT01554683|Levetiracetam|levetiracetam|mesh-list
2038438|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
2038439|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
2038440|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2038441|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
2038442|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038443|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2038444|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2038445|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
2038446|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038447|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038448|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2038449|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
2038450|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2038451|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2038452|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2038453|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
2038454|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038455|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038456|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
2038457|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038458|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
2038459|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2038460|NCT01555164|Metformin|metformin|mesh-list
2038461|NCT01555164|Ranolazine|ranolazine|mesh-list
2038462|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2038463|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038464|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2038465|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2038466|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038467|NCT01555463|Azelaic acid|azelaic acid|mesh-list
2038468|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038469|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
2038470|NCT01555541|Cytarabine|cytarabine|mesh-list
2038471|NCT01555541|Etoposide|etoposide|mesh-list
2038472|NCT01555541|Ofatumumab|ofatumumab|mesh-list
2038473|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2038474|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038475|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2038476|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2038477|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038478|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038479|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2038480|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
2038481|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
2038482|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2038483|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2038484|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
2038485|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038486|NCT01555671|Meperidine|meperidine|mesh-list
2038487|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2038488|NCT01555671|Narcotics|narcotics|mesh-ancestor
2038489|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2038490|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038491|NCT01555671|Analgesics|analgesics|mesh-ancestor
2038492|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
2038493|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038494|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2038495|NCT01555697|Memantine|memantine|mesh-list
2038496|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2038497|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2038498|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
2038499|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038500|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038501|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038502|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2038503|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2038504|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
2038505|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2038506|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
2038507|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2038508|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038509|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2038510|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2038511|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2038512|NCT01556165|Rasagiline|rasagiline|mesh-list
2038513|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2038514|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038515|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038516|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2038517|NCT01556165|Protective Agents|protective agents|mesh-ancestor
2038518|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038519|NCT01556347|Rituximab|rituximab|mesh-list
2038520|NCT01556347|Bortezomib|bortezomib|mesh-list
2038521|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
2038522|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2038523|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2038524|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2038525|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038526|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
2038527|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038528|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2038529|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2038530|NCT01556425|Naltrexone|naltrexone|mesh-list
2038531|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2038532|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2038533|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038534|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
2038535|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038536|NCT01556438|Dexamethasone|dexamethasone|mesh-list
2038537|NCT01556438|Bortezomib|bortezomib|mesh-list
2038538|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038539|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
2038540|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
2038541|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038542|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038543|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038544|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
2038545|NCT01556438|Hormones|hormones|mesh-ancestor
2038546|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038547|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2038548|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038549|NCT01556594|Glucagon|glucagon|mesh-list
2038550|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2038551|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038552|NCT01556594|Hormones|hormones|mesh-ancestor
2038553|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038554|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038555|NCT01556594|Incretins|incretins|mesh-ancestor
2038556|NCT01556633|Oseltamivir|oseltamivir|mesh-list
2038557|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
2038558|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2038559|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038560|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038561|NCT01556724|Ropivacaine|ropivacaine|mesh-list
2038562|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
2038563|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
2038564|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2038565|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038566|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
2038567|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038568|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
2038569|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2038570|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2038571|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038572|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2038573|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
2038574|NCT01556932|Promethazine|promethazine|mesh-list
2038575|NCT01556932|Lorazepam|lorazepam|mesh-list
2038576|NCT01556932|Haloperidol|haloperidol|mesh-list
2038577|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2038578|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2038579|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2038580|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038581|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
2038582|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
2038583|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
2038584|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038585|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
2038586|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
2038587|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038588|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2038589|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
2038590|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
2038591|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038592|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038593|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2038594|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
2038595|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
2038596|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2038597|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2038598|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2038599|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2038600|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
2038601|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2038602|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
2038603|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2038604|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
2038605|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
2038606|NCT01556997|Amlodipine|amlodipine|mesh-list
2038607|NCT01556997|Perindopril|perindopril|mesh-list
2038608|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2038609|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2038610|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2038611|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038612|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2038613|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038614|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
2038615|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2038616|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
2038617|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038618|NCT01557166|Liraglutide|liraglutide|mesh-list
2038619|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2475603|NCT01085097|Prednisone|prednisone|mesh-list
2038620|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038621|NCT01557166|Incretins|incretins|mesh-ancestor
2038622|NCT01557166|Hormones|hormones|mesh-ancestor
2038623|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038624|NCT01557244|Fesoterodine|fesoterodine|mesh-list
2038625|NCT01557244|Oxybutynin|oxybutynin|mesh-list
2038626|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2038627|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2038628|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
2038629|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038630|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038631|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038632|NCT01557244|Urological Agents|urological agents|mesh-ancestor
2038633|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
2038634|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
2038635|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038636|NCT01557283|Etanercept|etanercept|mesh-list
2038637|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2038638|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2038639|NCT01557283|Analgesics|analgesics|mesh-ancestor
2038640|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
2038641|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038642|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038643|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038644|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2038645|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038646|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2038647|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
2038648|NCT01557322|Etanercept|etanercept|mesh-list
2038649|NCT01557322|Methotrexate|methotrexate|mesh-list
2038650|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2038651|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
2038652|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2038653|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038654|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2038655|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
2038656|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038657|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038658|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
2038659|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038660|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2038661|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2038662|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
2038663|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2038664|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2038665|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2038666|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2038667|NCT01557322|Analgesics|analgesics|mesh-ancestor
2038668|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
2038669|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038670|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038671|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038672|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
2038673|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2038674|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038675|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038676|NCT01557504|Metformin|metformin|mesh-list
2038677|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2038678|NCT01557504|Hormones|hormones|mesh-list
2038679|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2038680|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038681|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038682|NCT01557504|Incretins|incretins|mesh-ancestor
2038683|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2038684|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
2038685|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038686|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038687|NCT01557517|Clobetasol|clobetasol|mesh-list
2038688|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038689|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
2038690|NCT01557517|Hormones|hormones|mesh-ancestor
2038691|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038692|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038693|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2038694|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2038695|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2038696|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2038697|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038698|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
2038699|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038700|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038701|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
2038702|NCT01557868|Hylan|hylan|mesh-list
2038703|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2038704|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
2038705|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038706|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
2038707|NCT01557868|Protective Agents|protective agents|mesh-ancestor
2038708|NCT01557920|Propofol|propofol|mesh-list
2038709|NCT01557920|Sevoflurane|sevoflurane|mesh-list
2038710|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2038711|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2038712|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038713|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2038714|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
2038715|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
2038716|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2038717|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2038718|NCT01557946|Citalopram|citalopram|mesh-list
2038719|NCT01557946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2038720|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2038721|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2038722|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038723|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038724|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
2038725|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038726|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2038727|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
2038728|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2038729|NCT01557959|Docetaxel|docetaxel|mesh-list
2038730|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2038731|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038732|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
2038733|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
2038734|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
2038735|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038736|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2038737|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038738|NCT01558063|Ketamine|ketamine|mesh-list
2038739|NCT01558063|Analgesics|analgesics|mesh-ancestor
2038740|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
2038741|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038742|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038743|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2038744|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2038745|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
2038746|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
2038747|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2038748|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2038749|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2038750|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038751|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038752|NCT01558089|Etanercept|etanercept|mesh-list
2038753|NCT01558089|Methotrexate|methotrexate|mesh-list
2038754|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2038755|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
2038756|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2038757|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038758|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2038759|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
2038760|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038761|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038762|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
2038763|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038764|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2038765|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2038766|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
2038767|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2038768|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2038769|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2038770|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2038771|NCT01558089|Analgesics|analgesics|mesh-ancestor
2038772|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
2038773|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038774|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038775|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038776|NCT01558128|Amiodarone|amiodarone|mesh-list
2038777|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2038778|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
2038779|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2038780|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2038781|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038782|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2038783|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2038784|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2038785|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038786|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2038787|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2038788|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2038789|NCT01558271|Liraglutide|liraglutide|mesh-list
2038790|NCT01558271|Dulaglutide|dulaglutide|mesh-list
2038791|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2038792|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038793|NCT01558271|Incretins|incretins|mesh-ancestor
2038794|NCT01558271|Hormones|hormones|mesh-ancestor
2038795|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038796|NCT01558661|Axitinib|axitinib|mesh-list
2038797|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038798|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2038799|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038800|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038801|NCT01558674|Torsemide|torsemide|mesh-list
2038802|NCT01558674|Furosemide|furosemide|mesh-list
2038803|NCT01558674|Diuretics|diuretics|mesh-ancestor
2038804|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
2038805|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038806|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2038807|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2038808|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038809|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2038810|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2038811|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2038812|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2038813|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2038814|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038815|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038816|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038817|NCT01558700|Analgesics|analgesics|mesh-ancestor
2038818|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
2038819|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038820|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
2038821|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2038822|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
2038823|NCT01559012|Clonidine|clonidine|mesh-list
2038824|NCT01559012|Analgesics|analgesics|mesh-ancestor
2038825|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
2038826|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038827|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038828|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2038829|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
2038830|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
2038831|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2038832|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2038833|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2038834|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
2038835|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038836|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038837|NCT01559064|Lidocaine|lidocaine|mesh-list
2038838|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
2038839|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
2038840|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
2038841|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2038842|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038843|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
2038844|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038845|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2038846|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2038847|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2038848|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2038849|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038850|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2038851|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
2038852|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
2038853|NCT01559064|Protective Agents|protective agents|mesh-ancestor
2038854|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2038855|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
2038856|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038857|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
2038858|NCT01559116|Olodaterol|olodaterol|mesh-list
2038859|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2038860|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
2038861|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038862|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038863|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2038864|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
2038865|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
2038866|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2038867|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
2038868|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038869|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038870|NCT01559129|Pomalidomide|pomalidomide|mesh-list
2038871|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
2038872|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038873|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2038874|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2038875|NCT01559129|Growth Substances|growth substances|mesh-ancestor
2038876|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
2038877|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038878|NCT01559259|Acetaminophen|acetaminophen|mesh-list
2038879|NCT01559259|Ibuprofen|ibuprofen|mesh-list
2038880|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2038881|NCT01559259|Analgesics|analgesics|mesh-ancestor
2038882|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
2038883|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038884|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038885|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
2038886|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2038887|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038888|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2038889|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2038890|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038891|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038892|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
2038893|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2038894|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2038895|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
2038896|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2038897|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038898|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038899|NCT01559389|Urological Agents|urological agents|mesh-ancestor
2038900|NCT01559454|Buprenorphine|buprenorphine|mesh-list
2038901|NCT01559454|Methadone|methadone|mesh-list
2038902|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2038903|NCT01559454|Naloxone|naloxone|mesh-list
2038904|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2038905|NCT01559454|Narcotics|narcotics|mesh-ancestor
2038906|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2038907|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038908|NCT01559454|Analgesics|analgesics|mesh-ancestor
2038909|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
2038910|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038911|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2038912|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
2038913|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
2038914|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
2475604|NCT01085097|Prednisolone|prednisolone|mesh-list
2038915|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2038916|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2038917|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2038918|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2038919|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2038920|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
2038921|NCT01559675|Prednisolone|prednisolone|mesh-list
2038922|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
2038923|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2038924|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
2038925|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038926|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
2038927|NCT01559675|Hormones|hormones|mesh-ancestor
2038928|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038929|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038930|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2038931|NCT01559675|Protective Agents|protective agents|mesh-ancestor
2038932|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2038933|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038934|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
2038935|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
2038936|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038937|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038938|NCT01559844|Ribavirin|ribavirin|mesh-list
2038939|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
2038940|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
2038941|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038942|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
2038943|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2038944|NCT01559857|Pioglitazone|pioglitazone|mesh-list
2038945|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2038946|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038947|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2038948|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
2038949|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2038950|NCT01559922|Protective Agents|protective agents|mesh-ancestor
2038951|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038952|NCT01559935|Clarithromycin|clarithromycin|mesh-list
2038953|NCT01559935|Dexamethasone|dexamethasone|mesh-list
2038954|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
2038955|NCT01559935|Lenalidomide|lenalidomide|mesh-list
2038956|NCT01559935|BB 1101|bb 1101|mesh-list
2038957|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2038958|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
2038959|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
2038960|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2038961|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038962|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038963|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
2038964|NCT01559935|Hormones|hormones|mesh-ancestor
2038965|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038966|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2038967|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038968|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
2038969|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038970|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038971|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
2038972|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2038973|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2038974|NCT01559935|Growth Substances|growth substances|mesh-ancestor
2038975|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
2038976|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2038977|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2038978|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2038979|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2038980|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2038981|NCT01560143|Tigecycline|tigecycline|mesh-list
2038982|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2038983|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2038984|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2038985|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2038986|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2038987|NCT01560403|Teduglutide|teduglutide|mesh-list
2038988|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2038989|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2038990|NCT01560403|Protective Agents|protective agents|mesh-ancestor
2038991|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2038992|NCT01560416|Fulvestrant|fulvestrant|mesh-list
2038993|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2038994|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2038995|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2038996|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2038997|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
2038998|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2038999|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039000|NCT01560624|Treprostinil|treprostinil|mesh-list
2039001|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2039002|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2039003|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2039004|NCT01560923|Tryptophan|tryptophan|mesh-list
2039005|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2039006|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
2039007|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2039008|NCT01560949|Gemcitabine|gemcitabine|mesh-list
2039009|NCT01560949|Fluorouracil|fluorouracil|mesh-list
2039010|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
2039011|NCT01560949|Irinotecan|irinotecan|mesh-list
2039012|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2039013|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
2039014|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039015|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039016|NCT01560949|Antiviral Agents|antiviral agents|mesh-ancestor
2039017|NCT01560949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039018|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039019|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2039020|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
2039021|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039022|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2039023|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2039024|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
2039025|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2039026|NCT01561053|Antibodies|antibodies|mesh-list
2039027|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
2039028|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039029|NCT01561079|Buprenorphine|buprenorphine|mesh-list
2039030|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2039031|NCT01561079|Narcotics|narcotics|mesh-ancestor
2039032|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2039033|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039034|NCT01561079|Analgesics|analgesics|mesh-ancestor
2039035|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
2039036|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039037|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2039038|NCT01561313|Adalimumab|adalimumab|mesh-list
2039039|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2039040|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2039041|NCT01561469|Vancomycin|vancomycin|mesh-list
2039042|NCT01561469|Linezolid|linezolid|mesh-list
2039043|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2039044|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039045|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2039046|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039047|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039048|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2039049|NCT01561703|Amoxicillin|amoxicillin|mesh-list
2039050|NCT01561703|Azithromycin|azithromycin|mesh-list
2039051|NCT01561703|Clindamycin|clindamycin|mesh-list
2039052|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
2039053|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2039054|NCT01561703|Cephalexin|cephalexin|mesh-list
2039055|NCT01561703|Cefdinir|cefdinir|mesh-list
2039056|NCT01561703|Cefaclor|cefaclor|mesh-list
2039057|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039058|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2039059|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039060|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039061|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2039062|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
2039063|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2039064|NCT01561755|Antibodies|antibodies|mesh-list
2039065|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
2039066|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2039067|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
2039068|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039069|NCT01561833|Sorafenib|sorafenib|mesh-list
2039070|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039071|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2039072|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039073|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039074|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2039075|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2039076|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2039077|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2039078|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039079|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2039080|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2039081|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2039082|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
2039083|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039084|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039085|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2039086|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2039087|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
2039088|NCT01561963|Rifampin|rifampin|mesh-list
2039089|NCT01561963|Apremilast|apremilast|mesh-list
2039090|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2039091|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
2039092|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2039093|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039094|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
2039095|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2039096|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039097|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039098|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2039099|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2039100|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2039101|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2039102|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2039103|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2039104|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2039105|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2039106|NCT01561963|Analgesics|analgesics|mesh-ancestor
2039107|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
2039108|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039109|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039110|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2039111|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2039112|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2039113|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2039114|NCT01561976|Metformin|metformin|mesh-list
2039115|NCT01561976|Glimepiride|glimepiride|mesh-list
2039116|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2039117|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039118|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2039119|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2039120|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
2039121|NCT01562028|Bevacizumab|bevacizumab|mesh-list
2039122|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2039123|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2039124|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039125|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2039126|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2039127|NCT01562028|Growth Substances|growth substances|mesh-ancestor
2039128|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039129|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
2039130|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2039131|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039132|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039133|NCT01562041|Ranolazine|ranolazine|mesh-list
2039134|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2039135|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2039136|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039137|NCT01562132|Fluconazole|fluconazole|mesh-list
2039138|NCT01562132|Flucytosine|flucytosine|mesh-list
2039139|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
2039140|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039141|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2039142|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2039143|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039144|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039145|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2039146|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
2039147|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2039148|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039149|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2039150|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2039151|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
2039152|NCT01562314|Cannabidiol|cannabidiol|mesh-list
2039153|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
2039154|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
2039155|NCT01562548|Guaifenesin|guaifenesin|mesh-list
2039156|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2039157|NCT01562548|Expectorants|expectorants|mesh-ancestor
2039158|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
2039159|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2039160|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2039161|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
2039162|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039163|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039164|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039165|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
2039166|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2039167|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
2039168|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
2039169|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039170|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
2039171|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2039172|NCT01562678|Liraglutide|liraglutide|mesh-list
2039173|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2039174|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039175|NCT01562678|Incretins|incretins|mesh-ancestor
2039176|NCT01562678|Hormones|hormones|mesh-ancestor
2039177|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2039178|NCT01562743|Rotigotine|rotigotine|mesh-list
2039179|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
2039180|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
2039181|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039182|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039183|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039184|NCT01562886|Rilpivirine|rilpivirine|mesh-list
2039185|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2039186|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2039187|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039188|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039189|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
2039190|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039191|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2039192|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2039193|NCT01563029|Fluticasone|fluticasone|mesh-list
2039194|NCT01563029|Xhance|xhance|mesh-list
2039195|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2039196|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2039197|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
2039198|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039199|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039200|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2039201|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
2039202|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
2039203|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2039204|NCT01563055|Ofatumumab|ofatumumab|mesh-list
2039205|NCT01563055|Chlorambucil|chlorambucil|mesh-list
2039206|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039207|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2039208|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
2039209|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039210|NCT01563081|Cetirizine|cetirizine|mesh-list
2039211|NCT01563081|Levocetirizine|levocetirizine|mesh-list
2039212|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2039213|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2039214|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
2039215|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
2039216|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039217|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039218|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039219|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2039220|NCT01563172|Listerine|listerine|mesh-list
2039221|NCT01563172|Fluorides|fluorides|mesh-list
2039222|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
2039223|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
2039224|NCT01563172|Protective Agents|protective agents|mesh-ancestor
2039225|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039226|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2039227|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039228|NCT01563185|Ibuprofen|ibuprofen|mesh-list
2039229|NCT01563185|Famotidine|famotidine|mesh-list
2039230|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2039231|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2039232|NCT01563185|Analgesics|analgesics|mesh-ancestor
2039233|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
2039234|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039235|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039236|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2039237|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2039238|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2039239|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039240|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039241|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2039242|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2039243|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2039244|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
2039245|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
2039246|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039247|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2039248|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2039249|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039250|NCT01563354|Everolimus|everolimus|mesh-list
2039251|NCT01563354|Pasireotide|pasireotide|mesh-list
2039252|NCT01563354|Somatostatin|somatostatin|mesh-list
2039253|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039254|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2039255|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
2039256|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039257|NCT01563354|Hormones|hormones|mesh-ancestor
2039258|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2039259|NCT01563406|Ethanol|ethanol|mesh-list
2039260|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
2039261|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2039262|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039263|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2039264|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039265|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
2039266|NCT01563536|Ritonavir|ritonavir|mesh-list
2039267|NCT01563536|Ribavirin|ribavirin|mesh-list
2039268|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2039269|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2039270|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
2039271|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039272|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039273|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2039274|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2039275|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
2039276|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039277|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2039278|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2039279|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
2039280|NCT01564277|Allopurinol|allopurinol|mesh-list
2039281|NCT01564277|Rasburicase|rasburicase|mesh-list
2039282|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
2039283|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039284|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039285|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
2039286|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2039287|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2039288|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
2039289|NCT01564277|Protective Agents|protective agents|mesh-ancestor
2039290|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746266|NCT05171309|Apatinib|apatinib|mesh-list
2746267|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746268|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2746269|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746270|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746271|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2746272|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2746273|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2746274|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
2746275|NCT05171231|Hemostatics|hemostatics|mesh-list
2746276|NCT05171231|Coagulants|coagulants|mesh-ancestor
2746277|NCT05171179|Lidocaine|lidocaine|mesh-list
2746278|NCT05171179|Bupivacaine|bupivacaine|mesh-list
2746279|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
2746280|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
2746281|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2746282|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746283|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
2746284|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2746285|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2746286|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2746287|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2039313|NCT01564758|Linezolid|linezolid|mesh-list
2039314|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2039315|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039316|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2039317|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039318|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039319|NCT01564784|Cytarabine|cytarabine|mesh-list
2039320|NCT01564784|Fludarabine|fludarabine|mesh-list
2039321|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
2039322|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2039323|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039324|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2039325|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
2039326|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039327|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2039328|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
2039329|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039330|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
2039331|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039332|NCT01564784|Analgesics|analgesics|mesh-ancestor
2039333|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
2039334|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039335|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2039336|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2039337|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039338|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2039339|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2039340|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2039341|NCT01564862|Vortioxetine|vortioxetine|mesh-list
2039342|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2039343|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2039344|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2039345|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039346|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039347|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039348|NCT01564862|Analgesics|analgesics|mesh-ancestor
2039349|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
2039350|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039351|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
2039352|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2039353|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
2039354|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2039355|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2039356|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2039357|NCT01564862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2039358|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
2039359|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2039360|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2039361|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2039362|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2039363|NCT01564914|Bevacizumab|bevacizumab|mesh-list
2039364|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2039365|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039366|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2039367|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2039368|NCT01564914|Growth Substances|growth substances|mesh-ancestor
2039369|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039370|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
2039371|NCT01565083|Trastuzumab|trastuzumab|mesh-list
2039372|NCT01565083|Pertuzumab|pertuzumab|mesh-list
2039373|NCT01565083|Vinorelbine|vinorelbine|mesh-list
2039374|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2039375|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039376|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2039377|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
2039378|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
2039379|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
2039380|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039381|NCT01565148|Ranibizumab|ranibizumab|mesh-list
2039382|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2039383|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2039384|NCT01565148|Growth Substances|growth substances|mesh-ancestor
2039385|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039386|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
2039387|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039388|NCT01565499|Paclitaxel|paclitaxel|mesh-list
2039389|NCT01565499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2039390|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2039391|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039392|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
2039393|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
2039394|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
2039395|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039396|NCT01565538|Pemetrexed|pemetrexed|mesh-list
2039397|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2039398|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039399|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039400|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039401|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2039402|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2039403|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2039404|NCT01565616|Fludarabine|fludarabine|mesh-list
2039405|NCT01565616|Busulfan|busulfan|mesh-list
2039406|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
2039407|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2039408|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039409|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039410|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2039411|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
2039412|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039413|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
2039414|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2039415|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2039416|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
2039417|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2039418|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2039419|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
2039420|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039421|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039422|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039423|NCT01565694|Urological Agents|urological agents|mesh-ancestor
2039424|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
2039425|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2039426|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2039427|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
2039428|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039429|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039430|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039431|NCT01565707|Urological Agents|urological agents|mesh-ancestor
2039432|NCT01565850|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2039433|NCT01565850|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2039434|NCT01565850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2039435|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039436|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039437|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
2039438|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039439|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2039440|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2039441|NCT01565889|Ritonavir|ritonavir|mesh-list
2039442|NCT01565889|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2039443|NCT01565889|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2039444|NCT01565889|Ribavirin|ribavirin|mesh-list
2039445|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2039446|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2039447|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
2039448|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039449|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039450|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2039451|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2039452|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
2039453|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039454|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2039455|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2039456|NCT01565889|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2039457|NCT01565889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2039458|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
2039459|NCT01565902|Siponimod|siponimod|mesh-list
2039460|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2039461|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039462|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2039463|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
2039464|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039465|NCT01565941|Insulin|insulin|mesh-list
2039466|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2039467|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2039468|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039469|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
2039470|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
2039471|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
2039472|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2039473|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
2039474|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039475|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039476|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2039477|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
2039478|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2039479|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2039480|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2039481|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
2039482|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039483|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039484|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2039485|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
2039486|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2039487|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2039488|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2039489|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2039490|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2039491|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039492|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2039493|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2039494|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2039495|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2039496|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
2039497|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039498|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039499|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2039500|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2039501|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
2039502|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2039503|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2039504|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
2039505|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2039506|NCT01566409|Laxatives|laxatives|mesh-ancestor
2039507|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2039508|NCT01566435|Paclitaxel|paclitaxel|mesh-list
2039509|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2039510|NCT01566435|Fluorouracil|fluorouracil|mesh-list
2039511|NCT01566435|Cetuximab|cetuximab|mesh-list
2039512|NCT01566435|Antibodies|antibodies|mesh-list
2039513|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2039514|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2039515|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039516|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
2039517|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
2039518|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
2039519|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039520|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
2039521|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039522|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
2039523|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2039524|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2039525|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2039526|NCT01566448|Ketamine|ketamine|mesh-list
2039527|NCT01566448|Analgesics|analgesics|mesh-ancestor
2039528|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
2039529|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039530|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039531|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2039532|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2039533|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
2039534|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
2039535|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2039536|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2039537|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2039538|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039539|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039540|NCT01566526|Dexamethasone|dexamethasone|mesh-list
2039541|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2039542|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
2039543|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
2039544|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039545|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039546|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2039547|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
2039548|NCT01566526|Hormones|hormones|mesh-ancestor
2039549|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2039550|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2039551|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039552|NCT01566539|Vasopressins|vasopressins|mesh-list
2039553|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
2039554|NCT01566539|Lorazepam|lorazepam|mesh-list
2039555|NCT01566539|Oxytocin|oxytocin|mesh-list
2039556|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
2039557|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2039558|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039559|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
2039560|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
2039561|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
2039562|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039563|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2039564|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2039565|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2039566|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2039567|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2039568|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2039569|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
2039570|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
2039571|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039572|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039573|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
2039574|NCT01566539|Coagulants|coagulants|mesh-ancestor
2039575|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2039576|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2039577|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
2039578|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
2039579|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2039580|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2039581|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2039582|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
2039583|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039584|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039585|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039592|NCT01566721|Trastuzumab|trastuzumab|mesh-list
2039593|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2039594|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039595|NCT01566773|Bromides|bromides|mesh-list
2039596|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
2039597|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2039598|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
2039599|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039600|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039601|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2039602|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
2039603|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
2039604|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2039605|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
2039606|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039607|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039608|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
2039609|NCT01566838|Bupivacaine|bupivacaine|mesh-list
2039610|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
2039611|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
2039612|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2039613|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039614|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
2039615|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039616|NCT01567085|Eculizumab|eculizumab|mesh-list
2039617|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2039618|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2039619|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
2039620|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039621|NCT01567163|Docetaxel|docetaxel|mesh-list
2039622|NCT01567163|Ramucirumab|ramucirumab|mesh-list
2039623|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039624|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
2039625|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
2039626|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
2039627|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039628|NCT01567527|Aripiprazole|aripiprazole|mesh-list
2039629|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
2039630|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2039631|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2039632|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2039633|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2039634|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039635|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
2039636|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
2039637|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039638|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039639|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2039640|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2039641|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
2039642|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2039643|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2039644|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2039645|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2039646|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2039647|NCT01567826|Atorvastatin|atorvastatin|mesh-list
2039648|NCT01567826|Simvastatin|simvastatin|mesh-list
2039649|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2039650|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2039651|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
2039652|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039653|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2039654|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2039655|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039656|NCT01567852|Ketamine|ketamine|mesh-list
2039657|NCT01567852|Methohexital|methohexital|mesh-list
2039658|NCT01567852|Analgesics|analgesics|mesh-ancestor
2039659|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
2039660|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039661|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039662|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2039663|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2039664|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
2039665|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
2039666|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2039667|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2039668|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2039669|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039670|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039671|NCT01567865|Vaccines|vaccines|mesh-list
2039672|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
2039673|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039674|NCT01568008|Bimatoprost|bimatoprost|mesh-list
2039675|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2039676|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2039677|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2039678|NCT01568034|Levodopa|levodopa|mesh-list
2039679|NCT01568034|Carbidopa|carbidopa|mesh-list
2039680|NCT01568034|Opicapone|opicapone|mesh-list
2039681|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2039682|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2039683|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
2039684|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039685|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039686|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039687|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2039688|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039689|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2039690|NCT01568047|Levodopa|levodopa|mesh-list
2039691|NCT01568047|Carbidopa|carbidopa|mesh-list
2039692|NCT01568047|Opicapone|opicapone|mesh-list
2039693|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2039694|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2039695|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
2039696|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039697|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039698|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039699|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2039700|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039701|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2039702|NCT01568073|Levodopa|levodopa|mesh-list
2039703|NCT01568073|Carbidopa|carbidopa|mesh-list
2039704|NCT01568073|Opicapone|opicapone|mesh-list
2039705|NCT01568073|Entacapone|entacapone|mesh-list
2039706|NCT01568073|Benserazide|benserazide|mesh-list
2039707|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2039708|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2039709|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
2039710|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039711|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039712|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039713|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2039714|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039715|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2039716|NCT01568112|Aspirin|aspirin|mesh-list
2039717|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2039718|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2039719|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2039720|NCT01568112|Analgesics|analgesics|mesh-ancestor
2039721|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
2039722|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039723|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039724|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2039725|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2039726|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2039727|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2039728|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039729|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2039730|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2039731|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039732|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
2039733|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
2039734|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2039735|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
2039736|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
2039737|NCT01568255|Vitamin D|vitamin d|mesh-list
2039738|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2039739|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039740|NCT01568255|Vitamins|vitamins|mesh-ancestor
2039741|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
2039742|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2039743|NCT01568528|Oxytocin|oxytocin|mesh-list
2039744|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
2039745|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2039746|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039747|NCT01568866|Dexamethasone|dexamethasone|mesh-list
2039748|NCT01568866|Bortezomib|bortezomib|mesh-list
2039749|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2039750|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
2039751|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
2039752|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039753|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039754|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2039755|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
2039756|NCT01568866|Hormones|hormones|mesh-ancestor
2039757|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2039758|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2039759|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039760|NCT01568892|Dolutegravir|dolutegravir|mesh-list
2039761|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2039762|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2039763|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039764|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039765|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2039766|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2039767|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
2039768|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039769|NCT01568905|Nicotine|nicotine|mesh-list
2039770|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2039771|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
2039772|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039773|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039774|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2039775|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2039776|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
2039777|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039778|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039779|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2039780|NCT01568944|Lansoprazole|lansoprazole|mesh-list
2039781|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039782|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2039783|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2039784|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2039785|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039786|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039787|NCT01569087|Lenograstim|lenograstim|mesh-list
2039788|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2039789|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
2039790|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039791|NCT01569126|Fluoxetine|fluoxetine|mesh-list
2039792|NCT01569126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2039793|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2039794|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2039795|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039796|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039797|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
2039798|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039799|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2039800|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
2039801|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2039802|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2039803|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2039804|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039805|NCT01569152|Methotrexate|methotrexate|mesh-list
2039806|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2039807|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
2039808|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2039809|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039810|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2039811|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
2039812|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039813|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039814|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
2039815|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039816|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2039817|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2039818|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
2039819|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2039820|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2039821|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
2039822|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2039823|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
2039824|NCT01569191|Epinastine|epinastine|mesh-list
2039825|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2039826|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2039827|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
2039828|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
2039829|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039830|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039831|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039832|NCT01569295|Rituximab|rituximab|mesh-list
2039833|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2039834|NCT01569295|Idelalisib|idelalisib|mesh-list
2039835|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2039836|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039837|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
2039838|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039839|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2039840|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2039841|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
2039842|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039843|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039844|NCT01569451|Rituximab|rituximab|mesh-list
2039845|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
2039846|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
2039847|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2039848|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039849|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
2039850|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039851|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2039852|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2039853|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2039854|NCT01569464|Rotigotine|rotigotine|mesh-list
2039855|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
2039856|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
2039857|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2039858|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039859|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039860|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2039861|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2039862|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039863|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2039864|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2039865|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039866|NCT01569841|Insulin|insulin|mesh-list
2039867|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2039868|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
2039869|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2039870|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039871|NCT01570036|Trastuzumab|trastuzumab|mesh-list
2039872|NCT01570036|Molgramostim|molgramostim|mesh-list
2039873|NCT01570036|Sargramostim|sargramostim|mesh-list
2039874|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2039875|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039876|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
2039877|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039878|NCT01570192|Vancomycin|vancomycin|mesh-list
2039879|NCT01570192|Gentamicins|gentamicins|mesh-list
2039880|NCT01570192|Meropenem|meropenem|mesh-list
2039881|NCT01570192|Linezolid|linezolid|mesh-list
2039882|NCT01570192|Tobramycin|tobramycin|mesh-list
2039883|NCT01570192|Amikacin|amikacin|mesh-list
2039884|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2039885|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039886|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2039887|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039888|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039889|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
2039890|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2039891|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2039892|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
2039893|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2039894|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039895|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2039896|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2039897|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2039898|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2039899|NCT01570244|Estrogens|estrogens|mesh-ancestor
2039900|NCT01570244|Hormones|hormones|mesh-ancestor
2039901|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2039902|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
2039903|NCT01570309|Vitamin D|vitamin d|mesh-list
2039904|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2039905|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039906|NCT01570309|Vitamins|vitamins|mesh-ancestor
2039907|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
2039908|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2039909|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
2039910|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
2039911|NCT01570348|Fludarabine|fludarabine|mesh-list
2039912|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
2039913|NCT01570348|Tacrolimus|tacrolimus|mesh-list
2039914|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2039915|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
2039916|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039917|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2039918|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2039919|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
2039920|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039921|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039922|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2039923|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2039924|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
2039925|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2039926|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039927|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2039928|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2039929|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
2039930|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2039931|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2039932|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2039933|NCT01570387|Dexamethasone|dexamethasone|mesh-list
2039934|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
2039935|NCT01570387|Pomalidomide|pomalidomide|mesh-list
2039936|NCT01570387|BB 1101|bb 1101|mesh-list
2039937|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2039938|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
2039939|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
2039940|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039941|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039942|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2039943|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
2039944|NCT01570387|Hormones|hormones|mesh-ancestor
2039945|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2039946|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2039947|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039948|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
2039949|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039950|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039951|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
2039952|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2039953|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2039954|NCT01570387|Growth Substances|growth substances|mesh-ancestor
2039955|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
2039956|NCT01570491|Anesthetics|anesthetics|mesh-list
2039957|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2039958|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039959|NCT01570751|Insulin|insulin|mesh-list
2039960|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2039961|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
2039962|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2039963|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039964|NCT01570868|Ponatinib|ponatinib|mesh-list
2039965|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039966|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2039967|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2039968|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2039969|NCT01571232|Dexamethasone|dexamethasone|mesh-list
2039970|NCT01571232|Bevacizumab|bevacizumab|mesh-list
2039971|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2039972|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039973|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2039974|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2039975|NCT01571232|Growth Substances|growth substances|mesh-ancestor
2039976|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039977|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
2039978|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2039979|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
2039980|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
2039981|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2039982|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2039983|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
2039984|NCT01571232|Hormones|hormones|mesh-ancestor
2039985|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2039986|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2039987|NCT01571284|Aflibercept|aflibercept|mesh-list
2039988|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2039989|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2039990|NCT01571284|Growth Substances|growth substances|mesh-ancestor
2039991|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2039992|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
2039993|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2039994|NCT01571362|Naltrexone|naltrexone|mesh-list
2039995|NCT01571362|Oxycodone|oxycodone|mesh-list
2039996|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2039997|NCT01571362|Narcotics|narcotics|mesh-ancestor
2039998|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2039999|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040000|NCT01571362|Analgesics|analgesics|mesh-ancestor
2040001|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
2040002|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040003|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2040004|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2040005|NCT01571453|Vortioxetine|vortioxetine|mesh-list
2040006|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2040007|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2040008|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2040009|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2040010|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040011|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040012|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040013|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2040014|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
2040015|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2040016|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2040017|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2040018|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040019|NCT01571453|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2040020|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
2040021|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2040022|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2040023|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2040024|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2040025|NCT01571557|Dexamethasone|dexamethasone|mesh-list
2040026|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040027|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
2040028|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
2040029|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040030|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040031|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2040032|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
2040033|NCT01571557|Hormones|hormones|mesh-ancestor
2040034|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2040035|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2040036|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040037|NCT01572038|Paclitaxel|paclitaxel|mesh-list
2040038|NCT01572038|Docetaxel|docetaxel|mesh-list
2040039|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2040040|NCT01572038|Trastuzumab|trastuzumab|mesh-list
2040041|NCT01572038|Pertuzumab|pertuzumab|mesh-list
2040042|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2040043|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040044|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
2040045|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
2040046|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
2040047|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040048|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2040049|NCT01572675|Celecoxib|celecoxib|mesh-list
2040050|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2040051|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2040052|NCT01572675|Analgesics|analgesics|mesh-ancestor
2040053|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
2040054|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040055|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040056|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040057|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2040058|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2040059|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2040060|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040061|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040062|NCT01572727|Paclitaxel|paclitaxel|mesh-list
2040063|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2040064|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040065|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
2040066|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
2040067|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
2040068|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040069|NCT01572740|Liraglutide|liraglutide|mesh-list
2040070|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2040071|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040072|NCT01572740|Incretins|incretins|mesh-ancestor
2040073|NCT01572740|Hormones|hormones|mesh-ancestor
2040074|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2040075|NCT01572792|Bromides|bromides|mesh-list
2040076|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
2040077|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2040078|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
2040079|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040080|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040081|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2040082|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
2040083|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2040084|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2040085|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2040086|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
2040087|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040088|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040089|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
2040090|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
2040091|NCT01572844|Antidotes|antidotes|mesh-ancestor
2040092|NCT01572844|Protective Agents|protective agents|mesh-ancestor
2040093|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040094|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
2040095|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040096|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
2040097|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2040098|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2040099|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
2040100|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
2040101|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
2040102|NCT01573000|Antibodies|antibodies|mesh-list
2040103|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
2040104|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
2040105|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040106|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040107|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
2040108|NCT01573052|Gabapentin|gabapentin|mesh-list
2040109|NCT01573052|Analgesics|analgesics|mesh-ancestor
2040110|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
2040111|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040112|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040113|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
2040114|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2040115|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2040116|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040117|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2040118|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2040119|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2040120|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040121|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040122|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
2040123|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2040124|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2040125|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
2040126|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
2040127|NCT01573169|Enoxaparin|enoxaparin|mesh-list
2040128|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
2040129|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2040130|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2040131|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040132|NCT01573273|Oxytocin|oxytocin|mesh-list
2040133|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
2040134|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2040135|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040136|NCT01573442|Testosterone|testosterone|mesh-list
2040137|NCT01573442|Androgens|androgens|mesh-ancestor
2040138|NCT01573442|Hormones|hormones|mesh-ancestor
2040139|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2040140|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040141|NCT01573533|Rituximab|rituximab|mesh-list
2040142|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2040143|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040144|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
2040145|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040146|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2040147|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2040148|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040149|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2040150|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040151|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040152|NCT01573767|Fluticasone|fluticasone|mesh-list
2040153|NCT01573767|Xhance|xhance|mesh-list
2040154|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040155|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2040156|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
2040157|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040158|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040159|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2040160|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
2040161|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
2040162|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2040163|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
2040164|NCT01573910|Ofloxacin|ofloxacin|mesh-list
2040165|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2040166|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2040167|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2040168|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2040169|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2040170|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2040171|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040172|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040173|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040174|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2040175|NCT01573910|Renal Agents|renal agents|mesh-ancestor
2040176|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2040177|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2040178|NCT01573949|Metformin|metformin|mesh-list
2040179|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2040180|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040181|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2040182|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
2040183|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2040184|NCT01574183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2040185|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2040186|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2040187|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040188|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040189|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
2040190|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040191|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2040192|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2040193|NCT01574248|Icatibant|icatibant|mesh-list
2040194|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2040195|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2040196|NCT01574248|Analgesics|analgesics|mesh-ancestor
2040197|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
2040198|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040199|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040200|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040201|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2040202|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
2040203|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
2040204|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040205|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2040206|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2040207|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
2040208|NCT01574326|Sevelamer|sevelamer|mesh-list
2040209|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
2040210|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
2040211|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040212|NCT01574612|Acyclovir|acyclovir|mesh-list
2040213|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
2040214|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040215|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
2040216|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2040217|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
2040218|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
2040219|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
2040220|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2040221|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
2040222|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040223|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040224|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2040225|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
2040226|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2040227|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2040228|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2040229|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
2040230|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040231|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040232|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
2040233|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2040234|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
2040235|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2040236|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2040237|NCT01574703|Bupropion|bupropion|mesh-list
2040238|NCT01574703|Nicotine|nicotine|mesh-list
2040239|NCT01574703|Varenicline|varenicline|mesh-list
2040240|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2040241|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
2040242|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040243|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040244|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2040245|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2040246|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
2040247|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040248|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040249|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2040250|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
2040251|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2040252|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2040253|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2040254|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2040255|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
2040256|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2040257|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2040258|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040259|NCT01574716|Gemcitabine|gemcitabine|mesh-list
2040260|NCT01574716|Docetaxel|docetaxel|mesh-list
2040261|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2040262|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
2040263|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040264|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040265|NCT01574716|Antiviral Agents|antiviral agents|mesh-ancestor
2040266|NCT01574716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2040267|NCT01574716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040268|NCT01574716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2040269|NCT01574716|Immunologic Factors|immunologic factors|mesh-ancestor
2040270|NCT01574716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040271|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
2040272|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
2040273|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
2040274|NCT01574807|Lidocaine|lidocaine|mesh-list
2040275|NCT01574807|Mepivacaine|mepivacaine|mesh-list
2040276|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
2040277|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
2040278|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040279|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040280|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
2040281|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040282|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2040283|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2040284|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2040285|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2040286|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040287|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
2040288|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2040289|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2040290|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2040291|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2040292|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040293|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
2040294|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040295|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040296|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2040297|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040298|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2040299|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2040300|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
2040301|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2040302|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2040303|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2040304|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040305|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040306|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2040307|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2040308|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2040309|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2040310|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
2040311|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040312|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040313|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2040314|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2040315|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
2040316|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2040317|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2040318|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
2040319|NCT01575834|Denosumab|denosumab|mesh-list
2040320|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2040321|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040322|NCT01575860|Lenalidomide|lenalidomide|mesh-list
2040323|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
2040324|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040325|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2040326|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2040327|NCT01575860|Growth Substances|growth substances|mesh-ancestor
2040328|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
2040329|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040330|NCT01575873|Denosumab|denosumab|mesh-list
2040331|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2040332|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040333|NCT01575899|Amoxicillin|amoxicillin|mesh-list
2040334|NCT01575899|Clarithromycin|clarithromycin|mesh-list
2040335|NCT01575899|Levofloxacin|levofloxacin|mesh-list
2040336|NCT01575899|Ofloxacin|ofloxacin|mesh-list
2040337|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
2040338|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2040339|NCT01575899|Rabeprazole|rabeprazole|mesh-list
2040340|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2040341|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2040342|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2040343|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040344|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040345|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2040346|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2040347|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2040348|NCT01575899|Renal Agents|renal agents|mesh-ancestor
2040349|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2040350|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2040351|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040352|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2040353|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2040354|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2040355|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2040356|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2040357|NCT01576042|Amiodarone|amiodarone|mesh-list
2040358|NCT01576042|Sotalol|sotalol|mesh-list
2040359|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2040360|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
2040361|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2040362|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2040363|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040364|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2040365|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2040366|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2040367|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040368|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2040369|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2040370|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2040371|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2040372|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2040373|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
2040374|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040375|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040376|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
2040377|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
2040378|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040379|NCT01576172|Prednisone|prednisone|mesh-list
2040380|NCT01576172|Cortisone|cortisone|mesh-list
2040381|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
2040382|NCT01576172|Veliparib|veliparib|mesh-list
2040383|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040384|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
2040385|NCT01576172|Hormones|hormones|mesh-ancestor
2040386|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2040387|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040388|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2040389|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040390|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2040391|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040392|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040393|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
2040394|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2040395|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2040396|NCT01576276|Ketorolac|ketorolac|mesh-list
2040397|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2040398|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2040399|NCT01576276|Analgesics|analgesics|mesh-ancestor
2040400|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
2040401|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040402|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040403|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040404|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2040405|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2040406|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040407|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040408|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
2040409|NCT01576341|Hematinics|hematinics|mesh-ancestor
2040410|NCT01576406|Crizotinib|crizotinib|mesh-list
2040411|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040412|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2040413|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040414|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040415|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2040416|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
2040417|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040418|NCT01576523|Complement C1s|complement c1s|mesh-list
2040419|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2040420|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2040421|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
2040422|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040423|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2040424|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2040425|NCT01576588|Rituximab|rituximab|mesh-list
2040426|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
2040427|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2040428|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040429|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
2040430|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040431|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2040432|NCT01576588|Hormones|hormones|mesh-ancestor
2040433|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2040434|NCT01576705|Leucovorin|leucovorin|mesh-list
2040435|NCT01576705|Folic Acid|folic acid|mesh-list
2040436|NCT01576705|Hormones|hormones|mesh-list
2040437|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
2040438|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2040439|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040440|NCT01576705|Antidotes|antidotes|mesh-ancestor
2040441|NCT01576705|Protective Agents|protective agents|mesh-ancestor
2040442|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
2040443|NCT01576705|Vitamins|vitamins|mesh-ancestor
2040444|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
2040445|NCT01576705|Hematinics|hematinics|mesh-ancestor
2040446|NCT01576718|Fluticasone|fluticasone|mesh-list
2040447|NCT01576718|Xhance|xhance|mesh-list
2040448|NCT01576718|Albuterol|albuterol|mesh-list
2040449|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
2040450|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040451|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2040452|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
2040453|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040454|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040455|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2040456|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
2040457|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
2040458|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2040459|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
2040460|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2040461|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2040462|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2040463|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
2040464|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040465|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040466|NCT01576809|Acetaminophen|acetaminophen|mesh-list
2040467|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
2040468|NCT01576809|Phenylephrine|phenylephrine|mesh-list
2040469|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
2040470|NCT01576809|Guaifenesin|guaifenesin|mesh-list
2040471|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2040472|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2040473|NCT01576809|Analgesics|analgesics|mesh-ancestor
2040474|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
2040475|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040476|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040477|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
2040478|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2040479|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
2040480|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
2040481|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
2040482|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2040483|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
2040484|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
2040485|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2040486|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2040487|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2040488|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
2040489|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040490|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040491|NCT01576809|Protective Agents|protective agents|mesh-ancestor
2040492|NCT01576809|Expectorants|expectorants|mesh-ancestor
2040493|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
2040494|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2040495|NCT01576874|Oxytocin|oxytocin|mesh-list
2040496|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
2040497|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2040498|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040499|NCT01576952|Bromfenac|bromfenac|mesh-list
2040500|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2040501|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2040502|NCT01576952|Analgesics|analgesics|mesh-ancestor
2040503|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
2040504|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040505|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040506|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040507|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2040508|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2040509|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2040510|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2040511|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040512|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040513|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2040514|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2040515|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2040516|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
2040517|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040518|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040519|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2040520|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2040521|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
2040522|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2040523|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2040524|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2040525|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040526|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040527|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2040528|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2040529|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2040530|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
2040531|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040532|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040533|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2040534|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2040535|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
2040536|NCT01577706|Alprazolam|alprazolam|mesh-list
2040537|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
2040538|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2040539|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040540|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040541|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2040542|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2040543|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2040544|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
2040545|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
2040546|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040547|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040548|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2040549|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2040550|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2040551|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2040552|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
2040553|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
2040554|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2040555|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2040556|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2040557|NCT01577966|Analgesics|analgesics|mesh-ancestor
2040558|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
2040559|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040560|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040561|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040562|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2040563|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2040564|NCT01578239|Octreotide|octreotide|mesh-list
2040565|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2040566|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2040567|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2040568|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040569|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2040570|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040571|NCT01578278|Fluticasone|fluticasone|mesh-list
2040572|NCT01578278|Xhance|xhance|mesh-list
2040573|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
2040574|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040575|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2040576|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
2040577|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040578|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040579|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2040580|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
2040581|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
2040582|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2040583|NCT01578317|Vaccines|vaccines|mesh-list
2040584|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
2040585|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040586|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2040587|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2040588|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040589|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2040590|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
2040591|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040592|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2040593|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2040594|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2040595|NCT01578486|Analgesics|analgesics|mesh-ancestor
2040596|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
2040597|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040598|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040599|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040600|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2040601|NCT01578499|Methotrexate|methotrexate|mesh-list
2040602|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2040603|NCT01578499|Bexarotene|bexarotene|mesh-list
2040604|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2040605|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
2040606|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2040607|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040608|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2040609|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
2040610|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040611|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040612|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
2040613|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040614|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2040615|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2040616|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
2040617|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2040618|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2040619|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2040620|NCT01578551|Metformin|metformin|mesh-list
2040621|NCT01578551|Biguanides|biguanides|mesh-list
2040622|NCT01578551|Paclitaxel|paclitaxel|mesh-list
2040623|NCT01578551|Bevacizumab|bevacizumab|mesh-list
2040624|NCT01578551|Carboplatin|carboplatin|mesh-list
2040625|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2040626|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040627|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
2040628|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
2040629|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
2040630|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040631|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2040632|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2040633|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2040634|NCT01578551|Growth Substances|growth substances|mesh-ancestor
2040635|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040636|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
2040637|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2040638|NCT01578707|Ofatumumab|ofatumumab|mesh-list
2040639|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040640|NCT01578772|Telmisartan|telmisartan|mesh-list
2040641|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2040642|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2040643|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2040644|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040645|NCT01578850|Etanercept|etanercept|mesh-list
2040646|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2040647|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2040648|NCT01578850|Analgesics|analgesics|mesh-ancestor
2040649|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
2040650|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040651|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040652|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040653|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2040654|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2040655|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2040656|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
2746288|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2746289|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040660|NCT01578980|Pancrelipase|pancrelipase|mesh-list
2040661|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2040662|NCT01579162|Cholic Acids|cholic acids|mesh-list
2040663|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2040664|NCT01579305|Lidocaine|lidocaine|mesh-list
2040665|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
2040666|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
2040667|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040668|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040669|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
2040670|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040671|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2040672|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2040673|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2040674|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2040675|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040676|NCT01579318|Interleukin-12|interleukin-12|mesh-list
2040677|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2040678|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
2040679|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040680|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2040681|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2040682|NCT01579318|Growth Substances|growth substances|mesh-ancestor
2040683|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
2040684|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040685|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
2040686|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2040687|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2040688|NCT01579513|Prednisolone|prednisolone|mesh-list
2040689|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
2040690|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2040691|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
2040692|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
2040693|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040694|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
2040695|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
2040696|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040697|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040698|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2040699|NCT01579513|Hormones|hormones|mesh-ancestor
2040700|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2040701|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2040702|NCT01579513|Protective Agents|protective agents|mesh-ancestor
2040703|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2040704|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040705|NCT01579578|Paclitaxel|paclitaxel|mesh-list
2040706|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2040707|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040708|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
2040709|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
2040710|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
2040711|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040712|NCT01579812|Metformin|metformin|mesh-list
2040713|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2040714|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040715|NCT01580020|Dexamethasone|dexamethasone|mesh-list
2040716|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2040717|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
2040718|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
2040719|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040720|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040721|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2040722|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
2040723|NCT01580020|Hormones|hormones|mesh-ancestor
2040724|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2040725|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2040726|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040727|NCT01580293|Factor VIII|factor viii|mesh-list
2040728|NCT01580293|Coagulants|coagulants|mesh-ancestor
2040729|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
2040730|NCT01580410|Mitomycins|mitomycins|mesh-list
2040731|NCT01580410|Mitomycin|mitomycin|mesh-list
2040732|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040733|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2040734|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
2040735|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040736|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2040737|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040738|NCT01580423|Aprepitant|aprepitant|mesh-list
2040739|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
2040740|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
2040741|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040742|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040743|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2040744|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2040745|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040746|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040747|NCT01580488|Calcitriol|calcitriol|mesh-list
2040748|NCT01580488|Calcipotriene|calcipotriene|mesh-list
2040749|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2040750|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
2040751|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2040752|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040753|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2040754|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2040755|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040756|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2040757|NCT01580488|Vitamins|vitamins|mesh-ancestor
2040758|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
2040759|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2040760|NCT01580592|Omalizumab|omalizumab|mesh-list
2040761|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2040762|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2040763|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2040764|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
2040765|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
2040766|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040767|NCT01580618|Tenecteplase|tenecteplase|mesh-list
2040768|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2040769|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2040770|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040771|NCT01580670|Infliximab|infliximab|mesh-list
2040772|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
2040773|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2040774|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2040775|NCT01580969|Minocycline|minocycline|mesh-list
2040776|NCT01580969|Bevacizumab|bevacizumab|mesh-list
2040777|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2040778|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040779|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2040780|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2040781|NCT01580969|Growth Substances|growth substances|mesh-ancestor
2040782|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040783|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
2040784|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2040785|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2040786|NCT01580995|Valacyclovir|valacyclovir|mesh-list
2040787|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
2040788|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2040789|NCT01581281|Topiramate|topiramate|mesh-list
2040790|NCT01581281|Amitriptyline|amitriptyline|mesh-list
2040791|NCT01581281|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2040792|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
2040793|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2040794|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040795|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2040796|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
2040797|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2040798|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2040799|NCT01581281|Analgesics|analgesics|mesh-ancestor
2040800|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
2040801|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040802|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2040803|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2040804|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2040805|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040806|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
2040807|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040808|NCT01581281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2040809|NCT01581281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2040810|NCT01581281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040811|NCT01581307|Leucovorin|leucovorin|mesh-list
2040812|NCT01581307|Folic Acid|folic acid|mesh-list
2040813|NCT01581307|Fluorouracil|fluorouracil|mesh-list
2040814|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
2040815|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
2040816|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
2040817|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040818|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2040819|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040820|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2040821|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
2040822|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040823|NCT01581307|Antidotes|antidotes|mesh-ancestor
2040824|NCT01581307|Protective Agents|protective agents|mesh-ancestor
2040825|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
2040826|NCT01581307|Vitamins|vitamins|mesh-ancestor
2040827|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
2040828|NCT01581307|Hematinics|hematinics|mesh-ancestor
2040829|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
2040830|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040831|NCT01581658|Empagliflozin|empagliflozin|mesh-list
2040832|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2040833|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040834|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2040835|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040836|NCT01581710|Montelukast|montelukast|mesh-list
2040837|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2040838|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
2040839|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2040840|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
2040841|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2040842|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040843|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2040844|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2040845|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040846|NCT01581931|Metformin|metformin|mesh-list
2040847|NCT01581931|Linagliptin|linagliptin|mesh-list
2040848|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2040849|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040850|NCT01581931|Incretins|incretins|mesh-ancestor
2040851|NCT01581931|Hormones|hormones|mesh-ancestor
2040852|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2040853|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2040854|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
2040855|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040856|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040857|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
2040858|NCT01581970|Cetuximab|cetuximab|mesh-list
2040859|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2040860|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
2040861|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040862|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2040863|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2040864|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
2040865|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040866|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040867|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2040868|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2040869|NCT01582009|Everolimus|everolimus|mesh-list
2040870|NCT01582009|Panobinostat|panobinostat|mesh-list
2040871|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2040872|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040873|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2040874|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
2040875|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040876|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040877|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040878|NCT01582061|Pasireotide|pasireotide|mesh-list
2040879|NCT01582061|Hormones|hormones|mesh-ancestor
2040880|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2040881|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040882|NCT01582152|Bevacizumab|bevacizumab|mesh-list
2040883|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2040884|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2040885|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2040886|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2040887|NCT01582152|Growth Substances|growth substances|mesh-ancestor
2040888|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040889|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
2040890|NCT01582243|Vildagliptin|vildagliptin|mesh-list
2040891|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2040892|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040893|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2040894|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
2040895|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040896|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040897|NCT01582282|Psyllium|psyllium|mesh-list
2040898|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
2040899|NCT01582282|Cathartics|cathartics|mesh-ancestor
2040900|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2040901|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
2040902|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2040903|NCT01582308|Vildagliptin|vildagliptin|mesh-list
2040904|NCT01582308|Saxagliptin|saxagliptin|mesh-list
2040905|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2040906|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040907|NCT01582308|Incretins|incretins|mesh-ancestor
2040908|NCT01582308|Hormones|hormones|mesh-ancestor
2040909|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2040910|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2040911|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
2040912|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2040913|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040914|NCT01582451|Insulin|insulin|mesh-list
2040915|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2040916|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
2040917|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2040918|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040919|NCT01582477|Bupivacaine|bupivacaine|mesh-list
2040920|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
2040921|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
2040922|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040923|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040924|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
2040925|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040926|NCT01582490|Bupivacaine|bupivacaine|mesh-list
2040927|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
2040928|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
2040929|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040930|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040931|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
2040932|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040933|NCT01582854|Actovegin|actovegin|mesh-list
2040934|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2040935|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040936|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2040937|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2040938|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
2040939|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040940|NCT01582854|Protective Agents|protective agents|mesh-ancestor
2040941|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2040942|NCT01582880|Riboflavin|riboflavin|mesh-list
2040943|NCT01582880|Vitamins|vitamins|mesh-ancestor
2040944|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
2040945|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040946|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
2040947|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2040948|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
2040949|NCT01582945|Ketamine|ketamine|mesh-list
2040950|NCT01582945|Analgesics|analgesics|mesh-ancestor
2040951|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
2040952|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040953|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040954|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2040955|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2040956|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
2040957|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
2040958|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040959|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2040960|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2040961|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040962|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040963|NCT01583166|Epinephrine|epinephrine|mesh-list
2040964|NCT01583166|Bupivacaine|bupivacaine|mesh-list
2040965|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
2040966|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
2040967|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040968|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040969|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
2040970|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040971|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2040972|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2040973|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
2040974|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2040975|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040976|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2040977|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2040978|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
2040979|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2040980|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
2040981|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
2040982|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
2040983|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2040984|NCT01583179|Buprenorphine|buprenorphine|mesh-list
2040985|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2040986|NCT01583179|Narcotics|narcotics|mesh-ancestor
2040987|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2040988|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2040989|NCT01583179|Analgesics|analgesics|mesh-ancestor
2040990|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
2040991|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2040992|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2040993|NCT01583218|Enoxaparin|enoxaparin|mesh-list
2040994|NCT01583218|Betrixaban|betrixaban|mesh-list
2040995|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
2040996|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2040997|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2040998|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2040999|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2041000|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
2041001|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2041002|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
2041003|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041004|NCT01583374|Thalidomide|thalidomide|mesh-list
2041005|NCT01583374|Apremilast|apremilast|mesh-list
2041006|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2041007|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2041008|NCT01583374|Analgesics|analgesics|mesh-ancestor
2041009|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
2041010|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041011|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041012|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2041013|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2041014|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2041015|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2041016|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041017|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041018|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2041019|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
2041020|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
2041021|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2041022|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041023|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2041024|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2041025|NCT01583374|Growth Substances|growth substances|mesh-ancestor
2041026|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
2041027|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041028|NCT01583530|Belimumab|belimumab|mesh-list
2041029|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2041030|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
2041031|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041032|NCT01583543|Olaparib|olaparib|mesh-list
2041033|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2041034|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041035|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041036|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041037|NCT01583686|Aldesleukin|aldesleukin|mesh-list
2041038|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
2041039|NCT01583686|Fludarabine|fludarabine|mesh-list
2041040|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2041041|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
2041042|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041043|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2041044|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2041045|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
2041046|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041047|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041048|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2041049|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2041050|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2041051|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
2041052|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041053|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
2041054|NCT01583985|Narcotics|narcotics|mesh-ancestor
2041055|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2041056|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041057|NCT01583985|Analgesics|analgesics|mesh-ancestor
2041058|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
2041059|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041060|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
2041061|NCT01584232|Dulaglutide|dulaglutide|mesh-list
2041062|NCT01584232|Biguanides|biguanides|mesh-list
2041063|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2041064|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041065|NCT01584388|Rituximab|rituximab|mesh-list
2041066|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2041067|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041068|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
2041069|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041070|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2041071|NCT01584440|Quinidine|quinidine|mesh-list
2041072|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
2041073|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
2041074|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
2041075|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2041076|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2041077|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041078|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041079|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041080|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2041081|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2041082|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
2041083|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2041084|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
2041085|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2041086|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2041087|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041088|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041089|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2041090|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2041091|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
2041092|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2041093|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2041094|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2041095|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2041096|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2041097|NCT01584518|Furosemide|furosemide|mesh-list
2041098|NCT01584518|Diuretics|diuretics|mesh-ancestor
2041099|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
2041100|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041101|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2041102|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2041103|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041104|NCT01584544|Capecitabine|capecitabine|mesh-list
2041105|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2041106|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
2041107|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041108|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041109|NCT01584648|Trametinib|trametinib|mesh-list
2041110|NCT01584648|Dabrafenib|dabrafenib|mesh-list
2041111|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041112|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2041113|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041114|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041115|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
2041116|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2041117|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2041118|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2041119|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2041120|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041121|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
2041122|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041123|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041124|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2041125|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041126|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2041127|NCT01585025|Cathartics|cathartics|mesh-ancestor
2041128|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2041129|NCT01585038|Efavirenz|efavirenz|mesh-list
2041130|NCT01585038|Rilpivirine|rilpivirine|mesh-list
2041131|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2041132|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2041133|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041134|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041135|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
2041136|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041137|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2041138|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2041139|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2041140|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2041141|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2041142|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2041143|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2041144|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2041145|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2041146|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2041147|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041148|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
2041149|NCT01585168|Memantine|memantine|mesh-list
2041150|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2041151|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2041152|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
2041153|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041154|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041155|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041156|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2041157|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2041158|NCT01585194|Nivolumab|nivolumab|mesh-list
2041159|NCT01585194|Ipilimumab|ipilimumab|mesh-list
2041160|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2041161|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041162|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2041163|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041164|NCT01585207|Vigabatrin|vigabatrin|mesh-list
2041165|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
2041166|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041167|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041168|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
2041169|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041170|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041171|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
2041172|NCT01585246|Urological Agents|urological agents|mesh-ancestor
2041173|NCT01585272|Rivastigmine|rivastigmine|mesh-list
2041174|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2041175|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041176|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041177|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
2041178|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041179|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041180|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2041181|NCT01585272|Protective Agents|protective agents|mesh-ancestor
2041182|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2041183|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2041184|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041185|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2041186|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
2041187|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041188|NCT01585324|Ribavirin|ribavirin|mesh-list
2041189|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2041190|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
2041191|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041192|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
2041193|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041194|NCT01585428|Aldesleukin|aldesleukin|mesh-list
2041195|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
2041196|NCT01585428|Fludarabine|fludarabine|mesh-list
2041197|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2041198|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
2041199|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041200|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2041201|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2041202|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
2041203|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041204|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041205|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2041206|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2041207|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2041208|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
2041209|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041210|NCT01585441|Finasteride|finasteride|mesh-list
2041211|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2041212|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2041213|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041214|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041215|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
2041216|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2041217|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041218|NCT01585441|Urological Agents|urological agents|mesh-ancestor
2041219|NCT01585558|Tamoxifen|tamoxifen|mesh-list
2041220|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2041221|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
2041222|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2041223|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041224|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2041225|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041226|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2041227|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2041228|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2041229|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
2041230|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041231|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041232|NCT01585831|Testosterone|testosterone|mesh-list
2041233|NCT01585831|Androgens|androgens|mesh-ancestor
2041234|NCT01585831|Hormones|hormones|mesh-ancestor
2041235|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2041236|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041237|NCT01585987|Ipilimumab|ipilimumab|mesh-list
2041238|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2041239|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041240|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2041241|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041242|NCT01586091|Fexofenadine|fexofenadine|mesh-list
2041243|NCT01586091|Levocetirizine|levocetirizine|mesh-list
2041244|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2041245|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2041246|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
2041247|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
2041248|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041249|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041250|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041251|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2041252|NCT01586156|Carvedilol|carvedilol|mesh-list
2041253|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2041254|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2041255|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
2041256|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041257|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041258|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041259|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2041260|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
2041261|NCT01586156|Protective Agents|protective agents|mesh-ancestor
2041262|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2041263|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2041264|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2041265|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
2041266|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2041267|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2041268|NCT01586195|Vemurafenib|vemurafenib|mesh-list
2041269|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041270|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2041271|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041272|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041273|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
2041274|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2041275|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
2041276|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041277|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
2041278|NCT01586312|Protective Agents|protective agents|mesh-ancestor
2041279|NCT01586338|Hylan|hylan|mesh-list
2041280|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
2041281|NCT01586338|Protective Agents|protective agents|mesh-ancestor
2041282|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041283|NCT01586806|Dexamethasone|dexamethasone|mesh-list
2041284|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
2041285|NCT01586806|Bupivacaine|bupivacaine|mesh-list
2041286|NCT01586806|BB 1101|bb 1101|mesh-list
2041287|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2041288|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
2041289|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
2041290|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041291|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041292|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2041293|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
2041294|NCT01586806|Hormones|hormones|mesh-ancestor
2041295|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2041296|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2041297|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041298|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
2041299|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041300|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041301|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
2041302|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
2041303|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2041304|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
2041305|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
2041306|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2041307|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2041308|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041309|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
2041310|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041311|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041312|NCT01586962|Acetaminophen|acetaminophen|mesh-list
2041313|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
2041314|NCT01586962|Ephedrine|ephedrine|mesh-list
2041315|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2041316|NCT01586962|Analgesics|analgesics|mesh-ancestor
2041317|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
2041318|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041319|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041320|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
2041321|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2041322|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
2041323|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2041324|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
2041325|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
2041326|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2041327|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2041328|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
2041329|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
2041330|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041331|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041332|NCT01586975|Aspirin|aspirin|mesh-list
2041333|NCT01586975|Clopidogrel|clopidogrel|mesh-list
2041334|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2041335|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2041336|NCT01586975|Analgesics|analgesics|mesh-ancestor
2041337|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
2041338|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041339|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041340|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2041341|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2041342|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2041343|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2041344|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041345|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2041346|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2041347|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041348|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
2041349|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2041350|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2041351|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2041352|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
2041353|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041354|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
2041355|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2041356|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
2041357|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041358|NCT01587001|Expectorants|expectorants|mesh-ancestor
2041359|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
2041360|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2041361|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
2041362|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041363|NCT01587001|Protective Agents|protective agents|mesh-ancestor
2041364|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041365|NCT01587001|Antidotes|antidotes|mesh-ancestor
2041366|NCT01587027|Aminophylline|aminophylline|mesh-list
2041367|NCT01587027|Methazolamide|methazolamide|mesh-list
2041368|NCT01587027|Theophylline|theophylline|mesh-list
2041369|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2041370|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
2041371|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041372|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041373|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2041374|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
2041375|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2041376|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041377|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041378|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
2041379|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2041380|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2041381|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
2041382|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041383|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2041384|NCT01587027|Protective Agents|protective agents|mesh-ancestor
2041385|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2041386|NCT01587027|Diuretics|diuretics|mesh-ancestor
2041387|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
2041388|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
2041389|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2041390|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
2041391|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041392|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041393|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2041394|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
2041395|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
2041396|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2041397|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
2041398|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041399|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041400|NCT01587118|Asenapine|asenapine|mesh-list
2041401|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2041402|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2041403|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2041404|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041405|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2041406|NCT01587274|Acetaminophen|acetaminophen|mesh-list
2041407|NCT01587274|Naproxen|naproxen|mesh-list
2041408|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2041409|NCT01587274|Oxycodone|oxycodone|mesh-list
2041410|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
2041411|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2041412|NCT01587274|Analgesics|analgesics|mesh-ancestor
2041413|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
2041414|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041415|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041416|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
2041417|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2041418|NCT01587274|Narcotics|narcotics|mesh-ancestor
2041419|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2041420|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2041421|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2041422|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2041423|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
2041424|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2041425|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041426|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041427|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2041428|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
2041429|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2041430|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2041431|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2041432|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2041433|NCT01587651|Ticagrelor|ticagrelor|mesh-list
2041434|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2041435|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2041436|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2041437|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2041438|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2041439|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
2041440|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041441|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041442|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041443|NCT01587885|Omeprazole|omeprazole|mesh-list
2041444|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2041445|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2041446|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2041447|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041448|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041449|NCT01587989|Methotrexate|methotrexate|mesh-list
2041450|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2041451|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
2041452|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2041453|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041454|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2041455|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
2041456|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041457|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041458|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
2041459|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041460|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2041461|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2041462|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
2041463|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2041464|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2041465|NCT01588158|Acetaminophen|acetaminophen|mesh-list
2041466|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2041467|NCT01588158|Hydrocodone|hydrocodone|mesh-list
2041468|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2041469|NCT01588158|Analgesics|analgesics|mesh-ancestor
2041470|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
2041471|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041472|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041473|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
2041474|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2041475|NCT01588158|Narcotics|narcotics|mesh-ancestor
2041476|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2041477|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
2041478|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
2041479|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2041480|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2041481|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2041482|NCT01588184|Bevacizumab|bevacizumab|mesh-list
2041483|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2041484|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041485|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2041486|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2041487|NCT01588184|Growth Substances|growth substances|mesh-ancestor
2041488|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041489|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
2041490|NCT01588405|Treprostinil|treprostinil|mesh-list
2041491|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2041492|NCT01588418|Exenatide|exenatide|mesh-list
2041493|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2041494|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041495|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2041496|NCT01588418|Incretins|incretins|mesh-ancestor
2041497|NCT01588418|Hormones|hormones|mesh-ancestor
2041498|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2041499|NCT01588457|Lamotrigine|lamotrigine|mesh-list
2041500|NCT01588457|Valproic Acid|valproic acid|mesh-list
2041501|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2041502|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
2041503|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
2041504|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2041505|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2041506|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2041507|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2041508|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041509|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041510|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041511|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
2041512|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
2041513|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2041514|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2041515|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2041516|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2041517|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
2041518|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041519|NCT01588470|Pioglitazone|pioglitazone|mesh-list
2041520|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2041521|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041522|NCT01588496|Evolocumab|evolocumab|mesh-list
2041523|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2041524|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2041525|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
2475605|NCT01085097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2041526|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041527|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2041528|NCT01588561|Nicotine|nicotine|mesh-list
2041529|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2041530|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
2041531|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041532|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041533|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2041534|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2041535|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
2041536|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041537|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041538|NCT01588951|Cytarabine|cytarabine|mesh-list
2041539|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2041540|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
2041541|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041542|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041543|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
2041544|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041545|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2041546|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
2041547|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041548|NCT01588990|Leucovorin|leucovorin|mesh-list
2041549|NCT01588990|Bevacizumab|bevacizumab|mesh-list
2041550|NCT01588990|Capecitabine|capecitabine|mesh-list
2041551|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
2041552|NCT01588990|Irinotecan|irinotecan|mesh-list
2041553|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2041554|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041555|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2041556|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2041557|NCT01588990|Growth Substances|growth substances|mesh-ancestor
2041558|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041559|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
2041560|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2041561|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
2041562|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041563|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2041564|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2041565|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041566|NCT01588990|Antidotes|antidotes|mesh-ancestor
2041567|NCT01588990|Protective Agents|protective agents|mesh-ancestor
2041568|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
2041569|NCT01588990|Vitamins|vitamins|mesh-ancestor
2041570|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
2041571|NCT01589094|Gemcitabine|gemcitabine|mesh-list
2041572|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041573|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2041574|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
2041575|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041576|NCT01589094|Antiviral Agents|antiviral agents|mesh-ancestor
2041577|NCT01589094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041578|NCT01589094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041579|NCT01589094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2041580|NCT01589094|Immunologic Factors|immunologic factors|mesh-ancestor
2041581|NCT01589094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041582|NCT01589263|Tamsulosin|tamsulosin|mesh-list
2041583|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2041584|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2041585|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2041586|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
2041587|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041588|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041589|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041590|NCT01589263|Urological Agents|urological agents|mesh-ancestor
2041591|NCT01589445|Metformin|metformin|mesh-list
2041592|NCT01589445|Pioglitazone|pioglitazone|mesh-list
2041593|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2041594|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041595|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
2041596|NCT01589497|Rifampin|rifampin|mesh-list
2041597|NCT01589497|Isoniazid|isoniazid|mesh-list
2041598|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
2041599|NCT01589497|Ethambutol|ethambutol|mesh-list
2041600|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2041601|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041602|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2041603|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2041604|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041605|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041606|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041607|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2041608|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
2041609|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
2041610|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2041611|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2041612|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2041613|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2041614|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2041615|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2041616|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2041617|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2041618|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2041619|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
2041620|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2041621|NCT01589510|Bimatoprost|bimatoprost|mesh-list
2041622|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2041623|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2041624|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2041625|NCT01589653|Insulin|insulin|mesh-list
2041626|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2041627|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
2041628|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
2041629|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2041630|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
2041631|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2041632|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
2041633|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2041634|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041635|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2041636|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
2041637|NCT01589822|Coagulants|coagulants|mesh-ancestor
2041638|NCT01589978|Aspirin|aspirin|mesh-list
2041639|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
2041640|NCT01589978|Salicylates|salicylates|mesh-list
2041641|NCT01589978|Ticlopidine|ticlopidine|mesh-list
2041642|NCT01589978|Clopidogrel|clopidogrel|mesh-list
2041643|NCT01589978|Ticagrelor|ticagrelor|mesh-list
2041644|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2041645|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2041646|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2041647|NCT01589978|Analgesics|analgesics|mesh-ancestor
2041648|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
2041649|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041650|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041651|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2041652|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2041653|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2041654|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2041655|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041656|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2041657|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2041658|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041659|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
2041660|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2041661|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2041662|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2041663|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
2041664|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041665|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041666|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
2041667|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
2041668|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
2041669|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2041670|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2041671|NCT01590017|Cisplatin|cisplatin|mesh-list
2475606|NCT01085097|Glucocorticoids|glucocorticoids|mesh-ancestor
2041672|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041673|NCT01590082|Doxycycline|doxycycline|mesh-list
2041674|NCT01590082|Temozolomide|temozolomide|mesh-list
2041675|NCT01590082|Ipilimumab|ipilimumab|mesh-list
2041676|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2041677|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
2041678|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041679|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041680|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2041681|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2041682|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2041683|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041684|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
2041685|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2041686|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2041687|NCT01590433|Exenatide|exenatide|mesh-list
2041688|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2041689|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041690|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2041691|NCT01590433|Incretins|incretins|mesh-ancestor
2041692|NCT01590433|Hormones|hormones|mesh-ancestor
2041693|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2041694|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
2041695|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2041696|NCT01590758|Pexiganan|pexiganan|mesh-list
2041697|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2041698|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041699|NCT01590771|Metformin|metformin|mesh-list
2041700|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2041701|NCT01590771|Glimepiride|glimepiride|mesh-list
2041702|NCT01590771|Gliclazide|gliclazide|mesh-list
2041703|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2041704|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041705|NCT01590771|Incretins|incretins|mesh-ancestor
2041706|NCT01590771|Hormones|hormones|mesh-ancestor
2041707|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2041708|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2041709|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
2041710|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041711|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041712|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2041713|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2041714|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
2041715|NCT01590797|Metformin|metformin|mesh-list
2041716|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2041717|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2041718|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041719|NCT01590797|Incretins|incretins|mesh-ancestor
2041720|NCT01590797|Hormones|hormones|mesh-ancestor
2041721|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2041722|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2041723|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
2041724|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041725|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041726|NCT01590875|Adenosine|adenosine|mesh-list
2041727|NCT01590875|Analgesics|analgesics|mesh-ancestor
2041728|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
2041729|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041730|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041731|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2041732|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
2041733|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2041734|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
2041735|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
2041736|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041737|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041738|NCT01590979|Ranolazine|ranolazine|mesh-list
2041739|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2041740|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2041741|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041742|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2041743|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2041744|NCT01591382|Ketamine|ketamine|mesh-list
2041745|NCT01591382|Hydromorphone|hydromorphone|mesh-list
2041746|NCT01591382|Analgesics|analgesics|mesh-ancestor
2041747|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
2041748|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041749|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041750|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2041751|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2041752|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
2041753|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
2041754|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2041755|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2041756|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2041757|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041758|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041759|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2041760|NCT01591382|Narcotics|narcotics|mesh-ancestor
2041761|NCT01591460|Ribavirin|ribavirin|mesh-list
2041762|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2041763|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
2041764|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
2041765|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041766|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
2041767|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041768|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
2041769|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041770|NCT01591616|Lidocaine|lidocaine|mesh-list
2041771|NCT01591616|Prilocaine|prilocaine|mesh-list
2041772|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
2041773|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
2041774|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2041775|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041776|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
2041777|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041778|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2041779|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2041780|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2041781|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2041782|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041783|NCT01591733|Capecitabine|capecitabine|mesh-list
2041784|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
2041785|NCT01591733|Irinotecan|irinotecan|mesh-list
2041786|NCT01591733|Folfirinox|folfirinox|mesh-list
2041787|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2041788|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
2041789|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041790|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041791|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2041792|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2041793|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041794|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
2041795|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2041796|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2041797|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2041798|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2041799|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041800|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
2041801|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041802|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041803|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2041804|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041805|NCT01591785|Retapamulin|retapamulin|mesh-list
2041806|NCT01591785|Petrolatum|petrolatum|mesh-list
2041807|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2041808|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041809|NCT01591785|Emollients|emollients|mesh-ancestor
2041810|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2041811|NCT01591837|Vaccines|vaccines|mesh-list
2041812|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
2041813|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041814|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
2041815|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2041816|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041817|NCT01592006|Ribavirin|ribavirin|mesh-list
2041818|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2041819|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
2041820|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041821|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
2041822|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041823|NCT01592045|Aldesleukin|aldesleukin|mesh-list
2041824|NCT01592045|Molgramostim|molgramostim|mesh-list
2041825|NCT01592045|Dinutuximab|dinutuximab|mesh-list
2041826|NCT01592045|Isotretinoin|isotretinoin|mesh-list
2041827|NCT01592045|Sargramostim|sargramostim|mesh-list
2041828|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
2041829|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041830|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041831|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2041832|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2041833|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
2041834|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041835|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
2041836|NCT01592240|Bococizumab|bococizumab|mesh-list
2041837|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2041838|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2041839|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
2041840|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041841|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2041842|NCT01592292|Adalimumab|adalimumab|mesh-list
2041843|NCT01592292|Etanercept|etanercept|mesh-list
2041844|NCT01592292|Rituximab|rituximab|mesh-list
2041845|NCT01592292|Infliximab|infliximab|mesh-list
2041846|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2041847|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041848|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
2041849|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041850|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2041851|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2041852|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2041853|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2041854|NCT01592292|Analgesics|analgesics|mesh-ancestor
2041855|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
2041856|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041857|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2041858|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2041859|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
2041860|NCT01592409|Dronabinol|dronabinol|mesh-list
2041861|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
2041862|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041863|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2041864|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2041865|NCT01592409|Analgesics|analgesics|mesh-ancestor
2041866|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
2041867|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041868|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2041869|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2041870|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041871|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041872|NCT01592409|Hormones|hormones|mesh-ancestor
2041873|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2041874|NCT01592695|Ethanol|ethanol|mesh-list
2041875|NCT01592695|Bupropion|bupropion|mesh-list
2041876|NCT01592695|Nicotine|nicotine|mesh-list
2041877|NCT01592695|Varenicline|varenicline|mesh-list
2041878|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2041879|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
2041880|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041881|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041882|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2041883|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2041884|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
2041885|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041886|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041887|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2041888|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041889|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2041890|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2041891|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
2041892|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2041893|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2041894|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2041895|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2041896|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
2041897|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2041898|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2041899|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041900|NCT01592708|Erythromycin|erythromycin|mesh-list
2041901|NCT01592708|Ibuprofen|ibuprofen|mesh-list
2041902|NCT01592708|Ketorolac|ketorolac|mesh-list
2041903|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2041904|NCT01592708|Fentanyl|fentanyl|mesh-list
2041905|NCT01592708|Scopolamine|scopolamine|mesh-list
2041906|NCT01592708|Droperidol|droperidol|mesh-list
2041907|NCT01592708|Remifentanil|remifentanil|mesh-list
2041908|NCT01592708|Hydrocodone|hydrocodone|mesh-list
2041909|NCT01592708|Ondansetron|ondansetron|mesh-list
2041910|NCT01592708|Antiemetics|antiemetics|mesh-list
2041911|NCT01592708|Propofol|propofol|mesh-list
2041912|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
2041913|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2041914|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041915|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2041916|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2041917|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
2041918|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2041919|NCT01592708|Narcotics|narcotics|mesh-ancestor
2041920|NCT01592708|Analgesics|analgesics|mesh-ancestor
2041921|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
2041922|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2041923|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2041924|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2041925|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2041926|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2041927|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2041928|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2041929|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2041930|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041931|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
2041932|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2041933|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
2041934|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
2041935|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2041936|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
2041937|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041938|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2041939|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2041940|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2041941|NCT01592708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2041942|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
2041943|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
2041944|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2041945|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2041946|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2041947|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
2041948|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2041949|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
2041950|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2041951|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
2041952|NCT01592708|Hormones|hormones|mesh-ancestor
2041953|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2041954|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2041955|NCT01592708|Protective Agents|protective agents|mesh-ancestor
2041956|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2041957|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2041958|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2041959|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2041960|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
2041961|NCT01592747|Memantine|memantine|mesh-list
2041962|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2041963|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2041964|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
2041965|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041966|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041967|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041968|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2041969|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2041970|NCT01592773|Memantine|memantine|mesh-list
2041971|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2041972|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2041973|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
2041974|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041975|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041976|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041977|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2041978|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2041979|NCT01592786|Memantine|memantine|mesh-list
2041980|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2041981|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2041982|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
2041983|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2041984|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2041985|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041986|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2041987|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2041988|NCT01592851|Fluorides|fluorides|mesh-list
2041989|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
2041990|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
2041991|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
2041992|NCT01592851|Protective Agents|protective agents|mesh-ancestor
2041993|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2041994|NCT01592864|Fluorides|fluorides|mesh-list
2041995|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
2041996|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
2041997|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
2041998|NCT01592864|Protective Agents|protective agents|mesh-ancestor
2041999|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042000|NCT01593020|Paclitaxel|paclitaxel|mesh-list
2042001|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
2042002|NCT01593020|Doxorubicin|doxorubicin|mesh-list
2042003|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2042004|NCT01593020|Fluorouracil|fluorouracil|mesh-list
2042005|NCT01593020|Epirubicin|epirubicin|mesh-list
2042006|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2042007|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042008|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
2042009|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
2042010|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
2042011|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042012|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2042013|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
2042014|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042015|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2042016|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2042017|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
2042018|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2042019|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2042020|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2042021|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2042022|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042023|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
2042024|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2042025|NCT01593215|Yohimbine|yohimbine|mesh-list
2042026|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
2042027|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
2042028|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042029|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042030|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2042031|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2042032|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2042033|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
2042034|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2042035|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042036|NCT01593215|Urological Agents|urological agents|mesh-ancestor
2042043|NCT01593592|Amoxicillin|amoxicillin|mesh-list
2042044|NCT01593592|Clarithromycin|clarithromycin|mesh-list
2042045|NCT01593592|Omeprazole|omeprazole|mesh-list
2042046|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2042047|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042048|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2042049|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2042050|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2042051|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042052|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042053|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2475607|NCT01085097|Hormones|hormones|mesh-ancestor
2042054|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2042055|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2042056|NCT01593670|Decitabine|decitabine|mesh-list
2042057|NCT01593670|Interleukin-2|interleukin-2|mesh-list
2042058|NCT01593670|Vorinostat|vorinostat|mesh-list
2042059|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2042060|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
2042061|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042062|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042063|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042064|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2042065|NCT01593670|Analgesics|analgesics|mesh-ancestor
2042066|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
2042067|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042068|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042069|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2042070|NCT01593722|Ivermectin|ivermectin|mesh-list
2042071|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
2042072|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2042073|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042074|NCT01593722|Filaricides|filaricides|mesh-ancestor
2042075|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
2042076|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
2042077|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2042078|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042079|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042080|NCT01593748|Gemcitabine|gemcitabine|mesh-list
2042081|NCT01593748|Docetaxel|docetaxel|mesh-list
2042082|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2042083|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
2042084|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042085|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042086|NCT01593748|Antiviral Agents|antiviral agents|mesh-ancestor
2042087|NCT01593748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042088|NCT01593748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042089|NCT01593748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2042090|NCT01593748|Immunologic Factors|immunologic factors|mesh-ancestor
2042091|NCT01593748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042092|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
2042093|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
2042094|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
2042095|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2042096|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2042097|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042098|NCT01594125|Nintedanib|nintedanib|mesh-list
2042099|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042100|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2042101|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042102|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042103|NCT01594281|Ranibizumab|ranibizumab|mesh-list
2042104|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2042105|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2042106|NCT01594281|Growth Substances|growth substances|mesh-ancestor
2042107|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042108|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
2042109|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042110|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
2042111|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2042112|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
2042113|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042114|NCT01594333|Methotrexate|methotrexate|mesh-list
2042115|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2042116|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
2042117|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2042118|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042119|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2042120|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
2042121|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042122|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042123|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
2042124|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042125|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2042126|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2042127|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
2042128|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2042129|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2042130|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
2042131|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2042132|NCT01594424|Antibodies|antibodies|mesh-list
2042133|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
2042134|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2042135|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
2042136|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042137|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
2042138|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2042139|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
2042140|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2042141|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042142|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2042143|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2042144|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2042145|NCT01594749|Dexamethasone|dexamethasone|mesh-list
2042146|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
2042147|NCT01594749|Ondansetron|ondansetron|mesh-list
2042148|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
2042149|NCT01594749|Aprepitant|aprepitant|mesh-list
2042150|NCT01594749|BB 1101|bb 1101|mesh-list
2042151|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2042152|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
2042153|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
2042154|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042155|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042156|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2042157|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
2042158|NCT01594749|Hormones|hormones|mesh-ancestor
2042159|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2042160|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2042161|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042162|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
2042163|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042164|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042165|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
2042166|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
2042167|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2042168|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
2042169|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2042170|NCT01594749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2042171|NCT01594749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2042172|NCT01594749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2042173|NCT01594749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2042174|NCT01594749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2042175|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2042176|NCT01594762|Pexiganan|pexiganan|mesh-list
2042177|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2042178|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042179|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
2042180|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2042181|NCT01594827|Vancomycin|vancomycin|mesh-list
2042182|NCT01594827|Doxycycline|doxycycline|mesh-list
2042183|NCT01594827|Rifampin|rifampin|mesh-list
2042184|NCT01594827|Trimethoprim|trimethoprim|mesh-list
2042185|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
2042186|NCT01594827|Mupirocin|mupirocin|mesh-list
2042187|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2042188|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042189|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
2042190|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
2042191|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2042192|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
2042193|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2042194|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2042195|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2042196|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
2042197|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
2042198|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2042199|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042200|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042201|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2042202|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2042203|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2042204|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2042205|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2042206|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2042207|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2042208|NCT01594827|Renal Agents|renal agents|mesh-ancestor
2042209|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2042210|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2042211|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2042212|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2042213|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2042214|NCT01594931|Artesunate|artesunate|mesh-list
2042215|NCT01594931|Pyronaridine|pyronaridine|mesh-list
2042216|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
2042217|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2042218|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2042219|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042220|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042221|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
2042222|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
2042223|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2042224|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
2042225|NCT01594970|Bimatoprost|bimatoprost|mesh-list
2042226|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2042232|NCT01595282|Ibuprofen|ibuprofen|mesh-list
2042233|NCT01595282|Ketorolac|ketorolac|mesh-list
2042234|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2042235|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2042236|NCT01595282|Analgesics|analgesics|mesh-ancestor
2042237|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
2042238|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042239|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042240|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2042241|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2042242|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2042243|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042244|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042245|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
2042246|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2042247|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2042248|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
2042249|NCT01595438|Ceftazidime|ceftazidime|mesh-list
2042250|NCT01595438|Doripenem|doripenem|mesh-list
2042251|NCT01595438|Avibactam|avibactam|mesh-list
2042252|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2042253|NCT01595438|Trimethoprim|trimethoprim|mesh-list
2042254|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
2042255|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2042256|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042257|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2042258|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2042259|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042260|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042261|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042262|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2042263|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2042264|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2042265|NCT01595438|Renal Agents|renal agents|mesh-ancestor
2042266|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
2042267|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2042268|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2042269|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2042270|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2042271|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2042272|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2042273|NCT01595516|Ascorbic Acid|ascorbic acid|mesh-list
2042274|NCT01595516|Metoprolol|metoprolol|mesh-list
2042275|NCT01595516|Nebivolol|nebivolol|mesh-list
2042276|NCT01595516|Bradykinin|bradykinin|mesh-list
2042277|NCT01595516|Kininogens|kininogens|mesh-list
2042278|NCT01595516|Vitamins|vitamins|mesh-ancestor
2042279|NCT01595516|Micronutrients|micronutrients|mesh-ancestor
2042280|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042281|NCT01595516|Antioxidants|antioxidants|mesh-ancestor
2042282|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042283|NCT01595516|Protective Agents|protective agents|mesh-ancestor
2042284|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2042285|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2042286|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
2042287|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
2042288|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042289|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2042290|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2042291|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2042292|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
2042293|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2042294|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
2042295|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2042296|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2042297|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2042298|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2042299|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
2042300|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042301|NCT01595529|Trimethoprim|trimethoprim|mesh-list
2042302|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
2042303|NCT01595529|Cephalexin|cephalexin|mesh-list
2042304|NCT01595529|Cefixime|cefixime|mesh-list
2042305|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2042306|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042307|NCT01595529|Renal Agents|renal agents|mesh-ancestor
2042308|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
2042309|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2042310|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2042311|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2042312|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042313|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042314|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2042315|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2042316|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2042317|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2042318|NCT01595646|Insulin|insulin|mesh-list
2042319|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2042320|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
2042321|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2042322|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042323|NCT01595854|Dabigatran|dabigatran|mesh-list
2042324|NCT01595854|Ticagrelor|ticagrelor|mesh-list
2042325|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2042326|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2042327|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2042328|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2042329|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
2042330|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2042331|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042332|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042333|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
2042334|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2042335|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
2042336|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042337|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
2042338|NCT01596062|Cyclosporine|cyclosporine|mesh-list
2042339|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
2042340|NCT01596062|Everolimus|everolimus|mesh-list
2042341|NCT01596062|Cyclosporins|cyclosporins|mesh-list
2042342|NCT01596062|Basiliximab|basiliximab|mesh-list
2042343|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042344|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042345|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2042346|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
2042347|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042348|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
2042349|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042350|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
2042351|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2042352|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2042353|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042354|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2042355|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2042356|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
2042357|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2042358|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
2042359|NCT01596088|Razoxane|razoxane|mesh-list
2042360|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042361|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2042362|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2042363|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2042364|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042365|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042366|NCT01596088|Protective Agents|protective agents|mesh-ancestor
2042367|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042368|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
2042369|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
2042370|NCT01596127|Rituximab|rituximab|mesh-list
2042371|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2042372|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042373|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
2042374|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042375|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2042376|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
2042377|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2042378|NCT01596335|Antibodies|antibodies|mesh-list
2042379|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
2042380|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042381|NCT01596504|Metformin|metformin|mesh-list
2042382|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
2042383|NCT01596504|Liraglutide|liraglutide|mesh-list
2042384|NCT01596504|Lixisenatide|lixisenatide|mesh-list
2042385|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2042386|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042387|NCT01596504|Incretins|incretins|mesh-ancestor
2042388|NCT01596504|Hormones|hormones|mesh-ancestor
2042389|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2042390|NCT01596699|Fludarabine|fludarabine|mesh-list
2042391|NCT01596699|Busulfan|busulfan|mesh-list
2042392|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
2042393|NCT01596699|Clofarabine|clofarabine|mesh-list
2042394|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042395|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2042396|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
2042397|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042398|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2042399|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
2042400|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042401|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
2042402|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2042403|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2042404|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2042405|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
2042406|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2042407|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042408|NCT01596842|Vitamins|vitamins|mesh-ancestor
2042409|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
2042410|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2042411|NCT01597193|Fulvestrant|fulvestrant|mesh-list
2042412|NCT01597193|Anastrozole|anastrozole|mesh-list
2042413|NCT01597193|Exemestane|exemestane|mesh-list
2042414|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2042415|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042416|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2042417|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2042418|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
2042419|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2042420|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042421|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2042422|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2042423|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042424|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042425|NCT01597245|Etanercept|etanercept|mesh-list
2042426|NCT01597245|Ixekizumab|ixekizumab|mesh-list
2042427|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2042428|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2042429|NCT01597245|Analgesics|analgesics|mesh-ancestor
2042430|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
2042431|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042432|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042433|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2042434|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2042435|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2042436|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2042437|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
2042438|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
2042439|NCT01597258|Crizotinib|crizotinib|mesh-list
2042440|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042441|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2042442|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042443|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042444|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2042445|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2042454|NCT01597479|Anesthetics|anesthetics|mesh-list
2042455|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
2042456|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
2042457|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2042458|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042459|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
2042460|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042461|NCT01597492|Vaccines|vaccines|mesh-list
2042462|NCT01597492|Belimumab|belimumab|mesh-list
2042463|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
2042464|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042465|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2042466|NCT01597505|Vancomycin|vancomycin|mesh-list
2042467|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2042468|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042469|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
2042470|NCT01597557|Analgesics|analgesics|mesh-ancestor
2042471|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
2042472|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042473|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042474|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
2042475|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2042476|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2042477|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
2042478|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2042479|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2042480|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042481|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2042482|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
2042483|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2042484|NCT01597622|Belimumab|belimumab|mesh-list
2042485|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2042486|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
2042487|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042488|NCT01597908|Trametinib|trametinib|mesh-list
2042489|NCT01597908|Vemurafenib|vemurafenib|mesh-list
2042490|NCT01597908|Dabrafenib|dabrafenib|mesh-list
2042491|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042492|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2042493|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042494|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042495|NCT01597973|Meropenem|meropenem|mesh-list
2042496|NCT01597973|Colistin|colistin|mesh-list
2042497|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2042498|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042499|NCT01598090|Ribavirin|ribavirin|mesh-list
2042500|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2042501|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
2042502|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042503|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
2042504|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042505|NCT01598207|Dronabinol|dronabinol|mesh-list
2042506|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
2042507|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042508|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2042509|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2042510|NCT01598207|Analgesics|analgesics|mesh-ancestor
2042511|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
2042512|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042513|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2042514|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2042515|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2042516|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042517|NCT01598207|Hormones|hormones|mesh-ancestor
2042518|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2042519|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2042520|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2042521|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2042522|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2042523|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042524|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2042525|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042526|NCT01598298|Analgesics|analgesics|mesh-ancestor
2042527|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
2042528|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042529|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
2042530|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2042531|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
2042532|NCT01598311|Vancomycin|vancomycin|mesh-list
2042533|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2042534|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042535|NCT01598506|Hydromorphone|hydromorphone|mesh-list
2042536|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2042537|NCT01598506|Narcotics|narcotics|mesh-ancestor
2042538|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2042539|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042540|NCT01598506|Analgesics|analgesics|mesh-ancestor
2042541|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
2042542|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042543|NCT01598545|Hydromorphone|hydromorphone|mesh-list
2042544|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2042545|NCT01598545|Narcotics|narcotics|mesh-ancestor
2042546|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2042547|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042548|NCT01598545|Analgesics|analgesics|mesh-ancestor
2042549|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
2042550|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042551|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
2042552|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2042553|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
2042554|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2042555|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042556|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2042557|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2042558|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2042559|NCT01598701|Acetaminophen|acetaminophen|mesh-list
2042560|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2042561|NCT01598701|Analgesics|analgesics|mesh-ancestor
2042562|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
2042563|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042564|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042565|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
2042566|NCT01598740|Spironolactone|spironolactone|mesh-list
2042567|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2042568|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
2042569|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2042570|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042571|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2042572|NCT01598740|Diuretics|diuretics|mesh-ancestor
2042573|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
2042574|NCT01598753|Tramadol|tramadol|mesh-list
2042575|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2042576|NCT01598753|Narcotics|narcotics|mesh-ancestor
2042577|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2042578|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042579|NCT01598753|Analgesics|analgesics|mesh-ancestor
2042580|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
2042581|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042582|NCT01598896|Clonidine|clonidine|mesh-list
2042583|NCT01598896|Dronabinol|dronabinol|mesh-list
2042584|NCT01598896|Analgesics|analgesics|mesh-ancestor
2042585|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
2042586|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042587|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042588|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2042589|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
2042590|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
2042591|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2042592|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2042593|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2042594|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
2042595|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2042596|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042597|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
2042598|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2042599|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2042600|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2042601|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2042602|NCT01598896|Hormones|hormones|mesh-ancestor
2042603|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2042604|NCT01598987|Cyclosporine|cyclosporine|mesh-list
2042605|NCT01598987|Everolimus|everolimus|mesh-list
2042606|NCT01598987|Tacrolimus|tacrolimus|mesh-list
2042607|NCT01598987|Cyclosporins|cyclosporins|mesh-list
2042608|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2042609|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
2042610|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042611|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2042612|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042613|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042614|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
2042615|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042616|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
2042617|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2042618|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042619|NCT01599104|Olmesartan|olmesartan|mesh-list
2042620|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2042621|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2042622|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2042623|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2042624|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042625|NCT01599234|Nabiximols|nabiximols|mesh-list
2042626|NCT01599234|Analgesics|analgesics|mesh-ancestor
2042627|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
2042628|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042629|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042630|NCT01599325|Azacitidine|azacitidine|mesh-list
2042631|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2042632|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
2042633|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042634|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042635|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042636|NCT01599650|Ranibizumab|ranibizumab|mesh-list
2042637|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2042638|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2042639|NCT01599650|Growth Substances|growth substances|mesh-ancestor
2042640|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042641|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
2042642|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042643|NCT01599754|Axitinib|axitinib|mesh-list
2042644|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042645|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2042646|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042647|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042648|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
2042649|NCT01599806|Ceftazidime|ceftazidime|mesh-list
2042650|NCT01599806|Doripenem|doripenem|mesh-list
2042651|NCT01599806|Avibactam|avibactam|mesh-list
2042652|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2042653|NCT01599806|Trimethoprim|trimethoprim|mesh-list
2042654|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
2042655|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2042656|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042657|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2042658|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2042659|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042660|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042661|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042662|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2042663|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2042664|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2042665|NCT01599806|Renal Agents|renal agents|mesh-ancestor
2042666|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
2042667|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2042668|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2042669|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2042670|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2042671|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2042672|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2042673|NCT01600053|Lenalidomide|lenalidomide|mesh-list
2042674|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
2042675|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042676|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2042677|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2042678|NCT01600053|Growth Substances|growth substances|mesh-ancestor
2042679|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
2042680|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042681|NCT01600170|Atorvastatin|atorvastatin|mesh-list
2042682|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2042683|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2042684|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
2042685|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042686|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2042687|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2042688|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042689|NCT01600287|Propofol|propofol|mesh-list
2042690|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2042691|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2042692|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042693|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2042694|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
2042695|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
2042696|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2042697|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2042698|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042699|NCT01600703|Incretins|incretins|mesh-ancestor
2042700|NCT01600703|Hormones|hormones|mesh-ancestor
2042701|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2042702|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2042703|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
2042704|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042705|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042706|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
2042707|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2042708|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2042709|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2042710|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2042711|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042712|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
2042713|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2042714|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042715|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2042716|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042717|NCT01600885|Guanfacine|guanfacine|mesh-list
2042718|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2042719|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2042720|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2042721|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2042722|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
2042723|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2042724|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042725|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042726|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
2042727|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2042728|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042729|NCT01601132|Colchicine|colchicine|mesh-list
2042730|NCT01601132|Theophylline|theophylline|mesh-list
2042731|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
2042732|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2042733|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
2042734|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
2042735|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
2042736|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042737|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042738|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2042739|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
2042740|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042741|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042742|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2042743|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
2042744|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2042745|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042746|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
2042747|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2042748|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2042749|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
2042750|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2042751|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2042752|NCT01601236|Hormones|hormones|mesh-ancestor
2042753|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2042754|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042755|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
2042756|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2042757|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
2042758|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2042759|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2042760|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042761|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042762|NCT01601470|Urological Agents|urological agents|mesh-ancestor
2042763|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2042764|NCT01601535|Irinotecan|irinotecan|mesh-list
2042765|NCT01601535|Temozolomide|temozolomide|mesh-list
2042766|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2042767|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2042768|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042769|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042770|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042771|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2042772|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
2042773|NCT01601626|Pyridoxine|pyridoxine|mesh-list
2042774|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
2042775|NCT01601626|Ritonavir|ritonavir|mesh-list
2042776|NCT01601626|Lopinavir|lopinavir|mesh-list
2042777|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
2042778|NCT01601626|Rifampin|rifampin|mesh-list
2042779|NCT01601626|Isoniazid|isoniazid|mesh-list
2042780|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
2042781|NCT01601626|Ethambutol|ethambutol|mesh-list
2042782|NCT01601626|Rifabutin|rifabutin|mesh-list
2042783|NCT01601626|Vitamins|vitamins|mesh-ancestor
2042784|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
2042785|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042786|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2042787|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2042788|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
2042789|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042790|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042791|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2042792|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2042793|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
2042794|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042795|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2042796|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2042797|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
2042798|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2042799|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2042800|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2042801|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
2042802|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2042803|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
2042804|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2042805|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2042806|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2042807|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2042808|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2042809|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2042810|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2042811|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2042812|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2042813|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
2042814|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2042815|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
2042816|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2042817|NCT01601821|Sirolimus|sirolimus|mesh-list
2042818|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2042819|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2042820|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2042821|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042822|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
2042823|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2042824|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
2042825|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042826|NCT01601847|Vitamin D|vitamin d|mesh-list
2042827|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
2042828|NCT01601847|Vitamins|vitamins|mesh-ancestor
2042829|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
2042830|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042831|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2042832|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2042833|NCT01601873|Heparin|heparin|mesh-list
2042834|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
2042835|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2042836|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2042837|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042838|NCT01602068|Dexamethasone|dexamethasone|mesh-list
2042839|NCT01602068|Citric Acid|citric acid|mesh-list
2042840|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
2042841|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2042842|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2042843|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
2042844|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
2042845|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042846|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042847|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2042848|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
2042849|NCT01602068|Hormones|hormones|mesh-ancestor
2042850|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2042851|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2042852|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042853|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
2042854|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2042855|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
2042856|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
2042857|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042858|NCT01602224|Dexamethasone|dexamethasone|mesh-list
2042859|NCT01602224|Bortezomib|bortezomib|mesh-list
2042860|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2042861|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
2042862|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
2042863|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042864|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042865|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2042866|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
2042867|NCT01602224|Hormones|hormones|mesh-ancestor
2042868|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2042869|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2042870|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042871|NCT01602315|Cetuximab|cetuximab|mesh-list
2042872|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2042873|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042874|NCT01602380|Fulvestrant|fulvestrant|mesh-list
2042875|NCT01602380|Anastrozole|anastrozole|mesh-list
2042876|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2042877|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042878|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2042879|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2042880|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
2042881|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2042882|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042883|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2042884|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2042885|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2042886|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042887|NCT01602510|Lamotrigine|lamotrigine|mesh-list
2042888|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
2042889|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2042890|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2042891|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042892|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2042893|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042894|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2042895|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2042896|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2042897|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2042898|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2042899|NCT01602562|Valacyclovir|valacyclovir|mesh-list
2042900|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
2042901|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2746311|NCT05171075|Dalteparin|dalteparin|mesh-list
2746312|NCT05171075|Tinzaparin|tinzaparin|mesh-list
2746313|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2746314|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
2746315|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2746316|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2746317|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746318|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
2746319|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2746320|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746321|NCT05171049|Apixaban|apixaban|mesh-list
2746322|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2746323|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
2746324|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2042921|NCT01602679|Progesterone|progesterone|mesh-list
2042922|NCT01602679|Progestins|progestins|mesh-ancestor
2042923|NCT01602679|Hormones|hormones|mesh-ancestor
2042924|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2042925|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042926|NCT01602692|Lidocaine|lidocaine|mesh-list
2042927|NCT01602692|Epinephrine|epinephrine|mesh-list
2042928|NCT01602692|Racepinephrine|racepinephrine|mesh-list
2042929|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2042930|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
2042931|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
2042932|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
2042933|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2042934|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042935|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
2042936|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042937|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2042938|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2042939|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2042940|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2042941|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042942|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2042943|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2042944|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
2042945|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2042946|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2042947|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2042948|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
2042949|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2042950|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
2042951|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
2042952|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
2042953|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2042954|NCT01603082|Clopidogrel|clopidogrel|mesh-list
2042955|NCT01603082|Ticagrelor|ticagrelor|mesh-list
2042956|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2042957|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2042958|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2042959|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2042960|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
2042961|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2042962|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042963|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042964|NCT01603277|Antibodies|antibodies|mesh-list
2042965|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2042966|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
2042967|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042968|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
2042969|NCT01603420|Docetaxel|docetaxel|mesh-list
2042970|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
2042971|NCT01603420|Hormones|hormones|mesh-list
2042972|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2042973|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2042974|NCT01603420|Androgens|androgens|mesh-list
2042975|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2042976|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
2042977|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
2042978|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
2042979|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042980|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2042981|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042982|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
2042983|NCT01603420|Protective Agents|protective agents|mesh-ancestor
2042984|NCT01603420|Vitamins|vitamins|mesh-ancestor
2042985|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
2042986|NCT01603420|Estrogens|estrogens|mesh-ancestor
2042987|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2042988|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
2042989|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2042990|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2042991|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2042992|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2042993|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2042994|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2042995|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2042996|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
2042997|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2042998|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
2042999|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2043000|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2043001|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2043002|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043003|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043004|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
2043005|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043006|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043007|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2043008|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043009|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
2043010|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2043011|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2043012|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2043013|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043014|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043015|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
2043016|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043017|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043018|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2043019|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043020|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
2043021|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2043022|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2043023|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2043024|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043025|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043026|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
2043027|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043028|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043029|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2043030|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043031|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
2043032|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2043033|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2043034|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2043035|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043036|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043037|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
2043038|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043039|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043040|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2043041|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043042|NCT01603940|Losartan|losartan|mesh-list
2043043|NCT01603940|Benazepril|benazepril|mesh-list
2043044|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2043045|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2043046|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2043047|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2043048|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043049|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2043050|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
2043051|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043052|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
2043053|NCT01604109|Caseins|caseins|mesh-list
2043054|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2043055|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
2043056|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043057|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043058|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043059|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
2043060|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
2043061|NCT01604265|Nabiximols|nabiximols|mesh-list
2043062|NCT01604265|Analgesics|analgesics|mesh-ancestor
2043063|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
2043064|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043065|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043066|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
2043067|NCT01604278|Bromides|bromides|mesh-list
2043068|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
2043069|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2043070|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2043071|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2043072|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
2043073|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043074|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043075|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043076|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2043077|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
2043078|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043079|NCT01604785|Dopamine|dopamine|mesh-list
2043080|NCT01604785|Propofol|propofol|mesh-list
2043081|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
2043082|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2043083|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2043084|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043085|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2043086|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
2043087|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
2043088|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2043089|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
2043090|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
2043091|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043092|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
2043093|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043094|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043095|NCT01604785|Protective Agents|protective agents|mesh-ancestor
2043096|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
2043097|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
2043098|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2043099|NCT01605032|Bortezomib|bortezomib|mesh-list
2043100|NCT01605032|Melphalan|melphalan|mesh-list
2043101|NCT01605032|Busulfan|busulfan|mesh-list
2043102|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043103|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2043104|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
2043105|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043106|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2746325|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
2043107|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2043108|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
2043109|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043110|NCT01605071|Estradiol|estradiol|mesh-list
2043111|NCT01605071|Estrogens|estrogens|mesh-ancestor
2043112|NCT01605071|Hormones|hormones|mesh-ancestor
2043113|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043114|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043115|NCT01605136|Afamelanotide|afamelanotide|mesh-list
2043116|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
2043117|NCT01605227|Prednisone|prednisone|mesh-list
2043118|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2043119|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
2043120|NCT01605227|Hormones|hormones|mesh-ancestor
2043121|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043122|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043123|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2043124|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043125|NCT01605396|Exemestane|exemestane|mesh-list
2043126|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043127|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2043128|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2043129|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043130|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043131|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2043132|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
2043133|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043134|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043135|NCT01605539|Cannabidiol|cannabidiol|mesh-list
2043136|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
2043137|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
2043138|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2043139|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043140|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043141|NCT01605890|Tenofovir|tenofovir|mesh-list
2043142|NCT01605890|Emtricitabine|emtricitabine|mesh-list
2043143|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
2043144|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2043145|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
2043146|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2043147|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2043148|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2043149|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043150|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043151|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2043152|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2043153|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2043154|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2043155|NCT01605903|Acetaminophen|acetaminophen|mesh-list
2043156|NCT01605903|Ibuprofen|ibuprofen|mesh-list
2043157|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2043158|NCT01605903|Analgesics|analgesics|mesh-ancestor
2043159|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
2043160|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043161|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043162|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
2043163|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2043164|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2043165|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2043166|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2043167|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043168|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043169|NCT01605942|Dexamethasone|dexamethasone|mesh-list
2043170|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2043171|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
2043172|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
2043173|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043174|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043175|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2043176|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
2043177|NCT01605942|Hormones|hormones|mesh-ancestor
2043178|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043179|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2043180|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043181|NCT01606007|Metformin|metformin|mesh-list
2043182|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
2043183|NCT01606007|Saxagliptin|saxagliptin|mesh-list
2043184|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2043185|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043186|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2043187|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043188|NCT01606007|Incretins|incretins|mesh-ancestor
2043189|NCT01606007|Hormones|hormones|mesh-ancestor
2043190|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043191|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2043192|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
2043193|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043194|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2043195|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
2043196|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043197|NCT01606124|Protective Agents|protective agents|mesh-ancestor
2043198|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043199|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2043200|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2043201|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043202|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2043203|NCT01606137|Nabiximols|nabiximols|mesh-list
2043204|NCT01606137|Analgesics|analgesics|mesh-ancestor
2043205|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
2043206|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043207|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043208|NCT01606176|Nabiximols|nabiximols|mesh-list
2043209|NCT01606176|Analgesics|analgesics|mesh-ancestor
2043210|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
2043211|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043212|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043213|NCT01606189|Nabiximols|nabiximols|mesh-list
2043214|NCT01606189|Analgesics|analgesics|mesh-ancestor
2043215|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
2043216|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043217|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043218|NCT01606202|Nabiximols|nabiximols|mesh-list
2043219|NCT01606202|Analgesics|analgesics|mesh-ancestor
2043220|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
2043221|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043222|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043223|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2043224|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2043225|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2043226|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2043227|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043228|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2043229|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2043230|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2043231|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
2043232|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043233|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043234|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2043235|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2043236|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
2043237|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2043238|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2043239|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2043240|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2043241|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043242|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2043243|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2043244|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2043245|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
2043246|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043247|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043248|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2043249|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2043250|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
2043251|NCT01606306|Fluticasone|fluticasone|mesh-list
2043252|NCT01606306|Xhance|xhance|mesh-list
2043253|NCT01606306|Montelukast|montelukast|mesh-list
2043254|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2043255|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2043256|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
2043257|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043258|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043259|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2043260|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
2043261|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
2043262|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2043263|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2043264|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
2043265|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043266|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2043267|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2043268|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043269|NCT01606319|Acetaminophen|acetaminophen|mesh-list
2043270|NCT01606319|Ibuprofen|ibuprofen|mesh-list
2043271|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2043272|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2043273|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2043274|NCT01606319|Analgesics|analgesics|mesh-ancestor
2043275|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
2043276|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043277|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043278|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
2043279|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2043280|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2043281|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043282|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043283|NCT01606748|Gemcitabine|gemcitabine|mesh-list
2043284|NCT01606748|Necitumumab|necitumumab|mesh-list
2043285|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043286|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2043287|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
2043288|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043289|NCT01606748|Antiviral Agents|antiviral agents|mesh-ancestor
2043290|NCT01606748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2043291|NCT01606748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043292|NCT01606748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2043293|NCT01606748|Immunologic Factors|immunologic factors|mesh-ancestor
2043294|NCT01606748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043295|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2043296|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2043297|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
2043298|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043299|NCT01606787|Mannitol|mannitol|mesh-list
2043300|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2043301|NCT01606787|Diuretics|diuretics|mesh-ancestor
2043302|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
2043303|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043304|NCT01606800|Ribavirin|ribavirin|mesh-list
2043305|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
2043306|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2043307|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
2043308|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043309|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
2043310|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2043311|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043312|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
2043313|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2043314|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2043315|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043316|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2043317|NCT01606852|Analgesics|analgesics|mesh-ancestor
2043318|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
2043319|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043320|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2043321|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2043322|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2043323|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
2043324|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043325|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043326|NCT01607073|Verapamil|verapamil|mesh-list
2043327|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2043328|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2043329|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043330|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043331|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2043332|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043333|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
2043334|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2043335|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2043336|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
2043337|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2043338|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
2043339|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2043340|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043341|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2043342|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2043343|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043344|NCT01607346|Ezogabine|ezogabine|mesh-list
2043345|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
2043346|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043347|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043348|NCT01607411|Fluorides|fluorides|mesh-list
2043349|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
2043350|NCT01607411|Protective Agents|protective agents|mesh-ancestor
2043351|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043352|NCT01607450|Glucagon|glucagon|mesh-list
2043353|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2043354|NCT01607450|Incretins|incretins|mesh-ancestor
2043355|NCT01607450|Hormones|hormones|mesh-ancestor
2043356|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043357|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043358|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2043359|NCT01607476|Corticosterone|corticosterone|mesh-list
2043360|NCT01607476|Flutemetamol|flutemetamol|mesh-list
2043361|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2043362|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2043363|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043364|NCT01607554|Irinotecan|irinotecan|mesh-list
2043365|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2043366|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2043367|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043368|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043369|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043370|NCT01607593|Sertraline|sertraline|mesh-list
2043371|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
2043372|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2043373|NCT01607593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2043374|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2043375|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043376|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043377|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043378|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
2043379|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043380|NCT01607645|Cytarabine|cytarabine|mesh-list
2043381|NCT01607645|Decitabine|decitabine|mesh-list
2043382|NCT01607645|Azacitidine|azacitidine|mesh-list
2043383|NCT01607645|Idarubicin|idarubicin|mesh-list
2043384|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2043385|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
2043386|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043387|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043388|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
2043389|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2043390|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2043391|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
2043392|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043393|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043394|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2043395|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2043396|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2043397|NCT01607853|Calcitriol|calcitriol|mesh-list
2043398|NCT01607853|Betamethasone|betamethasone|mesh-list
2043399|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2043400|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
2043401|NCT01607853|Hormones|hormones|mesh-ancestor
2043402|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043403|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043404|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2043405|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
2043406|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2043407|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2043408|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043409|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043410|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2043411|NCT01607853|Vitamins|vitamins|mesh-ancestor
2043412|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
2043413|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2043414|NCT01607905|Acetaminophen|acetaminophen|mesh-list
2043415|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2043416|NCT01607905|Analgesics|analgesics|mesh-ancestor
2043417|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
2043418|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043419|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043420|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
2043421|NCT01608087|Bevacizumab|bevacizumab|mesh-list
2043422|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2043423|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043424|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2043425|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2043426|NCT01608087|Growth Substances|growth substances|mesh-ancestor
2043427|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043428|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
2043429|NCT01608295|Paroxetine|paroxetine|mesh-list
2043430|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
2043431|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2043432|NCT01608295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2043433|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2043434|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043435|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043436|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043437|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
2043438|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043439|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2043440|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2043441|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2043442|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2043443|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043444|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2043445|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2043446|NCT01608308|Acetaminophen|acetaminophen|mesh-list
2043447|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2043448|NCT01608308|Analgesics|analgesics|mesh-ancestor
2043449|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
2043450|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043451|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043452|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
2043453|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
2043454|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2043455|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2043456|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2043457|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043458|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043459|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
2043460|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043461|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043462|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2043463|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043464|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
2043465|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2043466|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2043467|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2043468|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043469|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043470|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
2043471|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043472|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043473|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2043474|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043475|NCT01608724|Saxagliptin|saxagliptin|mesh-list
2043476|NCT01608724|Incretins|incretins|mesh-ancestor
2043477|NCT01608724|Hormones|hormones|mesh-ancestor
2043478|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043479|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043480|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2043481|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
2043482|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043483|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043484|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2043485|NCT01609010|Interferons|interferons|mesh-list
2043486|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
2043487|NCT01609010|Rituximab|rituximab|mesh-list
2043488|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2043489|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043490|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
2043491|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043492|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2043493|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
2043494|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2043495|NCT01609023|Rituximab|rituximab|mesh-list
2043496|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2043497|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043498|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
2043499|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043500|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2043501|NCT01609218|Charcoal|charcoal|mesh-list
2043502|NCT01609218|Antidotes|antidotes|mesh-ancestor
2043503|NCT01609218|Protective Agents|protective agents|mesh-ancestor
2043504|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043505|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2043506|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2043507|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2043508|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043509|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043510|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043511|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043512|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2043513|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
2043514|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2043515|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
2043516|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2043517|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
2043518|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2043519|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2043520|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043521|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2043522|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043523|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043524|NCT01609556|Maytansine|maytansine|mesh-list
2043525|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2043526|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043527|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
2043528|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
2043529|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
2043530|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043546|NCT01609933|Interferons|interferons|mesh-list
2043547|NCT01609933|Ritonavir|ritonavir|mesh-list
2043548|NCT01609933|Ribavirin|ribavirin|mesh-list
2043549|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
2043550|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
2043551|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2043552|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043553|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
2043554|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2043555|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2043556|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2043557|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
2043558|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043559|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043560|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2043561|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2043562|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2043563|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2043564|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
2043565|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
2043566|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043567|NCT01610011|Glycine|glycine|mesh-list
2043568|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
2043569|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043570|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043571|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043572|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
2043573|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2043574|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
2043575|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043576|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043577|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2043578|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
2043579|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
2043580|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2043581|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
2043582|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043583|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043584|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2043585|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2043586|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043587|NCT01610154|Incretins|incretins|mesh-ancestor
2043588|NCT01610154|Hormones|hormones|mesh-ancestor
2043589|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043590|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2043591|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
2043592|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043593|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043594|NCT01610167|Listerine|listerine|mesh-list
2043595|NCT01610167|Fluorides|fluorides|mesh-list
2043596|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
2043597|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
2043598|NCT01610167|Protective Agents|protective agents|mesh-ancestor
2043599|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043600|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2043601|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2043602|NCT01610206|Gemcitabine|gemcitabine|mesh-list
2043603|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2043604|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
2043605|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043606|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043607|NCT01610206|Antiviral Agents|antiviral agents|mesh-ancestor
2043608|NCT01610206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2043609|NCT01610206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043610|NCT01610206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2043611|NCT01610206|Immunologic Factors|immunologic factors|mesh-ancestor
2043612|NCT01610206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043613|NCT01610284|Fulvestrant|fulvestrant|mesh-list
2043614|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2043615|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043616|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2043617|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2043618|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
2043619|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043620|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043621|NCT01610297|Deferasirox|deferasirox|mesh-list
2043622|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2043623|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
2043624|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
2043625|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043626|NCT01610336|Gefitinib|gefitinib|mesh-list
2043627|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043628|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2043629|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043630|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043631|NCT01610492|Belimumab|belimumab|mesh-list
2043632|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2043633|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
2043634|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043635|NCT01610557|Bevacizumab|bevacizumab|mesh-list
2043636|NCT01610557|Ranibizumab|ranibizumab|mesh-list
2043637|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2043638|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043639|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2043640|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2043641|NCT01610557|Growth Substances|growth substances|mesh-ancestor
2043642|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043643|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
2043644|NCT01610570|Plicamycin|plicamycin|mesh-list
2043645|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2043646|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043647|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2043648|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043649|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2043650|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043651|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043652|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2043653|NCT01610596|Halobetasol|halobetasol|mesh-list
2043654|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2043655|NCT01610687|Nabiximols|nabiximols|mesh-list
2043656|NCT01610687|Analgesics|analgesics|mesh-ancestor
2043657|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
2043658|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043659|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043660|NCT01610700|Nabiximols|nabiximols|mesh-list
2043661|NCT01610700|Analgesics|analgesics|mesh-ancestor
2043662|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
2043663|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043664|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043665|NCT01610713|Nabiximols|nabiximols|mesh-list
2043666|NCT01610713|Analgesics|analgesics|mesh-ancestor
2043667|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
2043668|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043669|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043670|NCT01611090|Rituximab|rituximab|mesh-list
2043671|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2043672|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2043673|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043674|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
2043675|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043676|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2043677|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2043678|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
2043679|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043680|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2043681|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2043682|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2043683|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043684|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043685|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043686|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043687|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2043688|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
2043689|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2043690|NCT01611259|Rituximab|rituximab|mesh-list
2043691|NCT01611259|Lenalidomide|lenalidomide|mesh-list
2043692|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2043693|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043694|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
2043695|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043696|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2043697|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2043698|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2043699|NCT01611259|Growth Substances|growth substances|mesh-ancestor
2043700|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
2043701|NCT01611298|Vaccines|vaccines|mesh-list
2043702|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
2043703|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043704|NCT01611558|Ipilimumab|ipilimumab|mesh-list
2043705|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2043706|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043707|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2043708|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043709|NCT01611571|Teriparatide|teriparatide|mesh-list
2043710|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
2043711|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
2043712|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
2043713|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2043714|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043715|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2043716|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2043717|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043718|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043719|NCT01611662|Gemcitabine|gemcitabine|mesh-list
2043720|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043721|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2043722|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
2043723|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043724|NCT01611662|Antiviral Agents|antiviral agents|mesh-ancestor
2043725|NCT01611662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2043726|NCT01611662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043727|NCT01611662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2043728|NCT01611662|Immunologic Factors|immunologic factors|mesh-ancestor
2043729|NCT01611662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043730|NCT01611857|Leucovorin|leucovorin|mesh-list
2043731|NCT01611857|Fluorouracil|fluorouracil|mesh-list
2043732|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
2043733|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
2043734|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
2043735|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043736|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2043737|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043738|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2043739|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
2043740|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043741|NCT01611857|Antidotes|antidotes|mesh-ancestor
2043742|NCT01611857|Protective Agents|protective agents|mesh-ancestor
2043743|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
2043744|NCT01611857|Vitamins|vitamins|mesh-ancestor
2043745|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
2043746|NCT01611883|Ezetimibe|ezetimibe|mesh-list
2043747|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2043748|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2043749|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
2043750|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043751|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2043752|NCT01611935|Vasopressins|vasopressins|mesh-list
2043753|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
2043754|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
2043755|NCT01611935|Coagulants|coagulants|mesh-ancestor
2043756|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2043757|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2043758|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
2043759|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043760|NCT01611948|Aprepitant|aprepitant|mesh-list
2043761|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
2043762|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
2043763|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043764|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043765|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2043766|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2043767|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043768|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043769|NCT01611974|Maribavir|maribavir|mesh-list
2043770|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
2043771|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2043772|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
2043773|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
2043774|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
2043775|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043776|NCT01612156|Lidocaine|lidocaine|mesh-list
2043777|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
2043778|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
2043779|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2043780|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043781|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
2043782|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043783|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2043784|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2043785|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2043786|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043787|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043788|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
2043789|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2043790|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
2043791|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2043792|NCT01612221|Expectorants|expectorants|mesh-ancestor
2043793|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
2043794|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2043795|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
2043796|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043797|NCT01612221|Protective Agents|protective agents|mesh-ancestor
2043798|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043799|NCT01612221|Antidotes|antidotes|mesh-ancestor
2746326|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746327|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746328|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
2043812|NCT01612546|Camptothecin|camptothecin|mesh-list
2043813|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2043814|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043815|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2043816|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2043817|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043818|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043819|NCT01612702|Dexamethasone|dexamethasone|mesh-list
2043820|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2043821|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
2043822|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
2043823|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043824|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043825|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2043826|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
2043827|NCT01612702|Hormones|hormones|mesh-ancestor
2043828|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043829|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2043830|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043831|NCT01612858|Metformin|metformin|mesh-list
2043832|NCT01612858|Pioglitazone|pioglitazone|mesh-list
2043833|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2043834|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043835|NCT01612884|Clopidogrel|clopidogrel|mesh-list
2043836|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2043837|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2043838|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2043839|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2043840|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2043841|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
2043842|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043843|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043844|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043845|NCT01613027|Rituximab|rituximab|mesh-list
2043846|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2043847|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043848|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
2043849|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043850|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2043851|NCT01613118|Irbesartan|irbesartan|mesh-list
2043852|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2043853|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2043854|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2043855|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043856|NCT01613131|Estradiol|estradiol|mesh-list
2043857|NCT01613131|Estrogens|estrogens|mesh-ancestor
2043858|NCT01613131|Hormones|hormones|mesh-ancestor
2043859|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043860|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043861|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
2043862|NCT01613326|Albuterol|albuterol|mesh-list
2043863|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
2043864|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2043865|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
2043866|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043867|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043868|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2043869|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
2043870|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
2043871|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2043872|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
2043873|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043874|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043875|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
2043876|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2043877|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2043878|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2043879|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2043880|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
2043881|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2043882|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2043883|NCT01613599|Rituximab|rituximab|mesh-list
2043884|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2043885|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043886|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
2043887|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043888|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2043889|NCT01613716|Dexamethasone|dexamethasone|mesh-list
2043890|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2043891|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
2043892|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
2043893|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043894|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043895|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2043896|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
2043897|NCT01613716|Hormones|hormones|mesh-ancestor
2043898|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043899|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2043900|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043901|NCT01614093|Oxytocin|oxytocin|mesh-list
2043902|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
2043903|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2043904|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043905|NCT01614210|Tamoxifen|tamoxifen|mesh-list
2043906|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2043907|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
2043908|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043909|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043910|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2043911|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043912|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2043913|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2043914|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2043915|NCT01614457|Ivacaftor|ivacaftor|mesh-list
2043916|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2043917|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043918|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043919|NCT01614470|Ivacaftor|ivacaftor|mesh-list
2043920|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2043921|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043922|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043923|NCT01614509|Triamcinolone|triamcinolone|mesh-list
2043924|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2043925|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2043926|NCT01614509|Bevacizumab|bevacizumab|mesh-list
2043927|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2043928|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2043929|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043930|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2043931|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2043932|NCT01614509|Growth Substances|growth substances|mesh-ancestor
2043933|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043934|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
2043935|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2043936|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
2043937|NCT01614509|Hormones|hormones|mesh-ancestor
2043938|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2043939|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2043940|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
2043941|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043942|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043943|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2043944|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2043945|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2043946|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043947|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2043948|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2043949|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043950|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
2043951|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043952|NCT01614769|Glimepiride|glimepiride|mesh-list
2043953|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2043954|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2043955|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043956|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2043957|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
2043958|NCT01614795|Sirolimus|sirolimus|mesh-list
2043959|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2043960|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2043961|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2043962|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2043963|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2043964|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
2043965|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2043966|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
2043967|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043968|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
2043969|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2043970|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2043971|NCT01614886|Rivastigmine|rivastigmine|mesh-list
2043972|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2043973|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2043974|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043975|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
2043976|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043977|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043978|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2043979|NCT01614886|Protective Agents|protective agents|mesh-ancestor
2043980|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2043981|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2043982|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2043983|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2043984|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2043985|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2043986|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2043987|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2043988|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2043989|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
2043990|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2043991|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2043992|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2043993|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2043994|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
2043995|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2043996|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2043997|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
2043998|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2043999|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2044000|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2044001|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044002|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044003|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2044004|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2044005|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2044006|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2044007|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
2044008|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044009|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044010|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2044011|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2044012|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
2044013|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2044014|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2044015|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
2044036|NCT01615198|Olmesartan|olmesartan|mesh-list
2044037|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2044038|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2044039|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2044040|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2044041|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044042|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2044043|NCT01615731|Digoxin|digoxin|mesh-list
2044044|NCT01615731|Misoprostol|misoprostol|mesh-list
2044045|NCT01615731|Mifepristone|mifepristone|mesh-list
2044046|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2044047|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
2044048|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2044049|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044050|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2044051|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2044052|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
2044053|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2044054|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2044055|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044056|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044057|NCT01615731|Protective Agents|protective agents|mesh-ancestor
2044058|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2044059|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2044060|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2044061|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2044062|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
2044063|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2044064|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2044065|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
2044066|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2044067|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
2044068|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2044069|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2044070|NCT01615809|Amphotericin B|amphotericin b|mesh-list
2044071|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2044072|NCT01615809|Amebicides|amebicides|mesh-ancestor
2044073|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2044074|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2044075|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044076|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2044077|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
2044078|NCT01615822|Artefenomel|artefenomel|mesh-list
2044079|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
2044080|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2044081|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2044082|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044083|NCT01615939|Bupivacaine|bupivacaine|mesh-list
2044084|NCT01615939|Ropivacaine|ropivacaine|mesh-list
2044085|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
2044086|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
2044087|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044088|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044089|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
2044090|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044091|NCT01616082|Phentermine|phentermine|mesh-list
2044092|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2044093|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044094|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
2044095|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2044096|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
2044097|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
2044098|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044099|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
2044100|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044101|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044102|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
2044103|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2044104|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
2044105|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2044106|NCT01616173|Dexamethasone|dexamethasone|mesh-list
2044107|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
2044108|NCT01616173|BB 1101|bb 1101|mesh-list
2044109|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2044110|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
2044111|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
2044112|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044113|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044114|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2044115|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
2044116|NCT01616173|Hormones|hormones|mesh-ancestor
2044117|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2044118|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2044119|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044120|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
2044121|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044122|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044123|NCT01616459|Vaccines|vaccines|mesh-list
2044124|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2044125|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
2044126|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044127|NCT01616654|Tazarotene|tazarotene|mesh-list
2044128|NCT01616654|Trifarotene|trifarotene|mesh-list
2044129|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
2044130|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
2044131|NCT01616693|Zinc|zinc|mesh-list
2044132|NCT01616693|Vaccines|vaccines|mesh-list
2044133|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
2044134|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044135|NCT01616693|Trace Elements|trace elements|mesh-ancestor
2044136|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
2044137|NCT01617083|Azithromycin|azithromycin|mesh-list
2044138|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2044139|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044140|NCT01617148|Aflibercept|aflibercept|mesh-list
2044141|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2044142|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2044143|NCT01617148|Growth Substances|growth substances|mesh-ancestor
2044144|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044145|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
2044146|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044147|NCT01617187|Olanzapine|olanzapine|mesh-list
2044148|NCT01617187|Asenapine|asenapine|mesh-list
2044149|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
2044150|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
2044151|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044152|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044153|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2044154|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2044155|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2044156|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044157|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2044158|NCT01617187|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2044159|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2044160|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2044161|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044162|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044163|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
2044164|NCT01617434|Liraglutide|liraglutide|mesh-list
2044165|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2044166|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044167|NCT01617434|Incretins|incretins|mesh-ancestor
2044168|NCT01617434|Hormones|hormones|mesh-ancestor
2044169|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2044170|NCT01617447|Aripiprazole|aripiprazole|mesh-list
2044171|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
2044172|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2044173|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2044174|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2044175|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044176|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044177|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
2044178|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
2044179|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044180|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044181|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2044182|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2044183|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
2044184|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2044185|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2044186|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2044187|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2044188|NCT01617460|Aripiprazole|aripiprazole|mesh-list
2044189|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
2044190|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2044191|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2044192|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2044193|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044194|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044195|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
2044196|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
2044197|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044198|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044199|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2044200|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2044201|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
2044202|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2044203|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2044204|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2044205|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2044206|NCT01617577|Lenograstim|lenograstim|mesh-list
2044207|NCT01617577|Sargramostim|sargramostim|mesh-list
2044208|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2044209|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
2044210|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044211|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2044212|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
2044213|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044214|NCT01617668|Paclitaxel|paclitaxel|mesh-list
2044215|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2044216|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044217|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
2044218|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
2044219|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
2044220|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044221|NCT01617681|Valsartan|valsartan|mesh-list
2044222|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2044223|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2044224|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2044225|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044226|NCT01618162|Liraglutide|liraglutide|mesh-list
2044227|NCT01618162|Xultophy|xultophy|mesh-list
2044228|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2044229|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044230|NCT01618162|Incretins|incretins|mesh-ancestor
2044231|NCT01618162|Hormones|hormones|mesh-ancestor
2044232|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2044233|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
2044234|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
2044235|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2044236|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2044237|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044238|NCT01618266|Dexamethasone|dexamethasone|mesh-list
2044239|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2044240|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
2044241|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
2044242|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044243|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044244|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2044245|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
2044246|NCT01618266|Hormones|hormones|mesh-ancestor
2044247|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2044248|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2044249|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044250|NCT01618305|Lamivudine|lamivudine|mesh-list
2044251|NCT01618305|Zidovudine|zidovudine|mesh-list
2044252|NCT01618305|Efavirenz|efavirenz|mesh-list
2044253|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2044254|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
2044255|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2044256|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2044257|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044258|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044259|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
2044260|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044261|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2044262|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2044263|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
2044264|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2044265|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2044266|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2044267|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2044268|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2044269|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2044270|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2044271|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2044272|NCT01618669|Regadenoson|regadenoson|mesh-list
2044273|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2044274|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2044275|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
2044276|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
2044277|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044278|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044279|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044280|NCT01618708|Hylan|hylan|mesh-list
2044281|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
2044282|NCT01618708|Protective Agents|protective agents|mesh-ancestor
2044283|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044284|NCT01619059|Metformin|metformin|mesh-list
2044285|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
2044286|NCT01619059|Saxagliptin|saxagliptin|mesh-list
2044287|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2044288|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044289|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2044290|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044291|NCT01619059|Incretins|incretins|mesh-ancestor
2044292|NCT01619059|Hormones|hormones|mesh-ancestor
2044293|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2044294|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2044295|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
2044296|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044297|NCT01619085|Nintedanib|nintedanib|mesh-list
2044298|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044299|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2044300|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044301|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044302|NCT01619410|Clindamycin|clindamycin|mesh-list
2044303|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
2044304|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
2044305|NCT01619410|Linezolid|linezolid|mesh-list
2044306|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2044307|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044308|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2044309|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044310|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044311|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
2044312|NCT01619423|Edetic Acid|edetic acid|mesh-list
2044313|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
2044314|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2044315|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
2044316|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
2044317|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044318|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
2044319|NCT01619423|Vitamins|vitamins|mesh-ancestor
2044320|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
2044321|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044322|NCT01619774|Trametinib|trametinib|mesh-list
2044323|NCT01619774|Dabrafenib|dabrafenib|mesh-list
2044324|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044325|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2044326|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044327|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044328|NCT01619852|Lidocaine|lidocaine|mesh-list
2044329|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
2044330|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
2044331|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044332|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044333|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
2044334|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044335|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2044336|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2044337|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2044338|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2044339|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044340|NCT01619865|Edotreotide|edotreotide|mesh-list
2044341|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2044342|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044343|NCT01619878|Lumefantrine|lumefantrine|mesh-list
2044344|NCT01619878|Artemether|artemether|mesh-list
2044345|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2044346|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
2044347|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2044348|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2044349|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044350|NCT01619982|Vancomycin|vancomycin|mesh-list
2044351|NCT01619982|Cefazolin|cefazolin|mesh-list
2044352|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2044353|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044354|NCT01620047|Fentanyl|fentanyl|mesh-list
2044355|NCT01620047|Ropivacaine|ropivacaine|mesh-list
2044356|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
2044357|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
2044358|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044359|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044360|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
2044361|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044362|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2044363|NCT01620047|Narcotics|narcotics|mesh-ancestor
2044364|NCT01620047|Analgesics|analgesics|mesh-ancestor
2044365|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2044366|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2044367|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
2044368|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2044369|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2044370|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2044371|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044372|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044373|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2044374|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2044375|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2044376|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2044377|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
2044378|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044379|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044380|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2044381|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2044382|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
2044383|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2044384|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2044385|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
2044386|NCT01620138|Cabergoline|cabergoline|mesh-list
2044387|NCT01620138|Pasireotide|pasireotide|mesh-list
2044388|NCT01620138|Hormones|hormones|mesh-ancestor
2044389|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2044390|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044391|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2044392|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2044393|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
2044394|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
2044395|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044396|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044397|NCT01620177|Ethanol|ethanol|mesh-list
2044398|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2044399|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044400|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044401|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044402|NCT01620190|Paclitaxel|paclitaxel|mesh-list
2044403|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2044404|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2044405|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044406|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
2044407|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
2044408|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
2044409|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044410|NCT01620216|Sorafenib|sorafenib|mesh-list
2044411|NCT01620216|Sunitinib|sunitinib|mesh-list
2044412|NCT01620216|Dasatinib|dasatinib|mesh-list
2044413|NCT01620216|Ponatinib|ponatinib|mesh-list
2044414|NCT01620216|Idelalisib|idelalisib|mesh-list
2044415|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
2044416|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2044417|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2044418|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044419|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044420|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2044421|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2044422|NCT01620216|Growth Substances|growth substances|mesh-ancestor
2044423|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044424|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
2044425|NCT01620489|Liraglutide|liraglutide|mesh-list
2044426|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2044427|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044428|NCT01620489|Incretins|incretins|mesh-ancestor
2044429|NCT01620489|Hormones|hormones|mesh-ancestor
2044430|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2044431|NCT01620593|Metformin|metformin|mesh-list
2044432|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2044433|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746363|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2746364|NCT05170841|Tramadol|tramadol|mesh-list
2746365|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2746366|NCT05170841|Narcotics|narcotics|mesh-ancestor
2746367|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2746368|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746369|NCT05170841|Analgesics|analgesics|mesh-ancestor
2746370|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
2746371|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2746372|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2746373|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2746374|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2044452|NCT01621009|Bupropion|bupropion|mesh-list
2044453|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2044454|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
2044455|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2044456|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2044457|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2044458|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2044459|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044460|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
2044461|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044462|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044463|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2044464|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2044465|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044466|NCT01621178|Insulin|insulin|mesh-list
2044467|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2044468|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
2044469|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
2044470|NCT01621178|Dulaglutide|dulaglutide|mesh-list
2044471|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2044472|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044473|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2044474|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2044475|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2044476|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2044477|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044478|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044479|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044480|NCT01621191|Analgesics|analgesics|mesh-ancestor
2044481|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
2044482|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044483|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
2044484|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2044485|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
2044486|NCT01621230|Fentanyl|fentanyl|mesh-list
2044487|NCT01621230|Bupivacaine|bupivacaine|mesh-list
2044488|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
2044489|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
2044490|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044491|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044492|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
2044493|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044494|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2044495|NCT01621230|Narcotics|narcotics|mesh-ancestor
2044496|NCT01621230|Analgesics|analgesics|mesh-ancestor
2044497|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2044498|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2044499|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
2044500|NCT01621477|Cytarabine|cytarabine|mesh-list
2044501|NCT01621477|Plerixafor|plerixafor|mesh-list
2044502|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
2044503|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
2044504|NCT01621477|Busulfan|busulfan|mesh-list
2044505|NCT01621477|Clofarabine|clofarabine|mesh-list
2044506|NCT01621477|Tacrolimus|tacrolimus|mesh-list
2044507|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
2044508|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2044509|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2044510|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
2044511|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044512|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2044513|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2044514|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
2044515|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044516|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044517|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2746375|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2044518|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2044519|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
2044520|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
2044521|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044522|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2044523|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044524|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2044525|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2044526|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
2044527|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2044528|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2044529|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2044530|NCT01621490|Nivolumab|nivolumab|mesh-list
2044531|NCT01621490|Ipilimumab|ipilimumab|mesh-list
2044532|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2044533|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044534|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2044535|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044536|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2044537|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2044538|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044539|NCT01621672|Lenalidomide|lenalidomide|mesh-list
2044540|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
2044541|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044542|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2044543|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2044544|NCT01621672|Growth Substances|growth substances|mesh-ancestor
2044545|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
2044546|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044547|NCT01621776|Insulin|insulin|mesh-list
2044548|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2044549|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
2044550|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
2044551|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
2044552|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2044553|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044554|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
2044555|NCT01621880|Bevacizumab|bevacizumab|mesh-list
2044556|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2044557|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044558|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2044559|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2044560|NCT01621880|Growth Substances|growth substances|mesh-ancestor
2044561|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044562|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
2044563|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2044564|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
2044565|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
2044566|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044567|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2044568|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
2044569|NCT01621880|Hormones|hormones|mesh-ancestor
2044570|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2044571|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2044572|NCT01621880|Protective Agents|protective agents|mesh-ancestor
2044573|NCT01622231|Fluticasone|fluticasone|mesh-list
2044574|NCT01622231|Xhance|xhance|mesh-list
2044575|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2044576|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2044577|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
2044578|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044579|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044580|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2044581|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
2044582|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
2044583|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2044584|NCT01622257|Metformin|metformin|mesh-list
2044585|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2044586|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044587|NCT01622296|Lidocaine|lidocaine|mesh-list
2044588|NCT01622296|Epinephrine|epinephrine|mesh-list
2044589|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
2044590|NCT01622296|Anesthetics|anesthetics|mesh-list
2044591|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044592|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044593|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
2044594|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044595|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2044596|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2044597|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2044598|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2044599|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044600|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2044601|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2044602|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
2044603|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044604|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2044605|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2044606|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
2044607|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2044608|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
2044609|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
2044610|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
2044611|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2044612|NCT01622543|Leucovorin|leucovorin|mesh-list
2044613|NCT01622543|Bevacizumab|bevacizumab|mesh-list
2044614|NCT01622543|Fluorouracil|fluorouracil|mesh-list
2044615|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
2044616|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2044617|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044618|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2044619|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2044620|NCT01622543|Growth Substances|growth substances|mesh-ancestor
2044621|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044622|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
2044623|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
2044624|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044625|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2044626|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2044627|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
2044628|NCT01622543|Antidotes|antidotes|mesh-ancestor
2044629|NCT01622543|Protective Agents|protective agents|mesh-ancestor
2044630|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
2044631|NCT01622543|Vitamins|vitamins|mesh-ancestor
2044632|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
2044633|NCT01622569|Fluticasone|fluticasone|mesh-list
2044634|NCT01622569|Xhance|xhance|mesh-list
2044635|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2044636|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2044637|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
2044638|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044639|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044640|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2044641|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
2044642|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
2044643|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2044644|NCT01622660|Gemcitabine|gemcitabine|mesh-list
2044645|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2044646|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
2044647|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044648|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044649|NCT01622660|Antiviral Agents|antiviral agents|mesh-ancestor
2044650|NCT01622660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044651|NCT01622660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044652|NCT01622660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2044653|NCT01622660|Immunologic Factors|immunologic factors|mesh-ancestor
2044654|NCT01622660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044655|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
2044656|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
2044657|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2044658|NCT01622673|Antacids|antacids|mesh-list
2044659|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
2044660|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
2044661|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
2044662|NCT01622673|TEMPO|tempo|mesh-list
2044663|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044664|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2044665|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2044666|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
2044667|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044668|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2044669|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2044670|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044671|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044672|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2044673|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2044674|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
2044675|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
2044676|NCT01622673|Protective Agents|protective agents|mesh-ancestor
2044682|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2044683|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
2044684|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044685|NCT01623167|Cyclosporine|cyclosporine|mesh-list
2044686|NCT01623167|Cyclosporins|cyclosporins|mesh-list
2044687|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2044688|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044689|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044690|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2044691|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
2044692|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044693|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
2044694|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044695|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
2044696|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2044697|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2044698|NCT01623271|Gabapentin|gabapentin|mesh-list
2044699|NCT01623271|Analgesics|analgesics|mesh-ancestor
2044700|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
2044701|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044702|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044703|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
2044704|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2044705|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2044706|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044707|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2044708|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2044709|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2044710|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044711|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044712|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
2044713|NCT01623310|Fluticasone|fluticasone|mesh-list
2044714|NCT01623310|Xhance|xhance|mesh-list
2044715|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2044716|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2044717|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
2044718|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044719|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044720|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2044721|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
2044722|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
2044723|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2044724|NCT01623323|Fluticasone|fluticasone|mesh-list
2044725|NCT01623323|Xhance|xhance|mesh-list
2044726|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2044727|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2044728|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
2044729|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044730|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044731|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2044732|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
2044733|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
2044734|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2044735|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
2044736|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
2044737|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2044738|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044739|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2044740|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2044741|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2044742|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2044743|NCT01623479|Bimatoprost|bimatoprost|mesh-list
2044744|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2044745|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2044746|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2044747|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044748|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2044749|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
2044750|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044751|NCT01623752|Etanercept|etanercept|mesh-list
2044752|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2044753|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2044754|NCT01623752|Analgesics|analgesics|mesh-ancestor
2044755|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
2044756|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044757|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044758|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2044759|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2044760|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2044761|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2044762|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
2044763|NCT01623869|Trebananib|trebananib|mesh-list
2044764|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2044765|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2044766|NCT01623869|Growth Substances|growth substances|mesh-ancestor
2044767|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044768|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
2044769|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044770|NCT01624090|Plicamycin|plicamycin|mesh-list
2044771|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2044772|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044773|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2044774|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044775|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2044776|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044777|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044778|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2044779|NCT01624142|Evolocumab|evolocumab|mesh-list
2044780|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2044781|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2044782|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
2044783|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044784|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2044785|NCT01624194|Oxytocin|oxytocin|mesh-list
2044786|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
2044787|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2044788|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044789|NCT01624233|Ixekizumab|ixekizumab|mesh-list
2044790|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
2044791|NCT01624259|Metformin|metformin|mesh-list
2044792|NCT01624259|Liraglutide|liraglutide|mesh-list
2044793|NCT01624259|Dulaglutide|dulaglutide|mesh-list
2044794|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2044795|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044796|NCT01624259|Incretins|incretins|mesh-ancestor
2044797|NCT01624259|Hormones|hormones|mesh-ancestor
2044798|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2044799|NCT01624467|Necitumumab|necitumumab|mesh-list
2044800|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2044801|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044802|NCT01624662|Fluticasone|fluticasone|mesh-list
2044803|NCT01624662|Xhance|xhance|mesh-list
2044804|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2044805|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2044806|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
2044807|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044808|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044809|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2044810|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
2044811|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
2044812|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2044813|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
2044814|NCT01624948|Everolimus|everolimus|mesh-list
2044815|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044816|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2044817|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
2044818|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044819|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2044820|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2044821|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
2044822|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2044823|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044824|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044825|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044826|NCT01624974|Montelukast|montelukast|mesh-list
2044827|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2044828|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
2044829|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2044830|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
2044831|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2044832|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044833|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2044834|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2044835|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044836|NCT01625000|Risperidone|risperidone|mesh-list
2044837|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2044838|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
2044839|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044840|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044841|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044842|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2044843|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2044844|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044845|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2044846|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2044847|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
2044848|NCT01625013|Hylan|hylan|mesh-list
2044849|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
2044850|NCT01625013|Protective Agents|protective agents|mesh-ancestor
2044851|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044852|NCT01625091|Naltrexone|naltrexone|mesh-list
2044853|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2044854|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2044855|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044856|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
2044857|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044858|NCT01625169|Etravirine|etravirine|mesh-list
2044859|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2044860|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2044861|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044862|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044863|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
2044864|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044865|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2044866|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2044867|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044868|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2044869|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
2044870|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044871|NCT01625286|Paclitaxel|paclitaxel|mesh-list
2044872|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2044873|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2044874|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044875|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
2044876|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
2044877|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
2044878|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044879|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
2044880|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
2044881|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044882|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
2044883|NCT01625377|Everolimus|everolimus|mesh-list
2044884|NCT01625377|Tacrolimus|tacrolimus|mesh-list
2044885|NCT01625377|Basiliximab|basiliximab|mesh-list
2044886|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2044887|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
2044888|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044889|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2044890|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044891|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044892|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044893|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2044894|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2044895|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
2746376|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
2746377|NCT05170828|Sirolimus|sirolimus|mesh-list
2746378|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
2746379|NCT05170828|Busulfan|busulfan|mesh-list
2746380|NCT05170828|Fludarabine|fludarabine|mesh-list
2746381|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2746382|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
2746383|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746384|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2746385|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2746386|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
2746387|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746388|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044896|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2044897|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044898|NCT01625455|Aprepitant|aprepitant|mesh-list
2044899|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
2044900|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
2044901|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044902|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044903|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2044904|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2044905|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044906|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044907|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
2044908|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2044909|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044910|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044911|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2044912|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2044913|NCT01625845|Protective Agents|protective agents|mesh-ancestor
2044914|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044915|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
2044916|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2044917|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
2044918|NCT01625897|Risperidone|risperidone|mesh-list
2044919|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2044920|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
2044921|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044922|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044923|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044924|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2044925|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2044926|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044927|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2044928|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2044929|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
2044930|NCT01625923|Olanzapine|olanzapine|mesh-list
2044931|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
2044932|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
2044933|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044934|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044935|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2044936|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2044937|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2044938|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2044939|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2044940|NCT01625923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2044941|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2044942|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2044943|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044944|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2044945|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
2044946|NCT01626092|Cyclosporine|cyclosporine|mesh-list
2044947|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
2044948|NCT01626092|Melphalan|melphalan|mesh-list
2044949|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
2044950|NCT01626092|Clofarabine|clofarabine|mesh-list
2044951|NCT01626092|Cyclosporins|cyclosporins|mesh-list
2044952|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044953|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044954|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2044955|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
2044956|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044957|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
2044958|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2044959|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
2044960|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2044961|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2044962|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2044963|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044964|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2044965|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
2044966|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2044967|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2044968|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
2044969|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2044970|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2044971|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2044972|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
2044973|NCT01626118|Indomethacin|indomethacin|mesh-list
2044974|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2044975|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2044976|NCT01626118|Analgesics|analgesics|mesh-ancestor
2044977|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
2044978|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2044979|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2044980|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2044981|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2044982|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
2044983|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
2044984|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2044985|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2044986|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2044987|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044988|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2044989|NCT01626352|Ofatumumab|ofatumumab|mesh-list
2044990|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2044991|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
2044992|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2044993|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2044994|NCT01626664|Gemcitabine|gemcitabine|mesh-list
2044995|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
2044996|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
2044997|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2044998|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
2044999|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045000|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045001|NCT01626664|Antiviral Agents|antiviral agents|mesh-ancestor
2045002|NCT01626664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2045003|NCT01626664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045004|NCT01626664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2045005|NCT01626664|Immunologic Factors|immunologic factors|mesh-ancestor
2045006|NCT01626664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045007|NCT01626872|Risperidone|risperidone|mesh-list
2045008|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2045009|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
2045010|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045011|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045012|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045013|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2045014|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2045015|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2045016|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2045017|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2045018|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
2045019|NCT01627067|Metformin|metformin|mesh-list
2045020|NCT01627067|Everolimus|everolimus|mesh-list
2045021|NCT01627067|Exemestane|exemestane|mesh-list
2045022|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2045023|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045024|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045025|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2045026|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
2045027|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2045028|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2045029|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045030|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045031|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2045032|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
2045033|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2045034|NCT01627249|Bevacizumab|bevacizumab|mesh-list
2045035|NCT01627249|Ranibizumab|ranibizumab|mesh-list
2045036|NCT01627249|Aflibercept|aflibercept|mesh-list
2045037|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2045038|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045039|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2045040|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2045041|NCT01627249|Growth Substances|growth substances|mesh-ancestor
2045042|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045043|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
2045044|NCT01627327|Fluticasone|fluticasone|mesh-list
2045045|NCT01627327|Xhance|xhance|mesh-list
2045046|NCT01627327|Bromides|bromides|mesh-list
2045047|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
2045048|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2045049|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2045050|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
2045051|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045052|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045053|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2045054|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
2045055|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
2045056|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2045057|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
2045058|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2045059|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
2045060|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045061|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045062|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
2045063|NCT01627782|Ketamine|ketamine|mesh-list
2045064|NCT01627782|Analgesics|analgesics|mesh-ancestor
2045065|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
2045066|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045067|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045068|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2045069|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2045070|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
2045071|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
2045072|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2045073|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2045074|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2045075|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045076|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045077|NCT01627860|Topiramate|topiramate|mesh-list
2045078|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
2045079|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2045080|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045081|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
2045082|NCT01628107|Hematinics|hematinics|mesh-ancestor
2045083|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
2045084|NCT01628120|Hematinics|hematinics|mesh-ancestor
2045085|NCT01628393|Ozanimod|ozanimod|mesh-list
2045086|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2045087|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045088|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2045089|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
2045090|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045091|NCT01628549|Sarecycline|sarecycline|mesh-list
2045092|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2045093|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2045094|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
2045095|NCT01628588|Bimatoprost|bimatoprost|mesh-list
2045096|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2045097|NCT01628601|Timolol|timolol|mesh-list
2045098|NCT01628601|Bimatoprost|bimatoprost|mesh-list
2045099|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2045100|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2045101|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
2045102|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045103|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045104|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045105|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2045106|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2045107|NCT01628692|Ribavirin|ribavirin|mesh-list
2045108|NCT01628692|Simeprevir|simeprevir|mesh-list
2045109|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
2045110|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045111|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
2045112|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2045113|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
2045114|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045115|NCT01628874|Lidocaine|lidocaine|mesh-list
2045116|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2045117|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
2045118|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
2045119|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2045120|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045121|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
2045122|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045123|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2045124|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2045125|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2045126|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2045127|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045128|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2045129|NCT01628913|Everolimus|everolimus|mesh-list
2045130|NCT01628913|Dactolisib|dactolisib|mesh-list
2045131|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045132|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2045133|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
2045134|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045135|NCT01628926|Ropinirole|ropinirole|mesh-list
2045136|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2045137|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2045138|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
2045139|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
2045140|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045141|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045142|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045143|NCT01628965|Rotigotine|rotigotine|mesh-list
2045144|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
2045145|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
2045146|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045147|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045148|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045149|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
2045150|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2045151|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
2045152|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045153|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
2045154|NCT01629134|Protective Agents|protective agents|mesh-ancestor
2045155|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
2045156|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
2045157|NCT01629290|Protective Agents|protective agents|mesh-ancestor
2045158|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045159|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
2045160|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2045161|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
2045162|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2045163|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
2045164|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045165|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045166|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
2746389|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2746390|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2746391|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2746392|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
2746393|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2746394|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2746395|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746396|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
2746397|NCT05170789|Dexamethasone|dexamethasone|mesh-list
2746398|NCT05170789|Elotuzumab|elotuzumab|mesh-list
2746399|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2746400|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
2746401|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
2746402|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2746403|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746404|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2746405|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
2746406|NCT05170789|Hormones|hormones|mesh-ancestor
2746407|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2746408|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2746409|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045198|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
2045199|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2045200|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
2045201|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2045202|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045203|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2045204|NCT01629589|Vaccines|vaccines|mesh-list
2045205|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
2045206|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045207|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2045208|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
2045209|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045210|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2045211|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
2045212|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2045213|NCT01629966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2045214|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2045215|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2045216|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045217|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045218|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
2045219|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045220|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2045221|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2045222|NCT01630109|Metoclopramide|metoclopramide|mesh-list
2045223|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
2045224|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
2045225|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045226|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045227|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2045228|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2045229|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2045230|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
2045231|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045232|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045233|NCT01630135|Fluticasone|fluticasone|mesh-list
2045234|NCT01630135|Xhance|xhance|mesh-list
2045235|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2045236|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2045237|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
2045238|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045239|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045240|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2045241|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
2045242|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
2045243|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2045244|NCT01630811|Quinidine|quinidine|mesh-list
2045245|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
2045246|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
2045247|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
2045248|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2045249|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2045250|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045251|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045252|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045253|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2045254|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2045255|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
2045256|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2045257|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
2045258|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2045259|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2045260|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2045261|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045262|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2045263|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2045264|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
2045265|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2045266|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2045267|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2045268|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2045269|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2045270|NCT01631110|Vaccines|vaccines|mesh-list
2045271|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
2045272|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045273|NCT01631149|Rocuronium|rocuronium|mesh-list
2045274|NCT01631149|Atracurium|atracurium|mesh-list
2045275|NCT01631149|Mivacurium|mivacurium|mesh-list
2045276|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2045277|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2045278|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2045279|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045280|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045281|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2045282|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2045283|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
2045284|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045285|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045286|NCT01631214|Alendronate|alendronate|mesh-list
2045287|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2045288|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2045289|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045290|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
2045291|NCT01631227|Eprosartan|eprosartan|mesh-list
2045292|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2045293|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
2045294|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2045295|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045296|NCT01631630|Pioglitazone|pioglitazone|mesh-list
2045297|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2045298|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045299|NCT01631656|Azelaic acid|azelaic acid|mesh-list
2045300|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045301|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
2045302|NCT01631682|Propranolol|propranolol|mesh-list
2045303|NCT01631682|Oxytocin|oxytocin|mesh-list
2045304|NCT01631682|Mifepristone|mifepristone|mesh-list
2045305|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
2045306|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2045307|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045308|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2045309|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2045310|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
2045311|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045312|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045313|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2045314|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2045315|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
2045316|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2045317|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
2045318|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2045319|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2045320|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2045321|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
2045322|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2045323|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2045324|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
2045325|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2045326|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
2045327|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2045328|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2045329|NCT01631825|Rotigotine|rotigotine|mesh-list
2045330|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
2045331|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
2045332|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045333|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045334|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045335|NCT01631864|Amlodipine|amlodipine|mesh-list
2045336|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2045337|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2045338|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2045339|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2045340|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045341|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2045342|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045343|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
2045344|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2045345|NCT01632150|Thalidomide|thalidomide|mesh-list
2045346|NCT01632150|Dexamethasone|dexamethasone|mesh-list
2045347|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
2045348|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
2045349|NCT01632150|Elotuzumab|elotuzumab|mesh-list
2045350|NCT01632150|BB 1101|bb 1101|mesh-list
2045351|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2045352|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
2045353|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045354|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2045355|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2045356|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
2045357|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045358|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045359|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2045360|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2045361|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
2045362|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
2045363|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045364|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2045365|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
2045366|NCT01632150|Hormones|hormones|mesh-ancestor
2045367|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2045368|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2045369|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
2045370|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045371|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
2045372|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2045373|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2045374|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2045375|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2045376|NCT01632150|Growth Substances|growth substances|mesh-ancestor
2045377|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
2045378|NCT01632215|Gabapentin|gabapentin|mesh-list
2045379|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
2045380|NCT01632215|Analgesics|analgesics|mesh-ancestor
2045381|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
2045382|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045383|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045384|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2045385|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2045386|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2045387|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2045388|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2045389|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2045390|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045391|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045392|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
2045393|NCT01632241|Belimumab|belimumab|mesh-list
2045394|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2045395|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
2045396|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045397|NCT01632306|Leucovorin|leucovorin|mesh-list
2045398|NCT01632306|Gemcitabine|gemcitabine|mesh-list
2045399|NCT01632306|Paclitaxel|paclitaxel|mesh-list
2045400|NCT01632306|Fluorouracil|fluorouracil|mesh-list
2045401|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
2045402|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2045403|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045404|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
2045405|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
2045406|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
2045407|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045408|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2045409|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
2045410|NCT01632306|Antiviral Agents|antiviral agents|mesh-ancestor
2045411|NCT01632306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2045412|NCT01632306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045413|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2045414|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
2045415|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045416|NCT01632306|Antidotes|antidotes|mesh-ancestor
2045417|NCT01632306|Protective Agents|protective agents|mesh-ancestor
2045418|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
2045419|NCT01632306|Vitamins|vitamins|mesh-ancestor
2045420|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
2045421|NCT01632345|Efavirenz|efavirenz|mesh-list
2045422|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2045423|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2045424|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2045425|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045426|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045427|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
2045428|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2045429|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2045430|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2045431|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2045432|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2045433|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2045434|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2045435|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2045436|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2045437|NCT01632423|Bimatoprost|bimatoprost|mesh-list
2045438|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2045439|NCT01632566|Celecoxib|celecoxib|mesh-list
2045440|NCT01632566|Simvastatin|simvastatin|mesh-list
2045441|NCT01632566|LY3031207|ly3031207|mesh-list
2045442|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2045443|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2045444|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
2045445|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045446|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2045447|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2045448|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045449|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2045450|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2045451|NCT01632566|Analgesics|analgesics|mesh-ancestor
2045452|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
2045453|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045454|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045455|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2045456|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2045457|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2045458|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2045459|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
2045460|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
2045461|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2045462|NCT01632579|Celecoxib|celecoxib|mesh-list
2045463|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2045464|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2045465|NCT01632579|Analgesics|analgesics|mesh-ancestor
2045466|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
2045467|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045468|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045469|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2045470|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2045471|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2045472|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2045473|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045474|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045475|NCT01632709|Bupivacaine|bupivacaine|mesh-list
2045476|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
2045477|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
2045478|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2045479|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045480|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
2045481|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045482|NCT01632891|Ritonavir|ritonavir|mesh-list
2045483|NCT01632891|Lopinavir|lopinavir|mesh-list
2045484|NCT01632891|Tenofovir|tenofovir|mesh-list
2045485|NCT01632891|Emtricitabine|emtricitabine|mesh-list
2045486|NCT01632891|Nevirapine|nevirapine|mesh-list
2045487|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2045488|NCT01632891|Efavirenz|efavirenz|mesh-list
2045489|NCT01632891|Trimethoprim|trimethoprim|mesh-list
2045490|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
2045491|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2045492|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2045493|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
2045494|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045495|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045496|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2045497|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2045498|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
2045499|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2045500|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2045501|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2045502|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2045503|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2045504|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2045505|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2045506|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2045507|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2045508|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2045509|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2045510|NCT01632891|Renal Agents|renal agents|mesh-ancestor
2045511|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
2045512|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2045513|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2045514|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2045515|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2045516|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2045517|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
2045518|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045519|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
2045520|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045521|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045522|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2045523|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2045524|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2045525|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2045526|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045527|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045528|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
2746420|NCT05170672|Abatacept|abatacept|mesh-list
2746421|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2746422|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746423|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746424|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2746425|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
2746426|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746427|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2746428|NCT05170607|Antibodies|antibodies|mesh-list
2746429|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
2045529|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2045530|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2045531|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2045532|NCT01633060|Fulvestrant|fulvestrant|mesh-list
2045533|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2045534|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045535|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2045536|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2045537|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
2045538|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2045539|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045540|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
2045541|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2045542|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
2045543|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2045544|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045545|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2045546|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
2045547|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045548|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2045549|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2045550|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2045551|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2045552|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045553|NCT01633853|Vitamin D|vitamin d|mesh-list
2045554|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
2045555|NCT01633853|Calcitriol|calcitriol|mesh-list
2045556|NCT01633853|Vitamins|vitamins|mesh-list
2045557|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
2045558|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045559|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2045560|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2045561|NCT01633853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2045562|NCT01633853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2045563|NCT01633853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045564|NCT01633853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2045565|NCT01633944|Buprenorphine|buprenorphine|mesh-list
2045566|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2045567|NCT01633944|Narcotics|narcotics|mesh-ancestor
2045568|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2045569|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045570|NCT01633944|Analgesics|analgesics|mesh-ancestor
2045571|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
2045572|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045573|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2045574|NCT01634100|Empagliflozin|empagliflozin|mesh-list
2045575|NCT01634100|Rifampin|rifampin|mesh-list
2045576|NCT01634100|Probenecid|probenecid|mesh-list
2045577|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2045578|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045579|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2045580|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045581|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2045582|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
2045583|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2045584|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2045585|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
2045586|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2045587|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045588|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2045589|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2045590|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2045591|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2045592|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2045593|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2045594|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
2045595|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
2045596|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2045597|NCT01634100|Renal Agents|renal agents|mesh-ancestor
2045598|NCT01634113|Bromides|bromides|mesh-list
2045599|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
2045600|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2045601|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
2045602|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045603|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045604|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2045605|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
2045606|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
2045607|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2045608|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
2045609|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045610|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045611|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
2045612|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
2045613|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2045614|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
2045615|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045616|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045617|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2045618|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
2045619|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
2045620|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2045621|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
2045622|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045623|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045624|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
2045625|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2045626|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
2045627|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045628|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045629|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2045630|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
2045631|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
2045632|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2045633|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
2045634|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045635|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045636|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
2045637|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2045638|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045639|NCT01634178|Apremilast|apremilast|mesh-list
2045640|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2045641|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2045642|NCT01634178|Analgesics|analgesics|mesh-ancestor
2045643|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
2045644|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045645|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045646|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2045647|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2045648|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2045649|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2045650|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045651|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045652|NCT01634191|Apremilast|apremilast|mesh-list
2045653|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2045654|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2045655|NCT01634191|Analgesics|analgesics|mesh-ancestor
2045656|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
2045657|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045658|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045659|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2045660|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2045661|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2045662|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2045663|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045664|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045665|NCT01634243|Rotigotine|rotigotine|mesh-list
2045666|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
2045667|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
2045668|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045669|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045670|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045671|NCT01634555|Leucovorin|leucovorin|mesh-list
2045672|NCT01634555|Folic Acid|folic acid|mesh-list
2045673|NCT01634555|Fluorouracil|fluorouracil|mesh-list
2045674|NCT01634555|Irinotecan|irinotecan|mesh-list
2045675|NCT01634555|Ramucirumab|ramucirumab|mesh-list
2045676|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
2045677|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
2045678|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045679|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2045680|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045681|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2045682|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
2045683|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045684|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2045685|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2045686|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045687|NCT01634555|Antidotes|antidotes|mesh-ancestor
2045688|NCT01634555|Protective Agents|protective agents|mesh-ancestor
2045689|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
2045690|NCT01634555|Vitamins|vitamins|mesh-ancestor
2045691|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
2045692|NCT01634555|Hematinics|hematinics|mesh-ancestor
2045693|NCT01634854|Misoprostol|misoprostol|mesh-list
2045694|NCT01634854|Oxytocin|oxytocin|mesh-list
2045695|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
2045696|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2045697|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045698|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2045699|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
2045700|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2045701|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2045702|NCT01635062|Calcitriol|calcitriol|mesh-list
2045703|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
2045704|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2746430|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746431|NCT05170594|Bevacizumab|bevacizumab|mesh-list
2746432|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
2746433|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2746434|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746435|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2746436|NCT05170594|Growth Substances|growth substances|mesh-ancestor
2746437|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746438|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
2746439|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2746440|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045705|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045706|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2045707|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2045708|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045709|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2045710|NCT01635062|Vitamins|vitamins|mesh-ancestor
2045711|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
2045712|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2045713|NCT01635101|Acetaminophen|acetaminophen|mesh-list
2045714|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2045715|NCT01635101|Analgesics|analgesics|mesh-ancestor
2045716|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
2045717|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045718|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045719|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
2045720|NCT01635153|Micronutrients|micronutrients|mesh-list
2045721|NCT01635153|Trace Elements|trace elements|mesh-list
2045722|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045723|NCT01635218|Fluoxetine|fluoxetine|mesh-list
2045724|NCT01635218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2045725|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2045726|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2045727|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045728|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045729|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
2045730|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045731|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2045732|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
2045733|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2045734|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2045735|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2045736|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045737|NCT01635439|Dinoprostone|dinoprostone|mesh-list
2045738|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
2045739|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2045740|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045741|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
2045742|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2045743|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2045744|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2045745|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2045746|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045747|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
2045748|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045749|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045750|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2045751|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045752|NCT01635764|Adalimumab|adalimumab|mesh-list
2045753|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2045754|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2045755|NCT01636063|Misoprostol|misoprostol|mesh-list
2045756|NCT01636063|Mifepristone|mifepristone|mesh-list
2045757|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2045758|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
2045759|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2045760|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045761|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2045762|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2045763|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
2045764|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2045765|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2045766|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2045767|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2045768|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
2045769|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2045770|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2045771|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
2045772|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2045773|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
2045774|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2045775|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2045776|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2045777|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2045778|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
2045779|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045780|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045781|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2045782|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
2045783|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2045784|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2045785|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2045786|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
2045787|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045788|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045789|NCT01636206|Lifitegrast|lifitegrast|mesh-list
2045790|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2045791|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2045792|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2045793|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
2045794|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045795|NCT01636934|Minocycline|minocycline|mesh-list
2045796|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2045797|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2045798|NCT01636947|Dexamethasone|dexamethasone|mesh-list
2045799|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
2045800|NCT01636947|Ondansetron|ondansetron|mesh-list
2045801|NCT01636947|Aprepitant|aprepitant|mesh-list
2045802|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
2045803|NCT01636947|Metoclopramide|metoclopramide|mesh-list
2045804|NCT01636947|Granisetron|granisetron|mesh-list
2045805|NCT01636947|Tropisetron|tropisetron|mesh-list
2045806|NCT01636947|Dolasetron|dolasetron|mesh-list
2045807|NCT01636947|Alizapride|alizapride|mesh-list
2045808|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2045809|NCT01636947|BB 1101|bb 1101|mesh-list
2045810|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2045811|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
2045812|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
2045813|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045814|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045815|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2746441|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746442|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2746443|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
2746444|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2746445|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045816|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
2045817|NCT01636947|Hormones|hormones|mesh-ancestor
2045818|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2045819|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2045820|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045821|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
2045822|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045823|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045824|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
2045825|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
2045826|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2045827|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
2045828|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045829|NCT01636947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2045830|NCT01636947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2045831|NCT01636947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2045832|NCT01636947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2045833|NCT01636947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2045834|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2045835|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2045836|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2045837|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
2045838|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2045839|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2045840|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
2045841|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2045842|NCT01637077|Pregabalin|pregabalin|mesh-list
2045843|NCT01637077|Analgesics|analgesics|mesh-ancestor
2045844|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
2045845|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045846|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045847|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
2045848|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2045849|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2045850|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045851|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2045852|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2045853|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2045854|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2045855|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2045856|NCT01637090|Everolimus|everolimus|mesh-list
2045857|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045858|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2045859|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
2045860|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045861|NCT01637272|Pasireotide|pasireotide|mesh-list
2045862|NCT01637272|Hormones|hormones|mesh-ancestor
2045863|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2045864|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045865|NCT01637402|Prednisone|prednisone|mesh-list
2045866|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
2045867|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2045868|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
2045869|NCT01637402|Hormones|hormones|mesh-ancestor
2045870|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2045871|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045872|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2045873|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045874|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2045875|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045876|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045877|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
2045878|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2045879|NCT01637584|Prazosin|prazosin|mesh-list
2045880|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2045881|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2045882|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2045883|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2045884|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
2045885|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045886|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045887|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045888|NCT01637623|Allopurinol|allopurinol|mesh-list
2045889|NCT01637623|Losartan|losartan|mesh-list
2045890|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2045891|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2045892|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2045893|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2045894|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045895|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
2045896|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045897|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
2045898|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2045899|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2045900|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
2045901|NCT01637623|Protective Agents|protective agents|mesh-ancestor
2045902|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045903|NCT01637935|Pioglitazone|pioglitazone|mesh-list
2045904|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2045905|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045906|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
2045907|NCT01638000|Mirabegron|mirabegron|mesh-list
2045908|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2045909|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2045910|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
2045911|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045912|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045913|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045914|NCT01638000|Urological Agents|urological agents|mesh-ancestor
2045915|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2045916|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2045917|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2045918|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
2045919|NCT01638013|Peficitinib|peficitinib|mesh-list
2045920|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045921|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045922|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2045923|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
2045924|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045925|NCT01638052|Clonidine|clonidine|mesh-list
2045926|NCT01638052|Bupivacaine|bupivacaine|mesh-list
2045927|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
2045928|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
2045929|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2045930|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045931|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
2045932|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2045933|NCT01638052|Analgesics|analgesics|mesh-ancestor
2045934|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2045935|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
2045936|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
2045937|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2045938|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2045939|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2045940|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
2045941|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045942|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045943|NCT01638429|Rifaximin|rifaximin|mesh-list
2045944|NCT01638429|Neomycin|neomycin|mesh-list
2045945|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2045946|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2045947|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2045948|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2045949|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045950|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045951|NCT01638546|Temozolomide|temozolomide|mesh-list
2045952|NCT01638546|Veliparib|veliparib|mesh-list
2045953|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2045954|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
2045955|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045956|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045957|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2045958|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045959|NCT01639001|Carboplatin|carboplatin|mesh-list
2045960|NCT01639001|Pemetrexed|pemetrexed|mesh-list
2045961|NCT01639001|Crizotinib|crizotinib|mesh-list
2045962|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2045963|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2045964|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045965|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2045966|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2045967|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2045968|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2045969|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
2045970|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045971|NCT01639157|Buspirone|buspirone|mesh-list
2045972|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2045973|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2045974|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2045975|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045976|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2045977|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2045978|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
2045979|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2045980|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2045981|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
2045982|NCT01639222|Vitamin D|vitamin d|mesh-list
2045983|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
2045984|NCT01639222|Calcium|calcium|mesh-list
2045985|NCT01639222|Vitamins|vitamins|mesh-ancestor
2045986|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
2045987|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045988|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2045989|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2045990|NCT01639339|Belimumab|belimumab|mesh-list
2045991|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2045992|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
2045993|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045994|NCT01639352|Pasireotide|pasireotide|mesh-list
2045995|NCT01639352|Hormones|hormones|mesh-ancestor
2045996|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2045997|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2045998|NCT01639560|Varenicline|varenicline|mesh-list
2045999|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2046000|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2046001|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
2046002|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046003|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046004|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046005|NCT01639599|Dexamethasone|dexamethasone|mesh-list
2046006|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
2046007|NCT01639599|Haloperidol|haloperidol|mesh-list
2046008|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
2046009|NCT01639599|BB 1101|bb 1101|mesh-list
2046010|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2046011|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
2046012|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
2046013|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046014|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046015|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2046016|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
2046017|NCT01639599|Hormones|hormones|mesh-ancestor
2046018|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2046019|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2046020|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046021|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
2046022|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046023|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046024|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2046025|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2046026|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046027|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2046028|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2046029|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
2046030|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046031|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2046032|NCT01639729|Sufentanil|sufentanil|mesh-list
2046033|NCT01639729|Dsuvia|dsuvia|mesh-list
2046034|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2046035|NCT01639729|Narcotics|narcotics|mesh-ancestor
2046036|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046037|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046038|NCT01639729|Analgesics|analgesics|mesh-ancestor
2046039|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
2046040|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046041|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2046042|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2046043|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
2046044|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
2046045|NCT01639833|Hemostatics|hemostatics|mesh-list
2046046|NCT01639833|Coagulants|coagulants|mesh-ancestor
2046047|NCT01639872|Risperidone|risperidone|mesh-list
2046048|NCT01639872|Clozapine|clozapine|mesh-list
2046049|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2046050|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
2046051|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046052|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046053|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046054|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2046055|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2046056|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046057|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2046058|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2046059|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
2046060|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
2046061|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
2046062|NCT01640171|Ketorolac|ketorolac|mesh-list
2046063|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2046064|NCT01640171|Lidocaine|lidocaine|mesh-list
2046065|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
2046066|NCT01640171|Anesthetics|anesthetics|mesh-list
2046067|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
2046068|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046069|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046070|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
2046071|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046072|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2046073|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2046074|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2046075|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2046076|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046077|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2046078|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2046079|NCT01640171|Analgesics|analgesics|mesh-ancestor
2046080|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046081|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2046082|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046083|NCT01640184|Vitamin D|vitamin d|mesh-list
2046084|NCT01640184|Vitamins|vitamins|mesh-ancestor
2046085|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
2046086|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046087|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2046088|NCT01640197|Resveratrol|resveratrol|mesh-list
2046089|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
2046090|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046091|NCT01640197|Protective Agents|protective agents|mesh-ancestor
2046092|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046093|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046094|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2046095|NCT01640340|Dexamethasone|dexamethasone|mesh-list
2046096|NCT01640340|Ondansetron|ondansetron|mesh-list
2046097|NCT01640340|Aprepitant|aprepitant|mesh-list
2046098|NCT01640340|Palonosetron|palonosetron|mesh-list
2046099|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2046100|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
2046101|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
2046102|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046103|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046104|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2046105|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
2046106|NCT01640340|Hormones|hormones|mesh-ancestor
2046107|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2046108|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2046109|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046110|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
2046111|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
2046112|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2046113|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
2046114|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046115|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046116|NCT01640340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2046117|NCT01640340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2046118|NCT01640340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046119|NCT01640340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2046120|NCT01640340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2046121|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2046122|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2046123|NCT01640834|Glucagon|glucagon|mesh-list
2046124|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2046125|NCT01640834|Hormones|hormones|mesh-ancestor
2046126|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2046127|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046128|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
2046129|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2046130|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2046131|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046132|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
2046133|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
2046134|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2046135|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
2046136|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046137|NCT01640964|Terlipressin|terlipressin|mesh-list
2046138|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2046139|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2046140|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
2046141|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2046142|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
2046143|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046144|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046145|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2046146|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
2046147|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2046148|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2046149|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2046150|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
2046151|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046152|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046153|NCT01641120|Interferons|interferons|mesh-list
2046154|NCT01641120|Interferon-beta|interferon-beta|mesh-list
2046155|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
2046156|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046157|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
2046158|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046159|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
2046160|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046161|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2046162|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2046163|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
2046164|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046165|NCT01641159|Buspirone|buspirone|mesh-list
2046166|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2046167|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2046168|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046169|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046170|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2046171|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2046172|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
2046173|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046174|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046175|NCT01641237|Listerine|listerine|mesh-list
2046176|NCT01641237|Fluorides|fluorides|mesh-list
2046177|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
2046178|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
2046179|NCT01641237|Protective Agents|protective agents|mesh-ancestor
2046180|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046181|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2046182|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046183|NCT01641367|Tenofovir|tenofovir|mesh-list
2046184|NCT01641367|Emtricitabine|emtricitabine|mesh-list
2046185|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
2046186|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2046187|NCT01641367|Darunavir|darunavir|mesh-list
2046188|NCT01641367|Etravirine|etravirine|mesh-list
2046189|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2046190|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
2046191|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
2046192|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046193|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2046194|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2046195|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046196|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046197|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2046198|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2046199|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2046200|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2046201|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2046202|NCT01641445|Topiramate|topiramate|mesh-list
2046203|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
2046204|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2046205|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046206|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
2046207|NCT01641640|Ribavirin|ribavirin|mesh-list
2046208|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
2046209|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046210|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
2046211|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046212|NCT01641653|Midazolam|midazolam|mesh-list
2046213|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2046214|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2046215|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046216|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046217|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2046218|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2046219|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2046220|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2046221|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
2046222|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
2046223|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
2046224|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
2046225|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046226|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046227|NCT01641692|Albuterol|albuterol|mesh-list
2046228|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2046229|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
2046230|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046231|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046232|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2046233|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
2046234|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
2046235|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2046236|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2046237|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2046238|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2046239|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
2046240|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046241|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046242|NCT01641809|Tenofovir|tenofovir|mesh-list
2046243|NCT01641809|Lamivudine|lamivudine|mesh-list
2046244|NCT01641809|Emtricitabine|emtricitabine|mesh-list
2046245|NCT01641809|Efavirenz|efavirenz|mesh-list
2046246|NCT01641809|Abacavir|abacavir|mesh-list
2046247|NCT01641809|Rilpivirine|rilpivirine|mesh-list
2046248|NCT01641809|Cabotegravir|cabotegravir|mesh-list
2046249|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
2046250|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046251|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2046252|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2046253|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046254|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046255|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2046256|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2046257|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2046258|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2046259|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2046260|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2046261|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2046262|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2046263|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2046264|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2046265|NCT01641822|Tobramycin|tobramycin|mesh-list
2046266|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2046267|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046268|NCT01641900|Eszopiclone|eszopiclone|mesh-list
2046269|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2046270|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046271|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046272|NCT01641926|Interferons|interferons|mesh-list
2046273|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
2046274|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
2046275|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2046276|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2046277|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046278|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
2046279|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046280|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
2046281|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046282|NCT01641939|Trastuzumab|trastuzumab|mesh-list
2046283|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2046284|NCT01641939|Maytansine|maytansine|mesh-list
2046285|NCT01641939|Taxane|taxane|mesh-list
2046286|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2046287|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046288|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2046289|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
2046290|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
2046291|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
2046292|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046293|NCT01641952|Rituximab|rituximab|mesh-list
2046294|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2046295|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046296|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
2046297|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046298|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046299|NCT01642004|Docetaxel|docetaxel|mesh-list
2046300|NCT01642004|Nivolumab|nivolumab|mesh-list
2046301|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046302|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
2046303|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
2046304|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
2046305|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209033|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2046306|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2046307|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2046308|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2046309|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
2046310|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046311|NCT01642147|Anesthetics|anesthetics|mesh-list
2046312|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046313|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046314|NCT01642212|Budesonide|budesonide|mesh-list
2046315|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2046316|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2046317|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
2046318|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046319|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046320|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2046321|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
2046322|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
2046323|NCT01642212|Hormones|hormones|mesh-ancestor
2046324|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2046325|NCT01642238|Aspirin|aspirin|mesh-list
2046326|NCT01642238|Hirudins|hirudins|mesh-list
2046327|NCT01642238|Bivalirudin|bivalirudin|mesh-list
2046328|NCT01642238|Clopidogrel|clopidogrel|mesh-list
2046329|NCT01642238|Ticagrelor|ticagrelor|mesh-list
2046330|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2046331|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2046332|NCT01642238|Analgesics|analgesics|mesh-ancestor
2046333|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
2046334|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046335|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046336|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2046337|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046338|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2046339|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2046340|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046341|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2046342|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2046343|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046344|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
2046345|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2046346|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2046347|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2046348|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
2046349|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046350|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
2046351|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2046352|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
2046353|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
2046354|NCT01642251|Cisplatin|cisplatin|mesh-list
2046355|NCT01642251|Etoposide|etoposide|mesh-list
2046356|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
2046357|NCT01642251|Veliparib|veliparib|mesh-list
2046358|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
2046359|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046360|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2046361|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2046362|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2046363|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046364|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046365|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2046366|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
2046367|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
2046368|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
2046369|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
2046370|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
2046371|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
2046372|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2046373|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2046374|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
2046375|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046376|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046377|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046378|NCT01642277|Urological Agents|urological agents|mesh-ancestor
2046379|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
2046380|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
2046381|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2046382|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2046383|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046384|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046385|NCT01642407|Urological Agents|urological agents|mesh-ancestor
2046386|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
2046387|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2046388|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209034|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209035|NCT00013520|Lamivudine|lamivudine|mesh-list
2209036|NCT00013520|Zidovudine|zidovudine|mesh-list
2209037|NCT00013520|Efavirenz|efavirenz|mesh-list
2209038|NCT00013520|Nevirapine|nevirapine|mesh-list
2209039|NCT00013520|Abacavir|abacavir|mesh-list
2209040|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
2046389|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2046390|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046391|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2046392|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2046393|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046394|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046395|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046396|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2046397|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
2046398|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2046399|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2046400|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2046401|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2046402|NCT01642589|Vaccines|vaccines|mesh-list
2046403|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
2046404|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046405|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
2046406|NCT01642602|Lansoprazole|lansoprazole|mesh-list
2046407|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2046408|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2046409|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2046410|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046411|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046412|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
2046413|NCT01642615|Lansoprazole|lansoprazole|mesh-list
2046414|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2046415|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2046416|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2046417|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046418|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046419|NCT01642914|Linaclotide|linaclotide|mesh-list
2046420|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2046421|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
2046422|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046423|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2046424|NCT01643382|Insulin|insulin|mesh-list
2046425|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2046426|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2046427|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046428|NCT01643408|Asparaginase|asparaginase|mesh-list
2046429|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209041|NCT00013520|Stavudine|stavudine|mesh-list
2046430|NCT01643616|Midazolam|midazolam|mesh-list
2046431|NCT01643616|Ropivacaine|ropivacaine|mesh-list
2046432|NCT01643616|Prilocaine|prilocaine|mesh-list
2046433|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
2046434|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
2046435|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046436|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046437|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
2046438|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046439|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2046440|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2046441|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2046442|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2046443|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2046444|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2046445|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
2046446|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
2046447|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
2046448|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046449|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046450|NCT01643668|Busulfan|busulfan|mesh-list
2046451|NCT01643668|Clofarabine|clofarabine|mesh-list
2046452|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
2046453|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046454|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2046455|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
2046456|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046457|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2046458|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046459|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2046460|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2046461|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
2046462|NCT01643772|Oxycodone|oxycodone|mesh-list
2046463|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2046464|NCT01643772|Narcotics|narcotics|mesh-ancestor
2046465|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046466|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046467|NCT01643772|Analgesics|analgesics|mesh-ancestor
2046468|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
2046469|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046470|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2046471|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2046472|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2046473|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046474|NCT01643928|Rituximab|rituximab|mesh-list
2046475|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2046476|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046477|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
2046478|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046479|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046480|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2046481|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
2046482|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046483|NCT01644188|Ezetimibe|ezetimibe|mesh-list
2046484|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2046485|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2046486|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2046487|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
2046488|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046489|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2046490|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
2046491|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046492|NCT01644331|Tolvaptan|tolvaptan|mesh-list
2046493|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2046494|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046495|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
2046496|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046497|NCT01644396|Adalimumab|adalimumab|mesh-list
2046498|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2046499|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046500|NCT01644474|Ezetimibe|ezetimibe|mesh-list
2046501|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2046502|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2046503|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2046504|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
2046505|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046506|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2046507|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
2046508|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046509|NCT01644500|Glimepiride|glimepiride|mesh-list
2046510|NCT01644500|Dulaglutide|dulaglutide|mesh-list
2046511|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2046512|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2046513|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046514|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2046515|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
2046516|NCT01644643|Metronidazole|metronidazole|mesh-list
2046517|NCT01644643|Ceftazidime|ceftazidime|mesh-list
2046518|NCT01644643|Avibactam|avibactam|mesh-list
2046519|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046520|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2046521|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2046522|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2046523|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2046524|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046525|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046526|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
2046527|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2046528|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
2046529|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046530|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046531|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2046532|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
2046533|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
2046534|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2046535|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
2046536|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046537|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046538|NCT01644890|Paclitaxel|paclitaxel|mesh-list
2046539|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2046540|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046541|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
2046542|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
2046543|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
2046544|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046545|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
2046546|NCT01645098|Ketamine|ketamine|mesh-list
2046547|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2046548|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046549|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046550|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2046551|NCT01645098|Analgesics|analgesics|mesh-ancestor
2209042|NCT00013520|Didanosine|didanosine|mesh-list
2046552|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
2046553|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046554|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2046555|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2046556|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2046557|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
2046558|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046559|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046560|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2046561|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2046562|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
2046563|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
2046564|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2046565|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2046566|NCT01645111|Clevidipine|clevidipine|mesh-list
2046567|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2046568|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2046569|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046570|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2046571|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046572|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
2046573|NCT01645176|Atorvastatin|atorvastatin|mesh-list
2046574|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2046575|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2046576|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
2046577|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046578|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2046579|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2046580|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046581|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
2046582|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2046583|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2046584|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046585|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046586|NCT01645280|Methotrexate|methotrexate|mesh-list
2046587|NCT01645280|Ustekinumab|ustekinumab|mesh-list
2046588|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2046589|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
2046590|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2046591|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046592|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2046593|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
2046594|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046595|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046596|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
2046597|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046598|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2046599|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2046600|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
2046601|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046602|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2046603|NCT01645735|Vancomycin|vancomycin|mesh-list
2046604|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
2046605|NCT01645735|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2046606|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2046607|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046608|NCT01645930|Dexamethasone|dexamethasone|mesh-list
2046609|NCT01645930|Lenalidomide|lenalidomide|mesh-list
2046610|NCT01645930|Ixazomib|ixazomib|mesh-list
2046611|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2046612|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
2046613|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
2046614|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046615|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046616|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2046617|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
2046618|NCT01645930|Hormones|hormones|mesh-ancestor
2046619|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2046620|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2046621|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046622|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
2046623|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2046624|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2046625|NCT01645930|Growth Substances|growth substances|mesh-ancestor
2046626|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
2046627|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
2046628|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046629|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046630|NCT01646021|Sirolimus|sirolimus|mesh-list
2046631|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2046632|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046633|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2046634|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046635|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
2046636|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2046637|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
2046638|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046639|NCT01646073|Adalimumab|adalimumab|mesh-list
2046640|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2046641|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046642|NCT01646125|Docetaxel|docetaxel|mesh-list
2046643|NCT01646125|Pemetrexed|pemetrexed|mesh-list
2046644|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046645|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
2046646|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
2046647|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
2046648|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046649|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046650|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2046651|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2046652|NCT01646151|Bimatoprost|bimatoprost|mesh-list
2046653|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2046654|NCT01646177|Etanercept|etanercept|mesh-list
2046655|NCT01646177|Ixekizumab|ixekizumab|mesh-list
2046656|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2046657|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2046658|NCT01646177|Analgesics|analgesics|mesh-ancestor
2046659|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
2046660|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046661|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046662|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2046663|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046664|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2046665|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2046666|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
2046667|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
2046668|NCT01646255|Levodopa|levodopa|mesh-list
2046669|NCT01646255|Rotigotine|rotigotine|mesh-list
2046670|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2046671|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2046672|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
2046673|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046674|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046675|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046676|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
2046677|NCT01646268|Rotigotine|rotigotine|mesh-list
2046678|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
2046679|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
2046680|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046681|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046682|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046683|NCT01646320|Metformin|metformin|mesh-list
2046684|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
2046685|NCT01646320|Saxagliptin|saxagliptin|mesh-list
2046686|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2046687|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046688|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2046689|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046690|NCT01646320|Incretins|incretins|mesh-ancestor
2046691|NCT01646320|Hormones|hormones|mesh-ancestor
2046692|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2046693|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2046694|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
2046695|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046696|NCT01646385|Etanercept|etanercept|mesh-list
2046697|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
2046698|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2046699|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2046700|NCT01646385|Analgesics|analgesics|mesh-ancestor
2046701|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
2046702|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046703|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046704|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2046705|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2046706|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2046707|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
2046708|NCT01646398|Vaccines|vaccines|mesh-list
2046709|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2046710|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
2046711|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046712|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2046713|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2046714|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046715|NCT01646762|Paclitaxel|paclitaxel|mesh-list
2046716|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2046717|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2046718|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046719|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
2046720|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
2046721|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
2046722|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046723|NCT01646814|Aspirin|aspirin|mesh-list
2046724|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2046725|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2046726|NCT01646814|Analgesics|analgesics|mesh-ancestor
2046727|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
2046728|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046729|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046730|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2046731|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046732|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2046733|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2046734|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046735|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2046736|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2046737|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046738|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
2046739|NCT01646827|Aripiprazole|aripiprazole|mesh-list
2046740|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
2046741|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2046742|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2046743|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2046744|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046745|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046746|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
2046747|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
2046748|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046749|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046750|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2046751|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2046752|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
2046753|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2046754|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2046755|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2046756|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2046757|NCT01647282|Minocycline|minocycline|mesh-list
2046758|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2046759|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046760|NCT01647516|Ozanimod|ozanimod|mesh-list
2046761|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2046762|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046763|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2046764|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
2046765|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046766|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2046767|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2046768|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
2046769|NCT01647581|Hormones|hormones|mesh-ancestor
2046770|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2046771|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046772|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2046773|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046774|NCT01647945|Tacrolimus|tacrolimus|mesh-list
2046775|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2046776|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
2046777|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046778|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2046779|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046780|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046781|NCT01648101|Ezogabine|ezogabine|mesh-list
2046782|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
2046783|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2046784|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046785|NCT01648140|Interferons|interferons|mesh-list
2046786|NCT01648140|Ribavirin|ribavirin|mesh-list
2046787|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
2046788|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
2046789|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2046790|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046791|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
2046792|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046793|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
2046794|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046795|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
2046796|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046797|NCT01648283|Methadone|methadone|mesh-list
2046798|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2046799|NCT01648283|Narcotics|narcotics|mesh-ancestor
2046800|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046801|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046802|NCT01648283|Analgesics|analgesics|mesh-ancestor
2046803|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
2046804|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046805|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
2046806|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
2046807|NCT01648348|Bevacizumab|bevacizumab|mesh-list
2046808|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2046809|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
2046810|NCT01648348|Antibodies|antibodies|mesh-list
2046811|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
2046812|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2046813|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
2046814|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046815|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2046816|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2046817|NCT01648348|Growth Substances|growth substances|mesh-ancestor
2046818|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046819|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
2046820|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
2046821|NCT01648582|Metformin|metformin|mesh-list
2046822|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
2046823|NCT01648582|Dulaglutide|dulaglutide|mesh-list
2046824|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2046825|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046826|NCT01648699|Hydromorphone|hydromorphone|mesh-list
2046827|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2046828|NCT01648699|Narcotics|narcotics|mesh-ancestor
2046829|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2046830|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046831|NCT01648699|Analgesics|analgesics|mesh-ancestor
2046832|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
2046833|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046834|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2046835|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2046836|NCT01649180|Axitinib|axitinib|mesh-list
2046837|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046838|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2046839|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046840|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046841|NCT01649271|Trastuzumab|trastuzumab|mesh-list
2046842|NCT01649271|Afatinib|afatinib|mesh-list
2046843|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2046844|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046845|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2046846|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046847|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046848|NCT01649297|Empagliflozin|empagliflozin|mesh-list
2046849|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2046850|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046851|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2046852|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046853|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2046854|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
2046855|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046856|NCT01649427|Tacrolimus|tacrolimus|mesh-list
2046857|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2046858|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
2046859|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046860|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2046861|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046862|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046863|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
2046864|NCT01649609|Sirolimus|sirolimus|mesh-list
2046865|NCT01649609|Tacrolimus|tacrolimus|mesh-list
2046866|NCT01649609|Antimetabolites|antimetabolites|mesh-list
2046867|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2046868|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
2046869|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046870|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2046871|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046872|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046873|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2046874|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046875|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2046876|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
2046877|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2046878|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046879|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
2046880|NCT01649765|Belimumab|belimumab|mesh-list
2046881|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2046882|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
2046883|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046884|NCT01649791|Lenalidomide|lenalidomide|mesh-list
2046885|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
2046886|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046887|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2046888|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2046889|NCT01649791|Growth Substances|growth substances|mesh-ancestor
2046890|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
2046891|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046892|NCT01649856|Rituximab|rituximab|mesh-list
2046893|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2046894|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046895|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
2046896|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046897|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046898|NCT01649869|Valganciclovir|valganciclovir|mesh-list
2046899|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
2046900|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046901|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
2046902|NCT01649947|Paclitaxel|paclitaxel|mesh-list
2046903|NCT01649947|Bevacizumab|bevacizumab|mesh-list
2046904|NCT01649947|Carboplatin|carboplatin|mesh-list
2046905|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2046906|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046907|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
2046908|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
2046909|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
2046910|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046911|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2046912|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2046913|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2046914|NCT01649947|Growth Substances|growth substances|mesh-ancestor
2046915|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046916|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
2046917|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
2046918|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2046919|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2046920|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046921|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046922|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046923|NCT01650194|Prednisone|prednisone|mesh-list
2046924|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
2046925|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2046926|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
2046927|NCT01650194|Hormones|hormones|mesh-ancestor
2046928|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2046929|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046930|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2746470|NCT05170334|Belinostat|belinostat|mesh-list
2746471|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746472|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2746473|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746474|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746475|NCT05170256|Trastuzumab|trastuzumab|mesh-list
2746476|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2746477|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746478|NCT05170230|Terlipressin|terlipressin|mesh-list
2746479|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2746480|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2746481|NCT05170217|Cannabidiol|cannabidiol|mesh-list
2746482|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
2046931|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046932|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2046933|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046934|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046935|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
2046936|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2046937|NCT01650246|Lesinurad|lesinurad|mesh-list
2046938|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
2046939|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046940|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
2046941|NCT01650246|Renal Agents|renal agents|mesh-ancestor
2046942|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
2046943|NCT01650298|Thrombin|thrombin|mesh-list
2046944|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
2046945|NCT01650298|Coagulants|coagulants|mesh-ancestor
2046946|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
2046947|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2046948|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
2046949|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046950|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046951|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
2046952|NCT01650350|Naltrexone|naltrexone|mesh-list
2046953|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2046954|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2046955|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046956|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
2046957|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046958|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
2046959|NCT01650519|Ibuprofen|ibuprofen|mesh-list
2046960|NCT01650519|Ketorolac|ketorolac|mesh-list
2046961|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2046962|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2046963|NCT01650519|Analgesics|analgesics|mesh-ancestor
2046964|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
2046965|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2046966|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046967|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2046968|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046969|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2046970|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046971|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046972|NCT01650545|Cyclosporine|cyclosporine|mesh-list
2046973|NCT01650545|Sirolimus|sirolimus|mesh-list
2046974|NCT01650545|Tacrolimus|tacrolimus|mesh-list
2046975|NCT01650545|Cyclosporins|cyclosporins|mesh-list
2046976|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2046977|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
2046978|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2046979|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2046980|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2046981|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2046982|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
2046983|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046984|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
2046985|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046986|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2046987|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2046988|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2046989|NCT01650558|Chloroquine|chloroquine|mesh-list
2046990|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2046991|NCT01650558|Amebicides|amebicides|mesh-ancestor
2046992|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2046993|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2046994|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2046995|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
2046996|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2046997|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2046998|NCT01650558|Renal Agents|renal agents|mesh-ancestor
2046999|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2047000|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
2047001|NCT01650805|Ponatinib|ponatinib|mesh-list
2047002|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047003|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2047004|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047005|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047006|NCT01651000|Calcifediol|calcifediol|mesh-list
2047007|NCT01651000|Vitamins|vitamins|mesh-ancestor
2047008|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
2047009|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047010|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2047011|NCT01651039|Dexamethasone|dexamethasone|mesh-list
2047012|NCT01651039|Lenalidomide|lenalidomide|mesh-list
2047013|NCT01651039|Panobinostat|panobinostat|mesh-list
2047014|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2047015|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
2047016|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
2047017|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2047018|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047019|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2047020|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
2047021|NCT01651039|Hormones|hormones|mesh-ancestor
2047022|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2047023|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2047024|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047025|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
2047026|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2047027|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2047028|NCT01651039|Growth Substances|growth substances|mesh-ancestor
2047029|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
2047030|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2047031|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047032|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047033|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
2047034|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2047035|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047036|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047037|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2047038|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2047048|NCT01651442|Zolpidem|zolpidem|mesh-list
2047049|NCT01651442|Trazodone|trazodone|mesh-list
2047050|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2047051|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2047052|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2047053|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047054|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2047055|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
2047056|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
2047057|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047058|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047059|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2047060|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2047061|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2047062|NCT01651442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2047063|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2047064|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2047065|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
2047066|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2047067|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
2047068|NCT01651780|Heparin|heparin|mesh-list
2047069|NCT01651780|Calcium heparin|calcium heparin|mesh-list
2047070|NCT01651780|Bivalirudin|bivalirudin|mesh-list
2047071|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
2047072|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2047073|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2047074|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047075|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
2047076|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2047077|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
2047078|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047079|NCT01651793|Caffeine|caffeine|mesh-list
2047080|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2047081|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047082|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2047083|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047084|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047085|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2047086|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2047087|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
2047088|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047089|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
2047090|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2047091|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2047092|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047093|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
2047094|NCT01651806|Coagulants|coagulants|mesh-ancestor
2047095|NCT01651936|Methotrexate|methotrexate|mesh-list
2209043|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2209044|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2047096|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2047097|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
2047098|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2047099|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047100|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2047101|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
2047102|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047103|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047104|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
2047105|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047106|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2047107|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047108|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
2047109|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2047110|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2047111|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
2047112|NCT01652040|Testosterone|testosterone|mesh-list
2047113|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
2047114|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
2047115|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2047116|NCT01652040|Androgens|androgens|mesh-ancestor
2047117|NCT01652040|Hormones|hormones|mesh-ancestor
2047118|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2047119|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047120|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2047121|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047122|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
2047123|NCT01652469|Docetaxel|docetaxel|mesh-list
2047124|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2047125|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047126|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
2047127|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
2047128|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
2047129|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047130|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2047131|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047132|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
2047133|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2047134|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2047135|NCT01652495|Prednisolone|prednisolone|mesh-list
2047136|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
2047137|NCT01652495|Triamcinolone|triamcinolone|mesh-list
2047138|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2047139|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2047140|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2047141|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
2047142|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2047143|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2047144|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
2047145|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
2047146|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2047147|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047148|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2047149|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
2047150|NCT01652495|Hormones|hormones|mesh-ancestor
2047151|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2047152|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2047153|NCT01652495|Protective Agents|protective agents|mesh-ancestor
2047154|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2047155|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746501|NCT05170113|Caffeine|caffeine|mesh-list
2746502|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2047156|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047157|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
2047158|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047159|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746503|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746504|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2746505|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746506|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746507|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2746508|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2746509|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
2746510|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2746511|NCT05170061|Valsartan|valsartan|mesh-list
2746512|NCT05170061|Nebivolol|nebivolol|mesh-list
2746513|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2746514|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2047173|NCT01652573|Calcitonin|calcitonin|mesh-list
2047174|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
2047175|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2047176|NCT01652573|Katacalcin|katacalcin|mesh-list
2047177|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2047178|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047179|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2746515|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2746516|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746517|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
2746518|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2746519|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2746520|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2746521|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
2746522|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2746523|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746524|NCT05170009|Oseltamivir|oseltamivir|mesh-list
2746525|NCT05170009|Baloxavir|baloxavir|mesh-list
2746526|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
2746527|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2746528|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746529|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746530|NCT05169957|Nivolumab|nivolumab|mesh-list
2746531|NCT05169957|Ipilimumab|ipilimumab|mesh-list
2746532|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2746533|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746534|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2746535|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746536|NCT05169944|Magrolimab|magrolimab|mesh-list
2746537|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2746538|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746539|NCT05169905|Vaccines|vaccines|mesh-list
2746540|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
2746541|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047180|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
2047181|NCT01652664|Timolol|timolol|mesh-list
2047182|NCT01652664|Travoprost|travoprost|mesh-list
2047183|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2047184|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2047185|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2047186|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2047187|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
2047188|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047189|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047190|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047191|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2047192|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2047193|NCT01652690|Denosumab|denosumab|mesh-list
2047194|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2047195|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047196|NCT01652703|Evolocumab|evolocumab|mesh-list
2047197|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2047198|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2047199|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
2047200|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047201|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2047202|NCT01652716|Exenatide|exenatide|mesh-list
2047203|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2047204|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047205|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2047206|NCT01652716|Incretins|incretins|mesh-ancestor
2047207|NCT01652716|Hormones|hormones|mesh-ancestor
2047208|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2047209|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2047210|NCT01652729|Exenatide|exenatide|mesh-list
2047211|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2047212|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047213|NCT01652729|Incretins|incretins|mesh-ancestor
2047214|NCT01652729|Hormones|hormones|mesh-ancestor
2047215|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2047216|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2047217|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
2047218|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047219|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047220|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2047221|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
2047222|NCT01652872|Hematinics|hematinics|mesh-ancestor
2047223|NCT01652976|Leucovorin|leucovorin|mesh-list
2047224|NCT01652976|Fluorouracil|fluorouracil|mesh-list
2047225|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
2047226|NCT01652976|Dasatinib|dasatinib|mesh-list
2047227|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
2047228|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047229|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2047230|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047231|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047232|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
2047233|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047234|NCT01652976|Antidotes|antidotes|mesh-ancestor
2047235|NCT01652976|Protective Agents|protective agents|mesh-ancestor
2047236|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
2047237|NCT01652976|Vitamins|vitamins|mesh-ancestor
2047238|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
2047239|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2047240|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047241|NCT01653158|Docetaxel|docetaxel|mesh-list
2047242|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047243|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
2047244|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
2047245|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
2047246|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047247|NCT01653262|Brivaracetam|brivaracetam|mesh-list
2047248|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
2047249|NCT01653327|Ketamine|ketamine|mesh-list
2047250|NCT01653327|Analgesics|analgesics|mesh-ancestor
2047251|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
2047252|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2047253|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047254|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2047255|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2047256|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
2047257|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
2047258|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2047259|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2047260|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2047261|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047262|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047263|NCT01653418|Cytarabine|cytarabine|mesh-list
2047264|NCT01653418|Etoposide|etoposide|mesh-list
2047265|NCT01653418|Bortezomib|bortezomib|mesh-list
2047266|NCT01653418|Melphalan|melphalan|mesh-list
2047267|NCT01653418|Carmustine|carmustine|mesh-list
2047268|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2047269|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047270|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2047271|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2047272|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047273|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047274|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2047275|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
2047276|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
2047277|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047278|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047279|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
2047280|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047281|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2047282|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
2047283|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2047284|NCT01653509|Acyclovir|acyclovir|mesh-list
2047285|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
2047286|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047287|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2047288|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2047289|NCT01653743|Hormones|hormones|mesh-ancestor
2047290|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2047291|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047292|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2047293|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
2047294|NCT01653847|Everolimus|everolimus|mesh-list
2047295|NCT01653847|Tacrolimus|tacrolimus|mesh-list
2047296|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047297|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
2047298|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047299|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2047300|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047301|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047302|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047303|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2047304|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2047305|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
2047306|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2047307|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047308|NCT01653912|Paclitaxel|paclitaxel|mesh-list
2047309|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2047310|NCT01653912|Carboplatin|carboplatin|mesh-list
2047311|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2047312|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047313|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
2047314|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
2047315|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
2047316|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047317|NCT01654107|Nicotine|nicotine|mesh-list
2047318|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2047319|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
2047320|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2047321|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047322|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2047323|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2047324|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
2047325|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047326|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047327|NCT01654224|Vaccines|vaccines|mesh-list
2047328|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
2047329|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047330|NCT01654276|Febuxostat|febuxostat|mesh-list
2047331|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
2209045|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2209046|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2209047|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209048|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209049|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
2209050|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209051|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2209052|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2209053|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
2209054|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2209055|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2047332|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2047333|NCT01654302|Lidocaine|lidocaine|mesh-list
2047334|NCT01654302|Tetracaine|tetracaine|mesh-list
2047335|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
2047336|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
2047337|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2047338|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047339|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
2047340|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2047341|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2047342|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2047343|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2047344|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2047345|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047346|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
2047347|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2047348|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047349|NCT01654445|Tenecteplase|tenecteplase|mesh-list
2047350|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2047351|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2047352|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746556|NCT05169801|Paclitaxel|paclitaxel|mesh-list
2746557|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2746558|NCT05169801|Carboplatin|carboplatin|mesh-list
2746559|NCT05169801|Bevacizumab|bevacizumab|mesh-list
2746560|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2746561|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746562|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
2746563|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
2746564|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
2746565|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746566|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2746567|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2746568|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2746569|NCT05169801|Growth Substances|growth substances|mesh-ancestor
2047353|NCT01654536|Ciclesonide|ciclesonide|mesh-list
2047354|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
2047355|NCT01654536|Hormones|hormones|mesh-ancestor
2047356|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2047357|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047358|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2047359|NCT01654601|Clozapine|clozapine|mesh-list
2047360|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2047361|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
2047362|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047363|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047364|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047365|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2746570|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746571|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
2047366|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2047367|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2047368|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2047369|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
2047370|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
2047371|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
2047372|NCT01654861|Gemcitabine|gemcitabine|mesh-list
2047373|NCT01654861|Vitamins|vitamins|mesh-ancestor
2047374|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
2047375|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047376|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2047377|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
2047378|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047379|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047380|NCT01654861|Antiviral Agents|antiviral agents|mesh-ancestor
2047381|NCT01654861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047382|NCT01654861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047383|NCT01654861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047384|NCT01654861|Immunologic Factors|immunologic factors|mesh-ancestor
2047385|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
2047386|NCT01654861|Protective Agents|protective agents|mesh-ancestor
2047387|NCT01655043|Regadenoson|regadenoson|mesh-list
2047388|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2047389|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2047390|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
2047391|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
2047392|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047393|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047394|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047395|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
2047396|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2047397|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2047398|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
2047399|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047400|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047401|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047402|NCT01655069|Urological Agents|urological agents|mesh-ancestor
2047403|NCT01655563|Tacrolimus|tacrolimus|mesh-list
2047404|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047405|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
2047406|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047407|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2047408|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047409|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047410|NCT01655693|Doxorubicin|doxorubicin|mesh-list
2047411|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2047412|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2047413|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047414|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2047415|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2047416|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047417|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047418|NCT01655719|Pioglitazone|pioglitazone|mesh-list
2746572|NCT05169684|Docetaxel|docetaxel|mesh-list
2047419|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2047420|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047421|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
2047422|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
2047423|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
2047424|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2047425|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047426|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
2047427|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2047428|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2047429|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2047430|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047431|NCT01656031|Cytarabine|cytarabine|mesh-list
2047432|NCT01656031|Clofarabine|clofarabine|mesh-list
2047433|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2047434|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
2047435|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047436|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047437|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
2047438|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047439|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047440|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
2047441|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047442|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2047443|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
2047444|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2047445|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
2047446|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2047447|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047448|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2047449|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2047450|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047451|NCT01656187|Memantine|memantine|mesh-list
2047452|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2047453|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2047454|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
2047455|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047456|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047457|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047458|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2047459|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2047460|NCT01656252|Cytarabine|cytarabine|mesh-list
2047461|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2047462|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
2047463|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047464|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047465|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
2047466|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047467|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047468|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
2047469|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047470|NCT01656304|Bevacizumab|bevacizumab|mesh-list
2047471|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2047472|NCT01656304|Antibodies|antibodies|mesh-list
2047473|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
2047474|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2047475|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047476|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2047477|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2047478|NCT01656304|Growth Substances|growth substances|mesh-ancestor
2746573|NCT05169684|Nivolumab|nivolumab|mesh-list
2047479|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047480|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
2047481|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
2746574|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746575|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
2746576|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
2746577|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
2746578|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746579|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2746580|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2047482|NCT01656395|Montelukast|montelukast|mesh-list
2047483|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2047484|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
2047485|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2047486|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
2047487|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2047488|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047489|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2047490|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2047491|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047492|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
2047493|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2047494|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2047495|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2047496|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2047497|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
2047498|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2047499|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047500|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2047501|NCT01656434|Estrogens|estrogens|mesh-ancestor
2047502|NCT01656434|Hormones|hormones|mesh-ancestor
2047503|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2047504|NCT01656434|Trace Elements|trace elements|mesh-ancestor
2047505|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
2047506|NCT01656629|Vitamin D|vitamin d|mesh-list
2047507|NCT01656629|Alendronate|alendronate|mesh-list
2047508|NCT01656629|Teriparatide|teriparatide|mesh-list
2047509|NCT01656629|Calcium|calcium|mesh-list
2047510|NCT01656629|Vitamins|vitamins|mesh-ancestor
2047511|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
2047512|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047513|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2047514|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2047515|NCT01656733|Nicotine|nicotine|mesh-list
2047516|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2047517|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
2047518|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2047519|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047520|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2746581|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2746582|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
2746583|NCT05169658|Antibodies|antibodies|mesh-list
2746584|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
2746585|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2746586|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
2746587|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2746588|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
2746589|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047521|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2047522|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
2047523|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047524|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047525|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2047526|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2047527|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047528|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2047529|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2047530|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2047531|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047532|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
2047533|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047534|NCT01657162|Alendronate|alendronate|mesh-list
2047535|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2047536|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047537|NCT01657266|Nepafenac|nepafenac|mesh-list
2047538|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2047539|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2047540|NCT01657266|Analgesics|analgesics|mesh-ancestor
2047541|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
2047542|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2047543|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047544|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2047545|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2047546|NCT01657292|Octenidine|octenidine|mesh-list
2047547|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047548|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2047549|NCT01657461|Plasminogen|plasminogen|mesh-list
2047550|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2047551|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2047552|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2047553|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047554|NCT01657760|Citalopram|citalopram|mesh-list
2047555|NCT01657760|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2047556|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2047557|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2047558|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047559|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047560|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
2047561|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047562|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2047563|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
2047564|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2047565|NCT01657799|Veliparib|veliparib|mesh-list
2047566|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2047567|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047568|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047569|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047570|NCT01657877|Calcium|calcium|mesh-list
2047571|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2047572|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047573|NCT01657903|Listerine|listerine|mesh-list
2047574|NCT01657903|Fluorides|fluorides|mesh-list
2047575|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
2047576|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
2047577|NCT01657903|Protective Agents|protective agents|mesh-ancestor
2047578|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047579|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2047580|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047581|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
2047582|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2047583|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047584|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2047585|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2047586|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047587|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047588|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047589|NCT01658150|Isradipine|isradipine|mesh-list
2047590|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2047591|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2047592|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2047593|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047594|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2047595|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047596|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
2209056|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2209057|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2209058|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2209059|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2209060|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2209061|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2209062|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
2209063|NCT00013585|Selegiline|selegiline|mesh-list
2047597|NCT01658228|Donepezil|donepezil|mesh-list
2047598|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2047599|NCT01658228|Citalopram|citalopram|mesh-list
2047600|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2047601|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047602|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047603|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
2047604|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047605|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047606|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
2047607|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2047608|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2047609|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2746590|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746591|NCT05169593|Adalimumab|adalimumab|mesh-list
2047610|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2047611|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
2047612|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2047613|NCT01658228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2047614|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
2047615|NCT01658436|Dactolisib|dactolisib|mesh-list
2047616|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047617|NCT01658579|Insulin|insulin|mesh-list
2047618|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2047619|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
2047620|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2047621|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047622|NCT01658657|Metoprolol|metoprolol|mesh-list
2047623|NCT01658657|Amlodipine|amlodipine|mesh-list
2047624|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2047625|NCT01658657|Lisinopril|lisinopril|mesh-list
2047626|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
2047627|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2047628|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2047629|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2047630|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047631|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2047632|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047633|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
2047634|NCT01658657|Diuretics|diuretics|mesh-ancestor
2047635|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
2047636|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2047637|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2746592|NCT05169593|Infliximab|infliximab|mesh-list
2746593|NCT05169593|Ustekinumab|ustekinumab|mesh-list
2746594|NCT05169593|Vedolizumab|vedolizumab|mesh-list
2746595|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2746596|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2047638|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
2047639|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
2047640|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2047641|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2047642|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2047643|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2047644|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
2047645|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047646|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2047647|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
2047648|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047649|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2047650|NCT01658657|Protective Agents|protective agents|mesh-ancestor
2047651|NCT01658839|Travoprost|travoprost|mesh-list
2047652|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2047653|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2047654|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2047655|NCT01658904|Melphalan|melphalan|mesh-list
2047656|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
2746597|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
2047657|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047658|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2047659|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
2047660|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047661|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047662|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2047663|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047664|NCT01658943|Fluorouracil|fluorouracil|mesh-list
2047665|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
2047666|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
2047667|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746598|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2746607|NCT05169554|Amoxicillin|amoxicillin|mesh-list
2746608|NCT05169554|Clarithromycin|clarithromycin|mesh-list
2209064|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
2209065|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2209066|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2209067|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2209068|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2746609|NCT05169554|Rifampin|rifampin|mesh-list
2746610|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
2746611|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
2746612|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2047668|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2047669|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047670|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047671|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
2047672|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047673|NCT01658995|Doxycycline|doxycycline|mesh-list
2047674|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2047675|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047676|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
2047677|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2047678|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2047679|NCT01659021|Ofatumumab|ofatumumab|mesh-list
2047680|NCT01659021|Idelalisib|idelalisib|mesh-list
2047681|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047682|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047683|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047684|NCT01659320|Minocycline|minocycline|mesh-list
2746613|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2047685|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2047686|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047687|NCT01659567|Interferons|interferons|mesh-list
2047688|NCT01659567|Ribavirin|ribavirin|mesh-list
2047689|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
2047690|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
2047691|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2047692|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047693|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
2047694|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047695|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
2047696|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047697|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
2047698|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047699|NCT01659853|Azelaic acid|azelaic acid|mesh-list
2047700|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2047701|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2047702|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2047703|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2047704|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2047705|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
2047706|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047707|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047708|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047709|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047710|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
2047711|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
2047712|NCT01659866|Gentamicins|gentamicins|mesh-list
2047713|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
2047714|NCT01659866|Imipenem|imipenem|mesh-list
2047715|NCT01659866|Amikacin|amikacin|mesh-list
2047716|NCT01659866|Cefuroxime|cefuroxime|mesh-list
2047717|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2047718|NCT01659866|Aztreonam|aztreonam|mesh-list
2047719|NCT01659866|Trimethoprim|trimethoprim|mesh-list
2047720|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
2047721|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2047722|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047723|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2047724|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2047725|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047726|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209069|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209070|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209071|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2209072|NCT00013585|Protective Agents|protective agents|mesh-ancestor
2209073|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209074|NCT00013598|Pioglitazone|pioglitazone|mesh-list
2209075|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2209076|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209077|NCT00013624|Levodopa|levodopa|mesh-list
2209078|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2209079|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2209080|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
2209081|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209082|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047727|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047728|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2047729|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2047730|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2047731|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2047732|NCT01659866|Renal Agents|renal agents|mesh-ancestor
2047733|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
2047734|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2047735|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2047736|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2047737|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2047738|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2047739|NCT01660022|Piperaquine|piperaquine|mesh-list
2047740|NCT01660022|Artefenomel|artefenomel|mesh-list
2047741|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
2047742|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2047743|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2047744|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047745|NCT01660191|Atorvastatin|atorvastatin|mesh-list
2047746|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2047747|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2047748|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2047749|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
2047750|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047751|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2209083|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209084|NCT00013663|Aldesleukin|aldesleukin|mesh-list
2209085|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047752|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2047753|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047754|NCT01660256|Rebamipide|rebamipide|mesh-list
2047755|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2047756|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2047757|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
2047758|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047759|NCT01660256|Protective Agents|protective agents|mesh-ancestor
2047760|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047761|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047762|NCT01660334|Voriconazole|voriconazole|mesh-list
2047763|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
2047764|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047765|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2047766|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2047767|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209086|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2047768|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746614|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2746615|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2746616|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746617|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746618|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2746619|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2047769|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2047770|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
2047771|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2047772|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047773|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2047774|NCT01660672|Levetiracetam|levetiracetam|mesh-list
2047775|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
2047776|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
2047777|NCT01660711|Leucovorin|leucovorin|mesh-list
2047778|NCT01660711|Fluorouracil|fluorouracil|mesh-list
2047779|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
2047780|NCT01660711|Irinotecan|irinotecan|mesh-list
2047781|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
2047782|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047783|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2047784|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047785|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047786|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
2047787|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047788|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2047789|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2047790|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047791|NCT01660711|Antidotes|antidotes|mesh-ancestor
2047792|NCT01660711|Protective Agents|protective agents|mesh-ancestor
2047793|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
2047794|NCT01660711|Vitamins|vitamins|mesh-ancestor
2047795|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
2047796|NCT01660763|Sufentanil|sufentanil|mesh-list
2047797|NCT01660763|Dsuvia|dsuvia|mesh-list
2047798|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2047799|NCT01660763|Narcotics|narcotics|mesh-ancestor
2047800|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2047801|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047802|NCT01660763|Analgesics|analgesics|mesh-ancestor
2047803|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
2047804|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2047805|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2047806|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2047807|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
2047808|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
2047809|NCT01660802|Dexamethasone|dexamethasone|mesh-list
2047810|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2047811|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
2746620|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2746621|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
2746622|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
2746623|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2746624|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2746625|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2746626|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2746627|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2047812|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
2047813|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2047814|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047815|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2047816|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
2047817|NCT01660802|Hormones|hormones|mesh-ancestor
2047818|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2047819|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2047820|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047821|NCT01660893|Phenylephrine|phenylephrine|mesh-list
2047822|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
2047823|NCT01660893|Tetracaine|tetracaine|mesh-list
2047824|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
2047825|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
2047826|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2047827|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047828|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
2047829|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2047830|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2047831|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2746628|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2746629|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2746630|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2746634|NCT05169437|Niraparib|niraparib|mesh-list
2746635|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2047832|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
2047833|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047834|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047835|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
2047836|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
2047837|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
2047838|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2746636|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746637|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746638|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047839|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
2047840|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2047841|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
2047842|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2047843|NCT01660893|Protective Agents|protective agents|mesh-ancestor
2047844|NCT01660906|Dasatinib|dasatinib|mesh-list
2047845|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047846|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2047847|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047848|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047849|NCT01661088|Folfirinox|folfirinox|mesh-list
2047850|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047851|NCT01661114|Gemcitabine|gemcitabine|mesh-list
2047852|NCT01661114|Fluorouracil|fluorouracil|mesh-list
2047853|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047854|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2047855|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
2047856|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047857|NCT01661114|Antiviral Agents|antiviral agents|mesh-ancestor
2047858|NCT01661114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047859|NCT01661114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047860|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047861|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
2047862|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047863|NCT01661140|Methotrexate|methotrexate|mesh-list
2047864|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2047865|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
2047866|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2047867|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047868|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2047869|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
2047870|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047871|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047872|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
2047873|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047874|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2047875|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047876|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
2047877|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2047878|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2047879|NCT01661270|Aflibercept|aflibercept|mesh-list
2047880|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2047881|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2047882|NCT01661270|Growth Substances|growth substances|mesh-ancestor
2047883|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047884|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
2047885|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047886|NCT01661283|Bevacizumab|bevacizumab|mesh-list
2047887|NCT01661283|Everolimus|everolimus|mesh-list
2047888|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2047889|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047890|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2047891|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2047892|NCT01661283|Growth Substances|growth substances|mesh-ancestor
2047893|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047894|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
2047895|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047896|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
2047897|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
2047898|NCT01661595|Tadalafil|tadalafil|mesh-list
2047899|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
2047900|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2047901|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2047902|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2047903|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047904|NCT01661595|Urological Agents|urological agents|mesh-ancestor
2047905|NCT01661621|Doxazosin|doxazosin|mesh-list
2047906|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2047907|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2047908|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2047909|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2047910|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2047911|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
2047912|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047913|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047914|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047915|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2047916|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2047917|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
2047918|NCT01661621|Urological Agents|urological agents|mesh-ancestor
2047919|NCT01661790|Bevacizumab|bevacizumab|mesh-list
2047920|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2047921|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047922|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2047923|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2047924|NCT01661790|Growth Substances|growth substances|mesh-ancestor
2047925|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047926|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
2047927|NCT01661881|Cytarabine|cytarabine|mesh-list
2047928|NCT01661881|Rituximab|rituximab|mesh-list
2047929|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2047930|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2047931|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047932|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
2047933|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047934|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2047935|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2047936|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
2047937|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047938|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
2047939|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2047940|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2047941|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2047942|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
2047943|NCT01661946|Bevacizumab|bevacizumab|mesh-list
2047944|NCT01661946|Ranibizumab|ranibizumab|mesh-list
2047945|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2047946|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047947|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2047948|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2047949|NCT01661946|Growth Substances|growth substances|mesh-ancestor
2047950|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047951|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
2047952|NCT01661972|Capecitabine|capecitabine|mesh-list
2047953|NCT01661972|Aflibercept|aflibercept|mesh-list
2047954|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2047955|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
2047956|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047957|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2047958|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2047959|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2047960|NCT01661972|Growth Substances|growth substances|mesh-ancestor
2047961|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047962|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
2047963|NCT01662115|Nicotine|nicotine|mesh-list
2047964|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2047965|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
2047966|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2047967|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047968|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2047969|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2047970|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
2047971|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047972|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047973|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2047974|NCT01662297|Trazodone|trazodone|mesh-list
2047975|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
2047976|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2047977|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2047978|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2047979|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2047980|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047981|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2047982|NCT01662297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2047983|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2047984|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2047985|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2047986|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047987|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
2047988|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2047989|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2047990|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2047991|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2047992|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2047993|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2047994|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2047995|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2746657|NCT05169372|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2746658|NCT05169372|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2047996|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2047997|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
2047998|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2047999|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048000|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2048001|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2048002|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
2048003|NCT01662336|Ritonavir|ritonavir|mesh-list
2048004|NCT01662336|Lopinavir|lopinavir|mesh-list
2048005|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2048006|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2048007|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
2048008|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048009|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048010|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2048011|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2048012|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
2048013|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048014|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2048015|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2048016|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
2048017|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2048018|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2048019|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2048020|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2048021|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048022|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
2048023|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048024|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048025|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2048026|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048027|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2048028|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2048029|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2048030|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2048031|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048032|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2048033|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2746659|NCT05169372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746660|NCT05169268|Aripiprazole|aripiprazole|mesh-list
2746661|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
2746662|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
2746663|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2746664|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2746665|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2746666|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2746667|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746668|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
2746669|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
2746670|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2746671|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746672|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2746673|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2048034|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2048035|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
2048036|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048037|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048038|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2048039|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2048040|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
2048041|NCT01662791|Rifaximin|rifaximin|mesh-list
2048042|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2048043|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048044|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2048045|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2048046|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
2048047|NCT01662856|Coagulants|coagulants|mesh-ancestor
2048048|NCT01662895|Deferoxamine|deferoxamine|mesh-list
2048049|NCT01662895|Siderophores|siderophores|mesh-ancestor
2048050|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2048051|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
2048052|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
2048053|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048054|NCT01662908|Heparin|heparin|mesh-list
2048055|NCT01662908|Enoxaparin|enoxaparin|mesh-list
2048056|NCT01662908|Calcium heparin|calcium heparin|mesh-list
2048057|NCT01662908|Warfarin|warfarin|mesh-list
2048058|NCT01662908|Edoxaban|edoxaban|mesh-list
2048059|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
2048060|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2048061|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2048062|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048063|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2048064|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
2048065|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2048066|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
2048067|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048068|NCT01662986|Bromides|bromides|mesh-list
2048069|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
2048070|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2048071|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
2048072|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048073|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048074|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2048075|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
2048076|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
2746674|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
2048077|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2048078|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
2048079|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048080|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048081|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
2048082|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
2048083|NCT01662999|Saxagliptin|saxagliptin|mesh-list
2048084|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2048085|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048086|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2048087|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048088|NCT01662999|Incretins|incretins|mesh-ancestor
2048089|NCT01662999|Hormones|hormones|mesh-ancestor
2048090|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048091|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2048092|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
2048093|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048094|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
2048095|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048096|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2048097|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2048098|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048099|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048100|NCT01663103|Rilonacept|rilonacept|mesh-list
2048101|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2048102|NCT01663233|Amlodipine|amlodipine|mesh-list
2048103|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2048104|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2048105|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2048106|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2048107|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048108|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2048109|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048110|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
2048111|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2048112|NCT01663259|Cetuximab|cetuximab|mesh-list
2048113|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2048114|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048115|NCT01663272|Gemcitabine|gemcitabine|mesh-list
2048116|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2048117|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
2048118|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048119|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048120|NCT01663272|Antiviral Agents|antiviral agents|mesh-ancestor
2048121|NCT01663272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048122|NCT01663272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048123|NCT01663272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2048124|NCT01663272|Immunologic Factors|immunologic factors|mesh-ancestor
2048125|NCT01663272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048126|NCT01663532|Aripiprazole|aripiprazole|mesh-list
2048127|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
2048128|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2048129|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2048130|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2048131|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2048132|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048133|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
2048134|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
2048135|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048136|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048137|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2048138|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2746675|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2746676|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2048139|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
2048140|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2048141|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2048142|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2048143|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2048144|NCT01663623|Azathioprine|azathioprine|mesh-list
2048145|NCT01663623|Belimumab|belimumab|mesh-list
2048146|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
2048147|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048148|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2048149|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048150|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2048151|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
2048152|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048153|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2048154|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
2048155|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048156|NCT01663727|Paclitaxel|paclitaxel|mesh-list
2048157|NCT01663727|Bevacizumab|bevacizumab|mesh-list
2048158|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2048159|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048160|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
2048161|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
2048162|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
2048163|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048164|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2048165|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2048166|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2048167|NCT01663727|Growth Substances|growth substances|mesh-ancestor
2048168|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048169|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
2048170|NCT01663740|Valganciclovir|valganciclovir|mesh-list
2048171|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
2048172|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048173|NCT01663857|Gemcitabine|gemcitabine|mesh-list
2048174|NCT01663857|Carboplatin|carboplatin|mesh-list
2048175|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048176|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2048177|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
2048178|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048179|NCT01663857|Antiviral Agents|antiviral agents|mesh-ancestor
2048180|NCT01663857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048181|NCT01663857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048182|NCT01663857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2048183|NCT01663857|Immunologic Factors|immunologic factors|mesh-ancestor
2048184|NCT01663857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048185|NCT01663935|Levodopa|levodopa|mesh-list
2048186|NCT01663935|Carbidopa|carbidopa|mesh-list
2209087|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2209088|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
2209089|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209090|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
2209091|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
2209092|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2209093|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
2209094|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2209095|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2209096|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209097|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2209098|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209099|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209100|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2209101|NCT00013689|Renal Agents|renal agents|mesh-ancestor
2209102|NCT00013702|Adefovir|adefovir|mesh-list
2209103|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
2209104|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209105|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2209106|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2209107|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209108|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048187|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2048188|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2048189|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
2048190|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048191|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048192|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048193|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2048194|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048195|NCT01663987|Bromides|bromides|mesh-list
2048196|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
2048197|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2048198|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
2048199|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048200|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048201|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2048202|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
2048203|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
2048204|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2048205|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
2048206|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048207|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048208|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
2048209|NCT01664039|Bimatoprost|bimatoprost|mesh-list
2048210|NCT01664039|Travoprost|travoprost|mesh-list
2209109|NCT00013871|Vaccines|vaccines|mesh-list
2048211|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2048212|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2048213|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2048214|NCT01664247|Liraglutide|liraglutide|mesh-list
2048215|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2048216|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048217|NCT01664247|Incretins|incretins|mesh-ancestor
2048218|NCT01664247|Hormones|hormones|mesh-ancestor
2048219|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048220|NCT01664494|Capecitabine|capecitabine|mesh-list
2048221|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2048222|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
2048223|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048224|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048225|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2048226|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048227|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2048228|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048229|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048230|NCT01664559|Ketorolac|ketorolac|mesh-list
2048231|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2048232|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2048233|NCT01664559|Analgesics|analgesics|mesh-ancestor
2048234|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
2048235|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048236|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048237|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2048238|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2048239|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2048240|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048241|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048242|NCT01664624|Exenatide|exenatide|mesh-list
2048243|NCT01664624|Alogliptin|alogliptin|mesh-list
2048244|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2048245|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048246|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2048247|NCT01664624|Incretins|incretins|mesh-ancestor
2048248|NCT01664624|Hormones|hormones|mesh-ancestor
2048249|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048250|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2048251|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
2048252|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048253|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048254|NCT01664741|Nicotine|nicotine|mesh-list
2048255|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2048256|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
2048257|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048258|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048259|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2048260|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2048261|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
2048262|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048263|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048264|NCT01664793|Vaccines|vaccines|mesh-list
2048265|NCT01664793|Immunologic Factors|immunologic factors|mesh-ancestor
2048266|NCT01664793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048267|NCT01664858|Calcium|calcium|mesh-list
2048268|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2048269|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048270|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2048271|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048272|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2048273|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048274|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048275|NCT01664923|Bicalutamide|bicalutamide|mesh-list
2048276|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
2048277|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
2048278|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048279|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048280|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048281|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2048282|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2048283|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
2048284|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2048285|NCT01664949|Laxatives|laxatives|mesh-ancestor
2048286|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2746677|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2746678|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2746679|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2746680|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2746681|NCT05169229|Vancomycin|vancomycin|mesh-list
2746682|NCT05169229|Tobramycin|tobramycin|mesh-list
2048293|NCT01665508|Nebivolol|nebivolol|mesh-list
2048294|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2048295|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
2048296|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2048297|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2048298|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2048299|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
2048300|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048301|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048302|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048303|NCT01665599|Testosterone|testosterone|mesh-list
2048304|NCT01665599|Androgens|androgens|mesh-ancestor
2048305|NCT01665599|Hormones|hormones|mesh-ancestor
2048306|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048307|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048308|NCT01665768|Rituximab|rituximab|mesh-list
2048309|NCT01665768|Everolimus|everolimus|mesh-list
2048310|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2048311|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048312|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
2048313|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048314|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2048315|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2048316|NCT01665911|Listerine|listerine|mesh-list
2048317|NCT01665911|Fluorides|fluorides|mesh-list
2048318|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
2048319|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
2048320|NCT01665911|Protective Agents|protective agents|mesh-ancestor
2048321|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048322|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2746683|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2746684|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048323|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048324|NCT01665950|Simvastatin|simvastatin|mesh-list
2048325|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2048326|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2048327|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
2048328|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048329|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2048330|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2048331|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048332|NCT01666119|Buprenorphine|buprenorphine|mesh-list
2048333|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2048334|NCT01666119|Narcotics|narcotics|mesh-ancestor
2048335|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2048336|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048337|NCT01666119|Analgesics|analgesics|mesh-ancestor
2048338|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
2048339|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048340|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2048341|NCT01666197|Diclofenac|diclofenac|mesh-list
2746685|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
2746686|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2746687|NCT05169112|Leuprolide|leuprolide|mesh-list
2048342|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2048343|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2048344|NCT01666197|Analgesics|analgesics|mesh-ancestor
2048345|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
2048346|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048347|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048348|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2048349|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2048350|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2048351|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048352|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048353|NCT01666210|Dexamethasone|dexamethasone|mesh-list
2048354|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2048355|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
2048356|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
2048357|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048358|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048359|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2048360|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
2048361|NCT01666210|Hormones|hormones|mesh-ancestor
2048362|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048363|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2048364|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048365|NCT01666314|Prednisone|prednisone|mesh-list
2048366|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2048367|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
2048368|NCT01666314|Hormones|hormones|mesh-ancestor
2048369|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048370|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048371|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2048372|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048373|NCT01666444|Doxorubicin|doxorubicin|mesh-list
2048374|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2048375|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2048376|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048377|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2048378|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2048379|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048380|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048381|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2048382|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
2048383|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2048384|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
2048385|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048386|NCT01666652|Antacids|antacids|mesh-ancestor
2048387|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048388|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2048389|NCT01666730|Leucovorin|leucovorin|mesh-list
2048390|NCT01666730|Metformin|metformin|mesh-list
2048391|NCT01666730|Fluorouracil|fluorouracil|mesh-list
2048392|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
2048393|NCT01666730|Calcium|calcium|mesh-list
2048394|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
2048395|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2048396|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048397|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2048398|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
2048399|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048400|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2048401|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048402|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2048403|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
2048404|NCT01666730|Antidotes|antidotes|mesh-ancestor
2048405|NCT01666730|Protective Agents|protective agents|mesh-ancestor
2048406|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
2048407|NCT01666730|Vitamins|vitamins|mesh-ancestor
2048408|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
2048409|NCT01666782|Vaccines|vaccines|mesh-list
2048410|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
2048411|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048412|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
2048413|NCT01666912|Etonogestrel|etonogestrel|mesh-list
2048414|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2048415|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048416|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2048417|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2048418|NCT01666951|Tacrolimus|tacrolimus|mesh-list
2048419|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2048420|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
2048421|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048422|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2048423|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048424|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048425|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
2048426|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048427|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2048428|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2048429|NCT01667029|Analgesics|analgesics|mesh-ancestor
2048430|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
2048431|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048432|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048433|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2048434|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2048435|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2048436|NCT01667107|Posaconazole|posaconazole|mesh-list
2048437|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
2048438|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048439|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2048440|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2048441|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2048442|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2048443|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2048444|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048445|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048446|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2048447|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
2048448|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048449|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048450|NCT01667419|Vemurafenib|vemurafenib|mesh-list
2048451|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048452|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2048453|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048454|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048455|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2048456|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
2048457|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048458|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2048459|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048460|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2048461|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048462|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048463|NCT01667679|Sumatriptan|sumatriptan|mesh-list
2048464|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2048465|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2048466|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2048467|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
2048468|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048469|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048470|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048471|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
2048472|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
2048473|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048474|NCT01667796|Vitamin D|vitamin d|mesh-list
2048475|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
2048476|NCT01667796|Vitamins|vitamins|mesh-ancestor
2048477|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
2048478|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048479|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2048480|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2048481|NCT01667900|Dulaglutide|dulaglutide|mesh-list
2048482|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2048483|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048484|NCT01667926|Ketamine|ketamine|mesh-list
2048485|NCT01667926|Analgesics|analgesics|mesh-ancestor
2048486|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
2048487|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048488|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048489|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2048490|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2048491|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
2048492|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
2048493|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2048494|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2048495|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2048496|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048497|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048498|NCT01667978|Ritonavir|ritonavir|mesh-list
2048499|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2048500|NCT01667978|Norethindrone|norethindrone|mesh-list
2048501|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
2048502|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
2048503|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2048504|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2048505|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048506|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048507|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2048508|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2048509|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
2048510|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048511|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2048512|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2048513|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2048514|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2048515|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2048516|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
2048517|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2048518|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048519|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2048520|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2048521|NCT01668004|Golimumab|golimumab|mesh-list
2048522|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2048523|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2048524|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2048525|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
2048526|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048527|NCT01668017|Niacinamide|niacinamide|mesh-list
2048528|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
2048529|NCT01668017|Vitamins|vitamins|mesh-ancestor
2048530|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
2048531|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048532|NCT01668030|Bacitracin|bacitracin|mesh-list
2048533|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2048534|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048535|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2048536|NCT01668654|Ezogabine|ezogabine|mesh-list
2048537|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
2048538|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2048539|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048540|NCT01668667|Gabapentin|gabapentin|mesh-list
2048541|NCT01668667|Analgesics|analgesics|mesh-ancestor
2048542|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
2048543|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048544|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048545|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
2048546|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2048547|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2048548|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2048549|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2048550|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2048551|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2048552|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048553|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048554|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
2048555|NCT01668719|Dexamethasone|dexamethasone|mesh-list
2048556|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
2048557|NCT01668719|Lenalidomide|lenalidomide|mesh-list
2048558|NCT01668719|Bortezomib|bortezomib|mesh-list
2048559|NCT01668719|Elotuzumab|elotuzumab|mesh-list
2048560|NCT01668719|Ichthammol|ichthammol|mesh-list
2048561|NCT01668719|BB 1101|bb 1101|mesh-list
2048562|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2048563|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
2048564|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
2048565|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048566|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048567|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2048568|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
2048569|NCT01668719|Hormones|hormones|mesh-ancestor
2048570|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048571|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2048572|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048573|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
2048574|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2048575|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2048576|NCT01668719|Growth Substances|growth substances|mesh-ancestor
2048577|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
2048578|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
2048579|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048580|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048581|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
2048582|NCT01668784|Nivolumab|nivolumab|mesh-list
2048583|NCT01668784|Everolimus|everolimus|mesh-list
2048584|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2048585|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048586|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2048587|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048588|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2048589|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
2048590|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048591|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
2048592|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
2048593|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048594|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048595|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048596|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
2048597|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
2048598|NCT01668836|Resveratrol|resveratrol|mesh-list
2048599|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
2048600|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048601|NCT01668836|Protective Agents|protective agents|mesh-ancestor
2048602|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048603|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048604|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2048605|NCT01669122|Nicotine|nicotine|mesh-list
2048606|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2048607|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
2048608|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048609|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048610|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2048611|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2048612|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
2048613|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048614|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048615|NCT01669343|Letrozole|letrozole|mesh-list
2048616|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048617|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2048618|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2048619|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048620|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048621|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2048622|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
2048623|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048624|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048625|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
2048626|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2048627|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
2048628|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048629|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048630|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2048631|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2048632|NCT01669434|Ramipril|ramipril|mesh-list
2048633|NCT01669434|Enalapril|enalapril|mesh-list
2048634|NCT01669434|Enalaprilat|enalaprilat|mesh-list
2048635|NCT01669434|Lisinopril|lisinopril|mesh-list
2048636|NCT01669434|Perindopril|perindopril|mesh-list
2048637|NCT01669434|Benazepril|benazepril|mesh-list
2048638|NCT01669434|Captopril|captopril|mesh-list
2048639|NCT01669434|Quinapril|quinapril|mesh-list
2048640|NCT01669434|Trandolapril|trandolapril|mesh-list
2048641|NCT01669434|Fosinopril|fosinopril|mesh-list
2048642|NCT01669434|Moexipril|moexipril|mesh-list
2048643|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2048644|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
2048645|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048646|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048647|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2048648|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2048649|NCT01669434|Protective Agents|protective agents|mesh-ancestor
2048650|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048651|NCT01669538|Galantamine|galantamine|mesh-list
2048652|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2048653|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048654|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048655|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
2048656|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048657|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048658|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2048659|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
2048660|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048661|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
2048662|NCT01669642|Ketamine|ketamine|mesh-list
2048663|NCT01669642|Analgesics|analgesics|mesh-ancestor
2048664|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
2048665|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048666|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048667|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2048668|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2048669|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
2048670|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
2048671|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2048672|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2048673|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2048674|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048675|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048676|NCT01669720|Aflibercept|aflibercept|mesh-list
2048677|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2048678|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2048679|NCT01669720|Growth Substances|growth substances|mesh-ancestor
2048680|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048681|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
2048682|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048683|NCT01669785|Listerine|listerine|mesh-list
2048684|NCT01669785|Fluorides|fluorides|mesh-list
2048685|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
2048686|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
2048687|NCT01669785|Protective Agents|protective agents|mesh-ancestor
2048688|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048689|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2048690|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048691|NCT01669798|Nintedanib|nintedanib|mesh-list
2048692|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048693|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2048694|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048695|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048696|NCT01669811|Esomeprazole|esomeprazole|mesh-list
2048697|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2048698|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2048699|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2048700|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048701|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048702|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
2048703|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
2048704|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
2048705|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2048706|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2048707|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2048708|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048709|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048710|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
2048711|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048712|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2048713|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2048714|NCT01670019|Asenapine|asenapine|mesh-list
2048715|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2048716|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2048717|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2048718|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048719|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2048720|NCT01670097|Dexamethasone|dexamethasone|mesh-list
2048721|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2048722|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
2048723|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
2048724|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048725|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048726|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2048727|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
2048728|NCT01670097|Hormones|hormones|mesh-ancestor
2048729|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048730|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2048731|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048732|NCT01670110|Pasireotide|pasireotide|mesh-list
2048733|NCT01670110|Hormones|hormones|mesh-ancestor
2048734|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048735|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048736|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
2048737|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
2048738|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048739|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048740|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746688|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2746689|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
2746690|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2746691|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746692|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2746693|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746694|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2746695|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2746696|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2746697|NCT05169060|Analgesics|analgesics|mesh-ancestor
2746698|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
2746699|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2746700|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746701|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2746702|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2746703|NCT05169021|Folic Acid|folic acid|mesh-list
2048741|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
2048742|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
2048743|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
2048744|NCT01670500|Cisplatin|cisplatin|mesh-list
2048745|NCT01670500|Doxorubicin|doxorubicin|mesh-list
2048746|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2048747|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
2048748|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048749|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2048750|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2048751|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
2048752|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048753|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048754|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2048755|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2048756|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2048757|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2048758|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048759|NCT01670526|Rivastigmine|rivastigmine|mesh-list
2048760|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
2048761|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048762|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048763|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
2048764|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048765|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048766|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2048767|NCT01670526|Protective Agents|protective agents|mesh-ancestor
2048768|NCT01670656|Ibuprofen|ibuprofen|mesh-list
2048769|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
2048770|NCT01670656|Etonogestrel|etonogestrel|mesh-list
2048771|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2048772|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2048773|NCT01670656|Analgesics|analgesics|mesh-ancestor
2048774|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
2048775|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048776|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048777|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2048778|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2048779|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2048780|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048781|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048782|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2048783|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2048784|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2048785|NCT01670721|Leucovorin|leucovorin|mesh-list
2048786|NCT01670721|Fluorouracil|fluorouracil|mesh-list
2048787|NCT01670721|Irinotecan|irinotecan|mesh-list
2048788|NCT01670721|Aflibercept|aflibercept|mesh-list
2048789|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
2048790|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048791|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2048792|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048793|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2048794|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
2048795|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048796|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2048797|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2048798|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048799|NCT01670721|Antidotes|antidotes|mesh-ancestor
2048800|NCT01670721|Protective Agents|protective agents|mesh-ancestor
2048801|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
2048802|NCT01670721|Vitamins|vitamins|mesh-ancestor
2048803|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
2048804|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2048805|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2048806|NCT01670721|Growth Substances|growth substances|mesh-ancestor
2048807|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
2079380|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079381|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2079382|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
2079383|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2079384|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079385|NCT02057939|Leuprolide|leuprolide|mesh-list
2079386|NCT02057939|Androgens|androgens|mesh-list
2079387|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2079388|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
2079389|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2079390|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079391|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2079392|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079393|NCT02057939|Hormones|hormones|mesh-ancestor
2079394|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2079395|NCT02058095|Tadalafil|tadalafil|mesh-list
2079396|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
2079397|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2079398|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2079399|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079400|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079401|NCT02058095|Urological Agents|urological agents|mesh-ancestor
2079402|NCT02058108|Telbivudine|telbivudine|mesh-list
2079403|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
2048808|NCT01671280|Azithromycin|azithromycin|mesh-list
2048809|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2048810|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048811|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
2048812|NCT01671319|Docetaxel|docetaxel|mesh-list
2048813|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2048814|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
2048815|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048816|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2048817|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2048818|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
2048819|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048820|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048821|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2048822|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
2048823|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
2048824|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
2048825|NCT01671332|Suramin|suramin|mesh-list
2048826|NCT01671332|Docetaxel|docetaxel|mesh-list
2048827|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048828|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
2048829|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
2048830|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
2048831|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048832|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
2048833|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
2048834|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2048835|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048836|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2048837|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2048838|NCT01671423|Prednisone|prednisone|mesh-list
2048839|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2048840|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
2048841|NCT01671423|Hormones|hormones|mesh-ancestor
2048842|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048843|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048844|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2048845|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048846|NCT01671488|Mitomycins|mitomycins|mesh-list
2048847|NCT01671488|Mitomycin|mitomycin|mesh-list
2048848|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2048849|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048850|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
2048851|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048852|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2048853|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048854|NCT01672710|Niacin|niacin|mesh-list
2048855|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2048856|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
2048857|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048858|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2048859|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
2048860|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
2048861|NCT01672710|Vitamins|vitamins|mesh-ancestor
2048862|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
2048863|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048864|NCT01672723|Naltrexone|naltrexone|mesh-list
2048865|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2048866|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2048867|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048868|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
2048869|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048870|NCT01672736|Dexamethasone|dexamethasone|mesh-list
2048871|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
2048872|NCT01672736|Bortezomib|bortezomib|mesh-list
2048873|NCT01672736|BB 1101|bb 1101|mesh-list
2048874|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2048875|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
2048876|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
2048877|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048878|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048879|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2048880|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
2048881|NCT01672736|Hormones|hormones|mesh-ancestor
2048882|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048883|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2048884|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048885|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
2048886|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048887|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048888|NCT01672788|Metformin|metformin|mesh-list
2048889|NCT01672788|Empagliflozin|empagliflozin|mesh-list
2048890|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2048891|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048892|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2048893|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048894|NCT01672801|Nimodipine|nimodipine|mesh-list
2048895|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2048896|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2048897|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2048898|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048899|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2048900|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048901|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
2048902|NCT01672827|Flutemetamol|flutemetamol|mesh-list
2048903|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2048904|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048905|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
2048906|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2048907|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2048908|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048909|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2048910|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
2048911|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2048912|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048913|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048914|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048915|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
2048916|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048917|NCT01672983|Ritonavir|ritonavir|mesh-list
2048918|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2048919|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2048920|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
2048921|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048922|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048923|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2048924|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2048925|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
2048926|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2048927|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2048928|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2048929|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
2048930|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048931|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2048932|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048933|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048934|NCT01673191|Dexamethasone|dexamethasone|mesh-list
2048935|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
2048936|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2048937|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2048938|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
2048939|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
2048940|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048941|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048942|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2048943|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
2048944|NCT01673191|Hormones|hormones|mesh-ancestor
2048945|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048946|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2048947|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048948|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2048949|NCT01673282|Lacosamide|lacosamide|mesh-list
2048950|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
2048951|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2048952|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2048953|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2048954|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048955|NCT01673386|Sunitinib|sunitinib|mesh-list
2048956|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2048957|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2048958|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2048959|NCT01673386|Growth Substances|growth substances|mesh-ancestor
2048960|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048961|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
2048962|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2048963|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048964|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048965|NCT01673490|Tamsulosin|tamsulosin|mesh-list
2048966|NCT01673490|Dutasteride|dutasteride|mesh-list
2048967|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2048968|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2048969|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2048970|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
2048971|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2048972|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048973|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048974|NCT01673490|Urological Agents|urological agents|mesh-ancestor
2048975|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2048976|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2048977|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2048978|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
2048979|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048980|NCT01673594|Naltrexone|naltrexone|mesh-list
2048981|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2048982|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2048983|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048984|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
2048985|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2048986|NCT01673620|Loratadine|loratadine|mesh-list
2048987|NCT01673620|Montelukast|montelukast|mesh-list
2048988|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2048989|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
2048990|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2048991|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
2048992|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2048993|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2048994|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2048995|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2048996|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2048997|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
2048998|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
2048999|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2049000|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2049001|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2049002|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
2049003|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
2049004|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049005|NCT01673646|Pasireotide|pasireotide|mesh-list
2049006|NCT01673646|Hormones|hormones|mesh-ancestor
2049007|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2049008|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049009|NCT01673828|Pregnanolone|pregnanolone|mesh-list
2049010|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2049011|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
2049012|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049013|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049014|NCT01673854|Ipilimumab|ipilimumab|mesh-list
2049015|NCT01673854|Vemurafenib|vemurafenib|mesh-list
2049016|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2049017|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049018|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2049019|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049020|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2049021|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049022|NCT01673867|Docetaxel|docetaxel|mesh-list
2049023|NCT01673867|Nivolumab|nivolumab|mesh-list
2049024|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049025|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
2049026|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
2049027|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
2049028|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049029|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2049030|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2049031|NCT01673984|Goserelin|goserelin|mesh-list
2049032|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2049033|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2049034|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049035|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
2049036|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2049037|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
2049038|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2049039|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049040|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2049041|NCT01674010|Inositol|inositol|mesh-list
2049042|NCT01674010|Lamotrigine|lamotrigine|mesh-list
2049043|NCT01674010|Valproic Acid|valproic acid|mesh-list
2049044|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
2049045|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2049046|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2049047|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049048|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2049049|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049050|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2049051|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2049052|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049053|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2049054|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2049055|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049056|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
2049057|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049058|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
2049059|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
2049060|NCT01674010|Vitamins|vitamins|mesh-ancestor
2049061|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
2049062|NCT01674062|Trastuzumab|trastuzumab|mesh-list
2049063|NCT01674062|Pertuzumab|pertuzumab|mesh-list
2049064|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2049065|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049066|NCT01674569|Ranibizumab|ranibizumab|mesh-list
2049067|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2049068|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2049069|NCT01674569|Growth Substances|growth substances|mesh-ancestor
2049070|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049071|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
2049072|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049073|NCT01674621|Abaloparatide|abaloparatide|mesh-list
2049074|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
2049075|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2049076|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049077|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2049078|NCT01674647|Vitamin K|vitamin k|mesh-list
2049079|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
2049080|NCT01674647|Vitamins|vitamins|mesh-ancestor
2049081|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
2049082|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049083|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2049084|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
2049085|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2049086|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
2049087|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049088|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049089|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
2049090|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2049091|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2049092|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
2049093|NCT01674647|Coagulants|coagulants|mesh-ancestor
2049094|NCT01674712|Simvastatin|simvastatin|mesh-list
2049095|NCT01674712|Fenofibrate|fenofibrate|mesh-list
2049096|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2049097|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2049098|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
2079404|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049099|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049100|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2049101|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2049102|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049103|NCT01674725|Ribavirin|ribavirin|mesh-list
2049104|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
2049105|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049106|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
2049107|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049108|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
2049109|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
2049110|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
2049111|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2049112|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2049113|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
2049114|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
2049115|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049116|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049117|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049118|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2049119|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
2049120|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2049121|NCT01675128|Irinotecan|irinotecan|mesh-list
2049122|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2049123|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2049124|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049125|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049126|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049127|NCT01675141|Lenalidomide|lenalidomide|mesh-list
2049128|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
2049129|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049130|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2049131|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2049132|NCT01675141|Growth Substances|growth substances|mesh-ancestor
2049133|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
2049134|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049135|NCT01675154|Orlistat|orlistat|mesh-list
2049136|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049137|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049138|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2049139|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2049140|NCT01675167|Buprenorphine|buprenorphine|mesh-list
2049141|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2049142|NCT01675167|Narcotics|narcotics|mesh-ancestor
2049143|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049144|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049145|NCT01675167|Analgesics|analgesics|mesh-ancestor
2049146|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
2049147|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049148|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2049149|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
2049150|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
2049151|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
2049152|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2049153|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049154|NCT01675297|Vitamins|vitamins|mesh-ancestor
2049155|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
2049156|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2049157|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2049158|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2049159|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049160|NCT01675531|Oxycodone|oxycodone|mesh-list
2049161|NCT01675531|Naloxone|naloxone|mesh-list
2049162|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2049163|NCT01675531|Narcotics|narcotics|mesh-ancestor
2049164|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049165|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049166|NCT01675531|Analgesics|analgesics|mesh-ancestor
2049167|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
2049168|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049169|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2049170|NCT01675622|Morphine|morphine|mesh-list
2049171|NCT01675622|Oxycodone|oxycodone|mesh-list
2049172|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2049173|NCT01675622|Narcotics|narcotics|mesh-ancestor
2049174|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049175|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049176|NCT01675622|Analgesics|analgesics|mesh-ancestor
2049177|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
2049178|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049179|NCT01675635|Morphine|morphine|mesh-list
2049180|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2049181|NCT01675635|Narcotics|narcotics|mesh-ancestor
2049182|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049183|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049184|NCT01675635|Analgesics|analgesics|mesh-ancestor
2049185|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
2049186|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049187|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
2049188|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2049189|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
2049190|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049191|NCT01675661|Expectorants|expectorants|mesh-ancestor
2049192|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
2049193|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2049194|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
2049195|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049196|NCT01675661|Protective Agents|protective agents|mesh-ancestor
2049197|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049198|NCT01675661|Antidotes|antidotes|mesh-ancestor
2049199|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
2049200|NCT01675765|Cisplatin|cisplatin|mesh-list
2049201|NCT01675765|Pemetrexed|pemetrexed|mesh-list
2049202|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
2049203|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2049204|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049205|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2049206|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2049207|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
2049208|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049209|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049210|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2049211|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049212|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2049213|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2049214|NCT01675778|Hydromorphone|hydromorphone|mesh-list
2049215|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2049216|NCT01675778|Narcotics|narcotics|mesh-ancestor
2049217|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049218|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049219|NCT01675778|Analgesics|analgesics|mesh-ancestor
2049220|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
2049221|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049222|NCT01676116|Liraglutide|liraglutide|mesh-list
2049223|NCT01676116|Exenatide|exenatide|mesh-list
2049224|NCT01676116|Xultophy|xultophy|mesh-list
2049225|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2049226|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049227|NCT01676116|Incretins|incretins|mesh-ancestor
2049228|NCT01676116|Hormones|hormones|mesh-ancestor
2049229|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2049230|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2049231|NCT01676220|Insulin|insulin|mesh-list
2049232|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2049233|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
2049234|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2049235|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049236|NCT01676311|Huperzine A|huperzine a|mesh-list
2049237|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2049238|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049239|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049240|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
2049241|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049242|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049243|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2049244|NCT01676311|Protective Agents|protective agents|mesh-ancestor
2049245|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
2049246|NCT01676415|Prednisone|prednisone|mesh-list
2049247|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
2049248|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2049249|NCT01676415|Hormones|hormones|mesh-ancestor
2049250|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2049251|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049252|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2049253|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049254|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
2049255|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2049256|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
2049257|NCT01677195|Antacids|antacids|mesh-ancestor
2049258|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049259|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2049260|NCT01677286|Doxycycline|doxycycline|mesh-list
2049261|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2049262|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049263|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
2049264|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2049265|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2049266|NCT01677299|Metformin|metformin|mesh-list
2049267|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2049268|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049269|NCT01677377|Risperidone|risperidone|mesh-list
2049270|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2049271|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
2049272|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049273|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049274|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049275|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2049276|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2049277|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049278|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2049279|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2049280|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
2049281|NCT01677507|Timolol|timolol|mesh-list
2049282|NCT01677507|Latanoprost|latanoprost|mesh-list
2049283|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2049284|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2049285|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
2049286|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049287|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049288|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049289|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2049290|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2049291|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2049292|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2049293|NCT01677741|Dabrafenib|dabrafenib|mesh-list
2049294|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049295|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2049296|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049297|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049298|NCT01677858|Dexamethasone|dexamethasone|mesh-list
2049299|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2049300|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
2049301|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
2049302|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049303|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049304|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2049305|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
2049306|NCT01677858|Hormones|hormones|mesh-ancestor
2049307|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2049308|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2049309|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049310|NCT01677988|Folfirinox|folfirinox|mesh-list
2049311|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049312|NCT01678131|Ribavirin|ribavirin|mesh-list
2049313|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2049314|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
2049315|NCT01678131|Liver Extracts|liver extracts|mesh-list
2049316|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
2049317|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049318|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
2049319|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049320|NCT01678131|Hematinics|hematinics|mesh-ancestor
2049321|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049322|NCT01678209|Methylphenidate|methylphenidate|mesh-list
2049323|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2049324|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2049325|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049326|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2049327|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2049328|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2049329|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049330|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
2049331|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049332|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2049333|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
2049334|NCT01678313|Celecoxib|celecoxib|mesh-list
2049335|NCT01678313|Doxazosin|doxazosin|mesh-list
2049336|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2049337|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2049338|NCT01678313|Analgesics|analgesics|mesh-ancestor
2049339|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
2049340|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049341|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049342|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2049343|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2049344|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2049345|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2049346|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049347|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049348|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2049349|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2049350|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2049351|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2049352|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
2049353|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049354|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2049355|NCT01678443|Antibodies|antibodies|mesh-list
2049356|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
2049357|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2049358|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
2049359|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049360|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049361|NCT01678794|Candesartan|candesartan|mesh-list
2049362|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2049363|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2049364|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2049365|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049366|NCT01678820|Metformin|metformin|mesh-list
2049367|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2049368|NCT01678820|Glimepiride|glimepiride|mesh-list
2049369|NCT01678820|Simvastatin|simvastatin|mesh-list
2049370|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2049371|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049372|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2049373|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2049374|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
2049375|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049376|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2049377|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2049378|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049379|NCT01678820|Incretins|incretins|mesh-ancestor
2049380|NCT01678820|Hormones|hormones|mesh-ancestor
2049381|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2049382|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2049383|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
2049384|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2049385|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2049386|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
2049387|NCT01678911|Gabapentin|gabapentin|mesh-list
2049388|NCT01678911|Analgesics|analgesics|mesh-ancestor
2049389|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
2049390|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049391|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049392|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
2049393|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2049394|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2049395|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049396|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2049397|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2049398|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2049399|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049400|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049401|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
2049402|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2049403|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
2049404|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
2049405|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2049406|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2049407|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2049408|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049409|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2049410|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2049411|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2049412|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
2049413|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
2049414|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2049415|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2049416|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2049417|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049418|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2049419|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2049420|NCT01679405|Gemcitabine|gemcitabine|mesh-list
2049421|NCT01679405|Cisplatin|cisplatin|mesh-list
2049422|NCT01679405|Afatinib|afatinib|mesh-list
2049423|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049424|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2049425|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
2049426|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049427|NCT01679405|Antiviral Agents|antiviral agents|mesh-ancestor
2049428|NCT01679405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049429|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049430|NCT01679405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2049431|NCT01679405|Immunologic Factors|immunologic factors|mesh-ancestor
2049432|NCT01679405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049433|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2049434|NCT01679613|Ketoconazole|ketoconazole|mesh-list
2049435|NCT01679613|Nintedanib|nintedanib|mesh-list
2049436|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
2049437|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049438|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2049439|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2049440|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049441|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049442|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2049443|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
2049444|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2049445|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049446|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2049447|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049448|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2049449|NCT01680172|Ketamine|ketamine|mesh-list
2049450|NCT01680172|Analgesics|analgesics|mesh-ancestor
2049451|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
2049452|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049453|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049454|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2049455|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2049456|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
2049457|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
2049458|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2746704|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
2049459|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2049460|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2049461|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049462|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049463|NCT01680341|Insulin|insulin|mesh-list
2049464|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2049465|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
2049466|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
2049467|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2049468|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2049469|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049470|NCT01680458|Fluconazole|fluconazole|mesh-list
2049471|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
2049472|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049473|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2049474|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2049475|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049476|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049477|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2049478|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
2049479|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2049480|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049481|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2049482|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2049483|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
2049484|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2049485|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
2049486|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049487|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
2049488|NCT01680497|Protective Agents|protective agents|mesh-ancestor
2049489|NCT01680549|Gabapentin|gabapentin|mesh-list
2049490|NCT01680549|Analgesics|analgesics|mesh-ancestor
2049491|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
2049492|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049493|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049494|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
2049495|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2049496|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2049497|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049498|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2049499|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2049500|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2049501|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049502|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049503|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
2049504|NCT01680653|Glucagon|glucagon|mesh-list
2049505|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2049506|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2049507|NCT01680653|Hormones|hormones|mesh-ancestor
2049508|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2049509|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049510|NCT01680653|Incretins|incretins|mesh-ancestor
2049511|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
2049512|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
2049513|NCT01680861|Everolimus|everolimus|mesh-list
2049514|NCT01680861|Tacrolimus|tacrolimus|mesh-list
2049515|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2049516|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
2049517|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049518|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2049519|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079405|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2049520|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746705|NCT05169021|Amlodipine|amlodipine|mesh-list
2746706|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
2746707|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2746708|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2746709|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746710|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2746711|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746712|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
2746713|NCT05169021|Hematinics|hematinics|mesh-ancestor
2746714|NCT05169021|Vitamins|vitamins|mesh-ancestor
2049521|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049522|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2049523|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2049524|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
2049525|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2049526|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049527|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2049528|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
2049529|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
2049530|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049531|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2049532|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
2049533|NCT01680861|Hormones|hormones|mesh-ancestor
2049534|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2049535|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2049536|NCT01680861|Protective Agents|protective agents|mesh-ancestor
2049537|NCT01680887|Varenicline|varenicline|mesh-list
2049538|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2049539|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2049540|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
2049541|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049542|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049543|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049544|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2049545|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
2049546|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2049547|NCT01680900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2049548|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2049549|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2049550|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049551|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049552|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
2049553|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049554|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2049555|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2049556|NCT01680965|Ofatumumab|ofatumumab|mesh-list
2049557|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049558|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
2049559|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2049560|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746715|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
2746719|NCT05168930|Venetoclax|venetoclax|mesh-list
2746720|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
2746721|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746722|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2746723|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746724|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049561|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2049562|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
2049563|NCT01681030|Coagulants|coagulants|mesh-ancestor
2049564|NCT01681095|Tryptophan|tryptophan|mesh-list
2079406|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049565|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2049566|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
2049567|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2049568|NCT01681186|Lansoprazole|lansoprazole|mesh-list
2049569|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
2049570|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2049571|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2049572|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2049573|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049574|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049575|NCT01681212|Ipilimumab|ipilimumab|mesh-list
2049576|NCT01681212|Dacarbazine|dacarbazine|mesh-list
2049577|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2049578|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209110|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2049579|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2049580|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049581|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2049582|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
2049583|NCT01681433|Prednisone|prednisone|mesh-list
2049584|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
2049585|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2049586|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
2049587|NCT01681433|Hormones|hormones|mesh-ancestor
2049588|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2049589|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049590|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2049591|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049592|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2049593|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049594|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049595|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
2049596|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2049597|NCT01681472|Leucovorin|leucovorin|mesh-list
2049598|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
2049599|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
2049600|NCT01681472|Antidotes|antidotes|mesh-ancestor
2049601|NCT01681472|Protective Agents|protective agents|mesh-ancestor
2049602|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049603|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
2049604|NCT01681472|Vitamins|vitamins|mesh-ancestor
2049605|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
2049606|NCT01681576|Valsartan|valsartan|mesh-list
2049607|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2049608|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2049609|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2049610|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2049611|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049612|NCT01681849|Paroxetine|paroxetine|mesh-list
2049613|NCT01681849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2049614|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2049615|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2746743|NCT05168787|Valsartan|valsartan|mesh-list
2746744|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2746745|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2746746|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2746747|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746748|NCT05168735|Ketamine|ketamine|mesh-list
2746749|NCT05168735|Analgesics|analgesics|mesh-ancestor
2746750|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
2746751|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2746752|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746753|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2746754|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2746755|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
2746756|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
2049616|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049617|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049618|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
2746757|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049619|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049620|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2049621|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
2049622|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2049623|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2049624|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2049625|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049626|NCT01681992|Vaccines|vaccines|mesh-list
2209111|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
2209112|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209113|NCT00013897|Lamivudine|lamivudine|mesh-list
2209114|NCT00013897|Zidovudine|zidovudine|mesh-list
2209115|NCT00013897|Efavirenz|efavirenz|mesh-list
2209116|NCT00013897|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2209117|NCT00013897|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2049627|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
2049628|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049629|NCT01682031|Selenium|selenium|mesh-list
2049630|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
2049631|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049632|NCT01682031|Protective Agents|protective agents|mesh-ancestor
2049633|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049634|NCT01682031|Trace Elements|trace elements|mesh-ancestor
2049635|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
2049636|NCT01682044|Rituximab|rituximab|mesh-list
2049637|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2049638|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049639|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
2049640|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049641|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2049642|NCT01682083|Trametinib|trametinib|mesh-list
2049643|NCT01682083|Dabrafenib|dabrafenib|mesh-list
2049644|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049645|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2049646|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049647|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049648|NCT01682135|Ramucirumab|ramucirumab|mesh-list
2049649|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049650|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
2049651|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2049652|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2049653|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2049654|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2049655|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049656|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
2049657|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049658|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049659|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2049660|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049661|NCT01682213|Dabrafenib|dabrafenib|mesh-list
2049662|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049663|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2746758|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2746759|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2746760|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2746761|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049664|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049665|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049666|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2049667|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
2209118|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2209119|NCT00013897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2209120|NCT00013897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209121|NCT00013897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049668|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2049669|NCT01682512|Rituximab|rituximab|mesh-list
2049670|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2049671|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049672|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
2049673|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049674|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2049675|NCT01682538|Nitisinone|nitisinone|mesh-list
2049676|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049677|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049678|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
2049679|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2049680|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2049681|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2049682|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2049683|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049684|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
2049685|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049686|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049687|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2049688|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049689|NCT01682642|Goserelin|goserelin|mesh-list
2049690|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2049691|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049692|NCT01682681|Topiramate|topiramate|mesh-list
2049693|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
2049694|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2049695|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049696|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
2049697|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
2746762|NCT05168709|Vaccines|vaccines|mesh-list
2746763|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
2209122|NCT00013897|Antiviral Agents|antiviral agents|mesh-ancestor
2746764|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746765|NCT05168683|Rasburicase|rasburicase|mesh-list
2746766|NCT05168683|Uric Acid|uric acid|mesh-list
2746767|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
2746768|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746769|NCT05168683|Protective Agents|protective agents|mesh-ancestor
2746770|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049698|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049699|NCT01682759|Metformin|metformin|mesh-list
2049700|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
2049701|NCT01682759|Glimepiride|glimepiride|mesh-list
2049702|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2049703|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049704|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2049705|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2049706|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
2049707|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2049708|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2049709|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
2049710|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
2049711|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
2049712|NCT01682837|Citric Acid|citric acid|mesh-list
2049713|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
2049714|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
2049715|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2049716|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
2049717|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
2049718|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049719|NCT01682837|Diuretics|diuretics|mesh-ancestor
2049720|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
2049721|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049722|NCT01682837|Expectorants|expectorants|mesh-ancestor
2049723|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
2049724|NCT01682837|Cathartics|cathartics|mesh-ancestor
2049725|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2049726|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
2049727|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2049728|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2049729|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2049730|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
2049731|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049732|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049733|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049734|NCT01683058|Aripiprazole|aripiprazole|mesh-list
2049735|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
2049736|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2049737|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2049738|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2049739|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049740|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049741|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
2049742|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
2049743|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049744|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049745|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2049746|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2049747|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
2049748|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2049749|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2049750|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2049751|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2049752|NCT01683071|Bupivacaine|bupivacaine|mesh-list
2049753|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
2049754|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
2049755|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049756|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049757|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
2049758|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049759|NCT01683266|Insulin|insulin|mesh-list
2049760|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2049761|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
2049762|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2209123|NCT00013897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209124|NCT00013897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2209125|NCT00013897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2209126|NCT00013897|Antimetabolites|antimetabolites|mesh-ancestor
2209127|NCT00013897|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2209128|NCT00013897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2209129|NCT00013897|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2209130|NCT00013897|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2049763|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049764|NCT01683331|Insulin|insulin|mesh-list
2049765|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2049766|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049767|NCT01683422|Gemcitabine|gemcitabine|mesh-list
2049768|NCT01683422|Capecitabine|capecitabine|mesh-list
2209131|NCT00013897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2209132|NCT00013897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2209133|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2209134|NCT00013897|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2209135|NCT00013897|Protease Inhibitors|protease inhibitors|mesh-ancestor
2209136|NCT00013962|Vitamin D|vitamin d|mesh-list
2209137|NCT00013962|Vitamins|vitamins|mesh-ancestor
2746771|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
2746772|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2746775|NCT05168644|Niclosamide|niclosamide|mesh-list
2049769|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2049770|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2049771|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
2049772|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049773|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049774|NCT01683422|Antiviral Agents|antiviral agents|mesh-ancestor
2049775|NCT01683422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049776|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049777|NCT01683422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2049778|NCT01683422|Immunologic Factors|immunologic factors|mesh-ancestor
2049779|NCT01683422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049780|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2049781|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
2049782|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2049783|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2049784|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049785|NCT01683994|Prednisone|prednisone|mesh-list
2049786|NCT01683994|Docetaxel|docetaxel|mesh-list
2049787|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049788|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
2049789|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
2049790|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
2049791|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049792|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2049793|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
2049794|NCT01683994|Hormones|hormones|mesh-ancestor
2049795|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2049796|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049797|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2049798|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2049799|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
2049800|NCT01684020|Coagulants|coagulants|mesh-ancestor
2049801|NCT01684202|Tolvaptan|tolvaptan|mesh-list
2049802|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2746776|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
2746777|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2746778|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
2746779|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2746780|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2746781|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
2746782|NCT05168618|Atezolizumab|atezolizumab|mesh-list
2746783|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2746784|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746785|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
2746786|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746787|NCT05168566|Maleic acid|maleic acid|mesh-list
2746788|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049803|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049804|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
2049805|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049806|NCT01684215|Letrozole|letrozole|mesh-list
2049807|NCT01684215|Palbociclib|palbociclib|mesh-list
2049808|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049809|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2049810|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2049811|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746789|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209138|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
2049812|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049813|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2049814|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
2049815|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2049816|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049817|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2746806|NCT05168475|Rituximab|rituximab|mesh-list
2746807|NCT05168475|Infliximab|infliximab|mesh-list
2746808|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2746809|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049818|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
2049819|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2746810|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
2049820|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
2049821|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049822|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049823|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2049824|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2049825|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
2049826|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2049827|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
2049828|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2049829|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
2049830|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049831|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049832|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
2049833|NCT01684722|Vitamin D|vitamin d|mesh-list
2049834|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
2049835|NCT01684722|Vitamins|vitamins|mesh-list
2049836|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
2049837|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049838|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2049839|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2049840|NCT01684748|Olmesartan|olmesartan|mesh-list
2049841|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2049842|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2049843|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2049844|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2049845|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049846|NCT01684878|Gemcitabine|gemcitabine|mesh-list
2049847|NCT01684878|Paclitaxel|paclitaxel|mesh-list
2049848|NCT01684878|Topotecan|topotecan|mesh-list
2049849|NCT01684878|Pertuzumab|pertuzumab|mesh-list
2049850|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2049851|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049852|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
2049853|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
2049854|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
2049855|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049856|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2049857|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
2049858|NCT01684878|Antiviral Agents|antiviral agents|mesh-ancestor
2049859|NCT01684878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049860|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049861|NCT01684878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2049862|NCT01684878|Immunologic Factors|immunologic factors|mesh-ancestor
2049863|NCT01684878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049864|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2049865|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2049866|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2049867|NCT01684943|Insulin|insulin|mesh-list
2049868|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2049869|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049870|NCT01685060|Ceritinib|ceritinib|mesh-list
2049871|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049872|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2049873|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049874|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049875|NCT01685073|Zolpidem|zolpidem|mesh-list
2049876|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2049877|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2049878|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049879|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746811|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746812|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2746813|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
2746814|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2746815|NCT05168462|Norepinephrine|norepinephrine|mesh-list
2746816|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2746817|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2746818|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
2746819|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2746820|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746821|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746822|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
2746823|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
2746824|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2746825|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2049880|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2049881|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
2049882|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
2049883|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049884|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049885|NCT01685138|Ceritinib|ceritinib|mesh-list
2049886|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049887|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2049888|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049889|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049890|NCT01685203|Ribavirin|ribavirin|mesh-list
2049891|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
2049892|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049893|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
2049894|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049895|NCT01685242|Cetirizine|cetirizine|mesh-list
2049896|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2049897|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2049898|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2049899|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
2049900|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
2049901|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2049902|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049903|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049904|NCT01685372|Vaccines|vaccines|mesh-list
2049905|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
2049906|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049907|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
2049908|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
2049909|NCT01685411|Busulfan|busulfan|mesh-list
2049910|NCT01685411|Allopurinol|allopurinol|mesh-list
2049911|NCT01685411|Levetiracetam|levetiracetam|mesh-list
2049912|NCT01685411|Tacrolimus|tacrolimus|mesh-list
2049913|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2049914|NCT01685411|Lenograstim|lenograstim|mesh-list
2049915|NCT01685411|Sargramostim|sargramostim|mesh-list
2049916|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2049917|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
2049918|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049919|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2049920|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2049921|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
2049922|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049923|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049924|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2049925|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2049926|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2049927|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049928|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2049929|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2049930|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
2049931|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2049932|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2049933|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
2049934|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
2049935|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
2049936|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
2049937|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2049938|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
2049939|NCT01685411|Protective Agents|protective agents|mesh-ancestor
2049940|NCT01685684|Oxycodone|oxycodone|mesh-list
2049941|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2049942|NCT01685684|Narcotics|narcotics|mesh-ancestor
2049943|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2049944|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049945|NCT01685684|Analgesics|analgesics|mesh-ancestor
2049946|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
2049947|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2049948|NCT01685801|Ivacaftor|ivacaftor|mesh-list
2049949|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2049950|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2049951|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049952|NCT01685983|Prednisolone|prednisolone|mesh-list
2049953|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
2049954|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2049955|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
2049956|NCT01685983|Hormones|hormones|mesh-ancestor
2049957|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2049958|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049959|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2049960|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049961|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2049962|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049963|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049964|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
2049965|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2049966|NCT01685996|Zonisamide|zonisamide|mesh-list
2049967|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
2049968|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2049969|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2049970|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049971|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2049972|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049973|NCT01686152|Imiquimod|imiquimod|mesh-list
2049974|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2049975|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
2049976|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049977|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049978|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
2049979|NCT01686165|Rituximab|rituximab|mesh-list
2049980|NCT01686165|Belinostat|belinostat|mesh-list
2049981|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2049982|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2049983|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2049984|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
2049985|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2049986|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2049987|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2049988|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049989|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049990|NCT01686451|Simvastatin|simvastatin|mesh-list
2049991|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2049992|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2049993|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
2049994|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2049995|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2049996|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2049997|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2049998|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
2049999|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2050000|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2050001|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2050002|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2050003|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050004|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
2050005|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050006|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050007|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2050008|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050009|NCT01686633|Fluticasone|fluticasone|mesh-list
2050010|NCT01686633|Xhance|xhance|mesh-list
2050011|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050012|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2050013|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
2050014|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209139|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209140|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2209141|NCT00014001|Olanzapine|olanzapine|mesh-list
2209142|NCT00014001|Risperidone|risperidone|mesh-list
2209143|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2050015|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050016|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2050017|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
2050018|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
2050019|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2050020|NCT01686646|Acetaminophen|acetaminophen|mesh-list
2050021|NCT01686646|Caffeine|caffeine|mesh-list
2050022|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2050023|NCT01686646|Analgesics|analgesics|mesh-ancestor
2050024|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
2050025|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050026|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050027|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
2050028|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2050029|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2050030|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050031|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050032|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2050033|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2209144|NCT00014001|Ziprasidone|ziprasidone|mesh-list
2050034|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
2050035|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050036|NCT01686828|Letrozole|letrozole|mesh-list
2050037|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
2050038|NCT01686828|Acyline|acyline|mesh-list
2050039|NCT01686828|Testosterone|testosterone|mesh-list
2050040|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
2050041|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
2050042|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2050043|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050044|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2050045|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2209145|NCT00014001|Clozapine|clozapine|mesh-list
2209146|NCT00014001|Perphenazine|perphenazine|mesh-list
2209147|NCT00014001|Fluphenazine|fluphenazine|mesh-list
2209148|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
2209149|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
2209150|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2209151|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
2050046|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050047|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050048|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2050049|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
2050050|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2050051|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050052|NCT01686828|Androgens|androgens|mesh-ancestor
2050053|NCT01686828|Hormones|hormones|mesh-ancestor
2050054|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2050055|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
2050056|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2050057|NCT01686932|Vildagliptin|vildagliptin|mesh-list
2050058|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2050059|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050060|NCT01686932|Incretins|incretins|mesh-ancestor
2050061|NCT01686932|Hormones|hormones|mesh-ancestor
2050062|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2050063|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2050064|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
2050065|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050066|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050067|NCT01687101|Menthol|menthol|mesh-list
2050068|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
2050069|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
2050070|NCT01687166|Acifluorfen|acifluorfen|mesh-list
2050071|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050072|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050073|NCT01687179|Sirolimus|sirolimus|mesh-list
2050074|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
2050075|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2050076|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050077|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2050078|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050079|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
2050080|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2050081|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
2050082|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050083|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
2050084|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2050085|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2050086|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209152|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209153|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209154|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209155|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2209156|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2209157|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2209158|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2050087|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050088|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2050089|NCT01687218|Tenofovir|tenofovir|mesh-list
2050090|NCT01687218|Emtricitabine|emtricitabine|mesh-list
2050091|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2050092|NCT01687218|Glycerol|glycerol|mesh-list
2050093|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
2050094|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050095|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2050096|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2050097|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050098|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050099|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2050100|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2050101|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2050102|NCT01687218|Protective Agents|protective agents|mesh-ancestor
2209159|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2209160|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
2209161|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
2209162|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
2209163|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209164|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2209165|NCT00014001|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2209166|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2209167|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2209168|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
2209169|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
2209170|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
2209171|NCT00014014|Lamivudine|lamivudine|mesh-list
2050103|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050104|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
2050105|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
2209172|NCT00014014|Zidovudine|zidovudine|mesh-list
2209173|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2209174|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2209175|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2209176|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209177|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209178|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
2050106|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050107|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
2050108|NCT01687270|Ribavirin|ribavirin|mesh-list
2050109|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
2050110|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050111|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
2050112|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050113|NCT01687283|Fluticasone|fluticasone|mesh-list
2050114|NCT01687283|Xhance|xhance|mesh-list
2050115|NCT01687283|Budesonide|budesonide|mesh-list
2050116|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050117|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2050118|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
2050119|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050120|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050121|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2050122|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
2050123|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
2050124|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2050125|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
2050126|NCT01687283|Hormones|hormones|mesh-ancestor
2050127|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2050128|NCT01687296|Fluticasone|fluticasone|mesh-list
2050129|NCT01687296|Xhance|xhance|mesh-list
2050130|NCT01687296|Prednisone|prednisone|mesh-list
2050131|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2050132|NCT01687296|Albuterol|albuterol|mesh-list
2050133|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050134|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
2050135|NCT01687296|Hormones|hormones|mesh-ancestor
2050136|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2050137|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050138|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2209179|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209180|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2209181|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2209182|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
2209183|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
2050139|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050140|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2050141|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
2050142|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050143|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2050144|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
2050145|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
2050146|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2050147|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
2050148|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2209184|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2209185|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
2050149|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2050150|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2050151|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2050152|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
2050153|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050154|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050155|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2050156|NCT01687400|Decitabine|decitabine|mesh-list
2050157|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2050158|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
2209186|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050159|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050160|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050161|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050162|NCT01687413|Cisplatin|cisplatin|mesh-list
2209187|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209188|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2209189|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
2209190|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2209191|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
2209192|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209193|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209194|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2209195|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
2209196|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
2209197|NCT00014040|Protective Agents|protective agents|mesh-ancestor
2209198|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
2209199|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
2209200|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2209201|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
2209202|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209203|NCT00014092|Interferons|interferons|mesh-list
2209204|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
2209205|NCT00014092|Aldesleukin|aldesleukin|mesh-list
2209206|NCT00014092|Temozolomide|temozolomide|mesh-list
2209207|NCT00014092|Sargramostim|sargramostim|mesh-list
2050163|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050164|NCT01687478|Olanzapine|olanzapine|mesh-list
2050165|NCT01687478|Fluoxetine|fluoxetine|mesh-list
2050166|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
2050167|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
2050168|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050169|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050170|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2050171|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2050172|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2050173|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2050174|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2050175|NCT01687478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2050176|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2050177|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2050178|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050179|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050180|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
2050181|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2050182|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
2050183|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2050184|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2050185|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050186|NCT01687673|Sirolimus|sirolimus|mesh-list
2050187|NCT01687673|Sorafenib|sorafenib|mesh-list
2050188|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050189|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2050190|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050191|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050192|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2050193|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050194|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2050195|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
2746839|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
2746840|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2746841|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2746842|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746843|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2746844|NCT05168280|Analgesics|analgesics|mesh-ancestor
2209208|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209209|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
2050196|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2050197|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
2050198|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050199|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2050200|NCT01687712|Hormones|hormones|mesh-ancestor
2050201|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2050202|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209210|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209211|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2209212|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
2209213|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209214|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
2209215|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209216|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2209217|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2209218|NCT00014105|Carboplatin|carboplatin|mesh-list
2209219|NCT00014105|Temozolomide|temozolomide|mesh-list
2209220|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209221|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2050203|NCT01687998|Evacetrapib|evacetrapib|mesh-list
2050204|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2050205|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2050206|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
2050207|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050208|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2050209|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
2050210|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2050211|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2050212|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2050213|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050214|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
2050215|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050216|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050217|NCT01688102|Vitamin D|vitamin d|mesh-list
2050218|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
2050219|NCT01688102|Vitamins|vitamins|mesh-ancestor
2050220|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
2050221|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050222|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2050223|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2050224|NCT01688336|Leucovorin|leucovorin|mesh-list
2050225|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
2050226|NCT01688336|Irinotecan|irinotecan|mesh-list
2050227|NCT01688336|Folfirinox|folfirinox|mesh-list
2050228|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050229|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2050230|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2050231|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050232|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050233|NCT01688336|Antidotes|antidotes|mesh-ancestor
2050234|NCT01688336|Protective Agents|protective agents|mesh-ancestor
2050235|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050236|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
2050237|NCT01688336|Vitamins|vitamins|mesh-ancestor
2050238|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
2050239|NCT01688466|Pomalidomide|pomalidomide|mesh-list
2050240|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
2050241|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050242|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2209222|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
2209223|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746845|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
2746846|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2746847|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2050243|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2050244|NCT01688466|Growth Substances|growth substances|mesh-ancestor
2050245|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
2050246|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050247|NCT01688596|Bupivacaine|bupivacaine|mesh-list
2050248|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
2050249|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
2050250|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2050251|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050252|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
2050253|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2746848|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2746849|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2746850|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
2746851|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2746852|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050254|NCT01688609|Paclitaxel|paclitaxel|mesh-list
2050255|NCT01688609|Trastuzumab|trastuzumab|mesh-list
2050256|NCT01688609|Lapatinib|lapatinib|mesh-list
2050257|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2050258|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050259|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
2050260|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
2050261|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
2050262|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050263|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2050264|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2050265|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050266|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
2050267|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2050268|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050269|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2050270|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2050271|NCT01688739|Erenumab|erenumab|mesh-list
2050272|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2050273|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050274|NCT01688739|Analgesics|analgesics|mesh-ancestor
2050275|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
2050276|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050277|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050278|NCT01688830|Dabigatran|dabigatran|mesh-list
2050279|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
2050280|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2050281|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
2050282|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050283|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050284|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
2050285|NCT01688921|Vaccines|vaccines|mesh-list
2050286|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
2050287|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050288|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2050289|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050290|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2050291|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050292|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050293|NCT01689207|Aztreonam|aztreonam|mesh-list
2050294|NCT01689207|Avibactam|avibactam|mesh-list
2050295|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2050296|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050297|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2050298|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050299|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050300|NCT01689324|Vaccines|vaccines|mesh-list
2050301|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
2050302|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050303|NCT01689363|Histamine|histamine|mesh-list
2050304|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
2050305|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
2050306|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050307|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050308|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050309|NCT01689441|Calcitriol|calcitriol|mesh-list
2050310|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2050311|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050312|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2050313|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2050314|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050315|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2050316|NCT01689441|Vitamins|vitamins|mesh-ancestor
2050317|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
2050318|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2050319|NCT01689519|Vemurafenib|vemurafenib|mesh-list
2050320|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050321|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2050322|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050323|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050324|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2050325|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
2050326|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050327|NCT01689649|Topiramate|topiramate|mesh-list
2050328|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
2050329|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2050330|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050331|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2050332|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
2050333|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050334|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2050335|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
2050336|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050337|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050338|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2050339|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2050340|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2050341|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
2050342|NCT01689779|Vitamin D|vitamin d|mesh-list
2050343|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
2050344|NCT01689779|Vitamins|vitamins|mesh-ancestor
2050345|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
2050346|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050347|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2209224|NCT00014118|Paclitaxel|paclitaxel|mesh-list
2209225|NCT00014118|Carboplatin|carboplatin|mesh-list
2209226|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2209227|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209228|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
2209229|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
2050348|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2050349|NCT01689909|Zolpidem|zolpidem|mesh-list
2050350|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2050351|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2050352|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2050353|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050354|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2050355|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
2050356|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
2050357|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050358|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050359|NCT01690000|Melatonin|melatonin|mesh-list
2209230|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
2746853|NCT05168202|Azacitidine|azacitidine|mesh-list
2050360|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
2050361|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050362|NCT01690000|Protective Agents|protective agents|mesh-ancestor
2050363|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050364|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2050365|NCT01690052|Pilocarpine|pilocarpine|mesh-list
2050366|NCT01690052|Cevimeline|cevimeline|mesh-list
2050367|NCT01690052|Miotics|miotics|mesh-ancestor
2050368|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
2050369|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050370|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050371|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2050372|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2050373|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
2050374|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2746854|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2746855|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
2746856|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746857|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746858|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746859|NCT05168176|Dolutegravir|dolutegravir|mesh-list
2746860|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2050375|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050376|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2050377|NCT01690143|Melphalan|melphalan|mesh-list
2050378|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2050379|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
2050380|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050381|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050382|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2050383|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2050384|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
2050385|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050386|NCT01690299|Etanercept|etanercept|mesh-list
2050387|NCT01690299|Apremilast|apremilast|mesh-list
2050388|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2050389|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2050390|NCT01690299|Analgesics|analgesics|mesh-ancestor
2050391|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
2050392|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2746861|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2746862|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746863|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746864|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2050393|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050394|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050395|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2050396|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2050397|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2050398|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
2050399|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2050400|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2050401|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050402|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050403|NCT01690520|Cyclosporine|cyclosporine|mesh-list
2050404|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
2050405|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
2050406|NCT01690520|Thiotepa|thiotepa|mesh-list
2050407|NCT01690520|Fludarabine|fludarabine|mesh-list
2050408|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
2050409|NCT01690520|Cyclosporins|cyclosporins|mesh-list
2050410|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2050411|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
2050412|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050413|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2050414|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2050415|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
2050416|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050417|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050418|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2050419|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2050420|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
2050421|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050422|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
2050423|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209231|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209232|NCT00014144|Gefitinib|gefitinib|mesh-list
2209233|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209234|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2209235|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209236|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209237|NCT00014170|Gefitinib|gefitinib|mesh-list
2209238|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209239|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2209240|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209241|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209242|NCT00014183|Gefitinib|gefitinib|mesh-list
2050424|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
2050425|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2050426|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2050427|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2050428|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
2050429|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2050430|NCT01690546|Naltrexone|naltrexone|mesh-list
2050431|NCT01690546|Buprenorphine|buprenorphine|mesh-list
2050432|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2050433|NCT01690546|Naloxone|naloxone|mesh-list
2050434|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2050435|NCT01690546|Narcotics|narcotics|mesh-ancestor
2050436|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2050437|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050438|NCT01690546|Analgesics|analgesics|mesh-ancestor
2050439|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
2050440|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050441|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2050442|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2050443|NCT01690663|Dexamethasone|dexamethasone|mesh-list
2050444|NCT01690663|Bupivacaine|bupivacaine|mesh-list
2050445|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050446|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
2050447|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
2050448|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050449|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050450|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2050451|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
2050452|NCT01690663|Hormones|hormones|mesh-ancestor
2050453|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2050454|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2050455|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050456|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
2209243|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209244|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2209245|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209246|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209247|NCT00014196|Docetaxel|docetaxel|mesh-list
2209248|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746865|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2746866|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
2746867|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2746868|NCT05168163|Atezolizumab|atezolizumab|mesh-list
2746869|NCT05168163|Lenvatinib|lenvatinib|mesh-list
2050457|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
2050458|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2050459|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
2050460|NCT01690988|Ketamine|ketamine|mesh-list
2050461|NCT01690988|Analgesics|analgesics|mesh-ancestor
2050462|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
2050463|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050464|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050465|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2050466|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2050467|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
2050468|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
2746870|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2746871|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746872|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2746873|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746874|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050469|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2050470|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2050471|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2050472|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050473|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050474|NCT01691092|Ketamine|ketamine|mesh-list
2050475|NCT01691092|Analgesics|analgesics|mesh-ancestor
2050476|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
2050477|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050478|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050479|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2050480|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2050481|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
2050482|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
2050483|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2050484|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2050485|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2050486|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050487|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050488|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
2050489|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2050490|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050491|NCT01691313|Vanoxerine|vanoxerine|mesh-list
2050492|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2050493|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2050494|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2050495|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050496|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
2050497|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050498|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050499|NCT01691326|Vaccines|vaccines|mesh-list
2050500|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
2050501|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050502|NCT01691339|Vaccines|vaccines|mesh-list
2050503|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
2050504|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050505|NCT01691482|Albuterol|albuterol|mesh-list
2050506|NCT01691482|Ipratropium|ipratropium|mesh-list
2050507|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2050508|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
2050509|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050510|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050511|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2050512|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
2050513|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
2050514|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2050515|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2050516|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2050517|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2209249|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
2209250|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
2209251|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
2050518|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
2050519|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050520|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050521|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2050522|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
2050523|NCT01691508|Prednisone|prednisone|mesh-list
2050524|NCT01691508|Prednisolone|prednisolone|mesh-list
2050525|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050526|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
2050527|NCT01691508|Hormones|hormones|mesh-ancestor
2050528|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2050529|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050530|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2050531|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050532|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
2050533|NCT01691534|Clofazimine|clofazimine|mesh-list
2050534|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
2050535|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2050536|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050537|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050538|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
2050539|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
2050540|NCT01691560|Listerine|listerine|mesh-list
2050541|NCT01691560|Calcium|calcium|mesh-list
2050542|NCT01691560|Fluorides|fluorides|mesh-list
2050543|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
2050544|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
2050545|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2050546|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050547|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2050548|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
2050549|NCT01691560|Protective Agents|protective agents|mesh-ancestor
2050550|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2050551|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050552|NCT01691690|Acetaminophen|acetaminophen|mesh-list
2050553|NCT01691690|Dexamethasone|dexamethasone|mesh-list
2050554|NCT01691690|Midazolam|midazolam|mesh-list
2050555|NCT01691690|Morphine|morphine|mesh-list
2050556|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
2746875|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
2746876|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746877|NCT05168137|Colchicine|colchicine|mesh-list
2746878|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
2746879|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2050557|NCT01691690|Ondansetron|ondansetron|mesh-list
2050558|NCT01691690|Propofol|propofol|mesh-list
2050559|NCT01691690|Sevoflurane|sevoflurane|mesh-list
2050560|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050561|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
2050562|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
2050563|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050564|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050565|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2050566|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
2050567|NCT01691690|Hormones|hormones|mesh-ancestor
2050568|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2050569|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2050570|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050571|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2050572|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2050573|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2050574|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
2050575|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
2050576|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2050577|NCT01691690|Narcotics|narcotics|mesh-ancestor
2050578|NCT01691690|Analgesics|analgesics|mesh-ancestor
2050579|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
2050580|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2050581|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2050582|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2050583|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2050584|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
2050585|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
2050586|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050587|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050588|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2050589|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
2746880|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
2050590|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2050591|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2050592|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
2050593|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
2050594|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2050595|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
2050596|NCT01691690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2050597|NCT01691768|Tenofovir|tenofovir|mesh-list
2050598|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
2050599|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050600|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2050601|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2050602|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209252|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209253|NCT00014209|Gemcitabine|gemcitabine|mesh-list
2209254|NCT00014209|Dexamethasone|dexamethasone|mesh-list
2209255|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209256|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050603|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050604|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2050605|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2050606|NCT01691781|Lisinopril|lisinopril|mesh-list
2050607|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2050608|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
2050609|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050610|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050611|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2050612|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2050613|NCT01691781|Protective Agents|protective agents|mesh-ancestor
2050614|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050615|NCT01691794|Ritonavir|ritonavir|mesh-list
2050616|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2050617|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2050618|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2050619|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
2050620|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050621|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050622|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2050623|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2050624|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
2209257|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
2209258|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
2209259|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209260|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209261|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2209262|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
2209263|NCT00014209|Hormones|hormones|mesh-ancestor
2209264|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2209265|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2209266|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2209267|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
2209268|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209269|NCT00014209|Antiviral Agents|antiviral agents|mesh-ancestor
2209270|NCT00014209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209271|NCT00014209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209272|NCT00014209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209273|NCT00014209|Immunologic Factors|immunologic factors|mesh-ancestor
2209274|NCT00014235|Cyclosporine|cyclosporine|mesh-list
2209275|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
2209276|NCT00014235|Fludarabine|fludarabine|mesh-list
2209277|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
2209278|NCT00014235|Cyclosporins|cyclosporins|mesh-list
2209279|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050625|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050626|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2050627|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2050628|NCT01691833|Vitamin D|vitamin d|mesh-list
2050629|NCT01691833|Vitamins|vitamins|mesh-ancestor
2050630|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
2050631|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050632|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2050633|NCT01691885|Fluticasone|fluticasone|mesh-list
2050634|NCT01691885|Xhance|xhance|mesh-list
2050635|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050636|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2050637|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
2050638|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050639|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050640|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2050641|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
2050642|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
2050643|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2050644|NCT01691898|Rituximab|rituximab|mesh-list
2209280|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2209281|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
2746881|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
2050645|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
2050646|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2050647|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050648|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
2050649|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050650|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2050651|NCT01692197|Cytarabine|cytarabine|mesh-list
2050652|NCT01692197|Dexamethasone|dexamethasone|mesh-list
2050653|NCT01692197|Idarubicin|idarubicin|mesh-list
2050654|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050655|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
2050656|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
2050657|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050658|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050659|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2050660|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
2050661|NCT01692197|Hormones|hormones|mesh-ancestor
2050662|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2050663|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2050664|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050665|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2050666|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
2050667|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050668|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
2050669|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050670|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2050671|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
2050672|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2050673|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2050674|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2050675|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050676|NCT01692301|Amlodipine|amlodipine|mesh-list
2050677|NCT01692301|Valsartan|valsartan|mesh-list
2050678|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2050679|NCT01692301|Olmesartan|olmesartan|mesh-list
2746882|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
2746883|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746884|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746885|NCT05168059|Clevidipine|clevidipine|mesh-list
2746886|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2746887|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2050680|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2050681|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2050682|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2050683|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2050684|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2050685|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050686|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2050687|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050688|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
2050689|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2050690|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2050691|NCT01692301|Diuretics|diuretics|mesh-ancestor
2050692|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
2050693|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2050694|NCT01692340|Lycopene|lycopene|mesh-list
2050695|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050696|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
2050697|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050698|NCT01692340|Protective Agents|protective agents|mesh-ancestor
2050699|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050700|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2050701|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2050702|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050703|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
2050704|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2050705|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2050706|NCT01692626|Analgesics|analgesics|mesh-ancestor
2050707|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
2050708|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050709|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050710|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050711|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2050712|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
2050713|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2050714|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
2050715|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2050716|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050717|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050718|NCT01692756|Triamcinolone|triamcinolone|mesh-list
2050719|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2050720|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2050721|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2050722|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2050723|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050724|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
2050725|NCT01692756|Hormones|hormones|mesh-ancestor
2050726|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2050727|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050728|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2050729|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
2050730|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050731|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050732|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
2050733|NCT01693029|Hematinics|hematinics|mesh-ancestor
2050734|NCT01693068|Dacarbazine|dacarbazine|mesh-list
2050735|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2050736|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
2050737|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050738|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050739|NCT01693185|Midazolam|midazolam|mesh-list
2050740|NCT01693185|Meperidine|meperidine|mesh-list
2050741|NCT01693185|Remifentanil|remifentanil|mesh-list
2050742|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2050743|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2050744|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2050745|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050746|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2050747|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2050748|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2050749|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2050750|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
2050751|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
2050752|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
2050753|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
2050754|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050755|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050756|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2050757|NCT01693185|Narcotics|narcotics|mesh-ancestor
2050758|NCT01693185|Analgesics|analgesics|mesh-ancestor
2050759|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
2050760|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050761|NCT01693523|Minocycline|minocycline|mesh-list
2050762|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2050763|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050764|NCT01693562|Durvalumab|durvalumab|mesh-list
2050765|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2050766|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050767|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
2050768|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2050769|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
2050770|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050771|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2050772|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2050773|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2050774|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
2050775|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050776|NCT01694433|Vitamin D|vitamin d|mesh-list
2050777|NCT01694433|Calcitriol|calcitriol|mesh-list
2050778|NCT01694433|Calcipotriene|calcipotriene|mesh-list
2050779|NCT01694433|Vitamins|vitamins|mesh-ancestor
2050780|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
2050781|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050782|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2050783|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
2050784|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2050785|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2050786|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2050787|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050788|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2050789|NCT01694706|Omeprazole|omeprazole|mesh-list
2050790|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2050791|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2050792|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2050793|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050794|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050795|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
2050796|NCT01694771|Olodaterol|olodaterol|mesh-list
2050797|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2050798|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
2050799|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050800|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050801|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2050802|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
2050803|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
2050804|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2050805|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
2050806|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050807|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050808|NCT01694966|Methylene Blue|methylene blue|mesh-list
2050809|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050810|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050811|NCT01695135|Prednisone|prednisone|mesh-list
2050812|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
2050813|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050814|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
2050815|NCT01695135|Hormones|hormones|mesh-ancestor
2050816|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2050817|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050818|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2050819|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050820|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2050821|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050822|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050823|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
2050824|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2050825|NCT01695239|Adalimumab|adalimumab|mesh-list
2050826|NCT01695239|Ixekizumab|ixekizumab|mesh-list
2050827|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050828|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2050829|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
2050830|NCT01695291|Minocycline|minocycline|mesh-list
2050831|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2050832|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050833|NCT01695330|Bortezomib|bortezomib|mesh-list
2050834|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050835|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2050836|NCT01695668|Cyclosporine|cyclosporine|mesh-list
2050837|NCT01695668|Cyclosporins|cyclosporins|mesh-list
2050838|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050839|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050840|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2050841|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
2050842|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050843|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
2050844|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050845|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
2050846|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2050847|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2050848|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2050849|NCT01695772|Bevacizumab|bevacizumab|mesh-list
2050850|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2050851|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050852|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2050853|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2050854|NCT01695772|Growth Substances|growth substances|mesh-ancestor
2050855|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050856|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
2050857|NCT01695954|Ritonavir|ritonavir|mesh-list
2050858|NCT01695954|Darunavir|darunavir|mesh-list
2050859|NCT01695954|Efavirenz|efavirenz|mesh-list
2050860|NCT01695954|Pitavastatin|pitavastatin|mesh-list
2050861|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2050862|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2050863|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
2050864|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050865|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050866|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2050867|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2050868|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
2050869|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050870|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2050871|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2050872|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2050873|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2050874|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2050875|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2050876|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2050877|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2050878|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2050879|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2050880|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2050881|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2050882|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
2050883|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2050884|NCT01696032|Gemcitabine|gemcitabine|mesh-list
2050885|NCT01696032|Paclitaxel|paclitaxel|mesh-list
2050886|NCT01696032|Carboplatin|carboplatin|mesh-list
2050887|NCT01696032|Doxorubicin|doxorubicin|mesh-list
2050888|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2050889|NCT01696032|Topotecan|topotecan|mesh-list
2050890|NCT01696032|Guadecitabine|guadecitabine|mesh-list
2050891|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2050892|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050893|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
2050894|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
2050895|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
2050896|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050897|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2050898|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
2050899|NCT01696032|Antiviral Agents|antiviral agents|mesh-ancestor
2050900|NCT01696032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050901|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050902|NCT01696032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2050903|NCT01696032|Immunologic Factors|immunologic factors|mesh-ancestor
2050904|NCT01696032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050905|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2050906|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2050907|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2050908|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2050909|NCT01696045|Ipilimumab|ipilimumab|mesh-list
2050910|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2050911|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050912|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2050913|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050914|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
2050915|NCT01696058|Olodaterol|olodaterol|mesh-list
2050916|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2050917|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
2050918|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050919|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050920|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2050921|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
2050922|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
2050923|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2050924|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
2050925|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050926|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050927|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
2050928|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2050929|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
2050930|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050931|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050932|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2050933|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
2050934|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
2050935|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2050936|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
2050937|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050938|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050939|NCT01696084|Cytarabine|cytarabine|mesh-list
2050940|NCT01696084|Daunorubicin|daunorubicin|mesh-list
2050941|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2050942|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
2050943|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050944|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2050945|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
2050946|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2050947|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2050948|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
2050949|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050950|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2050951|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2050952|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2050953|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050954|NCT01696214|Fluticasone|fluticasone|mesh-list
2050955|NCT01696214|Xhance|xhance|mesh-list
2050956|NCT01696214|Theophylline|theophylline|mesh-list
2050957|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2050958|NCT01696214|Ipratropium|ipratropium|mesh-list
2050959|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2050960|NCT01696214|Montelukast|montelukast|mesh-list
2050961|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2050962|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2050963|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
2050964|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2050965|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050966|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2050967|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
2050968|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
2050969|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2050970|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2050971|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2050972|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2050973|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
2050974|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2050975|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050976|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2050977|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
2050978|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2050979|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2050980|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2050981|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2050982|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
2050983|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2050984|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2050985|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
2050986|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2050987|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2050988|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
2050989|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
2050990|NCT01696214|Hormones|hormones|mesh-ancestor
2050991|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
2050992|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
2050993|NCT01696279|Calcium|calcium|mesh-list
2050994|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2050995|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2050996|NCT01696279|Antacids|antacids|mesh-ancestor
2050997|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2050998|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2050999|NCT01696695|Capecitabine|capecitabine|mesh-list
2051000|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2051001|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
2051002|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051003|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051004|NCT01696760|Aspirin|aspirin|mesh-list
2051005|NCT01696760|Enoxaparin|enoxaparin|mesh-list
2051006|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
2051007|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
2051008|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2051009|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2051010|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051011|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2051012|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2051013|NCT01696760|Analgesics|analgesics|mesh-ancestor
2051014|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
2051015|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051016|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051017|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051018|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051019|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2051020|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2051021|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051022|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
2051023|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
2051024|NCT01696877|Molgramostim|molgramostim|mesh-list
2051025|NCT01696877|Sargramostim|sargramostim|mesh-list
2051026|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2051027|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
2051028|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051029|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051030|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2051031|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
2051032|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051033|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051034|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2051035|NCT01696942|Mesalamine|mesalamine|mesh-list
2746888|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746889|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2746890|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746891|NCT05168007|Cariprazine|cariprazine|mesh-list
2746892|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2746893|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2746894|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051036|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051037|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051038|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2051039|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2051040|NCT01696942|Analgesics|analgesics|mesh-ancestor
2051041|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
2051042|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051043|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051044|NCT01696955|Cetuximab|cetuximab|mesh-list
2051045|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2051046|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051047|NCT01697345|Testosterone|testosterone|mesh-list
2051048|NCT01697345|Androgens|androgens|mesh-ancestor
2051049|NCT01697345|Hormones|hormones|mesh-ancestor
2051050|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2051051|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051052|NCT01697579|Ondansetron|ondansetron|mesh-list
2051053|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
2051054|NCT01697579|Aprepitant|aprepitant|mesh-list
2051055|NCT01697579|Serotonin|serotonin|mesh-list
2051056|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
2051057|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
2051058|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051059|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051060|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2051061|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
2051062|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
2051063|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2051064|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
2051065|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051066|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051067|NCT01697579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2051068|NCT01697579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2051069|NCT01697579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051070|NCT01697579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2051071|NCT01697579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2051072|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2051073|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2051074|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
2746895|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746896|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2746897|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2746898|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2746899|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2746900|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2746901|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2746902|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746903|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2746904|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2746905|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746906|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
2746907|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2746908|NCT05167851|Lazertinib|lazertinib|mesh-list
2746909|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2746910|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746911|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209282|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209283|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209284|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
2209285|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209286|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209287|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
2051075|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2051076|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2051077|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2051078|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
2051079|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051080|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051081|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051082|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2051083|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
2051084|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2051085|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2051086|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2051087|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051088|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051089|NCT01697956|Beclomethasone|beclomethasone|mesh-list
2051090|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051091|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
2051092|NCT01697956|Hormones|hormones|mesh-ancestor
2051093|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2051094|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051095|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2051096|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
2051097|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2051098|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2051099|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2051100|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2051101|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2051102|NCT01697969|Analgesics|analgesics|mesh-ancestor
2051103|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
2051104|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051105|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209288|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209289|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
2209290|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2209291|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2209292|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2051106|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051107|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051108|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2051109|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2051110|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2051111|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
2051112|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
2051113|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051114|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051115|NCT01698320|Albuterol|albuterol|mesh-list
2051116|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2051117|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
2051118|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051119|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051120|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2051121|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
2051122|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
2051123|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2051124|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2051125|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2051126|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2051127|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
2051128|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051129|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051130|NCT01698554|Bimatoprost|bimatoprost|mesh-list
2051131|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2051132|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2051133|NCT01698710|Paclitaxel|paclitaxel|mesh-list
2051134|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2051135|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2051136|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051137|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
2051138|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
2051139|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
2051140|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051141|NCT01698775|Glipizide|glipizide|mesh-list
2051142|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2051143|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051144|NCT01698801|Dexamethasone|dexamethasone|mesh-list
2051145|NCT01698801|Lenalidomide|lenalidomide|mesh-list
2051146|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051147|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
2051148|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
2051149|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051150|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051151|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2051152|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
2051153|NCT01698801|Hormones|hormones|mesh-ancestor
2051154|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2051155|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2051156|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051157|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
2051158|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2051159|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2051160|NCT01698801|Growth Substances|growth substances|mesh-ancestor
2051161|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
2051162|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2051163|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2051164|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2051165|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2051166|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2051167|NCT01698814|Analgesics|analgesics|mesh-ancestor
2051168|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
2051169|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051170|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051171|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051172|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051173|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2051174|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2051175|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2051176|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
2051177|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
2051178|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051179|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051180|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
2051181|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2051182|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051183|NCT01699022|CycloProvera|cycloprovera|mesh-list
2051184|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2051185|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2051186|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2051187|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
2051188|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2051189|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051190|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2051191|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2051192|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
2051193|NCT01699178|Testosterone|testosterone|mesh-list
2051194|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
2051195|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
2051196|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2051197|NCT01699178|Androgens|androgens|mesh-ancestor
2051198|NCT01699178|Hormones|hormones|mesh-ancestor
2051199|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2051200|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051201|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2051202|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051203|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
2051204|NCT01699607|Amphetamine|amphetamine|mesh-list
2051205|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
2051206|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2051207|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051208|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
2051209|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
2051210|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051211|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
2051212|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051213|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051214|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
2051215|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2051216|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2051217|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2051218|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2051219|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
2051220|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2051221|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2051222|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2051223|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
2051224|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051225|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051226|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051227|NCT01699815|Acetaminophen|acetaminophen|mesh-list
2051228|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2051229|NCT01699815|Analgesics|analgesics|mesh-ancestor
2051230|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
2051231|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051232|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051233|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
2051234|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2051235|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
2051236|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2051237|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2051238|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
2051239|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051240|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051241|NCT01700179|Ribavirin|ribavirin|mesh-list
2051242|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
2051243|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051244|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
2051245|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2051246|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
2051247|NCT01700192|Loratadine|loratadine|mesh-list
2051248|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2051249|NCT01700192|Epinephrine|epinephrine|mesh-list
2051250|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2051251|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2051252|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2051253|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
2051254|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051255|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051256|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051257|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2051258|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2051259|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
2051260|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051261|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2051262|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
2051263|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
2051264|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
2051265|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2051266|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051267|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
2051268|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2051269|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
2051270|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2051271|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2051272|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
2051273|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
2051274|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2051275|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2051276|NCT01700192|Analgesics|analgesics|mesh-ancestor
2051277|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
2051278|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051279|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2051280|NCT01700387|Topiramate|topiramate|mesh-list
2051281|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
2051282|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2051283|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2051284|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2051285|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2051286|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051287|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
2051288|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051289|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051290|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2051291|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051292|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
2051293|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2051294|NCT01700517|Anesthetics|anesthetics|mesh-list
2051295|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051296|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051297|NCT01700530|Simvastatin|simvastatin|mesh-list
2051298|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2051299|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2051300|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2051301|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
2051302|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051303|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2051304|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051305|NCT01700621|Vaccines|vaccines|mesh-list
2051306|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
2051307|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051308|NCT01700673|Azacitidine|azacitidine|mesh-list
2051309|NCT01700673|Sargramostim|sargramostim|mesh-list
2051310|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2051311|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
2051312|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051313|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051314|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051315|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
2051316|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051317|NCT01700829|Midazolam|midazolam|mesh-list
2051318|NCT01700829|Ketamine|ketamine|mesh-list
2051319|NCT01700829|Analgesics|analgesics|mesh-ancestor
2051320|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
2051321|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051322|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051323|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2051324|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2051325|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
2051326|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
2051327|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051328|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2051329|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2051330|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051331|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051332|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2051333|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2051334|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2051335|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2051336|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2051337|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
2051338|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
2051339|NCT01700907|Sevoflurane|sevoflurane|mesh-list
2051340|NCT01700907|Desflurane|desflurane|mesh-list
2051341|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2051342|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2051343|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
2051344|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
2051345|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051346|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051347|NCT01700959|Melatonin|melatonin|mesh-list
2051348|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
2051349|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051350|NCT01700959|Protective Agents|protective agents|mesh-ancestor
2051351|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051352|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051353|NCT01701037|Trametinib|trametinib|mesh-list
2051354|NCT01701037|Dabrafenib|dabrafenib|mesh-list
2051355|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051356|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2051357|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051358|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051359|NCT01701063|Ribavirin|ribavirin|mesh-list
2051360|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2051361|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
2051362|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051363|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
2051364|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2051365|NCT01701102|Fentanyl|fentanyl|mesh-list
2051366|NCT01701102|Mepivacaine|mepivacaine|mesh-list
2051367|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2051368|NCT01701102|Narcotics|narcotics|mesh-ancestor
2051369|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051370|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051371|NCT01701102|Analgesics|analgesics|mesh-ancestor
2051372|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
2051373|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051374|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2051375|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2051376|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
2051377|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
2051378|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
2051379|NCT01701115|Bupivacaine|bupivacaine|mesh-list
2051380|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
2051381|NCT01701115|Mepivacaine|mepivacaine|mesh-list
2051382|NCT01701115|Anesthetics|anesthetics|mesh-list
2051383|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051384|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051385|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
2051386|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051387|NCT01701258|Amisulpride|amisulpride|mesh-list
2051388|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2051389|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2051390|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051391|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051392|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2051393|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2051394|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
2051395|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051396|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051397|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2051398|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
2051399|NCT01701362|Pregabalin|pregabalin|mesh-list
2051400|NCT01701362|Analgesics|analgesics|mesh-ancestor
2051401|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
2051402|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051403|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051404|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
2051405|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2051406|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2051407|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051408|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2051409|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2051410|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2051411|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051412|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2051413|NCT01701375|Palbociclib|palbociclib|mesh-list
2051414|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051415|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2051416|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051417|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051418|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
2051419|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2051420|NCT01701401|Ledipasvir|ledipasvir|mesh-list
2051421|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
2051422|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2051423|NCT01701414|Bupivacaine|bupivacaine|mesh-list
2051424|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
2051425|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
2051426|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051427|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051428|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
2051429|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051430|NCT01701505|Phenylephrine|phenylephrine|mesh-list
2051431|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
2051432|NCT01701505|Tetracaine|tetracaine|mesh-list
2051433|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
2051434|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
2051435|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051436|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051437|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
2051438|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051439|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2051440|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2051441|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
2051442|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051443|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051444|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
2051445|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
2051446|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
2051447|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2051448|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
2051449|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2051450|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
2051451|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2051452|NCT01701505|Protective Agents|protective agents|mesh-ancestor
2051481|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2051482|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2051483|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051484|NCT01701973|Incretins|incretins|mesh-ancestor
2051485|NCT01701973|Hormones|hormones|mesh-ancestor
2051486|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2051487|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2051488|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
2051489|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051490|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051491|NCT01702025|Aminophylline|aminophylline|mesh-list
2051492|NCT01702025|Methazolamide|methazolamide|mesh-list
2051493|NCT01702025|Theophylline|theophylline|mesh-list
2051494|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2051495|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
2051496|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051497|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051498|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2051499|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
2051500|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2051501|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051502|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051503|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
2051504|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2051505|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2051506|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
2051507|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051508|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2051509|NCT01702025|Protective Agents|protective agents|mesh-ancestor
2051510|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2051511|NCT01702025|Diuretics|diuretics|mesh-ancestor
2051512|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
2051513|NCT01702233|Dexamethasone|dexamethasone|mesh-list
2051514|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
2051515|NCT01702233|BB 1101|bb 1101|mesh-list
2051516|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051517|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
2051518|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
2051519|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051520|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051521|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2051522|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
2051523|NCT01702233|Hormones|hormones|mesh-ancestor
2051524|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2051525|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2051526|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051527|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
2051528|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051529|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051530|NCT01702246|Simvastatin|simvastatin|mesh-list
2051531|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2051532|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2051533|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
2051534|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051535|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2209293|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2051536|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2051537|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051538|NCT01702298|Metformin|metformin|mesh-list
2051539|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2051540|NCT01702298|Simvastatin|simvastatin|mesh-list
2051541|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2051542|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051543|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2051544|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2051545|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
2051546|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051547|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2051548|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2051549|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051550|NCT01702298|Incretins|incretins|mesh-ancestor
2051551|NCT01702298|Hormones|hormones|mesh-ancestor
2051552|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2051553|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2051554|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
2051555|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
2051556|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2051557|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051558|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2051559|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
2051560|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051561|NCT01702519|Nicotine|nicotine|mesh-list
2051562|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2051563|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
2051564|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051565|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051566|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2051567|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2051568|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
2051569|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051570|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051571|NCT01702532|Nicotine|nicotine|mesh-list
2051572|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2051573|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
2051574|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051575|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051576|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2051577|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2051578|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
2051579|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051580|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051581|NCT01702558|Capecitabine|capecitabine|mesh-list
2051582|NCT01702558|Trastuzumab|trastuzumab|mesh-list
2051583|NCT01702558|Maytansine|maytansine|mesh-list
2051584|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2051585|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2051586|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
2051587|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051588|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051589|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2051590|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2051591|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
2051592|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
2051593|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
2051594|NCT01702571|Trastuzumab|trastuzumab|mesh-list
2051595|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2051596|NCT01702571|Maytansine|maytansine|mesh-list
2051597|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2051598|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051599|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2051600|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
2051601|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
2051602|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
2051603|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051604|NCT01702844|Paclitaxel|paclitaxel|mesh-list
2051605|NCT01702844|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2051606|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2051607|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051608|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
2209294|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
2209295|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2051609|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
2051610|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
2051611|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051612|NCT01702961|Cytarabine|cytarabine|mesh-list
2051613|NCT01702961|Etoposide|etoposide|mesh-list
2051614|NCT01702961|Rituximab|rituximab|mesh-list
2051615|NCT01702961|Melphalan|melphalan|mesh-list
2051616|NCT01702961|Carmustine|carmustine|mesh-list
2051617|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2051618|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051619|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2051620|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2051621|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051622|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051623|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2051624|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
2051625|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
2051626|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2051627|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2051628|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
2051629|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051630|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2051631|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051632|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2051633|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
2051634|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2051635|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
2051636|NCT01702987|Atorvastatin|atorvastatin|mesh-list
2051637|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2051638|NCT01702987|Simvastatin|simvastatin|mesh-list
2051639|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2051640|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2051641|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
2051642|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051643|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2051644|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2051645|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051646|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
2051647|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051648|NCT01702987|Vitamins|vitamins|mesh-ancestor
2051649|NCT01703039|Riluzole|riluzole|mesh-list
2051650|NCT01703039|Sertraline|sertraline|mesh-list
2051651|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
2051652|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2051653|NCT01703039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2051654|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2051655|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2051656|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051657|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051658|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
2051659|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051660|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
2051661|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2051662|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2209296|NCT00014248|Adenosine|adenosine|mesh-list
2209297|NCT00014248|Analgesics|analgesics|mesh-ancestor
2051663|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2051664|NCT01703039|Protective Agents|protective agents|mesh-ancestor
2051665|NCT01703091|Docetaxel|docetaxel|mesh-list
2051666|NCT01703091|Ramucirumab|ramucirumab|mesh-list
2051667|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051668|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
2051669|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
2051670|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
2051671|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051672|NCT01703117|Riluzole|riluzole|mesh-list
2051673|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
2051674|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2051675|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2051676|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051677|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051678|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051679|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2051680|NCT01703117|Protective Agents|protective agents|mesh-ancestor
2051681|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2051682|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2051683|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051684|NCT01703221|Incretins|incretins|mesh-ancestor
2051685|NCT01703221|Hormones|hormones|mesh-ancestor
2051686|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2051687|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2051688|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
2051689|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051690|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051691|NCT01703260|Pioglitazone|pioglitazone|mesh-list
2051692|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2051693|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051694|NCT01703286|Glimepiride|glimepiride|mesh-list
2209298|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
2209299|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209300|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209301|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2209302|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
2209303|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2209304|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
2209305|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
2209306|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209307|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209308|NCT00014261|Interferons|interferons|mesh-list
2051695|NCT01703286|Linagliptin|linagliptin|mesh-list
2051696|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2051697|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2051698|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051699|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2051700|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
2051701|NCT01703286|Incretins|incretins|mesh-ancestor
2051702|NCT01703286|Hormones|hormones|mesh-ancestor
2051703|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2051704|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2051705|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
2051706|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051707|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051708|NCT01703507|Ipilimumab|ipilimumab|mesh-list
2051709|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2051710|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051711|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2051712|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051713|NCT01703741|Testosterone|testosterone|mesh-list
2051714|NCT01703741|Androgens|androgens|mesh-ancestor
2051715|NCT01703741|Hormones|hormones|mesh-ancestor
2051716|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2051717|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051718|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
2051719|NCT01703845|Olodaterol|olodaterol|mesh-list
2051720|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2051721|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
2051722|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051723|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051724|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2051725|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
2051726|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
2051727|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2051728|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
2051729|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051730|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051731|NCT01703858|Pantoprazole|pantoprazole|mesh-list
2051732|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2051733|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2051734|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2051735|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051736|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051737|NCT01704079|Calcifediol|calcifediol|mesh-list
2051738|NCT01704079|Vitamins|vitamins|mesh-ancestor
2051739|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
2051740|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051741|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2051742|NCT01704261|Metformin|metformin|mesh-list
2051743|NCT01704261|Glimepiride|glimepiride|mesh-list
2051744|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2051745|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051746|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2051747|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2051748|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
2051749|NCT01704287|Paclitaxel|paclitaxel|mesh-list
2051750|NCT01704287|Carboplatin|carboplatin|mesh-list
2051751|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
2051752|NCT01704287|Temozolomide|temozolomide|mesh-list
2051753|NCT01704287|Dacarbazine|dacarbazine|mesh-list
2051754|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2051755|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051756|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
2051757|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
2051758|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
2051759|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051760|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2051761|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2051762|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
2051763|NCT01704521|Ribavirin|ribavirin|mesh-list
2051764|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
2051765|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051766|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
2051767|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2051768|NCT01704599|Vitamins|vitamins|mesh-list
2051769|NCT01704599|Folic Acid|folic acid|mesh-list
2051770|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
2051771|NCT01704599|Pyridoxine|pyridoxine|mesh-list
2051772|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
2051773|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
2051774|NCT01704599|Adalimumab|adalimumab|mesh-list
2051775|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
2051776|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051777|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051778|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051779|NCT01704599|Hematinics|hematinics|mesh-ancestor
2051780|NCT01704651|Alvimopan|alvimopan|mesh-list
2051781|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2051782|NCT01704755|Ribavirin|ribavirin|mesh-list
2051783|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
2051784|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051785|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
2051786|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2051787|NCT01704781|Lenalidomide|lenalidomide|mesh-list
2051788|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
2051789|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051790|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2051791|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2051792|NCT01704781|Growth Substances|growth substances|mesh-ancestor
2051793|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
2051794|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051795|NCT01705145|Ivacaftor|ivacaftor|mesh-list
2051796|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2051797|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2051798|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051799|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2051800|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2051801|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051802|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2051803|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
2051804|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051805|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2051806|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2051807|NCT01705288|Morphine|morphine|mesh-list
2051808|NCT01705288|Narcotics|narcotics|mesh-list
2051809|NCT01705288|Anesthetics|anesthetics|mesh-list
2051810|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2051811|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051812|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2051813|NCT01705288|Analgesics|analgesics|mesh-ancestor
2051814|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
2051815|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051816|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2051817|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051818|NCT01705496|Fialuridine|fialuridine|mesh-list
2051819|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
2051820|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2051821|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2051822|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051823|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051824|NCT01705509|Ranolazine|ranolazine|mesh-list
2051825|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2051826|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2051827|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051828|NCT01705574|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2051829|NCT01705574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2051830|NCT01705574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2051831|NCT01705574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051832|NCT01705574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051833|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
2051834|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2051835|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2051836|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2051837|NCT01705587|Teriparatide|teriparatide|mesh-list
2051838|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2051839|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051840|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2051841|NCT01705691|Paclitaxel|paclitaxel|mesh-list
2051842|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
2051843|NCT01705691|Doxorubicin|doxorubicin|mesh-list
2051844|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2051845|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051846|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
2051847|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
2051848|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
2051849|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051850|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2051851|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
2051852|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051853|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051854|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2051855|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
2051856|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2051857|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2051858|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2051859|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2051860|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051861|NCT01705964|Epinephrine|epinephrine|mesh-list
2051862|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2051863|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2051864|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
2051865|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051866|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051867|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051868|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2051869|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2051870|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
2051871|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051872|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2051873|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
2051874|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
2051875|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
2051876|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2051877|NCT01705977|Belimumab|belimumab|mesh-list
2051878|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2051879|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
2051880|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051881|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
2051882|NCT01706146|Apixaban|apixaban|mesh-list
2051883|NCT01706146|Dabigatran|dabigatran|mesh-list
2051884|NCT01706146|Anticoagulants|anticoagulants|mesh-list
2051885|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2051886|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
2051887|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2051888|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
2051889|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051890|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051891|NCT01706198|Fluticasone|fluticasone|mesh-list
2051892|NCT01706198|Xhance|xhance|mesh-list
2051893|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051894|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2051895|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
2051896|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051897|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051898|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2209309|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
2209310|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
2209311|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2209312|NCT00014261|Temozolomide|temozolomide|mesh-list
2051899|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
2051900|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
2051901|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2051902|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
2051903|NCT01706250|Salicylates|salicylates|mesh-list
2051904|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2051905|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
2051906|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
2051907|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
2051908|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2051909|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2051910|NCT01706250|Analgesics|analgesics|mesh-ancestor
2051911|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
2051912|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051913|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051914|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051915|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051916|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2051917|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051918|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051919|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
2051920|NCT01706263|Salicylates|salicylates|mesh-list
2051921|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2051922|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
2051923|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
2051924|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
2051925|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2209313|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209314|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
2209315|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209316|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2209317|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
2209318|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209319|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
2209320|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209321|NCT00014274|Gemcitabine|gemcitabine|mesh-list
2209322|NCT00014274|Carboplatin|carboplatin|mesh-list
2209323|NCT00014274|Methotrexate|methotrexate|mesh-list
2209324|NCT00014274|Vinblastine|vinblastine|mesh-list
2051926|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2051927|NCT01706263|Analgesics|analgesics|mesh-ancestor
2051928|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
2051929|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051930|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051931|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051932|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051933|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2051934|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051935|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051936|NCT01706328|Fluticasone|fluticasone|mesh-list
2051937|NCT01706328|Xhance|xhance|mesh-list
2051938|NCT01706328|Albuterol|albuterol|mesh-list
2051939|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2051940|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051941|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2051942|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
2051943|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209325|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051944|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051945|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2051946|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
2051947|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
2051948|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2051949|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2051950|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2051951|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2051952|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
2051953|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2051954|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051955|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
2051956|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2051957|NCT01706575|Interferons|interferons|mesh-list
2051958|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051959|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
2051960|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2051961|NCT01706588|Diclofenac|diclofenac|mesh-list
2051962|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2051963|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2746917|NCT05167760|Apraclonidine|apraclonidine|mesh-list
2746918|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2746919|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2746920|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2746921|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
2051964|NCT01706588|Analgesics|analgesics|mesh-ancestor
2051965|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
2051966|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051967|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051968|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051969|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051970|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2051971|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2051972|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051973|NCT01706666|Dexamethasone|dexamethasone|mesh-list
2051974|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
2051975|NCT01706666|Lenalidomide|lenalidomide|mesh-list
2051976|NCT01706666|Bortezomib|bortezomib|mesh-list
2051977|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2051978|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
2051979|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2051980|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051981|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2051982|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
2051983|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2051984|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2051985|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2051986|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2051987|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
2051988|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
2051989|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2051990|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2051991|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
2051992|NCT01706666|Hormones|hormones|mesh-ancestor
2209326|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2209327|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
2209328|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209329|NCT00014274|Antiviral Agents|antiviral agents|mesh-ancestor
2209330|NCT00014274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209331|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209332|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209333|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
2209334|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209335|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2209336|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
2209337|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2209338|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
2209339|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2209340|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2051993|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2051994|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2051995|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2051996|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2051997|NCT01706666|Growth Substances|growth substances|mesh-ancestor
2051998|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
2051999|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
2052000|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2052001|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2052002|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
2052003|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052004|NCT01706952|Epinephrine|epinephrine|mesh-list
2052005|NCT01706952|Racepinephrine|racepinephrine|mesh-list
2052006|NCT01706952|Cocaine|cocaine|mesh-list
2052007|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2052008|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
2052009|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2052010|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2052011|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
2052012|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052013|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052014|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052015|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2052016|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2052017|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
2052018|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052019|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2052020|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
2052021|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
2209341|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2052022|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
2052023|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2052024|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
2052025|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
2052026|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2052027|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
2052028|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2052029|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2052030|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2052031|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
2052032|NCT01707004|Vidarabine|vidarabine|mesh-list
2052033|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
2052034|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
2052035|NCT01707004|Busulfan|busulfan|mesh-list
2052036|NCT01707004|Fludarabine|fludarabine|mesh-list
2052037|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
2052038|NCT01707004|Azacitidine|azacitidine|mesh-list
2052039|NCT01707004|Decitabine|decitabine|mesh-list
2052040|NCT01707004|Tacrolimus|tacrolimus|mesh-list
2052041|NCT01707004|Lenograstim|lenograstim|mesh-list
2052042|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2052043|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
2052044|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052045|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2052046|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2052047|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
2052048|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209342|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2209343|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
2209344|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
2209345|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
2209346|NCT00014287|Gemcitabine|gemcitabine|mesh-list
2209347|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2209348|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
2052049|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052050|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2052051|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2052052|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
2052053|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
2052054|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2052055|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2052056|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2052057|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052058|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2052059|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2052060|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
2052061|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2052062|NCT01707043|Calcitriol|calcitriol|mesh-list
2052063|NCT01707043|Betamethasone|betamethasone|mesh-list
2746922|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2746923|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052064|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
2052065|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2052066|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
2209349|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209350|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209351|NCT00014287|Antiviral Agents|antiviral agents|mesh-ancestor
2209352|NCT00014287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209353|NCT00014287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209354|NCT00014287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209355|NCT00014287|Immunologic Factors|immunologic factors|mesh-ancestor
2209356|NCT00014287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209357|NCT00014313|Etoposide|etoposide|mesh-list
2209358|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209359|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2209360|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2746924|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746925|NCT05167734|Dextrans|dextrans|mesh-list
2746926|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
2746927|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
2746928|NCT05167734|Hematinics|hematinics|mesh-ancestor
2746929|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
2746930|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
2746931|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
2746932|NCT05167643|Anastrozole|anastrozole|mesh-list
2746933|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2052067|NCT01707043|Calcipotriene|calcipotriene|mesh-list
2052068|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2052069|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2052070|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
2052071|NCT01707043|Hormones|hormones|mesh-ancestor
2746934|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746935|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2746936|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2746937|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746938|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746939|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2746940|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
2746941|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2746942|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052072|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2052073|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052074|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2052075|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
2052076|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
2052077|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2052078|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2052079|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2746943|NCT05167513|Metformin|metformin|mesh-list
2746944|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2746945|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2746946|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746947|NCT05167513|Incretins|incretins|mesh-ancestor
2746948|NCT05167513|Hormones|hormones|mesh-ancestor
2746949|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2746950|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2746951|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
2746952|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2746953|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052080|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052081|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2052082|NCT01707043|Vitamins|vitamins|mesh-ancestor
2052083|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
2052084|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2052085|NCT01707147|Linagliptin|linagliptin|mesh-list
2052086|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2052087|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052088|NCT01707147|Incretins|incretins|mesh-ancestor
2052089|NCT01707147|Hormones|hormones|mesh-ancestor
2052090|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2052091|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2052092|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
2052093|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052094|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052095|NCT01707225|Octreotide|octreotide|mesh-list
2052096|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2052097|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2052098|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052099|NCT01707290|Ivacaftor|ivacaftor|mesh-list
2052100|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2052101|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2052102|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052103|NCT01707381|Timolol|timolol|mesh-list
2052104|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2052105|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2052106|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
2052107|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052108|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052109|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052110|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2052111|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2746957|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
2746958|NCT05167409|Cetuximab|cetuximab|mesh-list
2746959|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2746960|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746965|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
2746966|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2746967|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
2052112|NCT01707420|Gabapentin|gabapentin|mesh-list
2052113|NCT01707420|Analgesics|analgesics|mesh-ancestor
2052114|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
2052115|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052116|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052117|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
2052118|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2052119|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2052120|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2052121|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2052122|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2052123|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2052124|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052125|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052126|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
2052127|NCT01707667|Prucalopride|prucalopride|mesh-list
2052128|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2746968|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
2746969|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2746970|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746971|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2746972|NCT05167331|Analgesics|analgesics|mesh-ancestor
2746973|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
2746974|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2746975|NCT05167175|Prednisone|prednisone|mesh-list
2746976|NCT05167175|Olaparib|olaparib|mesh-list
2052129|NCT01707667|Laxatives|laxatives|mesh-ancestor
2052130|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2052131|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2052132|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2052133|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
2052134|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052135|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052136|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052137|NCT01708122|Fentanyl|fentanyl|mesh-list
2052138|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2746977|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
2746978|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2746979|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
2746980|NCT05167175|Hormones|hormones|mesh-ancestor
2746981|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2052139|NCT01708122|Narcotics|narcotics|mesh-ancestor
2052140|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2052141|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746982|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2746983|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2746984|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2746985|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2052142|NCT01708122|Analgesics|analgesics|mesh-ancestor
2052143|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
2052144|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052145|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2052146|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2052147|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
2052148|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
2052149|NCT01708278|Folic Acid|folic acid|mesh-list
2052150|NCT01708278|Quercetin|quercetin|mesh-list
2052151|NCT01708278|Hematinics|hematinics|mesh-ancestor
2052152|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
2052153|NCT01708278|Vitamins|vitamins|mesh-ancestor
2052154|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
2052155|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052156|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
2052157|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052158|NCT01708278|Protective Agents|protective agents|mesh-ancestor
2052159|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
2052160|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052161|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2052162|NCT01708525|Protective Agents|protective agents|mesh-ancestor
2052163|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052164|NCT01708590|Brodalumab|brodalumab|mesh-list
2052165|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2052166|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
2052167|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
2052168|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052169|NCT01708603|Ustekinumab|ustekinumab|mesh-list
2052170|NCT01708603|Brodalumab|brodalumab|mesh-list
2052171|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2052172|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
2052173|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
2052174|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052175|NCT01708629|Ustekinumab|ustekinumab|mesh-list
2052176|NCT01708629|Brodalumab|brodalumab|mesh-list
2052177|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2052178|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
2052179|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
2052180|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052181|NCT01708902|Metformin|metformin|mesh-list
2052182|NCT01708902|Linagliptin|linagliptin|mesh-list
2052183|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2052184|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052185|NCT01708902|Incretins|incretins|mesh-ancestor
2052186|NCT01708902|Hormones|hormones|mesh-ancestor
2052187|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2052188|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2052189|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
2052190|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052191|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052192|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
2052193|NCT01708915|Capsaicin|capsaicin|mesh-list
2052194|NCT01708915|Nonivamide|nonivamide|mesh-list
2052195|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
2052196|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052197|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052198|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
2052199|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
2052200|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
2052201|NCT01708915|Vitamins|vitamins|mesh-ancestor
2052202|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
2052203|NCT01708941|Interferons|interferons|mesh-list
2052204|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
2052205|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
2052206|NCT01708941|Ipilimumab|ipilimumab|mesh-list
2052207|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052208|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
2052209|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2052210|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2052211|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2052212|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052213|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
2052214|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052215|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2052216|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052217|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2052218|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052219|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052220|NCT01709032|Deferasirox|deferasirox|mesh-list
2052221|NCT01709032|Deferiprone|deferiprone|mesh-list
2052222|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2052223|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
2052224|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
2052225|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052226|NCT01709084|Tenofovir|tenofovir|mesh-list
2052227|NCT01709084|Emtricitabine|emtricitabine|mesh-list
2052228|NCT01709084|Efavirenz|efavirenz|mesh-list
2052229|NCT01709084|Rilpivirine|rilpivirine|mesh-list
2052230|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
2052231|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2052232|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2052233|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2052234|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052235|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052236|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2052237|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2052238|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2052239|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2052240|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2052241|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2746986|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052242|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2052243|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2052244|NCT01709110|Vitamin D|vitamin d|mesh-list
2052245|NCT01709110|Teriparatide|teriparatide|mesh-list
2052246|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
2052247|NCT01709110|Calcium|calcium|mesh-list
2052248|NCT01709110|Vitamins|vitamins|mesh-ancestor
2052249|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
2052250|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052251|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2052252|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2052253|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2052254|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2052255|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052256|NCT01709149|Riluzole|riluzole|mesh-list
2052257|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
2052258|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2052259|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2052260|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052261|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052262|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052263|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2052264|NCT01709149|Protective Agents|protective agents|mesh-ancestor
2052265|NCT01709162|Ipilimumab|ipilimumab|mesh-list
2052266|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2052267|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052268|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2052269|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052270|NCT01709227|Furosemide|furosemide|mesh-list
2052271|NCT01709227|Diuretics|diuretics|mesh-ancestor
2052272|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
2052273|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052274|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2052275|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2052276|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052277|NCT01709305|Metformin|metformin|mesh-list
2052278|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2052279|NCT01709305|Glimepiride|glimepiride|mesh-list
2052280|NCT01709305|Acarbose|acarbose|mesh-list
2052281|NCT01709305|Repaglinide|repaglinide|mesh-list
2052282|NCT01709305|Gliclazide|gliclazide|mesh-list
2052283|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2052284|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052285|NCT01709305|Incretins|incretins|mesh-ancestor
2052286|NCT01709305|Hormones|hormones|mesh-ancestor
2052287|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2052288|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2052289|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
2052290|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052291|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052292|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2052293|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2052294|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
2052295|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2052296|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2052297|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2052298|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2052299|NCT01709318|Etonogestrel|etonogestrel|mesh-list
2052300|NCT01709318|Estradiol|estradiol|mesh-list
2052301|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2052302|NCT01709318|Estrogens|estrogens|mesh-ancestor
2052303|NCT01709318|Hormones|hormones|mesh-ancestor
2052304|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2052305|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052306|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2052307|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
2209361|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2209362|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052308|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2052309|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2052310|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2052311|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2052312|NCT01709409|Poractant alfa|poractant alfa|mesh-list
2052313|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2052314|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
2052315|NCT01709422|Midazolam|midazolam|mesh-list
2052316|NCT01709422|Meperidine|meperidine|mesh-list
2052317|NCT01709422|Propofol|propofol|mesh-list
2052318|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2052319|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2052320|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052321|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2052322|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
2052323|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
2052324|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2052325|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2052326|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2052327|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2052328|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
2052329|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
2052330|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052331|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052332|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2746987|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2746988|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2052333|NCT01709422|Narcotics|narcotics|mesh-ancestor
2052334|NCT01709422|Analgesics|analgesics|mesh-ancestor
2052335|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
2052336|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052337|NCT01709474|Vitamin D|vitamin d|mesh-list
2052338|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
2052339|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
2052340|NCT01709474|Vitamins|vitamins|mesh-list
2052341|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
2052342|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052343|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2209363|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209364|NCT00014339|Prednisone|prednisone|mesh-list
2052344|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2746989|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
2746990|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2746991|NCT05167123|Calcium|calcium|mesh-list
2746992|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2746993|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052345|NCT01709500|Atorvastatin|atorvastatin|mesh-list
2052346|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2052347|NCT01709500|Simvastatin|simvastatin|mesh-list
2052348|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2052349|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2052350|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
2052351|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052352|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2052353|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2052354|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052355|NCT01709513|Atorvastatin|atorvastatin|mesh-list
2052356|NCT01709513|Ezetimibe|ezetimibe|mesh-list
2052357|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2052358|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2052359|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
2052360|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052361|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2052362|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2052363|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052364|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
2052365|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
2052366|NCT01709578|Methotrexate|methotrexate|mesh-list
2052367|NCT01709578|Leflunomide|leflunomide|mesh-list
2052368|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2052369|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
2052370|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2052371|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052372|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2747030|NCT05166746|Clindamycin|clindamycin|mesh-list
2747031|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
2747032|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
2052373|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
2052374|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052375|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052376|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
2052377|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052378|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2052379|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2052380|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
2052381|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2052382|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2052383|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
2052384|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2052385|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2052386|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2052387|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2052388|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2052389|NCT01709578|Analgesics|analgesics|mesh-ancestor
2052390|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
2052391|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052392|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2052393|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2052394|NCT01709695|Guanfacine|guanfacine|mesh-list
2052395|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2052396|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2052397|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2052398|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2052399|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
2052400|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052401|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052402|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052403|NCT01709708|Bupivacaine|bupivacaine|mesh-list
2052404|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
2052405|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
2052406|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2052407|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052408|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
2052409|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052410|NCT01709721|Hydromorphone|hydromorphone|mesh-list
2052411|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2052412|NCT01709721|Narcotics|narcotics|mesh-ancestor
2052413|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2052414|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052415|NCT01709721|Analgesics|analgesics|mesh-ancestor
2052416|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
2052417|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052418|NCT01709747|Hydromorphone|hydromorphone|mesh-list
2052419|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2052420|NCT01709747|Narcotics|narcotics|mesh-ancestor
2052421|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2052422|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052423|NCT01709747|Analgesics|analgesics|mesh-ancestor
2052424|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
2052425|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052426|NCT01709838|Deferasirox|deferasirox|mesh-list
2052427|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2052428|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
2052429|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
2052430|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052431|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
2052432|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2052433|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2052434|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2052435|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
2052436|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052437|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052438|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052439|NCT01709903|Fluticasone|fluticasone|mesh-list
2209365|NCT00014339|Melphalan|melphalan|mesh-list
2209366|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2209367|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
2209368|NCT00014339|Hormones|hormones|mesh-ancestor
2209369|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2052440|NCT01709903|Xhance|xhance|mesh-list
2052441|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
2052442|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2052443|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2052444|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2052445|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2052446|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
2052447|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052448|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052449|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2052450|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
2052451|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
2052452|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2747033|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2747034|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2747035|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2747036|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2747037|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747038|NCT05166668|Letrozole|letrozole|mesh-list
2747039|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747040|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2747041|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2747042|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2747043|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747044|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2747045|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
2052453|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2052454|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2052455|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2052456|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
2052457|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052458|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052459|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
2052460|NCT01709903|Hormones|hormones|mesh-ancestor
2052461|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2052462|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
2052463|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2052464|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2052465|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2052466|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
2052467|NCT01709981|Colchicine|colchicine|mesh-list
2052468|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
2052469|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2052470|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
2052471|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
2052472|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
2052473|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052474|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747046|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2747047|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747048|NCT05166616|Osimertinib|osimertinib|mesh-list
2747049|NCT05166616|Triptolide|triptolide|mesh-list
2747050|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747051|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2747052|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2747053|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747054|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2747055|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747056|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2747057|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
2747058|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2052475|NCT01710020|Tofacitinib|tofacitinib|mesh-list
2052476|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2052477|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052478|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052479|NCT01710033|Tofacitinib|tofacitinib|mesh-list
2052480|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2052481|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052482|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052483|NCT01710046|Tofacitinib|tofacitinib|mesh-list
2747059|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2747060|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
2747061|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2747062|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
2052484|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2052485|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2747063|NCT05166577|Valganciclovir|valganciclovir|mesh-list
2052486|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052487|NCT01710137|Varenicline|varenicline|mesh-list
2052488|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2052489|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2052490|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
2052491|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052492|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052493|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052494|NCT01710254|Regadenoson|regadenoson|mesh-list
2052495|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2052496|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2052497|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
2052498|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
2052499|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052500|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052501|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052502|NCT01710332|Aflibercept|aflibercept|mesh-list
2052503|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2052504|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2052505|NCT01710332|Growth Substances|growth substances|mesh-ancestor
2052506|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052507|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
2052508|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052509|NCT01710345|Sufentanil|sufentanil|mesh-list
2052510|NCT01710345|Dsuvia|dsuvia|mesh-list
2052511|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2052512|NCT01710345|Narcotics|narcotics|mesh-ancestor
2052513|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2052514|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052515|NCT01710345|Analgesics|analgesics|mesh-ancestor
2052516|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
2052517|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052518|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2747064|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
2747065|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2747066|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747067|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
2747068|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2747069|NCT05166538|Clopidogrel|clopidogrel|mesh-list
2747070|NCT05166538|Ticagrelor|ticagrelor|mesh-list
2747071|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2747072|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2747073|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2747074|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2747075|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
2747076|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2747077|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747078|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747079|NCT05162131|Ticagrelor|ticagrelor|mesh-list
2747080|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2747081|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2747082|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2747083|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2747084|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
2747085|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2747086|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747087|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747093|NCT05161429|Insulin|insulin|mesh-list
2747094|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2747095|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747096|NCT05159453|Insulin|insulin|mesh-list
2052519|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2052520|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
2052521|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
2052522|NCT01710358|Adalimumab|adalimumab|mesh-list
2052523|NCT01710358|Methotrexate|methotrexate|mesh-list
2052524|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2052525|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
2209370|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209371|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2209372|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209373|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2209374|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
2209375|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209376|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2209377|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209378|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
2209379|NCT00014352|Ketoconazole|ketoconazole|mesh-list
2209380|NCT00014352|Docetaxel|docetaxel|mesh-list
2209381|NCT00014352|Doxorubicin|doxorubicin|mesh-list
2209382|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2209383|NCT00014352|Estramustine|estramustine|mesh-list
2209384|NCT00014352|Warfarin|warfarin|mesh-list
2209385|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209386|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
2052526|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2052527|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052528|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2052529|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
2052530|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052531|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052532|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
2052533|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052534|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2052535|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2052536|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
2052537|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2052538|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2052539|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2052540|NCT01710501|Interferons|interferons|mesh-list
2052541|NCT01710501|Ribavirin|ribavirin|mesh-list
2052542|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
2052543|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
2052544|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2052545|NCT01710501|Grazoprevir|grazoprevir|mesh-list
2052546|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052547|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
2052548|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2052549|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
2052550|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052551|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
2052552|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052553|NCT01710527|Metformin|metformin|mesh-list
2052554|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2052555|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052556|NCT01710657|Lacosamide|lacosamide|mesh-list
2052557|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
2052558|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2052559|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2052560|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2052561|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052562|NCT01710709|Aripiprazole|aripiprazole|mesh-list
2052563|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
2052564|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2209387|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
2209388|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
2209389|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209390|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2052565|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2052566|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2052567|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2052568|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052569|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
2052570|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
2052571|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052572|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052573|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2052574|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2052575|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
2052576|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2052577|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2052578|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2052579|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2052580|NCT01710787|Phenylephrine|phenylephrine|mesh-list
2052581|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
2052582|NCT01710787|Tetracaine|tetracaine|mesh-list
2052583|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
2052584|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
2052585|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2052586|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052587|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
2052588|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052589|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2052590|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2052591|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
2052592|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052593|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052594|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
2052595|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
2052596|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
2052597|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2052598|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
2747097|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2747098|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2747099|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052599|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2052600|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
2052601|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2052602|NCT01710787|Protective Agents|protective agents|mesh-ancestor
2052603|NCT01710800|Esomeprazole|esomeprazole|mesh-list
2052604|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2052605|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2052606|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2052607|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052608|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052609|NCT01710839|Ranibizumab|ranibizumab|mesh-list
2052610|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2052611|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2052612|NCT01710839|Growth Substances|growth substances|mesh-ancestor
2052613|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052614|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
2052615|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052616|NCT01711177|Travoprost|travoprost|mesh-list
2052617|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2052618|NCT01711359|Folic Acid|folic acid|mesh-list
2052619|NCT01711359|Methotrexate|methotrexate|mesh-list
2052620|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2052621|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
2052622|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2052623|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052624|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2052625|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
2052626|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052627|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052628|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
2747125|NCT05148949|Vaccines|vaccines|mesh-list
2747126|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
2209391|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2209392|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2209393|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052629|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052630|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2052631|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2052632|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
2052633|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2052634|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2052635|NCT01711359|Hematinics|hematinics|mesh-ancestor
2052636|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
2052637|NCT01711359|Vitamins|vitamins|mesh-ancestor
2052638|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
2209394|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
2209395|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
2209396|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209397|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2209398|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2209399|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2209400|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
2052661|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
2052662|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2052663|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
2052664|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052665|NCT01711645|Antacids|antacids|mesh-ancestor
2052666|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052667|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2052668|NCT01711658|Lapatinib|lapatinib|mesh-list
2052669|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052670|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2052671|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052672|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052673|NCT01711853|Dabigatran|dabigatran|mesh-list
2052674|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
2052675|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2052676|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
2052677|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052678|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052679|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
2052680|NCT01711866|Rotigotine|rotigotine|mesh-list
2747127|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747128|NCT05148377|Heparin|heparin|mesh-list
2747129|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
2747130|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2747131|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2747132|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209401|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2209402|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209403|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2052681|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
2052682|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
2052683|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052684|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052685|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052686|NCT01711879|Aflibercept|aflibercept|mesh-list
2052687|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2052688|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2052689|NCT01711879|Growth Substances|growth substances|mesh-ancestor
2052690|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052691|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
2052692|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052693|NCT01711918|Domperidone|domperidone|mesh-list
2052694|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
2052695|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
2052696|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052697|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052698|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2052699|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2052700|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
2052701|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052702|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052703|NCT01712009|Loratadine|loratadine|mesh-list
2209404|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2209405|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
2209406|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2209407|NCT00014391|Ribavirin|ribavirin|mesh-list
2209408|NCT00014391|Palivizumab|palivizumab|mesh-list
2209409|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
2209410|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209411|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
2052704|NCT01712009|Naproxen|naproxen|mesh-list
2052705|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2052706|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2052707|NCT01712009|Analgesics|analgesics|mesh-ancestor
2052708|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
2052709|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052710|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052711|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2052712|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2052713|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
2052714|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2052715|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052716|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052717|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
2052718|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
2052719|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2052720|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2052721|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2052722|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
2052723|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
2052724|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052725|NCT01712178|Adalimumab|adalimumab|mesh-list
2052726|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2052727|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2052728|NCT01712204|Febuxostat|febuxostat|mesh-list
2052729|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
2052730|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2052731|NCT01712230|Leuprolide|leuprolide|mesh-list
2052732|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2052733|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
2052734|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2052735|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052736|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2052737|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052738|NCT01712360|Naftifine|naftifine|mesh-list
2052739|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
2052740|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2052741|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
2052742|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2052743|NCT01712490|Doxorubicin|doxorubicin|mesh-list
2052744|NCT01712490|Bleomycin|bleomycin|mesh-list
2052745|NCT01712490|Dacarbazine|dacarbazine|mesh-list
2052746|NCT01712490|Vinblastine|vinblastine|mesh-list
2052747|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2052748|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2052749|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052750|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2052751|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2052752|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052753|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052754|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2052755|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
2052756|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2052757|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
2052758|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
2052759|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
2052760|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2052761|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
2052762|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2052763|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2052764|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2052765|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
2052766|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052767|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052768|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052769|NCT01712984|Fluconazole|fluconazole|mesh-list
2052770|NCT01712984|Vaccines|vaccines|mesh-list
2052771|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
2052772|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052773|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
2052774|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2052775|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2052776|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2052777|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052778|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052779|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2052780|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
2052781|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2052782|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2052783|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2052784|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
2052785|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
2747161|NCT05147220|Teriflunomide|teriflunomide|mesh-list
2747162|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2747163|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2747164|NCT05147220|Analgesics|analgesics|mesh-ancestor
2747165|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
2747166|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2747167|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747168|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2747169|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2052786|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2052787|NCT01713400|Sirolimus|sirolimus|mesh-list
2052788|NCT01713400|Ustekinumab|ustekinumab|mesh-list
2052789|NCT01713400|Tacrolimus|tacrolimus|mesh-list
2052790|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2747170|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2747171|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
2747172|NCT05145413|Xanomeline|xanomeline|mesh-list
2747173|NCT05145413|Trospium chloride|trospium chloride|mesh-list
2747174|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
2747175|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
2052791|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
2052792|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052793|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2052794|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052795|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052796|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2052797|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2052798|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2052799|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052800|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
2052801|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
2052802|NCT01713530|Insulin|insulin|mesh-list
2052803|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2052804|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
2052805|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
2052806|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2052807|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2052808|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052809|NCT01713608|Artefenomel|artefenomel|mesh-list
2052810|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
2052811|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2052812|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2052813|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2052814|NCT01713621|Artefenomel|artefenomel|mesh-list
2052815|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
2052816|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2052817|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2052818|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2052819|NCT01713946|Everolimus|everolimus|mesh-list
2052820|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
2052821|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052822|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2052823|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
2052824|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052825|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2052826|NCT01714310|Fluoxetine|fluoxetine|mesh-list
2209412|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209413|NCT00014404|Celecoxib|celecoxib|mesh-list
2209414|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2209415|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2209416|NCT00014404|Analgesics|analgesics|mesh-ancestor
2209417|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
2209418|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209419|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052827|NCT01714310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2052828|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2052829|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2052830|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052831|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052832|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
2052833|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052834|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2052835|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
2052836|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2052837|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2052838|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2052839|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052840|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2052841|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2052842|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
2052843|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
2052844|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2052845|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2052846|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052847|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
2052848|NCT01714336|Coagulants|coagulants|mesh-ancestor
2052849|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
2052850|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
2052851|NCT01714544|Hormones|hormones|mesh-ancestor
2052852|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2052853|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052854|NCT01714609|Sorafenib|sorafenib|mesh-list
2052855|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052856|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2052857|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2052858|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747176|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2747177|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747178|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2747179|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2747180|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
2747181|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2747182|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747183|NCT05145413|Urological Agents|urological agents|mesh-ancestor
2747184|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2747185|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2747186|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2747187|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2747188|NCT05144945|Vaccines|vaccines|mesh-list
2747189|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
2747190|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747191|NCT05144698|Sirolimus|sirolimus|mesh-list
2747192|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2747193|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2747194|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2747195|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747196|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
2747197|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2052880|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2052881|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
2052882|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2052883|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
2052884|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2052885|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052886|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2052887|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2052888|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052889|NCT01715207|Atenolol|atenolol|mesh-list
2052890|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2052891|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2052892|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
2052893|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
2052894|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2052895|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052896|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2209420|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2209421|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2209422|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2209423|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2209424|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209425|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209426|NCT00014430|Trastuzumab|trastuzumab|mesh-list
2052897|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2052898|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2052899|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
2052900|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052901|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052902|NCT01715233|Leucovorin|leucovorin|mesh-list
2052903|NCT01715233|Carboplatin|carboplatin|mesh-list
2052904|NCT01715233|Docetaxel|docetaxel|mesh-list
2052905|NCT01715233|Fluorouracil|fluorouracil|mesh-list
2052906|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052907|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
2052908|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
2052909|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
2209427|NCT00014430|Vinorelbine|vinorelbine|mesh-list
2052910|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052911|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
2052912|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2052913|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2052914|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
2052915|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052916|NCT01715233|Antidotes|antidotes|mesh-ancestor
2052917|NCT01715233|Protective Agents|protective agents|mesh-ancestor
2052918|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
2052919|NCT01715233|Vitamins|vitamins|mesh-ancestor
2052920|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
2747198|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
2747199|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747208|NCT05141721|Bevacizumab|bevacizumab|mesh-list
2747209|NCT05141721|Ipilimumab|ipilimumab|mesh-list
2747210|NCT05141721|Oxaliplatin|oxaliplatin|mesh-list
2747211|NCT05141721|Atezolizumab|atezolizumab|mesh-list
2747212|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2747213|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747214|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2747215|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2747216|NCT05141721|Growth Substances|growth substances|mesh-ancestor
2747217|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747218|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
2747219|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2747220|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052936|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
2052937|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2052938|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2052939|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2052940|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
2052941|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052942|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052943|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052944|NCT01715415|Ribavirin|ribavirin|mesh-list
2052945|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
2052946|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052947|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
2052948|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2052949|NCT01715805|Cariprazine|cariprazine|mesh-list
2052950|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
2052951|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2052952|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2052953|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2052954|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2209428|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2209429|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052955|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052956|NCT01715896|Golimumab|golimumab|mesh-list
2052957|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
2052958|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2052959|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2052960|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2052961|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
2052962|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052963|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2052964|NCT01716039|Adalimumab|adalimumab|mesh-list
2052965|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2052966|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2052967|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
2052968|NCT01716117|Antacids|antacids|mesh-ancestor
2052969|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052970|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2052971|NCT01716156|Ribavirin|ribavirin|mesh-list
2052972|NCT01716156|Grazoprevir|grazoprevir|mesh-list
2052973|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
2209430|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2209431|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
2209432|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
2209433|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
2209434|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209435|NCT00014443|Thalidomide|thalidomide|mesh-list
2209436|NCT00014443|Topotecan|topotecan|mesh-list
2209437|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2747226|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
2747227|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2747228|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2052974|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052975|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
2052976|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2052977|NCT01716195|Paclitaxel|paclitaxel|mesh-list
2052978|NCT01716195|Carboplatin|carboplatin|mesh-list
2052979|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2052980|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052981|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
2052982|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
2052983|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
2052984|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052985|NCT01716208|Ofatumumab|ofatumumab|mesh-list
2052986|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2052987|NCT01716221|Dexetimide|dexetimide|mesh-list
2052988|NCT01716221|Bupropion|bupropion|mesh-list
2052989|NCT01716221|Citalopram|citalopram|mesh-list
2052990|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2052991|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
2052992|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2052993|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2052994|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2052995|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2052996|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2052997|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
2052998|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2052999|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053000|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2053001|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2053002|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053003|NCT01716221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2053004|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
2053005|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2053006|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2053007|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
2053008|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
2053009|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053010|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2053011|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2053012|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
2053013|NCT01716234|Posaconazole|posaconazole|mesh-list
2053014|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
2053015|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053016|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2053017|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2053018|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2053019|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2053020|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2053021|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053022|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053023|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2053024|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
2053025|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2053026|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053027|NCT01716585|Ribavirin|ribavirin|mesh-list
2053028|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
2053029|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053030|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
2053031|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053032|NCT01716715|Paclitaxel|paclitaxel|mesh-list
2053033|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2053034|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2209438|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2209439|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209440|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209441|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209442|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209443|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
2209444|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053035|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053036|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
2053037|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
2053038|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
2053039|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053040|NCT01716754|Omalizumab|omalizumab|mesh-list
2053041|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2053042|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2053043|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
2053044|NCT01717040|Pioglitazone|pioglitazone|mesh-list
2053045|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2053046|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053047|NCT01717053|Prednisone|prednisone|mesh-list
2053048|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
2053049|NCT01717053|Androgens|androgens|mesh-list
2053050|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2053051|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
2053052|NCT01717053|Hormones|hormones|mesh-ancestor
2053053|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2209445|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
2209446|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2747247|NCT05134974|Phentolamine|phentolamine|mesh-list
2747248|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2747249|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2053054|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053055|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2053056|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053057|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2053058|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053059|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053060|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
2053061|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2053062|NCT01717209|Epoprostenol|epoprostenol|mesh-list
2053063|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
2053064|NCT01717209|Tezosentan|tezosentan|mesh-list
2053065|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2053066|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
2209447|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209448|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2209449|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2053067|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053068|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053069|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2053070|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
2053071|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2053072|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
2053073|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053074|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053075|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2209450|NCT00014443|Growth Substances|growth substances|mesh-ancestor
2209451|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
2209452|NCT00014456|Gemcitabine|gemcitabine|mesh-list
2209453|NCT00014456|Docetaxel|docetaxel|mesh-list
2053076|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
2053077|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
2053078|NCT01717209|Protective Agents|protective agents|mesh-ancestor
2053079|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2053080|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2053081|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
2053082|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2053083|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2053084|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
2053085|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2747250|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2747251|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2747252|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
2747253|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2747254|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747255|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747256|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2747257|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
2747258|NCT05134441|Calcium|calcium|mesh-list
2747259|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2747260|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747261|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2747262|NCT05133531|Ravulizumab|ravulizumab|mesh-list
2747263|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2747264|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2747265|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
2747266|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209454|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2209455|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
2209456|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209457|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209458|NCT00014456|Antiviral Agents|antiviral agents|mesh-ancestor
2209459|NCT00014456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209460|NCT00014456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053086|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2053087|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2053088|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053089|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053090|NCT01717313|Metformin|metformin|mesh-list
2053091|NCT01717313|Glimepiride|glimepiride|mesh-list
2053092|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2053093|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053094|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2053095|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2053096|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
2053097|NCT01717326|Ribavirin|ribavirin|mesh-list
2053098|NCT01717326|Grazoprevir|grazoprevir|mesh-list
2053099|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
2053100|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053101|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
2053102|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053103|NCT01717456|Loperamide|loperamide|mesh-list
2053104|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
2209461|NCT00014456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209462|NCT00014456|Immunologic Factors|immunologic factors|mesh-ancestor
2209463|NCT00014456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209464|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
2053105|NCT01717456|Laxatives|laxatives|mesh-list
2053106|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2053107|NCT01717638|Vaccines|vaccines|mesh-list
2053108|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
2747267|NCT05132920|Dexamethasone|dexamethasone|mesh-list
2747268|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2747269|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
2747270|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
2747271|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2747272|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747273|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2747274|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
2747275|NCT05132920|Hormones|hormones|mesh-ancestor
2747276|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2747277|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2747278|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053109|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209465|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
2209466|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
2209467|NCT00014469|Methotrexate|methotrexate|mesh-list
2209468|NCT00014469|Melphalan|melphalan|mesh-list
2209469|NCT00014469|Busulfan|busulfan|mesh-list
2209470|NCT00014469|Tacrolimus|tacrolimus|mesh-list
2209471|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2209472|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
2053110|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2053111|NCT01717742|Plasminogen|plasminogen|mesh-list
2053112|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2053113|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2053114|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053115|NCT01717768|Testosterone|testosterone|mesh-list
2053116|NCT01717768|Androgens|androgens|mesh-ancestor
2053117|NCT01717768|Hormones|hormones|mesh-ancestor
2053118|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2053119|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053120|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
2053121|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
2053122|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
2053123|NCT01717898|Prednisone|prednisone|mesh-list
2053124|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
2053125|NCT01717898|Dactolisib|dactolisib|mesh-list
2053126|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2053127|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
2053128|NCT01717898|Hormones|hormones|mesh-ancestor
2053129|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2053130|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053131|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2053132|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053133|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2053134|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053135|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053136|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
2053137|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2053138|NCT01718353|Prednisone|prednisone|mesh-list
2053139|NCT01718353|Docetaxel|docetaxel|mesh-list
2053140|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053141|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
2209473|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2209474|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209475|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2209476|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
2209477|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209478|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209479|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
2209480|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209481|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2209482|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209483|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
2209484|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2209485|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2209486|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2209487|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2209488|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
2209489|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2209490|NCT00014508|Cyclosporine|cyclosporine|mesh-list
2209491|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
2209492|NCT00014508|Melphalan|melphalan|mesh-list
2209493|NCT00014508|Fludarabine|fludarabine|mesh-list
2209494|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
2209495|NCT00014508|Cyclosporins|cyclosporins|mesh-list
2053142|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
2053143|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
2053144|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053145|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2053146|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
2053147|NCT01718353|Hormones|hormones|mesh-ancestor
2053148|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2053149|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053150|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2053151|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2209496|NCT00014508|Sargramostim|sargramostim|mesh-list
2209497|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209498|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
2209499|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209500|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2209501|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2209502|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
2209503|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053152|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2053153|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053154|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2053155|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2053156|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2053157|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053158|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
2053159|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053160|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2053161|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2053162|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053163|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2053164|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2053165|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2053166|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053167|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
2053168|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053169|NCT01718691|Rituximab|rituximab|mesh-list
2053170|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2053171|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053172|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
2053173|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053174|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2053175|NCT01719003|Metformin|metformin|mesh-list
2053176|NCT01719003|Empagliflozin|empagliflozin|mesh-list
2053177|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2053178|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053179|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2053180|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209504|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209505|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2209506|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2053181|NCT01719172|Hemostatics|hemostatics|mesh-list
2053182|NCT01719172|Coagulants|coagulants|mesh-ancestor
2053183|NCT01719367|Atenolol|atenolol|mesh-list
2053184|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2053185|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2053186|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
2053187|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
2053188|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053189|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053190|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2053191|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2053192|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2053193|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
2053194|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053195|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053196|NCT01719380|Cetuximab|cetuximab|mesh-list
2053197|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2053198|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053199|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2053200|NCT01719653|Laxatives|laxatives|mesh-ancestor
2053201|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2053202|NCT01719757|Oxycodone|oxycodone|mesh-list
2053203|NCT01719757|Naloxone|naloxone|mesh-list
2053204|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2053205|NCT01719757|Narcotics|narcotics|mesh-ancestor
2053206|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053207|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053208|NCT01719757|Analgesics|analgesics|mesh-ancestor
2053209|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
2053210|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053211|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2053212|NCT01719783|Vaccines|vaccines|mesh-list
2053213|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
2053214|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053215|NCT01719861|Desipramine|desipramine|mesh-list
2053216|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2053217|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
2053218|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2053219|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053220|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053221|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2053222|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2053223|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2053224|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
2053225|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053226|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053227|NCT01720043|Bortezomib|bortezomib|mesh-list
2053228|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209507|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
2209508|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209509|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
2209510|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209511|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
2209512|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2209513|NCT00014534|Gemcitabine|gemcitabine|mesh-list
2209514|NCT00014534|Doxorubicin|doxorubicin|mesh-list
2053229|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2053230|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
2053231|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053232|NCT01720225|Azacitidine|azacitidine|mesh-list
2053233|NCT01720225|Decitabine|decitabine|mesh-list
2053234|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2053235|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
2053236|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053237|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053238|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053239|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2053240|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2053241|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053242|NCT01720264|Incretins|incretins|mesh-ancestor
2053243|NCT01720264|Hormones|hormones|mesh-ancestor
2053244|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2053245|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2053246|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
2053247|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053248|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053249|NCT01720277|Vaccines|vaccines|mesh-list
2053250|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
2053251|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053252|NCT01720316|Glycine|glycine|mesh-list
2053253|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
2053254|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209515|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2209516|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747308|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
2747309|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
2747310|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2747311|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747312|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747313|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
2747314|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
2053255|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053256|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053257|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
2053258|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
2053259|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2053260|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2053261|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209517|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2747318|NCT05116059|Amphotericin B|amphotericin b|mesh-list
2747319|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2747320|NCT05116059|Amebicides|amebicides|mesh-ancestor
2747321|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2747322|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2747323|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2747324|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2747325|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
2747335|NCT05111912|Liraglutide|liraglutide|mesh-list
2747336|NCT05111912|Glucagon|glucagon|mesh-list
2747337|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2747338|NCT05111912|Incretins|incretins|mesh-ancestor
2747339|NCT05111912|Hormones|hormones|mesh-ancestor
2747340|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2747341|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747342|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2747343|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2747344|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
2747345|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2053262|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053263|NCT01720524|Urological Agents|urological agents|mesh-ancestor
2053264|NCT01720602|Letrozole|letrozole|mesh-list
2053265|NCT01720602|Vorinostat|vorinostat|mesh-list
2053266|NCT01720602|Anastrozole|anastrozole|mesh-list
2053267|NCT01720602|Exemestane|exemestane|mesh-list
2053268|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2053269|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053270|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2053271|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2053272|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053273|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053274|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2053275|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
2053276|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2053277|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053278|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2053279|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2053280|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2053281|NCT01720667|Levetiracetam|levetiracetam|mesh-list
2053282|NCT01720667|Phenobarbital|phenobarbital|mesh-list
2053283|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
2053284|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
2053285|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2053286|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053287|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053288|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2053289|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2053290|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053291|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053292|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
2053293|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
2053294|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2053295|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2053296|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2053297|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
2053298|NCT01720797|Anesthetics|anesthetics|mesh-list
2053299|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
2053300|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2053301|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053302|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
2053303|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053304|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053305|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
2053306|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053307|NCT01721070|Ketoconazole|ketoconazole|mesh-list
2053308|NCT01721070|Sufentanil|sufentanil|mesh-list
2053309|NCT01721070|Dsuvia|dsuvia|mesh-list
2053310|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2053311|NCT01721070|Narcotics|narcotics|mesh-ancestor
2053312|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053313|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053314|NCT01721070|Analgesics|analgesics|mesh-ancestor
2053315|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
2053316|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053317|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2053318|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2053319|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
2053320|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
2053321|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
2053322|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053323|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2053324|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2053325|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053326|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053327|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2053328|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
2053329|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2053330|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2053331|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2053332|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2053333|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2053334|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
2053335|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053336|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
2053337|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2053338|NCT01721226|Narcotics|narcotics|mesh-ancestor
2053339|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053340|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053341|NCT01721226|Analgesics|analgesics|mesh-ancestor
2053342|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
2053343|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053344|NCT01721317|Ezogabine|ezogabine|mesh-list
2053345|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
2053346|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2053347|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053348|NCT01721330|Naltrexone|naltrexone|mesh-list
2053349|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2053350|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2053351|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053352|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
2053353|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053354|NCT01721408|Imipenem|imipenem|mesh-list
2053355|NCT01721408|Tigecycline|tigecycline|mesh-list
2053356|NCT01721408|Cilastatin|cilastatin|mesh-list
2209518|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
2209519|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209520|NCT00014534|Antiviral Agents|antiviral agents|mesh-ancestor
2209521|NCT00014534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209522|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209523|NCT00014534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209524|NCT00014534|Immunologic Factors|immunologic factors|mesh-ancestor
2209525|NCT00014534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209526|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2209527|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2053357|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2053358|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053359|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2053360|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053361|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053362|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
2053363|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
2053364|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2053365|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053366|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053367|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2053368|NCT01721460|Analgesics|analgesics|mesh-ancestor
2053369|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
2053370|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053371|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2053372|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2053373|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2053374|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
2053375|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053376|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053377|NCT01721486|Acetaminophen|acetaminophen|mesh-list
2053378|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2053379|NCT01721486|Analgesics|analgesics|mesh-ancestor
2053380|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
2053381|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053382|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053383|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
2053384|NCT01721564|Bosentan|bosentan|mesh-list
2053385|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2053386|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2053387|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209528|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2209529|NCT00014547|BBR 3464|bbr 3464|mesh-list
2209530|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209531|NCT00014573|Aldesleukin|aldesleukin|mesh-list
2209532|NCT00014573|Paclitaxel|paclitaxel|mesh-list
2209533|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
2053388|NCT01721603|Trametinib|trametinib|mesh-list
2053389|NCT01721603|Dabrafenib|dabrafenib|mesh-list
2053390|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053391|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2053392|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053393|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053394|NCT01721746|Paclitaxel|paclitaxel|mesh-list
2053395|NCT01721746|Carboplatin|carboplatin|mesh-list
2053396|NCT01721746|Nivolumab|nivolumab|mesh-list
2053397|NCT01721746|Dacarbazine|dacarbazine|mesh-list
2053398|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2053399|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053400|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
2053401|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
2053402|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
2053403|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053404|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2053405|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2053406|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2053407|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
2747350|NCT05105672|Cisplatin|cisplatin|mesh-list
2747351|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053413|NCT01721772|Nivolumab|nivolumab|mesh-list
2053414|NCT01721772|Dacarbazine|dacarbazine|mesh-list
2053415|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2053416|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053417|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2053418|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053419|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2053420|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
2053421|NCT01721876|Cytarabine|cytarabine|mesh-list
2053422|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2053423|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
2053424|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053425|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053426|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
2053427|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053428|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2053429|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
2053430|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053431|NCT01721967|Ranolazine|ranolazine|mesh-list
2053432|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2053433|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2053434|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747358|NCT05104866|Gemcitabine|gemcitabine|mesh-list
2747359|NCT05104866|Capecitabine|capecitabine|mesh-list
2747360|NCT05104866|Vinorelbine|vinorelbine|mesh-list
2747361|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2747362|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
2747363|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747364|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747365|NCT05104866|Antiviral Agents|antiviral agents|mesh-ancestor
2747366|NCT05104866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2747367|NCT05104866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2747368|NCT05104866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2747369|NCT05104866|Immunologic Factors|immunologic factors|mesh-ancestor
2747370|NCT05104866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747371|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2053435|NCT01722045|Aflibercept|aflibercept|mesh-list
2053436|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2053437|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2053438|NCT01722045|Growth Substances|growth substances|mesh-ancestor
2053439|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053440|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
2053441|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053442|NCT01722071|Oxytocin|oxytocin|mesh-list
2747372|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
2747373|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
2747374|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
2209534|NCT00014573|Carmustine|carmustine|mesh-list
2209535|NCT00014573|Sargramostim|sargramostim|mesh-list
2209536|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2209537|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209538|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
2209539|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
2209540|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
2209541|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053443|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
2053444|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2053445|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053446|NCT01722097|Rocuronium|rocuronium|mesh-list
2053447|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2053448|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2053449|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2053450|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053451|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053452|NCT01722162|Bevacizumab|bevacizumab|mesh-list
2053453|NCT01722162|Capecitabine|capecitabine|mesh-list
2053454|NCT01722162|Levocetirizine|levocetirizine|mesh-list
2053455|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2053456|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053457|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2053458|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2053459|NCT01722162|Growth Substances|growth substances|mesh-ancestor
2053460|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053461|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
2053462|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2053463|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
2053464|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053465|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2053466|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2053467|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
2053468|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
2053469|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053470|NCT01722266|Liraglutide|liraglutide|mesh-list
2053471|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2053472|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053473|NCT01722266|Incretins|incretins|mesh-ancestor
2053474|NCT01722266|Hormones|hormones|mesh-ancestor
2053475|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2053476|NCT01722292|Carboplatin|carboplatin|mesh-list
2053477|NCT01722292|Etoposide|etoposide|mesh-list
2053478|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053479|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2053480|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2053481|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2053482|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053483|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053484|NCT01722318|Plecanatide|plecanatide|mesh-list
2053485|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2053486|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
2053487|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053488|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2053489|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2209542|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209543|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
2209544|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209545|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2209546|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2209547|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
2209548|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2209549|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2053490|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
2053491|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053492|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
2053493|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2053494|NCT01722435|Narcotics|narcotics|mesh-ancestor
2053495|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053496|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053497|NCT01722435|Analgesics|analgesics|mesh-ancestor
2053498|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
2053499|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053500|NCT01722487|Chlorambucil|chlorambucil|mesh-list
2053501|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2053502|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
2053503|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053504|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053505|NCT01722604|Brinzolamide|brinzolamide|mesh-list
2053506|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2053507|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053508|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053509|NCT01722669|Quercetin|quercetin|mesh-list
2053510|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
2053511|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053512|NCT01722669|Protective Agents|protective agents|mesh-ancestor
2053513|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053514|NCT01723072|Omalizumab|omalizumab|mesh-list
2053515|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2053516|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2053517|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2053518|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
2053519|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
2053520|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053521|NCT01723228|Rasagiline|rasagiline|mesh-list
2053522|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2053523|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053524|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053525|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2053526|NCT01723228|Protective Agents|protective agents|mesh-ancestor
2053527|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053528|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
2053529|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
2053530|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053531|NCT01723384|Naltrexone|naltrexone|mesh-list
2053532|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2053533|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2053534|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053535|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
2053536|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053537|NCT01723514|Erenumab|erenumab|mesh-list
2053538|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2053539|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209550|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2209551|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
2209552|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209553|NCT00014586|Goserelin|goserelin|mesh-list
2209554|NCT00014586|Bicalutamide|bicalutamide|mesh-list
2209555|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2209556|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209557|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
2053540|NCT01723514|Analgesics|analgesics|mesh-ancestor
2053541|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
2053542|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053543|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053544|NCT01723696|Vitamins|vitamins|mesh-list
2053545|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
2053546|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
2053547|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053548|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
2053549|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053550|NCT01723696|Protective Agents|protective agents|mesh-ancestor
2053551|NCT01723722|Methadone|methadone|mesh-list
2053552|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2053553|NCT01723722|Narcotics|narcotics|mesh-ancestor
2053554|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053555|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053556|NCT01723722|Analgesics|analgesics|mesh-ancestor
2053557|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
2053558|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053559|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
2053560|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
2053561|NCT01723904|Rotigotine|rotigotine|mesh-list
2053562|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
2053563|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
2053564|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053565|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053566|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053567|NCT01724021|Prednisone|prednisone|mesh-list
2053568|NCT01724021|Prednisolone|prednisolone|mesh-list
2053569|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2053570|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
2053571|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2053572|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
2053573|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
2053574|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2053575|NCT01724021|Rituximab|rituximab|mesh-list
2053576|NCT01724021|Vincristine|vincristine|mesh-list
2053577|NCT01724021|Doxorubicin|doxorubicin|mesh-list
2053578|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2053579|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2053580|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
2053581|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2053582|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
2053583|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053584|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2053585|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2053586|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
2053587|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053588|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053589|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2053590|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2053591|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2053592|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
2053593|NCT01724021|Hormones|hormones|mesh-ancestor
2053594|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2053595|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2053596|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2053597|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
2053598|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
2053599|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
2053600|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
2053601|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
2053602|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053603|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2053604|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2053605|NCT01724021|Protective Agents|protective agents|mesh-ancestor
2053606|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2053607|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2053608|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2053609|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053610|NCT01724177|Lenalidomide|lenalidomide|mesh-list
2053611|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
2053612|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053613|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2053614|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2053615|NCT01724177|Growth Substances|growth substances|mesh-ancestor
2053616|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
2053617|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053618|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2053619|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2053620|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2053621|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053622|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053623|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2053624|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2053625|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2053626|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
2053627|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053628|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053629|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2053630|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2053631|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
2053632|NCT01724489|Hormones|hormones|mesh-list
2053633|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2053634|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053635|NCT01724528|Allopurinol|allopurinol|mesh-list
2053636|NCT01724528|Febuxostat|febuxostat|mesh-list
2053637|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
2053638|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053639|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053640|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
2053641|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2053642|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2053643|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
2053644|NCT01724528|Protective Agents|protective agents|mesh-ancestor
2053645|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053646|NCT01725126|Metformin|metformin|mesh-list
2053647|NCT01725126|Liraglutide|liraglutide|mesh-list
2053648|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2053649|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053650|NCT01725126|Incretins|incretins|mesh-ancestor
2053651|NCT01725126|Hormones|hormones|mesh-ancestor
2053652|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2053653|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2053654|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
2053655|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2053656|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2053657|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2053658|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053659|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053660|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2053661|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
2053662|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2053663|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2053664|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2053665|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053666|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053667|NCT01725386|Capecitabine|capecitabine|mesh-list
2053668|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2053669|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
2053670|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053671|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053672|NCT01725451|Testosterone|testosterone|mesh-list
2053673|NCT01725451|Androgens|androgens|mesh-ancestor
2053674|NCT01725451|Hormones|hormones|mesh-ancestor
2053675|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2053676|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053677|NCT01725529|Ribavirin|ribavirin|mesh-list
2053678|NCT01725529|Simeprevir|simeprevir|mesh-list
2053679|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
2053680|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053681|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
2053682|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053683|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
2053684|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053685|NCT01726023|Metronidazole|metronidazole|mesh-list
2053686|NCT01726023|Meropenem|meropenem|mesh-list
2053687|NCT01726023|Ceftazidime|ceftazidime|mesh-list
2053688|NCT01726023|Avibactam|avibactam|mesh-list
2053689|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
2053690|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053691|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2053692|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2053693|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2053694|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2053695|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053696|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053697|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
2053698|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
2053699|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2053700|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2053701|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053702|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053703|NCT01726049|Urological Agents|urological agents|mesh-ancestor
2053704|NCT01726270|Tamsulosin|tamsulosin|mesh-list
2053705|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2053706|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2053707|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2053708|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
2053709|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053710|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053711|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053712|NCT01726270|Urological Agents|urological agents|mesh-ancestor
2053713|NCT01726335|Risperidone|risperidone|mesh-list
2053714|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2053715|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
2053716|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053717|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053718|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053719|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2053720|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2053721|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053722|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2053723|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2053724|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
2053725|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2053726|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
2053727|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053728|NCT01726621|Insulin|insulin|mesh-list
2053729|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2053730|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053731|NCT01726738|Trametinib|trametinib|mesh-list
2053732|NCT01726738|Dabrafenib|dabrafenib|mesh-list
2053733|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209558|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
2209559|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2209560|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209561|NCT00014599|Paclitaxel|paclitaxel|mesh-list
2209562|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2209563|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209564|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
2209565|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
2209566|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
2209567|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209568|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
2209569|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209570|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2209571|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209572|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209573|NCT00014638|Letrozole|letrozole|mesh-list
2209574|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209575|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2209576|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2209577|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053734|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2053735|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053736|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053737|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
2053738|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2053739|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
2053740|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053741|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053742|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2053743|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
2053744|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
2053745|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2053746|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
2053747|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053748|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053749|NCT01727089|Bevacizumab|bevacizumab|mesh-list
2053750|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2053751|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
2053752|NCT01727089|Antibodies|antibodies|mesh-list
2053753|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
2053754|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2053755|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
2053756|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053757|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2053758|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2053759|NCT01727089|Growth Substances|growth substances|mesh-ancestor
2053760|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053761|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
2053762|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
2053763|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
2053764|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2053765|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2053766|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2053767|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
2053768|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053769|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053770|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053771|NCT01727258|Fluorides|fluorides|mesh-list
2053772|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
2053773|NCT01727258|Protective Agents|protective agents|mesh-ancestor
2053774|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053775|NCT01727336|Axitinib|axitinib|mesh-list
2053776|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053777|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2053778|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053779|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053780|NCT01727414|Methylphenidate|methylphenidate|mesh-list
2053781|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2053782|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053783|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2053784|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2053785|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2053786|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053787|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
2053788|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053789|NCT01727700|Aripiprazole|aripiprazole|mesh-list
2053790|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
2053791|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2053792|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2053793|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2053794|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053795|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053796|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
2053797|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
2053798|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053799|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053800|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2053801|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2053802|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
2053803|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2053804|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2053805|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2053806|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2053807|NCT01727713|Aripiprazole|aripiprazole|mesh-list
2053808|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
2053809|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2053810|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2053811|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2053812|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053813|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053814|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
2053815|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
2053816|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053817|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053818|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2053819|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2053820|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
2053821|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2053822|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2053823|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2053824|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2053825|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2053826|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
2053827|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
2053828|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2053829|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2053830|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2053831|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053832|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053833|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
2053834|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053835|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053836|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
2053837|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
2053838|NCT01727791|Pregabalin|pregabalin|mesh-list
2053839|NCT01727791|Analgesics|analgesics|mesh-ancestor
2053840|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
2053841|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053842|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053843|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
2053844|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2053845|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2053846|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053847|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2053848|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2053849|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2053850|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053851|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2053852|NCT01728077|Brivaracetam|brivaracetam|mesh-list
2053853|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
2053854|NCT01728194|Citalopram|citalopram|mesh-list
2053855|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2053856|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2053857|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2053858|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053859|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053860|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
2053861|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053862|NCT01728194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2053863|NCT01728194|Antidepressive Agents|antidepressive agents|mesh-ancestor
2053864|NCT01728194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2053865|NCT01728246|Acetaminophen|acetaminophen|mesh-list
2053866|NCT01728246|Tramadol|tramadol|mesh-list
2053867|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2053868|NCT01728246|Analgesics|analgesics|mesh-ancestor
2053869|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
2053870|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053871|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053872|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
2053873|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2053874|NCT01728246|Narcotics|narcotics|mesh-ancestor
2053875|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053876|NCT01728324|Ribavirin|ribavirin|mesh-list
2053877|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
2053878|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053879|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
2053880|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053881|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
2053882|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2053883|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2053884|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2053885|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2053886|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053887|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
2053888|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2053889|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053890|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2053891|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053892|NCT01728376|Daptomycin|daptomycin|mesh-list
2053893|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2053894|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053895|NCT01728584|Bromides|bromides|mesh-list
2053896|NCT01728584|Rocuronium|rocuronium|mesh-list
2053897|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
2053898|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2053899|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2053900|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2053901|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2053902|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053903|NCT01728623|Lenvatinib|lenvatinib|mesh-list
2053904|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053905|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2053906|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053907|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053908|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
2053909|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2209578|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209579|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2209580|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
2209581|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2209582|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209583|NCT00014651|Vapreotide|vapreotide|mesh-list
2209584|NCT00014651|Analgesics|analgesics|mesh-ancestor
2209585|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
2209586|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209587|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209588|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209589|NCT00014677|Interleukin-4|interleukin-4|mesh-list
2209590|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2209591|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
2209592|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209593|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209594|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2209595|NCT00014690|Topotecan|topotecan|mesh-list
2209596|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2209597|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2053910|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2053911|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053912|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
2053913|NCT01728636|Coagulants|coagulants|mesh-ancestor
2053914|NCT01728779|Nelfinavir|nelfinavir|mesh-list
2053915|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2053916|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2053917|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
2053918|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053919|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053920|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2053921|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2053922|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
2053923|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053924|NCT01728805|Vorinostat|vorinostat|mesh-list
2053925|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
2053926|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053927|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2053928|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053929|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053930|NCT01729156|Metformin|metformin|mesh-list
2053931|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2053932|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053933|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
2053934|NCT01729338|Lenalidomide|lenalidomide|mesh-list
2053935|NCT01729338|Bortezomib|bortezomib|mesh-list
2053936|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2053937|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
2053938|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053939|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2053940|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2053941|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
2053942|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053943|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053944|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2053945|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2053946|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2053947|NCT01729338|Growth Substances|growth substances|mesh-ancestor
2053948|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
2053949|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
2053950|NCT01729494|Prednisone|prednisone|mesh-list
2053951|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
2053952|NCT01729494|Abatacept|abatacept|mesh-list
2053953|NCT01729494|Tacrolimus|tacrolimus|mesh-list
2053954|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
2053955|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2053956|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2053957|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
2053958|NCT01729494|Hormones|hormones|mesh-ancestor
2053959|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2053960|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053961|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2053962|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2053963|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2053964|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
2053965|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2053966|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053967|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053968|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2053969|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2053970|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
2053971|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2053972|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2053973|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2053974|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2053975|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2053976|NCT01729559|Heparin|heparin|mesh-list
2053977|NCT01729559|Enoxaparin|enoxaparin|mesh-list
2053978|NCT01729559|Calcium heparin|calcium heparin|mesh-list
2053979|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
2053980|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
2053981|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2053982|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2053983|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053984|NCT01729598|Valproic Acid|valproic acid|mesh-list
2053985|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
2053986|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053987|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2053988|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
2053989|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209598|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2053990|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2053991|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
2053992|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2053993|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053994|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2053995|NCT01729728|Tapentadol|tapentadol|mesh-list
2053996|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2053997|NCT01729728|Narcotics|narcotics|mesh-ancestor
2053998|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2053999|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054000|NCT01729728|Analgesics|analgesics|mesh-ancestor
2054001|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
2054002|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054003|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2054004|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2054005|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2054006|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054007|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
2054008|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054009|NCT01729754|Etanercept|etanercept|mesh-list
2054010|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2054011|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2054012|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2054013|NCT01729754|Analgesics|analgesics|mesh-ancestor
2054014|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
2054015|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054016|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054017|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2054018|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2054019|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2054020|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2054021|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
2054022|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2054023|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2054024|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2054025|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2054026|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
2054027|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054028|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054029|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054030|NCT01729819|Urological Agents|urological agents|mesh-ancestor
2054031|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
2054032|NCT01729819|Coagulants|coagulants|mesh-ancestor
2054033|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2054034|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
2054035|NCT01729845|Cytarabine|cytarabine|mesh-list
2054036|NCT01729845|Etoposide|etoposide|mesh-list
2054037|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
2054038|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
2054039|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
2054040|NCT01729845|Decitabine|decitabine|mesh-list
2054041|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2054042|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054043|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2054044|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2054045|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054046|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054047|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2054048|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
2054049|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
2054050|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2054051|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2054052|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
2054053|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054054|NCT01729845|Analgesics|analgesics|mesh-ancestor
2054055|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
2054056|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054057|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
2054058|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
2054059|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
2054060|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
2054061|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
2054062|NCT01729871|Vitamin K|vitamin k|mesh-list
2054063|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
2054064|NCT01729871|Vitamins|vitamins|mesh-ancestor
2054065|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
2054066|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054067|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2054068|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
2054069|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2054070|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
2054071|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054072|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054073|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
2054074|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2054075|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2054076|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
2054077|NCT01729871|Coagulants|coagulants|mesh-ancestor
2054078|NCT01729923|Celecoxib|celecoxib|mesh-list
2054079|NCT01729923|Capecitabine|capecitabine|mesh-list
2054080|NCT01729923|Benzenesulfonamide|benzenesulfonamide|mesh-list
2054081|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2054082|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
2054083|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054084|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054085|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2054086|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2054087|NCT01729923|Analgesics|analgesics|mesh-ancestor
2054088|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
2054089|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054090|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054091|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2054092|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2054093|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2054094|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2054095|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054096|NCT01729923|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2054097|NCT01730040|Atorvastatin|atorvastatin|mesh-list
2054098|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2054099|NCT01730040|Ezetimibe|ezetimibe|mesh-list
2054100|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2054101|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2054102|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
2054103|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054104|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2054105|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2054106|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054107|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2054108|NCT01730053|Ezetimibe|ezetimibe|mesh-list
2054109|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2054110|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2054111|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
2054112|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054113|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2054114|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2054115|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054116|NCT01730378|Vaccines|vaccines|mesh-list
2054117|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
2054118|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054119|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
2054120|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2054121|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054122|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2054123|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054124|NCT01730586|Paclitaxel|paclitaxel|mesh-list
2054125|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2054126|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2054127|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054128|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
2054129|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
2054130|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
2054131|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054132|NCT01730729|Cabergoline|cabergoline|mesh-list
2054133|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2054134|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2054135|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
2054136|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
2054137|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054138|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054139|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054140|NCT01730846|Doxazosin|doxazosin|mesh-list
2054141|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2054142|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2054143|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2054144|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2054145|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
2054146|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054147|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054148|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054149|NCT01730872|Prednisolone|prednisolone|mesh-list
2054150|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2054151|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
2054152|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2054153|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
2054154|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2054155|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2054156|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2054157|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
2054158|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2054159|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
2054160|NCT01730872|Hormones|hormones|mesh-ancestor
2054161|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2054162|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054163|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2054164|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054165|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
2054166|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
2054167|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054168|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2054169|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2054170|NCT01730872|Protective Agents|protective agents|mesh-ancestor
2054171|NCT01730950|Bevacizumab|bevacizumab|mesh-list
2054172|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2054173|NCT01730950|Antibodies|antibodies|mesh-list
2054174|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
2054175|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2054176|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054177|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2054178|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2054179|NCT01730950|Growth Substances|growth substances|mesh-ancestor
2054180|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054181|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
2054182|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
2054183|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2054184|NCT01731002|Latanoprost|latanoprost|mesh-list
2054185|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2054186|NCT01731041|Ticagrelor|ticagrelor|mesh-list
2054187|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2054188|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2054189|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2054190|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2054191|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
2054192|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054193|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054194|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054195|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2054196|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2054197|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2054198|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2054199|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054200|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2054201|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2054202|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2054203|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2054204|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
2054205|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054206|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054207|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2054208|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2054209|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
2054210|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2054211|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2054212|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
2054213|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
2054214|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2054215|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054216|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054217|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2054218|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2054219|NCT01731886|Dexamethasone|dexamethasone|mesh-list
2054220|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
2054221|NCT01731886|Melphalan|melphalan|mesh-list
2054222|NCT01731886|Lenalidomide|lenalidomide|mesh-list
2054223|NCT01731886|Lenograstim|lenograstim|mesh-list
2054224|NCT01731886|Sargramostim|sargramostim|mesh-list
2054225|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2054226|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
2054227|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054228|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2054229|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2054230|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
2054231|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054232|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054233|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2054234|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2054235|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
2054236|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
2054237|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054238|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2054239|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
2054240|NCT01731886|Hormones|hormones|mesh-ancestor
2054241|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2054242|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2054243|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2054244|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2054245|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2054246|NCT01731886|Growth Substances|growth substances|mesh-ancestor
2054247|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
2054248|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2054249|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
2054250|NCT01731938|Coagulants|coagulants|mesh-ancestor
2054251|NCT01731951|Imetelstat|imetelstat|mesh-list
2054252|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
2054253|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054254|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054255|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2054256|NCT01732445|Danazol|danazol|mesh-list
2054257|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2054258|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2054259|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
2054260|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2054261|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054262|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2054263|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054264|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054265|NCT01732458|Ondansetron|ondansetron|mesh-list
2054266|NCT01732458|Aprepitant|aprepitant|mesh-list
2054267|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
2054268|NCT01732458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2054269|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054270|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
2054271|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
2054272|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054273|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2054274|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
2054275|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
2054276|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2054277|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
2054278|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054279|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054280|NCT01732458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2054281|NCT01732458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2054282|NCT01732458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2054283|NCT01732458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2054284|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2054285|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
2054286|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2054287|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
2054288|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2054289|NCT01732588|Artefenomel|artefenomel|mesh-list
2054290|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
2054291|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2054292|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2054293|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2054294|NCT01732627|Vaccines|vaccines|mesh-list
2054295|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
2054296|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054297|NCT01732640|Paclitaxel|paclitaxel|mesh-list
2054298|NCT01732640|Cisplatin|cisplatin|mesh-list
2054299|NCT01732640|Carboplatin|carboplatin|mesh-list
2054300|NCT01732640|Afatinib|afatinib|mesh-list
2054301|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2054302|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054303|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
2054304|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
2054305|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
2054306|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054307|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2054308|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054309|NCT01732718|Atorvastatin|atorvastatin|mesh-list
2054310|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2054311|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2054312|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
2054313|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054314|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2054315|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2054316|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054317|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2054318|NCT01732757|Dextrans|dextrans|mesh-list
2054319|NCT01732757|Alcaftadine|alcaftadine|mesh-list
2054320|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2054321|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2054322|NCT01732757|Analgesics|analgesics|mesh-ancestor
2054323|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
2054324|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054325|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054326|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2054327|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2054328|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2054329|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2054330|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2054331|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
2054332|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
2054333|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054334|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054335|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
2054336|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
2054337|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
2054338|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
2054339|NCT01732770|Denosumab|denosumab|mesh-list
2054340|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2054341|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054342|NCT01732783|Panitumumab|panitumumab|mesh-list
2054343|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2054344|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054345|NCT01732796|Ribavirin|ribavirin|mesh-list
2054346|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
2054347|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054348|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
2054349|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2054350|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2054351|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2054352|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2054353|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054354|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054355|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2054356|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2054357|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054358|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
2054359|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054360|NCT01732822|Clopidogrel|clopidogrel|mesh-list
2054361|NCT01732822|Ticagrelor|ticagrelor|mesh-list
2054362|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2054363|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2054364|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2054365|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2054366|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
2054367|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054368|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054369|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054370|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
2054371|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2054372|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2054373|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2054374|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054375|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
2054376|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054377|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054378|NCT01733316|Cysteamine|cysteamine|mesh-list
2054379|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2054380|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054381|NCT01733329|Folic Acid|folic acid|mesh-list
2054382|NCT01733329|Misoprostol|misoprostol|mesh-list
2054383|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2054384|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
2054385|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2054386|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054387|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2054388|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2054389|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
2054390|NCT01733329|Hematinics|hematinics|mesh-ancestor
2054391|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
2054392|NCT01733329|Vitamins|vitamins|mesh-ancestor
2054393|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
2054394|NCT01733472|Remifentanil|remifentanil|mesh-list
2054395|NCT01733472|Propofol|propofol|mesh-list
2054396|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
2054397|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2054398|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054399|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2054400|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2054401|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
2054402|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2054403|NCT01733472|Narcotics|narcotics|mesh-ancestor
2054404|NCT01733472|Analgesics|analgesics|mesh-ancestor
2054405|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
2054406|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054407|NCT01733680|Amiloride|amiloride|mesh-list
2054408|NCT01733680|Diuretics|diuretics|mesh-ancestor
2054409|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
2054410|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054411|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2054412|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2054413|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2054414|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054415|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2054416|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2054417|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2054418|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
2054419|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2054420|NCT01733745|Vitamins|vitamins|mesh-list
2054421|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2054422|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
2054423|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054424|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2054425|NCT01733758|Liraglutide|liraglutide|mesh-list
2054426|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
2054427|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2054428|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2054429|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054430|NCT01733758|Incretins|incretins|mesh-ancestor
2054431|NCT01733758|Hormones|hormones|mesh-ancestor
2054432|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2054433|NCT01733953|Atorvastatin|atorvastatin|mesh-list
2054434|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2054435|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2054436|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
2054437|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054438|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2054439|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2054440|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054441|NCT01734161|Dexamethasone|dexamethasone|mesh-list
2054442|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2054443|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
2054444|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
2054445|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054446|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054447|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2054448|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
2054449|NCT01734161|Hormones|hormones|mesh-ancestor
2054450|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2054451|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2054452|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054453|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2054454|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
2054455|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054456|NCT01734395|Galantamine|galantamine|mesh-list
2054457|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2054458|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054459|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054460|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
2054461|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054462|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054463|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2054464|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
2054465|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054466|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
2054467|NCT01734512|Everolimus|everolimus|mesh-list
2054468|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054469|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2054470|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
2054471|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054472|NCT01734525|Anidulafungin|anidulafungin|mesh-list
2054473|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
2054474|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2054475|NCT01734551|Clonidine|clonidine|mesh-list
2209599|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209600|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209601|NCT00014729|Isotretinoin|isotretinoin|mesh-list
2209602|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
2209603|NCT00014755|Prednisone|prednisone|mesh-list
2209604|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
2209605|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2209606|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209607|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
2209608|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209609|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2054476|NCT01734551|Morphine|morphine|mesh-list
2209610|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2209611|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
2209612|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054477|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2054478|NCT01734551|Narcotics|narcotics|mesh-ancestor
2054479|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2054480|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054481|NCT01734551|Analgesics|analgesics|mesh-ancestor
2054482|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
2054483|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054484|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2054485|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
2054486|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
2054487|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2054488|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2054489|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2054490|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
2054491|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209613|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209614|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2209615|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2209616|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
2209617|NCT00014755|Hormones|hormones|mesh-ancestor
2209618|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2209619|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2209620|NCT00014937|Ritonavir|ritonavir|mesh-list
2209621|NCT00014937|Lopinavir|lopinavir|mesh-list
2209622|NCT00014937|Lamivudine|lamivudine|mesh-list
2054492|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054493|NCT01734772|Dabigatran|dabigatran|mesh-list
2054494|NCT01734772|Ticagrelor|ticagrelor|mesh-list
2054495|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2054496|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2054497|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2054498|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2054499|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
2054500|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054501|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054502|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054503|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
2054504|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2054505|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
2054506|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054507|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
2054508|NCT01734785|Empagliflozin|empagliflozin|mesh-list
2054509|NCT01734785|Linagliptin|linagliptin|mesh-list
2054510|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2054511|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054512|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2054513|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054514|NCT01734785|Incretins|incretins|mesh-ancestor
2054515|NCT01734785|Hormones|hormones|mesh-ancestor
2054516|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2054517|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2054518|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
2054519|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054520|NCT01734850|Busulfan|busulfan|mesh-list
2054521|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
2054522|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054523|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2054524|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
2054525|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054526|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2054527|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054528|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2054529|NCT01734889|Nitisinone|nitisinone|mesh-list
2054530|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054531|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054532|NCT01734902|Scopolamine|scopolamine|mesh-list
2054533|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2054534|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2054535|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
2054536|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
2054537|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054538|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054539|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2054540|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
2054541|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2054542|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
2054543|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054544|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054545|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2054546|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
2054547|NCT01735279|Mineral Oil|mineral oil|mesh-list
2054548|NCT01735279|Emollients|emollients|mesh-ancestor
2054549|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
2054550|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
2054551|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054552|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2054553|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054554|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054555|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
2054556|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2054557|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054558|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2054559|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
2054560|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2054561|NCT01735630|Inositol|inositol|mesh-list
2054562|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
2054563|NCT01735630|Vitamins|vitamins|mesh-ancestor
2054564|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
2747384|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
2747385|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
2747386|NCT05100654|Doxycycline|doxycycline|mesh-list
2747387|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
2747388|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2747389|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2747390|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2747391|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2747392|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
2747393|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2747394|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2054565|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054566|NCT01736085|Nicotine|nicotine|mesh-list
2054567|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2054568|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
2054569|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054570|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054571|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2054572|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2054573|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
2054574|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054575|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054576|NCT01736176|Levodopa|levodopa|mesh-list
2054577|NCT01736176|Carbidopa|carbidopa|mesh-list
2054578|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2054579|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2054580|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2054581|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
2054582|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054583|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054584|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054585|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2054586|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054587|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2054588|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
2054589|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
2054590|NCT01736189|Adalimumab|adalimumab|mesh-list
2054591|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2054592|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2054593|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
2054594|NCT01736215|Hematinics|hematinics|mesh-ancestor
2054595|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
2054596|NCT01736254|Evacetrapib|evacetrapib|mesh-list
2054597|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2054598|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
2054599|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054600|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2054601|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2054602|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2054603|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054604|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2747395|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2054605|NCT01736358|Ketorolac|ketorolac|mesh-list
2054606|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2054607|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2054608|NCT01736358|Analgesics|analgesics|mesh-ancestor
2054609|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
2054610|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054611|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054612|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2054613|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2054614|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2054615|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054616|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054617|NCT01736475|Factor VIII|factor viii|mesh-list
2054618|NCT01736475|BAX 855|bax 855|mesh-list
2054619|NCT01736475|Coagulants|coagulants|mesh-ancestor
2054620|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2054621|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2054622|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
2054623|NCT01736579|Antibodies|antibodies|mesh-list
2054624|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
2054625|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2054626|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2054627|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
2054628|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054629|NCT01736696|Tofacitinib|tofacitinib|mesh-list
2054630|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2054631|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054632|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054633|NCT01736852|Oxytocin|oxytocin|mesh-list
2054634|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
2209623|NCT00014937|Zidovudine|zidovudine|mesh-list
2209624|NCT00014937|Stavudine|stavudine|mesh-list
2209625|NCT00014937|Didanosine|didanosine|mesh-list
2209626|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2209627|NCT00014937|Efavirenz|efavirenz|mesh-list
2209628|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2209629|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2209630|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
2054635|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2054636|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054637|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
2054638|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2054639|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054640|NCT01736865|Vitamins|vitamins|mesh-ancestor
2054641|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
2054642|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2054643|NCT01736917|Dexamethasone|dexamethasone|mesh-list
2054644|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
2054645|NCT01736917|Aprepitant|aprepitant|mesh-list
2054646|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2054647|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
2054648|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
2054649|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054650|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054651|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2054652|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
2054653|NCT01736917|Hormones|hormones|mesh-ancestor
2054654|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2054655|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2054656|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054657|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2054658|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054659|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054660|NCT01736943|Doxorubicin|doxorubicin|mesh-list
2054661|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2054662|NCT01736943|Bortezomib|bortezomib|mesh-list
2054663|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2054664|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054665|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2054666|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2054667|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054668|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054669|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2054670|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
2054671|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2054672|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2054673|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2209631|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054674|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2054675|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054676|NCT01737593|Acetaminophen|acetaminophen|mesh-list
2054677|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2054678|NCT01737593|Analgesics|analgesics|mesh-ancestor
2054679|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
2054680|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054681|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054682|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
2054683|NCT01737710|Vaccines|vaccines|mesh-list
2054684|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
2054685|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054686|NCT01737840|Pantoprazole|pantoprazole|mesh-list
2054687|NCT01737840|Ranitidine|ranitidine|mesh-list
2054688|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2209632|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209633|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2209634|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2209635|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
2747396|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2747397|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2747398|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747399|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054689|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2054690|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2054691|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2054692|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054693|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054694|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2054695|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
2054696|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
2054697|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054698|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054699|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
2054700|NCT01737879|Hematinics|hematinics|mesh-ancestor
2054701|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
2054702|NCT01737931|Promethazine|promethazine|mesh-list
2054703|NCT01737931|Dexamethasone|dexamethasone|mesh-list
2054704|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2054705|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
2054706|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2054707|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
2054708|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
2054709|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2747400|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2747401|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2747402|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2747403|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2747404|NCT05100654|Renal Agents|renal agents|mesh-ancestor
2054710|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054711|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2054712|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
2054713|NCT01737931|Hormones|hormones|mesh-ancestor
2054714|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2054715|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2054716|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054717|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2054718|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2054719|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2054720|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
2054721|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
2054722|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
2054723|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
2054724|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054725|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054726|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2054727|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
2054728|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
2054729|NCT01737944|Methotrexate|methotrexate|mesh-list
2054730|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2054731|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
2054732|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2054733|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054734|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2054735|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
2054736|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054737|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054738|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
2054739|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054740|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2054741|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2054742|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
2054743|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2054744|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2054745|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2054746|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2054747|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2054748|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2054749|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054750|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
2054751|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054752|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054753|NCT01738503|Buprenorphine|buprenorphine|mesh-list
2054754|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2054755|NCT01738503|Narcotics|narcotics|mesh-ancestor
2054756|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2209636|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209637|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2209638|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2054757|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054758|NCT01738503|Analgesics|analgesics|mesh-ancestor
2054759|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
2054760|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054761|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2054762|NCT01738594|Romidepsin|romidepsin|mesh-list
2054763|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2054764|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054765|NCT01738646|Bevacizumab|bevacizumab|mesh-list
2054766|NCT01738646|Vorinostat|vorinostat|mesh-list
2054767|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2054768|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054769|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2054770|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2054771|NCT01738646|Growth Substances|growth substances|mesh-ancestor
2054772|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054773|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
2054774|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2054775|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054776|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054777|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
2054778|NCT01738672|Entonox|entonox|mesh-list
2054779|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2054780|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
2054781|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
2054782|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2054783|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054784|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2054785|NCT01738672|Analgesics|analgesics|mesh-ancestor
2054786|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
2054787|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2747414|NCT05093517|Volagidemab|volagidemab|mesh-list
2747415|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2747416|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747417|NCT05089370|Nivolumab|nivolumab|mesh-list
2747418|NCT05089370|Decitabine|decitabine|mesh-list
2054788|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2054789|NCT01738971|Progestins|progestins|mesh-list
2054790|NCT01738971|Hormones|hormones|mesh-ancestor
2054791|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2054792|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209639|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2209640|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2209641|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
2209642|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2209643|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2209644|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2209645|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2209646|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2209647|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
2209648|NCT00014989|Analgesics|analgesics|mesh-ancestor
2209649|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
2747419|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2054793|NCT01739335|Mifepristone|mifepristone|mesh-list
2054794|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2054795|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
2054796|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2054797|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054798|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2054799|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2054800|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2054801|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
2054802|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2054803|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2054804|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
2054805|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2054806|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
2054807|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2054808|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2054809|NCT01739361|Acetaminophen|acetaminophen|mesh-list
2054810|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2054811|NCT01739361|Analgesics|analgesics|mesh-ancestor
2054812|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
2054813|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054814|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054815|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
2054816|NCT01739400|Macitentan|macitentan|mesh-list
2054817|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2054818|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2747420|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747421|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2747422|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747423|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2747424|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
2054819|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054820|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2054821|NCT01739595|Enclomiphene|enclomiphene|mesh-list
2054822|NCT01739595|Clomiphene|clomiphene|mesh-list
2054823|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
2054824|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2054825|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
2054826|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2747425|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054827|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054828|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2054829|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
2054830|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2054831|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2054832|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2054833|NCT01739699|Acetaminophen|acetaminophen|mesh-list
2054834|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2054835|NCT01739699|Analgesics|analgesics|mesh-ancestor
2054836|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
2054837|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054838|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054839|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
2054840|NCT01739764|Vemurafenib|vemurafenib|mesh-list
2054841|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054842|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2054843|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054844|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054845|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
2054846|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2054847|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
2054848|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2054849|NCT01739790|Expectorants|expectorants|mesh-ancestor
2054850|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
2054851|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2054852|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
2054853|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054854|NCT01739790|Protective Agents|protective agents|mesh-ancestor
2054855|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054856|NCT01739790|Antidotes|antidotes|mesh-ancestor
2054857|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
2054858|NCT01739933|Propofol|propofol|mesh-list
2054859|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2054860|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2054861|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054862|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2054863|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
2054864|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
2054865|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2054866|NCT01739933|Analgesics|analgesics|mesh-ancestor
2054867|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
2054868|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054869|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2054870|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2054871|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2054872|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
2054873|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054874|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054875|NCT01740089|Ribavirin|ribavirin|mesh-list
2054876|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2054877|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
2054878|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054879|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
2054880|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2054881|NCT01740206|Methylphenidate|methylphenidate|mesh-list
2054882|NCT01740206|Amphetamine|amphetamine|mesh-list
2054883|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2054884|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054885|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2054886|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2054887|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2054888|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054889|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
2054890|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054891|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
2054892|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
2209650|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2747426|NCT05084859|Prednisone|prednisone|mesh-list
2747427|NCT05084859|Docetaxel|docetaxel|mesh-list
2747428|NCT05084859|Panitumumab|panitumumab|mesh-list
2747429|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747430|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
2747431|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
2747432|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
2747433|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747434|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2747435|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
2747436|NCT05084859|Hormones|hormones|mesh-ancestor
2054893|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054894|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
2054895|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2054896|NCT01740258|Bevacizumab|bevacizumab|mesh-list
2054897|NCT01740258|Temozolomide|temozolomide|mesh-list
2209651|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209652|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
2209653|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2209654|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2209655|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
2209656|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2209657|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2209658|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054898|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2054899|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054900|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2054901|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2054902|NCT01740258|Growth Substances|growth substances|mesh-ancestor
2054903|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054904|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
2054905|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2054906|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
2054907|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054908|NCT01740297|Ipilimumab|ipilimumab|mesh-list
2054909|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2054910|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2054911|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054912|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2054913|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054914|NCT01740323|Curcumin|curcumin|mesh-list
2054915|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2054916|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2054917|NCT01740323|Analgesics|analgesics|mesh-ancestor
2054918|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
2054919|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054920|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054921|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2054922|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2054923|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054924|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054925|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054926|NCT01740362|Tofacitinib|tofacitinib|mesh-list
2054927|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2054928|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054929|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054930|NCT01740388|Besifloxacin|besifloxacin|mesh-list
2054931|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2054932|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2054933|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2054934|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2054935|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054936|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054937|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054938|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
2054939|NCT01740401|Ipilimumab|ipilimumab|mesh-list
2054940|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2054941|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
2054942|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054943|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2054944|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2054945|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
2054946|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054947|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054948|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2054949|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2054950|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2054951|NCT01740414|Ibudilast|ibudilast|mesh-list
2054952|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2054953|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
2054954|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2054955|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054956|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2747437|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2747438|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747439|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2747440|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2747463|NCT05075161|Pirfenidone|pirfenidone|mesh-list
2747464|NCT05075161|Analgesics|analgesics|mesh-ancestor
2747465|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
2747466|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2747467|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747468|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2747469|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2747470|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2747471|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2747472|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054957|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
2054958|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2054959|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054960|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054961|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2054962|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
2054963|NCT01740427|Letrozole|letrozole|mesh-list
2054964|NCT01740427|Palbociclib|palbociclib|mesh-list
2054965|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2054966|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2054967|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2054968|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054969|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054970|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2054971|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
2054972|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2054973|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054974|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2054975|NCT01740713|Deferiprone|deferiprone|mesh-list
2054976|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2054977|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
2054978|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
2209659|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2209660|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
2209661|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2054979|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054980|NCT01740726|Fluoxetine|fluoxetine|mesh-list
2054981|NCT01740726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2054982|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2054983|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2054984|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2054985|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2054986|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
2054987|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2054988|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2054989|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
2054990|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2209662|NCT00015002|Betamethasone|betamethasone|mesh-list
2209663|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2209664|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
2209665|NCT00015002|Hormones|hormones|mesh-ancestor
2209666|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2209667|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209668|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2209669|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
2209670|NCT00015028|Buprenorphine|buprenorphine|mesh-list
2747491|NCT05071313|Vaccines|vaccines|mesh-list
2054991|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2054992|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2054993|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2054994|NCT01740791|Velpatasvir|velpatasvir|mesh-list
2054995|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
2054996|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2054997|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2747492|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
2054998|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2054999|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2055000|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2055001|NCT01741259|Meperidine|meperidine|mesh-list
2055002|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2055003|NCT01741259|Narcotics|narcotics|mesh-ancestor
2055004|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2055005|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055006|NCT01741259|Analgesics|analgesics|mesh-ancestor
2055007|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
2055008|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055009|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2055010|NCT01741454|Tamsulosin|tamsulosin|mesh-list
2055011|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2055012|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2055013|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2055014|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2055015|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
2055016|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055017|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055018|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055019|NCT01741454|Urological Agents|urological agents|mesh-ancestor
2055020|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2055021|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2055022|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
2055023|NCT01741532|Deferiprone|deferiprone|mesh-list
2055024|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2055025|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
2055026|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
2055027|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055028|NCT01741545|Interferons|interferons|mesh-list
2055029|NCT01741545|Ribavirin|ribavirin|mesh-list
2055030|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055031|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
2055032|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055033|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
2055034|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055035|NCT01741792|Blinatumomab|blinatumomab|mesh-list
2055036|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055037|NCT01742117|Clopidogrel|clopidogrel|mesh-list
2055038|NCT01742117|Ticagrelor|ticagrelor|mesh-list
2055039|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2055040|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2055041|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2055042|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2055043|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
2055044|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055045|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055046|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055047|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2055048|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2055049|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055050|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2055051|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055052|NCT01742286|Ceritinib|ceritinib|mesh-list
2055053|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055054|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2055055|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055056|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055057|NCT01742832|Citalopram|citalopram|mesh-list
2055058|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2055059|NCT01742832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2055060|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2055061|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2055062|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055063|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055064|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
2055065|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055066|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2055067|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
2055068|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2055069|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2055070|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2055071|NCT01742897|Fentanyl|fentanyl|mesh-list
2055072|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2055073|NCT01742897|Narcotics|narcotics|mesh-ancestor
2055074|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2055075|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055076|NCT01742897|Analgesics|analgesics|mesh-ancestor
2055077|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
2055078|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055079|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2055080|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2055081|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
2055082|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
2055083|NCT01743001|Macitentan|macitentan|mesh-list
2055084|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2055085|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2055086|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055087|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2055088|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2055089|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2055090|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2055091|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2055092|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2055093|NCT01743027|Analgesics|analgesics|mesh-ancestor
2055094|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
2055095|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209671|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2209672|NCT00015028|Naloxone|naloxone|mesh-list
2055096|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055097|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2055098|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2055099|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2055100|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2055101|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2055102|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
2055103|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
2055104|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055105|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055106|NCT01743131|Abatacept|abatacept|mesh-list
2055107|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2209673|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2209674|NCT00015028|Narcotics|narcotics|mesh-ancestor
2209675|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2209676|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209677|NCT00015028|Analgesics|analgesics|mesh-ancestor
2209678|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
2209679|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209680|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2209681|NCT00015041|Buprenorphine|buprenorphine|mesh-list
2209682|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2209683|NCT00015041|Narcotics|narcotics|mesh-ancestor
2209684|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2209685|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209686|NCT00015041|Analgesics|analgesics|mesh-ancestor
2747493|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747502|NCT05070156|Vaccines|vaccines|mesh-list
2747503|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
2747504|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747505|NCT05067920|Antibodies|antibodies|mesh-list
2747506|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
2747507|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747508|NCT05067894|Vaccines|vaccines|mesh-list
2747509|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
2747510|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055108|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055109|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055110|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2055111|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
2055112|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055113|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2055114|NCT01743521|Ribavirin|ribavirin|mesh-list
2055115|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
2055116|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055117|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
2055118|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055119|NCT01743560|Everolimus|everolimus|mesh-list
2055120|NCT01743560|Exemestane|exemestane|mesh-list
2055121|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055122|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2055123|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
2055124|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055125|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2055126|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2055127|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055128|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747525|NCT05061550|Durvalumab|durvalumab|mesh-list
2747526|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2747527|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055129|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2055130|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
2209687|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
2209688|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209689|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2209690|NCT00015054|Methylphenidate|methylphenidate|mesh-list
2209691|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2209692|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209693|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2209694|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2209695|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2209696|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209697|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
2209698|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209699|NCT00015067|Methylphenidate|methylphenidate|mesh-list
2209700|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2209701|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055131|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2055132|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
2055133|NCT01743677|Tofacitinib|tofacitinib|mesh-list
2055134|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2055135|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055136|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2055137|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2055138|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055139|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055140|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055141|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2055142|NCT01743729|Lifitegrast|lifitegrast|mesh-list
2055143|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2055144|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2055145|NCT01743859|Lenalidomide|lenalidomide|mesh-list
2055146|NCT01743859|Azacitidine|azacitidine|mesh-list
2055147|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
2055148|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055149|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2055150|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2055151|NCT01743859|Growth Substances|growth substances|mesh-ancestor
2055152|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
2055153|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055154|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2055155|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
2055156|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055157|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055158|NCT01743976|Donepezil|donepezil|mesh-list
2055159|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2055160|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055161|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055162|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
2055163|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055164|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055165|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
2055166|NCT01744093|Doxycycline|doxycycline|mesh-list
2055167|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2055168|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055169|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
2055170|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2055171|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2055172|NCT01744197|Lidocaine|lidocaine|mesh-list
2055173|NCT01744197|Tetracaine|tetracaine|mesh-list
2055174|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
2055175|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
2055176|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2055177|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209702|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2209703|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2209704|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2209705|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209706|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
2209707|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209708|NCT00015080|Naltrexone|naltrexone|mesh-list
2209709|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2209710|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2209711|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209712|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
2209713|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209714|NCT00015106|Lamotrigine|lamotrigine|mesh-list
2209715|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
2209716|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2209717|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2209718|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055178|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
2055179|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055180|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2055181|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2055182|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2055183|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2055184|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055185|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
2055186|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2209719|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2209720|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209721|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2209722|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2209723|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2209724|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2209725|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2055187|NCT01744353|Paclitaxel|paclitaxel|mesh-list
2055188|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055189|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055190|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2055191|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
2055192|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
2747545|NCT05053971|Entinostat|entinostat|mesh-list
2747546|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2747547|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747548|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2747549|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055193|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
2055194|NCT01744496|Rotigotine|rotigotine|mesh-list
2055195|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
2055196|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
2055197|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209726|NCT00015132|Sertraline|sertraline|mesh-list
2055198|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055199|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055200|NCT01744574|Progesterone|progesterone|mesh-list
2055201|NCT01744574|Progestins|progestins|mesh-ancestor
2055202|NCT01744574|Hormones|hormones|mesh-ancestor
2055203|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2055204|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055205|NCT01744704|Mitogens|mitogens|mesh-list
2055206|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
2209727|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
2055207|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055208|NCT01744730|Clindamycin|clindamycin|mesh-list
2055209|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
2055210|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
2055211|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2055212|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055213|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2055214|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055215|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055216|NCT01744782|Cysteamine|cysteamine|mesh-list
2747550|NCT05053828|Clopidogrel|clopidogrel|mesh-list
2747551|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2747552|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2747553|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2747554|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2747555|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
2747556|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2747557|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055217|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2055218|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055219|NCT01744821|Vitamin D|vitamin d|mesh-list
2055220|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
2055221|NCT01744821|Vitamins|vitamins|mesh-ancestor
2055222|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
2055223|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055224|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2747558|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747559|NCT05053087|Ropivacaine|ropivacaine|mesh-list
2747560|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
2747561|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
2747562|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2747563|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747564|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
2747565|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2747566|NCT05051189|Fentanyl|fentanyl|mesh-list
2747567|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2747568|NCT05051189|Narcotics|narcotics|mesh-ancestor
2747569|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2747570|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747571|NCT05051189|Analgesics|analgesics|mesh-ancestor
2747572|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
2747573|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2747574|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2747575|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2747576|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
2747577|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
2751247|NCT03991403|Paclitaxel|paclitaxel|mesh-list
2209728|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2209729|NCT00015132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2209730|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2209731|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2209732|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209733|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209734|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
2209735|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209736|NCT00015171|Buprenorphine|buprenorphine|mesh-list
2055225|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2055226|NCT01745055|Methotrexate|methotrexate|mesh-list
2055227|NCT01745055|Tofacitinib|tofacitinib|mesh-list
2055228|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2055229|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
2055230|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2055231|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055232|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2055233|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
2055234|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055235|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055236|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
2055237|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055238|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2055239|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2747583|NCT05045144|Vaccines|vaccines|mesh-list
2747584|NCT05045144|Immunologic Factors|immunologic factors|mesh-ancestor
2747585|NCT05045144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055240|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
2055241|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2055242|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2055243|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2055244|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
2055245|NCT01745094|Mirabegron|mirabegron|mesh-list
2055246|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2055247|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2055248|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
2055249|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055250|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055251|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055252|NCT01745094|Urological Agents|urological agents|mesh-ancestor
2055253|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2055254|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2055255|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2055256|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
2055257|NCT01745133|Calcitriol|calcitriol|mesh-list
2055258|NCT01745133|Clobetasol|clobetasol|mesh-list
2055259|NCT01745133|Calcipotriene|calcipotriene|mesh-list
2055260|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2055261|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
2055262|NCT01745133|Hormones|hormones|mesh-ancestor
2055263|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2055264|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055265|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
2055266|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2055267|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2055268|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2055269|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055270|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2055271|NCT01745133|Vitamins|vitamins|mesh-ancestor
2055272|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
2055273|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2055274|NCT01745367|Paclitaxel|paclitaxel|mesh-list
2055275|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2055276|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055277|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
2055278|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
2055279|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
2055280|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055281|NCT01745380|Phenylephrine|phenylephrine|mesh-list
2055282|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
2055283|NCT01745380|Tetracaine|tetracaine|mesh-list
2055284|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
2055285|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
2055286|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2055287|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055288|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
2055289|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055290|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2055291|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2055292|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
2055293|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055294|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055295|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
2055296|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
2055297|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
2055298|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2055299|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
2055300|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2055301|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
2055302|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2055303|NCT01745380|Protective Agents|protective agents|mesh-ancestor
2055304|NCT01745822|Tenofovir|tenofovir|mesh-list
2055305|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
2055306|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055307|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2209737|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2209738|NCT00015171|Naloxone|naloxone|mesh-list
2209739|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2209740|NCT00015171|Narcotics|narcotics|mesh-ancestor
2209741|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2747602|NCT05037500|Decitabine|decitabine|mesh-list
2055308|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2055309|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055310|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055311|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2055312|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2055313|NCT01746043|Minocycline|minocycline|mesh-list
2055314|NCT01746043|Modafinil|modafinil|mesh-list
2055315|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2055316|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055317|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2055318|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055319|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2055320|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2055321|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2055322|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055323|NCT01746095|Vancomycin|vancomycin|mesh-list
2055324|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2055325|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055326|NCT01746173|Gemcitabine|gemcitabine|mesh-list
2055327|NCT01746173|Plerixafor|plerixafor|mesh-list
2055328|NCT01746173|Prednisone|prednisone|mesh-list
2055329|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
2055330|NCT01746173|Melphalan|melphalan|mesh-list
2055331|NCT01746173|Busulfan|busulfan|mesh-list
2055332|NCT01746173|Doxorubicin|doxorubicin|mesh-list
2055333|NCT01746173|Etoposide|etoposide|mesh-list
2055334|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
2055335|NCT01746173|Vincristine|vincristine|mesh-list
2055336|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2055337|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
2055338|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055339|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2055340|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2055341|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
2747603|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2747604|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
2747605|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747606|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747607|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055342|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055343|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055344|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2055345|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2055346|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
2055347|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
2055348|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055349|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055350|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2055351|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2055352|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2055353|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2055354|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
2055355|NCT01746173|Hormones|hormones|mesh-ancestor
2055356|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2055357|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2055358|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2055359|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
2055360|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
2055361|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
2055362|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2055363|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2055364|NCT01746225|Paclitaxel|paclitaxel|mesh-list
2055365|NCT01746225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2055366|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2055367|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055368|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
2055369|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
2055370|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
2055371|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055372|NCT01746264|Vitamin D|vitamin d|mesh-list
2055373|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
2055374|NCT01746264|Vitamins|vitamins|mesh-ancestor
2055375|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
2055376|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055377|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2055378|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2055379|NCT01746420|Becaplermin|becaplermin|mesh-list
2055380|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
2055381|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2055382|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2055383|NCT01746420|Growth Substances|growth substances|mesh-ancestor
2055384|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055385|NCT01746511|Glycerol|glycerol|mesh-list
2055386|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2055387|NCT01746511|Protective Agents|protective agents|mesh-ancestor
2209742|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209743|NCT00015171|Analgesics|analgesics|mesh-ancestor
2209744|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
2055388|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055389|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
2055390|NCT01746732|Evacetrapib|evacetrapib|mesh-list
2209745|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209746|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2055391|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2055392|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2055393|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2055394|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
2055395|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055396|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2055397|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2055398|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055399|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2055400|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2055401|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055402|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055403|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2055404|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
2055405|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2055406|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055407|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2055408|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2055409|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2055410|NCT01746901|Naltrexone|naltrexone|mesh-list
2055411|NCT01746901|Oxycodone|oxycodone|mesh-list
2055412|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2055413|NCT01746901|Narcotics|narcotics|mesh-ancestor
2055414|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2747624|NCT05031078|Lidocaine|lidocaine|mesh-list
2747625|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747626|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
2055415|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055416|NCT01746901|Analgesics|analgesics|mesh-ancestor
2055417|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
2055418|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055419|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2055420|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2055421|NCT01746940|Cocaine|cocaine|mesh-list
2055422|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2055423|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
2747627|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
2747628|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2747629|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
2747630|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2747631|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2747632|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2747633|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2747634|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2747635|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055424|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
2055425|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2055426|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055427|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
2055428|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055429|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2055430|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2055431|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2055432|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2055433|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055434|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
2055435|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055436|NCT01746979|Gemcitabine|gemcitabine|mesh-list
2055437|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2055438|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
2055439|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055440|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055441|NCT01746979|Antiviral Agents|antiviral agents|mesh-ancestor
2055442|NCT01746979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055443|NCT01746979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055444|NCT01746979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2055445|NCT01746979|Immunologic Factors|immunologic factors|mesh-ancestor
2055446|NCT01746979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055447|NCT01747330|Pancreatin|pancreatin|mesh-list
2055448|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2055449|NCT01747447|Vitamin D|vitamin d|mesh-list
2209747|NCT00015210|Nefazodone|nefazodone|mesh-list
2055450|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
2055451|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
2055452|NCT01747447|Vitamins|vitamins|mesh-list
2055453|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
2055454|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055455|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2055456|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2055457|NCT01747499|Azacitidine|azacitidine|mesh-list
2055458|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2055459|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
2209748|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2209749|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2209750|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2209751|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209752|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209753|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209754|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2209755|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
2209756|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2209757|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2209758|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2209759|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
2209760|NCT00015223|Methylphenidate|methylphenidate|mesh-list
2209761|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2209762|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209763|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2209764|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2209765|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2209766|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209767|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
2209768|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209769|NCT00015236|Amantadine|amantadine|mesh-list
2209770|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2209771|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2209772|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
2209773|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209774|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
2751248|NCT03991403|Bevacizumab|bevacizumab|mesh-list
2055460|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055461|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055462|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055463|NCT01747551|Leucovorin|leucovorin|mesh-list
2055464|NCT01747551|Fluorouracil|fluorouracil|mesh-list
2055465|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
2055466|NCT01747551|Aflibercept|aflibercept|mesh-list
2055467|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
2055468|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055469|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2055470|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055471|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2055472|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
2209775|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209776|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209777|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055473|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055474|NCT01747551|Antidotes|antidotes|mesh-ancestor
2055475|NCT01747551|Protective Agents|protective agents|mesh-ancestor
2055476|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
2055477|NCT01747551|Vitamins|vitamins|mesh-ancestor
2055478|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
2055479|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2055480|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2055481|NCT01747551|Growth Substances|growth substances|mesh-ancestor
2055482|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
2055483|NCT01747629|Albuterol|albuterol|mesh-list
2055484|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2055485|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
2055486|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055487|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055488|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2055489|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
2055490|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
2055491|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2055492|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2055493|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2055494|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2055495|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
2055496|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055497|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055498|NCT01747850|Ethanol|ethanol|mesh-list
2055499|NCT01747850|Nabiximols|nabiximols|mesh-list
2055500|NCT01747850|Dronabinol|dronabinol|mesh-list
2055501|NCT01747850|Cannabidiol|cannabidiol|mesh-list
2055502|NCT01747850|Peppermint oil|peppermint oil|mesh-list
2055503|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2055504|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055505|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2055506|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055507|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
2055508|NCT01747850|Analgesics|analgesics|mesh-ancestor
2055509|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
2055510|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055511|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
2055512|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2055513|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2055514|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2055515|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2055516|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055517|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055518|NCT01747850|Hormones|hormones|mesh-ancestor
2055519|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2055520|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
2055521|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
2055522|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2055523|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
2055524|NCT01747915|Pregabalin|pregabalin|mesh-list
2055525|NCT01747915|Analgesics|analgesics|mesh-ancestor
2055526|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
2055527|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055528|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209778|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2209779|NCT00015236|Analgesics|analgesics|mesh-ancestor
2209780|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
2209781|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209782|NCT00015249|Amantadine|amantadine|mesh-list
2209783|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2209784|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2209785|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
2055529|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
2055530|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2055531|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2055532|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055533|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2055534|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2055535|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2055536|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2055537|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2055538|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
2055539|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2209786|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055540|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
2055541|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209787|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
2055542|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055543|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2055544|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
2055545|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2055546|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
2055547|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055548|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055549|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2055550|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
2055551|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
2055552|NCT01748045|Protective Agents|protective agents|mesh-ancestor
2055553|NCT01748240|Azacitidine|azacitidine|mesh-list
2055554|NCT01748240|Vorinostat|vorinostat|mesh-list
2055555|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2055556|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
2055557|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055558|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055559|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055560|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2055561|NCT01748292|Ranibizumab|ranibizumab|mesh-list
2055562|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2055563|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2055564|NCT01748292|Growth Substances|growth substances|mesh-ancestor
2055565|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055566|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
2055567|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055568|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
2055569|NCT01748643|Rocuronium|rocuronium|mesh-list
2055570|NCT01748643|Neostigmine|neostigmine|mesh-list
2055571|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2055572|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2055573|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2751249|NCT03991403|Carboplatin|carboplatin|mesh-list
2209788|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209789|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209790|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209791|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2055574|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055575|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055576|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2055577|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055578|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055579|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
2055580|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055581|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2055582|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
2055583|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2055584|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2055585|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2055586|NCT01748799|Ethanol|ethanol|mesh-list
2055587|NCT01748799|Nabiximols|nabiximols|mesh-list
2055588|NCT01748799|Dronabinol|dronabinol|mesh-list
2055589|NCT01748799|Cannabidiol|cannabidiol|mesh-list
2055590|NCT01748799|Peppermint oil|peppermint oil|mesh-list
2055591|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2055592|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055593|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2055594|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055595|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
2055596|NCT01748799|Analgesics|analgesics|mesh-ancestor
2055597|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
2055598|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055599|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
2055600|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2055601|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2055602|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2055603|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2055604|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055605|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055606|NCT01748799|Hormones|hormones|mesh-ancestor
2055607|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2055608|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
2055609|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
2055610|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2055611|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
2055612|NCT01748825|Adavosertib|adavosertib|mesh-list
2055613|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055614|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055615|NCT01748942|Dexamethasone|dexamethasone|mesh-list
2055616|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
2055617|NCT01748942|Ichthammol|ichthammol|mesh-list
2055618|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2055619|NCT01748942|BB 1101|bb 1101|mesh-list
2055620|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2055621|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
2055622|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
2055623|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055624|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055625|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2055626|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
2055627|NCT01748942|Hormones|hormones|mesh-ancestor
2055628|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2055629|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2055630|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055631|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
2055632|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055633|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055634|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
2055635|NCT01748955|Bupropion|bupropion|mesh-list
2055636|NCT01748955|Paroxetine|paroxetine|mesh-list
2055637|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2055638|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
2055639|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2055640|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2055641|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2055642|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2055643|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055644|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
2055645|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055646|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055647|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2055648|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2055649|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055650|NCT01748955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2055651|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
2055652|NCT01748994|Pioglitazone|pioglitazone|mesh-list
2055653|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2055654|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055655|NCT01749215|Topiramate|topiramate|mesh-list
2055656|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
2055657|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2055658|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055659|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
2055660|NCT01749293|Busulfan|busulfan|mesh-list
2055661|NCT01749293|Fludarabine|fludarabine|mesh-list
2055662|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2055663|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
2055664|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055665|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2055666|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2055667|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
2055668|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055669|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055670|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2055671|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
2055672|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2055673|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2055674|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2055675|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2055676|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055677|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
2055678|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055679|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055680|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2747665|NCT05028075|Cobalt|cobalt|mesh-list
2209792|NCT00015249|Analgesics|analgesics|mesh-ancestor
2209793|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
2209794|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209795|NCT00015275|Cocaine|cocaine|mesh-list
2209796|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
2055681|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055682|NCT01749501|Rocuronium|rocuronium|mesh-list
2055683|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2055684|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2055685|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2055686|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055687|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055688|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
2055689|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
2055690|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2055691|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055692|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2055693|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2055694|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055695|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055696|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055697|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2055698|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2055699|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2055700|NCT01749605|Renal Agents|renal agents|mesh-ancestor
2055701|NCT01749904|Timolol|timolol|mesh-list
2055702|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2055703|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2055704|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
2055705|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055706|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055707|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055708|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2055709|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2055710|NCT01749930|Timolol|timolol|mesh-list
2055711|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2055712|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2055713|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
2055714|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055715|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055716|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055717|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2055718|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2055719|NCT01749956|Leucovorin|leucovorin|mesh-list
2055720|NCT01749956|Fluorouracil|fluorouracil|mesh-list
2055721|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
2055722|NCT01749956|Aflibercept|aflibercept|mesh-list
2055723|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
2055724|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055725|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2055726|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055727|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2055728|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
2055729|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055730|NCT01749956|Antidotes|antidotes|mesh-ancestor
2055731|NCT01749956|Protective Agents|protective agents|mesh-ancestor
2055732|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
2055733|NCT01749956|Vitamins|vitamins|mesh-ancestor
2055734|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
2055735|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2055736|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2055737|NCT01749956|Growth Substances|growth substances|mesh-ancestor
2747666|NCT05028075|Trace Elements|trace elements|mesh-ancestor
2747667|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
2747668|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209797|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
2209798|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2209799|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055738|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
2055739|NCT01749982|Choline|choline|mesh-list
2055740|NCT01749982|Betaine|betaine|mesh-list
2055741|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
2055742|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2055743|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
2055744|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055745|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2055746|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2055747|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
2055748|NCT01750086|Denosumab|denosumab|mesh-list
2055749|NCT01750086|Alendronate|alendronate|mesh-list
2055750|NCT01750086|Teriparatide|teriparatide|mesh-list
2055751|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2055752|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055753|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2055754|NCT01750268|Topiramate|topiramate|mesh-list
2055755|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
2055756|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2055757|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055764|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
2055765|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2055766|NCT01750294|Diuretics|diuretics|mesh-ancestor
2055767|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
2055768|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055769|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2055770|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2055771|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055772|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
2055773|NCT01750398|Leuprolide|leuprolide|mesh-list
2055774|NCT01750398|Goserelin|goserelin|mesh-list
2055775|NCT01750398|Testosterone|testosterone|mesh-list
2055776|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
2055777|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
2055778|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2055779|NCT01750398|Androgens|androgens|mesh-ancestor
2055780|NCT01750398|Hormones|hormones|mesh-ancestor
2055781|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2055782|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055783|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2055784|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055785|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
2055786|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2055787|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
2055788|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2055789|NCT01750697|Rituximab|rituximab|mesh-list
2055790|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2055791|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055792|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
2055793|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055794|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2055795|NCT01750840|Cimetidine|cimetidine|mesh-list
2055796|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2055797|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2055798|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2055799|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
2055800|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
2055801|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2751250|NCT03991403|Pemetrexed|pemetrexed|mesh-list
2747690|NCT05026905|Leucovorin|leucovorin|mesh-list
2747691|NCT05026905|Gemcitabine|gemcitabine|mesh-list
2747692|NCT05026905|Paclitaxel|paclitaxel|mesh-list
2747693|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2747694|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
2747695|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2747696|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747697|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
2747698|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
2747699|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
2747700|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747701|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2747702|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
2747703|NCT05026905|Antiviral Agents|antiviral agents|mesh-ancestor
2747704|NCT05026905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2747705|NCT05026905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2747706|NCT05026905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2747707|NCT05026905|Immunologic Factors|immunologic factors|mesh-ancestor
2747708|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747709|NCT05026905|Antidotes|antidotes|mesh-ancestor
2747710|NCT05026905|Protective Agents|protective agents|mesh-ancestor
2747711|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
2747712|NCT05026905|Vitamins|vitamins|mesh-ancestor
2747713|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
2747714|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2747715|NCT05024188|Metronidazole|metronidazole|mesh-list
2747716|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
2747717|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2747718|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2747719|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2747720|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2747721|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2747722|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2747723|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747724|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747725|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2747726|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2747808|NCT05006079|Morphine|morphine|mesh-list
2747809|NCT05006079|Alprazolam|alprazolam|mesh-list
2747810|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2747811|NCT05006079|Narcotics|narcotics|mesh-ancestor
2747812|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2747813|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747814|NCT05006079|Analgesics|analgesics|mesh-ancestor
2747815|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
2747816|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2747817|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2747818|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2747819|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2747820|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2747821|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
2747822|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
2747823|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2747824|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747825|NCT05005507|Tenofovir|tenofovir|mesh-list
2209800|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
2209801|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055802|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055803|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055804|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2055805|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2055806|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055807|NCT01750918|Fluorouracil|fluorouracil|mesh-list
2055808|NCT01750918|Panitumumab|panitumumab|mesh-list
2055809|NCT01750918|Trametinib|trametinib|mesh-list
2055810|NCT01750918|Dabrafenib|dabrafenib|mesh-list
2055811|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
2055812|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055813|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2055814|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055815|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2055816|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
2055817|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055818|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2055819|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2055820|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055821|NCT01750931|Meloxicam|meloxicam|mesh-list
2055822|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2055823|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2055824|NCT01750931|Analgesics|analgesics|mesh-ancestor
2055825|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
2055826|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055827|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055828|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2747826|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2747827|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
2747828|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2747829|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2747830|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2747831|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2747832|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747833|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2747834|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2747838|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2747839|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2747840|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2747841|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2747842|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
2747843|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747844|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2747845|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2747846|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2747847|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2747848|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2747849|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
2747850|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2747851|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
2055829|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2055830|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2055831|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2055832|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055833|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055834|NCT01751087|Vitamins|vitamins|mesh-list
2055835|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
2055836|NCT01751087|Misoprostol|misoprostol|mesh-list
2055837|NCT01751087|Mifepristone|mifepristone|mesh-list
2055838|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
2055839|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055840|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2055841|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
2055842|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2055843|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2055844|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2055845|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
2055846|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
2055847|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2055848|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2055849|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2055850|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2055851|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
2055852|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2055853|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2055854|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
2055855|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2055856|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
2055857|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2055858|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2055859|NCT01751113|Fluticasone|fluticasone|mesh-list
2055860|NCT01751113|Xhance|xhance|mesh-list
2055861|NCT01751113|Bromides|bromides|mesh-list
2055862|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
2055863|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2055864|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2055865|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2055866|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2055867|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
2055868|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055869|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055870|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2055871|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
2055872|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
2055873|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2055874|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
2055875|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2055876|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
2055877|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055878|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055879|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2055880|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2055881|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2055882|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
2055883|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
2055884|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
2055885|NCT01751113|Hormones|hormones|mesh-ancestor
2055886|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2055887|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
2055888|NCT01751178|Ethanol|ethanol|mesh-list
2055889|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
2055890|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2055891|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2055892|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055893|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2055894|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055895|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
2055896|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
2055897|NCT01751386|Baclofen|baclofen|mesh-list
2055898|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2055899|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055900|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2055901|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2055902|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2055903|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
2055904|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
2055905|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055906|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055907|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
2055908|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055909|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2055910|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055911|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055912|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
2055913|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2055914|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055915|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2055916|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
2055917|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2055918|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2055919|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
2055920|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055921|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2055922|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2055923|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055924|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055925|NCT01751646|Vitamin D|vitamin d|mesh-list
2055926|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
2055927|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
2055928|NCT01751646|Vitamins|vitamins|mesh-list
2055929|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
2055930|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055931|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2055932|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2055933|NCT01751724|Caffeine|caffeine|mesh-list
2055934|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
2751251|NCT03991403|Atezolizumab|atezolizumab|mesh-list
2055935|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055936|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2055937|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055938|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2055939|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055940|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2055941|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2055942|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
2055943|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055944|NCT01751802|Ecopipam|ecopipam|mesh-list
2055945|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2055946|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2055947|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2055948|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055949|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2055950|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2055951|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
2055952|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2055953|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055954|NCT01751867|Decitabine|decitabine|mesh-list
2055955|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2055956|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
2055957|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055958|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055959|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055960|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
2055961|NCT01752413|Hematinics|hematinics|mesh-ancestor
2055962|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
2055963|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055964|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2055965|NCT01752426|Protective Agents|protective agents|mesh-ancestor
2055966|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055967|NCT01752712|Oxytocin|oxytocin|mesh-list
2055968|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
2055969|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2055970|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055971|NCT01752842|Fenofibrate|fenofibrate|mesh-list
2055972|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2055973|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
2055974|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055975|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2055976|NCT01752855|Adalimumab|adalimumab|mesh-list
2055977|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2055978|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2055979|NCT01752933|Guadecitabine|guadecitabine|mesh-list
2055980|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055981|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
2055982|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2055983|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2055984|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2055985|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2055986|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2055987|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2055988|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2055989|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2055990|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2055991|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2055992|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
2055993|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2055994|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
2055995|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2055996|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2055997|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2055998|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2055999|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056000|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
2056001|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2056002|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2056003|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2056004|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2056005|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056006|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
2056007|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056008|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056009|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2056010|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056011|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
2056012|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2056013|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2056014|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2056015|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2056016|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056017|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
2056018|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056019|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056020|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2056021|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056022|NCT01753362|Liraglutide|liraglutide|mesh-list
2056023|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2056024|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056025|NCT01753362|Incretins|incretins|mesh-ancestor
2056026|NCT01753362|Hormones|hormones|mesh-ancestor
2056027|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2056028|NCT01753401|Prednisone|prednisone|mesh-list
2056029|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2056030|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2056031|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
2056032|NCT01753401|Hormones|hormones|mesh-ancestor
2056033|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2056034|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056035|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2056036|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056037|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
2056038|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2056039|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
2056040|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056041|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056042|NCT01753570|Interferon-beta|interferon-beta|mesh-list
2056043|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056044|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
2056045|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056046|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
2056047|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056048|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
2056049|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2747852|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747853|NCT04995029|Buprenorphine|buprenorphine|mesh-list
2747854|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2747855|NCT04995029|Narcotics|narcotics|mesh-ancestor
2747856|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2747857|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747858|NCT04995029|Analgesics|analgesics|mesh-ancestor
2747859|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
2747860|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056050|NCT01753856|Vitamin D|vitamin d|mesh-list
2056051|NCT01753856|Denosumab|denosumab|mesh-list
2056052|NCT01753856|Teriparatide|teriparatide|mesh-list
2747861|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2056053|NCT01753856|Tetracycline|tetracycline|mesh-list
2056054|NCT01753856|Demeclocycline|demeclocycline|mesh-list
2056055|NCT01753856|Calcium|calcium|mesh-list
2056056|NCT01753856|Vitamins|vitamins|mesh-ancestor
2056057|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
2056058|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056059|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2056060|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2056061|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2056062|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056063|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2056064|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056065|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056066|NCT01754259|Ranolazine|ranolazine|mesh-list
2056067|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2056068|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2056069|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056070|NCT01754376|Aldesleukin|aldesleukin|mesh-list
2056071|NCT01754376|Interleukin-2|interleukin-2|mesh-list
2056072|NCT01754376|Vemurafenib|vemurafenib|mesh-list
2056073|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056074|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2056075|NCT01754376|Analgesics|analgesics|mesh-ancestor
2056076|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
2056077|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056078|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056079|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2056080|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2056081|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
2056082|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056083|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2056084|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056085|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056086|NCT01754389|Sirolimus|sirolimus|mesh-list
2056087|NCT01754389|Methotrexate|methotrexate|mesh-list
2056088|NCT01754389|Bortezomib|bortezomib|mesh-list
2747885|NCT04982367|Sirolimus|sirolimus|mesh-list
2747886|NCT04982367|Paclitaxel|paclitaxel|mesh-list
2747887|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2747888|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2747889|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056089|NCT01754389|Tacrolimus|tacrolimus|mesh-list
2056090|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2056091|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
2056092|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2056093|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056094|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2056095|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
2056096|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056097|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056098|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
2056099|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056100|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2056101|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2056102|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
2056103|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2056104|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2056105|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2056106|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2056107|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056108|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2056109|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
2056110|NCT01754402|Dexamethasone|dexamethasone|mesh-list
2056111|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2056112|NCT01754402|Pomalidomide|pomalidomide|mesh-list
2056113|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2056114|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
2056115|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
2056116|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056117|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056118|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2056119|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
2056120|NCT01754402|Hormones|hormones|mesh-ancestor
2056121|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2056122|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2056123|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056124|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2056125|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
2056126|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056127|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
2056128|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2056129|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2056130|NCT01754402|Growth Substances|growth substances|mesh-ancestor
2056131|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
2056132|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2056133|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
2056134|NCT01754480|Coagulants|coagulants|mesh-ancestor
2056135|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2747890|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
2747891|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
2747892|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
2056136|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2056137|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2056138|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2056139|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056140|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056141|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056142|NCT01754493|Analgesics|analgesics|mesh-ancestor
2056143|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
2056144|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056145|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
2056146|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2056147|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
2056148|NCT01754623|Gemcitabine|gemcitabine|mesh-list
2056149|NCT01754623|Fluorouracil|fluorouracil|mesh-list
2056150|NCT01754623|Capecitabine|capecitabine|mesh-list
2056151|NCT01754623|Docetaxel|docetaxel|mesh-list
2056152|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2056153|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
2056154|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056155|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056156|NCT01754623|Antiviral Agents|antiviral agents|mesh-ancestor
2056157|NCT01754623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056158|NCT01754623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056159|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2056160|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
2056161|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056162|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
2056163|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
2056164|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
2056165|NCT01754909|Enalapril|enalapril|mesh-list
2056166|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2056167|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
2056168|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056169|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056170|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2056171|NCT01755026|Cefazolin|cefazolin|mesh-list
2056172|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2056173|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056174|NCT01755091|Dronabinol|dronabinol|mesh-list
2056175|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
2056176|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056177|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2056178|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2056179|NCT01755091|Analgesics|analgesics|mesh-ancestor
2056180|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
2056181|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056182|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2056183|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2056184|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056185|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056186|NCT01755091|Hormones|hormones|mesh-ancestor
2056187|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2056188|NCT01755156|Metformin|metformin|mesh-list
2056189|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
2056190|NCT01755156|Glimepiride|glimepiride|mesh-list
2056191|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2056192|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056193|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2056194|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2056195|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
2056196|NCT01755169|Ketamine|ketamine|mesh-list
2056197|NCT01755169|Analgesics|analgesics|mesh-ancestor
2056198|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
2056199|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056200|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056201|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2056202|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2056203|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
2056204|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
2056205|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2056206|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2056207|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2056208|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056209|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056210|NCT01755234|Propofol|propofol|mesh-list
2056211|NCT01755234|Sevoflurane|sevoflurane|mesh-list
2056212|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2056213|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2056214|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056215|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2056216|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
2056217|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
2056218|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2056219|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2056220|NCT01755416|Insulin|insulin|mesh-list
2056221|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2056222|NCT01755416|Liraglutide|liraglutide|mesh-list
2056223|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2056224|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056225|NCT01755416|Incretins|incretins|mesh-ancestor
2056226|NCT01755416|Hormones|hormones|mesh-ancestor
2056227|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2056228|NCT01755546|Buprenorphine|buprenorphine|mesh-list
2056229|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2056230|NCT01755546|Narcotics|narcotics|mesh-ancestor
2056231|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2056232|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056233|NCT01755546|Analgesics|analgesics|mesh-ancestor
2056234|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
2056235|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056236|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2056237|NCT01755637|Albendazole|albendazole|mesh-list
2056238|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
2056239|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2056240|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056241|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
2056242|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2056243|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2056244|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
2056245|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
2056246|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
2056247|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056248|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056249|NCT01755702|Acetaminophen|acetaminophen|mesh-list
2056250|NCT01755702|Ibuprofen|ibuprofen|mesh-list
2056251|NCT01755702|Caffeine|caffeine|mesh-list
2056252|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2056253|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2056254|NCT01755702|Analgesics|analgesics|mesh-ancestor
2056255|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
2056256|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056257|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056258|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2056259|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2056260|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2056261|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056262|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056263|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
2056264|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2056265|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2056266|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2056267|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2056268|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
2056269|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056270|NCT01755949|Colchicine|colchicine|mesh-list
2056271|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
2056272|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2056273|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
2056274|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
2056275|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
2056276|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056277|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056278|NCT01756079|Ribavirin|ribavirin|mesh-list
2056279|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2056280|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
2056281|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056282|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
2056283|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056284|NCT01756157|Complement C1s|complement c1s|mesh-list
2056285|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2056286|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2056287|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
2056288|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056289|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2056290|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2056291|NCT01756209|Acetaminophen|acetaminophen|mesh-list
2056292|NCT01756209|Ibuprofen|ibuprofen|mesh-list
2056293|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2056294|NCT01756209|Analgesics|analgesics|mesh-ancestor
2056295|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
2056296|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056297|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056298|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
2056299|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2056300|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2056301|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2056302|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2056303|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056304|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056305|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2056306|NCT01756456|Mitogens|mitogens|mesh-list
2056307|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
2056308|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056309|NCT01756833|Doxycycline|doxycycline|mesh-list
2056310|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2056311|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056312|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
2056313|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2056314|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2056315|NCT01756885|Varenicline|varenicline|mesh-list
2056316|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2056317|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2056318|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
2056319|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056320|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056321|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056322|NCT01757275|Esomeprazole|esomeprazole|mesh-list
2056323|NCT01757275|Cimetidine|cimetidine|mesh-list
2056324|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2056325|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2056326|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2056327|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056328|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056329|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2056330|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
2056331|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
2056332|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056333|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056334|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2056335|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2056336|NCT01757288|Paclitaxel|paclitaxel|mesh-list
2056337|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2056338|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2056339|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056340|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
2056341|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
2056342|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
2056343|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747893|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747894|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2747895|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2747896|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2747897|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
2747898|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2747899|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
2747900|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747901|NCT04980482|Interferons|interferons|mesh-list
2056350|NCT01757561|Propofol|propofol|mesh-list
2056351|NCT01757561|Sevoflurane|sevoflurane|mesh-list
2056352|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2056353|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2056354|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056355|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2056356|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
2056357|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
2056358|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2056359|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2056360|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2056361|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2056362|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056363|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2056364|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
2056365|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056366|NCT01758432|Apixaban|apixaban|mesh-list
2056367|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2056368|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
2056369|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2056370|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
2056371|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056372|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056373|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
2056374|NCT01758523|Dutasteride|dutasteride|mesh-list
2056375|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2056376|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2056377|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056378|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056379|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
2056380|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2056381|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056382|NCT01758588|Interferons|interferons|mesh-list
2056383|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
2056384|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2056385|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056386|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
2056387|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056388|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
2056389|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056390|NCT01758731|Cetuximab|cetuximab|mesh-list
2056391|NCT01758731|Olaparib|olaparib|mesh-list
2056392|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2056393|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056394|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2056395|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056396|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056397|NCT01759277|Anesthetics|anesthetics|mesh-list
2056398|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
2056399|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2056400|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056401|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
2747902|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
2747903|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
2747904|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2056402|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056403|NCT01759407|Epinephrine|epinephrine|mesh-list
2056404|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2056405|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2056406|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
2056407|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056408|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056409|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056410|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2056411|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2056412|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
2056413|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056414|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2056415|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
2056416|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
2056417|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
2056418|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2056419|NCT01759420|Ondansetron|ondansetron|mesh-list
2056420|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
2056421|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
2056422|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2747905|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747906|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
2747907|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2747908|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
2747909|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056423|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056424|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2056425|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
2056426|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
2056427|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2056428|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
2056429|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056430|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056431|NCT01759420|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2056432|NCT01759420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2056433|NCT01759420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2056434|NCT01759420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2056435|NCT01759420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2056436|NCT01759602|Complement C1s|complement c1s|mesh-list
2056437|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2056438|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2056439|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
2056440|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056441|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2056442|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2056443|NCT01759862|Aminophylline|aminophylline|mesh-list
2056444|NCT01759862|Theophylline|theophylline|mesh-list
2056445|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2056446|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
2056447|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056448|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056449|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2056450|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
2056451|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2056452|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056453|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056454|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
2056455|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2056456|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2056457|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
2056458|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056459|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2056460|NCT01759862|Protective Agents|protective agents|mesh-ancestor
2056461|NCT01760304|Budesonide|budesonide|mesh-list
2056462|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
2056463|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2209802|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2209803|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2209804|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2209805|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2209806|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209807|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
2056464|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2056465|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
2209808|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209809|NCT00015288|Buprenorphine|buprenorphine|mesh-list
2209810|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2209811|NCT00015288|Naloxone|naloxone|mesh-list
2209812|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2209813|NCT00015288|Narcotics|narcotics|mesh-ancestor
2209814|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2209815|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209816|NCT00015288|Analgesics|analgesics|mesh-ancestor
2056466|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056467|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056468|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2056469|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
2056470|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
2056471|NCT01760304|Hormones|hormones|mesh-ancestor
2056472|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2056473|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2056474|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2056475|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2056476|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
2056477|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056478|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056479|NCT01760447|Metformin|metformin|mesh-list
2056480|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2056481|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2056482|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056483|NCT01760447|Incretins|incretins|mesh-ancestor
2056484|NCT01760447|Hormones|hormones|mesh-ancestor
2056485|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2056486|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2056487|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
2056488|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056489|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056490|NCT01760785|Valproic Acid|valproic acid|mesh-list
2056491|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
2056492|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056493|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056494|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
2056495|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056496|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056497|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
2056498|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2056499|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2056500|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2056501|NCT01761266|Sorafenib|sorafenib|mesh-list
2056502|NCT01761266|Lenvatinib|lenvatinib|mesh-list
2056503|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056504|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2056505|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056506|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056507|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
2056508|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2056509|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056510|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056511|NCT01761747|Ponatinib|ponatinib|mesh-list
2056512|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209817|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
2209818|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209819|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2209820|NCT00015301|Methylphenidate|methylphenidate|mesh-list
2209821|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2209822|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209823|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2209824|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2209825|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2209826|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209827|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
2209828|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056513|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2056514|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056515|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056516|NCT01762059|Pancrelipase|pancrelipase|mesh-list
2056517|NCT01762059|Pancreatin|pancreatin|mesh-list
2056518|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2056519|NCT01762501|Amlodipine|amlodipine|mesh-list
2056520|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2056521|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2056522|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2056523|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2056524|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056525|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2056526|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056527|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
2056528|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2056529|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2056530|NCT01762800|Fluticasone|fluticasone|mesh-list
2056531|NCT01762800|Xhance|xhance|mesh-list
2056532|NCT01762800|Bromides|bromides|mesh-list
2056533|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
2056534|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2056535|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2056536|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2056537|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2056538|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
2056539|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056540|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056541|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2056542|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
2056543|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
2056544|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2056545|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
2056546|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2056547|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
2056548|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056549|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056550|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2056551|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2056552|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2056553|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
2056554|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
2056555|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
2056556|NCT01762800|Hormones|hormones|mesh-ancestor
2056557|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2056558|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
2056559|NCT01762904|Ethanol|ethanol|mesh-list
2056560|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
2056561|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2056562|NCT01762904|Triclosan|triclosan|mesh-list
2056563|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2056564|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056565|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2056566|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056567|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
2056568|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
2056569|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2056570|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2056571|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
2056572|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056573|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2056574|NCT01762943|Leuprolide|leuprolide|mesh-list
2056575|NCT01762943|Estradiol|estradiol|mesh-list
2056576|NCT01762943|Progesterone|progesterone|mesh-list
2056577|NCT01762943|Estrogens|estrogens|mesh-ancestor
2056578|NCT01762943|Hormones|hormones|mesh-ancestor
2056579|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2056580|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056581|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2056582|NCT01762943|Progestins|progestins|mesh-ancestor
2056583|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2056584|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
2056585|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2056586|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056587|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
2056588|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2056589|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056590|NCT01763164|Dacarbazine|dacarbazine|mesh-list
2056591|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2056592|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
2209829|NCT00015340|Buprenorphine|buprenorphine|mesh-list
2056593|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056594|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056595|NCT01763346|Metformin|metformin|mesh-list
2056596|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2056597|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056598|NCT01763606|Aspirin|aspirin|mesh-list
2056599|NCT01763606|Enoxaparin|enoxaparin|mesh-list
2056600|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2056601|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2056602|NCT01763606|Analgesics|analgesics|mesh-ancestor
2056603|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
2056604|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056605|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056606|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2056607|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2056608|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2056609|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2056610|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056611|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2056612|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2056613|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056614|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
2056615|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
2056616|NCT01763645|Paclitaxel|paclitaxel|mesh-list
2056617|NCT01763645|Bevacizumab|bevacizumab|mesh-list
2056618|NCT01763645|Carboplatin|carboplatin|mesh-list
2056619|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2056620|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056621|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
2056622|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
2056623|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
2056624|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056625|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2056626|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2056627|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2056628|NCT01763645|Growth Substances|growth substances|mesh-ancestor
2056629|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056630|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
2056644|NCT01763827|Ezetimibe|ezetimibe|mesh-list
2056645|NCT01763827|Evolocumab|evolocumab|mesh-list
2056646|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2056647|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2056648|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2056649|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
2056650|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056651|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2056652|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
2056653|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056654|NCT01763866|Atorvastatin|atorvastatin|mesh-list
2056655|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2056656|NCT01763866|Simvastatin|simvastatin|mesh-list
2056657|NCT01763866|Ezetimibe|ezetimibe|mesh-list
2056658|NCT01763866|Evolocumab|evolocumab|mesh-list
2056659|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2056660|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2056661|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2056662|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
2056663|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056664|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2056665|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2056666|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056667|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
2056668|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056669|NCT01763905|Ezetimibe|ezetimibe|mesh-list
2056670|NCT01763905|Evolocumab|evolocumab|mesh-list
2056671|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2056672|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2056673|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2056674|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
2056675|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056676|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2056677|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
2056678|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056679|NCT01763918|Evolocumab|evolocumab|mesh-list
2056680|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2056681|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2056682|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
2056683|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056684|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2056685|NCT01763931|Digoxin|digoxin|mesh-list
2747928|NCT04975152|Cemiplimab|cemiplimab|mesh-list
2056686|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2056687|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2056688|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056689|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056690|NCT01763931|Protective Agents|protective agents|mesh-ancestor
2056691|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056692|NCT01763996|Febuxostat|febuxostat|mesh-list
2056693|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
2056694|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2056695|NCT01764022|Paclitaxel|paclitaxel|mesh-list
2056696|NCT01764022|Trastuzumab|trastuzumab|mesh-list
2056697|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2056698|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056699|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
2056700|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
2056701|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
2056702|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056703|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2056704|NCT01764464|Gabapentin|gabapentin|mesh-list
2056705|NCT01764464|Analgesics|analgesics|mesh-ancestor
2056706|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
2056707|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2056708|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056709|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
2056710|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2056711|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2056712|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2056713|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2056714|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2056715|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2056716|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056717|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056718|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
2056719|NCT01764607|Sirolimus|sirolimus|mesh-list
2056720|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2056721|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056722|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2056723|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056724|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
2056725|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2056726|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
2056727|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056728|NCT01764633|Evolocumab|evolocumab|mesh-list
2056729|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2056730|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2056731|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
2056732|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056733|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2056734|NCT01764685|Topiramate|topiramate|mesh-list
2056735|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
2056736|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2056737|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056738|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
2056739|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2056740|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056741|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2056742|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2747929|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2747930|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2747931|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
2747932|NCT04973566|Etanercept|etanercept|mesh-list
2747933|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
2747934|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2747935|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2747936|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2747937|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2747938|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747939|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2747940|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2747941|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2747942|NCT04973566|Analgesics|analgesics|mesh-ancestor
2747943|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
2747944|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2747945|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747946|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2747947|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2056743|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056744|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056745|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056746|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2056747|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2056748|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
2056749|NCT01765179|Testosterone|testosterone|mesh-list
2056750|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
2056751|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
2056752|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2056753|NCT01765179|Androgens|androgens|mesh-ancestor
2056754|NCT01765179|Hormones|hormones|mesh-ancestor
2056755|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2056756|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056757|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2056758|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056759|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
2056760|NCT01765192|Montelukast|montelukast|mesh-list
2056761|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2056762|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
2056763|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2056764|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
2056765|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2056766|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056767|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2056768|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2056769|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056770|NCT01765270|Saxagliptin|saxagliptin|mesh-list
2056771|NCT01765270|Incretins|incretins|mesh-ancestor
2056772|NCT01765270|Hormones|hormones|mesh-ancestor
2056773|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2056774|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056775|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2056776|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
2056777|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056778|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056779|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2056780|NCT01765543|Rifampin|rifampin|mesh-list
2056781|NCT01765543|Vemurafenib|vemurafenib|mesh-list
2056782|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2056783|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
2056784|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2056785|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056786|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
2056787|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2056788|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056789|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056790|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2056791|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2056792|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2056793|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2056794|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2056795|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2056796|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056797|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2056798|NCT01765569|Vemurafenib|vemurafenib|mesh-list
2056799|NCT01765569|Digoxin|digoxin|mesh-list
2056800|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2056801|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2056802|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056803|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056804|NCT01765569|Protective Agents|protective agents|mesh-ancestor
2056805|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056806|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056807|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2056808|NCT01765582|Leucovorin|leucovorin|mesh-list
2056809|NCT01765582|Folic Acid|folic acid|mesh-list
2056810|NCT01765582|Bevacizumab|bevacizumab|mesh-list
2056811|NCT01765582|Fluorouracil|fluorouracil|mesh-list
2056812|NCT01765582|Capecitabine|capecitabine|mesh-list
2056813|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
2056814|NCT01765582|Irinotecan|irinotecan|mesh-list
2056815|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
2056816|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2056817|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056818|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2056819|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2056820|NCT01765582|Growth Substances|growth substances|mesh-ancestor
2056821|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056822|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
2056823|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
2056824|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056825|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2056826|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2056827|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
2056828|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2056829|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2056830|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056831|NCT01765582|Antidotes|antidotes|mesh-ancestor
2056832|NCT01765582|Protective Agents|protective agents|mesh-ancestor
2056833|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
2056834|NCT01765582|Vitamins|vitamins|mesh-ancestor
2056835|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
2056836|NCT01765582|Hematinics|hematinics|mesh-ancestor
2056837|NCT01765764|Bimatoprost|bimatoprost|mesh-list
2056838|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2056839|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2056840|NCT01765803|Thioridazine|thioridazine|mesh-list
2056841|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2056842|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2056843|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2056844|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056845|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2056846|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2056847|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
2056848|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056849|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056850|NCT01766024|Interferons|interferons|mesh-list
2056851|NCT01766024|Interferon-beta|interferon-beta|mesh-list
2056852|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
2056853|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056854|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
2056855|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056856|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
2056857|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056858|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2056859|NCT01766050|Abatacept|abatacept|mesh-list
2056860|NCT01766050|Losartan|losartan|mesh-list
2056861|NCT01766050|Midazolam|midazolam|mesh-list
2056862|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
2056863|NCT01766050|Caffeine|caffeine|mesh-list
2056864|NCT01766050|Omeprazole|omeprazole|mesh-list
2056865|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2056866|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2056867|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2056868|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056869|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2056870|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2056871|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2056872|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2056873|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
2056874|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
2056875|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
2056876|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
2056877|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056878|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056879|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2056880|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2056881|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2056882|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2056883|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2056884|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2056885|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2056886|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056887|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2056888|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2056889|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2056890|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2056891|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
2056892|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
2056893|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
2056894|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2056895|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2056896|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2056897|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056898|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2056899|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
2056900|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2056901|NCT01766076|Atorvastatin|atorvastatin|mesh-list
2056902|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2056903|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2056904|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
2056905|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056906|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2056907|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2056908|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056909|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
2056910|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
2056911|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056912|NCT01766219|Protective Agents|protective agents|mesh-ancestor
2056913|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056914|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
2056915|NCT01766219|Vitamins|vitamins|mesh-ancestor
2056916|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
2056917|NCT01766310|Folic Acid|folic acid|mesh-list
2056918|NCT01766310|Hematinics|hematinics|mesh-ancestor
2056919|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
2056920|NCT01766310|Vitamins|vitamins|mesh-ancestor
2056921|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
2056922|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056923|NCT01766336|Inositol|inositol|mesh-list
2056924|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
2056925|NCT01766336|Vitamins|vitamins|mesh-ancestor
2056926|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
2056927|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056928|NCT01766440|Calcitriol|calcitriol|mesh-list
2056929|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2056930|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056931|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2056932|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2056933|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056934|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2056935|NCT01766440|Vitamins|vitamins|mesh-ancestor
2056936|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
2056937|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2056938|NCT01766466|Ticagrelor|ticagrelor|mesh-list
2056939|NCT01766466|Cangrelor|cangrelor|mesh-list
2056940|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2056941|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2056942|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2056943|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2056944|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
2056945|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2056946|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056947|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056948|NCT01766713|Ezetimibe|ezetimibe|mesh-list
2056949|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2056950|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2056951|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
2056952|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056953|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2056954|NCT01766778|Metformin|metformin|mesh-list
2056955|NCT01766778|Vildagliptin|vildagliptin|mesh-list
2056956|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2056957|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2056958|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2056959|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
2056960|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056961|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056962|NCT01767103|Deferiprone|deferiprone|mesh-list
2056963|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2056964|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
2056965|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
2056966|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056967|NCT01767116|Ribavirin|ribavirin|mesh-list
2056968|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
2056969|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056970|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
2056971|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056972|NCT01767155|Doxorubicin|doxorubicin|mesh-list
2056973|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2056974|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2056975|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056976|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2056977|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2056978|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056979|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056980|NCT01767194|Sirolimus|sirolimus|mesh-list
2056981|NCT01767194|Irinotecan|irinotecan|mesh-list
2056982|NCT01767194|Camptothecin|camptothecin|mesh-list
2056983|NCT01767194|Temozolomide|temozolomide|mesh-list
2056984|NCT01767194|Dinutuximab|dinutuximab|mesh-list
2056985|NCT01767194|Sargramostim|sargramostim|mesh-list
2056986|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2056987|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2056988|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2056989|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2056990|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2056991|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2056992|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
2056993|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2056994|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2056995|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2056996|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
2056997|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2056998|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
2056999|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057000|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2057001|NCT01767285|Etonogestrel|etonogestrel|mesh-list
2057002|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2057003|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
2057004|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2057005|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057006|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2057007|NCT01767506|Azithromycin|azithromycin|mesh-list
2057008|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2057009|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057010|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
2057011|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
2057012|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2057013|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2057014|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2057015|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2057016|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057017|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
2057018|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057019|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057020|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2057021|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057022|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2057023|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2057024|NCT01767519|Urological Agents|urological agents|mesh-ancestor
2057025|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
2057026|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2057027|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2057028|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
2057029|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057030|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2057031|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2057032|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057033|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057034|NCT01767792|Bevacizumab|bevacizumab|mesh-list
2057035|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
2057036|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2057037|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057038|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2057039|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2057040|NCT01767792|Growth Substances|growth substances|mesh-ancestor
2057041|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057042|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
2057043|NCT01767909|Insulin|insulin|mesh-list
2057044|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2057045|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2057046|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057047|NCT01767987|Ranolazine|ranolazine|mesh-list
2057048|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2057049|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2057050|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057051|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2057052|NCT01768286|Ledipasvir|ledipasvir|mesh-list
2057053|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
2057054|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057055|NCT01768520|Celecoxib|celecoxib|mesh-list
2057056|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2057057|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2057058|NCT01768520|Analgesics|analgesics|mesh-ancestor
2057059|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
2057060|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057061|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057062|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057063|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2057064|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2057065|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2057066|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057067|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057068|NCT01768559|Insulin|insulin|mesh-list
2057069|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2057070|NCT01768559|Metformin|metformin|mesh-list
2057071|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
2057072|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
2057073|NCT01768559|Lixisenatide|lixisenatide|mesh-list
2057074|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2057075|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057076|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
2057077|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
2057078|NCT01768572|Methotrexate|methotrexate|mesh-list
2057079|NCT01768572|Leflunomide|leflunomide|mesh-list
2057080|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2057081|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
2057082|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2057083|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057084|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2057085|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
2057086|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057087|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057088|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
2057089|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057090|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2057091|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2057092|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
2057093|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2057094|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2057095|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
2057096|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2057097|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2057098|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057099|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2057100|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2057101|NCT01768572|Analgesics|analgesics|mesh-ancestor
2057102|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
2057103|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057104|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057105|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2057106|NCT01768637|Aspirin|aspirin|mesh-list
2057107|NCT01768637|Clopidogrel|clopidogrel|mesh-list
2057108|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2057109|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2057110|NCT01768637|Analgesics|analgesics|mesh-ancestor
2057111|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
2057112|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057113|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057114|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057115|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2057116|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2057117|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2057118|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057119|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2057120|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2057121|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057122|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
2057123|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2057124|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2057125|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2057126|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
2057127|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057128|NCT01768858|Adalimumab|adalimumab|mesh-list
2057129|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057130|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2057131|NCT01769170|Cidofovir|cidofovir|mesh-list
2057132|NCT01769170|Brincidofovir|brincidofovir|mesh-list
2057133|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
2057134|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057135|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057136|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057137|NCT01769209|Cytarabine|cytarabine|mesh-list
2057138|NCT01769209|Dexamethasone|dexamethasone|mesh-list
2057139|NCT01769209|Doxorubicin|doxorubicin|mesh-list
2057140|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2057141|NCT01769209|Methotrexate|methotrexate|mesh-list
2057142|NCT01769209|Vincristine|vincristine|mesh-list
2057143|NCT01769209|Bortezomib|bortezomib|mesh-list
2057144|NCT01769209|Asparaginase|asparaginase|mesh-list
2057145|NCT01769209|Pegaspargase|pegaspargase|mesh-list
2057146|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057147|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
2057148|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
2057149|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057150|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057151|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2057152|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
2057153|NCT01769209|Hormones|hormones|mesh-ancestor
2057154|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2057155|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2057156|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057157|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2057158|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2057159|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2057160|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057161|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057162|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2057163|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
2057164|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2057165|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2057166|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
2057167|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
2057168|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2057169|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2057170|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
2057171|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2057172|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2057173|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
2057174|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057175|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2057176|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
2057177|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
2057178|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
2057179|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2057180|NCT01769222|Ipilimumab|ipilimumab|mesh-list
2057181|NCT01769222|Antibodies|antibodies|mesh-list
2057182|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
2057183|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2057184|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
2057185|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057186|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057187|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2057188|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057189|NCT01769339|Miconazole|miconazole|mesh-list
2057190|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
2057191|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057192|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
2057193|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057194|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2057195|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2057196|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057197|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057198|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2057199|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
2057200|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2057201|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057202|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2057203|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2057204|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
2057205|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057206|NCT01769365|Amoxicillin|amoxicillin|mesh-list
2057207|NCT01769365|Metronidazole|metronidazole|mesh-list
2057208|NCT01769365|Clarithromycin|clarithromycin|mesh-list
2057209|NCT01769365|Pantoprazole|pantoprazole|mesh-list
2057210|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2057211|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057212|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2057213|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2057214|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2057215|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057216|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057217|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2057218|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2057219|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2057220|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2057221|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2057222|NCT01769378|Glimepiride|glimepiride|mesh-list
2057223|NCT01769378|Dulaglutide|dulaglutide|mesh-list
2057224|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2057225|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2057226|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057227|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2057228|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
2057229|NCT01769391|Paclitaxel|paclitaxel|mesh-list
2057230|NCT01769391|Carboplatin|carboplatin|mesh-list
2057231|NCT01769391|Necitumumab|necitumumab|mesh-list
2057232|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2057233|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057234|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
2057235|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
2057236|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
2057237|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057238|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2057239|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
2057240|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2057241|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057242|NCT01769456|Tenofovir|tenofovir|mesh-list
2057243|NCT01769456|Emtricitabine|emtricitabine|mesh-list
2057244|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2057245|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
2057246|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057247|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2057248|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2057249|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057250|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057251|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2057252|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2057253|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2057254|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2057255|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2057256|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057257|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057258|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
2057259|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057260|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2057261|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2057262|NCT01769508|Fluorouracil|fluorouracil|mesh-list
2057263|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
2057264|NCT01769508|Lapatinib|lapatinib|mesh-list
2057265|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
2057266|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057267|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2057268|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057269|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2057270|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
2057271|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057272|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2057273|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057274|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
2057275|NCT01769586|Promethazine|promethazine|mesh-list
2057276|NCT01769586|Midazolam|midazolam|mesh-list
2057277|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2057278|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2057279|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2057280|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057281|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2057282|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2057283|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2057284|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2057285|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
2057286|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
2057287|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
2057288|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
2057289|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2747948|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2057290|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057291|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2057292|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
2057293|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
2057294|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057295|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
2057296|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
2057297|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2057298|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2057299|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
2057300|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
2057301|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2057302|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
2057303|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
2057304|NCT01770145|Levodopa|levodopa|mesh-list
2057305|NCT01770145|Carbidopa|carbidopa|mesh-list
2057306|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2057307|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
2057308|NCT01770145|Apomorphine|apomorphine|mesh-list
2057309|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2057310|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2057311|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
2057312|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057313|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057314|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057315|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2057316|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057317|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2057318|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
2057319|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
2057320|NCT01770145|Emetics|emetics|mesh-ancestor
2057321|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
2057322|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057323|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2057324|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
2057325|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2057326|NCT01770353|Hematinics|hematinics|mesh-ancestor
2057327|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2057328|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2057329|NCT01770392|Rifampin|rifampin|mesh-list
2057330|NCT01770392|Nintedanib|nintedanib|mesh-list
2057331|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2057332|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
2057333|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2057334|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057335|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
2057336|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2057337|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057338|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057339|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2057340|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2057341|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2057342|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2057343|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2057344|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2057345|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057346|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2057347|NCT01770483|Interferons|interferons|mesh-list
2057348|NCT01770483|Ribavirin|ribavirin|mesh-list
2057349|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
2057350|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
2057351|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057352|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
2057353|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057354|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
2057355|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057356|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
2057357|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057358|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2057359|NCT01770652|Deferiprone|deferiprone|mesh-list
2057360|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2057361|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
2057362|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
2057363|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057364|NCT01770743|Vaccines|vaccines|mesh-list
2057365|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
2057366|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057367|NCT01770912|Triamcinolone|triamcinolone|mesh-list
2057368|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2057369|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2057370|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2057371|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057372|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
2057373|NCT01770912|Hormones|hormones|mesh-ancestor
2057374|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2057375|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057376|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2057377|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
2057378|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057379|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057380|NCT01771250|Insulin|insulin|mesh-list
2057381|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2057382|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
2057383|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2057384|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057385|NCT01771627|Nicotine|nicotine|mesh-list
2057386|NCT01771627|Varenicline|varenicline|mesh-list
2057387|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2057388|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
2057389|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057390|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057391|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2057392|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2057393|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
2057394|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057395|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057396|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2057397|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2057398|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057399|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
2057400|NCT01771952|Hylan|hylan|mesh-list
2057401|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2057402|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
2057403|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057404|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
2057405|NCT01771952|Protective Agents|protective agents|mesh-ancestor
2057406|NCT01772134|Fluticasone|fluticasone|mesh-list
2057407|NCT01772134|Xhance|xhance|mesh-list
2057408|NCT01772134|Bromides|bromides|mesh-list
2057409|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2057410|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057411|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2057412|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
2057413|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057414|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057415|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2057416|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
2057417|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
2057418|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2057419|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2057420|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2057421|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2057422|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
2057423|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057424|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057425|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
2057426|NCT01772147|Fluticasone|fluticasone|mesh-list
2057427|NCT01772147|Xhance|xhance|mesh-list
2057428|NCT01772147|Bromides|bromides|mesh-list
2057429|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2057430|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057431|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2057432|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
2057433|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057434|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057435|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2057436|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
2057437|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
2057438|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2057439|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2057440|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2057441|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2057442|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
2057443|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057444|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057445|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
2057446|NCT01772368|Fluticasone|fluticasone|mesh-list
2057447|NCT01772368|Xhance|xhance|mesh-list
2057448|NCT01772368|Albuterol|albuterol|mesh-list
2057449|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2057450|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2057451|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
2057452|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057453|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2057454|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
2057455|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057456|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057457|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2057458|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
2057459|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
2057460|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2057461|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2057462|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2057463|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
2057464|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057465|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057466|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
2057467|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2057468|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
2057469|NCT01772368|Hormones|hormones|mesh-ancestor
2057470|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2057471|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
2057482|NCT01772537|Propofol|propofol|mesh-list
2057483|NCT01772537|Isoflurane|isoflurane|mesh-list
2057484|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2057485|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2057486|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057487|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2057488|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
2057489|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
2057490|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2057491|NCT01772758|Antioxidants|antioxidants|mesh-list
2057492|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057493|NCT01772758|Protective Agents|protective agents|mesh-ancestor
2057494|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057495|NCT01772823|Tenofovir|tenofovir|mesh-list
2057496|NCT01772823|Emtricitabine|emtricitabine|mesh-list
2057497|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2057498|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
2057499|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057500|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2057501|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2057502|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057503|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057504|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2057505|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2057506|NCT01773070|Ritonavir|ritonavir|mesh-list
2057507|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2057508|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2057509|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
2057510|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057511|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057512|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2057513|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2057514|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
2057515|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057516|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2057517|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2057518|NCT01773109|Irinotecan|irinotecan|mesh-list
2057519|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
2057520|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
2057521|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2057522|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057523|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057524|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057525|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2057526|NCT01773122|Dapsone|dapsone|mesh-list
2057527|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057528|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
2057529|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2057530|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2057531|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2057532|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057533|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057534|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
2057535|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2057536|NCT01773473|Insulin|insulin|mesh-list
2057537|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2057538|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
2057539|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2057540|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057541|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
2057542|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
2057543|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057544|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
2057545|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057546|NCT01773954|Aflibercept|aflibercept|mesh-list
2057547|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2057548|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2057549|NCT01773954|Growth Substances|growth substances|mesh-ancestor
2057550|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057551|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
2057552|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057553|NCT01773993|Pregabalin|pregabalin|mesh-list
2057554|NCT01773993|Analgesics|analgesics|mesh-ancestor
2057555|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
2057556|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057557|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057558|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
2057559|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2057560|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2057561|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057562|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2057563|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2057564|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2057565|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2057566|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2057567|NCT01774149|Diazepam|diazepam|mesh-list
2057568|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2057569|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
2057570|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
2057571|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
2057572|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057573|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057574|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2057575|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2057576|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2057577|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2057578|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2057579|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2057580|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2057581|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2057582|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2057583|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
2057584|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
2057585|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
2057586|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
2057587|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057588|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057589|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
2057590|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2057591|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2057592|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057593|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2057594|NCT01774305|Analgesics|analgesics|mesh-ancestor
2057595|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
2057596|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057597|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2057598|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2057599|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2057600|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
2057601|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057602|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747949|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
2057610|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2057611|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2057612|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2057613|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057614|NCT01774604|Indomethacin|indomethacin|mesh-list
2057615|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2057616|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2057617|NCT01774604|Analgesics|analgesics|mesh-ancestor
2057618|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
2057619|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057620|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057621|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057622|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2057623|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
2057624|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
2057625|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2057626|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2057627|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057628|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057629|NCT01774721|Gefitinib|gefitinib|mesh-list
2057630|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057631|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2057632|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057633|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057634|NCT01774786|Fluorouracil|fluorouracil|mesh-list
2057635|NCT01774786|Capecitabine|capecitabine|mesh-list
2057636|NCT01774786|Trastuzumab|trastuzumab|mesh-list
2057637|NCT01774786|Pertuzumab|pertuzumab|mesh-list
2057638|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057639|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
2057640|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057641|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2057642|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2057643|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
2057644|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057645|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2057646|NCT01774851|Paclitaxel|paclitaxel|mesh-list
2057647|NCT01774851|Trastuzumab|trastuzumab|mesh-list
2057648|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2057649|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057650|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
2057651|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
2057652|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
2057653|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057654|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2057655|NCT01774903|Fentanyl|fentanyl|mesh-list
2057656|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2057657|NCT01774903|Narcotics|narcotics|mesh-ancestor
2057658|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2057659|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057660|NCT01774903|Analgesics|analgesics|mesh-ancestor
2057661|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
2057662|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057663|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2057664|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2057665|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
2057666|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
2057667|NCT01774929|Fentanyl|fentanyl|mesh-list
2057668|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2057669|NCT01774929|Narcotics|narcotics|mesh-ancestor
2057670|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2057671|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057672|NCT01774929|Analgesics|analgesics|mesh-ancestor
2057673|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
2057674|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057675|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2057676|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2057677|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
2057678|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
2057679|NCT01774968|Insulin|insulin|mesh-list
2057680|NCT01774968|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2057681|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2057682|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057683|NCT01775124|Ranibizumab|ranibizumab|mesh-list
2057684|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2057685|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2057686|NCT01775124|Growth Substances|growth substances|mesh-ancestor
2057687|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057688|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
2057689|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057690|NCT01775189|Naltrexone|naltrexone|mesh-list
2057691|NCT01775189|Oxycodone|oxycodone|mesh-list
2057692|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2057693|NCT01775189|Narcotics|narcotics|mesh-ancestor
2057694|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2057695|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057696|NCT01775189|Analgesics|analgesics|mesh-ancestor
2057697|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
2057698|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057699|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2057700|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2057701|NCT01775501|Leucovorin|leucovorin|mesh-list
2057702|NCT01775501|Fluorouracil|fluorouracil|mesh-list
2057703|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
2057704|NCT01775501|Sorafenib|sorafenib|mesh-list
2057705|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
2057706|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057707|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2057708|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057709|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2057710|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
2057711|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057712|NCT01775501|Antidotes|antidotes|mesh-ancestor
2057713|NCT01775501|Protective Agents|protective agents|mesh-ancestor
2057714|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
2057715|NCT01775501|Vitamins|vitamins|mesh-ancestor
2057716|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
2057717|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2057718|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057719|NCT01775787|Menthol|menthol|mesh-list
2057720|NCT01775787|Nicotine|nicotine|mesh-list
2057721|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2057722|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
2057723|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057724|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057725|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2057726|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2057727|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
2057728|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057729|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057730|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
2057731|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
2057732|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2057733|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
2057734|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2057735|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2057736|NCT01775865|Analgesics|analgesics|mesh-ancestor
2057737|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
2057738|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057739|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057740|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057741|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2057742|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2057743|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057744|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057745|NCT01776008|Anastrozole|anastrozole|mesh-list
2057746|NCT01776008|Goserelin|goserelin|mesh-list
2057747|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2057748|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057749|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2057750|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2057751|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057752|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057753|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2057754|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
2057755|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2057756|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057757|NCT01776307|Capecitabine|capecitabine|mesh-list
2057758|NCT01776307|Cetuximab|cetuximab|mesh-list
2057759|NCT01776307|Panitumumab|panitumumab|mesh-list
2057760|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2057761|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
2057762|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057763|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057764|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2057765|NCT01776424|Aspirin|aspirin|mesh-list
2057766|NCT01776424|Pantoprazole|pantoprazole|mesh-list
2057767|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
2057768|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2057769|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2057770|NCT01776424|Analgesics|analgesics|mesh-ancestor
2057771|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
2057772|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057773|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057774|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057775|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2057776|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2057777|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2057778|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057779|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2057780|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2057781|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057782|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
2057783|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2057784|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
2057785|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2057786|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
2057787|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
2057788|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2209830|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2209831|NCT00015340|Naloxone|naloxone|mesh-list
2209832|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2209833|NCT00015340|Narcotics|narcotics|mesh-ancestor
2209834|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2209835|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209836|NCT00015340|Analgesics|analgesics|mesh-ancestor
2209837|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
2057789|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2057790|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2057791|NCT01777139|Ezogabine|ezogabine|mesh-list
2057792|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
2057793|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2057794|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057795|NCT01777152|Prednisone|prednisone|mesh-list
2057796|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
2057797|NCT01777152|Doxorubicin|doxorubicin|mesh-list
2057798|NCT01777152|Vincristine|vincristine|mesh-list
2057799|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2057800|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2057801|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
2057802|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057803|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2057804|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2057805|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
2057806|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057807|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057808|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2057809|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2057810|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2057811|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2057812|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057813|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057814|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
2057815|NCT01777152|Hormones|hormones|mesh-ancestor
2057816|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2057817|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2057818|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2057819|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
2057820|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
2057821|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
2057822|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2057823|NCT01777191|Ixekizumab|ixekizumab|mesh-list
2057824|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
2057825|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
2057826|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2057827|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2057828|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
2057829|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057830|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057831|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057832|NCT01777217|Urological Agents|urological agents|mesh-ancestor
2057833|NCT01777269|Tamsulosin|tamsulosin|mesh-list
2057834|NCT01777269|Dutasteride|dutasteride|mesh-list
2057835|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2057836|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2057837|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2057838|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
2057839|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057840|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057841|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057842|NCT01777269|Urological Agents|urological agents|mesh-ancestor
2057843|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2057844|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2057845|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057846|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
2057847|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2057848|NCT01777282|Biguanides|biguanides|mesh-list
2057849|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2057850|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
2057851|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
2057852|NCT01777282|Incretins|incretins|mesh-ancestor
2057853|NCT01777282|Hormones|hormones|mesh-ancestor
2057854|NCT01777282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2057855|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057856|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2057857|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057858|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057859|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
2057860|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2057861|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
2057862|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057863|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057864|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2057865|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
2057866|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
2057867|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2057868|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
2057869|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057870|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057871|NCT01777412|Bevacizumab|bevacizumab|mesh-list
2057872|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2057873|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057874|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2057875|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2057876|NCT01777412|Growth Substances|growth substances|mesh-ancestor
2057877|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057878|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
2209838|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209839|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2209840|NCT00015548|Olanzapine|olanzapine|mesh-list
2209841|NCT00015548|Risperidone|risperidone|mesh-list
2209842|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2209843|NCT00015548|Citalopram|citalopram|mesh-list
2209844|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2209845|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
2209846|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057879|NCT01777542|Insulin|insulin|mesh-list
2057880|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2057881|NCT01777542|Mitogens|mitogens|mesh-list
2057882|NCT01777542|Mecasermin|mecasermin|mesh-list
2057883|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2057884|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057885|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
2057886|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057887|NCT01777542|Growth Substances|growth substances|mesh-ancestor
2057888|NCT01777581|Milnacipran|milnacipran|mesh-list
2057889|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
2057890|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2057891|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2057892|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2057893|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057894|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057895|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057896|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2057897|NCT01777581|Analgesics|analgesics|mesh-ancestor
2057898|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
2057899|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057900|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
2057901|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2057902|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
2057903|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2057904|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2057905|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2057906|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2057907|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057908|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
2057909|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057910|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057911|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2057912|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057913|NCT01777763|Posaconazole|posaconazole|mesh-list
2057914|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
2057915|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057916|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2057917|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2057918|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2057919|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2057920|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2057921|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057922|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057923|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2057924|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
2057925|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2057926|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057927|NCT01777945|Docetaxel|docetaxel|mesh-list
2057928|NCT01777945|Capecitabine|capecitabine|mesh-list
2057929|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2057930|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
2057931|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
2057932|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
2057933|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057934|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2057935|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
2057936|NCT01777997|Tenofovir|tenofovir|mesh-list
2057937|NCT01777997|Emtricitabine|emtricitabine|mesh-list
2057938|NCT01777997|Rilpivirine|rilpivirine|mesh-list
2057939|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
2057940|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057941|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2057942|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2057943|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057944|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057945|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2057946|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2057947|NCT01778010|Cocaine|cocaine|mesh-list
2057948|NCT01778010|Modafinil|modafinil|mesh-list
2057949|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2057950|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057951|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2057952|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2057953|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2057954|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057955|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
2057956|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
2057957|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2057958|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
2057959|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057960|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2057961|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2057962|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2057963|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2057964|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
2057965|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2057966|NCT01778049|Empagliflozin|empagliflozin|mesh-list
2057967|NCT01778049|Linagliptin|linagliptin|mesh-list
2057968|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2057969|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057970|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2057971|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057972|NCT01778049|Incretins|incretins|mesh-ancestor
2057973|NCT01778049|Hormones|hormones|mesh-ancestor
2057974|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2057975|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2057976|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
2057977|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057978|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
2057979|NCT01778465|Salicylates|salicylates|mesh-list
2747965|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
2747966|NCT04972968|Hormones|hormones|mesh-ancestor
2747967|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2747968|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057980|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2057981|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2057982|NCT01778465|Analgesics|analgesics|mesh-ancestor
2057983|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
2057984|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2057985|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2057986|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2057987|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2057988|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2057989|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2057990|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2057991|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057992|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
2057993|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
2057994|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
2057995|NCT01778634|Azithromycin|azithromycin|mesh-list
2057996|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2057997|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2057998|NCT01778985|Estrogens|estrogens|mesh-list
2057999|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2058000|NCT01778985|Hormones|hormones|mesh-ancestor
2058001|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058002|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058003|NCT01779167|Thalidomide|thalidomide|mesh-list
2058004|NCT01779167|Rituximab|rituximab|mesh-list
2058005|NCT01779167|Lenalidomide|lenalidomide|mesh-list
2058006|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2058007|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058008|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
2058009|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058010|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2058011|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2058012|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2058013|NCT01779167|Growth Substances|growth substances|mesh-ancestor
2058014|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
2058015|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058016|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
2058017|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2058018|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058019|NCT01779375|Metformin|metformin|mesh-list
2058020|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
2058021|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2058022|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058023|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2058024|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2058025|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058026|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058027|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
2058028|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058029|NCT01779869|Regadenoson|regadenoson|mesh-list
2058030|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2058031|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2058032|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
2058033|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
2058034|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058035|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058036|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058037|NCT01780324|Lidocaine|lidocaine|mesh-list
2058038|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
2058039|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
2058040|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2058041|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058042|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
2058043|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058044|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2058045|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2058046|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2058047|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2058048|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058049|NCT01780337|Oxytocin|oxytocin|mesh-list
2058050|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
2058051|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2058052|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058053|NCT01780389|Milnacipran|milnacipran|mesh-list
2058054|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
2058055|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2058056|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2058057|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2058058|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058059|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058060|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058061|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2058062|NCT01780389|Analgesics|analgesics|mesh-ancestor
2058063|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
2058064|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058065|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
2058066|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2058067|NCT01780454|Rituximab|rituximab|mesh-list
2058068|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2058069|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058070|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
2058071|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058072|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2079407|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2747987|NCT04965506|Dulaglutide|dulaglutide|mesh-list
2058073|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2058074|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2058075|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2058076|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
2058077|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058078|NCT01780545|Docetaxel|docetaxel|mesh-list
2058079|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058080|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
2058081|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
2058082|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
2079408|NCT02058147|Insulin|insulin|mesh-list
2058083|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058084|NCT01780662|Gemcitabine|gemcitabine|mesh-list
2058085|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2058086|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2058087|NCT01780662|Antibodies|antibodies|mesh-list
2058088|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
2058089|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2058090|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
2058091|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
2058092|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058093|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2058094|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
2058095|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058096|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058097|NCT01780662|Antiviral Agents|antiviral agents|mesh-ancestor
2058098|NCT01780662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058099|NCT01780662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058100|NCT01780662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058101|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
2058102|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2058103|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2058104|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
2058105|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058106|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2058107|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2058108|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058109|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058110|NCT01780935|Ranibizumab|ranibizumab|mesh-list
2058111|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2079409|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2058112|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2058113|NCT01780935|Growth Substances|growth substances|mesh-ancestor
2058114|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058115|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
2058116|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058117|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
2058118|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
2058119|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058120|NCT01780974|Protective Agents|protective agents|mesh-ancestor
2058121|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058122|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
2058123|NCT01780974|Vitamins|vitamins|mesh-ancestor
2058124|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
2058125|NCT01780987|Heparin|heparin|mesh-list
2058126|NCT01780987|Calcium heparin|calcium heparin|mesh-list
2058127|NCT01780987|Warfarin|warfarin|mesh-list
2058128|NCT01780987|Apixaban|apixaban|mesh-list
2058129|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
2058130|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2058131|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2058132|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058133|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2058134|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
2058135|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2058136|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
2058137|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058138|NCT01781169|Vitamin D|vitamin d|mesh-list
2058139|NCT01781169|Vitamins|vitamins|mesh-ancestor
2058140|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
2058141|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058142|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2058143|NCT01781234|Insulin|insulin|mesh-list
2058144|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2058145|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058146|NCT01781403|Capecitabine|capecitabine|mesh-list
2058147|NCT01781403|Temozolomide|temozolomide|mesh-list
2058148|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2058149|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
2058150|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058151|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058152|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2058153|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
2058154|NCT01781468|Modafinil|modafinil|mesh-list
2058155|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2058156|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058157|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2058158|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2058159|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2058160|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058161|NCT01781611|Aspirin|aspirin|mesh-list
2058162|NCT01781611|Dipyridamole|dipyridamole|mesh-list
2058163|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2058164|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2058165|NCT01781611|Analgesics|analgesics|mesh-ancestor
2058166|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
2058167|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058168|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058169|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2747988|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2747989|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2747990|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2747991|NCT04960930|Minocycline|minocycline|mesh-list
2747992|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2747993|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058170|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2058171|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2058172|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2058173|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058174|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2058175|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2058176|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058177|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
2058178|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2058179|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
2058184|NCT01781806|Tenofovir|tenofovir|mesh-list
2058185|NCT01781806|Emtricitabine|emtricitabine|mesh-list
2058186|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
2058187|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058188|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2058189|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2058190|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058191|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058192|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2058193|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2058194|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
2058195|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058196|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2058197|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058198|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058199|NCT01782131|Voriconazole|voriconazole|mesh-list
2058200|NCT01782131|Posaconazole|posaconazole|mesh-list
2058201|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
2058202|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058203|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2058204|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2058205|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058206|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058207|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2058208|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
2058209|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058210|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058211|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2748004|NCT04957368|Midazolam|midazolam|mesh-list
2748005|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
2748006|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2748007|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2748008|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2058212|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2058213|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2058214|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2058215|NCT01782222|Rotigotine|rotigotine|mesh-list
2058216|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
2058217|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
2058218|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058219|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058220|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058221|NCT01782495|Ritonavir|ritonavir|mesh-list
2058222|NCT01782495|Ribavirin|ribavirin|mesh-list
2058223|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2058224|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2058225|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
2058226|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058227|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058228|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2748009|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748010|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2748011|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2748012|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2748013|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2748014|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
2058229|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2058230|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
2058231|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058232|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2058233|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2058234|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
2058235|NCT01782690|Gemcitabine|gemcitabine|mesh-list
2058236|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2058237|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2058238|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
2058239|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058240|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058241|NCT01782690|Antiviral Agents|antiviral agents|mesh-ancestor
2058242|NCT01782690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058243|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058244|NCT01782690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058245|NCT01782690|Immunologic Factors|immunologic factors|mesh-ancestor
2058246|NCT01782690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058247|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2058248|NCT01782742|Bexarotene|bexarotene|mesh-list
2058249|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058250|NCT01782859|Prednisone|prednisone|mesh-list
2058251|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
2058252|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2748015|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
2058253|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2058254|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2058255|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2058256|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
2058257|NCT01782859|Hormones|hormones|mesh-ancestor
2058258|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058259|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058260|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2058261|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058262|NCT01782872|Ropivacaine|ropivacaine|mesh-list
2058263|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
2058264|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
2058265|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2058266|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058267|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
2058268|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058269|NCT01782885|Acetaminophen|acetaminophen|mesh-list
2058270|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2058271|NCT01782885|Analgesics|analgesics|mesh-ancestor
2058272|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
2058273|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058274|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058275|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
2058276|NCT01782898|Esmolol|esmolol|mesh-list
2058277|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2748016|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
2748017|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
2748018|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2748019|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058278|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2058279|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2058280|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
2058281|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058282|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058283|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058284|NCT01782963|Dexamethasone|dexamethasone|mesh-list
2058285|NCT01782963|Lenalidomide|lenalidomide|mesh-list
2058286|NCT01782963|Bortezomib|bortezomib|mesh-list
2058287|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2058288|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
2058289|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
2058290|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058291|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058292|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2058293|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
2058294|NCT01782963|Hormones|hormones|mesh-ancestor
2058295|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058296|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2058297|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058298|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
2058299|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2058300|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2058301|NCT01782963|Growth Substances|growth substances|mesh-ancestor
2058302|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
2058303|NCT01783054|Gemcitabine|gemcitabine|mesh-list
2058304|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2058305|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
2058306|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058307|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058308|NCT01783054|Antiviral Agents|antiviral agents|mesh-ancestor
2058309|NCT01783054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058310|NCT01783054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058311|NCT01783054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058312|NCT01783054|Immunologic Factors|immunologic factors|mesh-ancestor
2058313|NCT01783054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058314|NCT01783236|Acetaminophen|acetaminophen|mesh-list
2058315|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2058316|NCT01783236|Analgesics|analgesics|mesh-ancestor
2058317|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
2058318|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058319|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058320|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
2058321|NCT01783444|Capecitabine|capecitabine|mesh-list
2058322|NCT01783444|Everolimus|everolimus|mesh-list
2058323|NCT01783444|Exemestane|exemestane|mesh-list
2058324|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2058325|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
2058326|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058327|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058328|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058329|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
2058330|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058331|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2079410|NCT02058147|Metformin|metformin|mesh-list
2058332|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2058333|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058334|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2058335|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
2058336|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058337|NCT01783470|Mirabegron|mirabegron|mesh-list
2058338|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
2058339|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
2058340|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2058341|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2058342|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058343|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058344|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058345|NCT01783470|Urological Agents|urological agents|mesh-ancestor
2058346|NCT01783548|Beclomethasone|beclomethasone|mesh-list
2058347|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2058348|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
2058349|NCT01783548|Hormones|hormones|mesh-ancestor
2058350|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058351|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058352|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2058353|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
2058354|NCT01783561|Caffeine|caffeine|mesh-list
2058355|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
2058356|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058357|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2058358|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058359|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2058360|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058361|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2058362|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2058363|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
2058364|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058365|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
2058366|NCT01783574|Testosterone|testosterone|mesh-list
2058367|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
2058368|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
2058369|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2058370|NCT01783574|Androgens|androgens|mesh-ancestor
2058371|NCT01783574|Hormones|hormones|mesh-ancestor
2058372|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058373|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058374|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2058375|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058376|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
2058377|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
2058378|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
2058379|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058380|NCT01783821|Budesonide|budesonide|mesh-list
2058381|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
2209847|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209848|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209849|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2209850|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2209851|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2209852|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2209853|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2209854|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
2209855|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
2209856|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
2209857|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2209858|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2058382|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2058383|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2058384|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
2058385|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058386|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058387|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2058388|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
2058389|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
2058390|NCT01783821|Hormones|hormones|mesh-ancestor
2058391|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058392|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2058393|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2058394|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2058395|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
2058396|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058397|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058398|NCT01783847|Prednisolone|prednisolone|mesh-list
2058399|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2058400|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
2058401|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2058402|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
2058403|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
2058404|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2058405|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
2058406|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2058407|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
2058408|NCT01783847|Hormones|hormones|mesh-ancestor
2058409|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058410|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058411|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2058412|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058413|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
2058414|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
2058415|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058416|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2058417|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2058418|NCT01783847|Protective Agents|protective agents|mesh-ancestor
2058419|NCT01783847|Hematinics|hematinics|mesh-ancestor
2058420|NCT01783860|Azithromycin|azithromycin|mesh-list
2058421|NCT01783860|Doxycycline|doxycycline|mesh-list
2058422|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2058423|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058424|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
2058425|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2058426|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2058427|NCT01783886|Aflibercept|aflibercept|mesh-list
2058428|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2058429|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2058430|NCT01783886|Growth Substances|growth substances|mesh-ancestor
2058431|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058432|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
2058433|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058434|NCT01783912|Nicotine|nicotine|mesh-list
2058435|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2058436|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
2058437|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058438|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058439|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2058440|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2058441|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
2058442|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058443|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058444|NCT01783938|Nivolumab|nivolumab|mesh-list
2058445|NCT01783938|Ipilimumab|ipilimumab|mesh-list
2058446|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2058447|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058448|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2058449|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058450|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
2058451|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058452|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
2058453|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058454|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058455|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2058456|NCT01784029|Vitamin D|vitamin d|mesh-list
2058457|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
2058458|NCT01784029|Vitamins|vitamins|mesh-ancestor
2058459|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
2058460|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058461|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2058462|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2058463|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
2058464|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2058465|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058466|NCT01784419|Ivacaftor|ivacaftor|mesh-list
2058467|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2058468|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2058469|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058470|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
2058471|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
2058472|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2058473|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2058474|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058475|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058476|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058477|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2058478|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2058479|NCT01784666|Isradipine|isradipine|mesh-list
2058480|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2058481|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2058482|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2058483|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058484|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2079411|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
2748020|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2748021|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2748022|NCT04957368|Analgesics|analgesics|mesh-ancestor
2748023|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
2748024|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2748025|NCT04950608|Psilocybin|psilocybin|mesh-list
2748026|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
2748027|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748028|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2058485|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058486|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
2058487|NCT01784770|Azithromycin|azithromycin|mesh-list
2058488|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2209859|NCT00015548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2209860|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2209861|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2209862|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
2209863|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2209864|NCT00015626|Metformin|metformin|mesh-list
2209865|NCT00015626|Pioglitazone|pioglitazone|mesh-list
2209866|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
2209867|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2058489|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058490|NCT01784861|Everolimus|everolimus|mesh-list
2058491|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058492|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058493|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
2058494|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058495|NCT01784965|Liraglutide|liraglutide|mesh-list
2058496|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2058497|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058498|NCT01784965|Incretins|incretins|mesh-ancestor
2058499|NCT01784965|Hormones|hormones|mesh-ancestor
2058500|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058501|NCT01785095|Hormones|hormones|mesh-list
2058502|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2058503|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058504|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058505|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
2058506|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2058507|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2058508|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
2058509|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058510|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2058511|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2058512|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058513|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058514|NCT01785186|Pyridoxine|pyridoxine|mesh-list
2058515|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
2058516|NCT01785186|Rifampin|rifampin|mesh-list
2058517|NCT01785186|Isoniazid|isoniazid|mesh-list
2058518|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
2058519|NCT01785186|Ethambutol|ethambutol|mesh-list
2058520|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2058521|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058522|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2058523|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2058524|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2748054|NCT04939792|Vitamin D|vitamin d|mesh-list
2058525|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058526|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058527|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058528|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2058529|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
2058530|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
2058531|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2058532|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2058533|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2058534|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2058535|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2058536|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2058537|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2058538|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2058539|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2058540|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
2058541|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2058542|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
2058543|NCT01785186|Vitamins|vitamins|mesh-ancestor
2058544|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
2058545|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
2058546|NCT01785459|Bupivacaine|bupivacaine|mesh-list
2058547|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
2058548|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
2058549|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2058550|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058551|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
2058552|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058553|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
2058554|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
2058555|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2058556|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2058557|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2058558|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2058559|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2058560|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
2058561|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058562|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058563|NCT01785472|Olmesartan|olmesartan|mesh-list
2058564|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2058565|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2058566|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2058567|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2058568|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2058569|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058570|NCT01785615|Atorvastatin|atorvastatin|mesh-list
2058571|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2058572|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2058573|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
2058574|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058575|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2058576|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2058577|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058578|NCT01785810|Maraviroc|maraviroc|mesh-list
2058579|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2058580|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2058581|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058582|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2058583|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2058584|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
2058585|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058586|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2058587|NCT01786109|Dronabinol|dronabinol|mesh-list
2058588|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
2058589|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058590|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2748055|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
2748056|NCT04939792|Vitamins|vitamins|mesh-list
2748057|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
2748058|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748059|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2748060|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2748064|NCT04935476|Dapsone|dapsone|mesh-list
2748065|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2748066|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
2748067|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2748068|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2058591|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2058592|NCT01786109|Analgesics|analgesics|mesh-ancestor
2058593|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
2058594|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058595|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2058596|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2058597|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058598|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058599|NCT01786109|Hormones|hormones|mesh-ancestor
2058600|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058601|NCT01786161|Vancomycin|vancomycin|mesh-list
2058602|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2058603|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058604|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2058605|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2058606|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058607|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058608|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
2058609|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058610|NCT01786239|Risperidone|risperidone|mesh-list
2058611|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2058612|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
2058613|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058614|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058615|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058616|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2058617|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2058618|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2058619|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2058620|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2058621|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
2058622|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2058623|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2058624|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058625|NCT01786343|Decitabine|decitabine|mesh-list
2058626|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2058627|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
2058628|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058629|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058630|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058631|NCT01786551|Eplerenone|eplerenone|mesh-list
2058632|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2058633|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
2058634|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058635|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058636|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2058637|NCT01786551|Diuretics|diuretics|mesh-ancestor
2058638|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
2058639|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2058640|NCT01786603|Rasagiline|rasagiline|mesh-list
2058641|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2058642|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058643|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058644|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2058645|NCT01786603|Protective Agents|protective agents|mesh-ancestor
2058646|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058647|NCT01786668|Tofacitinib|tofacitinib|mesh-list
2058648|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2058649|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058650|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058651|NCT01786707|Metformin|metformin|mesh-list
2058652|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2058653|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058654|NCT01786902|Hormones|hormones|mesh-list
2058655|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058656|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058657|NCT01786967|Fesoterodine|fesoterodine|mesh-list
2058658|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2058659|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2058660|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
2058661|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058662|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058663|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058664|NCT01786967|Urological Agents|urological agents|mesh-ancestor
2058665|NCT01787006|Fluorouracil|fluorouracil|mesh-list
2058666|NCT01787006|Cetuximab|cetuximab|mesh-list
2058667|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748069|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2748070|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2748071|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748072|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
2748073|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2748074|NCT04933682|Rifampin|rifampin|mesh-list
2058668|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
2079412|NCT02058147|Lixisenatide|lixisenatide|mesh-list
2748075|NCT04933682|Fluconazole|fluconazole|mesh-list
2748076|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2748077|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
2748078|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2748079|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2748080|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
2748081|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2748082|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2748083|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748084|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2748085|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2748086|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2748087|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2748088|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2748089|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2748090|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
2748091|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2748092|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2058669|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058670|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2058671|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058672|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
2058673|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058674|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2058675|NCT01787032|Ketoconazole|ketoconazole|mesh-list
2058676|NCT01787032|Voriconazole|voriconazole|mesh-list
2058677|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
2058678|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058679|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2058680|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2058681|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058682|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058683|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2209868|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209869|NCT00015652|Ribavirin|ribavirin|mesh-list
2209870|NCT00015652|Aldesleukin|aldesleukin|mesh-list
2209871|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2209872|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
2209873|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209874|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
2209875|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209876|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209877|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2058684|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
2058685|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058686|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058687|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2058688|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
2079413|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2058689|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2058690|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2058691|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
2058692|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058693|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058694|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2058695|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
2058696|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2058697|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2058698|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2058699|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
2058700|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058701|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058702|NCT01787188|Meloxicam|meloxicam|mesh-list
2058703|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2058704|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2058705|NCT01787188|Analgesics|analgesics|mesh-ancestor
2058706|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
2058707|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058708|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058709|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2058710|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2058711|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2058712|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2058713|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058714|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058715|NCT01787240|Citalopram|citalopram|mesh-list
2058716|NCT01787240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2058717|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2058718|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2058719|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058720|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058721|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
2058722|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058723|NCT01787240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2058724|NCT01787240|Antidepressive Agents|antidepressive agents|mesh-ancestor
2058725|NCT01787240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2058726|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2058727|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
2058728|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058729|NCT01787331|Itraconazole|itraconazole|mesh-list
2058730|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
2058731|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058732|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2058733|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2058734|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058735|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058736|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2058737|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
2058738|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058739|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058740|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2058741|NCT01787916|Liraglutide|liraglutide|mesh-list
2058742|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2058743|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058744|NCT01787916|Incretins|incretins|mesh-ancestor
2058745|NCT01787916|Hormones|hormones|mesh-ancestor
2058746|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058747|NCT01788215|Doxycycline|doxycycline|mesh-list
2058748|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2058749|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058750|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
2058751|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2058752|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2058753|NCT01788228|Vaccines|vaccines|mesh-list
2058754|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
2058755|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058756|NCT01788358|Candesartan|candesartan|mesh-list
2058757|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
2058758|NCT01788358|Nifedipine|nifedipine|mesh-list
2058759|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2058760|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2058761|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2058762|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058763|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2058764|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2058765|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2058766|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058767|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
2058768|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
2058769|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2058770|NCT01788566|Gemcitabine|gemcitabine|mesh-list
2058771|NCT01788566|Necitumumab|necitumumab|mesh-list
2058772|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058773|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2058774|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
2058775|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058776|NCT01788566|Antiviral Agents|antiviral agents|mesh-ancestor
2058777|NCT01788566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058778|NCT01788566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058779|NCT01788566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058780|NCT01788566|Immunologic Factors|immunologic factors|mesh-ancestor
2058781|NCT01788566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058782|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2058783|NCT01788631|Regadenoson|regadenoson|mesh-list
2058784|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2058785|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2058786|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
2058787|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
2058788|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058789|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058790|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058791|NCT01789047|Topiramate|topiramate|mesh-list
2058792|NCT01789047|Amantadine|amantadine|mesh-list
2058793|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
2058794|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2058795|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058796|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2058797|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2058798|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
2058799|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058800|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
2058801|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058802|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058803|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2058804|NCT01789047|Analgesics|analgesics|mesh-ancestor
2058805|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
2058806|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058807|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
2058808|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2058809|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058810|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2058811|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2058812|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058813|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058814|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058815|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2748093|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2748094|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
2058816|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2058817|NCT01789255|Cyclosporine|cyclosporine|mesh-list
2058818|NCT01789255|Methotrexate|methotrexate|mesh-list
2058819|NCT01789255|Vorinostat|vorinostat|mesh-list
2058820|NCT01789255|Tacrolimus|tacrolimus|mesh-list
2058821|NCT01789255|Cyclosporins|cyclosporins|mesh-list
2058822|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2058823|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
2058824|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2058825|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058826|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2058827|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
2058828|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058829|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058830|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
2058831|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058832|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2058833|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058834|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
2058835|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2058836|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2058837|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2209878|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2209879|NCT00015665|Voriconazole|voriconazole|mesh-list
2209880|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
2209881|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209882|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2209883|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2209884|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209885|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209886|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2209887|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
2058838|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
2058839|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058840|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2058841|NCT01789281|Everolimus|everolimus|mesh-list
2058842|NCT01789281|Octreotide|octreotide|mesh-list
2058843|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058844|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058845|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
2058846|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058847|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2058848|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2058849|NCT01789320|Triamcinolone|triamcinolone|mesh-list
2058850|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2058851|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2058852|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2058853|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2058854|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
2058855|NCT01789320|Hormones|hormones|mesh-ancestor
2058856|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058857|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058858|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058859|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
2058860|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058861|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058862|NCT01789606|Ibuprofen|ibuprofen|mesh-list
2058863|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2058864|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2058865|NCT01789606|Analgesics|analgesics|mesh-ancestor
2058866|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
2058867|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058868|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058869|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2058870|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2058871|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2058872|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058873|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058874|NCT01789814|Clopidogrel|clopidogrel|mesh-list
2058875|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2058876|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2058877|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2058878|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2058879|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2058880|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
2058881|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058882|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058883|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058884|NCT01789905|Tigecycline|tigecycline|mesh-list
2058885|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2058886|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209888|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2209889|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209890|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2209891|NCT00015691|Metformin|metformin|mesh-list
2209892|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
2209893|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2209894|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209895|NCT00015704|Aldesleukin|aldesleukin|mesh-list
2209896|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209897|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2209898|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2209899|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
2058887|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2058888|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058889|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058890|NCT01789970|Hydrocodone|hydrocodone|mesh-list
2058891|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2058892|NCT01789970|Narcotics|narcotics|mesh-ancestor
2058893|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2058894|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058895|NCT01789970|Analgesics|analgesics|mesh-ancestor
2209900|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209901|NCT00015769|Levetiracetam|levetiracetam|mesh-list
2209902|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
2209903|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
2209904|NCT00015808|Idebenone|idebenone|mesh-list
2209905|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
2209906|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209907|NCT00015808|Protective Agents|protective agents|mesh-ancestor
2209908|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209909|NCT00015821|Thalidomide|thalidomide|mesh-list
2058896|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
2058897|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058898|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
2058899|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
2058900|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2058901|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2058902|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058903|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2058904|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058905|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
2058906|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2748095|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058907|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
2058908|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2058909|NCT01790438|Insulin|insulin|mesh-list
2058910|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2058911|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
2058912|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
2209910|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209911|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
2209912|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209913|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
2209914|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2209915|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209916|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2209917|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2209918|NCT00015821|Growth Substances|growth substances|mesh-ancestor
2209919|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
2209920|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209921|NCT00015834|Cytarabine|cytarabine|mesh-list
2209922|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
2209923|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2209924|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
2209925|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209926|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209927|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
2209928|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209929|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209930|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
2209931|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209932|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2209933|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209934|NCT00015860|Prednisone|prednisone|mesh-list
2209935|NCT00015860|Vincristine|vincristine|mesh-list
2058913|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
2058914|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2058915|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058916|NCT01790490|Ketamine|ketamine|mesh-list
2058917|NCT01790490|Lorazepam|lorazepam|mesh-list
2209936|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
2058918|NCT01790490|Analgesics|analgesics|mesh-ancestor
2058919|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
2058920|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058921|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058922|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2058923|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2058924|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
2058925|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
2058926|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2058927|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2058928|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2058929|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2058930|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058931|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
2058932|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
2058933|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
2058934|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2058935|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2058936|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2058937|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2058938|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2058939|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
2058940|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
2058941|NCT01790503|Temozolomide|temozolomide|mesh-list
2058942|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2058943|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
2058944|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058945|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058946|NCT01790516|Cetuximab|cetuximab|mesh-list
2058947|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058948|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2058949|NCT01790568|Methotrexate|methotrexate|mesh-list
2058950|NCT01790568|Vorinostat|vorinostat|mesh-list
2058951|NCT01790568|Tacrolimus|tacrolimus|mesh-list
2058952|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2058953|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
2058954|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2058955|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058956|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2058957|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
2058958|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058959|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058960|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
2058961|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058962|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2058963|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058964|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
2058965|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2058966|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2058967|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2058968|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2058969|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
2058970|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
2058971|NCT01790594|Abatacept|abatacept|mesh-list
2058972|NCT01790594|Tacrolimus|tacrolimus|mesh-list
2058973|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
2058974|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2058975|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2058976|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
2058977|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2058978|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2058979|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2058980|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2058981|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2058982|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2058983|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2058984|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
2748096|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748097|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2748098|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2058985|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2058986|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2058987|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2058988|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
2058989|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
2058990|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2058991|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2058992|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
2058993|NCT01790594|Hormones|hormones|mesh-ancestor
2058994|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2058995|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2058996|NCT01790594|Protective Agents|protective agents|mesh-ancestor
2058997|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2058998|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2058999|NCT01790659|Gentamicins|gentamicins|mesh-list
2059000|NCT01790659|Paromomycin|paromomycin|mesh-list
2059001|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2059002|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059003|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2059004|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059005|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059006|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2059007|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2059008|NCT01790685|Dexamethasone|dexamethasone|mesh-list
2059009|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059010|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
2059011|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
2059012|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059013|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059014|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2059015|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
2059016|NCT01790685|Hormones|hormones|mesh-ancestor
2059017|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059018|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2059019|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059020|NCT01790828|Factor VIII|factor viii|mesh-list
2059021|NCT01790828|Coagulants|coagulants|mesh-ancestor
2059022|NCT01791153|Prednisone|prednisone|mesh-list
2059023|NCT01791153|Methotrexate|methotrexate|mesh-list
2059024|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059025|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
2059026|NCT01791153|Hormones|hormones|mesh-ancestor
2079414|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059027|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059028|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059029|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2059030|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059031|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2059032|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
2059033|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2059034|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2059035|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
2059036|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059037|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
2059038|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059039|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2059040|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2059041|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
2059042|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2059043|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2059044|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2059045|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
2059046|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2059047|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2059048|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2059049|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
2059050|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2059051|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059052|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2059053|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2059054|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2059055|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2059056|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059057|NCT01791465|Exenatide|exenatide|mesh-list
2059058|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2059059|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059060|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2059061|NCT01791465|Incretins|incretins|mesh-ancestor
2059062|NCT01791465|Hormones|hormones|mesh-ancestor
2059063|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059064|NCT01791491|Abatacept|abatacept|mesh-list
2059065|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2059066|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059067|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059068|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2059069|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
2059070|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059071|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2059072|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2059073|NCT01791803|Nicotine|nicotine|mesh-list
2059074|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2059075|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
2059076|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059077|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059078|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2059079|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2059080|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
2059081|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059082|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059083|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
2059084|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059085|NCT01791972|Albuterol|albuterol|mesh-list
2059086|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2059087|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
2059088|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059089|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059090|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2059091|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
2059092|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
2059093|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2059094|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2059095|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2059096|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2059097|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
2059098|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059099|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059100|NCT01792115|Vitamins|vitamins|mesh-list
2059101|NCT01792115|Vitamin E|vitamin e|mesh-list
2059102|NCT01792115|Tocopherols|tocopherols|mesh-list
2059103|NCT01792115|Tocotrienols|tocotrienols|mesh-list
2209937|NCT00015860|Daunorubicin|daunorubicin|mesh-list
2209938|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2209939|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
2209940|NCT00015860|Hormones|hormones|mesh-ancestor
2209941|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2209942|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209943|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2209944|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209945|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2209946|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
2209947|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
2209948|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
2209949|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209950|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2209951|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209952|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2209953|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2209954|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2209955|NCT00015873|Cytarabine|cytarabine|mesh-list
2209956|NCT00015873|Prednisolone|prednisolone|mesh-list
2209957|NCT00015873|Methotrexate|methotrexate|mesh-list
2059104|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
2059105|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
2059106|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059107|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
2748141|NCT04929600|Amlodipine|amlodipine|mesh-list
2748142|NCT04929600|Valsartan|valsartan|mesh-list
2748143|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2748144|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2748145|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2748146|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748147|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2748148|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748149|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
2059108|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059109|NCT01792115|Protective Agents|protective agents|mesh-ancestor
2209958|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
2209959|NCT00015873|Vincristine|vincristine|mesh-list
2209960|NCT00015873|Asparaginase|asparaginase|mesh-list
2209961|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2209962|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
2209963|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2209964|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059110|NCT01792284|Insulin|insulin|mesh-list
2059111|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2059112|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
2059113|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2059114|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059115|NCT01792518|Linagliptin|linagliptin|mesh-list
2059116|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2059117|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059118|NCT01792518|Incretins|incretins|mesh-ancestor
2059119|NCT01792518|Hormones|hormones|mesh-ancestor
2059120|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059121|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2059122|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
2059123|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059124|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059125|NCT01792830|Metformin|metformin|mesh-list
2059126|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
2059127|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2059128|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059129|NCT01793051|Minocycline|minocycline|mesh-list
2059130|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2059131|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059132|NCT01793285|Etanercept|etanercept|mesh-list
2059133|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2059134|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2059135|NCT01793285|Analgesics|analgesics|mesh-ancestor
2059136|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
2748150|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2748151|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2748152|NCT04928521|Bupivacaine|bupivacaine|mesh-list
2748153|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
2059137|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059138|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059139|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059140|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2059141|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2059142|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2059143|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
2748154|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
2059155|NCT01793688|Ampicillin|ampicillin|mesh-list
2059156|NCT01793688|Sulbactam|sulbactam|mesh-list
2059157|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2059158|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059159|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2059160|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059161|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059162|NCT01793883|Laninamivir|laninamivir|mesh-list
2059163|NCT01793883|Zanamivir|zanamivir|mesh-list
2059164|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
2748155|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2748156|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748157|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
2748158|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2748159|NCT04927780|Leucovorin|leucovorin|mesh-list
2748160|NCT04927780|Fluorouracil|fluorouracil|mesh-list
2748161|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
2748162|NCT04927780|Irinotecan|irinotecan|mesh-list
2748163|NCT04927780|Calcium|calcium|mesh-list
2748164|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
2748165|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2748166|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059165|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2748167|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
2059166|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059167|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059168|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2059169|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2059170|NCT01794039|Dexamethasone|dexamethasone|mesh-list
2748168|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748169|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2748170|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748171|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2748172|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
2748173|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2748174|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2748175|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2748176|NCT04927780|Antidotes|antidotes|mesh-ancestor
2748177|NCT04927780|Protective Agents|protective agents|mesh-ancestor
2748178|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
2748179|NCT04927780|Vitamins|vitamins|mesh-ancestor
2748180|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
2059171|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
2059172|NCT01794039|Lenalidomide|lenalidomide|mesh-list
2059173|NCT01794039|Pomalidomide|pomalidomide|mesh-list
2209965|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2748196|NCT04923542|Hormones|hormones|mesh-list
2059174|NCT01794039|Ichthammol|ichthammol|mesh-list
2059175|NCT01794039|BB 1101|bb 1101|mesh-list
2059176|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059177|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
2059178|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
2059179|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059180|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059181|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2059182|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
2059183|NCT01794039|Hormones|hormones|mesh-ancestor
2059184|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059185|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2059186|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059187|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
2059188|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2059189|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2059190|NCT01794039|Growth Substances|growth substances|mesh-ancestor
2059191|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
2059192|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
2059193|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059194|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059195|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
2059196|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2059197|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2059198|NCT01794455|Candesartan|candesartan|mesh-list
2059199|NCT01794455|Sertraline|sertraline|mesh-list
2059200|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
2059201|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2059202|NCT01794455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2059203|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2059204|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2079415|NCT02058160|Insulin|insulin|mesh-list
2059205|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059206|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2748197|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2748198|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059207|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
2059208|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059209|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2059210|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2059211|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2059212|NCT01794689|Morphine|morphine|mesh-list
2059213|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2059214|NCT01794689|Narcotics|narcotics|mesh-ancestor
2059215|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2059216|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059217|NCT01794689|Analgesics|analgesics|mesh-ancestor
2059218|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
2059219|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059220|NCT01794702|Cytarabine|cytarabine|mesh-list
2059221|NCT01794702|Decitabine|decitabine|mesh-list
2059222|NCT01794702|Clofarabine|clofarabine|mesh-list
2059223|NCT01794702|Idarubicin|idarubicin|mesh-list
2059224|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2059225|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
2059226|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059227|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059228|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
2059229|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059230|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2059231|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
2059232|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059233|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059234|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2059235|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2059236|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2059237|NCT01794741|Fluticasone|fluticasone|mesh-list
2059238|NCT01794741|Xhance|xhance|mesh-list
2059239|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059240|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2059241|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
2059242|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059243|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059244|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2059245|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
2059246|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
2209966|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
2209967|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209968|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209969|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
2059247|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2059248|NCT01794780|Fluticasone|fluticasone|mesh-list
2059249|NCT01794780|Budesonide|budesonide|mesh-list
2059250|NCT01794780|Theophylline|theophylline|mesh-list
2059251|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
2059252|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
2059253|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2059254|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059255|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2059256|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
2059257|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059258|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059259|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2059260|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
2059261|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
2059262|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2059263|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
2059264|NCT01794780|Hormones|hormones|mesh-ancestor
2059265|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059266|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2059267|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2059268|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2059269|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
2059270|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059271|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059272|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
2059273|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2059274|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
2059275|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2059276|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059277|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
2059278|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2059279|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2059280|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
2059281|NCT01794845|Docetaxel|docetaxel|mesh-list
2059282|NCT01794845|Cetuximab|cetuximab|mesh-list
2059283|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059284|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
2059285|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
2059286|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
2059287|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059288|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2059289|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
2059290|NCT01795495|Remifentanil|remifentanil|mesh-list
2059291|NCT01795495|Methadone|methadone|mesh-list
2059292|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2059293|NCT01795495|Narcotics|narcotics|mesh-ancestor
2059294|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2059295|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059296|NCT01795495|Analgesics|analgesics|mesh-ancestor
2059297|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
2059298|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059299|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
2059300|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2059301|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
2059302|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2059303|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2059304|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059305|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2059306|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
2059307|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2059308|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
2059309|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
2059310|NCT01795547|Aripiprazole|aripiprazole|mesh-list
2059311|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2059312|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
2059313|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2059314|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2059315|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2059316|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2059317|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209970|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209971|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2059318|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
2059319|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
2059320|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059321|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059322|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2209972|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209973|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
2209974|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2209975|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2209976|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
2209977|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209978|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2209979|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
2209980|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
2209981|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
2059323|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2059324|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
2059325|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2059326|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2059327|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2059328|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2059329|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
2059330|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059331|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2059332|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059333|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059334|NCT01795898|Fentanyl|fentanyl|mesh-list
2059335|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2059336|NCT01795898|Narcotics|narcotics|mesh-ancestor
2059337|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2059338|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059339|NCT01795898|Analgesics|analgesics|mesh-ancestor
2059340|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
2059341|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059342|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2059343|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2059344|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
2059345|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
2059346|NCT01795937|Itraconazole|itraconazole|mesh-list
2059347|NCT01795937|Atorvastatin|atorvastatin|mesh-list
2059348|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2059349|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2059350|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2059351|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
2059352|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059353|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2059354|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2059355|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059356|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
2059357|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059358|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2059359|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2059360|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2059361|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
2059362|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059363|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059364|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2748215|NCT04914676|Cytarabine|cytarabine|mesh-list
2748216|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2748217|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
2748218|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748219|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748220|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
2748221|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059388|NCT01796301|Teriparatide|teriparatide|mesh-list
2059389|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2059390|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059391|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2059392|NCT01796470|Idelalisib|idelalisib|mesh-list
2059393|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059394|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079416|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2059395|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059396|NCT01796665|Clindamycin|clindamycin|mesh-list
2059397|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
2059398|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
2059399|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2059400|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2059401|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059402|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2059403|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059404|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059405|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
2059406|NCT01796964|Aflibercept|aflibercept|mesh-list
2059407|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2059408|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2059409|NCT01796964|Growth Substances|growth substances|mesh-ancestor
2059410|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059411|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
2059412|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209982|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2209983|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
2209984|NCT00015873|Hormones|hormones|mesh-ancestor
2209985|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2209986|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2209987|NCT00015886|Docetaxel|docetaxel|mesh-list
2209988|NCT00015886|Fluorouracil|fluorouracil|mesh-list
2209989|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2209990|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
2059413|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
2059414|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2059415|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2059416|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2059417|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2059418|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059419|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
2059420|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059421|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059422|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2059423|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059424|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
2059425|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2059426|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2059427|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2059428|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2059429|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059430|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
2059431|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059432|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059433|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2059434|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059435|NCT01797120|Everolimus|everolimus|mesh-list
2059436|NCT01797120|Fulvestrant|fulvestrant|mesh-list
2059437|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059438|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2059439|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
2059440|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059441|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2059442|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2059443|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2059444|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
2748222|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2748223|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
2748224|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748225|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
2748226|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2748227|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059445|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059446|NCT01797302|Vitamin D|vitamin d|mesh-list
2059447|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
2059448|NCT01797302|Vitamins|vitamins|mesh-ancestor
2059449|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
2059450|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059451|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2059452|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2059453|NCT01797432|Triamcinolone|triamcinolone|mesh-list
2059454|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2059455|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2059456|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2059457|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059458|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
2059459|NCT01797432|Hormones|hormones|mesh-ancestor
2059460|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059461|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059462|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2059463|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
2059464|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059465|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059466|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2059467|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2059468|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2059469|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
2059470|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059471|NCT01797484|Ranolazine|ranolazine|mesh-list
2059472|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2059473|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2059474|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059475|NCT01797575|Aspirin|aspirin|mesh-list
2059476|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
2059477|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2059478|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2059479|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2059480|NCT01797575|Analgesics|analgesics|mesh-ancestor
2059481|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
2059482|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059483|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059484|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059485|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2059486|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2059487|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2209991|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
2209992|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
2209993|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209994|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
2209995|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2209996|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2209997|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
2059488|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059489|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2059490|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2059491|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059492|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
2059493|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
2059494|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059495|NCT01797575|Expectorants|expectorants|mesh-ancestor
2059496|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
2059497|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2059498|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
2059499|NCT01797575|Protective Agents|protective agents|mesh-ancestor
2059500|NCT01797575|Antidotes|antidotes|mesh-ancestor
2059501|NCT01797822|Dexamethasone|dexamethasone|mesh-list
2059502|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
2059503|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059504|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
2059505|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
2059506|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059507|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059508|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2059509|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
2059510|NCT01797822|Hormones|hormones|mesh-ancestor
2059511|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059512|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2059513|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059514|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2059515|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2059516|NCT01797965|Daclizumab|daclizumab|mesh-list
2059517|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2059518|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
2059519|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059520|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
2059521|NCT01798004|Melphalan|melphalan|mesh-list
2059522|NCT01798004|Busulfan|busulfan|mesh-list
2059523|NCT01798004|Doxorubicin|doxorubicin|mesh-list
2059524|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2059525|NCT01798004|Etoposide|etoposide|mesh-list
2059526|NCT01798004|Vincristine|vincristine|mesh-list
2059527|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
2059528|NCT01798004|Topotecan|topotecan|mesh-list
2059529|NCT01798004|Mesna|mesna|mesh-list
2059530|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2059531|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
2059532|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059533|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2059534|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2059535|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
2059536|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059537|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059538|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2059539|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2059540|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2059541|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2059542|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059543|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2059544|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
2059545|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
2059546|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
2059547|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2059548|NCT01798004|Protective Agents|protective agents|mesh-ancestor
2059549|NCT01798056|Vaccines|vaccines|mesh-list
2059550|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
2059551|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059552|NCT01798225|Doxycycline|doxycycline|mesh-list
2059553|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2059554|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059555|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
2059556|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2059557|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2059558|NCT01798264|Exenatide|exenatide|mesh-list
2059559|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2059560|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059561|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2059562|NCT01798264|Incretins|incretins|mesh-ancestor
2059563|NCT01798264|Hormones|hormones|mesh-ancestor
2059564|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059565|NCT01798316|Acetaminophen|acetaminophen|mesh-list
2059566|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2059567|NCT01798316|Analgesics|analgesics|mesh-ancestor
2059568|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
2059569|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059570|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059571|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
2059572|NCT01798394|Progesterone|progesterone|mesh-list
2059573|NCT01798394|Progestins|progestins|mesh-ancestor
2059574|NCT01798394|Hormones|hormones|mesh-ancestor
2059575|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059576|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059577|NCT01798485|Docetaxel|docetaxel|mesh-list
2209998|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2209999|NCT00015899|Lonafarnib|lonafarnib|mesh-list
2210000|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210001|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210002|NCT00015912|Interferons|interferons|mesh-list
2210003|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
2210004|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
2210005|NCT00015912|Thalidomide|thalidomide|mesh-list
2210006|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210007|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
2210008|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210009|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
2210010|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059578|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059579|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
2059580|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
2059581|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
2059582|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059583|NCT01798550|Enoxaparin|enoxaparin|mesh-list
2059584|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
2059585|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2059586|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2059587|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059588|NCT01798706|Lixisenatide|lixisenatide|mesh-list
2059589|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2059590|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059591|NCT01798992|Metoprolol|metoprolol|mesh-list
2059592|NCT01798992|Carvedilol|carvedilol|mesh-list
2059593|NCT01798992|Doxazosin|doxazosin|mesh-list
2059594|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2059595|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2059596|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
2059597|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
2059598|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059599|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059600|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2059601|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2059602|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2059603|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
2059604|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059605|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059606|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
2059607|NCT01798992|Protective Agents|protective agents|mesh-ancestor
2059608|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2059609|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2059610|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2059611|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
2059612|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2059613|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2059614|NCT01799213|Meloxicam|meloxicam|mesh-list
2059615|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2059616|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2059617|NCT01799213|Analgesics|analgesics|mesh-ancestor
2059618|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
2059619|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2748269|NCT04907539|Denosumab|denosumab|mesh-list
2748270|NCT04907539|Nivolumab|nivolumab|mesh-list
2748271|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2748272|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748273|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2748274|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210011|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210012|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
2210013|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2210014|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2210015|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2210016|NCT00015912|Growth Substances|growth substances|mesh-ancestor
2210017|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
2210018|NCT00015925|Entinostat|entinostat|mesh-list
2210019|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210020|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2210021|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210022|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210023|NCT00015938|Docetaxel|docetaxel|mesh-list
2210024|NCT00015938|Vinorelbine|vinorelbine|mesh-list
2210025|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210026|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
2210027|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210028|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210029|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210030|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2210031|NCT00015951|Cytarabine|cytarabine|mesh-list
2210032|NCT00015951|Bevacizumab|bevacizumab|mesh-list
2210033|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
2210034|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2210035|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210036|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2210037|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2210038|NCT00015951|Growth Substances|growth substances|mesh-ancestor
2210039|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210040|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
2210041|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210042|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
2210043|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210044|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
2210045|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210046|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210047|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
2210048|NCT00015951|Analgesics|analgesics|mesh-ancestor
2210049|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
2210050|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2210051|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2210052|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210053|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210054|NCT00015964|Gefitinib|gefitinib|mesh-list
2210055|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210056|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2079417|NCT02058160|Metformin|metformin|mesh-list
2059620|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059621|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059622|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2059623|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2059624|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2059625|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059626|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210057|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210058|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210059|NCT00015977|Interleukin-12|interleukin-12|mesh-list
2210060|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2210061|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
2210062|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059627|NCT01799226|Triclosan|triclosan|mesh-list
2059628|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2059629|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059630|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2059631|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2059632|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
2059633|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059634|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2059635|NCT01799590|Topiramate|topiramate|mesh-list
2059636|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
2059637|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2059638|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059639|NCT01799941|Quinidine|quinidine|mesh-list
2059640|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
2059641|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
2210063|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2748275|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2748276|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748277|NCT04905407|Azacitidine|azacitidine|mesh-list
2748278|NCT04905407|Venetoclax|venetoclax|mesh-list
2748279|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2748280|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
2748281|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748282|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748283|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059642|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
2059643|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2059644|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2059645|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059646|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059647|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059648|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2059649|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2059650|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
2059651|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2059652|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
2059653|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2059654|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2059655|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059656|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059657|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2059658|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2059659|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
2059660|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2059661|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2059662|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2059663|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2059664|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2059665|NCT01799993|Amikacin|amikacin|mesh-list
2059666|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2059667|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059668|NCT01800838|Silicon|silicon|mesh-list
2059669|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
2059670|NCT01800838|Trace Elements|trace elements|mesh-ancestor
2059671|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
2059672|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059673|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
2059674|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2059675|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2059676|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059677|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
2059678|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2059679|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
2059680|NCT01800877|Phenylephrine|phenylephrine|mesh-list
2059681|NCT01800877|Dopamine|dopamine|mesh-list
2059682|NCT01800877|Vasopressins|vasopressins|mesh-list
2059683|NCT01800877|Epinephrine|epinephrine|mesh-list
2059684|NCT01800877|Norepinephrine|norepinephrine|mesh-list
2059685|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2059686|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2059687|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2059688|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
2059689|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059690|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059691|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059692|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2059693|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2059694|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
2059695|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059696|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2059697|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
2059698|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
2059699|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
2059700|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2059701|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
2059702|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2059703|NCT01800877|Protective Agents|protective agents|mesh-ancestor
2059704|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
2059705|NCT01800877|Coagulants|coagulants|mesh-ancestor
2059706|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2059707|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
2059708|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
2059709|NCT01800968|Liraglutide|liraglutide|mesh-list
2059710|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2059711|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059712|NCT01800968|Incretins|incretins|mesh-ancestor
2059713|NCT01800968|Hormones|hormones|mesh-ancestor
2059714|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059715|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2059716|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059717|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2059718|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059719|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059720|NCT01801124|Bupivacaine|bupivacaine|mesh-list
2059721|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
2059722|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
2059723|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2059724|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059725|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
2059726|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059727|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
2059728|NCT01801280|Pantoprazole|pantoprazole|mesh-list
2059729|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2059730|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059731|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2059732|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
2059733|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2059734|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059735|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059736|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059737|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2059738|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2059739|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2059740|NCT01801436|Bortezomib|bortezomib|mesh-list
2059741|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059742|NCT01801449|Rilonacept|rilonacept|mesh-list
2059743|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059744|NCT01801475|Ondansetron|ondansetron|mesh-list
2059745|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
2059746|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
2059747|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059748|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059749|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2059750|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
2059751|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
2059752|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2059753|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
2059754|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059755|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059756|NCT01801475|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2059757|NCT01801475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2059758|NCT01801475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2059759|NCT01801475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2059760|NCT01801475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2059761|NCT01801735|Meloxicam|meloxicam|mesh-list
2059762|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2059763|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2059764|NCT01801735|Analgesics|analgesics|mesh-ancestor
2059765|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
2059766|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059767|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059768|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059769|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2059770|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2059771|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2059772|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059773|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059774|NCT01801917|Siponimod|siponimod|mesh-list
2059775|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2059776|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059777|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2059778|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
2059779|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059780|NCT01802073|Vancomycin|vancomycin|mesh-list
2059781|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2059782|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059783|NCT01802216|Minocycline|minocycline|mesh-list
2059784|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2059785|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059786|NCT01802333|Cytarabine|cytarabine|mesh-list
2059787|NCT01802333|Daunorubicin|daunorubicin|mesh-list
2210064|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2210065|NCT00015977|Growth Substances|growth substances|mesh-ancestor
2210066|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
2210067|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210068|NCT00015990|Thalidomide|thalidomide|mesh-list
2210069|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210070|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
2210071|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059788|NCT01802333|Vorinostat|vorinostat|mesh-list
2210072|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
2210073|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2210074|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210075|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2059789|NCT01802333|Idarubicin|idarubicin|mesh-list
2059790|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2059791|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
2059792|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059793|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059794|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
2059795|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059796|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2059797|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
2059798|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059799|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2059800|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2059801|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2059802|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059803|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2059804|NCT01802385|Sertraline|sertraline|mesh-list
2059805|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
2059806|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2059807|NCT01802385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2059808|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2059809|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2059810|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059811|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059812|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
2059813|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059814|NCT01802437|Fluoxetine|fluoxetine|mesh-list
2059815|NCT01802437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2059816|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2059817|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2059818|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059819|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059820|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
2059821|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059822|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2059823|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
2059824|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2059825|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2059826|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2059827|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059828|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2059829|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2079418|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
2059830|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2059831|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2059832|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059833|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
2059834|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059835|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059836|NCT01802580|Fluocinonide|fluocinonide|mesh-list
2059837|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059838|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
2059839|NCT01802580|Hormones|hormones|mesh-ancestor
2059840|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2059841|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059842|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2059843|NCT01802632|Osimertinib|osimertinib|mesh-list
2059844|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059845|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2059846|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059847|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059848|NCT01802775|Aspirin|aspirin|mesh-list
2059849|NCT01802775|Edoxaban|edoxaban|mesh-list
2059850|NCT01802775|Clopidogrel|clopidogrel|mesh-list
2059851|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2059852|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2059853|NCT01802775|Analgesics|analgesics|mesh-ancestor
2059854|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
2059855|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059856|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059857|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2059858|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2059859|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2059860|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2059861|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059862|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2059863|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2059864|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059865|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
2059866|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2059867|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2059868|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2059869|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
2059870|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059871|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2059872|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
2059873|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2059874|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
2059875|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
2059876|NCT01802879|Panobinostat|panobinostat|mesh-list
2059877|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059878|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2059879|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059880|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059881|NCT01803074|Ritonavir|ritonavir|mesh-list
2059882|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2059883|NCT01803074|Tenofovir|tenofovir|mesh-list
2059884|NCT01803074|Emtricitabine|emtricitabine|mesh-list
2059885|NCT01803074|BMS-955176|bms-955176|mesh-list
2210076|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2210077|NCT00015990|Growth Substances|growth substances|mesh-ancestor
2210078|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
2210079|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210080|NCT00016016|Cytarabine|cytarabine|mesh-list
2210081|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
2210082|NCT00016016|Alvocidib|alvocidib|mesh-list
2210083|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210084|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
2210085|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210086|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210087|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
2059886|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2059887|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2059888|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
2059889|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059890|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059891|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2059892|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2059893|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
2059894|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059895|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2059896|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2059897|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2059898|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2059899|NCT01803269|Topotecan|topotecan|mesh-list
2059900|NCT01803269|Camptothecin|camptothecin|mesh-list
2059901|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2059902|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2059903|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059904|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059905|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059906|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2059907|NCT01803282|Leucovorin|leucovorin|mesh-list
2059908|NCT01803282|Gemcitabine|gemcitabine|mesh-list
2059909|NCT01803282|Paclitaxel|paclitaxel|mesh-list
2059910|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2059911|NCT01803282|Bevacizumab|bevacizumab|mesh-list
2059912|NCT01803282|Carboplatin|carboplatin|mesh-list
2059913|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
2059914|NCT01803282|Irinotecan|irinotecan|mesh-list
2059915|NCT01803282|Pemetrexed|pemetrexed|mesh-list
2059916|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2059917|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059918|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
2059919|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210088|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059920|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
2059921|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059922|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2059923|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2059924|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2059925|NCT01803282|Growth Substances|growth substances|mesh-ancestor
2059926|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059927|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
2059928|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2059929|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
2059930|NCT01803282|Antiviral Agents|antiviral agents|mesh-ancestor
2059931|NCT01803282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059932|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059933|NCT01803282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2059934|NCT01803282|Immunologic Factors|immunologic factors|mesh-ancestor
2059935|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2059936|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2059937|NCT01803282|Antidotes|antidotes|mesh-ancestor
2059938|NCT01803282|Protective Agents|protective agents|mesh-ancestor
2059939|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
2059940|NCT01803282|Vitamins|vitamins|mesh-ancestor
2059941|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
2059942|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2059943|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2059944|NCT01804036|Zolpidem|zolpidem|mesh-list
2059945|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2059946|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2059947|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2059948|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059949|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2059950|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
2059951|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
2059952|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2059953|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059954|NCT01804049|Metformin|metformin|mesh-list
2059955|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2059956|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059957|NCT01804075|Morphine|morphine|mesh-list
2059958|NCT01804075|Methadone|methadone|mesh-list
2059959|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2059960|NCT01804075|Narcotics|narcotics|mesh-ancestor
2059961|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2059962|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059963|NCT01804075|Analgesics|analgesics|mesh-ancestor
2059964|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
2059965|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059966|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
2059967|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
2059968|NCT01804101|Cytarabine|cytarabine|mesh-list
2059969|NCT01804101|Daunorubicin|daunorubicin|mesh-list
2059970|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2059971|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
2059972|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2059973|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059974|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
2059975|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2059976|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2059977|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
2059978|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059979|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2059980|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2059981|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2059982|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2059983|NCT01804465|Ipilimumab|ipilimumab|mesh-list
2059984|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2059985|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2059986|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2059987|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748309|NCT04895748|Everolimus|everolimus|mesh-list
2748310|NCT04895748|Spartalizumab|spartalizumab|mesh-list
2059988|NCT01804673|Fentanyl|fentanyl|mesh-list
2059989|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2059990|NCT01804673|Narcotics|narcotics|mesh-ancestor
2059991|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2059992|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2059993|NCT01804673|Analgesics|analgesics|mesh-ancestor
2059994|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
2059995|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2059996|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2059997|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2059998|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
2059999|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
2060000|NCT01804946|Oseltamivir|oseltamivir|mesh-list
2060001|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
2060002|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060003|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060004|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060005|NCT01805037|Rituximab|rituximab|mesh-list
2060006|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2060007|NCT01805037|Antibodies|antibodies|mesh-list
2060008|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
2060009|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2060010|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
2060011|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
2210089|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210090|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
2210091|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060012|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060013|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2060014|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060015|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2060016|NCT01805089|Melatonin|melatonin|mesh-list
2060017|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
2060018|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060019|NCT01805089|Protective Agents|protective agents|mesh-ancestor
2060020|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060021|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2060022|NCT01805297|Aflibercept|aflibercept|mesh-list
2060023|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2060024|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2060025|NCT01805297|Growth Substances|growth substances|mesh-ancestor
2060026|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060027|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
2060028|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060029|NCT01805323|Dexamethasone|dexamethasone|mesh-list
2060030|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2060031|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
2060032|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
2060033|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060034|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060035|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2060036|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
2060037|NCT01805323|Hormones|hormones|mesh-ancestor
2060038|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2060039|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2060040|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060041|NCT01805687|Zileuton|zileuton|mesh-list
2060042|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2060043|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2060044|NCT01805687|Analgesics|analgesics|mesh-ancestor
2060045|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
2060046|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060047|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060048|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2060049|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2060050|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2060051|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060052|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060053|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2060054|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
2060055|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2060056|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
2060057|NCT01805882|Ledipasvir|ledipasvir|mesh-list
2060058|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
2060059|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060060|NCT01805895|Minocycline|minocycline|mesh-list
2060061|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2060062|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060063|NCT01806064|Axitinib|axitinib|mesh-list
2060064|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060065|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2060066|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060067|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060068|NCT01806259|Ketorolac|ketorolac|mesh-list
2060069|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2060070|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2060071|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2060072|NCT01806259|Analgesics|analgesics|mesh-ancestor
2060073|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
2060074|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060075|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060076|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2060077|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2060078|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2060079|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060080|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060081|NCT01806298|Hormones|hormones|mesh-list
2079419|NCT02058160|Lixisenatide|lixisenatide|mesh-list
2060082|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2060083|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060084|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
2060085|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
2060086|NCT01806545|Coagulants|coagulants|mesh-ancestor
2060087|NCT01806571|Cytarabine|cytarabine|mesh-list
2060088|NCT01806571|Daunorubicin|daunorubicin|mesh-list
2060089|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2060090|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
2060091|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060092|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060093|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
2060094|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060095|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2060096|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
2060097|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060098|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2060099|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2060100|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2060101|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060102|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
2060103|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
2060104|NCT01806584|Coagulants|coagulants|mesh-ancestor
2060105|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2060106|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
2060107|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060108|NCT01806623|Fluconazole|fluconazole|mesh-list
2060109|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
2060110|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060111|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2060112|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2060113|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060114|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060115|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2060116|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
2060117|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2060118|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060119|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2060120|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2060121|NCT01806662|Ustekinumab|ustekinumab|mesh-list
2060122|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
2060123|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2060124|NCT01806675|Glycine|glycine|mesh-list
2060125|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2060126|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060127|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
2060128|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060129|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060130|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2060131|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
2060132|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
2060133|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060134|NCT01806779|Bupropion|bupropion|mesh-list
2060135|NCT01806779|Nicotine|nicotine|mesh-list
2060136|NCT01806779|Varenicline|varenicline|mesh-list
2060137|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2060138|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
2060139|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060140|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060141|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2060142|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2060143|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
2060144|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060145|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060146|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2060147|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
2060148|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2060149|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2060150|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2060151|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060152|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
2060153|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2060154|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2060155|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060156|NCT01806857|Quinidine|quinidine|mesh-list
2060157|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
2060158|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
2060159|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
2060160|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2060161|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2060162|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060163|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060164|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060165|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2060166|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2060167|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
2060168|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2060169|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
2060170|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2060171|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2060172|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060173|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060174|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2060175|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2060176|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
2060177|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2060178|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2060179|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060180|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2060181|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2060182|NCT01807000|Prucalopride|prucalopride|mesh-list
2060183|NCT01807000|Laxatives|laxatives|mesh-ancestor
2060184|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2060185|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2060186|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2060187|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
2060188|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060189|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060190|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748311|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748312|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2748313|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
2060194|NCT01807221|Eplerenone|eplerenone|mesh-list
2060195|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2060196|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
2060197|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2060198|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060199|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2060200|NCT01807221|Diuretics|diuretics|mesh-ancestor
2060201|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
2060202|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2060203|NCT01807234|Ketorolac|ketorolac|mesh-list
2060204|NCT01807234|Sumatriptan|sumatriptan|mesh-list
2060205|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2060206|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2060207|NCT01807234|Analgesics|analgesics|mesh-ancestor
2060208|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
2060209|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060210|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060211|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2060212|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2060213|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2060214|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060215|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060216|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2060217|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2060218|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2060219|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
2060220|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060221|NCT01807455|Lidocaine|lidocaine|mesh-list
2060222|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
2060223|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
2060224|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2060225|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060226|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
2060227|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060228|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2060229|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2060230|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2060231|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060232|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060233|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2060234|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
2079420|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2060235|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060236|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2060237|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
2060238|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2060239|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060240|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
2060241|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060242|NCT01807624|Phenylephrine|phenylephrine|mesh-list
2060243|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
2060244|NCT01807624|Tetracaine|tetracaine|mesh-list
2060245|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
2060246|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
2060247|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2060248|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060249|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
2060250|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060251|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2060252|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2060253|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
2060254|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060255|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060256|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
2060257|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
2060258|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
2060259|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2060260|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
2060261|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2060262|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
2060263|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2060264|NCT01807624|Protective Agents|protective agents|mesh-ancestor
2060265|NCT01807871|Nicotine|nicotine|mesh-list
2060266|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2060267|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
2060268|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060269|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060270|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2060271|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2060272|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
2060273|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060274|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060275|NCT01807923|Ivacaftor|ivacaftor|mesh-list
2060276|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2060277|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060278|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060279|NCT01807949|Ivacaftor|ivacaftor|mesh-list
2060280|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2060281|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060282|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060283|NCT01808092|Meropenem|meropenem|mesh-list
2060284|NCT01808092|Ceftazidime|ceftazidime|mesh-list
2060285|NCT01808092|Avibactam|avibactam|mesh-list
2060286|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
2060287|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2060288|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060289|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2060290|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060291|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060292|NCT01808118|Adalimumab|adalimumab|mesh-list
2060293|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2060294|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2060295|NCT01808144|Febuxostat|febuxostat|mesh-list
2060296|NCT01808144|Lesinurad|lesinurad|mesh-list
2060297|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
2060298|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2060299|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
2060300|NCT01808144|Renal Agents|renal agents|mesh-ancestor
2060301|NCT01808196|Losartan|losartan|mesh-list
2060302|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
2060303|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2060304|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2060305|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2060306|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2060307|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060308|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2060309|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
2060310|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
2060311|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060312|NCT01808313|Ambrisentan|ambrisentan|mesh-list
2060313|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2060314|NCT01808326|Chlorambucil|chlorambucil|mesh-list
2060315|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2060316|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
2060317|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060318|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060319|NCT01808339|Fluticasone|fluticasone|mesh-list
2060320|NCT01808339|Xhance|xhance|mesh-list
2060321|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2060322|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2060323|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
2060324|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060325|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060326|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2060327|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
2060328|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
2060329|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2060330|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
2060331|NCT01808534|Ifosfamide|ifosfamide|mesh-list
2060332|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2060333|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
2060334|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060335|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060336|NCT01808547|Bromfenac|bromfenac|mesh-list
2060337|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2060338|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2060339|NCT01808547|Analgesics|analgesics|mesh-ancestor
2060340|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
2060341|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060342|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060343|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2060344|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2060345|NCT01808573|Capecitabine|capecitabine|mesh-list
2060346|NCT01808573|Lapatinib|lapatinib|mesh-list
2060347|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2060348|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
2060349|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060350|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060351|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2060352|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060353|NCT01808612|Fluoxetine|fluoxetine|mesh-list
2060354|NCT01808612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2060355|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2060356|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060357|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060358|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060359|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
2060360|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060361|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2060362|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
2060363|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2060364|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2060365|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2060366|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060367|NCT01808651|Fluoxetine|fluoxetine|mesh-list
2060368|NCT01808651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2060369|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2060370|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060371|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060372|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060373|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
2060374|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060375|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2060376|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
2060377|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2060378|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2060379|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2060380|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060381|NCT01808690|Metformin|metformin|mesh-list
2060382|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2060383|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060384|NCT01808755|Trimethoprim|trimethoprim|mesh-list
2060385|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
2060386|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2060387|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060388|NCT01808755|Renal Agents|renal agents|mesh-ancestor
2060389|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
2060390|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2060391|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2060392|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2060393|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060394|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060395|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2060396|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2060397|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2060398|NCT01809054|Aspirin|aspirin|mesh-list
2060399|NCT01809054|Fondaparinux|fondaparinux|mesh-list
2060400|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2060401|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2060402|NCT01809054|Analgesics|analgesics|mesh-ancestor
2060403|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
2060404|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060405|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060406|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2060407|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2060408|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2060409|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2060410|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060411|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2060412|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2060413|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060414|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
2060415|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2060416|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
2060417|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2060418|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
2060419|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
2060420|NCT01809106|Fentanyl|fentanyl|mesh-list
2060421|NCT01809106|Morphine|morphine|mesh-list
2060422|NCT01809106|Oxycodone|oxycodone|mesh-list
2060423|NCT01809106|Buprenorphine|buprenorphine|mesh-list
2060424|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2060425|NCT01809106|Narcotics|narcotics|mesh-ancestor
2060426|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2060427|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060428|NCT01809106|Analgesics|analgesics|mesh-ancestor
2060429|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
2060430|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060431|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2060432|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2060433|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
2060434|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
2060435|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2060436|NCT01809132|Zinc|zinc|mesh-list
2060437|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
2060438|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2060439|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2060440|NCT01809132|Prednisolone|prednisolone|mesh-list
2060441|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
2060442|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2060443|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
2060444|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
2060445|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2060446|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
2060447|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2060448|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
2060449|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
2060450|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060451|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060452|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2060453|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
2060454|NCT01809132|Hormones|hormones|mesh-ancestor
2060455|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2060456|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2060457|NCT01809132|Protective Agents|protective agents|mesh-ancestor
2060458|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2060459|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060460|NCT01809132|Trace Elements|trace elements|mesh-ancestor
2060461|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
2060462|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2060463|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2060464|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060465|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060466|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2060467|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2060468|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
2060469|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2060470|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
2060471|NCT01809132|Astringents|astringents|mesh-ancestor
2060472|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
2060473|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2060474|NCT01809210|Gemcitabine|gemcitabine|mesh-list
2060475|NCT01809210|Carboplatin|carboplatin|mesh-list
2060476|NCT01809210|Pemetrexed|pemetrexed|mesh-list
2060477|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060478|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2060479|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
2060480|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060481|NCT01809210|Antiviral Agents|antiviral agents|mesh-ancestor
2060482|NCT01809210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060483|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060484|NCT01809210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2060485|NCT01809210|Immunologic Factors|immunologic factors|mesh-ancestor
2060486|NCT01809210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060487|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2060488|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2060489|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
2060490|NCT01809314|Hematinics|hematinics|mesh-ancestor
2060491|NCT01809327|Metformin|metformin|mesh-list
2060492|NCT01809327|Canagliflozin|canagliflozin|mesh-list
2060493|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2060494|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060495|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2210092|NCT00016016|Analgesics|analgesics|mesh-ancestor
2060496|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060497|NCT01809639|Progesterone|progesterone|mesh-list
2060498|NCT01809639|Progestins|progestins|mesh-ancestor
2060499|NCT01809639|Hormones|hormones|mesh-ancestor
2060500|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2060501|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060502|NCT01810016|Poly I-C|poly i-c|mesh-list
2060503|NCT01810016|Ipilimumab|ipilimumab|mesh-list
2060504|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2060505|NCT01810016|Vaccines|vaccines|mesh-list
2060506|NCT01810016|Poly ICLC|poly iclc|mesh-list
2060507|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
2060508|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060509|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2060510|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060511|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2060512|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060513|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
2060514|NCT01810016|Laxatives|laxatives|mesh-ancestor
2060515|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2060516|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
2060517|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060518|NCT01810042|Ranibizumab|ranibizumab|mesh-list
2060519|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2060520|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2060521|NCT01810042|Growth Substances|growth substances|mesh-ancestor
2060522|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060523|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
2060524|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060525|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2060526|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
2060527|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
2060528|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2060529|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2060530|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2060531|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2060532|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060533|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
2060534|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060535|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060536|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
2060537|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
2060538|NCT01810432|Evacetrapib|evacetrapib|mesh-list
2060539|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2060540|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2060541|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
2060542|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060543|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2060544|NCT01810666|Factor VIII|factor viii|mesh-list
2060545|NCT01810666|Coagulants|coagulants|mesh-ancestor
2060546|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
2060547|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2060548|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
2060549|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060550|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060551|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2060552|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
2060553|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
2060554|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2060555|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
2060556|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060557|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060558|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
2060559|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
2060560|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060561|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060562|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060563|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
2060564|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
2060565|NCT01810952|Insulin|insulin|mesh-list
2060566|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2060567|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
2060568|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
2060569|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
2060570|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
2060571|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
2060572|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2060573|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060574|NCT01811147|Norepinephrine|norepinephrine|mesh-list
2060575|NCT01811147|Serotonin|serotonin|mesh-list
2060576|NCT01811147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2060577|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2060578|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2060579|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
2060580|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060581|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060582|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060583|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
2060584|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
2060585|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060586|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2060587|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2060588|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
2060589|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2060590|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060591|NCT01811186|Oxycodone|oxycodone|mesh-list
2060592|NCT01811186|Naloxone|naloxone|mesh-list
2060593|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2060594|NCT01811186|Narcotics|narcotics|mesh-ancestor
2060595|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2060596|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060597|NCT01811186|Analgesics|analgesics|mesh-ancestor
2060598|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
2060599|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060600|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2060601|NCT01811225|Progesterone|progesterone|mesh-list
2060602|NCT01811225|Progestins|progestins|mesh-ancestor
2060603|NCT01811225|Hormones|hormones|mesh-ancestor
2060604|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2060605|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060606|NCT01811238|Oxycodone|oxycodone|mesh-list
2060607|NCT01811238|Naloxone|naloxone|mesh-list
2060608|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2060609|NCT01811238|Narcotics|narcotics|mesh-ancestor
2060610|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2060611|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060612|NCT01811238|Analgesics|analgesics|mesh-ancestor
2060613|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
2060614|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060615|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2060616|NCT01811355|Mexiletine|mexiletine|mesh-list
2060617|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2060618|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2060619|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2060620|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060621|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060622|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
2060623|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2060624|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
2060625|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060626|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
2060627|NCT01811654|Protective Agents|protective agents|mesh-ancestor
2060628|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
2060629|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
2060630|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
2060631|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2060632|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060633|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060634|NCT01811732|Vancomycin|vancomycin|mesh-list
2060635|NCT01811732|Aztreonam|aztreonam|mesh-list
2060636|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2060637|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060638|NCT01811940|Topiramate|topiramate|mesh-list
2060639|NCT01811940|Adderall|adderall|mesh-list
2060640|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
2060641|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2060642|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060643|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2060644|NCT01811953|Metformin|metformin|mesh-list
2060645|NCT01811953|Empagliflozin|empagliflozin|mesh-list
2060646|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2060647|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060648|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2060649|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060650|NCT01812005|Rituximab|rituximab|mesh-list
2060651|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2060652|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060653|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
2060654|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060655|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2060656|NCT01812044|Lidocaine|lidocaine|mesh-list
2060657|NCT01812044|Bupivacaine|bupivacaine|mesh-list
2060658|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
2060659|NCT01812044|Anesthetics|anesthetics|mesh-list
2060660|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2060661|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060662|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
2060663|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060664|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2060665|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2060666|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2060667|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060668|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060669|NCT01812057|Dexamethasone|dexamethasone|mesh-list
2060670|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2060671|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
2060672|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
2060673|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060674|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060675|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2060676|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
2060677|NCT01812057|Hormones|hormones|mesh-ancestor
2060678|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2060679|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2060680|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060681|NCT01812668|Fluorides|fluorides|mesh-list
2060682|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
2060683|NCT01812668|Protective Agents|protective agents|mesh-ancestor
2060684|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060685|NCT01812707|Atorvastatin|atorvastatin|mesh-list
2060686|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2060687|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2060688|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2060689|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
2060690|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060691|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2060692|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2060693|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060694|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
2060695|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060696|NCT01812759|Fentanyl|fentanyl|mesh-list
2060697|NCT01812759|Hydromorphone|hydromorphone|mesh-list
2060698|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2060699|NCT01812759|Narcotics|narcotics|mesh-ancestor
2060700|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2060701|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060702|NCT01812759|Analgesics|analgesics|mesh-ancestor
2060703|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
2060704|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060705|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2060706|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2060707|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
2060708|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
2060709|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2060710|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2060711|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
2060712|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
2060713|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2060714|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2060715|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060716|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
2060717|NCT01813058|Coagulants|coagulants|mesh-ancestor
2060718|NCT01813149|Clonidine|clonidine|mesh-list
2060719|NCT01813149|Phenylephrine|phenylephrine|mesh-list
2060720|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
2060721|NCT01813149|Anesthetics|anesthetics|mesh-list
2060722|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
2060723|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2060724|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060725|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
2060726|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060727|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2060728|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
2060729|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
2060730|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
2060731|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2060732|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
2060733|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
2060734|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2060735|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2060736|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2060737|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
2060738|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060739|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060740|NCT01813149|Protective Agents|protective agents|mesh-ancestor
2060741|NCT01813149|Analgesics|analgesics|mesh-ancestor
2060742|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2060743|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
2060744|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2060745|NCT01813214|Vemurafenib|vemurafenib|mesh-list
2060746|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060747|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2060748|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060749|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060750|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2060751|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2060752|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2060753|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
2060754|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060755|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2060756|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2060757|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060758|NCT01813422|Evolocumab|evolocumab|mesh-list
2060759|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2060760|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2060761|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
2060762|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060763|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2060764|NCT01813435|Aspirin|aspirin|mesh-list
2060765|NCT01813435|Clopidogrel|clopidogrel|mesh-list
2060766|NCT01813435|Ticagrelor|ticagrelor|mesh-list
2060767|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2060768|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2060769|NCT01813435|Analgesics|analgesics|mesh-ancestor
2060770|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
2060771|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060772|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060773|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2060774|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2060775|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2060776|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2060777|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060778|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2060779|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2060780|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060781|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
2060782|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2060783|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2060784|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2060785|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
2060786|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060787|NCT01813474|Olaparib|olaparib|mesh-list
2060788|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2060789|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060790|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060791|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060792|NCT01813734|Ponatinib|ponatinib|mesh-list
2060793|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060794|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2060795|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060796|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060797|NCT01813890|Tapentadol|tapentadol|mesh-list
2060798|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2060799|NCT01813890|Narcotics|narcotics|mesh-ancestor
2060800|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2060801|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060802|NCT01813890|Analgesics|analgesics|mesh-ancestor
2060803|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
2060804|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060805|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2060806|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2060807|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060808|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060809|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
2060810|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060811|NCT01814046|Aldesleukin|aldesleukin|mesh-list
2060812|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
2060813|NCT01814046|Fludarabine|fludarabine|mesh-list
2060814|NCT01814046|Interleukin-2|interleukin-2|mesh-list
2060815|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210093|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
2210094|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2210095|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2210096|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210097|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210098|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
2210099|NCT00016016|Growth Substances|growth substances|mesh-ancestor
2210100|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2210101|NCT00016042|Interferons|interferons|mesh-list
2210102|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
2210103|NCT00016042|Fluorouracil|fluorouracil|mesh-list
2210104|NCT00016042|Sargramostim|sargramostim|mesh-list
2210105|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
2210106|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210107|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210108|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210109|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210110|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
2210111|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210112|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
2060816|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
2060817|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060818|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2060819|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2060820|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
2060821|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060822|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060823|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2060824|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2060825|NCT01814046|Analgesics|analgesics|mesh-ancestor
2060826|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
2060827|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060828|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2060829|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2060830|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
2060831|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060832|NCT01814137|Insulin|insulin|mesh-list
2060833|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2060834|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
2060835|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
2060836|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2060837|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2060838|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060839|NCT01814371|Mupirocin|mupirocin|mesh-list
2060840|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2060841|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060842|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2060843|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060844|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060845|NCT01814397|Letrozole|letrozole|mesh-list
2060846|NCT01814397|Anastrozole|anastrozole|mesh-list
2060847|NCT01814397|Exemestane|exemestane|mesh-list
2060848|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060849|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2060850|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2060851|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060852|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060853|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2060854|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
2060855|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2060856|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060857|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2060858|NCT01814553|Afatinib|afatinib|mesh-list
2060859|NCT01814553|Loperamide|loperamide|mesh-list
2060860|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
2060861|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060862|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2060863|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060864|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060865|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2060866|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
2060867|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2060868|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2060869|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2060870|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060871|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060872|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
2060873|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060874|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060875|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2060876|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060877|NCT01814748|Metformin|metformin|mesh-list
2060878|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2060879|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060880|NCT01814761|Bimatoprost|bimatoprost|mesh-list
2060881|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2060882|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
2060883|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
2060884|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060885|NCT01814813|Bevacizumab|bevacizumab|mesh-list
2060886|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2060887|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060888|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2060889|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2060890|NCT01814813|Growth Substances|growth substances|mesh-ancestor
2060891|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060892|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
2748314|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748315|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2748316|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060900|NCT01814878|Acetaminophen|acetaminophen|mesh-list
2060901|NCT01814878|Tramadol|tramadol|mesh-list
2060902|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2060903|NCT01814878|Analgesics|analgesics|mesh-ancestor
2060904|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
2060905|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060906|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060907|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
2060908|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2060909|NCT01814878|Narcotics|narcotics|mesh-ancestor
2060910|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2060911|NCT01815008|Aspirin|aspirin|mesh-list
2060912|NCT01815008|Clopidogrel|clopidogrel|mesh-list
2060913|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2060914|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2060915|NCT01815008|Analgesics|analgesics|mesh-ancestor
2060916|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
2060917|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060918|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060919|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2060920|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2060921|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2060922|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2060923|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060924|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2060925|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2060926|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060927|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
2060928|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2060929|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2060930|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2060931|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
2060932|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060933|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2060934|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2060935|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060936|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2060937|NCT01815333|Hematinics|hematinics|mesh-ancestor
2060938|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2060939|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2060940|NCT01815424|Tofacitinib|tofacitinib|mesh-list
2060941|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2060942|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060943|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060944|NCT01815736|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2060945|NCT01815736|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2060946|NCT01815736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2060947|NCT01815736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2060948|NCT01815736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2060949|NCT01815736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060950|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
2060951|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060952|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2060953|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2060954|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
2060955|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2060956|NCT01816048|Listerine|listerine|mesh-list
2060957|NCT01816048|Fluorides|fluorides|mesh-list
2060958|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
2060959|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
2060960|NCT01816048|Protective Agents|protective agents|mesh-ancestor
2060961|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060962|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2060963|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2060964|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2060965|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2060966|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060967|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2060968|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2060969|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2060970|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2060971|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
2060972|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2060973|NCT01816243|Fentanyl|fentanyl|mesh-list
2060974|NCT01816243|Morphine|morphine|mesh-list
2060975|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2060976|NCT01816243|Narcotics|narcotics|mesh-ancestor
2060977|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2060978|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060979|NCT01816243|Analgesics|analgesics|mesh-ancestor
2060980|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
2060981|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2060982|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2060983|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2060984|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
2060985|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
2060986|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
2060987|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2060988|NCT01816295|Testosterone|testosterone|mesh-list
2060989|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
2060990|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
2060991|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2060992|NCT01816295|Androgens|androgens|mesh-ancestor
2060993|NCT01816295|Hormones|hormones|mesh-ancestor
2060994|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2060995|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2060996|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2060997|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2060998|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
2060999|NCT01816477|Ropivacaine|ropivacaine|mesh-list
2061000|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
2210113|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210114|NCT00016055|Temozolomide|temozolomide|mesh-list
2210115|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210116|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
2210117|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210118|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061001|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
2061002|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2210119|NCT00016068|Valganciclovir|valganciclovir|mesh-list
2210120|NCT00016068|Ganciclovir|ganciclovir|mesh-list
2210121|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2210122|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
2210123|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210124|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2210125|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061003|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061004|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
2061005|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061006|NCT01816594|Paclitaxel|paclitaxel|mesh-list
2061007|NCT01816594|Trastuzumab|trastuzumab|mesh-list
2061008|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2061009|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061010|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
2061011|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
2061012|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
2061013|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061014|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2061015|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2061016|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061017|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2061018|NCT01816984|Cetuximab|cetuximab|mesh-list
2061019|NCT01816984|Antibodies|antibodies|mesh-list
2061020|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
2061021|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2061022|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
2061023|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061024|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061025|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
2061026|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2061027|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2061028|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061029|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
2061030|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
2061031|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2061032|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2061033|NCT01817530|Norethindrone|norethindrone|mesh-list
2061034|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
2061035|NCT01817530|Estradiol|estradiol|mesh-list
2061036|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2061037|NCT01817530|Estrogens|estrogens|mesh-ancestor
2061038|NCT01817530|Hormones|hormones|mesh-ancestor
2061039|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2061040|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061041|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2061042|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
2061043|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2061044|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2061045|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2061046|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2061047|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2061048|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2061049|NCT01817582|Cyclosporine|cyclosporine|mesh-list
2061050|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2061051|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
2061052|NCT01817582|Cyclosporins|cyclosporins|mesh-list
2061053|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061054|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061055|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2061056|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
2061057|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061058|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
2061059|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061060|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
2061061|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2061062|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2061063|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2061064|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2061065|NCT01817751|Sorafenib|sorafenib|mesh-list
2061066|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
2061067|NCT01817751|Valproic Acid|valproic acid|mesh-list
2061068|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061069|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061070|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2061071|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061072|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
2061073|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2061074|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2061075|NCT01817751|Urological Agents|urological agents|mesh-ancestor
2061076|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
2061077|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
2061078|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061079|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061080|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
2061081|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2061082|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2210126|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210127|NCT00016081|Ribavirin|ribavirin|mesh-list
2210128|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
2210129|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061083|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2061084|NCT01817764|Fluticasone|fluticasone|mesh-list
2061085|NCT01817764|Xhance|xhance|mesh-list
2061086|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2061087|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2061088|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2061089|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
2061090|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061091|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061092|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2061093|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
2061094|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
2061095|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2061096|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2061097|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2061098|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2061099|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
2061100|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061101|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061102|NCT01817777|Metformin|metformin|mesh-list
2061103|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2061104|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061105|NCT01817790|Fluticasone|fluticasone|mesh-list
2061106|NCT01817790|Xhance|xhance|mesh-list
2061107|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2061108|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2061109|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
2061110|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061111|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061112|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2061113|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
2061114|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
2061115|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2061116|NCT01817855|AZD7624|azd7624|mesh-list
2061117|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2210130|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
2210131|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210132|NCT00016094|Bevacizumab|bevacizumab|mesh-list
2210133|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2061118|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061119|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061120|NCT01817907|Trazodone|trazodone|mesh-list
2061121|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2061122|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2061123|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2061124|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061125|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2061126|NCT01817907|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2061127|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2061128|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2061129|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061130|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061131|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
2061132|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2061133|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
2061134|NCT01818063|Paclitaxel|paclitaxel|mesh-list
2061135|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
2061136|NCT01818063|Carboplatin|carboplatin|mesh-list
2061137|NCT01818063|Doxorubicin|doxorubicin|mesh-list
2061138|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2061139|NCT01818063|Veliparib|veliparib|mesh-list
2061140|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2061141|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061142|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
2061143|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
2061144|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
2061145|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061146|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2061147|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
2061148|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061149|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2061150|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2061151|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
2061152|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2061153|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2061154|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2061155|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2061156|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061157|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2061158|NCT01818141|Vancomycin|vancomycin|mesh-list
2061159|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
2061160|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2061161|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061162|NCT01818258|Ritonavir|ritonavir|mesh-list
2061163|NCT01818258|Lopinavir|lopinavir|mesh-list
2061164|NCT01818258|Lamivudine|lamivudine|mesh-list
2061165|NCT01818258|Zidovudine|zidovudine|mesh-list
2061166|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2061167|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2061168|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
2061169|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061170|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061171|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2061172|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2061173|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
2061174|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061175|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2061176|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2061177|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2061178|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2061179|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
2061180|NCT01818284|Plerixafor|plerixafor|mesh-list
2061181|NCT01818284|Lenograstim|lenograstim|mesh-list
2061182|NCT01818284|Sargramostim|sargramostim|mesh-list
2061183|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2061184|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
2061185|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061186|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2061187|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2061188|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
2061189|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061190|NCT01818336|Amoxicillin|amoxicillin|mesh-list
2061191|NCT01818336|Penicillins|penicillins|mesh-list
2061192|NCT01818336|Penicillin G|penicillin g|mesh-list
2061193|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2061194|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061195|NCT01818414|Vitamins|vitamins|mesh-list
2061196|NCT01818414|Folic Acid|folic acid|mesh-list
2061197|NCT01818414|Misoprostol|misoprostol|mesh-list
2061198|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
2061199|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061200|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2061201|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
2061202|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2061203|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2061204|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2061205|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
2061206|NCT01818414|Hematinics|hematinics|mesh-ancestor
2061207|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
2061208|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2061209|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2061210|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2061211|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
2061212|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061213|NCT01818700|Buprenorphine|buprenorphine|mesh-list
2061214|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2061215|NCT01818700|Narcotics|narcotics|mesh-ancestor
2061216|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2061217|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061218|NCT01818700|Analgesics|analgesics|mesh-ancestor
2210134|NCT00016094|Antibodies|antibodies|mesh-list
2210135|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
2210136|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2061219|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
2061220|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061221|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2061222|NCT01818726|Deferasirox|deferasirox|mesh-list
2061223|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2061224|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
2061225|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
2061226|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061227|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2061228|NCT01818752|Prednisone|prednisone|mesh-list
2061229|NCT01818752|Bortezomib|bortezomib|mesh-list
2061230|NCT01818752|Melphalan|melphalan|mesh-list
2061231|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2061232|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
2061233|NCT01818752|Hormones|hormones|mesh-ancestor
2061234|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2210137|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210138|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2210139|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2061235|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210140|NCT00016094|Growth Substances|growth substances|mesh-ancestor
2061236|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2061237|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061238|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2061239|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
2061240|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061241|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2061242|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2061243|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
2061244|NCT01819129|Insulin|insulin|mesh-list
2061245|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2061246|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
2061247|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
2061248|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
2061249|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2061250|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2061251|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061252|NCT01819415|Bevacizumab|bevacizumab|mesh-list
2061253|NCT01819415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2061254|NCT01819415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061255|NCT01819415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2061256|NCT01819415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2061257|NCT01819415|Growth Substances|growth substances|mesh-ancestor
2061258|NCT01819415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061259|NCT01819415|Growth Inhibitors|growth inhibitors|mesh-ancestor
2061260|NCT01819935|Vancomycin|vancomycin|mesh-list
2061261|NCT01819935|Linezolid|linezolid|mesh-list
2061262|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2061263|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061264|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2061265|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061266|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061267|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2061268|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
2061269|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2061270|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2061271|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2061272|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061273|NCT01820572|Cyclosporine|cyclosporine|mesh-list
2061274|NCT01820572|Abatacept|abatacept|mesh-list
2061275|NCT01820572|Tacrolimus|tacrolimus|mesh-list
2061276|NCT01820572|Cyclosporins|cyclosporins|mesh-list
2061277|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2061278|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
2061279|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061280|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2061281|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061282|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061283|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
2061284|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061285|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
2061286|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2061287|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2061288|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061289|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2061290|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
2061291|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2061292|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2061293|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2061294|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061295|NCT01820637|Paclitaxel|paclitaxel|mesh-list
2061296|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2061297|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061298|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
2061299|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
2061300|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
2061301|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061302|NCT01820754|Paclitaxel|paclitaxel|mesh-list
2061303|NCT01820754|Carboplatin|carboplatin|mesh-list
2061304|NCT01820754|Ipilimumab|ipilimumab|mesh-list
2061305|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2061306|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061307|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
2061308|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
2061309|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
2061310|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061311|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2061312|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2061313|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2061314|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2061315|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061316|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2061317|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2061318|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2061319|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2061320|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061321|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2061322|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2061323|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2061324|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2061325|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
2061326|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061327|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061328|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2061329|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2061330|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
2061331|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2061332|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2061333|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
2061334|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2061335|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2061336|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
2061337|NCT01821560|Baclofen|baclofen|mesh-list
2061338|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2061339|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061340|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2061341|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061342|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2061343|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
2061344|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
2061345|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061346|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061347|NCT01821729|Leucovorin|leucovorin|mesh-list
2061348|NCT01821729|Fluorouracil|fluorouracil|mesh-list
2061349|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
2061350|NCT01821729|Folfirinox|folfirinox|mesh-list
2061351|NCT01821729|Losartan|losartan|mesh-list
2061352|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
2061353|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061354|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2061355|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061356|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2061357|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
2061358|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061359|NCT01821729|Antidotes|antidotes|mesh-ancestor
2061360|NCT01821729|Protective Agents|protective agents|mesh-ancestor
2061361|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
2061362|NCT01821729|Vitamins|vitamins|mesh-ancestor
2061363|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
2061364|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2061365|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2061366|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2061367|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2061368|NCT01822132|Naltrexone|naltrexone|mesh-list
2061369|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2061370|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2061371|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061372|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
2061373|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061374|NCT01822496|Paclitaxel|paclitaxel|mesh-list
2061375|NCT01822496|Etoposide|etoposide|mesh-list
2061376|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
2061377|NCT01822496|Cisplatin|cisplatin|mesh-list
2061378|NCT01822496|Carboplatin|carboplatin|mesh-list
2061379|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2061380|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2061381|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
2061382|NCT01822496|Crizotinib|crizotinib|mesh-list
2061383|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2061384|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061385|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
2061386|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
2061387|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
2061388|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061389|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2061390|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2061391|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061392|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2061393|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
2061394|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
2210141|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210142|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
2210143|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
2210144|NCT00016107|Bevacizumab|bevacizumab|mesh-list
2210145|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2210146|NCT00016107|Docetaxel|docetaxel|mesh-list
2210147|NCT00016107|Estramustine|estramustine|mesh-list
2210148|NCT00016107|Antibodies|antibodies|mesh-list
2210149|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
2210150|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2210151|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210152|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2210153|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2061395|NCT01822535|Midodrine|midodrine|mesh-list
2061396|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
2061397|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
2061398|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061399|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061400|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2210154|NCT00016107|Growth Substances|growth substances|mesh-ancestor
2210155|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210156|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
2210157|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
2210158|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
2210159|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
2061401|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2061402|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2061403|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2061404|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
2061405|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061406|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061407|NCT01822548|Metformin|metformin|mesh-list
2061408|NCT01822548|Vildagliptin|vildagliptin|mesh-list
2061409|NCT01822548|Glyburide|glyburide|mesh-list
2061410|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2061411|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061412|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2061413|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
2061414|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061415|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061416|NCT01822561|Eplerenone|eplerenone|mesh-list
2061417|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2061418|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
2061419|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2061420|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061421|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2061422|NCT01822561|Diuretics|diuretics|mesh-ancestor
2210160|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210161|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210162|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210163|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
2210164|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2210165|NCT00016133|Leucovorin|leucovorin|mesh-list
2210166|NCT00016133|Fluorouracil|fluorouracil|mesh-list
2210167|NCT00016133|Vaccines|vaccines|mesh-list
2210168|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
2210169|NCT00016133|Calcium|calcium|mesh-list
2210170|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
2210171|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
2210172|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210173|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2061423|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
2061424|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2061425|NCT01822587|Propranolol|propranolol|mesh-list
2061426|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2061427|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2061428|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
2061429|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061430|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061431|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748382|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
2748383|NCT04889118|Lenvatinib|lenvatinib|mesh-list
2748384|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2061432|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2061433|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2061434|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
2061435|NCT01822665|Acetaminophen|acetaminophen|mesh-list
2061436|NCT01822665|Ibuprofen|ibuprofen|mesh-list
2061437|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2061438|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2061439|NCT01822665|Analgesics|analgesics|mesh-ancestor
2061440|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
2210174|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
2061441|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061442|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061443|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2061444|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2061445|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2061446|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061447|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061448|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
2061449|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2061450|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
2061451|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2061452|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2061453|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2061454|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061455|NCT01822756|Gemcitabine|gemcitabine|mesh-list
2061456|NCT01822756|Paclitaxel|paclitaxel|mesh-list
2061457|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2061458|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061459|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
2061460|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
2061461|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
2061462|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061463|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2061464|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
2061465|NCT01822756|Antiviral Agents|antiviral agents|mesh-ancestor
2061466|NCT01822756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061467|NCT01822756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061468|NCT01822756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2061469|NCT01822756|Immunologic Factors|immunologic factors|mesh-ancestor
2061470|NCT01822756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061471|NCT01822821|Acetaminophen|acetaminophen|mesh-list
2061472|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2061473|NCT01822821|Analgesics|analgesics|mesh-ancestor
2061474|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
2061475|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061476|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061477|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
2061478|NCT01822886|Gemcitabine|gemcitabine|mesh-list
2061479|NCT01822886|Romidepsin|romidepsin|mesh-list
2061480|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2061481|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
2748385|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748386|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2748387|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2748388|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210175|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210176|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210177|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210178|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210179|NCT00016133|Antidotes|antidotes|mesh-ancestor
2210180|NCT00016133|Protective Agents|protective agents|mesh-ancestor
2210181|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
2210182|NCT00016133|Vitamins|vitamins|mesh-ancestor
2210183|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
2210184|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2210185|NCT00016159|Idarubicin|idarubicin|mesh-list
2210186|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
2210187|NCT00016159|Tretinoin|tretinoin|mesh-list
2210188|NCT00016159|Lintuzumab|lintuzumab|mesh-list
2061482|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210189|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2210190|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210191|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2210192|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2061483|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061484|NCT01822886|Antiviral Agents|antiviral agents|mesh-ancestor
2061485|NCT01822886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061486|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061487|NCT01822886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2061488|NCT01822886|Immunologic Factors|immunologic factors|mesh-ancestor
2061489|NCT01822886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061490|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2061491|NCT01822899|Fluticasone|fluticasone|mesh-list
2061492|NCT01822899|Xhance|xhance|mesh-list
2061493|NCT01822899|Bromides|bromides|mesh-list
2061494|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2061495|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2061496|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2061497|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
2061498|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061499|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061500|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2061501|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
2061502|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
2061503|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2061504|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2061505|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2061506|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2061507|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
2061508|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061509|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061510|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
2061511|NCT01823146|Oxytocin|oxytocin|mesh-list
2061512|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
2061513|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2061514|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061515|NCT01823224|Acetaminophen|acetaminophen|mesh-list
2061516|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2061517|NCT01823224|Analgesics|analgesics|mesh-ancestor
2061518|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
2061519|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061520|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061521|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
2061522|NCT01823289|Itraconazole|itraconazole|mesh-list
2061523|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
2061524|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061525|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2061526|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2061527|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061528|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061529|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2061530|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
2079421|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210193|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210194|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210195|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
2210196|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
2210197|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2210198|NCT00016172|Doxorubicin|doxorubicin|mesh-list
2210199|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2210200|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2210201|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210202|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2210203|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210204|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210205|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210206|NCT00016185|Docetaxel|docetaxel|mesh-list
2210207|NCT00016185|Alvocidib|alvocidib|mesh-list
2210208|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210209|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
2210210|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210211|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210212|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748427|NCT04885530|Fluticasone|fluticasone|mesh-list
2748428|NCT04885530|Xhance|xhance|mesh-list
2748429|NCT04885530|Ivermectin|ivermectin|mesh-list
2748430|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
2748431|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2748432|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2748433|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
2748434|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2210213|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
2210214|NCT00016185|Growth Substances|growth substances|mesh-ancestor
2210215|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210216|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2061531|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2061532|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061533|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2061534|NCT01823328|Ketamine|ketamine|mesh-list
2061535|NCT01823328|Etomidate|etomidate|mesh-list
2061536|NCT01823328|Analgesics|analgesics|mesh-ancestor
2061537|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
2061538|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061539|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061540|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2061541|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2061542|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
2061543|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
2061544|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2061545|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2061546|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2061547|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061548|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061549|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2061550|NCT01823497|Morphine|morphine|mesh-list
2061551|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2061552|NCT01823497|Narcotics|narcotics|mesh-ancestor
2061553|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2061554|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061555|NCT01823497|Analgesics|analgesics|mesh-ancestor
2061556|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
2061557|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061558|NCT01823510|Aspirin|aspirin|mesh-list
2061559|NCT01823510|Clopidogrel|clopidogrel|mesh-list
2061560|NCT01823510|Ticagrelor|ticagrelor|mesh-list
2061561|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2061562|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2061563|NCT01823510|Analgesics|analgesics|mesh-ancestor
2061564|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
2061565|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061566|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061567|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2061568|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2061569|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2061570|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2061571|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061572|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2061573|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2061574|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061575|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
2061576|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2061577|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2061578|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2061579|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
2061580|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061581|NCT01823679|Capecitabine|capecitabine|mesh-list
2061582|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2061583|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
2061584|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061585|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748435|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748436|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2748437|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
2748438|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
2748439|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2061586|NCT01823835|Palbociclib|palbociclib|mesh-list
2061587|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061588|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2061589|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061590|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061591|NCT01824290|Tadalafil|tadalafil|mesh-list
2061592|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
2210217|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061593|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2061594|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2061595|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061596|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061597|NCT01824290|Urological Agents|urological agents|mesh-ancestor
2061598|NCT01824342|Denosumab|denosumab|mesh-list
2061599|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2061600|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061601|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2061602|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
2061603|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2061604|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2061605|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2061606|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210218|NCT00016198|Leucovorin|leucovorin|mesh-list
2748440|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2748441|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748442|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2748443|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2748444|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2748445|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2748446|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2748447|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2748448|NCT04885530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2748449|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2748450|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2061607|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
2061608|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
2061609|NCT01824693|Melphalan|melphalan|mesh-list
2061610|NCT01824693|Busulfan|busulfan|mesh-list
2061611|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
2061612|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2061613|NCT01824693|Fludarabine|fludarabine|mesh-list
2061614|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
2061615|NCT01824693|Tacrolimus|tacrolimus|mesh-list
2061616|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210219|NCT00016198|Fluorouracil|fluorouracil|mesh-list
2210220|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
2210221|NCT00016198|Calcium|calcium|mesh-list
2210222|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
2210223|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2210224|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061617|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
2061618|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061619|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2061620|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2061621|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
2061622|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061623|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061624|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2061625|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2061626|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
2061627|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2061628|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061629|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2061630|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2061631|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
2061632|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2061633|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061634|NCT01824823|Afatinib|afatinib|mesh-list
2061635|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061636|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2061637|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061638|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061639|NCT01824901|Docetaxel|docetaxel|mesh-list
2061640|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061641|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
2061642|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
2061643|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
2061644|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061645|NCT01825122|Nadolol|nadolol|mesh-list
2061646|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2061647|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2061648|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
2061649|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061650|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061651|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061652|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2061653|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2061654|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
2061655|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
2061656|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061657|NCT01825408|Azithromycin|azithromycin|mesh-list
2061658|NCT01825408|Doxycycline|doxycycline|mesh-list
2061659|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2061660|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2061661|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061662|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
2061663|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2061664|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2061665|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2061666|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061667|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061668|NCT01825512|Deferasirox|deferasirox|mesh-list
2061669|NCT01825512|Deferiprone|deferiprone|mesh-list
2061670|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2061671|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
2061672|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
2061673|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061674|NCT01825577|Methylphenidate|methylphenidate|mesh-list
2061675|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2061676|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061677|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2061678|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2061679|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2210225|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
2210226|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210227|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210228|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210229|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210230|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
2210231|NCT00016198|Antidotes|antidotes|mesh-ancestor
2210232|NCT00016198|Protective Agents|protective agents|mesh-ancestor
2061680|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061681|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
2061682|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061683|NCT01825655|Cetirizine|cetirizine|mesh-list
2061684|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2061685|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2061686|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2061687|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
2061688|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
2061689|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2210233|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
2061690|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061691|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061692|NCT01825798|Metformin|metformin|mesh-list
2061693|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2061694|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061695|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2061696|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
2061697|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2061698|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2061699|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2061700|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061701|NCT01825876|Warfarin|warfarin|mesh-list
2061702|NCT01825876|Evacetrapib|evacetrapib|mesh-list
2061703|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
2061704|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2061705|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2061706|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
2061707|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061708|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2061709|NCT01825889|Evacetrapib|evacetrapib|mesh-list
2061710|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2061711|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2061712|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
2061713|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061714|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2061715|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
2061716|NCT01825941|Promethazine|promethazine|mesh-list
2061717|NCT01825941|Metoclopramide|metoclopramide|mesh-list
2061718|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2061719|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2061720|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2061721|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061722|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
2061723|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
2061724|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
2061725|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061726|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
2061727|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
2061728|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2061729|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2061730|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
2061731|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
2061732|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061733|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061734|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2061735|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
2061736|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
2061737|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2061738|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2061739|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
2061740|NCT01826370|Linagliptin|linagliptin|mesh-list
2061741|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2061742|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061743|NCT01826370|Incretins|incretins|mesh-ancestor
2061744|NCT01826370|Hormones|hormones|mesh-ancestor
2061745|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2061746|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2210234|NCT00016198|Vitamins|vitamins|mesh-ancestor
2210235|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
2210236|NCT00016224|Thalidomide|thalidomide|mesh-list
2748451|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2748452|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
2748453|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2748454|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
2748455|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2748456|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2748457|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2748458|NCT04863950|Lomustine|lomustine|mesh-list
2748459|NCT04863950|Imipramine|imipramine|mesh-list
2210237|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210238|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
2210239|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210240|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
2210241|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2210242|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210243|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2061747|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
2061748|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061749|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061750|NCT01826448|Vemurafenib|vemurafenib|mesh-list
2061751|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748460|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2748461|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
2748462|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748463|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748464|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2748465|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
2748466|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2748467|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2061752|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2061753|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061754|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061755|NCT01826851|Bupivacaine|bupivacaine|mesh-list
2061756|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
2061757|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
2061758|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2061759|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061760|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
2061761|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061762|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
2061763|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
2061764|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061765|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2061766|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2061767|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2061768|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061769|NCT01827163|Paclitaxel|paclitaxel|mesh-list
2061770|NCT01827163|Trastuzumab|trastuzumab|mesh-list
2061771|NCT01827163|Lapatinib|lapatinib|mesh-list
2061772|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2061773|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061774|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
2061775|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
2061776|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
2061777|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210244|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2210245|NCT00016224|Growth Substances|growth substances|mesh-ancestor
2210246|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
2210247|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079422|NCT02058251|Oxytocin|oxytocin|mesh-list
2061778|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2061779|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2061780|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061781|NCT01827254|Sunitinib|sunitinib|mesh-list
2061782|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061783|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2061784|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2061785|NCT01827254|Growth Substances|growth substances|mesh-ancestor
2061786|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061787|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
2061788|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2061789|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061790|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061791|NCT01827267|Sirolimus|sirolimus|mesh-list
2061792|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2061793|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061794|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2061795|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061796|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
2061797|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2061798|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
2061799|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061800|NCT01827332|Oxytocin|oxytocin|mesh-list
2061801|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
2061802|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2061803|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061804|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
2061805|NCT01827358|Mupirocin|mupirocin|mesh-list
2061806|NCT01827358|Calcium|calcium|mesh-list
2061807|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2061808|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061809|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2061810|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2061811|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061812|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2061813|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061814|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061815|NCT01827462|Vaccines|vaccines|mesh-list
2061816|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
2061817|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061818|NCT01827475|Acetaminophen|acetaminophen|mesh-list
2061819|NCT01827475|Ibuprofen|ibuprofen|mesh-list
2061820|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2061821|NCT01827475|Analgesics|analgesics|mesh-ancestor
2061822|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
2061823|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061824|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061825|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
2061826|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2061827|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2061828|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2061829|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2061830|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061831|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061832|NCT01827670|Fluorides|fluorides|mesh-list
2061833|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
2061834|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
2061835|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
2061836|NCT01827670|Protective Agents|protective agents|mesh-ancestor
2061837|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061838|NCT01827839|Vaccines|vaccines|mesh-list
2061839|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
2061840|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061841|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
2061842|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061843|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2061844|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061845|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061846|NCT01827943|Sirolimus|sirolimus|mesh-list
2061847|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2061848|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061849|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2061850|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061851|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
2061852|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2061853|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
2061854|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061855|NCT01828021|Margetuximab|margetuximab|mesh-list
2061856|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061857|NCT01828034|Gemcitabine|gemcitabine|mesh-list
2061858|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061859|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2061860|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
2061861|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061862|NCT01828034|Antiviral Agents|antiviral agents|mesh-ancestor
2061863|NCT01828034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061864|NCT01828034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061865|NCT01828034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2061866|NCT01828034|Immunologic Factors|immunologic factors|mesh-ancestor
2061867|NCT01828034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061868|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
2061869|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2061870|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2210248|NCT00016263|Dacarbazine|dacarbazine|mesh-list
2210249|NCT00016263|Oblimersen|oblimersen|mesh-list
2210250|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210251|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
2210252|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061871|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
2061872|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061873|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2061874|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2061875|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061876|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748468|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2748469|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2748470|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
2748471|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2748472|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061886|NCT01828112|Docetaxel|docetaxel|mesh-list
2061887|NCT01828112|Pemetrexed|pemetrexed|mesh-list
2061888|NCT01828112|Ceritinib|ceritinib|mesh-list
2061889|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061890|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
2061891|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
2061892|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
2061893|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061894|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061895|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2061896|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2061897|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2061898|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
2061899|NCT01828476|Navitoclax|navitoclax|mesh-list
2061900|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
2061901|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2061902|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2061903|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061904|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061905|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061906|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2061907|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061908|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
2061909|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2061910|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2061911|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
2061912|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2061913|NCT01828515|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2061914|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2061915|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2061916|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061917|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061918|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
2061919|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061920|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2061921|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2210253|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210254|NCT00016276|Tamoxifen|tamoxifen|mesh-list
2210255|NCT00016276|Paclitaxel|paclitaxel|mesh-list
2210256|NCT00016276|Razoxane|razoxane|mesh-list
2210257|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
2210258|NCT00016276|Doxorubicin|doxorubicin|mesh-list
2210259|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2210260|NCT00016276|Trastuzumab|trastuzumab|mesh-list
2210261|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
2210262|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2210263|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210264|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
2210265|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210266|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210267|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061922|NCT01828554|Capecitabine|capecitabine|mesh-list
2061923|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2061924|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
2210268|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210269|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
2210270|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061925|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061926|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061927|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
2061928|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2061929|NCT01828593|Antibodies|antibodies|mesh-list
2061930|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
2061931|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061932|NCT01829217|Sunitinib|sunitinib|mesh-list
2061933|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061934|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2061935|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2061936|NCT01829217|Growth Substances|growth substances|mesh-ancestor
2061937|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061938|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
2061939|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2061940|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061941|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061942|NCT01829243|Milnacipran|milnacipran|mesh-list
2061943|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
2061944|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2061945|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2079423|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
2061946|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2061947|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061948|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061949|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061950|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2061951|NCT01829243|Analgesics|analgesics|mesh-ancestor
2061952|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
2061953|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061954|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
2061955|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2061956|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
2061957|NCT01829295|Prednisone|prednisone|mesh-list
2061958|NCT01829295|Methotrexate|methotrexate|mesh-list
2061959|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2061960|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
2061961|NCT01829295|Hormones|hormones|mesh-ancestor
2061962|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2061963|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061964|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2061965|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2061966|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2061967|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
2061968|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2210271|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2210272|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210273|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
2061969|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2061970|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
2061971|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061972|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
2061973|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210274|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2210275|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2210276|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2210277|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210278|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2061974|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2061975|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2061976|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
2061977|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2061978|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2061979|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2061980|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2061981|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
2061982|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2061983|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2061984|NCT01829399|Epinephrine|epinephrine|mesh-list
2061985|NCT01829399|Bupivacaine|bupivacaine|mesh-list
2061986|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
2061987|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
2061988|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2061989|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2061990|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
2061991|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2061992|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2061993|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2061994|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
2061995|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2061996|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2061997|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2061998|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2061999|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
2062000|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2062001|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
2062002|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
2062003|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
2062004|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2062005|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2062006|NCT01829425|Oxybutynin|oxybutynin|mesh-list
2062007|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2062008|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2062009|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
2062010|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062011|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062012|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062013|NCT01829425|Urological Agents|urological agents|mesh-ancestor
2062014|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
2062015|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
2062016|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062017|NCT01829503|Cytarabine|cytarabine|mesh-list
2062018|NCT01829503|Decitabine|decitabine|mesh-list
2062019|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2062020|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
2062021|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062022|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062023|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
2062024|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062025|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2748500|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2748501|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
2748502|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748503|NCT04850599|Pomalidomide|pomalidomide|mesh-list
2748504|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2748505|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
2748506|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748507|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2748508|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2748509|NCT04850599|Growth Substances|growth substances|mesh-ancestor
2748510|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
2062026|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
2062027|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062028|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062029|NCT01829516|Oxytocin|oxytocin|mesh-list
2062030|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
2062031|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2062032|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748511|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062037|NCT01829919|Paroxetine|paroxetine|mesh-list
2062038|NCT01829919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2062039|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2210279|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2210280|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2210281|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
2210282|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2062040|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2062041|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062042|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062043|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
2062044|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062045|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2062046|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
2062047|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2062048|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2062049|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2062050|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062051|NCT01830127|Ribavirin|ribavirin|mesh-list
2062052|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
2062053|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210283|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2210284|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2210285|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2210286|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2210287|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2210288|NCT00016276|Protective Agents|protective agents|mesh-ancestor
2210289|NCT00016289|Interleukin-12|interleukin-12|mesh-list
2210290|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2210291|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
2210292|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210293|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2210294|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2062054|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
2062055|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062056|NCT01830140|Bimatoprost|bimatoprost|mesh-list
2062057|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2062058|NCT01830543|Aspirin|aspirin|mesh-list
2062059|NCT01830543|Vitamin K|vitamin k|mesh-list
2062060|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
2062061|NCT01830543|Clopidogrel|clopidogrel|mesh-list
2062062|NCT01830543|Ticagrelor|ticagrelor|mesh-list
2062063|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2062064|NCT01830543|Vitamins|vitamins|mesh-ancestor
2062065|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
2062066|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062067|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2062068|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2062069|NCT01830543|Analgesics|analgesics|mesh-ancestor
2062070|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
2062071|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2748518|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2748519|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
2748520|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
2748521|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748522|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2748523|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
2748524|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062072|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2062073|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2062074|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2062075|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2062076|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062077|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2062078|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2062079|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062080|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
2062081|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2062082|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2062083|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2062084|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
2062085|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2748525|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748526|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2748527|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2748528|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2748529|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
2748534|NCT04840615|Ipilimumab|ipilimumab|mesh-list
2748535|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2748536|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748537|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2748538|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062086|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2062087|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
2062088|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2062089|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
2062090|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
2062091|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2062092|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
2062093|NCT01830543|Coagulants|coagulants|mesh-ancestor
2062094|NCT01830595|Lactoferrin|lactoferrin|mesh-list
2062095|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062096|NCT01830699|Triamcinolone|triamcinolone|mesh-list
2062097|NCT01830699|Rilonacept|rilonacept|mesh-list
2062098|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2062099|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
2062100|NCT01830699|Hormones|hormones|mesh-ancestor
2062101|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2062102|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062103|NCT01830816|Ixazomib|ixazomib|mesh-list
2062104|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062105|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
2062106|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062107|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062108|NCT01830842|Nicotine|nicotine|mesh-list
2062109|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2062110|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
2062111|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062112|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062113|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2062114|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2062115|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
2062116|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062117|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062118|NCT01830881|Ibuprofen|ibuprofen|mesh-list
2062119|NCT01830881|Lidocaine|lidocaine|mesh-list
2062120|NCT01830881|Midazolam|midazolam|mesh-list
2062121|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
2062122|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
2062123|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2062124|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062125|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
2062126|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062127|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2062128|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2062129|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2062130|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2062131|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062132|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2062133|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2062134|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2062135|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2062136|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2062137|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2062138|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
2062139|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
2062140|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
2062141|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062142|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2062143|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2062144|NCT01830881|Analgesics|analgesics|mesh-ancestor
2062145|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2062146|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2062147|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2062148|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062149|NCT01831076|Tamoxifen|tamoxifen|mesh-list
2062150|NCT01831076|Exemestane|exemestane|mesh-list
2062151|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2062152|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
2062153|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2062154|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062155|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2062156|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062157|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2062158|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2062159|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2062160|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2062161|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2062162|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062163|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062164|NCT01831089|Paclitaxel|paclitaxel|mesh-list
2062165|NCT01831089|Bevacizumab|bevacizumab|mesh-list
2062166|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2062167|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062168|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
2062169|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
2062170|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
2062171|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062172|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2062173|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2062174|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2062175|NCT01831089|Growth Substances|growth substances|mesh-ancestor
2062176|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062177|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
2062178|NCT01831232|Cytarabine|cytarabine|mesh-list
2062179|NCT01831232|Idarubicin|idarubicin|mesh-list
2062180|NCT01831232|Pravastatin|pravastatin|mesh-list
2062181|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2062182|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
2062183|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062184|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062185|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
2062186|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062187|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2062188|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
2062189|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062190|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2062191|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2062192|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2062193|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062194|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2062195|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2062196|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2062197|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2062198|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2062199|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
2062200|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062201|NCT01831466|Tofacitinib|tofacitinib|mesh-list
2062202|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2062203|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079424|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2062204|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062205|NCT01831765|Insulin|insulin|mesh-list
2062206|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2062207|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
2062208|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
2062209|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2062210|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
2062211|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2062212|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062213|NCT01831791|Dutasteride|dutasteride|mesh-list
2062214|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2062215|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2062216|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062217|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062218|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
2062219|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2210295|NCT00016289|Growth Substances|growth substances|mesh-ancestor
2062220|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062221|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
2062222|NCT01831817|Listerine|listerine|mesh-list
2062223|NCT01831817|Calcium|calcium|mesh-list
2062224|NCT01831817|Fluorides|fluorides|mesh-list
2062225|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
2062226|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
2062227|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2062228|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062229|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2062230|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
2062231|NCT01831817|Protective Agents|protective agents|mesh-ancestor
2062232|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2062233|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210296|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
2210297|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210298|NCT00016302|Leucovorin|leucovorin|mesh-list
2210299|NCT00016302|Cytarabine|cytarabine|mesh-list
2210300|NCT00016302|Dexamethasone|dexamethasone|mesh-list
2210301|NCT00016302|Prednisone|prednisone|mesh-list
2210302|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
2210303|NCT00016302|Doxorubicin|doxorubicin|mesh-list
2210304|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2210305|NCT00016302|Methotrexate|methotrexate|mesh-list
2062234|NCT01831934|Vaccines|vaccines|mesh-list
2210306|NCT00016302|Vincristine|vincristine|mesh-list
2210307|NCT00016302|Daunorubicin|daunorubicin|mesh-list
2210308|NCT00016302|Asparaginase|asparaginase|mesh-list
2062235|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
2062236|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062237|NCT01832038|Lacosamide|lacosamide|mesh-list
2062238|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
2062239|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2062240|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2062241|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2062242|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062243|NCT01832402|Fentanyl|fentanyl|mesh-list
2062244|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2062245|NCT01832402|Narcotics|narcotics|mesh-ancestor
2062246|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2062247|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062248|NCT01832402|Analgesics|analgesics|mesh-ancestor
2062249|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
2062250|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062251|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2062252|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2062253|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
2062254|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
2062255|NCT01832532|Liraglutide|liraglutide|mesh-list
2062256|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2062257|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062258|NCT01832532|Incretins|incretins|mesh-ancestor
2062259|NCT01832532|Hormones|hormones|mesh-ancestor
2062260|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2062261|NCT01832727|Dexamethasone|dexamethasone|mesh-list
2062262|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2062263|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
2062264|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
2062265|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062266|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062267|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2062268|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
2062269|NCT01832727|Hormones|hormones|mesh-ancestor
2062270|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2062271|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2062272|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062273|NCT01832766|Dronabinol|dronabinol|mesh-list
2062274|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
2062275|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062276|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2062277|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2062278|NCT01832766|Analgesics|analgesics|mesh-ancestor
2062279|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
2062280|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062281|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2062282|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2062283|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062284|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062285|NCT01832766|Hormones|hormones|mesh-ancestor
2062286|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2062287|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
2062288|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
2062289|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062290|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210309|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
2210310|NCT00016302|Thioguanine|thioguanine|mesh-list
2210311|NCT00016302|Pegaspargase|pegaspargase|mesh-list
2210312|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
2210313|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2748553|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
2748554|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2748555|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2748556|NCT04826588|Prednisolone|prednisolone|mesh-list
2748557|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
2748558|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2748559|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
2748560|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
2748561|NCT04826588|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2748562|NCT04826588|Antibodies|antibodies|mesh-list
2748563|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2748564|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
2062291|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2062292|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
2062293|NCT01833026|Albuterol|albuterol|mesh-list
2062294|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2062295|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
2062296|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062297|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062298|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2062299|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
2062300|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
2210314|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
2748565|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
2062301|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2062302|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2062303|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2062304|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2062305|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
2062306|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062307|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062308|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
2062309|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2062310|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2062311|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2062312|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2210315|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210316|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2210317|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2062313|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062314|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
2062315|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062316|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062317|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2062318|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062319|NCT01833143|Acyclovir|acyclovir|mesh-list
2062320|NCT01833143|Bortezomib|bortezomib|mesh-list
2062321|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062322|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
2062323|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062324|NCT01833455|Flecainide|flecainide|mesh-list
2062325|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2062326|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2062327|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2062328|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2062329|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062330|NCT01833533|Ribavirin|ribavirin|mesh-list
2062331|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
2062332|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062333|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
2062334|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062335|NCT01833546|Gemcitabine|gemcitabine|mesh-list
2062336|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2062337|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
2062338|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062339|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062340|NCT01833546|Antiviral Agents|antiviral agents|mesh-ancestor
2062341|NCT01833546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062342|NCT01833546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062343|NCT01833546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2062344|NCT01833546|Immunologic Factors|immunologic factors|mesh-ancestor
2062345|NCT01833546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062346|NCT01833741|Bimatoprost|bimatoprost|mesh-list
2062347|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2062348|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
2062349|NCT01833832|Antidotes|antidotes|mesh-ancestor
2062350|NCT01833832|Protective Agents|protective agents|mesh-ancestor
2062351|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062352|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
2062353|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062354|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
2062355|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2062356|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062357|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
2062358|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
2062359|NCT01833845|Ribavirin|ribavirin|mesh-list
2062360|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
2062361|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
2062362|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062363|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
2062364|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062365|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
2062366|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2062367|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2062368|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062369|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2062370|NCT01833897|Cycloserine|cycloserine|mesh-list
2062371|NCT01833897|Ketamine|ketamine|mesh-list
2062372|NCT01833897|Olanzapine|olanzapine|mesh-list
2062373|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2062374|NCT01833897|Fluoxetine|fluoxetine|mesh-list
2062375|NCT01833897|Analgesics|analgesics|mesh-ancestor
2062376|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
2062377|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062378|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062379|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2062380|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2062381|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
2062382|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
2062383|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2062384|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2062385|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2062386|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062387|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062388|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
2062389|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
2062390|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2062391|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2062392|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2062393|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2062394|NCT01833897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2062395|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2062396|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2062397|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
2748566|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2748567|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748568|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2748569|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
2748570|NCT04826588|Hormones|hormones|mesh-ancestor
2748571|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2748572|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2748573|NCT04826588|Protective Agents|protective agents|mesh-ancestor
2748574|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2748575|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748576|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
2062398|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
2062399|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2062400|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2062401|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2062402|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062403|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2062404|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062405|NCT01833897|Renal Agents|renal agents|mesh-ancestor
2062406|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2062407|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
2062408|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2062409|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
2062410|NCT01833988|Pancrelipase|pancrelipase|mesh-list
2062411|NCT01833988|Pancreatin|pancreatin|mesh-list
2062412|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2062413|NCT01834261|Oxytocin|oxytocin|mesh-list
2062414|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
2062415|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2062416|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062417|NCT01834274|Metformin|metformin|mesh-list
2062418|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2062419|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2210318|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
2210319|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210320|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210321|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2210322|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2210323|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
2210324|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
2062420|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062421|NCT01834274|Incretins|incretins|mesh-ancestor
2062422|NCT01834274|Hormones|hormones|mesh-ancestor
2062423|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2062424|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2062425|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
2062426|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062427|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062428|NCT01834404|Topiramate|topiramate|mesh-list
2062429|NCT01834404|Phentermine|phentermine|mesh-list
2062430|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
2062431|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2062432|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062433|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2062434|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
2062435|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2062436|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
2062437|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
2062438|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062439|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
2062440|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062441|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062442|NCT01834586|Anesthetics|anesthetics|mesh-list
2062443|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2210325|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2210326|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2751252|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2062444|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062445|NCT01834729|Alfuzosin|alfuzosin|mesh-list
2062446|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2062447|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2062448|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2062449|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
2062450|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062451|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062452|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062453|NCT01834729|Urological Agents|urological agents|mesh-ancestor
2062462|NCT01835158|Sunitinib|sunitinib|mesh-list
2062463|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062464|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2062465|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2062466|NCT01835158|Growth Substances|growth substances|mesh-ancestor
2062467|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062468|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
2062469|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2062470|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062471|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062472|NCT01835262|Morphine|morphine|mesh-list
2062473|NCT01835262|Ketamine|ketamine|mesh-list
2062474|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2062475|NCT01835262|Narcotics|narcotics|mesh-ancestor
2062476|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2062477|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062478|NCT01835262|Analgesics|analgesics|mesh-ancestor
2062479|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
2062480|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062481|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2210327|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
2210328|NCT00016302|Hormones|hormones|mesh-ancestor
2210329|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2210330|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2210331|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2062482|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2062483|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
2062484|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
2062485|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2062486|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2062487|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062488|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062489|NCT01835431|Insulin|insulin|mesh-list
2062490|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2062491|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
2062492|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
2062493|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2062494|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
2062495|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2062496|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062497|NCT01835470|Abatacept|abatacept|mesh-list
2062498|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2062499|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062500|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062501|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2062502|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
2062503|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062504|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2062505|NCT01835496|Deferiprone|deferiprone|mesh-list
2062506|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2062507|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
2062508|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
2062509|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062510|NCT01835587|Cc-486|cc-486|mesh-list
2062511|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062512|NCT01835912|Citric Acid|citric acid|mesh-list
2062513|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
2062514|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
2062515|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2062516|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
2062517|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
2062518|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062519|NCT01836029|Carboplatin|carboplatin|mesh-list
2062520|NCT01836029|Fluorouracil|fluorouracil|mesh-list
2062521|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062522|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
2062523|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062524|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2062525|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2062526|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
2062527|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062528|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2062529|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062530|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2062531|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062532|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062533|NCT01836185|Evacetrapib|evacetrapib|mesh-list
2062534|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2062535|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2062536|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
2079425|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062537|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062538|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2062539|NCT01836198|Clarithromycin|clarithromycin|mesh-list
2062540|NCT01836198|Ketoconazole|ketoconazole|mesh-list
2062541|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
2062542|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2062543|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062544|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2062545|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062546|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062547|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2062548|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2062549|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
2062550|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2062551|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2062552|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
2062553|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2062554|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062555|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2062556|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
2062557|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2062558|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2062559|NCT01836276|Varenicline|varenicline|mesh-list
2062560|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2062561|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2210332|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2210333|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210334|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210335|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2210336|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
2210337|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2210338|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210339|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
2210340|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
2210341|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2210342|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2210343|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
2210344|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062562|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
2062563|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062564|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062565|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062566|NCT01836471|Fluticasone|fluticasone|mesh-list
2062567|NCT01836471|Xhance|xhance|mesh-list
2062568|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
2062569|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2062570|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2062571|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
2062572|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062573|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062574|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2062575|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
2062576|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
2062577|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2062578|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2062579|NCT01836471|Growth Substances|growth substances|mesh-ancestor
2062580|NCT01836523|Liraglutide|liraglutide|mesh-list
2062581|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2062582|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062583|NCT01836523|Incretins|incretins|mesh-ancestor
2062584|NCT01836523|Hormones|hormones|mesh-ancestor
2062585|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2062586|NCT01836549|Imetelstat|imetelstat|mesh-list
2062587|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
2062588|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062589|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062590|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2062591|NCT01837069|Metoprolol|metoprolol|mesh-list
2062592|NCT01837069|Lisinopril|lisinopril|mesh-list
2062593|NCT01837069|Atorvastatin|atorvastatin|mesh-list
2062594|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2062595|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2062596|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2062597|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
2062598|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062599|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2062600|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2062601|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062602|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2062603|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2062604|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
2062605|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
2062606|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062607|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062608|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2062609|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2062610|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2062611|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
2062612|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062613|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
2062614|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2062615|NCT01837069|Protective Agents|protective agents|mesh-ancestor
2062616|NCT01837680|Insulin|insulin|mesh-list
2062617|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2062618|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2062619|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062620|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2062621|NCT01837719|Cobicistat|cobicistat|mesh-list
2062622|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2062623|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2062624|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
2062625|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062626|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062627|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2062628|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2062629|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
2062630|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062631|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2210345|NCT00016302|Antidotes|antidotes|mesh-ancestor
2210346|NCT00016302|Protective Agents|protective agents|mesh-ancestor
2210347|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
2210348|NCT00016302|Vitamins|vitamins|mesh-ancestor
2062632|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2062633|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
2062634|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
2062635|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062636|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062637|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062638|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
2062639|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
2062640|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2062641|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2062642|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2062643|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
2062644|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062645|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2062646|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2062647|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062648|NCT01838044|Celecoxib|celecoxib|mesh-list
2062649|NCT01838044|Pregabalin|pregabalin|mesh-list
2062650|NCT01838044|Analgesics|analgesics|mesh-ancestor
2062651|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
2062652|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062653|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062654|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
2062655|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2062656|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2062657|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062658|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2062659|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2062660|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2062661|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2062662|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2062663|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2062664|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2210349|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
2210350|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2062665|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2062666|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2062667|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2062668|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2062669|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062670|NCT01838200|Isoniazid|isoniazid|mesh-list
2062671|NCT01838200|Ipilimumab|ipilimumab|mesh-list
2062672|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
2062673|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2062674|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062675|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2062676|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062677|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
2062678|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2062679|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2748613|NCT04817241|Cytarabine|cytarabine|mesh-list
2748614|NCT04817241|Decitabine|decitabine|mesh-list
2748615|NCT04817241|Daunorubicin|daunorubicin|mesh-list
2748616|NCT04817241|Venetoclax|venetoclax|mesh-list
2748617|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2748618|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
2748619|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748620|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748621|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
2748622|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2748623|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2748624|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
2748625|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062680|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2062681|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2062682|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
2062683|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2062684|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2062685|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
2062686|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062687|NCT01838317|Pioglitazone|pioglitazone|mesh-list
2062688|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2062689|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062690|NCT01838447|Vitamin D|vitamin d|mesh-list
2062691|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
2062692|NCT01838447|Vitamins|vitamins|mesh-ancestor
2062693|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
2062694|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062695|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2062696|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2062697|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
2062698|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
2062699|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062700|NCT01838616|Oxycodone|oxycodone|mesh-list
2062701|NCT01838616|Tapentadol|tapentadol|mesh-list
2062702|NCT01838616|Naloxone|naloxone|mesh-list
2062703|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2062704|NCT01838616|Narcotics|narcotics|mesh-ancestor
2062705|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2062706|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062707|NCT01838616|Analgesics|analgesics|mesh-ancestor
2062708|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
2062709|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062710|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2062711|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2062712|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2062713|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2062714|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062715|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
2062716|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062717|NCT01838642|Ponatinib|ponatinib|mesh-list
2062718|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062719|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2062720|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062721|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062722|NCT01838655|Nitisinone|nitisinone|mesh-list
2062723|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062724|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062725|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
2062726|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
2062727|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062728|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062729|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062730|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
2062731|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
2062732|NCT01838876|Cariprazine|cariprazine|mesh-list
2062733|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
2062734|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2062735|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2062736|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2062737|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2062738|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062739|NCT01838941|Betaine|betaine|mesh-list
2062740|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2062741|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
2062742|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2210351|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
2210352|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210353|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210354|NCT00016315|Gemcitabine|gemcitabine|mesh-list
2210355|NCT00016315|Paclitaxel|paclitaxel|mesh-list
2210356|NCT00016315|Carboplatin|carboplatin|mesh-list
2748626|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2748627|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2748628|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2748629|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062743|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
2062744|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062745|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2062746|NCT01839110|Ranolazine|ranolazine|mesh-list
2062747|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2062748|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2062749|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062750|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2062751|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
2062752|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210357|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2062753|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
2062754|NCT01839279|Tizanidine|tizanidine|mesh-list
2062755|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2062756|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062757|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2062758|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2062759|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062760|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062761|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062762|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062763|NCT01839279|Analgesics|analgesics|mesh-ancestor
2062764|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
2062765|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062766|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
2062767|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2062768|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2062769|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
2062770|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
2062771|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2062772|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2062773|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2062774|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
2062775|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062776|NCT01839487|Gemcitabine|gemcitabine|mesh-list
2062777|NCT01839487|Dexamethasone|dexamethasone|mesh-list
2062778|NCT01839487|Paclitaxel|paclitaxel|mesh-list
2062779|NCT01839487|Enoxaparin|enoxaparin|mesh-list
2062780|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2748633|NCT04812002|Bevacizumab|bevacizumab|mesh-list
2748634|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2748635|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2748636|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748637|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2748638|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2748639|NCT04812002|Growth Substances|growth substances|mesh-ancestor
2748640|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748641|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
2748642|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748643|NCT04809311|Insulin|insulin|mesh-list
2062781|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062782|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
2062783|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
2062784|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
2062785|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748644|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2748645|NCT04809311|Glucagon|glucagon|mesh-list
2748646|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2210358|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210359|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
2210360|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210361|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210362|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210363|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210364|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
2210365|NCT00016315|Antiviral Agents|antiviral agents|mesh-ancestor
2210366|NCT00016315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210367|NCT00016315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062786|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2062787|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
2062788|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
2748647|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2748648|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748649|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2748650|NCT04809311|Hormones|hormones|mesh-ancestor
2748651|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2748652|NCT04809311|Incretins|incretins|mesh-ancestor
2748653|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2748654|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2748655|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062789|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062790|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062791|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2062792|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
2062793|NCT01839487|Hormones|hormones|mesh-ancestor
2062794|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2062795|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2062796|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210368|NCT00016315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2062797|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
2062798|NCT01839487|Antiviral Agents|antiviral agents|mesh-ancestor
2062799|NCT01839487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062800|NCT01839487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062801|NCT01839487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2062802|NCT01839487|Immunologic Factors|immunologic factors|mesh-ancestor
2062803|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
2062804|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2062805|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2062806|NCT01839799|Gemcitabine|gemcitabine|mesh-list
2062807|NCT01839799|Paclitaxel|paclitaxel|mesh-list
2062808|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2062809|NCT01839799|Folfirinox|folfirinox|mesh-list
2062810|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2062811|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062812|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
2062813|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
2062814|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
2062815|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062816|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2062817|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
2062818|NCT01839799|Antiviral Agents|antiviral agents|mesh-ancestor
2062819|NCT01839799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062820|NCT01839799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062821|NCT01839799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2062822|NCT01839799|Immunologic Factors|immunologic factors|mesh-ancestor
2062823|NCT01839799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062824|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
2062825|NCT01840228|Progesterone|progesterone|mesh-list
2062826|NCT01840228|Progestins|progestins|mesh-ancestor
2210369|NCT00016315|Immunologic Factors|immunologic factors|mesh-ancestor
2210370|NCT00016315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210371|NCT00016328|Sirolimus|sirolimus|mesh-list
2210372|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2210373|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210374|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2210375|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210376|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
2210377|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210378|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
2062827|NCT01840228|Hormones|hormones|mesh-ancestor
2062828|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2062829|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062830|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
2062831|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2062832|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
2062833|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062834|NCT01840345|Expectorants|expectorants|mesh-ancestor
2062835|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
2062836|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2062837|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
2062838|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062839|NCT01840345|Protective Agents|protective agents|mesh-ancestor
2062840|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062841|NCT01840345|Antidotes|antidotes|mesh-ancestor
2062842|NCT01840410|Ranibizumab|ranibizumab|mesh-list
2062843|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2079426|NCT02058290|Morphine|morphine|mesh-list
2062844|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2062845|NCT01840410|Growth Substances|growth substances|mesh-ancestor
2062846|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062847|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
2062848|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062849|NCT01840579|Paclitaxel|paclitaxel|mesh-list
2062850|NCT01840579|Etoposide|etoposide|mesh-list
2062851|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2062852|NCT01840579|Carboplatin|carboplatin|mesh-list
2062853|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
2062854|NCT01840579|Pemetrexed|pemetrexed|mesh-list
2210379|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210380|NCT00016341|Tamoxifen|tamoxifen|mesh-list
2210381|NCT00016341|Paclitaxel|paclitaxel|mesh-list
2210382|NCT00016341|Doxorubicin|doxorubicin|mesh-list
2210383|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2210384|NCT00016341|Megestrol|megestrol|mesh-list
2210385|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
2210386|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2210387|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210388|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
2062855|NCT01840579|Ipilimumab|ipilimumab|mesh-list
2062856|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2062857|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062858|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
2062859|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
2062860|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
2062861|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079427|NCT02058290|Bupivacaine|bupivacaine|mesh-list
2210389|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
2062862|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2062863|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2062864|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2062865|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062866|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2062867|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2062868|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2062869|NCT01840605|Ketotifen|ketotifen|mesh-list
2062870|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
2062871|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
2062872|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
2062873|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2062874|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
2062875|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
2062876|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062877|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062878|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062879|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2062880|NCT01840943|Topotecan|topotecan|mesh-list
2062881|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2062882|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2062883|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062884|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062885|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062886|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2062887|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
2062888|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2062889|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062890|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
2062891|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062892|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
2062893|NCT01841593|Amlodipine|amlodipine|mesh-list
2062894|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2062895|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2062896|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2062897|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062898|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2062899|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062900|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
2062901|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2062902|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2062903|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
2079428|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
2062904|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062905|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2062906|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2062907|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062908|NCT01841606|Ondansetron|ondansetron|mesh-list
2062909|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
2062910|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
2062911|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062912|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062913|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2062914|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
2062915|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
2062916|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2062917|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
2062918|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062919|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062920|NCT01841606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2062921|NCT01841606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2210390|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210391|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210392|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2062922|NCT01841606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2062923|NCT01841606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2062924|NCT01841606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2062925|NCT01841697|Metformin|metformin|mesh-list
2062926|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2062927|NCT01841697|Glimepiride|glimepiride|mesh-list
2062928|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2062929|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062930|NCT01841697|Incretins|incretins|mesh-ancestor
2062931|NCT01841697|Hormones|hormones|mesh-ancestor
2062932|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2062933|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2062934|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
2062935|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062936|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062937|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2062938|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2062939|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
2062940|NCT01841762|Macitentan|macitentan|mesh-list
2062941|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2062942|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2062943|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062944|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2062945|NCT01842308|Melphalan|melphalan|mesh-list
2062946|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
2062947|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2062948|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2062949|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
2062950|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062951|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062952|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2062953|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2062954|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
2062955|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062956|NCT01842334|Nicotine|nicotine|mesh-list
2062957|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2062958|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
2062959|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062960|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062961|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2062962|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2062963|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
2062964|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2062965|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062966|NCT01842581|Rifaximin|rifaximin|mesh-list
2062967|NCT01842581|Lactulose|lactulose|mesh-list
2062968|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2062969|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062970|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2062971|NCT01842594|Sirolimus|sirolimus|mesh-list
2062972|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
2062973|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2062974|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2062975|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2062976|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2062977|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
2062978|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2062979|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
2062980|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062981|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
2062982|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2062983|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2062984|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2062985|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2062986|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2062987|NCT01842620|Metformin|metformin|mesh-list
2062988|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2062989|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062990|NCT01842633|Acetaminophen|acetaminophen|mesh-list
2062991|NCT01842633|Ibuprofen|ibuprofen|mesh-list
2062992|NCT01842633|Caffeine|caffeine|mesh-list
2062993|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2062994|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2062995|NCT01842633|Analgesics|analgesics|mesh-ancestor
2062996|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
2062997|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2062998|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2062999|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2063000|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2063001|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2063002|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063003|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063004|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
2063005|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2063006|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2063007|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2063008|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2063009|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
2063010|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063011|NCT01843023|Naltrexone|naltrexone|mesh-list
2063012|NCT01843023|Buprenorphine|buprenorphine|mesh-list
2063013|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2210393|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2210394|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210395|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210396|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210397|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2210398|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
2210399|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2210400|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2210401|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2210402|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2210403|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2063014|NCT01843023|Narcotics|narcotics|mesh-ancestor
2063015|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2063016|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063017|NCT01843023|Analgesics|analgesics|mesh-ancestor
2063018|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
2063019|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063020|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2063021|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2063022|NCT01843205|Methamphetamine|methamphetamine|mesh-list
2063023|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2063024|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063025|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
2063026|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
2063027|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063028|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
2063029|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2210404|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2210405|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2063030|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063031|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
2063032|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2063033|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2063034|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2063035|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2063036|NCT01843348|Cyclosporine|cyclosporine|mesh-list
2063037|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
2063038|NCT01843348|Everolimus|everolimus|mesh-list
2063039|NCT01843348|Tacrolimus|tacrolimus|mesh-list
2063040|NCT01843348|Cyclosporins|cyclosporins|mesh-list
2063041|NCT01843348|Basiliximab|basiliximab|mesh-list
2063042|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2063043|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
2063044|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063045|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2063046|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063047|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063048|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
2063049|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2063050|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
2063051|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2063052|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063053|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2063054|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2063055|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
2063056|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2063057|NCT01843374|Tremelimumab|tremelimumab|mesh-list
2079429|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
2063058|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063059|NCT01843621|Vaccines|vaccines|mesh-list
2063060|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
2063061|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063062|NCT01843660|Acetaminophen|acetaminophen|mesh-list
2063063|NCT01843660|Tramadol|tramadol|mesh-list
2063064|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2063065|NCT01843660|Analgesics|analgesics|mesh-ancestor
2063066|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
2063067|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063068|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063069|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
2063070|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2063071|NCT01843660|Narcotics|narcotics|mesh-ancestor
2063072|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2063073|NCT01843751|Buprenorphine|buprenorphine|mesh-list
2063074|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2063075|NCT01843751|Naloxone|naloxone|mesh-list
2063076|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2063077|NCT01843751|Narcotics|narcotics|mesh-ancestor
2063078|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2063079|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063080|NCT01843751|Analgesics|analgesics|mesh-ancestor
2063081|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
2063082|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063083|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2063084|NCT01843920|Trimethoprim|trimethoprim|mesh-list
2063085|NCT01843920|Polymyxins|polymyxins|mesh-list
2063086|NCT01843920|Polymyxin B|polymyxin b|mesh-list
2063087|NCT01843920|Prednisolone|prednisolone|mesh-list
2063088|NCT01843920|Timolol|timolol|mesh-list
2063089|NCT01843920|Dorzolamide|dorzolamide|mesh-list
2063090|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2063091|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
2063092|NCT01843920|Hormones|hormones|mesh-ancestor
2063093|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2063094|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063095|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2063096|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063097|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2063098|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2063099|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
2063100|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063101|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063102|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2063103|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2063104|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2063105|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2063106|NCT01843920|Renal Agents|renal agents|mesh-ancestor
2063107|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
2063108|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2063109|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2063110|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2063111|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063112|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2063113|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2063114|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2063115|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2063116|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2063117|NCT01844076|Quinacrine|quinacrine|mesh-list
2063118|NCT01844076|Capecitabine|capecitabine|mesh-list
2063119|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2063120|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
2063121|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063122|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063123|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
2063124|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2063125|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
2063126|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2063127|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2063128|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
2063129|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2063130|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
2063131|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063132|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2063133|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
2063134|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2063135|NCT01844115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2063136|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2063137|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2063138|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063139|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063140|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
2063141|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063142|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2063143|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2063144|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2063145|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2063146|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2063147|NCT01844388|Laxatives|laxatives|mesh-ancestor
2063148|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2063163|NCT01844531|Metformin|metformin|mesh-list
2063164|NCT01844531|Empagliflozin|empagliflozin|mesh-list
2063165|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2063166|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063167|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2063168|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063169|NCT01844583|Rifampin|rifampin|mesh-list
2063170|NCT01844583|Esomeprazole|esomeprazole|mesh-list
2063171|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2063172|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2063173|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2063174|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063175|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063176|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2063177|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
2063178|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2063179|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2063180|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
2063181|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2063182|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2063183|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2063184|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2063185|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2063186|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2063187|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2063188|NCT01844687|Cannabidiol|cannabidiol|mesh-list
2063189|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
2063190|NCT01844700|Risperidone|risperidone|mesh-list
2063191|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2063192|NCT01844700|Aripiprazole|aripiprazole|mesh-list
2063193|NCT01844700|Ziprasidone|ziprasidone|mesh-list
2063194|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2063195|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
2063196|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063197|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063198|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063199|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2063200|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2063201|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2063202|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2063203|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2063204|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
2063205|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
2063206|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
2063207|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2063208|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2063209|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2063210|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2063211|NCT01844778|Tobramycin|tobramycin|mesh-list
2063212|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2063213|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2063214|NCT01844830|Phenylephrine|phenylephrine|mesh-list
2063215|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
2063216|NCT01844830|Tetracaine|tetracaine|mesh-list
2063217|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
2063218|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
2063219|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2063220|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063221|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
2063222|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063223|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2063224|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2063225|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
2063226|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063227|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063228|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
2063229|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
2063230|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
2063231|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2063232|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
2063233|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2063234|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
2063235|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2063236|NCT01844830|Protective Agents|protective agents|mesh-ancestor
2063240|NCT01844895|Abatacept|abatacept|mesh-list
2063241|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2063242|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063243|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063244|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2063245|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
2063246|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063247|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2063248|NCT01844986|Olaparib|olaparib|mesh-list
2063249|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2063250|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063251|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063252|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063253|NCT01845025|Fluticasone|fluticasone|mesh-list
2063254|NCT01845025|Xhance|xhance|mesh-list
2063255|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
2063256|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2063257|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2063258|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
2063259|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063260|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063261|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2063262|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
2063263|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
2063264|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2063265|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2063266|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2063267|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2063268|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
2063269|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063270|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063271|NCT01845077|Metformin|metformin|mesh-list
2063272|NCT01845077|Linagliptin|linagliptin|mesh-list
2063273|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2063274|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063275|NCT01845077|Incretins|incretins|mesh-ancestor
2063276|NCT01845077|Hormones|hormones|mesh-ancestor
2063277|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2063278|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2063279|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
2063280|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063281|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063282|NCT01845636|Atropine|atropine|mesh-list
2063283|NCT01845636|Donepezil|donepezil|mesh-list
2063284|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2063285|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2063286|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2063287|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063288|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063289|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
2063290|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063291|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063292|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
2063293|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2063294|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2063295|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2063296|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
2063297|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063298|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2063299|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
2063300|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
2063301|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
2063302|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2063303|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2063304|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
2063305|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063306|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2063307|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063308|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063309|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
2063310|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2063311|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063312|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2063313|NCT01845831|Metformin|metformin|mesh-list
2063314|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
2063315|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2063316|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2063317|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063318|NCT01845831|Incretins|incretins|mesh-ancestor
2063319|NCT01845831|Hormones|hormones|mesh-ancestor
2063320|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2063321|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2063322|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
2063323|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063324|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063325|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
2063326|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2063327|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
2063328|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063329|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
2063330|NCT01846039|Protective Agents|protective agents|mesh-ancestor
2063331|NCT01846104|Vaccines|vaccines|mesh-list
2063332|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
2063333|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063334|NCT01846221|Clonidine|clonidine|mesh-list
2063335|NCT01846221|Fentanyl|fentanyl|mesh-list
2063336|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2063337|NCT01846221|Narcotics|narcotics|mesh-ancestor
2063338|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2063339|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063340|NCT01846221|Analgesics|analgesics|mesh-ancestor
2063341|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
2063342|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063343|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2063344|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2063345|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
2063346|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
2063347|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2063348|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
2063349|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
2063350|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2063351|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2063352|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2063353|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
2063354|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063355|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063366|NCT01846299|Ranibizumab|ranibizumab|mesh-list
2063367|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2063368|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2063369|NCT01846299|Growth Substances|growth substances|mesh-ancestor
2063370|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063371|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
2063372|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063373|NCT01846416|Atezolizumab|atezolizumab|mesh-list
2063374|NCT01846416|Antibodies|antibodies|mesh-list
2063375|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
2063376|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063377|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063378|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2063379|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2063380|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
2063381|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063382|NCT01846455|Promethazine|promethazine|mesh-list
2063383|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
2063384|NCT01846455|Buprenorphine|buprenorphine|mesh-list
2063385|NCT01846455|Naloxone|naloxone|mesh-list
2063386|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2063387|NCT01846455|Narcotics|narcotics|mesh-ancestor
2210406|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2210407|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
2210408|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2063388|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2063389|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063390|NCT01846455|Analgesics|analgesics|mesh-ancestor
2063391|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
2063392|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063393|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2063394|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
2063395|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
2063396|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2063397|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
2063398|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
2063399|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063400|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063401|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2063402|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2063403|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2063404|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
2063405|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
2063406|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
2063407|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
2063408|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2063409|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
2063410|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2063411|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2063412|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063413|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
2063414|NCT01846507|Coagulants|coagulants|mesh-ancestor
2063415|NCT01846611|Dexamethasone|dexamethasone|mesh-list
2063416|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2063417|NCT01846611|Doxorubicin|doxorubicin|mesh-list
2063418|NCT01846611|Trabectedin|trabectedin|mesh-list
2063419|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2063420|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
2063421|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
2063422|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063423|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063424|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2063425|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
2063426|NCT01846611|Hormones|hormones|mesh-ancestor
2063427|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2063428|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2063429|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063430|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2063431|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2063432|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2063433|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063434|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063435|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2063436|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
2063437|NCT01846624|Decitabine|decitabine|mesh-list
2063438|NCT01846624|Azacitidine|azacitidine|mesh-list
2063439|NCT01846624|Midostaurin|midostaurin|mesh-list
2063440|NCT01846624|Staurosporine|staurosporine|mesh-list
2063441|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2063442|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
2063443|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063444|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063445|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063446|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2063447|NCT01846728|Estrogens|estrogens|mesh-list
2063448|NCT01846728|Hormones|hormones|mesh-ancestor
2063449|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2063450|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063451|NCT01847001|Paclitaxel|paclitaxel|mesh-list
2063452|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2063453|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
2063454|NCT01847001|Doxorubicin|doxorubicin|mesh-list
2063455|NCT01847001|Trastuzumab|trastuzumab|mesh-list
2063456|NCT01847001|Pertuzumab|pertuzumab|mesh-list
2063457|NCT01847001|Propranolol|propranolol|mesh-list
2063458|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2063459|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063460|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
2063461|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
2063462|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
2063463|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063464|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2063465|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
2063466|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063467|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2063468|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2063469|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
2063470|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2063471|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2063472|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2063473|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2063474|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063475|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2063476|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2063477|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2063478|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
2063479|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063480|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2063481|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2063482|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
2063483|NCT01847014|Macitentan|macitentan|mesh-list
2063484|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2063485|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2063486|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063487|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2063488|NCT01847131|Phenylephrine|phenylephrine|mesh-list
2063489|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
2063490|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2063491|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2063492|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
2063493|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063494|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063495|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063496|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
2063497|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
2063498|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063499|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
2063500|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2063501|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
2063502|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2063503|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
2063504|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2063505|NCT01847131|Protective Agents|protective agents|mesh-ancestor
2063506|NCT01847274|Niraparib|niraparib|mesh-list
2063507|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2063508|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063509|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063510|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063511|NCT01847313|Liraglutide|liraglutide|mesh-list
2063512|NCT01847313|Glucagon|glucagon|mesh-list
2063513|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2063514|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2063515|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063516|NCT01847313|Incretins|incretins|mesh-ancestor
2063517|NCT01847313|Hormones|hormones|mesh-ancestor
2063518|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2063519|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2063520|NCT01847443|Nicotine|nicotine|mesh-list
2063521|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2063522|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
2063523|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063524|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063525|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2063526|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2063527|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
2063528|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063529|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063530|NCT01847469|Zonisamide|zonisamide|mesh-list
2063531|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
2063532|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2063533|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2063534|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063535|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2063536|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063537|NCT01847638|Nepafenac|nepafenac|mesh-list
2063538|NCT01847638|Bromfenac|bromfenac|mesh-list
2210409|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2210410|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2210411|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
2210412|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2210413|NCT00016367|Gemcitabine|gemcitabine|mesh-list
2210414|NCT00016367|Cisplatin|cisplatin|mesh-list
2210415|NCT00016367|Trastuzumab|trastuzumab|mesh-list
2210416|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210417|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210418|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
2210419|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210420|NCT00016367|Antiviral Agents|antiviral agents|mesh-ancestor
2210421|NCT00016367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210422|NCT00016367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210423|NCT00016367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210424|NCT00016367|Immunologic Factors|immunologic factors|mesh-ancestor
2210425|NCT00016367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210426|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2210427|NCT00016380|Dexamethasone|dexamethasone|mesh-list
2210428|NCT00016380|Ondansetron|ondansetron|mesh-list
2210429|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2210430|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
2210431|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
2210432|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2210433|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210434|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2210435|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
2210436|NCT00016380|Hormones|hormones|mesh-ancestor
2210437|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2063539|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2063540|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2063541|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2063542|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2063543|NCT01847638|Analgesics|analgesics|mesh-ancestor
2063544|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
2063545|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2210438|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2210439|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210440|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
2210441|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
2210442|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2210443|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
2210444|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2210445|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210446|NCT00016380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2210447|NCT00016380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2063546|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063547|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2063548|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2063549|NCT01848041|Phenylephrine|phenylephrine|mesh-list
2063550|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
2063551|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2063552|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2063553|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2063554|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2063555|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
2063556|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063557|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063558|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063559|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
2063560|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
2063561|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063562|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
2063563|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2063564|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
2063565|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2063566|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
2063567|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2063568|NCT01848041|Protective Agents|protective agents|mesh-ancestor
2063569|NCT01848054|Buprenorphine|buprenorphine|mesh-list
2063570|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2063571|NCT01848054|Naloxone|naloxone|mesh-list
2063572|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2063573|NCT01848054|Narcotics|narcotics|mesh-ancestor
2063574|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2063575|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063576|NCT01848054|Analgesics|analgesics|mesh-ancestor
2063577|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
2063578|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063579|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2063580|NCT01848067|Prednisone|prednisone|mesh-list
2063581|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
2063582|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2063583|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
2063584|NCT01848067|Hormones|hormones|mesh-ancestor
2063585|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2063586|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063587|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2063588|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063589|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2063590|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063591|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063592|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
2063593|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2063594|NCT01848145|Ofatumumab|ofatumumab|mesh-list
2063595|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063596|NCT01848210|Troxerutin|troxerutin|mesh-list
2063597|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
2063598|NCT01848457|Methotrexate|methotrexate|mesh-list
2063599|NCT01848457|Pantoprazole|pantoprazole|mesh-list
2063600|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2063601|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
2063602|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2063603|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063604|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2063605|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
2063606|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063607|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063608|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
2063609|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063610|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2063611|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2063612|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
2063613|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2063614|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2063615|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2063616|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2063617|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2063618|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
2063619|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2063620|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063621|NCT01848899|Bivalirudin|bivalirudin|mesh-list
2063622|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
2063623|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2063624|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
2063625|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063626|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063627|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
2063628|NCT01848990|Insulin|insulin|mesh-list
2063629|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2063630|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
2063631|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
2063632|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
2063633|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2063634|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063635|NCT01849055|Celecoxib|celecoxib|mesh-list
2063636|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2063637|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2063638|NCT01849055|Analgesics|analgesics|mesh-ancestor
2063639|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
2063640|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063641|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063642|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2063643|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2063644|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2063645|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2063646|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063647|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063648|NCT01849068|Ezetimibe|ezetimibe|mesh-list
2063649|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2063650|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2063651|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
2063652|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063653|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2063654|NCT01849276|Metformin|metformin|mesh-list
2063655|NCT01849276|Cytarabine|cytarabine|mesh-list
2063656|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2063657|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063658|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2063659|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
2063660|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063661|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063662|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
2063663|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2063664|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2063665|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
2063666|NCT01849289|Insulin|insulin|mesh-list
2063667|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2063668|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
2063669|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2063670|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063671|NCT01849419|Oxytocin|oxytocin|mesh-list
2063672|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
2063673|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2063674|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063675|NCT01849497|Evolocumab|evolocumab|mesh-list
2063676|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2063677|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2063678|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2063679|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
2063680|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063681|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2063682|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
2063683|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063684|NCT01849562|Ribavirin|ribavirin|mesh-list
2063685|NCT01849562|Odalasvir|odalasvir|mesh-list
2063686|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
2063687|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063688|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
2063689|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2063690|NCT01849588|Sorafenib|sorafenib|mesh-list
2063691|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063692|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2063693|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063694|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063695|NCT01849692|Ranibizumab|ranibizumab|mesh-list
2063696|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2063697|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2063698|NCT01849692|Growth Substances|growth substances|mesh-ancestor
2063699|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063700|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
2063701|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063702|NCT01849770|Mexiletine|mexiletine|mesh-list
2063703|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2063704|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2063705|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2063706|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2063707|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063713|NCT01850030|Progesterone|progesterone|mesh-list
2063714|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
2063715|NCT01850030|Progestins|progestins|mesh-ancestor
2063716|NCT01850030|Hormones|hormones|mesh-ancestor
2063717|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2063718|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063719|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
2063720|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2063721|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2063722|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063723|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
2063724|NCT01850394|Coagulants|coagulants|mesh-ancestor
2063725|NCT01850446|Oseltamivir|oseltamivir|mesh-list
2063726|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
2063727|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2063728|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063729|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063730|NCT01850524|Dexamethasone|dexamethasone|mesh-list
2063731|NCT01850524|Lenalidomide|lenalidomide|mesh-list
2063732|NCT01850524|Ixazomib|ixazomib|mesh-list
2063733|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2063734|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
2063735|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
2063736|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063737|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063738|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2063739|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
2063740|NCT01850524|Hormones|hormones|mesh-ancestor
2063741|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2063742|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2063743|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063744|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
2063745|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2063746|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2063747|NCT01850524|Growth Substances|growth substances|mesh-ancestor
2063748|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
2063749|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
2063750|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063751|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063752|NCT01850602|Sevelamer|sevelamer|mesh-list
2063753|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
2063754|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
2063755|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063756|NCT01850615|Insulin|insulin|mesh-list
2063757|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2063758|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
2063759|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2063760|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063761|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
2063762|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2063763|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
2063764|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2063765|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
2063766|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2063767|NCT01851330|Ledipasvir|ledipasvir|mesh-list
2063768|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
2063769|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2063770|NCT01851590|Terbinafine|terbinafine|mesh-list
2063771|NCT01851590|Amorolfine|amorolfine|mesh-list
2063772|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
2063773|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2063774|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063775|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063776|NCT01851720|Fentanyl|fentanyl|mesh-list
2063777|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2063778|NCT01851720|Narcotics|narcotics|mesh-ancestor
2063779|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2063780|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063781|NCT01851720|Analgesics|analgesics|mesh-ancestor
2063782|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
2063783|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063784|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2063785|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2063786|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
2063787|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
2063788|NCT01851863|Flupenthixol|flupenthixol|mesh-list
2063789|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
2063790|NCT01851863|Omeprazole|omeprazole|mesh-list
2063791|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2063792|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2063793|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2063794|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063795|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063796|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2063797|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2063798|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2063799|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063800|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2063801|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2063802|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
2063803|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063804|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2063805|NCT01852019|Cangrelor|cangrelor|mesh-list
2063806|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2063807|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2063808|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2063809|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2063810|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
2063811|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063812|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063813|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063814|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
2063815|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2063816|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2063817|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2063818|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2063819|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063820|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
2063821|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063822|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063823|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2063824|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063825|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
2063826|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2063827|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2210448|NCT00016380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2210449|NCT00016380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2210450|NCT00016380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2210451|NCT00016406|Paclitaxel|paclitaxel|mesh-list
2210452|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
2210453|NCT00016406|Doxorubicin|doxorubicin|mesh-list
2210454|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2210455|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063828|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2063829|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2063830|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063831|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
2063832|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063833|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063834|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2063835|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063836|NCT01852071|Busulfan|busulfan|mesh-list
2063837|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
2063838|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063839|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2063840|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
2063841|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063842|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2063843|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063844|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2063845|NCT01852162|Dabigatran|dabigatran|mesh-list
2063846|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
2063847|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2063848|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
2063849|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063850|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063851|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
2063852|NCT01852175|Ticagrelor|ticagrelor|mesh-list
2063853|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2063854|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2063855|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2063856|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2063857|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2063858|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
2063859|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063860|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063861|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063862|NCT01852214|Ticagrelor|ticagrelor|mesh-list
2063863|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2063864|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2063865|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2063866|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2063867|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2063868|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
2063869|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063870|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063871|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063872|NCT01852292|Paclitaxel|paclitaxel|mesh-list
2063873|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2063874|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063875|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
2063876|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
2063877|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
2063878|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063879|NCT01852344|Methylphenidate|methylphenidate|mesh-list
2063880|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2063881|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063882|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2063883|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2063884|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2063885|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063886|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
2063887|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063888|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2063889|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2210456|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
2063890|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2063891|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2063892|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063893|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063894|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063895|NCT01852383|Analgesics|analgesics|mesh-ancestor
2063896|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
2063897|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063898|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
2063899|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2063900|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
2063901|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2063902|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
2063903|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063904|NCT01852669|Furosemide|furosemide|mesh-list
2063905|NCT01852669|Diuretics|diuretics|mesh-ancestor
2063906|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
2063907|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063908|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2063909|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2063910|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063911|NCT01852812|Montelukast|montelukast|mesh-list
2063912|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2063913|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
2063914|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2063915|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
2063916|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2063917|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063918|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2063919|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2063920|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063921|NCT01852942|Losartan|losartan|mesh-list
2063922|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2063923|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2063924|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2063925|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2063926|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063927|NCT01852955|Acetaminophen|acetaminophen|mesh-list
2063928|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2063929|NCT01852955|Analgesics|analgesics|mesh-ancestor
2063930|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
2063931|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063932|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063933|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
2063934|NCT01853072|Prednisolone|prednisolone|mesh-list
2063935|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2063936|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
2063937|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2063938|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
2063939|NCT01853072|Nepafenac|nepafenac|mesh-list
2063940|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2063941|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
2063942|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2063943|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
2063944|NCT01853072|Hormones|hormones|mesh-ancestor
2063945|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2063946|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063947|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2063948|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063949|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
2063950|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
2063951|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2063952|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2063953|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2063954|NCT01853072|Protective Agents|protective agents|mesh-ancestor
2063955|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2063956|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2063957|NCT01853072|Analgesics|analgesics|mesh-ancestor
2063958|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
2063959|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2063960|NCT01853085|Bimatoprost|bimatoprost|mesh-list
2063961|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2063962|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2063963|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2063964|NCT01853228|Cytarabine|cytarabine|mesh-list
2063965|NCT01853228|Decitabine|decitabine|mesh-list
2063966|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2063967|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
2063968|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063969|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2063970|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
2063971|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2063972|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2063973|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
2063974|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063975|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2063976|NCT01853254|Ribavirin|ribavirin|mesh-list
2063977|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2063978|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
2063979|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063980|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
2063981|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2063982|NCT01853280|Methylphenidate|methylphenidate|mesh-list
2063983|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2063984|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2063985|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2063986|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2063987|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2063988|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2063989|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
2063990|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2063991|NCT01853475|Artefenomel|artefenomel|mesh-list
2063992|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
2063993|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2063994|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2063995|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2063996|NCT01853553|Spironolactone|spironolactone|mesh-list
2063997|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2063998|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
2063999|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2064000|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064001|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2064002|NCT01853553|Diuretics|diuretics|mesh-ancestor
2064003|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
2064004|NCT01853618|Tremelimumab|tremelimumab|mesh-list
2064005|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064006|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2064007|NCT01853696|Prednisolone|prednisolone|mesh-list
2064008|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2064009|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
2064010|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2064011|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
2064012|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2064013|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
2064014|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2064015|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
2064016|NCT01853696|Hormones|hormones|mesh-ancestor
2064017|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2064018|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064019|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2064020|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064021|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
2064022|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
2064023|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064024|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2064025|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2064026|NCT01853696|Protective Agents|protective agents|mesh-ancestor
2064027|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2064028|NCT01854047|Albuterol|albuterol|mesh-list
2064029|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2064030|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
2064031|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064032|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064033|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2064034|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
2064035|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
2064036|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2064037|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2064038|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2064039|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2064040|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
2064041|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064042|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064043|NCT01854177|Aprepitant|aprepitant|mesh-list
2064044|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
2064045|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
2064046|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
2064047|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064048|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064049|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2064050|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2064051|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064052|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064053|NCT01854268|Capsaicin|capsaicin|mesh-list
2064054|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
2064055|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
2064056|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
2064057|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064058|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064059|NCT01854359|Idebenone|idebenone|mesh-list
2064060|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
2064061|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064062|NCT01854359|Protective Agents|protective agents|mesh-ancestor
2064063|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064064|NCT01854528|Interferons|interferons|mesh-list
2064065|NCT01854528|Ribavirin|ribavirin|mesh-list
2064066|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064067|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
2064068|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064069|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
2064070|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064071|NCT01854593|Bevacizumab|bevacizumab|mesh-list
2064072|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2064073|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064074|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2064075|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2064076|NCT01854593|Growth Substances|growth substances|mesh-ancestor
2064077|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064078|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
2064079|NCT01854645|Bromides|bromides|mesh-list
2064080|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
2064081|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2064082|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
2210457|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210458|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210459|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210460|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210461|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
2210462|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210463|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2210464|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210465|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
2210466|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2210467|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2210468|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2210469|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210470|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210471|NCT00016419|Cyclosporine|cyclosporine|mesh-list
2210472|NCT00016419|Cyclosporins|cyclosporins|mesh-list
2064083|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064084|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064085|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2064086|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
2064087|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
2064088|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2064089|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
2064090|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064091|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064092|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
2064093|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
2064094|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
2064095|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2064096|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
2210473|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2210474|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210475|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210476|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210477|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
2064097|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064098|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064099|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2064100|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
2064101|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2064102|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2064103|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2064104|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
2064105|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064106|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064107|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2064108|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2064109|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2064110|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
2064111|NCT01854697|Interferons|interferons|mesh-list
2210478|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210479|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
2210480|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210481|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
2210482|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2210483|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2210484|NCT00016432|Exemestane|exemestane|mesh-list
2210485|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210486|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2210487|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2064112|NCT01854697|Ribavirin|ribavirin|mesh-list
2064113|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
2064114|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
2064115|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2064116|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064117|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
2064118|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064119|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
2064120|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064121|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
2064122|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064123|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
2064124|NCT01854710|Loxapine|loxapine|mesh-list
2064125|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2064126|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064127|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2748727|NCT04796363|Anesthetics|anesthetics|mesh-list
2748728|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2748729|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210488|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210489|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210490|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2210491|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
2210492|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2210493|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210494|NCT00016445|Hormones|hormones|mesh-list
2210495|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2210496|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210497|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
2210498|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2064128|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2064129|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064130|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064131|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064132|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064133|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2064134|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2064135|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2064136|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2064137|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2064138|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
2064139|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064140|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2064141|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2064142|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2064143|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
2064144|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064145|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
2064146|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2064147|NCT01854827|Antibodies|antibodies|mesh-list
2064148|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
2064149|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2064150|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
2064151|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064152|NCT01854918|Evolocumab|evolocumab|mesh-list
2064153|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2064154|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2064155|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
2064156|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064157|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2064158|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
2064159|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
2064160|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064161|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064162|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064163|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
2064164|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
2064165|NCT01855074|Risperidone|risperidone|mesh-list
2064166|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2064167|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
2064168|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064169|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064170|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064171|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2064172|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2064173|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2064174|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2064175|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2064176|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
2064177|NCT01855243|Insulin|insulin|mesh-list
2064178|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2064179|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2064180|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064181|NCT01855360|Doxycycline|doxycycline|mesh-list
2064182|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
2064183|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2064184|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064185|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
2064186|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2064187|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2064188|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
2064189|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2064190|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2064191|NCT01855750|Prednisone|prednisone|mesh-list
2064192|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
2064193|NCT01855750|Rituximab|rituximab|mesh-list
2210499|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210500|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
2210501|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210502|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2064194|NCT01855750|Doxorubicin|doxorubicin|mesh-list
2064195|NCT01855750|Vincristine|vincristine|mesh-list
2064196|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2064197|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
2064198|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064199|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2064200|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2064201|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
2064202|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064203|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064204|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2064205|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2064206|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2064207|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2064208|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2064209|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064210|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2064211|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
2064212|NCT01855750|Hormones|hormones|mesh-ancestor
2064213|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2064214|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2064215|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2064216|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
2064217|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
2064218|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
2064219|NCT01855789|Methotrexate|methotrexate|mesh-list
2064220|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2064221|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
2064222|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2064223|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064224|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2064225|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
2064226|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064227|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064228|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
2064229|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064230|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2064231|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2064232|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
2064233|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2064234|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2064235|NCT01855828|Paclitaxel|paclitaxel|mesh-list
2064236|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
2064237|NCT01855828|Fluorouracil|fluorouracil|mesh-list
2064238|NCT01855828|Trastuzumab|trastuzumab|mesh-list
2064239|NCT01855828|Epirubicin|epirubicin|mesh-list
2064240|NCT01855828|Pertuzumab|pertuzumab|mesh-list
2064241|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2064242|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064243|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
2064244|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
2064245|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
2064246|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064247|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2064248|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
2064249|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064250|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2064251|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2064252|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
2064253|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2064254|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
2064255|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2064256|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2064257|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2064258|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2064259|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2064260|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064261|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2064262|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2064263|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2064264|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2064265|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064266|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064267|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064268|NCT01855919|Analgesics|analgesics|mesh-ancestor
2064269|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
2064270|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064271|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
2064272|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2064273|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
2064274|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2064275|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
2064276|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
2064277|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210503|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210504|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
2210505|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210506|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210507|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2210508|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
2210509|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2210510|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
2210511|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2210512|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210513|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2210514|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
2210515|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2210516|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
2210517|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210518|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2210519|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2210520|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
2210521|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
2210522|NCT00016523|Protective Agents|protective agents|mesh-ancestor
2210523|NCT00016549|Bevacizumab|bevacizumab|mesh-list
2210524|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2210525|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210526|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2210527|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2210528|NCT00016549|Growth Substances|growth substances|mesh-ancestor
2210529|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210530|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
2210531|NCT00016588|Tenofovir|tenofovir|mesh-list
2210532|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
2210533|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210534|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2210535|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2210536|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210537|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210538|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2210539|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2210540|NCT00016601|Ritonavir|ritonavir|mesh-list
2210541|NCT00016601|Nelfinavir|nelfinavir|mesh-list
2210542|NCT00016601|Indinavir|indinavir|mesh-list
2210543|NCT00016601|Nevirapine|nevirapine|mesh-list
2210544|NCT00016601|Efavirenz|efavirenz|mesh-list
2210545|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2210546|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
2064278|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064279|NCT01856114|Fentanyl|fentanyl|mesh-list
2064280|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2064281|NCT01856114|Narcotics|narcotics|mesh-ancestor
2064282|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2064283|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064284|NCT01856114|Analgesics|analgesics|mesh-ancestor
2064285|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
2064286|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064287|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2748730|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2748735|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
2748736|NCT04787744|Prednisone|prednisone|mesh-list
2748737|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
2748738|NCT04787744|Docetaxel|docetaxel|mesh-list
2748739|NCT04787744|Leuprolide|leuprolide|mesh-list
2748740|NCT04787744|Goserelin|goserelin|mesh-list
2748741|NCT04787744|Bicalutamide|bicalutamide|mesh-list
2748742|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2748743|NCT04787744|Flutamide|flutamide|mesh-list
2748744|NCT04787744|Nilutamide|nilutamide|mesh-list
2064288|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2064289|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
2064290|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
2064291|NCT01856192|Prednisone|prednisone|mesh-list
2064292|NCT01856192|Cortisone|cortisone|mesh-list
2064293|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
2064294|NCT01856192|Rituximab|rituximab|mesh-list
2064295|NCT01856192|Doxorubicin|doxorubicin|mesh-list
2064296|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2064297|NCT01856192|Vincristine|vincristine|mesh-list
2064298|NCT01856192|Lenalidomide|lenalidomide|mesh-list
2064299|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2064300|NCT01856192|Antibodies|antibodies|mesh-list
2064301|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
2064302|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2064303|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2064304|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
2064305|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064306|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2064307|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2064308|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
2064309|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064310|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064311|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2064312|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2064313|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2064314|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2064315|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064316|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2064317|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
2064318|NCT01856192|Hormones|hormones|mesh-ancestor
2064319|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2064320|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2064321|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2064322|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
2064323|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
2064324|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
2064325|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2064326|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2064327|NCT01856192|Growth Substances|growth substances|mesh-ancestor
2064328|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
2064329|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
2064330|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
2064331|NCT01856257|Abatacept|abatacept|mesh-list
2064332|NCT01856257|Tacrolimus|tacrolimus|mesh-list
2064333|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
2064334|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2064335|NCT01856257|Basiliximab|basiliximab|mesh-list
2064336|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2064337|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
2064338|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064339|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2064340|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064341|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064342|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2064343|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210547|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2210548|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2210549|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
2210550|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210551|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210552|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2210553|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2748745|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748746|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
2748747|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
2748748|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
2064344|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2064345|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
2064346|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2064347|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064348|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2064349|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
2064350|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
2064351|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064352|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2064353|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
2064354|NCT01856257|Hormones|hormones|mesh-ancestor
2064355|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2064356|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2064357|NCT01856257|Protective Agents|protective agents|mesh-ancestor
2748749|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748750|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2748751|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
2748752|NCT04787744|Hormones|hormones|mesh-ancestor
2748753|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2748754|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748755|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2748756|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
2064358|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2064359|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2748757|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
2064379|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2064380|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
2064381|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064382|NCT01856530|Oxytocin|oxytocin|mesh-list
2064383|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
2064384|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2064385|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064386|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
2064387|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2064388|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
2064389|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2064390|NCT01856712|Naltrexone|naltrexone|mesh-list
2210554|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
2210555|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210556|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2064391|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2064392|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2064393|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064394|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
2064395|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064396|NCT01856790|Liraglutide|liraglutide|mesh-list
2064397|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2064398|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064399|NCT01856790|Incretins|incretins|mesh-ancestor
2064400|NCT01856790|Hormones|hormones|mesh-ancestor
2064401|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2064402|NCT01856907|Metformin|metformin|mesh-list
2064403|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2064404|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2064405|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064406|NCT01856907|Incretins|incretins|mesh-ancestor
2064407|NCT01856907|Hormones|hormones|mesh-ancestor
2064408|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2064409|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2064410|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
2064411|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064412|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064413|NCT01857063|Montelukast|montelukast|mesh-list
2064414|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2064415|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
2064416|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2064417|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
2064418|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2064419|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064420|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2064421|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2064422|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064423|NCT01857206|Vaccines|vaccines|mesh-list
2210557|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2210558|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2210559|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2210560|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2210561|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2064424|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
2064425|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064426|NCT01857232|Dexamethasone|dexamethasone|mesh-list
2748758|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2748759|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2748760|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2748761|NCT04787744|Protective Agents|protective agents|mesh-ancestor
2748762|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2064427|NCT01857232|Ondansetron|ondansetron|mesh-list
2064428|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
2064429|NCT01857232|Aprepitant|aprepitant|mesh-list
2064430|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2064431|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
2210562|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2210563|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2210564|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2210565|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2210566|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2210567|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2210568|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
2210569|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2210570|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210571|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2064432|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
2748763|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
2748764|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2748765|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
2748766|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
2748767|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
2748768|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2748769|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
2748770|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2748779|NCT04784208|Hormones|hormones|mesh-list
2751253|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210572|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2210573|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2210574|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2210575|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210576|NCT00016666|Propranolol|propranolol|mesh-list
2210577|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2210578|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2210579|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
2210580|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2210581|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210582|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210583|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2210584|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2210585|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
2210586|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2210587|NCT00016744|Genistein|genistein|mesh-list
2210588|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210589|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2210590|NCT00016744|Protective Agents|protective agents|mesh-ancestor
2210591|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210592|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2210593|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210594|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210595|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
2210596|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2064433|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064434|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064435|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2064436|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
2064437|NCT01857232|Hormones|hormones|mesh-ancestor
2064438|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2064439|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2064440|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064441|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
2064442|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
2064443|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2064444|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
2064445|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064446|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064447|NCT01857232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2064448|NCT01857232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2064449|NCT01857232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2064450|NCT01857232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2064451|NCT01857232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2064452|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2064453|NCT01857297|Vaccines|vaccines|mesh-list
2064454|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
2064455|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064456|NCT01857310|Folic Acid|folic acid|mesh-list
2064457|NCT01857310|Hematinics|hematinics|mesh-ancestor
2064458|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
2064459|NCT01857310|Vitamins|vitamins|mesh-ancestor
2064460|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
2064461|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064462|NCT01857323|Albuterol|albuterol|mesh-list
2064463|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2064464|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
2064465|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064466|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064467|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2064468|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
2064469|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
2064470|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2064471|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2064472|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2064473|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2064474|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
2064475|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064476|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064477|NCT01857362|Nitisinone|nitisinone|mesh-list
2064478|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064479|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064480|NCT01857531|Nicotine|nicotine|mesh-list
2064481|NCT01857531|Ganaxolone|ganaxolone|mesh-list
2064482|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2064483|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
2064484|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064485|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064486|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2064487|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2064488|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
2064489|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064490|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064491|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
2064492|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
2064493|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
2064494|NCT01857583|PENTA|penta|mesh-list
2064495|NCT01857583|Edoxaban|edoxaban|mesh-list
2064496|NCT01857583|Fondaparinux|fondaparinux|mesh-list
2064497|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2064498|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
2064499|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2064500|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
2210597|NCT00016744|Estrogens|estrogens|mesh-ancestor
2210598|NCT00016744|Hormones|hormones|mesh-ancestor
2210599|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2210600|NCT00016835|Metronidazole|metronidazole|mesh-list
2210601|NCT00016835|Doxycycline|doxycycline|mesh-list
2210602|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210603|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2210604|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2210605|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2210606|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
2748780|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2748781|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064501|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064502|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064503|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
2064504|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2064505|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2064506|NCT01857622|Edoxaban|edoxaban|mesh-list
2064507|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2064508|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
2064509|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2064510|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
2064511|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064512|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064513|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
2064514|NCT01858363|Paclitaxel|paclitaxel|mesh-list
2064515|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2210607|NCT00016861|Irinotecan|irinotecan|mesh-list
2064516|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064517|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
2064518|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
2064519|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
2064520|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064521|NCT01858428|Paclitaxel|paclitaxel|mesh-list
2064522|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2064523|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064524|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
2064525|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
2064526|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
2064527|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064528|NCT01858532|Atrasentan|atrasentan|mesh-list
2064529|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064530|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2064531|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2064532|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064533|NCT01858766|Ribavirin|ribavirin|mesh-list
2064534|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
2064535|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064536|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
2064537|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064538|NCT01859013|Topiramate|topiramate|mesh-list
2210608|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2210609|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210610|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210611|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210612|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064539|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
2064540|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2064541|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064542|NCT01859078|Digoxin|digoxin|mesh-list
2064543|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2064544|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2064545|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064546|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064547|NCT01859078|Protective Agents|protective agents|mesh-ancestor
2748796|NCT04780321|Antibodies|antibodies|mesh-list
2748797|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2748798|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
2064548|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064549|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
2064550|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2064551|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2064552|NCT01859390|Antioxidants|antioxidants|mesh-list
2064553|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064554|NCT01859390|Protective Agents|protective agents|mesh-ancestor
2064555|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064556|NCT01859637|Lenograstim|lenograstim|mesh-list
2064557|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2064558|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
2064559|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064560|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
2064561|NCT01859702|Dexamethasone|dexamethasone|mesh-list
2064562|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2064563|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2064564|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
2064565|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
2064566|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064567|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064568|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2064569|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
2064570|NCT01859702|Hormones|hormones|mesh-ancestor
2064571|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2064572|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2064573|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064574|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2064575|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2064576|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064577|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2064578|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2064579|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064580|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064581|NCT01859715|Oxycodone|oxycodone|mesh-list
2064582|NCT01859715|Hydrocodone|hydrocodone|mesh-list
2210613|NCT00016874|Paclitaxel|paclitaxel|mesh-list
2210614|NCT00016874|Cisplatin|cisplatin|mesh-list
2210615|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2210616|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210617|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
2210618|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210619|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
2064583|NCT01859715|Ondansetron|ondansetron|mesh-list
2064584|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2064585|NCT01859715|Narcotics|narcotics|mesh-ancestor
2064586|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2064587|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210620|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210621|NCT00016887|Interferons|interferons|mesh-list
2210622|NCT00016887|Cytarabine|cytarabine|mesh-list
2210623|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
2210624|NCT00016887|Dexamethasone|dexamethasone|mesh-list
2210625|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
2210626|NCT00016887|Melphalan|melphalan|mesh-list
2210627|NCT00016887|Carmustine|carmustine|mesh-list
2210628|NCT00016887|Etoposide|etoposide|mesh-list
2210629|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210630|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
2210631|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210632|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2210633|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2064588|NCT01859715|Analgesics|analgesics|mesh-ancestor
2064589|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
2064590|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064591|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
2064592|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
2064593|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2064594|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
2064595|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
2064596|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2064597|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
2064598|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064599|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064600|NCT01859715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2064601|NCT01859715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2064602|NCT01859715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2064603|NCT01859715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2064604|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
2064605|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
2064606|NCT01859741|Carboplatin|carboplatin|mesh-list
2064607|NCT01859741|Etoposide|etoposide|mesh-list
2064608|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064609|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2210634|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
2064610|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2064611|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2064612|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064613|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064614|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2064615|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2064616|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064617|NCT01859793|Incretins|incretins|mesh-ancestor
2064618|NCT01859793|Hormones|hormones|mesh-ancestor
2064619|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2064620|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2064621|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
2064622|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064623|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064624|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
2064625|NCT01860170|Bortezomib|bortezomib|mesh-list
2064626|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2064627|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
2064628|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064629|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2064630|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2064631|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
2064632|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064633|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064634|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2064635|NCT01860287|Buprenorphine|buprenorphine|mesh-list
2064636|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2064637|NCT01860287|Narcotics|narcotics|mesh-ancestor
2064638|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2064639|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064640|NCT01860287|Analgesics|analgesics|mesh-ancestor
2064641|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
2064642|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064643|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2064644|NCT01860521|Sufentanil|sufentanil|mesh-list
2064645|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
2064646|NCT01860521|Gemeprost|gemeprost|mesh-list
2064647|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
2064648|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
2064649|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2751254|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
2064650|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064651|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
2064652|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064653|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2064654|NCT01860521|Narcotics|narcotics|mesh-ancestor
2064655|NCT01860521|Analgesics|analgesics|mesh-ancestor
2064656|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2064657|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2064658|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
2064659|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2064660|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
2064661|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2064662|NCT01860586|Bevacizumab|bevacizumab|mesh-list
2064663|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2064664|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064665|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2064666|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2064667|NCT01860586|Growth Substances|growth substances|mesh-ancestor
2064668|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064669|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
2064670|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
2064671|NCT01860703|Deferiprone|deferiprone|mesh-list
2064672|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2064673|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064674|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2064675|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2064676|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064677|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210635|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210636|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210637|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2210638|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2210639|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
2210640|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
2210641|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064678|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064679|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2064680|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
2064681|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
2064682|NCT01860807|Ibudilast|ibudilast|mesh-list
2064683|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2064684|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
2064685|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064686|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210642|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2210643|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
2210644|NCT00016887|Hormones|hormones|mesh-ancestor
2210645|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2748799|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748800|NCT04780204|Tenofovir|tenofovir|mesh-list
2748801|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
2748802|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2748803|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2748804|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2748805|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064687|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2064688|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
2064689|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2064690|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064691|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064692|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2064693|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
2064694|NCT01860976|Abatacept|abatacept|mesh-list
2064695|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2064696|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064697|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064698|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2064699|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
2064700|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064701|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2064702|NCT01861002|Vidarabine|vidarabine|mesh-list
2064703|NCT01861002|Cytarabine|cytarabine|mesh-list
2064704|NCT01861002|Methotrexate|methotrexate|mesh-list
2064705|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
2748806|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748807|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2748808|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2748809|NCT04778397|Cytarabine|cytarabine|mesh-list
2748810|NCT04778397|Azacitidine|azacitidine|mesh-list
2748811|NCT04778397|Daunorubicin|daunorubicin|mesh-list
2748812|NCT04778397|Venetoclax|venetoclax|mesh-list
2748813|NCT04778397|Idarubicin|idarubicin|mesh-list
2748814|NCT04778397|Magrolimab|magrolimab|mesh-list
2064706|NCT01861002|Azacitidine|azacitidine|mesh-list
2064707|NCT01861002|Fludarabine|fludarabine|mesh-list
2064708|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2748815|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2751255|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210646|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2210647|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2210648|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2064709|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
2064710|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2064711|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064712|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2064713|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
2064714|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064715|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064716|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
2064717|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064718|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2064719|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2064720|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
2064721|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2064722|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2064723|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
2064724|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064725|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2064726|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064727|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
2064728|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2064729|NCT01861665|Bupivacaine|bupivacaine|mesh-list
2064730|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
2064731|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
2064732|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2064733|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064734|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
2064735|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064736|NCT01862250|Clonidine|clonidine|mesh-list
2064737|NCT01862250|Analgesics|analgesics|mesh-ancestor
2064738|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
2064739|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064740|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064741|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2064742|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
2064743|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
2748816|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2748817|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
2748818|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748819|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748820|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
2748821|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2748822|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2748823|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
2748824|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064744|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2064745|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2064746|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2748825|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2748826|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2748827|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2210649|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2064747|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
2064748|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064749|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748828|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2748829|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2751256|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
2064750|NCT01862328|Gemcitabine|gemcitabine|mesh-list
2064751|NCT01862328|Paclitaxel|paclitaxel|mesh-list
2064752|NCT01862328|Docetaxel|docetaxel|mesh-list
2210650|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210651|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
2064753|NCT01862328|Carboplatin|carboplatin|mesh-list
2064754|NCT01862328|Pevonedistat|pevonedistat|mesh-list
2064755|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2064756|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064757|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
2064758|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
2064759|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
2064760|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064761|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2064762|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
2064763|NCT01862328|Antiviral Agents|antiviral agents|mesh-ancestor
2064764|NCT01862328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064765|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064766|NCT01862328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2064767|NCT01862328|Immunologic Factors|immunologic factors|mesh-ancestor
2064768|NCT01862328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064769|NCT01862536|Tadalafil|tadalafil|mesh-list
2064770|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
2064771|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2064772|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2064773|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064774|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064775|NCT01862536|Urological Agents|urological agents|mesh-ancestor
2210652|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210653|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210654|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
2210655|NCT00016900|Paclitaxel|paclitaxel|mesh-list
2210656|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2210657|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210658|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
2210659|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210660|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210661|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210662|NCT00016926|Capecitabine|capecitabine|mesh-list
2210663|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210664|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
2210665|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210666|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210667|NCT00016939|Alvocidib|alvocidib|mesh-list
2210668|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210669|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
2210670|NCT00016939|Growth Substances|growth substances|mesh-ancestor
2064776|NCT01862614|Epinephrine|epinephrine|mesh-list
2064777|NCT01862614|Racepinephrine|racepinephrine|mesh-list
2064778|NCT01862614|Carticaine|carticaine|mesh-list
2064779|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
2064780|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2064781|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2064782|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
2064783|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064784|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064785|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064786|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2064787|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2064788|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
2064789|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064790|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2064791|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
2064792|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
2064793|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
2064794|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2210671|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210672|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2210673|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210674|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210675|NCT00016952|Leucovorin|leucovorin|mesh-list
2210676|NCT00016952|Fluorouracil|fluorouracil|mesh-list
2064795|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
2064796|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
2064797|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2064798|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
2064799|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
2064800|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
2064801|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064802|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064803|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064804|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
2064805|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
2064806|NCT01862874|Vaccines|vaccines|mesh-list
2064807|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
2064808|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064809|NCT01862991|Digoxin|digoxin|mesh-list
2064810|NCT01862991|Misoprostol|misoprostol|mesh-list
2064811|NCT01862991|Mifepristone|mifepristone|mesh-list
2064812|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2064813|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
2064814|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2748830|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2748841|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2748842|NCT04773353|Hormones|hormones|mesh-ancestor
2210677|NCT00016952|Irinotecan|irinotecan|mesh-list
2210678|NCT00016952|Calcium|calcium|mesh-list
2210679|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
2210680|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2210681|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210682|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
2210683|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210684|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210685|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210686|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210687|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
2210688|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2210689|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210690|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210691|NCT00016952|Antidotes|antidotes|mesh-ancestor
2210692|NCT00016952|Protective Agents|protective agents|mesh-ancestor
2210693|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
2748843|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2748844|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748845|NCT04772547|Vigabatrin|vigabatrin|mesh-list
2748846|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
2210694|NCT00016952|Vitamins|vitamins|mesh-ancestor
2210695|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
2210696|NCT00016978|Leucovorin|leucovorin|mesh-list
2064815|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064816|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2064817|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2064818|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
2064819|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2064820|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2064821|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064822|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064823|NCT01862991|Protective Agents|protective agents|mesh-ancestor
2064824|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2064825|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2064826|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2064827|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2064828|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
2079430|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2748847|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2748848|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748849|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
2748850|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2748851|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748856|NCT04769206|Galantamine|galantamine|mesh-list
2748857|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2748858|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2748859|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748860|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
2748861|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2748862|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748863|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2748864|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
2748865|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2748866|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
2748880|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2748881|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2751262|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748882|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748883|NCT04763343|Ketamine|ketamine|mesh-list
2748884|NCT04763343|Analgesics|analgesics|mesh-ancestor
2748885|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
2748886|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2748887|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748888|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2748889|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2748890|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
2748891|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
2748892|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2748893|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2748894|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2064829|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2064830|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2064831|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
2064832|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2064833|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
2064834|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2064835|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2064836|NCT01863134|Eptifibatide|eptifibatide|mesh-list
2064837|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2064838|NCT01863186|Lofexidine|lofexidine|mesh-list
2064839|NCT01863186|Clonidine|clonidine|mesh-list
2064840|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2064841|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2064842|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064843|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
2064844|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064845|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2064846|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2064847|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2064848|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
2064849|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064850|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064851|NCT01863186|Analgesics|analgesics|mesh-ancestor
2064852|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
2064853|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
2064854|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2064855|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
2064856|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2064857|NCT01863667|Glimepiride|glimepiride|mesh-list
2064858|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2210697|NCT00016978|Fluorouracil|fluorouracil|mesh-list
2210698|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
2210699|NCT00016978|Calcium|calcium|mesh-list
2210700|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
2210701|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2210702|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210703|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
2210704|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210705|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210706|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210707|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210708|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
2210709|NCT00016978|Antidotes|antidotes|mesh-ancestor
2210710|NCT00016978|Protective Agents|protective agents|mesh-ancestor
2210711|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
2210712|NCT00016978|Vitamins|vitamins|mesh-ancestor
2210713|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
2210714|NCT00016991|Gefitinib|gefitinib|mesh-list
2210715|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210716|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2210717|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210718|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210719|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
2210720|NCT00017004|Hematinics|hematinics|mesh-ancestor
2210721|NCT00017017|Paclitaxel|paclitaxel|mesh-list
2064859|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2064860|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064861|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2064862|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
2064863|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2064864|NCT01863680|Hormones|hormones|mesh-list
2064865|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2748895|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2748896|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210722|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2210723|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2064866|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2064867|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064868|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2064869|NCT01863771|Golimumab|golimumab|mesh-list
2064870|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2064871|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2064872|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2064873|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
2064874|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064875|NCT01863849|Vaccines|vaccines|mesh-list
2064876|NCT01863849|Immunologic Factors|immunologic factors|mesh-ancestor
2064877|NCT01863849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064878|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2064879|NCT01863953|Bimatoprost|bimatoprost|mesh-list
2064880|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2064881|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2064882|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2064883|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2064884|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2064885|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2064886|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
2748897|NCT04762758|Naltrexone|naltrexone|mesh-list
2064887|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064888|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064889|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064890|NCT01864005|Clopidogrel|clopidogrel|mesh-list
2064891|NCT01864005|Ticagrelor|ticagrelor|mesh-list
2064892|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2064893|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2064894|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2064895|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2064896|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
2064897|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064898|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064899|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064900|NCT01864148|Interferons|interferons|mesh-list
2064901|NCT01864148|Interferon-beta|interferon-beta|mesh-list
2064902|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
2064903|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064904|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
2064905|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064906|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
2064907|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210724|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210725|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
2748898|NCT04762758|Baclofen|baclofen|mesh-list
2748899|NCT04762758|Sorbitol|sorbitol|mesh-list
2748900|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2748901|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2748902|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748903|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
2748904|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2748905|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2748906|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2748907|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2748908|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
2064908|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2064909|NCT01864174|Metformin|metformin|mesh-list
2064910|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2064911|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064912|NCT01865084|Tadalafil|tadalafil|mesh-list
2064913|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
2064914|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2064915|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2064916|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064917|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064918|NCT01865084|Urological Agents|urological agents|mesh-ancestor
2064919|NCT01865552|Etanercept|etanercept|mesh-list
2064920|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2064921|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2064922|NCT01865552|Analgesics|analgesics|mesh-ancestor
2064923|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
2064924|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064925|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064926|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2064927|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2064928|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2064929|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2064930|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
2064931|NCT01865708|Ethanol|ethanol|mesh-list
2064932|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2064933|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064934|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2064935|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064936|NCT01865747|Everolimus|everolimus|mesh-list
2064937|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064938|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2064939|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
2748909|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
2748910|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2064940|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064941|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2748911|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748912|NCT04762758|Cathartics|cathartics|mesh-ancestor
2748913|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2748917|NCT04762160|Rituximab|rituximab|mesh-list
2748918|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2748919|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748920|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
2748921|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748922|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2748928|NCT04757090|Trastuzumab|trastuzumab|mesh-list
2748929|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2748930|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064942|NCT01865812|Cathartics|cathartics|mesh-ancestor
2064943|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2064944|NCT01866098|Naltrexone|naltrexone|mesh-list
2064945|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2064946|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2064947|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064948|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
2064949|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064950|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
2064951|NCT01866319|Ipilimumab|ipilimumab|mesh-list
2064952|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2064953|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064954|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2064955|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064956|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2064957|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064958|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2064959|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064960|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064961|NCT01866592|Adalimumab|adalimumab|mesh-list
2064962|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2064963|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2064964|NCT01866826|Rifaximin|rifaximin|mesh-list
2064965|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2064966|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2064967|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2064968|NCT01866917|Ropivacaine|ropivacaine|mesh-list
2064969|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
2064970|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
2064971|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2064972|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064973|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
2064974|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2064975|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
2064976|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2064977|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2064978|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064979|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
2064980|NCT01866943|Coagulants|coagulants|mesh-ancestor
2210726|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210727|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210728|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210729|NCT00017030|Trabectedin|trabectedin|mesh-list
2210730|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210731|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
2210732|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210733|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210734|NCT00017069|Dexamethasone|dexamethasone|mesh-list
2064981|NCT01867021|Vaccines|vaccines|mesh-list
2064982|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
2064983|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064984|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2064985|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
2064986|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2064987|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2064988|NCT01867086|Carboplatin|carboplatin|mesh-list
2064989|NCT01867086|Vaccines|vaccines|mesh-list
2064990|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
2064991|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2064992|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2064993|NCT01867294|Doxycycline|doxycycline|mesh-list
2064994|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
2064995|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2064996|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2064997|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2064998|NCT01867294|Spironolactone|spironolactone|mesh-list
2064999|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
2065000|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2065001|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2065002|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065003|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
2065004|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2065005|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2065006|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2065007|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
2065008|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2065009|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065010|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2210735|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
2210736|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2065011|NCT01867294|Diuretics|diuretics|mesh-ancestor
2065012|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
2065013|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2065014|NCT01867294|Protective Agents|protective agents|mesh-ancestor
2065015|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
2065016|NCT01867307|Empagliflozin|empagliflozin|mesh-list
2065017|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2065018|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065019|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2065020|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065021|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
2065022|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2065023|NCT01867606|Antibodies|antibodies|mesh-list
2065024|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
2065025|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065026|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
2065027|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065028|NCT01867710|Dexamethasone|dexamethasone|mesh-list
2065029|NCT01867710|Prednisone|prednisone|mesh-list
2065030|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
2065031|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2065032|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
2065033|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
2065034|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065035|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065036|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065037|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
2065038|NCT01867710|Hormones|hormones|mesh-ancestor
2065039|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2065040|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2065041|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065042|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2065043|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065044|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065045|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
2065046|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2065047|NCT01868022|Paclitaxel|paclitaxel|mesh-list
2065048|NCT01868022|Docetaxel|docetaxel|mesh-list
2065049|NCT01868022|Carboplatin|carboplatin|mesh-list
2065050|NCT01868022|Pemetrexed|pemetrexed|mesh-list
2065051|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2065052|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065053|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
2065054|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
2065055|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210737|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
2210738|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
2210739|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2210740|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210741|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2210742|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
2210743|NCT00017069|Hormones|hormones|mesh-ancestor
2210744|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2210745|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2210746|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210747|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
2210748|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210749|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
2210750|NCT00017095|Docetaxel|docetaxel|mesh-list
2210751|NCT00017095|Fluorouracil|fluorouracil|mesh-list
2210752|NCT00017095|Epirubicin|epirubicin|mesh-list
2065056|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065057|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065058|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2065059|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2065060|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
2065061|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065062|NCT01868243|Warfarin|warfarin|mesh-list
2065063|NCT01868243|Dabigatran|dabigatran|mesh-list
2065064|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
2065065|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
2065066|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2065067|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
2065068|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065069|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065070|NCT01868334|Vaccines|vaccines|mesh-list
2065071|NCT01868334|Immunologic Factors|immunologic factors|mesh-ancestor
2065072|NCT01868334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065073|NCT01868425|Acetaminophen|acetaminophen|mesh-list
2065074|NCT01868425|Ketamine|ketamine|mesh-list
2065075|NCT01868425|Gabapentin|gabapentin|mesh-list
2065076|NCT01868425|Bupivacaine|bupivacaine|mesh-list
2065077|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
2065078|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
2065079|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2065080|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065081|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
2065082|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065083|NCT01868425|Analgesics|analgesics|mesh-ancestor
2065084|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2065085|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2065086|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
2065087|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2065088|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2065089|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079431|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2748942|NCT04745975|Gemcitabine|gemcitabine|mesh-list
2748943|NCT04745975|Paclitaxel|paclitaxel|mesh-list
2748944|NCT04745975|Vinorelbine|vinorelbine|mesh-list
2748945|NCT04745975|Capecitabine|capecitabine|mesh-list
2748946|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2748947|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748948|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
2748949|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210753|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210754|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
2210755|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210756|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2210757|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210758|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
2210759|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210760|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210761|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2210762|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
2210763|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210764|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
2065090|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065091|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2065092|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
2065093|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
2065094|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2065095|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2065096|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2065097|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
2065098|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
2065099|NCT01868477|Deferasirox|deferasirox|mesh-list
2065100|NCT01868477|Hematinics|hematinics|mesh-ancestor
2065101|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2065102|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
2065103|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
2065104|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065105|NCT01868503|Lapatinib|lapatinib|mesh-list
2065106|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065107|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2065108|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065109|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065110|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
2065111|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2065112|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065113|NCT01868633|Dexamethasone|dexamethasone|mesh-list
2065114|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2065115|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
2065116|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
2065117|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065118|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065119|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065120|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
2065121|NCT01868633|Hormones|hormones|mesh-ancestor
2065122|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2065123|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2065124|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065125|NCT01868776|Lidocaine|lidocaine|mesh-list
2065126|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
2065127|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
2065128|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2210765|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
2065129|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065130|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
2065131|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065132|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2065133|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2065134|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2065135|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2065136|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065137|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
2065138|NCT01868893|Chlorambucil|chlorambucil|mesh-list
2065139|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2065140|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065141|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2065142|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
2065143|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065144|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
2065145|NCT01869192|Docetaxel|docetaxel|mesh-list
2065146|NCT01869192|Capecitabine|capecitabine|mesh-list
2065147|NCT01869192|Epirubicin|epirubicin|mesh-list
2065148|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2065149|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
2065150|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065151|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2065152|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2065153|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
2065154|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065155|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065156|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2065157|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
2748950|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210766|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210767|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2210768|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2210769|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210770|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210771|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
2210772|NCT00017108|Chlorambucil|chlorambucil|mesh-list
2065158|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
2065159|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
2065160|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2065161|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
2065162|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2065163|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2065164|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2065165|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065166|NCT01869634|Ritonavir|ritonavir|mesh-list
2065167|NCT01869634|Darunavir|darunavir|mesh-list
2065168|NCT01869634|Emtricitabine|emtricitabine|mesh-list
2065169|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2065170|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2210773|NCT00017108|Fludarabine|fludarabine|mesh-list
2210774|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
2210775|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210776|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
2210777|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210778|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2210779|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210780|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
2210781|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065171|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
2065172|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065173|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065174|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2210782|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210783|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2210784|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210785|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
2210786|NCT00017121|Sargramostim|sargramostim|mesh-list
2210787|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
2210788|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210789|NCT00017134|Fenretinide|fenretinide|mesh-list
2210790|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210791|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2210792|NCT00017134|Protective Agents|protective agents|mesh-ancestor
2210793|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210794|NCT00017147|Carmustine|carmustine|mesh-list
2210795|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2065175|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2065176|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
2065177|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065178|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2065179|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2065180|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2065181|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2065182|NCT01869686|Denosumab|denosumab|mesh-list
2065183|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2065184|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065185|NCT01869699|Acetaminophen|acetaminophen|mesh-list
2751263|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
2065186|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2065187|NCT01869699|Analgesics|analgesics|mesh-ancestor
2065188|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
2065189|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065190|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065191|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
2065192|NCT01869725|Octreotide|octreotide|mesh-list
2065193|NCT01869725|Edotreotide|edotreotide|mesh-list
2065194|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
2065195|NCT01869725|Somatostatin|somatostatin|mesh-list
2065196|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065197|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2065198|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065199|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065200|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065201|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2065202|NCT01869725|Hormones|hormones|mesh-ancestor
2065203|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2065204|NCT01870297|Liraglutide|liraglutide|mesh-list
2065205|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2065206|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065207|NCT01870297|Incretins|incretins|mesh-ancestor
2065208|NCT01870297|Hormones|hormones|mesh-ancestor
2065209|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2065210|NCT01870583|Iodine|iodine|mesh-list
2065211|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
2065212|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2065213|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
2065214|NCT01870583|Povidone|povidone|mesh-list
2065215|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2065216|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065217|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
2065218|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
2065219|NCT01870583|Trace Elements|trace elements|mesh-ancestor
2065220|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
2065221|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065222|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
2065223|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
2065224|NCT01870596|Cytarabine|cytarabine|mesh-list
2748951|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748952|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2748953|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
2748954|NCT04745975|Antiviral Agents|antiviral agents|mesh-ancestor
2748955|NCT04745975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2748956|NCT04745975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2748957|NCT04745975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2748958|NCT04745975|Immunologic Factors|immunologic factors|mesh-ancestor
2748959|NCT04745975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751264|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210796|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210797|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
2210798|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210799|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210800|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210801|NCT00017160|Doxorubicin|doxorubicin|mesh-list
2210802|NCT00017160|Ifosfamide|ifosfamide|mesh-list
2210803|NCT00017160|Sargramostim|sargramostim|mesh-list
2065225|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2065226|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
2065227|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065228|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065229|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
2065230|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065231|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2065232|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
2065233|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065234|NCT01870739|Amlodipine|amlodipine|mesh-list
2065235|NCT01870739|Valsartan|valsartan|mesh-list
2065236|NCT01870739|Olmesartan|olmesartan|mesh-list
2065237|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2065238|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2065239|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2065240|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2065241|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2065242|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065243|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2065244|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065245|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
2065246|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2065247|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2065248|NCT01870843|Citalopram|citalopram|mesh-list
2065249|NCT01870843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2065250|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2065251|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2065252|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065253|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065254|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
2065255|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065256|NCT01870843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2065257|NCT01870843|Antidepressive Agents|antidepressive agents|mesh-ancestor
2065258|NCT01870843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2065259|NCT01870921|Ticagrelor|ticagrelor|mesh-list
2065260|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2065261|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2210804|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
2065262|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2065263|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2065264|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
2065265|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065266|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065267|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065268|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2065269|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2065270|NCT01870973|Analgesics|analgesics|mesh-list
2065271|NCT01870973|Anesthetics|anesthetics|mesh-list
2065272|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2065273|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065274|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210805|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2210806|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210807|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2210808|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210809|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210810|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210811|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210812|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210813|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
2065275|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
2065276|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
2065277|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065278|NCT01870999|Aripiprazole|aripiprazole|mesh-list
2210814|NCT00017173|Cisplatin|cisplatin|mesh-list
2210815|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210816|NCT00017186|Gemcitabine|gemcitabine|mesh-list
2210817|NCT00017186|Epirubicin|epirubicin|mesh-list
2210818|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210819|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
2210820|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748965|NCT04744831|Camptothecin|camptothecin|mesh-list
2748966|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
2748967|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2748968|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2748969|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2748970|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2748971|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2748972|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2748973|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
2748974|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065279|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
2065280|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2065281|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2065282|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2065283|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2065284|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065285|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
2065286|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
2065287|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065288|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065289|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2065290|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2065291|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
2065292|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2065293|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2065294|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2065295|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2065296|NCT01871077|Ketorolac|ketorolac|mesh-list
2065297|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2065298|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2210821|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210822|NCT00017186|Antiviral Agents|antiviral agents|mesh-ancestor
2210823|NCT00017186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210824|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210825|NCT00017186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210826|NCT00017186|Immunologic Factors|immunologic factors|mesh-ancestor
2210827|NCT00017186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210828|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2210829|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2210830|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210831|NCT00017199|Bortezomib|bortezomib|mesh-list
2210832|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210833|NCT00017212|Exatecan|exatecan|mesh-list
2065299|NCT01871077|Analgesics|analgesics|mesh-ancestor
2065300|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
2065301|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065302|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065303|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2065304|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2065305|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2065306|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065307|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065308|NCT01871285|Morphine|morphine|mesh-list
2065309|NCT01871285|Oxycodone|oxycodone|mesh-list
2065310|NCT01871285|Buprenorphine|buprenorphine|mesh-list
2065311|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2065312|NCT01871285|Narcotics|narcotics|mesh-ancestor
2065313|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2065314|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065315|NCT01871285|Analgesics|analgesics|mesh-ancestor
2065316|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
2065317|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065318|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2065319|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
2065320|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
2065321|NCT01871441|Tacrolimus|tacrolimus|mesh-list
2065322|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2065323|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
2065324|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065325|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2065326|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2065327|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
2065328|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065329|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065330|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2065331|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2065332|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065333|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2065334|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2065335|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
2065336|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2065337|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065338|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2065339|NCT01871532|Hormones|hormones|mesh-ancestor
2065340|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2065341|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065342|NCT01871558|Metformin|metformin|mesh-list
2065343|NCT01871558|Vildagliptin|vildagliptin|mesh-list
2065344|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2065345|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065346|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2065347|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
2065348|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065349|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065350|NCT01871870|Pancrelipase|pancrelipase|mesh-list
2065351|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065352|NCT01872611|Prednisolone|prednisolone|mesh-list
2065353|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2065354|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
2065355|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2065356|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
2065357|NCT01872611|Nepafenac|nepafenac|mesh-list
2065358|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2065359|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
2065360|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2065361|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
2065362|NCT01872611|Hormones|hormones|mesh-ancestor
2210834|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2210835|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210836|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065363|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2065364|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065365|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2065366|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065367|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
2065368|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
2065369|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065370|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065371|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2065372|NCT01872611|Protective Agents|protective agents|mesh-ancestor
2065373|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2065374|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2065375|NCT01872611|Analgesics|analgesics|mesh-ancestor
2065376|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
2065377|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2065378|NCT01872689|Pirfenidone|pirfenidone|mesh-list
2065379|NCT01872689|Analgesics|analgesics|mesh-ancestor
2065380|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
2065381|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065382|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065383|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2065384|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2065385|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2065386|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2065387|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065388|NCT01872715|Doxycycline|doxycycline|mesh-list
2065389|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2065390|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065391|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
2065392|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2065393|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2065394|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
2065395|NCT01872910|Celecoxib|celecoxib|mesh-list
2065396|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2065397|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2065398|NCT01872910|Analgesics|analgesics|mesh-ancestor
2065399|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
2065400|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065401|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065402|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2065403|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2065404|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2065405|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2065406|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065407|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065408|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2065409|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
2210837|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210838|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210839|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
2210840|NCT00017225|Melphalan|melphalan|mesh-list
2210841|NCT00017225|Ifosfamide|ifosfamide|mesh-list
2210842|NCT00017225|Dacarbazine|dacarbazine|mesh-list
2210843|NCT00017225|Carboplatin|carboplatin|mesh-list
2210844|NCT00017225|Doxorubicin|doxorubicin|mesh-list
2210845|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2210846|NCT00017225|Etoposide|etoposide|mesh-list
2210847|NCT00017225|Vincristine|vincristine|mesh-list
2210848|NCT00017225|Tretinoin|tretinoin|mesh-list
2210849|NCT00017225|Vindesine|vindesine|mesh-list
2210850|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210851|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
2210852|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210853|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2210854|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210855|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
2210856|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210857|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210858|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2210859|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2210860|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2065410|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2065411|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
2065412|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065413|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
2065414|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2065415|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065416|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2065417|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065418|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065419|NCT01873729|Naltrexone|naltrexone|mesh-list
2065420|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2065421|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2065422|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065423|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
2065424|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065425|NCT01873859|Metformin|metformin|mesh-list
2065426|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2065427|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065428|NCT01873950|Quinidine|quinidine|mesh-list
2065429|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
2065430|NCT01873950|Verapamil|verapamil|mesh-list
2210861|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210862|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210863|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2210864|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
2210865|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210866|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
2065431|NCT01873950|Dofetilide|dofetilide|mesh-list
2065432|NCT01873950|Ranolazine|ranolazine|mesh-list
2065433|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2210867|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
2210868|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
2210869|NCT00017238|KRN 5500|krn 5500|mesh-list
2065434|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2210870|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210871|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2210872|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210873|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210874|NCT00017251|Carboplatin|carboplatin|mesh-list
2210875|NCT00017251|Etoposide|etoposide|mesh-list
2210876|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
2210877|NCT00017251|Oblimersen|oblimersen|mesh-list
2210878|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210879|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2210880|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2210881|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210882|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210883|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210884|NCT00017264|Atrasentan|atrasentan|mesh-list
2210885|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210886|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2065435|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2065436|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065437|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2065438|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065439|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
2065440|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2065441|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2065442|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2065443|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
2065444|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065445|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
2065446|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2749010|NCT04738643|Varenicline|varenicline|mesh-list
2749011|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2749012|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2749013|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
2749014|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2749015|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749016|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065447|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2065448|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065449|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065450|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2065451|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2065452|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
2065453|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2065454|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2065455|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2065456|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2065457|NCT01873989|Testosterone|testosterone|mesh-list
2065458|NCT01873989|Androgens|androgens|mesh-ancestor
2065459|NCT01873989|Hormones|hormones|mesh-ancestor
2065460|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2065461|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065462|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2065463|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2065464|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2065465|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
2065466|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065467|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065468|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2065469|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
2065470|NCT01874119|Aprepitant|aprepitant|mesh-list
2065471|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
2065472|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
2065473|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065474|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065475|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065476|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2065477|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065478|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065479|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
2065480|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
2065481|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2065482|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
2065483|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065484|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2065485|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2065486|NCT01874392|Insulin|insulin|mesh-list
2210887|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2210888|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210889|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
2210890|NCT00017277|Hematinics|hematinics|mesh-ancestor
2210891|NCT00017290|Prednisone|prednisone|mesh-list
2210892|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
2210893|NCT00017290|Vincristine|vincristine|mesh-list
2210894|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
2210895|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2210896|NCT00017290|Antibodies|antibodies|mesh-list
2210897|NCT00017290|Sargramostim|sargramostim|mesh-list
2210898|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2210899|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2210900|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210901|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
2210902|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210903|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2210904|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210905|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
2065487|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2065488|NCT01874392|Pancrelipase|pancrelipase|mesh-list
2065489|NCT01874392|Pancreatin|pancreatin|mesh-list
2065490|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2065491|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065492|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065493|NCT01874535|Esomeprazole|esomeprazole|mesh-list
2065494|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2065495|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065496|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2065497|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065498|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065499|NCT01874665|Ponatinib|ponatinib|mesh-list
2065500|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065501|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2065502|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065503|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065504|NCT01874951|Naltrexone|naltrexone|mesh-list
2065505|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2065506|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2065507|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065508|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
2065509|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065510|NCT01875159|Caffeine|caffeine|mesh-list
2065511|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
2065512|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065513|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2065514|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065515|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2065516|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065517|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2065518|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2065519|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
2065520|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2210906|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210907|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210908|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2749030|NCT04727307|Bevacizumab|bevacizumab|mesh-list
2749031|NCT04727307|Atezolizumab|atezolizumab|mesh-list
2749032|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2749033|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2065537|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
2065538|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2065539|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2065540|NCT01875237|Prednisolone|prednisolone|mesh-list
2065541|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
2065542|NCT01875237|Methotrexate|methotrexate|mesh-list
2065543|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
2065544|NCT01875237|Fludarabine|fludarabine|mesh-list
2065545|NCT01875237|Melphalan|melphalan|mesh-list
2065546|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
2065547|NCT01875237|Tacrolimus|tacrolimus|mesh-list
2065548|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2065549|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
2065550|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2065551|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
2065552|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2065553|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065554|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2065555|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
2210909|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2210910|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
2210911|NCT00017290|Hormones|hormones|mesh-ancestor
2210912|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2210913|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2210914|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2210915|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
2210916|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210917|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210918|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2210919|NCT00017303|Paclitaxel|paclitaxel|mesh-list
2210920|NCT00017303|Carboplatin|carboplatin|mesh-list
2210921|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2210922|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065556|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749034|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749035|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2749036|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2749037|NCT04727307|Growth Substances|growth substances|mesh-ancestor
2749038|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749039|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
2749040|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
2749041|NCT04726969|Ivermectin|ivermectin|mesh-list
2065557|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749042|NCT04726969|Albendazole|albendazole|mesh-list
2749043|NCT04726969|Moxidectin|moxidectin|mesh-list
2749044|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2749045|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2749046|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
2749047|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
2749048|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2749049|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2749050|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
2749051|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
2749052|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
2749053|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749054|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749055|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
2210923|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
2210924|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210925|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210926|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210927|NCT00017316|Thalidomide|thalidomide|mesh-list
2065558|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
2065559|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065560|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2065561|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2065562|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
2065563|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2065564|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2065565|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2065566|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2065567|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
2065568|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2065569|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2065570|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
2065571|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
2065572|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065573|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065574|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
2065575|NCT01875237|Hormones|hormones|mesh-ancestor
2065576|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2065577|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2065578|NCT01875237|Protective Agents|protective agents|mesh-ancestor
2065579|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2065580|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2065581|NCT01875250|Metronidazole|metronidazole|mesh-list
2065582|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065583|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2065584|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2210928|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210929|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
2210930|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065585|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2065586|NCT01875367|Trastuzumab|trastuzumab|mesh-list
2065587|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2065588|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065589|NCT01875445|Inositol|inositol|mesh-list
2065590|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
2065591|NCT01875445|Vitamins|vitamins|mesh-ancestor
2065592|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
2065593|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065594|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2065595|NCT01875510|SMOFlipid|smoflipid|mesh-list
2065596|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2065597|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2065598|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2065599|NCT01875848|Buprenorphine|buprenorphine|mesh-list
2065600|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2065601|NCT01875848|Naloxone|naloxone|mesh-list
2065602|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2065603|NCT01875848|Narcotics|narcotics|mesh-ancestor
2065604|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2065605|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065606|NCT01875848|Analgesics|analgesics|mesh-ancestor
2065607|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
2065608|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065609|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2065610|NCT01875991|Etanercept|etanercept|mesh-list
2065611|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2065612|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2065613|NCT01875991|Analgesics|analgesics|mesh-ancestor
2065614|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
2065615|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065616|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065617|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2065618|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2065619|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065620|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2065621|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
2065622|NCT01876082|Methotrexate|methotrexate|mesh-list
2065623|NCT01876082|Vinblastine|vinblastine|mesh-list
2065624|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2065625|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
2065626|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2065627|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065628|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2065629|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
2065630|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065631|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065632|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
2065633|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065634|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2065635|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2065636|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
2065637|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2065638|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2210931|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
2210932|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2210933|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210934|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2210935|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2065639|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2065640|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
2065641|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
2065642|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
2065643|NCT01876212|Dasatinib|dasatinib|mesh-list
2065644|NCT01876212|Vaccines|vaccines|mesh-list
2065645|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
2065646|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065647|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065648|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2065649|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065650|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065651|NCT01876251|Docetaxel|docetaxel|mesh-list
2065652|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065653|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
2065654|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
2065655|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
2065656|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065657|NCT01876368|Olmesartan|olmesartan|mesh-list
2210936|NCT00017316|Growth Substances|growth substances|mesh-ancestor
2065658|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2079432|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
2065659|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2065660|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2065661|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2065662|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2065663|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065664|NCT01876381|Tolvaptan|tolvaptan|mesh-list
2065665|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2065666|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065667|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
2065668|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065669|NCT01876446|Irinotecan|irinotecan|mesh-list
2065670|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2065671|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2065672|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065673|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065674|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065675|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
2210937|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
2210938|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210939|NCT00017329|Bortezomib|bortezomib|mesh-list
2751265|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2210940|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210941|NCT00017342|Cytarabine|cytarabine|mesh-list
2210942|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
2210943|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2210944|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
2210945|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210946|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210947|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
2210948|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2210949|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210950|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
2210951|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065676|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2065677|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065678|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
2065679|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
2065680|NCT01876732|Vitamins|vitamins|mesh-ancestor
2065681|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
2065682|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065683|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
2065684|NCT01876732|Hematinics|hematinics|mesh-ancestor
2065685|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
2065686|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2065687|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
2065688|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065689|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2065690|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2065691|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2065692|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065693|NCT01876823|Memantine|memantine|mesh-list
2065694|NCT01876823|Citalopram|citalopram|mesh-list
2065695|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2065696|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2065697|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
2065698|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065699|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065700|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065701|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2210952|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2210953|NCT00017355|Lenograstim|lenograstim|mesh-list
2210954|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2210955|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
2210956|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210957|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
2210958|NCT00017368|Melphalan|melphalan|mesh-list
2210959|NCT00017368|Ifosfamide|ifosfamide|mesh-list
2210960|NCT00017368|Thiotepa|thiotepa|mesh-list
2210961|NCT00017368|Carboplatin|carboplatin|mesh-list
2210962|NCT00017368|Doxorubicin|doxorubicin|mesh-list
2210963|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2210964|NCT00017368|Etoposide|etoposide|mesh-list
2210965|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
2065702|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2065703|NCT01876823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2065704|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2065705|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2065706|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
2065707|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2065708|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
2065709|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2065710|NCT01876953|Cytarabine|cytarabine|mesh-list
2065711|NCT01876953|Dasatinib|dasatinib|mesh-list
2065712|NCT01876953|Idarubicin|idarubicin|mesh-list
2065713|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2065714|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
2065715|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065716|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065717|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
2065718|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065719|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2065720|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
2065721|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065722|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2065723|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065724|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2065725|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2065726|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2065727|NCT01876992|Metformin|metformin|mesh-list
2065728|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2065729|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065730|NCT01877083|Lenvatinib|lenvatinib|mesh-list
2065731|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210966|NCT00017368|Vincristine|vincristine|mesh-list
2065732|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2065733|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065734|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065735|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
2065736|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065737|NCT01877538|Donepezil|donepezil|mesh-list
2065738|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2065739|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065740|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065741|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
2065742|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065743|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065744|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
2065745|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
2065746|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
2065747|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065748|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2065749|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065750|NCT01877642|Lorazepam|lorazepam|mesh-list
2065751|NCT01877642|Loxapine|loxapine|mesh-list
2065752|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
2065753|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
2065754|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
2210967|NCT00017368|Isotretinoin|isotretinoin|mesh-list
2065755|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065756|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065757|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065758|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2065759|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2065760|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2065761|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2065762|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2065763|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
2065764|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
2065765|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065766|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065767|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2065768|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2065769|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
2065770|NCT01877668|Adalimumab|adalimumab|mesh-list
2065771|NCT01877668|Tofacitinib|tofacitinib|mesh-list
2065772|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2065773|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2065774|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2210968|NCT00017368|Sargramostim|sargramostim|mesh-list
2210969|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210970|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
2210971|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210972|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2210973|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210974|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
2210975|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210976|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210977|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2210978|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2210979|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2210980|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2210981|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2210982|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2065775|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079433|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065776|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065777|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
2065778|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2210983|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
2210984|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
2210985|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
2210986|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
2210987|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
2210988|NCT00017381|Rituximab|rituximab|mesh-list
2210989|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2210990|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2210991|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
2210992|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2210993|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2210994|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2210995|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
2210996|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2210997|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2210998|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2210999|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2211000|NCT00017394|Bevacizumab|bevacizumab|mesh-list
2065779|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
2065780|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2065781|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
2065782|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065783|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065784|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
2065785|NCT01878006|Morphine|morphine|mesh-list
2065786|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2065787|NCT01878006|Narcotics|narcotics|mesh-ancestor
2065788|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2211001|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2211002|NCT00017394|Vinorelbine|vinorelbine|mesh-list
2211003|NCT00017394|Antibodies|antibodies|mesh-list
2065789|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065790|NCT01878006|Analgesics|analgesics|mesh-ancestor
2065791|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
2065792|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065793|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2065794|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
2065795|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2065796|NCT01878292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2065797|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2065798|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2065799|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065800|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065801|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
2065802|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065803|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2065804|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2065805|NCT01878526|Domperidone|domperidone|mesh-list
2065806|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
2065807|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
2065808|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065809|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065810|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065811|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2065812|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
2065813|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065814|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065815|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
2065816|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
2065817|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065818|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2065819|NCT01878656|Sevoflurane|sevoflurane|mesh-list
2065820|NCT01878656|Desflurane|desflurane|mesh-list
2065821|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2065822|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2065823|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
2065824|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
2065825|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2065826|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065827|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
2065828|NCT01878799|Ledipasvir|ledipasvir|mesh-list
2065829|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
2065830|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065831|NCT01878890|Efavirenz|efavirenz|mesh-list
2065832|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2065833|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2065834|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065835|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065836|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
2065837|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065838|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2065839|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2065840|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2065841|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2065842|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2065843|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2065844|NCT01879319|Evolocumab|evolocumab|mesh-list
2065845|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2065846|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2065847|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2065848|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
2065849|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065850|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2065851|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
2065852|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065853|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2065854|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
2065855|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2065856|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2065857|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2065858|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065859|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2065860|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
2065861|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2065862|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2065863|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2065864|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065865|NCT01879371|Ibuprofen|ibuprofen|mesh-list
2065866|NCT01879371|Caffeine|caffeine|mesh-list
2065867|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2065868|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2065869|NCT01879371|Analgesics|analgesics|mesh-ancestor
2065870|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
2065871|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065872|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065873|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2065874|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2065875|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2065876|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065877|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065878|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2065879|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2065880|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2065881|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2065882|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
2065883|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065884|NCT01879579|Insulin|insulin|mesh-list
2065885|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2065886|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065887|NCT01879618|Dalteparin|dalteparin|mesh-list
2065888|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
2065889|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2065890|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2065891|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065892|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
2065893|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065894|NCT01880086|Clomiphene|clomiphene|mesh-list
2065895|NCT01880086|Enclomiphene|enclomiphene|mesh-list
2065896|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
2065897|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2065898|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
2065899|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2065900|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065901|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2065902|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
2065903|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2065904|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2065905|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2065906|NCT01880099|Galantamine|galantamine|mesh-list
2065907|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
2065908|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065909|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065910|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
2065911|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065912|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065913|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2065914|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
2065915|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065916|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
2065917|NCT01880424|Linaclotide|linaclotide|mesh-list
2065918|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2065919|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
2065920|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065921|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2065922|NCT01880437|Cytarabine|cytarabine|mesh-list
2065923|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2065924|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
2065925|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065926|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2065927|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
2065928|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065929|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2065930|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
2065931|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065932|NCT01880515|Tetracycline|tetracycline|mesh-list
2065933|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2065934|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2065935|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2065936|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065937|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065938|NCT01880528|Lisinopril|lisinopril|mesh-list
2065939|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2065940|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
2065941|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065942|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065943|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2065944|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2065945|NCT01880528|Protective Agents|protective agents|mesh-ancestor
2065946|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065947|NCT01880593|Ketamine|ketamine|mesh-list
2065948|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
2065949|NCT01880593|Analgesics|analgesics|mesh-ancestor
2065950|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
2065951|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065952|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065953|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2065954|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2065955|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
2065956|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
2065957|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2065958|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2065959|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2065960|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065961|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065962|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
2065963|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2065964|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065965|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
2065966|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2211004|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
2211005|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2211006|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211007|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2065967|NCT01880723|Albuterol|albuterol|mesh-list
2211008|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2211009|NCT00017394|Growth Substances|growth substances|mesh-ancestor
2065968|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2065969|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
2065970|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065971|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065972|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2065973|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
2065974|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
2065975|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2065976|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2065977|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2065978|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2065979|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
2065980|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2065981|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065982|NCT01880736|Insulin|insulin|mesh-list
2065983|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2065984|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
2065985|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2749097|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
2749098|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2749099|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
2749100|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749101|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
2749102|NCT04704531|Protective Agents|protective agents|mesh-ancestor
2065986|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065987|NCT01880840|Azelastine|azelastine|mesh-list
2065988|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2065989|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
2065990|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2065991|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2065992|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2065993|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
2065994|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2065995|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2065996|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2065997|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2065998|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2065999|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2066000|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
2066001|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
2066002|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066003|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
2066004|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
2066005|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
2066006|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2066007|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066008|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
2066009|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066010|NCT01881113|Cetirizine|cetirizine|mesh-list
2066011|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2066012|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2066013|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2066014|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
2066015|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
2066016|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066017|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066018|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066019|NCT01881126|Timolol|timolol|mesh-list
2066020|NCT01881126|Bimatoprost|bimatoprost|mesh-list
2066021|NCT01881126|Travoprost|travoprost|mesh-list
2066022|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2066023|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2066024|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
2066025|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066026|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066027|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066028|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2066029|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2066030|NCT01881230|Gemcitabine|gemcitabine|mesh-list
2066031|NCT01881230|Paclitaxel|paclitaxel|mesh-list
2066032|NCT01881230|Carboplatin|carboplatin|mesh-list
2066033|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2066034|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066035|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
2066036|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
2066037|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
2066038|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066039|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2066040|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
2066041|NCT01881230|Antiviral Agents|antiviral agents|mesh-ancestor
2066042|NCT01881230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2066043|NCT01881230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066044|NCT01881230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066045|NCT01881230|Immunologic Factors|immunologic factors|mesh-ancestor
2749103|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
2749104|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2749105|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
2749106|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749107|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
2749108|NCT04704518|Protective Agents|protective agents|mesh-ancestor
2749109|NCT04702893|Nintedanib|nintedanib|mesh-list
2749110|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749111|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2749112|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751266|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2066046|NCT01881230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066047|NCT01881412|Fluticasone|fluticasone|mesh-list
2066048|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2211010|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211011|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
2211012|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
2211013|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2211014|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
2066049|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2066050|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
2066051|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066052|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066053|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2066054|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
2066055|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
2066056|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2066057|NCT01881789|Dexamethasone|dexamethasone|mesh-list
2066058|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
2066059|NCT01881789|Lenalidomide|lenalidomide|mesh-list
2066060|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066061|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
2066062|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066063|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2066064|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2066065|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
2066066|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066067|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066068|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2066069|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066070|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
2066071|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
2066072|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066073|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2066074|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
2211015|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
2211016|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
2211017|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211018|NCT00017407|Paclitaxel|paclitaxel|mesh-list
2211019|NCT00017407|Carboplatin|carboplatin|mesh-list
2211020|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2211021|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211022|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
2211023|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
2211024|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
2066075|NCT01881789|Hormones|hormones|mesh-ancestor
2066076|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2066077|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2066078|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2066079|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2066080|NCT01881789|Growth Substances|growth substances|mesh-ancestor
2066081|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
2066082|NCT01881828|Metformin|metformin|mesh-list
2066083|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2066084|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066085|NCT01882088|Psyllium|psyllium|mesh-list
2066086|NCT01882088|Cathartics|cathartics|mesh-ancestor
2066087|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2066088|NCT01882439|Tofacitinib|tofacitinib|mesh-list
2066089|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2066090|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066091|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066092|NCT01882829|Quinidine|quinidine|mesh-list
2066093|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
2066094|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
2066095|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
2211025|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211026|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
2066096|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2066097|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2066098|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066099|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079434|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2749113|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749117|NCT04691960|Metformin|metformin|mesh-list
2749118|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2066100|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066101|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2066102|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2066103|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
2066104|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2066105|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
2066106|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2066107|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2066108|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2066109|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066110|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2066111|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2066112|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
2066113|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2066114|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2066115|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2066116|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2066117|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2066118|NCT01882868|Leucovorin|leucovorin|mesh-list
2066119|NCT01882868|Irinotecan|irinotecan|mesh-list
2066120|NCT01882868|Aflibercept|aflibercept|mesh-list
2066121|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
2066122|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2066123|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2066124|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066125|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066126|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749119|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749124|NCT04679012|Prednisone|prednisone|mesh-list
2749125|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
2749126|NCT04679012|Rituximab|rituximab|mesh-list
2066127|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2066128|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2749127|NCT04679012|Doxorubicin|doxorubicin|mesh-list
2066129|NCT01882868|Growth Substances|growth substances|mesh-ancestor
2066130|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066131|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
2066132|NCT01882868|Antidotes|antidotes|mesh-ancestor
2066133|NCT01882868|Protective Agents|protective agents|mesh-ancestor
2066134|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
2066135|NCT01882868|Vitamins|vitamins|mesh-ancestor
2066136|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
2066137|NCT01882907|Pioglitazone|pioglitazone|mesh-list
2066138|NCT01882907|Vildagliptin|vildagliptin|mesh-list
2066139|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2066140|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066141|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2066142|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
2066143|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066144|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066145|NCT01882985|Lycopene|lycopene|mesh-list
2066146|NCT01882985|Docetaxel|docetaxel|mesh-list
2066147|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066148|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
2066149|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
2066150|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
2066151|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066152|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066153|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
2749128|NCT04679012|Etoposide|etoposide|mesh-list
2749129|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2749130|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2749131|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
2749132|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749133|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2749134|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2749135|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
2749136|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749137|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749138|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2749139|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2066154|NCT01882985|Protective Agents|protective agents|mesh-ancestor
2066155|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066156|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2066157|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2066158|NCT01883362|Midostaurin|midostaurin|mesh-list
2066159|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066160|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2066161|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066162|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066175|NCT01884337|Apixaban|apixaban|mesh-list
2066176|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2066177|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
2066178|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2066179|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
2066180|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066181|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066182|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
2066183|NCT01884350|Apixaban|apixaban|mesh-list
2066184|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2066185|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
2066186|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2066187|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
2211027|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211028|NCT00017459|Vinorelbine|vinorelbine|mesh-list
2211029|NCT00017459|Tirapazamine|tirapazamine|mesh-list
2211030|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211031|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2211032|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
2749140|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2749141|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2211033|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
2211034|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
2211035|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066188|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066189|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066190|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
2066191|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
2066192|NCT01884571|Prednisone|prednisone|mesh-list
2066193|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
2066194|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2066195|NCT01884571|Tacrolimus|tacrolimus|mesh-list
2066196|NCT01884571|Basiliximab|basiliximab|mesh-list
2066197|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066198|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
2066199|NCT01884571|Hormones|hormones|mesh-ancestor
2066200|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2066201|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066202|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2066203|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066204|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066205|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
2066206|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2066207|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066208|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066209|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2066210|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2066211|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
2066212|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2066213|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2066214|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
2066215|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
2066216|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066217|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2066218|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2066219|NCT01884571|Protective Agents|protective agents|mesh-ancestor
2066220|NCT01884597|Ranibizumab|ranibizumab|mesh-list
2066221|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2066222|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2066223|NCT01884597|Growth Substances|growth substances|mesh-ancestor
2066224|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066225|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
2066226|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066227|NCT01884675|Ambrisentan|ambrisentan|mesh-list
2066228|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2066229|NCT01884844|Vitamin D|vitamin d|mesh-list
2066230|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
2066231|NCT01884844|Vitamins|vitamins|mesh-ancestor
2066232|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
2066233|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066234|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2066235|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2066236|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2066237|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2066238|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2066239|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2066240|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2066241|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
2066242|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066243|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066244|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066245|NCT01885104|Bisacodyl|bisacodyl|mesh-list
2066246|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2066247|NCT01885104|Laxatives|laxatives|mesh-list
2066248|NCT01885104|Cathartics|cathartics|mesh-ancestor
2066249|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2066250|NCT01885182|Oxycodone|oxycodone|mesh-list
2066251|NCT01885182|Naloxone|naloxone|mesh-list
2066252|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2066253|NCT01885182|Narcotics|narcotics|mesh-ancestor
2066254|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2066255|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066256|NCT01885182|Analgesics|analgesics|mesh-ancestor
2066257|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
2066258|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066259|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2066260|NCT01885208|Exenatide|exenatide|mesh-list
2066261|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2066262|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066263|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2066264|NCT01885208|Incretins|incretins|mesh-ancestor
2066265|NCT01885208|Hormones|hormones|mesh-ancestor
2079435|NCT02058290|Narcotics|narcotics|mesh-ancestor
2211036|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2211037|NCT00017472|Antibodies|antibodies|mesh-list
2211038|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
2211039|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2211040|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
2211041|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211042|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211043|NCT00017498|Gemcitabine|gemcitabine|mesh-list
2211044|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2211045|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
2211046|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211047|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211048|NCT00017498|Antiviral Agents|antiviral agents|mesh-ancestor
2211049|NCT00017498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211050|NCT00017498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211051|NCT00017498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211052|NCT00017498|Immunologic Factors|immunologic factors|mesh-ancestor
2211053|NCT00017498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211054|NCT00017511|Cevimeline|cevimeline|mesh-list
2066266|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2066267|NCT01885559|Telmisartan|telmisartan|mesh-list
2066268|NCT01885559|Lisinopril|lisinopril|mesh-list
2066269|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2066270|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2066271|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2066272|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2066273|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066274|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
2066275|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066276|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2211055|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2211056|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
2211057|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211058|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211059|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2211060|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2211061|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
2211062|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211063|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211064|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2211065|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
2211066|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211067|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211068|NCT00017576|Calcitriol|calcitriol|mesh-list
2211069|NCT00017576|Carboplatin|carboplatin|mesh-list
2211070|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211071|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2211072|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211073|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2211074|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2211075|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211076|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2211077|NCT00017576|Vitamins|vitamins|mesh-ancestor
2211078|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
2211079|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2211080|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
2066277|NCT01885559|Protective Agents|protective agents|mesh-ancestor
2066278|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211081|NCT00017589|Oblimersen|oblimersen|mesh-list
2066279|NCT01885910|Doxycycline|doxycycline|mesh-list
2066280|NCT01885910|Dapsone|dapsone|mesh-list
2066281|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2066282|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2066283|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
2066284|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2066285|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2066286|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2066287|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066288|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066289|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
2066290|NCT01885936|Albuterol|albuterol|mesh-list
2066291|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2066292|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
2066293|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066294|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066295|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2066296|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
2066297|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
2066298|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2066299|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2066300|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2066301|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2066302|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
2066303|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066304|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066305|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
2066306|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2066307|NCT01886105|Analgesics|analgesics|mesh-ancestor
2066308|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
2066309|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066310|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066311|NCT01886287|Octreotide|octreotide|mesh-list
2066312|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2066313|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2066314|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066315|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2066316|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2066317|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2066318|NCT01886690|Laxatives|laxatives|mesh-ancestor
2066319|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2066333|NCT01886937|Phentermine|phentermine|mesh-list
2066334|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2066335|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066336|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
2066337|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2066338|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
2066339|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
2066340|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066341|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
2066342|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066343|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066344|NCT01887132|Donepezil|donepezil|mesh-list
2066345|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2066346|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066347|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066348|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
2066349|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066350|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066351|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
2066352|NCT01887171|Tacrolimus|tacrolimus|mesh-list
2066353|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211082|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2211083|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211084|NCT00017602|Dexamethasone|dexamethasone|mesh-list
2211085|NCT00017602|Oblimersen|oblimersen|mesh-list
2211086|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2211087|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
2211088|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
2211089|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211090|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211091|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2211092|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
2211093|NCT00017602|Hormones|hormones|mesh-ancestor
2066354|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
2066355|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066356|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2066357|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066358|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066359|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
2066360|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066361|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066362|NCT01887353|Ranolazine|ranolazine|mesh-list
2066363|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2066364|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2066365|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066366|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
2066367|NCT01887418|Testosterone|testosterone|mesh-list
2066368|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
2066369|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
2066370|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2066371|NCT01887418|Androgens|androgens|mesh-ancestor
2066372|NCT01887418|Hormones|hormones|mesh-ancestor
2066373|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2066374|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066375|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2066376|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066377|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
2066378|NCT01887587|Dexamethasone|dexamethasone|mesh-list
2066379|NCT01887587|Doxorubicin|doxorubicin|mesh-list
2066380|NCT01887587|Vincristine|vincristine|mesh-list
2066381|NCT01887587|Ixazomib|ixazomib|mesh-list
2066382|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066383|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
2066384|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
2066385|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066386|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066387|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2066388|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
2066389|NCT01887587|Hormones|hormones|mesh-ancestor
2066390|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2066391|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2066392|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066393|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2066394|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2066395|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2066396|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066397|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066398|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2211094|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2211095|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2211096|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211097|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
2211098|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2211099|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2211100|NCT00017628|Prednisolone|prednisolone|mesh-list
2211101|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
2211102|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
2211103|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2211104|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
2211105|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211106|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
2211107|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211108|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2211109|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2211110|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
2749142|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2066399|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
2066400|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
2066401|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
2066402|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
2066403|NCT01887717|Sorafenib|sorafenib|mesh-list
2066404|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066405|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2066406|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066407|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066408|NCT01887990|Ketamine|ketamine|mesh-list
2066409|NCT01887990|Analgesics|analgesics|mesh-ancestor
2066410|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
2066411|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066412|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079436|NCT02058290|Analgesics|analgesics|mesh-ancestor
2749143|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2749144|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066413|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2066414|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2066415|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
2066416|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
2066417|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2066418|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2066419|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2066420|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066421|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066422|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
2066423|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2066424|NCT01888003|Hematinics|hematinics|mesh-ancestor
2066425|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2066426|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2066427|NCT01888432|Everolimus|everolimus|mesh-list
2066428|NCT01888432|Tacrolimus|tacrolimus|mesh-list
2066429|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066430|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
2066431|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066432|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2066433|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066434|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066435|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066436|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
2066437|NCT01888497|Promethazine|promethazine|mesh-list
2066438|NCT01888497|Triazolam|triazolam|mesh-list
2066439|NCT01888497|Gabapentin|gabapentin|mesh-list
2066440|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066441|NCT01888497|Analgesics|analgesics|mesh-ancestor
2749145|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
2749146|NCT04679012|Hormones|hormones|mesh-ancestor
2749147|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2749148|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2749149|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2749150|NCT04677959|Fluticasone|fluticasone|mesh-list
2749151|NCT04677959|Xhance|xhance|mesh-list
2749152|NCT04677959|Albuterol|albuterol|mesh-list
2749153|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2749154|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2749155|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2749156|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
2749157|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2749158|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066442|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
2066443|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066444|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066445|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
2066446|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2066447|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2066448|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2066449|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2066450|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2066451|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2066452|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066453|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
2066454|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2066455|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2066456|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
2066457|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
2066458|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
2066459|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
2066460|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2066461|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2066462|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
2066463|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
2066464|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2066465|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
2066466|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
2066467|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2066468|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
2066469|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
2066470|NCT01888952|Prednisone|prednisone|mesh-list
2066471|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066472|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
2066473|NCT01888952|Hormones|hormones|mesh-ancestor
2066474|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2211111|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066475|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066476|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2066477|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066478|NCT01889069|Prednisone|prednisone|mesh-list
2066479|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
2066480|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2066481|NCT01889069|Rituximab|rituximab|mesh-list
2066482|NCT01889069|Doxorubicin|doxorubicin|mesh-list
2066483|NCT01889069|Vincristine|vincristine|mesh-list
2066484|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066485|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
2066486|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066487|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2066488|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2066489|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
2066490|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066491|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066492|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2066493|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2066494|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2066495|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2066496|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2066497|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066498|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066499|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
2066500|NCT01889069|Hormones|hormones|mesh-ancestor
2066501|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2066502|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2066503|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2066504|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
2066505|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
2066506|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
2066507|NCT01889602|Topiramate|topiramate|mesh-list
2066508|NCT01889602|Lorazepam|lorazepam|mesh-list
2066509|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
2066510|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2066511|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066512|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
2066513|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
2066514|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066515|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2066516|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2066517|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2066518|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2066519|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2066520|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2066521|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
2066522|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
2066523|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066524|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066525|NCT01889667|Insulin|insulin|mesh-list
2066526|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2066527|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2066528|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066529|NCT01889797|Rituximab|rituximab|mesh-list
2066530|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
2066531|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2066532|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066533|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
2066534|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066535|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2066536|NCT01889862|Dextrans|dextrans|mesh-list
2066537|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
2066538|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
2066539|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
2066540|NCT01890109|Erenumab|erenumab|mesh-list
2066541|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2066542|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066543|NCT01890109|Analgesics|analgesics|mesh-ancestor
2066544|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
2066545|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066546|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066547|NCT01890122|Metformin|metformin|mesh-list
2211112|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066548|NCT01890122|Alogliptin|alogliptin|mesh-list
2066549|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2066550|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066551|NCT01890122|Incretins|incretins|mesh-ancestor
2066552|NCT01890122|Hormones|hormones|mesh-ancestor
2066553|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2066554|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2066555|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
2066556|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066557|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066558|NCT01890265|Pirfenidone|pirfenidone|mesh-list
2066559|NCT01890265|Nintedanib|nintedanib|mesh-list
2066560|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
2066561|NCT01890265|Antibodies|antibodies|mesh-list
2066562|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
2066563|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2066564|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
2066565|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066566|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066567|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2066568|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066569|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066570|NCT01890265|Analgesics|analgesics|mesh-ancestor
2066571|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
2066572|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066573|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2066574|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2066575|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066576|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2066577|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2066578|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2066579|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066580|NCT01890473|Abatacept|abatacept|mesh-list
2066581|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2066582|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066583|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066584|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066585|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
2066586|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066587|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2066588|NCT01890642|Lidocaine|lidocaine|mesh-list
2066589|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
2066590|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
2066591|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2066592|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066593|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
2066594|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066595|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2211113|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2211114|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2211115|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
2211116|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
2211117|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211118|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2211119|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
2211120|NCT00017628|Hormones|hormones|mesh-ancestor
2211121|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2211122|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2211123|NCT00017628|Protective Agents|protective agents|mesh-ancestor
2211124|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2211125|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
2211126|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2066596|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2066597|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2066598|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2066599|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066600|NCT01890707|Anesthetics|anesthetics|mesh-list
2066601|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2066602|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066603|NCT01890746|Cytarabine|cytarabine|mesh-list
2066604|NCT01890746|Daunorubicin|daunorubicin|mesh-list
2066605|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2066606|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
2066607|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066608|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066609|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
2066610|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2066611|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066612|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
2066613|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066614|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2066615|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2066616|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2066617|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066618|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2066619|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2066620|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066621|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2066622|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2066623|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2066624|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066625|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
2066626|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066627|NCT01890967|Atorvastatin|atorvastatin|mesh-list
2066628|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2066629|NCT01890967|Simvastatin|simvastatin|mesh-list
2066630|NCT01890967|Ezetimibe|ezetimibe|mesh-list
2066631|NCT01890967|Pravastatin|pravastatin|mesh-list
2066632|NCT01890967|Pitavastatin|pitavastatin|mesh-list
2066633|NCT01890967|Lovastatin|lovastatin|mesh-list
2066634|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2066635|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2211127|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066636|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
2066637|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066638|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2066639|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2066640|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066641|NCT01891331|Fluconazole|fluconazole|mesh-list
2066642|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
2066643|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2066644|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2066645|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2066646|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066647|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066648|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2066649|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
2066650|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2066651|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066652|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2066653|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2066654|NCT01891344|Rucaparib|rucaparib|mesh-list
2066655|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2066656|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066657|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066658|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066659|NCT01891357|Paclitaxel|paclitaxel|mesh-list
2066660|NCT01891357|Trastuzumab|trastuzumab|mesh-list
2066661|NCT01891357|Lapatinib|lapatinib|mesh-list
2066662|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2066663|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066664|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
2066665|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
2066666|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
2066667|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066668|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2066669|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2066670|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2749159|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2749160|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
2749161|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
2749162|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2749163|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2749164|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2749165|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2749166|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
2749167|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2749168|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749169|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
2749170|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2749171|NCT04675931|Artesunate|artesunate|mesh-list
2749172|NCT04675931|Lumefantrine|lumefantrine|mesh-list
2749173|NCT04675931|Artemether|artemether|mesh-list
2749174|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2749175|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
2749176|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2749177|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2749178|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2749179|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749180|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
2749181|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
2066695|NCT01891669|PF-06263507|pf-06263507|mesh-list
2066696|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2066697|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066698|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
2066699|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
2066700|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066701|NCT01891864|Etanercept|etanercept|mesh-list
2066702|NCT01891864|GP2015|gp2015|mesh-list
2066703|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2066704|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2066705|NCT01891864|Analgesics|analgesics|mesh-ancestor
2066706|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
2066707|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066708|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066709|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066710|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2066711|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2066712|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066713|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
2066714|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
2066715|NCT01891890|Lamotrigine|lamotrigine|mesh-list
2066716|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
2066717|NCT01891890|Levetiracetam|levetiracetam|mesh-list
2066718|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
2066719|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
2066720|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2066721|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2211128|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
2211129|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211130|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2211131|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2211132|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
2066722|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066723|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2066724|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066725|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2066726|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2066727|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2066728|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2066729|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2066730|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2066731|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2066732|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2066733|NCT01891968|Bortezomib|bortezomib|mesh-list
2066734|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066735|NCT01892020|Insulin|insulin|mesh-list
2066736|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2066737|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
2066738|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
2066739|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2066740|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066741|NCT01892163|Dexamethasone|dexamethasone|mesh-list
2066742|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066743|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
2066744|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
2066745|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066746|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066747|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2066748|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
2066749|NCT01892163|Hormones|hormones|mesh-ancestor
2066750|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2066751|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2066752|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066753|NCT01892189|Ketamine|ketamine|mesh-list
2066754|NCT01892189|Analgesics|analgesics|mesh-ancestor
2066755|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
2066756|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066757|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066758|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2066759|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2066760|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
2066761|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
2066762|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2066763|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2066764|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2066765|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066766|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066767|NCT01892345|Eculizumab|eculizumab|mesh-list
2066768|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2066769|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066770|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
2066771|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066772|NCT01892709|Hydromorphone|hydromorphone|mesh-list
2066773|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2066774|NCT01892709|Narcotics|narcotics|mesh-ancestor
2066775|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2066776|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066777|NCT01892709|Analgesics|analgesics|mesh-ancestor
2066778|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
2066779|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066780|NCT01892722|Interferons|interferons|mesh-list
2066781|NCT01892722|Interferon-beta|interferon-beta|mesh-list
2066782|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
2066783|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2066784|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066785|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
2066786|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2066787|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
2066788|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066789|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2066790|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2066791|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066792|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066793|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2066794|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2066795|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
2066796|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
2066797|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2066798|NCT01893281|Testosterone|testosterone|mesh-list
2066799|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
2066800|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
2066801|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2066802|NCT01893281|Androgens|androgens|mesh-ancestor
2066803|NCT01893281|Hormones|hormones|mesh-ancestor
2066804|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2066805|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066806|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2066807|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066808|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
2066809|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
2066810|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2066811|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2066812|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2066813|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2066814|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2066815|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066816|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
2066817|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066818|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066819|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2066820|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066821|NCT01893567|Clobetasol|clobetasol|mesh-list
2066822|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066823|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
2066824|NCT01893567|Hormones|hormones|mesh-ancestor
2066825|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2066826|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066827|NCT01893632|Gabapentin|gabapentin|mesh-list
2066828|NCT01893632|Analgesics|analgesics|mesh-ancestor
2066829|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
2066830|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066831|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066832|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
2066833|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2066834|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2066835|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2066836|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2066837|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2066838|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2066839|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066840|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066841|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
2066842|NCT01893801|Gemcitabine|gemcitabine|mesh-list
2066843|NCT01893801|Paclitaxel|paclitaxel|mesh-list
2066844|NCT01893801|Cisplatin|cisplatin|mesh-list
2079437|NCT02058368|Tamsulosin|tamsulosin|mesh-list
2066845|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2066846|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066847|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
2066848|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
2066849|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
2066850|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066851|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2066852|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
2066853|NCT01893801|Antiviral Agents|antiviral agents|mesh-ancestor
2066854|NCT01893801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2066855|NCT01893801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066856|NCT01893801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066857|NCT01893801|Immunologic Factors|immunologic factors|mesh-ancestor
2066858|NCT01893801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066859|NCT01893827|Naltrexone|naltrexone|mesh-list
2066860|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2066861|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2066862|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066863|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
2066864|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066865|NCT01893879|Ketoprofen|ketoprofen|mesh-list
2066866|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2066867|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2066868|NCT01893879|Analgesics|analgesics|mesh-ancestor
2066869|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
2066870|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066871|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066872|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066873|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2066874|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2066875|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066876|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066877|NCT01894022|Ambrisentan|ambrisentan|mesh-list
2066878|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2066879|NCT01894152|Everolimus|everolimus|mesh-list
2066880|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066881|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066882|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
2066883|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066884|NCT01894243|Olaparib|olaparib|mesh-list
2066885|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2066886|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066887|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066888|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066889|NCT01894256|Olaparib|olaparib|mesh-list
2066890|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2066891|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066892|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066893|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066894|NCT01894477|Fludarabine|fludarabine|mesh-list
2066895|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
2066896|NCT01894477|Treosulfan|treosulfan|mesh-list
2066897|NCT01894477|Busulfan|busulfan|mesh-list
2066898|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066899|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2066900|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
2066901|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066902|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066903|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
2066904|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066905|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2066906|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
2066907|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2066908|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
2066909|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066910|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
2066911|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2066912|NCT01894555|Aspirin|aspirin|mesh-list
2066913|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2066914|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2066915|NCT01894555|Analgesics|analgesics|mesh-ancestor
2066916|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
2066917|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066918|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066919|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2066920|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2066921|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2066922|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2066923|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066924|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2211133|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211134|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211135|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2211136|NCT00017654|Cyclosporine|cyclosporine|mesh-list
2211137|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
2211138|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
2211139|NCT00017654|Cyclosporins|cyclosporins|mesh-list
2211140|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2211141|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211142|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
2211143|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066925|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2066926|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2066927|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
2066928|NCT01894568|Insulin|insulin|mesh-list
2066929|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2066930|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
2066931|NCT01894568|Pioglitazone|pioglitazone|mesh-list
2066932|NCT01894568|Biguanides|biguanides|mesh-list
2066933|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2066934|NCT01894568|Meglitinide|meglitinide|mesh-list
2066935|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066936|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2066937|NCT01894581|Hormones|hormones|mesh-ancestor
2066938|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2066939|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066940|NCT01894776|Maraviroc|maraviroc|mesh-list
2066941|NCT01894776|Rifabutin|rifabutin|mesh-list
2066942|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2066943|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2066944|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066945|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2066946|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2066947|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
2066948|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2066949|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2066950|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2066951|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2066952|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
2066953|NCT01894919|Vaccines|vaccines|mesh-list
2066954|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
2066955|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066956|NCT01894984|Risperidone|risperidone|mesh-list
2066957|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
2066958|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2066959|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
2066960|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2066961|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749182|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2749183|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
2749184|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
2749185|NCT04673617|Rituximab|rituximab|mesh-list
2749186|NCT04673617|Fludarabine|fludarabine|mesh-list
2749187|NCT04673617|Interleukin-2|interleukin-2|mesh-list
2749188|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2749189|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
2749190|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749191|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2749192|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2749193|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
2749194|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749195|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2066962|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066963|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2066964|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2066965|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2066966|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2066967|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
2066968|NCT01895036|Naltrexone|naltrexone|mesh-list
2066969|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2066970|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2066971|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066972|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
2066973|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2066974|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
2066975|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2066976|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2066977|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066978|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
2066979|NCT01895101|Coagulants|coagulants|mesh-ancestor
2066980|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
2066981|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2066982|NCT01895127|Antibodies|antibodies|mesh-list
2066983|NCT01895127|Eculizumab|eculizumab|mesh-list
2066984|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
2066985|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066986|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2066987|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2066988|NCT01895270|Isradipine|isradipine|mesh-list
2066989|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2066990|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2066991|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2066992|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2066993|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2066994|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2066995|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
2066996|NCT01895309|Etanercept|etanercept|mesh-list
2066997|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2066998|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2066999|NCT01895309|Analgesics|analgesics|mesh-ancestor
2067000|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
2067001|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067002|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067003|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067004|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2067005|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2067006|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2067007|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
2067008|NCT01895322|Tolvaptan|tolvaptan|mesh-list
2067009|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2067010|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067011|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
2749196|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2067012|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067013|NCT01895335|Teriflunomide|teriflunomide|mesh-list
2067014|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2067015|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2067016|NCT01895335|Analgesics|analgesics|mesh-ancestor
2067017|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
2067018|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067019|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067020|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067021|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2067022|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2067023|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
2067024|NCT01895777|Dabigatran|dabigatran|mesh-list
2067025|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
2067026|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2067027|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
2067028|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067029|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067030|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
2067031|NCT01896050|Tamoxifen|tamoxifen|mesh-list
2067032|NCT01896050|Letrozole|letrozole|mesh-list
2067033|NCT01896050|Anastrozole|anastrozole|mesh-list
2067034|NCT01896050|Exemestane|exemestane|mesh-list
2067035|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067036|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2067037|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2067038|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067039|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067040|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2067041|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
2067042|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067043|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067044|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2067045|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2067046|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2067047|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2067048|NCT01896128|Modafinil|modafinil|mesh-list
2067049|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2067050|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067051|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2067052|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2067053|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2067054|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067055|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
2067056|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
2067057|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2067058|NCT01896232|Cinacalcet|cinacalcet|mesh-list
2067059|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2067060|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067061|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2067062|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
2067063|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067064|NCT01896297|Dabigatran|dabigatran|mesh-list
2067065|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
2067066|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2067067|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
2067068|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067069|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067070|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
2067071|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
2067072|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2067073|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067074|NCT01896544|Vitamins|vitamins|mesh-ancestor
2067075|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
2067076|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2067077|NCT01896557|Omeprazole|omeprazole|mesh-list
2067078|NCT01896557|Ranitidine|ranitidine|mesh-list
2067079|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2067080|NCT01896557|Clopidogrel|clopidogrel|mesh-list
2067081|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
2067082|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2067083|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2067084|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2067085|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
2067086|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067087|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067088|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067089|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2067090|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2067091|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2067092|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067093|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2067094|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
2067095|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
2067096|NCT01896700|Methylphenidate|methylphenidate|mesh-list
2067097|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2067098|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067099|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2067100|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2067101|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2067102|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067103|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
2067104|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067105|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2067106|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2067107|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2067108|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
2067109|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2067110|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067111|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2067112|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2067113|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2067114|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2067115|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2067116|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2067117|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2067118|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2067119|NCT01896856|Trifluridine|trifluridine|mesh-list
2067120|NCT01896856|Irinotecan|irinotecan|mesh-list
2067121|NCT01896856|Guadecitabine|guadecitabine|mesh-list
2067122|NCT01896856|Azacitidine|azacitidine|mesh-list
2067123|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2067124|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2067125|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067126|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067127|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067128|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
2067129|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
2067130|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2067131|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2067132|NCT01896869|Ipilimumab|ipilimumab|mesh-list
2067133|NCT01896869|Folfirinox|folfirinox|mesh-list
2067134|NCT01896869|Vaccines|vaccines|mesh-list
2067135|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
2067136|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067137|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2067138|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067139|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2067140|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067141|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
2067142|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2067143|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2067144|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2067145|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2067146|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2067147|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067148|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
2067149|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067150|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067151|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2067152|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067153|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
2067154|NCT01896921|Maraviroc|maraviroc|mesh-list
2067155|NCT01896921|Dolutegravir|dolutegravir|mesh-list
2067156|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2067157|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2067158|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
2067159|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2067160|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2067161|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2067162|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067163|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067164|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2067165|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2067166|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2067167|NCT01896934|Sertraline|sertraline|mesh-list
2067168|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
2067169|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2067170|NCT01896934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2067171|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2067172|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2067173|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067174|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067175|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
2067176|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067177|NCT01897233|Ivacaftor|ivacaftor|mesh-list
2067178|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2067179|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2067180|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067181|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2067182|NCT01897285|Laxatives|laxatives|mesh-ancestor
2067183|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2067184|NCT01897402|Vaccines|vaccines|mesh-list
2067185|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
2067186|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067187|NCT01897493|Digoxin|digoxin|mesh-list
2067188|NCT01897493|Evacetrapib|evacetrapib|mesh-list
2067189|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2067190|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2067191|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067192|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067193|NCT01897493|Protective Agents|protective agents|mesh-ancestor
2067194|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067195|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2067196|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2067197|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
2067198|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2067199|NCT01897532|Linagliptin|linagliptin|mesh-list
2067200|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2067201|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067202|NCT01897532|Incretins|incretins|mesh-ancestor
2067203|NCT01897532|Hormones|hormones|mesh-ancestor
2067204|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067205|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2067206|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
2067207|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067208|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067209|NCT01897714|Dexamethasone|dexamethasone|mesh-list
2067210|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067211|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
2067212|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
2067213|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067214|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067215|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2067216|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
2067217|NCT01897714|Hormones|hormones|mesh-ancestor
2067218|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067219|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2067220|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067221|NCT01897727|Spironolactone|spironolactone|mesh-list
2067222|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2067223|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
2067224|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067225|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067226|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2067227|NCT01897727|Diuretics|diuretics|mesh-ancestor
2067228|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
2067229|NCT01897792|Vitamins|vitamins|mesh-list
2067230|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
2067231|NCT01897792|Vitamin E|vitamin e|mesh-list
2067232|NCT01897792|Tocopherols|tocopherols|mesh-list
2067233|NCT01897792|Tocotrienols|tocotrienols|mesh-list
2067234|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
2067235|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
2067236|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067237|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
2067238|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067239|NCT01897792|Protective Agents|protective agents|mesh-ancestor
2067240|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
2067241|NCT01898091|Glycerol|glycerol|mesh-list
2067242|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
2067243|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067244|NCT01898091|Protective Agents|protective agents|mesh-ancestor
2067245|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067246|NCT01898091|Vitamins|vitamins|mesh-ancestor
2067247|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
2067248|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2067249|NCT01898130|Bevacizumab|bevacizumab|mesh-list
2067250|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2067251|NCT01898130|Antibodies|antibodies|mesh-list
2067252|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
2067253|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2067254|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067255|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2067256|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2067257|NCT01898130|Growth Substances|growth substances|mesh-ancestor
2067258|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067259|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
2067260|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
2067261|NCT01898195|Varenicline|varenicline|mesh-list
2067262|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2067263|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2067264|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
2067265|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067266|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067267|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067268|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
2067269|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2067270|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2067271|NCT01898442|Ticagrelor|ticagrelor|mesh-list
2067272|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2067273|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2067274|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2067275|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2067276|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
2067277|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067278|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067279|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067280|NCT01898689|Ropivacaine|ropivacaine|mesh-list
2067281|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
2067282|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
2067283|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067284|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067285|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
2067286|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067287|NCT01898806|Triamcinolone|triamcinolone|mesh-list
2067288|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2067289|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2067290|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2067291|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067292|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
2067293|NCT01898806|Hormones|hormones|mesh-ancestor
2067294|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067295|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067296|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2067297|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
2067298|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067299|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067300|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2067301|NCT01898923|Laxatives|laxatives|mesh-ancestor
2067302|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2067303|NCT01899053|Serabelisib|serabelisib|mesh-list
2067304|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067305|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067323|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
2067324|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2067325|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
2067326|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067327|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067328|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2067329|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
2067330|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
2067331|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2067332|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
2067333|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067334|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067335|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
2067336|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2067337|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2067338|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2067339|NCT01900431|Leucovorin|leucovorin|mesh-list
2067340|NCT01900431|Folic Acid|folic acid|mesh-list
2067341|NCT01900431|Prednisone|prednisone|mesh-list
2067342|NCT01900431|Methotrexate|methotrexate|mesh-list
2067343|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
2067344|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067345|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
2067346|NCT01900431|Hormones|hormones|mesh-ancestor
2067347|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067348|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067349|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2067350|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067351|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2067352|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
2067353|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2067354|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2067355|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
2067356|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067357|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
2067358|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067359|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2067360|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2067361|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
2067362|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2067363|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2067364|NCT01900431|Antidotes|antidotes|mesh-ancestor
2067365|NCT01900431|Protective Agents|protective agents|mesh-ancestor
2067366|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
2067367|NCT01900431|Vitamins|vitamins|mesh-ancestor
2067368|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
2067369|NCT01900431|Hematinics|hematinics|mesh-ancestor
2067370|NCT01900444|Vaccines|vaccines|mesh-list
2067371|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
2067372|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067373|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2067374|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067375|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2067376|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067377|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067378|NCT01901146|Paclitaxel|paclitaxel|mesh-list
2067379|NCT01901146|Trastuzumab|trastuzumab|mesh-list
2067380|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2067381|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067382|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
2067383|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
2067384|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
2067385|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067386|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2067387|NCT01901185|Etanercept|etanercept|mesh-list
2067388|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2067389|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2067390|NCT01901185|Analgesics|analgesics|mesh-ancestor
2067391|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
2067392|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067393|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067394|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067395|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2067396|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2067397|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2067398|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
2067399|NCT01901250|Fluorides|fluorides|mesh-list
2067400|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
2067401|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
2067402|NCT01901250|Protective Agents|protective agents|mesh-ancestor
2067403|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067404|NCT01901393|Ibuprofen|ibuprofen|mesh-list
2067405|NCT01901393|Ketorolac|ketorolac|mesh-list
2067406|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2067407|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2067408|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2067409|NCT01901393|Analgesics|analgesics|mesh-ancestor
2067410|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
2067411|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067412|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067413|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067414|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2067415|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2067416|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067417|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067418|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
2067419|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
2749197|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2749198|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2749199|NCT04673617|Analgesics|analgesics|mesh-ancestor
2749200|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
2067424|NCT01901575|Remifentanil|remifentanil|mesh-list
2067425|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2067426|NCT01901575|Narcotics|narcotics|mesh-ancestor
2067427|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067428|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067429|NCT01901575|Analgesics|analgesics|mesh-ancestor
2067430|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
2067431|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067432|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
2067433|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2067434|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067435|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067436|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2067437|NCT01901588|Analgesics|analgesics|mesh-ancestor
2067438|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
2067439|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067440|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2067441|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2067442|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2067443|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
2067444|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067445|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067446|NCT01901614|Anesthetics|anesthetics|mesh-list
2067447|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067448|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067449|NCT01901809|Dopamine|dopamine|mesh-list
2067450|NCT01901809|Furosemide|furosemide|mesh-list
2067451|NCT01901809|Diuretics|diuretics|mesh-ancestor
2067452|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
2067453|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067454|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2067455|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2067456|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067457|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2067458|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
2067459|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
2067460|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067461|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
2067462|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067463|NCT01901809|Protective Agents|protective agents|mesh-ancestor
2067464|NCT01901848|Bupropion|bupropion|mesh-list
2067465|NCT01901848|Nicotine|nicotine|mesh-list
2067466|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2067467|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
2067468|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067469|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067470|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2067471|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2067472|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
2067473|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067474|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067475|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2067476|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
2067477|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2067478|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2067479|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2067480|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2067481|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
2067482|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2067483|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2067484|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067485|NCT01902004|Memantine|memantine|mesh-list
2067486|NCT01902004|Citalopram|citalopram|mesh-list
2067487|NCT01902004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2067488|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2067489|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2067490|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067491|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067492|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
2067493|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067494|NCT01902004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2067495|NCT01902004|Antidepressive Agents|antidepressive agents|mesh-ancestor
2067496|NCT01902004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2067497|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2067498|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2067499|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
2067500|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2067501|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2067502|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2067503|NCT01902134|Tramadol|tramadol|mesh-list
2067504|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2067505|NCT01902134|Narcotics|narcotics|mesh-ancestor
2067506|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067507|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067508|NCT01902134|Analgesics|analgesics|mesh-ancestor
2067509|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
2067510|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067511|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2067512|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2067513|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067514|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2067515|NCT01902173|Trametinib|trametinib|mesh-list
2067516|NCT01902173|Dabrafenib|dabrafenib|mesh-list
2067517|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2067518|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067519|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2067520|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067521|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067522|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2211144|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2211145|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2211146|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
2211147|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211148|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211149|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2211150|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211151|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
2211152|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211153|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
2211154|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2211155|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2211156|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
2211157|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
2211158|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211159|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2211160|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
2211161|NCT00017654|Hormones|hormones|mesh-ancestor
2211162|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2211163|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2211164|NCT00017654|Protective Agents|protective agents|mesh-ancestor
2211165|NCT00017680|Melphalan|melphalan|mesh-list
2211166|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2211167|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
2211168|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211169|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211170|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2211171|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211172|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
2211173|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211174|NCT00017693|Interleukin-4|interleukin-4|mesh-list
2211175|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2211176|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
2211177|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211178|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211179|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2211180|NCT00017719|Lamivudine|lamivudine|mesh-list
2211181|NCT00017719|Zidovudine|zidovudine|mesh-list
2211182|NCT00017719|Nevirapine|nevirapine|mesh-list
2211183|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2211184|NCT00017719|Nelfinavir|nelfinavir|mesh-list
2211185|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2749201|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2749202|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
2749203|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
2749204|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749205|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2067523|NCT01902173|Protective Agents|protective agents|mesh-ancestor
2067524|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067525|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2067526|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
2067527|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2067528|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
2067529|NCT01902459|Coagulants|coagulants|mesh-ancestor
2067530|NCT01902758|Ambrisentan|ambrisentan|mesh-list
2067531|NCT01902758|Theophylline|theophylline|mesh-list
2067532|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2067533|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
2067534|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067535|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067536|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2067537|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
2079438|NCT02058368|Dutasteride|dutasteride|mesh-list
2749206|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2749207|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
2749208|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2749209|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749210|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2067538|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2067539|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067540|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067541|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
2067542|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2067543|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2067544|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
2067545|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067546|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2067547|NCT01903005|Buprenorphine|buprenorphine|mesh-list
2067548|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2067549|NCT01903005|Naloxone|naloxone|mesh-list
2067550|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2067551|NCT01903005|Narcotics|narcotics|mesh-ancestor
2067552|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2211186|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2211187|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211188|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067553|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067554|NCT01903005|Analgesics|analgesics|mesh-ancestor
2067555|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
2067556|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067557|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2067558|NCT01903031|Ritonavir|ritonavir|mesh-list
2067559|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2067560|NCT01903031|Tenofovir|tenofovir|mesh-list
2067561|NCT01903031|Efavirenz|efavirenz|mesh-list
2067562|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2211189|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
2067563|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2067564|NCT01903031|Etonogestrel|etonogestrel|mesh-list
2067565|NCT01903031|NuvaRing|nuvaring|mesh-list
2067566|NCT01903031|Estradiol|estradiol|mesh-list
2067567|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2067568|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2067569|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
2067570|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067571|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067572|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2067573|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2067574|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
2067575|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2067576|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2067577|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2067578|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2067579|NCT01903031|Estrogens|estrogens|mesh-ancestor
2067580|NCT01903031|Hormones|hormones|mesh-ancestor
2067581|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067582|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067583|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2067584|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
2067585|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2067586|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2067587|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2067588|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2067589|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2067590|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2067591|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2067592|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2067593|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2067594|NCT01903252|Mesalamine|mesalamine|mesh-list
2067595|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2067596|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2067597|NCT01903252|Analgesics|analgesics|mesh-ancestor
2067598|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
2067599|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067600|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067601|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067602|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2067603|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
2067604|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2067605|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
2067606|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2067607|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2067608|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067609|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2067610|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067611|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2067612|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067613|NCT01903356|Linagliptin|linagliptin|mesh-list
2067614|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2067615|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067616|NCT01903356|Incretins|incretins|mesh-ancestor
2067617|NCT01903356|Hormones|hormones|mesh-ancestor
2079439|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2067618|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067619|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2749232|NCT04667078|Cangrelor|cangrelor|mesh-list
2749233|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2749234|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2749235|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2067620|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
2067621|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067622|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067623|NCT01903434|Evacetrapib|evacetrapib|mesh-list
2067624|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2211190|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211191|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211192|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211193|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
2067625|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2067626|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
2211194|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2211195|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2211196|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2211197|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2067627|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067628|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2067629|NCT01903720|Dexamethasone|dexamethasone|mesh-list
2067630|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067631|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
2067632|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
2067633|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067634|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067635|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2067636|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
2067637|NCT01903720|Hormones|hormones|mesh-ancestor
2067638|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067639|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2067640|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067641|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
2067642|NCT01903798|Prednisolone|prednisolone|mesh-list
2067643|NCT01903798|Rilonacept|rilonacept|mesh-list
2067644|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2067645|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067646|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2067647|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
2067648|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2067649|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2067650|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079440|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2067651|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067652|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067653|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
2067654|NCT01903798|Hormones|hormones|mesh-ancestor
2067655|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067656|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067657|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2067658|NCT01903811|Dexamethasone|dexamethasone|mesh-list
2067659|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
2067660|NCT01903811|Ichthammol|ichthammol|mesh-list
2067661|NCT01903811|BB 1101|bb 1101|mesh-list
2067662|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067663|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
2067664|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
2067665|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067666|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067667|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2067668|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
2067669|NCT01903811|Hormones|hormones|mesh-ancestor
2067670|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067671|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2067672|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067673|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
2067674|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067675|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067676|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
2067677|NCT01903837|Naltrexone|naltrexone|mesh-list
2067678|NCT01903837|Olanzapine|olanzapine|mesh-list
2067679|NCT01903837|ALKS-33|alks-33|mesh-list
2067680|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
2067681|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
2749236|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2749237|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
2749238|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2749239|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749240|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749250|NCT04662944|Ranibizumab|ranibizumab|mesh-list
2749251|NCT04662944|Aflibercept|aflibercept|mesh-list
2749252|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2749253|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2749254|NCT04662944|Growth Substances|growth substances|mesh-ancestor
2749255|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749256|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
2749257|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067682|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067683|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067684|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2067685|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2067686|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2067687|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067688|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2211198|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
2211199|NCT00017758|Efavirenz|efavirenz|mesh-list
2211200|NCT00017758|Nelfinavir|nelfinavir|mesh-list
2211201|NCT00017758|Atorvastatin|atorvastatin|mesh-list
2211202|NCT00017758|Simvastatin|simvastatin|mesh-list
2211203|NCT00017758|Pravastatin|pravastatin|mesh-list
2211204|NCT00017758|Calcium|calcium|mesh-list
2211205|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2067689|NCT01903837|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2067690|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2067691|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2067692|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067693|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067694|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
2067695|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2067696|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
2067697|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2067698|NCT01903993|Docetaxel|docetaxel|mesh-list
2211206|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067699|NCT01903993|Atezolizumab|atezolizumab|mesh-list
2067700|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067701|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
2067702|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
2067703|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
2067704|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067705|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2067706|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2067707|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2067708|NCT01904071|Morphine|morphine|mesh-list
2067709|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2067710|NCT01904071|Narcotics|narcotics|mesh-ancestor
2067711|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067712|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067713|NCT01904071|Analgesics|analgesics|mesh-ancestor
2067714|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
2067715|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067716|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2067717|NCT01904149|Tramadol|tramadol|mesh-list
2067718|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2067719|NCT01904149|Narcotics|narcotics|mesh-ancestor
2067720|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067721|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067722|NCT01904149|Analgesics|analgesics|mesh-ancestor
2211207|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2211208|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2211209|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
2067723|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
2067724|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067725|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2067726|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2067727|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067728|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2067729|NCT01904526|Guanfacine|guanfacine|mesh-list
2067730|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2067731|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2067732|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2067733|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2067734|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
2211210|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211211|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2211212|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2211213|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067735|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067736|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067737|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067738|NCT01904721|Bimatoprost|bimatoprost|mesh-list
2067739|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2211214|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2211215|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2211216|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
2211217|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211218|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2211219|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2211220|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2211221|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2211222|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2067740|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2067741|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
2067742|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2067743|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067744|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067745|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2067746|NCT01904760|Analgesics|analgesics|mesh-ancestor
2067747|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
2067748|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067749|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2067750|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2067751|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2067752|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
2067753|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067754|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067755|NCT01904864|Iron|iron|mesh-list
2067756|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
2067757|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067758|NCT01904864|Trace Elements|trace elements|mesh-ancestor
2067759|NCT01904903|Trastuzumab|trastuzumab|mesh-list
2067760|NCT01904903|Pertuzumab|pertuzumab|mesh-list
2067761|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2067762|NCT01904903|Maytansine|maytansine|mesh-list
2067763|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2067764|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067765|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2067766|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
2067767|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
2749277|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2749283|NCT04652700|Tenofovir|tenofovir|mesh-list
2749284|NCT04652700|Emtricitabine|emtricitabine|mesh-list
2749285|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2749286|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2749287|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
2749288|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2749289|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2749290|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2749291|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2749292|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749293|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2749294|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2749295|NCT04648930|Omalizumab|omalizumab|mesh-list
2749296|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2749297|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2749298|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
2749299|NCT04648033|Atovaquone|atovaquone|mesh-list
2749300|NCT04648033|Cisplatin|cisplatin|mesh-list
2749301|NCT04648033|Vinorelbine|vinorelbine|mesh-list
2749302|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749303|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2749304|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
2211223|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2211224|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2211225|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2211226|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
2211227|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211228|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211229|NCT00017784|Valganciclovir|valganciclovir|mesh-list
2211230|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
2211231|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211232|NCT00017862|Reslizumab|reslizumab|mesh-list
2211233|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2211234|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
2211235|NCT00017940|Mitogens|mitogens|mesh-list
2211236|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
2067768|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
2067769|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067770|NCT01905423|Albendazole|albendazole|mesh-list
2067771|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
2067772|NCT01905423|Piperazine|piperazine|mesh-list
2211237|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211238|NCT00017992|Ritonavir|ritonavir|mesh-list
2211239|NCT00017992|Lopinavir|lopinavir|mesh-list
2211240|NCT00017992|Emtricitabine|emtricitabine|mesh-list
2211241|NCT00017992|Stavudine|stavudine|mesh-list
2211242|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2211243|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2211244|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
2211245|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211246|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211247|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211248|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211249|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
2211250|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2067773|NCT01905423|Mebendazole|mebendazole|mesh-list
2067774|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
2067775|NCT01905423|Citric Acid|citric acid|mesh-list
2067776|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
2067777|NCT01905423|DMP 777|dmp 777|mesh-list
2067778|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
2067779|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2067780|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
2067781|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
2067782|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067783|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
2067784|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2067785|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2067786|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
2067787|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2067788|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2067789|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
2067790|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
2067791|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
2067792|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067793|NCT01905423|Filaricides|filaricides|mesh-ancestor
2067794|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
2067795|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2067796|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067797|NCT01905592|Niraparib|niraparib|mesh-list
2067798|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2067799|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067800|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067801|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067802|NCT01905657|Docetaxel|docetaxel|mesh-list
2067803|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
2067804|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067805|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
2067806|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
2067807|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
2067808|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067809|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2067810|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
2067811|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2067812|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2067813|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2749305|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
2211251|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2067814|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2067815|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2067816|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067817|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
2067818|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067819|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067820|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2067821|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067822|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
2067823|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2067824|NCT01905943|Chlorambucil|chlorambucil|mesh-list
2067825|NCT01905943|Fludarabine|fludarabine|mesh-list
2067826|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
2067827|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2067828|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
2067829|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067830|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2067831|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2067832|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
2067833|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067834|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067835|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2749306|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
2067836|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2067837|NCT01906008|Minocycline|minocycline|mesh-list
2067838|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2067839|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211252|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2211253|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2211254|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2211255|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
2211256|NCT00018018|Zidovudine|zidovudine|mesh-list
2211257|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
2211258|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211259|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2067840|NCT01906346|Cocaine|cocaine|mesh-list
2067841|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
2067842|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
2067843|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067844|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067845|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
2067846|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067847|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2067848|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2067849|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2067850|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2067851|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067852|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
2749307|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749308|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2749309|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
2749310|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2749311|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2749312|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2749313|NCT04645212|Aflibercept|aflibercept|mesh-list
2749314|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2067853|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067854|NCT01906372|Hormones|hormones|mesh-list
2067855|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2067856|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2067857|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
2067858|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067859|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067860|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067861|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067862|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2067863|NCT01906658|Hormones|hormones|mesh-ancestor
2067864|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067865|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749315|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2749316|NCT04645212|Growth Substances|growth substances|mesh-ancestor
2749317|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749318|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
2749319|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749320|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
2749321|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
2749322|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749323|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
2749324|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2749325|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749326|NCT04644029|Tenofovir|tenofovir|mesh-list
2067866|NCT01906866|Melatonin|melatonin|mesh-list
2067867|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
2067868|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067869|NCT01906866|Protective Agents|protective agents|mesh-ancestor
2067870|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067871|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067872|NCT01907100|Cisplatin|cisplatin|mesh-list
2067873|NCT01907100|Pemetrexed|pemetrexed|mesh-list
2067874|NCT01907100|Nintedanib|nintedanib|mesh-list
2067875|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067876|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067877|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749327|NCT04644029|Emtricitabine|emtricitabine|mesh-list
2067878|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2067879|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2067880|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2067881|NCT01907113|Empagliflozin|empagliflozin|mesh-list
2067882|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2067883|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749328|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2749329|NCT04644029|Islatravir|islatravir|mesh-list
2749330|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
2749331|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2749332|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2749333|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2749334|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2749335|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749336|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2749337|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211260|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2211261|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067884|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2067885|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067886|NCT01907217|Methohexital|methohexital|mesh-list
2067887|NCT01907217|Succinylcholine|succinylcholine|mesh-list
2067888|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2067889|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2067890|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2067891|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067892|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067893|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2067894|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
2067895|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
2067896|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067897|NCT01907321|Capsaicin|capsaicin|mesh-list
2067898|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
2067899|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
2067900|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
2067901|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067902|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067903|NCT01907334|Fluticasone|fluticasone|mesh-list
2067904|NCT01907334|Xhance|xhance|mesh-list
2067905|NCT01907334|Albuterol|albuterol|mesh-list
2067906|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2067907|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2067908|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
2067909|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067910|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2067911|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
2211262|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
2211263|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2067912|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067913|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067914|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2067915|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
2067916|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
2067917|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2067918|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2067919|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2067920|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2211264|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211265|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2067921|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
2067922|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2067923|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067924|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
2067925|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2067926|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
2067927|NCT01907334|Hormones|hormones|mesh-ancestor
2067928|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067929|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
2067930|NCT01907334|Miotics|miotics|mesh-ancestor
2067931|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2067932|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2067933|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2067934|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2067935|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
2067945|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
2067946|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
2067947|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
2067948|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2067949|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067950|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
2067951|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067952|NCT01907607|Palbociclib|palbociclib|mesh-list
2067953|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067954|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2067955|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067956|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067957|NCT01907815|Trametinib|trametinib|mesh-list
2067958|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067959|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2067960|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067961|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067962|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2067963|NCT01907854|Liraglutide|liraglutide|mesh-list
2067964|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2067965|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067966|NCT01907854|Incretins|incretins|mesh-ancestor
2067967|NCT01907854|Hormones|hormones|mesh-ancestor
2067968|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2067969|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2067970|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
2067971|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2067972|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067973|NCT01908062|Naltrexone|naltrexone|mesh-list
2067974|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2067975|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2067976|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067977|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
2067978|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067979|NCT01908101|Halichondrin B|halichondrin b|mesh-list
2067980|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
2067981|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
2067982|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
2067983|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2067984|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2067985|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
2067986|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2067987|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
2067988|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
2067989|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
2067990|NCT01908140|Fluticasone|fluticasone|mesh-list
2067991|NCT01908140|Bromides|bromides|mesh-list
2067992|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
2067993|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2067994|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2067995|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2067996|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
2067997|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2067998|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2067999|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2068000|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
2068001|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
2068002|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2068003|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2068004|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2068005|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2068006|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
2749357|NCT04632706|Ivermectin|ivermectin|mesh-list
2749358|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2749359|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2068007|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068008|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068009|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
2068010|NCT01908205|Oxytocin|oxytocin|mesh-list
2068011|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
2068012|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2068013|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068014|NCT01908582|Rifampin|rifampin|mesh-list
2068015|NCT01908582|Evacetrapib|evacetrapib|mesh-list
2068016|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2068017|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
2068018|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2068019|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2068020|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
2211280|NCT00018083|Efavirenz|efavirenz|mesh-list
2211281|NCT00018083|Isoniazid|isoniazid|mesh-list
2211282|NCT00018083|Rifabutin|rifabutin|mesh-list
2211283|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2211284|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2211285|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211286|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211287|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
2211288|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211289|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2211290|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2211291|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2211292|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2749387|NCT04629781|Docetaxel|docetaxel|mesh-list
2749388|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749389|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
2749390|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
2749391|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
2749392|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068021|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2068022|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068023|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068024|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2068025|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2068026|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2068027|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2068028|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2068029|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2068030|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2068031|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2068032|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
2068033|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2068034|NCT01908699|Beraprost|beraprost|mesh-list
2068035|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2068036|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
2068037|NCT01908751|Vitamin D|vitamin d|mesh-list
2068038|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
2068039|NCT01908751|Vitamins|vitamins|mesh-list
2068040|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
2068041|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068042|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2068043|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2068044|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
2068045|NCT01908803|Dexamethasone|dexamethasone|mesh-list
2068046|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2068047|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
2068048|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
2068049|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068050|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068051|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2068052|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
2068053|NCT01908803|Hormones|hormones|mesh-ancestor
2068054|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2068055|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2068056|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211293|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2211294|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2211295|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
2211296|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2211297|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2211298|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2211299|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
2211300|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2211301|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2211302|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2211303|NCT00018135|Calcium|calcium|mesh-list
2211304|NCT00018135|Sevelamer|sevelamer|mesh-list
2211305|NCT00018135|Calcium acetate|calcium acetate|mesh-list
2211306|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2211307|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211308|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
2211309|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
2211310|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068057|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2068058|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2068059|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2068060|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2068061|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068062|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068063|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2068064|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2068065|NCT01908816|Ranibizumab|ranibizumab|mesh-list
2211311|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2211312|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
2211313|NCT00018135|Antacids|antacids|mesh-ancestor
2068066|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2068067|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2068068|NCT01908816|Growth Substances|growth substances|mesh-ancestor
2068069|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068070|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
2068071|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068072|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
2068073|NCT01908829|Mirabegron|mirabegron|mesh-list
2068074|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2068075|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2068076|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
2068077|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068078|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068079|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068080|NCT01908829|Urological Agents|urological agents|mesh-ancestor
2068081|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2068082|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2068083|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2068084|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
2068085|NCT01908842|Buprenorphine|buprenorphine|mesh-list
2068086|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2068087|NCT01908842|Narcotics|narcotics|mesh-ancestor
2211314|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2211315|NCT00018148|Nortriptyline|nortriptyline|mesh-list
2211316|NCT00018148|Nicotine|nicotine|mesh-list
2211317|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2211318|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
2211319|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211320|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211321|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2211322|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2211323|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
2211324|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211325|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211326|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2211327|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
2211328|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2211329|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2068088|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2068089|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068090|NCT01908842|Analgesics|analgesics|mesh-ancestor
2068091|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
2068092|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068093|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2068094|NCT01908972|Prednisolone|prednisolone|mesh-list
2068095|NCT01908972|Propranolol|propranolol|mesh-list
2068096|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2068097|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
2068098|NCT01908972|Hormones|hormones|mesh-ancestor
2068099|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2068100|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068101|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2068102|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068103|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2068104|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2068105|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
2068106|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068107|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068108|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2068109|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2211330|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2068110|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
2068111|NCT01909141|Metformin|metformin|mesh-list
2068112|NCT01909141|Pioglitazone|pioglitazone|mesh-list
2068113|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
2068114|NCT01909141|Letrozole|letrozole|mesh-list
2068115|NCT01909141|Clomiphene|clomiphene|mesh-list
2068116|NCT01909141|Enclomiphene|enclomiphene|mesh-list
2068117|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
2211331|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2211332|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
2211333|NCT00018161|Mecamylamine|mecamylamine|mesh-list
2211334|NCT00018161|Nicotine|nicotine|mesh-list
2211335|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2211336|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
2211337|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211338|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211339|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2211340|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2068118|NCT01909141|Hormones|hormones|mesh-list
2068119|NCT01909141|Estradiol|estradiol|mesh-list
2068120|NCT01909141|Testosterone|testosterone|mesh-list
2068121|NCT01909141|Progesterone|progesterone|mesh-list
2068122|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2068123|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2068124|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068125|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068126|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2068127|NCT01909141|Estrogens|estrogens|mesh-ancestor
2068128|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2068129|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068130|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2068131|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2211341|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
2068132|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068133|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2068134|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
2068135|NCT01909141|Androgens|androgens|mesh-ancestor
2068136|NCT01909141|Progestins|progestins|mesh-ancestor
2068137|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2068138|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2068139|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2068140|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
2068141|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2068142|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2068143|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2068144|NCT01909453|Vemurafenib|vemurafenib|mesh-list
2068145|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068146|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2068147|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068148|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068149|NCT01909466|Aripiprazole|aripiprazole|mesh-list
2068150|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
2068151|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2068152|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2068153|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2068154|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2211342|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211343|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211344|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2211345|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2211346|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2211347|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2211348|NCT00018174|Fluoxetine|fluoxetine|mesh-list
2211349|NCT00018174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2211350|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2211351|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2211352|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211353|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211354|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
2211355|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211356|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2211357|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
2211358|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2211359|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2211360|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2211361|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211362|NCT00018187|Mecamylamine|mecamylamine|mesh-list
2211363|NCT00018187|Bupropion|bupropion|mesh-list
2211364|NCT00018187|Nicotine|nicotine|mesh-list
2211365|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2211366|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
2211367|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068155|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068156|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
2068157|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
2068158|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068159|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068160|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2068161|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2068162|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
2068163|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2068164|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2068165|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2068166|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2211368|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211369|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2211370|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2211371|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
2211372|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211373|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211374|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2211375|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
2211376|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2068167|NCT01909791|Bevacizumab|bevacizumab|mesh-list
2068168|NCT01909791|Aflibercept|aflibercept|mesh-list
2068169|NCT01909791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2068170|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068171|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2068172|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2068173|NCT01909791|Growth Substances|growth substances|mesh-ancestor
2068174|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068175|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
2068176|NCT01909804|Ribavirin|ribavirin|mesh-list
2068177|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
2068178|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2068179|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
2068180|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068181|NCT01910064|Adapalene|adapalene|mesh-list
2068182|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2068183|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
2211377|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2211378|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2211379|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2211380|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
2211381|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2068184|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2068185|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2068186|NCT01910064|Analgesics|analgesics|mesh-ancestor
2068187|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
2068188|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068189|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068190|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2068191|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2068192|NCT01910181|Vemurafenib|vemurafenib|mesh-list
2068193|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068194|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2068195|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068196|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068197|NCT01910311|Rifampin|rifampin|mesh-list
2749430|NCT04626635|Cemiplimab|cemiplimab|mesh-list
2749431|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2749432|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068198|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2068199|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
2068200|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2068201|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2068202|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
2068203|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2068204|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068205|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068206|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2068207|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2068208|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2068209|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2068210|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2068211|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2068234|NCT01910519|Vaccines|vaccines|mesh-list
2068235|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
2068236|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068237|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
2068238|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
2068239|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2068240|NCT01911065|Vaccines|vaccines|mesh-list
2068241|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
2068242|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068243|NCT01911169|Vitamin D|vitamin d|mesh-list
2068244|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
2068245|NCT01911169|Vitamins|vitamins|mesh-list
2068246|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
2068247|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068248|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2068249|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2068250|NCT01911260|Chelating Agents|chelating agents|mesh-list
2211382|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2211383|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211384|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2211385|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2211386|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2211387|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2211388|NCT00018200|Benztropine|benztropine|mesh-list
2211389|NCT00018200|Fluoxetine|fluoxetine|mesh-list
2211390|NCT00018200|Desipramine|desipramine|mesh-list
2068251|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
2068252|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068253|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
2068254|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2068255|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
2068256|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
2068257|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2068258|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068259|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2068260|NCT01911351|Analgesics|analgesics|mesh-ancestor
2068261|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
2068262|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068263|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2068264|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2068265|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2068266|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2068267|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068268|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2068269|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2068270|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2068271|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2068272|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
2068273|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068274|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068275|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2068276|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2068277|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
2068278|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2068279|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2068280|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
2068281|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2068282|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2068283|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2068284|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2068285|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068286|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2068287|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2068288|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2068289|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2068290|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
2068291|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068292|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068293|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2068294|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2068295|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
2068296|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2068297|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2068298|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
2068299|NCT01911546|Everolimus|everolimus|mesh-list
2068300|NCT01911546|Tacrolimus|tacrolimus|mesh-list
2068301|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2068302|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
2068303|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068304|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2068305|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068306|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068307|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068308|NCT01911780|Amlodipine|amlodipine|mesh-list
2068309|NCT01911780|Telmisartan|telmisartan|mesh-list
2068310|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2068311|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2068312|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2068313|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2068314|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068315|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2068316|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068317|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
2068318|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2068319|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2068320|NCT01911780|Diuretics|diuretics|mesh-ancestor
2068321|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
2068322|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2068323|NCT01911845|Ribavirin|ribavirin|mesh-list
2068324|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
2068325|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068326|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
2068327|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2068328|NCT01912222|Ixazomib|ixazomib|mesh-list
2068329|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068330|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
2068331|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068332|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068333|NCT01912274|Azacitidine|azacitidine|mesh-list
2068334|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2068335|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
2079441|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2211391|NCT00018200|Clomipramine|clomipramine|mesh-list
2211392|NCT00018200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2211393|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2211394|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2211395|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211396|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211397|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
2068336|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068337|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068338|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068339|NCT01912352|Methylphenidate|methylphenidate|mesh-list
2068340|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2068341|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068342|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2068343|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2068344|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2068345|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068346|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
2068347|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068348|NCT01912456|Complement C1s|complement c1s|mesh-list
2068349|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2068350|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2068351|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
2068352|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068353|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2068354|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2068355|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2068356|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2068357|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2068358|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2068359|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068360|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211398|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211399|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2211400|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
2211401|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2211402|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2211403|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2211404|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211405|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2211406|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2211407|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
2211408|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2749500|NCT04620187|Cisplatin|cisplatin|mesh-list
2068361|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068362|NCT01912612|Analgesics|analgesics|mesh-ancestor
2068363|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
2068364|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068365|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
2068366|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2068367|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
2068368|NCT01912716|Indomethacin|indomethacin|mesh-list
2068369|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2068370|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2068371|NCT01912716|Analgesics|analgesics|mesh-ancestor
2068372|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
2068373|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068374|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068375|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2068376|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2068377|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
2068378|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
2068379|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2068380|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2068381|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068382|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068383|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2068384|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2068385|NCT01912807|Ondansetron|ondansetron|mesh-list
2068386|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
2068387|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
2068388|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068389|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068390|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2068391|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
2068392|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
2068393|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2068394|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
2068395|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068396|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068397|NCT01912807|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2068398|NCT01912807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2068399|NCT01912807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2068400|NCT01912807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2068401|NCT01912807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2068402|NCT01912872|Omalizumab|omalizumab|mesh-list
2068403|NCT01912872|Budesonide|budesonide|mesh-list
2068404|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
2068405|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2068406|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2068407|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
2068408|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068409|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068410|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2068411|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
2068412|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
2068413|NCT01912872|Hormones|hormones|mesh-ancestor
2068414|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2068415|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2068416|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2068417|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2068418|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
2068419|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068420|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068421|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2068422|NCT01912963|Trastuzumab|trastuzumab|mesh-list
2068423|NCT01912963|Pertuzumab|pertuzumab|mesh-list
2068424|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2068425|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068426|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
2068427|NCT01913340|Hematinics|hematinics|mesh-ancestor
2068428|NCT01913405|Factor VIII|factor viii|mesh-list
2749501|NCT04620187|Carboplatin|carboplatin|mesh-list
2749502|NCT04620187|Trastuzumab|trastuzumab|mesh-list
2749503|NCT04620187|Maytansine|maytansine|mesh-list
2749504|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749505|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2749506|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2749507|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
2749508|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
2068429|NCT01913405|BAX 855|bax 855|mesh-list
2068430|NCT01913405|Coagulants|coagulants|mesh-ancestor
2068431|NCT01913470|Losartan|losartan|mesh-list
2068432|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2068433|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2068434|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2068435|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2068436|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068437|NCT01913483|Heparin|heparin|mesh-list
2068438|NCT01913483|Calcium heparin|calcium heparin|mesh-list
2068439|NCT01913483|Bivalirudin|bivalirudin|mesh-list
2068440|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
2068441|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2068442|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2068443|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068444|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
2068445|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2068446|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
2068447|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068448|NCT01913535|Aticaprant|aticaprant|mesh-list
2068449|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2068450|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068451|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
2068452|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068453|NCT01913639|Leucovorin|leucovorin|mesh-list
2068454|NCT01913639|Fluorouracil|fluorouracil|mesh-list
2068455|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
2068456|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
2068457|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068458|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2068459|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068460|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2068461|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
2068462|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068463|NCT01913639|Antidotes|antidotes|mesh-ancestor
2068464|NCT01913639|Protective Agents|protective agents|mesh-ancestor
2068465|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
2068466|NCT01913639|Vitamins|vitamins|mesh-ancestor
2068467|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
2749509|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
2749510|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068468|NCT01914159|Ranibizumab|ranibizumab|mesh-list
2068469|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2068470|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2068471|NCT01914159|Growth Substances|growth substances|mesh-ancestor
2068472|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068473|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
2068474|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068475|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2068476|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2068477|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2068478|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2211409|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2068479|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068480|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2068481|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2068482|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2068483|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2068484|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
2068485|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068486|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068487|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2068488|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2068489|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
2068490|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2068491|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2068492|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
2068493|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2068494|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2068495|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2068496|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2068497|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068498|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068499|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068500|NCT01914666|Analgesics|analgesics|mesh-ancestor
2068501|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
2068502|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068503|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
2068504|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2068505|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
2068506|NCT01914757|Benralizumab|benralizumab|mesh-list
2068507|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2068508|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
2068509|NCT01914926|Metoprolol|metoprolol|mesh-list
2068510|NCT01914926|Diltiazem|diltiazem|mesh-list
2068511|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2068512|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2068513|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
2068514|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
2068515|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068516|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068517|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2068518|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2068519|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2068520|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
2068521|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068522|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068523|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2068524|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2068525|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2068526|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
2211410|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
2211411|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
2211412|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211413|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2068527|NCT01915108|Remifentanil|remifentanil|mesh-list
2068528|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2068529|NCT01915108|Narcotics|narcotics|mesh-ancestor
2068530|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2068531|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068532|NCT01915108|Analgesics|analgesics|mesh-ancestor
2068533|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
2068534|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068535|NCT01915303|Cabergoline|cabergoline|mesh-list
2068536|NCT01915303|Pasireotide|pasireotide|mesh-list
2068537|NCT01915303|Hormones|hormones|mesh-ancestor
2068538|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2068539|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068540|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2068541|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2068542|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
2068543|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
2068544|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068545|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068546|NCT01915732|Clindamycin|clindamycin|mesh-list
2068547|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
2068548|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
2068549|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2068550|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2068551|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2068552|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068553|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068554|NCT01915823|Fluticasone|fluticasone|mesh-list
2068555|NCT01915823|Xhance|xhance|mesh-list
2068556|NCT01915823|Azelastine|azelastine|mesh-list
2068557|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2068558|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2068559|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
2068560|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068561|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068562|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2068563|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
2068564|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
2068565|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2068566|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2068567|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068568|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068569|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2068570|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2068571|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
2211414|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2211415|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
2211416|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2211417|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
2068572|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
2068573|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068574|NCT01915849|Licogliflozin|licogliflozin|mesh-list
2079442|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
2211418|NCT00018213|Naltrexone|naltrexone|mesh-list
2068575|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2068576|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068577|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2068578|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068579|NCT01915914|Fluticasone|fluticasone|mesh-list
2068580|NCT01915914|Xhance|xhance|mesh-list
2068581|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2068582|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2068583|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
2068584|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068585|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068586|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2068587|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
2068588|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
2068589|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2068590|NCT01915940|Timolol|timolol|mesh-list
2068591|NCT01915940|Bimatoprost|bimatoprost|mesh-list
2068592|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2068593|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2068594|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2068595|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2068596|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
2068597|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068598|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068599|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068600|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2068601|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2068602|NCT01916109|Gemcitabine|gemcitabine|mesh-list
2068603|NCT01916109|Carboplatin|carboplatin|mesh-list
2068604|NCT01916109|Panitumumab|panitumumab|mesh-list
2068605|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068606|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2068607|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
2068608|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068609|NCT01916109|Antiviral Agents|antiviral agents|mesh-ancestor
2211419|NCT00018213|Nicotine|nicotine|mesh-list
2211420|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2211421|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
2068610|NCT01916109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2068611|NCT01916109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068612|NCT01916109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2068613|NCT01916109|Immunologic Factors|immunologic factors|mesh-ancestor
2068614|NCT01916109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068615|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2068616|NCT01916226|Cetirizine|cetirizine|mesh-list
2211422|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211423|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068617|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2068618|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2068619|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2068620|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
2068621|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
2068622|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068623|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068624|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068625|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
2068626|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2068627|NCT01916629|Protective Agents|protective agents|mesh-ancestor
2068628|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068629|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
2068630|NCT01916681|Misoprostol|misoprostol|mesh-list
2068631|NCT01916681|Oxytocin|oxytocin|mesh-list
2068632|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
2068633|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2211424|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2211425|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2211426|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
2211427|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211428|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211429|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2211430|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2068634|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211431|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
2211432|NCT00018278|Donepezil|donepezil|mesh-list
2211433|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2211434|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211435|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211436|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
2211437|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211438|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211439|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
2211440|NCT00018291|Gabapentin|gabapentin|mesh-list
2211441|NCT00018291|Risperidone|risperidone|mesh-list
2211442|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2211443|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
2211444|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211445|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211446|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211447|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2068635|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2068636|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
2068637|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2068638|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2068639|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2068640|NCT01916824|Mirtazapine|mirtazapine|mesh-list
2068641|NCT01916824|Citalopram|citalopram|mesh-list
2068642|NCT01916824|Bupropion|bupropion|mesh-list
2068643|NCT01916824|Fluoxetine|fluoxetine|mesh-list
2068644|NCT01916824|Paroxetine|paroxetine|mesh-list
2068645|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2068646|NCT01916824|Sertraline|sertraline|mesh-list
2068647|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
2068648|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2068649|NCT01916824|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2068650|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2068651|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2068652|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068653|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068654|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
2068655|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068656|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2068657|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2068658|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068659|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2068660|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
2068661|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2068662|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2068663|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068664|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2068665|NCT01916824|Analgesics|analgesics|mesh-ancestor
2068666|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
2068667|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2068668|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
2068669|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
2068670|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2068671|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2068672|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2068673|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2068674|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2068675|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2068676|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
2068677|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2068678|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2068679|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2068680|NCT01916941|Prazosin|prazosin|mesh-list
2068681|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2068682|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2068683|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2068684|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2068685|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
2068686|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068687|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068688|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068689|NCT01916967|Desloratadine|desloratadine|mesh-list
2068690|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2068691|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
2068692|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068693|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068694|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068695|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2068696|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2068697|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
2068698|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
2068699|NCT01916980|Desloratadine|desloratadine|mesh-list
2068700|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2068701|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
2068702|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068703|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068704|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068705|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2068706|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2211448|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2211449|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2211450|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2211451|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2211452|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
2211453|NCT00018291|Analgesics|analgesics|mesh-ancestor
2211454|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
2211455|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211456|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
2211457|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2211458|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2211459|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2211460|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
2211461|NCT00018343|Estrogens|estrogens|mesh-list
2211462|NCT00018343|Hormones|hormones|mesh-ancestor
2211463|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2211464|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211465|NCT00018356|Testosterone|testosterone|mesh-list
2068707|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
2068708|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
2068709|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
2068710|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2068711|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2068712|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2068713|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2068714|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068715|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
2068716|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068717|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068718|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2068719|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068720|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2068721|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2068722|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068723|NCT01917214|Sunitinib|sunitinib|mesh-list
2068724|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068725|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2068726|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2068727|NCT01917214|Growth Substances|growth substances|mesh-ancestor
2068728|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068729|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
2068730|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2068731|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068732|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068739|NCT01917656|Metformin|metformin|mesh-list
2068740|NCT01917656|Liraglutide|liraglutide|mesh-list
2068741|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2068742|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068743|NCT01917656|Incretins|incretins|mesh-ancestor
2068744|NCT01917656|Hormones|hormones|mesh-ancestor
2068745|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2068746|NCT01917773|Octreotide|octreotide|mesh-list
2068747|NCT01917773|Bisacodyl|bisacodyl|mesh-list
2068748|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2068749|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2068750|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068751|NCT01917773|Cathartics|cathartics|mesh-ancestor
2068752|NCT01917773|Laxatives|laxatives|mesh-ancestor
2068753|NCT01918033|Desloratadine|desloratadine|mesh-list
2068754|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2068755|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
2068756|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068757|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068758|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068759|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2068760|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2068761|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
2068762|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
2068763|NCT01918306|Cisplatin|cisplatin|mesh-list
2068764|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068765|NCT01918332|Valsartan|valsartan|mesh-list
2068766|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2068767|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2068768|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2068769|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
2068770|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068771|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2068772|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2068773|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068774|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2068775|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2068776|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2068777|NCT01918371|Bevacizumab|bevacizumab|mesh-list
2068778|NCT01918371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2068779|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068780|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2068781|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2068782|NCT01918371|Growth Substances|growth substances|mesh-ancestor
2068783|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068784|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
2068785|NCT01918761|Pemetrexed|pemetrexed|mesh-list
2068786|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749530|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2749531|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2749534|NCT04599634|Venetoclax|venetoclax|mesh-list
2211466|NCT00018356|Androgens|androgens|mesh-ancestor
2211467|NCT00018356|Hormones|hormones|mesh-ancestor
2211468|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2211469|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211470|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
2211471|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2211472|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211473|NCT00018447|Fluorides|fluorides|mesh-list
2211474|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
2068787|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068788|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068789|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2749535|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
2068790|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2068791|NCT01919164|Mitogens|mitogens|mesh-list
2068792|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
2068793|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068794|NCT01919190|Bupivacaine|bupivacaine|mesh-list
2068795|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
2068796|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
2068797|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2068798|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068799|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
2068800|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068801|NCT01919216|Citalopram|citalopram|mesh-list
2068802|NCT01919216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2068803|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2068804|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2068805|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068806|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068807|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
2068808|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068809|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2068810|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
2068811|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2068812|NCT01919229|Letrozole|letrozole|mesh-list
2068813|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068814|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2068815|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2068816|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211475|NCT00018447|Protective Agents|protective agents|mesh-ancestor
2211476|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211477|NCT00018460|Vitamins|vitamins|mesh-list
2211478|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
2211479|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
2211480|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068817|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068818|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2068819|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
2068820|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2068821|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068822|NCT01919411|Amoxicillin|amoxicillin|mesh-list
2068823|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
2068824|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
2068825|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2068826|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2068827|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2068828|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2068829|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068830|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068831|NCT01919450|Regadenoson|regadenoson|mesh-list
2068832|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2068833|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2068834|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
2068835|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
2068836|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068837|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068838|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068839|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
2068840|NCT01919489|Liraglutide|liraglutide|mesh-list
2068841|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2068842|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068843|NCT01919489|Incretins|incretins|mesh-ancestor
2068844|NCT01919489|Hormones|hormones|mesh-ancestor
2068845|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2068846|NCT01919606|Bupivacaine|bupivacaine|mesh-list
2068847|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
2068848|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
2068849|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2211481|NCT00018551|Folic Acid|folic acid|mesh-list
2211482|NCT00018551|Hematinics|hematinics|mesh-ancestor
2211483|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
2211484|NCT00018551|Vitamins|vitamins|mesh-ancestor
2211485|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
2211486|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068850|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068851|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
2068852|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068853|NCT01919697|Plecanatide|plecanatide|mesh-list
2068854|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2068855|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
2068856|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068857|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2068858|NCT01919723|Ticagrelor|ticagrelor|mesh-list
2211487|NCT00018603|Guanfacine|guanfacine|mesh-list
2211488|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2068859|NCT01919723|Eptifibatide|eptifibatide|mesh-list
2068860|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2068861|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2068862|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2068863|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2068864|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
2068865|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068866|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068867|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068868|NCT01919801|Icatibant|icatibant|mesh-list
2068869|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2068870|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2068871|NCT01919801|Analgesics|analgesics|mesh-ancestor
2068872|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
2068873|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068874|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068875|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2068876|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2068877|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
2068878|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
2068879|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068880|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2068881|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2068882|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
2068883|NCT01919996|Azithromycin|azithromycin|mesh-list
2068884|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2068885|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2068886|NCT01920061|Docetaxel|docetaxel|mesh-list
2068887|NCT01920061|Gedatolisib|gedatolisib|mesh-list
2068888|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068889|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
2068890|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
2068891|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
2068892|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068893|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2068894|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2068895|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
2068896|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2068897|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
2068898|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068899|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
2068900|NCT01920152|Protective Agents|protective agents|mesh-ancestor
2068901|NCT01920282|Nebivolol|nebivolol|mesh-list
2068902|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2068903|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
2068904|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2068905|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2068906|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2068907|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
2068908|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068909|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068910|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068911|NCT01920477|Ofatumumab|ofatumumab|mesh-list
2068912|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068913|NCT01920555|Midazolam|midazolam|mesh-list
2068914|NCT01920555|Ketamine|ketamine|mesh-list
2068915|NCT01920555|Analgesics|analgesics|mesh-ancestor
2068916|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
2068917|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068918|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068919|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2068920|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2068921|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
2068922|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
2068923|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2749536|NCT04599634|Magrolimab|magrolimab|mesh-list
2068924|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2068925|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2068926|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068927|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068928|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2068929|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2068930|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2068931|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2068932|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2068933|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
2068934|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
2068935|NCT01920568|Vitamin D|vitamin d|mesh-list
2068936|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
2068937|NCT01920568|Denosumab|denosumab|mesh-list
2068938|NCT01920568|Calcium|calcium|mesh-list
2068939|NCT01920568|Vitamins|vitamins|mesh-ancestor
2068940|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
2068941|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068942|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2068943|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2068944|NCT01920711|Valsartan|valsartan|mesh-list
2068945|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2068946|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2068947|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2068948|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2749537|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749538|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2211489|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2211490|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2211491|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2211492|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
2211493|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211494|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211495|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211496|NCT00018642|Haloperidol|haloperidol|mesh-list
2211497|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2211498|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
2211499|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
2211500|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2211501|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2211502|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2211503|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2211504|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211505|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
2211506|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
2211507|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211508|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2211509|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2211510|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
2211511|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211512|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211513|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2211514|NCT00018668|Olanzapine|olanzapine|mesh-list
2211515|NCT00018668|Risperidone|risperidone|mesh-list
2211516|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2211517|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2211518|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
2211519|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211520|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211521|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211522|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2211523|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2211524|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2211525|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2211526|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2211527|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
2211528|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
2211529|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
2211530|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211531|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2211532|NCT00018668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2211533|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2211534|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2211535|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
2068949|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068950|NCT01920802|Olanzapine|olanzapine|mesh-list
2068951|NCT01920802|Iloperidone|iloperidone|mesh-list
2068952|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
2068953|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
2068954|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2068955|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068956|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2068957|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2068958|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2068959|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2068960|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2068961|NCT01920802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2068962|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2068963|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2068964|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068965|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2068966|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
2068967|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
2068968|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2068969|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2068970|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
2068971|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2068972|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
2068973|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068974|NCT01921166|Leuprolide|leuprolide|mesh-list
2068975|NCT01921166|Clomiphene|clomiphene|mesh-list
2068976|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2068977|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
2068978|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2068979|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2068980|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2068981|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2068982|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2068983|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
2068984|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2068985|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2068986|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2068987|NCT01921205|Lacosamide|lacosamide|mesh-list
2211536|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2211537|NCT00018694|Cathartics|cathartics|mesh-ancestor
2211538|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2211539|NCT00018733|Paroxetine|paroxetine|mesh-list
2211540|NCT00018733|Desipramine|desipramine|mesh-list
2211541|NCT00018733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2211542|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2211543|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2211544|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2068988|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
2068989|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2068990|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2749557|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
2749558|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2749559|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749560|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2211545|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211546|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
2068991|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2068992|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749561|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069020|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2069021|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2069022|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2069023|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2069024|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069025|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
2069026|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069027|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069028|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2069029|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069030|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
2069031|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2069032|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
2069033|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2069034|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2069035|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069036|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2069037|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069038|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2069039|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2069040|NCT01921387|Cytarabine|cytarabine|mesh-list
2069041|NCT01921387|Etoposide|etoposide|mesh-list
2069042|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
2069043|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
2069044|NCT01921387|Melphalan|melphalan|mesh-list
2069045|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
2069046|NCT01921387|Carmustine|carmustine|mesh-list
2069047|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2069048|NCT01921387|Antibodies|antibodies|mesh-list
2069049|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2069050|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
2069051|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069052|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2069053|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069054|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2069055|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2069056|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069057|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069058|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2069059|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
2069060|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
2069061|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069062|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2069063|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2069064|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
2069065|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2069066|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
2069067|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
2211547|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211548|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2211549|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
2211550|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2211551|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2211552|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2211553|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211554|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2211555|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2211556|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
2211557|NCT00018759|Paroxetine|paroxetine|mesh-list
2211558|NCT00018759|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2211559|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2211560|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2069068|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
2069069|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
2069070|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
2069071|NCT01921751|Gemcitabine|gemcitabine|mesh-list
2069072|NCT01921751|Paclitaxel|paclitaxel|mesh-list
2069073|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2069074|NCT01921751|Capecitabine|capecitabine|mesh-list
2069075|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2211561|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211562|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211563|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
2211564|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211565|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2211566|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
2211567|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2211568|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2211569|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2211570|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211571|NCT00018824|Naltrexone|naltrexone|mesh-list
2211572|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2211573|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2211574|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211575|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
2069076|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069077|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
2069078|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
2069079|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
2069080|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069081|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2069082|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
2069083|NCT01921751|Antiviral Agents|antiviral agents|mesh-ancestor
2069084|NCT01921751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069085|NCT01921751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069086|NCT01921751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2069087|NCT01921751|Immunologic Factors|immunologic factors|mesh-ancestor
2069088|NCT01921751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069089|NCT01921829|Diuretics|diuretics|mesh-list
2069090|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
2069091|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069092|NCT01921894|Vitamin D|vitamin d|mesh-list
2069093|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
2069094|NCT01921894|Vitamins|vitamins|mesh-ancestor
2069095|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
2211576|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211577|NCT00018850|Haloperidol|haloperidol|mesh-list
2211578|NCT00018850|Ondansetron|ondansetron|mesh-list
2211579|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
2211580|NCT00018850|Nicotine|nicotine|mesh-list
2211581|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2211582|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
2211583|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211584|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211585|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2069096|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069097|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2069098|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2211586|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2749597|NCT04588818|Adalimumab|adalimumab|mesh-list
2749598|NCT04588818|Methotrexate|methotrexate|mesh-list
2749599|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2749600|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
2749601|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2749602|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749603|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2749604|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
2749605|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749606|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749607|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
2749608|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211587|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
2211588|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069099|NCT01922011|Vancomycin|vancomycin|mesh-list
2069100|NCT01922011|Daptomycin|daptomycin|mesh-list
2069101|NCT01922011|Nafcillin|nafcillin|mesh-list
2069102|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2069103|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069104|NCT01922037|Omalizumab|omalizumab|mesh-list
2069105|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2069106|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2069107|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
2069108|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2069109|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2069110|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069111|NCT01922102|Ranibizumab|ranibizumab|mesh-list
2069112|NCT01922102|Verteporfin|verteporfin|mesh-list
2069113|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2069114|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2069115|NCT01922102|Growth Substances|growth substances|mesh-ancestor
2069116|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069117|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
2069118|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069119|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2069120|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
2069121|NCT01922115|Trospium chloride|trospium chloride|mesh-list
2069122|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
2069123|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
2069124|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069125|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069126|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2211589|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211590|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
2211591|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2069127|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2069128|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
2069129|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069130|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069131|NCT01922115|Urological Agents|urological agents|mesh-ancestor
2069132|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
2069133|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
2069134|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069135|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069136|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069137|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
2069138|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
2069139|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
2069140|NCT01922271|Albuterol|albuterol|mesh-list
2069141|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
2211592|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
2211593|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
2211594|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2211595|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
2211596|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2211597|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2211598|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2211599|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2211600|NCT00018850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2211601|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2211602|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
2211603|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2211604|NCT00018863|Methylphenidate|methylphenidate|mesh-list
2211605|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2211606|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211607|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2069142|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2069143|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
2069144|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069145|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211608|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2211609|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2211610|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211611|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
2211612|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211613|NCT00018902|Fluoxetine|fluoxetine|mesh-list
2211614|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2211615|NCT00018902|Citalopram|citalopram|mesh-list
2211616|NCT00018902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2211617|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2211618|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2211619|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211620|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211621|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
2211622|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069146|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2069147|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
2069148|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
2069149|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2069150|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
2211623|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2211624|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
2211625|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2211626|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2211627|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2211628|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211629|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2211630|NCT00018941|Aldesleukin|aldesleukin|mesh-list
2211631|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211632|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211633|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211634|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
2749609|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2749610|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2749611|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
2749612|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2211635|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211636|NCT00018954|Cytarabine|cytarabine|mesh-list
2211637|NCT00018954|Prednisone|prednisone|mesh-list
2211638|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
2211639|NCT00018954|Ifosfamide|ifosfamide|mesh-list
2211640|NCT00018954|Doxorubicin|doxorubicin|mesh-list
2211641|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2211642|NCT00018954|Methotrexate|methotrexate|mesh-list
2069151|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069152|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069153|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
2069154|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2211643|NCT00018954|Etoposide|etoposide|mesh-list
2211644|NCT00018954|Vincristine|vincristine|mesh-list
2211645|NCT00018954|Daunorubicin|daunorubicin|mesh-list
2211646|NCT00018954|Asparaginase|asparaginase|mesh-list
2211647|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
2211648|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211649|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
2211650|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211651|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2069155|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2069156|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2069157|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2069158|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
2069159|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2069160|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2069161|NCT01922336|Infliximab|infliximab|mesh-list
2069162|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
2069163|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2069164|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2069165|NCT01922739|Hydrocodone|hydrocodone|mesh-list
2069166|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2069167|NCT01922739|Narcotics|narcotics|mesh-ancestor
2069168|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2069169|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069170|NCT01922739|Analgesics|analgesics|mesh-ancestor
2069171|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
2069172|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069173|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
2069174|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
2069175|NCT01922934|Topiramate|topiramate|mesh-list
2069176|NCT01922934|Phentermine|phentermine|mesh-list
2069177|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
2069178|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2069179|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069180|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2069181|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
2069182|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2069183|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
2069184|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
2069185|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069186|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
2069187|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211652|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2211653|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
2211654|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211655|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211656|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2211657|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2211658|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2211659|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2211660|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211661|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2211662|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
2069188|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069189|NCT01923129|Prazosin|prazosin|mesh-list
2069190|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2069191|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2069192|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2069193|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2069194|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
2211663|NCT00018954|Hormones|hormones|mesh-ancestor
2211664|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2211665|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2211666|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2211667|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
2211668|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2749613|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2749614|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2211669|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2211670|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
2211671|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
2069195|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211672|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2211673|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2211674|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2211675|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
2211676|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211677|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
2211678|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
2211679|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
2211680|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
2211681|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2211682|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
2211683|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211684|NCT00019019|Paclitaxel|paclitaxel|mesh-list
2069196|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069197|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069198|NCT01923311|Elvitegravir|elvitegravir|mesh-list
2211685|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
2211686|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2211687|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069199|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2069200|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2069201|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
2069202|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069203|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2069204|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069205|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069206|NCT01923363|Tazobactam|tazobactam|mesh-list
2069207|NCT01923363|Piperacillin|piperacillin|mesh-list
2069208|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2069209|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2069210|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069211|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2069212|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211688|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
2211689|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
2211690|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
2211691|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211692|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2211693|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2211694|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2211695|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211696|NCT00019032|Antibodies|antibodies|mesh-list
2211697|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2211698|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
2211699|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211700|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
2211701|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
2211702|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211703|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
2211704|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211705|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211706|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2211707|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2211708|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2211709|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2211710|NCT00019058|Protective Agents|protective agents|mesh-ancestor
2211711|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211712|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
2211713|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2211714|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
2211715|NCT00019071|Cladribine|cladribine|mesh-list
2211716|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211717|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211718|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
2211719|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211720|NCT00019084|Aldesleukin|aldesleukin|mesh-list
2211721|NCT00019084|Vaccines|vaccines|mesh-list
2211722|NCT00019084|Sargramostim|sargramostim|mesh-list
2211723|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
2211724|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211725|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211726|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211727|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211728|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
2069213|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069214|NCT01923467|Nicotine|nicotine|mesh-list
2069215|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2069216|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
2069217|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069218|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069219|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2069220|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2069221|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
2069222|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069223|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069224|NCT01923896|Cycloserine|cycloserine|mesh-list
2069225|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2069226|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069227|NCT01923896|Renal Agents|renal agents|mesh-ancestor
2069228|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2069229|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
2069230|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2069231|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
2069232|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069233|NCT01924169|Lenalidomide|lenalidomide|mesh-list
2069234|NCT01924169|Vaccines|vaccines|mesh-list
2069235|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
2069236|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069237|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2069238|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2069239|NCT01924169|Growth Substances|growth substances|mesh-ancestor
2069240|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
2069241|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069242|NCT01924182|Morphine|morphine|mesh-list
2069243|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2069244|NCT01924182|Narcotics|narcotics|mesh-ancestor
2069245|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2069246|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069247|NCT01924182|Analgesics|analgesics|mesh-ancestor
2069248|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
2069249|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069250|NCT01924299|Fluconazole|fluconazole|mesh-list
2069251|NCT01924299|Ketoconazole|ketoconazole|mesh-list
2069252|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
2069253|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069254|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2069255|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2069256|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069257|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069258|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2069259|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
2069260|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2069261|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069262|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2069263|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2069264|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2069265|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2069266|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2069267|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069268|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2069269|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2069270|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2069271|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069272|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
2069273|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069274|NCT01924533|Paclitaxel|paclitaxel|mesh-list
2069275|NCT01924533|Olaparib|olaparib|mesh-list
2069276|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2069277|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069278|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
2069279|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
2069280|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
2069281|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069282|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2069283|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069284|NCT01924767|Empagliflozin|empagliflozin|mesh-list
2069285|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2069286|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069287|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2069288|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069289|NCT01924871|Remifentanil|remifentanil|mesh-list
2069290|NCT01924871|Desflurane|desflurane|mesh-list
2069291|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2069292|NCT01924871|Narcotics|narcotics|mesh-ancestor
2069293|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2069294|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069295|NCT01924871|Analgesics|analgesics|mesh-ancestor
2069296|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
2069297|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069298|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2069299|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
2069300|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
2069301|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
2069302|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2069303|NCT01924949|Ledipasvir|ledipasvir|mesh-list
2069304|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
2069305|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069306|NCT01925144|Omeprazole|omeprazole|mesh-list
2069307|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2069308|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2069309|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2069310|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069311|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069312|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2069313|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2069314|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069315|NCT01925183|Interferons|interferons|mesh-list
2069316|NCT01925183|Ribavirin|ribavirin|mesh-list
2069317|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
2069318|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
2069319|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2069320|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069321|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
2069322|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211729|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211730|NCT00019097|Melphalan|melphalan|mesh-list
2211731|NCT00019097|Sargramostim|sargramostim|mesh-list
2069323|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
2069324|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069325|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
2069326|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069327|NCT01925274|Irinotecan|irinotecan|mesh-list
2069328|NCT01925274|Cetuximab|cetuximab|mesh-list
2069329|NCT01925274|Gedatolisib|gedatolisib|mesh-list
2069330|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2069331|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2069332|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069333|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069334|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069335|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2069336|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2069337|NCT01925469|Benzocaine|benzocaine|mesh-list
2069338|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
2069339|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
2069340|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2069341|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069342|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
2069343|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069344|NCT01925612|Prednisone|prednisone|mesh-list
2069345|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
2069346|NCT01925612|Rituximab|rituximab|mesh-list
2069347|NCT01925612|Doxorubicin|doxorubicin|mesh-list
2069348|NCT01925612|Vincristine|vincristine|mesh-list
2069349|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2069350|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2069351|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2069352|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
2069353|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069354|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2069355|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2069356|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
2069357|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069358|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069359|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2211732|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2211733|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2211734|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
2069360|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2069361|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2069362|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2069363|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2069364|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069365|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2069366|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
2069367|NCT01925612|Hormones|hormones|mesh-ancestor
2069368|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2069369|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2069370|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2069371|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
2069372|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
2069373|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
2069374|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
2069375|NCT01925703|Hematinics|hematinics|mesh-ancestor
2069376|NCT01925768|Apremilast|apremilast|mesh-list
2069377|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2069378|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2069379|NCT01925768|Analgesics|analgesics|mesh-ancestor
2069380|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
2069381|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069382|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069383|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2211735|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211736|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211737|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2211738|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211739|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
2069384|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2069385|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2069386|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2069387|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069388|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069389|NCT01925781|Nicotine|nicotine|mesh-list
2069390|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2069391|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
2069392|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069393|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069394|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2069395|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2069396|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
2069397|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069398|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069399|NCT01925950|Beclomethasone|beclomethasone|mesh-list
2069400|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2069401|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
2069402|NCT01925950|Hormones|hormones|mesh-ancestor
2069403|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2069404|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069405|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2069406|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
2069407|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
2069408|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2069409|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069410|NCT01926444|Trimebutine|trimebutine|mesh-list
2069411|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2069412|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
2069413|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
2069414|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069415|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069416|NCT01926496|Imiquimod|imiquimod|mesh-list
2069417|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2069418|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
2069419|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069420|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069421|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
2069422|NCT01926626|Moclobemide|moclobemide|mesh-list
2069423|NCT01926626|Nicotine|nicotine|mesh-list
2069424|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2069425|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
2069426|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069427|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069428|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2069429|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2069430|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
2069431|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069432|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069433|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
2069434|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2211740|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211741|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2211742|NCT00019123|Thalidomide|thalidomide|mesh-list
2069435|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2069436|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069437|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2069438|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
2069439|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069440|NCT01926886|Trastuzumab|trastuzumab|mesh-list
2069441|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2069442|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069443|NCT01926977|Ranibizumab|ranibizumab|mesh-list
2069444|NCT01926977|Aflibercept|aflibercept|mesh-list
2069445|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2069446|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2069447|NCT01926977|Growth Substances|growth substances|mesh-ancestor
2069448|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069449|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
2069450|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069451|NCT01927055|Mannitol|mannitol|mesh-list
2069452|NCT01927055|Droxidopa|droxidopa|mesh-list
2069453|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2069454|NCT01927055|Diuretics|diuretics|mesh-ancestor
2069455|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
2069456|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069457|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2069458|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2069459|NCT01927120|Sirolimus|sirolimus|mesh-list
2069460|NCT01927120|Aldesleukin|aldesleukin|mesh-list
2069461|NCT01927120|Tacrolimus|tacrolimus|mesh-list
2069462|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2069463|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
2069464|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069465|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2211743|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211744|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
2069466|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069467|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069468|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2069469|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069470|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2069471|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069472|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
2069473|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2069474|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2069475|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
2069476|NCT01927341|Panitumumab|panitumumab|mesh-list
2069477|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2069478|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069485|NCT01927718|Thalidomide|thalidomide|mesh-list
2069486|NCT01927718|Lenalidomide|lenalidomide|mesh-list
2069487|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
2069488|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069489|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2069490|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2069491|NCT01927718|Growth Substances|growth substances|mesh-ancestor
2069492|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
2069493|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069494|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2069495|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
2069496|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2211745|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211746|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
2211747|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2211748|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211749|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2211750|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2211751|NCT00019123|Growth Substances|growth substances|mesh-ancestor
2211752|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
2211753|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211754|NCT00019136|Aldesleukin|aldesleukin|mesh-list
2211755|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211756|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2069497|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069498|NCT01927757|Etanercept|etanercept|mesh-list
2069499|NCT01927757|Methotrexate|methotrexate|mesh-list
2069500|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2069501|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
2069502|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2069503|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069504|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2069505|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
2069506|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069507|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069508|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
2069509|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069510|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2069511|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2069512|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
2069513|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2069514|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2069515|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2069516|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2069517|NCT01927757|Analgesics|analgesics|mesh-ancestor
2069518|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
2069519|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069520|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2069521|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2069522|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2069523|NCT01927887|Hematinics|hematinics|mesh-ancestor
2069524|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2069525|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2069526|NCT01928186|Alovudine|alovudine|mesh-list
2069527|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
2069528|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069529|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2069530|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2211757|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211758|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
2211759|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211760|NCT00019175|Aldesleukin|aldesleukin|mesh-list
2211761|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211762|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211763|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211764|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
2211765|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211766|NCT00019188|Interleukin-12|interleukin-12|mesh-list
2069531|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069532|NCT01928199|Incretins|incretins|mesh-ancestor
2069533|NCT01928199|Hormones|hormones|mesh-ancestor
2069534|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2069535|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2069536|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
2069537|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069538|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069539|NCT01928225|Vaccines|vaccines|mesh-list
2069540|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
2069541|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069542|NCT01928290|Leucovorin|leucovorin|mesh-list
2211767|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2211768|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
2211769|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211770|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2211771|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2211772|NCT00019188|Growth Substances|growth substances|mesh-ancestor
2211773|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
2211774|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211775|NCT00019214|Aldesleukin|aldesleukin|mesh-list
2211776|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211777|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211778|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211779|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
2211780|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211781|NCT00019227|Calcium|calcium|mesh-list
2211782|NCT00019227|Daclizumab|daclizumab|mesh-list
2211783|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
2211784|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2211785|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069543|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
2069544|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
2069545|NCT01928290|Fluorouracil|fluorouracil|mesh-list
2069546|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
2069547|NCT01928290|Irinotecan|irinotecan|mesh-list
2069548|NCT01928290|Trastuzumab|trastuzumab|mesh-list
2069549|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
2069550|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
2069551|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211786|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211787|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
2211788|NCT00019227|Antidotes|antidotes|mesh-ancestor
2211789|NCT00019227|Protective Agents|protective agents|mesh-ancestor
2069552|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2069553|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069554|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2069555|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
2069556|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069557|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2069558|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2069559|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069560|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2069561|NCT01928290|Antidotes|antidotes|mesh-ancestor
2069562|NCT01928290|Protective Agents|protective agents|mesh-ancestor
2069563|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
2069564|NCT01928290|Vitamins|vitamins|mesh-ancestor
2069565|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
2069566|NCT01928329|Exenatide|exenatide|mesh-list
2069567|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2069568|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069569|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2069570|NCT01928329|Incretins|incretins|mesh-ancestor
2069571|NCT01928329|Hormones|hormones|mesh-ancestor
2069572|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2069573|NCT01928381|Pregabalin|pregabalin|mesh-list
2069574|NCT01928381|Analgesics|analgesics|mesh-ancestor
2069575|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
2069576|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069577|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069578|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
2069579|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2069580|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2069581|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069582|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2069583|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2069584|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2069585|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2069586|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2069587|NCT01928394|Nivolumab|nivolumab|mesh-list
2069588|NCT01928394|Ipilimumab|ipilimumab|mesh-list
2069589|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2069590|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069591|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2069592|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069593|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
2069594|NCT01928433|Finafloxacin|finafloxacin|mesh-list
2069595|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
2069596|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2069597|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069598|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2069599|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2069600|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211790|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
2211791|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
2211792|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211793|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2211794|NCT00019240|Cidofovir|cidofovir|mesh-list
2211795|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
2211796|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211797|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211798|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211799|NCT00019318|Romidepsin|romidepsin|mesh-list
2069601|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069602|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069603|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2069604|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2069605|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2069606|NCT01928433|Renal Agents|renal agents|mesh-ancestor
2069607|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2069608|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
2069609|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
2069610|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2069611|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069612|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069613|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
2069614|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2069615|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2749644|NCT04579510|Vaccines|vaccines|mesh-list
2749645|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
2069616|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069617|NCT01928680|Capecitabine|capecitabine|mesh-list
2069618|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069619|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2069620|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
2069621|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069622|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
2211800|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2211801|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211802|NCT00019331|Aldesleukin|aldesleukin|mesh-list
2211803|NCT00019331|Sargramostim|sargramostim|mesh-list
2211804|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
2211805|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211806|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211807|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211808|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211809|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
2211810|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211811|NCT00019344|Alvocidib|alvocidib|mesh-list
2211812|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211813|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
2069623|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
2069624|NCT01928693|Besifloxacin|besifloxacin|mesh-list
2069625|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2211814|NCT00019344|Growth Substances|growth substances|mesh-ancestor
2069626|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2069627|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2069628|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2069629|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069630|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2069631|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2069632|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211815|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749646|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211816|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2211817|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211818|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211819|NCT00019357|Aldesleukin|aldesleukin|mesh-list
2211820|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211821|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211822|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211823|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
2211824|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211825|NCT00019383|Aldesleukin|aldesleukin|mesh-list
2211826|NCT00019383|Sargramostim|sargramostim|mesh-list
2211827|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
2211828|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
2211829|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211830|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211831|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211832|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211833|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
2211834|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211835|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2211836|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
2069633|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069634|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069635|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2069636|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
2069637|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2069638|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069639|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2069640|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2069641|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2069642|NCT01928719|Nicotine|nicotine|mesh-list
2069643|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2069644|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
2069645|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069646|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069647|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2069648|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2069649|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
2069650|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069651|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069652|NCT01928758|Nicotine|nicotine|mesh-list
2069653|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2069654|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
2069655|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069656|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069657|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2069658|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2069659|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
2069660|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069661|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069662|NCT01928771|Benralizumab|benralizumab|mesh-list
2069663|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2069664|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
2069665|NCT01928849|Valproic Acid|valproic acid|mesh-list
2069666|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
2069667|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069668|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069669|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
2069670|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069671|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069672|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
2069673|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2069674|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2069675|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2069676|NCT01928927|Telmisartan|telmisartan|mesh-list
2069677|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2069678|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2069679|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2069680|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069681|NCT01928940|Trametinib|trametinib|mesh-list
2069682|NCT01928940|Dabrafenib|dabrafenib|mesh-list
2069683|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069684|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2069685|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069686|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069687|NCT01929031|Ibuprofen|ibuprofen|mesh-list
2069688|NCT01929031|Caffeine|caffeine|mesh-list
2069689|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2069690|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2069691|NCT01929031|Analgesics|analgesics|mesh-ancestor
2211837|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2211838|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
2211839|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211840|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2211841|NCT00019396|Protective Agents|protective agents|mesh-ancestor
2211842|NCT00019409|Cytarabine|cytarabine|mesh-list
2211843|NCT00019409|Prednisone|prednisone|mesh-list
2211844|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
2211845|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2069692|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
2069693|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069694|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069695|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2069696|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2069697|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2069698|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069699|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211846|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2211847|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2211848|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
2211849|NCT00019409|Methotrexate|methotrexate|mesh-list
2211850|NCT00019409|Vincristine|vincristine|mesh-list
2211851|NCT00019409|Daunorubicin|daunorubicin|mesh-list
2211852|NCT00019409|Asparaginase|asparaginase|mesh-list
2211853|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
2211854|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211855|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
2211856|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211857|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2211858|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2211859|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
2211860|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211861|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211862|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2211863|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2211864|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
2211865|NCT00019409|Hormones|hormones|mesh-ancestor
2211866|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2211867|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2211868|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2069700|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2069701|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2069702|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2069703|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2069704|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
2069705|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069706|NCT01929044|Anisodamine|anisodamine|mesh-list
2069707|NCT01929044|Scopolamine|scopolamine|mesh-list
2069708|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2069709|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2069710|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
2069711|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
2069712|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069713|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069714|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2069715|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
2069716|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2069717|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
2069718|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069719|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211869|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
2211870|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2069720|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2069721|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
2069722|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2069723|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2069724|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
2069725|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2069726|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2069727|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2069728|NCT01929044|Analgesics|analgesics|mesh-ancestor
2069729|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
2069730|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2069731|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2069732|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2069733|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
2069734|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2069735|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
2069736|NCT01929044|Protective Agents|protective agents|mesh-ancestor
2069737|NCT01929083|Ibutilide|ibutilide|mesh-list
2069738|NCT01929083|Progesterone|progesterone|mesh-list
2069739|NCT01929083|Progestins|progestins|mesh-ancestor
2069740|NCT01929083|Hormones|hormones|mesh-ancestor
2069741|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2069742|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069743|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2069744|NCT01929135|Atorvastatin|atorvastatin|mesh-list
2069745|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2069746|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2069747|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
2069748|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069749|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2069750|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2069751|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069752|NCT01929291|Vaccines|vaccines|mesh-list
2069753|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
2069754|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069755|NCT01929317|Ropinirole|ropinirole|mesh-list
2069756|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2069757|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2069758|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
2069759|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
2069760|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069761|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069762|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069763|NCT01929343|Lidocaine|lidocaine|mesh-list
2069764|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
2069765|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
2069766|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2069767|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069768|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
2069769|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069770|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2069771|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2069772|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2211871|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2211872|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
2211873|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
2211874|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211875|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2211876|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2211877|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
2211878|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211879|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2211880|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
2069773|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2069774|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069775|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
2069776|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2069777|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069778|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2069779|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2069780|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069781|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069782|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069783|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2069784|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2069785|NCT01929642|Sirolimus|sirolimus|mesh-list
2069786|NCT01929642|Everolimus|everolimus|mesh-list
2069787|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069788|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2069789|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
2069790|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069791|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2069792|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069793|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2069794|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
2069795|NCT01929759|Tenofovir|tenofovir|mesh-list
2069796|NCT01929759|Emtricitabine|emtricitabine|mesh-list
2069797|NCT01929759|Cobicistat|cobicistat|mesh-list
2069798|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2069799|NCT01929759|Elvitegravir|elvitegravir|mesh-list
2069800|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
2069801|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211881|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
2211882|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
2211883|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2211884|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2211885|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2211886|NCT00019422|Carboplatin|carboplatin|mesh-list
2211887|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211888|NCT00019435|Immunotoxins|immunotoxins|mesh-list
2211889|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
2211890|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211891|NCT00019448|Interleukin-2|interleukin-2|mesh-list
2211892|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211893|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2211894|NCT00019448|Analgesics|analgesics|mesh-ancestor
2211895|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
2211896|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211897|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069802|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2069803|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2069804|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069805|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069806|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2069807|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2069808|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2069809|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2069810|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2069811|NCT01929863|Metformin|metformin|mesh-list
2069812|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2069813|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069814|NCT01929876|Itraconazole|itraconazole|mesh-list
2069815|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
2069816|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069817|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2069818|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2069819|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069820|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069821|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2069822|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
2069823|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2069824|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069825|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2069826|NCT01929889|Iloperidone|iloperidone|mesh-list
2069827|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2069828|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2069829|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2069830|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069831|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2069832|NCT01929980|Bortezomib|bortezomib|mesh-list
2069833|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069834|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
2069835|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
2069836|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2069837|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2069838|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
2069839|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069840|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2069841|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2069842|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069843|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069844|NCT01930045|Antacids|antacids|mesh-ancestor
2069845|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2069846|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2069847|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2069848|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069849|NCT01930188|Incretins|incretins|mesh-ancestor
2069850|NCT01930188|Hormones|hormones|mesh-ancestor
2069851|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2069852|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2069853|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
2069854|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069855|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069856|NCT01930487|Antioxidants|antioxidants|mesh-list
2069857|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069858|NCT01930487|Protective Agents|protective agents|mesh-ancestor
2069859|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069860|NCT01930747|Remifentanil|remifentanil|mesh-list
2069861|NCT01930747|Sevoflurane|sevoflurane|mesh-list
2069862|NCT01930747|Rocuronium|rocuronium|mesh-list
2069863|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2211898|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
2211899|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211900|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2211901|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2211902|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211903|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2211904|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211905|NCT00019474|Interferons|interferons|mesh-list
2211906|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
2211907|NCT00019474|Fluorouracil|fluorouracil|mesh-list
2211908|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
2211909|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
2211910|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211911|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2211912|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211913|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211914|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
2211915|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211916|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
2211917|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211918|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
2211919|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211920|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2211921|NCT00019487|Aldesleukin|aldesleukin|mesh-list
2211922|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
2211923|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211924|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211925|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211926|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
2211927|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211928|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2211929|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
2211930|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211931|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2211932|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2211933|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
2211934|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2069864|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2069865|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
2069866|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
2069867|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2069868|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069869|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2069870|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2069871|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2069872|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069873|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2069874|NCT01930747|Narcotics|narcotics|mesh-ancestor
2749676|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
2069875|NCT01930747|Analgesics|analgesics|mesh-ancestor
2069876|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
2069877|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
2211935|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211936|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2211937|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2211938|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2211939|NCT00019513|Leucovorin|leucovorin|mesh-list
2211940|NCT00019513|Gemcitabine|gemcitabine|mesh-list
2069878|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2069879|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069880|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2069881|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
2069882|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2069883|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069884|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069885|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069886|NCT01931059|Risperidone|risperidone|mesh-list
2069887|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2069888|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
2069889|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069890|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069891|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069892|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2069893|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2069894|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2069895|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2069896|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2069897|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
2749677|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2749678|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749679|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
2749680|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2749681|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2749682|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
2069904|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2069905|NCT01931150|Dapsone|dapsone|mesh-list
2069906|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069907|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
2069908|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2069909|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2069910|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2069911|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2069912|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069913|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
2069914|NCT01931163|Everolimus|everolimus|mesh-list
2069915|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069916|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2069917|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
2069918|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069919|NCT01931202|Citalopram|citalopram|mesh-list
2069920|NCT01931202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2069921|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2069922|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2211941|NCT00019513|Fluorouracil|fluorouracil|mesh-list
2211942|NCT00019513|Calcium|calcium|mesh-list
2211943|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
2211944|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2211945|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
2211946|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211947|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211948|NCT00019513|Antiviral Agents|antiviral agents|mesh-ancestor
2211949|NCT00019513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211950|NCT00019513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2211951|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211952|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
2211953|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211954|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2211955|NCT00019513|Antidotes|antidotes|mesh-ancestor
2211956|NCT00019513|Protective Agents|protective agents|mesh-ancestor
2211957|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
2211958|NCT00019513|Vitamins|vitamins|mesh-ancestor
2211959|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
2211960|NCT00019539|Thalidomide|thalidomide|mesh-list
2211961|NCT00019539|Bevacizumab|bevacizumab|mesh-list
2211962|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2211963|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211964|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2211965|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2211966|NCT00019539|Growth Substances|growth substances|mesh-ancestor
2211967|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211968|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
2211969|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2211970|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
2069923|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069924|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069925|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
2069926|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069927|NCT01931202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2069928|NCT01931202|Antidepressive Agents|antidepressive agents|mesh-ancestor
2069929|NCT01931202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2069930|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2069931|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2069932|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2069933|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2069934|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069935|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069936|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069937|NCT01931475|Analgesics|analgesics|mesh-ancestor
2069938|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
2069939|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2211971|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
2211972|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2211973|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2069940|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
2069941|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2069942|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
2069943|NCT01931527|Rasburicase|rasburicase|mesh-list
2069944|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
2069945|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2069946|NCT01931566|Pioglitazone|pioglitazone|mesh-list
2069947|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2069948|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069949|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2069950|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2069951|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069952|NCT01931839|Ivacaftor|ivacaftor|mesh-list
2069953|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2069954|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2069955|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069956|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2069957|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2069958|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069959|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069960|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2069961|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2069962|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069963|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
2069964|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069965|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2069966|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2069967|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069968|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069969|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2069970|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2069971|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069972|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
2069973|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069974|NCT01932060|Oxytocin|oxytocin|mesh-list
2069975|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
2069976|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2069977|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069978|NCT01932112|Adenosine|adenosine|mesh-list
2069979|NCT01932112|Analgesics|analgesics|mesh-ancestor
2069980|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
2069981|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2069982|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2069983|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2069984|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
2069985|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2069986|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
2069987|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
2069988|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2069989|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069990|NCT01932697|Docetaxel|docetaxel|mesh-list
2069991|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2069992|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
2069993|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
2069994|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
2069995|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2069996|NCT01932762|Ribavirin|ribavirin|mesh-list
2069997|NCT01932762|Grazoprevir|grazoprevir|mesh-list
2069998|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
2069999|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070000|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
2070001|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070002|NCT01932788|Vitamin D|vitamin d|mesh-list
2070003|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
2070004|NCT01932788|Vitamins|vitamins|mesh-list
2070005|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
2070006|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070007|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2070008|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2070009|NCT01932996|Nicotine|nicotine|mesh-list
2070010|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2070011|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
2070012|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070013|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070014|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2070015|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2070016|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
2070017|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211974|NCT00019552|Irofulven|irofulven|mesh-list
2211975|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2070018|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070019|NCT01933048|Vaccines|vaccines|mesh-list
2070020|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
2070021|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070022|NCT01933217|Methylphenidate|methylphenidate|mesh-list
2070023|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2070024|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070025|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2070026|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2070027|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2070028|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070029|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
2070030|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070031|NCT01933334|Pirfenidone|pirfenidone|mesh-list
2070032|NCT01933334|Analgesics|analgesics|mesh-ancestor
2070033|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
2070034|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070035|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070036|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2070037|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2070038|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2070039|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2070040|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070041|NCT01933425|Rocuronium|rocuronium|mesh-list
2070042|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2070043|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2070044|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2070045|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070046|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070047|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
2070048|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
2070049|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
2070050|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070051|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2070052|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2070053|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
2070054|NCT01933594|Romidepsin|romidepsin|mesh-list
2070055|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2070056|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070057|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2070058|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2070059|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070060|NCT01933672|Incretins|incretins|mesh-ancestor
2070061|NCT01933672|Hormones|hormones|mesh-ancestor
2070062|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2070063|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2211976|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
2211977|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070064|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
2070065|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070066|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070067|NCT01933776|Vaccines|vaccines|mesh-list
2070068|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
2070069|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070070|NCT01933880|Methylphenidate|methylphenidate|mesh-list
2070071|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2070072|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070073|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2070074|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2211978|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211979|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2211980|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2070075|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2070076|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070077|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
2070078|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070079|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
2070080|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070081|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070082|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2070083|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2070084|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2070085|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070086|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2070087|NCT01933919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2070088|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2070089|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2070090|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070091|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
2070092|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2070093|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
2070094|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2070095|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2070096|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2070103|NCT01933984|Fluticasone|fluticasone|mesh-list
2070104|NCT01933984|Fenoterol|fenoterol|mesh-list
2070105|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2070106|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
2070107|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2070108|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
2070109|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070110|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070111|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2070112|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
2070113|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
2070114|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2070115|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2070116|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2070117|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2070118|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
2070119|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070120|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070121|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
2070122|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
2070123|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2070124|NCT01934192|Metoclopramide|metoclopramide|mesh-list
2070125|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
2070126|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
2070127|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070128|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070129|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2070130|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2070131|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2070132|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
2070133|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070134|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070135|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
2070136|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2070137|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
2070138|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070139|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
2070140|NCT01934218|Protective Agents|protective agents|mesh-ancestor
2070141|NCT01934231|Amoxicillin|amoxicillin|mesh-list
2070142|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
2070143|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
2070144|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2070145|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2070146|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070147|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2070148|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070149|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070150|NCT01934556|Ranibizumab|ranibizumab|mesh-list
2070151|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2070152|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2070153|NCT01934556|Growth Substances|growth substances|mesh-ancestor
2070154|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070155|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
2070156|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070157|NCT01934582|Treprostinil|treprostinil|mesh-list
2070158|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2070159|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2070160|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070161|NCT01934894|Lapatinib|lapatinib|mesh-list
2070162|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070163|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2070164|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070165|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070166|NCT01934972|Cycloserine|cycloserine|mesh-list
2070167|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2070168|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070169|NCT01934972|Renal Agents|renal agents|mesh-ancestor
2070170|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2070171|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
2070172|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2070173|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
2070174|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070175|NCT01935622|Doxycycline|doxycycline|mesh-list
2070176|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2070177|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070178|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
2070179|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2070180|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2070181|NCT01935700|Colchicine|colchicine|mesh-list
2070182|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
2070183|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2070184|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
2070185|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
2070186|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
2070187|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070188|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070189|NCT01935791|Glucagon|glucagon|mesh-list
2070190|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2070191|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2070192|NCT01935791|Hormones|hormones|mesh-ancestor
2079443|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070193|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2070194|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070195|NCT01935791|Incretins|incretins|mesh-ancestor
2070196|NCT01936181|Infliximab|infliximab|mesh-list
2070197|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
2070198|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2070199|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2070200|NCT01936363|Niacinamide|niacinamide|mesh-list
2070201|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
2070202|NCT01936363|Vitamins|vitamins|mesh-ancestor
2070203|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
2070204|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070205|NCT01936519|Cyclosporine|cyclosporine|mesh-list
2070206|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
2070207|NCT01936519|Everolimus|everolimus|mesh-list
2070208|NCT01936519|Tacrolimus|tacrolimus|mesh-list
2070209|NCT01936519|Cyclosporins|cyclosporins|mesh-list
2070210|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2070211|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2070212|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
2070213|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070214|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070215|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070216|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
2070217|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070218|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
2070219|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2070220|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070221|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2070222|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2070223|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
2070224|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2070225|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2070226|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070227|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070228|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070229|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2070230|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2070231|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2070232|NCT01936857|Buprenorphine|buprenorphine|mesh-list
2070233|NCT01936857|Methadone|methadone|mesh-list
2070234|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2070235|NCT01936857|Naloxone|naloxone|mesh-list
2070236|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2070237|NCT01936857|Narcotics|narcotics|mesh-ancestor
2070238|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2070239|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2211981|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211982|NCT00019591|Aldesleukin|aldesleukin|mesh-list
2211983|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211984|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211985|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2211986|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
2211987|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2211988|NCT00019630|Doxorubicin|doxorubicin|mesh-list
2211989|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2211990|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2211991|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211992|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2070240|NCT01936857|Analgesics|analgesics|mesh-ancestor
2070241|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
2070242|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070243|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2070244|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
2070245|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
2070246|NCT01936870|Fesoterodine|fesoterodine|mesh-list
2070247|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2070248|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2070249|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
2070250|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2211993|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2070251|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070252|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070253|NCT01936870|Urological Agents|urological agents|mesh-ancestor
2070254|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2070255|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
2070256|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2070257|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2070258|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
2070259|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070260|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070261|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2070262|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2070263|NCT01937026|Probenecid|probenecid|mesh-list
2070264|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
2070265|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
2070266|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2070267|NCT01937026|Renal Agents|renal agents|mesh-ancestor
2070268|NCT01937117|Trastuzumab|trastuzumab|mesh-list
2070269|NCT01937117|Pertuzumab|pertuzumab|mesh-list
2070270|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2070271|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070272|NCT01937260|Brodalumab|brodalumab|mesh-list
2070273|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
2070274|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2070275|NCT01937299|Travoprost|travoprost|mesh-list
2070276|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2070277|NCT01937299|Brinzolamide|brinzolamide|mesh-list
2070278|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2070279|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2070280|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2070281|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2070282|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2070283|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
2070284|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070285|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070286|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070287|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2070288|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070289|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2070290|NCT01937312|Travoprost|travoprost|mesh-list
2070291|NCT01937312|Brinzolamide|brinzolamide|mesh-list
2070292|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2070293|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2070294|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2070295|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2070296|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
2070297|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070298|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070299|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070300|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2070301|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070302|NCT01937364|Baclofen|baclofen|mesh-list
2070303|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2070304|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070305|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2070306|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070307|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2070308|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
2070309|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
2070310|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070311|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070312|NCT01937390|Bromides|bromides|mesh-list
2070313|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
2070314|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2070315|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
2070316|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070317|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070318|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2070319|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
2070320|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
2070321|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2070322|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
2070323|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070324|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070325|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
2070326|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
2070327|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2070328|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2070329|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070330|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
2070331|NCT01937559|Coagulants|coagulants|mesh-ancestor
2070332|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2070333|NCT01937598|Liraglutide|liraglutide|mesh-list
2070334|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2070335|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070336|NCT01937598|Incretins|incretins|mesh-ancestor
2070337|NCT01937598|Hormones|hormones|mesh-ancestor
2070338|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2070339|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2070340|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
2070341|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070342|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070343|NCT01937715|Bevacizumab|bevacizumab|mesh-list
2070344|NCT01937715|Gedatolisib|gedatolisib|mesh-list
2070345|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2070346|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070347|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2070348|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2070349|NCT01937715|Growth Substances|growth substances|mesh-ancestor
2070350|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070351|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
2070352|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2070353|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070354|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070355|NCT01937871|Tadalafil|tadalafil|mesh-list
2070356|NCT01937871|Tamsulosin|tamsulosin|mesh-list
2070357|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
2070358|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2070359|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2070360|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070361|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070362|NCT01937871|Urological Agents|urological agents|mesh-ancestor
2070363|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2070364|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2070365|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2070366|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
2070367|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070368|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070369|NCT01937975|Grazoprevir|grazoprevir|mesh-list
2070370|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
2070371|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070372|NCT01938001|Rituximab|rituximab|mesh-list
2070373|NCT01938001|Lenalidomide|lenalidomide|mesh-list
2070374|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2070375|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070376|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
2070377|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070378|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2070379|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2070380|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2070381|NCT01938001|Growth Substances|growth substances|mesh-ancestor
2070382|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
2070383|NCT01938040|Ibuprofen|ibuprofen|mesh-list
2070384|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2070385|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2070386|NCT01938040|Analgesics|analgesics|mesh-ancestor
2070387|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
2070388|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070389|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070390|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2070391|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2070392|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2070393|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070394|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070395|NCT01938079|Ketamine|ketamine|mesh-list
2070396|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2070397|NCT01938079|Analgesics|analgesics|mesh-ancestor
2070398|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
2070399|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070400|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070401|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2070402|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2070403|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
2070404|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
2070405|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2070406|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2070407|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2070408|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070409|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070410|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
2070411|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2070412|NCT01938430|Ledipasvir|ledipasvir|mesh-list
2070413|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
2070414|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070415|NCT01938573|Gemcitabine|gemcitabine|mesh-list
2070416|NCT01938573|Sirolimus|sirolimus|mesh-list
2070417|NCT01938573|Cisplatin|cisplatin|mesh-list
2070418|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070419|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2070420|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
2070421|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070422|NCT01938573|Antiviral Agents|antiviral agents|mesh-ancestor
2070423|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070424|NCT01938573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070425|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2070426|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
2070427|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070428|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2070429|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2070430|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
2070431|NCT01938625|Cyclosporine|cyclosporine|mesh-list
2070432|NCT01938625|Ribavirin|ribavirin|mesh-list
2070433|NCT01938625|Simeprevir|simeprevir|mesh-list
2070434|NCT01938625|Tacrolimus|tacrolimus|mesh-list
2070435|NCT01938625|Cyclosporins|cyclosporins|mesh-list
2070436|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2070437|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
2211994|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070438|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070439|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2070440|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070441|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070442|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
2070443|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070444|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
2070445|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2070446|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
2070447|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
2070448|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
2070449|NCT01938664|Candesartan|candesartan|mesh-list
2070450|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2070451|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2070452|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2070453|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070454|NCT01938846|Paclitaxel|paclitaxel|mesh-list
2070455|NCT01938846|Exemestane|exemestane|mesh-list
2070456|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2070457|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070458|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
2070459|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
2070460|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
2070461|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070462|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2070463|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2070464|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070465|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2070466|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
2070467|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2070468|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070469|NCT01938989|Methamphetamine|methamphetamine|mesh-list
2070470|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
2070471|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2070472|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2070473|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2070474|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070475|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
2070476|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
2070477|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070478|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
2070479|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070480|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070481|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
2070482|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2070483|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2070484|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2070485|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2070486|NCT01938989|Hormones|hormones|mesh-ancestor
2070487|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2070488|NCT01939002|Interferons|interferons|mesh-list
2070489|NCT01939002|Interferon-beta|interferon-beta|mesh-list
2070490|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
2070491|NCT01939002|Naproxen|naproxen|mesh-list
2070492|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2070493|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2070494|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070495|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
2070496|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070497|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2070498|NCT01939002|Analgesics|analgesics|mesh-ancestor
2070499|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
2070500|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070501|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070502|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2070503|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
2070504|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2070505|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070506|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070507|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
2070508|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2070509|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2070510|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2070511|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
2070512|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070513|NCT01939197|Ritonavir|ritonavir|mesh-list
2070514|NCT01939197|Ribavirin|ribavirin|mesh-list
2070515|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2070516|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2070517|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
2070518|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070519|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070520|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2070521|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2070522|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
2070523|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070524|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2070525|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2070526|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
2070527|NCT01939275|Copper|copper|mesh-list
2070528|NCT01939275|Trastuzumab|trastuzumab|mesh-list
2070529|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2070530|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070531|NCT01939275|Trace Elements|trace elements|mesh-ancestor
2070532|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
2070533|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070534|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
2070535|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2070536|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
2070537|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070538|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070539|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2070540|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
2070541|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2070542|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
2070543|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070544|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070545|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2070546|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
2070547|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
2070548|NCT01939301|Protective Agents|protective agents|mesh-ancestor
2070549|NCT01939314|Bupivacaine|bupivacaine|mesh-list
2070550|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
2070551|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
2070552|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2070553|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070554|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
2070555|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070556|NCT01939366|Pregabalin|pregabalin|mesh-list
2070557|NCT01939366|Analgesics|analgesics|mesh-ancestor
2070558|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
2070559|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070560|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070561|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
2070562|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2070563|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2070564|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070565|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2070566|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2070567|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2070568|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2070569|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2070570|NCT01939496|Canagliflozin|canagliflozin|mesh-list
2070571|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2070572|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070573|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2070574|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070575|NCT01939899|Ixazomib|ixazomib|mesh-list
2070576|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070577|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
2070578|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070579|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070580|NCT01939977|Calcifediol|calcifediol|mesh-list
2070581|NCT01939977|Vitamins|vitamins|mesh-ancestor
2070582|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
2070583|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070584|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2070585|NCT01940276|Prednisone|prednisone|mesh-list
2070586|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
2070587|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2070588|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
2070589|NCT01940276|Hormones|hormones|mesh-ancestor
2070590|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2070591|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070592|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2070593|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070594|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2070595|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070596|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070597|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
2070598|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2070599|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
2070600|NCT01940484|Hematinics|hematinics|mesh-ancestor
2070601|NCT01940497|Paclitaxel|paclitaxel|mesh-list
2070602|NCT01940497|Docetaxel|docetaxel|mesh-list
2070603|NCT01940497|Doxorubicin|doxorubicin|mesh-list
2070604|NCT01940497|Trastuzumab|trastuzumab|mesh-list
2070605|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2070606|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070607|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
2070608|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
2070609|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
2070610|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070611|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2070612|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2070613|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2070614|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070615|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2070616|NCT01940510|Rifampin|rifampin|mesh-list
2070617|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2070618|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
2070619|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2070620|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070621|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
2070622|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2070623|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070624|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070625|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2070626|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2070627|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2070628|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2070629|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2070630|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2070631|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
2070632|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2070633|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2070634|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070635|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
2070636|NCT01940523|Coagulants|coagulants|mesh-ancestor
2070637|NCT01940887|Bevacizumab|bevacizumab|mesh-list
2070638|NCT01940887|Aflibercept|aflibercept|mesh-list
2070639|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2070640|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070641|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2070642|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2070643|NCT01940887|Growth Substances|growth substances|mesh-ancestor
2070644|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070645|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
2070646|NCT01940900|Ranibizumab|ranibizumab|mesh-list
2070647|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2070648|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2070649|NCT01940900|Growth Substances|growth substances|mesh-ancestor
2070650|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070651|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
2070652|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070653|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
2070654|NCT01941095|Chloroquine|chloroquine|mesh-list
2070655|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
2070656|NCT01941095|Methotrexate|methotrexate|mesh-list
2070657|NCT01941095|Azathioprine|azathioprine|mesh-list
2070658|NCT01941095|Leflunomide|leflunomide|mesh-list
2070659|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2070660|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
2070661|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2070662|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070663|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2070664|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
2070665|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070666|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070667|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
2070668|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070669|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2070670|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2070671|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
2070672|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2070673|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2070674|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
2070675|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2070676|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2070677|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070678|NCT01941095|Amebicides|amebicides|mesh-ancestor
2070679|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2070680|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2070681|NCT01941095|Analgesics|analgesics|mesh-ancestor
2070682|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
2070683|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070684|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2070685|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2070686|NCT01941537|Fezakinumab|fezakinumab|mesh-list
2070687|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
2070688|NCT01941628|Rocuronium|rocuronium|mesh-list
2070689|NCT01941628|Succinylcholine|succinylcholine|mesh-list
2070690|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2070691|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2070692|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2070693|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070694|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070695|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2070696|NCT01941927|Trametinib|trametinib|mesh-list
2070697|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070698|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2070699|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070700|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070713|NCT01942148|Aripiprazole|aripiprazole|mesh-list
2070714|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
2070715|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2070716|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2070717|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2070718|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2070719|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070720|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
2070721|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
2070722|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070723|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070724|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2070725|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2070726|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
2070727|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2070728|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2070729|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2070730|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2070731|NCT01942161|Aripiprazole|aripiprazole|mesh-list
2070732|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
2070733|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2070734|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2070735|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2070736|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2070737|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070738|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
2070739|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
2070740|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070741|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070742|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2070743|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2070744|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
2070745|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2070746|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2070747|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2070748|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2070749|NCT01942590|Clenbuterol|clenbuterol|mesh-list
2070750|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2070751|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2070752|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
2070753|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070754|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070755|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070756|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2070757|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
2070758|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070759|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2070760|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
2070761|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
2070762|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2070763|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2070764|NCT01942668|Estradiol|estradiol|mesh-list
2070765|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2070766|NCT01942668|Progesterone|progesterone|mesh-list
2070767|NCT01942668|Estrogens|estrogens|mesh-ancestor
2070768|NCT01942668|Hormones|hormones|mesh-ancestor
2070769|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2070770|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070771|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2070772|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
2070773|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2070774|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2070775|NCT01942668|Progestins|progestins|mesh-ancestor
2070776|NCT01942694|Vitamin D|vitamin d|mesh-list
2070777|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
2070778|NCT01942694|Vitamins|vitamins|mesh-ancestor
2070779|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
2070780|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070781|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2070782|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2070783|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
2070784|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
2070785|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070786|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070787|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070788|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
2070789|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
2070790|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
2070791|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
2070792|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070793|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070794|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070795|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
2070796|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
2070797|NCT01942993|Vemurafenib|vemurafenib|mesh-list
2070798|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070799|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2070800|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070801|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070802|NCT01943435|Acetaminophen|acetaminophen|mesh-list
2070803|NCT01943435|Ibuprofen|ibuprofen|mesh-list
2070804|NCT01943435|Celecoxib|celecoxib|mesh-list
2070805|NCT01943435|Diclofenac|diclofenac|mesh-list
2070806|NCT01943435|Gabapentin|gabapentin|mesh-list
2070807|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2070808|NCT01943435|Tramadol|tramadol|mesh-list
2070809|NCT01943435|Analgesics|analgesics|mesh-list
2070810|NCT01943435|Mirtazapine|mirtazapine|mesh-list
2070811|NCT01943435|Trazodone|trazodone|mesh-list
2070812|NCT01943435|Sertraline|sertraline|mesh-list
2070813|NCT01943435|Nortriptyline|nortriptyline|mesh-list
2070814|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
2070815|NCT01943435|Misoprostol|misoprostol|mesh-list
2070816|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2070817|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
2070818|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070819|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070820|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
2070821|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2070822|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2070823|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2070824|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2070825|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070826|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070827|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2070828|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2070829|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
2070830|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2070831|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2070832|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2070833|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
2070834|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
2070835|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2070836|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2070837|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2070838|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2070839|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2070840|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2070841|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070842|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
2070843|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2070844|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2070845|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2070846|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
2070847|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2070848|NCT01943435|Narcotics|narcotics|mesh-ancestor
2070849|NCT01943435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2070850|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
2070851|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2070852|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
2070853|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
2070854|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2070855|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2070856|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2070857|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
2070858|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2070859|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2070860|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2070861|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2070862|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2070863|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2070864|NCT01943461|Avelumab|avelumab|mesh-list
2070865|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2070866|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2070867|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070868|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
2070869|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070870|NCT01943552|Bromides|bromides|mesh-list
2070871|NCT01943552|Ipratropium|ipratropium|mesh-list
2070872|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
2070873|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2070874|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
2070875|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070876|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070877|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2070878|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
2070879|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2070880|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
2070881|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070882|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070883|NCT01943565|Hydromorphone|hydromorphone|mesh-list
2070884|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2070885|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070886|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2070887|NCT01943565|Narcotics|narcotics|mesh-ancestor
2070888|NCT01943565|Analgesics|analgesics|mesh-ancestor
2070889|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
2070890|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070891|NCT01943825|Vaccines|vaccines|mesh-list
2070892|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
2070893|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070894|NCT01943864|Trametinib|trametinib|mesh-list
2070895|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070896|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2070897|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070898|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070899|NCT01944046|Oxytocin|oxytocin|mesh-list
2070900|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
2070901|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2070902|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070903|NCT01944098|Lidocaine|lidocaine|mesh-list
2070904|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
2070905|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
2070906|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2070907|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070908|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
2070909|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070910|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2070911|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2070912|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2070913|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2070914|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070915|NCT01944293|Midazolam|midazolam|mesh-list
2070916|NCT01944293|Ketamine|ketamine|mesh-list
2070917|NCT01944293|Analgesics|analgesics|mesh-ancestor
2070918|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
2070919|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070920|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070921|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2070922|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2070923|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
2070924|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
2070925|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2070926|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2070927|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2070928|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070929|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070930|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2070931|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2070932|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2070933|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2070934|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2070935|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
2070936|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
2070937|NCT01944319|Meropenem|meropenem|mesh-list
2070938|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2070939|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070940|NCT01944371|Disulfiram|disulfiram|mesh-list
2070941|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2070942|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2070943|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070944|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070945|NCT01944423|Cycloserine|cycloserine|mesh-list
2070946|NCT01944423|Nicotine|nicotine|mesh-list
2070947|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2070948|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
2070949|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2070950|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070951|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2070952|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2070953|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
2070954|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070955|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070956|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2070957|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070958|NCT01944423|Renal Agents|renal agents|mesh-ancestor
2070959|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2070960|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
2070961|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2070962|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
2070963|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2070964|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
2070965|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070966|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
2070967|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2070968|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2070969|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2070970|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2070971|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2070972|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070973|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070974|NCT01944839|Ranibizumab|ranibizumab|mesh-list
2070975|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2070976|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2070977|NCT01944839|Growth Substances|growth substances|mesh-ancestor
2070978|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070979|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
2070980|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2070981|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
2070982|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
2070983|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2070984|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2070985|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070986|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
2070987|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
2070993|NCT01945086|Ustekinumab|ustekinumab|mesh-list
2070994|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
2070995|NCT01945138|Insulin|insulin|mesh-list
2070996|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2070997|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2070998|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2070999|NCT01945216|Alogliptin|alogliptin|mesh-list
2071000|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2071001|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071002|NCT01945216|Incretins|incretins|mesh-ancestor
2071003|NCT01945216|Hormones|hormones|mesh-ancestor
2071004|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071005|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2071006|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
2071007|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071008|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071009|NCT01945242|Alogliptin|alogliptin|mesh-list
2071010|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2071011|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071012|NCT01945242|Incretins|incretins|mesh-ancestor
2071013|NCT01945242|Hormones|hormones|mesh-ancestor
2071014|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071015|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2071016|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
2071017|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071018|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071019|NCT01945281|Amphotericin B|amphotericin b|mesh-list
2071020|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2071021|NCT01945281|Caspofungin|caspofungin|mesh-list
2071022|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
2071023|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
2071024|NCT01945281|Amebicides|amebicides|mesh-ancestor
2071025|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2071026|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2071027|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071028|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2071029|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
2071030|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071031|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071032|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2071033|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2071034|NCT01945294|Interferons|interferons|mesh-list
2071035|NCT01945294|Ribavirin|ribavirin|mesh-list
2071036|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
2071037|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
2071038|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2071039|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071040|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
2071041|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071042|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
2071043|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071044|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
2071045|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071046|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
2071047|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2071048|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2071049|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2071050|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2071051|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071052|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
2071053|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071054|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071055|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2071056|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071057|NCT01945593|Factor VIII|factor viii|mesh-list
2071058|NCT01945593|BAX 855|bax 855|mesh-list
2071059|NCT01945593|Coagulants|coagulants|mesh-ancestor
2071065|NCT01945866|Dexamethasone|dexamethasone|mesh-list
2071066|NCT01945866|Ranibizumab|ranibizumab|mesh-list
2071067|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2071068|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
2071069|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
2071070|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071071|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071072|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2071073|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
2071074|NCT01945866|Hormones|hormones|mesh-ancestor
2071075|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071076|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2071077|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071078|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2071079|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2071080|NCT01945866|Growth Substances|growth substances|mesh-ancestor
2071081|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
2071082|NCT01946152|Dexamethasone|dexamethasone|mesh-list
2071083|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
2071084|NCT01946152|Pomalidomide|pomalidomide|mesh-list
2071085|NCT01946152|Ichthammol|ichthammol|mesh-list
2071086|NCT01946152|Lenograstim|lenograstim|mesh-list
2071087|NCT01946152|BB 1101|bb 1101|mesh-list
2071088|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2071089|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
2071090|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
2071091|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071092|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071093|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2071094|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
2071095|NCT01946152|Hormones|hormones|mesh-ancestor
2071096|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071097|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2071098|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071099|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2071100|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
2211995|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2211996|NCT00019669|Aldesleukin|aldesleukin|mesh-list
2211997|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2211998|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2211999|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2212000|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
2212001|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071101|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
2212002|NCT00019695|Alendronate|alendronate|mesh-list
2212003|NCT00019695|Ketoconazole|ketoconazole|mesh-list
2212004|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
2212005|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212006|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2212007|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2212008|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212009|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212010|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2212011|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
2212012|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071102|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071103|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071104|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2071105|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2071106|NCT01946152|Growth Substances|growth substances|mesh-ancestor
2071107|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
2071108|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
2071109|NCT01946165|Prednisone|prednisone|mesh-list
2071110|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
2071111|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2071112|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
2071113|NCT01946165|Hormones|hormones|mesh-ancestor
2071114|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071115|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071116|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2071117|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071118|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2749720|NCT04553666|Vitamins|vitamins|mesh-list
2749721|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
2749722|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2749723|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
2749724|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749725|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
2749726|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749727|NCT04553666|Protective Agents|protective agents|mesh-ancestor
2749728|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2749729|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2749730|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749731|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2212013|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212014|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2212015|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2212016|NCT00019721|Aldesleukin|aldesleukin|mesh-list
2212017|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
2212018|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212019|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2212020|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2071119|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071120|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071121|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
2071122|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2071123|NCT01946412|Ivacaftor|ivacaftor|mesh-list
2071124|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2071125|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2071126|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071127|NCT01946425|Vaccines|vaccines|mesh-list
2071128|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
2071129|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071130|NCT01946438|Vaccines|vaccines|mesh-list
2071131|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
2212021|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
2071132|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071133|NCT01946529|Sirolimus|sirolimus|mesh-list
2749748|NCT04545554|Vitamin D|vitamin d|mesh-list
2749749|NCT04545554|Calcium|calcium|mesh-list
2749750|NCT04545554|Vitamins|vitamins|mesh-ancestor
2749751|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
2212022|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212023|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2212024|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
2212025|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212026|NCT00019734|Aldesleukin|aldesleukin|mesh-list
2212027|NCT00019734|Vaccines|vaccines|mesh-list
2212028|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
2212029|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071134|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
2071135|NCT01946529|Temozolomide|temozolomide|mesh-list
2071136|NCT01946529|Ifosfamide|ifosfamide|mesh-list
2071137|NCT01946529|Bevacizumab|bevacizumab|mesh-list
2071138|NCT01946529|Doxorubicin|doxorubicin|mesh-list
2071139|NCT01946529|Etoposide|etoposide|mesh-list
2071140|NCT01946529|Vincristine|vincristine|mesh-list
2071141|NCT01946529|Sorafenib|sorafenib|mesh-list
2071142|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2071143|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
2071144|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071145|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2071146|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2071147|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
2071148|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071149|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071150|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2071151|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2071152|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2071153|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2071154|NCT01946529|Growth Substances|growth substances|mesh-ancestor
2071155|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
2071156|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2071157|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2071158|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2071159|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071160|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2071161|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
2071162|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212030|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212031|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2212032|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2749752|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749753|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2749754|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2071163|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
2071164|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2071165|NCT01946529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2071166|NCT01946529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071167|NCT01946529|Antifungal Agents|antifungal agents|mesh-ancestor
2071168|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
2071169|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
2071170|NCT01946880|Chloroquine|chloroquine|mesh-list
2071171|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2071172|NCT01946880|Prednisone|prednisone|mesh-list
2071173|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2071174|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
2071175|NCT01946880|Hormones|hormones|mesh-ancestor
2071176|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071177|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071178|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2071179|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071180|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2071181|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2071182|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
2071183|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2071184|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071185|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071186|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071187|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
2071188|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2071189|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2071190|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2071191|NCT01946880|Amebicides|amebicides|mesh-ancestor
2071192|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2071193|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2071194|NCT01946880|Analgesics|analgesics|mesh-ancestor
2071195|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
2071196|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071197|NCT01946880|Filaricides|filaricides|mesh-ancestor
2749768|NCT04540835|Calcium|calcium|mesh-list
2749769|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2749770|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749771|NCT04540211|Paclitaxel|paclitaxel|mesh-list
2749772|NCT04540211|Atezolizumab|atezolizumab|mesh-list
2749773|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2071198|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
2071199|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
2749774|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2749775|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749776|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
2749777|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212033|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
2212034|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212035|NCT00019760|Leucovorin|leucovorin|mesh-list
2212036|NCT00019760|Melphalan|melphalan|mesh-list
2212037|NCT00019760|Floxuridine|floxuridine|mesh-list
2212038|NCT00019760|Calcium|calcium|mesh-list
2212039|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
2212040|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2212041|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212042|NCT00019760|Antidotes|antidotes|mesh-ancestor
2212043|NCT00019760|Protective Agents|protective agents|mesh-ancestor
2212044|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
2212045|NCT00019760|Vitamins|vitamins|mesh-ancestor
2212046|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
2212047|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2212048|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
2212049|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212050|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212051|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2212052|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212053|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
2212054|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212055|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
2212056|NCT00019773|Capecitabine|capecitabine|mesh-list
2212057|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
2212058|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212059|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
2212060|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212061|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212062|NCT00019786|Melphalan|melphalan|mesh-list
2212063|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2212064|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
2212065|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212066|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212067|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2212068|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212069|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
2212070|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212071|NCT00019812|Paclitaxel|paclitaxel|mesh-list
2212072|NCT00019812|Trastuzumab|trastuzumab|mesh-list
2212073|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2212074|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212075|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212076|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212077|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212078|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212079|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2212080|NCT00019825|Decitabine|decitabine|mesh-list
2212081|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212082|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
2212083|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212084|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212085|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212086|NCT00019838|Fludarabine|fludarabine|mesh-list
2212087|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
2071200|NCT01947153|Metformin|metformin|mesh-list
2071201|NCT01947153|Linagliptin|linagliptin|mesh-list
2071202|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2071203|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071204|NCT01947153|Incretins|incretins|mesh-ancestor
2071205|NCT01947153|Hormones|hormones|mesh-ancestor
2071206|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071207|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2071208|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
2071209|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071210|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071211|NCT01947855|Empagliflozin|empagliflozin|mesh-list
2071212|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2071213|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071214|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2071215|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071216|NCT01947907|Hormones|hormones|mesh-list
2071217|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2212088|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2212089|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212090|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2071218|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071219|NCT01947946|Benralizumab|benralizumab|mesh-list
2071220|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2071221|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
2071222|NCT01948141|Nintedanib|nintedanib|mesh-list
2071223|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071224|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2071225|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071226|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071227|NCT01948310|Ranolazine|ranolazine|mesh-list
2071228|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2071229|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2071230|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071231|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2071232|NCT01948388|Hormones|hormones|mesh-ancestor
2071233|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071234|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071235|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
2071236|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
2071237|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2071238|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2071239|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071240|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071241|NCT01948518|Urological Agents|urological agents|mesh-ancestor
2749778|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
2749779|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749780|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
2749781|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749789|NCT04539730|Bupivacaine|bupivacaine|mesh-list
2749790|NCT04539730|Ropivacaine|ropivacaine|mesh-list
2749791|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
2749792|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
2749793|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2749794|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749795|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
2749796|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071242|NCT01948791|Rivastigmine|rivastigmine|mesh-list
2071243|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2071244|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071245|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071246|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
2071247|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071248|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071249|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2071250|NCT01948791|Protective Agents|protective agents|mesh-ancestor
2071251|NCT01948830|Ranibizumab|ranibizumab|mesh-list
2071252|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2071253|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2071254|NCT01948830|Growth Substances|growth substances|mesh-ancestor
2071255|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071256|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
2071257|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071258|NCT01948908|Midazolam|midazolam|mesh-list
2071259|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2071260|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2071261|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2071262|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071263|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2071264|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2071265|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2071266|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2071267|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
2071268|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
2071269|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
2071270|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
2071271|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071272|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212091|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
2749811|NCT04538378|Durvalumab|durvalumab|mesh-list
2749812|NCT04538378|Olaparib|olaparib|mesh-list
2749813|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2749814|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749815|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2749816|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212092|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212093|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212094|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
2212095|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212096|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2212097|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212098|NCT00019864|Leucovorin|leucovorin|mesh-list
2212099|NCT00019864|Doxorubicin|doxorubicin|mesh-list
2749817|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749818|NCT04537208|Vaccines|vaccines|mesh-list
2749819|NCT04537208|Immunologic Factors|immunologic factors|mesh-ancestor
2749820|NCT04537208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749821|NCT04535791|Vitamin D|vitamin d|mesh-list
2749822|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
2212100|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2212101|NCT00019864|Methotrexate|methotrexate|mesh-list
2212102|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
2212103|NCT00019864|Razoxane|razoxane|mesh-list
2212104|NCT00019864|Calcium|calcium|mesh-list
2749823|NCT04535791|Vitamins|vitamins|mesh-ancestor
2749824|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
2749825|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749826|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2749827|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2212105|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
2071273|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
2071274|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2071275|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071276|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2071277|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071278|NCT01949051|Levocabastine|levocabastine|mesh-list
2071279|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2071280|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2071281|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
2071282|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
2071283|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071284|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071285|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071286|NCT01949116|Folic Acid|folic acid|mesh-list
2071287|NCT01949116|Methotrexate|methotrexate|mesh-list
2071288|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2071289|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
2071290|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2071291|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071292|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2071293|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
2071294|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071295|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212106|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212107|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2212108|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2212109|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212110|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212111|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212112|NCT00019864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2212113|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212114|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2212115|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
2212116|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2212117|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212118|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
2212119|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
2212120|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2212121|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212122|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
2212123|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2212124|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2212125|NCT00019864|Antidotes|antidotes|mesh-ancestor
2212126|NCT00019864|Protective Agents|protective agents|mesh-ancestor
2212127|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
2212128|NCT00019864|Vitamins|vitamins|mesh-ancestor
2212129|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
2212130|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2212131|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212132|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212133|NCT00019890|Sargramostim|sargramostim|mesh-list
2071296|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
2071297|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071298|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2071299|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2071300|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
2071301|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2071302|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2071303|NCT01949116|Hematinics|hematinics|mesh-ancestor
2071304|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
2071305|NCT01949116|Vitamins|vitamins|mesh-ancestor
2071306|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
2071307|NCT01949337|Prednisone|prednisone|mesh-list
2071308|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2071309|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
2212134|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
2212135|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071310|NCT01949337|Hormones|hormones|mesh-ancestor
2071311|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071312|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212136|NCT00019916|Aldesleukin|aldesleukin|mesh-list
2071313|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2071314|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071315|NCT01949662|Lorazepam|lorazepam|mesh-list
2071316|NCT01949662|Haloperidol|haloperidol|mesh-list
2071317|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
2071318|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
2071319|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
2071320|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071321|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071322|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2071323|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2071324|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2071325|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2071326|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2071327|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2071328|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
2212137|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071329|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071330|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071331|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2071332|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
2071333|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2071334|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2071335|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
2071336|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
2071337|NCT01949844|Regadenoson|regadenoson|mesh-list
2071338|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2071339|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2071340|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
2071341|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
2071342|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071343|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071344|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071345|NCT01949870|Gemcitabine|gemcitabine|mesh-list
2071346|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071347|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2071348|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
2071349|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071350|NCT01949870|Antiviral Agents|antiviral agents|mesh-ancestor
2071351|NCT01949870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071352|NCT01949870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071353|NCT01949870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2071354|NCT01949870|Immunologic Factors|immunologic factors|mesh-ancestor
2071355|NCT01949870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071356|NCT01950039|Betaine|betaine|mesh-list
2071357|NCT01950039|Glycine|glycine|mesh-list
2071358|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
2071359|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071360|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071361|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071362|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2071363|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
2071364|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2071365|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
2071366|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2071367|NCT01950169|Vitamin D|vitamin d|mesh-list
2071368|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
2071369|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
2071370|NCT01950169|Diphosphonates|diphosphonates|mesh-list
2071371|NCT01950169|Calcium|calcium|mesh-list
2071372|NCT01950169|Vitamins|vitamins|mesh-ancestor
2071373|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
2212138|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2212139|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2212140|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
2212141|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212142|NCT00019968|Melphalan|melphalan|mesh-list
2071374|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071375|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2071376|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2071377|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2071378|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2212143|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2212144|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
2212145|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212146|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212147|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2212148|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212149|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
2212150|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212151|NCT00019994|Aldesleukin|aldesleukin|mesh-list
2212152|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
2212153|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212154|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2071379|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071380|NCT01950260|Hormones|hormones|mesh-list
2071381|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071382|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071383|NCT01950273|Rituximab|rituximab|mesh-list
2071384|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2071385|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071386|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
2071387|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071388|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2071389|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2071390|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2071391|NCT01950364|Rifampin|rifampin|mesh-list
2071392|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2071393|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2071394|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2071395|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071396|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
2071397|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071398|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2071399|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
2071400|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2071401|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071402|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
2071403|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2212155|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2212156|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
2212157|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212158|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2212159|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
2212160|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071404|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071405|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071406|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2071407|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2071408|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2071409|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2071410|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2071411|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2071412|NCT01950741|Aflibercept|aflibercept|mesh-list
2071413|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2071414|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2071415|NCT01950741|Growth Substances|growth substances|mesh-ancestor
2071416|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071417|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
2071418|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071419|NCT01950819|Cyclosporine|cyclosporine|mesh-list
2071420|NCT01950819|Prednisone|prednisone|mesh-list
2071421|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
2212161|NCT00020007|Paclitaxel|paclitaxel|mesh-list
2212162|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2212163|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212164|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212165|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212166|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212167|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212168|NCT00020046|Thalidomide|thalidomide|mesh-list
2212169|NCT00020046|Docetaxel|docetaxel|mesh-list
2212170|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212171|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212172|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212173|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212174|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212175|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212176|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
2212177|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071422|NCT01950819|Tacrolimus|tacrolimus|mesh-list
2071423|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
2071424|NCT01950819|Cyclosporins|cyclosporins|mesh-list
2071425|NCT01950819|Basiliximab|basiliximab|mesh-list
2212178|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
2212179|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2212180|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212181|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2212182|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2212183|NCT00020046|Growth Substances|growth substances|mesh-ancestor
2212184|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
2212185|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
2212186|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071426|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2071427|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
2071428|NCT01950819|Hormones|hormones|mesh-ancestor
2071429|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071430|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071431|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2071432|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071433|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
2071434|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
2071435|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071436|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2071437|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2071438|NCT01950819|Protective Agents|protective agents|mesh-ancestor
2071439|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2071440|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
2071441|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2071442|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071443|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071444|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071445|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
2071446|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
2071447|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2071448|NCT01951066|Dexamethasone|dexamethasone|mesh-list
2071449|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2071450|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
2071451|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
2071452|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071453|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071454|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2071455|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
2071456|NCT01951066|Hormones|hormones|mesh-ancestor
2212187|NCT00020124|Doxorubicin|doxorubicin|mesh-list
2212188|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2071457|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071458|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2071459|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071460|NCT01951105|Naproxen|naproxen|mesh-list
2071461|NCT01951105|Levodopa|levodopa|mesh-list
2071462|NCT01951105|Carbidopa|carbidopa|mesh-list
2071463|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2212189|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2071464|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2071465|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2071466|NCT01951105|Analgesics|analgesics|mesh-ancestor
2071467|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
2071468|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071469|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071470|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2071471|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2071472|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
2071473|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2071474|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071475|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071476|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2071477|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2071478|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
2071479|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071480|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2071481|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2071482|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
2071483|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
2071484|NCT01951118|Donepezil|donepezil|mesh-list
2071485|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2071486|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071487|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071488|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
2071489|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071490|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071491|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
2071492|NCT01951157|Gemcitabine|gemcitabine|mesh-list
2071493|NCT01951157|Docetaxel|docetaxel|mesh-list
2071494|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2071495|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
2071496|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071497|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071498|NCT01951157|Antiviral Agents|antiviral agents|mesh-ancestor
2071499|NCT01951157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071500|NCT01951157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071501|NCT01951157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2071502|NCT01951157|Immunologic Factors|immunologic factors|mesh-ancestor
2071503|NCT01951157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071504|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
2071505|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
2071506|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
2071507|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2212190|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212191|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2212192|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212193|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212194|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212195|NCT00020150|Temozolomide|temozolomide|mesh-list
2212196|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2212197|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2212198|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
2212199|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071508|NCT01951339|Glimepiride|glimepiride|mesh-list
2071509|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2071510|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071511|NCT01951339|Incretins|incretins|mesh-ancestor
2212200|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071512|NCT01951339|Hormones|hormones|mesh-ancestor
2071513|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071514|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2071515|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
2071516|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071517|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071518|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2071519|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2071520|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
2071521|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
2071522|NCT01951391|Triclocarban|triclocarban|mesh-list
2071523|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2071524|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071525|NCT01951417|Adapalene|adapalene|mesh-list
2071526|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2071527|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
2071528|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2071529|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2071530|NCT01951417|Analgesics|analgesics|mesh-ancestor
2071531|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
2071532|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071533|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071534|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2071535|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2071536|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
2071537|NCT01951586|Denosumab|denosumab|mesh-list
2071538|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2071539|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071540|NCT01951651|Exenatide|exenatide|mesh-list
2212201|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212202|NCT00020176|Cyclosporine|cyclosporine|mesh-list
2212203|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
2212204|NCT00020176|Fludarabine|fludarabine|mesh-list
2071541|NCT01951651|Glipizide|glipizide|mesh-list
2071542|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2071543|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071544|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2071545|NCT01951651|Incretins|incretins|mesh-ancestor
2071546|NCT01951651|Hormones|hormones|mesh-ancestor
2071547|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071548|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2071549|NCT01951768|Gentamicins|gentamicins|mesh-list
2071550|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071551|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2071552|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212205|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
2071553|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071554|NCT01951820|Lidocaine|lidocaine|mesh-list
2071555|NCT01951820|Tetracaine|tetracaine|mesh-list
2071556|NCT01951820|Carticaine|carticaine|mesh-list
2071557|NCT01951820|Benzocaine|benzocaine|mesh-list
2071558|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
2071559|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
2071560|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2071561|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071562|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
2071563|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071564|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2071565|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2071566|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2071567|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2071568|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071569|NCT01951950|Nicardipine|nicardipine|mesh-list
2071570|NCT01951950|Esmolol|esmolol|mesh-list
2071571|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2071572|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2071573|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2071574|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
2071575|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071576|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071577|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071578|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2749888|NCT04525547|Nintedanib|nintedanib|mesh-list
2749889|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749890|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2749891|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2749892|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749893|NCT04523246|Vaccines|vaccines|mesh-list
2749894|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
2749895|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071579|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2071580|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2212206|NCT00020176|Cyclosporins|cyclosporins|mesh-list
2749903|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
2212207|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212208|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
2212209|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071581|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2071582|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
2071583|NCT01951963|Morphine|morphine|mesh-list
2071584|NCT01951963|Ketamine|ketamine|mesh-list
2071585|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2071586|NCT01951963|Narcotics|narcotics|mesh-ancestor
2071587|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2071588|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071589|NCT01951963|Analgesics|analgesics|mesh-ancestor
2071590|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
2749904|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2212210|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2212211|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2212212|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
2212213|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212214|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212215|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2212216|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212217|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
2212218|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071591|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071592|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2071593|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2071594|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
2071595|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
2071596|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2071597|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2071598|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071599|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071600|NCT01952054|Denosumab|denosumab|mesh-list
2071601|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2071602|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212219|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
2212220|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212221|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
2212222|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2212223|NCT00020189|Aspirin|aspirin|mesh-list
2071603|NCT01952080|Teduglutide|teduglutide|mesh-list
2071604|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2071605|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2071606|NCT01952080|Protective Agents|protective agents|mesh-ancestor
2071607|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071608|NCT01952145|Insulin|insulin|mesh-list
2071609|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2071610|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
2071611|NCT01952145|Liraglutide|liraglutide|mesh-list
2071612|NCT01952145|Xultophy|xultophy|mesh-list
2071613|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2071614|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071615|NCT01952145|Incretins|incretins|mesh-ancestor
2071616|NCT01952145|Hormones|hormones|mesh-ancestor
2212224|NCT00020189|Alvocidib|alvocidib|mesh-list
2212225|NCT00020189|Clopidogrel|clopidogrel|mesh-list
2212226|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2212227|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2212228|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2212229|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2212230|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
2212231|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071617|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071618|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
2071619|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2071620|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071621|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2071622|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2071623|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071624|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071625|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212232|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212233|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212234|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2212235|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2212236|NCT00020189|Analgesics|analgesics|mesh-ancestor
2212237|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
2212238|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2212239|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2212240|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2212241|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2212242|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2212243|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2212244|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212245|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
2212246|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212247|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
2212248|NCT00020189|Growth Substances|growth substances|mesh-ancestor
2071626|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2071627|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2071628|NCT01952574|Erenumab|erenumab|mesh-list
2071629|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2071630|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2071631|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071632|NCT01952574|Analgesics|analgesics|mesh-ancestor
2212249|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2071633|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
2071634|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071635|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071636|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
2071637|NCT01952834|Vancomycin|vancomycin|mesh-list
2071638|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2212250|NCT00020202|Romidepsin|romidepsin|mesh-list
2212251|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2212252|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212253|NCT00020254|Aldesleukin|aldesleukin|mesh-list
2071639|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071640|NCT01953003|Capecitabine|capecitabine|mesh-list
2071641|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2071642|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
2071643|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071644|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071645|NCT01953081|Metoclopramide|metoclopramide|mesh-list
2071646|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
2071647|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
2071648|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071649|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071650|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2071651|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2071652|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2071653|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
2071654|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071655|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071656|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
2071657|NCT01953211|Norinyl|norinyl|mesh-list
2071658|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
2071659|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2071660|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2071661|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071662|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2071663|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2071664|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2071665|NCT01953328|Atorvastatin|atorvastatin|mesh-list
2071666|NCT01953328|Evolocumab|evolocumab|mesh-list
2071667|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2071668|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2071669|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2071670|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
2071671|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071672|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2071673|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2071674|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071675|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
2071676|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071677|NCT01953432|Doxazosin|doxazosin|mesh-list
2071678|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2071679|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2071680|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2071681|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2071682|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
2071683|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071684|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071685|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071686|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
2071687|NCT01953692|Lenalidomide|lenalidomide|mesh-list
2071688|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2071689|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071690|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
2071691|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071692|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2212254|NCT00020254|Nilutamide|nilutamide|mesh-list
2212255|NCT00020254|Vaccines|vaccines|mesh-list
2212256|NCT00020254|Sargramostim|sargramostim|mesh-list
2212257|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
2212258|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212259|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212260|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2212261|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2212262|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
2212263|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212264|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
2212265|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
2071693|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2071694|NCT01953692|Growth Substances|growth substances|mesh-ancestor
2071695|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
2071696|NCT01953783|Ixazomib|ixazomib|mesh-list
2071697|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212266|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2212267|NCT00020267|Interleukin-2|interleukin-2|mesh-list
2212268|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071698|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
2071699|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071700|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071701|NCT01953913|Afatinib|afatinib|mesh-list
2071702|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212269|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2212270|NCT00020267|Analgesics|analgesics|mesh-ancestor
2212271|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
2212272|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2212273|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212274|NCT00020332|Docetaxel|docetaxel|mesh-list
2212275|NCT00020332|Alvocidib|alvocidib|mesh-list
2212276|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212277|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212278|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212279|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212280|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071703|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2071704|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071705|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071706|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
2071707|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2071708|NCT01954082|Inositol|inositol|mesh-list
2071709|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
2071710|NCT01954082|Vitamins|vitamins|mesh-ancestor
2071711|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
2071712|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071713|NCT01954121|Carbamazepine|carbamazepine|mesh-list
2071714|NCT01954121|Levetiracetam|levetiracetam|mesh-list
2071715|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
2212281|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
2071716|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
2071717|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
2212282|NCT00020332|Growth Substances|growth substances|mesh-ancestor
2212283|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212284|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2212285|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212286|NCT00020345|Gemcitabine|gemcitabine|mesh-list
2212287|NCT00020345|Fluorouracil|fluorouracil|mesh-list
2212288|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212289|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
2212290|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212291|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212292|NCT00020345|Antiviral Agents|antiviral agents|mesh-ancestor
2212293|NCT00020345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212294|NCT00020345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212295|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212296|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
2212297|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212298|NCT00020358|Aldesleukin|aldesleukin|mesh-list
2212299|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
2212300|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212301|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2212302|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2212303|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
2212304|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212305|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2212306|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
2212307|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212308|NCT00020371|Lenograstim|lenograstim|mesh-list
2071718|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2071719|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2071720|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071721|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2071722|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2071723|NCT01954121|Analgesics|analgesics|mesh-ancestor
2071724|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
2071725|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071726|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2071727|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2071728|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071729|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2071730|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2071731|NCT01954251|Vaccines|vaccines|mesh-list
2071732|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
2071733|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071734|NCT01954927|Gabapentin|gabapentin|mesh-list
2071735|NCT01954927|Analgesics|analgesics|mesh-ancestor
2071736|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
2071737|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071738|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071739|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
2071740|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2071741|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2071742|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2071743|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2071744|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2071745|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2071746|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071747|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071748|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
2071749|NCT01955382|Artesunate|artesunate|mesh-list
2071750|NCT01955382|Amodiaquine|amodiaquine|mesh-list
2071751|NCT01955382|Charcoal|charcoal|mesh-list
2071752|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
2071753|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2071754|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2071755|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071756|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071757|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
2071758|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
2071759|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2071760|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
2071761|NCT01955382|Antidotes|antidotes|mesh-ancestor
2071762|NCT01955382|Protective Agents|protective agents|mesh-ancestor
2071763|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071764|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
2071765|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2071766|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
2071767|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071768|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2212309|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2212310|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
2212311|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212312|NCT00020397|Aldesleukin|aldesleukin|mesh-list
2071769|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2071770|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
2071771|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071772|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071773|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2071774|NCT01955629|Capecitabine|capecitabine|mesh-list
2071775|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
2071776|NCT01955629|Aflibercept|aflibercept|mesh-list
2212313|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212314|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2212315|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2212316|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
2212317|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071777|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2071778|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
2071779|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071780|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071781|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2071782|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2071783|NCT01955629|Growth Substances|growth substances|mesh-ancestor
2071784|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071785|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
2071786|NCT01955707|Natalizumab|natalizumab|mesh-list
2071787|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
2071788|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212318|NCT00020410|Antibodies|antibodies|mesh-list
2212319|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2212320|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
2212321|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212322|NCT00020449|Paclitaxel|paclitaxel|mesh-list
2212323|NCT00020449|Doxorubicin|doxorubicin|mesh-list
2071793|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2071794|NCT01956123|Hormones|hormones|mesh-ancestor
2071795|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071796|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071797|NCT01957150|Fluticasone|fluticasone|mesh-list
2071798|NCT01957150|Xhance|xhance|mesh-list
2071799|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2071800|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2071801|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
2071802|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071803|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212324|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2212325|NCT00020449|Interleukin-12|interleukin-12|mesh-list
2212326|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2212327|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212328|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212329|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212330|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212331|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212332|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2212333|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2212334|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212335|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071804|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2071805|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
2071806|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
2071807|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2071808|NCT01957202|Levocabastine|levocabastine|mesh-list
2071809|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2071810|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2071811|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
2071812|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
2212336|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2212337|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
2212338|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212339|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2212340|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2212341|NCT00020449|Growth Substances|growth substances|mesh-ancestor
2212342|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
2212343|NCT00020462|Aldesleukin|aldesleukin|mesh-list
2212344|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212345|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2212346|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2212347|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
2212348|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212349|NCT00020475|Interleukin-2|interleukin-2|mesh-list
2212350|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071813|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071814|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071815|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071816|NCT01957215|Indomethacin|indomethacin|mesh-list
2071817|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2071818|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2071819|NCT01957215|Analgesics|analgesics|mesh-ancestor
2071820|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
2212351|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2212352|NCT00020475|Analgesics|analgesics|mesh-ancestor
2212353|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
2212354|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2212355|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212356|NCT00020488|Leucovorin|leucovorin|mesh-list
2212357|NCT00020488|Fluorouracil|fluorouracil|mesh-list
2212358|NCT00020488|Irinotecan|irinotecan|mesh-list
2212359|NCT00020488|Calcium|calcium|mesh-list
2212360|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
2212361|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2212362|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212363|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
2212364|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212365|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212366|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212367|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212368|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
2212369|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2212370|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212371|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212372|NCT00020488|Antidotes|antidotes|mesh-ancestor
2212373|NCT00020488|Protective Agents|protective agents|mesh-ancestor
2212374|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
2212375|NCT00020488|Vitamins|vitamins|mesh-ancestor
2071821|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071822|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071823|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2071824|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2071825|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
2071826|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
2071827|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2071828|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2071829|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071830|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071831|NCT01957410|Ketamine|ketamine|mesh-list
2749922|NCT04500847|Emtricitabine|emtricitabine|mesh-list
2749923|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
2749924|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071832|NCT01957410|Analgesics|analgesics|mesh-ancestor
2071833|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
2071834|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071835|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071836|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2071837|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2071838|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
2071839|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
2071840|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2071841|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2071842|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2071843|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071844|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071845|NCT01957644|Azacitidine|azacitidine|mesh-list
2071846|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212376|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
2212377|NCT00020501|Leucovorin|leucovorin|mesh-list
2212378|NCT00020501|Fluorouracil|fluorouracil|mesh-list
2212379|NCT00020501|Floxuridine|floxuridine|mesh-list
2212380|NCT00020501|Irinotecan|irinotecan|mesh-list
2212381|NCT00020501|Melphalan|melphalan|mesh-list
2212382|NCT00020501|Calcium|calcium|mesh-list
2212383|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
2071847|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
2071848|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071849|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071850|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2071851|NCT01957709|Interferons|interferons|mesh-list
2071852|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
2071853|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071854|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
2212384|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2212385|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212386|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
2212387|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212388|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212389|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212390|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212391|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
2212392|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2212393|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212394|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212395|NCT00020501|Antidotes|antidotes|mesh-ancestor
2212396|NCT00020501|Protective Agents|protective agents|mesh-ancestor
2212397|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
2212398|NCT00020501|Vitamins|vitamins|mesh-ancestor
2212399|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
2212400|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2071855|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212401|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
2212402|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2212403|NCT00020527|Caspofungin|caspofungin|mesh-list
2212404|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
2212405|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212406|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212407|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212408|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
2212409|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2212410|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
2212411|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212412|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2212413|NCT00020540|Protective Agents|protective agents|mesh-ancestor
2212414|NCT00020566|Dactinomycin|dactinomycin|mesh-list
2212415|NCT00020566|Doxorubicin|doxorubicin|mesh-list
2212416|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2071856|NCT01957930|Insulin|insulin|mesh-list
2071857|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2071858|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2071859|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749925|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2749926|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2749927|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2749928|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749929|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2749930|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2071870|NCT01958073|Estradiol|estradiol|mesh-list
2071871|NCT01958073|Estrogens|estrogens|mesh-list
2071872|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2071873|NCT01958073|Hormones|hormones|mesh-ancestor
2071874|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2071875|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071876|NCT01958112|Trametinib|trametinib|mesh-list
2071877|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071878|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2071879|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212417|NCT00020566|Etoposide|etoposide|mesh-list
2071880|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071881|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2071882|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2071883|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2071884|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071885|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
2071886|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2071887|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
2071888|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071889|NCT01958476|Morphine|morphine|mesh-list
2071890|NCT01958476|Methadone|methadone|mesh-list
2071891|NCT01958476|Phenobarbital|phenobarbital|mesh-list
2212418|NCT00020566|Vincristine|vincristine|mesh-list
2212419|NCT00020566|Melphalan|melphalan|mesh-list
2212420|NCT00020566|Busulfan|busulfan|mesh-list
2212421|NCT00020566|Ifosfamide|ifosfamide|mesh-list
2212422|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2212423|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212424|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2212425|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212426|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212427|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212428|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2212429|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212430|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212431|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212432|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2212433|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
2212434|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2212435|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212436|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
2212437|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212438|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2212439|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212440|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2212441|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2212442|NCT00020579|Entinostat|entinostat|mesh-list
2212443|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212444|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2212445|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212446|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212447|NCT00020605|Naloxone|naloxone|mesh-list
2212448|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2212449|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212450|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
2212451|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2212452|NCT00020618|Morphine|morphine|mesh-list
2212453|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2212454|NCT00020618|Narcotics|narcotics|mesh-ancestor
2212455|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2212456|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212457|NCT00020618|Analgesics|analgesics|mesh-ancestor
2212458|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
2212459|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2212460|NCT00020631|Pirfenidone|pirfenidone|mesh-list
2212461|NCT00020631|Analgesics|analgesics|mesh-ancestor
2212462|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
2212463|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2212464|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212465|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2212466|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2212467|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2212468|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2212469|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212470|NCT00020644|Gemcitabine|gemcitabine|mesh-list
2212471|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212472|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
2212473|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212474|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212475|NCT00020644|Antiviral Agents|antiviral agents|mesh-ancestor
2212476|NCT00020644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212477|NCT00020644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212478|NCT00020644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212479|NCT00020644|Immunologic Factors|immunologic factors|mesh-ancestor
2212480|NCT00020644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212481|NCT00020657|Ondansetron|ondansetron|mesh-list
2212482|NCT00020657|Granisetron|granisetron|mesh-list
2212483|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
2212484|NCT00020657|Dolasetron|dolasetron|mesh-list
2212485|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
2212486|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
2212487|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2212488|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212489|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2071892|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2071893|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2071894|NCT01958476|Narcotics|narcotics|mesh-ancestor
2071895|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2071896|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071897|NCT01958476|Analgesics|analgesics|mesh-ancestor
2071898|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
2071899|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2071900|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
2212490|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
2212491|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
2212492|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2212493|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
2212494|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2212495|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212496|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2212497|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2071901|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
2071902|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
2071903|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2071904|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2071905|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2071906|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071907|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071908|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
2071909|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
2071910|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2071911|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2071912|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2071913|NCT01958489|Pravastatin|pravastatin|mesh-list
2071914|NCT01958489|Evacetrapib|evacetrapib|mesh-list
2071915|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2071916|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2071917|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
2071918|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071919|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2071920|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2071921|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212498|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2212499|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2212500|NCT00020657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2212501|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2212502|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
2212503|NCT00020670|Vaccines|vaccines|mesh-list
2212504|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
2212505|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212506|NCT00020696|Tirapazamine|tirapazamine|mesh-list
2212507|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212508|NCT00020709|Docetaxel|docetaxel|mesh-list
2212509|NCT00020709|Etoposide|etoposide|mesh-list
2212510|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
2212511|NCT00020709|Gefitinib|gefitinib|mesh-list
2212512|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212513|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212514|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212515|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212516|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212517|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2071933|NCT01958619|Artefenomel|artefenomel|mesh-list
2071934|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
2071935|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2071936|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2071937|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2071938|NCT01958671|Metformin|metformin|mesh-list
2071939|NCT01958671|Glimepiride|glimepiride|mesh-list
2071940|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
2071941|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2071942|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071943|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2071944|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2071945|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
2071946|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2071947|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071948|NCT01958827|Adalimumab|adalimumab|mesh-list
2071949|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2071950|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2071951|NCT01958918|Ranibizumab|ranibizumab|mesh-list
2071952|NCT01958918|Aflibercept|aflibercept|mesh-list
2071953|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2071954|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2071955|NCT01958918|Growth Substances|growth substances|mesh-ancestor
2071956|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071957|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
2071958|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2071959|NCT01959035|Aripiprazole|aripiprazole|mesh-list
2071960|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
2071961|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2071962|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2071963|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2071964|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2071965|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071966|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
2071967|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
2071968|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071969|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071970|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2071971|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2071972|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
2071973|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2071974|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2071975|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2071976|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2071977|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2071978|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2071979|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2071980|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2071981|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2071982|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2071983|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2071984|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
2071985|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2071986|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071987|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071988|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2071989|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2071990|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2071991|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2071992|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2071993|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2071994|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2071995|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
2071996|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2212518|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2212519|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212520|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212521|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2212522|NCT00020735|Toremifene|toremifene|mesh-list
2212523|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2212524|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212525|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2212526|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2212527|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
2212528|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2212529|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212530|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2212531|NCT00020748|Irinotecan|irinotecan|mesh-list
2212532|NCT00020748|Epirubicin|epirubicin|mesh-list
2212533|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2212534|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212535|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212536|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212537|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212538|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2071997|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2071998|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2071999|NCT01959334|Glucagon|glucagon|mesh-list
2072000|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2072001|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2072002|NCT01959334|Hormones|hormones|mesh-ancestor
2072003|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072004|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072005|NCT01959334|Incretins|incretins|mesh-ancestor
2072006|NCT01959464|Progesterone|progesterone|mesh-list
2072007|NCT01959464|Progestins|progestins|mesh-ancestor
2072008|NCT01959464|Hormones|hormones|mesh-ancestor
2072009|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072010|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212539|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2212540|NCT00020761|Paclitaxel|paclitaxel|mesh-list
2212541|NCT00020761|Irinotecan|irinotecan|mesh-list
2212542|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2212543|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212544|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212545|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212546|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212547|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212548|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2212549|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212550|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212551|NCT00020774|Gemcitabine|gemcitabine|mesh-list
2212552|NCT00020774|Lonafarnib|lonafarnib|mesh-list
2072011|NCT01959490|Paclitaxel|paclitaxel|mesh-list
2072012|NCT01959490|Docetaxel|docetaxel|mesh-list
2072013|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
2072014|NCT01959490|Bevacizumab|bevacizumab|mesh-list
2072015|NCT01959490|Carboplatin|carboplatin|mesh-list
2072016|NCT01959490|Doxorubicin|doxorubicin|mesh-list
2072017|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2072018|NCT01959490|Trastuzumab|trastuzumab|mesh-list
2072019|NCT01959490|Pertuzumab|pertuzumab|mesh-list
2212553|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212554|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
2212555|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212556|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212557|NCT00020774|Antiviral Agents|antiviral agents|mesh-ancestor
2212558|NCT00020774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212559|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212560|NCT00020774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212561|NCT00020774|Immunologic Factors|immunologic factors|mesh-ancestor
2212562|NCT00020774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072020|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2072021|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072022|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
2072023|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
2072024|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
2072025|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072026|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2072027|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
2212563|NCT00020787|Cisplatin|cisplatin|mesh-list
2212564|NCT00020787|Fluorouracil|fluorouracil|mesh-list
2212565|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212566|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
2212567|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212568|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212569|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212570|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
2212571|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072028|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072029|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2072030|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2072031|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
2072032|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2072033|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2072034|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2072035|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2072036|NCT01959490|Growth Substances|growth substances|mesh-ancestor
2072037|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
2072038|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2072039|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2072040|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2072041|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072042|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
2072043|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
2072044|NCT01959503|Coagulants|coagulants|mesh-ancestor
2212572|NCT00020800|Rituximab|rituximab|mesh-list
2212573|NCT00020800|Fludarabine|fludarabine|mesh-list
2212574|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
2212575|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2212576|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212577|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
2212578|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212579|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2212580|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212581|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
2212582|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212583|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212584|NCT00020839|Temozolomide|temozolomide|mesh-list
2072045|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
2072046|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
2072047|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2072048|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
2072049|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072050|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072051|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2072052|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
2072053|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
2072054|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2072055|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
2072056|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2072057|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072058|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2212585|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2212586|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
2212587|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212588|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212589|NCT00020865|Levofloxacin|levofloxacin|mesh-list
2212590|NCT00020865|Ofloxacin|ofloxacin|mesh-list
2212591|NCT00020865|Cefepime|cefepime|mesh-list
2212592|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2212593|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072059|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2072060|NCT01959529|Insulin|insulin|mesh-list
2072061|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2072062|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
2072063|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2072064|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072065|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
2072066|NCT01959672|Leucovorin|leucovorin|mesh-list
2072067|NCT01959672|Folic Acid|folic acid|mesh-list
2072068|NCT01959672|Gemcitabine|gemcitabine|mesh-list
2072069|NCT01959672|Nelfinavir|nelfinavir|mesh-list
2072070|NCT01959672|Fluorouracil|fluorouracil|mesh-list
2072071|NCT01959672|Oregovomab|oregovomab|mesh-list
2072072|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2072073|NCT01959672|Antibodies|antibodies|mesh-list
2072074|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
2072075|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2072076|NCT01959672|Calcium|calcium|mesh-list
2072077|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
2072078|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
2072079|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072080|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2072081|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
2072082|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072083|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072084|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
2072085|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072086|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072087|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2072088|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2749944|NCT04493216|Dolutegravir|dolutegravir|mesh-list
2749945|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2749946|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2749947|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2749948|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072089|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2072090|NCT01959672|Antidotes|antidotes|mesh-ancestor
2212594|NCT00020865|Renal Agents|renal agents|mesh-ancestor
2212595|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2212596|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2212597|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212598|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212599|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212600|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212601|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2212602|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2212603|NCT00020878|Celecoxib|celecoxib|mesh-list
2212604|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2212605|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2212606|NCT00020878|Analgesics|analgesics|mesh-ancestor
2212607|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
2072091|NCT01959672|Protective Agents|protective agents|mesh-ancestor
2072092|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
2072093|NCT01959672|Vitamins|vitamins|mesh-ancestor
2072094|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
2749949|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2749950|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2749951|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
2749952|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2749963|NCT04484675|Milrinone|milrinone|mesh-list
2749964|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2072095|NCT01959672|Hematinics|hematinics|mesh-ancestor
2072096|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2072097|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2072098|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
2072099|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2072100|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2749965|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2749966|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
2749967|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2749968|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2749969|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2749970|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072101|NCT01959685|Enclomiphene|enclomiphene|mesh-list
2072102|NCT01959685|Clomiphene|clomiphene|mesh-list
2072103|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
2072104|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2072105|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
2072106|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072107|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072108|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2072109|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
2072110|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2072111|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2072112|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2072113|NCT01959698|Rituximab|rituximab|mesh-list
2072114|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2072115|NCT01959698|Carboplatin|carboplatin|mesh-list
2072116|NCT01959698|Etoposide|etoposide|mesh-list
2072117|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
2072118|NCT01959698|Ifosfamide|ifosfamide|mesh-list
2072119|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
2072120|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
2072121|NCT01959698|Antibodies|antibodies|mesh-list
2072122|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
2072123|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2072124|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
2072125|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072126|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072127|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2072128|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2072129|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2072130|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2072131|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072132|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072133|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2072134|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
2072135|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
2072136|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
2072137|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
2072138|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
2072139|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
2072140|NCT01959841|Valacyclovir|valacyclovir|mesh-list
2072141|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
2072142|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072143|NCT01959919|Factor VIII|factor viii|mesh-list
2072144|NCT01959919|Coagulants|coagulants|mesh-ancestor
2072145|NCT01959945|Vaccines|vaccines|mesh-list
2072146|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
2072147|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
2072148|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072149|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
2072150|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
2072151|NCT01960075|Levetiracetam|levetiracetam|mesh-list
2072152|NCT01960075|Valproic Acid|valproic acid|mesh-list
2072153|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
2072154|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
2072155|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072156|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072157|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
2072158|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2072159|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072160|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
2072161|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2072162|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2072163|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2072164|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2072165|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2072166|NCT01960114|Acetaminophen|acetaminophen|mesh-list
2072167|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2072168|NCT01960114|Analgesics|analgesics|mesh-ancestor
2072169|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
2072170|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072171|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072172|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
2072173|NCT01960140|Simvastatin|simvastatin|mesh-list
2072174|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2072175|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2072176|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
2072177|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072178|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2072179|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2072180|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212608|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2212609|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212610|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2212611|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2212612|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2212613|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2212614|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2749971|NCT04484675|Protective Agents|protective agents|mesh-ancestor
2072181|NCT01960296|Clopidogrel|clopidogrel|mesh-list
2072182|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2072183|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2072184|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2072185|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2749972|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749973|NCT04483115|Tadalafil|tadalafil|mesh-list
2749974|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
2749975|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2749976|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2749977|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2749978|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749979|NCT04483115|Urological Agents|urological agents|mesh-ancestor
2749980|NCT04476277|Biotin|biotin|mesh-list
2749981|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
2749982|NCT04476277|Vitamins|vitamins|mesh-ancestor
2749983|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
2749984|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2749985|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
2749986|NCT04475939|Niraparib|niraparib|mesh-list
2749987|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2749988|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2749989|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2749990|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072186|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
2072187|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2072188|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072189|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072190|NCT01960387|Cytarabine|cytarabine|mesh-list
2072191|NCT01960387|Clofarabine|clofarabine|mesh-list
2072192|NCT01960387|Antimetabolites|antimetabolites|mesh-list
2072193|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2072194|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072195|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072196|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
2072197|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072198|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2072199|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
2072200|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072201|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
2072202|NCT01960413|Montelukast|montelukast|mesh-list
2072203|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2072204|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
2072205|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2072206|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
2072207|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072208|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072209|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2072210|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2072211|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072212|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072213|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
2072214|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212615|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212616|NCT00020917|Leucovorin|leucovorin|mesh-list
2212617|NCT00020917|Fluorouracil|fluorouracil|mesh-list
2212618|NCT00020917|Irinotecan|irinotecan|mesh-list
2212619|NCT00020917|Cetuximab|cetuximab|mesh-list
2212620|NCT00020917|Calcium|calcium|mesh-list
2212621|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
2212622|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2212623|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212624|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
2212625|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072215|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2072216|NCT01960530|Dexamethasone|dexamethasone|mesh-list
2072217|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
2072218|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2072219|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2212626|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212627|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212628|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212629|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
2212630|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2212631|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212632|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072220|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2072221|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2072222|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
2072223|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
2072224|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072225|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072226|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2072227|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
2072228|NCT01960530|Hormones|hormones|mesh-ancestor
2072229|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072230|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2072231|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072232|NCT01960842|Levodopa|levodopa|mesh-list
2072233|NCT01960842|Carbidopa|carbidopa|mesh-list
2212633|NCT00020917|Antidotes|antidotes|mesh-ancestor
2212634|NCT00020917|Protective Agents|protective agents|mesh-ancestor
2212635|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
2212636|NCT00020917|Vitamins|vitamins|mesh-ancestor
2212637|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
2212638|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2212639|NCT00020930|Cetuximab|cetuximab|mesh-list
2212640|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2212641|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212642|NCT00020943|Leucovorin|leucovorin|mesh-list
2212643|NCT00020943|Cytarabine|cytarabine|mesh-list
2212644|NCT00020943|Prednisone|prednisone|mesh-list
2072234|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2072235|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2212645|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
2212646|NCT00020943|Carmustine|carmustine|mesh-list
2072236|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2072237|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
2072238|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2072239|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072240|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072241|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2072242|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072243|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2072244|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
2072245|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
2072246|NCT01960855|Upadacitinib|upadacitinib|mesh-list
2072247|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2072248|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2072249|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072250|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072251|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2072252|NCT01961271|Buprenorphine|buprenorphine|mesh-list
2072253|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2072254|NCT01961271|Narcotics|narcotics|mesh-ancestor
2072255|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2072256|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072257|NCT01961271|Analgesics|analgesics|mesh-ancestor
2072258|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
2072259|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072260|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2072261|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
2072262|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2072263|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2072264|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
2072265|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
2072266|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2072267|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072268|NCT01961323|Nebivolol|nebivolol|mesh-list
2072269|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2072270|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
2212647|NCT00020943|Rituximab|rituximab|mesh-list
2212648|NCT00020943|Doxorubicin|doxorubicin|mesh-list
2212649|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2212650|NCT00020943|Methotrexate|methotrexate|mesh-list
2212651|NCT00020943|Etoposide|etoposide|mesh-list
2212652|NCT00020943|Vincristine|vincristine|mesh-list
2072271|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2072272|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2072273|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2072274|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
2072275|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2072276|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072277|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072278|NCT01961349|Propofol|propofol|mesh-list
2072279|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2072280|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2212653|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
2212654|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212655|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
2212656|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212657|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2212658|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2212659|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
2212660|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072281|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2072282|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072283|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2072284|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
2072285|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
2072286|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2072287|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2072288|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2072289|NCT01962103|Paclitaxel|paclitaxel|mesh-list
2072290|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2072291|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2072292|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072293|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
2072294|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
2072295|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
2072296|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072297|NCT01962298|Rocuronium|rocuronium|mesh-list
2072298|NCT01962298|Neostigmine|neostigmine|mesh-list
2072299|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2072300|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2072301|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2072302|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072303|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072304|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2072305|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072306|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072307|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
2072308|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2072309|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2072310|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
2072311|NCT01962428|Ticagrelor|ticagrelor|mesh-list
2072312|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2072313|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2072314|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2072315|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2212661|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212662|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2212663|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2212664|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2072316|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
2072317|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2072318|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072319|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072320|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
2072321|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
2072322|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072323|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
2072324|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2072325|NCT01962493|Listerine|listerine|mesh-list
2072326|NCT01962493|Fluorides|fluorides|mesh-list
2072327|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
2072328|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
2072329|NCT01962493|Protective Agents|protective agents|mesh-ancestor
2072330|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072331|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2072332|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072333|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
2072334|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
2072335|NCT01962688|Diuretics|diuretics|mesh-list
2072336|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
2212665|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2212666|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212667|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212668|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2212669|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
2212670|NCT00020943|Hormones|hormones|mesh-ancestor
2212671|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2212672|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2212673|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2212674|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
2212675|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2212676|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212677|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
2212678|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
2212679|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2212680|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2212681|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2212682|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
2212683|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212684|NCT00020943|Antidotes|antidotes|mesh-ancestor
2212685|NCT00020943|Protective Agents|protective agents|mesh-ancestor
2212686|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
2212687|NCT00020943|Vitamins|vitamins|mesh-ancestor
2212688|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
2212689|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212690|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212691|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212692|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
2212693|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212694|NCT00021034|Taurolidine|taurolidine|mesh-list
2212695|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212696|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2212697|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212698|NCT00021047|Carboplatin|carboplatin|mesh-list
2212699|NCT00021047|Capecitabine|capecitabine|mesh-list
2212700|NCT00021047|Epirubicin|epirubicin|mesh-list
2212701|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212702|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212703|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
2212704|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212705|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2212706|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2749991|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2749994|NCT04460937|Adavosertib|adavosertib|mesh-list
2749995|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2749996|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072337|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072338|NCT01962870|Vasopressins|vasopressins|mesh-list
2072339|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
2072340|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
2072341|NCT01962870|Coagulants|coagulants|mesh-ancestor
2072342|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2072343|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2072344|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
2072345|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072346|NCT01962896|Sirolimus|sirolimus|mesh-list
2072347|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2072348|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072349|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2072350|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072351|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072352|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2072353|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072354|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2072355|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
2072356|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2072357|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
2072358|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072359|NCT01962922|Tacrolimus|tacrolimus|mesh-list
2072360|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2072361|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
2072362|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072363|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2072364|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072365|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072366|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
2072367|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2072368|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
2072369|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072370|NCT01962961|Expectorants|expectorants|mesh-ancestor
2072371|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
2072372|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2072373|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
2072374|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072375|NCT01962961|Protective Agents|protective agents|mesh-ancestor
2072376|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072377|NCT01962961|Antidotes|antidotes|mesh-ancestor
2072378|NCT01962987|Diclofenac|diclofenac|mesh-list
2072379|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2072380|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2072381|NCT01962987|Analgesics|analgesics|mesh-ancestor
2072382|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
2072383|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072384|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072385|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2072386|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2072387|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2072388|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072389|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072390|NCT01963078|Oxytocin|oxytocin|mesh-list
2072391|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
2072392|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2072393|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072394|NCT01963091|Oxytocin|oxytocin|mesh-list
2072395|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
2072396|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2072397|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072398|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
2072399|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2072400|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2072401|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
2212707|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212708|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212709|NCT00021060|Paclitaxel|paclitaxel|mesh-list
2072402|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072403|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
2072404|NCT01963481|Exemestane|exemestane|mesh-list
2072405|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2072406|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
2072407|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072408|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2072409|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2072410|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
2072411|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072412|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072413|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2072414|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2072415|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2072416|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072417|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2072418|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
2072419|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072420|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
2072421|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2072422|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
2072423|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072424|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2072425|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2072426|NCT01963793|Aprepitant|aprepitant|mesh-list
2072427|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
2072428|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
2072429|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
2072430|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072431|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072432|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2072433|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2072434|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2072435|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072436|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2072437|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2072438|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072439|NCT01963845|Incretins|incretins|mesh-ancestor
2072440|NCT01963845|Hormones|hormones|mesh-ancestor
2072441|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072442|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2072443|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
2072444|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072445|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072446|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2072447|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
2072448|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072449|NCT01964326|Atorvastatin|atorvastatin|mesh-list
2072450|NCT01964326|Calcium|calcium|mesh-list
2072451|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2072452|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072453|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2072454|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2072455|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
2072456|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212710|NCT00021060|Bevacizumab|bevacizumab|mesh-list
2212711|NCT00021060|Carboplatin|carboplatin|mesh-list
2212712|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2212713|NCT00021060|Antibodies|antibodies|mesh-list
2212714|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
2212715|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2212716|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2212717|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212718|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212719|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212720|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212721|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212722|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2072457|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2072458|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2072459|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072460|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
2072461|NCT01964352|Olodaterol|olodaterol|mesh-list
2072462|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2072463|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
2072464|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072465|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072466|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2072467|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
2072468|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
2072469|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2072470|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
2072471|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2072472|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072473|NCT01964378|Morphine|morphine|mesh-list
2072474|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2072475|NCT01964378|Narcotics|narcotics|mesh-ancestor
2072476|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2072477|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072478|NCT01964378|Analgesics|analgesics|mesh-ancestor
2072479|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
2072480|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072481|NCT01964430|Gemcitabine|gemcitabine|mesh-list
2212723|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2072482|NCT01964430|Paclitaxel|paclitaxel|mesh-list
2212724|NCT00021060|Growth Substances|growth substances|mesh-ancestor
2072483|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2072484|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072485|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
2072486|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
2072487|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
2072488|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072489|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2072490|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
2072491|NCT01964430|Antiviral Agents|antiviral agents|mesh-ancestor
2072492|NCT01964430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072493|NCT01964430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072494|NCT01964430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2072495|NCT01964430|Immunologic Factors|immunologic factors|mesh-ancestor
2072496|NCT01964430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072497|NCT01964547|Nabiximols|nabiximols|mesh-list
2072498|NCT01964547|Analgesics|analgesics|mesh-ancestor
2072499|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
2072500|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072501|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072502|NCT01964716|Vaccines|vaccines|mesh-list
2072503|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2072504|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
2072505|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072506|NCT01964755|Leucovorin|leucovorin|mesh-list
2072507|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
2072508|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
2072509|NCT01964755|Zidovudine|zidovudine|mesh-list
2072510|NCT01964755|Rituximab|rituximab|mesh-list
2072511|NCT01964755|Doxorubicin|doxorubicin|mesh-list
2072512|NCT01964755|Methotrexate|methotrexate|mesh-list
2072513|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
2072514|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
2072515|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2072516|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072517|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
2072518|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072519|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2072520|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2072521|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2072522|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2072523|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072524|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072525|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2072526|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
2072527|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2072528|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2072529|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
2072530|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
2072531|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2072532|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2072533|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2072534|NCT01964755|Antidotes|antidotes|mesh-ancestor
2072535|NCT01964755|Protective Agents|protective agents|mesh-ancestor
2072536|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
2072537|NCT01964755|Vitamins|vitamins|mesh-ancestor
2072538|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
2072539|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2072540|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
2072541|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072542|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2072543|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2072544|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
2072545|NCT01964898|Nicotine|nicotine|mesh-list
2072546|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2072547|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
2072548|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072549|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072550|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2072551|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2072552|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
2072553|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2212725|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072554|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072555|NCT01964924|Trametinib|trametinib|mesh-list
2072556|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072557|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2072558|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072559|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072560|NCT01964963|Alogliptin|alogliptin|mesh-list
2072561|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2072562|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072563|NCT01964963|Incretins|incretins|mesh-ancestor
2072564|NCT01964963|Hormones|hormones|mesh-ancestor
2072565|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072566|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2072567|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
2072568|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072569|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072570|NCT01965002|Aspirin|aspirin|mesh-list
2072571|NCT01965002|Enoxaparin|enoxaparin|mesh-list
2072572|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2072573|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2072574|NCT01965002|Analgesics|analgesics|mesh-ancestor
2072575|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
2072576|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072577|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072578|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2072579|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2072580|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2072581|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2072582|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072583|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2072584|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2072585|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072586|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
2072587|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
2072588|NCT01965327|Interferons|interferons|mesh-list
2072589|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
2072590|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072591|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
2072592|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072593|NCT01965366|Dexamethasone|dexamethasone|mesh-list
2072594|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2072595|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
2072596|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
2072597|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072598|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072599|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2072600|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
2072601|NCT01965366|Hormones|hormones|mesh-ancestor
2072602|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072603|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2072604|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072605|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
2072606|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2072607|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072608|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2072609|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2072610|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072611|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072612|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072613|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
2072614|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2072615|NCT01965535|Ledipasvir|ledipasvir|mesh-list
2072616|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
2072617|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072618|NCT01965756|Metformin|metformin|mesh-list
2072619|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2072620|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072621|NCT01965834|Fenofibrate|fenofibrate|mesh-list
2072622|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
2072623|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2072624|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
2072625|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072626|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2072627|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2072628|NCT01966003|Paclitaxel|paclitaxel|mesh-list
2072629|NCT01966003|Bevacizumab|bevacizumab|mesh-list
2072630|NCT01966003|Carboplatin|carboplatin|mesh-list
2072631|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2072632|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072633|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
2072634|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
2072635|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
2072636|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072637|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2072638|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2072639|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2072640|NCT01966003|Growth Substances|growth substances|mesh-ancestor
2072641|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072642|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
2072643|NCT01966107|Bromides|bromides|mesh-list
2072644|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
2072645|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2072646|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2072647|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
2072648|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
2072649|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2072650|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
2072651|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072652|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212726|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
2212727|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
2212728|NCT00021073|Leucovorin|leucovorin|mesh-list
2212729|NCT00021073|Fluorouracil|fluorouracil|mesh-list
2750022|NCT04452383|Ketamine|ketamine|mesh-list
2750023|NCT04452383|Propofol|propofol|mesh-list
2750024|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2750025|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2750026|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750027|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2750028|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
2750029|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
2750030|NCT04452383|Analgesics|analgesics|mesh-ancestor
2750031|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
2750032|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2750033|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2750034|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2750035|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2750036|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2750037|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072682|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2072683|NCT01966718|Hormones|hormones|mesh-ancestor
2072684|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072685|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750038|NCT04447755|Lenvatinib|lenvatinib|mesh-list
2212730|NCT00021073|Irinotecan|irinotecan|mesh-list
2212731|NCT00021073|Alvocidib|alvocidib|mesh-list
2750039|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750040|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2750041|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750042|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072692|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2072693|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072694|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
2072695|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2072696|NCT01966978|Insulin|insulin|mesh-list
2072697|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2072698|NCT01966978|Metformin|metformin|mesh-list
2072699|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
2072700|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
2072701|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2072702|NCT01966978|Liraglutide|liraglutide|mesh-list
2072703|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
2072704|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2072705|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072706|NCT01966978|Incretins|incretins|mesh-ancestor
2072707|NCT01966978|Hormones|hormones|mesh-ancestor
2072708|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072709|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2072710|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2072711|NCT01967173|Fluticasone|fluticasone|mesh-list
2072712|NCT01967173|Xhance|xhance|mesh-list
2072713|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2072714|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2072715|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
2072716|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072717|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072718|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2072719|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
2072720|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
2072721|NCT01967173|Hormones|hormones|mesh-ancestor
2072722|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072723|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
2072724|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2072725|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
2072726|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2072727|NCT01967225|Linezolid|linezolid|mesh-list
2072728|NCT01967225|Tedizolid|tedizolid|mesh-list
2072729|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
2072730|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2072731|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072732|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2072733|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072734|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072735|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
2072736|NCT01967433|Promethazine|promethazine|mesh-list
2072737|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2072738|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2072739|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2072740|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072741|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
2072742|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
2072743|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
2072744|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072745|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
2072746|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
2072747|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2072748|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2072749|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
2072750|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
2072751|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2072752|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072753|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2072754|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
2072755|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
2072756|NCT01967550|Diclofenac|diclofenac|mesh-list
2072757|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2072758|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2072759|NCT01967550|Analgesics|analgesics|mesh-ancestor
2072760|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
2072761|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072762|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072763|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2072764|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2072765|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2072766|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072767|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072768|NCT01967576|Axitinib|axitinib|mesh-list
2072769|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072770|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2072771|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072772|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072773|NCT01967628|Vitamin D|vitamin d|mesh-list
2072774|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
2072775|NCT01967628|Vitamins|vitamins|mesh-ancestor
2072776|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
2072777|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072778|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2072779|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2072780|NCT01967641|Buprenorphine|buprenorphine|mesh-list
2072781|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2072782|NCT01967641|Naloxone|naloxone|mesh-list
2072783|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2072784|NCT01967641|Narcotics|narcotics|mesh-ancestor
2072785|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2072786|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072787|NCT01967641|Analgesics|analgesics|mesh-ancestor
2072788|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
2072789|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072790|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2072807|NCT01967862|Listerine|listerine|mesh-list
2072808|NCT01967862|Fluorides|fluorides|mesh-list
2072809|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
2072810|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
2072811|NCT01967862|Protective Agents|protective agents|mesh-ancestor
2072812|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072813|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2072814|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072815|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2072816|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2072817|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2072818|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2072819|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
2072820|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072821|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072822|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2072823|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2072824|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
2072825|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072826|NCT01968031|Istradefylline|istradefylline|mesh-list
2072827|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2072828|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2072829|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2072830|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
2072831|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2072832|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072833|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072834|NCT01968057|Cyclosporine|cyclosporine|mesh-list
2072835|NCT01968057|Cyclosporins|cyclosporins|mesh-list
2072836|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072837|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072838|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2072839|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
2072840|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072841|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
2072842|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072843|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
2072844|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2072845|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2750065|NCT04438824|Palbociclib|palbociclib|mesh-list
2750066|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750067|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2750068|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750069|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750070|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2750071|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
2750072|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072846|NCT01968070|Celecoxib|celecoxib|mesh-list
2072847|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2072848|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2072849|NCT01968070|Analgesics|analgesics|mesh-ancestor
2072850|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
2072851|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072852|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072853|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2072854|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2072855|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2072856|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2072857|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072858|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072859|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
2072860|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
2072861|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2072862|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2072863|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072864|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2072865|NCT01968213|Rucaparib|rucaparib|mesh-list
2072866|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2072867|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072868|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072869|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072870|NCT01968317|Metformin|metformin|mesh-list
2072871|NCT01968317|Megestrol|megestrol|mesh-list
2072872|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
2072873|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2072874|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072875|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2072876|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2072877|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2072878|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
2072879|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2072880|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2072881|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2072882|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2072883|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072884|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
2072885|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2072886|NCT01968356|Ethanol|ethanol|mesh-list
2072887|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
2072888|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2072889|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2072890|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212732|NCT00021073|Calcium|calcium|mesh-list
2212733|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
2212734|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2212735|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212736|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
2212737|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212738|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212739|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212740|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212741|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
2212742|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2212743|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212744|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212745|NCT00021073|Antidotes|antidotes|mesh-ancestor
2212746|NCT00021073|Protective Agents|protective agents|mesh-ancestor
2212747|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
2212748|NCT00021073|Vitamins|vitamins|mesh-ancestor
2212749|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
2212750|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
2072891|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2072892|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072893|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
2072894|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
2072895|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
2072896|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2072897|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
2072898|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072899|NCT01968434|Carbocysteine|carbocysteine|mesh-list
2072900|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2072901|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072902|NCT01968434|Expectorants|expectorants|mesh-ancestor
2072903|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
2072904|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2072905|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2072906|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2072907|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
2072908|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072909|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
2072910|NCT01968694|Promethazine|promethazine|mesh-list
2072911|NCT01968694|Lidocaine|lidocaine|mesh-list
2072912|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
2072913|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
2072914|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2072915|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072916|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
2072917|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2072918|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2072919|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2072920|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2072921|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2212751|NCT00021073|Growth Substances|growth substances|mesh-ancestor
2212752|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2072922|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072923|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2072924|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2072925|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
2072926|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
2072927|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2072928|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2072929|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
2072930|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
2072931|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2072932|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2072933|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
2072934|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
2072935|NCT01968707|Ethanol|ethanol|mesh-list
2072936|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
2072937|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2072938|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2072939|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072940|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2072941|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072942|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
2072943|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
2072944|NCT01968954|Bococizumab|bococizumab|mesh-list
2072945|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2072946|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2072947|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
2072948|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072949|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2072950|NCT01968967|Bococizumab|bococizumab|mesh-list
2072951|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2072952|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2072953|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
2072954|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072955|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2072956|NCT01968980|Bococizumab|bococizumab|mesh-list
2072957|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2072958|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2072959|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
2072960|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072961|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2072962|NCT01969058|Isotretinoin|isotretinoin|mesh-list
2072963|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
2072964|NCT01969084|Linagliptin|linagliptin|mesh-list
2072965|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2072966|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072967|NCT01969084|Incretins|incretins|mesh-ancestor
2072968|NCT01969084|Hormones|hormones|mesh-ancestor
2072969|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072970|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2072971|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
2072972|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072973|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072974|NCT01969201|Hormones|hormones|mesh-list
2072975|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2072976|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2072983|NCT01969435|Cytarabine|cytarabine|mesh-list
2072984|NCT01969435|Etoposide|etoposide|mesh-list
2072985|NCT01969435|Melphalan|melphalan|mesh-list
2072986|NCT01969435|Carmustine|carmustine|mesh-list
2072987|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
2072988|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2072989|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072990|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2072991|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2072992|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2072993|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2072994|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212753|NCT00021099|Epothilones|epothilones|mesh-list
2212754|NCT00021099|Epothilone B|epothilone b|mesh-list
2212755|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212756|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212757|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212758|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212759|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212760|NCT00021112|Etoposide|etoposide|mesh-list
2212761|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2072995|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
2072996|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
2072997|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2072998|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2072999|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
2073000|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073001|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2073002|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
2073003|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2073004|NCT01969708|Bevacizumab|bevacizumab|mesh-list
2073005|NCT01969708|Aflibercept|aflibercept|mesh-list
2073006|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2073007|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073008|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2073009|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2073010|NCT01969708|Growth Substances|growth substances|mesh-ancestor
2073011|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073012|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
2073013|NCT01969721|Fluticasone|fluticasone|mesh-list
2073014|NCT01969721|Xhance|xhance|mesh-list
2073015|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
2073016|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2073017|NCT01969721|Olodaterol|olodaterol|mesh-list
2073018|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073019|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2073020|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
2073021|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073022|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073023|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2073024|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
2073025|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
2073026|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2073027|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
2073028|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2073029|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
2073030|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073031|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073032|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2073033|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2073034|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2073035|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
2073036|NCT01969747|Empagliflozin|empagliflozin|mesh-list
2073037|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2073038|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073039|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2073040|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073041|NCT01969799|Amikacin|amikacin|mesh-list
2073042|NCT01969799|Fosfomycin|fosfomycin|mesh-list
2073043|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2073044|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2073045|NCT01969851|Lacosamide|lacosamide|mesh-list
2073046|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
2073047|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2073048|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2073049|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2073050|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073051|NCT01969916|Regadenoson|regadenoson|mesh-list
2073052|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2073053|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2073054|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
2073055|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
2073056|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073057|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073058|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073059|NCT01970176|Tadalafil|tadalafil|mesh-list
2073060|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
2073061|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2073062|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2073063|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073064|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073065|NCT01970176|Urological Agents|urological agents|mesh-ancestor
2073066|NCT01970241|Insulin|insulin|mesh-list
2073067|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2073068|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2073069|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073070|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2073071|NCT01970371|Meropenem|meropenem|mesh-list
2073072|NCT01970371|Colistin|colistin|mesh-list
2073073|NCT01970371|Tigecycline|tigecycline|mesh-list
2073074|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2073075|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2073076|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073077|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073078|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
2073079|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2073080|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
2073081|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073082|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
2073083|NCT01970397|Protective Agents|protective agents|mesh-ancestor
2073084|NCT01970475|Adalimumab|adalimumab|mesh-list
2073085|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073086|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073087|NCT01970488|Adalimumab|adalimumab|mesh-list
2073088|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073089|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073090|NCT01970527|Ipilimumab|ipilimumab|mesh-list
2073091|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2073092|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073093|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2073094|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073095|NCT01970540|Doxorubicin|doxorubicin|mesh-list
2073096|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2073097|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073098|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2073099|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2073100|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073101|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073102|NCT01970865|Crizotinib|crizotinib|mesh-list
2073103|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073104|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2073105|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073106|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073107|NCT01970878|Bromides|bromides|mesh-list
2073108|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
2073109|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2073110|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
2073111|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073112|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073113|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2073114|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
2073115|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
2073116|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2073117|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
2073118|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073119|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073120|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
2073121|NCT01970995|Menthol|menthol|mesh-list
2073122|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
2073123|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
2073124|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2073125|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
2073126|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2073127|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2073128|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2073129|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2073130|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073131|NCT01971346|Etanercept|etanercept|mesh-list
2073132|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2073133|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2073134|NCT01971346|Analgesics|analgesics|mesh-ancestor
2073135|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
2073136|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073137|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073138|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073139|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073140|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2073141|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2073142|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
2073143|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2073144|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
2073145|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2073146|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
2073147|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073148|NCT01971580|Ambrisentan|ambrisentan|mesh-list
2073149|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2073150|NCT01971593|Eplerenone|eplerenone|mesh-list
2073151|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2073152|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
2073153|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2073154|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073155|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2073156|NCT01971593|Diuretics|diuretics|mesh-ancestor
2073157|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
2073158|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2073159|NCT01971645|Dexamethasone|dexamethasone|mesh-list
2073160|NCT01971645|Ropivacaine|ropivacaine|mesh-list
2073161|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073162|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
2073163|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
2073164|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073165|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073166|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2073167|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
2073168|NCT01971645|Hormones|hormones|mesh-ancestor
2073169|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2073170|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2073171|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073172|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
2073173|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
2073174|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2073175|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
2073176|NCT01972074|Memantine|memantine|mesh-list
2073177|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2073178|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2073179|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
2073180|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073181|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073182|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073183|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2073184|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2073185|NCT01972152|Glucagon|glucagon|mesh-list
2073186|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2073187|NCT01972152|Hormones|hormones|mesh-ancestor
2073188|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2073189|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073203|NCT01972464|Progesterone|progesterone|mesh-list
2073204|NCT01972464|Progestins|progestins|mesh-ancestor
2073205|NCT01972464|Hormones|hormones|mesh-ancestor
2073206|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2073207|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073208|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
2073209|NCT01972659|Analgesics|analgesics|mesh-ancestor
2073210|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
2073211|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073212|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073213|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
2073214|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2073215|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2073216|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
2073217|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2073218|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2073219|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073220|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2073221|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
2073222|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2073223|NCT01972724|Metformin|metformin|mesh-list
2073224|NCT01972724|Pioglitazone|pioglitazone|mesh-list
2073225|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2073226|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073227|NCT01972789|Ranibizumab|ranibizumab|mesh-list
2073228|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2073229|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2073230|NCT01972789|Growth Substances|growth substances|mesh-ancestor
2073231|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073232|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
2073233|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073234|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
2073235|NCT01972841|Mirabegron|mirabegron|mesh-list
2073236|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2073237|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2073238|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
2073239|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073240|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073241|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073242|NCT01972841|Urological Agents|urological agents|mesh-ancestor
2073243|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2073244|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2073245|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2073246|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
2073247|NCT01973036|Oxytocin|oxytocin|mesh-list
2073248|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
2073249|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2073250|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073251|NCT01973205|Aspirin|aspirin|mesh-list
2073252|NCT01973205|Acetaminophen|acetaminophen|mesh-list
2073253|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2073254|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2073255|NCT01973205|Analgesics|analgesics|mesh-ancestor
2073256|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
2073257|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073258|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073259|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073260|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073261|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2073262|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2073263|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073264|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2073265|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2073266|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073267|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
2073268|NCT01973218|Vaccines|vaccines|mesh-list
2073269|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
2073270|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073271|NCT01973231|Liraglutide|liraglutide|mesh-list
2073272|NCT01973231|Lixisenatide|lixisenatide|mesh-list
2073273|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2073274|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073275|NCT01973231|Incretins|incretins|mesh-ancestor
2073276|NCT01973231|Hormones|hormones|mesh-ancestor
2073277|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2073278|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2073279|NCT01973283|Citalopram|citalopram|mesh-list
2073280|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
2073281|NCT01973283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2073282|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2073283|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2073284|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073285|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073286|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
2073287|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073288|NCT01973283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2073289|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2073290|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073291|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2073292|NCT01973283|Analgesics|analgesics|mesh-ancestor
2073293|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
2073294|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
2073295|NCT01973335|Spironolactone|spironolactone|mesh-list
2073296|NCT01973335|Acetazolamide|acetazolamide|mesh-list
2073297|NCT01973335|Bumetanide|bumetanide|mesh-list
2073298|NCT01973335|Diuretics|diuretics|mesh-list
2073299|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
2073300|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2073301|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
2073302|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2073303|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073304|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2073305|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
2073306|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
2073307|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2073308|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073309|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073310|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2073311|NCT01973348|Methamphetamine|methamphetamine|mesh-list
2073312|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2073313|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073314|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
2073315|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
2073316|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073317|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
2073318|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073319|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073320|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
2073321|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2073322|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2073323|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2073324|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2073325|NCT01973387|Rituximab|rituximab|mesh-list
2073326|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2073327|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073328|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
2073329|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073330|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073331|NCT01973413|Insulin|insulin|mesh-list
2073332|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2073333|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073334|NCT01973439|Abacavir|abacavir|mesh-list
2073335|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
2073336|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2073337|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2073338|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073339|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073340|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
2073341|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2073342|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2073343|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2073344|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
2073345|NCT01973569|Denosumab|denosumab|mesh-list
2073346|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2073347|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073348|NCT01974141|Dapsone|dapsone|mesh-list
2073349|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2073350|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
2073351|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2073352|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2073353|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2073354|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073355|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073356|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
2073357|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2073358|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
2073359|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2073360|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212762|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2073361|NCT01974245|Vitamins|vitamins|mesh-ancestor
2073362|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
2073363|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2073364|NCT01974323|Dapsone|dapsone|mesh-list
2073365|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2073366|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
2073367|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2073368|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2073369|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2073370|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073371|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073372|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
2073373|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2073374|NCT01974687|Itraconazole|itraconazole|mesh-list
2073375|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
2073376|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
2073377|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2073378|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2073379|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2073380|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073381|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073382|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2073383|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
2073384|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2073385|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073386|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2073387|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
2073388|NCT01974700|Levetiracetam|levetiracetam|mesh-list
2073389|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
2073390|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
2073391|NCT01974752|Dacarbazine|dacarbazine|mesh-list
2073392|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2073393|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
2073394|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073395|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073396|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2073397|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
2073398|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073399|NCT01975220|Metformin|metformin|mesh-list
2073400|NCT01975220|Empagliflozin|empagliflozin|mesh-list
2073401|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2073402|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073403|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2073404|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073405|NCT01975246|Amlodipine|amlodipine|mesh-list
2073406|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2073407|NCT01975246|Telmisartan|telmisartan|mesh-list
2073408|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2073409|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2073410|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2073411|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2073412|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073413|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2073414|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073415|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
2073416|NCT01975246|Diuretics|diuretics|mesh-ancestor
2073417|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
2073418|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2073419|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2073420|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2073421|NCT01975285|Dexamethasone|dexamethasone|mesh-list
2073422|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073423|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
2073424|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
2073425|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073426|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073427|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2073428|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
2073429|NCT01975285|Hormones|hormones|mesh-ancestor
2073430|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2073431|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2073432|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073433|NCT01975376|Bococizumab|bococizumab|mesh-list
2073434|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2073435|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2073436|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
2073437|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073438|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2073439|NCT01975389|Bococizumab|bococizumab|mesh-list
2073440|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2073441|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2073442|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
2073443|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073444|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2073445|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2073446|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
2073447|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073448|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
2073449|NCT01975675|Ledipasvir|ledipasvir|mesh-list
2073450|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
2073451|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2073452|NCT01975701|Infigratinib|infigratinib|mesh-list
2073453|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073454|NCT01975831|Durvalumab|durvalumab|mesh-list
2073455|NCT01975831|Tremelimumab|tremelimumab|mesh-list
2073456|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2073457|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073458|NCT01975935|Amlexanox|amlexanox|mesh-list
2073459|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2750073|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2750074|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
2750075|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073463|NCT01976312|Ranibizumab|ranibizumab|mesh-list
2073464|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2073465|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2073466|NCT01976312|Growth Substances|growth substances|mesh-ancestor
2073467|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073468|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
2073469|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073470|NCT01976338|Ranibizumab|ranibizumab|mesh-list
2073471|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2073472|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2073473|NCT01976338|Growth Substances|growth substances|mesh-ancestor
2073474|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073475|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
2073476|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073477|NCT01976364|Methotrexate|methotrexate|mesh-list
2073478|NCT01976364|Tofacitinib|tofacitinib|mesh-list
2073479|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2073480|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
2073481|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2073482|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073483|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2073484|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
2073485|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073486|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073487|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
2073488|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073489|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2073490|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2073491|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
2073492|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073493|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2073494|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2073495|NCT01976390|Sirolimus|sirolimus|mesh-list
2073496|NCT01976390|Everolimus|everolimus|mesh-list
2073497|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073498|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2073499|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
2073500|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073501|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2073502|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2073503|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2073504|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
2073505|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
2073506|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073507|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
2073508|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073509|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073510|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2073511|NCT01976507|Dabigatran|dabigatran|mesh-list
2073512|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
2073513|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2073514|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
2073515|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073516|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073517|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
2073518|NCT01976572|Candesartan|candesartan|mesh-list
2073519|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2073520|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2073521|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2073522|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073523|NCT01976624|Timolol|timolol|mesh-list
2073524|NCT01976624|Bimatoprost|bimatoprost|mesh-list
2073525|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2073526|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2073527|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
2073528|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073529|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073530|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073531|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2073532|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2073533|NCT01976650|Dexamethasone|dexamethasone|mesh-list
2073534|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073535|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
2073536|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
2073537|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073538|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073539|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2073540|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
2073541|NCT01976650|Hormones|hormones|mesh-ancestor
2073542|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2073543|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2073544|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073545|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2073546|NCT01976728|Hormones|hormones|mesh-ancestor
2073547|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2073548|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073549|NCT01976806|Aspirin|aspirin|mesh-list
2073550|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2073551|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2073552|NCT01976806|Analgesics|analgesics|mesh-ancestor
2073553|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
2073554|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073555|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073556|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073557|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073558|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2073559|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2073560|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073561|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2073562|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2073563|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073564|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
2073565|NCT01976845|Midazolam|midazolam|mesh-list
2073566|NCT01976845|Propofol|propofol|mesh-list
2073567|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2073568|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2073569|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073570|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2073571|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
2073572|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
2073573|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2073574|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2073575|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2073576|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2073577|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
2073578|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
2073579|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073580|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073581|NCT01976871|Rotigotine|rotigotine|mesh-list
2073582|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
2073583|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
2073584|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073585|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073586|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073587|NCT01976988|Heparin|heparin|mesh-list
2073588|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
2073589|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2073590|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2073591|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073592|NCT01977352|Bupivacaine|bupivacaine|mesh-list
2073593|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
2073594|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
2073595|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2073596|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073597|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
2073598|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073599|NCT01977456|Eptifibatide|eptifibatide|mesh-list
2073600|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2073601|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2073602|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2073603|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073604|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2073605|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2073606|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2073607|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073608|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
2073609|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073610|NCT01977677|Plerixafor|plerixafor|mesh-list
2073611|NCT01977677|Temozolomide|temozolomide|mesh-list
2073612|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2073613|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
2073614|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073615|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073616|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2073617|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2073618|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
2073619|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2073620|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
2073621|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2073622|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2073623|NCT01977781|Prednisolone|prednisolone|mesh-list
2073624|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
2073625|NCT01977781|Tacrolimus|tacrolimus|mesh-list
2073626|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2073627|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
2073628|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2073629|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
2073630|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073631|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2073632|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073633|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073634|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073635|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
2073636|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
2073637|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073638|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2073639|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
2073640|NCT01977781|Hormones|hormones|mesh-ancestor
2073641|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2073642|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2073643|NCT01977781|Protective Agents|protective agents|mesh-ancestor
2750076|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750077|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2750078|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2750079|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2212763|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2212764|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212765|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212766|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212767|NCT00021138|Nicotine|nicotine|mesh-list
2212768|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2212769|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
2212770|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2212771|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212772|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2073644|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2073645|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073646|NCT01977794|Amlodipine|amlodipine|mesh-list
2073647|NCT01977794|Bisoprolol|bisoprolol|mesh-list
2073648|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2750080|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
2750081|NCT04436913|Fluorides|fluorides|mesh-list
2750082|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
2750083|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
2750084|NCT04436913|Protective Agents|protective agents|mesh-ancestor
2750085|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750086|NCT04418401|Antibodies|antibodies|mesh-list
2073649|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2073650|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2073651|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073652|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2073653|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073654|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
2073655|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
2212773|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2212774|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
2212775|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2212776|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212777|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
2212778|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2212779|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212780|NCT00021164|Aldesleukin|aldesleukin|mesh-list
2212781|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
2212782|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212783|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2212784|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2073656|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
2073657|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2212785|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
2073658|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2073659|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2073660|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2073661|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
2073662|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073663|NCT01977898|Morphine|morphine|mesh-list
2073664|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2073665|NCT01977898|Narcotics|narcotics|mesh-ancestor
2073666|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2073667|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073668|NCT01977898|Analgesics|analgesics|mesh-ancestor
2073669|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
2073670|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073671|NCT01977937|Gabapentin|gabapentin|mesh-list
2073672|NCT01977937|Analgesics|analgesics|mesh-ancestor
2073673|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
2073674|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073675|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073676|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
2073677|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2073678|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2073679|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2073680|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2073681|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2073682|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2073683|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073684|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073685|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
2073686|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2073687|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
2073688|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073689|NCT01978184|Gemcitabine|gemcitabine|mesh-list
2073690|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
2073691|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2073692|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2073693|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
2073694|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073695|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212786|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212787|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2212788|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
2212789|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212790|NCT00021216|Bortezomib|bortezomib|mesh-list
2212791|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212792|NCT00021242|Docetaxel|docetaxel|mesh-list
2073696|NCT01978184|Antiviral Agents|antiviral agents|mesh-ancestor
2073697|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2073698|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073699|NCT01978184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2073700|NCT01978184|Immunologic Factors|immunologic factors|mesh-ancestor
2073701|NCT01978184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073702|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
2073703|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2212793|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212794|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212795|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
2073704|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2073705|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073706|NCT01978236|Trametinib|trametinib|mesh-list
2073707|NCT01978236|Dabrafenib|dabrafenib|mesh-list
2073708|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212796|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
2750087|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
2750088|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073709|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2073710|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212797|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212798|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
2212799|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212800|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
2212801|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212802|NCT00021281|Leucovorin|leucovorin|mesh-list
2212803|NCT00021281|Fluorouracil|fluorouracil|mesh-list
2073711|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073712|NCT01978600|Timolol|timolol|mesh-list
2073713|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2212804|NCT00021281|Irinotecan|irinotecan|mesh-list
2212805|NCT00021281|Calcium|calcium|mesh-list
2212806|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
2212807|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2212808|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212809|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
2212810|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212811|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212812|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073714|NCT01978600|Brinzolamide|brinzolamide|mesh-list
2073715|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2073716|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2073717|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
2212813|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212814|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
2212815|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2212816|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2212817|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212818|NCT00021281|Antidotes|antidotes|mesh-ancestor
2212819|NCT00021281|Protective Agents|protective agents|mesh-ancestor
2073718|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073719|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073720|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073721|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2073722|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2212820|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
2073723|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073724|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2073725|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2212821|NCT00021281|Vitamins|vitamins|mesh-ancestor
2212822|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
2212823|NCT00021294|Eflornithine|eflornithine|mesh-list
2212824|NCT00021294|Triamcinolone|triamcinolone|mesh-list
2212825|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2212826|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
2212827|NCT00021294|Hormones|hormones|mesh-ancestor
2212828|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2212829|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212830|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073726|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2073727|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2073728|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
2073729|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2073730|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2073731|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
2073732|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2073733|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2073734|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2073735|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073736|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212831|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212832|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212833|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2073750|NCT01979016|Emollients|emollients|mesh-list
2073751|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
2073752|NCT01979185|Simvastatin|simvastatin|mesh-list
2073753|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2073754|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2073755|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
2073756|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073757|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2073758|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2073759|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073760|NCT01979276|Dexamethasone|dexamethasone|mesh-list
2073761|NCT01979276|Pomalidomide|pomalidomide|mesh-list
2073762|NCT01979276|Romidepsin|romidepsin|mesh-list
2073763|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073764|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
2073765|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
2073766|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073767|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073768|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2073769|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
2073770|NCT01979276|Hormones|hormones|mesh-ancestor
2073771|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2073772|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2073773|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212834|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2212835|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2212836|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212837|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2212838|NCT00021307|Carboplatin|carboplatin|mesh-list
2212839|NCT00021307|Temozolomide|temozolomide|mesh-list
2073774|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
2073775|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2073776|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2212840|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212841|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2212842|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
2212843|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212844|NCT00021320|Paclitaxel|paclitaxel|mesh-list
2212845|NCT00021320|Fluorouracil|fluorouracil|mesh-list
2212846|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2212847|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212848|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212849|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212850|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
2073777|NCT01979276|Growth Substances|growth substances|mesh-ancestor
2212851|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212852|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
2073778|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
2073779|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2073780|NCT01979445|Clopidogrel|clopidogrel|mesh-list
2073781|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2073782|NCT01979445|Cangrelor|cangrelor|mesh-list
2073783|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2073784|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2073785|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2073786|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2073787|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
2073788|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073789|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073790|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212853|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212854|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212855|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
2212856|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212857|NCT00021333|Paclitaxel|paclitaxel|mesh-list
2212858|NCT00021333|Cisplatin|cisplatin|mesh-list
2212859|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2212860|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212861|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212862|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212863|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212864|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212865|NCT00021346|Gemcitabine|gemcitabine|mesh-list
2212866|NCT00021346|Carboplatin|carboplatin|mesh-list
2212867|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212868|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212869|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
2212870|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212871|NCT00021346|Antiviral Agents|antiviral agents|mesh-ancestor
2212872|NCT00021346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212873|NCT00021346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212874|NCT00021346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212875|NCT00021346|Immunologic Factors|immunologic factors|mesh-ancestor
2212876|NCT00021346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212877|NCT00021359|Dexamethasone|dexamethasone|mesh-list
2212878|NCT00021359|Isotretinoin|isotretinoin|mesh-list
2212879|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2212880|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
2212881|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
2212882|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2212883|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212884|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2212885|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
2212886|NCT00021359|Hormones|hormones|mesh-ancestor
2212887|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2212888|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2212889|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212890|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
2073791|NCT01979523|Trametinib|trametinib|mesh-list
2073792|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073793|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2073794|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073795|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073796|NCT01979952|Nintedanib|nintedanib|mesh-list
2073797|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073798|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2073799|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073800|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073801|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
2073802|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
2073803|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073804|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
2073805|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073806|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073807|NCT01980524|Acipimox|acipimox|mesh-list
2073808|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2073809|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
2212891|NCT00021372|Paclitaxel|paclitaxel|mesh-list
2212892|NCT00021372|Estramustine|estramustine|mesh-list
2212893|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2212894|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212895|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
2212896|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
2212897|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
2212898|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212899|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2212900|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
2212901|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2212902|NCT00021385|Squalamine|squalamine|mesh-list
2212903|NCT00021385|Carboplatin|carboplatin|mesh-list
2212904|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212905|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2212906|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212907|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2212908|NCT00021385|Protective Agents|protective agents|mesh-ancestor
2212909|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212910|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2212911|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2212912|NCT00021385|Growth Substances|growth substances|mesh-ancestor
2212913|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
2212914|NCT00021398|Leucovorin|leucovorin|mesh-list
2212915|NCT00021398|Fluorouracil|fluorouracil|mesh-list
2212916|NCT00021398|Calcium|calcium|mesh-list
2212917|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
2212918|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2212919|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212920|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
2212921|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212922|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2212923|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212924|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2212925|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
2212926|NCT00021398|Antidotes|antidotes|mesh-ancestor
2212927|NCT00021398|Protective Agents|protective agents|mesh-ancestor
2212928|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
2212929|NCT00021398|Vitamins|vitamins|mesh-ancestor
2212930|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
2212931|NCT00021450|Goserelin|goserelin|mesh-list
2212932|NCT00021450|Bicalutamide|bicalutamide|mesh-list
2212933|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2212934|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212935|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
2212936|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
2212937|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2212938|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212939|NCT00021463|Lamivudine|lamivudine|mesh-list
2212940|NCT00021463|Zidovudine|zidovudine|mesh-list
2212941|NCT00021463|Efavirenz|efavirenz|mesh-list
2212942|NCT00021463|Nevirapine|nevirapine|mesh-list
2212943|NCT00021463|Abacavir|abacavir|mesh-list
2212944|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
2212945|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2212946|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2212947|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212948|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212949|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
2212950|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212951|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2212952|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2212953|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
2750115|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2750116|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2073810|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073811|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2073812|NCT01980589|Dexamethasone|dexamethasone|mesh-list
2073813|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
2073814|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2073815|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
2073816|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212954|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2212955|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2073817|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073818|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2073819|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
2073820|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212956|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2212957|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2212958|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2212959|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2212960|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
2212961|NCT00021489|Abacavir|abacavir|mesh-list
2212962|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2212963|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2212964|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2073821|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073822|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2073823|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073824|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
2073825|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
2073826|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073827|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2073828|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
2073829|NCT01980589|Hormones|hormones|mesh-ancestor
2073830|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2073831|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2073832|NCT01980654|Rituximab|rituximab|mesh-list
2073833|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2073834|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073835|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
2073836|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073837|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073838|NCT01980706|Baclofen|baclofen|mesh-list
2073839|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2073840|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073841|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2073842|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2750117|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2750127|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
2750128|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2750129|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073843|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2073844|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
2073845|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
2073846|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073847|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073848|NCT01980888|Rituximab|rituximab|mesh-list
2073849|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2073850|NCT01980888|Idelalisib|idelalisib|mesh-list
2073851|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2073852|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073853|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
2073854|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073855|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073856|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2073857|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
2073858|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073859|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073860|NCT01980940|Etoricoxib|etoricoxib|mesh-list
2073861|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2073862|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2073863|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2073864|NCT01980940|Analgesics|analgesics|mesh-ancestor
2073865|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
2073866|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073867|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073868|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073869|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073870|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2073871|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2073872|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073873|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073874|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2073875|NCT01980940|Protective Agents|protective agents|mesh-ancestor
2073876|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2073877|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
2073878|NCT01981473|Infliximab|infliximab|mesh-list
2073879|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
2073880|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2073881|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073882|NCT01981616|Vedolizumab|vedolizumab|mesh-list
2073883|NCT01981616|Vaccines|vaccines|mesh-list
2073884|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
2073885|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073886|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2073887|NCT01981759|Cycloserine|cycloserine|mesh-list
2073888|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2073889|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2073890|NCT01981759|Renal Agents|renal agents|mesh-ancestor
2073891|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2073892|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
2073893|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2073894|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
2073895|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073896|NCT01981772|Lidocaine|lidocaine|mesh-list
2073897|NCT01981772|Epinephrine|epinephrine|mesh-list
2073898|NCT01981772|Racepinephrine|racepinephrine|mesh-list
2073899|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
2073900|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
2073901|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
2073902|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2073903|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073904|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
2073905|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073906|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2073907|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2073908|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2073909|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2073910|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073911|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2073912|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2073913|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
2073914|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073915|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2073916|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2073917|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
2073918|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2073919|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
2073920|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
2073921|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
2073922|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2073923|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
2073924|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2073925|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2073926|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073927|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
2073928|NCT01981863|Coagulants|coagulants|mesh-ancestor
2073929|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
2073930|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2212965|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
2212966|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2212967|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2212968|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212969|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073931|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2073932|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
2073933|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2073934|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073935|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073936|NCT01981954|Urological Agents|urological agents|mesh-ancestor
2073937|NCT01981967|Vaccines|vaccines|mesh-list
2073938|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
2073939|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073940|NCT01982123|Edetic Acid|edetic acid|mesh-list
2073941|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
2073942|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
2073943|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
2073944|NCT01982123|Antidotes|antidotes|mesh-ancestor
2073945|NCT01982123|Protective Agents|protective agents|mesh-ancestor
2073946|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073947|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
2073948|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
2073949|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073950|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2073951|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
2073952|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2073953|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2073954|NCT01982240|Bisacodyl|bisacodyl|mesh-list
2073955|NCT01982240|Plecanatide|plecanatide|mesh-list
2073956|NCT01982240|Cathartics|cathartics|mesh-ancestor
2073957|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2073958|NCT01982240|Laxatives|laxatives|mesh-ancestor
2073959|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2073960|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
2073961|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073962|NCT01982331|Vaccines|vaccines|mesh-list
2073963|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
2073964|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073965|NCT01982435|Ranibizumab|ranibizumab|mesh-list
2073966|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2073967|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2073968|NCT01982435|Growth Substances|growth substances|mesh-ancestor
2073969|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073970|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
2073971|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073972|NCT01982448|Paclitaxel|paclitaxel|mesh-list
2073973|NCT01982448|Cisplatin|cisplatin|mesh-list
2073974|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2073975|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2073976|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
2073977|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
2073978|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
2073979|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073980|NCT01982539|Diclofenac|diclofenac|mesh-list
2073981|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2073982|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2073983|NCT01982539|Analgesics|analgesics|mesh-ancestor
2073984|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
2073985|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073986|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073987|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2073988|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2073989|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2073990|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2073991|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2073992|NCT01982643|Naltrexone|naltrexone|mesh-list
2073993|NCT01982643|Bupropion|bupropion|mesh-list
2073994|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2073995|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2073996|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2073997|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
2073998|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2073999|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2074000|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
2074001|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2074002|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2074003|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2074004|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2074005|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074006|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
2074007|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2750135|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
2750136|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2750137|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750138|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2750139|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212970|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2212971|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2074008|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2074009|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2074010|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074011|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
2074012|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
2074013|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2074014|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
2074015|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074016|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2074017|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2074018|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
2074019|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074020|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074021|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2074022|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2212972|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
2212973|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2212974|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2212975|NCT00021528|Mirtazapine|mirtazapine|mesh-list
2212976|NCT00021528|Buspirone|buspirone|mesh-list
2212977|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
2212978|NCT00021528|Sertraline|sertraline|mesh-list
2212979|NCT00021528|Citalopram|citalopram|mesh-list
2074023|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2074024|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
2074025|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2074026|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074027|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074028|NCT01982695|Losartan|losartan|mesh-list
2074029|NCT01982695|Lisinopril|lisinopril|mesh-list
2074030|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2074031|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2212980|NCT00021528|Nortriptyline|nortriptyline|mesh-list
2074032|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2074033|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2074034|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074035|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2074036|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
2074037|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074038|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2074039|NCT01982695|Protective Agents|protective agents|mesh-ancestor
2074040|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074041|NCT01982812|Levetiracetam|levetiracetam|mesh-list
2074042|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
2074043|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
2074044|NCT01982942|Ibudilast|ibudilast|mesh-list
2074045|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2074046|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
2074047|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2212981|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
2212982|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2212983|NCT00021528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2212984|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2212985|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2212986|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2212987|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2212988|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
2212989|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2212990|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2212991|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2212992|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2212993|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2212994|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2212995|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
2212996|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
2212997|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2212998|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2212999|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2213000|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2213001|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
2213002|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2213003|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2213004|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2074048|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213005|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2074049|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2074050|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
2074051|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2074052|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074053|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074054|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2074055|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
2074056|NCT01982955|Carboplatin|carboplatin|mesh-list
2074057|NCT01982955|Pemetrexed|pemetrexed|mesh-list
2074058|NCT01982955|Gefitinib|gefitinib|mesh-list
2074059|NCT01982955|Tepotinib|tepotinib|mesh-list
2074060|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074061|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074062|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074063|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2074064|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2074065|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2074066|NCT01983020|Lidocaine|lidocaine|mesh-list
2074067|NCT01983020|Ketamine|ketamine|mesh-list
2074068|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
2074069|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
2074070|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074071|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074072|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
2074073|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074074|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2074075|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2074076|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2074077|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2074078|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074079|NCT01983020|Analgesics|analgesics|mesh-ancestor
2074080|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2074081|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2074082|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
2074083|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2074084|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2074085|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074086|NCT01983111|Acetaminophen|acetaminophen|mesh-list
2074087|NCT01983111|Buprenorphine|buprenorphine|mesh-list
2074088|NCT01983111|Tramadol|tramadol|mesh-list
2213006|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2074089|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2074090|NCT01983111|Analgesics|analgesics|mesh-ancestor
2074091|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
2074092|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074093|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074094|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
2074095|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2074096|NCT01983111|Narcotics|narcotics|mesh-ancestor
2074097|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074098|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2074099|NCT01983566|Omeprazole|omeprazole|mesh-list
2074100|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2213007|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2213008|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2213009|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
2213010|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2213011|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2213012|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213013|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2213014|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2213015|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
2213016|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213017|NCT00021567|Interferons|interferons|mesh-list
2213018|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
2213019|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213020|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
2213021|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213022|NCT00021645|Vitamin E|vitamin e|mesh-list
2213023|NCT00021645|Vitamins|vitamins|mesh-ancestor
2074101|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2213024|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
2213025|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213026|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
2213027|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213028|NCT00021645|Protective Agents|protective agents|mesh-ancestor
2213029|NCT00021671|Metronidazole|metronidazole|mesh-list
2213030|NCT00021671|Nevirapine|nevirapine|mesh-list
2213031|NCT00021671|Erythromycin|erythromycin|mesh-list
2213032|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
2213033|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2213034|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
2213035|NCT00021671|Ampicillin|ampicillin|mesh-list
2213036|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213037|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2213038|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2213039|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2213040|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2213041|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2213042|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213043|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213044|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
2213045|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2213046|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2213047|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2213048|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2213049|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2213050|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2074102|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2074103|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074104|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074105|NCT01983683|Vancomycin|vancomycin|mesh-list
2074106|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
2074107|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2074108|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074109|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2074110|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074111|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074112|NCT01983878|Ramucirumab|ramucirumab|mesh-list
2213051|NCT00021736|Bevacizumab|bevacizumab|mesh-list
2213052|NCT00021736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2213053|NCT00021736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213054|NCT00021736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2213055|NCT00021736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2213056|NCT00021736|Growth Substances|growth substances|mesh-ancestor
2213057|NCT00021736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074113|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074114|NCT01983969|Pyridoxine|pyridoxine|mesh-list
2074115|NCT01983969|Gemcitabine|gemcitabine|mesh-list
2074116|NCT01983969|Dexamethasone|dexamethasone|mesh-list
2074117|NCT01983969|Rituximab|rituximab|mesh-list
2074118|NCT01983969|Azacitidine|azacitidine|mesh-list
2074119|NCT01983969|Melphalan|melphalan|mesh-list
2074120|NCT01983969|Busulfan|busulfan|mesh-list
2074121|NCT01983969|Vorinostat|vorinostat|mesh-list
2074122|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2074123|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
2074124|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
2074125|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074126|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074127|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2074128|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
2074129|NCT01983969|Hormones|hormones|mesh-ancestor
2074130|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2074131|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2074132|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074133|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2074134|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
2074135|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2074136|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2074137|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
2074138|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074139|NCT01983969|Antiviral Agents|antiviral agents|mesh-ancestor
2074140|NCT01983969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074141|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074142|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2074143|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2074144|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
2074145|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2074146|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2074147|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
2074148|NCT01983969|Vitamins|vitamins|mesh-ancestor
2074149|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
2074150|NCT01984164|Candesartan|candesartan|mesh-list
2074151|NCT01984164|Lisinopril|lisinopril|mesh-list
2074152|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2074153|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2074154|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2074155|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074156|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2074157|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
2074158|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074159|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2074160|NCT01984164|Protective Agents|protective agents|mesh-ancestor
2074161|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074162|NCT01984229|Posaconazole|posaconazole|mesh-list
2074163|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
2074164|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074165|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2074166|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2074167|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2074168|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2074169|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2074170|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074171|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074172|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2074173|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
2074174|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2074175|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074176|NCT01984242|Bevacizumab|bevacizumab|mesh-list
2074177|NCT01984242|Sunitinib|sunitinib|mesh-list
2074178|NCT01984242|Atezolizumab|atezolizumab|mesh-list
2074179|NCT01984242|Antibodies|antibodies|mesh-list
2074180|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2074181|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2074182|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750177|NCT04371380|Rilpivirine|rilpivirine|mesh-list
2750178|NCT04371380|Cabotegravir|cabotegravir|mesh-list
2750179|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2750180|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2750181|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750182|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750183|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
2750184|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2750185|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2750186|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2750187|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2750188|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2074183|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2074184|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2074185|NCT01984242|Growth Substances|growth substances|mesh-ancestor
2074186|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074187|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
2213058|NCT00021736|Growth Inhibitors|growth inhibitors|mesh-ancestor
2213059|NCT00021814|Doxazosin|doxazosin|mesh-list
2213060|NCT00021814|Finasteride|finasteride|mesh-list
2213061|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2213062|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2213063|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213064|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213065|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
2213066|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2213067|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213068|NCT00021814|Urological Agents|urological agents|mesh-ancestor
2213069|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2074188|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
2074189|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2074190|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074191|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074192|NCT01984294|Ribavirin|ribavirin|mesh-list
2074193|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
2074194|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074195|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
2074196|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074197|NCT01984398|Citric Acid|citric acid|mesh-list
2213070|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2213071|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2074198|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
2074199|NCT01984398|Enclomiphene|enclomiphene|mesh-list
2074200|NCT01984398|Clomiphene|clomiphene|mesh-list
2074201|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
2074202|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
2074203|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2074204|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
2074205|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
2213072|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2213073|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
2213074|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2213075|NCT00021827|Hormones|hormones|mesh-list
2213076|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
2213077|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
2213078|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2213079|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213080|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2213081|NCT00021983|Immunotoxins|immunotoxins|mesh-list
2213082|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
2213083|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213084|NCT00021996|Valdecoxib|valdecoxib|mesh-list
2213085|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2213086|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2074206|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074207|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2074208|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
2074209|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2074210|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074211|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2074212|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
2074213|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2074214|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2074215|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2074216|NCT01984424|Atorvastatin|atorvastatin|mesh-list
2074217|NCT01984424|Ezetimibe|ezetimibe|mesh-list
2213087|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213088|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213089|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2213090|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2213091|NCT00021996|Analgesics|analgesics|mesh-ancestor
2213092|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
2213093|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2213094|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213095|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2074218|NCT01984424|Evolocumab|evolocumab|mesh-list
2074219|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2074220|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2074221|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2074222|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
2074223|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074224|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2074225|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2074226|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074227|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
2074228|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074229|NCT01984684|Vancomycin|vancomycin|mesh-list
2074230|NCT01984684|Aztreonam|aztreonam|mesh-list
2074231|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2074232|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074233|NCT01984892|Poly ICLC|poly iclc|mesh-list
2074234|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
2074235|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
2074236|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074237|NCT01985126|Acetaminophen|acetaminophen|mesh-list
2074238|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
2074239|NCT01985126|Promethazine|promethazine|mesh-list
2074240|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
2074241|NCT01985126|Daratumumab|daratumumab|mesh-list
2074242|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2074243|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2074244|NCT01985126|Analgesics|analgesics|mesh-ancestor
2074245|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
2074246|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2213096|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2750203|NCT04363840|Aspirin|aspirin|mesh-list
2750204|NCT04363840|Vitamin D|vitamin d|mesh-list
2750205|NCT04363840|Vitamins|vitamins|mesh-ancestor
2750206|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
2750207|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750208|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2750209|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2750210|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2750211|NCT04363840|Analgesics|analgesics|mesh-ancestor
2750212|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
2213097|NCT00022009|Gemcitabine|gemcitabine|mesh-list
2213098|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2213099|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
2213100|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213101|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213102|NCT00022009|Antiviral Agents|antiviral agents|mesh-ancestor
2213103|NCT00022009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213104|NCT00022009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213105|NCT00022009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213106|NCT00022009|Immunologic Factors|immunologic factors|mesh-ancestor
2213107|NCT00022009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213108|NCT00022022|Docetaxel|docetaxel|mesh-list
2074247|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074248|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
2074249|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2074250|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
2213109|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213110|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213111|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
2213112|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
2213113|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213114|NCT00022048|Bevacizumab|bevacizumab|mesh-list
2213115|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2074251|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
2213116|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074252|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2074253|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
2074254|NCT01985126|Hormones|hormones|mesh-ancestor
2074255|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2074256|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2213117|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2213118|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2213119|NCT00022048|Growth Substances|growth substances|mesh-ancestor
2213120|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213121|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
2213122|NCT00022074|Gabapentin|gabapentin|mesh-list
2213123|NCT00022074|Analgesics|analgesics|mesh-ancestor
2213124|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
2213125|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2213126|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213127|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
2213128|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2213129|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2213130|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2213131|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2213132|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2074257|NCT01985126|Protective Agents|protective agents|mesh-ancestor
2074258|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074259|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
2074260|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2074261|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2074262|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074263|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
2074264|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
2074265|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2074266|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
2074267|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
2074268|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074269|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074270|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2074271|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
2074272|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
2750213|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2750214|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2750215|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2750216|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2750217|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2750218|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750219|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2750220|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2750221|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750222|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
2750238|NCT04337060|Lidocaine|lidocaine|mesh-list
2750239|NCT04337060|Morphine|morphine|mesh-list
2750240|NCT04337060|Bupivacaine|bupivacaine|mesh-list
2750241|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
2750242|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
2750243|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074273|NCT01985321|Ethanol|ethanol|mesh-list
2074274|NCT01985321|Glycolic acid|glycolic acid|mesh-list
2074275|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2074276|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074277|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074278|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074279|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
2074280|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
2074281|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
2074282|NCT01985334|Bromides|bromides|mesh-list
2074283|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
2074284|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074285|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2074286|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2074287|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2074288|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
2074289|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074290|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213133|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2213134|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2213135|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213136|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
2213137|NCT00022087|Vitamin D|vitamin d|mesh-list
2213138|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
2213139|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
2213140|NCT00022087|Calcium|calcium|mesh-list
2213141|NCT00022087|Vitamins|vitamins|mesh-ancestor
2213142|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
2213143|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213144|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2074291|NCT01985425|Colchicine|colchicine|mesh-list
2074292|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
2074293|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2074294|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
2074295|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
2074296|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
2074297|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074298|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074299|NCT01985581|Guanfacine|guanfacine|mesh-list
2074300|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2074301|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2074302|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2074303|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2074304|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
2074305|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074306|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074307|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074308|NCT01985685|Thiamine|thiamine|mesh-list
2074309|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
2074310|NCT01985685|Vitamins|vitamins|mesh-ancestor
2074311|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
2074312|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074313|NCT01985763|Genistein|genistein|mesh-list
2074314|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2074315|NCT01985763|Protective Agents|protective agents|mesh-ancestor
2074316|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213145|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2074317|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074318|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2074319|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074320|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074321|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
2074322|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2074323|NCT01985763|Estrogens|estrogens|mesh-ancestor
2074324|NCT01985763|Hormones|hormones|mesh-ancestor
2074325|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2074326|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
2074327|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2074328|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
2074329|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074330|NCT01986010|Antacids|antacids|mesh-ancestor
2074331|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074332|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2074333|NCT01986062|Amphetamine|amphetamine|mesh-list
2074334|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2074335|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074336|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
2074337|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
2074338|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074339|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
2213146|NCT00022126|Cytarabine|cytarabine|mesh-list
2213147|NCT00022126|Cyclosporine|cyclosporine|mesh-list
2213148|NCT00022126|Dexamethasone|dexamethasone|mesh-list
2074340|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074341|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074342|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
2074343|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2074344|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2074345|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2074346|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2074347|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2074348|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2074349|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2074350|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074351|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074352|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2074353|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2074354|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2074355|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2074356|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
2074357|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074358|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213149|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
2750244|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750245|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
2750246|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2750247|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2750248|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2750249|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2213150|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
2213151|NCT00022126|Doxorubicin|doxorubicin|mesh-list
2213152|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2213153|NCT00022126|Methotrexate|methotrexate|mesh-list
2213154|NCT00022126|Vincristine|vincristine|mesh-list
2213155|NCT00022126|Daunorubicin|daunorubicin|mesh-list
2213156|NCT00022126|Asparaginase|asparaginase|mesh-list
2213157|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
2213158|NCT00022126|Thioguanine|thioguanine|mesh-list
2074359|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2074360|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2074361|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
2074362|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2074363|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2074364|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
2074365|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2213159|NCT00022126|Pegaspargase|pegaspargase|mesh-list
2213160|NCT00022126|Cyclosporins|cyclosporins|mesh-list
2213161|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213162|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
2213163|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213164|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213165|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2213166|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
2074366|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2074367|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2074368|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074369|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213167|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213168|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213169|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2213170|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2213171|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
2074370|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2074371|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2074372|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2074373|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2074374|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
2074375|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074376|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074377|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2074378|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2074379|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
2074380|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2074381|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2074382|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
2074383|NCT01986231|Glucagon|glucagon|mesh-list
2074384|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2074385|NCT01986231|Hormones|hormones|mesh-ancestor
2074386|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2074387|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074388|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
2074389|NCT01986361|Analgesics|analgesics|mesh-ancestor
2074390|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
2074391|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074392|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074393|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2074394|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2074395|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2213172|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
2213173|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2213174|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2213175|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
2213176|NCT00022126|Hormones|hormones|mesh-ancestor
2213177|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2213178|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2213179|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2213180|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2213181|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2213182|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213183|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2213184|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
2213185|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2213186|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2213187|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
2213188|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
2213189|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2213190|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2213191|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
2213192|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213193|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2213194|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213195|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
2213196|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
2213197|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
2213198|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2213199|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2213200|NCT00022126|Protective Agents|protective agents|mesh-ancestor
2074396|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2074397|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2074398|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074399|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074400|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
2074401|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2074402|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074403|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2074404|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213201|NCT00022139|Paclitaxel|paclitaxel|mesh-list
2213202|NCT00022139|Carboplatin|carboplatin|mesh-list
2213203|NCT00022139|Fluorouracil|fluorouracil|mesh-list
2213204|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2213205|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213206|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213207|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
2213208|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
2213209|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213210|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
2213211|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2213212|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213213|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
2213214|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213215|NCT00022152|Vinorelbine|vinorelbine|mesh-list
2213216|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2213217|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213218|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213219|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
2213220|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
2213221|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213222|NCT00022165|Selenium|selenium|mesh-list
2213223|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
2213224|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213225|NCT00022165|Protective Agents|protective agents|mesh-ancestor
2213226|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213227|NCT00022165|Trace Elements|trace elements|mesh-ancestor
2213228|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
2213229|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
2213230|NCT00022178|Doxorubicin|doxorubicin|mesh-list
2213231|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2213232|NCT00022178|Fluorouracil|fluorouracil|mesh-list
2213233|NCT00022178|Vincristine|vincristine|mesh-list
2213234|NCT00022178|Epirubicin|epirubicin|mesh-list
2213235|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2074405|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
2074406|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2074407|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074408|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2074409|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074410|NCT01986907|Ranibizumab|ranibizumab|mesh-list
2074411|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2074412|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2074413|NCT01986907|Growth Substances|growth substances|mesh-ancestor
2750250|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2750251|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750252|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2750253|NCT04337060|Narcotics|narcotics|mesh-ancestor
2213236|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
2213237|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213238|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213239|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2213240|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
2213241|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213242|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213243|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2213244|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2213245|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2213246|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2213247|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213248|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
2750254|NCT04337060|Analgesics|analgesics|mesh-ancestor
2074414|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213249|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2213250|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2213251|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213252|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
2213253|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
2213254|NCT00022191|Gemcitabine|gemcitabine|mesh-list
2213255|NCT00022191|Paclitaxel|paclitaxel|mesh-list
2213256|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2213257|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213258|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213259|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
2213260|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
2213261|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213262|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2213263|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
2213264|NCT00022191|Antiviral Agents|antiviral agents|mesh-ancestor
2213265|NCT00022191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213266|NCT00022191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213267|NCT00022191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213268|NCT00022191|Immunologic Factors|immunologic factors|mesh-ancestor
2213269|NCT00022191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213270|NCT00022204|Vitamin E|vitamin e|mesh-list
2213271|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
2074415|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
2074416|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074417|NCT01986946|Hydromorphone|hydromorphone|mesh-list
2213272|NCT00022204|Vitamins|vitamins|mesh-ancestor
2213273|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
2213274|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213275|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
2213276|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074418|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2074419|NCT01986946|Narcotics|narcotics|mesh-ancestor
2074420|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074421|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074422|NCT01986946|Analgesics|analgesics|mesh-ancestor
2074423|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
2074424|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074425|NCT01987102|Leucovorin|leucovorin|mesh-list
2074426|NCT01987102|Calcium|calcium|mesh-list
2074427|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
2074428|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2074429|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074430|NCT01987102|Antidotes|antidotes|mesh-ancestor
2074431|NCT01987102|Protective Agents|protective agents|mesh-ancestor
2074432|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
2074433|NCT01987102|Vitamins|vitamins|mesh-ancestor
2074434|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
2074435|NCT01987219|Bromides|bromides|mesh-list
2074436|NCT01987219|Albuterol|albuterol|mesh-list
2074437|NCT01987219|Ipratropium|ipratropium|mesh-list
2074438|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
2074439|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2074440|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
2074441|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074442|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074443|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2074444|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
2074445|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
2074446|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2074447|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2213277|NCT00022204|Protective Agents|protective agents|mesh-ancestor
2213278|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2213279|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213280|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2213281|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2213282|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
2213283|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2213284|NCT00022217|Paclitaxel|paclitaxel|mesh-list
2213285|NCT00022217|Carboplatin|carboplatin|mesh-list
2213286|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2213287|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074448|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2074449|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2074450|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
2074451|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074452|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074453|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2074454|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
2074455|NCT01987232|Carboplatin|carboplatin|mesh-list
2074456|NCT01987232|Etoposide|etoposide|mesh-list
2074457|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074458|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2074459|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2074460|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2074461|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074462|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074463|NCT01987427|Phentermine|phentermine|mesh-list
2074464|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2074465|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074466|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
2074467|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2074468|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
2074469|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
2074470|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074471|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
2074472|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074473|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074474|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
2074475|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2074476|NCT01987453|Ledipasvir|ledipasvir|mesh-list
2074477|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
2074478|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074479|NCT01987479|Methotrexate|methotrexate|mesh-list
2074480|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2213288|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213289|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
2213290|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
2213291|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213292|NCT00022230|Aldesleukin|aldesleukin|mesh-list
2213293|NCT00022230|Paclitaxel|paclitaxel|mesh-list
2213294|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
2213295|NCT00022230|Doxorubicin|doxorubicin|mesh-list
2213296|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2213297|NCT00022230|Sargramostim|sargramostim|mesh-list
2213298|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2213299|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213300|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213301|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
2213302|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
2213303|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213304|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213305|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
2213306|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213307|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213308|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2213309|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
2213310|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2074481|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
2213311|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2750280|NCT04330183|Ketamine|ketamine|mesh-list
2750281|NCT04330183|Analgesics|analgesics|mesh-ancestor
2213312|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2213313|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2213314|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213315|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2213316|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2213317|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
2213318|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213319|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
2213320|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213321|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2213322|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
2213323|NCT00022308|Irinotecan|irinotecan|mesh-list
2750282|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
2074482|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2074483|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074484|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2074485|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
2074486|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074487|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213324|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213325|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2213326|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2213327|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213328|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213329|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
2213330|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2213331|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213332|NCT00022360|Taurolidine|taurolidine|mesh-list
2213333|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213334|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2213335|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213336|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
2213337|NCT00022386|Hematinics|hematinics|mesh-ancestor
2213338|NCT00022399|Celecoxib|celecoxib|mesh-list
2213339|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2213340|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2213341|NCT00022399|Analgesics|analgesics|mesh-ancestor
2213342|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
2213343|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2213344|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213345|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2213346|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213347|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2213348|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2213349|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074488|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
2074489|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074490|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2074491|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2074492|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
2074493|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213350|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213351|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2213352|NCT00022412|Vitamins|vitamins|mesh-ancestor
2213353|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
2213354|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213355|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2213356|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
2213357|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213358|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213359|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213360|NCT00022438|Aldesleukin|aldesleukin|mesh-list
2213361|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
2213362|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213363|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2213364|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2213365|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
2074494|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2074495|NCT01987505|Rituximab|rituximab|mesh-list
2074496|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2074497|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074498|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
2074499|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074500|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213366|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213367|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2213368|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
2213369|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213370|NCT00022451|Tipifarnib|tipifarnib|mesh-list
2213371|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213372|NCT00022464|Sirolimus|sirolimus|mesh-list
2213373|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2074501|NCT01987596|Lenograstim|lenograstim|mesh-list
2074502|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2074503|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
2074504|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074505|NCT01987752|Timolol|timolol|mesh-list
2074506|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2074507|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2074508|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
2074509|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2074510|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2074511|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2074512|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
2074513|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074514|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074515|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074516|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2074517|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2074518|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2074519|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2074520|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2074521|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2074522|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2074523|NCT01987895|Vancomycin|vancomycin|mesh-list
2074524|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
2074525|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2074526|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074527|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2074528|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074529|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074530|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
2074531|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
2074532|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074533|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074534|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213374|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213375|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2213376|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213377|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
2213378|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213379|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
2213380|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213381|NCT00022529|Trastuzumab|trastuzumab|mesh-list
2213382|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2213383|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213384|NCT00022542|Epothilones|epothilones|mesh-list
2213385|NCT00022542|Epothilone B|epothilone b|mesh-list
2213386|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213387|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
2213388|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
2074535|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
2074536|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
2074537|NCT01988090|Vitamin D|vitamin d|mesh-list
2074538|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
2074539|NCT01988090|Vitamins|vitamins|mesh-list
2074540|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
2213389|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213390|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213391|NCT00022555|Vincristine|vincristine|mesh-list
2213392|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
2213393|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2213394|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213395|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213396|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
2213397|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
2213398|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750283|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2750284|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750285|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2750286|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2750287|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
2750288|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
2750289|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2750290|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2750291|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2213399|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2213400|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
2213401|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213402|NCT00022581|Thalidomide|thalidomide|mesh-list
2213403|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213404|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
2213405|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213406|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
2213407|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2074541|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074542|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2074543|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2074544|NCT01988103|Thalidomide|thalidomide|mesh-list
2074545|NCT01988103|Apremilast|apremilast|mesh-list
2074546|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2074547|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2074548|NCT01988103|Analgesics|analgesics|mesh-ancestor
2074549|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
2074550|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074551|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074552|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2074553|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2074554|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2074555|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2074556|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074557|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074558|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2074559|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
2074560|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
2074561|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2074562|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074563|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2074564|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2074565|NCT01988103|Growth Substances|growth substances|mesh-ancestor
2074566|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
2074567|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074568|NCT01988246|Aflibercept|aflibercept|mesh-list
2074569|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2074570|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2750292|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2750293|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074571|NCT01988246|Growth Substances|growth substances|mesh-ancestor
2074572|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074573|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
2074574|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213408|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213409|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2213410|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2213411|NCT00022581|Growth Substances|growth substances|mesh-ancestor
2074575|NCT01988402|Allopurinol|allopurinol|mesh-list
2074576|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
2074577|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074578|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074579|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
2074580|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2074581|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2074582|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
2074583|NCT01988402|Protective Agents|protective agents|mesh-ancestor
2074584|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074585|NCT01988493|Sorafenib|sorafenib|mesh-list
2074586|NCT01988493|Tepotinib|tepotinib|mesh-list
2074587|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074588|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2074589|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074590|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074591|NCT01988662|Ranibizumab|ranibizumab|mesh-list
2074592|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2074593|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2074594|NCT01988662|Growth Substances|growth substances|mesh-ancestor
2074595|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074596|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
2074597|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074598|NCT01988779|Levofloxacin|levofloxacin|mesh-list
2074599|NCT01988779|Ofloxacin|ofloxacin|mesh-list
2074600|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2074601|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074602|NCT01988779|Renal Agents|renal agents|mesh-ancestor
2074603|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2074604|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2074605|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2074606|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074607|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213412|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
2213413|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213414|NCT00022594|Lurtotecan|lurtotecan|mesh-list
2213415|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213416|NCT00022607|Thalidomide|thalidomide|mesh-list
2213417|NCT00022607|Bevacizumab|bevacizumab|mesh-list
2213418|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2213419|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213420|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2213421|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2074608|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074609|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2074610|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2074611|NCT01988922|Ketamine|ketamine|mesh-list
2074612|NCT01988922|Analgesics|analgesics|mesh-ancestor
2074613|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
2074614|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074615|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074616|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2074617|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2074618|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
2074619|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
2074620|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074621|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2074622|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2074623|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074624|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074625|NCT01989156|Menthol|menthol|mesh-list
2213422|NCT00022607|Growth Substances|growth substances|mesh-ancestor
2213423|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213424|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
2213425|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213426|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
2213427|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
2074626|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
2074627|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
2074628|NCT01989169|Midazolam|midazolam|mesh-list
2074629|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2074630|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2074631|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074632|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074633|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2074634|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2074635|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2074636|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2074637|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
2074638|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
2074639|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
2074640|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
2074641|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074642|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074643|NCT01989195|Manganese|manganese|mesh-list
2074644|NCT01989195|Trace Elements|trace elements|mesh-ancestor
2074645|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
2074646|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074647|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
2074648|NCT01989208|Cathartics|cathartics|mesh-ancestor
2074649|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2074650|NCT01989221|Granisetron|granisetron|mesh-list
2074651|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
2074652|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
2074653|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074654|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074655|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2074656|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2074657|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
2074658|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074659|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213428|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2213429|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213430|NCT00022620|Paclitaxel|paclitaxel|mesh-list
2213431|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2074660|NCT01989455|Deferiprone|deferiprone|mesh-list
2213432|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213433|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213434|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
2074661|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2074662|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
2074663|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
2074664|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074665|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2074666|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
2213435|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
2213436|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213437|NCT00022646|Gemcitabine|gemcitabine|mesh-list
2213438|NCT00022646|Pemetrexed|pemetrexed|mesh-list
2213439|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2213440|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
2213441|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213442|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213443|NCT00022646|Antiviral Agents|antiviral agents|mesh-ancestor
2213444|NCT00022646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213445|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074667|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074668|NCT01989546|Talazoparib|talazoparib|mesh-list
2213446|NCT00022646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213447|NCT00022646|Immunologic Factors|immunologic factors|mesh-ancestor
2213448|NCT00022646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213449|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2213450|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2213451|NCT00022685|Epratuzumab|epratuzumab|mesh-list
2074669|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2074670|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074671|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074672|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074673|NCT01989572|Sargramostim|sargramostim|mesh-list
2074674|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
2074675|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750312|NCT04311723|Anesthetics|anesthetics|mesh-list
2750313|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2750314|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074686|NCT01989689|Etanercept|etanercept|mesh-list
2074687|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2074688|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2074689|NCT01989689|Analgesics|analgesics|mesh-ancestor
2213452|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2213453|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213454|NCT00022711|Temozolomide|temozolomide|mesh-list
2213455|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2213456|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
2213457|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213458|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213459|NCT00022724|Sirolimus|sirolimus|mesh-list
2213460|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2213461|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213462|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
563704|NCT03705442|Loperamide|loperamide|mesh-list
563705|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
563706|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
563707|NCT03705429|Paclitaxel|paclitaxel|mesh-list
563708|NCT03705429|Docetaxel|docetaxel|mesh-list
563709|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
563710|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
563711|NCT03705429|Trastuzumab|trastuzumab|mesh-list
563712|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
563713|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
563714|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
563715|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
563716|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
563717|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
563718|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
563719|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
563720|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563721|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
563722|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
563723|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
563724|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
563725|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
563726|NCT03705351|Temozolomide|temozolomide|mesh-list
563727|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
563728|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
563729|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
563730|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
563731|NCT03705338|Propofol|propofol|mesh-list
563732|NCT03705338|Anesthetics|anesthetics|mesh-list
563733|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
563734|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
563735|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
563736|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563737|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2074690|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
2074691|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074692|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074693|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2074694|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2074695|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2074696|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2074697|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
2074698|NCT01989754|Canagliflozin|canagliflozin|mesh-list
2074699|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2074700|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074701|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2074702|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074703|NCT01989793|Losartan|losartan|mesh-list
2074704|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2074705|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2074706|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
563755|NCT03705195|Gliclazide|gliclazide|mesh-list
563756|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
563757|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074707|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
563761|NCT03705065|Bupivacaine|bupivacaine|mesh-list
563762|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
563763|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
563764|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
563765|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563766|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
563767|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
563768|NCT03704909|Epinephrine|epinephrine|mesh-list
563769|NCT03704909|Racepinephrine|racepinephrine|mesh-list
563770|NCT03704909|Ephedrine|ephedrine|mesh-list
563771|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
563772|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
563773|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
563774|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
563775|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
563776|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
563777|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563778|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
563779|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
563780|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
563781|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
563782|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
563783|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
563784|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
563785|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
563786|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
563787|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
563788|NCT03704831|Anesthetics|anesthetics|mesh-list
563789|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
563790|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
563791|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563792|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
563793|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
563794|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
563795|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
563796|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
563797|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
563798|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563799|NCT03704766|Defensins|defensins|mesh-list
563800|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
563801|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
563802|NCT03704753|Ropivacaine|ropivacaine|mesh-list
563803|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
563804|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
563805|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
563806|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563807|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
563808|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
563809|NCT03704714|Prednisone|prednisone|mesh-list
563810|NCT03704714|Cortisone|cortisone|mesh-list
563811|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
563812|NCT03704714|Rituximab|rituximab|mesh-list
563813|NCT03704714|Doxorubicin|doxorubicin|mesh-list
563814|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
563815|NCT03704714|Nivolumab|nivolumab|mesh-list
563816|NCT03704714|Vincristine|vincristine|mesh-list
563817|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
563818|NCT03704714|Antibodies|antibodies|mesh-list
563819|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
563820|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
563821|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
563822|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
563823|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563824|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
563825|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
563826|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
563827|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
563828|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
563829|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
563830|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
563831|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
563832|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
563833|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
563834|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
563835|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
563836|NCT03704714|Hormones|hormones|mesh-ancestor
563837|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
563838|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
563839|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
563840|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
563841|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
563842|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
563843|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
563844|NCT03704688|Trametinib|trametinib|mesh-list
563845|NCT03704688|Ponatinib|ponatinib|mesh-list
563846|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
563847|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
563848|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
563849|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
563850|NCT03704623|Acetaminophen|acetaminophen|mesh-list
563851|NCT03704623|Parecoxib|parecoxib|mesh-list
563852|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
563853|NCT03704623|Analgesics|analgesics|mesh-ancestor
563854|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
563855|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
563856|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563857|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
563858|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
563859|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
563860|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
563861|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
563862|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
563863|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
563864|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2074708|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074709|NCT01989910|Efavirenz|efavirenz|mesh-list
2074710|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
2074711|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2074712|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2074713|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074714|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074715|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
2074716|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074717|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2074718|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2074719|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2074720|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2074721|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2074722|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2074723|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2074724|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2074725|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2074726|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2074727|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2074728|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074729|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2074730|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074731|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074732|NCT01990300|Pioglitazone|pioglitazone|mesh-list
2074733|NCT01990300|Alogliptin|alogliptin|mesh-list
2074734|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2074735|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074736|NCT01990300|Incretins|incretins|mesh-ancestor
2074737|NCT01990300|Hormones|hormones|mesh-ancestor
2074738|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2074739|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2213463|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213464|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
563899|NCT03704506|Amoxicillin|amoxicillin|mesh-list
563900|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
563901|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
563902|NCT03704480|Durvalumab|durvalumab|mesh-list
563903|NCT03704480|Tremelimumab|tremelimumab|mesh-list
563904|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
563905|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213465|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213466|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
563910|NCT03704441|Bupivacaine|bupivacaine|mesh-list
563911|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
563912|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
563913|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
563914|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563915|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
563916|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074740|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
2074741|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074742|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074743|NCT01990339|Lansoprazole|lansoprazole|mesh-list
2074744|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
2074745|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2074746|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2074747|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2074748|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074749|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074750|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2074751|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2074752|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074753|NCT01990560|Mifepristone|mifepristone|mesh-list
2074754|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2074755|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
2074756|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
563935|NCT03704363|Infliximab|infliximab|mesh-list
563936|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
563937|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
563938|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2074757|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074758|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2074759|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2074760|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2074761|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
2074762|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2074763|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2074764|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
2074765|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2074766|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
563950|NCT03704285|Propofol|propofol|mesh-list
563951|NCT03704285|Anesthetics|anesthetics|mesh-list
563952|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
563953|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
563954|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
563955|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563956|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
563957|NCT03704246|Antibodies|antibodies|mesh-list
563958|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
563959|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
563960|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563961|NCT03704220|Warfarin|warfarin|mesh-list
563962|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
563963|NCT03704181|Colchicine|colchicine|mesh-list
563964|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
563965|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
563966|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
563967|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
563968|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
563969|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
563970|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
563971|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
563972|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
563973|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
563974|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
563975|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
563976|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
563977|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
563978|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
563979|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563980|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
563981|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
563982|NCT03704077|Paclitaxel|paclitaxel|mesh-list
563983|NCT03704077|Nivolumab|nivolumab|mesh-list
563984|NCT03704077|Ramucirumab|ramucirumab|mesh-list
563985|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
563986|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
563987|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
563988|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
563989|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
563990|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
563991|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
563992|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
563993|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
563994|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
563995|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563996|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
563997|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
563998|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
563999|NCT03703856|Memantine|memantine|mesh-list
564000|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
564001|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
564002|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
564003|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
564004|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564005|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564006|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
564007|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
564025|NCT03703596|Docetaxel|docetaxel|mesh-list
564026|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564027|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
564028|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
564029|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
564030|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074767|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2074768|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2074769|NCT01990573|Methadone|methadone|mesh-list
2074770|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2074771|NCT01990573|Narcotics|narcotics|mesh-ancestor
564036|NCT03703427|Capecitabine|capecitabine|mesh-list
564037|NCT03703427|Vinorelbine|vinorelbine|mesh-list
564038|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
564039|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
564040|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564041|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564042|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
564043|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
564044|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
564045|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
564046|NCT03703375|Gemcitabine|gemcitabine|mesh-list
564047|NCT03703375|Azacitidine|azacitidine|mesh-list
564048|NCT03703375|Romidepsin|romidepsin|mesh-list
564049|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
564050|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
564051|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564052|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564053|NCT03703375|Antiviral Agents|antiviral agents|mesh-ancestor
564054|NCT03703375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564055|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564056|NCT03703375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
564057|NCT03703375|Immunologic Factors|immunologic factors|mesh-ancestor
564058|NCT03703375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564059|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
564060|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
564061|NCT03703349|Analgesics|analgesics|mesh-ancestor
564062|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
564063|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564064|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564065|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
564066|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
564067|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
564068|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
564069|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
564070|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
564071|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564072|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
564073|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
564074|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
564075|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
564076|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
564081|NCT03703271|Methotrexate|methotrexate|mesh-list
564082|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
564083|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
564084|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
564085|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564086|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
564087|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
564088|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564089|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564090|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
564091|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564092|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
564093|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
564094|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
564095|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
564096|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
564097|NCT03703206|Anesthetics|anesthetics|mesh-list
564098|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
564099|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
564100|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564101|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
564102|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564103|NCT03703167|Rituximab|rituximab|mesh-list
564104|NCT03703167|Lenalidomide|lenalidomide|mesh-list
564105|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
564106|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564107|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
564108|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564109|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
564110|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
564111|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
564112|NCT03703167|Growth Substances|growth substances|mesh-ancestor
564113|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
564114|NCT03703154|Tacrolimus|tacrolimus|mesh-list
564115|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
564116|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
564117|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564118|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
564119|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564120|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564121|NCT03703102|KHK4083|khk4083|mesh-list
564122|NCT03703102|Dermatologic Agents|dermatologic agents|mesh-ancestor
564123|NCT03703089|Gemcitabine|gemcitabine|mesh-list
564124|NCT03703089|Paclitaxel|paclitaxel|mesh-list
564125|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
564126|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564127|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
564128|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
564129|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
564130|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564131|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
564132|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
564133|NCT03703089|Antiviral Agents|antiviral agents|mesh-ancestor
564134|NCT03703089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564135|NCT03703089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564136|NCT03703089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
564137|NCT03703089|Immunologic Factors|immunologic factors|mesh-ancestor
564138|NCT03703089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564139|NCT03703063|Leucovorin|leucovorin|mesh-list
564140|NCT03703063|Gemcitabine|gemcitabine|mesh-list
564141|NCT03703063|Paclitaxel|paclitaxel|mesh-list
564142|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
564143|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564144|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
564145|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
564146|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
564147|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564148|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
564149|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
564150|NCT03703063|Antiviral Agents|antiviral agents|mesh-ancestor
564151|NCT03703063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564152|NCT03703063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564153|NCT03703063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
564154|NCT03703063|Immunologic Factors|immunologic factors|mesh-ancestor
564155|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564156|NCT03703063|Antidotes|antidotes|mesh-ancestor
564157|NCT03703063|Protective Agents|protective agents|mesh-ancestor
564158|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
564159|NCT03703063|Vitamins|vitamins|mesh-ancestor
564160|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
564161|NCT03703050|Nivolumab|nivolumab|mesh-list
564162|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
564163|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564164|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
564165|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564166|NCT03702985|Capecitabine|capecitabine|mesh-list
564167|NCT03702985|Irinotecan|irinotecan|mesh-list
564168|NCT03702985|Amifostine|amifostine|mesh-list
564169|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
564170|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
564171|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564172|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564173|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
564174|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
564175|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564176|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
564177|NCT03702985|Protective Agents|protective agents|mesh-ancestor
564178|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564179|NCT03702959|Betamethasone|betamethasone|mesh-list
564180|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
564181|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
564182|NCT03702959|Hormones|hormones|mesh-ancestor
564183|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
564184|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564185|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
564186|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
564187|NCT03702946|Oxytocin|oxytocin|mesh-list
564188|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
564189|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
564190|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564191|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
564192|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
564193|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564194|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
564195|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564196|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564197|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
564198|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
564199|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
564200|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
564201|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564202|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
564203|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
564204|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564205|NCT03702803|Alprazolam|alprazolam|mesh-list
564206|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
564207|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
564208|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564209|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
564210|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
564211|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
564212|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
564213|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
564214|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
564215|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564216|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
564217|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
564218|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
564219|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564220|NCT03702738|Expectorants|expectorants|mesh-ancestor
564221|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
564222|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
564223|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
564224|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564225|NCT03702738|Protective Agents|protective agents|mesh-ancestor
564226|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564227|NCT03702738|Antidotes|antidotes|mesh-ancestor
564228|NCT03702725|Dexamethasone|dexamethasone|mesh-list
564229|NCT03702725|Lenalidomide|lenalidomide|mesh-list
564230|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
564231|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
564232|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
564233|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564234|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564235|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
564236|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
564237|NCT03702725|Hormones|hormones|mesh-ancestor
564238|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
564239|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
564240|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564241|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
564242|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
564243|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
564244|NCT03702725|Growth Substances|growth substances|mesh-ancestor
564245|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
564246|NCT03702647|Ropivacaine|ropivacaine|mesh-list
564247|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
564248|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
564249|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
564250|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564251|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
564252|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564253|NCT03702621|Bupivacaine|bupivacaine|mesh-list
564254|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
564255|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
564256|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
564257|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564258|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
564259|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564260|NCT03702582|Warfarin|warfarin|mesh-list
564261|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
564262|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
564263|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
564264|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
564265|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
564266|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
564267|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564268|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564269|NCT03702530|Albendazole|albendazole|mesh-list
564270|NCT03702530|Vaccines|vaccines|mesh-list
564271|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
564272|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
564273|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564274|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
564275|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
564276|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
564277|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
564278|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
564279|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
564280|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564281|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564282|NCT03702530|Immunologic Factors|immunologic factors|mesh-ancestor
564283|NCT03702530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564284|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
564285|NCT03702491|Apatinib|apatinib|mesh-list
564286|NCT03702491|Tegafur|tegafur|mesh-list
564287|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564288|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
564289|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564290|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564291|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
564292|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
564293|NCT03702426|Norfloxacin|norfloxacin|mesh-list
564294|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
564295|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564296|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
564297|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
564298|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564299|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564300|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564301|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
564302|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
564303|NCT03702400|Phenylephrine|phenylephrine|mesh-list
564304|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
564305|NCT03702400|Norepinephrine|norepinephrine|mesh-list
564306|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
564307|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
564308|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
564309|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564310|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564311|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
564312|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
564313|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
564314|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
564315|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
564316|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
564317|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
564318|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
564319|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
564320|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564321|NCT03702400|Protective Agents|protective agents|mesh-ancestor
564322|NCT03702387|Anesthetics|anesthetics|mesh-list
564323|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
564324|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564325|NCT03702374|Antioxidants|antioxidants|mesh-list
564326|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564327|NCT03702374|Protective Agents|protective agents|mesh-ancestor
564328|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074772|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074773|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074774|NCT01990573|Analgesics|analgesics|mesh-ancestor
564335|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
564336|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564337|NCT03702205|Betaine|betaine|mesh-list
564338|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
564339|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
564340|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
564341|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
564342|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564343|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
564344|NCT03702179|Durvalumab|durvalumab|mesh-list
564345|NCT03702179|Tremelimumab|tremelimumab|mesh-list
564346|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
564347|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564348|NCT03702140|Teriparatide|teriparatide|mesh-list
564349|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
564350|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564351|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
564352|NCT03702023|Acetaminophen|acetaminophen|mesh-list
564353|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
564354|NCT03702023|Analgesics|analgesics|mesh-ancestor
564355|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
564356|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564357|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564358|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
564359|NCT03701984|Lidocaine|lidocaine|mesh-list
564360|NCT03701984|Tramadol|tramadol|mesh-list
564361|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
564362|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
564363|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
564364|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564365|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
564366|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564367|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
564368|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
564369|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
564370|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
564371|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564372|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
564373|NCT03701984|Narcotics|narcotics|mesh-ancestor
564374|NCT03701984|Analgesics|analgesics|mesh-ancestor
564375|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
564376|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
564377|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
564378|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
564379|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564380|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
564381|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
564382|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564383|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
564384|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564385|NCT03701880|Bisoprolol|bisoprolol|mesh-list
564386|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
564387|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
564388|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
564389|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564390|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564391|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
564392|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
564393|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
564394|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
564395|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
564396|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074775|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
2074776|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074777|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
2074778|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
2074779|NCT01990677|Eplerenone|eplerenone|mesh-list
2074780|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2074781|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
2074782|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2074783|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074784|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2074785|NCT01990677|Diuretics|diuretics|mesh-ancestor
2074786|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
2074787|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
564410|NCT03701750|Heparin|heparin|mesh-list
564411|NCT03701750|Enoxaparin|enoxaparin|mesh-list
564412|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
564413|NCT03701750|Tinzaparin|tinzaparin|mesh-list
564414|NCT03701750|Dalteparin|dalteparin|mesh-list
564415|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
564416|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
564417|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
564418|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
564419|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074788|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
2074789|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2074790|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
2074791|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2074792|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074793|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2074794|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2074795|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
564428|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
564429|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
564430|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
564431|NCT03701698|Prednisolone|prednisolone|mesh-list
564432|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
564433|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
564434|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
564435|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
564436|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
564437|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
564438|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564439|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564440|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
564441|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
564442|NCT03701698|Hormones|hormones|mesh-ancestor
564443|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
564444|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
564445|NCT03701698|Protective Agents|protective agents|mesh-ancestor
564446|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
564447|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564448|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
564449|NCT03701672|Analgesics|analgesics|mesh-list
564450|NCT03701672|Narcotics|narcotics|mesh-ancestor
564451|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
564452|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564453|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
564454|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564455|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
564456|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
564457|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
564458|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564459|NCT03701529|Anesthetics|anesthetics|mesh-list
564460|NCT03701529|Propofol|propofol|mesh-list
564461|NCT03701529|Sevoflurane|sevoflurane|mesh-list
564462|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
564463|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564464|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
564465|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
564466|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
564467|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
564468|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
564469|NCT03701503|Hormones|hormones|mesh-list
564470|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
564471|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564472|NCT03701490|Progesterone|progesterone|mesh-list
564473|NCT03701490|Progestins|progestins|mesh-ancestor
564474|NCT03701490|Hormones|hormones|mesh-ancestor
564475|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
564476|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564477|NCT03701451|Decitabine|decitabine|mesh-list
564478|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
564479|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
564480|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564481|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564482|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564483|NCT03701321|Dexamethasone|dexamethasone|mesh-list
564484|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
564485|NCT03701321|Bortezomib|bortezomib|mesh-list
564486|NCT03701321|Venetoclax|venetoclax|mesh-list
564487|NCT03701321|Daratumumab|daratumumab|mesh-list
564488|NCT03701321|Ichthammol|ichthammol|mesh-list
564489|NCT03701321|BB 1101|bb 1101|mesh-list
564490|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
564491|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
564492|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
564493|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564494|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564495|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
564496|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
564497|NCT03701321|Hormones|hormones|mesh-ancestor
564498|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
564499|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
564500|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564501|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
564502|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564503|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564504|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
2074796|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
2074797|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2074798|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2074799|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074800|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
2074801|NCT01990768|Coagulants|coagulants|mesh-ancestor
2074802|NCT01990859|Ipilimumab|ipilimumab|mesh-list
2074803|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2074804|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074805|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2074806|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074807|NCT01990898|Cyclosporine|cyclosporine|mesh-list
2074808|NCT01990898|Cyclosporins|cyclosporins|mesh-list
2074809|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213467|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213468|NCT00022737|Leucovorin|leucovorin|mesh-list
2213469|NCT00022737|Cytarabine|cytarabine|mesh-list
2213470|NCT00022737|Cyclosporine|cyclosporine|mesh-list
2213471|NCT00022737|Dexamethasone|dexamethasone|mesh-list
2213472|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
2213473|NCT00022737|Ifosfamide|ifosfamide|mesh-list
2213474|NCT00022737|Methotrexate|methotrexate|mesh-list
564530|NCT03701256|Atracurium|atracurium|mesh-list
564531|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
564532|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
564533|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
564534|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564535|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564536|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
564537|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
564538|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
564539|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
564540|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564541|NCT03701126|Bupivacaine|bupivacaine|mesh-list
564542|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
564543|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
564544|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
564545|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564546|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
564547|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564548|NCT03701087|Vitamin D|vitamin d|mesh-list
564549|NCT03701087|Vitamins|vitamins|mesh-ancestor
564550|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
564551|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564552|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2213475|NCT00022737|Etoposide|etoposide|mesh-list
2213476|NCT00022737|Vincristine|vincristine|mesh-list
2213477|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
2213478|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
2213479|NCT00022737|Daunorubicin|daunorubicin|mesh-list
2213480|NCT00022737|Asparaginase|asparaginase|mesh-list
2213481|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
2213482|NCT00022737|Pegaspargase|pegaspargase|mesh-list
2213483|NCT00022737|Cyclosporins|cyclosporins|mesh-list
2213484|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
2213485|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213486|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
2213487|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213488|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213489|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2213490|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
2213491|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564570|NCT03701022|Apatinib|apatinib|mesh-list
564571|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564572|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
564573|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564574|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564582|NCT03700905|Nivolumab|nivolumab|mesh-list
564583|NCT03700905|Ipilimumab|ipilimumab|mesh-list
564584|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
564585|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564586|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
564587|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213492|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213493|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2213494|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2213495|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
2213496|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
2213497|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564594|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
564595|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
564596|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564597|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
564598|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213498|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2213499|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
564599|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564600|NCT03700801|Insulin|insulin|mesh-list
564601|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
564602|NCT03700801|Metformin|metformin|mesh-list
564603|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
564604|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
564605|NCT03700801|Saxagliptin|saxagliptin|mesh-list
564606|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
564607|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564608|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
564609|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564610|NCT03700801|Incretins|incretins|mesh-ancestor
564611|NCT03700801|Hormones|hormones|mesh-ancestor
564612|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
564613|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
564614|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
564615|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564616|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
564617|NCT03700788|Calcium|calcium|mesh-list
564618|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
564619|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564620|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
564621|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564622|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
564623|NCT03700749|Iodine|iodine|mesh-list
564624|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
564625|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
564626|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
564627|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
564628|NCT03700749|Povidone|povidone|mesh-list
564629|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
564630|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564631|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
564632|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
564633|NCT03700749|Trace Elements|trace elements|mesh-ancestor
564634|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
564635|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564636|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
564637|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
564651|NCT03700645|Allopurinol|allopurinol|mesh-list
564652|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
564653|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564654|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564655|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
564656|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
564657|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
564658|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
564659|NCT03700645|Protective Agents|protective agents|mesh-ancestor
564660|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564670|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
564671|NCT03700515|Hematinics|hematinics|mesh-ancestor
564672|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
564673|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
564674|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
564675|NCT03700489|Protective Agents|protective agents|mesh-ancestor
564751|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
564676|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564677|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
564678|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
564679|NCT03700476|Gemcitabine|gemcitabine|mesh-list
564680|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564681|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
564682|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
564683|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564684|NCT03700476|Antiviral Agents|antiviral agents|mesh-ancestor
564685|NCT03700476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564686|NCT03700476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564687|NCT03700476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
564688|NCT03700476|Immunologic Factors|immunologic factors|mesh-ancestor
564689|NCT03700476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564690|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
564691|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
564692|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
564693|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564694|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
564695|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
564696|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
564697|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564698|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564699|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
564709|NCT03700359|Etoposide|etoposide|mesh-list
564710|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
564711|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564712|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
564713|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
564714|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564715|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564716|NCT03700333|Pemetrexed|pemetrexed|mesh-list
564717|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564718|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564719|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564720|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
564721|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
564722|NCT03700229|Rituximab|rituximab|mesh-list
564723|NCT03700229|Bortezomib|bortezomib|mesh-list
564724|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
564725|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564726|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
564727|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564728|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
564729|NCT03700177|Dexamethasone|dexamethasone|mesh-list
564730|NCT03700177|Ropivacaine|ropivacaine|mesh-list
564731|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
564732|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
564733|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
564734|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564735|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564736|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
564737|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
564738|NCT03700177|Hormones|hormones|mesh-ancestor
564739|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
564740|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
564741|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564742|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
564743|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
564744|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
564745|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
564746|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
564747|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
564748|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564749|NCT03700099|Docetaxel|docetaxel|mesh-list
564750|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564752|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
564753|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
564754|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564755|NCT03699995|Lidocaine|lidocaine|mesh-list
564756|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
564757|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
564758|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
564759|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564760|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
564761|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564762|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
564763|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
564764|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
564765|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
564766|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564767|NCT03699956|Carboplatin|carboplatin|mesh-list
564768|NCT03699956|Etoposide|etoposide|mesh-list
564769|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564770|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
564771|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
564772|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
564773|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564774|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564775|NCT03699904|Valacyclovir|valacyclovir|mesh-list
564776|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
564777|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564788|NCT03699839|Vaccines|vaccines|mesh-list
564789|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
564790|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564791|NCT03699774|Firuglipel|firuglipel|mesh-list
564792|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
564793|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
564794|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
564795|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
564796|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564797|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
564798|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
564799|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564800|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
564801|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564802|NCT03699696|Propofol|propofol|mesh-list
564803|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
564804|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
564805|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564806|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
564807|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
564808|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
564809|NCT03699631|Methotrexate|methotrexate|mesh-list
564810|NCT03699631|Tacrolimus|tacrolimus|mesh-list
564811|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
564812|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
564813|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
564814|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564815|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
564816|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
564817|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564818|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564819|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
564820|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564821|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
564822|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
564823|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
564824|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
564825|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
564826|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
564827|NCT03699618|Bevacizumab|bevacizumab|mesh-list
564828|NCT03699618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
564829|NCT03699618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564830|NCT03699618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
564831|NCT03699618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
564832|NCT03699618|Growth Substances|growth substances|mesh-ancestor
564833|NCT03699618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564834|NCT03699618|Growth Inhibitors|growth inhibitors|mesh-ancestor
564840|NCT03699475|Cyclophosphamide|cyclophosphamide|mesh-list
564841|NCT03699475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
564842|NCT03699475|Immunologic Factors|immunologic factors|mesh-ancestor
564843|NCT03699475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564844|NCT03699475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
564845|NCT03699475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
564846|NCT03699475|Alkylating Agents|alkylating agents|mesh-ancestor
564847|NCT03699475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564848|NCT03699475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564849|NCT03699475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
564850|NCT03699449|Paclitaxel|paclitaxel|mesh-list
564851|NCT03699449|Durvalumab|durvalumab|mesh-list
564852|NCT03699449|Olaparib|olaparib|mesh-list
564853|NCT03699449|Tremelimumab|tremelimumab|mesh-list
564854|NCT03699449|Cediranib|cediranib|mesh-list
564855|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
564856|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
564857|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564858|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
564859|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
564860|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
564861|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564862|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
564863|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
564864|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564865|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
564866|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564867|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
564868|NCT03699423|Atropine|atropine|mesh-list
564869|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
564870|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
564871|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
564872|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
564873|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
564874|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
564875|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564876|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564877|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
564878|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
564879|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
564880|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
564881|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
564882|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
564883|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
564884|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
564885|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564886|NCT03699384|Azacitidine|azacitidine|mesh-list
564887|NCT03699384|Avelumab|avelumab|mesh-list
564888|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
564889|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
564890|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564891|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564892|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564893|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
564894|NCT03699332|Labetuzumab|labetuzumab|mesh-list
564895|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
564896|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564897|NCT03699319|Leucovorin|leucovorin|mesh-list
564898|NCT03699319|Folic Acid|folic acid|mesh-list
564899|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
564900|NCT03699319|Irinotecan|irinotecan|mesh-list
564901|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
564902|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564903|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564904|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
564905|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
564906|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564907|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564908|NCT03699319|Antidotes|antidotes|mesh-ancestor
564909|NCT03699319|Protective Agents|protective agents|mesh-ancestor
564910|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
564911|NCT03699319|Vitamins|vitamins|mesh-ancestor
564912|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
564913|NCT03699319|Hematinics|hematinics|mesh-ancestor
564914|NCT03699293|Aspirin|aspirin|mesh-list
564915|NCT03699293|Celecoxib|celecoxib|mesh-list
564916|NCT03699293|Naproxen|naproxen|mesh-list
564917|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
564918|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
564919|NCT03699293|Analgesics|analgesics|mesh-ancestor
564920|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
564921|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564922|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564923|NCT03699293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
564924|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
564925|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
564926|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
564927|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564928|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
564929|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
564930|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564931|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
564932|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
564933|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
564934|NCT03699254|Valganciclovir|valganciclovir|mesh-list
564935|NCT03699254|Ganciclovir|ganciclovir|mesh-list
564936|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
564937|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
564938|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564939|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
564940|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564941|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564942|NCT03699215|Simendan|simendan|mesh-list
564943|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
564944|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
564945|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
564946|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
564947|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564948|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564949|NCT03699215|Protective Agents|protective agents|mesh-ancestor
564950|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564951|NCT03699202|Ziresovir|ziresovir|mesh-list
564952|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
564953|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
564954|NCT03699033|Paclitaxel|paclitaxel|mesh-list
564955|NCT03699033|Carboplatin|carboplatin|mesh-list
564956|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
564957|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
564958|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
564959|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
564960|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
564961|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564962|NCT03698916|Celecoxib|celecoxib|mesh-list
564963|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
564964|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
564965|NCT03698916|Analgesics|analgesics|mesh-ancestor
564966|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
564967|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564968|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564969|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
564970|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
564971|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
564972|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
564973|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
564974|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564975|NCT03698851|Methamphetamine|methamphetamine|mesh-list
564976|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
565279|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
564977|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564978|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
564979|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
564980|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564981|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
564982|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
564983|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
564984|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
564985|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
564986|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
564987|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
564988|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
564989|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
564990|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
564991|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
564992|NCT03698734|Analgesics|analgesics|mesh-ancestor
564993|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
564994|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
564995|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
564996|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
564997|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
564998|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
564999|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
565000|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565001|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
565002|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
565003|NCT03698695|Mefloquine|mefloquine|mesh-list
565004|NCT03698695|Donepezil|donepezil|mesh-list
565005|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
565006|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565007|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565008|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
565009|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
565010|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565011|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
565012|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
565013|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
565014|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
565015|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
565016|NCT03698682|Levofloxacin|levofloxacin|mesh-list
565017|NCT03698682|Ofloxacin|ofloxacin|mesh-list
565018|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
565019|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
565020|NCT03698682|Renal Agents|renal agents|mesh-ancestor
565021|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
565022|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
565023|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
565024|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565025|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565026|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565027|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
565028|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
565029|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
565030|NCT03698669|Narcotics|narcotics|mesh-ancestor
565031|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565032|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565033|NCT03698669|Analgesics|analgesics|mesh-ancestor
565034|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
565035|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565036|NCT03698630|Dexamethasone|dexamethasone|mesh-list
565037|NCT03698630|Prednisolone|prednisolone|mesh-list
565038|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
565039|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
565040|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
565041|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
565042|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
565043|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
565044|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
565045|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
565046|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
565047|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565048|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565049|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
565050|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
565051|NCT03698630|Hormones|hormones|mesh-ancestor
565581|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
565052|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
565053|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
565054|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565055|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
565056|NCT03698630|Protective Agents|protective agents|mesh-ancestor
565057|NCT03698617|Propofol|propofol|mesh-list
565058|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
565059|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565060|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565061|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
565062|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
565063|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
565067|NCT03698513|Aspirin|aspirin|mesh-list
565068|NCT03698513|Clopidogrel|clopidogrel|mesh-list
565069|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
565070|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
565071|NCT03698513|Analgesics|analgesics|mesh-ancestor
565072|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
565073|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565074|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565075|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
565076|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
565077|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
565078|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
565079|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565080|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
565081|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
565082|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565083|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
565084|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
565085|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
565086|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
565087|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
565088|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
565089|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
565090|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
565091|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
565092|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
565093|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565094|NCT03698474|Analgesics|analgesics|mesh-ancestor
565095|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
565096|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565097|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565098|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
565099|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565100|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
565101|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
565102|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
565103|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
565104|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
565105|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
565106|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
565107|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
565108|NCT03698474|Protective Agents|protective agents|mesh-ancestor
565109|NCT03698474|Vitamins|vitamins|mesh-ancestor
565110|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
565111|NCT03698474|Cathartics|cathartics|mesh-ancestor
565112|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
565113|NCT03698461|Leucovorin|leucovorin|mesh-list
565114|NCT03698461|Bevacizumab|bevacizumab|mesh-list
565115|NCT03698461|Fluorouracil|fluorouracil|mesh-list
565116|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
565117|NCT03698461|Atezolizumab|atezolizumab|mesh-list
565118|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
565119|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565120|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565121|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
565122|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
565123|NCT03698461|Growth Substances|growth substances|mesh-ancestor
565124|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565125|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
565126|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
565127|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565128|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
565129|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
565130|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
565131|NCT03698461|Antidotes|antidotes|mesh-ancestor
565132|NCT03698461|Protective Agents|protective agents|mesh-ancestor
565133|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
565134|NCT03698461|Vitamins|vitamins|mesh-ancestor
565135|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
565136|NCT03698435|Valganciclovir|valganciclovir|mesh-list
565137|NCT03698435|Ganciclovir|ganciclovir|mesh-list
565138|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
565139|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
565140|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
565141|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
565142|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565143|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565144|NCT03698383|Trastuzumab|trastuzumab|mesh-list
565145|NCT03698383|Gedatolisib|gedatolisib|mesh-list
565146|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565147|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565148|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
565149|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565150|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565151|NCT03698292|Metoclopramide|metoclopramide|mesh-list
565152|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
565153|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
565154|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565155|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565156|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
565157|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
565158|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
565159|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
565160|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
565161|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213500|NCT00022737|Hormones|hormones|mesh-ancestor
2213501|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2213502|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
565165|NCT03698227|Doxorubicin|doxorubicin|mesh-list
565166|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
565167|NCT03698227|Razoxane|razoxane|mesh-list
565168|NCT03698227|Olaratumab|olaratumab|mesh-list
565169|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
565170|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565171|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
565172|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
565173|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565174|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565175|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
565176|NCT03698227|Protective Agents|protective agents|mesh-ancestor
565177|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565178|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
565179|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
2074810|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074811|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2074812|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
2074813|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074814|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
2074815|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074816|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
2074817|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
565188|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
565189|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2074818|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2074819|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2074820|NCT01991197|Gliclazide|gliclazide|mesh-list
565193|NCT03698006|Ropivacaine|ropivacaine|mesh-list
565194|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
565195|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
565196|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
565197|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565198|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565199|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
565200|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2213503|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2213504|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
2213505|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2213506|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2213507|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
2213508|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
2213509|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213510|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2213511|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2213512|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2213513|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2213514|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2213515|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
565215|NCT03697889|Naproxen|naproxen|mesh-list
565216|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
565217|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
565218|NCT03697889|Analgesics|analgesics|mesh-ancestor
565219|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
565220|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565221|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565222|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
565223|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
565224|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
565225|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
565226|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565227|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565234|NCT03697850|Atezolizumab|atezolizumab|mesh-list
565235|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565236|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
565237|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
565238|NCT03697824|Fludarabine|fludarabine|mesh-list
565239|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
565240|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
565241|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565242|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
565243|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
565244|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
565245|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565246|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565247|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
565248|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565249|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
565250|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
565251|NCT03697746|Acetaminophen|acetaminophen|mesh-list
565252|NCT03697746|Ibuprofen|ibuprofen|mesh-list
565253|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
565254|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
565255|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
565256|NCT03697746|Analgesics|analgesics|mesh-ancestor
565257|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
565258|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565259|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565260|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
565261|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
565262|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
565263|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565264|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565265|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
565266|NCT03697720|Naproxen|naproxen|mesh-list
565267|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
565268|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
565269|NCT03697720|Analgesics|analgesics|mesh-ancestor
565270|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
565271|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565272|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565273|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
565274|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
565275|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
565276|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
565277|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565278|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213516|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
565280|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
565281|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
565282|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565283|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
565284|NCT03697681|Coagulants|coagulants|mesh-ancestor
565285|NCT03697668|Piperaquine|piperaquine|mesh-list
565286|NCT03697668|Artenimol|artenimol|mesh-list
565287|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
565288|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565289|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
565290|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565291|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565292|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
565293|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
565294|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
565295|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
565296|NCT03697655|Daratumumab|daratumumab|mesh-list
565297|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565298|NCT03697629|Daratumumab|daratumumab|mesh-list
565299|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565300|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
565301|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
565302|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
565303|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565304|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565305|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
565306|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
565307|NCT03697564|Gemcitabine|gemcitabine|mesh-list
565308|NCT03697564|Nivolumab|nivolumab|mesh-list
565309|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
565310|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
565311|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565312|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565313|NCT03697564|Antiviral Agents|antiviral agents|mesh-ancestor
565314|NCT03697564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
565315|NCT03697564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565316|NCT03697564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
565317|NCT03697564|Immunologic Factors|immunologic factors|mesh-ancestor
565318|NCT03697564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565319|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565320|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2074821|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2074822|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074823|NCT01991197|Incretins|incretins|mesh-ancestor
2074824|NCT01991197|Hormones|hormones|mesh-ancestor
2074825|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2074826|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
565327|NCT03697408|Everolimus|everolimus|mesh-list
565328|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565329|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
565330|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
565331|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565332|NCT03697356|Dexamethasone|dexamethasone|mesh-list
565333|NCT03697356|Rituximab|rituximab|mesh-list
565334|NCT03697356|Lenalidomide|lenalidomide|mesh-list
565335|NCT03697356|Bortezomib|bortezomib|mesh-list
565336|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
565337|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
565338|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
565339|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565340|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565341|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
565342|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
565343|NCT03697356|Hormones|hormones|mesh-ancestor
565344|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
565345|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
565346|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565347|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565348|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
565349|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
565350|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
565351|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
565352|NCT03697356|Growth Substances|growth substances|mesh-ancestor
565353|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
565354|NCT03697265|Pregnanolone|pregnanolone|mesh-list
565355|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
565356|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565357|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213517|NCT00022737|Antidotes|antidotes|mesh-ancestor
2213518|NCT00022737|Protective Agents|protective agents|mesh-ancestor
2213519|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
2213520|NCT00022737|Vitamins|vitamins|mesh-ancestor
2213521|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
2213522|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213523|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
2213524|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
2213525|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
2213526|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2213527|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2213528|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2213529|NCT00022841|Pamidronate|pamidronate|mesh-list
2213530|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2213531|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213532|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
565374|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
565375|NCT03697239|Gemcitabine|gemcitabine|mesh-list
565376|NCT03697239|Paclitaxel|paclitaxel|mesh-list
565377|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
565378|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
565379|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565380|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
565381|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
565382|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
565383|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565384|NCT03697239|Vitamins|vitamins|mesh-ancestor
565385|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
565386|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565387|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
565388|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
565389|NCT03697239|Antiviral Agents|antiviral agents|mesh-ancestor
565390|NCT03697239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
565391|NCT03697239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565392|NCT03697239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
565393|NCT03697239|Immunologic Factors|immunologic factors|mesh-ancestor
565394|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
565395|NCT03697239|Protective Agents|protective agents|mesh-ancestor
565396|NCT03697161|Gaboxadol|gaboxadol|mesh-list
565397|NCT03697161|Analgesics|analgesics|mesh-ancestor
565398|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
565399|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565400|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565401|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
565402|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
565403|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
565404|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
565405|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565406|NCT03697057|Anesthetics|anesthetics|mesh-list
565407|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565408|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565409|NCT03697044|Irinotecan|irinotecan|mesh-list
565410|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
565411|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
565412|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565413|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565414|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074827|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
2074828|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074829|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074830|NCT01991548|Insulin|insulin|mesh-list
565419|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
565420|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
565421|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
565422|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565423|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565424|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
565425|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
565426|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565427|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565428|NCT03696940|Atorvastatin|atorvastatin|mesh-list
565429|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
565430|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
565431|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
565432|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213533|NCT00022880|Antibodies|antibodies|mesh-list
565433|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
565434|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
565435|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565436|NCT03696901|Dalbavancin|dalbavancin|mesh-list
565437|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
565438|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074831|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2074832|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074833|NCT01991743|Bupivacaine|bupivacaine|mesh-list
2074834|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
2074835|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
2074836|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074837|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074838|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
2074839|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074840|NCT01991795|Ticagrelor|ticagrelor|mesh-list
2074841|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2074842|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2213534|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
2213535|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213536|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213537|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
2213538|NCT00022893|Antibodies|antibodies|mesh-list
2213539|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
2213540|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213541|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213542|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
2213543|NCT00022906|Antibodies|antibodies|mesh-list
2213544|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
2213545|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213546|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213547|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
2213548|NCT00022932|Antibodies|antibodies|mesh-list
2213549|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
2213550|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213551|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213552|NCT00022945|Prednisone|prednisone|mesh-list
565470|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
565471|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
565472|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
565473|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565474|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565475|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
565476|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
565477|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565478|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565479|NCT03696537|Fludarabine|fludarabine|mesh-list
565480|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565481|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
565482|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
565483|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
565484|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
565485|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
565486|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
565487|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565488|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565489|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565490|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
565491|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
565492|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
565493|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565494|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
565495|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
565496|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
565497|NCT03696355|GDC-0084|gdc-0084|mesh-list
565498|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565499|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213553|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
2213554|NCT00022945|Doxorubicin|doxorubicin|mesh-list
2213555|NCT00022945|Vincristine|vincristine|mesh-list
2213556|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
2213557|NCT00022945|Antibodies|antibodies|mesh-list
2213558|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213559|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
2213560|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213561|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213562|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2213563|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
2213564|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213565|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565512|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
565513|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
565514|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
565515|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
565516|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565517|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
565518|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
565519|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565520|NCT03696290|Aztreonam|aztreonam|mesh-list
565521|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
565522|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
565523|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
565524|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565525|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565526|NCT03696199|Anesthetics|anesthetics|mesh-list
565527|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565528|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565529|NCT03696186|Phenobarbital|phenobarbital|mesh-list
565530|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
565531|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
565532|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565533|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565534|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
565535|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
565536|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
565537|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565538|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
565539|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
565540|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
565541|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
565542|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
565543|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
565544|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
565545|NCT03696121|Coagulants|coagulants|mesh-ancestor
565546|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
565547|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
565548|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565549|NCT03696095|Ropivacaine|ropivacaine|mesh-list
565550|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
565551|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
565552|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565553|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565554|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
565555|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565556|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
565557|NCT03695952|Nivolumab|nivolumab|mesh-list
565558|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
565559|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565560|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565561|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565562|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
565563|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
565564|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
565565|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
565566|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565567|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565568|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
565569|NCT03695887|Analgesics|analgesics|mesh-ancestor
565570|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
565571|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565572|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
565573|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
565574|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565575|NCT03695835|Sargramostim|sargramostim|mesh-list
565576|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
565577|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565578|NCT03695822|Mirabegron|mirabegron|mesh-list
565579|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
565580|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
565582|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
565583|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
565584|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565585|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565586|NCT03695822|Urological Agents|urological agents|mesh-ancestor
565587|NCT03695744|Dexamethasone|dexamethasone|mesh-list
565588|NCT03695744|Bortezomib|bortezomib|mesh-list
565589|NCT03695744|Daratumumab|daratumumab|mesh-list
565590|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
565591|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
565592|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
565593|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565594|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565595|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
565596|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
565597|NCT03695744|Hormones|hormones|mesh-ancestor
565598|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
565599|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
565600|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565601|NCT03695705|Rifaximin|rifaximin|mesh-list
565602|NCT03695705|Norfloxacin|norfloxacin|mesh-list
565603|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
565604|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
565605|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
565606|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
565607|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
565608|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565609|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565610|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565611|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
565612|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
565613|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
565614|NCT03695640|Analgesics|analgesics|mesh-ancestor
565615|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
565616|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565617|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565618|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
565619|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565620|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
565621|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
565622|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
565623|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
565624|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565625|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
565626|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
565627|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
565628|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
565629|NCT03695510|Afatinib|afatinib|mesh-list
565630|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565631|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565632|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
565633|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565634|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565635|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
565636|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565637|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565638|NCT03695445|Norepinephrine|norepinephrine|mesh-list
565639|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
565640|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
565641|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
565642|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
565643|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565644|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565645|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
565646|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
565647|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565648|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2074843|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2074844|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2074845|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
2074846|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074847|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074848|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074849|NCT01991860|Amisulpride|amisulpride|mesh-list
2074850|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2074851|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2074852|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074853|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074854|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2074855|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2074856|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
2074857|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074858|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074859|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2074860|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
2074861|NCT01991977|Temozolomide|temozolomide|mesh-list
2074862|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
565677|NCT03695237|Leuprolide|leuprolide|mesh-list
565678|NCT03695237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
565679|NCT03695237|Fertility Agents|fertility agents|mesh-ancestor
565680|NCT03695237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
565681|NCT03695237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565682|NCT03695237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
565683|NCT03695237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565691|NCT03695107|Nifedipine|nifedipine|mesh-list
565692|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
565693|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
565694|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565695|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
565696|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565697|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
565698|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
565699|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2213566|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2213567|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2213568|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2213569|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2213570|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213571|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2213572|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
2213573|NCT00022945|Hormones|hormones|mesh-ancestor
2213574|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2213575|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2213576|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2213577|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213578|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
2213579|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
2213580|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
2213581|NCT00022958|Antibodies|antibodies|mesh-list
2213582|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
2213583|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213584|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565719|NCT03695029|Tenofovir|tenofovir|mesh-list
565720|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
565721|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
565722|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
565723|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
565724|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565725|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565726|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
565727|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
565728|NCT03694977|Spartalizumab|spartalizumab|mesh-list
565729|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
565730|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565731|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565732|NCT03694886|Caffeine|caffeine|mesh-list
565733|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
565734|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565735|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
565736|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565737|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565738|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
565739|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
565740|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
565741|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
565742|NCT03694873|Celecoxib|celecoxib|mesh-list
565743|NCT03694873|Tramadol|tramadol|mesh-list
565744|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
565745|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
565746|NCT03694873|Analgesics|analgesics|mesh-ancestor
565747|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
565748|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565749|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565750|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
565751|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
565752|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
565753|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
565754|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565755|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565756|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
565757|NCT03694873|Narcotics|narcotics|mesh-ancestor
565758|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074863|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
2074864|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213585|NCT00022971|Rituximab|rituximab|mesh-list
2213586|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2213587|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213588|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
2213589|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213590|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213591|NCT00023153|Adefovir|adefovir|mesh-list
2213592|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2213593|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
2213594|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213595|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2213596|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2213597|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213598|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213599|NCT00023166|Paclitaxel|paclitaxel|mesh-list
2213600|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2213601|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213602|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
2213603|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
2213604|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
2213605|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213606|NCT00023218|Ritonavir|ritonavir|mesh-list
2213607|NCT00023218|Lopinavir|lopinavir|mesh-list
2213608|NCT00023218|Efavirenz|efavirenz|mesh-list
2213609|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2213610|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2213611|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
2213612|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213613|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213614|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2213615|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2213616|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
565794|NCT03694808|Vaccines|vaccines|mesh-list
565795|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
565796|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565797|NCT03694587|Ibuprofen|ibuprofen|mesh-list
565798|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
565799|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
565800|NCT03694587|Analgesics|analgesics|mesh-ancestor
565801|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
565802|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565803|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565804|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
565805|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
565806|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
565807|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565808|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565809|NCT03694535|Mitomycins|mitomycins|mesh-list
565810|NCT03694535|Mitomycin|mitomycin|mesh-list
565811|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
565812|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565813|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
565814|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565815|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
565816|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565817|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
565818|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565819|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565820|NCT03694262|Bevacizumab|bevacizumab|mesh-list
565821|NCT03694262|Atezolizumab|atezolizumab|mesh-list
565822|NCT03694262|Rucaparib|rucaparib|mesh-list
565823|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565824|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565825|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
565826|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
565827|NCT03694262|Growth Substances|growth substances|mesh-ancestor
565828|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565829|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
565830|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
565831|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565832|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565833|NCT03694249|Ifetroban|ifetroban|mesh-list
565834|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
565835|NCT03694236|Durvalumab|durvalumab|mesh-list
565836|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565837|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565838|NCT03694119|Phenelzine|phenelzine|mesh-list
565839|NCT03694119|Ozanimod|ozanimod|mesh-list
565840|NCT03694119|Tyramine|tyramine|mesh-list
565841|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
565842|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565843|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
565844|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
565845|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565846|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
565847|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
565848|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
565849|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565850|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
565851|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
565852|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565853|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
565854|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
565855|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
565856|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
565857|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
565858|NCT03694080|Calcium|calcium|mesh-list
565859|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
565860|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213617|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213618|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2213619|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2213620|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2213621|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2213622|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
565885|NCT03693976|Xylometazoline|xylometazoline|mesh-list
565886|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
565887|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
565888|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
2213623|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
565891|NCT03693885|Oxytocin|oxytocin|mesh-list
565892|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
565893|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
565894|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565895|NCT03693872|Dopamine|dopamine|mesh-list
565896|NCT03693872|Apomorphine|apomorphine|mesh-list
565897|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
565898|NCT03693872|Emetics|emetics|mesh-ancestor
565899|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565900|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
565901|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565902|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
565903|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
565904|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
565905|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565906|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
565907|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
565908|NCT03693872|Protective Agents|protective agents|mesh-ancestor
565915|NCT03693833|Cannabidiol|cannabidiol|mesh-list
565916|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
2074865|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074866|NCT01992016|Ranolazine|ranolazine|mesh-list
2074867|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2074868|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2074869|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074870|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
2074871|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2074872|NCT01992172|Protective Agents|protective agents|mesh-ancestor
2074873|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074874|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
2074875|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
2074876|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2074877|NCT01992185|Protective Agents|protective agents|mesh-ancestor
2074878|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074879|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
2074880|NCT01992523|Ticagrelor|ticagrelor|mesh-list
2074881|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2074882|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
565937|NCT03693781|Colchicine|colchicine|mesh-list
565938|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
565939|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
565940|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
565941|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
565942|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
565943|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565944|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565945|NCT03693677|Gemcitabine|gemcitabine|mesh-list
565946|NCT03693677|Paclitaxel|paclitaxel|mesh-list
565947|NCT03693677|Irinotecan|irinotecan|mesh-list
565948|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
565949|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565950|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
565951|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
565952|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
565953|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565954|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
565955|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
565956|NCT03693677|Antiviral Agents|antiviral agents|mesh-ancestor
565957|NCT03693677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
565958|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
565959|NCT03693677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
565960|NCT03693677|Immunologic Factors|immunologic factors|mesh-ancestor
565961|NCT03693677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565962|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
565963|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
565964|NCT03693638|Fentanyl|fentanyl|mesh-list
565965|NCT03693638|Bupivacaine|bupivacaine|mesh-list
565966|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
565967|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
565968|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
565969|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565970|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
565971|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
565972|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
565973|NCT03693638|Narcotics|narcotics|mesh-ancestor
565974|NCT03693638|Analgesics|analgesics|mesh-ancestor
565975|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
565976|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
565977|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
565978|NCT03693612|Paclitaxel|paclitaxel|mesh-list
565979|NCT03693612|Docetaxel|docetaxel|mesh-list
565980|NCT03693612|Cetuximab|cetuximab|mesh-list
565981|NCT03693612|Tremelimumab|tremelimumab|mesh-list
565982|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
565983|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565984|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
565985|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
565986|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
565987|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
565988|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565989|NCT03693599|Carbetocin|carbetocin|mesh-list
565990|NCT03693599|Syntometrine|syntometrine|mesh-list
565991|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
565992|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
565993|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
565994|NCT03693573|Bevacizumab|bevacizumab|mesh-list
565995|NCT03693573|Atezolizumab|atezolizumab|mesh-list
565996|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
565997|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
565998|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
565999|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
566000|NCT03693573|Growth Substances|growth substances|mesh-ancestor
566001|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566002|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
566003|NCT03693560|Metformin|metformin|mesh-list
566004|NCT03693560|Glimepiride|glimepiride|mesh-list
566005|NCT03693560|Vildagliptin|vildagliptin|mesh-list
566006|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
566007|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566008|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
566009|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
566010|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
566011|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
566012|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
566013|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566014|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566015|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
566016|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
566017|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
566018|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
566019|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566020|NCT03693404|Ketorolac|ketorolac|mesh-list
566021|NCT03693404|Morphine|morphine|mesh-list
566022|NCT03693404|Bupivacaine|bupivacaine|mesh-list
566023|NCT03693404|Anesthetics|anesthetics|mesh-list
566024|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
566025|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
566026|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
566027|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566028|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
566029|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566030|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
566031|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
566032|NCT03693404|Analgesics|analgesics|mesh-ancestor
566033|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
566034|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
566035|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
566036|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566037|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566038|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
566039|NCT03693404|Narcotics|narcotics|mesh-ancestor
566040|NCT03693391|Fluorides|fluorides|mesh-list
566041|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
566042|NCT03693391|Protective Agents|protective agents|mesh-ancestor
566043|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566044|NCT03693326|Spartalizumab|spartalizumab|mesh-list
566045|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
566046|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566047|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074883|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2074884|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2074885|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
566051|NCT03693248|Paclitaxel|paclitaxel|mesh-list
566052|NCT03693248|Carboplatin|carboplatin|mesh-list
566053|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
566054|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566055|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
566056|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
566057|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
566058|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566059|NCT03693222|Morphine|morphine|mesh-list
566060|NCT03693222|Tramadol|tramadol|mesh-list
566061|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
566062|NCT03693222|Narcotics|narcotics|mesh-ancestor
566063|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
566064|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566065|NCT03693222|Analgesics|analgesics|mesh-ancestor
566066|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
566067|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566068|NCT03693183|Ketorolac|ketorolac|mesh-list
566069|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
566070|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
566071|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
566072|NCT03693183|Analgesics|analgesics|mesh-ancestor
566073|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
566074|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566075|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566076|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
566077|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
566078|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
566079|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566080|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566081|NCT03693170|Cetuximab|cetuximab|mesh-list
566082|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
566083|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566084|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
566085|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
566086|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
566087|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
566088|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
566089|NCT03693066|Disinfectants|disinfectants|mesh-list
566090|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
566091|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566092|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
2074886|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074887|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074888|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566101|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
566102|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
566103|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566104|NCT03692819|Amoxicillin|amoxicillin|mesh-list
566105|NCT03692819|Metronidazole|metronidazole|mesh-list
566106|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
566107|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566108|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
566109|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
566110|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
566111|NCT03692754|Dexamethasone|dexamethasone|mesh-list
566112|NCT03692754|Atorvastatin|atorvastatin|mesh-list
566113|NCT03692754|Calcium|calcium|mesh-list
566114|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
566115|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
566116|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
566117|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566118|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566119|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
566120|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
566121|NCT03692754|Hormones|hormones|mesh-ancestor
566122|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
566123|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
566124|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566125|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
566126|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
566127|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
566128|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
566129|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
566130|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566131|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
566132|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
566133|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750372|NCT04308304|Donepezil|donepezil|mesh-list
2750373|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2750374|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750375|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750376|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
2750377|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2750378|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750379|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
2750380|NCT04300595|Anesthetics|anesthetics|mesh-list
2750381|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2750382|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750383|NCT04297293|Ramosetron|ramosetron|mesh-list
2074914|NCT01992874|Niacinamide|niacinamide|mesh-list
2074915|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
566156|NCT03692546|Bupivacaine|bupivacaine|mesh-list
566157|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
566158|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
566159|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
566160|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566161|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
566162|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566163|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
566164|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
566165|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566166|NCT03692416|Prednisone|prednisone|mesh-list
566167|NCT03692416|Ibuprofen|ibuprofen|mesh-list
566168|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
566169|NCT03692416|Methotrexate|methotrexate|mesh-list
566170|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
566171|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
566172|NCT03692416|Hormones|hormones|mesh-ancestor
566173|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
566174|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566175|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
566176|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566177|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
566178|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
566179|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
566180|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
566181|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
566182|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566183|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
566184|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566185|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2074916|NCT01992874|Vitamins|vitamins|mesh-ancestor
2750384|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
566186|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
566187|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
566188|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
566189|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
566190|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
566191|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
566192|NCT03692416|Analgesics|analgesics|mesh-ancestor
566193|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
566194|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566195|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
566196|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
566197|NCT03692416|Protective Agents|protective agents|mesh-ancestor
2074917|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
2074918|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074919|NCT01993017|Bupropion|bupropion|mesh-list
2074920|NCT01993017|Sertraline|sertraline|mesh-list
2074921|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
2074922|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2074923|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2074924|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2074925|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2074926|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2074927|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566209|NCT03692299|Metronidazole|metronidazole|mesh-list
566210|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566211|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
566212|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
566213|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
566214|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
566215|NCT03692286|Calcium|calcium|mesh-list
566216|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
566217|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566218|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
566219|NCT03692143|Alendronate|alendronate|mesh-list
566220|NCT03692143|Teriparatide|teriparatide|mesh-list
566221|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
566222|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566223|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
566224|NCT03692065|Apixaban|apixaban|mesh-list
566225|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
566226|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
566227|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
566228|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
566229|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566230|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566231|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
566232|NCT03692026|Melatonin|melatonin|mesh-list
566233|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
566234|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
566235|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566236|NCT03692026|Protective Agents|protective agents|mesh-ancestor
566237|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566238|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
566239|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
566240|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
566241|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
566242|NCT03692013|Losartan|losartan|mesh-list
566243|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
566244|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
566245|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
566246|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
566247|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074928|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
2074929|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074930|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074931|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2074932|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2213624|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2213625|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2213626|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2213627|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
2213628|NCT00023231|Sirolimus|sirolimus|mesh-list
2750385|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
566336|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2213629|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
566261|NCT03691935|Ropivacaine|ropivacaine|mesh-list
566262|NCT03691935|Anesthetics|anesthetics|mesh-list
566263|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
566264|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
566265|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566266|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
566267|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566268|NCT03691922|Epinephrine|epinephrine|mesh-list
566269|NCT03691922|Racepinephrine|racepinephrine|mesh-list
566270|NCT03691922|Bupivacaine|bupivacaine|mesh-list
566271|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
566272|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
566273|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
566274|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
566275|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566276|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
566277|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566278|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
566279|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
566280|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
566281|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
566282|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566283|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
566284|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
566285|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
566286|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
566287|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
566288|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
566289|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
566290|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
566291|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
566292|NCT03691896|Vitamin D|vitamin d|mesh-list
566293|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
566294|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566295|NCT03691896|Vitamins|vitamins|mesh-ancestor
566296|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
566297|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2213630|NCT00023231|Ganciclovir|ganciclovir|mesh-list
2213631|NCT00023231|Prednisone|prednisone|mesh-list
2213632|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
566301|NCT03691818|Ibuprofen|ibuprofen|mesh-list
566302|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
566303|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
566304|NCT03691818|Analgesics|analgesics|mesh-ancestor
566305|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
566306|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566307|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566308|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
566309|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
566310|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
566311|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566312|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074933|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074934|NCT01993017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2074935|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
2074936|NCT01993108|Naltrexone|naltrexone|mesh-list
2213633|NCT00023231|Atorvastatin|atorvastatin|mesh-list
2213634|NCT00023231|Daclizumab|daclizumab|mesh-list
2213635|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2213636|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
2213637|NCT00023231|Hormones|hormones|mesh-ancestor
2074937|NCT01993108|Methylphenidate|methylphenidate|mesh-list
2074938|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2074939|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2074940|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566326|NCT03691688|Aspirin|aspirin|mesh-list
566327|NCT03691688|Clopidogrel|clopidogrel|mesh-list
566328|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
566329|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
566330|NCT03691688|Analgesics|analgesics|mesh-ancestor
566331|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
566332|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566333|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566334|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
566335|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213638|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
566337|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
566338|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566339|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
566340|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
566341|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566342|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
566343|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
566344|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
566345|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
566346|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
566347|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
566348|NCT03691662|Timolol|timolol|mesh-list
566349|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
566350|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
566351|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
566352|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
566353|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
566354|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
566355|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566356|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566357|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
566358|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
566359|NCT03691649|Timolol|timolol|mesh-list
566360|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
566361|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
566362|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
566363|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
566364|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
566365|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
566366|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566367|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566368|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
566369|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
566370|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
566371|NCT03691636|Lifitegrast|lifitegrast|mesh-list
566372|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2074941|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
2074942|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074943|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
566377|NCT03691493|Tamoxifen|tamoxifen|mesh-list
566378|NCT03691493|Letrozole|letrozole|mesh-list
566379|NCT03691493|Fulvestrant|fulvestrant|mesh-list
566380|NCT03691493|Palbociclib|palbociclib|mesh-list
566381|NCT03691493|Anastrozole|anastrozole|mesh-list
566382|NCT03691493|Exemestane|exemestane|mesh-list
566383|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566384|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
566385|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
566386|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566387|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566388|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
566389|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
566390|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
566391|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566392|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
566393|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
566394|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
566395|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
566396|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
566397|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
566398|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
566399|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
566400|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
566401|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566402|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
566403|NCT03691467|Protective Agents|protective agents|mesh-ancestor
566404|NCT03691454|Docetaxel|docetaxel|mesh-list
566405|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
566406|NCT03691454|Trastuzumab|trastuzumab|mesh-list
566407|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566408|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
566409|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
566410|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
566411|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566412|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
566413|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
566414|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
566415|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
566416|NCT03691376|Aldesleukin|aldesleukin|mesh-list
566417|NCT03691376|Melphalan|melphalan|mesh-list
566418|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
566419|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
566420|NCT03691376|Interleukin-2|interleukin-2|mesh-list
566421|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
566422|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
566423|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566424|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566425|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
566426|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
566427|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
566428|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566429|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
566430|NCT03691376|Analgesics|analgesics|mesh-ancestor
566431|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
566432|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566433|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
566434|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
566435|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
566436|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566437|NCT03691350|Nicotine|nicotine|mesh-list
566438|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
566439|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
566440|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566441|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566442|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
566443|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
566444|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
566445|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
566446|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566447|NCT03691337|Bupivacaine|bupivacaine|mesh-list
566448|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
566449|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
566450|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
566451|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
566452|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566453|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
566454|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2074944|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2074945|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
566458|NCT03691090|Paclitaxel|paclitaxel|mesh-list
566459|NCT03691090|Cisplatin|cisplatin|mesh-list
566460|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
566461|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566462|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
566463|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
566464|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
566465|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566466|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
566467|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
566468|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566469|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
566470|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
566471|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566477|NCT03691038|Pregabalin|pregabalin|mesh-list
566478|NCT03691038|Analgesics|analgesics|mesh-ancestor
566479|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
566480|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566481|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566482|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
566483|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
566484|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
566485|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566486|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
566487|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
566488|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
566489|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
566490|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
566491|NCT03690986|Nivolumab|nivolumab|mesh-list
566492|NCT03690986|Ipilimumab|ipilimumab|mesh-list
566493|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
566494|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566495|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
566496|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566497|NCT03690947|Ranibizumab|ranibizumab|mesh-list
566498|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
566499|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
566500|NCT03690947|Growth Substances|growth substances|mesh-ancestor
566501|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566502|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
566503|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566504|NCT03690921|Cisplatin|cisplatin|mesh-list
566505|NCT03690921|Fluorouracil|fluorouracil|mesh-list
566506|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566507|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
566508|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566509|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
566510|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
566511|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
566512|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566513|NCT03690869|Cemiplimab|cemiplimab|mesh-list
566514|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
566515|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566516|NCT03690778|Metformin|metformin|mesh-list
566517|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
566518|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
566519|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566520|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
566521|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
566522|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
566523|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566524|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
566525|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
566526|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566532|NCT03690739|Gemcitabine|gemcitabine|mesh-list
566533|NCT03690739|Paclitaxel|paclitaxel|mesh-list
566534|NCT03690739|Bevacizumab|bevacizumab|mesh-list
566535|NCT03690739|Carboplatin|carboplatin|mesh-list
566536|NCT03690739|Trabectedin|trabectedin|mesh-list
566537|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
566538|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566539|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
566540|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
566541|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
566542|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566543|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
566544|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
566545|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
566546|NCT03690739|Growth Substances|growth substances|mesh-ancestor
566547|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566548|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
566549|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
566550|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
566551|NCT03690739|Antiviral Agents|antiviral agents|mesh-ancestor
566552|NCT03690739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566553|NCT03690739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566554|NCT03690739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
566555|NCT03690739|Immunologic Factors|immunologic factors|mesh-ancestor
566556|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
566557|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
566558|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
566559|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
566560|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
566561|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566562|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
566563|NCT03690622|Analgesics|analgesics|mesh-ancestor
566564|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
566565|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566566|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
566567|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
566568|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
566569|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
566570|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
566571|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566572|NCT03690583|Zinc|zinc|mesh-list
566573|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
566574|NCT03690583|Trace Elements|trace elements|mesh-ancestor
566575|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
566576|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566577|NCT03690583|Astringents|astringents|mesh-ancestor
566578|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
566579|NCT03690544|Apremilast|apremilast|mesh-list
566580|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
566581|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
566582|NCT03690544|Analgesics|analgesics|mesh-ancestor
566583|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
566584|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566585|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566586|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
566587|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
566588|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
566589|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
566590|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566591|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074946|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2074947|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566595|NCT03690414|Atropine|atropine|mesh-list
566596|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
566597|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
566598|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
566599|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
566600|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
566601|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
566602|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566603|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566604|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
566605|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
566606|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
566607|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
566608|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
566609|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
566610|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
566611|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
566612|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566613|NCT03690323|Gemcitabine|gemcitabine|mesh-list
566614|NCT03690323|Paclitaxel|paclitaxel|mesh-list
566615|NCT03690323|Folfirinox|folfirinox|mesh-list
566616|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
566617|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566618|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
566619|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
566620|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
566621|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566622|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
566623|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
566624|NCT03690323|Antiviral Agents|antiviral agents|mesh-ancestor
566625|NCT03690323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566626|NCT03690323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566627|NCT03690323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
566628|NCT03690323|Immunologic Factors|immunologic factors|mesh-ancestor
566629|NCT03690323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566630|NCT03690167|Mitogens|mitogens|mesh-list
566631|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
566632|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566633|NCT03690115|Ponatinib|ponatinib|mesh-list
566634|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566635|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
566636|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566637|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566638|NCT03690089|Atropine|atropine|mesh-list
566639|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
566640|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
566641|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
566642|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
566643|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566644|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566645|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
566646|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
566647|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
566648|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
566649|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
566650|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
566651|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
566652|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
566653|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566654|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
566655|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
566656|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
566657|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566658|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
566659|NCT03690037|Coagulants|coagulants|mesh-ancestor
2750386|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2750387|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750388|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2750389|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2750390|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
2750391|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2750392|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750393|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
2750394|NCT04295863|Nivolumab|nivolumab|mesh-list
2750395|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2750396|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566671|NCT03689998|Melatonin|melatonin|mesh-list
566672|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
566673|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566674|NCT03689998|Protective Agents|protective agents|mesh-ancestor
566675|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566676|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
566677|NCT03689972|Natalizumab|natalizumab|mesh-list
566678|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
566679|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566680|NCT03689946|Listerine|listerine|mesh-list
566681|NCT03689946|Evolocumab|evolocumab|mesh-list
566682|NCT03689946|Fluorides|fluorides|mesh-list
566683|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
566684|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
566685|NCT03689946|Protective Agents|protective agents|mesh-ancestor
566686|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566687|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
566688|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566689|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
566690|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
566691|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
566692|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566693|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
566694|NCT03689894|Rituximab|rituximab|mesh-list
566695|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
566696|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566697|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
566698|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566699|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
566700|NCT03689855|Atezolizumab|atezolizumab|mesh-list
566701|NCT03689855|Ramucirumab|ramucirumab|mesh-list
566702|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566708|NCT03689699|Nivolumab|nivolumab|mesh-list
566709|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
566710|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566711|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
566712|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566721|NCT03689465|Cyclosporine|cyclosporine|mesh-list
566722|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
566723|NCT03689465|Methotrexate|methotrexate|mesh-list
566724|NCT03689465|Cyclosporins|cyclosporins|mesh-list
566725|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
566726|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
566727|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
566728|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566729|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
566730|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
566731|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566732|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566733|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
566734|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566735|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
566736|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
566737|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
566738|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
566739|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
566740|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
566741|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566742|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
566743|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
566744|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
566745|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
566746|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2074948|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
2074949|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2074950|NCT01993186|Glycerol|glycerol|mesh-list
2074951|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2074952|NCT01993186|Protective Agents|protective agents|mesh-ancestor
2074953|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074954|NCT01993329|Mitomycin|mitomycin|mesh-list
2074955|NCT01993329|Cisplatin|cisplatin|mesh-list
566755|NCT03689114|Topiramate|topiramate|mesh-list
566756|NCT03689114|Lamotrigine|lamotrigine|mesh-list
566757|NCT03689114|Zonisamide|zonisamide|mesh-list
566758|NCT03689114|Carbamazepine|carbamazepine|mesh-list
566759|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
566760|NCT03689114|Gabapentin|gabapentin|mesh-list
566761|NCT03689114|Levetiracetam|levetiracetam|mesh-list
566762|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
566763|NCT03689114|Valproic Acid|valproic acid|mesh-list
566764|NCT03689114|Analgesics|analgesics|mesh-ancestor
566765|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
566766|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566767|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566768|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
566769|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
566770|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
566771|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
566772|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
566773|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
566774|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
566775|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566776|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
566777|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
566778|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
566779|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
566780|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
566781|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
566782|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
566783|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
566784|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566785|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
566786|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
566787|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
566788|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
566789|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
566790|NCT03689075|Tacrolimus|tacrolimus|mesh-list
566791|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
566792|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
566793|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566794|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
566795|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566796|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566797|NCT03689010|Azelaic acid|azelaic acid|mesh-list
566798|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566799|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
566800|NCT03688971|Ketoconazole|ketoconazole|mesh-list
566801|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
566802|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566803|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
566804|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
566805|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566806|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566807|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
566808|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
566809|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
566810|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566811|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
566812|NCT03688958|Iodine|iodine|mesh-list
566813|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
566814|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
566815|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566816|NCT03688958|Trace Elements|trace elements|mesh-ancestor
566817|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
566818|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074956|NCT01993329|Ifosfamide|ifosfamide|mesh-list
2074957|NCT01993329|Mesna|mesna|mesh-list
2074958|NCT01993329|Protective Agents|protective agents|mesh-ancestor
2074959|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074960|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
2074961|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074962|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2074963|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074964|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2074965|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074966|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2074967|NCT01993667|Acetazolamide|acetazolamide|mesh-list
2074968|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
2074969|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2074970|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074971|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074972|NCT01993667|Diuretics|diuretics|mesh-ancestor
2074973|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
2074974|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074975|NCT01993823|Clotrimazole|clotrimazole|mesh-list
2074976|NCT01993823|Miconazole|miconazole|mesh-list
566840|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
566841|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
566842|NCT03688659|Vancomycin|vancomycin|mesh-list
566843|NCT03688659|Gentamicins|gentamicins|mesh-list
566844|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
566845|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566846|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
566847|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566848|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074977|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2074978|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2074979|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
2074980|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
566854|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
566855|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566856|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
566857|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566858|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566859|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
566860|NCT03688464|Promethazine|promethazine|mesh-list
566861|NCT03688464|Melatonin|melatonin|mesh-list
566862|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
566863|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566864|NCT03688464|Protective Agents|protective agents|mesh-ancestor
566865|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566866|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
566867|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
566868|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
566869|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
566870|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
566871|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
566872|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566873|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
566874|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
566875|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
566876|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
566877|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
566878|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
566879|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
566880|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
566881|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
566882|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
566883|NCT03688451|Rituximab|rituximab|mesh-list
566884|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
566885|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566886|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
566887|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566888|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
566889|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
566890|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
566891|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566892|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
566893|NCT03688269|Dexamethasone|dexamethasone|mesh-list
566894|NCT03688269|Ropivacaine|ropivacaine|mesh-list
566895|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
566896|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
566897|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
566898|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566899|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566900|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
566901|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
566902|NCT03688269|Hormones|hormones|mesh-ancestor
566903|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
566904|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
566905|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566906|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
566907|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
566908|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
566909|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
566910|NCT03688230|Cetuximab|cetuximab|mesh-list
566911|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
566912|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566913|NCT03688191|Sirolimus|sirolimus|mesh-list
566914|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
566915|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566916|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
566917|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566918|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
566919|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
566920|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
566921|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566922|NCT03688178|Temozolomide|temozolomide|mesh-list
566923|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
566924|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
566925|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566926|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2074981|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2074982|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2074983|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074984|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2074985|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
566932|NCT03687931|Dexamethasone|dexamethasone|mesh-list
566933|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
566934|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
566935|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
566936|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566937|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566938|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
566939|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
566940|NCT03687931|Hormones|hormones|mesh-ancestor
566941|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
566942|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
566943|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566944|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
566945|NCT03687905|Chloroquine|chloroquine|mesh-list
566946|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
566947|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
566948|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
566949|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
566950|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
566951|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566952|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
566953|NCT03687905|Amebicides|amebicides|mesh-ancestor
2213639|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213640|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2213641|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213642|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2213643|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2213644|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
2213645|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2213646|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213647|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213648|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213649|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
2213650|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213651|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
2213652|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
2213653|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
566972|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
566973|NCT03687606|Menotropins|menotropins|mesh-list
566974|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
566975|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566976|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
566977|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
566978|NCT03687515|Prednisone|prednisone|mesh-list
566979|NCT03687515|Budesonide|budesonide|mesh-list
566980|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
566981|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
566982|NCT03687515|Hormones|hormones|mesh-ancestor
566983|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
566984|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
566985|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
566986|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566987|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
566988|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
566989|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
566990|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
566991|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
566992|NCT03687463|Decitabine|decitabine|mesh-list
566993|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
566994|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
566995|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
566996|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
566997|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213654|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2213655|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2213656|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
567001|NCT03687268|Naloxone|naloxone|mesh-list
567002|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
567003|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567004|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
567005|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567006|NCT03687255|Tazobactam|tazobactam|mesh-list
567007|NCT03687255|Piperacillin|piperacillin|mesh-list
567008|NCT03687255|Cefepime|cefepime|mesh-list
567009|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
567010|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
567011|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
567012|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567013|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
567014|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567015|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567016|NCT03687229|Insulin|insulin|mesh-list
567017|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
567018|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567019|NCT03687073|Silybin|silybin|mesh-list
567020|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
567021|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
567022|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567023|NCT03687073|Protective Agents|protective agents|mesh-ancestor
567024|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567025|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
567026|NCT03687034|Temozolomide|temozolomide|mesh-list
567027|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
567028|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
567029|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567030|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567031|NCT03687021|Progesterone|progesterone|mesh-list
567032|NCT03687021|Progestins|progestins|mesh-ancestor
567033|NCT03687021|Hormones|hormones|mesh-ancestor
567034|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
567035|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567036|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
567037|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
567038|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567039|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
567040|NCT03686878|Lifitegrast|lifitegrast|mesh-list
567041|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
567042|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
567050|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
567051|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
567052|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
567053|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567054|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
567055|NCT03686787|Coagulants|coagulants|mesh-ancestor
567056|NCT03686774|Memantine|memantine|mesh-list
567057|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
567058|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
567059|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
567060|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
567061|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567062|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567063|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
567064|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
567065|NCT03686722|Metformin|metformin|mesh-list
567066|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
567067|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567068|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
567069|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
567070|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
567071|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
567072|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
567073|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
567074|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567075|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567076|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
567077|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567078|NCT03686657|Metformin|metformin|mesh-list
567079|NCT03686657|Celecoxib|celecoxib|mesh-list
567080|NCT03686657|Valsartan|valsartan|mesh-list
567081|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
567082|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567083|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
567084|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
567085|NCT03686657|Analgesics|analgesics|mesh-ancestor
567086|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
567087|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567088|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
567089|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
567090|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
567091|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
567092|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567093|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567094|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
567095|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
567096|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
567097|NCT03686618|Secretin|secretin|mesh-list
567098|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
567099|NCT03686618|Hormones|hormones|mesh-ancestor
567100|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
567101|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074986|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2074987|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567109|NCT03686332|Atezolizumab|atezolizumab|mesh-list
567110|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
567111|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567112|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
567113|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750397|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2750398|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750399|NCT04295772|Islatravir|islatravir|mesh-list
2750400|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
2750401|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2750402|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750403|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567121|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
567122|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
567123|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
567124|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567125|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567126|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
567127|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
567128|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
567129|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567130|NCT03686254|Bevacizumab|bevacizumab|mesh-list
567131|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
567132|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567133|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
567134|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
567135|NCT03686254|Growth Substances|growth substances|mesh-ancestor
567136|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567137|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
567138|NCT03686163|Mitogens|mitogens|mesh-list
567139|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
567140|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567141|NCT03686150|Vitamin D|vitamin d|mesh-list
567142|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
567143|NCT03686150|Vitamins|vitamins|mesh-ancestor
567144|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
567145|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567146|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
567147|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
567148|NCT03686124|Atezolizumab|atezolizumab|mesh-list
567149|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567150|NCT03686085|Dinoprostone|dinoprostone|mesh-list
567151|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
567152|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
567153|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567154|NCT03685890|Nivolumab|nivolumab|mesh-list
567155|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
567156|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567157|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
567158|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2074988|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2074989|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2074990|NCT01993836|Anesthetics|anesthetics|mesh-list
2074991|NCT01993836|Propofol|propofol|mesh-list
2074992|NCT01993836|Isoflurane|isoflurane|mesh-list
2074993|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2074994|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2074995|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2074996|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2074997|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
2074998|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
567173|NCT03685747|Vancomycin|vancomycin|mesh-list
567174|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
567175|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567176|NCT03685630|Brivaracetam|brivaracetam|mesh-list
567177|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
567178|NCT03685500|Emtricitabine|emtricitabine|mesh-list
567179|NCT03685500|Darunavir|darunavir|mesh-list
567180|NCT03685500|Cobicistat|cobicistat|mesh-list
567181|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
567182|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567183|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
567184|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
567185|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567186|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567187|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
567188|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
567189|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
567190|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
567191|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
567192|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
567193|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
567194|NCT03685409|Metformin|metformin|mesh-list
567195|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
567196|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213657|NCT00023231|Protective Agents|protective agents|mesh-ancestor
2213658|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2074999|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
2075000|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2075001|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
2075002|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075003|NCT01993849|Expectorants|expectorants|mesh-ancestor
2075004|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
2075005|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
567206|NCT03685331|Olaparib|olaparib|mesh-list
567207|NCT03685331|Fulvestrant|fulvestrant|mesh-list
567208|NCT03685331|Palbociclib|palbociclib|mesh-list
567209|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
567210|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567211|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567212|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567213|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
567214|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
567215|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
567216|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
567217|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
567218|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567219|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
567220|NCT03685253|Niacinamide|niacinamide|mesh-list
567221|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
567222|NCT03685253|Vitamins|vitamins|mesh-ancestor
567223|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
567224|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567225|NCT03685188|Sufentanil|sufentanil|mesh-list
567226|NCT03685188|Oxycodone|oxycodone|mesh-list
567227|NCT03685188|Dsuvia|dsuvia|mesh-list
567228|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
567229|NCT03685188|Narcotics|narcotics|mesh-ancestor
567230|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
567231|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567232|NCT03685188|Analgesics|analgesics|mesh-ancestor
567233|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
567234|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567235|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
567236|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
567237|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
567238|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
567239|NCT03685149|Flecainide|flecainide|mesh-list
567240|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
567241|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
567242|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
567243|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
567244|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567245|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
567246|NCT03685084|Piperacillin|piperacillin|mesh-list
567247|NCT03685084|Cefepime|cefepime|mesh-list
567248|NCT03685084|Lactams|lactams|mesh-list
567249|NCT03685084|beta-Lactams|beta-lactams|mesh-list
567250|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
567251|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
567252|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567253|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
567254|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
567255|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567256|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567257|NCT03685032|Dexamethasone|dexamethasone|mesh-list
567258|NCT03685032|Ondansetron|ondansetron|mesh-list
567259|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
567260|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
567261|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
567262|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567263|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567264|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
567265|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
567266|NCT03685032|Hormones|hormones|mesh-ancestor
567267|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
567268|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
567269|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567270|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
567271|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
567272|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
567273|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
567274|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
567275|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567276|NCT03685032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
567277|NCT03685032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
567278|NCT03685032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
567279|NCT03685032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
567280|NCT03685032|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
567281|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
567282|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
567283|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
567284|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567285|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
567286|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
567311|NCT03684876|Diuretics|diuretics|mesh-list
567312|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
567313|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567314|NCT03684863|Capecitabine|capecitabine|mesh-list
567315|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
567316|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
567317|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567318|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567319|NCT03684837|Vitamin D|vitamin d|mesh-list
567320|NCT03684837|Vitamins|vitamins|mesh-ancestor
567321|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
567322|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567323|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
567324|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
567325|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
567326|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
567327|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
567328|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
567329|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567330|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
567331|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
567332|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567333|NCT03684811|Gemcitabine|gemcitabine|mesh-list
567334|NCT03684811|Nivolumab|nivolumab|mesh-list
567335|NCT03684811|Azacitidine|azacitidine|mesh-list
567336|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567337|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
567338|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
567339|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567340|NCT03684811|Antiviral Agents|antiviral agents|mesh-ancestor
567341|NCT03684811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567342|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567343|NCT03684811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
567344|NCT03684811|Immunologic Factors|immunologic factors|mesh-ancestor
567345|NCT03684811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567346|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
567347|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2075006|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
2075007|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075008|NCT01993849|Protective Agents|protective agents|mesh-ancestor
2075009|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567352|NCT03684772|Digoxin|digoxin|mesh-list
567353|NCT03684772|Furosemide|furosemide|mesh-list
567354|NCT03684772|Diuretics|diuretics|mesh-ancestor
567355|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
567356|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567357|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
567358|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
567359|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567360|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
567361|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
567362|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567363|NCT03684772|Protective Agents|protective agents|mesh-ancestor
567364|NCT03684707|Metformin|metformin|mesh-list
567365|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
567366|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075010|NCT01993849|Antidotes|antidotes|mesh-ancestor
2075011|NCT01993875|Lubiprostone|lubiprostone|mesh-list
2075012|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2075013|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2075014|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075015|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2075016|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
567382|NCT03684564|Warfarin|warfarin|mesh-list
567383|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
567384|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
567385|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
567386|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
567387|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
567388|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
567389|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567390|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567391|NCT03684538|Zinc|zinc|mesh-list
567392|NCT03684538|Trace Elements|trace elements|mesh-ancestor
567393|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
567394|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567395|NCT03684447|Propofol|propofol|mesh-list
567396|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
567397|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
567398|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567399|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
567400|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
567401|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
567402|NCT03684395|Warfarin|warfarin|mesh-list
567403|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
567404|NCT03684395|Dabigatran|dabigatran|mesh-list
567405|NCT03684395|Apixaban|apixaban|mesh-list
567406|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
567407|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
567408|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
567409|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
567410|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
567411|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567412|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567413|NCT03684330|Vitamin D|vitamin d|mesh-list
567414|NCT03684330|Vitamins|vitamins|mesh-ancestor
567415|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
567416|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567417|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
567418|NCT03684278|Infliximab|infliximab|mesh-list
567419|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
567420|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
567421|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213659|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2213660|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
2213661|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2213662|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2213663|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
2213664|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2213665|NCT00023231|Renal Agents|renal agents|mesh-ancestor
2213666|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
2213667|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2213668|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2213669|NCT00023244|Cyclosporine|cyclosporine|mesh-list
2213670|NCT00023244|Sirolimus|sirolimus|mesh-list
2213671|NCT00023244|Trimethoprim|trimethoprim|mesh-list
567435|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
567436|NCT03684213|Norepinephrine|norepinephrine|mesh-list
567437|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
567438|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
567439|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567440|NCT03684213|Protective Agents|protective agents|mesh-ancestor
567441|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567442|NCT03684213|Vitamins|vitamins|mesh-ancestor
567443|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
567444|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
567445|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
567446|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
567447|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
567448|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
567449|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
567450|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567451|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
567452|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213672|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
2213673|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2213674|NCT00023244|Prednisone|prednisone|mesh-list
2213675|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
2213676|NCT00023244|Tacrolimus|tacrolimus|mesh-list
567458|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
567459|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
567460|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567461|NCT03683914|Dinoprostone|dinoprostone|mesh-list
567462|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
567463|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
567464|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567465|NCT03683810|Lactoferrin|lactoferrin|mesh-list
567466|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
567467|NCT03683810|Hematinics|hematinics|mesh-ancestor
567468|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567469|NCT03683667|Azithromycin|azithromycin|mesh-list
567470|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
567471|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567472|NCT03683563|Citric Acid|citric acid|mesh-list
567473|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
567474|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
567475|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
567476|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
567477|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
567478|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567479|NCT03683524|Darunavir|darunavir|mesh-list
567480|NCT03683524|Dolutegravir|dolutegravir|mesh-list
567481|NCT03683524|Cobicistat|cobicistat|mesh-list
2213677|NCT00023244|Cyclosporins|cyclosporins|mesh-list
2213678|NCT00023244|Basiliximab|basiliximab|mesh-list
567482|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
567483|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
567484|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
567485|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567486|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567487|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
567488|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
567489|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
567490|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567491|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
567492|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
567493|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
567494|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
567495|NCT03683433|Azacitidine|azacitidine|mesh-list
567496|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
567497|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
567498|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567499|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567500|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567501|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
567502|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
567503|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567504|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
567505|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567506|NCT03683277|Dexamethasone|dexamethasone|mesh-list
567507|NCT03683277|Pomalidomide|pomalidomide|mesh-list
567508|NCT03683277|Ixazomib|ixazomib|mesh-list
567509|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
567510|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
567511|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
567512|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567513|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567514|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
567515|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
567516|NCT03683277|Hormones|hormones|mesh-ancestor
567517|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
567518|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
567519|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567520|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
567521|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
567522|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
567523|NCT03683277|Growth Substances|growth substances|mesh-ancestor
567524|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
567525|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
567526|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567527|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750404|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2750405|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2750406|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2750407|NCT04292223|Pimavanserin|pimavanserin|mesh-list
2750408|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2750409|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2750410|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
567535|NCT03683108|Resveratrol|resveratrol|mesh-list
567536|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
567537|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567538|NCT03683108|Protective Agents|protective agents|mesh-ancestor
567539|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567540|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567541|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2075017|NCT01993888|Coagulants|coagulants|mesh-ancestor
2075018|NCT01993927|Voglibose|voglibose|mesh-list
2075019|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2075020|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075021|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2075022|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075023|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075024|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
2075025|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
2075026|NCT01994109|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2075027|NCT01994109|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2075028|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2075029|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2075030|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075031|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
567557|NCT03683043|Leuprolide|leuprolide|mesh-list
567558|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
567559|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
567560|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
567561|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567562|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
567563|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567564|NCT03682978|Baclofen|baclofen|mesh-list
567565|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
567566|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567567|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
567568|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567569|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
567570|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
567571|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
567572|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
567573|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567574|NCT03682952|Alprostadil|alprostadil|mesh-list
567575|NCT03682952|Beraprost|beraprost|mesh-list
567576|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
567577|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
567578|NCT03682952|Urological Agents|urological agents|mesh-ancestor
567579|NCT03682939|Vaccines|vaccines|mesh-list
567580|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
567581|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075032|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075033|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075034|NCT01994109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
567585|NCT03682718|Misoprostol|misoprostol|mesh-list
567586|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
567587|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
567588|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
567589|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567590|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
567591|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
567592|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
2213679|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2213680|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
2213681|NCT00023244|Hormones|hormones|mesh-ancestor
2213682|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2213683|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213684|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
567599|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
567600|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
567601|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567602|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567603|NCT03682653|Azithromycin|azithromycin|mesh-list
567604|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
567605|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567606|NCT03682640|Insulin|insulin|mesh-list
567607|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
567608|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
567609|NCT03682640|Azithromycin|azithromycin|mesh-list
567610|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
567611|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567612|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
567613|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075035|NCT01994109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075036|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2075037|NCT01994226|Naproxen|naproxen|mesh-list
567617|NCT03682497|Spironolactone|spironolactone|mesh-list
567618|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
567619|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
567620|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
567621|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567622|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
567623|NCT03682497|Diuretics|diuretics|mesh-ancestor
567624|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
567625|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
567626|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
567627|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
567628|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
567629|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2213685|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213686|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213687|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
2213688|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2213689|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213690|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213691|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
2213692|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213693|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
2213694|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213695|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2213696|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2213697|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
2213698|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
2213699|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2213700|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2213701|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2213702|NCT00023244|Protective Agents|protective agents|mesh-ancestor
2213703|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2213704|NCT00023244|Renal Agents|renal agents|mesh-ancestor
2213705|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
567652|NCT03682289|Olaparib|olaparib|mesh-list
567653|NCT03682289|Adenosine|adenosine|mesh-list
567654|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
567655|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567656|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567657|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567658|NCT03682289|Analgesics|analgesics|mesh-ancestor
567659|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
567660|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567661|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567662|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
567663|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
567664|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
567665|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
567666|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
567667|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
567668|NCT03682276|Nivolumab|nivolumab|mesh-list
567669|NCT03682276|Ipilimumab|ipilimumab|mesh-list
567670|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
567671|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567672|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
567673|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075038|NCT01994226|Colchicine|colchicine|mesh-list
2075039|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2075040|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2075041|NCT01994226|Analgesics|analgesics|mesh-ancestor
2075042|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
2075043|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075044|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075045|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2075046|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2075047|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
2075048|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2075049|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075050|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075051|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
2075052|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
2075053|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
2075054|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075055|NCT01994291|Ranibizumab|ranibizumab|mesh-list
2075056|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2075057|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2213706|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
567695|NCT03682211|Fentanyl|fentanyl|mesh-list
567696|NCT03682211|Morphine|morphine|mesh-list
567697|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
567698|NCT03682211|Narcotics|narcotics|mesh-ancestor
567699|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
567700|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567701|NCT03682211|Analgesics|analgesics|mesh-ancestor
567702|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
567703|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567704|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
567705|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
567706|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
567707|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
567708|NCT03682198|Phenylephrine|phenylephrine|mesh-list
567709|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
567710|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
567711|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
567712|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
567713|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567714|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567715|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
567716|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
567717|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
567718|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
567719|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
567720|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
567721|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
567722|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
567723|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
567724|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567725|NCT03682198|Protective Agents|protective agents|mesh-ancestor
567726|NCT03682172|Glucagon|glucagon|mesh-list
567727|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
567728|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
567729|NCT03682172|Hormones|hormones|mesh-ancestor
567730|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
567731|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567732|NCT03682172|Incretins|incretins|mesh-ancestor
2075058|NCT01994291|Growth Substances|growth substances|mesh-ancestor
2075059|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075060|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
2075061|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075062|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
2075063|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
2075064|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075065|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
2075066|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2075067|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2075068|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
2075069|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075070|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075071|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075072|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
567748|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
567749|NCT03682029|Vitamins|vitamins|mesh-ancestor
567750|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
567751|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567752|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
567753|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567754|NCT03682029|Protective Agents|protective agents|mesh-ancestor
2213707|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2213708|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2213709|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
567758|NCT03681691|Estradiol|estradiol|mesh-list
567759|NCT03681691|Estrogens|estrogens|mesh-ancestor
567760|NCT03681691|Hormones|hormones|mesh-ancestor
567761|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
567762|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567763|NCT03681652|Azathioprine|azathioprine|mesh-list
567764|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
567765|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
567766|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567767|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
567768|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567769|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
567770|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
567771|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567772|NCT03681639|Cobalt|cobalt|mesh-list
567773|NCT03681639|Chromium|chromium|mesh-list
567774|NCT03681639|Trace Elements|trace elements|mesh-ancestor
567775|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
567776|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567777|NCT03681613|Pyrantel|pyrantel|mesh-list
567778|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
567779|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
567780|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
567781|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
567782|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567783|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
567784|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
567785|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
567786|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567787|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567788|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
567789|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
567790|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
567791|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567792|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567793|NCT03681561|Nivolumab|nivolumab|mesh-list
567794|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
567795|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567796|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
567797|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567798|NCT03681548|Doxorubicin|doxorubicin|mesh-list
567799|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
567800|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
567801|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567802|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
567803|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
567804|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567805|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567806|NCT03681509|Pramipexole|pramipexole|mesh-list
567807|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
567808|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567809|NCT03681509|Protective Agents|protective agents|mesh-ancestor
567810|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567811|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
567812|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
567813|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
567814|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
567815|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
567816|NCT03681470|Dapsone|dapsone|mesh-list
567817|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567818|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
567819|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
567820|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
567821|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
567822|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567823|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567824|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
567825|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
567826|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
567827|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
567828|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567829|NCT03681275|Tofacitinib|tofacitinib|mesh-list
567830|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
567831|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567832|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567833|NCT03681197|Metformin|metformin|mesh-list
567834|NCT03681197|Clomiphene|clomiphene|mesh-list
567835|NCT03681197|Enclomiphene|enclomiphene|mesh-list
567836|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
567837|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
567838|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567839|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
567840|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
567841|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
567842|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
567843|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
567844|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
567845|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
567846|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
567847|NCT03681158|Valproic Acid|valproic acid|mesh-list
567848|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
567849|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567850|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567851|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
567852|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
567853|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567854|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
567855|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
567856|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
567857|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2213710|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2213711|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2213712|NCT00023283|Buprenorphine|buprenorphine|mesh-list
567862|NCT03680976|CXA-10|cxa-10|mesh-list
567863|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2213713|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2213714|NCT00023283|Narcotics|narcotics|mesh-ancestor
2213715|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2213716|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213717|NCT00023283|Analgesics|analgesics|mesh-ancestor
2213718|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
2213719|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2213720|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2213721|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
2213722|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2213723|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
2213724|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567876|NCT03680885|Lidocaine|lidocaine|mesh-list
567877|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
567878|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
567879|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
567880|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567881|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
567882|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567883|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
567884|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
567885|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
567886|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
567887|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567888|NCT03680716|Ropivacaine|ropivacaine|mesh-list
567889|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
567890|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
567891|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
567892|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567893|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
567894|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567895|NCT03680638|Allopurinol|allopurinol|mesh-list
567896|NCT03680638|Tempol|tempol|mesh-list
567897|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
567898|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567899|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567900|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
567901|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
567902|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
567903|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
567904|NCT03680638|Protective Agents|protective agents|mesh-ancestor
567905|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567906|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
567907|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
567908|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
567909|NCT03680612|Cefepime|cefepime|mesh-list
567910|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
567911|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
567912|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567913|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
567914|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567915|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567916|NCT03680573|Allopurinol|allopurinol|mesh-list
567917|NCT03680573|Nitroprusside|nitroprusside|mesh-list
567918|NCT03680573|Nitroarginine|nitroarginine|mesh-list
567919|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
567920|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
567921|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567922|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567923|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
567924|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
567925|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
567926|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
567927|NCT03680573|Protective Agents|protective agents|mesh-ancestor
567928|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567929|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
567930|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
567931|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
567932|NCT03680560|Trastuzumab|trastuzumab|mesh-list
567933|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
567934|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213725|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213726|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2750411|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2213727|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
2213728|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
567940|NCT03680508|Antibodies|antibodies|mesh-list
567941|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
567942|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
567943|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567944|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
567945|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
567946|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
567947|NCT03680495|Prednisolone|prednisolone|mesh-list
567948|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
567949|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
567950|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
567951|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
567952|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
567953|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
567954|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567955|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567956|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
567957|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
567958|NCT03680495|Hormones|hormones|mesh-ancestor
567959|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
567960|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
567961|NCT03680495|Protective Agents|protective agents|mesh-ancestor
567962|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
567963|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
567964|NCT03680404|Allopurinol|allopurinol|mesh-list
567965|NCT03680404|Phenylephrine|phenylephrine|mesh-list
567966|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
567967|NCT03680404|Tempol|tempol|mesh-list
567968|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
567969|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
567970|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
567971|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
567972|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
567973|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
567974|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
567975|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
567976|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
567977|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
567978|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
567979|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
567980|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
567981|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
567982|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
567983|NCT03680404|Protective Agents|protective agents|mesh-ancestor
567984|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
567985|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
567986|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
567987|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
567988|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
567989|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
567990|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
567991|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
567992|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
567993|NCT03680378|Cefepime|cefepime|mesh-list
567994|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
567995|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
567996|NCT03680352|Cefepime|cefepime|mesh-list
567997|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
567998|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
567999|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568000|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
568001|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568002|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568003|NCT03680339|Misoprostol|misoprostol|mesh-list
568004|NCT03680339|Oxytocin|oxytocin|mesh-list
568005|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
568006|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
568007|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568008|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
568009|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
568010|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
568011|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
568012|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
568013|NCT03680274|Vitamins|vitamins|mesh-ancestor
568014|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
568015|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568016|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
568017|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568018|NCT03680274|Protective Agents|protective agents|mesh-ancestor
568019|NCT03680183|Entecavir|entecavir|mesh-list
568020|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
568021|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568022|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
568023|NCT03680092|Methotrexate|methotrexate|mesh-list
568024|NCT03680092|Abatacept|abatacept|mesh-list
568025|NCT03680092|Tacrolimus|tacrolimus|mesh-list
568026|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
568027|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
568028|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568029|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
568030|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
568031|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
568032|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568033|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568034|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
568035|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
568036|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
568037|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
568038|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
568039|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
568040|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
568041|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568042|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
568043|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
568044|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
568045|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
568046|NCT03680053|Cetrorelix|cetrorelix|mesh-list
568047|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
568048|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
568049|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
568050|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
568051|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568052|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
568053|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
568054|NCT03680053|Progestins|progestins|mesh-ancestor
568055|NCT03680053|Hormones|hormones|mesh-ancestor
2213729|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
2213730|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213731|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2213732|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2213733|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
2213734|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
2213735|NCT00023296|Protective Agents|protective agents|mesh-ancestor
2213736|NCT00023335|Isoniazid|isoniazid|mesh-list
2213737|NCT00023335|Rifapentine|rifapentine|mesh-list
568065|NCT03679949|Oxycodone|oxycodone|mesh-list
568066|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
568067|NCT03679949|Narcotics|narcotics|mesh-ancestor
568068|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568069|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568070|NCT03679949|Analgesics|analgesics|mesh-ancestor
568071|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
568072|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568073|NCT03679897|Ropivacaine|ropivacaine|mesh-list
568074|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
568075|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
568076|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
568077|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
568078|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568079|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568080|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
568081|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568082|NCT03679780|Nitroprusside|nitroprusside|mesh-list
568083|NCT03679780|BQ 788|bq 788|mesh-list
568084|NCT03679780|Nitroarginine|nitroarginine|mesh-list
568085|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
568086|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
568087|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
568088|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
568089|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568090|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
568091|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2213738|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
568092|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568093|NCT03679676|Omalizumab|omalizumab|mesh-list
568094|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
568095|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
568096|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
2075073|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
2075074|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075075|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
2075076|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2075077|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
2075078|NCT01994590|Prednisone|prednisone|mesh-list
2075079|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
2075080|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2075081|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
2075082|NCT01994590|Hormones|hormones|mesh-ancestor
2075083|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2075084|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075085|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2075086|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075087|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2075088|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568115|NCT03679546|Infliximab|infliximab|mesh-list
568116|NCT03679546|Vedolizumab|vedolizumab|mesh-list
568117|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
568118|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
568119|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
568120|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
568121|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
568122|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
568123|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568124|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
568125|NCT03679481|Coagulants|coagulants|mesh-ancestor
568126|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
568127|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
568128|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568129|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
568130|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
568131|NCT03679442|Antidotes|antidotes|mesh-list
568132|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568133|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
568134|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568135|NCT03679442|Expectorants|expectorants|mesh-ancestor
568136|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
568137|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
568138|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
568139|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568140|NCT03679442|Protective Agents|protective agents|mesh-ancestor
568141|NCT03679390|Ketamine|ketamine|mesh-list
568142|NCT03679390|Analgesics|analgesics|mesh-ancestor
568143|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
568144|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568145|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568146|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
568147|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
568148|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
568149|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
568150|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568151|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
568152|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
568153|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
568154|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568155|NCT03679325|Vitamin D|vitamin d|mesh-list
568156|NCT03679325|Vitamins|vitamins|mesh-ancestor
568157|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
568158|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568159|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
568160|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
568161|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
568162|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
568163|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568164|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568165|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
568166|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
568167|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
568168|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
568169|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568170|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
568171|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
568172|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
568173|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
568174|NCT03679312|Protective Agents|protective agents|mesh-ancestor
568175|NCT03679182|Olanzapine|olanzapine|mesh-list
568176|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
568177|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
568178|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568179|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568180|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
568181|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
568182|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
568183|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568184|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
568185|NCT03679182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
568186|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
568187|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
568188|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568189|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
568190|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
2750412|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2750413|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750414|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2750415|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2750416|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2750417|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
2750418|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2750419|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568201|NCT03679065|Acetaminophen|acetaminophen|mesh-list
568202|NCT03679065|Dexamethasone|dexamethasone|mesh-list
568203|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
568204|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
568205|NCT03679065|BB 1101|bb 1101|mesh-list
568206|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
568207|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
568208|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
568209|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568210|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568211|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
568212|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
568213|NCT03679065|Hormones|hormones|mesh-ancestor
568214|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
568215|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
568216|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568217|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
568218|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568219|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568220|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
568221|NCT03679065|Analgesics|analgesics|mesh-ancestor
568222|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
568223|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
568224|NCT03679052|Clonidine|clonidine|mesh-list
568225|NCT03679052|Mirtazapine|mirtazapine|mesh-list
568226|NCT03679052|Analgesics|analgesics|mesh-ancestor
568227|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
568228|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568229|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568230|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
568231|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
568232|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
568233|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
568234|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
568235|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
568236|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
568237|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
568238|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568239|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
568240|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
568241|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
568242|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
568243|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
568244|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
568245|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
568246|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568247|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
568248|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
568249|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
568250|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
568251|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
568252|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
568253|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
568254|NCT03679013|Acetaminophen|acetaminophen|mesh-list
568255|NCT03679013|Gabapentin|gabapentin|mesh-list
568256|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
568257|NCT03679013|Analgesics|analgesics|mesh-ancestor
568258|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
568259|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568260|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568261|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
568262|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
568263|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
568264|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
568265|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568266|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
568267|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
568268|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
568269|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
568270|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568271|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
568272|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
568273|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
568274|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568275|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
568276|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
568277|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
568278|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568279|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568280|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568281|NCT03678883|Gemcitabine|gemcitabine|mesh-list
568282|NCT03678883|Paclitaxel|paclitaxel|mesh-list
568283|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
568284|NCT03678883|Carboplatin|carboplatin|mesh-list
568285|NCT03678883|Doxorubicin|doxorubicin|mesh-list
568286|NCT03678883|Irinotecan|irinotecan|mesh-list
568287|NCT03678883|Lomustine|lomustine|mesh-list
568288|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
568289|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568290|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
568291|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
568292|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
568293|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568294|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
568295|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
568296|NCT03678883|Antiviral Agents|antiviral agents|mesh-ancestor
568297|NCT03678883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568298|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568299|NCT03678883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
568300|NCT03678883|Immunologic Factors|immunologic factors|mesh-ancestor
568301|NCT03678883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568302|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
568303|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
568304|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
568305|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
568306|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
568307|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
2213739|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2213740|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213741|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2213742|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2213743|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
2213744|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213745|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
568315|NCT03678792|Morphine|morphine|mesh-list
568316|NCT03678792|Buprenorphine|buprenorphine|mesh-list
568317|NCT03678792|Tramadol|tramadol|mesh-list
568318|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
568319|NCT03678792|Naloxone|naloxone|mesh-list
568320|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
568321|NCT03678792|Narcotics|narcotics|mesh-ancestor
568322|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568323|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568324|NCT03678792|Analgesics|analgesics|mesh-ancestor
568325|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
568326|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568327|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
568330|NCT03678688|Bedaquiline|bedaquiline|mesh-list
568331|NCT03678688|Diarylquinolines|diarylquinolines|mesh-list
568332|NCT03678688|Antitubercular Agents|antitubercular agents|mesh-ancestor
568333|NCT03678688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
568334|NCT03678688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568335|NCT03678675|Ketorolac|ketorolac|mesh-list
568336|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
568337|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
568338|NCT03678675|Analgesics|analgesics|mesh-ancestor
568339|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
568340|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568341|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568342|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
568343|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
568344|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
568345|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568346|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568347|NCT03678649|Capecitabine|capecitabine|mesh-list
568348|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
568349|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
568350|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568351|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568352|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
568353|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
568354|NCT03678610|Ionomycin|ionomycin|mesh-list
568355|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
568356|NCT03678610|Ionophores|ionophores|mesh-ancestor
568357|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
568358|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075089|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075090|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
568362|NCT03678532|Midazolam|midazolam|mesh-list
568363|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
568364|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
568365|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568366|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568367|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
568368|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
568369|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
568370|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
568371|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
568372|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
568373|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
568374|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
568375|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
568376|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568377|NCT03678506|Apixaban|apixaban|mesh-list
568378|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
568379|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
568380|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
568381|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
568382|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568383|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568384|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
568385|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
568386|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
568387|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
568388|NCT03678428|Leucovorin|leucovorin|mesh-list
568389|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
568390|NCT03678428|Irinotecan|irinotecan|mesh-list
568391|NCT03678428|Floxuridine|floxuridine|mesh-list
568392|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568393|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
568394|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
568395|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568396|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568397|NCT03678428|Antidotes|antidotes|mesh-ancestor
568398|NCT03678428|Protective Agents|protective agents|mesh-ancestor
568399|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568400|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
568401|NCT03678428|Vitamins|vitamins|mesh-ancestor
568402|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
568403|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
568404|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
2075091|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2075092|NCT01994720|Aspirin|aspirin|mesh-list
2075093|NCT01994720|Ticagrelor|ticagrelor|mesh-list
2075094|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2075095|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
568410|NCT03678233|Testosterone|testosterone|mesh-list
568411|NCT03678233|Androgens|androgens|mesh-ancestor
568412|NCT03678233|Hormones|hormones|mesh-ancestor
568413|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
568414|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568415|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
568416|NCT03678142|Vancomycin|vancomycin|mesh-list
568417|NCT03678142|Imipenem|imipenem|mesh-list
568418|NCT03678142|Floxacillin|floxacillin|mesh-list
568419|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568420|NCT03678116|Caffeine|caffeine|mesh-list
568421|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
568422|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568423|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
568424|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568425|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568426|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
568427|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
568428|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
568429|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
568430|NCT03678090|Plasminogen|plasminogen|mesh-list
568431|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
568432|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
568433|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
568434|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568435|NCT03678038|Triamcinolone|triamcinolone|mesh-list
568436|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
568437|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
568438|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
568439|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
568440|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
568441|NCT03678038|Hormones|hormones|mesh-ancestor
568442|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
568443|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568444|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
568445|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
568446|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568447|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075096|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2075097|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2075098|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
2075099|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075100|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075101|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075102|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2075103|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2075104|NCT01994720|Analgesics|analgesics|mesh-ancestor
2075105|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
2075106|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075107|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2075108|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2075109|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2075110|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2075111|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2075112|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075113|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
2075114|NCT01994746|Glucagon|glucagon|mesh-list
2075115|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2075116|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2075117|NCT01994746|Hormones|hormones|mesh-ancestor
2075118|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2075119|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075120|NCT01994746|Incretins|incretins|mesh-ancestor
2075121|NCT01994837|Venetoclax|venetoclax|mesh-list
2075122|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075123|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2075124|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2075125|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568481|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
568482|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
568483|NCT03678012|Hematinics|hematinics|mesh-ancestor
568484|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
568485|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
568486|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
568487|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075126|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2075127|NCT01994993|Metronidazole|metronidazole|mesh-list
2075128|NCT01994993|Clindamycin|clindamycin|mesh-list
2075129|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
2075130|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
2075131|NCT01994993|Gentamicins|gentamicins|mesh-list
2075132|NCT01994993|Tazobactam|tazobactam|mesh-list
568495|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
568496|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
568497|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
568498|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568499|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
568500|NCT03677895|Protective Agents|protective agents|mesh-ancestor
568501|NCT03677830|Acetaminophen|acetaminophen|mesh-list
568502|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
568503|NCT03677830|Analgesics|analgesics|mesh-ancestor
568504|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
568505|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568506|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568507|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
568508|NCT03677817|Lidocaine|lidocaine|mesh-list
568509|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
568510|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
568511|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568512|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568513|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
568514|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568515|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
568516|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
568517|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
568518|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
568519|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075133|NCT01994993|Piperacillin|piperacillin|mesh-list
2075134|NCT01994993|Ampicillin|ampicillin|mesh-list
2075135|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2075136|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568524|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
568525|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
568526|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568527|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568528|NCT03677466|Tenecteplase|tenecteplase|mesh-list
568529|NCT03677466|Streptokinase|streptokinase|mesh-list
568530|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
568531|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
568532|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213746|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2213747|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
2213748|NCT00023348|Isoniazid|isoniazid|mesh-list
2213749|NCT00023348|Rifabutin|rifabutin|mesh-list
2213750|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
568538|NCT03677336|Progesterone|progesterone|mesh-list
568539|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
568540|NCT03677336|Progestins|progestins|mesh-ancestor
568541|NCT03677336|Hormones|hormones|mesh-ancestor
568542|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
568543|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568544|NCT03677323|Sufentanil|sufentanil|mesh-list
568545|NCT03677323|Droperidol|droperidol|mesh-list
568546|NCT03677323|Propofol|propofol|mesh-list
568547|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
568548|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568549|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075137|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2075138|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2213751|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
568550|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
568551|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
568552|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
568553|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
568554|NCT03677323|Narcotics|narcotics|mesh-ancestor
568555|NCT03677323|Analgesics|analgesics|mesh-ancestor
568556|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
568557|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568558|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
568559|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
568560|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
568561|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
568562|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
568563|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
568564|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
568565|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
568566|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
568567|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
568568|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
568569|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568570|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
568571|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
568572|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
568573|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
568574|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568575|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
568576|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
568577|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568578|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
568579|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
568580|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
568581|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568582|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
568583|NCT03677258|Protective Agents|protective agents|mesh-ancestor
2075139|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2075140|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075141|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075142|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2075143|NCT01995045|Triamcinolone|triamcinolone|mesh-list
2075144|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2075145|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2075146|NCT01995045|Bupivacaine|bupivacaine|mesh-list
2075147|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2075148|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
2075149|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
2075150|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2075151|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075152|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
568624|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
568625|NCT03676985|Antibodies|antibodies|mesh-list
568626|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
568627|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
568628|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
568629|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568630|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568631|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
568632|NCT03676959|Antibodies|antibodies|mesh-list
568633|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
568634|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
568635|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
568636|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568637|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568638|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
568639|NCT03676946|Antibodies|antibodies|mesh-list
568640|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
568641|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
568642|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
568643|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568644|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568645|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
568646|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
568647|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
568648|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
568649|NCT03676764|Azithromycin|azithromycin|mesh-list
568650|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
568651|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568652|NCT03676751|Azithromycin|azithromycin|mesh-list
568653|NCT03676751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
568654|NCT03676751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213752|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213753|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2213754|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2213755|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
2213756|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213757|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2213758|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2213759|NCT00023361|Rifabutin|rifabutin|mesh-list
2213760|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2213761|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213762|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2213763|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
568667|NCT03676621|Misoprostol|misoprostol|mesh-list
568668|NCT03676621|Oxytocin|oxytocin|mesh-list
568669|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
568670|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
568671|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568672|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
568673|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
568674|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
568675|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
568676|NCT03676608|Propolis|propolis|mesh-list
568677|NCT03676608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568678|NCT03676556|Lidocaine|lidocaine|mesh-list
568679|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
568680|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
568681|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568682|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568683|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
568684|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568685|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
568686|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
568687|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
568688|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
568689|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568690|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
568691|NCT03676504|Fludarabine|fludarabine|mesh-list
568692|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
568693|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
568694|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568695|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
568696|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
568697|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
568698|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568699|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568700|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2213764|NCT00023374|Rifampin|rifampin|mesh-list
568701|NCT03676413|Fluticasone|fluticasone|mesh-list
568702|NCT03676413|Xhance|xhance|mesh-list
568703|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
568704|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
568705|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
568706|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
568707|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
568708|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568709|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568710|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
568711|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
568712|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
568713|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
568714|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
568715|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
568716|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
568717|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
568718|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
568719|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568720|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
568721|NCT03676413|Hormones|hormones|mesh-ancestor
568722|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
568723|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
568724|NCT03676374|Prucalopride|prucalopride|mesh-list
568725|NCT03676374|Laxatives|laxatives|mesh-ancestor
568726|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
568727|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
568728|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
568729|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
568730|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
568731|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568732|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568733|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
568734|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
568735|NCT03676361|Coagulants|coagulants|mesh-ancestor
568736|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
568737|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
568738|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568739|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
568740|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
568741|NCT03676296|Puerarin|puerarin|mesh-list
568742|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
568743|NCT03676192|Bevacizumab|bevacizumab|mesh-list
568744|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
568745|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568746|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
568747|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
568748|NCT03676192|Growth Substances|growth substances|mesh-ancestor
568749|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568750|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
568751|NCT03676140|Azithromycin|azithromycin|mesh-list
568752|NCT03676140|Ivermectin|ivermectin|mesh-list
568753|NCT03676140|Albendazole|albendazole|mesh-list
568754|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
568755|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
568756|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568757|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
568758|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
568759|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
568760|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
568761|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
568762|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
568763|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
568764|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
568765|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568766|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568767|NCT03676140|Filaricides|filaricides|mesh-ancestor
568768|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
568769|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
568770|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568771|NCT03676114|Ketamine|ketamine|mesh-list
568772|NCT03676114|Analgesics|analgesics|mesh-ancestor
568773|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
568774|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568775|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568776|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
568777|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
568778|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
568779|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
568780|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568781|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
568782|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
568783|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
568784|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568785|NCT03676088|Mitogens|mitogens|mesh-list
568786|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
568787|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568788|NCT03676049|Cannabidiol|cannabidiol|mesh-list
568789|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
568790|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
568791|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
568792|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
568793|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
568794|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
568795|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
568796|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
568797|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568798|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
568799|NCT03676023|Coagulants|coagulants|mesh-ancestor
568800|NCT03675893|Letrozole|letrozole|mesh-list
568801|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568802|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
568803|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
568804|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568805|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568806|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
568807|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
568808|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
568809|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568810|NCT03675854|Cefazolin|cefazolin|mesh-list
568811|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
568812|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568813|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
568814|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
568815|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
568816|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568817|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
568818|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
568819|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
568820|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
568821|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568822|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568823|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568824|NCT03675815|Ritonavir|ritonavir|mesh-list
568825|NCT03675815|Darunavir|darunavir|mesh-list
568826|NCT03675815|Tenofovir|tenofovir|mesh-list
568827|NCT03675815|Lamivudine|lamivudine|mesh-list
568828|NCT03675815|Emtricitabine|emtricitabine|mesh-list
568829|NCT03675815|Dolutegravir|dolutegravir|mesh-list
568830|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
568831|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
568832|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
568833|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
568834|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568835|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568836|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
568837|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
568838|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
568839|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568840|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
568841|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
568842|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
568843|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
568844|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
568845|NCT03675802|Misoprostol|misoprostol|mesh-list
568846|NCT03675802|Dinoprostone|dinoprostone|mesh-list
568847|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
568848|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
568849|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
568850|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568851|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
568852|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
568853|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
568866|NCT03675672|Misoprostol|misoprostol|mesh-list
568867|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
568868|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
568869|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
568870|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568871|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
568872|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
568873|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
568874|NCT03675646|Morphine|morphine|mesh-list
568875|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
568876|NCT03675646|Narcotics|narcotics|mesh-ancestor
568877|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568878|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568879|NCT03675646|Analgesics|analgesics|mesh-ancestor
568880|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
568881|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568882|NCT03675594|Cobalt|cobalt|mesh-list
568883|NCT03675594|Chromium|chromium|mesh-list
568884|NCT03675594|Trace Elements|trace elements|mesh-ancestor
568885|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
568886|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213765|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
2213766|NCT00023374|Ethambutol|ethambutol|mesh-list
2213767|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2213768|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
2213769|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2213770|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213771|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
2213772|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2213773|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213774|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213775|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2213776|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2213777|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2213778|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2213779|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2213780|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2213781|NCT00023387|Isoniazid|isoniazid|mesh-list
2213782|NCT00023387|Rifapentine|rifapentine|mesh-list
2213783|NCT00023387|Rifampin|rifampin|mesh-list
568906|NCT03675555|Dexamethasone|dexamethasone|mesh-list
568907|NCT03675555|Mirtazapine|mirtazapine|mesh-list
568908|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
568909|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
568910|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
568911|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
568912|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568913|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568914|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
568915|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
568916|NCT03675555|Hormones|hormones|mesh-ancestor
568917|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
568918|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
568919|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568920|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
568921|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
568922|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
568923|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
568924|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
568925|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
568926|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568927|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2213784|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
2213785|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
568928|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
568929|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
568930|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
568931|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
568932|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
568933|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
568934|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
568935|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
568936|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
568937|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2213786|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213787|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2213788|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
568941|NCT03675412|Caffeine|caffeine|mesh-list
568942|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
568943|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568944|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
568945|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568946|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568947|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
568948|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
568949|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
568950|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075153|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075154|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2075155|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
568954|NCT03675191|Orlistat|orlistat|mesh-list
568955|NCT03675191|Phentermine|phentermine|mesh-list
568956|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
568957|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
568958|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
568959|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
568960|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
568961|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568962|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
568963|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
568964|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
568965|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
568966|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
568967|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
568968|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
568969|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
568970|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
568971|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
568972|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
568973|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
568974|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
568975|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
568976|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
568977|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
568978|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
568979|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
568980|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
568981|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
568982|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
568983|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
568984|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
568985|NCT03675139|Progestins|progestins|mesh-ancestor
568986|NCT03675139|Hormones|hormones|mesh-ancestor
568987|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2213789|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
2213790|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213791|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2213792|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2213793|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
2213794|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2213795|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213796|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2213797|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
568998|NCT03674866|Insulin|insulin|mesh-list
568999|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
569000|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569001|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
569002|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
569003|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
569004|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
569005|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
569006|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569007|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2075156|NCT01995045|Hormones|hormones|mesh-ancestor
2075157|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2075158|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
569011|NCT03674671|Ketamine|ketamine|mesh-list
569012|NCT03674671|Analgesics|analgesics|mesh-ancestor
569013|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
569014|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569015|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569016|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
569017|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
569018|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
569019|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
569020|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
569021|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
569022|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
569023|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569024|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569025|NCT03674658|Propafenone|propafenone|mesh-list
569026|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
569027|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
569028|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
569029|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
569030|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569031|NCT03674606|Aspirin|aspirin|mesh-list
569032|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
569033|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
569034|NCT03674606|Analgesics|analgesics|mesh-ancestor
569035|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
569036|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569037|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569038|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
569039|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
569040|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
569041|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
569042|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569043|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
569044|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
569045|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569046|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
2075159|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
2075160|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569050|NCT03674541|Bromides|bromides|mesh-list
569051|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
569052|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
569053|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
569054|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569055|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569056|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
569057|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569058|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569059|NCT03674424|Avelumab|avelumab|mesh-list
569060|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
569061|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569062|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
569063|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
569064|NCT03674411|Melphalan|melphalan|mesh-list
569065|NCT03674411|Busulfan|busulfan|mesh-list
569066|NCT03674411|Fludarabine|fludarabine|mesh-list
569067|NCT03674411|Tacrolimus|tacrolimus|mesh-list
569068|NCT03674411|Sargramostim|sargramostim|mesh-list
569069|NCT03674411|Lenograstim|lenograstim|mesh-list
569070|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
569071|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
569072|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569073|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
569074|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
569075|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
569076|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569077|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569078|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
569079|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
569080|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569081|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
569082|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
569083|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
569084|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
569085|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
569086|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
569087|NCT03674385|Vitamin E|vitamin e|mesh-list
569088|NCT03674385|Metformin|metformin|mesh-list
569089|NCT03674385|Clomiphene|clomiphene|mesh-list
569090|NCT03674385|Enclomiphene|enclomiphene|mesh-list
569091|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
569092|NCT03674385|Vitamins|vitamins|mesh-ancestor
569093|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
569094|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569095|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
569096|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569097|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
569098|NCT03674385|Protective Agents|protective agents|mesh-ancestor
569099|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
569100|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
569101|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
569102|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
569103|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
569104|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
569105|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
569106|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
569107|NCT03674333|Folic Acid|folic acid|mesh-list
569108|NCT03674333|Hematinics|hematinics|mesh-ancestor
569109|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
569110|NCT03674333|Vitamins|vitamins|mesh-ancestor
569111|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
569112|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569113|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
569114|NCT03674320|Testosterone|testosterone|mesh-list
569115|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
569116|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
569117|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
569118|NCT03674320|Androgens|androgens|mesh-ancestor
569119|NCT03674320|Hormones|hormones|mesh-ancestor
569120|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
569121|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569122|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
569123|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569124|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
569125|NCT03674294|Dexamethasone|dexamethasone|mesh-list
569126|NCT03674294|Aprepitant|aprepitant|mesh-list
569127|NCT03674294|Palonosetron|palonosetron|mesh-list
569128|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
569129|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
569130|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
569131|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569132|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569133|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
569134|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
569135|NCT03674294|Hormones|hormones|mesh-ancestor
569136|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
569137|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
569138|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569139|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
569140|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569141|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569142|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
569143|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
569144|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
569145|NCT03674242|Gemcitabine|gemcitabine|mesh-list
569146|NCT03674242|Carboplatin|carboplatin|mesh-list
569147|NCT03674242|Asparaginase|asparaginase|mesh-list
569148|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569149|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
569150|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
569151|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569152|NCT03674242|Antiviral Agents|antiviral agents|mesh-ancestor
569153|NCT03674242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
569154|NCT03674242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569155|NCT03674242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
569156|NCT03674242|Immunologic Factors|immunologic factors|mesh-ancestor
569157|NCT03674242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213798|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2213799|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2213800|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
569161|NCT03674151|Povidone|povidone|mesh-list
569162|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
569163|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
2213801|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2213802|NCT00023400|Nelfinavir|nelfinavir|mesh-list
2213803|NCT00023400|Rifabutin|rifabutin|mesh-list
2213804|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
569168|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
569169|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
569170|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
569171|NCT03674099|Prednisolone|prednisolone|mesh-list
569172|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
569173|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
569174|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
569175|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
569176|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
569177|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
569178|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
569179|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569180|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569181|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
569182|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
569183|NCT03674099|Hormones|hormones|mesh-ancestor
569184|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
569185|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
569186|NCT03674099|Protective Agents|protective agents|mesh-ancestor
569187|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
569188|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569189|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
569190|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569191|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569192|NCT03674073|Vaccines|vaccines|mesh-list
569193|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
569194|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569195|NCT03674060|Sorafenib|sorafenib|mesh-list
569196|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569197|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
569198|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569199|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569200|NCT03674008|Propofol|propofol|mesh-list
569201|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
569202|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
569203|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569204|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
569205|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
569206|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
569207|NCT03673995|Inositol|inositol|mesh-list
569208|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
569209|NCT03673995|Vitamins|vitamins|mesh-ancestor
569210|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
569211|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569212|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
569213|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
569214|NCT03673826|Dexamethasone|dexamethasone|mesh-list
569215|NCT03673826|Lenalidomide|lenalidomide|mesh-list
569216|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
569217|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
569218|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
569219|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569220|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569221|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
569222|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
569223|NCT03673826|Hormones|hormones|mesh-ancestor
569224|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
569225|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
569226|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569227|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
569228|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
569229|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
569230|NCT03673826|Growth Substances|growth substances|mesh-ancestor
569231|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
569232|NCT03673787|Atezolizumab|atezolizumab|mesh-list
569233|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569234|NCT03673735|Durvalumab|durvalumab|mesh-list
569235|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569236|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2213805|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2213806|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
2213807|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213808|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213809|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2213810|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2213811|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
2213812|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213813|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2213814|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2213815|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
2213816|NCT00023413|Efavirenz|efavirenz|mesh-list
2213817|NCT00023413|Rifabutin|rifabutin|mesh-list
569250|NCT03673605|Warfarin|warfarin|mesh-list
569251|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
569252|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
569253|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
569254|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
569255|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
569256|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
569257|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569258|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569259|NCT03673527|Tacrolimus|tacrolimus|mesh-list
569260|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
569261|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
569262|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569263|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
569264|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569265|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569266|NCT03673501|Sunitinib|sunitinib|mesh-list
569267|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569268|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
569269|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
569270|NCT03673501|Growth Substances|growth substances|mesh-ancestor
569271|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569272|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
569273|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
569274|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569275|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075161|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075162|NCT01995071|Ribavirin|ribavirin|mesh-list
2075163|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
569279|NCT03673384|Fluticasone|fluticasone|mesh-list
569280|NCT03673384|Xhance|xhance|mesh-list
569281|NCT03673384|Histamine|histamine|mesh-list
569282|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
569283|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
569284|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
569285|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569286|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569287|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
569288|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
569289|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
569290|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
569291|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
569292|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
569293|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569294|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569295|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
569296|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569297|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569298|NCT03673280|Morphine|morphine|mesh-list
569299|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
569300|NCT03673280|Narcotics|narcotics|mesh-ancestor
569301|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
569302|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569303|NCT03673280|Analgesics|analgesics|mesh-ancestor
569304|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
569305|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2213818|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2075164|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075165|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
2075166|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075167|NCT01995136|Travoprost|travoprost|mesh-list
2075168|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2075169|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2075170|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2075171|NCT01995201|Methotrexate|methotrexate|mesh-list
2075172|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
569316|NCT03673163|Lidocaine|lidocaine|mesh-list
569317|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
569318|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
569319|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
569320|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569321|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
569322|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569323|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
569324|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
569325|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
569326|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
569327|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569328|NCT03673137|Gemcitabine|gemcitabine|mesh-list
569329|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
569330|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
569331|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569332|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569333|NCT03673137|Antiviral Agents|antiviral agents|mesh-ancestor
569334|NCT03673137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
569335|NCT03673137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569336|NCT03673137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
569337|NCT03673137|Immunologic Factors|immunologic factors|mesh-ancestor
569338|NCT03673137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569339|NCT03673124|Letrozole|letrozole|mesh-list
569340|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569341|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
569342|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
569343|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569344|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569345|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
569346|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
569347|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
569348|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569349|NCT03673072|Gemcitabine|gemcitabine|mesh-list
569350|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569351|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
569352|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
569353|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569354|NCT03673072|Antiviral Agents|antiviral agents|mesh-ancestor
569355|NCT03673072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
569356|NCT03673072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569357|NCT03673072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
569358|NCT03673072|Immunologic Factors|immunologic factors|mesh-ancestor
569359|NCT03673072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569360|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
569361|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
569362|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569363|NCT03672812|Liraglutide|liraglutide|mesh-list
569364|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
569365|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569366|NCT03672812|Incretins|incretins|mesh-ancestor
569367|NCT03672812|Hormones|hormones|mesh-ancestor
569368|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2075173|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
2075174|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2075175|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075176|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2075177|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
2075178|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075179|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075180|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
569377|NCT03672695|Venetoclax|venetoclax|mesh-list
569378|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075181|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750466|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
2750467|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2075182|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2075183|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2075184|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
2075185|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2075186|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2075187|NCT01995266|Asunaprevir|asunaprevir|mesh-list
2075188|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
2075189|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075190|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075191|NCT01995513|Prednisone|prednisone|mesh-list
2075192|NCT01995513|Prednisolone|prednisolone|mesh-list
2075193|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
2075194|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2075195|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
2075196|NCT01995513|Hormones|hormones|mesh-ancestor
2075197|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2075198|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569401|NCT03672539|Cytarabine|cytarabine|mesh-list
569402|NCT03672539|Daunorubicin|daunorubicin|mesh-list
569403|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
569404|NCT03672539|Calicheamicins|calicheamicins|mesh-list
569405|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
569406|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
569407|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569408|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569409|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
569410|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
569411|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
569412|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
569413|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569414|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
569415|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
569416|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
569417|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569418|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
569419|NCT03672500|Epinephrine|epinephrine|mesh-list
569420|NCT03672500|Bupivacaine|bupivacaine|mesh-list
569421|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
569422|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
569423|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
569424|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569425|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
569426|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569427|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
569428|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
569429|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
569430|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569431|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569432|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
569433|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
569434|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
569435|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
569436|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
569437|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
569438|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
569439|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2075199|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2075200|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075201|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2075202|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075203|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075204|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
2075205|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2075206|NCT01995526|Insulin|insulin|mesh-list
569448|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
569449|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
569450|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
569451|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
569452|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569453|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
569454|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569455|NCT03672357|Liver Extracts|liver extracts|mesh-list
569456|NCT03672357|Hematinics|hematinics|mesh-ancestor
569457|NCT03672292|Voriconazole|voriconazole|mesh-list
569458|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
569459|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
569460|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
569461|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
569462|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
569463|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569464|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569465|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
569466|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
569467|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
569468|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569469|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
569470|NCT03672149|Cefazolin|cefazolin|mesh-list
569471|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
569472|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075207|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2075208|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569475|NCT03672071|Ephedrine|ephedrine|mesh-list
569476|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
569477|NCT03672071|Norepinephrine|norepinephrine|mesh-list
569478|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
569479|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569480|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
569481|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
569482|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569483|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
569484|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
569485|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569486|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569487|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
569488|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
569489|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
569490|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
569491|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
569492|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
569493|NCT03672045|Carbetocin|carbetocin|mesh-list
569494|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
569495|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
569496|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213819|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2213820|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213821|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213822|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
2213823|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075209|NCT01995825|Lamotrigine|lamotrigine|mesh-list
2075210|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
2075211|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2075212|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2075213|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075214|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2075215|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075216|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
569512|NCT03671941|Ticagrelor|ticagrelor|mesh-list
569513|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
569514|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
569515|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
569516|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
569517|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
569518|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569519|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569520|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569521|NCT03671915|Insulin|insulin|mesh-list
569522|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
569523|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569524|NCT03671811|Megestrol|megestrol|mesh-list
569525|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
569526|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
569527|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
569528|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
569529|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
569530|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
569531|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569532|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
569533|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
569534|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
569535|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569536|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
569537|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
569538|NCT03671759|Caffeine|caffeine|mesh-list
569539|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
569540|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569541|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
569542|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569543|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569544|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
569545|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
569546|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
569547|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569548|NCT03671746|Ketorolac|ketorolac|mesh-list
569549|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
569550|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
569551|NCT03671746|Analgesics|analgesics|mesh-ancestor
569552|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
569553|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569554|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569555|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
569556|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
569557|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
569558|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569559|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569560|NCT03671733|Liraglutide|liraglutide|mesh-list
569561|NCT03671733|Exenatide|exenatide|mesh-list
569562|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
569563|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569564|NCT03671733|Incretins|incretins|mesh-ancestor
569565|NCT03671733|Hormones|hormones|mesh-ancestor
569566|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
569567|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
569568|NCT03671707|Nicotine|nicotine|mesh-list
569569|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
569570|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
569571|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569572|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569573|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
569574|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
569575|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
569576|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569577|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569578|NCT03671655|Paclitaxel|paclitaxel|mesh-list
569579|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
569580|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569581|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
569582|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
569583|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
569584|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569585|NCT03671538|Pemetrexed|pemetrexed|mesh-list
569586|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569587|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569588|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569589|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
569590|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2075217|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2075218|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2075219|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2075220|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2075221|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2075222|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075223|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2075224|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569599|NCT03671369|Vaccines|vaccines|mesh-list
569600|NCT03671369|Immunologic Factors|immunologic factors|mesh-ancestor
569601|NCT03671369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569615|NCT03671265|Apatinib|apatinib|mesh-list
569616|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569617|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
569618|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569619|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569620|NCT03671174|Aspirin|aspirin|mesh-list
569621|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
569622|NCT03671174|Prednisone|prednisone|mesh-list
569623|NCT03671174|Heparin|heparin|mesh-list
569624|NCT03671174|Enoxaparin|enoxaparin|mesh-list
569625|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
569626|NCT03671174|Tinzaparin|tinzaparin|mesh-list
569627|NCT03671174|Dalteparin|dalteparin|mesh-list
569628|NCT03671174|Nadroparin|nadroparin|mesh-list
569629|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
569630|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
569631|NCT03671174|Hormones|hormones|mesh-ancestor
569632|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
569633|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569634|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
569635|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569636|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
569637|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
569638|NCT03671174|Analgesics|analgesics|mesh-ancestor
569639|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
569640|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569641|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
569642|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
569643|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
569644|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569645|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
569646|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
569647|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569648|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
569649|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
569650|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
569651|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
569652|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
569653|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
569654|NCT03671161|Insulin|insulin|mesh-list
569655|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
569656|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569657|NCT03671109|Piperaquine|piperaquine|mesh-list
569658|NCT03671109|Artenimol|artenimol|mesh-list
569659|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
569660|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
569661|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
569662|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
569663|NCT03671070|Epinephrine|epinephrine|mesh-list
569664|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
569665|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
569666|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
569667|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569668|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569669|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569670|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
569671|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
569672|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
569673|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569674|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
569675|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
569676|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
569677|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
569678|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
569679|NCT03671057|Midazolam|midazolam|mesh-list
569906|NCT03669614|Gallium citrate|gallium citrate|mesh-list
569680|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
569681|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
569682|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
569683|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569684|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
569685|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
569686|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
569687|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
569688|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
569689|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
569690|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
569691|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
569692|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569693|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569694|NCT03671044|Docetaxel|docetaxel|mesh-list
569695|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569696|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
569697|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
569698|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
569699|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075225|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075226|NCT01996657|Warfarin|warfarin|mesh-list
2075227|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
2075228|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2075229|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
2075230|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2075231|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2075232|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075233|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
2075234|NCT01996826|Bevacizumab|bevacizumab|mesh-list
2075235|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2075236|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2075237|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075238|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2075239|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2075240|NCT01996826|Growth Substances|growth substances|mesh-ancestor
2075241|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075242|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
2075243|NCT01996826|Laxatives|laxatives|mesh-ancestor
2075244|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2075245|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2075246|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2075247|NCT01996943|Ethanol|ethanol|mesh-list
2075248|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2075249|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075250|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2075251|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075252|NCT01997229|Eculizumab|eculizumab|mesh-list
569728|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
569729|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
569730|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
569731|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569732|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
569733|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
569734|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
569735|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
569736|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569737|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569738|NCT03670901|Rituximab|rituximab|mesh-list
569739|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
569740|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569741|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
569742|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569743|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
569744|NCT03670888|Rituximab|rituximab|mesh-list
569745|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
569746|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569747|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
569748|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569749|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
569750|NCT03670875|Curcumin|curcumin|mesh-list
569751|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
569752|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
569753|NCT03670875|Analgesics|analgesics|mesh-ancestor
569754|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
569755|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569756|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569757|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
569758|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
569759|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569760|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569761|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569762|NCT03670836|Misoprostol|misoprostol|mesh-list
569763|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
569764|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
569765|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
569766|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569767|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
569768|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
569769|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
2213824|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2213825|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2213826|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2213827|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2213828|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2213829|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
569776|NCT03670758|Protein S|protein s|mesh-list
569777|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
569778|NCT03670706|Analgesics|analgesics|mesh-list
569779|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
569780|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569781|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075253|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2075254|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2075255|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
2075256|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075257|NCT01997333|Capecitabine|capecitabine|mesh-list
2075258|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2075259|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
2075260|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075261|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075262|NCT01997411|Glucagon|glucagon|mesh-list
2075263|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2075264|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2075265|NCT01997411|Hormones|hormones|mesh-ancestor
569795|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
569796|NCT03670212|Yohimbine|yohimbine|mesh-list
569797|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
569798|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
569799|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
569800|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569801|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569802|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
569803|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
569804|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
569805|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
569806|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569807|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569808|NCT03670212|Urological Agents|urological agents|mesh-ancestor
2075266|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2075267|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075268|NCT01997411|Incretins|incretins|mesh-ancestor
2075269|NCT01997515|Ketamine|ketamine|mesh-list
2075270|NCT01997515|Analgesics|analgesics|mesh-ancestor
2075271|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
2075272|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075273|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075274|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2075275|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2075276|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
2075277|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
2075278|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2075279|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2075280|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2075281|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075282|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075283|NCT01997905|Protein S|protein s|mesh-list
2075284|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
2075285|NCT01998399|Ticagrelor|ticagrelor|mesh-list
2075286|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2075287|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2075288|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2075289|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
569834|NCT03670095|Memantine|memantine|mesh-list
569835|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
569836|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
569837|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
569838|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
569839|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569840|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569841|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
569842|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
569843|NCT03670056|Nivolumab|nivolumab|mesh-list
569844|NCT03670056|Ipilimumab|ipilimumab|mesh-list
569845|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
569846|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569847|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
569848|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569849|NCT03670043|Metformin|metformin|mesh-list
569850|NCT03670043|Psyllium|psyllium|mesh-list
569851|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
569852|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569853|NCT03670043|Cathartics|cathartics|mesh-ancestor
569854|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2213830|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2213831|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2213832|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
2213833|NCT00023426|Rifapentine|rifapentine|mesh-list
2213834|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2213835|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
2213836|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2213837|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213838|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
2213839|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2213840|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
2213841|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213842|NCT00023530|Thalidomide|thalidomide|mesh-list
2213843|NCT00023530|Fluconazole|fluconazole|mesh-list
2213844|NCT00023530|Voriconazole|voriconazole|mesh-list
2213845|NCT00023530|Dexamethasone|dexamethasone|mesh-list
2213846|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
569872|NCT03669783|Dactinomycin|dactinomycin|mesh-list
569873|NCT03669783|Carboplatin|carboplatin|mesh-list
569874|NCT03669783|Doxorubicin|doxorubicin|mesh-list
569875|NCT03669783|Etoposide|etoposide|mesh-list
569876|NCT03669783|Vincristine|vincristine|mesh-list
569877|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569878|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
569879|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
569880|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
569881|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569882|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569883|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
569884|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
569885|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
569886|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
569887|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
569888|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
569889|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
569890|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
569891|NCT03669757|Betamethasone|betamethasone|mesh-list
569892|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
569893|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
569894|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
569895|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
569896|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
569897|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
569898|NCT03669757|Hormones|hormones|mesh-ancestor
569899|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
569900|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569901|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
569902|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
2750468|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750469|NCT04260854|Bupivacaine|bupivacaine|mesh-list
2750470|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
2213847|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
569907|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569908|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
569909|NCT03669601|Gemcitabine|gemcitabine|mesh-list
569910|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
569911|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
569912|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569913|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569914|NCT03669601|Antiviral Agents|antiviral agents|mesh-ancestor
569915|NCT03669601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
569916|NCT03669601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569917|NCT03669601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
569918|NCT03669601|Immunologic Factors|immunologic factors|mesh-ancestor
569919|NCT03669601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569920|NCT03669562|Alprostadil|alprostadil|mesh-list
569921|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
569922|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
569923|NCT03669562|Urological Agents|urological agents|mesh-ancestor
2075290|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
2075291|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075292|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075293|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075294|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
2075295|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2075296|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2075297|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569932|NCT03669484|Fentanyl|fentanyl|mesh-list
569933|NCT03669484|Bromides|bromides|mesh-list
569934|NCT03669484|Propofol|propofol|mesh-list
569935|NCT03669484|Rocuronium|rocuronium|mesh-list
569936|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
569937|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
569938|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569939|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
569940|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
569941|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
569942|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
569943|NCT03669484|Narcotics|narcotics|mesh-ancestor
569944|NCT03669484|Analgesics|analgesics|mesh-ancestor
569945|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
569946|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569947|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
569948|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
569949|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
569950|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
569951|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
569952|NCT03669445|Dexamethasone|dexamethasone|mesh-list
569953|NCT03669445|Lenalidomide|lenalidomide|mesh-list
569954|NCT03669445|Daratumumab|daratumumab|mesh-list
569955|NCT03669445|Ixazomib|ixazomib|mesh-list
569956|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
569957|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
569958|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
569959|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569960|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569961|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
569962|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
569963|NCT03669445|Hormones|hormones|mesh-ancestor
569964|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
569965|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
569966|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569967|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
569968|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
569969|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
569970|NCT03669445|Growth Substances|growth substances|mesh-ancestor
569971|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
569972|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
569973|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
569974|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569975|NCT03669367|Abatacept|abatacept|mesh-list
569976|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
569977|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
569978|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
569979|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
569980|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
569981|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569982|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
569983|NCT03669328|Anesthetics|anesthetics|mesh-list
569984|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
569985|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569986|NCT03669263|Fentanyl|fentanyl|mesh-list
569987|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
569988|NCT03669263|Narcotics|narcotics|mesh-ancestor
569989|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
569990|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
569991|NCT03669263|Analgesics|analgesics|mesh-ancestor
569992|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
569993|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
569994|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
569995|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
569996|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
569997|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
569998|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
569999|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
570000|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
570001|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570002|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
570003|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
2213848|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
2213849|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2213850|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213851|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2213852|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
2213853|NCT00023530|Hormones|hormones|mesh-ancestor
2213854|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2213855|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2213856|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213857|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213858|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
2213859|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
2213860|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2213861|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213862|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2213863|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2213864|NCT00023530|Growth Substances|growth substances|mesh-ancestor
2213865|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
2213866|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
2213867|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2213868|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
570032|NCT03669029|Golimumab|golimumab|mesh-list
570033|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
570034|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
570035|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
570036|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
570037|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
570038|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570039|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
570040|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
570041|NCT03669003|Coagulants|coagulants|mesh-ancestor
570042|NCT03668964|Vitamin D|vitamin d|mesh-list
570043|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
570044|NCT03668964|Vitamins|vitamins|mesh-list
570045|NCT03668964|Vitamin E|vitamin e|mesh-list
570046|NCT03668964|Tocopherols|tocopherols|mesh-list
570047|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
570048|NCT03668964|Vitamin A|vitamin a|mesh-list
570049|NCT03668964|Riboflavin|riboflavin|mesh-list
570050|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
570051|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
570052|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570053|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
570054|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
570055|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
570056|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570057|NCT03668964|Protective Agents|protective agents|mesh-ancestor
570058|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
570059|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
570060|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
570061|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
570062|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570063|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570064|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
570065|NCT03668951|Analgesics|analgesics|mesh-ancestor
570066|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
570067|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570068|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
570069|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
570070|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
570071|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
570072|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570073|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570074|NCT03668860|Dexamethasone|dexamethasone|mesh-list
570075|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
570076|NCT03668860|Betamethasone|betamethasone|mesh-list
570077|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
570078|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
570079|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
570080|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
570081|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
570082|NCT03668860|BB 1101|bb 1101|mesh-list
570083|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
570084|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
570085|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
570086|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570087|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570088|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
570089|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
570090|NCT03668860|Hormones|hormones|mesh-ancestor
570091|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
570092|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
570093|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570094|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
570095|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570096|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570097|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
570098|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
570099|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
570100|NCT03668808|Insulin|insulin|mesh-list
570101|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
570102|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
570103|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
570104|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
570105|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570106|NCT03668730|Paclitaxel|paclitaxel|mesh-list
570107|NCT03668730|Fluorouracil|fluorouracil|mesh-list
570108|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
570109|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570110|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
570111|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
570112|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
570113|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570114|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
570115|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
570116|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
570117|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
570118|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570119|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
570120|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
570121|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
570122|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570123|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
570124|NCT03668665|Protective Agents|protective agents|mesh-ancestor
2750471|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
2750472|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2750473|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750474|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
2750475|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2750479|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
2750480|NCT04249297|Progestins|progestins|mesh-ancestor
2750481|NCT04249297|Hormones|hormones|mesh-ancestor
2751257|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213869|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213870|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570140|NCT03668470|Dulaglutide|dulaglutide|mesh-list
570141|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
570142|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570143|NCT03668431|Trametinib|trametinib|mesh-list
570144|NCT03668431|Dabrafenib|dabrafenib|mesh-list
570145|NCT03668431|Spartalizumab|spartalizumab|mesh-list
570146|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570147|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
570148|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570149|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570150|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
570151|NCT03668418|Gemcitabine|gemcitabine|mesh-list
570152|NCT03668418|Camptothecin|camptothecin|mesh-list
570153|NCT03668418|Docetaxel|docetaxel|mesh-list
570154|NCT03668418|Fluorouracil|fluorouracil|mesh-list
570155|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
570156|NCT03668418|Irinotecan|irinotecan|mesh-list
570157|NCT03668418|Epirubicin|epirubicin|mesh-list
570158|NCT03668418|Taxane|taxane|mesh-list
570159|NCT03668418|Antimetabolites|antimetabolites|mesh-list
570160|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
570161|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570162|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
570163|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
570164|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
570165|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570166|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
570167|NCT03668418|Antiviral Agents|antiviral agents|mesh-ancestor
570168|NCT03668418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570169|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570170|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
570171|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
570172|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570173|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
570174|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
570175|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
570176|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
570179|NCT03668340|Adavosertib|adavosertib|mesh-list
570180|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570181|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570182|NCT03668262|Atracurium|atracurium|mesh-list
570183|NCT03668262|Cisatracurium|cisatracurium|mesh-list
570184|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
570185|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
570186|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
570187|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570188|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570189|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
570190|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
570191|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
570192|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570193|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570200|NCT03668054|Bevacizumab|bevacizumab|mesh-list
570201|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
570202|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570203|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
570204|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
570205|NCT03668054|Growth Substances|growth substances|mesh-ancestor
570206|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570207|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
570208|NCT03668041|Gabapentin|gabapentin|mesh-list
570209|NCT03668041|Trazodone|trazodone|mesh-list
570210|NCT03668041|Eszopiclone|eszopiclone|mesh-list
570211|NCT03668041|Analgesics|analgesics|mesh-ancestor
570212|NCT03668041|Sensory System Agents|sensory system agents|mesh-ancestor
570286|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
570213|NCT03668041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570214|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570215|NCT03668041|Anticonvulsants|anticonvulsants|mesh-ancestor
570216|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
570217|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
570218|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570219|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
570220|NCT03668041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
570221|NCT03668041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
570222|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570223|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570224|NCT03668041|Antimanic Agents|antimanic agents|mesh-ancestor
570225|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
570226|NCT03668041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
570227|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
570228|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
570229|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
570230|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
570231|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
570232|NCT03668015|Sorbitol|sorbitol|mesh-list
570233|NCT03668015|Cathartics|cathartics|mesh-ancestor
570234|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
570235|NCT03667963|Lactulose|lactulose|mesh-list
570236|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
570237|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
570238|NCT03667937|Laxatives|laxatives|mesh-ancestor
570239|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2075298|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
2075299|NCT01998438|Coagulants|coagulants|mesh-ancestor
2075300|NCT01998880|Rituximab|rituximab|mesh-list
2075301|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
570244|NCT03667820|Osimertinib|osimertinib|mesh-list
570245|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570246|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
570247|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570248|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570254|NCT03667703|Famotidine|famotidine|mesh-list
570255|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
570256|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
570257|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
570258|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
570259|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
570260|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570261|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570262|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570263|NCT03667690|Fluconazole|fluconazole|mesh-list
570264|NCT03667690|Caspofungin|caspofungin|mesh-list
570265|NCT03667690|Rezafungin|rezafungin|mesh-list
570266|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
570267|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570268|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
570269|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
570270|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570271|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570272|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
570273|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
570274|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
570275|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570276|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
570277|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
570278|NCT03667677|Amlodipine|amlodipine|mesh-list
570279|NCT03667677|Tandospirone|tandospirone|mesh-list
570280|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
570281|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
570282|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
570283|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570284|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
570285|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075302|NCT01998880|Chlorambucil|chlorambucil|mesh-list
570287|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
570288|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
570289|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570290|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
570291|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
570292|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
570293|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570294|NCT03667651|Decanoic acid|decanoic acid|mesh-list
570295|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
570296|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213871|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2213872|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
2213873|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2213874|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2213875|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2213876|NCT00023621|Celecoxib|celecoxib|mesh-list
2213877|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2213878|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2213879|NCT00023621|Analgesics|analgesics|mesh-ancestor
2075303|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2075304|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570309|NCT03667443|Inositol|inositol|mesh-list
570310|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
570311|NCT03667443|Vitamins|vitamins|mesh-ancestor
570312|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
570313|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570314|NCT03667352|Fentanyl|fentanyl|mesh-list
570315|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
570316|NCT03667352|Narcotics|narcotics|mesh-ancestor
570317|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570318|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570319|NCT03667352|Analgesics|analgesics|mesh-ancestor
570320|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
570321|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570322|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
570323|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
570324|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
570325|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
570326|NCT03667326|Aspirin|aspirin|mesh-list
570327|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
570328|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
570329|NCT03667326|Analgesics|analgesics|mesh-ancestor
570330|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
570331|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570332|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570333|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
570334|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
570335|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
570336|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
570337|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570338|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
570339|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
570340|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570341|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
570342|NCT03667313|Sirolimus|sirolimus|mesh-list
570343|NCT03667313|Paclitaxel|paclitaxel|mesh-list
570344|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
570345|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570346|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
570347|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
570348|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
570349|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570350|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
570351|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570352|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
570353|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
570354|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
570355|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
570356|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570357|NCT03667300|Linagliptin|linagliptin|mesh-list
570358|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
570359|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570360|NCT03667300|Incretins|incretins|mesh-ancestor
570361|NCT03667300|Hormones|hormones|mesh-ancestor
570362|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
570363|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
570364|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
570365|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570366|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570367|NCT03667235|Glutaral|glutaral|mesh-list
570368|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
570369|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570370|NCT03667222|Minocycline|minocycline|mesh-list
570371|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
570372|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570373|NCT03667131|Enalapril|enalapril|mesh-list
570374|NCT03667131|Enalaprilat|enalaprilat|mesh-list
570375|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
570376|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
570377|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570378|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
570379|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
570380|NCT03667079|Vaccines|vaccines|mesh-list
570381|NCT03667079|Immunologic Factors|immunologic factors|mesh-ancestor
570382|NCT03667079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570383|NCT03667066|Clopidogrel|clopidogrel|mesh-list
570384|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
570385|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
570386|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
570387|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
570388|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
570389|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570390|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570391|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213880|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
2213881|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2213882|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213883|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
570397|NCT03667001|Lidocaine|lidocaine|mesh-list
570398|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
570399|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
570400|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570401|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570402|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
570403|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570404|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
570405|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
570406|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
570407|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
570408|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570409|NCT03666949|Anesthetics|anesthetics|mesh-list
570410|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570411|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570412|NCT03666884|Cyclosporine|cyclosporine|mesh-list
570413|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
570414|NCT03666884|Cyclosporins|cyclosporins|mesh-list
570415|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
570416|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570417|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570418|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
570419|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
570420|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570421|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
570422|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570423|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
570424|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
570425|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
570426|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
570427|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
570428|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
570429|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570430|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570431|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
570432|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
570433|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
570434|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
570435|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570436|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570512|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
570437|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
570438|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
570439|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
2213884|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213885|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2213886|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2213887|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213888|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213889|NCT00023634|Sargramostim|sargramostim|mesh-list
2213890|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
2213891|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213892|NCT00023660|Celecoxib|celecoxib|mesh-list
2213893|NCT00023660|Fluorouracil|fluorouracil|mesh-list
2213894|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213895|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
2213896|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213897|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
570454|NCT03666650|Edoxaban|edoxaban|mesh-list
570455|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
570456|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
570457|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
570458|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
570459|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570460|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570461|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
570462|NCT03666559|Azacitidine|azacitidine|mesh-list
570463|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
570464|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
570465|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570466|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570467|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570468|NCT03666546|Methamphetamine|methamphetamine|mesh-list
570469|NCT03666546|Lactulose|lactulose|mesh-list
570470|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
570471|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
570472|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570473|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
570474|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
570475|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570476|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
570477|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570478|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570479|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
570480|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
570481|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
570482|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
570483|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
570484|NCT03666494|Fentanyl|fentanyl|mesh-list
570485|NCT03666494|Ketamine|ketamine|mesh-list
570486|NCT03666494|Propofol|propofol|mesh-list
570487|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
570488|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570489|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570490|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
570491|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
570492|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
570493|NCT03666494|Analgesics|analgesics|mesh-ancestor
570494|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
570495|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570496|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
570497|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
570498|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
570499|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570500|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570501|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
570502|NCT03666494|Narcotics|narcotics|mesh-ancestor
570503|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
570504|NCT03666390|Midazolam|midazolam|mesh-list
570505|NCT03666390|Ketamine|ketamine|mesh-list
570506|NCT03666390|Analgesics|analgesics|mesh-ancestor
570507|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
570508|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570509|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570510|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
570511|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
570513|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
570514|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570515|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
570516|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
570517|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570518|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570519|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
570520|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
570521|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
570522|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
570523|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
570524|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
570525|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
570526|NCT03666351|Losartan|losartan|mesh-list
570527|NCT03666351|Amlodipine|amlodipine|mesh-list
570528|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
570529|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
570530|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
570531|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
570532|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570533|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
570534|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570535|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
570536|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
570537|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
570538|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
570539|NCT03666351|Diuretics|diuretics|mesh-ancestor
570540|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
570541|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
570542|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
570543|NCT03666325|Cetuximab|cetuximab|mesh-list
570544|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
570545|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570546|NCT03666299|Lidocaine|lidocaine|mesh-list
570547|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
570548|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
570549|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570550|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570551|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
570552|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570553|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
570554|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
570555|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
570556|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
570557|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075305|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
2075306|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075307|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
570561|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
570562|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
570563|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570564|NCT03666208|Sirolimus|sirolimus|mesh-list
570565|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
570566|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570567|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
570568|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570569|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
570570|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
570571|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
570572|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570573|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
570574|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
570575|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
570576|NCT03666195|Protective Agents|protective agents|mesh-ancestor
570577|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570578|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
570579|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
570580|NCT03666065|Insulin|insulin|mesh-list
570581|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
570582|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
570583|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
570584|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570585|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
570586|NCT03666000|Fludarabine|fludarabine|mesh-list
570587|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
570588|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
570589|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570590|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
570591|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
570592|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
570593|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570594|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570595|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
570596|NCT03665779|Pyridoxine|pyridoxine|mesh-list
570597|NCT03665779|Isosorbide|isosorbide|mesh-list
570598|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
570599|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
570600|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
570601|NCT03665779|Diuretics|diuretics|mesh-ancestor
570602|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
570603|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570604|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
570605|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
570606|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570607|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
570608|NCT03665779|Vitamins|vitamins|mesh-ancestor
570609|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
570610|NCT03665766|Cycloserine|cycloserine|mesh-list
570611|NCT03665766|Tacrolimus|tacrolimus|mesh-list
570612|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
570613|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
570614|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570615|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
570616|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570617|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570618|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
570619|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570620|NCT03665766|Renal Agents|renal agents|mesh-ancestor
570621|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
570622|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
570623|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
570624|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
570625|NCT03665753|Ketorolac|ketorolac|mesh-list
570626|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
570627|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
570628|NCT03665753|Analgesics|analgesics|mesh-ancestor
570629|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
570630|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570631|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570632|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
570633|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
570634|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
570635|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570636|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570637|NCT03665740|Resveratrol|resveratrol|mesh-list
570638|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
570639|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570640|NCT03665740|Protective Agents|protective agents|mesh-ancestor
570641|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570642|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570643|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
570644|NCT03665610|Ozanimod|ozanimod|mesh-list
570645|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
570646|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570647|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
570648|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
570649|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570650|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
570651|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
570652|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570653|NCT03665545|Poly I-C|poly i-c|mesh-list
570654|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
570655|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
570656|NCT03665545|Poly ICLC|poly iclc|mesh-list
570657|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
570658|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570659|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
570660|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
570661|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570662|NCT03665545|Laxatives|laxatives|mesh-ancestor
570663|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
570664|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
570665|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570666|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
570667|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
570668|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2075308|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2075309|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
2075310|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075311|NCT01998893|Rituximab|rituximab|mesh-list
2213898|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
570674|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
570675|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
570676|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
570677|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570678|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
570679|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
570680|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
570681|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
570682|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570683|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570684|NCT03665441|Leucovorin|leucovorin|mesh-list
570685|NCT03665441|Gemcitabine|gemcitabine|mesh-list
570686|NCT03665441|Paclitaxel|paclitaxel|mesh-list
570687|NCT03665441|Irinotecan|irinotecan|mesh-list
570688|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
570689|NCT03665441|Asparaginase|asparaginase|mesh-list
570690|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
570691|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570692|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
570693|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
570694|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
570695|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570696|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
570697|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
570698|NCT03665441|Antiviral Agents|antiviral agents|mesh-ancestor
570699|NCT03665441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570700|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570701|NCT03665441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
570702|NCT03665441|Immunologic Factors|immunologic factors|mesh-ancestor
570703|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570704|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
570705|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
570706|NCT03665441|Antidotes|antidotes|mesh-ancestor
570707|NCT03665441|Protective Agents|protective agents|mesh-ancestor
570708|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
570709|NCT03665441|Vitamins|vitamins|mesh-ancestor
570710|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
570711|NCT03665428|Bismuth|bismuth|mesh-list
570712|NCT03665428|Antacids|antacids|mesh-ancestor
570713|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570714|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
570715|NCT03665402|Isoniazid|isoniazid|mesh-list
570716|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
570717|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
570718|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570719|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
570720|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
570721|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
570722|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570723|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
570724|NCT03665350|Insulin|insulin|mesh-list
570725|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
570726|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570727|NCT03665207|Insulin|insulin|mesh-list
570728|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
570729|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570730|NCT03665181|Bismuth|bismuth|mesh-list
570731|NCT03665181|Antacids|antacids|mesh-ancestor
570732|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570733|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2213899|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
570750|NCT03664986|Bupivacaine|bupivacaine|mesh-list
570751|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
570752|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
570753|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570754|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570755|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
570756|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570757|NCT03664908|Antibodies|antibodies|mesh-list
570758|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
570759|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570760|NCT03664895|Goserelin|goserelin|mesh-list
570761|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
570762|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570763|NCT03664882|Fexofenadine|fexofenadine|mesh-list
570764|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
570765|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
570766|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
570767|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
570768|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
570769|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570770|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570771|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570772|NCT03664869|Mitomycins|mitomycins|mesh-list
570773|NCT03664869|Mitomycin|mitomycin|mesh-list
570774|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
570775|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570776|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
570777|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570778|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
570779|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570780|NCT03664830|Plerixafor|plerixafor|mesh-list
570781|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
570782|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
570783|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
570784|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570785|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
570786|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
570787|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570788|NCT03664622|Morphine|morphine|mesh-list
570789|NCT03664622|Ketamine|ketamine|mesh-list
570790|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
570791|NCT03664622|Narcotics|narcotics|mesh-ancestor
570792|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570793|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570794|NCT03664622|Analgesics|analgesics|mesh-ancestor
570795|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
570796|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570797|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
570798|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
570799|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
570800|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
570801|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
570802|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
570803|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570804|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570805|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
570806|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
570807|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2213900|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213901|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2213902|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2213903|NCT00023660|Analgesics|analgesics|mesh-ancestor
2213904|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
2213905|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2213906|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
570815|NCT03664440|Nevirapine|nevirapine|mesh-list
570816|NCT03664440|Rilpivirine|rilpivirine|mesh-list
570817|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
570818|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
570819|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570820|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570821|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
570822|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570823|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
570824|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
570825|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
570826|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
570827|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
570828|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
570829|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570830|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570831|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
570832|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
570833|NCT03664414|Protective Agents|protective agents|mesh-ancestor
570834|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570835|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
570836|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
570837|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
570838|NCT03664388|Clopidogrel|clopidogrel|mesh-list
570839|NCT03664388|Ticagrelor|ticagrelor|mesh-list
570840|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
570841|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
570842|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
570843|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
570844|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
570845|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570846|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570847|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570848|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
570849|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
570850|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
570851|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
570852|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
570853|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570854|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
570855|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
570856|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570857|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
570858|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075312|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2075313|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075314|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
570862|NCT03664180|Heparin|heparin|mesh-list
570863|NCT03664180|Calcium heparin|calcium heparin|mesh-list
570864|NCT03664180|Enoxaparin|enoxaparin|mesh-list
570865|NCT03664180|Hirudins|hirudins|mesh-list
570866|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
570867|NCT03664180|Bivalirudin|bivalirudin|mesh-list
570868|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
570869|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
570870|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
570871|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570872|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
570873|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
570874|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
570875|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570876|NCT03664115|Itraconazole|itraconazole|mesh-list
570877|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
570878|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570879|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
570880|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
570881|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570882|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570883|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
570884|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
570885|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
570886|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570887|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
570888|NCT03664063|Azithromycin|azithromycin|mesh-list
570889|NCT03664063|Ivermectin|ivermectin|mesh-list
570890|NCT03664063|Albendazole|albendazole|mesh-list
570891|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
570892|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
570893|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570894|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
570895|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
570896|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
570897|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
570898|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
570899|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
570900|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
570901|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
570902|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570903|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570904|NCT03664063|Filaricides|filaricides|mesh-ancestor
570905|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
570906|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
570907|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570908|NCT03664050|Letrozole|letrozole|mesh-list
570909|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570910|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
570911|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
570912|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570913|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570914|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
570915|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
570916|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
570917|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570918|NCT03664037|Dexamethasone|dexamethasone|mesh-list
570919|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
570920|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
570921|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
570922|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
570923|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570924|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570925|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
570926|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
570927|NCT03664037|Hormones|hormones|mesh-ancestor
570928|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
570929|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
570930|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075315|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075316|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2075317|NCT01998906|Paclitaxel|paclitaxel|mesh-list
2075318|NCT01998906|Doxorubicin|doxorubicin|mesh-list
2075319|NCT01998906|Trastuzumab|trastuzumab|mesh-list
2075320|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2075321|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075322|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
2075323|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
570940|NCT03663751|Decitabine|decitabine|mesh-list
570941|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
570942|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
570943|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570944|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
570945|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075324|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
2075325|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075326|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
570949|NCT03663673|Decanoic acid|decanoic acid|mesh-list
570950|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
570951|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213907|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2213908|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2213909|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2213910|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213911|NCT00023699|Gefitinib|gefitinib|mesh-list
570957|NCT03663543|Estrogens|estrogens|mesh-list
570958|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
570959|NCT03663543|Hormones|hormones|mesh-ancestor
570960|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
570961|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570962|NCT03663504|Metronidazole|metronidazole|mesh-list
570963|NCT03663504|Neomycin|neomycin|mesh-list
570964|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
570965|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
570966|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2075327|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
570967|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
570968|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
570969|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
570970|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
570971|NCT03663478|Ropivacaine|ropivacaine|mesh-list
570972|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
570973|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
570974|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570975|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570976|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
570977|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
570978|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
570979|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
570980|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
570981|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
570982|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2213912|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213913|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2213914|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213915|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213916|NCT00023725|Semaxinib|semaxinib|mesh-list
2213917|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2213918|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2075328|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2075329|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075330|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2075331|NCT01998919|Gemcitabine|gemcitabine|mesh-list
2075332|NCT01998919|Carboplatin|carboplatin|mesh-list
2075333|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2075334|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075335|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2075336|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
2075337|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075338|NCT01998919|Antiviral Agents|antiviral agents|mesh-ancestor
2075339|NCT01998919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075340|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075341|NCT01998919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
571011|NCT03663114|Lenvatinib|lenvatinib|mesh-list
571012|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571013|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
571014|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571015|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213919|NCT00023725|Growth Substances|growth substances|mesh-ancestor
2213920|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213921|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
2213922|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213923|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2213924|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213925|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213926|NCT00023738|Doxorubicin|doxorubicin|mesh-list
2213927|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2213928|NCT00023738|Ifosfamide|ifosfamide|mesh-list
2213929|NCT00023738|Dacarbazine|dacarbazine|mesh-list
2213930|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2213931|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213932|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2213933|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2213934|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213935|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213936|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2213937|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
571035|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
571036|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
571037|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
571038|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571039|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
571040|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
571041|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
571042|NCT03662958|Leuprolide|leuprolide|mesh-list
571043|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
571044|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
571045|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
571046|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571047|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
571048|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571049|NCT03662919|Adalimumab|adalimumab|mesh-list
571050|NCT03662919|Infliximab|infliximab|mesh-list
571051|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
571052|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
571053|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
571054|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
571055|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
571056|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
571057|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
571058|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
571059|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571060|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075342|NCT01998919|Immunologic Factors|immunologic factors|mesh-ancestor
2075343|NCT01998919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075344|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2075345|NCT01998958|Esketamine|esketamine|mesh-list
2075346|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
2213938|NCT00023751|Leucovorin|leucovorin|mesh-list
2213939|NCT00023751|Fluorouracil|fluorouracil|mesh-list
571068|NCT03662763|Guanfacine|guanfacine|mesh-list
571069|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
571070|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
571071|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
571072|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
571073|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
571074|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
571075|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571076|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571077|NCT03662724|Venetoclax|venetoclax|mesh-list
571078|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571079|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
571080|NCT03662711|Olodaterol|olodaterol|mesh-list
571081|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
571082|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571083|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571084|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
571085|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
571086|NCT03662685|Coal Tar|coal tar|mesh-list
571087|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
571088|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
2075347|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2075348|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
2075349|NCT01999114|Naltrexone|naltrexone|mesh-list
2075350|NCT01999114|Buprenorphine|buprenorphine|mesh-list
2075351|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
571094|NCT03662620|Amlodipine|amlodipine|mesh-list
571095|NCT03662620|Telmisartan|telmisartan|mesh-list
571096|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
571097|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
571098|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
571099|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
571100|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571101|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
571102|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571103|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
571104|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
571105|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
571106|NCT03662620|Diuretics|diuretics|mesh-ancestor
571107|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
571108|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
571109|NCT03662568|Ritonavir|ritonavir|mesh-list
571110|NCT03662568|Tenofovir|tenofovir|mesh-list
571111|NCT03662568|Entecavir|entecavir|mesh-list
571112|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
571113|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
571114|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
571115|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571116|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075352|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
571117|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
571118|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
571119|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
571120|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
571121|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
571122|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
571123|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
571124|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2075353|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075354|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2075355|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2075356|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075357|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075358|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213940|NCT00023751|Calcium|calcium|mesh-list
571132|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
571133|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
571134|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
571135|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
571136|NCT03662516|Estradiol|estradiol|mesh-list
571137|NCT03662516|Abrocitinib|abrocitinib|mesh-list
571138|NCT03662516|Estrogens|estrogens|mesh-ancestor
571139|NCT03662516|Hormones|hormones|mesh-ancestor
571140|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
571141|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571142|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
571143|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
571144|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
571145|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
571146|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
571147|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
571148|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571149|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571150|NCT03662425|Oxytocin|oxytocin|mesh-list
571151|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
571152|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
571153|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571154|NCT03662412|Sirolimus|sirolimus|mesh-list
571155|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
571156|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
571157|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
571158|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571159|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
571160|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
571161|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
571162|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213941|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
2213942|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
571166|NCT03662269|Indomethacin|indomethacin|mesh-list
571167|NCT03662269|Omeprazole|omeprazole|mesh-list
571168|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
571169|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
571170|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
571171|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571172|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571173|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
571174|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
571175|NCT03662269|Analgesics|analgesics|mesh-ancestor
571176|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
571177|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571178|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571179|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
571180|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
571181|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
571182|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
571183|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
571184|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
571185|NCT03662113|Domperidone|domperidone|mesh-list
571186|NCT03662113|Simethicone|simethicone|mesh-list
571187|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
571188|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
571189|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571190|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571191|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
571192|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
571193|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
571194|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
571195|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571196|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
571197|NCT03662113|Emollients|emollients|mesh-ancestor
571198|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
571199|NCT03662100|Mirikizumab|mirikizumab|mesh-list
571200|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
571201|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
571202|NCT03662100|Analgesics|analgesics|mesh-ancestor
571203|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
571204|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571205|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571206|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
571207|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
571208|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
571209|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2075359|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2075360|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
2075361|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2075362|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075363|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2075364|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2075365|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2075366|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2075367|NCT01999114|Narcotics|narcotics|mesh-ancestor
2075368|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2075369|NCT01999114|Analgesics|analgesics|mesh-ancestor
2075370|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
2075371|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571224|NCT03662035|Apatinib|apatinib|mesh-list
571225|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571226|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
571227|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571228|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571229|NCT03662022|Rifampin|rifampin|mesh-list
571230|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
571231|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
571232|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
571233|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
571234|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
571235|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
571236|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571237|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571238|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
571239|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
571240|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
571241|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
571242|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
571243|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
571244|NCT03661996|Lidocaine|lidocaine|mesh-list
571245|NCT03661996|Epinephrine|epinephrine|mesh-list
571246|NCT03661996|Capsaicin|capsaicin|mesh-list
571247|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
571248|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
571249|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
571250|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571251|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
571252|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571253|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
571254|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
571255|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
571256|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
571257|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571258|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
571259|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
571260|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
571261|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
571262|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
571263|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
571264|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
571265|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
571266|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
571267|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
571268|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
571269|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
571270|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
571271|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
2213943|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213944|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
2213945|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213946|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2213947|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213948|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213949|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
2213950|NCT00023751|Antidotes|antidotes|mesh-ancestor
2213951|NCT00023751|Protective Agents|protective agents|mesh-ancestor
2213952|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
2213953|NCT00023751|Vitamins|vitamins|mesh-ancestor
2213954|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
2213955|NCT00023777|Cytarabine|cytarabine|mesh-list
2213956|NCT00023777|Daunorubicin|daunorubicin|mesh-list
2213957|NCT00023777|Sargramostim|sargramostim|mesh-list
2213958|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
2213959|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213960|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
571290|NCT03661892|Dronabinol|dronabinol|mesh-list
571291|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
571292|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571293|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
571294|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
571295|NCT03661892|Analgesics|analgesics|mesh-ancestor
571296|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
571297|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571298|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
571299|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
571300|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
571301|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571302|NCT03661892|Hormones|hormones|mesh-ancestor
571303|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
571304|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
571305|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
571306|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
571307|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
571308|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571309|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
571310|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
571311|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571312|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
571313|NCT03661775|Analgesics|analgesics|mesh-ancestor
571314|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
571315|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571316|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571317|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
571318|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
571319|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
571320|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
571321|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
571322|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
571323|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571324|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
571325|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
571326|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
571327|NCT03661723|Bevacizumab|bevacizumab|mesh-list
571328|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
571329|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
571330|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571331|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
571332|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
571333|NCT03661723|Growth Substances|growth substances|mesh-ancestor
571334|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571335|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
571336|NCT03661684|Prednisone|prednisone|mesh-list
571337|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
571338|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
571339|NCT03661684|Hormones|hormones|mesh-ancestor
571414|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213961|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
571340|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
571341|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571342|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
571343|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571344|NCT03661645|Dexamethasone|dexamethasone|mesh-list
571345|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
571346|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
571347|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
571348|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
571349|NCT03661645|BB 1101|bb 1101|mesh-list
571350|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
571351|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
571352|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
571353|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571354|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571355|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
571356|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
571357|NCT03661645|Hormones|hormones|mesh-ancestor
571358|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
571359|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
571360|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571361|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
571362|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571363|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571364|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
571365|NCT03661645|Protective Agents|protective agents|mesh-ancestor
2075372|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2075373|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2075374|NCT01999218|Metformin|metformin|mesh-list
2075375|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2075376|NCT01999218|Glimepiride|glimepiride|mesh-list
571371|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
571372|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
571373|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
571374|NCT03661567|Prednisolone|prednisolone|mesh-list
571375|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
571376|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
571377|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
571378|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
571379|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
571380|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
571381|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571382|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571383|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
571384|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
571385|NCT03661567|Hormones|hormones|mesh-ancestor
571386|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
571387|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
571388|NCT03661567|Protective Agents|protective agents|mesh-ancestor
571389|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
571390|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075377|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
2075378|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2075379|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075380|NCT01999218|Incretins|incretins|mesh-ancestor
571395|NCT03661515|Cytarabine|cytarabine|mesh-list
571396|NCT03661515|Fludarabine|fludarabine|mesh-list
571397|NCT03661515|Idarubicin|idarubicin|mesh-list
571398|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571399|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
571400|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
571401|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571402|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
571403|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
571404|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571405|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
571406|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
571407|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
571408|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
571409|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
571410|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571411|NCT03661489|Propofol|propofol|mesh-list
571412|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
571413|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2075381|NCT01999218|Hormones|hormones|mesh-ancestor
2075382|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
571415|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
571416|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
571417|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
571418|NCT03661463|Aspirin|aspirin|mesh-list
571419|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
571420|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
571421|NCT03661463|Analgesics|analgesics|mesh-ancestor
571422|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
571423|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571424|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571425|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
571426|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
571427|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
571428|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
571429|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571430|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
571431|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
571432|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571433|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
571434|NCT03661411|Aspirin|aspirin|mesh-list
571435|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
571436|NCT03661411|Clopidogrel|clopidogrel|mesh-list
571437|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
571438|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
571439|NCT03661411|Analgesics|analgesics|mesh-ancestor
571440|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
571441|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571442|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571443|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
571444|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
571445|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
571446|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
571447|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571448|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
571449|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
571450|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571451|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
571452|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
571453|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
571454|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
571455|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
571456|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
571457|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
571458|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
571459|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
571460|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571461|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571462|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
571463|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
571464|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
571465|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
571466|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571467|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
571468|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
571469|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
571470|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
571471|NCT03661385|Protective Agents|protective agents|mesh-ancestor
2213962|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2213963|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213964|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
2213965|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213966|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2213967|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2213968|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2213969|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2213970|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2213971|NCT00023790|Silicon|silicon|mesh-list
2213972|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
2213973|NCT00023790|Trace Elements|trace elements|mesh-ancestor
2213974|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
2213975|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213976|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
2213977|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
571502|NCT03661307|Decitabine|decitabine|mesh-list
571503|NCT03661307|Venetoclax|venetoclax|mesh-list
571504|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
571505|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
571506|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571507|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571508|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750482|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2750483|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571515|NCT03661125|Saracatinib|saracatinib|mesh-list
571516|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571517|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571518|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075383|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2075384|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
2075385|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571522|NCT03660943|Capsaicin|capsaicin|mesh-list
571523|NCT03660943|Antipruritics|antipruritics|mesh-ancestor
571524|NCT03660943|Dermatologic Agents|dermatologic agents|mesh-ancestor
571525|NCT03660943|Sensory System Agents|sensory system agents|mesh-ancestor
571526|NCT03660943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571527|NCT03660943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571528|NCT03660930|Sirolimus|sirolimus|mesh-list
571529|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
571530|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
571531|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
571532|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571533|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
571534|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
571535|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
571536|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571537|NCT03660917|Riluzole|riluzole|mesh-list
571538|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
571539|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
571540|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
571541|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
571542|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571543|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571544|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
571545|NCT03660917|Protective Agents|protective agents|mesh-ancestor
571546|NCT03660878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
571547|NCT03660878|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2213978|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2213979|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213980|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
2213981|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2213982|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
2213983|NCT00023816|Carbendazim|carbendazim|mesh-list
2075386|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075387|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2075388|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2075389|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
2075390|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2075391|NCT01999322|Insulin|insulin|mesh-list
2075392|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2075393|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
2075394|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
2075395|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2075396|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2075397|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075398|NCT01999335|Dexamethasone|dexamethasone|mesh-list
571569|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
571570|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
571571|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
571572|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
571573|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
571574|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571575|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
571576|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
571577|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571578|NCT03660761|Apatinib|apatinib|mesh-list
571579|NCT03660761|Temozolomide|temozolomide|mesh-list
571580|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571581|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
571582|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571583|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571584|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
571585|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
571586|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
571587|NCT03660683|Saxagliptin|saxagliptin|mesh-list
571588|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
571589|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571590|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
571591|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571592|NCT03660683|Incretins|incretins|mesh-ancestor
571593|NCT03660683|Hormones|hormones|mesh-ancestor
571594|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
571595|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
571596|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
571597|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075399|NCT01999335|Pomalidomide|pomalidomide|mesh-list
2075400|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2075401|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
2075402|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
2075403|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075404|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075405|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
571605|NCT03660488|Penicillins|penicillins|mesh-list
571606|NCT03660488|Cefixime|cefixime|mesh-list
571607|NCT03660488|Penicillin G|penicillin g|mesh-list
571608|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
571609|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
571610|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
571611|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
571612|NCT03660475|Naltrexone|naltrexone|mesh-list
571613|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
571614|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
571615|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571616|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
571617|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571618|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
571619|NCT03660436|BMS-986165|bms-986165|mesh-list
571620|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
571621|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571622|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
571623|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
571624|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
571625|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
571626|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571627|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571628|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
571629|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
571630|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
571631|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
571632|NCT03660306|Anesthetics|anesthetics|mesh-list
571633|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
571634|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571635|NCT03660306|Narcotics|narcotics|mesh-ancestor
571636|NCT03660306|Analgesics|analgesics|mesh-ancestor
571637|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
571638|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571639|NCT03660293|Captopril|captopril|mesh-list
571640|NCT03660293|Atorvastatin|atorvastatin|mesh-list
571641|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
571642|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
571643|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
571644|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571645|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
571646|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
571647|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571648|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
571649|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
571650|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
571651|NCT03660267|Caffeine|caffeine|mesh-list
571652|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
571653|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571654|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
571655|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571656|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571657|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
571658|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
571659|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
571660|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075406|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
2075407|NCT01999335|Hormones|hormones|mesh-ancestor
2075408|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2075409|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2075410|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075411|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
2075412|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2075413|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2075414|NCT01999335|Growth Substances|growth substances|mesh-ancestor
2075415|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
2075416|NCT01999348|Timolol|timolol|mesh-list
571672|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
571673|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
571674|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
571675|NCT03660046|Etonogestrel|etonogestrel|mesh-list
571676|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
571677|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
571678|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
571679|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571680|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
571681|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
571682|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
571683|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
571684|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
571685|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
571686|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571687|NCT03660020|Anesthetics|anesthetics|mesh-list
571688|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
571689|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
571690|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571691|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
571692|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571693|NCT03659929|Amphetamine|amphetamine|mesh-list
571694|NCT03659929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
571695|NCT03659929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571696|NCT03659929|Sympathomimetics|sympathomimetics|mesh-ancestor
571697|NCT03659929|Autonomic Agents|autonomic agents|mesh-ancestor
571698|NCT03659929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571699|NCT03659929|Dopamine Agents|dopamine agents|mesh-ancestor
571700|NCT03659929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
571701|NCT03659929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571702|NCT03659929|Adrenergic Agents|adrenergic agents|mesh-ancestor
571703|NCT03659929|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
571704|NCT03659929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
571705|NCT03659929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
571706|NCT03659929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
571707|NCT03659851|Simendan|simendan|mesh-list
571708|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
571709|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
571710|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
571711|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
571712|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571713|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571714|NCT03659851|Protective Agents|protective agents|mesh-ancestor
2075417|NCT01999348|Bimatoprost|bimatoprost|mesh-list
571715|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571716|NCT03659799|Insulin|insulin|mesh-list
571717|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
571718|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
571719|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
571720|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571721|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
571722|NCT03659734|Narcotics|narcotics|mesh-ancestor
571723|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
571724|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571725|NCT03659734|Analgesics|analgesics|mesh-ancestor
571726|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
571727|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075418|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2075419|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2075420|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
2075421|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075422|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075423|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075424|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2075425|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2075426|NCT01999400|Mesalamine|mesalamine|mesh-list
571741|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
571742|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
571743|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571744|NCT03659461|Incretins|incretins|mesh-ancestor
571745|NCT03659461|Hormones|hormones|mesh-ancestor
571746|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
571747|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
571748|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
571749|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571750|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571751|NCT03659435|Rivastigmine|rivastigmine|mesh-list
571752|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
571753|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571754|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571755|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
571756|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
571757|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571758|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
571759|NCT03659435|Protective Agents|protective agents|mesh-ancestor
571760|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
571761|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571762|NCT03659305|Bevacizumab|bevacizumab|mesh-list
571763|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
571764|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571765|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
571766|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
571767|NCT03659305|Growth Substances|growth substances|mesh-ancestor
571768|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571769|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
571770|NCT03659292|Anesthetics|anesthetics|mesh-list
571771|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
571772|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571773|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
571774|NCT03659162|Clotrimazole|clotrimazole|mesh-list
571775|NCT03659162|Miconazole|miconazole|mesh-list
571776|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
571777|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
571778|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
571779|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
571780|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571781|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571782|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
571783|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
571784|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
571785|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571786|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
571787|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2075427|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2075428|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2075429|NCT01999400|Analgesics|analgesics|mesh-ancestor
2075430|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
2075431|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075432|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075433|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2075434|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2075435|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
2075436|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
2075437|NCT01999530|Prazosin|prazosin|mesh-list
2075438|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
571801|NCT03659084|Deferasirox|deferasirox|mesh-list
571802|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
571803|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
571804|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
571805|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571806|NCT03659058|Colchicine|colchicine|mesh-list
571807|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
571808|NCT03659058|Antioxidants|antioxidants|mesh-list
571809|NCT03659058|Silymarin|silymarin|mesh-list
571810|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
571811|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
571812|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
571813|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
571814|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
571815|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571816|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571817|NCT03659058|Protective Agents|protective agents|mesh-ancestor
571818|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571819|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
571820|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
571821|NCT03658993|Rifaximin|rifaximin|mesh-list
571822|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
571823|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
571824|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2213984|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
2213985|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
571827|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
571828|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
571829|NCT03658850|Diuretics|diuretics|mesh-ancestor
571830|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
571831|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571832|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
571833|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
571834|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571835|NCT03658785|Aldesleukin|aldesleukin|mesh-list
571836|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
571837|NCT03658785|Fludarabine|fludarabine|mesh-list
571838|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
571839|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
571840|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571841|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
571842|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
571843|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
571844|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571845|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571846|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
571847|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
571848|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
571849|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
571850|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075439|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2075440|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2075441|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
571854|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
571855|NCT03658746|Amoxicillin|amoxicillin|mesh-list
571856|NCT03658746|Metronidazole|metronidazole|mesh-list
571857|NCT03658746|Clarithromycin|clarithromycin|mesh-list
571858|NCT03658746|Levofloxacin|levofloxacin|mesh-list
571859|NCT03658746|Ofloxacin|ofloxacin|mesh-list
571860|NCT03658746|Tetracycline|tetracycline|mesh-list
571861|NCT03658746|Tinidazole|tinidazole|mesh-list
571862|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
571863|NCT03658746|Furazolidone|furazolidone|mesh-list
571864|NCT03658746|Bismuth|bismuth|mesh-list
571865|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
571866|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
571867|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
571868|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
571869|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
571870|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
571871|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571872|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571873|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
571874|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
571875|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
571876|NCT03658746|Renal Agents|renal agents|mesh-ancestor
571877|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
571878|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
571879|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571880|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
571881|NCT03658746|Antacids|antacids|mesh-ancestor
571882|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
571883|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
571884|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
571885|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
571886|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
571887|NCT03658733|Amoxicillin|amoxicillin|mesh-list
571888|NCT03658733|Tetracycline|tetracycline|mesh-list
571889|NCT03658733|Furazolidone|furazolidone|mesh-list
571890|NCT03658733|Esomeprazole|esomeprazole|mesh-list
571891|NCT03658733|Rabeprazole|rabeprazole|mesh-list
571892|NCT03658733|Bismuth|bismuth|mesh-list
571893|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
571894|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
571895|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
571896|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
571897|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
571898|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571899|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571900|NCT03658733|Antacids|antacids|mesh-ancestor
571901|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
571902|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
571903|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
571904|NCT03658733|Renal Agents|renal agents|mesh-ancestor
571905|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
571906|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
571907|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
571908|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
571909|NCT03658720|Ibuprofen|ibuprofen|mesh-list
571910|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
571911|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
571912|NCT03658720|Analgesics|analgesics|mesh-ancestor
571913|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
571914|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571915|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571916|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
571917|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
571918|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
571919|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571920|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571921|NCT03658590|Dexamethasone|dexamethasone|mesh-list
571922|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
571923|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
571924|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
571925|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571926|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571927|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
571928|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
571929|NCT03658590|Hormones|hormones|mesh-ancestor
571930|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
571931|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
571932|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571933|NCT03658473|Naproxen|naproxen|mesh-list
571934|NCT03658473|Rabeprazole|rabeprazole|mesh-list
571935|NCT03658473|Rebamipide|rebamipide|mesh-list
571936|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
571937|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
571938|NCT03658473|Analgesics|analgesics|mesh-ancestor
571939|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
571940|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571941|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571942|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
571943|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
571944|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
571945|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
571946|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
571947|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571948|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
571949|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
571950|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
571951|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
571952|NCT03658473|Protective Agents|protective agents|mesh-ancestor
571953|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
571954|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
571955|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
571956|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
571957|NCT03658421|Morphine|morphine|mesh-list
571958|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
571959|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
571960|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571961|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
571962|NCT03658421|Analgesics|analgesics|mesh-ancestor
571963|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
571964|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571965|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
571966|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
571967|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
571968|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
571969|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
571970|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571971|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
571972|NCT03658421|Narcotics|narcotics|mesh-ancestor
571973|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
571974|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
571975|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
571976|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571977|NCT03658330|Naltrexone|naltrexone|mesh-list
571978|NCT03658330|Ketamine|ketamine|mesh-list
571979|NCT03658330|Analgesics|analgesics|mesh-ancestor
571980|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
571981|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
571982|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
571983|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
571984|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
571985|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
571986|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
571987|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
571988|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
571989|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
571990|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
571991|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571992|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
571993|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
571994|NCT03658317|Uric Acid|uric acid|mesh-list
571995|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
571996|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
571997|NCT03658317|Protective Agents|protective agents|mesh-ancestor
571998|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572007|NCT03658291|Levofloxacin|levofloxacin|mesh-list
572008|NCT03658291|Ofloxacin|ofloxacin|mesh-list
572009|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
572010|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572011|NCT03658291|Renal Agents|renal agents|mesh-ancestor
572012|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
572013|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
572014|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
572015|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572016|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572017|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572018|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
572019|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
572020|NCT03658213|Goserelin|goserelin|mesh-list
572021|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
572022|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572023|NCT03658109|Lidocaine|lidocaine|mesh-list
572024|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
572025|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
572026|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
572027|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572028|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
572029|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572030|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
572031|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
572032|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
572033|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
572034|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572035|NCT03658057|Rocuronium|rocuronium|mesh-list
572036|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
572037|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
572038|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
572039|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572040|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572041|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
572042|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
572043|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572044|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
572045|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572046|NCT03657979|Ropivacaine|ropivacaine|mesh-list
572047|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
572048|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
572049|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
572050|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572051|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
572052|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572053|NCT03657966|Gemcitabine|gemcitabine|mesh-list
572054|NCT03657966|Paclitaxel|paclitaxel|mesh-list
572055|NCT03657966|Carboplatin|carboplatin|mesh-list
572056|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
572057|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572058|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
572059|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
572060|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
572061|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572062|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
572063|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
572064|NCT03657966|Antiviral Agents|antiviral agents|mesh-ancestor
572065|NCT03657966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572066|NCT03657966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572067|NCT03657966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
572068|NCT03657966|Immunologic Factors|immunologic factors|mesh-ancestor
572069|NCT03657966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572070|NCT03657862|Fluorides|fluorides|mesh-list
572071|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
572072|NCT03657862|Protective Agents|protective agents|mesh-ancestor
572073|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572074|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
572075|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572076|NCT03657797|Latanoprost|latanoprost|mesh-list
572077|NCT03657797|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
572078|NCT03657797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
572079|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
572080|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
572081|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
572082|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
572083|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572084|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
572085|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
572086|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572087|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
572088|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
572089|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572090|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
572091|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
572092|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
572093|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
572094|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572095|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
572096|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
572097|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
572098|NCT03657550|Niacin|niacin|mesh-list
572099|NCT03657550|Amlodipine|amlodipine|mesh-list
572100|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
572101|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
572102|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
572103|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572104|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
572105|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572106|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
572107|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
572108|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
572109|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
572110|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
572111|NCT03657550|Vitamins|vitamins|mesh-ancestor
572112|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
572113|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
572114|NCT03657472|Atorvastatin|atorvastatin|mesh-list
572115|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
572116|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
572117|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
572118|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572119|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
572120|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
572121|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572122|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
572123|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
572124|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
572125|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572126|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
572127|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
572128|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572129|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572130|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572131|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
572132|NCT03657433|Hematinics|hematinics|mesh-ancestor
572133|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
572134|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
572135|NCT03657420|Dexamethasone|dexamethasone|mesh-list
572136|NCT03657420|Pomalidomide|pomalidomide|mesh-list
572137|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
572138|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
572139|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
572140|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572141|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572142|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
572143|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
572144|NCT03657420|Hormones|hormones|mesh-ancestor
572145|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
572146|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
572147|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572148|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
572149|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
572150|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
572151|NCT03657420|Growth Substances|growth substances|mesh-ancestor
572152|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
2213986|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2213987|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2213988|NCT00023829|Bicalutamide|bicalutamide|mesh-list
2213989|NCT00023829|Flutamide|flutamide|mesh-list
572157|NCT03657381|Antibodies|antibodies|mesh-list
572158|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
572159|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
572160|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572161|NCT03657355|Zolpidem|zolpidem|mesh-list
572162|NCT03657355|Suvorexant|suvorexant|mesh-list
572163|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
572164|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
572165|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
572166|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572167|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
572168|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
572169|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
572170|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572171|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572172|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
572173|NCT03657342|Cyclosporine|cyclosporine|mesh-list
572174|NCT03657342|Cyclosporins|cyclosporins|mesh-list
572175|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572176|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572177|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
572178|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
572179|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572180|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
572181|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572182|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
572183|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
572184|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2213990|NCT00023829|Hormones|hormones|mesh-list
2213991|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2213992|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2213993|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
2213994|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
2213995|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2213996|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2213997|NCT00023842|Mitomycins|mitomycins|mesh-list
572193|NCT03657212|Zolpidem|zolpidem|mesh-list
572194|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
572195|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
572196|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
572197|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572198|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
572199|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
572200|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
572201|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572202|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572203|NCT03657160|Vedolizumab|vedolizumab|mesh-list
572204|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2213998|NCT00023842|Mitomycin|mitomycin|mesh-list
2213999|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
2214000|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2075442|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
2075443|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075444|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572211|NCT03656965|Acyclovir|acyclovir|mesh-list
572212|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
572213|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572214|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
572215|NCT03656952|PF-06700841|pf-06700841|mesh-list
572216|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
572217|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572218|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
572219|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
572220|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572221|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572222|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572223|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
572224|NCT03656926|Cyclosporine|cyclosporine|mesh-list
572225|NCT03656926|Cyclosporins|cyclosporins|mesh-list
572226|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572227|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572228|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
572229|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
572230|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572231|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
572232|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572233|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
572234|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
572235|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
572236|NCT03656783|Tenofovir|tenofovir|mesh-list
572237|NCT03656783|Emtricitabine|emtricitabine|mesh-list
572238|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
572239|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
572240|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572241|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
572242|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
572243|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572244|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572245|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
572246|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2214001|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214002|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
2214003|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214004|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
572256|NCT03656679|Iodine|iodine|mesh-list
572257|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
572258|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572259|NCT03656679|Trace Elements|trace elements|mesh-ancestor
572260|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
572261|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572262|NCT03656666|Thalidomide|thalidomide|mesh-list
572263|NCT03656666|Apremilast|apremilast|mesh-list
572264|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
572265|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
572266|NCT03656666|Analgesics|analgesics|mesh-ancestor
572267|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
572268|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572269|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572270|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
572271|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
572272|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
572273|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
572274|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572275|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572276|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
572277|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
572278|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
572279|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
572280|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572281|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
572282|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
572283|NCT03656666|Growth Substances|growth substances|mesh-ancestor
572284|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
572285|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572286|NCT03656627|Nivolumab|nivolumab|mesh-list
572287|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
572288|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572289|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
572290|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572291|NCT03656614|Neostigmine|neostigmine|mesh-list
572292|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
572293|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572294|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572295|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
572296|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572297|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572298|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
572299|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
572300|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572301|NCT03656588|Iodine|iodine|mesh-list
572302|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
572303|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
572304|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
572305|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
572306|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
572307|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572308|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
572309|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
572310|NCT03656588|Trace Elements|trace elements|mesh-ancestor
572311|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
572312|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750491|NCT04245514|Durvalumab|durvalumab|mesh-list
2750492|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
572316|NCT03656549|Pemetrexed|pemetrexed|mesh-list
572317|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572318|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572319|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572320|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
572321|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
572322|NCT03656536|Gemcitabine|gemcitabine|mesh-list
572323|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572324|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
572325|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
572326|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572327|NCT03656536|Antiviral Agents|antiviral agents|mesh-ancestor
572328|NCT03656536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572329|NCT03656536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572330|NCT03656536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
572331|NCT03656536|Immunologic Factors|immunologic factors|mesh-ancestor
572332|NCT03656536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572333|NCT03656484|Metronidazole|metronidazole|mesh-list
572334|NCT03656484|Tetracycline|tetracycline|mesh-list
572335|NCT03656484|Melatonin|melatonin|mesh-list
572336|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
572337|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572338|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
572339|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
572340|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
572341|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
572342|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572343|NCT03656484|Protective Agents|protective agents|mesh-ancestor
572344|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572345|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
572346|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
572347|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
572348|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
572349|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
572350|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572351|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
572352|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
572353|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
572354|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572355|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
572356|NCT03656445|Coagulants|coagulants|mesh-ancestor
572357|NCT03656432|Fluorides|fluorides|mesh-list
572358|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
572359|NCT03656432|Protective Agents|protective agents|mesh-ancestor
572360|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572361|NCT03656393|Carboplatin|carboplatin|mesh-list
572362|NCT03656393|Vinorelbine|vinorelbine|mesh-list
572363|NCT03656393|Gefitinib|gefitinib|mesh-list
572364|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572365|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
572366|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
572367|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
572368|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
572369|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572370|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
572371|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572372|NCT03656289|Etonogestrel|etonogestrel|mesh-list
572373|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
572374|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
572375|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
572376|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572377|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
572378|NCT03656094|Docetaxel|docetaxel|mesh-list
572379|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
572380|NCT03656094|Pemetrexed|pemetrexed|mesh-list
572381|NCT03656094|Vinorelbine|vinorelbine|mesh-list
572382|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572383|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
572384|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
572385|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
572386|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572387|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
572388|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572389|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
572390|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
572391|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
572392|NCT03656081|Itraconazole|itraconazole|mesh-list
572393|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
572394|NCT03656081|Amphotericin B|amphotericin b|mesh-list
572395|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
572396|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572397|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
572398|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
572399|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572400|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572401|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
572402|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
572403|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
572404|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572405|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
572406|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
572407|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
572408|NCT03656081|Amebicides|amebicides|mesh-ancestor
572409|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
572413|NCT03656042|Lenograstim|lenograstim|mesh-list
572414|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
572415|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
572416|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572417|NCT03655964|Olmesartan|olmesartan|mesh-list
572418|NCT03655964|Nebivolol|nebivolol|mesh-list
572419|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
572420|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
572421|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
572422|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572423|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
572424|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
572425|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
572426|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
572427|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
572428|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572429|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572430|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
572431|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
572432|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
572433|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572434|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
572435|NCT03655847|Analgesics|analgesics|mesh-ancestor
572436|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
572437|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572438|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
572439|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
572440|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
572441|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
572442|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572443|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572444|NCT03655834|Pemetrexed|pemetrexed|mesh-list
572445|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572446|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572447|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572448|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
572449|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
572450|NCT03655821|Pemetrexed|pemetrexed|mesh-list
572451|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572452|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572453|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572454|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
572455|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
572456|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
572457|NCT03655717|Ethanol|ethanol|mesh-list
572458|NCT03655717|Dronabinol|dronabinol|mesh-list
572459|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
572460|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572461|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
572462|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572463|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
572464|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
572465|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
572466|NCT03655717|Analgesics|analgesics|mesh-ancestor
572467|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
572468|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572469|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
572470|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
572471|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572472|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572473|NCT03655717|Hormones|hormones|mesh-ancestor
572474|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
572475|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
572476|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
572477|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
572478|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
572479|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
572480|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572481|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
572482|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572483|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572484|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
572485|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572486|NCT03655665|Ofloxacin|ofloxacin|mesh-list
572487|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
572488|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572489|NCT03655665|Renal Agents|renal agents|mesh-ancestor
572490|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
572491|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
572492|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
572493|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572494|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572495|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572496|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
572497|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
572498|NCT03655613|Nivolumab|nivolumab|mesh-list
572499|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
572500|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572501|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
572502|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572503|NCT03655535|PAZ320|paz320|mesh-list
572504|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
572505|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572506|NCT03655457|Poractant alfa|poractant alfa|mesh-list
572507|NCT03655457|Beractant|beractant|mesh-list
572508|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
572509|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
2214005|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214006|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2214007|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
2214008|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214009|NCT00023855|Doxorubicin|doxorubicin|mesh-list
572515|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
572516|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
572517|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
572518|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572519|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572520|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
572521|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
572522|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
572523|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
572524|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572525|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572526|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
572527|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
572528|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
572529|NCT03655392|Protective Agents|protective agents|mesh-ancestor
2214010|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2214011|NCT00023855|Bortezomib|bortezomib|mesh-list
2214012|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
572533|NCT03655197|Doxycycline|doxycycline|mesh-list
572534|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
572535|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572536|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
572537|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
572538|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2075445|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075446|NCT01999569|Letrozole|letrozole|mesh-list
2214013|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075447|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075448|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2075449|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2075450|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075451|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075452|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
572547|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
572548|NCT03655002|Nivolumab|nivolumab|mesh-list
572549|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
572550|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
572551|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572552|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
572553|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
572554|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
572555|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572556|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572557|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
572558|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
572559|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
572560|NCT03654989|Treprostinil|treprostinil|mesh-list
572561|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
572562|NCT03654937|Vaccines|vaccines|mesh-list
572563|NCT03654937|Immunologic Factors|immunologic factors|mesh-ancestor
572564|NCT03654937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572565|NCT03654833|Bevacizumab|bevacizumab|mesh-list
572566|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
572567|NCT03654833|Atezolizumab|atezolizumab|mesh-list
572568|NCT03654833|Niraparib|niraparib|mesh-list
572569|NCT03654833|Rucaparib|rucaparib|mesh-list
572570|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
572571|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572572|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
572573|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
572574|NCT03654833|Growth Substances|growth substances|mesh-ancestor
572575|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572576|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
572577|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
572578|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572579|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572580|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
572581|NCT03654794|Tacrolimus|tacrolimus|mesh-list
572582|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
572583|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
572584|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572585|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
572586|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572587|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572588|NCT03654768|Dasatinib|dasatinib|mesh-list
572589|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
572590|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572591|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
572592|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572593|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750493|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572605|NCT03654716|Cytarabine|cytarabine|mesh-list
572606|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
572607|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
572608|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572609|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572610|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
572611|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
572612|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
572613|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
572614|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572615|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
2075453|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
572616|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
572617|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
572618|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572619|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
572620|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
572621|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
572622|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572623|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572624|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
572625|NCT03654612|Apatinib|apatinib|mesh-list
572626|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572627|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
572628|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572629|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214014|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2214015|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214016|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214017|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214018|NCT00023868|Leucovorin|leucovorin|mesh-list
2214019|NCT00023868|Doxorubicin|doxorubicin|mesh-list
2214020|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2214021|NCT00023868|Fluorouracil|fluorouracil|mesh-list
2214022|NCT00023868|Irinotecan|irinotecan|mesh-list
2214023|NCT00023868|Mitomycins|mitomycins|mesh-list
2214024|NCT00023868|Mitomycin|mitomycin|mesh-list
2214025|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
572642|NCT03654365|Caffeine|caffeine|mesh-list
572643|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
572644|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572645|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
572646|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572647|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572648|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
572649|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
572650|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
572651|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2214026|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214027|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214028|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2214029|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214030|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214031|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214032|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214033|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
2214034|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214035|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214036|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
2214037|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2214038|NCT00023868|Antidotes|antidotes|mesh-ancestor
572665|NCT03654274|Norethindrone|norethindrone|mesh-list
572666|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
572667|NCT03654274|Estradiol|estradiol|mesh-list
572668|NCT03654274|Relugolix|relugolix|mesh-list
572669|NCT03654274|Estrogens|estrogens|mesh-ancestor
572670|NCT03654274|Hormones|hormones|mesh-ancestor
572671|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
572672|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572673|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
572674|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
572675|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
572676|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
572677|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
572678|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
572679|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
572680|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
572681|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
572682|NCT03654170|BI 425809|bi 425809|mesh-list
572683|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
572684|NCT03654144|Dienogest|dienogest|mesh-list
572685|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
572686|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
572687|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
572688|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
572689|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214039|NCT00023868|Protective Agents|protective agents|mesh-ancestor
2214040|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
572690|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
572691|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
572692|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
572693|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
572694|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
572695|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
572696|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
572697|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572698|NCT03654105|Aspirin|aspirin|mesh-list
572699|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
572700|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
572701|NCT03654105|Analgesics|analgesics|mesh-ancestor
572702|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
572703|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572704|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572705|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
572706|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
572707|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
572708|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
572709|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572710|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
572711|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
572712|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572713|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
572714|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
572715|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
572716|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
572717|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
572718|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
572719|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572720|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
572721|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572722|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572723|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
572724|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572725|NCT03654053|Simvastatin|simvastatin|mesh-list
572726|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
572727|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
572728|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
572729|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572730|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
572731|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
572732|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572733|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
572734|NCT03654040|Everolimus|everolimus|mesh-list
572735|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
572736|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
572737|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572738|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
572739|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
572740|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
572741|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572742|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572743|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
572744|NCT03654027|Docetaxel|docetaxel|mesh-list
572745|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572746|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
572747|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
572748|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
572749|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572750|NCT03653845|Epinephrine|epinephrine|mesh-list
572751|NCT03653845|Racepinephrine|racepinephrine|mesh-list
572752|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
572753|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
572754|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
572755|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
572756|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572757|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572758|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572759|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
572760|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
572761|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
572762|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572763|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
572764|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
572765|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
572766|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
572767|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
572768|NCT03653832|Clonidine|clonidine|mesh-list
572769|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
572770|NCT03653832|Propofol|propofol|mesh-list
572771|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
572772|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
572773|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572774|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
572775|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
572776|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
572777|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
572778|NCT03653832|Analgesics|analgesics|mesh-ancestor
572779|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
572780|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572781|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
572782|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
572783|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
572784|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
572785|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572786|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572787|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
572788|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
572789|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
572790|NCT03653663|Simvastatin|simvastatin|mesh-list
572791|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
572792|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
572793|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
572794|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572795|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
572796|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
572797|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572798|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
572799|NCT03653546|Gefitinib|gefitinib|mesh-list
572800|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572801|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
572802|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572803|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572804|NCT03653520|Diazepam|diazepam|mesh-list
572805|NCT03653520|Tramadol|tramadol|mesh-list
572806|NCT03653520|Ondansetron|ondansetron|mesh-list
572807|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
572808|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
572809|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572810|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572811|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
572812|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
572813|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
572814|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
572815|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
572816|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572817|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572818|NCT03653520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
572819|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
572820|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
572821|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
572822|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
572823|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
572824|NCT03653520|Narcotics|narcotics|mesh-ancestor
572825|NCT03653520|Analgesics|analgesics|mesh-ancestor
572826|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
572827|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
572828|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
572829|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
572830|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
572831|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
572832|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
572833|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
572834|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
572835|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
572836|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
2075454|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2075455|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075456|NCT01999868|Abatacept|abatacept|mesh-list
2075457|NCT01999868|Ustekinumab|ustekinumab|mesh-list
2075458|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
2214041|NCT00023868|Vitamins|vitamins|mesh-ancestor
2214042|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
2214043|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
2214044|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2214045|NCT00023881|Bortezomib|bortezomib|mesh-list
2214046|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214047|NCT00023894|Alvocidib|alvocidib|mesh-list
2214048|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214049|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
2214050|NCT00023894|Growth Substances|growth substances|mesh-ancestor
2214051|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214052|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2214053|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075459|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
2075460|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075461|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2075462|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075463|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572861|NCT03653338|Rituximab|rituximab|mesh-list
572862|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
572863|NCT03653338|Fludarabine|fludarabine|mesh-list
572864|NCT03653338|Thiotepa|thiotepa|mesh-list
572865|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
572866|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
572867|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572868|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
572869|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572870|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
572871|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572872|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
572873|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
572874|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
572875|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
572876|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
572877|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572878|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
572879|NCT03653260|Lidocaine|lidocaine|mesh-list
572880|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
572881|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
572882|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
572883|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572884|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
572885|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572886|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
572887|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
572888|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
572889|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
572890|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572905|NCT03653052|Durvalumab|durvalumab|mesh-list
572906|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
572907|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075464|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2075465|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2075466|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
2075467|NCT01999894|Memantine|memantine|mesh-list
2075468|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2075469|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
572914|NCT03653000|Anesthetics|anesthetics|mesh-list
572915|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
2075470|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
572916|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
572917|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572918|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
572919|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572920|NCT03652974|Valproic Acid|valproic acid|mesh-list
572921|NCT03652974|Clozapine|clozapine|mesh-list
572922|NCT03652974|Amisulpride|amisulpride|mesh-list
572923|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
572924|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572925|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572926|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
572927|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572928|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572929|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
572930|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
572931|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
572932|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
572933|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
572934|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
572935|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
572936|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
572937|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
572938|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
572939|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
572940|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
572941|NCT03652961|Abatacept|abatacept|mesh-list
572942|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
572943|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572944|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572945|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
572946|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
572947|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572948|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
572949|NCT03652896|Liver Extracts|liver extracts|mesh-list
572950|NCT03652896|Hematinics|hematinics|mesh-ancestor
572951|NCT03652870|Dexetimide|dexetimide|mesh-list
572952|NCT03652870|Citalopram|citalopram|mesh-list
572953|NCT03652870|Nortriptyline|nortriptyline|mesh-list
572954|NCT03652870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
572955|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
572956|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
572957|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572958|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
572959|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
572960|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
572961|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
572962|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
572963|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
572964|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
572965|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
572966|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
572967|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
572968|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
572969|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
572970|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
572971|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
572972|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
572973|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
572974|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
572975|NCT03652857|Apatinib|apatinib|mesh-list
572976|NCT03652857|Vinorelbine|vinorelbine|mesh-list
572977|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
572978|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
572979|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
572980|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
572981|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
572982|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
572983|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
572984|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
2075471|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075472|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075473|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075474|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2075475|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2075476|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2075477|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
2075478|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2075479|NCT01999920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2075480|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2075481|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2075482|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075483|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075484|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
2075485|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573002|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
573003|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
573004|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
573005|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573006|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
573007|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
573008|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
573009|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
573010|NCT03652753|Expectorants|expectorants|mesh-ancestor
573011|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
573012|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
573013|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
573014|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573015|NCT03652753|Protective Agents|protective agents|mesh-ancestor
573016|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573017|NCT03652753|Antidotes|antidotes|mesh-ancestor
573018|NCT03652714|Anesthetics|anesthetics|mesh-list
573019|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
573020|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
573021|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573022|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
573023|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2214054|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214055|NCT00023907|Paclitaxel|paclitaxel|mesh-list
573027|NCT03652571|Nortriptyline|nortriptyline|mesh-list
573028|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
573029|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
573030|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
573031|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
573032|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
573033|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
573034|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573035|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
573036|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
573037|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573038|NCT03652493|Carboplatin|carboplatin|mesh-list
573039|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573040|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
573041|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
573042|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
573043|NCT03652480|Prednisolone|prednisolone|mesh-list
573044|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
573045|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
573046|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
573047|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
573048|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
573049|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
573050|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573051|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573052|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
573053|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
573054|NCT03652480|Hormones|hormones|mesh-ancestor
573055|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
573056|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
573057|NCT03652480|Protective Agents|protective agents|mesh-ancestor
573058|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
573059|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573060|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
573061|NCT03652467|Deferoxamine|deferoxamine|mesh-list
573062|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
573063|NCT03652467|Estrogens|estrogens|mesh-ancestor
573064|NCT03652467|Hormones|hormones|mesh-ancestor
573065|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
573066|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573067|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
573068|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573069|NCT03652467|Siderophores|siderophores|mesh-ancestor
573070|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
573071|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
573072|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
573073|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573074|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
573075|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
573076|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573077|NCT03652428|Gemcitabine|gemcitabine|mesh-list
573078|NCT03652428|Paclitaxel|paclitaxel|mesh-list
573079|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
573080|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573081|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
573082|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
573083|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
573084|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573085|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
573086|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
573087|NCT03652428|Antiviral Agents|antiviral agents|mesh-ancestor
573088|NCT03652428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
573089|NCT03652428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573090|NCT03652428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
573091|NCT03652428|Immunologic Factors|immunologic factors|mesh-ancestor
573092|NCT03652428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573093|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
573094|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
573095|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
573096|NCT03652376|Benralizumab|benralizumab|mesh-list
573097|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
573098|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
573099|NCT03652233|Nivolumab|nivolumab|mesh-list
573100|NCT03652233|Afatinib|afatinib|mesh-list
573101|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
573102|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573103|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
573104|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573105|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
573106|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573107|NCT03652142|Nivolumab|nivolumab|mesh-list
573108|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
573109|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573110|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
573111|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573112|NCT03652116|Meperidine|meperidine|mesh-list
573113|NCT03652116|Bupivacaine|bupivacaine|mesh-list
573114|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
573115|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
573116|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
573117|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573118|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
573119|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573120|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
573121|NCT03652116|Narcotics|narcotics|mesh-ancestor
573122|NCT03652116|Analgesics|analgesics|mesh-ancestor
573123|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
573124|NCT03652103|Bupivacaine|bupivacaine|mesh-list
573125|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
573126|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
573127|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
573128|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573129|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
573130|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075486|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2075487|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2075488|NCT01999946|Naltrexone|naltrexone|mesh-list
2075489|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2075490|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2075491|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075492|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
2075493|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075494|NCT01999972|Axitinib|axitinib|mesh-list
2075495|NCT01999972|Crizotinib|crizotinib|mesh-list
2075496|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573219|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2075497|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2075498|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075499|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075500|NCT01999985|Dasatinib|dasatinib|mesh-list
2075501|NCT01999985|Afatinib|afatinib|mesh-list
2075502|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075503|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2075504|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573151|NCT03651947|Denosumab|denosumab|mesh-list
573152|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
573153|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573154|NCT03651934|Iron|iron|mesh-list
573155|NCT03651934|Selenium|selenium|mesh-list
573156|NCT03651934|Trace Elements|trace elements|mesh-ancestor
573157|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
573158|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573159|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
573160|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573161|NCT03651934|Protective Agents|protective agents|mesh-ancestor
573162|NCT03651895|Metformin|metformin|mesh-list
573163|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
573164|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573165|NCT03651882|Oxytocin|oxytocin|mesh-list
573166|NCT03651882|Carbetocin|carbetocin|mesh-list
573167|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
573168|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
573169|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573182|NCT03651726|Palmidrol|palmidrol|mesh-list
573183|NCT03651726|Dronabinol|dronabinol|mesh-list
573184|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
573185|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573186|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
573187|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
573188|NCT03651726|Analgesics|analgesics|mesh-ancestor
573189|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
573190|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573191|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
573192|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
573193|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
573194|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573195|NCT03651726|Hormones|hormones|mesh-ancestor
573196|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
573197|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
573198|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
573199|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
573200|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
573201|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
573202|NCT03651674|Olanzapine|olanzapine|mesh-list
573203|NCT03651674|Clozapine|clozapine|mesh-list
573204|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
573205|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
573206|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573207|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573208|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
573209|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
573210|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
573211|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
573212|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
573213|NCT03651674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
573214|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
573215|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
573216|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573217|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
573218|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
573220|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
573221|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
573222|NCT03651661|Insulin|insulin|mesh-list
573223|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
573224|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
573225|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573226|NCT03651557|Salicylates|salicylates|mesh-list
573227|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
573228|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
573229|NCT03651557|Analgesics|analgesics|mesh-ancestor
573230|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
573231|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573232|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573233|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
573234|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
573235|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
573236|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573237|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573238|NCT03651531|Metformin|metformin|mesh-list
573239|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
573240|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573250|NCT03651427|Estradiol|estradiol|mesh-list
573251|NCT03651427|Estrogens|estrogens|mesh-ancestor
573252|NCT03651427|Hormones|hormones|mesh-ancestor
573253|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
573254|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573261|NCT03651219|Irinotecan|irinotecan|mesh-list
573262|NCT03651219|Apatinib|apatinib|mesh-list
573263|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
573264|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
573265|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573266|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573267|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573268|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2750513|NCT04238390|Meropenem|meropenem|mesh-list
2750514|NCT04238390|Tazobactam|tazobactam|mesh-list
2750515|NCT04238390|Ceftolozane|ceftolozane|mesh-list
2750516|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2750517|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2075505|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750518|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2750519|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2075508|NCT02000531|Gemcitabine|gemcitabine|mesh-list
2075509|NCT02000531|Cisplatin|cisplatin|mesh-list
2075510|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2075511|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075512|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2075513|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
2075514|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075515|NCT02000531|Antiviral Agents|antiviral agents|mesh-ancestor
2075516|NCT02000531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075517|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075518|NCT02000531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2075519|NCT02000531|Immunologic Factors|immunologic factors|mesh-ancestor
2075520|NCT02000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075521|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2075522|NCT02000622|Olaparib|olaparib|mesh-list
2075523|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2075524|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075525|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075526|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075527|NCT02000921|Nicotine|nicotine|mesh-list
2075528|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
573300|NCT03651102|Thalidomide|thalidomide|mesh-list
573301|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
573302|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
573303|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573304|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
573305|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
573306|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
573307|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
573308|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
573309|NCT03651102|Growth Substances|growth substances|mesh-ancestor
573310|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
573311|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573312|NCT03651011|Aflibercept|aflibercept|mesh-list
573313|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
573314|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
573315|NCT03651011|Growth Substances|growth substances|mesh-ancestor
573316|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573317|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
573318|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573319|NCT03650998|Ropivacaine|ropivacaine|mesh-list
573320|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
573321|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
573322|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
573323|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573324|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
573325|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573326|NCT03650894|Nivolumab|nivolumab|mesh-list
573327|NCT03650894|Ipilimumab|ipilimumab|mesh-list
573328|NCT03650894|Bicalutamide|bicalutamide|mesh-list
573329|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
573330|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573331|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
573332|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573333|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
573334|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
573335|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
573336|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573337|NCT03650881|Adapalene|adapalene|mesh-list
573338|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
573339|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
573340|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
573341|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
573342|NCT03650881|Analgesics|analgesics|mesh-ancestor
573343|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
573344|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573345|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573346|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
573347|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
573348|NCT03650777|Warfarin|warfarin|mesh-list
573349|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
2075529|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
2075530|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075531|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075532|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
573354|NCT03650738|Paclitaxel|paclitaxel|mesh-list
573355|NCT03650738|Carboplatin|carboplatin|mesh-list
573356|NCT03650738|Apatinib|apatinib|mesh-list
573357|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
573358|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573359|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
573360|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
573361|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
573362|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573363|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
573364|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573365|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
573366|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
573367|NCT03650582|Glucagon|glucagon|mesh-list
573368|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
573369|NCT03650582|Hormones|hormones|mesh-ancestor
573370|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
573371|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573372|NCT03650543|Amoxicillin|amoxicillin|mesh-list
573373|NCT03650543|Clarithromycin|clarithromycin|mesh-list
573374|NCT03650543|Omeprazole|omeprazole|mesh-list
573375|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
573376|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
573377|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
573378|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
573379|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
573380|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573381|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573382|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
573383|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
573384|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2214056|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214057|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214058|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214059|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214060|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214061|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214062|NCT00023920|Cytarabine|cytarabine|mesh-list
2214063|NCT00023920|Bevacizumab|bevacizumab|mesh-list
2214064|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2214065|NCT00023920|Idarubicin|idarubicin|mesh-list
2214066|NCT00023920|Antibodies|antibodies|mesh-list
2214067|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
573397|NCT03650361|Adapalene|adapalene|mesh-list
573398|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
573399|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
573400|NCT03650361|Analgesics|analgesics|mesh-ancestor
573401|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
573402|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573403|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573404|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
573405|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
573406|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
573407|NCT03650348|Atezolizumab|atezolizumab|mesh-list
573408|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573409|NCT03650270|Phenytoin|phenytoin|mesh-list
573410|NCT03650270|Midazolam|midazolam|mesh-list
573411|NCT03650270|Phenobarbital|phenobarbital|mesh-list
573412|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
573413|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
573414|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
573415|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573416|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
573417|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
573418|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
573419|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
573420|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
573421|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
573422|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
573423|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
573424|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
573425|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573426|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
573427|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
573428|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
573429|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
573430|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
573431|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
573432|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
573433|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
573434|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
573435|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
573436|NCT03650257|Temozolomide|temozolomide|mesh-list
573437|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
573438|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
573439|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573440|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075533|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2075534|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
2075535|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075536|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075537|NCT02000973|Lidocaine|lidocaine|mesh-list
2075538|NCT02000973|Bupivacaine|bupivacaine|mesh-list
2214068|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2075539|NCT02000973|Ropivacaine|ropivacaine|mesh-list
2075540|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
573449|NCT03650023|Chitosan|chitosan|mesh-list
573450|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
573451|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
573452|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
573453|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573454|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
573455|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
573456|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
573457|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
573458|NCT03650023|Coagulants|coagulants|mesh-ancestor
573459|NCT03649945|Docetaxel|docetaxel|mesh-list
573460|NCT03649945|Endostar protein|endostar protein|mesh-list
573461|NCT03649945|Nedaplatin|nedaplatin|mesh-list
573462|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573463|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
573464|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
573465|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
573466|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573467|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
573468|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
573469|NCT03649945|Growth Substances|growth substances|mesh-ancestor
573470|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573471|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
573472|NCT03649880|Misonidazole|misonidazole|mesh-list
573473|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573474|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
573475|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
573476|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
573477|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
573478|NCT03649841|Prednisone|prednisone|mesh-list
573479|NCT03649841|Cortisone|cortisone|mesh-list
573480|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
573481|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
573482|NCT03649841|Hormones|hormones|mesh-list
573483|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
573484|NCT03649841|Androgens|androgens|mesh-list
573485|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
573486|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
573487|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
573488|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
573489|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573490|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
573491|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573492|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
573493|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573494|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573495|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
573496|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
573497|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
573498|NCT03649841|Protective Agents|protective agents|mesh-ancestor
573499|NCT03649841|Vitamins|vitamins|mesh-ancestor
573500|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
573501|NCT03649841|Estrogens|estrogens|mesh-ancestor
573502|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
573503|NCT03649802|Vitamin D|vitamin d|mesh-list
573504|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
573505|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
573506|NCT03649802|Vitamins|vitamins|mesh-list
573507|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
573508|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573509|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
573510|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
573511|NCT03649763|Lidocaine|lidocaine|mesh-list
573512|NCT03649763|Bupivacaine|bupivacaine|mesh-list
573513|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
573514|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
573515|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
573516|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573517|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
573518|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573519|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
573520|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
573521|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
573522|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
573523|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075541|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
2214069|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214070|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
573527|NCT03649724|Leuprolide|leuprolide|mesh-list
573528|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
573529|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
573530|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
573531|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573532|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
573533|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573534|NCT03649711|Aspirin|aspirin|mesh-list
573535|NCT03649711|Clopidogrel|clopidogrel|mesh-list
573536|NCT03649711|Ticagrelor|ticagrelor|mesh-list
573537|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
573538|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
573539|NCT03649711|Analgesics|analgesics|mesh-ancestor
573540|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
573541|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573542|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573543|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
573544|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
573545|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
573546|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
573547|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573548|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
573549|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
573550|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573551|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
573552|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
573553|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
573554|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
573555|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
573556|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
573557|NCT03649659|Fluorides|fluorides|mesh-list
573558|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
573559|NCT03649659|Protective Agents|protective agents|mesh-ancestor
573560|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573561|NCT03649633|Vitamins|vitamins|mesh-list
573562|NCT03649633|Ascorbic Acid|ascorbic acid|mesh-list
573563|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
573564|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
573565|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573566|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
573567|NCT03649633|Antioxidants|antioxidants|mesh-ancestor
573568|NCT03649633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573569|NCT03649633|Protective Agents|protective agents|mesh-ancestor
2075542|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2075543|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075544|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
2075545|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075546|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
573575|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
2075547|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2075548|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2075549|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
573581|NCT03649334|Ketorolac|ketorolac|mesh-list
573582|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
573583|NCT03649334|Fentanyl|fentanyl|mesh-list
573584|NCT03649334|Ketamine|ketamine|mesh-list
573585|NCT03649334|Analgesics|analgesics|mesh-ancestor
573586|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
573587|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573588|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573589|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
573590|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
573591|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
573592|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
573593|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
573594|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
573595|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
573596|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
573597|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573598|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
573599|NCT03649334|Narcotics|narcotics|mesh-ancestor
573600|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
573601|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
573602|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
573603|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
573604|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
573605|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
573606|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075550|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075551|NCT02001181|Tofacitinib|tofacitinib|mesh-list
2075552|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2075553|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075554|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750520|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750521|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750522|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2750523|NCT04238390|Renal Agents|renal agents|mesh-ancestor
2750524|NCT04236830|Fluorides|fluorides|mesh-list
2750525|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
2750526|NCT04236830|Protective Agents|protective agents|mesh-ancestor
2075562|NCT02001987|Methotrexate|methotrexate|mesh-list
2075563|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2075564|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
573623|NCT03649269|Bezafibrate|bezafibrate|mesh-list
573624|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
573625|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
573626|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573627|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
573628|NCT03649243|Propolis|propolis|mesh-list
573629|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
573630|NCT03649230|Palonosetron|palonosetron|mesh-list
573631|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
573632|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
573633|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573634|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573635|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
573636|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
573637|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
573638|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
573639|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
573640|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573641|NCT03649165|Acetaminophen|acetaminophen|mesh-list
573642|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
573643|NCT03649165|Analgesics|analgesics|mesh-ancestor
573644|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
573645|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573646|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573647|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
573648|NCT03649152|Proxigermanium|proxigermanium|mesh-list
573649|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573650|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
573651|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
573652|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573653|NCT03649061|Etanercept|etanercept|mesh-list
573654|NCT03649061|Leflunomide|leflunomide|mesh-list
573655|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
573656|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
573657|NCT03649061|Analgesics|analgesics|mesh-ancestor
573658|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
573659|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573660|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573661|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
573662|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
573663|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
573664|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
573665|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
573666|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573667|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573668|NCT03649048|Cisplatin|cisplatin|mesh-list
573669|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573670|NCT03649009|Thiamine|thiamine|mesh-list
573671|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
573672|NCT03649009|Metoclopramide|metoclopramide|mesh-list
573673|NCT03649009|Vitamins|vitamins|mesh-ancestor
573674|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
573675|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573676|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
573677|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
573678|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
573679|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
573680|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573681|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
573682|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
573683|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
573684|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
573685|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
573686|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573687|NCT03648996|Allopurinol|allopurinol|mesh-list
573688|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
573689|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573690|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573691|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
573692|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
573693|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
573694|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
573695|NCT03648996|Protective Agents|protective agents|mesh-ancestor
573696|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573697|NCT03648970|Pravastatin|pravastatin|mesh-list
573698|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
573699|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
573700|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
573701|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573702|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
573703|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
573704|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075565|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2075566|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075567|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2075568|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
2075569|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075570|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075571|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
2075572|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075573|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2075574|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2075575|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
2075576|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2075577|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2075578|NCT02002221|Metformin|metformin|mesh-list
2075579|NCT02002221|Vildagliptin|vildagliptin|mesh-list
2075580|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2075581|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075582|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2075583|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
2075584|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075585|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075586|NCT02002650|Indomethacin|indomethacin|mesh-list
2075587|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2075588|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
573729|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
573730|NCT03648697|Fludarabine|fludarabine|mesh-list
573731|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
573732|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
573733|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573734|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
573735|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
573736|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
573737|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573738|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573739|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
573740|NCT03648684|Caffeine|caffeine|mesh-list
573741|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
573742|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573743|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
573744|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573745|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573746|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
573747|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
573748|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
573749|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
573750|NCT03648671|Rasagiline|rasagiline|mesh-list
573751|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
573752|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573753|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573754|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
573755|NCT03648671|Protective Agents|protective agents|mesh-ancestor
573756|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573757|NCT03648658|Acetaminophen|acetaminophen|mesh-list
573758|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
573759|NCT03648658|Analgesics|analgesics|mesh-ancestor
573760|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
573761|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573762|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573763|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
573764|NCT03648554|Dulaglutide|dulaglutide|mesh-list
573765|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
573766|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573767|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
573768|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
573769|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573770|NCT03648528|Vitamins|vitamins|mesh-ancestor
573771|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
573772|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
573773|NCT03648489|Paclitaxel|paclitaxel|mesh-list
573774|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
573775|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573776|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
573777|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
573778|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
573779|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573780|NCT03648437|Acetaminophen|acetaminophen|mesh-list
573781|NCT03648437|Ibuprofen|ibuprofen|mesh-list
573782|NCT03648437|Indomethacin|indomethacin|mesh-list
573783|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
573784|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
573785|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
573786|NCT03648437|Analgesics|analgesics|mesh-ancestor
573787|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
573788|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573789|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573790|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
573791|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
573792|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
573793|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573794|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573795|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
573796|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
573797|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
573798|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
573803|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
573804|NCT03648333|Niacin|niacin|mesh-list
573805|NCT03648333|Amlodipine|amlodipine|mesh-list
573806|NCT03648333|Valsartan|valsartan|mesh-list
573807|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
573808|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
573809|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
573810|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
573811|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573812|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
573813|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573814|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
573815|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
573816|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
573817|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
573818|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
573819|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
573820|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
573821|NCT03648333|Vitamins|vitamins|mesh-ancestor
573822|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
573823|NCT03648229|Timolol|timolol|mesh-list
573824|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
573825|NCT03648229|Latanoprost|latanoprost|mesh-list
573826|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
573827|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
573828|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
573829|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
573830|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
573831|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573832|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573833|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
573834|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
573835|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
573836|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
573837|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
573838|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
573839|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
573840|NCT03648034|Ropivacaine|ropivacaine|mesh-list
573841|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
573842|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
573843|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
573844|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573845|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
573846|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573854|NCT03648008|Morphine|morphine|mesh-list
573855|NCT03648008|Hydromorphone|hydromorphone|mesh-list
573856|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
573857|NCT03648008|Narcotics|narcotics|mesh-ancestor
573858|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
573859|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573860|NCT03648008|Analgesics|analgesics|mesh-ancestor
573861|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
573862|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573863|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
573864|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
573865|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573866|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573867|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
573868|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
573869|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573870|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
573871|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
573872|NCT03647969|Nivolumab|nivolumab|mesh-list
573873|NCT03647969|Ipilimumab|ipilimumab|mesh-list
573874|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
573875|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573876|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
573877|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573878|NCT03647956|Bevacizumab|bevacizumab|mesh-list
573879|NCT03647956|Carboplatin|carboplatin|mesh-list
573880|NCT03647956|Pemetrexed|pemetrexed|mesh-list
573881|NCT03647956|Atezolizumab|atezolizumab|mesh-list
573882|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
573883|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573884|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
573885|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
573886|NCT03647956|Growth Substances|growth substances|mesh-ancestor
573887|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573888|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
573889|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573890|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573891|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
573892|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
573978|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
573913|NCT03647839|Nivolumab|nivolumab|mesh-list
573914|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
573915|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573916|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
573917|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573918|NCT03647774|Naltrexone|naltrexone|mesh-list
573919|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
573920|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
573921|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573922|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
573923|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2214071|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2214072|NCT00023920|Growth Substances|growth substances|mesh-ancestor
2214073|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214074|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
2214075|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
2214076|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214077|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
573931|NCT03647670|Midazolam|midazolam|mesh-list
573932|NCT03647670|Abrocitinib|abrocitinib|mesh-list
573933|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
573934|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
573935|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
573936|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573937|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
573938|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
573939|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
573940|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
573941|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
573942|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
573943|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
573944|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
573945|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
573946|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573947|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
573948|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573949|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
573950|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
573951|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573952|NCT03647592|Bevacizumab|bevacizumab|mesh-list
573953|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
573954|NCT03647592|Gefitinib|gefitinib|mesh-list
573955|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
573956|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
573957|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
573958|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
573959|NCT03647592|Growth Substances|growth substances|mesh-ancestor
573960|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573961|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
573962|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
573963|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
573964|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573965|NCT03647579|Midazolam|midazolam|mesh-list
573966|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
573967|NCT03647579|Ketamine|ketamine|mesh-list
573968|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
573969|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
573970|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573971|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
573972|NCT03647579|Analgesics|analgesics|mesh-ancestor
573973|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
573974|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
573975|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
573976|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
573977|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
573979|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
573980|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
573981|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
573982|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
573983|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
573984|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
573985|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
573986|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
573987|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
573988|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
573989|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
573990|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
573991|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
573992|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
573993|NCT03647566|Listerine|listerine|mesh-list
573994|NCT03647566|Fluorides|fluorides|mesh-list
573995|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
573996|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
573997|NCT03647566|Protective Agents|protective agents|mesh-ancestor
573998|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
573999|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
574000|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
574001|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
574002|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075589|NCT02002650|Analgesics|analgesics|mesh-ancestor
2075590|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
2075591|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075592|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075593|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2075594|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2075595|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
2075596|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
574011|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
574012|NCT03647423|Cetuximab|cetuximab|mesh-list
574013|NCT03647423|Avelumab|avelumab|mesh-list
574014|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
574015|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
574016|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574017|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
574018|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
574019|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
574020|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574021|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574022|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
574023|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
574024|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
574025|NCT03647280|Epirubicin|epirubicin|mesh-list
574026|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574027|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574028|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
574029|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
574030|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
574031|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075597|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2075598|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2075599|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574035|NCT03647150|Amoxicillin|amoxicillin|mesh-list
574036|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
574037|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
574038|NCT03647124|Lenalidomide|lenalidomide|mesh-list
574039|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
574040|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574041|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
574042|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
574043|NCT03647124|Growth Substances|growth substances|mesh-ancestor
574044|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
574045|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574046|NCT03647111|Crizotinib|crizotinib|mesh-list
574047|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574048|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
574049|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574050|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574051|NCT03647072|Famotidine|famotidine|mesh-list
574052|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
574053|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
574054|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
574055|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
574056|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
574057|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
574058|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574059|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574060|NCT03646994|Crizotinib|crizotinib|mesh-list
574061|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574062|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
574063|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574064|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574065|NCT03646968|Docetaxel|docetaxel|mesh-list
574066|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574067|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
574068|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
574069|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
574070|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574071|NCT03646916|Dexamethasone|dexamethasone|mesh-list
574072|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
574073|NCT03646916|BB 1101|bb 1101|mesh-list
574074|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
574075|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
574076|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
574077|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574078|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574079|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
574080|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
574081|NCT03646916|Hormones|hormones|mesh-ancestor
574082|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
574083|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
574084|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574085|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
574086|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574087|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574088|NCT03646825|Antioxidants|antioxidants|mesh-list
574089|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574090|NCT03646825|Protective Agents|protective agents|mesh-ancestor
574091|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574092|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
574093|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
574094|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574095|NCT03646721|Incretins|incretins|mesh-ancestor
574096|NCT03646721|Hormones|hormones|mesh-ancestor
574097|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
574098|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
574099|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
574100|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574101|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574102|NCT03646617|Nivolumab|nivolumab|mesh-list
574103|NCT03646617|Ipilimumab|ipilimumab|mesh-list
574104|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
574105|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574106|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
574107|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750527|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574114|NCT03646526|Amitriptyline|amitriptyline|mesh-list
574115|NCT03646526|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
574116|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
574117|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
574118|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
574119|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
574120|NCT03646526|Analgesics|analgesics|mesh-ancestor
574121|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
574122|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574123|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574124|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
574125|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
574126|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
574201|NCT03646175|Choline|choline|mesh-list
574127|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574128|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
574129|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
574130|NCT03646526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
574131|NCT03646526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
574132|NCT03646526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
574133|NCT03646500|Remifentanil|remifentanil|mesh-list
574134|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
574135|NCT03646500|Narcotics|narcotics|mesh-ancestor
574136|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
574137|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574138|NCT03646500|Analgesics|analgesics|mesh-ancestor
574139|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
574140|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574141|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
574142|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
574143|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
574144|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574145|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
574146|NCT03646474|Coagulants|coagulants|mesh-ancestor
574153|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
574154|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
574155|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
574156|NCT03646370|Tenofovir|tenofovir|mesh-list
574157|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
574158|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
574159|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
574160|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
574161|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574162|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574163|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
574164|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
574165|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
574166|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
574167|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
574168|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
574169|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574170|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574171|NCT03646318|Ketanserin|ketanserin|mesh-list
574172|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
574173|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
574174|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
574175|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
574176|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
574177|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574178|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574179|NCT03646292|Pioglitazone|pioglitazone|mesh-list
574180|NCT03646292|Empagliflozin|empagliflozin|mesh-list
574181|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
574182|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574183|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
574184|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574185|NCT03646266|Bromides|bromides|mesh-list
574186|NCT03646266|Rocuronium|rocuronium|mesh-list
574187|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
574188|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
574189|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
574190|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
574191|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574192|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574193|NCT03646188|Doxorubicin|doxorubicin|mesh-list
574194|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
574195|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
574196|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574197|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
574198|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
574199|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574200|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574202|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
574203|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
574204|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
574205|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574206|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
574207|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
574208|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
2075600|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075601|NCT02002767|Velpatasvir|velpatasvir|mesh-list
2075602|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
2075603|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075604|NCT02002832|Risperidone|risperidone|mesh-list
2075605|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2075606|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2075607|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
2075608|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075609|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075610|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075611|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2075612|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2075613|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2075614|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2075615|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2075616|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
2075617|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2075618|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2075619|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2075620|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
2075621|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2075622|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2075623|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
2075624|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2075625|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2075626|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2075627|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2075628|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
574238|NCT03646058|Buprenorphine|buprenorphine|mesh-list
574239|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
574240|NCT03646058|Narcotics|narcotics|mesh-ancestor
574241|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
574242|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574243|NCT03646058|Analgesics|analgesics|mesh-ancestor
574244|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
574245|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574246|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
574247|NCT03646006|Bupivacaine|bupivacaine|mesh-list
574248|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
574249|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
574250|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
574251|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574252|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
574253|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574254|NCT03645980|Sorafenib|sorafenib|mesh-list
574255|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574256|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
574257|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574258|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075629|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075630|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
2075631|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075632|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075633|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2075634|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075635|NCT02002975|Pioglitazone|pioglitazone|mesh-list
574266|NCT03645876|Capecitabine|capecitabine|mesh-list
574267|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
574268|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
574269|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
574270|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574271|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214078|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214079|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
2214080|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
574276|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
574277|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
574278|NCT03645668|Meropenem|meropenem|mesh-list
574279|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
574280|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
574281|NCT03645642|Midodrine|midodrine|mesh-list
574282|NCT03645642|Diuretics|diuretics|mesh-list
574283|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
574284|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574285|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
574286|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
574287|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574288|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
574289|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
574290|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
574291|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
574292|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
574293|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
574294|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075636|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2075637|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075638|NCT02003014|Pioglitazone|pioglitazone|mesh-list
2075639|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2075640|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075641|NCT02003365|Triamcinolone|triamcinolone|mesh-list
2075642|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2075643|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2075644|NCT02003365|FX006|fx006|mesh-list
2075645|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2075646|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2075647|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
2075648|NCT02003365|Hormones|hormones|mesh-ancestor
2075649|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
574309|NCT03645408|Exenatide|exenatide|mesh-list
574310|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
574311|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574312|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
574313|NCT03645408|Incretins|incretins|mesh-ancestor
574314|NCT03645408|Hormones|hormones|mesh-ancestor
574315|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
574316|NCT03645304|Ropivacaine|ropivacaine|mesh-list
574317|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
574318|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
574319|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
574320|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574321|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
574322|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574323|NCT03645200|Apatinib|apatinib|mesh-list
574324|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574325|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
574326|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574327|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574328|NCT03645187|Celecoxib|celecoxib|mesh-list
574329|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
574330|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
574331|NCT03645187|Analgesics|analgesics|mesh-ancestor
574332|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
574333|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574334|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574335|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
574336|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
574337|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
574338|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
574339|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574340|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075650|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075651|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2075652|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
2075653|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075654|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574346|NCT03645109|Vitamin D|vitamin d|mesh-list
574347|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
574348|NCT03645109|Vitamins|vitamins|mesh-ancestor
574349|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
574350|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574351|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2075655|NCT02003391|Timolol|timolol|mesh-list
574352|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
574353|NCT03645057|Tacrolimus|tacrolimus|mesh-list
574354|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
574355|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
574356|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574357|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
574358|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574359|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574360|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
574361|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075656|NCT02003391|Travoprost|travoprost|mesh-list
2075657|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2075658|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2075659|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2075660|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2075661|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
574368|NCT03644823|Atezolizumab|atezolizumab|mesh-list
574369|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574370|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
574371|NCT03644706|Diuretics|diuretics|mesh-ancestor
574372|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
574373|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574374|NCT03644706|Expectorants|expectorants|mesh-ancestor
574375|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
574376|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
574377|NCT03644667|Prednisone|prednisone|mesh-list
574378|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
574379|NCT03644667|Tacrolimus|tacrolimus|mesh-list
574380|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
574381|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
574382|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
574383|NCT03644667|Hormones|hormones|mesh-ancestor
574384|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
574385|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574386|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
574387|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574388|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
574389|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
574390|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574391|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574392|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
574393|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
574394|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
574395|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
574396|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
574397|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
574398|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
574399|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574400|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
574401|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
574402|NCT03644667|Protective Agents|protective agents|mesh-ancestor
574403|NCT03644641|Propofol|propofol|mesh-list
574404|NCT03644641|Desflurane|desflurane|mesh-list
574405|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
574406|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
574407|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574408|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
574409|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
574410|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
574411|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
574412|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
574413|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
574414|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
574415|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574416|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
574417|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
574418|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574419|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
574420|NCT03644576|Ephedrine|ephedrine|mesh-list
574421|NCT03644576|Ozanimod|ozanimod|mesh-list
574422|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
574423|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
574424|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574425|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574426|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
574427|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
574428|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
2075662|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
574429|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
574430|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
574431|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
574432|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
574433|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
574434|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574435|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
574436|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
574437|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
2075663|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075664|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075665|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
574441|NCT03644511|Sorafenib|sorafenib|mesh-list
574442|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574443|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
574444|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574445|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075666|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2075667|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2075668|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2075669|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2075670|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2075671|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2075672|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
2075673|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075674|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075675|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075676|NCT02003573|Decitabine|decitabine|mesh-list
2075677|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2075678|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
2075679|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574460|NCT03644446|Bisoprolol|bisoprolol|mesh-list
574461|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
574462|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
574463|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
574464|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574465|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574466|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
574467|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
574468|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
574469|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
574470|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
574471|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574472|NCT03644264|Sevelamer|sevelamer|mesh-list
574473|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
574474|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
574475|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214081|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214082|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214083|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2214084|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214085|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214086|NCT00023933|Antibodies|antibodies|mesh-list
2214087|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2075680|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075681|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075682|NCT02003625|Meloxicam|meloxicam|mesh-list
2075683|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2075684|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2075685|NCT02003625|Analgesics|analgesics|mesh-ancestor
2075686|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
2075687|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075688|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075689|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2075690|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2075691|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2075692|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2075693|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075694|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075695|NCT02003638|Niacin|niacin|mesh-list
2075696|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2075697|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
2214088|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
2075698|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574504|NCT03644147|Acetaminophen|acetaminophen|mesh-list
574505|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
574506|NCT03644147|Analgesics|analgesics|mesh-ancestor
574507|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
574508|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574509|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574510|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
2214089|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214090|NCT00023946|Epothilones|epothilones|mesh-list
2214091|NCT00023946|Epothilone B|epothilone b|mesh-list
2214092|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214093|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214094|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214095|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214096|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214097|NCT00023959|Bevacizumab|bevacizumab|mesh-list
2214098|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2214099|NCT00023959|Fluorouracil|fluorouracil|mesh-list
2214100|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
2214101|NCT00023959|Antibodies|antibodies|mesh-list
2214102|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
2214103|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2214104|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214105|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2214106|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2214107|NCT00023959|Growth Substances|growth substances|mesh-ancestor
2214108|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214109|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
2750533|NCT04233216|Islatravir|islatravir|mesh-list
2750534|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
2750535|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2750536|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750537|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750538|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2750539|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2750540|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2750541|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
2750542|NCT04231708|Yohimbine|yohimbine|mesh-list
2750543|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2214110|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
2214111|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
2214112|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574546|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
574547|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
574548|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574549|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574550|NCT03643900|Indomethacin|indomethacin|mesh-list
574551|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
574552|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
574553|NCT03643900|Analgesics|analgesics|mesh-ancestor
574554|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
574555|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574556|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574557|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
574558|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
574559|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
574560|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
574561|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
574562|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
574563|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574564|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574565|NCT03643874|Albuterol|albuterol|mesh-list
574566|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
574567|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
574568|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574569|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574570|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
574571|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
574572|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
574573|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
574574|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
574575|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
574576|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
574577|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
2750544|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
574578|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
574579|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075699|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2075700|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
2075701|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
2075702|NCT02003638|Vitamins|vitamins|mesh-ancestor
2075703|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
2075704|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075705|NCT02003898|Insulin|insulin|mesh-list
2075706|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2075707|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075708|NCT02003911|Azithromycin|azithromycin|mesh-list
2075709|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2075710|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075711|NCT02004093|Gemcitabine|gemcitabine|mesh-list
2075712|NCT02004093|Paclitaxel|paclitaxel|mesh-list
2075713|NCT02004093|Carboplatin|carboplatin|mesh-list
2075714|NCT02004093|Pertuzumab|pertuzumab|mesh-list
2075715|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2075716|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075717|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
2075718|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
2075719|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
2075720|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075721|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2075722|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
2075723|NCT02004093|Antiviral Agents|antiviral agents|mesh-ancestor
2075724|NCT02004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075725|NCT02004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075726|NCT02004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2075727|NCT02004093|Immunologic Factors|immunologic factors|mesh-ancestor
2075728|NCT02004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075729|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2075730|NCT02004132|Testosterone|testosterone|mesh-list
2075731|NCT02004132|Androgens|androgens|mesh-ancestor
2075732|NCT02004132|Hormones|hormones|mesh-ancestor
2075733|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2075734|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075735|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
2075736|NCT02004262|Pancrelipase|pancrelipase|mesh-list
2075737|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2075738|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
2075739|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075740|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2075741|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2075742|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
2075743|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075744|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075745|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2075746|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2075747|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
2075748|NCT02004366|Linagliptin|linagliptin|mesh-list
2075749|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2075750|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574632|NCT03643757|Bupivacaine|bupivacaine|mesh-list
574633|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
574634|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
574635|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
574636|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574637|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
574638|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075751|NCT02004366|Incretins|incretins|mesh-ancestor
2075752|NCT02004366|Hormones|hormones|mesh-ancestor
574652|NCT03643666|Dexamethasone|dexamethasone|mesh-list
574653|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
574654|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
574655|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
574656|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
574657|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574658|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574659|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
574660|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
574661|NCT03643666|Hormones|hormones|mesh-ancestor
574662|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
574663|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
574664|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574665|NCT03643666|Analgesics|analgesics|mesh-ancestor
574666|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
574667|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
574668|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
574669|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
574670|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
574671|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
574672|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
574673|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574674|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
574675|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
574676|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
574677|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
574678|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
574679|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
574680|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574681|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
574682|NCT03643588|Protective Agents|protective agents|mesh-ancestor
2214113|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214114|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214115|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
2214116|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214117|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2214118|NCT00023972|Gemcitabine|gemcitabine|mesh-list
2214119|NCT00023972|Exatecan|exatecan|mesh-list
2214120|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214121|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
2214122|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214123|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214124|NCT00023972|Antiviral Agents|antiviral agents|mesh-ancestor
2214125|NCT00023972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214126|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214127|NCT00023972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214128|NCT00023972|Immunologic Factors|immunologic factors|mesh-ancestor
2214129|NCT00023972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214130|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
574701|NCT03643549|Bortezomib|bortezomib|mesh-list
574702|NCT03643549|Temozolomide|temozolomide|mesh-list
574703|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574704|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
574705|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
574706|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574707|NCT03643510|Fulvestrant|fulvestrant|mesh-list
574708|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
574709|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574710|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
574711|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
574712|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
574713|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
574714|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574715|NCT03643497|Meropenem|meropenem|mesh-list
574716|NCT03643497|Linezolid|linezolid|mesh-list
574717|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
574718|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
574719|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
574720|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574721|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574722|NCT03643367|Propofol|propofol|mesh-list
574723|NCT03643367|Sevoflurane|sevoflurane|mesh-list
574724|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
574725|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
574726|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574727|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
574728|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
574729|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
574730|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
574731|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
574732|NCT03643276|Cytarabine|cytarabine|mesh-list
574733|NCT03643276|Dexamethasone|dexamethasone|mesh-list
574734|NCT03643276|Prednisone|prednisone|mesh-list
574735|NCT03643276|Prednisolone|prednisolone|mesh-list
574736|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
574737|NCT03643276|Ifosfamide|ifosfamide|mesh-list
574738|NCT03643276|Doxorubicin|doxorubicin|mesh-list
574739|NCT03643276|Methotrexate|methotrexate|mesh-list
574740|NCT03643276|Fludarabine|fludarabine|mesh-list
574741|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
574742|NCT03643276|Etoposide|etoposide|mesh-list
574743|NCT03643276|Vincristine|vincristine|mesh-list
574744|NCT03643276|Bortezomib|bortezomib|mesh-list
574745|NCT03643276|Daunorubicin|daunorubicin|mesh-list
574746|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
574747|NCT03643276|Pegaspargase|pegaspargase|mesh-list
574748|NCT03643276|Blinatumomab|blinatumomab|mesh-list
574749|NCT03643276|Vindesine|vindesine|mesh-list
574750|NCT03643276|Asparaginase|asparaginase|mesh-list
574751|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
574752|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
574753|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574754|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
574755|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
574756|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
574757|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574758|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574759|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
574760|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
574761|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
574762|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
574763|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
574764|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
574765|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
574766|NCT03643276|Hormones|hormones|mesh-ancestor
574767|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
574768|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
574769|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
574770|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
574771|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
574772|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574773|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
574774|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
574775|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
574776|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
574777|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
574778|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
574779|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
574780|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
574781|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
574782|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
574783|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
574784|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
574785|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
574786|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
574787|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
574788|NCT03643198|Metronidazole|metronidazole|mesh-list
574789|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
574790|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
574791|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
574792|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
574793|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
574794|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
574795|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574796|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574797|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574798|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
574799|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2214131|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214132|NCT00023998|Leucovorin|leucovorin|mesh-list
2214133|NCT00023998|Doxorubicin|doxorubicin|mesh-list
2214134|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2214135|NCT00023998|Methotrexate|methotrexate|mesh-list
2214136|NCT00023998|Etoposide|etoposide|mesh-list
2214137|NCT00023998|Trastuzumab|trastuzumab|mesh-list
2214138|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
2214139|NCT00023998|Ifosfamide|ifosfamide|mesh-list
2214140|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
2214141|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214142|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214143|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2214144|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214145|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214146|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214147|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214148|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2214149|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
574818|NCT03643133|Mifamurtide|mifamurtide|mesh-list
574819|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
574820|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
574821|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574822|NCT03643107|Prednisolone|prednisolone|mesh-list
574823|NCT03643107|Irofulven|irofulven|mesh-list
574824|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
574825|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
574826|NCT03643107|Hormones|hormones|mesh-ancestor
574827|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
574828|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574829|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
574830|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574831|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
574832|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
574833|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574834|NCT03642990|Niacinamide|niacinamide|mesh-list
574835|NCT03642990|Niacin|niacin|mesh-list
574836|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
574837|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
574838|NCT03642990|Vitamins|vitamins|mesh-ancestor
574839|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
574840|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574841|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
574842|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
574843|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574844|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
574845|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
2214150|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2214151|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214152|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
2214153|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
2214154|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2214155|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214156|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
2214157|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214158|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2214159|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214160|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2214161|NCT00023998|Antidotes|antidotes|mesh-ancestor
2214162|NCT00023998|Protective Agents|protective agents|mesh-ancestor
2214163|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
2214164|NCT00023998|Vitamins|vitamins|mesh-ancestor
2214165|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
2214166|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214167|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
2214168|NCT00024011|Bortezomib|bortezomib|mesh-list
2214169|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214170|NCT00024050|Cyclosporine|cyclosporine|mesh-list
2214171|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
2214172|NCT00024050|Busulfan|busulfan|mesh-list
2214173|NCT00024050|Methotrexate|methotrexate|mesh-list
2214174|NCT00024050|Cyclosporins|cyclosporins|mesh-list
574871|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
574872|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
574873|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214175|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214176|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
2214177|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214178|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214179|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
574879|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2214180|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
2214181|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574880|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
574881|NCT03642665|Estradiol|estradiol|mesh-list
574882|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
574883|NCT03642665|Progesterone|progesterone|mesh-list
574884|NCT03642665|Estrogens|estrogens|mesh-ancestor
574885|NCT03642665|Hormones|hormones|mesh-ancestor
574886|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
574887|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574888|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
574889|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
574890|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
574891|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
574892|NCT03642665|Progestins|progestins|mesh-ancestor
574893|NCT03642626|Vidarabine|vidarabine|mesh-list
574894|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
574895|NCT03642626|Fludarabine|fludarabine|mesh-list
574896|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
574897|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
574898|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
574899|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574900|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
574901|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
574902|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
574903|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574904|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
574905|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
574906|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
574907|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
574908|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
574909|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
574910|NCT03642600|Folic Acid|folic acid|mesh-list
574911|NCT03642600|Inositol|inositol|mesh-list
574912|NCT03642600|Liraglutide|liraglutide|mesh-list
574913|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
574914|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574915|NCT03642600|Incretins|incretins|mesh-ancestor
574916|NCT03642600|Hormones|hormones|mesh-ancestor
574917|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
574918|NCT03642600|Hematinics|hematinics|mesh-ancestor
574919|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
574920|NCT03642600|Vitamins|vitamins|mesh-ancestor
574921|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
574922|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
574923|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
574924|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
574925|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
574926|NCT03642509|Apixaban|apixaban|mesh-list
574927|NCT03642509|Edoxaban|edoxaban|mesh-list
574928|NCT03642509|Dabigatran|dabigatran|mesh-list
574929|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
574930|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
574931|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
574932|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
574933|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574934|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574935|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
2214182|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214183|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214184|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2214185|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
2214186|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2214187|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214188|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
574943|NCT03642366|Tadalafil|tadalafil|mesh-list
574944|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
574945|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
574946|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
574947|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574948|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574949|NCT03642366|Urological Agents|urological agents|mesh-ancestor
574950|NCT03642353|Listerine|listerine|mesh-list
574951|NCT03642353|Triclosan|triclosan|mesh-list
574952|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
574953|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
574954|NCT03642353|Protective Agents|protective agents|mesh-ancestor
574955|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574956|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
574957|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
574958|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
574959|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
574960|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
574961|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574962|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2214189|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
2214190|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214191|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2075753|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2075754|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2075755|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
2075756|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075757|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574974|NCT03642184|Empagliflozin|empagliflozin|mesh-list
574975|NCT03642184|Linagliptin|linagliptin|mesh-list
574976|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
574977|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
574978|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
574979|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
574980|NCT03642184|Incretins|incretins|mesh-ancestor
574981|NCT03642184|Hormones|hormones|mesh-ancestor
574982|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
574983|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
574984|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
574985|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
574986|NCT03642145|Deflazacort|deflazacort|mesh-list
574987|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
574988|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
574989|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
574990|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575017|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
575018|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
575019|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
575020|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
575021|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
575022|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575023|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
575024|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575025|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575026|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
575027|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575028|NCT03641846|Tadalafil|tadalafil|mesh-list
575029|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
575030|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
575031|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
575032|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575033|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575034|NCT03641846|Urological Agents|urological agents|mesh-ancestor
575041|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
575042|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
575043|NCT03641651|Frovatriptan|frovatriptan|mesh-list
575044|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
575045|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
575046|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575047|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575048|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075760|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
2075761|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2075762|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2075763|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575053|NCT03641547|Capecitabine|capecitabine|mesh-list
575054|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575055|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
575056|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
575057|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214192|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2214193|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
2214194|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214195|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2214196|NCT00024063|Orantinib|orantinib|mesh-list
2214197|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2214198|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214199|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214200|NCT00024089|Gefitinib|gefitinib|mesh-list
2214201|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214202|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2214203|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750545|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
575071|NCT03641456|Dexamethasone|dexamethasone|mesh-list
575072|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
575073|NCT03641456|Lenalidomide|lenalidomide|mesh-list
575074|NCT03641456|Bortezomib|bortezomib|mesh-list
575075|NCT03641456|BB 1101|bb 1101|mesh-list
575076|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
575077|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
575078|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
575079|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575080|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575081|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
575082|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
575083|NCT03641456|Hormones|hormones|mesh-ancestor
575084|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
575085|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
575086|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575087|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
575088|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575089|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575090|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
575091|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
575092|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
575093|NCT03641456|Growth Substances|growth substances|mesh-ancestor
575094|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
575095|NCT03641404|Ergothioneine|ergothioneine|mesh-list
575096|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
575097|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575098|NCT03641404|Protective Agents|protective agents|mesh-ancestor
575099|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575100|NCT03641326|Sunitinib|sunitinib|mesh-list
575101|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575102|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
575103|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
575104|NCT03641326|Growth Substances|growth substances|mesh-ancestor
575105|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575106|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
575107|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
575108|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575109|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575110|NCT03641313|Irinotecan|irinotecan|mesh-list
575111|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
575112|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
575113|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575114|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575115|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575116|NCT03641209|Acetaminophen|acetaminophen|mesh-list
575117|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
575118|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
575119|NCT03641209|Analgesics|analgesics|mesh-ancestor
575120|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
575121|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575122|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575123|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
575124|NCT03641053|Iodine|iodine|mesh-list
575125|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
575126|NCT03641053|Povidone|povidone|mesh-list
575127|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
575128|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575129|NCT03641053|Trace Elements|trace elements|mesh-ancestor
575130|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
575131|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575132|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
575133|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
575134|NCT03641001|Micronutrients|micronutrients|mesh-list
575135|NCT03641001|Trace Elements|trace elements|mesh-list
575136|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075764|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2075765|NCT02004613|Analgesics|analgesics|mesh-ancestor
2075766|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
2075767|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575160|NCT03640728|Tenofovir|tenofovir|mesh-list
575161|NCT03640728|Entecavir|entecavir|mesh-list
575162|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
575163|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575164|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
575165|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
575166|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575167|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575168|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
575169|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
575170|NCT03640650|Triamcinolone|triamcinolone|mesh-list
575171|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
575172|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
575173|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
575174|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
575175|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
575176|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
575177|NCT03640650|Hormones|hormones|mesh-ancestor
575178|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
575179|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575180|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
575181|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
575182|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575183|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575184|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2214204|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214205|NCT00024115|Antibodies|antibodies|mesh-list
2214206|NCT00024115|Immunotoxins|immunotoxins|mesh-list
575189|NCT03640468|Lidocaine|lidocaine|mesh-list
575190|NCT03640468|Midazolam|midazolam|mesh-list
575191|NCT03640468|Ketamine|ketamine|mesh-list
575192|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
575193|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
575194|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575195|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575196|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
575197|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575198|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
575199|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
575200|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
575201|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
575202|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575203|NCT03640468|Analgesics|analgesics|mesh-ancestor
575204|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
575205|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
575206|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
575207|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
575208|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
575209|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575210|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
575211|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
575212|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
575213|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
575214|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
575215|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
575216|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
575217|NCT03640403|Artesunate|artesunate|mesh-list
575218|NCT03640403|Piperaquine|piperaquine|mesh-list
575219|NCT03640403|Amodiaquine|amodiaquine|mesh-list
575220|NCT03640403|Artenimol|artenimol|mesh-list
575221|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
575222|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
575223|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
575224|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575225|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575226|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
575227|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
575228|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
575229|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
575230|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
575231|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
575232|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
575233|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575234|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575235|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
575236|NCT03640390|Analgesics|analgesics|mesh-ancestor
575237|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
575238|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575239|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
575240|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
575241|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
575242|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
575243|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575244|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575245|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
575246|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
575247|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
575248|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
575249|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
575250|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
575251|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
575252|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
575253|NCT03640377|Praziquantel|praziquantel|mesh-list
575254|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
575255|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
575256|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575257|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
575258|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
575259|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
575260|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
575261|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
575262|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575263|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
575264|NCT03640351|Protective Agents|protective agents|mesh-ancestor
575265|NCT03640312|Candesartan|candesartan|mesh-list
575266|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
575267|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
575268|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
575269|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575270|NCT03640273|Loratadine|loratadine|mesh-list
575271|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
575272|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
575273|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
575274|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
575275|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
575276|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
575277|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
575278|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575279|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575280|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575281|NCT03640247|Acetaminophen|acetaminophen|mesh-list
575282|NCT03640247|Ibuprofen|ibuprofen|mesh-list
575283|NCT03640247|Oxycodone|oxycodone|mesh-list
575284|NCT03640247|Tramadol|tramadol|mesh-list
575285|NCT03640247|Hydrocodone|hydrocodone|mesh-list
575286|NCT03640247|Narcotics|narcotics|mesh-list
575287|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
575288|NCT03640247|Analgesics|analgesics|mesh-ancestor
575289|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
575290|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575291|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575292|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
575293|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
575294|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
575295|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
575296|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
575297|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575298|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575299|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
575300|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575301|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
575302|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
575303|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
575304|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
575305|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
575306|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
575307|NCT03640221|Diuretics|diuretics|mesh-ancestor
575308|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
575309|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575310|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
575311|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
575312|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575313|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
575314|NCT03640156|Oxytocin|oxytocin|mesh-list
575315|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
575316|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
575317|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575318|NCT03640026|Tacrolimus|tacrolimus|mesh-list
575319|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
575320|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
575321|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575322|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
575323|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575324|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575334|NCT03639935|Nivolumab|nivolumab|mesh-list
575335|NCT03639935|Rucaparib|rucaparib|mesh-list
575336|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
575337|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575338|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
575339|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575340|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
575341|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575342|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
575343|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575344|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
575345|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575346|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575347|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
575348|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
575349|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575350|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575351|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
575352|NCT03639896|Analgesics|analgesics|mesh-ancestor
575353|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
575354|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575355|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
575356|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
575357|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
575358|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
575359|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575360|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214207|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
2214208|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214209|NCT00024128|Cyclosporine|cyclosporine|mesh-list
2214210|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
2214211|NCT00024128|Cyclosporins|cyclosporins|mesh-list
2214212|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2214213|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214214|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
2214215|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214216|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214217|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214218|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
2214219|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214220|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214221|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214222|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214223|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
2214224|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214225|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
2214226|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2214227|NCT00024141|Fluorouracil|fluorouracil|mesh-list
575382|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
575383|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
575384|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575385|NCT03639727|Mannitol|mannitol|mesh-list
575386|NCT03639727|Citric Acid|citric acid|mesh-list
575387|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
575388|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
575389|NCT03639727|Diuretics|diuretics|mesh-ancestor
575390|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
575391|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575392|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
575393|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
575394|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
575395|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
575396|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575397|NCT03639714|Nivolumab|nivolumab|mesh-list
575398|NCT03639714|Ipilimumab|ipilimumab|mesh-list
575399|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
575400|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575401|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
575402|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214228|NCT00024141|Irinotecan|irinotecan|mesh-list
2214229|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
2214230|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214231|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214232|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214233|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214234|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
2075768|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2214235|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075769|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2075770|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2075771|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
2075772|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075773|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075774|NCT02004886|Metformin|metformin|mesh-list
2075775|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2075776|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075777|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
2075778|NCT02004990|Povidone|povidone|mesh-list
2075779|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
2075780|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
2075781|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2075782|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075783|NCT02005029|Erythromycin|erythromycin|mesh-list
2075784|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
2075785|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
575429|NCT03639571|Ibuprofen|ibuprofen|mesh-list
575430|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
575431|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
575432|NCT03639571|Analgesics|analgesics|mesh-ancestor
575433|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
575434|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575435|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575436|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
575437|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
575438|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
575439|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575440|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575441|NCT03639558|Promethazine|promethazine|mesh-list
575442|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
575443|NCT03639558|Haloperidol|haloperidol|mesh-list
575444|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
575445|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
575446|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
575447|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
575448|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575449|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575450|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
575451|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
575452|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
575453|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575454|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
575455|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
575456|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
575457|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575458|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575459|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
575460|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
575461|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
575462|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
575463|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
575464|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
575465|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
575466|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
575467|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
575468|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
575469|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
575470|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
575471|NCT03639545|Metformin|metformin|mesh-list
575472|NCT03639545|Empagliflozin|empagliflozin|mesh-list
575473|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
575474|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575475|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
575476|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575477|NCT03639532|Tacrine|tacrine|mesh-list
575478|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
575479|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575480|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575481|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
575482|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575483|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575484|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
575485|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
575486|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075786|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
575487|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
575488|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
575489|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
575490|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575491|NCT03639519|Protective Agents|protective agents|mesh-ancestor
575492|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575493|NCT03639519|Vitamins|vitamins|mesh-ancestor
575494|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
575495|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
575496|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
575497|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
575498|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
575499|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
575500|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575501|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
575502|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
575503|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575504|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
575505|NCT03639480|Amlodipine|amlodipine|mesh-list
575506|NCT03639480|Valsartan|valsartan|mesh-list
575507|NCT03639480|Atorvastatin|atorvastatin|mesh-list
575508|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
575509|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
575510|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
575511|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575512|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
575513|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
575514|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575515|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
575516|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
575517|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
575518|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
575519|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575520|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
575521|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
575522|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
575523|NCT03639467|Gemcitabine|gemcitabine|mesh-list
575524|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575525|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
575526|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
575527|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575528|NCT03639467|Antiviral Agents|antiviral agents|mesh-ancestor
575529|NCT03639467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575530|NCT03639467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575531|NCT03639467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
575532|NCT03639467|Immunologic Factors|immunologic factors|mesh-ancestor
575533|NCT03639467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575534|NCT03639428|Midazolam|midazolam|mesh-list
575535|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
575536|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
575537|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575538|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575539|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
575540|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
575541|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
575542|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
575543|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
575544|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
575545|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
575546|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
575547|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575548|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575549|NCT03639415|Oxycodone|oxycodone|mesh-list
575550|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
575551|NCT03639415|Narcotics|narcotics|mesh-ancestor
575552|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575553|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575554|NCT03639415|Analgesics|analgesics|mesh-ancestor
575555|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
575556|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575557|NCT03639389|Morphine|morphine|mesh-list
575558|NCT03639389|Analgesics|analgesics|mesh-list
575559|NCT03639389|Bupivacaine|bupivacaine|mesh-list
575560|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
575561|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
575562|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575563|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575564|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
575565|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575566|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
575567|NCT03639389|Narcotics|narcotics|mesh-ancestor
575568|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
575569|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
575570|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
575571|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575572|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
575573|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
575574|NCT03639246|Paclitaxel|paclitaxel|mesh-list
575575|NCT03639246|Doxorubicin|doxorubicin|mesh-list
575576|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
575577|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
575578|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575579|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
575580|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
575581|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
575582|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575583|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
575584|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
575585|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
575586|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575587|NCT03639168|Cisplatin|cisplatin|mesh-list
575588|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575589|NCT03639155|Glycine|glycine|mesh-list
575590|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
575591|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575592|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575593|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575594|NCT03638999|Ketorolac|ketorolac|mesh-list
575595|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
575596|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
575597|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
575598|NCT03638999|Analgesics|analgesics|mesh-ancestor
575599|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
575600|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575601|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575602|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
575603|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
575604|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
575605|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575606|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575607|NCT03638960|Bupivacaine|bupivacaine|mesh-list
575608|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
575609|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
575610|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575611|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575612|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
575613|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575614|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
575615|NCT03638947|Povidone|povidone|mesh-list
575616|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
575617|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
575618|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
575619|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214236|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2214237|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214238|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214239|NCT00024154|Trastuzumab|trastuzumab|mesh-list
2214240|NCT00024154|Gefitinib|gefitinib|mesh-list
2214241|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2214242|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214243|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2214244|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214245|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214246|NCT00024180|Romidepsin|romidepsin|mesh-list
2214247|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214248|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214249|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
575634|NCT03638869|Methadone|methadone|mesh-list
575635|NCT03638869|D-methadone|d-methadone|mesh-list
575636|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
575637|NCT03638869|Narcotics|narcotics|mesh-ancestor
575715|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
2214250|NCT00024193|Melphalan|melphalan|mesh-list
2214251|NCT00024193|Busulfan|busulfan|mesh-list
575638|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575639|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575640|NCT03638869|Analgesics|analgesics|mesh-ancestor
575641|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
575642|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575643|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
575644|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
575645|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
575646|NCT03638856|Misoprostol|misoprostol|mesh-list
575647|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
575648|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
575649|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
575650|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575651|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
575652|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
575653|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
575654|NCT03638726|Atropine|atropine|mesh-list
575655|NCT03638726|Phenylephrine|phenylephrine|mesh-list
575656|NCT03638726|Epinephrine|epinephrine|mesh-list
575657|NCT03638726|Racepinephrine|racepinephrine|mesh-list
575658|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
575659|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
575660|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
575661|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
575662|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
575663|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
575664|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575665|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575666|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575667|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
575668|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
575669|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
575670|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575671|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
575672|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
575673|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
575674|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
575675|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
575676|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
575677|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
575678|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
575679|NCT03638726|Protective Agents|protective agents|mesh-ancestor
575680|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
575681|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
575682|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
575683|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
575684|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
575685|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
575686|NCT03638648|Capecitabine|capecitabine|mesh-list
575687|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
575688|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
575689|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575690|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214252|NCT00024193|Doxorubicin|doxorubicin|mesh-list
2214253|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2214254|NCT00024193|Etoposide|etoposide|mesh-list
2214255|NCT00024193|Vincristine|vincristine|mesh-list
2214256|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214257|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
2214258|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214259|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214260|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214261|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
575701|NCT03638440|Naloxegol|naloxegol|mesh-list
575702|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
575703|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575704|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
575705|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575706|NCT03638401|Morphine|morphine|mesh-list
575707|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
575708|NCT03638401|Narcotics|narcotics|mesh-ancestor
575709|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575710|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575711|NCT03638401|Analgesics|analgesics|mesh-ancestor
575712|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
575713|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575714|NCT03638375|Interferons|interferons|mesh-list
575716|NCT03638375|Nivolumab|nivolumab|mesh-list
575717|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
575718|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575719|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
575720|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575721|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
575722|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575723|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
575724|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575725|NCT03638310|Gentamicins|gentamicins|mesh-list
575726|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
575727|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575728|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
575729|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575730|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575731|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
575732|NCT03638297|Antibodies|antibodies|mesh-list
575733|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
575734|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575735|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575736|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575737|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
575738|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
575739|NCT03638297|Analgesics|analgesics|mesh-ancestor
575740|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
575741|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575742|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
575743|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
575744|NCT03638141|Durvalumab|durvalumab|mesh-list
575745|NCT03638141|Ipilimumab|ipilimumab|mesh-list
575746|NCT03638141|Tremelimumab|tremelimumab|mesh-list
575747|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
575748|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
575749|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575750|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
575751|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575752|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
575753|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750546|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2750547|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750548|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
575757|NCT03638076|Ritonavir|ritonavir|mesh-list
575758|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
575759|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
575760|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
575761|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575762|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575763|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
575764|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
575765|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
575766|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575767|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
575768|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
575769|NCT03638063|Adenosine|adenosine|mesh-list
575770|NCT03638063|Capsaicin|capsaicin|mesh-list
575771|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
575772|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
575773|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
575774|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575775|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575776|NCT03638063|Analgesics|analgesics|mesh-ancestor
575777|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
575778|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
575779|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
575780|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
575781|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
575782|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575783|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575784|NCT03638037|Vitamin D|vitamin d|mesh-list
575785|NCT03638037|Vitamins|vitamins|mesh-ancestor
575786|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
575787|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575788|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
575789|NCT03637972|Nicotine|nicotine|mesh-list
575790|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
575791|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
575792|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575793|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575794|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
575795|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
575796|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
575797|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575798|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575799|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
575800|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
575801|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575802|NCT03637790|Rifampin|rifampin|mesh-list
575803|NCT03637790|Abrocitinib|abrocitinib|mesh-list
575804|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
575805|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
575806|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
575807|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575808|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
575809|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
575810|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575811|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575812|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
575813|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
575814|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
575815|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
575816|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
575817|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
575818|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2075787|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2075788|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075789|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2075790|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2075791|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075792|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575827|NCT03637582|Lidocaine|lidocaine|mesh-list
575828|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
575829|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
575830|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575831|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575832|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
575833|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575834|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
575835|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
575836|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
575837|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
575838|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575844|NCT03637543|Nivolumab|nivolumab|mesh-list
575845|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
575846|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575847|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
575848|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575856|NCT03637400|Doxycycline|doxycycline|mesh-list
575857|NCT03637400|Trimethoprim|trimethoprim|mesh-list
575858|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
575859|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
575860|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575861|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
575862|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
575863|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
575864|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
575865|NCT03637400|Renal Agents|renal agents|mesh-ancestor
575866|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
575867|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575868|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575869|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
575870|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
575871|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
575872|NCT03637361|Methadone|methadone|mesh-list
575873|NCT03637361|D-methadone|d-methadone|mesh-list
575874|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
575875|NCT03637361|Narcotics|narcotics|mesh-ancestor
575876|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575877|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575878|NCT03637361|Analgesics|analgesics|mesh-ancestor
575879|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
575880|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575881|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
575882|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
575883|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
575884|NCT03637335|Carboplatin|carboplatin|mesh-list
575885|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575886|NCT03637283|Bevacizumab|bevacizumab|mesh-list
575887|NCT03637283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
575888|NCT03637283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575889|NCT03637283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
575890|NCT03637283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
575891|NCT03637283|Growth Substances|growth substances|mesh-ancestor
575892|NCT03637283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575893|NCT03637283|Growth Inhibitors|growth inhibitors|mesh-ancestor
575894|NCT03637075|Insulin|insulin|mesh-list
575895|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
575896|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575897|NCT03637062|Progesterone|progesterone|mesh-list
575898|NCT03637062|Progestins|progestins|mesh-ancestor
575899|NCT03637062|Hormones|hormones|mesh-ancestor
575900|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
575901|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575902|NCT03637049|Midazolam|midazolam|mesh-list
575903|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
575904|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
575905|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575906|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575907|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
575908|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
575909|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
575910|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
575911|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
575912|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
575913|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
575914|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
575915|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
575916|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575917|NCT03636971|Mannitol|mannitol|mesh-list
575918|NCT03636971|Sorbitol|sorbitol|mesh-list
575919|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
575920|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
575921|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
575922|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575923|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
575924|NCT03636971|Protective Agents|protective agents|mesh-ancestor
575925|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
575926|NCT03636971|Diuretics|diuretics|mesh-ancestor
575927|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
575928|NCT03636971|Cathartics|cathartics|mesh-ancestor
575929|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
575930|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
575931|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
575932|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
575933|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
575934|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575935|NCT03636932|Expectorants|expectorants|mesh-ancestor
575936|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
575937|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
575938|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
575939|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575940|NCT03636932|Protective Agents|protective agents|mesh-ancestor
575941|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575942|NCT03636932|Antidotes|antidotes|mesh-ancestor
575943|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
575944|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575945|NCT03636685|Paclitaxel|paclitaxel|mesh-list
575946|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
575947|NCT03636685|Carboplatin|carboplatin|mesh-list
575948|NCT03636685|Pemetrexed|pemetrexed|mesh-list
575949|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
575950|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575951|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
575952|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
575953|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
575954|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575955|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
575956|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
575957|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
575958|NCT03636659|Amphotericin B|amphotericin b|mesh-list
575959|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
575960|NCT03636659|Amebicides|amebicides|mesh-ancestor
575961|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
575962|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
575963|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
575964|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
575965|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
575966|NCT03636555|Oxytocin|oxytocin|mesh-list
575967|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
575968|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
575969|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575970|NCT03636542|Bupivacaine|bupivacaine|mesh-list
575971|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
575972|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
575973|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
575974|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575975|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
575976|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
575977|NCT03636503|Rituximab|rituximab|mesh-list
575978|NCT03636503|Avelumab|avelumab|mesh-list
575979|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
575980|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575981|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
575982|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575983|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
575984|NCT03636477|Nivolumab|nivolumab|mesh-list
575985|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
575986|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
575987|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
575988|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
575989|NCT03636373|Triamcinolone|triamcinolone|mesh-list
575990|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
575991|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
575992|NCT03636373|Etanercept|etanercept|mesh-list
575993|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
575994|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
575995|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
575996|NCT03636373|Hormones|hormones|mesh-ancestor
575997|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
575998|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
575999|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
576000|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
576001|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576002|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576003|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
576004|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
576005|NCT03636373|Analgesics|analgesics|mesh-ancestor
576006|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
576007|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576008|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
576009|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
576010|NCT03636308|Gemcitabine|gemcitabine|mesh-list
576011|NCT03636308|Paclitaxel|paclitaxel|mesh-list
576012|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
576013|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
576014|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576015|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
576016|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
576017|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
576018|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576019|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
576020|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
576021|NCT03636308|Antiviral Agents|antiviral agents|mesh-ancestor
576022|NCT03636308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
576023|NCT03636308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576024|NCT03636308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
576025|NCT03636308|Immunologic Factors|immunologic factors|mesh-ancestor
576026|NCT03636308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075793|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
2075794|NCT02005354|Anesthetics|anesthetics|mesh-list
2075795|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
2075796|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2075797|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075798|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
2075799|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075800|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
576035|NCT03636178|Daminozide|daminozide|mesh-list
576036|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
576037|NCT03636178|Growth Substances|growth substances|mesh-ancestor
576038|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075801|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
2075802|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2075803|NCT02005354|Analgesics|analgesics|mesh-ancestor
2075804|NCT02005471|Rituximab|rituximab|mesh-list
2075805|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2075806|NCT02005471|Venetoclax|venetoclax|mesh-list
2075807|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2075808|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075809|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
2075810|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075811|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2075812|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2075813|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
2075814|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075815|NCT02005484|Trastuzumab|trastuzumab|mesh-list
2075816|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2075817|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075818|NCT02005549|Bevacizumab|bevacizumab|mesh-list
2075819|NCT02005549|Docetaxel|docetaxel|mesh-list
2075820|NCT02005549|Capecitabine|capecitabine|mesh-list
2075821|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2075822|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075823|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2075824|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
576064|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
576065|NCT03636152|Chloroquine|chloroquine|mesh-list
576066|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
576067|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
576068|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
576069|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
576070|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576071|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576072|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
576073|NCT03636152|Amebicides|amebicides|mesh-ancestor
576074|NCT03636048|Bupivacaine|bupivacaine|mesh-list
576075|NCT03636048|Anesthetics|anesthetics|mesh-list
576076|NCT03636048|Propofol|propofol|mesh-list
576077|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
576078|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576079|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576080|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
576081|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576082|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
576083|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
576084|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
576085|NCT03635996|Etripamil|etripamil|mesh-list
576086|NCT03635996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
576087|NCT03635996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
576088|NCT03635996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576089|NCT03635996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
576090|NCT03635996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576170|NCT03635749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2214262|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214263|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214264|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214265|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214266|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2214267|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214268|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214269|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214270|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214271|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214272|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214273|NCT00024206|Orantinib|orantinib|mesh-list
2214274|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2214275|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214276|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214277|NCT00024232|Antibodies|antibodies|mesh-list
2214278|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2214279|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
2214280|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214281|NCT00024245|Probenecid|probenecid|mesh-list
576117|NCT03635931|Mitogens|mitogens|mesh-list
576118|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
576119|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576120|NCT03635905|Gabapentin|gabapentin|mesh-list
576121|NCT03635905|Analgesics|analgesics|mesh-ancestor
576122|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
576123|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576124|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576125|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
576126|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
576127|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
576128|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576129|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
576130|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
576131|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
576132|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576133|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576134|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
576135|NCT03635892|Nivolumab|nivolumab|mesh-list
576136|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
576137|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576138|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
576139|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576140|NCT03635827|Xenon|xenon|mesh-list
576141|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
576142|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
576143|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
576144|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576145|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075825|NCT02005549|Growth Substances|growth substances|mesh-ancestor
2075826|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075827|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
2075828|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
2075829|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
2075830|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
2075831|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075832|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2075833|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
2075834|NCT02005562|Cyclosporine|cyclosporine|mesh-list
2075835|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
2075836|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
576158|NCT03635749|Aspirin|aspirin|mesh-list
576159|NCT03635749|Atorvastatin|atorvastatin|mesh-list
576160|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
576161|NCT03635749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
576162|NCT03635749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
576163|NCT03635749|Analgesics|analgesics|mesh-ancestor
576164|NCT03635749|Sensory System Agents|sensory system agents|mesh-ancestor
576165|NCT03635749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576166|NCT03635749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576167|NCT03635749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
576168|NCT03635749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
576169|NCT03635749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
576171|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576172|NCT03635749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
576173|NCT03635749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
576174|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576175|NCT03635749|Antipyretics|antipyretics|mesh-ancestor
576176|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
576177|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
576178|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
576179|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
576180|NCT03635684|Acetaminophen|acetaminophen|mesh-list
576181|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
576182|NCT03635684|Analgesics|analgesics|mesh-ancestor
576183|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
576184|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576185|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576186|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
2075837|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2075838|NCT02005562|Cyclosporins|cyclosporins|mesh-list
2075839|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075840|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075841|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2075842|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
2075843|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075844|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
2075845|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075846|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
2075847|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
576198|NCT03635567|Paclitaxel|paclitaxel|mesh-list
576199|NCT03635567|Bevacizumab|bevacizumab|mesh-list
576200|NCT03635567|Carboplatin|carboplatin|mesh-list
576201|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
576202|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
576203|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576204|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
576205|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
576206|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
576207|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576208|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
576209|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
576210|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
576211|NCT03635567|Growth Substances|growth substances|mesh-ancestor
576212|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576213|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
2075848|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2075849|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2075850|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075851|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2075852|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
2075853|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2075854|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2075855|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
2075856|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
2075857|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075858|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2075859|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
2075860|NCT02005562|Hormones|hormones|mesh-ancestor
2075861|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2075862|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
576229|NCT03635437|Alprazolam|alprazolam|mesh-list
576230|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
576231|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
576232|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576233|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576234|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
576235|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
576236|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
576237|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
576238|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
576239|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576240|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576241|NCT03635411|Niacinamide|niacinamide|mesh-list
576242|NCT03635411|Niacin|niacin|mesh-list
576243|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
576244|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
576245|NCT03635411|Vitamins|vitamins|mesh-ancestor
576246|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
576769|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
576247|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576248|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
576249|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
576250|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576251|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
576252|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
576253|NCT03635398|Midazolam|midazolam|mesh-list
576254|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
576255|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
576256|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576257|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576258|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
576259|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
576260|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
576261|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
576262|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
576263|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
576264|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
576265|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
576266|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576267|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576268|NCT03635372|Sucralfate|sucralfate|mesh-list
576269|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
576270|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
576271|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
576272|NCT03635372|Antacids|antacids|mesh-ancestor
576273|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576274|NCT03635333|Nicotine|nicotine|mesh-list
576275|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
576276|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
576277|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576278|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576279|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
576280|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
576281|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
576282|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576283|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576287|NCT03635125|Metoprolol|metoprolol|mesh-list
576288|NCT03635125|Nebivolol|nebivolol|mesh-list
576289|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
576290|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
576291|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
576292|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
576293|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576294|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576295|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
576296|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
576297|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
576298|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
576299|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576300|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576301|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
576302|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
576303|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
576304|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
576305|NCT03635021|Bevacizumab|bevacizumab|mesh-list
576306|NCT03635021|Panitumumab|panitumumab|mesh-list
576307|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
576308|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576309|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
576310|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
576311|NCT03635021|Growth Substances|growth substances|mesh-ancestor
576312|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576313|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
576314|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
576315|NCT03634917|Acamprosate|acamprosate|mesh-list
576316|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
576317|NCT03634917|Calcium|calcium|mesh-list
576318|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
576319|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576320|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
576321|NCT03634917|Antacids|antacids|mesh-ancestor
576322|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576323|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
576324|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
576325|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
576326|NCT03634852|Dexamethasone|dexamethasone|mesh-list
576327|NCT03634852|Triamcinolone|triamcinolone|mesh-list
576328|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
576329|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
576330|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
576331|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
576332|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
576333|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
576334|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
576335|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
576336|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576337|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576338|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
576339|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
576340|NCT03634852|Hormones|hormones|mesh-ancestor
576341|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
576342|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
576343|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576344|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
576345|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
576346|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
576347|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
576348|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576349|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576350|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
576351|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
576352|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
576353|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
576354|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
576355|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
576356|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
576357|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
576358|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
576359|NCT03634839|Nicotine|nicotine|mesh-list
576360|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
576361|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
576362|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576363|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576364|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
576365|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
576366|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
576367|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576368|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214282|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
2214283|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
2214284|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214285|NCT00024245|Renal Agents|renal agents|mesh-ancestor
2214286|NCT00024271|Gemcitabine|gemcitabine|mesh-list
576374|NCT03634735|Thiamine|thiamine|mesh-list
576375|NCT03634735|Vitamins|vitamins|mesh-ancestor
576376|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
576377|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576378|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
576379|NCT03634605|Tetracycline|tetracycline|mesh-list
576380|NCT03634605|Lidocaine|lidocaine|mesh-list
576381|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
576382|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
576383|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576384|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576385|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
576386|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576387|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
576388|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
576389|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
576390|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
576391|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576392|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
576393|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
576394|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
576395|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576396|NCT03634514|Hormones|hormones|mesh-list
576919|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2214287|NCT00024271|Interferons|interferons|mesh-list
576397|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
576398|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750549|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2750550|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2750551|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
2750552|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2750553|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750554|NCT04231708|Urological Agents|urological agents|mesh-ancestor
576405|NCT03634345|Fluconazole|fluconazole|mesh-list
576406|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
576407|NCT03634345|Abrocitinib|abrocitinib|mesh-list
576408|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
576409|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
576410|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
576411|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
576412|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576413|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576414|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
576415|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
576416|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
576417|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576418|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
576419|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
576420|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
576421|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
576422|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576423|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
576424|NCT03634345|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
576425|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
576426|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
576427|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576428|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
576429|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
576430|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
576431|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
576432|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
576433|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
576434|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
576435|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075863|NCT02005562|Protective Agents|protective agents|mesh-ancestor
2075864|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2075865|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2075866|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2075867|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2075868|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2075869|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075870|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075871|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075872|NCT02005601|Analgesics|analgesics|mesh-ancestor
2075873|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
2075874|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075875|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
2075876|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
576450|NCT03634202|Capecitabine|capecitabine|mesh-list
576451|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
576452|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
576453|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576454|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576455|NCT03634189|Cannabidiol|cannabidiol|mesh-list
576456|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
2075877|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
2075878|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
2075879|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075880|NCT02005666|Clindamycin|clindamycin|mesh-list
2075881|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
2075882|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
2075883|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
576464|NCT03634137|Afamelanotide|afamelanotide|mesh-list
576465|NCT03634137|alpha-MSH|alpha-msh|mesh-list
576466|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
576467|NCT03634137|Hormones|hormones|mesh-ancestor
576468|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
576469|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576470|NCT03634111|Morphine|morphine|mesh-list
576471|NCT03634111|Ropivacaine|ropivacaine|mesh-list
576472|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
576473|NCT03634111|Narcotics|narcotics|mesh-ancestor
576474|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576475|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576476|NCT03634111|Analgesics|analgesics|mesh-ancestor
576477|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
576478|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576479|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
576480|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
576481|NCT03634059|Apatinib|apatinib|mesh-list
576482|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576483|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
576484|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576485|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576486|NCT03634020|Sirolimus|sirolimus|mesh-list
576487|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
576488|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
576489|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
576490|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576491|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
576492|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
576493|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
576494|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576495|NCT03633994|Heparin|heparin|mesh-list
576496|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
576497|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
576498|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
576499|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576500|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
576501|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
576502|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
576503|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576504|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576505|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576506|NCT03633747|Propranolol|propranolol|mesh-list
576507|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
576508|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
576509|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
576510|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576511|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576512|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576513|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
576514|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
576515|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
576516|NCT03633734|Folfirinox|folfirinox|mesh-list
576517|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576518|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
576519|NCT03633630|Antacids|antacids|mesh-ancestor
576520|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576521|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
576522|NCT03633604|HBOC 201|hboc 201|mesh-list
576523|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
576524|NCT03633591|Tolcapone|tolcapone|mesh-list
576525|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
576526|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
576527|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
576528|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576529|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576530|NCT03633565|Prednisolone|prednisolone|mesh-list
576531|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
576532|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
576533|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
576534|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
576535|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
576536|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
576537|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
576538|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
576539|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
576540|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
576541|NCT03633565|Hormones|hormones|mesh-ancestor
576542|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
576543|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576920|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
576544|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
576545|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576546|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
576547|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
576548|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576549|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
576550|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
576551|NCT03633565|Protective Agents|protective agents|mesh-ancestor
576552|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
576553|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
576554|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576555|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576556|NCT03633565|Urological Agents|urological agents|mesh-ancestor
576557|NCT03633552|Temozolomide|temozolomide|mesh-list
576558|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
576559|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
576560|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576561|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214288|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
2214289|NCT00024271|Doxorubicin|doxorubicin|mesh-list
2214290|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2214291|NCT00024271|Mitomycins|mitomycins|mesh-list
2214292|NCT00024271|Mitomycin|mitomycin|mesh-list
2214293|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214294|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214295|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
2214296|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214297|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
2214298|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214299|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214300|NCT00024271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214301|NCT00024271|Immunologic Factors|immunologic factors|mesh-ancestor
2214302|NCT00024271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214303|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214304|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2214305|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214306|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
2214307|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2214308|NCT00024284|Carboplatin|carboplatin|mesh-list
2214309|NCT00024284|Irinotecan|irinotecan|mesh-list
2214310|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214311|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2214312|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214313|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214314|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214315|NCT00024297|Warfarin|warfarin|mesh-list
2214316|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
2214317|NCT00024310|Folic Acid|folic acid|mesh-list
2075884|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2075885|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075886|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2075887|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075888|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075889|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
2075890|NCT02005887|Letrozole|letrozole|mesh-list
2075891|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2075892|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075893|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2075894|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2075895|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075896|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075897|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2075898|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
576607|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
576608|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576609|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576610|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
576611|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
576612|NCT03633266|Bevacizumab|bevacizumab|mesh-list
576613|NCT03633266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
576614|NCT03633266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576615|NCT03633266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
576616|NCT03633266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
576617|NCT03633266|Growth Substances|growth substances|mesh-ancestor
2214318|NCT00024310|Paclitaxel|paclitaxel|mesh-list
2214319|NCT00024310|Lometrexol|lometrexol|mesh-list
576618|NCT03633266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576619|NCT03633266|Growth Inhibitors|growth inhibitors|mesh-ancestor
576620|NCT03633175|Progesterone|progesterone|mesh-list
576621|NCT03633175|Progestins|progestins|mesh-ancestor
576622|NCT03633175|Hormones|hormones|mesh-ancestor
576623|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
576624|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576625|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
576626|NCT03633110|Nivolumab|nivolumab|mesh-list
576627|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
576628|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576629|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
576630|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075899|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2075900|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075901|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
2075902|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2075903|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
2075904|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2075905|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2075906|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2075907|NCT02006056|Ondansetron|ondansetron|mesh-list
2075908|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
2075909|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
2075910|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075911|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075912|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2075913|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
2075914|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
2075915|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
576648|NCT03632915|Lacosamide|lacosamide|mesh-list
576649|NCT03632915|Phenytoin|phenytoin|mesh-list
576650|NCT03632915|Ketamine|ketamine|mesh-list
576651|NCT03632915|Levetiracetam|levetiracetam|mesh-list
576652|NCT03632915|Valproic Acid|valproic acid|mesh-list
576653|NCT03632915|Phenobarbital|phenobarbital|mesh-list
576654|NCT03632915|Analgesics|analgesics|mesh-ancestor
576655|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
576656|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576657|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576658|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
576659|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
576660|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
576661|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
576662|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576663|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
576664|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
576665|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576666|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576667|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
576668|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
576669|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576670|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
576671|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
576672|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
576673|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
576674|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
576675|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
576676|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
576677|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
576678|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
576679|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
576680|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
576681|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
576682|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
576683|NCT03632876|Vitamin A|vitamin a|mesh-list
576684|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
576685|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
576686|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576687|NCT03632876|Protective Agents|protective agents|mesh-ancestor
576688|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576689|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
576690|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576691|NCT03632876|Vitamins|vitamins|mesh-ancestor
576692|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
576693|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
576694|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
576695|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
576696|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576697|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
576698|NCT03632824|Coagulants|coagulants|mesh-ancestor
576699|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
576700|NCT03632772|Mirabegron|mirabegron|mesh-list
576701|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
576702|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
576703|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
576704|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576705|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576706|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576707|NCT03632772|Urological Agents|urological agents|mesh-ancestor
576708|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
576709|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
576710|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
576711|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
576723|NCT03632733|Tetracycline|tetracycline|mesh-list
576724|NCT03632733|Clotrimazole|clotrimazole|mesh-list
576725|NCT03632733|Miconazole|miconazole|mesh-list
576726|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
576727|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
576728|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
576729|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576730|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576731|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
576732|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
576733|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
576734|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
576735|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
576736|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
576737|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
576738|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576739|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
576740|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2075916|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
2075917|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2750555|NCT04226248|Rivastigmine|rivastigmine|mesh-list
576744|NCT03632681|Insulin|insulin|mesh-list
576745|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
576746|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
576747|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576748|NCT03632642|Floxacillin|floxacillin|mesh-list
576749|NCT03632642|Penicillin G|penicillin g|mesh-list
576750|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
576751|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
576752|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
576753|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
576754|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
576755|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
576756|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
576757|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576758|NCT03632590|Analgesics|analgesics|mesh-ancestor
576759|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
576760|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576761|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576762|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
576763|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576764|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
576765|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
576766|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
576767|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
576768|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
576770|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
576771|NCT03632590|Cathartics|cathartics|mesh-ancestor
576772|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
576773|NCT03632590|Antacids|antacids|mesh-ancestor
576774|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
576775|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
576776|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
576777|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
576778|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
576779|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576780|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576781|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
576782|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
576783|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576784|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576785|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
576786|NCT03632460|Analgesics|analgesics|mesh-ancestor
576787|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
576788|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576789|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
576790|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
576791|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
576792|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
576793|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576794|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576795|NCT03632408|Zopiclone|zopiclone|mesh-list
576796|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
576797|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576798|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576799|NCT03632369|Xenon|xenon|mesh-list
576800|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
576801|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
576802|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
576803|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576804|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576805|NCT03632330|Midazolam|midazolam|mesh-list
576806|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
576807|NCT03632330|Propofol|propofol|mesh-list
576808|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
576809|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576810|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576811|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
576812|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
576813|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
576814|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
576815|NCT03632330|Analgesics|analgesics|mesh-ancestor
576816|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
576817|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576818|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
576819|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
576820|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
576821|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
576822|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576823|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576824|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
576825|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
576826|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
576827|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
576828|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
576829|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
576830|NCT03632317|Everolimus|everolimus|mesh-list
576831|NCT03632317|Panobinostat|panobinostat|mesh-list
576832|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576833|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
576834|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
576835|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576836|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
576837|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576838|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576839|NCT03632304|Anesthetics|anesthetics|mesh-list
576840|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576841|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576842|NCT03632213|Losartan|losartan|mesh-list
576843|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
576844|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
576921|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
576845|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
576846|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
576847|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576848|NCT03632187|Abatacept|abatacept|mesh-list
576849|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
576850|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576851|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576852|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
576853|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
576854|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576855|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
576856|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
576857|NCT03632161|Bupivacaine|bupivacaine|mesh-list
576858|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
576859|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
576860|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576861|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576862|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
576863|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576864|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
576865|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
576866|NCT03632161|Analgesics|analgesics|mesh-ancestor
576867|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
576868|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
576869|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
576870|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
576871|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576872|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214320|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214321|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214322|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214323|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214324|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214325|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214326|NCT00024310|Hematinics|hematinics|mesh-ancestor
2214327|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
2214328|NCT00024310|Vitamins|vitamins|mesh-ancestor
2214329|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
576883|NCT03632044|Ropivacaine|ropivacaine|mesh-list
576884|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
576885|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
576886|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576887|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576888|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
576889|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576890|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
576891|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
576892|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
576893|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576894|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
576895|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576896|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576897|NCT03631953|Trametinib|trametinib|mesh-list
576898|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576899|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
576900|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576901|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576902|NCT03631901|Diazepam|diazepam|mesh-list
576903|NCT03631901|Melatonin|melatonin|mesh-list
576904|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
576905|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576906|NCT03631901|Protective Agents|protective agents|mesh-ancestor
576907|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576908|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576909|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
576910|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
576911|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
576912|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
576913|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576914|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
576915|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
576916|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
576917|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
576918|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
576922|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
576923|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
576924|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
576925|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
576926|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576927|NCT03631875|Ketamine|ketamine|mesh-list
576928|NCT03631875|Propofol|propofol|mesh-list
576929|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
576930|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
576931|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576932|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
576933|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
576934|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
576935|NCT03631875|Analgesics|analgesics|mesh-ancestor
576936|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
576937|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
576938|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
576939|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
576940|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
576941|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
576942|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576943|NCT03631862|Apatinib|apatinib|mesh-list
576944|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576945|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
576946|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576947|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576948|NCT03631836|Bevacizumab|bevacizumab|mesh-list
576949|NCT03631836|Antibodies|antibodies|mesh-list
576950|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
576951|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
576952|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576953|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
576954|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
576955|NCT03631836|Growth Substances|growth substances|mesh-ancestor
576956|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576957|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
576958|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
576959|NCT03631823|Temozolomide|temozolomide|mesh-list
576960|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
576961|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
576962|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576963|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075918|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075919|NCT02006056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2075920|NCT02006056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2075921|NCT02006056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2075922|NCT02006056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2075923|NCT02006056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2075924|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2075925|NCT02006108|Hematinics|hematinics|mesh-ancestor
2075926|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2075927|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2075928|NCT02006121|Apomorphine|apomorphine|mesh-list
2075929|NCT02006121|Emetics|emetics|mesh-ancestor
2075930|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075931|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
2075932|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075933|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2075934|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
2075935|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
576982|NCT03631641|Nivolumab|nivolumab|mesh-list
576983|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
576984|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
576985|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
576986|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576987|NCT03631615|Antibodies|antibodies|mesh-list
576988|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
576989|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
576990|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
576991|NCT03631602|Clotrimazole|clotrimazole|mesh-list
576992|NCT03631602|Miconazole|miconazole|mesh-list
576993|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
576994|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
576995|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
576996|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
576997|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
576998|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
576999|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
577000|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
577001|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
577002|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577003|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
577004|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
577005|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
577006|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
577007|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075936|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075937|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075938|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
2075939|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2075940|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2075941|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075942|NCT02006342|Insulin|insulin|mesh-list
2075943|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2075944|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
2075945|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2075946|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075947|NCT02006576|Ibuprofen|ibuprofen|mesh-list
2214330|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214331|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214332|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
2214333|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2214334|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214335|NCT00024323|Cisplatin|cisplatin|mesh-list
2214336|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214337|NCT00024336|Tamoxifen|tamoxifen|mesh-list
2214338|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2214339|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
2214340|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2214341|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214342|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2214343|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577034|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
577035|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
577036|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214344|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2214345|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2214346|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2214347|NCT00024349|Fluorouracil|fluorouracil|mesh-list
2214348|NCT00024349|Mitomycins|mitomycins|mesh-list
2214349|NCT00024349|Mitomycin|mitomycin|mesh-list
577043|NCT03631316|Valganciclovir|valganciclovir|mesh-list
577044|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
577045|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
577046|NCT03631277|Calcium|calcium|mesh-list
577047|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
577048|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075948|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2075949|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2075950|NCT02006576|Analgesics|analgesics|mesh-ancestor
2075951|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
2075952|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2075953|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075954|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2075955|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2075956|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2075957|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075958|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075959|NCT02006628|Cannabidiol|cannabidiol|mesh-list
2075960|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
2075961|NCT02006667|Gemcitabine|gemcitabine|mesh-list
2075962|NCT02006667|Trastuzumab|trastuzumab|mesh-list
2075963|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577067|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
577068|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
577069|NCT03631147|Rifaximin|rifaximin|mesh-list
577070|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
577071|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
577072|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
577073|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
577074|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577075|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
577076|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577077|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
577078|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
577079|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075964|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2075965|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
2075966|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075967|NCT02006667|Antiviral Agents|antiviral agents|mesh-ancestor
2075968|NCT02006667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2075969|NCT02006667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075970|NCT02006667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2075971|NCT02006667|Immunologic Factors|immunologic factors|mesh-ancestor
2075972|NCT02006667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577105|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
577106|NCT03630991|Edetic Acid|edetic acid|mesh-list
577107|NCT03630991|Calcium|calcium|mesh-list
577108|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
577109|NCT03630991|Succimer|succimer|mesh-list
577110|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577111|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
577112|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
577113|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
577114|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
577115|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
577116|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
577117|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577118|NCT03630991|Antidotes|antidotes|mesh-ancestor
577119|NCT03630991|Protective Agents|protective agents|mesh-ancestor
577120|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
577121|NCT03630952|Aflibercept|aflibercept|mesh-list
577122|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
577123|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
577124|NCT03630952|Growth Substances|growth substances|mesh-ancestor
577125|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577126|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
577127|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075973|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2075974|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
2075975|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2075976|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2075977|NCT02006706|Prednisolone|prednisolone|mesh-list
2075978|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
577134|NCT03630796|Sevoflurane|sevoflurane|mesh-list
577135|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
577136|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
577137|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
577138|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
577139|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
577140|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075979|NCT02006706|Rituximab|rituximab|mesh-list
2075980|NCT02006706|Methotrexate|methotrexate|mesh-list
2075981|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
577153|NCT03630614|Nicotine|nicotine|mesh-list
577154|NCT03630614|Varenicline|varenicline|mesh-list
577155|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
577156|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
577157|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577158|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577159|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
577160|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
577161|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
577162|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
577163|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577164|NCT03630367|Dexamethasone|dexamethasone|mesh-list
577165|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
577166|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
577167|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
577168|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577169|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577170|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
577171|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
577172|NCT03630367|Hormones|hormones|mesh-ancestor
577173|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
577174|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
577175|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577176|NCT03630341|Clomiphene|clomiphene|mesh-list
577177|NCT03630341|Enclomiphene|enclomiphene|mesh-list
577178|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
577179|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
577180|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
577181|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
577182|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577183|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
577184|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
577185|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
577186|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
577187|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
577188|NCT03630315|Bevacizumab|bevacizumab|mesh-list
577189|NCT03630315|Ranibizumab|ranibizumab|mesh-list
577190|NCT03630315|Aflibercept|aflibercept|mesh-list
577191|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
577192|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577193|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
577194|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
577195|NCT03630315|Growth Substances|growth substances|mesh-ancestor
577196|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577197|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
2075982|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
2075983|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2214350|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
2214351|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214352|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214353|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214354|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214355|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
2214356|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214357|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214358|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
2214359|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2214360|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214361|NCT00024362|BBR 3464|bbr 3464|mesh-list
2750556|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2750557|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750558|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214362|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214363|NCT00024375|Paclitaxel|paclitaxel|mesh-list
2214364|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214365|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214366|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214367|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
577241|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
577242|NCT03630081|Meropenem|meropenem|mesh-list
577243|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
577244|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
577245|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
577246|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
577247|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
577248|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577249|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577250|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
577251|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
577252|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
577253|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
577254|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
577255|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
577256|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
577257|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
577258|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577259|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
577260|NCT03630042|Rituximab|rituximab|mesh-list
577261|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
577262|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
577263|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577264|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
577265|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577266|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
577267|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
577268|NCT03630029|Hematinics|hematinics|mesh-ancestor
2075984|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2075985|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
2075986|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2075987|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2075988|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2214368|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214369|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214370|NCT00024388|Paclitaxel|paclitaxel|mesh-list
2214371|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214372|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214373|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214374|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214375|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214376|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214377|NCT00024401|Paclitaxel|paclitaxel|mesh-list
2214378|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214379|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577307|NCT03629847|Everolimus|everolimus|mesh-list
577308|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577309|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
577310|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
577311|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577312|NCT03629717|Vitamin D|vitamin d|mesh-list
577313|NCT03629717|Denosumab|denosumab|mesh-list
577314|NCT03629717|Calcium|calcium|mesh-list
577315|NCT03629717|Vitamins|vitamins|mesh-ancestor
577316|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
577317|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577318|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
577319|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
577320|NCT03629639|Metformin|metformin|mesh-list
577321|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
577322|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577323|NCT03629613|Antioxidants|antioxidants|mesh-list
577324|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577325|NCT03629613|Protective Agents|protective agents|mesh-ancestor
577326|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577327|NCT03629600|Indomethacin|indomethacin|mesh-list
577328|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
577329|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
577330|NCT03629600|Analgesics|analgesics|mesh-ancestor
577331|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
577332|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577333|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577334|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
577335|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
577336|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
577337|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
577338|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
577339|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
577340|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
577341|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577342|NCT03629522|Ondansetron|ondansetron|mesh-list
577343|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
577344|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
577345|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577346|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577347|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
577348|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
577349|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
577350|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
577351|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
577352|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
577353|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577354|NCT03629522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
577355|NCT03629522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
577356|NCT03629522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
577357|NCT03629522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
577358|NCT03629522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
577359|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
577360|NCT03629483|Ropivacaine|ropivacaine|mesh-list
577361|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
577362|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
577363|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577364|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
577365|NCT03629483|Analgesics|analgesics|mesh-ancestor
577366|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
577367|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577368|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
577369|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
577370|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
577371|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
577372|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
577373|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577374|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
577375|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
577376|NCT03629418|Phenylephrine|phenylephrine|mesh-list
577377|NCT03629418|Norepinephrine|norepinephrine|mesh-list
577378|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
577379|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
577380|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
577381|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577382|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577383|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
577384|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
577385|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
577386|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
577387|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
577388|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
577389|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
577390|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
577391|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
577392|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577393|NCT03629418|Protective Agents|protective agents|mesh-ancestor
577394|NCT03629379|Ustekinumab|ustekinumab|mesh-list
577395|NCT03629379|Vedolizumab|vedolizumab|mesh-list
577396|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
577397|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
577417|NCT03629288|Azithromycin|azithromycin|mesh-list
577418|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
577419|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
577420|NCT03629262|Sufentanil|sufentanil|mesh-list
577421|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
577422|NCT03629262|Dsuvia|dsuvia|mesh-list
577423|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
577424|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
577425|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577426|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
577427|NCT03629262|Analgesics|analgesics|mesh-ancestor
577428|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
577429|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577430|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
577431|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
577432|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
577433|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
577434|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
577435|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577436|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
577437|NCT03629262|Narcotics|narcotics|mesh-ancestor
577438|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
577439|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
577440|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
577441|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
2214380|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214381|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214382|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214383|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577446|NCT03629223|Tepotinib|tepotinib|mesh-list
577447|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577448|NCT03629210|Dexamethasone|dexamethasone|mesh-list
577449|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
577450|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
577451|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
577452|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577453|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577454|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
577455|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
577456|NCT03629210|Hormones|hormones|mesh-ancestor
577457|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
577458|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
577459|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214384|NCT00024414|Paclitaxel|paclitaxel|mesh-list
2214385|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214386|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214387|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214388|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214389|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
577482|NCT03629093|Anesthetics|anesthetics|mesh-list
577483|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
577484|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
577485|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214390|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214391|NCT00024427|Gemcitabine|gemcitabine|mesh-list
2214392|NCT00024427|Fluorouracil|fluorouracil|mesh-list
2214393|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214394|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
2214395|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214396|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214397|NCT00024427|Antiviral Agents|antiviral agents|mesh-ancestor
2214398|NCT00024427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214399|NCT00024427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214400|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214401|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
2214402|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214403|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
2214404|NCT00024440|Fludarabine|fludarabine|mesh-list
2214405|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
577502|NCT03628716|Atezolizumab|atezolizumab|mesh-list
577503|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577504|NCT03628625|Letrozole|letrozole|mesh-list
577505|NCT03628625|Misoprostol|misoprostol|mesh-list
577506|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577507|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
577508|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
577509|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
577510|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577511|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
577512|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
577513|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
577514|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577515|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
577516|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
577517|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
577518|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
577519|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
577520|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
577521|NCT03628521|Gemcitabine|gemcitabine|mesh-list
577522|NCT03628521|Carboplatin|carboplatin|mesh-list
577523|NCT03628521|Pemetrexed|pemetrexed|mesh-list
577524|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
577525|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577526|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
577527|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
2750559|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
577528|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577529|NCT03628521|Antiviral Agents|antiviral agents|mesh-ancestor
577530|NCT03628521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
577531|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
577532|NCT03628521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
577533|NCT03628521|Immunologic Factors|immunologic factors|mesh-ancestor
577534|NCT03628521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577535|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
577536|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
577537|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
577538|NCT03628443|Mitogens|mitogens|mesh-list
577539|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
577540|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577541|NCT03628430|Lidocaine|lidocaine|mesh-list
577542|NCT03628430|Epinephrine|epinephrine|mesh-list
577543|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
577544|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
577545|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
577546|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577547|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
577548|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577549|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
577550|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
577551|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
577552|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
577553|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577554|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
577555|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
577556|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
577557|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
577558|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
577559|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
577560|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
577561|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
577562|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
577563|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
577564|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
577565|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2214406|NCT00024440|Oblimersen|oblimersen|mesh-list
2214407|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214408|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
2214409|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214410|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214411|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
577572|NCT03628391|Haloperidol|haloperidol|mesh-list
577573|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
577574|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
577575|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
577576|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577577|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577578|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
577579|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
577580|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
577581|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
577582|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
577583|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
577584|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
577585|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
577586|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577587|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
577588|NCT03628339|Tepotinib|tepotinib|mesh-list
577589|NCT03628339|Midazolam|midazolam|mesh-list
577590|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
577591|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
577592|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
577593|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577594|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
577595|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
577596|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
577597|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
577598|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
577599|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
577600|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
577601|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
577602|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2075989|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
577603|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577604|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577605|NCT03628300|Piperacillin|piperacillin|mesh-list
577606|NCT03628300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
577607|NCT03628300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
577608|NCT03628209|Nivolumab|nivolumab|mesh-list
577609|NCT03628209|Azacitidine|azacitidine|mesh-list
577610|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
577611|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577612|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
577613|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577614|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
577615|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
577616|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
577617|NCT03628131|Carboplatin|carboplatin|mesh-list
577618|NCT03628131|Etoposide|etoposide|mesh-list
577619|NCT03628131|Ifosfamide|ifosfamide|mesh-list
577620|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577621|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
577622|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
577623|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
577624|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
577625|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577626|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
577627|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
577628|NCT03628079|Mebendazole|mebendazole|mesh-list
577629|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
577630|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
577631|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
577632|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
577633|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
577634|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
577635|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
577636|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577637|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577638|NCT03628066|Letrozole|letrozole|mesh-list
577639|NCT03628066|Palbociclib|palbociclib|mesh-list
577640|NCT03628066|Goserelin|goserelin|mesh-list
577641|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577642|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
577643|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
577644|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
577645|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577646|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
577647|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
577648|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
577649|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577650|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
577651|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
577652|NCT03628053|Blinatumomab|blinatumomab|mesh-list
577653|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
577654|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577655|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
577656|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
577657|NCT03628040|Ropivacaine|ropivacaine|mesh-list
577658|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
577659|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
577660|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
577661|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577662|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
577663|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577671|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2075990|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2075991|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2075992|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
2075993|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2075994|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
2075995|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2075996|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2075997|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2075998|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2075999|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2076000|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
2076001|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
2076002|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076003|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2076004|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
2076005|NCT02006706|Hormones|hormones|mesh-ancestor
2076006|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2076007|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2076008|NCT02006706|Protective Agents|protective agents|mesh-ancestor
2076009|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2076010|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
2214412|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
2214413|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214414|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214415|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
577699|NCT03627741|Triamcinolone|triamcinolone|mesh-list
577700|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
577701|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
577702|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
577703|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
577704|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
577705|NCT03627741|Hormones|hormones|mesh-ancestor
577706|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
577707|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577708|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
577709|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
577710|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
577711|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577712|NCT03627715|Proxigermanium|proxigermanium|mesh-list
577713|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577714|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
577715|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
577716|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577717|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
577718|NCT03627546|Velpatasvir|velpatasvir|mesh-list
577719|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
577720|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
577721|NCT03627468|Bromides|bromides|mesh-list
577722|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
577723|NCT03627390|Molybdenum|molybdenum|mesh-list
577724|NCT03627390|Trace Elements|trace elements|mesh-ancestor
577725|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
577726|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577727|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
577728|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
577729|NCT03627260|Protective Agents|protective agents|mesh-ancestor
577730|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577731|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
2214416|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214417|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
2214418|NCT00024453|Teicoplanin|teicoplanin|mesh-list
2214419|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2214420|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214421|NCT00024466|Vaccines|vaccines|mesh-list
2214422|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
2214423|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214424|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
2214425|NCT00024492|Analgesics|analgesics|mesh-ancestor
2214426|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
2214427|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2214428|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214429|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214430|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2214431|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214432|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214433|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577750|NCT03627039|Metformin|metformin|mesh-list
577751|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
577752|NCT03627039|Empagliflozin|empagliflozin|mesh-list
577753|NCT03627039|Canagliflozin|canagliflozin|mesh-list
577754|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2076011|NCT02006732|Olodaterol|olodaterol|mesh-list
2214434|NCT00024518|Interferons|interferons|mesh-list
577755|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577756|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
577757|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577758|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
577759|NCT03626922|Folic Acid|folic acid|mesh-list
577760|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
577761|NCT03626922|Hydroxocobalamin|hydroxocobalamin|mesh-list
577762|NCT03626922|Dexamethasone|dexamethasone|mesh-list
577763|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
577764|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
577765|NCT03626922|Pemetrexed|pemetrexed|mesh-list
577766|NCT03626922|Vitamins|vitamins|mesh-ancestor
577767|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
577768|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577769|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
577770|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
577771|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
577772|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577773|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
577774|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
577775|NCT03626922|Hormones|hormones|mesh-ancestor
577776|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
577777|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
577778|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577779|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
577780|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
577781|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577782|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
577783|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
577784|NCT03626922|Hematinics|hematinics|mesh-ancestor
577785|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
577786|NCT03626831|Evolocumab|evolocumab|mesh-list
577787|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
577788|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
577789|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
577790|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577791|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
577792|NCT03626753|Acetaminophen|acetaminophen|mesh-list
577793|NCT03626753|Piroxicam|piroxicam|mesh-list
577794|NCT03626753|Nefopam|nefopam|mesh-list
577795|NCT03626753|Proroxan|proroxan|mesh-list
577796|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
577797|NCT03626753|Analgesics|analgesics|mesh-ancestor
577798|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
577799|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577800|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577801|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
577802|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
577803|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
577804|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
577805|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
577806|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
577807|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577808|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
577809|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
577810|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
577811|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
577812|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
577813|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
577814|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
577815|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
577816|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
577817|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
577818|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
577819|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214435|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
2214436|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214437|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
2214438|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214439|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
2214440|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214441|NCT00024531|Atorvastatin|atorvastatin|mesh-list
577827|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
577828|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
577829|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076012|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2214442|NCT00024531|Calcium|calcium|mesh-list
2076013|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
2076014|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076015|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076016|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2076017|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
577836|NCT03626519|Menthol|menthol|mesh-list
577837|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
577838|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
577839|NCT03626506|Amlodipine|amlodipine|mesh-list
577840|NCT03626506|Indapamide|indapamide|mesh-list
577841|NCT03626506|Spironolactone|spironolactone|mesh-list
577842|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
577843|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
577844|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
577845|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577846|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
577847|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577848|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
577849|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
577850|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
577851|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
577852|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
577853|NCT03626506|Diuretics|diuretics|mesh-ancestor
577854|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
577855|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
577856|NCT03626454|Norepinephrine|norepinephrine|mesh-list
577857|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
577858|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
577859|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
577860|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
577861|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
577862|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577863|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577864|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
577865|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
577866|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577867|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2214443|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2214444|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214445|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2214446|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
577883|NCT03626298|Niacinamide|niacinamide|mesh-list
577884|NCT03626298|Niacin|niacin|mesh-list
577885|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
577886|NCT03626298|Adapalene|adapalene|mesh-list
577887|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
577888|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
577889|NCT03626298|Analgesics|analgesics|mesh-ancestor
577890|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
577891|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577892|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577893|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
577894|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
577895|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
577896|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
577897|NCT03626298|Vitamins|vitamins|mesh-ancestor
577898|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
577899|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
577900|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
577901|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577902|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
577903|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
577904|NCT03626259|Losartan|losartan|mesh-list
577905|NCT03626259|Amlodipine|amlodipine|mesh-list
577906|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
577907|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
577908|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
577909|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577910|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
577911|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577912|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
577913|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
577914|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
577915|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
577916|NCT03626064|Nicotine|nicotine|mesh-list
577917|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
577918|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
577919|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
577920|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
577921|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
577922|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
577923|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
577924|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
577925|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076018|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
2076019|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2076020|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
2076021|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076022|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076023|NCT02006836|Insulin|insulin|mesh-list
2076024|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2076025|NCT02006836|Metformin|metformin|mesh-list
2076026|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
2076027|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
577936|NCT03625960|Cantharidin|cantharidin|mesh-list
577937|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
577938|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577939|NCT03625830|Paclitaxel|paclitaxel|mesh-list
577940|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
577941|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577942|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
577943|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
577944|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
577945|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577946|NCT03625739|Amoxicillin|amoxicillin|mesh-list
577947|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
577948|NCT03625739|Levofloxacin|levofloxacin|mesh-list
577949|NCT03625739|Isoniazid|isoniazid|mesh-list
577950|NCT03625739|Cycloserine|cycloserine|mesh-list
577951|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
577952|NCT03625739|Imipenem|imipenem|mesh-list
577953|NCT03625739|Amikacin|amikacin|mesh-list
577954|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
577955|NCT03625739|Ethambutol|ethambutol|mesh-list
577956|NCT03625739|Bedaquiline|bedaquiline|mesh-list
577957|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
577958|NCT03625739|Clofazimine|clofazimine|mesh-list
577959|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
577960|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
577961|NCT03625739|Streptomycin|streptomycin|mesh-list
577962|NCT03625739|Kanamycin|kanamycin|mesh-list
577963|NCT03625739|Ethionamide|ethionamide|mesh-list
577964|NCT03625739|Capreomycin|capreomycin|mesh-list
577965|NCT03625739|Thioacetazone|thioacetazone|mesh-list
577966|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
577967|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
577968|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
577969|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
577970|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
577971|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
577972|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
577973|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
577974|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
577975|NCT03625739|Renal Agents|renal agents|mesh-ancestor
577976|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
577977|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
577978|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
577979|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
577980|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
577981|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
577982|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
577983|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
577984|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
577985|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
577986|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
577987|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
577988|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
577989|NCT03625726|Thrombin|thrombin|mesh-list
577990|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
577991|NCT03625726|Coagulants|coagulants|mesh-ancestor
577992|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
577993|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
577994|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
578006|NCT03625531|Letrozole|letrozole|mesh-list
578007|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578008|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
578009|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
578010|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578011|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578012|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
578013|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
578014|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
578015|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578016|NCT03625518|Oxytocin|oxytocin|mesh-list
578017|NCT03625518|Dinoprostone|dinoprostone|mesh-list
578018|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
578019|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
578020|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578021|NCT03625505|Venetoclax|venetoclax|mesh-list
578022|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750560|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2750561|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750562|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2750563|NCT04226248|Protective Agents|protective agents|mesh-ancestor
578032|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
578033|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578034|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076028|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076029|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
2076030|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
578038|NCT03625310|Listerine|listerine|mesh-list
578039|NCT03625310|Fluorides|fluorides|mesh-list
578040|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
578041|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
578042|NCT03625310|Protective Agents|protective agents|mesh-ancestor
578043|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578044|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
578045|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
578046|NCT03625219|Prednisone|prednisone|mesh-list
578047|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
578048|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
578049|NCT03625219|Hormones|hormones|mesh-ancestor
578050|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
578051|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578052|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
578053|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578054|NCT03625167|Petrolatum|petrolatum|mesh-list
578055|NCT03625167|Emollients|emollients|mesh-ancestor
578056|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
578063|NCT03625089|Atorvastatin|atorvastatin|mesh-list
578064|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
578065|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
578066|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
578067|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578068|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
578069|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
578070|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578071|NCT03625076|Lidocaine|lidocaine|mesh-list
578072|NCT03625076|Propofol|propofol|mesh-list
578073|NCT03625076|Etomidate|etomidate|mesh-list
578074|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
578075|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
578076|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578077|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578078|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
578079|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578080|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
578081|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
578082|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
578083|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
578084|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578085|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
578086|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
578087|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
578088|NCT03625050|Celecoxib|celecoxib|mesh-list
578089|NCT03625050|Esomeprazole|esomeprazole|mesh-list
578090|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
578091|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
578092|NCT03625050|Analgesics|analgesics|mesh-ancestor
578093|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
578094|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578095|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578096|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
578097|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
578098|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
578099|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
578100|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578101|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578102|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
578103|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
578104|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
578105|NCT03625011|Gabapentin|gabapentin|mesh-list
578106|NCT03625011|Analgesics|analgesics|mesh-ancestor
578107|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
578108|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578109|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578110|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
578111|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
578112|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
578113|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578114|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
578115|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
578116|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
578117|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578118|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578119|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
578120|NCT03624985|Lidocaine|lidocaine|mesh-list
578121|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
578122|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
578123|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578124|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578125|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
578126|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578127|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
578128|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
578129|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
578130|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
578131|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578132|NCT03624959|Itraconazole|itraconazole|mesh-list
578133|NCT03624959|Rifampin|rifampin|mesh-list
578134|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
578135|NCT03624959|Ozanimod|ozanimod|mesh-list
578136|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
578137|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
578138|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
578139|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
578140|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578141|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578142|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
578143|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
578144|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
578145|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578146|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
578147|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
578148|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
578149|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
578150|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
578151|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
578152|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
578153|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
578154|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
578155|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
578156|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
578157|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
578158|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
578159|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
578160|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
578161|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
578162|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
578163|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
578164|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
2214447|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
2214448|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214449|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2214450|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2214451|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214452|NCT00024544|Antibodies|antibodies|mesh-list
2214453|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
578173|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
578174|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
578175|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578176|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578177|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
578178|NCT03624595|Analgesics|analgesics|mesh-ancestor
578179|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
578180|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578181|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
578182|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
578183|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
578184|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
578185|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578186|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578191|NCT03624322|Olanzapine|olanzapine|mesh-list
578192|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
578193|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
578194|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578195|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578196|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
578197|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
578198|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
578199|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578200|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
578201|NCT03624322|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
578202|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
578203|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
578204|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578205|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578206|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
578207|NCT03624309|Docetaxel|docetaxel|mesh-list
578208|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578209|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
578210|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
578211|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
578212|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578213|NCT03624283|Betahistine|betahistine|mesh-list
578214|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
578215|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
578216|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
578217|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578218|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578219|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578220|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
578221|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
578222|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
578223|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578224|NCT03624270|Protective Agents|protective agents|mesh-ancestor
578225|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578226|NCT03624270|Vitamins|vitamins|mesh-ancestor
578227|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
578228|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578229|NCT03624244|Letrozole|letrozole|mesh-list
578230|NCT03624244|Exemestane|exemestane|mesh-list
578231|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
578232|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578233|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
578234|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578235|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578236|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
578237|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
578238|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
578239|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578240|NCT03624231|Durvalumab|durvalumab|mesh-list
578241|NCT03624231|Tremelimumab|tremelimumab|mesh-list
578242|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
578243|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578244|NCT03624205|Paclitaxel|paclitaxel|mesh-list
578245|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
578246|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578247|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
578248|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
578249|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
578250|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578251|NCT03624166|Ketamine|ketamine|mesh-list
578252|NCT03624166|Anesthetics|anesthetics|mesh-list
578253|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
578254|NCT03624166|Analgesics|analgesics|mesh-ancestor
578255|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
578256|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578257|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578258|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
578259|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
578260|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578261|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
578262|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
578263|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578264|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578265|NCT03624127|Apremilast|apremilast|mesh-list
578266|NCT03624127|BMS-986165|bms-986165|mesh-list
578267|NCT03624127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
578268|NCT03624127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
578269|NCT03624127|Analgesics|analgesics|mesh-ancestor
578270|NCT03624127|Sensory System Agents|sensory system agents|mesh-ancestor
578271|NCT03624127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578272|NCT03624127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578273|NCT03624127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
578274|NCT03624127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
578275|NCT03624127|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
578276|NCT03624127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
578277|NCT03624127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578278|NCT03624127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578279|NCT03624127|Dermatologic Agents|dermatologic agents|mesh-ancestor
578280|NCT03624127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
578281|NCT03624101|Ivacaftor|ivacaftor|mesh-list
578282|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
578283|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
578284|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578285|NCT03624062|Insulin|insulin|mesh-list
578286|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
578287|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076031|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076032|NCT02007096|Bupivacaine|bupivacaine|mesh-list
2076033|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
2076034|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
2076035|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2076036|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076037|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
2076038|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076039|NCT02007278|Metformin|metformin|mesh-list
2076040|NCT02007278|Glimepiride|glimepiride|mesh-list
2076041|NCT02007278|Vildagliptin|vildagliptin|mesh-list
578299|NCT03624010|Simendan|simendan|mesh-list
578300|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
578301|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
578302|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
578303|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
578304|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578305|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578306|NCT03624010|Protective Agents|protective agents|mesh-ancestor
578307|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578308|NCT03623854|Nivolumab|nivolumab|mesh-list
578309|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
578310|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
578311|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
578312|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578313|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
578314|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578315|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
578316|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578317|NCT03623828|Apomorphine|apomorphine|mesh-list
578318|NCT03623828|Emetics|emetics|mesh-ancestor
578319|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578320|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
578321|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578322|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
578323|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
578324|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
578325|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578326|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578327|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
578328|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
578329|NCT03623789|Hemostatics|hemostatics|mesh-list
578330|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
578331|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
578332|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578333|NCT03623789|Coagulants|coagulants|mesh-ancestor
578334|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
578335|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
578336|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
578337|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578338|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
578339|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
578340|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578341|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578342|NCT03623776|Carboplatin|carboplatin|mesh-list
578343|NCT03623776|Pemetrexed|pemetrexed|mesh-list
578344|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578345|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578346|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578347|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
578348|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
578349|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
578350|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
578351|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
578352|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578353|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
578354|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
578355|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
578356|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076042|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
578357|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578358|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
578359|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
578360|NCT03623711|Citalopram|citalopram|mesh-list
578361|NCT03623711|Bupropion|bupropion|mesh-list
578362|NCT03623711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
578363|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
578364|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
578365|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578366|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578367|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
578368|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578369|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
578370|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
578371|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
578372|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578373|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
578374|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
578375|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
578376|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
578377|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578378|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
578379|NCT03623711|Analgesics|analgesics|mesh-ancestor
578380|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
578381|NCT03623633|Denosumab|denosumab|mesh-list
578382|NCT03623633|Alendronate|alendronate|mesh-list
578383|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
578384|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
578385|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578386|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
578387|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
578388|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
578389|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
578390|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
578391|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
578392|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
578393|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
578394|NCT03623529|Giapreza|giapreza|mesh-list
578395|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
578396|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
578397|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
578398|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
578399|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578400|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578401|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
578402|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
578403|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214454|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
2214455|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214456|NCT00024687|Immunotoxins|immunotoxins|mesh-list
2214457|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
2214458|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214459|NCT00024986|Tenofovir|tenofovir|mesh-list
2214460|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
2214461|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214462|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2214463|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2214464|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214465|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214466|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2214467|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2214468|NCT00025012|Isotretinoin|isotretinoin|mesh-list
2214469|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
2214470|NCT00025038|Cytarabine|cytarabine|mesh-list
2076043|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076044|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2076045|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076046|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
2076047|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2076048|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
2076049|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076050|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076051|NCT02007434|Loratadine|loratadine|mesh-list
2076052|NCT02007434|Ibuprofen|ibuprofen|mesh-list
2076053|NCT02007434|Lidocaine|lidocaine|mesh-list
2076054|NCT02007434|Epinephrine|epinephrine|mesh-list
2076055|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
578434|NCT03623256|Fentanyl|fentanyl|mesh-list
578435|NCT03623256|Bupivacaine|bupivacaine|mesh-list
578436|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
578437|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
578438|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578439|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578440|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
578441|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578442|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
578443|NCT03623256|Narcotics|narcotics|mesh-ancestor
578444|NCT03623256|Analgesics|analgesics|mesh-ancestor
578445|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
578446|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
578447|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
578454|NCT03623230|Bupivacaine|bupivacaine|mesh-list
578455|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
578456|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
578457|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
578458|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578459|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578460|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
578461|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578462|NCT03623087|Gemcitabine|gemcitabine|mesh-list
578463|NCT03623087|Dexamethasone|dexamethasone|mesh-list
578464|NCT03623087|Etoposide|etoposide|mesh-list
578465|NCT03623087|Asparaginase|asparaginase|mesh-list
578466|NCT03623087|Ifosfamide|ifosfamide|mesh-list
578467|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578468|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
578469|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
578470|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
578471|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578472|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578473|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
578474|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
578475|NCT03623087|Hormones|hormones|mesh-ancestor
578476|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
578477|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
578478|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
578479|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
578480|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578481|NCT03623087|Antiviral Agents|antiviral agents|mesh-ancestor
578482|NCT03623087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
578483|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578484|NCT03623087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
578485|NCT03623087|Immunologic Factors|immunologic factors|mesh-ancestor
578486|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
578487|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
578488|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
578489|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
578490|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
578491|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
578492|NCT03623048|Propolis|propolis|mesh-list
578493|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
578494|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
578495|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
578496|NCT03622918|Rifampin|rifampin|mesh-list
578497|NCT03622918|Colistin|colistin|mesh-list
578498|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
578499|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
578500|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
578501|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
578502|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
578503|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
578504|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578505|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578506|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2076056|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
578507|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
578508|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
578509|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
578510|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
578511|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
578512|NCT03622827|Endostar protein|endostar protein|mesh-list
578513|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
578514|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
578515|NCT03622827|Growth Substances|growth substances|mesh-ancestor
578516|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578517|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
578518|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076057|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
2076058|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2076059|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076060|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
2076061|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076062|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2076063|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2076064|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2076065|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2076066|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076067|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2076068|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2214471|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
2214472|NCT00025038|Fludarabine|fludarabine|mesh-list
2214473|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
2214474|NCT00025038|Tipifarnib|tipifarnib|mesh-list
2214475|NCT00025038|Isotretinoin|isotretinoin|mesh-list
2076069|NCT02007434|Analgesics|analgesics|mesh-ancestor
2076070|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2076071|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2076072|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2076073|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214476|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
2214477|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
578545|NCT03622580|Aflibercept|aflibercept|mesh-list
578546|NCT03622580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
578547|NCT03622580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
578548|NCT03622580|Growth Substances|growth substances|mesh-ancestor
578549|NCT03622580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578550|NCT03622580|Growth Inhibitors|growth inhibitors|mesh-ancestor
578551|NCT03622580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578552|NCT03622541|Sorafenib|sorafenib|mesh-list
578553|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578554|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
578555|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578556|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578557|NCT03622515|Anesthetics|anesthetics|mesh-list
578558|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578559|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578560|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
578561|NCT03622502|Remifentanil|remifentanil|mesh-list
578562|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
578563|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578564|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578565|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
578566|NCT03622502|Analgesics|analgesics|mesh-ancestor
578567|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
578568|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578569|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
578570|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
578571|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
578572|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
578573|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578574|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578575|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
578576|NCT03622502|Narcotics|narcotics|mesh-ancestor
578577|NCT03622489|Acetaminophen|acetaminophen|mesh-list
578578|NCT03622489|Dipyrone|dipyrone|mesh-list
578579|NCT03622489|Ibuprofen|ibuprofen|mesh-list
578580|NCT03622489|Morphine|morphine|mesh-list
578581|NCT03622489|Tramadol|tramadol|mesh-list
578582|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
578583|NCT03622489|Narcotics|narcotics|mesh-ancestor
578584|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578585|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578586|NCT03622489|Analgesics|analgesics|mesh-ancestor
578587|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
578588|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578589|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
578590|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
578591|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
578592|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
578593|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
578594|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
578595|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578596|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578597|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
578598|NCT03622450|Levofloxacin|levofloxacin|mesh-list
578599|NCT03622450|Gentamicins|gentamicins|mesh-list
578600|NCT03622450|Meropenem|meropenem|mesh-list
578601|NCT03622450|Amikacin|amikacin|mesh-list
578602|NCT03622450|Colistin|colistin|mesh-list
578603|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
578604|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
578605|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
578606|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
578607|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578608|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578609|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578610|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
578611|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
578612|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
578613|NCT03622450|Renal Agents|renal agents|mesh-ancestor
578614|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
578615|NCT03622073|Misoprostol|misoprostol|mesh-list
578616|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
578617|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
578618|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
578619|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578620|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
578621|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
578622|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
578623|NCT03622060|Nicardipine|nicardipine|mesh-list
578624|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
578625|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
578626|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
578627|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
578628|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
578629|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578630|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
578631|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578632|NCT03622047|Sufentanil|sufentanil|mesh-list
578633|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
578634|NCT03622047|Ropivacaine|ropivacaine|mesh-list
578635|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
578636|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578637|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578638|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
578639|NCT03622047|Analgesics|analgesics|mesh-ancestor
578640|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
578641|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578642|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
578643|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
578644|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
578645|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
578646|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578647|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578648|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
578649|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
578650|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
578651|NCT03622047|Narcotics|narcotics|mesh-ancestor
578652|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
578653|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
578654|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
578655|NCT03621995|Catalase|catalase|mesh-list
578656|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
578657|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578658|NCT03621995|Protective Agents|protective agents|mesh-ancestor
578659|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076074|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2076075|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2076076|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
578663|NCT03621904|Tamoxifen|tamoxifen|mesh-list
578664|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
578665|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
578666|NCT03621904|Progesterone|progesterone|mesh-list
578667|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
578668|NCT03621904|Progestins|progestins|mesh-ancestor
578669|NCT03621904|Hormones|hormones|mesh-ancestor
578670|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
578671|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578672|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
578673|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
578674|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
578675|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
578676|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
578677|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
578678|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578679|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578680|NCT03621800|Menthol|menthol|mesh-list
578681|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
578682|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
578683|NCT03621761|Modafinil|modafinil|mesh-list
578684|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
578685|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578686|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
578687|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
578688|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
578689|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076077|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076078|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2076079|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2076080|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
2076081|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
578695|NCT03621683|Antioxidants|antioxidants|mesh-list
578696|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578697|NCT03621683|Protective Agents|protective agents|mesh-ancestor
578698|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076082|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
2076083|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
2076084|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
578702|NCT03621618|Dobutamine|dobutamine|mesh-list
578703|NCT03621618|Norepinephrine|norepinephrine|mesh-list
578704|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
578705|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
578706|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
578707|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578708|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578709|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578710|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
578711|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
578712|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578713|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
578714|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
578715|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
578716|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
578717|NCT03621618|Protective Agents|protective agents|mesh-ancestor
578718|NCT03621553|Vitamin D|vitamin d|mesh-list
578719|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
578720|NCT03621553|Vitamins|vitamins|mesh-list
578721|NCT03621553|Calcium|calcium|mesh-list
578722|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
578723|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578724|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
578725|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
578726|NCT03621527|Remifentanil|remifentanil|mesh-list
578727|NCT03621527|Anesthetics|anesthetics|mesh-list
578728|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578729|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578730|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
578731|NCT03621527|Narcotics|narcotics|mesh-ancestor
578732|NCT03621527|Analgesics|analgesics|mesh-ancestor
578733|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
2076085|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
578734|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578735|NCT03621514|Lidocaine|lidocaine|mesh-list
578736|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
578737|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
578738|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578739|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578740|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
578741|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578742|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
578743|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
578744|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
578745|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
578746|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578747|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
578748|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
578749|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
578750|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578751|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578752|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
578753|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
578754|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578755|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076086|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
2076087|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
2076088|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2076089|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2076090|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2076091|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
2076092|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
2076093|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2076094|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2076095|NCT02007512|Exemestane|exemestane|mesh-list
2076096|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076097|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2076098|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2076099|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578770|NCT03621072|Fluconazole|fluconazole|mesh-list
578771|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
578772|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
578773|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
578774|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
578775|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578776|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578777|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
578778|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
578779|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
578780|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578781|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
578782|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
578783|NCT03621046|Zolpidem|zolpidem|mesh-list
578784|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
578785|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
578786|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578787|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578788|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
578789|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
578790|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
578791|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578792|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578793|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
578794|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
578795|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578796|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578797|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578798|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
578799|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
578800|NCT03620942|Phenylephrine|phenylephrine|mesh-list
578801|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
578802|NCT03620942|Ephedrine|ephedrine|mesh-list
578803|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
578804|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
578805|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
578806|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
2214478|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
578807|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578808|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578809|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
578810|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
578811|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
578812|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
578813|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
578814|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
578815|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
578816|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578817|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578818|NCT03620942|Protective Agents|protective agents|mesh-ancestor
578819|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
578820|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
578821|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
578822|NCT03620929|Estradiol|estradiol|mesh-list
578823|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
578824|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
578825|NCT03620929|Estrogens|estrogens|mesh-ancestor
578826|NCT03620929|Hormones|hormones|mesh-ancestor
578827|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
578828|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578829|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
578830|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
578831|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
578832|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
578833|NCT03620929|Progestins|progestins|mesh-ancestor
578834|NCT03620916|Morphine|morphine|mesh-list
578835|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
578836|NCT03620916|Narcotics|narcotics|mesh-ancestor
578837|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578838|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578839|NCT03620916|Analgesics|analgesics|mesh-ancestor
578840|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
578841|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076100|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214479|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214480|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
2214481|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214482|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
578848|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
578849|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
578850|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
578851|NCT03620838|Progesterone|progesterone|mesh-list
578852|NCT03620838|Progestins|progestins|mesh-ancestor
578853|NCT03620838|Hormones|hormones|mesh-ancestor
578854|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
578855|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578856|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
578857|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
578858|NCT03620825|Indomethacin|indomethacin|mesh-list
578859|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
578860|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
578861|NCT03620825|Analgesics|analgesics|mesh-ancestor
578862|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
578863|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578864|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578865|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
578866|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
578867|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
578868|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
578869|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
578870|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
578871|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578872|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578873|NCT03620760|Aspirin|aspirin|mesh-list
578874|NCT03620760|Ticagrelor|ticagrelor|mesh-list
578875|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
578876|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
578877|NCT03620760|Analgesics|analgesics|mesh-ancestor
578878|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
578879|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578880|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578881|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
578882|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
578883|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
578884|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
578885|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578886|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
578887|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
578888|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578889|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
578890|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
578891|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
578892|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
578893|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
578894|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2214483|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214484|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
2214485|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214486|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214487|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214488|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214489|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
2214490|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
2214491|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214492|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
2076101|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2076102|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
2076103|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2076104|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076105|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2076106|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2076107|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2076108|NCT02007577|Analgesics|analgesics|mesh-ancestor
2076109|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
2076110|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076111|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076112|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2076113|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2076114|NCT02007863|Fludarabine|fludarabine|mesh-list
2076115|NCT02007863|Melphalan|melphalan|mesh-list
578920|NCT03620591|Lidocaine|lidocaine|mesh-list
578921|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
578922|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
578923|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578924|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578925|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
578926|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578927|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
578928|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
578929|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
578930|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
578931|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578932|NCT03620578|Nivolumab|nivolumab|mesh-list
578933|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
578934|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578935|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
578936|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578937|NCT03620526|Iloprost|iloprost|mesh-list
578938|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
578939|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
578940|NCT03620513|Lidocaine|lidocaine|mesh-list
578941|NCT03620513|Phenylephrine|phenylephrine|mesh-list
578942|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
578943|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
578944|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
578945|NCT03620513|Ephedrine|ephedrine|mesh-list
578946|NCT03620513|Anesthetics|anesthetics|mesh-list
578947|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
578948|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
578949|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578950|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
578951|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578952|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
578953|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
578954|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2076116|NCT02007863|Busulfan|busulfan|mesh-list
578955|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
578956|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578957|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
578958|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
578959|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
578960|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
578961|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
578962|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
578963|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
578964|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
578965|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
578966|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
578967|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
578968|NCT03620513|Protective Agents|protective agents|mesh-ancestor
578969|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
578970|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
578971|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
578972|NCT03620461|Gemcitabine|gemcitabine|mesh-list
578973|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
578974|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
578975|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
578976|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
578977|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578978|NCT03620461|Antiviral Agents|antiviral agents|mesh-ancestor
578979|NCT03620461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
578980|NCT03620461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
578981|NCT03620461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
578982|NCT03620461|Immunologic Factors|immunologic factors|mesh-ancestor
578983|NCT03620461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578984|NCT03620435|Atezolizumab|atezolizumab|mesh-list
578985|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
578986|NCT03620422|Mannitol|mannitol|mesh-list
578987|NCT03620422|Albuterol|albuterol|mesh-list
578988|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
578989|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
578990|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
578991|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
578992|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
578993|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
578994|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
578995|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
578996|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
578997|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
578998|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
578999|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
579000|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
579001|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579002|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
579003|NCT03620422|Diuretics|diuretics|mesh-ancestor
579004|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
579005|NCT03620318|Crenolanib|crenolanib|mesh-list
579006|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579007|NCT03620292|Bevacizumab|bevacizumab|mesh-list
579008|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
579009|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579010|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
579011|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
579012|NCT03620292|Growth Substances|growth substances|mesh-ancestor
579013|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579014|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
579015|NCT03620253|Modafinil|modafinil|mesh-list
579016|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
579017|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579018|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
579019|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
579020|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
579021|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076117|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214493|NCT00025051|Celecoxib|celecoxib|mesh-list
2214494|NCT00025051|Mitogens|mitogens|mesh-list
2214495|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2214496|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
579027|NCT03620149|Denosumab|denosumab|mesh-list
579028|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
579029|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076118|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076119|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076120|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
2076121|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076122|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2076123|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
2076124|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2076125|NCT02008227|Docetaxel|docetaxel|mesh-list
2076126|NCT02008227|Atezolizumab|atezolizumab|mesh-list
579040|NCT03620032|Vinorelbine|vinorelbine|mesh-list
579041|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
579042|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
579043|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579044|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
579045|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
579046|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
579047|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579048|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
579049|NCT03620019|Denosumab|denosumab|mesh-list
579050|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
579051|NCT03620019|Nivolumab|nivolumab|mesh-list
579052|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
579053|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579054|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
579055|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579056|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
579057|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579058|NCT03619876|Adalimumab|adalimumab|mesh-list
579059|NCT03619876|Abatacept|abatacept|mesh-list
579060|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
579061|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
579062|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
579063|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579064|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579065|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
579066|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
579067|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579068|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
579069|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
579070|NCT03619850|Hematinics|hematinics|mesh-ancestor
579071|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
579072|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2214497|NCT00025051|Analgesics|analgesics|mesh-ancestor
2214498|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
2214499|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2214500|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579078|NCT03619824|Gemcitabine|gemcitabine|mesh-list
579079|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579080|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
579081|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
579082|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579083|NCT03619824|Antiviral Agents|antiviral agents|mesh-ancestor
579084|NCT03619824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579085|NCT03619824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579086|NCT03619824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
579087|NCT03619824|Immunologic Factors|immunologic factors|mesh-ancestor
579088|NCT03619824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579089|NCT03619785|Acetaminophen|acetaminophen|mesh-list
579090|NCT03619785|Ibuprofen|ibuprofen|mesh-list
579091|NCT03619785|Ketorolac|ketorolac|mesh-list
579092|NCT03619785|Fentanyl|fentanyl|mesh-list
579093|NCT03619785|Morphine|morphine|mesh-list
579094|NCT03619785|Hydromorphone|hydromorphone|mesh-list
579095|NCT03619785|Hydrocodone|hydrocodone|mesh-list
579096|NCT03619785|Ketamine|ketamine|mesh-list
579097|NCT03619785|Gabapentin|gabapentin|mesh-list
579098|NCT03619785|Bupivacaine|bupivacaine|mesh-list
579099|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
579100|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
579101|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
579102|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579103|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
579104|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579105|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
579106|NCT03619785|Narcotics|narcotics|mesh-ancestor
579107|NCT03619785|Analgesics|analgesics|mesh-ancestor
579108|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
579109|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
579110|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
579111|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
579112|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
579113|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
579114|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579115|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
579116|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
579117|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
579118|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
579119|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
579120|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
579121|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
579122|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579123|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
579124|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
579125|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
579126|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
579127|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
579128|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
579129|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
579130|NCT03619707|Progesterone|progesterone|mesh-list
579131|NCT03619707|Progestins|progestins|mesh-ancestor
579132|NCT03619707|Hormones|hormones|mesh-ancestor
579133|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
579134|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076127|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076128|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
2076129|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
2076130|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
2076131|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579144|NCT03619538|Nefopam|nefopam|mesh-list
579145|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
579146|NCT03619538|Analgesics|analgesics|mesh-ancestor
579147|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
579148|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579149|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579150|NCT03619408|Antacids|antacids|mesh-list
579151|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579152|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
579153|NCT03619330|Liraglutide|liraglutide|mesh-list
579154|NCT03619330|Testosterone|testosterone|mesh-list
579155|NCT03619330|Androgens|androgens|mesh-ancestor
579156|NCT03619330|Hormones|hormones|mesh-ancestor
579157|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
579158|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579159|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
579160|NCT03619330|Incretins|incretins|mesh-ancestor
579161|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
579162|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
579163|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
579164|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579165|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579171|NCT03619057|Anesthetics|anesthetics|mesh-list
579172|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
579173|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579174|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
579175|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
579176|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
579177|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579178|NCT03618953|Atezolizumab|atezolizumab|mesh-list
579179|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076143|NCT02008565|Loperamide|loperamide|mesh-list
2076144|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
2076145|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2076146|NCT02008617|Bupivacaine|bupivacaine|mesh-list
2076147|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
2076148|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
2076149|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2076150|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076151|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
2076152|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579198|NCT03618797|Fenofibrate|fenofibrate|mesh-list
579199|NCT03618797|Pitavastatin|pitavastatin|mesh-list
579200|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
579201|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
579202|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579203|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
579204|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
579205|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
579206|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579207|NCT03618758|Paclitaxel|paclitaxel|mesh-list
579208|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
579209|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579210|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
579211|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
579212|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
579213|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579217|NCT03618654|Metformin|metformin|mesh-list
579218|NCT03618654|Durvalumab|durvalumab|mesh-list
579219|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
579220|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
579221|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
579222|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
579223|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579224|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
579225|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579226|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
2214501|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2214502|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214503|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2214504|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2214505|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214506|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214507|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214508|NCT00025064|Prednisolone|prednisolone|mesh-list
579235|NCT03618589|Pregabalin|pregabalin|mesh-list
579236|NCT03618589|Analgesics|analgesics|mesh-ancestor
579237|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
579238|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579239|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579240|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
579241|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
579242|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
579243|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579244|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
579245|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
579246|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
579247|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
579248|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
579249|NCT03618550|Gemcitabine|gemcitabine|mesh-list
579250|NCT03618550|Doxorubicin|doxorubicin|mesh-list
579251|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
579252|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
579253|NCT03618550|Vinorelbine|vinorelbine|mesh-list
579254|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
579255|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
579256|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579257|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579258|NCT03618550|Antiviral Agents|antiviral agents|mesh-ancestor
2076153|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
579259|NCT03618550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579260|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579261|NCT03618550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
579262|NCT03618550|Immunologic Factors|immunologic factors|mesh-ancestor
579263|NCT03618550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579264|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
579265|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
579266|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
579267|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
579268|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
579269|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
579270|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
579271|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
579288|NCT03618472|Metformin|metformin|mesh-list
579289|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
579290|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579291|NCT03618355|Sirolimus|sirolimus|mesh-list
579292|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
579293|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579294|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
579295|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579296|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
579297|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
579298|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
579299|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579300|NCT03618316|Cimetidine|cimetidine|mesh-list
579301|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
579302|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
579303|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
579304|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
579305|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
579306|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
579307|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579308|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579309|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
579310|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
579311|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579312|NCT03618264|Dexamethasone|dexamethasone|mesh-list
579313|NCT03618264|Ropivacaine|ropivacaine|mesh-list
579314|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
579315|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
579316|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
579317|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579318|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579319|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
579320|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
579321|NCT03618264|Hormones|hormones|mesh-ancestor
579322|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
579323|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
579324|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579325|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
579326|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
579327|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
579328|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
2076154|NCT02008682|Liraglutide|liraglutide|mesh-list
2076155|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2076156|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076157|NCT02008682|Incretins|incretins|mesh-ancestor
2076158|NCT02008682|Hormones|hormones|mesh-ancestor
2214509|NCT00025064|Doxorubicin|doxorubicin|mesh-list
2076159|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2076160|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2076161|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
2076162|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076163|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076164|NCT02008773|Valacyclovir|valacyclovir|mesh-list
2076165|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
2076166|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076167|NCT02008877|Sirolimus|sirolimus|mesh-list
579342|NCT03618173|Dexamethasone|dexamethasone|mesh-list
579343|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
579344|NCT03618173|BB 1101|bb 1101|mesh-list
579345|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
579346|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
579347|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
579348|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579349|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579350|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
579351|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
579352|NCT03618173|Hormones|hormones|mesh-ancestor
579353|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
579354|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
579355|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579356|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
579357|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579358|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579371|NCT03618108|Azithromycin|azithromycin|mesh-list
579372|NCT03618108|Doxycycline|doxycycline|mesh-list
579373|NCT03618108|Rifabutin|rifabutin|mesh-list
579374|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
579375|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579376|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
579377|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
579378|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
579379|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
579380|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
579381|NCT03618082|Desflurane|desflurane|mesh-list
579382|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
579383|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
579384|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
579385|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
579386|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214510|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2214511|NCT00025064|Etoposide|etoposide|mesh-list
2214512|NCT00025064|Vincristine|vincristine|mesh-list
2214513|NCT00025064|Melphalan|melphalan|mesh-list
2214514|NCT00025064|Ifosfamide|ifosfamide|mesh-list
2214515|NCT00025064|Dacarbazine|dacarbazine|mesh-list
2214516|NCT00025064|Bleomycin|bleomycin|mesh-list
2214517|NCT00025064|Vinblastine|vinblastine|mesh-list
2214518|NCT00025064|Procarbazine|procarbazine|mesh-list
2214519|NCT00025064|Chlorambucil|chlorambucil|mesh-list
2214520|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214521|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214522|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2214523|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214524|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214525|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214526|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214527|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
579405|NCT03617900|Acetaminophen|acetaminophen|mesh-list
579406|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
579407|NCT03617900|Analgesics|analgesics|mesh-ancestor
579408|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
579409|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2214528|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
579410|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579411|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
2214529|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214530|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214531|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
2214532|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214533|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076168|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2076169|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076170|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2076171|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076172|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
579441|NCT03617705|Ethanol|ethanol|mesh-list
579442|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
579443|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579444|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
579445|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579446|NCT03617679|Rucaparib|rucaparib|mesh-list
579447|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
579448|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579449|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579450|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579451|NCT03617666|Avelumab|avelumab|mesh-list
579452|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
579453|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579454|NCT03617575|Lactoferrin|lactoferrin|mesh-list
579455|NCT03617575|Fesoterodine|fesoterodine|mesh-list
579456|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579457|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
579458|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
579459|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
579460|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
579461|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579462|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579463|NCT03617575|Urological Agents|urological agents|mesh-ancestor
2214534|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
2214535|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214536|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
579467|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
579468|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
579469|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
579470|NCT03617510|Analgesics|analgesics|mesh-ancestor
579471|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
579472|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579473|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579474|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
579475|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
579476|NCT03617484|Bortezomib|bortezomib|mesh-list
579477|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579478|NCT03617471|Acetaminophen|acetaminophen|mesh-list
579479|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
579480|NCT03617471|Analgesics|analgesics|mesh-ancestor
579481|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
579482|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579483|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579484|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
579485|NCT03617458|Metformin|metformin|mesh-list
579486|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
579487|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076173|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076174|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
2076175|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579491|NCT03617432|Prednisone|prednisone|mesh-list
579492|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
579493|NCT03617432|Doxorubicin|doxorubicin|mesh-list
579494|NCT03617432|Etoposide|etoposide|mesh-list
579495|NCT03617432|Vincristine|vincristine|mesh-list
579496|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
579497|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
579498|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579499|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
579500|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
579501|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
579502|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579503|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579504|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
579505|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
579506|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
579507|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
579508|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579509|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
579510|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
579511|NCT03617432|Hormones|hormones|mesh-ancestor
579512|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
579513|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
579514|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
579515|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
579516|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
579517|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
579528|NCT03617328|Poly ICLC|poly iclc|mesh-list
579529|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
579530|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579531|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
579532|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
579533|NCT03617289|Analgesics|analgesics|mesh-ancestor
579534|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
579535|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579536|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579537|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
579538|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
579539|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
579540|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
579541|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
579542|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
579543|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579544|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
579545|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
579546|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
579547|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
579548|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
579549|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579550|NCT03617172|Misoprostol|misoprostol|mesh-list
579551|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
579552|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
579553|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
579554|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579555|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
579556|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
579557|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
579558|NCT03617055|Cystatins|cystatins|mesh-list
579559|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
579560|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
579561|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579562|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579563|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
579564|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579565|NCT03617016|Domperidone|domperidone|mesh-list
579566|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
579567|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
579568|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579569|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579570|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
579571|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
579572|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
579573|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
579574|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214537|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
2214538|NCT00025064|Hormones|hormones|mesh-ancestor
579588|NCT03616808|Hemostatics|hemostatics|mesh-list
579589|NCT03616808|Coagulants|coagulants|mesh-ancestor
579590|NCT03616782|Ixazomib|ixazomib|mesh-list
579591|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579592|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
579593|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579594|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579595|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
579596|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
579597|NCT03616717|Modafinil|modafinil|mesh-list
579598|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
579599|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579600|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
579601|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
579602|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
579603|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579604|NCT03616691|Bevacizumab|bevacizumab|mesh-list
579605|NCT03616691|Atezolizumab|atezolizumab|mesh-list
579606|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
579607|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
579608|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579609|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
579610|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
579611|NCT03616691|Growth Substances|growth substances|mesh-ancestor
579612|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579613|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
579614|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
579615|NCT03616639|Morphine|morphine|mesh-list
579616|NCT03616639|Oxycodone|oxycodone|mesh-list
579617|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
579618|NCT03616639|Narcotics|narcotics|mesh-ancestor
579619|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
579620|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579621|NCT03616639|Analgesics|analgesics|mesh-ancestor
579622|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
579623|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076176|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2076177|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
2076178|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076179|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2076180|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
2076181|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076182|NCT02008942|Aspirin|aspirin|mesh-list
2076183|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2076184|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
579638|NCT03616561|Apremilast|apremilast|mesh-list
579639|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
579640|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
579641|NCT03616561|Analgesics|analgesics|mesh-ancestor
579642|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
579643|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579644|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579645|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
579646|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
579647|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
579648|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
579649|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579650|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579651|NCT03616509|Hormones|hormones|mesh-list
579652|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
579653|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579656|NCT03616405|Amoxicillin|amoxicillin|mesh-list
579657|NCT03616405|Tetracycline|tetracycline|mesh-list
579658|NCT03616405|Furazolidone|furazolidone|mesh-list
579659|NCT03616405|Rabeprazole|rabeprazole|mesh-list
579660|NCT03616405|Bismuth|bismuth|mesh-list
579661|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
579662|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579663|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
579664|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
579665|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
579666|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579667|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579668|NCT03616405|Antacids|antacids|mesh-ancestor
579669|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
579670|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
579671|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
579672|NCT03616405|Renal Agents|renal agents|mesh-ancestor
579673|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
579674|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
579675|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
579676|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
579677|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
579678|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
579679|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579680|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
579681|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579682|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579683|NCT03616288|Thiamine|thiamine|mesh-list
579684|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
579685|NCT03616288|Vitamins|vitamins|mesh-ancestor
579686|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
579687|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579688|NCT03616262|Lidocaine|lidocaine|mesh-list
579689|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
579690|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
579691|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
579692|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579693|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
579694|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579695|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
579696|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
579697|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
579698|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
579699|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579700|NCT03616236|Buprenorphine|buprenorphine|mesh-list
579701|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
579702|NCT03616236|Naloxone|naloxone|mesh-list
579703|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
579704|NCT03616236|Narcotics|narcotics|mesh-ancestor
579705|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
579706|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579707|NCT03616236|Analgesics|analgesics|mesh-ancestor
579708|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
579709|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579710|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
579711|NCT03616132|Sirolimus|sirolimus|mesh-list
579712|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
579713|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579714|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
579715|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579716|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
579717|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
579718|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
579719|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579720|NCT03615950|Vitamin D|vitamin d|mesh-list
579721|NCT03615950|Vitamins|vitamins|mesh-ancestor
579722|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
579723|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579724|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2214539|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2214540|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2214541|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
2214542|NCT00025077|Thiotepa|thiotepa|mesh-list
2214543|NCT00025077|Carboplatin|carboplatin|mesh-list
2214544|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214545|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
2214546|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214547|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
579734|NCT03615833|Vitamin D|vitamin d|mesh-list
579735|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
579736|NCT03615833|Vitamins|vitamins|mesh-ancestor
579737|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
579738|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579739|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
579740|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2214548|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214549|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
579743|NCT03615768|Clindamycin|clindamycin|mesh-list
579744|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
579745|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
579746|NCT03615768|Adapalene|adapalene|mesh-list
579747|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
579748|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579749|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
579750|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579751|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579752|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
579753|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
579754|NCT03615768|Analgesics|analgesics|mesh-ancestor
579755|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
579756|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579757|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579758|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
579759|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
579760|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
2076185|NCT02008942|Analgesics|analgesics|mesh-ancestor
2076186|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
2076187|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076188|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076189|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2076190|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2076191|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2076192|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2076193|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076194|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
579772|NCT03615677|Esomeprazole|esomeprazole|mesh-list
579773|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
579774|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
579775|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
579776|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579777|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579802|NCT03615547|Clomiphene|clomiphene|mesh-list
579803|NCT03615547|Enclomiphene|enclomiphene|mesh-list
579804|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
579805|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
579806|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
579807|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
579808|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579809|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
579810|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
579811|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
579812|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
579813|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2214550|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214551|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214552|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214553|NCT00025090|Fluorouracil|fluorouracil|mesh-list
2214554|NCT00025090|Mitomycins|mitomycins|mesh-list
2214555|NCT00025090|Mitomycin|mitomycin|mesh-list
2214556|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214557|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
2214558|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214559|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214560|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214561|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
2214562|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214563|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214564|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
2214565|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2214566|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214567|NCT00025103|Dactinomycin|dactinomycin|mesh-list
2214568|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
2214569|NCT00025103|Melphalan|melphalan|mesh-list
2214570|NCT00025103|Carboplatin|carboplatin|mesh-list
2214571|NCT00025103|Doxorubicin|doxorubicin|mesh-list
2214572|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2214573|NCT00025103|Etoposide|etoposide|mesh-list
2214574|NCT00025103|Vincristine|vincristine|mesh-list
2214575|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214576|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
2214577|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214578|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214579|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214580|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
2214581|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579846|NCT03615430|Anesthetics|anesthetics|mesh-list
579847|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
579848|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
579849|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579850|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
579851|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579852|NCT03615417|Anesthetics|anesthetics|mesh-list
579853|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
579854|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214582|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214583|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214584|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214585|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
579860|NCT03615326|Capecitabine|capecitabine|mesh-list
579861|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
579862|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
579863|NCT03615326|Trastuzumab|trastuzumab|mesh-list
579941|NCT03614715|Interferon-beta|interferon-beta|mesh-list
579864|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579865|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
579866|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
579867|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579868|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
579869|NCT03615313|Antibodies|antibodies|mesh-list
579870|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
579871|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579872|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
579873|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2214586|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214587|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214588|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214589|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214590|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214591|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214592|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2214593|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214594|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2214595|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2214596|NCT00025116|Gefitinib|gefitinib|mesh-list
2214597|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214598|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2214599|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214600|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214601|NCT00025142|Leucovorin|leucovorin|mesh-list
2214602|NCT00025142|Fluorouracil|fluorouracil|mesh-list
2214603|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
2214604|NCT00025142|Gefitinib|gefitinib|mesh-list
579916|NCT03614832|Clopidogrel|clopidogrel|mesh-list
579917|NCT03614832|Ticagrelor|ticagrelor|mesh-list
579918|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
579919|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
579920|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
579921|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
579922|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
579923|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
579924|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579925|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579926|NCT03614741|Tinzaparin|tinzaparin|mesh-list
579927|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
579928|NCT03614741|Dalteparin|dalteparin|mesh-list
579929|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
579930|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
579931|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
579932|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579940|NCT03614715|Interferons|interferons|mesh-list
579942|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
579943|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
579944|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
579945|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579946|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
579947|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579948|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
579949|NCT03614533|Vaccines|vaccines|mesh-list
579950|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
579951|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579952|NCT03614494|Piroxicam|piroxicam|mesh-list
579953|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
579954|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
579955|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
579956|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
579957|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579958|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
579959|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
579960|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
579961|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
579962|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
579963|NCT03614494|Analgesics|analgesics|mesh-ancestor
579964|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
579965|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
579966|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
579967|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
579968|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
579969|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579970|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579971|NCT03614455|Itraconazole|itraconazole|mesh-list
579972|NCT03614455|Posaconazole|posaconazole|mesh-list
579973|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
579974|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
579975|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579976|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
579977|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
579978|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
579979|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
579980|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
579981|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
579982|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
579983|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579984|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
579985|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
579986|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
579987|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
579988|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
579989|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
579990|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
579991|NCT03614403|Vitamin D|vitamin d|mesh-list
579992|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
579993|NCT03614403|Vitamins|vitamins|mesh-ancestor
579994|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
579995|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
579996|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
579997|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
579998|NCT03614273|Epinephrine|epinephrine|mesh-list
579999|NCT03614273|Racepinephrine|racepinephrine|mesh-list
580000|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
580001|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
580002|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
580003|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
580004|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580005|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580006|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580007|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
580008|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
580009|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
580010|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580011|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
580012|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
580013|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
580014|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
580015|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
580016|NCT03614221|Tacrolimus|tacrolimus|mesh-list
580468|NCT03611556|Paclitaxel|paclitaxel|mesh-list
580017|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
580018|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
580019|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580020|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
580021|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580022|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580023|NCT03614065|Endostar protein|endostar protein|mesh-list
580024|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
580025|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
580026|NCT03614065|Growth Substances|growth substances|mesh-ancestor
580027|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580028|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
580029|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580030|NCT03614052|Tamsulosin|tamsulosin|mesh-list
580031|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
580032|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
580033|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
580034|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
580035|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580036|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580037|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580038|NCT03614052|Urological Agents|urological agents|mesh-ancestor
580039|NCT03613974|Lidocaine|lidocaine|mesh-list
580040|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
580041|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
580042|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580043|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580044|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
580045|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580046|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
580047|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
580048|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
580049|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
580050|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580051|NCT03613961|Anesthetics|anesthetics|mesh-list
580052|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580053|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580054|NCT03613857|Clopidogrel|clopidogrel|mesh-list
580055|NCT03613857|Ticagrelor|ticagrelor|mesh-list
580056|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
580057|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
580058|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
580059|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
580060|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
580061|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580062|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580063|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580064|NCT03613792|Fentanyl|fentanyl|mesh-list
580065|NCT03613792|Midazolam|midazolam|mesh-list
580066|NCT03613792|Ketamine|ketamine|mesh-list
580067|NCT03613792|Remifentanil|remifentanil|mesh-list
580068|NCT03613792|Analgesics|analgesics|mesh-ancestor
580069|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
580070|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580071|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580072|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
580073|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
580074|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
580075|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
580076|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580077|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
580078|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
580079|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580080|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580081|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
580082|NCT03613792|Narcotics|narcotics|mesh-ancestor
580083|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
580084|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
580085|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
580086|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
580087|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
580088|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
580089|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
580090|NCT03613753|Irinotecan|irinotecan|mesh-list
580091|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
580092|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
580093|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580094|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580095|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076195|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2076196|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076197|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
2076198|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2076199|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2076200|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214605|NCT00025142|Calcium|calcium|mesh-list
2214606|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
2214607|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2214608|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214609|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
2214610|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214611|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214612|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580111|NCT03613597|Etoposide|etoposide|mesh-list
580112|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
580113|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580114|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
580115|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
580116|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
580117|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580118|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580119|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
580120|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
580121|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580122|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580123|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
580124|NCT03613558|Analgesics|analgesics|mesh-ancestor
580125|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
580126|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580127|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
580128|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
580129|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
580130|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
580131|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580132|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580133|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
580134|NCT03613545|Rifaximin|rifaximin|mesh-list
580135|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
580136|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
580137|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
580138|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
580154|NCT03613506|Captopril|captopril|mesh-list
580155|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
580156|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
580157|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580158|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580159|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
580160|NCT03613428|Prednisone|prednisone|mesh-list
580161|NCT03613428|Vincristine|vincristine|mesh-list
580162|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
580163|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
580164|NCT03613428|Hormones|hormones|mesh-ancestor
580165|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
580166|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580167|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
580168|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580169|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
580170|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
580171|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
580172|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
580173|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580174|NCT03613389|Vitamin E|vitamin e|mesh-list
580175|NCT03613389|Vitamins|vitamins|mesh-ancestor
580176|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
580177|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580178|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
580179|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580180|NCT03613389|Protective Agents|protective agents|mesh-ancestor
580181|NCT03613259|Alovudine|alovudine|mesh-list
580182|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
580183|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
580184|NCT03613207|Lidocaine|lidocaine|mesh-list
580185|NCT03613207|Prilocaine|prilocaine|mesh-list
580186|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
580187|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
580188|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580189|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580190|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
580191|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580192|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
580193|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
580194|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
580195|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
580196|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580197|NCT03613181|Paclitaxel|paclitaxel|mesh-list
580198|NCT03613181|Capecitabine|capecitabine|mesh-list
580199|NCT03613181|Methotrexate|methotrexate|mesh-list
580200|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
580201|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580202|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
580203|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
580204|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
580205|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580206|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
580207|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
580208|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
580209|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
580210|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
580211|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580212|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
580213|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580214|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
580215|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
580216|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
580217|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
580218|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
580219|NCT03613168|Trastuzumab|trastuzumab|mesh-list
580220|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
580221|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076201|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2076202|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2076203|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2076204|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076205|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
2076206|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580229|NCT03612973|Insulin|insulin|mesh-list
580230|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
580231|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580232|NCT03612960|Nicotine|nicotine|mesh-list
580233|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
580234|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
580235|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580236|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580237|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
580238|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
580239|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
580240|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580469|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
580241|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580242|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
580243|NCT03612947|Bupivacaine|bupivacaine|mesh-list
580244|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
580245|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
580246|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580247|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580248|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
580249|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580250|NCT03612947|Analgesics|analgesics|mesh-ancestor
580251|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
580252|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
580253|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
580254|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
580255|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580256|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
580257|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
580258|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2076207|NCT02009332|Gemcitabine|gemcitabine|mesh-list
2076208|NCT02009332|Sirolimus|sirolimus|mesh-list
2076209|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2076210|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
2076211|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076212|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076213|NCT02009332|Antiviral Agents|antiviral agents|mesh-ancestor
2076214|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076215|NCT02009332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076216|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076217|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
2076218|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076219|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
580272|NCT03612817|Timolol|timolol|mesh-list
580273|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
580274|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
580275|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
580276|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580277|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580278|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580279|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
580280|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
580281|NCT03612791|Atezolizumab|atezolizumab|mesh-list
580282|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580283|NCT03612739|Azacitidine|azacitidine|mesh-list
580284|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
580285|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
580286|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580287|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580288|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580297|NCT03612557|Penicillins|penicillins|mesh-list
580298|NCT03612557|Penicillin G|penicillin g|mesh-list
580299|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
580300|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
580301|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
580302|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
580303|NCT03612492|Lidocaine|lidocaine|mesh-list
580304|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
580305|NCT03612492|Anesthetics|anesthetics|mesh-list
580306|NCT03612492|Esmolol|esmolol|mesh-list
580307|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580308|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580309|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
580310|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580311|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
580312|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
580313|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
580314|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
580315|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580316|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
580317|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
580318|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
580319|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580320|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2076220|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2076221|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
2076222|NCT02009397|Ipilimumab|ipilimumab|mesh-list
2076223|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2076224|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076225|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2076226|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076227|NCT02009722|Morphine|morphine|mesh-list
2076228|NCT02009722|Hydromorphone|hydromorphone|mesh-list
2076229|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2076230|NCT02009722|Narcotics|narcotics|mesh-ancestor
580333|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
580334|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
580335|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580336|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580337|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
580338|NCT03612440|Analgesics|analgesics|mesh-ancestor
580339|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
580340|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580341|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
580342|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
580343|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
580344|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
580345|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580346|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580347|NCT03612401|Mirabegron|mirabegron|mesh-list
580348|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
580349|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
580350|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
580351|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
580352|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580353|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580354|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580355|NCT03612401|Urological Agents|urological agents|mesh-ancestor
580356|NCT03612349|Menthol|menthol|mesh-list
580357|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
580358|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
580359|NCT03612323|Piroxicam|piroxicam|mesh-list
580360|NCT03612323|Carticaine|carticaine|mesh-list
580361|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
580362|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
580363|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580364|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580365|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
580366|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580367|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
580368|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
580369|NCT03612323|Analgesics|analgesics|mesh-ancestor
580370|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
580371|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
580372|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
580373|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580374|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580375|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
580376|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
580377|NCT03612219|Apatinib|apatinib|mesh-list
580378|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580379|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
580380|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580381|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580382|NCT03612180|Metoprolol|metoprolol|mesh-list
580383|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
580384|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
580385|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
580386|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
580387|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580388|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580389|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
580390|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
580391|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
580392|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
580393|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580394|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580395|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
580396|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
580397|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580398|NCT03612037|Protective Agents|protective agents|mesh-ancestor
580399|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580400|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
580401|NCT03612037|Vitamins|vitamins|mesh-ancestor
580402|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
580403|NCT03611985|Taxane|taxane|mesh-list
580404|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580405|NCT03611920|Tetracycline|tetracycline|mesh-list
580406|NCT03611920|Dexamethasone|dexamethasone|mesh-list
580407|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
580408|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
580409|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
580410|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580411|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580412|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
580413|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
580414|NCT03611920|Hormones|hormones|mesh-ancestor
580415|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
580416|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
580417|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580418|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
580419|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
580420|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
580421|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580422|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580423|NCT03611881|Nicotine|nicotine|mesh-list
580424|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
580425|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
580426|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580427|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580428|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
580429|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
580430|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
580431|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580432|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076231|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2076232|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076233|NCT02009722|Analgesics|analgesics|mesh-ancestor
2076234|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
2076235|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076236|NCT02009878|Tolvaptan|tolvaptan|mesh-list
2076237|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2076238|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076239|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
2076240|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076241|NCT02010021|Letrozole|letrozole|mesh-list
580461|NCT03611595|Tretinoin|tretinoin|mesh-list
580462|NCT03611595|Isotretinoin|isotretinoin|mesh-list
580463|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580464|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
580465|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
580466|NCT03611556|Leucovorin|leucovorin|mesh-list
580467|NCT03611556|Gemcitabine|gemcitabine|mesh-list
580470|NCT03611556|Fluorouracil|fluorouracil|mesh-list
580471|NCT03611556|Durvalumab|durvalumab|mesh-list
580472|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
580473|NCT03611556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
580474|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580475|NCT03611556|Tubulin Modulators|tubulin modulators|mesh-ancestor
580476|NCT03611556|Antimitotic Agents|antimitotic agents|mesh-ancestor
580477|NCT03611556|Mitosis Modulators|mitosis modulators|mesh-ancestor
580478|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580479|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
580480|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
580481|NCT03611556|Antiviral Agents|antiviral agents|mesh-ancestor
580482|NCT03611556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
580483|NCT03611556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580484|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
580485|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
580486|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580487|NCT03611556|Antidotes|antidotes|mesh-ancestor
580488|NCT03611556|Protective Agents|protective agents|mesh-ancestor
580489|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
580490|NCT03611556|Vitamins|vitamins|mesh-ancestor
580491|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
580492|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
580493|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
580494|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
580495|NCT03611504|Hemostatics|hemostatics|mesh-list
580496|NCT03611504|Coagulants|coagulants|mesh-ancestor
580497|NCT03611491|Lidocaine|lidocaine|mesh-list
580498|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
580499|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
580500|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580501|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580502|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
580503|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580504|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
580505|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
580506|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
580507|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
580508|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580509|NCT03611426|Thrombin|thrombin|mesh-list
580510|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
580511|NCT03611426|Coagulants|coagulants|mesh-ancestor
580512|NCT03611348|Latanoprost|latanoprost|mesh-list
580513|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
580514|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
580515|NCT03611244|Benzocaine|benzocaine|mesh-list
580516|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
580517|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
580518|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580519|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580520|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
580521|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580522|NCT03611179|Bevacizumab|bevacizumab|mesh-list
580523|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
580524|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580525|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
580526|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
580527|NCT03611179|Growth Substances|growth substances|mesh-ancestor
580528|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580529|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
580530|NCT03611049|Vitamin D|vitamin d|mesh-list
580531|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
580532|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
580533|NCT03611049|Vitamins|vitamins|mesh-list
580534|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
580535|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580536|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
580537|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
580538|NCT03611010|Atorvastatin|atorvastatin|mesh-list
580539|NCT03611010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
580540|NCT03611010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
580541|NCT03611010|Antimetabolites|antimetabolites|mesh-ancestor
580542|NCT03611010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580543|NCT03611010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
580544|NCT03611010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
580545|NCT03611010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580546|NCT03610945|Fluconazole|fluconazole|mesh-list
580547|NCT03610945|Quinidine|quinidine|mesh-list
580548|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
580549|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
580550|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
580551|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
580552|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580553|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580554|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
580555|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
580556|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
580557|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580558|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
580559|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
580560|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
580561|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
580562|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
580563|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580564|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
580565|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
580566|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
580567|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
580568|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
580569|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
580570|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
580571|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
580572|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
580573|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
580574|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
580575|NCT03610932|Ascorbic Acid|ascorbic acid|mesh-list
580576|NCT03610932|Vitamins|vitamins|mesh-ancestor
580577|NCT03610932|Micronutrients|micronutrients|mesh-ancestor
580578|NCT03610932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580579|NCT03610932|Antioxidants|antioxidants|mesh-ancestor
580580|NCT03610932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580581|NCT03610932|Protective Agents|protective agents|mesh-ancestor
580582|NCT03610893|Dexamethasone|dexamethasone|mesh-list
580583|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
580584|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
580585|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
580586|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
580587|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580588|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580589|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
580590|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
580591|NCT03610893|Hormones|hormones|mesh-ancestor
580592|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
580593|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
580594|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580595|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
580596|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580597|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
580598|NCT03610893|Analgesics|analgesics|mesh-ancestor
580599|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
580600|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
580601|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
580602|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
580603|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
580604|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580605|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580606|NCT03610880|Yimitasvir|yimitasvir|mesh-list
580607|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
580608|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
580609|NCT03610711|Nivolumab|nivolumab|mesh-list
580610|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
580611|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580612|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
580613|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580614|NCT03610685|Prednisolone|prednisolone|mesh-list
580615|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
580616|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
580617|NCT03610685|Hormones|hormones|mesh-ancestor
580618|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
580619|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580620|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
580621|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214613|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214614|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
2214615|NCT00025142|Antidotes|antidotes|mesh-ancestor
2214616|NCT00025142|Protective Agents|protective agents|mesh-ancestor
2076242|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076243|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2076244|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2076245|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076246|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076247|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2076248|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
2076249|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2076250|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076251|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
2076252|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2076253|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
2076254|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076255|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
2076256|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2076257|NCT02010255|Ledipasvir|ledipasvir|mesh-list
2076258|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
2214617|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
2214618|NCT00025142|Vitamins|vitamins|mesh-ancestor
2214619|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
2214620|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2214621|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214622|NCT00025168|Gemcitabine|gemcitabine|mesh-list
2214623|NCT00025168|Irinotecan|irinotecan|mesh-list
2214624|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214625|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
2214626|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214627|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214628|NCT00025168|Antiviral Agents|antiviral agents|mesh-ancestor
2214629|NCT00025168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214630|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214631|NCT00025168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
580662|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
580663|NCT03610412|Antacids|antacids|mesh-ancestor
580664|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580665|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2214632|NCT00025168|Immunologic Factors|immunologic factors|mesh-ancestor
2214633|NCT00025168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214634|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2214635|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214636|NCT00025181|Ipilimumab|ipilimumab|mesh-list
580671|NCT03610347|Paclitaxel|paclitaxel|mesh-list
580672|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
580673|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580674|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
580675|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
580676|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
580677|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580678|NCT03610321|Gefarnate|gefarnate|mesh-list
580679|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
580680|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
580681|NCT03610282|Propofol|propofol|mesh-list
580682|NCT03610282|Methylphenidate|methylphenidate|mesh-list
580683|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
580684|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580685|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580686|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
580687|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
580688|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
580689|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
580690|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
580691|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
580692|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
580693|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580694|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
2214637|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
580695|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580696|NCT03610230|Iron|iron|mesh-list
580697|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
580698|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
580699|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
580700|NCT03610230|Trace Elements|trace elements|mesh-ancestor
580701|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
580702|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580703|NCT03610230|Hematinics|hematinics|mesh-ancestor
580704|NCT03610178|Insulin|insulin|mesh-list
580705|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
580706|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
580707|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580708|NCT03610139|Vitamin D|vitamin d|mesh-list
580709|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
580710|NCT03610139|Vitamins|vitamins|mesh-ancestor
580711|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
580712|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580713|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
580714|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
580715|NCT03610100|Gemcitabine|gemcitabine|mesh-list
580716|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
580717|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
580718|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580719|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580720|NCT03610100|Antiviral Agents|antiviral agents|mesh-ancestor
580721|NCT03610100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
580722|NCT03610100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580723|NCT03610100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
580724|NCT03610100|Immunologic Factors|immunologic factors|mesh-ancestor
580725|NCT03610100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580729|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
580730|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
580731|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
580732|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580733|NCT03609996|Ranibizumab|ranibizumab|mesh-list
580734|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
580735|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
580736|NCT03609996|Growth Substances|growth substances|mesh-ancestor
580737|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580738|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
580739|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580740|NCT03609970|Vitamin D|vitamin d|mesh-list
580741|NCT03609970|Vitamins|vitamins|mesh-ancestor
580742|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
580743|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580744|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
580745|NCT03609892|Amoxicillin|amoxicillin|mesh-list
580746|NCT03609892|Tetracycline|tetracycline|mesh-list
580747|NCT03609892|Furazolidone|furazolidone|mesh-list
580748|NCT03609892|Esomeprazole|esomeprazole|mesh-list
580749|NCT03609892|Bismuth|bismuth|mesh-list
580750|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
580751|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
580752|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
580753|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
580754|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
580755|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580756|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580757|NCT03609892|Antacids|antacids|mesh-ancestor
580758|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
580759|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
580760|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
580761|NCT03609892|Renal Agents|renal agents|mesh-ancestor
580762|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
580763|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
580764|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
580765|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
580766|NCT03609840|Thiotepa|thiotepa|mesh-list
580767|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
580768|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
580769|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
580770|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580771|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
580772|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
580773|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
580774|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580775|NCT03609827|Melphalan|melphalan|mesh-list
580776|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
580777|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
580778|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580779|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580780|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
580781|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
580782|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
580783|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580784|NCT03609814|Fludarabine|fludarabine|mesh-list
580785|NCT03609814|Clofarabine|clofarabine|mesh-list
580786|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580787|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
580788|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
580789|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580790|NCT03609775|Ethanol|ethanol|mesh-list
580791|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
580792|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
580793|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580794|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580795|NCT03609593|Rituximab|rituximab|mesh-list
580796|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
580797|NCT03609593|Venetoclax|venetoclax|mesh-list
580798|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
580799|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580800|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
580801|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580802|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
580803|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
580804|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
580805|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580806|NCT03609580|Tamsulosin|tamsulosin|mesh-list
580807|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
580808|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
580809|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
580810|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
580811|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580812|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580813|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580814|NCT03609580|Urological Agents|urological agents|mesh-ancestor
580815|NCT03609489|Capecitabine|capecitabine|mesh-list
580816|NCT03609489|Apatinib|apatinib|mesh-list
580817|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
580818|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
580819|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580820|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580821|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
580822|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580823|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
580824|NCT03609424|Spartalizumab|spartalizumab|mesh-list
580825|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580826|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
580827|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580828|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580829|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
580830|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
580831|NCT03609359|Lenvatinib|lenvatinib|mesh-list
580832|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
580833|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580834|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
580835|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580836|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580837|NCT03609307|Bevacizumab|bevacizumab|mesh-list
580838|NCT03609307|Propranolol|propranolol|mesh-list
580839|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
580840|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580841|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
580842|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
580843|NCT03609307|Growth Substances|growth substances|mesh-ancestor
580844|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580845|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
580846|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
580847|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
580848|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
580849|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580850|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580851|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
580852|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
580853|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
580854|NCT03609294|Linagliptin|linagliptin|mesh-list
580855|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
580856|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580857|NCT03609294|Incretins|incretins|mesh-ancestor
580858|NCT03609294|Hormones|hormones|mesh-ancestor
580859|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
580860|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
580861|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
580862|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580863|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076259|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076260|NCT02010567|Capecitabine|capecitabine|mesh-list
2076261|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2076262|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
2076263|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076264|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076265|NCT02010632|Clopidogrel|clopidogrel|mesh-list
2076266|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2076267|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2076268|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
580875|NCT03609190|Ketamine|ketamine|mesh-list
580876|NCT03609190|Analgesics|analgesics|mesh-ancestor
580877|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
580878|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580879|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580880|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
580881|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
580882|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
580883|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
580884|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580885|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
580886|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
580887|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
580888|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580889|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
580890|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
580891|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
580892|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
580893|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
580894|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
580895|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
580896|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580897|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580898|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580899|NCT03609086|Melatonin|melatonin|mesh-list
580900|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
580901|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580902|NCT03609086|Protective Agents|protective agents|mesh-ancestor
580903|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580904|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580905|NCT03609060|Dexamethasone|dexamethasone|mesh-list
580906|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
580907|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
580908|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
580909|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580910|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580911|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
580912|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
580913|NCT03609060|Hormones|hormones|mesh-ancestor
580914|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
580915|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
580916|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580917|NCT03609047|Paclitaxel|paclitaxel|mesh-list
580918|NCT03609047|Docetaxel|docetaxel|mesh-list
580919|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
580920|NCT03609047|Doxorubicin|doxorubicin|mesh-list
580921|NCT03609047|Epirubicin|epirubicin|mesh-list
580922|NCT03609047|Palbociclib|palbociclib|mesh-list
580923|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
580924|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
580925|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
580926|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
580927|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
580928|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580929|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
580930|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
580931|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580932|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
580933|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
580934|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
580935|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
580936|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
580937|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
580938|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
580939|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580940|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
580941|NCT03609008|Cromakalim|cromakalim|mesh-list
580942|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
580943|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
580944|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
580945|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580946|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580947|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
580948|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
580949|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
580950|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
2214638|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2214639|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214640|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2214641|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214642|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2214643|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
2214644|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214645|NCT00025194|Estramustine|estramustine|mesh-list
2214646|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214647|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
2214648|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214649|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214650|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2214651|NCT00025207|Gefitinib|gefitinib|mesh-list
2214652|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214653|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2214654|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214655|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214656|NCT00025220|Thalidomide|thalidomide|mesh-list
2214657|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214658|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
2214659|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214660|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
580980|NCT03608761|Rebamipide|rebamipide|mesh-list
580981|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
580982|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
580983|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
580984|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
580985|NCT03608761|Protective Agents|protective agents|mesh-ancestor
580986|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580987|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
580988|NCT03608696|Buprenorphine|buprenorphine|mesh-list
580989|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
580990|NCT03608696|Narcotics|narcotics|mesh-ancestor
580991|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
580992|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
580993|NCT03608696|Analgesics|analgesics|mesh-ancestor
580994|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
580995|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
580996|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2076269|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2076270|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
2076271|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076272|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076273|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076274|NCT02010645|Decitabine|decitabine|mesh-list
2076275|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2076276|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
2076277|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076278|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076279|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076280|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
2076281|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
581010|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
581011|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
581012|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
581013|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581014|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
581015|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
581016|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
581017|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581018|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581019|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
581020|NCT03608514|Terlipressin|terlipressin|mesh-list
581021|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
581022|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
581023|NCT03608501|Thalidomide|thalidomide|mesh-list
581024|NCT03608501|Dexamethasone|dexamethasone|mesh-list
581025|NCT03608501|Ixazomib|ixazomib|mesh-list
581026|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
581027|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
581028|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
581029|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581030|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581031|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
581032|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
581033|NCT03608501|Hormones|hormones|mesh-ancestor
581034|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
581035|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
581036|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581037|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581038|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
581039|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
581040|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
581041|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
581042|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
581043|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
581044|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
581045|NCT03608501|Growth Substances|growth substances|mesh-ancestor
581046|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
581047|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
581048|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214661|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2214662|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214663|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2214664|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2214665|NCT00025220|Growth Substances|growth substances|mesh-ancestor
2076282|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2076283|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2076284|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2076285|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076286|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
2076287|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076288|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581062|NCT03608397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
581063|NCT03608397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
581064|NCT03608397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
581065|NCT03608397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581066|NCT03608397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581067|NCT03608397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
581068|NCT03608397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
581069|NCT03608397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581070|NCT03608397|Cholinergic Agents|cholinergic agents|mesh-ancestor
581071|NCT03608397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
581072|NCT03608358|Metformin|metformin|mesh-list
581073|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
581074|NCT03608358|Saxagliptin|saxagliptin|mesh-list
581075|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
581076|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581077|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
581078|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581079|NCT03608358|Incretins|incretins|mesh-ancestor
581080|NCT03608358|Hormones|hormones|mesh-ancestor
581081|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
581082|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
581083|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
581084|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581085|NCT03608306|Methamphetamine|methamphetamine|mesh-list
581086|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
581087|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581088|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
581089|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
581090|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581091|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
581092|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
581093|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581094|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
581095|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
581096|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
581097|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
581098|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
581099|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
581100|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
581101|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
581102|NCT03608241|Estradiol|estradiol|mesh-list
581103|NCT03608241|Estrogens|estrogens|mesh-ancestor
581104|NCT03608241|Hormones|hormones|mesh-ancestor
581105|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
581106|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581107|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
581108|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
581109|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
581110|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2076289|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2076290|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076291|NCT02011113|Dexamethasone|dexamethasone|mesh-list
2076292|NCT02011113|Pomalidomide|pomalidomide|mesh-list
2076293|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2076294|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
2076295|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
2076296|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581119|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
581120|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
581121|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
581122|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
581123|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
581124|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581125|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581126|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
581127|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
581128|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581129|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
581130|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
581131|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
581132|NCT03608046|Irinotecan|irinotecan|mesh-list
581133|NCT03608046|Cetuximab|cetuximab|mesh-list
581134|NCT03608046|Avelumab|avelumab|mesh-list
581135|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
581136|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
581137|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581138|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581139|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581140|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
581141|NCT03608007|Ensartinib|ensartinib|mesh-list
581142|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581143|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
581144|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581145|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581146|NCT03607955|Paclitaxel|paclitaxel|mesh-list
581147|NCT03607955|Carboplatin|carboplatin|mesh-list
2214666|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
581148|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
581149|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581150|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
581151|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
581152|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
581153|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581154|NCT03607916|Morphine|morphine|mesh-list
581155|NCT03607916|Prilocaine|prilocaine|mesh-list
581156|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
581157|NCT03607916|Narcotics|narcotics|mesh-ancestor
581158|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
581159|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581160|NCT03607916|Analgesics|analgesics|mesh-ancestor
581161|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
581162|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581163|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
581164|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
581165|NCT03607903|Adalimumab|adalimumab|mesh-list
581166|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
581167|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
581168|NCT03607890|Nivolumab|nivolumab|mesh-list
581169|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
581170|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581171|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
581172|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581173|NCT03607851|Lacosamide|lacosamide|mesh-list
581174|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
581175|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
581176|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
581177|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
581178|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581179|NCT03607734|Amoxicillin|amoxicillin|mesh-list
581180|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
581181|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
581182|NCT03607656|Docetaxel|docetaxel|mesh-list
581183|NCT03607656|Capecitabine|capecitabine|mesh-list
581184|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
581185|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581186|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
581187|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
581188|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
581189|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581190|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
581191|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
581192|NCT03607643|Leucovorin|leucovorin|mesh-list
581193|NCT03607643|Gemcitabine|gemcitabine|mesh-list
581194|NCT03607643|Bevacizumab|bevacizumab|mesh-list
581195|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
581196|NCT03607643|Irinotecan|irinotecan|mesh-list
581197|NCT03607643|Bortezomib|bortezomib|mesh-list
581198|NCT03607643|Temozolomide|temozolomide|mesh-list
581199|NCT03607643|Cannabidiol|cannabidiol|mesh-list
581200|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
581201|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581202|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
581203|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
581204|NCT03607643|Growth Substances|growth substances|mesh-ancestor
581205|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581206|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
581207|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
581208|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
581209|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581210|NCT03607643|Antiviral Agents|antiviral agents|mesh-ancestor
581211|NCT03607643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
581212|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581213|NCT03607643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
581214|NCT03607643|Immunologic Factors|immunologic factors|mesh-ancestor
581215|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
581216|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
581217|NCT03607643|Antidotes|antidotes|mesh-ancestor
581218|NCT03607643|Protective Agents|protective agents|mesh-ancestor
581219|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
581220|NCT03607643|Vitamins|vitamins|mesh-ancestor
581221|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
581222|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
581223|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
581224|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
581225|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
581226|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
581227|NCT03607578|Protective Agents|protective agents|mesh-ancestor
581228|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581229|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
2214667|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214668|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
2214669|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214670|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2214671|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214672|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581236|NCT03607422|Upadacitinib|upadacitinib|mesh-list
581237|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
581238|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
581239|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581240|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581241|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
581242|NCT03607383|Red yeast rice|red yeast rice|mesh-list
581243|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
581244|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
581245|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
581246|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
581247|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581248|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581249|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
581250|NCT03607331|Citalopram|citalopram|mesh-list
581251|NCT03607331|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
581252|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
581253|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
581254|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581255|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
581256|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
581257|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581258|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
581259|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
581260|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
581261|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
581262|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
581263|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
581264|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
581265|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581266|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
581267|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581268|NCT03607175|Triamcinolone|triamcinolone|mesh-list
581269|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
581270|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
581271|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
581272|NCT03607175|Hormones|hormones|mesh-ancestor
581273|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
581274|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581275|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
581276|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
581277|NCT03607149|Pemetrexed|pemetrexed|mesh-list
581278|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581279|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581280|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581281|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
581282|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
581283|NCT03607110|Fentanyl|fentanyl|mesh-list
581284|NCT03607110|Ketamine|ketamine|mesh-list
581285|NCT03607110|Analgesics|analgesics|mesh-ancestor
581286|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
581287|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581288|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581289|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
581290|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
581291|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
581292|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
581293|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
581294|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
581295|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
581296|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
581297|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581298|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
581299|NCT03607110|Narcotics|narcotics|mesh-ancestor
581300|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
581301|NCT03607071|Prednisolone|prednisolone|mesh-list
581302|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
581303|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
581304|NCT03607071|Hormones|hormones|mesh-ancestor
581305|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
581306|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581307|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
581308|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581309|NCT03606980|Dexamethasone|dexamethasone|mesh-list
581310|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
581311|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
581312|NCT03606980|BB 1101|bb 1101|mesh-list
581313|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
581314|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
581315|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
581316|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581317|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581318|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
581319|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
581320|NCT03606980|Hormones|hormones|mesh-ancestor
581321|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
581322|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
581323|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581324|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
581325|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581326|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076297|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076298|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2076299|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
2076300|NCT02011113|Hormones|hormones|mesh-ancestor
2076301|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2076302|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2076303|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076304|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
2076305|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2076306|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2076307|NCT02011113|Growth Substances|growth substances|mesh-ancestor
2076308|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
2076309|NCT02011386|Golimumab|golimumab|mesh-list
2076310|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2076311|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2076312|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076313|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
2076314|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076315|NCT02011464|Bupivacaine|bupivacaine|mesh-list
2076316|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
2076317|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
2076318|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2076319|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076320|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
2076321|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076322|NCT02011516|Baclofen|baclofen|mesh-list
2076323|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2076324|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076325|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2076326|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581360|NCT03606928|Leucovorin|leucovorin|mesh-list
581361|NCT03606928|Docetaxel|docetaxel|mesh-list
581362|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
581363|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581364|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
581365|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
581366|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
581367|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581368|NCT03606928|Antidotes|antidotes|mesh-ancestor
581369|NCT03606928|Protective Agents|protective agents|mesh-ancestor
581370|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581371|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
581372|NCT03606928|Vitamins|vitamins|mesh-ancestor
581373|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
581374|NCT03606902|Fentanyl|fentanyl|mesh-list
581375|NCT03606902|Bupivacaine|bupivacaine|mesh-list
581376|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
581377|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
581378|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
581379|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581380|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
581381|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581382|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
581383|NCT03606902|Narcotics|narcotics|mesh-ancestor
581384|NCT03606902|Analgesics|analgesics|mesh-ancestor
581385|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
581386|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
581387|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
581388|NCT03606889|Bupivacaine|bupivacaine|mesh-list
581389|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
581390|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
581391|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
581392|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581393|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
581394|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581395|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
581396|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
581397|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581398|NCT03606824|Pitavastatin|pitavastatin|mesh-list
581399|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
581400|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
581401|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
581402|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
581403|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581404|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581405|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
581406|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
581407|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
581408|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
581409|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581410|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
581411|NCT03606785|Coagulants|coagulants|mesh-ancestor
581412|NCT03606694|Metformin|metformin|mesh-list
581413|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
581414|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581415|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
581416|NCT03606681|Calcium|calcium|mesh-list
581417|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
581418|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581419|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
581420|NCT03606590|Sorafenib|sorafenib|mesh-list
581421|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581422|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
581423|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581424|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581425|NCT03606577|Dexamethasone|dexamethasone|mesh-list
581426|NCT03606577|Lenalidomide|lenalidomide|mesh-list
581427|NCT03606577|Daratumumab|daratumumab|mesh-list
581428|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
581429|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
581430|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
581431|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581432|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581433|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
581434|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
581435|NCT03606577|Hormones|hormones|mesh-ancestor
581436|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
581437|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
581438|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581439|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
581440|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
581441|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
581442|NCT03606577|Growth Substances|growth substances|mesh-ancestor
581443|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
581444|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
581445|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
581446|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581447|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
581448|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
581449|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
581450|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581451|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
581452|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
581453|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
581454|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
2076327|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2076328|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
581457|NCT03606473|Amphetamine|amphetamine|mesh-list
581458|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
581459|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
581460|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581461|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
581462|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
581463|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581464|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
581465|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
581466|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581467|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
581468|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
581469|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
581470|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
581471|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2214673|NCT00025272|Carboplatin|carboplatin|mesh-list
2214674|NCT00025272|Etoposide|etoposide|mesh-list
2214675|NCT00025272|Topotecan|topotecan|mesh-list
581475|NCT03606369|Ondansetron|ondansetron|mesh-list
581476|NCT03606369|Palonosetron|palonosetron|mesh-list
581477|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
581478|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
581479|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581480|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581481|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
581482|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
581483|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
581484|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
581485|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
581486|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
581487|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581488|NCT03606369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
581489|NCT03606369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
581490|NCT03606369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
581491|NCT03606369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
581492|NCT03606369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
581493|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
581494|NCT03606213|Vaccines|vaccines|mesh-list
581495|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
581496|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581497|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
581498|NCT03606174|Nivolumab|nivolumab|mesh-list
581499|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
581500|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581501|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
581502|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581503|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
581504|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
581505|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
581506|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581507|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
581508|NCT03606109|Coagulants|coagulants|mesh-ancestor
581509|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
581510|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
581511|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
581512|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
581513|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
581514|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
581515|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581516|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581517|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581518|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
581519|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
581520|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
581521|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581522|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
581523|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
581524|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
581525|NCT03606018|Insulin|insulin|mesh-list
581526|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
581527|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
581528|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2214676|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581529|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581530|NCT03605940|Methoxsalen|methoxsalen|mesh-list
581531|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
581532|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
581533|NCT03605927|Sirolimus|sirolimus|mesh-list
581534|NCT03605927|Tacrolimus|tacrolimus|mesh-list
581535|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
581536|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
581537|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581538|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
581539|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581540|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581541|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
581542|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
581543|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
581544|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581545|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
2214677|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214678|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2214679|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214680|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214681|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214682|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2214683|NCT00025285|Thalidomide|thalidomide|mesh-list
2214684|NCT00025285|Carboplatin|carboplatin|mesh-list
2214685|NCT00025285|Irinotecan|irinotecan|mesh-list
2214686|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214687|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2214688|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214689|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214690|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214691|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214692|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
2214693|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214694|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
2214695|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
581566|NCT03605901|Methadone|methadone|mesh-list
581567|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
581568|NCT03605901|Narcotics|narcotics|mesh-ancestor
581569|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
581570|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581571|NCT03605901|Analgesics|analgesics|mesh-ancestor
581572|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
581573|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581574|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
581575|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
581576|NCT03605862|Nitazoxanide|nitazoxanide|mesh-list
581577|NCT03605862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
581578|NCT03605862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
581579|NCT03605758|Ivermectin|ivermectin|mesh-list
581580|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
581581|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2750631|NCT04214249|Cytarabine|cytarabine|mesh-list
581598|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
581599|NCT03605654|Tacrolimus|tacrolimus|mesh-list
581600|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
581601|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
581602|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581603|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
581604|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581605|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581606|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
581607|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581608|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
581609|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
581610|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
581611|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
581612|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
581613|NCT03605589|Blinatumomab|blinatumomab|mesh-list
581614|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
581615|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581616|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
581617|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
581618|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
581619|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
581620|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
581621|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
581622|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581623|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
581624|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
581625|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
581626|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
581627|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
581628|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581629|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581630|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
581631|NCT03605342|Buprenorphine|buprenorphine|mesh-list
581632|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
581633|NCT03605342|Narcotics|narcotics|mesh-ancestor
581634|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
581635|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581636|NCT03605342|Analgesics|analgesics|mesh-ancestor
581637|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
581638|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581639|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2214696|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214697|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2214698|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
581643|NCT03605199|Denosumab|denosumab|mesh-list
581644|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
581645|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581646|NCT03605173|Vitamin D|vitamin d|mesh-list
581647|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
581648|NCT03605173|Vitamins|vitamins|mesh-list
581649|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
581650|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581651|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
581652|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
581653|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
581654|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
581655|NCT03605056|Dexamethasone|dexamethasone|mesh-list
581656|NCT03605056|Lenalidomide|lenalidomide|mesh-list
581657|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
581658|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
581659|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
581660|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581661|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581662|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
581663|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
581664|NCT03605056|Hormones|hormones|mesh-ancestor
581665|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
581666|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
581667|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581668|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
581669|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
581670|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
581671|NCT03605056|Growth Substances|growth substances|mesh-ancestor
581672|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
2076329|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
2076330|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076331|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076332|NCT02011945|Nivolumab|nivolumab|mesh-list
2076333|NCT02011945|Dasatinib|dasatinib|mesh-list
2076334|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2076335|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076336|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2076337|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076338|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2076339|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750632|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
2750633|NCT04214249|Daunorubicin|daunorubicin|mesh-list
2750634|NCT04214249|Idarubicin|idarubicin|mesh-list
2750635|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2750636|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750637|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
581692|NCT03604874|Oxytocin|oxytocin|mesh-list
581693|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
581694|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
581695|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581696|NCT03604796|Acetaminophen|acetaminophen|mesh-list
581697|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
581698|NCT03604796|Analgesics|analgesics|mesh-ancestor
581699|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
581700|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581701|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581702|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
581703|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
581704|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
581705|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581706|NCT03604744|Psilocybin|psilocybin|mesh-list
581707|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
581708|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581709|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
581710|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
581711|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
581712|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
581713|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581714|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581715|NCT03604653|Cisplatin|cisplatin|mesh-list
581716|NCT03604653|Doxorubicin|doxorubicin|mesh-list
581717|NCT03604653|Mitomycins|mitomycins|mesh-list
581718|NCT03604653|Mitomycin|mitomycin|mesh-list
581719|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581720|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
581721|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
581722|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
581723|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581724|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581725|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
581726|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
581727|NCT03604627|Calcium|calcium|mesh-list
581728|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
581729|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581730|NCT03604575|Insulin|insulin|mesh-list
581731|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
581732|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
581733|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
581734|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581735|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
581736|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581737|NCT03604471|Atorvastatin|atorvastatin|mesh-list
581738|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
581739|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
581740|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
581741|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581742|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
581743|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
581744|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581745|NCT03604419|Metformin|metformin|mesh-list
581746|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
581747|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581748|NCT03604406|Vaccines|vaccines|mesh-list
581749|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
581750|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581751|NCT03604354|Pregabalin|pregabalin|mesh-list
581752|NCT03604354|Tapentadol|tapentadol|mesh-list
581753|NCT03604354|Analgesics|analgesics|mesh-ancestor
581754|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
581755|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581756|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581757|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
581758|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2076340|NCT02012192|Paclitaxel|paclitaxel|mesh-list
2750638|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
581759|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
581760|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581761|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
581762|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
581763|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
581764|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
581765|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
581766|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
581767|NCT03604354|Narcotics|narcotics|mesh-ancestor
581768|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
581769|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
581770|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
581771|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2214699|NCT00025285|Growth Substances|growth substances|mesh-ancestor
2214700|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
2214701|NCT00025298|Paclitaxel|paclitaxel|mesh-list
2214702|NCT00025298|Carboplatin|carboplatin|mesh-list
2214703|NCT00025298|Amifostine|amifostine|mesh-list
2214704|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214705|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214706|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214707|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214708|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214709|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214710|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2214711|NCT00025298|Protective Agents|protective agents|mesh-ancestor
2214712|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581786|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
581787|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
581788|NCT03604315|Fluorides|fluorides|mesh-list
581789|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
581790|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581791|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
581792|NCT03604315|Protective Agents|protective agents|mesh-ancestor
581793|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581794|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
581795|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
581796|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2750639|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750640|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
581800|NCT03604224|Canagliflozin|canagliflozin|mesh-list
581801|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
581802|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581803|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
581804|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581815|NCT03604016|Tenofovir|tenofovir|mesh-list
581816|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
581817|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
581818|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
581819|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
581820|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581821|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581822|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
581823|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
581824|NCT03604003|Losartan|losartan|mesh-list
581825|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
581826|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
581827|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
581828|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
581829|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581830|NCT03603964|Guadecitabine|guadecitabine|mesh-list
581831|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581832|NCT03603938|Losartan|losartan|mesh-list
2214713|NCT00025311|Topotecan|topotecan|mesh-list
581833|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
581834|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
581835|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
581836|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
581837|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750641|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2750642|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
581841|NCT03603899|Xenon|xenon|mesh-list
581842|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
581843|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
581844|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
581845|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
581846|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581847|NCT03603834|Leucovorin|leucovorin|mesh-list
581848|NCT03603834|Fluorouracil|fluorouracil|mesh-list
581849|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
581850|NCT03603834|Irinotecan|irinotecan|mesh-list
581851|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
581852|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581853|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
581854|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581855|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
581856|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
581857|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581858|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
581859|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
581860|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581861|NCT03603834|Antidotes|antidotes|mesh-ancestor
581862|NCT03603834|Protective Agents|protective agents|mesh-ancestor
581863|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
581864|NCT03603834|Vitamins|vitamins|mesh-ancestor
581865|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
2076341|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2076342|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076343|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
581869|NCT03603756|Paclitaxel|paclitaxel|mesh-list
581870|NCT03603756|Irinotecan|irinotecan|mesh-list
581871|NCT03603756|Apatinib|apatinib|mesh-list
581872|NCT03603756|Nedaplatin|nedaplatin|mesh-list
581873|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
581874|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581875|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
581876|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
581877|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
581878|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581879|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
581880|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
581881|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581882|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
581883|NCT03603626|Pregabalin|pregabalin|mesh-list
581884|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581885|NCT03603626|Analgesics|analgesics|mesh-ancestor
581886|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
581887|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581888|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
581889|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
581890|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
581891|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581892|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
581893|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
581894|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
581895|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
581896|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
581897|NCT03603548|Tacrolimus|tacrolimus|mesh-list
581898|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
581899|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
581900|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581901|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
581902|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581903|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581907|NCT03603496|Nicotine|nicotine|mesh-list
581908|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
581909|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
581910|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581911|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581912|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
581913|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
581914|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
581915|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
581916|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581917|NCT03603418|Dexamethasone|dexamethasone|mesh-list
581918|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
581919|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
581920|NCT03603418|BB 1101|bb 1101|mesh-list
581921|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
581922|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
581923|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
581924|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581925|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581926|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
581927|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
581928|NCT03603418|Hormones|hormones|mesh-ancestor
581929|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
581930|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
581931|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581932|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
581933|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581934|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581935|NCT03603366|Aspirin|aspirin|mesh-list
581936|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
581937|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
581938|NCT03603366|Analgesics|analgesics|mesh-ancestor
581939|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
581940|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581941|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581942|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
581943|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
581944|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
581945|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
581946|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581947|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
581948|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
581949|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
581950|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
581951|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
581952|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2750643|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
2750644|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750645|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2750646|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
581958|NCT03603249|Trimetazidine|trimetazidine|mesh-list
581959|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
581960|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
581961|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
581962|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581972|NCT03603119|Dexamethasone|dexamethasone|mesh-list
581973|NCT03603119|Midazolam|midazolam|mesh-list
581974|NCT03603119|Ondansetron|ondansetron|mesh-list
581975|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
581976|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
581977|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
581978|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
581979|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
581980|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
581981|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
581982|NCT03603119|Hormones|hormones|mesh-ancestor
581983|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
581984|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
581985|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
581986|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
581987|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
581988|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
581989|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
581990|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
581991|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
581992|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
581993|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
581994|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
581995|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
581996|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
581997|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
581998|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
581999|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
582000|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
582001|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
582002|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
582003|NCT03603119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
582004|NCT03603080|Metformin|metformin|mesh-list
582005|NCT03603080|Topiramate|topiramate|mesh-list
582006|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
582007|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
582008|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582009|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
582010|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
582011|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
582012|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
582013|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
582014|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
582015|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582016|NCT03602898|Cyclosporine|cyclosporine|mesh-list
582017|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
582018|NCT03602898|Busulfan|busulfan|mesh-list
582019|NCT03602898|Methotrexate|methotrexate|mesh-list
582020|NCT03602898|Fludarabine|fludarabine|mesh-list
582021|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
582022|NCT03602898|Tacrolimus|tacrolimus|mesh-list
582023|NCT03602898|Cyclosporins|cyclosporins|mesh-list
582024|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
582025|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
582026|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
582027|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582028|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
582029|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
582030|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
582031|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582032|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582033|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
582034|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
582035|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
582036|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
582037|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
582038|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
582039|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
582040|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582041|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
582042|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
582043|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
582044|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
582045|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582046|NCT03602859|Niraparib|niraparib|mesh-list
582047|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
582048|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582049|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582050|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582051|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
582052|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582053|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
582054|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
582055|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
582056|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582057|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582058|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
582059|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
582060|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
582061|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
582062|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582063|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582064|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
582065|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
582066|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
582067|NCT03602781|Protective Agents|protective agents|mesh-ancestor
582068|NCT03602690|Ritonavir|ritonavir|mesh-list
582069|NCT03602690|Darunavir|darunavir|mesh-list
582070|NCT03602690|Dolutegravir|dolutegravir|mesh-list
582071|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
582072|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
582073|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
582074|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582075|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582076|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
582077|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
582078|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
582079|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582080|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
582081|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
582082|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
582083|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
582084|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
582085|NCT03602638|Acarbose|acarbose|mesh-list
582086|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
582087|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582088|NCT03602638|Incretins|incretins|mesh-ancestor
582089|NCT03602638|Hormones|hormones|mesh-ancestor
582090|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
582091|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
582092|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
582093|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582094|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582095|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
582107|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
582108|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
582109|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582110|NCT03602560|Seladelpar|seladelpar|mesh-list
582111|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
582112|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
582113|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582114|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
582115|NCT03602547|Vorolanib|vorolanib|mesh-list
582116|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
582117|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582118|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582119|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
582120|NCT03602508|Mirabegron|mirabegron|mesh-list
582121|NCT03602508|Fesoterodine|fesoterodine|mesh-list
582122|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
582123|NCT03602508|Oxybutynin|oxybutynin|mesh-list
582124|NCT03602508|Darifenacin|darifenacin|mesh-list
582125|NCT03602508|Propiverine|propiverine|mesh-list
582126|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
582127|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
582128|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
582129|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582130|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582131|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582132|NCT03602508|Urological Agents|urological agents|mesh-ancestor
582133|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
582134|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
582135|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
582136|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
582137|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
582138|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
582139|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582140|NCT03602469|Bupivacaine|bupivacaine|mesh-list
582141|NCT03602469|Propofol|propofol|mesh-list
582142|NCT03602469|Sevoflurane|sevoflurane|mesh-list
582143|NCT03602469|Rocuronium|rocuronium|mesh-list
582144|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
582145|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
582146|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
582147|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582148|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
582149|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582150|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
582151|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
582152|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
582153|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
582154|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
582155|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
582156|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
582157|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
582158|NCT03602430|Vitamin D|vitamin d|mesh-list
582159|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
582160|NCT03602430|Vitamins|vitamins|mesh-ancestor
582161|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
582162|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582163|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
582164|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
582165|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
582166|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2214714|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2214715|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214716|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214717|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582171|NCT03602287|Lidocaine|lidocaine|mesh-list
582172|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
582173|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
582174|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
582175|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582176|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
582177|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582178|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
582179|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
582180|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
582181|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
582182|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582183|NCT03602261|Calcifediol|calcifediol|mesh-list
582184|NCT03602261|Vitamins|vitamins|mesh-ancestor
582185|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
582186|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582187|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
582188|NCT03602248|Methamphetamine|methamphetamine|mesh-list
582189|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
582190|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582191|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
582192|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
582193|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582194|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
582195|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582196|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582197|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
582198|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
582199|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
582200|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
582201|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
582216|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
582217|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2750647|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2750648|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582224|NCT03602131|Gemcitabine|gemcitabine|mesh-list
582225|NCT03602131|Busulfan|busulfan|mesh-list
582226|NCT03602131|Cladribine|cladribine|mesh-list
582227|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
582228|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
582229|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582230|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582231|NCT03602131|Antiviral Agents|antiviral agents|mesh-ancestor
582232|NCT03602131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582233|NCT03602131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582234|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
582235|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
582236|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582237|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
582238|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
582239|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
582240|NCT03602118|Phenobarbital|phenobarbital|mesh-list
582241|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
582242|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
582243|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
582244|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582245|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
582246|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
582247|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582248|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582249|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
582250|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
582251|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
582252|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
582253|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
582254|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
582255|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
582256|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
582257|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582258|NCT03602027|Gefitinib|gefitinib|mesh-list
582259|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582260|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
582261|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582262|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582263|NCT03602014|Droxidopa|droxidopa|mesh-list
582264|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
582265|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
582266|NCT03601975|Gemcitabine|gemcitabine|mesh-list
582267|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582268|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
582269|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
582270|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582271|NCT03601975|Antiviral Agents|antiviral agents|mesh-ancestor
582272|NCT03601975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582273|NCT03601975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582274|NCT03601975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
582275|NCT03601975|Immunologic Factors|immunologic factors|mesh-ancestor
582276|NCT03601975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582277|NCT03601923|Niraparib|niraparib|mesh-list
582278|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
582279|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582280|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582281|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582282|NCT03601897|Paclitaxel|paclitaxel|mesh-list
582283|NCT03601897|Rebastinib|rebastinib|mesh-list
582284|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
582285|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582286|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
582287|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
582288|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
582364|NCT03601611|Prednisolone|prednisolone|mesh-list
582289|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582290|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
582291|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582292|NCT03601871|Thalidomide|thalidomide|mesh-list
582293|NCT03601871|Dexamethasone|dexamethasone|mesh-list
582294|NCT03601871|Palonosetron|palonosetron|mesh-list
582295|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
582296|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
582297|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
582298|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
582299|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582300|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582301|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
582302|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
582303|NCT03601871|Hormones|hormones|mesh-ancestor
582304|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
582305|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
582306|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582307|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
582308|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
582309|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
582310|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
582311|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582312|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
582313|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
582314|NCT03601871|Growth Substances|growth substances|mesh-ancestor
582315|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
582316|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
582317|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
582318|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582319|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582320|NCT03601806|Thalidomide|thalidomide|mesh-list
582321|NCT03601806|Pomalidomide|pomalidomide|mesh-list
582322|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
582323|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
582324|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582325|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
582326|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
582327|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582328|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
582329|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
582330|NCT03601806|Growth Substances|growth substances|mesh-ancestor
582331|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
582332|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582333|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
582334|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2076344|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
2076345|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
2076346|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076347|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
582339|NCT03601624|Dexamethasone|dexamethasone|mesh-list
582340|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
582341|NCT03601624|Pomalidomide|pomalidomide|mesh-list
582342|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
582343|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
582344|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582345|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
582346|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
582347|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
582348|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582349|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582350|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
582351|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
582352|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
582353|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
582354|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582355|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
582356|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
582357|NCT03601624|Hormones|hormones|mesh-ancestor
582358|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
582359|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
582360|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
582361|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
582362|NCT03601624|Growth Substances|growth substances|mesh-ancestor
582363|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
582365|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
582366|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
582367|NCT03601611|Hormones|hormones|mesh-ancestor
582368|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
582369|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582370|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
582371|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582372|NCT03601533|Phenol|phenol|mesh-list
582373|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
582374|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582375|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
582376|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
582377|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
582378|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
582379|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582380|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582393|NCT03601338|Bemiparin|bemiparin|mesh-list
582394|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
582395|NCT03601260|Allopurinol|allopurinol|mesh-list
582396|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
582397|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582398|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582399|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
582400|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
582401|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
582402|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
582403|NCT03601260|Protective Agents|protective agents|mesh-ancestor
582404|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582405|NCT03601091|Midazolam|midazolam|mesh-list
582406|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
582407|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
582408|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
582409|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582410|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
582411|NCT03601091|Analgesics|analgesics|mesh-ancestor
582412|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
582413|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582414|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
582415|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
582416|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
582417|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
582418|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582419|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582420|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
582421|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
582422|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
582423|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
582424|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
582425|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
582426|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
582427|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
582428|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
582429|NCT03600974|Domperidone|domperidone|mesh-list
582430|NCT03600974|Citalopram|citalopram|mesh-list
582431|NCT03600974|Esomeprazole|esomeprazole|mesh-list
582432|NCT03600974|Omeprazole|omeprazole|mesh-list
582433|NCT03600974|Rabeprazole|rabeprazole|mesh-list
582434|NCT03600974|Pantoprazole|pantoprazole|mesh-list
582435|NCT03600974|Lansoprazole|lansoprazole|mesh-list
582436|NCT03600974|Mosapride|mosapride|mesh-list
582437|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
582438|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
582439|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
582440|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
582441|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582442|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582443|NCT03600974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
582444|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
582445|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
582446|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
582447|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582448|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
582449|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
582450|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
582451|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
582452|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582453|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
582454|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
582455|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
582456|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
582457|NCT03600961|Sirolimus|sirolimus|mesh-list
582458|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
582459|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582460|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
582461|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582462|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
582463|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
582464|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
582465|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582466|NCT03600948|Sirolimus|sirolimus|mesh-list
582467|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
582468|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582469|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
582470|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582471|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
582472|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
582473|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
582474|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582475|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
582476|NCT03600909|Busulfan|busulfan|mesh-list
582477|NCT03600909|Fludarabine|fludarabine|mesh-list
582478|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
582479|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
582480|NCT03600909|Lenograstim|lenograstim|mesh-list
582481|NCT03600909|Sargramostim|sargramostim|mesh-list
582482|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
582483|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
582484|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582485|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
582486|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
582487|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
582488|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582489|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582490|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
582491|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2076348|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
2076349|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076350|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076351|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076352|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
2076353|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
2076354|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2076355|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
2076356|NCT02012348|Triclocarban|triclocarban|mesh-list
2076357|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076358|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2076359|NCT02012491|Misoprostol|misoprostol|mesh-list
2076360|NCT02012491|Mifepristone|mifepristone|mesh-list
2076361|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2076362|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
582507|NCT03600870|Midodrine|midodrine|mesh-list
582508|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
582509|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
582510|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582511|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582512|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
582513|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
582514|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
582515|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
582516|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
582517|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582518|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582519|NCT03600857|Misoprostol|misoprostol|mesh-list
582520|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
582521|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
582522|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
582523|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582524|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
582525|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
582526|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
582527|NCT03600831|Docetaxel|docetaxel|mesh-list
582528|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582529|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
582530|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
582531|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
582532|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582533|NCT03600818|Prednisone|prednisone|mesh-list
582534|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
582535|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
582536|NCT03600818|Hormones|hormones|mesh-ancestor
582537|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
582538|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582539|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
582540|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582549|NCT03600766|Mirabegron|mirabegron|mesh-list
582550|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
582551|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
582552|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
582553|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
582554|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582555|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582556|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582557|NCT03600766|Urological Agents|urological agents|mesh-ancestor
582558|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
582559|NCT03600727|Propofol|propofol|mesh-list
582560|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
582561|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
582562|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582563|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
582564|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
582565|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
582566|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
582567|NCT03600727|Analgesics|analgesics|mesh-ancestor
582568|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
582569|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582570|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
582571|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
582572|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
582573|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
582574|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582575|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076363|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2076364|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076365|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2076366|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2076367|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
2076368|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2076369|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2076370|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2076371|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2076372|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
2076373|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2076374|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2076375|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
2076376|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2076377|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
2076378|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2076379|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2076380|NCT02012959|Tolvaptan|tolvaptan|mesh-list
582610|NCT03600623|Gemcitabine|gemcitabine|mesh-list
582611|NCT03600623|Paclitaxel|paclitaxel|mesh-list
582612|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
582613|NCT03600623|Fluorouracil|fluorouracil|mesh-list
582614|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
582615|NCT03600623|Irinotecan|irinotecan|mesh-list
582616|NCT03600623|Folfirinox|folfirinox|mesh-list
582617|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
582618|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582619|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
582620|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
582621|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
582622|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582623|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
582624|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
582625|NCT03600623|Antiviral Agents|antiviral agents|mesh-ancestor
582626|NCT03600623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582627|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582628|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
582629|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
582630|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582631|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
582632|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
582633|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
582634|NCT03600506|Sympatholytics|sympatholytics|mesh-list
582635|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
582636|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
582637|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582638|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
582639|NCT03600506|Analgesics|analgesics|mesh-ancestor
582640|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
582641|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582642|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
582643|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
582644|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
582645|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
582646|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582647|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582648|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
582649|NCT03600493|Lidocaine|lidocaine|mesh-list
582650|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
582651|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
582652|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
582653|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
582654|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582655|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
582656|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582657|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
582658|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
582659|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
582660|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
582661|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582662|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
582663|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
582664|NCT03600493|Analgesics|analgesics|mesh-ancestor
582665|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
582666|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
582667|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
582668|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
582669|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582670|NCT03600467|Seviteronel|seviteronel|mesh-list
582671|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582672|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
582673|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582674|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582675|NCT03600454|Anesthetics|anesthetics|mesh-list
582676|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
582677|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582678|NCT03600441|Abexinostat|abexinostat|mesh-list
582679|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
582680|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582681|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214718|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214719|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
2214720|NCT00025324|Thiotepa|thiotepa|mesh-list
2214721|NCT00025324|Carboplatin|carboplatin|mesh-list
2214722|NCT00025324|Etoposide|etoposide|mesh-list
2214723|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214724|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
2214725|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582690|NCT03600363|Metformin|metformin|mesh-list
582691|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
582692|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582693|NCT03600350|Nivolumab|nivolumab|mesh-list
582694|NCT03600350|Sargramostim|sargramostim|mesh-list
582695|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
582696|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582697|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
582698|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582699|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
582700|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582701|NCT03600311|Vitamin D|vitamin d|mesh-list
582702|NCT03600311|Calcium|calcium|mesh-list
582703|NCT03600311|Vitamins|vitamins|mesh-ancestor
582704|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
582705|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582706|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
582707|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
582708|NCT03600155|Nivolumab|nivolumab|mesh-list
582709|NCT03600155|Ipilimumab|ipilimumab|mesh-list
582710|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
582711|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582712|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
582713|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582714|NCT03600129|Ropivacaine|ropivacaine|mesh-list
582715|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
582716|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
582717|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
582718|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582719|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
582720|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582721|NCT03600116|Insulin Lispro|insulin lispro|mesh-list
582722|NCT03600116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
582723|NCT03600116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582724|NCT03600090|Paclitaxel|paclitaxel|mesh-list
582725|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
582726|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582727|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
582728|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
582729|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
582730|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582731|NCT03600064|Misoprostol|misoprostol|mesh-list
582732|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
582733|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
582734|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
582735|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582736|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
582737|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
582738|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
582739|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
582740|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
582741|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
582742|NCT03599791|Fluticasone|fluticasone|mesh-list
582743|NCT03599791|Xhance|xhance|mesh-list
582744|NCT03599791|Azelastine|azelastine|mesh-list
2214726|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
582745|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
582746|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
582747|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
582748|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582749|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582750|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
582751|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
582752|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
582753|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
582754|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
582755|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582756|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582757|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
582758|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
582759|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
582760|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
582761|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582762|NCT03599778|Apatinib|apatinib|mesh-list
582763|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582764|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
582765|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582766|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582767|NCT03599726|Donepezil|donepezil|mesh-list
582768|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
582769|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582770|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582771|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
582772|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582773|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582774|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
2750666|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
2750667|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750668|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
2750669|NCT04198428|Narcotics|narcotics|mesh-ancestor
2750670|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2750671|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076381|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2076382|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076383|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
2076384|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582787|NCT03599609|Simvastatin|simvastatin|mesh-list
582788|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
582789|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
582790|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
582791|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582792|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
582793|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
582794|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582795|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
582796|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
582797|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
582798|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
582799|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
582800|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
582801|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582802|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
582803|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582804|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582805|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
582806|NCT03599596|Renal Agents|renal agents|mesh-ancestor
582807|NCT03599518|Gefitinib|gefitinib|mesh-list
582808|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582809|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
582810|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582811|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582812|NCT03599466|Lisinopril|lisinopril|mesh-list
582813|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
582814|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
582815|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582816|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582817|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
582818|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
582819|NCT03599466|Protective Agents|protective agents|mesh-ancestor
582820|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582821|NCT03599453|Interferons|interferons|mesh-list
582822|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
582823|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
582824|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
582825|NCT03599453|Poly I-C|poly i-c|mesh-list
582826|NCT03599453|Celecoxib|celecoxib|mesh-list
582827|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
582828|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
582829|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
582830|NCT03599453|Benzenesulfonamide|benzenesulfonamide|mesh-list
582831|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
582832|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582833|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
582834|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582835|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
582836|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582837|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
582838|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
582839|NCT03599453|Analgesics|analgesics|mesh-ancestor
582840|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
582841|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582842|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
582843|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
582844|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
582845|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
582846|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582847|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582848|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
582849|NCT03599453|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
582850|NCT03599427|Lidocaine|lidocaine|mesh-list
582851|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
582852|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
582853|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
582854|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582855|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
582856|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
582857|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
582858|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
582859|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
582860|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
582861|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076385|NCT02013037|Eculizumab|eculizumab|mesh-list
2076386|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2076387|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076388|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
2076389|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582867|NCT03599323|Clotrimazole|clotrimazole|mesh-list
582868|NCT03599323|Miconazole|miconazole|mesh-list
582869|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
582870|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582871|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
582872|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
582873|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
582874|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582875|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582876|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
582877|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
582878|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
582879|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582880|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
582881|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
582882|NCT03599284|Clopidogrel|clopidogrel|mesh-list
582883|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
582884|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
582885|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
582886|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
582887|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
582888|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582889|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582890|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750672|NCT04198428|Analgesics|analgesics|mesh-ancestor
2750673|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
2076392|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2214727|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214728|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
2214729|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214730|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214731|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214732|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214733|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2214734|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214735|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214736|NCT00025337|Leucovorin|leucovorin|mesh-list
2214737|NCT00025337|Bevacizumab|bevacizumab|mesh-list
2214738|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2214739|NCT00025337|Fluorouracil|fluorouracil|mesh-list
2214740|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
2214741|NCT00025337|Antibodies|antibodies|mesh-list
2214742|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
2214743|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2214744|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
2214745|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214746|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2214747|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2214748|NCT00025337|Growth Substances|growth substances|mesh-ancestor
2214749|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214750|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
2214751|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
2214752|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
2214753|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582923|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
582924|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
582925|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
582926|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582927|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
582928|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582929|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582930|NCT03598959|Tofacitinib|tofacitinib|mesh-list
582931|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
582932|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582933|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582934|NCT03598868|Vortioxetine|vortioxetine|mesh-list
582935|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
582936|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
582937|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
582938|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
582939|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
582940|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582941|NCT03598868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
582942|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
582943|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
582944|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582945|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
582946|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
582947|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
582948|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
582949|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
582950|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
582951|NCT03598842|Metronidazole|metronidazole|mesh-list
582952|NCT03598842|Ivermectin|ivermectin|mesh-list
582953|NCT03598842|Albendazole|albendazole|mesh-list
582954|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
582955|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
582956|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
582957|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
582958|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
582959|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
582960|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
582961|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
582962|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
582963|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
582964|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582965|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582966|NCT03598816|Durvalumab|durvalumab|mesh-list
582967|NCT03598816|Tremelimumab|tremelimumab|mesh-list
583045|NCT03598556|Vitamins|vitamins|mesh-ancestor
582968|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
582969|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750674|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2750675|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2750676|NCT04197687|Trastuzumab|trastuzumab|mesh-list
2750677|NCT04197687|Pertuzumab|pertuzumab|mesh-list
2750678|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2750679|NCT04197687|Maytansine|maytansine|mesh-list
2750680|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2750681|NCT04197687|Vaccines|vaccines|mesh-list
2750682|NCT04197687|Antibodies|antibodies|mesh-list
2750683|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
2750684|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
582981|NCT03598738|Esomeprazole|esomeprazole|mesh-list
582982|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
582983|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
582984|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
582985|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
582986|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
582987|NCT03598725|Prednisone|prednisone|mesh-list
582988|NCT03598725|Rituximab|rituximab|mesh-list
582989|NCT03598725|Factor VIII|factor viii|mesh-list
582990|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
582991|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
582992|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
582993|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
582994|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
582995|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
582996|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
582997|NCT03598725|Hormones|hormones|mesh-ancestor
582998|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
582999|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
583000|NCT03598725|Coagulants|coagulants|mesh-ancestor
583001|NCT03598673|Nebivolol|nebivolol|mesh-list
583002|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
583003|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
583004|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
583005|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
583006|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
583007|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
583008|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
583009|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583010|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583011|NCT03598634|Riboflavin|riboflavin|mesh-list
583012|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
583013|NCT03598634|Vitamins|vitamins|mesh-ancestor
583014|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
583015|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583016|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
583017|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
2076393|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076394|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2076395|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583021|NCT03598595|Gemcitabine|gemcitabine|mesh-list
583022|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
583023|NCT03598595|Docetaxel|docetaxel|mesh-list
583024|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
583025|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
583026|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583027|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583028|NCT03598595|Antiviral Agents|antiviral agents|mesh-ancestor
583029|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
583030|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583031|NCT03598595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
583032|NCT03598595|Immunologic Factors|immunologic factors|mesh-ancestor
583033|NCT03598595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583034|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
583035|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
583036|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
583037|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
583038|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
583039|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
583040|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
583041|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
583042|NCT03598582|Hematinics|hematinics|mesh-ancestor
583043|NCT03598556|Vitamin D|vitamin d|mesh-list
583044|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
2750685|NCT04197687|Sargramostim|sargramostim|mesh-list
2750686|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
583046|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
583047|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583048|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
583049|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
583050|NCT03598452|Ganciclovir|ganciclovir|mesh-list
583051|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
583052|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
583053|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
583054|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
583055|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583056|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583057|NCT03598426|Dexamethasone|dexamethasone|mesh-list
583058|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
583059|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
583060|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
583061|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583062|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583063|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
583064|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
583065|NCT03598426|Hormones|hormones|mesh-ancestor
583066|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
583067|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
583068|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583069|NCT03598374|Folic Acid|folic acid|mesh-list
583070|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
583071|NCT03598374|Inositol|inositol|mesh-list
583072|NCT03598374|Hematinics|hematinics|mesh-ancestor
583073|NCT03598374|Vitamins|vitamins|mesh-ancestor
583074|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
583075|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583076|NCT03598348|Capecitabine|capecitabine|mesh-list
583077|NCT03598348|Apatinib|apatinib|mesh-list
583078|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
583079|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
583080|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583081|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583082|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
583083|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076396|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076397|NCT02013245|Vaccines|vaccines|mesh-list
2076398|NCT02013245|Immunoglobulins|immunoglobulins|mesh-list
2076399|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
2076400|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076401|NCT02013375|Sirolimus|sirolimus|mesh-list
2076402|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
2076403|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
2076404|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076405|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
2076406|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076407|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
583096|NCT03598270|Gemcitabine|gemcitabine|mesh-list
583097|NCT03598270|Paclitaxel|paclitaxel|mesh-list
583098|NCT03598270|Carboplatin|carboplatin|mesh-list
583099|NCT03598270|Doxorubicin|doxorubicin|mesh-list
583100|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
583101|NCT03598270|Atezolizumab|atezolizumab|mesh-list
583102|NCT03598270|Niraparib|niraparib|mesh-list
583103|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
583104|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
583105|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583106|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
583107|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
583108|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
583109|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583110|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
583111|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
583112|NCT03598270|Antiviral Agents|antiviral agents|mesh-ancestor
583113|NCT03598270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
583114|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583115|NCT03598270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
583116|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
583117|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583118|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
583119|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
583120|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
583121|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2076408|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2076409|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
2076410|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076411|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076412|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
583127|NCT03598192|Sufentanil|sufentanil|mesh-list
583128|NCT03598192|Dsuvia|dsuvia|mesh-list
583129|NCT03598192|Ropivacaine|ropivacaine|mesh-list
583130|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
583131|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
583132|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583133|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583134|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
583135|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583136|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
583137|NCT03598192|Narcotics|narcotics|mesh-ancestor
583138|NCT03598192|Analgesics|analgesics|mesh-ancestor
583139|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
583140|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
583141|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
2214754|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214755|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214756|NCT00025337|Antidotes|antidotes|mesh-ancestor
2214757|NCT00025337|Protective Agents|protective agents|mesh-ancestor
2214758|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
2214759|NCT00025337|Vitamins|vitamins|mesh-ancestor
2214760|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
583149|NCT03598075|Pramlintide|pramlintide|mesh-list
583150|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
583151|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583152|NCT03597997|Propofol|propofol|mesh-list
583153|NCT03597997|Sevoflurane|sevoflurane|mesh-list
583154|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
583155|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583156|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583157|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
583158|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
583159|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
583160|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
583161|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
583162|NCT03597945|Lidocaine|lidocaine|mesh-list
583163|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
583164|NCT03597945|Epinephrine|epinephrine|mesh-list
583165|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
583166|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
583167|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583168|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583169|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
583170|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583171|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
583172|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
583173|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
583174|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
583175|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583176|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
583177|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
583178|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
583179|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
583180|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
583181|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
583182|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
583183|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
583184|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
583185|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
583186|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
583187|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
583188|NCT03597945|Analgesics|analgesics|mesh-ancestor
583189|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
583190|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
583191|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
583192|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
583193|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
583194|NCT03597919|Vaccines|vaccines|mesh-list
583195|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
583196|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583197|NCT03597893|Oxytocin|oxytocin|mesh-list
583198|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
583199|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2214761|NCT00025350|Gefitinib|gefitinib|mesh-list
583200|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583201|NCT03597867|Diclofenac|diclofenac|mesh-list
583202|NCT03597867|Indomethacin|indomethacin|mesh-list
583203|NCT03597867|Nepafenac|nepafenac|mesh-list
583204|NCT03597867|Bromfenac|bromfenac|mesh-list
583205|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
583206|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
583207|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
583208|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
583209|NCT03597867|Analgesics|analgesics|mesh-ancestor
583210|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
583211|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583212|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583213|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
583214|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
583215|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
583216|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583217|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583218|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
583219|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
583220|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
583221|NCT03597815|Aflibercept|aflibercept|mesh-list
583222|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
583223|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
583224|NCT03597815|Growth Substances|growth substances|mesh-ancestor
583225|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583226|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
583227|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583228|NCT03597776|Lidocaine|lidocaine|mesh-list
583229|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
583230|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
583231|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583232|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583233|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
583234|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583235|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
583236|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
583237|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
583238|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
583239|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583240|NCT03597594|Fludarabine|fludarabine|mesh-list
583241|NCT03597594|Busulfan|busulfan|mesh-list
583242|NCT03597594|Thiotepa|thiotepa|mesh-list
583243|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
583244|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
583245|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583246|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583247|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
583248|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
583249|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583250|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
583251|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
583252|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2076413|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2076414|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076415|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2076416|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
2076417|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2076418|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
2076419|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
2076420|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
583268|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
583269|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
583270|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
583271|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
583272|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
583273|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583274|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750687|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
2214762|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214763|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2214764|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214765|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214766|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
2214767|NCT00025363|Ifosfamide|ifosfamide|mesh-list
583281|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
583282|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
583283|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583284|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583285|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
583286|NCT03597477|Analgesics|analgesics|mesh-ancestor
583287|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
583288|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583289|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
583290|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
583291|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
583292|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
583293|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
583294|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076421|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076422|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076423|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
2076424|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
2214768|NCT00025363|Doxorubicin|doxorubicin|mesh-list
583300|NCT03597308|Acetaminophen|acetaminophen|mesh-list
583301|NCT03597308|Ibuprofen|ibuprofen|mesh-list
583302|NCT03597308|Oxycodone|oxycodone|mesh-list
583303|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
583304|NCT03597308|Analgesics|analgesics|mesh-ancestor
583305|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
583306|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583307|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583308|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
583309|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
583310|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
583311|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
583312|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
583313|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583314|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583315|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
583316|NCT03597308|Narcotics|narcotics|mesh-ancestor
583317|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583318|NCT03597282|Nivolumab|nivolumab|mesh-list
583319|NCT03597282|Ipilimumab|ipilimumab|mesh-list
583320|NCT03597282|Poly ICLC|poly iclc|mesh-list
583321|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
583322|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583323|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
583324|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583325|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
583326|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
583327|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214769|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2214770|NCT00025363|Etoposide|etoposide|mesh-list
2214771|NCT00025363|Irinotecan|irinotecan|mesh-list
2214772|NCT00025363|Vincristine|vincristine|mesh-list
2214773|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
2214774|NCT00025363|Tirapazamine|tirapazamine|mesh-list
2214775|NCT00025363|Sargramostim|sargramostim|mesh-list
2214776|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214777|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
2214778|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214779|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214780|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214781|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
2214782|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583342|NCT03597087|Anesthetics|anesthetics|mesh-list
583343|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583344|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583345|NCT03597035|Spironolactone|spironolactone|mesh-list
583346|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
583347|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
583348|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
583423|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
583349|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583350|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
583351|NCT03597035|Diuretics|diuretics|mesh-ancestor
583352|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
2214783|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214784|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214785|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214786|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2214787|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214788|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214789|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214790|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2214791|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214792|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214793|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214794|NCT00025376|Bortezomib|bortezomib|mesh-list
2214795|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214796|NCT00025389|Paclitaxel|paclitaxel|mesh-list
2214797|NCT00025389|Bevacizumab|bevacizumab|mesh-list
2214798|NCT00025389|Carboplatin|carboplatin|mesh-list
2214799|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214800|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214801|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214802|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
583373|NCT03596970|Everolimus|everolimus|mesh-list
583374|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583375|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
583376|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
583377|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583378|NCT03596957|Tolvaptan|tolvaptan|mesh-list
583379|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
583380|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583381|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
583382|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583383|NCT03596918|Vincristine|vincristine|mesh-list
583384|NCT03596918|Bleomycin|bleomycin|mesh-list
583385|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
583386|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583387|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
583388|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
583389|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
583390|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583391|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
583397|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
583398|NCT03596892|Busulfan|busulfan|mesh-list
583399|NCT03596892|Decitabine|decitabine|mesh-list
583400|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
583401|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
583402|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583403|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
583404|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
583405|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
583406|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583407|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583408|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
583409|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
583410|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
583411|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583412|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
583413|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
583414|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583415|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583416|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
583417|NCT03596775|Analgesics|analgesics|mesh-ancestor
583418|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
583419|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583420|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
583421|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
583422|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2214803|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
583424|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
583425|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583426|NCT03596749|Sevelamer|sevelamer|mesh-list
583427|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
583428|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
583429|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214804|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214805|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2214806|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2214807|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2214808|NCT00025389|Growth Substances|growth substances|mesh-ancestor
2214809|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214810|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
2214811|NCT00025402|Interferons|interferons|mesh-list
2214812|NCT00025402|Cytarabine|cytarabine|mesh-list
2214813|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
2214814|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
2214815|NCT00025402|Busulfan|busulfan|mesh-list
2214816|NCT00025402|Etoposide|etoposide|mesh-list
2214817|NCT00025402|Idarubicin|idarubicin|mesh-list
2214818|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
2214819|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214820|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
2214821|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214822|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214823|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2076425|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2076426|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2076427|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
2076428|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076429|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
2076430|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
2076431|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076432|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076433|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214824|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
583460|NCT03596502|Warfarin|warfarin|mesh-list
583461|NCT03596502|Anticoagulants|anticoagulants|mesh-list
583462|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
583463|NCT03596424|Ketamine|ketamine|mesh-list
583464|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
583465|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583466|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583467|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
583468|NCT03596424|Analgesics|analgesics|mesh-ancestor
583469|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
583470|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583471|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
583472|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
583473|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
583474|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
583475|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
583476|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583477|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
583478|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
583479|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
583480|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
583481|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
583482|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
583483|NCT03596385|Metoprolol|metoprolol|mesh-list
583484|NCT03596385|Atenolol|atenolol|mesh-list
583485|NCT03596385|Carvedilol|carvedilol|mesh-list
583486|NCT03596385|Bisoprolol|bisoprolol|mesh-list
583487|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
583488|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
583489|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
583490|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
583491|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
583492|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583493|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583494|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
583495|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
583496|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
583497|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
583498|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583499|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
583500|NCT03596385|Protective Agents|protective agents|mesh-ancestor
583501|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
583502|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
583503|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
583504|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
583505|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
583506|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
583507|NCT03596294|Rifampin|rifampin|mesh-list
583508|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
583509|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
583510|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
583511|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
583512|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
583513|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
583514|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583515|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583516|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
583517|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
583518|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
583519|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
583520|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
583521|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
583522|NCT03596281|Bevacizumab|bevacizumab|mesh-list
583523|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
583524|NCT03596281|Doxorubicin|doxorubicin|mesh-list
583525|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
583526|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
583527|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583528|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
583529|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
583530|NCT03596281|Growth Substances|growth substances|mesh-ancestor
583531|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583532|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
583533|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
583534|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
583535|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
583536|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583537|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583543|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
583544|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
583545|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
583546|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
583547|NCT03596125|Expectorants|expectorants|mesh-ancestor
583548|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
583549|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
583550|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
583551|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583552|NCT03596125|Protective Agents|protective agents|mesh-ancestor
583553|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583554|NCT03596125|Antidotes|antidotes|mesh-ancestor
583555|NCT03596099|Acetic Acid|acetic acid|mesh-list
583556|NCT03596099|Retinol acetate|retinol acetate|mesh-list
583557|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
583558|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
583559|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
583560|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
583561|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583562|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
583563|NCT03596099|Protective Agents|protective agents|mesh-ancestor
583564|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076434|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
2076435|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
2076436|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
583569|NCT03596060|Fentanyl|fentanyl|mesh-list
583570|NCT03596060|Morphine|morphine|mesh-list
583571|NCT03596060|Propofol|propofol|mesh-list
583572|NCT03596060|Rocuronium|rocuronium|mesh-list
583573|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
583574|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583575|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583576|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
583577|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
583578|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
583579|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
583580|NCT03596060|Narcotics|narcotics|mesh-ancestor
583581|NCT03596060|Analgesics|analgesics|mesh-ancestor
583582|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
583583|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583584|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
583585|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
583586|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
583587|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
583588|NCT03595982|Nifedipine|nifedipine|mesh-list
583589|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
583590|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
583591|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583592|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
583593|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583594|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
583595|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
583596|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
583597|NCT03595930|Fluticasone|fluticasone|mesh-list
583598|NCT03595930|Xhance|xhance|mesh-list
583599|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
583600|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
583601|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
583602|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583603|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583604|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
583605|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
583606|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
583607|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2076437|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
2076438|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076439|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076440|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076441|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
2076442|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
2076443|NCT02013674|Remestemcel-l|remestemcel-l|mesh-list
2076444|NCT02013674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2076445|NCT02013674|Antiviral Agents|antiviral agents|mesh-ancestor
2076446|NCT02013674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076447|NCT02013765|Trastuzumab|trastuzumab|mesh-list
2076448|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
583620|NCT03595852|Cefazolin|cefazolin|mesh-list
583621|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
583622|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
583623|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
583624|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
583625|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076449|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076450|NCT02013791|Cyclosporine|cyclosporine|mesh-list
2076451|NCT02013791|Cyclosporins|cyclosporins|mesh-list
2076452|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076453|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076454|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076455|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
2076456|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076457|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
2076458|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076459|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
2076460|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2076461|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2076462|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
2076463|NCT02013817|Rituximab|rituximab|mesh-list
2076464|NCT02013817|Fludarabine|fludarabine|mesh-list
2076465|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076466|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
2076467|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076468|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2076469|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2076470|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
2076471|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076472|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076473|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
583802|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2076474|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2214825|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214826|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214827|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214828|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214829|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2214830|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214831|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214832|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
2214833|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214834|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214835|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
2214836|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214837|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
2214838|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2750688|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750689|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750690|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2750691|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
2750692|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
583673|NCT03595514|Dexamethasone|dexamethasone|mesh-list
583674|NCT03595514|Lidocaine|lidocaine|mesh-list
583675|NCT03595514|Epinephrine|epinephrine|mesh-list
583676|NCT03595514|Bupivacaine|bupivacaine|mesh-list
583677|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
583678|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
583679|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
583680|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583681|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583682|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
583683|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
583684|NCT03595514|Hormones|hormones|mesh-ancestor
583685|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
583686|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
583687|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583688|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
583689|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
583690|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583691|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
583692|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
583693|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
583694|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
583695|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
583696|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583697|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
583698|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
583699|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
583700|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
583701|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
583702|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
583703|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
583704|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
583705|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
583706|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
583707|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2214839|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
2214840|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214841|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2214842|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214843|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214844|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
2214845|NCT00025428|Carboplatin|carboplatin|mesh-list
2214846|NCT00025428|Doxorubicin|doxorubicin|mesh-list
2214847|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2214848|NCT00025428|Etoposide|etoposide|mesh-list
2214849|NCT00025428|Vincristine|vincristine|mesh-list
2214850|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
583720|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
583721|NCT03595397|Fentanyl|fentanyl|mesh-list
583722|NCT03595397|Bupivacaine|bupivacaine|mesh-list
583723|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
583724|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
583725|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
584104|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2214851|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
2214852|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583726|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583727|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
583728|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583729|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
583730|NCT03595397|Narcotics|narcotics|mesh-ancestor
583731|NCT03595397|Analgesics|analgesics|mesh-ancestor
583732|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
583733|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
583734|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
583735|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
583736|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
583737|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
583738|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
583739|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583740|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
583741|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
583742|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
583743|NCT03595371|Dapansutrile|dapansutrile|mesh-list
583744|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
583745|NCT03595319|Sevoflurane|sevoflurane|mesh-list
583746|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
583747|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
583748|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
583749|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
583750|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583751|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583752|NCT03595254|Nicotine|nicotine|mesh-list
583753|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
583754|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
583755|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583756|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583757|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
583758|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
583759|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
583760|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
583761|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583762|NCT03595189|Cilastatin|cilastatin|mesh-list
583763|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
583764|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583765|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583766|NCT03595163|Folic Acid|folic acid|mesh-list
583767|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
583768|NCT03595163|Propofol|propofol|mesh-list
583769|NCT03595163|Sevoflurane|sevoflurane|mesh-list
583770|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
583771|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583772|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583773|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
583774|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
583775|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
583776|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
583777|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
583778|NCT03595163|Hematinics|hematinics|mesh-ancestor
583779|NCT03595163|Vitamins|vitamins|mesh-ancestor
583780|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
583781|NCT03595150|Diclofenac|diclofenac|mesh-list
583782|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
583783|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
583784|NCT03595150|Analgesics|analgesics|mesh-ancestor
583785|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
583786|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583787|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583788|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
583789|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
583790|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
583791|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583792|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076475|NCT02013830|Bevacizumab|bevacizumab|mesh-list
2076476|NCT02013830|Capecitabine|capecitabine|mesh-list
2076477|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2076478|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076479|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2076480|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2076481|NCT02013830|Growth Substances|growth substances|mesh-ancestor
2076482|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583801|NCT03595085|Streptokinase|streptokinase|mesh-list
583803|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
583804|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076483|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
2076484|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2076485|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
2076486|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076487|NCT02014363|Amitriptyline|amitriptyline|mesh-list
2076488|NCT02014363|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2076489|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
583813|NCT03595046|Dexamethasone|dexamethasone|mesh-list
583814|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
583815|NCT03595046|Ropivacaine|ropivacaine|mesh-list
583816|NCT03595046|BB 1101|bb 1101|mesh-list
583817|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
583818|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
583819|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
583820|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583821|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583822|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
583823|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
583824|NCT03595046|Hormones|hormones|mesh-ancestor
583825|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
583826|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
583827|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583828|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
583829|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583830|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583831|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
583832|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
583833|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583834|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
583835|NCT03594968|Progesterone|progesterone|mesh-list
583836|NCT03594968|Progestins|progestins|mesh-ancestor
583837|NCT03594968|Hormones|hormones|mesh-ancestor
583838|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
583839|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583840|NCT03594825|Valsartan|valsartan|mesh-list
583841|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
583842|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
583843|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
583844|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583845|NCT03594747|Paclitaxel|paclitaxel|mesh-list
583846|NCT03594747|Carboplatin|carboplatin|mesh-list
583847|NCT03594747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
583848|NCT03594747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583849|NCT03594747|Tubulin Modulators|tubulin modulators|mesh-ancestor
583850|NCT03594747|Antimitotic Agents|antimitotic agents|mesh-ancestor
583851|NCT03594747|Mitosis Modulators|mitosis modulators|mesh-ancestor
583852|NCT03594747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583853|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
583854|NCT03594604|Norethindrone|norethindrone|mesh-list
583855|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
583856|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
583857|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
583858|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
583859|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583860|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
583861|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
583862|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
583863|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
583864|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
583865|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583866|NCT03594565|Fluticasone|fluticasone|mesh-list
583867|NCT03594565|Xhance|xhance|mesh-list
583868|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
583869|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
583870|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
583871|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583872|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583873|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
583874|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
583875|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
583876|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
583877|NCT03594552|Baclofen|baclofen|mesh-list
583878|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
583879|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583880|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
583881|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583882|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
583883|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
583884|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
583885|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
583886|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583887|NCT03594513|Dipyrone|dipyrone|mesh-list
583888|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
583889|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
583890|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
583891|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
583892|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
583893|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
583894|NCT03594513|Analgesics|analgesics|mesh-ancestor
583895|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
583896|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583897|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583898|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
583899|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
583900|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
2750693|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
2750694|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750695|NCT04196257|Paclitaxel|paclitaxel|mesh-list
2750696|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
583905|NCT03594461|Aflibercept|aflibercept|mesh-list
583906|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
583907|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
583908|NCT03594461|Growth Substances|growth substances|mesh-ancestor
583909|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583910|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
583911|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583912|NCT03594435|Ibudilast|ibudilast|mesh-list
583913|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
583914|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
583915|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
583916|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583917|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
583918|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
583919|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
583920|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583921|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583922|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
583923|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
583924|NCT03594396|Durvalumab|durvalumab|mesh-list
583925|NCT03594396|Olaparib|olaparib|mesh-list
583926|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
583927|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583928|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
583929|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583930|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583931|NCT03594240|Folic Acid|folic acid|mesh-list
583932|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
583933|NCT03594240|Vitamins|vitamins|mesh-ancestor
583934|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
583935|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583936|NCT03594240|Hematinics|hematinics|mesh-ancestor
583937|NCT03594214|Vitamin D|vitamin d|mesh-list
583938|NCT03594214|Vitamins|vitamins|mesh-ancestor
583939|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
583940|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583941|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
583942|NCT03594188|Anesthetics|anesthetics|mesh-list
583943|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
583944|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
583945|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
583946|NCT03594175|Reteplase|reteplase|mesh-list
583947|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
583948|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
583949|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750697|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750698|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
2750699|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
2750700|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
2750701|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750702|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
2750703|NCT04195568|Antacids|antacids|mesh-ancestor
2750704|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750705|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
583961|NCT03594149|Levofloxacin|levofloxacin|mesh-list
583962|NCT03594149|Ofloxacin|ofloxacin|mesh-list
583963|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
583964|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
583965|NCT03594149|Renal Agents|renal agents|mesh-ancestor
583966|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
583967|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
583968|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
583969|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
583970|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583971|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
583972|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
583973|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2750710|NCT04191928|Apixaban|apixaban|mesh-list
2750711|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2750712|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
2750713|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2750714|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
2076490|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
2076491|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2076492|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2076493|NCT02014363|Analgesics|analgesics|mesh-ancestor
2076494|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
583986|NCT03594058|Solabegron|solabegron|mesh-list
583987|NCT03594058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
583988|NCT03594058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
583989|NCT03594058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
583990|NCT03594058|Adrenergic Agents|adrenergic agents|mesh-ancestor
583991|NCT03594058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
583992|NCT03594058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
583993|NCT03594058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214853|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214854|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214855|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
2214856|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214857|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214858|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214859|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214860|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
584002|NCT03593954|Ritonavir|ritonavir|mesh-list
584003|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
584004|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
584005|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
584006|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584007|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584008|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
584009|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
584010|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
584011|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
584012|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
584013|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2076495|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076496|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076497|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2076498|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2076499|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2076500|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076501|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
2076502|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076503|NCT02014363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2076504|NCT02014363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2076505|NCT02014363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2214861|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2750715|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214862|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214863|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214864|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214865|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214866|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214867|NCT00025441|Dactinomycin|dactinomycin|mesh-list
2214868|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
2214869|NCT00025441|Ifosfamide|ifosfamide|mesh-list
2214870|NCT00025441|Carboplatin|carboplatin|mesh-list
2214871|NCT00025441|Doxorubicin|doxorubicin|mesh-list
2214872|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2214873|NCT00025441|Etoposide|etoposide|mesh-list
2214874|NCT00025441|Vincristine|vincristine|mesh-list
2214875|NCT00025441|Epirubicin|epirubicin|mesh-list
2214876|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214877|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
2214878|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214879|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214880|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214881|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
2214882|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214883|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214884|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214885|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214886|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2214887|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2214888|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214889|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2214890|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214891|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214892|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
584059|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
584060|NCT03593811|Ondansetron|ondansetron|mesh-list
584061|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
584062|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
584063|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
584064|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584065|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
584066|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
584067|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
584068|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
584069|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
584070|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
584071|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584072|NCT03593811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
584073|NCT03593811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
584074|NCT03593811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
584075|NCT03593811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
584076|NCT03593811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
584077|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
584078|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
584079|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
584080|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2076506|NCT02014402|Thrombin|thrombin|mesh-list
2076507|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
2076508|NCT02014402|Coagulants|coagulants|mesh-ancestor
2076509|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2076510|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2076511|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076512|NCT02014467|Vitamin D|vitamin d|mesh-list
2076513|NCT02014467|Denosumab|denosumab|mesh-list
2076514|NCT02014467|Calcium|calcium|mesh-list
2076515|NCT02014467|Vitamins|vitamins|mesh-ancestor
2076516|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
2076517|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076518|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2076519|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2750716|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750717|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
584103|NCT03593707|Metformin|metformin|mesh-list
2214893|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2214894|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
584105|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584106|NCT03593668|Metformin|metformin|mesh-list
584107|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
584108|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750732|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
2750733|NCT04181515|Yohimbine|yohimbine|mesh-list
2750734|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2750735|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
2750736|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
2750737|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2750738|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214895|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2214896|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2214897|NCT00025454|Tipifarnib|tipifarnib|mesh-list
584126|NCT03593473|Oxytocin|oxytocin|mesh-list
584127|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
584128|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
584129|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584130|NCT03593447|Ribavirin|ribavirin|mesh-list
584131|NCT03593447|Yimitasvir|yimitasvir|mesh-list
584132|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
584133|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584134|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
584135|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
584136|NCT03593434|Xenon|xenon|mesh-list
584137|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
584138|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
584139|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
584140|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
584141|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584142|NCT03593408|Fentanyl|fentanyl|mesh-list
584143|NCT03593408|Midazolam|midazolam|mesh-list
584144|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
584145|NCT03593408|Morphine|morphine|mesh-list
584146|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
584147|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
584148|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584149|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
584150|NCT03593408|Analgesics|analgesics|mesh-ancestor
584151|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
584152|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
584153|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
584154|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
584155|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
584156|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
584157|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
584158|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584159|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
584160|NCT03593408|Narcotics|narcotics|mesh-ancestor
584161|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
584162|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
584163|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
584164|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
584165|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
584166|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
584167|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
584168|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
584169|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
584170|NCT03593317|Spironolactone|spironolactone|mesh-list
584171|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
584172|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
584173|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
584174|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584175|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
584176|NCT03593317|Diuretics|diuretics|mesh-ancestor
584177|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
584178|NCT03593304|Vitamins|vitamins|mesh-list
584179|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
584180|NCT03593304|Pyridoxine|pyridoxine|mesh-list
584181|NCT03593304|Pyridoxal|pyridoxal|mesh-list
584182|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
584183|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
584184|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
584185|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584186|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
584187|NCT03593291|Dalteparin|dalteparin|mesh-list
584188|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
584189|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
584190|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
584191|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750739|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2750740|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2750741|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2750742|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
2750743|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2750744|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750745|NCT04181515|Urological Agents|urological agents|mesh-ancestor
584217|NCT03593213|Cariprazine|cariprazine|mesh-list
584218|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
584219|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
584220|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
584221|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584222|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
584223|NCT03593135|Metformin|metformin|mesh-list
584224|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
584225|NCT03593135|Acetic Acid|acetic acid|mesh-list
584226|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
584227|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584228|NCT03593135|Incretins|incretins|mesh-ancestor
584229|NCT03593135|Hormones|hormones|mesh-ancestor
584230|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
584231|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
584232|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
584233|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584234|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584235|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
584236|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
584237|NCT03593044|Atropine|atropine|mesh-list
584238|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
584239|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
584240|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
584241|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
584242|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
584243|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584244|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
584245|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
584246|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
584247|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
584248|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
584249|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
584250|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
584251|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
584252|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584270|NCT03592992|Morphine|morphine|mesh-list
584271|NCT03592992|Hydromorphone|hydromorphone|mesh-list
584272|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
584273|NCT03592992|Narcotics|narcotics|mesh-ancestor
584274|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
584275|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584276|NCT03592992|Analgesics|analgesics|mesh-ancestor
584277|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
584278|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
584279|NCT03592901|Anesthetics|anesthetics|mesh-list
584280|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
584281|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584282|NCT03592836|Furosemide|furosemide|mesh-list
584283|NCT03592836|Diuretics|diuretics|mesh-list
584284|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
584285|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
584286|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584287|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
584288|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584289|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
584290|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
584291|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
584292|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
584293|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
584294|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584295|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584296|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
584306|NCT03592680|Ascorbic Acid|ascorbic acid|mesh-list
584307|NCT03592680|Vitamins|vitamins|mesh-ancestor
584308|NCT03592680|Micronutrients|micronutrients|mesh-ancestor
584309|NCT03592680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584310|NCT03592680|Antioxidants|antioxidants|mesh-ancestor
584311|NCT03592680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584312|NCT03592680|Protective Agents|protective agents|mesh-ancestor
584313|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
584314|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
584315|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584316|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
584317|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584318|NCT03592576|Venetoclax|venetoclax|mesh-list
584319|NCT03592576|Navitoclax|navitoclax|mesh-list
584320|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584321|NCT03592537|Fentanyl|fentanyl|mesh-list
584322|NCT03592537|Midazolam|midazolam|mesh-list
584323|NCT03592537|Bupivacaine|bupivacaine|mesh-list
584324|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
584325|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
584326|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
584327|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584328|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
584329|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
584330|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
584331|NCT03592537|Narcotics|narcotics|mesh-ancestor
584332|NCT03592537|Analgesics|analgesics|mesh-ancestor
584333|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
584334|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
584335|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
584336|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
584337|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
584338|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
584339|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
584340|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
584341|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
584342|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
584343|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584344|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
584345|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
584346|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
584347|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
584348|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
584349|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
584350|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
584351|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
584352|NCT03592485|Acetaminophen|acetaminophen|mesh-list
584353|NCT03592485|Oxycodone|oxycodone|mesh-list
584354|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
584355|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584356|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
584357|NCT03592485|Analgesics|analgesics|mesh-ancestor
584358|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
584359|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
584360|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
584361|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
584362|NCT03592485|Narcotics|narcotics|mesh-ancestor
584363|NCT03592472|Abexinostat|abexinostat|mesh-list
584364|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
584365|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584366|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584367|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
584368|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
584369|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584370|NCT03592342|Clobetasol|clobetasol|mesh-list
584371|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
584372|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
584373|NCT03592342|Hormones|hormones|mesh-ancestor
584374|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
584375|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584376|NCT03592277|Vitamins|vitamins|mesh-list
584377|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
584378|NCT03592277|Thiamine|thiamine|mesh-list
584379|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
584380|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584381|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
584382|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584383|NCT03592277|Protective Agents|protective agents|mesh-ancestor
584384|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
2076547|NCT02014584|Dutasteride|dutasteride|mesh-list
2076548|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2076549|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2076550|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076551|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076552|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
2076553|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2076554|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076555|NCT02014740|Metformin|metformin|mesh-list
2076556|NCT02014740|Liraglutide|liraglutide|mesh-list
2076557|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2214898|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584400|NCT03592199|Sunitinib|sunitinib|mesh-list
584401|NCT03592199|Axitinib|axitinib|mesh-list
584402|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584403|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
584404|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
584405|NCT03592199|Growth Substances|growth substances|mesh-ancestor
584406|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584407|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
584408|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
584409|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584410|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214899|NCT00025467|Thalidomide|thalidomide|mesh-list
2214900|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214901|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
2214902|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214903|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
2214904|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2214905|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214906|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2214907|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2214908|NCT00025467|Growth Substances|growth substances|mesh-ancestor
2214909|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
2214910|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214911|NCT00025480|Paclitaxel|paclitaxel|mesh-list
2214912|NCT00025480|Carboplatin|carboplatin|mesh-list
2214913|NCT00025480|Tipifarnib|tipifarnib|mesh-list
2214914|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
584428|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
584429|NCT03592082|Bismuth|bismuth|mesh-list
584430|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
584431|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
584432|NCT03592082|Antacids|antacids|mesh-ancestor
584433|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584434|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
584435|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
584436|NCT03592069|Amoxicillin|amoxicillin|mesh-list
584437|NCT03592069|Metronidazole|metronidazole|mesh-list
584438|NCT03592069|Clarithromycin|clarithromycin|mesh-list
584439|NCT03592069|Esomeprazole|esomeprazole|mesh-list
584440|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
584441|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
584442|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
584443|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
584444|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
584445|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
584446|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
584447|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584448|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584449|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
584450|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
584451|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
584452|NCT03591991|Empagliflozin|empagliflozin|mesh-list
584453|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
584454|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584455|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
584456|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584457|NCT03591913|Misoprostol|misoprostol|mesh-list
584458|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
584459|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
584460|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
584461|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584462|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
584463|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
584464|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
584465|NCT03591900|Insulin|insulin|mesh-list
584466|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
584467|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584468|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
584469|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
584470|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
584471|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
584472|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
584473|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
584474|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
584475|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584476|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584477|NCT03591861|Carmustine|carmustine|mesh-list
584478|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
584479|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
584480|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584481|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584485|NCT03591757|Tolcapone|tolcapone|mesh-list
584486|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
584487|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
584488|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
584489|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584642|NCT03591289|Rocuronium|rocuronium|mesh-list
2214915|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584490|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584491|NCT03591744|Dexamethasone|dexamethasone|mesh-list
584492|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
584493|NCT03591744|Doxorubicin|doxorubicin|mesh-list
584494|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
584495|NCT03591744|Lenalidomide|lenalidomide|mesh-list
584496|NCT03591744|Bortezomib|bortezomib|mesh-list
584497|NCT03591744|Daratumumab|daratumumab|mesh-list
584498|NCT03591744|Ichthammol|ichthammol|mesh-list
584499|NCT03591744|BB 1101|bb 1101|mesh-list
584500|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
584501|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
584502|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
584503|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
584504|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584505|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
584506|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
584507|NCT03591744|Hormones|hormones|mesh-ancestor
584508|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
584509|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
584510|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584511|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
584512|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
584513|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
584514|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584515|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584516|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
584517|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
584518|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
584519|NCT03591744|Growth Substances|growth substances|mesh-ancestor
584520|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
584521|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
584522|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
584523|NCT03591731|Nivolumab|nivolumab|mesh-list
584524|NCT03591731|Ipilimumab|ipilimumab|mesh-list
584525|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
584526|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584527|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
584528|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584529|NCT03591679|Oxytocin|oxytocin|mesh-list
584530|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
584531|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
584532|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584533|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
584534|NCT03591575|Deferiprone|deferiprone|mesh-list
584535|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
584536|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
584537|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
584538|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584539|NCT03591549|Fulvestrant|fulvestrant|mesh-list
584540|NCT03591549|Goserelin|goserelin|mesh-list
584541|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
584542|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584543|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
584544|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
584545|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
584546|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
584547|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584548|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
584549|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
584550|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584551|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584552|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
584553|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
584554|NCT03591536|Protective Agents|protective agents|mesh-ancestor
584555|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584556|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
584557|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
584558|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
2076558|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076559|NCT02014740|Incretins|incretins|mesh-ancestor
2076560|NCT02014740|Hormones|hormones|mesh-ancestor
2076561|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2076562|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
2076563|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
584643|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
2076564|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
2076565|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076566|NCT02015195|Ethanol|ethanol|mesh-list
2076567|NCT02015195|Acetic Acid|acetic acid|mesh-list
2076568|NCT02015195|Retinol acetate|retinol acetate|mesh-list
2076569|NCT02015195|Lidocaine|lidocaine|mesh-list
2076570|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
2076571|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
2076572|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2076573|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076574|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
2076575|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076576|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2076577|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2076578|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2076579|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2076580|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584584|NCT03591471|Prednisone|prednisone|mesh-list
584585|NCT03591471|Benazepril|benazepril|mesh-list
584586|NCT03591471|Heparin|heparin|mesh-list
584587|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
584588|NCT03591471|Tinzaparin|tinzaparin|mesh-list
584589|NCT03591471|Dalteparin|dalteparin|mesh-list
584590|NCT03591471|Calcium heparin|calcium heparin|mesh-list
584591|NCT03591471|Dipyridamole|dipyridamole|mesh-list
584592|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584593|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
584594|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
584595|NCT03591471|Hormones|hormones|mesh-ancestor
584596|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
584597|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
584598|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584599|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
584600|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
584601|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
584602|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584603|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
584604|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
584605|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584606|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
584607|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
584608|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
584609|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
2214916|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214917|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214918|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214919|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214920|NCT00025493|Docetaxel|docetaxel|mesh-list
2214921|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214922|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
2214923|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
2214924|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
2214925|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214926|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
2214927|NCT00025519|Thalidomide|thalidomide|mesh-list
2214928|NCT00025519|Fludarabine|fludarabine|mesh-list
2214929|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
2214930|NCT00025519|Tacrolimus|tacrolimus|mesh-list
2214931|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214932|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2214933|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
2214934|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214935|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214936|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
584635|NCT03591341|Melatonin|melatonin|mesh-list
584636|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
584637|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584638|NCT03591341|Protective Agents|protective agents|mesh-ancestor
584639|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584640|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
584641|NCT03591289|Bromides|bromides|mesh-list
2214937|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584644|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
584645|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
584646|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
584647|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
584648|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584649|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
584650|NCT03591172|Propolis|propolis|mesh-list
584651|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214938|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2214939|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214940|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2214941|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2214942|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
2214943|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2214944|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214945|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
2214946|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2214947|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2214948|NCT00025519|Growth Substances|growth substances|mesh-ancestor
2214949|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
2214950|NCT00025532|Antibodies|antibodies|mesh-list
2214951|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2214952|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
2214953|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214954|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
2214955|NCT00025545|Methotrexate|methotrexate|mesh-list
584670|NCT03591003|Antibodies|antibodies|mesh-list
584671|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
584672|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
584673|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584674|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
584675|NCT03590912|Cetirizine|cetirizine|mesh-list
584676|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
584677|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
584678|NCT03590912|Prednisolone|prednisolone|mesh-list
584679|NCT03590912|Phenylephrine|phenylephrine|mesh-list
584680|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
584681|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
584682|NCT03590912|Levocetirizine|levocetirizine|mesh-list
584683|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
584684|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
584685|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
584686|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
584687|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
584688|NCT03590912|Hormones|hormones|mesh-ancestor
584689|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
584690|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584691|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
584692|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584693|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
584694|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
584695|NCT03590912|Protective Agents|protective agents|mesh-ancestor
584696|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
584697|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
584698|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
584699|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
584700|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
584701|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584702|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
584703|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
584704|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
584705|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
584706|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
584707|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
584708|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
584709|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
584710|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
584711|NCT03590873|Vasopressins|vasopressins|mesh-list
584712|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
584713|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584714|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
584715|NCT03590873|Coagulants|coagulants|mesh-ancestor
584716|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
584717|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
584718|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
584737|NCT03590808|Vaccines|vaccines|mesh-list
584738|NCT03590808|Immunologic Factors|immunologic factors|mesh-ancestor
584739|NCT03590808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584740|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
584741|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
584742|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214956|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214957|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
2214958|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214959|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214960|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214961|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
2214962|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584751|NCT03590652|Dexamethasone|dexamethasone|mesh-list
584752|NCT03590652|Pomalidomide|pomalidomide|mesh-list
584753|NCT03590652|Daratumumab|daratumumab|mesh-list
584754|NCT03590652|Ixazomib|ixazomib|mesh-list
584755|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
584756|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
584757|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
584758|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
584759|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584760|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
584761|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
584762|NCT03590652|Hormones|hormones|mesh-ancestor
584763|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
584764|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
584765|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584766|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
584767|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
584768|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
584769|NCT03590652|Growth Substances|growth substances|mesh-ancestor
584770|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
584771|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
584772|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584773|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584774|NCT03590626|Dulaglutide|dulaglutide|mesh-list
584775|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
584776|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584777|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
584778|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
584779|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
584780|NCT03590587|Hormones|hormones|mesh-ancestor
584781|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
584782|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584783|NCT03590496|Calcium|calcium|mesh-list
584784|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
584785|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584786|NCT03590444|Ranibizumab|ranibizumab|mesh-list
584787|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
584788|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
584789|NCT03590444|Growth Substances|growth substances|mesh-ancestor
584790|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584791|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
584792|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584793|NCT03590431|Iodine|iodine|mesh-list
584794|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
584795|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
584796|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
584797|NCT03590431|Trace Elements|trace elements|mesh-ancestor
584798|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
584799|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584800|NCT03590275|Folfirinox|folfirinox|mesh-list
584801|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584802|NCT03590262|Metformin|metformin|mesh-list
584803|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
584804|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584805|NCT03590210|Nivolumab|nivolumab|mesh-list
584806|NCT03590210|Trabectedin|trabectedin|mesh-list
584807|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
584808|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584809|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
584810|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584811|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
584812|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
584813|NCT03590197|Melatonin|melatonin|mesh-list
584814|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
584815|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584816|NCT03590197|Protective Agents|protective agents|mesh-ancestor
584817|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584818|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
584819|NCT03590171|Bortezomib|bortezomib|mesh-list
584820|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584821|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
584822|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
584823|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584824|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
584825|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
584826|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
584827|NCT03590080|Prednisolone|prednisolone|mesh-list
584828|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
584829|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
584830|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
584831|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
584832|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
584833|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
584834|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
584835|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584836|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
584837|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
584838|NCT03590080|Hormones|hormones|mesh-ancestor
584839|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
584840|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
584841|NCT03590080|Protective Agents|protective agents|mesh-ancestor
584842|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
584843|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584844|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
584845|NCT03590054|Abexinostat|abexinostat|mesh-list
584846|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
584847|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584848|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
584849|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584850|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750764|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
2750765|NCT04180969|Yohimbine|yohimbine|mesh-list
2750766|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2750767|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
2750768|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
2750769|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2750770|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750771|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2750772|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
584860|NCT03589898|Gabapentin|gabapentin|mesh-list
584861|NCT03589898|Analgesics|analgesics|mesh-ancestor
584862|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
584863|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
584864|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584865|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
584866|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
584867|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
584868|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
584869|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
584870|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
584871|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
584872|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
584873|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584874|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
2214963|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214964|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214965|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
584878|NCT03589833|Methotrexate|methotrexate|mesh-list
584879|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
584880|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
584881|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
584882|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584883|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
584884|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
584885|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584886|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584887|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
584888|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584889|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
584890|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
584891|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
584892|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
584893|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
584894|NCT03589768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
584895|NCT03589768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
584896|NCT03589768|Immunologic Factors|immunologic factors|mesh-ancestor
584897|NCT03589768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584898|NCT03589768|Antacids|antacids|mesh-ancestor
584899|NCT03589768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584900|NCT03589768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
584901|NCT03589729|Cytarabine|cytarabine|mesh-list
584902|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
584903|NCT03589729|Idarubicin|idarubicin|mesh-list
584904|NCT03589729|Cladribine|cladribine|mesh-list
584905|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
584906|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
584907|NCT03589729|Razoxane|razoxane|mesh-list
584908|NCT03589729|Calicheamicins|calicheamicins|mesh-list
584909|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
584910|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
584911|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584912|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584913|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
584914|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
584915|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
584916|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
584917|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584918|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
584919|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
584920|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
584921|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584922|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
584923|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
584924|NCT03589729|Protective Agents|protective agents|mesh-ancestor
584925|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
584926|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
584927|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
584928|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
584929|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584930|NCT03589690|Protective Agents|protective agents|mesh-ancestor
584931|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584932|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
584933|NCT03589690|Vitamins|vitamins|mesh-ancestor
584934|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
584935|NCT03589547|Durvalumab|durvalumab|mesh-list
584936|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
584937|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
584938|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
584939|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
584940|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
584941|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
584942|NCT03589495|Expectorants|expectorants|mesh-ancestor
584943|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
584944|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
584945|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
584946|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584947|NCT03589495|Protective Agents|protective agents|mesh-ancestor
584948|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
584949|NCT03589495|Antidotes|antidotes|mesh-ancestor
2214966|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
2214967|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2214968|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
584953|NCT03589430|Protein C|protein c|mesh-list
584954|NCT03589430|Antithrombins|antithrombins|mesh-list
584955|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
584956|NCT03589430|Protein S|protein s|mesh-list
584957|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
584958|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
584959|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
584960|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
584961|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
584962|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
584963|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2076581|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2076582|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076583|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2076584|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2076585|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
2076586|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2076587|NCT02015195|Protective Agents|protective agents|mesh-ancestor
2076588|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076589|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
2076590|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2076591|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
2076592|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2076593|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2076594|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076595|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2076596|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076597|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2076598|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2076599|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2076600|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
2076601|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2076602|NCT02015546|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2076603|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2076604|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2076605|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076606|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076607|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
2076608|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076609|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2076610|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2076611|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
2076612|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2076613|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076614|NCT02015676|Paclitaxel|paclitaxel|mesh-list
2076615|NCT02015676|Trastuzumab|trastuzumab|mesh-list
2076616|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
585002|NCT03589222|Dexamethasone|dexamethasone|mesh-list
585003|NCT03589222|Bortezomib|bortezomib|mesh-list
585004|NCT03589222|Daratumumab|daratumumab|mesh-list
585005|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
585006|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
585007|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
585008|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585009|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585010|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
585011|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
585012|NCT03589222|Hormones|hormones|mesh-ancestor
585013|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
585014|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
585015|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585019|NCT03589066|Rotigotine|rotigotine|mesh-list
585020|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
585021|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
585022|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585023|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585024|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585025|NCT03589040|Darunavir|darunavir|mesh-list
585026|NCT03589040|Rilpivirine|rilpivirine|mesh-list
585027|NCT03589040|Etonogestrel|etonogestrel|mesh-list
585028|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
585029|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
585030|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
585031|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585032|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585033|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
585034|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
585035|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
585036|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
585037|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
585038|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
585039|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
585040|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
585041|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
585042|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585043|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
585044|NCT03589027|Ritonavir|ritonavir|mesh-list
585045|NCT03589027|Darunavir|darunavir|mesh-list
585046|NCT03589027|Rilpivirine|rilpivirine|mesh-list
585047|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
585048|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
585049|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
585050|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
585051|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585052|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585053|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
585054|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
585055|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
585056|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
585057|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
585058|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
585059|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
585060|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
585061|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
585062|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585063|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
585064|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
585065|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
585066|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
585067|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
585068|NCT03589014|Propranolol|propranolol|mesh-list
585069|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
585070|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
585071|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
585072|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585073|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585074|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585075|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
585076|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
585077|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
585078|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
585079|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
585080|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585081|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585082|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
585083|NCT03588988|Analgesics|analgesics|mesh-ancestor
585084|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
585085|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585086|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
585087|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
585088|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
585089|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
585090|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585091|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585092|NCT03588936|Nivolumab|nivolumab|mesh-list
585093|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
585094|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585095|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
585096|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214969|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
2214970|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
2214971|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2214972|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2214973|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2214974|NCT00025558|Carboplatin|carboplatin|mesh-list
2214975|NCT00025558|Temozolomide|temozolomide|mesh-list
2214976|NCT00025558|Thiotepa|thiotepa|mesh-list
2214977|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214978|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
2214979|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2214980|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214981|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
2214982|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2214983|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2214984|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2214985|NCT00025584|Bortezomib|bortezomib|mesh-list
585115|NCT03588884|Cholecalciferol|cholecalciferol|mesh-list
585116|NCT03588884|Calcifediol|calcifediol|mesh-list
585117|NCT03588884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
585118|NCT03588884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585119|NCT03588884|Vitamins|vitamins|mesh-ancestor
585120|NCT03588884|Micronutrients|micronutrients|mesh-ancestor
585121|NCT03588884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
585122|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
585123|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
585124|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2214986|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2214987|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
2214988|NCT00025597|Carboplatin|carboplatin|mesh-list
2214989|NCT00025597|Doxorubicin|doxorubicin|mesh-list
2214990|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2214991|NCT00025597|Etoposide|etoposide|mesh-list
2214992|NCT00025597|Vincristine|vincristine|mesh-list
2214993|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
585133|NCT03588767|Vitamin D|vitamin d|mesh-list
585134|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
585135|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
585136|NCT03588767|Vitamins|vitamins|mesh-list
585137|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
585138|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
585139|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585140|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
585141|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
585142|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
585143|NCT03588767|Hormones|hormones|mesh-ancestor
585144|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
585145|NCT03588754|Propranolol|propranolol|mesh-list
585146|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
585147|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
585148|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
585149|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585150|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585151|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585152|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
585153|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
585154|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
585155|NCT03588715|Interferons|interferons|mesh-list
585156|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
585157|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
585158|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
585159|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585160|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
585161|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
585162|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
585163|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585164|NCT03588689|Ropivacaine|ropivacaine|mesh-list
585165|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
585166|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
585167|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585168|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585169|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
585170|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585171|NCT03588676|Melatonin|melatonin|mesh-list
585172|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
585173|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585174|NCT03588676|Protective Agents|protective agents|mesh-ancestor
585175|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585176|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585177|NCT03588611|Hirudins|hirudins|mesh-list
2214994|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
2214995|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585178|NCT03588611|Bivalirudin|bivalirudin|mesh-list
585179|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
585180|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
585181|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
585182|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585183|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585184|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
585185|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
585186|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2076617|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076618|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
2076619|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
2076620|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
2076621|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076622|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2076623|NCT02015793|Adalimumab|adalimumab|mesh-list
2076624|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2076625|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2076626|NCT02015819|Leucovorin|leucovorin|mesh-list
585197|NCT03588533|Capecitabine|capecitabine|mesh-list
585198|NCT03588533|Trastuzumab|trastuzumab|mesh-list
585199|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585200|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
585201|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
585202|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585203|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
585204|NCT03588494|Endostar protein|endostar protein|mesh-list
585205|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
585206|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
585207|NCT03588494|Growth Substances|growth substances|mesh-ancestor
585208|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585209|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
585210|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585211|NCT03588429|Sevoflurane|sevoflurane|mesh-list
585212|NCT03588429|Isoflurane|isoflurane|mesh-list
585213|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
585214|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
585215|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
585216|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
585217|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585218|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585219|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
585220|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
585221|NCT03588351|Chitosan|chitosan|mesh-list
585222|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
585223|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
585224|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
585225|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
585226|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
585227|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
585228|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
585229|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585230|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
585231|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
585232|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
585233|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
585234|NCT03588351|Coagulants|coagulants|mesh-ancestor
585235|NCT03588338|Acetaminophen|acetaminophen|mesh-list
585236|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
585237|NCT03588338|Analgesics|analgesics|mesh-ancestor
585238|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
585239|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585240|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585241|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
585242|NCT03588273|Amoxicillin|amoxicillin|mesh-list
585243|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
585244|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
585245|NCT03588091|Docetaxel|docetaxel|mesh-list
585246|NCT03588091|Trastuzumab|trastuzumab|mesh-list
585247|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585248|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
585249|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
585250|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
585251|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585252|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
585253|NCT03588078|Azacitidine|azacitidine|mesh-list
2076627|NCT02015819|Flucytosine|flucytosine|mesh-list
2076628|NCT02015819|Calcium|calcium|mesh-list
585254|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
585255|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
585256|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585257|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585258|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585259|NCT03588039|Paclitaxel|paclitaxel|mesh-list
585260|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
585261|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
585262|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585263|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
585264|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
585265|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
585266|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585267|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
585268|NCT03587961|Ivacaftor|ivacaftor|mesh-list
585269|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
585270|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
585271|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076629|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
2076630|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2076631|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076632|NCT02015819|Antidotes|antidotes|mesh-ancestor
2076633|NCT02015819|Protective Agents|protective agents|mesh-ancestor
2076634|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
585278|NCT03587779|Sevoflurane|sevoflurane|mesh-list
585279|NCT03587779|Desflurane|desflurane|mesh-list
585280|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
585281|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
585282|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
585283|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
585284|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585285|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076635|NCT02015819|Vitamins|vitamins|mesh-ancestor
2076636|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
2076637|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
2076638|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076639|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
2076640|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076641|NCT02016105|Adalimumab|adalimumab|mesh-list
585293|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
585294|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
585295|NCT03587662|Gemcitabine|gemcitabine|mesh-list
585296|NCT03587662|Doxorubicin|doxorubicin|mesh-list
585297|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
585298|NCT03587662|Daunorubicin|daunorubicin|mesh-list
585299|NCT03587662|Ixazomib|ixazomib|mesh-list
585300|NCT03587662|Glycine|glycine|mesh-list
585301|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
585302|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
585303|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585304|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585305|NCT03587662|Antiviral Agents|antiviral agents|mesh-ancestor
585306|NCT03587662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
585307|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585308|NCT03587662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
585309|NCT03587662|Immunologic Factors|immunologic factors|mesh-ancestor
585310|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585311|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
585312|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
585313|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
585314|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
585315|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
585316|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585317|NCT03587636|Bupivacaine|bupivacaine|mesh-list
585318|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
585319|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
585320|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585321|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585322|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
585323|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585324|NCT03587610|Vaccines|vaccines|mesh-list
585325|NCT03587610|Immunologic Factors|immunologic factors|mesh-ancestor
585326|NCT03587610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076642|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2076643|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2076644|NCT02016170|Ticagrelor|ticagrelor|mesh-list
2076645|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2076646|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2076647|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2076648|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2076649|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
585334|NCT03587558|Flecainide|flecainide|mesh-list
585335|NCT03587558|Carvedilol|carvedilol|mesh-list
585336|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
585337|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
585338|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
585339|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585340|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585341|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585342|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
585343|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
585344|NCT03587558|Protective Agents|protective agents|mesh-ancestor
585345|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
585346|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
585347|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
585348|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
585349|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
585350|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
585351|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
585352|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
585353|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
585354|NCT03587441|Neostigmine|neostigmine|mesh-list
585355|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
585356|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585357|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585358|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
585359|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585360|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585361|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
585362|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
585363|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2214996|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2214997|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2214998|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
585368|NCT03587324|Clopidogrel|clopidogrel|mesh-list
585369|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
585370|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
585371|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
585372|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
585373|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
585374|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585375|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585376|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076650|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
2076651|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076652|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076653|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076654|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2076655|NCT02016183|Candesartan|candesartan|mesh-list
2076656|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
2076657|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2076658|NCT02016183|Diuretics|diuretics|mesh-ancestor
2076659|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
2076660|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076661|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2076662|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2076663|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076664|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2076665|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2076666|NCT02016482|Adalimumab|adalimumab|mesh-list
2076667|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2076668|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2076669|NCT02016625|Cyclosporine|cyclosporine|mesh-list
585399|NCT03587285|Goserelin|goserelin|mesh-list
585400|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
585401|NCT03587285|Bicalutamide|bicalutamide|mesh-list
585402|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
585403|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585478|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
585404|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
585405|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585406|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585407|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
585408|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
585409|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585410|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
585411|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
2076670|NCT02016625|Tacrolimus|tacrolimus|mesh-list
2076671|NCT02016625|Cyclosporins|cyclosporins|mesh-list
2076672|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076673|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
2076674|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076675|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2076676|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076677|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076678|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
2076679|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076680|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
585423|NCT03587220|Lidocaine|lidocaine|mesh-list
585424|NCT03587220|Capsaicin|capsaicin|mesh-list
585425|NCT03587220|Histamine|histamine|mesh-list
585426|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
585427|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
585428|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585429|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585430|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
585431|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585432|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
585433|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
585434|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
585435|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
585436|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585437|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
585438|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
585439|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
585440|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
585441|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2214999|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215000|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585445|NCT03587194|Apremilast|apremilast|mesh-list
585446|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
585447|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
585448|NCT03587194|Analgesics|analgesics|mesh-ancestor
585449|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
585450|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585451|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585452|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
585453|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
585454|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
585455|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
585456|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585457|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585458|NCT03587142|Buspirone|buspirone|mesh-list
585459|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
585460|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
585461|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585462|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585463|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
585464|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
585465|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
585466|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585467|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585468|NCT03587129|Apatinib|apatinib|mesh-list
585469|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585470|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
585471|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585472|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585473|NCT03587077|Isosorbide|isosorbide|mesh-list
585474|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
585475|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
585476|NCT03587077|Misoprostol|misoprostol|mesh-list
585477|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
585479|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
585480|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585481|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
585482|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
585483|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
585484|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
585485|NCT03587077|Diuretics|diuretics|mesh-ancestor
585486|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
585487|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
585488|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
585489|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585490|NCT03587038|Temozolomide|temozolomide|mesh-list
585491|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
585492|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
585493|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585494|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585495|NCT03587025|Amitriptyline|amitriptyline|mesh-list
585496|NCT03587025|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
585497|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
585498|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
585499|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
585500|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
585501|NCT03587025|Analgesics|analgesics|mesh-ancestor
585502|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
585503|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585504|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585505|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
585506|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
585507|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
585508|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585509|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
585510|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585511|NCT03587025|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
585512|NCT03587025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
585513|NCT03587025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2076681|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2076682|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2076683|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
2076684|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076685|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
585519|NCT03586947|Vitamin D|vitamin d|mesh-list
585520|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
585521|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
585522|NCT03586947|Vitamins|vitamins|mesh-list
585523|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
585524|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585525|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
585526|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
585527|NCT03586934|Acetaminophen|acetaminophen|mesh-list
585528|NCT03586934|Celecoxib|celecoxib|mesh-list
585529|NCT03586934|Ketorolac|ketorolac|mesh-list
585530|NCT03586934|Meloxicam|meloxicam|mesh-list
585531|NCT03586934|Morphine|morphine|mesh-list
585532|NCT03586934|Oxycodone|oxycodone|mesh-list
585533|NCT03586934|Tramadol|tramadol|mesh-list
585534|NCT03586934|Hydrocodone|hydrocodone|mesh-list
585535|NCT03586934|Ropivacaine|ropivacaine|mesh-list
585536|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
585537|NCT03586934|Narcotics|narcotics|mesh-ancestor
585538|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585539|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585540|NCT03586934|Analgesics|analgesics|mesh-ancestor
585541|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
585542|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585543|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
585544|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
585545|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
585546|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
585547|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
585548|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
585549|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
585550|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
585551|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
585552|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585553|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585554|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
2076686|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
585555|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
585556|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
585557|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
585558|NCT03586869|Leucovorin|leucovorin|mesh-list
585559|NCT03586869|Paclitaxel|paclitaxel|mesh-list
585560|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
585561|NCT03586869|Bevacizumab|bevacizumab|mesh-list
585562|NCT03586869|Fluorouracil|fluorouracil|mesh-list
585563|NCT03586869|Capecitabine|capecitabine|mesh-list
585564|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
585565|NCT03586869|Avelumab|avelumab|mesh-list
585566|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
585567|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585568|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
585569|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
585570|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
585571|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585572|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
585573|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
585574|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585575|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
585576|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
585577|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
585578|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
585579|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
585580|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
585581|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
585582|NCT03586869|Growth Substances|growth substances|mesh-ancestor
585583|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
585584|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
585585|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
585586|NCT03586869|Antidotes|antidotes|mesh-ancestor
585587|NCT03586869|Protective Agents|protective agents|mesh-ancestor
585588|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
585589|NCT03586869|Vitamins|vitamins|mesh-ancestor
585590|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
585591|NCT03586817|Palonosetron|palonosetron|mesh-list
585592|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
585593|NCT03586817|Aprepitant|aprepitant|mesh-list
585594|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
585595|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
585596|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585597|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585598|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
585599|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
585600|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
585601|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
585602|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585603|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585604|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
585605|NCT03586791|Anesthetics|anesthetics|mesh-list
585606|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585607|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215001|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2215002|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2215003|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2215004|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2215005|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215006|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2215007|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
2215008|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
2215009|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
2215010|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
2215011|NCT00025610|Carboplatin|carboplatin|mesh-list
2215012|NCT00025610|Doxorubicin|doxorubicin|mesh-list
2215013|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2215014|NCT00025610|Etoposide|etoposide|mesh-list
2215015|NCT00025610|Vincristine|vincristine|mesh-list
585623|NCT03586687|Triamcinolone|triamcinolone|mesh-list
585624|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
585625|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
585626|NCT03586687|Hormones|hormones|mesh-ancestor
585627|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
585628|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585629|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
585630|NCT03586674|Fenofibrate|fenofibrate|mesh-list
2215016|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215017|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
585631|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
585632|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
585633|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585634|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
585635|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
585636|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
585637|NCT03586661|Niraparib|niraparib|mesh-list
585638|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
585639|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585640|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585641|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215018|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215019|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215020|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2215021|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
2215022|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215023|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215024|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2215025|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2215026|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2215027|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2215028|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215029|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2215030|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
2215031|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
2215032|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
585672|NCT03586466|Buprenorphine|buprenorphine|mesh-list
585673|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
585674|NCT03586466|Naloxone|naloxone|mesh-list
585675|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
585676|NCT03586466|Narcotics|narcotics|mesh-ancestor
585677|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585678|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585679|NCT03586466|Analgesics|analgesics|mesh-ancestor
585680|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
585681|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585682|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
585683|NCT03586453|Osimertinib|osimertinib|mesh-list
585684|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585685|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
585686|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585687|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585688|NCT03586414|Ubiquinone|ubiquinone|mesh-list
585689|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
585690|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585691|NCT03586323|Lidocaine|lidocaine|mesh-list
585692|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
585693|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
585694|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585695|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585696|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
585697|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585698|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
585699|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
585700|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
585701|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
585702|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585703|NCT03586284|Valganciclovir|valganciclovir|mesh-list
585704|NCT03586284|Ganciclovir|ganciclovir|mesh-list
585705|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
585706|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
585707|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
585708|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
585709|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585710|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585711|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
585712|NCT03586219|Narcotics|narcotics|mesh-ancestor
585713|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585714|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585715|NCT03586219|Analgesics|analgesics|mesh-ancestor
585716|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
585717|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585718|NCT03586154|Ketamine|ketamine|mesh-list
585719|NCT03586154|Bupivacaine|bupivacaine|mesh-list
585720|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
585721|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
585722|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585723|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585724|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
585725|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585726|NCT03586154|Analgesics|analgesics|mesh-ancestor
585727|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
585728|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
585729|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
585730|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
585731|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
585732|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585733|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585734|NCT03586089|Diazepam|diazepam|mesh-list
585735|NCT03586089|Phenobarbital|phenobarbital|mesh-list
585736|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
585737|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
585738|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
585739|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
585740|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585741|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585742|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
585743|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
585744|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585745|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
585746|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
585747|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
585748|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
585749|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
585750|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
585751|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
585752|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
585753|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
585754|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
585755|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585756|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585757|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
585758|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
585759|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
585760|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
585761|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
585762|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
585763|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
585764|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585765|NCT03585998|Cisplatin|cisplatin|mesh-list
585766|NCT03585998|Etoposide|etoposide|mesh-list
585767|NCT03585998|Durvalumab|durvalumab|mesh-list
585768|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585769|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
585770|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
585771|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
585772|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585773|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585774|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
585775|NCT03585894|Ketorolac|ketorolac|mesh-list
585776|NCT03585894|Sumatriptan|sumatriptan|mesh-list
585777|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
585778|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
585779|NCT03585894|Analgesics|analgesics|mesh-ancestor
585780|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
585781|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585782|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585783|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
585784|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
585785|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
585786|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585787|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585788|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
585789|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
585790|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
585791|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
585792|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585793|NCT03585829|Prednisolone|prednisolone|mesh-list
585794|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
585795|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
585796|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
585797|NCT03585829|Hormones|hormones|mesh-ancestor
585798|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
585799|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585800|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
585801|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585802|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
585803|NCT03585751|Simvastatin|simvastatin|mesh-list
585804|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
585805|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
585806|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
585807|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
585808|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585809|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
585810|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
585811|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585812|NCT03585738|Folic Acid|folic acid|mesh-list
585813|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
585814|NCT03585738|Inositol|inositol|mesh-list
585815|NCT03585738|Hematinics|hematinics|mesh-ancestor
585816|NCT03585738|Vitamins|vitamins|mesh-ancestor
585817|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
585818|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585819|NCT03585725|Ribavirin|ribavirin|mesh-list
585820|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
585821|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585822|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
585823|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215033|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
2215034|NCT00025623|Carboplatin|carboplatin|mesh-list
2215035|NCT00025623|Doxorubicin|doxorubicin|mesh-list
2215036|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2215037|NCT00025623|Etoposide|etoposide|mesh-list
2215038|NCT00025623|Vincristine|vincristine|mesh-list
2215039|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215040|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
2215041|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585833|NCT03585686|Cytarabine|cytarabine|mesh-list
585834|NCT03585686|Vemurafenib|vemurafenib|mesh-list
585835|NCT03585686|Cladribine|cladribine|mesh-list
585836|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
585837|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
585838|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585839|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585840|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
585841|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
585842|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
585843|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
585844|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585845|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
585846|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585847|NCT03585673|Docetaxel|docetaxel|mesh-list
585848|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
585849|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585850|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
585851|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
585852|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
585853|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585854|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
585855|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
585856|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2215042|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
585857|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
585858|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585859|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
585860|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585861|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585862|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
585863|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585864|NCT03585556|Prednisolone|prednisolone|mesh-list
585865|NCT03585556|Bevacizumab|bevacizumab|mesh-list
585866|NCT03585556|Ranibizumab|ranibizumab|mesh-list
585867|NCT03585556|Aflibercept|aflibercept|mesh-list
585868|NCT03585556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
585869|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585870|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
585871|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
585872|NCT03585556|Growth Substances|growth substances|mesh-ancestor
585873|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585874|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
585875|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
585876|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
585877|NCT03585556|Hormones|hormones|mesh-ancestor
585878|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
585879|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
585880|NCT03585530|Raltitrexed|raltitrexed|mesh-list
585881|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
585882|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
585883|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585884|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585885|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
585886|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215043|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2215044|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
2215045|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215046|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215047|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
585893|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
585894|NCT03585465|Capecitabine|capecitabine|mesh-list
585895|NCT03585465|Nivolumab|nivolumab|mesh-list
585896|NCT03585465|Vinblastine|vinblastine|mesh-list
585897|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
585898|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
585899|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585900|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
585901|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
585902|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
585903|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585904|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585905|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
585906|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
585907|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
585908|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
585909|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
585910|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
585911|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
585912|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
585913|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
585914|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
585915|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
585916|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585917|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585918|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
585919|NCT03585452|Analgesics|analgesics|mesh-ancestor
585920|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
585921|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585922|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
585923|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
585924|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
585925|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
585926|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
585927|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585928|NCT03585426|Vancomycin|vancomycin|mesh-list
585929|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
585930|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
585931|NCT03585413|Micronutrients|micronutrients|mesh-list
585932|NCT03585413|Trace Elements|trace elements|mesh-list
585933|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585934|NCT03585374|Acetaminophen|acetaminophen|mesh-list
585935|NCT03585374|Ketoprofen|ketoprofen|mesh-list
585936|NCT03585374|Morphine|morphine|mesh-list
585937|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
585938|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
585939|NCT03585374|Narcotics|narcotics|mesh-ancestor
585940|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
585941|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585942|NCT03585374|Analgesics|analgesics|mesh-ancestor
585943|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
585944|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585945|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
585946|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
585947|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
585948|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
585949|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
585950|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
585951|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
585952|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585953|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
585954|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
585955|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
585956|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
585957|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
585958|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585959|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585960|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
585961|NCT03585179|Hydroquinone|hydroquinone|mesh-list
585962|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
585963|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
585964|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585965|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
585966|NCT03585179|Coagulants|coagulants|mesh-ancestor
585967|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
585968|NCT03585179|Protective Agents|protective agents|mesh-ancestor
585969|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585970|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
585971|NCT03585140|Doxycycline|doxycycline|mesh-list
585972|NCT03585140|Adapalene|adapalene|mesh-list
585973|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
585974|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
585975|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
585976|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
585977|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
585978|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
585979|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
585980|NCT03585140|Analgesics|analgesics|mesh-ancestor
585981|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
585982|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
585983|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
585984|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
585985|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
585986|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
585987|NCT03585101|Grazoprevir|grazoprevir|mesh-list
585988|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
585989|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
585990|NCT03585062|Paclitaxel|paclitaxel|mesh-list
585991|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
585992|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
585993|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
585994|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
585995|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
585996|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
585997|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
585998|NCT03585036|Tramadol|tramadol|mesh-list
585999|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
586000|NCT03585036|Narcotics|narcotics|mesh-ancestor
586001|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
586002|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586003|NCT03585036|Analgesics|analgesics|mesh-ancestor
586004|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
586005|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586006|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
586007|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
586008|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
586009|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
586010|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
586011|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
586012|NCT03584984|Coagulants|coagulants|mesh-ancestor
586013|NCT03584919|Doxycycline|doxycycline|mesh-list
586014|NCT03584919|Cefuroxime|cefuroxime|mesh-list
586015|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
586016|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
586017|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
586018|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
586019|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
586020|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
586021|NCT03584854|Methylergonovine|methylergonovine|mesh-list
586022|NCT03584854|Carboprost|carboprost|mesh-list
586023|NCT03584854|Dinoprost|dinoprost|mesh-list
586024|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
586025|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
586026|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
586027|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586028|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
586029|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
586030|NCT03584841|Pilocarpine|pilocarpine|mesh-list
586031|NCT03584841|Miotics|miotics|mesh-ancestor
586032|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
586033|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586034|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586035|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
586036|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
586037|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
586038|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
586039|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586040|NCT03584711|Panitumumab|panitumumab|mesh-list
586041|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
586042|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586043|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
586044|NCT03584698|Misoprostol|misoprostol|mesh-list
586045|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
586046|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
586047|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
586048|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586049|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
586050|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
586051|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
586052|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
586053|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
586054|NCT03584698|Analgesics|analgesics|mesh-ancestor
586055|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
586056|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586057|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
586058|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
586059|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
586060|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
586061|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586062|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
586063|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
586064|NCT03584529|Vitamin D|vitamin d|mesh-list
586065|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
586066|NCT03584529|Vitamins|vitamins|mesh-ancestor
586067|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
586068|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586069|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
586070|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
586092|NCT03584373|Acetaminophen|acetaminophen|mesh-list
586093|NCT03584373|Ketorolac|ketorolac|mesh-list
586094|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
586095|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
586096|NCT03584373|Oxycodone|oxycodone|mesh-list
586097|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
586098|NCT03584373|Analgesics|analgesics|mesh-ancestor
586099|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
586100|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586101|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586102|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
586103|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
586104|NCT03584373|Narcotics|narcotics|mesh-ancestor
586105|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
586106|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
586107|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
586108|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
586109|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
586110|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586111|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586112|NCT03584360|Calcitriol|calcitriol|mesh-list
586113|NCT03584360|Betamethasone|betamethasone|mesh-list
586114|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
586115|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
586116|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
586117|NCT03584360|Calcipotriene|calcipotriene|mesh-list
586118|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
586119|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
586120|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
586121|NCT03584360|Hormones|hormones|mesh-ancestor
586122|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
586123|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586124|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
586125|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
586126|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
586127|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
586128|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
586129|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
586130|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586131|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
586132|NCT03584360|Vitamins|vitamins|mesh-ancestor
586133|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
586134|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2750773|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2750774|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
2750775|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
586138|NCT03584178|Budesonide|budesonide|mesh-list
586139|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
586140|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
586141|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
586142|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586143|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586144|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
586145|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
586146|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
586147|NCT03584178|Hormones|hormones|mesh-ancestor
586148|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
586149|NCT03584152|Acetaminophen|acetaminophen|mesh-list
586150|NCT03584152|Ibuprofen|ibuprofen|mesh-list
586151|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
586152|NCT03584152|Analgesics|analgesics|mesh-ancestor
586153|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
586154|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586155|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586156|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
586157|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
586158|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
586159|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
586160|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
586161|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586162|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586163|NCT03584087|Terlipressin|terlipressin|mesh-list
586164|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
586165|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
586166|NCT03584074|Celecoxib|celecoxib|mesh-list
586167|NCT03584074|Pregabalin|pregabalin|mesh-list
586168|NCT03584074|Analgesics|analgesics|mesh-ancestor
586169|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
586170|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586171|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586172|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
586173|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
586174|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
586175|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586176|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
586177|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
586178|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
586179|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
586180|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
586181|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
586182|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
586183|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
586184|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
586185|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
586186|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
586187|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215048|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2215049|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2215050|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2215051|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215052|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2215053|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
2215054|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
2215055|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
2215056|NCT00025636|Cytarabine|cytarabine|mesh-list
586197|NCT03583957|Caffeine|caffeine|mesh-list
586198|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
586199|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586200|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
586201|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586202|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586203|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
586204|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
586205|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
586206|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
586207|NCT03583892|Gabapentin|gabapentin|mesh-list
586208|NCT03583892|Analgesics|analgesics|mesh-ancestor
586209|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
586210|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586211|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586212|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
586213|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
586214|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
586215|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
586216|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
586217|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
586218|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
586219|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
586220|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586221|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
586222|NCT03583866|Candesartan|candesartan|mesh-list
586223|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
586224|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
586225|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
586226|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586227|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
586228|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
586229|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
586230|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
586231|NCT03583710|Cisplatin|cisplatin|mesh-list
586232|NCT03583710|Etoposide|etoposide|mesh-list
586233|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
2215057|NCT00025636|Dexamethasone|dexamethasone|mesh-list
586234|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
586235|NCT03583710|Mitotane|mitotane|mesh-list
586236|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586237|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
586238|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
586239|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
586240|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586241|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586242|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
586243|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
586244|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
586245|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
586246|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
586247|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
586248|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
586249|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
586250|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586251|NCT03583658|Ambroxol|ambroxol|mesh-list
586252|NCT03583658|Expectorants|expectorants|mesh-ancestor
586253|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
586254|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
586255|NCT03583567|Ranitidine|ranitidine|mesh-list
586256|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
586257|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
586258|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
586259|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
586260|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
586261|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
586262|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
586263|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586264|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586265|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
586266|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
586267|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
586268|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
586269|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
586270|NCT03583528|Edotreotide|edotreotide|mesh-list
586271|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
586272|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586273|NCT03583489|Ondansetron|ondansetron|mesh-list
586274|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
586275|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
586276|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586277|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586278|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
586279|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
586280|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
586281|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
586282|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
586283|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
586284|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586285|NCT03583489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
586286|NCT03583489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
586287|NCT03583489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
586288|NCT03583489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
586289|NCT03583489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
586290|NCT03583476|Amoxicillin|amoxicillin|mesh-list
586291|NCT03583476|Metronidazole|metronidazole|mesh-list
586292|NCT03583476|Clarithromycin|clarithromycin|mesh-list
586293|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
586294|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
586295|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
586296|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
586297|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
586298|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
586299|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586300|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586301|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
586302|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
586303|NCT03583424|Cytarabine|cytarabine|mesh-list
586304|NCT03583424|Etoposide|etoposide|mesh-list
586305|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
586306|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
586307|NCT03583424|Melphalan|melphalan|mesh-list
586308|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
586309|NCT03583424|Venetoclax|venetoclax|mesh-list
586310|NCT03583424|Carmustine|carmustine|mesh-list
586311|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
586312|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
586313|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586314|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
586315|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
586316|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586317|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586318|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
586319|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
586320|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
586321|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
586322|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
586323|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
586324|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586325|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
586326|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
586327|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
586328|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
586329|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
586330|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
586331|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
586332|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
2215058|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
2215059|NCT00025636|Melphalan|melphalan|mesh-list
2215060|NCT00025636|Carmustine|carmustine|mesh-list
2215061|NCT00025636|Methotrexate|methotrexate|mesh-list
2215062|NCT00025636|Etoposide|etoposide|mesh-list
2215063|NCT00025636|Vincristine|vincristine|mesh-list
2215064|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215065|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
2215066|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215067|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215068|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
586344|NCT03583359|Lidocaine|lidocaine|mesh-list
586345|NCT03583359|Anesthetics, Local|anesthetics, local|mesh-ancestor
586346|NCT03583359|Anesthetics|anesthetics|mesh-ancestor
586347|NCT03583359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
586348|NCT03583359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586349|NCT03583359|Sensory System Agents|sensory system agents|mesh-ancestor
586350|NCT03583359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586351|NCT03583359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
586352|NCT03583359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
586353|NCT03583359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
586354|NCT03583359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
586355|NCT03583359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076687|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2076688|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2076689|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
2076690|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076691|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215069|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
586371|NCT03583255|Dexamethasone|dexamethasone|mesh-list
586372|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
586373|NCT03583255|Ichthammol|ichthammol|mesh-list
586374|NCT03583255|BB 1101|bb 1101|mesh-list
586375|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
586376|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
586377|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
586378|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586379|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586380|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
586381|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
586382|NCT03583255|Hormones|hormones|mesh-ancestor
586383|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
586384|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
586385|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586386|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
2751258|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
586387|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586388|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586389|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
586390|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
586391|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
586392|NCT03583242|Growth Substances|growth substances|mesh-ancestor
586393|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586394|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
586395|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586396|NCT03583229|Aspirin|aspirin|mesh-list
586397|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
586398|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
586399|NCT03583229|Analgesics|analgesics|mesh-ancestor
586400|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
586401|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586402|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586403|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
586404|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
586405|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
586406|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
586407|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586408|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
586409|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
586410|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586411|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
586412|NCT03583164|Olorofim|olorofim|mesh-list
586413|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
586414|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
586415|NCT03583138|Buprenorphine|buprenorphine|mesh-list
586416|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
586417|NCT03583138|Narcotics|narcotics|mesh-ancestor
586418|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
586419|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586420|NCT03583138|Analgesics|analgesics|mesh-ancestor
586421|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
586422|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586423|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
586424|NCT03583086|Nivolumab|nivolumab|mesh-list
586425|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
586426|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586427|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
586428|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586429|NCT03583021|Neostigmine|neostigmine|mesh-list
586430|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
586431|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586432|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586433|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
586434|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
586435|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586436|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
586437|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
586438|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586439|NCT03582930|Calfactant|calfactant|mesh-list
586440|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
586441|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
586442|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
586443|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
586444|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
586445|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586446|NCT03582917|Vitamins|vitamins|mesh-ancestor
586447|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
586448|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
586449|NCT03582878|Sirolimus|sirolimus|mesh-list
586450|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
586451|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586452|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
586453|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
586454|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
586455|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
586456|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586457|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586458|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
586459|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
586460|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
586461|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586462|NCT03582865|Tamoxifen|tamoxifen|mesh-list
586463|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
586464|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
586465|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
586466|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586467|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
586468|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586469|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
586470|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
586471|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2076692|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076693|NCT02016898|Mitomycins|mitomycins|mesh-list
2076694|NCT02016898|Mitomycin|mitomycin|mesh-list
2076695|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2076696|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076697|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
2076698|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076699|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
586480|NCT03582722|Orlistat|orlistat|mesh-list
586481|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586482|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586483|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
586484|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2076700|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076701|NCT02017015|Gemcitabine|gemcitabine|mesh-list
2076702|NCT02017015|Paclitaxel|paclitaxel|mesh-list
2076703|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2215070|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586490|NCT03582605|Amoxicillin|amoxicillin|mesh-list
586491|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
586492|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215071|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215072|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2215073|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2215074|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
2215075|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
2215076|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2750776|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750777|NCT04180969|Urological Agents|urological agents|mesh-ancestor
586502|NCT03582475|Cisplatin|cisplatin|mesh-list
586503|NCT03582475|Carboplatin|carboplatin|mesh-list
586504|NCT03582475|Docetaxel|docetaxel|mesh-list
586505|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
586506|NCT03582475|Etoposide|etoposide|mesh-list
586507|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
586508|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
586509|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586510|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
586511|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
586512|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
586513|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586514|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
586515|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
586516|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
586517|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
586518|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586519|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
586520|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
586521|NCT03582332|Indomethacin|indomethacin|mesh-list
586522|NCT03582332|Etoricoxib|etoricoxib|mesh-list
586523|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
586524|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
586525|NCT03582332|Analgesics|analgesics|mesh-ancestor
586526|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
586527|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586528|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586529|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
586530|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
586531|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
586532|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
586533|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
586534|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
586535|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586536|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586537|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
586538|NCT03582319|Formaldehyde|formaldehyde|mesh-list
586539|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
586540|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
586541|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
586542|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
586543|NCT03582306|Protective Agents|protective agents|mesh-ancestor
586544|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586545|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
586546|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
586547|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
586548|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586549|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
586550|NCT03582293|Coagulants|coagulants|mesh-ancestor
586551|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
586552|NCT03582280|Calcium|calcium|mesh-list
586553|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
586554|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586555|NCT03582280|Antacids|antacids|mesh-ancestor
586556|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586557|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2215077|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2215078|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
2215079|NCT00025636|Hormones|hormones|mesh-ancestor
2215080|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2215081|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2215082|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2215083|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
2215084|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2215085|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2215086|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
2215087|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
2215088|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215089|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2215090|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2215091|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2215092|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2215093|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2215094|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
2215095|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215096|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
586589|NCT03582137|Cannabidiol|cannabidiol|mesh-list
586590|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
586591|NCT03582124|Panitumumab|panitumumab|mesh-list
586592|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
586593|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586594|NCT03582098|Rituximab|rituximab|mesh-list
586595|NCT03582098|Idelalisib|idelalisib|mesh-list
586596|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
586597|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586598|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
586599|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586600|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
586601|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586602|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586603|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
586604|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
586605|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
586606|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076704|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076705|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
2076706|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
2076707|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
2076708|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076709|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2076710|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
2076711|NCT02017015|Antiviral Agents|antiviral agents|mesh-ancestor
2076712|NCT02017015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076713|NCT02017015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076714|NCT02017015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076715|NCT02017015|Immunologic Factors|immunologic factors|mesh-ancestor
2076716|NCT02017015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076717|NCT02017171|Allopurinol|allopurinol|mesh-list
2076718|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
2076719|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076720|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586625|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
586626|NCT03582007|Murepavadin|murepavadin|mesh-list
586627|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
586628|NCT03581968|Pancrelipase|pancrelipase|mesh-list
586629|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
586630|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
586631|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
586632|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586633|NCT03581903|Vaccines|vaccines|mesh-list
586634|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
586635|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586636|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
586637|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
586638|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
586639|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586640|NCT03581773|Folic Acid|folic acid|mesh-list
586641|NCT03581773|Hematinics|hematinics|mesh-ancestor
586642|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
586643|NCT03581773|Vitamins|vitamins|mesh-ancestor
586644|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
586645|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586646|NCT03581734|Vaccines|vaccines|mesh-list
586647|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
586648|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586649|NCT03581630|Naltrexone|naltrexone|mesh-list
586650|NCT03581630|Bupropion|bupropion|mesh-list
586651|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
586652|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
586653|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586654|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
586655|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586656|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
586657|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
586658|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
586659|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
586660|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
586661|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
586662|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586663|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
586664|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
586665|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
586666|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
586667|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076721|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
2076722|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2076723|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2076724|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
2076725|NCT02017171|Protective Agents|protective agents|mesh-ancestor
2076726|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076727|NCT02017327|Bimatoprost|bimatoprost|mesh-list
2076728|NCT02017327|Latanoprost|latanoprost|mesh-list
2076729|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2076730|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2076731|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2076732|NCT02017535|Fluoxetine|fluoxetine|mesh-list
586680|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
586681|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
586682|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586683|NCT03581409|Aspirin|aspirin|mesh-list
586684|NCT03581409|Cilostazol|cilostazol|mesh-list
586685|NCT03581409|Clopidogrel|clopidogrel|mesh-list
586686|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
586687|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
586688|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
586689|NCT03581409|Analgesics|analgesics|mesh-ancestor
586690|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
586691|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076733|NCT02017535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
586692|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586693|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
586694|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
586695|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
586696|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
586697|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586698|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
586699|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
586700|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586701|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
586702|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
586703|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
586704|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
586705|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
586706|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
586707|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
586708|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
586709|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
586710|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
586711|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
586712|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
586713|NCT03581409|Protective Agents|protective agents|mesh-ancestor
586714|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
586715|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
586716|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
586717|NCT03581370|Cephalosporins|cephalosporins|mesh-list
586718|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
586719|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
586720|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
586721|NCT03581370|Renal Agents|renal agents|mesh-ancestor
586722|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
586723|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
586724|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586725|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076734|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2076735|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2076736|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076737|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076738|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
2076739|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076740|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2076741|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
586734|NCT03581240|Eflornithine|eflornithine|mesh-list
586735|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586736|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
586737|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
586738|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
586739|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
586740|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
586741|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586742|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586743|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
586744|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
586745|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
586746|NCT03581149|Laxatives|laxatives|mesh-list
586747|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586748|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
586749|NCT03581149|Protective Agents|protective agents|mesh-ancestor
586750|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586751|NCT03581149|Vitamins|vitamins|mesh-ancestor
586752|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
586753|NCT03581149|Cathartics|cathartics|mesh-ancestor
586754|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2076742|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2076743|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2076744|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2076745|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076746|NCT02017860|Everolimus|everolimus|mesh-list
2076747|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076748|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076749|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
2076750|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076751|NCT02017899|Vaccines|vaccines|mesh-list
586767|NCT03580980|Acetaminophen|acetaminophen|mesh-list
586768|NCT03580980|Morphine|morphine|mesh-list
586769|NCT03580980|Ketamine|ketamine|mesh-list
586770|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
586771|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
586772|NCT03580980|Narcotics|narcotics|mesh-ancestor
586773|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
586774|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586775|NCT03580980|Analgesics|analgesics|mesh-ancestor
586776|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
586777|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586778|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
586779|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
586780|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
586781|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
586782|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
586783|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
586784|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
586785|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586786|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
586787|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
586788|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
586789|NCT03580967|Vortioxetine|vortioxetine|mesh-list
586790|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
586791|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
586792|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
586793|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
586794|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
586795|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586796|NCT03580967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
586797|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
586798|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
586799|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586800|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
586801|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
586802|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
586803|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
586804|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
586805|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2076752|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
2076753|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586811|NCT03580902|Buprenorphine|buprenorphine|mesh-list
586812|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
586813|NCT03580902|Naloxone|naloxone|mesh-list
586814|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
586815|NCT03580902|Narcotics|narcotics|mesh-ancestor
586816|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
586817|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586818|NCT03580902|Analgesics|analgesics|mesh-ancestor
586819|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
586820|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586821|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
586822|NCT03580889|Atropine|atropine|mesh-list
586823|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
586824|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
586825|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
586826|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
586827|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
586828|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586829|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586830|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
586831|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
586832|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
586833|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
586834|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
586835|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
586836|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
586837|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
586838|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586839|NCT03580876|Azathioprine|azathioprine|mesh-list
586840|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
586841|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586842|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
586843|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586844|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
586845|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
586846|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586847|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
586848|NCT03580733|Caspofungin|caspofungin|mesh-list
586849|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
586850|NCT03580733|Clotrimazole|clotrimazole|mesh-list
586851|NCT03580733|Miconazole|miconazole|mesh-list
586852|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
586853|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586854|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586855|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
586856|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
586857|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
586858|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
586859|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
586860|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
586861|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586862|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
586863|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
586864|NCT03580694|Cemiplimab|cemiplimab|mesh-list
586865|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
586866|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586867|NCT03580681|Vitamin E|vitamin e|mesh-list
586868|NCT03580681|Vitamins|vitamins|mesh-ancestor
586869|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
586870|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586871|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
586872|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586873|NCT03580681|Protective Agents|protective agents|mesh-ancestor
586874|NCT03580590|Diltiazem|diltiazem|mesh-list
586875|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
586876|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
586877|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
586878|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586879|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
586880|NCT03580590|Coagulants|coagulants|mesh-ancestor
586881|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
586882|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
586883|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
586884|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
586885|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586886|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
586887|NCT03580525|Nicotine|nicotine|mesh-list
586888|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
586889|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
586890|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586891|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586892|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
586893|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
586894|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
586895|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
586896|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586897|NCT03580499|Vitamins|vitamins|mesh-list
586898|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
586899|NCT03580499|Pyridoxal|pyridoxal|mesh-list
586900|NCT03580499|Pyridoxine|pyridoxine|mesh-list
586901|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
586902|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
586903|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586930|NCT03580408|Nivolumab|nivolumab|mesh-list
586931|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
586932|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586933|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
586934|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586935|NCT03580395|Paclitaxel|paclitaxel|mesh-list
586936|NCT03580395|Apatinib|apatinib|mesh-list
586937|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
586938|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586939|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
586940|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
586941|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
586942|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586943|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
586944|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215097|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
2215098|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
2215099|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
2215100|NCT00025649|Melphalan|melphalan|mesh-list
2215101|NCT00025649|Busulfan|busulfan|mesh-list
2215102|NCT00025649|Carboplatin|carboplatin|mesh-list
2215103|NCT00025649|Doxorubicin|doxorubicin|mesh-list
2215104|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2076786|NCT02018042|Abatacept|abatacept|mesh-list
2076787|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2076788|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076789|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076790|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215105|NCT00025649|Etoposide|etoposide|mesh-list
2215106|NCT00025649|Vincristine|vincristine|mesh-list
2215107|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215108|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
586965|NCT03580317|Carbamazepine|carbamazepine|mesh-list
586966|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
586967|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
586968|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
586969|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
586970|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586971|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
586972|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
586973|NCT03580317|Analgesics|analgesics|mesh-ancestor
586974|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
586975|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
586976|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
586977|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
586978|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586979|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
586980|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
586981|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
586982|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
586983|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586984|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
586985|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
586986|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
586987|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
586988|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
586989|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
586990|NCT03580239|Everolimus|everolimus|mesh-list
586991|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
586992|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215109|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215110|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
586993|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
586994|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
586995|NCT03580187|Morphine|morphine|mesh-list
586996|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
586997|NCT03580187|Narcotics|narcotics|mesh-ancestor
586998|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
586999|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587000|NCT03580187|Analgesics|analgesics|mesh-ancestor
587001|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
587002|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587010|NCT03580148|Cortisone|cortisone|mesh-list
587011|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
587012|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
587013|NCT03580135|Propolis|propolis|mesh-list
587014|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076791|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
2076792|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076793|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2076794|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2076795|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2076796|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076797|NCT02018458|Paclitaxel|paclitaxel|mesh-list
587022|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
587023|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
587024|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
587025|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587026|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
587027|NCT03580018|Coagulants|coagulants|mesh-ancestor
587028|NCT03580005|Methylphenidate|methylphenidate|mesh-list
587029|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
587030|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587031|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
587032|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
587033|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
587034|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587035|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
587036|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
587037|NCT03579979|Methylene Blue|methylene blue|mesh-list
587038|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587039|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587040|NCT03579966|Amifampridine|amifampridine|mesh-list
587041|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
587042|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587043|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587044|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
587045|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
587046|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215111|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2215112|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
2215113|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215114|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215115|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
587053|NCT03579927|Cytarabine|cytarabine|mesh-list
587054|NCT03579927|Rituximab|rituximab|mesh-list
587055|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
587056|NCT03579927|Etoposide|etoposide|mesh-list
587057|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
587058|NCT03579927|Melphalan|melphalan|mesh-list
587059|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
587060|NCT03579927|Carmustine|carmustine|mesh-list
587061|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
587062|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
587063|NCT03579927|Antibodies|antibodies|mesh-list
587064|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
587065|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
587066|NCT03579927|Lenograstim|lenograstim|mesh-list
587067|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
587068|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587069|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587070|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
587071|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
587072|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
587073|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
587074|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587075|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587076|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
587077|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
587078|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
587079|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
587080|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
587081|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
587082|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
587083|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
587084|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
587085|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
587086|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
587087|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
587088|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
587089|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
2076798|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2076799|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
2076800|NCT02018458|Carboplatin|carboplatin|mesh-list
2076801|NCT02018458|Doxorubicin|doxorubicin|mesh-list
2076802|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2076803|NCT02018458|Vaccines|vaccines|mesh-list
2076804|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
2076805|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076806|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2076807|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076808|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
2076809|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
2076810|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
587103|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
587104|NCT03579888|Fludarabine|fludarabine|mesh-list
587105|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
587106|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
587107|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587108|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
587109|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
587110|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
587111|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587112|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587113|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
587114|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
587115|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
587116|NCT03579875|Busulfan|busulfan|mesh-list
587117|NCT03579875|Rituximab|rituximab|mesh-list
587118|NCT03579875|Fludarabine|fludarabine|mesh-list
587119|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
587120|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
587121|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587122|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
587123|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
587124|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
587125|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587126|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587127|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
587128|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
587129|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
587130|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
587131|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
587132|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587133|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
587134|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
587135|NCT03579875|Hormones|hormones|mesh-ancestor
587136|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
587137|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
587138|NCT03579875|Protective Agents|protective agents|mesh-ancestor
587139|NCT03579836|Gemcitabine|gemcitabine|mesh-list
587140|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
587141|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
587142|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215116|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2215117|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
587143|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587144|NCT03579836|Antiviral Agents|antiviral agents|mesh-ancestor
587145|NCT03579836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
587146|NCT03579836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587147|NCT03579836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
587148|NCT03579836|Immunologic Factors|immunologic factors|mesh-ancestor
587149|NCT03579836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587150|NCT03579823|Adalimumab|adalimumab|mesh-list
587151|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
587152|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
587153|NCT03579784|Paclitaxel|paclitaxel|mesh-list
587154|NCT03579784|Durvalumab|durvalumab|mesh-list
587155|NCT03579784|Olaparib|olaparib|mesh-list
587156|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
587157|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587158|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
587159|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
587160|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
587161|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587162|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
587163|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
587164|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587165|NCT03579771|Gemcitabine|gemcitabine|mesh-list
587166|NCT03579771|Paclitaxel|paclitaxel|mesh-list
587167|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
587168|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
587169|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587170|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
587171|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
587172|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
587173|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587174|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
587175|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
587176|NCT03579771|Antiviral Agents|antiviral agents|mesh-ancestor
587177|NCT03579771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
587178|NCT03579771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587179|NCT03579771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
587180|NCT03579771|Immunologic Factors|immunologic factors|mesh-ancestor
587181|NCT03579771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587182|NCT03579758|Gemcitabine|gemcitabine|mesh-list
587183|NCT03579758|Capecitabine|capecitabine|mesh-list
587184|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587185|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
587186|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
587187|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587188|NCT03579758|Antiviral Agents|antiviral agents|mesh-ancestor
587189|NCT03579758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
587190|NCT03579758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587191|NCT03579758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
587192|NCT03579758|Immunologic Factors|immunologic factors|mesh-ancestor
587193|NCT03579758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587194|NCT03579732|Aspirin|aspirin|mesh-list
587195|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
587196|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
587197|NCT03579732|Analgesics|analgesics|mesh-ancestor
587198|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
587199|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587200|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587201|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
587202|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
587203|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
587204|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
587205|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587206|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
587207|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
587208|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587209|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
2215118|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2215119|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215120|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2215121|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
2215122|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
2215123|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
2215124|NCT00025675|Gefitinib|gefitinib|mesh-list
2215125|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215126|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2215127|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215128|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215129|NCT00025688|Paclitaxel|paclitaxel|mesh-list
2076811|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076812|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076813|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2076814|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2076815|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
2076816|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2076817|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2076818|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2076819|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2076820|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076821|NCT02018627|Glucagon|glucagon|mesh-list
2076822|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2076823|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
587239|NCT03579589|Neostigmine|neostigmine|mesh-list
587240|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
587241|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587242|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587243|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
587244|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
587245|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587246|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
587247|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
587248|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587249|NCT03579576|Ribavirin|ribavirin|mesh-list
587250|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
587251|NCT03579576|Velpatasvir|velpatasvir|mesh-list
587252|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
587253|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587254|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
587255|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
587256|NCT03579472|Halichondrin B|halichondrin b|mesh-list
587257|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587258|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
587259|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
587260|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
587261|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076824|NCT02018627|Hormones|hormones|mesh-ancestor
2076825|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2076826|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076827|NCT02018627|Incretins|incretins|mesh-ancestor
2076828|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
2076829|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
2076830|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
2076831|NCT02018653|Calcium|calcium|mesh-list
2076832|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2076833|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076834|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2076835|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2076836|NCT02018822|Urethane|urethane|mesh-list
2215130|NCT00025688|Carboplatin|carboplatin|mesh-list
587296|NCT03579082|Decitabine|decitabine|mesh-list
587297|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
587298|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
587299|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587300|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587301|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587302|NCT03579043|Cocaine|cocaine|mesh-list
587303|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
587304|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
587305|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
587306|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587307|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
587308|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587309|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
587310|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
587311|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
587312|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
587313|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587314|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
587315|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
587316|NCT03579004|Paclitaxel|paclitaxel|mesh-list
587317|NCT03579004|Fluorouracil|fluorouracil|mesh-list
587318|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
587319|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587320|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
587321|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
587322|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
587323|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587324|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
587325|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
587326|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
587327|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
587328|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076837|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076838|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2076839|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
587332|NCT03578900|Citric Acid|citric acid|mesh-list
587333|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
587334|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
587335|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
587336|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
587337|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
587338|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587339|NCT03578874|Capecitabine|capecitabine|mesh-list
587340|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
587341|NCT03578874|Sorafenib|sorafenib|mesh-list
587342|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
587343|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
587344|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587345|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587346|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
587347|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587348|NCT03578822|Aspirin|aspirin|mesh-list
587349|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
587350|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
587351|NCT03578822|Analgesics|analgesics|mesh-ancestor
587352|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
587353|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587354|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587355|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
587356|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
587357|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
587358|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
587359|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587360|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
587361|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
587362|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587363|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
587364|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
587365|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
587366|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
587367|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
587368|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587369|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
587370|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587371|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
587372|NCT03578679|Ivermectin|ivermectin|mesh-list
587373|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
587374|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
587375|NCT03578640|Grazoprevir|grazoprevir|mesh-list
587376|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
587377|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
587378|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
587379|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
587380|NCT03578432|Everolimus|everolimus|mesh-list
587381|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587382|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
587383|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
587384|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076840|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
2076841|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2076842|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076843|NCT02019069|Cytarabine|cytarabine|mesh-list
2076844|NCT02019069|Daunorubicin|daunorubicin|mesh-list
2076845|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2076846|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
2076847|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076848|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587395|NCT03578354|Atenolol|atenolol|mesh-list
587396|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
587397|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
587398|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
587399|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
587400|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
587401|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587402|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587403|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
587404|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
587405|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
587406|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
587407|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
587408|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587409|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
587410|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
587411|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
587412|NCT03578276|Prednisolone|prednisolone|mesh-list
587413|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
587414|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
587415|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
587416|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
587417|NCT03578276|Bromfenac|bromfenac|mesh-list
587418|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
587419|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
587420|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
587421|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
587422|NCT03578276|Hormones|hormones|mesh-ancestor
587423|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
587424|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587425|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
587426|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587427|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
587428|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
587429|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587430|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
587431|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
587432|NCT03578276|Protective Agents|protective agents|mesh-ancestor
587433|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
587434|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
587435|NCT03578276|Analgesics|analgesics|mesh-ancestor
587436|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
587437|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
587438|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
587439|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
587440|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
587441|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
587442|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
587443|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
587444|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587445|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587446|NCT03578263|Oxytocin|oxytocin|mesh-list
587447|NCT03578263|Carbetocin|carbetocin|mesh-list
587448|NCT03578263|Ergonovine|ergonovine|mesh-list
587449|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
587450|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
587451|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587452|NCT03578198|Rituximab|rituximab|mesh-list
587453|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
587454|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587455|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
587456|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587457|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215131|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2215132|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215133|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
2215134|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
2215135|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
2215136|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215137|NCT00025727|Ritonavir|ritonavir|mesh-list
2215138|NCT00025727|Lopinavir|lopinavir|mesh-list
2076849|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
2076850|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076851|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076852|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
2076853|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076854|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2076855|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2076856|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2076857|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076858|NCT02019277|Paclitaxel|paclitaxel|mesh-list
2076859|NCT02019277|Docetaxel|docetaxel|mesh-list
2076860|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2076861|NCT02019277|Trastuzumab|trastuzumab|mesh-list
2076862|NCT02019277|Pertuzumab|pertuzumab|mesh-list
2076863|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2076864|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076865|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
2076866|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
2076867|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
2076868|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076869|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2076870|NCT02019420|Linezolid|linezolid|mesh-list
2076871|NCT02019420|Tedizolid|tedizolid|mesh-list
2076872|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
2076873|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2076874|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076875|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2076876|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076877|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076878|NCT02019472|Adalimumab|adalimumab|mesh-list
2076879|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2076880|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2076881|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
587506|NCT03578042|Losartan|losartan|mesh-list
587507|NCT03578042|Amlodipine|amlodipine|mesh-list
587508|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
587509|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
587510|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
587511|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
587512|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587513|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
587514|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587515|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
587516|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
587517|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
587518|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
587519|NCT03578042|Diuretics|diuretics|mesh-ancestor
587520|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
587521|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
587522|NCT03577977|Interferons|interferons|mesh-list
587523|NCT03577977|Interferon-beta|interferon-beta|mesh-list
2215139|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
587524|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
587525|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587526|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
587527|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
587528|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
587529|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587530|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
587531|NCT03577912|Anesthetics|anesthetics|mesh-list
587532|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
587533|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587534|NCT03577899|Aflibercept|aflibercept|mesh-list
587535|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
587536|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
587537|NCT03577899|Growth Substances|growth substances|mesh-ancestor
587538|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587539|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
587540|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587541|NCT03577860|Bupivacaine|bupivacaine|mesh-list
587542|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
587543|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
587544|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
587545|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587546|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
587547|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587548|NCT03577834|Acetic Acid|acetic acid|mesh-list
587549|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
587550|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
587551|NCT03577782|Vedolizumab|vedolizumab|mesh-list
587552|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
587553|NCT03577743|Bevacizumab|bevacizumab|mesh-list
587554|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
587555|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587556|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
587557|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
587558|NCT03577743|Growth Substances|growth substances|mesh-ancestor
587559|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587560|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215140|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2215141|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2215142|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
2215143|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215144|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215145|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2215146|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2215147|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
2215148|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215149|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2215150|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
587596|NCT03577652|Ticagrelor|ticagrelor|mesh-list
587597|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
587598|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
587599|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
587600|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
587601|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
587602|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
587603|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587604|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587605|NCT03577626|Hemay005|hemay005|mesh-list
587606|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
587607|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
587608|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
587609|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587610|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587611|NCT03577574|Anesthetics|anesthetics|mesh-list
587612|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
587613|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587614|NCT03577496|Peppermint oil|peppermint oil|mesh-list
587615|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
587616|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
587617|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587618|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587619|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
587620|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
587621|NCT03577457|Oxytocin|oxytocin|mesh-list
587622|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
587623|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
587624|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076882|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
2076883|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076884|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
2076885|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2076886|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
2076887|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076888|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2076889|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
2076890|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2076891|NCT02019667|Protective Agents|protective agents|mesh-ancestor
2076892|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587636|NCT03577392|Capecitabine|capecitabine|mesh-list
587637|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
587638|NCT03577392|Endostatins|endostatins|mesh-list
587639|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
587640|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
587641|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587642|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587643|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
587644|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
587645|NCT03577392|Growth Substances|growth substances|mesh-ancestor
587646|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587647|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215151|NCT00025740|Clonazepam|clonazepam|mesh-list
2215152|NCT00025740|Paroxetine|paroxetine|mesh-list
2215153|NCT00025740|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2215154|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2215155|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2215156|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215157|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2215158|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
587656|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
587657|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
587658|NCT03577184|Metformin|metformin|mesh-list
587659|NCT03577184|Vildagliptin|vildagliptin|mesh-list
587660|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
587661|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587662|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
587663|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
587664|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587665|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215159|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215160|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
587669|NCT03577158|Insulin|insulin|mesh-list
587670|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
587671|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587672|NCT03577132|Atezolizumab|atezolizumab|mesh-list
587673|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587674|NCT03576989|Mineral Oil|mineral oil|mesh-list
587675|NCT03576989|Emollients|emollients|mesh-ancestor
587676|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
587677|NCT03576963|Nivolumab|nivolumab|mesh-list
587678|NCT03576963|Guadecitabine|guadecitabine|mesh-list
587679|NCT03576963|Azacitidine|azacitidine|mesh-list
587680|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
587681|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587682|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
587683|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587684|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
587685|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
587686|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587687|NCT03576911|Ubiquinone|ubiquinone|mesh-list
587688|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
587689|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
587690|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587691|NCT03576911|Vitamins|vitamins|mesh-ancestor
587692|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
587693|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
587694|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
587695|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587696|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587697|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
587698|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
587699|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
587700|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
587701|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587702|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
587703|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
587704|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
587705|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
587706|NCT03576885|Protective Agents|protective agents|mesh-ancestor
587707|NCT03576820|Lidocaine|lidocaine|mesh-list
587708|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
587709|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
587710|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
587711|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
587712|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587713|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
587714|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587715|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
587716|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
587717|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
587718|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
587719|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587720|NCT03576794|Prednisolone|prednisolone|mesh-list
587721|NCT03576794|Leflunomide|leflunomide|mesh-list
587722|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
587723|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
587724|NCT03576794|Hormones|hormones|mesh-ancestor
587725|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
587726|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587727|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
587728|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587729|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587730|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587731|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
587732|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
587733|NCT03576755|Spironolactone|spironolactone|mesh-list
587734|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
587735|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
587736|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
587737|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587738|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
587739|NCT03576755|Diuretics|diuretics|mesh-ancestor
587740|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
2215161|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
2215162|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2215163|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2215164|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2215165|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587747|NCT03576677|Simendan|simendan|mesh-list
587748|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
587749|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
587750|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
587751|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
587752|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587753|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587754|NCT03576677|Protective Agents|protective agents|mesh-ancestor
587755|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587756|NCT03576664|Carvedilol|carvedilol|mesh-list
587757|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
587758|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
587759|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
587760|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
587761|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587762|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587763|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
587764|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
587765|NCT03576664|Protective Agents|protective agents|mesh-ancestor
587766|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
587767|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
587768|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
587769|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
587770|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
587771|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
587772|NCT03576651|Bevacizumab|bevacizumab|mesh-list
587773|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
587774|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587775|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
587776|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
587777|NCT03576651|Growth Substances|growth substances|mesh-ancestor
587778|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587779|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
587780|NCT03576638|Levodopa|levodopa|mesh-list
587781|NCT03576638|Carbidopa|carbidopa|mesh-list
587782|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
587783|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
587784|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
587785|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
587786|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
587787|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587788|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587789|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
587790|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587791|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
587792|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
587793|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
587806|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
587807|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
587808|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587809|NCT03576547|Dexamethasone|dexamethasone|mesh-list
587810|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
587811|NCT03576547|Rituximab|rituximab|mesh-list
587812|NCT03576547|Venetoclax|venetoclax|mesh-list
587813|NCT03576547|Ponatinib|ponatinib|mesh-list
587814|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
587815|NCT03576547|Antibodies|antibodies|mesh-list
587816|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
587817|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
587818|NCT03576547|BB 1101|bb 1101|mesh-list
587819|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
587820|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587821|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
587822|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
587823|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
587824|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587825|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
587826|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
587827|NCT03576547|Hormones|hormones|mesh-ancestor
587828|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
587829|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
587830|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587831|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
587832|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
587833|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587834|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587835|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
587836|NCT03576508|Lidocaine|lidocaine|mesh-list
587837|NCT03576508|Epinephrine|epinephrine|mesh-list
587838|NCT03576508|Capsaicin|capsaicin|mesh-list
587839|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
587840|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
587841|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
587842|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587843|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
587844|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587845|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
587846|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
587847|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
587848|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
587849|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587850|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
587851|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
587852|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
587853|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
587854|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
587855|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
587856|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
587857|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
587858|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
587859|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
587860|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
587861|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
587862|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
587863|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
587864|NCT03576469|Complement C1s|complement c1s|mesh-list
587865|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
587866|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
587867|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
587868|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587869|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
587870|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
587871|NCT03576456|Alprazolam|alprazolam|mesh-list
587872|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
587873|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
587874|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587875|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
587876|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
587877|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
587878|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
587879|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
587880|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
587881|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076893|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
2076894|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
2076895|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076896|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587886|NCT03576417|Nivolumab|nivolumab|mesh-list
587887|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587888|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
587889|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
587890|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587891|NCT03576378|Prednisone|prednisone|mesh-list
587892|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
587893|NCT03576378|Etoposide|etoposide|mesh-list
587894|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
587895|NCT03576378|Procarbazine|procarbazine|mesh-list
587896|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
587897|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
587898|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587899|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
587900|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
587901|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
587902|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587903|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587904|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
587905|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
587906|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
587907|NCT03576378|Hormones|hormones|mesh-ancestor
587908|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
587909|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
587910|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
587911|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
587912|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
587913|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587914|NCT03576378|Analgesics|analgesics|mesh-ancestor
587915|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
587916|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587917|NCT03576313|Ivermectin|ivermectin|mesh-list
587918|NCT03576313|Piperaquine|piperaquine|mesh-list
587919|NCT03576313|Artenimol|artenimol|mesh-list
587920|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
587921|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
587922|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
587923|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
587924|NCT03576287|Apremilast|apremilast|mesh-list
587925|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
587926|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
587927|NCT03576287|Analgesics|analgesics|mesh-ancestor
587928|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
587929|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587930|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587931|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
587932|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
587933|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
587934|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
587935|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587936|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587940|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
587941|NCT03576105|Methylene Blue|methylene blue|mesh-list
587942|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
587943|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587944|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
587945|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
587946|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
587947|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
587948|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
587949|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
2215166|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
2215167|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
2215168|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
2215169|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
2215170|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2215171|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215172|NCT00025779|Guanfacine|guanfacine|mesh-list
2215173|NCT00025779|Methylphenidate|methylphenidate|mesh-list
2215174|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2215175|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587960|NCT03576053|Lidocaine|lidocaine|mesh-list
587961|NCT03576053|Serotonin|serotonin|mesh-list
587962|NCT03576053|Histamine|histamine|mesh-list
587963|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
587964|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
587965|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
587966|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587967|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
587968|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
587969|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
587970|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
587971|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
587972|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
587973|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587974|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
587975|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
587976|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
587977|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
587978|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
587979|NCT03576040|Edotreotide|edotreotide|mesh-list
587980|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
587981|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587982|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
587983|NCT03576001|Testosterone|testosterone|mesh-list
587984|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
587985|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
587986|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
587987|NCT03576001|Androgens|androgens|mesh-ancestor
587988|NCT03576001|Hormones|hormones|mesh-ancestor
587989|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
587990|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
587991|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
587992|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
587993|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
587994|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
587995|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
587996|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
587997|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
587998|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
587999|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
588000|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215176|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2215177|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2215178|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2215179|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215180|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
2215181|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2215182|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2215183|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2215184|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2215185|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2215186|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
2215187|NCT00025792|Pramipexole|pramipexole|mesh-list
588013|NCT03575793|Nivolumab|nivolumab|mesh-list
588014|NCT03575793|Ipilimumab|ipilimumab|mesh-list
588015|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
588016|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588017|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
588018|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588019|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
588020|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588021|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215188|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
2215189|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215190|NCT00025792|Protective Agents|protective agents|mesh-ancestor
2215191|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215192|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2215193|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2215194|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
2215195|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
588030|NCT03575637|Olanzapine|olanzapine|mesh-list
588031|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
588032|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
588033|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588034|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588035|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
588036|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
588037|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
588038|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
588039|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
588040|NCT03575637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
588041|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
588042|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
588043|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588044|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588045|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
588046|NCT03575598|Nivolumab|nivolumab|mesh-list
588047|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
588048|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588049|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
588050|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588051|NCT03575572|Colchicine|colchicine|mesh-list
588052|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
588053|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
588054|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
588055|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
588056|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
588057|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588058|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588059|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
588060|NCT03575520|Doxorubicin|doxorubicin|mesh-list
588061|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
588062|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
588063|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588064|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
588065|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
588066|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
588067|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588068|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588069|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
588070|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
588071|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
588072|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
588073|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2076897|NCT02019758|Fluticasone|fluticasone|mesh-list
2076898|NCT02019758|Budesonide|budesonide|mesh-list
2076899|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2076900|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2076901|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
2076902|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076903|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076904|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2076905|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
2076906|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
2076907|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2076908|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
2076909|NCT02019758|Hormones|hormones|mesh-ancestor
2076910|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2076911|NCT02019940|Riluzole|riluzole|mesh-list
2076912|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
588090|NCT03575325|Cytarabine|cytarabine|mesh-list
588091|NCT03575325|Daunorubicin|daunorubicin|mesh-list
588092|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
588093|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
588094|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588095|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588096|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
588097|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
588098|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
588099|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
588100|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588101|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
588102|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
588103|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
588104|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588105|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
588106|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
588107|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
588108|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
588109|NCT03575247|Hormones|hormones|mesh-ancestor
588110|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
588111|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588112|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
588113|NCT03575234|Nivolumab|nivolumab|mesh-list
588114|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
588115|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
588116|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588117|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
588118|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
588119|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
588120|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588121|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588122|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
588123|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
588124|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2076913|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2076914|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2076915|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076916|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076917|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076918|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2076919|NCT02019940|Protective Agents|protective agents|mesh-ancestor
2076920|NCT02019979|Metformin|metformin|mesh-list
2076921|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2076922|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076923|NCT02020031|Vancomycin|vancomycin|mesh-list
2076924|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2076925|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2076926|NCT02020278|Tolvaptan|tolvaptan|mesh-list
588137|NCT03575195|Rifaximin|rifaximin|mesh-list
588138|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
588139|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
588140|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
588141|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
588142|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
588143|NCT03575078|Olaparib|olaparib|mesh-list
588144|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
588145|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588146|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588147|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076927|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2076928|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076929|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
2076930|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076931|NCT02020408|Raclopride|raclopride|mesh-list
2076932|NCT02020408|Amphetamine|amphetamine|mesh-list
2076933|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
2076934|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2076935|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076936|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
2076937|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
2076938|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588161|NCT03575013|Docetaxel|docetaxel|mesh-list
588162|NCT03575013|Avelumab|avelumab|mesh-list
588163|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588164|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
588165|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
588166|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
588167|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588168|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
588169|NCT03575000|Bromocriptine|bromocriptine|mesh-list
588170|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
588171|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
588172|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
588173|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
588174|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588175|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
588176|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
588177|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588178|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588179|NCT03574909|Aspirin|aspirin|mesh-list
588180|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
588181|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
588182|NCT03574909|Analgesics|analgesics|mesh-ancestor
588183|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
588184|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588185|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588186|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
588187|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
588188|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
588189|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
588190|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588191|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
588192|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
588193|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588194|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
588195|NCT03574857|Metolazone|metolazone|mesh-list
588196|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
588197|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
588198|NCT03574857|Diuretics|diuretics|mesh-ancestor
588199|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
588200|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588201|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
588202|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
588203|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215196|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2215197|NCT00026039|Estrogens|estrogens|mesh-list
2215198|NCT00026039|Hormones|hormones|mesh-ancestor
2215199|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2215200|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215201|NCT00026052|Riluzole|riluzole|mesh-list
2215202|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
2215203|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2215204|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2215205|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2215206|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215207|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750809|NCT04170348|Vitamin D|vitamin d|mesh-list
2750810|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
2750811|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
2750812|NCT04170348|Vitamins|vitamins|mesh-list
2750813|NCT04170348|Trientine|trientine|mesh-list
2750814|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
2750815|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750816|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2750817|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2750818|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
2750819|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
2750820|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750821|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
2750822|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
588244|NCT03574779|Bevacizumab|bevacizumab|mesh-list
588245|NCT03574779|Niraparib|niraparib|mesh-list
588246|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
588247|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588248|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
588249|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
588250|NCT03574779|Growth Substances|growth substances|mesh-ancestor
588251|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588252|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
588253|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
588254|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588255|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588256|NCT03574701|Vitamin A|vitamin a|mesh-list
588257|NCT03574701|Vitamins|vitamins|mesh-ancestor
588258|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
588259|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588260|NCT03574649|Paclitaxel|paclitaxel|mesh-list
588261|NCT03574649|Docetaxel|docetaxel|mesh-list
588262|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
588263|NCT03574649|Carboplatin|carboplatin|mesh-list
588264|NCT03574649|Fluorouracil|fluorouracil|mesh-list
588265|NCT03574649|Avelumab|avelumab|mesh-list
588266|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
588267|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588268|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
588269|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
588270|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
588271|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588272|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
588273|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
588274|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588275|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2750823|NCT04167761|Glipizide|glipizide|mesh-list
588276|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
588277|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
588278|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
588279|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
588280|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
588281|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2076939|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
2076940|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076941|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076942|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
2076943|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2076944|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
588288|NCT03574402|Gemcitabine|gemcitabine|mesh-list
588289|NCT03574402|Carboplatin|carboplatin|mesh-list
588290|NCT03574402|Pemetrexed|pemetrexed|mesh-list
588291|NCT03574402|Afatinib|afatinib|mesh-list
588292|NCT03574402|Crizotinib|crizotinib|mesh-list
588293|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
588294|NCT03574402|Ensartinib|ensartinib|mesh-list
588295|NCT03574402|Maleic acid|maleic acid|mesh-list
588296|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588297|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
588298|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
588299|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588300|NCT03574402|Antiviral Agents|antiviral agents|mesh-ancestor
588301|NCT03574402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
588302|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588303|NCT03574402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
588304|NCT03574402|Immunologic Factors|immunologic factors|mesh-ancestor
588305|NCT03574402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588306|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
588307|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
588308|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
588309|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
588310|NCT03574376|Bupivacaine|bupivacaine|mesh-list
588311|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
588312|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
588313|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
588314|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588315|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
588316|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588317|NCT03574337|Neostigmine|neostigmine|mesh-list
588318|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
588319|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588320|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588321|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
588322|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588323|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588324|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
588325|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
588326|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588327|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
588328|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
588329|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
588330|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588331|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
588332|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
588333|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
588334|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588335|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588336|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
588337|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
588338|NCT03574246|Benzydamine|benzydamine|mesh-list
588339|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
588340|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
588341|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
588342|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
588343|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
588344|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
588345|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
588346|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588347|NCT03574090|Amoxicillin|amoxicillin|mesh-list
588348|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
588349|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
588350|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
588351|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
588352|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
588353|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
588354|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588355|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588356|NCT03574064|Glucagon|glucagon|mesh-list
588357|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
588358|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
588359|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
588360|NCT03574064|Hormones|hormones|mesh-ancestor
588361|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
588362|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588363|NCT03574064|Incretins|incretins|mesh-ancestor
588364|NCT03573999|Mannitol|mannitol|mesh-list
588365|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
588366|NCT03573999|Diuretics|diuretics|mesh-ancestor
588367|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
588368|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588369|NCT03573986|Bevacizumab|bevacizumab|mesh-list
588370|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
588371|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588372|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
588373|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
588374|NCT03573986|Growth Substances|growth substances|mesh-ancestor
588375|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588376|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
2750824|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750825|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2750826|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750827|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
588382|NCT03573947|Paclitaxel|paclitaxel|mesh-list
588383|NCT03573947|Nivolumab|nivolumab|mesh-list
588384|NCT03573947|Ipilimumab|ipilimumab|mesh-list
588385|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
588386|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588387|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
588388|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
588389|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
588390|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588391|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
588392|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
588393|NCT03573934|Glucagon|glucagon|mesh-list
588394|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
588395|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
588396|NCT03573934|Hormones|hormones|mesh-ancestor
588397|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
588398|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588399|NCT03573934|Incretins|incretins|mesh-ancestor
588400|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2215208|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2215209|NCT00026052|Protective Agents|protective agents|mesh-ancestor
2215210|NCT00026078|Docetaxel|docetaxel|mesh-list
2215211|NCT00026078|Ifosfamide|ifosfamide|mesh-list
2215212|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215213|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
2215214|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
2215215|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
2215216|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215217|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2215218|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
2215219|NCT00026091|Fenretinide|fenretinide|mesh-list
2215220|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215221|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2215222|NCT00026091|Protective Agents|protective agents|mesh-ancestor
2215223|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215224|NCT00026104|Gemcitabine|gemcitabine|mesh-list
2215225|NCT00026104|Paclitaxel|paclitaxel|mesh-list
2076945|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2076946|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2076947|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2076948|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2076949|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2076950|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2076951|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2215226|NCT00026104|Tipifarnib|tipifarnib|mesh-list
2215227|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2076952|NCT02020512|Bimatoprost|bimatoprost|mesh-list
2076953|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2076954|NCT02020577|Cetuximab|cetuximab|mesh-list
2076955|NCT02020577|Afatinib|afatinib|mesh-list
588430|NCT03573687|Caseins|caseins|mesh-list
588431|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
588432|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
588433|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588441|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
588442|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
588443|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
588444|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588445|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
588446|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
588447|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
588448|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588449|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588450|NCT03573596|Dasatinib|dasatinib|mesh-list
588451|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588452|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
588453|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588454|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588455|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
588456|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
588457|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
588458|NCT03573349|Ketamine|ketamine|mesh-list
588459|NCT03573349|Analgesics|analgesics|mesh-ancestor
588460|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
588461|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588462|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588463|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
588464|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
588465|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
588466|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
588467|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
588468|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
588469|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
588470|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588471|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215228|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215229|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
2076956|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2076957|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076958|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
588477|NCT03573297|Cariprazine|cariprazine|mesh-list
588478|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
588479|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
588480|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
588481|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588482|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
588483|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
588484|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
588485|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
588486|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588487|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588488|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
588489|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
588490|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
588491|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
588492|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588493|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588494|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
588495|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
588496|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
588497|NCT03573284|Protective Agents|protective agents|mesh-ancestor
588498|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
588499|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2076959|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588500|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
588501|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588502|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
588503|NCT03573245|Coagulants|coagulants|mesh-ancestor
588504|NCT03573115|Adapalene|adapalene|mesh-list
588505|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
588506|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
588507|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
588508|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
588509|NCT03573115|Analgesics|analgesics|mesh-ancestor
588510|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
588511|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588512|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588513|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
588514|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
588515|NCT03573102|Aspirin|aspirin|mesh-list
588516|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
588517|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
588518|NCT03573102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
588519|NCT03573102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
588520|NCT03573102|Analgesics|analgesics|mesh-ancestor
588521|NCT03573102|Sensory System Agents|sensory system agents|mesh-ancestor
588522|NCT03573102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588523|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588524|NCT03573102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
588525|NCT03573102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
588526|NCT03573102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
588527|NCT03573102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
588528|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588529|NCT03573102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
588530|NCT03573102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
588531|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588532|NCT03573102|Antipyretics|antipyretics|mesh-ancestor
588533|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
588534|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
588535|NCT03573063|Androgens|androgens|mesh-list
588536|NCT03573063|Hormones|hormones|mesh-ancestor
588537|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
588538|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588539|NCT03573050|Rivastigmine|rivastigmine|mesh-list
588540|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
588541|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588542|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588543|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
588544|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588545|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588546|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
588547|NCT03573050|Protective Agents|protective agents|mesh-ancestor
588548|NCT03573037|Anticoagulants|anticoagulants|mesh-list
588549|NCT03573024|Azacitidine|azacitidine|mesh-list
588550|NCT03573024|Venetoclax|venetoclax|mesh-list
588551|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
588552|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
588553|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588554|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588555|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215230|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
2215231|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
2215232|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215233|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2215234|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
2215235|NCT00026104|Antiviral Agents|antiviral agents|mesh-ancestor
2215236|NCT00026104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215237|NCT00026104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215238|NCT00026104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
588567|NCT03572959|Triamcinolone|triamcinolone|mesh-list
588568|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
588569|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
588570|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
588571|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
588572|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
588573|NCT03572959|Hormones|hormones|mesh-ancestor
588574|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
588575|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588576|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
588577|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
588578|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588579|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588580|NCT03572933|Pregnanolone|pregnanolone|mesh-list
588581|NCT03572933|Ganaxolone|ganaxolone|mesh-list
588582|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
588583|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588584|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588585|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588586|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
588587|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
588588|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
588589|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
588590|NCT03572829|Dexamethasone|dexamethasone|mesh-list
588591|NCT03572829|Ondansetron|ondansetron|mesh-list
588592|NCT03572829|Aprepitant|aprepitant|mesh-list
588593|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
588594|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
588595|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
588596|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588597|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588598|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
588599|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
588600|NCT03572829|Hormones|hormones|mesh-ancestor
588601|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
588602|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
588603|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588604|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588605|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
588606|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
588607|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
588608|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
588609|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588610|NCT03572829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
588611|NCT03572829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
588612|NCT03572829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
588613|NCT03572829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
588614|NCT03572829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
588615|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
588616|NCT03572790|Prucalopride|prucalopride|mesh-list
588617|NCT03572790|Laxatives|laxatives|mesh-ancestor
588618|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
588619|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
588620|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
588621|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
588622|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588623|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588624|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588625|NCT03572764|Cytarabine|cytarabine|mesh-list
588626|NCT03572764|Daunorubicin|daunorubicin|mesh-list
588627|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
588628|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
588629|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588630|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588631|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
588632|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
588633|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
588634|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
588635|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588636|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
588637|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
588638|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
588639|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588640|NCT03572686|Dexamethasone|dexamethasone|mesh-list
588641|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
588642|NCT03572686|Ropivacaine|ropivacaine|mesh-list
588643|NCT03572686|BB 1101|bb 1101|mesh-list
588644|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
588645|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
588646|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
588647|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588648|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588649|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
588650|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
588651|NCT03572686|Hormones|hormones|mesh-ancestor
588727|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
588652|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
588653|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
588654|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588655|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
588656|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588657|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588658|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
588659|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
588660|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
588661|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
588662|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
588663|NCT03572647|Hematinics|hematinics|mesh-ancestor
588664|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
588665|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
588666|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588667|NCT03572582|Nivolumab|nivolumab|mesh-list
588668|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
588669|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588670|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
588671|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076960|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076961|NCT02020616|Metformin|metformin|mesh-list
2076962|NCT02020616|Exenatide|exenatide|mesh-list
2076963|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2076964|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076965|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2076966|NCT02020616|Incretins|incretins|mesh-ancestor
588679|NCT03572517|Morphine|morphine|mesh-list
588680|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
588681|NCT03572517|Narcotics|narcotics|mesh-ancestor
588682|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
588683|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588684|NCT03572517|Analgesics|analgesics|mesh-ancestor
588685|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
588686|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2215239|NCT00026104|Immunologic Factors|immunologic factors|mesh-ancestor
2215240|NCT00026104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215241|NCT00026130|Gemcitabine|gemcitabine|mesh-list
2215242|NCT00026130|Fluorouracil|fluorouracil|mesh-list
2215243|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2215244|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
2215245|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215246|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076967|NCT02020616|Hormones|hormones|mesh-ancestor
2076968|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2076969|NCT02020941|Dexamethasone|dexamethasone|mesh-list
2076970|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2076971|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
2076972|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
2076973|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076974|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588703|NCT03572400|Gemcitabine|gemcitabine|mesh-list
588704|NCT03572400|Durvalumab|durvalumab|mesh-list
588705|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
588706|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
588707|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588708|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588709|NCT03572400|Antiviral Agents|antiviral agents|mesh-ancestor
588710|NCT03572400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
588711|NCT03572400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588712|NCT03572400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
588713|NCT03572400|Immunologic Factors|immunologic factors|mesh-ancestor
588714|NCT03572400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588715|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
588716|NCT03572387|Azacitidine|azacitidine|mesh-list
588717|NCT03572387|Tretinoin|tretinoin|mesh-list
588718|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
588719|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
588720|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588721|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588722|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588723|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
588724|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
588725|NCT03572283|Bethanechol|bethanechol|mesh-list
588726|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
588728|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588729|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588730|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
588731|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
588732|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
588733|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588734|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588735|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
588736|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
588737|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
588738|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
588739|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
588740|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
588741|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588742|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
588743|NCT03572231|Mirabegron|mirabegron|mesh-list
588744|NCT03572231|Fesoterodine|fesoterodine|mesh-list
588745|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
588746|NCT03572231|Oxybutynin|oxybutynin|mesh-list
588747|NCT03572231|Darifenacin|darifenacin|mesh-list
588748|NCT03572231|Propiverine|propiverine|mesh-list
588749|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
588750|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
588751|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
588752|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588753|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588754|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588755|NCT03572231|Urological Agents|urological agents|mesh-ancestor
588756|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
588757|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
588758|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
588759|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
588760|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
588761|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
588762|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588763|NCT03572088|Terlipressin|terlipressin|mesh-list
588764|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
588765|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
588779|NCT03572010|Fesoterodine|fesoterodine|mesh-list
588780|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
588781|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
588782|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
588783|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
588784|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588785|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588786|NCT03572010|Urological Agents|urological agents|mesh-ancestor
588787|NCT03571945|Anesthetics|anesthetics|mesh-list
588788|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
588789|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588790|NCT03571932|Vaccines|vaccines|mesh-list
588791|NCT03571932|Immunologic Factors|immunologic factors|mesh-ancestor
588792|NCT03571932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588793|NCT03571919|Lidocaine|lidocaine|mesh-list
588794|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
588795|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
588796|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
588797|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588798|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
588799|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588800|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
588801|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
588802|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
588803|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
588804|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588805|NCT03571815|Listerine|listerine|mesh-list
588806|NCT03571815|Fluorides|fluorides|mesh-list
588807|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
588808|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
588809|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
588810|NCT03571815|Protective Agents|protective agents|mesh-ancestor
588811|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588812|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
588813|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
588814|NCT03571802|Simvastatin|simvastatin|mesh-list
588815|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
588816|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
588817|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
588818|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588819|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
588820|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
588821|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588822|NCT03571737|Ibuprofen|ibuprofen|mesh-list
588823|NCT03571737|Lidocaine|lidocaine|mesh-list
588824|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
588825|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
588826|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
588827|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588828|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
588829|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588830|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
588831|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
588832|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
588833|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
588834|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588835|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
588836|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
588837|NCT03571737|Analgesics|analgesics|mesh-ancestor
588838|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
588839|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
588840|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
588841|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215247|NCT00026130|Antiviral Agents|antiviral agents|mesh-ancestor
2215248|NCT00026130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215249|NCT00026130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215250|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215251|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
2215252|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215253|NCT00026143|Interferons|interferons|mesh-list
2215254|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
2215255|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
2215256|NCT00026143|Interleukin-12|interleukin-12|mesh-list
2215257|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215258|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
2215259|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
588855|NCT03571711|Meropenem|meropenem|mesh-list
588856|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
588857|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
588858|NCT03571633|Paclitaxel|paclitaxel|mesh-list
588859|NCT03571633|Trastuzumab|trastuzumab|mesh-list
588860|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
588861|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588862|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
588863|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
588864|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
588865|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588866|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2215260|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
2215261|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215262|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
588870|NCT03571594|Octreotide|octreotide|mesh-list
588871|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
588872|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
588873|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588874|NCT03571568|Rituximab|rituximab|mesh-list
588875|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
588876|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215263|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
588877|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
588878|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588879|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215264|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2215265|NCT00026143|Growth Substances|growth substances|mesh-ancestor
2215266|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215267|NCT00026156|Docetaxel|docetaxel|mesh-list
2215268|NCT00026156|Vinorelbine|vinorelbine|mesh-list
588885|NCT03571490|Ropivacaine|ropivacaine|mesh-list
588886|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
588887|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
588888|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
588889|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588890|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
588891|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588892|NCT03571438|Sirolimus|sirolimus|mesh-list
588893|NCT03571438|Sunitinib|sunitinib|mesh-list
588894|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588895|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
588896|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
588897|NCT03571438|Growth Substances|growth substances|mesh-ancestor
588898|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588899|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
588900|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
588901|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588902|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588903|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
588904|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
588905|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
588906|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
588907|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
588908|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
588918|NCT03571321|Cytarabine|cytarabine|mesh-list
588919|NCT03571321|Dexamethasone|dexamethasone|mesh-list
588920|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
588921|NCT03571321|Rituximab|rituximab|mesh-list
588922|NCT03571321|Doxorubicin|doxorubicin|mesh-list
588923|NCT03571321|Methotrexate|methotrexate|mesh-list
588924|NCT03571321|Vincristine|vincristine|mesh-list
588925|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
588926|NCT03571321|Thioguanine|thioguanine|mesh-list
588927|NCT03571321|Pegaspargase|pegaspargase|mesh-list
588928|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
588929|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
588930|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588931|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
588932|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
588933|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
588934|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588935|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588936|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
588937|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
588938|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
588939|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
588940|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
588941|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
588942|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
588943|NCT03571321|Hormones|hormones|mesh-ancestor
588944|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
588945|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
588946|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
588947|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
588948|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
588949|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
588950|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588951|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
588952|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
588953|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
588954|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
588955|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
588956|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
588957|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
588958|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
588959|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
588960|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
588961|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
588962|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
588963|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
588964|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
588965|NCT03571308|Prednisolone|prednisolone|mesh-list
588966|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
588967|NCT03571308|Doxorubicin|doxorubicin|mesh-list
588968|NCT03571308|Vincristine|vincristine|mesh-list
588969|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
588970|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
588971|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
588972|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
588973|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
588974|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
588975|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
588976|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
588977|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
588978|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
588979|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
588980|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
588981|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
588982|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
588983|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
588984|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
588985|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
588986|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
588987|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
588988|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
588989|NCT03571308|Hormones|hormones|mesh-ancestor
588990|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
588991|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
588992|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
588993|NCT03571230|Amoxicillin|amoxicillin|mesh-list
588994|NCT03571230|Metronidazole|metronidazole|mesh-list
588995|NCT03571230|Clarithromycin|clarithromycin|mesh-list
588996|NCT03571230|Levofloxacin|levofloxacin|mesh-list
588997|NCT03571230|Tetracycline|tetracycline|mesh-list
588998|NCT03571230|Tinidazole|tinidazole|mesh-list
588999|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
589000|NCT03571230|Furazolidone|furazolidone|mesh-list
589001|NCT03571230|Bismuth|bismuth|mesh-list
589002|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
589003|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
589004|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
589005|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
589006|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
589007|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
589008|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589009|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589010|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
589011|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
589012|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
589013|NCT03571230|Renal Agents|renal agents|mesh-ancestor
589014|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
589015|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
589016|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589017|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
589018|NCT03571230|Antacids|antacids|mesh-ancestor
589019|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
589020|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
589021|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
589022|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
589023|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
589027|NCT03571126|Olanzapine|olanzapine|mesh-list
589028|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
589029|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
589030|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589031|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589032|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
589033|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
589034|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
589035|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589036|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
589037|NCT03571126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
589038|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
589039|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
589040|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589041|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
589042|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
589043|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
589044|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
589045|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
589046|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
589047|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
589048|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
589049|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
589050|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
589051|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
589052|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
589053|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589054|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
589055|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
589056|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589057|NCT03570983|Cytarabine|cytarabine|mesh-list
589058|NCT03570983|Etoposide|etoposide|mesh-list
589059|NCT03570983|Melphalan|melphalan|mesh-list
589060|NCT03570983|Carmustine|carmustine|mesh-list
589061|NCT03570983|Allopurinol|allopurinol|mesh-list
589062|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
589063|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589064|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
589065|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
589066|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589067|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589068|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
589069|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
589070|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
589071|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
589072|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
589073|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
589074|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589075|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
589076|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
589077|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
589078|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
589079|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
589080|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
589081|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
589082|NCT03570983|Protective Agents|protective agents|mesh-ancestor
589083|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
589084|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
589085|NCT03570827|Androgens|androgens|mesh-list
589086|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
589087|NCT03570827|Hormones|hormones|mesh-ancestor
589088|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
589089|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589090|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
589091|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589092|NCT03570827|Protective Agents|protective agents|mesh-ancestor
589093|NCT03570827|Vitamins|vitamins|mesh-ancestor
589094|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
589095|NCT03570827|Estrogens|estrogens|mesh-ancestor
589096|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
589097|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589098|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
589099|NCT03570814|Azithromycin|azithromycin|mesh-list
589100|NCT03570814|Ivermectin|ivermectin|mesh-list
589101|NCT03570814|Albendazole|albendazole|mesh-list
589102|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
589103|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
589104|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
589105|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
589106|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
589107|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
589108|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
589109|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
589110|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
589111|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
589112|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589113|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589114|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
589115|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
589116|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
589117|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589118|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
589119|NCT03570710|Coagulants|coagulants|mesh-ancestor
2076975|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2076976|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
2076977|NCT02020941|Hormones|hormones|mesh-ancestor
2076978|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2076979|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2076980|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2076981|NCT02021292|Macitentan|macitentan|mesh-list
2076982|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2215269|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589129|NCT03570645|Dexamethasone|dexamethasone|mesh-list
589130|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
589131|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
589132|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
589133|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
589134|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589135|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589136|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
589137|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
589138|NCT03570645|Hormones|hormones|mesh-ancestor
589139|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
589140|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
589141|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589142|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
589143|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589144|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
589145|NCT03570645|Analgesics|analgesics|mesh-ancestor
589146|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
589147|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
589148|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
589149|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
589150|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
589151|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
589152|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750828|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
2750829|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750830|NCT04165239|Protective Agents|protective agents|mesh-ancestor
2750831|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751259|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2215270|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
2215271|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
2215272|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
2215273|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215274|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2215275|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
2215276|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215277|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2215278|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215279|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215280|NCT00026182|Rituximab|rituximab|mesh-list
2215281|NCT00026182|Interleukin-12|interleukin-12|mesh-list
2215282|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2215283|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215284|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
2215285|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589179|NCT03570541|Acetaminophen|acetaminophen|mesh-list
589180|NCT03570541|Morphine|morphine|mesh-list
589181|NCT03570541|Ropivacaine|ropivacaine|mesh-list
589182|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
589183|NCT03570541|Narcotics|narcotics|mesh-ancestor
589184|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589185|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589186|NCT03570541|Analgesics|analgesics|mesh-ancestor
589187|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
589188|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589189|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
589190|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
589191|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
589192|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
2215286|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215287|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2215288|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2215289|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2215290|NCT00026182|Growth Substances|growth substances|mesh-ancestor
589198|NCT03570437|Paclitaxel|paclitaxel|mesh-list
589199|NCT03570437|Olaparib|olaparib|mesh-list
589200|NCT03570437|Cediranib|cediranib|mesh-list
589201|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
589202|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589203|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
589204|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
589205|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
589206|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589207|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
589208|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589209|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
589210|NCT03570359|Interferons|interferons|mesh-list
589211|NCT03570359|Interferon-beta|interferon-beta|mesh-list
589212|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
589213|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589214|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
589215|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
589216|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
589217|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589218|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
589219|NCT03570346|Hemay005|hemay005|mesh-list
589220|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
589221|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
589222|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
589223|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589224|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589225|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
589226|NCT03570320|Narcotics|narcotics|mesh-ancestor
589227|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589228|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589229|NCT03570320|Analgesics|analgesics|mesh-ancestor
589230|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
589231|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589232|NCT03570294|Atosiban|atosiban|mesh-list
589233|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
589234|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
589235|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589236|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
589237|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
589238|NCT03570281|Enoxaparin|enoxaparin|mesh-list
589239|NCT03570281|Edoxaban|edoxaban|mesh-list
589240|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
589241|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
589242|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
589243|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589244|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
589245|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
589246|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
589247|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
589248|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589249|NCT03570164|Sevoflurane|sevoflurane|mesh-list
589250|NCT03570164|Desflurane|desflurane|mesh-list
589251|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
589252|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
589253|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
589254|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
589255|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589256|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589257|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
589258|NCT03570112|Velpatasvir|velpatasvir|mesh-list
589259|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
2215291|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
589260|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
589261|NCT03570099|Naloxone|naloxone|mesh-list
589262|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
589263|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589264|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
589265|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589266|NCT03569995|Cytarabine|cytarabine|mesh-list
589267|NCT03569995|Rituximab|rituximab|mesh-list
589268|NCT03569995|Methotrexate|methotrexate|mesh-list
589269|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
589270|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589271|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
589272|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589273|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
589274|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
589275|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
589276|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
589277|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
589278|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
589279|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589280|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
589281|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589282|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
589283|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
589284|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
589285|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
589286|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
589287|NCT03569839|Propofol|propofol|mesh-list
589288|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
589289|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589290|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589291|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
589292|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
589293|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
589294|NCT03569696|Nivolumab|nivolumab|mesh-list
589295|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
589296|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589297|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
589298|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589299|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
589300|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
589301|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
589302|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589303|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
589304|NCT03569683|Protective Agents|protective agents|mesh-ancestor
589305|NCT03569579|Memantine|memantine|mesh-list
589306|NCT03569579|Donepezil|donepezil|mesh-list
589307|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
589308|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589309|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589310|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
589311|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
589312|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589313|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
589314|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
589315|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
589316|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
589317|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
589318|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
589319|NCT03569540|Glyburide|glyburide|mesh-list
589320|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
589321|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589322|NCT03569475|Milnacipran|milnacipran|mesh-list
589323|NCT03569475|Fluoxetine|fluoxetine|mesh-list
589324|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
589325|NCT03569475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
589326|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
589327|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
589328|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589329|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
589330|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
589331|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589332|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
589333|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
589334|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
589335|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
589336|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
589337|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589338|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
589339|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
589340|NCT03569475|Analgesics|analgesics|mesh-ancestor
589341|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
589342|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589343|NCT03569293|Upadacitinib|upadacitinib|mesh-list
589344|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
589345|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
589346|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589347|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589348|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
589349|NCT03569241|Androgens|androgens|mesh-list
589350|NCT03569241|Hormones|hormones|mesh-ancestor
589351|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
589352|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215292|NCT00026195|Irinotecan|irinotecan|mesh-list
2215293|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2215294|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2215295|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215296|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215297|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215298|NCT00026234|Dexamethasone|dexamethasone|mesh-list
2215299|NCT00026234|Capecitabine|capecitabine|mesh-list
2215300|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
2215301|NCT00026234|Floxuridine|floxuridine|mesh-list
2215302|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2215303|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
2215304|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
2215305|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2215306|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215307|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
589369|NCT03569085|Sevoflurane|sevoflurane|mesh-list
589370|NCT03569085|Isoflurane|isoflurane|mesh-list
589371|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
589372|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
589373|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
589374|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
589375|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589376|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589377|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
589378|NCT03569046|Bupivacaine|bupivacaine|mesh-list
589379|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
589380|NCT03569046|Anesthetics|anesthetics|mesh-list
589381|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
589382|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589383|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589384|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
589385|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2076983|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2076984|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076985|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2076986|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
2076987|NCT02021318|Hematinics|hematinics|mesh-ancestor
2076988|NCT02021331|Ethanol|ethanol|mesh-list
2076989|NCT02021331|Povidone-Iodine|povidone-iodine|mesh-list
2076990|NCT02021331|Cimetidine|cimetidine|mesh-list
2076991|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2076992|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2076993|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2076994|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
2076995|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
2076996|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2076997|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2076998|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2076999|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2077000|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2077001|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077002|NCT02021331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2077003|NCT02021331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215308|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
2215309|NCT00026234|Hormones|hormones|mesh-ancestor
589409|NCT03568968|Niacinamide|niacinamide|mesh-list
589410|NCT03568968|Niacin|niacin|mesh-list
589411|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
589412|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
589413|NCT03568968|Vitamins|vitamins|mesh-ancestor
589414|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
589415|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589416|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
589417|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
589418|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589419|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
589420|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
2077004|NCT02021331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2077005|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2077006|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
589425|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
589426|NCT03568916|Apixaban|apixaban|mesh-list
589427|NCT03568916|Dabigatran|dabigatran|mesh-list
589428|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
589429|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
589430|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
589431|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
589432|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589433|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589434|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
589435|NCT03568890|Aspirin|aspirin|mesh-list
589436|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
589437|NCT03568890|Apixaban|apixaban|mesh-list
589438|NCT03568890|Edoxaban|edoxaban|mesh-list
589439|NCT03568890|Dabigatran|dabigatran|mesh-list
589440|NCT03568890|Clopidogrel|clopidogrel|mesh-list
589441|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
589442|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
589443|NCT03568890|Analgesics|analgesics|mesh-ancestor
589444|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
589445|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589446|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589447|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
589448|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
589449|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
589450|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
589451|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589452|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
589453|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
589454|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589455|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
589456|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
589457|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
589458|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
589459|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
589460|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
589461|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
589462|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
589463|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
589464|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
589465|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
589466|NCT03568838|Enoxaparin|enoxaparin|mesh-list
589467|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
589468|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
589469|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
589470|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589471|NCT03568721|Acetaminophen|acetaminophen|mesh-list
589472|NCT03568721|Ibuprofen|ibuprofen|mesh-list
589473|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
589474|NCT03568721|Analgesics|analgesics|mesh-ancestor
589475|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
589476|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589477|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589478|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
589479|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
589480|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
589481|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
589482|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
589483|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589484|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589485|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
589486|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
589487|NCT03568708|Estradiol|estradiol|mesh-list
589488|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
589489|NCT03568708|Estrogens|estrogens|mesh-list
589490|NCT03568708|Hormones|hormones|mesh-ancestor
589491|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
589492|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589493|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
589494|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
589495|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
589496|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2077007|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2077008|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2077009|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2077010|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077011|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
2077012|NCT02021643|Ribavirin|ribavirin|mesh-list
2077013|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
2077014|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077015|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
589506|NCT03568643|Amoxicillin|amoxicillin|mesh-list
589507|NCT03568643|Azithromycin|azithromycin|mesh-list
589508|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
589509|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
589510|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
589511|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
589512|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
589513|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589514|NCT03568578|Entecavir|entecavir|mesh-list
589515|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
589516|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
589517|NCT03568513|Curcumin|curcumin|mesh-list
589518|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
589519|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
589520|NCT03568513|Analgesics|analgesics|mesh-ancestor
589521|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
589522|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589523|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589524|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
589525|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
589526|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589527|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589528|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215310|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2215311|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2215312|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215313|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2215314|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
2215315|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215316|NCT00026260|Semaxinib|semaxinib|mesh-list
2215317|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2215318|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2215319|NCT00026260|Growth Substances|growth substances|mesh-ancestor
2215320|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215321|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215322|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215323|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2215324|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215325|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215326|NCT00026273|Leucovorin|leucovorin|mesh-list
2215327|NCT00026273|Fluorouracil|fluorouracil|mesh-list
2215328|NCT00026273|Irinotecan|irinotecan|mesh-list
2215329|NCT00026273|Calcium|calcium|mesh-list
2215330|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
2215331|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2215332|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215333|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
2215334|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215335|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2215336|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589557|NCT03568474|Fluorides|fluorides|mesh-list
589558|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
589559|NCT03568474|Protective Agents|protective agents|mesh-ancestor
589560|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077016|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077017|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
2077018|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2077019|NCT02021656|Ledipasvir|ledipasvir|mesh-list
2077020|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
2077021|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077025|NCT02021929|Sorafenib|sorafenib|mesh-list
2077026|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077027|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2077028|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077029|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077030|NCT02021942|Pasireotide|pasireotide|mesh-list
2077031|NCT02021942|Hormones|hormones|mesh-ancestor
2077032|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2077033|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077034|NCT02022007|Metformin|metformin|mesh-list
2077035|NCT02022007|Saxagliptin|saxagliptin|mesh-list
2077036|NCT02022007|Biguanides|biguanides|mesh-list
2077037|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2077038|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2077039|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589584|NCT03568318|Upadacitinib|upadacitinib|mesh-list
589585|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
589586|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
589587|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589588|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589589|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
589590|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
589591|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
589592|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589593|NCT03568097|Avelumab|avelumab|mesh-list
589594|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
589595|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589596|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
589597|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
589598|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589599|NCT03567941|Acetaminophen|acetaminophen|mesh-list
589600|NCT03567941|Hydrocodone|hydrocodone|mesh-list
589601|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
589602|NCT03567941|Analgesics|analgesics|mesh-ancestor
589603|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
589604|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589605|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589606|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
589607|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
589608|NCT03567941|Narcotics|narcotics|mesh-ancestor
589609|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589610|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
589611|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
589612|NCT03567928|Propofol|propofol|mesh-list
589613|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
589614|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589615|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589616|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
589617|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
589618|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
589619|NCT03567876|Venetoclax|venetoclax|mesh-list
589620|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589621|NCT03567720|Paclitaxel|paclitaxel|mesh-list
589622|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
589623|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
589624|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589625|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
589626|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
589627|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
589628|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589629|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
589630|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
589631|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
589632|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
589633|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
589634|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
589635|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589636|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
589637|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
589638|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
589639|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
589640|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
589641|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
589642|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589643|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
589644|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
589645|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
589646|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077040|NCT02022007|Incretins|incretins|mesh-ancestor
2077041|NCT02022007|Hormones|hormones|mesh-ancestor
2077042|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2077043|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
2077044|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077045|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077046|NCT02022657|Tenofovir|tenofovir|mesh-list
2077047|NCT02022657|Emtricitabine|emtricitabine|mesh-list
2077048|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
589656|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
589657|NCT03567629|Leucovorin|leucovorin|mesh-list
589658|NCT03567629|Bevacizumab|bevacizumab|mesh-list
589659|NCT03567629|Cetuximab|cetuximab|mesh-list
589660|NCT03567629|Fluorouracil|fluorouracil|mesh-list
589661|NCT03567629|Capecitabine|capecitabine|mesh-list
589662|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
589663|NCT03567629|Irinotecan|irinotecan|mesh-list
589664|NCT03567629|Calcium|calcium|mesh-list
589665|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
589666|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
589667|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589668|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
589669|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
589670|NCT03567629|Growth Substances|growth substances|mesh-ancestor
589671|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589672|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
589673|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
589674|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
589675|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
589676|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589677|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
589678|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
589679|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
589680|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
589681|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
589682|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589683|NCT03567629|Antidotes|antidotes|mesh-ancestor
589684|NCT03567629|Protective Agents|protective agents|mesh-ancestor
589685|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
589686|NCT03567629|Vitamins|vitamins|mesh-ancestor
589687|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
2215337|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215338|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
2215339|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2215340|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2215341|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215342|NCT00026273|Antidotes|antidotes|mesh-ancestor
2215343|NCT00026273|Protective Agents|protective agents|mesh-ancestor
2215344|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
2215345|NCT00026273|Vitamins|vitamins|mesh-ancestor
2215346|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
2215347|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2215348|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
2215349|NCT00026286|Estrogens|estrogens|mesh-list
2215350|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2215351|NCT00026286|Hormones|hormones|mesh-ancestor
2215352|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2215353|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215354|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2215355|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
589707|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
589708|NCT03567473|Dexamethasone|dexamethasone|mesh-list
589709|NCT03567473|Epinephrine|epinephrine|mesh-list
589710|NCT03567473|Racepinephrine|racepinephrine|mesh-list
589711|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
589712|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
589713|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
589714|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
589715|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589716|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589717|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
589718|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
589719|NCT03567473|Hormones|hormones|mesh-ancestor
589720|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
589721|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
589722|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589723|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
589724|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
589725|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
589726|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
589727|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589728|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
589729|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
589730|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
589731|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
589732|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
589733|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
589734|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
589735|NCT03567447|Droxidopa|droxidopa|mesh-list
589736|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
589737|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
589738|NCT03567434|Ethanol|ethanol|mesh-list
589739|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
589740|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
589741|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589742|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589743|NCT03567408|Bivalirudin|bivalirudin|mesh-list
589744|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
589745|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
589746|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
589747|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589748|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589749|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
589750|NCT03567395|Melatonin|melatonin|mesh-list
589751|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
589752|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589753|NCT03567395|Protective Agents|protective agents|mesh-ancestor
589754|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589755|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2215356|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2215357|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
2215358|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2215359|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2215360|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2215361|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2215362|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2215363|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589765|NCT03567369|Dexamethasone|dexamethasone|mesh-list
589766|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
589767|NCT03567369|BB 1101|bb 1101|mesh-list
589768|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
589769|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
589770|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
589771|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589772|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589773|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
589774|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
589775|NCT03567369|Hormones|hormones|mesh-ancestor
589776|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
589777|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
589778|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589779|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
589780|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589781|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589782|NCT03567343|Melatonin|melatonin|mesh-list
589783|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
589784|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589785|NCT03567343|Protective Agents|protective agents|mesh-ancestor
589786|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589787|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589788|NCT03567304|Rilpivirine|rilpivirine|mesh-list
589789|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
589790|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
589791|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589792|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589793|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
589794|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
589795|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
589796|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
589797|NCT03567135|Temozolomide|temozolomide|mesh-list
589798|NCT03567135|Apatinib|apatinib|mesh-list
589799|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
589800|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
589801|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589802|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589803|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
589804|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215364|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
2215365|NCT00026299|Gefitinib|gefitinib|mesh-list
2215366|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215367|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2215368|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215369|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215370|NCT00026338|Gemcitabine|gemcitabine|mesh-list
2215371|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2215372|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2215373|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
2215374|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215375|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215376|NCT00026338|Antiviral Agents|antiviral agents|mesh-ancestor
589831|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
589832|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
589833|NCT03566914|Tadalafil|tadalafil|mesh-list
589834|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
589835|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
589836|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
589837|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589838|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589839|NCT03566914|Urological Agents|urological agents|mesh-ancestor
2215377|NCT00026338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215378|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215379|NCT00026338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
589843|NCT03566667|Metoprolol|metoprolol|mesh-list
589844|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
589845|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
589846|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
589847|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
589848|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589849|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589850|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
589851|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
589852|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
589853|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
589854|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
589855|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589856|NCT03566576|Docetaxel|docetaxel|mesh-list
589857|NCT03566576|Pemetrexed|pemetrexed|mesh-list
589858|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
589859|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
589860|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
589861|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
589862|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589863|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589864|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
589865|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2215380|NCT00026338|Immunologic Factors|immunologic factors|mesh-ancestor
589871|NCT03566394|Gabapentin|gabapentin|mesh-list
589872|NCT03566394|Analgesics|analgesics|mesh-ancestor
589873|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
589874|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589875|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589876|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
589877|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
589878|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
589879|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589880|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
589881|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
589882|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
589883|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
589884|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589885|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
589886|NCT03566329|Lidocaine|lidocaine|mesh-list
589887|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
589888|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
589889|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
589890|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
589891|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589892|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
589893|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
589894|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
589895|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
589896|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
589897|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
589898|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589899|NCT03566329|Analgesics|analgesics|mesh-ancestor
589900|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
589901|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
589902|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
589903|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
589904|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
589905|NCT03566316|Amlodipine|amlodipine|mesh-list
589906|NCT03566316|Telmisartan|telmisartan|mesh-list
589907|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
589908|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
589909|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
589910|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
589911|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
589912|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589913|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
589914|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589915|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
589916|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
589917|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
589918|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
589919|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
589920|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
589921|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589922|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
589923|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
589924|NCT03566303|Vitamin K|vitamin k|mesh-list
589925|NCT03566303|Warfarin|warfarin|mesh-list
589926|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
589927|NCT03566303|Vitamins|vitamins|mesh-ancestor
589928|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
589929|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589930|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
589931|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
589932|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
589933|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
589934|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
589935|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589936|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589937|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
589938|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
589939|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
589940|NCT03566303|Coagulants|coagulants|mesh-ancestor
589941|NCT03566225|Metformin|metformin|mesh-list
589942|NCT03566225|Pioglitazone|pioglitazone|mesh-list
589943|NCT03566225|Clomiphene|clomiphene|mesh-list
589944|NCT03566225|Enclomiphene|enclomiphene|mesh-list
589945|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
589946|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
589947|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589948|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
589949|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
589950|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
589951|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
589952|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
589953|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
589954|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
589955|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2077049|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
2077050|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077051|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2077052|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2077053|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589961|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
589962|NCT03566134|DA-8010|da-8010|mesh-list
589963|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
589964|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
589965|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
589966|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
589967|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589968|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589969|NCT03566134|Urological Agents|urological agents|mesh-ancestor
589970|NCT03566069|Oxytocin|oxytocin|mesh-list
589971|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
589972|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
589973|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589974|NCT03566030|Tenofovir|tenofovir|mesh-list
589975|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
589976|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
589977|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
589978|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
589979|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
589980|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
589981|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
589982|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2750845|NCT04163900|Gemcitabine|gemcitabine|mesh-list
589990|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
589991|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
589992|NCT03565913|Calcium|calcium|mesh-list
589993|NCT03565913|Calcium acetate|calcium acetate|mesh-list
589994|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
589995|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
589996|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
589997|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
589998|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
589999|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590000|NCT03565913|Cathartics|cathartics|mesh-ancestor
590001|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2077054|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077055|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2077056|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2215381|NCT00026338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750846|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750847|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2750848|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
2750849|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750850|NCT04163900|Antiviral Agents|antiviral agents|mesh-ancestor
2750851|NCT04163900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2750852|NCT04163900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750853|NCT04163900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2750854|NCT04163900|Immunologic Factors|immunologic factors|mesh-ancestor
2750855|NCT04163900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750856|NCT04160052|Azacitidine|azacitidine|mesh-list
2077057|NCT02022748|Ticagrelor|ticagrelor|mesh-list
2750857|NCT04160052|Venetoclax|venetoclax|mesh-list
2750858|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2750859|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
2750860|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215382|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2215383|NCT00026351|Rituximab|rituximab|mesh-list
2215384|NCT00026351|Pentostatin|pentostatin|mesh-list
2215385|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2215386|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215387|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
2215388|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215389|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215390|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
590033|NCT03565536|Sorafenib|sorafenib|mesh-list
590034|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590035|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
590036|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590037|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590038|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
590039|NCT03565458|Empagliflozin|empagliflozin|mesh-list
590040|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
590041|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590042|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
590043|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077058|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2077059|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2077060|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2077061|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2077062|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
2077063|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
590050|NCT03565406|Nivolumab|nivolumab|mesh-list
590051|NCT03565406|Ipilimumab|ipilimumab|mesh-list
590052|NCT03565406|Mocetinostat|mocetinostat|mesh-list
590053|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
590054|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590055|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
590056|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590057|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
590058|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590059|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
590060|NCT03565354|Hematinics|hematinics|mesh-ancestor
2215391|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215392|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215393|NCT00026364|Leucovorin|leucovorin|mesh-list
2215394|NCT00026364|Fluorouracil|fluorouracil|mesh-list
2215395|NCT00026364|Irinotecan|irinotecan|mesh-list
2215396|NCT00026364|Gefitinib|gefitinib|mesh-list
2215397|NCT00026364|Calcium|calcium|mesh-list
2215398|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
2215399|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2215400|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215401|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
590073|NCT03565302|Terbutaline|terbutaline|mesh-list
590074|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
590075|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
590076|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
590077|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590078|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590079|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
590080|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
590081|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
590082|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
590083|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
590084|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
590085|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
590086|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590087|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
590088|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
590089|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
590090|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
590091|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
590092|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
590093|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590094|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
590095|NCT03565276|Coagulants|coagulants|mesh-ancestor
2215402|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215403|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2215404|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215405|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
590101|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
590102|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
590103|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590104|NCT03565133|Quinine|quinine|mesh-list
590105|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
590106|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
590107|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
590108|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590109|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
590110|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590111|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
590112|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590113|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
590114|NCT03565133|Analgesics|analgesics|mesh-ancestor
590115|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
590116|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
590117|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
590118|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
590119|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
590120|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590121|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590122|NCT03564912|Capecitabine|capecitabine|mesh-list
590123|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
590124|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
590125|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
590126|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590127|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077064|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077065|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077066|NCT02023099|Ritonavir|ritonavir|mesh-list
2077067|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2077068|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2077069|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
2077070|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077071|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077072|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2077073|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2077074|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
2077075|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077076|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
590141|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
590142|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
590143|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
590144|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590145|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
590146|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
590147|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
590148|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
590149|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
590150|NCT03564756|Vitamins|vitamins|mesh-ancestor
590151|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
590152|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590153|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
590154|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590155|NCT03564756|Protective Agents|protective agents|mesh-ancestor
590156|NCT03564704|Cytarabine|cytarabine|mesh-list
590157|NCT03564704|Dexamethasone|dexamethasone|mesh-list
590158|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
590159|NCT03564704|Methotrexate|methotrexate|mesh-list
590160|NCT03564704|Etoposide|etoposide|mesh-list
590161|NCT03564704|Vincristine|vincristine|mesh-list
590162|NCT03564704|Doxorubicin|doxorubicin|mesh-list
590163|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
590164|NCT03564704|Idarubicin|idarubicin|mesh-list
590165|NCT03564704|Pegaspargase|pegaspargase|mesh-list
590166|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
590167|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
590168|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590169|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
590170|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
590171|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
590172|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590173|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590174|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
590175|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
590176|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
590177|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
590178|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590179|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
590180|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
590181|NCT03564704|Hormones|hormones|mesh-ancestor
590182|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
590183|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
590184|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
590185|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
590186|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
590187|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
590188|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
590189|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
590190|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590191|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
590192|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
590193|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
590194|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
590195|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
590196|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
590197|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590198|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
590199|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
590200|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
590201|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2077077|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2077078|NCT02023112|Ritonavir|ritonavir|mesh-list
2077079|NCT02023112|Ribavirin|ribavirin|mesh-list
2077080|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2077081|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2077082|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
2077083|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077084|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077085|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2077086|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2077087|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
2077088|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077089|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2077090|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2077091|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
2077092|NCT02023125|Esomeprazole|esomeprazole|mesh-list
2077093|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2215406|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
590220|NCT03564678|Folic Acid|folic acid|mesh-list
590221|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
590222|NCT03564678|Vitamins|vitamins|mesh-ancestor
590223|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
590224|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590225|NCT03564678|Hematinics|hematinics|mesh-ancestor
590226|NCT03564652|Azithromycin|azithromycin|mesh-list
590227|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
590228|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590229|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
590230|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
590231|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
590232|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
590233|NCT03564548|Morphine|morphine|mesh-list
590234|NCT03564548|Oxycodone|oxycodone|mesh-list
590235|NCT03564548|Hydromorphone|hydromorphone|mesh-list
590236|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
590237|NCT03564548|Narcotics|narcotics|mesh-ancestor
590238|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
590239|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590240|NCT03564548|Analgesics|analgesics|mesh-ancestor
590241|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
590242|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590243|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
590244|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
590245|NCT03564509|Hormones|hormones|mesh-ancestor
590246|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
590247|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590248|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
590249|NCT03564470|Dasatinib|dasatinib|mesh-list
590250|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590251|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
590252|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590253|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590254|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
590255|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590256|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077094|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2077095|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2077096|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590260|NCT03564301|Metronidazole|metronidazole|mesh-list
590261|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590262|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
590263|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
590264|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
590265|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
590266|NCT03564158|Meropenem|meropenem|mesh-list
590267|NCT03564158|Vaborbactam|vaborbactam|mesh-list
590268|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
590269|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590270|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
590271|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
590272|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590273|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590274|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590275|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
590276|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
590277|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
590278|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
590279|NCT03564106|Prednisolone|prednisolone|mesh-list
590280|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
590281|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
590282|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
590283|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
590284|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
590285|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
590286|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590287|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590288|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
590289|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
590290|NCT03564106|Hormones|hormones|mesh-ancestor
590291|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
590292|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
590293|NCT03564106|Protective Agents|protective agents|mesh-ancestor
590294|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
590295|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590296|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
590297|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
590298|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
590299|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590300|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
590301|NCT03564093|Analgesics|analgesics|mesh-ancestor
590302|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
590303|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590304|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
590305|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
590306|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
590307|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
590308|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
590309|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590310|NCT03563963|Lidocaine|lidocaine|mesh-list
590311|NCT03563963|Ropivacaine|ropivacaine|mesh-list
590312|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
590313|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
590314|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
590315|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
590316|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590317|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
590318|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590319|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
590627|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
590320|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
590321|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
590322|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
590323|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590324|NCT03563950|Rifampin|rifampin|mesh-list
590325|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
590326|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
590327|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
590328|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590329|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
590330|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
590331|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590332|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590333|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
590334|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
590335|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
590336|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
590337|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
590338|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
590339|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
590340|NCT03563937|Apixaban|apixaban|mesh-list
590341|NCT03563937|Edoxaban|edoxaban|mesh-list
590342|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
590343|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
590344|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
590345|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
590346|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
590347|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590348|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590349|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
590350|NCT03563833|Anesthetics|anesthetics|mesh-list
590351|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
590352|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590353|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
590354|NCT03563794|Vildagliptin|vildagliptin|mesh-list
590355|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
590356|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590357|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
590358|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
590359|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590360|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590372|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
590373|NCT03563729|Nivolumab|nivolumab|mesh-list
590374|NCT03563729|Ipilimumab|ipilimumab|mesh-list
590375|NCT03563729|Trametinib|trametinib|mesh-list
590376|NCT03563729|Dabrafenib|dabrafenib|mesh-list
590377|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
590378|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590379|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
590380|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590381|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
590382|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077097|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077098|NCT02023151|Omalizumab|omalizumab|mesh-list
590385|NCT03563690|Celecoxib|celecoxib|mesh-list
590386|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
590387|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
590388|NCT03563690|Analgesics|analgesics|mesh-ancestor
590389|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
590390|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590391|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590392|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
590393|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
590394|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
590395|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
590396|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590397|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590398|NCT03563664|Danazol|danazol|mesh-list
590399|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
590400|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
590401|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
590402|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590403|NCT03563625|Bupivacaine|bupivacaine|mesh-list
590404|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
590405|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
590406|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
590407|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590408|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
590409|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590410|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
590411|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590412|NCT03563560|Cytarabine|cytarabine|mesh-list
590413|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
590414|NCT03563560|Alvocidib|alvocidib|mesh-list
590415|NCT03563560|Daunorubicin|daunorubicin|mesh-list
590416|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
590417|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
590418|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590419|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590420|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
590421|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590422|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
590423|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
590424|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590425|NCT03563560|Analgesics|analgesics|mesh-ancestor
590426|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
590427|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590428|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
590429|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
590430|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590431|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
590432|NCT03563560|Growth Substances|growth substances|mesh-ancestor
590433|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
590434|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
590435|NCT03563534|Fluorides|fluorides|mesh-list
590436|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
590437|NCT03563534|Protective Agents|protective agents|mesh-ancestor
590438|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590439|NCT03563365|Adapalene|adapalene|mesh-list
590440|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
590441|NCT03563365|Resveratrol|resveratrol|mesh-list
590442|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
590443|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590444|NCT03563365|Protective Agents|protective agents|mesh-ancestor
590445|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590446|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590447|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
590448|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
590449|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
590450|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
590451|NCT03563365|Analgesics|analgesics|mesh-ancestor
590452|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
590453|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590454|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
590455|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
590456|NCT03563248|Nivolumab|nivolumab|mesh-list
590457|NCT03563248|Folfirinox|folfirinox|mesh-list
590458|NCT03563248|Losartan|losartan|mesh-list
590459|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
590460|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590461|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
590462|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590463|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
590464|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
590465|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
590466|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
590467|NCT03563235|Calcitriol|calcitriol|mesh-list
590468|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
590469|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590470|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
590471|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
590472|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590473|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
590474|NCT03563235|Vitamins|vitamins|mesh-ancestor
590475|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
590476|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
590477|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
590478|NCT03563222|SMOFlipid|smoflipid|mesh-list
590479|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
590480|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
590481|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
590482|NCT03563170|Leucovorin|leucovorin|mesh-list
590483|NCT03563170|Paclitaxel|paclitaxel|mesh-list
590484|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
590485|NCT03563170|Fluorouracil|fluorouracil|mesh-list
590486|NCT03563170|Capecitabine|capecitabine|mesh-list
590487|NCT03563170|Cetuximab|cetuximab|mesh-list
590488|NCT03563170|Sorafenib|sorafenib|mesh-list
590489|NCT03563170|Avelumab|avelumab|mesh-list
590490|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
590491|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590492|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
590493|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
590494|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
590495|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590496|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
590497|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
590498|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590499|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
590500|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
590501|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
590502|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
590503|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
590504|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
590505|NCT03563170|Antidotes|antidotes|mesh-ancestor
590506|NCT03563170|Protective Agents|protective agents|mesh-ancestor
590507|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
590508|NCT03563170|Vitamins|vitamins|mesh-ancestor
590509|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
590510|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
590511|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
590512|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590513|NCT03563157|Leucovorin|leucovorin|mesh-list
590514|NCT03563157|Paclitaxel|paclitaxel|mesh-list
590515|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
590516|NCT03563157|Fluorouracil|fluorouracil|mesh-list
590517|NCT03563157|Capecitabine|capecitabine|mesh-list
590518|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
590519|NCT03563157|Cetuximab|cetuximab|mesh-list
590520|NCT03563157|Avelumab|avelumab|mesh-list
590521|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
590522|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590523|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
590524|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
590525|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
590526|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590527|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
590528|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
590529|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590530|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
590531|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
590532|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
590533|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
590534|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
590535|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
590536|NCT03563157|Antidotes|antidotes|mesh-ancestor
590537|NCT03563157|Protective Agents|protective agents|mesh-ancestor
590538|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
590539|NCT03563157|Vitamins|vitamins|mesh-ancestor
590540|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
590541|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
590542|NCT03563144|Leucovorin|leucovorin|mesh-list
590543|NCT03563144|Gemcitabine|gemcitabine|mesh-list
590544|NCT03563144|Paclitaxel|paclitaxel|mesh-list
590545|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
590546|NCT03563144|Bevacizumab|bevacizumab|mesh-list
590547|NCT03563144|Fluorouracil|fluorouracil|mesh-list
590548|NCT03563144|Capecitabine|capecitabine|mesh-list
590549|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
590550|NCT03563144|Avelumab|avelumab|mesh-list
590551|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
590552|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590553|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
590554|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
590555|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
590556|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590557|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
590558|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
590559|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590560|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
590561|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
590562|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
590563|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
590564|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
590565|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
590566|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
590567|NCT03563144|Growth Substances|growth substances|mesh-ancestor
590568|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
590569|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
590570|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
590571|NCT03563144|Antiviral Agents|antiviral agents|mesh-ancestor
590572|NCT03563144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590573|NCT03563144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590574|NCT03563144|Antidotes|antidotes|mesh-ancestor
590575|NCT03563144|Protective Agents|protective agents|mesh-ancestor
590576|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
590577|NCT03563144|Vitamins|vitamins|mesh-ancestor
590578|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
2077099|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2077100|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2215407|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
590582|NCT03563040|Methoxsalen|methoxsalen|mesh-list
590583|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
590584|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
590585|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
590586|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590587|NCT03563001|Budesonide|budesonide|mesh-list
590588|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
590589|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
590590|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
590591|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
590592|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590593|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590594|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
590595|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
590596|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
590597|NCT03563001|Hormones|hormones|mesh-ancestor
590598|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
590599|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
590600|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
590601|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
590602|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
590603|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
590604|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215408|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2215409|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215410|NCT00026364|Antidotes|antidotes|mesh-ancestor
2215411|NCT00026364|Protective Agents|protective agents|mesh-ancestor
2215412|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
2215413|NCT00026364|Vitamins|vitamins|mesh-ancestor
2215414|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
590612|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
590613|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
590614|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590615|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
590616|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
590617|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
590618|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590619|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590620|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
590621|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
590622|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
590623|NCT03562923|Hormones|hormones|mesh-ancestor
590624|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
590625|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
590626|NCT03562871|Carboplatin|carboplatin|mesh-list
590628|NCT03562871|Pemetrexed|pemetrexed|mesh-list
590629|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590630|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
590631|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590632|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590633|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
590634|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
590639|NCT03562780|Acetaminophen|acetaminophen|mesh-list
590640|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
590641|NCT03562780|Analgesics|analgesics|mesh-ancestor
590642|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
590643|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590644|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590645|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
590646|NCT03562754|Heparin|heparin|mesh-list
590647|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
590648|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590649|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
590650|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
590651|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
590652|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
590653|NCT03562611|Nalbuphine|nalbuphine|mesh-list
590654|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
590655|NCT03562611|Narcotics|narcotics|mesh-ancestor
590656|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
590657|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590658|NCT03562611|Analgesics|analgesics|mesh-ancestor
590659|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
590660|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590661|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
590662|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
590663|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
590664|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
590665|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
590666|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590667|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590668|NCT03562585|Antibodies|antibodies|mesh-list
590669|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
590670|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
590671|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590672|NCT03562533|Paclitaxel|paclitaxel|mesh-list
590673|NCT03562533|Carboplatin|carboplatin|mesh-list
590674|NCT03562533|Doxorubicin|doxorubicin|mesh-list
590675|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
590676|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
590677|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590678|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
590679|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
590680|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
590681|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590682|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
590683|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
590684|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
590685|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590686|NCT03562507|Nivolumab|nivolumab|mesh-list
590687|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
590688|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590689|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
590690|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215415|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2215416|NCT00026377|Leuprolide|leuprolide|mesh-list
2215417|NCT00026377|Goserelin|goserelin|mesh-list
2215418|NCT00026377|Flutamide|flutamide|mesh-list
2215419|NCT00026377|Bicalutamide|bicalutamide|mesh-list
2215420|NCT00026377|Semaxinib|semaxinib|mesh-list
2215421|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2215422|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
2215423|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2215424|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215425|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2215426|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215427|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
2215428|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
2215429|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2215430|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2215431|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2215432|NCT00026377|Growth Substances|growth substances|mesh-ancestor
2215433|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215434|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2215435|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215436|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215437|NCT00026403|Gemcitabine|gemcitabine|mesh-list
2215438|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215439|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2215440|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
2215441|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215442|NCT00026403|Antiviral Agents|antiviral agents|mesh-ancestor
590718|NCT03562468|Niacinamide|niacinamide|mesh-list
590719|NCT03562468|Niacin|niacin|mesh-list
590720|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
590721|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
590722|NCT03562468|Vitamins|vitamins|mesh-ancestor
590723|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
590724|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590725|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
590726|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
590727|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590728|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
590729|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
590730|NCT03562416|Nintedanib|nintedanib|mesh-list
590731|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590732|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
590733|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590734|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590735|NCT03562390|Irinotecan|irinotecan|mesh-list
590736|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
590737|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
590738|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590739|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590740|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215443|NCT00026403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215444|NCT00026403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077101|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
2077102|NCT02023411|Teriparatide|teriparatide|mesh-list
2077103|NCT02023411|Hormones|hormones|mesh-list
2077104|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
2077105|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2077106|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077107|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2077108|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2077109|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2077110|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077111|NCT02023866|Cysteamine|cysteamine|mesh-list
2077112|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2077113|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077114|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
590759|NCT03562169|Thalidomide|thalidomide|mesh-list
590760|NCT03562169|Dexamethasone|dexamethasone|mesh-list
590761|NCT03562169|Ixazomib|ixazomib|mesh-list
590762|NCT03562169|Glycine|glycine|mesh-list
590763|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
590764|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
590765|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
590766|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590767|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590768|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
590769|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
590770|NCT03562169|Hormones|hormones|mesh-ancestor
590771|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
590772|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
590773|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590774|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
590775|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
590776|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
590777|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
590778|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590779|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
590780|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
590781|NCT03562169|Growth Substances|growth substances|mesh-ancestor
590782|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
590783|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
590784|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590785|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590786|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
590787|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
590788|NCT03562143|Iron|iron|mesh-list
590789|NCT03562143|Trace Elements|trace elements|mesh-ancestor
590790|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
590791|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590792|NCT03562130|Teduglutide|teduglutide|mesh-list
590793|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
590794|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
590795|NCT03562130|Protective Agents|protective agents|mesh-ancestor
590796|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590797|NCT03561935|Propafenone|propafenone|mesh-list
590798|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
590799|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
590800|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
590801|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
590802|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590803|NCT03561870|Olaparib|olaparib|mesh-list
590804|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
590805|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590806|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590807|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077115|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
2077116|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077117|NCT02024087|Sorafenib|sorafenib|mesh-list
2077118|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077119|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2077120|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077121|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077122|NCT02024204|Fluticasone|fluticasone|mesh-list
2077123|NCT02024204|Xhance|xhance|mesh-list
2077124|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
590818|NCT03561740|Capecitabine|capecitabine|mesh-list
590819|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
590820|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
590821|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590822|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590823|NCT03561675|Acetazolamide|acetazolamide|mesh-list
590824|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
590825|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
590826|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590827|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590828|NCT03561675|Diuretics|diuretics|mesh-ancestor
590829|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
590830|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590831|NCT03561649|Adalimumab|adalimumab|mesh-list
590832|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
590833|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
590834|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
590835|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590836|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
590837|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
590838|NCT03561584|Analgesics|analgesics|mesh-ancestor
590839|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
590840|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590841|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590842|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
590843|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
590844|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
590845|NCT03561558|Ibuprofen|ibuprofen|mesh-list
590846|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
590847|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
590848|NCT03561558|Analgesics|analgesics|mesh-ancestor
590849|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
590850|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590851|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590852|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
590853|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
590854|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
590855|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590856|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590857|NCT03561415|Posaconazole|posaconazole|mesh-list
590858|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
590859|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590860|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
590861|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
590862|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
590863|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
590864|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
590865|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590866|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590867|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
590868|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
590869|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
590870|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590871|NCT03561402|Teriflunomide|teriflunomide|mesh-list
590872|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
590873|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
590874|NCT03561402|Analgesics|analgesics|mesh-ancestor
590875|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
590876|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590877|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590878|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
590879|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
590880|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
590881|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
590882|NCT03561376|Petrolatum|petrolatum|mesh-list
590883|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
590884|NCT03561376|Emollients|emollients|mesh-ancestor
590885|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
590886|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
590887|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
590888|NCT03561376|Protective Agents|protective agents|mesh-ancestor
590889|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590890|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
590891|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590892|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
590893|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590894|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077125|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2077126|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2077127|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2077128|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
2077129|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077130|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590902|NCT03561233|Omeprazole|omeprazole|mesh-list
590903|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
590904|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
590905|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
590906|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590907|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590908|NCT03561181|Vaccines|vaccines|mesh-list
590909|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
590910|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590911|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
590912|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
590913|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590914|NCT03560973|Gemcitabine|gemcitabine|mesh-list
590915|NCT03560973|Ramucirumab|ramucirumab|mesh-list
590916|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
590917|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
590918|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590919|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590920|NCT03560973|Antiviral Agents|antiviral agents|mesh-ancestor
590921|NCT03560973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
590922|NCT03560973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590923|NCT03560973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
590924|NCT03560973|Immunologic Factors|immunologic factors|mesh-ancestor
590925|NCT03560973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590929|NCT03560934|Dronabinol|dronabinol|mesh-list
590930|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
590931|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590932|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
590933|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
590934|NCT03560934|Analgesics|analgesics|mesh-ancestor
590935|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
590936|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590937|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
590938|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
590939|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
590940|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590941|NCT03560934|Hormones|hormones|mesh-ancestor
590942|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
590943|NCT03560908|Dasatinib|dasatinib|mesh-list
590944|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590945|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
590946|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590947|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590948|NCT03560882|Atorvastatin|atorvastatin|mesh-list
590949|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
590950|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
590951|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
590952|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590953|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
590954|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
590955|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590956|NCT03560856|Fulvestrant|fulvestrant|mesh-list
590957|NCT03560856|Palbociclib|palbociclib|mesh-list
590958|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
590959|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
590960|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
590961|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
590962|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
590963|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
590964|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590965|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
590966|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
590967|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590968|NCT03560804|Olmesartan|olmesartan|mesh-list
590969|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
590970|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
590971|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
590972|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
590973|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
590974|NCT03560804|Diuretics|diuretics|mesh-ancestor
590975|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
590976|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590977|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
590978|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
590979|NCT03560752|Vaccines|vaccines|mesh-list
590980|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
590981|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215445|NCT00026403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215446|NCT00026403|Immunologic Factors|immunologic factors|mesh-ancestor
2215447|NCT00026403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215448|NCT00026416|Interferons|interferons|mesh-list
2215449|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
590987|NCT03560583|Metoclopramide|metoclopramide|mesh-list
590988|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
590989|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
590990|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
590991|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
590992|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
590993|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
590994|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
590995|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
590996|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
590997|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077131|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2077132|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
2077133|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
2077134|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
591075|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2077135|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2077136|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2077137|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2077138|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
2077139|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2077140|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077141|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
2077142|NCT02024204|Hormones|hormones|mesh-ancestor
2077143|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2077144|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
591012|NCT03560440|Vancomycin|vancomycin|mesh-list
591013|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
591014|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
591015|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
591016|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
591017|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
591018|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
591019|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591020|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
591021|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591022|NCT03560427|Analgesics|analgesics|mesh-ancestor
591023|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
591024|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
591025|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
591026|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
591027|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
591028|NCT03560375|Empagliflozin|empagliflozin|mesh-list
591029|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
591030|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591031|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
591032|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591033|NCT03560362|Epinephrine|epinephrine|mesh-list
591034|NCT03560362|Bupivacaine|bupivacaine|mesh-list
591035|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
591036|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
591037|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
591038|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591039|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
591040|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
591041|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
591042|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
591043|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
591044|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
591045|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591046|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
591047|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
591048|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
591049|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
591050|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
591051|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
591052|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
591053|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
591054|NCT03560349|Lidocaine|lidocaine|mesh-list
591055|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
591056|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
591057|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
591058|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591059|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
591060|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
591061|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
591062|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
591063|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
591064|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
591065|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591066|NCT03560336|Liraglutide|liraglutide|mesh-list
591067|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
591068|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591069|NCT03560336|Incretins|incretins|mesh-ancestor
591070|NCT03560336|Hormones|hormones|mesh-ancestor
591071|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
591072|NCT03560310|Ticagrelor|ticagrelor|mesh-list
591073|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
591074|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
591076|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
591077|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
591078|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
591079|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591080|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591081|NCT03560297|Nitrazepam|nitrazepam|mesh-list
591082|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
591083|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
591084|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
591085|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591086|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
591087|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
591088|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
591089|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
591090|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
591091|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
591092|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077145|NCT02024386|Riociguat|riociguat|mesh-list
2077146|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
2215450|NCT00026416|Thalidomide|thalidomide|mesh-list
2215451|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215452|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
2215453|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215454|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
2215455|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591101|NCT03560232|Clindamycin|clindamycin|mesh-list
591102|NCT03560232|Gentamicins|gentamicins|mesh-list
591103|NCT03560232|Cefazolin|cefazolin|mesh-list
591104|NCT03560232|Tazobactam|tazobactam|mesh-list
591105|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
591106|NCT03560232|Piperacillin|piperacillin|mesh-list
591107|NCT03560232|Ampicillin|ampicillin|mesh-list
591108|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
591109|NCT03560232|Sulbactam|sulbactam|mesh-list
591110|NCT03560232|Sultamicillin|sultamicillin|mesh-list
591111|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
591112|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
591113|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
591114|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591115|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591116|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
591128|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
591129|NCT03560024|Growth Substances|growth substances|mesh-ancestor
591130|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591131|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
591132|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
591133|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591134|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
591135|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
591136|NCT03560011|Antibodies|antibodies|mesh-list
591137|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
591138|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591139|NCT03559985|Acetaminophen|acetaminophen|mesh-list
591140|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
591141|NCT03559985|Analgesics|analgesics|mesh-ancestor
591142|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
591143|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
591144|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591145|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
591146|NCT03559920|Propofol|propofol|mesh-list
591147|NCT03559920|Sevoflurane|sevoflurane|mesh-list
591148|NCT03559920|Anesthetics|anesthetics|mesh-list
591149|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
591150|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
591151|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591152|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
591153|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
591154|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
591155|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
591156|NCT03559868|Digoxin|digoxin|mesh-list
591157|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
591158|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
591159|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591160|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591161|NCT03559868|Protective Agents|protective agents|mesh-ancestor
591162|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591163|NCT03559803|Cisplatin|cisplatin|mesh-list
591164|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591165|NCT03559790|Tenofovir|tenofovir|mesh-list
591166|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
591167|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
591168|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
591169|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
591170|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591171|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591172|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
591173|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
591174|NCT03559751|Nicotine|nicotine|mesh-list
591175|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
591176|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
591177|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
591178|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591179|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
591180|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
591181|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
591182|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
591183|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591184|NCT03559725|Menthol|menthol|mesh-list
591185|NCT03559725|Nicotine|nicotine|mesh-list
591186|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
591187|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
591188|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
591189|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591190|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
591191|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
591192|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
591193|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
591194|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591195|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
591196|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
591197|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
591198|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
591199|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
591200|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591201|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
591202|NCT03559673|Lacosamide|lacosamide|mesh-list
591203|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
591204|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
591205|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
591206|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
591207|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591208|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
591209|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
591210|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
591211|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591212|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2077147|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215456|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215457|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
591217|NCT03559504|Sevoflurane|sevoflurane|mesh-list
591218|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
591219|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
591220|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
591221|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
591222|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
591223|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591224|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
591225|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
591226|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
591227|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591228|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
591229|NCT03559413|Imiquimod|imiquimod|mesh-list
591230|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
591231|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591232|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
591233|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591234|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
2077148|NCT02024477|Saxagliptin|saxagliptin|mesh-list
2077149|NCT02024477|Incretins|incretins|mesh-ancestor
2077150|NCT02024477|Hormones|hormones|mesh-ancestor
2077151|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2077152|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077153|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
591241|NCT03559387|Sargramostim|sargramostim|mesh-list
591242|NCT03559387|Lenograstim|lenograstim|mesh-list
591243|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
591244|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591245|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
591246|NCT03559348|Leucovorin|leucovorin|mesh-list
591247|NCT03559348|Gemcitabine|gemcitabine|mesh-list
591248|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
591249|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
591250|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591251|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591252|NCT03559348|Antiviral Agents|antiviral agents|mesh-ancestor
591253|NCT03559348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
591254|NCT03559348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591255|NCT03559348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
591256|NCT03559348|Immunologic Factors|immunologic factors|mesh-ancestor
591257|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591258|NCT03559348|Antidotes|antidotes|mesh-ancestor
591259|NCT03559348|Protective Agents|protective agents|mesh-ancestor
591260|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
591261|NCT03559348|Vitamins|vitamins|mesh-ancestor
591262|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
2215458|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2215459|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2215460|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2215461|NCT00026416|Growth Substances|growth substances|mesh-ancestor
2215462|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215463|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
2215464|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591270|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
591271|NCT03559114|Dalteparin|dalteparin|mesh-list
591272|NCT03559114|Tinzaparin|tinzaparin|mesh-list
591273|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
591274|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
591275|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
591276|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
591277|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215465|NCT00026442|Capecitabine|capecitabine|mesh-list
2215466|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2215467|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
2215468|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591282|NCT03559049|Carboplatin|carboplatin|mesh-list
591283|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
591284|NCT03559049|Pemetrexed|pemetrexed|mesh-list
591285|NCT03559049|Rucaparib|rucaparib|mesh-list
591286|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591287|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
591288|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591289|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591290|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
591291|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
591292|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
591293|NCT03559010|Norgestrel|norgestrel|mesh-list
591294|NCT03559010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
591295|NCT03559010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
591296|NCT03559010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
591297|NCT03559010|Contraceptive Agents|contraceptive agents|mesh-ancestor
591298|NCT03559010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
591299|NCT03559010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591300|NCT03559010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
591301|NCT03559010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2215469|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215470|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
2215471|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591305|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
591306|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
591307|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
591308|NCT03558919|Mirabegron|mirabegron|mesh-list
591309|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
591310|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
591311|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
591312|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
591313|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591314|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591315|NCT03558919|Urological Agents|urological agents|mesh-ancestor
591316|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
591317|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
591318|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
591319|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
591320|NCT03558880|Anesthetics|anesthetics|mesh-list
591321|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
591322|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591323|NCT03558867|Metformin|metformin|mesh-list
591324|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
591325|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077154|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
2077155|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077156|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077157|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2750861|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750862|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750863|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
2750864|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2750865|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750866|NCT04156334|Anesthetics|anesthetics|mesh-list
2750867|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2750868|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591344|NCT03558750|Rituximab|rituximab|mesh-list
591345|NCT03558750|Nivolumab|nivolumab|mesh-list
591346|NCT03558750|Lenalidomide|lenalidomide|mesh-list
591347|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
591348|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591349|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
591350|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591351|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
591352|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
591353|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591354|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
591355|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
591356|NCT03558750|Growth Substances|growth substances|mesh-ancestor
591357|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
591358|NCT03558724|Bevacizumab|bevacizumab|mesh-list
591359|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
591360|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591361|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
591362|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
591363|NCT03558724|Growth Substances|growth substances|mesh-ancestor
591364|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591365|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215472|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2215473|NCT00026468|Protective Agents|protective agents|mesh-ancestor
2215474|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215475|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2215476|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215477|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591373|NCT03558477|Esomeprazole|esomeprazole|mesh-list
591374|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
591375|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
591376|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
591377|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591378|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591379|NCT03558412|Decitabine|decitabine|mesh-list
591380|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
591381|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
591382|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591383|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591384|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591385|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
591386|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
591387|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591388|NCT03558295|Anticoagulants|anticoagulants|mesh-list
591389|NCT03558243|Hemostatics|hemostatics|mesh-list
591390|NCT03558243|Coagulants|coagulants|mesh-ancestor
2750875|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
591393|NCT03558139|Avelumab|avelumab|mesh-list
591394|NCT03558139|Magrolimab|magrolimab|mesh-list
591395|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
591396|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750876|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2750877|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750878|NCT04147546|Artenimol|artenimol|mesh-list
2750879|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
2750880|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2750881|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2750882|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215478|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2215479|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
591411|NCT03557996|Listerine|listerine|mesh-list
591412|NCT03557996|Fluorides|fluorides|mesh-list
591413|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
591414|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
591415|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
591416|NCT03557996|Protective Agents|protective agents|mesh-ancestor
591417|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591418|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
591419|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
591420|NCT03557983|Fenofibrate|fenofibrate|mesh-list
591421|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
591422|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
591423|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591424|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2215480|NCT00026468|Analgesics|analgesics|mesh-ancestor
2215481|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
2215482|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2215483|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2215484|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215485|NCT00026520|Interferons|interferons|mesh-list
2215486|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
2215487|NCT00026520|Thalidomide|thalidomide|mesh-list
2215488|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215489|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
2215490|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215491|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
2215492|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215493|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215494|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
2215495|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2215496|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2215497|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2215498|NCT00026520|Growth Substances|growth substances|mesh-ancestor
2215499|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215500|NCT00026533|Thalidomide|thalidomide|mesh-list
2215501|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215502|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
2215503|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215504|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
2215505|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2215506|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215507|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2215508|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2215509|NCT00026533|Growth Substances|growth substances|mesh-ancestor
2215510|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215511|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215512|NCT00026585|Tamoxifen|tamoxifen|mesh-list
2215513|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2215514|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
591461|NCT03557918|Tremelimumab|tremelimumab|mesh-list
591462|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591463|NCT03557853|Golimumab|golimumab|mesh-list
591464|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
591465|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
591466|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
591467|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
591468|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591469|NCT03557840|Temocillin|temocillin|mesh-list
591470|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
591471|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
591472|NCT03557788|Rifaximin|rifaximin|mesh-list
591473|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
591474|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
591475|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2215515|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2215516|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077184|NCT02024607|Leucovorin|leucovorin|mesh-list
2077185|NCT02024607|Bevacizumab|bevacizumab|mesh-list
2077186|NCT02024607|Fluorouracil|fluorouracil|mesh-list
2077187|NCT02024607|Capecitabine|capecitabine|mesh-list
2077188|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
2077189|NCT02024607|Irinotecan|irinotecan|mesh-list
2077190|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2077191|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077192|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2077193|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2077194|NCT02024607|Growth Substances|growth substances|mesh-ancestor
2077195|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077196|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
2077197|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
2077198|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077199|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2077200|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2077201|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
591497|NCT03557580|Isosorbide|isosorbide|mesh-list
591498|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
591499|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
591500|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
591501|NCT03557580|Diuretics|diuretics|mesh-ancestor
591502|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
591503|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591504|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
591505|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
591506|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591507|NCT03557437|Amoxicillin|amoxicillin|mesh-list
591508|NCT03557437|Metronidazole|metronidazole|mesh-list
591509|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
591510|NCT03557437|Esomeprazole|esomeprazole|mesh-list
591511|NCT03557437|Bismuth|bismuth|mesh-list
591512|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591513|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
591514|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
591515|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
591516|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
591517|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
591518|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
591519|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
591520|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591521|NCT03557437|Antacids|antacids|mesh-ancestor
591522|NCT03557437|Diuretics|diuretics|mesh-ancestor
591523|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
591524|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591525|NCT03557437|Expectorants|expectorants|mesh-ancestor
591526|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
591527|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
591528|NCT03557424|Cathartics|cathartics|mesh-ancestor
591529|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2077202|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2077203|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2077204|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077205|NCT02024607|Antidotes|antidotes|mesh-ancestor
2077206|NCT02024607|Protective Agents|protective agents|mesh-ancestor
2077207|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
2077208|NCT02024607|Vitamins|vitamins|mesh-ancestor
2077209|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
2077210|NCT02024646|Brodalumab|brodalumab|mesh-list
2077211|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2077212|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
2077213|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
2077214|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077215|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
2077216|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2077217|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
2077218|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077219|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
2077220|NCT02024711|Protective Agents|protective agents|mesh-ancestor
2215517|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2215518|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215519|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2215520|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2215521|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2215522|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2215523|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2215524|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
2215525|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215526|NCT00026637|Sertraline|sertraline|mesh-list
2077221|NCT02024724|Dexamethasone|dexamethasone|mesh-list
2077222|NCT02024724|Triamcinolone|triamcinolone|mesh-list
2077223|NCT02024724|Bupivacaine|bupivacaine|mesh-list
2077224|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2077225|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
2077226|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
2077227|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077228|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077229|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2077230|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
591571|NCT03557255|Simendan|simendan|mesh-list
591572|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
591573|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
591574|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
591575|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
591576|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591577|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591578|NCT03557255|Protective Agents|protective agents|mesh-ancestor
591579|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591598|NCT03557229|Vitamins|vitamins|mesh-list
591599|NCT03557229|Ascorbic Acid|ascorbic acid|mesh-list
591600|NCT03557229|Vitamin E|vitamin e|mesh-list
591601|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
591602|NCT03557229|Melatonin|melatonin|mesh-list
591603|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
591604|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
591605|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591606|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
591607|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591608|NCT03557229|Protective Agents|protective agents|mesh-ancestor
591609|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
591610|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
591611|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
591612|NCT03557229|Expectorants|expectorants|mesh-ancestor
2077231|NCT02024724|Hormones|hormones|mesh-ancestor
2077232|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
591613|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
591614|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
591615|NCT03557229|Antidotes|antidotes|mesh-ancestor
591616|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
591617|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591618|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
591629|NCT03556917|Caffeine|caffeine|mesh-list
591630|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
591631|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591632|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
591633|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591634|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591635|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
591636|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
591637|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
591638|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2077233|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2077234|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077235|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
2077236|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
2077237|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2077238|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
2077239|NCT02024867|Trimethoprim|trimethoprim|mesh-list
2077240|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2077241|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
591648|NCT03556852|Misoprostol|misoprostol|mesh-list
591649|NCT03556852|Carbetocin|carbetocin|mesh-list
591650|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
591651|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
591652|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
591653|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591654|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
591655|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
591656|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
591657|NCT03556839|Paclitaxel|paclitaxel|mesh-list
591658|NCT03556839|Bevacizumab|bevacizumab|mesh-list
591659|NCT03556839|Carboplatin|carboplatin|mesh-list
591660|NCT03556839|Atezolizumab|atezolizumab|mesh-list
591661|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
591662|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591663|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
591664|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
591665|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
591666|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591667|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
591668|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
591669|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
591670|NCT03556839|Growth Substances|growth substances|mesh-ancestor
591671|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591672|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
591673|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
591674|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
591675|NCT03556800|Estradiol|estradiol|mesh-list
591676|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
591677|NCT03556800|Estrogens|estrogens|mesh-ancestor
591678|NCT03556800|Hormones|hormones|mesh-ancestor
591679|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
591680|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591681|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
591682|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
591683|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
591684|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2215527|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
2215528|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2215529|NCT00026637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2215530|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2215531|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2215532|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591705|NCT03556592|Metoprolol|metoprolol|mesh-list
591706|NCT03556592|Midazolam|midazolam|mesh-list
591707|NCT03556592|Caffeine|caffeine|mesh-list
591708|NCT03556592|Omeprazole|omeprazole|mesh-list
591709|NCT03556592|Warfarin|warfarin|mesh-list
591710|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
591711|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
591712|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
591713|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591714|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
591715|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
591716|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
591717|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
591718|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
591719|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
591720|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
591721|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
591722|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
591723|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591724|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
591725|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
591726|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
591727|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
591728|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591729|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
591730|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
591731|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
591732|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
591733|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
591734|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
591735|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
591736|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
591737|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
591738|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
591739|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
591740|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
591741|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
591742|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
591743|NCT03556384|Temozolomide|temozolomide|mesh-list
591744|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
591745|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
591746|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591747|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591748|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
591749|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
591750|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
591751|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
591752|NCT03556371|Expectorants|expectorants|mesh-ancestor
591753|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
591754|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
591755|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
591756|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591757|NCT03556371|Protective Agents|protective agents|mesh-ancestor
591758|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591759|NCT03556371|Antidotes|antidotes|mesh-ancestor
2077242|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2077243|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077244|NCT02024867|Renal Agents|renal agents|mesh-ancestor
2077245|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
2077246|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2077247|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2077248|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2077249|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077250|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077251|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2077252|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2077253|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2077254|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2077255|NCT02024971|Metformin|metformin|mesh-list
2077256|NCT02024971|Pioglitazone|pioglitazone|mesh-list
2077257|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2077258|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077259|NCT02025075|Rocuronium|rocuronium|mesh-list
2077260|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2077261|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2077262|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2077263|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077264|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077265|NCT02025179|Teriparatide|teriparatide|mesh-list
2077266|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2077267|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077268|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2077269|NCT02025426|Phenylephrine|phenylephrine|mesh-list
2077270|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
591815|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
591816|NCT03556098|Hormones|hormones|mesh-list
591817|NCT03556098|Incretins|incretins|mesh-list
591818|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591819|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
591820|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
591821|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
591822|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
591823|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591824|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
591825|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591828|NCT03555994|Liraglutide|liraglutide|mesh-list
591829|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
591830|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591831|NCT03555994|Incretins|incretins|mesh-ancestor
591832|NCT03555994|Hormones|hormones|mesh-ancestor
591833|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
591834|NCT03555968|Dronabinol|dronabinol|mesh-list
591835|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
591836|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591837|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
591838|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
591839|NCT03555968|Analgesics|analgesics|mesh-ancestor
591840|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
591841|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
591842|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
591843|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
591844|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
591845|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591846|NCT03555968|Hormones|hormones|mesh-ancestor
591847|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
591848|NCT03555929|Dexamethasone|dexamethasone|mesh-list
591849|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
591850|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
591851|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
591852|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
591853|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591854|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
591855|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
591856|NCT03555929|Hormones|hormones|mesh-ancestor
591857|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
591858|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
591859|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591860|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
591861|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
591862|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
591863|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591864|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
591865|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
591866|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591867|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
591868|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2215533|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2215534|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
2215535|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215536|NCT00026819|Rofecoxib|rofecoxib|mesh-list
2215537|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2215538|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2215539|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215540|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215541|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
591879|NCT03555877|Letrozole|letrozole|mesh-list
591880|NCT03555877|Fulvestrant|fulvestrant|mesh-list
591881|NCT03555877|Anastrozole|anastrozole|mesh-list
591882|NCT03555877|Exemestane|exemestane|mesh-list
591883|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591884|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
591885|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
591886|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591887|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591888|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
591889|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
591890|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
591891|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591892|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
591893|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2077271|NCT02025426|Ephedrine|ephedrine|mesh-list
2077272|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2077273|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
2077274|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
2077275|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077276|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077277|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
2077278|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2077279|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
2077280|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
591904|NCT03555617|Itraconazole|itraconazole|mesh-list
591905|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
591906|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
591907|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
591908|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
591909|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591910|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591911|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
591912|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
2077281|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
591913|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
591914|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591915|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2215542|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2215543|NCT00026819|Analgesics|analgesics|mesh-ancestor
2215544|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
2215545|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2215546|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215547|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2215548|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215549|NCT00026962|Estradiol|estradiol|mesh-list
2215550|NCT00026962|Progesterone|progesterone|mesh-list
2215551|NCT00026962|Estrogens|estrogens|mesh-ancestor
2215552|NCT00026962|Hormones|hormones|mesh-ancestor
591934|NCT03555526|Amoxicillin|amoxicillin|mesh-list
591935|NCT03555526|Metronidazole|metronidazole|mesh-list
591936|NCT03555526|Clarithromycin|clarithromycin|mesh-list
591937|NCT03555526|Levofloxacin|levofloxacin|mesh-list
591938|NCT03555526|Ofloxacin|ofloxacin|mesh-list
591939|NCT03555526|Tetracycline|tetracycline|mesh-list
591940|NCT03555526|Esomeprazole|esomeprazole|mesh-list
591941|NCT03555526|Bismuth|bismuth|mesh-list
591942|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
591943|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
591944|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
591945|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
591946|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
591947|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
591948|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
591949|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
591950|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591951|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
591952|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
591953|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
591954|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
591955|NCT03555526|Renal Agents|renal agents|mesh-ancestor
591956|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
591957|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
591958|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
591959|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
591960|NCT03555526|Antacids|antacids|mesh-ancestor
591961|NCT03555487|Choline|choline|mesh-list
591962|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
591963|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
591964|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
591965|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591966|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
591967|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
591968|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
591969|NCT03555383|Hemostatics|hemostatics|mesh-list
591970|NCT03555383|Coagulants|coagulants|mesh-ancestor
2215553|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2215554|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215555|NCT00026962|Progestins|progestins|mesh-ancestor
2215556|NCT00027014|Fentanyl|fentanyl|mesh-list
2215557|NCT00027014|Oxycodone|oxycodone|mesh-list
591976|NCT03555188|Ondansetron|ondansetron|mesh-list
591977|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
591978|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
591979|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
591980|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
591981|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
591982|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
591983|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
591984|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
591985|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
591986|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
591987|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
591988|NCT03555188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
591989|NCT03555188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2215558|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
591990|NCT03555188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
591991|NCT03555188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
591992|NCT03555188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2077282|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2077283|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2077284|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
2077285|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2077286|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077287|NCT02025426|Protective Agents|protective agents|mesh-ancestor
2077288|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2077289|NCT02025439|Amantadine|amantadine|mesh-list
2077290|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
592002|NCT03555136|Vortioxetine|vortioxetine|mesh-list
592003|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
592004|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
592005|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
592006|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
592007|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
592008|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592009|NCT03555136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
592010|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
592011|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
592012|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592013|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592014|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
592015|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
592016|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
592017|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
592018|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
592019|NCT03555071|Vaccines|vaccines|mesh-list
592020|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
592021|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592022|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
592023|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
592024|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592025|NCT03554980|Listerine|listerine|mesh-list
592026|NCT03554980|Fluorides|fluorides|mesh-list
592027|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
592028|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
592029|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
592030|NCT03554980|Protective Agents|protective agents|mesh-ancestor
592031|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592032|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
592033|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
592034|NCT03554915|Midazolam|midazolam|mesh-list
592035|NCT03554915|Ketamine|ketamine|mesh-list
592036|NCT03554915|Analgesics|analgesics|mesh-ancestor
592037|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
592038|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592039|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592040|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
592041|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
592042|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
592043|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
592044|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
592045|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
592046|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
592047|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592048|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592049|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
592050|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
592051|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
592052|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
592053|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
592054|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
592055|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
592056|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
592057|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
592058|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215559|NCT00027014|Narcotics|narcotics|mesh-ancestor
2215560|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2215561|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215562|NCT00027014|Analgesics|analgesics|mesh-ancestor
2215563|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
2215564|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2215565|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2215566|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2215567|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
2215568|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
2215569|NCT00027040|Selegiline|selegiline|mesh-list
2215570|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
2215571|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2215572|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
592073|NCT03554707|Bevacizumab|bevacizumab|mesh-list
592074|NCT03554707|Irinotecan|irinotecan|mesh-list
592075|NCT03554707|Temozolomide|temozolomide|mesh-list
592076|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
592077|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592078|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
592079|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
592080|NCT03554707|Growth Substances|growth substances|mesh-ancestor
592081|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592082|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
592083|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
592084|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
592085|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592086|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592087|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
592088|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
592089|NCT03554590|Insulin|insulin|mesh-list
592090|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
592091|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215573|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2215574|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2215575|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215576|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215577|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2215578|NCT00027040|Protective Agents|protective agents|mesh-ancestor
2215579|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077291|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2077292|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
2077293|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077294|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
2077295|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2077296|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077297|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077298|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2077299|NCT02025439|Analgesics|analgesics|mesh-ancestor
592108|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
592109|NCT03554447|Dexetimide|dexetimide|mesh-list
592110|NCT03554447|Citalopram|citalopram|mesh-list
592111|NCT03554447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
592112|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
592113|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
592114|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592115|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592116|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
592117|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592118|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
592119|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
592120|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
592121|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
592122|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
592123|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
592124|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
592125|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592126|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
592127|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
592128|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
592129|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
592130|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592131|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
592132|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
592133|NCT03554447|Protective Agents|protective agents|mesh-ancestor
592134|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
592135|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
592136|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
592137|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
592138|NCT03554408|Antibodies|antibodies|mesh-list
592139|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
2215580|NCT00027053|Trazodone|trazodone|mesh-list
592140|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
592141|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
592142|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592143|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592144|NCT03554395|Antibodies|antibodies|mesh-list
592145|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
592146|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
592147|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077300|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
2077301|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077302|NCT02025621|Simendan|simendan|mesh-list
2077303|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2077304|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
2077305|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2077306|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2077307|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077308|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077309|NCT02025621|Protective Agents|protective agents|mesh-ancestor
2077310|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077311|NCT02025634|Acetaminophen|acetaminophen|mesh-list
2077312|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2077313|NCT02025634|Analgesics|analgesics|mesh-ancestor
2077314|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
2077315|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592164|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
592165|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
592166|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
592167|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
592168|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
592169|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
592170|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592171|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592172|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592173|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
592174|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
592175|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
592176|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592177|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
592178|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
592179|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
592180|NCT03554291|Famotidine|famotidine|mesh-list
592181|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
592182|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
592183|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
592184|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
592185|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
592186|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592187|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592188|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592189|NCT03554200|Empagliflozin|empagliflozin|mesh-list
592190|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
592191|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592192|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
592193|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077316|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077317|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
2077318|NCT02025725|Metoclopramide|metoclopramide|mesh-list
2077319|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
592198|NCT03554109|Leucovorin|leucovorin|mesh-list
592199|NCT03554109|Paclitaxel|paclitaxel|mesh-list
592200|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
592201|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
592202|NCT03554109|Doxorubicin|doxorubicin|mesh-list
592203|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
592204|NCT03554109|Fluorouracil|fluorouracil|mesh-list
592205|NCT03554109|Avelumab|avelumab|mesh-list
592206|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
592207|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592208|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
592209|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
592210|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
592211|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592212|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
592213|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
592214|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592215|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
592216|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
592217|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
592218|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
592219|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
592220|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
592221|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
592222|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592223|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
592224|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
592225|NCT03554109|Antidotes|antidotes|mesh-ancestor
592226|NCT03554109|Protective Agents|protective agents|mesh-ancestor
592227|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
592228|NCT03554109|Vitamins|vitamins|mesh-ancestor
592229|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
592230|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
592231|NCT03554083|Atezolizumab|atezolizumab|mesh-list
592232|NCT03554083|Vemurafenib|vemurafenib|mesh-list
592233|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
592234|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592235|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
592236|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592237|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
592238|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592239|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592275|NCT03554031|Hormones|hormones|mesh-list
592276|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
592277|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215581|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2215582|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2215583|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2215584|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215585|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2215586|NCT00027053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2215587|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2215588|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2215589|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215590|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2215591|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
2215592|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2215593|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
2215594|NCT00027066|Aspirin|aspirin|mesh-list
2215595|NCT00027066|Warfarin|warfarin|mesh-list
2215596|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2215597|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2215598|NCT00027066|Analgesics|analgesics|mesh-ancestor
2215599|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
2215600|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2215601|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215602|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2215603|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215604|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2215605|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2215606|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215607|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2077320|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
2077321|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077322|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592310|NCT03553875|Memantine|memantine|mesh-list
592311|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
592312|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
592313|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
592314|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592315|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592316|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592317|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
592318|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
592319|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
592320|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
592321|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592322|NCT03553810|Valsartan|valsartan|mesh-list
592323|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
592324|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
592325|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
592326|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
592327|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215608|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2215609|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215610|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
2215611|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
2215612|NCT00027079|Naltrexone|naltrexone|mesh-list
2215613|NCT00027079|Ondansetron|ondansetron|mesh-list
2215614|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2215615|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2215616|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215617|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
2215618|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2215619|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
2215620|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
2215621|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
592342|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
592343|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
592344|NCT03553628|Propolis|propolis|mesh-list
592345|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
592346|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
592347|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
592348|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
592349|NCT03553615|Ivermectin|ivermectin|mesh-list
592350|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
592351|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077323|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2077324|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2077325|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2077326|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
2077327|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2215622|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
592358|NCT03553537|Prednisone|prednisone|mesh-list
592359|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
592360|NCT03553537|Doxorubicin|doxorubicin|mesh-list
592361|NCT03553537|Vincristine|vincristine|mesh-list
592362|NCT03553537|Decitabine|decitabine|mesh-list
592363|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
592364|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
592365|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592366|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215623|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
592367|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
592368|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
592369|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592370|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592371|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
592372|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
592373|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
592374|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
592375|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592376|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
592377|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
592378|NCT03553537|Hormones|hormones|mesh-ancestor
592379|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
592380|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
592381|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
592382|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
592383|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
592384|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
592385|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
592386|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
592387|NCT03553498|Acetaminophen|acetaminophen|mesh-list
592388|NCT03553498|Hydromorphone|hydromorphone|mesh-list
592389|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
592390|NCT03553498|Analgesics|analgesics|mesh-ancestor
592391|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
592392|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592393|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592394|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
592395|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
592396|NCT03553498|Narcotics|narcotics|mesh-ancestor
592397|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
592398|NCT03553446|Sevoflurane|sevoflurane|mesh-list
592399|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
592400|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
592401|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
592402|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
592403|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
592404|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592405|NCT03553433|Apremilast|apremilast|mesh-list
592406|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
592407|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
592408|NCT03553433|Analgesics|analgesics|mesh-ancestor
592409|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
592410|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592411|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592412|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
592413|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
592414|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
592415|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
592416|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592417|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592418|NCT03553329|Trametinib|trametinib|mesh-list
592419|NCT03553329|Dabrafenib|dabrafenib|mesh-list
592420|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592421|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
592422|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592423|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592424|NCT03553303|Valsartan|valsartan|mesh-list
592425|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
592426|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
592427|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
592428|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592429|NCT03553238|Cytarabine|cytarabine|mesh-list
592430|NCT03553238|Dexamethasone|dexamethasone|mesh-list
592431|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
592432|NCT03553238|Methotrexate|methotrexate|mesh-list
592433|NCT03553238|Etoposide|etoposide|mesh-list
592434|NCT03553238|Vincristine|vincristine|mesh-list
592435|NCT03553238|Doxorubicin|doxorubicin|mesh-list
592436|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
592437|NCT03553238|Idarubicin|idarubicin|mesh-list
592438|NCT03553238|Pegaspargase|pegaspargase|mesh-list
592439|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
592440|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
592441|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592442|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
592443|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
592444|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
592445|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592446|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592447|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
592448|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
592449|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
592450|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
592451|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592452|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
592453|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
592454|NCT03553238|Hormones|hormones|mesh-ancestor
592455|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
592456|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
592457|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
592458|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
592459|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
592460|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
592461|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
592462|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
592463|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592464|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
592465|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
592466|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
592467|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
592468|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
592469|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
592470|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
592471|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
592472|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
592473|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
592474|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
592475|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
592476|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
592477|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
592478|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592479|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
592480|NCT03553186|Coagulants|coagulants|mesh-ancestor
592481|NCT03553173|Bupropion|bupropion|mesh-list
592482|NCT03553173|Varenicline|varenicline|mesh-list
592483|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
592484|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
592485|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
592486|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
592487|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
592488|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
592489|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592490|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
592491|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592492|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592493|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
592494|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
592495|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592496|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
592497|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
592498|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
592499|NCT03553108|Olaparib|olaparib|mesh-list
592500|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
592501|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592502|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592503|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592504|NCT03553082|Propofol|propofol|mesh-list
592505|NCT03553082|Sevoflurane|sevoflurane|mesh-list
592506|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
592507|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
592508|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592509|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
592510|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
592511|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
592512|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
592513|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
592514|NCT03553004|Niraparib|niraparib|mesh-list
592515|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
592516|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592517|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592518|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592519|NCT03552770|Bevacizumab|bevacizumab|mesh-list
592520|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
592521|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592522|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
592523|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
592524|NCT03552770|Growth Substances|growth substances|mesh-ancestor
592525|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592526|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
592527|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
592528|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
592529|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
592530|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592531|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
592532|NCT03552705|Coagulants|coagulants|mesh-ancestor
2077328|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077329|NCT02025751|Metoclopramide|metoclopramide|mesh-list
592535|NCT03552666|Vitamin D|vitamin d|mesh-list
592536|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
592537|NCT03552666|Vitamins|vitamins|mesh-ancestor
592538|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
592539|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592540|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
592541|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
592542|NCT03552653|Vitamin D|vitamin d|mesh-list
592543|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
592544|NCT03552653|Vitamins|vitamins|mesh-list
592545|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
592546|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592547|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
592548|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
592549|NCT03552601|Methamphetamine|methamphetamine|mesh-list
592550|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
592551|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592552|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
592553|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
592554|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592555|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
592556|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592557|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592558|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
592559|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
592560|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
592561|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
592562|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
592563|NCT03552575|Valsartan|valsartan|mesh-list
592564|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
592565|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
592566|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
592567|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215624|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2215625|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
2215626|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2215627|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215628|NCT00027079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2215629|NCT00027079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2215630|NCT00027079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2215631|NCT00027079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2215632|NCT00027079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
592579|NCT03552471|Rucaparib|rucaparib|mesh-list
592580|NCT03552471|Maytansine|maytansine|mesh-list
592581|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
592582|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592583|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592584|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592585|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
592586|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
592587|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
592588|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
592589|NCT03552406|Cetuximab|cetuximab|mesh-list
592590|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
592591|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592601|NCT03552354|Argatroban|argatroban|mesh-list
592602|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
592603|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
592604|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
592605|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592606|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592607|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
592608|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
592609|NCT03552315|Chromium|chromium|mesh-list
592610|NCT03552315|Trace Elements|trace elements|mesh-ancestor
592611|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
592612|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592613|NCT03552211|Biotin|biotin|mesh-list
592614|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
592615|NCT03552211|Vitamins|vitamins|mesh-ancestor
592616|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
592617|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592618|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
592619|NCT03552146|Propofol|propofol|mesh-list
592620|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
592621|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
592622|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592623|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
592624|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
592625|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
592626|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
592627|NCT03552146|Analgesics|analgesics|mesh-ancestor
592628|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
592629|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592630|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
592631|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
592632|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
592633|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
592634|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592635|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592650|NCT03552016|Riboflavin|riboflavin|mesh-list
592651|NCT03552016|Vitamins|vitamins|mesh-ancestor
592652|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
592653|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592654|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
592655|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
592656|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
592657|NCT03551964|Ticagrelor|ticagrelor|mesh-list
592658|NCT03551964|Cangrelor|cangrelor|mesh-list
592659|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
592660|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
592661|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
592662|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
592663|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
592664|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592665|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592666|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592667|NCT03551873|Plecanatide|plecanatide|mesh-list
592668|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
592669|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
592670|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592671|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
592672|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
592673|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
592674|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
592675|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
592676|NCT03551808|Ketorolac|ketorolac|mesh-list
592677|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
592678|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
592679|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
592680|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
592681|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
592682|NCT03551808|Analgesics|analgesics|mesh-ancestor
592683|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
592684|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592685|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592686|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
592687|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
592688|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
592689|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592690|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215633|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
2215634|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215635|NCT00027287|Vitamin E|vitamin e|mesh-list
2215636|NCT00027287|Vitamins|vitamins|mesh-ancestor
2215637|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
2215638|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215639|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
2215640|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215641|NCT00027287|Protective Agents|protective agents|mesh-ancestor
2215642|NCT00027300|Natalizumab|natalizumab|mesh-list
2215643|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
2215644|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215645|NCT00027339|Ritonavir|ritonavir|mesh-list
2215646|NCT00027339|Lopinavir|lopinavir|mesh-list
592705|NCT03551691|Omeprazole|omeprazole|mesh-list
592706|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
592707|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
592708|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
592709|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592710|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592711|NCT03551652|Rocuronium|rocuronium|mesh-list
592712|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
592713|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
592714|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
592715|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592716|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077330|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
2077331|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
2077332|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077333|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077334|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2077335|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
592723|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
592724|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
592725|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
592726|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
592727|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
592728|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
592729|NCT03551548|Spironolactone|spironolactone|mesh-list
592730|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
592731|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
592732|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
592733|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592734|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
592735|NCT03551548|Diuretics|diuretics|mesh-ancestor
592736|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
592742|NCT03551210|Levofloxacin|levofloxacin|mesh-list
592743|NCT03551210|Ofloxacin|ofloxacin|mesh-list
2215647|NCT00027339|Indinavir|indinavir|mesh-list
592744|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
592745|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
592746|NCT03551210|Renal Agents|renal agents|mesh-ancestor
592747|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
592748|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
592749|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
592750|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592751|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592752|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592753|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
592754|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
592755|NCT03551197|Budesonide|budesonide|mesh-list
592756|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
592757|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
592758|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
592759|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
592760|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592761|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592762|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
592763|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
592764|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
592765|NCT03551197|Hormones|hormones|mesh-ancestor
592766|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
592767|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
592768|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
592769|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
592770|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
592771|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592772|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592773|NCT03551171|Niraparib|niraparib|mesh-list
592774|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
592775|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592776|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592777|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592778|NCT03551067|Midazolam|midazolam|mesh-list
592779|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
592780|NCT03551067|Ketamine|ketamine|mesh-list
592781|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
592782|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
592783|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592784|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
592785|NCT03551067|Analgesics|analgesics|mesh-ancestor
592786|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
592787|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592788|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
592789|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
592790|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
592791|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
592792|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592793|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592794|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
592795|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
592796|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
592797|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
592798|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
592799|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
592800|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
592801|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
592802|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
592803|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
592804|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
592805|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
592806|NCT03550859|Telmisartan|telmisartan|mesh-list
592807|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
592808|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
592809|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
592810|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
592811|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592812|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
592813|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
592814|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592815|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
592816|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
592817|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
592818|NCT03550794|Thiamine|thiamine|mesh-list
592819|NCT03550794|Vitamins|vitamins|mesh-ancestor
592820|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
592821|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592822|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
592823|NCT03550781|Prednisone|prednisone|mesh-list
592824|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
592825|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
592826|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
592827|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592828|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
592829|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
592830|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
592831|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592832|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592833|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
592834|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
592835|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
592836|NCT03550781|Hormones|hormones|mesh-ancestor
592837|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
592838|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
592839|NCT03550677|Anesthetics|anesthetics|mesh-list
592840|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
592841|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592842|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
592843|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
592844|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
592845|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
592846|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
592847|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
592848|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
592849|NCT03550534|Calcium|calcium|mesh-list
592850|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
592851|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592852|NCT03550534|Antacids|antacids|mesh-ancestor
592853|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592854|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
592855|NCT03550508|Antibodies|antibodies|mesh-list
592856|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
592857|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
592858|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077336|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2077337|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
2077338|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2077339|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077340|NCT02025907|Canagliflozin|canagliflozin|mesh-list
2077341|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2077342|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077343|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2077344|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077345|NCT02026011|Naltrexone|naltrexone|mesh-list
2077346|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2077347|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
592871|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
592872|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
592873|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
592874|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
592875|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
592876|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592877|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
592878|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592879|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592880|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
592881|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592882|NCT03549923|Esmolol|esmolol|mesh-list
592883|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
592884|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
592885|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
592886|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
592887|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592888|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592889|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592890|NCT03549897|Albuterol|albuterol|mesh-list
592891|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
592892|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
592893|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592894|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592895|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
592896|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
592897|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
592898|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
592899|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
592900|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
592901|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
592902|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
592903|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592904|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592905|NCT03549832|Ritonavir|ritonavir|mesh-list
592906|NCT03549832|Ribavirin|ribavirin|mesh-list
592907|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
592908|NCT03549832|Simeprevir|simeprevir|mesh-list
592909|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
592910|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
592911|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
592912|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592913|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592914|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
592915|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
592916|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
592917|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
592918|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
592919|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
592920|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
592921|NCT03549819|Cannabidiol|cannabidiol|mesh-list
592922|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
592923|NCT03549741|Cabergoline|cabergoline|mesh-list
592924|NCT03549741|Clomiphene|clomiphene|mesh-list
592925|NCT03549741|Enclomiphene|enclomiphene|mesh-list
592926|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
592927|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592928|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
592929|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
592930|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
592931|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592932|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
592933|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
592934|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
592935|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
592936|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
592937|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
592938|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
592939|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
592940|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
592941|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
592942|NCT03549728|Lenograstim|lenograstim|mesh-list
592943|NCT03549728|Sargramostim|sargramostim|mesh-list
592944|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
592945|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
592946|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077348|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077349|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
2077350|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077351|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
592951|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
592952|NCT03549702|Povidone|povidone|mesh-list
592953|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
592954|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
592955|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
592956|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
592957|NCT03549689|Tenofovir|tenofovir|mesh-list
592958|NCT03549689|Lamivudine|lamivudine|mesh-list
592959|NCT03549689|Dolutegravir|dolutegravir|mesh-list
592960|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
592961|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
592962|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
592963|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
592964|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592965|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592966|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
592967|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
592968|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
592969|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
592970|NCT03549663|Prednisone|prednisone|mesh-list
592971|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
592972|NCT03549663|Tacrolimus|tacrolimus|mesh-list
592973|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
592974|NCT03549663|Hormones|hormones|mesh-ancestor
592975|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
592976|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592977|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
592978|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
592979|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
592980|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
592981|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
592982|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
592983|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
592984|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
592985|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
592986|NCT03549611|Acetaminophen|acetaminophen|mesh-list
592987|NCT03549611|Celecoxib|celecoxib|mesh-list
592988|NCT03549611|Oxycodone|oxycodone|mesh-list
592989|NCT03549611|Gabapentin|gabapentin|mesh-list
592990|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
592991|NCT03549611|Analgesics|analgesics|mesh-ancestor
592992|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
592993|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
592994|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
592995|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
592996|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
592997|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
592998|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
592999|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
593000|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
593001|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593002|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593003|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
593004|NCT03549611|Narcotics|narcotics|mesh-ancestor
593005|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
593006|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
593007|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
593008|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
593009|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
593010|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
593011|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
593012|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593013|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
2215648|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
2215649|NCT00027339|Tenofovir|tenofovir|mesh-list
2215650|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
593017|NCT03549312|Tenofovir|tenofovir|mesh-list
593018|NCT03549312|Emtricitabine|emtricitabine|mesh-list
593019|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
593020|NCT03549312|Cobicistat|cobicistat|mesh-list
593021|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
593022|NCT03549312|Velpatasvir|velpatasvir|mesh-list
593023|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
593024|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
593025|NCT03549312|Elvitegravir|elvitegravir|mesh-list
593026|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
593027|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
593028|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
593029|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
593030|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593031|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593032|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
593033|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
593034|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
593035|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
593036|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
593037|NCT03549221|Ketorolac|ketorolac|mesh-list
593038|NCT03549221|Epinephrine|epinephrine|mesh-list
593039|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
593040|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
593041|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
593042|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
593191|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
593043|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593044|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593045|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593046|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
593047|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
593048|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
593049|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593050|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
593051|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
593052|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
593053|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
593054|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
593055|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
593056|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
593057|NCT03549221|Analgesics|analgesics|mesh-ancestor
593058|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
593059|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
593060|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
593061|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
593062|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593063|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
593064|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
593065|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
593066|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
593067|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
593068|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593069|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
593070|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
593071|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
593072|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
593073|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593074|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593075|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593076|NCT03549026|Analgesics|analgesics|mesh-ancestor
593077|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
593078|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593079|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
593080|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
593081|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
2077352|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2077353|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2077354|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077355|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
593086|NCT03548948|Iron|iron|mesh-list
593087|NCT03548948|Trace Elements|trace elements|mesh-ancestor
593088|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
593089|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593090|NCT03548818|Interferons|interferons|mesh-list
593091|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
593092|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593093|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
593094|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
593095|NCT03548805|Mitomycins|mitomycins|mesh-list
593096|NCT03548805|Mitomycin|mitomycin|mesh-list
593097|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
593098|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593099|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
593100|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593101|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
593102|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593103|NCT03548714|Ethanol|ethanol|mesh-list
593104|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
593105|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
593106|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
593107|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593108|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
593109|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
593110|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
593111|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593112|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
593113|NCT03548662|Protective Agents|protective agents|mesh-ancestor
593565|NCT03545516|Bupivacaine|bupivacaine|mesh-list
593121|NCT03548571|Temozolomide|temozolomide|mesh-list
593122|NCT03548571|Vaccines|vaccines|mesh-list
593123|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
593124|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
593125|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593126|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593127|NCT03548571|Immunologic Factors|immunologic factors|mesh-ancestor
593128|NCT03548571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593129|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
593130|NCT03548493|Fentanyl|fentanyl|mesh-list
593131|NCT03548493|Propofol|propofol|mesh-list
593132|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
593133|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
593134|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593135|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
593136|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
593137|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
593138|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
593139|NCT03548493|Narcotics|narcotics|mesh-ancestor
593140|NCT03548493|Analgesics|analgesics|mesh-ancestor
593141|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
593142|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593143|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
593144|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
593145|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
593146|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
593147|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
593148|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593149|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
593150|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
593151|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
593152|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
593153|NCT03548454|Desipramine|desipramine|mesh-list
593154|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
593155|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
593156|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
593157|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593158|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593159|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593160|NCT03548454|Analgesics|analgesics|mesh-ancestor
593161|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
593162|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593163|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
593164|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
593165|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
593166|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
593167|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593168|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
593169|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
593172|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
593173|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
593174|NCT03548311|Vitamins|vitamins|mesh-ancestor
593175|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
593176|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750892|NCT04139304|Prednisone|prednisone|mesh-list
2750893|NCT04139304|Cortisone|cortisone|mesh-list
2750894|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
2750895|NCT04139304|Doxorubicin|doxorubicin|mesh-list
2750896|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2750897|NCT04139304|Etoposide|etoposide|mesh-list
2750898|NCT04139304|Vincristine|vincristine|mesh-list
2750899|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
2750900|NCT04139304|Daunorubicin|daunorubicin|mesh-list
2750901|NCT04139304|Daratumumab|daratumumab|mesh-list
2750902|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
593189|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
593190|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2750903|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2750904|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
2750905|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593192|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593193|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
593194|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
593195|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
593196|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593197|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
593198|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
593199|NCT03548129|Fosfomycin|fosfomycin|mesh-list
593200|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
2077356|NCT02026141|Analgesics|analgesics|mesh-ancestor
2077357|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
2077358|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077359|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2077360|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2077361|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2077362|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
2077363|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2077364|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077365|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
2077366|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2077367|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2077368|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593222|NCT03547895|Vitamin K|vitamin k|mesh-list
593223|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
593224|NCT03547895|Ribavirin|ribavirin|mesh-list
593225|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
593226|NCT03547895|Furosemide|furosemide|mesh-list
593227|NCT03547895|Spironolactone|spironolactone|mesh-list
593228|NCT03547895|Silymarin|silymarin|mesh-list
593229|NCT03547895|Vitamins|vitamins|mesh-ancestor
593230|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
593231|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593232|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
593233|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593234|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
593235|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
593236|NCT03547895|Diuretics|diuretics|mesh-ancestor
593237|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
593238|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
593239|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
593240|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
593241|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
593242|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
593243|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
593244|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
593245|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
593246|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
593247|NCT03547895|Coagulants|coagulants|mesh-ancestor
593248|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
593249|NCT03547895|Protective Agents|protective agents|mesh-ancestor
593250|NCT03547830|Plerixafor|plerixafor|mesh-list
593251|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
593252|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
593253|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
593254|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
593255|NCT03547804|Apatinib|apatinib|mesh-list
593256|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593257|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
593258|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593259|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593260|NCT03547791|Betamethasone|betamethasone|mesh-list
593261|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
593262|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
593263|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
593264|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
593265|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
593266|NCT03547791|Hormones|hormones|mesh-ancestor
593267|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2077369|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
593268|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593269|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
593270|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
593271|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
593272|NCT03547778|Misoprostol|misoprostol|mesh-list
593273|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
593274|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
593275|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
593276|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593277|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
593278|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
593279|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
593280|NCT03547700|Ixazomib|ixazomib|mesh-list
593281|NCT03547700|Romidepsin|romidepsin|mesh-list
593282|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593283|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
593284|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593285|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593286|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
593287|NCT03547622|Galantamine|galantamine|mesh-list
593288|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
593289|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593290|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593291|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
593292|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593293|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593294|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
593295|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
593296|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593297|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
593298|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
593299|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
593300|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
593301|NCT03547505|Protective Agents|protective agents|mesh-ancestor
593302|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593303|NCT03547427|Acetaminophen|acetaminophen|mesh-list
593304|NCT03547427|Insulin|insulin|mesh-list
593305|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
593306|NCT03547427|Pramlintide|pramlintide|mesh-list
593307|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
593308|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593309|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
593310|NCT03547427|Analgesics|analgesics|mesh-ancestor
593311|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
593312|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593313|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
593314|NCT03547375|Apatinib|apatinib|mesh-list
593315|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593316|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
593317|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593318|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593319|NCT03547362|Caseins|caseins|mesh-list
593320|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
593321|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
593322|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077370|NCT02026297|Coagulants|coagulants|mesh-ancestor
2077371|NCT02027311|Midazolam|midazolam|mesh-list
2077372|NCT02027311|Meperidine|meperidine|mesh-list
2077373|NCT02027311|Etomidate|etomidate|mesh-list
593327|NCT03547232|Indomethacin|indomethacin|mesh-list
593328|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
593329|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
593330|NCT03547232|Analgesics|analgesics|mesh-ancestor
593331|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
593332|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593333|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593334|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
593335|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
593336|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
593337|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
593338|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
593339|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
593340|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593341|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593342|NCT03547219|Citalopram|citalopram|mesh-list
593343|NCT03547219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2077374|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
593344|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
593345|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
593346|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593347|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593348|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
593349|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593350|NCT03547219|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
593351|NCT03547219|Antidepressive Agents|antidepressive agents|mesh-ancestor
593352|NCT03547219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2215651|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2215652|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
2215653|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215654|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215655|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2215656|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2215657|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
2215658|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215659|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2215660|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2215661|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
593370|NCT03547024|Midazolam|midazolam|mesh-list
593371|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
593372|NCT03547024|Omeprazole|omeprazole|mesh-list
593373|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
593374|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
593375|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
593376|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
593377|NCT03547024|Estradiol|estradiol|mesh-list
593378|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
593379|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
593380|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
593381|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593382|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
593383|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
593384|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
593385|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
593386|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
593387|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
593388|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
593389|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
593390|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593391|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593392|NCT03547024|Estrogens|estrogens|mesh-ancestor
593393|NCT03547024|Hormones|hormones|mesh-ancestor
593394|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
593395|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
593396|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
593397|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
593398|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
593399|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
593400|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
593401|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
593402|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593403|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
593404|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
593405|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
593406|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
593407|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
593408|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
593409|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
593410|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
593411|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
593412|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
593413|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
593414|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
593415|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
593416|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
593417|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
593418|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593419|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
593420|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593421|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593422|NCT03546907|Cholinergic Agents|cholinergic agents|mesh-list
593423|NCT03546907|Muscarinic Agonists|muscarinic agonists|mesh-list
593424|NCT03546907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593425|NCT03546907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593426|NCT03546907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593427|NCT03546907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
593428|NCT03546894|Ceritinib|ceritinib|mesh-list
593429|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593430|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
593431|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593432|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593433|NCT03546855|Apatinib|apatinib|mesh-list
593434|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593435|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
593436|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593437|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750906|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2750907|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2750908|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
2215662|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2215663|NCT00027391|Albuterol|albuterol|mesh-list
2215664|NCT00027391|Oxandrolone|oxandrolone|mesh-list
2215665|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2215666|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
593446|NCT03546803|Protective Agents|protective agents|mesh-list
593447|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593448|NCT03546686|Nivolumab|nivolumab|mesh-list
593449|NCT03546686|Ipilimumab|ipilimumab|mesh-list
593450|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
593451|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593452|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
593453|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593454|NCT03546634|Vaccines|vaccines|mesh-list
593455|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
593456|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215667|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2215668|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215669|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2215670|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
2215671|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
2215672|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2215673|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2215674|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2215675|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
593466|NCT03546608|Tepotinib|tepotinib|mesh-list
593467|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077375|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2077376|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2215676|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
593471|NCT03546556|Alovudine|alovudine|mesh-list
593472|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
593473|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
593474|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
593475|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
593476|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593477|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
593478|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
593479|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593480|NCT03546530|Interferons|interferons|mesh-list
593481|NCT03546530|Resveratrol|resveratrol|mesh-list
593482|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593483|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
593484|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
593485|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
593486|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593487|NCT03546530|Protective Agents|protective agents|mesh-ancestor
593488|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593489|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593490|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
593491|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
593492|NCT03546426|Interleukin-2|interleukin-2|mesh-list
593493|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
593494|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593495|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
593496|NCT03546426|Analgesics|analgesics|mesh-ancestor
593497|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
593498|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593499|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593500|NCT03546400|Methylphenidate|methylphenidate|mesh-list
593501|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
593502|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593503|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
593504|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
593505|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
593506|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593507|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
593508|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593509|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
593510|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
593511|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593512|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
593513|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
593514|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
593515|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593516|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593517|NCT03546283|Protective Agents|protective agents|mesh-ancestor
593518|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215677|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2215678|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215679|NCT00027391|Androgens|androgens|mesh-ancestor
593522|NCT03546088|Anesthetics|anesthetics|mesh-list
593523|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
593524|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593525|NCT03546075|Resveratrol|resveratrol|mesh-list
593526|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
593527|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593528|NCT03546075|Protective Agents|protective agents|mesh-ancestor
593529|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593530|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593531|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
593532|NCT03545997|Montelukast|montelukast|mesh-list
593533|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
593534|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
593535|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
593536|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
593537|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
593538|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593539|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
593540|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
593541|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215680|NCT00027391|Hormones|hormones|mesh-ancestor
2215681|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2215682|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
2215683|NCT00027404|Fluoxetine|fluoxetine|mesh-list
2215684|NCT00027404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2215685|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2215686|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2215687|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215688|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2215689|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
2215690|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215691|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2215692|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
2215693|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2215694|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
593558|NCT03545711|Irinotecan|irinotecan|mesh-list
593559|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
593560|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
593561|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593562|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593563|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593564|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
593566|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
593567|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
593568|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
593569|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593570|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
593571|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593572|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
593573|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
593574|NCT03545516|Analgesics|analgesics|mesh-ancestor
593575|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
593576|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
593577|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
593578|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
593579|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593580|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077377|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077378|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2077379|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2077380|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2077381|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2077382|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
2077383|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
2077384|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
2077385|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
2077386|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2077387|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077388|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2077389|NCT02027311|Narcotics|narcotics|mesh-ancestor
2077390|NCT02027311|Analgesics|analgesics|mesh-ancestor
2077391|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
2077392|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077393|NCT02027376|Docetaxel|docetaxel|mesh-list
2077394|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077395|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
2077396|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
2077397|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
2077398|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077399|NCT02027428|Paclitaxel|paclitaxel|mesh-list
2077400|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2077401|NCT02027428|Carboplatin|carboplatin|mesh-list
2077402|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2077403|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077404|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
2077405|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
2077406|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
2077407|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593612|NCT03545373|Amoxicillin|amoxicillin|mesh-list
593613|NCT03545373|Azithromycin|azithromycin|mesh-list
593614|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
593615|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
593616|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
593617|NCT03545347|Nandrolone|nandrolone|mesh-list
593618|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
593619|NCT03545347|Androgens|androgens|mesh-ancestor
593620|NCT03545347|Hormones|hormones|mesh-ancestor
593621|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
593622|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593623|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
593624|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
593625|NCT03545308|Rocuronium|rocuronium|mesh-list
593626|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
593627|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
593628|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
593629|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593630|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593631|NCT03545243|Pantoprazole|pantoprazole|mesh-list
593632|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
593633|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
593634|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
593635|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593636|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215695|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2215696|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215697|NCT00027443|Cyclosporine|cyclosporine|mesh-list
593716|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
2077408|NCT02028221|Metformin|metformin|mesh-list
2215698|NCT00027443|Cyclosporins|cyclosporins|mesh-list
593641|NCT03545035|Rituximab|rituximab|mesh-list
593642|NCT03545035|Idelalisib|idelalisib|mesh-list
593643|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
593644|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593645|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
593646|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593647|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
593648|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593649|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593650|NCT03544996|Insulin|insulin|mesh-list
593651|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
593652|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593653|NCT03544827|Atropine|atropine|mesh-list
593654|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
593655|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
593656|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
593657|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
593658|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593659|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593660|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
593661|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
593662|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
593663|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
593664|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
593665|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
593666|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
593667|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593668|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593669|NCT03544814|Cisplatin|cisplatin|mesh-list
593670|NCT03544814|Pemetrexed|pemetrexed|mesh-list
593671|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593672|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593673|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593674|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
593675|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
593676|NCT03544775|Anesthetics|anesthetics|mesh-list
593677|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
593678|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077409|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2077410|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077411|NCT02028676|Lamivudine|lamivudine|mesh-list
2077412|NCT02028676|Zidovudine|zidovudine|mesh-list
2077413|NCT02028676|Efavirenz|efavirenz|mesh-list
2077414|NCT02028676|Nevirapine|nevirapine|mesh-list
2077415|NCT02028676|Abacavir|abacavir|mesh-list
2077416|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
2077417|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2077418|NCT02028676|Trimethoprim|trimethoprim|mesh-list
2077419|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
593690|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
593691|NCT03544723|Nivolumab|nivolumab|mesh-list
593692|NCT03544723|Durvalumab|durvalumab|mesh-list
593693|NCT03544723|Atezolizumab|atezolizumab|mesh-list
593694|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
593695|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593696|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
593697|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593698|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
593699|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
593700|NCT03544671|Vitamin D|vitamin d|mesh-list
593701|NCT03544671|Vitamins|vitamins|mesh-ancestor
593702|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
593703|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593704|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
593705|NCT03544606|Pyridoxine|pyridoxine|mesh-list
593706|NCT03544606|Isosorbide|isosorbide|mesh-list
593707|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
593708|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
593709|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
593710|NCT03544606|Diuretics|diuretics|mesh-ancestor
593711|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
593712|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593713|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
593714|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
593715|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077420|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2215699|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
593717|NCT03544606|Vitamins|vitamins|mesh-ancestor
593718|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
593719|NCT03544567|Paclitaxel|paclitaxel|mesh-list
593720|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
593721|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593722|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
593723|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
593724|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
593725|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593726|NCT03544281|Dexamethasone|dexamethasone|mesh-list
593727|NCT03544281|Lenalidomide|lenalidomide|mesh-list
593728|NCT03544281|Bortezomib|bortezomib|mesh-list
593729|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
593730|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
593731|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
593732|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593733|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593734|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
593735|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
593736|NCT03544281|Hormones|hormones|mesh-ancestor
593737|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
593738|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
593739|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593740|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
593741|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
593742|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
593743|NCT03544281|Growth Substances|growth substances|mesh-ancestor
593744|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
593745|NCT03544229|Maleic acid|maleic acid|mesh-list
593746|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593747|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593748|NCT03544125|Durvalumab|durvalumab|mesh-list
593749|NCT03544125|Olaparib|olaparib|mesh-list
593750|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
593751|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
593752|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
593753|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
593754|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
593755|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593756|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
593757|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593758|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593759|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593760|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
593761|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
593762|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593763|NCT03544073|Leuprolide|leuprolide|mesh-list
593764|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
593765|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
593766|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
593767|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593768|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
593769|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593770|NCT03544047|Paclitaxel|paclitaxel|mesh-list
593771|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
593772|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593773|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
593774|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
593775|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
593776|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593777|NCT03543969|Vemurafenib|vemurafenib|mesh-list
593778|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593779|NCT03543969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
593780|NCT03543969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593781|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750909|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750910|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750911|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
593786|NCT03543826|Rocuronium|rocuronium|mesh-list
593787|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
593788|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
593789|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
593790|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593791|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593792|NCT03543774|Simvastatin|simvastatin|mesh-list
593793|NCT03543774|Ezetimibe|ezetimibe|mesh-list
593794|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
593795|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
593796|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
593797|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
593798|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593799|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
593800|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
593801|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593802|NCT03543683|Aspirin|aspirin|mesh-list
593803|NCT03543683|Osimertinib|osimertinib|mesh-list
593804|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
593805|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
593806|NCT03543683|Analgesics|analgesics|mesh-ancestor
593807|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
593808|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593809|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593810|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
593811|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
593812|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
593813|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
593814|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593815|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
593816|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
593817|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593818|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
593819|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593820|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
593821|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
593822|NCT03543657|Hematinics|hematinics|mesh-ancestor
593823|NCT03543436|Meropenem|meropenem|mesh-list
593824|NCT03543436|Imipenem|imipenem|mesh-list
593825|NCT03543436|Temocillin|temocillin|mesh-list
593826|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
593827|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215700|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215701|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215702|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
593831|NCT03543306|Trametinib|trametinib|mesh-list
593832|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593833|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
593834|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593835|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593836|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
593837|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
593838|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
593839|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
593840|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
593841|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593842|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
593843|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593844|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593845|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
593846|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593847|NCT03543202|Anesthetics|anesthetics|mesh-list
593848|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
593849|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215703|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
2215704|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215705|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
2215706|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215707|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
2215708|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215709|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2215710|NCT00027495|Curcumin|curcumin|mesh-list
2215711|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
593869|NCT03543072|Diphosphonates|diphosphonates|mesh-list
593870|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
593871|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593872|NCT03542955|Etoricoxib|etoricoxib|mesh-list
593873|NCT03542955|Analgesics|analgesics|mesh-list
593874|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
593875|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593876|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593877|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
593878|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
593879|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
593880|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
593881|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
593882|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
593883|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593884|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593885|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
593886|NCT03542851|Convulsants|convulsants|mesh-ancestor
593887|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
593888|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593889|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
593890|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
593891|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593892|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593893|NCT03542825|Iron|iron|mesh-list
593894|NCT03542825|Lactoferrin|lactoferrin|mesh-list
593895|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
593896|NCT03542825|Trace Elements|trace elements|mesh-ancestor
593897|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
593898|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593899|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
593900|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
593901|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
593902|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593903|NCT03542760|Methylene Blue|methylene blue|mesh-list
593904|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593905|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077421|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2077422|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2077423|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077424|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077425|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
593912|NCT03542617|Dexamethasone|dexamethasone|mesh-list
593913|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
593914|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
593915|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
593916|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593917|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593918|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
593919|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
593920|NCT03542617|Hormones|hormones|mesh-ancestor
593921|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
593922|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
593923|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593924|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
593925|NCT03542552|Nifedipine|nifedipine|mesh-list
593926|NCT03542552|Analgesics|analgesics|mesh-ancestor
593927|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
593928|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593929|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593930|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
593931|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
593932|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
593933|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
593934|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
593935|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
593936|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593937|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
593938|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
593939|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
593940|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
593941|NCT03542461|Nivolumab|nivolumab|mesh-list
593942|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
593943|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593944|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
593945|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593946|NCT03542422|Apatinib|apatinib|mesh-list
593947|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593948|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
593949|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593950|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593951|NCT03542357|Calcitonin|calcitonin|mesh-list
593952|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
593953|NCT03542357|Sumatriptan|sumatriptan|mesh-list
593954|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
593955|NCT03542357|Katacalcin|katacalcin|mesh-list
593956|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
593957|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
593958|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
593959|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
593960|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
593961|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593962|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593963|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
593964|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
593965|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
593966|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
593967|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593968|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
593969|NCT03542279|Hormones|hormones|mesh-ancestor
593970|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
593971|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215712|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2215713|NCT00027495|Analgesics|analgesics|mesh-ancestor
2215714|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
2215715|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2215716|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215717|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
593979|NCT03542240|Curcumin|curcumin|mesh-list
593980|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
593981|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
593982|NCT03542240|Analgesics|analgesics|mesh-ancestor
593983|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
593984|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
593985|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
593986|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
593987|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
593988|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
593989|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
593990|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
593991|NCT03542214|Calcium|calcium|mesh-list
593992|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
593993|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077426|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077427|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2077428|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2077429|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
2077430|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
593999|NCT03542149|Tocopherols|tocopherols|mesh-list
594000|NCT03542149|Vitamin E|vitamin e|mesh-list
594001|NCT03542149|Tocotrienols|tocotrienols|mesh-list
594002|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
594003|NCT03542149|Piperaquine|piperaquine|mesh-list
594004|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
594005|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
594006|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
594007|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
594008|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
594009|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594010|NCT03542149|Protective Agents|protective agents|mesh-ancestor
594011|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594012|NCT03542149|Vitamins|vitamins|mesh-ancestor
594013|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
594014|NCT03542058|Carvedilol|carvedilol|mesh-list
594015|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
594016|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
594017|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
2077431|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
594018|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
594019|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594020|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594021|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
594022|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
594023|NCT03542058|Protective Agents|protective agents|mesh-ancestor
594024|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
594025|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
594026|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
594027|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
594028|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
594029|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
594030|NCT03542006|Brinzolamide|brinzolamide|mesh-list
594031|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
594032|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594033|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594034|NCT03541993|Resveratrol|resveratrol|mesh-list
594035|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
594036|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594037|NCT03541993|Protective Agents|protective agents|mesh-ancestor
594038|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594039|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594040|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2215718|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215719|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215720|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215721|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215722|NCT00027508|Trabectedin|trabectedin|mesh-list
2215723|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2077432|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2077433|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2077434|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2077435|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2077436|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2077437|NCT02028676|Renal Agents|renal agents|mesh-ancestor
594055|NCT03541928|Valacyclovir|valacyclovir|mesh-list
594056|NCT03541928|Leuprolide|leuprolide|mesh-list
594057|NCT03541928|Bicalutamide|bicalutamide|mesh-list
594058|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
594059|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
594060|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
594061|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594062|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
594063|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594064|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
594065|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
594066|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
594067|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
594068|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
594069|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
594070|NCT03541915|Analgesics|analgesics|mesh-ancestor
594071|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
594072|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594073|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594074|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
594075|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594076|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
594077|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
594078|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
594079|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
594080|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594081|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
594082|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
594083|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
594084|NCT03541902|Sunitinib|sunitinib|mesh-list
594085|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594086|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
594087|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
594088|NCT03541902|Growth Substances|growth substances|mesh-ancestor
594089|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594090|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
594091|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
594092|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594093|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077438|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
2077439|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2077440|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2077441|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2077442|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2077443|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2077444|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2077445|NCT02028715|Acetaminophen|acetaminophen|mesh-list
2077446|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2077447|NCT02028715|Analgesics|analgesics|mesh-ancestor
2077448|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
2077449|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077450|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077451|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
2077452|NCT02028754|Levofloxacin|levofloxacin|mesh-list
2077453|NCT02028754|Ofloxacin|ofloxacin|mesh-list
2077454|NCT02028754|Prednisolone|prednisolone|mesh-list
2077455|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
594112|NCT03541837|Ropivacaine|ropivacaine|mesh-list
594113|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
594114|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
594115|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594116|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594117|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
594118|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594119|NCT03541798|Anesthetics|anesthetics|mesh-list
594120|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594121|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594122|NCT03541759|Hydromorphone|hydromorphone|mesh-list
594123|NCT03541759|Pirinitramide|pirinitramide|mesh-list
594124|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
594125|NCT03541759|Narcotics|narcotics|mesh-ancestor
594126|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594127|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594128|NCT03541759|Analgesics|analgesics|mesh-ancestor
594129|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
594130|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594131|NCT03541681|Anesthetics|anesthetics|mesh-list
594132|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
594133|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594134|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594135|NCT03541681|Hormones|hormones|mesh-ancestor
594136|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
594137|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
594138|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
594139|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
594140|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594141|NCT03541655|Celecoxib|celecoxib|mesh-list
594142|NCT03541655|Bupivacaine|bupivacaine|mesh-list
594143|NCT03541655|Anesthetics, Local|anesthetics, local|mesh-ancestor
594144|NCT03541655|Anesthetics|anesthetics|mesh-ancestor
594145|NCT03541655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594146|NCT03541655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594147|NCT03541655|Sensory System Agents|sensory system agents|mesh-ancestor
594148|NCT03541655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594149|NCT03541655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
594150|NCT03541655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
594151|NCT03541655|Analgesics|analgesics|mesh-ancestor
594152|NCT03541655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
594153|NCT03541655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
594154|NCT03541655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
594155|NCT03541655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
594156|NCT03541655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594157|NCT03541655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594158|NCT03541603|Simendan|simendan|mesh-list
594159|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
594160|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
594161|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
594162|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
594163|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594164|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594165|NCT03541603|Protective Agents|protective agents|mesh-ancestor
594166|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594167|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
594168|NCT03541564|BMS-986165|bms-986165|mesh-list
594169|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
594170|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
594171|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
594172|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
594173|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594174|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594175|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594176|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
594177|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
594178|NCT03541486|Gemcitabine|gemcitabine|mesh-list
594179|NCT03541486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594180|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
594181|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
594182|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594183|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594184|NCT03541486|Antiviral Agents|antiviral agents|mesh-ancestor
594185|NCT03541486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
594186|NCT03541486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594187|NCT03541486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
594188|NCT03541486|Immunologic Factors|immunologic factors|mesh-ancestor
594189|NCT03541447|Octreotide|octreotide|mesh-list
594190|NCT03541447|Tolvaptan|tolvaptan|mesh-list
594191|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
594192|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
594193|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594194|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
594195|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594196|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
594197|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215724|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
2215725|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215726|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215727|NCT00027521|Bleomycin|bleomycin|mesh-list
2215728|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2215729|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215730|NCT00027534|Metronidazole|metronidazole|mesh-list
2215731|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215732|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2215733|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2215734|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
594209|NCT03541265|Bupivacaine|bupivacaine|mesh-list
594210|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
594211|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
594212|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594213|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594214|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
594215|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594216|NCT03541252|Cisplatin|cisplatin|mesh-list
594217|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215735|NCT00027547|Cytarabine|cytarabine|mesh-list
2215736|NCT00027547|Cyclosporine|cyclosporine|mesh-list
2215737|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
2215738|NCT00027547|Methotrexate|methotrexate|mesh-list
2215739|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
2215740|NCT00027547|Fludarabine|fludarabine|mesh-list
2215741|NCT00027547|Cyclosporins|cyclosporins|mesh-list
2215742|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2215743|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
2215744|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
594230|NCT03541031|Micronutrients|micronutrients|mesh-list
594231|NCT03541031|Trace Elements|trace elements|mesh-list
594232|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594233|NCT03540979|Letrozole|letrozole|mesh-list
594234|NCT03540979|Progesterone|progesterone|mesh-list
594235|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594236|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
594237|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
594238|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594239|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594240|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
594241|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
2215745|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215746|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
594242|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
594243|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594244|NCT03540979|Progestins|progestins|mesh-ancestor
594245|NCT03540979|Hormones|hormones|mesh-ancestor
594246|NCT03540953|Mitomycins|mitomycins|mesh-list
594247|NCT03540953|Mitomycin|mitomycin|mesh-list
594248|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
594249|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594250|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
594251|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594252|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
594253|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594254|NCT03540914|Acetazolamide|acetazolamide|mesh-list
594255|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
594256|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
594257|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594258|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594259|NCT03540914|Diuretics|diuretics|mesh-ancestor
594260|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
594261|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077456|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2077457|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2077458|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
2077459|NCT02028754|Hormones|hormones|mesh-ancestor
2077460|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2077461|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077462|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2077463|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077464|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2077465|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2077466|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077467|NCT02028754|Renal Agents|renal agents|mesh-ancestor
2077468|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2077469|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2077470|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2077471|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077472|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077473|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2077474|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2077475|NCT02028754|Laxatives|laxatives|mesh-ancestor
2077476|NCT02028767|Metformin|metformin|mesh-list
594283|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
594284|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
594285|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594286|NCT03540836|Cortisone|cortisone|mesh-list
594287|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
594288|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
594289|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
594290|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
594291|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
594292|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
594293|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594294|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594295|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2077477|NCT02028767|Empagliflozin|empagliflozin|mesh-list
2077478|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2077479|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077480|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2077481|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077482|NCT02028780|Dabigatran|dabigatran|mesh-list
2077483|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
2077484|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2077485|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
2077486|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215747|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
594310|NCT03540628|Ascorbic Acid|ascorbic acid|mesh-list
594311|NCT03540628|Thiamine|thiamine|mesh-list
594312|NCT03540628|Vitamins|vitamins|mesh-ancestor
594313|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
594314|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594315|NCT03540628|Antioxidants|antioxidants|mesh-ancestor
594316|NCT03540628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594317|NCT03540628|Protective Agents|protective agents|mesh-ancestor
594318|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
594319|NCT03540485|Melatonin|melatonin|mesh-list
594320|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
594321|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594322|NCT03540485|Protective Agents|protective agents|mesh-ancestor
594323|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594324|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594325|NCT03540472|Tacrolimus|tacrolimus|mesh-list
594326|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
594327|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
594328|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594329|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
594330|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594331|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594334|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
594335|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
594336|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
594337|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594338|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
594339|NCT03540368|Coagulants|coagulants|mesh-ancestor
594340|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
594341|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
594342|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
594343|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
594344|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594345|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
594346|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
594347|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594348|NCT03540225|Progesterone|progesterone|mesh-list
594349|NCT03540225|Progestins|progestins|mesh-ancestor
594350|NCT03540225|Hormones|hormones|mesh-ancestor
594351|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
594352|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594353|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
594354|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
594355|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
594356|NCT03540199|Antibodies|antibodies|mesh-list
594357|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
594358|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
594359|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215748|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215749|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215750|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
2215751|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215752|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
594365|NCT03540095|Bupivacaine|bupivacaine|mesh-list
594366|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
594367|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
594368|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594369|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594370|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
594371|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2215753|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215754|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
2215755|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215756|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2215757|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
2215758|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215759|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
2215760|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2215761|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2215762|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2215763|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
2215764|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2215765|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
2215766|NCT00027573|Methotrexate|methotrexate|mesh-list
2215767|NCT00027573|Fludarabine|fludarabine|mesh-list
2215768|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
2215769|NCT00027573|Tacrolimus|tacrolimus|mesh-list
2215770|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215771|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
2215772|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215773|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215774|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2215775|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
2215776|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215777|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215778|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2215779|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2215780|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
2215781|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2215782|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2215783|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
2215784|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
2215785|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215786|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2215787|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2215788|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2215789|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
2215790|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215791|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2215792|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215793|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215794|NCT00027599|Bevacizumab|bevacizumab|mesh-list
2215795|NCT00027599|Sargramostim|sargramostim|mesh-list
2215796|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2215797|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215798|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
594421|NCT03540017|Cisplatin|cisplatin|mesh-list
594422|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594423|NCT03539952|Penicillamine|penicillamine|mesh-list
594424|NCT03539952|Trientine|trientine|mesh-list
594425|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
594426|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
594427|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594428|NCT03539952|Antidotes|antidotes|mesh-ancestor
594429|NCT03539952|Protective Agents|protective agents|mesh-ancestor
594430|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594431|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
594432|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
594433|NCT03539900|Naltrexone|naltrexone|mesh-list
594434|NCT03539900|Bupropion|bupropion|mesh-list
594435|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
594436|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
594437|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594438|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
594439|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594440|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
594441|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
594442|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
594443|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
594444|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
594445|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
594446|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594447|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
594448|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
594449|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
594450|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
594451|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594452|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
594453|NCT03539887|Ketamine|ketamine|mesh-list
594454|NCT03539887|Analgesics|analgesics|mesh-ancestor
594455|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
594456|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594457|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594458|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
594459|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
594460|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
594461|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
594462|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594463|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
594464|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
594465|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
594466|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077487|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077488|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
2077489|NCT02028871|Insulin|insulin|mesh-list
2077490|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2077491|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077492|NCT02029235|Acetaminophen|acetaminophen|mesh-list
2077493|NCT02029235|Ibuprofen|ibuprofen|mesh-list
2077494|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2077495|NCT02029235|Hydrocodone|hydrocodone|mesh-list
2077496|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2077497|NCT02029235|Analgesics|analgesics|mesh-ancestor
2077498|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
2077499|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077500|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077501|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
2077502|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2077503|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2077504|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2077505|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2077506|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077507|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594489|NCT03539731|Piperazine|piperazine|mesh-list
594490|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
594491|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
594492|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
594493|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
594494|NCT03539718|Taurolidine|taurolidine|mesh-list
594495|NCT03539718|Heparin|heparin|mesh-list
594496|NCT03539718|Calcium heparin|calcium heparin|mesh-list
594497|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
594498|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
594499|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
594500|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594501|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
594502|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
594503|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594504|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
594505|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
594506|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
594507|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594508|NCT03539614|Prazosin|prazosin|mesh-list
594509|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
594510|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
594511|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
594512|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
594513|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
594514|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
594515|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594516|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594534|NCT03539562|Promethazine|promethazine|mesh-list
594535|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
594536|NCT03539562|Morphine|morphine|mesh-list
594537|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
594538|NCT03539562|Narcotics|narcotics|mesh-ancestor
594539|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594540|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594541|NCT03539562|Analgesics|analgesics|mesh-ancestor
594542|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
594543|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594544|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
594545|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
594546|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
594547|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
594548|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
594549|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
594550|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594551|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
594552|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
594553|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
594554|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
594555|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
594556|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
594557|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
594558|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2215799|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2215800|NCT00027599|Growth Substances|growth substances|mesh-ancestor
2215801|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594562|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
594563|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
594564|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
594565|NCT03539445|Protective Agents|protective agents|mesh-ancestor
594566|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077508|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2077509|NCT02029235|Narcotics|narcotics|mesh-ancestor
2077510|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2077511|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
2077512|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
2077513|NCT02029274|Siponimod|siponimod|mesh-list
2077514|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2077515|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594575|NCT03539367|Acetazolamide|acetazolamide|mesh-list
594576|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
594577|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
594578|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594579|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594580|NCT03539367|Diuretics|diuretics|mesh-ancestor
594581|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
594582|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594583|NCT03539328|Gemcitabine|gemcitabine|mesh-list
594584|NCT03539328|Paclitaxel|paclitaxel|mesh-list
594585|NCT03539328|Doxorubicin|doxorubicin|mesh-list
594586|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
594587|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
594588|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
594589|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594590|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
594591|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
594592|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
594593|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594594|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
594595|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
594596|NCT03539328|Antiviral Agents|antiviral agents|mesh-ancestor
594597|NCT03539328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
594598|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594599|NCT03539328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
594600|NCT03539328|Immunologic Factors|immunologic factors|mesh-ancestor
594601|NCT03539328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594602|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
594603|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
594604|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
594605|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
594612|NCT03539224|Lamivudine|lamivudine|mesh-list
594613|NCT03539224|Dolutegravir|dolutegravir|mesh-list
594614|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
594615|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
594616|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594617|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594618|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
594619|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
594620|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
594621|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
594622|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
594623|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
594624|NCT03539198|Nivolumab|nivolumab|mesh-list
594625|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
594626|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594627|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
594628|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594629|NCT03539172|Apatinib|apatinib|mesh-list
594630|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594631|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
594632|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594633|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594634|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
594635|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
594636|NCT03539055|Dabigatran|dabigatran|mesh-list
594637|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
594638|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
594639|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
594640|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594641|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594642|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
594643|NCT03539003|Remifentanil|remifentanil|mesh-list
594644|NCT03539003|Propofol|propofol|mesh-list
594645|NCT03539003|Sevoflurane|sevoflurane|mesh-list
594646|NCT03539003|Desflurane|desflurane|mesh-list
594647|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
594648|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594649|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594650|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
594651|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
594652|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
594653|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
594654|NCT03539003|Narcotics|narcotics|mesh-ancestor
594655|NCT03539003|Analgesics|analgesics|mesh-ancestor
594656|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
594657|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594658|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
594659|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2077516|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2077517|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
2077518|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077519|NCT02029417|Cytarabine|cytarabine|mesh-list
2077520|NCT02029417|Decitabine|decitabine|mesh-list
2077521|NCT02029417|Azacitidine|azacitidine|mesh-list
2077522|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
2077523|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2077524|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
2077525|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077526|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077527|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
2077528|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077529|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2077530|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
2077531|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077532|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077533|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2077534|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2215802|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215803|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
2215804|NCT00027612|Irinotecan|irinotecan|mesh-list
2215805|NCT00027612|Carmustine|carmustine|mesh-list
2215806|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2215807|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2215808|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594686|NCT03538704|Metformin|metformin|mesh-list
594687|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
594688|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594689|NCT03538691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
594690|NCT03538691|Dexetimide|dexetimide|mesh-list
594691|NCT03538691|Citalopram|citalopram|mesh-list
594692|NCT03538691|Fluoxetine|fluoxetine|mesh-list
594693|NCT03538691|Paroxetine|paroxetine|mesh-list
594694|NCT03538691|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
594695|NCT03538691|Sertraline|sertraline|mesh-list
594696|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
594697|NCT03538691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
594698|NCT03538691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
594699|NCT03538691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2077535|NCT02029495|Brodalumab|brodalumab|mesh-list
2750912|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
594700|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594701|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
594702|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
594703|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594704|NCT03538691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
594705|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-ancestor
594706|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
594707|NCT03538691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
594708|NCT03538691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
594709|NCT03538691|Parasympatholytics|parasympatholytics|mesh-ancestor
594710|NCT03538691|Autonomic Agents|autonomic agents|mesh-ancestor
594711|NCT03538691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594712|NCT03538691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
594713|NCT03538691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
594714|NCT03538691|Cholinergic Agents|cholinergic agents|mesh-ancestor
594715|NCT03538691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
594716|NCT03538691|Analgesics|analgesics|mesh-ancestor
594717|NCT03538691|Sensory System Agents|sensory system agents|mesh-ancestor
594718|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
594719|NCT03538691|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
594720|NCT03538691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
594721|NCT03538691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594722|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
594723|NCT03538496|Bupivacaine|bupivacaine|mesh-list
594724|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
594725|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
594726|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594727|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594728|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
594729|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594730|NCT03538483|Bupivacaine|bupivacaine|mesh-list
594731|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
594732|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
594733|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594734|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594735|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
594736|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594737|NCT03538457|Acetaminophen|acetaminophen|mesh-list
594738|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
594739|NCT03538457|Analgesics|analgesics|mesh-ancestor
594740|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
594741|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594742|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594743|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
2215809|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215810|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215811|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2215812|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
2215813|NCT00027625|Temozolomide|temozolomide|mesh-list
2215814|NCT00027625|Gefitinib|gefitinib|mesh-list
2215815|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2215816|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
2215817|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215818|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594754|NCT03538327|Silybin|silybin|mesh-list
594755|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
594756|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594757|NCT03538327|Protective Agents|protective agents|mesh-ancestor
594758|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594759|NCT03538171|Exemestane|exemestane|mesh-list
594760|NCT03538171|Entinostat|entinostat|mesh-list
594761|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594762|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
594763|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
594764|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594765|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594766|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
594767|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
594768|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
594769|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594770|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
594771|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
594772|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
594773|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
594774|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
594775|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
594776|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
594777|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594778|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215819|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2215820|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215821|NCT00027638|Thalidomide|thalidomide|mesh-list
2215822|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215823|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
2215824|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215825|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
2215826|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2215827|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215828|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2215829|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2215830|NCT00027638|Growth Substances|growth substances|mesh-ancestor
2215831|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215832|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215833|NCT00027664|Interferons|interferons|mesh-list
2215834|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
594795|NCT03537950|Cannabidiol|cannabidiol|mesh-list
594796|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
594797|NCT03537924|Acetazolamide|acetazolamide|mesh-list
594798|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
594799|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
594800|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594801|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594802|NCT03537924|Diuretics|diuretics|mesh-ancestor
594803|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
594804|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594805|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
594806|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
594807|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
594808|NCT03537833|Pemetrexed|pemetrexed|mesh-list
594809|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594810|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594811|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594812|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
594813|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
594814|NCT03537807|Riluzole|riluzole|mesh-list
594815|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
594816|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
594817|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
594818|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
594819|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594820|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594821|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
594822|NCT03537807|Protective Agents|protective agents|mesh-ancestor
594823|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
594824|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
594825|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
594826|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
594827|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
594828|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594829|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
594830|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
594831|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2077536|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2077537|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
2077538|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
2077539|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077540|NCT02029638|Acetaminophen|acetaminophen|mesh-list
2077541|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
2077542|NCT02029638|Promethazine|promethazine|mesh-list
2077543|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
2077544|NCT02029638|Prednisone|prednisone|mesh-list
2077545|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
2077546|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
2077547|NCT02029638|Fludarabine|fludarabine|mesh-list
594844|NCT03537612|Clonidine|clonidine|mesh-list
594845|NCT03537612|Morphine|morphine|mesh-list
594846|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
594847|NCT03537612|Narcotics|narcotics|mesh-ancestor
2077548|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
2077549|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2215835|NCT00027664|Thalidomide|thalidomide|mesh-list
2215836|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594848|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594849|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594850|NCT03537612|Analgesics|analgesics|mesh-ancestor
594851|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
594852|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594853|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
594854|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
594855|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
594856|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
594857|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
594858|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
594859|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
594860|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
594861|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594862|NCT03537599|Daratumumab|daratumumab|mesh-list
594863|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594864|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
594865|NCT03537573|Narcotics|narcotics|mesh-ancestor
594866|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594867|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594868|NCT03537573|Analgesics|analgesics|mesh-ancestor
594869|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
594870|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594871|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
594872|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
594873|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
594874|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
594875|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594876|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594877|NCT03537534|Lidocaine|lidocaine|mesh-list
594878|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
594879|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
594880|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
594881|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594882|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
594883|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594884|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
594885|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
594886|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
594887|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
594888|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077550|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2077551|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
2077552|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594892|NCT03537495|Linezolid|linezolid|mesh-list
594893|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
594894|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
594895|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
594896|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594897|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594898|NCT03537443|Vitamin D|vitamin d|mesh-list
594899|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
594900|NCT03537443|Vitamins|vitamins|mesh-ancestor
594901|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
594902|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594903|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
594904|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2215837|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
2215838|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215839|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
2215840|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215841|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215842|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
2215843|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2215844|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2215845|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2215846|NCT00027664|Growth Substances|growth substances|mesh-ancestor
2215847|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215848|NCT00027677|Halofuginone|halofuginone|mesh-list
2215849|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215850|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
2215851|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2215852|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2215853|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215854|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2215855|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594923|NCT03537391|Fluorides|fluorides|mesh-list
594924|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
594925|NCT03537391|Protective Agents|protective agents|mesh-ancestor
594926|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594927|NCT03537326|Budesonide|budesonide|mesh-list
594928|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
594929|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
594930|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
594931|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594932|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594933|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
594934|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
594935|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
594936|NCT03537326|Hormones|hormones|mesh-ancestor
594937|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
594938|NCT03537287|Progesterone|progesterone|mesh-list
594939|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
594940|NCT03537287|Progestins|progestins|mesh-ancestor
594941|NCT03537287|Hormones|hormones|mesh-ancestor
594942|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
594943|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215856|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215857|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2215858|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2215859|NCT00027677|Growth Substances|growth substances|mesh-ancestor
2215860|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215861|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215862|NCT00027690|Gefitinib|gefitinib|mesh-list
2215863|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
594953|NCT03537196|Ribavirin|ribavirin|mesh-list
594954|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
594955|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
594956|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594957|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
594958|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
594959|NCT03537157|Rifaximin|rifaximin|mesh-list
594960|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
594961|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
594962|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
594963|NCT03537144|Acetaminophen|acetaminophen|mesh-list
594964|NCT03537144|Indomethacin|indomethacin|mesh-list
594965|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
594966|NCT03537144|Analgesics|analgesics|mesh-ancestor
594967|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
594968|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
594969|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594970|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
594971|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
594972|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
594973|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
594974|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
594975|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
594976|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
594977|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
594978|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
594979|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594980|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
594981|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
594982|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
594983|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
594984|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594985|NCT03537027|Vitamin D|vitamin d|mesh-list
594986|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
594987|NCT03537027|Vitamins|vitamins|mesh-ancestor
594988|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
594989|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
594990|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
594991|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2077553|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2077554|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2077555|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
2077556|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077557|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595073|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077558|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2077559|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2077560|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
2077561|NCT02029638|Hormones|hormones|mesh-ancestor
2077562|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2215864|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2215865|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595005|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
595006|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
595007|NCT03536910|Coagulants|coagulants|mesh-ancestor
595008|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
595009|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
595010|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
595011|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595012|NCT03536845|Vitamin D|vitamin d|mesh-list
595013|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
595014|NCT03536845|Vitamins|vitamins|mesh-ancestor
595015|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
595016|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595017|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
595018|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
595019|NCT03536806|Canrenone|canrenone|mesh-list
595020|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
595021|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
595022|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
595023|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595024|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
595025|NCT03536806|Diuretics|diuretics|mesh-ancestor
595026|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
595027|NCT03536780|Gemcitabine|gemcitabine|mesh-list
595028|NCT03536780|Avelumab|avelumab|mesh-list
595029|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
595030|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
595031|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595032|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595033|NCT03536780|Antiviral Agents|antiviral agents|mesh-ancestor
595034|NCT03536780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
595035|NCT03536780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595036|NCT03536780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
595037|NCT03536780|Immunologic Factors|immunologic factors|mesh-ancestor
595038|NCT03536780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595039|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
595040|NCT03536741|Anesthetics|anesthetics|mesh-list
595041|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
595042|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
595043|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595044|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
2077563|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2077564|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2077565|NCT02029638|Analgesics|analgesics|mesh-ancestor
2077566|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
2077567|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077568|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
2077569|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2077570|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2077571|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
595054|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
595055|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
595056|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
595057|NCT03536611|Warfarin|warfarin|mesh-list
595058|NCT03536611|Dabigatran|dabigatran|mesh-list
595059|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
595060|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
595061|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
595062|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
595063|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595064|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595065|NCT03536598|Amlodipine|amlodipine|mesh-list
595066|NCT03536598|Valsartan|valsartan|mesh-list
595067|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
595068|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
595069|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
595070|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
595071|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595072|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2077572|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
595074|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
595075|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
595076|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
595077|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
595078|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
595079|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
595080|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595081|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
595082|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2077573|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077574|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077575|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
2077576|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
2077577|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2077578|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2077579|NCT02029638|Protective Agents|protective agents|mesh-ancestor
2077580|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2077581|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2077582|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2077583|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
2077584|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
2077585|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2077586|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
2077587|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
2077588|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
595099|NCT03536494|Mirabegron|mirabegron|mesh-list
595100|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
595101|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
595102|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
595103|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
595104|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
595105|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595106|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595107|NCT03536494|Urological Agents|urological agents|mesh-ancestor
595108|NCT03536481|Ensartinib|ensartinib|mesh-list
595109|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595110|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
595111|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595112|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077589|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2077590|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
2077591|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
2077592|NCT02029703|Hylan|hylan|mesh-list
2077593|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
2077594|NCT02029703|Protective Agents|protective agents|mesh-ancestor
2077595|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077596|NCT02029755|Anesthetics|anesthetics|mesh-list
2077597|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
2077598|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2077599|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077600|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
2077601|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077602|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
2077603|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2077604|NCT02029872|Mupirocin|mupirocin|mesh-list
595129|NCT03536390|Methylphenidate|methylphenidate|mesh-list
595130|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
595131|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595132|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
595133|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
595134|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
595135|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595136|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
595137|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
595138|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
595139|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
595140|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595141|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
595142|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
595143|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
595144|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
595145|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
595146|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077605|NCT02029872|Calcium|calcium|mesh-list
2077606|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
595147|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
595148|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
595149|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595150|NCT03536208|Warfarin|warfarin|mesh-list
595151|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
595152|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
595153|NCT03536065|Narcotics|narcotics|mesh-ancestor
595154|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
595155|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595156|NCT03536065|Analgesics|analgesics|mesh-ancestor
595157|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
595158|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595159|NCT03536039|Prednisone|prednisone|mesh-list
595160|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
595161|NCT03536039|Rituximab|rituximab|mesh-list
595162|NCT03536039|Doxorubicin|doxorubicin|mesh-list
595163|NCT03536039|Vincristine|vincristine|mesh-list
595164|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
595165|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
595166|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595167|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
595168|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
595169|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
595170|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595171|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595172|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
595173|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
595174|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
595175|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
595176|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
595177|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595178|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
595179|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
595180|NCT03536039|Hormones|hormones|mesh-ancestor
595181|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
595182|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
595183|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
595184|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
595185|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
595186|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
595187|NCT03535961|Etoposide|etoposide|mesh-list
595188|NCT03535961|Apatinib|apatinib|mesh-list
595189|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
595190|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595191|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
595192|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
595193|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595194|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595195|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
595196|NCT03535883|Anticoagulants|anticoagulants|mesh-list
595197|NCT03535883|Coagulants|coagulants|mesh-list
595198|NCT03535870|Fluticasone|fluticasone|mesh-list
595199|NCT03535870|Xhance|xhance|mesh-list
595200|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
595201|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
595202|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
595203|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
595204|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
595205|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595206|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595207|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
595208|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
595209|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
595210|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
595211|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
595212|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
595213|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
595214|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
595215|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
595216|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595217|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
595218|NCT03535870|Hormones|hormones|mesh-ancestor
595219|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
595220|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
595221|NCT03535792|Fentanyl|fentanyl|mesh-list
595222|NCT03535792|Nalbuphine|nalbuphine|mesh-list
595223|NCT03535792|Bupivacaine|bupivacaine|mesh-list
595224|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
595225|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
595226|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
595227|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595228|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
595229|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595230|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
595231|NCT03535792|Narcotics|narcotics|mesh-ancestor
595232|NCT03535792|Analgesics|analgesics|mesh-ancestor
595233|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
595234|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
595235|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
595236|NCT03535753|Decitabine|decitabine|mesh-list
595237|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
595238|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
595239|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595240|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595241|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595264|NCT03535701|Paclitaxel|paclitaxel|mesh-list
595265|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
595266|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
595267|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595268|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
595269|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
595270|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
595271|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595281|NCT03535662|Itraconazole|itraconazole|mesh-list
595282|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
595283|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
595284|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
595285|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
595286|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595287|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595288|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
595289|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
595290|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
595291|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595292|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
595293|NCT03535558|Azithromycin|azithromycin|mesh-list
595294|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
595295|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
595296|NCT03535558|Trimethoprim|trimethoprim|mesh-list
595297|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
595298|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
595299|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
595300|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
595301|NCT03535558|Renal Agents|renal agents|mesh-ancestor
595302|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
595303|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
595304|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
595305|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
595306|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595307|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595308|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
595309|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
595310|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
595311|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
595312|NCT03535519|Methotrexate|methotrexate|mesh-list
595313|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
595314|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
595315|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
595316|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595317|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
595318|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
595319|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595320|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595321|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
595322|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595323|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
595324|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
595325|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
595326|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
595327|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
595328|NCT03535506|Palbociclib|palbociclib|mesh-list
595329|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595330|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
595331|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595332|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595333|NCT03535480|Sargramostim|sargramostim|mesh-list
595334|NCT03535480|Lenograstim|lenograstim|mesh-list
595335|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
595336|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595337|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
595338|NCT03535415|Hormones|hormones|mesh-list
595339|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
595340|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595341|NCT03535376|Valsartan|valsartan|mesh-list
595342|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
595343|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
595344|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
595345|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077607|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077608|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2077609|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077610|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
2077611|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
595356|NCT03535298|Interferons|interferons|mesh-list
595357|NCT03535298|Interferon-beta|interferon-beta|mesh-list
595358|NCT03535298|Teriflunomide|teriflunomide|mesh-list
595359|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
595360|NCT03535298|Ofatumumab|ofatumumab|mesh-list
595361|NCT03535298|Cladribine|cladribine|mesh-list
595362|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
595363|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
595364|NCT03535298|Natalizumab|natalizumab|mesh-list
595365|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
595366|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
595367|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
595368|NCT03535298|Ozanimod|ozanimod|mesh-list
595369|NCT03535298|Ponesimod|ponesimod|mesh-list
595370|NCT03535298|Siponimod|siponimod|mesh-list
595371|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
595372|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595373|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
595374|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595375|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
595376|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
595377|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
595378|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
595379|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
595380|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
595381|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
595382|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595383|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
595384|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
595385|NCT03535298|Analgesics|analgesics|mesh-ancestor
595386|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
595387|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595388|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
595389|NCT03535272|Bismuth|bismuth|mesh-list
595390|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
595391|NCT03535272|Antacids|antacids|mesh-ancestor
595392|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595393|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
595394|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
595395|NCT03535259|Sorafenib|sorafenib|mesh-list
595396|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595397|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
595398|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595399|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595400|NCT03535233|Triamcinolone|triamcinolone|mesh-list
595401|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
595402|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
595403|NCT03535233|Clobetasol|clobetasol|mesh-list
595404|NCT03535233|Minoxidil|minoxidil|mesh-list
595405|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
595406|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
595407|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
595408|NCT03535233|Hormones|hormones|mesh-ancestor
595409|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
595410|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595411|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
595412|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
595413|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595414|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595415|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
595416|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
595417|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
595418|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
595419|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
595420|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595421|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595422|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
595423|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
595424|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
595425|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
595426|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215866|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215867|NCT00027703|Gemcitabine|gemcitabine|mesh-list
2215868|NCT00027703|Bevacizumab|bevacizumab|mesh-list
2215869|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2215870|NCT00027703|Antibodies|antibodies|mesh-list
2215871|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
2215872|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2215873|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215874|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2215875|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2215876|NCT00027703|Growth Substances|growth substances|mesh-ancestor
595438|NCT03535168|Midazolam|midazolam|mesh-list
595439|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
595440|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
595441|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
595442|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595443|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
595444|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
595445|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
595446|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
595447|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
595448|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
595449|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
595450|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
595451|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
595452|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595453|NCT03535116|Ketorolac|ketorolac|mesh-list
595454|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
595455|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
595456|NCT03535116|Analgesics|analgesics|mesh-ancestor
595457|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
595458|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595459|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595460|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
595461|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
595462|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
595463|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595464|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595465|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
595466|NCT03535103|Hormones|hormones|mesh-ancestor
595467|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
595468|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595469|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
595470|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
595471|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
595472|NCT03535090|Prednisolone|prednisolone|mesh-list
595473|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
595474|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
595475|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
595476|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
595477|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
595478|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
595479|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595480|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595481|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
595482|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
595483|NCT03535090|Hormones|hormones|mesh-ancestor
595484|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
595485|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
595486|NCT03535090|Protective Agents|protective agents|mesh-ancestor
595487|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
595488|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595489|NCT03535051|Tacrolimus|tacrolimus|mesh-list
595490|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
595491|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
595492|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595493|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
595494|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595495|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595496|NCT03534973|Caffeine|caffeine|mesh-list
595497|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
595498|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595499|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
595500|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595501|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595502|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
595503|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
595504|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
595505|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
595506|NCT03534947|Imiquimod|imiquimod|mesh-list
595507|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
595508|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
595509|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595510|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595511|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
595512|NCT03534895|Midazolam|midazolam|mesh-list
595513|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
595514|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
595515|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595516|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
595517|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
595518|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
595519|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
595520|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
595521|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
595522|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
595523|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
595524|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
595525|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
595526|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595527|NCT03534869|Analgesics|analgesics|mesh-list
595528|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
595529|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595530|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595534|NCT03534713|Paclitaxel|paclitaxel|mesh-list
595535|NCT03534713|Carboplatin|carboplatin|mesh-list
595536|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
595537|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595538|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
595539|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
595540|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
595541|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595542|NCT03534674|Vitamin D|vitamin d|mesh-list
595543|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
595544|NCT03534674|Vitamins|vitamins|mesh-ancestor
595545|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
595546|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595547|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
595548|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
595549|NCT03534661|Teduglutide|teduglutide|mesh-list
595550|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
595551|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595552|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595553|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
595554|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
595555|NCT03534661|Protective Agents|protective agents|mesh-ancestor
595556|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595560|NCT03534531|Methylprednisolone|methylprednisolone|mesh-list
595561|NCT03534531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
595562|NCT03534531|Antiemetics|antiemetics|mesh-ancestor
595563|NCT03534531|Autonomic Agents|autonomic agents|mesh-ancestor
595564|NCT03534531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595565|NCT03534531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595566|NCT03534531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
595567|NCT03534531|Glucocorticoids|glucocorticoids|mesh-ancestor
595568|NCT03534531|Hormones|hormones|mesh-ancestor
595569|NCT03534531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
595570|NCT03534531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
595571|NCT03534531|Protective Agents|protective agents|mesh-ancestor
595572|NCT03534505|Ketorolac|ketorolac|mesh-list
595573|NCT03534505|Bupivacaine|bupivacaine|mesh-list
595574|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
595575|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
595576|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
595577|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595578|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
595579|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595580|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
595581|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
595582|NCT03534505|Analgesics|analgesics|mesh-ancestor
595583|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
595584|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
595585|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
595586|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595587|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595588|NCT03534492|Durvalumab|durvalumab|mesh-list
595589|NCT03534492|Olaparib|olaparib|mesh-list
595590|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
595591|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595592|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
595593|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595594|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595595|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
595596|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
595597|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077612|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2077613|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2077614|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077615|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077616|NCT02030041|Vitamin D|vitamin d|mesh-list
595603|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
595604|NCT03534388|Eusol|eusol|mesh-list
595605|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
595606|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077617|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
2077618|NCT02030041|Simvastatin|simvastatin|mesh-list
595609|NCT03534310|Liraglutide|liraglutide|mesh-list
595610|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
595611|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595612|NCT03534310|Incretins|incretins|mesh-ancestor
595613|NCT03534310|Hormones|hormones|mesh-ancestor
595614|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
595615|NCT03534297|Dapansutrile|dapansutrile|mesh-list
595616|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2077619|NCT02030041|Vitamins|vitamins|mesh-ancestor
2077620|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
2077621|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077622|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2077623|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2077624|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2077625|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2077626|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
2077627|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077628|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2077629|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2077630|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077631|NCT02030405|Ixazomib|ixazomib|mesh-list
2077632|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
595631|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
595632|NCT03534180|Venetoclax|venetoclax|mesh-list
595633|NCT03534180|Romidepsin|romidepsin|mesh-list
595634|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
595635|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595636|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
595637|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
595638|NCT03534102|Narcotics|narcotics|mesh-ancestor
595639|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
595640|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595641|NCT03534102|Analgesics|analgesics|mesh-ancestor
595642|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
595643|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595644|NCT03534037|Febuxostat|febuxostat|mesh-list
595645|NCT03534037|Benzbromarone|benzbromarone|mesh-list
595646|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
595647|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
595648|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
595649|NCT03534037|Renal Agents|renal agents|mesh-ancestor
595650|NCT03534024|Curcumin|curcumin|mesh-list
595651|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
595652|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
595653|NCT03534024|Analgesics|analgesics|mesh-ancestor
595654|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
595655|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595656|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595657|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
595658|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
595659|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595660|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595661|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077633|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077634|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
2077635|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077636|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077637|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
595667|NCT03533803|Indomethacin|indomethacin|mesh-list
595668|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
595669|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
595670|NCT03533803|Analgesics|analgesics|mesh-ancestor
595671|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
595672|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595673|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077638|NCT02030535|Olodaterol|olodaterol|mesh-list
595674|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
595675|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
595676|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
595677|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
595678|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
595679|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
595680|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595681|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595682|NCT03533712|Folic Acid|folic acid|mesh-list
595683|NCT03533712|Hematinics|hematinics|mesh-ancestor
595684|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
595685|NCT03533712|Vitamins|vitamins|mesh-ancestor
595686|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
595687|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595688|NCT03533699|Propranolol|propranolol|mesh-list
595689|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
595690|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
595691|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
595692|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
595693|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595694|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595695|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
595696|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
595697|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
595698|NCT03533582|Gemcitabine|gemcitabine|mesh-list
595699|NCT03533582|Cisplatin|cisplatin|mesh-list
595700|NCT03533582|Carboplatin|carboplatin|mesh-list
595701|NCT03533582|Doxorubicin|doxorubicin|mesh-list
595702|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
595703|NCT03533582|Fluorouracil|fluorouracil|mesh-list
595704|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
595705|NCT03533582|Etoposide|etoposide|mesh-list
595706|NCT03533582|Irinotecan|irinotecan|mesh-list
595707|NCT03533582|Vincristine|vincristine|mesh-list
595708|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
595709|NCT03533582|Sorafenib|sorafenib|mesh-list
595710|NCT03533582|Daunorubicin|daunorubicin|mesh-list
595711|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
595712|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595713|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
595714|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
595715|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595716|NCT03533582|Antiviral Agents|antiviral agents|mesh-ancestor
595717|NCT03533582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
595718|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595719|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
595720|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
595721|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595722|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
595723|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
595724|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
595725|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
595726|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
595727|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
595728|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
595729|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
595730|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
595731|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
595732|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
595733|NCT03533556|Caffeine|caffeine|mesh-list
595734|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
595735|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595736|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
595737|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595738|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595739|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
595740|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
595741|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
595742|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
595743|NCT03533452|Ropivacaine|ropivacaine|mesh-list
595744|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
595745|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
595746|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
595747|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595748|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
595749|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595750|NCT03533387|Ibudilast|ibudilast|mesh-list
595751|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
595752|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
595753|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595754|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595755|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
595756|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
595757|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
595758|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595759|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595760|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
595761|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
595762|NCT03533361|Lenvatinib|lenvatinib|mesh-list
595763|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595764|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
595765|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595766|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595767|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
595768|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
595769|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
595770|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
595771|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
595772|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
2077639|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2077640|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
2077641|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077642|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077643|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2077644|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
2077645|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
2077646|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2077647|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
2077648|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2215877|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215878|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
2215879|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
595786|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
595787|NCT03533231|Metronidazole|metronidazole|mesh-list
595788|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
595789|NCT03533231|Propolis|propolis|mesh-list
595790|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
595791|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
595792|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
595793|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
595794|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
595795|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595796|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595797|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595798|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
595799|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
595800|NCT03533179|Glucagon|glucagon|mesh-list
595801|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
595802|NCT03533179|Esmolol|esmolol|mesh-list
595803|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
595804|NCT03533179|Hormones|hormones|mesh-ancestor
595805|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
595806|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595807|NCT03533179|Incretins|incretins|mesh-ancestor
595808|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
595809|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
595810|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
595811|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
595812|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
595813|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595814|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
595815|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
595816|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
595817|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
595818|NCT03533127|Bevacizumab|bevacizumab|mesh-list
595819|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
595820|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595821|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
595822|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
595823|NCT03533127|Growth Substances|growth substances|mesh-ancestor
595824|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595825|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
595826|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
595827|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
595828|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
595829|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
595830|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
595831|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
595832|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595833|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
595834|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
595835|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595836|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
595837|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595838|NCT03533010|Vitamin D|vitamin d|mesh-list
595839|NCT03533010|Vitamins|vitamins|mesh-ancestor
595840|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
595841|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595842|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
595843|NCT03532919|Cystatins|cystatins|mesh-list
595844|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
595845|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
595846|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595847|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595848|NCT03532906|Bupivacaine|bupivacaine|mesh-list
595849|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
595850|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
595851|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
595852|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595853|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
595854|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595855|NCT03532880|Olaparib|olaparib|mesh-list
595856|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
595857|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595858|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595859|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595860|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
595861|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
595862|NCT03532867|Protective Agents|protective agents|mesh-ancestor
595863|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595864|NCT03532854|Valsartan|valsartan|mesh-list
595865|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
595866|NCT03532854|Ezetimibe|ezetimibe|mesh-list
595867|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
595868|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
595869|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
595870|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595871|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
595872|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
595873|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595874|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
595875|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
595876|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
595877|NCT03532841|Tramadol|tramadol|mesh-list
595878|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
595879|NCT03532841|Narcotics|narcotics|mesh-ancestor
595880|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
595881|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595882|NCT03532841|Analgesics|analgesics|mesh-ancestor
595883|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
595884|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595885|NCT03532802|Metoprolol|metoprolol|mesh-list
595886|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
595887|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
595888|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
595889|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
595890|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595891|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595892|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
595893|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
595894|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
595895|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
595896|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
595897|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215880|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2215881|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
2215882|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215883|NCT00027703|Antiviral Agents|antiviral agents|mesh-ancestor
2215884|NCT00027703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215885|NCT00027703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215886|NCT00027703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215887|NCT00027716|Bortezomib|bortezomib|mesh-list
2215888|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595907|NCT03532763|Tocotrienols|tocotrienols|mesh-list
595908|NCT03532763|Vitamin E|vitamin e|mesh-list
595909|NCT03532763|Tocopherols|tocopherols|mesh-list
595910|NCT03532763|Tocovid|tocovid|mesh-list
595911|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
595912|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595913|NCT03532763|Protective Agents|protective agents|mesh-ancestor
595914|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595915|NCT03532763|Vitamins|vitamins|mesh-ancestor
595916|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
595917|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
595918|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
595919|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595920|NCT03532711|Leucovorin|leucovorin|mesh-list
595921|NCT03532711|Fluorouracil|fluorouracil|mesh-list
595922|NCT03532711|Capecitabine|capecitabine|mesh-list
595923|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
595924|NCT03532711|Irinotecan|irinotecan|mesh-list
595925|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
595926|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595927|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
595928|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595929|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
595930|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595931|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
595932|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
595933|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
595934|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
595935|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595936|NCT03532711|Antidotes|antidotes|mesh-ancestor
595937|NCT03532711|Protective Agents|protective agents|mesh-ancestor
595938|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
595939|NCT03532711|Vitamins|vitamins|mesh-ancestor
595940|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
595941|NCT03532698|Aspirin|aspirin|mesh-list
595942|NCT03532698|Osimertinib|osimertinib|mesh-list
595943|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
595944|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
595945|NCT03532698|Analgesics|analgesics|mesh-ancestor
595946|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
595947|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
595948|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595949|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
595950|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
595951|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
595952|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
595953|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595954|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
595955|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
595956|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595957|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
595958|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
595959|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
595960|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
595961|NCT03532620|Atorvastatin|atorvastatin|mesh-list
595962|NCT03532620|Pitavastatin|pitavastatin|mesh-list
595963|NCT03532620|Calcium|calcium|mesh-list
595964|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
595965|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595966|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
595967|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
595968|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
595969|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
595970|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595971|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
595972|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
595973|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
595974|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2215889|NCT00027742|Interferons|interferons|mesh-list
595979|NCT03532516|Brivaracetam|brivaracetam|mesh-list
595980|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
595981|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
595982|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
595983|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
595984|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
595985|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
595986|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
595987|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
595988|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
595989|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
595990|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
595991|NCT03532464|Azithromycin|azithromycin|mesh-list
595992|NCT03532464|Doxycycline|doxycycline|mesh-list
595993|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
595994|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
595995|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
595996|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
595997|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2215890|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
2215891|NCT00027742|Temozolomide|temozolomide|mesh-list
2215892|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215893|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
2215894|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
596003|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
596004|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
596005|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
596006|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596007|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596008|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
596009|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
596010|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
596011|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
596012|NCT03532399|Bivalirudin|bivalirudin|mesh-list
596013|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
596014|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
596015|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
596016|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596017|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596018|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
2077649|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077650|NCT02030574|Gemcitabine|gemcitabine|mesh-list
2077651|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077652|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2077653|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
2077654|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077655|NCT02030574|Antiviral Agents|antiviral agents|mesh-ancestor
2077656|NCT02030574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
596033|NCT03532178|Rocuronium|rocuronium|mesh-list
596034|NCT03532178|Succinylcholine|succinylcholine|mesh-list
596035|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
596036|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
596037|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
596038|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596039|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596040|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2750913|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2750914|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2750915|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750916|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2750917|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
2750918|NCT04139304|Hormones|hormones|mesh-ancestor
2750919|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2750920|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2750921|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2215895|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2750922|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
2750923|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
2750924|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
596054|NCT03532087|Denosumab|denosumab|mesh-list
596055|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
596056|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596057|NCT03532035|Brincidofovir|brincidofovir|mesh-list
596058|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
596059|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
596060|NCT03532022|Dexamethasone|dexamethasone|mesh-list
596061|NCT03532022|Prednisone|prednisone|mesh-list
596062|NCT03532022|Prednisolone|prednisolone|mesh-list
596063|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
596064|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
596065|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
596066|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
596067|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
596068|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
596069|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
596070|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596071|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596072|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
596073|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
596074|NCT03532022|Hormones|hormones|mesh-ancestor
596075|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
596076|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
596077|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596078|NCT03531970|Dexamethasone|dexamethasone|mesh-list
596079|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
596080|NCT03531970|Lidocaine|lidocaine|mesh-list
596081|NCT03531970|Epinephrine|epinephrine|mesh-list
596082|NCT03531970|BB 1101|bb 1101|mesh-list
596083|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
596084|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
596085|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
596086|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596087|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596088|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
596089|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
596090|NCT03531970|Hormones|hormones|mesh-ancestor
596091|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
596092|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
596093|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596094|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
596095|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596096|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596097|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
596098|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
596099|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596100|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
596101|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
596102|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
596103|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
596104|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
596105|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
596106|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
596107|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
596108|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
596109|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
596110|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
596111|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
596112|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
596113|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
596114|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
596115|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
596116|NCT03531931|Apatinib|apatinib|mesh-list
596117|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596118|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
596119|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596120|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596121|NCT03531918|Cytarabine|cytarabine|mesh-list
596122|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
596123|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
596124|NCT03531918|Cladribine|cladribine|mesh-list
596125|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
596126|NCT03531918|Calicheamicins|calicheamicins|mesh-list
596127|NCT03531918|Sargramostim|sargramostim|mesh-list
596128|NCT03531918|Lenograstim|lenograstim|mesh-list
596129|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
596130|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
596131|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596132|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596133|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
596134|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
596135|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
596136|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
596137|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596138|NCT03531918|Analgesics|analgesics|mesh-ancestor
596139|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
596140|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596141|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
596142|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
596143|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596144|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
596145|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
596146|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2215896|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
2215897|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215898|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
2215899|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215900|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
2215901|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215902|NCT00027807|Aldesleukin|aldesleukin|mesh-list
2215903|NCT00027807|Molgramostim|molgramostim|mesh-list
2215904|NCT00027807|Sargramostim|sargramostim|mesh-list
2215905|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
2215906|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215907|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215908|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2215909|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2215910|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
596162|NCT03531762|Tepotinib|tepotinib|mesh-list
596163|NCT03531762|Omeprazole|omeprazole|mesh-list
596164|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
596165|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
596166|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
596167|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596168|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596169|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596170|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
596171|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
596172|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596173|NCT03531749|Protective Agents|protective agents|mesh-ancestor
596174|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596175|NCT03531749|Vitamins|vitamins|mesh-ancestor
596176|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
596192|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
596193|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
596194|NCT03531645|Fulvestrant|fulvestrant|mesh-list
596195|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
596196|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596197|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
596198|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
596199|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
596200|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
596201|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596202|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2215911|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215912|NCT00027820|Cyclosporine|cyclosporine|mesh-list
596203|NCT03531437|Gestodene|gestodene|mesh-list
596204|NCT03531437|Estradiol|estradiol|mesh-list
596205|NCT03531437|Estrogens|estrogens|mesh-ancestor
596206|NCT03531437|Hormones|hormones|mesh-ancestor
596207|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
596208|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596209|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
596210|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
596211|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
596212|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
596213|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
596214|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
596215|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
596216|NCT03531437|Progestins|progestins|mesh-ancestor
596217|NCT03531372|Antacids|antacids|mesh-list
596218|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596219|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
596220|NCT03531359|Midazolam|midazolam|mesh-list
596221|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
596222|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
596223|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596224|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596225|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
596226|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
596227|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
596228|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
596229|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
596230|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
596231|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
596232|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
596233|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
596234|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596235|NCT03531294|Aflibercept|aflibercept|mesh-list
596236|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
596237|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
596238|NCT03531294|Growth Substances|growth substances|mesh-ancestor
596239|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596240|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
596241|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596242|NCT03531281|Sirolimus|sirolimus|mesh-list
596243|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
596244|NCT03531281|Etoposide|etoposide|mesh-list
596245|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
596246|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
596247|NCT03531281|Tacrolimus|tacrolimus|mesh-list
596248|NCT03531281|Mitogens|mitogens|mesh-list
596249|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
596250|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
596251|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596252|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
596253|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
596254|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
596255|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596256|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596257|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
596258|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
596259|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
596260|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
596261|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596262|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
596263|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
596264|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
596265|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
596266|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
596267|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
596268|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
596269|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
596270|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
596271|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
596272|NCT03531073|Methotrexate|methotrexate|mesh-list
596273|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
596274|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
596275|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
596276|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596277|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
596278|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
2750925|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
596279|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596280|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596281|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
596282|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596283|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
596284|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
596285|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
596286|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
596287|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
596288|NCT03531047|Riboflavin|riboflavin|mesh-list
596289|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
596290|NCT03531047|Vitamins|vitamins|mesh-ancestor
596291|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
596292|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596293|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
596294|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
2077657|NCT02030574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077658|NCT02030574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2077659|NCT02030574|Immunologic Factors|immunologic factors|mesh-ancestor
2077660|NCT02030574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077661|NCT02030600|Insulin|insulin|mesh-list
2077662|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2077663|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
2077664|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2077665|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077666|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
2077667|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
2077668|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2077669|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2077670|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077671|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
2077672|NCT02030821|Coagulants|coagulants|mesh-ancestor
2077673|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2077674|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
2077675|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077676|NCT02031458|Atezolizumab|atezolizumab|mesh-list
2077677|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077678|NCT02031536|Everolimus|everolimus|mesh-list
2077679|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077680|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2077681|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
2077682|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077683|NCT02031640|Beclomethasone|beclomethasone|mesh-list
2077684|NCT02031640|Albuterol|albuterol|mesh-list
2077685|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
596324|NCT03530800|Dronabinol|dronabinol|mesh-list
596325|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
596326|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596327|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
596328|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
596329|NCT03530800|Analgesics|analgesics|mesh-ancestor
596330|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
596331|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596332|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
596333|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
596334|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
596335|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596336|NCT03530800|Hormones|hormones|mesh-ancestor
596337|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2750926|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
2750934|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
2750935|NCT04134325|Nivolumab|nivolumab|mesh-list
2077686|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
2077687|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077688|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750936|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2750937|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2750938|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2750939|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596361|NCT03530670|Midazolam|midazolam|mesh-list
596362|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
596363|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
596364|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596365|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596366|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
596367|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
596368|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
596369|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
596370|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
596371|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
596372|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
596373|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
596374|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
596375|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215913|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
2215914|NCT00027820|Fludarabine|fludarabine|mesh-list
2215915|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
596379|NCT03530488|Lidocaine|lidocaine|mesh-list
596380|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
596381|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
596382|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596383|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596384|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
596385|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596386|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
596387|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
596388|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
596389|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
596390|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596391|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
596392|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
596393|NCT03530462|Rituximab|rituximab|mesh-list
596394|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
596395|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
596396|NCT03530462|Antibodies|antibodies|mesh-list
596397|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
596398|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
596399|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
596400|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
596401|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596402|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
596403|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
596404|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
596405|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596406|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596407|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
596408|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
596409|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
596410|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
596411|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
596412|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596413|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
596414|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
596415|NCT03530462|Hormones|hormones|mesh-ancestor
596416|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
596417|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
596418|NCT03530462|Protective Agents|protective agents|mesh-ancestor
596419|NCT03530436|Curcumin|curcumin|mesh-list
596420|NCT03530436|Turmeric extract|turmeric extract|mesh-list
596421|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
596422|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
596423|NCT03530436|Analgesics|analgesics|mesh-ancestor
596424|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
596425|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596426|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596427|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2215916|NCT00027820|Cyclosporins|cyclosporins|mesh-list
596428|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
596429|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596430|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596431|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596432|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
596433|NCT03530436|Protective Agents|protective agents|mesh-ancestor
2077689|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2077690|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
2077691|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
2077692|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2077693|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2077694|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2077695|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2077696|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
2077697|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
596443|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
596444|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
596445|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596446|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596447|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
596448|NCT03530371|Analgesics|analgesics|mesh-ancestor
596449|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
596450|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596451|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
596452|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
596453|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
596454|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
596455|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
596456|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596457|NCT03530319|Azithromycin|azithromycin|mesh-list
596458|NCT03530319|Doxycycline|doxycycline|mesh-list
596459|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
596460|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
596461|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
596462|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
596463|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
596464|NCT03530280|Pregabalin|pregabalin|mesh-list
596465|NCT03530280|Bupivacaine|bupivacaine|mesh-list
596466|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
596467|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
596468|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596469|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596470|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
596471|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596472|NCT03530280|Analgesics|analgesics|mesh-ancestor
596473|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
596474|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
596475|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
596476|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596477|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
596478|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
596479|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
596480|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
596481|NCT03530267|Aflibercept|aflibercept|mesh-list
596482|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
596483|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
596484|NCT03530267|Growth Substances|growth substances|mesh-ancestor
596485|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596486|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
596487|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596488|NCT03530228|Esomeprazole|esomeprazole|mesh-list
596489|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
596490|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
596491|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
596492|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596493|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596494|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
596495|NCT03530189|Insulin|insulin|mesh-list
596496|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
596497|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596498|NCT03530176|Listerine|listerine|mesh-list
596499|NCT03530176|Fluorides|fluorides|mesh-list
596500|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
596501|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
596502|NCT03530176|Protective Agents|protective agents|mesh-ancestor
596503|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596504|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
596505|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
596506|NCT03530150|Pirfenidone|pirfenidone|mesh-list
596507|NCT03530150|Analgesics|analgesics|mesh-ancestor
596508|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
596509|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596510|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596511|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
596512|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
596513|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
596514|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
596515|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596520|NCT03530085|Fludarabine|fludarabine|mesh-list
596521|NCT03530085|Busulfan|busulfan|mesh-list
596522|NCT03530085|Decitabine|decitabine|mesh-list
596523|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596524|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
596525|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
596526|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596527|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
596528|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
596529|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596530|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
596531|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
596532|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
596533|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596534|NCT03530033|Lidocaine|lidocaine|mesh-list
596535|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
596536|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
596537|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596538|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596539|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
596540|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596541|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
596542|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
596543|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
596544|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
596545|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596546|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
596547|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
596548|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
596549|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596550|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596551|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
596552|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
596553|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596554|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596555|NCT03530007|Ondansetron|ondansetron|mesh-list
596556|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
596557|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
596558|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596559|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596560|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
596561|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
596562|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
596563|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
596564|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
596565|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
596566|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596567|NCT03530007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
596568|NCT03530007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
596569|NCT03530007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596570|NCT03530007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
596571|NCT03530007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
596572|NCT03529955|Apremilast|apremilast|mesh-list
596573|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
596574|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
596575|NCT03529955|Analgesics|analgesics|mesh-ancestor
596576|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
596577|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596578|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596579|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
596580|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
596581|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
596582|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
596583|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596584|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215917|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215918|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2215919|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
2215920|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215921|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215922|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
2215923|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596593|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
596594|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
596595|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
596596|NCT03529929|Prednisolone|prednisolone|mesh-list
596597|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
596598|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
596599|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
596600|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
596601|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
596602|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
596603|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596604|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596605|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
596606|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
596607|NCT03529929|Hormones|hormones|mesh-ancestor
596608|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
596609|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
596610|NCT03529929|Protective Agents|protective agents|mesh-ancestor
596611|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
596612|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077698|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077699|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2077700|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
2077701|NCT02031640|Hormones|hormones|mesh-ancestor
2077702|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2077703|NCT02032173|Ranibizumab|ranibizumab|mesh-list
2077704|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2077705|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2077706|NCT02032173|Growth Substances|growth substances|mesh-ancestor
596622|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
596623|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
596624|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596625|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596626|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
596627|NCT03529643|Analgesics|analgesics|mesh-ancestor
596628|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
596629|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596630|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
596631|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
596632|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
596633|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
596634|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
596635|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596636|NCT03529487|Phenylephrine|phenylephrine|mesh-list
596637|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
596638|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
596639|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
596640|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
596641|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
596642|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596643|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596644|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
596645|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
596646|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596647|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
596648|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
596649|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
596650|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
596651|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
596652|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
596653|NCT03529487|Protective Agents|protective agents|mesh-ancestor
596654|NCT03529448|Temozolomide|temozolomide|mesh-list
596655|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
596656|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
596657|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596658|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596659|NCT03529422|Durvalumab|durvalumab|mesh-list
596660|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
596661|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596662|NCT03529396|Chloroquine|chloroquine|mesh-list
596663|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
596664|NCT03529396|Primaquine|primaquine|mesh-list
596665|NCT03529396|Amebicides|amebicides|mesh-ancestor
596666|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
596667|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
596668|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
596669|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
596670|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
596671|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
596672|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
596673|NCT03529396|Analgesics|analgesics|mesh-ancestor
596674|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
596675|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596676|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596677|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
596678|NCT03529396|Filaricides|filaricides|mesh-ancestor
596679|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
596680|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
596681|NCT03529331|Acetaminophen|acetaminophen|mesh-list
596682|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
596683|NCT03529331|Morphine|morphine|mesh-list
596684|NCT03529331|Oxycodone|oxycodone|mesh-list
596685|NCT03529331|Hydrocodone|hydrocodone|mesh-list
596686|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
596687|NCT03529331|Narcotics|narcotics|mesh-ancestor
596688|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596689|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596690|NCT03529331|Analgesics|analgesics|mesh-ancestor
596691|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
596692|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596693|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
596694|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
596695|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
596696|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
596697|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
596698|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
596699|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
596700|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
596701|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
596702|NCT03529266|Coagulants|coagulants|mesh-ancestor
596703|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
596704|NCT03529253|Calcium|calcium|mesh-list
596705|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
596706|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596707|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
596708|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
596709|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
596710|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596711|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
596712|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
596713|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596714|NCT03529201|Fentanyl|fentanyl|mesh-list
596715|NCT03529201|Oxycodone|oxycodone|mesh-list
596716|NCT03529201|Sevoflurane|sevoflurane|mesh-list
596717|NCT03529201|Rocuronium|rocuronium|mesh-list
596718|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
596719|NCT03529201|Narcotics|narcotics|mesh-ancestor
596720|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596721|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596722|NCT03529201|Analgesics|analgesics|mesh-ancestor
596723|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
596724|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596725|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
596726|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
596727|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
596728|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
596729|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
596730|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
596731|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
596732|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
596733|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
596734|NCT03529175|Gemcitabine|gemcitabine|mesh-list
596735|NCT03529175|Paclitaxel|paclitaxel|mesh-list
596736|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
596737|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
596738|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596739|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
596740|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
596741|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
596742|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596743|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
596744|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
596745|NCT03529175|Antiviral Agents|antiviral agents|mesh-ancestor
596746|NCT03529175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
596747|NCT03529175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596748|NCT03529175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
596749|NCT03529175|Immunologic Factors|immunologic factors|mesh-ancestor
596750|NCT03529175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596751|NCT03529149|Diltiazem|diltiazem|mesh-list
596752|NCT03529149|Urapidil|urapidil|mesh-list
596753|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
596754|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
596755|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
596756|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596757|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
596758|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596759|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
596760|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
596761|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
596762|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
596763|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
596764|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
596765|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
596766|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
596767|NCT03529123|Insulin|insulin|mesh-list
596768|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
596769|NCT03529123|Metformin|metformin|mesh-list
596770|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
596771|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
596772|NCT03529123|Lixisenatide|lixisenatide|mesh-list
596773|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
596774|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596792|NCT03529097|Dipyrone|dipyrone|mesh-list
596793|NCT03529097|Diclofenac|diclofenac|mesh-list
596794|NCT03529097|Morphine|morphine|mesh-list
596795|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
596796|NCT03529097|Narcotics|narcotics|mesh-ancestor
596797|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596798|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596799|NCT03529097|Analgesics|analgesics|mesh-ancestor
596800|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
596801|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596802|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
596803|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
596804|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
596805|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
596806|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
596807|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596808|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596809|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
596810|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
596811|NCT03529084|Gefitinib|gefitinib|mesh-list
596812|NCT03529084|Nazartinib|nazartinib|mesh-list
596813|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596814|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
596815|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596816|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596817|NCT03529032|Methadone|methadone|mesh-list
596818|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
596819|NCT03529032|Narcotics|narcotics|mesh-ancestor
596820|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596821|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596822|NCT03529032|Analgesics|analgesics|mesh-ancestor
596823|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
596824|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596825|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
596826|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
596827|NCT03528967|Aspirin|aspirin|mesh-list
596828|NCT03528967|Enoxaparin|enoxaparin|mesh-list
596829|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
596830|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
596831|NCT03528967|Analgesics|analgesics|mesh-ancestor
596832|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
596833|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596834|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596835|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
596836|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
596837|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
596838|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
596839|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596840|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
596841|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
596842|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596843|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
596844|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
596845|NCT03528954|Propofol|propofol|mesh-list
596846|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
596847|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
596848|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596849|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
596850|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
596851|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
596852|NCT03528941|Lamivudine|lamivudine|mesh-list
596853|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
596854|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
596855|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596856|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596857|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
596858|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
596859|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
596860|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
596861|NCT03528915|Rifamycins|rifamycins|mesh-list
596862|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
596863|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
596864|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
596865|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
596866|NCT03528902|Tamoxifen|tamoxifen|mesh-list
596867|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
596868|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
596869|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
596870|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596871|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
596872|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596873|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
596874|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
596875|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
596876|NCT03528824|Diclofenac|diclofenac|mesh-list
596877|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
596878|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
596879|NCT03528824|Analgesics|analgesics|mesh-ancestor
596880|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
597475|NCT03525652|Vaccines|vaccines|mesh-list
596881|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596882|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596883|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
596884|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
596885|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
596886|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596887|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596888|NCT03528785|Leucovorin|leucovorin|mesh-list
596889|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
596890|NCT03528785|Irinotecan|irinotecan|mesh-list
596891|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
596892|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
596893|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
596894|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
596895|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596896|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596897|NCT03528785|Antidotes|antidotes|mesh-ancestor
596898|NCT03528785|Protective Agents|protective agents|mesh-ancestor
596899|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596900|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
596901|NCT03528785|Vitamins|vitamins|mesh-ancestor
596902|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
596903|NCT03528772|Minoxidil|minoxidil|mesh-list
596904|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
596905|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
596906|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
2077707|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077708|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
2077709|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077710|NCT02032212|Nicotine|nicotine|mesh-list
2077711|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2077712|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
2077713|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077714|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077715|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2077716|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2077717|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
2077718|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
596919|NCT03528616|Propranolol|propranolol|mesh-list
596920|NCT03528616|Digoxin|digoxin|mesh-list
596921|NCT03528616|Adenosine|adenosine|mesh-list
596922|NCT03528616|Amiodarone|amiodarone|mesh-list
596923|NCT03528616|Flecainide|flecainide|mesh-list
596924|NCT03528616|Procainamide|procainamide|mesh-list
596925|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
596926|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
596927|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
596928|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
596929|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
596930|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596931|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
596932|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
596933|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
596934|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
596935|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
596936|NCT03528616|Protective Agents|protective agents|mesh-ancestor
596937|NCT03528616|Analgesics|analgesics|mesh-ancestor
596938|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
596939|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
596940|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
596941|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
596942|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
596943|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
596944|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
596945|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
596946|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
596947|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
596948|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
596949|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
596950|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
596951|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2215924|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215925|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
2215926|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215927|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
2215928|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
597476|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
2215929|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2215930|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2215931|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2215932|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
2215933|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2215934|NCT00027833|Leucovorin|leucovorin|mesh-list
2215935|NCT00027833|Fluorouracil|fluorouracil|mesh-list
2215936|NCT00027833|Irinotecan|irinotecan|mesh-list
2215937|NCT00027833|Calcium|calcium|mesh-list
2215938|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
2215939|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2215940|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
596969|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
596970|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
596971|NCT03528564|Hematinics|hematinics|mesh-ancestor
2077719|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077720|NCT02032407|Dapsone|dapsone|mesh-list
596974|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
596975|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
596976|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215941|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
2215942|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215943|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2215944|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215945|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2215946|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
2215947|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2215948|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2215949|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215950|NCT00027833|Antidotes|antidotes|mesh-ancestor
2215951|NCT00027833|Protective Agents|protective agents|mesh-ancestor
2215952|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
2215953|NCT00027833|Vitamins|vitamins|mesh-ancestor
2215954|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
2215955|NCT00027859|Ketoconazole|ketoconazole|mesh-list
2215956|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
2215957|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2215958|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2215959|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2215960|NCT00027859|Docetaxel|docetaxel|mesh-list
2215961|NCT00027859|Estramustine|estramustine|mesh-list
2215962|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215963|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
2215964|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
2215965|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
597002|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
597003|NCT03528421|Fludarabine|fludarabine|mesh-list
597004|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
597005|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
597006|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597007|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
597008|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
597009|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
597010|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597011|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597012|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2077721|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077722|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
2077723|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2077724|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2077725|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2077726|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215966|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215967|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2215968|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
2215969|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2215970|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2215971|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2215972|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2215973|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
597027|NCT03528070|Tranilast|tranilast|mesh-list
597028|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
597029|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
597030|NCT03528070|Analgesics|analgesics|mesh-ancestor
597031|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
597032|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597853|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
597033|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597034|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
597035|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
597036|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
597037|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
597038|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597039|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
597040|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
597041|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
597042|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
597043|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597044|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
597045|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
597046|NCT03528057|Hemostatics|hemostatics|mesh-list
597047|NCT03528057|Coagulants|coagulants|mesh-ancestor
597048|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
597049|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
597050|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597051|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597052|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597053|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
597054|NCT03527836|Lidocaine|lidocaine|mesh-list
597055|NCT03527836|Bupivacaine|bupivacaine|mesh-list
597056|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
597057|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
597058|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
597059|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597060|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
597061|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597062|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
597063|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
597064|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
597065|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
597066|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215974|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
2215975|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2215976|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215977|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2215978|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2215979|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
2215980|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2215981|NCT00027872|Tipifarnib|tipifarnib|mesh-list
2215982|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215983|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
2215984|NCT00027885|Bevacizumab|bevacizumab|mesh-list
2215985|NCT00027885|Docetaxel|docetaxel|mesh-list
597079|NCT03527732|Ivermectin|ivermectin|mesh-list
597080|NCT03527732|Albendazole|albendazole|mesh-list
597081|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
597082|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
597083|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
597084|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
597085|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
597086|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
597087|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
597088|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
597089|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
597090|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597091|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597092|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
597093|NCT03527628|Dacarbazine|dacarbazine|mesh-list
597094|NCT03527628|Doxorubicin|doxorubicin|mesh-list
597095|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
597096|NCT03527628|Bleomycin|bleomycin|mesh-list
597097|NCT03527628|Vinblastine|vinblastine|mesh-list
597098|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
597099|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
597100|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
597101|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597102|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
597103|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
597104|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
597105|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597106|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597107|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
597108|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
597109|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
597110|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
597111|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597112|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
597113|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
597114|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
597115|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
597116|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597117|NCT03527576|Dexamethasone|dexamethasone|mesh-list
597118|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
597119|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
597120|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
597121|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597122|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597123|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
597124|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
597125|NCT03527576|Hormones|hormones|mesh-ancestor
597126|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
597127|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
597128|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597132|NCT03527472|Memantine|memantine|mesh-list
597133|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
597134|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
597135|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
597136|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597137|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597138|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597139|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
597140|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
597141|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
597142|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
597143|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
597144|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597145|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597146|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
597147|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
597148|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
597149|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
597150|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597151|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597152|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
597153|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
597154|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
597155|NCT03527381|Protective Agents|protective agents|mesh-ancestor
597156|NCT03527355|Vaccines|vaccines|mesh-list
597157|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
597158|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597170|NCT03527264|Nivolumab|nivolumab|mesh-list
597171|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597172|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597173|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
597174|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597175|NCT03527251|Ipilimumab|ipilimumab|mesh-list
597176|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597177|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597178|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
597179|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215986|NCT00027885|Doxorubicin|doxorubicin|mesh-list
2215987|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2215988|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
597202|NCT03527147|Rituximab|rituximab|mesh-list
597203|NCT03527147|Magrolimab|magrolimab|mesh-list
597204|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
597205|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597206|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597207|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
597208|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597209|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
597210|NCT03527134|Amantadine|amantadine|mesh-list
597211|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
597212|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
597213|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
597214|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
597215|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
597216|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597217|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597218|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597219|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
597220|NCT03527134|Analgesics|analgesics|mesh-ancestor
597221|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
597222|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597223|NCT03527108|Nivolumab|nivolumab|mesh-list
597224|NCT03527108|Ramucirumab|ramucirumab|mesh-list
597225|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597226|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597227|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
597228|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597229|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
597230|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
597231|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
597232|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
597233|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597234|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
597235|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
597236|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597237|NCT03527043|Citalopram|citalopram|mesh-list
597238|NCT03527043|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
597239|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
597240|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
597241|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597242|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597243|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
597244|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597245|NCT03527043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
597246|NCT03527043|Antidepressive Agents|antidepressive agents|mesh-ancestor
597247|NCT03527043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2077727|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597250|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
597251|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597252|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597253|NCT03526874|Lidocaine|lidocaine|mesh-list
597254|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
597255|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
597256|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
597257|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597258|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
597259|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597260|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
597261|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
597262|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
597263|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
597264|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597272|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
597273|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
597274|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
597275|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
597281|NCT03526575|Zaleplon|zaleplon|mesh-list
597282|NCT03526575|Zolpidem|zolpidem|mesh-list
597283|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
597284|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
597285|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
597286|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597287|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
597288|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
597289|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
597290|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597291|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597292|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
597293|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
597294|NCT03526536|Insulin|insulin|mesh-list
597295|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
597296|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
597297|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597298|NCT03526445|Glucagon|glucagon|mesh-list
597299|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
597300|NCT03526445|Hormones|hormones|mesh-ancestor
597301|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
597302|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597303|NCT03526432|Bevacizumab|bevacizumab|mesh-list
597304|NCT03526432|Atezolizumab|atezolizumab|mesh-list
597305|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597306|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597307|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
597308|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
597309|NCT03526432|Growth Substances|growth substances|mesh-ancestor
597310|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597311|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
597312|NCT03526419|Bupivacaine|bupivacaine|mesh-list
597313|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
597314|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
597315|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
597316|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597317|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
597318|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597319|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
597320|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
597321|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
597322|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
597323|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597324|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
597325|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
597326|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597927|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
597338|NCT03526315|Fluorides|fluorides|mesh-list
597339|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
597340|NCT03526315|Protective Agents|protective agents|mesh-ancestor
597341|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597342|NCT03526276|Fluorides|fluorides|mesh-list
597343|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
597344|NCT03526276|Protective Agents|protective agents|mesh-ancestor
597345|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077728|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
2077729|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2077730|NCT02032433|Naltrexone|naltrexone|mesh-list
2077731|NCT02032433|Buprenorphine|buprenorphine|mesh-list
2077732|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
597351|NCT03526224|Teriflunomide|teriflunomide|mesh-list
597352|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
597353|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
597354|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
597355|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
597356|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597357|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
597358|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
597359|NCT03526224|Analgesics|analgesics|mesh-ancestor
597360|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
597361|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597362|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
597363|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
597364|NCT03526185|Nivolumab|nivolumab|mesh-list
597365|NCT03526185|Ipilimumab|ipilimumab|mesh-list
597366|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597367|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597368|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
597369|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597370|NCT03526159|Gentamicins|gentamicins|mesh-list
597371|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
597372|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
597373|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
597374|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597375|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597376|NCT03526107|Theobromine|theobromine|mesh-list
597377|NCT03526107|Caffeine|caffeine|mesh-list
597378|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
597379|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597380|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
597381|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597382|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597383|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
597384|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
597385|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
597386|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597387|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
597388|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
597389|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597390|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
597391|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
597392|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
597393|NCT03526042|Losartan|losartan|mesh-list
597394|NCT03526042|Enalapril|enalapril|mesh-list
597395|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
597396|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
597397|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
597398|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
597399|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
597400|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
597401|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597402|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
597403|NCT03525925|Nivolumab|nivolumab|mesh-list
597404|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597405|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597406|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
597407|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597408|NCT03525912|Ketamine|ketamine|mesh-list
597409|NCT03525912|Analgesics|analgesics|mesh-list
597410|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
597411|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597412|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597413|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
597414|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
597415|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
597416|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
597417|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
597418|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
597419|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
597420|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597421|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077733|NCT02032433|Naloxone|naloxone|mesh-list
2077734|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2077735|NCT02032433|Narcotics|narcotics|mesh-ancestor
2077736|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2077737|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077738|NCT02032433|Analgesics|analgesics|mesh-ancestor
2077739|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
2077740|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077741|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2215989|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
2215990|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215991|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2215992|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2215993|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
597436|NCT03525821|Ketamine|ketamine|mesh-list
597437|NCT03525821|Analgesics|analgesics|mesh-ancestor
597438|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
597439|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597440|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597441|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
597442|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
597443|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
597444|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
597445|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
597446|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
597447|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
597448|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597449|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597450|NCT03525795|Ipilimumab|ipilimumab|mesh-list
597451|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
597452|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597453|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597454|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
597455|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597456|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597457|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
597458|NCT03525730|Valproic Acid|valproic acid|mesh-list
597459|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
597460|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
597461|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
597462|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
597463|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
597464|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597465|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597466|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
597467|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
597468|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597469|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597470|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
597471|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
597472|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
597473|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
597474|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2077742|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
597477|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597478|NCT03525574|Ivacaftor|ivacaftor|mesh-list
597479|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
597480|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
597481|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597482|NCT03525561|Acetazolamide|acetazolamide|mesh-list
597483|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
597484|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
597485|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597486|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597487|NCT03525561|Diuretics|diuretics|mesh-ancestor
597488|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
597489|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2215994|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2215995|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2215996|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2215997|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2215998|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
597495|NCT03525522|Betamethasone|betamethasone|mesh-list
597496|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
597497|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
597498|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
597499|NCT03525522|Hormones|hormones|mesh-ancestor
597500|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
597501|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597502|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
597503|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
597504|NCT03525509|Morphine|morphine|mesh-list
597505|NCT03525509|Methadone|methadone|mesh-list
597506|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
597507|NCT03525509|Narcotics|narcotics|mesh-ancestor
597508|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
597509|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597510|NCT03525509|Analgesics|analgesics|mesh-ancestor
597511|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
597512|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597513|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
597514|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
2215999|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2216000|NCT00027885|Growth Substances|growth substances|mesh-ancestor
2216001|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
2216002|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216003|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
597520|NCT03525379|Resveratrol|resveratrol|mesh-list
597521|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
597522|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597523|NCT03525379|Protective Agents|protective agents|mesh-ancestor
597524|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597525|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597526|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
597527|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
597528|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2216004|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216005|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
597532|NCT03525028|Metformin|metformin|mesh-list
597533|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
597534|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597535|NCT03525002|Bromocriptine|bromocriptine|mesh-list
597536|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
597537|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
597538|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
597539|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
597540|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597541|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
597542|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
597543|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597544|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597545|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
597546|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
597547|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
597548|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597549|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
597550|NCT03524950|Analgesics|analgesics|mesh-ancestor
598454|NCT03520543|Yohimbine|yohimbine|mesh-list
597551|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
597552|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597553|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
597554|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
597555|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
597556|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
597557|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597558|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597559|NCT03524937|Melatonin|melatonin|mesh-list
597560|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
597561|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597562|NCT03524937|Protective Agents|protective agents|mesh-ancestor
597563|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597564|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2077743|NCT02032758|Propranolol|propranolol|mesh-list
2077744|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2077745|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2077746|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
2077747|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2077748|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077749|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077750|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2077751|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2077752|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
2077753|NCT02032810|Ipilimumab|ipilimumab|mesh-list
2077754|NCT02032810|Panobinostat|panobinostat|mesh-list
2077755|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2077756|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077757|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2077758|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597581|NCT03524872|Analgesics|analgesics|mesh-list
597582|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597583|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
597584|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597585|NCT03524846|Vitamins|vitamins|mesh-list
597586|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
597587|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
597588|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597589|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
597590|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597591|NCT03524846|Protective Agents|protective agents|mesh-ancestor
597592|NCT03524833|Amoxicillin|amoxicillin|mesh-list
597593|NCT03524833|Metronidazole|metronidazole|mesh-list
597594|NCT03524833|Lansoprazole|lansoprazole|mesh-list
597595|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
597596|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
597597|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
597598|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
597599|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
597600|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
597601|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
597602|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
597603|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597604|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597605|NCT03524820|Cetuximab|cetuximab|mesh-list
597606|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597607|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597608|NCT03524508|Fluorouracil|fluorouracil|mesh-list
597609|NCT03524508|Irinotecan|irinotecan|mesh-list
597610|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
597611|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597612|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
597613|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597614|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
597615|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
597616|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597617|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
597618|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
597619|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597620|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
597621|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
597622|NCT03524417|Antibodies|antibodies|mesh-list
597623|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
597624|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077759|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2077760|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077761|NCT02032875|Ribavirin|ribavirin|mesh-list
2077762|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
2077763|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
2077764|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077765|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
2077766|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077767|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
2077768|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
2077769|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077770|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
2077771|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
2077772|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077773|NCT02033369|Pramipexole|pramipexole|mesh-list
597641|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
597642|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
597643|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597644|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
597645|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597646|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597647|NCT03524274|Antibodies|antibodies|mesh-list
597648|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
597649|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
597650|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597651|NCT03524261|Antibodies|antibodies|mesh-list
597652|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
597653|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
597654|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077774|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
2077775|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077776|NCT02033369|Protective Agents|protective agents|mesh-ancestor
2077777|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077778|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2077779|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2077780|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
2077781|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
2077782|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2077783|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2077784|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
597666|NCT03524170|Atezolizumab|atezolizumab|mesh-list
597667|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216006|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2216007|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2216008|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216009|NCT00027898|Carboplatin|carboplatin|mesh-list
2216010|NCT00027898|Etoposide|etoposide|mesh-list
2216011|NCT00027898|Bortezomib|bortezomib|mesh-list
2216012|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
2216013|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077785|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2077786|NCT02033889|Insulin|insulin|mesh-list
2077787|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2077788|NCT02033889|Metformin|metformin|mesh-list
2077789|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
2077790|NCT02033889|Glimepiride|glimepiride|mesh-list
2077791|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
2077792|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
2077793|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2077794|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077795|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
597687|NCT03524079|Ajmaline|ajmaline|mesh-list
597688|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
597689|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
597690|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
597691|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
597692|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216014|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216015|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2216016|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2216017|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216018|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216019|NCT00027911|Sargramostim|sargramostim|mesh-list
2216020|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
2216021|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216022|NCT00027924|Cyclosporine|cyclosporine|mesh-list
2077796|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2077797|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
2077798|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2216023|NCT00027924|Methotrexate|methotrexate|mesh-list
2216024|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
2216025|NCT00027924|Fludarabine|fludarabine|mesh-list
2216026|NCT00027924|Busulfan|busulfan|mesh-list
2216027|NCT00027924|Cyclosporins|cyclosporins|mesh-list
2216028|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
597707|NCT03523975|Rituximab|rituximab|mesh-list
597708|NCT03523975|Lenalidomide|lenalidomide|mesh-list
597709|NCT03523975|Venetoclax|venetoclax|mesh-list
597710|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597711|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597712|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
597713|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597714|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
597715|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
597716|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
597717|NCT03523975|Growth Substances|growth substances|mesh-ancestor
597718|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
2077799|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077800|NCT02033993|Paclitaxel|paclitaxel|mesh-list
2077801|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
597722|NCT03523832|Celecoxib|celecoxib|mesh-list
597723|NCT03523832|Pregabalin|pregabalin|mesh-list
597724|NCT03523832|Analgesics|analgesics|mesh-ancestor
597725|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
597726|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597727|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597728|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
597729|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
597730|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
597731|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597732|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
597733|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
597734|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
597735|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
597736|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
597737|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
597738|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
597739|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
597740|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
597741|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
597742|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
597743|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597744|NCT03523754|Isosorbide|isosorbide|mesh-list
597745|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
597746|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
597747|NCT03523754|Misoprostol|misoprostol|mesh-list
597748|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
597749|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
597750|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
597751|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597752|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
597753|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
597754|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
597755|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
597756|NCT03523754|Diuretics|diuretics|mesh-ancestor
597757|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
597758|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
597759|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
597760|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597761|NCT03523741|Clozapine|clozapine|mesh-list
597762|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
597763|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
597764|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597765|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597766|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597767|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
597768|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
597769|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
597770|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
597771|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
597772|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
2216029|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
2216030|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2216031|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597776|NCT03523650|Propranolol|propranolol|mesh-list
597777|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2750967|NCT04122170|Aspirin|aspirin|mesh-list
597778|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
597779|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
597780|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597781|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597782|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597783|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
597784|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
597785|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
597786|NCT03523585|Capecitabine|capecitabine|mesh-list
597787|NCT03523585|Trastuzumab|trastuzumab|mesh-list
597788|NCT03523585|Lapatinib|lapatinib|mesh-list
597789|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
597790|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
597791|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597792|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597793|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597794|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
597795|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597796|NCT03523572|Nivolumab|nivolumab|mesh-list
597797|NCT03523572|Trastuzumab|trastuzumab|mesh-list
597798|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597799|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597800|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
597801|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597802|NCT03523520|Naltrexone|naltrexone|mesh-list
597803|NCT03523520|Bromides|bromides|mesh-list
597804|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
597805|NCT03523520|Naloxegol|naloxegol|mesh-list
597806|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
597807|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
597808|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597809|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
597810|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597811|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
597812|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
597813|NCT03523455|Hematinics|hematinics|mesh-ancestor
597814|NCT03523429|Blinatumomab|blinatumomab|mesh-list
597815|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597816|NCT03523390|Avelumab|avelumab|mesh-list
597817|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
597818|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077802|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2077803|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077804|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
2077805|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
2077806|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
597824|NCT03523273|Liraglutide|liraglutide|mesh-list
597825|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
597826|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597827|NCT03523273|Incretins|incretins|mesh-ancestor
597828|NCT03523273|Hormones|hormones|mesh-ancestor
597829|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
597830|NCT03523221|Dexamethasone|dexamethasone|mesh-list
597831|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
597832|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
597833|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
597834|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597835|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597836|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
597837|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
597838|NCT03523221|Hormones|hormones|mesh-ancestor
597839|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
597840|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
597841|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597842|NCT03523156|Azithromycin|azithromycin|mesh-list
597843|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
597844|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
597845|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
597846|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
597847|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
597848|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597849|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597850|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
597851|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
597852|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750968|NCT04122170|Ticagrelor|ticagrelor|mesh-list
597854|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597855|NCT03522987|Citalopram|citalopram|mesh-list
597856|NCT03522987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
597857|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
597858|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
597859|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597860|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597861|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
597862|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597863|NCT03522987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
597864|NCT03522987|Antidepressive Agents|antidepressive agents|mesh-ancestor
597865|NCT03522987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
597866|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
597867|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
597868|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
597869|NCT03522961|Renal Agents|renal agents|mesh-ancestor
597870|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
597871|NCT03522935|Elafin|elafin|mesh-list
597872|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
597873|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597874|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597875|NCT03522922|Ascorbic Acid|ascorbic acid|mesh-list
597876|NCT03522922|Vitamins|vitamins|mesh-ancestor
597877|NCT03522922|Micronutrients|micronutrients|mesh-ancestor
597878|NCT03522922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597879|NCT03522922|Antioxidants|antioxidants|mesh-ancestor
597880|NCT03522922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597881|NCT03522922|Protective Agents|protective agents|mesh-ancestor
597893|NCT03522831|Albuterol|albuterol|mesh-list
597894|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
597895|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
597896|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597897|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597898|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
597899|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
597900|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
597901|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
597902|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
597903|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
597904|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
597905|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
597906|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597907|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077807|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077808|NCT02034006|Ranibizumab|ranibizumab|mesh-list
2077809|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2077810|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2077811|NCT02034006|Growth Substances|growth substances|mesh-ancestor
2077812|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077813|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
2077814|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597916|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
597917|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
597918|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
597919|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597920|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
597921|NCT03522688|Analgesics|analgesics|mesh-ancestor
597922|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
597923|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
597924|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
597925|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
597926|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
597928|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
597929|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597930|NCT03522649|Leucovorin|leucovorin|mesh-list
597931|NCT03522649|Fluorouracil|fluorouracil|mesh-list
597932|NCT03522649|Irinotecan|irinotecan|mesh-list
597933|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
597934|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597935|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
597936|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597937|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
597938|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
597939|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597940|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
597941|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
597942|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597943|NCT03522649|Antidotes|antidotes|mesh-ancestor
597944|NCT03522649|Protective Agents|protective agents|mesh-ancestor
597945|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
597946|NCT03522649|Vitamins|vitamins|mesh-ancestor
597947|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
597960|NCT03522532|Zinc|zinc|mesh-list
597961|NCT03522532|Trace Elements|trace elements|mesh-ancestor
597962|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
597963|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216032|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2216033|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
2216034|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216035|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216036|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
2216037|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216038|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2216039|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216040|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
2216041|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216042|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2216043|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
2216044|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216045|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2216046|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
597979|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
597980|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
597981|NCT03522428|Vitamins|vitamins|mesh-ancestor
597982|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
597983|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597984|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
597985|NCT03522428|Hematinics|hematinics|mesh-ancestor
597986|NCT03522415|Methotrexate|methotrexate|mesh-list
597987|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
597988|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
597989|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
597990|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
597991|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
597992|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
597993|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
597994|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
597995|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
597996|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
597997|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
597998|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
597999|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
598000|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
598001|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
598002|NCT03522402|Sevoflurane|sevoflurane|mesh-list
598003|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2216047|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
598004|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
598005|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
598006|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
598007|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
598008|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598009|NCT03522298|GDC-0084|gdc-0084|mesh-list
598010|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598011|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598012|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
598013|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
598014|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
598015|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
598016|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
598017|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598018|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598019|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
2077815|NCT02034019|Dexamethasone|dexamethasone|mesh-list
2077816|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2077817|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
2077818|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
2077819|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077820|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077821|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2077822|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
598028|NCT03522207|Trazodone|trazodone|mesh-list
598029|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
598030|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
598031|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
598032|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598033|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
598034|NCT03522207|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
598035|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
598036|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
598037|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598038|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
598039|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
598040|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
598041|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
598042|NCT03522194|Propofol|propofol|mesh-list
598043|NCT03522194|Sevoflurane|sevoflurane|mesh-list
598044|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
598045|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
598046|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598047|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
598048|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
598049|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
598050|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
598051|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
598052|NCT03522181|Insulin|insulin|mesh-list
598053|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
598054|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
598055|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598056|NCT03522168|Risperidone|risperidone|mesh-list
598057|NCT03522168|Aripiprazole|aripiprazole|mesh-list
598058|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
598059|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
598060|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
598061|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598062|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598063|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
598064|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
598065|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
598066|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
598067|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
598068|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
598069|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
598070|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
598071|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
598072|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
598073|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
598074|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
598075|NCT03522077|Hemostatics|hemostatics|mesh-list
598076|NCT03522077|Coagulants|coagulants|mesh-ancestor
2077823|NCT02034019|Hormones|hormones|mesh-ancestor
2077824|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2077825|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2077826|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077827|NCT02034162|Mebendazole|mebendazole|mesh-list
2077828|NCT02034162|Piperazine|piperazine|mesh-list
2077829|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
2077830|NCT02034162|DMP 777|dmp 777|mesh-list
2077831|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
2077832|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
2077833|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2077834|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077835|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
2077836|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
598091|NCT03522051|Calcium|calcium|mesh-list
598092|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
598093|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598094|NCT03521960|Buspirone|buspirone|mesh-list
598095|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
598096|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
598097|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
598098|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598099|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
598100|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
598101|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
598102|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
598103|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598104|NCT03521934|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
598105|NCT03521934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
598106|NCT03521934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598107|NCT03521934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
598108|NCT03521934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598109|NCT03521895|Aflibercept|aflibercept|mesh-list
598110|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
598111|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
598112|NCT03521895|Growth Substances|growth substances|mesh-ancestor
598113|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598114|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
598115|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598116|NCT03521830|Nivolumab|nivolumab|mesh-list
598117|NCT03521830|Ipilimumab|ipilimumab|mesh-list
598118|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
598119|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598120|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
598121|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216048|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2216049|NCT00027937|Aldesleukin|aldesleukin|mesh-list
2216050|NCT00027937|Paclitaxel|paclitaxel|mesh-list
2216051|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
2216052|NCT00027937|Melphalan|melphalan|mesh-list
2216053|NCT00027937|Busulfan|busulfan|mesh-list
2216054|NCT00027937|Thiotepa|thiotepa|mesh-list
2216055|NCT00027937|Sargramostim|sargramostim|mesh-list
2216056|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216057|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216058|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216059|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216060|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216061|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598136|NCT03521726|Amoxicillin|amoxicillin|mesh-list
598137|NCT03521726|Rabeprazole|rabeprazole|mesh-list
598138|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
598139|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
598140|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
598141|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
598142|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
598143|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598144|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598145|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
598146|NCT03521713|Hematinics|hematinics|mesh-ancestor
598147|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
598148|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
598149|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
598150|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
598151|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077837|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216062|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216063|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
598152|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
598153|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
598154|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598155|NCT03521687|Apremilast|apremilast|mesh-list
598156|NCT03521687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
598157|NCT03521687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
598158|NCT03521687|Analgesics|analgesics|mesh-ancestor
598159|NCT03521687|Sensory System Agents|sensory system agents|mesh-ancestor
598160|NCT03521687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598161|NCT03521687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598162|NCT03521687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
598163|NCT03521687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
598164|NCT03521687|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
598165|NCT03521687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
598166|NCT03521687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598167|NCT03521687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216064|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216065|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216066|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2216067|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
2216068|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2216069|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2216070|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2216071|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
2216072|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216073|NCT00027963|Gabapentin|gabapentin|mesh-list
598178|NCT03521570|Nivolumab|nivolumab|mesh-list
598179|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
598180|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598181|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
598182|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216074|NCT00027963|Analgesics|analgesics|mesh-ancestor
2216075|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
2216076|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2216077|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216078|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
2216079|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2216080|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2216081|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2216082|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2216083|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2216084|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2216085|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2216086|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216087|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
2216088|NCT00027976|Celecoxib|celecoxib|mesh-list
2216089|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2216090|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2216091|NCT00027976|Analgesics|analgesics|mesh-ancestor
598201|NCT03521492|Vitamin D|vitamin d|mesh-list
598202|NCT03521492|Calcium|calcium|mesh-list
598203|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
598204|NCT03521492|Hormones|hormones|mesh-list
598205|NCT03521492|Vitamins|vitamins|mesh-ancestor
598206|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
598207|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598208|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
598209|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
598210|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2216092|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
2216093|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2216094|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216095|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
598215|NCT03521414|Sevoflurane|sevoflurane|mesh-list
598216|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
598217|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
598218|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
598219|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
598220|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
598221|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598222|NCT03521245|Trastuzumab|trastuzumab|mesh-list
598223|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
598224|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598232|NCT03521219|Apatinib|apatinib|mesh-list
598233|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598234|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
598235|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598236|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077838|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077839|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077840|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077841|NCT02034435|Amlodipine|amlodipine|mesh-list
2077842|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2077843|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2077844|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2077845|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077846|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2077847|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077848|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
2077849|NCT02034513|Insulin|insulin|mesh-list
2077850|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2077851|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
2077852|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
2077853|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
598253|NCT03521167|Acetaminophen|acetaminophen|mesh-list
598254|NCT03521167|Lidocaine|lidocaine|mesh-list
598255|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
598256|NCT03521167|Ketamine|ketamine|mesh-list
598257|NCT03521167|Gabapentin|gabapentin|mesh-list
598258|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
598259|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
598260|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
598261|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598262|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
598263|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598264|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
598265|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
598266|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
598267|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
598268|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598269|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
598270|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
598271|NCT03521167|Analgesics|analgesics|mesh-ancestor
598272|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
598273|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
598274|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
598275|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
598276|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
598277|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
598278|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
598279|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
598280|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
598281|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
598282|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
598283|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
598284|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
598285|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
598286|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
598287|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
2077854|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077855|NCT02034552|Prednisone|prednisone|mesh-list
2077856|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
2077857|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2077858|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2216096|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216097|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2216098|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2216099|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216100|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216101|NCT00027989|Gemcitabine|gemcitabine|mesh-list
2216102|NCT00027989|Doxorubicin|doxorubicin|mesh-list
2216103|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2216104|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2077859|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
2216105|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
2077860|NCT02034552|Hormones|hormones|mesh-ancestor
2077861|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2077862|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077863|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2077864|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077865|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2077866|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077867|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077868|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
2077869|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2077870|NCT02034565|Apixaban|apixaban|mesh-list
598315|NCT03521063|Budesonide|budesonide|mesh-list
598316|NCT03521063|Poractant alfa|poractant alfa|mesh-list
598317|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
598318|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
598319|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
598320|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598321|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598322|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
598323|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
598324|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
598325|NCT03521063|Hormones|hormones|mesh-ancestor
598326|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
598327|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2077871|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2077872|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
2077873|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2077874|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
2077875|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598333|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
598334|NCT03521024|Ether|ether|mesh-list
598335|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
598336|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
598337|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598338|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598339|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
598340|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
598341|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
598342|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598343|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
598344|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
598345|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
598346|NCT03520985|Dexamethasone|dexamethasone|mesh-list
598347|NCT03520985|Pomalidomide|pomalidomide|mesh-list
598348|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
598349|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
598350|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
598351|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598352|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598353|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
598354|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
598355|NCT03520985|Hormones|hormones|mesh-ancestor
598356|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
598357|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
598358|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598359|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
598360|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
598361|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
598362|NCT03520985|Growth Substances|growth substances|mesh-ancestor
598363|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
598364|NCT03520946|Ramucirumab|ramucirumab|mesh-list
598365|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077876|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077877|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
2077878|NCT02034578|Apixaban|apixaban|mesh-list
2077879|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2077880|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
2077881|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2077882|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
2077883|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077884|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598408|NCT03520686|Paclitaxel|paclitaxel|mesh-list
598409|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
598410|NCT03520686|Cisplatin|cisplatin|mesh-list
598411|NCT03520686|Carboplatin|carboplatin|mesh-list
598412|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
598413|NCT03520686|Pemetrexed|pemetrexed|mesh-list
598414|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
598415|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598416|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
598417|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
598418|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
598419|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598420|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
598421|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598422|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
598423|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2077885|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
2077886|NCT02034591|Apixaban|apixaban|mesh-list
2077887|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
598437|NCT03520595|Diclofenac|diclofenac|mesh-list
598438|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
598439|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
598440|NCT03520595|Analgesics|analgesics|mesh-ancestor
598441|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
598442|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598443|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598444|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
598445|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
598446|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
598447|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598448|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598449|NCT03520569|Octreotide|octreotide|mesh-list
598450|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
598451|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
598452|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598453|NCT03520543|Clonidine|clonidine|mesh-list
2077888|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
598455|NCT03520543|Analgesics|analgesics|mesh-ancestor
598456|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
598457|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598458|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598459|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
598460|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
598461|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
598462|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
598463|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
598464|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
598465|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
598466|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
598467|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598468|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
598469|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
598470|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
598471|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
598472|NCT03520543|Urological Agents|urological agents|mesh-ancestor
598473|NCT03520491|Nivolumab|nivolumab|mesh-list
598474|NCT03520491|Ipilimumab|ipilimumab|mesh-list
598475|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
598476|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598477|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
598478|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598479|NCT03520478|Bicalutamide|bicalutamide|mesh-list
598480|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
598481|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
598482|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
598483|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598484|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598485|NCT03520439|Mifepristone|mifepristone|mesh-list
598486|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
598487|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
598488|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
598489|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598490|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
598491|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
598492|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
598493|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
598494|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
598495|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
598496|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
598497|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
598498|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
598499|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
598500|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
598501|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2216106|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216107|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216108|NCT00027989|Antiviral Agents|antiviral agents|mesh-ancestor
2216109|NCT00027989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
598507|NCT03520257|Apatinib|apatinib|mesh-list
598508|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598509|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
598510|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598511|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077889|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2077890|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
2077891|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077892|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077893|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
2077894|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2077895|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
2077896|NCT02034799|Coagulants|coagulants|mesh-ancestor
2077897|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2077898|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
2077899|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077900|NCT02034916|Talazoparib|talazoparib|mesh-list
2077901|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2077902|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077903|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077904|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077905|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
598531|NCT03520062|Liraglutide|liraglutide|mesh-list
598532|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
598533|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598534|NCT03520062|Incretins|incretins|mesh-ancestor
598535|NCT03520062|Hormones|hormones|mesh-ancestor
598536|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
598537|NCT03520049|Oseltamivir|oseltamivir|mesh-list
598538|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
598539|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
598540|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598541|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750969|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2750970|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2750971|NCT04122170|Analgesics|analgesics|mesh-ancestor
2077906|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2077907|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2077908|NCT02035345|Carboplatin|carboplatin|mesh-list
2077909|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077910|NCT02035553|Pimavanserin|pimavanserin|mesh-list
2077911|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2077912|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2077913|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2077914|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2077915|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2077916|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077917|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2077918|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2077919|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2077920|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
2077921|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2077922|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2077923|NCT02035696|Vaccines|vaccines|mesh-list
2077924|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
2077925|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077926|NCT02036424|Dexamethasone|dexamethasone|mesh-list
2077927|NCT02036424|Bevacizumab|bevacizumab|mesh-list
2077928|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2077929|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077930|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2077931|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2077932|NCT02036424|Growth Substances|growth substances|mesh-ancestor
2077933|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077934|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
2077935|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2077936|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
2077937|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
2077938|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077939|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2077940|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
2077941|NCT02036424|Hormones|hormones|mesh-ancestor
2077942|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2077943|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2077944|NCT02036502|Dexamethasone|dexamethasone|mesh-list
2077945|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
2077946|NCT02036502|Lenalidomide|lenalidomide|mesh-list
2077947|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2077948|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
2077949|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
598590|NCT03519906|Metoprolol|metoprolol|mesh-list
598591|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
598592|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
598593|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
598594|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
598595|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598596|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598597|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
598598|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
598599|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
598600|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
598601|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
598602|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598603|NCT03519893|Losartan|losartan|mesh-list
598604|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
598605|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2216110|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598606|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
598607|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
598608|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216111|NCT00027989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216112|NCT00027989|Immunologic Factors|immunologic factors|mesh-ancestor
2216113|NCT00027989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216114|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2216115|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2216116|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2216117|NCT00028028|Sirolimus|sirolimus|mesh-list
2216118|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2216119|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216120|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2216121|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216122|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
2216123|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216124|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
2216125|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216126|NCT00028067|Atazanavir Sulfate|atazanavir sulfate|mesh-list
598625|NCT03519776|Progesterone|progesterone|mesh-list
598626|NCT03519776|Progestins|progestins|mesh-ancestor
598627|NCT03519776|Hormones|hormones|mesh-ancestor
598628|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
598629|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598630|NCT03519750|Melatonin|melatonin|mesh-list
598631|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
598632|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598633|NCT03519750|Protective Agents|protective agents|mesh-ancestor
598634|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598635|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
598636|NCT03519724|Neostigmine|neostigmine|mesh-list
598637|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
598638|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598639|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598640|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
598641|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
598642|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598643|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
598644|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
598645|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598646|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
598647|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
598648|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598649|NCT03519646|Eliglustat|eliglustat|mesh-list
598650|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598651|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598652|NCT03519633|Neostigmine|neostigmine|mesh-list
598653|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
598654|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598655|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598656|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
598657|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
598658|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598659|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
598660|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
598661|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598662|NCT03519568|Vaccines|vaccines|mesh-list
598663|NCT03519568|Immunologic Factors|immunologic factors|mesh-ancestor
598664|NCT03519568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598665|NCT03519542|Sunitinib|sunitinib|mesh-list
598666|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598667|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
598668|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
598669|NCT03519542|Growth Substances|growth substances|mesh-ancestor
598670|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598671|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
598672|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
598673|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598674|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216127|NCT00028067|Nelfinavir|nelfinavir|mesh-list
2216128|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2216129|NCT00028067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2216130|NCT00028067|Protease Inhibitors|protease inhibitors|mesh-ancestor
2216131|NCT00028067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216132|NCT00028067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216133|NCT00028067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2216134|NCT00028067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2216135|NCT00028067|Antiviral Agents|antiviral agents|mesh-ancestor
2216136|NCT00028067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216137|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2216138|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216139|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216140|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216141|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
598690|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
598691|NCT03519412|Temozolomide|temozolomide|mesh-list
598692|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
598693|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598694|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
598695|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
598696|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598697|NCT03519386|Travoprost|travoprost|mesh-list
598698|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
598699|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
598700|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
598701|NCT03519308|Gemcitabine|gemcitabine|mesh-list
598702|NCT03519308|Paclitaxel|paclitaxel|mesh-list
598703|NCT03519308|Nivolumab|nivolumab|mesh-list
598704|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
598705|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598706|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
598707|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
598708|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
598709|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598710|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
598711|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
598712|NCT03519308|Antiviral Agents|antiviral agents|mesh-ancestor
598713|NCT03519308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
598714|NCT03519308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598715|NCT03519308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
598716|NCT03519308|Immunologic Factors|immunologic factors|mesh-ancestor
598717|NCT03519308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598718|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
598719|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2750972|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
2750973|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598722|NCT03519256|Nivolumab|nivolumab|mesh-list
598723|NCT03519256|Linrodostat|linrodostat|mesh-list
598724|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
598725|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598726|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
598727|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598728|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216142|NCT00028132|Tenofovir|tenofovir|mesh-list
2216143|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
2216144|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216145|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2216146|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2216147|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216148|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216149|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2216150|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2216151|NCT00028171|Tacrolimus|tacrolimus|mesh-list
2216152|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216153|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
2216154|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216155|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
598743|NCT03519152|Diclofenac|diclofenac|mesh-list
598744|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
598745|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
598746|NCT03519152|Analgesics|analgesics|mesh-ancestor
598747|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
598748|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598749|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598750|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
598751|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
598752|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
598753|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216156|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598754|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598755|NCT03519074|Cisplatin|cisplatin|mesh-list
598756|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598757|NCT03519061|Budesonide|budesonide|mesh-list
598758|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
598759|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
598760|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
598761|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598762|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598763|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
598764|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
598765|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
598766|NCT03519061|Hormones|hormones|mesh-ancestor
598767|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
598768|NCT03519022|Cocaine|cocaine|mesh-list
598769|NCT03519022|Methylphenidate|methylphenidate|mesh-list
598770|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
598771|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598772|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
598773|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
598774|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
598775|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598776|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
598777|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
598778|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
598779|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
598780|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
598781|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
598782|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598783|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
598784|NCT03518801|Cannabidiol|cannabidiol|mesh-list
598785|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
598796|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
598797|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
598798|NCT03518528|Estradiol|estradiol|mesh-list
598799|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
598800|NCT03518528|Estrogens|estrogens|mesh-ancestor
598801|NCT03518528|Hormones|hormones|mesh-ancestor
598802|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
598803|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598804|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
598805|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
598806|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
598807|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
598808|NCT03518502|Sorafenib|sorafenib|mesh-list
598809|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598810|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
598811|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598812|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598813|NCT03518489|Lappaconitine|lappaconitine|mesh-list
598814|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
598815|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
598816|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
598817|NCT03518489|Analgesics|analgesics|mesh-ancestor
598818|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
598819|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598820|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598821|NCT03518320|Gemcitabine|gemcitabine|mesh-list
598822|NCT03518320|Nivolumab|nivolumab|mesh-list
598823|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
598824|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
598825|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598826|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598827|NCT03518320|Antiviral Agents|antiviral agents|mesh-ancestor
598828|NCT03518320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
598829|NCT03518320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598830|NCT03518320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
598831|NCT03518320|Immunologic Factors|immunologic factors|mesh-ancestor
598832|NCT03518320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598833|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
598834|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
598835|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
598836|NCT03518242|Capecitabine|capecitabine|mesh-list
598837|NCT03518242|Methotrexate|methotrexate|mesh-list
598838|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
598839|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
598840|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598841|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
598842|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
598843|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
598844|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598845|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598846|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
598847|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
598848|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
598849|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
598850|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
598851|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
598852|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
598853|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598854|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
598855|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2750974|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2750975|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2750976|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2750977|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2750978|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2216157|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216158|NCT00028275|Interferons|interferons|mesh-list
2216159|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
598864|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
598865|NCT03518112|Leucovorin|leucovorin|mesh-list
598866|NCT03518112|Folic Acid|folic acid|mesh-list
598867|NCT03518112|Cytarabine|cytarabine|mesh-list
598868|NCT03518112|Dexamethasone|dexamethasone|mesh-list
598869|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
598870|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
598871|NCT03518112|Rituximab|rituximab|mesh-list
598872|NCT03518112|Methotrexate|methotrexate|mesh-list
598873|NCT03518112|Vincristine|vincristine|mesh-list
598874|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
598875|NCT03518112|Blinatumomab|blinatumomab|mesh-list
598876|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
598877|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
598878|NCT03518112|Antibodies|antibodies|mesh-list
598879|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
598880|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
598881|NCT03518112|Lenograstim|lenograstim|mesh-list
598882|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
598883|NCT03518112|BB 1101|bb 1101|mesh-list
598884|NCT03518112|Calcium|calcium|mesh-list
598885|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
598886|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
598887|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
598888|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598889|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
598890|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
598891|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
598892|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598893|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598894|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
598895|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
598896|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
598897|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
598898|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598899|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
598900|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
598901|NCT03518112|Hormones|hormones|mesh-ancestor
598902|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
598903|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
598904|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
598905|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598906|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
598907|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
598908|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
598909|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
598910|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
598911|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
598912|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
598913|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
598914|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
598915|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
598916|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
598917|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
598918|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
598919|NCT03518112|Antidotes|antidotes|mesh-ancestor
598920|NCT03518112|Protective Agents|protective agents|mesh-ancestor
598921|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
598922|NCT03518112|Vitamins|vitamins|mesh-ancestor
598923|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
598924|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
598925|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
598926|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
598927|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
598928|NCT03518112|Hematinics|hematinics|mesh-ancestor
2077950|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077951|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077952|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2077953|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
2077954|NCT02036502|Hormones|hormones|mesh-ancestor
2077955|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2077956|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2077957|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2077958|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2077959|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
2077960|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
598940|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
598941|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
598942|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
598943|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
598944|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077961|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2077962|NCT02036502|Growth Substances|growth substances|mesh-ancestor
2077963|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
2077964|NCT02036515|Metformin|metformin|mesh-list
598950|NCT03518021|Naloxone|naloxone|mesh-list
598951|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
598952|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598953|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
598954|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598955|NCT03517995|Sulforaphane|sulforaphane|mesh-list
598956|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
598957|NCT03517995|Protective Agents|protective agents|mesh-ancestor
598958|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598959|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598960|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
598961|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
598962|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
598963|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
598964|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
598965|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
598966|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
598967|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
598968|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598976|NCT03517943|Loratadine|loratadine|mesh-list
598977|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
598978|NCT03517943|Ephedrine|ephedrine|mesh-list
598979|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
598980|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
598981|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
598982|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
598983|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
598984|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
598985|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
598986|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
598987|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
598988|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
598989|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
598990|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
598991|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
598992|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
598993|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
598994|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
598995|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
598996|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
598997|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
598998|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
598999|NCT03517930|Loratadine|loratadine|mesh-list
599000|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
599001|NCT03517930|Ephedrine|ephedrine|mesh-list
599002|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
599003|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
599004|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
599005|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599006|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
599007|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
599008|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
599009|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
599010|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
599011|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
599012|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
599013|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599014|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599015|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
599016|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
599017|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
599018|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
599019|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
599020|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
599021|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
599022|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
599023|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2077965|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2077966|NCT02036515|Glimepiride|glimepiride|mesh-list
2077967|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
2077968|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2077969|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077970|NCT02036515|Incretins|incretins|mesh-ancestor
2077971|NCT02036515|Hormones|hormones|mesh-ancestor
2077972|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2077973|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2077974|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
2077975|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2077976|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599037|NCT03517722|Ustekinumab|ustekinumab|mesh-list
599038|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
599039|NCT03517683|Methamphetamine|methamphetamine|mesh-list
599040|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
599041|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599042|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
599043|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
599044|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
599045|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
599046|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599047|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599048|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
599049|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
599050|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
599051|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
599052|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
599053|NCT03517670|Milrinone|milrinone|mesh-list
599054|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
599055|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
599056|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
599057|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
599058|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
599059|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599060|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599061|NCT03517670|Protective Agents|protective agents|mesh-ancestor
599062|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599063|NCT03517631|Busulfan|busulfan|mesh-list
599064|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
599065|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599066|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
599067|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
599068|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599069|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
599070|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599071|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
599072|NCT03517618|Leucovorin|leucovorin|mesh-list
599073|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599074|NCT03517618|Antidotes|antidotes|mesh-ancestor
599075|NCT03517618|Protective Agents|protective agents|mesh-ancestor
599076|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
599077|NCT03517618|Vitamins|vitamins|mesh-ancestor
599078|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
2077977|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2077978|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2077979|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
2077980|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2077981|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2077982|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
2077983|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599086|NCT03517462|Ivermectin|ivermectin|mesh-list
599087|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
599088|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077984|NCT02036775|Ambroxol|ambroxol|mesh-list
2077985|NCT02036775|Expectorants|expectorants|mesh-ancestor
2077986|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
2077987|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2077988|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2077989|NCT02037061|Bupivacaine|bupivacaine|mesh-list
2077990|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
2077991|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
2077992|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2077993|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2077994|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
2077995|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2077996|NCT02037165|Celecoxib|celecoxib|mesh-list
2077997|NCT02037165|Pregabalin|pregabalin|mesh-list
2077998|NCT02037165|Analgesics|analgesics|mesh-ancestor
2077999|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
599105|NCT03517423|Brivaracetam|brivaracetam|mesh-list
599106|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
599107|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
599108|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
599109|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
599110|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
599111|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
599112|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599113|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
599114|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599115|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599116|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
599117|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
599118|NCT03517176|Gemcitabine|gemcitabine|mesh-list
599119|NCT03517176|Paclitaxel|paclitaxel|mesh-list
599120|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
599121|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599122|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
599123|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
599124|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
599125|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599126|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
599127|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
599128|NCT03517176|Antiviral Agents|antiviral agents|mesh-ancestor
599129|NCT03517176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599130|NCT03517176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599131|NCT03517176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
599132|NCT03517176|Immunologic Factors|immunologic factors|mesh-ancestor
599133|NCT03517176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599134|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
599135|NCT03517137|Dacarbazine|dacarbazine|mesh-list
2078000|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
599136|NCT03517137|Etoposide|etoposide|mesh-list
599137|NCT03517137|Doxorubicin|doxorubicin|mesh-list
599138|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
599139|NCT03517137|Vinblastine|vinblastine|mesh-list
599140|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
599141|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
599142|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
599143|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599144|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
599145|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
599146|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
599147|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599148|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599149|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
599150|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
599151|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
599152|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
599153|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599154|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
599155|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
599156|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
599157|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
599158|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
599159|NCT03517033|Nebivolol|nebivolol|mesh-list
599160|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
599161|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
599162|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
599163|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
599164|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
599165|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
599166|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599167|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599168|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599169|NCT03517020|Nebivolol|nebivolol|mesh-list
599170|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
599171|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
599172|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
599173|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
599174|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
599175|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
599176|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599177|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599178|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078001|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078002|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
2078003|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2078004|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2078005|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078006|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
599186|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
599187|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
599188|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599189|NCT03516968|Vitamins|vitamins|mesh-ancestor
599190|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
599191|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
599192|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
599193|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
599194|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
599195|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
599196|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599197|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
599198|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
599199|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599200|NCT03516903|Folic Acid|folic acid|mesh-list
599201|NCT03516903|Methotrexate|methotrexate|mesh-list
599202|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
599203|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
599204|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
599205|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599206|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
599207|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
599208|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599209|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599210|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
599211|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599212|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
599213|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
599214|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
599215|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
599216|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
599217|NCT03516903|Hematinics|hematinics|mesh-ancestor
599218|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
599219|NCT03516903|Vitamins|vitamins|mesh-ancestor
599220|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
599221|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
599222|NCT03516812|Olaparib|olaparib|mesh-list
599223|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
599224|NCT03516812|Testosterone|testosterone|mesh-list
599225|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
599226|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
599227|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
599228|NCT03516812|Androgens|androgens|mesh-ancestor
599229|NCT03516812|Hormones|hormones|mesh-ancestor
599230|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
599231|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599232|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
599233|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599234|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
599235|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599236|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599237|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
599238|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
599239|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599240|NCT03516747|Hormones|hormones|mesh-list
599241|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
599242|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
599243|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599244|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
599245|NCT03516669|Amoxicillin|amoxicillin|mesh-list
599246|NCT03516669|Clarithromycin|clarithromycin|mesh-list
599247|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
599248|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599249|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
599250|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599251|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599252|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
599253|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
599254|NCT03516656|Heparin|heparin|mesh-list
599255|NCT03516656|Calcium heparin|calcium heparin|mesh-list
599256|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
599257|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
599258|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
599259|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599260|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
599261|NCT03516630|Trazodone|trazodone|mesh-list
599262|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
599263|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599264|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
599265|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
599266|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599267|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599268|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599269|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599270|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
599271|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
599272|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
599273|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
599274|NCT03516630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
599275|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
599276|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
599277|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599278|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
599279|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
599280|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
599281|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
599282|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
599283|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
599284|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599285|NCT03516604|Citalopram|citalopram|mesh-list
599286|NCT03516604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
599287|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
599288|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
599289|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599290|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599291|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
599292|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599293|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
599294|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
599295|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
599296|NCT03516526|Natalizumab|natalizumab|mesh-list
599297|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
599298|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599299|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
599300|NCT03516500|Hematinics|hematinics|mesh-ancestor
599301|NCT03516305|Alprazolam|alprazolam|mesh-list
599302|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
599303|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
599304|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599305|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
599306|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
599307|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
599308|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
599309|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
599310|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599311|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750979|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750980|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
599323|NCT03516214|Trametinib|trametinib|mesh-list
599324|NCT03516214|Nazartinib|nazartinib|mesh-list
599325|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599326|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
599327|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599328|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599329|NCT03516188|Antacids|antacids|mesh-list
599330|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599331|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2216160|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216161|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
2216162|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216163|NCT00028288|Daclizumab|daclizumab|mesh-list
2216164|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216165|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
2216166|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216167|NCT00028301|Ritonavir|ritonavir|mesh-list
2216168|NCT00028301|Lopinavir|lopinavir|mesh-list
2216169|NCT00028301|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2216170|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2216171|NCT00028301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2216172|NCT00028301|Protease Inhibitors|protease inhibitors|mesh-ancestor
2216173|NCT00028301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216174|NCT00028301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216175|NCT00028301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
599348|NCT03515837|Carboplatin|carboplatin|mesh-list
599349|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
599350|NCT03515837|Pemetrexed|pemetrexed|mesh-list
599351|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
599352|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599353|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
599354|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599355|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599356|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
599357|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
599358|NCT03515798|Paclitaxel|paclitaxel|mesh-list
599359|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
599360|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
599361|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
599362|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
599363|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599364|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
599365|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
599366|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
599367|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599368|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
599369|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
599370|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599371|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
599372|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
599373|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
599374|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
599375|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
599376|NCT03515772|Darunavir|darunavir|mesh-list
599377|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
599378|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
599379|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
599380|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599381|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599382|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
599383|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
599384|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
599385|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599386|NCT03515707|Etoposide|etoposide|mesh-list
599387|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
599388|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
599389|NCT03515707|Busulfan|busulfan|mesh-list
599390|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
599391|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599392|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
599393|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
599394|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599395|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599396|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
599397|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
599398|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
599399|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599400|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
599401|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
599402|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
599403|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
599404|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
599405|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
599406|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
599407|NCT03515668|Methylphenidate|methylphenidate|mesh-list
599408|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
599409|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599410|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
599411|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
599412|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
599413|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599414|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
599415|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599416|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
599417|NCT03515629|Cemiplimab|cemiplimab|mesh-list
599418|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
599419|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599420|NCT03515577|Edetic Acid|edetic acid|mesh-list
599421|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
599422|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
599423|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
599424|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599425|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
599426|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
599427|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
599428|NCT03515538|Cisplatin|cisplatin|mesh-list
599429|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599430|NCT03515382|Itraconazole|itraconazole|mesh-list
599431|NCT03515382|Voriconazole|voriconazole|mesh-list
599432|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
599433|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599434|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
599435|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
599436|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599437|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599438|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
599439|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
599440|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
599441|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599442|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
599443|NCT03515369|Liver Extracts|liver extracts|mesh-list
599444|NCT03515369|Hematinics|hematinics|mesh-ancestor
599451|NCT03515213|Fenofibrate|fenofibrate|mesh-list
599452|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
599453|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
599454|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599455|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
599456|NCT03515200|Cytarabine|cytarabine|mesh-list
599457|NCT03515200|Dexamethasone|dexamethasone|mesh-list
599458|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
599459|NCT03515200|Doxorubicin|doxorubicin|mesh-list
599460|NCT03515200|Methotrexate|methotrexate|mesh-list
599461|NCT03515200|Bortezomib|bortezomib|mesh-list
599462|NCT03515200|Dasatinib|dasatinib|mesh-list
599463|NCT03515200|Palbociclib|palbociclib|mesh-list
599464|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
599465|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
599466|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
599467|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
599468|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599469|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
599470|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
599471|NCT03515200|Hormones|hormones|mesh-ancestor
599472|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
599473|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
599474|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599475|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
599476|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
599477|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
599478|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599479|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599480|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
599481|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
599482|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
599483|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
599484|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
599485|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
599486|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
599487|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
599488|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
599489|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
599490|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
599491|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
599492|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599493|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
599494|NCT03515187|Bromides|bromides|mesh-list
599495|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
599496|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
599497|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
599498|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
599499|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
599500|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
599501|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599502|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
599503|NCT03515187|Protective Agents|protective agents|mesh-ancestor
599504|NCT03515044|Rifaximin|rifaximin|mesh-list
599505|NCT03515044|Lactulose|lactulose|mesh-list
599506|NCT03515044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
599507|NCT03515044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599508|NCT03515044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
599509|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
599510|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
599511|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599512|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
599513|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599514|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599515|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
599516|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
599517|NCT03514979|Vaccines|vaccines|mesh-list
599518|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
599519|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078007|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2078008|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2078009|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2078010|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2078011|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2078012|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
599526|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
599527|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
599528|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
599529|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599530|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
599531|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
599532|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
599533|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599534|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599535|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
599536|NCT03514810|Ketoprofen|ketoprofen|mesh-list
599537|NCT03514810|Sertraline|sertraline|mesh-list
599538|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
599539|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
599540|NCT03514810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
599541|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
599542|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
599543|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599544|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599545|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
599546|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599547|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
599548|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
599549|NCT03514810|Analgesics|analgesics|mesh-ancestor
599550|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
599551|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
599552|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
599553|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
599554|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
599555|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599556|NCT03514771|Valacyclovir|valacyclovir|mesh-list
599557|NCT03514771|Isotretinoin|isotretinoin|mesh-list
599558|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
599559|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599560|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
599561|NCT03514732|Melatonin|melatonin|mesh-list
599562|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
599563|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599564|NCT03514732|Protective Agents|protective agents|mesh-ancestor
599565|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599566|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2078013|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2078014|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2078015|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2078016|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2078017|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078018|NCT02037230|Gemcitabine|gemcitabine|mesh-list
599573|NCT03514667|Curcumin|curcumin|mesh-list
599574|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
599575|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
599576|NCT03514667|Analgesics|analgesics|mesh-ancestor
599577|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
599578|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
599579|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599580|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
599581|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
599582|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599583|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599584|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216176|NCT00028301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2216177|NCT00028301|Antiviral Agents|antiviral agents|mesh-ancestor
599588|NCT03514589|Cosyntropin|cosyntropin|mesh-list
599589|NCT03514589|Hormones|hormones|mesh-ancestor
599590|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
599591|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599592|NCT03514576|Pasireotide|pasireotide|mesh-list
599593|NCT03514576|Hormones|hormones|mesh-ancestor
599594|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
599595|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599596|NCT03514550|Propofol|propofol|mesh-list
599597|NCT03514550|Sevoflurane|sevoflurane|mesh-list
599598|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
599599|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
599600|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599601|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
599602|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
599603|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
599604|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
599605|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
599606|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
599607|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599608|NCT03514381|Doxorubicin|doxorubicin|mesh-list
599609|NCT03514381|Ifosfamide|ifosfamide|mesh-list
599610|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
599611|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599612|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
599613|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
599614|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599615|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599616|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
599617|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
2750981|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2750982|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2750983|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
599621|NCT03514342|Ropivacaine|ropivacaine|mesh-list
599622|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
599623|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
599624|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
599625|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599626|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
599627|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2216178|NCT00028301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216179|NCT00028301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2216180|NCT00028301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2216181|NCT00028314|Ritonavir|ritonavir|mesh-list
2216182|NCT00028314|Lopinavir|lopinavir|mesh-list
2216183|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2216184|NCT00028314|Nevirapine|nevirapine|mesh-list
599635|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
599636|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
599637|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599641|NCT03514108|Metformin|metformin|mesh-list
599642|NCT03514108|Hydralazine|hydralazine|mesh-list
599643|NCT03514108|Isosorbide|isosorbide|mesh-list
599644|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
599645|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
599646|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
599647|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599648|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
599649|NCT03514108|Diuretics|diuretics|mesh-ancestor
599650|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
599651|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
599652|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
599653|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599654|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
599660|NCT03514030|Antibodies|antibodies|mesh-list
599661|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
2216185|NCT00028314|Abacavir|abacavir|mesh-list
599662|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078019|NCT02037230|Adavosertib|adavosertib|mesh-list
2078020|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2078021|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
2078022|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216186|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
599671|NCT03513874|Metformin|metformin|mesh-list
599672|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
599673|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599674|NCT03513822|Midazolam|midazolam|mesh-list
599675|NCT03513822|Ketamine|ketamine|mesh-list
599676|NCT03513822|Analgesics|analgesics|mesh-ancestor
599677|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
599678|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
599679|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599680|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
599681|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
599682|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
599683|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
599684|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
599685|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
599686|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
599687|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599688|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599689|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
599690|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
599691|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
599692|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
599693|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
599694|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
599695|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
2216187|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2216188|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
2216189|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216190|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216191|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2216192|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2216193|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
2216194|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216195|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2216196|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2216197|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2216198|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2216199|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2216200|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2216201|NCT00028327|Lamivudine|lamivudine|mesh-list
2216202|NCT00028327|Zidovudine|zidovudine|mesh-list
2216203|NCT00028327|Efavirenz|efavirenz|mesh-list
2216204|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2216205|NCT00028327|Nelfinavir|nelfinavir|mesh-list
2216206|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2216207|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2216208|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216209|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216210|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
2216211|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216212|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2216213|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2216214|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
2216215|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2216216|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2216217|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
599742|NCT03513601|Rituximab|rituximab|mesh-list
599743|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
599744|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599745|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
599746|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599747|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
599748|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
599749|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
599750|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599751|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
2078023|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078024|NCT02037230|Antiviral Agents|antiviral agents|mesh-ancestor
599754|NCT03513549|Loxapine|loxapine|mesh-list
599755|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
599756|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
599757|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
599758|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599759|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
599760|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
599761|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
599762|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599763|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599764|NCT03513484|Azacitidine|azacitidine|mesh-list
599765|NCT03513484|Nintedanib|nintedanib|mesh-list
599766|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
599767|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
599768|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599769|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599770|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599771|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
599772|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
599773|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
599774|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
599775|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
599801|NCT03513432|Ethanol|ethanol|mesh-list
599802|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
599803|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599804|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
599805|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599806|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
599807|NCT03513406|Neostigmine|neostigmine|mesh-list
599808|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
599809|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599810|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599811|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
599812|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599813|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599814|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
599815|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
599816|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
599817|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
599818|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
599819|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
599820|NCT03513393|Velpatasvir|velpatasvir|mesh-list
599821|NCT03513393|Omeprazole|omeprazole|mesh-list
599822|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
599823|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
599824|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
599825|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599826|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599827|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
599828|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599829|NCT03513328|Thiotepa|thiotepa|mesh-list
599830|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
599831|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
599832|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599833|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599834|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
599835|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
599836|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
599837|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599838|NCT03513276|Epinephrine|epinephrine|mesh-list
599839|NCT03513276|Racepinephrine|racepinephrine|mesh-list
599840|NCT03513276|Ropivacaine|ropivacaine|mesh-list
599841|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
599842|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
599843|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
599844|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
599845|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599846|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
599847|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
599848|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
599849|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
599850|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
599851|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599852|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599853|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
599854|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
599855|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
599856|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
599857|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
599858|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
599859|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
599860|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
599876|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
599877|NCT03513211|Itraconazole|itraconazole|mesh-list
599878|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
599879|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
599880|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
599881|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599882|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599883|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599884|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
599885|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
599886|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
599887|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
599888|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
599889|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
599890|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
599891|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599892|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
599893|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
599894|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
599895|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
599896|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
599897|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
599898|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
599899|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599900|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599901|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599902|NCT03513055|Insulin|insulin|mesh-list
599903|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
599904|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599905|NCT03512990|Bupivacaine|bupivacaine|mesh-list
599906|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
599907|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
599908|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
599909|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599910|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
599911|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
599912|NCT03512964|Dolutegravir|dolutegravir|mesh-list
599913|NCT03512964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
599914|NCT03512964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
599915|NCT03512964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
599916|NCT03512964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599917|NCT03512964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599918|NCT03512964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
599919|NCT03512964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
599920|NCT03512964|Antiviral Agents|antiviral agents|mesh-ancestor
599921|NCT03512964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599922|NCT03512964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
599923|NCT03512964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
599924|NCT03512873|Tranilast|tranilast|mesh-list
599925|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
599926|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
599927|NCT03512873|Analgesics|analgesics|mesh-ancestor
599928|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
599929|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
599930|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599931|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
599932|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
599933|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
599934|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
599935|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599936|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
599937|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
599938|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
599939|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
599940|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599941|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
599942|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
599943|NCT03512860|Valproic Acid|valproic acid|mesh-list
599944|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
599945|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599946|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599947|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
599948|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
599949|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599950|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
599951|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
599952|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
599953|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
599954|NCT03512834|Paclitaxel|paclitaxel|mesh-list
599955|NCT03512834|Avelumab|avelumab|mesh-list
599956|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
599957|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599958|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
599959|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
599960|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
599961|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599962|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
599963|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
599964|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
599965|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
599966|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
599967|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
599968|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
599969|NCT03512756|Gemcitabine|gemcitabine|mesh-list
599970|NCT03512756|Sirolimus|sirolimus|mesh-list
599971|NCT03512756|Capecitabine|capecitabine|mesh-list
599972|NCT03512756|Phenytoin|phenytoin|mesh-list
599973|NCT03512756|Methoxsalen|methoxsalen|mesh-list
599974|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
599975|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
599976|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
599977|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
599978|NCT03512756|Antiviral Agents|antiviral agents|mesh-ancestor
599979|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
599980|NCT03512756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
599981|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
599982|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
599983|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
599984|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
599985|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
599986|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
599987|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
599988|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
599989|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
599990|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
599991|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
599992|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
599993|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
599994|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
599995|NCT03512574|Pregabalin|pregabalin|mesh-list
599996|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
599997|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
599998|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
599999|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600000|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
600001|NCT03512574|Analgesics|analgesics|mesh-ancestor
600002|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
600003|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
600004|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
600005|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
600006|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
600007|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
600008|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600009|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600010|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
600011|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
600012|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
600013|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
600014|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
600015|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
600016|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
600017|NCT03512548|Itraconazole|itraconazole|mesh-list
600018|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
600019|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
600020|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
600021|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
600022|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600023|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600024|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
600025|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
600026|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
600027|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600028|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
600029|NCT03512496|Caffeine|caffeine|mesh-list
600030|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
600031|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600032|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
600033|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600034|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600035|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
600036|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
600037|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
600038|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600039|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
600040|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
600041|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
600042|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600043|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600044|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
600045|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
600046|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
600047|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
600048|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
600049|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
600050|NCT03512405|Blinatumomab|blinatumomab|mesh-list
600051|NCT03512405|Antibodies|antibodies|mesh-list
600052|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
600053|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
600054|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
600055|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
600056|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
600057|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600058|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600059|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216218|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2216219|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2216220|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2216221|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2216222|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2216223|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
2216224|NCT00028353|Toremifene|toremifene|mesh-list
2216225|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2216226|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216227|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2216228|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2216229|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
2216230|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2216231|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216232|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
600075|NCT03512275|Antibodies|antibodies|mesh-list
600076|NCT03512275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
600077|NCT03512275|Immunologic Factors|immunologic factors|mesh-ancestor
600078|NCT03512275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078025|NCT02037230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078026|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078027|NCT02037230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078028|NCT02037230|Immunologic Factors|immunologic factors|mesh-ancestor
2078029|NCT02037230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600084|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
600085|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
600086|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078030|NCT02037256|Bortezomib|bortezomib|mesh-list
2078031|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078032|NCT02037295|Vancomycin|vancomycin|mesh-list
2078033|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2078034|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078035|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2078036|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2078037|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2078038|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078039|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078040|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2078041|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2216233|NCT00028366|Ritonavir|ritonavir|mesh-list
2216234|NCT00028366|Lopinavir|lopinavir|mesh-list
2216235|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
2078042|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078043|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
2078044|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078045|NCT02037477|Esomeprazole|esomeprazole|mesh-list
2078046|NCT02037477|Rabeprazole|rabeprazole|mesh-list
2078047|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
600109|NCT03512171|Amphetamine|amphetamine|mesh-list
600110|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
600111|NCT03512171|Fallypride|fallypride|mesh-list
2078048|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
600112|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
600113|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600114|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
600115|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
600116|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
600117|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
600118|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600119|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600120|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
600121|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
600122|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
600123|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
600124|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
600125|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
600126|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2078049|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2078050|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078051|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078052|NCT02037555|Antithrombins|antithrombins|mesh-list
600131|NCT03511976|Methylphenidate|methylphenidate|mesh-list
600132|NCT03511976|Amphetamine|amphetamine|mesh-list
600133|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
600134|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600135|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
600136|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
600137|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
600138|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600139|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
600140|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600141|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
600142|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
600143|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
600144|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
600145|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
600154|NCT03511846|Capsaicin|capsaicin|mesh-list
600155|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
600156|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
600157|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
600158|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
600159|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600160|NCT03511833|Morphine|morphine|mesh-list
600161|NCT03511833|Ketamine|ketamine|mesh-list
600162|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
600163|NCT03511833|Narcotics|narcotics|mesh-ancestor
600164|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
600165|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600166|NCT03511833|Analgesics|analgesics|mesh-ancestor
600167|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
600168|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
600169|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
600170|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
600171|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
600172|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
600173|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
600174|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
600175|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600176|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600177|NCT03511820|Amphotericin B|amphotericin b|mesh-list
600178|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
600179|NCT03511820|Amebicides|amebicides|mesh-ancestor
600180|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
600181|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
600182|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
600183|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
600184|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
600185|NCT03511768|Octreotide|octreotide|mesh-list
2078053|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
600186|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
600187|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
600188|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600189|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
600190|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600191|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600192|NCT03511703|Apatinib|apatinib|mesh-list
600193|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600194|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
600195|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600196|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078054|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2078055|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
2078056|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600230|NCT03511560|Tacrolimus|tacrolimus|mesh-list
600231|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
600232|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
600233|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600234|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
600235|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600236|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216236|NCT00028366|Tenofovir|tenofovir|mesh-list
2216237|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2216238|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2216239|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
2216240|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216241|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216242|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2216243|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
600245|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
600246|NCT03511391|Nivolumab|nivolumab|mesh-list
600247|NCT03511391|Atezolizumab|atezolizumab|mesh-list
600248|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
600249|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
600250|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600251|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216244|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
2216245|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216246|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
600256|NCT03511261|Curcumin|curcumin|mesh-list
600257|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
600258|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
600259|NCT03511261|Analgesics|analgesics|mesh-ancestor
600260|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
600261|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
600262|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600263|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
600264|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
600265|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600266|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600267|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600268|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
600269|NCT03511222|Nivolumab|nivolumab|mesh-list
600270|NCT03511222|Vorolanib|vorolanib|mesh-list
600271|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
600272|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600273|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
600274|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600275|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
600276|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600286|NCT03511183|Bevacizumab|bevacizumab|mesh-list
600287|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
600288|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600289|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
600290|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
600291|NCT03511183|Growth Substances|growth substances|mesh-ancestor
600292|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600293|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
2078057|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078058|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
2078059|NCT02037893|Antipyrine|antipyrine|mesh-list
2078060|NCT02037893|Benzocaine|benzocaine|mesh-list
2078061|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2078062|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
2078063|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
2078064|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2078065|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078066|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
2078067|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078068|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2078069|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2078070|NCT02037893|Analgesics|analgesics|mesh-ancestor
2078071|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2078072|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2078073|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2078074|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
2078075|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078076|NCT02038010|Trastuzumab|trastuzumab|mesh-list
2078077|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2078078|NCT02038010|Maytansine|maytansine|mesh-list
2078079|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
2078080|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
2078081|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2078082|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078083|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2078084|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
2078085|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
2078086|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
2078087|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078088|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
2078089|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078090|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078091|NCT02038023|Iron|iron|mesh-list
2078092|NCT02038023|Dextrans|dextrans|mesh-list
2078093|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
2078094|NCT02038023|Trace Elements|trace elements|mesh-ancestor
2078095|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
2078096|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078097|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
2078098|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
2078099|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
2078100|NCT02038023|Hematinics|hematinics|mesh-ancestor
2078101|NCT02038179|Allopurinol|allopurinol|mesh-list
2078102|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
2078103|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078104|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078105|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
2078106|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2078107|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2078108|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
2078109|NCT02038179|Protective Agents|protective agents|mesh-ancestor
2078110|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078111|NCT02038647|Paclitaxel|paclitaxel|mesh-list
2078112|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2078113|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078114|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
2078115|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
2078116|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
2078117|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078118|NCT02038790|Buprenorphine|buprenorphine|mesh-list
2078119|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2078120|NCT02038790|Naloxone|naloxone|mesh-list
2078121|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2078122|NCT02038790|Narcotics|narcotics|mesh-ancestor
2078123|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2078124|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078125|NCT02038790|Analgesics|analgesics|mesh-ancestor
2078126|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
2078127|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078128|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2078129|NCT02038881|Vaccines|vaccines|mesh-list
2078130|NCT02038881|Immunologic Factors|immunologic factors|mesh-ancestor
2078131|NCT02038881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078132|NCT02038894|Propofol|propofol|mesh-list
2078133|NCT02038894|Sevoflurane|sevoflurane|mesh-list
2078134|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2078135|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2078136|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078137|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2078138|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
2078139|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
2078140|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2078141|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2078142|NCT02038907|Vaccines|vaccines|mesh-list
2078143|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
2078144|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078145|NCT02038920|Vedolizumab|vedolizumab|mesh-list
2078146|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2078147|NCT02038933|Nivolumab|nivolumab|mesh-list
2078148|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2078149|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078150|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2078151|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078157|NCT02039115|Prednisone|prednisone|mesh-list
2078158|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2078159|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
2078160|NCT02039115|Hormones|hormones|mesh-ancestor
2078161|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2078162|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078163|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2078164|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600408|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
600409|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
600410|NCT03510975|Coagulants|coagulants|mesh-ancestor
600411|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
600412|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
600413|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600414|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
600415|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2078165|NCT02039427|Dexamethasone|dexamethasone|mesh-list
2078166|NCT02039427|Ketorolac|ketorolac|mesh-list
2078167|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
600416|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
600417|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
2216247|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2216248|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2216249|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2216250|NCT00028405|Talaporfin|talaporfin|mesh-list
2216251|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216252|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2216253|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
600448|NCT03510871|Nivolumab|nivolumab|mesh-list
600449|NCT03510871|Ipilimumab|ipilimumab|mesh-list
600450|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
600451|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600452|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
600453|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600454|NCT03510793|Anesthetics|anesthetics|mesh-list
600455|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
600456|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600457|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
600458|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
600459|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
600460|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
600461|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
600462|NCT03510741|Expectorants|expectorants|mesh-ancestor
600463|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
600464|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
600465|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
600466|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600467|NCT03510741|Protective Agents|protective agents|mesh-ancestor
600468|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600469|NCT03510741|Antidotes|antidotes|mesh-ancestor
600470|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
2216254|NCT00028418|Clofarabine|clofarabine|mesh-list
2216255|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2216256|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
2216257|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216258|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216259|NCT00028431|Ipilimumab|ipilimumab|mesh-list
2216260|NCT00028431|Antibodies|antibodies|mesh-list
2216261|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
2216262|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216263|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2216264|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216265|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2216266|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216267|NCT00028483|Docetaxel|docetaxel|mesh-list
2216268|NCT00028483|Doxorubicin|doxorubicin|mesh-list
2216269|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
2216270|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216271|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216272|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216273|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216274|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216275|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2216276|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2216277|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2216278|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216279|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
2216280|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600502|NCT03510611|Ensartinib|ensartinib|mesh-list
600503|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600504|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
600505|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600506|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600510|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
600511|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
600512|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600513|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600514|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
600515|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600516|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600517|NCT03510533|Autoantibodies|autoantibodies|mesh-list
600518|NCT03510533|alpha-MSH|alpha-msh|mesh-list
600519|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
600520|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600521|NCT03510533|Hormones|hormones|mesh-ancestor
600522|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2216281|NCT00028496|Metronidazole|metronidazole|mesh-list
2216282|NCT00028496|Molgramostim|molgramostim|mesh-list
2216283|NCT00028496|Vaccines|vaccines|mesh-list
2216284|NCT00028496|Sargramostim|sargramostim|mesh-list
2216285|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
2216286|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078168|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
2078169|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
2078170|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078171|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078172|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2078173|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
2078174|NCT02039427|Hormones|hormones|mesh-ancestor
2078175|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2078176|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2078177|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078178|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2078179|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2078180|NCT02039427|Analgesics|analgesics|mesh-ancestor
2078181|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
2078182|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2078183|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2078184|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216287|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216288|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
600548|NCT03510416|Apatinib|apatinib|mesh-list
600549|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600550|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
600551|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600552|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078185|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600556|NCT03510351|Tazobactam|tazobactam|mesh-list
600557|NCT03510351|Ceftolozane|ceftolozane|mesh-list
600558|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
600559|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
600560|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
600561|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
600562|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600563|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600564|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
600565|NCT03510351|Renal Agents|renal agents|mesh-ancestor
600566|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
600567|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
600568|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
600569|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
600570|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600571|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600572|NCT03510338|Urological Agents|urological agents|mesh-ancestor
600573|NCT03510325|Olanzapine|olanzapine|mesh-list
600574|NCT03510325|Risperidone|risperidone|mesh-list
600575|NCT03510325|Aripiprazole|aripiprazole|mesh-list
600576|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
600577|NCT03510325|Amisulpride|amisulpride|mesh-list
600578|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
600579|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
600580|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600581|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600582|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600583|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
600584|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
600585|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
600586|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
600587|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
600588|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
600589|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
600590|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
600591|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
600592|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
600593|NCT03510325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
600594|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
600595|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
600596|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
600597|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
600598|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
600599|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
600600|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
600601|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
600602|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
600603|NCT03510221|Antioxidants|antioxidants|mesh-list
600604|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600605|NCT03510221|Protective Agents|protective agents|mesh-ancestor
600606|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600607|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
600608|NCT03510208|Panitumumab|panitumumab|mesh-list
600609|NCT03510208|Antibodies|antibodies|mesh-list
600610|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
600611|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
600612|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
600613|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600614|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600615|NCT03510078|Insulin|insulin|mesh-list
600616|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
600617|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600618|NCT03510013|Sevoflurane|sevoflurane|mesh-list
600619|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
600620|NCT03510013|Anesthetics|anesthetics|mesh-list
600621|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
600622|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
600623|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
600624|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600625|NCT03510000|Empagliflozin|empagliflozin|mesh-list
600626|NCT03510000|Pancrelipase|pancrelipase|mesh-list
600627|NCT03510000|Hormones|hormones|mesh-list
600628|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
600629|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600630|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
600631|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600632|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
600633|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
600634|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
600635|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
600636|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
600637|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600638|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
600639|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
600640|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
600641|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600642|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216289|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2216290|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2216291|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2216292|NCT00028535|Paclitaxel|paclitaxel|mesh-list
2216293|NCT00028535|Trastuzumab|trastuzumab|mesh-list
2216294|NCT00028535|Interleukin-12|interleukin-12|mesh-list
2216295|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216296|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600651|NCT03509831|Irsogladine|irsogladine|mesh-list
600652|NCT03509831|Nizatidine|nizatidine|mesh-list
600653|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600654|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
600655|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
600656|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
600657|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
600658|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
600659|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600660|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600661|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600662|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
600663|NCT03509831|Protective Agents|protective agents|mesh-ancestor
600664|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2216297|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216298|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216299|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216300|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216301|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2216302|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
600671|NCT03509740|Acetaminophen|acetaminophen|mesh-list
600672|NCT03509740|Tramadol|tramadol|mesh-list
600673|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
600674|NCT03509740|Analgesics|analgesics|mesh-ancestor
600675|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
600676|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
600677|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600678|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
600679|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
600680|NCT03509740|Narcotics|narcotics|mesh-ancestor
600681|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
600682|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
600683|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
600684|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600685|NCT03509714|Protective Agents|protective agents|mesh-ancestor
600686|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600687|NCT03509714|Vitamins|vitamins|mesh-ancestor
600688|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
600689|NCT03509701|Antibodies|antibodies|mesh-list
600690|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
600691|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600692|NCT03509688|Entecavir|entecavir|mesh-list
600693|NCT03509688|Resveratrol|resveratrol|mesh-list
600694|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
600695|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
600696|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
600697|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600698|NCT03509688|Protective Agents|protective agents|mesh-ancestor
600699|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600700|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600701|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2216303|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
2216304|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216305|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2216306|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2216307|NCT00028535|Growth Substances|growth substances|mesh-ancestor
2216308|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
2216309|NCT00028561|Carboplatin|carboplatin|mesh-list
2216310|NCT00028561|Epothilone B|epothilone b|mesh-list
2216311|NCT00028561|Epothilones|epothilones|mesh-list
2216312|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216313|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216314|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
600714|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
600715|NCT03509662|Thiamine|thiamine|mesh-list
600716|NCT03509662|Vitamins|vitamins|mesh-ancestor
600717|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
600718|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600719|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
600720|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600721|NCT03509662|Protective Agents|protective agents|mesh-ancestor
600722|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
600723|NCT03509584|Nivolumab|nivolumab|mesh-list
600724|NCT03509584|Ipilimumab|ipilimumab|mesh-list
600801|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
2216315|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
600725|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
600726|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600727|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
600728|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600729|NCT03509545|Torsemide|torsemide|mesh-list
600730|NCT03509545|Furosemide|furosemide|mesh-list
600731|NCT03509545|Diuretics|diuretics|mesh-ancestor
600732|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
600733|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600734|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
600735|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
600736|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600737|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2216316|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216317|NCT00028574|Gabapentin|gabapentin|mesh-list
2216318|NCT00028574|Analgesics|analgesics|mesh-ancestor
2216319|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
2216320|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2216321|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216322|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
2216323|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2216324|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2216325|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2216326|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2216327|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2216328|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2216329|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600752|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
600753|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
600754|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600755|NCT03509298|Antibodies|antibodies|mesh-list
600756|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
600757|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
600758|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600759|NCT03509285|Cenobamate|cenobamate|mesh-list
600760|NCT03509285|Alprazolam|alprazolam|mesh-list
600761|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
600762|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
600763|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600764|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
600765|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
600766|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
600767|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
600768|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
600769|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600770|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600771|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
600772|NCT03509246|Doxorubicin|doxorubicin|mesh-list
600773|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
600774|NCT03509246|Bortezomib|bortezomib|mesh-list
600775|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
600776|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600777|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
600778|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
600779|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600780|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216330|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216331|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
2216332|NCT00028587|Paclitaxel|paclitaxel|mesh-list
2216333|NCT00028587|Carboplatin|carboplatin|mesh-list
2216334|NCT00028587|Bortezomib|bortezomib|mesh-list
600786|NCT03509168|Misoprostol|misoprostol|mesh-list
600787|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
600788|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
600789|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
600790|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600791|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
600792|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
600793|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
600794|NCT03509142|Sirolimus|sirolimus|mesh-list
600795|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
600796|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
600797|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
600798|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600799|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
600800|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
600802|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600803|NCT03509051|Vaccines|vaccines|mesh-list
600804|NCT03509051|Immunologic Factors|immunologic factors|mesh-ancestor
600805|NCT03509051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600826|NCT03508999|Metronidazole|metronidazole|mesh-list
600827|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
600828|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
600829|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
600830|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
600831|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
600832|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
600833|NCT03508921|Trimethoprim|trimethoprim|mesh-list
600834|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
600835|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
600836|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
600837|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
600838|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
600839|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
600840|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
600841|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600842|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
600843|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
600844|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600845|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
600846|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600847|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
600848|NCT03508921|Renal Agents|renal agents|mesh-ancestor
600849|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
600850|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
600851|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
600852|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
600853|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
600854|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
600855|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
600856|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
600857|NCT03508895|Caseins|caseins|mesh-list
600858|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
600859|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
600860|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600861|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
600862|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
600863|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
600864|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
600865|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
600866|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600867|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
600868|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600869|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600870|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
600871|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
600872|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
600873|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
600874|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
600875|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
600876|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
600877|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
600878|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
600879|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
600880|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600881|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600882|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600883|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
600884|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
600885|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
600886|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
600887|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2216335|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216336|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216337|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216338|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216339|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216340|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600895|NCT03508817|Atropine|atropine|mesh-list
600896|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
600897|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
600898|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
600899|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
600900|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
600901|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
600902|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
600903|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600904|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
600905|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
600906|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
600907|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
600908|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
600909|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
600910|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
600911|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
600912|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600913|NCT03508804|Lidocaine|lidocaine|mesh-list
600914|NCT03508804|Prilocaine|prilocaine|mesh-list
600915|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
600916|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
600917|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
600918|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
600919|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600920|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
600921|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
600922|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
600923|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
600924|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
600925|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
600926|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600927|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
600933|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
600934|NCT03508726|Vitamins|vitamins|mesh-ancestor
600935|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
600936|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600937|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
600938|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600939|NCT03508726|Protective Agents|protective agents|mesh-ancestor
600940|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
600941|NCT03508635|Prednisone|prednisone|mesh-list
600942|NCT03508635|Cortisone|cortisone|mesh-list
600943|NCT03508635|Mifepristone|mifepristone|mesh-list
600944|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
600945|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
600946|NCT03508635|Hormones|hormones|mesh-ancestor
600947|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
600948|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600949|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
600950|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600951|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
600952|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
600953|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
600954|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
600955|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
600956|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
600957|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
600958|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
600959|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
600960|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
600961|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
600962|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
600963|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
600964|NCT03508570|Nivolumab|nivolumab|mesh-list
600965|NCT03508570|Ipilimumab|ipilimumab|mesh-list
600966|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
600967|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600968|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
600969|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600970|NCT03508440|Prednisone|prednisone|mesh-list
600971|NCT03508440|Prednisolone|prednisolone|mesh-list
600972|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
600973|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
600974|NCT03508440|Hormones|hormones|mesh-ancestor
600975|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
600976|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600977|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
600978|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078186|NCT02039505|Vedolizumab|vedolizumab|mesh-list
2078187|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2078188|NCT02039674|Paclitaxel|paclitaxel|mesh-list
2078189|NCT02039674|Bevacizumab|bevacizumab|mesh-list
2078190|NCT02039674|Carboplatin|carboplatin|mesh-list
2078191|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
600985|NCT03508102|Remifentanil|remifentanil|mesh-list
600986|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
600987|NCT03508102|Narcotics|narcotics|mesh-ancestor
600988|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
600989|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
600990|NCT03508102|Analgesics|analgesics|mesh-ancestor
600991|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
600992|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
600993|NCT03507842|Cytarabine|cytarabine|mesh-list
600994|NCT03507842|Daunorubicin|daunorubicin|mesh-list
600995|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
600996|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
600997|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
600998|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
600999|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
601000|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
601001|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
601002|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
601003|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601004|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
601005|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
601006|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
601007|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601008|NCT03507829|Insulin|insulin|mesh-list
601009|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
601010|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
601011|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
601012|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
601013|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
601014|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
601015|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601016|NCT03507751|Meropenem|meropenem|mesh-list
601017|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
601018|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
601019|NCT03507699|Nivolumab|nivolumab|mesh-list
601020|NCT03507699|Ipilimumab|ipilimumab|mesh-list
601021|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
601022|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601023|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
601024|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601025|NCT03507634|Lidocaine|lidocaine|mesh-list
601026|NCT03507634|Fentanyl|fentanyl|mesh-list
601027|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
601028|NCT03507634|Remifentanil|remifentanil|mesh-list
2078192|NCT02039674|Pemetrexed|pemetrexed|mesh-list
601029|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
601030|NCT03507634|Anesthetics|anesthetics|mesh-list
601031|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
601032|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
601033|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601034|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
601035|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601036|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
601037|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
601038|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
601039|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
601040|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601041|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
601042|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
601043|NCT03507634|Analgesics|analgesics|mesh-ancestor
601044|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
601045|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
601046|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
601047|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
601048|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
601049|NCT03507634|Narcotics|narcotics|mesh-ancestor
601050|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
601051|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
601052|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
601053|NCT03507608|Flutamide|flutamide|mesh-list
601054|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
601055|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
601056|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
601057|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601058|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
601059|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601060|NCT03507556|Metronidazole|metronidazole|mesh-list
601061|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
601062|NCT03507556|Minocycline|minocycline|mesh-list
601063|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
601064|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
601065|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
601066|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
601067|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
601068|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
601069|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
601070|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601071|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601072|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601073|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
601074|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
601075|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
601076|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
601077|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
601078|NCT03507556|Protective Agents|protective agents|mesh-ancestor
601079|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078193|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2078194|NCT02039674|Ipilimumab|ipilimumab|mesh-list
2078195|NCT02039674|Gefitinib|gefitinib|mesh-list
2078196|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2078197|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078198|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
2078199|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
2078200|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
2078201|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078202|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2078203|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2078204|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2078205|NCT02039674|Growth Substances|growth substances|mesh-ancestor
2078206|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078207|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
601096|NCT03507465|Capecitabine|capecitabine|mesh-list
601097|NCT03507465|Letrozole|letrozole|mesh-list
601098|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
601099|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
601100|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601101|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601102|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
601103|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
601104|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601105|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
601106|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
601107|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
601108|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078208|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078209|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2078210|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
601112|NCT03507426|Ketamine|ketamine|mesh-list
601113|NCT03507426|Analgesics|analgesics|mesh-ancestor
601114|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
601115|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601116|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601117|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
601118|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
601119|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
601120|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
601121|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
601122|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
601123|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
601124|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
601125|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601126|NCT03507413|Metformin|metformin|mesh-list
601127|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
601128|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601129|NCT03507387|Phenylephrine|phenylephrine|mesh-list
601130|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
601131|NCT03507387|Bupivacaine|bupivacaine|mesh-list
601132|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
601133|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
601134|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
601135|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601136|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
601137|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601138|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
601139|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
601140|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
601141|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
601142|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
601143|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
601144|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
601145|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
601146|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
601147|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
601148|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
601149|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
601150|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601151|NCT03507387|Protective Agents|protective agents|mesh-ancestor
601152|NCT03507348|Rituximab|rituximab|mesh-list
601153|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
601154|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601155|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
601156|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601157|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
601158|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
601159|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
601160|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601161|NCT03507244|Dexamethasone|dexamethasone|mesh-list
601162|NCT03507244|Pemetrexed|pemetrexed|mesh-list
601163|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
601164|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
601165|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
601166|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601167|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601168|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
601169|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
601170|NCT03507244|Hormones|hormones|mesh-ancestor
601171|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
601172|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
601173|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601174|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601175|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601176|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
601177|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
601178|NCT03507231|Vaccines|vaccines|mesh-list
601179|NCT03507231|Immunologic Factors|immunologic factors|mesh-ancestor
601180|NCT03507231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601181|NCT03507166|Trastuzumab|trastuzumab|mesh-list
601182|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
601183|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601184|NCT03507127|Varenicline|varenicline|mesh-list
601185|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
601186|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
601187|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
601188|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
601189|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601190|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601191|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
601192|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
601193|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
601194|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
601195|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
601196|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601197|NCT03506919|Allopurinol|allopurinol|mesh-list
601198|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
601199|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601200|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601201|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
601202|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
601203|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
601204|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
601205|NCT03506919|Protective Agents|protective agents|mesh-ancestor
601206|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601207|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
601208|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
601209|NCT03506841|Protective Agents|protective agents|mesh-ancestor
601210|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601211|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
601212|NCT03506828|Phenol|phenol|mesh-list
601213|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
601214|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
601215|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
601216|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
601217|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
601218|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
601219|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
601220|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
601221|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
601222|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
601223|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601224|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601225|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
601226|NCT03506802|Aldesleukin|aldesleukin|mesh-list
601227|NCT03506802|Plerixafor|plerixafor|mesh-list
601228|NCT03506802|Lenalidomide|lenalidomide|mesh-list
601229|NCT03506802|Melphalan|melphalan|mesh-list
601230|NCT03506802|Interleukin-2|interleukin-2|mesh-list
601231|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
601232|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
601233|NCT03506802|Lenograstim|lenograstim|mesh-list
601234|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
601235|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
601236|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601237|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
601238|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
601239|NCT03506802|Growth Substances|growth substances|mesh-ancestor
601240|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
601241|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601242|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
601243|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
601244|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601245|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
601246|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
601247|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
601248|NCT03506802|Analgesics|analgesics|mesh-ancestor
601249|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
601250|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601251|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
601252|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
601253|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
601254|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
601255|NCT03506789|Dexamethasone|dexamethasone|mesh-list
601256|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
601257|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
601258|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
601259|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601260|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601261|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
601262|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
601263|NCT03506789|Hormones|hormones|mesh-ancestor
601264|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
601265|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
601266|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601267|NCT03506763|Diclofenac|diclofenac|mesh-list
601268|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
601269|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
601270|NCT03506763|Analgesics|analgesics|mesh-ancestor
601271|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
601272|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601273|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601274|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
601275|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
601276|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
601277|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601278|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216341|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
2216342|NCT00028600|Melphalan|melphalan|mesh-list
2216343|NCT00028600|Methotrexate|methotrexate|mesh-list
2216344|NCT00028600|Fludarabine|fludarabine|mesh-list
2216345|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
2216346|NCT00028600|Tacrolimus|tacrolimus|mesh-list
2216347|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216348|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
2216349|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216350|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216351|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2216352|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
2216353|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216354|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216355|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2216356|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2216357|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
2216358|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2216359|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2216360|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
601299|NCT03506620|Ropivacaine|ropivacaine|mesh-list
601300|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
601301|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
601302|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
601303|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601304|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
601305|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601306|NCT03506542|Mitomycins|mitomycins|mesh-list
601307|NCT03506542|Mitomycin|mitomycin|mesh-list
601308|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
601309|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601310|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
601311|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601312|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
601313|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601314|NCT03506516|Ethanol|ethanol|mesh-list
601315|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
601316|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
601317|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
601318|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601319|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
601320|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
601321|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601322|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
601323|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
601324|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
601325|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
601326|NCT03506399|Estradiol|estradiol|mesh-list
601327|NCT03506399|Estrogens|estrogens|mesh-ancestor
601328|NCT03506399|Hormones|hormones|mesh-ancestor
601405|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2216361|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
601329|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
601330|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601331|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
601332|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
601333|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
601334|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
601335|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
601336|NCT03506373|Ixazomib|ixazomib|mesh-list
601337|NCT03506373|Glycine|glycine|mesh-list
601338|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601339|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601340|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
601341|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601342|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
601343|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
601344|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601345|NCT03506360|Dexamethasone|dexamethasone|mesh-list
601346|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
601347|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
601348|NCT03506360|Ixazomib|ixazomib|mesh-list
601349|NCT03506360|Ichthammol|ichthammol|mesh-list
601350|NCT03506360|BB 1101|bb 1101|mesh-list
601351|NCT03506360|Glycine|glycine|mesh-list
601352|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
601353|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
601354|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
601355|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601356|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601357|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
601358|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
601359|NCT03506360|Hormones|hormones|mesh-ancestor
601360|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
601361|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
601362|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601363|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
601364|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601365|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601366|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
601367|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
601368|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
601369|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2216362|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216363|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
601373|NCT03506256|Norfloxacin|norfloxacin|mesh-list
601374|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
601375|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
601376|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
601377|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
601378|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601379|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601380|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601381|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
601382|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
601383|NCT03506178|Phenylephrine|phenylephrine|mesh-list
601384|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
601385|NCT03506178|Menthol|menthol|mesh-list
601386|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
601387|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
601388|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
601389|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
601390|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
601391|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
601392|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601393|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601394|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
601395|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
601396|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601397|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
601398|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
601399|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
601400|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
601401|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
601402|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
601403|NCT03506178|Protective Agents|protective agents|mesh-ancestor
601404|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
601406|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
601407|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
601408|NCT03506061|Ivacaftor|ivacaftor|mesh-list
601409|NCT03506061|Elexacaftor|elexacaftor|mesh-list
601410|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
601411|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
601412|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601413|NCT03506048|Lenvatinib|lenvatinib|mesh-list
601414|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601415|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
601416|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601417|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601418|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
601419|NCT03506009|Argatroban|argatroban|mesh-list
601420|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
601421|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
601422|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601423|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
601424|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
601425|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
601426|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601427|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
601428|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2078211|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2078212|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
601431|NCT03505788|Acetazolamide|acetazolamide|mesh-list
601432|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
601433|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
601434|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601435|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601436|NCT03505788|Diuretics|diuretics|mesh-ancestor
601437|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
601438|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078213|NCT02039778|Temozolomide|temozolomide|mesh-list
2078214|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2078215|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
2078216|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078217|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078218|NCT02039908|Methylphenidate|methylphenidate|mesh-list
2078219|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2078220|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078221|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2078222|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2078223|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2078224|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078225|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
2078226|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078227|NCT02039947|Trametinib|trametinib|mesh-list
2078228|NCT02039947|Dabrafenib|dabrafenib|mesh-list
2078229|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078230|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2078231|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078232|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078233|NCT02040116|Rituximab|rituximab|mesh-list
2078234|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2078235|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078236|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
2078237|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078238|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2078239|NCT02040298|Clemastine|clemastine|mesh-list
2078240|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
2078241|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
2078242|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2078243|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
601472|NCT03505736|Adenosine|adenosine|mesh-list
601473|NCT03505736|Regadenoson|regadenoson|mesh-list
601474|NCT03505736|Analgesics|analgesics|mesh-ancestor
601475|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
601476|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601477|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601478|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
601479|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
601480|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
601481|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
601482|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
601483|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
601484|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601485|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
601486|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
601487|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
601488|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
601489|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601490|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
601491|NCT03505723|Coagulants|coagulants|mesh-ancestor
601504|NCT03505528|Paclitaxel|paclitaxel|mesh-list
601505|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
601506|NCT03505528|Phenelzine|phenelzine|mesh-list
601507|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
601508|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601509|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
601510|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
601511|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
601512|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601513|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
601514|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
601515|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
601516|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601517|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
601518|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
601519|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
601520|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601521|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
601522|NCT03505502|Coagulants|coagulants|mesh-ancestor
601523|NCT03505489|Mannitol|mannitol|mesh-list
601524|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
601525|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
601526|NCT03505489|Diuretics|diuretics|mesh-ancestor
601527|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
601528|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601529|NCT03505489|Miotics|miotics|mesh-ancestor
601530|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
601531|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601532|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
601533|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
601534|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
601535|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
601536|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
601537|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
601538|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
601539|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601540|NCT03505411|Melatonin|melatonin|mesh-list
601541|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
601542|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601543|NCT03505411|Protective Agents|protective agents|mesh-ancestor
601544|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601545|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2078244|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
2078245|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078246|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078247|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078248|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2078249|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2078250|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
2078251|NCT02040428|Coagulants|coagulants|mesh-ancestor
2078252|NCT02040532|Gabapentin|gabapentin|mesh-list
2078253|NCT02040532|Analgesics|analgesics|mesh-ancestor
2078254|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
2078255|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601634|NCT03504865|Bupivacaine|bupivacaine|mesh-list
2078256|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078257|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
2078258|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2078259|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2078260|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2078261|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2078262|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2078263|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2216364|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
601568|NCT03505255|Neostigmine|neostigmine|mesh-list
601569|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
601570|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601571|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601572|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
601573|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
601574|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601575|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
601576|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
601577|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601578|NCT03505151|BI 409306|bi 409306|mesh-list
601579|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
601580|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601581|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601582|NCT03505047|Copper|copper|mesh-list
601583|NCT03505047|Trace Elements|trace elements|mesh-ancestor
601584|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
601585|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216365|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2216366|NCT00028613|Antibodies|antibodies|mesh-list
2216367|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2216368|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
2216369|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216370|NCT00028639|Bortezomib|bortezomib|mesh-list
2216371|NCT00028639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216372|NCT00028652|Interleukin-12|interleukin-12|mesh-list
2216373|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
601595|NCT03505008|Adalimumab|adalimumab|mesh-list
601596|NCT03505008|Methotrexate|methotrexate|mesh-list
601597|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
601598|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
601599|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
601600|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601601|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
601602|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
601603|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601604|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601605|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
601606|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601607|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
601608|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
601609|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
601610|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
601611|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
601612|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
601613|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
601614|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
601615|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
601616|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
601617|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
601618|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601619|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601620|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601621|NCT03504956|Metoprolol|metoprolol|mesh-list
601622|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
601623|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
601624|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
601625|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
601626|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
601627|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601628|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601629|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
601630|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
601631|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
601632|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
601633|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601635|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
601636|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
601637|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
601638|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601639|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
601640|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601641|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
601642|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
601643|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
601644|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
601645|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601646|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
601647|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
601648|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
601649|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
601650|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
601651|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601652|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
601653|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601654|NCT03504644|Vincristine|vincristine|mesh-list
601655|NCT03504644|Venetoclax|venetoclax|mesh-list
601656|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
601657|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601658|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
601659|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
601660|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
601661|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601662|NCT03504566|Empagliflozin|empagliflozin|mesh-list
601663|NCT03504566|Linagliptin|linagliptin|mesh-list
601664|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
601665|NCT03504566|Telmisartan|telmisartan|mesh-list
601666|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
601667|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
601668|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
601669|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601670|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
601671|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
601672|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601673|NCT03504566|Incretins|incretins|mesh-ancestor
601674|NCT03504566|Hormones|hormones|mesh-ancestor
601675|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
601676|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
601677|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
601678|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601679|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
601680|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
601681|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
601682|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
601683|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
601684|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
601685|NCT03504527|Budesonide|budesonide|mesh-list
601686|NCT03504527|Bromides|bromides|mesh-list
601687|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
601688|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
601689|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
601690|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
601691|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601692|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601693|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
601694|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
601695|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
601696|NCT03504527|Hormones|hormones|mesh-ancestor
601697|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
601698|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
601699|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
601700|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
601701|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
601702|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601703|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
601704|NCT03504501|Lamotrigine|lamotrigine|mesh-list
601705|NCT03504501|Lovastatin|lovastatin|mesh-list
601706|NCT03504501|L 647318|l 647318|mesh-list
601707|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
601708|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
601709|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
601710|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
601711|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601712|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
601713|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601714|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
601715|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
601716|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
601717|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
601718|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
601719|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
601720|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
601721|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
601722|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
601723|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
601724|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601725|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
601726|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601727|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601728|NCT03504475|Paroxetine|paroxetine|mesh-list
601729|NCT03504475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
601730|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
601731|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
601732|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601733|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
601734|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
601735|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601736|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
601737|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
601738|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
601739|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
601740|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
601741|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078264|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078265|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078266|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
2078267|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2078268|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2078269|NCT02040766|Beclomethasone|beclomethasone|mesh-list
2078270|NCT02040766|Albuterol|albuterol|mesh-list
2078271|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
2078272|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
2078273|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078274|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078275|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2078276|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
2078277|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
2078278|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2078279|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2078280|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2078281|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2078282|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
2078283|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078284|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078285|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2078286|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
2078287|NCT02040766|Hormones|hormones|mesh-ancestor
2078288|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2078289|NCT02040779|Beclomethasone|beclomethasone|mesh-list
2078290|NCT02040779|Albuterol|albuterol|mesh-list
2078291|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
2078292|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
2078293|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078294|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078295|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2078296|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
2078297|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
2078298|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2078299|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2078300|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2078301|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2078302|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
2078303|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078304|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078305|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2078306|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
2078307|NCT02040779|Hormones|hormones|mesh-ancestor
2078308|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2078309|NCT02040857|Tamoxifen|tamoxifen|mesh-list
2078310|NCT02040857|Letrozole|letrozole|mesh-list
2078311|NCT02040857|Palbociclib|palbociclib|mesh-list
2078312|NCT02040857|Anastrozole|anastrozole|mesh-list
2078313|NCT02040857|Exemestane|exemestane|mesh-list
2078314|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2078315|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601798|NCT03504345|Progesterone|progesterone|mesh-list
601799|NCT03504345|Progestins|progestins|mesh-ancestor
601800|NCT03504345|Hormones|hormones|mesh-ancestor
601801|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
601802|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601803|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
601804|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
601805|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601806|NCT03504280|Vitamins|vitamins|mesh-ancestor
601807|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
601808|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
601809|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
601810|NCT03504241|Sirolimus|sirolimus|mesh-list
601811|NCT03504241|Prednisone|prednisone|mesh-list
601812|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
601813|NCT03504241|Abatacept|abatacept|mesh-list
601814|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
601815|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
601816|NCT03504241|Hormones|hormones|mesh-ancestor
601817|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
601818|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601819|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
601820|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601821|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
601822|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
601823|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
601824|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
601825|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
601826|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601827|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601828|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
601829|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
601830|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
601831|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
601832|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
601833|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
601834|NCT03504202|Trimetazidine|trimetazidine|mesh-list
601835|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
601836|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
601837|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
601838|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601839|NCT03504072|Etanercept|etanercept|mesh-list
601840|NCT03504072|Tofacitinib|tofacitinib|mesh-list
601841|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
601842|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
601843|NCT03504072|Analgesics|analgesics|mesh-ancestor
601844|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
601845|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601846|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601847|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
601848|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
601849|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
601850|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
601851|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
601852|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
601853|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601854|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601855|NCT03504046|Pancrelipase|pancrelipase|mesh-list
601856|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
601857|NCT03504033|Desflurane|desflurane|mesh-list
601858|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
601859|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
601860|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
601861|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
601862|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601863|NCT03503994|Beclomethasone|beclomethasone|mesh-list
601864|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
601865|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
601866|NCT03503994|Hormones|hormones|mesh-ancestor
601867|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
601868|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601869|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
601870|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
601871|NCT03503942|Metformin|metformin|mesh-list
601872|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
601873|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601874|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
601875|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601876|NCT03503786|Paclitaxel|paclitaxel|mesh-list
601877|NCT03503786|Carboplatin|carboplatin|mesh-list
601878|NCT03503786|Avelumab|avelumab|mesh-list
601879|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
601880|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601881|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
601882|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
601883|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
601884|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601885|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
601886|NCT03503604|Leucovorin|leucovorin|mesh-list
601887|NCT03503604|Gemcitabine|gemcitabine|mesh-list
601888|NCT03503604|Paclitaxel|paclitaxel|mesh-list
601889|NCT03503604|Carboplatin|carboplatin|mesh-list
601890|NCT03503604|Fluorouracil|fluorouracil|mesh-list
601891|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
601892|NCT03503604|Irinotecan|irinotecan|mesh-list
601893|NCT03503604|Bevacizumab|bevacizumab|mesh-list
601894|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
601895|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601896|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
601897|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
601898|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
601899|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601900|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
601901|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
601902|NCT03503604|Antiviral Agents|antiviral agents|mesh-ancestor
601903|NCT03503604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
601904|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601905|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
601906|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
601907|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601908|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
601909|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
601910|NCT03503604|Antidotes|antidotes|mesh-ancestor
601911|NCT03503604|Protective Agents|protective agents|mesh-ancestor
601912|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
601913|NCT03503604|Vitamins|vitamins|mesh-ancestor
601914|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
601915|NCT03503604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
601916|NCT03503604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
601917|NCT03503604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
601918|NCT03503604|Growth Substances|growth substances|mesh-ancestor
601919|NCT03503604|Growth Inhibitors|growth inhibitors|mesh-ancestor
2216374|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
2216375|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216376|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2216377|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2216378|NCT00028652|Growth Substances|growth substances|mesh-ancestor
2216379|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
2216380|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216381|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
2216382|NCT00028665|Carmustine|carmustine|mesh-list
2216383|NCT00028665|Rituximab|rituximab|mesh-list
2216384|NCT00028665|Etoposide|etoposide|mesh-list
2216385|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216386|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
2216387|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216388|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216389|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2216390|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
601937|NCT03503513|Gentamicins|gentamicins|mesh-list
601938|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2216391|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601939|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
601940|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
601941|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601942|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
601943|NCT03503409|Ivosidenib|ivosidenib|mesh-list
601944|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601945|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
601946|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2750984|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2750985|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2750986|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2750987|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
2750988|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2216392|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216393|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2216394|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2216395|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216396|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2216397|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2216398|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216399|NCT00028678|Dalteparin|dalteparin|mesh-list
2216400|NCT00028678|Tinzaparin|tinzaparin|mesh-list
2216401|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2216402|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
2216403|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2216404|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2216405|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216406|NCT00028691|Chlorambucil|chlorambucil|mesh-list
2216407|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2216408|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
601981|NCT03503227|Aspirin|aspirin|mesh-list
601982|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
601983|NCT03503227|Prednisolone|prednisolone|mesh-list
601984|NCT03503227|Salicylates|salicylates|mesh-list
601985|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
601986|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
601987|NCT03503227|Hormones|hormones|mesh-ancestor
601988|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
601989|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
601990|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
601991|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
601992|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
601993|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
601994|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
601995|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
601996|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
601997|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
601998|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
601999|NCT03503227|Analgesics|analgesics|mesh-ancestor
602000|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
602001|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
602002|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
602003|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602004|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602005|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
602006|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
602007|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
602008|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
602009|NCT03503201|Chromium|chromium|mesh-list
602010|NCT03503201|Trace Elements|trace elements|mesh-ancestor
602011|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
602012|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602013|NCT03503136|Cisplatin|cisplatin|mesh-list
602014|NCT03503136|Docetaxel|docetaxel|mesh-list
602015|NCT03503136|Fluorouracil|fluorouracil|mesh-list
602016|NCT03503136|Capecitabine|capecitabine|mesh-list
602017|NCT03503136|Nedaplatin|nedaplatin|mesh-list
602018|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602019|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
602020|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
602021|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
602022|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602023|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
602024|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
602025|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
602026|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
602027|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602028|NCT03503058|Chloroquine|chloroquine|mesh-list
602029|NCT03503058|Amebicides|amebicides|mesh-ancestor
602030|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
602031|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
602032|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602033|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
602034|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
602035|NCT03502993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
602036|NCT03502993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216409|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216410|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216411|NCT00028717|Prednisone|prednisone|mesh-list
2216412|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
2216413|NCT00028717|Rituximab|rituximab|mesh-list
2216414|NCT00028717|Doxorubicin|doxorubicin|mesh-list
2216415|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2216416|NCT00028717|Vincristine|vincristine|mesh-list
2216417|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216418|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
602047|NCT03502889|Ropivacaine|ropivacaine|mesh-list
602048|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
602049|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
602050|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602051|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602052|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
602053|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602054|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
602055|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
602058|NCT03502746|Nivolumab|nivolumab|mesh-list
602059|NCT03502746|Ramucirumab|ramucirumab|mesh-list
602060|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
602061|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602062|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
602063|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602064|NCT03502733|Nivolumab|nivolumab|mesh-list
602065|NCT03502733|Ipilimumab|ipilimumab|mesh-list
602066|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
602067|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602068|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
602069|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216419|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216420|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216421|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
602079|NCT03502642|Morphine|morphine|mesh-list
602080|NCT03502642|Ropivacaine|ropivacaine|mesh-list
602081|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
602082|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602083|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602084|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
602085|NCT03502642|Narcotics|narcotics|mesh-ancestor
602086|NCT03502642|Analgesics|analgesics|mesh-ancestor
602087|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
602088|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602089|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
2216422|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
2216423|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216424|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216425|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
602094|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
602095|NCT03502577|Fludarabine|fludarabine|mesh-list
602096|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
602097|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
602098|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602099|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
602100|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
602101|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
602102|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602103|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602104|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
602105|NCT03502551|Ketamine|ketamine|mesh-list
602106|NCT03502551|Analgesics|analgesics|mesh-ancestor
602107|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
602108|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602109|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602110|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
602111|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
602112|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
602113|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
602114|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602115|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
602116|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
602117|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
602118|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602119|NCT03502434|Petrolatum|petrolatum|mesh-list
602120|NCT03502434|Emollients|emollients|mesh-ancestor
602121|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
602122|NCT03502421|Ketamine|ketamine|mesh-list
602123|NCT03502421|Analgesics|analgesics|mesh-ancestor
602124|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
602125|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602126|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602127|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
602128|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
602129|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
602130|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
602131|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602132|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
602133|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
602134|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
602135|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602136|NCT03502395|Lidocaine|lidocaine|mesh-list
602137|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
602138|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
602139|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602140|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602141|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
602142|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602143|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
602144|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
602145|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
602146|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
602147|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602148|NCT03502356|Azithromycin|azithromycin|mesh-list
602149|NCT03502356|Cefazolin|cefazolin|mesh-list
602150|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
602151|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602152|NCT03502343|Gemcitabine|gemcitabine|mesh-list
602153|NCT03502343|Paclitaxel|paclitaxel|mesh-list
602154|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
602155|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602156|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
602157|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
602158|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
602159|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602160|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
602161|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
602162|NCT03502343|Antiviral Agents|antiviral agents|mesh-ancestor
602163|NCT03502343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602164|NCT03502343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602165|NCT03502343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
602166|NCT03502343|Immunologic Factors|immunologic factors|mesh-ancestor
602167|NCT03502343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602168|NCT03502330|Nivolumab|nivolumab|mesh-list
602169|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
602170|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602171|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
602172|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602173|NCT03502291|Vaccines|vaccines|mesh-list
602174|NCT03502291|Immunologic Factors|immunologic factors|mesh-ancestor
602175|NCT03502291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078316|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2078317|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602178|NCT03502135|Phenylephrine|phenylephrine|mesh-list
602179|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
602180|NCT03502135|Tetracaine|tetracaine|mesh-list
602181|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
602182|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
602183|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602184|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602185|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
602186|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602187|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
602188|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
602189|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
602190|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
602191|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602192|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
602193|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
602194|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
602195|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
602196|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
602197|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
602198|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
602199|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
602200|NCT03502135|Protective Agents|protective agents|mesh-ancestor
2216426|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2216427|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
602228|NCT03502018|Bupivacaine|bupivacaine|mesh-list
602229|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
602230|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
602231|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602232|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602233|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
602234|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602235|NCT03502005|Tenofovir|tenofovir|mesh-list
602236|NCT03502005|Emtricitabine|emtricitabine|mesh-list
602237|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
602238|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
602239|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602240|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
602241|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
602242|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602243|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602244|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
602245|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2078318|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078319|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2078320|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
2078321|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2078322|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078323|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2078324|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2078325|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2078326|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2078327|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
602256|NCT03501966|Acetazolamide|acetazolamide|mesh-list
602257|NCT03501966|Diuretics|diuretics|mesh-list
602258|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
602259|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602260|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
602261|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
602262|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602263|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602268|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
602269|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602270|NCT03501680|Insulin|insulin|mesh-list
602271|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
602272|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602273|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
602274|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078328|NCT02040870|Ceritinib|ceritinib|mesh-list
2078329|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216428|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2216429|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2216430|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602281|NCT03501498|Loperamide|loperamide|mesh-list
602282|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
602283|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
602284|NCT03501459|Rituximab|rituximab|mesh-list
602285|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
602286|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602287|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
602288|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602289|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
602290|NCT03501433|Niacinamide|niacinamide|mesh-list
602291|NCT03501433|Niacin|niacin|mesh-list
602292|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
602293|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
602294|NCT03501433|Vitamins|vitamins|mesh-ancestor
602295|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
602296|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602297|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
602298|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
602299|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602300|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
602301|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
2216431|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2216432|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
2216433|NCT00028717|Hormones|hormones|mesh-ancestor
2216434|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2216435|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2216436|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216437|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216438|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216439|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216440|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
2216441|NCT00028730|Thiotepa|thiotepa|mesh-list
602335|NCT03501251|Albendazole|albendazole|mesh-list
602336|NCT03501251|Moxidectin|moxidectin|mesh-list
602337|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
602338|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
602339|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602340|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
602341|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
602342|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
602343|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
602344|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
602345|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
602346|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602347|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602348|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
602349|NCT03501212|Anesthetics|anesthetics|mesh-list
602350|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
602351|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602352|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602353|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
602354|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602355|NCT03501056|Antibodies|antibodies|mesh-list
602356|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
602357|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
602358|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216442|NCT00028730|Fludarabine|fludarabine|mesh-list
2216443|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
2216444|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2216445|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216446|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
2216447|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216448|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
602366|NCT03500913|Hormones|hormones|mesh-list
602367|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
602368|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602369|NCT03500900|Vildagliptin|vildagliptin|mesh-list
602370|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
602371|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602372|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
602373|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
602374|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602375|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602376|NCT03500874|Leucovorin|leucovorin|mesh-list
602377|NCT03500874|Fluorouracil|fluorouracil|mesh-list
602378|NCT03500874|Floxuridine|floxuridine|mesh-list
602379|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
602380|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
602381|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602382|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
602383|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602384|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
602385|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
602386|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602387|NCT03500874|Antidotes|antidotes|mesh-ancestor
602388|NCT03500874|Protective Agents|protective agents|mesh-ancestor
602389|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
602390|NCT03500874|Vitamins|vitamins|mesh-ancestor
602391|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
602392|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
602393|NCT03500848|Sirolimus|sirolimus|mesh-list
602394|NCT03500848|Tacrolimus|tacrolimus|mesh-list
602395|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
602396|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
2216449|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
602397|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602398|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
602399|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602400|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602401|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
602402|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602403|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
602404|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
602405|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
602406|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602407|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
602408|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
602409|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
602410|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
602411|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602412|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602413|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
602414|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
602415|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
602416|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
602417|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602418|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
602419|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
602420|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
602421|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
602422|NCT03500783|Protective Agents|protective agents|mesh-ancestor
602423|NCT03500731|Rituximab|rituximab|mesh-list
602424|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
602425|NCT03500731|Fludarabine|fludarabine|mesh-list
602426|NCT03500731|Thiotepa|thiotepa|mesh-list
602427|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
602428|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
602429|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602430|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
602431|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602432|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
602433|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602434|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
602435|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
602436|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
602437|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
602438|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
602439|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602440|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
602441|NCT03500653|Curcumin|curcumin|mesh-list
602442|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
602443|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
602444|NCT03500653|Analgesics|analgesics|mesh-ancestor
602445|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
602446|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602447|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602448|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
602449|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
602450|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602451|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602452|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602453|NCT03500549|Eculizumab|eculizumab|mesh-list
602454|NCT03500549|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
602455|NCT03500549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
602456|NCT03500549|Immunologic Factors|immunologic factors|mesh-ancestor
602457|NCT03500549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078330|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2078331|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078332|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078333|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2078334|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
2078335|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078336|NCT02041299|Deferiprone|deferiprone|mesh-list
2078337|NCT02041299|Deferoxamine|deferoxamine|mesh-list
602467|NCT03500445|Dexamethasone|dexamethasone|mesh-list
602468|NCT03500445|Lenalidomide|lenalidomide|mesh-list
602469|NCT03500445|Daratumumab|daratumumab|mesh-list
602470|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
602471|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
602472|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
602473|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602474|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602475|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
602476|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
602477|NCT03500445|Hormones|hormones|mesh-ancestor
602478|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
602479|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
602480|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602481|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
602482|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
602483|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
602484|NCT03500445|Growth Substances|growth substances|mesh-ancestor
602485|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
602486|NCT03500432|Lidocaine|lidocaine|mesh-list
602487|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
602488|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
602489|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602490|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602491|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
602492|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602493|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
602494|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
602495|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
602496|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
602497|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602498|NCT03500380|Capecitabine|capecitabine|mesh-list
602499|NCT03500380|Lapatinib|lapatinib|mesh-list
602500|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
602501|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
602502|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602503|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602504|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
602505|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602506|NCT03500367|Sirolimus|sirolimus|mesh-list
602507|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
602508|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602509|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
602510|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602511|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
602512|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
602513|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
602514|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216450|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
2216451|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216452|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216453|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2216454|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2216455|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
2216456|NCT00028743|Paclitaxel|paclitaxel|mesh-list
2216457|NCT00028743|Carboplatin|carboplatin|mesh-list
2216458|NCT00028743|Topotecan|topotecan|mesh-list
2216459|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216460|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216461|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216462|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216463|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216464|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216465|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2216466|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2216467|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216468|NCT00028756|Gemcitabine|gemcitabine|mesh-list
2216469|NCT00028756|Doxorubicin|doxorubicin|mesh-list
2216470|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2216471|NCT00028756|Methotrexate|methotrexate|mesh-list
2216472|NCT00028756|Vinblastine|vinblastine|mesh-list
2216473|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216474|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2216475|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
2216476|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216477|NCT00028756|Antiviral Agents|antiviral agents|mesh-ancestor
2216478|NCT00028756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216479|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216480|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216481|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
2216482|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216483|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2216484|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2216485|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2216486|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2216487|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
2216488|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2216489|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
602555|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
602556|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
602557|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
602558|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602559|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602560|NCT03500133|Cytarabine|cytarabine|mesh-list
602561|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
602562|NCT03500133|Cisplatin|cisplatin|mesh-list
602563|NCT03500133|Etoposide|etoposide|mesh-list
602564|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602565|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
602566|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
602567|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602568|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
602569|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602570|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
602571|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
602572|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602573|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
602574|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
602575|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
602576|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602577|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
602578|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
602579|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
602580|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602581|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
602582|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
602583|NCT03500133|Hormones|hormones|mesh-ancestor
602584|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
602585|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
602586|NCT03500133|Protective Agents|protective agents|mesh-ancestor
602587|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
602588|NCT03500120|Captopril|captopril|mesh-list
602589|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
602590|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
602591|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602592|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602593|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
602594|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
602595|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
602596|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2078338|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2078339|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
2078340|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
2078341|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078342|NCT02041299|Siderophores|siderophores|mesh-ancestor
602602|NCT03499886|Ketamine|ketamine|mesh-list
602603|NCT03499886|Analgesics|analgesics|mesh-ancestor
602604|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
602605|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602606|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602607|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
602608|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
602609|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
602610|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
602611|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602612|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
602613|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
602614|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
602615|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216490|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2216491|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216492|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2216493|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216494|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216495|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216496|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216497|NCT00028782|Etanidazole|etanidazole|mesh-list
2216498|NCT00028782|Imidazole|imidazole|mesh-list
602625|NCT03499743|Celecoxib|celecoxib|mesh-list
602626|NCT03499743|Scopolamine|scopolamine|mesh-list
602627|NCT03499743|Bromides|bromides|mesh-list
602628|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
602629|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
602630|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
602631|NCT03499743|Analgesics|analgesics|mesh-ancestor
602632|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
602633|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602634|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602635|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
602636|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
602637|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
602638|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
602639|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602640|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602641|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
602642|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
602643|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
602644|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
602645|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
602646|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
602647|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
602648|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
602649|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
602650|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
602651|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
602652|NCT03499730|Midazolam|midazolam|mesh-list
602653|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
602654|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
602655|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602656|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602657|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
602658|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
602659|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
602660|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
602661|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
602662|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
602663|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
602664|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
602665|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
602666|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602667|NCT03499704|Metformin|metformin|mesh-list
602668|NCT03499704|Pioglitazone|pioglitazone|mesh-list
602669|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
602670|NCT03499704|Alogliptin|alogliptin|mesh-list
602671|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
602672|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602673|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
602674|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602675|NCT03499704|Incretins|incretins|mesh-ancestor
602676|NCT03499704|Hormones|hormones|mesh-ancestor
602677|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
602678|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
602679|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
602680|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602681|NCT03499639|Ritonavir|ritonavir|mesh-list
602682|NCT03499639|Ribavirin|ribavirin|mesh-list
602683|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
602684|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
602685|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
602686|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602687|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602688|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
602689|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
602690|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
602691|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602692|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
602693|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
602694|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
602695|NCT03499483|Tenofovir|tenofovir|mesh-list
602696|NCT03499483|Emtricitabine|emtricitabine|mesh-list
602697|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
602698|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
2216499|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602699|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602700|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
602701|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
602702|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602703|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602704|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
602705|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
602706|NCT03499457|Amoxicillin|amoxicillin|mesh-list
602707|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
602708|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602709|NCT03499444|Rucaparib|rucaparib|mesh-list
602710|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
602711|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602712|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602713|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602714|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
602715|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
602716|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
602717|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
602718|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602719|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
602720|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
602721|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2078343|NCT02041325|Lenalidomide|lenalidomide|mesh-list
2078344|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
2078345|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078346|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2078347|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
602727|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
602728|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
602729|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
602730|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602731|NCT03499249|Expectorants|expectorants|mesh-ancestor
602732|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
602733|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
602734|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
602735|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602736|NCT03499249|Protective Agents|protective agents|mesh-ancestor
602737|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602738|NCT03499249|Antidotes|antidotes|mesh-ancestor
602739|NCT03499223|Ranibizumab|ranibizumab|mesh-list
602740|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
602741|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
602742|NCT03499223|Growth Substances|growth substances|mesh-ancestor
602743|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602744|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
602745|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602746|NCT03499184|Metronidazole|metronidazole|mesh-list
602747|NCT03499184|Amoxicillin|amoxicillin|mesh-list
602748|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602749|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
602750|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
602751|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
602752|NCT03499171|Citalopram|citalopram|mesh-list
602753|NCT03499171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
602754|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
602755|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
602756|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602757|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
602758|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
602759|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602760|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
602761|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
602762|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
602763|NCT03499132|Anesthetics|anesthetics|mesh-list
602764|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602765|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078348|NCT02041325|Growth Substances|growth substances|mesh-ancestor
602773|NCT03499106|Itraconazole|itraconazole|mesh-list
602774|NCT03499106|Praliciguat|praliciguat|mesh-list
602775|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
602776|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602777|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
602778|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
602779|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602780|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602781|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
602782|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
602783|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
602784|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602785|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
602786|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
602787|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
602788|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
602789|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
602790|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
602791|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602792|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602793|NCT03498820|Remifentanil|remifentanil|mesh-list
602794|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
602795|NCT03498820|Narcotics|narcotics|mesh-ancestor
602796|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602797|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602798|NCT03498820|Analgesics|analgesics|mesh-ancestor
602799|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
602800|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078349|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
2078350|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078351|NCT02041429|Paclitaxel|paclitaxel|mesh-list
2078352|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2078353|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078354|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
2078355|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
2078356|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
2078357|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078358|NCT02041533|Gemcitabine|gemcitabine|mesh-list
2078359|NCT02041533|Paclitaxel|paclitaxel|mesh-list
2078360|NCT02041533|Carboplatin|carboplatin|mesh-list
2078361|NCT02041533|Nivolumab|nivolumab|mesh-list
2078362|NCT02041533|Pemetrexed|pemetrexed|mesh-list
2078363|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2078364|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078365|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
2078366|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
2078367|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
2078368|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078369|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2078370|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
602823|NCT03498703|Azathioprine|azathioprine|mesh-list
602824|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
602825|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602826|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
602827|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602828|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
602829|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
602830|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602831|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
602835|NCT03498534|Isoniazid|isoniazid|mesh-list
602836|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
602837|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
602838|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602839|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
602840|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
602841|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
602842|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602843|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2078371|NCT02041533|Antiviral Agents|antiviral agents|mesh-ancestor
2078372|NCT02041533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078373|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078374|NCT02041533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078375|NCT02041533|Immunologic Factors|immunologic factors|mesh-ancestor
2078376|NCT02041533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078377|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2078378|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2078379|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2078380|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2078381|NCT02042183|Lubiprostone|lubiprostone|mesh-list
2078382|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2078383|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2078384|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078385|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
2078386|NCT02042443|Leucovorin|leucovorin|mesh-list
2078387|NCT02042443|Folic Acid|folic acid|mesh-list
2078388|NCT02042443|Fluorouracil|fluorouracil|mesh-list
2078389|NCT02042443|Capecitabine|capecitabine|mesh-list
2078390|NCT02042443|Trametinib|trametinib|mesh-list
2078391|NCT02042443|Calcium|calcium|mesh-list
2078392|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
2078393|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2078394|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078395|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2078396|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
602871|NCT03498456|Amoxicillin|amoxicillin|mesh-list
602872|NCT03498456|Clarithromycin|clarithromycin|mesh-list
602873|NCT03498456|Lansoprazole|lansoprazole|mesh-list
602874|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
602875|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
602876|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602877|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
602878|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602879|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602880|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
602881|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
602882|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
602883|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
602884|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
602885|NCT03498417|Antibodies|antibodies|mesh-list
602886|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
602887|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602904|NCT03498378|Cetuximab|cetuximab|mesh-list
602905|NCT03498378|Avelumab|avelumab|mesh-list
602906|NCT03498378|Palbociclib|palbociclib|mesh-list
602907|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
602908|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602909|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
602910|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602911|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602912|NCT03498326|Gemcitabine|gemcitabine|mesh-list
602913|NCT03498326|Celecoxib|celecoxib|mesh-list
602914|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
602915|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
602916|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602917|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602918|NCT03498326|Antiviral Agents|antiviral agents|mesh-ancestor
602919|NCT03498326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602920|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602921|NCT03498326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
602922|NCT03498326|Immunologic Factors|immunologic factors|mesh-ancestor
602923|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602924|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
602925|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
602926|NCT03498326|Analgesics|analgesics|mesh-ancestor
602927|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
602928|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602929|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
602930|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
602931|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
602932|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
602933|NCT03498313|Estradiol|estradiol|mesh-list
602934|NCT03498313|Progesterone|progesterone|mesh-list
602935|NCT03498313|Estrogens|estrogens|mesh-ancestor
602936|NCT03498313|Hormones|hormones|mesh-ancestor
602937|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
602938|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602939|NCT03498313|Progestins|progestins|mesh-ancestor
602940|NCT03498261|Gabapentin|gabapentin|mesh-list
602941|NCT03498261|Analgesics|analgesics|mesh-ancestor
602942|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
602943|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
602944|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602945|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
602946|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
602947|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
602948|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602949|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
602950|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
602951|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
602952|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
602953|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602954|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
602955|NCT03498248|Lenograstim|lenograstim|mesh-list
602956|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
602957|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
602958|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602959|NCT03498235|Propofol|propofol|mesh-list
602960|NCT03498235|Sevoflurane|sevoflurane|mesh-list
602961|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
602962|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
602963|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602964|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
602965|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
602966|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
602967|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
602968|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
602969|NCT03498222|Carboplatin|carboplatin|mesh-list
602970|NCT03498222|Pemetrexed|pemetrexed|mesh-list
602971|NCT03498222|Atezolizumab|atezolizumab|mesh-list
602972|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602973|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602974|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602975|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
602976|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2216500|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216501|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
602980|NCT03498170|Itraconazole|itraconazole|mesh-list
602981|NCT03498170|Acumapimod|acumapimod|mesh-list
602982|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
602983|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
602984|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
602985|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
602986|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
602987|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602988|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
602989|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
602990|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
602991|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602992|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
602993|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
602994|NCT03498131|Melatonin|melatonin|mesh-list
602995|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
602996|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
602997|NCT03498131|Protective Agents|protective agents|mesh-ancestor
602998|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
602999|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603000|NCT03498118|Bupivacaine|bupivacaine|mesh-list
603001|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
603002|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
603003|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603004|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603005|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
603006|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
603007|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
603008|NCT03498092|Bupivacaine|bupivacaine|mesh-list
603009|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
603010|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
603011|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603012|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603013|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
603014|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
603015|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
603016|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
603017|NCT03498092|Analgesics|analgesics|mesh-ancestor
603018|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
603019|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
603020|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
603021|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
603022|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603023|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603024|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
603025|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
603026|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
603027|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603028|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603029|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603037|NCT03498001|Liraglutide|liraglutide|mesh-list
603038|NCT03498001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
603039|NCT03498001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603040|NCT03498001|Incretins|incretins|mesh-ancestor
603041|NCT03498001|Hormones|hormones|mesh-ancestor
603042|NCT03498001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
603043|NCT03497988|Oxytocin|oxytocin|mesh-list
603044|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
603045|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
603046|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603047|NCT03497975|Nalbuphine|nalbuphine|mesh-list
603048|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
603049|NCT03497975|Narcotics|narcotics|mesh-ancestor
603050|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603051|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603052|NCT03497975|Analgesics|analgesics|mesh-ancestor
603053|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
603054|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
603055|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
603056|NCT03497923|Analgesics|analgesics|mesh-ancestor
603057|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
603058|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
603059|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603060|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
603061|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603062|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
603063|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
603064|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
603065|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
603066|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603067|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
603068|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
603069|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2216502|NCT00028795|Temozolomide|temozolomide|mesh-list
603519|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
2216503|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
603073|NCT03497767|Osimertinib|osimertinib|mesh-list
603074|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603075|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
603076|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603077|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603078|NCT03497715|Ibuprofen|ibuprofen|mesh-list
603079|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
603080|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
603081|NCT03497715|Analgesics|analgesics|mesh-ancestor
603082|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
603083|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
603084|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603085|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
603086|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
603087|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
603088|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603089|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603090|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
603091|NCT03497702|Docetaxel|docetaxel|mesh-list
603092|NCT03497702|Doxorubicin|doxorubicin|mesh-list
603093|NCT03497702|Letrozole|letrozole|mesh-list
603094|NCT03497702|Leuprolide|leuprolide|mesh-list
603095|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
603096|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
603097|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603098|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
603099|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
603100|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
603101|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603102|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603103|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
603104|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
603105|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
603106|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
603107|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
603108|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
603109|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
603110|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603111|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
603112|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
603113|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
603114|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
603115|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
603116|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
603117|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
603118|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
603119|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
603120|NCT03497689|Treprostinil|treprostinil|mesh-list
603121|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2078397|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078398|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2078399|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078400|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078401|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
2078402|NCT02042443|Antidotes|antidotes|mesh-ancestor
2078403|NCT02042443|Protective Agents|protective agents|mesh-ancestor
2078404|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
2078405|NCT02042443|Vitamins|vitamins|mesh-ancestor
2078406|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
2078407|NCT02042443|Hematinics|hematinics|mesh-ancestor
2078408|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
603134|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
603135|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
603136|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
603137|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
603138|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
603139|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
603140|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603141|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603142|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078409|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078410|NCT02042534|Warfarin|warfarin|mesh-list
2078411|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
2078412|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
2078413|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2078414|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
603148|NCT03497364|Bupivacaine|bupivacaine|mesh-list
603149|NCT03497364|Ropivacaine|ropivacaine|mesh-list
603150|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
603151|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
603152|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603153|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603154|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
603155|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
603156|NCT03497351|Nicardipine|nicardipine|mesh-list
603157|NCT03497351|Urapidil|urapidil|mesh-list
603158|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
603159|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
603160|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
603161|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603162|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
603163|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603164|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
603165|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
603166|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
603167|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603168|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
603169|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
603170|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
603171|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
603172|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
603173|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
603174|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603175|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
603176|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
603177|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
603178|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603179|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
603180|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603181|NCT03497156|Lercanidipine|lercanidipine|mesh-list
603182|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
603183|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
603184|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
603185|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603186|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
603187|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603188|NCT03497143|Lamotrigine|lamotrigine|mesh-list
603189|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
603190|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
603191|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
603192|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603193|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
603194|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603195|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
603196|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
603197|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603198|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
603199|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2216504|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
2216505|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216506|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216507|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
2216508|NCT00028821|Estradiol|estradiol|mesh-list
2216509|NCT00028821|Estrogens|estrogens|mesh-ancestor
2216510|NCT00028821|Hormones|hormones|mesh-ancestor
2216511|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2216512|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216513|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216514|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216515|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216516|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216517|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216518|NCT00028834|Gemcitabine|gemcitabine|mesh-list
2216519|NCT00028834|Bevacizumab|bevacizumab|mesh-list
2216520|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
603594|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
2216521|NCT00028834|Antibodies|antibodies|mesh-list
2216522|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
603219|NCT03496870|Levodopa|levodopa|mesh-list
603220|NCT03496870|Carbidopa|carbidopa|mesh-list
603221|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
603222|NCT03496870|Opicapone|opicapone|mesh-list
603223|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
603224|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
603225|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
603226|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603227|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603228|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603229|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
603230|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603231|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
603232|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
603233|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
603234|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
603235|NCT03496831|Adalimumab|adalimumab|mesh-list
603236|NCT03496831|Etanercept|etanercept|mesh-list
603237|NCT03496831|Golimumab|golimumab|mesh-list
603238|NCT03496831|Abatacept|abatacept|mesh-list
603239|NCT03496831|Infliximab|infliximab|mesh-list
603240|NCT03496831|Ustekinumab|ustekinumab|mesh-list
603241|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603242|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
603243|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603244|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
603245|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
603246|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
603247|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
603248|NCT03496831|Analgesics|analgesics|mesh-ancestor
603249|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
603250|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
603251|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
603252|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
603253|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
603254|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
603255|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603256|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
603257|NCT03496779|Gemcitabine|gemcitabine|mesh-list
603258|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
603259|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
603260|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
603261|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
603262|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603263|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603264|NCT03496779|Antiviral Agents|antiviral agents|mesh-ancestor
603265|NCT03496779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
603266|NCT03496779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603267|NCT03496779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
603268|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
603269|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603270|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
603271|NCT03496766|Tipifarnib|tipifarnib|mesh-list
603272|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603273|NCT03496740|Bupivacaine|bupivacaine|mesh-list
603274|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
603275|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
603276|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603277|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603278|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
603279|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078415|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2078416|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
2078417|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078418|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078419|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
2078420|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2078421|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078422|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
2078423|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
2078424|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2078425|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078426|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
2216523|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2078427|NCT02043132|Coagulants|coagulants|mesh-ancestor
2078428|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
2078429|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2078430|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2078431|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
603299|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
603300|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
603301|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
603302|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603303|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
603304|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603305|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078432|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2078433|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078434|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
2216524|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216525|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2216526|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2216527|NCT00028834|Growth Substances|growth substances|mesh-ancestor
2216528|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216529|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
2216530|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
2216531|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2216532|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
2216533|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216534|NCT00028834|Antiviral Agents|antiviral agents|mesh-ancestor
2216535|NCT00028834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216536|NCT00028834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216537|NCT00028834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216538|NCT00028847|Cytarabine|cytarabine|mesh-list
2216539|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
603332|NCT03496519|Durvalumab|durvalumab|mesh-list
603333|NCT03496519|Trabectedin|trabectedin|mesh-list
603334|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
603335|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
603336|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603337|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
603338|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603339|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
603340|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
603341|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603342|NCT03496506|Selexipag|selexipag|mesh-list
603343|NCT03496506|Clopidogrel|clopidogrel|mesh-list
603344|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
603345|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
603346|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
603347|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
603348|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
603349|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603350|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603351|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603352|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2078435|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078436|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078437|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2078438|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078439|NCT02043301|Bococizumab|bococizumab|mesh-list
2078440|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2078441|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2078442|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
2078443|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603362|NCT03496389|Acetaminophen|acetaminophen|mesh-list
603363|NCT03496389|Gabapentin|gabapentin|mesh-list
603364|NCT03496389|Tramadol|tramadol|mesh-list
603365|NCT03496389|Analgesics|analgesics|mesh-ancestor
603366|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
603367|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
603368|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603369|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
603370|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
603371|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
603372|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603373|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
603374|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
603375|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
603376|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603377|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603378|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
603379|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
603380|NCT03496389|Narcotics|narcotics|mesh-ancestor
603381|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
603382|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
2216540|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2216541|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
2216542|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216543|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216544|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
2216545|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216546|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216547|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
2216548|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216549|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2216550|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216551|NCT00028860|Gemcitabine|gemcitabine|mesh-list
2078444|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2078445|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
2078446|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
603398|NCT03496246|Vitamin D|vitamin d|mesh-list
603399|NCT03496246|Calcifediol|calcifediol|mesh-list
603400|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
603401|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
603402|NCT03496246|Calcium|calcium|mesh-list
603403|NCT03496246|Vitamins|vitamins|mesh-ancestor
603404|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
603405|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603406|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
603407|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
603408|NCT03496233|Grazoprevir|grazoprevir|mesh-list
603409|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
603410|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
603411|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
603412|NCT03495973|Ustekinumab|ustekinumab|mesh-list
603413|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
2078447|NCT02043366|Sufentanil|sufentanil|mesh-list
2078448|NCT02043366|Remifentanil|remifentanil|mesh-list
2078449|NCT02043366|Butorphanol|butorphanol|mesh-list
2078450|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2078451|NCT02043366|Narcotics|narcotics|mesh-ancestor
2078452|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2078453|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078454|NCT02043366|Analgesics|analgesics|mesh-ancestor
2078455|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
2078456|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078457|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2078458|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2078459|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
2078460|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
2078461|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2078462|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2078463|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2078464|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2078465|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2078466|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078467|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078468|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
2078469|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
2078470|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2078471|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2078472|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
2078473|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078474|NCT02043652|Chloroquine|chloroquine|mesh-list
2078475|NCT02043652|Primaquine|primaquine|mesh-list
2078476|NCT02043652|Amebicides|amebicides|mesh-ancestor
2078477|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2216552|NCT00028860|Paclitaxel|paclitaxel|mesh-list
2078478|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2078479|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078480|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
2078481|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
603454|NCT03495804|Mannitol|mannitol|mesh-list
603455|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
603456|NCT03495804|Diuretics|diuretics|mesh-ancestor
603457|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
603458|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603459|NCT03495765|Ranibizumab|ranibizumab|mesh-list
603460|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
603461|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
603462|NCT03495765|Growth Substances|growth substances|mesh-ancestor
603463|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603464|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
603465|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603466|NCT03495739|Dabigatran|dabigatran|mesh-list
603467|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
603468|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
603469|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
603470|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603471|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603472|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
603473|NCT03495713|Nivolumab|nivolumab|mesh-list
603474|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
603475|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603476|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
603477|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603478|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
603479|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
603480|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603481|NCT03495466|Anesthetics|anesthetics|mesh-list
603482|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603483|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603484|NCT03495232|Cimetidine|cimetidine|mesh-list
603485|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
603486|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
603487|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
603488|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
603489|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
603490|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603491|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603492|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603493|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
603494|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
603495|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603496|NCT03495206|Edaravone|edaravone|mesh-list
603497|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
603498|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
603499|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603500|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
603501|NCT03495206|Protective Agents|protective agents|mesh-ancestor
603502|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216553|NCT00028860|Carboplatin|carboplatin|mesh-list
2216554|NCT00028860|Ifosfamide|ifosfamide|mesh-list
2216555|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
603506|NCT03495063|Caffeine|caffeine|mesh-list
603507|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
603508|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603509|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
603510|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603511|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603512|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
603513|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
603514|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
603515|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603516|NCT03495024|Varenicline|varenicline|mesh-list
603517|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
603518|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2216556|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603520|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603521|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603522|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216557|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216558|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
603525|NCT03494972|Tetracycline|tetracycline|mesh-list
603526|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
603527|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
603528|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
603529|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603530|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603531|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
603532|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
603533|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
603534|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
603535|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
603536|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
603537|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603538|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603539|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603540|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
603541|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
603542|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
603543|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603544|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
603545|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
603546|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2216559|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216560|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216561|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2216562|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
603552|NCT03494686|Anesthetics|anesthetics|mesh-list
603553|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603554|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603555|NCT03494569|Fludarabine|fludarabine|mesh-list
603556|NCT03494569|Melphalan|melphalan|mesh-list
603557|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
603558|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
603559|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603560|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603561|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
603562|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
603563|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603564|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
603565|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
603566|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
603567|NCT03494530|Edoxaban|edoxaban|mesh-list
603568|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
603569|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
603570|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
603571|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
603572|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603573|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603574|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
603575|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
603576|NCT03494517|Analgesics|analgesics|mesh-ancestor
603577|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
603578|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
603579|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603580|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
603581|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603582|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
603583|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
603584|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
603585|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
603586|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603587|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
603588|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
603589|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
603590|NCT03494504|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
603591|NCT03494504|Ophthalmic Solutions|ophthalmic solutions|mesh-list
603592|NCT03494426|Pregabalin|pregabalin|mesh-list
603593|NCT03494426|Tramadol|tramadol|mesh-list
603595|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
603596|NCT03494426|Analgesics|analgesics|mesh-ancestor
603597|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
603598|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
603599|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603600|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
603601|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
603602|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
603603|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603604|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
603605|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
603606|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
603607|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603608|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
603609|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
603610|NCT03494426|Narcotics|narcotics|mesh-ancestor
603611|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
603612|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
603613|NCT03494387|Antioxidants|antioxidants|mesh-list
603614|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
603615|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
603616|NCT03494387|Expectorants|expectorants|mesh-ancestor
603617|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
603618|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
603619|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603620|NCT03494387|Protective Agents|protective agents|mesh-ancestor
603621|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603622|NCT03494387|Vitamins|vitamins|mesh-ancestor
603623|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
603624|NCT03494322|Cetuximab|cetuximab|mesh-list
603625|NCT03494322|Avelumab|avelumab|mesh-list
603626|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
603627|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603628|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
603629|NCT03494257|Brinzolamide|brinzolamide|mesh-list
603630|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
603631|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
603632|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
603633|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
603634|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
603635|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603636|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603637|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603638|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
603639|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216563|NCT00028860|Antiviral Agents|antiviral agents|mesh-ancestor
2216564|NCT00028860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216565|NCT00028860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216566|NCT00028860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216567|NCT00028860|Immunologic Factors|immunologic factors|mesh-ancestor
2216568|NCT00028860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216569|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2216570|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
2216571|NCT00028873|Paclitaxel|paclitaxel|mesh-list
2216572|NCT00028873|Docetaxel|docetaxel|mesh-list
2216573|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216574|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216575|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216576|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216577|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216578|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216579|NCT00028886|Interferons|interferons|mesh-list
2216580|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
2216581|NCT00028886|Thalidomide|thalidomide|mesh-list
2216582|NCT00028886|Dexamethasone|dexamethasone|mesh-list
2216583|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
2216584|NCT00028886|Melphalan|melphalan|mesh-list
2216585|NCT00028886|Doxorubicin|doxorubicin|mesh-list
2216586|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2216587|NCT00028886|Vincristine|vincristine|mesh-list
603744|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2216588|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216589|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
603671|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
603672|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
603673|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603674|NCT03493841|Protective Agents|protective agents|mesh-ancestor
603675|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603676|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
603677|NCT03493841|Vitamins|vitamins|mesh-ancestor
603678|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
2216590|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216591|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216592|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2216593|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
2216594|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216595|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216596|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
603686|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
603687|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
603688|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
603689|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603690|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
603691|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
603692|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216597|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2216598|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
2216599|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
2216600|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2216601|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2216602|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
2216603|NCT00028886|Hormones|hormones|mesh-ancestor
2216604|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2216605|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2216606|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2216607|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2216608|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2216609|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216610|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
2216611|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
603708|NCT03493685|Irbesartan|irbesartan|mesh-list
603709|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
603710|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
603711|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
603712|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603713|NCT03493646|Azacitidine|azacitidine|mesh-list
603714|NCT03493646|Cc-486|cc-486|mesh-list
603715|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
603716|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
603717|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603718|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603719|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603720|NCT03493568|Dolutegravir|dolutegravir|mesh-list
603721|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
603722|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
603723|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
603724|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603725|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603726|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
603727|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
603728|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
603729|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216612|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216613|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216614|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
603733|NCT03493503|Albuterol|albuterol|mesh-list
603734|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
603735|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
603736|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
603737|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603738|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
603739|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
603740|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
603741|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
603742|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
603743|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
603745|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
603746|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603747|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603748|NCT03493490|Diclofenac|diclofenac|mesh-list
603749|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
603750|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
603751|NCT03493490|Analgesics|analgesics|mesh-ancestor
603752|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
603753|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
603754|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603755|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
603756|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
603757|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
603758|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603759|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078492|NCT02043704|Acetaminophen|acetaminophen|mesh-list
2078493|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2078494|NCT02043704|Analgesics|analgesics|mesh-ancestor
2216615|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
603768|NCT03493412|Verapamil|verapamil|mesh-list
603769|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
603770|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
603771|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
603772|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603773|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
603774|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603775|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
2216616|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
2216617|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2216618|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2216619|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
603781|NCT03493269|Midazolam|midazolam|mesh-list
603782|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
603783|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
603784|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603785|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603786|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
603787|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
603788|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
603789|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
603790|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
603791|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
603792|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
603793|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
603794|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603795|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603796|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
603797|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
603798|NCT03493178|Glycine|glycine|mesh-list
603799|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
603800|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
603801|NCT03493178|Expectorants|expectorants|mesh-ancestor
603802|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
603803|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
603804|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
603805|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603806|NCT03493178|Protective Agents|protective agents|mesh-ancestor
603807|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603808|NCT03493178|Antidotes|antidotes|mesh-ancestor
603809|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
603810|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603811|NCT03493165|Everolimus|everolimus|mesh-list
603812|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603813|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
603814|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
603815|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603816|NCT03493152|Everolimus|everolimus|mesh-list
603817|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603818|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
603819|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
603820|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603826|NCT03493087|Vitamin K|vitamin k|mesh-list
603827|NCT03493087|Vitamins|vitamins|mesh-ancestor
603828|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
603829|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603830|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
603831|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
603832|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603833|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
603834|NCT03493087|Coagulants|coagulants|mesh-ancestor
603835|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
603836|NCT03493061|Irinotecan|irinotecan|mesh-list
603837|NCT03493061|Floxuridine|floxuridine|mesh-list
603838|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603839|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
603840|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
603841|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603842|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603843|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
603844|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
603845|NCT03493048|Leucovorin|leucovorin|mesh-list
603846|NCT03493048|Fluorouracil|fluorouracil|mesh-list
603847|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
603848|NCT03493048|Irinotecan|irinotecan|mesh-list
603849|NCT03493048|Cetuximab|cetuximab|mesh-list
603850|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
603851|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603852|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
603853|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603854|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
603855|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
603856|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603857|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
603858|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
603859|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603860|NCT03493048|Antidotes|antidotes|mesh-ancestor
603861|NCT03493048|Protective Agents|protective agents|mesh-ancestor
603862|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
603863|NCT03493048|Vitamins|vitamins|mesh-ancestor
603864|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
603865|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
603866|NCT03492996|Delpazolid|delpazolid|mesh-list
603867|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
603868|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
603869|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
603870|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603871|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603872|NCT03492970|Melatonin|melatonin|mesh-list
603873|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
603874|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603875|NCT03492970|Protective Agents|protective agents|mesh-ancestor
603876|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603877|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603878|NCT03492931|Ticagrelor|ticagrelor|mesh-list
603879|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
603880|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
603881|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
603882|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
603883|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
603884|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
603885|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603886|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603887|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
603888|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
603889|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603890|NCT03492866|Gentamicins|gentamicins|mesh-list
603891|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
603892|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
603893|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
603894|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603895|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603896|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
603897|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
603898|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
603899|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
603900|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
603901|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
603902|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
603903|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
603904|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
603905|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
603906|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603907|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603908|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
603909|NCT03492736|Melatonin|melatonin|mesh-list
603910|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
603911|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603912|NCT03492736|Protective Agents|protective agents|mesh-ancestor
603913|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603914|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
603915|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
603916|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
603917|NCT03492710|Antibodies|antibodies|mesh-list
603918|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
603919|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603920|NCT03492671|Gemcitabine|gemcitabine|mesh-list
603921|NCT03492671|Paclitaxel|paclitaxel|mesh-list
603922|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
603923|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603924|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
603925|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
603926|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
603927|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603928|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
603929|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
603930|NCT03492671|Antiviral Agents|antiviral agents|mesh-ancestor
603931|NCT03492671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
603932|NCT03492671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603933|NCT03492671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
603934|NCT03492671|Immunologic Factors|immunologic factors|mesh-ancestor
603935|NCT03492671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603936|NCT03492658|Methotrexate|methotrexate|mesh-list
603937|NCT03492658|Abatacept|abatacept|mesh-list
603938|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
603939|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
603940|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
603941|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603942|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
603943|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
603944|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603945|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603946|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
603947|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603948|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
603949|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
603950|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
603951|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
603952|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
603953|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
603954|NCT03492632|Hormones|hormones|mesh-list
603955|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
603956|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603957|NCT03492593|Beta Carotene|beta carotene|mesh-list
603958|NCT03492593|Lycopene|lycopene|mesh-list
603959|NCT03492593|Carotenoids|carotenoids|mesh-list
603960|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
603961|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
603962|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603963|NCT03492593|Protective Agents|protective agents|mesh-ancestor
603964|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603965|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
603966|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
603967|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603968|NCT03492593|Provitamins|provitamins|mesh-ancestor
603969|NCT03492593|Vitamins|vitamins|mesh-ancestor
603970|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
603971|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
603972|NCT03492580|Empagliflozin|empagliflozin|mesh-list
603973|NCT03492580|Canagliflozin|canagliflozin|mesh-list
603974|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
603975|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
603976|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
603977|NCT03492580|Glucagon|glucagon|mesh-list
603978|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
603979|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603980|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
603981|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
603982|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
603983|NCT03492580|Hormones|hormones|mesh-ancestor
603984|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
603985|NCT03492580|Incretins|incretins|mesh-ancestor
603986|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
603987|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
603988|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
603989|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
603990|NCT03492489|Cemiplimab|cemiplimab|mesh-list
603991|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
603992|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
603993|NCT03492463|Nicotine|nicotine|mesh-list
603994|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
603995|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
603996|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
603997|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
603998|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
603999|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
604000|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
604001|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
604002|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604003|NCT03492437|Tepotinib|tepotinib|mesh-list
604004|NCT03492437|Dabigatran|dabigatran|mesh-list
604005|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
604006|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
604007|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
604008|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604009|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604010|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
604011|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604012|NCT03492385|Ticagrelor|ticagrelor|mesh-list
604013|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
604014|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
604015|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
604016|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
604017|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
604018|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
604019|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604020|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216620|NCT00028886|Growth Substances|growth substances|mesh-ancestor
2216621|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
2216622|NCT00028899|Cytarabine|cytarabine|mesh-list
2216623|NCT00028899|Asparaginase|asparaginase|mesh-list
2216624|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
2216625|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
2216626|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2216627|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
604029|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
604030|NCT03492255|Prednisone|prednisone|mesh-list
604031|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
604032|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
604033|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
604034|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
604035|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604036|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
604037|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
604038|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
604039|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604040|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604041|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
604042|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
604043|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
604044|NCT03492255|Hormones|hormones|mesh-ancestor
604045|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
604046|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2216628|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604047|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
604048|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
604049|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
604050|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
604051|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604052|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604053|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
604054|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
604055|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604056|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604057|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
604058|NCT03492255|Protective Agents|protective agents|mesh-ancestor
604059|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
604060|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604061|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078495|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
2216629|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604064|NCT03492138|Dexamethasone|dexamethasone|mesh-list
604065|NCT03492138|Ixazomib|ixazomib|mesh-list
604066|NCT03492138|TIC10 compound|tic10 compound|mesh-list
604067|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
604068|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
604069|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
604070|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604071|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604072|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604073|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
604074|NCT03492138|Hormones|hormones|mesh-ancestor
604075|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
604076|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
604077|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604078|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
604079|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604080|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216630|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
2216631|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216632|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216633|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
2216634|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216635|NCT00028899|Analgesics|analgesics|mesh-ancestor
2216636|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
2216637|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604094|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
604095|NCT03492047|Paclitaxel|paclitaxel|mesh-list
604096|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
604097|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
604098|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604099|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
604100|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
604101|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
604102|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604103|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
604104|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604105|NCT03492047|Expectorants|expectorants|mesh-ancestor
604106|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
604107|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
604108|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
604109|NCT03492047|Protective Agents|protective agents|mesh-ancestor
604110|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604111|NCT03492047|Antidotes|antidotes|mesh-ancestor
604112|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
604113|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
604114|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604115|NCT03491969|Protective Agents|protective agents|mesh-ancestor
604116|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604117|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
604118|NCT03491969|Vitamins|vitamins|mesh-ancestor
604119|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
604120|NCT03491904|Fasinumab|fasinumab|mesh-list
604121|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
604122|NCT03491904|Analgesics|analgesics|mesh-ancestor
604123|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
604124|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604125|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604126|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
604127|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
604128|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
604129|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604130|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
604131|NCT03491761|Protective Agents|protective agents|mesh-ancestor
604132|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
604133|NCT03491748|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
604134|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
604135|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604136|NCT03491709|Cetuximab|cetuximab|mesh-list
604137|NCT03491709|Antibodies|antibodies|mesh-list
604138|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
604139|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
604140|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604141|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
604142|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604143|NCT03491696|Metyrapone|metyrapone|mesh-list
604144|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
604145|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604146|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078496|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078497|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078498|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
2078499|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2078500|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078501|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078502|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604154|NCT03491631|Apatinib|apatinib|mesh-list
604155|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604156|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
604157|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604158|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604159|NCT03491579|Cytarabine|cytarabine|mesh-list
604160|NCT03491579|Cladribine|cladribine|mesh-list
604161|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
604162|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
604163|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604164|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604165|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
604166|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604167|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
604168|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
604169|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604170|NCT03491540|Gentamicins|gentamicins|mesh-list
604171|NCT03491540|Ornidazole|ornidazole|mesh-list
604172|NCT03491540|Sennosides|sennosides|mesh-list
604173|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
604174|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604175|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
604176|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604177|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604178|NCT03491540|Laxatives|laxatives|mesh-ancestor
604179|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604180|NCT03491540|Amebicides|amebicides|mesh-ancestor
604181|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
604182|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
604183|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
604184|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
604185|NCT03491527|Pemetrexed|pemetrexed|mesh-list
604186|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604187|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604188|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604189|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
604190|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
604191|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604192|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
604193|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
604194|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
604195|NCT03491475|Ajmaline|ajmaline|mesh-list
604196|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
604197|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
604198|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
604199|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
604200|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604201|NCT03491410|Aspirin|aspirin|mesh-list
604202|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
604203|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
604204|NCT03491410|Analgesics|analgesics|mesh-ancestor
604205|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
604206|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604207|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604208|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
604209|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
604210|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
604211|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
604212|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604213|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
604214|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
604215|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604216|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
604217|NCT03491371|Apatinib|apatinib|mesh-list
604218|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604219|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
604220|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604221|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604222|NCT03491345|Avelumab|avelumab|mesh-list
604223|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
604224|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604229|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
604230|NCT03491098|Prednisolone|prednisolone|mesh-list
604231|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
604232|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
604233|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
604234|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
604235|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
604236|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
604237|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
604238|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
604239|NCT03491098|Hormones|hormones|mesh-ancestor
604240|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
604241|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604242|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
604243|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604244|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
604245|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
604246|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604247|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604248|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
604249|NCT03491098|Protective Agents|protective agents|mesh-ancestor
604250|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
604251|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
604252|NCT03491085|Amoxicillin|amoxicillin|mesh-list
604253|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
604254|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
604255|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
604256|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
604257|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604258|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
604259|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604260|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604261|NCT03491072|Fentanyl|fentanyl|mesh-list
604262|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
604263|NCT03491072|Narcotics|narcotics|mesh-ancestor
604264|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
604265|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604266|NCT03491072|Analgesics|analgesics|mesh-ancestor
604267|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
604268|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604269|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
604270|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
604271|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
604272|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
2078503|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2078504|NCT02044094|Buprenorphine|buprenorphine|mesh-list
2078505|NCT02044094|Hydromorphone|hydromorphone|mesh-list
2078506|NCT02044094|Naloxone|naloxone|mesh-list
2078507|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2078508|NCT02044094|Narcotics|narcotics|mesh-ancestor
2078509|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2078510|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078511|NCT02044094|Analgesics|analgesics|mesh-ancestor
2078512|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
2078513|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604283|NCT03490994|Warfarin|warfarin|mesh-list
604284|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
604285|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
604286|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
604287|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
604288|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
604289|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
604290|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604291|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216638|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2216639|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2216640|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216641|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2216642|NCT00028912|Carboplatin|carboplatin|mesh-list
2216643|NCT00028912|Bortezomib|bortezomib|mesh-list
2216644|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216645|NCT00028925|Carboplatin|carboplatin|mesh-list
2216646|NCT00028925|Topotecan|topotecan|mesh-list
2216647|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216648|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2216649|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2216650|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216651|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216652|NCT00028938|Paclitaxel|paclitaxel|mesh-list
2078514|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2078515|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
2078516|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2078517|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2078518|NCT02044367|Dabigatran|dabigatran|mesh-list
2078519|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
2078520|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2078521|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
2078522|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078523|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078524|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
2078525|NCT02044380|Afatinib|afatinib|mesh-list
2078526|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078527|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2078528|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078529|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078530|NCT02044393|Itraconazole|itraconazole|mesh-list
2078531|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
2078532|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078533|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2216653|NCT00028938|Carboplatin|carboplatin|mesh-list
604334|NCT03490825|Melatonin|melatonin|mesh-list
604335|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
604336|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604337|NCT03490825|Protective Agents|protective agents|mesh-ancestor
604338|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604339|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
604343|NCT03490708|Tranilast|tranilast|mesh-list
604344|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
604345|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
604346|NCT03490708|Analgesics|analgesics|mesh-ancestor
604347|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
604348|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604349|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604350|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
604351|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
604352|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
604353|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
604354|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604355|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
604356|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
604357|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
604358|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
604359|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
604360|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
604361|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
604362|NCT03490617|Misoprostol|misoprostol|mesh-list
604363|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
604364|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
604365|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
604366|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604367|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
604368|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604369|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
604370|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
604371|NCT03490539|Azathioprine|azathioprine|mesh-list
604372|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
604373|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604374|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
604375|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
604376|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
604377|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604378|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604379|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604380|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
604381|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
604382|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
604383|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
604384|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604385|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
604397|NCT03490487|Prednisolone|prednisolone|mesh-list
604398|NCT03490487|Carbamazepine|carbamazepine|mesh-list
604399|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
604400|NCT03490487|Levetiracetam|levetiracetam|mesh-list
604401|NCT03490487|Valproic Acid|valproic acid|mesh-list
604402|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
604403|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
604404|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
604405|NCT03490487|Hormones|hormones|mesh-ancestor
604406|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
604407|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604408|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
604409|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604410|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604411|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
604412|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604413|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604414|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
604415|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
604416|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
604417|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
604418|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
604419|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
604420|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
604421|NCT03490487|Analgesics|analgesics|mesh-ancestor
604422|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
604423|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
604424|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
604425|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
604426|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
604427|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
604428|NCT03490396|Povidone|povidone|mesh-list
604429|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
604430|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
604431|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
604432|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604433|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
604434|NCT03490396|Protective Agents|protective agents|mesh-ancestor
604435|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
604436|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
604437|NCT03490344|Lenalidomide|lenalidomide|mesh-list
604438|NCT03490344|Daratumumab|daratumumab|mesh-list
604439|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
604440|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604441|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
604442|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
604443|NCT03490344|Growth Substances|growth substances|mesh-ancestor
604444|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
604445|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604446|NCT03490292|Paclitaxel|paclitaxel|mesh-list
604447|NCT03490292|Carboplatin|carboplatin|mesh-list
604448|NCT03490292|Avelumab|avelumab|mesh-list
604449|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
604450|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604451|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
604452|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
604453|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
604454|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604455|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
604456|NCT03490279|Lactoferrin|lactoferrin|mesh-list
604457|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604458|NCT03490123|Azithromycin|azithromycin|mesh-list
604459|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
604460|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604461|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
604462|NCT03490097|Simvastatin|simvastatin|mesh-list
604463|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
604464|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
604465|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
604466|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604467|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
604468|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
604469|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604470|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
604471|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604481|NCT03490019|Metformin|metformin|mesh-list
604482|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
604483|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216654|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
2216655|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216656|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216657|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216658|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216659|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216660|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216661|NCT00028938|Hematinics|hematinics|mesh-ancestor
2216662|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2216663|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
604494|NCT03489928|Misoprostol|misoprostol|mesh-list
604495|NCT03489928|Dinoprostone|dinoprostone|mesh-list
604496|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
604497|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
604498|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
604499|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604500|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
604501|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604502|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
604503|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
604504|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
604505|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2216664|NCT00028951|Coagulants|coagulants|mesh-ancestor
2216665|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
2216666|NCT00028964|Doxorubicin|doxorubicin|mesh-list
2216667|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2216668|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216669|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
2216670|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216671|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216672|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2216673|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
2216674|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216675|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216676|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2216677|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2216678|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2216679|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2216680|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216681|NCT00028990|Paclitaxel|paclitaxel|mesh-list
2216682|NCT00028990|Bevacizumab|bevacizumab|mesh-list
2216683|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216684|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216685|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
604528|NCT03489837|Dipropizine|dipropizine|mesh-list
604529|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
604530|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
604531|NCT03489798|Alprostadil|alprostadil|mesh-list
604532|NCT03489798|Misoprostol|misoprostol|mesh-list
604533|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
604534|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
604535|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
604536|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604537|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
604538|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604539|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
604540|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
604541|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
604542|NCT03489798|Urological Agents|urological agents|mesh-ancestor
604543|NCT03489668|Metformin|metformin|mesh-list
604544|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
604545|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604546|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
604547|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
604548|NCT03489629|Minocycline|minocycline|mesh-list
604549|NCT03489629|Trimethoprim|trimethoprim|mesh-list
604550|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
604551|NCT03489629|Mupirocin|mupirocin|mesh-list
604552|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
604553|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
604554|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604555|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
604556|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
604557|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
604558|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
604559|NCT03489629|Renal Agents|renal agents|mesh-ancestor
604560|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
604561|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
604562|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
604563|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
604564|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604565|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604566|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
604567|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
604568|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
604569|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
604570|NCT03489616|Pemetrexed|pemetrexed|mesh-list
604571|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604572|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604573|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604574|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
604575|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2216686|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216687|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216688|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216689|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2216690|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2216691|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2216692|NCT00028990|Growth Substances|growth substances|mesh-ancestor
2216693|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216694|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
2216695|NCT00029003|Gefitinib|gefitinib|mesh-list
2216696|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216697|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2216698|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216699|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216700|NCT00029042|Infliximab|infliximab|mesh-list
2216701|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
2078534|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2078535|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078536|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078537|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2216702|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604596|NCT03489395|Edoxaban|edoxaban|mesh-list
604597|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
604598|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
604599|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
604600|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
604601|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604602|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604603|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
604604|NCT03489317|Metformin|metformin|mesh-list
604605|NCT03489317|Amlodipine|amlodipine|mesh-list
604606|NCT03489317|Simvastatin|simvastatin|mesh-list
604607|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
604608|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604609|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
604610|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
604611|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
604612|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604613|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
604614|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
604615|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
604616|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
604617|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
604618|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
604619|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
604620|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216703|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216704|NCT00029159|Estrogens|estrogens|mesh-list
2216705|NCT00029159|Androgens|androgens|mesh-list
2216706|NCT00029159|Hormones|hormones|mesh-ancestor
2216707|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2216708|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216709|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
2216710|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2216711|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604630|NCT03489265|Eluxadoline|eluxadoline|mesh-list
604631|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604632|NCT03489239|Tenofovir|tenofovir|mesh-list
604633|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
604634|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604635|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
604636|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
604637|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604638|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604639|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
604640|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
604641|NCT03489161|Buprenorphine|buprenorphine|mesh-list
604642|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
604643|NCT03489161|Narcotics|narcotics|mesh-ancestor
604644|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
604645|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604646|NCT03489161|Analgesics|analgesics|mesh-ancestor
604647|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
604648|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604649|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
604650|NCT03489044|Levetiracetam|levetiracetam|mesh-list
604651|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
604652|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
604653|NCT03489018|Vaccines|vaccines|mesh-list
604654|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
604655|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
604656|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604657|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
604658|NCT03489005|Zamicastat|zamicastat|mesh-list
604659|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
604660|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604661|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
604662|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
604663|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604664|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604665|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604666|NCT03488888|Bupivacaine|bupivacaine|mesh-list
604667|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
604668|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
604669|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
604670|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604671|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
604672|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604673|NCT03488810|Hormones|hormones|mesh-list
604674|NCT03488810|Androgens|androgens|mesh-list
604675|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
604676|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
604677|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
604678|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604679|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
604680|NCT03488719|Metoprolol|metoprolol|mesh-list
604681|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
604682|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
604683|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
604684|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
604685|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604686|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604687|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
604688|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
604689|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
604690|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
604691|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
604692|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604693|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
604694|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
604695|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604696|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
604697|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
604698|NCT03488485|Ledipasvir|ledipasvir|mesh-list
604699|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604700|NCT03488420|Edoxaban|edoxaban|mesh-list
604701|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
604702|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
604703|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
604704|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
604705|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604706|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604707|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
604708|NCT03488316|Calcium|calcium|mesh-list
604709|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
604710|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604711|NCT03488251|Gemcitabine|gemcitabine|mesh-list
604712|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
604713|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
604714|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604715|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604716|NCT03488251|Antiviral Agents|antiviral agents|mesh-ancestor
604717|NCT03488251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604718|NCT03488251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604719|NCT03488251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
604720|NCT03488251|Immunologic Factors|immunologic factors|mesh-ancestor
604721|NCT03488251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216712|NCT00029250|Allicin|allicin|mesh-list
2216713|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216714|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2216715|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
2216716|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216717|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2216718|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
2216719|NCT00029250|Protective Agents|protective agents|mesh-ancestor
2216720|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216721|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2216722|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2216723|NCT00029315|Plasminogen|plasminogen|mesh-list
2216724|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2216725|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2216726|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2216727|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216728|NCT00029328|Etanercept|etanercept|mesh-list
2216729|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2216730|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2216731|NCT00029328|Analgesics|analgesics|mesh-ancestor
2216732|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
2216733|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2216734|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216735|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2216736|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216737|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2216738|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216739|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
2216740|NCT00029380|Cyclosporine|cyclosporine|mesh-list
2216741|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
2216742|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
2216743|NCT00029380|Busulfan|busulfan|mesh-list
2216744|NCT00029380|Cyclosporins|cyclosporins|mesh-list
2216745|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216746|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
2216747|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216748|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216749|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2216750|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
2216751|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216752|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216753|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2216754|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216755|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
2216756|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216757|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
2216758|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2216759|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2216760|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2216761|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
2216762|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2216763|NCT00029458|Clozapine|clozapine|mesh-list
2216764|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2216765|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
2216766|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2216767|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216768|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216769|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2216770|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2216771|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2216772|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2216773|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
2216774|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
2216775|NCT00029497|Amitriptyline|amitriptyline|mesh-list
2216776|NCT00029497|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
604791|NCT03488186|Lansoprazole|lansoprazole|mesh-list
604792|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
604793|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
604794|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604795|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
604796|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604797|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604798|NCT03488173|Lansoprazole|lansoprazole|mesh-list
604799|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
604800|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
604801|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604802|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
604803|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604804|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604805|NCT03488147|Esomeprazole|esomeprazole|mesh-list
604806|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
604807|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604808|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
604809|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604810|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216777|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2216778|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
2216779|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
604814|NCT03487939|Fluorouracil|fluorouracil|mesh-list
604815|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
604816|NCT03487939|Irinotecan|irinotecan|mesh-list
604817|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
604818|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604819|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
604820|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604821|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
604822|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
604823|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604824|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
604825|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
604826|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604827|NCT03487874|Ropivacaine|ropivacaine|mesh-list
604828|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
604829|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
604830|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
604831|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604832|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
604833|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2216780|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2216781|NCT00029497|Analgesics|analgesics|mesh-ancestor
604837|NCT03487809|Budesonide|budesonide|mesh-list
604838|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
604839|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
604840|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
604841|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604842|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604843|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
604844|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
604845|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
604846|NCT03487809|Hormones|hormones|mesh-ancestor
604847|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
604848|NCT03487783|Aripiprazole|aripiprazole|mesh-list
604849|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
604850|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
604851|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
604852|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
604853|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
604854|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
604855|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604856|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
604857|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
604858|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
604859|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604860|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
604861|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
604862|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
604863|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
604864|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
604865|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
604866|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
604867|NCT03487770|Aripiprazole|aripiprazole|mesh-list
604868|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
604869|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
604870|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
604871|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
604872|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
604873|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
604874|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604875|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
604876|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
604877|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
604878|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604879|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
604880|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
604881|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
604882|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
604883|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
604884|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
604885|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
604886|NCT03487666|Capecitabine|capecitabine|mesh-list
604887|NCT03487666|Nivolumab|nivolumab|mesh-list
604888|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
604889|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
604890|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604891|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604892|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
604893|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
604894|NCT03487562|Amoxicillin|amoxicillin|mesh-list
604895|NCT03487562|Clarithromycin|clarithromycin|mesh-list
604896|NCT03487562|Lansoprazole|lansoprazole|mesh-list
604897|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
604898|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
604899|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604900|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
604901|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604902|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604903|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
604904|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
604905|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
604906|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604907|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2216782|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
2216783|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2216784|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216785|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
604912|NCT03487406|Aspirin|aspirin|mesh-list
604913|NCT03487406|Ticagrelor|ticagrelor|mesh-list
604914|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
604915|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
604916|NCT03487406|Analgesics|analgesics|mesh-ancestor
604917|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
604918|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604919|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604920|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
604921|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
604922|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
604923|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
604924|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604925|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
604926|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
604927|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
604928|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
604929|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
604930|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
604931|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
604932|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
604933|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
604934|NCT03487354|Misoprostol|misoprostol|mesh-list
604935|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
604936|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
604937|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
604938|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604939|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
604940|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604941|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
2216786|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2216787|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2216788|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216789|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
604947|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
604948|NCT03487211|Citalopram|citalopram|mesh-list
604949|NCT03487211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
604950|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
604951|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
604952|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604953|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
604954|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
604955|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604956|NCT03487211|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
604957|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
604958|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
604959|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604960|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
604961|NCT03487211|Analgesics|analgesics|mesh-ancestor
604962|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
604963|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
604964|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
604965|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
604966|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
604967|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
604968|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604969|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
604970|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
604971|NCT03487172|Mannitol|mannitol|mesh-list
604972|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
604973|NCT03487172|Diuretics|diuretics|mesh-ancestor
604974|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
604975|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604976|NCT03487133|Dexamethasone|dexamethasone|mesh-list
604977|NCT03487133|Bortezomib|bortezomib|mesh-list
604978|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
604979|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
604980|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
604981|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
604982|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
604983|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
604984|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
604985|NCT03487133|Hormones|hormones|mesh-ancestor
604986|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
604987|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
604988|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
604989|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
604990|NCT03487107|Yimitasvir|yimitasvir|mesh-list
604991|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
604992|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
604993|NCT03487042|Bimatoprost|bimatoprost|mesh-list
604994|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
604995|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
604996|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
604997|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
604998|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
604999|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
605000|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
605001|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605002|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605003|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605004|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
605005|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
605006|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605007|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
605008|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
605009|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
605010|NCT03487016|Gemcitabine|gemcitabine|mesh-list
605011|NCT03487016|Paclitaxel|paclitaxel|mesh-list
605012|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
605013|NCT03487016|Irinotecan|irinotecan|mesh-list
605014|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
605015|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605016|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
605017|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
605018|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
605019|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605020|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
605021|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
605022|NCT03487016|Antiviral Agents|antiviral agents|mesh-ancestor
605023|NCT03487016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605024|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605025|NCT03487016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
605026|NCT03487016|Immunologic Factors|immunologic factors|mesh-ancestor
605027|NCT03487016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605028|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
605029|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
605030|NCT03487003|Bromides|bromides|mesh-list
605031|NCT03487003|Rocuronium|rocuronium|mesh-list
605032|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
605033|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
605034|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
605035|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
605036|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605037|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605038|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
605039|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
605040|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605041|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605042|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
605043|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605044|NCT03486925|Oxytocin|oxytocin|mesh-list
605045|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
605046|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
605047|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078538|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
2078539|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2216790|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605051|NCT03486626|Metformin|metformin|mesh-list
605052|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
605053|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605054|NCT03486561|Ranolazine|ranolazine|mesh-list
605055|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
605056|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
605057|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605058|NCT03486548|Dexamethasone|dexamethasone|mesh-list
605059|NCT03486548|Lidocaine|lidocaine|mesh-list
605060|NCT03486548|Bupivacaine|bupivacaine|mesh-list
605061|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
605062|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
605063|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
605064|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605065|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605066|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
605067|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
605068|NCT03486548|Hormones|hormones|mesh-ancestor
605069|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
605070|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
605071|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605072|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
605073|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
605074|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605075|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
605076|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
605077|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
605078|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
605079|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
605080|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605081|NCT03486509|Afatinib|afatinib|mesh-list
605082|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605083|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
605084|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605085|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605086|NCT03486496|Gefitinib|gefitinib|mesh-list
605087|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605088|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
605089|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605090|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605091|NCT03486457|Tofacitinib|tofacitinib|mesh-list
605092|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
605093|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605094|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216791|NCT00029497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2216792|NCT00029497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2216793|NCT00029497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2216794|NCT00029523|Cytarabine|cytarabine|mesh-list
2216795|NCT00029523|Methotrexate|methotrexate|mesh-list
2216796|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
605101|NCT03486353|Azacitidine|azacitidine|mesh-list
605102|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
605103|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
605104|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605105|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605106|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605107|NCT03486314|Rifampin|rifampin|mesh-list
605108|NCT03486314|Paclitaxel|paclitaxel|mesh-list
605109|NCT03486314|Docetaxel|docetaxel|mesh-list
605110|NCT03486314|Carboplatin|carboplatin|mesh-list
605111|NCT03486314|Pevonedistat|pevonedistat|mesh-list
605112|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
605113|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605114|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
605115|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
605116|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
605117|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605118|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
605119|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
605120|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
605121|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605122|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
605123|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
605124|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605125|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
605126|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
605127|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
605128|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
605129|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
605130|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2078540|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078541|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2078542|NCT02044510|Mirabegron|mirabegron|mesh-list
605134|NCT03486236|Ivacaftor|ivacaftor|mesh-list
605135|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
605136|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
605137|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605141|NCT03486184|Cystatins|cystatins|mesh-list
605142|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
605143|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
605144|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605145|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605146|NCT03486119|Nivolumab|nivolumab|mesh-list
605147|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
605148|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605149|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
605150|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605151|NCT03486106|Propofol|propofol|mesh-list
605152|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
605153|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605154|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605155|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
605156|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
605157|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
605158|NCT03486080|Lenograstim|lenograstim|mesh-list
605159|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
605160|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
605161|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216797|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
2216798|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2216799|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216800|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2216801|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
2216802|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216803|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216804|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
2216805|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216806|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2216807|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216808|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
2216809|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216810|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2216811|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
605178|NCT03485846|Ritonavir|ritonavir|mesh-list
605179|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
605180|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
605181|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
605182|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605183|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605184|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
605185|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
605186|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
605187|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605188|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
605189|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
605190|NCT03485729|TIC10 compound|tic10 compound|mesh-list
605191|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605192|NCT03485703|Azithromycin|azithromycin|mesh-list
605193|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
605194|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605195|NCT03485677|Eliglustat|eliglustat|mesh-list
605196|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605197|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605198|NCT03485625|Acetaminophen|acetaminophen|mesh-list
605199|NCT03485625|Ketorolac|ketorolac|mesh-list
605200|NCT03485625|Lidocaine|lidocaine|mesh-list
605201|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
605202|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
605203|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605204|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605205|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
605206|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605207|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
605208|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
605209|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
605210|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
605211|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605212|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
605213|NCT03485625|Analgesics|analgesics|mesh-ancestor
605214|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
605215|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
605216|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
605217|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
605218|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
605219|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605220|NCT03485547|Venetoclax|venetoclax|mesh-list
605221|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605222|NCT03485534|Tenofovir|tenofovir|mesh-list
605223|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
605224|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605225|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
605226|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
605227|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605228|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605229|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
605230|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
605231|NCT03485482|Bisoprolol|bisoprolol|mesh-list
605232|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
605233|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
605234|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
605235|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605236|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605237|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
605238|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
605239|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
605240|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
605241|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605242|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605243|NCT03485456|Tobramycin|tobramycin|mesh-list
605244|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
605245|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605246|NCT03485417|Aripiprazole|aripiprazole|mesh-list
605247|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
605248|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
605249|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
605250|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
605251|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
605252|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605253|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605254|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
605255|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
605256|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605257|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605258|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
605259|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
605260|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
605261|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
605262|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
605263|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
605264|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
605265|NCT03485404|Vitamins|vitamins|mesh-list
605266|NCT03485404|Folic Acid|folic acid|mesh-list
605267|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
605268|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
605269|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
605270|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605271|NCT03485404|Hematinics|hematinics|mesh-ancestor
605272|NCT03485300|Warfarin|warfarin|mesh-list
605273|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
2216812|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216813|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2216814|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2216815|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2216816|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2216817|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216818|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
2216819|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2216820|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216821|NCT00029627|Yohimbine|yohimbine|mesh-list
2216822|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
605285|NCT03485274|Vortioxetine|vortioxetine|mesh-list
605286|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
605287|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
605288|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
605289|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
605290|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605291|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605292|NCT03485274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
605293|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
605294|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
605295|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605296|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605297|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
605298|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
605299|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
605300|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
605301|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2216823|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
2216824|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2216825|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216826|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2216827|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2078543|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2078544|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2078545|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
605310|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
605311|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
605312|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605313|NCT03485118|Rituximab|rituximab|mesh-list
605314|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
605315|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605316|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
605317|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605318|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
605319|NCT03485092|Empagliflozin|empagliflozin|mesh-list
605320|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
605321|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605322|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
605323|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605324|NCT03484962|Antibodies|antibodies|mesh-list
605325|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
605326|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
605327|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605332|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
605333|NCT03484845|Lactoferrin|lactoferrin|mesh-list
605334|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605335|NCT03484845|Trace Elements|trace elements|mesh-ancestor
605336|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
605337|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605338|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
605339|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
605340|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
605341|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
605342|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605343|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605344|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
605345|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605346|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
605352|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
605353|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
605354|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
605355|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605356|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
605357|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605358|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605359|NCT03484650|Lidocaine|lidocaine|mesh-list
605360|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
605361|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
605362|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605363|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605364|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
605365|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605366|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
605367|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
605368|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
605369|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
605370|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605371|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
605372|NCT03484611|Cetrorelix|cetrorelix|mesh-list
605373|NCT03484611|Menotropins|menotropins|mesh-list
605374|NCT03484611|Progesterone|progesterone|mesh-list
605375|NCT03484611|Progestins|progestins|mesh-ancestor
605376|NCT03484611|Hormones|hormones|mesh-ancestor
605377|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
605378|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605379|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
605380|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
605381|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
605382|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
605385|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
605386|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
605387|NCT03484507|Prednisolone|prednisolone|mesh-list
605388|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
605389|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
605390|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
605391|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
605392|NCT03484507|Povidone|povidone|mesh-list
605393|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
605394|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
605395|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
605396|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
605397|NCT03484507|Hormones|hormones|mesh-ancestor
605398|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
605399|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605400|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
605401|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605402|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
605403|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
605404|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605405|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
605406|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
605407|NCT03484507|Protective Agents|protective agents|mesh-ancestor
605408|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
605409|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605410|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
605411|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
605412|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
605413|NCT03484416|Vitamin D|vitamin d|mesh-list
605414|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
605415|NCT03484416|Calcium|calcium|mesh-list
605416|NCT03484416|Vitamins|vitamins|mesh-ancestor
605417|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
605418|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605419|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
605420|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
605421|NCT03484416|Antacids|antacids|mesh-ancestor
605422|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605423|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
605424|NCT03484299|Gemcitabine|gemcitabine|mesh-list
605425|NCT03484299|Folfirinox|folfirinox|mesh-list
605426|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
605427|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
605428|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605429|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605430|NCT03484299|Antiviral Agents|antiviral agents|mesh-ancestor
605431|NCT03484299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605432|NCT03484299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605433|NCT03484299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
605434|NCT03484299|Immunologic Factors|immunologic factors|mesh-ancestor
605435|NCT03484299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605436|NCT03484260|Testosterone|testosterone|mesh-list
605437|NCT03484260|Androgens|androgens|mesh-ancestor
605438|NCT03484260|Hormones|hormones|mesh-ancestor
605439|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
605440|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605441|NCT03484221|Fluorouracil|fluorouracil|mesh-list
605442|NCT03484221|Capecitabine|capecitabine|mesh-list
605443|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
605444|NCT03484221|Irinotecan|irinotecan|mesh-list
605445|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
605446|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605447|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
605448|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605449|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
605450|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
605451|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605452|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
605453|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
605454|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605455|NCT03484195|Fluorouracil|fluorouracil|mesh-list
605456|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
605457|NCT03484195|Irinotecan|irinotecan|mesh-list
605458|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
605459|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605460|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
605461|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605462|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
605463|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
605464|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605465|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
605466|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
605467|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605468|NCT03484091|Hylan|hylan|mesh-list
605469|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
605470|NCT03484091|Protective Agents|protective agents|mesh-ancestor
605471|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605472|NCT03483948|Azacitidine|azacitidine|mesh-list
605473|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
605474|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
605475|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605476|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605477|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605478|NCT03483883|Gemcitabine|gemcitabine|mesh-list
605479|NCT03483883|Avelumab|avelumab|mesh-list
605480|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
605481|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
605482|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605483|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605484|NCT03483883|Antiviral Agents|antiviral agents|mesh-ancestor
605485|NCT03483883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605486|NCT03483883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605487|NCT03483883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
605488|NCT03483883|Immunologic Factors|immunologic factors|mesh-ancestor
605489|NCT03483883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605490|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
605491|NCT03483870|Morphine|morphine|mesh-list
605492|NCT03483870|Granisetron|granisetron|mesh-list
605493|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
605494|NCT03483870|Narcotics|narcotics|mesh-ancestor
605495|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605496|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605497|NCT03483870|Analgesics|analgesics|mesh-ancestor
605498|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
605499|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605500|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
605501|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
605502|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
605503|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
605504|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
605505|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605506|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605507|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
605508|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605509|NCT03483753|Vasopressins|vasopressins|mesh-list
605510|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
605511|NCT03483753|Norepinephrine|norepinephrine|mesh-list
605512|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
605513|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
605514|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
605515|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605516|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605517|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605518|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
605519|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
605520|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605521|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
605522|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
605523|NCT03483753|Coagulants|coagulants|mesh-ancestor
605524|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
605525|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
2216828|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2216829|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
2216830|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605529|NCT03483649|Bevacizumab|bevacizumab|mesh-list
605530|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
605531|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605532|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
605533|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
605534|NCT03483649|Growth Substances|growth substances|mesh-ancestor
605535|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605536|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
605537|NCT03483636|Lemborexant|lemborexant|mesh-list
605538|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
605539|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605540|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605541|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
605542|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
605543|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605544|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605545|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
605546|NCT03483545|Hormones|hormones|mesh-ancestor
605547|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
605548|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605549|NCT03483415|Morphine|morphine|mesh-list
605550|NCT03483415|Bupivacaine|bupivacaine|mesh-list
605551|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
605552|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
605553|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605554|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605555|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
605556|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605557|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
605558|NCT03483415|Narcotics|narcotics|mesh-ancestor
605559|NCT03483415|Analgesics|analgesics|mesh-ancestor
605560|NCT03483389|Ethanol|ethanol|mesh-list
605561|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
605562|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605563|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605564|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605565|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
605566|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
605567|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
605568|NCT03483363|Bacitracin|bacitracin|mesh-list
605569|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
605570|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605571|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
605572|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
605573|NCT03483350|Midazolam|midazolam|mesh-list
605574|NCT03483350|Granisetron|granisetron|mesh-list
605575|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
605576|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
605577|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605578|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605579|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
605580|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
605581|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
605582|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
605583|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
605584|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
605585|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
605586|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
605587|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605588|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605589|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
605590|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
605591|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605592|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
605593|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
605594|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
605595|NCT03483207|Heparin|heparin|mesh-list
605596|NCT03483207|Warfarin|warfarin|mesh-list
605597|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
605598|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
605599|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
605600|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605601|NCT03483181|Enoxaparin|enoxaparin|mesh-list
605602|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
605603|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
605604|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
605605|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
605606|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
605607|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605608|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605609|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
605610|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
605611|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
605612|NCT03483142|Misoprostol|misoprostol|mesh-list
605613|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
605614|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
605615|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
605616|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605617|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
605618|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
605619|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
2216831|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216832|NCT00029627|Urological Agents|urological agents|mesh-ancestor
2216833|NCT00029679|Borage oil|borage oil|mesh-list
2216834|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216835|NCT00029757|Estrogens|estrogens|mesh-list
2216836|NCT00029757|Hormones|hormones|mesh-ancestor
2216837|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
605635|NCT03482960|Xenon|xenon|mesh-list
605636|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
605637|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
605638|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
605639|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605640|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216838|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216839|NCT00029770|Acetaminophen|acetaminophen|mesh-list
2216840|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2216841|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2216842|NCT00029770|Codeine|codeine|mesh-list
2216843|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2216844|NCT00029770|Analgesics|analgesics|mesh-ancestor
2216845|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
2216846|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2216847|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216848|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
2216849|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2216850|NCT00029770|Narcotics|narcotics|mesh-ancestor
605654|NCT03482752|Molgramostim|molgramostim|mesh-list
605655|NCT03482752|Sargramostim|sargramostim|mesh-list
605656|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605657|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
605658|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216851|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2216852|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
2216853|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
2216854|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2216855|NCT00029822|Alfuzosin|alfuzosin|mesh-list
2216856|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2216857|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2216858|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2216859|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
2216860|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605669|NCT03482544|Pregabalin|pregabalin|mesh-list
605670|NCT03482544|Analgesics|analgesics|mesh-ancestor
605671|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
605672|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605673|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605674|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
605675|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
605676|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
605677|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605678|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
605679|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
605680|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
605681|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605682|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
605683|NCT03482492|Acetaminophen|acetaminophen|mesh-list
605684|NCT03482492|Tramadol|tramadol|mesh-list
605685|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
605686|NCT03482492|Analgesics|analgesics|mesh-ancestor
605687|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
605688|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605689|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605690|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
605691|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
605692|NCT03482492|Narcotics|narcotics|mesh-ancestor
605693|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605700|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
605701|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
605702|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
605703|NCT03482440|Analgesics|analgesics|mesh-ancestor
605704|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
605705|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605706|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605707|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
605708|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
605709|NCT03482362|Vinorelbine|vinorelbine|mesh-list
605710|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
605711|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605712|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
605713|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
605714|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
605715|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605716|NCT03482336|Immunoconjugates|immunoconjugates|mesh-list
2216861|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605717|NCT03482336|Immunologic Factors|immunologic factors|mesh-ancestor
605718|NCT03482336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078546|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
2078547|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078548|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078549|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078550|NCT02044510|Urological Agents|urological agents|mesh-ancestor
2078551|NCT02044796|Cytarabine|cytarabine|mesh-list
2078552|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
2078553|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
2078554|NCT02044796|Cladribine|cladribine|mesh-list
2078555|NCT02044796|Lenograstim|lenograstim|mesh-list
2078556|NCT02044796|Sargramostim|sargramostim|mesh-list
2078557|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
605731|NCT03482232|Acetaminophen|acetaminophen|mesh-list
605732|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
605733|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
605734|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
605735|NCT03482232|Ibuprofen|ibuprofen|mesh-list
605736|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
605737|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
605738|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
605739|NCT03482232|Expectorants|expectorants|mesh-list
605740|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
605741|NCT03482232|Analgesics|analgesics|mesh-ancestor
605742|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
605743|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605744|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605745|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
605746|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
605747|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605748|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605749|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
605750|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
605751|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
605752|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
605753|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
605754|NCT03482180|Atorvastatin|atorvastatin|mesh-list
605755|NCT03482180|Calcium|calcium|mesh-list
605756|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
605757|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605758|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
605759|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
605760|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
605761|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605762|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
605763|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
605764|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605765|NCT03482167|Niacinamide|niacinamide|mesh-list
605766|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
605767|NCT03482167|Vitamins|vitamins|mesh-ancestor
605768|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
605769|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605770|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
605771|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605772|NCT03482102|Durvalumab|durvalumab|mesh-list
605773|NCT03482102|Tremelimumab|tremelimumab|mesh-list
605774|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
605775|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605776|NCT03482024|Tirzepatide|tirzepatide|mesh-list
605777|NCT03482024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
605778|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605779|NCT03482024|Incretins|incretins|mesh-ancestor
605780|NCT03482024|Hormones|hormones|mesh-ancestor
605781|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2216862|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216863|NCT00029822|Urological Agents|urological agents|mesh-ancestor
2216864|NCT00029835|Rimonabant|rimonabant|mesh-list
2216865|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2216866|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2216867|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2216868|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2216869|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216870|NCT00029835|Hormones|hormones|mesh-ancestor
2216871|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2078558|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
2216872|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605793|NCT03481998|Letrozole|letrozole|mesh-list
605794|NCT03481998|Fulvestrant|fulvestrant|mesh-list
605795|NCT03481998|Anastrozole|anastrozole|mesh-list
605796|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
605797|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
605798|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
605799|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605800|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605801|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
605802|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
605803|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
605804|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605805|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
605806|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
605807|NCT03481972|Doxycycline|doxycycline|mesh-list
605808|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
605809|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
605810|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605811|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
605812|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
605813|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
605814|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
605815|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
605816|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
605817|NCT03481959|Methylphenidate|methylphenidate|mesh-list
605818|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
605819|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605820|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
605821|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
605822|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
605823|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605824|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
605825|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605826|NCT03481920|Avelumab|avelumab|mesh-list
605827|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
605828|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078559|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078560|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2078561|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
2078562|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078563|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078564|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
2216873|NCT00029848|Rimonabant|rimonabant|mesh-list
2216874|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2216875|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
605838|NCT03481790|Folic Acid|folic acid|mesh-list
605839|NCT03481790|Lactoferrin|lactoferrin|mesh-list
605840|NCT03481790|Vitamins|vitamins|mesh-ancestor
605841|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
605842|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605843|NCT03481790|Hematinics|hematinics|mesh-ancestor
605844|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
605845|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216876|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2216877|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078565|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078566|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078567|NCT02044796|Analgesics|analgesics|mesh-ancestor
2078568|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
2078569|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078570|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2078571|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
605863|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
605864|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
605865|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
605866|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078572|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078573|NCT02045264|Icatibant|icatibant|mesh-list
2078574|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2078575|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2078576|NCT02045264|Analgesics|analgesics|mesh-ancestor
2078577|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
2078578|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078579|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078580|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2078581|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2078582|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
2078583|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
2078584|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078585|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2078586|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078587|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
2078588|NCT02045836|Vaccines|vaccines|mesh-list
2078589|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2078590|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
2078591|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605889|NCT03481517|Bupivacaine|bupivacaine|mesh-list
605890|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
605891|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
605892|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605893|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605894|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
605895|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605896|NCT03481400|Calcitonin|calcitonin|mesh-list
605897|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
605898|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
605899|NCT03481400|Katacalcin|katacalcin|mesh-list
605900|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
605901|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605902|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
605903|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
605904|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
605905|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
605906|NCT03480997|Bromides|bromides|mesh-list
605907|NCT03480997|Albuterol|albuterol|mesh-list
605908|NCT03480997|Ipratropium|ipratropium|mesh-list
605909|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
605910|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
605911|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
605912|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605913|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605914|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
605915|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
605916|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
605917|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
605918|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
605919|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
605920|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
605921|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
605922|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605923|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605924|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
605925|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
605926|NCT03480971|Tempol|tempol|mesh-list
605927|NCT03480971|TEMPO|tempo|mesh-list
605928|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
605929|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605930|NCT03480971|Protective Agents|protective agents|mesh-ancestor
605931|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605932|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
605933|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
605934|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
605935|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
605936|NCT03480958|Morphine|morphine|mesh-list
605937|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
605938|NCT03480958|Narcotics|narcotics|mesh-ancestor
605939|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605940|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605941|NCT03480958|Analgesics|analgesics|mesh-ancestor
605942|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
605943|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605944|NCT03480945|Nitroprusside|nitroprusside|mesh-list
605945|NCT03480945|Serotonin|serotonin|mesh-list
605946|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
605947|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
605948|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605949|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605950|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605951|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
605952|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
605953|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2216878|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216879|NCT00029848|Hormones|hormones|mesh-ancestor
2216880|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2216881|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216882|NCT00029861|Rimonabant|rimonabant|mesh-list
2216883|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2216884|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2216885|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2216886|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2216887|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605964|NCT03480906|Latanoprost|latanoprost|mesh-list
605965|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
605966|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
605967|NCT03480867|Temozolomide|temozolomide|mesh-list
605968|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
605969|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
605970|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
605971|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216888|NCT00029861|Hormones|hormones|mesh-ancestor
2216889|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2216890|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605975|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
605976|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
605977|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
605978|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
605979|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
605980|NCT03480789|Analgesics|analgesics|mesh-ancestor
605981|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
605982|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
605983|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
605984|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
605985|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
605986|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
605987|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
605988|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078592|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
2078593|NCT02045862|Mirabegron|mirabegron|mesh-list
2078594|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2078595|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2078596|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
2078597|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078598|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078599|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078600|NCT02045862|Urological Agents|urological agents|mesh-ancestor
2078601|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2078602|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2078603|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2078604|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
2078605|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
2078606|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
2078607|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2078608|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
2078609|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078610|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216891|NCT00029874|Minocycline|minocycline|mesh-list
2216892|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2216893|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216894|NCT00030004|Midazolam|midazolam|mesh-list
2216895|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2216896|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2216897|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2216898|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216899|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2216900|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
606020|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
606021|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
606022|NCT03480698|Protective Agents|protective agents|mesh-ancestor
606023|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606024|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
606025|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
606026|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
606027|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606028|NCT03480646|Prednisone|prednisone|mesh-list
606029|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
606030|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
606031|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
606032|NCT03480646|Hormones|hormones|mesh-ancestor
606033|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
606034|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606035|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
606036|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606037|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606038|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606039|NCT03480607|Dexamethasone|dexamethasone|mesh-list
606040|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
606041|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
606042|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
606043|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
606044|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606045|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606046|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
606047|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
606048|NCT03480607|Hormones|hormones|mesh-ancestor
606049|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
606050|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
606051|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606052|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
606053|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606054|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
606055|NCT03480607|Analgesics|analgesics|mesh-ancestor
606056|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
606057|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
606058|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
606059|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
606060|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
606061|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
606062|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606063|NCT03480568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
606064|NCT03480568|Immunologic Factors|immunologic factors|mesh-ancestor
606065|NCT03480568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606066|NCT03480516|Fluorides|fluorides|mesh-list
606067|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
606068|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
606069|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
606070|NCT03480516|Protective Agents|protective agents|mesh-ancestor
606071|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606072|NCT03480438|Blinatumomab|blinatumomab|mesh-list
606073|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606074|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
606075|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
606076|NCT03480360|Fludarabine|fludarabine|mesh-list
606077|NCT03480360|Tacrolimus|tacrolimus|mesh-list
606078|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
606079|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
606080|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606081|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
606082|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
606083|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
606084|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606085|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606086|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
606087|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
606088|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606089|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
606090|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
606091|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
606092|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
606093|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
606094|NCT03480334|Nivolumab|nivolumab|mesh-list
606095|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
606096|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606097|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
606098|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606099|NCT03480321|Cilostazol|cilostazol|mesh-list
606100|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
606101|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
606102|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606103|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606104|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
606105|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
606106|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
606107|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
606108|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606109|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
606110|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
606111|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
606112|NCT03480321|Protective Agents|protective agents|mesh-ancestor
606113|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
606114|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
606115|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606116|NCT03480308|Dexamethasone|dexamethasone|mesh-list
606117|NCT03480308|Fentanyl|fentanyl|mesh-list
606118|NCT03480308|Bupivacaine|bupivacaine|mesh-list
606119|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
606120|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
606121|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
606122|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606123|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606124|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
606125|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
606126|NCT03480308|Hormones|hormones|mesh-ancestor
606127|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
606128|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
606129|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606130|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
606131|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
606132|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606133|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
606134|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
606135|NCT03480308|Narcotics|narcotics|mesh-ancestor
606136|NCT03480308|Analgesics|analgesics|mesh-ancestor
606137|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
606138|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
606139|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
606140|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
606141|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
606142|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
606143|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606144|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
606145|NCT03480295|Protective Agents|protective agents|mesh-ancestor
2216901|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2216902|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2216903|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
2216904|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
2216905|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
2216906|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
2216907|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2216908|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216909|NCT00030030|Silymarin|silymarin|mesh-list
2216910|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
606156|NCT03480191|Daptomycin|daptomycin|mesh-list
606157|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
606158|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
606159|NCT03480165|Parecoxib|parecoxib|mesh-list
606160|NCT03480165|Ropivacaine|ropivacaine|mesh-list
606161|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
606162|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
606163|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606164|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606165|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
606166|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606167|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
606168|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
606169|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606320|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606170|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606171|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
606172|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
606173|NCT03480165|Analgesics|analgesics|mesh-ancestor
606174|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
606175|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
606176|NCT03480100|Xylometazoline|xylometazoline|mesh-list
606177|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
606178|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
606179|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
606180|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
606181|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
606182|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606183|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606184|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
606185|NCT03480061|Analgesics|analgesics|mesh-ancestor
606186|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
606187|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606188|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
606189|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
606190|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
606191|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
606192|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
606193|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216911|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216912|NCT00030030|Protective Agents|protective agents|mesh-ancestor
2216913|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216914|NCT00030056|Molgramostim|molgramostim|mesh-list
2216915|NCT00030056|Sargramostim|sargramostim|mesh-list
2216916|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
2216917|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216918|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216919|NCT00030069|Calcitriol|calcitriol|mesh-list
2216920|NCT00030069|Dexamethasone|dexamethasone|mesh-list
2216921|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2216922|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
2216923|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
2216924|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2216925|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216926|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2216927|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
2216928|NCT00030069|Hormones|hormones|mesh-ancestor
2216929|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2216930|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2216931|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606215|NCT03479996|Bupivacaine|bupivacaine|mesh-list
606216|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
606217|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
606218|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606219|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606220|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
606221|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606222|NCT03479918|Prednisone|prednisone|mesh-list
606223|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
606224|NCT03479918|Doxorubicin|doxorubicin|mesh-list
606225|NCT03479918|Etoposide|etoposide|mesh-list
606226|NCT03479918|Vincristine|vincristine|mesh-list
606227|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
606228|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
606229|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606230|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
606231|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
606232|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
606233|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606234|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606235|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
606236|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
606237|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
606238|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
606239|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606240|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
606241|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
606242|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
606243|NCT03479918|Hormones|hormones|mesh-ancestor
2216932|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
606244|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
606245|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
606246|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
606247|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
606248|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
606249|NCT03479879|Misoprostol|misoprostol|mesh-list
606250|NCT03479879|Estradiol|estradiol|mesh-list
606251|NCT03479879|Estrogens|estrogens|mesh-ancestor
606252|NCT03479879|Hormones|hormones|mesh-ancestor
606253|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
606254|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606255|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
606256|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
606257|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
606258|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
606259|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
606260|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
606261|NCT03479762|Liraglutide|liraglutide|mesh-list
606262|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
606263|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606264|NCT03479762|Incretins|incretins|mesh-ancestor
606265|NCT03479762|Hormones|hormones|mesh-ancestor
606266|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
606267|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
606268|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
606269|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
606270|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
606271|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
606272|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
606273|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606274|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606275|NCT03479684|Warfarin|warfarin|mesh-list
606276|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
606281|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
606282|NCT03479502|Doxycycline|doxycycline|mesh-list
606283|NCT03479502|Prednisone|prednisone|mesh-list
606284|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
606285|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
606286|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
606287|NCT03479502|Prednisolone|prednisolone|mesh-list
606288|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
606289|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
606290|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
606291|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
606292|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
606293|NCT03479502|Hormones|hormones|mesh-ancestor
606294|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
606295|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606296|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
606297|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606298|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
606299|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
606300|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606301|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
606302|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
606303|NCT03479502|Protective Agents|protective agents|mesh-ancestor
606304|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
606305|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
606306|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
606307|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
606308|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
606309|NCT03479476|Metformin|metformin|mesh-list
606310|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
606311|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606312|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
606313|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
606314|NCT03479411|Itraconazole|itraconazole|mesh-list
606315|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
606316|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
606317|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
606318|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
606319|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
606321|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606322|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
606323|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
606324|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
606325|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606326|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
606327|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
606328|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
606329|NCT03479320|Lidocaine|lidocaine|mesh-list
606330|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
606331|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
606332|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606333|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606334|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
606335|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606336|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
606337|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
606338|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
606339|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
606340|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606353|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
606354|NCT03479268|Pevonedistat|pevonedistat|mesh-list
606355|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216933|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2216934|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2216935|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216936|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2216937|NCT00030069|Vitamins|vitamins|mesh-ancestor
2216938|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
2216939|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2216940|NCT00030082|Melphalan|melphalan|mesh-list
2216941|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2216942|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
2216943|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216944|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216945|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2216946|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216947|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
2216948|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216949|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
2216950|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216951|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216952|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216953|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216954|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216955|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
2216956|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
2216957|NCT00030173|Epothilones|epothilones|mesh-list
606381|NCT03479086|Topiramate|topiramate|mesh-list
606382|NCT03479086|Naltrexone|naltrexone|mesh-list
606383|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
606384|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
606385|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606386|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
606387|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606388|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
606389|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2216958|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
2216959|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216960|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216961|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216962|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216963|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216964|NCT00030238|Calcium|calcium|mesh-list
2216965|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2216966|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2216967|NCT00030342|Interferons|interferons|mesh-list
2216968|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
2216969|NCT00030342|Fluorouracil|fluorouracil|mesh-list
2216970|NCT00030342|Sargramostim|sargramostim|mesh-list
2216971|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
2216972|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216973|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2216974|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216975|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2216976|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
2216977|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078611|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2078612|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
2078613|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2078614|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2078615|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2078616|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
2078617|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078618|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078619|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2078620|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
2078621|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2078622|NCT02045979|Adalimumab|adalimumab|mesh-list
2078623|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2078624|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2078625|NCT02046070|Dexamethasone|dexamethasone|mesh-list
2078626|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
2078627|NCT02046070|Ixazomib|ixazomib|mesh-list
2078628|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078629|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
2078630|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606432|NCT03478709|Norepinephrine|norepinephrine|mesh-list
606433|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
606434|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
606435|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
606436|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
606437|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606438|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606439|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
606440|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
606441|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606442|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2216978|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
2216979|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2216980|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
2216981|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216982|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216983|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2216984|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2216985|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216986|NCT00030368|Paclitaxel|paclitaxel|mesh-list
2216987|NCT00030368|Bortezomib|bortezomib|mesh-list
2216988|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2216989|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216990|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
2216991|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
2216992|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
2216993|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2216994|NCT00030381|Esorubicin|esorubicin|mesh-list
2216995|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2216996|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216997|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
2216998|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2216999|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2217000|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217001|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217002|NCT00030407|Celecoxib|celecoxib|mesh-list
2217003|NCT00030407|Docetaxel|docetaxel|mesh-list
2217004|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217005|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217006|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217007|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217008|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217009|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2217010|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2217011|NCT00030407|Analgesics|analgesics|mesh-ancestor
2217012|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
2217013|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2217014|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217015|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2217016|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217017|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2217018|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2217019|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217020|NCT00030420|Celecoxib|celecoxib|mesh-list
2217021|NCT00030420|Docetaxel|docetaxel|mesh-list
2217022|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217023|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217024|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217025|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217026|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217027|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2217028|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
606495|NCT03478605|Dexamethasone|dexamethasone|mesh-list
606496|NCT03478605|Ondansetron|ondansetron|mesh-list
606497|NCT03478605|Olanzapine|olanzapine|mesh-list
606498|NCT03478605|Aprepitant|aprepitant|mesh-list
606499|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
606500|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
606501|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
606502|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606503|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606504|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
606505|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
606506|NCT03478605|Hormones|hormones|mesh-ancestor
606507|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
606508|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
606509|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606510|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
606511|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
606512|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
606513|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
606514|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
606515|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606516|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
606517|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
606518|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606519|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
606520|NCT03478605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
606521|NCT03478605|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
606522|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
606523|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
606524|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
606525|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
606526|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
606527|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
606528|NCT03478514|Palbociclib|palbociclib|mesh-list
606529|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606530|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
606531|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606532|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606533|NCT03478488|Gemcitabine|gemcitabine|mesh-list
606534|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
606535|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
606536|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
606537|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606538|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606539|NCT03478488|Antiviral Agents|antiviral agents|mesh-ancestor
606540|NCT03478488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
606541|NCT03478488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606542|NCT03478488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
606543|NCT03478488|Immunologic Factors|immunologic factors|mesh-ancestor
606544|NCT03478488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606545|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
606546|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2217029|NCT00030420|Analgesics|analgesics|mesh-ancestor
606547|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606548|NCT03478475|Vitamins|vitamins|mesh-ancestor
606549|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
606550|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
606551|NCT03478436|Doxycycline|doxycycline|mesh-list
606552|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
606553|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
606554|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
606555|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
606556|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
606557|NCT03478423|Oxycodone|oxycodone|mesh-list
606558|NCT03478423|Hydromorphone|hydromorphone|mesh-list
606559|NCT03478423|Codeine|codeine|mesh-list
606560|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
606561|NCT03478423|Narcotics|narcotics|mesh-ancestor
606562|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606563|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606564|NCT03478423|Analgesics|analgesics|mesh-ancestor
606565|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
606566|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606567|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
606568|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
606569|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
606570|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
606571|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
606572|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
606573|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
606574|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606575|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
606576|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
606577|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606578|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
606579|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
606580|NCT03478306|Melatonin|melatonin|mesh-list
606581|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
606582|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606583|NCT03478306|Protective Agents|protective agents|mesh-ancestor
606584|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606585|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606586|NCT03478280|Brodalumab|brodalumab|mesh-list
606587|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
2217030|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
2217031|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2217032|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217033|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2217034|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217035|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2217036|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2217037|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217038|NCT00030433|Gemcitabine|gemcitabine|mesh-list
2217039|NCT00030433|Irinotecan|irinotecan|mesh-list
2217040|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2217041|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
606600|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
606601|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
606602|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
606603|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
606604|NCT03478150|Protective Agents|protective agents|mesh-ancestor
606605|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606606|NCT03478111|Methotrexate|methotrexate|mesh-list
606607|NCT03478111|Infliximab|infliximab|mesh-list
606608|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
606609|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
606610|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
606611|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606612|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
606613|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
606614|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606615|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606616|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
606617|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606618|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
606619|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
606620|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
606621|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
606622|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
606623|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
606624|NCT03478033|Rifampin|rifampin|mesh-list
606625|NCT03478033|Rifabutin|rifabutin|mesh-list
606626|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
606627|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
606628|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
606629|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
606630|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
606631|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
606632|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606633|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606634|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
606635|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
606636|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
606637|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
606638|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
606639|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
606640|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
606641|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
606642|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
606643|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
606644|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606645|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
606646|NCT03477994|Clonidine|clonidine|mesh-list
606647|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
606648|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
606649|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606650|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606651|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
606652|NCT03477994|Analgesics|analgesics|mesh-ancestor
606653|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
606654|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606655|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
606656|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
606657|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
606658|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
606659|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
606660|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606661|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
606662|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
606663|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
606664|NCT03477955|Silicon|silicon|mesh-list
606665|NCT03477955|Trace Elements|trace elements|mesh-ancestor
606666|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
606667|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606668|NCT03477929|Cetrorelix|cetrorelix|mesh-list
606669|NCT03477929|Ganirelix|ganirelix|mesh-list
606670|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
606671|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
606672|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606673|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
606674|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
606675|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2217042|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217043|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217044|NCT00030433|Antiviral Agents|antiviral agents|mesh-ancestor
2217045|NCT00030433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217046|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217047|NCT00030433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217048|NCT00030433|Immunologic Factors|immunologic factors|mesh-ancestor
2217049|NCT00030433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217050|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2217051|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
606687|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
606688|NCT03477864|Ipilimumab|ipilimumab|mesh-list
606689|NCT03477864|Cemiplimab|cemiplimab|mesh-list
606690|NCT03477864|Antibodies|antibodies|mesh-list
606691|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
606692|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
606693|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
606694|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606695|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606696|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
606697|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078631|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2078632|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2078633|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
2078634|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078635|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078636|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2078637|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
606706|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
606707|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
606708|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
606709|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606710|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
606711|NCT03477630|Protective Agents|protective agents|mesh-ancestor
606712|NCT03477539|Lenalidomide|lenalidomide|mesh-list
606713|NCT03477539|Daratumumab|daratumumab|mesh-list
606714|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
606715|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606716|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
606717|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
606718|NCT03477539|Growth Substances|growth substances|mesh-ancestor
606719|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
606720|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606721|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
606722|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
606723|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
606724|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
606725|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606726|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
606727|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
606728|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
606729|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606730|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606731|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
606732|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
606733|NCT03477461|Terlipressin|terlipressin|mesh-list
606734|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
606735|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
606736|NCT03477448|Bleomycin|bleomycin|mesh-list
606737|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
606738|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606739|NCT03477422|Meropenem|meropenem|mesh-list
606740|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
606741|NCT03477422|Sulbactam|sulbactam|mesh-list
606742|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
606743|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
606744|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
606745|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606746|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606757|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
606758|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
606759|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606760|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606761|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
606762|NCT03477344|Analgesics|analgesics|mesh-ancestor
606763|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
606764|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606765|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
606766|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
606767|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
606768|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
606769|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
606770|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606771|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
606772|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
606773|NCT03477266|Mosapride|mosapride|mesh-list
607072|NCT03475693|Analgesics|analgesics|mesh-ancestor
606774|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
606775|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
606776|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
606777|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
606778|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606779|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606780|NCT03477175|Sorafenib|sorafenib|mesh-list
606781|NCT03477175|Lenvatinib|lenvatinib|mesh-list
606782|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606783|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
606784|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606785|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606789|NCT03477136|Vitamin D|vitamin d|mesh-list
606790|NCT03477136|Vitamins|vitamins|mesh-ancestor
606791|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
606792|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606793|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
606794|NCT03477110|Temozolomide|temozolomide|mesh-list
606795|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
606796|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
606797|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606798|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606799|NCT03476941|Clindamycin|clindamycin|mesh-list
606800|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
606801|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
606802|NCT03476941|Gentamicins|gentamicins|mesh-list
606803|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
606804|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
606805|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
606806|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606807|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606808|NCT03476811|Analgesics|analgesics|mesh-list
606809|NCT03476811|Bupivacaine|bupivacaine|mesh-list
606810|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
606811|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
606812|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606813|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606814|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
606815|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2217052|NCT00030446|Carboplatin|carboplatin|mesh-list
2217053|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2217054|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217055|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2217056|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217057|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217058|NCT00030459|Vinorelbine|vinorelbine|mesh-list
2217059|NCT00030459|Mitomycins|mitomycins|mesh-list
2217060|NCT00030459|Mitomycin|mitomycin|mesh-list
2217061|NCT00030459|Vinblastine|vinblastine|mesh-list
2217062|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217063|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
606828|NCT03476772|Nalbuphine|nalbuphine|mesh-list
606829|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
606830|NCT03476772|Narcotics|narcotics|mesh-ancestor
606831|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606832|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606833|NCT03476772|Analgesics|analgesics|mesh-ancestor
606834|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
606835|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2217064|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
606857|NCT03476616|Valsartan|valsartan|mesh-list
606858|NCT03476616|Eplerenone|eplerenone|mesh-list
606859|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
606860|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
606861|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
606862|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606863|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
606864|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
606865|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
606866|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606867|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
606868|NCT03476616|Diuretics|diuretics|mesh-ancestor
606869|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
606870|NCT03476603|Irbesartan|irbesartan|mesh-list
606871|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
606872|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
606873|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
606874|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606875|NCT03476577|Ibuprofen|ibuprofen|mesh-list
606876|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
606877|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
606878|NCT03476577|Analgesics|analgesics|mesh-ancestor
606879|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
606880|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606881|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606882|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
606883|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
606884|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
606885|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606886|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606887|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
606888|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
606889|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606890|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606891|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
606892|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
606893|NCT03476564|Protective Agents|protective agents|mesh-ancestor
606894|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606895|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
606896|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
606897|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
606898|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
606899|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
606900|NCT03476551|Diuretics|diuretics|mesh-ancestor
606901|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
606902|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606903|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
606904|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
606905|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606906|NCT03476538|Gabapentin|gabapentin|mesh-list
606907|NCT03476538|Analgesics|analgesics|mesh-ancestor
606908|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
606909|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
606910|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606911|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
606912|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
606913|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
606914|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
606915|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
606916|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
606917|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
606918|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
606919|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606920|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
606921|NCT03476525|Fluoxetine|fluoxetine|mesh-list
606922|NCT03476525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
606923|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
606924|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
606925|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606926|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
606927|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
606928|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606929|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
606930|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
606931|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
606932|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
606933|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
606934|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606955|NCT03476356|Clomiphene|clomiphene|mesh-list
606956|NCT03476356|Enclomiphene|enclomiphene|mesh-list
606957|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
606958|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
606959|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
606960|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
606961|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606962|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
606963|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
606964|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
606965|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
606966|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2078638|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
2078639|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
2078640|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078641|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2078642|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
606972|NCT03476317|Vancomycin|vancomycin|mesh-list
606973|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
606974|NCT03476317|Neomycin|neomycin|mesh-list
606975|NCT03476317|Fluconazole|fluconazole|mesh-list
606976|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
606977|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
606978|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
606979|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
606980|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
606981|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
606982|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
606983|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
606984|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
606985|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
606986|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
606987|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
606988|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
606989|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
606990|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
606991|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
606992|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
606993|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
606994|NCT03476317|Laxatives|laxatives|mesh-ancestor
606995|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
606996|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2217065|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217066|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
606999|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
607000|NCT03476174|Interleukin-2|interleukin-2|mesh-list
607001|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
607002|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607003|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
607004|NCT03476174|Analgesics|analgesics|mesh-ancestor
607005|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
607006|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607007|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607008|NCT03476109|Omalizumab|omalizumab|mesh-list
607009|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
607010|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
607011|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
607012|NCT03476083|Tenofovir|tenofovir|mesh-list
607013|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
607014|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607015|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
607016|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
607017|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607018|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607019|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
607020|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
607021|NCT03476044|Selenium|selenium|mesh-list
607022|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
607023|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607024|NCT03476044|Protective Agents|protective agents|mesh-ancestor
607025|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607026|NCT03476044|Trace Elements|trace elements|mesh-ancestor
607027|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
607034|NCT03475862|Oxycodone|oxycodone|mesh-list
607035|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
607036|NCT03475862|Narcotics|narcotics|mesh-ancestor
607037|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
607038|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607039|NCT03475862|Analgesics|analgesics|mesh-ancestor
607040|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
607041|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607042|NCT03475810|Midazolam|midazolam|mesh-list
607043|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
607044|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
607045|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
607046|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607047|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
607048|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
607049|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
607050|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
607051|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
607052|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
607053|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
607054|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
607055|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607056|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607057|NCT03475758|Goserelin|goserelin|mesh-list
607058|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
607059|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607060|NCT03475706|Solabegron|solabegron|mesh-list
607061|NCT03475706|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
607062|NCT03475706|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
607063|NCT03475706|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
607064|NCT03475706|Adrenergic Agents|adrenergic agents|mesh-ancestor
607065|NCT03475706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607066|NCT03475706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607067|NCT03475706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607068|NCT03475693|Acetaminophen|acetaminophen|mesh-list
607069|NCT03475693|Ondansetron|ondansetron|mesh-list
607070|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
607071|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
607073|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
607074|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607075|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607076|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
607077|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
607078|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
607079|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
607080|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
607081|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
607082|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
607083|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
607084|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607085|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607086|NCT03475693|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
607087|NCT03475693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
607088|NCT03475693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
607089|NCT03475693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
607090|NCT03475693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
607091|NCT03475693|Antacids|antacids|mesh-ancestor
607092|NCT03475680|Gentamicins|gentamicins|mesh-list
607093|NCT03475680|Ornidazole|ornidazole|mesh-list
607094|NCT03475680|Sennosides|sennosides|mesh-list
607095|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
607096|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607097|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
607098|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607099|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607100|NCT03475680|Laxatives|laxatives|mesh-ancestor
607101|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
607102|NCT03475680|Amebicides|amebicides|mesh-ancestor
607103|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
607104|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
607105|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
607106|NCT03475628|Daratumumab|daratumumab|mesh-list
607107|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607108|NCT03475615|Paclitaxel|paclitaxel|mesh-list
607109|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
607110|NCT03475615|Tegafur|tegafur|mesh-list
607111|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
607112|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607113|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
607114|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
607115|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
607116|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607117|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
607118|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
607119|NCT03475589|Apatinib|apatinib|mesh-list
607120|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607121|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
607122|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607123|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607124|NCT03475524|Metformin|metformin|mesh-list
607125|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
607126|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607127|NCT03475459|Melatonin|melatonin|mesh-list
607128|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
607129|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607130|NCT03475459|Protective Agents|protective agents|mesh-ancestor
607131|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607132|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
607133|NCT03475407|Dexamethasone|dexamethasone|mesh-list
607134|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
607135|NCT03475407|BB 1101|bb 1101|mesh-list
607136|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
607137|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
607138|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
607139|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607140|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607141|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
607142|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
607143|NCT03475407|Hormones|hormones|mesh-ancestor
607144|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
607145|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
607146|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607147|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
607148|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607149|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607150|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
607151|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
607152|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607153|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
607158|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
607159|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
607160|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
607161|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607162|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
607163|NCT03475342|Coagulants|coagulants|mesh-ancestor
607178|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
607179|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
607180|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607181|NCT03475225|Vitamins|vitamins|mesh-ancestor
607182|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
607183|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
607184|NCT03475186|Ramipril|ramipril|mesh-list
607185|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
607186|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
607187|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607188|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607189|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
607190|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
607191|NCT03475160|Citric Acid|citric acid|mesh-list
607192|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
607193|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
607194|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
607195|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
607196|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
607197|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607198|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
607199|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
607200|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
607201|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607202|NCT03475160|Urological Agents|urological agents|mesh-ancestor
2078643|NCT02046070|Hormones|hormones|mesh-ancestor
2078644|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2078645|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2078646|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
2078647|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078648|NCT02046122|Cytarabine|cytarabine|mesh-list
2078649|NCT02046122|Idarubicin|idarubicin|mesh-list
2078650|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2078651|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
2078652|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078653|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078654|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
2078655|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078656|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078657|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
2078658|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078659|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2078660|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2078661|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
607222|NCT03475121|Topotecan|topotecan|mesh-list
607223|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
607224|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
607225|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607226|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607227|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607228|NCT03475017|Curcumin|curcumin|mesh-list
607229|NCT03475017|Piperine|piperine|mesh-list
607230|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
607231|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
607232|NCT03475017|Analgesics|analgesics|mesh-ancestor
607233|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
607234|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607235|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607236|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
607237|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
607238|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607239|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607240|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607241|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
607251|NCT03474939|Midazolam|midazolam|mesh-list
607252|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
607253|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
607254|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
607255|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607256|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
607257|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
607258|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
607259|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
607260|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
607261|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
607262|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
607263|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
607264|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607265|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607266|NCT03474770|Huperzine A|huperzine a|mesh-list
607267|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
607268|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607269|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607270|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
607271|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607272|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607273|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
607274|NCT03474770|Protective Agents|protective agents|mesh-ancestor
607279|NCT03474614|Propranolol|propranolol|mesh-list
607280|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
607281|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
607282|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
607283|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607284|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607285|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607286|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
607287|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
607288|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
607289|NCT03474601|Hormones|hormones|mesh-list
607290|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
607291|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607292|NCT03474510|Bupivacaine|bupivacaine|mesh-list
607293|NCT03474510|Ropivacaine|ropivacaine|mesh-list
607294|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
607295|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
607296|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
607297|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607298|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
607375|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
607299|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078662|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078663|NCT02046200|Ethanol|ethanol|mesh-list
2078664|NCT02046200|Ivermectin|ivermectin|mesh-list
607303|NCT03474458|Doxycycline|doxycycline|mesh-list
607304|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
607305|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607306|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
607307|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
607308|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
607309|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
607310|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
607311|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607312|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
607313|NCT03474276|Azithromycin|azithromycin|mesh-list
607314|NCT03474276|Albendazole|albendazole|mesh-list
607315|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
607316|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607317|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
607318|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
607319|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
607320|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
607321|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
607322|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
607323|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
607324|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607325|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607326|NCT03474263|Antibodies|antibodies|mesh-list
607327|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
607328|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
607329|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607330|NCT03474237|Hormones|hormones|mesh-list
607331|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
607332|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607333|NCT03474198|Levofloxacin|levofloxacin|mesh-list
607334|NCT03474198|Rifampin|rifampin|mesh-list
607335|NCT03474198|Isoniazid|isoniazid|mesh-list
607336|NCT03474198|Linezolid|linezolid|mesh-list
607337|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
607338|NCT03474198|Ethambutol|ethambutol|mesh-list
607339|NCT03474198|Rifapentine|rifapentine|mesh-list
607340|NCT03474198|Bedaquiline|bedaquiline|mesh-list
607341|NCT03474198|Clofazimine|clofazimine|mesh-list
607342|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
607343|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607344|NCT03474198|Renal Agents|renal agents|mesh-ancestor
607345|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
607346|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
607347|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
607348|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607349|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607350|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607351|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
607352|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
607353|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
607354|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
607355|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
607356|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
607357|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
607358|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
607359|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
607360|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
607361|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
607362|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
607363|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
607364|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
607365|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
607366|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
607367|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
607368|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
607369|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
607370|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
607371|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
607372|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607373|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
607374|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
2078665|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
607376|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
607377|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078666|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078667|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2078668|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078669|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2078670|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2078671|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2078672|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2078673|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
607386|NCT03474094|Atezolizumab|atezolizumab|mesh-list
607387|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
607388|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607389|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
607390|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217067|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217068|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2217069|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
2217070|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2217071|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217072|NCT00030472|Doxorubicin|doxorubicin|mesh-list
2217073|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2217074|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2217075|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217076|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2217077|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2217078|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217079|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217080|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2217081|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217082|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2217083|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217084|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217085|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2078674|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078675|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2078676|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
607434|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
607435|NCT03473964|Hormones|hormones|mesh-ancestor
607436|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
607437|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607438|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
607439|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
607440|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078677|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2078678|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
607445|NCT03473730|Daratumumab|daratumumab|mesh-list
607446|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607447|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
607448|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
607449|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217086|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217087|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2217088|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217089|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217090|NCT00030511|Fluorouracil|fluorouracil|mesh-list
2217091|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
2217092|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217093|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2217094|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217095|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217096|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
2217097|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217098|NCT00030524|Gefitinib|gefitinib|mesh-list
2217099|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217100|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2217101|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217102|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217103|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
607469|NCT03473639|Capecitabine|capecitabine|mesh-list
607470|NCT03473639|Entinostat|entinostat|mesh-list
607471|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
607472|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
607473|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607474|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607475|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
607476|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607477|NCT03473626|Alicaforsen|alicaforsen|mesh-list
607478|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
607479|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
607480|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
607481|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607482|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
607483|NCT03473613|Cabergoline|cabergoline|mesh-list
607484|NCT03473613|Calcium|calcium|mesh-list
607485|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
607486|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607487|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
607488|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
607489|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
607490|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
607491|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
607492|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607493|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607494|NCT03473600|Triamcinolone|triamcinolone|mesh-list
607495|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
607496|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
607497|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
607498|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
607499|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
607500|NCT03473600|Hormones|hormones|mesh-ancestor
607501|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
607502|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607503|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
607504|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
607505|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607506|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078679|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
2078680|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078681|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078682|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2078683|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2078684|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
2078685|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2078686|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2078687|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
2078688|NCT02046382|Acetaminophen|acetaminophen|mesh-list
2078689|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2078690|NCT02046382|Analgesics|analgesics|mesh-ancestor
2078691|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
607527|NCT03473431|Ketamine|ketamine|mesh-list
607528|NCT03473431|Analgesics|analgesics|mesh-ancestor
607529|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
607530|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607531|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607532|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
607533|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
607534|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
607535|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
607536|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
607537|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
607538|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
607539|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607540|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607541|NCT03473418|Ketoconazole|ketoconazole|mesh-list
607542|NCT03473418|Terconazole|terconazole|mesh-list
607543|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
607544|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607545|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
607546|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
607547|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607548|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607549|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
607550|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
607551|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
607552|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607553|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
607564|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
607565|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
607566|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
607567|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607568|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607569|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
607570|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
607571|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
607572|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
607573|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607574|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607575|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
607576|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
607577|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
607578|NCT03473314|Protective Agents|protective agents|mesh-ancestor
607579|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
607580|NCT03473210|Erythromycin|erythromycin|mesh-list
607581|NCT03473210|Ampicillin|ampicillin|mesh-list
607582|NCT03473210|Dexamethasone|dexamethasone|mesh-list
607583|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
607584|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
607585|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
607586|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607587|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607588|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
607589|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
607590|NCT03473210|Hormones|hormones|mesh-ancestor
607591|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
607592|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
607593|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607594|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607595|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607596|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607597|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2217104|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217105|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2217106|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607602|NCT03473132|Thrombin|thrombin|mesh-list
607603|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
607604|NCT03473132|Coagulants|coagulants|mesh-ancestor
607605|NCT03473093|Pregabalin|pregabalin|mesh-list
607606|NCT03473093|Morphine|morphine|mesh-list
607607|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
607608|NCT03473093|Narcotics|narcotics|mesh-ancestor
607609|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
607610|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607611|NCT03473093|Analgesics|analgesics|mesh-ancestor
607612|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
607613|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607614|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
607615|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
607616|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
607617|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607618|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
607619|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
607620|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
607621|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
607622|NCT03472976|Imiquimod|imiquimod|mesh-list
607623|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
607624|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
607625|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607626|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607627|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
607628|NCT03472963|Darunavir|darunavir|mesh-list
607629|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
607630|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
607631|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
607632|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
607633|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607634|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607635|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
607636|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
607637|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
607638|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607639|NCT03472950|Ranolazine|ranolazine|mesh-list
607640|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
607641|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
607642|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217107|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217108|NCT00030550|Thalidomide|thalidomide|mesh-list
2217109|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217110|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
607648|NCT03472872|Acetaminophen|acetaminophen|mesh-list
607649|NCT03472872|Ketorolac|ketorolac|mesh-list
607650|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
607651|NCT03472872|Analgesics|analgesics|mesh-ancestor
607652|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
607653|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607654|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607655|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
607656|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
607657|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
607658|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
607659|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
607660|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607661|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607662|NCT03472846|Teriparatide|teriparatide|mesh-list
607663|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
607664|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607665|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
607666|NCT03472677|Capsaicin|capsaicin|mesh-list
607667|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
607668|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
607669|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
607670|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607671|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607672|NCT03472651|Flupenthixol|flupenthixol|mesh-list
607673|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
607674|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
607675|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
607676|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
607677|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607678|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
607679|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
607680|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
607681|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607682|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078692|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078693|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078694|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
2078695|NCT02046603|Methotrexate|methotrexate|mesh-list
2078696|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2078697|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
607689|NCT03472573|Dexamethasone|dexamethasone|mesh-list
607690|NCT03472573|Palbociclib|palbociclib|mesh-list
607691|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
607692|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
607693|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
607694|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607695|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607696|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
607697|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
607698|NCT03472573|Hormones|hormones|mesh-ancestor
607699|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
607700|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
607701|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607702|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
607703|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607704|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607705|NCT03472560|Avelumab|avelumab|mesh-list
607706|NCT03472560|Axitinib|axitinib|mesh-list
607707|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
607708|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607709|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
607710|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607711|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217111|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217112|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
2217113|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2217114|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078698|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2078699|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078700|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2078701|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
2078702|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078703|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078704|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
2078705|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078706|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2078707|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078708|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
2078709|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2078710|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2078711|NCT02046616|Methotrexate|methotrexate|mesh-list
607731|NCT03472508|Folic Acid|folic acid|mesh-list
607732|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
607733|NCT03472508|Enalapril|enalapril|mesh-list
607734|NCT03472508|Enalaprilat|enalaprilat|mesh-list
607735|NCT03472508|Hematinics|hematinics|mesh-ancestor
607736|NCT03472508|Vitamins|vitamins|mesh-ancestor
607737|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
607738|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607739|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607740|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607741|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
607742|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
607743|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
607744|NCT03472495|Diltiazem|diltiazem|mesh-list
607745|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
607746|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
607747|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
607748|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607749|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
607750|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607751|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
2217115|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2217116|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2217117|NCT00030550|Growth Substances|growth substances|mesh-ancestor
2217118|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
2217119|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217120|NCT00030563|Irinotecan|irinotecan|mesh-list
2217121|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2217122|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2217123|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217124|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217125|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217126|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2217127|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217128|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2217129|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217130|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217131|NCT00030589|Bexarotene|bexarotene|mesh-list
2217132|NCT00030589|Methoxsalen|methoxsalen|mesh-list
2217133|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217134|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2217135|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
2217136|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
2217137|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2217138|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
2217139|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217140|NCT00030615|Decitabine|decitabine|mesh-list
2217141|NCT00030615|Azacitidine|azacitidine|mesh-list
2217142|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2217143|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
2217144|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217145|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217146|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217147|NCT00030641|Docetaxel|docetaxel|mesh-list
2217148|NCT00030641|Oblimersen|oblimersen|mesh-list
2217149|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217150|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217151|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217152|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217153|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217154|NCT00030654|Ketoconazole|ketoconazole|mesh-list
2217155|NCT00030654|Vinblastine|vinblastine|mesh-list
607793|NCT03472456|Eugenol|eugenol|mesh-list
607794|NCT03472456|Carticaine|carticaine|mesh-list
607795|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
607796|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
607797|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
607798|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607799|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
607800|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607801|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607802|NCT03472378|Celecoxib|celecoxib|mesh-list
607803|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
607804|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
607805|NCT03472378|Analgesics|analgesics|mesh-ancestor
607806|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
607807|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607808|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607809|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
607810|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
607811|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
607812|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
607813|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607814|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607815|NCT03472365|Capecitabine|capecitabine|mesh-list
607816|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
607817|NCT03472365|Apatinib|apatinib|mesh-list
607818|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
607819|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
607820|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607821|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607822|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
607823|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607824|NCT03472339|Diclofenac|diclofenac|mesh-list
607825|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
607826|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
607827|NCT03472339|Analgesics|analgesics|mesh-ancestor
607828|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
607829|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607830|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607831|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
607832|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
607833|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
607834|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607835|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217156|NCT00030654|Docetaxel|docetaxel|mesh-list
2217157|NCT00030654|Doxorubicin|doxorubicin|mesh-list
2217158|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2217159|NCT00030654|Bicalutamide|bicalutamide|mesh-list
2217160|NCT00030654|Flutamide|flutamide|mesh-list
2217161|NCT00030654|Estramustine|estramustine|mesh-list
2217162|NCT00030654|Hormones|hormones|mesh-list
2217163|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2217164|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217165|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217166|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
607847|NCT03472274|Durvalumab|durvalumab|mesh-list
607848|NCT03472274|Tremelimumab|tremelimumab|mesh-list
607849|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607850|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
607851|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
607852|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
607853|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
607854|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
607855|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
607856|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607857|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
607858|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607859|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607860|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
607861|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607862|NCT03472170|Lactoferrin|lactoferrin|mesh-list
607863|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607864|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
607865|NCT03472144|Levofloxacin|levofloxacin|mesh-list
607866|NCT03472144|Ofloxacin|ofloxacin|mesh-list
607867|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
607868|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607869|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
607870|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
607871|NCT03472144|Renal Agents|renal agents|mesh-ancestor
607872|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
607873|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
607874|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607875|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607876|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
607877|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
607878|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
607879|NCT03472092|Amitriptyline|amitriptyline|mesh-list
607880|NCT03472092|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
607881|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
607882|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
607883|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
607884|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
607885|NCT03472092|Analgesics|analgesics|mesh-ancestor
607886|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
607887|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607888|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607889|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
607890|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
607891|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
607892|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607893|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
607894|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607895|NCT03472092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
607896|NCT03472092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
607897|NCT03472092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
607898|NCT03472040|Berotralstat|berotralstat|mesh-list
607899|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607900|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217167|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
607901|NCT03471988|Voriconazole|voriconazole|mesh-list
607902|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
607903|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
607904|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
607905|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
607906|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607907|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607908|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
607909|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
607910|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
607911|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607912|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2217168|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217169|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2217170|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2217171|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2217172|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217173|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2217174|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217175|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
607921|NCT03471819|Serotonin|serotonin|mesh-list
607922|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
607923|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
607924|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607925|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607926|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607927|NCT03471767|Dextromethorphan|dextromethorphan|mesh-list
607928|NCT03471767|Bupropion|bupropion|mesh-list
607929|NCT03471767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
607930|NCT03471767|Antidepressive Agents|antidepressive agents|mesh-ancestor
607931|NCT03471767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
607932|NCT03471767|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
607933|NCT03471767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
607934|NCT03471767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
607935|NCT03471767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607936|NCT03471767|Dopamine Agents|dopamine agents|mesh-ancestor
607937|NCT03471767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607938|NCT03471767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607939|NCT03471767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
607940|NCT03471767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
607941|NCT03471767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607942|NCT03471767|Antitussive Agents|antitussive agents|mesh-ancestor
607943|NCT03471767|Respiratory System Agents|respiratory system agents|mesh-ancestor
607944|NCT03471767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
607945|NCT03471767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2078712|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2078713|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
2078714|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2078715|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078716|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2078717|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
2078718|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078719|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078720|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
2078721|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078722|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2078723|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078724|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
607965|NCT03471611|Sargramostim|sargramostim|mesh-list
607966|NCT03471611|Lenograstim|lenograstim|mesh-list
607967|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
607968|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607969|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
607970|NCT03471585|Dronabinol|dronabinol|mesh-list
607971|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
607972|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607973|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
607974|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
607975|NCT03471585|Analgesics|analgesics|mesh-ancestor
607976|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
607977|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607978|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
607979|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
607980|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
607981|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607982|NCT03471585|Hormones|hormones|mesh-ancestor
607983|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
607984|NCT03471559|Cannabidiol|cannabidiol|mesh-list
607985|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
607986|NCT03471507|Diclofenac|diclofenac|mesh-list
607987|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
607988|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
607989|NCT03471507|Analgesics|analgesics|mesh-ancestor
607990|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
607991|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
607992|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
607993|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
607994|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
607995|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
607996|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
607997|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
607998|NCT03471455|Itraconazole|itraconazole|mesh-list
607999|NCT03471455|Terbinafine|terbinafine|mesh-list
608000|NCT03471455|Isotretinoin|isotretinoin|mesh-list
608001|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
608002|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
608003|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
608004|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
608005|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608006|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608007|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
608008|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
608009|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
608010|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608011|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
608012|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
608013|NCT03471442|Bupivacaine|bupivacaine|mesh-list
608014|NCT03471442|Ropivacaine|ropivacaine|mesh-list
608015|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
608016|NCT03471442|Anesthetics|anesthetics|mesh-list
608017|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
608018|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
608019|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608020|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
608021|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608034|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
608035|NCT03471351|Tenalisib|tenalisib|mesh-list
608036|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
608037|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608038|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
608039|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608040|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608041|NCT03471325|Methamphetamine|methamphetamine|mesh-list
608042|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
608043|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608044|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
608045|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
608046|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608047|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
608048|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608049|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608050|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
608051|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
608052|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
608053|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
608054|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
608055|NCT03471260|Azacitidine|azacitidine|mesh-list
608056|NCT03471260|Venetoclax|venetoclax|mesh-list
608057|NCT03471260|Ivosidenib|ivosidenib|mesh-list
608058|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
608059|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
608060|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608061|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608062|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608063|NCT03471182|Cocaine|cocaine|mesh-list
608064|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
608065|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
608066|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
608067|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608068|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
608069|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608070|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
608071|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
608072|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
608073|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
608074|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608075|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
608076|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608077|NCT03471143|Betadex|betadex|mesh-list
608078|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
608079|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608080|NCT03471117|Pioglitazone|pioglitazone|mesh-list
608081|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
608082|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608083|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
608084|NCT03471039|Growth Substances|growth substances|mesh-ancestor
608085|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608086|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
608087|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608088|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608089|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
608090|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
608091|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608092|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
608093|NCT03470922|Nivolumab|nivolumab|mesh-list
608094|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
608095|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608096|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
608097|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608098|NCT03470805|Olaparib|olaparib|mesh-list
608099|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
608100|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608101|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608102|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608103|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
608104|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
608269|NCT03469700|Anesthetics|anesthetics|mesh-list
608122|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
608123|NCT03470649|Hematinics|hematinics|mesh-ancestor
608124|NCT03470610|Estradiol|estradiol|mesh-list
608125|NCT03470610|Progesterone|progesterone|mesh-list
608126|NCT03470610|Estrogens|estrogens|mesh-ancestor
608127|NCT03470610|Hormones|hormones|mesh-ancestor
608128|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
608129|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608130|NCT03470610|Progestins|progestins|mesh-ancestor
608131|NCT03470597|Iodine|iodine|mesh-list
608132|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
608133|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
608134|NCT03470597|Trace Elements|trace elements|mesh-ancestor
608135|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
608136|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608137|NCT03470532|Epinephrine|epinephrine|mesh-list
608138|NCT03470532|Racepinephrine|racepinephrine|mesh-list
608139|NCT03470532|Mepivacaine|mepivacaine|mesh-list
608140|NCT03470532|Carticaine|carticaine|mesh-list
608141|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
608142|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
608143|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
608144|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
608145|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608146|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608147|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608148|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
608149|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
608150|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
608151|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608152|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
608153|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
608154|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
608155|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
608156|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
608157|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
608158|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
608159|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
608160|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
608161|NCT03470480|Methamphetamine|methamphetamine|mesh-list
608162|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
608163|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608164|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
608165|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
608166|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608167|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
608168|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608169|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608170|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
608171|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
608172|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
608173|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
608174|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
608175|NCT03470454|Linagliptin|linagliptin|mesh-list
608176|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
608177|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608178|NCT03470454|Incretins|incretins|mesh-ancestor
608179|NCT03470454|Hormones|hormones|mesh-ancestor
608180|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
608181|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
608182|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
608183|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608184|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608185|NCT03470363|Sufentanil|sufentanil|mesh-list
608186|NCT03470363|Bupivacaine|bupivacaine|mesh-list
608187|NCT03470363|Sevoflurane|sevoflurane|mesh-list
608188|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
608189|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
608190|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
608191|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608192|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
608193|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608194|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
608195|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
608196|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
608197|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
608198|NCT03470363|Narcotics|narcotics|mesh-ancestor
608199|NCT03470363|Analgesics|analgesics|mesh-ancestor
608200|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
608201|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
608202|NCT03470350|Capecitabine|capecitabine|mesh-list
608203|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
608204|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
608205|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608206|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608207|NCT03470337|Wobenzym|wobenzym|mesh-list
608208|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
608209|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
608210|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608211|NCT03470311|Benralizumab|benralizumab|mesh-list
608212|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
608213|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
608214|NCT03470103|Aflibercept|aflibercept|mesh-list
608215|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
608216|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
608217|NCT03470103|Growth Substances|growth substances|mesh-ancestor
608218|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608219|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
608220|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608221|NCT03470077|Nalbuphine|nalbuphine|mesh-list
608222|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
608223|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608224|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
608225|NCT03470077|Narcotics|narcotics|mesh-ancestor
608226|NCT03470077|Analgesics|analgesics|mesh-ancestor
608227|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
608228|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608229|NCT03470038|Mitogens|mitogens|mesh-list
608230|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
608231|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078725|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2078726|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2078727|NCT02046772|Morphine|morphine|mesh-list
2078728|NCT02046772|Bupivacaine|bupivacaine|mesh-list
2078729|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
2078730|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
2078731|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2078732|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078733|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
2078734|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078735|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
608243|NCT03469960|Nivolumab|nivolumab|mesh-list
608244|NCT03469960|Ipilimumab|ipilimumab|mesh-list
608245|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
608246|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608247|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
608248|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608249|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
608250|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
608251|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
608252|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608253|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
608254|NCT03469947|Coagulants|coagulants|mesh-ancestor
608255|NCT03469895|Idelalisib|idelalisib|mesh-list
608256|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608257|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608258|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608259|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
608260|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
608261|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
608262|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
608263|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608264|NCT03469713|Nivolumab|nivolumab|mesh-list
608265|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
608266|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608267|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
608268|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078736|NCT02046772|Narcotics|narcotics|mesh-ancestor
608270|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
608271|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608272|NCT03469583|Entecavir|entecavir|mesh-list
608273|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
608274|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
608275|NCT03469557|Capecitabine|capecitabine|mesh-list
608276|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
608277|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608278|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
608279|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
608280|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608281|NCT03469544|Hormones|hormones|mesh-list
608282|NCT03469544|Antibodies|antibodies|mesh-list
608283|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
608284|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608285|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
608286|NCT03469531|Cisplatin|cisplatin|mesh-list
608287|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
608288|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608289|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
608290|NCT03469492|Insulin|insulin|mesh-list
608291|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
608292|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608293|NCT03469375|Folfirinox|folfirinox|mesh-list
608294|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217176|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217177|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2217178|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2217179|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2217180|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
2217181|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2217182|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
2217183|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2217184|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2217185|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
2217186|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
2217187|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217188|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2217189|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217190|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217191|NCT00030693|Metronidazole|metronidazole|mesh-list
2217192|NCT00030693|Vaccines|vaccines|mesh-list
2217193|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
608314|NCT03469323|Succinylcholine|succinylcholine|mesh-list
608315|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
608316|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
608317|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
608318|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608319|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608320|NCT03469310|Acetaminophen|acetaminophen|mesh-list
608321|NCT03469310|Tramadol|tramadol|mesh-list
608322|NCT03469310|Codeine|codeine|mesh-list
608323|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
608324|NCT03469310|Analgesics|analgesics|mesh-ancestor
608325|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
608326|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608327|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608328|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
608329|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
608330|NCT03469310|Narcotics|narcotics|mesh-ancestor
608331|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
608332|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
608333|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
608334|NCT03469284|Methylene Blue|methylene blue|mesh-list
608335|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608336|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608337|NCT03469271|Calcitriol|calcitriol|mesh-list
608338|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
608339|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
608340|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608341|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
608342|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
608343|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608344|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
608345|NCT03469271|Vitamins|vitamins|mesh-ancestor
608346|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
608347|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2217194|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217195|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
608351|NCT03469167|Epinephrine|epinephrine|mesh-list
608352|NCT03469167|CEGP-003|cegp-003|mesh-list
608353|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
608354|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
608355|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
608356|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608357|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608358|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608359|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
608360|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
608361|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
608362|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608363|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
608364|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
608365|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
608366|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
608367|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
608368|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
608369|NCT03469167|Coagulants|coagulants|mesh-ancestor
608370|NCT03469128|Sertraline|sertraline|mesh-list
608371|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
608372|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
608373|NCT03469128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
608374|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
608375|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
608376|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608377|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608378|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
608379|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608380|NCT03469089|Ketamine|ketamine|mesh-list
608381|NCT03469089|Modafinil|modafinil|mesh-list
608382|NCT03469089|Analgesics|analgesics|mesh-ancestor
608383|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
608384|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608385|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608386|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
608387|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
608388|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
608389|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
608390|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
608391|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
608392|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
608393|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608394|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608395|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
608396|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
608397|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
608398|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2078737|NCT02046772|Analgesics|analgesics|mesh-ancestor
2078738|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
2078739|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2078740|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
608403|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
608404|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608405|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
608406|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608407|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608414|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
608415|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
608416|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608417|NCT03468946|Caffeine|caffeine|mesh-list
608418|NCT03468946|Citric Acid|citric acid|mesh-list
608419|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
608420|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608421|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
608422|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608423|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608424|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
608425|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
608426|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
608427|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608428|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
608429|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
608430|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
608431|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
2217196|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2217197|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2217198|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2217199|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
2217200|NCT00030719|Melphalan|melphalan|mesh-list
2217201|NCT00030719|Busulfan|busulfan|mesh-list
2217202|NCT00030719|Carboplatin|carboplatin|mesh-list
2217203|NCT00030719|Etoposide|etoposide|mesh-list
2217204|NCT00030719|Vincristine|vincristine|mesh-list
2217205|NCT00030719|Dinutuximab|dinutuximab|mesh-list
2217206|NCT00030719|Isotretinoin|isotretinoin|mesh-list
2217207|NCT00030719|Antibodies|antibodies|mesh-list
608444|NCT03468907|Tenofovir|tenofovir|mesh-list
608445|NCT03468907|Telbivudine|telbivudine|mesh-list
608446|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
608447|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
608448|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
608449|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
608450|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608451|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608452|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
608453|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
608454|NCT03468829|Gontivimab|gontivimab|mesh-list
608455|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
608456|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
608457|NCT03468790|Fluticasone|fluticasone|mesh-list
608458|NCT03468790|Xhance|xhance|mesh-list
608459|NCT03468790|Budesonide|budesonide|mesh-list
608460|NCT03468790|Albuterol|albuterol|mesh-list
608461|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
608462|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
608463|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
608464|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
608465|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
608466|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
608467|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
608468|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608469|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608470|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
608471|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
608472|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
608473|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
608474|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
608475|NCT03468790|Hormones|hormones|mesh-ancestor
608476|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
608477|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
608478|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
608479|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
608480|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
608481|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608482|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608483|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
608484|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
608485|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
608486|NCT03468777|Lansoprazole|lansoprazole|mesh-list
608487|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
608488|NCT03468777|Ranitidine|ranitidine|mesh-list
608489|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
608490|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
608491|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
608492|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
608493|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608494|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608495|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
608496|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
2217208|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2217209|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
608497|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
608498|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608499|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608500|NCT03468595|Listerine|listerine|mesh-list
608501|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
608502|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217210|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
2217211|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217212|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217213|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2217214|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
2217215|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217216|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217217|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2217218|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
608512|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
608513|NCT03468478|Sirolimus|sirolimus|mesh-list
608514|NCT03468478|Everolimus|everolimus|mesh-list
608515|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608516|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
608517|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
608518|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608519|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
608520|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
608521|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
608522|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
608523|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
608524|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608525|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608526|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
608527|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
608528|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
608529|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
608530|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
608531|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608532|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608533|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608534|NCT03468465|Urological Agents|urological agents|mesh-ancestor
608535|NCT03468439|Phenol|phenol|mesh-list
608536|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
608537|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
608538|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
608539|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
608540|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
608541|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
608542|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
608543|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
608544|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
608545|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608546|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608547|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608548|NCT03468348|Analgesics|analgesics|mesh-ancestor
608549|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
608550|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608551|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
608552|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
608553|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
608554|NCT03468335|Irinotecan|irinotecan|mesh-list
608555|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
608556|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
608557|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608558|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608559|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608560|NCT03468296|Aflibercept|aflibercept|mesh-list
608561|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
608562|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
608563|NCT03468296|Growth Substances|growth substances|mesh-ancestor
608564|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608565|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
608566|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608567|NCT03468231|Leucovorin|leucovorin|mesh-list
608568|NCT03468231|Fluorouracil|fluorouracil|mesh-list
608569|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
608570|NCT03468231|Sorafenib|sorafenib|mesh-list
608571|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
608572|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608573|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
608574|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608575|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
608576|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
608577|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608578|NCT03468231|Antidotes|antidotes|mesh-ancestor
608579|NCT03468231|Protective Agents|protective agents|mesh-ancestor
608580|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
608581|NCT03468231|Vitamins|vitamins|mesh-ancestor
608582|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
608583|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
608584|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608585|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
608586|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
608587|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608588|NCT03468140|Eculizumab|eculizumab|mesh-list
608589|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
608590|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
608591|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
608592|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217219|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2217220|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2217221|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217222|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217223|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217224|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217225|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
2217226|NCT00030732|Gemcitabine|gemcitabine|mesh-list
2217227|NCT00030732|Capecitabine|capecitabine|mesh-list
2217228|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2217229|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
2217230|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217231|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217232|NCT00030732|Antiviral Agents|antiviral agents|mesh-ancestor
2217233|NCT00030732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217234|NCT00030732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608609|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
608610|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
608611|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
608612|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608613|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
608614|NCT03468062|Analgesics|analgesics|mesh-ancestor
608615|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
608616|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608617|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
608618|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
608619|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
608620|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
608621|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608622|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608623|NCT03468023|Calpastatin|calpastatin|mesh-list
608624|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
608625|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
608626|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608627|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608628|NCT03468010|Paclitaxel|paclitaxel|mesh-list
608629|NCT03468010|Cisplatin|cisplatin|mesh-list
608630|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
608631|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608632|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
608633|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
608634|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
608635|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608636|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
608637|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
608638|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217235|NCT00030732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217236|NCT00030732|Immunologic Factors|immunologic factors|mesh-ancestor
2217237|NCT00030732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078741|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
2078742|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078743|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078744|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078745|NCT02047032|Urological Agents|urological agents|mesh-ancestor
2078746|NCT02047045|Prucalopride|prucalopride|mesh-list
2217238|NCT00030745|Gemcitabine|gemcitabine|mesh-list
2217239|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217240|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2217241|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
608653|NCT03467932|Insulin|insulin|mesh-list
608654|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
608655|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
608656|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608657|NCT03467893|Antacids|antacids|mesh-list
608658|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608659|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
608660|NCT03467867|Rituximab|rituximab|mesh-list
608661|NCT03467867|Venetoclax|venetoclax|mesh-list
608662|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
608663|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608664|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
608665|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608666|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217242|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217243|NCT00030745|Antiviral Agents|antiviral agents|mesh-ancestor
2217244|NCT00030745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
608678|NCT03467750|Ketorolac|ketorolac|mesh-list
608679|NCT03467750|Morphine|morphine|mesh-list
608680|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
608681|NCT03467750|Narcotics|narcotics|mesh-ancestor
608682|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
608683|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608684|NCT03467750|Analgesics|analgesics|mesh-ancestor
608685|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
608686|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608687|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
608688|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
608689|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
608690|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
608691|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
608692|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608693|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217245|NCT00030745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217246|NCT00030745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
608697|NCT03467620|Cannabidiol|cannabidiol|mesh-list
608698|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
608699|NCT03467438|Polaprezinc|polaprezinc|mesh-list
608700|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
608701|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2078747|NCT02047045|Serotonin|serotonin|mesh-list
2078748|NCT02047045|Laxatives|laxatives|mesh-ancestor
2078749|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2078750|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2078751|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2078752|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
2078753|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078754|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078755|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078756|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2078757|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
2078758|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078759|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2078760|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2078761|NCT02047227|Hormones|hormones|mesh-ancestor
2078762|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2078763|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078764|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2078765|NCT02047253|Acyclovir|acyclovir|mesh-list
2078766|NCT02047253|Dexamethasone|dexamethasone|mesh-list
2078767|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2078768|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
2078769|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
2078770|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078771|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078772|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2078773|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
2078774|NCT02047253|Hormones|hormones|mesh-ancestor
2078775|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2078776|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2078777|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078778|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
2078779|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078780|NCT02047500|Gemcitabine|gemcitabine|mesh-list
2078781|NCT02047500|Paclitaxel|paclitaxel|mesh-list
2078782|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2078783|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078784|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
2078785|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
2078786|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
2078787|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078788|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2078789|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
2078790|NCT02047500|Antiviral Agents|antiviral agents|mesh-ancestor
608760|NCT03467334|Simethicone|simethicone|mesh-list
608761|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
608762|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608763|NCT03467334|Emollients|emollients|mesh-ancestor
608764|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
608765|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
608766|NCT03467256|Fludarabine|fludarabine|mesh-list
608767|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
608768|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
608769|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608770|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
608771|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
608772|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
608773|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608774|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608775|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2078791|NCT02047500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078792|NCT02047500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078793|NCT02047500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078794|NCT02047500|Immunologic Factors|immunologic factors|mesh-ancestor
2078795|NCT02047500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078796|NCT02047734|Interferons|interferons|mesh-list
608782|NCT03467178|Gemcitabine|gemcitabine|mesh-list
608783|NCT03467178|Paclitaxel|paclitaxel|mesh-list
608784|NCT03467178|Carboplatin|carboplatin|mesh-list
608785|NCT03467178|Doxorubicin|doxorubicin|mesh-list
608786|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
608787|NCT03467178|Decitabine|decitabine|mesh-list
608788|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
608789|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608790|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
608791|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
608792|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
608793|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608794|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
608795|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
608796|NCT03467178|Antiviral Agents|antiviral agents|mesh-ancestor
608797|NCT03467178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
608798|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608799|NCT03467178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078797|NCT02047734|Interferon-beta|interferon-beta|mesh-list
2078798|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
2078799|NCT02047734|Ozanimod|ozanimod|mesh-list
608800|NCT03467178|Immunologic Factors|immunologic factors|mesh-ancestor
608801|NCT03467178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608802|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
608803|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
608804|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
608805|NCT03467113|Cannabidiol|cannabidiol|mesh-list
608806|NCT03467113|Anticonvulsants|anticonvulsants|mesh-ancestor
608807|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
608808|NCT03467022|Vitamins|vitamins|mesh-ancestor
608809|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
608810|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608811|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
608812|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608813|NCT03467022|Protective Agents|protective agents|mesh-ancestor
608814|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
608815|NCT03466983|Hematinics|hematinics|mesh-ancestor
608816|NCT03466801|Prednisone|prednisone|mesh-list
608817|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
608818|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
608819|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
608820|NCT03466801|Hormones|hormones|mesh-ancestor
608821|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
608822|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608823|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
608824|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608825|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
608826|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
608827|NCT03466775|Giapreza|giapreza|mesh-list
608828|NCT03466775|Antibodies|antibodies|mesh-list
608829|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
608830|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
608831|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608832|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
608833|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
608834|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
608835|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608836|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608837|NCT03466749|Paclitaxel|paclitaxel|mesh-list
608838|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
608839|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608840|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
608841|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
608842|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
608843|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608844|NCT03466736|Flutemetamol|flutemetamol|mesh-list
608845|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
608846|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217247|NCT00030745|Immunologic Factors|immunologic factors|mesh-ancestor
2217248|NCT00030745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608849|NCT03466645|Vancomycin|vancomycin|mesh-list
608850|NCT03466645|Cefazolin|cefazolin|mesh-list
608851|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
608852|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
608853|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
608854|NCT03466632|Propofol|propofol|mesh-list
608855|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
608856|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
608857|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608858|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
608859|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
608860|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
608861|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
608862|NCT03466632|Analgesics|analgesics|mesh-ancestor
608863|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
608864|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608865|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
608866|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
608867|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
608868|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
608869|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608870|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608871|NCT03466567|Cyclosporine|cyclosporine|mesh-list
608872|NCT03466567|Probenecid|probenecid|mesh-list
608873|NCT03466567|Cyclosporins|cyclosporins|mesh-list
608874|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608875|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608876|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
608877|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
608878|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608879|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
608880|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
608881|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
608882|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
608883|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
608884|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
608885|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
608886|NCT03466567|Renal Agents|renal agents|mesh-ancestor
608887|NCT03466528|Thiamine|thiamine|mesh-list
608888|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
608889|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
608890|NCT03466528|Vitamins|vitamins|mesh-ancestor
608891|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
608892|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608893|NCT03466528|Analgesics|analgesics|mesh-ancestor
608894|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
608895|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608896|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
608897|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
608898|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
608899|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
608900|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
608901|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
608902|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608903|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
608904|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
608905|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
608906|NCT03466502|Vancomycin|vancomycin|mesh-list
608907|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
608908|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
608909|NCT03466450|Temozolomide|temozolomide|mesh-list
608910|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
608911|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
608912|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608913|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608914|NCT03466437|Methamphetamine|methamphetamine|mesh-list
608915|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
608916|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608917|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
608918|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
608919|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608920|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
608921|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608922|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608923|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
608924|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
608925|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
608926|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
608927|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
608933|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
608934|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608935|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078800|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078801|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
2078802|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078803|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
2078804|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078805|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2078806|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2078807|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078808|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078809|NCT02047903|Afatinib|afatinib|mesh-list
2078810|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078811|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2078812|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078813|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608950|NCT03466333|Enalapril|enalapril|mesh-list
2078814|NCT02047981|Azithromycin|azithromycin|mesh-list
608951|NCT03466333|Enalaprilat|enalaprilat|mesh-list
608952|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
608953|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608954|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
608955|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
608956|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
608957|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
608958|NCT03466320|Fludarabine|fludarabine|mesh-list
608959|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
608960|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
608961|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608962|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
608963|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
608964|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
608965|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608966|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
608967|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2078815|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2078816|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078817|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2078818|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2078819|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078820|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078821|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
608975|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
608976|NCT03466242|Ketamine|ketamine|mesh-list
608977|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
608978|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
608979|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
608980|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
608981|NCT03466242|Analgesics|analgesics|mesh-ancestor
608982|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
608983|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
608984|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
608985|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
608986|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
608987|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
608988|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
608989|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
608990|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
608991|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
608992|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
608993|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
608994|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
608995|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
608996|NCT03466216|Octreotide|octreotide|mesh-list
608997|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
608998|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
608999|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078822|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078823|NCT02048241|Guanfacine|guanfacine|mesh-list
2078824|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2078825|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2078826|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2078827|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2078828|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
2078829|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2217249|NCT00030758|Lenograstim|lenograstim|mesh-list
2217250|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2217251|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
609011|NCT03466021|Liraglutide|liraglutide|mesh-list
609012|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
609013|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609014|NCT03466021|Incretins|incretins|mesh-ancestor
609015|NCT03466021|Hormones|hormones|mesh-ancestor
609016|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
609017|NCT03465969|Tacrolimus|tacrolimus|mesh-list
609018|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
609019|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
609020|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609021|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
609022|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609023|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217252|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217253|NCT00030784|Doxorubicin|doxorubicin|mesh-list
2217254|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
609029|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
609030|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
609031|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
609032|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
609033|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
609034|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
609035|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
609036|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609037|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
609038|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
609039|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
609040|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
609041|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
609042|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609043|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
609044|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
609045|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
609046|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
609047|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
609048|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
609049|NCT03465774|Doxycycline|doxycycline|mesh-list
609050|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
609051|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
609052|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
609053|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
609054|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2217255|NCT00030784|Ifosfamide|ifosfamide|mesh-list
2217256|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2217257|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217258|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2217259|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2217260|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217261|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217262|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2217263|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
2217264|NCT00030797|Irinotecan|irinotecan|mesh-list
2217265|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2217266|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2217267|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217268|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609072|NCT03465592|Nivolumab|nivolumab|mesh-list
609073|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
609074|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609075|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
609076|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609077|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
609078|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
609079|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609097|NCT03465527|Prednisolone|prednisolone|mesh-list
609098|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
609099|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
609100|NCT03465527|Hormones|hormones|mesh-ancestor
609101|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
609404|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
609102|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609103|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
609104|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609105|NCT03465488|Albendazole|albendazole|mesh-list
609106|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
609107|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
609108|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
609109|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
609110|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
609111|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
609112|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
609113|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
609114|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
609115|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609116|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217269|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217270|NCT00030810|Docetaxel|docetaxel|mesh-list
2217271|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217272|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217273|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217274|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217275|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217276|NCT00030849|Interferons|interferons|mesh-list
2217277|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
2217278|NCT00030849|Bexarotene|bexarotene|mesh-list
2217279|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217280|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
2217281|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
609130|NCT03465423|Propofol|propofol|mesh-list
609131|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
609132|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
609133|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609134|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
609135|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
609136|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
609137|NCT03465410|Tacrolimus|tacrolimus|mesh-list
609138|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
609139|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
609140|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609141|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
609142|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609143|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609144|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
609145|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
609146|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609147|NCT03465345|Metformin|metformin|mesh-list
609148|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
609149|NCT03465345|Procyanidin|procyanidin|mesh-list
609150|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
609151|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609152|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
609153|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609154|NCT03465345|Protective Agents|protective agents|mesh-ancestor
609155|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
609156|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
609157|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217282|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
609213|NCT03465202|Capecitabine|capecitabine|mesh-list
609214|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
609215|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
609216|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609217|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609226|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
609227|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
609228|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609229|NCT03465085|Heparin|heparin|mesh-list
609230|NCT03465085|Calcium heparin|calcium heparin|mesh-list
609231|NCT03465085|Streptokinase|streptokinase|mesh-list
609232|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
609233|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
609234|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
609235|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609236|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
609237|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609238|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
609239|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609240|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609241|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
609242|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
609243|NCT03464968|Leucovorin|leucovorin|mesh-list
609244|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
609245|NCT03464968|Irinotecan|irinotecan|mesh-list
609246|NCT03464968|Fluorouracil|fluorouracil|mesh-list
609247|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
609248|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609249|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
609250|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
609251|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609252|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609253|NCT03464968|Antidotes|antidotes|mesh-ancestor
609254|NCT03464968|Protective Agents|protective agents|mesh-ancestor
609255|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609256|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
609257|NCT03464968|Vitamins|vitamins|mesh-ancestor
609258|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
609259|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
609260|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
609261|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
609262|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
609263|NCT03464942|Atezolizumab|atezolizumab|mesh-list
609264|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609265|NCT03464864|Treprostinil|treprostinil|mesh-list
609266|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
609267|NCT03464734|Paclitaxel|paclitaxel|mesh-list
609268|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
609269|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
609270|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
609271|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609272|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
609273|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
609274|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
609275|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609276|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
609277|NCT03464682|Atorvastatin|atorvastatin|mesh-list
609278|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
609279|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
609280|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
609281|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609282|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
609283|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
609284|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609285|NCT03464656|Antioxidants|antioxidants|mesh-list
609286|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609287|NCT03464656|Protective Agents|protective agents|mesh-ancestor
609288|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609289|NCT03464552|Celecoxib|celecoxib|mesh-list
609290|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
609291|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
609292|NCT03464552|Analgesics|analgesics|mesh-ancestor
609293|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
609294|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609295|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609296|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
609297|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
609298|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
609299|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
609300|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609301|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609302|NCT03464539|Chitosan|chitosan|mesh-list
609303|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
609304|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
609305|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
609306|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609307|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
609308|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
609309|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
609310|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
609311|NCT03464539|Coagulants|coagulants|mesh-ancestor
609312|NCT03464461|Ketorolac|ketorolac|mesh-list
609313|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
609314|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
609315|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
609316|NCT03464461|Analgesics|analgesics|mesh-ancestor
609317|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
609318|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609319|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609320|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
609321|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
609322|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
609323|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609324|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609325|NCT03464448|Teriflunomide|teriflunomide|mesh-list
609326|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
609327|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
609328|NCT03464448|Analgesics|analgesics|mesh-ancestor
609329|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
609330|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609331|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609332|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
609333|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
609334|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
609335|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
609336|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
609337|NCT03464435|Tobramycin|tobramycin|mesh-list
609338|NCT03464435|Tacrolimus|tacrolimus|mesh-list
609339|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
609340|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
609341|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609342|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
609343|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609344|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609345|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
609346|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
609347|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2217283|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217284|NCT00030862|Irinotecan|irinotecan|mesh-list
2217285|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217286|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2217287|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2217288|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217289|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217290|NCT00030875|Bortezomib|bortezomib|mesh-list
2217291|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217292|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2217293|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609359|NCT03464305|Aspirin|aspirin|mesh-list
609360|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
609361|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
609362|NCT03464305|Analgesics|analgesics|mesh-ancestor
609363|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
609364|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609365|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609366|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
609367|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
609368|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
609369|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
609370|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609371|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
609372|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
609373|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609374|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
609375|NCT03464292|Capsaicin|capsaicin|mesh-list
609376|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
609377|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
609378|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
609379|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609380|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609381|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
609382|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
609383|NCT03464266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
609384|NCT03464266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
609385|NCT03464266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
609386|NCT03464266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609387|NCT03464266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609388|NCT03464266|Antiviral Agents|antiviral agents|mesh-ancestor
609389|NCT03464266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
609390|NCT03464266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
609391|NCT03464266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2078830|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078831|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078832|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2078833|NCT02048891|Progesterone|progesterone|mesh-list
2078834|NCT02048891|Progestins|progestins|mesh-ancestor
2078835|NCT02048891|Hormones|hormones|mesh-ancestor
609403|NCT03464084|Melatonin|melatonin|mesh-list
2217294|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
609405|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609406|NCT03464084|Protective Agents|protective agents|mesh-ancestor
609407|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609408|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
609409|NCT03464058|Rabeprazole|rabeprazole|mesh-list
609410|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
609411|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
609412|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
609413|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609414|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078836|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2078837|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078838|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
2078839|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2078840|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
2078841|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2078842|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2217295|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609423|NCT03464019|Etripamil|etripamil|mesh-list
609424|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
609425|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
609426|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609427|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
609428|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609429|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
609430|NCT03463993|Oxytocin|oxytocin|mesh-list
609431|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
609432|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
609433|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609434|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
609435|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
609436|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609437|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
609438|NCT03463993|Coagulants|coagulants|mesh-ancestor
609439|NCT03463967|Lycopene|lycopene|mesh-list
609440|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
609441|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
609442|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609443|NCT03463967|Protective Agents|protective agents|mesh-ancestor
609444|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609445|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
609446|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
609447|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217296|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217297|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2217298|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2217299|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
2217300|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2217301|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2217302|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2217303|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217304|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2217305|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217306|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2217307|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
2217308|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2217309|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2217310|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2217311|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2217312|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
2217313|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
609469|NCT03463876|Apatinib|apatinib|mesh-list
609470|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609471|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
609472|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609473|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609474|NCT03463733|Temozolomide|temozolomide|mesh-list
609475|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
609476|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
609477|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
609630|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
609478|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609479|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609480|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
609481|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609482|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
609483|NCT03463642|Vitamin D|vitamin d|mesh-list
609484|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
609485|NCT03463642|Mineral Oil|mineral oil|mesh-list
609486|NCT03463642|Vitamins|vitamins|mesh-ancestor
609487|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
609488|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609489|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
609490|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
609491|NCT03463642|Emollients|emollients|mesh-ancestor
609492|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
609493|NCT03463577|Vaccines|vaccines|mesh-list
609494|NCT03463577|Immunologic Factors|immunologic factors|mesh-ancestor
609495|NCT03463577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609496|NCT03463564|Insulin|insulin|mesh-list
609497|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
609498|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
609499|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609500|NCT03463525|Osimertinib|osimertinib|mesh-list
609501|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609502|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
609503|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609504|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217314|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2217315|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2217316|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2217317|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2217318|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217319|NCT00030966|Natalizumab|natalizumab|mesh-list
609511|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
609512|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
609513|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
609514|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609515|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
609516|NCT03463499|Protective Agents|protective agents|mesh-ancestor
609517|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
609518|NCT03463460|Sunitinib|sunitinib|mesh-list
609519|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
609520|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609521|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
609522|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
609523|NCT03463460|Growth Substances|growth substances|mesh-ancestor
609524|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609525|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
609526|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
609527|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609528|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078843|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2078844|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078845|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
2078846|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078847|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
2078848|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609535|NCT03463382|Bupivacaine|bupivacaine|mesh-list
609536|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
609537|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
609538|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
609539|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609540|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
609541|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609542|NCT03463317|Aspirin|aspirin|mesh-list
609543|NCT03463317|Warfarin|warfarin|mesh-list
609544|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
609545|NCT03463317|Dabigatran|dabigatran|mesh-list
609546|NCT03463317|Apixaban|apixaban|mesh-list
609547|NCT03463317|Edoxaban|edoxaban|mesh-list
609548|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
609549|NCT03463317|Clopidogrel|clopidogrel|mesh-list
609550|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
609551|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
609552|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
609553|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
609554|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
609555|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
609556|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609557|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609558|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
609559|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
609560|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
609561|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
609562|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
609563|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609564|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
609565|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
609566|NCT03463317|Analgesics|analgesics|mesh-ancestor
609567|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
609568|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609569|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
609570|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
609571|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
609572|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
609573|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
609574|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
609575|NCT03463265|Sirolimus|sirolimus|mesh-list
609576|NCT03463265|Bevacizumab|bevacizumab|mesh-list
609577|NCT03463265|Temozolomide|temozolomide|mesh-list
609578|NCT03463265|Lomustine|lomustine|mesh-list
609579|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
609580|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609581|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
609582|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
609583|NCT03463265|Growth Substances|growth substances|mesh-ancestor
609584|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609585|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
609586|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
609587|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
609588|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609589|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
609590|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
609591|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
609592|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
609593|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
609594|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
609595|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
609596|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
609597|NCT03463252|Progesterone|progesterone|mesh-list
609598|NCT03463252|Progestins|progestins|mesh-ancestor
609599|NCT03463252|Hormones|hormones|mesh-ancestor
609600|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
609601|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609602|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
609603|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
609604|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
609605|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
609606|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
609607|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
609608|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
609609|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
609610|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
609611|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217320|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
2217321|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217322|NCT00030979|Donepezil|donepezil|mesh-list
609615|NCT03463083|Fentanyl|fentanyl|mesh-list
609616|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
609617|NCT03463083|Bupivacaine|bupivacaine|mesh-list
609618|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
609619|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
609620|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
609621|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609622|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
609623|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609624|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
609625|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
609626|NCT03463083|Analgesics|analgesics|mesh-ancestor
609627|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
609628|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
609629|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
609631|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
609632|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609633|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
609634|NCT03463083|Narcotics|narcotics|mesh-ancestor
609635|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
609636|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
609637|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
609638|NCT03463070|Misoprostol|misoprostol|mesh-list
609639|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
609640|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
609641|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
609642|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609643|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
609644|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
609645|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
609648|NCT03463044|Nangibotide|nangibotide|mesh-list
609649|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
609650|NCT03463005|Propolis|propolis|mesh-list
609651|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078849|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2078850|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2078851|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
2078852|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609656|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
609657|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
609658|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
609659|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
609660|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
609661|NCT03462836|Lidocaine|lidocaine|mesh-list
609662|NCT03462836|Ketamine|ketamine|mesh-list
609663|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
609664|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
609665|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
609666|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609667|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
609668|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609669|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
609670|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
609671|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
609672|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
609673|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609674|NCT03462836|Analgesics|analgesics|mesh-ancestor
609675|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
609676|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
609677|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
609678|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
609679|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
609680|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
609681|NCT03462810|Cabotegravir|cabotegravir|mesh-list
609682|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
609683|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
609684|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609685|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609686|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
609687|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
609688|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
609689|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078853|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078854|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2078855|NCT02049307|Losartan|losartan|mesh-list
2078856|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2078857|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2078858|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2078859|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2078860|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078861|NCT02049385|Diazoxide|diazoxide|mesh-list
2078862|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2078863|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
2078864|NCT02049476|Dexamethasone|dexamethasone|mesh-list
2078865|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2078866|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
2078867|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
2078868|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609708|NCT03462641|Flumazenil|flumazenil|mesh-list
609709|NCT03462641|Antidotes|antidotes|mesh-ancestor
609710|NCT03462641|Protective Agents|protective agents|mesh-ancestor
609711|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609712|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
609713|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
609714|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
609715|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609719|NCT03462446|Vitamin K|vitamin k|mesh-list
609720|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
609721|NCT03462446|Vitamins|vitamins|mesh-ancestor
609722|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
609723|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609724|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
609725|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
609726|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
609727|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
609728|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609729|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609730|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
609731|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
609732|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
609733|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
609734|NCT03462446|Coagulants|coagulants|mesh-ancestor
609735|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
609736|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
609742|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
609743|NCT03462329|Doxycycline|doxycycline|mesh-list
609744|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
609745|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
609746|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
609747|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2751108|NCT04060758|Latanoprost|latanoprost|mesh-list
2751109|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2751110|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2078869|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078870|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2078871|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
2078872|NCT02049476|Hormones|hormones|mesh-ancestor
2078873|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2078874|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2078875|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078876|NCT02049814|Metformin|metformin|mesh-list
2078877|NCT02049814|Acarbose|acarbose|mesh-list
2078878|NCT02049814|Voglibose|voglibose|mesh-list
2078879|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2078880|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078881|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2078882|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078883|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078884|NCT02049866|Denosumab|denosumab|mesh-list
2078885|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2078886|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078887|NCT02049944|Cefazolin|cefazolin|mesh-list
2078888|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2078889|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078890|NCT02049957|Fulvestrant|fulvestrant|mesh-list
2078891|NCT02049957|Exemestane|exemestane|mesh-list
2078892|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2078893|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078894|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2751260|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2078895|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
609785|NCT03462212|Paclitaxel|paclitaxel|mesh-list
609786|NCT03462212|Bevacizumab|bevacizumab|mesh-list
609787|NCT03462212|Carboplatin|carboplatin|mesh-list
609788|NCT03462212|Rucaparib|rucaparib|mesh-list
609789|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
609790|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609791|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
609792|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
609793|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
609794|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609795|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
609796|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
609797|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
609798|NCT03462212|Growth Substances|growth substances|mesh-ancestor
609799|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609800|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
609801|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
609802|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609803|NCT03462173|Yimitasvir|yimitasvir|mesh-list
609804|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
609805|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
609806|NCT03462069|Empagliflozin|empagliflozin|mesh-list
609807|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
609808|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
609809|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609810|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
609811|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609812|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
609813|NCT03462017|Acetylcholine|acetylcholine|mesh-list
609814|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
609815|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
609816|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
609817|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609818|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609819|NCT03462017|Urological Agents|urological agents|mesh-ancestor
609820|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
609821|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
609822|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
609823|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078896|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
2078897|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2078898|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078899|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2078900|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
609830|NCT03461783|Charcoal|charcoal|mesh-list
609831|NCT03461783|Antidotes|antidotes|mesh-ancestor
609832|NCT03461783|Protective Agents|protective agents|mesh-ancestor
609833|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609834|NCT03461718|Fentanyl|fentanyl|mesh-list
609835|NCT03461718|Midazolam|midazolam|mesh-list
609836|NCT03461718|Ketamine|ketamine|mesh-list
609837|NCT03461718|Analgesics|analgesics|mesh-ancestor
609838|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
609839|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609840|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609841|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
609842|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
609843|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
609844|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
609845|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
609846|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
609847|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
609848|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
609849|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609850|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
609851|NCT03461718|Narcotics|narcotics|mesh-ancestor
609852|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
609853|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
609854|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
609855|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
609856|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
609857|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
609858|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
609859|NCT03461627|Fluticasone|fluticasone|mesh-list
609860|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
609861|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
609862|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
609863|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
609864|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
609865|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609866|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609867|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
609868|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
609869|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
609870|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
609871|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
609872|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
609873|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
609874|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
609875|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
609876|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609877|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
609878|NCT03461627|Hormones|hormones|mesh-ancestor
609879|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
609880|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
609881|NCT03461575|Cyclosporine|cyclosporine|mesh-list
609882|NCT03461575|Cyclosporins|cyclosporins|mesh-list
609883|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609884|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609885|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
609886|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
609887|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609888|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
609889|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
609890|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
609891|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
609892|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
609893|NCT03461445|Tacrolimus|tacrolimus|mesh-list
609894|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
609895|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
609896|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609897|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
609898|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609899|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078901|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078902|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609903|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
609904|NCT03461328|Analgesics|analgesics|mesh-ancestor
609905|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
609906|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609907|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609908|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
609909|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
609910|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
609911|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
609912|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
609913|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
609914|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609915|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
609916|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
609917|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
609918|NCT03461302|Coal Tar|coal tar|mesh-list
609919|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
609920|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
609921|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
609922|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
609923|NCT03461185|Growth Substances|growth substances|mesh-ancestor
609924|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609925|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
609926|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
609933|NCT03461081|Amlodipine|amlodipine|mesh-list
609934|NCT03461081|Telmisartan|telmisartan|mesh-list
609935|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
609936|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
609937|NCT03461081|Atorvastatin|atorvastatin|mesh-list
609938|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
609939|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
609940|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
609941|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609942|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
609943|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
609944|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609945|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
609946|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
609947|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
609948|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
609949|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609950|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
609951|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
609952|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
609953|NCT03461003|Losartan|losartan|mesh-list
609954|NCT03461003|Amlodipine|amlodipine|mesh-list
609955|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
609956|NCT03461003|Lisinopril|lisinopril|mesh-list
609957|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
609958|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
609959|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
609960|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609961|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
609962|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609963|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
609964|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
609965|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
609966|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
609967|NCT03461003|Diuretics|diuretics|mesh-ancestor
609968|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
609969|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
609970|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
609971|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
609972|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
609973|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
609974|NCT03461003|Protective Agents|protective agents|mesh-ancestor
2217323|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2217324|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217325|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217326|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
2217327|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
609980|NCT03460964|Pilocarpine|pilocarpine|mesh-list
609981|NCT03460964|Miotics|miotics|mesh-ancestor
609982|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
609983|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
609984|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
609985|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
609986|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
609987|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
609988|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
609989|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217328|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217329|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
609992|NCT03460860|Tocopherols|tocopherols|mesh-list
609993|NCT03460860|Vitamin E|vitamin e|mesh-list
609994|NCT03460860|Tocotrienols|tocotrienols|mesh-list
609995|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
609996|NCT03460860|Lycopene|lycopene|mesh-list
609997|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
609998|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
609999|NCT03460860|Protective Agents|protective agents|mesh-ancestor
610000|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610001|NCT03460860|Vitamins|vitamins|mesh-ancestor
610002|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
610003|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
610004|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
610005|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
610006|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610007|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
610008|NCT03460808|Atorvastatin|atorvastatin|mesh-list
610009|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
610010|NCT03460808|Danazol|danazol|mesh-list
610011|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
610012|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
610013|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
610014|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610015|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
610016|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
610017|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610018|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
610019|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
610020|NCT03460808|Expectorants|expectorants|mesh-ancestor
610021|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
610022|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
610023|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
610024|NCT03460808|Protective Agents|protective agents|mesh-ancestor
610025|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610026|NCT03460808|Antidotes|antidotes|mesh-ancestor
610027|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
610028|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
610029|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
610030|NCT03460782|Ipilimumab|ipilimumab|mesh-list
610031|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
610032|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610033|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
610034|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610035|NCT03460756|Ganaxolone|ganaxolone|mesh-list
610036|NCT03460756|Neurosteroids|neurosteroids|mesh-ancestor
610037|NCT03460756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610038|NCT03460756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610039|NCT03460756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610040|NCT03460756|GABA Modulators|gaba modulators|mesh-ancestor
610041|NCT03460756|GABA Agents|gaba agents|mesh-ancestor
610042|NCT03460743|Vaccines|vaccines|mesh-list
610043|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
610044|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
610045|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610046|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
610047|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
610048|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
610049|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610050|NCT03460678|Pemetrexed|pemetrexed|mesh-list
610051|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
610052|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610053|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610054|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610055|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
610056|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
610057|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
610058|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
610059|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
610060|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610061|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
610062|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
610063|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
610064|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
610065|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
610066|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610067|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610068|NCT03460470|Urological Agents|urological agents|mesh-ancestor
610069|NCT03460405|Vaccines|vaccines|mesh-list
610070|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
610071|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610072|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
610073|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
610074|NCT03460379|Citalopram|citalopram|mesh-list
610075|NCT03460379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
610076|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
610077|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
610078|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610079|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610080|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
610081|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610082|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
610083|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
610084|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
610085|NCT03460366|Enalapril|enalapril|mesh-list
610086|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
610087|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
610088|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610089|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610090|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
610091|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
610092|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
610093|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610094|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
610095|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
610096|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
610097|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610098|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
610099|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610100|NCT03460327|Candesartan|candesartan|mesh-list
610101|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
610102|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
610103|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
610104|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610105|NCT03460314|Buprenorphine|buprenorphine|mesh-list
610106|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
610107|NCT03460314|Narcotics|narcotics|mesh-ancestor
610108|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
610109|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610110|NCT03460314|Analgesics|analgesics|mesh-ancestor
610111|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
610112|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610113|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
610114|NCT03460275|Osimertinib|osimertinib|mesh-list
610115|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610116|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
610117|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610118|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610119|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
610120|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
610121|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
610122|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
610123|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610124|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
610125|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610126|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751125|NCT04058990|Paclitaxel|paclitaxel|mesh-list
2751126|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2751127|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2078914|NCT02050321|Vemurafenib|vemurafenib|mesh-list
2078915|NCT02050321|Acitretin|acitretin|mesh-list
610133|NCT03460145|Propofol|propofol|mesh-list
610134|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
610135|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
610136|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610137|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
610138|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
610139|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
610140|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
610141|NCT03460041|Bupivacaine|bupivacaine|mesh-list
610142|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
610143|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
610144|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
610145|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610146|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
610147|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610148|NCT03460041|Analgesics|analgesics|mesh-ancestor
610149|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
610150|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
610151|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
610152|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
610153|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610154|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
610155|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
610156|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
610167|NCT03460002|Vaccines|vaccines|mesh-list
610168|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
610169|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610170|NCT03459911|Losartan|losartan|mesh-list
610171|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
610172|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
610173|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
610174|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
610175|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078916|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2078917|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2078918|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078919|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078920|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
2078921|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
2078922|NCT02050334|Caffeic acid|caffeic acid|mesh-list
610195|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
610196|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
610197|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
610198|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610199|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
610200|NCT03459833|Protective Agents|protective agents|mesh-ancestor
610201|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
2217330|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
2217331|NCT00031018|Donepezil|donepezil|mesh-list
2217332|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2217333|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217334|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217335|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
2217336|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2217337|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217338|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
2217339|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
2217340|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217341|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217342|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
2217343|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2217344|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2217345|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217346|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2217347|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2217348|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
2217349|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217350|NCT00031057|Riboflavin|riboflavin|mesh-list
2217351|NCT00031057|Thiamine|thiamine|mesh-list
2217352|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
2217353|NCT00031057|Vitamins|vitamins|mesh-ancestor
2217354|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
2217355|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751261|NCT03991403|Growth Substances|growth substances|mesh-ancestor
610229|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
610230|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
610231|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078923|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
610232|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
610233|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610234|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610235|NCT03459417|Morphine|morphine|mesh-list
610236|NCT03459417|Sulpiride|sulpiride|mesh-list
610237|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
610238|NCT03459417|Narcotics|narcotics|mesh-ancestor
610239|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
610240|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610241|NCT03459417|Analgesics|analgesics|mesh-ancestor
610242|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
610243|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610244|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
610245|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
610246|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
610247|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
610248|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
610249|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610250|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610251|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
610252|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
610253|NCT03459404|Sufentanil|sufentanil|mesh-list
610254|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
610255|NCT03459404|Narcotics|narcotics|mesh-ancestor
610256|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
610257|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610258|NCT03459404|Analgesics|analgesics|mesh-ancestor
610259|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
610260|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610261|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
610262|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
610263|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
610264|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
610265|NCT03459248|Anesthetics|anesthetics|mesh-list
610266|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
610267|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078924|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078925|NCT02050334|Protective Agents|protective agents|mesh-ancestor
2078926|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078927|NCT02050919|Sorafenib|sorafenib|mesh-list
2078928|NCT02050919|Ifosfamide|ifosfamide|mesh-list
2078929|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
2078930|NCT02050919|Epirubicin|epirubicin|mesh-list
2078931|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610276|NCT03459144|Ranibizumab|ranibizumab|mesh-list
610277|NCT03459144|Verteporfin|verteporfin|mesh-list
610278|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
610279|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
610280|NCT03459144|Growth Substances|growth substances|mesh-ancestor
610281|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610282|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
610283|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610284|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
610285|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
610286|NCT03459105|Bupivacaine|bupivacaine|mesh-list
610287|NCT03459105|Anesthetics|anesthetics|mesh-list
610288|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
610289|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
610290|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610291|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
610292|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610293|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
610294|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
610295|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
610296|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
610297|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
610298|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610299|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
610300|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610301|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610302|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
610303|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2217356|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2217357|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
2217358|NCT00031070|Cyclosporine|cyclosporine|mesh-list
2217359|NCT00031070|Lamivudine|lamivudine|mesh-list
2217360|NCT00031070|Zidovudine|zidovudine|mesh-list
2217361|NCT00031070|Efavirenz|efavirenz|mesh-list
2217362|NCT00031070|Abacavir|abacavir|mesh-list
2217363|NCT00031070|Vaccines|vaccines|mesh-list
610311|NCT03458923|Diclofenac|diclofenac|mesh-list
610312|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
610313|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
610314|NCT03458923|Ranibizumab|ranibizumab|mesh-list
610315|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
610316|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
610317|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
610318|NCT03458923|Growth Substances|growth substances|mesh-ancestor
610319|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610320|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
610321|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610322|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610323|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
610324|NCT03458923|Analgesics|analgesics|mesh-ancestor
610325|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
610326|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610327|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
610328|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
610329|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610330|NCT03458715|Empagliflozin|empagliflozin|mesh-list
610331|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
610332|NCT03458715|Linagliptin|linagliptin|mesh-list
610333|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
610334|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610335|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
610336|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610337|NCT03458715|Incretins|incretins|mesh-ancestor
610338|NCT03458715|Hormones|hormones|mesh-ancestor
610339|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
610340|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
610341|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610342|NCT03458689|Analgesics|analgesics|mesh-list
610343|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
610344|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610345|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610346|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
610347|NCT03458598|Narcotics|narcotics|mesh-ancestor
610348|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
610349|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610350|NCT03458598|Analgesics|analgesics|mesh-ancestor
610351|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
610352|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610353|NCT03458559|Etidronic Acid|etidronic acid|mesh-list
610354|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
610355|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610356|NCT03458559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
610357|NCT03458559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610358|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
610359|NCT03458481|Yimitasvir|yimitasvir|mesh-list
610360|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
610361|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
610362|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
610363|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
610364|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
610365|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610366|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
610367|NCT03458468|Coagulants|coagulants|mesh-ancestor
610368|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
610369|NCT03458455|Nivolumab|nivolumab|mesh-list
610370|NCT03458455|Ipilimumab|ipilimumab|mesh-list
610371|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
610372|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610373|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
610374|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610375|NCT03458429|Sargramostim|sargramostim|mesh-list
610376|NCT03458429|Lenograstim|lenograstim|mesh-list
610377|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
610378|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610379|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
610380|NCT03458416|Cannabidiol|cannabidiol|mesh-list
610381|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
610382|NCT03458260|Rituximab|rituximab|mesh-list
610383|NCT03458260|Etoposide|etoposide|mesh-list
610384|NCT03458260|Ifosfamide|ifosfamide|mesh-list
2217364|NCT00031070|Cyclosporins|cyclosporins|mesh-list
610385|NCT03458260|Pixantrone|pixantrone|mesh-list
610386|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
610387|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610388|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
610389|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610390|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
610391|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
610392|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
610393|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
610394|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610395|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610396|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
610397|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
610407|NCT03458221|Tamoxifen|tamoxifen|mesh-list
610408|NCT03458221|Itraconazole|itraconazole|mesh-list
610409|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
610410|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
610411|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
610412|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610413|NCT03458221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
610414|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610415|NCT03458221|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
610416|NCT03458221|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
610417|NCT03458221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
610418|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
610419|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
610420|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
610421|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
610422|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610423|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610424|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
610425|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
610426|NCT03458208|Metformin|metformin|mesh-list
610427|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
610428|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610429|NCT03458143|Ketamine|ketamine|mesh-list
610430|NCT03458143|Remifentanil|remifentanil|mesh-list
610431|NCT03458143|Analgesics|analgesics|mesh-ancestor
610432|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
610433|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610434|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610435|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
610436|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
610437|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
610438|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
610439|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
610440|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
610441|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
610442|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610443|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610444|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
610445|NCT03458143|Narcotics|narcotics|mesh-ancestor
610449|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
610450|NCT03458078|Midazolam|midazolam|mesh-list
610451|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
610452|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
610453|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
610454|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610455|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
610456|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
610457|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
610458|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
610459|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
610460|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
610461|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
610462|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
610463|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610464|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610465|NCT03458078|Analgesics|analgesics|mesh-ancestor
610466|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
610467|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610468|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
610469|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
610470|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
610471|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
610472|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
610473|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
610474|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2751128|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751129|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
2751130|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
2751131|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
2751132|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751133|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
610481|NCT03457896|Trastuzumab|trastuzumab|mesh-list
610482|NCT03457896|Cetuximab|cetuximab|mesh-list
610483|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
610484|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217365|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2217366|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
2217367|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610496|NCT03457753|Riluzole|riluzole|mesh-list
610497|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
610498|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
610499|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
610500|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610501|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610502|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610503|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
610504|NCT03457753|Protective Agents|protective agents|mesh-ancestor
2217368|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217369|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217370|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217371|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
2217372|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217373|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
2078932|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2078933|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217374|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217375|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2217376|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2217377|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2217378|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
2217379|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2217380|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2217381|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
2217382|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2217383|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2217384|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2217385|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2217386|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2217387|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2217388|NCT00031083|Interferons|interferons|mesh-list
2217389|NCT00031083|Interferon-beta|interferon-beta|mesh-list
2217390|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751134|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
610533|NCT03457597|Pioglitazone|pioglitazone|mesh-list
610534|NCT03457597|Tolbutamide|tolbutamide|mesh-list
610535|NCT03457597|Metoprolol|metoprolol|mesh-list
610536|NCT03457597|Midazolam|midazolam|mesh-list
610537|NCT03457597|Omeprazole|omeprazole|mesh-list
610538|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
610539|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
610540|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
610541|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610542|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
610543|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
610544|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
610545|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
610546|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
610547|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
610548|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
610549|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
610550|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610551|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610552|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
610553|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
610554|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
610555|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
610556|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610557|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
610558|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
610559|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
610560|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
610561|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610562|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
610563|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
610564|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
610565|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
610566|NCT03457467|Apatinib|apatinib|mesh-list
610567|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610568|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
610569|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610570|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610571|NCT03457389|Cabergoline|cabergoline|mesh-list
610572|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
610573|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
610574|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
610575|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
610576|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610577|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610578|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610579|NCT03457337|Gefitinib|gefitinib|mesh-list
610580|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610581|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
610582|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610583|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610584|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
610585|NCT03457233|Cetrorelix|cetrorelix|mesh-list
610586|NCT03457233|Menotropins|menotropins|mesh-list
610587|NCT03457233|Progesterone|progesterone|mesh-list
610588|NCT03457233|Progestins|progestins|mesh-ancestor
610589|NCT03457233|Hormones|hormones|mesh-ancestor
610590|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
610591|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610592|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
610593|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
610594|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
610595|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
610596|NCT03457194|Vaccines|vaccines|mesh-list
610597|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
610598|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610599|NCT03457142|Dexamethasone|dexamethasone|mesh-list
610600|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
610601|NCT03457142|Abatacept|abatacept|mesh-list
610602|NCT03457142|Ixazomib|ixazomib|mesh-list
610603|NCT03457142|Ichthammol|ichthammol|mesh-list
610604|NCT03457142|BB 1101|bb 1101|mesh-list
610605|NCT03457142|Glycine|glycine|mesh-list
610606|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
610607|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
610608|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
610609|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610610|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610611|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
610612|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
610613|NCT03457142|Hormones|hormones|mesh-ancestor
610614|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
610615|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
610616|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610617|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610618|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
610619|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610620|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
610621|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
610622|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
610623|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
610624|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
610625|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
610626|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610627|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
610628|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217391|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
2217392|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217393|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
2217394|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217395|NCT00031096|Azelaic acid|azelaic acid|mesh-list
2217396|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217397|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
2217398|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2217399|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2217400|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
2217401|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217402|NCT00031109|Antacids|antacids|mesh-ancestor
2217403|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217404|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2217405|NCT00031135|Choline|choline|mesh-list
2217406|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
610645|NCT03456947|Pregabalin|pregabalin|mesh-list
610646|NCT03456947|Analgesics|analgesics|mesh-ancestor
610647|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
610648|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610649|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610650|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
610651|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
610652|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
610653|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610654|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
610655|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
610656|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
610657|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
610658|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2078934|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078935|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2078936|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
2078937|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2078938|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2078939|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2078940|NCT02051296|Minocycline|minocycline|mesh-list
2078941|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2078942|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217407|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2751135|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
2751136|NCT04055116|Lidocaine|lidocaine|mesh-list
2751137|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
2751138|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
2751139|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2751140|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751141|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
2751142|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2751143|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2751144|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2751145|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2751146|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2751147|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610691|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
610692|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610693|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610694|NCT03456752|Dexamethasone|dexamethasone|mesh-list
610695|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
610696|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
610697|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
610698|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610699|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610700|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
610701|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
610702|NCT03456752|Hormones|hormones|mesh-ancestor
610703|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
610704|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
610705|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610706|NCT03456713|Mirikizumab|mirikizumab|mesh-list
610707|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
610708|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
610709|NCT03456713|Analgesics|analgesics|mesh-ancestor
610710|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
610711|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610712|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610713|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
610714|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
610715|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
610716|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2217408|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
2217409|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217410|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2217411|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2217412|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
2217413|NCT00031148|Mitogens|mitogens|mesh-list
2217414|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217415|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217416|NCT00031161|Nitisinone|nitisinone|mesh-list
2217417|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610728|NCT03456687|Exenatide|exenatide|mesh-list
610729|NCT03456687|Glucagon|glucagon|mesh-list
610730|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
610731|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
610732|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610733|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
610734|NCT03456687|Incretins|incretins|mesh-ancestor
610735|NCT03456687|Hormones|hormones|mesh-ancestor
610736|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
610737|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
610738|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
610739|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
610740|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
610741|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
610742|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610743|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
610744|NCT03456661|Analgesics|analgesics|mesh-ancestor
610745|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
610746|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610747|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
610748|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
610749|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
610750|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
610751|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610752|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610753|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
610754|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
610755|NCT03456648|Apixaban|apixaban|mesh-list
610756|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
610757|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
610758|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
610759|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
610760|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610761|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610762|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
610765|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
610766|NCT03456570|Progestins|progestins|mesh-ancestor
610767|NCT03456570|Hormones|hormones|mesh-ancestor
610768|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
610769|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610770|NCT03456544|Vancomycin|vancomycin|mesh-list
610771|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
610772|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
610773|NCT03456531|Aspirin|aspirin|mesh-list
610774|NCT03456531|Analgesics|analgesics|mesh-list
610775|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
610776|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
610777|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
610778|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610779|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610780|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
610781|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
610782|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
610783|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
610784|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610785|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
610786|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
610787|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610788|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
610789|NCT03456466|Rituximab|rituximab|mesh-list
610790|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
610791|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610792|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
610793|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610794|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
610795|NCT03456401|Sorafenib|sorafenib|mesh-list
610796|NCT03456401|Sunitinib|sunitinib|mesh-list
610797|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610798|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
610799|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610800|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610801|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
610802|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
610803|NCT03456401|Growth Substances|growth substances|mesh-ancestor
610804|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610805|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
610806|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
610807|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
610808|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
610809|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
610810|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
610811|NCT03456102|Pravastatin|pravastatin|mesh-list
610812|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
610813|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
610814|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
610815|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610816|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
610817|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
610818|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078943|NCT02051335|Scopolamine|scopolamine|mesh-list
2078944|NCT02051335|Donepezil|donepezil|mesh-list
2078945|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2078946|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2078947|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078948|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078949|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
2078950|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078951|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078952|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
2078953|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2078954|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
2078955|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
2078956|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2078957|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2078958|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
2078959|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2078960|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2078961|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
2078962|NCT02051452|Methylphenidate|methylphenidate|mesh-list
2078963|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2078964|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078965|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2078966|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2078967|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2078968|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078969|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
2078970|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2078971|NCT02051595|Vancomycin|vancomycin|mesh-list
2078972|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2078973|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2078974|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
2078975|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2078976|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2078977|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078978|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
2078979|NCT02051686|Coagulants|coagulants|mesh-ancestor
2078980|NCT02052011|Ranolazine|ranolazine|mesh-list
2078981|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2078982|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2078983|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078984|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2751159|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
2751160|NCT04047628|Ofatumumab|ofatumumab|mesh-list
2751161|NCT04047628|Cladribine|cladribine|mesh-list
2217418|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217419|NCT00031187|Docetaxel|docetaxel|mesh-list
2217420|NCT00031187|Doxorubicin|doxorubicin|mesh-list
2217421|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
2217422|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217423|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217424|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217425|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217426|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217427|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2217428|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2078985|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2078986|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2078987|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
2078988|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078989|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
2078990|NCT02052310|Hematinics|hematinics|mesh-ancestor
2751162|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
610900|NCT03455426|Letrozole|letrozole|mesh-list
610901|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610902|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
610903|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
610904|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610905|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610906|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
610907|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
610908|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
610909|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610910|NCT03455322|Octreotide|octreotide|mesh-list
610911|NCT03455322|Norepinephrine|norepinephrine|mesh-list
610912|NCT03455322|Midodrine|midodrine|mesh-list
610913|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
610914|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
610915|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610916|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
610917|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
610918|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
610919|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610920|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610921|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610922|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
610923|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
610924|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610925|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
610926|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2217429|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2217430|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217431|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
2217432|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217433|NCT00031278|Trastuzumab|trastuzumab|mesh-list
2217434|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2217435|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217436|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
2217437|NCT00031291|Antibodies|antibodies|mesh-list
2217438|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
2217439|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2217440|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2217441|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
2217442|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217443|NCT00031317|Clozapine|clozapine|mesh-list
610947|NCT03455179|Methamphetamine|methamphetamine|mesh-list
610948|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
610949|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610950|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
610951|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
610952|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610953|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
610954|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610955|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610956|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
610957|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
610958|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
610959|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
610960|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
610961|NCT03455140|BCT-100|bct-100|mesh-list
610962|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
610963|NCT03455088|Fluoxetine|fluoxetine|mesh-list
610964|NCT03455088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
610965|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
610966|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
610967|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
610968|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
610969|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
610970|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610971|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
610972|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
610973|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
610974|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
610975|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
610976|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
610977|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
610978|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
610979|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
610980|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
610981|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610982|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
610983|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
610984|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
610985|NCT03455049|Andrographolide|andrographolide|mesh-list
610986|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
610987|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
610988|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2217444|NCT00031317|Paroxetine|paroxetine|mesh-list
2751163|NCT04047628|Natalizumab|natalizumab|mesh-list
610989|NCT03455049|Analgesics|analgesics|mesh-ancestor
610990|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
610991|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
610992|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
610993|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
610994|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
610995|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
610996|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
610997|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
610998|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
610999|NCT03454984|Guadecitabine|guadecitabine|mesh-list
611000|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611001|NCT03454945|Doxycycline|doxycycline|mesh-list
611002|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
611003|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611004|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
611005|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
611006|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
611007|NCT03454919|Palbociclib|palbociclib|mesh-list
611008|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611009|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
611010|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611011|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611012|NCT03454841|Ticagrelor|ticagrelor|mesh-list
611013|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
611014|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
611015|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
611016|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
611017|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
611018|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
611019|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611020|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611021|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611022|NCT03454789|Lidocaine|lidocaine|mesh-list
611023|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
611024|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
611025|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611026|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611027|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
611028|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611029|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
611030|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
611031|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
611032|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
611033|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611034|NCT03454724|Sirolimus|sirolimus|mesh-list
611035|NCT03454724|Everolimus|everolimus|mesh-list
611036|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611037|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
611038|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
611039|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611040|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
611041|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611042|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
611043|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
611044|NCT03454646|Rivastigmine|rivastigmine|mesh-list
611045|NCT03454646|Donepezil|donepezil|mesh-list
611046|NCT03454646|Galantamine|galantamine|mesh-list
611047|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
611048|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611049|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611050|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
611051|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611052|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611053|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
611054|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
611055|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
611056|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611057|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
611058|NCT03454646|Protective Agents|protective agents|mesh-ancestor
611059|NCT03454620|Irinotecan|irinotecan|mesh-list
611060|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
611061|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
611062|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611063|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611064|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611065|NCT03454529|Simvastatin|simvastatin|mesh-list
611066|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
611067|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
611068|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
611069|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611070|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
611071|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
611072|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611073|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
611074|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611075|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
611076|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611077|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611078|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
611079|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
611080|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611081|NCT03454217|Oxycodone|oxycodone|mesh-list
611082|NCT03454217|Tramadol|tramadol|mesh-list
611083|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
611084|NCT03454217|Narcotics|narcotics|mesh-ancestor
611085|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611086|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611087|NCT03454217|Analgesics|analgesics|mesh-ancestor
611088|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
611089|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2217445|NCT00031317|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2217446|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2217447|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2217448|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217449|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2217450|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
2217451|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217452|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2217453|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
2217454|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2217455|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2217456|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2217457|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217458|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2217459|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
611112|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
611113|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
611114|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
611115|NCT03453931|Hormones|hormones|mesh-ancestor
611116|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
611117|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611118|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
611119|NCT03453931|Protective Agents|protective agents|mesh-ancestor
611120|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
611121|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611122|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
611123|NCT03453892|Nivolumab|nivolumab|mesh-list
611124|NCT03453892|Ipilimumab|ipilimumab|mesh-list
611125|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
611126|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611127|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
611128|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611129|NCT03453840|Lumefantrine|lumefantrine|mesh-list
611130|NCT03453840|Artemether|artemether|mesh-list
611131|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
611132|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
611133|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
611134|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
611135|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611136|NCT03453723|Lidocaine|lidocaine|mesh-list
611137|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
611138|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
611139|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611140|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611141|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
611142|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611143|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
611144|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
611145|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
611146|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
611147|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611148|NCT03453684|Vancomycin|vancomycin|mesh-list
611149|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
611150|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611151|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
611152|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
611153|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
611154|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611155|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
611156|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611157|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611158|NCT03453541|Ketorolac|ketorolac|mesh-list
611159|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
611160|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
611161|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
611162|NCT03453541|Analgesics|analgesics|mesh-ancestor
611163|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
611164|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611165|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611166|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
611167|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
611168|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
611169|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611170|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611171|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
611172|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
611173|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611174|NCT03453489|Tryptophan|tryptophan|mesh-list
611175|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
611176|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
611177|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
611178|NCT03453346|Ribavirin|ribavirin|mesh-list
611179|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
611180|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
611181|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611182|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
611183|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611184|NCT03453281|Bevacizumab|bevacizumab|mesh-list
611185|NCT03453281|Aflibercept|aflibercept|mesh-list
611186|NCT03453281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
611187|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611188|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
611189|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
611190|NCT03453281|Growth Substances|growth substances|mesh-ancestor
611191|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611192|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
611193|NCT03453190|Apremilast|apremilast|mesh-list
611194|NCT03453190|Clobetasol|clobetasol|mesh-list
611195|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
611196|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
611197|NCT03453190|Analgesics|analgesics|mesh-ancestor
611198|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
611199|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611200|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611201|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
611202|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
611203|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
611204|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
611205|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611206|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611207|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
611208|NCT03453190|Hormones|hormones|mesh-ancestor
611209|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
611210|NCT03453177|Fosfomycin|fosfomycin|mesh-list
611211|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
611212|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611213|NCT03453164|Nivolumab|nivolumab|mesh-list
611214|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
611215|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611216|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
611217|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217460|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2217461|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2217462|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
2217463|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
2217464|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2217465|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
2217466|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217467|NCT00031395|Clonidine|clonidine|mesh-list
2217468|NCT00031395|Methylphenidate|methylphenidate|mesh-list
611227|NCT03452930|Benzimidazole|benzimidazole|mesh-list
611228|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
611229|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
611230|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611231|NCT03452891|Simvastatin|simvastatin|mesh-list
611232|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
611233|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
611234|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
611235|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611236|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
611237|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
611238|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2078991|NCT02052414|Gabapentin|gabapentin|mesh-list
2078992|NCT02052414|Analgesics|analgesics|mesh-ancestor
2078993|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
2078994|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611252|NCT03452722|Plasminogen|plasminogen|mesh-list
611253|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
611254|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
611255|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
611256|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611257|NCT03452696|Calcium|calcium|mesh-list
611258|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
611259|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611260|NCT03452657|Ranibizumab|ranibizumab|mesh-list
611261|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
611262|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
611263|NCT03452657|Growth Substances|growth substances|mesh-ancestor
611264|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611265|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
611266|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611267|NCT03452579|Bevacizumab|bevacizumab|mesh-list
611268|NCT03452579|Nivolumab|nivolumab|mesh-list
611269|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
611270|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611271|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
611272|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
611273|NCT03452579|Growth Substances|growth substances|mesh-ancestor
611274|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611275|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
611276|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
611277|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611278|NCT03452553|Doxorubicin|doxorubicin|mesh-list
611279|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
611280|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611281|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
611282|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
611283|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611284|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217469|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2217470|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217471|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2217472|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2217473|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2217474|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217475|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
2217476|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611294|NCT03452501|Infliximab|infliximab|mesh-list
611295|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
611296|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
611297|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
611298|NCT03452475|Lumefantrine|lumefantrine|mesh-list
611299|NCT03452475|Artemether|artemether|mesh-list
611300|NCT03452475|Piperaquine|piperaquine|mesh-list
611301|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
611302|NCT03452475|Mefloquine|mefloquine|mesh-list
611303|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
611304|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
611305|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
611306|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611307|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
611308|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
611309|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611310|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611311|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
611312|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
611313|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611314|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
611315|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611316|NCT03452332|Durvalumab|durvalumab|mesh-list
611317|NCT03452332|Ipilimumab|ipilimumab|mesh-list
611318|NCT03452332|Tremelimumab|tremelimumab|mesh-list
611319|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
611320|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
611321|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
611322|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
611323|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611324|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
611325|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611326|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
611327|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611328|NCT03452306|Metformin|metformin|mesh-list
611329|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
611330|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611331|NCT03452267|Metformin|metformin|mesh-list
611332|NCT03452267|Pioglitazone|pioglitazone|mesh-list
611333|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
611334|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217477|NCT00031395|Analgesics|analgesics|mesh-ancestor
2217478|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
2078995|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2078996|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
611362|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
611363|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
611364|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611365|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
611366|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
611367|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
611368|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
611369|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2078997|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2078998|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2078999|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079000|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2079001|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2079002|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2079003|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079004|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079005|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
2079006|NCT02052440|Baclofen|baclofen|mesh-list
2079007|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2079008|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217479|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2751164|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2751165|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751166|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
2751167|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751168|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2751169|NCT04047251|Topotecan|topotecan|mesh-list
2751170|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2751171|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2751172|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751173|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751174|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217480|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2217481|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
2217482|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
2217483|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2217484|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2217485|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2217486|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
2217487|NCT00031434|Valganciclovir|valganciclovir|mesh-list
2217488|NCT00031434|Ganciclovir|ganciclovir|mesh-list
2217489|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2217490|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
611405|NCT03451734|Metformin|metformin|mesh-list
611406|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
611407|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
611408|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611409|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
611410|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611411|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
611412|NCT03451695|Morphine|morphine|mesh-list
611413|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
611414|NCT03451695|Narcotics|narcotics|mesh-ancestor
611415|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611416|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611417|NCT03451695|Analgesics|analgesics|mesh-ancestor
611418|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
611419|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611420|NCT03451682|Procyanidin|procyanidin|mesh-list
611421|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
611422|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611423|NCT03451682|Protective Agents|protective agents|mesh-ancestor
611424|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611425|NCT03451591|Cilostazol|cilostazol|mesh-list
611426|NCT03451591|Isosorbide|isosorbide|mesh-list
611427|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
611428|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
611429|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
611430|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
611431|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611432|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611433|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
611434|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
611435|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
611436|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
611437|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611438|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
611439|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
611440|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
611441|NCT03451591|Protective Agents|protective agents|mesh-ancestor
611442|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
611443|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
611444|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611445|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
611446|NCT03451591|Diuretics|diuretics|mesh-ancestor
611447|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
611448|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2079009|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2079010|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079011|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2079012|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
611453|NCT03451500|Levodopa|levodopa|mesh-list
611454|NCT03451500|Carbidopa|carbidopa|mesh-list
611455|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
611456|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
611457|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
611458|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
611459|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611460|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611461|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611462|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
611463|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611464|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
611465|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
611466|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
611467|NCT03451487|Acetaminophen|acetaminophen|mesh-list
611468|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
611469|NCT03451487|Analgesics|analgesics|mesh-ancestor
611470|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
611471|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611472|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611473|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
611474|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
611475|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
611476|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
611477|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611478|NCT03451435|Expectorants|expectorants|mesh-ancestor
611479|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
611480|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
611481|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
611482|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611483|NCT03451435|Protective Agents|protective agents|mesh-ancestor
611484|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611485|NCT03451435|Antidotes|antidotes|mesh-ancestor
611486|NCT03451396|Lifitegrast|lifitegrast|mesh-list
611487|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
611488|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
611489|NCT03451370|Bevacizumab|bevacizumab|mesh-list
611490|NCT03451370|Capecitabine|capecitabine|mesh-list
611491|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
611492|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
611493|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611494|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
611495|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
611496|NCT03451370|Growth Substances|growth substances|mesh-ancestor
611497|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611498|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
611499|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
611500|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
611501|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611502|NCT03451331|Gemcitabine|gemcitabine|mesh-list
611503|NCT03451331|Carboplatin|carboplatin|mesh-list
611504|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
611505|NCT03451331|Nivolumab|nivolumab|mesh-list
611506|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611507|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
611508|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
611509|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611510|NCT03451331|Antiviral Agents|antiviral agents|mesh-ancestor
611511|NCT03451331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611512|NCT03451331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611513|NCT03451331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
611514|NCT03451331|Immunologic Factors|immunologic factors|mesh-ancestor
611515|NCT03451331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611516|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
611517|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
611518|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
611519|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
611520|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
611521|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
611522|NCT03451266|Ascorbic Acid|ascorbic acid|mesh-list
611523|NCT03451266|Vitamins|vitamins|mesh-ancestor
611524|NCT03451266|Micronutrients|micronutrients|mesh-ancestor
611525|NCT03451266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611526|NCT03451266|Antioxidants|antioxidants|mesh-ancestor
611527|NCT03451266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611528|NCT03451266|Protective Agents|protective agents|mesh-ancestor
611529|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
611530|NCT03451227|Remifentanil|remifentanil|mesh-list
611531|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
611532|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611533|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611534|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
611535|NCT03451227|Analgesics|analgesics|mesh-ancestor
611536|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
611537|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611538|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
611539|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
611540|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
611541|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
611542|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611543|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611544|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
611545|NCT03451227|Narcotics|narcotics|mesh-ancestor
611546|NCT03451110|Fluconazole|fluconazole|mesh-list
611547|NCT03451110|Lemborexant|lemborexant|mesh-list
611548|NCT03451110|Famotidine|famotidine|mesh-list
611549|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
611550|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
611551|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611552|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
611553|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
611554|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611555|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611556|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
611557|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
611558|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
611559|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611560|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
611561|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
611562|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
611563|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
611564|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
611565|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
611566|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
611567|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611568|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
611569|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
611570|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
611571|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611572|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
611573|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
611574|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
611575|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
611576|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
611577|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
611578|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
611579|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
611580|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
611581|NCT03451019|Sevelamer|sevelamer|mesh-list
611582|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
611583|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
611584|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079013|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
2079014|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079015|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611588|NCT03450967|Durvalumab|durvalumab|mesh-list
611589|NCT03450967|Tremelimumab|tremelimumab|mesh-list
611590|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
611591|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611592|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
611593|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
611594|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611595|NCT03450798|Anesthetics|anesthetics|mesh-list
611596|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611597|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079016|NCT02052557|Bupivacaine|bupivacaine|mesh-list
2079017|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
2079018|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
2751175|NCT04046939|Pramipexole|pramipexole|mesh-list
2751176|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
2751177|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751178|NCT04046939|Protective Agents|protective agents|mesh-ancestor
611606|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
611607|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
611608|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
611609|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
611610|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
611611|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
611612|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
611613|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
611614|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611615|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611616|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611617|NCT03450499|Ketamine|ketamine|mesh-list
611618|NCT03450499|Analgesics|analgesics|mesh-ancestor
611619|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
611620|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611621|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611622|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
611623|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
611624|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
611625|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
611626|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611627|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
611628|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
611629|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611630|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611631|NCT03450434|Histamine|histamine|mesh-list
611632|NCT03450434|Glutarimide|glutarimide|mesh-list
611633|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
611634|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
611635|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611636|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611637|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611638|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
611639|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079019|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079020|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079021|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
2079022|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079023|NCT02052635|Clopidogrel|clopidogrel|mesh-list
2079024|NCT02052635|Ticagrelor|ticagrelor|mesh-list
611646|NCT03450317|Aspirin|aspirin|mesh-list
611647|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
611648|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
611649|NCT03450317|Analgesics|analgesics|mesh-ancestor
611650|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
611651|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611652|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611653|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
611654|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
611655|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
611656|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
611657|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611658|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
611659|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
611660|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611661|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
611662|NCT03450226|Bupivacaine|bupivacaine|mesh-list
611663|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
611664|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
611665|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611666|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611667|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
611668|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611669|NCT03450161|Fentanyl|fentanyl|mesh-list
611670|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
611671|NCT03450161|Narcotics|narcotics|mesh-ancestor
611672|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611673|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611674|NCT03450161|Analgesics|analgesics|mesh-ancestor
611675|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
611676|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611677|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
611678|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
611679|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
611680|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
611681|NCT03450122|Aldesleukin|aldesleukin|mesh-list
611682|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
611683|NCT03450122|Interleukin-2|interleukin-2|mesh-list
611684|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
611685|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
611686|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611687|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
611688|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
611689|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
611690|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611691|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611692|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
611693|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
611694|NCT03450122|Analgesics|analgesics|mesh-ancestor
611695|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
611696|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611697|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
611698|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
611699|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
611700|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611701|NCT03450109|Goserelin|goserelin|mesh-list
611702|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
611703|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217491|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217492|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2217493|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611707|NCT03450057|Daratumumab|daratumumab|mesh-list
611708|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611709|NCT03450018|Gemcitabine|gemcitabine|mesh-list
611710|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
611711|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
611712|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611713|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611714|NCT03450018|Antiviral Agents|antiviral agents|mesh-ancestor
611715|NCT03450018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611716|NCT03450018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611717|NCT03450018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
611718|NCT03450018|Immunologic Factors|immunologic factors|mesh-ancestor
611719|NCT03450018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611720|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
611721|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
611722|NCT03449940|Diclofenac|diclofenac|mesh-list
611723|NCT03449940|Lidocaine|lidocaine|mesh-list
611724|NCT03449940|Analgesics|analgesics|mesh-list
611725|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
611726|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
611727|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611728|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611729|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
611730|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611731|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
611732|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
611733|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
611734|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
611735|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611736|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611737|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
611738|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
611739|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
611740|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
611741|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
611742|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611743|NCT03449901|Gemcitabine|gemcitabine|mesh-list
611744|NCT03449901|Docetaxel|docetaxel|mesh-list
611745|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
611746|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
611747|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611748|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611749|NCT03449901|Antiviral Agents|antiviral agents|mesh-ancestor
611750|NCT03449901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611751|NCT03449901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611752|NCT03449901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
611753|NCT03449901|Immunologic Factors|immunologic factors|mesh-ancestor
611754|NCT03449901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611755|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
611756|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
611757|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
611758|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
611759|NCT03449888|Calcium|calcium|mesh-list
611760|NCT03449888|Regadenoson|regadenoson|mesh-list
611761|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
611762|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611763|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
611764|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
611765|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
611766|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
611767|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
611768|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611769|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611770|NCT03449836|Fluticasone|fluticasone|mesh-list
611771|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
611772|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
611773|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
611774|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
611775|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611776|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611777|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
611778|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
611779|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
611780|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
611781|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
611782|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
611783|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
611784|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
611785|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2217494|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217495|NCT00031473|Ribavirin|ribavirin|mesh-list
2217496|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
2217497|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217498|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
2217499|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217500|NCT00031499|Azithromycin|azithromycin|mesh-list
2217501|NCT00031499|Doxycycline|doxycycline|mesh-list
2217502|NCT00031499|Penicillins|penicillins|mesh-list
2217503|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2217504|NCT00031499|Penicillin G|penicillin g|mesh-list
2217505|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
2217506|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2217507|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217508|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
2217509|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2217510|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2217511|NCT00031512|Pleconaril|pleconaril|mesh-list
2217512|NCT00031512|Antiviral Agents|antiviral agents|mesh-ancestor
2217513|NCT00031512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217514|NCT00031564|Aldesleukin|aldesleukin|mesh-list
2217515|NCT00031564|Interleukin-2|interleukin-2|mesh-list
2217516|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217517|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217518|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2217519|NCT00031564|Analgesics|analgesics|mesh-ancestor
2217520|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
2217521|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2217522|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2217523|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2217524|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
2217525|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217526|NCT00031577|Paclitaxel|paclitaxel|mesh-list
2217527|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
611819|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
611820|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611821|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
611822|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611823|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611824|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
611825|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
611826|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611827|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2079025|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2079026|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2217528|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611831|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
611832|NCT03449693|Antacids|antacids|mesh-ancestor
611833|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611834|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
611835|NCT03449654|Liraglutide|liraglutide|mesh-list
611836|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
611837|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611838|NCT03449654|Incretins|incretins|mesh-ancestor
611839|NCT03449654|Hormones|hormones|mesh-ancestor
611840|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
611841|NCT03449537|Caseins|caseins|mesh-list
611842|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
611843|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
611844|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611845|NCT03449524|CXA-10|cxa-10|mesh-list
611846|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
611847|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
611848|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
611849|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
611850|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611851|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611852|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
611853|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
611854|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
611855|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611856|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611857|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
611858|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
611859|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
611860|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
611861|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
611862|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
611863|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611864|NCT03449459|Amikacin|amikacin|mesh-list
611865|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
611866|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217529|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217530|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217531|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217532|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217533|NCT00031616|Brivudine|brivudine|mesh-list
2217534|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
2217535|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
2217536|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217537|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217538|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611878|NCT03449251|Verapamil|verapamil|mesh-list
611879|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
611880|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
611881|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
611882|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
611883|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611884|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
611885|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611886|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
611887|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611888|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
611889|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
611890|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611891|NCT03449173|Sunitinib|sunitinib|mesh-list
611892|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611893|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
611894|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
611895|NCT03449173|Growth Substances|growth substances|mesh-ancestor
611896|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611897|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
611898|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
611899|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611900|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079027|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2079028|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2079029|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
2079030|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079031|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079032|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079033|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2079034|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
2079035|NCT02052960|Cisplatin|cisplatin|mesh-list
2079036|NCT02052960|Fluorouracil|fluorouracil|mesh-list
2079037|NCT02052960|Cetuximab|cetuximab|mesh-list
2079038|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079039|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
2079040|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079041|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2079042|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2079043|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
2079044|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079045|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2079046|NCT02053493|Isosorbide|isosorbide|mesh-list
2079047|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2079048|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2079049|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2079050|NCT02053493|Diuretics|diuretics|mesh-ancestor
611926|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
611927|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
611928|NCT03449082|Coagulants|coagulants|mesh-ancestor
611929|NCT03449056|Albuterol|albuterol|mesh-list
611930|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
611931|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
611932|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
611933|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611934|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
611935|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
611936|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
611937|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
611938|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
611939|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
611940|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
611941|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
611942|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
611943|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611944|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
611945|NCT03448978|Fludarabine|fludarabine|mesh-list
611946|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
611947|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
611948|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611949|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
611950|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
611951|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
611952|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611953|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611954|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
611955|NCT03448835|Docetaxel|docetaxel|mesh-list
611956|NCT03448835|Capecitabine|capecitabine|mesh-list
611957|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
611958|NCT03448835|Atezolizumab|atezolizumab|mesh-list
611959|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611960|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
611961|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
611962|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
611963|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611964|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
611965|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
611966|NCT03448783|Apixaban|apixaban|mesh-list
611967|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
611968|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
611969|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
611970|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
611971|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611972|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611973|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
611974|NCT03448770|Lactulose|lactulose|mesh-list
611975|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
611976|NCT03448744|Entecavir|entecavir|mesh-list
611977|NCT03448744|Thymalfasin|thymalfasin|mesh-list
611978|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
611979|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611980|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
611981|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
611982|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
611983|NCT03448731|Doxycycline|doxycycline|mesh-list
611984|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
611985|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
611986|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
611987|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
611988|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
611989|NCT03448718|Olaparib|olaparib|mesh-list
611990|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
611991|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
611992|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
611993|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
611994|NCT03448705|Vaccines|vaccines|mesh-list
611995|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
611996|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079051|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
2079052|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079053|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
612000|NCT03448640|Tropicamide|tropicamide|mesh-list
612001|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
612002|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
612003|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612004|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612005|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
612006|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
612007|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
612008|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
612009|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612010|NCT03448588|Selenium|selenium|mesh-list
612011|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
612012|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612013|NCT03448588|Protective Agents|protective agents|mesh-ancestor
612014|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612015|NCT03448588|Trace Elements|trace elements|mesh-ancestor
612016|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
612017|NCT03448549|Capecitabine|capecitabine|mesh-list
612018|NCT03448549|Tegafur|tegafur|mesh-list
612019|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
612020|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
612021|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
612022|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612023|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217539|NCT00031629|Gemcitabine|gemcitabine|mesh-list
2217540|NCT00031629|Docetaxel|docetaxel|mesh-list
2217541|NCT00031629|Lenograstim|lenograstim|mesh-list
2217542|NCT00031629|Sargramostim|sargramostim|mesh-list
2217543|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2217544|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
2217545|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217546|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217547|NCT00031629|Antiviral Agents|antiviral agents|mesh-ancestor
2217548|NCT00031629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217549|NCT00031629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217550|NCT00031629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217551|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
2217552|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217553|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217554|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217555|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217556|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2217557|NCT00031642|Rituximab|rituximab|mesh-list
2217558|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2217559|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217560|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
2217561|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217562|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217563|NCT00031655|Cyclosporine|cyclosporine|mesh-list
2217564|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
2217565|NCT00031655|Fludarabine|fludarabine|mesh-list
2079054|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2079055|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079056|NCT02053610|Rituximab|rituximab|mesh-list
2079057|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
2079058|NCT02053610|Chlorambucil|chlorambucil|mesh-list
2079059|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2079060|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079061|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
2079062|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079063|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2079064|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
612060|NCT03448159|Fluoxetine|fluoxetine|mesh-list
612061|NCT03448159|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
612062|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
612063|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
612064|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612065|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
612066|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
612067|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612068|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
612069|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
612070|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
612071|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
612072|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
612073|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612074|NCT03448107|Fluorides|fluorides|mesh-list
612075|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
612076|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
612077|NCT03448107|Protective Agents|protective agents|mesh-ancestor
612078|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612079|NCT03448094|Resveratrol|resveratrol|mesh-list
612080|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
612081|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612082|NCT03448094|Protective Agents|protective agents|mesh-ancestor
612083|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612084|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612085|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
612086|NCT03448081|Calcipotriene|calcipotriene|mesh-list
612087|NCT03448081|Dermatologic Agents|dermatologic agents|mesh-ancestor
2217566|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
2217567|NCT00031655|Cyclosporins|cyclosporins|mesh-list
2217568|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217569|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2217570|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
2217571|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217572|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217573|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
2217574|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217575|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217576|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
2217577|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217578|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
2217579|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
612102|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
612103|NCT03447925|Salicylates|salicylates|mesh-list
612104|NCT03447925|Petrolatum|petrolatum|mesh-list
612105|NCT03447925|Emollients|emollients|mesh-ancestor
612106|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
612107|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
612108|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
612109|NCT03447925|Analgesics|analgesics|mesh-ancestor
612110|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
612111|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612112|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612113|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
612114|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
612115|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
612116|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612117|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612118|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612119|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
612120|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
2217580|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
612121|NCT03447873|Lamivudine|lamivudine|mesh-list
612122|NCT03447873|Cobicistat|cobicistat|mesh-list
612123|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
612124|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
612125|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612126|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612127|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
612128|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612129|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
612130|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
612131|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
612132|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2217581|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2217582|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2217583|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
2217584|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2217585|NCT00031681|Irinotecan|irinotecan|mesh-list
612138|NCT03447808|Daratumumab|daratumumab|mesh-list
612139|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612140|NCT03447782|Naltrexone|naltrexone|mesh-list
612141|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
612142|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
612143|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612144|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
612145|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612146|NCT03447691|Remifentanil|remifentanil|mesh-list
612147|NCT03447691|Anesthetics|anesthetics|mesh-list
612148|NCT03447691|Propofol|propofol|mesh-list
612149|NCT03447691|Desflurane|desflurane|mesh-list
612150|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
612151|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612152|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
612153|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
612154|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
612155|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
612156|NCT03447691|Narcotics|narcotics|mesh-ancestor
612157|NCT03447691|Analgesics|analgesics|mesh-ancestor
612158|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
612159|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612160|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
612161|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
612162|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
612163|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217586|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2217587|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2217588|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2217589|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217590|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217591|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751179|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751180|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2751181|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2751182|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
2751183|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
612175|NCT03447470|Nivolumab|nivolumab|mesh-list
612176|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
612177|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612178|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
612179|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217592|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2217593|NCT00031707|Megestrol|megestrol|mesh-list
2217594|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
2217595|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2217596|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2217597|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2217598|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
2217599|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2217600|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217601|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2217602|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2217603|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2217604|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217605|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
2217606|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2217607|NCT00031720|Tamoxifen|tamoxifen|mesh-list
2217608|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2217609|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
2217610|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2217611|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217612|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2217613|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217614|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2217615|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2217616|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2217617|NCT00031733|Interleukin-12|interleukin-12|mesh-list
2217618|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2217619|NCT00031733|Sargramostim|sargramostim|mesh-list
2217620|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
2217621|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
2217622|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
612219|NCT03447184|Androgens|androgens|mesh-list
612220|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
612221|NCT03447184|Hormones|hormones|mesh-ancestor
612222|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
612223|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612224|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
612225|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612226|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612227|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
612228|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
612229|NCT03447132|Fulvestrant|fulvestrant|mesh-list
612230|NCT03447132|Goserelin|goserelin|mesh-list
612231|NCT03447132|Palbociclib|palbociclib|mesh-list
612232|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
612233|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612234|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
612235|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
612236|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
612237|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
612238|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612239|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
612240|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612241|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612242|NCT03447093|Methimazole|methimazole|mesh-list
612243|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
612244|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
612245|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
612246|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
612247|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612248|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
612249|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612250|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
612251|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
612252|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612253|NCT03446937|Dexamethasone|dexamethasone|mesh-list
612254|NCT03446937|Betamethasone|betamethasone|mesh-list
612255|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
612256|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
612257|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
612258|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
612259|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
612260|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
612261|NCT03446937|BB 1101|bb 1101|mesh-list
612262|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
612263|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
612264|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
612265|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612266|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612267|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
612268|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
612269|NCT03446937|Hormones|hormones|mesh-ancestor
612270|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
612271|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
612272|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612273|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
612274|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
612275|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
612276|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612277|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612278|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
612279|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
612280|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217623|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217624|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217625|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2217626|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2217627|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2217628|NCT00031733|Growth Substances|growth substances|mesh-ancestor
2217629|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
2217630|NCT00031733|Antacids|antacids|mesh-ancestor
2217631|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612290|NCT03446872|Leucovorin|leucovorin|mesh-list
612291|NCT03446872|Fluorouracil|fluorouracil|mesh-list
612292|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
612293|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612294|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
612295|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612296|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
612297|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
612298|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612299|NCT03446872|Antidotes|antidotes|mesh-ancestor
612300|NCT03446872|Protective Agents|protective agents|mesh-ancestor
612301|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
612302|NCT03446872|Vitamins|vitamins|mesh-ancestor
612303|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
612304|NCT03446807|Droxidopa|droxidopa|mesh-list
612305|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
612306|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
612307|NCT03446638|Cytarabine|cytarabine|mesh-list
612308|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
612309|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
612310|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612311|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612312|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
612313|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612314|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
612315|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
612316|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612317|NCT03446625|Resveratrol|resveratrol|mesh-list
612318|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
612319|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612320|NCT03446625|Protective Agents|protective agents|mesh-ancestor
612321|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612322|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612323|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2217632|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2217633|NCT00031746|Caseins|caseins|mesh-list
2217634|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
2217635|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
2217636|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217637|NCT00031759|Imiquimod|imiquimod|mesh-list
2217638|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2217639|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
2217640|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217641|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217642|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
2217643|NCT00031785|Megestrol|megestrol|mesh-list
2217644|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
2217645|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
612338|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
612339|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
612340|NCT03446599|Methylene Blue|methylene blue|mesh-list
612341|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612342|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612343|NCT03446599|Hematinics|hematinics|mesh-ancestor
612344|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
612345|NCT03446599|Vitamins|vitamins|mesh-ancestor
612346|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
612347|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612348|NCT03446547|Durvalumab|durvalumab|mesh-list
2217646|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
612349|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
612350|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612351|NCT03446534|Amoxicillin|amoxicillin|mesh-list
612352|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
612353|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612354|NCT03446495|Trabectedin|trabectedin|mesh-list
612355|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
612356|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
612357|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612358|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612367|NCT03446443|Metronidazole|metronidazole|mesh-list
612368|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612369|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
612370|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
612371|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
612384|NCT03446001|Methylene Blue|methylene blue|mesh-list
612385|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612386|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612387|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
612388|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
612389|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612390|NCT03445897|Miltefosine|miltefosine|mesh-list
612391|NCT03445897|Pentamidine|pentamidine|mesh-list
612392|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
612393|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612394|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612395|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
612396|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
612397|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
612398|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
612399|NCT03445858|Decitabine|decitabine|mesh-list
612400|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
612401|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612402|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
612403|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
612404|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612405|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612406|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
612407|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
612408|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
612409|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
612410|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
612411|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
612412|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612413|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
612414|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079065|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
2079066|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079067|NCT02053753|Denosumab|denosumab|mesh-list
2079068|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2079069|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079070|NCT02054156|Azithromycin|azithromycin|mesh-list
2079071|NCT02054156|Tobramycin|tobramycin|mesh-list
612423|NCT03445702|Metformin|metformin|mesh-list
612424|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
612730|NCT03443765|Vitamin D|vitamin d|mesh-list
612425|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612426|NCT03445624|Infliximab|infliximab|mesh-list
612427|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
612428|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
612429|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
612430|NCT03445611|Lidocaine|lidocaine|mesh-list
612431|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
612432|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
612433|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
612434|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
612435|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612436|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
612437|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612438|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
612439|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
612440|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
612441|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
612442|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612443|NCT03445533|Ipilimumab|ipilimumab|mesh-list
612444|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
612445|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612446|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
612447|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612448|NCT03445468|Vaccines|vaccines|mesh-list
612449|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
612450|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217647|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2217648|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
2217649|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2217650|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217651|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2217652|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2217653|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
612458|NCT03445286|Fluorides|fluorides|mesh-list
612459|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
612460|NCT03445286|Protective Agents|protective agents|mesh-ancestor
612461|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217654|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217655|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
2217656|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2217657|NCT00031798|Methylphenidate|methylphenidate|mesh-list
2217658|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2217659|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217660|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
612472|NCT03445182|Anesthetics|anesthetics|mesh-list
612473|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
612474|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612475|NCT03445104|Huperzine A|huperzine a|mesh-list
612476|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
612477|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612478|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612479|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
612480|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
612481|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612482|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
612483|NCT03445104|Protective Agents|protective agents|mesh-ancestor
612484|NCT03445078|Selenium|selenium|mesh-list
612485|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
612486|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612487|NCT03445078|Protective Agents|protective agents|mesh-ancestor
612488|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612489|NCT03445078|Trace Elements|trace elements|mesh-ancestor
612490|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
612491|NCT03444831|Buspirone|buspirone|mesh-list
612492|NCT03444831|Omeprazole|omeprazole|mesh-list
612493|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
612494|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
612495|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
612496|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612497|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612498|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
612499|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
612500|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
612501|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612502|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
612503|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
612504|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
612505|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2217661|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2217662|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2217663|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217664|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
2217665|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079072|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2079073|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079074|NCT02054325|Polidocanol|polidocanol|mesh-list
2079075|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2079076|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2079077|NCT02054338|Gemcitabine|gemcitabine|mesh-list
612517|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
612518|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
612519|NCT03444649|Cytarabine|cytarabine|mesh-list
612520|NCT03444649|Daunorubicin|daunorubicin|mesh-list
612521|NCT03444649|Idarubicin|idarubicin|mesh-list
612522|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
612523|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
612524|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612525|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612526|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
612527|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612528|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
612529|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
612530|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612531|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
612532|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
612533|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
612534|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612535|NCT03444636|Fentanyl|fentanyl|mesh-list
612536|NCT03444636|Bupivacaine|bupivacaine|mesh-list
612537|NCT03444636|Ropivacaine|ropivacaine|mesh-list
612538|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
612539|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
612540|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
612541|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612542|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
612543|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612544|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
612545|NCT03444636|Narcotics|narcotics|mesh-ancestor
612546|NCT03444636|Analgesics|analgesics|mesh-ancestor
612547|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
612548|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
612549|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
2217666|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2217667|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
612553|NCT03444519|Mannitol|mannitol|mesh-list
612554|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
612555|NCT03444519|Diuretics|diuretics|mesh-ancestor
612556|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
612557|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612558|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
612559|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
612560|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
612561|NCT03444506|Analgesics|analgesics|mesh-ancestor
612562|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
612563|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612564|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612565|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
612566|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
612567|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
612568|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
612569|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
612570|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
612571|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
612572|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
612573|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612574|NCT03444467|Glucagon|glucagon|mesh-list
612575|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
612576|NCT03444467|Hormones|hormones|mesh-ancestor
612731|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
2079078|NCT02054338|Paclitaxel|paclitaxel|mesh-list
612577|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
612578|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612579|NCT03444402|Esomeprazole|esomeprazole|mesh-list
612580|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
612581|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
612582|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
612583|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612584|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612585|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
612586|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
612587|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612588|NCT03444298|Vitamin E|vitamin e|mesh-list
612589|NCT03444298|Tocopherols|tocopherols|mesh-list
612590|NCT03444298|Tocotrienols|tocotrienols|mesh-list
612591|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
612592|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
612593|NCT03444298|Vitamins|vitamins|mesh-ancestor
612594|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
612595|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612596|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
612597|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612598|NCT03444298|Protective Agents|protective agents|mesh-ancestor
612599|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
612600|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
612601|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612602|NCT03444246|Iodine|iodine|mesh-list
612603|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
612604|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
612605|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612606|NCT03444246|Trace Elements|trace elements|mesh-ancestor
612607|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
612608|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217668|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
2217669|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2217670|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217671|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
612615|NCT03444142|Exenatide|exenatide|mesh-list
612616|NCT03444142|Dulaglutide|dulaglutide|mesh-list
612617|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
612618|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612619|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
612620|NCT03444142|Incretins|incretins|mesh-ancestor
612621|NCT03444142|Hormones|hormones|mesh-ancestor
612622|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
612623|NCT03444025|Goserelin|goserelin|mesh-list
612624|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
612625|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612626|NCT03444012|Ticagrelor|ticagrelor|mesh-list
612627|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
612628|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
612629|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
612630|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
612631|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
612632|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
612633|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612634|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612635|NCT03443999|Sirolimus|sirolimus|mesh-list
612636|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
612637|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612638|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
612639|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612640|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
612641|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
612642|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
612643|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612644|NCT03443960|Amitriptyline|amitriptyline|mesh-list
612645|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
612646|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
612647|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
612648|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
612649|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
612650|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612651|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
612652|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612653|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
612811|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
612654|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
612655|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
612656|NCT03443960|Analgesics|analgesics|mesh-ancestor
612657|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
612658|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
612659|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
612660|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
612661|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612662|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
612663|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
612664|NCT03443921|Paclitaxel|paclitaxel|mesh-list
612665|NCT03443921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
612666|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
612667|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612668|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
612669|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
612670|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
612671|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612672|NCT03443869|Valganciclovir|valganciclovir|mesh-list
612673|NCT03443869|Acyclovir|acyclovir|mesh-list
612674|NCT03443869|Letermovir|letermovir|mesh-list
612675|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
612676|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612677|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
612678|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612679|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612680|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612681|NCT03443856|Nivolumab|nivolumab|mesh-list
612682|NCT03443856|Ipilimumab|ipilimumab|mesh-list
612683|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
612684|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612685|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
612686|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612687|NCT03443843|Fluticasone|fluticasone|mesh-list
612688|NCT03443843|Xhance|xhance|mesh-list
612689|NCT03443843|Loratadine|loratadine|mesh-list
612690|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
612691|NCT03443843|Ephedrine|ephedrine|mesh-list
612692|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
612693|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
612694|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
612695|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612696|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612697|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
612698|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
612699|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
612700|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
612701|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
612702|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
612703|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
612704|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
612705|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
612706|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
612707|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612708|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
612709|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
612710|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
612711|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
612712|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
612713|NCT03443778|Dexamethasone|dexamethasone|mesh-list
612714|NCT03443778|Bupivacaine|bupivacaine|mesh-list
612715|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
612716|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
612717|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
612718|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612719|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612720|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
612721|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
612722|NCT03443778|Hormones|hormones|mesh-ancestor
612723|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
612724|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
612725|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612726|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
612727|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
612728|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
612729|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
612732|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
612733|NCT03443765|Antibodies|antibodies|mesh-list
612734|NCT03443765|Vitamins|vitamins|mesh-ancestor
612735|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
612736|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612737|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
612738|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
612739|NCT03443726|Epinephrine|epinephrine|mesh-list
612740|NCT03443726|Carticaine|carticaine|mesh-list
612741|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
612742|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
612743|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
612744|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
612745|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612746|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612747|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
612748|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
612749|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
612750|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612751|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
612752|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
612753|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
612754|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
612755|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
612756|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
612757|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
612758|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
612759|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
612760|NCT03443570|Rituximab|rituximab|mesh-list
612761|NCT03443570|Bortezomib|bortezomib|mesh-list
612762|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
612763|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612764|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
612765|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612766|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
612767|NCT03443518|Remifentanil|remifentanil|mesh-list
612768|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
612769|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612770|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
612771|NCT03443518|Narcotics|narcotics|mesh-ancestor
612772|NCT03443518|Analgesics|analgesics|mesh-ancestor
612773|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
612774|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612775|NCT03443492|Leucovorin|leucovorin|mesh-list
612776|NCT03443492|Gemcitabine|gemcitabine|mesh-list
612777|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
612778|NCT03443492|Irinotecan|irinotecan|mesh-list
612779|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
612780|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
612781|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
612782|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612783|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612784|NCT03443492|Antiviral Agents|antiviral agents|mesh-ancestor
612785|NCT03443492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612786|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612787|NCT03443492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
612788|NCT03443492|Immunologic Factors|immunologic factors|mesh-ancestor
612789|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612790|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
612791|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
612792|NCT03443492|Antidotes|antidotes|mesh-ancestor
612793|NCT03443492|Protective Agents|protective agents|mesh-ancestor
612794|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
612795|NCT03443492|Vitamins|vitamins|mesh-ancestor
612796|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
612797|NCT03443271|Bupivacaine|bupivacaine|mesh-list
612798|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
612799|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
612800|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
612801|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612802|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
612803|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612804|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
612805|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
612806|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
612807|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612808|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612809|NCT03443141|Vitamin E|vitamin e|mesh-list
612810|NCT03443141|Vitamins|vitamins|mesh-ancestor
612812|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612813|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
612814|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612815|NCT03443141|Protective Agents|protective agents|mesh-ancestor
612816|NCT03443128|Vinorelbine|vinorelbine|mesh-list
612817|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
612818|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612819|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
612820|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
612821|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
612822|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217672|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2217673|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2217674|NCT00031824|Cyclosporine|cyclosporine|mesh-list
2217675|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
2217676|NCT00031824|Prednisone|prednisone|mesh-list
2217677|NCT00031824|Tacrolimus|tacrolimus|mesh-list
2217678|NCT00031824|Cyclosporins|cyclosporins|mesh-list
2217679|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
612831|NCT03443037|Amantadine|amantadine|mesh-list
612832|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
612833|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
612834|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
612835|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612836|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
612837|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
612838|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612839|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612840|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
612841|NCT03443037|Analgesics|analgesics|mesh-ancestor
612842|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
612843|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612844|NCT03442972|Teduglutide|teduglutide|mesh-list
612845|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
612846|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
612847|NCT03442972|Protective Agents|protective agents|mesh-ancestor
612848|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612849|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
612850|NCT03442751|Riboflavin|riboflavin|mesh-list
612851|NCT03442751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
612852|NCT03442751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
612853|NCT03442751|Vitamin B Complex|vitamin b complex|mesh-ancestor
612854|NCT03442751|Vitamins|vitamins|mesh-ancestor
612855|NCT03442751|Micronutrients|micronutrients|mesh-ancestor
612856|NCT03442751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612857|NCT03442751|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
612858|NCT03442751|Dermatologic Agents|dermatologic agents|mesh-ancestor
612859|NCT03442673|Gemcitabine|gemcitabine|mesh-list
612860|NCT03442673|Vinorelbine|vinorelbine|mesh-list
612861|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
612862|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
612863|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612864|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612865|NCT03442673|Antiviral Agents|antiviral agents|mesh-ancestor
612866|NCT03442673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612867|NCT03442673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612868|NCT03442673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
612869|NCT03442673|Immunologic Factors|immunologic factors|mesh-ancestor
612870|NCT03442673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612871|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
612872|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
612873|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
612874|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
612875|NCT03442621|Cortisone|cortisone|mesh-list
612876|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2079079|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2079080|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079081|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
2079082|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
2079083|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
2079084|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079085|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2079086|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
2079087|NCT02054338|Antiviral Agents|antiviral agents|mesh-ancestor
2079088|NCT02054338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217680|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
2217681|NCT00031824|Hormones|hormones|mesh-ancestor
2079089|NCT02054338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079090|NCT02054338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2079091|NCT02054338|Immunologic Factors|immunologic factors|mesh-ancestor
2079092|NCT02054338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079093|NCT02054481|Ustekinumab|ustekinumab|mesh-list
2079094|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
612894|NCT03442491|Hemostatics|hemostatics|mesh-list
612895|NCT03442491|Coagulants|coagulants|mesh-ancestor
612896|NCT03442413|Nicotine|nicotine|mesh-list
612897|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
612898|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
612899|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612900|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612901|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
612902|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
612903|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
612904|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
612905|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612906|NCT03442309|Fluorides|fluorides|mesh-list
612907|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
612908|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
612909|NCT03442309|Protective Agents|protective agents|mesh-ancestor
612910|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612911|NCT03442283|Vitamins|vitamins|mesh-list
612912|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
612913|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612914|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
612915|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
612916|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
612917|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
612918|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612919|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
612920|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
612921|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
612922|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
612923|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612924|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2079095|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
2079096|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
2079097|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079098|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
2079099|NCT02054520|Nivolumab|nivolumab|mesh-list
2079100|NCT02054520|Ipilimumab|ipilimumab|mesh-list
2079101|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2079102|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079103|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2079104|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079105|NCT02054702|Aripiprazole|aripiprazole|mesh-list
2079106|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
2079107|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
612938|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
612939|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
612940|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
612941|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612942|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
612943|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
612944|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
612945|NCT03441893|Mesalamine|mesalamine|mesh-list
612946|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
612947|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
612948|NCT03441893|Analgesics|analgesics|mesh-ancestor
612949|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
612950|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612951|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612952|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
612953|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
612954|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
612955|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
612956|NCT03441841|Lidocaine|lidocaine|mesh-list
612957|NCT03441841|Prilocaine|prilocaine|mesh-list
612958|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
612959|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
612960|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
612961|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
612962|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612963|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
2079108|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2079109|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
612964|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
612965|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
612966|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
612967|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
612968|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
612969|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612970|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
612971|NCT03441815|Histamine|histamine|mesh-list
612972|NCT03441815|Glutarimide|glutarimide|mesh-list
612973|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
612974|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
612975|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
612976|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
612977|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
612978|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
612979|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217682|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2217683|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217684|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2217685|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217686|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217687|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
2217688|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2217689|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217690|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217691|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
2217692|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217693|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
2217694|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217695|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
2079110|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2079111|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2217696|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2217697|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2217698|NCT00031837|Gemcitabine|gemcitabine|mesh-list
2217699|NCT00031837|Dalteparin|dalteparin|mesh-list
2217700|NCT00031837|Tinzaparin|tinzaparin|mesh-list
2217701|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2217702|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2217703|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
2217704|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217705|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217706|NCT00031837|Antiviral Agents|antiviral agents|mesh-ancestor
613018|NCT03441529|Tazobactam|tazobactam|mesh-list
613019|NCT03441529|Piperacillin|piperacillin|mesh-list
613020|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
613021|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
613022|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
613023|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
613024|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613025|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613026|NCT03441412|Metoprolol|metoprolol|mesh-list
613027|NCT03441412|Epinephrine|epinephrine|mesh-list
613028|NCT03441412|Ticagrelor|ticagrelor|mesh-list
613029|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
613030|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
613031|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
613032|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
613033|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613034|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613035|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
613036|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
613037|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
613038|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613039|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
613040|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
613041|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
613042|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
613043|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
613044|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
613045|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
613046|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
613047|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
613048|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
613049|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
613050|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
613051|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
613052|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
613053|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
613054|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
613055|NCT03441373|Histamine|histamine|mesh-list
613056|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
613057|NCT03441373|Glutarimide|glutarimide|mesh-list
613058|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
613059|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
613060|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
613061|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613062|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613063|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
613064|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217707|NCT00031837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217708|NCT00031837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217709|NCT00031837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217710|NCT00031837|Immunologic Factors|immunologic factors|mesh-ancestor
2217711|NCT00031837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217712|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
2217713|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2217714|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2217715|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2217716|NCT00031850|Goserelin|goserelin|mesh-list
2217717|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2217718|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613089|NCT03441217|Scopolamine|scopolamine|mesh-list
613090|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
613091|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
613092|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
613093|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
613094|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613095|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613096|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
613097|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
613098|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
613099|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
613100|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
613101|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613102|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
613103|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
2079112|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079113|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
2079114|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
2079115|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079116|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079117|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2079118|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2079119|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
2217719|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2217720|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
613116|NCT03441048|Cytarabine|cytarabine|mesh-list
613117|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
613118|NCT03441048|Cladribine|cladribine|mesh-list
613119|NCT03441048|Lintuzumab|lintuzumab|mesh-list
613120|NCT03441048|Sargramostim|sargramostim|mesh-list
613121|NCT03441048|Lenograstim|lenograstim|mesh-list
613122|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
613123|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
613124|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613125|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613126|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
613127|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
613128|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
613129|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
613130|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613131|NCT03441048|Analgesics|analgesics|mesh-ancestor
613132|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
613133|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613134|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
613135|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
613136|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613137|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
613138|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
613139|NCT03441035|Anesthetics|anesthetics|mesh-list
613140|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613141|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613142|NCT03440996|Listerine|listerine|mesh-list
613143|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
613144|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
613145|NCT03440996|Protective Agents|protective agents|mesh-ancestor
613146|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613147|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
613148|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217721|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
613151|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
613152|NCT03440892|Methotrexate|methotrexate|mesh-list
613153|NCT03440892|Abatacept|abatacept|mesh-list
613154|NCT03440892|Tofacitinib|tofacitinib|mesh-list
613155|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
613156|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
613157|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
613158|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613159|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
613160|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
613161|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613162|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613163|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
613164|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613165|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
613166|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
613167|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
613168|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
613169|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
613170|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
613171|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
613172|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
613173|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
613174|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
613175|NCT03440892|Analgesics|analgesics|mesh-ancestor
613176|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
613177|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613178|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
613179|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
613180|NCT03440879|Goserelin|goserelin|mesh-list
613181|NCT03440879|Androgens|androgens|mesh-list
613182|NCT03440879|Hormones|hormones|mesh-ancestor
613183|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
613184|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613185|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
613186|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613187|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
613188|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
613189|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613190|NCT03440567|Rituximab|rituximab|mesh-list
613191|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
613192|NCT03440567|Avelumab|avelumab|mesh-list
613193|NCT03440567|Carboplatin|carboplatin|mesh-list
613194|NCT03440567|Etoposide|etoposide|mesh-list
613195|NCT03440567|Ifosfamide|ifosfamide|mesh-list
613196|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
613197|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
613198|NCT03440567|Antibodies|antibodies|mesh-list
613199|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
613200|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
613201|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
613202|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
613203|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613204|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613205|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
613206|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
613207|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
613208|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
613209|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613210|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613211|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
613212|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
613213|NCT03440515|Prednisone|prednisone|mesh-list
613214|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
613215|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
613216|NCT03440515|Hormones|hormones|mesh-ancestor
613217|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
613218|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613219|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
613220|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613221|NCT03440502|Anesthetics|anesthetics|mesh-list
613222|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613223|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751184|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2217722|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217723|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2217724|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2217725|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2217726|NCT00031863|Rofecoxib|rofecoxib|mesh-list
2217727|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2217728|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2217729|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217730|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217731|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2217732|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2217733|NCT00031863|Analgesics|analgesics|mesh-ancestor
2217734|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
2217735|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2217736|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217737|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2217738|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217739|NCT00031876|Paclitaxel|paclitaxel|mesh-list
2217740|NCT00031876|Capecitabine|capecitabine|mesh-list
2217741|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2217742|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217743|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217744|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217745|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217746|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217747|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2217748|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
2217749|NCT00031889|Exemestane|exemestane|mesh-list
2217750|NCT00031889|Bicalutamide|bicalutamide|mesh-list
2217751|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217752|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2217753|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2217754|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079120|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2079121|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2079122|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2079123|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2079124|NCT02054754|HU 211|hu 211|mesh-list
2079125|NCT02054754|Dronabinol|dronabinol|mesh-list
2079126|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2079127|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
2079128|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
2079129|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079130|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079131|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
613280|NCT03440359|Letrozole|letrozole|mesh-list
613281|NCT03440359|Progesterone|progesterone|mesh-list
613282|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613283|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
613284|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
613285|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613286|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613287|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
613288|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
613289|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
613290|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613291|NCT03440359|Progestins|progestins|mesh-ancestor
613292|NCT03440359|Hormones|hormones|mesh-ancestor
613293|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
613294|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
613295|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
613296|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
613297|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
613298|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
613299|NCT03440268|Expectorants|expectorants|mesh-ancestor
613300|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
613301|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
613302|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
613303|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613304|NCT03440268|Protective Agents|protective agents|mesh-ancestor
613305|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613306|NCT03440268|Antidotes|antidotes|mesh-ancestor
2079132|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2079133|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2079134|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
613310|NCT03440216|Meropenem|meropenem|mesh-list
613311|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
613312|NCT03440216|Temocillin|temocillin|mesh-list
613313|NCT03440216|Penicillins|penicillins|mesh-list
613314|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
613315|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
613316|NCT03440190|Methylphenidate|methylphenidate|mesh-list
613317|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
613318|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613319|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
613320|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
613321|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
613322|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613323|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
613324|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
613325|NCT03440177|Ramipril|ramipril|mesh-list
613326|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
613327|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
613328|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613329|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613330|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
613331|NCT03440112|Clarithromycin|clarithromycin|mesh-list
613332|NCT03440112|Flumazenil|flumazenil|mesh-list
613333|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
613334|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
613335|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
613336|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613337|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613338|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2079135|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613339|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
613340|NCT03440112|Antidotes|antidotes|mesh-ancestor
613341|NCT03440112|Protective Agents|protective agents|mesh-ancestor
613342|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613343|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
613344|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
613345|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
613346|NCT03440034|Pioglitazone|pioglitazone|mesh-list
613347|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
613348|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613349|NCT03439943|Lixisenatide|lixisenatide|mesh-list
613350|NCT03439943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
613351|NCT03439943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613352|NCT03439891|Nivolumab|nivolumab|mesh-list
613353|NCT03439891|Sorafenib|sorafenib|mesh-list
613354|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
613355|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613356|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
613357|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613358|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
613359|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613360|NCT03439865|Ivacaftor|ivacaftor|mesh-list
613361|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
613362|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
613363|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613364|NCT03439787|Epinephrine|epinephrine|mesh-list
613365|NCT03439787|Bupivacaine|bupivacaine|mesh-list
613366|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
613367|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
613368|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613369|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613370|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
613371|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613372|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
613373|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
613374|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
613375|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
613376|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613377|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
613378|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
613379|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
613380|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
613381|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
613382|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
613383|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
613384|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
613385|NCT03439709|Lanreotide|lanreotide|mesh-list
613386|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613387|NCT03439670|Prednisone|prednisone|mesh-list
613388|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
613389|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
613390|NCT03439670|Hormones|hormones|mesh-ancestor
613391|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
613392|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613393|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
613394|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217755|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217756|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2217757|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
613398|NCT03439501|Avelumab|avelumab|mesh-list
613399|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
613400|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613401|NCT03439462|Sirolimus|sirolimus|mesh-list
613402|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
613403|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
613404|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
613405|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613406|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
613407|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
613408|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
613409|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613410|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
613411|NCT03439358|Analgesics|analgesics|mesh-ancestor
613412|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
613413|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613414|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613415|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
613416|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613417|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
613418|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
613419|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
613420|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
613421|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613422|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
613423|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
613424|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
613425|NCT03439345|Fenofibrate|fenofibrate|mesh-list
613426|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
613427|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
613428|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613429|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
613447|NCT03439280|Dexamethasone|dexamethasone|mesh-list
613448|NCT03439280|Pomalidomide|pomalidomide|mesh-list
613449|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
613450|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
613451|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
613452|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613453|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613454|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
613455|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
613456|NCT03439280|Hormones|hormones|mesh-ancestor
613457|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
613458|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
613459|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613460|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
613461|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
613462|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
613463|NCT03439280|Growth Substances|growth substances|mesh-ancestor
613464|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
613465|NCT03439267|Calcium|calcium|mesh-list
613466|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
613467|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613468|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
613469|NCT03439254|Cathartics|cathartics|mesh-ancestor
613470|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2217758|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2217759|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217760|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
2217761|NCT00031902|Prednisolone|prednisolone|mesh-list
2217762|NCT00031902|Rituximab|rituximab|mesh-list
2217763|NCT00031902|Vincristine|vincristine|mesh-list
613478|NCT03439085|Durvalumab|durvalumab|mesh-list
613479|NCT03439085|Interleukin-12|interleukin-12|mesh-list
613480|NCT03439085|Vaccines|vaccines|mesh-list
613481|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
613482|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
613483|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
613484|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
613485|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613486|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
613487|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613488|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
613489|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
613490|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
613491|NCT03439085|Growth Substances|growth substances|mesh-ancestor
613492|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
2217764|NCT00031902|Bleomycin|bleomycin|mesh-list
2217765|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2217766|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217767|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
2217768|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217769|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217770|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2751208|NCT04035837|Interferons|interferons|mesh-list
613513|NCT03439033|Edetic Acid|edetic acid|mesh-list
613514|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
613515|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
613516|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
613517|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613518|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
613519|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
613520|NCT03438955|Telmisartan|telmisartan|mesh-list
613521|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
613522|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
613523|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
613524|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613525|NCT03438942|Folic Acid|folic acid|mesh-list
613526|NCT03438942|Hematinics|hematinics|mesh-ancestor
613527|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
613528|NCT03438942|Vitamins|vitamins|mesh-ancestor
613529|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
613530|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613531|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
613532|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
613533|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
613534|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
613535|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
613536|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
613537|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
613538|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613539|NCT03438773|Tacrolimus|tacrolimus|mesh-list
613540|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
613541|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
613542|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613543|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
613544|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613545|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613546|NCT03438708|Axitinib|axitinib|mesh-list
613547|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613548|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
613549|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613550|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613551|NCT03438604|Donepezil|donepezil|mesh-list
613552|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
613553|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613554|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613555|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
613556|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
613557|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613558|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
613565|NCT03438487|Vaccines|vaccines|mesh-list
2751209|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
613566|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
613567|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079136|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2079137|NCT02054754|Protective Agents|protective agents|mesh-ancestor
2079138|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
613571|NCT03438344|Vaccines|vaccines|mesh-list
613572|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
613573|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613574|NCT03438318|Atezolizumab|atezolizumab|mesh-list
613575|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217771|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217772|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217773|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217774|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217775|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2217776|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
613582|NCT03438253|Anesthetics|anesthetics|mesh-list
613583|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613584|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613585|NCT03438240|Fentanyl|fentanyl|mesh-list
613586|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
613587|NCT03438240|Bupivacaine|bupivacaine|mesh-list
613588|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
613589|NCT03438240|Anesthetics|anesthetics|mesh-list
613590|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
613591|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613592|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613593|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
613594|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613595|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
613596|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
613597|NCT03438240|Analgesics|analgesics|mesh-ancestor
613598|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
613599|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
613600|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
613601|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
613602|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
613603|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613604|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
613605|NCT03438240|Narcotics|narcotics|mesh-ancestor
613606|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
613607|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
613608|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
613609|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
613610|NCT03438227|Dextrans|dextrans|mesh-list
613611|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
613612|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
613613|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
613614|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
613615|NCT03438227|Hematinics|hematinics|mesh-ancestor
613616|NCT03438214|Vancomycin|vancomycin|mesh-list
613617|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
613618|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217777|NCT00031902|Hormones|hormones|mesh-ancestor
2217778|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
613622|NCT03437980|Propofol|propofol|mesh-list
613623|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
613624|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613625|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613626|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
613627|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
613628|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
613629|NCT03437902|Vitamins|vitamins|mesh-list
613630|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
613631|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
613632|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613633|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
613634|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613635|NCT03437902|Protective Agents|protective agents|mesh-ancestor
613636|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
613637|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
613638|NCT03437824|Vitamins|vitamins|mesh-ancestor
613639|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
613640|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613641|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
613642|NCT03437824|Hematinics|hematinics|mesh-ancestor
613643|NCT03437785|Ethanol|ethanol|mesh-list
613644|NCT03437785|Rebamipide|rebamipide|mesh-list
613645|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
613646|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
613647|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613648|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613649|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
613650|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
613651|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
613652|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613653|NCT03437785|Protective Agents|protective agents|mesh-ancestor
613654|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613655|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
613656|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
613657|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
613658|NCT03437746|Prednisolone|prednisolone|mesh-list
613659|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
613660|NCT03437746|Anesthetics|anesthetics|mesh-list
613661|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
613662|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
613663|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
613664|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
613665|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
613666|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613667|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613668|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
613669|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
613670|NCT03437746|Hormones|hormones|mesh-ancestor
613671|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
613672|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
613673|NCT03437746|Protective Agents|protective agents|mesh-ancestor
613674|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
613675|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613676|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613677|NCT03437707|Acetaminophen|acetaminophen|mesh-list
613678|NCT03437707|Ibuprofen|ibuprofen|mesh-list
613679|NCT03437707|Morphine|morphine|mesh-list
613680|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
613681|NCT03437707|Narcotics|narcotics|mesh-ancestor
613682|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613683|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613684|NCT03437707|Analgesics|analgesics|mesh-ancestor
613685|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
613686|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613687|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
613688|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
613689|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
613690|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
613691|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
613692|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613693|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613694|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
613695|NCT03437655|Eugenol|eugenol|mesh-list
613696|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
613697|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
613698|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
613699|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
613700|NCT03437655|Protective Agents|protective agents|mesh-ancestor
613701|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613702|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
613703|NCT03437629|Calcium|calcium|mesh-list
613704|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
613705|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613706|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
613707|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
613708|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
613709|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
613710|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
613711|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
613712|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613713|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217779|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2217780|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2217781|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
2217782|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217783|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2217784|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217785|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217786|NCT00031928|Mafosfamide|mafosfamide|mesh-list
2217787|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2217788|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
2217789|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217790|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217791|NCT00031941|Lenalidomide|lenalidomide|mesh-list
2217792|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
2217793|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217794|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2217795|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2217796|NCT00031941|Growth Substances|growth substances|mesh-ancestor
2217797|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
2217798|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217799|NCT00031954|Gemcitabine|gemcitabine|mesh-list
2217800|NCT00031954|Paclitaxel|paclitaxel|mesh-list
2217801|NCT00031954|Carboplatin|carboplatin|mesh-list
2217802|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
613738|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
613739|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
613740|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
613741|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613742|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613743|NCT03437460|Ibuprofen|ibuprofen|mesh-list
613744|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613745|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
613746|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
613747|NCT03437460|Analgesics|analgesics|mesh-ancestor
613748|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
613749|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613750|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
613751|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
613752|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
613753|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613754|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217803|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217804|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217805|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217806|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
613759|NCT03437421|Vitamin D|vitamin d|mesh-list
613760|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
613761|NCT03437421|Vitamins|vitamins|mesh-ancestor
613762|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
613763|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613764|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
613765|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
613766|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2079139|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2079140|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2079141|NCT02054754|Analgesics|analgesics|mesh-ancestor
2079142|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
2079143|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2079144|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
613773|NCT03437226|Simendan|simendan|mesh-list
613774|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
613775|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
613776|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
613777|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
613778|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613779|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613780|NCT03437226|Protective Agents|protective agents|mesh-ancestor
613781|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613782|NCT03437213|Anesthetics|anesthetics|mesh-list
613783|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613784|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613785|NCT03437200|Nivolumab|nivolumab|mesh-list
613786|NCT03437200|Ipilimumab|ipilimumab|mesh-list
613787|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
613788|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613789|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
613790|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613791|NCT03437187|Analgesics|analgesics|mesh-list
613792|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613793|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
2079145|NCT02054754|Hormones|hormones|mesh-ancestor
2217807|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613794|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613795|NCT03437070|Doxorubicin|doxorubicin|mesh-list
613796|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
613797|NCT03437070|Trabectedin|trabectedin|mesh-list
613798|NCT03437070|Olaratumab|olaratumab|mesh-list
613799|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
613800|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613801|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
613802|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
613803|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613804|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613805|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
613806|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
613807|NCT03437057|Aspirin|aspirin|mesh-list
613808|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
613809|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
613810|NCT03437057|Analgesics|analgesics|mesh-ancestor
613811|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
613812|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613813|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613814|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
613815|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
613816|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
613817|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
613818|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613819|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
613820|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
613821|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613822|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
2079146|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2079154|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
2079155|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
613833|NCT03437005|Ketoconazole|ketoconazole|mesh-list
613834|NCT03437005|Desonide|desonide|mesh-list
613835|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
613836|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
613837|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
613838|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
613839|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613840|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613841|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
613842|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
613843|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
613844|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613845|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
613846|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
613847|NCT03436992|Resveratrol|resveratrol|mesh-list
613848|NCT03436992|Antioxidants|antioxidants|mesh-list
613849|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613850|NCT03436992|Protective Agents|protective agents|mesh-ancestor
613851|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613852|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613853|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2079156|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079157|NCT02055352|Fluticasone|fluticasone|mesh-list
2079158|NCT02055352|Budesonide|budesonide|mesh-list
2079159|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2079160|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
613859|NCT03436836|Lidocaine|lidocaine|mesh-list
613860|NCT03436836|Nalbuphine|nalbuphine|mesh-list
613861|NCT03436836|Bupivacaine|bupivacaine|mesh-list
613862|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
613863|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
613864|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613865|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613866|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
2079161|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
613867|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613868|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
613869|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
613870|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
613871|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
613872|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613873|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
613874|NCT03436836|Narcotics|narcotics|mesh-ancestor
613875|NCT03436836|Analgesics|analgesics|mesh-ancestor
2079162|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
2079163|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079164|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079165|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2079166|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
2079167|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
2079168|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2079169|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
2079170|NCT02055352|Hormones|hormones|mesh-ancestor
2079171|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
613886|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
613887|NCT03436719|Metronidazole|metronidazole|mesh-list
613888|NCT03436719|Erythromycin|erythromycin|mesh-list
613889|NCT03436719|Cefoperazone|cefoperazone|mesh-list
613890|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
613891|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
613892|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
613893|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
613894|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
613895|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
613896|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
613897|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613898|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613899|NCT03436693|Canagliflozin|canagliflozin|mesh-list
613900|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
613901|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613902|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
613903|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079172|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2079173|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2079174|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2079175|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
2079176|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079177|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079178|NCT02055638|SRX246|srx246|mesh-list
2079179|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2079180|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079181|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
2079182|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079183|NCT02055820|Prednisone|prednisone|mesh-list
2079184|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
2079185|NCT02055820|Rituximab|rituximab|mesh-list
613920|NCT03436498|Insulin|insulin|mesh-list
613921|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
613922|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
613923|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
613924|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
613925|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
613926|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613927|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
613928|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
613929|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613930|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613931|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
613932|NCT03436472|Analgesics|analgesics|mesh-ancestor
613933|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
613934|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613935|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
613936|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
613937|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
613938|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
613939|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614090|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
613940|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217808|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2217809|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
2217810|NCT00031954|Antiviral Agents|antiviral agents|mesh-ancestor
613952|NCT03436368|Anesthetics|anesthetics|mesh-list
613953|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
613954|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613955|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
613956|NCT03436303|Progestins|progestins|mesh-ancestor
613957|NCT03436303|Hormones|hormones|mesh-ancestor
613958|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
613959|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613960|NCT03436225|Dexamethasone|dexamethasone|mesh-list
613961|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
613962|NCT03436225|Budesonide|budesonide|mesh-list
613963|NCT03436225|Albuterol|albuterol|mesh-list
613964|NCT03436225|BB 1101|bb 1101|mesh-list
613965|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
613966|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
613967|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
613968|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
613969|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
613970|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
613971|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
613972|NCT03436225|Hormones|hormones|mesh-ancestor
613973|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
613974|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
613975|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
613976|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
613977|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
613978|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
613979|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
613980|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
613981|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
613982|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
613983|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
613984|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
613985|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
613986|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
613987|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
613988|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614002|NCT03436173|Fluoxetine|fluoxetine|mesh-list
614003|NCT03436173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
614004|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
614005|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
614006|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614007|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614008|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
614009|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614010|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
614011|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
614012|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
614013|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
614014|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
614015|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614016|NCT03436121|Midazolam|midazolam|mesh-list
614017|NCT03436121|Ketamine|ketamine|mesh-list
614018|NCT03436121|Analgesics|analgesics|mesh-ancestor
614019|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
614020|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614021|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614022|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
614023|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
614024|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
614025|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
614026|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
614027|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
614028|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
614029|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614030|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614031|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
614032|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
614033|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
614034|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
614035|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
614036|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
614037|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
614048|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
614049|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
614050|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614051|NCT03435952|Doxycycline|doxycycline|mesh-list
614052|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
614053|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
614054|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614055|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
614056|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614057|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
614058|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
614059|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2079186|NCT02055820|Doxorubicin|doxorubicin|mesh-list
2079187|NCT02055820|Vincristine|vincristine|mesh-list
2079188|NCT02055820|Venetoclax|venetoclax|mesh-list
2079189|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
2079190|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2079191|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
614066|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
614067|NCT03435900|Metronidazole|metronidazole|mesh-list
614068|NCT03435900|Fosfomycin|fosfomycin|mesh-list
614069|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
614070|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614071|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
614072|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
614073|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
614074|NCT03435744|Simvastatin|simvastatin|mesh-list
614075|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
614076|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
614077|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
614078|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614079|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
614080|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
614081|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614082|NCT03435718|Albendazole|albendazole|mesh-list
614083|NCT03435718|Oxfendazole|oxfendazole|mesh-list
614084|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
614085|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
614086|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614087|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
614088|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
614089|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2079192|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079193|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
614091|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
614092|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
614093|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614094|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614095|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
2079194|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2079195|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
2079196|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079197|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079198|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2079199|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2079200|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2079201|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2079202|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2079203|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079204|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2079205|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
2079206|NCT02055820|Hormones|hormones|mesh-ancestor
2079207|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2079208|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2079209|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2079210|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
2079211|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
2079212|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
2079213|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
2079214|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2079215|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2079216|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
2079217|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
2079218|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079219|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079220|NCT02055976|Ezetimibe|ezetimibe|mesh-list
2079221|NCT02055976|Bococizumab|bococizumab|mesh-list
2079222|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2079223|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2079224|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
2079225|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079226|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2079227|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2079228|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
2079229|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2079230|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2079231|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2079232|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079233|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079234|NCT02056288|Fentanyl|fentanyl|mesh-list
2079235|NCT02056288|Ropivacaine|ropivacaine|mesh-list
2079236|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
2079237|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
2079238|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
614141|NCT03435666|Capecitabine|capecitabine|mesh-list
614142|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
614143|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
614144|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614145|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079239|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217811|NCT00031954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217812|NCT00031954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217813|NCT00031954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217814|NCT00031954|Immunologic Factors|immunologic factors|mesh-ancestor
2217815|NCT00031954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217816|NCT00031967|Melatonin|melatonin|mesh-list
614157|NCT03435458|Misoprostol|misoprostol|mesh-list
614158|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
614159|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
614160|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
614161|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614162|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
614163|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
614164|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
614165|NCT03435302|Temozolomide|temozolomide|mesh-list
614166|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614167|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
614168|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
614169|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614170|NCT03435289|Gemcitabine|gemcitabine|mesh-list
614171|NCT03435289|Paclitaxel|paclitaxel|mesh-list
614172|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
614173|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
614174|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614175|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
614176|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
614177|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
614178|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614179|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
614180|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
614181|NCT03435289|Antiviral Agents|antiviral agents|mesh-ancestor
614182|NCT03435289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614183|NCT03435289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614184|NCT03435289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
614185|NCT03435289|Immunologic Factors|immunologic factors|mesh-ancestor
614186|NCT03435289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614187|NCT03435250|Gemcitabine|gemcitabine|mesh-list
614188|NCT03435250|Paclitaxel|paclitaxel|mesh-list
614189|NCT03435250|Docetaxel|docetaxel|mesh-list
614190|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
614191|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614192|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
614193|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
614194|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
614195|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614196|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
614197|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
614198|NCT03435250|Antiviral Agents|antiviral agents|mesh-ancestor
614199|NCT03435250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614200|NCT03435250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614201|NCT03435250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
614202|NCT03435250|Immunologic Factors|immunologic factors|mesh-ancestor
614203|NCT03435250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217817|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
2217818|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217819|NCT00031967|Protective Agents|protective agents|mesh-ancestor
2217820|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217821|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2217822|NCT00031980|Cyclosporine|cyclosporine|mesh-list
2217823|NCT00031980|Cyclosporins|cyclosporins|mesh-list
2217824|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217825|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217826|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217827|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
2217828|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614216|NCT03435133|Ticagrelor|ticagrelor|mesh-list
614217|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
614218|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
614219|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
614220|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
614221|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
614222|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
614223|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614224|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614225|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614226|NCT03435107|Durvalumab|durvalumab|mesh-list
614227|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
614228|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614229|NCT03435094|Alendronate|alendronate|mesh-list
614230|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
614231|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079240|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
2079241|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079242|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2079243|NCT02056288|Narcotics|narcotics|mesh-ancestor
2079244|NCT02056288|Analgesics|analgesics|mesh-ancestor
2079245|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2079246|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2079247|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
2079248|NCT02056301|Morphine|morphine|mesh-list
2079249|NCT02056301|Hydromorphone|hydromorphone|mesh-list
2217829|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
2217830|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217831|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
2217832|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217833|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
614305|NCT03434951|Morphine|morphine|mesh-list
614306|NCT03434951|Bupivacaine|bupivacaine|mesh-list
614307|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
614308|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
614309|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
614310|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614311|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
614312|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614313|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
614314|NCT03434951|Narcotics|narcotics|mesh-ancestor
614315|NCT03434951|Analgesics|analgesics|mesh-ancestor
614316|NCT03434782|Listerine|listerine|mesh-list
614317|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
614318|NCT03434782|Fluorides|fluorides|mesh-list
614319|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
614320|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
614321|NCT03434782|Protective Agents|protective agents|mesh-ancestor
614322|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217834|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
614323|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
614324|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614325|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
614326|NCT03434769|Fludarabine|fludarabine|mesh-list
614327|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
614328|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
614329|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614330|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
614331|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
614332|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
614333|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614334|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614335|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
614357|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
614358|NCT03434704|Clotrimazole|clotrimazole|mesh-list
614359|NCT03434704|Miconazole|miconazole|mesh-list
614360|NCT03434704|Fludarabine|fludarabine|mesh-list
614361|NCT03434704|Thiotepa|thiotepa|mesh-list
614362|NCT03434704|Treosulfan|treosulfan|mesh-list
614363|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614364|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614365|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
614366|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
614367|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614368|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
614369|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
614370|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
614371|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614372|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
614373|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
614374|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
614375|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614376|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
614377|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
614378|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
614379|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
614380|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
614381|NCT03434691|Remifentanil|remifentanil|mesh-list
614382|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
614383|NCT03434691|Narcotics|narcotics|mesh-ancestor
614384|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
614385|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614386|NCT03434691|Analgesics|analgesics|mesh-ancestor
614387|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
614388|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614389|NCT03434678|Fentanyl|fentanyl|mesh-list
614390|NCT03434678|Bupivacaine|bupivacaine|mesh-list
614391|NCT03434678|Propofol|propofol|mesh-list
614392|NCT03434678|Rocuronium|rocuronium|mesh-list
614393|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
614394|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
614395|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
614396|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614397|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
614398|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614399|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
614400|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
614401|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
614402|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
614403|NCT03434678|Narcotics|narcotics|mesh-ancestor
614404|NCT03434678|Analgesics|analgesics|mesh-ancestor
614405|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
614406|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
614407|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
614408|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
614409|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
614410|NCT03434613|Ezetimibe|ezetimibe|mesh-list
614411|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
614412|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
614413|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
614414|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614415|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
614416|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
614417|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614418|NCT03434444|Propranolol|propranolol|mesh-list
614419|NCT03434444|Oxytocin|oxytocin|mesh-list
614420|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
614421|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
614422|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614423|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
614424|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
614425|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
614426|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614427|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614428|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
614429|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
614430|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
2079250|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2079251|NCT02056301|Narcotics|narcotics|mesh-ancestor
2079252|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079253|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079254|NCT02056301|Analgesics|analgesics|mesh-ancestor
614436|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
2079255|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
2079256|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079257|NCT02056340|Atorvastatin|atorvastatin|mesh-list
2079258|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2079259|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2079260|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
2079261|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079262|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2079263|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2079264|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079265|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
2079266|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2079267|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614450|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
614451|NCT03434366|Ketamine|ketamine|mesh-list
614452|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
614453|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
614454|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614455|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
614456|NCT03434366|Analgesics|analgesics|mesh-ancestor
614457|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
614458|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614459|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
614460|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
614461|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
614462|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
614463|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614464|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614465|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
614466|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
614467|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
614468|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
614469|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
614470|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
614471|NCT03434340|Dexamethasone|dexamethasone|mesh-list
614472|NCT03434340|Granisetron|granisetron|mesh-list
614473|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
614474|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
614475|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
614476|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614477|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614478|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
614479|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
614480|NCT03434340|Hormones|hormones|mesh-ancestor
614481|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
614482|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
614483|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614484|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
614485|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
614486|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614487|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614488|NCT03434275|Meloxicam|meloxicam|mesh-list
614489|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
614490|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
614491|NCT03434275|Analgesics|analgesics|mesh-ancestor
614492|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
614493|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614494|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614495|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
614496|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
614497|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
614498|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
614499|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614500|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614501|NCT03434262|Gemcitabine|gemcitabine|mesh-list
614502|NCT03434262|Trametinib|trametinib|mesh-list
614503|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
614504|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
614505|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614506|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614507|NCT03434262|Antiviral Agents|antiviral agents|mesh-ancestor
614508|NCT03434262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614509|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614510|NCT03434262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
614511|NCT03434262|Immunologic Factors|immunologic factors|mesh-ancestor
614512|NCT03434262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614513|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
614514|NCT03434197|Diclofenac|diclofenac|mesh-list
614515|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
614516|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
614517|NCT03434197|Analgesics|analgesics|mesh-ancestor
614518|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
614519|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614520|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614521|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
614522|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
614523|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
614524|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614525|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614526|NCT03434158|Olaparib|olaparib|mesh-list
614527|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
614528|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614529|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614530|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217835|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217836|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2217837|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217838|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217839|NCT00032019|Prednisone|prednisone|mesh-list
614537|NCT03434106|Dextrans|dextrans|mesh-list
614538|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
614539|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
614540|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
614541|NCT03434054|Losartan|losartan|mesh-list
614542|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
614543|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
614544|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
614545|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
614546|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614547|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
614548|NCT03434041|Citalopram|citalopram|mesh-list
614549|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
614550|NCT03434041|Sertraline|sertraline|mesh-list
614551|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
614552|NCT03434041|Esketamine|esketamine|mesh-list
614553|NCT03434041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
614554|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
614555|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
614556|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614557|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614558|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
614559|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614560|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
614561|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
614562|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614563|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
614564|NCT03434041|Analgesics|analgesics|mesh-ancestor
614565|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
614566|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
614567|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
614568|NCT03433976|Anesthetics|anesthetics|mesh-list
614569|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
614570|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614571|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
614572|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
614573|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
614574|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614575|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614576|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
614577|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
614578|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614579|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
614580|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614581|NCT03433833|Digoxin|digoxin|mesh-list
614582|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
614583|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
614584|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614585|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614586|NCT03433833|Protective Agents|protective agents|mesh-ancestor
614587|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614588|NCT03433807|Idebenone|idebenone|mesh-list
614589|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
614590|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614591|NCT03433807|Protective Agents|protective agents|mesh-ancestor
614592|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217840|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
2217841|NCT00032019|Rituximab|rituximab|mesh-list
2217842|NCT00032019|Doxorubicin|doxorubicin|mesh-list
2217843|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2217844|NCT00032019|Etoposide|etoposide|mesh-list
2217845|NCT00032019|Vincristine|vincristine|mesh-list
2217846|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217847|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
2217848|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217849|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217850|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2217851|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
2217852|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217853|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614607|NCT03433586|Aspirin|aspirin|mesh-list
614608|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
614609|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
614610|NCT03433586|Analgesics|analgesics|mesh-ancestor
614611|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
614612|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614613|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614614|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
614615|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
614616|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
614617|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
614618|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614619|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
614620|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2217854|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
614621|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614622|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
614623|NCT03433534|Nivolumab|nivolumab|mesh-list
614624|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
614625|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614626|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
614627|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614628|NCT03433469|Osimertinib|osimertinib|mesh-list
614629|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614630|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
614631|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614632|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614633|NCT03433378|Tretinoin|tretinoin|mesh-list
614634|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614635|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
614636|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
614637|NCT03433352|Methimazole|methimazole|mesh-list
614638|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
614639|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
614640|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
614641|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
614642|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614643|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
614644|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614645|NCT03433326|Grazoprevir|grazoprevir|mesh-list
614646|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
614647|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614648|NCT03433313|Trastuzumab|trastuzumab|mesh-list
614649|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
614650|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614664|NCT03433235|Edoxaban|edoxaban|mesh-list
614665|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
614666|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
614667|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
614668|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
614669|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614670|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614671|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
614672|NCT03433222|Coal Tar|coal tar|mesh-list
614673|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
614674|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
614675|NCT03433196|Atorvastatin|atorvastatin|mesh-list
614676|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
614677|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
614678|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
614679|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614680|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
614681|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
614682|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614683|NCT03433183|Sirolimus|sirolimus|mesh-list
614684|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
614685|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614686|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
614687|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614688|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
614689|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
614690|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
614691|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614692|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
614693|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
614694|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
614695|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614696|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
614697|NCT03433144|Coagulants|coagulants|mesh-ancestor
614698|NCT03433092|Carotenoids|carotenoids|mesh-list
614699|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
614700|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614701|NCT03433092|Protective Agents|protective agents|mesh-ancestor
614702|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614711|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
614712|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
614713|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
614714|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
614715|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614716|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
614717|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614718|NCT03433001|Dexamethasone|dexamethasone|mesh-list
614719|NCT03433001|Lenalidomide|lenalidomide|mesh-list
614720|NCT03433001|Ixazomib|ixazomib|mesh-list
614721|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
614722|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
614723|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
614724|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614725|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614726|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
614727|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
614728|NCT03433001|Hormones|hormones|mesh-ancestor
614729|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
614730|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
614731|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614732|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
614733|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
614734|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
614735|NCT03433001|Growth Substances|growth substances|mesh-ancestor
614736|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
614737|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
614738|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614739|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614740|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
614741|NCT03432975|Povidone|povidone|mesh-list
614742|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
614743|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
614744|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
614745|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614746|NCT03432949|Dexamethasone|dexamethasone|mesh-list
614747|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
614748|NCT03432949|BB 1101|bb 1101|mesh-list
614749|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
614750|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
614751|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
614752|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614753|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614754|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
614755|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
614756|NCT03432949|Hormones|hormones|mesh-ancestor
614757|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
614758|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
614759|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614760|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
614761|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614762|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614763|NCT03432923|Benzocaine|benzocaine|mesh-list
614764|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
614765|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
614766|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
614767|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614768|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
614769|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614770|NCT03432897|Olaparib|olaparib|mesh-list
614771|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
614772|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614773|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614774|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614775|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
614776|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
614777|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
614778|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614779|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
614780|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
614781|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614782|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614783|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614784|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
614785|NCT03432871|Niacinamide|niacinamide|mesh-list
614786|NCT03432871|Niacin|niacin|mesh-list
614787|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
614788|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
614789|NCT03432871|Vitamins|vitamins|mesh-ancestor
614790|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
614791|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614792|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
614793|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
614794|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614795|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
614796|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
2079268|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2079269|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2079270|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751210|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614801|NCT03432793|Itraconazole|itraconazole|mesh-list
614802|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
614803|NCT03432793|Caffeine|caffeine|mesh-list
614804|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
614805|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614806|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
614807|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614808|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614809|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
614810|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
614811|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
614812|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614813|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
614814|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614815|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
614816|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
614817|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
614818|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
614819|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
614820|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
614821|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
614822|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
614823|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
614824|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
614825|NCT03432793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
614826|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
614827|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
614828|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
614829|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
614830|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
614831|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
614832|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
614833|NCT03432780|Docetaxel|docetaxel|mesh-list
614834|NCT03432780|Hormones|hormones|mesh-list
614835|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614836|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
614837|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
614838|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
614839|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614840|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
614841|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751211|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
2751212|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2751213|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
2751214|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751215|NCT04019327|Temozolomide|temozolomide|mesh-list
2751216|NCT04019327|Talazoparib|talazoparib|mesh-list
2751217|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2751218|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
2751219|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751220|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751221|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2751222|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751223|NCT04019288|Durvalumab|durvalumab|mesh-list
2751224|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
2751225|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2751226|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
2751227|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2751228|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751229|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
2751230|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614873|NCT03432728|Anesthetics|anesthetics|mesh-list
614874|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
614875|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614876|NCT03432689|Cycloserine|cycloserine|mesh-list
614877|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
614878|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614879|NCT03432689|Renal Agents|renal agents|mesh-ancestor
614880|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
614881|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
614882|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
614883|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
614884|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614885|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
614886|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
614887|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614888|NCT03432663|Amiodarone|amiodarone|mesh-list
614889|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
614890|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
614891|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
614892|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
614893|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614894|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
614895|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
614896|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
614897|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614898|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
614899|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
614900|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
614901|NCT03432650|Dexamethasone|dexamethasone|mesh-list
614902|NCT03432650|Bupivacaine|bupivacaine|mesh-list
614903|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
614904|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
614905|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
614906|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614907|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614908|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
614909|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
614910|NCT03432650|Hormones|hormones|mesh-ancestor
614911|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
614912|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
614913|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614914|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
614915|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
614916|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
614917|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
614918|NCT03432637|Anesthetics|anesthetics|mesh-list
614919|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
614920|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614921|NCT03432598|Gemcitabine|gemcitabine|mesh-list
614922|NCT03432598|Paclitaxel|paclitaxel|mesh-list
614923|NCT03432598|Etoposide|etoposide|mesh-list
614924|NCT03432598|Carboplatin|carboplatin|mesh-list
614925|NCT03432598|Pemetrexed|pemetrexed|mesh-list
614926|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
614927|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
614928|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
614929|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
614930|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
614931|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614932|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
614933|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
614934|NCT03432598|Antiviral Agents|antiviral agents|mesh-ancestor
614935|NCT03432598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614936|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614937|NCT03432598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
614938|NCT03432598|Immunologic Factors|immunologic factors|mesh-ancestor
614939|NCT03432598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614940|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
614941|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
614942|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
614943|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
614944|NCT03432572|Riboflavin|riboflavin|mesh-list
614945|NCT03432572|Thiamine|thiamine|mesh-list
614946|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
614947|NCT03432572|Vitamins|vitamins|mesh-ancestor
614948|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
614949|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614950|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
614951|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
2217855|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2217856|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2217857|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
614955|NCT03432468|Valsartan|valsartan|mesh-list
614956|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
614957|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
614958|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
614959|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614960|NCT03432442|Ivermectin|ivermectin|mesh-list
614961|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
614962|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
614963|NCT03432312|Nicotine|nicotine|mesh-list
614964|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
614965|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
614966|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614967|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614968|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
614969|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
614970|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
614971|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614972|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614973|NCT03432273|Nicotine|nicotine|mesh-list
614974|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
614975|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
614976|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
614977|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614978|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
614979|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
614980|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
614981|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614982|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614983|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
614984|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
614985|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
614986|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
614987|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614988|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614989|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614990|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
614991|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
614992|NCT03432195|Donepezil|donepezil|mesh-list
614993|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
614994|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
614995|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
614996|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
614997|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
614998|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
614999|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
615000|NCT03432091|Melatonin|melatonin|mesh-list
615001|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
615002|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615003|NCT03432091|Protective Agents|protective agents|mesh-ancestor
615004|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615005|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615016|NCT03431987|Ethanol|ethanol|mesh-list
615017|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
615018|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
615019|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615020|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615021|NCT03431974|Aminopterin|aminopterin|mesh-list
615022|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
615023|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615024|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615025|NCT03431961|Triamcinolone|triamcinolone|mesh-list
615026|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
615027|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
615028|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
615029|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
615030|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
615031|NCT03431961|Hormones|hormones|mesh-ancestor
615032|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
615033|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615034|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
615035|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
615036|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615037|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615038|NCT03431948|Nivolumab|nivolumab|mesh-list
615039|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
615040|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615041|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
615042|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615043|NCT03431909|Aspirin|aspirin|mesh-list
615044|NCT03431909|Kallikreins|kallikreins|mesh-list
615045|NCT03431909|Clopidogrel|clopidogrel|mesh-list
615046|NCT03431909|Atorvastatin|atorvastatin|mesh-list
615047|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
615048|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
615049|NCT03431909|Analgesics|analgesics|mesh-ancestor
615050|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
615051|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615052|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615053|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
615054|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
615055|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
615056|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
615057|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615058|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
615059|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
615060|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615061|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
615062|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
615063|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
615064|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
615065|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
615066|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
615067|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
615068|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
615069|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
615070|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
615071|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615072|NCT03431909|Coagulants|coagulants|mesh-ancestor
615073|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
615074|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
615075|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
615076|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
615077|NCT03431831|Naltrexone|naltrexone|mesh-list
615078|NCT03431831|Bupropion|bupropion|mesh-list
615079|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
615080|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
615081|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
615082|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615083|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
615084|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615085|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
615086|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
615087|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
615088|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
615089|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
615090|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
615091|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615092|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
615093|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615094|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
615095|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
615096|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615097|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
615098|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
615099|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
615100|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615101|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
615102|NCT03431805|Coagulants|coagulants|mesh-ancestor
615103|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
615104|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
615105|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
615106|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
615107|NCT03431714|Artesunate|artesunate|mesh-list
615108|NCT03431714|Piperaquine|piperaquine|mesh-list
615109|NCT03431714|Amodiaquine|amodiaquine|mesh-list
615110|NCT03431714|Artenimol|artenimol|mesh-list
615111|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
615112|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
615113|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
615114|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
615115|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615116|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
615117|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
615118|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
615119|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
615120|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
615121|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
615122|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
615123|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
615124|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
615125|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
615126|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
615127|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
615128|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
615129|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
615130|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615131|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615132|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615133|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
615134|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
615135|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
615136|NCT03431649|Beraprost|beraprost|mesh-list
615137|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615138|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
615139|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
615140|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
615141|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615142|NCT03431649|Urological Agents|urological agents|mesh-ancestor
615143|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
615144|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
615145|NCT03431623|Hematinics|hematinics|mesh-ancestor
615146|NCT03431597|Micronutrients|micronutrients|mesh-list
615147|NCT03431597|Trace Elements|trace elements|mesh-list
615148|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615149|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
615150|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
615151|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
615152|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615153|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
615154|NCT03431584|Protective Agents|protective agents|mesh-ancestor
615155|NCT03431558|Lactoferrin|lactoferrin|mesh-list
615156|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079271|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079272|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079273|NCT02056626|Carvedilol|carvedilol|mesh-list
2079274|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2079275|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2079276|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
2079277|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079278|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079279|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079280|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2079281|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
2079282|NCT02056626|Protective Agents|protective agents|mesh-ancestor
2079283|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2079284|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2079285|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2079286|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
2217858|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2217859|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217860|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
615176|NCT03431285|Morphine|morphine|mesh-list
615177|NCT03431285|Ketamine|ketamine|mesh-list
615178|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
615179|NCT03431285|Narcotics|narcotics|mesh-ancestor
615180|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615181|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615182|NCT03431285|Analgesics|analgesics|mesh-ancestor
615183|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
615184|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615185|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
615186|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
615187|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
615188|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
615189|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
615190|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
615191|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615192|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615193|NCT03431272|Lifitegrast|lifitegrast|mesh-list
615194|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
615195|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
615196|NCT03431194|Midodrine|midodrine|mesh-list
615197|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
615198|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
615199|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615200|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615201|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
615202|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
615203|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
615204|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
615205|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
615206|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615207|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615208|NCT03431168|Azithromycin|azithromycin|mesh-list
615209|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
615210|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
615211|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
615212|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
615213|NCT03431168|Renal Agents|renal agents|mesh-ancestor
615214|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
615215|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
615216|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
615217|NCT03431142|Aspirin|aspirin|mesh-list
615218|NCT03431142|Clopidogrel|clopidogrel|mesh-list
615219|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
615220|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
615221|NCT03431142|Analgesics|analgesics|mesh-ancestor
615222|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
615223|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615224|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615225|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
615226|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
615227|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
615228|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
615229|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615230|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
615231|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
615232|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615233|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
615234|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
615235|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
615236|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
615237|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
615238|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615239|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
615240|NCT03431077|Giapreza|giapreza|mesh-list
615241|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
615242|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
615243|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
615244|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
615245|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615246|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217861|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
2217862|NCT00032019|Hormones|hormones|mesh-ancestor
2217863|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2217864|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2217865|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2217866|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217867|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217868|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217869|NCT00032032|Paclitaxel|paclitaxel|mesh-list
2217870|NCT00032032|Carboplatin|carboplatin|mesh-list
2217871|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2217872|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615259|NCT03430947|Vemurafenib|vemurafenib|mesh-list
615260|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615261|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
615262|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615263|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079287|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2079288|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2079289|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2079290|NCT02057198|Metronidazole|metronidazole|mesh-list
615268|NCT03430882|Paclitaxel|paclitaxel|mesh-list
615269|NCT03430882|Carboplatin|carboplatin|mesh-list
615270|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
615271|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
615272|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615273|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
615274|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
615275|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
615276|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217873|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217874|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
2217875|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217876|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217877|NCT00032045|Ipilimumab|ipilimumab|mesh-list
2079291|NCT02057198|Vancomycin|vancomycin|mesh-list
2079292|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
2079293|NCT02057198|Amebicides|amebicides|mesh-list
2079294|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079295|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2079296|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2079297|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
2079298|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
2079299|NCT02057250|Methotrexate|methotrexate|mesh-list
2079300|NCT02057250|Leflunomide|leflunomide|mesh-list
2079301|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2079302|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
615294|NCT03430817|Amantadine|amantadine|mesh-list
615295|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
615296|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2079303|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
615297|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
615298|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
615299|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
615300|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
615301|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615302|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615303|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615304|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
615305|NCT03430817|Analgesics|analgesics|mesh-ancestor
615306|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
615307|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615308|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
2079304|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079305|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2079306|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
2079307|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079308|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615315|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
615316|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
615317|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615318|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
615319|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
615320|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615321|NCT03430661|Clopidogrel|clopidogrel|mesh-list
615322|NCT03430661|Ticagrelor|ticagrelor|mesh-list
615323|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
615324|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
615325|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
615326|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
615327|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
615328|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
615329|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615330|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615331|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615332|NCT03430609|Hormones|hormones|mesh-list
615333|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
615334|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615335|NCT03430596|Pramipexole|pramipexole|mesh-list
615336|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
615337|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
615338|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615339|NCT03430596|Protective Agents|protective agents|mesh-ancestor
615340|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615341|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
615342|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
615343|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
615344|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
615345|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615346|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
615347|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
615348|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
615349|NCT03430544|Cariprazine|cariprazine|mesh-list
615350|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
615351|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
615352|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615353|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615354|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
615355|NCT03430531|Lidocaine|lidocaine|mesh-list
615356|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
615357|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
615358|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615359|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615360|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
615361|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615362|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
615363|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
615364|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
615365|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
615366|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615367|NCT03430518|Durvalumab|durvalumab|mesh-list
615368|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
615369|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615370|NCT03430505|Albuterol|albuterol|mesh-list
615371|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
615372|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
615373|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615374|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615375|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
615376|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
615377|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
615378|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
615379|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
615380|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
615381|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
615382|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
615383|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615384|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615385|NCT03430466|Fulvestrant|fulvestrant|mesh-list
615386|NCT03430466|Tremelimumab|tremelimumab|mesh-list
615387|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
615388|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615389|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
615390|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
615391|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
615392|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
615393|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615394|NCT03430362|Scopolamine|scopolamine|mesh-list
615395|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
615396|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
615397|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
615398|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
615399|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615400|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615401|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
615402|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
615403|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
615404|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
615405|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615406|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615407|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
615408|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
615409|NCT03430297|Dacarbazine|dacarbazine|mesh-list
615410|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
615411|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
615412|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615413|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615414|NCT03430219|Calcium|calcium|mesh-list
615415|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
615416|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615417|NCT03430180|Naloxone|naloxone|mesh-list
615418|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
615419|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615420|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
615421|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079309|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
2079310|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079311|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2079312|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2079313|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
2079314|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217878|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
2217879|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2217880|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217881|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
615433|NCT03430024|Estrogens|estrogens|mesh-list
615434|NCT03430024|Hormones|hormones|mesh-ancestor
615435|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
615436|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615437|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
615438|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
615439|NCT03429998|Evolocumab|evolocumab|mesh-list
615440|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
615441|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
615442|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
615443|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
615518|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615444|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615445|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
615446|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
615447|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615448|NCT03429972|Paclitaxel|paclitaxel|mesh-list
615449|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
615450|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615451|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
615452|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
615453|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
615454|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615455|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
615456|NCT03429946|Spironolactone|spironolactone|mesh-list
615457|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
615458|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
615459|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
615460|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615461|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
615462|NCT03429946|Diuretics|diuretics|mesh-ancestor
615463|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
615464|NCT03429738|Ibuprofen|ibuprofen|mesh-list
615465|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
615466|NCT03429738|Ephedrine|ephedrine|mesh-list
615467|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
615468|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
615469|NCT03429738|Analgesics|analgesics|mesh-ancestor
615470|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
615471|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615472|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615473|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
615474|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
615475|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
615476|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615477|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615478|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
615479|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
615480|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
615481|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
615482|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
615483|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
615484|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
615485|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
615486|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
615487|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615488|NCT03429621|Simethicone|simethicone|mesh-list
615489|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
615490|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615491|NCT03429621|Emollients|emollients|mesh-ancestor
615492|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
2217882|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217883|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2217884|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
2217885|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217886|NCT00032084|Bupropion|bupropion|mesh-list
2217887|NCT00032084|Nicotine|nicotine|mesh-list
2217888|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2079315|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2079316|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
2079317|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2079318|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2079319|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079320|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2079321|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2079322|NCT02057250|Analgesics|analgesics|mesh-ancestor
2079323|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
2079324|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079325|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2079326|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
615512|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
615513|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
615514|NCT03429400|Morphine|morphine|mesh-list
615515|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
615516|NCT03429400|Narcotics|narcotics|mesh-ancestor
615517|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2217889|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
615519|NCT03429400|Analgesics|analgesics|mesh-ancestor
615520|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
615521|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615522|NCT03429309|Propofol|propofol|mesh-list
615523|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
615524|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615525|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615526|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
615527|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
615528|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
615529|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
615530|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
615531|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615532|NCT03429179|Butorphanol|butorphanol|mesh-list
615533|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
615534|NCT03429179|Narcotics|narcotics|mesh-ancestor
615535|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615536|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615537|NCT03429179|Analgesics|analgesics|mesh-ancestor
615538|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
615539|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615540|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
615541|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
615542|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
615543|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
615544|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
615545|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
615546|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615547|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
615548|NCT03429140|Protective Agents|protective agents|mesh-ancestor
615549|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
615550|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
615551|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
615552|NCT03429101|Trastuzumab|trastuzumab|mesh-list
615553|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
615554|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
615555|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615556|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
615557|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
615558|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
615559|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615560|NCT03429075|Citalopram|citalopram|mesh-list
615561|NCT03429075|Psilocybin|psilocybin|mesh-list
615562|NCT03429075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
615563|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
615564|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
615565|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615566|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615567|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
615568|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615569|NCT03429075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
615570|NCT03429075|Antidepressive Agents|antidepressive agents|mesh-ancestor
615571|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
615572|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
615573|NCT03429049|Capsaicin|capsaicin|mesh-list
615574|NCT03429049|Antipruritics|antipruritics|mesh-ancestor
615575|NCT03429049|Dermatologic Agents|dermatologic agents|mesh-ancestor
615576|NCT03429049|Sensory System Agents|sensory system agents|mesh-ancestor
615577|NCT03429049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615578|NCT03429049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615579|NCT03429010|Anesthetics|anesthetics|mesh-list
615580|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615581|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615613|NCT03428906|Oxytocin|oxytocin|mesh-list
615614|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
615615|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
615616|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615617|NCT03428880|Morphine|morphine|mesh-list
615618|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
615619|NCT03428880|Narcotics|narcotics|mesh-ancestor
615620|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615621|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615622|NCT03428880|Analgesics|analgesics|mesh-ancestor
615623|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
615624|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615625|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
615626|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
615627|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615628|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
615629|NCT03428685|Progestins|progestins|mesh-ancestor
615630|NCT03428685|Hormones|hormones|mesh-ancestor
615631|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
615632|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615633|NCT03428633|Morphine|morphine|mesh-list
615634|NCT03428633|Ropivacaine|ropivacaine|mesh-list
615635|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
615636|NCT03428633|Narcotics|narcotics|mesh-ancestor
615637|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615638|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615639|NCT03428633|Analgesics|analgesics|mesh-ancestor
615640|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
615641|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615642|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
615643|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
615644|NCT03428607|Olaparib|olaparib|mesh-list
615645|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
615646|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615647|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615648|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615649|NCT03428568|Clarithromycin|clarithromycin|mesh-list
615650|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
615651|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
615652|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
615653|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615654|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615655|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
615656|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
615657|NCT03428529|Fluorouracil|fluorouracil|mesh-list
615658|NCT03428529|Capecitabine|capecitabine|mesh-list
615659|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
615660|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615661|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
615662|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615663|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
615664|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
615665|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615666|NCT03428503|Acetaminophen|acetaminophen|mesh-list
615667|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
615668|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
615669|NCT03428503|Analgesics|analgesics|mesh-ancestor
615670|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
615671|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615672|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615673|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
615674|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
615675|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
615676|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
615677|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
615678|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
615679|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
615680|NCT03428425|Paclitaxel|paclitaxel|mesh-list
615681|NCT03428425|Apatinib|apatinib|mesh-list
615682|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
615683|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615684|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
615685|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
615686|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
615687|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615688|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
615689|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615690|NCT03428373|Aspirin|aspirin|mesh-list
615691|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
615692|NCT03428373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
615693|NCT03428373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
615694|NCT03428373|Analgesics|analgesics|mesh-ancestor
615695|NCT03428373|Sensory System Agents|sensory system agents|mesh-ancestor
615696|NCT03428373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615697|NCT03428373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615698|NCT03428373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
615699|NCT03428373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
615700|NCT03428373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
615701|NCT03428373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
615702|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615703|NCT03428373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
615704|NCT03428373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
615705|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615706|NCT03428373|Antipyretics|antipyretics|mesh-ancestor
615707|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
615708|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
615709|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
615710|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
615711|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
2217896|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217897|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2217898|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
2217899|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2217900|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2217901|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2217902|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2217903|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
2217904|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2217905|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2217906|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217907|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
2217908|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217909|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2217910|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
2217911|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2217912|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217913|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2217914|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217915|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217916|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2217917|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615734|NCT03428282|Anesthetics|anesthetics|mesh-list
615735|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615736|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615737|NCT03428256|Anesthetics|anesthetics|mesh-list
615738|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615739|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217918|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2217919|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217920|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217921|NCT00032136|Tamoxifen|tamoxifen|mesh-list
2217922|NCT00032136|Exemestane|exemestane|mesh-list
2217923|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217924|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2217925|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
2217926|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
615752|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
615753|NCT03428191|Remifentanil|remifentanil|mesh-list
615754|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
615755|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615756|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615757|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
615758|NCT03428191|Analgesics|analgesics|mesh-ancestor
615759|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
615760|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615761|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
615762|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
615763|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
615764|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
615765|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615766|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615767|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
615768|NCT03428191|Narcotics|narcotics|mesh-ancestor
615769|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
615770|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
615771|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615772|NCT03428139|Protective Agents|protective agents|mesh-ancestor
615773|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615774|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
615775|NCT03428139|Vitamins|vitamins|mesh-ancestor
615776|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
615777|NCT03428126|Durvalumab|durvalumab|mesh-list
615778|NCT03428126|Trametinib|trametinib|mesh-list
615779|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
615780|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615781|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
615782|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615783|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615784|NCT03428022|Apatinib|apatinib|mesh-list
615785|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615786|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
615787|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615788|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615789|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
615790|NCT03427944|Calcium|calcium|mesh-list
615791|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
615792|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615793|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
615794|NCT03427944|Coagulants|coagulants|mesh-ancestor
2217927|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217928|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2217929|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217930|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2217931|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
615802|NCT03427801|Hematinics|hematinics|mesh-list
615820|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
615821|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
615822|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
615823|NCT03427632|Protective Agents|protective agents|mesh-ancestor
662936|NCT03196882|Iron|iron|mesh-list
615824|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079517|NCT02059161|Insulin|insulin|mesh-list
2079518|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
615827|NCT03427554|Tretinoin|tretinoin|mesh-list
615828|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615829|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
615830|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
615831|NCT03427502|Epinephrine|epinephrine|mesh-list
615832|NCT03427502|Bupivacaine|bupivacaine|mesh-list
615833|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
615834|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
615835|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615836|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615837|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
615838|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615839|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
615840|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
615841|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
615842|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615843|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615844|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
615845|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
615846|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
615847|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
615848|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
615849|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
615850|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
615851|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
615852|NCT03427463|Morphine|morphine|mesh-list
615853|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
615854|NCT03427463|Narcotics|narcotics|mesh-ancestor
615855|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615856|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615857|NCT03427463|Analgesics|analgesics|mesh-ancestor
615858|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
615859|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615860|NCT03427437|Epinephrine|epinephrine|mesh-list
615861|NCT03427437|Racepinephrine|racepinephrine|mesh-list
615862|NCT03427437|Bupivacaine|bupivacaine|mesh-list
615863|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
615864|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
615865|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
615866|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615867|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615868|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
615869|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615870|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
615871|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
615872|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
615873|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615874|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615875|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
615876|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
615877|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
615878|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
615879|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
615880|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
615881|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
615882|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
615883|NCT03427385|Ropivacaine|ropivacaine|mesh-list
615884|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
615885|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
615886|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615887|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615888|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
615889|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615890|NCT03427359|Capecitabine|capecitabine|mesh-list
615891|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615892|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
615893|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
615894|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615895|NCT03427242|Apatinib|apatinib|mesh-list
615896|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615897|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
615898|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615899|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615900|NCT03427229|Vancomycin|vancomycin|mesh-list
615901|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
615902|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
615903|NCT03427216|Diazepam|diazepam|mesh-list
615904|NCT03427216|Baclofen|baclofen|mesh-list
615905|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
615906|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615907|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
615908|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
615909|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
615910|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
615911|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
615912|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
615913|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615914|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
615915|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
615916|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
615917|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
615918|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
615919|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
615920|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
615921|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
615922|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
615923|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
615924|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
615925|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
615926|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
615927|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
615928|NCT03427125|Sevelamer|sevelamer|mesh-list
615929|NCT03427125|Chelating Agents|chelating agents|mesh-ancestor
615930|NCT03427125|Sequestering Agents|sequestering agents|mesh-ancestor
615931|NCT03427125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615932|NCT03427086|Biotin|biotin|mesh-list
615933|NCT03427086|Vitamins|vitamins|mesh-ancestor
615934|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
615935|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615936|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
615937|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
615938|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217932|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2217933|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2217934|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
615942|NCT03426982|Heparin|heparin|mesh-list
615943|NCT03426982|Calcium heparin|calcium heparin|mesh-list
615944|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
615945|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
615946|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
615947|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615948|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
615949|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
615950|NCT03426969|Melphalan|melphalan|mesh-list
615951|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
615952|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
615953|NCT03426969|Fludarabine|fludarabine|mesh-list
615954|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
615955|NCT03426969|Tacrolimus|tacrolimus|mesh-list
615956|NCT03426969|Lenograstim|lenograstim|mesh-list
615957|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
615958|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
615959|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615960|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
615961|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
615962|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
615963|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615964|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615965|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
615966|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
615967|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
615968|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
615969|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
615970|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
615971|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
615972|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
615973|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
615974|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
615975|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
615976|NCT03426956|Canagliflozin|canagliflozin|mesh-list
615977|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
615978|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615979|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
615980|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615981|NCT03426904|Leucovorin|leucovorin|mesh-list
615982|NCT03426904|Fluorouracil|fluorouracil|mesh-list
615983|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
615984|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
615985|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
615986|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
615987|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
615988|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
615989|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
615990|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
615991|NCT03426904|Antidotes|antidotes|mesh-ancestor
615992|NCT03426904|Protective Agents|protective agents|mesh-ancestor
615993|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
615994|NCT03426904|Vitamins|vitamins|mesh-ancestor
615995|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
2079519|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
2079520|NCT02059161|MK-1293|mk-1293|mesh-list
2079521|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2079522|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079523|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2079524|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
2079525|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079526|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2079527|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
2079528|NCT02059174|MK-1293|mk-1293|mesh-list
616006|NCT03426761|Vancomycin|vancomycin|mesh-list
616007|NCT03426761|Cefazolin|cefazolin|mesh-list
616008|NCT03426761|Daptomycin|daptomycin|mesh-list
616009|NCT03426761|Dalbavancin|dalbavancin|mesh-list
616010|NCT03426761|Nafcillin|nafcillin|mesh-list
616011|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
616012|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
616013|NCT03426657|Durvalumab|durvalumab|mesh-list
616014|NCT03426657|Tremelimumab|tremelimumab|mesh-list
616015|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
616016|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616017|NCT03426592|Vitamin D|vitamin d|mesh-list
616018|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
616019|NCT03426592|Vitamins|vitamins|mesh-ancestor
616020|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
616021|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616022|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
616023|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
616024|NCT03426553|Riboflavin|riboflavin|mesh-list
616025|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
616026|NCT03426553|Vitamins|vitamins|mesh-ancestor
616027|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
616028|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616029|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
616030|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
616031|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
616032|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
616033|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
616034|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616035|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616036|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
616037|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
616038|NCT03426527|Analgesics|analgesics|mesh-ancestor
616039|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
616040|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616041|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
616042|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
616043|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
616044|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
616045|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
616046|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616047|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
616048|NCT03426462|Propofol|propofol|mesh-list
616049|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
616050|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616051|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616052|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
616053|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
616054|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
616055|NCT03426293|Heparin|heparin|mesh-list
616056|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
616057|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2079529|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
616058|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
616059|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079530|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079531|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2079532|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
2079533|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079534|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2217935|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217936|NCT00032149|Prednisolone|prednisolone|mesh-list
2217937|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
2217938|NCT00032149|Etoposide|etoposide|mesh-list
2217939|NCT00032149|Vincristine|vincristine|mesh-list
2217940|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
616071|NCT03426202|Modafinil|modafinil|mesh-list
616072|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
616073|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616074|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
616075|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
616076|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
616077|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616078|NCT03426176|Oxytocin|oxytocin|mesh-list
616079|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
616080|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
616081|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217941|NCT00032149|Bleomycin|bleomycin|mesh-list
2217942|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217943|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
2217944|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217945|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217946|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2217947|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
2217948|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217949|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217950|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2217951|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2217952|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2217953|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2217954|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217955|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
2217956|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
616098|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
616099|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
616100|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616101|NCT03426085|Liraglutide|liraglutide|mesh-list
616102|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
616103|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616104|NCT03426085|Incretins|incretins|mesh-ancestor
616105|NCT03426085|Hormones|hormones|mesh-ancestor
616106|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
616107|NCT03426033|Warfarin|warfarin|mesh-list
616108|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
616109|NCT03426020|Midazolam|midazolam|mesh-list
616110|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
616111|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
616112|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616113|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616114|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
616115|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
616116|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
616117|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
616118|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
616119|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
616120|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
616121|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
616122|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
616123|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616124|NCT03425994|Emtricitabine|emtricitabine|mesh-list
616125|NCT03425994|Cobicistat|cobicistat|mesh-list
616126|NCT03425994|Elvitegravir|elvitegravir|mesh-list
616127|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
616128|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
616129|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
616130|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
616131|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616132|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616133|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
616134|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
616135|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
616136|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
616137|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
616138|NCT03425929|Oxytocin|oxytocin|mesh-list
616139|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
616140|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
616141|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616142|NCT03425838|Letrozole|letrozole|mesh-list
616143|NCT03425838|Fulvestrant|fulvestrant|mesh-list
616144|NCT03425838|Palbociclib|palbociclib|mesh-list
616145|NCT03425838|Anastrozole|anastrozole|mesh-list
616146|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
616147|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616148|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
616149|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616150|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616151|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
616152|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
616153|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
616154|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616155|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
616156|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
616157|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
616158|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
616159|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
616160|NCT03425812|Analgesics|analgesics|mesh-ancestor
616161|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
616162|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616163|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616164|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
616165|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2217957|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
2217958|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2217959|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
2217960|NCT00032149|Hormones|hormones|mesh-ancestor
2217961|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
616172|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
616173|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
616174|NCT03425747|Calcium|calcium|mesh-list
616175|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
616176|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616177|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
616178|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616179|NCT03425747|Antacids|antacids|mesh-ancestor
616180|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
616181|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
616182|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
616183|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616184|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616185|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
616186|NCT03425734|Analgesics|analgesics|mesh-ancestor
616187|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
616188|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616189|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
616190|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
616191|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
616192|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
616193|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
616194|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616195|NCT03425708|Febuxostat|febuxostat|mesh-list
616196|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
616197|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
616198|NCT03425669|Methylphenidate|methylphenidate|mesh-list
616199|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
616200|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616201|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
616202|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
616203|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
616204|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616205|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
779558|NCT02657096|Hybenx|hybenx|mesh-list
616206|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
616207|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
616208|NCT03425656|Docetaxel|docetaxel|mesh-list
616209|NCT03425656|Doxorubicin|doxorubicin|mesh-list
616210|NCT03425656|Trastuzumab|trastuzumab|mesh-list
616211|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
616212|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
616213|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616214|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
616215|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
616216|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
616217|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616218|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616219|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
616220|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
616221|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
616222|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
616223|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
616224|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
616225|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
616226|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616227|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2079535|NCT02059187|Insulin|insulin|mesh-list
2079536|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2079537|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
2079538|NCT02059187|MK-1293|mk-1293|mesh-list
2079539|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2079540|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079541|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2079542|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
2079543|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079544|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2079545|NCT02059213|Palbociclib|palbociclib|mesh-list
2079546|NCT02059213|Leuprolide|leuprolide|mesh-list
2079547|NCT02059213|Goserelin|goserelin|mesh-list
2079548|NCT02059213|Bicalutamide|bicalutamide|mesh-list
2079549|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079550|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
616244|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
616245|NCT03425617|Olodaterol|olodaterol|mesh-list
616246|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
616247|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
616248|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616249|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616250|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
616251|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
616252|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
616253|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
616254|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
616255|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
616256|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079551|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079552|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079553|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
616260|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
616261|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
616262|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
616263|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616264|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616265|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
616266|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
616267|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
616268|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
616269|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
616270|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616271|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
616272|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
616273|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
616274|NCT03425474|Propofol|propofol|mesh-list
616275|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
616276|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616277|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616278|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
616279|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
616280|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
2079554|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
616281|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
616282|NCT03425461|Nivolumab|nivolumab|mesh-list
616283|NCT03425461|Ipilimumab|ipilimumab|mesh-list
616284|NCT03425461|Antibodies|antibodies|mesh-list
616285|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
616286|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
616287|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
616288|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616289|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616290|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
616291|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616292|NCT03425448|Heparin|heparin|mesh-list
616293|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
616294|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
616295|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
616296|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217962|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2217963|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2217964|NCT00032149|Analgesics|analgesics|mesh-ancestor
2217965|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
2217966|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2079555|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2079556|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079557|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2079558|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
2079559|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
2079560|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
616308|NCT03425292|Bevacizumab|bevacizumab|mesh-list
616309|NCT03425292|Nivolumab|nivolumab|mesh-list
616310|NCT03425292|Ipilimumab|ipilimumab|mesh-list
616311|NCT03425292|Temozolomide|temozolomide|mesh-list
616312|NCT03425292|Lomustine|lomustine|mesh-list
616313|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
616314|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616315|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
616316|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
616317|NCT03425292|Growth Substances|growth substances|mesh-ancestor
616318|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616319|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
616320|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
616321|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616322|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
616323|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
616324|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
616325|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616326|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217967|NCT00032162|Carboplatin|carboplatin|mesh-list
2217968|NCT00032162|Doxorubicin|doxorubicin|mesh-list
2217969|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2217970|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217971|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2217972|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2217973|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2217974|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217975|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2217976|NCT00032175|Gemcitabine|gemcitabine|mesh-list
2217977|NCT00032175|Capecitabine|capecitabine|mesh-list
2217978|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2079561|NCT02059239|Cytarabine|cytarabine|mesh-list
2079562|NCT02059239|Rituximab|rituximab|mesh-list
2079563|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
2079564|NCT02059239|Etoposide|etoposide|mesh-list
2079565|NCT02059239|Melphalan|melphalan|mesh-list
616344|NCT03425162|Morphine|morphine|mesh-list
616345|NCT03425162|Bupivacaine|bupivacaine|mesh-list
616346|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
616347|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
616348|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616349|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616350|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
616351|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616352|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
616353|NCT03425162|Narcotics|narcotics|mesh-ancestor
616354|NCT03425162|Analgesics|analgesics|mesh-ancestor
2217979|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
2217980|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079566|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2217981|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217982|NCT00032175|Antiviral Agents|antiviral agents|mesh-ancestor
2217983|NCT00032175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2217984|NCT00032175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2217985|NCT00032175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2217986|NCT00032175|Immunologic Factors|immunologic factors|mesh-ancestor
2217987|NCT00032175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217988|NCT00032188|Aldesleukin|aldesleukin|mesh-list
616364|NCT03425084|Morphine|morphine|mesh-list
616365|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
616366|NCT03425084|Narcotics|narcotics|mesh-ancestor
616367|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616368|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616369|NCT03425084|Analgesics|analgesics|mesh-ancestor
616370|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
616371|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079567|NCT02059239|Carmustine|carmustine|mesh-list
2079568|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2079569|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616375|NCT03424928|Thalidomide|thalidomide|mesh-list
616376|NCT03424928|Pomalidomide|pomalidomide|mesh-list
616377|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
616378|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616379|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
616380|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
616381|NCT03424928|Growth Substances|growth substances|mesh-ancestor
616382|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
616383|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616384|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
616385|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
616386|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
616387|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
616388|NCT03424889|Xylometazoline|xylometazoline|mesh-list
616389|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
616390|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
616391|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
616392|NCT03424876|Sunitinib|sunitinib|mesh-list
616393|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
616394|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616395|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
616396|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
616397|NCT03424876|Growth Substances|growth substances|mesh-ancestor
616398|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616399|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
616400|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
616401|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616402|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616403|NCT03424759|Osimertinib|osimertinib|mesh-list
616404|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616405|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
616406|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616407|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616408|NCT03424746|Edetic Acid|edetic acid|mesh-list
616409|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
616410|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
616411|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
616412|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
616413|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
616414|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616415|NCT03424746|Antidotes|antidotes|mesh-ancestor
616416|NCT03424746|Protective Agents|protective agents|mesh-ancestor
616417|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616418|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
616419|NCT03424733|Acetaminophen|acetaminophen|mesh-list
616420|NCT03424733|Interferons|interferons|mesh-list
616421|NCT03424733|Interferon-beta|interferon-beta|mesh-list
616422|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
616423|NCT03424733|Prednisone|prednisone|mesh-list
616424|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
616425|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
616426|NCT03424733|Hormones|hormones|mesh-ancestor
616427|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
616428|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616429|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
616430|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616431|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
2217989|NCT00032188|Interleukin-2|interleukin-2|mesh-list
2217990|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
616432|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
616433|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
616434|NCT03424733|Analgesics|analgesics|mesh-ancestor
616435|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
616436|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616437|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
616438|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
616439|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
616440|NCT03424707|Eperisone|eperisone|mesh-list
616441|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
616442|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
616443|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
616444|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616445|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
616446|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616447|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
616448|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
616449|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616450|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
616451|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
616452|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
2217991|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2217992|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2217993|NCT00032188|Analgesics|analgesics|mesh-ancestor
2217994|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
2217995|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2217996|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2217997|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
616460|NCT03424629|Methotrexate|methotrexate|mesh-list
616461|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
616462|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
616463|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
616464|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616465|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
616466|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
616467|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616468|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616469|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
616470|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616471|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
616472|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
616473|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
616474|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
616475|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
616489|NCT03424473|Tucatinib|tucatinib|mesh-list
616490|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616491|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
616492|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616493|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079570|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
2217998|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
616496|NCT03424408|Aspirin|aspirin|mesh-list
616497|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
616498|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
616499|NCT03424408|Analgesics|analgesics|mesh-ancestor
616500|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
616501|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616502|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616503|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
616504|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
616505|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2217999|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
616506|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
616507|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616508|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
616509|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
616510|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616511|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
616512|NCT03424356|Fentanyl|fentanyl|mesh-list
616513|NCT03424356|Narcotics|narcotics|mesh-list
616514|NCT03424356|Analgesics|analgesics|mesh-list
616515|NCT03424356|Bromides|bromides|mesh-list
616516|NCT03424356|Propofol|propofol|mesh-list
616517|NCT03424356|Rocuronium|rocuronium|mesh-list
616518|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
616519|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616520|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616521|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
616522|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
616523|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
616524|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
616525|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
616526|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616527|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
616528|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
616529|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
616530|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
616531|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
616532|NCT03424291|Apatinib|apatinib|mesh-list
616533|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616534|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
616535|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616536|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218000|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218001|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2218002|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
2218003|NCT00032279|Visilizumab|visilizumab|mesh-list
2218004|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
2218005|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218006|NCT00032292|Visilizumab|visilizumab|mesh-list
2218007|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
616545|NCT03424226|Acetazolamide|acetazolamide|mesh-list
616546|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
616547|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
616548|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616549|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616550|NCT03424226|Diuretics|diuretics|mesh-ancestor
616551|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
616552|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616553|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
616554|NCT03424135|Promethazine|promethazine|mesh-list
616555|NCT03424135|Naproxen|naproxen|mesh-list
616556|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
616557|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
616558|NCT03424135|Analgesics|analgesics|mesh-ancestor
616559|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
616560|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616561|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616562|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
616563|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
616564|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
616565|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
616566|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616567|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616568|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
616569|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
616570|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616571|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
616572|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
616573|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
616574|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
616575|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
616576|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
616577|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
616578|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
616579|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
616580|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
616581|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
616582|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
2218008|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218009|NCT00032305|Visilizumab|visilizumab|mesh-list
2218010|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
2218011|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218012|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2218013|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
616600|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
616601|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
616602|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079571|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079572|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2079573|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2079574|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2079575|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2079576|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079577|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079578|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2079579|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
2079580|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
2079581|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079582|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2079583|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2079584|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
2079585|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2079591|NCT02059278|Latanoprost|latanoprost|mesh-list
2079592|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2079593|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2079594|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
616628|NCT03423979|Paclitaxel|paclitaxel|mesh-list
616629|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
616630|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616631|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
616632|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
616633|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
616634|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616635|NCT03423849|Gemcitabine|gemcitabine|mesh-list
616636|NCT03423849|Capecitabine|capecitabine|mesh-list
616637|NCT03423849|Vinorelbine|vinorelbine|mesh-list
616638|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616639|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
616640|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
616641|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616642|NCT03423849|Antiviral Agents|antiviral agents|mesh-ancestor
616643|NCT03423849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
616644|NCT03423849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616645|NCT03423849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
616646|NCT03423849|Immunologic Factors|immunologic factors|mesh-ancestor
616647|NCT03423849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616648|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
616649|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
616650|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
616651|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
616652|NCT03423823|Ranibizumab|ranibizumab|mesh-list
616653|NCT03423823|Aflibercept|aflibercept|mesh-list
616654|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616655|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
616656|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
616657|NCT03423823|Growth Substances|growth substances|mesh-ancestor
616658|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616659|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
616660|NCT03423810|Hydralazine|hydralazine|mesh-list
616661|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
616662|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
616663|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2079595|NCT02059434|LAS190792|las190792|mesh-list
2079596|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2079597|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
2079598|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079599|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079600|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2079601|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
2079602|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
2079603|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2079604|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
2079605|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079606|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079607|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2079608|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2079609|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2079610|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2079611|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
2079612|NCT02059642|Metadoxine|metadoxine|mesh-list
616682|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
616683|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
616684|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
616685|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
616686|NCT03423667|Expectorants|expectorants|mesh-ancestor
616687|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
616688|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
616689|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
616690|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616691|NCT03423667|Protective Agents|protective agents|mesh-ancestor
616692|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616693|NCT03423667|Antidotes|antidotes|mesh-ancestor
2218014|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
2218015|NCT00032396|Hormones|hormones|mesh-ancestor
616696|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
616697|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
616698|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616699|NCT03423472|Vitamin A|vitamin a|mesh-list
616700|NCT03423472|Vitamins|vitamins|mesh-ancestor
616701|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
616702|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616714|NCT03423342|Niacinamide|niacinamide|mesh-list
616715|NCT03423342|Niacin|niacin|mesh-list
616716|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
616717|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
616718|NCT03423342|Vitamins|vitamins|mesh-ancestor
616719|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
616720|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616721|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
616722|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
616723|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616724|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
616725|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
616726|NCT03423329|Ibuprofen|ibuprofen|mesh-list
616727|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
616728|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
616729|NCT03423329|Analgesics|analgesics|mesh-ancestor
616730|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
616731|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616732|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616733|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
616734|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
616735|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2079613|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
616736|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616737|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079614|NCT02059902|Lidocaine|lidocaine|mesh-list
2079615|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
2079616|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
2079617|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079618|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079619|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
2079620|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079621|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2079622|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2079623|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2079624|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2079625|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079626|NCT02060370|Sunitinib|sunitinib|mesh-list
2079627|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079628|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
616753|NCT03423225|Tacrolimus|tacrolimus|mesh-list
616754|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
616755|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
616756|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616757|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
616758|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616759|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616760|NCT03423199|Tamoxifen|tamoxifen|mesh-list
616761|NCT03423199|Goserelin|goserelin|mesh-list
616762|NCT03423199|Palbociclib|palbociclib|mesh-list
616763|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
616764|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
616765|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
616766|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616767|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
616768|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616769|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
616770|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
616771|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
616772|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
616773|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616774|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616775|NCT03423147|Chlorhexidine|chlorhexidine|mesh-list
616776|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
616777|NCT03423147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
616778|NCT03423147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
616779|NCT03423147|Disinfectants|disinfectants|mesh-ancestor
616780|NCT03423147|Dermatologic Agents|dermatologic agents|mesh-ancestor
616786|NCT03423030|Macozinone|macozinone|mesh-list
616787|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
616788|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
616789|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
616790|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
616791|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
616792|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616793|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616794|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
616795|NCT03422978|Analgesics|analgesics|mesh-ancestor
616796|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
616797|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616798|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
616799|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
616800|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
616801|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
616802|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
616803|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616804|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
616805|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
616806|NCT03422887|Nalbuphine|nalbuphine|mesh-list
616807|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
616808|NCT03422887|Narcotics|narcotics|mesh-ancestor
616809|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616810|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616811|NCT03422887|Analgesics|analgesics|mesh-ancestor
616812|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
616813|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616814|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
616815|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
616816|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
616817|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
616818|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
616819|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616820|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616821|NCT03422874|Nelfinavir|nelfinavir|mesh-list
616822|NCT03422874|Ixazomib|ixazomib|mesh-list
616823|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616824|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
616825|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616826|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616827|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
616828|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
616829|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
616830|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
616831|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
616832|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
616833|NCT03422861|Nabilone|nabilone|mesh-list
616834|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
616835|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
616836|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616837|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616838|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
616839|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
616840|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
616841|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616842|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2079629|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2079630|NCT02060370|Growth Substances|growth substances|mesh-ancestor
2079631|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079632|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
616847|NCT03422796|Cilostazol|cilostazol|mesh-list
616848|NCT03422796|Sumatriptan|sumatriptan|mesh-list
616849|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
616850|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
616851|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
616852|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
616853|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
616854|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616855|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616856|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
616857|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
616858|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616859|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
616860|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
616861|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
616862|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
616863|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
616864|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
616865|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
616866|NCT03422796|Protective Agents|protective agents|mesh-ancestor
616867|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
616868|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
616869|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079633|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2079634|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102943|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
616873|NCT03422705|Lisinopril|lisinopril|mesh-list
616874|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
616875|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
616876|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616877|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616878|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
616879|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
616880|NCT03422705|Protective Agents|protective agents|mesh-ancestor
616881|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616882|NCT03422666|Teduglutide|teduglutide|mesh-list
616883|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
616884|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
616885|NCT03422666|Protective Agents|protective agents|mesh-ancestor
616886|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616887|NCT03422640|Apremilast|apremilast|mesh-list
616888|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
616889|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
616890|NCT03422640|Analgesics|analgesics|mesh-ancestor
616891|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
616892|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616893|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616894|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
616895|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
616896|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
616897|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
616898|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616899|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616900|NCT03422575|Etoricoxib|etoricoxib|mesh-list
616901|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
616902|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
616903|NCT03422575|Analgesics|analgesics|mesh-ancestor
616904|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
616905|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
616906|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616907|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
616908|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
616909|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
616910|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
616911|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616912|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616913|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
616914|NCT03422536|Cetuximab|cetuximab|mesh-list
616915|NCT03422536|Antibodies|antibodies|mesh-list
616916|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
616917|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
616918|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
616919|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616920|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616921|NCT03422523|Gemcitabine|gemcitabine|mesh-list
616922|NCT03422523|Rituximab|rituximab|mesh-list
616923|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
616924|NCT03422523|Atezolizumab|atezolizumab|mesh-list
616925|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
616926|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616927|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
616928|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616929|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
616930|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
616931|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
616932|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616933|NCT03422523|Antiviral Agents|antiviral agents|mesh-ancestor
616934|NCT03422523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
616935|NCT03422523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616936|NCT03422523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
616937|NCT03422510|CXA-10|cxa-10|mesh-list
616938|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
616939|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
616940|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616941|NCT03422445|Temozolomide|temozolomide|mesh-list
616942|NCT03422445|Apatinib|apatinib|mesh-list
616943|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
616944|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
616945|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616946|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
616947|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
616948|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
616949|NCT03422419|Heparin|heparin|mesh-list
616950|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
616951|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
616952|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
616953|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
616954|NCT03422406|Iodine|iodine|mesh-list
616955|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
616956|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
616957|NCT03422406|Trace Elements|trace elements|mesh-ancestor
616958|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
616959|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616960|NCT03422393|Venetoclax|venetoclax|mesh-list
616961|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079635|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079636|NCT02060383|Metformin|metformin|mesh-list
2079637|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2079638|NCT02060383|Liraglutide|liraglutide|mesh-list
2079639|NCT02060383|Pasireotide|pasireotide|mesh-list
616967|NCT03422315|Propofol|propofol|mesh-list
616968|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
616969|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
616970|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
616971|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
616972|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
616973|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
616974|NCT03422289|Folic Acid|folic acid|mesh-list
616975|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
616976|NCT03422289|Inositol|inositol|mesh-list
616977|NCT03422289|Hematinics|hematinics|mesh-ancestor
616978|NCT03422289|Vitamins|vitamins|mesh-ancestor
616979|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
616980|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218016|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2218017|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218018|NCT00032734|Satavaptan|satavaptan|mesh-list
2218019|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2218020|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218021|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
2218022|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218023|NCT00032747|Vasopressins|vasopressins|mesh-list
2218024|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
2218025|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
616993|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
616994|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
616995|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079640|NCT02060383|Somatostatin|somatostatin|mesh-list
2079641|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2079642|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079643|NCT02060383|Incretins|incretins|mesh-ancestor
2079644|NCT02060383|Hormones|hormones|mesh-ancestor
2079645|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2079646|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2079647|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
2079648|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079649|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617006|NCT03422055|Fucoidan|fucoidan|mesh-list
617007|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
617008|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
617009|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
617010|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617011|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
617012|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
617013|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
617014|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
617015|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
617016|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
617017|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617018|NCT03421990|Anesthetics|anesthetics|mesh-list
617019|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617020|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617021|NCT03421860|Phenylephrine|phenylephrine|mesh-list
617022|NCT03421860|Epinephrine|epinephrine|mesh-list
617023|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
617024|NCT03421860|Ephedrine|ephedrine|mesh-list
617025|NCT03421860|Norepinephrine|norepinephrine|mesh-list
617026|NCT03421860|Ondansetron|ondansetron|mesh-list
617027|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
617028|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
617029|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
617030|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
617031|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617032|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617033|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
617034|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
617035|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
617036|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617037|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
617038|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
2079650|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
617039|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
617040|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
617041|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
617042|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
617043|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
617044|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
617045|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
617046|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
617047|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
617048|NCT03421860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
617049|NCT03421860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
617050|NCT03421860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617051|NCT03421860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
617052|NCT03421860|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
617053|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
617054|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
617055|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
617056|NCT03421860|Protective Agents|protective agents|mesh-ancestor
617057|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
617058|NCT03421821|Ropivacaine|ropivacaine|mesh-list
617059|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
617060|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
617061|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617062|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617063|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
617064|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617065|NCT03421756|Sirolimus|sirolimus|mesh-list
617066|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
617067|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
617068|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
617069|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
617070|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617071|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
617072|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
617073|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
617074|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617075|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
617076|NCT03421743|Molgramostim|molgramostim|mesh-list
617077|NCT03421743|Sargramostim|sargramostim|mesh-list
617078|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617079|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
617080|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218026|NCT00032747|Coagulants|coagulants|mesh-ancestor
2218027|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2218028|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2218029|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
2218030|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218031|NCT00032773|Pentostatin|pentostatin|mesh-list
2218032|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218033|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2218034|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218035|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218036|NCT00032786|Natalizumab|natalizumab|mesh-list
617092|NCT03421717|Chitosan|chitosan|mesh-list
617093|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
617094|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
617095|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
617096|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617097|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
617098|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
617099|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
617100|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
617101|NCT03421717|Coagulants|coagulants|mesh-ancestor
617102|NCT03421652|Nivolumab|nivolumab|mesh-list
617103|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
617104|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617105|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
617106|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617107|NCT03421639|Ulipristal acetate|ulipristal acetate|mesh-list
617108|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
617109|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
617110|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617111|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617112|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
617113|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
617114|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
617115|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617116|NCT03421639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
617117|NCT03421639|Contraceptive Agents|contraceptive agents|mesh-ancestor
617118|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
617119|NCT03421639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
617120|NCT03421496|Cannabidiol|cannabidiol|mesh-list
617121|NCT03421496|Vigabatrin|vigabatrin|mesh-list
617122|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
617123|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617124|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617125|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
617126|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
617127|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617128|NCT03421483|Folic Acid|folic acid|mesh-list
617129|NCT03421483|Hematinics|hematinics|mesh-ancestor
617130|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
617131|NCT03421483|Vitamins|vitamins|mesh-ancestor
617132|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
617133|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218037|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
2218038|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218039|NCT00032799|Natalizumab|natalizumab|mesh-list
2218040|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
2218041|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218042|NCT00032812|Raclopride|raclopride|mesh-list
2218043|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
617141|NCT03421366|Posaconazole|posaconazole|mesh-list
617142|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
617143|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
617144|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
617145|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
617146|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
617147|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
617148|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
617149|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617150|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617151|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
617152|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
617153|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
617154|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079651|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2079652|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
2079653|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2079654|NCT02061280|Fluticasone|fluticasone|mesh-list
2079655|NCT02061280|Xhance|xhance|mesh-list
2079656|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2079657|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2079658|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2079659|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2079660|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
2079661|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079662|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079663|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2079664|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
2079665|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
2079666|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2079667|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2079668|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2079669|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
617174|NCT03421314|Selenium|selenium|mesh-list
617175|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
617176|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617177|NCT03421314|Protective Agents|protective agents|mesh-ancestor
617178|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617179|NCT03421314|Trace Elements|trace elements|mesh-ancestor
617180|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
617181|NCT03421288|Leucovorin|leucovorin|mesh-list
617182|NCT03421288|Docetaxel|docetaxel|mesh-list
617183|NCT03421288|Fluorouracil|fluorouracil|mesh-list
617184|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
617185|NCT03421288|Atezolizumab|atezolizumab|mesh-list
617186|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617187|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
617188|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
617189|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
617190|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617191|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
617192|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
617193|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
617194|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
617195|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617196|NCT03421288|Antidotes|antidotes|mesh-ancestor
617197|NCT03421288|Protective Agents|protective agents|mesh-ancestor
617198|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
617199|NCT03421288|Vitamins|vitamins|mesh-ancestor
617200|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
617201|NCT03421275|Fentanyl|fentanyl|mesh-list
617202|NCT03421275|Esketamine|esketamine|mesh-list
617203|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
617204|NCT03421275|Narcotics|narcotics|mesh-ancestor
617205|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617206|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617207|NCT03421275|Analgesics|analgesics|mesh-ancestor
617208|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
617209|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617210|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
617211|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
617212|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
617213|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
617214|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
617215|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2218044|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2218045|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2218046|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218047|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2218048|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2218049|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
2218050|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218051|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218052|NCT00032825|Ketoconazole|ketoconazole|mesh-list
2218053|NCT00032825|Docetaxel|docetaxel|mesh-list
617226|NCT03421119|Insulin|insulin|mesh-list
617227|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
617228|NCT03421119|Metformin|metformin|mesh-list
617229|NCT03421119|Liraglutide|liraglutide|mesh-list
617230|NCT03421119|Secretagogues|secretagogues|mesh-list
617231|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
617232|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617233|NCT03421119|Incretins|incretins|mesh-ancestor
617234|NCT03421119|Hormones|hormones|mesh-ancestor
617235|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
617248|NCT03421002|Micafungin|micafungin|mesh-list
617249|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
617250|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
617251|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
617252|NCT03420963|Etoposide|etoposide|mesh-list
617253|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
617254|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
617255|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
617256|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
617257|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617258|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
617259|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
617260|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
617261|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617262|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617263|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
617264|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
617265|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
617266|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
617267|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617268|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
617269|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
617270|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
617271|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
617272|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
617273|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
617274|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617275|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617276|NCT03420937|Atropine|atropine|mesh-list
617277|NCT03420937|Neostigmine|neostigmine|mesh-list
617278|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
617279|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
617280|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
617281|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
617282|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617283|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617284|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
617285|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
617286|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
617287|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
617288|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
617289|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
617290|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
617291|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
617292|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617293|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
617294|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617295|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
617296|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
617297|NCT03420911|Midazolam|midazolam|mesh-list
617298|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
617299|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
617300|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617301|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617302|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
617303|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
617304|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
617305|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
617306|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
617307|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
617308|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
617309|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
617310|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
617311|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617312|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
617313|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
617314|NCT03420911|Analgesics|analgesics|mesh-ancestor
617315|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
617316|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617317|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
617318|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
617319|NCT03420794|Analgesics|analgesics|mesh-list
617320|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
617321|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
617322|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617323|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617324|NCT03420742|Midazolam|midazolam|mesh-list
617325|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
617326|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
617327|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617328|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617329|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
617330|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
617331|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
617332|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
617333|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
617334|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
617335|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
617336|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
617337|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
617338|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617339|NCT03420703|Morphine|morphine|mesh-list
617340|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
617341|NCT03420703|Narcotics|narcotics|mesh-ancestor
617342|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617343|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617344|NCT03420703|Analgesics|analgesics|mesh-ancestor
617345|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
617346|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617347|NCT03420638|Epinephrine|epinephrine|mesh-list
617348|NCT03420638|Bupivacaine|bupivacaine|mesh-list
617349|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
617350|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
617351|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617352|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617353|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
617354|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617355|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
617356|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
617357|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
617358|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
617359|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617360|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
617361|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
617362|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
617363|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
617364|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
617365|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
617366|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
617367|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
617368|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
617369|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
617370|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
617371|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
617372|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617373|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617374|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
617375|NCT03420586|Analgesics|analgesics|mesh-ancestor
617376|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
617377|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617378|NCT03420534|Iloperidone|iloperidone|mesh-list
617379|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
617380|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
617381|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617382|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617383|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
617395|NCT03420469|Bupropion|bupropion|mesh-list
617396|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
617397|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
617398|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
617399|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
617400|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
617401|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
617402|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617403|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
617404|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
617405|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617406|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
617407|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
617408|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617409|NCT03420378|Vitamin D|vitamin d|mesh-list
617410|NCT03420378|Vitamins|vitamins|mesh-ancestor
617411|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
617412|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617413|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
617414|NCT03420339|Adderall|adderall|mesh-list
617415|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
617416|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617417|NCT03420313|Buprenorphine|buprenorphine|mesh-list
617418|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
617419|NCT03420313|Naloxone|naloxone|mesh-list
617420|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
617421|NCT03420313|Narcotics|narcotics|mesh-ancestor
617422|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617423|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617424|NCT03420313|Analgesics|analgesics|mesh-ancestor
617425|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
617426|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617427|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2218054|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218055|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
2218056|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
617431|NCT03420144|Hormones|hormones|mesh-list
617432|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
617433|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617434|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
617435|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
617436|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617437|NCT03420014|Doxorubicin|doxorubicin|mesh-list
617438|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
617439|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
617440|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617441|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
617442|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
617443|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617444|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617445|NCT03419975|Latanoprost|latanoprost|mesh-list
617446|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
617447|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
617448|NCT03419949|Pregabalin|pregabalin|mesh-list
617449|NCT03419949|Lamotrigine|lamotrigine|mesh-list
617450|NCT03419949|Analgesics|analgesics|mesh-ancestor
617451|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
617452|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617453|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617454|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
617455|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
617456|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
617457|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617458|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
617459|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
617460|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
617461|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617462|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
617463|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
617464|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
617465|NCT03419923|Citric Acid|citric acid|mesh-list
617466|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
617467|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
617468|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
617469|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
617470|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
617471|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617472|NCT03419910|Cyclosporine|cyclosporine|mesh-list
617473|NCT03419910|BMS-986165|bms-986165|mesh-list
617474|NCT03419910|Cyclosporins|cyclosporins|mesh-list
617475|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617476|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617477|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
617478|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
617479|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617480|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
617481|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
617482|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
617483|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
617484|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
617485|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
617486|NCT03419858|Naloxone|naloxone|mesh-list
617487|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
617488|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617489|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
617490|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617491|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
617492|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
617493|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
617494|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617495|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2218057|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
617496|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
617497|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
617498|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
617499|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
617500|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617501|NCT03419767|Melatonin|melatonin|mesh-list
617502|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
617503|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617504|NCT03419767|Protective Agents|protective agents|mesh-ancestor
617505|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617506|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617507|NCT03419715|Bimatoprost|bimatoprost|mesh-list
617508|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
617509|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
617510|NCT03419650|Hormones|hormones|mesh-ancestor
617511|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
617512|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617513|NCT03419624|Metformin|metformin|mesh-list
617514|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
617515|NCT03419624|Exenatide|exenatide|mesh-list
617516|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
617517|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617518|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
617519|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617520|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
617521|NCT03419624|Incretins|incretins|mesh-ancestor
617522|NCT03419624|Hormones|hormones|mesh-ancestor
617523|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
617524|NCT03419559|Durvalumab|durvalumab|mesh-list
617525|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
617526|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617527|NCT03419494|Doxorubicin|doxorubicin|mesh-list
617528|NCT03419494|Daunorubicin|daunorubicin|mesh-list
617529|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
617530|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
617531|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617532|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
617533|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
617534|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617535|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079670|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
2079671|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102944|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
617539|NCT03419442|Docetaxel|docetaxel|mesh-list
617540|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617541|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
617542|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
617543|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
617544|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617545|NCT03419429|Simvastatin|simvastatin|mesh-list
617546|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
617547|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
617548|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
617549|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617550|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
617551|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
617552|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218058|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218059|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
2218060|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218061|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2218062|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2218063|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218064|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
617561|NCT03419364|Niacinamide|niacinamide|mesh-list
617562|NCT03419364|Niacin|niacin|mesh-list
617563|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
617564|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
617565|NCT03419364|Vitamins|vitamins|mesh-ancestor
617566|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
617567|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617568|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
617569|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
617570|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617571|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
617572|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
617599|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
617600|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
617601|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617602|NCT03418974|Atorvastatin|atorvastatin|mesh-list
617603|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
617604|NCT03418974|Pitavastatin|pitavastatin|mesh-list
617605|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
617606|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
617607|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
617608|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617609|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
617610|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
617611|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079672|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079673|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
2079674|NCT02061280|Hormones|hormones|mesh-ancestor
2079675|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2079676|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
2079677|NCT02061384|Calcitriol|calcitriol|mesh-list
2079678|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
2079679|NCT02061384|Tretinoin|tretinoin|mesh-list
2079680|NCT02061384|Isotretinoin|isotretinoin|mesh-list
2079681|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079682|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
2079683|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
2079684|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2079685|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079686|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2079687|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
617628|NCT03418935|Niacinamide|niacinamide|mesh-list
617629|NCT03418935|Niacin|niacin|mesh-list
617630|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
617631|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
617632|NCT03418935|Vitamins|vitamins|mesh-ancestor
617633|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
617634|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617635|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
617636|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
617637|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617638|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
617639|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
617640|NCT03418922|Nivolumab|nivolumab|mesh-list
617641|NCT03418922|Lenvatinib|lenvatinib|mesh-list
617642|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
617643|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617644|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
617645|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617646|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
617647|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617648|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
617649|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
617650|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617651|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
617652|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
617653|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
617654|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
617655|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617656|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
617657|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
617658|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2079688|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079689|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2079690|NCT02061384|Vitamins|vitamins|mesh-ancestor
617662|NCT03418805|Ibuprofen|ibuprofen|mesh-list
617663|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
617664|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
617665|NCT03418805|Analgesics|analgesics|mesh-ancestor
617666|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
617667|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617668|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617669|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
617670|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
617671|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
617672|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617673|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617674|NCT03418779|Prednisolone|prednisolone|mesh-list
617675|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
617676|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
617677|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
617678|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617679|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
617680|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
617681|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
617682|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617683|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617684|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
617685|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
617686|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
617687|NCT03418779|Hormones|hormones|mesh-ancestor
617688|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
617689|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
617690|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
617691|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
617692|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
617693|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
617694|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
617695|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
617696|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
617697|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
617698|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
617699|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
617700|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617701|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617702|NCT03418727|Laxatives|laxatives|mesh-ancestor
617703|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2218065|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
2218066|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2218067|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617708|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
617709|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
617710|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
617711|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617712|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617713|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
617714|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
2079691|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
2079692|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2079693|NCT02061397|Sirolimus|sirolimus|mesh-list
2079694|NCT02061397|Everolimus|everolimus|mesh-list
2079695|NCT02061397|Simvastatin|simvastatin|mesh-list
2079696|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102945|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
2079697|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2079698|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
2079699|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218068|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
617724|NCT03418610|Azelaic acid|azelaic acid|mesh-list
617725|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617726|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
617727|NCT03418597|Anesthetics|anesthetics|mesh-list
617728|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617729|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218069|NCT00032838|Yohimbine|yohimbine|mesh-list
2218070|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
617733|NCT03418558|Trastuzumab|trastuzumab|mesh-list
617734|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
617735|NCT03418558|Maytansine|maytansine|mesh-list
617736|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
617737|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617738|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
617739|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
617740|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
617741|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
617742|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617743|NCT03418532|Osimertinib|osimertinib|mesh-list
617744|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617745|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
617746|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617747|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617748|NCT03418506|Lobeline|lobeline|mesh-list
617749|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
617750|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
617751|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617752|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617753|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
617754|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
617755|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
617756|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
617757|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617758|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
617759|NCT03418337|Lansoprazole|lansoprazole|mesh-list
617760|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
617761|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
617762|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
617763|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
617764|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617765|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617766|NCT03418246|Calcium|calcium|mesh-list
617767|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
617768|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617769|NCT03418090|Xenon|xenon|mesh-list
617770|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
617771|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
617772|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
617773|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617774|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617775|NCT03418038|Vitamins|vitamins|mesh-list
617776|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
617777|NCT03418038|Gemcitabine|gemcitabine|mesh-list
617778|NCT03418038|Cytarabine|cytarabine|mesh-list
617779|NCT03418038|Dexamethasone|dexamethasone|mesh-list
617780|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
617781|NCT03418038|Cisplatin|cisplatin|mesh-list
617782|NCT03418038|Rituximab|rituximab|mesh-list
617783|NCT03418038|Carboplatin|carboplatin|mesh-list
617784|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
617785|NCT03418038|Etoposide|etoposide|mesh-list
617786|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
617787|NCT03418038|Ifosfamide|ifosfamide|mesh-list
617788|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
617789|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
617790|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
617791|NCT03418038|Antibodies|antibodies|mesh-list
617792|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
617793|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
617794|NCT03418038|BB 1101|bb 1101|mesh-list
617795|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
617796|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617797|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617798|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
617799|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
617800|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
617801|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
617802|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617803|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
617804|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
617805|NCT03418038|Hormones|hormones|mesh-ancestor
617806|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
617807|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
617808|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
617809|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617810|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617811|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
617812|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
617813|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
617814|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
617815|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
617816|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
617817|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
617818|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
617819|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
617820|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
617821|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
617822|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
617823|NCT03418038|Protective Agents|protective agents|mesh-ancestor
617824|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
617825|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
617826|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
617827|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
617828|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
617843|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
617844|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
617845|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
617846|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617847|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617848|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
617849|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
617850|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
617851|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
617852|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617853|NCT03417947|Vitamin D|vitamin d|mesh-list
617854|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
617855|NCT03417947|Vitamins|vitamins|mesh-ancestor
617856|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
617857|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617858|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
617859|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
617860|NCT03417921|Gemcitabine|gemcitabine|mesh-list
617861|NCT03417921|Paclitaxel|paclitaxel|mesh-list
617862|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
617863|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617864|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
617865|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
617866|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
617867|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617868|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
617869|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
617870|NCT03417921|Antiviral Agents|antiviral agents|mesh-ancestor
617871|NCT03417921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
617872|NCT03417921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617873|NCT03417921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
617874|NCT03417921|Immunologic Factors|immunologic factors|mesh-ancestor
617875|NCT03417921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617876|NCT03417895|Apatinib|apatinib|mesh-list
617877|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617878|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
617879|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617880|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617881|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
617882|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
617883|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617884|NCT03417700|Vitamin D|vitamin d|mesh-list
617885|NCT03417700|Vitamins|vitamins|mesh-ancestor
617886|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
617887|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617888|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
617889|NCT03417687|Xenon|xenon|mesh-list
617890|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
617891|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
617892|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
617893|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617894|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617895|NCT03417648|Vitamin E|vitamin e|mesh-list
617896|NCT03417648|Vitamins|vitamins|mesh-ancestor
617897|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
617898|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617899|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
617900|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617901|NCT03417648|Protective Agents|protective agents|mesh-ancestor
617907|NCT03417518|Propofol|propofol|mesh-list
617908|NCT03417518|Desflurane|desflurane|mesh-list
617909|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
617910|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
617911|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617912|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
617913|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
617914|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
617915|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
617916|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
617917|NCT03417492|Citric Acid|citric acid|mesh-list
617918|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
617919|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
617920|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
617921|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
617922|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
617923|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617924|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
617925|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
617926|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
617927|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617928|NCT03417492|Urological Agents|urological agents|mesh-ancestor
2751328|NCT03978091|Ceftazidime|ceftazidime|mesh-list
2751329|NCT03978091|Avibactam|avibactam|mesh-list
2751330|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
2751331|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2751332|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2751333|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2751334|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751335|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751336|NCT03971110|Goserelin|goserelin|mesh-list
2751337|NCT03971110|Bicalutamide|bicalutamide|mesh-list
2751338|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2751339|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751340|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
2751341|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
2792705|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
617944|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
617945|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
617946|NCT03417427|Cytarabine|cytarabine|mesh-list
617947|NCT03417427|Decitabine|decitabine|mesh-list
617948|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
617949|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
617950|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617951|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
617952|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
617953|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
617954|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
617955|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
617956|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617957|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617958|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
617959|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
617960|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
617961|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617962|NCT03417388|Aspirin|aspirin|mesh-list
617963|NCT03417388|Losartan|losartan|mesh-list
617964|NCT03417388|Lisinopril|lisinopril|mesh-list
617965|NCT03417388|Atorvastatin|atorvastatin|mesh-list
617966|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
617967|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
617968|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
617969|NCT03417388|Analgesics|analgesics|mesh-ancestor
617970|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
617971|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
617972|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
617973|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
617974|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
617975|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
617976|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
617977|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
617978|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
617979|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
617980|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
617981|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
617982|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
617983|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
617984|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
617985|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
617986|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
617987|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
617988|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
617989|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
617990|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
617991|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
617992|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
617993|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
617994|NCT03417388|Protective Agents|protective agents|mesh-ancestor
617995|NCT03417284|Melphalan|melphalan|mesh-list
617996|NCT03417284|Lenograstim|lenograstim|mesh-list
617997|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
617998|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
617999|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618000|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
618001|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
618002|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618003|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618004|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
618005|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
618006|NCT03417206|Remifentanil|remifentanil|mesh-list
618007|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
618008|NCT03417206|Narcotics|narcotics|mesh-ancestor
618009|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618010|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618011|NCT03417206|Analgesics|analgesics|mesh-ancestor
618012|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
618013|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618014|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
618015|NCT03417193|Anesthetics|anesthetics|mesh-list
618016|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618017|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618018|NCT03417193|Narcotics|narcotics|mesh-ancestor
618019|NCT03417193|Analgesics|analgesics|mesh-ancestor
618020|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
618021|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618030|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
618031|NCT03417154|Nivolumab|nivolumab|mesh-list
618032|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
618033|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
618034|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618035|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
618036|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
618037|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
618038|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618039|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618040|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
618041|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
618042|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2218071|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
2218072|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218073|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218074|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2218075|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
618048|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
618049|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
618050|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618051|NCT03417037|Nivolumab|nivolumab|mesh-list
618052|NCT03417037|Linrodostat|linrodostat|mesh-list
618053|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
618054|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618055|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
618056|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618057|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079700|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2079701|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079702|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2079703|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
618062|NCT03416777|Tocopherols|tocopherols|mesh-list
618063|NCT03416777|Vitamin E|vitamin e|mesh-list
618064|NCT03416777|Tocotrienols|tocotrienols|mesh-list
618065|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
618066|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
618067|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618068|NCT03416777|Protective Agents|protective agents|mesh-ancestor
618069|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618070|NCT03416777|Vitamins|vitamins|mesh-ancestor
618071|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
618072|NCT03416569|Prazosin|prazosin|mesh-list
618073|NCT03416569|Nicotine|nicotine|mesh-list
618074|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
618075|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
618076|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618077|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618078|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
618079|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
618080|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
618081|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
618082|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618083|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
618084|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
618085|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
618086|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
618087|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
618088|NCT03416530|TIC10 compound|tic10 compound|mesh-list
618089|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618090|NCT03416517|Irinotecan|irinotecan|mesh-list
618091|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
618092|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
618093|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618094|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618095|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618096|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
618097|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
618098|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
618099|NCT03416374|Dexamethasone|dexamethasone|mesh-list
618100|NCT03416374|Lenalidomide|lenalidomide|mesh-list
618101|NCT03416374|Bortezomib|bortezomib|mesh-list
618102|NCT03416374|Ixazomib|ixazomib|mesh-list
618103|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
618104|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
618105|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
618106|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618107|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618108|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
618109|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
618110|NCT03416374|Hormones|hormones|mesh-ancestor
618111|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
618112|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
618113|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618114|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
618115|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
618116|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
618117|NCT03416374|Growth Substances|growth substances|mesh-ancestor
618118|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
618119|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
618120|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618121|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618122|NCT03416361|Vitamin D|vitamin d|mesh-list
618123|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
618124|NCT03416361|Vitamins|vitamins|mesh-ancestor
618125|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
618126|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618127|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
618128|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
618129|NCT03416348|Ethanol|ethanol|mesh-list
618130|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
618131|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
618132|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618133|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079704|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2079705|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2079706|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
618137|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
618138|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
618139|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618140|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
618141|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079707|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079708|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2079709|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2079710|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079711|NCT02061683|Bimatoprost|bimatoprost|mesh-list
2079712|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
618148|NCT03416231|Docetaxel|docetaxel|mesh-list
618149|NCT03416231|Apatinib|apatinib|mesh-list
618150|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618151|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
618152|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
618153|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
618154|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618155|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
618156|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079713|NCT02061774|Acetaminophen|acetaminophen|mesh-list
2079714|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2079715|NCT02061774|Analgesics|analgesics|mesh-ancestor
2079716|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
2079717|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079718|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079719|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
2079720|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
2079721|NCT02061969|Linagliptin|linagliptin|mesh-list
2079722|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2079723|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079724|NCT02061969|Incretins|incretins|mesh-ancestor
2079725|NCT02061969|Hormones|hormones|mesh-ancestor
2079726|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2079727|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2079728|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
618173|NCT03416153|Paclitaxel|paclitaxel|mesh-list
618174|NCT03416153|Carboplatin|carboplatin|mesh-list
618175|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
618176|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618177|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
618178|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
618179|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
618180|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218076|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2218077|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
2218078|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218079|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618186|NCT03416062|Niacinamide|niacinamide|mesh-list
618187|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
618188|NCT03416062|Vitamins|vitamins|mesh-ancestor
618189|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
618190|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618191|NCT03415906|Valsartan|valsartan|mesh-list
618192|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
618193|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
618194|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
618195|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618196|NCT03415854|Gemcitabine|gemcitabine|mesh-list
618197|NCT03415854|Paclitaxel|paclitaxel|mesh-list
618198|NCT03415854|Cisplatin|cisplatin|mesh-list
618199|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
618200|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
618201|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618202|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
618203|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
618204|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
618205|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618206|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
618207|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
618208|NCT03415854|Antiviral Agents|antiviral agents|mesh-ancestor
618209|NCT03415854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
618210|NCT03415854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618211|NCT03415854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
618212|NCT03415854|Immunologic Factors|immunologic factors|mesh-ancestor
618213|NCT03415854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618214|NCT03415828|Ethanol|ethanol|mesh-list
618215|NCT03415828|Prednisolone|prednisolone|mesh-list
618216|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
618217|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
618218|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
618219|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
618220|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
618221|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
618222|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
618223|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
618224|NCT03415828|Hormones|hormones|mesh-ancestor
618225|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
618226|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618227|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
618228|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618229|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
618230|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
618231|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618232|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
618233|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
618234|NCT03415828|Protective Agents|protective agents|mesh-ancestor
618235|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
618236|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
618237|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618238|NCT03415802|Paclitaxel|paclitaxel|mesh-list
618239|NCT03415802|Tegafur|tegafur|mesh-list
618240|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
618241|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618242|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
618243|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
618244|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
618245|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618246|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
618247|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
618248|NCT03415763|Leucovorin|leucovorin|mesh-list
618249|NCT03415763|Capecitabine|capecitabine|mesh-list
618250|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
618251|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
618252|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
618253|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618254|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618255|NCT03415763|Antidotes|antidotes|mesh-ancestor
618256|NCT03415763|Protective Agents|protective agents|mesh-ancestor
618257|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618258|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
618259|NCT03415763|Vitamins|vitamins|mesh-ancestor
618260|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
618261|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
618262|NCT03415750|Everolimus|everolimus|mesh-list
618263|NCT03415750|Tacrolimus|tacrolimus|mesh-list
618264|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
618265|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
618266|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618267|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
618268|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618269|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618270|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618271|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
618272|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
618273|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
618274|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
618275|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
618276|NCT03415711|Mesalamine|mesalamine|mesh-list
618277|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
618278|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
618279|NCT03415711|Analgesics|analgesics|mesh-ancestor
618280|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
618281|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618282|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618283|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
618284|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
618285|NCT03415646|Morphine|morphine|mesh-list
618286|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
618287|NCT03415646|Narcotics|narcotics|mesh-ancestor
618288|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618289|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618290|NCT03415646|Analgesics|analgesics|mesh-ancestor
618291|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
618292|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618293|NCT03415594|Glucagon|glucagon|mesh-list
618294|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
618295|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
618296|NCT03415594|Hormones|hormones|mesh-ancestor
618297|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
618298|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618299|NCT03415594|Incretins|incretins|mesh-ancestor
2218080|NCT00032838|Urological Agents|urological agents|mesh-ancestor
2218081|NCT00032890|Celecoxib|celecoxib|mesh-list
2218082|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2218083|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2218084|NCT00032890|Analgesics|analgesics|mesh-ancestor
2218085|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
2218086|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218087|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618308|NCT03415555|Acetaminophen|acetaminophen|mesh-list
618309|NCT03415555|Oxycodone|oxycodone|mesh-list
618310|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618311|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618312|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
618313|NCT03415555|Analgesics|analgesics|mesh-ancestor
618314|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
618315|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618316|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
618317|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
618318|NCT03415555|Narcotics|narcotics|mesh-ancestor
618319|NCT03415477|Denosumab|denosumab|mesh-list
618320|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
618321|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618322|NCT03415386|Anticoagulants|anticoagulants|mesh-list
618323|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
618324|NCT03415269|Ambroxol|ambroxol|mesh-list
618325|NCT03415269|Expectorants|expectorants|mesh-ancestor
618326|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
2218088|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2218089|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2218090|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2218091|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2218092|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218093|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079729|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218094|NCT00032929|Selegiline|selegiline|mesh-list
2218095|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
2218096|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2218097|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2218098|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2218099|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2218100|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218101|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218102|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2218103|NCT00032929|Protective Agents|protective agents|mesh-ancestor
2218104|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218105|NCT00032942|Lofexidine|lofexidine|mesh-list
2218106|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2218107|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2218108|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218109|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
2218110|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218111|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2218112|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
618354|NCT03415191|Ketamine|ketamine|mesh-list
618355|NCT03415191|Analgesics|analgesics|mesh-ancestor
618356|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
618357|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618358|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618359|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
618360|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
618361|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
618362|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
618363|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618364|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
618365|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
618366|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
618367|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218113|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2218114|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
2218115|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218116|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218117|NCT00032955|Buprenorphine|buprenorphine|mesh-list
2218118|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2218119|NCT00032955|Naloxone|naloxone|mesh-list
2218120|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2218121|NCT00032955|Narcotics|narcotics|mesh-ancestor
618377|NCT03415087|Fentanyl|fentanyl|mesh-list
618378|NCT03415087|Bupivacaine|bupivacaine|mesh-list
618379|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
618380|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
618381|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618382|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618383|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
618384|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618385|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
618386|NCT03415087|Narcotics|narcotics|mesh-ancestor
618387|NCT03415087|Analgesics|analgesics|mesh-ancestor
618388|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
618389|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
618390|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
2079730|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079731|NCT02062177|Midazolam|midazolam|mesh-list
2079732|NCT02062177|Propofol|propofol|mesh-list
2079733|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2079734|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079735|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079736|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2079737|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
2079738|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
2079739|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2079740|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2079741|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2079742|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2079743|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
2079744|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
2079745|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079746|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079747|NCT02062359|Aldesleukin|aldesleukin|mesh-list
2079748|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
2079749|NCT02062359|Fludarabine|fludarabine|mesh-list
2079750|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2079751|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
2079752|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079753|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2079754|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2079755|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
618418|NCT03414931|Sertraline|sertraline|mesh-list
618419|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
618420|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
618421|NCT03414931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
618422|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
618423|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
618424|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618425|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
618426|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
618427|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618428|NCT03414918|Clarithromycin|clarithromycin|mesh-list
618429|NCT03414918|Roxithromycin|roxithromycin|mesh-list
618430|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
618431|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
618432|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
618433|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618434|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618435|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
618436|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
618437|NCT03414879|Lidocaine|lidocaine|mesh-list
618438|NCT03414879|Ketamine|ketamine|mesh-list
618439|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
618440|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
618441|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618442|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618443|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
618444|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618445|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
618446|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
618447|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
618448|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
618449|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618450|NCT03414879|Analgesics|analgesics|mesh-ancestor
618451|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
618452|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
618453|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
618454|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
618455|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
618456|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
618457|NCT03414840|Atorvastatin|atorvastatin|mesh-list
618458|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
618459|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
618460|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
618461|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618462|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
618463|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
618464|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618465|NCT03414814|Osimertinib|osimertinib|mesh-list
618466|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618467|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
618468|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618469|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618470|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
618471|NCT03414723|Ramipril|ramipril|mesh-list
618472|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
618473|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
618474|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618475|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618476|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
618477|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
618478|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
618479|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079756|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079757|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079758|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2079759|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
618486|NCT03414658|Trastuzumab|trastuzumab|mesh-list
618487|NCT03414658|Avelumab|avelumab|mesh-list
618488|NCT03414658|Vinorelbine|vinorelbine|mesh-list
618489|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
618490|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618491|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
618492|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
618493|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
618494|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
618495|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079760|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2079761|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
2079762|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079763|NCT02062632|Doxepin|doxepin|mesh-list
2079764|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2079765|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2079766|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079767|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079768|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2079769|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
2079770|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2079771|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
2079772|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
2079773|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079774|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079775|NCT02062645|Amlodipine|amlodipine|mesh-list
618512|NCT03414450|Dasatinib|dasatinib|mesh-list
618513|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618514|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
618515|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618516|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218122|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2218123|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218124|NCT00032955|Analgesics|analgesics|mesh-ancestor
2218125|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
2218126|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218127|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2218128|NCT00032968|Buprenorphine|buprenorphine|mesh-list
2218129|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2218130|NCT00032968|Naloxone|naloxone|mesh-list
2218131|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2218132|NCT00032968|Narcotics|narcotics|mesh-ancestor
2218133|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2218134|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618530|NCT03414333|Hormones|hormones|mesh-list
618531|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
618532|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618533|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
618534|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
618535|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618536|NCT03414164|Procyanidin|procyanidin|mesh-list
618537|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
618538|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618539|NCT03414164|Protective Agents|protective agents|mesh-ancestor
618540|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618541|NCT03414112|Oxytocin|oxytocin|mesh-list
618542|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
618543|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
618544|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618545|NCT03414034|Prednisone|prednisone|mesh-list
618546|NCT03414034|Onvansertib|onvansertib|mesh-list
618547|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
618548|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
618549|NCT03414034|Hormones|hormones|mesh-ancestor
618550|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
618551|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618552|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
618553|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618554|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
618555|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618556|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079776|NCT02062645|Valsartan|valsartan|mesh-list
2218135|NCT00032968|Analgesics|analgesics|mesh-ancestor
618557|NCT03413995|Rucaparib|rucaparib|mesh-list
618558|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
618559|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618560|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618561|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618562|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
618563|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
618564|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
618565|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618566|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
618567|NCT03413891|Coagulants|coagulants|mesh-ancestor
618568|NCT03413800|Dexamethasone|dexamethasone|mesh-list
618569|NCT03413800|Lenalidomide|lenalidomide|mesh-list
618570|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
618571|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
618572|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
618573|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618574|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618575|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
618576|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
618577|NCT03413800|Hormones|hormones|mesh-ancestor
618578|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
618579|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
618580|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618581|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
618582|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
618583|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
618584|NCT03413800|Growth Substances|growth substances|mesh-ancestor
618585|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
618586|NCT03413722|Everolimus|everolimus|mesh-list
618587|NCT03413722|Tacrolimus|tacrolimus|mesh-list
618588|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
618589|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
618590|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618591|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
618592|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618593|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618594|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218136|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
2218137|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218138|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2218139|NCT00033033|Reserpine|reserpine|mesh-list
2218140|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2218141|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2218142|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2218143|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618603|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
618604|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
618605|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618606|NCT03413436|Cisplatin|cisplatin|mesh-list
618607|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618608|NCT03413410|Metoprolol|metoprolol|mesh-list
618609|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
618610|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
618611|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
618612|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
618613|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618614|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618615|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
618616|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
618617|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
618618|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
618619|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
618620|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618621|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
618622|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
618623|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
618624|NCT03413371|Acetaminophen|acetaminophen|mesh-list
618625|NCT03413371|Lidocaine|lidocaine|mesh-list
618626|NCT03413371|Bupivacaine|bupivacaine|mesh-list
618627|NCT03413371|Ropivacaine|ropivacaine|mesh-list
618628|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
618629|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
618630|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618631|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618632|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
2102946|NCT02415400|Coagulants|coagulants|mesh-ancestor
618633|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618634|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
618635|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
618636|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
618637|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
618638|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618639|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
618640|NCT03413371|Analgesics|analgesics|mesh-ancestor
618641|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
618642|NCT03413358|Carboplatin|carboplatin|mesh-list
618643|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618644|NCT03413319|Tilavonemab|tilavonemab|mesh-list
618645|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
618646|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
618647|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
618648|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
618649|NCT03413202|Protective Agents|protective agents|mesh-ancestor
618650|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618651|NCT03413150|Amiodarone|amiodarone|mesh-list
618652|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
618653|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
618654|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
618655|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
618656|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618657|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
618658|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
618659|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
618660|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618661|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
618662|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
618663|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
618664|NCT03413059|Triamcinolone|triamcinolone|mesh-list
618665|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
618666|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
618667|NCT03413059|Morphine|morphine|mesh-list
618668|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
618669|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
618670|NCT03413059|Narcotics|narcotics|mesh-ancestor
618671|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618672|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618673|NCT03413059|Analgesics|analgesics|mesh-ancestor
618674|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
618675|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618676|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
618677|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
618678|NCT03413059|Hormones|hormones|mesh-ancestor
618679|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
618680|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
618681|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
618682|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618683|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618684|NCT03413020|Amoxicillin|amoxicillin|mesh-list
618685|NCT03413020|Metronidazole|metronidazole|mesh-list
618686|NCT03413020|Clarithromycin|clarithromycin|mesh-list
618687|NCT03413020|Levofloxacin|levofloxacin|mesh-list
618688|NCT03413020|Ofloxacin|ofloxacin|mesh-list
618689|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
618690|NCT03413020|Esomeprazole|esomeprazole|mesh-list
618691|NCT03413020|Bismuth|bismuth|mesh-list
618692|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618693|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
618694|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
618695|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
618696|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
618697|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
618698|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
618699|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
618700|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618701|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
618702|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
618703|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
618704|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
618705|NCT03413020|Renal Agents|renal agents|mesh-ancestor
618706|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
618707|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
618708|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618709|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
618710|NCT03413020|Antacids|antacids|mesh-ancestor
618711|NCT03413020|Diuretics|diuretics|mesh-ancestor
618712|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
618713|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618714|NCT03413020|Expectorants|expectorants|mesh-ancestor
618715|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
618716|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
618717|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
618718|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618719|NCT03412994|Apatinib|apatinib|mesh-list
618720|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618721|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
618722|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618723|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618724|NCT03412890|Norethindrone|norethindrone|mesh-list
618725|NCT03412890|Norethindrone Acetate|norethindrone acetate|mesh-list
618726|NCT03412890|Estradiol|estradiol|mesh-list
618727|NCT03412890|Relugolix|relugolix|mesh-list
618728|NCT03412890|Estrogens|estrogens|mesh-ancestor
618729|NCT03412890|Hormones|hormones|mesh-ancestor
618730|NCT03412890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
618731|NCT03412890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618732|NCT03412890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
618733|NCT03412890|Contraceptive Agents|contraceptive agents|mesh-ancestor
618734|NCT03412890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
618735|NCT03412890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
618736|NCT03412890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
618737|NCT03412890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
618738|NCT03412890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
618739|NCT03412890|Androgen Antagonists|androgen antagonists|mesh-ancestor
618740|NCT03412890|Hormone Antagonists|hormone antagonists|mesh-ancestor
618741|NCT03412877|Aldesleukin|aldesleukin|mesh-list
618742|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
618743|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
618744|NCT03412877|Fludarabine|fludarabine|mesh-list
618745|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
618746|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
618747|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618748|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
618749|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
618750|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
618751|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618752|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618753|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
618754|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
618755|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
618756|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
618757|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
618758|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
618776|NCT03412773|Sorafenib|sorafenib|mesh-list
618777|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618778|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
618779|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618780|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618781|NCT03412747|Adalimumab|adalimumab|mesh-list
618782|NCT03412747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
618783|NCT03412747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2218144|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218145|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
618788|NCT03412721|Analgesics|analgesics|mesh-list
618789|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
618790|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618791|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618792|NCT03412682|Budesonide|budesonide|mesh-list
618793|NCT03412682|Mesalamine|mesalamine|mesh-list
618794|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
618795|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
618796|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
618797|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618798|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618799|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
618800|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
618801|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
618802|NCT03412682|Hormones|hormones|mesh-ancestor
618803|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
618804|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
618805|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
618806|NCT03412682|Analgesics|analgesics|mesh-ancestor
618807|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
618808|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2079777|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
2079778|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2079779|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2079780|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2079781|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079782|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2079783|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079784|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
2079785|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2079786|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2079787|NCT02062658|Ketamine|ketamine|mesh-list
2079788|NCT02062658|Analgesics|analgesics|mesh-ancestor
2079789|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
2079790|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079791|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079792|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2079793|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2079794|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
2079795|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
2079796|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079797|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2079798|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2079799|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
618832|NCT03412591|Suvorexant|suvorexant|mesh-list
618833|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
618834|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
618835|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618836|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618837|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
618838|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
618839|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079800|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079801|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
2079802|NCT02062710|Promethazine|promethazine|mesh-list
2079803|NCT02062710|Phenylephrine|phenylephrine|mesh-list
2079804|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
2079805|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
2079806|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2079807|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
2079808|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
2079809|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079810|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079811|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
2079812|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2079813|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
2079814|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
2079815|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2079816|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2079817|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2079818|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
2079819|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079820|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079821|NCT02062710|Protective Agents|protective agents|mesh-ancestor
2079822|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2079823|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
618867|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
618868|NCT03412552|Analgesics|analgesics|mesh-ancestor
618869|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
618870|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618871|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618872|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
618873|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618874|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
618875|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
618876|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
618877|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
618878|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618879|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
618880|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
618881|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
618882|NCT03412526|Fludarabine|fludarabine|mesh-list
618883|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618884|NCT03412513|Mirabegron|mirabegron|mesh-list
618885|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
618886|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
618887|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
618888|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
618889|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
618890|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618891|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618892|NCT03412513|Urological Agents|urological agents|mesh-ancestor
618893|NCT03412500|Vancomycin|vancomycin|mesh-list
618894|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
618895|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
618896|NCT03412474|Acetaminophen|acetaminophen|mesh-list
618897|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
618898|NCT03412474|Bupivacaine|bupivacaine|mesh-list
618899|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
618900|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
618901|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
618902|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618903|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
618904|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
618905|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
618906|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
618907|NCT03412474|Analgesics|analgesics|mesh-ancestor
618908|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
618909|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
618910|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
618911|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
618912|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
618913|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618914|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
618915|NCT03412409|Cytarabine|cytarabine|mesh-list
618916|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
618917|NCT03412409|Busulfan|busulfan|mesh-list
618918|NCT03412409|Semustine|semustine|mesh-list
618919|NCT03412409|Fludarabine|fludarabine|mesh-list
618920|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
618921|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
618922|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
618923|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618924|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
618925|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
618926|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
618927|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618928|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618929|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
618930|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
618931|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
618932|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
618933|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
618934|NCT03412305|Amoxicillin|amoxicillin|mesh-list
618935|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
618936|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
618937|NCT03412266|Cytarabine|cytarabine|mesh-list
618938|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
618939|NCT03412266|Busulfan|busulfan|mesh-list
618940|NCT03412266|Semustine|semustine|mesh-list
618941|NCT03412266|Fludarabine|fludarabine|mesh-list
618942|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
618943|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
618944|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
618945|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
618946|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
618947|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
618948|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
618949|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618950|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618951|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
618952|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
618953|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
618954|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
618955|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079824|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079825|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
2079826|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
2079827|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
2079828|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
2079829|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2079830|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2079831|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
2079832|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
2079833|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2079834|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
2079835|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
618968|NCT03412071|Metronidazole|metronidazole|mesh-list
618969|NCT03412071|Clindamycin|clindamycin|mesh-list
618970|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
618971|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
618972|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
618973|NCT03412071|Tinidazole|tinidazole|mesh-list
618974|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
618975|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
618976|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
618977|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
618978|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
618979|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618980|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618981|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
618982|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
618983|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
618984|NCT03412006|Fulacimstat|fulacimstat|mesh-list
618985|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618986|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618987|NCT03411967|Docetaxel|docetaxel|mesh-list
618988|NCT03411967|Apatinib|apatinib|mesh-list
618989|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
618990|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
618991|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
618992|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
618993|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
618994|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
618995|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
618996|NCT03411941|Aflibercept|aflibercept|mesh-list
618997|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
618998|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
618999|NCT03411941|Growth Substances|growth substances|mesh-ancestor
619000|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619001|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
619002|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218146|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2218147|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2218148|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2218149|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218150|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
2218151|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218152|NCT00033046|Modafinil|modafinil|mesh-list
619010|NCT03411850|Abatacept|abatacept|mesh-list
619011|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
619012|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079836|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
2218153|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
619013|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619014|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
619015|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
619016|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619017|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
619018|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
619019|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
619020|NCT03411798|Methotrexate|methotrexate|mesh-list
619021|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
619022|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
619023|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
619024|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619025|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
619026|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
619027|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619028|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619029|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
619030|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619031|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
619032|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
619033|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
619034|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
619035|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
619036|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
619037|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
619038|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
619039|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
619040|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
619041|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
619042|NCT03411798|Analgesics|analgesics|mesh-ancestor
619043|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
619044|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619045|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
619046|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
619047|NCT03411551|Anesthetics|anesthetics|mesh-list
619048|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619049|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619050|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
619051|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619052|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619053|NCT03411434|Methylphenidate|methylphenidate|mesh-list
619054|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
619055|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619056|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
619057|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
619058|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
619059|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619060|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
619061|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
619062|NCT03411369|Vitamins|vitamins|mesh-list
619063|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
619064|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619065|NCT03411330|Lidocaine|lidocaine|mesh-list
619066|NCT03411330|Bupivacaine|bupivacaine|mesh-list
619067|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
619068|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
619069|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619070|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619071|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
619072|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619073|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
619074|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
619075|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
619076|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
619077|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619078|NCT03411252|Mirabegron|mirabegron|mesh-list
619079|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
619080|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
619081|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
619082|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
619083|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
619084|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619085|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619086|NCT03411252|Urological Agents|urological agents|mesh-ancestor
619087|NCT03411161|Paclitaxel|paclitaxel|mesh-list
619088|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
619089|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
619090|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619091|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
619092|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
619093|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
619094|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619095|NCT03411109|Hydromorphone|hydromorphone|mesh-list
619096|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
619097|NCT03411109|Narcotics|narcotics|mesh-ancestor
619098|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619099|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619100|NCT03411109|Analgesics|analgesics|mesh-ancestor
619101|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
619102|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619103|NCT03411096|Ropivacaine|ropivacaine|mesh-list
619104|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
619105|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
619106|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619107|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619108|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
619109|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079837|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2079838|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2079839|NCT02062801|Ephedrine|ephedrine|mesh-list
2079840|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2079841|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079842|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
2079843|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
2079844|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079845|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2079846|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
2079847|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079848|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079849|NCT02062879|Ketamine|ketamine|mesh-list
2079850|NCT02062879|Hydromorphone|hydromorphone|mesh-list
2079851|NCT02062879|Analgesics|analgesics|mesh-ancestor
2079852|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
2079853|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079854|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079855|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2079856|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2079857|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
2079858|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
2079859|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619134|NCT03410901|Antibodies|antibodies|mesh-list
619135|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
619136|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619137|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
619138|NCT03410875|Vemurafenib|vemurafenib|mesh-list
619139|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619140|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619141|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
619142|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619143|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619144|NCT03410836|Lidocaine|lidocaine|mesh-list
619145|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
619146|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
619147|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619148|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619149|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
619150|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619151|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
619152|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
619153|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
619154|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
619155|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619156|NCT03410784|Paclitaxel|paclitaxel|mesh-list
619157|NCT03410784|Carboplatin|carboplatin|mesh-list
619158|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
619159|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
619160|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619161|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
619162|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
619163|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
619164|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619165|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619166|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
619167|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079860|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2079861|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2079862|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079863|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079864|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2079865|NCT02062879|Narcotics|narcotics|mesh-ancestor
2079866|NCT02062905|Dexamethasone|dexamethasone|mesh-list
2079867|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
619176|NCT03410654|Tacrolimus|tacrolimus|mesh-list
619177|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
619178|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
619179|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619180|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
619181|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619182|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079868|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
2079869|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
2079870|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619187|NCT03410524|Simethicone|simethicone|mesh-list
619188|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
619189|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619190|NCT03410524|Emollients|emollients|mesh-ancestor
619191|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
619192|NCT03410511|Nicotine|nicotine|mesh-list
619193|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
619194|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
619195|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619196|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619197|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
619198|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
619199|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
619200|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
619201|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619202|NCT03410446|Ketamine|ketamine|mesh-list
619203|NCT03410446|Analgesics|analgesics|mesh-ancestor
619204|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
619205|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619206|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619207|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
619208|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
619209|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
619210|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
619211|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619212|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
619213|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
619214|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
619215|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619216|NCT03410355|Cortisone|cortisone|mesh-list
619217|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
619218|NCT03410212|Ketorolac|ketorolac|mesh-list
619219|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
619220|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
619221|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
619222|NCT03410212|Analgesics|analgesics|mesh-ancestor
619223|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
619224|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619225|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619226|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
619227|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
619228|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
619229|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619230|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619231|NCT03410043|Osimertinib|osimertinib|mesh-list
619232|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619233|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
619234|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619235|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619259|NCT03409874|Diclofenac|diclofenac|mesh-list
619260|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
619261|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
619262|NCT03409874|Analgesics|analgesics|mesh-ancestor
619263|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
619264|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619265|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619266|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
619267|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
619268|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
619269|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619270|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619271|NCT03409848|Nivolumab|nivolumab|mesh-list
619272|NCT03409848|Ipilimumab|ipilimumab|mesh-list
619273|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619274|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619275|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
619276|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619277|NCT03409835|Ramosetron|ramosetron|mesh-list
619278|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
619279|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
619280|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619281|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619282|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
619283|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
619284|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
619285|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
619286|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079871|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079872|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2079873|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
2079874|NCT02062905|Hormones|hormones|mesh-ancestor
2079875|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2079876|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2079877|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079878|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
2079879|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2079880|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2079881|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079882|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
619299|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
619300|NCT03409679|Murepavadin|murepavadin|mesh-list
619301|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
619302|NCT03409614|Cemiplimab|cemiplimab|mesh-list
619303|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619304|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619305|NCT03409588|Riociguat|riociguat|mesh-list
619306|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
619307|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079883|NCT02063035|Coagulants|coagulants|mesh-ancestor
2079884|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
2079885|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
619311|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
619312|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
619313|NCT03409432|Lenalidomide|lenalidomide|mesh-list
619314|NCT03409432|Antibodies|antibodies|mesh-list
619315|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
619316|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
619317|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
619318|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
619319|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619320|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619321|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
619322|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
619323|NCT03409432|Growth Substances|growth substances|mesh-ancestor
619324|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
619325|NCT03409367|Emollients|emollients|mesh-list
619326|NCT03409367|Petrolatum|petrolatum|mesh-list
619327|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
619328|NCT03409276|Vaccines|vaccines|mesh-list
619329|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
619330|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619331|NCT03409250|Ranibizumab|ranibizumab|mesh-list
619332|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
619333|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
619334|NCT03409250|Growth Substances|growth substances|mesh-ancestor
619335|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619336|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
619337|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619338|NCT03409237|Mannitol|mannitol|mesh-list
619339|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
619340|NCT03409237|Diuretics|diuretics|mesh-ancestor
619341|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
619342|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619363|NCT03409068|Anesthetics|anesthetics|mesh-list
619364|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619365|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619369|NCT03408873|Aripiprazole|aripiprazole|mesh-list
619370|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
619371|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
619372|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
619373|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
619374|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619375|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619376|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
619377|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
619378|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
619379|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619380|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
619381|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
619382|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
619383|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
619384|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
619385|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
619386|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
619387|NCT03408847|Beclomethasone|beclomethasone|mesh-list
619388|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
619389|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
619390|NCT03408847|Hormones|hormones|mesh-ancestor
619391|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
619392|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619393|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
619394|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
619395|NCT03408756|Methotrexate|methotrexate|mesh-list
619396|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
619397|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
619398|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
619399|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619400|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
619401|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
619402|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619403|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619404|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
619405|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619406|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
619407|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
619408|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
619409|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
619410|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2218154|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218155|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2218156|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2079886|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2079887|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
2079888|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
2102947|NCT02415556|Insulin|insulin|mesh-list
2218157|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2218158|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218159|NCT00033059|Tolcapone|tolcapone|mesh-list
2218160|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2218161|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2218162|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2218163|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218164|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619426|NCT03408587|Ipilimumab|ipilimumab|mesh-list
619427|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619428|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619429|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
619430|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218165|NCT00033072|Selegiline|selegiline|mesh-list
2218166|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
2218167|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2218168|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2218169|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2218170|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2218171|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218172|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218173|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2218174|NCT00033072|Protective Agents|protective agents|mesh-ancestor
2218175|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218176|NCT00033085|Ondansetron|ondansetron|mesh-list
2218177|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
2218178|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
2218179|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218180|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218181|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2218182|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
2218183|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
2218184|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2218185|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
619470|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
619471|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
619472|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
619473|NCT03408405|Hormones|hormones|mesh-ancestor
619474|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
619475|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619476|NCT03408340|Fentanyl|fentanyl|mesh-list
619477|NCT03408340|Ketamine|ketamine|mesh-list
619478|NCT03408340|Propofol|propofol|mesh-list
619479|NCT03408340|Sevoflurane|sevoflurane|mesh-list
619480|NCT03408340|Rocuronium|rocuronium|mesh-list
619481|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
619482|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619483|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619484|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
619485|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619486|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
619487|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
619488|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
619489|NCT03408340|Analgesics|analgesics|mesh-ancestor
619490|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
619491|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
619492|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
619493|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
619494|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619495|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
619496|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
619497|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
619498|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
619499|NCT03408340|Narcotics|narcotics|mesh-ancestor
619500|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
619501|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
619502|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
619503|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
619504|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
619505|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
619506|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
619507|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
619508|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619509|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
619510|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
619511|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619512|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
619513|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619514|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
619515|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
619516|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
619517|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619518|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
619519|NCT03408145|Protective Agents|protective agents|mesh-ancestor
619520|NCT03408119|Vitamin D|vitamin d|mesh-list
619521|NCT03408119|Calcium|calcium|mesh-list
619522|NCT03408119|Vitamins|vitamins|mesh-ancestor
619523|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
619524|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619525|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
619526|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
619527|NCT03408093|Interferons|interferons|mesh-list
619528|NCT03408093|Interferon-beta|interferon-beta|mesh-list
619529|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
619530|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619531|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
619532|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
619533|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
619534|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619535|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
619536|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
619537|NCT03408054|Oxytocin|oxytocin|mesh-list
619538|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
619539|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
619540|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619541|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
619542|NCT03408015|Lifitegrast|lifitegrast|mesh-list
619543|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
619544|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
619545|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
619546|NCT03407976|Apatinib|apatinib|mesh-list
619547|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619548|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619549|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
619550|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619551|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619552|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
619553|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619554|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619555|NCT03407872|Esketamine|esketamine|mesh-list
619556|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
619557|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
619558|NCT03407703|Grazoprevir|grazoprevir|mesh-list
619559|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
619560|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
619561|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218186|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218187|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218188|NCT00033085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2218189|NCT00033085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2218190|NCT00033085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2218191|NCT00033085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2218192|NCT00033085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2218193|NCT00033098|Metyrapone|metyrapone|mesh-list
619570|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
619571|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
619572|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
619573|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
619574|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619575|NCT03407521|Isosorbide|isosorbide|mesh-list
619576|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
619577|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
619578|NCT03407521|Misoprostol|misoprostol|mesh-list
619579|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
619580|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
619581|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
619582|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619583|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
619584|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
619585|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
619586|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
619587|NCT03407521|Diuretics|diuretics|mesh-ancestor
619588|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
619589|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
619590|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
619591|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218194|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
2218195|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218196|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218197|NCT00033111|Cabergoline|cabergoline|mesh-list
2218198|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2218199|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2218200|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
2218201|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
2218202|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218203|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218204|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218205|NCT00033163|Tenofovir|tenofovir|mesh-list
2218206|NCT00033163|Adefovir|adefovir|mesh-list
2218207|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
619606|NCT03407404|Midazolam|midazolam|mesh-list
619607|NCT03407404|Morphine|morphine|mesh-list
619608|NCT03407404|Ketamine|ketamine|mesh-list
619609|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
619610|NCT03407404|Narcotics|narcotics|mesh-ancestor
619611|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619612|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619613|NCT03407404|Analgesics|analgesics|mesh-ancestor
619614|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
619615|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619616|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
619617|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
619618|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
619619|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
2218208|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
619620|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
619621|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
619622|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
619623|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619624|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
619625|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
619626|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
619627|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
619628|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
619629|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
619630|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
619631|NCT03407300|Docetaxel|docetaxel|mesh-list
619632|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619633|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
619634|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
619635|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
619636|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619637|NCT03407209|Anesthetics|anesthetics|mesh-list
619638|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
619639|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619640|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619641|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
619642|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619643|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
619644|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
619645|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619646|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
619647|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218209|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218210|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2218211|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2079889|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079890|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079891|NCT02063698|Auranofin|auranofin|mesh-list
2079892|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2079893|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
2079894|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
2079895|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2079896|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2079897|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079898|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2079899|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079900|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2079901|NCT02064166|Insulin|insulin|mesh-list
2079902|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2079903|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079904|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
2079905|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2079906|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
2079907|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2079908|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
2079909|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079910|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079911|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
2079912|NCT02064582|Leuprolide|leuprolide|mesh-list
2079913|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2079914|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
2079915|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2079916|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079917|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2079918|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079919|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
2079920|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2218212|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218213|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619688|NCT03407105|Ipilimumab|ipilimumab|mesh-list
619689|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619690|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619691|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
619692|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619693|NCT03407027|Triamcinolone|triamcinolone|mesh-list
619694|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
619695|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
619696|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
619697|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
619698|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
619699|NCT03407027|Hormones|hormones|mesh-ancestor
619700|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
619701|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619702|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
619703|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
619704|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619705|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619706|NCT03406988|Nifedipine|nifedipine|mesh-list
619707|NCT03406988|Iloprost|iloprost|mesh-list
619708|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
619709|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
619710|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619711|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
619712|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619713|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
619714|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
619715|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
619716|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
619717|NCT03406936|Midazolam|midazolam|mesh-list
619718|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
619719|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
619720|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619721|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619722|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
619723|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
619724|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
619725|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
619726|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
619727|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
619728|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
619729|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
619730|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
619731|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751342|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2751343|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751346|NCT03961204|Cladribine|cladribine|mesh-list
2751347|NCT03961204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619739|NCT03406871|Nivolumab|nivolumab|mesh-list
619740|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619741|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619742|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
619743|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619744|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
619745|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
619746|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619747|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619748|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
619749|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619750|NCT03406832|Nitroprusside|nitroprusside|mesh-list
619751|NCT03406832|Tirofiban|tirofiban|mesh-list
619752|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
619753|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
619754|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
619755|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619756|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
619757|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
619758|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
619759|NCT03406819|Nitroprusside|nitroprusside|mesh-list
619760|NCT03406819|Tirofiban|tirofiban|mesh-list
619761|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
619762|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
619763|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
619764|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619765|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
619766|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
619767|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
619768|NCT03406793|Iron|iron|mesh-list
619769|NCT03406793|Zinc|zinc|mesh-list
619770|NCT03406793|Trace Elements|trace elements|mesh-ancestor
619771|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
619772|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619779|NCT03406689|Nepafenac|nepafenac|mesh-list
619780|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
619781|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
619782|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
619783|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
619784|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
619785|NCT03406689|Analgesics|analgesics|mesh-ancestor
619786|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
619787|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619788|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619789|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
619790|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
619791|NCT03406676|Methylene Blue|methylene blue|mesh-list
619792|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619793|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619794|NCT03406650|Durvalumab|durvalumab|mesh-list
619795|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619796|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619797|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
619798|NCT03406546|Remifentanil|remifentanil|mesh-list
619799|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
619800|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619801|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619802|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
619803|NCT03406546|Analgesics|analgesics|mesh-ancestor
619804|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
619805|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619806|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
619807|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
619808|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
619809|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
619810|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
619811|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619812|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
619813|NCT03406546|Narcotics|narcotics|mesh-ancestor
619814|NCT03406533|Fentanyl|fentanyl|mesh-list
619815|NCT03406533|Midazolam|midazolam|mesh-list
619816|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
619817|NCT03406533|Remifentanil|remifentanil|mesh-list
619818|NCT03406533|Propofol|propofol|mesh-list
619819|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
619820|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619821|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619822|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
619823|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
619824|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
619825|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
619826|NCT03406533|Analgesics|analgesics|mesh-ancestor
619827|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
619828|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619829|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
619830|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
619831|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
619832|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
619833|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
619834|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619835|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
619836|NCT03406533|Narcotics|narcotics|mesh-ancestor
619837|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
619838|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
619839|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
619840|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
619841|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
619842|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
619843|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
619844|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
619845|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
619846|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
619847|NCT03406507|Ravulizumab|ravulizumab|mesh-list
619848|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
619849|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
619850|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
619851|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619852|NCT03406403|Anesthetics|anesthetics|mesh-list
619853|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
619854|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619855|NCT03406299|Leucovorin|leucovorin|mesh-list
619856|NCT03406299|Gemcitabine|gemcitabine|mesh-list
619857|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
619858|NCT03406299|Tegafur|tegafur|mesh-list
619859|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619860|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
619861|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
619862|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619863|NCT03406299|Antiviral Agents|antiviral agents|mesh-ancestor
619864|NCT03406299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
619865|NCT03406299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619866|NCT03406299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
619867|NCT03406299|Immunologic Factors|immunologic factors|mesh-ancestor
619868|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619869|NCT03406299|Antidotes|antidotes|mesh-ancestor
619870|NCT03406299|Protective Agents|protective agents|mesh-ancestor
619871|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
619872|NCT03406299|Vitamins|vitamins|mesh-ancestor
619873|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
2751348|NCT03961204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2751349|NCT03961204|Immunologic Factors|immunologic factors|mesh-ancestor
2751350|NCT03961204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751351|NCT03954041|Glyburide|glyburide|mesh-list
2751352|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2218214|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2218215|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2218216|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
2218217|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
2218218|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218219|NCT00033176|Protective Agents|protective agents|mesh-ancestor
619885|NCT03406247|Nivolumab|nivolumab|mesh-list
619886|NCT03406247|Ipilimumab|ipilimumab|mesh-list
619887|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619888|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619889|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
619890|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619891|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
619892|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
619893|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
619894|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
619895|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
619896|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619897|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619898|NCT03406169|Urological Agents|urological agents|mesh-ancestor
619899|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
619900|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
619901|NCT03406169|Protective Agents|protective agents|mesh-ancestor
619902|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619903|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
619904|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
619913|NCT03406091|Plerixafor|plerixafor|mesh-list
619914|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
619915|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
619916|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
619917|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
619918|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
619919|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
619920|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619921|NCT03405974|Aspirin|aspirin|mesh-list
619922|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
619923|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
619924|NCT03405974|Analgesics|analgesics|mesh-ancestor
2751353|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619925|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
619926|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
619927|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619928|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
619929|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
619930|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
619931|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
619932|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619933|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
619934|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
619935|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619936|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
619937|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
619938|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
619939|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
619940|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619941|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
619942|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
619943|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218220|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218221|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
2218222|NCT00033176|Vitamins|vitamins|mesh-ancestor
619951|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
619952|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
619953|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079921|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
2079922|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079923|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079924|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
2079925|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079926|NCT02064894|Ibuprofen|ibuprofen|mesh-list
2079927|NCT02064894|Morphine|morphine|mesh-list
2079928|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2079929|NCT02064894|Narcotics|narcotics|mesh-ancestor
619963|NCT03405584|Amoxicillin|amoxicillin|mesh-list
619964|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
619965|NCT03405584|Esomeprazole|esomeprazole|mesh-list
619966|NCT03405584|Bismuth|bismuth|mesh-list
619967|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
619968|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
619969|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
619970|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
619971|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
619972|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
619973|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
619974|NCT03405584|Antacids|antacids|mesh-ancestor
619975|NCT03405584|Diuretics|diuretics|mesh-ancestor
619976|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
619977|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619978|NCT03405584|Expectorants|expectorants|mesh-ancestor
619979|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
619980|NCT03405454|Durvalumab|durvalumab|mesh-list
619981|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619982|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619983|NCT03405376|Aflibercept|aflibercept|mesh-list
619984|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
619985|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
619986|NCT03405376|Growth Substances|growth substances|mesh-ancestor
619987|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619988|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
619989|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
619990|NCT03405337|Factor VIII|factor viii|mesh-list
619991|NCT03405337|Coagulants|coagulants|mesh-ancestor
619992|NCT03405272|Cetuximab|cetuximab|mesh-list
619993|NCT03405272|Antibodies|antibodies|mesh-list
619994|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
619995|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
619996|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
619997|NCT03405272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
619998|NCT03405272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218223|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
2218224|NCT00033189|Ubiquinone|ubiquinone|mesh-list
2218225|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
2102948|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2218226|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
2218227|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620004|NCT03405207|Vitamin D|vitamin d|mesh-list
620005|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
620006|NCT03405207|Vitamins|vitamins|mesh-ancestor
620007|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
620008|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620009|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
620010|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
620011|NCT03405194|Efavirenz|efavirenz|mesh-list
620012|NCT03405194|Cobicistat|cobicistat|mesh-list
620013|NCT03405194|Elvitegravir|elvitegravir|mesh-list
620014|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
620015|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
620016|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620017|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620018|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
620019|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620020|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
620021|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
620022|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
620023|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
620024|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
620025|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
620026|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
620027|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
620028|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
620029|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
620030|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
620031|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
620032|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
620033|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620034|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
620035|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
620036|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620037|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620038|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620039|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
620040|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
620041|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
620042|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620043|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
620044|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
620045|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
620046|NCT03405155|Nivolumab|nivolumab|mesh-list
620047|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
620048|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620049|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
620050|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620051|NCT03405142|Panitumumab|panitumumab|mesh-list
620052|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
620053|NCT03405142|Dextrans|dextrans|mesh-list
620054|NCT03405142|Edetic Acid|edetic acid|mesh-list
620055|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
620056|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
620057|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620058|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
620059|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
620060|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
620061|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
620062|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620063|NCT03405142|Antidotes|antidotes|mesh-ancestor
620064|NCT03405142|Protective Agents|protective agents|mesh-ancestor
620065|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620066|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
620067|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
620068|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
620069|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
620070|NCT03405090|Fentanyl|fentanyl|mesh-list
620071|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
620072|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
620073|NCT03405090|Narcotics|narcotics|mesh-ancestor
620074|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
620075|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620076|NCT03405090|Analgesics|analgesics|mesh-ancestor
620077|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
620078|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
620079|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
620080|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
620081|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
620082|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
620083|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
620084|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
620085|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
620086|NCT03405064|Linezolid|linezolid|mesh-list
620087|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
620088|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
620089|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620090|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
620091|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620092|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620102|NCT03404947|Ethanol|ethanol|mesh-list
620103|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
620104|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620105|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
620106|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620107|NCT03404908|Acetaminophen|acetaminophen|mesh-list
620108|NCT03404908|Dipyrone|dipyrone|mesh-list
620109|NCT03404908|Ketoprofen|ketoprofen|mesh-list
620110|NCT03404908|Morphine|morphine|mesh-list
620111|NCT03404908|Ropivacaine|ropivacaine|mesh-list
620112|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
620113|NCT03404908|Narcotics|narcotics|mesh-ancestor
620114|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
620115|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620116|NCT03404908|Analgesics|analgesics|mesh-ancestor
620117|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
620118|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
620119|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
620120|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
620121|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
620122|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
620123|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
620124|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
620125|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
620126|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
620127|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620128|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218228|NCT00033189|Vitamins|vitamins|mesh-ancestor
2218229|NCT00033215|S 3304|s 3304|mesh-list
2218230|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
2218231|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
2218232|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218233|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218234|NCT00033241|Gemcitabine|gemcitabine|mesh-list
2218235|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2218236|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
620138|NCT03404804|Amoxicillin|amoxicillin|mesh-list
620139|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
620140|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079930|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079931|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079932|NCT02064894|Analgesics|analgesics|mesh-ancestor
2079933|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
2079934|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079935|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2079936|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2079937|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2079938|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2079939|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2079940|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218237|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
2079941|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079942|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
2079943|NCT02064907|Lansoprazole|lansoprazole|mesh-list
2079944|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2079945|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2079946|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2079947|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079948|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079949|NCT02064920|Donepezil|donepezil|mesh-list
2079950|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2079951|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620164|NCT03404752|Lenograstim|lenograstim|mesh-list
620165|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
620166|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
620167|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620168|NCT03404739|Ceftazidime|ceftazidime|mesh-list
620169|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
620170|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620171|NCT03404661|Secretin|secretin|mesh-list
620172|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
620173|NCT03404661|Hormones|hormones|mesh-ancestor
620174|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
620175|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218238|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218239|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218240|NCT00033241|Antiviral Agents|antiviral agents|mesh-ancestor
2218241|NCT00033241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218242|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218243|NCT00033241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2218244|NCT00033241|Immunologic Factors|immunologic factors|mesh-ancestor
620184|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
620185|NCT03404635|Apixaban|apixaban|mesh-list
620186|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
620187|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
620188|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
620189|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
620190|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620191|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620192|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
620203|NCT03404544|Carbetocin|carbetocin|mesh-list
620204|NCT03404544|Oxytocin|oxytocin|mesh-list
620205|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
620206|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
620207|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620208|NCT03404518|Acetaminophen|acetaminophen|mesh-list
620209|NCT03404518|Ibuprofen|ibuprofen|mesh-list
620210|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
620211|NCT03404518|Hydrocodone|hydrocodone|mesh-list
620212|NCT03404518|Narcotics|narcotics|mesh-list
620213|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
620214|NCT03404518|Analgesics|analgesics|mesh-ancestor
620215|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
620216|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
620217|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620218|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
620219|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
620220|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
620221|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
620222|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
620223|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620224|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620225|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
620226|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
620227|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
620228|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
2102949|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
620229|NCT03404479|Celecoxib|celecoxib|mesh-list
620230|NCT03404479|Diacetylrhein|diacetylrhein|mesh-list
620231|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
620232|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
620233|NCT03404479|Analgesics|analgesics|mesh-ancestor
620234|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
620235|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
620236|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620237|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
620238|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
620239|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
620240|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
620241|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620242|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620243|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
620244|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
620245|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620246|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
620247|NCT03404310|Astringents|astringents|mesh-ancestor
620248|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620249|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
620250|NCT03404284|Vaccines|vaccines|mesh-list
620251|NCT03404284|Immunologic Factors|immunologic factors|mesh-ancestor
620252|NCT03404284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218245|NCT00033241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218246|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2218247|NCT00033254|Thalidomide|thalidomide|mesh-list
2218248|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2218249|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
2218250|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218251|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
2218252|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2218253|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218254|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2218255|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2218256|NCT00033254|Growth Substances|growth substances|mesh-ancestor
2218257|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
2218258|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620267|NCT03404193|Decitabine|decitabine|mesh-list
620268|NCT03404193|Venetoclax|venetoclax|mesh-list
620269|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
620270|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
620271|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620272|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620273|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079952|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079953|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
2079954|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079955|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079956|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
2079957|NCT02064985|Ticagrelor|ticagrelor|mesh-list
2079958|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2079959|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2079960|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2079961|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2079962|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
2079963|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079964|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079965|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079966|NCT02065245|Penicillins|penicillins|mesh-list
2079967|NCT02065245|Streptomycin|streptomycin|mesh-list
2079968|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
620292|NCT03404115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
620293|NCT03404115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
620294|NCT03404037|Endostatins|endostatins|mesh-list
620295|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620296|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
620297|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
620298|NCT03404037|Growth Substances|growth substances|mesh-ancestor
620299|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620300|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
620301|NCT03404024|Mitogens|mitogens|mesh-list
620302|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
620303|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620304|NCT03404011|Glycerol|glycerol|mesh-list
620305|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
620306|NCT03404011|Protective Agents|protective agents|mesh-ancestor
620307|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620308|NCT03403985|Calcium|calcium|mesh-list
620309|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
620310|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620311|NCT03403972|Vancomycin|vancomycin|mesh-list
620312|NCT03403972|Simvastatin|simvastatin|mesh-list
620313|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
620314|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
620315|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
620316|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620317|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
620318|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
620319|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620320|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
620321|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620322|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
620323|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
620324|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
620325|NCT03403842|Sufentanil|sufentanil|mesh-list
620326|NCT03403842|Morphine|morphine|mesh-list
620327|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
620328|NCT03403842|Narcotics|narcotics|mesh-ancestor
620329|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
620330|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620331|NCT03403842|Analgesics|analgesics|mesh-ancestor
620332|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
620333|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
620334|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
620335|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
620336|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
620337|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
620338|NCT03403829|Gemcitabine|gemcitabine|mesh-list
620339|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
620340|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
620341|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620342|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620343|NCT03403829|Antiviral Agents|antiviral agents|mesh-ancestor
620344|NCT03403829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620345|NCT03403829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620346|NCT03403829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
620347|NCT03403829|Immunologic Factors|immunologic factors|mesh-ancestor
620348|NCT03403829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620349|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
620350|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
620351|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
620352|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
620353|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
620354|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
620355|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620356|NCT03403777|Avelumab|avelumab|mesh-list
620357|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
620358|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218259|NCT00033267|Sirolimus|sirolimus|mesh-list
2218260|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2218261|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218262|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2218263|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218264|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
2218265|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2218266|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
2218267|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218268|NCT00033280|Temozolomide|temozolomide|mesh-list
2218269|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2218270|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
2218271|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218272|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218273|NCT00033306|Irinotecan|irinotecan|mesh-list
2218274|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2218275|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2218276|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620377|NCT03403647|Vitamin D|vitamin d|mesh-list
620378|NCT03403647|Vitamins|vitamins|mesh-ancestor
620379|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
620380|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620381|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2079969|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079970|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2079971|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079972|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079973|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
2079974|NCT02065336|Entecavir|entecavir|mesh-list
2079975|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
2079976|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079977|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
2079978|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
2079979|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2079980|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
2079981|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
2079982|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079983|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079984|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079985|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2079986|NCT02065479|Ticagrelor|ticagrelor|mesh-list
2079987|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2079988|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2079989|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2079990|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2079991|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2079992|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
2079993|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079994|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079995|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079996|NCT02065557|Adalimumab|adalimumab|mesh-list
2218277|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620411|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
620412|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
620413|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620414|NCT03403569|Triptolide|triptolide|mesh-list
620415|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
620416|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620417|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
620418|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
620419|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
620420|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
620421|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
620422|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
620423|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
620424|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620425|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218278|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218279|NCT00033319|Aspirin|aspirin|mesh-list
2218280|NCT00033319|Folic Acid|folic acid|mesh-list
2218281|NCT00033319|Hematinics|hematinics|mesh-ancestor
2218282|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
2218283|NCT00033319|Vitamins|vitamins|mesh-ancestor
2218284|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
2218285|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218286|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2218287|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2218288|NCT00033319|Analgesics|analgesics|mesh-ancestor
2218289|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
2218290|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218291|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2218292|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2218293|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2218294|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2218295|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218296|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2218297|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2218298|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218299|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
2218300|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
2218301|NCT00033332|Pamidronate|pamidronate|mesh-list
2218302|NCT00033332|Thalidomide|thalidomide|mesh-list
2218303|NCT00033332|Dexamethasone|dexamethasone|mesh-list
2218304|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2218305|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
2218306|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
620455|NCT03403452|Apatinib|apatinib|mesh-list
620456|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620457|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
620458|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620459|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620460|NCT03403439|Itraconazole|itraconazole|mesh-list
620461|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
620462|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620463|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
620464|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
620465|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620466|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620467|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
620468|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
620469|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
620470|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620471|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2218307|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218308|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218309|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2218310|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
2218311|NCT00033332|Hormones|hormones|mesh-ancestor
2218312|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
620478|NCT03403140|Etanercept|etanercept|mesh-list
620479|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
620480|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
620481|NCT03403140|Analgesics|analgesics|mesh-ancestor
620482|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
620483|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
620484|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620485|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
620486|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
620487|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
620488|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
620489|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
620490|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
620491|NCT03403101|Irinotecan|irinotecan|mesh-list
620492|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620493|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
620494|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
620495|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620496|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620497|NCT03403049|Gemcitabine|gemcitabine|mesh-list
620498|NCT03403049|Capecitabine|capecitabine|mesh-list
620499|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
620500|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620501|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
620502|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
620503|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620504|NCT03403049|Antiviral Agents|antiviral agents|mesh-ancestor
620505|NCT03403049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620506|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620507|NCT03403049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
620508|NCT03403049|Immunologic Factors|immunologic factors|mesh-ancestor
620509|NCT03403049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620510|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2218313|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
620513|NCT03403023|Cyclosporine|cyclosporine|mesh-list
620514|NCT03403023|Cyclosporins|cyclosporins|mesh-list
620515|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620516|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620517|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
620518|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
620519|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620520|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
620521|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620522|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
620523|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
620524|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
620525|NCT03402984|Z 338|z 338|mesh-list
620526|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
620527|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620528|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620529|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
620530|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
620531|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620532|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
620533|NCT03402945|Vancomycin|vancomycin|mesh-list
620534|NCT03402945|Cefazolin|cefazolin|mesh-list
620535|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
620536|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620537|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
620538|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
620539|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
620540|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
620541|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620542|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
620543|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079997|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2079998|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2079999|NCT02065570|Adalimumab|adalimumab|mesh-list
2080000|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080001|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
620549|NCT03402815|Maraviroc|maraviroc|mesh-list
620550|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
620551|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
620552|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620553|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
620554|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
620555|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
620556|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620557|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
620558|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
620559|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
620560|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620561|NCT03402698|Vitamins|vitamins|mesh-ancestor
620562|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
620563|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
620564|NCT03402503|Montelukast|montelukast|mesh-list
620565|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
620566|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
620567|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
620568|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
620569|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
620570|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620571|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
620572|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
620573|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620574|NCT03402438|Fulacimstat|fulacimstat|mesh-list
620575|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620576|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620577|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
620578|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
620579|NCT03402321|Coagulants|coagulants|mesh-ancestor
620580|NCT03402295|Thalidomide|thalidomide|mesh-list
620581|NCT03402295|Dexamethasone|dexamethasone|mesh-list
620582|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
620583|NCT03402295|Bortezomib|bortezomib|mesh-list
620584|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
620585|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
620586|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620587|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
620588|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
620589|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
620590|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620591|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620592|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
620593|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
620594|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
620595|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
620596|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
620597|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
620598|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
620599|NCT03402295|Hormones|hormones|mesh-ancestor
620600|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
620601|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
620602|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
620603|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
620604|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620605|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2080002|NCT02065622|Adalimumab|adalimumab|mesh-list
620606|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
620607|NCT03402295|Growth Substances|growth substances|mesh-ancestor
620608|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
2218314|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218315|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
620612|NCT03402204|Ubenimex|ubenimex|mesh-list
620613|NCT03402204|Simvastatin|simvastatin|mesh-list
620614|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
620615|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
620616|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
620617|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620618|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
620619|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
620620|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620621|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
620622|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
620623|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620624|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
620625|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620626|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
620627|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620628|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
620629|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
620630|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
620631|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
620632|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
620633|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
620634|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
620635|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
620636|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620637|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620638|NCT03402191|Urological Agents|urological agents|mesh-ancestor
620639|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
620640|NCT03402165|Ledipasvir|ledipasvir|mesh-list
620641|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
620642|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
620643|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620644|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
620645|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
620646|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
620647|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
620648|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620649|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
620650|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
620651|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
620652|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
620653|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
620654|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
620655|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620656|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
620657|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
620658|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
620659|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
620660|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
620661|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
620662|NCT03402113|Midazolam|midazolam|mesh-list
620663|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
620664|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
620665|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
620666|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620667|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
620668|NCT03402113|Analgesics|analgesics|mesh-ancestor
620669|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
620670|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
620671|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
620672|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
620673|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
620674|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
620675|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
620676|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620677|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
620678|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
620679|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
620680|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
620681|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
620682|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
620683|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
620684|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
620685|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
620686|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
620687|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
620688|NCT03402087|Leucovorin|leucovorin|mesh-list
620689|NCT03402087|Methotrexate|methotrexate|mesh-list
620690|NCT03402087|BMS-986165|bms-986165|mesh-list
620691|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
620692|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
620693|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
620694|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620695|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
620696|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
620697|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620698|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620699|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
620700|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620701|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
620702|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
620703|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
620704|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
620705|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
620706|NCT03402087|Antidotes|antidotes|mesh-ancestor
620707|NCT03402087|Protective Agents|protective agents|mesh-ancestor
620708|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
620709|NCT03402087|Vitamins|vitamins|mesh-ancestor
620710|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
620711|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
620712|NCT03402048|Gemcitabine|gemcitabine|mesh-list
620713|NCT03402048|Carboplatin|carboplatin|mesh-list
620714|NCT03402048|Docetaxel|docetaxel|mesh-list
620715|NCT03402048|Pemetrexed|pemetrexed|mesh-list
620716|NCT03402048|Vinorelbine|vinorelbine|mesh-list
620717|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620718|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
620719|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
620720|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620721|NCT03402048|Antiviral Agents|antiviral agents|mesh-ancestor
620722|NCT03402048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620723|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620724|NCT03402048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
620725|NCT03402048|Immunologic Factors|immunologic factors|mesh-ancestor
620726|NCT03402048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620727|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
620728|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
620729|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
620730|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
620731|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
620732|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
620733|NCT03401957|Cetuximab|cetuximab|mesh-list
620734|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
620735|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620738|NCT03401853|Rituximab|rituximab|mesh-list
620739|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
620740|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
620741|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
620742|NCT03401853|Antibodies|antibodies|mesh-list
620743|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
620744|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
620745|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
620746|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620747|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620748|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
620749|NCT03401827|Gemcitabine|gemcitabine|mesh-list
620750|NCT03401827|Paclitaxel|paclitaxel|mesh-list
620751|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
620752|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620753|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
620754|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
620755|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
620756|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620757|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
620758|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
620759|NCT03401827|Antiviral Agents|antiviral agents|mesh-ancestor
620760|NCT03401827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620761|NCT03401827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620762|NCT03401827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
620763|NCT03401827|Immunologic Factors|immunologic factors|mesh-ancestor
620764|NCT03401827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620765|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
620766|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
620767|NCT03401749|Allantoin|allantoin|mesh-list
620768|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
620769|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
620770|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
620771|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
620772|NCT03401736|Midazolam|midazolam|mesh-list
620773|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
620774|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
620775|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
620776|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620777|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
620778|NCT03401736|Analgesics|analgesics|mesh-ancestor
620779|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
620780|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
620781|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
620782|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
620783|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
620784|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
620785|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
620786|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620787|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
620788|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
620789|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
620790|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
620791|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
620792|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
620793|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
620794|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
620795|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
620798|NCT03401619|Vitamin D|vitamin d|mesh-list
620799|NCT03401619|Calcitonin|calcitonin|mesh-list
620800|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
620801|NCT03401619|Diphosphonates|diphosphonates|mesh-list
620802|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
620803|NCT03401619|Katacalcin|katacalcin|mesh-list
620804|NCT03401619|Vitamins|vitamins|mesh-ancestor
620805|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
620806|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620807|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
620808|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
620809|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
620810|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
620811|NCT03401606|Remifentanil|remifentanil|mesh-list
620812|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
620813|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
620814|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620815|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
620816|NCT03401606|Analgesics|analgesics|mesh-ancestor
620817|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
620818|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
620819|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
620820|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
620821|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
620822|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
620823|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
620824|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620825|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
620826|NCT03401606|Narcotics|narcotics|mesh-ancestor
620827|NCT03401593|Fentanyl|fentanyl|mesh-list
620828|NCT03401593|Midazolam|midazolam|mesh-list
620829|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
620830|NCT03401593|Narcotics|narcotics|mesh-ancestor
620831|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
620832|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620833|NCT03401593|Analgesics|analgesics|mesh-ancestor
620834|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
620835|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
620836|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
620837|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
620838|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
620839|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
620840|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
620841|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
620842|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
620843|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
620844|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
620845|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
620846|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
620847|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620848|NCT03401541|Vitamin D|vitamin d|mesh-list
620849|NCT03401541|Calcifediol|calcifediol|mesh-list
620850|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
620851|NCT03401541|Vitamins|vitamins|mesh-ancestor
620852|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
620853|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620854|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
620855|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
620856|NCT03401515|Propranolol|propranolol|mesh-list
620857|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
620858|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
620859|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
620860|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
620861|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620862|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620863|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
620864|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
620865|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
620866|NCT03401502|Ranolazine|ranolazine|mesh-list
620867|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
620868|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
620869|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620870|NCT03401476|Morphine|morphine|mesh-list
620871|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
620872|NCT03401476|Narcotics|narcotics|mesh-ancestor
620873|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
620874|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620875|NCT03401476|Analgesics|analgesics|mesh-ancestor
620876|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
620877|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080003|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080004|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080005|NCT02065687|Metformin|metformin|mesh-list
2080006|NCT02065687|Paclitaxel|paclitaxel|mesh-list
2080007|NCT02065687|Carboplatin|carboplatin|mesh-list
2080008|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2080009|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2080010|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080011|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
2080012|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
2080013|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
2080014|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620890|NCT03401372|Doxycycline|doxycycline|mesh-list
620891|NCT03401372|Dexamethasone|dexamethasone|mesh-list
620892|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
620893|NCT03401372|Bortezomib|bortezomib|mesh-list
620894|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
620895|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
620896|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620897|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
620898|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
620899|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
620900|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620901|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620902|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
620903|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
620904|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
620905|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
620906|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
620907|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
620908|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
620909|NCT03401372|Hormones|hormones|mesh-ancestor
620910|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
620911|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
620912|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
620913|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080015|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
620914|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
620915|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
620916|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
620917|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
620918|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
620919|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
620920|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
620921|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
620922|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620923|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620924|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
620925|NCT03401346|Analgesics|analgesics|mesh-ancestor
620926|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
620927|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080016|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080017|NCT02065713|Golimumab|golimumab|mesh-list
2080018|NCT02065713|Methotrexate|methotrexate|mesh-list
2080019|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2080020|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
2080021|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2080022|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080023|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2080024|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
2080025|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620938|NCT03401294|Leucovorin|leucovorin|mesh-list
620939|NCT03401294|Bevacizumab|bevacizumab|mesh-list
620940|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
620941|NCT03401294|Irinotecan|irinotecan|mesh-list
620942|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
620943|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
620944|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
620945|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
620946|NCT03401294|Growth Substances|growth substances|mesh-ancestor
620947|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620948|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
620949|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
620950|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
620951|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620952|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620953|NCT03401294|Antidotes|antidotes|mesh-ancestor
620954|NCT03401294|Protective Agents|protective agents|mesh-ancestor
620955|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
620956|NCT03401294|Vitamins|vitamins|mesh-ancestor
620957|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
620958|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
620959|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
620960|NCT03401268|Antibodies|antibodies|mesh-list
620961|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
620962|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080026|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080027|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
2080028|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080029|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2080030|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2080031|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
2080032|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
620970|NCT03401177|Naproxen|naproxen|mesh-list
620971|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
620972|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
620973|NCT03401177|Analgesics|analgesics|mesh-ancestor
620974|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
620975|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
620976|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620977|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
620978|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
620979|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
620980|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
620981|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
620982|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
620983|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
620984|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
620985|NCT03401073|Antibodies|antibodies|mesh-list
620986|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
620987|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
620988|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
620989|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620990|NCT03401060|Denosumab|denosumab|mesh-list
620991|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
620992|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620993|NCT03401047|Estradiol|estradiol|mesh-list
620994|NCT03401047|Estrogens|estrogens|mesh-ancestor
620995|NCT03401047|Hormones|hormones|mesh-ancestor
620996|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
620997|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
620998|NCT03400995|Ziresovir|ziresovir|mesh-list
620999|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
621000|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
621001|NCT03400969|Glycerol|glycerol|mesh-list
621002|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
621003|NCT03400969|Protective Agents|protective agents|mesh-ancestor
621004|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218316|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
2218317|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
2218318|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2218319|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
621009|NCT03400826|Simvastatin|simvastatin|mesh-list
621010|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
621011|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
621012|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
621013|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621014|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
621015|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
621016|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621017|NCT03400735|Cefdinir|cefdinir|mesh-list
621018|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
621019|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
621020|NCT03400722|Clomiphene|clomiphene|mesh-list
621021|NCT03400722|Hormones|hormones|mesh-list
621022|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
621023|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621024|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
621025|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
621026|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
621027|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
621028|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
621029|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
621030|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
621031|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
621032|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
621033|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
621034|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
621035|NCT03400709|Expectorants|expectorants|mesh-ancestor
621036|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
621037|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
621038|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
621039|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621040|NCT03400709|Protective Agents|protective agents|mesh-ancestor
621041|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621042|NCT03400709|Antidotes|antidotes|mesh-ancestor
621043|NCT03400683|Letrozole|letrozole|mesh-list
621044|NCT03400683|Misoprostol|misoprostol|mesh-list
621045|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621046|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
621047|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
621048|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621049|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621050|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
621051|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
621052|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
621053|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621054|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
621055|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
621056|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
621057|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
621058|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
621059|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
621060|NCT03400592|Irinotecan|irinotecan|mesh-list
621061|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
621062|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
621063|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
621064|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621065|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218320|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
621066|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621067|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2080033|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2080034|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2080035|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080036|NCT02065791|Canagliflozin|canagliflozin|mesh-list
2218321|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2218322|NCT00033332|Growth Substances|growth substances|mesh-ancestor
2218323|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
2218324|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2218325|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
2218326|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2218327|NCT00033345|Protective Agents|protective agents|mesh-ancestor
2218328|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218329|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621081|NCT03400423|Caffeine|caffeine|mesh-list
621082|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
621083|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621084|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
621085|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621086|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621087|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
621088|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
621089|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
621090|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621091|NCT03400332|Nivolumab|nivolumab|mesh-list
621092|NCT03400332|Ipilimumab|ipilimumab|mesh-list
621093|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
621094|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621095|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
621096|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751363|NCT03945357|Gemcitabine|gemcitabine|mesh-list
2751364|NCT03945357|Clindamycin|clindamycin|mesh-list
2751365|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
2751366|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
621108|NCT03400267|Acetaminophen|acetaminophen|mesh-list
621109|NCT03400267|Fentanyl|fentanyl|mesh-list
621110|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
621111|NCT03400267|Narcotics|narcotics|mesh-ancestor
621112|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621113|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621114|NCT03400267|Analgesics|analgesics|mesh-ancestor
621115|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
621116|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621117|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
621118|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
621119|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
621120|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
621121|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
621122|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
621123|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
621124|NCT03400254|Gedatolisib|gedatolisib|mesh-list
621125|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
621126|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
621127|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
621128|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
621129|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621130|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621131|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
621132|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
621133|NCT03400241|Bromides|bromides|mesh-list
621134|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
621135|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
621136|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
621137|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621138|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621139|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
621140|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
621141|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
621142|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
621143|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
621144|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621145|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621146|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
621147|NCT03400189|Sulthiame|sulthiame|mesh-list
621148|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
621149|NCT03400111|Acetaminophen|acetaminophen|mesh-list
621150|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
621151|NCT03400111|Analgesics|analgesics|mesh-ancestor
621152|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
621153|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621154|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621155|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
2218330|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2218331|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
621158|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
621159|NCT03400020|Vitamins|vitamins|mesh-ancestor
621160|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
621161|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621162|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
621163|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621164|NCT03400020|Protective Agents|protective agents|mesh-ancestor
621165|NCT03399981|Natalizumab|natalizumab|mesh-list
621166|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
621167|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621168|NCT03399955|Amphotericin B|amphotericin b|mesh-list
621169|NCT03399955|Paromomycin|paromomycin|mesh-list
621170|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
621171|NCT03399955|Miltefosine|miltefosine|mesh-list
621172|NCT03399955|Amebicides|amebicides|mesh-ancestor
621173|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
621174|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
621175|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
621176|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
621177|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
621178|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621179|NCT03399903|Mesalamine|mesalamine|mesh-list
621180|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
621181|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
621182|NCT03399903|Analgesics|analgesics|mesh-ancestor
621183|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
621184|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621185|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621186|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
621187|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
621188|NCT03399838|Midazolam|midazolam|mesh-list
621189|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
621190|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
621191|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621192|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621193|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
621194|NCT03399838|Analgesics|analgesics|mesh-ancestor
621195|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
621196|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621197|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
621198|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
621199|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
621200|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
621201|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621202|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621203|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
621204|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
621205|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
621206|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
621207|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
621208|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
621209|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
621210|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
621211|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
2080037|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2080038|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080039|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2080040|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080041|NCT02066129|Fluticasone|fluticasone|mesh-list
2080042|NCT02066129|Xhance|xhance|mesh-list
2080043|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080044|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2080045|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
2080046|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080047|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621224|NCT03399708|Apremilast|apremilast|mesh-list
621225|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
621226|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
621227|NCT03399708|Analgesics|analgesics|mesh-ancestor
621228|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
621229|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621230|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621231|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
621232|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
621233|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
621234|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
621235|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621236|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621237|NCT03399669|Gefitinib|gefitinib|mesh-list
621238|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621239|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
621240|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621241|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621242|NCT03399643|Atezolizumab|atezolizumab|mesh-list
621243|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621244|NCT03399617|Micronutrients|micronutrients|mesh-list
621245|NCT03399617|Trace Elements|trace elements|mesh-list
621246|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621247|NCT03399604|Treprostinil|treprostinil|mesh-list
621248|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
621249|NCT03399552|Avelumab|avelumab|mesh-list
621250|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
621251|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621276|NCT03399526|Calcitriol|calcitriol|mesh-list
621277|NCT03399526|Betamethasone|betamethasone|mesh-list
621278|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
621279|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
621280|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
621281|NCT03399526|Clobetasol|clobetasol|mesh-list
621282|NCT03399526|Prednicarbate|prednicarbate|mesh-list
621283|NCT03399526|Calcipotriene|calcipotriene|mesh-list
621284|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
621285|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
621286|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
621287|NCT03399526|Hormones|hormones|mesh-ancestor
621288|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
621289|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621290|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
621291|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
621292|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
621293|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
621294|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
621295|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
621296|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080048|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
621297|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
621298|NCT03399526|Vitamins|vitamins|mesh-ancestor
621299|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
621300|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
621301|NCT03399487|Ceritinib|ceritinib|mesh-list
621302|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621303|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
621304|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621305|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621306|NCT03399474|Lidocaine|lidocaine|mesh-list
621307|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
621308|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
621309|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
621310|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621311|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621312|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
621313|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621314|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
621315|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
621316|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
621317|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
621318|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621319|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
621320|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
621321|NCT03399474|Analgesics|analgesics|mesh-ancestor
621322|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
621323|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
621324|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
621325|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
621326|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621327|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
621328|NCT03399448|Fludarabine|fludarabine|mesh-list
621329|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
621330|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
621331|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621332|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
621333|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
621334|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
621335|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621336|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621337|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
621338|NCT03399435|Epinephrine|epinephrine|mesh-list
621339|NCT03399435|Racepinephrine|racepinephrine|mesh-list
621340|NCT03399435|Bupivacaine|bupivacaine|mesh-list
621341|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
621342|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
621343|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
621344|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
621345|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621346|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621347|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
621348|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621349|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
621350|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
621351|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
621352|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621353|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621354|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
621355|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
621356|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
621357|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
621358|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
621359|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
621360|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
621361|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
621362|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
621363|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
621364|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
621365|NCT03399318|Acetaminophen|acetaminophen|mesh-list
621366|NCT03399318|Ibuprofen|ibuprofen|mesh-list
621367|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
621368|NCT03399318|Analgesics|analgesics|mesh-ancestor
621369|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
621370|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621371|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621372|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
621373|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
621374|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
621375|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
621376|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
621377|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621378|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621379|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
621380|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
621381|NCT03399201|Anesthetics|anesthetics|mesh-list
621382|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621383|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621387|NCT03399110|Capecitabine|capecitabine|mesh-list
621388|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
621389|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
621390|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
621391|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621392|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621393|NCT03399032|Caspofungin|caspofungin|mesh-list
621394|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
621395|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
621396|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621397|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621398|NCT03399019|Midazolam|midazolam|mesh-list
621399|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
621400|NCT03399019|Propofol|propofol|mesh-list
621401|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
621402|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621403|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621404|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
621405|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
621406|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
621407|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
621408|NCT03399019|Analgesics|analgesics|mesh-ancestor
621409|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
621410|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621411|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
621412|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
621413|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
621414|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
621415|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621416|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621417|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
621418|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
621419|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
621420|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
621421|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
621422|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
621423|NCT03398993|Clomiphene|clomiphene|mesh-list
621424|NCT03398993|Enclomiphene|enclomiphene|mesh-list
621425|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
621426|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
621427|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
621428|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
621429|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
621430|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621431|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
621432|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
621433|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
621434|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
621435|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
621436|NCT03398941|Octreotide|octreotide|mesh-list
621437|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
621438|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
621439|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621440|NCT03398876|Nicotine|nicotine|mesh-list
621441|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
621442|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
621443|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621444|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621445|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
621446|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
621447|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
621523|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
621448|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621449|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621450|NCT03398824|Metformin|metformin|mesh-list
621451|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
621452|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621453|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
621454|NCT03398811|Etonogestrel|etonogestrel|mesh-list
621455|NCT03398811|Desogestrel|desogestrel|mesh-list
621456|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
621457|NCT03398811|Progesterone|progesterone|mesh-list
621458|NCT03398811|Progestins|progestins|mesh-ancestor
621459|NCT03398811|Hormones|hormones|mesh-ancestor
621460|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
621461|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621462|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
621463|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
621464|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
621465|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
621466|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
621467|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
621468|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
621469|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
621470|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
621471|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621472|NCT03398785|Epinephrine|epinephrine|mesh-list
621473|NCT03398785|Racepinephrine|racepinephrine|mesh-list
621474|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
621475|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
621476|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
621477|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
621478|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621479|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621480|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621481|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
621482|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
621483|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
621484|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621485|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
621486|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
621487|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
621488|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
621489|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
621490|NCT03398759|Butorphanol|butorphanol|mesh-list
621491|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
621492|NCT03398759|Narcotics|narcotics|mesh-ancestor
621493|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621494|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621495|NCT03398759|Analgesics|analgesics|mesh-ancestor
621496|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
621497|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621498|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
621499|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
621500|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2080049|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
2080050|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
2080051|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2751367|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2751368|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
2751369|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751370|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751371|NCT03945357|Antiviral Agents|antiviral agents|mesh-ancestor
621509|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
621510|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
621511|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621512|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
621513|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621514|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
621515|NCT03398473|Hematinics|hematinics|mesh-ancestor
621516|NCT03398434|Apixaban|apixaban|mesh-list
621517|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
621518|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
621519|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
621520|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
621521|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621522|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218332|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
2218333|NCT00033358|Norgestrel|norgestrel|mesh-list
2218334|NCT00033358|Estradiol|estradiol|mesh-list
2218335|NCT00033358|Estrogens|estrogens|mesh-ancestor
2218336|NCT00033358|Hormones|hormones|mesh-ancestor
2218337|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2218338|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218339|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2218340|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
2218341|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2218342|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2218343|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2218344|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2218345|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2218346|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2218347|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2218348|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218349|NCT00033410|Paclitaxel|paclitaxel|mesh-list
2218350|NCT00033410|Carboplatin|carboplatin|mesh-list
2218351|NCT00033410|Tirapazamine|tirapazamine|mesh-list
2218352|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2218353|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218354|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
2218355|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
2218356|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
2218357|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218358|NCT00033423|Rituximab|rituximab|mesh-list
2218359|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2218360|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218361|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
2218362|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218363|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2218364|NCT00033436|Niacinamide|niacinamide|mesh-list
621557|NCT03398252|Doxazosin|doxazosin|mesh-list
621558|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
621559|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
621560|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
621561|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
621562|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
621563|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621564|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621565|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080057|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
2080058|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
2080059|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
621569|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
621570|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
621571|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621572|NCT03398122|Apatinib|apatinib|mesh-list
621573|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621574|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
621575|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621576|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621577|NCT03398083|Alprazolam|alprazolam|mesh-list
621578|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
621579|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621580|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621581|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
621582|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
621583|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
621584|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
621585|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
621586|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621587|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621588|NCT03398044|Dexamethasone|dexamethasone|mesh-list
621589|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
621590|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
621591|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
621592|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621593|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621594|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
621595|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
621596|NCT03398044|Hormones|hormones|mesh-ancestor
621597|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2080060|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
2218365|NCT00033436|Niacin|niacin|mesh-list
621598|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
621599|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621600|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
621601|NCT03398031|Antacids|antacids|mesh-ancestor
621602|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621603|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
621604|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
621605|NCT03398018|Hormones|hormones|mesh-ancestor
621606|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
621607|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621608|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
621609|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
621610|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
621611|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
621612|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621613|NCT03397953|Vinorelbine|vinorelbine|mesh-list
621614|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
621615|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621616|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
621617|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
621618|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
621619|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621620|NCT03397914|Colistin|colistin|mesh-list
621621|NCT03397914|Polymyxins|polymyxins|mesh-list
621622|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
621623|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
621624|NCT03397888|Betrixaban|betrixaban|mesh-list
621625|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
621626|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
621627|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
621628|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
621629|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621630|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621631|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
621632|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
621633|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
621634|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
621635|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
621636|NCT03397875|Protective Agents|protective agents|mesh-ancestor
621637|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621638|NCT03397862|Donepezil|donepezil|mesh-list
621639|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
621640|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621641|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621642|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
621643|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621644|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621645|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
621646|NCT03397797|Rocuronium|rocuronium|mesh-list
621647|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
621648|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
621649|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
621650|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621651|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621652|NCT03397706|Valganciclovir|valganciclovir|mesh-list
621653|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
621654|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
621655|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
621656|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
621657|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621658|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
621659|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
621660|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
621661|NCT03397537|Letrozole|letrozole|mesh-list
621662|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621663|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
621664|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
621665|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621666|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621667|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
621668|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
621669|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
621670|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621671|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
621672|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
621673|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621674|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
621675|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
621676|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
621677|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621678|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
621679|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218366|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
2218367|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
2218368|NCT00033436|Vitamins|vitamins|mesh-ancestor
2218369|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
2218370|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621685|NCT03397264|Aflibercept|aflibercept|mesh-list
621686|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
621687|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
621688|NCT03397264|Growth Substances|growth substances|mesh-ancestor
621689|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621690|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
621691|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621692|NCT03397199|Apatinib|apatinib|mesh-list
621693|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621694|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
621695|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621696|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621697|NCT03397186|Trabectedin|trabectedin|mesh-list
621698|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
621699|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
621700|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621701|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621702|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
621703|NCT03397173|Azacitidine|azacitidine|mesh-list
621704|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
621705|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
621706|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621707|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621708|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621709|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
621710|NCT03397173|Protective Agents|protective agents|mesh-ancestor
621711|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621712|NCT03397173|Vitamins|vitamins|mesh-ancestor
621713|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
621714|NCT03397082|Lidocaine|lidocaine|mesh-list
621715|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
621716|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
621717|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621718|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621719|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
621720|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621721|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
621722|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
621723|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
621724|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
621725|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621726|NCT03397069|Midazolam|midazolam|mesh-list
621727|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
621728|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
621729|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621730|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621731|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
621732|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
621733|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
621734|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
621735|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
621736|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
621737|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
621738|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
621739|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621740|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080061|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080062|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080063|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2080064|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
2080065|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
2218371|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2218372|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
2218373|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218374|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2218375|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
2218376|NCT00033449|Gefitinib|gefitinib|mesh-list
2218377|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218378|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2218379|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218380|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218381|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2218382|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218383|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2218384|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218385|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218386|NCT00033553|Gemcitabine|gemcitabine|mesh-list
2218387|NCT00033553|Paclitaxel|paclitaxel|mesh-list
2218388|NCT00033553|Carboplatin|carboplatin|mesh-list
2218389|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2218390|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218391|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
2218392|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
621768|NCT03396926|Bevacizumab|bevacizumab|mesh-list
621769|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
621770|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
621771|NCT03396926|Capecitabine|capecitabine|mesh-list
621772|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
621773|NCT03396926|Antibodies|antibodies|mesh-list
621774|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
621775|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
621776|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
621777|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621778|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
621779|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
621780|NCT03396926|Growth Substances|growth substances|mesh-ancestor
621781|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621782|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
621783|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
621784|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
621785|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
621786|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621787|NCT03396874|Edetic Acid|edetic acid|mesh-list
621788|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
621789|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
621790|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621791|NCT03396874|Anticoagulants|anticoagulants|mesh-ancestor
621792|NCT03396874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
621793|NCT03396874|Chelating Agents|chelating agents|mesh-ancestor
621794|NCT03396874|Sequestering Agents|sequestering agents|mesh-ancestor
621795|NCT03396861|Aflibercept|aflibercept|mesh-list
621796|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
621797|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
621798|NCT03396861|Growth Substances|growth substances|mesh-ancestor
621799|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621800|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
621801|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621813|NCT03396601|Ketamine|ketamine|mesh-list
621814|NCT03396601|Analgesics|analgesics|mesh-ancestor
621815|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
621816|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621817|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621818|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
621819|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
621820|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
621821|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
621822|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621823|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
621824|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
621825|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621826|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621827|NCT03396588|Clonidine|clonidine|mesh-list
621828|NCT03396588|Morphine|morphine|mesh-list
621829|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
621830|NCT03396588|Narcotics|narcotics|mesh-ancestor
621831|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621832|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621833|NCT03396588|Analgesics|analgesics|mesh-ancestor
621834|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
621835|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621836|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
621837|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
621838|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
621839|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
621840|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
621841|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
621842|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
621843|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621844|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080066|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2080067|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
2080068|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080069|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080070|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080071|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
2080072|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2080073|NCT02066311|Nelfinavir|nelfinavir|mesh-list
2080074|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2080075|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2080076|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
2080077|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621857|NCT03396523|Losartan|losartan|mesh-list
621858|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
621859|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
621860|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
621861|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
621862|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621863|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
621864|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
621865|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621866|NCT03396484|Methyldopa|methyldopa|mesh-list
621867|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
621868|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
621869|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
621870|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621871|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621872|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
621873|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
621874|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
621875|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
621876|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621877|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621878|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
621879|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
621880|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080078|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080079|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2080080|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2080081|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
2080082|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080083|NCT02066389|Upadacitinib|upadacitinib|mesh-list
2080084|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2080085|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2080086|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080087|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080088|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080089|NCT02066402|Linezolid|linezolid|mesh-list
2080090|NCT02066402|Tedizolid|tedizolid|mesh-list
2080091|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
621895|NCT03396393|Artenimol|artenimol|mesh-list
621896|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
621897|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
621898|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
621899|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
621900|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
621901|NCT03396380|Vitamin D|vitamin d|mesh-list
621902|NCT03396380|Citric Acid|citric acid|mesh-list
621903|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
621904|NCT03396380|Clomiphene|clomiphene|mesh-list
621905|NCT03396380|Enclomiphene|enclomiphene|mesh-list
621906|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
621907|NCT03396380|Calcium|calcium|mesh-list
621908|NCT03396380|Vitamins|vitamins|mesh-ancestor
621909|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
621910|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621911|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
621912|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
621913|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
621914|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
621915|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
621916|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
621917|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621918|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
621919|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
621920|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
621921|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
621922|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
621923|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
621924|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
621925|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
621926|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
621927|NCT03396315|Alendronate|alendronate|mesh-list
621928|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
621929|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621930|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
621931|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
621932|NCT03396276|Narcotics|narcotics|mesh-ancestor
621933|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621934|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621935|NCT03396276|Analgesics|analgesics|mesh-ancestor
621936|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
621937|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621938|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
621939|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
621940|NCT03396250|Promethazine|promethazine|mesh-list
621941|NCT03396250|Naproxen|naproxen|mesh-list
621942|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
621943|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
621944|NCT03396250|Analgesics|analgesics|mesh-ancestor
621945|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
621946|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621947|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621948|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
621949|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
621950|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
621951|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
621952|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621953|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621954|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
621955|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
621956|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621957|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
621958|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
621959|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
621960|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
621961|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
621962|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
621963|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
621964|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
621965|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
621966|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
621967|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
621968|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
621969|NCT03396211|Nivolumab|nivolumab|mesh-list
621970|NCT03396211|Apatinib|apatinib|mesh-list
621971|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
621972|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621973|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
621974|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
621975|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
621976|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
621977|NCT03396107|Dexamethasone|dexamethasone|mesh-list
621978|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
621979|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
621980|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
621981|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
621982|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621983|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
621984|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
621985|NCT03396107|Hormones|hormones|mesh-ancestor
621986|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
621987|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
621988|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
621989|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
621990|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
621991|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
621992|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
621993|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
621994|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
621995|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
621996|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
621997|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
621998|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
621999|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622000|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622001|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
622002|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
622003|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
622004|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
622005|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
622006|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
2218393|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
2218394|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218395|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2218396|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
2218397|NCT00033553|Antiviral Agents|antiviral agents|mesh-ancestor
2218398|NCT00033553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218399|NCT00033553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218400|NCT00033553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
622015|NCT03395977|Febuxostat|febuxostat|mesh-list
622016|NCT03395977|Rasburicase|rasburicase|mesh-list
622017|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
622018|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
622019|NCT03395951|Diuretics|diuretics|mesh-list
622020|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
622021|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622022|NCT03395912|Anesthetics|anesthetics|mesh-list
622023|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
622024|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622025|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622026|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
622027|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622028|NCT03395899|Bevacizumab|bevacizumab|mesh-list
622029|NCT03395899|Atezolizumab|atezolizumab|mesh-list
622030|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
622031|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622032|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
622033|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
622034|NCT03395899|Growth Substances|growth substances|mesh-ancestor
622035|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622036|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
2218401|NCT00033553|Immunologic Factors|immunologic factors|mesh-ancestor
2218402|NCT00033553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218403|NCT00033566|S 3304|s 3304|mesh-list
2218404|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
2218405|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
2218406|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218407|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218408|NCT00033592|Bupropion|bupropion|mesh-list
2218409|NCT00033592|Nicotine|nicotine|mesh-list
2218410|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2218411|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
2218412|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218413|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218414|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2218415|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2218416|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
2218417|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622054|NCT03395873|Decitabine|decitabine|mesh-list
622055|NCT03395873|Avelumab|avelumab|mesh-list
622056|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
622057|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
622058|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622059|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622060|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622061|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
622062|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
622063|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
622064|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218418|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218419|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2218420|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
2218421|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2218422|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2218423|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2218424|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
622073|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
622074|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
622075|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
622076|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
622077|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
622078|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
622079|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
622080|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622081|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
622082|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
622083|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
622084|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
622085|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622086|NCT03395730|Oxytocin|oxytocin|mesh-list
622087|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
622088|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
622089|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622090|NCT03395704|Hepcidins|hepcidins|mesh-list
622091|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
622092|NCT03395665|Estradiol|estradiol|mesh-list
622093|NCT03395665|Progesterone|progesterone|mesh-list
622094|NCT03395665|Estrogens|estrogens|mesh-ancestor
622095|NCT03395665|Hormones|hormones|mesh-ancestor
622096|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
622097|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622098|NCT03395665|Progestins|progestins|mesh-ancestor
2080092|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2080093|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080094|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2080095|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080096|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080097|NCT02066415|Erenumab|erenumab|mesh-list
2080098|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2080099|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080100|NCT02066415|Analgesics|analgesics|mesh-ancestor
2080101|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
2080102|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622112|NCT03395587|Temozolomide|temozolomide|mesh-list
622113|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
622114|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
622115|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622116|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622117|NCT03395574|Terlipressin|terlipressin|mesh-list
622118|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
622119|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
622120|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
622121|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
622122|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
622123|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
622124|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622125|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
622126|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
622127|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622128|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
622129|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
622130|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
622131|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
622132|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
622133|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
622134|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622135|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622136|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
622137|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
622138|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
622139|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
622140|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
622141|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622142|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622143|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
622144|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
622145|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
622146|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
622147|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
622148|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
2218425|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
2218426|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2218427|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2218428|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218429|NCT00033605|Octreotide|octreotide|mesh-list
2218430|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2218431|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2218432|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218433|NCT00033618|Epothilones|epothilones|mesh-list
2218434|NCT00033618|Epothilone B|epothilone b|mesh-list
2218435|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
2218436|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
2218437|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
2080103|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080104|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
2080105|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2080106|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2080107|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080108|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2080109|NCT02066727|Analgesics|analgesics|mesh-ancestor
2080110|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
2080111|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080112|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2080113|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2080114|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2080115|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
2080116|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080117|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080118|NCT02066792|Cycloserine|cycloserine|mesh-list
2080119|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2080120|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080121|NCT02066792|Renal Agents|renal agents|mesh-ancestor
2080122|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2080123|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
2080124|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
622184|NCT03395262|Caffeine|caffeine|mesh-list
622185|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
622186|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622187|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
622188|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622189|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622190|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
622191|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
622192|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
622193|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622194|NCT03395223|Methylene Blue|methylene blue|mesh-list
622195|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622196|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080125|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
2080126|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218438|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080127|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
2080128|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2751372|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2751373|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751374|NCT03945357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2751375|NCT03945357|Immunologic Factors|immunologic factors|mesh-ancestor
622206|NCT03395171|Vitamin D|vitamin d|mesh-list
622207|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
622208|NCT03395171|Vitamins|vitamins|mesh-ancestor
622209|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
622210|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622211|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
622212|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
622213|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
622214|NCT03395132|Betamethasone|betamethasone|mesh-list
622215|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
622216|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
622217|NCT03395132|Hormones|hormones|mesh-ancestor
622218|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
622219|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622220|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
622221|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
622222|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
622223|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
622224|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
622225|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622226|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622227|NCT03395093|Fentanyl|fentanyl|mesh-list
622228|NCT03395093|Midazolam|midazolam|mesh-list
622229|NCT03395093|Propofol|propofol|mesh-list
622230|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
622231|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622232|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622233|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
622234|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
622235|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
622236|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
622237|NCT03395093|Narcotics|narcotics|mesh-ancestor
622238|NCT03395093|Analgesics|analgesics|mesh-ancestor
622239|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
622240|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622241|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
622242|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
622243|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
622244|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
622245|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
622246|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
622247|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622248|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622249|NCT03395080|Paclitaxel|paclitaxel|mesh-list
622250|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
622251|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622252|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
622253|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
622254|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
622255|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622256|NCT03395028|Lenograstim|lenograstim|mesh-list
622257|NCT03395028|Sargramostim|sargramostim|mesh-list
622258|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
622259|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
622260|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622261|NCT03395002|Fluticasone|fluticasone|mesh-list
622262|NCT03395002|Xhance|xhance|mesh-list
622263|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
622264|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
622265|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
622266|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
622267|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
622268|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622269|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622270|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
622271|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
622272|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
622273|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
622274|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
622275|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
622276|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
2751376|NCT03945357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622277|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622278|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622279|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
622280|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
622281|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
622282|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
622283|NCT03394989|Fluticasone|fluticasone|mesh-list
622284|NCT03394989|Xhance|xhance|mesh-list
622285|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
622286|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
622287|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
622288|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
622289|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
622290|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622291|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622292|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
622293|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
622294|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
622295|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
622296|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
622297|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
622298|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
622299|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
622300|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622301|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622302|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
622303|NCT03394989|Hormones|hormones|mesh-ancestor
622304|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
622305|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
622306|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
622307|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
622308|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
622309|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218439|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218440|NCT00033644|Doxorubicin|doxorubicin|mesh-list
2218441|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2218442|NCT00033644|Mitomycins|mitomycins|mesh-list
2218443|NCT00033644|Mitomycin|mitomycin|mesh-list
2218444|NCT00033644|Dacarbazine|dacarbazine|mesh-list
2218445|NCT00033644|Sargramostim|sargramostim|mesh-list
2218446|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218447|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2218448|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2218449|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2218450|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218451|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218452|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
2218453|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218454|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
622326|NCT03394833|Polygeline|polygeline|mesh-list
622327|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
622328|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
622329|NCT03394820|Dexamethasone|dexamethasone|mesh-list
622330|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
622331|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
622332|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
622333|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622334|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622335|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
622336|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
622337|NCT03394820|Hormones|hormones|mesh-ancestor
622338|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
622339|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
622340|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622341|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
622342|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
622343|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
622344|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622345|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622346|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
622347|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622348|NCT03394729|Propolis|propolis|mesh-list
622349|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
622350|NCT03394586|Golimumab|golimumab|mesh-list
622351|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
622352|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
622353|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
622354|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
622355|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622356|NCT03394573|Aflibercept|aflibercept|mesh-list
622357|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
622358|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
622359|NCT03394573|Growth Substances|growth substances|mesh-ancestor
622360|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622361|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
622362|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622363|NCT03394430|Midazolam|midazolam|mesh-list
622364|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
622365|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
622366|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622367|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622368|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
622369|NCT03394430|Analgesics|analgesics|mesh-ancestor
622370|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
622371|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622372|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
622373|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
622374|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
622375|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
622376|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622377|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622378|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
622379|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
622380|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
622381|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
622382|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
622383|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
622384|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
622385|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
622386|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
622387|NCT03394287|Apatinib|apatinib|mesh-list
622388|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622389|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
622390|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622391|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622392|NCT03394222|Budesonide|budesonide|mesh-list
622393|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
622394|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
622395|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
622396|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622397|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622398|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
622399|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
622400|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
622401|NCT03394222|Hormones|hormones|mesh-ancestor
622402|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
622403|NCT03394209|Oseltamivir|oseltamivir|mesh-list
622404|NCT03394209|Favipiravir|favipiravir|mesh-list
622405|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
622406|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
622407|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622408|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622409|NCT03394196|Ritonavir|ritonavir|mesh-list
622410|NCT03394196|Lopinavir|lopinavir|mesh-list
622411|NCT03394196|Darunavir|darunavir|mesh-list
622412|NCT03394196|Tenofovir|tenofovir|mesh-list
622413|NCT03394196|Lamivudine|lamivudine|mesh-list
622414|NCT03394196|Zidovudine|zidovudine|mesh-list
622415|NCT03394196|Emtricitabine|emtricitabine|mesh-list
622416|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
622417|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
622418|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
622419|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
622420|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622421|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622422|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
622423|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
622424|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
622425|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
622426|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
622427|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
622428|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
622429|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
622430|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
622431|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
622432|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
622433|NCT03394144|Durvalumab|durvalumab|mesh-list
622434|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
622435|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622436|NCT03394131|Insulin|insulin|mesh-list
622437|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
622438|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
622439|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622440|NCT03394118|Osimertinib|osimertinib|mesh-list
622441|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622442|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
622443|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622444|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622445|NCT03394105|Docetaxel|docetaxel|mesh-list
622446|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622447|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
622448|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
622449|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
622450|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622453|NCT03394001|Ketorolac|ketorolac|mesh-list
622454|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
622455|NCT03394001|Lidocaine|lidocaine|mesh-list
622456|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
622457|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
622458|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622459|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622460|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
622461|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622462|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
622463|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
622464|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
622465|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
622466|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622467|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
622468|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
622469|NCT03394001|Analgesics|analgesics|mesh-ancestor
622470|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
622471|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
622472|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
622473|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622474|NCT03393988|Fentanyl|fentanyl|mesh-list
622475|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
622476|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
622477|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
622478|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622479|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622480|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
622481|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
622482|NCT03393988|Analgesics|analgesics|mesh-ancestor
622483|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
622484|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622485|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
622486|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
622487|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
622488|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
622489|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622490|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622491|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
622492|NCT03393988|Narcotics|narcotics|mesh-ancestor
622493|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
622494|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
622495|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
622496|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
622497|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
622498|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
622499|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
622500|NCT03393949|Prednisolone|prednisolone|mesh-list
622501|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
622502|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
622503|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
622504|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
622505|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
622506|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
622507|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622508|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622509|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
622510|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
622511|NCT03393949|Hormones|hormones|mesh-ancestor
622512|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
622513|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
622514|NCT03393949|Protective Agents|protective agents|mesh-ancestor
622515|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
622516|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622517|NCT03393884|Paclitaxel|paclitaxel|mesh-list
622518|NCT03393884|Carboplatin|carboplatin|mesh-list
622519|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
622520|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622521|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
622522|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
622523|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
622524|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622525|NCT03393858|Antibodies|antibodies|mesh-list
622526|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
622527|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080129|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
2080130|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2080131|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080132|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2080133|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2080134|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2080135|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2080136|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2080137|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
2080138|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622538|NCT03393819|Ethanol|ethanol|mesh-list
622539|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
622540|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
622541|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
622542|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622543|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622544|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
622545|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
622546|NCT03393780|Hormones|hormones|mesh-ancestor
622547|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
622548|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622549|NCT03393767|Ranibizumab|ranibizumab|mesh-list
622550|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
622551|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
622552|NCT03393767|Growth Substances|growth substances|mesh-ancestor
622553|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622554|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
622555|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218455|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2218456|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2218457|NCT00033683|Tamoxifen|tamoxifen|mesh-list
2751377|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2751378|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2751379|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2751380|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2751381|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751382|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2751383|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
2751384|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622572|NCT03393728|Propranolol|propranolol|mesh-list
622573|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
622574|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
622575|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
622576|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622577|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622578|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622579|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2080139|NCT02067676|Antacids|antacids|mesh-ancestor
622580|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
622581|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
622582|NCT03393715|Perindopril|perindopril|mesh-list
622583|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
622584|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
622585|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622586|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622587|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
622588|NCT03393702|Gabapentin|gabapentin|mesh-list
622589|NCT03393702|Analgesics|analgesics|mesh-ancestor
622590|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
622591|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622592|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622593|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
622594|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
622595|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
622596|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622597|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
622598|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
622599|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
622600|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622601|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622602|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
622624|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
622625|NCT03393572|Nalbuphine|nalbuphine|mesh-list
622626|NCT03393572|Bupivacaine|bupivacaine|mesh-list
622627|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
622628|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
622629|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622630|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622631|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
622632|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622633|NCT03393572|Analgesics|analgesics|mesh-ancestor
622634|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
622635|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
622636|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
622637|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
622638|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622639|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
622640|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
622641|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
622642|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
622643|NCT03393572|Narcotics|narcotics|mesh-ancestor
622644|NCT03393507|Apatinib|apatinib|mesh-list
622645|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622646|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
622647|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622648|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080140|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080141|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2080142|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
2080143|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
2080144|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
2080145|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2080146|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080147|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
2080148|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622660|NCT03393481|Enoxaparin|enoxaparin|mesh-list
622661|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
622662|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
622663|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
622664|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080153|NCT02068027|Clonidine|clonidine|mesh-list
2080154|NCT02068027|Analgesics|analgesics|mesh-ancestor
622670|NCT03393416|Antibodies|antibodies|mesh-list
622671|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
622672|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622673|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
622674|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
622675|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622676|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622677|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
622678|NCT03393403|Analgesics|analgesics|mesh-ancestor
622679|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
622680|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622681|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
622682|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
622683|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
622684|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
622685|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622686|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622687|NCT03393377|Valsartan|valsartan|mesh-list
622688|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
622689|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
622690|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
622691|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622692|NCT03393364|Ketorolac|ketorolac|mesh-list
622693|NCT03393364|Oxycodone|oxycodone|mesh-list
622694|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
622695|NCT03393364|Narcotics|narcotics|mesh-ancestor
622696|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622697|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622698|NCT03393364|Analgesics|analgesics|mesh-ancestor
622699|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
622700|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622701|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
622702|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
622703|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
622704|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
622705|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
622706|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622707|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622708|NCT03393325|Tadalafil|tadalafil|mesh-list
622709|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
622710|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
622711|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
622712|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622713|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622714|NCT03393325|Urological Agents|urological agents|mesh-ancestor
622715|NCT03393273|Elotuzumab|elotuzumab|mesh-list
622716|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622717|NCT03393247|Azathioprine|azathioprine|mesh-list
622718|NCT03393247|Infliximab|infliximab|mesh-list
622719|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
622720|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
622721|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
622722|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
622723|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622724|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
622725|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622726|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
622727|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
622728|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218458|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
2218459|NCT00033683|Docetaxel|docetaxel|mesh-list
2218460|NCT00033683|Fluorouracil|fluorouracil|mesh-list
622732|NCT03393117|Narcotics|narcotics|mesh-list
622733|NCT03393117|Bupivacaine|bupivacaine|mesh-list
622734|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
622735|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
622736|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622737|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622738|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
622739|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622740|NCT03393117|Analgesics|analgesics|mesh-ancestor
622741|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
622742|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
622743|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
622744|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622745|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622746|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
622747|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
622748|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
622749|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
622750|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
622751|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622752|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622753|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
622754|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
622755|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
622756|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
622757|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
622758|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
2218461|NCT00033683|Methotrexate|methotrexate|mesh-list
2218462|NCT00033683|Epirubicin|epirubicin|mesh-list
2218463|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2218464|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
2218465|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218466|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2218467|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2218468|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
2218469|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218470|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622769|NCT03392961|Insulin|insulin|mesh-list
622770|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
622771|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622772|NCT03392909|Gentamicins|gentamicins|mesh-list
622773|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
622774|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
622775|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
622776|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622777|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622778|NCT03392792|Plasminogen|plasminogen|mesh-list
622779|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
622780|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
622781|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
622782|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622783|NCT03392740|Lisinopril|lisinopril|mesh-list
622784|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
622785|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
622786|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622787|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622788|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
622789|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
622790|NCT03392740|Protective Agents|protective agents|mesh-ancestor
622791|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622792|NCT03392623|Niacinamide|niacinamide|mesh-list
622793|NCT03392623|Niacin|niacin|mesh-list
622794|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
622795|NCT03392623|Tretinoin|tretinoin|mesh-list
622796|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
622797|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622798|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
622799|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
622800|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
622801|NCT03392623|Protective Agents|protective agents|mesh-ancestor
622802|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622803|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
622804|NCT03392623|Vitamins|vitamins|mesh-ancestor
622805|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
622806|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
622807|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
622808|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622809|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
622810|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
622811|NCT03392571|Gemcitabine|gemcitabine|mesh-list
622812|NCT03392571|Paclitaxel|paclitaxel|mesh-list
622813|NCT03392571|Cisplatin|cisplatin|mesh-list
622814|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
622815|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622816|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
622817|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
622818|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
622819|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622820|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
622821|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
622822|NCT03392571|Antiviral Agents|antiviral agents|mesh-ancestor
622823|NCT03392571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
622824|NCT03392571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622825|NCT03392571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
622826|NCT03392571|Immunologic Factors|immunologic factors|mesh-ancestor
622827|NCT03392571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622828|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
622829|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
622830|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622831|NCT03392441|Insulin|insulin|mesh-list
622832|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
622833|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622834|NCT03392428|177Lu-PSMA-617|177lu-psma-617|mesh-list
622835|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
622836|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622837|NCT03392376|Haloperidol|haloperidol|mesh-list
622838|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
622839|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
622840|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
622841|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622842|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622843|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
622844|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
622845|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
622846|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622847|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
622848|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
622849|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
622850|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622851|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622852|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
622853|NCT03392311|Calcipotriene|calcipotriene|mesh-list
622854|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
622855|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
622856|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
622857|NCT03392272|Coagulants|coagulants|mesh-ancestor
622863|NCT03392103|Raltitrexed|raltitrexed|mesh-list
622864|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
622865|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
622866|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622867|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622868|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
622869|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622870|NCT03392051|Clopidogrel|clopidogrel|mesh-list
622871|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
622872|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
622873|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
622874|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
622875|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
622876|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622877|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622878|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622879|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
622880|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
622881|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622882|NCT03391934|Leucovorin|leucovorin|mesh-list
622883|NCT03391934|Fluorouracil|fluorouracil|mesh-list
622884|NCT03391934|Irinotecan|irinotecan|mesh-list
622885|NCT03391934|Cetuximab|cetuximab|mesh-list
622886|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622887|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
622888|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622889|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
622890|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622891|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
622892|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
622893|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
622894|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
622895|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622896|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
622897|NCT03391934|Antidotes|antidotes|mesh-ancestor
622898|NCT03391934|Protective Agents|protective agents|mesh-ancestor
622899|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
622900|NCT03391934|Vitamins|vitamins|mesh-ancestor
622901|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
2080155|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
2080156|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080157|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080158|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2080159|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
2080160|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
2080161|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2080162|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2080163|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2080164|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
2080165|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080166|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080167|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2080168|NCT02068157|Trioxsalen|trioxsalen|mesh-list
2080169|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080170|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
622918|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
622919|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
622920|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
622921|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
622922|NCT03391856|Expectorants|expectorants|mesh-ancestor
622923|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
622924|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
622925|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
622926|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622927|NCT03391856|Protective Agents|protective agents|mesh-ancestor
622928|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622929|NCT03391856|Antidotes|antidotes|mesh-ancestor
622930|NCT03391843|Cetuximab|cetuximab|mesh-list
622931|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
622932|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
622933|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
622934|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
622935|NCT03391830|Atorvastatin|atorvastatin|mesh-list
622936|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
622937|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
622938|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
622939|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622940|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
622941|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
622942|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622943|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
622944|NCT03391830|Protective Agents|protective agents|mesh-ancestor
622945|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622946|NCT03391830|Vitamins|vitamins|mesh-ancestor
622947|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
2218471|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2218472|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
622950|NCT03391700|Rocuronium|rocuronium|mesh-list
622951|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
622952|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
622953|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
622954|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622955|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622956|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
622957|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
622958|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
622959|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622960|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
622961|NCT03391609|Analgesics|analgesics|mesh-ancestor
622962|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
622963|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622964|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
622965|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
622966|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
622967|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
622968|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
622969|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622970|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
622971|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
622972|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
622973|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
622974|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
622975|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
622976|NCT03391570|Analgesics|analgesics|mesh-ancestor
622977|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
622978|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
622979|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
622980|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
622981|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080171|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2080172|NCT02068222|Ritonavir|ritonavir|mesh-list
2080173|NCT02068222|Ribavirin|ribavirin|mesh-list
2080174|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2080175|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2080176|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
2080177|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080178|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080179|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2080180|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2080181|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
2080182|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080183|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2080184|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
622996|NCT03391427|Lidocaine|lidocaine|mesh-list
622997|NCT03391427|Ketamine|ketamine|mesh-list
622998|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
622999|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
623000|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623001|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623002|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
623003|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623004|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
623005|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
623006|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
623007|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
623008|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623009|NCT03391427|Analgesics|analgesics|mesh-ancestor
623010|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
623011|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
623012|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
623013|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
623014|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
623015|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
623016|NCT03391284|Acetaminophen|acetaminophen|mesh-list
623017|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
623018|NCT03391284|Analgesics|analgesics|mesh-ancestor
623019|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
623020|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623021|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623022|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
623023|NCT03391245|Vitamin D|vitamin d|mesh-list
623024|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
623025|NCT03391245|Calcifediol|calcifediol|mesh-list
623026|NCT03391245|Vitamins|vitamins|mesh-ancestor
623027|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
623028|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623029|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
623030|NCT03391219|Bevacizumab|bevacizumab|mesh-list
623031|NCT03391219|Fasudil|fasudil|mesh-list
623032|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
623033|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080185|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
623034|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
623035|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
623036|NCT03391219|Growth Substances|growth substances|mesh-ancestor
623037|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623038|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
623039|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
623040|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
623041|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623042|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
623043|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
623044|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
623045|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623046|NCT03391193|Vaccines|vaccines|mesh-list
623047|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
623048|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623049|NCT03391050|Dabrafenib|dabrafenib|mesh-list
623050|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623051|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
623052|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623053|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623054|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
623055|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
623056|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623057|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623058|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
623059|NCT03390972|Analgesics|analgesics|mesh-ancestor
623060|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
623061|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623062|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
623063|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
623064|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
623065|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
623066|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
623067|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623068|NCT03390933|Fluoxetine|fluoxetine|mesh-list
623069|NCT03390933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
623070|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
623071|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
623072|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623073|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
623074|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
623075|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623076|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
623077|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
623078|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
623079|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
623080|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
623081|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623082|NCT03390790|Lidocaine|lidocaine|mesh-list
623083|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
623084|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
623085|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623086|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623087|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
623088|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623089|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
623090|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
623091|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
623092|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
623093|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623094|NCT03390738|Nivolumab|nivolumab|mesh-list
623095|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
623096|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623097|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
623098|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623099|NCT03390712|Risperidone|risperidone|mesh-list
623100|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
623101|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
623102|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
623103|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
623104|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080186|NCT02068443|Metformin|metformin|mesh-list
623105|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623106|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623107|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
623108|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623109|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
623110|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
623111|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
623112|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
623113|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
623114|NCT03390686|Paclitaxel|paclitaxel|mesh-list
623115|NCT03390686|Bevacizumab|bevacizumab|mesh-list
623116|NCT03390686|Carboplatin|carboplatin|mesh-list
623117|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
623118|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623119|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
623120|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
623121|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
623122|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623123|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
623124|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
623125|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
623126|NCT03390686|Growth Substances|growth substances|mesh-ancestor
623127|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623128|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
623129|NCT03390673|Bevacizumab|bevacizumab|mesh-list
623130|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
623131|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623132|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
623133|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
623134|NCT03390673|Growth Substances|growth substances|mesh-ancestor
623135|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623136|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
623137|NCT03390608|Trastuzumab|trastuzumab|mesh-list
623138|NCT03390608|Estrogens|estrogens|mesh-list
623139|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
623140|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623141|NCT03390608|Hormones|hormones|mesh-ancestor
623142|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
623143|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623144|NCT03390595|Gemcitabine|gemcitabine|mesh-list
623145|NCT03390595|Carboplatin|carboplatin|mesh-list
623146|NCT03390595|Avelumab|avelumab|mesh-list
623147|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623148|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
623149|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
623150|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623151|NCT03390595|Antiviral Agents|antiviral agents|mesh-ancestor
623152|NCT03390595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
623153|NCT03390595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623154|NCT03390595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
623155|NCT03390595|Immunologic Factors|immunologic factors|mesh-ancestor
623156|NCT03390595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623157|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
623158|NCT03390582|Methimazole|methimazole|mesh-list
623159|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
623160|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
623161|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
623162|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080187|NCT02068443|Alogliptin|alogliptin|mesh-list
2080188|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2080189|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080190|NCT02068443|Incretins|incretins|mesh-ancestor
2080191|NCT02068443|Hormones|hormones|mesh-ancestor
2080192|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2080193|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2080194|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
623172|NCT03390465|Amlodipine|amlodipine|mesh-list
623173|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
623174|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
623175|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
623176|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
623177|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623178|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
623179|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623180|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
623181|NCT03390465|Diuretics|diuretics|mesh-ancestor
623182|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
623183|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2218473|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
2218474|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
2218475|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
2218476|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2218477|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2218478|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
2218479|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
623191|NCT03390387|Dexamethasone|dexamethasone|mesh-list
623192|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
623193|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
623194|NCT03390387|Bortezomib|bortezomib|mesh-list
623195|NCT03390387|Daunorubicin|daunorubicin|mesh-list
623196|NCT03390387|Idarubicin|idarubicin|mesh-list
623197|NCT03390387|BB 1101|bb 1101|mesh-list
623198|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
623199|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
623200|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
623201|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623202|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623203|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
623204|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
623205|NCT03390387|Hormones|hormones|mesh-ancestor
623206|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
623207|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
623208|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623209|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
623210|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623211|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623212|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
623213|NCT03390387|Protective Agents|protective agents|mesh-ancestor
623214|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
623215|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
623216|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
623217|NCT03390374|Nystatin|nystatin|mesh-list
623218|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
623219|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
623220|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
623221|NCT03390374|Ionophores|ionophores|mesh-ancestor
623222|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
623223|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218480|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
2218481|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218482|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
623245|NCT03390062|Apatinib|apatinib|mesh-list
623246|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623247|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
623248|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623249|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623250|NCT03390036|Triamcinolone|triamcinolone|mesh-list
623251|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
623252|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
623253|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
623254|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
623255|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
623256|NCT03390036|Hormones|hormones|mesh-ancestor
623257|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
623258|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623259|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
623260|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
623261|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623262|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623263|NCT03390010|Misoprostol|misoprostol|mesh-list
623264|NCT03390010|Oxytocin|oxytocin|mesh-list
623265|NCT03390010|Methylergonovine|methylergonovine|mesh-list
623266|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
623267|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
623268|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
623269|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623270|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
623271|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
623272|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
623273|NCT03389958|Copper|copper|mesh-list
623274|NCT03389958|Trace Elements|trace elements|mesh-ancestor
623275|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
623276|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218483|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2218484|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2218485|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
623280|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
623281|NCT03389776|Anesthetics|anesthetics|mesh-list
623282|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623283|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623284|NCT03389763|Remifentanil|remifentanil|mesh-list
623285|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
623286|NCT03389763|Narcotics|narcotics|mesh-ancestor
623287|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623288|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623289|NCT03389763|Analgesics|analgesics|mesh-ancestor
623290|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
623291|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623292|NCT03389750|Oxymorphone|oxymorphone|mesh-list
623293|NCT03389750|Morphine|morphine|mesh-list
623294|NCT03389750|Oxycodone|oxycodone|mesh-list
623295|NCT03389750|Hydromorphone|hydromorphone|mesh-list
623296|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
623297|NCT03389750|Narcotics|narcotics|mesh-ancestor
623298|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623299|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623300|NCT03389750|Analgesics|analgesics|mesh-ancestor
623301|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
623302|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623303|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
623304|NCT03389724|Captopril|captopril|mesh-list
623305|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
623306|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
623307|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623308|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623309|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
623310|NCT03389672|Anesthetics|anesthetics|mesh-list
623311|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623312|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623313|NCT03389659|Vitamin D|vitamin d|mesh-list
623314|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
623315|NCT03389659|Vitamins|vitamins|mesh-ancestor
623316|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
623317|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623318|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
623319|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
623320|NCT03389620|Dexamethasone|dexamethasone|mesh-list
623321|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
623322|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
623323|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
623324|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623325|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623326|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
623327|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
623328|NCT03389620|Hormones|hormones|mesh-ancestor
623329|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
623330|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
623331|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623332|NCT03389607|Anesthetics|anesthetics|mesh-list
623333|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623334|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218486|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2218487|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2218488|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
2218489|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2218490|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2218491|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2218492|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2218493|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2218494|NCT00033696|Paclitaxel|paclitaxel|mesh-list
2218495|NCT00033696|Etoposide|etoposide|mesh-list
2218496|NCT00033696|Carboplatin|carboplatin|mesh-list
623346|NCT03389490|Insulin|insulin|mesh-list
623347|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
623348|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
623349|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
623350|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
623351|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
623352|NCT03389490|Protamines|protamines|mesh-list
623353|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
623354|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623355|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
623356|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623357|NCT03389490|Coagulants|coagulants|mesh-ancestor
2080195|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080196|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080197|NCT02068495|Amlodipine|amlodipine|mesh-list
2080198|NCT02068495|Candesartan|candesartan|mesh-list
2080199|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
2080200|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2080201|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2080202|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
623366|NCT03389451|Edetic Acid|edetic acid|mesh-list
623367|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
623368|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
623369|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623370|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
623371|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
623372|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
623373|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
623374|NCT03389412|Coagulants|coagulants|mesh-ancestor
623375|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
623376|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
623377|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623378|NCT03389321|Macitentan|macitentan|mesh-list
623379|NCT03389321|Riociguat|riociguat|mesh-list
623380|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
623381|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
623382|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623383|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
623384|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
2218497|NCT00033696|Topotecan|topotecan|mesh-list
623387|NCT03389295|Cisplatin|cisplatin|mesh-list
623388|NCT03389295|Docetaxel|docetaxel|mesh-list
623389|NCT03389295|Fluorouracil|fluorouracil|mesh-list
623390|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623391|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
623392|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
623393|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
623394|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623395|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
623396|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
623397|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
623398|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
623399|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623400|NCT03389256|Apatinib|apatinib|mesh-list
623401|NCT03389256|Gefitinib|gefitinib|mesh-list
623402|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623403|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
623404|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623405|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623406|NCT03389243|Acetaminophen|acetaminophen|mesh-list
623407|NCT03389243|Dipyrone|dipyrone|mesh-list
623408|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
623409|NCT03389243|Analgesics|analgesics|mesh-ancestor
623410|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
623411|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623412|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623413|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
623414|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
623415|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
623416|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
623417|NCT03389191|Acyclovir|acyclovir|mesh-list
623418|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
623419|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
623420|NCT03389139|Anesthetics|anesthetics|mesh-list
623421|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623422|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623423|NCT03389126|Avelumab|avelumab|mesh-list
623424|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
623425|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623426|NCT03389087|Etoposide|etoposide|mesh-list
623427|NCT03389087|Apatinib|apatinib|mesh-list
623428|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
623429|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623430|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
623431|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
623432|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623433|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623434|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
623435|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
623436|NCT03389061|Velpatasvir|velpatasvir|mesh-list
623437|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
623438|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
623439|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080203|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080204|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2080205|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080206|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
2080207|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2080208|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2080209|NCT02068508|Pioglitazone|pioglitazone|mesh-list
2080210|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2080211|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080212|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
2080213|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
2080214|NCT02068820|Protective Agents|protective agents|mesh-ancestor
2080215|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080216|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
623454|NCT03388970|Vitamin K|vitamin k|mesh-list
623455|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
623456|NCT03388970|Vitamins|vitamins|mesh-ancestor
623457|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
623458|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623459|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
623460|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
623461|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623462|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
623463|NCT03388970|Coagulants|coagulants|mesh-ancestor
623464|NCT03388957|Propranolol|propranolol|mesh-list
623465|NCT03388957|Midazolam|midazolam|mesh-list
623466|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
623467|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
623468|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623469|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623470|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
623471|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
623472|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
623473|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
623474|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
623475|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
623476|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
623477|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
623478|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
623479|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623480|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
623481|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
623482|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
623483|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
623484|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
623485|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
623486|NCT03388892|Paclitaxel|paclitaxel|mesh-list
623942|NCT03387098|Bevacizumab|bevacizumab|mesh-list
623487|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
623488|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623489|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
623490|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
623491|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
623492|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623493|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
623494|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623495|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
623496|NCT03388853|Doxofylline|doxofylline|mesh-list
623497|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
623498|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
623499|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
623500|NCT03388853|Expectorants|expectorants|mesh-ancestor
623501|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
623502|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
623503|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
623504|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623505|NCT03388853|Protective Agents|protective agents|mesh-ancestor
623506|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623507|NCT03388853|Antidotes|antidotes|mesh-ancestor
623508|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
623509|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
623510|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
623511|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623512|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
623513|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
623514|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623515|NCT03388827|Misoprostol|misoprostol|mesh-list
623516|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
623517|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
623518|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
623519|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623520|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
623521|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
623522|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
623523|NCT03388814|Bupivacaine|bupivacaine|mesh-list
623524|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
623525|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
623526|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623527|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623528|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
623529|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623530|NCT03388788|CGP 12177|cgp 12177|mesh-list
623531|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
623532|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
623533|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
623534|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
623535|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623536|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623537|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
623538|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
623539|NCT03388749|Annamycin|annamycin|mesh-list
623540|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
623541|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623542|NCT03388697|Insulin|insulin|mesh-list
623543|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
623544|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623545|NCT03388671|Bupivacaine|bupivacaine|mesh-list
623546|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
623547|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
623548|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623549|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623550|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
623551|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080217|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2080218|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080219|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2080220|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2080221|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102950|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623558|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
623559|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
623560|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623561|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623943|NCT03387098|Fluorouracil|fluorouracil|mesh-list
623562|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
623563|NCT03388541|Analgesics|analgesics|mesh-ancestor
623564|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
623565|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623566|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
623567|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
623568|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
623569|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
623570|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
623571|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623572|NCT03388463|Omeprazole|omeprazole|mesh-list
623573|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
623574|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
623575|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
623576|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623577|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623578|NCT03388372|Temozolomide|temozolomide|mesh-list
623579|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
623580|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
623581|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
623582|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623583|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623584|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
623585|NCT03388346|Edetic Acid|edetic acid|mesh-list
623586|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
623587|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
623588|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623589|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
623590|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2218498|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2218499|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218500|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
2218501|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
2218502|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
2218503|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218504|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2218505|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2218506|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218507|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2218508|NCT00033709|Thalidomide|thalidomide|mesh-list
2218509|NCT00033709|Temozolomide|temozolomide|mesh-list
2218510|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2218511|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
2218512|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218513|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218514|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2218515|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
2218516|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218517|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
2218518|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2218519|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
623633|NCT03388151|Midazolam|midazolam|mesh-list
623634|NCT03388151|Propofol|propofol|mesh-list
623635|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
623636|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623637|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623638|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
623639|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
623640|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
623641|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
623642|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
623643|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
623644|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
623645|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
623646|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
623647|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
623648|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080222|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080223|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080224|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2080225|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2080226|NCT02069041|Leucovorin|leucovorin|mesh-list
2080227|NCT02069041|Fluorouracil|fluorouracil|mesh-list
2080228|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
2080229|NCT02069041|Ramucirumab|ramucirumab|mesh-list
2080230|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
2080231|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623659|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
623660|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
623661|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2080232|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2080233|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080234|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2080235|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
2080236|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080237|NCT02069041|Antidotes|antidotes|mesh-ancestor
2080238|NCT02069041|Protective Agents|protective agents|mesh-ancestor
2080239|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
2080240|NCT02069041|Vitamins|vitamins|mesh-ancestor
2080241|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
2080242|NCT02069093|Dexamethasone|dexamethasone|mesh-list
2080243|NCT02069093|Everolimus|everolimus|mesh-list
2080244|NCT02069093|Exemestane|exemestane|mesh-list
2080245|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080246|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
2080247|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
2080248|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080249|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080250|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2080251|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
2080252|NCT02069093|Hormones|hormones|mesh-ancestor
2080253|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2080254|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2080255|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080256|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2080257|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
2080258|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2080259|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2080260|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080261|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080262|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2080263|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
623694|NCT03387956|Dexamethasone|dexamethasone|mesh-list
623695|NCT03387956|Atropine|atropine|mesh-list
623696|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
623697|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
623698|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
623699|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623700|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623701|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
623702|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
623703|NCT03387956|Hormones|hormones|mesh-ancestor
623704|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
623705|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
623706|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623707|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
623708|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
623709|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
623710|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
623711|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
623712|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
623713|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
623714|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
623715|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
623716|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
623717|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
623718|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623719|NCT03387943|Cisplatin|cisplatin|mesh-list
623720|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623724|NCT03387904|Irinotecan|irinotecan|mesh-list
623725|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
623726|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
623727|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623728|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623729|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623730|NCT03387852|Fluticasone|fluticasone|mesh-list
623731|NCT03387852|Xhance|xhance|mesh-list
623732|NCT03387852|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
623733|NCT03387852|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
623734|NCT03387852|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
623735|NCT03387852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
623736|NCT03387852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
623737|NCT03387852|Autonomic Agents|autonomic agents|mesh-ancestor
623738|NCT03387852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623739|NCT03387852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623740|NCT03387852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
623741|NCT03387852|Respiratory System Agents|respiratory system agents|mesh-ancestor
623742|NCT03387852|Dermatologic Agents|dermatologic agents|mesh-ancestor
623743|NCT03387852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
623744|NCT03387852|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
623745|NCT03387852|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
623746|NCT03387852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
623747|NCT03387852|Adrenergic Agents|adrenergic agents|mesh-ancestor
623748|NCT03387852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
623749|NCT03387852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623750|NCT03387852|Immunologic Factors|immunologic factors|mesh-ancestor
623751|NCT03387852|Glucocorticoids|glucocorticoids|mesh-ancestor
623752|NCT03387852|Hormones|hormones|mesh-ancestor
623753|NCT03387852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
623754|NCT03387852|Sympathomimetics|sympathomimetics|mesh-ancestor
623755|NCT03387826|Ticagrelor|ticagrelor|mesh-list
623756|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
623757|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
623758|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
623759|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
623760|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
623761|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
623762|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
623763|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623764|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623765|NCT03387787|Insulin|insulin|mesh-list
623766|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
623767|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623774|NCT03387761|Nivolumab|nivolumab|mesh-list
623775|NCT03387761|Ipilimumab|ipilimumab|mesh-list
623776|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
623777|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623778|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
623779|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218520|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2218521|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2218522|NCT00033709|Growth Substances|growth substances|mesh-ancestor
2218523|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
2218524|NCT00033722|Folic Acid|folic acid|mesh-list
623785|NCT03387670|Simvastatin|simvastatin|mesh-list
623786|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
623787|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
623788|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
2218525|NCT00033722|Lometrexol|lometrexol|mesh-list
623789|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623790|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
623791|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
623792|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623793|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
623794|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
623795|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
623796|NCT03387657|Diuretics|diuretics|mesh-ancestor
623797|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
623798|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623799|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
623800|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
623801|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623802|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
623803|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
623804|NCT03387644|Pregabalin|pregabalin|mesh-list
623805|NCT03387644|Analgesics|analgesics|mesh-ancestor
623806|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
623807|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623808|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623809|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
623810|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
623811|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
623812|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623813|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
623814|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
623815|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
623816|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
623817|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
623818|NCT03387631|Lumefantrine|lumefantrine|mesh-list
623819|NCT03387631|Artemether|artemether|mesh-list
623820|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
623821|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
623822|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
623823|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
623824|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
623825|NCT03387592|Leucovorin|leucovorin|mesh-list
623826|NCT03387592|Fluorouracil|fluorouracil|mesh-list
623827|NCT03387592|Capecitabine|capecitabine|mesh-list
623828|NCT03387592|Temozolomide|temozolomide|mesh-list
623829|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
623830|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
623831|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623832|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
623833|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623834|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
623835|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
623836|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623837|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
623838|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
623839|NCT03387592|Antidotes|antidotes|mesh-ancestor
623840|NCT03387592|Protective Agents|protective agents|mesh-ancestor
623841|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
623842|NCT03387592|Vitamins|vitamins|mesh-ancestor
623843|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
623849|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
623850|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
623851|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
623852|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623853|NCT03387566|Growth Substances|growth substances|mesh-ancestor
623854|NCT03387501|Mitogens|mitogens|mesh-list
623855|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
623856|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623857|NCT03387475|Deferasirox|deferasirox|mesh-list
623858|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
623859|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
623860|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
623861|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080264|NCT02069184|Acetaminophen|acetaminophen|mesh-list
2080265|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2080266|NCT02069184|Analgesics|analgesics|mesh-ancestor
2080267|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
2080268|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080269|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080270|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
2080271|NCT02069379|Metformin|metformin|mesh-list
623872|NCT03387423|Tofacitinib|tofacitinib|mesh-list
623873|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
623874|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
623875|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623876|NCT03387241|Fluticasone|fluticasone|mesh-list
623877|NCT03387241|Xhance|xhance|mesh-list
623878|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
623879|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
623880|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
623881|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
623882|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
623883|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
623884|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
623885|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623886|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
623887|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
623888|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
623889|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
623890|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
623891|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
623892|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
623893|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
623894|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
623895|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623896|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
623897|NCT03387241|Hormones|hormones|mesh-ancestor
623898|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
623899|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
623900|NCT03387163|Valsartan|valsartan|mesh-list
623901|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
623902|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
623903|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
623904|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623905|NCT03387111|Leucovorin|leucovorin|mesh-list
623906|NCT03387111|Paclitaxel|paclitaxel|mesh-list
623907|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
623908|NCT03387111|Bevacizumab|bevacizumab|mesh-list
623909|NCT03387111|Fluorouracil|fluorouracil|mesh-list
623910|NCT03387111|Capecitabine|capecitabine|mesh-list
623911|NCT03387111|Cetuximab|cetuximab|mesh-list
623912|NCT03387111|Avelumab|avelumab|mesh-list
623913|NCT03387111|Necitumumab|necitumumab|mesh-list
623914|NCT03387111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
623915|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623916|NCT03387111|Tubulin Modulators|tubulin modulators|mesh-ancestor
623917|NCT03387111|Antimitotic Agents|antimitotic agents|mesh-ancestor
623918|NCT03387111|Mitosis Modulators|mitosis modulators|mesh-ancestor
623919|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623920|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
623921|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
623922|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623923|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
623924|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
623925|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
623926|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
623927|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
623928|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
623929|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
623930|NCT03387111|Growth Substances|growth substances|mesh-ancestor
623931|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
623932|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
623933|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
623934|NCT03387111|Antidotes|antidotes|mesh-ancestor
623935|NCT03387111|Protective Agents|protective agents|mesh-ancestor
623936|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
623937|NCT03387111|Vitamins|vitamins|mesh-ancestor
623938|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
623939|NCT03387098|Leucovorin|leucovorin|mesh-list
623940|NCT03387098|Paclitaxel|paclitaxel|mesh-list
623941|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
2080272|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
623944|NCT03387098|Capecitabine|capecitabine|mesh-list
623945|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
623946|NCT03387098|Avelumab|avelumab|mesh-list
623947|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
623948|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623949|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
623950|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
623951|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
623952|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623953|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
623954|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
623955|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623956|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
623957|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
623958|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
623959|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
623960|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
623961|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
623962|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
623963|NCT03387098|Growth Substances|growth substances|mesh-ancestor
623964|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
623965|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
623966|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
623967|NCT03387098|Antidotes|antidotes|mesh-ancestor
623968|NCT03387098|Protective Agents|protective agents|mesh-ancestor
623969|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
623970|NCT03387098|Vitamins|vitamins|mesh-ancestor
623971|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
623972|NCT03387085|Leucovorin|leucovorin|mesh-list
623973|NCT03387085|Paclitaxel|paclitaxel|mesh-list
623974|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
623975|NCT03387085|Bevacizumab|bevacizumab|mesh-list
623976|NCT03387085|Fluorouracil|fluorouracil|mesh-list
623977|NCT03387085|Capecitabine|capecitabine|mesh-list
623978|NCT03387085|Avelumab|avelumab|mesh-list
623979|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
623980|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
623981|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
623982|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
623983|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
623984|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
623985|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
623986|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
623987|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
623988|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
623989|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
623990|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
623991|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
623992|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
623993|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
623994|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
623995|NCT03387085|Growth Substances|growth substances|mesh-ancestor
623996|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
623997|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
623998|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
623999|NCT03387085|Antidotes|antidotes|mesh-ancestor
624000|NCT03387085|Protective Agents|protective agents|mesh-ancestor
624001|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
624002|NCT03387085|Vitamins|vitamins|mesh-ancestor
624003|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
2218526|NCT00033722|Hematinics|hematinics|mesh-ancestor
2218527|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
2218528|NCT00033722|Vitamins|vitamins|mesh-ancestor
2218529|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
2218530|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218531|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2218532|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
2218533|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218534|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218535|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2218536|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218537|NCT00033735|Fluorouracil|fluorouracil|mesh-list
2218538|NCT00033735|Irofulven|irofulven|mesh-list
2218539|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
2218540|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218541|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2218542|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218543|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2218544|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
2218545|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218546|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2218547|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
2218548|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2218549|NCT00033748|Antibodies|antibodies|mesh-list
2218550|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
624029|NCT03386929|Palbociclib|palbociclib|mesh-list
624030|NCT03386929|Avelumab|avelumab|mesh-list
624031|NCT03386929|Axitinib|axitinib|mesh-list
624032|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624033|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
624034|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624035|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624036|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
624037|NCT03386838|Carboplatin|carboplatin|mesh-list
624038|NCT03386838|Fluorouracil|fluorouracil|mesh-list
624039|NCT03386838|Nivolumab|nivolumab|mesh-list
624040|NCT03386838|Cetuximab|cetuximab|mesh-list
624041|NCT03386838|Linrodostat|linrodostat|mesh-list
624042|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624043|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
624044|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624045|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
624046|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
624047|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
624048|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624049|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
624050|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
624051|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080273|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080274|NCT02069392|Nicotine|nicotine|mesh-list
2080275|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2080276|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
2080277|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080278|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080279|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2080280|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2080281|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
2080282|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080283|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080284|NCT02069704|Leucovorin|leucovorin|mesh-list
2080285|NCT02069704|Folic Acid|folic acid|mesh-list
2080286|NCT02069704|Bevacizumab|bevacizumab|mesh-list
2080287|NCT02069704|Fluorouracil|fluorouracil|mesh-list
2080288|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
2080289|NCT02069704|Irinotecan|irinotecan|mesh-list
2080290|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
624070|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
624071|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
624072|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
624073|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624074|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
624075|NCT03386656|Coagulants|coagulants|mesh-ancestor
624076|NCT03386643|Clobetasol|clobetasol|mesh-list
624077|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
624078|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
624079|NCT03386643|Hormones|hormones|mesh-ancestor
624080|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
624081|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624082|NCT03386630|Sufentanil|sufentanil|mesh-list
624083|NCT03386630|Morphine|morphine|mesh-list
624084|NCT03386630|Dsuvia|dsuvia|mesh-list
624085|NCT03386630|Bupivacaine|bupivacaine|mesh-list
624086|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
624087|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
624088|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
624089|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624090|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
624091|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624092|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
624093|NCT03386630|Narcotics|narcotics|mesh-ancestor
624094|NCT03386630|Analgesics|analgesics|mesh-ancestor
624095|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
624096|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
624097|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
624098|NCT03386591|Naloxone|naloxone|mesh-list
624099|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
624399|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
2102951|NCT02415595|BMS-955176|bms-955176|mesh-list
624100|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624101|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
624102|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080291|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2080292|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080293|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2080294|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2080295|NCT02069704|Growth Substances|growth substances|mesh-ancestor
2080296|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080297|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
2080298|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
2080299|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080300|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2102952|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
624114|NCT03386565|Lidocaine|lidocaine|mesh-list
624115|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
624116|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
624117|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
624118|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
624119|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624120|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
624121|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624122|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
624123|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
624124|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
624125|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
624126|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624127|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
624128|NCT03386539|Everolimus|everolimus|mesh-list
624129|NCT03386539|Tacrolimus|tacrolimus|mesh-list
624130|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
624131|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
624132|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624133|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
624134|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624135|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624136|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624137|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
624138|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
624139|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
624140|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
624141|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
624142|NCT03386500|Manganese|manganese|mesh-list
624143|NCT03386500|Trace Elements|trace elements|mesh-ancestor
624144|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
624145|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218551|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2218552|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
2218553|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218554|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218555|NCT00033813|Oxatomide|oxatomide|mesh-list
2218556|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2218557|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
2218558|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
2218559|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218560|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218561|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218562|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2218563|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2218564|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
2218565|NCT00033891|Infliximab|infliximab|mesh-list
2218566|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
2218567|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2218568|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2218569|NCT00033982|Posaconazole|posaconazole|mesh-list
2218570|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
2218571|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218572|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2218573|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2218574|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2218575|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
624172|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
624173|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
624174|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218576|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2218577|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218578|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218579|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2218580|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
624180|NCT03386318|Oxycodone|oxycodone|mesh-list
624181|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
624182|NCT03386318|Narcotics|narcotics|mesh-ancestor
624183|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
624184|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624185|NCT03386318|Analgesics|analgesics|mesh-ancestor
624186|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
624187|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624188|NCT03386305|Tacrolimus|tacrolimus|mesh-list
624189|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
624190|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
624191|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624192|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
624193|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624194|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624195|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
624196|NCT03386279|Abrocitinib|abrocitinib|mesh-list
624197|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
624198|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
624199|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
624200|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
624201|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624202|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624203|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624204|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
624205|NCT03386240|Triclosan|triclosan|mesh-list
624206|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
624207|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
624208|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
624209|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
624210|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
624211|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624212|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
624213|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
624214|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080301|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2080302|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
2080303|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
624218|NCT03386201|Methylene Blue|methylene blue|mesh-list
624219|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624220|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624221|NCT03386162|Fulvestrant|fulvestrant|mesh-list
624222|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
624223|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624224|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
624225|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
624226|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
624227|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
624228|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624229|NCT03386149|Loxoprofen|loxoprofen|mesh-list
624230|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
624231|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
624232|NCT03386149|Analgesics|analgesics|mesh-ancestor
624233|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
624234|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624235|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624236|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
624237|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
624238|NCT03386071|Trametinib|trametinib|mesh-list
624239|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624240|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
624241|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624242|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218581|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2218582|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624245|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
624246|NCT03385967|Ropivacaine|ropivacaine|mesh-list
624552|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
2218583|NCT00034047|Nafarelin|nafarelin|mesh-list
624247|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
624248|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
624249|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624250|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
624251|NCT03385967|Analgesics|analgesics|mesh-ancestor
624252|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
624253|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624254|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
624255|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
624256|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
624257|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
624258|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
624259|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624260|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
624261|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
624262|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
624263|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
624264|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
624265|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624266|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
624267|NCT03385928|Coagulants|coagulants|mesh-ancestor
624268|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
624269|NCT03385863|Poractant alfa|poractant alfa|mesh-list
624270|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
624271|NCT03385668|Pirfenidone|pirfenidone|mesh-list
624272|NCT03385668|Analgesics|analgesics|mesh-ancestor
624273|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
624274|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624275|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624276|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
624277|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
624278|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
624279|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
624280|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624289|NCT03385551|Estradiol|estradiol|mesh-list
624290|NCT03385551|Estrogens|estrogens|mesh-ancestor
624291|NCT03385551|Hormones|hormones|mesh-ancestor
624292|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
624293|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624294|NCT03385538|Clopidogrel|clopidogrel|mesh-list
624295|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
624296|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
624297|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
624298|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
624299|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
624300|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
624301|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624302|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624303|NCT03385525|Valproic Acid|valproic acid|mesh-list
624304|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
624305|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624306|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624307|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
624308|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
624309|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624310|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
624311|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
624312|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
624313|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
624314|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
624315|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
624316|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
624317|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
624318|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624319|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624320|NCT03385382|Dexamethasone|dexamethasone|mesh-list
624321|NCT03385382|Ranibizumab|ranibizumab|mesh-list
624322|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
624323|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
624324|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
624325|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624326|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624327|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
624328|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
624329|NCT03385382|Hormones|hormones|mesh-ancestor
624330|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
624331|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
624332|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624333|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
624334|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
624335|NCT03385382|Growth Substances|growth substances|mesh-ancestor
624336|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
624337|NCT03385356|Vitamin D|vitamin d|mesh-list
624338|NCT03385356|Vitamins|vitamins|mesh-ancestor
624339|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
624340|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624341|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
624342|NCT03385304|Iodine|iodine|mesh-list
624343|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
624344|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
624345|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
624346|NCT03385304|Povidone|povidone|mesh-list
624347|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
624348|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
624349|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
624350|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
624351|NCT03385304|Trace Elements|trace elements|mesh-ancestor
624352|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
624353|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624354|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
624355|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
624356|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
624357|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
624358|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624359|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
624360|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
624361|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624362|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
624363|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
624364|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624365|NCT03385161|Ethanol|ethanol|mesh-list
624366|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
624367|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
624368|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
624369|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
624370|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
624371|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624372|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
624373|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
624374|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624375|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
624376|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
624377|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
624378|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
624379|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624380|NCT03385135|Allopurinol|allopurinol|mesh-list
624381|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
624382|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624383|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624384|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
624385|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
624386|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
624387|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
624388|NCT03385135|Protective Agents|protective agents|mesh-ancestor
624389|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624390|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
624391|NCT03385096|Melphalan|melphalan|mesh-list
624392|NCT03385096|Busulfan|busulfan|mesh-list
624393|NCT03385096|Etoposide|etoposide|mesh-list
624394|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
624395|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
624396|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624397|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
624398|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
624400|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624401|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624402|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
624403|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
624404|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
624405|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
624406|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624407|NCT03385057|Acetaminophen|acetaminophen|mesh-list
624408|NCT03385057|Ibuprofen|ibuprofen|mesh-list
624409|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
624410|NCT03385057|Analgesics|analgesics|mesh-ancestor
624411|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
624412|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624413|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624414|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
624415|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
624416|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
624417|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
624418|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
624419|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624420|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080304|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2080305|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080306|NCT02069704|Antidotes|antidotes|mesh-ancestor
2080307|NCT02069704|Protective Agents|protective agents|mesh-ancestor
2080308|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
2080309|NCT02069704|Vitamins|vitamins|mesh-ancestor
624427|NCT03384862|Folic Acid|folic acid|mesh-list
624428|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
624429|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
624430|NCT03384862|Vitamins|vitamins|mesh-ancestor
624431|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
624432|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624433|NCT03384862|Hematinics|hematinics|mesh-ancestor
624434|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
2080310|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
2080311|NCT02069704|Hematinics|hematinics|mesh-ancestor
2080312|NCT02069847|Budesonide|budesonide|mesh-list
2080313|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080314|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2080315|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
2080316|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080317|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080318|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2080319|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
2080320|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
2080321|NCT02069847|Hormones|hormones|mesh-ancestor
2080322|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2080323|NCT02070237|Enoxaparin|enoxaparin|mesh-list
2080324|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
2080325|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2080326|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2080327|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080328|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
2080329|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2080330|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2080331|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2080332|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2080333|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218584|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2218585|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
2218586|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2218587|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218588|NCT00034060|Etanercept|etanercept|mesh-list
2080334|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
2080335|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080336|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080337|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2080338|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080339|NCT02070692|Tamoxifen|tamoxifen|mesh-list
2080340|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2080341|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
2080342|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2080343|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080344|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2218589|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2080345|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080346|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2080347|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2080348|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2080349|NCT02070744|Ivacaftor|ivacaftor|mesh-list
2080350|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2080351|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2080352|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080353|NCT02070757|Meropenem|meropenem|mesh-list
2080354|NCT02070757|Tazobactam|tazobactam|mesh-list
2080355|NCT02070757|Ceftolozane|ceftolozane|mesh-list
2080356|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2080357|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2080358|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080359|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2080360|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080361|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080362|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2080363|NCT02070757|Renal Agents|renal agents|mesh-ancestor
2080364|NCT02070991|Macitentan|macitentan|mesh-list
2080365|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2080366|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2080367|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080368|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2080369|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2080370|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2080371|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2080372|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
2080373|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080374|NCT02071095|Poly I-C|poly i-c|mesh-list
624510|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
624511|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
624512|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624513|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
624514|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
624515|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
624516|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624517|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
624518|NCT03384563|Analgesics|analgesics|mesh-ancestor
624519|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
624520|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624521|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
624522|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
624523|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
624524|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
624525|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
624526|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624527|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
624528|NCT03384537|Listerine|listerine|mesh-list
624529|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
624530|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
624531|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
624532|NCT03384524|Metoprolol|metoprolol|mesh-list
624533|NCT03384524|Bromocriptine|bromocriptine|mesh-list
624534|NCT03384524|Tamsulosin|tamsulosin|mesh-list
624535|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
624536|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
624537|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
624538|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
624539|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624540|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624541|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
624542|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
624543|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
624544|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
624545|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
624546|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624547|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
624548|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
624549|NCT03384524|Urological Agents|urological agents|mesh-ancestor
624550|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
624551|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
624553|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
624554|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
624555|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
624556|NCT03384511|Apatinib|apatinib|mesh-list
624557|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624558|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
624559|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624560|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218590|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2218591|NCT00034060|Analgesics|analgesics|mesh-ancestor
2218592|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
2218593|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218594|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218595|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2218596|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2218597|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2218598|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2218599|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
624571|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
624572|NCT03384277|Rituximab|rituximab|mesh-list
624573|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
624574|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
624575|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624576|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
624577|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
624578|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
624579|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624580|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624581|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
624582|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
624583|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
624584|NCT03384238|Panitumumab|panitumumab|mesh-list
624585|NCT03384238|Antibodies|antibodies|mesh-list
624586|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
624587|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
624588|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
624589|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624590|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080375|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2080376|NCT02071095|Poly ICLC|poly iclc|mesh-list
2080377|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
2080378|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
2080379|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080380|NCT02071095|Laxatives|laxatives|mesh-ancestor
2080381|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2080382|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
2080383|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080384|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2080385|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
2080386|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2080387|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
2080388|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080389|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080390|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2080391|NCT02071810|Opicapone|opicapone|mesh-list
2080392|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2080393|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080394|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080395|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2080396|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2080397|NCT02071823|Opicapone|opicapone|mesh-list
2080398|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2080399|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080400|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080401|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2080402|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2080403|NCT02072096|Metformin|metformin|mesh-list
2080404|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
2080405|NCT02072096|Pioglitazone|pioglitazone|mesh-list
624623|NCT03384121|Rifampin|rifampin|mesh-list
624624|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
624625|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
624626|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
624627|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
624628|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
624629|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
624630|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624631|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624632|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
624633|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
624634|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
624635|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
624636|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
624637|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
624638|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
624639|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
624640|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
624641|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624642|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
624643|NCT03384095|Protective Agents|protective agents|mesh-ancestor
624644|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
624645|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
624646|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
624647|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
624648|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624649|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624650|NCT03383822|Insulin|insulin|mesh-list
624651|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
624652|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
624653|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218600|NCT00034086|Ritonavir|ritonavir|mesh-list
2218601|NCT00034086|Lopinavir|lopinavir|mesh-list
2218602|NCT00034086|Tenofovir|tenofovir|mesh-list
2218603|NCT00034086|Lamivudine|lamivudine|mesh-list
2218604|NCT00034086|Zidovudine|zidovudine|mesh-list
2218605|NCT00034086|Stavudine|stavudine|mesh-list
2218606|NCT00034086|Didanosine|didanosine|mesh-list
2218607|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
624662|NCT03383770|Anesthetics|anesthetics|mesh-list
624663|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
624664|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624665|NCT03383744|Vitamin A|vitamin a|mesh-list
624666|NCT03383744|Vitamins|vitamins|mesh-ancestor
624667|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
624668|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218608|NCT00034086|Vaccines|vaccines|mesh-list
2218609|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2218610|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
2218611|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218612|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2218613|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2218614|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
2218615|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218616|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218617|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2218618|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2218619|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
2218620|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218621|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2218622|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2218623|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2218624|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2218625|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
2218626|NCT00034125|Tamoxifen|tamoxifen|mesh-list
2080406|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2080407|NCT02072096|Liraglutide|liraglutide|mesh-list
2080408|NCT02072096|Exenatide|exenatide|mesh-list
2080409|NCT02072096|Glimepiride|glimepiride|mesh-list
2080410|NCT02072096|Linagliptin|linagliptin|mesh-list
2218627|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2218628|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
2218629|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2218630|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218631|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2218632|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218633|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2218634|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2218635|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2218636|NCT00034138|Oregovomab|oregovomab|mesh-list
2080411|NCT02072096|Acarbose|acarbose|mesh-list
2080412|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2218637|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2218638|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218639|NCT00034151|Paclitaxel|paclitaxel|mesh-list
2218640|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2218641|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218642|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
2218643|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
2218644|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
2218645|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218646|NCT00034164|Paclitaxel|paclitaxel|mesh-list
2218647|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2218648|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218649|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
2218650|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
2218651|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
2218652|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218653|NCT00034177|Paclitaxel|paclitaxel|mesh-list
2218654|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2218655|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2218656|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218657|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
624725|NCT03383575|Azacitidine|azacitidine|mesh-list
624726|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
624727|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
624728|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624729|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624730|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218658|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
2218659|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
2218660|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218661|NCT00034190|Paclitaxel|paclitaxel|mesh-list
2218662|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2080413|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080414|NCT02072096|Incretins|incretins|mesh-ancestor
2080415|NCT02072096|Hormones|hormones|mesh-ancestor
2080416|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2080417|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
624744|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
624745|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
624746|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
624747|NCT03383406|Cytarabine|cytarabine|mesh-list
624748|NCT03383406|Methotrexate|methotrexate|mesh-list
624749|NCT03383406|Etoposide|etoposide|mesh-list
624750|NCT03383406|Ifosfamide|ifosfamide|mesh-list
624751|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
624752|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
624753|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
624754|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624755|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
624756|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
624757|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624758|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624759|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
624760|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624761|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
624762|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
624763|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
624764|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
624765|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
624766|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
624767|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
624768|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
624769|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
624770|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
624771|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
624772|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
624773|NCT03383393|Adenosine|adenosine|mesh-list
624774|NCT03383393|Eptifibatide|eptifibatide|mesh-list
624775|NCT03383393|Analgesics|analgesics|mesh-ancestor
624776|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
624777|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624778|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624779|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
624780|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
624781|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
624782|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
624783|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
624784|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
624785|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624786|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
624787|NCT03383380|Sirolimus|sirolimus|mesh-list
624788|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
624789|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
624790|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
624791|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624792|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
624793|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
624794|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
624795|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624796|NCT03383367|TEMPO|tempo|mesh-list
624797|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
624798|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624799|NCT03383367|Protective Agents|protective agents|mesh-ancestor
624800|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624801|NCT03383328|Prednisolone|prednisolone|mesh-list
624802|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
624803|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
624804|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
624805|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
624806|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
624807|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
624808|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
624809|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
624810|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
624811|NCT03383328|Hormones|hormones|mesh-ancestor
624812|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
624813|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624814|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
624815|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624816|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
624817|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
624818|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624819|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
624820|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
624821|NCT03383328|Protective Agents|protective agents|mesh-ancestor
624822|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
624823|NCT03383328|Analgesics|analgesics|mesh-ancestor
624824|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
624825|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
624826|NCT03383315|Tramadol|tramadol|mesh-list
624827|NCT03383315|Metoclopramide|metoclopramide|mesh-list
624828|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
624829|NCT03383315|Narcotics|narcotics|mesh-ancestor
624830|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
624831|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624832|NCT03383315|Analgesics|analgesics|mesh-ancestor
624833|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
624834|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624835|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
624836|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
624837|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
624838|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
624839|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
624840|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
624841|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
624842|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624843|NCT03383302|Nivolumab|nivolumab|mesh-list
624844|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
624845|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624846|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
624847|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624848|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
624849|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
624850|NCT03383237|Apatinib|apatinib|mesh-list
624851|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624852|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
624853|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624854|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080418|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
2080419|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080420|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080421|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2080422|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2080423|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2080424|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
2080425|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2080426|NCT02072200|Prednisone|prednisone|mesh-list
2080427|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2218663|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218664|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
2218665|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
2218666|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
2218667|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218668|NCT00034229|Felbamate|felbamate|mesh-list
2218669|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
624872|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
624873|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
624874|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
624875|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
624876|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
624877|NCT03383185|Progestins|progestins|mesh-list
624878|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
624879|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624880|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
624881|NCT03383185|Hormones|hormones|mesh-ancestor
624882|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
624883|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
624884|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
624885|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
624886|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
624887|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
624888|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624889|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
624890|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
624891|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
624892|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624893|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
624894|NCT03383068|Metformin|metformin|mesh-list
624895|NCT03383068|Exenatide|exenatide|mesh-list
624896|NCT03383068|Acarbose|acarbose|mesh-list
624897|NCT03383068|Orlistat|orlistat|mesh-list
624898|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
624899|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624900|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
624901|NCT03383068|Incretins|incretins|mesh-ancestor
624902|NCT03383068|Hormones|hormones|mesh-ancestor
624903|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
624904|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
624905|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624906|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624907|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
624908|NCT03383003|Amoxicillin|amoxicillin|mesh-list
624909|NCT03383003|Metronidazole|metronidazole|mesh-list
624910|NCT03383003|Clarithromycin|clarithromycin|mesh-list
624911|NCT03383003|Esomeprazole|esomeprazole|mesh-list
624912|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
624913|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
624914|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
624915|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
624916|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
624917|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
624918|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
624919|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
624920|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624921|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
624922|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
624923|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
624924|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
624925|NCT03382938|Ropivacaine|ropivacaine|mesh-list
624926|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
624927|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
624928|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624929|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
624930|NCT03382938|Analgesics|analgesics|mesh-ancestor
624931|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
624932|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
624933|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
624934|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
624935|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
624936|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
624937|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
624938|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
624939|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
624940|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
2218670|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2218671|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2218672|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218673|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218674|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218675|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
2218676|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2218677|NCT00034242|Antibodies|antibodies|mesh-list
2218678|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
2218679|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2218680|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
2218681|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218682|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
2218683|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2218684|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218685|NCT00034346|Paclitaxel|paclitaxel|mesh-list
2218686|NCT00034346|Carboplatin|carboplatin|mesh-list
2218687|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2218688|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218689|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
2218690|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
2218691|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
2218692|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218693|NCT00034359|Lamivudine|lamivudine|mesh-list
2218694|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2218695|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2218696|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218697|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218698|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
2218699|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218700|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
624972|NCT03382886|Bevacizumab|bevacizumab|mesh-list
624973|NCT03382886|Nivolumab|nivolumab|mesh-list
624974|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
624975|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
624976|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
624977|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
624978|NCT03382886|Growth Substances|growth substances|mesh-ancestor
624979|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
624980|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
624981|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
624982|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080428|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
2080429|NCT02072200|Hormones|hormones|mesh-ancestor
2080430|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2080431|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080432|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2080433|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080434|NCT02072226|Aspirin|aspirin|mesh-list
2080435|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2080436|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2080437|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2080438|NCT02072226|Analgesics|analgesics|mesh-ancestor
2080439|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
2080440|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080441|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080442|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080443|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080444|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2218701|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2218702|NCT00034372|Oregovomab|oregovomab|mesh-list
2218703|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2218704|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218705|NCT00034385|Valganciclovir|valganciclovir|mesh-list
2218706|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
2218707|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218708|NCT00034463|Folic Acid|folic acid|mesh-list
2218709|NCT00034463|Vitamins|vitamins|mesh-ancestor
2218710|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
2218711|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218712|NCT00034463|Hematinics|hematinics|mesh-ancestor
2218713|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
2218714|NCT00034489|Gemcitabine|gemcitabine|mesh-list
2218715|NCT00034489|Pemetrexed|pemetrexed|mesh-list
2218716|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2218717|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
2218718|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218719|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218720|NCT00034489|Antiviral Agents|antiviral agents|mesh-ancestor
2218721|NCT00034489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218722|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218723|NCT00034489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2218724|NCT00034489|Immunologic Factors|immunologic factors|mesh-ancestor
2218725|NCT00034489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218726|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2218727|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2218728|NCT00034502|Irinotecan|irinotecan|mesh-list
2218729|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2218730|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2218731|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218732|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218733|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625033|NCT03382756|Choline|choline|mesh-list
625034|NCT03382756|Atorvastatin|atorvastatin|mesh-list
625035|NCT03382756|Fenofibrate|fenofibrate|mesh-list
625036|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
625037|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
625038|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
625039|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625040|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
625041|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
625042|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625043|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
625044|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
625045|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
625046|NCT03382743|Lidocaine|lidocaine|mesh-list
625047|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
625048|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
625049|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
625050|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625051|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
625052|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
625053|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
625054|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
625055|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
625056|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
625057|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625058|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
625059|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
625060|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
625061|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625062|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
625063|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
625064|NCT03382717|Amorolfine|amorolfine|mesh-list
625065|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
625066|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625067|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
625068|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
625069|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625070|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
625071|NCT03382587|Aflibercept|aflibercept|mesh-list
625072|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
625073|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
625074|NCT03382587|Growth Substances|growth substances|mesh-ancestor
625075|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625076|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
625077|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218734|NCT00034528|Prednisone|prednisone|mesh-list
2218735|NCT00034528|Fludarabine|fludarabine|mesh-list
2751407|NCT03934814|Rituximab|rituximab|mesh-list
2751408|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
625100|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
625101|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
625102|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625103|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
625104|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
625105|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
625106|NCT03382431|PC-786|pc-786|mesh-list
625107|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
625108|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625109|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625110|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218736|NCT00034528|Busulfan|busulfan|mesh-list
2218737|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2218738|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
2218739|NCT00034528|Hormones|hormones|mesh-ancestor
2218740|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2218741|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218742|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
625118|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
625119|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
625120|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
625121|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625122|NCT03382314|Vitamins|vitamins|mesh-ancestor
625123|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
625124|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
625125|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
625126|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
625127|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
625128|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
625141|NCT03382275|Iron|iron|mesh-list
625142|NCT03382275|Ferric maltol|ferric maltol|mesh-list
625143|NCT03382275|Trace Elements|trace elements|mesh-ancestor
625144|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
625145|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625146|NCT03382275|Hematinics|hematinics|mesh-ancestor
2218743|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218744|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218745|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2218746|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
2218747|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
2218748|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2218749|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2218750|NCT00034541|Paclitaxel|paclitaxel|mesh-list
2218751|NCT00034541|Carboplatin|carboplatin|mesh-list
2218752|NCT00034541|Cetuximab|cetuximab|mesh-list
2218753|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2218754|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218755|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
2218756|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
625161|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
625162|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
625163|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
625164|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
625165|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625166|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625167|NCT03382106|Urological Agents|urological agents|mesh-ancestor
625168|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
625169|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
625170|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625171|NCT03381859|Grazoprevir|grazoprevir|mesh-list
625172|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
625173|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
625174|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625175|NCT03381833|Hepcidins|hepcidins|mesh-list
625176|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625177|NCT03381781|Cytarabine|cytarabine|mesh-list
625178|NCT03381781|Decitabine|decitabine|mesh-list
625179|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
625180|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
625181|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
625182|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625183|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625184|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
625185|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625186|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
625187|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
625188|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625189|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625190|NCT03381755|Ticagrelor|ticagrelor|mesh-list
625191|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
625192|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
625193|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
625194|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
625195|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
625196|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
625197|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625198|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218757|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
2218758|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218759|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2218760|NCT00034580|Olanzapine|olanzapine|mesh-list
2218761|NCT00034580|Risperidone|risperidone|mesh-list
2218762|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2218763|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
2218764|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218765|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218766|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625209|NCT03381703|YH12852|yh12852|mesh-list
625210|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
625211|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
625212|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
625213|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
625214|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625215|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625216|NCT03381664|Quinidine|quinidine|mesh-list
625217|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
625218|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
625219|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
625220|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
625221|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
625222|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
625223|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625224|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625225|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
625226|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
625227|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
625228|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
625229|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
625230|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
625231|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
625232|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625233|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625234|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
625235|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
625236|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
625237|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
625238|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
625239|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
625240|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
625241|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
625242|NCT03381599|Lenograstim|lenograstim|mesh-list
625243|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
625244|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
625245|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625246|NCT03381495|Sufentanil|sufentanil|mesh-list
625247|NCT03381495|Ropivacaine|ropivacaine|mesh-list
625248|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
625249|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
625250|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
625251|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625252|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
625253|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
625254|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
625255|NCT03381495|Narcotics|narcotics|mesh-ancestor
625256|NCT03381495|Analgesics|analgesics|mesh-ancestor
625257|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
625258|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
625259|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
625260|NCT03381482|Anesthetics|anesthetics|mesh-list
625261|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
625262|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625263|NCT03381430|Gefitinib|gefitinib|mesh-list
625264|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625265|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
625266|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625267|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625268|NCT03381352|Capecitabine|capecitabine|mesh-list
625269|NCT03381352|Mitomycins|mitomycins|mesh-list
625270|NCT03381352|Mitomycin|mitomycin|mesh-list
625271|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
625272|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
625273|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625274|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625275|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
625276|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
625277|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
625278|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080445|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2080446|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080447|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2080448|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2080449|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625284|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
625285|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
625286|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
625287|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
625288|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
625289|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625290|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
625291|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
625292|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625293|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
625294|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218767|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2218768|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2218769|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2218770|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2218771|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2218772|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
2080450|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
2080451|NCT02072434|Enoxaparin|enoxaparin|mesh-list
2080452|NCT02072434|Warfarin|warfarin|mesh-list
625304|NCT03381118|Cytarabine|cytarabine|mesh-list
625305|NCT03381118|Nivolumab|nivolumab|mesh-list
2751409|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
625306|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
625307|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625308|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
625309|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625310|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
625311|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
625312|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
625313|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625314|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
625315|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
625316|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625317|NCT03381066|Cisplatin|cisplatin|mesh-list
625318|NCT03381066|Pemetrexed|pemetrexed|mesh-list
625319|NCT03381066|Vinorelbine|vinorelbine|mesh-list
625320|NCT03381066|Gefitinib|gefitinib|mesh-list
625321|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625322|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625323|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625324|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
625325|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
625326|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
625327|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
625328|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
625329|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
625330|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
625331|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
625332|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625333|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
625334|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625335|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625336|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
625337|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
625338|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
625339|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625340|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
625341|NCT03381040|Protective Agents|protective agents|mesh-ancestor
625342|NCT03380975|Montelukast|montelukast|mesh-list
625343|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
625344|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
625345|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
625346|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
625347|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
625348|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625349|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
625350|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
625351|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625352|NCT03380949|Remifentanil|remifentanil|mesh-list
625353|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
625354|NCT03380949|Narcotics|narcotics|mesh-ancestor
625355|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
625356|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625357|NCT03380949|Analgesics|analgesics|mesh-ancestor
625358|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
625359|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
625360|NCT03380936|Tacrolimus|tacrolimus|mesh-list
625361|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
625362|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
625363|NCT03380936|Antibodies|antibodies|mesh-list
625364|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
625365|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
625366|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
625367|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
625368|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625369|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
625370|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625371|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625372|NCT03380871|Carboplatin|carboplatin|mesh-list
625373|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
625374|NCT03380871|Pemetrexed|pemetrexed|mesh-list
625375|NCT03380871|Poly ICLC|poly iclc|mesh-list
625376|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625377|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
625378|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625379|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625380|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
625381|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
625382|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
625383|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
625384|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625385|NCT03380728|Ibogaine|ibogaine|mesh-list
625386|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
625387|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625388|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
625389|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
625390|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
625391|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
625392|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625393|NCT03380689|Bevacizumab|bevacizumab|mesh-list
625394|NCT03380689|Irinotecan|irinotecan|mesh-list
625395|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
625396|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625397|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
625398|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
625399|NCT03380689|Growth Substances|growth substances|mesh-ancestor
625400|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625401|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
625402|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
625403|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
625404|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625405|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625406|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
625407|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
625408|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
625409|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625410|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
625411|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
625412|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625413|NCT03380546|Insulin|insulin|mesh-list
625414|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
625415|NCT03380546|Acarbose|acarbose|mesh-list
625416|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
625417|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
625418|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625419|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
625420|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625421|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625422|NCT03380533|Buprenorphine|buprenorphine|mesh-list
625423|NCT03380533|Tramadol|tramadol|mesh-list
625424|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
625425|NCT03380533|Narcotics|narcotics|mesh-ancestor
625426|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
625427|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625428|NCT03380533|Analgesics|analgesics|mesh-ancestor
625429|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
625430|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
625431|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2751410|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751411|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
2751412|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751413|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2751414|NCT03933215|Cladribine|cladribine|mesh-list
2751415|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625439|NCT03380468|Pemetrexed|pemetrexed|mesh-list
625440|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625441|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625442|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625443|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
625444|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
625445|NCT03380455|Cimetidine|cimetidine|mesh-list
625446|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
625447|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
625448|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
625449|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
625450|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
625451|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
625452|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625453|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625454|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
625757|NCT03378466|Heparin|heparin|mesh-list
625455|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
625456|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625457|NCT03380442|Ketamine|ketamine|mesh-list
625458|NCT03380442|Psilocybin|psilocybin|mesh-list
625459|NCT03380442|Analgesics|analgesics|mesh-ancestor
625460|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
625461|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
625462|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625463|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
625464|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
625465|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
625466|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
625467|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
625468|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
625469|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
625470|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
625471|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625472|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
625473|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2218773|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
2218774|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
2218775|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218776|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2218777|NCT00034580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2218778|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2218779|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2218780|NCT00034593|Gemcitabine|gemcitabine|mesh-list
2218781|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2218782|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
2218783|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218784|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218785|NCT00034593|Antiviral Agents|antiviral agents|mesh-ancestor
2218786|NCT00034593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218787|NCT00034593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625489|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
625490|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
625491|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625492|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
625493|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
625494|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625495|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625496|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625497|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
625498|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2218788|NCT00034593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2218789|NCT00034593|Immunologic Factors|immunologic factors|mesh-ancestor
2218790|NCT00034593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218791|NCT00034606|Gemcitabine|gemcitabine|mesh-list
2218792|NCT00034606|Pemetrexed|pemetrexed|mesh-list
2218793|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2218794|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
2218795|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218796|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218797|NCT00034606|Antiviral Agents|antiviral agents|mesh-ancestor
2218798|NCT00034606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218799|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218800|NCT00034606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2218801|NCT00034606|Immunologic Factors|immunologic factors|mesh-ancestor
2218802|NCT00034606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218803|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2218804|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2218805|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
625517|NCT03380325|Iloprost|iloprost|mesh-list
625518|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
625519|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
625520|NCT03380130|Nivolumab|nivolumab|mesh-list
625521|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
625522|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625523|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
625524|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218806|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218807|NCT00034632|Posaconazole|posaconazole|mesh-list
2218808|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
2218809|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218810|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2218811|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2218812|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2218813|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
625534|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
625535|NCT03380039|Fludarabine|fludarabine|mesh-list
625536|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
625537|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
625538|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625539|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
625540|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
625541|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
625542|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625543|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625544|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2080453|NCT02072434|Edoxaban|edoxaban|mesh-list
2080454|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
2080455|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2080456|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2080457|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080458|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2080459|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
2080460|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2080461|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
2080462|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080463|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
2080464|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2080465|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
2080466|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2080467|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
2080468|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080469|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625562|NCT03379987|Morphine|morphine|mesh-list
625563|NCT03379987|Bupivacaine|bupivacaine|mesh-list
625564|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
625565|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
625566|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
625567|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625568|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
625569|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
625570|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
625571|NCT03379987|Narcotics|narcotics|mesh-ancestor
625572|NCT03379987|Analgesics|analgesics|mesh-ancestor
625573|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
625574|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
625575|NCT03379974|Coagulants|coagulants|mesh-ancestor
625576|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
625577|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
625578|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625579|NCT03379909|Metformin|metformin|mesh-list
625580|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
625581|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080470|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
2080471|NCT02072824|Pregabalin|pregabalin|mesh-list
2080472|NCT02072824|Analgesics|analgesics|mesh-ancestor
2080473|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
2080474|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218814|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2218815|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751416|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
625590|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
625591|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
625592|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625593|NCT03379428|Trastuzumab|trastuzumab|mesh-list
625594|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
625595|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751417|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
2751418|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751419|NCT03930771|Capecitabine|capecitabine|mesh-list
2751420|NCT03930771|Temozolomide|temozolomide|mesh-list
2751421|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2751422|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
2751423|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751424|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751425|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2080475|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080476|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
2751426|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
625608|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
625609|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625610|NCT03379181|Propranolol|propranolol|mesh-list
625611|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
625612|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
625613|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
625614|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
625615|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625616|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625617|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
625618|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
625619|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
625620|NCT03379103|Propofol|propofol|mesh-list
625621|NCT03379103|Sevoflurane|sevoflurane|mesh-list
625622|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
625623|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
625624|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625625|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
625626|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
625627|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
625628|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
625629|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2080477|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2080478|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2080479|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080480|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2080481|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2080482|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2080483|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2080484|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2218816|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625639|NCT03379012|Sunitinib|sunitinib|mesh-list
625640|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
625641|NCT03379012|Testosterone|testosterone|mesh-list
625642|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
625643|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
625644|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
625645|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625646|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
625647|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
625648|NCT03379012|Growth Substances|growth substances|mesh-ancestor
625649|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625650|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
625651|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
625652|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625653|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625654|NCT03379012|Androgens|androgens|mesh-ancestor
625655|NCT03379012|Hormones|hormones|mesh-ancestor
625656|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
625657|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
625658|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
2218817|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2218818|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
2218819|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2218820|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218821|NCT00034645|Posaconazole|posaconazole|mesh-list
2218822|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
2218823|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218824|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2218825|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2218826|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2218827|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2218828|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
625673|NCT03378960|Omeprazole|omeprazole|mesh-list
625674|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
625675|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
625676|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
625677|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625678|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625679|NCT03378934|Aspirin|aspirin|mesh-list
625680|NCT03378934|Clopidogrel|clopidogrel|mesh-list
625681|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
625682|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
625683|NCT03378934|Analgesics|analgesics|mesh-ancestor
625684|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
625685|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
625686|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625687|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
625688|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
625689|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
625690|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
625691|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625692|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
625693|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
625694|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625695|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
625696|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
625697|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
625698|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
625699|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
625700|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
625701|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
625702|NCT03378791|Trace Elements|trace elements|mesh-ancestor
625703|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
625704|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625705|NCT03378726|Micronutrients|micronutrients|mesh-list
625706|NCT03378726|Trace Elements|trace elements|mesh-list
625707|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625708|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
625709|NCT03378713|Testosterone|testosterone|mesh-list
625710|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
625711|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
625712|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
625713|NCT03378713|Androgens|androgens|mesh-ancestor
625714|NCT03378713|Hormones|hormones|mesh-ancestor
625715|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
625716|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625717|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
625718|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625719|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
625720|NCT03378674|Remifentanil|remifentanil|mesh-list
625721|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
625722|NCT03378674|Narcotics|narcotics|mesh-ancestor
625723|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
625724|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625725|NCT03378674|Analgesics|analgesics|mesh-ancestor
625726|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
625727|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
625728|NCT03378661|Benzonidazole|benzonidazole|mesh-list
625729|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
625730|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
625731|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625732|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
625733|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
625734|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
625735|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625736|NCT03378648|Bromides|bromides|mesh-list
625737|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
2218829|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218830|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218831|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2218832|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
2273735|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
625743|NCT03378479|Posaconazole|posaconazole|mesh-list
625744|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
625745|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625746|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
625747|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
625748|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
625749|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
625750|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
625751|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625752|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625753|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
625754|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
625755|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
625756|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625758|NCT03378466|Calcium heparin|calcium heparin|mesh-list
625759|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
625760|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
625761|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
625762|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625763|NCT03378427|Doxycycline|doxycycline|mesh-list
625764|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
625765|NCT03378427|Levofloxacin|levofloxacin|mesh-list
625766|NCT03378427|Ofloxacin|ofloxacin|mesh-list
625767|NCT03378427|Minocycline|minocycline|mesh-list
625768|NCT03378427|Rifampin|rifampin|mesh-list
625769|NCT03378427|Clindamycin|clindamycin|mesh-list
625770|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
625771|NCT03378427|Tedizolid|tedizolid|mesh-list
625772|NCT03378427|Teicoplanin|teicoplanin|mesh-list
625773|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
625774|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
625775|NCT03378427|Trimethoprim|trimethoprim|mesh-list
625776|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
625777|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
625778|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625779|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
625780|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
625781|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
625782|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
625783|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
625784|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625785|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625786|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625787|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
625788|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
625789|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
625790|NCT03378427|Renal Agents|renal agents|mesh-ancestor
625791|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
625792|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
625793|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
625794|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
625795|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
625796|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
625797|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
625798|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
625799|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
625800|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
625801|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
625802|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
625803|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
625804|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
625805|NCT03378401|Octenidine|octenidine|mesh-list
625806|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625807|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
625808|NCT03378323|Anesthetics|anesthetics|mesh-list
625809|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
625810|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
625811|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625812|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
625813|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
625814|NCT03378310|Linrodostat|linrodostat|mesh-list
625815|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625816|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625817|NCT03378297|Aspirin|aspirin|mesh-list
625818|NCT03378297|Metformin|metformin|mesh-list
625819|NCT03378297|Letrozole|letrozole|mesh-list
625820|NCT03378297|Olaparib|olaparib|mesh-list
625821|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
625822|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625823|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625824|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
625825|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
625826|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625827|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625828|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
625829|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
625830|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
625831|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
625832|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
625833|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
625834|NCT03378297|Analgesics|analgesics|mesh-ancestor
625835|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
625836|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
625837|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
625838|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
625839|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
625840|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
625841|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
625842|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
625843|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
625844|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
625845|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
625846|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218833|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2218834|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218835|NCT00034658|Posaconazole|posaconazole|mesh-list
2218836|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
2218837|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218838|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2218839|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2218840|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2218841|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2218842|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2218843|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218844|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218845|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
625861|NCT03377907|Lidocaine|lidocaine|mesh-list
625862|NCT03377907|Ketamine|ketamine|mesh-list
625863|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
625864|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
625865|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
625866|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625867|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
625868|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
625869|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
625870|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
625871|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
625872|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
625873|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625874|NCT03377907|Analgesics|analgesics|mesh-ancestor
625875|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
625876|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
625877|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
625878|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
625879|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
625880|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
625881|NCT03377842|Leucovorin|leucovorin|mesh-list
625882|NCT03377842|Apatinib|apatinib|mesh-list
625883|NCT03377842|Fluorouracil|fluorouracil|mesh-list
625884|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
625885|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625886|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
625887|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625888|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625889|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
625890|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
625891|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
625892|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
625893|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625894|NCT03377842|Antidotes|antidotes|mesh-ancestor
625895|NCT03377842|Protective Agents|protective agents|mesh-ancestor
625896|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
625897|NCT03377842|Vitamins|vitamins|mesh-ancestor
625898|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
2751429|NCT03926624|Cytarabine|cytarabine|mesh-list
625901|NCT03377725|Decitabine|decitabine|mesh-list
625902|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
625903|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
625904|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
625905|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625906|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625907|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080485|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
2080486|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2080487|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2080488|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2080489|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2080490|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625914|NCT03377608|Tenofovir|tenofovir|mesh-list
625915|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
625916|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
625917|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
625918|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625919|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
625920|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
625921|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625922|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625923|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
625924|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
625925|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
625926|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
625927|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
625928|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625929|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
625930|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
625931|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
625932|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625933|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
625934|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
625935|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2218846|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
2218847|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2218848|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218849|NCT00034671|Posaconazole|posaconazole|mesh-list
2218850|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
625941|NCT03377543|Aspirin|aspirin|mesh-list
625942|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
625943|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
625944|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
625945|NCT03377543|Analgesics|analgesics|mesh-ancestor
625946|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
625947|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
625948|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625949|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
625950|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
625951|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
625952|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625953|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
625954|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
625955|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625956|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
2080491|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
2080492|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080493|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080494|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2080495|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080496|NCT02073448|Adapalene|adapalene|mesh-list
2080497|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2080498|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
2080499|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2080500|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2080501|NCT02073448|Analgesics|analgesics|mesh-ancestor
2080502|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
2080503|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080504|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080505|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
625973|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
625974|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
625975|NCT03377478|Velpatasvir|velpatasvir|mesh-list
625976|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
625977|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
625978|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
625979|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
625980|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
625981|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
625982|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
625983|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625984|NCT03377400|Cisplatin|cisplatin|mesh-list
625985|NCT03377400|Durvalumab|durvalumab|mesh-list
625986|NCT03377400|Tremelimumab|tremelimumab|mesh-list
625987|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
625988|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
625989|NCT03377387|Capecitabine|capecitabine|mesh-list
625990|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
625991|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
625992|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
625993|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751430|NCT03926624|Fludarabine|fludarabine|mesh-list
2751431|NCT03926624|Etoposide|etoposide|mesh-list
2751432|NCT03926624|Azacitidine|azacitidine|mesh-list
2751433|NCT03926624|Decitabine|decitabine|mesh-list
2751434|NCT03926624|Venetoclax|venetoclax|mesh-list
2751435|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
2751436|NCT03926624|Idarubicin|idarubicin|mesh-list
2751437|NCT03926624|Cladribine|cladribine|mesh-list
2751438|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626003|NCT03377348|Triamcinolone|triamcinolone|mesh-list
626004|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
626005|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
626006|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
626007|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
626008|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
626009|NCT03377348|Hormones|hormones|mesh-ancestor
626010|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
626011|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626012|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
626013|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
626014|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626015|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626016|NCT03377335|Metformin|metformin|mesh-list
626017|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
626018|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
626019|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626020|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
626021|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626022|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
626023|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
626024|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
626025|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626026|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
626027|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
626028|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
626029|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
626030|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
626031|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
626032|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626033|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626034|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626035|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
626036|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
626037|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626038|NCT03377218|Iodine|iodine|mesh-list
626039|NCT03377218|Selenium|selenium|mesh-list
626040|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
626041|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
626042|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
626043|NCT03377218|Trace Elements|trace elements|mesh-ancestor
626044|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
626045|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626046|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
626047|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626048|NCT03377218|Protective Agents|protective agents|mesh-ancestor
626057|NCT03377101|Fulvestrant|fulvestrant|mesh-list
626058|NCT03377101|Palbociclib|palbociclib|mesh-list
626059|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2751439|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2751440|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
626060|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626061|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
626062|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
626063|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
626064|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
626065|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626066|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
626067|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626068|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626069|NCT03377049|Acetazolamide|acetazolamide|mesh-list
626070|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
626071|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
626072|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626073|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626074|NCT03377049|Diuretics|diuretics|mesh-ancestor
626075|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
626076|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080506|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080507|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2080508|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
2080509|NCT02073487|Paclitaxel|paclitaxel|mesh-list
2080510|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2080511|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2080512|NCT02073487|Trastuzumab|trastuzumab|mesh-list
2080513|NCT02073487|Lapatinib|lapatinib|mesh-list
2080514|NCT02073487|Pertuzumab|pertuzumab|mesh-list
626086|NCT03376958|Apatinib|apatinib|mesh-list
626087|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626088|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
626089|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626090|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626091|NCT03376932|Albuterol|albuterol|mesh-list
626092|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
626093|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
626094|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
626095|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626096|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626097|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
626098|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
626099|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
626100|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
626101|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
626102|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626103|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626104|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
626105|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
626106|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
626107|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
626108|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
626109|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
626110|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
626111|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
626112|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626113|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626114|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
626115|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
626116|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626117|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
626118|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
626119|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
626120|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
626121|NCT03376789|MYL-1501D|myl-1501d|mesh-list
626122|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
626123|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751441|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751442|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2751443|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
2751444|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751445|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2751446|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2751447|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2751448|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751449|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
2080515|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2751450|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2751451|NCT03926624|Analgesics|analgesics|mesh-ancestor
2751452|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
2751453|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2751454|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
626142|NCT03376737|Pemetrexed|pemetrexed|mesh-list
626143|NCT03376737|Apatinib|apatinib|mesh-list
626144|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626145|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626146|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626147|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
626148|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
626149|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
626150|NCT03376698|Colchicine|colchicine|mesh-list
626151|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
626152|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
626153|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
626154|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
626155|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
626156|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626157|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626158|NCT03376672|Dexamethasone|dexamethasone|mesh-list
626159|NCT03376672|Lenalidomide|lenalidomide|mesh-list
626160|NCT03376672|Ixazomib|ixazomib|mesh-list
626161|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
626162|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
626163|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
626164|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626165|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626166|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
626167|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
626168|NCT03376672|Hormones|hormones|mesh-ancestor
626169|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
626170|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
626171|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626172|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
626173|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
626174|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
626175|NCT03376672|Growth Substances|growth substances|mesh-ancestor
626176|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
626177|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
626178|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626179|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751468|NCT03919071|Trametinib|trametinib|mesh-list
2751469|NCT03919071|Dabrafenib|dabrafenib|mesh-list
2751470|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
626193|NCT03376646|Paclitaxel|paclitaxel|mesh-list
626194|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
626195|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626196|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
626197|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
626198|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
626199|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626200|NCT03376594|Loratadine|loratadine|mesh-list
626201|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
626202|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
626203|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
626204|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
626205|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
626206|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
626207|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
626208|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2751471|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626209|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626210|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626211|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
626212|NCT03376555|Acetylcholine|acetylcholine|mesh-list
626213|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
626214|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
626215|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
626216|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626217|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626218|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626219|NCT03376529|Tazobactam|tazobactam|mesh-list
626220|NCT03376529|Piperacillin|piperacillin|mesh-list
626221|NCT03376529|Ceftazidime|ceftazidime|mesh-list
626222|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
626223|NCT03376529|Aztreonam|aztreonam|mesh-list
626224|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
626225|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
626226|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
626227|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626228|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626241|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
626242|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
626243|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626244|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626245|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
626246|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
626247|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626248|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
626249|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626250|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2218851|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218852|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2218853|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2218854|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2218855|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2218856|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2218857|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218858|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218859|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2218860|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
2218861|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
626263|NCT03376243|Emollients|emollients|mesh-list
626264|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
626265|NCT03376191|Apatinib|apatinib|mesh-list
626266|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626267|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
626268|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626269|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626270|NCT03376178|Lidocaine|lidocaine|mesh-list
626271|NCT03376178|Ropivacaine|ropivacaine|mesh-list
626272|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
626273|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
626274|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626275|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626276|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
626277|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626278|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
626279|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
626280|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
626281|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
626282|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626283|NCT03376139|Zonisamide|zonisamide|mesh-list
626284|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
626285|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
626286|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
626287|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626288|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
626289|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218862|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218863|NCT00034697|Temozolomide|temozolomide|mesh-list
2218864|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2218865|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
2218866|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626296|NCT03376048|Ropivacaine|ropivacaine|mesh-list
626297|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
626298|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
626299|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626300|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626301|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
626302|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626303|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
626304|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
626305|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
626306|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
626307|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
626308|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626309|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626310|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
626311|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
626312|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
626313|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
626314|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626315|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626316|NCT03375788|Hormones|hormones|mesh-list
626317|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
626318|NCT03375788|Tesamorelin|tesamorelin|mesh-list
626319|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
626320|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626321|NCT03375788|Growth Substances|growth substances|mesh-ancestor
626322|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
626323|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626324|NCT03375671|Midazolam|midazolam|mesh-list
626325|NCT03375671|Ketamine|ketamine|mesh-list
626326|NCT03375671|Haloperidol|haloperidol|mesh-list
626327|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
626328|NCT03375671|Analgesics|analgesics|mesh-ancestor
626329|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
626330|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626331|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626332|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
626333|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
626334|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
626335|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
626336|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626337|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
626338|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
626339|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626340|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626341|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
626342|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
626343|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
626344|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
626345|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
626346|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
626347|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
626348|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
626349|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
626350|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
626351|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
626352|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
626353|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
626354|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
626355|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
626356|NCT03375645|Narcotics|narcotics|mesh-ancestor
626357|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626358|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626359|NCT03375645|Analgesics|analgesics|mesh-ancestor
626360|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
626361|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626362|NCT03375632|Dotinurad|dotinurad|mesh-list
626363|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
626364|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
626365|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
626366|NCT03375632|Renal Agents|renal agents|mesh-ancestor
626367|NCT03375593|Acetaminophen|acetaminophen|mesh-list
626368|NCT03375593|Ibuprofen|ibuprofen|mesh-list
626369|NCT03375593|Oxycodone|oxycodone|mesh-list
626370|NCT03375593|Hydrocodone|hydrocodone|mesh-list
626371|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
626372|NCT03375593|Analgesics|analgesics|mesh-ancestor
626373|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
626374|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626375|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626376|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
626377|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
626378|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
626379|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
626380|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
626381|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626382|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626383|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
626384|NCT03375593|Narcotics|narcotics|mesh-ancestor
626385|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626386|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
626387|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
626388|NCT03375580|Metformin|metformin|mesh-list
626389|NCT03375580|Simvastatin|simvastatin|mesh-list
626390|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
626391|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626392|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
626393|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
626394|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
626395|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626396|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
626397|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
626398|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626399|NCT03375515|Hydromorphone|hydromorphone|mesh-list
626400|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
626401|NCT03375515|Narcotics|narcotics|mesh-ancestor
626402|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626403|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626404|NCT03375515|Analgesics|analgesics|mesh-ancestor
626405|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
626406|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626407|NCT03375502|Vaccines|vaccines|mesh-list
626408|NCT03375502|Immunologic Factors|immunologic factors|mesh-ancestor
626409|NCT03375502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626410|NCT03375463|Tirzepatide|tirzepatide|mesh-list
626411|NCT03375463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
626412|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626413|NCT03375463|Incretins|incretins|mesh-ancestor
626414|NCT03375463|Hormones|hormones|mesh-ancestor
626415|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
626416|NCT03375424|Vedolizumab|vedolizumab|mesh-list
626417|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
626418|NCT03375398|PAZ320|paz320|mesh-list
626419|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
626420|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626421|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
626422|NCT03375385|Propofol|propofol|mesh-list
626423|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
626424|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626425|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626426|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
626427|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
626428|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
626429|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
626430|NCT03375385|Analgesics|analgesics|mesh-ancestor
626431|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
626432|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626433|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
626434|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
626435|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
626436|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
626437|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626438|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080516|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080517|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
2080518|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
2080519|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
2080520|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218867|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218868|NCT00034710|Capsaicin|capsaicin|mesh-list
2218869|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
2218870|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
2218871|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
2218872|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218873|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218874|NCT00034736|Levofloxacin|levofloxacin|mesh-list
2218875|NCT00034736|Ofloxacin|ofloxacin|mesh-list
2218876|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
626454|NCT03375242|Crizotinib|crizotinib|mesh-list
626455|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626456|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
626457|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626458|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626459|NCT03375203|Zolpidem|zolpidem|mesh-list
626460|NCT03375203|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
626461|NCT03375203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
626462|NCT03375203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626463|NCT03375203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626464|NCT03375203|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
626465|NCT03375203|GABA Agonists|gaba agonists|mesh-ancestor
626466|NCT03375203|GABA Agents|gaba agents|mesh-ancestor
626467|NCT03375203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626468|NCT03375203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626469|NCT03375138|Abatacept|abatacept|mesh-list
626470|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
626471|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626472|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626473|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
626474|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
626475|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626476|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
626477|NCT03375112|Bupivacaine|bupivacaine|mesh-list
626478|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
626479|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
626480|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626481|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626482|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
626483|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626484|NCT03375034|Clonazepam|clonazepam|mesh-list
626485|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
626486|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
626487|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
626488|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626489|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626490|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080521|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2080522|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2080523|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080524|NCT02073565|Everolimus|everolimus|mesh-list
2080525|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080526|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2080527|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
2080528|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080529|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
2080530|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2080531|NCT02073656|Ledipasvir|ledipasvir|mesh-list
2080532|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
2080533|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080534|NCT02073682|Heparin|heparin|mesh-list
2080535|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2080536|NCT02073682|Tinzaparin|tinzaparin|mesh-list
2080537|NCT02073682|Dalteparin|dalteparin|mesh-list
2080538|NCT02073682|Edoxaban|edoxaban|mesh-list
2080539|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
2080540|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
626585|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080541|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2080542|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080543|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2080544|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
2080545|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2080546|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
2080547|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080548|NCT02073747|Albuterol|albuterol|mesh-list
2080549|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2080550|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
2080551|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080552|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080553|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2080554|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
626524|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
626525|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
626526|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
626527|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626528|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
626529|NCT03374839|Nivolumab|nivolumab|mesh-list
626530|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
626531|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626532|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
626533|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751472|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2751473|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751474|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751475|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2751476|NCT03919071|Protective Agents|protective agents|mesh-ancestor
626540|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
626541|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
626542|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626543|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
626544|NCT03374722|Narcotics|narcotics|mesh-ancestor
626545|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626546|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626547|NCT03374722|Analgesics|analgesics|mesh-ancestor
626548|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
626549|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626550|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
626551|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
626552|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
626553|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
626554|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
626555|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626556|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
626557|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
626558|NCT03374670|Aflibercept|aflibercept|mesh-list
626559|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
626560|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
626561|NCT03374670|Growth Substances|growth substances|mesh-ancestor
626562|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626563|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
626564|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626565|NCT03374540|Vitamin K|vitamin k|mesh-list
626566|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
626567|NCT03374540|Vitamins|vitamins|mesh-ancestor
626568|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
626569|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626570|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
626571|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
626572|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
626573|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
626574|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626575|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626576|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
626577|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
626578|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
626579|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
626580|NCT03374540|Coagulants|coagulants|mesh-ancestor
626581|NCT03374514|Dexamethasone|dexamethasone|mesh-list
626582|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
626583|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
626584|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
626662|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626586|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626587|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
626588|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
626589|NCT03374514|Hormones|hormones|mesh-ancestor
626590|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
626591|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
626592|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626593|NCT03374501|PAZ320|paz320|mesh-list
626594|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
626595|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080555|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
2080556|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2080557|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2218877|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218878|NCT00034736|Renal Agents|renal agents|mesh-ancestor
2218879|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2218880|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2218881|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2218882|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218883|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218884|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218885|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
626608|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
626609|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626610|NCT03374345|Mitogens|mitogens|mesh-ancestor
626611|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
626612|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626613|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
626614|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
626615|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626616|NCT03374306|Atropine|atropine|mesh-list
626617|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
626618|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
626619|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
626620|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
626621|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
626622|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626623|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626624|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
626625|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
626626|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
626627|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
626628|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
626629|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
626630|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
626631|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626632|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626633|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
626634|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
626635|NCT03374293|Antibodies|antibodies|mesh-list
626636|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
626637|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626638|NCT03374280|Cisplatin|cisplatin|mesh-list
626639|NCT03374280|Pemetrexed|pemetrexed|mesh-list
626640|NCT03374280|Gefitinib|gefitinib|mesh-list
626641|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626642|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626643|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626644|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
626645|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
626646|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
626647|NCT03374254|Leucovorin|leucovorin|mesh-list
626648|NCT03374254|Fluorouracil|fluorouracil|mesh-list
626649|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
626650|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
626651|NCT03374254|Irinotecan|irinotecan|mesh-list
626652|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626653|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
626654|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626655|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
626656|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626657|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
626658|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
626659|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
626660|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
626661|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
626663|NCT03374254|Antidotes|antidotes|mesh-ancestor
626664|NCT03374254|Protective Agents|protective agents|mesh-ancestor
626665|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
626666|NCT03374254|Vitamins|vitamins|mesh-ancestor
626667|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
626668|NCT03374228|Linrodostat|linrodostat|mesh-list
626669|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626670|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218886|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2218887|NCT00034749|Risperidone|risperidone|mesh-list
2218888|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2218889|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
2218890|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218891|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218892|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218893|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2218894|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2218895|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2218896|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
626683|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
626684|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
626685|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
626686|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2080558|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2080559|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2080560|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
626690|NCT03374085|Dexamethasone|dexamethasone|mesh-list
626691|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
626692|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
626693|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
626694|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626695|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626696|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
626697|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
626698|NCT03374085|Hormones|hormones|mesh-ancestor
626699|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
626700|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
626701|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626702|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
626703|NCT03374007|Antibodies|antibodies|mesh-list
626704|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
626705|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
626706|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
626707|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626708|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626709|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
626710|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
626711|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626712|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
626713|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
626714|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626715|NCT03373903|Everolimus|everolimus|mesh-list
626716|NCT03373903|Dactolisib|dactolisib|mesh-list
626717|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626718|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
626719|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
626720|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626721|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
626722|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626723|NCT03373864|Anesthetics|anesthetics|mesh-list
626724|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626725|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626726|NCT03373851|Sufentanil|sufentanil|mesh-list
626727|NCT03373851|Dsuvia|dsuvia|mesh-list
626728|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
626729|NCT03373851|Narcotics|narcotics|mesh-ancestor
626730|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626731|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626732|NCT03373851|Analgesics|analgesics|mesh-ancestor
626733|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
626734|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626735|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
626736|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
626737|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
626738|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
626739|NCT03373825|Fentanyl|fentanyl|mesh-list
626740|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
626741|NCT03373825|Narcotics|narcotics|mesh-ancestor
626742|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626743|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626744|NCT03373825|Analgesics|analgesics|mesh-ancestor
626745|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
626746|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626747|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
626748|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
626749|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
626750|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
626763|NCT03373708|Tamoxifen|tamoxifen|mesh-list
626764|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
626765|NCT03373708|Docetaxel|docetaxel|mesh-list
626766|NCT03373708|Letrozole|letrozole|mesh-list
626767|NCT03373708|Epirubicin|epirubicin|mesh-list
626768|NCT03373708|Goserelin|goserelin|mesh-list
626769|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
626770|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
626771|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626772|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
626773|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
626774|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
626775|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626776|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626777|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
626778|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
626779|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
626780|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
626781|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
626782|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
626783|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626784|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
626785|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
626786|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
626787|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
626788|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
626789|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
626790|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
626791|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
626792|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
626793|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
626794|NCT03373669|Vaccines|vaccines|mesh-list
626795|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
626796|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626797|NCT03373656|Vaccines|vaccines|mesh-list
626798|NCT03373656|Immunologic Factors|immunologic factors|mesh-ancestor
626799|NCT03373656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218897|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2218898|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
2218899|NCT00034762|Risperidone|risperidone|mesh-list
2218900|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2218901|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
2218902|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218903|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626807|NCT03373435|Glucagon|glucagon|mesh-list
626808|NCT03373435|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
626809|NCT03373435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
626810|NCT03373435|Hormones|hormones|mesh-ancestor
626811|NCT03373435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
626812|NCT03373435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626813|NCT03373435|Incretins|incretins|mesh-ancestor
626814|NCT03373409|Albuterol|albuterol|mesh-list
626815|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
626816|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
626817|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626818|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626819|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
626820|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
626821|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
626822|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
626823|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
626824|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
626825|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
626826|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
626827|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626828|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626829|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
626830|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
626831|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
626832|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
626833|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
626834|NCT03373305|Lenalidomide|lenalidomide|mesh-list
626835|NCT03373305|Piperidine|piperidine|mesh-list
626836|NCT03373305|Antibodies|antibodies|mesh-list
626837|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
626838|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
626839|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
626840|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
626841|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626842|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626843|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
626844|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
626845|NCT03373305|Growth Substances|growth substances|mesh-ancestor
626846|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
626847|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
626848|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
626849|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626850|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
626851|NCT03373266|Sevoflurane|sevoflurane|mesh-list
626852|NCT03373266|Isoflurane|isoflurane|mesh-list
626853|NCT03373266|Anesthetics|anesthetics|mesh-list
626854|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
626855|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
626856|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
626857|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626858|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626859|NCT03373227|Tacrolimus|tacrolimus|mesh-list
626860|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
626861|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
626862|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626863|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
626864|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626865|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218904|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218905|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2218906|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2218907|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2218908|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2218909|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2218910|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
2218911|NCT00034775|Risperidone|risperidone|mesh-list
2218912|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2218913|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
626886|NCT03373149|Hormones|hormones|mesh-list
626887|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
626888|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
626889|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218914|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626890|NCT03372967|Vaccines|vaccines|mesh-list
626891|NCT03372967|Immunologic Factors|immunologic factors|mesh-ancestor
626892|NCT03372967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080561|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080562|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080563|NCT02073929|Liraglutide|liraglutide|mesh-list
626896|NCT03372850|Esomeprazole|esomeprazole|mesh-list
626897|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
626898|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
626899|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
626900|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626901|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626902|NCT03372837|Rituximab|rituximab|mesh-list
626903|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
626904|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
626905|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
626906|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626907|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
626908|NCT03372785|Aspirin|aspirin|mesh-list
626909|NCT03372785|Metoprolol|metoprolol|mesh-list
626910|NCT03372785|Clopidogrel|clopidogrel|mesh-list
626911|NCT03372785|Ticagrelor|ticagrelor|mesh-list
626912|NCT03372785|Atorvastatin|atorvastatin|mesh-list
626913|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
626914|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
626915|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
626916|NCT03372785|Analgesics|analgesics|mesh-ancestor
626917|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
626918|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626919|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626920|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
626921|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
626922|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
626923|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
626924|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626925|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
626926|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
626927|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
626928|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
626929|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
626930|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
626931|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
626932|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
626933|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
626934|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
626935|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
626936|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
626937|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
626938|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626939|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
626940|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
626941|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
626942|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
626943|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
626944|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
626945|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
626946|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
626947|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
626948|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
626949|NCT03372486|Bupivacaine|bupivacaine|mesh-list
626950|NCT03372486|Naloxone|naloxone|mesh-list
626951|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
626952|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
626953|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
626954|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626955|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
626956|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
626957|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
626958|NCT03372473|Loratadine|loratadine|mesh-list
626959|NCT03372473|Montelukast|montelukast|mesh-list
626960|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
626961|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
626962|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
626963|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
626964|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
626965|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626966|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
626967|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
626968|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
626969|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
626970|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
626971|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
626972|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
626973|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
626974|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
626975|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
626976|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
626977|NCT03372447|Thiamine|thiamine|mesh-list
626978|NCT03372447|Pyridoxine|pyridoxine|mesh-list
626979|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
626980|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
626981|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
626982|NCT03372447|Vitamins|vitamins|mesh-ancestor
626983|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
626984|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
626985|NCT03372447|Hematinics|hematinics|mesh-ancestor
2218915|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218916|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218917|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2218918|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2218919|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2218920|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2218921|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2218922|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
2218923|NCT00034788|Becaplermin|becaplermin|mesh-list
2218924|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
2218925|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2218926|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2218927|NCT00034788|Growth Substances|growth substances|mesh-ancestor
2218928|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627000|NCT03372304|Ropivacaine|ropivacaine|mesh-list
627001|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
627002|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
627003|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627004|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627005|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
627006|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627007|NCT03372265|Ropivacaine|ropivacaine|mesh-list
627008|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
627009|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
627010|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627011|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627012|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
627013|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627014|NCT03372239|Tryptophan|tryptophan|mesh-list
627015|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
627016|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
627017|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
627018|NCT03372200|Febuxostat|febuxostat|mesh-list
627019|NCT03372200|Dotinurad|dotinurad|mesh-list
627020|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
627021|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
627022|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
627023|NCT03372200|Renal Agents|renal agents|mesh-ancestor
627024|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
627025|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
627026|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
627027|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
627028|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
627029|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
627030|NCT03372109|Calcium|calcium|mesh-list
627031|NCT03372109|Turmeric extract|turmeric extract|mesh-list
627032|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
627033|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627034|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
627035|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627036|NCT03372109|Protective Agents|protective agents|mesh-ancestor
2218929|NCT00034801|Olanzapine|olanzapine|mesh-list
2218930|NCT00034801|Ziprasidone|ziprasidone|mesh-list
2218931|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
2218932|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
2218933|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627042|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
627043|NCT03371992|Nivolumab|nivolumab|mesh-list
627044|NCT03371992|Atezolizumab|atezolizumab|mesh-list
627045|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
627046|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627047|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
627048|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080564|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2080565|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080566|NCT02073929|Incretins|incretins|mesh-ancestor
627052|NCT03371953|Atracurium|atracurium|mesh-list
627053|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
627054|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
627055|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
627056|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
627057|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627058|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627059|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
627060|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
627061|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
627062|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
627063|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627064|NCT03371862|Liraglutide|liraglutide|mesh-list
627065|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
627066|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627067|NCT03371862|Incretins|incretins|mesh-ancestor
627068|NCT03371862|Hormones|hormones|mesh-ancestor
627069|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
627070|NCT03371849|Montelukast|montelukast|mesh-list
627071|NCT03371849|Levocetirizine|levocetirizine|mesh-list
627072|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
627073|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
627074|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
627075|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
627076|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
627077|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627078|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
627079|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
627080|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627081|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
627082|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
627083|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
627084|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
627085|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218934|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218935|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2218936|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2218937|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2218938|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2218939|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2218940|NCT00034801|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2218941|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2218942|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2218943|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218944|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
627098|NCT03371797|Amlodipine|amlodipine|mesh-list
627099|NCT03371797|Valsartan|valsartan|mesh-list
627100|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
627101|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
627102|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
627103|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627104|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
627105|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627106|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
627107|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
627108|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
627109|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
627110|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080567|NCT02073929|Hormones|hormones|mesh-ancestor
2080568|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
627719|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2080578|NCT02074358|Apixaban|apixaban|mesh-list
2080579|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2080580|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
2080581|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2080582|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
627127|NCT03371589|Dexamethasone|dexamethasone|mesh-list
627128|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
627129|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
627130|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
627131|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627132|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627133|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
627134|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
627135|NCT03371589|Hormones|hormones|mesh-ancestor
627136|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
627137|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
627138|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627139|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
627140|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
627141|NCT03371550|Docetaxel|docetaxel|mesh-list
627142|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627143|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
627144|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
627145|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
627146|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627147|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
627148|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
627149|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
627150|NCT03371498|Prednisolone|prednisolone|mesh-list
627151|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
627152|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
627153|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
627154|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
627155|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
627156|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
627157|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627158|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627159|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
627160|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
627161|NCT03371498|Hormones|hormones|mesh-ancestor
627162|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
627163|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
627164|NCT03371498|Protective Agents|protective agents|mesh-ancestor
627165|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
627166|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218945|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
2218946|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2218947|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2218948|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
2218949|NCT00034840|Valsartan|valsartan|mesh-list
2218950|NCT00034840|Telmisartan|telmisartan|mesh-list
2218951|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2218952|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2218953|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2218954|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218955|NCT00034853|Naproxen|naproxen|mesh-list
2218956|NCT00034853|Meloxicam|meloxicam|mesh-list
2218957|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2218958|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2218959|NCT00034853|Analgesics|analgesics|mesh-ancestor
2218960|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
2218961|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2218962|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218963|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2218964|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
627187|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
627188|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
627189|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080583|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218965|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
627190|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627191|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
627192|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
627193|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627194|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
627195|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
627196|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
627197|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
627198|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627199|NCT03371173|Ferric maltol|ferric maltol|mesh-list
627200|NCT03371173|Hematinics|hematinics|mesh-ancestor
627201|NCT03371108|Insulin Glargine|insulin glargine|mesh-list
627202|NCT03371108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
627203|NCT03371108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627204|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
627205|NCT03371095|Infliximab|infliximab|mesh-list
627206|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
627207|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
627208|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627209|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
627210|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
627211|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
627212|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627213|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627214|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
627215|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
627216|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
627217|NCT03371082|Insulin Glargine|insulin glargine|mesh-list
627218|NCT03371082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
627219|NCT03371082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627220|NCT03371069|Methylphenidate|methylphenidate|mesh-list
627221|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
627222|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627223|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
627224|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
627225|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
627226|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627227|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
627228|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
627229|NCT03371043|Analgesics|analgesics|mesh-list
627230|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
627231|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627232|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080584|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080585|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
2080586|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
2080587|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
2080588|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080589|NCT02074709|Bupivacaine|bupivacaine|mesh-list
2080590|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
2080591|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
2080592|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2080593|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080594|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
2080595|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080596|NCT02074735|Choline|choline|mesh-list
627247|NCT03370848|Aspirin|aspirin|mesh-list
627248|NCT03370848|Psyllium|psyllium|mesh-list
627249|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
627250|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
627251|NCT03370848|Analgesics|analgesics|mesh-ancestor
627252|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
627253|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627254|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627255|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
627256|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
627257|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
627258|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
627259|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627260|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
627261|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
627262|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
627263|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
627264|NCT03370848|Cathartics|cathartics|mesh-ancestor
627265|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
627266|NCT03370835|Metoprolol|metoprolol|mesh-list
627267|NCT03370835|Carvedilol|carvedilol|mesh-list
627268|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
627269|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
627270|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
627271|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
627272|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627273|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627274|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
627275|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
627276|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
627277|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
627278|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
627279|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627280|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
627281|NCT03370835|Protective Agents|protective agents|mesh-ancestor
627282|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
627283|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
627284|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
627285|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
627286|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
627287|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
627288|NCT03370783|Ethanol|ethanol|mesh-list
627289|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
627290|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
627291|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627292|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218966|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2218967|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2218968|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218969|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2218970|NCT00034866|Tipranavir|tipranavir|mesh-list
2218971|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
627299|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
627300|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
627301|NCT03370705|Captopril|captopril|mesh-list
627302|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
627303|NCT03370705|Atorvastatin|atorvastatin|mesh-list
627304|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
627305|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
627306|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
627307|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
627308|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627309|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
627310|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
627311|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
627312|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
627313|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
627314|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
627315|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
627316|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
627317|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
627318|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627319|NCT03370705|Analgesics|analgesics|mesh-ancestor
627320|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
627321|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627322|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
627323|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
627324|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
627325|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
627326|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
627327|NCT03370627|Antibodies|antibodies|mesh-list
627328|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
627329|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627330|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
627331|NCT03370601|Azathioprine|azathioprine|mesh-list
627332|NCT03370601|Infliximab|infliximab|mesh-list
627333|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
627334|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
627335|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
627336|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
627337|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627338|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
627339|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627340|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
627341|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
627342|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627343|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
627344|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
627345|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
627346|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
627347|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627348|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627349|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
627350|NCT03370588|Analgesics|analgesics|mesh-ancestor
627351|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
627352|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627353|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
627354|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
627355|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
627356|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
627357|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
627358|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627359|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
627360|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
627361|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627362|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627363|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
627364|NCT03370562|Analgesics|analgesics|mesh-ancestor
627365|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
627366|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627367|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
627368|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
627369|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
627370|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
627371|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
627372|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218972|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
2218973|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
627375|NCT03370510|Oxytocin|oxytocin|mesh-list
627376|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
627377|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
627378|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627379|NCT03370406|Fluorouracil|fluorouracil|mesh-list
627380|NCT03370406|Imiquimod|imiquimod|mesh-list
627381|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
627382|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627383|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
627384|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627385|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
627386|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
627387|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627388|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
627389|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
627390|NCT03370380|Aflibercept|aflibercept|mesh-list
627391|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
627392|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
627393|NCT03370380|Growth Substances|growth substances|mesh-ancestor
627394|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627395|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
627396|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627397|NCT03370367|Tretinoin|tretinoin|mesh-list
627398|NCT03370367|Isotretinoin|isotretinoin|mesh-list
627399|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627400|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
627401|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
627402|NCT03370328|Peppermint oil|peppermint oil|mesh-list
627403|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
627404|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
627405|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627406|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627407|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
627408|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
2218974|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2218975|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
2218976|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
627412|NCT03370276|Nivolumab|nivolumab|mesh-list
627413|NCT03370276|Cetuximab|cetuximab|mesh-list
627414|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
627415|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627416|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
627417|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080597|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2080598|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
2080599|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2080600|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
2080601|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218977|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
627424|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
627425|NCT03370159|Docetaxel|docetaxel|mesh-list
627426|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627427|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
627428|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
627429|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
627430|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627431|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
627432|NCT03370159|Protective Agents|protective agents|mesh-ancestor
627433|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627434|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
627435|NCT03370159|Vitamins|vitamins|mesh-ancestor
627436|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
627437|NCT03370133|Ustekinumab|ustekinumab|mesh-list
627438|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
627439|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
627440|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
627441|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
627442|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
627443|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
627444|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627445|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
627446|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
627447|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627448|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
627449|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627450|NCT03369964|Atezolizumab|atezolizumab|mesh-list
627451|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
627452|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627453|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2218978|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218979|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
627457|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
627458|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
627459|NCT03369847|Budesonide|budesonide|mesh-list
627460|NCT03369847|Beclomethasone|beclomethasone|mesh-list
627461|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
627462|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
627463|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
627464|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627465|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627466|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
627467|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
627468|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
627469|NCT03369847|Hormones|hormones|mesh-ancestor
627470|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
627471|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
627472|NCT03369808|Vaccines|vaccines|mesh-list
627473|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
627474|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627475|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
627476|NCT03369808|Antacids|antacids|mesh-ancestor
627477|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627478|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
627479|NCT03369795|Methotrexate|methotrexate|mesh-list
627480|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
627481|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
627482|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
627483|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627484|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
627485|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
627486|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627487|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627488|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
627489|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
627490|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
627491|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
627492|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
627493|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
627494|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
627495|NCT03369782|Rocuronium|rocuronium|mesh-list
627496|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
627497|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
627498|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
627499|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627500|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627501|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
627502|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
627503|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
627504|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
627505|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
627506|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627507|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
627508|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2218980|NCT00034879|Gefitinib|gefitinib|mesh-list
2218981|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218982|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2218983|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
627518|NCT03369574|Reslizumab|reslizumab|mesh-list
627519|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
627520|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
627521|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
627522|NCT03369379|Vitamins|vitamins|mesh-ancestor
627523|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
627524|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627525|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
627526|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
627527|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
627528|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
627529|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
627530|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
627531|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
627532|NCT03369301|Antibodies|antibodies|mesh-list
627533|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
627534|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627535|NCT03369262|Atosiban|atosiban|mesh-list
627536|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
627537|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
627538|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627539|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
627540|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2751477|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751478|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2751479|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
2080602|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2080603|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2080604|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
627550|NCT03369119|Montelukast|montelukast|mesh-list
627551|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
627552|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
627553|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
627554|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
627555|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
627556|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627557|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
627558|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
627559|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627560|NCT03369093|Amoxicillin|amoxicillin|mesh-list
627561|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
627562|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
627563|NCT03369067|Insulin|insulin|mesh-list
627564|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
627565|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
627566|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627573|NCT03369015|Amphetamine|amphetamine|mesh-list
627574|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
627575|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
627576|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627577|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
627578|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
627579|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627580|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
627581|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
627582|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627583|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
627584|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
627585|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
627586|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
627587|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
627588|NCT03369002|Seladelpar|seladelpar|mesh-list
627589|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
627590|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
627591|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627592|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
627593|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
627594|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2218984|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218985|NCT00034892|Olanzapine|olanzapine|mesh-list
2218986|NCT00034892|Risperidone|risperidone|mesh-list
2218987|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2218988|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
2218989|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2218990|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2218991|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2218992|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2218993|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2218994|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2218995|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2218996|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2218997|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
2218998|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
2218999|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
2219000|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219001|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219002|NCT00034892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2219003|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2219004|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2219005|NCT00034905|Risperidone|risperidone|mesh-list
2219006|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2219007|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2219008|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
2219009|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
627632|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
627633|NCT03368794|Narcotics|narcotics|mesh-ancestor
627634|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627635|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627636|NCT03368794|Analgesics|analgesics|mesh-ancestor
627637|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
627638|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627646|NCT03368664|Interferons|interferons|mesh-list
627647|NCT03368664|Acyclovir|acyclovir|mesh-list
627648|NCT03368664|Interferon-beta|interferon-beta|mesh-list
627649|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
627650|NCT03368664|Prednisolone|prednisolone|mesh-list
627651|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
627652|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
627653|NCT03368664|Ranitidine|ranitidine|mesh-list
627654|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
627655|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
627656|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627657|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
627658|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
627659|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
627660|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
627661|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
627662|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627663|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627664|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
627665|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
627666|NCT03368664|Hormones|hormones|mesh-ancestor
627667|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
627668|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
627669|NCT03368664|Protective Agents|protective agents|mesh-ancestor
627670|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
627671|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
627672|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
627673|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
627674|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
627675|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
627676|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
627677|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
627678|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
627679|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
627680|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
627681|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627682|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
627683|NCT03368547|Edetic Acid|edetic acid|mesh-list
627684|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
627685|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
627686|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
627687|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627688|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
627689|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
627690|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
627691|NCT03368430|Melatonin|melatonin|mesh-list
627692|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
627693|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627694|NCT03368430|Protective Agents|protective agents|mesh-ancestor
627695|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627696|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627697|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
627698|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
627699|NCT03368391|Lidocaine|lidocaine|mesh-list
627700|NCT03368391|Phenylephrine|phenylephrine|mesh-list
627701|NCT03368391|Epinephrine|epinephrine|mesh-list
627702|NCT03368391|Racepinephrine|racepinephrine|mesh-list
627703|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
627704|NCT03368391|Tetracaine|tetracaine|mesh-list
627705|NCT03368391|Mepivacaine|mepivacaine|mesh-list
627706|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
627707|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
627708|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
627709|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627710|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627711|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
627712|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627713|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
627714|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
627715|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
627716|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
627717|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627718|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
627720|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
627721|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
627722|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
627723|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
627724|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
627725|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
627726|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
627727|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
627728|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
627729|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
627730|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
627731|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
627732|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
627733|NCT03368391|Protective Agents|protective agents|mesh-ancestor
627734|NCT03368352|Melatonin|melatonin|mesh-list
627735|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
627736|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627737|NCT03368352|Protective Agents|protective agents|mesh-ancestor
627738|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627739|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627740|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
627741|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
627742|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
627743|NCT03368274|Hormones|hormones|mesh-ancestor
627744|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
627745|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219010|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219011|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219012|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2219013|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2219014|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2219015|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219016|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2219017|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
627754|NCT03368131|Capecitabine|capecitabine|mesh-list
627755|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
627756|NCT03368131|Trastuzumab|trastuzumab|mesh-list
627757|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
627758|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
627759|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627760|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627761|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
627766|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
627767|NCT03367988|Anesthetics|anesthetics|mesh-list
627768|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627769|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627770|NCT03367988|Narcotics|narcotics|mesh-ancestor
627771|NCT03367988|Analgesics|analgesics|mesh-ancestor
627772|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
627773|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080605|NCT02074982|Ustekinumab|ustekinumab|mesh-list
2080606|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2080607|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
2080608|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080609|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
2080610|NCT02075047|Ziprasidone|ziprasidone|mesh-list
2080611|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2080612|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
2080613|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080614|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080615|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080616|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2080617|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2080618|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2080619|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2080620|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2080621|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
2080622|NCT02075073|Trastuzumab|trastuzumab|mesh-list
2080623|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2080624|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080625|NCT02075125|Ticagrelor|ticagrelor|mesh-list
627812|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
627813|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
627814|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080626|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2080627|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2080628|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2080629|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2080630|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
627820|NCT03367728|Ropivacaine|ropivacaine|mesh-list
627821|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
627822|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
627823|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627824|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627825|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
627826|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080631|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
2080632|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080633|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080634|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080635|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
2080636|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
627833|NCT03367689|Olaparib|olaparib|mesh-list
627834|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
627835|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
627836|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627837|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627838|NCT03367676|Docetaxel|docetaxel|mesh-list
627839|NCT03367676|Trastuzumab|trastuzumab|mesh-list
627840|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627841|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
627842|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
627843|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
627844|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627845|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
627846|NCT03367663|Prednisone|prednisone|mesh-list
627847|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
627848|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
627849|NCT03367663|Hormones|hormones|mesh-ancestor
627850|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
627851|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627852|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
627853|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627854|NCT03367585|Vitamin D|vitamin d|mesh-list
627855|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
627856|NCT03367585|Vitamins|vitamins|mesh-ancestor
627857|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
627858|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627859|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
627860|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2080637|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
2080638|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080639|NCT02075255|Benralizumab|benralizumab|mesh-list
2080640|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2080641|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
2080642|NCT02075515|Vaccines|vaccines|mesh-list
2080643|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
2080644|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080645|NCT02075606|Lanreotide|lanreotide|mesh-list
2080646|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080647|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
2080648|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080649|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
2080650|NCT02075632|Hormones|hormones|mesh-ancestor
2080651|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2080652|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627896|NCT03367533|Ketamine|ketamine|mesh-list
627897|NCT03367533|Analgesics|analgesics|mesh-ancestor
627898|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
627899|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
627900|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627901|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
627902|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
627903|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
627904|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
627905|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627906|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
627907|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
627908|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
627909|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627910|NCT03367494|Bromides|bromides|mesh-list
627911|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
627912|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
627913|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
627914|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627915|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
627916|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
627917|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627918|NCT03367312|Xenon|xenon|mesh-list
627919|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
627920|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
627921|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
627922|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627923|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627926|NCT03367195|Omeprazole|omeprazole|mesh-list
627927|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
627928|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
627929|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
627930|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
627931|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627932|NCT03367182|Paclitaxel|paclitaxel|mesh-list
627933|NCT03367182|Bevacizumab|bevacizumab|mesh-list
627934|NCT03367182|Doxorubicin|doxorubicin|mesh-list
627935|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
627936|NCT03367182|Topotecan|topotecan|mesh-list
627937|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
627938|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627939|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
627940|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
627941|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
627942|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627943|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
627944|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
627945|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
627946|NCT03367182|Growth Substances|growth substances|mesh-ancestor
627947|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627948|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
627949|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
627950|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
627951|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
627952|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
627953|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
627973|NCT03367143|Carboplatin|carboplatin|mesh-list
627974|NCT03367143|Etoposide|etoposide|mesh-list
627975|NCT03367143|Lenalidomide|lenalidomide|mesh-list
627976|NCT03367143|Ifosfamide|ifosfamide|mesh-list
627977|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
627978|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
627979|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
627980|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
627981|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
627982|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
627983|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
627984|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627985|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
627986|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
627987|NCT03367143|Growth Substances|growth substances|mesh-ancestor
627988|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
627989|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
627990|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
627991|NCT03367013|Lactoferrin|lactoferrin|mesh-list
627992|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
627993|NCT03366974|Clarithromycin|clarithromycin|mesh-list
627994|NCT03366974|Midazolam|midazolam|mesh-list
627995|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
627996|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
627997|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
627998|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
627999|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
628000|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
628001|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
628002|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
628003|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
628004|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
628005|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
628006|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
628007|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
628008|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628009|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
628010|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628011|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
628012|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628013|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
628014|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
628015|NCT03366883|Paclitaxel|paclitaxel|mesh-list
628016|NCT03366883|Cisplatin|cisplatin|mesh-list
628017|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
628018|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628019|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
628020|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
628021|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
628100|NCT03366415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628022|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628026|NCT03366766|Gemcitabine|gemcitabine|mesh-list
628027|NCT03366766|Cisplatin|cisplatin|mesh-list
628028|NCT03366766|Nivolumab|nivolumab|mesh-list
628029|NCT03366766|Pemetrexed|pemetrexed|mesh-list
628030|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628031|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
628032|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
628033|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628034|NCT03366766|Antiviral Agents|antiviral agents|mesh-ancestor
628035|NCT03366766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628036|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628037|NCT03366766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
628038|NCT03366766|Immunologic Factors|immunologic factors|mesh-ancestor
628039|NCT03366766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628040|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
628041|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
628042|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
628043|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
628044|NCT03366597|Sevoflurane|sevoflurane|mesh-list
628045|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
628046|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
628047|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
628048|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
628049|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
628050|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628051|NCT03366584|Vitamin D|vitamin d|mesh-list
628052|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
628053|NCT03366584|Beta Carotene|beta carotene|mesh-list
628054|NCT03366584|Zinc|zinc|mesh-list
628055|NCT03366584|Dexamethasone|dexamethasone|mesh-list
628056|NCT03366584|Carotenoids|carotenoids|mesh-list
628057|NCT03366584|Picolinic acid|picolinic acid|mesh-list
628058|NCT03366584|Vitamins|vitamins|mesh-ancestor
628059|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
628060|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628061|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
628062|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
628063|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
628064|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628065|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
628066|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
628067|NCT03366584|Hormones|hormones|mesh-ancestor
628068|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
628069|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
628070|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628071|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
628072|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
628073|NCT03366584|Trace Elements|trace elements|mesh-ancestor
628074|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
628075|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628076|NCT03366584|Protective Agents|protective agents|mesh-ancestor
628077|NCT03366584|Provitamins|provitamins|mesh-ancestor
628078|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
628079|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
628080|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
628081|NCT03366571|Entecavir|entecavir|mesh-list
628082|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
628083|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628084|NCT03366480|Paclitaxel|paclitaxel|mesh-list
628085|NCT03366480|Carboplatin|carboplatin|mesh-list
628086|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
628087|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628088|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
628089|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
628090|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
628091|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628092|NCT03366415|Gemcitabine|gemcitabine|mesh-list
628093|NCT03366415|Cisplatin|cisplatin|mesh-list
628094|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628095|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
628096|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
628097|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628098|NCT03366415|Antiviral Agents|antiviral agents|mesh-ancestor
628099|NCT03366415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628101|NCT03366415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
628102|NCT03366415|Immunologic Factors|immunologic factors|mesh-ancestor
628103|NCT03366415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219018|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
2219019|NCT00034944|Aprepitant|aprepitant|mesh-list
2219020|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
2219021|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
2219022|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219023|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219024|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219025|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2219026|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219027|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219028|NCT00034983|Aprepitant|aprepitant|mesh-list
2219029|NCT00034983|Paroxetine|paroxetine|mesh-list
2219030|NCT00034983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2219031|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2219032|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2219033|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219034|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219035|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
2080677|NCT02076100|Ruzasvir|ruzasvir|mesh-list
2080678|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
2080679|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080680|NCT02076152|Bevacizumab|bevacizumab|mesh-list
2080681|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2080682|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080683|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2080684|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2080685|NCT02076152|Growth Substances|growth substances|mesh-ancestor
2080686|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080687|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
2080688|NCT02076243|Paclitaxel|paclitaxel|mesh-list
2080689|NCT02076243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2080690|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2080691|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628139|NCT03366259|Misoprostol|misoprostol|mesh-list
628140|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
628141|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
628142|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
628143|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628144|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
628145|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
628146|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
628147|NCT03366246|Lidocaine|lidocaine|mesh-list
628148|NCT03366246|Prilocaine|prilocaine|mesh-list
628149|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
628150|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
628151|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
628152|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
628153|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628154|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
628155|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628156|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
628157|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
628158|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
628159|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
628160|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628161|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2219036|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219037|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2219038|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
2219039|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219040|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2219041|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2219042|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219043|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
2219044|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
2080692|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
2080693|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
628186|NCT03366064|Pemetrexed|pemetrexed|mesh-list
628187|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628188|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628189|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628190|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
628191|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
628192|NCT03366025|Progesterone|progesterone|mesh-list
628193|NCT03366025|Progestins|progestins|mesh-ancestor
628194|NCT03366025|Hormones|hormones|mesh-ancestor
628195|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
628196|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628197|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
628198|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
628199|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
628200|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
628201|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628202|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
628203|NCT03365999|Coagulants|coagulants|mesh-ancestor
2219045|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628206|NCT03365908|Ropivacaine|ropivacaine|mesh-list
628207|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
628208|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
628209|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
628210|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628211|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
628212|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080694|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
2080695|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080696|NCT02076321|Acetaminophen|acetaminophen|mesh-list
2080697|NCT02076321|Ibuprofen|ibuprofen|mesh-list
2080698|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2080699|NCT02076321|Analgesics|analgesics|mesh-ancestor
2080700|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
2080701|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080702|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080703|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
2080704|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2080705|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080706|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080707|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2080708|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080709|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628230|NCT03365869|Sirolimus|sirolimus|mesh-list
628231|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
628232|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628233|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
628234|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628235|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
628236|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
628237|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
628238|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628239|NCT03365817|Fentanyl|fentanyl|mesh-list
628240|NCT03365817|Morphine|morphine|mesh-list
628241|NCT03365817|Oxycodone|oxycodone|mesh-list
628242|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
628243|NCT03365817|Tramadol|tramadol|mesh-list
628244|NCT03365817|Methadone|methadone|mesh-list
628245|NCT03365817|Narcotics|narcotics|mesh-ancestor
628246|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
628247|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628248|NCT03365817|Analgesics|analgesics|mesh-ancestor
628249|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
628250|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628251|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
628252|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
628253|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
628254|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
628255|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
628256|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
2219046|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219047|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2219048|NCT00035009|Aprepitant|aprepitant|mesh-list
2219049|NCT00035009|Paroxetine|paroxetine|mesh-list
628261|NCT03365765|Fluorouracil|fluorouracil|mesh-list
628262|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
628263|NCT03365765|Apatinib|apatinib|mesh-list
628264|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
628265|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628266|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
628267|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628268|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
628269|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
628270|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628271|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
628272|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628273|NCT03365752|Anesthetics|anesthetics|mesh-list
628274|NCT03365752|Mepivacaine|mepivacaine|mesh-list
628275|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
628276|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
628277|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
628278|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628279|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
628280|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
628281|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628282|NCT03365726|Dobutamine|dobutamine|mesh-list
628283|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
628284|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
628285|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
628286|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628287|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628288|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
628289|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
628290|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
628291|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
628292|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
628293|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628294|NCT03365726|Protective Agents|protective agents|mesh-ancestor
628295|NCT03365687|Vitamin D|vitamin d|mesh-list
628296|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
628297|NCT03365687|Vitamins|vitamins|mesh-ancestor
628298|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
628299|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628300|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
628301|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
628320|NCT03365479|Iloprost|iloprost|mesh-list
628321|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
628322|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
628323|NCT03365466|Aspirin|aspirin|mesh-list
628324|NCT03365466|Heparin|heparin|mesh-list
628325|NCT03365466|Calcium heparin|calcium heparin|mesh-list
628326|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
628327|NCT03365466|Tinzaparin|tinzaparin|mesh-list
628328|NCT03365466|Dalteparin|dalteparin|mesh-list
628329|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
628330|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
628331|NCT03365466|Analgesics|analgesics|mesh-ancestor
628332|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
628333|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628334|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628335|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
628336|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
628337|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
628338|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
628339|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628340|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
628341|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
628342|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628343|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
628344|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
628345|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
628346|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
628347|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
628348|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
628349|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628350|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
628351|NCT03365388|Protective Agents|protective agents|mesh-ancestor
628352|NCT03365362|Varenicline|varenicline|mesh-list
628353|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
628354|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
628355|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
628356|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
628357|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628358|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628359|NCT03365336|Oseltamivir|oseltamivir|mesh-list
628360|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
628361|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628362|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628363|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628364|NCT03365141|Triamcinolone|triamcinolone|mesh-list
628365|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
628366|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
628367|NCT03365141|Tacrolimus|tacrolimus|mesh-list
628368|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
628369|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
628370|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
628371|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628372|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
628373|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628374|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628375|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
628376|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
628377|NCT03365141|Hormones|hormones|mesh-ancestor
628378|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
628379|NCT03365115|Fentanyl|fentanyl|mesh-list
628380|NCT03365115|Morphine|morphine|mesh-list
628381|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
628382|NCT03365115|Narcotics|narcotics|mesh-ancestor
628383|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
628384|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628385|NCT03365115|Analgesics|analgesics|mesh-ancestor
628386|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
628387|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628388|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
628389|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
628390|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
628391|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
2219050|NCT00035009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2219051|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2219052|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2219053|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219054|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219055|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
2219056|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219057|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
628402|NCT03364998|Factor VIII|factor viii|mesh-list
628403|NCT03364998|Coagulants|coagulants|mesh-ancestor
628404|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
628405|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
628406|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628407|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
628408|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628409|NCT03364868|Insulin|insulin|mesh-list
628410|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
628411|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628412|NCT03364842|Furosemide|furosemide|mesh-list
628413|NCT03364842|Diuretics|diuretics|mesh-ancestor
628414|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
628415|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628416|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
628417|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
628418|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628419|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
628420|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
628421|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
628422|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
628423|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
628424|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
628425|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628426|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628427|NCT03364764|Sirolimus|sirolimus|mesh-list
628428|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
628429|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628430|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
628431|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628432|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
628433|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
628434|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
628435|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628436|NCT03364686|Biotin|biotin|mesh-list
628437|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
628438|NCT03364686|Vitamins|vitamins|mesh-ancestor
628439|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
628440|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219058|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
2219059|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219060|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2219061|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2219062|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219063|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
2219064|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
2219065|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219066|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219067|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2219068|NCT00035035|Gemcitabine|gemcitabine|mesh-list
2219069|NCT00035035|Pemetrexed|pemetrexed|mesh-list
2219070|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2219071|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
2219072|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628456|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
628457|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
628458|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
628459|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628460|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
628461|NCT03364569|Coagulants|coagulants|mesh-ancestor
628462|NCT03364530|Gemcitabine|gemcitabine|mesh-list
628463|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
628464|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
628465|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
628466|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628467|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628468|NCT03364530|Antiviral Agents|antiviral agents|mesh-ancestor
628469|NCT03364530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628470|NCT03364530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628471|NCT03364530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
628472|NCT03364530|Immunologic Factors|immunologic factors|mesh-ancestor
628473|NCT03364530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628480|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
628481|NCT03364348|Trastuzumab|trastuzumab|mesh-list
628482|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
628483|NCT03364348|Maytansine|maytansine|mesh-list
628484|NCT03364348|Antibodies|antibodies|mesh-list
628485|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
628486|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
628487|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
628488|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
628489|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
628490|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628491|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628492|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
628493|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
628494|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
628495|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
628496|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219073|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219074|NCT00035035|Antiviral Agents|antiviral agents|mesh-ancestor
628499|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
628500|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
628501|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
628502|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
628503|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628504|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628505|NCT03364244|Urological Agents|urological agents|mesh-ancestor
628506|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
628507|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
628508|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
628509|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628510|NCT03364218|Expectorants|expectorants|mesh-ancestor
628511|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
628512|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
628513|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
628514|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628515|NCT03364218|Protective Agents|protective agents|mesh-ancestor
628516|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628517|NCT03364218|Antidotes|antidotes|mesh-ancestor
628518|NCT03364088|Oxycodone|oxycodone|mesh-list
628519|NCT03364088|Anesthetics|anesthetics|mesh-list
628520|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
628521|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628522|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
628523|NCT03364088|Narcotics|narcotics|mesh-ancestor
628524|NCT03364088|Analgesics|analgesics|mesh-ancestor
628525|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
628526|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628527|NCT03364075|Propranolol|propranolol|mesh-list
628528|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
628529|NCT03364075|Serotonin|serotonin|mesh-list
628530|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
628531|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
628532|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
628533|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628534|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
628535|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628536|NCT03364075|Analgesics|analgesics|mesh-ancestor
628537|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
628538|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628539|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
628540|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
628541|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
628542|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
628543|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
628544|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
628545|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
628546|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
628547|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
628548|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
628549|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
2080710|NCT02076919|Acrizanib|acrizanib|mesh-list
2080711|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2080712|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2219075|NCT00035035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219076|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219077|NCT00035035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2219078|NCT00035035|Immunologic Factors|immunologic factors|mesh-ancestor
628558|NCT03363984|Midazolam|midazolam|mesh-list
628559|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
628560|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2080713|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
628561|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
628562|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628563|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
628564|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
628565|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
628566|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
628567|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
628568|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
628569|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
628570|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
628571|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
628572|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219079|NCT00035035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219080|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2219081|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2219082|NCT00035048|Aprepitant|aprepitant|mesh-list
2219083|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
2080714|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080715|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080716|NCT02076997|Methotrexate|methotrexate|mesh-list
2080717|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2080718|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
2080719|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2080720|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080721|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
628586|NCT03363867|Bevacizumab|bevacizumab|mesh-list
628587|NCT03363867|Atezolizumab|atezolizumab|mesh-list
628588|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
628589|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628590|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
628591|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
628592|NCT03363867|Growth Substances|growth substances|mesh-ancestor
628593|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628594|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
628595|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
628596|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
628597|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628598|NCT03363815|Vitamin K|vitamin k|mesh-list
628599|NCT03363815|Metformin|metformin|mesh-list
628600|NCT03363815|Nintedanib|nintedanib|mesh-list
628601|NCT03363815|Digoxin|digoxin|mesh-list
628602|NCT03363815|Midazolam|midazolam|mesh-list
628603|NCT03363815|Omeprazole|omeprazole|mesh-list
628604|NCT03363815|Warfarin|warfarin|mesh-list
628605|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
628606|NCT03363815|Vitamins|vitamins|mesh-ancestor
628607|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
628608|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628609|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
628610|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
628611|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
628612|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
628613|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
628614|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
628615|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
628616|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
628617|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
628618|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
628619|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
628620|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
628621|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
628622|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628623|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
628624|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
628625|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
628626|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
628627|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
628628|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628629|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
628630|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
628631|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
628632|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
628633|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
628634|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
628635|NCT03363815|Protective Agents|protective agents|mesh-ancestor
628636|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
628637|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
628638|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
628639|NCT03363815|Coagulants|coagulants|mesh-ancestor
628640|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628641|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2219084|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
2219085|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219086|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219087|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219088|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
628647|NCT03363763|Sirolimus|sirolimus|mesh-list
628648|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
628649|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628650|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
628651|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628652|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
628653|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
628654|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
628655|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628656|NCT03363659|Copper|copper|mesh-list
628657|NCT03363659|Temozolomide|temozolomide|mesh-list
628658|NCT03363659|Disulfiram|disulfiram|mesh-list
628659|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
628660|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
628661|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628662|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628663|NCT03363659|Trace Elements|trace elements|mesh-ancestor
628664|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
628665|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628666|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
628667|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
628668|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219089|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219090|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219091|NCT00035061|Pemetrexed|pemetrexed|mesh-list
628690|NCT03363477|Enoxaparin|enoxaparin|mesh-list
628691|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
628692|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
628693|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
628694|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
628695|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080722|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
2080723|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080724|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080725|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
2080726|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080727|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2080728|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2080729|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
628704|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
628705|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628706|NCT03363425|Lidocaine|lidocaine|mesh-list
628707|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
628708|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
628709|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
628710|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
628711|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628712|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
628713|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628865|NCT03362281|Omeprazole|omeprazole|mesh-list
628714|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
628715|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
628716|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
628717|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
628718|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628719|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
628720|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
628721|NCT03363425|Analgesics|analgesics|mesh-ancestor
628722|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
628723|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
628724|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
628725|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
628726|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
628727|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
628728|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
628729|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628730|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
628731|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
628732|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628733|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628734|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628735|NCT03363217|Trametinib|trametinib|mesh-list
628736|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628737|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
628738|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628739|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628740|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
628741|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628742|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
628743|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
628744|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
628745|NCT03363191|Fluticasone|fluticasone|mesh-list
628746|NCT03363191|Xhance|xhance|mesh-list
628747|NCT03363191|Albuterol|albuterol|mesh-list
628748|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
628749|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
628750|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
628751|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628752|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628753|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
628754|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
628755|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
628756|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
628757|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
628758|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
628759|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
628760|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
628761|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
628762|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
628763|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
628764|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628765|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
628766|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
628767|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
628768|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628769|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
628770|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
628771|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080730|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080731|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2080732|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2080733|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
2080734|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080735|NCT02078102|Meloxicam|meloxicam|mesh-list
2080736|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080737|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2080738|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2080739|NCT02078102|Analgesics|analgesics|mesh-ancestor
628783|NCT03362905|Lidocaine|lidocaine|mesh-list
628784|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
628785|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
628786|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
628787|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628788|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
628789|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628790|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
628791|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
628792|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
628793|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
628794|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628795|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
628796|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
628797|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628798|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
628799|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
628800|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628801|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628802|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628803|NCT03362814|Ritonavir|ritonavir|mesh-list
628804|NCT03362814|Ribavirin|ribavirin|mesh-list
628805|NCT03362814|Lactams|lactams|mesh-list
628806|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
628807|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
628808|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
628809|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628810|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628811|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
628812|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
628813|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
628814|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628815|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
628816|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
628817|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
628818|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
628819|NCT03362788|Vitamin K|vitamin k|mesh-list
628820|NCT03362788|Anticoagulants|anticoagulants|mesh-list
628821|NCT03362788|Vitamins|vitamins|mesh-ancestor
628822|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
628823|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628824|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
628825|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
628826|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628827|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
628828|NCT03362788|Coagulants|coagulants|mesh-ancestor
628829|NCT03362775|Propofol|propofol|mesh-list
628830|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
628831|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
628832|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628833|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
628834|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
628835|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
628836|NCT03362736|Ustekinumab|ustekinumab|mesh-list
628837|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
628838|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
628839|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628840|NCT03362684|Cetuximab|cetuximab|mesh-list
628841|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
628842|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628843|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
628844|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628845|NCT03362515|Furosemide|furosemide|mesh-list
628846|NCT03362515|Diuretics|diuretics|mesh-ancestor
628847|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
628848|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628849|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
628850|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
628851|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628852|NCT03362411|Linrodostat|linrodostat|mesh-list
628853|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628854|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628855|NCT03362359|Edetic Acid|edetic acid|mesh-list
628856|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
628857|NCT03362359|Chelating Agents|chelating agents|mesh-ancestor
628858|NCT03362359|Sequestering Agents|sequestering agents|mesh-ancestor
628859|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628860|NCT03362359|Anticoagulants|anticoagulants|mesh-ancestor
628861|NCT03362359|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
628862|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
628863|NCT03362281|Amoxicillin|amoxicillin|mesh-list
628864|NCT03362281|Clarithromycin|clarithromycin|mesh-list
628866|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
628867|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
628868|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
628869|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
628870|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
628871|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628872|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628873|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
628874|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
628875|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
628876|NCT03362268|Omeprazole|omeprazole|mesh-list
628877|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
628878|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
628879|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
628880|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628881|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628882|NCT03362216|Diclofenac|diclofenac|mesh-list
628883|NCT03362216|Salicylates|salicylates|mesh-list
628884|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
628885|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
628886|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
628887|NCT03362216|Analgesics|analgesics|mesh-ancestor
628888|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
628889|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628890|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628891|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
628892|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
628893|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
628894|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628895|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628896|NCT03362190|Ranibizumab|ranibizumab|mesh-list
628897|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
628898|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
628899|NCT03362190|Growth Substances|growth substances|mesh-ancestor
628900|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628901|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
628902|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628903|NCT03362099|Bupropion|bupropion|mesh-list
628904|NCT03362099|Varenicline|varenicline|mesh-list
628905|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
628906|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
628907|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
628908|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
628909|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
628910|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
628911|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628912|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
628913|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
628914|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628915|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
628916|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
628917|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628918|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
628919|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
628920|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
628921|NCT03362073|Ketamine|ketamine|mesh-list
628922|NCT03362073|Analgesics|analgesics|mesh-ancestor
628923|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
628924|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628925|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628926|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
628927|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
628928|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
628929|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
628930|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
628931|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
628932|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
628933|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
628934|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628935|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
628936|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
628937|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628938|NCT03362047|Macitentan|macitentan|mesh-list
628939|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
628940|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
628941|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628942|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
628943|NCT03362008|Varenicline|varenicline|mesh-list
628944|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
628945|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
628946|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
628947|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
628948|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628949|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628950|NCT03361878|Metformin|metformin|mesh-list
628951|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
628952|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219092|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219093|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219094|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080740|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
2080741|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080742|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080743|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080744|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2080745|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2219095|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
628963|NCT03361800|Entinostat|entinostat|mesh-list
628964|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628965|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
628966|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
628967|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
628968|NCT03361774|Fluorides|fluorides|mesh-list
628969|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
628970|NCT03361774|Protective Agents|protective agents|mesh-ancestor
628971|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628972|NCT03361735|Leuprolide|leuprolide|mesh-list
628973|NCT03361735|Goserelin|goserelin|mesh-list
628974|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
628975|NCT03361735|Hormones|hormones|mesh-list
628976|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
628977|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628978|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
628979|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
628980|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
628981|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
628982|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628983|NCT03361709|Dexamethasone|dexamethasone|mesh-list
628984|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
628985|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
628986|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
628987|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
628988|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628989|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
628990|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
628991|NCT03361709|Hormones|hormones|mesh-ancestor
628992|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
628993|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
628994|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
628995|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
628996|NCT03361618|Astringents|astringents|mesh-ancestor
628997|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
628998|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
2219096|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2219097|NCT00035074|Methotrexate|methotrexate|mesh-list
2219098|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2219099|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
2219100|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
629012|NCT03361397|Lidocaine|lidocaine|mesh-list
629013|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
629014|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
629015|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
629016|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629017|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
629018|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629019|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
629020|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
629021|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
629022|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
629023|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629030|NCT03361319|Paclitaxel|paclitaxel|mesh-list
629031|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
629032|NCT03361319|Nintedanib|nintedanib|mesh-list
629033|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
629034|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629035|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
629036|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
629037|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
629038|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629039|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
629040|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080746|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219101|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629043|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
629044|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
629045|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
629046|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
629047|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629048|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219102|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2219103|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
2219104|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219105|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219106|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
2219107|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219108|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2219109|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2219110|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
2219111|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219112|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2219113|NCT00035087|Epothilones|epothilones|mesh-list
2219114|NCT00035087|Epothilone B|epothilone b|mesh-list
2219115|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
2219116|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
2219117|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
2219118|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219119|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219120|NCT00035100|Epothilones|epothilones|mesh-list
629068|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
629069|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
629070|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
629071|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
629072|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
629073|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629074|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629075|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
629076|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
629077|NCT03361124|Oxytocin|oxytocin|mesh-list
629078|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
629079|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
629080|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629081|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
629082|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
629083|NCT03361098|Exenatide|exenatide|mesh-list
629084|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629085|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
629086|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629087|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
629088|NCT03361098|Incretins|incretins|mesh-ancestor
629089|NCT03361098|Hormones|hormones|mesh-ancestor
629090|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
629091|NCT03360981|Incretins|incretins|mesh-list
629092|NCT03360981|Hormones|hormones|mesh-ancestor
629093|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
629094|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629095|NCT03360955|Anesthetics|anesthetics|mesh-list
629096|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
629097|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629098|NCT03360916|Atorvastatin|atorvastatin|mesh-list
629099|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
629100|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
629101|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
629102|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629103|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
629104|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
629105|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219121|NCT00035100|Epothilone B|epothilone b|mesh-list
2219122|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
2219123|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
2219124|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
2219125|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219126|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219127|NCT00035113|Epothilones|epothilones|mesh-list
2219128|NCT00035113|Epothilone B|epothilone b|mesh-list
2219129|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
2219130|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
2080747|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080748|NCT02078180|Bupropion|bupropion|mesh-list
2080749|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2080750|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
2080751|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2080752|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2080753|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2219131|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
629124|NCT03360760|Doxorubicin|doxorubicin|mesh-list
629125|NCT03360760|Methotrexate|methotrexate|mesh-list
629126|NCT03360760|Ifosfamide|ifosfamide|mesh-list
629127|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
629128|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629129|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
629130|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
629131|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
629132|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629133|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629134|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
629135|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
629136|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
629137|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629138|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
629139|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
629140|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
629141|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
629142|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
629143|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
629144|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
629145|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
629146|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
629147|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
629148|NCT03360734|Cetuximab|cetuximab|mesh-list
629149|NCT03360734|Panitumumab|panitumumab|mesh-list
629150|NCT03360734|Necitumumab|necitumumab|mesh-list
629151|NCT03360734|Antibodies|antibodies|mesh-list
629152|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
629153|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629154|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
629155|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629156|NCT03360721|Prednisone|prednisone|mesh-list
629157|NCT03360721|Cortisone|cortisone|mesh-list
629158|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
629159|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
629160|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
629161|NCT03360721|Hormones|hormones|mesh-ancestor
629162|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
629163|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629164|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
629165|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629166|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
629167|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629168|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629169|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
629170|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
629171|NCT03360682|Tenofovir|tenofovir|mesh-list
629172|NCT03360682|Lamivudine|lamivudine|mesh-list
629173|NCT03360682|Emtricitabine|emtricitabine|mesh-list
629174|NCT03360682|Abacavir|abacavir|mesh-list
629175|NCT03360682|Dolutegravir|dolutegravir|mesh-list
629176|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
629177|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
629178|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
629179|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
629180|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629181|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629182|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
629183|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
629184|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
629185|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
629186|NCT03360279|Paclitaxel|paclitaxel|mesh-list
629187|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
629188|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629189|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
629190|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
629191|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
629192|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629193|NCT03360266|Listerine|listerine|mesh-list
629194|NCT03360266|Fluorides|fluorides|mesh-list
629195|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
629196|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
629197|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
629198|NCT03360266|Protective Agents|protective agents|mesh-ancestor
629199|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629200|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
629201|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
629202|NCT03360214|Bupivacaine|bupivacaine|mesh-list
629203|NCT03360214|Ropivacaine|ropivacaine|mesh-list
629204|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
629205|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
629206|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
629207|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629208|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
629209|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629210|NCT03360123|Midazolam|midazolam|mesh-list
629211|NCT03360123|Triazolam|triazolam|mesh-list
629212|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
629213|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
629214|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
629215|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629216|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
629217|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
629218|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
629219|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
629220|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
629221|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
629222|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
629223|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
629224|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
629225|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219132|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629228|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
629229|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
629230|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
629231|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
629232|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629233|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
629234|NCT03360045|Coagulants|coagulants|mesh-ancestor
629235|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
629236|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
629237|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629238|NCT03359876|Warfarin|warfarin|mesh-list
629239|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
629240|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
629241|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
629242|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
629243|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
629244|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
629245|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629246|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629247|NCT03359863|Pirfenidone|pirfenidone|mesh-list
629248|NCT03359863|Analgesics|analgesics|mesh-ancestor
629249|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
629250|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629251|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629252|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
629253|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
629254|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
629255|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
629256|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219133|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219134|NCT00035126|Epothilones|epothilones|mesh-list
2219135|NCT00035126|Epothilone B|epothilone b|mesh-list
2219136|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
2219137|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
629262|NCT03359837|Insulin|insulin|mesh-list
629263|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
629264|NCT03359837|Metformin|metformin|mesh-list
629265|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
629266|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
629267|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
629268|NCT03359837|Acarbose|acarbose|mesh-list
629269|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
629270|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
629271|NCT03359837|Repaglinide|repaglinide|mesh-list
629272|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
629273|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629274|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
629275|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629276|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629277|NCT03359811|Bupivacaine|bupivacaine|mesh-list
629278|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
629279|NCT03359811|Anesthetics|anesthetics|mesh-list
629280|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
629281|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629282|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
629283|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629284|NCT03359798|Narcotics|narcotics|mesh-list
629285|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
629286|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629287|NCT03359798|Analgesics|analgesics|mesh-ancestor
629288|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
629289|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629290|NCT03359746|Grazoprevir|grazoprevir|mesh-list
629291|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
629292|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
629293|NCT03359694|Docetaxel|docetaxel|mesh-list
629294|NCT03359694|Doxorubicin|doxorubicin|mesh-list
629295|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
629296|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629297|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
629298|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
629299|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
629300|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629301|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
629302|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
629303|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
629304|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629305|NCT03359681|Metformin|metformin|mesh-list
629306|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
629307|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629308|NCT03359655|Scopolamine|scopolamine|mesh-list
629309|NCT03359655|Bromides|bromides|mesh-list
629310|NCT03359655|Misoprostol|misoprostol|mesh-list
629311|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
629312|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
629313|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
629314|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
629315|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219138|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
629316|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
629317|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
629318|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
629319|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
629320|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
629321|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
629322|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
629323|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629324|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
629325|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
629326|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
629327|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
629328|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629329|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
629330|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
2219139|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219140|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219141|NCT00035139|Methylphenidate|methylphenidate|mesh-list
2219142|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2219143|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219144|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2219145|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2219146|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2219147|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219148|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
629341|NCT03359538|Sirolimus|sirolimus|mesh-list
629342|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
629343|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
629344|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
629345|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629346|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
629347|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
629348|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
629349|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629350|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
629351|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
629352|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
629353|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629354|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
629355|NCT03359525|Coagulants|coagulants|mesh-ancestor
629356|NCT03359499|Trimebutine|trimebutine|mesh-list
629357|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
629358|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
629359|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
629360|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629361|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219149|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219150|NCT00035152|Paclitaxel|paclitaxel|mesh-list
2219151|NCT00035152|Carboplatin|carboplatin|mesh-list
2219152|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2219153|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080754|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2080755|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080756|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
2080757|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080758|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080759|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2219154|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
2219155|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
2219156|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
2219157|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219158|NCT00035165|Epothilones|epothilones|mesh-list
2219159|NCT00035165|Epothilone B|epothilone b|mesh-list
2219160|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
2219161|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
2219162|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
2219163|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629386|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
629387|NCT03359291|Macitentan|macitentan|mesh-list
629388|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
629389|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
629390|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
629391|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629392|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
629393|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
629394|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629395|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
629396|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
629397|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
629398|NCT03359239|Atezolizumab|atezolizumab|mesh-list
629399|NCT03359239|Poly ICLC|poly iclc|mesh-list
629400|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629401|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
629402|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
629403|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219164|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219165|NCT00035178|Argatroban|argatroban|mesh-list
2219166|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
2219167|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
629408|NCT03359161|Furosemide|furosemide|mesh-list
629409|NCT03359161|Diuretics|diuretics|mesh-ancestor
629410|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
629411|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629412|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
629413|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
629414|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629415|NCT03359070|Miconazole|miconazole|mesh-list
629416|NCT03359070|Clotrimazole|clotrimazole|mesh-list
629417|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
629418|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
629419|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
629420|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
629421|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629422|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629423|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
629424|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
629425|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
629426|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629427|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
629428|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
629429|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
629430|NCT03359057|Folic Acid|folic acid|mesh-list
629431|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
629432|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
629433|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
629434|NCT03359057|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
629435|NCT03359057|Estradiol|estradiol|mesh-list
629436|NCT03359057|Estrogens|estrogens|mesh-ancestor
629437|NCT03359057|Hormones|hormones|mesh-ancestor
629438|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
629439|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629440|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
629441|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
629442|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
629443|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
629444|NCT03359057|Hematinics|hematinics|mesh-ancestor
629445|NCT03359057|Vitamins|vitamins|mesh-ancestor
629446|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
629447|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
629448|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
629449|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
629450|NCT03359057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
629451|NCT03359018|Apatinib|apatinib|mesh-list
629452|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629453|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
629454|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629455|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629456|NCT03359005|Vincristine|vincristine|mesh-list
629457|NCT03359005|Temozolomide|temozolomide|mesh-list
629458|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
629459|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629460|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
629461|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
629462|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
629463|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629464|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
629465|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
629466|NCT03358953|Nicotine|nicotine|mesh-list
629467|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
629468|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
629469|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629470|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629471|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
629472|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
629473|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
629474|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
629475|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629476|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
629477|NCT03358888|Narcotics|narcotics|mesh-ancestor
629478|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
629479|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629480|NCT03358888|Analgesics|analgesics|mesh-ancestor
629481|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
629482|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629483|NCT03358875|Docetaxel|docetaxel|mesh-list
629484|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629485|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
629486|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
629487|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
629488|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629489|NCT03358719|Poly I-C|poly i-c|mesh-list
629490|NCT03358719|Nivolumab|nivolumab|mesh-list
629491|NCT03358719|Decitabine|decitabine|mesh-list
629492|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
629493|NCT03358719|Poly ICLC|poly iclc|mesh-list
629494|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
629495|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629496|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
629497|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629498|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
629499|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
629500|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629501|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
629502|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
629503|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629504|NCT03358719|Laxatives|laxatives|mesh-ancestor
629505|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
629506|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
629507|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080760|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2080761|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080762|NCT02078193|Abatacept|abatacept|mesh-list
2080763|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2080764|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080765|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080766|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2080767|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
2080768|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080769|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080770|NCT02078219|Allopurinol|allopurinol|mesh-list
2080771|NCT02078219|Verinurad|verinurad|mesh-list
2080772|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
2080773|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080774|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080775|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
2080776|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080777|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2080778|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
2080779|NCT02078219|Protective Agents|protective agents|mesh-ancestor
2080780|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080781|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2080782|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2080783|NCT02078284|Protective Agents|protective agents|mesh-ancestor
2080784|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080785|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2080786|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
2080787|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080788|NCT02078492|Ketorolac|ketorolac|mesh-list
2080789|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2080790|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2080791|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2080792|NCT02078492|Analgesics|analgesics|mesh-ancestor
2080793|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
2080794|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080795|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080796|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080797|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080798|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2080799|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629550|NCT03358693|Infliximab|infliximab|mesh-list
629551|NCT03358693|Upadacitinib|upadacitinib|mesh-list
629552|NCT03358693|Ustekinumab|ustekinumab|mesh-list
629553|NCT03358693|Ixekizumab|ixekizumab|mesh-list
629554|NCT03358693|Brodalumab|brodalumab|mesh-list
629555|NCT03358693|Abrocitinib|abrocitinib|mesh-list
629556|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
629557|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
629558|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
629559|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
629560|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
629561|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629562|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219168|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
2219169|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219170|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219171|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
2219172|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2219173|NCT00035191|Galantamine|galantamine|mesh-list
2219174|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2219175|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219176|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219177|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
2219178|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219179|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219180|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2219181|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
2219182|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219183|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
2219184|NCT00035204|Galantamine|galantamine|mesh-list
2219185|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2219186|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219187|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219188|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
2219189|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219190|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219191|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2219192|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
629603|NCT03358524|Vitamins|vitamins|mesh-list
629604|NCT03358524|Vitamin E|vitamin e|mesh-list
629605|NCT03358524|Tocopherols|tocopherols|mesh-list
629606|NCT03358524|Tocotrienols|tocotrienols|mesh-list
629607|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
629608|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
629609|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629610|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
629611|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629612|NCT03358524|Protective Agents|protective agents|mesh-ancestor
2219193|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219194|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
2219195|NCT00035230|Topiramate|topiramate|mesh-list
2219196|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
2219197|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2219198|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219199|NCT00035243|Epothilones|epothilones|mesh-list
2219200|NCT00035243|Epothilone B|epothilone b|mesh-list
2219201|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
2219202|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
2219203|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
629625|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
629626|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
629627|NCT03358277|Methylphenidate|methylphenidate|mesh-list
629628|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629629|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
629630|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
629631|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629632|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
629633|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
629634|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
629635|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
629636|NCT03358212|Denosumab|denosumab|mesh-list
629637|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
629638|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219204|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219205|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219206|NCT00035256|Teriparatide|teriparatide|mesh-list
2219207|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2219208|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2219209|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219210|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2219211|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2219212|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
2219213|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2219214|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
629651|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
629652|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
629653|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
629654|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
629655|NCT03358082|Tacrolimus|tacrolimus|mesh-list
629656|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
629657|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
629658|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629659|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
629660|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629661|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629662|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
629663|NCT03358030|Riboflavin|riboflavin|mesh-list
629664|NCT03358030|Vitamin B Complex|vitamin b complex|mesh-ancestor
629665|NCT03358030|Vitamins|vitamins|mesh-ancestor
629666|NCT03358030|Micronutrients|micronutrients|mesh-ancestor
629667|NCT03358030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629668|NCT03358030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
629669|NCT03358030|Dermatologic Agents|dermatologic agents|mesh-ancestor
629670|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
629671|NCT03358017|Atorvastatin|atorvastatin|mesh-list
629672|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
629673|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
629674|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
629675|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629676|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
629677|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
629678|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629679|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
629680|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629681|NCT03358004|Capecitabine|capecitabine|mesh-list
629682|NCT03358004|Vinorelbine|vinorelbine|mesh-list
629683|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
629684|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
629685|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629686|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629687|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
629688|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
629689|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
629690|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
2080800|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629693|NCT03357939|Adalimumab|adalimumab|mesh-list
629694|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
629695|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
629696|NCT03357900|Remifentanil|remifentanil|mesh-list
629697|NCT03357900|Propofol|propofol|mesh-list
629698|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
629699|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
629700|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629701|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
629702|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
629703|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
629704|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
629705|NCT03357900|Narcotics|narcotics|mesh-ancestor
629706|NCT03357900|Analgesics|analgesics|mesh-ancestor
629707|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
629708|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629709|NCT03357874|Clopidogrel|clopidogrel|mesh-list
629710|NCT03357874|Ticagrelor|ticagrelor|mesh-list
629711|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
629712|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
629713|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
629714|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
629715|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
629716|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
629717|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629718|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629719|NCT03357822|Interferons|interferons|mesh-list
629720|NCT03357822|Tenofovir|tenofovir|mesh-list
629721|NCT03357822|Entecavir|entecavir|mesh-list
629722|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629723|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
629724|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
629725|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
629726|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
629727|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629728|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629729|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
629730|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
629731|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
629732|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
629733|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
629734|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
629735|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629736|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
629737|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629738|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
629739|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
629740|NCT03357757|Avelumab|avelumab|mesh-list
629741|NCT03357757|Valproic Acid|valproic acid|mesh-list
629742|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
629743|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629744|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
629745|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629746|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629747|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
629748|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
629749|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629750|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
629751|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
629752|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
629753|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219215|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2219216|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
629756|NCT03357718|Midazolam|midazolam|mesh-list
629757|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
629758|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
629759|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
629760|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629761|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
629762|NCT03357718|Analgesics|analgesics|mesh-ancestor
629763|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
629764|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629765|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
629766|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
629767|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
629768|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
629769|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
629770|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629771|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
629772|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
629773|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
629774|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
629775|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
629776|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
629777|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
629778|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
629779|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
629780|NCT03357653|Losartan|losartan|mesh-list
629781|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
629782|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
629783|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
629784|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
629785|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629786|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
629787|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
629788|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
629789|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
629790|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629791|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
629792|NCT03357627|Venetoclax|venetoclax|mesh-list
629793|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219217|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219218|NCT00035282|Aprepitant|aprepitant|mesh-list
2219219|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
2219220|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
2219221|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219222|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219223|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219224|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2219225|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219226|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219227|NCT00035295|Aprepitant|aprepitant|mesh-list
2219228|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
2219229|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
2219230|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219231|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219232|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219233|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2219234|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219235|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219236|NCT00035308|Abetimus|abetimus|mesh-list
2219237|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2219238|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
629816|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
629817|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
629818|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
629819|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629820|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
629821|NCT03357575|Protective Agents|protective agents|mesh-ancestor
629822|NCT03357419|Clindamycin|clindamycin|mesh-list
629823|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
629824|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
629825|NCT03357419|Cephalexin|cephalexin|mesh-list
629826|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
629827|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
629828|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
629829|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629830|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219239|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219240|NCT00035321|Olanzapine|olanzapine|mesh-list
2219241|NCT00035321|Fluoxetine|fluoxetine|mesh-list
2219242|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
2219243|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
2219244|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219245|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219246|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219247|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2219248|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2219249|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2219250|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219251|NCT00035321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2219252|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2219253|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2219254|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219255|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219256|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
2219257|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2219258|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
2219259|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2219260|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2219261|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219262|NCT00035347|Azithromycin|azithromycin|mesh-list
2219263|NCT00035347|Levofloxacin|levofloxacin|mesh-list
2219264|NCT00035347|Ofloxacin|ofloxacin|mesh-list
2219265|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
2219266|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2219267|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219268|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2219269|NCT00035347|Renal Agents|renal agents|mesh-ancestor
2219270|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2219271|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2219272|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219273|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219274|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219275|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2219276|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2219277|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2219278|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
2219279|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219280|NCT00035425|Vancomycin|vancomycin|mesh-list
2219281|NCT00035425|Linezolid|linezolid|mesh-list
2219282|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2219283|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
629879|NCT03357224|Atezolizumab|atezolizumab|mesh-list
629880|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629881|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
629882|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
629883|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
629884|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
629885|NCT03357159|Antibodies|antibodies|mesh-list
629886|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
629887|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
629888|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629889|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
629890|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
629891|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
629892|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629893|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629894|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
629895|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
629896|NCT03357133|Tirofiban|tirofiban|mesh-list
629897|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
629898|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
629899|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629900|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
629901|NCT03357055|Ketamine|ketamine|mesh-list
629902|NCT03357055|Analgesics|analgesics|mesh-ancestor
629903|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
629904|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629905|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629906|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
629907|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
629908|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
629909|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
629910|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
629911|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
629912|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
629913|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
629914|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629915|NCT03356964|Hormones|hormones|mesh-list
629916|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
629917|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
629918|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629919|NCT03356912|Prednisone|prednisone|mesh-list
629920|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
629921|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
629922|NCT03356912|Hormones|hormones|mesh-ancestor
629923|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
629924|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629925|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
629926|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629927|NCT03356899|Bupivacaine|bupivacaine|mesh-list
629928|NCT03356899|Anesthetics|anesthetics|mesh-list
629929|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
629930|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
629931|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629932|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
629933|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629934|NCT03356873|Vitamin D|vitamin d|mesh-list
629935|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
629936|NCT03356873|Vitamins|vitamins|mesh-list
629937|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
629938|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629939|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
629940|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
629941|NCT03356860|Paclitaxel|paclitaxel|mesh-list
629942|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
629943|NCT03356860|Durvalumab|durvalumab|mesh-list
629944|NCT03356860|Epirubicin|epirubicin|mesh-list
629945|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
629946|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629947|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
629948|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
629949|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
629950|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629951|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
629952|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
629953|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629954|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
629955|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
629956|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
629957|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
629958|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
629959|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
629960|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
629961|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
629962|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629963|NCT03356834|Tenofovir|tenofovir|mesh-list
629964|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
629965|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
629966|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
629967|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
629968|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629969|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629970|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
629971|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
629972|NCT03356769|Aspirin|aspirin|mesh-list
629973|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
629974|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
629975|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
629976|NCT03356769|Analgesics|analgesics|mesh-ancestor
629977|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
629978|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
629979|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629980|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
629981|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
629982|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
629983|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
629984|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629985|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
629986|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
629987|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
629988|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
629989|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
629990|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
629991|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
629992|NCT03356730|Vitamin D|vitamin d|mesh-list
629993|NCT03356730|Vitamins|vitamins|mesh-ancestor
629994|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
629995|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
629996|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
629997|NCT03356600|Apatinib|apatinib|mesh-list
629998|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
629999|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
630000|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630001|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751576|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
2751577|NCT03912831|Fludarabine|fludarabine|mesh-list
2751578|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2751579|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
630016|NCT03356444|Docetaxel|docetaxel|mesh-list
630017|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
630018|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630019|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
630020|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
630021|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
630022|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630023|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
630024|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630025|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
630026|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
630027|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630028|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
630029|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
630030|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630031|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
630032|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
630033|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
630034|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630035|NCT03356353|Urological Agents|urological agents|mesh-ancestor
630036|NCT03356158|Cetuximab|cetuximab|mesh-list
630037|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
630038|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630039|NCT03356080|Cytarabine|cytarabine|mesh-list
630040|NCT03356080|Decitabine|decitabine|mesh-list
630041|NCT03356080|Tretinoin|tretinoin|mesh-list
630042|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
630043|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630044|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
630045|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
630046|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630047|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630048|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
630049|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
630050|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
630051|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630052|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
630053|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
630054|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
630055|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
630056|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630057|NCT03355976|Nivolumab|nivolumab|mesh-list
630058|NCT03355976|Ipilimumab|ipilimumab|mesh-list
630059|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
630060|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630061|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
630062|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630063|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
630064|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
630065|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
630066|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
630067|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
630068|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630069|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
630070|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
630071|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630072|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
630073|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219284|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2219285|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630077|NCT03355794|Everolimus|everolimus|mesh-list
630078|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630079|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
630080|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
630081|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630082|NCT03355768|Romidepsin|romidepsin|mesh-list
630083|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
630084|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630085|NCT03355716|Fentanyl|fentanyl|mesh-list
630086|NCT03355716|Morphine|morphine|mesh-list
630087|NCT03355716|Ketamine|ketamine|mesh-list
630088|NCT03355716|Bupivacaine|bupivacaine|mesh-list
630089|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
630090|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
630091|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
630092|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630093|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
630094|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630095|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
630096|NCT03355716|Narcotics|narcotics|mesh-ancestor
630097|NCT03355716|Analgesics|analgesics|mesh-ancestor
630098|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
630099|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
630100|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
630101|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
630102|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
630103|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
630104|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630105|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
630106|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
630107|NCT03355638|Aflibercept|aflibercept|mesh-list
630108|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
630109|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
630110|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
630111|NCT03355638|Growth Substances|growth substances|mesh-ancestor
630112|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630113|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
630114|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630115|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
630116|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
630117|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
630118|NCT03355638|Analgesics|analgesics|mesh-ancestor
630119|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
630120|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630121|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
630122|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
630123|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
630124|NCT03355612|Capecitabine|capecitabine|mesh-list
630125|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
630126|NCT03355612|Apatinib|apatinib|mesh-list
630127|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
630128|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
630129|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630130|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630131|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
630132|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630133|NCT03355560|Nivolumab|nivolumab|mesh-list
630134|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
630135|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630136|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
630137|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630138|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
630139|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
630140|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
630141|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630142|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
630143|NCT03355534|Analgesics|analgesics|mesh-ancestor
630144|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
630145|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630146|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
630147|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
630148|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
630149|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
630150|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
630151|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630152|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
630153|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
630154|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
630155|NCT03355482|Prednisolone|prednisolone|mesh-list
630156|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
630157|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
630158|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
630159|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
630160|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
630161|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
630162|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630163|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630164|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
630165|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
630166|NCT03355482|Hormones|hormones|mesh-ancestor
630167|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
630168|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
630169|NCT03355482|Protective Agents|protective agents|mesh-ancestor
630170|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
630171|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630172|NCT03355469|Metformin|metformin|mesh-list
630173|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
630174|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630175|NCT03355352|Sufentanil|sufentanil|mesh-list
630176|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
630177|NCT03355352|Narcotics|narcotics|mesh-ancestor
630178|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
630179|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630180|NCT03355352|Analgesics|analgesics|mesh-ancestor
630181|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
630182|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630183|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
630184|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
630185|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
630186|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
2080801|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
2080802|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2080803|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080804|NCT02078726|Glucagon|glucagon|mesh-list
630191|NCT03355300|Cannabidiol|cannabidiol|mesh-list
630192|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
630193|NCT03355248|Acetaminophen|acetaminophen|mesh-list
630194|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
630195|NCT03355248|Oxycodone|oxycodone|mesh-list
630196|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
630197|NCT03355248|Analgesics|analgesics|mesh-ancestor
630198|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
630199|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630200|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630201|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
630202|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
630203|NCT03355248|Narcotics|narcotics|mesh-ancestor
630204|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
630205|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
630206|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
630207|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
630208|NCT03355170|Domperidone|domperidone|mesh-list
630209|NCT03355170|Lansoprazole|lansoprazole|mesh-list
630210|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
630211|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
630212|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
630213|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
630214|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630215|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630216|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
630217|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
630218|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630219|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630220|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
630221|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
630222|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
630223|NCT03355157|Tamoxifen|tamoxifen|mesh-list
630224|NCT03355157|Paclitaxel|paclitaxel|mesh-list
630225|NCT03355157|Vinorelbine|vinorelbine|mesh-list
630226|NCT03355157|Capecitabine|capecitabine|mesh-list
630227|NCT03355157|Letrozole|letrozole|mesh-list
630228|NCT03355157|Epirubicin|epirubicin|mesh-list
630229|NCT03355157|Fulvestrant|fulvestrant|mesh-list
630230|NCT03355157|Palbociclib|palbociclib|mesh-list
630231|NCT03355157|Exemestane|exemestane|mesh-list
630232|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
630233|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630234|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
630235|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
630236|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
630237|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630238|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
630239|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
630240|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
630241|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
630242|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630243|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
630244|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
630245|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
630246|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630247|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
630248|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
630249|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
630250|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
630251|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
630252|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
630253|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
630254|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
630255|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
630256|NCT03355118|Anesthetics|anesthetics|mesh-list
630257|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
630258|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630259|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
630260|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
630261|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
630262|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630263|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
630264|NCT03355053|Analgesics|analgesics|mesh-ancestor
630265|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
630266|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630267|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
630268|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
630269|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
630270|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
630271|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
630272|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630273|NCT03355027|Atorvastatin|atorvastatin|mesh-list
630274|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
630275|NCT03355027|Simvastatin|simvastatin|mesh-list
630276|NCT03355027|Ezetimibe|ezetimibe|mesh-list
630277|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
630278|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
630279|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
630280|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630281|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
630282|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
630283|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630284|NCT03355014|Metformin|metformin|mesh-list
630285|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
630286|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630287|NCT03354962|Nivolumab|nivolumab|mesh-list
630288|NCT03354962|Ipilimumab|ipilimumab|mesh-list
630289|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
630290|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630291|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
630292|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630293|NCT03354897|Torsemide|torsemide|mesh-list
630294|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
630295|NCT03354897|Diuretics|diuretics|mesh-ancestor
630296|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
630297|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630298|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
630299|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
630300|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630301|NCT03354806|Analgesics|analgesics|mesh-list
630302|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
630303|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630304|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630308|NCT03354624|Mitogens|mitogens|mesh-list
630309|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
630310|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219286|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219287|NCT00035451|Sotalol|sotalol|mesh-list
2219288|NCT00035451|Azimilide|azimilide|mesh-list
2219289|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2219290|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2219291|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
2219292|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219293|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219294|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219295|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2219296|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
2219297|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
2219298|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219299|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2219300|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
630326|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
630327|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
630328|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
630329|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
630330|NCT03354572|Expectorants|expectorants|mesh-ancestor
630331|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
630332|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
630333|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
630334|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630335|NCT03354572|Protective Agents|protective agents|mesh-ancestor
630336|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630337|NCT03354572|Antidotes|antidotes|mesh-ancestor
630338|NCT03354494|Desogestrel|desogestrel|mesh-list
630339|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
630340|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
630341|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
630342|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
630343|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
630344|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630345|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
630346|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
630347|NCT03354494|Progestins|progestins|mesh-ancestor
630348|NCT03354494|Hormones|hormones|mesh-ancestor
630349|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2219301|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2219302|NCT00035464|Azimilide|azimilide|mesh-list
2219303|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2219304|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2219305|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2219306|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219307|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2219308|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630359|NCT03354338|Amoxicillin|amoxicillin|mesh-list
630360|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
630361|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
630362|NCT03354312|Lidocaine|lidocaine|mesh-list
630363|NCT03354312|Epinephrine|epinephrine|mesh-list
630364|NCT03354312|Racepinephrine|racepinephrine|mesh-list
630365|NCT03354312|Carticaine|carticaine|mesh-list
630366|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
630367|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
630368|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
630369|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
630370|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630371|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
630372|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630373|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
630374|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
630375|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
630376|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
630377|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630378|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
630379|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
630380|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
630381|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
630382|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
630383|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
630384|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
630385|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
630386|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
630387|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
630388|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
630389|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
630390|NCT03354117|Meloxicam|meloxicam|mesh-list
630391|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
630392|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
630393|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
630394|NCT03354117|Analgesics|analgesics|mesh-ancestor
630395|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
630396|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630397|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630398|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
630399|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
630400|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
630401|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
630402|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630403|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630404|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
630405|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
630406|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
630407|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
630408|NCT03354039|Tamoxifen|tamoxifen|mesh-list
630409|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
630410|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
630411|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
630412|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630413|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
630414|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630415|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
630416|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
630417|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
630418|NCT03354013|Calcium|calcium|mesh-list
630419|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
630420|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630421|NCT03353948|Metformin|metformin|mesh-list
630422|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
630423|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219309|NCT00035477|Azimilide|azimilide|mesh-list
2219310|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2219311|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2219312|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2219313|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219314|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2219315|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219316|NCT00035490|Azimilide|azimilide|mesh-list
2219317|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2219318|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2219319|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
630435|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
630436|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
630437|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
630438|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630439|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
630440|NCT03353909|Protective Agents|protective agents|mesh-ancestor
630441|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
630442|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
630443|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
630444|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
630445|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
630446|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630447|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
630448|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
630449|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630450|NCT03353857|Rifampin|rifampin|mesh-list
630451|NCT03353857|Dienogest|dienogest|mesh-list
630452|NCT03353857|Drospirenone|drospirenone|mesh-list
630453|NCT03353857|Midazolam|midazolam|mesh-list
630454|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
630455|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
630456|NCT03353857|Norethindrone|norethindrone|mesh-list
630457|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
630458|NCT03353857|Desogestrel|desogestrel|mesh-list
630459|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
630460|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
630461|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
630462|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630463|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
630464|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
630465|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
630466|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
630467|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
630468|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
630469|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
630470|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
630471|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
630472|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630473|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
630474|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
630475|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
630476|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
630477|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
630478|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
630479|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
630480|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
630481|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
630482|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
630483|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
630484|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
630485|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630486|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
630487|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
630488|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
630489|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
630490|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
630491|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
630492|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
630493|NCT03353857|Estrogens|estrogens|mesh-ancestor
630494|NCT03353857|Hormones|hormones|mesh-ancestor
630495|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
630496|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
630497|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
630498|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
630499|NCT03353857|Diuretics|diuretics|mesh-ancestor
630500|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
630501|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
630502|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
630503|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630504|NCT03353857|Progestins|progestins|mesh-ancestor
630505|NCT03353831|Bevacizumab|bevacizumab|mesh-list
630506|NCT03353831|Atezolizumab|atezolizumab|mesh-list
630507|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
630508|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630509|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
630510|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
630511|NCT03353831|Growth Substances|growth substances|mesh-ancestor
630512|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630513|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
2080805|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2080806|NCT02078726|Hormones|hormones|mesh-ancestor
2080807|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2080808|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080809|NCT02078817|Ketamine|ketamine|mesh-list
2080810|NCT02078817|Analgesics|analgesics|mesh-ancestor
630525|NCT03353480|Azithromycin|azithromycin|mesh-list
630526|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
630527|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
630528|NCT03353441|Glycine|glycine|mesh-list
630529|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
630530|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
630531|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630532|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630533|NCT03353363|Bupivacaine|bupivacaine|mesh-list
630534|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
630535|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
630536|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
630537|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630538|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
630539|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630543|NCT03353324|Bevacizumab|bevacizumab|mesh-list
630544|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
630545|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630546|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
630547|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
630548|NCT03353324|Growth Substances|growth substances|mesh-ancestor
630549|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630550|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
630551|NCT03353298|Allopurinol|allopurinol|mesh-list
630552|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
630553|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630554|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630555|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
630556|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
630557|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
630558|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
630559|NCT03353298|Protective Agents|protective agents|mesh-ancestor
630560|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080811|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
2080812|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080813|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080814|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2080815|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
630574|NCT03353103|Listerine|listerine|mesh-list
630575|NCT03353103|Fluorides|fluorides|mesh-list
630576|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
630577|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
630578|NCT03353103|Protective Agents|protective agents|mesh-ancestor
630579|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630580|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
630581|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
630582|NCT03353025|Dopamine|dopamine|mesh-list
630583|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
630584|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
630585|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
630586|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
630587|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630588|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630589|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
630590|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
630591|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630592|NCT03353025|Protective Agents|protective agents|mesh-ancestor
630593|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
630594|NCT03353012|Etonogestrel|etonogestrel|mesh-list
630595|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
630596|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
630597|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
630598|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630599|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
630600|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
630601|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
630602|NCT03352947|Trametinib|trametinib|mesh-list
630603|NCT03352947|Dabrafenib|dabrafenib|mesh-list
630604|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630605|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
630606|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630607|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630608|NCT03352934|Avelumab|avelumab|mesh-list
630609|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
630610|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630611|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
630612|NCT03352895|Resveratrol|resveratrol|mesh-list
630613|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
630614|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630615|NCT03352895|Protective Agents|protective agents|mesh-ancestor
630616|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630617|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630618|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
630619|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
630620|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630621|NCT03352869|Metformin|metformin|mesh-list
630622|NCT03352869|Exenatide|exenatide|mesh-list
630623|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
630624|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630625|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
630626|NCT03352869|Incretins|incretins|mesh-ancestor
630627|NCT03352869|Hormones|hormones|mesh-ancestor
630628|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
630629|NCT03352843|Primaquine|primaquine|mesh-list
630630|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
630631|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
630632|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
630633|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080816|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
2080817|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
2080818|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2080819|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2080820|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2080821|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080822|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080823|NCT02078882|Abatacept|abatacept|mesh-list
2080824|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2080825|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080826|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080827|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2080828|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
630647|NCT03352700|Dyclonine|dyclonine|mesh-list
630648|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
630649|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
630650|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
630651|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630652|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
630653|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630654|NCT03352674|Insulin|insulin|mesh-list
630655|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
630656|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
630657|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
630658|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630659|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
630660|NCT03352479|Narcotics|narcotics|mesh-ancestor
630661|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
630662|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630663|NCT03352479|Analgesics|analgesics|mesh-ancestor
630664|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
630665|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080829|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080830|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080831|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
2080832|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2080833|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080834|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2080835|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080836|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219320|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630677|NCT03352362|Acetaminophen|acetaminophen|mesh-list
630678|NCT03352362|Ibuprofen|ibuprofen|mesh-list
630679|NCT03352362|Propacetamol|propacetamol|mesh-list
630680|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
630681|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
630682|NCT03352362|Analgesics|analgesics|mesh-ancestor
630683|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
630684|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630685|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630686|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
630687|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
630688|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
630689|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630690|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630691|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
630692|NCT03352349|Terlipressin|terlipressin|mesh-list
630693|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
630694|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2080837|NCT02079077|Aspirin|aspirin|mesh-list
2080838|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
2080839|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
2080840|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2080841|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2080842|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080843|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080844|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080845|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080846|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2080847|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2080848|NCT02079077|Analgesics|analgesics|mesh-ancestor
2080849|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
2080850|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080851|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080852|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080853|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2080854|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
630713|NCT03352128|Calcium|calcium|mesh-list
630714|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
630715|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630716|NCT03352115|Prednisolone|prednisolone|mesh-list
630717|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
630718|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
630719|NCT03352115|Hormones|hormones|mesh-ancestor
630720|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
630721|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630722|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
630723|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630724|NCT03352076|Danazol|danazol|mesh-list
630725|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
630726|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
630727|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
630728|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630729|NCT03351998|Atorvastatin|atorvastatin|mesh-list
630730|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
630731|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
630732|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
630733|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630734|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
630735|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
630736|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219321|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2219322|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219323|NCT00035516|Epothilones|epothilones|mesh-list
2219324|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
2219325|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
2219326|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
630744|NCT03351842|Cisplatin|cisplatin|mesh-list
630745|NCT03351842|Carboplatin|carboplatin|mesh-list
630746|NCT03351842|Pemetrexed|pemetrexed|mesh-list
630747|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630748|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630749|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630750|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
630751|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
630752|NCT03351751|PF-06372865|pf-06372865|mesh-list
630753|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
630754|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
630755|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
630756|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630757|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630758|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
630759|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
630760|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
630761|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630762|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
630763|NCT03351686|Coagulants|coagulants|mesh-ancestor
630764|NCT03351647|Ustekinumab|ustekinumab|mesh-list
630765|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
2219327|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219328|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219329|NCT00035529|Abatacept|abatacept|mesh-list
2219330|NCT00035529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2219331|NCT00035529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219332|NCT00035529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219333|NCT00035529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2219334|NCT00035529|Immunologic Factors|immunologic factors|mesh-ancestor
2219335|NCT00035529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219336|NCT00035529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219337|NCT00035542|Metformin|metformin|mesh-list
2219338|NCT00035542|Glyburide|glyburide|mesh-list
2219339|NCT00035542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2219340|NCT00035542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219341|NCT00035568|Metformin|metformin|mesh-list
2219342|NCT00035568|Glyburide|glyburide|mesh-list
2219343|NCT00035568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2219344|NCT00035568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219345|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2219346|NCT00035581|Poly I-C|poly i-c|mesh-list
2219347|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
630787|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
630788|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
630789|NCT03351569|Antibodies|antibodies|mesh-list
630790|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
630791|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
630792|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
630793|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630794|NCT03351517|Tapentadol|tapentadol|mesh-list
630795|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
630796|NCT03351517|Narcotics|narcotics|mesh-ancestor
630797|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
630798|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630799|NCT03351517|Analgesics|analgesics|mesh-ancestor
630800|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
630801|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630802|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
630803|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
630804|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
630805|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630806|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
630807|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219348|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219349|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
2219350|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
2219351|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219352|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
2219353|NCT00035607|Hematinics|hematinics|mesh-ancestor
2080855|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2080856|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2080857|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
2080858|NCT02079519|Bevacizumab|bevacizumab|mesh-list
2080859|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2080860|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080861|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2080862|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2080863|NCT02079519|Growth Substances|growth substances|mesh-ancestor
2080864|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080865|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
2080866|NCT02079532|Rituximab|rituximab|mesh-list
2080867|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2080868|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080869|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
2080870|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080871|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219354|NCT00035620|Lenograstim|lenograstim|mesh-list
630906|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2219355|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2219356|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
2080872|NCT02079636|Gemcitabine|gemcitabine|mesh-list
2080873|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
2080874|NCT02079636|Pemetrexed|pemetrexed|mesh-list
2080875|NCT02079636|Ramucirumab|ramucirumab|mesh-list
2080876|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2080877|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
2080878|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080879|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080880|NCT02079636|Antiviral Agents|antiviral agents|mesh-ancestor
630841|NCT03351361|Nivolumab|nivolumab|mesh-list
630842|NCT03351361|Ipilimumab|ipilimumab|mesh-list
630843|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
630844|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630845|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
630846|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080881|NCT02079636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080882|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080883|NCT02079636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2080884|NCT02079636|Immunologic Factors|immunologic factors|mesh-ancestor
2080885|NCT02079636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080886|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2080887|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
630854|NCT03351322|Minoxidil|minoxidil|mesh-list
630855|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
630856|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
630857|NCT03351296|Bevacizumab|bevacizumab|mesh-list
630858|NCT03351296|Capecitabine|capecitabine|mesh-list
630859|NCT03351296|Temozolomide|temozolomide|mesh-list
630860|NCT03351296|Streptozocin|streptozocin|mesh-list
630861|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
630862|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630863|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
630864|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
630865|NCT03351296|Growth Substances|growth substances|mesh-ancestor
630866|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630867|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
630868|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
630869|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
630870|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630871|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
630872|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
630873|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
630874|NCT03351244|BI 409306|bi 409306|mesh-list
630875|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
630876|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630877|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219357|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219358|NCT00035633|Entecavir|entecavir|mesh-list
2219359|NCT00035633|Antiviral Agents|antiviral agents|mesh-ancestor
2219360|NCT00035633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219361|NCT00035789|Entecavir|entecavir|mesh-list
630883|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
630884|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
630885|NCT03351205|Estradiol|estradiol|mesh-list
630886|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
630887|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
630888|NCT03351205|Estrogens|estrogens|mesh-ancestor
630889|NCT03351205|Hormones|hormones|mesh-ancestor
630890|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
630891|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630892|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
630893|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
630894|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
630895|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
630896|NCT03351205|Progestins|progestins|mesh-ancestor
630897|NCT03351062|Tamoxifen|tamoxifen|mesh-list
630898|NCT03351062|Toremifene|toremifene|mesh-list
630899|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
630900|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
630901|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
630902|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630903|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
630904|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630905|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2080888|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2219362|NCT00035789|Antiviral Agents|antiviral agents|mesh-ancestor
630907|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2219363|NCT00035789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219364|NCT00035802|Topiramate|topiramate|mesh-list
2219365|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
2219366|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2219367|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219368|NCT00035854|Linezolid|linezolid|mesh-list
2219369|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2219370|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219371|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2080889|NCT02079649|Dexamethasone|dexamethasone|mesh-list
2080890|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2080891|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
630920|NCT03350737|Heparin|heparin|mesh-list
630921|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
630922|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
630923|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
630924|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630925|NCT03350659|Midodrine|midodrine|mesh-list
630926|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
630927|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
630928|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
630929|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
630930|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630931|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
630932|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
630933|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630934|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
630935|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
630936|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630937|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
630938|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
630939|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
630940|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
630941|NCT03350633|Azathioprine|azathioprine|mesh-list
630942|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
630943|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630944|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
630945|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
630946|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
630947|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
630948|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630949|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
630950|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
630951|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
630952|NCT03350516|Calcium|calcium|mesh-list
630953|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
630954|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630955|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
630956|NCT03350516|Antacids|antacids|mesh-ancestor
630957|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630958|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
630959|NCT03350399|Mitogens|mitogens|mesh-list
630960|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
630961|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630962|NCT03350386|Oxaprozin|oxaprozin|mesh-list
630963|NCT03350386|Dotinurad|dotinurad|mesh-list
630964|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
630965|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
630966|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
630967|NCT03350386|Renal Agents|renal agents|mesh-ancestor
630968|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
630969|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
630970|NCT03350386|Analgesics|analgesics|mesh-ancestor
630971|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
630972|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630973|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630974|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
630975|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
630976|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
630977|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630978|NCT03350373|Dotinurad|dotinurad|mesh-list
630979|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
630980|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
630981|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
630982|NCT03350373|Renal Agents|renal agents|mesh-ancestor
630983|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
630984|NCT03350347|Hematinics|hematinics|mesh-ancestor
630985|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
630986|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
630987|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
630988|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
630989|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
630990|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
630991|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
630992|NCT03350334|Analgesics|analgesics|mesh-ancestor
630993|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
630994|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
630995|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
630996|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
630997|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
630998|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
630999|NCT03350321|Hematinics|hematinics|mesh-ancestor
631000|NCT03350295|Nifurtimox|nifurtimox|mesh-list
631001|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
631002|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
631003|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
631004|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219372|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219373|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219374|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
631008|NCT03350191|Exenatide|exenatide|mesh-list
631009|NCT03350191|Glucagon|glucagon|mesh-list
631010|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
631011|NCT03350191|Hormones|hormones|mesh-ancestor
631012|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
631013|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631014|NCT03350191|Incretins|incretins|mesh-ancestor
631015|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
631016|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
631017|NCT03350126|Nivolumab|nivolumab|mesh-list
631018|NCT03350126|Ipilimumab|ipilimumab|mesh-list
631019|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
631020|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631021|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
631022|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631023|NCT03350035|Ganaxolone|ganaxolone|mesh-list
631024|NCT03350035|Neurosteroids|neurosteroids|mesh-ancestor
631025|NCT03350035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
631026|NCT03350035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631027|NCT03350035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631028|NCT03350035|GABA Modulators|gaba modulators|mesh-ancestor
631029|NCT03350035|GABA Agents|gaba agents|mesh-ancestor
631030|NCT03349957|Idarubicin|idarubicin|mesh-list
631031|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
631032|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631033|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
631034|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
631035|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631036|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631037|NCT03349866|Capecitabine|capecitabine|mesh-list
631038|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
631039|NCT03349866|Apatinib|apatinib|mesh-list
631040|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
631041|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
631042|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631043|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631044|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
631045|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631046|NCT03349840|Insulin|insulin|mesh-list
631047|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
631048|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
631049|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
631050|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631051|NCT03349827|Apatinib|apatinib|mesh-list
631052|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631053|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
631054|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631055|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219375|NCT00035893|Poly I-C|poly i-c|mesh-list
2219376|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
2219377|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219378|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
2219379|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
631065|NCT03349684|Metformin|metformin|mesh-list
631066|NCT03349684|Acarbose|acarbose|mesh-list
631067|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
631068|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631069|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
631070|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631071|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631072|NCT03349658|Anesthetics|anesthetics|mesh-list
631073|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631074|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631075|NCT03349619|Resveratrol|resveratrol|mesh-list
631076|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
631077|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631078|NCT03349619|Protective Agents|protective agents|mesh-ancestor
631079|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631080|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631081|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
631082|NCT03349606|Amphetamine|amphetamine|mesh-list
631083|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
631084|NCT03349606|FLB 457|flb 457|mesh-list
631085|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
631086|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631087|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
631088|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
631089|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631090|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
631091|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
631092|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631093|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
631094|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
631095|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
631096|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
631097|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
631098|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2219380|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631100|NCT03349489|Insulin|insulin|mesh-list
631101|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
631102|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
631103|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631104|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
631105|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
631106|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
631107|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
631108|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631109|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
631110|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
631111|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
631112|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631113|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631114|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
631115|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
631116|NCT03349424|Somatostatin|somatostatin|mesh-list
631117|NCT03349424|Hormones|hormones|mesh-ancestor
631118|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
631119|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631120|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
631121|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
631122|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631123|NCT03349346|Rituximab|rituximab|mesh-list
631124|NCT03349346|Carboplatin|carboplatin|mesh-list
631125|NCT03349346|Etoposide|etoposide|mesh-list
631126|NCT03349346|Ifosfamide|ifosfamide|mesh-list
631127|NCT03349346|Idelalisib|idelalisib|mesh-list
631128|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
631129|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631130|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
631131|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631132|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
631133|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
631134|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2219381|NCT00035958|Prednisone|prednisone|mesh-list
631135|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
631136|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631137|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631138|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
631139|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
2219382|NCT00035958|Etanercept|etanercept|mesh-list
2219383|NCT00035958|Methotrexate|methotrexate|mesh-list
2219384|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2219385|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
2219386|NCT00035958|Hormones|hormones|mesh-ancestor
2219387|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2219388|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080892|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2080893|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
2080894|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
2080895|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080896|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080897|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2080898|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
2080899|NCT02079649|Hormones|hormones|mesh-ancestor
2080900|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2080901|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2080902|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080903|NCT02079805|Telmisartan|telmisartan|mesh-list
2080904|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2080905|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2080906|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2080907|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2080908|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080909|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
2080910|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2080911|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2080912|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080913|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2080914|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
2080915|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
2080916|NCT02080195|Fludarabine|fludarabine|mesh-list
2080917|NCT02080195|Tacrolimus|tacrolimus|mesh-list
2080918|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
2080919|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2080920|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2080921|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
2080922|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080923|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2080924|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2080925|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
2080926|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080927|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080928|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2080929|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2080930|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080931|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
631190|NCT03349268|Xenon|xenon|mesh-list
631191|NCT03349268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
631192|NCT03349268|Anesthetics, General|anesthetics, general|mesh-ancestor
631193|NCT03349268|Anesthetics|anesthetics|mesh-ancestor
631194|NCT03349268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631195|NCT03349268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631196|NCT03349216|Anesthetics|anesthetics|mesh-list
631197|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631198|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631199|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
631200|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
631201|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
631202|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
631203|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631204|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
631205|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
631206|NCT03349177|Docetaxel|docetaxel|mesh-list
631207|NCT03349177|Fluorouracil|fluorouracil|mesh-list
631208|NCT03349177|Epirubicin|epirubicin|mesh-list
631209|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
631210|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
631211|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631212|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
631213|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
631214|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
631215|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631216|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631217|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
631218|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
631219|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
631220|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
631221|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
631222|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
631223|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
631224|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
631225|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
631226|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631227|NCT03349112|Lidocaine|lidocaine|mesh-list
631228|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
631229|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
631230|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631231|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631232|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
631233|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631234|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
631235|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
631236|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
631237|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
631238|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219389|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2219390|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219391|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2219392|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
631243|NCT03349008|Entecavir|entecavir|mesh-list
631244|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
631245|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
631246|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631247|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
631248|NCT03348969|Mitomycins|mitomycins|mesh-list
631249|NCT03348969|Mitomycin|mitomycin|mesh-list
631250|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
631251|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631252|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
631253|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631254|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
631255|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631256|NCT03348930|Tolcapone|tolcapone|mesh-list
631257|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
631258|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
631259|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
631260|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631261|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631262|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
631263|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
631264|NCT03348917|Povidone|povidone|mesh-list
631265|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
631266|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631267|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
631268|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
631269|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
2219393|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2219394|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2219395|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
2219396|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219397|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
2219398|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219399|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2219400|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2219401|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
2219402|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219403|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2219404|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2219405|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2219406|NCT00035958|Analgesics|analgesics|mesh-ancestor
2219407|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
2219408|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219409|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219410|NCT00035971|Alendronate|alendronate|mesh-list
2219411|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2219412|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2219413|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631293|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
631294|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
631295|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
631296|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
631297|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631298|NCT03348800|Anesthetics|anesthetics|mesh-list
631299|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631300|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631301|NCT03348735|Lidocaine|lidocaine|mesh-list
631302|NCT03348735|Pregabalin|pregabalin|mesh-list
631303|NCT03348735|Capsaicin|capsaicin|mesh-list
631304|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
631305|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
631306|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631307|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631308|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
631309|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631310|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
631311|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
631312|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
631313|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
631314|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631315|NCT03348735|Analgesics|analgesics|mesh-ancestor
631316|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
631317|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
631318|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
631319|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
631320|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
631321|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
631322|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
631323|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
631324|NCT03348696|Dexamethasone|dexamethasone|mesh-list
631325|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
631326|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
631327|NCT03348696|BB 1101|bb 1101|mesh-list
631328|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
631329|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
631330|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
631331|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631332|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631333|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
631334|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
631335|NCT03348696|Hormones|hormones|mesh-ancestor
631336|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
631337|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
631338|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631339|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
631340|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631341|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219414|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2219415|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
2219416|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2219417|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2219418|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2219419|NCT00035984|Exenatide|exenatide|mesh-list
2219420|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2219421|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219422|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2219423|NCT00035984|Incretins|incretins|mesh-ancestor
631357|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
631358|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
631359|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
631360|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
631361|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631362|NCT03348462|Anthralin|anthralin|mesh-list
2219424|NCT00035984|Hormones|hormones|mesh-ancestor
631363|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
631364|NCT03348423|Fentanyl|fentanyl|mesh-list
631365|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
631366|NCT03348423|Narcotics|narcotics|mesh-ancestor
631367|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631368|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631369|NCT03348423|Analgesics|analgesics|mesh-ancestor
631370|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
631371|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631372|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
631373|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
631374|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
631375|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
631376|NCT03348371|Ethanol|ethanol|mesh-list
631377|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
631378|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631379|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631380|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631381|NCT03348267|Caseins|caseins|mesh-list
631382|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
631383|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
631384|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631385|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
631386|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
631387|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631388|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
631389|NCT03348098|Paclitaxel|paclitaxel|mesh-list
631390|NCT03348098|Apatinib|apatinib|mesh-list
631391|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
631392|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631393|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
631394|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
631395|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
631396|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631397|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
631398|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631399|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
631400|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631401|NCT03348046|Infliximab|infliximab|mesh-list
631402|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
631403|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
631404|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
631405|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
631406|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
631407|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
631408|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631409|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631410|NCT03347968|Warfarin|warfarin|mesh-list
631411|NCT03347968|Esmolol|esmolol|mesh-list
631412|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
631413|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
631414|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
631415|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
631416|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
631417|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
631418|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631419|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631420|NCT03347929|Naproxen|naproxen|mesh-list
631421|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
631422|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
631423|NCT03347929|Analgesics|analgesics|mesh-ancestor
631424|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
631425|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631426|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631427|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
631428|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
631429|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
631430|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
631431|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631432|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631433|NCT03347916|Gabapentin|gabapentin|mesh-list
631434|NCT03347916|Analgesics|analgesics|mesh-ancestor
631435|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
631436|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631437|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631438|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
631439|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
631440|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
631441|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631442|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
631443|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
631444|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
631445|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
631446|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631447|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
631448|NCT03347890|Liraglutide|liraglutide|mesh-list
631449|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
631450|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631451|NCT03347890|Incretins|incretins|mesh-ancestor
631452|NCT03347890|Hormones|hormones|mesh-ancestor
631453|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
631454|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
631455|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
631456|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080932|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2080933|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
2080934|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2080935|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080936|NCT02080221|Leucovorin|leucovorin|mesh-list
631462|NCT03347786|Verapamil|verapamil|mesh-list
631463|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
631464|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
631465|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
631466|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631467|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
631468|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631469|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
631470|NCT03347760|Octreotide|octreotide|mesh-list
631471|NCT03347760|Edotreotide|edotreotide|mesh-list
631472|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
631473|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631474|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
631475|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
631476|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631477|NCT03347721|Lidocaine|lidocaine|mesh-list
631478|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
631479|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
631480|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631481|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631482|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
631483|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631484|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
631485|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
631486|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
631487|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
631488|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631489|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
631490|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
631491|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
631492|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
631493|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631494|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
631495|NCT03347708|Protective Agents|protective agents|mesh-ancestor
2080937|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
2080938|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080939|NCT02080221|Antidotes|antidotes|mesh-ancestor
2080940|NCT02080221|Protective Agents|protective agents|mesh-ancestor
2080941|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080942|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
2080943|NCT02080221|Vitamins|vitamins|mesh-ancestor
631503|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
631504|NCT03347591|Hemostatics|hemostatics|mesh-list
631505|NCT03347591|Coagulants|coagulants|mesh-ancestor
631506|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
631507|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
631508|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631509|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
631510|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631511|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
2080944|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
631512|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631513|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
631514|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
631515|NCT03347591|Protective Agents|protective agents|mesh-ancestor
631516|NCT03347526|Vigabatrin|vigabatrin|mesh-list
631517|NCT03347526|Cosyntropin|cosyntropin|mesh-list
631518|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
631519|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631520|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631521|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
631522|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
631523|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631524|NCT03347526|Hormones|hormones|mesh-ancestor
631525|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
631526|NCT03347513|Glycine|glycine|mesh-list
631527|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
631528|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
631529|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631530|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631531|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
631532|NCT03347461|Dexamethasone|dexamethasone|mesh-list
631533|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
631534|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
631535|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
631536|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631537|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631538|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
631539|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
631540|NCT03347461|Hormones|hormones|mesh-ancestor
631541|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
631542|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
631543|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631544|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631545|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631546|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
631547|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631548|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
631549|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
631550|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
631551|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
631552|NCT03347370|Interferons|interferons|mesh-list
631553|NCT03347370|Interferon-beta|interferon-beta|mesh-list
631554|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
631555|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
631556|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631557|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
631558|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631559|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
631560|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631561|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
631562|NCT03347357|Tacrolimus|tacrolimus|mesh-list
631563|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
631564|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
631565|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631566|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
631567|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631568|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631569|NCT03347344|Riluzole|riluzole|mesh-list
631570|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
631571|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
631572|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
631573|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
631574|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631575|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631576|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
631577|NCT03347344|Protective Agents|protective agents|mesh-ancestor
631578|NCT03347331|Befiradol|befiradol|mesh-list
631579|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
631580|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
631581|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
631582|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
631583|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631584|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273736|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080945|NCT02080273|Listerine|listerine|mesh-list
2080946|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
2080947|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
2080948|NCT02080273|Protective Agents|protective agents|mesh-ancestor
2080949|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631591|NCT03347240|Baclofen|baclofen|mesh-list
631592|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
631593|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631594|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
631595|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631596|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
631597|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
631598|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
631599|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
631600|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631601|NCT03347123|Nivolumab|nivolumab|mesh-list
631602|NCT03347123|Ipilimumab|ipilimumab|mesh-list
631603|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
631604|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631605|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
631606|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631607|NCT03346993|Bupivacaine|bupivacaine|mesh-list
631608|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
631609|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
631610|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631611|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631612|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
631613|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631614|NCT03346837|Itraconazole|itraconazole|mesh-list
631615|NCT03346837|Rifampin|rifampin|mesh-list
631616|NCT03346837|Linrodostat|linrodostat|mesh-list
631617|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
631618|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631619|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
631620|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
631621|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631622|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631623|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
631624|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
631625|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
631626|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631627|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
631628|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
631629|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
631630|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
631631|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
631632|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
631633|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
631634|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
631635|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
631636|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
631637|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
631638|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
631639|NCT03346772|Vaccines|vaccines|mesh-list
631640|NCT03346772|Immunologic Factors|immunologic factors|mesh-ancestor
631641|NCT03346772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631642|NCT03346733|Psyllium|psyllium|mesh-list
631643|NCT03346733|Cathartics|cathartics|mesh-ancestor
631644|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
631645|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
631646|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
631647|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
631648|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631649|NCT03346681|Expectorants|expectorants|mesh-ancestor
631650|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
631651|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
631652|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
631653|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631654|NCT03346681|Protective Agents|protective agents|mesh-ancestor
631655|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631656|NCT03346681|Antidotes|antidotes|mesh-ancestor
631657|NCT03346668|Gabapentin|gabapentin|mesh-list
631658|NCT03346668|Analgesics|analgesics|mesh-ancestor
631659|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
2080950|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
631660|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631661|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631662|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
631663|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
631664|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
631665|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631666|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
631667|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
631668|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
631669|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
631670|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631671|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
631672|NCT03346642|Decitabine|decitabine|mesh-list
631673|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
631674|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
631675|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
631676|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631677|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631678|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631679|NCT03346629|Misoprostol|misoprostol|mesh-list
631680|NCT03346629|Mifepristone|mifepristone|mesh-list
631681|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
631682|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
631683|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
631684|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631685|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
631686|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
631687|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
631688|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
631689|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
631690|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
631691|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
631692|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
631693|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
631694|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
631695|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
631696|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
631697|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
631698|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
631699|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
631700|NCT03346538|Edaravone|edaravone|mesh-list
631701|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
631702|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
631703|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631704|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
631705|NCT03346538|Protective Agents|protective agents|mesh-ancestor
631706|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631707|NCT03346525|Penicillins|penicillins|mesh-list
631708|NCT03346525|Penicillin G|penicillin g|mesh-list
631709|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
631710|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
631711|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
631712|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631713|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
631714|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
631715|NCT03346317|Estradiol|estradiol|mesh-list
631716|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
631717|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
631718|NCT03346317|Estrogens|estrogens|mesh-ancestor
631719|NCT03346317|Hormones|hormones|mesh-ancestor
631720|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
631721|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631722|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
631723|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
631724|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
631725|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
631726|NCT03346317|Progestins|progestins|mesh-ancestor
631727|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
631728|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
631729|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
631730|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
631731|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
631732|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631733|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
631734|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
631735|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631736|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
631737|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080951|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080952|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
2080953|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2080954|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2080955|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080956|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
2080957|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
2080958|NCT02080455|Atorvastatin|atorvastatin|mesh-list
2080959|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2080960|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2080961|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
631749|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
631750|NCT03346226|Propofol|propofol|mesh-list
631751|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
631752|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631753|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631754|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
631755|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
631756|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
631757|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
631758|NCT03346226|Analgesics|analgesics|mesh-ancestor
631759|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
631760|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631761|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
631762|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
631763|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
631764|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
631765|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
631766|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631767|NCT03346200|Tamoxifen|tamoxifen|mesh-list
631768|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
631769|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
631770|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
631771|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631772|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
631773|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631774|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
631775|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
631776|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
631777|NCT03346187|Atorvastatin|atorvastatin|mesh-list
631778|NCT03346187|Fenofibrate|fenofibrate|mesh-list
631779|NCT03346187|Calcium|calcium|mesh-list
631780|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
631781|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631782|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
631783|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
631784|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
631785|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631786|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
631787|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
631788|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631801|NCT03346096|Thiotepa|thiotepa|mesh-list
631802|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
631803|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
631804|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631805|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2080962|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080963|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
631806|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
631807|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
631808|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
631809|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631810|NCT03346083|Betrixaban|betrixaban|mesh-list
631811|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
631812|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
631813|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
631814|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
631815|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631816|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631817|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
2219425|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2219426|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
2219427|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2219428|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219429|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
2219430|NCT00036023|Hematinics|hematinics|mesh-ancestor
2219431|NCT00036062|Sivelestat|sivelestat|mesh-list
2219432|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2219433|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
2219434|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219435|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219436|NCT00036088|Olanzapine|olanzapine|mesh-list
2219437|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
2219438|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
2219439|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219440|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219441|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219442|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2219443|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2219444|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2219445|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219446|NCT00036088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2219447|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2219448|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2219449|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219450|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219451|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
2219452|NCT00036101|Aripiprazole|aripiprazole|mesh-list
2219453|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
2219454|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219455|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2219456|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2219457|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2219458|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219459|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
2219460|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
2219461|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219462|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219463|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2219464|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
631858|NCT03345992|Clarithromycin|clarithromycin|mesh-list
631859|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
631860|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631861|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
631862|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631863|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631864|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
631865|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2219465|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
2219466|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2219467|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2219468|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2219469|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2219470|NCT00036114|Aripiprazole|aripiprazole|mesh-list
2219471|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
2219472|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219473|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2219474|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2219475|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2219476|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219477|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
2219478|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
2219479|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219480|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219481|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2219482|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
631886|NCT03345966|Antibodies|antibodies|mesh-list
631887|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
631888|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631889|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
631890|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
631891|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
631892|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
631893|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
631894|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631895|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
631896|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631897|NCT03345849|Upadacitinib|upadacitinib|mesh-list
631898|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
631899|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
631900|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631901|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631902|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
631903|NCT03345836|Upadacitinib|upadacitinib|mesh-list
631904|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
631905|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
631906|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631907|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631908|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
631915|NCT03345810|Gemcitabine|gemcitabine|mesh-list
631916|NCT03345810|Paclitaxel|paclitaxel|mesh-list
631917|NCT03345810|Vinorelbine|vinorelbine|mesh-list
631918|NCT03345810|Carboplatin|carboplatin|mesh-list
631919|NCT03345810|Durvalumab|durvalumab|mesh-list
631920|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
631921|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631922|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
631923|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
631924|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
631925|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
631926|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
631927|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
631928|NCT03345810|Antiviral Agents|antiviral agents|mesh-ancestor
631929|NCT03345810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
631930|NCT03345810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
631931|NCT03345810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
631932|NCT03345810|Immunologic Factors|immunologic factors|mesh-ancestor
631933|NCT03345810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631934|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
631935|NCT03345797|Testosterone|testosterone|mesh-list
631936|NCT03345797|Androgens|androgens|mesh-ancestor
631937|NCT03345797|Hormones|hormones|mesh-ancestor
631938|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
631939|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080964|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2080965|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080966|NCT02080468|Norgestimate|norgestimate|mesh-list
2080967|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
631947|NCT03345667|Ranibizumab|ranibizumab|mesh-list
631948|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
631949|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
631950|NCT03345667|Growth Substances|growth substances|mesh-ancestor
631951|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631952|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
631953|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631954|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
631955|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
631956|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631957|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
631958|NCT03345576|Testosterone|testosterone|mesh-list
631959|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
631960|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
631961|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
631962|NCT03345576|Androgens|androgens|mesh-ancestor
631963|NCT03345576|Hormones|hormones|mesh-ancestor
631964|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
631965|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631966|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
631967|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631968|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
631969|NCT03345498|Entecavir|entecavir|mesh-list
631970|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
631971|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219483|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
2219484|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2219485|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2219486|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2219487|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2219488|NCT00036127|Aripiprazole|aripiprazole|mesh-list
2219489|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
2219490|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219491|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2219492|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2219493|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2219494|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219495|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
2219496|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
2219497|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219498|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219499|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2219500|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
631990|NCT03345303|Bortezomib|bortezomib|mesh-list
631991|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
631992|NCT03345173|Ketamine|ketamine|mesh-list
631993|NCT03345173|Analgesics|analgesics|mesh-ancestor
631994|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
631995|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
631996|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
631997|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
631998|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
631999|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
632000|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
632001|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632002|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
632003|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
632004|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
632005|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632006|NCT03345147|Vitamins|vitamins|mesh-list
632007|NCT03345147|Vitamin A|vitamin a|mesh-list
632008|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
632009|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
632010|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632011|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
632012|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632013|NCT03345147|Protective Agents|protective agents|mesh-ancestor
632014|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
632015|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632016|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
632017|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
632018|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632019|NCT03345095|Temozolomide|temozolomide|mesh-list
632020|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
632021|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
632022|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632023|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632024|NCT03345082|Ranibizumab|ranibizumab|mesh-list
632025|NCT03345082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
632026|NCT03345082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
632027|NCT03345082|Growth Substances|growth substances|mesh-ancestor
632028|NCT03345082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632029|NCT03345082|Growth Inhibitors|growth inhibitors|mesh-ancestor
632030|NCT03345082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632031|NCT03345004|Vitamin D|vitamin d|mesh-list
632032|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
632033|NCT03345004|Vitamins|vitamins|mesh-list
632034|NCT03345004|Aluminum sulfate|aluminum sulfate|mesh-list
632035|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
632036|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632037|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
632038|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
632039|NCT03345004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
632040|NCT03345004|Immunologic Factors|immunologic factors|mesh-ancestor
632041|NCT03344965|Olaparib|olaparib|mesh-list
632042|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
632043|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632044|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632045|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632046|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
632047|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
632048|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
632049|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
632050|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
632051|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632052|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
632053|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
632054|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632055|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
632056|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219501|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
2219502|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2219503|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2219504|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2219505|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
632062|NCT03344822|Choline|choline|mesh-list
632063|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
632064|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
632065|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
632066|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
632067|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632068|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
632069|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
632070|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
632071|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
632072|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
632073|NCT03344705|Fludarabine|fludarabine|mesh-list
632074|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
632075|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
632076|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632077|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
632078|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
632079|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
632080|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632081|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632082|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
632083|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
632084|NCT03344679|Adenosine|adenosine|mesh-list
632085|NCT03344679|Bupivacaine|bupivacaine|mesh-list
632086|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
632087|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
632088|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632089|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632090|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
632091|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632092|NCT03344679|Analgesics|analgesics|mesh-ancestor
632093|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
632094|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
632095|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
632096|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
632097|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632098|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
632099|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
632100|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
632101|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
632102|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
632103|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
632104|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
632105|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
632106|NCT03344627|Meropenem|meropenem|mesh-list
632107|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
632108|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632109|NCT03344614|Apatinib|apatinib|mesh-list
632110|NCT03344614|Raltitrexed|raltitrexed|mesh-list
632111|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632112|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
632113|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632114|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632115|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
632116|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
632117|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
632118|NCT03344536|Fulvestrant|fulvestrant|mesh-list
632119|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
632120|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632121|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
632122|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
632123|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
632124|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
632125|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632126|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
632127|NCT03344523|Hematinics|hematinics|mesh-ancestor
2219506|NCT00036153|Methotrexate|methotrexate|mesh-list
2219507|NCT00036153|Tacrolimus|tacrolimus|mesh-list
2219508|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
632131|NCT03344445|Anesthetics|anesthetics|mesh-list
632132|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632133|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632134|NCT03344419|Ketamine|ketamine|mesh-list
632135|NCT03344419|Analgesics|analgesics|mesh-ancestor
632136|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
632137|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632138|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632139|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
632140|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
632141|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
632142|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
632143|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632144|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
632145|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
632146|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
632147|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632148|NCT03344393|Ketamine|ketamine|mesh-list
632149|NCT03344393|Analgesics|analgesics|mesh-ancestor
632150|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
632151|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632152|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632153|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
632154|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
632155|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
632156|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
632157|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632158|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
632159|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
632160|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
632161|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751580|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751581|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2751582|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2751583|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
2751584|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751585|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751586|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
632170|NCT03344328|Bortezomib|bortezomib|mesh-list
632171|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632172|NCT03344302|Oxytocin|oxytocin|mesh-list
632173|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
632174|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
632175|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632176|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
632177|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219509|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
2219510|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2219511|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219512|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2219513|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
2219514|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219515|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219516|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
2219517|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219518|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2219519|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2219520|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
2219521|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219522|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2219523|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2219524|NCT00036166|Micafungin|micafungin|mesh-list
2219525|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
2219526|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219527|NCT00036179|Micafungin|micafungin|mesh-list
2219528|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
2219529|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219530|NCT00036218|Ropinirole|ropinirole|mesh-list
2219531|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2080968|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
2080969|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2080970|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080971|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2080972|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2080973|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2080974|NCT02080637|Ambrisentan|ambrisentan|mesh-list
2080975|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
632210|NCT03344094|Interferons|interferons|mesh-list
632211|NCT03344094|Interferon-beta|interferon-beta|mesh-list
632212|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
632213|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632214|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
632215|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632216|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
632217|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632218|NCT03344042|Fentanyl|fentanyl|mesh-list
632219|NCT03344042|Sufentanil|sufentanil|mesh-list
632220|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
632221|NCT03344042|Narcotics|narcotics|mesh-ancestor
632222|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632223|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632224|NCT03344042|Analgesics|analgesics|mesh-ancestor
632225|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
632226|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632227|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
632228|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
632229|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
632230|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
632231|NCT03344029|Vaccines|vaccines|mesh-list
632232|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
632233|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632234|NCT03344003|Factor VIII|factor viii|mesh-list
632235|NCT03344003|Coagulants|coagulants|mesh-ancestor
632236|NCT03343977|Docetaxel|docetaxel|mesh-list
632237|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632238|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
632239|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
632240|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
632241|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632242|NCT03343873|Midazolam|midazolam|mesh-list
632243|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
632244|NCT03343873|Propofol|propofol|mesh-list
632245|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
632246|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632247|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632248|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
632249|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
632250|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
632251|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
632252|NCT03343873|Analgesics|analgesics|mesh-ancestor
632253|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
632254|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632255|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
632256|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
632257|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
632258|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
632259|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080976|NCT02080780|Clarithromycin|clarithromycin|mesh-list
2219532|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
632260|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632261|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
632262|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
632263|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
632264|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
632265|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
632266|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
632267|NCT03343795|Progesterone|progesterone|mesh-list
632268|NCT03343795|Progestins|progestins|mesh-ancestor
632269|NCT03343795|Hormones|hormones|mesh-ancestor
632270|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
632271|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632272|NCT03343678|Venetoclax|venetoclax|mesh-list
632273|NCT03343678|BI 836826|bi 836826|mesh-list
632274|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632275|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
632276|NCT03343665|Nivolumab|nivolumab|mesh-list
632277|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
632278|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632279|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
632280|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632281|NCT03343652|Nivolumab|nivolumab|mesh-list
632282|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
632283|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
632284|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632285|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
632286|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632287|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
632288|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
2219533|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
2219534|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
2219535|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219536|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219537|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632294|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
632295|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632296|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
632297|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632298|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632299|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
632300|NCT03343548|Analgesics|analgesics|mesh-ancestor
632301|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
632302|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632303|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632304|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
632305|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632306|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
632307|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
632308|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
632309|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
632310|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632311|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
632312|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
632313|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
632314|NCT03343509|Metronidazole|metronidazole|mesh-list
632315|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632316|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
632317|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
632318|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
632319|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
632320|NCT03343444|Ledipasvir|ledipasvir|mesh-list
632321|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
632322|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632323|NCT03343431|Tenofovir|tenofovir|mesh-list
632324|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
632325|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632326|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
632327|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
632328|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632329|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632330|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
632331|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
632332|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
632333|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
2219538|NCT00036231|Secretin|secretin|mesh-list
632334|NCT03343418|Coagulants|coagulants|mesh-ancestor
632335|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
632336|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
632337|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632338|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
632339|NCT03343366|Metronidazole|metronidazole|mesh-list
632340|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632341|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
632342|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
632343|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
632344|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
632345|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632346|NCT03343197|Ivosidenib|ivosidenib|mesh-list
632347|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632348|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632349|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219539|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219540|NCT00036231|Hormones|hormones|mesh-ancestor
2219541|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2219542|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219543|NCT00036244|Secretin|secretin|mesh-list
2219544|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219545|NCT00036244|Hormones|hormones|mesh-ancestor
2219546|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2219547|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219548|NCT00036283|Celecoxib|celecoxib|mesh-list
2219549|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2219550|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2219551|NCT00036283|Analgesics|analgesics|mesh-ancestor
2219552|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
2219553|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219554|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219555|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2219556|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219557|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2219558|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2219559|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219560|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219561|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2219562|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2219563|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2219564|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
632376|NCT03343054|Talazoparib|talazoparib|mesh-list
632377|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
632378|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632379|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632380|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632381|NCT03343002|Fentanyl|fentanyl|mesh-list
632382|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
632383|NCT03343002|Narcotics|narcotics|mesh-ancestor
632384|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632385|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632386|NCT03343002|Analgesics|analgesics|mesh-ancestor
632387|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
632388|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632389|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
632390|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
632391|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
632392|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
2219565|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219566|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219567|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219568|NCT00036309|Analgesics|analgesics|mesh-ancestor
2219569|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
2219570|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219571|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
2219572|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219573|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
2219574|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2219575|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2219576|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2219577|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2273737|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2219578|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219579|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219580|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219581|NCT00036335|Analgesics|analgesics|mesh-ancestor
2219582|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
2219583|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080977|NCT02080780|Diltiazem|diltiazem|mesh-list
2080978|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2080979|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2080980|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2080981|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2080982|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080983|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2219584|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
632423|NCT03342911|Paclitaxel|paclitaxel|mesh-list
632424|NCT03342911|Carboplatin|carboplatin|mesh-list
632425|NCT03342911|Nivolumab|nivolumab|mesh-list
632426|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
632427|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632428|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
632429|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
632430|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
632431|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632432|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
632433|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
632434|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
632435|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
632436|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
632437|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
632438|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632439|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
632440|NCT03342807|Insulin|insulin|mesh-list
632441|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
632442|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219585|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219586|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
2219587|NCT00036348|Aripiprazole|aripiprazole|mesh-list
2219588|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
2219589|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219590|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2219591|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2219592|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2219593|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632452|NCT03342651|Vitamin D|vitamin d|mesh-list
632453|NCT03342651|Vitamins|vitamins|mesh-ancestor
632454|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
632455|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632456|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2219594|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
2219595|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
2219596|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219597|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219598|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2219599|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2219600|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
2219601|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2219602|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2219603|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2219604|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2219605|NCT00036361|Aripiprazole|aripiprazole|mesh-list
2219606|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
2219607|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219608|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2219609|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2219610|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2219611|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219612|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
2219613|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
2219614|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219615|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219616|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
632481|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
632482|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
632483|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632484|NCT03342599|Protective Agents|protective agents|mesh-ancestor
632485|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632486|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
632487|NCT03342599|Vitamins|vitamins|mesh-ancestor
632488|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
632489|NCT03342456|Amoxicillin|amoxicillin|mesh-list
632490|NCT03342456|Doxycycline|doxycycline|mesh-list
632491|NCT03342456|Furazolidone|furazolidone|mesh-list
632492|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
632493|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632494|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
632495|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632496|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
632497|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
632498|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
632499|NCT03342456|Diuretics|diuretics|mesh-ancestor
632500|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
632501|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632502|NCT03342456|Expectorants|expectorants|mesh-ancestor
632503|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
632504|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
632505|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
632506|NCT03342456|Renal Agents|renal agents|mesh-ancestor
632507|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
632508|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
632509|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632510|NCT03342443|Memantine|memantine|mesh-list
632511|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
632512|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
632513|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
632514|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
632515|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632516|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632517|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
632518|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2080984|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2080985|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2080986|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2080987|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2080988|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2080989|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080990|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
632527|NCT03342352|Carboplatin|carboplatin|mesh-list
632528|NCT03342352|Fluorouracil|fluorouracil|mesh-list
632529|NCT03342352|Nivolumab|nivolumab|mesh-list
632530|NCT03342352|Cetuximab|cetuximab|mesh-list
632531|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632532|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
632533|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632534|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
632535|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
632536|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
632537|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632538|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
632539|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
632540|NCT03342300|Doxorubicin|doxorubicin|mesh-list
632541|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
632542|NCT03342300|Pirarubicin|pirarubicin|mesh-list
632543|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
632544|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632545|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
632546|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
632547|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632548|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632549|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
632550|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632564|NCT03342170|Thrombin|thrombin|mesh-list
632565|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
632566|NCT03342170|Coagulants|coagulants|mesh-ancestor
2219617|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2219618|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
2219619|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2219620|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2219621|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
632572|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
632573|NCT03342079|Anesthetics|anesthetics|mesh-list
632574|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
632575|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632576|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632577|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
632578|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632579|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
632580|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
632581|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
632582|NCT03342079|Analgesics|analgesics|mesh-ancestor
632583|NCT03342040|Bupivacaine|bupivacaine|mesh-list
632584|NCT03342040|Ropivacaine|ropivacaine|mesh-list
632585|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
632586|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
632587|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632588|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632589|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
632590|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2080991|NCT02080819|Levodopa|levodopa|mesh-list
2080992|NCT02080819|Carbidopa|carbidopa|mesh-list
2080993|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2080994|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2080995|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
2080996|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2080997|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2080998|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2080999|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2081000|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081001|NCT02080832|Dexetimide|dexetimide|mesh-list
2081002|NCT02080832|Citalopram|citalopram|mesh-list
2081003|NCT02080832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2081004|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2219622|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2219623|NCT00036374|Infliximab|infliximab|mesh-list
2219624|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
2219625|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219626|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219627|NCT00036387|Infliximab|infliximab|mesh-list
2219628|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
2219629|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
632613|NCT03341988|Ritonavir|ritonavir|mesh-list
632614|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
632615|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
632616|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
632617|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632618|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632619|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
632620|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
632621|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
632622|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632623|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
632624|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2081005|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2081006|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081007|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
632628|NCT03341936|Nivolumab|nivolumab|mesh-list
632629|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
632630|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632631|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
632632|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219630|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219631|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
2219632|NCT00036400|Hematinics|hematinics|mesh-ancestor
2219633|NCT00036439|Infliximab|infliximab|mesh-list
2081008|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
2219634|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
2219635|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219636|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219637|NCT00036452|Ritonavir|ritonavir|mesh-list
632641|NCT03341845|Avelumab|avelumab|mesh-list
632642|NCT03341845|Axitinib|axitinib|mesh-list
632643|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
632644|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632645|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
632646|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632647|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632651|NCT03341767|Clofazimine|clofazimine|mesh-list
632652|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
632653|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
632654|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
632655|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632656|NCT03341741|Tobramycin|tobramycin|mesh-list
632657|NCT03341741|Colistin|colistin|mesh-list
632658|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
632659|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632660|NCT03341689|Psilocybin|psilocybin|mesh-list
632661|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
632662|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632663|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
632664|NCT03341676|Dexamethasone|dexamethasone|mesh-list
632665|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
632666|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
632667|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
632668|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632669|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632670|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
632671|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
632672|NCT03341676|Hormones|hormones|mesh-ancestor
632673|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
632674|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
632675|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632676|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
632677|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
632678|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632679|NCT03341494|Thalidomide|thalidomide|mesh-list
632680|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
632681|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
632682|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632683|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
632684|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
632685|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632686|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
632687|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
632688|NCT03341494|Growth Substances|growth substances|mesh-ancestor
632689|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
632690|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632691|NCT03341429|Liraglutide|liraglutide|mesh-list
632692|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
632693|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632694|NCT03341429|Incretins|incretins|mesh-ancestor
632695|NCT03341429|Hormones|hormones|mesh-ancestor
632696|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
632697|NCT03341390|Aspirin|aspirin|mesh-list
632698|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
632699|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
632700|NCT03341390|Analgesics|analgesics|mesh-ancestor
632701|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
632702|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632703|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632704|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
632705|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
632706|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
632707|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
632708|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632709|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
632710|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
632711|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632712|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
2219638|NCT00036452|Lopinavir|lopinavir|mesh-list
2219639|NCT00036452|Tenofovir|tenofovir|mesh-list
2219640|NCT00036452|Emtricitabine|emtricitabine|mesh-list
2219641|NCT00036452|Stavudine|stavudine|mesh-list
2219642|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2219643|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2219644|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
2219645|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219646|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632722|NCT03341260|Diclofenac|diclofenac|mesh-list
632723|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
632724|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
632725|NCT03341260|Analgesics|analgesics|mesh-ancestor
632726|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
632727|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632728|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632729|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
632730|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
632731|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
632732|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632733|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632734|NCT03341234|Bupivacaine|bupivacaine|mesh-list
632735|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
632736|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
632737|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632738|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632739|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
632740|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081009|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081010|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2081011|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
632747|NCT03341117|Aspirin|aspirin|mesh-list
632748|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
632749|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
632750|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
632751|NCT03341117|Analgesics|analgesics|mesh-ancestor
632752|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
632753|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632754|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632755|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
632756|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
632757|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
632758|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
632759|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632760|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
632761|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
632762|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632763|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
632764|NCT03341117|Antacids|antacids|mesh-ancestor
632765|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
632766|NCT03341104|Bupivacaine|bupivacaine|mesh-list
632767|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
632768|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
632769|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632770|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632771|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
632772|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219647|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2219648|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2219649|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
2219650|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219651|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
632796|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
632797|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
632798|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632799|NCT03340909|Prednisolone|prednisolone|mesh-list
632800|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
632801|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
632802|NCT03340909|Hormones|hormones|mesh-ancestor
632803|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
632804|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632805|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
632806|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632807|NCT03340896|Docetaxel|docetaxel|mesh-list
632808|NCT03340896|Fluorouracil|fluorouracil|mesh-list
632809|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632810|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
632811|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
632812|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
632813|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632814|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
632815|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
632816|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
632817|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
632818|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632819|NCT03340779|Dobutamine|dobutamine|mesh-list
632820|NCT03340779|Norepinephrine|norepinephrine|mesh-list
632821|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
632822|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
632823|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
632824|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
632825|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632826|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632827|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
632828|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
632829|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632830|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
632831|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
632832|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
632833|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
632834|NCT03340779|Protective Agents|protective agents|mesh-ancestor
632835|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
632836|NCT03340766|Blinatumomab|blinatumomab|mesh-list
632837|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
632838|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632839|NCT03340753|Mineralocorticoids|mineralocorticoids|mesh-list
632840|NCT03340753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
632841|NCT03340753|Hormones|hormones|mesh-ancestor
632842|NCT03340753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
632843|NCT03340753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632844|NCT03340753|Hormone Antagonists|hormone antagonists|mesh-ancestor
632845|NCT03340753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
632846|NCT03340753|Diuretics|diuretics|mesh-ancestor
632847|NCT03340753|Natriuretic Agents|natriuretic agents|mesh-ancestor
632848|NCT03340740|Cetirizine|cetirizine|mesh-list
632849|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
632850|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
632851|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
632852|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
632853|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
632854|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
632855|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632856|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632868|NCT03340701|Progesterone|progesterone|mesh-list
632869|NCT03340701|Progestins|progestins|mesh-ancestor
632870|NCT03340701|Hormones|hormones|mesh-ancestor
632871|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
632872|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632873|NCT03340675|Ifetroban|ifetroban|mesh-list
632874|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
632875|NCT03340662|Itraconazole|itraconazole|mesh-list
632876|NCT03340662|Rifampin|rifampin|mesh-list
632877|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
632878|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
632879|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632880|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
632881|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
632882|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632883|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632884|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
632885|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
632886|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
632887|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632888|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
632889|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
632890|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
632891|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
632892|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
632893|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
632894|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
632895|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
632896|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
632897|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
632898|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
632899|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
632900|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
632901|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
632902|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
632903|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
632904|NCT03340662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
632905|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
632906|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
632907|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
632908|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
632909|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
632910|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
632911|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
632912|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
632913|NCT03340597|Olorofim|olorofim|mesh-list
632914|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
632915|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
632916|NCT03340558|Atezolizumab|atezolizumab|mesh-list
632917|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081012|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2081013|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2081014|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2081015|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
2081016|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
2081017|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
632924|NCT03340493|Tenecteplase|tenecteplase|mesh-list
632925|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
632926|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
632927|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632928|NCT03340376|Doxorubicin|doxorubicin|mesh-list
632929|NCT03340376|Atezolizumab|atezolizumab|mesh-list
632930|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
632931|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632932|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
632933|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
632934|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632935|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219652|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2219653|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
632939|NCT03340168|Bisphenol A|bisphenol a|mesh-list
632940|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
632941|NCT03340168|Estrogens|estrogens|mesh-ancestor
632942|NCT03340168|Hormones|hormones|mesh-ancestor
632943|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
632944|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632945|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
632946|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
632947|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632948|NCT03340168|Protective Agents|protective agents|mesh-ancestor
632949|NCT03340129|Nivolumab|nivolumab|mesh-list
632950|NCT03340129|Ipilimumab|ipilimumab|mesh-list
632951|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
632952|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632953|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
632954|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632955|NCT03340064|Levetiracetam|levetiracetam|mesh-list
632956|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
632957|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
632958|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
632959|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
632960|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
632961|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632962|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
632963|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
632964|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632965|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
632966|NCT03339804|Doxorubicin|doxorubicin|mesh-list
632967|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
632968|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
632969|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
632970|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
632971|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
632972|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
632973|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632974|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
632975|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
632976|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
632977|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
632978|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
632979|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
632980|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
632981|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
632982|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
632983|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
632984|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
632985|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
632986|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
632987|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219654|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2219655|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
2219656|NCT00036491|Rituximab|rituximab|mesh-list
2219657|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2219658|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219659|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
2219660|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219661|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219662|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
2219663|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2219664|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219665|NCT00036543|Atrasentan|atrasentan|mesh-list
2219666|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219667|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2219668|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2219669|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219670|NCT00036556|Atrasentan|atrasentan|mesh-list
633006|NCT03339700|Gemcitabine|gemcitabine|mesh-list
633007|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
633008|NCT03339700|Busulfan|busulfan|mesh-list
633009|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
633010|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
633011|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633012|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
633013|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
633014|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
633015|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633016|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633017|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
633018|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
633019|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
633020|NCT03339700|Antiviral Agents|antiviral agents|mesh-ancestor
633021|NCT03339700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
633022|NCT03339700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
633023|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
633024|NCT03339635|Testosterone|testosterone|mesh-list
633025|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
633026|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
633027|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
633028|NCT03339635|Androgens|androgens|mesh-ancestor
633029|NCT03339635|Hormones|hormones|mesh-ancestor
633030|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
633031|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633032|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
633033|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633034|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
633035|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
633036|NCT03339596|Hematinics|hematinics|mesh-ancestor
2219671|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219672|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2219673|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2219674|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633041|NCT03339544|Celecoxib|celecoxib|mesh-list
633042|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
633043|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
633044|NCT03339544|Analgesics|analgesics|mesh-ancestor
633045|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
633046|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633047|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633048|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
633049|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
633050|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
633051|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
633052|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
633053|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219675|NCT00036582|Clozapine|clozapine|mesh-list
2219676|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2219677|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
2219678|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2219679|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219680|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219681|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
633061|NCT03339427|Vitamin D|vitamin d|mesh-list
633062|NCT03339427|Vitamins|vitamins|mesh-ancestor
633063|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
633064|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633065|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2219682|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
633069|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
633070|NCT03339362|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
633071|NCT03339362|Bupivacaine|bupivacaine|mesh-list
633072|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
633073|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
633074|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633075|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633076|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
633077|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633078|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
633079|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
633080|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
633081|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
633082|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
633083|NCT03339362|Hormones|hormones|mesh-ancestor
633084|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
633085|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
633086|NCT03339362|Protective Agents|protective agents|mesh-ancestor
633087|NCT03339349|Enoxaparin|enoxaparin|mesh-list
633088|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
633089|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
633090|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
633091|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219683|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2219684|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219685|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
2219686|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
2219687|NCT00036608|Entecavir|entecavir|mesh-list
633120|NCT03339258|Doxazosin|doxazosin|mesh-list
633121|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
633122|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
633123|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
633124|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
633125|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
633126|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
633127|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633128|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219688|NCT00036608|Antiviral Agents|antiviral agents|mesh-ancestor
2081018|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2081019|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
633132|NCT03339024|Oxytocin|oxytocin|mesh-list
633133|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
633134|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
633135|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081020|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
2081021|NCT02081001|Glucagon|glucagon|mesh-list
2081022|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2081023|NCT02081001|Hormones|hormones|mesh-ancestor
2081024|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081025|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081026|NCT02081014|Glucagon|glucagon|mesh-list
633143|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
633144|NCT03338972|Fludarabine|fludarabine|mesh-list
633145|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
633146|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
633147|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633148|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
633149|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
633150|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
633151|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633152|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633153|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2081027|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2081028|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2081029|NCT02081014|Hormones|hormones|mesh-ancestor
2081030|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081031|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081032|NCT02081014|Incretins|incretins|mesh-ancestor
2081033|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
2219689|NCT00036608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081034|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2081035|NCT02081079|Ledipasvir|ledipasvir|mesh-list
2219690|NCT00036634|Tenofovir|tenofovir|mesh-list
2219691|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
2219692|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219693|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2219694|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2219695|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219696|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219697|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2219698|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2219699|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2219700|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219701|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2219702|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219703|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219704|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
633180|NCT03338790|Prednisone|prednisone|mesh-list
633181|NCT03338790|Docetaxel|docetaxel|mesh-list
633182|NCT03338790|Nivolumab|nivolumab|mesh-list
633183|NCT03338790|Rucaparib|rucaparib|mesh-list
633184|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633185|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
633186|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
633187|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
633188|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633189|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
633190|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
633191|NCT03338790|Hormones|hormones|mesh-ancestor
633192|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
633193|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633194|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
633195|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
633196|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
633197|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
633198|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081036|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
2081037|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
633206|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
633207|NCT03338621|Rifampin|rifampin|mesh-list
633208|NCT03338621|Isoniazid|isoniazid|mesh-list
633209|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
633210|NCT03338621|Ethambutol|ethambutol|mesh-list
633211|NCT03338621|Bedaquiline|bedaquiline|mesh-list
633212|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
633213|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
633214|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
633215|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
633216|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
633217|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633218|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633219|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
633220|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
633221|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
633222|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
633223|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
633224|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
633225|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
633226|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
633227|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
633228|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
633229|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
633230|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
633231|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
633232|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2219705|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219706|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2219707|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219708|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219709|NCT00036764|Epothilones|epothilones|mesh-list
2219710|NCT00036764|Epothilone B|epothilone b|mesh-list
2219711|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
633240|NCT03338426|Atorvastatin|atorvastatin|mesh-list
633241|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
633242|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
633243|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
633244|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633245|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
633246|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
633247|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219712|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
2219713|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
2219714|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219715|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219716|NCT00036777|Carboplatin|carboplatin|mesh-list
2219717|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2219718|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219719|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2219720|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219721|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219722|NCT00036790|Doxorubicin|doxorubicin|mesh-list
2219723|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
633260|NCT03338387|Acipimox|acipimox|mesh-list
633261|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
633262|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
633263|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633264|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
633265|NCT03338348|Azacitidine|azacitidine|mesh-list
633266|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
633267|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
633268|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633269|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633270|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
633271|NCT03338244|Azithromycin|azithromycin|mesh-list
633272|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
633273|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
633274|NCT03338205|Ketamine|ketamine|mesh-list
633275|NCT03338205|Analgesics|analgesics|mesh-ancestor
633276|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
633277|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633278|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633279|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
633280|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
633281|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
633282|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
633283|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633284|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
633285|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
633286|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
633287|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219724|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
2219725|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2219726|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219727|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2219728|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2219729|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219730|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219731|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2219732|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
2219733|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
633298|NCT03337932|Doxycycline|doxycycline|mesh-list
633299|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
633300|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
633301|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
633302|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
633303|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
633304|NCT03337919|Nivolumab|nivolumab|mesh-list
633305|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
633306|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633307|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
633308|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633309|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
633310|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2219734|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633311|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633312|NCT03337828|Ethanol|ethanol|mesh-list
633313|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
633314|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
633315|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633316|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081053|NCT02081443|Ticagrelor|ticagrelor|mesh-list
2081054|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2081055|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2081056|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2081057|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2081058|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
2081059|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081060|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081061|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081062|NCT02081599|Insulin|insulin|mesh-list
2081063|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2081064|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081065|NCT02081638|Aspirin|aspirin|mesh-list
2081066|NCT02081638|Atorvastatin|atorvastatin|mesh-list
2081067|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2081068|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2081069|NCT02081638|Analgesics|analgesics|mesh-ancestor
2081070|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
2081071|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081072|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081073|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081074|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2081075|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2081076|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2081077|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633361|NCT03337672|Midazolam|midazolam|mesh-list
633362|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
633363|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
633364|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633365|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633366|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
633367|NCT03337672|Analgesics|analgesics|mesh-ancestor
633368|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
633369|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633370|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
633371|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
633372|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
633373|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
633374|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
633375|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633376|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
633377|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
633378|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
633379|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
633380|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
633381|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
633382|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
633383|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
633384|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
633385|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
633386|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
633387|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633388|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
633389|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
633390|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
633391|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633392|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
633393|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
633394|NCT03337607|Celecoxib|celecoxib|mesh-list
633395|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
633396|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
633397|NCT03337607|Eperisone|eperisone|mesh-list
633398|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
633399|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
633400|NCT03337607|Analgesics|analgesics|mesh-ancestor
633401|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
633402|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633403|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633404|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
633405|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
633406|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
633407|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
633408|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633409|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
633410|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
633411|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
633412|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
633413|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
633414|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
633415|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
633416|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
633421|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
633422|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
633423|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633424|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633425|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
633426|NCT03337581|Analgesics|analgesics|mesh-ancestor
633427|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
633428|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633429|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
633430|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
633431|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
633432|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
633433|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
633434|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633435|NCT03337529|Ascorbic Acid|ascorbic acid|mesh-list
633436|NCT03337529|Vitamins|vitamins|mesh-ancestor
633437|NCT03337529|Micronutrients|micronutrients|mesh-ancestor
633438|NCT03337529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633439|NCT03337529|Antioxidants|antioxidants|mesh-ancestor
633440|NCT03337529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633441|NCT03337529|Protective Agents|protective agents|mesh-ancestor
633442|NCT03337503|Dronabinol|dronabinol|mesh-list
633443|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
633444|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633445|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
633446|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
633447|NCT03337503|Analgesics|analgesics|mesh-ancestor
633448|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
633449|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633450|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
633451|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
633452|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
633453|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633454|NCT03337503|Hormones|hormones|mesh-ancestor
633455|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2219735|NCT00036855|Rituximab|rituximab|mesh-list
2219736|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2219737|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2219738|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219739|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
633463|NCT03337373|Cisatracurium|cisatracurium|mesh-list
633464|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
633465|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
633466|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633467|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219740|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219741|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219742|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
2219743|NCT00036868|Fluorouracil|fluorouracil|mesh-list
2219744|NCT00036868|Methotrexate|methotrexate|mesh-list
2219745|NCT00036868|Trastuzumab|trastuzumab|mesh-list
2219746|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2219747|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
2219748|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219749|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
633478|NCT03337282|Anesthetics|anesthetics|mesh-list
633479|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633480|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633481|NCT03337191|Morphine|morphine|mesh-list
633482|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
633483|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
633484|NCT03337191|Narcotics|narcotics|mesh-ancestor
633485|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633486|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633487|NCT03337191|Analgesics|analgesics|mesh-ancestor
633488|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
633489|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633490|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
633491|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
2081078|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2081079|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2081080|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081081|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
2081082|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2081083|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2081084|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
2219750|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
633500|NCT03337126|Metronidazole|metronidazole|mesh-list
633501|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
633502|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
633503|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
633504|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
633505|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
633506|NCT03337087|Leucovorin|leucovorin|mesh-list
633507|NCT03337087|Folic Acid|folic acid|mesh-list
633508|NCT03337087|Fluorouracil|fluorouracil|mesh-list
633509|NCT03337087|Irinotecan|irinotecan|mesh-list
633510|NCT03337087|Rucaparib|rucaparib|mesh-list
633511|NCT03337087|Calcium|calcium|mesh-list
633512|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
633513|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
633514|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633515|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
633516|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
633517|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633518|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
633519|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633520|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
633521|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
633522|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
633523|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
633524|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
633525|NCT03337087|Antidotes|antidotes|mesh-ancestor
633526|NCT03337087|Protective Agents|protective agents|mesh-ancestor
633527|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
633528|NCT03337087|Vitamins|vitamins|mesh-ancestor
633529|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
633530|NCT03337087|Hematinics|hematinics|mesh-ancestor
633531|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
633532|NCT03337035|Oxytocin|oxytocin|mesh-list
633533|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
633534|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
633535|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633536|NCT03337009|Naloxone|naloxone|mesh-list
633537|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
633538|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633539|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
633540|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633541|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
633542|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
633543|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633544|NCT03336970|Calcium|calcium|mesh-list
633545|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
633546|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633547|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
633548|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633549|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
633550|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
633551|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
633552|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
633553|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
633554|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633555|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219751|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
2219752|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219753|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219754|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
633560|NCT03336840|Metformin|metformin|mesh-list
633561|NCT03336840|Promethazine|promethazine|mesh-list
633562|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
633563|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
633564|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633565|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
633566|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
633567|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
633568|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
633569|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
633570|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
633571|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633572|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
633573|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
633574|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
633575|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633576|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
633577|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
633578|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
633579|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633580|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
633581|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
633582|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
633583|NCT03336814|Terlipressin|terlipressin|mesh-list
633584|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
633585|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
633586|NCT03336801|Propofol|propofol|mesh-list
633587|NCT03336801|Sevoflurane|sevoflurane|mesh-list
633588|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
633589|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633590|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633591|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
633592|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
633593|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
633594|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
633595|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2219755|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
2219756|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2219757|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2219758|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
2219759|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2219760|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
2219761|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219762|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2219763|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2219764|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2219765|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
2219766|NCT00036881|Astringents|astringents|mesh-ancestor
2219767|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219768|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
633611|NCT03336632|Cyclosporine|cyclosporine|mesh-list
633612|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
633613|NCT03336632|Cyclosporins|cyclosporins|mesh-list
633614|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
633615|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
633616|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633617|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
633618|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
633619|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
633620|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633621|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633622|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
633623|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
633624|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
633625|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
633626|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
633627|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
633628|NCT03336619|Nitazoxanide|nitazoxanide|mesh-list
633629|NCT03336619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
633630|NCT03336619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
633631|NCT03336593|Vaccines|vaccines|mesh-list
633632|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
633633|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751616|NCT03905902|Vaccines|vaccines|mesh-list
2751617|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
2751618|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633648|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
633649|NCT03336528|Insulin, Long-Acting|insulin, long-acting|mesh-list
633650|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
633651|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219769|NCT00036894|Lenalidomide|lenalidomide|mesh-list
2219770|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
2219771|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219772|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2219773|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2219774|NCT00036894|Growth Substances|growth substances|mesh-ancestor
2219775|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
2219776|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219777|NCT00036946|Aflibercept|aflibercept|mesh-list
2219778|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2219779|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2219780|NCT00036946|Growth Substances|growth substances|mesh-ancestor
2219781|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219782|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
2219783|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219784|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
2219785|NCT00036985|Doxorubicin|doxorubicin|mesh-list
2219786|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2219787|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2219788|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
2219789|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219790|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219791|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2219792|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
2219793|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219794|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219795|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2219796|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2219797|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
633681|NCT03336437|Estradiol|estradiol|mesh-list
633682|NCT03336437|Estrogens|estrogens|mesh-ancestor
633683|NCT03336437|Hormones|hormones|mesh-ancestor
633684|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
633685|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633686|NCT03336398|Ketamine|ketamine|mesh-list
633687|NCT03336398|Analgesics|analgesics|mesh-ancestor
633688|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
633689|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633690|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633691|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2789037|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
633692|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
633693|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
633694|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
633695|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633696|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
633697|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
633698|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
633699|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633700|NCT03336346|Efavirenz|efavirenz|mesh-list
633701|NCT03336346|Dolutegravir|dolutegravir|mesh-list
633702|NCT03336346|Etonogestrel|etonogestrel|mesh-list
633703|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
633704|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
633705|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
633706|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633707|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
633708|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
633709|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
633710|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
633711|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
633712|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
633713|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
633714|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
633715|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
633716|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
633717|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
633718|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
633719|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
633720|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
633721|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
633722|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633723|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2081085|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2081086|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2081087|NCT02081690|Macitentan|macitentan|mesh-list
2081088|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2081089|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2081090|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081091|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2081092|NCT02081950|Enoxaparin|enoxaparin|mesh-list
2081093|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
2081094|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
2081095|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2081096|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2081097|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081098|NCT02081963|Amikacin|amikacin|mesh-list
633738|NCT03336281|Ustekinumab|ustekinumab|mesh-list
633739|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
633740|NCT03336242|Cannabidiol|cannabidiol|mesh-list
633741|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
2751630|NCT03889743|Dexamethasone|dexamethasone|mesh-list
2751631|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2751632|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
2751633|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
2751634|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2751635|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751636|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2751637|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
2751638|NCT03889743|Hormones|hormones|mesh-ancestor
2751639|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2751640|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2751641|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751642|NCT03889275|Durvalumab|durvalumab|mesh-list
2751643|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2751644|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751653|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
2751654|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2751655|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751664|NCT03869892|Trifluridine|trifluridine|mesh-list
2751665|NCT03869892|Bevacizumab|bevacizumab|mesh-list
633783|NCT03336125|Vitamin D|vitamin d|mesh-list
633784|NCT03336125|Vitamins|vitamins|mesh-ancestor
633785|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
633786|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633787|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
633788|NCT03336073|Dexamethasone|dexamethasone|mesh-list
633789|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
633790|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
633791|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
633792|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633793|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
633794|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
633795|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
633796|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633797|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633798|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
633799|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
633800|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
633801|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
633802|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633803|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
633804|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
633805|NCT03336073|Hormones|hormones|mesh-ancestor
633806|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
633807|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
633808|NCT03335956|Pioglitazone|pioglitazone|mesh-list
633809|NCT03335956|Prednisone|prednisone|mesh-list
633810|NCT03335956|Cortisone|cortisone|mesh-list
633811|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
633812|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
633813|NCT03335956|Hormones|hormones|mesh-ancestor
633814|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
633815|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633816|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
633817|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633818|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
633819|NCT03335904|Losartan|losartan|mesh-list
633820|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
633821|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
633822|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
633823|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
633824|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633825|NCT03335839|Plasminogen|plasminogen|mesh-list
633826|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
633827|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
633828|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
633829|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633830|NCT03335826|Anesthetics|anesthetics|mesh-list
633831|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633832|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633833|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
633834|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
633835|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
633836|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
633837|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
633838|NCT03335579|Sufentanil|sufentanil|mesh-list
633839|NCT03335579|Remifentanil|remifentanil|mesh-list
633840|NCT03335579|Propofol|propofol|mesh-list
633841|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
633842|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633843|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633844|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
633845|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
633846|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
633847|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
633848|NCT03335579|Narcotics|narcotics|mesh-ancestor
633849|NCT03335579|Analgesics|analgesics|mesh-ancestor
633850|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
633851|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633852|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
633853|NCT03335540|Nivolumab|nivolumab|mesh-list
633854|NCT03335540|Ipilimumab|ipilimumab|mesh-list
633855|NCT03335540|Linrodostat|linrodostat|mesh-list
633856|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
633857|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633858|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
633859|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633860|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
633861|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
633862|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
633863|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633864|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633865|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
633866|NCT03335527|Analgesics|analgesics|mesh-ancestor
633867|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
633868|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633869|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
633870|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
633871|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
633872|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
633873|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
633874|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633875|NCT03335501|Pancrelipase|pancrelipase|mesh-list
633876|NCT03335501|Hormones|hormones|mesh-list
633877|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633878|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
633879|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
633880|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
633881|NCT03335488|Glycerol|glycerol|mesh-list
633882|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
633883|NCT03335488|Protective Agents|protective agents|mesh-ancestor
633884|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633885|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633886|NCT03335436|Gabapentin|gabapentin|mesh-list
633887|NCT03335436|Analgesics|analgesics|mesh-ancestor
633888|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
633889|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633890|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633891|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
633892|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
633893|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
633894|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633895|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
633896|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
633897|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
633898|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
633899|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633900|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
633901|NCT03335423|Metformin|metformin|mesh-list
633902|NCT03335423|Codeine|codeine|mesh-list
633903|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
633904|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633905|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
633906|NCT03335423|Narcotics|narcotics|mesh-ancestor
633907|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
633908|NCT03335423|Analgesics|analgesics|mesh-ancestor
633909|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
633910|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633911|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
633912|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
633913|NCT03335293|Epinephrine|epinephrine|mesh-list
633914|NCT03335293|Racepinephrine|racepinephrine|mesh-list
633915|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
633916|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
633917|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
633918|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
633919|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
633920|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633921|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633922|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
633923|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
633924|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
633925|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633926|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
633927|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
633928|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
633929|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
633930|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
633931|NCT03335241|Doxorubicin|doxorubicin|mesh-list
633932|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
633933|NCT03335241|Fludarabine|fludarabine|mesh-list
633934|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
633935|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633936|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
633937|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
633938|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
633939|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633940|NCT03335163|Topiramate|topiramate|mesh-list
633941|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
633942|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
633943|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633944|NCT03335124|Vitamins|vitamins|mesh-list
633945|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
633946|NCT03335124|Thiamine|thiamine|mesh-list
633947|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
633948|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
633949|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633950|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
633951|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
633952|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633953|NCT03335124|Protective Agents|protective agents|mesh-ancestor
633954|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
633955|NCT03335098|Thalidomide|thalidomide|mesh-list
633956|NCT03335098|Dexamethasone|dexamethasone|mesh-list
633957|NCT03335098|Bortezomib|bortezomib|mesh-list
633958|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
633959|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
633960|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
633961|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633962|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633963|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
633964|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
633965|NCT03335098|Hormones|hormones|mesh-ancestor
633966|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
633967|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
633968|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633969|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
633970|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
633971|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
633972|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
633973|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
633974|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
633975|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
633976|NCT03335098|Growth Substances|growth substances|mesh-ancestor
633977|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
633978|NCT03335085|Oxytocin|oxytocin|mesh-list
633979|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
633980|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
633981|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
633982|NCT03335072|Azithromycin|azithromycin|mesh-list
633983|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
633984|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
633985|NCT03335059|Mitomycins|mitomycins|mesh-list
633986|NCT03335059|Mitomycin|mitomycin|mesh-list
633987|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
633988|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
633989|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
633990|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
633991|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
633992|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
633993|NCT03335007|Aceclofenac|aceclofenac|mesh-list
633994|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
633995|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
633996|NCT03335007|Analgesics|analgesics|mesh-ancestor
633997|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
633998|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
633999|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634000|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
634001|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
634002|NCT03334981|Buprenorphine|buprenorphine|mesh-list
634003|NCT03334981|Methadone|methadone|mesh-list
634004|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
634005|NCT03334981|Narcotics|narcotics|mesh-ancestor
634006|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
634007|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634008|NCT03334981|Analgesics|analgesics|mesh-ancestor
634009|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
634010|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634011|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
634012|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
634013|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
2219798|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2219799|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219800|NCT00037011|Antibodies|antibodies|mesh-list
2219801|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2219802|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
2219803|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219804|NCT00037037|Sargramostim|sargramostim|mesh-list
2219805|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
2219806|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219807|NCT00037050|Vancomycin|vancomycin|mesh-list
2219808|NCT00037050|Linezolid|linezolid|mesh-list
2219809|NCT00037050|Oxacillin|oxacillin|mesh-list
2219810|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
2219811|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2219812|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
634029|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
634030|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
634031|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634032|NCT03334838|Nifurtimox|nifurtimox|mesh-list
634033|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
634034|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
634035|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
634036|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219813|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2219814|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219815|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219816|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
2219817|NCT00037063|Vitamin E|vitamin e|mesh-list
2219818|NCT00037063|Riboflavin|riboflavin|mesh-list
2219819|NCT00037063|Thiamine|thiamine|mesh-list
2219820|NCT00037063|Vitamins|vitamins|mesh-ancestor
2219821|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
2219822|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219823|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
2219824|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219825|NCT00037063|Protective Agents|protective agents|mesh-ancestor
2219826|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
2219827|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2219828|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
2219829|NCT00037089|Tegafur|tegafur|mesh-list
2219830|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2219831|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
2219832|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219833|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219834|NCT00037102|Interferons|interferons|mesh-list
2219835|NCT00037102|Interferon-beta|interferon-beta|mesh-list
2219836|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
2219837|NCT00037102|Methotrexate|methotrexate|mesh-list
2219838|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2219839|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
2219840|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2219841|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219842|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2219843|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
2219844|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634069|NCT03334682|Doxycycline|doxycycline|mesh-list
634070|NCT03334682|Spironolactone|spironolactone|mesh-list
634071|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
634072|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
634073|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
634074|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2219845|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219846|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
634075|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
634076|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
634077|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
634078|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
634079|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634080|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
634081|NCT03334682|Diuretics|diuretics|mesh-ancestor
634082|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
2081099|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2081100|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081101|NCT02082210|Ramucirumab|ramucirumab|mesh-list
2081102|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081103|NCT02082392|Citalopram|citalopram|mesh-list
2081104|NCT02082392|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2081105|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2081106|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2081107|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081108|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634093|NCT03334591|Apatinib|apatinib|mesh-list
634094|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634095|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
634096|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634097|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634100|NCT03334513|Bevacizumab|bevacizumab|mesh-list
634101|NCT03334513|Ranibizumab|ranibizumab|mesh-list
634102|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
634103|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634104|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
634105|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
634106|NCT03334513|Growth Substances|growth substances|mesh-ancestor
634107|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634108|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
634109|NCT03334487|Dexamethasone|dexamethasone|mesh-list
634110|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
634111|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
634112|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
634113|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634114|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634115|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
634116|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
634117|NCT03334487|Hormones|hormones|mesh-ancestor
634118|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
634119|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
634120|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634121|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
634122|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219847|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219848|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2219849|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
634126|NCT03334409|Vitamins|vitamins|mesh-list
634127|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
634128|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
634129|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634130|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
634131|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634132|NCT03334409|Protective Agents|protective agents|mesh-ancestor
634133|NCT03334318|Allopurinol|allopurinol|mesh-list
634134|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
634135|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634136|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634137|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
634138|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
634139|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
634140|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
634141|NCT03334318|Protective Agents|protective agents|mesh-ancestor
634142|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634143|NCT03334305|Vaccines|vaccines|mesh-list
634144|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
634145|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081109|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
2081110|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081111|NCT02082392|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2081112|NCT02082392|Antidepressive Agents|antidepressive agents|mesh-ancestor
2081113|NCT02082392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2081114|NCT02082522|Gemcitabine|gemcitabine|mesh-list
2081115|NCT02082522|Cisplatin|cisplatin|mesh-list
2081116|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2081117|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
2081118|NCT02082522|Trioxsalen|trioxsalen|mesh-list
2081119|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081120|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2081121|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
2081122|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081123|NCT02082522|Antiviral Agents|antiviral agents|mesh-ancestor
2081124|NCT02082522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081125|NCT02082522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634164|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
634165|NCT03334136|Calcifediol|calcifediol|mesh-list
634166|NCT03334136|Vitamins|vitamins|mesh-ancestor
634167|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
634168|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634169|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
634170|NCT03333824|Midazolam|midazolam|mesh-list
634171|NCT03333824|Granisetron|granisetron|mesh-list
634172|NCT03333824|Caffeine|caffeine|mesh-list
634173|NCT03333824|Omeprazole|omeprazole|mesh-list
634174|NCT03333824|Adavosertib|adavosertib|mesh-list
634175|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
634176|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
634177|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
634178|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634179|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
634180|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
634181|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
634182|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
634183|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
634184|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
634185|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
634186|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
634187|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634188|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634189|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
634190|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
634191|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
634192|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634193|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
634194|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
634195|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
634196|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
634197|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
634198|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
634199|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
634200|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634201|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
634202|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
2219850|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
2219851|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219852|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2219853|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
2219854|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219855|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2219856|NCT00037115|Interferons|interferons|mesh-list
2219857|NCT00037115|Interferon-beta|interferon-beta|mesh-list
2219858|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
2219859|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
2219860|NCT00037115|Methotrexate|methotrexate|mesh-list
2219861|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
634215|NCT03333668|Guanfacine|guanfacine|mesh-list
634216|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
634217|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
634218|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634219|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
634220|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
634221|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
634222|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634223|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
634224|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634225|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
634450|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
2081126|NCT02082522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2219862|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
634226|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
634227|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
634228|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
634229|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
634230|NCT03333616|Nivolumab|nivolumab|mesh-list
634231|NCT03333616|Ipilimumab|ipilimumab|mesh-list
634232|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
634233|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634234|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
634235|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634236|NCT03333603|Esomeprazole|esomeprazole|mesh-list
634237|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
634238|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
634239|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
634240|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634241|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634242|NCT03333525|Insulin|insulin|mesh-list
634243|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
634244|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634245|NCT03333499|Trimetazidine|trimetazidine|mesh-list
634246|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
2081127|NCT02082522|Immunologic Factors|immunologic factors|mesh-ancestor
2081128|NCT02082522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081129|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
2081130|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2081131|NCT02082678|Ondansetron|ondansetron|mesh-list
2081132|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
2081133|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
2081134|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081135|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081136|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2081137|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
2081138|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
2081139|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2081140|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
634261|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
634262|NCT03333408|Clindamycin|clindamycin|mesh-list
634263|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
634264|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
634265|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
634266|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
634267|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
634268|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634269|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634270|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
634271|NCT03333395|Heparin|heparin|mesh-list
634272|NCT03333395|Albuterol|albuterol|mesh-list
634273|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
634274|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
634275|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
634276|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634277|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
634278|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
634279|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634280|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634281|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
634282|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
634283|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
634284|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
634285|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
634286|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
634287|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
634288|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
634289|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634290|NCT03333369|Levodopa|levodopa|mesh-list
634291|NCT03333369|Benserazide|benserazide|mesh-list
634292|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
634293|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
634294|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
634295|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634296|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634297|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634298|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634299|NCT03333343|Gefitinib|gefitinib|mesh-list
634300|NCT03333343|Trametinib|trametinib|mesh-list
634301|NCT03333343|Nazartinib|nazartinib|mesh-list
2081141|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634302|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634303|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
634304|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634305|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634306|NCT03333278|Vitamins|vitamins|mesh-list
634307|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
634308|NCT03333278|Thiamine|thiamine|mesh-list
634309|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
634310|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
634311|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
634312|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634313|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
634314|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
634315|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634316|NCT03333278|Protective Agents|protective agents|mesh-ancestor
634317|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
2219863|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2219864|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219865|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2219866|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
2219867|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219868|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219869|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
634325|NCT03333083|Lamivudine|lamivudine|mesh-list
634326|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
634327|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
634328|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
634329|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634330|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634331|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
634332|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
634333|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
634334|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
634335|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
634336|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
634337|NCT03333018|Bromides|bromides|mesh-list
634338|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
634339|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
634340|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
634341|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634342|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634343|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
634344|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
634345|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
634346|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
634347|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
634348|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
634349|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634350|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634351|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
634352|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
634353|NCT03333005|Clotrimazole|clotrimazole|mesh-list
634354|NCT03333005|Miconazole|miconazole|mesh-list
634355|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
634356|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
634357|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
634358|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
634359|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634360|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634361|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
634362|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
634363|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
634364|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634365|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
634366|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
634367|NCT03332953|Nicotine|nicotine|mesh-list
634368|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
634369|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
634370|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634371|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634372|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
634373|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
634374|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
634375|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634376|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634377|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
634378|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
634379|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634380|NCT03332888|Rituximab|rituximab|mesh-list
634381|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
634382|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634383|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
634384|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634385|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2081142|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081143|NCT02082678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2081144|NCT02082678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2081145|NCT02082678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2081146|NCT02082678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2219870|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219871|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2219872|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2219873|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
2219874|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219875|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2219876|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
2219877|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219878|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2219879|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
634401|NCT03332732|Metronidazole|metronidazole|mesh-list
634402|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
634403|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
634404|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
634405|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
634406|NCT03332719|Etanercept|etanercept|mesh-list
634407|NCT03332719|Methotrexate|methotrexate|mesh-list
634408|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
634409|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
634410|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
634411|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634412|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
634413|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
634414|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634415|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634416|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
634417|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634418|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
634419|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
634420|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
634421|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
634422|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
634423|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
634424|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
634425|NCT03332719|Analgesics|analgesics|mesh-ancestor
634426|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
634427|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634428|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
634429|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
634430|NCT03332667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
634431|NCT03332667|Vorinostat|vorinostat|mesh-list
634432|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
634433|NCT03332667|Dinutuximab|dinutuximab|mesh-list
634434|NCT03332667|Antibodies|antibodies|mesh-list
634435|NCT03332667|Immunoglobulins|immunoglobulins|mesh-list
634436|NCT03332667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
634437|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
634438|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634439|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634440|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
634441|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634442|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634443|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
634444|NCT03332602|Vitamins|vitamins|mesh-list
634445|NCT03332602|Folic Acid|folic acid|mesh-list
634446|NCT03332602|Vitamin A|vitamin a|mesh-list
634447|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
634448|NCT03332602|Fesoterodine|fesoterodine|mesh-list
634449|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
2219880|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
2219881|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634451|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634452|NCT03332602|Hematinics|hematinics|mesh-ancestor
634453|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
634454|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
634455|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
634456|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
634457|NCT03332602|Protective Agents|protective agents|mesh-ancestor
634458|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
634459|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634460|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
634461|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634462|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
634463|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
634464|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
634465|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634466|NCT03332602|Urological Agents|urological agents|mesh-ancestor
634467|NCT03332589|Dabrafenib|dabrafenib|mesh-list
634468|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634469|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
634470|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634471|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634472|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
634473|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
634474|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
634475|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634476|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
634477|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
634478|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
634479|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634480|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634481|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
634482|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
634483|NCT03332524|Ibuprofen|ibuprofen|mesh-list
634484|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
634485|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
634486|NCT03332524|Analgesics|analgesics|mesh-ancestor
634487|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
634488|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634489|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634490|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
634491|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
634492|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
634493|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634494|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634495|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
634496|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
634497|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
634498|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
634499|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
634500|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634501|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2219882|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219883|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
2219884|NCT00037115|Hormones|hormones|mesh-ancestor
634505|NCT03332329|Entecavir|entecavir|mesh-list
634506|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
634507|NCT03332329|Molgramostim|molgramostim|mesh-list
634508|NCT03332329|Vaccines|vaccines|mesh-list
634509|NCT03332329|Sargramostim|sargramostim|mesh-list
634510|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
634511|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634512|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
634513|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
634514|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634515|NCT03332316|Dexamethasone|dexamethasone|mesh-list
634516|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
634517|NCT03332316|Ropivacaine|ropivacaine|mesh-list
634518|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
634519|NCT03332316|BB 1101|bb 1101|mesh-list
634520|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
634521|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
634522|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
634523|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634524|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634525|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
634526|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
634527|NCT03332316|Hormones|hormones|mesh-ancestor
634602|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
634528|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
634529|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
634530|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634531|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
634532|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
634533|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
634534|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
634535|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
634536|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634537|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634538|NCT03332303|Estradiol|estradiol|mesh-list
634539|NCT03332303|Estrogens|estrogens|mesh-ancestor
634540|NCT03332303|Hormones|hormones|mesh-ancestor
634541|NCT03332303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
634542|NCT03332303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634543|NCT03332225|Interferons|interferons|mesh-list
634544|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
634545|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
634546|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634547|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
634548|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
634549|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219885|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2219886|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2219887|NCT00037115|Protective Agents|protective agents|mesh-ancestor
2219888|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2219889|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
634555|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
634556|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634557|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
634558|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634559|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081147|NCT02082678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2081148|NCT02082769|Allopurinol|allopurinol|mesh-list
2081149|NCT02082769|Febuxostat|febuxostat|mesh-list
2081150|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
2081151|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081152|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081153|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
2081154|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2081155|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2081156|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
634570|NCT03332069|Cisplatin|cisplatin|mesh-list
634571|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634572|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
634573|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
634574|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
634575|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634576|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
634577|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634578|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219890|NCT00037154|Urological Agents|urological agents|mesh-ancestor
2219891|NCT00037180|Leucovorin|leucovorin|mesh-list
2219892|NCT00037180|Celecoxib|celecoxib|mesh-list
2219893|NCT00037180|Fluorouracil|fluorouracil|mesh-list
2219894|NCT00037180|Irinotecan|irinotecan|mesh-list
2219895|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
2219896|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219897|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2219898|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219899|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2219900|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
634590|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
634591|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
634592|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
634593|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
634594|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
634595|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634596|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
634597|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634598|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634599|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
634600|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634601|NCT03331861|Metformin|metformin|mesh-list
2219901|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634603|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219902|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2219903|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
634606|NCT03331770|Latanoprost|latanoprost|mesh-list
634607|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
634608|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2751666|NCT03869892|Capecitabine|capecitabine|mesh-list
2751667|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2751668|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634612|NCT03331692|Anesthetics|anesthetics|mesh-list
634613|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
634614|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219904|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219905|NCT00037180|Antidotes|antidotes|mesh-ancestor
2219906|NCT00037180|Protective Agents|protective agents|mesh-ancestor
2219907|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
2219908|NCT00037180|Vitamins|vitamins|mesh-ancestor
2219909|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
634621|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
634622|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
634623|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
634624|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634625|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
634626|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634627|NCT03331562|Vitamins|vitamins|mesh-ancestor
634628|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
634629|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
634630|NCT03331523|Betamethasone|betamethasone|mesh-list
634631|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
634632|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
634633|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
634634|NCT03331523|Calcipotriene|calcipotriene|mesh-list
634635|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
634636|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
634637|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
634638|NCT03331523|Hormones|hormones|mesh-ancestor
634639|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
634640|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634641|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
634642|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
634643|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
634644|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
634645|NCT03331484|Ticagrelor|ticagrelor|mesh-list
634646|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
634647|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
634648|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
634649|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
634650|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
634651|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634652|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634653|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634654|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
634655|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
634656|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
634657|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
634658|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634659|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
634660|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
634661|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
634662|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
634663|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634664|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634665|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
634666|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
634667|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
634668|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
634669|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634670|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634671|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
634672|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
634673|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
634674|NCT03331445|Protective Agents|protective agents|mesh-ancestor
634675|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
634676|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
634677|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
634678|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
634679|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2081157|NCT02082769|Protective Agents|protective agents|mesh-ancestor
2081158|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081159|NCT02082912|Cycloserine|cycloserine|mesh-list
2081160|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2081161|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081162|NCT02082912|Renal Agents|renal agents|mesh-ancestor
2081163|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2081164|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
2081165|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2081166|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
2081167|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081168|NCT02083107|Misoprostol|misoprostol|mesh-list
2081169|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2081170|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
2081171|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2081172|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081173|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2081174|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2081175|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
2219910|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2219911|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2219912|NCT00037180|Analgesics|analgesics|mesh-ancestor
2219913|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
2219914|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219915|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2219916|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2219917|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2219918|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2219919|NCT00037206|Anidulafungin|anidulafungin|mesh-list
2219920|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
2219921|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219922|NCT00037219|Anidulafungin|anidulafungin|mesh-list
2219923|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
634713|NCT03331302|Xenon|xenon|mesh-list
634714|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
634715|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
634716|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
634717|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
634718|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634729|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
634730|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
634731|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
634732|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
634733|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
634734|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
634735|NCT03331211|Dasatinib|dasatinib|mesh-list
634736|NCT03331211|Ponatinib|ponatinib|mesh-list
634737|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634738|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
634739|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634740|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081176|NCT02083185|Leuprolide|leuprolide|mesh-list
2081177|NCT02083185|Relugolix|relugolix|mesh-list
634743|NCT03330990|Midazolam|midazolam|mesh-list
634744|NCT03330990|Entrectinib|entrectinib|mesh-list
634745|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
634746|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
634747|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
634748|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634749|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
634750|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
634751|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
634752|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
634753|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
634754|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
634755|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
634756|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
634757|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634758|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634759|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
634760|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634761|NCT03330886|Atezolizumab|atezolizumab|mesh-list
634762|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634763|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
634764|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
634765|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
634766|NCT03330860|Hormones|hormones|mesh-ancestor
634767|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
634768|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634769|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634770|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081178|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2081179|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
2081180|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2081181|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081182|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2081183|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081184|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
2081185|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
2081186|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081193|NCT02083380|Piperaquine|piperaquine|mesh-list
2081194|NCT02083380|Artefenomel|artefenomel|mesh-list
2081195|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
2081196|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2081197|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2081198|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081199|NCT02083406|Artefenomel|artefenomel|mesh-list
634793|NCT03330808|Anesthetics|anesthetics|mesh-list
634794|NCT03330808|Ropivacaine|ropivacaine|mesh-list
634795|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
634796|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634797|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
634798|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
634799|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634800|NCT03330782|Remifentanil|remifentanil|mesh-list
634801|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
634802|NCT03330782|Narcotics|narcotics|mesh-ancestor
634803|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
634804|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634805|NCT03330782|Analgesics|analgesics|mesh-ancestor
634806|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
634807|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634808|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
634809|NCT03330717|Anesthetics|anesthetics|mesh-list
634810|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
634811|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634812|NCT03330639|Capsaicin|capsaicin|mesh-list
634813|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
634814|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
634815|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
634816|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634817|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634818|NCT03330613|Anesthetics|anesthetics|mesh-list
634819|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
634820|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219924|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219925|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
2219926|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2219927|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219928|NCT00037518|Cinacalcet|cinacalcet|mesh-list
2219929|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2219930|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219931|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2751669|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2751670|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2751671|NCT03869892|Growth Substances|growth substances|mesh-ancestor
2751672|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751673|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
2751674|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2751675|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
2751676|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751677|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
634839|NCT03330249|Cisplatin|cisplatin|mesh-list
634840|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219932|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
2219933|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2751678|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
634844|NCT03330223|Clopidogrel|clopidogrel|mesh-list
634845|NCT03330223|Ticagrelor|ticagrelor|mesh-list
634846|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
634847|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
634848|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
634849|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
634850|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
634851|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634852|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634853|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634854|NCT03330171|Vaccines|vaccines|mesh-list
634855|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
634856|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634857|NCT03330132|Vaccines|vaccines|mesh-list
634858|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
634859|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
634860|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634861|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
634862|NCT03330106|Paclitaxel|paclitaxel|mesh-list
634863|NCT03330106|Docetaxel|docetaxel|mesh-list
634864|NCT03330106|Carboplatin|carboplatin|mesh-list
634865|NCT03330106|Pevonedistat|pevonedistat|mesh-list
634866|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
634867|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634868|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
634869|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
634870|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
634871|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634872|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634873|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
634874|NCT03330028|Promethazine|promethazine|mesh-list
634875|NCT03330028|Dexamethasone|dexamethasone|mesh-list
634876|NCT03330028|Paclitaxel|paclitaxel|mesh-list
634877|NCT03330028|Cisplatin|cisplatin|mesh-list
634878|NCT03330028|Mitomycins|mitomycins|mesh-list
634879|NCT03330028|Mitomycin|mitomycin|mesh-list
634880|NCT03330028|Famotidine|famotidine|mesh-list
634881|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
634882|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634883|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
634884|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
634885|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
634886|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634887|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
634888|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
634889|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
634890|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634891|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634892|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
634893|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
634894|NCT03330028|Hormones|hormones|mesh-ancestor
634895|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
634896|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
634897|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
634898|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
634899|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
634900|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634901|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
634902|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
634903|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
634904|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
634905|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
634906|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
634907|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
634908|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
634909|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
634910|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
634911|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
634912|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
634913|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
634914|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
634915|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
634916|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
634917|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
634918|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219934|NCT00037531|Sirolimus|sirolimus|mesh-list
2219935|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2219936|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219937|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2219938|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219939|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
2219940|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2219941|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
2219942|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219943|NCT00037544|Factor VIII|factor viii|mesh-list
2219944|NCT00037544|Coagulants|coagulants|mesh-ancestor
2219945|NCT00037570|Pantoprazole|pantoprazole|mesh-list
2219946|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2219947|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2219948|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2219949|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219950|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219951|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
2219952|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2219953|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634939|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
634940|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
634941|NCT03329898|Estradiol|estradiol|mesh-list
634942|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
634943|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
634944|NCT03329898|Estrogens|estrogens|mesh-ancestor
634945|NCT03329898|Hormones|hormones|mesh-ancestor
634946|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
634947|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634948|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
634949|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
634950|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
634951|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
634952|NCT03329898|Progestins|progestins|mesh-ancestor
2219954|NCT00037596|Cytarabine|cytarabine|mesh-list
2219955|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
2219956|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2219957|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
2219958|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219959|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219960|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
634960|NCT03329781|Curcumin|curcumin|mesh-list
634961|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
634962|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
634963|NCT03329781|Analgesics|analgesics|mesh-ancestor
634964|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
634965|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
634966|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634967|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
634968|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
634969|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
634970|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634971|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634972|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
634973|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
634974|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
634975|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
634976|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
634977|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
634978|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
634979|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
634980|NCT03329651|Metformin|metformin|mesh-list
634981|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
634982|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
634983|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2219961|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
634984|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2219962|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2219963|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
2219964|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219965|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2219966|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
2219967|NCT00037609|Capecitabine|capecitabine|mesh-list
2219968|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2219969|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
2219970|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219971|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2219972|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2219973|NCT00037609|Protective Agents|protective agents|mesh-ancestor
2219974|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219975|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
634999|NCT03329547|Cefixime|cefixime|mesh-list
635000|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
635001|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
635002|NCT03329508|Pramipexole|pramipexole|mesh-list
635003|NCT03329508|Rasagiline|rasagiline|mesh-list
635004|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
635005|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635006|NCT03329508|Protective Agents|protective agents|mesh-ancestor
635007|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635008|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
635009|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
635010|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
635011|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
635012|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635013|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
635014|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635015|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
635016|NCT03329456|Ropivacaine|ropivacaine|mesh-list
635017|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
635018|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
635019|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635020|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635021|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
635022|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635023|NCT03329443|Spironolactone|spironolactone|mesh-list
635024|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
635025|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
635026|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
635027|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635028|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
635029|NCT03329443|Diuretics|diuretics|mesh-ancestor
635030|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
2081200|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
2081201|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2081202|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2081203|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081204|NCT02083653|Fluorouracil|fluorouracil|mesh-list
2081205|NCT02083653|Capecitabine|capecitabine|mesh-list
2081206|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2081207|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
2081208|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081209|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2081210|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081211|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2081212|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
2081213|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081214|NCT02083679|Gemcitabine|gemcitabine|mesh-list
2081215|NCT02083679|Paclitaxel|paclitaxel|mesh-list
2081216|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2081217|NCT02083679|Cisplatin|cisplatin|mesh-list
2081218|NCT02083679|Carboplatin|carboplatin|mesh-list
2081219|NCT02083679|Pemetrexed|pemetrexed|mesh-list
2081220|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2081221|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2081222|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081223|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
2081224|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
2081225|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
635057|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
635058|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
635213|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
2219976|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635059|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635060|NCT03329339|Protective Agents|protective agents|mesh-ancestor
635061|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635062|NCT03329339|Vitamins|vitamins|mesh-ancestor
635063|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
635066|NCT03329261|Clopidogrel|clopidogrel|mesh-list
635067|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
635068|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
635069|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
635070|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
635071|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
635072|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635073|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635074|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635075|NCT03329248|Leucovorin|leucovorin|mesh-list
635076|NCT03329248|Paclitaxel|paclitaxel|mesh-list
635077|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
635078|NCT03329248|Bevacizumab|bevacizumab|mesh-list
635079|NCT03329248|Fluorouracil|fluorouracil|mesh-list
635080|NCT03329248|Capecitabine|capecitabine|mesh-list
635081|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
635082|NCT03329248|Avelumab|avelumab|mesh-list
635083|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
635084|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635085|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
635086|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
635087|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
635088|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635089|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
635090|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
635091|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635092|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
635093|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
635094|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
635095|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
635096|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
635097|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
635098|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
635099|NCT03329248|Growth Substances|growth substances|mesh-ancestor
635100|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
635101|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
635102|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
635103|NCT03329248|Antidotes|antidotes|mesh-ancestor
635104|NCT03329248|Protective Agents|protective agents|mesh-ancestor
635105|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
635106|NCT03329248|Vitamins|vitamins|mesh-ancestor
635107|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
2219977|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2219978|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2219979|NCT00037609|Analgesics|analgesics|mesh-ancestor
635112|NCT03329183|Irinotecan|irinotecan|mesh-list
635113|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
635114|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
635115|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635116|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635117|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635118|NCT03329118|Simvastatin|simvastatin|mesh-list
635119|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
635120|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
635121|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
635122|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635123|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
635124|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
635125|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635126|NCT03329001|Niraparib|niraparib|mesh-list
635127|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
635128|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635129|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635130|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635131|NCT03328975|Dexamethasone|dexamethasone|mesh-list
635132|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
635133|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
635134|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
635365|NCT03327727|Amphotericin B|amphotericin b|mesh-list
635135|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635136|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635137|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
635138|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
635139|NCT03328975|Hormones|hormones|mesh-ancestor
635140|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
635141|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
635142|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635143|NCT03328936|Melphalan|melphalan|mesh-list
635144|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
635145|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
635146|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635147|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635148|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
635149|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
635150|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
635151|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219980|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
2219981|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2219982|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2219983|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
635156|NCT03328884|Irinotecan|irinotecan|mesh-list
635157|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
635158|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
635159|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635160|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635161|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751679|NCT03867201|Erenumab|erenumab|mesh-list
2751680|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2751681|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751682|NCT03867201|Analgesics|analgesics|mesh-ancestor
2751683|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
2219984|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
2219985|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2219986|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2219987|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2219988|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2219989|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
2219990|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2219991|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2219992|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2219993|NCT00037635|Cinacalcet|cinacalcet|mesh-list
2219994|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2219995|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2219996|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2219997|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
2219998|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2219999|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2220000|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220001|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2220002|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2220003|NCT00037674|Topiramate|topiramate|mesh-list
635190|NCT03328728|Hylan|hylan|mesh-list
635191|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
635192|NCT03328728|Protective Agents|protective agents|mesh-ancestor
635193|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635194|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
635195|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
635196|NCT03328676|Protective Agents|protective agents|mesh-ancestor
635197|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635198|NCT03328533|Phenylephrine|phenylephrine|mesh-list
635199|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
635200|NCT03328533|Norepinephrine|norepinephrine|mesh-list
635201|NCT03328533|Bupivacaine|bupivacaine|mesh-list
635202|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
635203|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
635204|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635205|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635206|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
635207|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635208|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
635209|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
635210|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
635211|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
635212|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
635214|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
635215|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
635216|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
635217|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
635218|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
635219|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635220|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635221|NCT03328533|Protective Agents|protective agents|mesh-ancestor
635222|NCT03328494|Paclitaxel|paclitaxel|mesh-list
635223|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
635224|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635225|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
635226|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
635227|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
635228|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635229|NCT03328481|Anesthetics|anesthetics|mesh-list
635230|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635231|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635232|NCT03328364|Docetaxel|docetaxel|mesh-list
635233|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635234|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
635235|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
635236|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
635237|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220004|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
2220005|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2220006|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635241|NCT03328312|Atropine|atropine|mesh-list
635242|NCT03328312|Neostigmine|neostigmine|mesh-list
635243|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
635244|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
635245|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
635246|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
635247|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635248|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635249|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
635250|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
635251|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
635252|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
635253|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
635254|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
635255|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
635256|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635257|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635258|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
635259|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635260|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
635261|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
635262|NCT03328299|Bupivacaine|bupivacaine|mesh-list
635263|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
635264|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
635265|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635266|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635267|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
635268|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635269|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
635270|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
635271|NCT03328299|Analgesics|analgesics|mesh-ancestor
635272|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
635273|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
635274|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
635275|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
635276|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635277|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751684|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635280|NCT03328234|Paclitaxel|paclitaxel|mesh-list
635281|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
635282|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
635283|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635284|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
635285|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
635286|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
635287|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635288|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
635289|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635290|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
635291|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635292|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635293|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
635294|NCT03328104|Etoposide|etoposide|mesh-list
635295|NCT03328104|Everolimus|everolimus|mesh-list
635296|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
635297|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
635298|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635299|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
635300|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
635301|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
635302|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635303|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635304|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
635305|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
635306|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
635307|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
635308|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635309|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
635310|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2081226|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081227|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2081228|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
2081229|NCT02083679|Antiviral Agents|antiviral agents|mesh-ancestor
2081230|NCT02083679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081231|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081232|NCT02083679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2081233|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
2081234|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081235|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2081236|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2081237|NCT02083783|Amphetamine|amphetamine|mesh-list
2081238|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2081239|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635325|NCT03327987|Vaccines|vaccines|mesh-list
635326|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
635327|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081240|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
2081241|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
2081242|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081243|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
2081244|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081245|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081246|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
2081247|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2081248|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2081249|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2081250|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2081251|NCT02083809|Oxytocin|oxytocin|mesh-list
2081252|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
2081253|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2081254|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081255|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
2081256|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2081257|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2081258|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
635348|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
635349|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
635350|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
635351|NCT03327805|Choline|choline|mesh-list
635352|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
635353|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
635354|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
635355|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635356|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
635357|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
635358|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
635359|NCT03327766|Calcifediol|calcifediol|mesh-list
635360|NCT03327766|Vitamins|vitamins|mesh-ancestor
635361|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
635362|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635363|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
635364|NCT03327727|Voriconazole|voriconazole|mesh-list
635366|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
635367|NCT03327727|Isavuconazole|isavuconazole|mesh-list
635368|NCT03327727|VL-2397|vl-2397|mesh-list
635369|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
635370|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
635371|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
635372|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
635373|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635374|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635375|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
635376|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
635377|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
635378|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635379|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
635380|NCT03327727|Amebicides|amebicides|mesh-ancestor
635381|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
635382|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
635383|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
635384|NCT03327701|Benralizumab|benralizumab|mesh-list
635385|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
635386|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
635387|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
635388|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
635389|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635390|NCT03327558|Mesalamine|mesalamine|mesh-list
635391|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
635392|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
635393|NCT03327558|Analgesics|analgesics|mesh-ancestor
635394|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
635395|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635396|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635397|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
635398|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
635399|NCT03327506|Alprazolam|alprazolam|mesh-list
635400|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
635401|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635402|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635403|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
635404|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
635405|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
635406|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
635407|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
635408|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635409|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635410|NCT03327454|Etanercept|etanercept|mesh-list
635411|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
635412|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
635413|NCT03327454|Analgesics|analgesics|mesh-ancestor
635414|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
635415|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635416|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635417|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
635418|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
635419|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
635420|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
635421|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
635422|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
635423|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
635424|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635425|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635426|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
635427|NCT03327389|Analgesics|analgesics|mesh-ancestor
635428|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
635429|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635430|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
635431|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
635432|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
635433|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
635434|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635435|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635436|NCT03327350|Anticoagulants|anticoagulants|mesh-list
635437|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
635438|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
635439|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
635440|NCT03327272|Prednisolone|prednisolone|mesh-list
635441|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
635442|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
635443|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
635444|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
635445|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
635446|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
635447|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635448|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635449|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
635450|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
635451|NCT03327272|Hormones|hormones|mesh-ancestor
635452|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
635453|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
635454|NCT03327272|Protective Agents|protective agents|mesh-ancestor
635455|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
635456|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635457|NCT03327168|Adenosine|adenosine|mesh-list
635458|NCT03327168|Analgesics|analgesics|mesh-ancestor
635459|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
635460|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635461|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635462|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
635463|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
635464|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
635465|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
635466|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
635467|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635468|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635469|NCT03327155|Tenofovir|tenofovir|mesh-list
635470|NCT03327155|Emtricitabine|emtricitabine|mesh-list
635471|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
635472|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
635473|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
635474|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
635475|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635476|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635477|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
635478|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
635479|NCT03327116|Methotrexate|methotrexate|mesh-list
635480|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
635481|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
635482|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
635483|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635484|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
635485|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
635486|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635487|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635488|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
635489|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635490|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
635491|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
635492|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
635493|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
635494|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2220007|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2220008|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220009|NCT00037752|Sibutramine|sibutramine|mesh-list
2220010|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
2220011|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2220012|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
2220013|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2220014|NCT00037804|Irinotecan|irinotecan|mesh-list
2220015|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2220016|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2220017|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220018|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220019|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635508|NCT03326960|Propofol|propofol|mesh-list
635509|NCT03326960|Sevoflurane|sevoflurane|mesh-list
635510|NCT03326960|Desflurane|desflurane|mesh-list
635511|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
635512|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635513|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635514|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2220020|NCT00037817|Celecoxib|celecoxib|mesh-list
635515|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
635516|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
635517|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
635518|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
635519|NCT03326947|Docetaxel|docetaxel|mesh-list
635520|NCT03326947|Fluorouracil|fluorouracil|mesh-list
635521|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635522|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
635523|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
635524|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
635525|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635526|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
635527|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
635528|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
635529|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
635530|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635531|NCT03326921|Vidarabine|vidarabine|mesh-list
635532|NCT03326921|Fludarabine|fludarabine|mesh-list
635533|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
635534|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635535|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
635536|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
635537|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635538|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
635539|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
635540|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635541|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
635542|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220021|NCT00037817|Decitabine|decitabine|mesh-list
2220022|NCT00037817|Romidepsin|romidepsin|mesh-list
2220023|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2220024|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2220025|NCT00037817|Analgesics|analgesics|mesh-ancestor
2220026|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
2220027|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2220028|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220029|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2220030|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220031|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
635554|NCT03326791|Aspirin|aspirin|mesh-list
635555|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
635556|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
635557|NCT03326791|Analgesics|analgesics|mesh-ancestor
635558|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
635559|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635560|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635561|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
635562|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
635563|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
635564|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
635565|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635566|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
635567|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
635568|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635569|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
635570|NCT03326752|Nivolumab|nivolumab|mesh-list
635571|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
635572|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
635573|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635574|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635575|NCT03326674|Capecitabine|capecitabine|mesh-list
635576|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
635577|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
635578|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635579|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635580|NCT03326661|Clindamycin|clindamycin|mesh-list
635581|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
635582|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
635583|NCT03326661|Penicillins|penicillins|mesh-list
635584|NCT03326661|Penicillin V|penicillin v|mesh-list
635585|NCT03326661|Metronidazole|metronidazole|mesh-list
635586|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
635587|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
635588|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
635589|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220032|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
635590|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635591|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
635592|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
635593|NCT03326609|Ropivacaine|ropivacaine|mesh-list
635594|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
635595|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
635596|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635597|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635598|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
635599|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635600|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
635601|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
635602|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
635603|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635604|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
635605|NCT03326596|Coagulants|coagulants|mesh-ancestor
635606|NCT03326492|Antivenins|antivenins|mesh-list
635607|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
635608|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635609|NCT03326310|Azacitidine|azacitidine|mesh-list
635610|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
635611|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
635612|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635613|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635614|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635615|NCT03326258|Nivolumab|nivolumab|mesh-list
635616|NCT03326258|Ipilimumab|ipilimumab|mesh-list
635617|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
635618|NCT03326258|Antibodies|antibodies|mesh-list
635619|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
635620|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
635621|NCT03326258|Immunotoxins|immunotoxins|mesh-list
635622|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
635623|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
635624|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635625|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
635626|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635627|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
635628|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635650|NCT03326180|Bupivacaine|bupivacaine|mesh-list
635651|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
635652|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
635653|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635654|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635655|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
635656|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635657|NCT03326128|Bupropion|bupropion|mesh-list
635658|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
635659|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
635660|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
635661|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
635662|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
635663|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
635664|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635665|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
635666|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635667|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635668|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
635669|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
635670|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635671|NCT03326102|Paclitaxel|paclitaxel|mesh-list
635672|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
635673|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
635674|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635675|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
635676|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
635677|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
635678|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635679|NCT03326063|Ifetroban|ifetroban|mesh-list
635680|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
635681|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
635682|NCT03326050|Rifampin|rifampin|mesh-list
635683|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
635684|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
635685|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
635686|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
635687|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
635688|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635689|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635690|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635691|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
635692|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
635693|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
635694|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
635695|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
635696|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
635697|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
635698|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
635699|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
635700|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
635701|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
635702|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
635703|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
635704|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
635705|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635706|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635707|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
635708|NCT03325972|Analgesics|analgesics|mesh-ancestor
635709|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
635710|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635711|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
635712|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
635713|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
635714|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
635715|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635716|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635717|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
635718|NCT03325959|Analgesics|analgesics|mesh-ancestor
635719|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
635720|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635721|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635722|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
635723|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635724|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
635725|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
635726|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
635727|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635728|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
635729|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
635730|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
635731|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
635732|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
635733|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
635734|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635735|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2220033|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220034|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220035|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2220036|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
2220037|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220038|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2220039|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
635743|NCT03325803|Lidocaine|lidocaine|mesh-list
635744|NCT03325803|Prilocaine|prilocaine|mesh-list
635745|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
635746|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
635747|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
635748|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635749|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635750|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
635751|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635752|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
635753|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
635754|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
635755|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
635756|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635757|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
635758|NCT03325790|Ebselen|ebselen|mesh-list
635759|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
635760|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
635761|NCT03325790|Analgesics|analgesics|mesh-ancestor
635762|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
635763|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635764|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635765|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
635766|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
635767|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
635768|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
635769|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
635770|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635771|NCT03325790|Protective Agents|protective agents|mesh-ancestor
635772|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
635773|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635774|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
635775|NCT03325686|Vitamin D|vitamin d|mesh-list
635776|NCT03325686|Vitamins|vitamins|mesh-ancestor
635777|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
635778|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635779|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
635780|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
635781|NCT03325647|Testosterone|testosterone|mesh-list
635782|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
635783|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
635784|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
635785|NCT03325647|Androgens|androgens|mesh-ancestor
635786|NCT03325647|Hormones|hormones|mesh-ancestor
635787|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
635788|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635789|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
635790|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635791|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
2220040|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220041|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220042|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220043|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2220044|NCT00037882|Interferons|interferons|mesh-list
2220045|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
2220046|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
2220047|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2220048|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220049|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
2220050|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220051|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
2220052|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635805|NCT03325491|Acipimox|acipimox|mesh-list
635806|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
635807|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
635808|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220053|NCT00037999|Testosterone|testosterone|mesh-list
635809|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
635810|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
635811|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
635812|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635815|NCT03325413|Anesthetics|anesthetics|mesh-list
635816|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635817|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635818|NCT03325400|Fluorides|fluorides|mesh-list
635819|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
635820|NCT03325400|Protective Agents|protective agents|mesh-ancestor
635821|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635822|NCT03325348|Labetalol|labetalol|mesh-list
635823|NCT03325348|Nifedipine|nifedipine|mesh-list
635824|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
635825|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
635826|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635827|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
635828|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635829|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
635830|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
635831|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
635832|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
635833|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
635834|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
635835|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635836|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
635837|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
635838|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
635839|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635840|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
635841|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
635842|NCT03325335|Midazolam|midazolam|mesh-list
635843|NCT03325335|Remifentanil|remifentanil|mesh-list
635844|NCT03325335|Propofol|propofol|mesh-list
635845|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
635846|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635847|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635848|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
635849|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
635850|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
635851|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
635852|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
635853|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
635854|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
635855|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
635856|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
635857|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635858|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635859|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
635860|NCT03325335|Narcotics|narcotics|mesh-ancestor
635861|NCT03325335|Analgesics|analgesics|mesh-ancestor
635862|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
635863|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635864|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
635865|NCT03325270|Trace Elements|trace elements|mesh-ancestor
635866|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
635867|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635868|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
635869|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
635870|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
635871|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635872|NCT03325166|Hematinics|hematinics|mesh-ancestor
635873|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
635874|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
635875|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
635876|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220054|NCT00037999|Androgens|androgens|mesh-ancestor
2220055|NCT00037999|Hormones|hormones|mesh-ancestor
2220056|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2220057|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220058|NCT00038012|Carboplatin|carboplatin|mesh-list
2220059|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220060|NCT00038025|Pentostatin|pentostatin|mesh-list
2220061|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220062|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2081259|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081260|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635888|NCT03324984|Bupivacaine|bupivacaine|mesh-list
635889|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
635890|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
635891|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
635892|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635893|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635894|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
635895|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635896|NCT03324932|Denosumab|denosumab|mesh-list
635897|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
635898|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635899|NCT03324867|Insulin|insulin|mesh-list
635900|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
635901|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
635902|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635903|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
635904|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
635905|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
635906|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
635907|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
635908|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
635909|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635910|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635911|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635912|NCT03324815|Morphine|morphine|mesh-list
635913|NCT03324815|Methadone|methadone|mesh-list
635914|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
635915|NCT03324815|Narcotics|narcotics|mesh-ancestor
635916|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635917|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635918|NCT03324815|Analgesics|analgesics|mesh-ancestor
635919|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
635920|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635921|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
635922|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
635923|NCT03324776|Insulin|insulin|mesh-list
635924|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
635925|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
635926|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635927|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
635928|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
635929|NCT03324685|Estradiol|estradiol|mesh-list
635930|NCT03324685|Estrogens|estrogens|mesh-ancestor
635931|NCT03324685|Hormones|hormones|mesh-ancestor
635932|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
635933|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635934|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
635935|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
635936|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
635937|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
635938|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
635939|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
635940|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2081261|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081262|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
2081263|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
2081264|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081265|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
2081266|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2081267|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
2081268|NCT02083926|Ketamine|ketamine|mesh-list
635949|NCT03324542|Ranibizumab|ranibizumab|mesh-list
635950|NCT03324542|Aflibercept|aflibercept|mesh-list
635951|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635952|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
635953|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
635954|NCT03324542|Growth Substances|growth substances|mesh-ancestor
635955|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635956|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
635957|NCT03324503|Prednisone|prednisone|mesh-list
635958|NCT03324503|Prednisolone|prednisolone|mesh-list
635959|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
635960|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
635961|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2081269|NCT02083926|Analgesics|analgesics|mesh-ancestor
2220063|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
635962|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
635963|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
635964|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
635965|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
635966|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
635967|NCT03324503|Hormones|hormones|mesh-ancestor
635968|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
635969|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635970|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
635971|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
635972|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
635973|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
635974|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635975|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
635976|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
635977|NCT03324503|Protective Agents|protective agents|mesh-ancestor
635978|NCT03324490|Fentanyl|fentanyl|mesh-list
635979|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
635980|NCT03324490|Bupivacaine|bupivacaine|mesh-list
635981|NCT03324490|Anesthetics|anesthetics|mesh-list
635982|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
635983|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
635984|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
635985|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
635986|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
635987|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
635988|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
635989|NCT03324490|Analgesics|analgesics|mesh-ancestor
635990|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
635991|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
635992|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
635993|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
635994|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
635995|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
635996|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
635997|NCT03324490|Narcotics|narcotics|mesh-ancestor
635998|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
635999|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
636000|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
2220064|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220065|NCT00038051|Lintuzumab|lintuzumab|mesh-list
2220066|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
636004|NCT03324425|Simvastatin|simvastatin|mesh-list
636005|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
636006|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
636007|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
636008|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636009|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
636010|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
636011|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751685|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636021|NCT03324334|Antibodies|antibodies|mesh-list
636022|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
636023|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636024|NCT03324282|Avelumab|avelumab|mesh-list
636025|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
636026|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636027|NCT03324243|Cytarabine|cytarabine|mesh-list
636028|NCT03324243|Fludarabine|fludarabine|mesh-list
636029|NCT03324243|Crenolanib|crenolanib|mesh-list
636030|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636031|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
636032|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
636033|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636034|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
636035|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
636036|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636037|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
636038|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
636039|NCT03324139|Heparin|heparin|mesh-list
636040|NCT03324139|Calcium heparin|calcium heparin|mesh-list
636041|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
636042|NCT03324139|Tinzaparin|tinzaparin|mesh-list
636043|NCT03324139|Dalteparin|dalteparin|mesh-list
636044|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
636045|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
636046|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
636047|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636048|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
636049|NCT03324113|Promethazine|promethazine|mesh-list
636050|NCT03324113|Dexamethasone|dexamethasone|mesh-list
636051|NCT03324113|Naphazoline|naphazoline|mesh-list
636052|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
636053|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
636054|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
636055|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
636056|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636057|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636058|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
636059|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
636060|NCT03324113|Hormones|hormones|mesh-ancestor
636061|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
636062|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
636063|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636064|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
636065|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
636066|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
636067|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
636068|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
636069|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
636070|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
636071|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
636072|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
636073|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
636074|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
636075|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636076|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
636077|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
636078|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
636079|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
636080|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
636081|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
636082|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
636083|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
636084|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
636085|NCT03324061|Fulvestrant|fulvestrant|mesh-list
636086|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
636087|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636088|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
636089|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
636090|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
636091|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
636092|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636093|NCT03324035|Tramadol|tramadol|mesh-list
636094|NCT03324035|Amitriptyline|amitriptyline|mesh-list
636095|NCT03324035|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
636096|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
636097|NCT03324035|Narcotics|narcotics|mesh-ancestor
636098|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
636099|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636100|NCT03324035|Analgesics|analgesics|mesh-ancestor
636101|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
636102|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636103|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
636104|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
636105|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
636106|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
636107|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
636108|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
636109|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
636110|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636111|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
636112|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
636113|NCT03324035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
636114|NCT03324035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
636115|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
636116|NCT03323866|Budesonide|budesonide|mesh-list
636117|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
636118|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
636119|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
636120|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636121|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636122|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
636123|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
636124|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
636125|NCT03323866|Hormones|hormones|mesh-ancestor
636126|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
636127|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
636128|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2081270|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
2081271|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081272|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081273|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
636134|NCT03323710|Sunitinib|sunitinib|mesh-list
636135|NCT03323710|Propranolol|propranolol|mesh-list
636136|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636137|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
636138|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
636139|NCT03323710|Growth Substances|growth substances|mesh-ancestor
636140|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636141|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
636142|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
636143|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636144|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636145|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
636146|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
636147|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
636148|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
636149|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
636150|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
636151|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
636152|NCT03323697|Citalopram|citalopram|mesh-list
636153|NCT03323697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
636154|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
636155|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
636156|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636157|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
636158|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
636159|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636160|NCT03323697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
636161|NCT03323697|Antidepressive Agents|antidepressive agents|mesh-ancestor
636162|NCT03323697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
636163|NCT03323684|Acetaminophen|acetaminophen|mesh-list
636164|NCT03323684|Ketorolac|ketorolac|mesh-list
636165|NCT03323684|Fentanyl|fentanyl|mesh-list
636166|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
636167|NCT03323684|Narcotics|narcotics|mesh-ancestor
636168|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
636169|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636170|NCT03323684|Analgesics|analgesics|mesh-ancestor
636171|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
636172|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636173|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
636174|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
636175|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
636176|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
636177|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
636178|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
636179|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
636180|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
636181|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
636182|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
636183|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636184|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636185|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
636186|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
636187|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
636188|NCT03323671|Analgesics|analgesics|mesh-ancestor
636189|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
636190|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636191|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636192|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
636193|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
636194|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
636195|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636196|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636197|NCT03323658|Bexarotene|bexarotene|mesh-list
636198|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636199|NCT03323619|Anesthetics|anesthetics|mesh-list
636200|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
636201|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636202|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
636203|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
636204|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
636205|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636206|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
636207|NCT03323593|Analgesics|analgesics|mesh-ancestor
636208|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
636209|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636210|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
636211|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
636212|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
636213|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
636214|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
636215|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636216|NCT03323567|Lidocaine|lidocaine|mesh-list
636217|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
636218|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
636219|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
636220|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
636221|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636222|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
636223|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636224|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
636225|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
636226|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
636227|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
636228|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636229|NCT03323541|Lenograstim|lenograstim|mesh-list
636230|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
636231|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
636232|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636233|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
636234|NCT03323528|Benzocaine|benzocaine|mesh-list
636235|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
636236|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
636237|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
636238|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636239|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
636240|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636241|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
636242|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
636243|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
636244|NCT03323476|Prednisone|prednisone|mesh-list
636245|NCT03323476|Rituximab|rituximab|mesh-list
636246|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
636247|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
636248|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636249|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
636250|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636251|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
636252|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
636253|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
636254|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
636255|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
636256|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
636257|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636258|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636259|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
636260|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
636261|NCT03323476|Hormones|hormones|mesh-ancestor
636336|NCT03323047|Acetaminophen|acetaminophen|mesh-list
636262|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
636263|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2081274|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2081275|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
2081276|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
2081277|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2081278|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2081279|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2081280|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081281|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081282|NCT02083965|Factor VIII|factor viii|mesh-list
636273|NCT03323437|Risperidone|risperidone|mesh-list
636274|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
636275|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
636276|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
636277|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636278|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636279|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
636280|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
636281|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
636282|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
636283|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
636284|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
636288|NCT03323385|Meloxicam|meloxicam|mesh-list
636289|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
636290|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
636291|NCT03323385|Analgesics|analgesics|mesh-ancestor
636292|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
636293|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636294|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636295|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
636296|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
636297|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
636298|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
636299|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636300|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636301|NCT03323372|Listerine|listerine|mesh-list
636302|NCT03323372|Fluorides|fluorides|mesh-list
636303|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
636304|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
636305|NCT03323372|Protective Agents|protective agents|mesh-ancestor
636306|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636307|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
636308|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
636309|NCT03323346|Disulfiram|disulfiram|mesh-list
636310|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
636311|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
636312|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636313|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220067|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220068|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
2220069|NCT00038064|Hematinics|hematinics|mesh-ancestor
2220070|NCT00038077|Metoprolol|metoprolol|mesh-list
2220071|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2220072|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2220073|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
2220074|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
2220075|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2220076|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220077|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2220078|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2220079|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2081283|NCT02083965|Coagulants|coagulants|mesh-ancestor
2081284|NCT02084056|Metformin|metformin|mesh-list
2081285|NCT02084056|Linagliptin|linagliptin|mesh-list
2081286|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2081287|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081288|NCT02084056|Incretins|incretins|mesh-ancestor
2081289|NCT02084056|Hormones|hormones|mesh-ancestor
2081290|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081291|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2220080|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
636337|NCT03323047|Dexamethasone|dexamethasone|mesh-list
636338|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
636339|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
636340|NCT03323047|BB 1101|bb 1101|mesh-list
636341|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
636342|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
636343|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
636344|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636345|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636346|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
636347|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
636348|NCT03323047|Hormones|hormones|mesh-ancestor
636349|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
636350|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
636351|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636352|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
636353|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636354|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636355|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
636356|NCT03323047|Analgesics|analgesics|mesh-ancestor
636357|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
636358|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
636359|NCT03323034|Irinotecan|irinotecan|mesh-list
636360|NCT03323034|Temozolomide|temozolomide|mesh-list
636361|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
636362|NCT03323034|Pevonedistat|pevonedistat|mesh-list
636363|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
636364|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
636365|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636366|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636367|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
636368|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
636369|NCT03322995|Fluorouracil|fluorouracil|mesh-list
636370|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
636371|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636372|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
636373|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636374|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
636375|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
636376|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636377|NCT03322969|Paclitaxel|paclitaxel|mesh-list
636378|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
636379|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636380|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
636381|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
636382|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
636383|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636384|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
636385|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
636386|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
636387|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636388|NCT03322878|Analgesics|analgesics|mesh-ancestor
636389|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
636390|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636391|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
636392|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
636393|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
636394|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
636395|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636396|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
636397|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
636398|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
636399|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
636400|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
636401|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636402|NCT03322800|Ziresovir|ziresovir|mesh-list
636403|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
636404|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
636405|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
636406|NCT03322735|Fludarabine|fludarabine|mesh-list
636407|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
636408|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
636409|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636410|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
636411|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
636412|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
636413|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636414|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636415|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2081292|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
2081293|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081294|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081295|NCT02084069|Atorvastatin|atorvastatin|mesh-list
2081296|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2081297|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2081298|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
2081299|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081300|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2081301|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2081302|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081303|NCT02084082|Metformin|metformin|mesh-list
2081304|NCT02084082|Linagliptin|linagliptin|mesh-list
2081305|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
636430|NCT03322631|Tirzepatide|tirzepatide|mesh-list
636431|NCT03322631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
636432|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636433|NCT03322631|Incretins|incretins|mesh-ancestor
636434|NCT03322631|Hormones|hormones|mesh-ancestor
636435|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2220081|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2220082|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220083|NCT00038090|Thalidomide|thalidomide|mesh-list
2220084|NCT00038090|Dexamethasone|dexamethasone|mesh-list
2220085|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2220086|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
636442|NCT03322488|Metronidazole|metronidazole|mesh-list
636443|NCT03322488|Doxycycline|doxycycline|mesh-list
636444|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
636445|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
636446|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
636447|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
636448|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
636449|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
636450|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
636451|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
636452|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636453|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636454|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636455|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
636456|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
636457|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
636458|NCT03322358|Promethazine|promethazine|mesh-list
636459|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
636460|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
636461|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
636462|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636463|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
636464|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
636465|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
636466|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636467|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
636468|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
636469|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
636470|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
636471|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
636472|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
636473|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
636474|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636475|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
636476|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
636477|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
2220087|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
2220088|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2220089|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081306|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081307|NCT02084082|Incretins|incretins|mesh-ancestor
2081308|NCT02084082|Hormones|hormones|mesh-ancestor
2081309|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081310|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2081311|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
2081312|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636489|NCT03322267|Cisplatin|cisplatin|mesh-list
636490|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
636491|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636492|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
636493|NCT03322215|Capecitabine|capecitabine|mesh-list
636494|NCT03322215|Fulvestrant|fulvestrant|mesh-list
636495|NCT03322215|Palbociclib|palbociclib|mesh-list
636496|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
636497|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
636498|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636499|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636500|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
636501|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
636502|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
636503|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
636504|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
636505|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636506|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
636507|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636508|NCT03322150|Atropine|atropine|mesh-list
636509|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
636510|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
636511|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
636512|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
636513|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
636514|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636515|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636516|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
636517|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
636518|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
636519|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
636520|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
636521|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
636522|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
636523|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
636524|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636525|NCT03322124|Octenidine|octenidine|mesh-list
636526|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
636527|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
636528|NCT03322098|Atropine|atropine|mesh-list
636529|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
636530|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
636531|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
636532|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
636533|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
636534|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636535|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636536|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
636537|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
636538|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
636539|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
636540|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
636541|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
636542|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
636543|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
636544|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636545|NCT03321981|Trastuzumab|trastuzumab|mesh-list
636546|NCT03321981|Letrozole|letrozole|mesh-list
636547|NCT03321981|Vinorelbine|vinorelbine|mesh-list
636548|NCT03321981|Fulvestrant|fulvestrant|mesh-list
636549|NCT03321981|Exemestane|exemestane|mesh-list
636550|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
636551|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636552|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
636553|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
636554|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636555|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636556|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
636557|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
636558|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
636559|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636560|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
636561|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
636562|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
636563|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
636564|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
636565|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
636566|NCT03321955|Ziconotide|ziconotide|mesh-list
636567|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
636568|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
636569|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636570|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
636571|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636572|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
636573|NCT03321955|Protective Agents|protective agents|mesh-ancestor
636574|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
636575|NCT03321955|Analgesics|analgesics|mesh-ancestor
636576|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
636577|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636578|NCT03321903|Charcoal|charcoal|mesh-list
636579|NCT03321903|Antidotes|antidotes|mesh-ancestor
636580|NCT03321903|Protective Agents|protective agents|mesh-ancestor
636581|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636582|NCT03321890|Prednisone|prednisone|mesh-list
636583|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
636584|NCT03321890|Methotrexate|methotrexate|mesh-list
636585|NCT03321890|Etoposide|etoposide|mesh-list
636586|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
636587|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
636588|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636589|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
636590|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
636591|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
636592|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636593|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636594|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
636595|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
636596|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
636597|NCT03321890|Hormones|hormones|mesh-ancestor
636598|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
636599|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
636600|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
636601|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
636602|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
636603|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
636604|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
636605|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
636606|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636607|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
636608|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
636609|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
636610|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
636611|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
636612|NCT03321825|Lidocaine|lidocaine|mesh-list
636613|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
636614|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
636615|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
636616|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
636617|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636618|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
636619|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636620|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
636621|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
636622|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
636623|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
636624|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636625|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
636626|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
636627|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
636628|NCT03321825|Protective Agents|protective agents|mesh-ancestor
636629|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
636630|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
636631|NCT03321773|Amoxicillin|amoxicillin|mesh-list
636632|NCT03321773|Metronidazole|metronidazole|mesh-list
636633|NCT03321773|Clarithromycin|clarithromycin|mesh-list
636634|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
636635|NCT03321773|Pantoprazole|pantoprazole|mesh-list
636636|NCT03321773|Bismuth|bismuth|mesh-list
636637|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
636638|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
636639|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
636640|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
636641|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
636642|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636643|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636644|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
636645|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
636646|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
636647|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
636648|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
636649|NCT03321773|Antacids|antacids|mesh-ancestor
636650|NCT03321734|Caffeine|caffeine|mesh-list
636651|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
636652|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636653|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
636654|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636655|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636656|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
636657|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
636658|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
636659|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
636660|NCT03321656|Tacrolimus|tacrolimus|mesh-list
636661|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
636662|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
636663|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636664|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
636665|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636666|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636693|NCT03321526|Norepinephrine|norepinephrine|mesh-list
636694|NCT03321526|Quetiapine Fumarate|quetiapine fumarate|mesh-list
636695|NCT03321526|Serotonin|serotonin|mesh-list
636696|NCT03321526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
636697|NCT03321526|Antidepressive Agents|antidepressive agents|mesh-ancestor
636698|NCT03321526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
636699|NCT03321526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
636700|NCT03321526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
636701|NCT03321526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
636702|NCT03321526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636703|NCT03321526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
636704|NCT03321526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
636705|NCT03321526|Adrenergic Agents|adrenergic agents|mesh-ancestor
636706|NCT03321526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
636707|NCT03321526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636708|NCT03321526|Sympathomimetics|sympathomimetics|mesh-ancestor
636709|NCT03321526|Autonomic Agents|autonomic agents|mesh-ancestor
636710|NCT03321526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636711|NCT03321526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
636712|NCT03321526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
636713|NCT03321526|Serotonin Agents|serotonin agents|mesh-ancestor
636714|NCT03321526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
636715|NCT03321526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2220090|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2220091|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
2220092|NCT00038090|Hormones|hormones|mesh-ancestor
636728|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
636729|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
636730|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
636731|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636732|NCT03321318|Vitamins|vitamins|mesh-ancestor
636733|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
636734|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
636735|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
636736|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
636737|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
636738|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
636739|NCT03321292|Aspirin|aspirin|mesh-list
636740|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
636741|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
636742|NCT03321292|Analgesics|analgesics|mesh-ancestor
636743|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
636744|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636745|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636746|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
636747|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
636748|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
636749|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
636750|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636751|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
636752|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
636753|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636754|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
636755|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
636756|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
636757|NCT03321201|Coagulants|coagulants|mesh-ancestor
636766|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
636767|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
636768|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636769|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
636770|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
636771|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
636772|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
636773|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636774|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
636775|NCT03321110|Ubiquinone|ubiquinone|mesh-list
636776|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
636777|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
636778|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636779|NCT03321110|Vitamins|vitamins|mesh-ancestor
2220093|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2220094|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2220095|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220096|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220097|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
2220098|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
2220099|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
636787|NCT03321045|Trastuzumab|trastuzumab|mesh-list
2220100|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
636788|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
636789|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636790|NCT03321019|Capsaicin|capsaicin|mesh-list
636791|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
636792|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
636793|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
636794|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636795|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220101|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2220102|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2220103|NCT00038090|Growth Substances|growth substances|mesh-ancestor
2220104|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
2220105|NCT00038116|Dopamine|dopamine|mesh-list
2220106|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2220107|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
2220108|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
2220109|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2220110|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220111|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
2220112|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2220113|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220114|NCT00038116|Protective Agents|protective agents|mesh-ancestor
2220115|NCT00038168|Paclitaxel|paclitaxel|mesh-list
2220116|NCT00038168|Estramustine|estramustine|mesh-list
2220117|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
636813|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
636814|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
636815|NCT03320967|Coagulants|coagulants|mesh-ancestor
636816|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
636817|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
636818|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
636819|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220118|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220119|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
2220120|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
2220121|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
2220122|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636825|NCT03320928|Methotrexate|methotrexate|mesh-list
636826|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
636827|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
636828|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
636829|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636830|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
636831|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
636832|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636833|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636834|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
636835|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636836|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
636837|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
636838|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
636839|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
636840|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
636841|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
636842|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
636843|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636844|NCT03320915|Vitamins|vitamins|mesh-ancestor
636845|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
636846|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2220123|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2220124|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
2220125|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2220126|NCT00038181|Thalidomide|thalidomide|mesh-list
2220127|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220128|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
2220129|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220130|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
2220131|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2220132|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220133|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
636858|NCT03320707|Daratumumab|daratumumab|mesh-list
636859|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636860|NCT03320694|Insulin|insulin|mesh-list
636861|NCT03320694|Metformin|metformin|mesh-list
2220134|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2220135|NCT00038181|Growth Substances|growth substances|mesh-ancestor
636862|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
636863|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
636864|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
636865|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636866|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
636867|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636868|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636869|NCT03320629|Apatinib|apatinib|mesh-list
636870|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636871|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
636872|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636873|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636874|NCT03320603|Thrombin|thrombin|mesh-list
636875|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
636876|NCT03320603|Coagulants|coagulants|mesh-ancestor
2220136|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
2220137|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220138|NCT00038194|Docetaxel|docetaxel|mesh-list
636880|NCT03320538|Rabeprazole|rabeprazole|mesh-list
636881|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
636882|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
636883|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
636884|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636885|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636886|NCT03320486|Ketoconazole|ketoconazole|mesh-list
636887|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
636888|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
636889|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
636890|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
636891|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636892|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636893|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
636894|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
636895|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
636896|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636897|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
636898|NCT03320460|Clobetasol|clobetasol|mesh-list
636899|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
636900|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
636901|NCT03320460|Hormones|hormones|mesh-ancestor
636902|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
636903|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636904|NCT03320447|Lidocaine|lidocaine|mesh-list
636905|NCT03320447|Prilocaine|prilocaine|mesh-list
636906|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
636907|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
636908|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
636909|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
636910|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
636911|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
636912|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636913|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
636914|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636915|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
636916|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
636917|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
636918|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
636919|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636920|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
636921|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
636922|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
636923|NCT03320434|Prednisolone acetate|prednisolone acetate|mesh-list
636924|NCT03320434|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
636925|NCT03320434|Methylprednisolone|methylprednisolone|mesh-list
636926|NCT03320434|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
636927|NCT03320434|Prednisolone|prednisolone|mesh-list
636928|NCT03320434|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
636929|NCT03320434|Prednisolone phosphate|prednisolone phosphate|mesh-list
636930|NCT03320434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
636931|NCT03320434|Antiemetics|antiemetics|mesh-ancestor
636932|NCT03320434|Autonomic Agents|autonomic agents|mesh-ancestor
636933|NCT03320434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
636934|NCT03320434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636935|NCT03320434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
636936|NCT03320434|Glucocorticoids|glucocorticoids|mesh-ancestor
636937|NCT03320434|Hormones|hormones|mesh-ancestor
636938|NCT03320434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
636939|NCT03320434|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
636940|NCT03320434|Protective Agents|protective agents|mesh-ancestor
636941|NCT03320434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
636942|NCT03320434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
636943|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
636944|NCT03320187|Dinoprostone|dinoprostone|mesh-list
636945|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
636946|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
636947|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
636948|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636949|NCT03320174|Tafenoquine|tafenoquine|mesh-list
636950|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
636951|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
636952|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
636953|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
636954|NCT03320109|Vitamin D|vitamin d|mesh-list
636955|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
636956|NCT03320109|Vitamins|vitamins|mesh-list
636957|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
636958|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636959|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
636960|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2081313|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081314|NCT02084134|Dexamethasone|dexamethasone|mesh-list
2081315|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
2081316|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
2220139|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
2220140|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220141|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
2220142|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
2220143|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
2220144|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220145|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2220146|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220147|NCT00038207|Vincristine|vincristine|mesh-list
2220148|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2220149|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220150|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
2220151|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
2220152|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
2220153|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220154|NCT00038220|Ritonavir|ritonavir|mesh-list
636981|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
636982|NCT03320031|Linagliptin|linagliptin|mesh-list
636983|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
636984|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
636985|NCT03320031|Incretins|incretins|mesh-ancestor
636986|NCT03320031|Hormones|hormones|mesh-ancestor
636987|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
636988|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
636989|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
636990|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
636991|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
636992|NCT03320018|Minocycline|minocycline|mesh-list
636993|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
636994|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220155|NCT00038220|Lopinavir|lopinavir|mesh-list
2220156|NCT00038220|Tenofovir|tenofovir|mesh-list
2220157|NCT00038220|Lamivudine|lamivudine|mesh-list
2220158|NCT00038220|Efavirenz|efavirenz|mesh-list
2220159|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2081317|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2081318|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2081319|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
637003|NCT03319901|Venetoclax|venetoclax|mesh-list
637004|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637005|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
637006|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
637007|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637008|NCT03319823|Diuretics|diuretics|mesh-ancestor
637009|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
2081320|NCT02084134|BB 1101|bb 1101|mesh-list
2220160|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2220161|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
637010|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220162|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220163|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220164|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2220165|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2220166|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
637016|NCT03319784|Triamcinolone|triamcinolone|mesh-list
637017|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
637018|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
637019|NCT03319784|Ketorolac|ketorolac|mesh-list
637020|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
637021|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
637022|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
637023|NCT03319784|Hormones|hormones|mesh-ancestor
637024|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
637025|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637026|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
637027|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
637028|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637029|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637030|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
637031|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
637032|NCT03319784|Analgesics|analgesics|mesh-ancestor
637033|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
637034|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637035|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
637036|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
637037|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
637038|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
637039|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220167|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220168|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2220169|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2220170|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2220171|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2220172|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2220173|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2220174|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2220175|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2220176|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2220177|NCT00038233|Thalidomide|thalidomide|mesh-list
2220178|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220179|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
2220180|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220181|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
2220182|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
637057|NCT03319706|Olmesartan|olmesartan|mesh-list
637058|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
637059|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
637060|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
637061|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
637062|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637063|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
637064|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2081321|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081322|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
2081323|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
2081324|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081325|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081326|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2081327|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
2081328|NCT02084134|Hormones|hormones|mesh-ancestor
2081329|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081330|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2081331|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081332|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
2081333|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081334|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081335|NCT02084238|Interleukin-2|interleukin-2|mesh-list
2081336|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081337|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2081338|NCT02084238|Analgesics|analgesics|mesh-ancestor
2081339|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
2081340|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081341|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081342|NCT02084511|Celecoxib|celecoxib|mesh-list
2081343|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2081344|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2081345|NCT02084511|Analgesics|analgesics|mesh-ancestor
2081346|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
2081347|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081348|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081349|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081350|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2081351|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2081352|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2081353|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081354|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081355|NCT02084706|Triamcinolone|triamcinolone|mesh-list
2081356|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2081357|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2081358|NCT02084706|Lidocaine|lidocaine|mesh-list
2081359|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2081360|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
2081361|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
637108|NCT03319563|Epinephrine|epinephrine|mesh-list
637109|NCT03319563|Anesthetics|anesthetics|mesh-list
637110|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
637111|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
637112|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
637113|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
637114|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637115|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637116|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637117|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
637118|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
637119|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
637120|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637121|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
637122|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
637123|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
637124|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
637125|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
637126|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637127|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
637128|NCT03319550|Caseins|caseins|mesh-list
637129|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
637130|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
637131|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637132|NCT03319537|Pemetrexed|pemetrexed|mesh-list
637133|NCT03319537|Pevonedistat|pevonedistat|mesh-list
637134|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637135|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637136|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637137|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
637138|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
637139|NCT03319498|Peppermint oil|peppermint oil|mesh-list
637140|NCT03319498|Mineral Oil|mineral oil|mesh-list
637141|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
637142|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
637143|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637144|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637145|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
637146|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
637147|NCT03319498|Emollients|emollients|mesh-ancestor
637148|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
2081362|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2081363|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081364|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
2220183|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
637153|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
637154|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2220184|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2220185|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
637313|NCT03318770|Dasatinib|dasatinib|mesh-list
2220186|NCT00038233|Growth Substances|growth substances|mesh-ancestor
2220187|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
2220188|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220189|NCT00038246|Thalidomide|thalidomide|mesh-list
637167|NCT03319238|Ketamine|ketamine|mesh-list
637168|NCT03319238|Analgesics|analgesics|mesh-ancestor
637169|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
637170|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637171|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637172|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
637173|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
637174|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
637175|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
637176|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637177|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
637178|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
637179|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637180|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637181|NCT03319121|Theophylline|theophylline|mesh-list
637182|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
637183|NCT03319121|Lansoprazole|lansoprazole|mesh-list
637184|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
637185|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
637186|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637187|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637188|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
637189|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
637190|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
637191|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637192|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637193|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
637194|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
637195|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
637196|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
637197|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637198|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
637199|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
637200|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
637201|NCT03319043|Budesonide|budesonide|mesh-list
637202|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
637203|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
637204|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
637205|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
637206|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637207|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637208|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
637209|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
637210|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
637211|NCT03319043|Hormones|hormones|mesh-ancestor
637212|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
637213|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
637214|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
637215|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
637216|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
637217|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637218|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081365|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081366|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2081367|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2081368|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2220190|NCT00038246|Paclitaxel|paclitaxel|mesh-list
2081369|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2081370|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081371|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081372|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
2081373|NCT02084706|Hormones|hormones|mesh-ancestor
2081374|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081375|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2081376|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
2081377|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081378|NCT02084797|Tolvaptan|tolvaptan|mesh-list
2081379|NCT02084797|Vasopressins|vasopressins|mesh-list
2081380|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
2081381|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2081382|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081383|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
2081384|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081385|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
637254|NCT03318887|Ribavirin|ribavirin|mesh-list
637255|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
637256|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
637257|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637258|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
637259|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081386|NCT02084797|Coagulants|coagulants|mesh-ancestor
2081387|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2081388|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2081389|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
2081390|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2081391|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081392|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
2081393|NCT02085161|Olodaterol|olodaterol|mesh-list
2081394|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2081395|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
2081396|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081397|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081398|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2081399|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
2081400|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
2081401|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2081402|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
637277|NCT03318835|Thalidomide|thalidomide|mesh-list
637278|NCT03318835|Prednisone|prednisone|mesh-list
637279|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
637280|NCT03318835|Vincristine|vincristine|mesh-list
637281|NCT03318835|Rituximab|rituximab|mesh-list
637282|NCT03318835|Doxorubicin|doxorubicin|mesh-list
637283|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
637284|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
637285|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637286|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
637287|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
637288|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
637289|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
637290|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
637291|NCT03318835|Growth Substances|growth substances|mesh-ancestor
637292|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
637293|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637294|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
637295|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
637296|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
637297|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637298|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
637299|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
637300|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
637301|NCT03318835|Hormones|hormones|mesh-ancestor
637302|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
637303|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
637304|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
637305|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
637306|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
637307|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
637308|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
637309|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
637310|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
637311|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
637312|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637314|NCT03318770|Blinatumomab|blinatumomab|mesh-list
637315|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637316|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
637317|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637318|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637319|NCT03318757|Bupivacaine|bupivacaine|mesh-list
637320|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
637321|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
637322|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637323|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637324|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
637325|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637326|NCT03318744|Aspirin|aspirin|mesh-list
637327|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
637328|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
637329|NCT03318744|Analgesics|analgesics|mesh-ancestor
637330|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
637331|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637332|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637333|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
637334|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
637335|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
637336|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
637337|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637338|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
637339|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
637340|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637341|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
637342|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
637343|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
637344|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637345|NCT03318718|Rocuronium|rocuronium|mesh-list
637346|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637347|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
637348|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
637349|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
637350|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637351|NCT03318536|Granisetron|granisetron|mesh-list
637352|NCT03318536|Serotonin|serotonin|mesh-list
637353|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
637354|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
637355|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637356|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637357|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
637358|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
637359|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
637360|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637361|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637362|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
637363|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
637364|NCT03318471|Analgesics|analgesics|mesh-ancestor
637365|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
637366|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637367|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637368|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
637369|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637370|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
637371|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
637372|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
637373|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
637374|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637375|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
637376|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
637377|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
637378|NCT03318445|Irinotecan|irinotecan|mesh-list
637379|NCT03318445|Rucaparib|rucaparib|mesh-list
637380|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
637381|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
637382|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637383|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637384|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637385|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
637386|NCT03318419|Cytarabine|cytarabine|mesh-list
637387|NCT03318419|Pegaspargase|pegaspargase|mesh-list
637388|NCT03318419|Asparaginase|asparaginase|mesh-list
637389|NCT03318419|Cladribine|cladribine|mesh-list
637390|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
637391|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
637392|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637393|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637394|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
637395|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
637396|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
637397|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
637398|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637399|NCT03318393|Heparin|heparin|mesh-list
637400|NCT03318393|Calcium heparin|calcium heparin|mesh-list
637401|NCT03318393|Bivalirudin|bivalirudin|mesh-list
637402|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
637403|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
637404|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
637405|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637406|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
637407|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
637408|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
637409|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637410|NCT03318354|Olmesartan|olmesartan|mesh-list
637411|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
637412|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
637413|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
637414|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
637415|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220191|NCT00038246|Estramustine|estramustine|mesh-list
2220192|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2220193|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637419|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
637420|NCT03318211|Analgesics|analgesics|mesh-ancestor
637421|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
637422|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637423|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637424|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
637425|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637426|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
637427|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
637428|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
637429|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
637430|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637431|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
637432|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
637433|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
637434|NCT03318159|Posaconazole|posaconazole|mesh-list
637435|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
637436|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
637437|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
637438|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
637439|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
637440|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
637441|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
637442|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637443|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637444|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
637445|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
637446|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
637447|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637448|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
637449|NCT03318146|Latanoprost|latanoprost|mesh-list
637450|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
637451|NCT03318133|Anesthetics|anesthetics|mesh-list
637452|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637453|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637454|NCT03318094|Nitroprusside|nitroprusside|mesh-list
637455|NCT03318094|Phentolamine|phentolamine|mesh-list
637456|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
637457|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
637458|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
637459|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
637460|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
637461|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637462|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
637463|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637464|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637465|NCT03318029|Vitamin D|vitamin d|mesh-list
637466|NCT03318029|Vitamins|vitamins|mesh-ancestor
637467|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
637468|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637469|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
637470|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
637471|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
637472|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
637473|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637474|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
637475|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
637476|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
637477|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637478|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637479|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
637480|NCT03317912|Lidocaine|lidocaine|mesh-list
637481|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
637482|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
637483|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637484|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637485|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
637486|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637487|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
637488|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
637489|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
637490|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
637491|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637492|NCT03317899|Lenograstim|lenograstim|mesh-list
637493|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
637494|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
637495|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637496|NCT03317847|Dexamethasone|dexamethasone|mesh-list
637497|NCT03317847|Bromfenac|bromfenac|mesh-list
637498|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
637499|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
637500|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
637501|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
637502|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637503|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637504|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
637505|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
637506|NCT03317847|Hormones|hormones|mesh-ancestor
637507|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
637508|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
637509|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637510|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
637511|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
637512|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
637513|NCT03317847|Analgesics|analgesics|mesh-ancestor
637514|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
637515|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2751710|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
2751711|NCT03858049|Progestins|progestins|mesh-ancestor
2751712|NCT03858049|Hormones|hormones|mesh-ancestor
2751713|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2751714|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751715|NCT03852888|Methotrexate|methotrexate|mesh-list
2751716|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
2751717|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
637530|NCT03317730|Oxycodone|oxycodone|mesh-list
637531|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
637532|NCT03317730|Narcotics|narcotics|mesh-ancestor
637533|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637534|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637535|NCT03317730|Analgesics|analgesics|mesh-ancestor
637536|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
637537|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637538|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
637539|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
637540|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637541|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637542|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
637543|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
637544|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637545|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
637546|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637547|NCT03317652|Nitroprusside|nitroprusside|mesh-list
637548|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
637549|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
637550|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
637551|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637552|NCT03317613|Capsaicin|capsaicin|mesh-list
637553|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
637554|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
637555|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
637556|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637557|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637558|NCT03317600|Lidocaine|lidocaine|mesh-list
637559|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
637560|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
637561|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637562|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637563|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
637564|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637565|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
637566|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
637567|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
637568|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
637569|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637570|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
637571|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
637572|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
637573|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
637574|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
637575|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637576|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
637577|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637578|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637579|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
637580|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637581|NCT03317548|Progesterone|progesterone|mesh-list
637582|NCT03317548|Progestins|progestins|mesh-ancestor
637583|NCT03317548|Hormones|hormones|mesh-ancestor
637584|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
637585|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637586|NCT03317535|Anesthetics|anesthetics|mesh-list
637587|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637588|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637608|NCT03317457|Doxorubicin|doxorubicin|mesh-list
637609|NCT03317457|Durvalumab|durvalumab|mesh-list
637610|NCT03317457|Tremelimumab|tremelimumab|mesh-list
637611|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
637612|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637613|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
637614|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
637615|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637616|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637617|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
637618|NCT03317405|Tamoxifen|tamoxifen|mesh-list
637619|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
637620|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
637621|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
637622|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637623|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
637624|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637625|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
637626|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
637627|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2081403|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081404|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081405|NCT02085252|Bicalutamide|bicalutamide|mesh-list
2081406|NCT02085252|Leuprolide|leuprolide|mesh-list
2081407|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
2081408|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
637634|NCT03317327|Nivolumab|nivolumab|mesh-list
637635|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
637636|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637637|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
637638|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637639|NCT03317275|Fluorides|fluorides|mesh-list
637640|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
637641|NCT03317275|Protective Agents|protective agents|mesh-ancestor
637642|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637643|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
637644|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
637645|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
637646|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
637647|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
637648|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637649|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081409|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081410|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081411|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081412|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2081413|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
2081414|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2081415|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2081416|NCT02085447|Haloperidol|haloperidol|mesh-list
2081417|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2081418|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
2081419|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
2081420|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2081421|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637663|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
637664|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
637665|NCT03317210|Hematinics|hematinics|mesh-ancestor
637666|NCT03317197|Vasopressins|vasopressins|mesh-list
637667|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
637668|NCT03317197|Epinephrine|epinephrine|mesh-list
637669|NCT03317197|Racepinephrine|racepinephrine|mesh-list
637670|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
637671|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
637672|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
637673|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
637674|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637675|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637676|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637677|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
637678|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
637679|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
637680|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637681|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
637682|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
637683|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
637684|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
637685|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
637686|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
637687|NCT03317197|Coagulants|coagulants|mesh-ancestor
637688|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
637689|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
637690|NCT03317158|Durvalumab|durvalumab|mesh-list
637691|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
637692|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
637693|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637694|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
637695|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
637696|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637697|NCT03317119|Trifluridine|trifluridine|mesh-list
637698|NCT03317119|Trametinib|trametinib|mesh-list
637699|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637700|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
637701|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637702|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637703|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
637704|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
637705|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
637706|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
637707|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
637708|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
637709|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
637710|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
637711|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
637712|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637713|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637714|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
637715|NCT03317067|Analgesics|analgesics|mesh-ancestor
637716|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
637717|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637718|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
637719|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
637720|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
637721|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
637722|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637723|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637724|NCT03317015|Fluticasone|fluticasone|mesh-list
637725|NCT03317015|Triamcinolone|triamcinolone|mesh-list
637726|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
637727|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
637728|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
637729|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637730|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637731|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
637732|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
637733|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
637734|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
637735|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
637736|NCT03317015|Hormones|hormones|mesh-ancestor
637737|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2220194|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
2220195|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
2220196|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
2220197|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220198|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220199|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
2220200|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637745|NCT03316963|Neostigmine|neostigmine|mesh-list
637746|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
637747|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637748|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637749|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
637750|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637751|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637752|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
637753|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
637754|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637755|NCT03316898|Memantine|memantine|mesh-list
637756|NCT03316898|Donepezil|donepezil|mesh-list
637757|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
637758|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637759|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637760|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
637761|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637762|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637763|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
637764|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
637765|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
637766|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
637767|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
637768|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2081422|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081423|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2081424|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
637772|NCT03316859|Naloxegol|naloxegol|mesh-list
637773|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
637774|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637775|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
637776|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2220201|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
2220202|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2220203|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
637780|NCT03316781|Adalimumab|adalimumab|mesh-list
637781|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
637782|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
637783|NCT03316690|Metformin|metformin|mesh-list
637784|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
637785|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637786|NCT03316599|Gemcitabine|gemcitabine|mesh-list
637787|NCT03316599|Paclitaxel|paclitaxel|mesh-list
637788|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
637789|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637790|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
637791|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
637792|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
637793|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637794|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
637795|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
637796|NCT03316599|Antiviral Agents|antiviral agents|mesh-ancestor
637797|NCT03316599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
637798|NCT03316599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637799|NCT03316599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
637800|NCT03316599|Immunologic Factors|immunologic factors|mesh-ancestor
637801|NCT03316599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637807|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
637808|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
637809|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637810|NCT03316534|Aspirin|aspirin|mesh-list
637811|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
637812|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
637813|NCT03316534|Analgesics|analgesics|mesh-ancestor
637814|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
637815|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637816|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637817|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
637818|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
637819|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
637820|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
637821|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637822|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
637823|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
637824|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637825|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
637826|NCT03316482|Leuprolide|leuprolide|mesh-list
637827|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
637828|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
637829|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
637830|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637831|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
637832|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637833|NCT03316469|Clomiphene|clomiphene|mesh-list
637834|NCT03316469|Enclomiphene|enclomiphene|mesh-list
637835|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
637836|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
637837|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
637838|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
637839|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637840|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
637841|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
637842|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
637843|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
637844|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2220204|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2220205|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2220206|NCT00038246|Growth Substances|growth substances|mesh-ancestor
2220207|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
2220208|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2220209|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
2220210|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
637852|NCT03316352|Bupivacaine|bupivacaine|mesh-list
637853|NCT03316352|Anesthetics|anesthetics|mesh-list
637854|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
637855|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637856|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637857|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
637858|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637859|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
637860|NCT03316339|Remifentanil|remifentanil|mesh-list
637861|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
637862|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637863|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637864|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
637865|NCT03316339|Analgesics|analgesics|mesh-ancestor
637866|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
637867|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637868|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
637869|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
637870|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
637871|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
637872|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637873|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637874|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
637875|NCT03316339|Narcotics|narcotics|mesh-ancestor
637876|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
637877|NCT03316326|Irinotecan|irinotecan|mesh-list
637878|NCT03316326|Tegafur|tegafur|mesh-list
637879|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637880|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
637881|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
637882|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637883|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637884|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
637885|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
637886|NCT03316313|Antibodies|antibodies|mesh-list
637887|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
637888|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
637889|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081425|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2081426|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
2081427|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081428|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081429|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2220211|NCT00038259|Aldesleukin|aldesleukin|mesh-list
2220212|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220213|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2220214|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2220215|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
2220216|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220217|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
2220218|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2220219|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637904|NCT03316118|Bupivacaine|bupivacaine|mesh-list
637905|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
637906|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
637907|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637908|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637909|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
637910|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637911|NCT03316066|Ropivacaine|ropivacaine|mesh-list
637912|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
637913|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
637914|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637915|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637916|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
637917|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637918|NCT03315923|Rituximab|rituximab|mesh-list
637919|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
637920|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
637921|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
637922|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637923|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
637924|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637925|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
637926|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
637927|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2081430|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2081431|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
2081432|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
2081433|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
2081434|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081435|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2081436|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2081437|NCT02085460|Rebamipide|rebamipide|mesh-list
2081438|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2081439|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
637938|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
637939|NCT03315897|Hematinics|hematinics|mesh-ancestor
637940|NCT03315845|Anesthetics|anesthetics|mesh-list
637941|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
637942|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081440|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
2081441|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081442|NCT02085460|Protective Agents|protective agents|mesh-ancestor
2081443|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081444|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220220|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2220221|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
2220222|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2220223|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220224|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220225|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220226|NCT00038376|Interferons|interferons|mesh-list
2220227|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
2220228|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
2220229|NCT00038376|Isotretinoin|isotretinoin|mesh-list
2220230|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220231|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
2220232|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220233|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
2220234|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220235|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
637964|NCT03315741|Pirfenidone|pirfenidone|mesh-list
637965|NCT03315741|Analgesics|analgesics|mesh-ancestor
637966|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
637967|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637968|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637969|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
637970|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
637971|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
637972|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
637973|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
637974|NCT03315676|Esomeprazole|esomeprazole|mesh-list
637975|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
637976|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
637977|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
637978|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637979|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220236|NCT00038389|Rofecoxib|rofecoxib|mesh-list
2220237|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2220238|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2220239|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
637984|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
637985|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2081445|NCT02086175|Rituximab|rituximab|mesh-list
2081446|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2220240|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637986|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
637987|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
637988|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
637989|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
637990|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
637991|NCT03315533|Analgesics|analgesics|mesh-ancestor
637992|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
637993|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
637994|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
637995|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
637996|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
637997|NCT03315520|Cytarabine|cytarabine|mesh-list
637998|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
637999|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
638000|NCT03315520|Etoposide|etoposide|mesh-list
638001|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
638002|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
638003|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638004|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
638005|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
638006|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
638007|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638008|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638009|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
638010|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
638011|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
638012|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
638013|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638014|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
638015|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
638016|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
638017|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638018|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
638019|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
638020|NCT03315442|Caffeine|caffeine|mesh-list
638021|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
638022|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638023|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
638024|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638025|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638026|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
638027|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
638028|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
638029|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
638030|NCT03315364|Paclitaxel|paclitaxel|mesh-list
638031|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
638032|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
638033|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638034|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
638035|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
638036|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
638037|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638038|NCT03315338|Prednisone|prednisone|mesh-list
638039|NCT03315338|Cortisone|cortisone|mesh-list
638040|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
638041|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
638042|NCT03315338|Hormones|hormones|mesh-ancestor
638043|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
638044|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638045|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
638046|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638047|NCT03315312|Fluorides|fluorides|mesh-list
638048|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
638049|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
638050|NCT03315312|Protective Agents|protective agents|mesh-ancestor
638051|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081447|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081448|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
638054|NCT03315143|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
638055|NCT03315143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
638056|NCT03315143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638057|NCT03315143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
638058|NCT03315143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220241|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2220242|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2220243|NCT00038389|Analgesics|analgesics|mesh-ancestor
2220244|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
2220245|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2751718|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
638065|NCT03315091|Adavosertib|adavosertib|mesh-list
638066|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638067|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638068|NCT03315078|Busulfan|busulfan|mesh-list
638069|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
638070|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638071|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
638072|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
638073|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638074|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
638075|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638076|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
638077|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
638078|NCT03315052|Prednisone|prednisone|mesh-list
638079|NCT03315052|Budesonide|budesonide|mesh-list
638080|NCT03315052|Tacrolimus|tacrolimus|mesh-list
638081|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
638082|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
638083|NCT03315052|Hormones|hormones|mesh-ancestor
638084|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
638085|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638086|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
638087|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638088|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
638089|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
638090|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
638091|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638092|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638093|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
638094|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
638095|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
638096|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
638097|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638098|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
638099|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
638100|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638101|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
638102|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
638103|NCT03315039|Annamycin|annamycin|mesh-list
638104|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
638105|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081449|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081450|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
638108|NCT03315000|Fluticasone|fluticasone|mesh-list
638109|NCT03315000|Xhance|xhance|mesh-list
638110|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
638111|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
638112|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
638113|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638114|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638115|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
638116|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
638117|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
638118|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2081451|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
2081452|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2081453|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2081454|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081455|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
2081456|NCT02086500|Coagulants|coagulants|mesh-ancestor
2751719|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2751720|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751721|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2751722|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
2751723|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751724|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751725|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
2081465|NCT02086591|Doxycycline|doxycycline|mesh-list
2081466|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2081467|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081468|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
2081469|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2081470|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2081471|NCT02086786|Risperidone|risperidone|mesh-list
2081472|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2081473|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
638143|NCT03314792|Oxycodone|oxycodone|mesh-list
638144|NCT03314792|Tapentadol|tapentadol|mesh-list
638145|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
638146|NCT03314792|Narcotics|narcotics|mesh-ancestor
638147|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
638148|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638149|NCT03314792|Analgesics|analgesics|mesh-ancestor
638150|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
638151|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638152|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
638153|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
638154|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
638155|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638156|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
638157|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
638158|NCT03314740|Paclitaxel|paclitaxel|mesh-list
638159|NCT03314740|Olaparib|olaparib|mesh-list
638160|NCT03314740|Cediranib|cediranib|mesh-list
638161|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
638162|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638163|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
638164|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
638165|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
638166|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638167|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
638168|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638169|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2220246|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220247|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2220248|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220249|NCT00038402|Paclitaxel|paclitaxel|mesh-list
2220250|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
638175|NCT03314636|Dexamethasone|dexamethasone|mesh-list
638176|NCT03314636|Lenalidomide|lenalidomide|mesh-list
638177|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
638178|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
638179|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
638180|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638181|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638182|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
638183|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
638184|NCT03314636|Hormones|hormones|mesh-ancestor
638185|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
638186|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
638187|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638188|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
638189|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
638190|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
638191|NCT03314636|Growth Substances|growth substances|mesh-ancestor
638192|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
638193|NCT03314493|Spironolactone|spironolactone|mesh-list
638194|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
638195|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
638196|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
638197|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638198|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
638199|NCT03314493|Diuretics|diuretics|mesh-ancestor
638200|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
638201|NCT03314363|Trace Elements|trace elements|mesh-list
638202|NCT03314363|Micronutrients|micronutrients|mesh-list
638203|NCT03314363|Citric Acid|citric acid|mesh-list
638204|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
638205|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638206|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
638207|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
638208|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
638209|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
638210|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638211|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
638212|NCT03314298|Anastrozole|anastrozole|mesh-list
638213|NCT03314298|Testosterone|testosterone|mesh-list
638214|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
638215|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
638216|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
638217|NCT03314298|Androgens|androgens|mesh-ancestor
638218|NCT03314298|Hormones|hormones|mesh-ancestor
638219|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
638220|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638221|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
638222|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638223|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
638224|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
638225|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
638226|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638227|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638228|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
638229|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
638230|NCT03314259|Tamsulosin|tamsulosin|mesh-list
638231|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
638232|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
638233|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
638234|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
638235|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
638236|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638237|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638238|NCT03314259|Urological Agents|urological agents|mesh-ancestor
2081474|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081475|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081476|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081477|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2081478|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2081479|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2081480|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2081481|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2081482|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
2081483|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2081484|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2081485|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2081486|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2081487|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
638254|NCT03314064|Dolutegravir|dolutegravir|mesh-list
638255|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
638256|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
638257|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638258|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638259|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
638260|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
638261|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
638262|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638263|NCT03314025|Tamsulosin|tamsulosin|mesh-list
638264|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
638265|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
638266|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
638267|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
638268|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
638269|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638270|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638271|NCT03314025|Urological Agents|urological agents|mesh-ancestor
638272|NCT03313960|Insulin|insulin|mesh-list
638273|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
638274|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638275|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
638276|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
638277|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
638278|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638279|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
638280|NCT03313934|Protective Agents|protective agents|mesh-ancestor
638281|NCT03313869|Vitamin E|vitamin e|mesh-list
638282|NCT03313869|Selenium|selenium|mesh-list
638283|NCT03313869|Vitamins|vitamins|mesh-ancestor
638284|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
638285|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638286|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
638287|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638288|NCT03313869|Protective Agents|protective agents|mesh-ancestor
638289|NCT03313869|Trace Elements|trace elements|mesh-ancestor
638290|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
638291|NCT03313856|Antacids|antacids|mesh-ancestor
638292|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638293|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
638294|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
638295|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638296|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638297|NCT03313791|Caseins|caseins|mesh-list
638298|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
638299|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
638300|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081488|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
2081489|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081490|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638304|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
638305|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
638306|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638307|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
638308|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638309|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
638310|NCT03313726|Hormones|hormones|mesh-ancestor
638311|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
638312|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638313|NCT03313661|Gliclazide|gliclazide|mesh-list
638314|NCT03313661|Cabergoline|cabergoline|mesh-list
638315|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
638316|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
638317|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
638318|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
638319|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
638320|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638321|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638322|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
638323|NCT03313557|Adavosertib|adavosertib|mesh-list
638324|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638325|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638326|NCT03313544|Nivolumab|nivolumab|mesh-list
638327|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
638328|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638329|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
638330|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638331|NCT03313531|Thrombin|thrombin|mesh-list
638332|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
638333|NCT03313531|Coagulants|coagulants|mesh-ancestor
638334|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
638335|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
638336|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
638337|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638338|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
638339|NCT03313479|Analgesics|analgesics|mesh-ancestor
638340|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
638341|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638342|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
638343|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
638344|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
638345|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
638346|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
638347|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638348|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
638349|NCT03313414|Velpatasvir|velpatasvir|mesh-list
638350|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
638351|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638352|NCT03313401|Aflibercept|aflibercept|mesh-list
638353|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
638354|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
638355|NCT03313401|Growth Substances|growth substances|mesh-ancestor
638356|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638357|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
638358|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638359|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
638360|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
638361|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
638362|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
638363|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638364|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
638365|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638366|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
638367|NCT03313323|Ipilimumab|ipilimumab|mesh-list
638368|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
638369|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638370|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
638371|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638372|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
638373|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
638374|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081491|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081492|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
2081493|NCT02087176|Adavosertib|adavosertib|mesh-list
2081494|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081495|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220251|NCT00038402|Fluorouracil|fluorouracil|mesh-list
2220252|NCT00038402|Trastuzumab|trastuzumab|mesh-list
2220253|NCT00038402|Epirubicin|epirubicin|mesh-list
2220254|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2220255|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220256|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
2220257|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
2220258|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
2220259|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220260|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220261|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
638399|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
638400|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
638401|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638402|NCT03312777|Tramadol|tramadol|mesh-list
638403|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
638404|NCT03312777|Narcotics|narcotics|mesh-ancestor
638405|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
638406|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638407|NCT03312777|Analgesics|analgesics|mesh-ancestor
638408|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
638409|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638410|NCT03312738|Everolimus|everolimus|mesh-list
638411|NCT03312738|Exemestane|exemestane|mesh-list
638412|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638413|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
638414|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
638415|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638416|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
638417|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
638418|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638419|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638420|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
638421|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
638422|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
638423|NCT03312699|Vaccines|vaccines|mesh-list
638424|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
638425|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638426|NCT03312582|Metformin|metformin|mesh-list
638427|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
638428|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638429|NCT03312530|Atezolizumab|atezolizumab|mesh-list
638430|NCT03312530|Venetoclax|venetoclax|mesh-list
638431|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220262|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220263|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220264|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2220265|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
2220266|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2220267|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
2220268|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2220269|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2220270|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
638440|NCT03312478|Antibodies|antibodies|mesh-list
638441|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638442|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
638443|NCT03312426|Linrodostat|linrodostat|mesh-list
638444|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638445|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638446|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
638447|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
638448|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
638449|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638450|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
638451|NCT03312413|Analgesics|analgesics|mesh-ancestor
638452|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
638453|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638454|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
638455|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
638456|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
638457|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
638458|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
638459|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751726|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751727|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2751728|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2751729|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
2751730|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
638465|NCT03312335|Aldesleukin|aldesleukin|mesh-list
638466|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638467|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
638468|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
638469|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
638470|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638471|NCT03312283|Ranibizumab|ranibizumab|mesh-list
638472|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
638473|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
638474|NCT03312283|Growth Substances|growth substances|mesh-ancestor
638475|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638476|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
638477|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638478|NCT03312257|Atropine|atropine|mesh-list
638479|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
638480|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
638481|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
638482|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
638483|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638484|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638485|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
638486|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
638487|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
638488|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
638489|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
638490|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
638491|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
638492|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
638493|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638494|NCT03312244|Bromides|bromides|mesh-list
638495|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
638496|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
638497|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
638498|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638499|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638500|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
638501|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
638502|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638503|NCT03312179|Incretins|incretins|mesh-list
638504|NCT03312179|Hormones|hormones|mesh-ancestor
638505|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
638506|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638507|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
638508|NCT03312153|Eusol|eusol|mesh-list
638509|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
638510|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638511|NCT03312140|Choline|choline|mesh-list
638512|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
638513|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
638514|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
638515|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638516|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
638517|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
638518|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
2220271|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2220272|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2220273|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220274|NCT00038480|Ritonavir|ritonavir|mesh-list
2220275|NCT00038480|Lopinavir|lopinavir|mesh-list
2220276|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2220277|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2220278|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
638527|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
638528|NCT03311984|Dalteparin|dalteparin|mesh-list
638529|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
638530|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
638531|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
638532|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638533|NCT03311971|Methamphetamine|methamphetamine|mesh-list
638534|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
638535|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638536|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
638537|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
638538|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638539|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
638540|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
638541|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638542|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
638543|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
638544|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
638545|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
638546|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
638547|NCT03311958|Nivolumab|nivolumab|mesh-list
638548|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
638549|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638550|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
638551|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638552|NCT03311945|Lamivudine|lamivudine|mesh-list
638553|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
638554|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
638555|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
638556|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638557|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638558|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
638559|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638560|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
638561|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
638562|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
638563|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
638564|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
638565|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
638566|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
638567|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638568|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
638569|NCT03311906|Protective Agents|protective agents|mesh-ancestor
2220279|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220280|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220281|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2220282|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2220283|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
2220284|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220285|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2220286|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2220287|NCT00038493|Temozolomide|temozolomide|mesh-list
2220288|NCT00038493|Lonafarnib|lonafarnib|mesh-list
2220289|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2220290|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
2220291|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220292|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220293|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220294|NCT00038506|Tenofovir|tenofovir|mesh-list
2220295|NCT00038506|Lamivudine|lamivudine|mesh-list
2220296|NCT00038506|Zidovudine|zidovudine|mesh-list
2220297|NCT00038506|Abacavir|abacavir|mesh-list
2220298|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2220299|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
2220300|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220301|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2220302|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2220303|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220304|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220305|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2220306|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2220307|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
2220308|NCT00038519|Ritonavir|ritonavir|mesh-list
2220309|NCT00038519|Saquinavir|saquinavir|mesh-list
2220310|NCT00038519|Amprenavir|amprenavir|mesh-list
2220311|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2220312|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2220313|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
2220314|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220315|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220316|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2220317|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2220318|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
2220319|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220320|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2220321|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
638613|NCT03311828|Daratumumab|daratumumab|mesh-list
638614|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638615|NCT03311789|Gemcitabine|gemcitabine|mesh-list
638616|NCT03311789|Nivolumab|nivolumab|mesh-list
638617|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
638618|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638619|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
638620|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
638621|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638622|NCT03311789|Antiviral Agents|antiviral agents|mesh-ancestor
638623|NCT03311789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638624|NCT03311789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638625|NCT03311789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
638626|NCT03311789|Immunologic Factors|immunologic factors|mesh-ancestor
638627|NCT03311789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638628|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
638629|NCT03311750|Panitumumab|panitumumab|mesh-list
638630|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
638631|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638632|NCT03311737|Anesthetics|anesthetics|mesh-list
638633|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
638634|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220322|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2220323|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
2220324|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2220325|NCT00038532|Ritonavir|ritonavir|mesh-list
2220326|NCT00038532|Saquinavir|saquinavir|mesh-list
2220327|NCT00038532|Amprenavir|amprenavir|mesh-list
638641|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
638642|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
638643|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220328|NCT00038532|Efavirenz|efavirenz|mesh-list
2220329|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2220330|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2220331|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
2220332|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220333|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220334|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2220335|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2220336|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
2220337|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638654|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
638655|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
638656|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638657|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
638658|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
638659|NCT03311594|Ethanol|ethanol|mesh-list
638660|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
638661|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638964|NCT03309592|Urological Agents|urological agents|mesh-ancestor
2220338|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
638662|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
638663|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638664|NCT03311581|Propofol|propofol|mesh-list
638665|NCT03311581|Sevoflurane|sevoflurane|mesh-list
638666|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
638667|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
638668|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638669|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
638670|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
638671|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
638672|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
638673|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2081496|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
2081497|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081498|NCT02087241|Carboplatin|carboplatin|mesh-list
2081499|NCT02087241|Pemetrexed|pemetrexed|mesh-list
2081500|NCT02087241|Adavosertib|adavosertib|mesh-list
2081501|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081502|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081503|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081504|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2081505|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
638684|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
638685|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
638686|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638687|NCT03311516|Insulin|insulin|mesh-list
638688|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
638689|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
638690|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638691|NCT03311464|Adalimumab|adalimumab|mesh-list
638692|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
638693|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
638694|NCT03311425|Dexamethasone|dexamethasone|mesh-list
638695|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
638696|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
638697|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
638698|NCT03311425|Prednisolone|prednisolone|mesh-list
638699|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
638700|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
638701|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
638702|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
638703|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
638704|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
638705|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638706|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638707|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
638708|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
638709|NCT03311425|Hormones|hormones|mesh-ancestor
638710|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
638711|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
638712|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638713|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
638714|NCT03311425|Protective Agents|protective agents|mesh-ancestor
638715|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
638716|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
638717|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
638718|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638719|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
638720|NCT03311334|Nivolumab|nivolumab|mesh-list
638721|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
638722|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638723|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
638724|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638725|NCT03311321|Vitamin K|vitamin k|mesh-list
638726|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
638727|NCT03311321|Vitamin MK 7|vitamin mk 7|mesh-list
638728|NCT03311321|Vitamins|vitamins|mesh-ancestor
638729|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
638730|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638731|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
638732|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
638733|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638734|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
638735|NCT03311321|Coagulants|coagulants|mesh-ancestor
2081506|NCT02087306|Brincidofovir|brincidofovir|mesh-list
638742|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
638743|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
638744|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
638745|NCT03311178|Dobutamine|dobutamine|mesh-list
638746|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
638747|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
638748|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
638749|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638750|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638751|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
638752|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
638753|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
638754|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
638755|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
638756|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638757|NCT03311178|Protective Agents|protective agents|mesh-ancestor
638758|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
638759|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
638760|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638761|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
638762|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
638763|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
638764|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
638765|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638766|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638767|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
638768|NCT03311022|Nefopam|nefopam|mesh-list
638769|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
638770|NCT03311022|Analgesics|analgesics|mesh-ancestor
638771|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
638772|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638773|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081507|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
2081508|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081509|NCT02087423|Durvalumab|durvalumab|mesh-list
2081510|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2081511|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081512|NCT02087748|Diclofenac|diclofenac|mesh-list
2081513|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2081514|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2081515|NCT02087748|Analgesics|analgesics|mesh-ancestor
2081516|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
2081517|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081518|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081519|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081520|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2081521|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
638789|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
638790|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
638791|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638792|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
638793|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638797|NCT03310762|Silicon|silicon|mesh-list
638798|NCT03310762|Trace Elements|trace elements|mesh-ancestor
638799|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
638800|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638801|NCT03310749|Metformin|metformin|mesh-list
638802|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
638803|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638804|NCT03310736|Hepcidins|hepcidins|mesh-list
638805|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081522|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081523|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081524|NCT02087943|Thalidomide|thalidomide|mesh-list
2081525|NCT02087943|Apremilast|apremilast|mesh-list
2081526|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2081527|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2081528|NCT02087943|Analgesics|analgesics|mesh-ancestor
638812|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
638813|NCT03310606|Lactams|lactams|mesh-list
638814|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638815|NCT03310593|Cannabidiol|cannabidiol|mesh-list
638816|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
2220339|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2220340|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
638819|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
638820|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
638821|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638822|NCT03310541|Fulvestrant|fulvestrant|mesh-list
638823|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
638824|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638825|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
638826|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
638827|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
638828|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
638829|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220341|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2220342|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2220343|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2220344|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2220345|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2220346|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2220347|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2220348|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
2220349|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
638839|NCT03310372|Temozolomide|temozolomide|mesh-list
638840|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
638841|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
638842|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638843|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638844|NCT03310333|Dinoprostone|dinoprostone|mesh-list
638845|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
638846|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
638847|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220350|NCT00038545|Paclitaxel|paclitaxel|mesh-list
2220351|NCT00038545|Topotecan|topotecan|mesh-list
2220352|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2220353|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220354|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
2220355|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
2220356|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
2220357|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638858|NCT03310242|Vitamin D|vitamin d|mesh-list
638859|NCT03310242|Vitamins|vitamins|mesh-ancestor
638860|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
638861|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638862|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
638863|NCT03310125|Colchicine|colchicine|mesh-list
638864|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
638865|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
638866|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
638867|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
638868|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
638869|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638870|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
638871|NCT03310073|Vaccines|vaccines|mesh-list
638872|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
638873|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638874|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
638875|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
638876|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
638877|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
638878|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638879|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
638880|NCT03310060|Coagulants|coagulants|mesh-ancestor
638881|NCT03310047|Lidocaine|lidocaine|mesh-list
638882|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
638883|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
638884|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
638885|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638886|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
638887|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638888|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
638889|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
638890|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
638891|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
638892|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220358|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2220359|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2220360|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220361|NCT00038558|Doxorubicin|doxorubicin|mesh-list
2220362|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2220363|NCT00038558|Bleomycin|bleomycin|mesh-list
2220364|NCT00038558|Dacarbazine|dacarbazine|mesh-list
2220365|NCT00038558|Vinblastine|vinblastine|mesh-list
2220366|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2220367|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220368|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2220369|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2220370|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220371|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220372|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2220373|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
2220374|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2220375|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
2220376|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
2220377|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
638921|NCT03309865|Vedolizumab|vedolizumab|mesh-list
638922|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
638923|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
638924|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
638925|NCT03309735|Progesterone|progesterone|mesh-list
638926|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
638927|NCT03309735|Progestins|progestins|mesh-ancestor
638928|NCT03309735|Hormones|hormones|mesh-ancestor
638929|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
638930|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638931|NCT03309709|Progesterone|progesterone|mesh-list
638932|NCT03309709|Progestins|progestins|mesh-ancestor
638933|NCT03309709|Hormones|hormones|mesh-ancestor
638934|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
638935|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220378|NCT00038571|Bortezomib|bortezomib|mesh-list
2220379|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220380|NCT00038584|Lonafarnib|lonafarnib|mesh-list
2220381|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220382|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220383|NCT00038597|Lonafarnib|lonafarnib|mesh-list
2220384|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220385|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220386|NCT00038623|Rituximab|rituximab|mesh-list
2220387|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
638946|NCT03309644|Iodine|iodine|mesh-list
638947|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
638948|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638949|NCT03309644|Trace Elements|trace elements|mesh-ancestor
638950|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
638951|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638952|NCT03309618|Valsartan|valsartan|mesh-list
638953|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
638954|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
638955|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
638956|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638957|NCT03309592|Ambrisentan|ambrisentan|mesh-list
638958|NCT03309592|Tadalafil|tadalafil|mesh-list
638959|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
638960|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
638961|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
638962|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638963|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638965|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
638966|NCT03309566|Tenofovir|tenofovir|mesh-list
638967|NCT03309566|Emtricitabine|emtricitabine|mesh-list
638968|NCT03309566|Efavirenz|efavirenz|mesh-list
638969|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
638970|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
638971|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
638972|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
638973|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
638974|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
638975|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
638976|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
638977|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
638978|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
638979|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
638980|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
638981|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
638982|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
638983|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
638984|NCT03309527|Promethazine|promethazine|mesh-list
638985|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
638986|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
638987|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
638988|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
638989|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
638990|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
638991|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
638992|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
638993|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
638994|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
638995|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
638996|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
638997|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
638998|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
638999|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
639000|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639001|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
639002|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
639003|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
639004|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
639005|NCT03309436|Clomiphene|clomiphene|mesh-list
639006|NCT03309436|Enclomiphene|enclomiphene|mesh-list
639007|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
639008|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
639009|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
639010|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
639011|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639012|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
639013|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
639014|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
639015|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
639016|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
639017|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
639018|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
639019|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639020|NCT03309215|Nickel|nickel|mesh-list
639021|NCT03309215|Trace Elements|trace elements|mesh-ancestor
639022|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
639023|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639024|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
639025|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
639026|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
639027|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
639028|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
639029|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
639030|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
639031|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639032|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
639033|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
639034|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
639035|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
639036|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639037|NCT03309163|Tramadol|tramadol|mesh-list
639038|NCT03309163|Hydromorphone|hydromorphone|mesh-list
639039|NCT03309163|Ropivacaine|ropivacaine|mesh-list
639040|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
639041|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
639042|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
639043|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639044|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
639045|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639046|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
639047|NCT03309163|Narcotics|narcotics|mesh-ancestor
639048|NCT03309163|Analgesics|analgesics|mesh-ancestor
639049|NCT03309150|Paclitaxel|paclitaxel|mesh-list
639050|NCT03309150|Carboplatin|carboplatin|mesh-list
639051|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
639052|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639053|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
639054|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
639055|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
639056|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639057|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
639058|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
639059|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639060|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
639061|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
639062|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
639063|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
639064|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
639065|NCT03309059|Protective Agents|protective agents|mesh-ancestor
639066|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639067|NCT03309007|Metformin|metformin|mesh-list
639068|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
639069|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
639070|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639071|NCT03309007|Antacids|antacids|mesh-ancestor
639072|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639073|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
639074|NCT03308955|Tramadol|tramadol|mesh-list
639075|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
639076|NCT03308955|Narcotics|narcotics|mesh-ancestor
639077|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
639078|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639079|NCT03308955|Analgesics|analgesics|mesh-ancestor
639080|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
639081|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081529|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
2081530|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081531|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081532|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081533|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2081534|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2081535|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
639089|NCT03308916|Liver Extracts|liver extracts|mesh-list
639090|NCT03308916|Hematinics|hematinics|mesh-ancestor
639091|NCT03308890|Entecavir|entecavir|mesh-list
639092|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
639093|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220388|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220389|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
639097|NCT03308786|Aldesleukin|aldesleukin|mesh-list
639098|NCT03308786|Interleukin-2|interleukin-2|mesh-list
639099|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639100|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
639101|NCT03308786|Analgesics|analgesics|mesh-ancestor
639102|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
639103|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639104|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639105|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
639106|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
639107|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
639108|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639109|NCT03308708|Norepinephrine|norepinephrine|mesh-list
639110|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
639111|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
639112|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
639113|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
639114|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639115|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639116|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
639117|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
639118|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639119|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
639120|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
639121|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
639122|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220390|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220391|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220392|NCT00038636|Ritonavir|ritonavir|mesh-list
2220393|NCT00038636|Lopinavir|lopinavir|mesh-list
2220394|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2220395|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2220396|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
2220397|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220398|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639132|NCT03308643|Oxytocin|oxytocin|mesh-list
639133|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
639134|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
639135|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639136|NCT03308604|Cisplatin|cisplatin|mesh-list
639137|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639138|NCT03308578|Atorvastatin|atorvastatin|mesh-list
639139|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
639140|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
639141|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
639142|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639143|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
639144|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
639145|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639146|NCT03308552|Paclitaxel|paclitaxel|mesh-list
639147|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
639148|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
639149|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639150|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
639151|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
639152|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
639153|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639154|NCT03308487|Vitamin D|vitamin d|mesh-list
639155|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
639156|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
639157|NCT03308487|Vitamins|vitamins|mesh-list
639158|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
639159|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639160|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
639161|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
639164|NCT03308396|Durvalumab|durvalumab|mesh-list
639165|NCT03308396|Guadecitabine|guadecitabine|mesh-list
639166|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
639167|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639168|NCT03308357|Infliximab|infliximab|mesh-list
639169|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
639170|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
639171|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
639172|NCT03308331|Nicotine|nicotine|mesh-list
639173|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
639174|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
639175|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639176|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639177|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
639178|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
639179|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
639180|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
639181|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639182|NCT03308253|Vancomycin|vancomycin|mesh-list
639183|NCT03308253|Tobramycin|tobramycin|mesh-list
639184|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
639185|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639186|NCT03308214|Imipenem|imipenem|mesh-list
639187|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
639188|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639189|NCT03308201|Letrozole|letrozole|mesh-list
639190|NCT03308201|Fulvestrant|fulvestrant|mesh-list
639191|NCT03308201|Exemestane|exemestane|mesh-list
639192|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639193|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
639194|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
639195|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639196|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639197|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
639198|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
639199|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
639200|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639201|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
639202|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
639203|NCT03308149|Triamcinolone|triamcinolone|mesh-list
639204|NCT03308149|Bupivacaine|bupivacaine|mesh-list
639205|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
639206|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
639207|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
639208|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639209|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
639210|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639211|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
639212|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
639213|NCT03308149|Hormones|hormones|mesh-ancestor
639214|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
639215|NCT03308136|Lidocaine|lidocaine|mesh-list
639216|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
639217|NCT03308136|Anesthetics|anesthetics|mesh-list
639218|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
639219|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639220|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
639221|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639222|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
639223|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
639224|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
639225|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
639226|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639227|NCT03308084|Dexamethasone|dexamethasone|mesh-list
639228|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
639229|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
639230|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
639231|NCT03308084|Prednisolone|prednisolone|mesh-list
639232|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
639233|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
639234|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
639235|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
639236|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
639237|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
639238|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639239|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639240|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
639241|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
639242|NCT03308084|Hormones|hormones|mesh-ancestor
639243|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
639244|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
639245|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639246|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
639247|NCT03308084|Protective Agents|protective agents|mesh-ancestor
639248|NCT03307941|Fluorouracil|fluorouracil|mesh-list
639249|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
639250|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
639251|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639252|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
639253|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639254|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
639255|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
639256|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639257|NCT03307902|Imiquimod|imiquimod|mesh-list
639258|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
639259|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
639260|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639261|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639262|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
639263|NCT03307863|Topiramate|topiramate|mesh-list
639264|NCT03307863|Carbamazepine|carbamazepine|mesh-list
639265|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
639266|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
639267|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639268|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
639269|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
639270|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
639271|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
639272|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
639273|NCT03307863|Analgesics|analgesics|mesh-ancestor
639274|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
639275|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639276|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
639277|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
639278|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639279|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
639280|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2081536|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081537|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081538|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2081539|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
2081540|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
2081541|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2081542|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081543|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2081544|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2081545|NCT02087943|Growth Substances|growth substances|mesh-ancestor
2081546|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
2081547|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081548|NCT02088034|Metformin|metformin|mesh-list
2081549|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2081550|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081551|NCT02088177|Naltrexone|naltrexone|mesh-list
2081552|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2081553|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2081554|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081555|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
2081556|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081557|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
639303|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
639304|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
639305|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639306|NCT03307746|Rituximab|rituximab|mesh-list
639307|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
639308|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639309|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
639310|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639311|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
639312|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
639313|NCT03307720|Hormones|hormones|mesh-list
639314|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
639315|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639316|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
639317|NCT03307616|Nivolumab|nivolumab|mesh-list
639318|NCT03307616|Ipilimumab|ipilimumab|mesh-list
639319|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
639320|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639321|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
639322|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639323|NCT03307603|Nivolumab|nivolumab|mesh-list
639324|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
639325|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639326|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
639327|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639328|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
639329|NCT03307590|Bupivacaine|bupivacaine|mesh-list
639330|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
639331|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
639332|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
639333|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639334|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
639335|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639336|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
639337|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
639338|NCT03307590|Analgesics|analgesics|mesh-ancestor
639339|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
639340|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
639341|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
639342|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
639343|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
639344|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639345|NCT03307551|Propofol|propofol|mesh-list
639346|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
639347|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
639348|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639349|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
639350|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
639351|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
639352|NCT03307512|Insulin|insulin|mesh-list
639353|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
639354|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
639355|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
639356|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220399|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2220400|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2220401|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
2220402|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220403|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2220404|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2220405|NCT00038662|Atrasentan|atrasentan|mesh-list
2220406|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220407|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2220408|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2220409|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220415|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
2220416|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2220417|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220418|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2220419|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2220420|NCT00038701|Growth Substances|growth substances|mesh-ancestor
2220421|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220422|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
2220423|NCT00038766|Semapimod|semapimod|mesh-list
2220424|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2220425|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2220426|NCT00038766|Analgesics|analgesics|mesh-ancestor
2220427|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
2220428|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2220429|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220430|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2220431|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220432|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220433|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
2220434|NCT00038792|Mitogens|mitogens|mesh-list
2220435|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
2220436|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220437|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
2220438|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2220439|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220440|NCT00038831|Vidarabine|vidarabine|mesh-list
2220441|NCT00038831|Fludarabine|fludarabine|mesh-list
2220442|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
2220443|NCT00038831|Melphalan|melphalan|mesh-list
2220444|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
2220445|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2220446|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
2220447|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220448|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2220449|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
639408|NCT03307213|Sirolimus|sirolimus|mesh-list
639409|NCT03307213|Umirolimus|umirolimus|mesh-list
639410|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
639411|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
639412|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
639413|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639414|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
639415|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639416|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
639417|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639418|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
2220450|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220451|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220452|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
2220453|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220454|NCT00038831|Antiviral Agents|antiviral agents|mesh-ancestor
2220455|NCT00038831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220456|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2220457|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
2220458|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2220459|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2220460|NCT00038844|Vidarabine|vidarabine|mesh-list
2220461|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
2220462|NCT00038844|Rituximab|rituximab|mesh-list
639433|NCT03307148|Gemcitabine|gemcitabine|mesh-list
639434|NCT03307148|Paclitaxel|paclitaxel|mesh-list
639435|NCT03307148|Tretinoin|tretinoin|mesh-list
639436|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
639437|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639438|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
639439|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
639440|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
639441|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639442|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
639443|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
639444|NCT03307148|Antiviral Agents|antiviral agents|mesh-ancestor
639445|NCT03307148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639446|NCT03307148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639447|NCT03307148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
639448|NCT03307148|Immunologic Factors|immunologic factors|mesh-ancestor
639449|NCT03307148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639450|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
639451|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
2220463|NCT00038844|Fludarabine|fludarabine|mesh-list
2220464|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
2220465|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
2220466|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220467|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
2220468|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220469|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220470|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2220471|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
2220472|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639462|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
639463|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
639464|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
639465|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639466|NCT03306979|Expectorants|expectorants|mesh-ancestor
639467|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
639468|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
639469|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
639470|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639471|NCT03306979|Protective Agents|protective agents|mesh-ancestor
639472|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639473|NCT03306979|Antidotes|antidotes|mesh-ancestor
639474|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
639475|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
639476|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
639477|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
639478|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
639479|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639480|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
639481|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
639482|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639483|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
639484|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639485|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
639486|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
639487|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
639488|NCT03306901|Fluorouracil|fluorouracil|mesh-list
639489|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639490|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
639491|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639492|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
639493|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
639494|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
639495|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639496|NCT03306836|Heparin|heparin|mesh-list
639497|NCT03306836|Calcium heparin|calcium heparin|mesh-list
639498|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
639499|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
639500|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
639501|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639502|NCT03306745|Folic Acid|folic acid|mesh-list
639503|NCT03306745|Hematinics|hematinics|mesh-ancestor
639504|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
639505|NCT03306745|Vitamins|vitamins|mesh-ancestor
639506|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
639507|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639508|NCT03306732|Thiamine|thiamine|mesh-list
639509|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
639510|NCT03306732|Vitamins|vitamins|mesh-ancestor
639511|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
639512|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639513|NCT03306667|Dotinurad|dotinurad|mesh-list
639514|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
639515|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
639516|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
639517|NCT03306667|Renal Agents|renal agents|mesh-ancestor
639518|NCT03306602|Z 350|z 350|mesh-list
639519|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
639520|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
639521|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639522|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639523|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
639524|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
639525|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220473|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220474|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2220475|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2220476|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2220477|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
2220478|NCT00038844|Antiviral Agents|antiviral agents|mesh-ancestor
2220479|NCT00038844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639534|NCT03306550|Aspirin|aspirin|mesh-list
639535|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
639536|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
639537|NCT03306550|Analgesics|analgesics|mesh-ancestor
639538|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
639539|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639540|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639541|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
639542|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
639543|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
639544|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
639545|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639546|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
639547|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
639548|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639549|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
639550|NCT03306472|Letrozole|letrozole|mesh-list
639551|NCT03306472|Megestrol|megestrol|mesh-list
639552|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
639553|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639554|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
639555|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
639556|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639557|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639558|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
639559|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
639560|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
639561|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639562|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
639563|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
639564|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
639565|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
639566|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
639567|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
639568|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
639569|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
639570|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
639571|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
639572|NCT03306446|Adalimumab|adalimumab|mesh-list
639573|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
639574|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2081558|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2081559|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
2081560|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081561|NCT02088216|Expectorants|expectorants|mesh-ancestor
2081562|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
639580|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
639581|NCT03306368|Narcotics|narcotics|mesh-ancestor
639582|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
639583|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639584|NCT03306368|Analgesics|analgesics|mesh-ancestor
639585|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
639586|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639587|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
639588|NCT03306290|Cefoxitin|cefoxitin|mesh-list
639589|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639590|NCT03306264|Decitabine|decitabine|mesh-list
639591|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
639592|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
639593|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639594|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639595|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639596|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
639597|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
639598|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
639599|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
639600|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
639601|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639602|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
639603|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
639604|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639605|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
639606|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639607|NCT03305978|Ivermectin|ivermectin|mesh-list
639608|NCT03305978|Selamectin|selamectin|mesh-list
639609|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
639610|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639611|NCT03305848|Nitroglycerin|nitroglycerin|mesh-list
639612|NCT03305848|Vasodilator Agents|vasodilator agents|mesh-ancestor
2220480|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
2220481|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2220482|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220483|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2220484|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2220485|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2220486|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2220487|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220488|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2220489|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220490|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2220491|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
2220492|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2220493|NCT00038922|Oprelvekin|oprelvekin|mesh-list
2220494|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220495|NCT00038935|Factor VIII|factor viii|mesh-list
2220496|NCT00038935|Coagulants|coagulants|mesh-ancestor
639631|NCT03305536|Vitamin D|vitamin d|mesh-list
639632|NCT03305536|Vitamins|vitamins|mesh-list
639633|NCT03305536|Vitamin K|vitamin k|mesh-list
639634|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
639635|NCT03305536|Vitamin MK 7|vitamin mk 7|mesh-list
639636|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
639637|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639638|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
639639|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
639640|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
639641|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639642|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
639643|NCT03305536|Coagulants|coagulants|mesh-ancestor
639644|NCT03305510|Vitamin D|vitamin d|mesh-list
639645|NCT03305510|Vitamins|vitamins|mesh-ancestor
639646|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
639647|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639648|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
639649|NCT03305471|Sevelamer|sevelamer|mesh-list
639650|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
639651|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
639652|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639653|NCT03305445|Nivolumab|nivolumab|mesh-list
639654|NCT03305445|Ipilimumab|ipilimumab|mesh-list
639655|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
639656|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639657|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
639658|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081563|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2081564|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
2081565|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081566|NCT02088216|Protective Agents|protective agents|mesh-ancestor
2081567|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639664|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
639665|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
639666|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
639667|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
639668|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639669|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639670|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639671|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220497|NCT00038961|PENTA|penta|mesh-list
2220498|NCT00038961|Fondaparinux|fondaparinux|mesh-list
2220499|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2220500|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
2220501|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2220502|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
2220503|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220504|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220505|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
2220506|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2220507|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2220508|NCT00038974|Ribavirin|ribavirin|mesh-list
2220509|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2220510|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
2220511|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220512|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
2220513|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220514|NCT00039013|Exenatide|exenatide|mesh-list
2220515|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2220516|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220517|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
639693|NCT03305068|Celecoxib|celecoxib|mesh-list
639694|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
639695|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
639696|NCT03305068|Analgesics|analgesics|mesh-ancestor
639697|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
639698|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639699|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639700|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
639701|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
639702|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
639703|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
639704|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639705|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220518|NCT00039013|Incretins|incretins|mesh-ancestor
2220519|NCT00039013|Hormones|hormones|mesh-ancestor
2220520|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2220521|NCT00039026|Exenatide|exenatide|mesh-list
2220522|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2220523|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220524|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2220525|NCT00039026|Incretins|incretins|mesh-ancestor
2220526|NCT00039026|Hormones|hormones|mesh-ancestor
2220527|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2220528|NCT00039039|Paclitaxel|paclitaxel|mesh-list
2220529|NCT00039039|Carboplatin|carboplatin|mesh-list
2220530|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2220531|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220532|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
2220533|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
2220534|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
2220535|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220536|NCT00039052|Interleukin-4|interleukin-4|mesh-list
2220537|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2220538|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
2081568|NCT02088216|Antidotes|antidotes|mesh-ancestor
2081569|NCT02088541|Cytarabine|cytarabine|mesh-list
2081570|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
639730|NCT03304717|Tenofovir|tenofovir|mesh-list
639731|NCT03304717|Emtricitabine|emtricitabine|mesh-list
639732|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
639733|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639734|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
639735|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
639736|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639737|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639738|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
639739|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
639740|NCT03304652|Zaleplon|zaleplon|mesh-list
639741|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
639742|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
639743|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
639744|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639745|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
639746|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
639747|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
639748|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081571|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2081572|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
2081573|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220539|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220540|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220541|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220542|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2220543|NCT00039091|Ipilimumab|ipilimumab|mesh-list
2220544|NCT00039091|Antibodies|antibodies|mesh-list
2220545|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
2220546|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2220547|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
2220548|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220549|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220550|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2220551|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220552|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
639766|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
639767|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
639768|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
639769|NCT03304457|Olanzapine|olanzapine|mesh-list
639770|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
639771|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
639772|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
639773|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639774|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639775|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
639776|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
639777|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
639778|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
639779|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
639780|NCT03304457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
639781|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
639782|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
639783|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639784|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
639785|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
639786|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
639787|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
639788|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
639789|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
639790|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
639791|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
639792|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
639793|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
639794|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
639795|NCT03304444|Bupivacaine|bupivacaine|mesh-list
639796|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
639797|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
639798|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
639799|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639800|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
639801|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639802|NCT03304431|Lidocaine|lidocaine|mesh-list
639803|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
639804|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
639805|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
639806|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639807|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
639808|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639809|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
639810|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
639811|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
639812|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
639813|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639814|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
639815|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639816|NCT03304379|Celecoxib|celecoxib|mesh-list
639817|NCT03304379|Diclofenac|diclofenac|mesh-list
639818|NCT03304379|Fasinumab|fasinumab|mesh-list
639819|NCT03304379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
639820|NCT03304379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
639821|NCT03304379|Analgesics|analgesics|mesh-ancestor
639822|NCT03304379|Sensory System Agents|sensory system agents|mesh-ancestor
639823|NCT03304379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639824|NCT03304379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639825|NCT03304379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
639826|NCT03304379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
639827|NCT03304379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
639828|NCT03304379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
639829|NCT03304379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639830|NCT03304379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639831|NCT03304288|Rituximab|rituximab|mesh-list
639832|NCT03304288|Tretinoin|tretinoin|mesh-list
639833|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
639834|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639835|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
639836|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639837|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
639838|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
639839|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
639840|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
639841|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639842|NCT03304093|Nivolumab|nivolumab|mesh-list
639843|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
639844|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639845|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
639846|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639847|NCT03304080|Trastuzumab|trastuzumab|mesh-list
639848|NCT03304080|Pertuzumab|pertuzumab|mesh-list
639849|NCT03304080|Palbociclib|palbociclib|mesh-list
639850|NCT03304080|Anastrozole|anastrozole|mesh-list
639851|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
639852|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639853|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
639854|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639855|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639856|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
639857|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
639858|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
639859|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
639860|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
639861|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
639862|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220553|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2220554|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220555|NCT00039117|Cytarabine|cytarabine|mesh-list
2220556|NCT00039117|Daunorubicin|daunorubicin|mesh-list
2220557|NCT00039117|Oblimersen|oblimersen|mesh-list
2220558|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2220559|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
2081574|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081575|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
2081576|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081577|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2081578|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
2081579|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081580|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
2081581|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220560|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081582|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
639879|NCT03303976|Vaccines|vaccines|mesh-list
639880|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
639881|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
639882|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081583|NCT02089113|Dexamethasone|dexamethasone|mesh-list
2081584|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081585|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
2081586|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
2081587|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081588|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081589|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2081590|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
2081591|NCT02089113|Hormones|hormones|mesh-ancestor
2081592|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081593|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2081594|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639895|NCT03303924|Sulbactam|sulbactam|mesh-list
639896|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
639897|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639898|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
639899|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639900|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220561|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220562|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
2220563|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220564|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220565|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
2220566|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220567|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
639908|NCT03303677|Vancomycin|vancomycin|mesh-list
639909|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
639910|NCT03303677|Gentamicins|gentamicins|mesh-list
639911|NCT03303677|Mupirocin|mupirocin|mesh-list
639912|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
639913|NCT03303677|Trimethoprim|trimethoprim|mesh-list
639914|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
639915|NCT03303677|Budesonide|budesonide|mesh-list
639916|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
639917|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
639918|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
639919|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639920|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639921|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
639922|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
639923|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
639924|NCT03303677|Hormones|hormones|mesh-ancestor
639925|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
639926|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
639927|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
639928|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
639929|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639930|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639931|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639932|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
639933|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
639934|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
639935|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
639936|NCT03303677|Renal Agents|renal agents|mesh-ancestor
639937|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
639938|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
639939|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
639940|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
639941|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
639942|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
639943|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
639944|NCT03303651|Narcotics|narcotics|mesh-ancestor
639945|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
639946|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639947|NCT03303651|Analgesics|analgesics|mesh-ancestor
639948|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
639949|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
639950|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
639951|NCT03303573|Hematinics|hematinics|mesh-ancestor
639952|NCT03303495|Leucovorin|leucovorin|mesh-list
639953|NCT03303495|Bevacizumab|bevacizumab|mesh-list
2081595|NCT02089347|Vaccines|vaccines|mesh-list
639954|NCT03303495|Fluorouracil|fluorouracil|mesh-list
639955|NCT03303495|Irinotecan|irinotecan|mesh-list
639956|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
639957|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
639958|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
639959|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
639960|NCT03303495|Growth Substances|growth substances|mesh-ancestor
639961|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639962|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
639963|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
639964|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639965|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
639966|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
639967|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
639968|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
639969|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
639970|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
639971|NCT03303495|Antidotes|antidotes|mesh-ancestor
639972|NCT03303495|Protective Agents|protective agents|mesh-ancestor
639973|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
639974|NCT03303495|Vitamins|vitamins|mesh-ancestor
639975|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
639976|NCT03303378|Melatonin|melatonin|mesh-list
639977|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
639978|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
639979|NCT03303378|Protective Agents|protective agents|mesh-ancestor
639980|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
639981|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2081596|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
2081597|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081598|NCT02089737|Panitumumab|panitumumab|mesh-list
2081599|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2081600|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081601|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
2081602|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2081603|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2081604|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081605|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2081606|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081607|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2220568|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2220569|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
639996|NCT03303235|Methylergonovine|methylergonovine|mesh-list
639997|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
639998|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
639999|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640000|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
640001|NCT03303209|Narcotics|narcotics|mesh-ancestor
640002|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640003|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640004|NCT03303209|Analgesics|analgesics|mesh-ancestor
640005|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
640006|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2220570|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220571|NCT00039156|IDN 5109|idn 5109|mesh-list
2220572|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220573|NCT00039169|IDN 5109|idn 5109|mesh-list
2220574|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220575|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2220576|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220577|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2220578|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640018|NCT03303053|Prednisolone|prednisolone|mesh-list
640019|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
640020|NCT03303053|Carbimazole|carbimazole|mesh-list
640021|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
640022|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
640023|NCT03303053|Hormones|hormones|mesh-ancestor
640024|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
640025|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640026|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
640027|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640028|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
640029|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
640030|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
640031|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640032|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
640033|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
640034|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
640035|NCT03302910|Torsemide|torsemide|mesh-list
640036|NCT03302910|Furosemide|furosemide|mesh-list
640037|NCT03302910|Bumetanide|bumetanide|mesh-list
640038|NCT03302910|Nitroglycerin|nitroglycerin|mesh-list
640039|NCT03302910|Diuretics|diuretics|mesh-list
640040|NCT03302910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
640041|NCT03302910|Natriuretic Agents|natriuretic agents|mesh-ancestor
640042|NCT03302910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640043|NCT03302910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
640044|NCT03302910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640045|NCT03302910|Vasodilator Agents|vasodilator agents|mesh-ancestor
640046|NCT03302910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
640047|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
640048|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
640049|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
640050|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
640051|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
640052|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640053|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
640054|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640055|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640056|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
640057|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640058|NCT03302845|Omeprazole|omeprazole|mesh-list
640059|NCT03302845|Famotidine|famotidine|mesh-list
640060|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
640061|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
640062|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
640063|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640064|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640065|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
640066|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
640067|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
640068|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640069|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640070|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
640071|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
640072|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220579|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220580|NCT00039208|Leucovorin|leucovorin|mesh-list
2220581|NCT00039208|Fluorouracil|fluorouracil|mesh-list
2220582|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
2220583|NCT00039208|Irinotecan|irinotecan|mesh-list
2220584|NCT00039208|Calcium|calcium|mesh-list
2220585|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
640080|NCT03302728|Lenalidomide|lenalidomide|mesh-list
640081|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
640082|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
640083|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640084|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
640085|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
640086|NCT03302728|Growth Substances|growth substances|mesh-ancestor
640087|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
640088|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640089|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
640090|NCT03302689|Ropivacaine|ropivacaine|mesh-list
640091|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
640092|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
640093|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
640094|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
640095|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640096|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640097|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
640098|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640099|NCT03302650|Norepinephrine|norepinephrine|mesh-list
640100|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
640101|NCT03302650|Giapreza|giapreza|mesh-list
640102|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
640103|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
640104|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
640105|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
640182|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2220586|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
640106|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640107|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640108|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640109|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
640110|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
640111|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640112|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
640113|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
640114|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
640115|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640116|NCT03302585|Vitamin D|vitamin d|mesh-list
640117|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
640118|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
640119|NCT03302585|Vitamins|vitamins|mesh-list
640120|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
640121|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640122|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
640123|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2220587|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220588|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
2220589|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220590|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2220591|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220592|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220593|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
2220594|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2220595|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2220596|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220597|NCT00039208|Antidotes|antidotes|mesh-ancestor
2220598|NCT00039208|Protective Agents|protective agents|mesh-ancestor
2220599|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
2220600|NCT00039208|Vitamins|vitamins|mesh-ancestor
640139|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
640140|NCT03302403|Fludarabine|fludarabine|mesh-list
640141|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
640142|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
640143|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640144|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
640145|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
640146|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
640147|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640148|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640149|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
640150|NCT03302390|Lidocaine|lidocaine|mesh-list
640151|NCT03302390|Epinephrine|epinephrine|mesh-list
640152|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
640153|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
640154|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640155|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640156|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
640157|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640158|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
640159|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
640160|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
640161|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
640162|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640163|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
640164|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
640165|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
640166|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640167|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
640168|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
640169|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
640170|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
640171|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
640172|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
640173|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
640174|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
640175|NCT03302364|Risperidone|risperidone|mesh-list
640176|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
640177|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
640178|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640179|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640180|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640181|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
640183|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640184|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
640185|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
640186|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
640187|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
640188|NCT03302351|Ketamine|ketamine|mesh-list
640189|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
640190|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640191|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640192|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
640193|NCT03302351|Analgesics|analgesics|mesh-ancestor
640194|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
640195|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640196|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
640197|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
640198|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
640199|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
640200|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640201|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640202|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
640203|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
640204|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
640205|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
640206|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
640207|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
640208|NCT03302299|Pyridoxine|pyridoxine|mesh-list
640209|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
640210|NCT03302299|Isoniazid|isoniazid|mesh-list
640211|NCT03302299|Vitamins|vitamins|mesh-ancestor
640212|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
640213|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640214|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
640215|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
640216|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
640217|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
640218|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
640219|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
640220|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
640221|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640222|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2220601|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
2220602|NCT00039234|Aldesleukin|aldesleukin|mesh-list
2220603|NCT00039234|Histamine|histamine|mesh-list
2220604|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
2220605|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220606|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2220607|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2220608|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
2220609|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220610|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
2220611|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
2220612|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2220613|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220614|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220615|NCT00039273|Panitumumab|panitumumab|mesh-list
2220616|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2220617|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220618|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2220619|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2220620|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640249|NCT03302221|Ropivacaine|ropivacaine|mesh-list
640250|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
640251|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640252|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640253|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
640254|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
640255|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640256|NCT03302208|Pregabalin|pregabalin|mesh-list
640257|NCT03302208|Analgesics|analgesics|mesh-ancestor
640258|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
2220621|NCT00039338|Cisplatin|cisplatin|mesh-list
640259|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640260|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640261|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
640262|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
640263|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
640264|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640265|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
640266|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
640267|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
640268|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640269|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
640270|NCT03302195|Heparin|heparin|mesh-list
640271|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
640272|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
640273|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
640274|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640275|NCT03302182|Ritonavir|ritonavir|mesh-list
640276|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
640277|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
640278|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
640279|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640280|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640281|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
640282|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
640283|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
640284|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
640285|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
640286|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
640287|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
640288|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
640289|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
640290|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640291|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640292|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
640293|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
640294|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
640295|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
640296|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
640297|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640298|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640299|NCT03302039|Phenylephrine|phenylephrine|mesh-list
640300|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
640301|NCT03302039|Bupivacaine|bupivacaine|mesh-list
640302|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
640303|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
640304|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640305|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640306|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
640307|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640308|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
640309|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
640310|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
640311|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
640312|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
640313|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
640314|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
640315|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
640316|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
640317|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
640318|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
640319|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640320|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640321|NCT03302039|Protective Agents|protective agents|mesh-ancestor
640322|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
640323|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
640324|NCT03301974|Coagulants|coagulants|mesh-ancestor
2081608|NCT02090075|Warfarin|warfarin|mesh-list
2081609|NCT02090075|Apixaban|apixaban|mesh-list
2081610|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
2081611|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2081612|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
640335|NCT03301766|Lidocaine|lidocaine|mesh-list
640336|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
640337|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
640338|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640339|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640340|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
640341|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640342|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
640343|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
640344|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
640345|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
640346|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220622|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220623|NCT00039351|Prednisone|prednisone|mesh-list
2220624|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
640350|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
640351|NCT03301636|Nivolumab|nivolumab|mesh-list
640352|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
640353|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640354|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
640355|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081613|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2081614|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
2081615|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081616|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081617|NCT02090374|Vitamin D|vitamin d|mesh-list
640361|NCT03301454|Paclitaxel|paclitaxel|mesh-list
640362|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
640363|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640364|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
640365|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
640366|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
640367|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081618|NCT02090374|Poly ICLC|poly iclc|mesh-list
2081619|NCT02090374|Vitamins|vitamins|mesh-ancestor
2081620|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
640371|NCT03301350|Paclitaxel|paclitaxel|mesh-list
640372|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
640373|NCT03301350|Carboplatin|carboplatin|mesh-list
640374|NCT03301350|Doxorubicin|doxorubicin|mesh-list
640375|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
640376|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640377|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
640378|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
640379|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
640380|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640381|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
640382|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
640383|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640384|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
640385|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
640386|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
640387|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
640388|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
640389|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
640390|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
640391|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640392|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
640393|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
640394|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220625|NCT00039351|Vincristine|vincristine|mesh-list
2220626|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220627|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
2220628|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220629|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220630|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2220631|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
2220632|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220633|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220634|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
640405|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
640406|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
640407|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2220635|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
640408|NCT03301233|Estradiol|estradiol|mesh-list
640409|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
640410|NCT03301233|Estrogens|estrogens|mesh-ancestor
640411|NCT03301233|Hormones|hormones|mesh-ancestor
640412|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
640413|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640414|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
640415|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
640416|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
640417|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
640418|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
640419|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
640420|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
640421|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640422|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640423|NCT03301233|Urological Agents|urological agents|mesh-ancestor
2081621|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640426|NCT03301207|Midazolam|midazolam|mesh-list
640427|NCT03301207|Bupropion|bupropion|mesh-list
640428|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
640429|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
640430|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
640431|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
640432|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
640433|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640434|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640435|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
640436|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
640437|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
640438|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
640439|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
640440|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
640441|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
640442|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
640443|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640444|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640445|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
640446|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
640447|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
640448|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
640449|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
640450|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
640451|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
640452|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
640453|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640454|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
640455|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
640456|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
640457|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
640458|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
640459|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
640460|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
640461|NCT03301207|Estrogens|estrogens|mesh-ancestor
640462|NCT03301207|Hormones|hormones|mesh-ancestor
640463|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
640464|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
640465|NCT03301181|Itraconazole|itraconazole|mesh-list
640466|NCT03301181|Rifampin|rifampin|mesh-list
640467|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
640468|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
640469|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
640470|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
640471|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
640472|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640473|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640474|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
640475|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
640476|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
640477|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640478|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
640479|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
640480|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
640481|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
640482|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
640483|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
640484|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
640485|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
640486|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
640487|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
640488|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
640489|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
640490|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640491|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
640492|NCT03301051|Vaccines|vaccines|mesh-list
640493|NCT03301051|Immunologic Factors|immunologic factors|mesh-ancestor
640494|NCT03301051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640495|NCT03301038|Rifampin|rifampin|mesh-list
640496|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
640497|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
640498|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
640499|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
640500|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
640501|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
640502|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640503|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640504|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
640505|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
640506|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
640507|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
640508|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
640509|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
640510|NCT03301025|Pregabalin|pregabalin|mesh-list
640511|NCT03301025|Analgesics|analgesics|mesh-ancestor
640512|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
640513|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640514|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640515|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
640516|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
640517|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
640518|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640519|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
640520|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
640521|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
640522|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640523|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
640524|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
640525|NCT03300960|Ganirelix|ganirelix|mesh-list
640526|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
640527|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
640528|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640529|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
640530|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
640531|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
640532|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
640533|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
640534|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
640535|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640536|NCT03300947|Lorazepam|lorazepam|mesh-list
640537|NCT03300947|Psilocybin|psilocybin|mesh-list
640538|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
640539|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
640540|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
640541|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640542|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640543|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
640544|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
640545|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640546|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
640547|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
640548|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
640549|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
640550|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
640551|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640552|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640553|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
2081622|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2081623|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
2081624|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
2081625|NCT02090413|Aspirin|aspirin|mesh-list
640558|NCT03300765|Apatinib|apatinib|mesh-list
640559|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640560|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
640561|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640562|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220636|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
2220637|NCT00039351|Hormones|hormones|mesh-ancestor
2220638|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2220639|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2220640|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2220641|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
2220642|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
2220643|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
2220644|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
2220645|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220646|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2220647|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220648|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220649|NCT00039390|Capecitabine|capecitabine|mesh-list
2220650|NCT00039390|Gefitinib|gefitinib|mesh-list
2220651|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
640579|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
640580|NCT03300609|Leucovorin|leucovorin|mesh-list
640581|NCT03300609|Folic Acid|folic acid|mesh-list
640582|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
640583|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
640584|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
640585|NCT03300609|Panitumumab|panitumumab|mesh-list
640586|NCT03300609|Fluorouracil|fluorouracil|mesh-list
640587|NCT03300609|Capecitabine|capecitabine|mesh-list
640588|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
640589|NCT03300609|Antibodies|antibodies|mesh-list
640590|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
640591|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
640592|NCT03300609|Calcium|calcium|mesh-list
640593|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
640594|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
640595|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640596|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640597|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
640598|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
640599|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
640600|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640601|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
640602|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
640603|NCT03300609|Antidotes|antidotes|mesh-ancestor
640604|NCT03300609|Protective Agents|protective agents|mesh-ancestor
640605|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
640606|NCT03300609|Vitamins|vitamins|mesh-ancestor
640607|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
640608|NCT03300609|Hematinics|hematinics|mesh-ancestor
2220652|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
2220653|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220654|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220655|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2220656|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751731|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2751732|NCT03850418|Azacitidine|azacitidine|mesh-list
2751733|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2751734|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
2751735|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751736|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751737|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751738|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
2751739|NCT03850379|Levofloxacin|levofloxacin|mesh-list
2751740|NCT03850379|Ofloxacin|ofloxacin|mesh-list
2751741|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
640642|NCT03300531|Betamethasone|betamethasone|mesh-list
640643|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
640644|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
640645|NCT03300531|Hormones|hormones|mesh-ancestor
640646|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
640647|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640648|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
640649|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
2081626|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2081627|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2081628|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2081629|NCT02090413|Analgesics|analgesics|mesh-ancestor
2081630|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
2081631|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081632|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081633|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081634|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2081635|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2081636|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2081637|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081638|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2081639|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2081640|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081641|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
640681|NCT03300440|Vitamins|vitamins|mesh-list
640682|NCT03300440|Biotin|biotin|mesh-list
640683|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
640684|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
640685|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751742|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2751743|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2751744|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2751745|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751746|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751747|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640692|NCT03300362|Vaccines|vaccines|mesh-list
640693|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
640694|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640695|NCT03300115|Abivertinib|abivertinib|mesh-list
640696|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
640697|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640698|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640699|NCT03300089|Anesthetics|anesthetics|mesh-list
640700|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640701|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640702|NCT03299998|Anesthetics|anesthetics|mesh-list
640703|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640704|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751748|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
640705|NCT03299946|Nivolumab|nivolumab|mesh-list
640706|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
640707|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640708|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
640709|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640710|NCT03299842|Fenfluramine|fenfluramine|mesh-list
640711|NCT03299842|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
640712|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
640713|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
640714|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640715|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640716|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
640717|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640718|NCT03299829|Trientine|trientine|mesh-list
640719|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
640720|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
640721|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640722|NCT03299725|Bismuth|bismuth|mesh-list
640723|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640724|NCT03299725|Antacids|antacids|mesh-ancestor
640725|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
640726|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
640727|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
640728|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
640729|NCT03299712|Protective Agents|protective agents|mesh-ancestor
640730|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640731|NCT03299660|Fluorouracil|fluorouracil|mesh-list
640732|NCT03299660|Capecitabine|capecitabine|mesh-list
640733|NCT03299660|Avelumab|avelumab|mesh-list
640734|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
640735|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640736|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
640737|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640738|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
640739|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
640740|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640741|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
640742|NCT03299621|Rocuronium|rocuronium|mesh-list
640743|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
640744|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
640745|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
640746|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640747|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640748|NCT03299517|Lidocaine|lidocaine|mesh-list
640749|NCT03299517|Amiodarone|amiodarone|mesh-list
640750|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
640751|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
640752|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
640753|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640754|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640755|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
640756|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640757|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
640758|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
640759|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
640760|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640761|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
640762|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
640763|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
640764|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
640765|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640766|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
640767|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
640768|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
640769|NCT03299426|Vaccines|vaccines|mesh-list
640770|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
640771|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640772|NCT03299387|Gentamicins|gentamicins|mesh-list
640773|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
640774|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
640775|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
640776|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
640777|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640778|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640779|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
640780|NCT03299387|Renal Agents|renal agents|mesh-ancestor
2081642|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
2081643|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2081644|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
640784|NCT03299296|Enoxaparin|enoxaparin|mesh-list
640785|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
640786|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
640787|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
640788|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
640789|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
640790|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640791|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640792|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
640793|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
640794|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
640795|NCT03299257|Donepezil|donepezil|mesh-list
640796|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
640797|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640798|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640799|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
640800|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640801|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640802|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
2220657|NCT00039403|Gemcitabine|gemcitabine|mesh-list
2220658|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2220659|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2220660|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
2220661|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220662|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081645|NCT02091206|Cannabidiol|cannabidiol|mesh-list
2081646|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
2081647|NCT02091362|Metformin|metformin|mesh-list
2081648|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2081649|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081650|NCT02091375|Cannabidiol|cannabidiol|mesh-list
2081651|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
2220663|NCT00039403|Antiviral Agents|antiviral agents|mesh-ancestor
2220664|NCT00039403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220665|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220666|NCT00039403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220667|NCT00039403|Immunologic Factors|immunologic factors|mesh-ancestor
2220668|NCT00039403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220669|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2220670|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
2220671|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220672|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2220673|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220674|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640828|NCT03299036|Doxorubicin|doxorubicin|mesh-list
640829|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
640830|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640831|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
640832|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
640833|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640834|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220675|NCT00039429|Atrasentan|atrasentan|mesh-list
2220676|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220677|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2220678|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2220679|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220680|NCT00039442|Capecitabine|capecitabine|mesh-list
2220681|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2220682|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
2220683|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220684|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220685|NCT00039455|Trastuzumab|trastuzumab|mesh-list
2220686|NCT00039455|Alvocidib|alvocidib|mesh-list
2220687|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2220688|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220689|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
2220690|NCT00039455|Growth Substances|growth substances|mesh-ancestor
2220691|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081652|NCT02091414|Cyclosporine|cyclosporine|mesh-list
2220692|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
640854|NCT03298958|Sirolimus|sirolimus|mesh-list
640855|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
640856|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
640857|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
640858|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640859|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
640860|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
640861|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
640862|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081653|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
2081654|NCT02091414|Cyclosporins|cyclosporins|mesh-list
2081655|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640866|NCT03298906|Ticlopidine|ticlopidine|mesh-list
640867|NCT03298906|Esketamine|esketamine|mesh-list
640868|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
640869|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
640870|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
640871|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
640872|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640873|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
640874|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
640875|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
640876|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
640877|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
640878|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640879|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640880|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
640881|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
640882|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640883|NCT03298893|Nivolumab|nivolumab|mesh-list
640884|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640885|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
640886|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
640887|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640888|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
640889|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
640890|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640891|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
640892|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
640893|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
640894|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
640895|NCT03298802|Diuretics|diuretics|mesh-ancestor
640896|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
640897|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640898|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
640899|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
640900|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640901|NCT03298698|Prednisone|prednisone|mesh-list
640902|NCT03298698|Prednisolone|prednisolone|mesh-list
640903|NCT03298698|Rituximab|rituximab|mesh-list
640904|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
640905|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640906|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
640907|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640908|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
640909|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
640910|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
640911|NCT03298698|Hormones|hormones|mesh-ancestor
640912|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
640913|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
640914|NCT03298646|Diclofenac|diclofenac|mesh-list
640915|NCT03298646|Lidocaine|lidocaine|mesh-list
640916|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
640917|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
640918|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
640919|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640920|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
640921|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
640922|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
640923|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
640924|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
640925|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2220693|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640926|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640927|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
640928|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
640929|NCT03298646|Analgesics|analgesics|mesh-ancestor
640930|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
640931|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
640932|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
640933|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640934|NCT03298581|Clobetasol|clobetasol|mesh-list
640935|NCT03298581|Halobetasol|halobetasol|mesh-list
640936|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
640937|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
640938|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
640939|NCT03298581|Hormones|hormones|mesh-ancestor
640940|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
640941|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640942|NCT03298542|Golimumab|golimumab|mesh-list
640943|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
640944|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
640945|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
640946|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
640947|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640948|NCT03298516|Azacitidine|azacitidine|mesh-list
640949|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
640950|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
640951|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640952|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640953|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640954|NCT03298464|Pioglitazone|pioglitazone|mesh-list
640955|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
640956|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081656|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081657|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2081658|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
2081659|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081660|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
2081661|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081662|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
2081663|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2081664|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2081665|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2220694|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220695|NCT00039468|Thalidomide|thalidomide|mesh-list
640970|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
640971|NCT03298373|Nandrolone|nandrolone|mesh-list
640972|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
640973|NCT03298373|Androgens|androgens|mesh-ancestor
640974|NCT03298373|Hormones|hormones|mesh-ancestor
640975|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
640976|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640977|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
640978|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
640979|NCT03298347|Caffeine|caffeine|mesh-list
640980|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
640981|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640982|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
640983|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640984|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640985|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
640986|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
640987|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
640988|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
640989|NCT03298321|Azacitidine|azacitidine|mesh-list
640990|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
640991|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
640992|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
640993|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
640994|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
640995|NCT03298295|Insulin|insulin|mesh-list
640996|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
640997|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
640998|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
640999|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
641000|NCT03298191|Ritodrine|ritodrine|mesh-list
641001|NCT03298191|Calcium|calcium|mesh-list
641002|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
641003|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641004|NCT03298191|Analgesics|analgesics|mesh-ancestor
641005|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
641006|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641007|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
641008|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
641009|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
641010|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
641011|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
641012|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641013|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
641014|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
641015|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
641016|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
641017|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
641018|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
641019|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
641020|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
641021|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2220696|NCT00039468|Irinotecan|irinotecan|mesh-list
2220697|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
641024|NCT03298087|Leuprolide|leuprolide|mesh-list
641025|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
641026|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
641027|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
641028|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641029|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
641030|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641031|NCT03298074|Etoposide|etoposide|mesh-list
641032|NCT03298074|Apatinib|apatinib|mesh-list
641033|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
641034|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641035|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
641036|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
641037|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641038|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641039|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
641040|NCT03298061|Prednisolone|prednisolone|mesh-list
641041|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
641042|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
641043|NCT03298061|Hormones|hormones|mesh-ancestor
641044|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
641045|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641046|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
641047|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641048|NCT03298009|Canagliflozin|canagliflozin|mesh-list
641049|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
641050|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641051|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
641052|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220698|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2220699|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220700|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220701|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220702|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220703|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
2220704|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220705|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
2220706|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2220707|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220708|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2220709|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2220710|NCT00039468|Growth Substances|growth substances|mesh-ancestor
2220711|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
641068|NCT03297931|Iproplatin|iproplatin|mesh-list
641069|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641070|NCT03297879|Metformin|metformin|mesh-list
641071|NCT03297879|Exenatide|exenatide|mesh-list
641072|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
641073|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641074|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
641075|NCT03297879|Incretins|incretins|mesh-ancestor
641076|NCT03297879|Hormones|hormones|mesh-ancestor
641385|NCT03296189|Hormones|hormones|mesh-ancestor
641077|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
641078|NCT03297710|Trifluridine|trifluridine|mesh-list
641079|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
641080|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641081|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
641082|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
641083|NCT03297684|Aflibercept|aflibercept|mesh-list
641084|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
641085|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
641086|NCT03297684|Growth Substances|growth substances|mesh-ancestor
641087|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641088|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
641089|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081666|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081667|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2081668|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
2081669|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2081670|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
2081671|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2081672|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2081673|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2081674|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2081675|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2081676|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081677|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
2081678|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081679|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081680|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2081681|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081682|NCT02091882|Aripiprazole|aripiprazole|mesh-list
2081683|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
2081684|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2081685|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2081686|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2220712|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
2220713|NCT00039481|Doxorubicin|doxorubicin|mesh-list
641113|NCT03297593|Nivolumab|nivolumab|mesh-list
641114|NCT03297593|Ipilimumab|ipilimumab|mesh-list
641115|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
641116|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641117|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
641118|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641119|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
641120|NCT03297502|Tacrolimus|tacrolimus|mesh-list
641121|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
641122|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
641123|NCT03297502|Analgesics|analgesics|mesh-ancestor
641124|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
641125|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641126|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641127|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
641128|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
641129|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
641130|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
641131|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
641132|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
641133|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641134|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641135|NCT03297463|Ipilimumab|ipilimumab|mesh-list
641136|NCT03297463|Interleukin-2|interleukin-2|mesh-list
641137|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
641138|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641139|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
641140|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641141|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
641142|NCT03297463|Analgesics|analgesics|mesh-ancestor
641143|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
641144|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641145|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220714|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2220715|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
2220716|NCT00039481|Razoxane|razoxane|mesh-list
2220717|NCT00039481|Oblimersen|oblimersen|mesh-list
2220718|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220719|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
2220720|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220721|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220722|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2220723|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
2220724|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220725|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220726|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2220727|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
641162|NCT03297359|Dalteparin|dalteparin|mesh-list
641163|NCT03297359|Tinzaparin|tinzaparin|mesh-list
641164|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
641165|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
641166|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
641167|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
641168|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220728|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2220729|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2220730|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220731|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2220732|NCT00039481|Protective Agents|protective agents|mesh-ancestor
2220733|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
2220734|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
2220735|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
641177|NCT03297073|Acetaminophen|acetaminophen|mesh-list
641178|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
641179|NCT03297073|Analgesics|analgesics|mesh-ancestor
641180|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
641181|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641182|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641183|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
2220736|NCT00039494|Temozolomide|temozolomide|mesh-list
2220737|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220738|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2220739|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220740|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220741|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2220742|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
2220743|NCT00039520|Sulindac|sulindac|mesh-list
2220744|NCT00039520|Docetaxel|docetaxel|mesh-list
2220745|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220746|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
2220747|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
2220748|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
2220749|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220750|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2220751|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
641201|NCT03296982|Enoxaparin|enoxaparin|mesh-list
641202|NCT03296982|Edoxaban|edoxaban|mesh-list
641203|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
641204|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
641205|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
641206|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641207|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
641208|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
641209|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
641210|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
641211|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641212|NCT03296930|Ritonavir|ritonavir|mesh-list
641213|NCT03296930|Ribavirin|ribavirin|mesh-list
641214|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
641215|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
641216|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
641217|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
641218|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641219|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641220|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
641221|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
641222|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
641223|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
641224|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
641225|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
641226|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
2220752|NCT00039520|Analgesics|analgesics|mesh-ancestor
2220753|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
2220754|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2220755|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220756|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2220757|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220758|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2220759|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220760|NCT00039546|Gemcitabine|gemcitabine|mesh-list
2220761|NCT00039546|Paclitaxel|paclitaxel|mesh-list
2220762|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
2220763|NCT00039546|Epirubicin|epirubicin|mesh-list
2220764|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2220765|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220766|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
2220767|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
2220768|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
2220769|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220770|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220771|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
2220772|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220773|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220774|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2220775|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
2220776|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2220777|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2220778|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
2220779|NCT00039546|Antiviral Agents|antiviral agents|mesh-ancestor
2220780|NCT00039546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
641265|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
641266|NCT03296670|Alprostadil|alprostadil|mesh-list
641267|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
641268|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
641269|NCT03296670|Urological Agents|urological agents|mesh-ancestor
641270|NCT03296657|Fluorides|fluorides|mesh-list
641271|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
641272|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
641273|NCT03296657|Protective Agents|protective agents|mesh-ancestor
641274|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641275|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
641276|NCT03296579|Aminophylline|aminophylline|mesh-list
641277|NCT03296579|Albuterol|albuterol|mesh-list
641278|NCT03296579|Ipratropium|ipratropium|mesh-list
641279|NCT03296579|Analgesics|analgesics|mesh-ancestor
641280|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
641281|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641282|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641283|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
641284|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
641285|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
641286|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
641287|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
641288|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
641289|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641290|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
641291|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
641292|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
641293|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
641294|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
641295|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
641296|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
641297|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
641298|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
641299|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
641300|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
641301|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
641302|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
641303|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
641304|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
641305|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
641306|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220781|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641307|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
641308|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
641309|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
641310|NCT03296579|Protective Agents|protective agents|mesh-ancestor
641315|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
641316|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2220782|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2220783|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2220784|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2220785|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
641321|NCT03296488|Fentanyl|fentanyl|mesh-list
641322|NCT03296488|Nalbuphine|nalbuphine|mesh-list
641323|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
641324|NCT03296488|Narcotics|narcotics|mesh-ancestor
641325|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
641326|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641327|NCT03296488|Analgesics|analgesics|mesh-ancestor
641328|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
641329|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641330|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
641331|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
641332|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
641333|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
641334|NCT03296423|Vaccines|vaccines|mesh-list
641335|NCT03296423|Immunologic Factors|immunologic factors|mesh-ancestor
641336|NCT03296423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641337|NCT03296410|Vaccines|vaccines|mesh-list
641338|NCT03296410|Immunoglobulins|immunoglobulins|mesh-list
641339|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
641340|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641341|NCT03296397|Vaccines|vaccines|mesh-list
641342|NCT03296397|Immunologic Factors|immunologic factors|mesh-ancestor
641343|NCT03296397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641344|NCT03296358|Dexamethasone|dexamethasone|mesh-list
641345|NCT03296358|Prednisolone|prednisolone|mesh-list
641346|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
641347|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
641348|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
641349|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641350|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641351|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
641352|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
641353|NCT03296358|Hormones|hormones|mesh-ancestor
641354|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
641355|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
641356|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220786|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220787|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2220788|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220789|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220790|NCT00039611|Leucovorin|leucovorin|mesh-list
2220791|NCT00039611|Fluorouracil|fluorouracil|mesh-list
2220792|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
2220793|NCT00039611|Calcium|calcium|mesh-list
2220794|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
2220795|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2220796|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220797|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
2220798|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220799|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
641371|NCT03296306|Cisplatin|cisplatin|mesh-list
641372|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641373|NCT03296189|Dexamethasone|dexamethasone|mesh-list
641374|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
641375|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
641376|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
641377|NCT03296189|BB 1101|bb 1101|mesh-list
641378|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
641379|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
641380|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
641381|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641382|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641383|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
641384|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
641386|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
641387|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
641388|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641389|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
641390|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
641391|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
641392|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
641393|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
641394|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641395|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220800|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220801|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2220802|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
2220803|NCT00039611|Antidotes|antidotes|mesh-ancestor
2220804|NCT00039611|Protective Agents|protective agents|mesh-ancestor
2220805|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
2220806|NCT00039611|Vitamins|vitamins|mesh-ancestor
2220807|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
2220808|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
2220809|NCT00039663|Pravastatin|pravastatin|mesh-list
2220810|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
2220811|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2220812|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220813|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2220814|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
641411|NCT03296137|Aldesleukin|aldesleukin|mesh-list
641412|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
641413|NCT03296137|Nivolumab|nivolumab|mesh-list
641414|NCT03296137|Ipilimumab|ipilimumab|mesh-list
641415|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
641416|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
641417|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
641418|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641419|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
641420|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
641421|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
641422|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641423|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641424|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
641425|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
641426|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
641427|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
641428|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
641429|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
641430|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
641431|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
641432|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
641433|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
641434|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
641435|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
641436|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
641437|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641438|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2220815|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
2220816|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220817|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2220818|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2220819|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220820|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2220821|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2220822|NCT00039767|Lepirudin|lepirudin|mesh-list
2220823|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
2751749|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2751750|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2751751|NCT03850379|Renal Agents|renal agents|mesh-ancestor
2751752|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
2751753|NCT03850366|Bortezomib|bortezomib|mesh-list
2751754|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2081687|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2081688|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641457|NCT03295968|Ibuprofen|ibuprofen|mesh-list
641458|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
641459|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
641460|NCT03295968|Analgesics|analgesics|mesh-ancestor
641461|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
641462|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641463|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641464|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
641465|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
641466|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
641467|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641468|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641469|NCT03295955|Amoxicillin|amoxicillin|mesh-list
641470|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
641471|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
641472|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
641473|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
641474|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
641475|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
641476|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641477|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641478|NCT03295903|Cannabidiol|cannabidiol|mesh-list
641479|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
641480|NCT03295851|Iron|iron|mesh-list
641481|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
641482|NCT03295851|Trace Elements|trace elements|mesh-ancestor
641483|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
641484|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641485|NCT03295825|Heparin|heparin|mesh-list
641486|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
641487|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
641488|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
641489|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641490|NCT03295786|Dopamine|dopamine|mesh-list
641491|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
641492|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
641493|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
641494|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641495|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641496|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
641497|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
641498|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641499|NCT03295786|Protective Agents|protective agents|mesh-ancestor
641500|NCT03295760|Ubiquinone|ubiquinone|mesh-list
641501|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
641502|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
641503|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641504|NCT03295760|Vitamins|vitamins|mesh-ancestor
641505|NCT03295747|Peppermint oil|peppermint oil|mesh-list
641506|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
641507|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
641508|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641509|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641510|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
641511|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
641512|NCT03295734|Losartan|losartan|mesh-list
641513|NCT03295734|Perindopril|perindopril|mesh-list
641514|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
641515|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
641516|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
641517|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
641518|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641519|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
641520|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
641521|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081689|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
2081690|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
2081691|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081692|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081693|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2081694|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
641529|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
641530|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
641531|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641532|NCT03295552|Carboplatin|carboplatin|mesh-list
641533|NCT03295552|Decitabine|decitabine|mesh-list
641534|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641535|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
641536|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
641537|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641538|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641539|NCT03295487|Estrogens|estrogens|mesh-list
641540|NCT03295487|Hormones|hormones|mesh-ancestor
641541|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
641542|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641543|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
641544|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
641545|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
641546|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
2081695|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
2751755|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
641549|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
641550|NCT03295383|Rituximab|rituximab|mesh-list
641551|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
641552|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
641553|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641554|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
641555|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
641556|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
641557|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641558|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641559|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
641560|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
641561|NCT03295240|Rituximab|rituximab|mesh-list
641562|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
641563|NCT03295240|Venetoclax|venetoclax|mesh-list
641564|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
641565|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641566|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
641567|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641568|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
641569|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
641570|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
641571|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641572|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
641573|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
641574|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641575|NCT03295214|Acetaminophen|acetaminophen|mesh-list
641576|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
641577|NCT03295214|Analgesics|analgesics|mesh-ancestor
641578|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
641579|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641580|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641581|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
641582|NCT03295162|Melatonin|melatonin|mesh-list
641583|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
641584|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641585|NCT03295162|Protective Agents|protective agents|mesh-ancestor
641586|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641587|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
641588|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
641589|NCT03295084|Capecitabine|capecitabine|mesh-list
641590|NCT03295084|Irinotecan|irinotecan|mesh-list
641591|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
641592|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
641593|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641594|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641595|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
641596|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
641597|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641598|NCT03294967|Vitamin E|vitamin e|mesh-list
641599|NCT03294967|Caffeine|caffeine|mesh-list
641600|NCT03294967|Vitamins|vitamins|mesh-ancestor
641601|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
641602|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641603|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
641604|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
641605|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641606|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641607|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
641608|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
641609|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
641610|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
641611|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
641612|NCT03294967|Protective Agents|protective agents|mesh-ancestor
641624|NCT03294798|Interferons|interferons|mesh-list
641625|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
641626|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
641627|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
641628|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641629|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
641630|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
641631|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
641632|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641633|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
641634|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
641635|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
641636|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
641637|NCT03294707|Coal Tar|coal tar|mesh-list
641638|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
641639|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
641640|NCT03294694|Fulvestrant|fulvestrant|mesh-list
641641|NCT03294694|Spartalizumab|spartalizumab|mesh-list
641642|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
641643|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641644|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
641645|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
641646|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
641647|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
641648|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641649|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
641650|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641651|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
641652|NCT03294577|Docetaxel|docetaxel|mesh-list
641653|NCT03294577|Doxorubicin|doxorubicin|mesh-list
641654|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
641655|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
641656|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641657|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
641658|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
641659|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
641660|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641661|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641662|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
641663|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
641664|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
641665|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
641666|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
641667|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
641668|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
641669|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641670|NCT03294551|Vaccines|vaccines|mesh-list
641671|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
641672|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220824|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2220825|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
2220826|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220827|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220828|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
2220829|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2220830|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2220831|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
2220832|NCT00039780|Protective Agents|protective agents|mesh-ancestor
2220833|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220834|NCT00039832|Reteplase|reteplase|mesh-list
2220835|NCT00039832|Abciximab|abciximab|mesh-list
641685|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
641686|NCT03294525|Mirtazapine|mirtazapine|mesh-list
641687|NCT03294525|Citalopram|citalopram|mesh-list
641688|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
641689|NCT03294525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
641690|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
641691|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
641692|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641693|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
641694|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
641695|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641696|NCT03294525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
641697|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
641698|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641699|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
641700|NCT03294525|Analgesics|analgesics|mesh-ancestor
641701|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
641702|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
641703|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
641704|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
641705|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
641706|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
641707|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
641708|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
641709|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
641710|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
641711|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
641712|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
641713|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
641714|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
641715|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
641716|NCT03294486|Flucytosine|flucytosine|mesh-list
641717|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
641718|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
641719|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
641720|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641726|NCT03294395|Gentamicins|gentamicins|mesh-list
641727|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
641728|NCT03294395|Ertapenem|ertapenem|mesh-list
641729|NCT03294395|Fosfomycin|fosfomycin|mesh-list
641730|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
641731|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
641732|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
641733|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641734|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641735|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
641736|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
641737|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
641738|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
641739|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
641740|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641741|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
641742|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
641743|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641744|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
641745|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2751756|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751757|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2751758|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2751759|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
2751760|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751761|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751762|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2751763|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
2751764|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2751765|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641760|NCT03294252|Leucovorin|leucovorin|mesh-list
641761|NCT03294252|Folic Acid|folic acid|mesh-list
641762|NCT03294252|Fluorouracil|fluorouracil|mesh-list
641763|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
641764|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
641765|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
641766|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641767|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
641768|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641769|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
641770|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
641771|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641772|NCT03294252|Antidotes|antidotes|mesh-ancestor
641773|NCT03294252|Protective Agents|protective agents|mesh-ancestor
641774|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
641775|NCT03294252|Vitamins|vitamins|mesh-ancestor
641776|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
641777|NCT03294252|Hematinics|hematinics|mesh-ancestor
641778|NCT03294174|Ropivacaine|ropivacaine|mesh-list
641779|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
641780|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
641781|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
641782|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641783|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
641784|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641785|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
641786|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
641787|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
641788|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081696|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2081697|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2081698|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2081699|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2081700|NCT02091921|Ticagrelor|ticagrelor|mesh-list
2081701|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2081702|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
641796|NCT03294083|Cemiplimab|cemiplimab|mesh-list
641797|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
641798|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641799|NCT03294070|Amlodipine|amlodipine|mesh-list
641800|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
641801|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
641802|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
641803|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641804|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
641805|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641806|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
641807|NCT03293992|Latanoprost|latanoprost|mesh-list
641808|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
641809|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
641810|NCT03293927|Fentanyl|fentanyl|mesh-list
641811|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
641812|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
641813|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
641814|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641815|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
641816|NCT03293927|Analgesics|analgesics|mesh-ancestor
641817|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
641818|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641819|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
641820|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
641821|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
641822|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
641823|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
641824|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641825|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
641826|NCT03293927|Narcotics|narcotics|mesh-ancestor
641827|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
641828|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
641829|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
641830|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
2081703|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2081704|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2081705|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
2081706|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081707|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081708|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081712|NCT02091986|Budesonide|budesonide|mesh-list
2081713|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2081714|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081715|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
641845|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
641846|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
641847|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220836|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
2220837|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2220838|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2220839|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2220840|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220841|NCT00039858|Argatroban|argatroban|mesh-list
2220842|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
2220843|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
641856|NCT03293641|Folic Acid|folic acid|mesh-list
641857|NCT03293641|Penicillins|penicillins|mesh-list
641858|NCT03293641|Penicillin V|penicillin v|mesh-list
641859|NCT03293641|Proguanil|proguanil|mesh-list
641860|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
641861|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
641862|NCT03293641|Hematinics|hematinics|mesh-ancestor
641863|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
641864|NCT03293641|Vitamins|vitamins|mesh-ancestor
641865|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
641866|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641867|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
641868|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
641869|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641870|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641871|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
641872|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
641873|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
641874|NCT03293641|Astringents|astringents|mesh-ancestor
641875|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
641876|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
641877|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
641878|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
641879|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
641880|NCT03293511|Oxytocin|oxytocin|mesh-list
641881|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
641882|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
641883|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220844|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
2220845|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220846|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220847|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
2220848|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2220849|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
2220850|NCT00039884|Hematinics|hematinics|mesh-ancestor
2220851|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2220852|NCT00039962|Thymalfasin|thymalfasin|mesh-list
2220853|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
641894|NCT03293472|Bupivacaine|bupivacaine|mesh-list
641895|NCT03293472|Ropivacaine|ropivacaine|mesh-list
641896|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
641897|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
641898|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
641899|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641900|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
641901|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641902|NCT03293407|Iloprost|iloprost|mesh-list
641903|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
641904|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
641905|NCT03293368|Triamcinolone|triamcinolone|mesh-list
641906|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
641907|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
641908|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
641909|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
641910|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
641911|NCT03293368|Hormones|hormones|mesh-ancestor
641912|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
641913|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641914|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
641915|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
641916|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641917|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641918|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
641919|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
641920|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
641921|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641922|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
641923|NCT03293277|Analgesics|analgesics|mesh-ancestor
641924|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
641925|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641926|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
641927|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
641928|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
641929|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
641930|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
641931|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641932|NCT03293108|Vitamin D|vitamin d|mesh-list
641933|NCT03293108|Denosumab|denosumab|mesh-list
641934|NCT03293108|Calcium|calcium|mesh-list
641935|NCT03293108|Vitamins|vitamins|mesh-ancestor
641936|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
641937|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641938|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
641939|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
641940|NCT03293069|Deferiprone|deferiprone|mesh-list
641941|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
641942|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
641943|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
641944|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081716|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
2081717|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081718|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081719|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2081720|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
2081721|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
2081722|NCT02091986|Hormones|hormones|mesh-ancestor
2081723|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081724|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2081725|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2081726|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2081727|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081728|NCT02092116|Romidepsin|romidepsin|mesh-list
2081729|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2081730|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081731|NCT02092168|Opicapone|opicapone|mesh-list
2081732|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2081733|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081734|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081735|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2081736|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2081737|NCT02092181|Mirabegron|mirabegron|mesh-list
2081738|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
641970|NCT03293004|Vitamins|vitamins|mesh-list
641971|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
641972|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
641973|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641974|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
641975|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641976|NCT03293004|Protective Agents|protective agents|mesh-ancestor
641977|NCT03292965|Neostigmine|neostigmine|mesh-list
641978|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
641979|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
641980|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
641981|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
641982|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
641983|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641984|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
641985|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
641986|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641987|NCT03292926|Dexamethasone|dexamethasone|mesh-list
641988|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
641989|NCT03292926|Bupivacaine|bupivacaine|mesh-list
641990|NCT03292926|BB 1101|bb 1101|mesh-list
641991|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
641992|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
641993|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
641994|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
641995|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
641996|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
641997|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
641998|NCT03292926|Hormones|hormones|mesh-ancestor
641999|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
642000|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
642001|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642002|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
642003|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642004|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642005|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
642006|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
642007|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
642008|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
2081739|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2081740|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2081741|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
2081742|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081743|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081744|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081745|NCT02092181|Urological Agents|urological agents|mesh-ancestor
2081746|NCT02092220|Pancrelipase|pancrelipase|mesh-list
2081747|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2081748|NCT02092285|Golimumab|golimumab|mesh-list
2081749|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2081750|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081751|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2081752|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
2081753|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081754|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
2081755|NCT02092298|Cisplatin|cisplatin|mesh-list
642026|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
642027|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
642028|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642029|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642030|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642031|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
642032|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
642033|NCT03292822|Paclitaxel|paclitaxel|mesh-list
642034|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
642035|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642036|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
642037|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
642038|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
642039|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220854|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220855|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
642042|NCT03292796|Bimatoprost|bimatoprost|mesh-list
642043|NCT03292796|Latanoprost|latanoprost|mesh-list
642044|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
642045|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
642046|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
642047|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
642048|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
642049|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
642050|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
642051|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642052|NCT03292744|Vitamins|vitamins|mesh-ancestor
642053|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
642054|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
642055|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
642056|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
642057|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
642058|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
642059|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
642060|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642061|NCT03292731|Progestins|progestins|mesh-ancestor
642062|NCT03292731|Hormones|hormones|mesh-ancestor
2081756|NCT02092298|Mitomycins|mitomycins|mesh-list
2081757|NCT02092298|Mitomycin|mitomycin|mesh-list
2081758|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081759|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2081760|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
2081761|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081762|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2081763|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081764|NCT02092298|Antidotes|antidotes|mesh-ancestor
2220856|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
2220857|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220858|NCT00039975|Ritonavir|ritonavir|mesh-list
2220859|NCT00039975|Indinavir|indinavir|mesh-list
2220860|NCT00039975|Amlodipine|amlodipine|mesh-list
2220861|NCT00039975|Diltiazem|diltiazem|mesh-list
2220862|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2220863|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2220864|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
2220865|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220866|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220867|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2220868|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
642088|NCT03292575|Anticoagulants|anticoagulants|mesh-list
642096|NCT03292315|Exenatide|exenatide|mesh-list
642097|NCT03292315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
642098|NCT03292315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642099|NCT03292315|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
642100|NCT03292315|Incretins|incretins|mesh-ancestor
642101|NCT03292315|Hormones|hormones|mesh-ancestor
642102|NCT03292315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
642103|NCT03292263|Nivolumab|nivolumab|mesh-list
642104|NCT03292263|Melphalan|melphalan|mesh-list
642105|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
642106|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642107|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
642108|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642109|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
642110|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
642111|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
642112|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
642113|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
642114|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642115|NCT03292250|Durvalumab|durvalumab|mesh-list
642116|NCT03292250|Tremelimumab|tremelimumab|mesh-list
642117|NCT03292250|Nintedanib|nintedanib|mesh-list
642118|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
642119|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642120|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
642121|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642122|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642123|NCT03292185|Insulin|insulin|mesh-list
642124|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
642125|NCT03292185|Liraglutide|liraglutide|mesh-list
642126|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
642127|NCT03292185|Xultophy|xultophy|mesh-list
642128|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
642129|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642130|NCT03292185|Incretins|incretins|mesh-ancestor
642131|NCT03292185|Hormones|hormones|mesh-ancestor
642132|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
642133|NCT03292172|Atezolizumab|atezolizumab|mesh-list
642134|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081765|NCT02092298|Protective Agents|protective agents|mesh-ancestor
2081766|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081767|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
2081768|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
2220869|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
2220870|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220871|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2220872|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2220873|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2220874|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2220875|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2220876|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2220877|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220878|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
2220879|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
2220880|NCT00039988|Albuterol|albuterol|mesh-list
2081769|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2081770|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081771|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
2081772|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
2081773|NCT02092350|Grazoprevir|grazoprevir|mesh-list
642160|NCT03291899|Folfirinox|folfirinox|mesh-list
642161|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642162|NCT03291886|Exemestane|exemestane|mesh-list
642163|NCT03291886|Entinostat|entinostat|mesh-list
642164|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642165|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
642166|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
642167|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642168|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642169|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
642170|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
642171|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
642172|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642173|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
642174|NCT03291847|Buprenorphine|buprenorphine|mesh-list
642175|NCT03291847|Methadone|methadone|mesh-list
642176|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
642177|NCT03291847|Naloxone|naloxone|mesh-list
642178|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
642179|NCT03291847|Narcotics|narcotics|mesh-ancestor
642180|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
642181|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642182|NCT03291847|Analgesics|analgesics|mesh-ancestor
642183|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
642184|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642185|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
642186|NCT03291847|Antitussive Agents|antitussive agents|mesh-ancestor
642187|NCT03291847|Respiratory System Agents|respiratory system agents|mesh-ancestor
642188|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
642189|NCT03291821|Cetrorelix|cetrorelix|mesh-list
642190|NCT03291821|Menotropins|menotropins|mesh-list
642191|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
642192|NCT03291821|Ganirelix|ganirelix|mesh-list
642193|NCT03291821|Hormones|hormones|mesh-ancestor
642194|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
642195|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642196|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
642197|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
642198|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
642199|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
642200|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
642201|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
642202|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642203|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
642204|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
642205|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
642206|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
642207|NCT03291457|Hormones|hormones|mesh-ancestor
642208|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
642209|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642210|NCT03291418|Naproxen|naproxen|mesh-list
642211|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
642212|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
642213|NCT03291418|Analgesics|analgesics|mesh-ancestor
642214|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
642215|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642216|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642217|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
642218|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
642219|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
642220|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
642221|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642222|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081774|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
2220881|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
642223|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
642224|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
642225|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642226|NCT03291314|Avelumab|avelumab|mesh-list
642227|NCT03291314|Axitinib|axitinib|mesh-list
642228|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
642229|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642230|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
642231|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642232|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220882|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2220883|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
2220884|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2220885|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220886|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2220887|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
2220888|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
2220889|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2220890|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2220891|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2220892|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2220893|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
2220894|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2220895|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220896|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2220897|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
2220898|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
642250|NCT03291249|Omeprazole|omeprazole|mesh-list
642251|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
642252|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
642253|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
642254|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642255|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220899|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2220900|NCT00040014|Exemestane|exemestane|mesh-list
2220901|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220902|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2220903|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2220904|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642263|NCT03291158|Minocycline|minocycline|mesh-list
642264|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
642265|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
642266|NCT03291145|Spironolactone|spironolactone|mesh-list
642267|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
642268|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
642269|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
642270|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
642271|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642272|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
642273|NCT03291145|Diuretics|diuretics|mesh-ancestor
642274|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
642275|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
642276|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
642277|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642278|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642279|NCT03291093|Flutemetamol|flutemetamol|mesh-list
642280|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
642281|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081775|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081776|NCT02092467|Adalimumab|adalimumab|mesh-list
2081777|NCT02092467|Etanercept|etanercept|mesh-list
2081778|NCT02092467|Tofacitinib|tofacitinib|mesh-list
2081779|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
642287|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
642288|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
642289|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642293|NCT03290963|Ketamine|ketamine|mesh-list
642294|NCT03290963|Analgesics|analgesics|mesh-ancestor
642295|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
642296|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642297|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642298|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
642299|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
642300|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
642301|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
642302|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
642303|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
642304|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
642305|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642306|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081780|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2081781|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2081782|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2081783|NCT02092467|Analgesics|analgesics|mesh-ancestor
2081784|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
2081785|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081786|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081787|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2081788|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2081789|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
2081790|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2081791|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081792|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081793|NCT02092961|Adalimumab|adalimumab|mesh-list
2081794|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081795|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2081796|NCT02093026|Folic Acid|folic acid|mesh-list
2081797|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
2081798|NCT02093026|Rituximab|rituximab|mesh-list
2081799|NCT02093026|Methotrexate|methotrexate|mesh-list
2081800|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2081801|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081802|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
2081803|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642331|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
642332|NCT03290937|Cetuximab|cetuximab|mesh-list
642333|NCT03290937|Irinotecan|irinotecan|mesh-list
642334|NCT03290937|Camptothecin|camptothecin|mesh-list
642335|NCT03290937|Antibodies|antibodies|mesh-list
642336|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
642337|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
642338|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
642339|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
642340|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642341|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642342|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
642343|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
642344|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642345|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642346|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
642347|NCT03290859|Propofol|propofol|mesh-list
642348|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
642349|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
642350|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642351|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
642352|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
642353|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
642354|NCT03290846|Secretin|secretin|mesh-list
642355|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
642356|NCT03290846|Hormones|hormones|mesh-ancestor
642357|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
642358|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642359|NCT03290820|Aspirin|aspirin|mesh-list
642360|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
642361|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
642362|NCT03290820|Analgesics|analgesics|mesh-ancestor
642363|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
642364|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642365|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642366|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
642367|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
642368|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
642369|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
642370|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642371|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
642372|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
642373|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642374|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
2081804|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2081805|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2081806|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
2081807|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2081808|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2081809|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
2081810|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642382|NCT03290703|Rabeprazole|rabeprazole|mesh-list
642383|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
642384|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
642385|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
642386|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642387|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642388|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
642389|NCT03290625|Ketamine|ketamine|mesh-list
642390|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
642391|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
642392|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642393|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
642394|NCT03290625|Analgesics|analgesics|mesh-ancestor
642395|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
642396|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642397|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
642398|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
642399|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
642400|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
642401|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642402|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642403|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
642404|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
642405|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
642406|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
642407|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
642408|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
642409|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
642410|NCT03290612|Vitamins|vitamins|mesh-ancestor
642411|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
642412|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642413|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
642414|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642415|NCT03290612|Protective Agents|protective agents|mesh-ancestor
642416|NCT03290560|Kallikreins|kallikreins|mesh-list
642417|NCT03290560|Coagulants|coagulants|mesh-ancestor
642418|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
642419|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
642420|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
642421|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642422|NCT03290495|Ketamine|ketamine|mesh-list
642423|NCT03290495|Analgesics|analgesics|mesh-ancestor
642424|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
642425|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642426|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642427|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
642428|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
642429|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
642430|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
642431|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
642432|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
642433|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
642434|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642435|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642436|NCT03290456|Prednisone|prednisone|mesh-list
642437|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
642438|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
642439|NCT03290456|Hormones|hormones|mesh-ancestor
642440|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
642441|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642442|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
642443|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642444|NCT03290430|Nicotine|nicotine|mesh-list
642445|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
642446|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
642447|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642448|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642449|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
642450|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
642451|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
642452|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642453|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642454|NCT03290417|Vitamin D|vitamin d|mesh-list
642455|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
642456|NCT03290417|Vitamins|vitamins|mesh-list
642457|NCT03290417|Curcumin|curcumin|mesh-list
642458|NCT03290417|Turmeric extract|turmeric extract|mesh-list
642459|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
642460|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642461|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
642462|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
642463|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
642464|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
642465|NCT03290417|Analgesics|analgesics|mesh-ancestor
642466|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
642467|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642468|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
642469|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
642470|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642471|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642472|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642473|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
642474|NCT03290417|Protective Agents|protective agents|mesh-ancestor
642475|NCT03290391|Naltrexone|naltrexone|mesh-list
642476|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
642477|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
642478|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642479|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
642480|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2220905|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220906|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2220907|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
2220908|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2220909|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220910|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2220911|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
2220912|NCT00040027|Thymalfasin|thymalfasin|mesh-list
642489|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
642490|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
642491|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
642492|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642493|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
642494|NCT03290365|Protective Agents|protective agents|mesh-ancestor
2081811|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
2081812|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642497|NCT03290196|Bupivacaine|bupivacaine|mesh-list
642498|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
642499|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
642500|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
642501|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642502|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
642503|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2220913|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
2220914|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081813|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
642516|NCT03289949|Ketanserin|ketanserin|mesh-list
642517|NCT03289949|Psilocybin|psilocybin|mesh-list
642518|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
642519|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642520|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
642521|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
642522|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
642523|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
642524|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
642525|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642526|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642527|NCT03289910|Carboplatin|carboplatin|mesh-list
642528|NCT03289910|Topotecan|topotecan|mesh-list
642529|NCT03289910|Veliparib|veliparib|mesh-list
642530|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642531|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
642532|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
642533|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642534|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642535|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
642536|NCT03289871|Amorolfine|amorolfine|mesh-list
642537|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
642538|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220915|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
2220916|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220917|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2220918|NCT00040040|Bupropion|bupropion|mesh-list
2220919|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2220920|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
2220921|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
642546|NCT03289819|Paclitaxel|paclitaxel|mesh-list
642547|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
642548|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
642549|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
642550|NCT03289819|Epirubicin|epirubicin|mesh-list
642551|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
642552|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642553|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
642554|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
642555|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
642556|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642557|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
642558|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
642559|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642560|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
642561|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
642562|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
642563|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
642564|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
642565|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
642566|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
642567|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
642568|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642569|NCT03289741|Octreotide|octreotide|mesh-list
642570|NCT03289741|Lanreotide|lanreotide|mesh-list
642571|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
642572|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
642573|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642574|NCT03289728|Dobutamine|dobutamine|mesh-list
642575|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
642576|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
642577|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
642578|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642579|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642580|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
642581|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
642582|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
642583|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
642584|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642585|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642586|NCT03289728|Protective Agents|protective agents|mesh-ancestor
2220922|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2220923|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2220924|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2220925|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220926|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
2220927|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2220928|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220929|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
642604|NCT03289637|Vitamin D|vitamin d|mesh-list
642605|NCT03289637|Vitamins|vitamins|mesh-ancestor
642606|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
642607|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642608|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
642609|NCT03289559|Testosterone|testosterone|mesh-list
642610|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
642611|NCT03289559|Androgens|androgens|mesh-ancestor
642612|NCT03289559|Hormones|hormones|mesh-ancestor
642613|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
642614|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642615|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
642616|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642617|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642618|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
642619|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
2220930|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2220931|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220932|NCT00040053|Ondansetron|ondansetron|mesh-list
2220933|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
2220934|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
2220935|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2220936|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642627|NCT03289520|Clopidogrel|clopidogrel|mesh-list
642628|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
642629|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
642630|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
642631|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
642632|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
642633|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642634|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642635|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642636|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
642637|NCT03289429|Atorvastatin|atorvastatin|mesh-list
642638|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
642639|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
642640|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
642641|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642642|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
642643|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
642644|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642645|NCT03289429|Analgesics|analgesics|mesh-ancestor
642646|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
642647|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642648|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642649|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
642650|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
642651|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
642652|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
642653|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
642654|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
642655|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
642656|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
642657|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
642658|NCT03289390|Acetaminophen|acetaminophen|mesh-list
642659|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
642660|NCT03289390|Analgesics|analgesics|mesh-ancestor
642661|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
642662|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642663|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642664|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
642665|NCT03289351|Tazobactam|tazobactam|mesh-list
642666|NCT03289351|Piperacillin|piperacillin|mesh-list
642667|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
642668|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
642669|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
642670|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
642671|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642672|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642673|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
642674|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
642675|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
642676|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
642677|NCT03289338|Prednisolone|prednisolone|mesh-list
642678|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
642679|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
642680|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
642681|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
642682|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
642683|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
642684|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642685|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642686|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
642687|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
642688|NCT03289338|Hormones|hormones|mesh-ancestor
642689|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
642690|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
642691|NCT03289338|Protective Agents|protective agents|mesh-ancestor
642692|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
642693|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642694|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2081814|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2081815|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2081816|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081817|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
2081818|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
2081819|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081820|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2081821|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
2081822|NCT02093026|Hormones|hormones|mesh-ancestor
2081823|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081824|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2081825|NCT02093026|Protective Agents|protective agents|mesh-ancestor
2081826|NCT02093026|Hematinics|hematinics|mesh-ancestor
2081827|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
642709|NCT03289299|Dexamethasone|dexamethasone|mesh-list
642710|NCT03289299|Lenalidomide|lenalidomide|mesh-list
642711|NCT03289299|Daratumumab|daratumumab|mesh-list
642712|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
642713|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
642714|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
642715|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642716|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642717|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
642718|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
642719|NCT03289299|Hormones|hormones|mesh-ancestor
642720|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
642721|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
642722|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642723|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
642724|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
642725|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
642726|NCT03289299|Growth Substances|growth substances|mesh-ancestor
642727|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
642728|NCT03289260|Imiquimod|imiquimod|mesh-list
642729|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
642730|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
642731|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642732|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642733|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
2220937|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2220938|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
2220939|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
2220940|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2220941|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
2220942|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2220943|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220944|NCT00040053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2220945|NCT00040053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2220946|NCT00040053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2220947|NCT00040053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2220948|NCT00040053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2220949|NCT00040066|Cocaine|cocaine|mesh-list
2220950|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
642748|NCT03289182|Rituximab|rituximab|mesh-list
642749|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
642750|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081828|NCT02093026|Vitamins|vitamins|mesh-ancestor
2081829|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
642751|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
642752|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642753|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
642754|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
642755|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
642756|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642757|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642758|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
642759|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
642760|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642761|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
642762|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081830|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
2081831|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2081832|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
2081833|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081834|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081835|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2081836|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2081837|NCT02093351|Tamoxifen|tamoxifen|mesh-list
642771|NCT03289026|Aripiprazole|aripiprazole|mesh-list
642772|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
642773|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
642774|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
642775|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
642776|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
642777|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642778|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
642779|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
642780|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642781|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642782|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
642783|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
642784|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
642785|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
642786|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
642787|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
642788|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2220951|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
2220952|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2220953|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220954|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
2220955|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2220956|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2220957|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2220958|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2220959|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2220960|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220961|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
2220962|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2220963|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
2220964|NCT00040105|Tipifarnib|tipifarnib|mesh-list
2220965|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220966|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2220967|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220968|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220969|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
2220970|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2220971|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
642813|NCT03288974|Pomalidomide|pomalidomide|mesh-list
642814|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
642815|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642816|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
642817|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
642818|NCT03288974|Growth Substances|growth substances|mesh-ancestor
642819|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
642820|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642821|NCT03288896|Ethanol|ethanol|mesh-list
642822|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
642823|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
642824|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2081838|NCT02093351|Letrozole|letrozole|mesh-list
2081839|NCT02093351|Olaparib|olaparib|mesh-list
642825|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642826|NCT03288870|Docetaxel|docetaxel|mesh-list
642827|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642828|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
642829|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
642830|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
642831|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642832|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
642833|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
642834|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642835|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
642836|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642837|NCT03288675|Serotonin|serotonin|mesh-list
642838|NCT03288675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
642839|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
642840|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
642841|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642842|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642843|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642844|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
642845|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
642846|NCT03288636|Ritonavir|ritonavir|mesh-list
642847|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
642848|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
642849|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
642850|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642851|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642852|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
642853|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
642854|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
642855|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
642856|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
642857|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
642858|NCT03288610|Vasopressins|vasopressins|mesh-list
642859|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
642860|NCT03288610|Coagulants|coagulants|mesh-ancestor
642861|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
642862|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
642863|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
642864|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642865|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
642866|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
642867|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081840|NCT02093351|Anastrozole|anastrozole|mesh-list
2081841|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081842|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2081843|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2081844|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081845|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081846|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2081847|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
2081848|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081849|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081850|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2081851|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
642882|NCT03288532|Durvalumab|durvalumab|mesh-list
642883|NCT03288532|Tremelimumab|tremelimumab|mesh-list
642884|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
642885|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642886|NCT03288454|Apixaban|apixaban|mesh-list
642887|NCT03288454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
642888|NCT03288454|Antithrombins|antithrombins|mesh-ancestor
642889|NCT03288454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
642890|NCT03288454|Protease Inhibitors|protease inhibitors|mesh-ancestor
642891|NCT03288454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642892|NCT03288454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642893|NCT03288454|Anticoagulants|anticoagulants|mesh-ancestor
642894|NCT03288428|Morphine|morphine|mesh-list
642895|NCT03288428|Nalbuphine|nalbuphine|mesh-list
642896|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
642897|NCT03288428|Narcotics|narcotics|mesh-ancestor
642898|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
642899|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642900|NCT03288428|Analgesics|analgesics|mesh-ancestor
642901|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
642902|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642903|NCT03288402|Caffeine|caffeine|mesh-list
642904|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
642905|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642906|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
642907|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
642908|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642909|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
642910|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
642911|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
642912|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642913|NCT03288350|Avelumab|avelumab|mesh-list
642914|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
642915|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
642920|NCT03288259|Anesthetics|anesthetics|mesh-list
642921|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
642922|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
642923|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642924|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
642925|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642926|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
642927|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
642928|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642929|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
642930|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642931|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642932|NCT03288077|Tryptophan|tryptophan|mesh-list
642933|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
642934|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
642935|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
642936|NCT03288051|Dobutamine|dobutamine|mesh-list
642937|NCT03288051|Norepinephrine|norepinephrine|mesh-list
642938|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
642939|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
642940|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
642941|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
642942|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642943|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642944|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
642945|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
642946|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642947|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
642948|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
642949|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
642950|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
642951|NCT03288051|Protective Agents|protective agents|mesh-ancestor
642952|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
642953|NCT03288038|Ezetimibe|ezetimibe|mesh-list
642954|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
642955|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
642956|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
642957|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
642958|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
642959|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
642960|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220972|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220973|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220974|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
2220975|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220976|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
642966|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
642967|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
642968|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
642969|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
642970|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
642971|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
642990|NCT03287882|Micronutrients|micronutrients|mesh-list
642991|NCT03287882|Trace Elements|trace elements|mesh-list
642992|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2220977|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2220978|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
2220979|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2220980|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2220981|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2220982|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220983|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
2220984|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2220985|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2220986|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2220987|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2220988|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2220989|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2220990|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081852|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2081853|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2081854|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2081855|NCT02093390|Fluconazole|fluconazole|mesh-list
2081856|NCT02093390|Atorvastatin|atorvastatin|mesh-list
2220991|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220992|NCT00040209|Levodopa|levodopa|mesh-list
2220993|NCT00040209|Apomorphine|apomorphine|mesh-list
2220994|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2220995|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2220996|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
2220997|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2220998|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2220999|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221000|NCT00040209|Emetics|emetics|mesh-ancestor
2221001|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
2221002|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221003|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2221004|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
2221005|NCT00040248|Daclizumab|daclizumab|mesh-list
2221006|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221007|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
2221008|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221009|NCT00040261|Memantine|memantine|mesh-list
2221010|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2221011|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2221012|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
2221013|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2221014|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221015|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221016|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2221017|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2221018|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
2221019|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
643043|NCT03287609|Evolocumab|evolocumab|mesh-list
643044|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
643045|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
643046|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
643047|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643048|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
643049|NCT03287505|Aripiprazole|aripiprazole|mesh-list
643050|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
643051|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
643052|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
643053|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
643054|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
643055|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643056|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
643057|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
643058|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
643059|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643060|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
643061|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
643062|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
643063|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
643064|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
643065|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
643066|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
643067|NCT03287388|Rocuronium|rocuronium|mesh-list
643068|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
643069|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
643070|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
643071|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
643072|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643073|NCT03287375|Cisplatin|cisplatin|mesh-list
643074|NCT03287375|Doxorubicin|doxorubicin|mesh-list
643075|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
643076|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643077|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
643078|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
643079|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
643080|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643081|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643082|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
643083|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
643084|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
643085|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643086|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
643087|NCT03287336|Coagulants|coagulants|mesh-ancestor
2221020|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2221021|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221022|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221023|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
2221024|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221025|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2221026|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2221027|NCT00040300|Racivir|racivir|mesh-list
2221028|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
2221029|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221030|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
2221031|NCT00040378|Vitamins|vitamins|mesh-list
2221032|NCT00040378|Vitamin E|vitamin e|mesh-list
2221033|NCT00040378|Tocopherols|tocopherols|mesh-list
2221034|NCT00040378|Tocotrienols|tocotrienols|mesh-list
643103|NCT03287271|Paclitaxel|paclitaxel|mesh-list
643104|NCT03287271|Carboplatin|carboplatin|mesh-list
643105|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
643106|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643107|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
643108|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
643109|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
643110|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643111|NCT03287232|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
643112|NCT03287232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
643113|NCT03287232|Immunologic Factors|immunologic factors|mesh-ancestor
643114|NCT03287232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221035|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
2221036|NCT00040378|Selenium|selenium|mesh-list
2221037|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
643118|NCT03287180|Buprenorphine|buprenorphine|mesh-list
643119|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
643120|NCT03287180|Naloxone|naloxone|mesh-list
643121|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
643122|NCT03287180|Narcotics|narcotics|mesh-ancestor
643123|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
643124|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643125|NCT03287180|Analgesics|analgesics|mesh-ancestor
2221038|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221039|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
2273738|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
643126|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
643127|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
643128|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
643129|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
643130|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
643131|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221040|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221041|NCT00040378|Protective Agents|protective agents|mesh-ancestor
2221042|NCT00040378|Trace Elements|trace elements|mesh-ancestor
2221043|NCT00040391|Leucovorin|leucovorin|mesh-list
2221044|NCT00040391|Fluorouracil|fluorouracil|mesh-list
643137|NCT03287076|Exenatide|exenatide|mesh-list
643138|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
643139|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643140|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
643141|NCT03287076|Incretins|incretins|mesh-ancestor
643142|NCT03287076|Hormones|hormones|mesh-ancestor
643143|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2751787|NCT03840148|Meropenem|meropenem|mesh-list
2751788|NCT03840148|Cefepime|cefepime|mesh-list
643147|NCT03287011|Listerine|listerine|mesh-list
643148|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
643149|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
643150|NCT03287011|Protective Agents|protective agents|mesh-ancestor
643151|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643152|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
643153|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
643154|NCT03286959|Calcium|calcium|mesh-list
643155|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
643156|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081857|NCT02093390|Relugolix|relugolix|mesh-list
2081858|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2081859|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2081860|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
2081861|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221045|NCT00040391|Irinotecan|irinotecan|mesh-list
2221046|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
2221047|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221048|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221049|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221050|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221051|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
2221052|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221053|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2221054|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2221055|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221056|NCT00040391|Antidotes|antidotes|mesh-ancestor
2221057|NCT00040391|Protective Agents|protective agents|mesh-ancestor
643175|NCT03286803|Vaccines|vaccines|mesh-list
643176|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
643177|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643178|NCT03286764|Peppermint oil|peppermint oil|mesh-list
643179|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
643180|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
643181|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
643182|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643183|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
643184|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
2221058|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
2221059|NCT00040391|Vitamins|vitamins|mesh-ancestor
2221060|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
643188|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
643189|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
643190|NCT03286673|Calcium|calcium|mesh-list
643191|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
643192|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643193|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
643194|NCT03286673|Antacids|antacids|mesh-ancestor
643195|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643196|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
643197|NCT03286634|Cytarabine|cytarabine|mesh-list
643198|NCT03286634|Prednisolone|prednisolone|mesh-list
643199|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
643200|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
643201|NCT03286634|Methotrexate|methotrexate|mesh-list
643202|NCT03286634|Vincristine|vincristine|mesh-list
2221061|NCT00040417|Fludarabine|fludarabine|mesh-list
2221062|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
643203|NCT03286634|Daunorubicin|daunorubicin|mesh-list
643204|NCT03286634|Asparaginase|asparaginase|mesh-list
643205|NCT03286634|Epirubicin|epirubicin|mesh-list
643206|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
643207|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
643208|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
643209|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643210|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
643211|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
643212|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
643213|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643214|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643215|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
643216|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
643217|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
643218|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
643219|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
643220|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
643221|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
643222|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643223|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
643224|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
643225|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
643226|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
643227|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
643228|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
643229|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
643230|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
643231|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
643232|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
643233|NCT03286634|Hormones|hormones|mesh-ancestor
643234|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
643235|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
643236|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
643237|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
643238|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
643239|NCT03286582|Clobetasol|clobetasol|mesh-list
643240|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
643241|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
643242|NCT03286582|Hormones|hormones|mesh-ancestor
643243|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
643244|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643250|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
643251|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
643252|NCT03286296|Antibodies|antibodies|mesh-list
643253|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
643254|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
643255|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643256|NCT03286244|Paclitaxel|paclitaxel|mesh-list
643257|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
643258|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643259|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
643260|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
643261|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
643262|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221063|NCT00040417|Sargramostim|sargramostim|mesh-list
2221064|NCT00040417|Lenograstim|lenograstim|mesh-list
2221065|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221066|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
2221067|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221068|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2221069|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2221070|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
2221071|NCT00040469|Busulfan|busulfan|mesh-list
2221072|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
2221073|NCT00040469|Phenytoin|phenytoin|mesh-list
2221074|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221075|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
2221076|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643277|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
643278|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2221077|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
643279|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643280|NCT03286101|Ivermectin|ivermectin|mesh-list
643281|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
643282|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221078|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2221079|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
2221080|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221081|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221082|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2221083|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2221084|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
2221085|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
643291|NCT03285906|Apatinib|apatinib|mesh-list
643292|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643293|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
643294|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643295|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643296|NCT03285802|Everolimus|everolimus|mesh-list
643297|NCT03285802|Letrozole|letrozole|mesh-list
643298|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643299|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
643300|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
643301|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643302|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
643303|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
643304|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643305|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643306|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
643307|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
643308|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081862|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2081863|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2221086|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2221087|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2221088|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2221089|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2221090|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
2221091|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
643317|NCT03285607|Paclitaxel|paclitaxel|mesh-list
643318|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
643319|NCT03285607|Doxorubicin|doxorubicin|mesh-list
643320|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
643321|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643322|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
643323|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
643324|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
643325|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643326|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
643327|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
643328|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643329|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
643330|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
643331|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
643332|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
643333|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
643334|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
643335|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
643336|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221092|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
2221093|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221094|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2221095|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2221096|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
643343|NCT03285568|Palbociclib|palbociclib|mesh-list
643344|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643345|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
643346|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643347|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643348|NCT03285503|Aripiprazole|aripiprazole|mesh-list
643349|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
643350|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
643351|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
643352|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
643353|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
643354|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643355|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
643356|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
643357|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
643358|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643359|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
643360|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
643361|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
643362|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
643363|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
643364|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
643365|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2221097|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221098|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221099|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2221100|NCT00040495|Pantoprazole|pantoprazole|mesh-list
2221101|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2221102|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
643372|NCT03285360|Fluorides|fluorides|mesh-list
643373|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
643374|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
643375|NCT03285360|Protective Agents|protective agents|mesh-ancestor
643376|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643377|NCT03285321|Nivolumab|nivolumab|mesh-list
643378|NCT03285321|Ipilimumab|ipilimumab|mesh-list
643379|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
643380|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643381|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
643382|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221103|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2221104|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273739|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
643386|NCT03285165|Propofol|propofol|mesh-list
643387|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
643388|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
643389|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643390|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
643391|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
643392|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
643393|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
643394|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
643395|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
643396|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643397|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
643398|NCT03285087|Analgesics|analgesics|mesh-ancestor
643399|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
643400|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
643401|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
643402|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
643403|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
643404|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
643405|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
643406|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643407|NCT03284957|Everolimus|everolimus|mesh-list
643408|NCT03284957|Palbociclib|palbociclib|mesh-list
643409|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643410|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
643411|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
643412|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643413|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
643414|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643415|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643416|NCT03284866|Vaccines|vaccines|mesh-list
643417|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
643418|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643422|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
643423|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
643424|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
643425|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
643426|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
643427|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643428|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643429|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
643430|NCT03284749|Copper|copper|mesh-list
643431|NCT03284749|Trace Elements|trace elements|mesh-ancestor
643432|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
643433|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751789|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2751790|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2751797|NCT03832127|Fludarabine|fludarabine|mesh-list
2751798|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751799|NCT03824522|BAX 855|bax 855|mesh-list
2751800|NCT03824522|Coagulants|coagulants|mesh-ancestor
643446|NCT03284645|Tenofovir|tenofovir|mesh-list
643447|NCT03284645|Lamivudine|lamivudine|mesh-list
643448|NCT03284645|Zidovudine|zidovudine|mesh-list
643449|NCT03284645|Efavirenz|efavirenz|mesh-list
643450|NCT03284645|Abacavir|abacavir|mesh-list
643451|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
643452|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
643453|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
643454|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
643455|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643456|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643457|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
643458|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
643459|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
643460|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
643461|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
643462|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
643463|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
643464|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
643465|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
643466|NCT03284593|Azacitidine|azacitidine|mesh-list
643467|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
643468|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
643469|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643470|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643471|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643472|NCT03284515|Vaccines|vaccines|mesh-list
643473|NCT03284515|Immunologic Factors|immunologic factors|mesh-ancestor
643474|NCT03284515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643475|NCT03284502|Cetuximab|cetuximab|mesh-list
643476|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
643477|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643478|NCT03284463|Glyburide|glyburide|mesh-list
643479|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
643480|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081864|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081865|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
2081866|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081867|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2081868|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2081869|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
643487|NCT03284307|Midazolam|midazolam|mesh-list
643488|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
643489|NCT03284307|Ketamine|ketamine|mesh-list
643490|NCT03284307|Propofol|propofol|mesh-list
643491|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
643492|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
643493|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643494|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
643495|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
643496|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
643497|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
643498|NCT03284307|Analgesics|analgesics|mesh-ancestor
643499|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
643500|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
643501|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
643502|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
643503|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2751801|NCT03823365|Blinatumomab|blinatumomab|mesh-list
643504|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
643505|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
643506|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643507|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
643508|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
643509|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
643510|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
643511|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
643512|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
643513|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
643514|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
643515|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
643516|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
643517|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
643518|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643519|NCT03284294|Vitamins|vitamins|mesh-ancestor
643520|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
643521|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
643522|NCT03284177|Calcium|calcium|mesh-list
643523|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
643524|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643525|NCT03284164|Tenofovir|tenofovir|mesh-list
643526|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
643527|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
643528|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
643529|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
643530|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643531|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643532|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
643533|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2751802|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751808|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
2751809|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2751810|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
2751811|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2751812|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081870|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
2081871|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
643548|NCT03283943|Durvalumab|durvalumab|mesh-list
643549|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
643550|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643551|NCT03283917|Dexamethasone|dexamethasone|mesh-list
643552|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
643553|NCT03283917|Daratumumab|daratumumab|mesh-list
643554|NCT03283917|Ixazomib|ixazomib|mesh-list
643555|NCT03283917|Ichthammol|ichthammol|mesh-list
643556|NCT03283917|BB 1101|bb 1101|mesh-list
643557|NCT03283917|Glycine|glycine|mesh-list
643558|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
643559|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
643560|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
643561|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
643562|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643563|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
643564|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
643565|NCT03283917|Hormones|hormones|mesh-ancestor
643566|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
643567|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
643568|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643569|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
643570|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643571|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643572|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
643573|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
643574|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
643575|NCT03283878|Cefazolin|cefazolin|mesh-list
643576|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
643577|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
643578|NCT03283813|Inositol|inositol|mesh-list
643579|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
643580|NCT03283813|Vitamins|vitamins|mesh-ancestor
643581|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
643582|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643583|NCT03283800|Copper|copper|mesh-list
643584|NCT03283800|Trace Elements|trace elements|mesh-ancestor
643585|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
643586|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221105|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221106|NCT00040508|Sirolimus|sirolimus|mesh-list
2221107|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2221108|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221109|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2221110|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221111|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
2221112|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221113|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
2221114|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643618|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
643619|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
643620|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
643621|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
643622|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
643623|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643624|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
643625|NCT03283670|Analgesics|analgesics|mesh-ancestor
643626|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
643627|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081872|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081873|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2081874|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
643632|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
643633|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
643634|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
643635|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
643636|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
643637|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643638|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643639|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
643640|NCT03283488|Megestrol|megestrol|mesh-list
643641|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
643642|NCT03283488|Mirtazapine|mirtazapine|mesh-list
643643|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
643644|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
643645|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
643646|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
643647|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
643648|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
643649|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643650|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643651|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
643652|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
643653|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
643654|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
643655|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
643656|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
643657|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
643658|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
643659|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
643660|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
643661|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
643662|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
643663|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
643664|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
643665|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
643666|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
643667|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
643668|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
643669|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
643670|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643671|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
643672|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2221115|NCT00040521|Oprelvekin|oprelvekin|mesh-list
2221116|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221117|NCT00040586|Interleukin-2|interleukin-2|mesh-list
2221118|NCT00040586|Antibodies|antibodies|mesh-list
2221119|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2221120|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
2221121|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643680|NCT03283410|Propofol|propofol|mesh-list
643681|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
643682|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
643683|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643684|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
643685|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
643686|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
643687|NCT03283384|Letrozole|letrozole|mesh-list
643688|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643689|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
643690|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
643691|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643692|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643693|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
643694|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
643695|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
643696|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221122|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221123|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2221124|NCT00040586|Analgesics|analgesics|mesh-ancestor
643700|NCT03283202|Prednisone|prednisone|mesh-list
643701|NCT03283202|Prednisolone|prednisolone|mesh-list
643702|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
643703|NCT03283202|Rituximab|rituximab|mesh-list
643704|NCT03283202|Vincristine|vincristine|mesh-list
643705|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
643706|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
643707|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643708|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
643709|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
643710|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
643711|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643712|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643713|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
643714|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
643715|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
643716|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
643717|NCT03283202|Hormones|hormones|mesh-ancestor
643718|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
643719|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
643720|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
643721|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
643722|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
643723|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
643724|NCT03283176|Folic Acid|folic acid|mesh-list
643725|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
643726|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
643727|NCT03283176|Vitamins|vitamins|mesh-ancestor
643728|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
643729|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643730|NCT03283176|Hematinics|hematinics|mesh-ancestor
643731|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
643732|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
643733|NCT03283150|Remifentanil|remifentanil|mesh-list
643734|NCT03283150|Propofol|propofol|mesh-list
2221125|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
643735|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
643736|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
643737|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643738|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
643739|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
643740|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
643741|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
643742|NCT03283150|Analgesics|analgesics|mesh-ancestor
643743|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
643744|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
643745|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
643746|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
643747|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
643748|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
643749|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
643750|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643751|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
643752|NCT03283150|Narcotics|narcotics|mesh-ancestor
643756|NCT03283059|Donepezil|donepezil|mesh-list
643757|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
643758|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643759|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643760|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
643761|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
643762|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643763|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
643764|NCT03283046|Dexamethasone|dexamethasone|mesh-list
643765|NCT03283046|Nivolumab|nivolumab|mesh-list
643766|NCT03283046|Lenalidomide|lenalidomide|mesh-list
643767|NCT03283046|Ipilimumab|ipilimumab|mesh-list
643768|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
643769|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
643770|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
643771|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
643772|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643773|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
643774|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
643775|NCT03283046|Hormones|hormones|mesh-ancestor
643776|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
643777|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
643778|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643779|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
643780|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
643781|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643782|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
643783|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
643784|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
643785|NCT03283046|Growth Substances|growth substances|mesh-ancestor
643786|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
643787|NCT03283020|Naltrexone|naltrexone|mesh-list
643788|NCT03283020|Remifentanil|remifentanil|mesh-list
643789|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
643790|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
643791|NCT03283020|Narcotics|narcotics|mesh-ancestor
643792|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
643793|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643794|NCT03283020|Analgesics|analgesics|mesh-ancestor
643795|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
643796|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
643797|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
643798|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
643799|NCT03283007|Nintedanib|nintedanib|mesh-list
643800|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643801|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
643802|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643803|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643816|NCT03282838|Celecoxib|celecoxib|mesh-list
643817|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
643818|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
643819|NCT03282838|Analgesics|analgesics|mesh-ancestor
643820|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
643821|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
643822|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643823|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
643824|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
643825|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
643826|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
643827|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643828|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643829|NCT03282825|Paclitaxel|paclitaxel|mesh-list
643830|NCT03282825|Decitabine|decitabine|mesh-list
643831|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
643832|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643833|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
643834|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
643835|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
643836|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643837|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
643838|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
643839|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643840|NCT03282799|Etonogestrel|etonogestrel|mesh-list
643841|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
643842|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
643843|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
643844|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643845|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
643846|NCT03282669|Morphine|morphine|mesh-list
643847|NCT03282669|Hydromorphone|hydromorphone|mesh-list
643848|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
643849|NCT03282669|Narcotics|narcotics|mesh-ancestor
643850|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
643851|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643852|NCT03282669|Analgesics|analgesics|mesh-ancestor
643853|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
643854|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
643855|NCT03282643|Heparin|heparin|mesh-list
643856|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
643857|NCT03282643|Tinzaparin|tinzaparin|mesh-list
643858|NCT03282643|Dalteparin|dalteparin|mesh-list
643859|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
643860|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
643861|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
643862|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
643863|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643864|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
643865|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
643866|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
643867|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
643868|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221126|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221127|NCT00040599|Labetuzumab|labetuzumab|mesh-list
2221128|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2221129|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221130|NCT00040625|Pemetrexed|pemetrexed|mesh-list
643874|NCT03282513|Ivosidenib|ivosidenib|mesh-list
643875|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643876|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
643877|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643878|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
643879|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
643880|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
643881|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
643882|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221131|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221132|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221133|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221134|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2221135|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
643889|NCT03282344|Nivolumab|nivolumab|mesh-list
643890|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
643891|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643892|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
643893|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221136|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
2221137|NCT00040651|Fludarabine|fludarabine|mesh-list
2221138|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
2221139|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221140|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
2221141|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221142|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2221143|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2221144|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
2221145|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221146|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221147|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2221148|NCT00040690|Leucovorin|leucovorin|mesh-list
2221149|NCT00040690|Cytarabine|cytarabine|mesh-list
643908|NCT03282188|Sargramostim|sargramostim|mesh-list
643909|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
643910|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643911|NCT03282162|Oxytocin|oxytocin|mesh-list
643912|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
643913|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
643914|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643915|NCT03282136|Incretins|incretins|mesh-list
643916|NCT03282136|Hormones|hormones|mesh-ancestor
643917|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
643918|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221150|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
2221151|NCT00040690|Ifosfamide|ifosfamide|mesh-list
2221152|NCT00040690|Doxorubicin|doxorubicin|mesh-list
2221153|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2221154|NCT00040690|Methotrexate|methotrexate|mesh-list
2221155|NCT00040690|Etoposide|etoposide|mesh-list
2221156|NCT00040690|Vincristine|vincristine|mesh-list
2221157|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
2221158|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221159|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
2221160|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643930|NCT03282110|Citalopram|citalopram|mesh-list
643931|NCT03282110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
643932|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
643933|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
643934|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643935|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
643936|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
643937|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643938|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
643939|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
643940|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
643941|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
643942|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
643943|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
643944|NCT03282006|Renal Agents|renal agents|mesh-ancestor
643945|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
643946|NCT03281954|Atezolizumab|atezolizumab|mesh-list
643947|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
643948|NCT03281941|Capsaicin|capsaicin|mesh-list
643949|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
643950|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
643951|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
643952|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
643953|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643954|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
643955|NCT03281928|Diuretics|diuretics|mesh-ancestor
643956|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
643957|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643958|NCT03281928|Expectorants|expectorants|mesh-ancestor
643959|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
643960|NCT03281863|Antibodies|antibodies|mesh-list
643961|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
643962|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
2221161|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2221162|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2221163|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
643963|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643964|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
643965|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
643966|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
643967|NCT03281694|Nicotine|nicotine|mesh-list
643968|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
643969|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
643970|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
643971|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
643972|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
643973|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
643974|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
643975|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
643976|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643977|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
643978|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
643979|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
643980|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
643981|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081875|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
2081876|NCT02093663|Mesalamine|mesalamine|mesh-list
2081877|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2081878|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2081879|NCT02093663|Analgesics|analgesics|mesh-ancestor
2081880|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
2081881|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081882|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081883|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081884|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2081885|NCT02093897|Factor VIII|factor viii|mesh-list
2081886|NCT02093897|Coagulants|coagulants|mesh-ancestor
2081887|NCT02093962|Pemetrexed|pemetrexed|mesh-list
2081888|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2081889|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081890|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081891|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2081892|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2081893|NCT02094443|Ribavirin|ribavirin|mesh-list
2081894|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
2081895|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081896|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
2081897|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081898|NCT02094534|Insulin|insulin|mesh-list
2081899|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2081900|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081901|NCT02094716|Permethrin|permethrin|mesh-list
2081902|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081903|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081904|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2221164|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221165|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221166|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2221167|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2221168|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2221169|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2221170|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221171|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
644022|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
644023|NCT03281187|Testosterone|testosterone|mesh-list
644024|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
644025|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
644026|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
644027|NCT03281187|Androgens|androgens|mesh-ancestor
644028|NCT03281187|Hormones|hormones|mesh-ancestor
644029|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
644030|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644031|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
644032|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644033|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
644034|NCT03280927|Efinaconazole|efinaconazole|mesh-list
644035|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
644036|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644037|NCT03280849|Chitosan|chitosan|mesh-list
644038|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
644039|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
644040|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
644041|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644042|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
644043|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
644044|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
644045|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
644046|NCT03280849|Coagulants|coagulants|mesh-ancestor
644047|NCT03280667|Denosumab|denosumab|mesh-list
644048|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
644049|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
644050|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644051|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
644052|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644053|NCT03280641|Warfarin|warfarin|mesh-list
644054|NCT03280641|Dabigatran|dabigatran|mesh-list
644055|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
644056|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
644057|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
644058|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
644059|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644060|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081905|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
2081906|NCT02094885|Coagulants|coagulants|mesh-ancestor
2081907|NCT02094898|Ketamine|ketamine|mesh-list
2081908|NCT02094898|Analgesics|analgesics|mesh-ancestor
2081909|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
2081910|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081911|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081912|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2081913|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2081914|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
2081915|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
2081916|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2081917|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2081918|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2081919|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081920|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081921|NCT02094937|Fluticasone|fluticasone|mesh-list
2081922|NCT02094937|Xhance|xhance|mesh-list
2081923|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081924|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2081925|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
2081926|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081927|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081928|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2081929|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
2081930|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
2081931|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2081932|NCT02095106|Calpastatin|calpastatin|mesh-list
2221172|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
2221173|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2221174|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221175|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
2221176|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
2221177|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2221178|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
644097|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
644098|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644099|NCT03280407|Leucovorin|leucovorin|mesh-list
644100|NCT03280407|Capecitabine|capecitabine|mesh-list
644101|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
644102|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
644103|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
644104|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
644105|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644106|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644107|NCT03280407|Antidotes|antidotes|mesh-ancestor
644108|NCT03280407|Protective Agents|protective agents|mesh-ancestor
644109|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644110|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
644111|NCT03280407|Vitamins|vitamins|mesh-ancestor
644112|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
644113|NCT03280342|Topiramate|topiramate|mesh-list
644114|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
644115|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
644116|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644117|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2081933|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
644118|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
644119|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
644120|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
644121|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
644122|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
644123|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644124|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
644125|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644126|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644127|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
644128|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644129|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
644130|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
644131|NCT03280316|Urological Agents|urological agents|mesh-ancestor
644132|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
644133|NCT03280277|Hematinics|hematinics|mesh-ancestor
644134|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
644135|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
644136|NCT03280251|Methylphenidate|methylphenidate|mesh-list
644137|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
644138|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644139|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
644140|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
644141|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
644142|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644143|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
644144|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644145|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
644146|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
644147|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
644148|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644149|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
644150|NCT03280212|Coagulants|coagulants|mesh-ancestor
644151|NCT03280160|Ofatumumab|ofatumumab|mesh-list
644152|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644153|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
644154|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
644155|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644156|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
644157|NCT03280095|Acetaminophen|acetaminophen|mesh-list
644158|NCT03280095|Codeine|codeine|mesh-list
644159|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
644160|NCT03280095|Analgesics|analgesics|mesh-ancestor
644161|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
644162|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644163|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644164|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
644165|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
644166|NCT03280095|Narcotics|narcotics|mesh-ancestor
644167|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
644168|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
644169|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
644170|NCT03280030|Midostaurin|midostaurin|mesh-list
644171|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644172|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
644173|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644174|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644175|NCT03280017|Ketamine|ketamine|mesh-list
644176|NCT03280017|Analgesics|analgesics|mesh-ancestor
644177|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
644178|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644179|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644180|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
644181|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
644182|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
644183|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
644184|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
644185|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
644186|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
644187|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644188|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644189|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
644190|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
644191|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
644192|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644193|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
644194|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
644195|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644196|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644197|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644198|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
644199|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
644200|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
644201|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644202|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
644203|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
644204|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
644205|NCT03279978|Midazolam|midazolam|mesh-list
644206|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
644207|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
644208|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
644209|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644210|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
644211|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
644212|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
644213|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
644214|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
644215|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
644216|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
644217|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
644218|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644219|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644220|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
644221|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644222|NCT03279861|Valsartan|valsartan|mesh-list
644223|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
644224|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
644225|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
644226|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
644227|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644228|NCT03279809|Aspirin|aspirin|mesh-list
644229|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
644230|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
644231|NCT03279809|Analgesics|analgesics|mesh-ancestor
644232|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
644233|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644234|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644235|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
644236|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
644237|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
644238|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
644239|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644240|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
644241|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
644242|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644243|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
644244|NCT03279796|Betamethasone|betamethasone|mesh-list
644245|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
644246|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
644247|NCT03279796|Hormones|hormones|mesh-ancestor
644248|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
644249|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644250|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
644251|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
644252|NCT03279757|Lidocaine|lidocaine|mesh-list
644253|NCT03279757|Epinephrine|epinephrine|mesh-list
644254|NCT03279757|Racepinephrine|racepinephrine|mesh-list
644255|NCT03279757|Tetracaine|tetracaine|mesh-list
644256|NCT03279757|Carticaine|carticaine|mesh-list
644257|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
644258|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
644259|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
644260|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
644261|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644262|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
644263|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644264|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
644265|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
644266|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
644267|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
644268|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644269|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
644270|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
644271|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
644272|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644273|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
644274|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
644275|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
644276|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
644277|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
644278|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
644279|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
644280|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2221179|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2221180|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
2221181|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221182|NCT00040690|Antidotes|antidotes|mesh-ancestor
2221183|NCT00040690|Protective Agents|protective agents|mesh-ancestor
2221184|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
644287|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
644288|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
644289|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644290|NCT03279679|Ropivacaine|ropivacaine|mesh-list
644291|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
644292|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
644293|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
644294|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644295|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
644296|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644297|NCT03279601|Capecitabine|capecitabine|mesh-list
644298|NCT03279601|Temozolomide|temozolomide|mesh-list
644299|NCT03279601|Dacarbazine|dacarbazine|mesh-list
644300|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
644301|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
644302|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644303|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644304|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
644305|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
644306|NCT03279562|Nalmefene|nalmefene|mesh-list
644307|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
644308|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644309|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
644310|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644311|NCT03279549|Mitogens|mitogens|mesh-list
644312|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
644313|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644314|NCT03279536|Lactoferrin|lactoferrin|mesh-list
644315|NCT03279536|Dextrans|dextrans|mesh-list
644316|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
644317|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644318|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
644319|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
644320|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
644321|NCT03279536|Hematinics|hematinics|mesh-ancestor
644332|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
644333|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
644334|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644335|NCT03279341|Prucalopride|prucalopride|mesh-list
644336|NCT03279341|Bisacodyl|bisacodyl|mesh-list
644337|NCT03279341|Laxatives|laxatives|mesh-ancestor
644338|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
644339|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
644340|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
644341|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
2221185|NCT00040690|Vitamins|vitamins|mesh-ancestor
644342|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644343|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644344|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644345|NCT03279341|Cathartics|cathartics|mesh-ancestor
644346|NCT03279328|Petrolatum|petrolatum|mesh-list
644347|NCT03279328|Emollients|emollients|mesh-ancestor
644348|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
644349|NCT03279289|Leucovorin|leucovorin|mesh-list
644350|NCT03279289|Folic Acid|folic acid|mesh-list
644351|NCT03279289|Fluorouracil|fluorouracil|mesh-list
644352|NCT03279289|Irinotecan|irinotecan|mesh-list
644353|NCT03279289|Aflibercept|aflibercept|mesh-list
644354|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
644355|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
644356|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644357|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
644358|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644359|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
644360|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
644361|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644362|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
644363|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
644364|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644365|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
644366|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
644367|NCT03279289|Growth Substances|growth substances|mesh-ancestor
644368|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
644369|NCT03279289|Antidotes|antidotes|mesh-ancestor
644370|NCT03279289|Protective Agents|protective agents|mesh-ancestor
644371|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
644372|NCT03279289|Vitamins|vitamins|mesh-ancestor
644373|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
644374|NCT03279289|Hematinics|hematinics|mesh-ancestor
644375|NCT03279250|Prednisone|prednisone|mesh-list
644376|NCT03279250|Cortisone|cortisone|mesh-list
644377|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
644378|NCT03279250|Hormones|hormones|mesh-list
644379|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
644380|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
644381|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
644382|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
644383|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644384|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
644385|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644386|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
644387|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644388|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644389|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
644390|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2221186|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
2221187|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
2221188|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
2221189|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
2221190|NCT00040768|Bortezomib|bortezomib|mesh-list
2221191|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221192|NCT00040781|Gefitinib|gefitinib|mesh-list
2221193|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221194|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2221195|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221196|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221197|NCT00040794|Paclitaxel|paclitaxel|mesh-list
2221198|NCT00040794|Carboplatin|carboplatin|mesh-list
2221199|NCT00040794|Gefitinib|gefitinib|mesh-list
2221200|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2221201|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221202|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
2221203|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
2221204|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
2221205|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221206|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2221207|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221208|NCT00040807|Docetaxel|docetaxel|mesh-list
2221209|NCT00040807|Irinotecan|irinotecan|mesh-list
644416|NCT03279146|Tenofovir|tenofovir|mesh-list
644417|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
644418|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644419|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
644420|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
644421|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644422|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644423|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
644424|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
644425|NCT03279133|Ledipasvir|ledipasvir|mesh-list
644426|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
644427|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644428|NCT03279120|Tenofovir|tenofovir|mesh-list
644429|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
644430|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
644431|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644432|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
644433|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
644434|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644435|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644436|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
644437|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
644438|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
644439|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
644440|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
644441|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644442|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
644443|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
644444|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
644445|NCT03278938|Bupropion|bupropion|mesh-list
644446|NCT03278938|Citalopram|citalopram|mesh-list
644447|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
644448|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
644449|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
644450|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
644451|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
644452|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
644453|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644454|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
644455|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644456|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644457|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
644458|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
644459|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644460|NCT03278938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
644461|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
2221210|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221211|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
2221212|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
2221213|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
2221214|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221215|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
644478|NCT03278860|Oxytocin|oxytocin|mesh-list
644479|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
644480|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
644481|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644482|NCT03278808|Azithromycin|azithromycin|mesh-list
644483|NCT03278808|Chloroquine|chloroquine|mesh-list
644484|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
644485|NCT03278808|Atovaquone|atovaquone|mesh-list
644486|NCT03278808|Proguanil|proguanil|mesh-list
644487|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
644488|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
644489|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644490|NCT03278808|Amebicides|amebicides|mesh-ancestor
644491|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
644492|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
644493|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
644494|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
644495|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
644496|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
644497|NCT03278808|Analgesics|analgesics|mesh-ancestor
644498|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
644499|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644500|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644501|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
644502|NCT03278808|Filaricides|filaricides|mesh-ancestor
644503|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
644504|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
644505|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644506|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644507|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
644508|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
644509|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
644510|NCT03278782|Romidepsin|romidepsin|mesh-list
644511|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
644512|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644513|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644514|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2081934|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
2081935|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081936|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081937|NCT02095158|Phenylephrine|phenylephrine|mesh-list
2081938|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
2081939|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2081940|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2081941|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
2081942|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081943|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081944|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081945|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
2081946|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
2081947|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081948|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
2081949|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2081950|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
2081951|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2081952|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
644534|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
644535|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
644536|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644537|NCT03278652|Analgesics|analgesics|mesh-list
644538|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
644539|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644540|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644541|NCT03278626|Paclitaxel|paclitaxel|mesh-list
644542|NCT03278626|Carboplatin|carboplatin|mesh-list
644543|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
644544|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644545|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
644546|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
644547|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
644548|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644549|NCT03278522|Ramosetron|ramosetron|mesh-list
644550|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
644551|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
644552|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644553|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644554|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
644555|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
644556|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
644557|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644558|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644559|NCT03278509|Metoprolol|metoprolol|mesh-list
644560|NCT03278509|Bisoprolol|bisoprolol|mesh-list
644561|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
644562|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
644563|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
644564|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
644565|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644566|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644567|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
644568|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
644569|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
644570|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
644571|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644724|NCT03277495|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
644572|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644573|NCT03278483|Rifampin|rifampin|mesh-list
644574|NCT03278483|Isoniazid|isoniazid|mesh-list
644575|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
644576|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
644577|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
644578|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644579|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
644580|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
644581|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644582|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644583|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
644584|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
644585|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
644586|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
644587|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
644588|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
644589|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
644590|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
644591|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
644592|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
644593|NCT03278444|Trimetazidine|trimetazidine|mesh-list
644594|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
644595|NCT03278431|Albendazole|albendazole|mesh-list
644596|NCT03278431|Mebendazole|mebendazole|mesh-list
644597|NCT03278431|Piperazine|piperazine|mesh-list
644598|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
644599|NCT03278431|Pyrantel|pyrantel|mesh-list
644600|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
644601|NCT03278431|Oxantel|oxantel|mesh-list
644602|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
644603|NCT03278431|DMP 777|dmp 777|mesh-list
644604|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
644605|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
644606|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644607|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
644608|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
644609|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
644610|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
644611|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
644612|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
644613|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644614|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644615|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
644616|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644617|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
644618|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
644619|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
644620|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644621|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644622|NCT03278405|Avelumab|avelumab|mesh-list
644623|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
644624|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644625|NCT03278379|Avelumab|avelumab|mesh-list
644626|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
644627|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644628|NCT03278314|Ivacaftor|ivacaftor|mesh-list
644629|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
644630|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
644631|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644632|NCT03278262|Aflibercept|aflibercept|mesh-list
644633|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
644634|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
644635|NCT03278262|Growth Substances|growth substances|mesh-ancestor
644636|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644637|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
644638|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221216|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2081953|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2081954|NCT02095158|Protective Agents|protective agents|mesh-ancestor
2081955|NCT02095197|Triamcinolone|triamcinolone|mesh-list
2081956|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2081957|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
2221217|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644646|NCT03278015|Gemcitabine|gemcitabine|mesh-list
644647|NCT03278015|Paclitaxel|paclitaxel|mesh-list
2081958|NCT02095197|Hormones|hormones|mesh-ancestor
644648|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
644649|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
644650|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644651|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
644652|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
644653|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
644654|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644655|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
644656|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
644657|NCT03278015|Antiviral Agents|antiviral agents|mesh-ancestor
644658|NCT03278015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644659|NCT03278015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644660|NCT03278015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
644661|NCT03278015|Immunologic Factors|immunologic factors|mesh-ancestor
644662|NCT03278015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081959|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2081960|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081961|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
2081962|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2081963|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2081964|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081965|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
2081966|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
2081967|NCT02095873|Resveratrol|resveratrol|mesh-list
2081968|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
2081969|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081970|NCT02095873|Protective Agents|protective agents|mesh-ancestor
2081971|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644676|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
644677|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
644678|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
644679|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
644680|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
644681|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644702|NCT03277599|Tramadol|tramadol|mesh-list
644703|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
644704|NCT03277599|Narcotics|narcotics|mesh-ancestor
644705|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
644706|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644707|NCT03277599|Analgesics|analgesics|mesh-ancestor
644708|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
644709|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644710|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
644711|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
644712|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
644713|NCT03277573|Analgesics|analgesics|mesh-ancestor
644714|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
644715|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644716|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644717|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
644718|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
644719|NCT03277495|Nicotine|nicotine|mesh-list
644720|NCT03277495|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
644721|NCT03277495|Autonomic Agents|autonomic agents|mesh-ancestor
644722|NCT03277495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644723|NCT03277495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644725|NCT03277495|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
644726|NCT03277495|Cholinergic Agents|cholinergic agents|mesh-ancestor
644727|NCT03277495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644728|NCT03277495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644729|NCT03277482|Durvalumab|durvalumab|mesh-list
644730|NCT03277482|Tremelimumab|tremelimumab|mesh-list
644731|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
644732|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644733|NCT03277430|Tacrolimus|tacrolimus|mesh-list
644734|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
644735|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
644736|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644737|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
644738|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644739|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644740|NCT03277391|Droperidol|droperidol|mesh-list
644741|NCT03277391|Morphine|morphine|mesh-list
644742|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
644743|NCT03277391|Narcotics|narcotics|mesh-ancestor
644744|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
644745|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644746|NCT03277391|Analgesics|analgesics|mesh-ancestor
644747|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
644748|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644749|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
644750|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
644751|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
644752|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
644753|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
644754|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
644755|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
644756|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
644757|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
644758|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
644759|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644760|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221218|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
2221219|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221220|NCT00040859|Capecitabine|capecitabine|mesh-list
644764|NCT03277339|Paroxetine|paroxetine|mesh-list
644765|NCT03277339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
644766|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
644767|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
644768|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644769|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644770|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
644771|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644772|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
644773|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
644774|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
644775|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
644776|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
644777|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644778|NCT03277313|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
644779|NCT03277313|Immunologic Factors|immunologic factors|mesh-ancestor
644780|NCT03277313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751813|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2751814|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2751815|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2221221|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
644803|NCT03277222|Insulin|insulin|mesh-list
644804|NCT03277222|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
644805|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
644806|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644807|NCT03277209|Plerixafor|plerixafor|mesh-list
644808|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
644809|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
644810|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
644811|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221222|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221223|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
2081972|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2081973|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2081974|NCT02095951|Ethanol|ethanol|mesh-list
2081975|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2081976|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2081977|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2081978|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081979|NCT02096003|Morphine|morphine|mesh-list
2081980|NCT02096003|Hydromorphone|hydromorphone|mesh-list
2081981|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
644828|NCT03277079|Ezetimibe|ezetimibe|mesh-list
644829|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
644830|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
644831|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
644832|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
644833|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644834|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
644835|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644848|NCT03277001|Enoxaparin|enoxaparin|mesh-list
644849|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
644850|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
644851|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
644852|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
644853|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
644854|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644855|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644856|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
644857|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
644858|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2221224|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644862|NCT03276858|Midazolam|midazolam|mesh-list
644863|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
644864|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
644865|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
644866|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
644867|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644868|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
644869|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
644870|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
644871|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
644872|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
644873|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
644874|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
2081982|NCT02096003|Narcotics|narcotics|mesh-ancestor
2081983|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
644875|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
644876|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644877|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644878|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
644879|NCT03276832|Imiquimod|imiquimod|mesh-list
644880|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
644881|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644882|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
644883|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
644884|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644885|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
644886|NCT03276689|Pregabalin|pregabalin|mesh-list
644887|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
644888|NCT03276689|Analgesics|analgesics|mesh-ancestor
644889|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
644890|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644891|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644892|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
644893|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
644894|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
644895|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644896|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
644897|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
644898|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
644899|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
644900|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
644901|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
644902|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
644903|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644904|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
644905|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
644906|NCT03276598|Losartan|losartan|mesh-list
644907|NCT03276598|Amlodipine|amlodipine|mesh-list
644908|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
644909|NCT03276598|Bisoprolol|bisoprolol|mesh-list
644910|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
644911|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
644912|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
644913|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644914|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
644915|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644916|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
644917|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
644918|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
644919|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
644920|NCT03276598|Diuretics|diuretics|mesh-ancestor
644921|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
644922|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
644923|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
644924|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
644925|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644926|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
644927|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
644928|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
644929|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
644930|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644931|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
644932|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
644933|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644934|NCT03276533|Lidocaine|lidocaine|mesh-list
644935|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
644936|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
644937|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
644938|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
644939|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644940|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
644941|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644942|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
644943|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
644944|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
644945|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
644946|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644947|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
644948|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
644949|NCT03276533|Analgesics|analgesics|mesh-ancestor
644950|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
644951|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
644952|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
644953|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
644954|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
644955|NCT03276520|Ethanol|ethanol|mesh-list
644956|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
644957|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
644958|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
644959|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751838|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
644965|NCT03276325|Dexamethasone|dexamethasone|mesh-list
644966|NCT03276325|Nalbuphine|nalbuphine|mesh-list
644967|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
644968|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
644969|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
644970|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
644971|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
644972|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
644973|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
644974|NCT03276325|Hormones|hormones|mesh-ancestor
644975|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
644976|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
644977|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644978|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
644979|NCT03276325|Narcotics|narcotics|mesh-ancestor
644980|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
644981|NCT03276325|Analgesics|analgesics|mesh-ancestor
644982|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
644983|NCT03276156|Apatinib|apatinib|mesh-list
644984|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
644985|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
644986|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
644987|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644988|NCT03276143|Enoxaparin|enoxaparin|mesh-list
644989|NCT03276143|Apixaban|apixaban|mesh-list
644990|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
644991|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
644992|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
644993|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
644994|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
644995|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
644996|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
644997|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
644998|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221225|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221226|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
2221227|NCT00040872|Thiotepa|thiotepa|mesh-list
2221228|NCT00040872|Carboplatin|carboplatin|mesh-list
2221229|NCT00040872|Doxorubicin|doxorubicin|mesh-list
2221230|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2221231|NCT00040872|Etoposide|etoposide|mesh-list
2221232|NCT00040872|Vincristine|vincristine|mesh-list
2221233|NCT00040872|Topotecan|topotecan|mesh-list
2221234|NCT00040872|Isotretinoin|isotretinoin|mesh-list
2221235|NCT00040872|Antibodies|antibodies|mesh-list
2221236|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2221237|NCT00040872|Sargramostim|sargramostim|mesh-list
2221238|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221239|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
2081984|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221240|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221241|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2221242|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2221243|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
2221244|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221245|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221246|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2221247|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2221248|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2221249|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2221250|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221251|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
645026|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
645027|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
645028|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221252|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
2221253|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
2221254|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
2221255|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2221256|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
2221257|NCT00040885|Docetaxel|docetaxel|mesh-list
2221258|NCT00040885|Infliximab|infliximab|mesh-list
2221259|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751839|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
645039|NCT03275818|Paclitaxel|paclitaxel|mesh-list
645040|NCT03275818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
645041|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
645042|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645043|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
645044|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
645045|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
645046|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645047|NCT03275701|Triumeq|triumeq|mesh-list
645048|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
645049|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
645050|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
645051|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221260|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
2221261|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
645054|NCT03275597|Durvalumab|durvalumab|mesh-list
645055|NCT03275597|Tremelimumab|tremelimumab|mesh-list
645056|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
645057|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645058|NCT03275558|Sunitinib|sunitinib|mesh-list
645059|NCT03275558|Axitinib|axitinib|mesh-list
645060|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645061|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
645062|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
645063|NCT03275558|Growth Substances|growth substances|mesh-ancestor
645064|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645065|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
645066|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
645067|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645068|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645069|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
645070|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
645071|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
645072|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
645073|NCT03275506|Bevacizumab|bevacizumab|mesh-list
645074|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
645075|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
645076|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645077|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
645078|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
645079|NCT03275506|Growth Substances|growth substances|mesh-ancestor
645080|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645081|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
645082|NCT03275415|Budesonide|budesonide|mesh-list
645083|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
645084|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
645085|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
645086|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645087|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645088|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
645089|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
645090|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
645091|NCT03275415|Hormones|hormones|mesh-ancestor
645092|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
645093|NCT03275376|Atorvastatin|atorvastatin|mesh-list
645094|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
645095|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
645096|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
645097|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645098|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
645099|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
645100|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221262|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
645101|NCT03275350|Naltrexone|naltrexone|mesh-list
645102|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
645103|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
645104|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645105|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
645106|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645107|NCT03275285|Dexamethasone|dexamethasone|mesh-list
645108|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
645109|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
645110|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
645111|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645112|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645113|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
645114|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
645115|NCT03275285|Hormones|hormones|mesh-ancestor
645116|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
645117|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
645118|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645119|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
645120|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
645121|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
645122|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645123|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
645124|NCT03275207|Analgesics|analgesics|mesh-ancestor
645125|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
645126|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645127|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
645128|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
645129|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
645130|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
645131|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645132|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645133|NCT03275116|Bromides|bromides|mesh-list
645134|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
645135|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
645136|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
645137|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
645138|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645139|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645140|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
645141|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
645142|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
645143|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
645144|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
645145|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
645146|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645147|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645148|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
645149|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
645150|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
645151|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
645152|NCT03275090|SMOFlipid|smoflipid|mesh-list
645153|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
645154|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
645155|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
645156|NCT03275012|Morphine|morphine|mesh-list
645157|NCT03275012|Gabapentin|gabapentin|mesh-list
645158|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
645159|NCT03275012|Narcotics|narcotics|mesh-ancestor
645160|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
645161|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645162|NCT03275012|Analgesics|analgesics|mesh-ancestor
645163|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
645164|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645165|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
645166|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
645167|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
645168|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
645169|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
645170|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
645171|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645172|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645173|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
645174|NCT03274895|Biguanides|biguanides|mesh-list
645175|NCT03274895|Polihexanide|polihexanide|mesh-list
645176|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
645177|NCT03274895|Propamidine|propamidine|mesh-list
645178|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
645179|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645180|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
645181|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
645182|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
645183|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
645184|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
645185|NCT03274817|Citalopram|citalopram|mesh-list
645186|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
645187|NCT03274817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
645188|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
645189|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
645190|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645191|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645192|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
645193|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645194|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
645195|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
645196|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
645197|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2221263|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221264|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
2221265|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2221266|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2221267|NCT00040950|Rituximab|rituximab|mesh-list
2221268|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2221269|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221270|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
2221271|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221272|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2221273|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2221274|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645210|NCT03274765|Estradiol|estradiol|mesh-list
645211|NCT03274765|Estrogens|estrogens|mesh-ancestor
645212|NCT03274765|Hormones|hormones|mesh-ancestor
645213|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
645214|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645215|NCT03274752|Paroxetine|paroxetine|mesh-list
645216|NCT03274752|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
645217|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
645218|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
645219|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645220|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645221|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
645222|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645223|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
645224|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
645225|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
645226|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
645227|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
645228|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645229|NCT03274700|Tamsulosin|tamsulosin|mesh-list
645230|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
645231|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
645232|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
645233|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
645234|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645235|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645236|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645237|NCT03274700|Urological Agents|urological agents|mesh-ancestor
645241|NCT03274596|Vitamin E|vitamin e|mesh-list
645242|NCT03274596|Vitamins|vitamins|mesh-ancestor
645243|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
645244|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645245|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
645246|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645247|NCT03274596|Protective Agents|protective agents|mesh-ancestor
2081985|NCT02096003|Analgesics|analgesics|mesh-ancestor
2081986|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
2081987|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081988|NCT02096029|Nicotine|nicotine|mesh-list
2081989|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2081990|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
2081991|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2081992|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2081993|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2081994|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2081995|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
2081996|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2081997|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2081998|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
2081999|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2082000|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2082001|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2082002|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2082003|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2082004|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082005|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
2082006|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082007|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082008|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2082009|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082010|NCT02096107|Everolimus|everolimus|mesh-list
2082011|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082012|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2082013|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
2221275|NCT00041015|Etoposide|etoposide|mesh-list
2221276|NCT00041015|Topotecan|topotecan|mesh-list
2221277|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221278|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2221279|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2221280|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2221281|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221282|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221283|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2221284|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
2221285|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221286|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2221287|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221288|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221289|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
2221290|NCT00041054|Carboplatin|carboplatin|mesh-list
2221291|NCT00041054|Etoposide|etoposide|mesh-list
645295|NCT03274427|Trimetazidine|trimetazidine|mesh-list
645296|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
645297|NCT03274414|Cisplatin|cisplatin|mesh-list
645298|NCT03274414|Etoposide|etoposide|mesh-list
645299|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645300|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
645301|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
645302|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
645303|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645304|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645305|NCT03274401|Anticoagulants|anticoagulants|mesh-list
2082014|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082015|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2082016|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
2082017|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082018|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
2221292|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645312|NCT03274323|Travoprost|travoprost|mesh-list
645313|NCT03274323|Latanoprost|latanoprost|mesh-list
645314|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
645315|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
645316|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
645317|NCT03274258|Nivolumab|nivolumab|mesh-list
645318|NCT03274258|Ipilimumab|ipilimumab|mesh-list
645319|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
645320|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645321|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
645322|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645323|NCT03274167|Gabapentin|gabapentin|mesh-list
645324|NCT03274167|Analgesics|analgesics|mesh-ancestor
645325|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
645326|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645327|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645328|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
645329|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
645330|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
645331|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
645332|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
645333|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
645334|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
645335|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645336|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645337|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
645338|NCT03274102|Vaccines|vaccines|mesh-list
645339|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
645340|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221293|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2221294|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2221295|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2221296|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645345|NCT03274024|Mitomycins|mitomycins|mesh-list
645346|NCT03274024|Mitomycin|mitomycin|mesh-list
645347|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
645348|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645349|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
645350|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645351|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
645352|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645353|NCT03274011|Apatinib|apatinib|mesh-list
645354|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645355|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
645356|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645357|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221297|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221298|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2221299|NCT00041054|Protective Agents|protective agents|mesh-ancestor
2221300|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221301|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2221302|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2221303|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2221304|NCT00041054|Analgesics|analgesics|mesh-ancestor
2221305|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
645369|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
645370|NCT03273712|Octreotide|octreotide|mesh-list
645371|NCT03273712|Edotreotide|edotreotide|mesh-list
645372|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
645373|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
645374|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645375|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
645376|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645377|NCT03273634|Lansoprazole|lansoprazole|mesh-list
645378|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
645379|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
645380|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
645381|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
645382|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645383|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645384|NCT03273595|Paclitaxel|paclitaxel|mesh-list
645385|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
645386|NCT03273595|Trastuzumab|trastuzumab|mesh-list
645387|NCT03273595|Epirubicin|epirubicin|mesh-list
645388|NCT03273595|Lapatinib|lapatinib|mesh-list
645389|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
645390|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645391|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
645392|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
645393|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
645394|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645395|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
645396|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
645397|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645398|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
645399|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
645400|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
645401|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
645553|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
645402|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
645403|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
645404|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
645405|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
645406|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645407|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
645408|NCT03273556|Lidocaine|lidocaine|mesh-list
645409|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
645410|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
645411|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
645412|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645413|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
645414|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645415|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
645416|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
645417|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
645418|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
645419|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221306|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221307|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
645438|NCT03273296|Amoxicillin|amoxicillin|mesh-list
645439|NCT03273296|Azithromycin|azithromycin|mesh-list
645440|NCT03273296|Vancomycin|vancomycin|mesh-list
645441|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
645442|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221308|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2221309|NCT00041093|Docetaxel|docetaxel|mesh-list
2221310|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645446|NCT03273231|Ketamine|ketamine|mesh-list
645447|NCT03273231|Analgesics|analgesics|mesh-ancestor
645448|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
645449|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645450|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645451|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
645452|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
645453|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
645454|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
645455|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
645456|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
645457|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
645458|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645459|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645460|NCT03273192|Adalimumab|adalimumab|mesh-list
645461|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
645462|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2221311|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
2221312|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
2221313|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
2273740|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
645467|NCT03273088|Etanercept|etanercept|mesh-list
645468|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
645469|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
645470|NCT03273088|Analgesics|analgesics|mesh-ancestor
645471|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
645472|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645473|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645474|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
645475|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
645476|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
645477|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
645478|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
645479|NCT03273075|Ticagrelor|ticagrelor|mesh-list
645480|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
645481|NCT03273075|Cangrelor|cangrelor|mesh-list
645482|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
645483|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
645484|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
645485|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
645486|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
645487|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645488|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645489|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645490|NCT03273062|Tolcapone|tolcapone|mesh-list
645491|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
645492|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
645493|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
645494|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645495|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645496|NCT03273036|Triamcinolone|triamcinolone|mesh-list
645497|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
645498|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
645499|NCT03273036|Hormones|hormones|mesh-ancestor
645500|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
645501|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082019|NCT02096458|Lansoprazole|lansoprazole|mesh-list
2082020|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2082021|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2082022|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2082023|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082024|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082025|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
645510|NCT03272867|Mannitol|mannitol|mesh-list
645511|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
645512|NCT03272867|Diuretics|diuretics|mesh-ancestor
645513|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
645514|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645515|NCT03272802|Riluzole|riluzole|mesh-list
645516|NCT03272802|Edaravone|edaravone|mesh-list
645517|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
645518|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
645519|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
645520|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645521|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645522|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645523|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
645524|NCT03272802|Protective Agents|protective agents|mesh-ancestor
645525|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
645526|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
645527|NCT05075460|Azacitidine|azacitidine|mesh-list
645529|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
645530|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
645531|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645532|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645533|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645528|NCT05075265|Methadone|methadone|mesh-list
645534|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
645535|NCT05075265|Narcotics|narcotics|mesh-ancestor
645536|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
645537|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645538|NCT05075265|Analgesics|analgesics|mesh-ancestor
645539|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
645540|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645541|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
645542|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
645555|NCT05075330|Narcotics|narcotics|mesh-ancestor
645556|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
645557|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645558|NCT05075330|Analgesics|analgesics|mesh-ancestor
645559|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
645560|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082026|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2082027|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
2082028|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
2082029|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2082030|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082031|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
645561|NCT05075512|Fulvestrant|fulvestrant|mesh-list
645567|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
645568|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645569|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
645570|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
645571|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
645572|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
645573|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645574|NCT05075499|Vaccines|vaccines|mesh-list
645575|NCT05075499|Immunologic Factors|immunologic factors|mesh-ancestor
645576|NCT05075499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645577|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
645578|NCT05075122|Sargramostim|sargramostim|mesh-list
645579|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
645580|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645581|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
645582|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645583|NCT05074992|Ipilimumab|ipilimumab|mesh-list
645584|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
645585|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645586|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
645587|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645588|NCT05074706|Antibodies|antibodies|mesh-list
645589|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
645590|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
645591|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645592|NCT05074966|Cetuximab|cetuximab|mesh-list
645594|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
645595|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082032|NCT02096575|Analgesics|analgesics|mesh-ancestor
2082033|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
2082034|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082035|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
2082036|NCT02096588|Doxorubicin|doxorubicin|mesh-list
2082037|NCT02096588|Simvastatin|simvastatin|mesh-list
2082038|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2082039|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
2082040|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082041|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2082042|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2082043|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
2082044|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082045|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645609|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
645610|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
645611|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
645612|NCT05074628|Renal Agents|renal agents|mesh-ancestor
645613|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
645614|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
645615|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
645616|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645617|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
645618|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645619|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645654|NCT05074355|Azacitidine|azacitidine|mesh-list
645655|NCT05074355|Venetoclax|venetoclax|mesh-list
645656|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
645657|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
645658|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645659|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645660|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082046|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
645709|NCT05073965|Vitamin D|vitamin d|mesh-list
645620|NCT05074602|Fluconazole|fluconazole|mesh-list
645621|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
645622|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
645623|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
645624|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
645625|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645626|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645627|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
645628|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
645629|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
645630|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645631|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
645632|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
645633|NCT05074589|Leucovorin|leucovorin|mesh-list
645634|NCT05074589|Fluorouracil|fluorouracil|mesh-list
645635|NCT05074589|Irinotecan|irinotecan|mesh-list
645636|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
645637|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
645638|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645639|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
645640|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645641|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
645642|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
645643|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645644|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
645645|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
645646|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645647|NCT05074589|Antidotes|antidotes|mesh-ancestor
645648|NCT05074589|Protective Agents|protective agents|mesh-ancestor
645649|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
645650|NCT05074589|Vitamins|vitamins|mesh-ancestor
645651|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
645833|NCT05004805|Methylene Blue|methylene blue|mesh-list
645834|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645835|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082047|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2082048|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2082049|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2082050|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082051|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
645956|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
645957|NCT04928300|Ketamine|ketamine|mesh-list
645958|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
645959|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
645960|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645961|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
645962|NCT04928300|Analgesics|analgesics|mesh-ancestor
645963|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
645964|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645965|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
645966|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
645967|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
645968|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
645969|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645970|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645971|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
645972|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
645973|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
645974|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
645975|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
645976|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2082052|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2082053|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
2082054|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2082055|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2082056|NCT02096679|Osimertinib|osimertinib|mesh-list
2082057|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082058|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2082059|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082060|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082061|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
2082062|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2082063|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082064|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
645663|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
645664|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082065|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082066|NCT02096718|Afatinib|afatinib|mesh-list
2082067|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082068|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2082069|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082070|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082071|NCT02096744|Clonidine|clonidine|mesh-list
2082072|NCT02096744|Analgesics|analgesics|mesh-ancestor
2082073|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
2082074|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082075|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082076|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
645677|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
645678|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2751840|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082077|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
2082078|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
2082079|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2082080|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2082081|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2082082|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
2082083|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082084|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082085|NCT02096835|Dexamethasone|dexamethasone|mesh-list
2082086|NCT02096835|Tropisetron|tropisetron|mesh-list
2082087|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2082088|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
2082089|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
2082090|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082091|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082092|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2082093|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
2082094|NCT02096835|Hormones|hormones|mesh-ancestor
2082095|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2082096|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2082097|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082098|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2082099|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2082100|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
2082101|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082102|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082103|NCT02096861|Infliximab|infliximab|mesh-list
2082104|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
2082105|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2082106|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2082107|NCT02096900|Midazolam|midazolam|mesh-list
2082108|NCT02096900|Zolpidem|zolpidem|mesh-list
2082109|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2082110|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2082111|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2082112|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082113|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2082114|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2082115|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2082116|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2082117|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
2082118|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
2082119|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
2082120|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
2082121|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082122|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082123|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2082124|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2082125|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
2082126|NCT02096952|Methylphenidate|methylphenidate|mesh-list
2082127|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2082128|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082129|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2082130|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2082131|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2082132|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082133|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
2082134|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082135|NCT02097056|Donepezil|donepezil|mesh-list
2082136|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2082137|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082138|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082139|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
2082140|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082141|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082142|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
2082143|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
2082144|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2082145|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2082146|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
2082147|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082148|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2082149|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2082150|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082151|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646462|NCT04647383|Lemborexant|lemborexant|mesh-list
646463|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
646464|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
646465|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646466|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
646467|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
646468|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
646469|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082163|NCT02097238|Halichondrin B|halichondrin b|mesh-list
2082164|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
2082165|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
2082166|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
2082167|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082168|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082169|NCT02097303|Prednisone|prednisone|mesh-list
2082170|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
2082171|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2082172|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2082173|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
2082174|NCT02097303|Hormones|hormones|mesh-ancestor
2082175|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2082176|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082177|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2082178|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082179|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2082180|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082181|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082182|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
2082183|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2082184|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2082185|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
2082186|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082187|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
2082188|NCT02097537|Miotics|miotics|mesh-ancestor
2082189|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
2082190|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082191|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082192|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2082193|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2082194|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
2082195|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2082196|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2082197|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
2082198|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082199|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082200|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
2082201|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2082202|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2082203|NCT02097719|Timolol|timolol|mesh-list
2082204|NCT02097719|Bimatoprost|bimatoprost|mesh-list
2082205|NCT02097719|Travoprost|travoprost|mesh-list
2082206|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2082207|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
645758|NCT05014061|Adenosine|adenosine|mesh-list
645759|NCT05014061|Analgesics|analgesics|mesh-ancestor
645760|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
645761|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645762|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645763|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
645764|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
645765|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
645766|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
645767|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
645768|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645769|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082208|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
2082209|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082210|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082211|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082212|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2082213|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2082214|NCT02097732|Ipilimumab|ipilimumab|mesh-list
2082215|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2082216|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082217|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2082218|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082219|NCT02097745|Rituximab|rituximab|mesh-list
2082220|NCT02097745|Methotrexate|methotrexate|mesh-list
2082221|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2082222|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082223|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
2082224|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082225|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2082226|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2082227|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
2082228|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2082229|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2082230|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
2082231|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082232|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
2082233|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082234|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2082235|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2082236|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2082237|NCT02097823|Olanzapine|olanzapine|mesh-list
2082238|NCT02097823|Aprepitant|aprepitant|mesh-list
2082239|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
2082240|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
2082241|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082242|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647486|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
647487|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
647488|NCT03854370|Povidone|povidone|mesh-list
647489|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
647490|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
647491|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
647492|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
647493|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
645710|NCT05073965|Vitamins|vitamins|mesh-ancestor
645711|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
645712|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645713|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
645714|NCT05068063|Bupivacaine|bupivacaine|mesh-list
645715|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
645716|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
645717|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
645718|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645719|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
645720|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082243|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2082244|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2082245|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2082246|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2082247|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2082248|NCT02097823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2082249|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2082250|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2082251|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082252|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082253|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
2082254|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2082255|NCT02097849|Interferons|interferons|mesh-list
2082256|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2082257|NCT02097849|Vaccines|vaccines|mesh-list
2082258|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2082259|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
2082260|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082261|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
646152|NCT04878315|Captopril|captopril|mesh-list
646153|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
646154|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
646155|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
646156|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646157|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2082262|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
2082263|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082264|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
2082265|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2082266|NCT02098109|Plerixafor|plerixafor|mesh-list
2082267|NCT02098109|Lenograstim|lenograstim|mesh-list
2082268|NCT02098109|Sargramostim|sargramostim|mesh-list
2082269|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2082270|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
2082271|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082272|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2082273|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
646656|NCT04542408|Heparin|heparin|mesh-list
646657|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
646658|NCT04542408|Tinzaparin|tinzaparin|mesh-list
646659|NCT04542408|Dalteparin|dalteparin|mesh-list
646660|NCT04542408|Edoxaban|edoxaban|mesh-list
646661|NCT04542408|Anticoagulants|anticoagulants|mesh-list
646662|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
646663|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
646664|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646665|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
646666|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
646667|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
646668|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
646669|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751867|NCT03808077|Rocuronium|rocuronium|mesh-list
2751868|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2751869|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2751870|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2751871|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2751872|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082274|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
2751873|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
645721|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
645722|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
645723|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
645724|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645725|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
645726|NCT05065775|Analgesics|analgesics|mesh-ancestor
645727|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
645728|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645729|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
645730|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
645731|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
645732|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
645733|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645734|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645907|NCT04962022|Ritonavir|ritonavir|mesh-list
645908|NCT04962022|Itraconazole|itraconazole|mesh-list
645909|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
645910|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
645911|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
645912|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645913|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645914|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
645915|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
645916|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
645917|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
645918|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
645919|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
645920|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
645921|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
645922|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
645923|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
645924|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
645925|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082275|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082276|NCT02098395|Liraglutide|liraglutide|mesh-list
2082277|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2082278|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082279|NCT02098395|Incretins|incretins|mesh-ancestor
2082280|NCT02098395|Hormones|hormones|mesh-ancestor
2082281|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2082282|NCT02098733|Pioglitazone|pioglitazone|mesh-list
2082283|NCT02098733|Glimepiride|glimepiride|mesh-list
2082284|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2082285|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082286|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2082287|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2082288|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
2082289|NCT02098746|Pioglitazone|pioglitazone|mesh-list
2082290|NCT02098746|Glimepiride|glimepiride|mesh-list
2082291|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2082292|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082293|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2082294|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2082295|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
2082296|NCT02098993|Heparin|heparin|mesh-list
2082297|NCT02098993|Calcium heparin|calcium heparin|mesh-list
2082298|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
2082299|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2082300|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2082301|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082302|NCT02099006|Ketoprofen|ketoprofen|mesh-list
2082303|NCT02099006|Ketamine|ketamine|mesh-list
2082304|NCT02099006|Gabapentin|gabapentin|mesh-list
2082305|NCT02099006|Amitriptyline|amitriptyline|mesh-list
2082306|NCT02099006|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2082307|NCT02099006|Baclofen|baclofen|mesh-list
2082308|NCT02099006|Loperamide|loperamide|mesh-list
2082309|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
2082310|NCT02099006|Analgesics|analgesics|mesh-ancestor
2082311|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
2082312|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082313|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082314|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2082315|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2082316|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
2082317|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
2082318|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2082319|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2082320|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2082321|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082322|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082323|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
2082324|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2082325|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2082326|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2082327|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
2082328|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2082329|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2751874|NCT03804268|Pilocarpine|pilocarpine|mesh-list
2751875|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2751876|NCT03804268|Miotics|miotics|mesh-ancestor
2082330|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2082331|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
2082332|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
2082333|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2082334|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2082335|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2082336|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2082337|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2082338|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082339|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2082340|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
2082341|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2082342|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2082343|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2082344|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
2082345|NCT02099006|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2082346|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2082347|NCT02099084|Teduglutide|teduglutide|mesh-list
2082348|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2082349|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2082350|NCT02099084|Protective Agents|protective agents|mesh-ancestor
2082351|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082352|NCT02099110|Metformin|metformin|mesh-list
2082353|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
2082354|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2082355|NCT02099110|Glimepiride|glimepiride|mesh-list
2082356|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
2082357|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2082358|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082359|NCT02099110|Incretins|incretins|mesh-ancestor
2082360|NCT02099110|Hormones|hormones|mesh-ancestor
2082361|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2082362|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2082363|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
646718|NCT04486716|Ofatumumab|ofatumumab|mesh-list
646719|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751877|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
647521|NCT03821883|Aspirin|aspirin|mesh-list
647522|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
647523|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
647524|NCT03821883|Analgesics|analgesics|mesh-ancestor
647525|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
647526|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
647527|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647528|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
647529|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
647530|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
647531|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
647532|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
647533|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
647534|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
647535|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
647536|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
2082364|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082365|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082366|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2082367|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2082368|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
2082369|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2082370|NCT02099461|Denosumab|denosumab|mesh-list
645770|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
645771|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
645772|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
645773|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645774|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
645775|NCT05045586|Protective Agents|protective agents|mesh-ancestor
2082371|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2082372|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082373|NCT02099682|Lansoprazole|lansoprazole|mesh-list
2082374|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
2082375|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2082376|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2082377|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2082378|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082379|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082380|NCT02099708|Lansoprazole|lansoprazole|mesh-list
2082381|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
2082382|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2082383|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2082384|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2082385|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082386|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082387|NCT02099838|Metformin|metformin|mesh-list
2082388|NCT02099838|Pioglitazone|pioglitazone|mesh-list
2082389|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2082390|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082391|NCT02100007|Topotecan|topotecan|mesh-list
2082392|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2082393|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2082394|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082395|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082396|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082397|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
2082398|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2082399|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082400|NCT02100228|Vitamin K|vitamin k|mesh-list
2082401|NCT02100228|Heparin|heparin|mesh-list
2082402|NCT02100228|Apixaban|apixaban|mesh-list
2082403|NCT02100228|Vitamins|vitamins|mesh-ancestor
2082404|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
2082405|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082406|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
2082407|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2082408|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2082409|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082410|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2082411|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
2082412|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2082413|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
2082414|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082415|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2082416|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
2082417|NCT02100228|Coagulants|coagulants|mesh-ancestor
2082418|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2082419|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2082420|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2082421|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082422|NCT02100475|Insulin|insulin|mesh-list
2082423|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2082424|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
645977|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
645978|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
645979|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
645980|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
645981|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082425|NCT02100475|Liraglutide|liraglutide|mesh-list
2082426|NCT02100475|Xultophy|xultophy|mesh-list
2082427|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2082428|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082429|NCT02100475|Incretins|incretins|mesh-ancestor
2082430|NCT02100475|Hormones|hormones|mesh-ancestor
2082431|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2082432|NCT02100514|Bococizumab|bococizumab|mesh-list
2082433|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2082434|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2082435|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
2082436|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082437|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2082438|NCT02100579|Bupivacaine|bupivacaine|mesh-list
645866|NCT04981678|Buprenorphine|buprenorphine|mesh-list
645882|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
645883|NCT04981678|Narcotics|narcotics|mesh-ancestor
645884|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
645885|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645886|NCT04981678|Analgesics|analgesics|mesh-ancestor
645887|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
645888|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645889|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2751878|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2751879|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751880|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2751881|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
646235|NCT04824417|Itraconazole|itraconazole|mesh-list
646236|NCT04824417|Voriconazole|voriconazole|mesh-list
646237|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
646238|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
646239|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
646240|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
646241|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
646242|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646243|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
646244|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
646245|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
646246|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
646247|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2082439|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
2082440|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
2082441|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2082442|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082443|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
2082444|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082445|NCT02100644|Lamotrigine|lamotrigine|mesh-list
2082446|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
2082447|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2082448|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2082449|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082450|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2082451|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082452|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2082453|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2082454|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2082455|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2082456|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2082457|NCT02100657|Dexamethasone|dexamethasone|mesh-list
2082458|NCT02100657|Bortezomib|bortezomib|mesh-list
2082459|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2082460|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
2082461|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
2082462|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082463|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082464|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2082465|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
2082466|NCT02100657|Hormones|hormones|mesh-ancestor
2082467|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2082468|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2082469|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082470|NCT02100670|Diclofenac|diclofenac|mesh-list
2082471|NCT02100670|Menthol|menthol|mesh-list
2082472|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2082473|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2082474|NCT02100670|Analgesics|analgesics|mesh-ancestor
2082475|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
2082476|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082477|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082478|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2082479|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2082480|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2082481|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082482|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082483|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
2082484|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
2082485|NCT02100696|Etrolizumab|etrolizumab|mesh-list
2082486|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2082487|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
2082488|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751882|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
2751883|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2751884|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751885|NCT03804138|Vaccines|vaccines|mesh-list
2751886|NCT03804138|Immunologic Factors|immunologic factors|mesh-ancestor
2751887|NCT03804138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751888|NCT03796273|Ketoconazole|ketoconazole|mesh-list
2751889|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
2751890|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2751891|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2751892|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2082489|NCT02100748|Morphine|morphine|mesh-list
2082490|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2082491|NCT02100748|Narcotics|narcotics|mesh-ancestor
2082492|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2082493|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082494|NCT02100748|Analgesics|analgesics|mesh-ancestor
2082495|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
2082496|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082497|NCT02100826|Cephalexin|cephalexin|mesh-list
2082498|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2082499|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082500|NCT02100930|Molgramostim|molgramostim|mesh-list
2082501|NCT02100930|Isotretinoin|isotretinoin|mesh-list
2082502|NCT02100930|Antibodies|antibodies|mesh-list
2082503|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2082504|NCT02100930|Sargramostim|sargramostim|mesh-list
2082505|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
2082506|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082507|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
2082508|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082509|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
2082510|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
2082511|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2082512|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2082513|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
2082514|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082515|NCT02101008|Disulfiram|disulfiram|mesh-list
2082516|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2082517|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2082518|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082519|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082520|NCT02101021|Gemcitabine|gemcitabine|mesh-list
2082521|NCT02101021|Paclitaxel|paclitaxel|mesh-list
2082522|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2082523|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2082524|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082525|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
2082526|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
2082527|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
2082528|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646810|NCT04431466|Ivermectin|ivermectin|mesh-list
646813|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
645935|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
645936|NCT04955158|Ketamine|ketamine|mesh-list
645937|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
645938|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
645939|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
645940|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
645941|NCT04955158|Analgesics|analgesics|mesh-ancestor
645942|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
645943|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
645944|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
645945|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
645946|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
645947|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
645948|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
645949|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
645950|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
645951|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
645952|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
645953|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
645954|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
645955|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2082529|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2082530|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
2082531|NCT02101021|Antiviral Agents|antiviral agents|mesh-ancestor
2082532|NCT02101021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082533|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082534|NCT02101021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2082535|NCT02101021|Immunologic Factors|immunologic factors|mesh-ancestor
2082536|NCT02101021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082537|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2082538|NCT02101034|Cetuximab|cetuximab|mesh-list
2082539|NCT02101034|Palbociclib|palbociclib|mesh-list
2082540|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2082541|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082542|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2082543|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082544|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082545|NCT02101112|Apixaban|apixaban|mesh-list
2082546|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2082547|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
2082548|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2082549|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
2082550|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082551|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082552|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
2082553|NCT02101190|Opicapone|opicapone|mesh-list
2082554|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2082555|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082556|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082557|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2082558|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2082559|NCT02101281|Mitogens|mitogens|mesh-list
2082560|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
2082561|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082562|NCT02101359|Tetracaine|tetracaine|mesh-list
2221314|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221315|NCT00041106|Gemcitabine|gemcitabine|mesh-list
2221316|NCT00041106|Gefitinib|gefitinib|mesh-list
2221317|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221318|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221319|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
2221320|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221321|NCT00041106|Antiviral Agents|antiviral agents|mesh-ancestor
2082563|NCT02101359|Tropicamide|tropicamide|mesh-list
2082564|NCT02101359|Mydriatics|mydriatics|mesh-list
2082565|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
2082566|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
2082567|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2082568|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082569|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
2082570|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082571|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
2082572|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2082573|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2082574|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
2082575|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082576|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646065|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
646072|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
646073|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
646074|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646075|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
646076|NCT04905901|Coagulants|coagulants|mesh-ancestor
646158|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
646159|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
646160|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
646161|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
646162|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646163|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
646164|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
646165|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
646166|NCT04878107|Docetaxel|docetaxel|mesh-list
646167|NCT04878107|Apatinib|apatinib|mesh-list
646168|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
646169|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
646170|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
646171|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
646172|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646173|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
646174|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
646336|NCT04780464|Prednisolone|prednisolone|mesh-list
646337|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
646338|NCT04780464|Doxorubicin|doxorubicin|mesh-list
646339|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
646340|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
646341|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
646342|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
646343|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
646344|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
646345|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
646346|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646347|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
646348|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
646349|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
646350|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
646351|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
646352|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
646353|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
646354|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
646355|NCT04780464|Hormones|hormones|mesh-ancestor
646356|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
646357|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
646406|NCT04713098|Coal Tar|coal tar|mesh-list
646407|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
646408|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
646085|NCT04897841|Bupivacaine|bupivacaine|mesh-list
646086|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
646087|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
646088|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
646089|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
646090|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
646091|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
646561|NCT04591925|Insulin|insulin|mesh-list
646562|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
646563|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
646564|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751893|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751894|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751895|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
647051|NCT04179032|Belimumab|belimumab|mesh-list
647052|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
647053|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
647054|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082612|NCT02101918|Aflibercept|aflibercept|mesh-list
2082613|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
2082614|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2082615|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2082616|NCT02101918|Growth Substances|growth substances|mesh-ancestor
2082617|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082618|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
2082619|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082620|NCT02101983|Cytarabine|cytarabine|mesh-list
2082621|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2082622|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
2082623|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082624|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082625|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
2082626|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082627|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2082628|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
2082629|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082630|NCT02102100|Menthol|menthol|mesh-list
2221322|NCT00041106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221323|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221324|NCT00041106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221325|NCT00041106|Immunologic Factors|immunologic factors|mesh-ancestor
2221326|NCT00041106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221327|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2082631|NCT02102100|Nicotine|nicotine|mesh-list
2082632|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2082633|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
2082634|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082635|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751896|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
2751897|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2751898|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751899|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2751900|NCT03794583|Treprostinil|treprostinil|mesh-list
2751901|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2082636|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2082637|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2082638|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
2082639|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082640|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082641|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
2082642|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
2082643|NCT02102932|Metformin|metformin|mesh-list
2082644|NCT02102932|Empagliflozin|empagliflozin|mesh-list
2082645|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2082646|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648553|NCT03270033|Dexamethasone|dexamethasone|mesh-list
648554|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
648555|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
648556|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
648557|NCT03270033|BB 1101|bb 1101|mesh-list
648558|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
648559|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
648560|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
648561|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648562|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648563|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
648564|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
648565|NCT03270033|Hormones|hormones|mesh-ancestor
648566|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
648567|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
648568|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648569|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
648570|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648571|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648572|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
648573|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
648574|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
648575|NCT03270033|Analgesics|analgesics|mesh-ancestor
648576|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
648577|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
648578|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
648579|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
648580|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
648581|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2221328|NCT00041171|Docetaxel|docetaxel|mesh-list
2221329|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221330|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
2221331|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
2221332|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
2221333|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221334|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
2221335|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221336|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2221337|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082647|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2082648|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646310|NCT04797325|Prednisolone|prednisolone|mesh-list
646311|NCT04797325|Infliximab|infliximab|mesh-list
646312|NCT04797325|Vedolizumab|vedolizumab|mesh-list
646313|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
646314|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
646315|NCT04797325|Hormones|hormones|mesh-ancestor
646316|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
646317|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
646318|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
646319|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
646320|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
646321|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
646322|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
646565|NCT04630002|Ritonavir|ritonavir|mesh-list
646566|NCT04630002|Darunavir|darunavir|mesh-list
646567|NCT04630002|Etravirine|etravirine|mesh-list
646568|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
646569|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
646570|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
646571|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
646572|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646573|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
646574|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
646575|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
646576|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
646577|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
646578|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
646579|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
646580|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2082649|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2082650|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082651|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
2082652|NCT02103114|Antithrombins|antithrombins|mesh-list
2082653|NCT02103114|Thrombin|thrombin|mesh-list
2082654|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
2082655|NCT02103114|Coagulants|coagulants|mesh-ancestor
2082656|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2082657|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
2082658|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082659|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082660|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
2082661|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2082662|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
2082663|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082664|NCT02103478|Decitabine|decitabine|mesh-list
647926|NCT03536429|Acetazolamide|acetazolamide|mesh-list
647927|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
647928|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
647929|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
647930|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
647931|NCT03536429|Diuretics|diuretics|mesh-ancestor
647932|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
647933|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273741|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082665|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2082666|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
2082667|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082668|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082669|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082670|NCT02103855|Abatacept|abatacept|mesh-list
2082671|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2082672|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082673|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082674|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2082675|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
2082676|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082677|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2082678|NCT02104414|Epinephrine|epinephrine|mesh-list
2082679|NCT02104414|Bupivacaine|bupivacaine|mesh-list
2082680|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
2082681|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
2082682|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2082683|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082684|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
2082685|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082686|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2082687|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2082688|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
2082689|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082690|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082691|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2082692|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2082693|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
2082694|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2082695|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
2082696|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
2082697|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
2082698|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2082699|NCT02104505|Tocopherols|tocopherols|mesh-list
2082700|NCT02104505|Vitamin E|vitamin e|mesh-list
2082701|NCT02104505|Tocotrienols|tocotrienols|mesh-list
2082702|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
2082703|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
2082704|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
2082705|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082706|NCT02104505|Protective Agents|protective agents|mesh-ancestor
2082707|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082708|NCT02104505|Vitamins|vitamins|mesh-ancestor
2082709|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
2082710|NCT02104739|Exenatide|exenatide|mesh-list
2082711|NCT02104739|Saxagliptin|saxagliptin|mesh-list
2082712|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2082713|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082714|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2082715|NCT02104739|Incretins|incretins|mesh-ancestor
2082716|NCT02104739|Hormones|hormones|mesh-ancestor
2082717|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2082718|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2082719|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
2082720|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082721|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082722|NCT02104752|Curcumin|curcumin|mesh-list
2082723|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2082724|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2082725|NCT02104752|Analgesics|analgesics|mesh-ancestor
2082726|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
2082727|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082728|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082729|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2082730|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2082731|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082732|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082733|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082734|NCT02104804|Insulin|insulin|mesh-list
2082735|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2082736|NCT02104804|Metformin|metformin|mesh-list
2082737|NCT02104804|Saxagliptin|saxagliptin|mesh-list
2082738|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
2082739|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2082740|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082741|NCT02104804|Incretins|incretins|mesh-ancestor
2082742|NCT02104804|Hormones|hormones|mesh-ancestor
2082743|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2082744|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2082745|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
2082746|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082747|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082748|NCT02104830|Lenograstim|lenograstim|mesh-list
2082749|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2082750|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
2082751|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082752|NCT02105272|Carteolol|carteolol|mesh-list
647118|NCT04126538|Pirfenidone|pirfenidone|mesh-list
647119|NCT04126538|Analgesics|analgesics|mesh-ancestor
647120|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
647121|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
647122|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647123|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
647124|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
647125|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
647126|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
647127|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082753|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2082754|NCT02105272|Latanoprost|latanoprost|mesh-list
2082755|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2082756|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2082757|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2082758|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
2082759|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082760|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648336|NCT03271164|Vitamin E|vitamin e|mesh-list
648337|NCT03271164|Vitamins|vitamins|mesh-ancestor
648338|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
648339|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648340|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
648341|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648342|NCT03271164|Protective Agents|protective agents|mesh-ancestor
648516|NCT03270007|Vinorelbine|vinorelbine|mesh-list
648517|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
648518|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648519|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
648520|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
648521|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
648522|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648602|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
648603|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
648604|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
648605|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
648773|NCT03268954|Azacitidine|azacitidine|mesh-list
648774|NCT03268954|Pevonedistat|pevonedistat|mesh-list
648775|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
648776|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
648777|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648778|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648779|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649522|NCT03263936|Cytarabine|cytarabine|mesh-list
649523|NCT03263936|Fludarabine|fludarabine|mesh-list
649524|NCT03263936|Decitabine|decitabine|mesh-list
649525|NCT03263936|Vorinostat|vorinostat|mesh-list
649526|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649527|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
649528|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
649529|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649530|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
649531|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
649532|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649533|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
649534|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649535|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649536|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
650318|NCT03260023|Avelumab|avelumab|mesh-list
650319|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
650320|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650577|NCT03258723|Metformin|metformin|mesh-list
650578|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
650579|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651367|NCT03254628|Misoprostol|misoprostol|mesh-list
646248|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
646249|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
646250|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
646251|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646252|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
646253|NCT04818866|Coagulants|coagulants|mesh-ancestor
2082761|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082762|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2082763|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2082764|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
2082765|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
2082766|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082767|NCT02105285|Carteolol|carteolol|mesh-list
2082768|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2082769|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2082770|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2082771|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2082772|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
2082773|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082774|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082775|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082776|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2082777|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2082778|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
2082779|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
2082780|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082781|NCT02105324|Pancrelipase|pancrelipase|mesh-list
2082782|NCT02105324|Pancreatin|pancreatin|mesh-list
2082783|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2082784|NCT02105415|Ketamine|ketamine|mesh-list
2082785|NCT02105415|Propofol|propofol|mesh-list
2082786|NCT02105415|Etomidate|etomidate|mesh-list
2082787|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2082788|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2082789|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082790|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2082791|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
2082792|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
2082793|NCT02105415|Analgesics|analgesics|mesh-ancestor
2082794|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
2082795|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082796|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2082797|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2082798|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2082799|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082800|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082801|NCT02105454|Ribavirin|ribavirin|mesh-list
2082802|NCT02105454|Grazoprevir|grazoprevir|mesh-list
2082803|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
2082804|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082805|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
2082806|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082807|NCT02105467|Grazoprevir|grazoprevir|mesh-list
2082808|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
2082809|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082810|NCT02105558|Anesthetics|anesthetics|mesh-list
2082811|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2082812|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649091|NCT03266965|Carbidopa|carbidopa|mesh-list
2082837|NCT02105662|Grazoprevir|grazoprevir|mesh-list
2082838|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
2751927|NCT03785925|Nivolumab|nivolumab|mesh-list
2751928|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2751929|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751930|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2751931|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
647098|NCT04151667|Dexamethasone|dexamethasone|mesh-list
647099|NCT04151667|Lenalidomide|lenalidomide|mesh-list
647100|NCT04151667|Bortezomib|bortezomib|mesh-list
647101|NCT04151667|Daratumumab|daratumumab|mesh-list
647102|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
647103|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
647104|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
647105|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
647106|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647107|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
647108|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
647109|NCT04151667|Hormones|hormones|mesh-ancestor
647110|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
647111|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
647112|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
647113|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
647114|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
647115|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
647116|NCT04151667|Growth Substances|growth substances|mesh-ancestor
647117|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
2082839|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082840|NCT02105688|Grazoprevir|grazoprevir|mesh-list
2082841|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
2082842|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082843|NCT02105701|Ribavirin|ribavirin|mesh-list
2082844|NCT02105701|Grazoprevir|grazoprevir|mesh-list
2082845|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
2082846|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082847|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
2082848|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082849|NCT02105974|Fluticasone|fluticasone|mesh-list
2082850|NCT02105974|Xhance|xhance|mesh-list
2082851|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2082852|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2082853|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
2082854|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082855|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648276|NCT03271983|Metronidazole|metronidazole|mesh-list
648277|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
648278|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
648279|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
648280|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2082856|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
646205|NCT04877821|Paclitaxel|paclitaxel|mesh-list
646206|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
646207|NCT04877821|Carboplatin|carboplatin|mesh-list
646208|NCT04877821|Epirubicin|epirubicin|mesh-list
646209|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
646210|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
646211|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
646212|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
646213|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
646214|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646215|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
646216|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
646217|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
646218|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
646219|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
646220|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
646221|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
646222|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
646223|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
646224|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
646225|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
646323|NCT04756804|Ethanol|ethanol|mesh-list
646324|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
646325|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
646326|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
646327|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
646328|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
646329|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
646330|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
646331|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
2082857|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
2082858|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
2082859|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2082860|NCT02106156|Interferons|interferons|mesh-list
2082861|NCT02106156|Ribavirin|ribavirin|mesh-list
2082862|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
2082863|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
2082864|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2082865|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082866|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
2082867|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082868|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
2082869|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082870|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
2082871|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082872|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
2082873|NCT02106325|Promethazine|promethazine|mesh-list
2082874|NCT02106325|Ketamine|ketamine|mesh-list
2082875|NCT02106325|Analgesics|analgesics|mesh-ancestor
2082876|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
2082877|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082878|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082879|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2082880|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2082881|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
647305|NCT03920527|Itraconazole|itraconazole|mesh-list
647306|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
647307|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
647308|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
647309|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
647310|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
647311|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
647312|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
647313|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
2082882|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
2082883|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2082884|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2082885|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2082886|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082887|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082888|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2082889|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2082890|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
2082891|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
2082892|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
2082893|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2082894|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2082895|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
2082896|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
2082897|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2082898|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
2082899|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
2082900|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
2082901|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2082902|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2082903|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2082904|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2082905|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082906|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
2082907|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082908|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082909|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2082910|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082911|NCT02106390|Vaccines|vaccines|mesh-list
2082912|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
2082913|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082914|NCT02106403|Disinfectants|disinfectants|mesh-list
2082915|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082916|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
646358|NCT04744181|Folic Acid|folic acid|mesh-list
646359|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
646360|NCT04744181|Vitamins|vitamins|mesh-ancestor
646361|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
646362|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
646363|NCT04744181|Hematinics|hematinics|mesh-ancestor
2082917|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2082918|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2082919|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082920|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2082921|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082922|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2082923|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
2082924|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2082925|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2082926|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082927|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2082928|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082929|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2082930|NCT02106494|Dexamethasone|dexamethasone|mesh-list
2082931|NCT02106494|Ondansetron|ondansetron|mesh-list
2082932|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
2082933|NCT02106494|Aprepitant|aprepitant|mesh-list
2082934|NCT02106494|Granisetron|granisetron|mesh-list
2082935|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2082936|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
2082937|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
2082938|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2082939|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082940|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2082941|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
2082942|NCT02106494|Hormones|hormones|mesh-ancestor
2082943|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2082944|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
646812|NCT04427904|Lidocaine|lidocaine|mesh-list
646817|NCT04427904|Epinephrine|epinephrine|mesh-list
646818|NCT04427904|Racepinephrine|racepinephrine|mesh-list
646819|NCT04427904|Bupivacaine|bupivacaine|mesh-list
646820|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
646821|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
646822|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
646823|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
646824|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
646369|NCT04733560|Bupivacaine|bupivacaine|mesh-list
646370|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
646371|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
646372|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
646373|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
646374|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
646375|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
646443|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
646444|NCT04669561|Lifitegrast|lifitegrast|mesh-list
646445|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
646859|NCT04377451|Metformin|metformin|mesh-list
646860|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
646861|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082945|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082946|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
2082947|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
2082948|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2082949|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
2082950|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2082951|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082952|NCT02106494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2082953|NCT02106494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2082954|NCT02106494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2082955|NCT02106494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2082956|NCT02106494|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2082957|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2082958|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
2082959|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2082960|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082961|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2082962|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2082963|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082964|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082965|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082966|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2082967|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2082968|NCT02106884|Gemcitabine|gemcitabine|mesh-list
2082969|NCT02106884|Paclitaxel|paclitaxel|mesh-list
2082970|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2082971|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2082972|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
2082973|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
2082974|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
2082975|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082976|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2082977|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
2082978|NCT02106884|Antiviral Agents|antiviral agents|mesh-ancestor
2082979|NCT02106884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082980|NCT02106884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2082981|NCT02106884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2082982|NCT02106884|Immunologic Factors|immunologic factors|mesh-ancestor
648944|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
648945|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
648946|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649126|NCT03266731|Aspirin|aspirin|mesh-list
649127|NCT03266731|Clopidogrel|clopidogrel|mesh-list
649128|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
649129|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
649130|NCT03266731|Analgesics|analgesics|mesh-ancestor
649131|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
649132|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649133|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649134|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
649135|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
649136|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
649137|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
649138|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649139|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
649140|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
649141|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649142|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
649143|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
649144|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
649145|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2082983|NCT02106884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082984|NCT02106923|Metformin|metformin|mesh-list
2082985|NCT02106923|Empagliflozin|empagliflozin|mesh-list
2082986|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2082987|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2082988|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2082989|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082990|NCT02106962|Bacitracin|bacitracin|mesh-list
2082991|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
2082992|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2082993|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2082994|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2082995|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
2082996|NCT02106962|Coagulants|coagulants|mesh-ancestor
2082997|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2082998|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2082999|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2083000|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
2083001|NCT02106975|Vitamins|vitamins|mesh-ancestor
2083002|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
2083003|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083004|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
2083005|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083006|NCT02106975|Protective Agents|protective agents|mesh-ancestor
647425|NCT03873480|Epinephrine|epinephrine|mesh-list
647426|NCT03873480|Bupivacaine|bupivacaine|mesh-list
647427|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
647428|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
647429|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
647430|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
647431|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
647432|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647433|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
647434|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
647435|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
647436|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
647437|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
647438|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
647439|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
647440|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
647441|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
647442|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
647443|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
647444|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
647445|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
647494|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
647495|NCT03849651|Melphalan|melphalan|mesh-list
647496|NCT03849651|Thiotepa|thiotepa|mesh-list
647497|NCT03849651|Fludarabine|fludarabine|mesh-list
647498|NCT03849651|Blinatumomab|blinatumomab|mesh-list
647499|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
647500|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
647501|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
647502|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647503|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
647504|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
647505|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
647506|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
647507|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
647508|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2083007|NCT02107014|Naltrexone|naltrexone|mesh-list
2083008|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2083009|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2083010|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083011|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
2083012|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083013|NCT02107131|Ranibizumab|ranibizumab|mesh-list
2083014|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2083015|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2083016|NCT02107131|Growth Substances|growth substances|mesh-ancestor
2083017|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083018|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
2083019|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083020|NCT02107274|Azithromycin|azithromycin|mesh-list
2083021|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2083022|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083023|NCT02107339|Methadone|methadone|mesh-list
2083024|NCT02107339|Hydromorphone|hydromorphone|mesh-list
2083025|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2083026|NCT02107339|Narcotics|narcotics|mesh-ancestor
2083027|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
647058|NCT04177758|Vitamin D|vitamin d|mesh-list
647059|NCT04177758|Vitamins|vitamins|mesh-ancestor
647060|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
647061|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647062|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
647128|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
647129|NCT04130516|Antibodies|antibodies|mesh-list
647130|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
647131|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647132|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
647133|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751958|NCT03770689|Capecitabine|capecitabine|mesh-list
2751959|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2751960|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
2751961|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751962|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
647876|NCT03545464|Prednisone|prednisone|mesh-list
647877|NCT03545464|Levocetirizine|levocetirizine|mesh-list
647878|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
647879|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
647880|NCT03545464|Hormones|hormones|mesh-ancestor
647881|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
647882|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647883|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
647884|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
647885|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
647886|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
647887|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
647888|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
647889|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
647890|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083028|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083029|NCT02107339|Analgesics|analgesics|mesh-ancestor
2083030|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
2083031|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649318|NCT03265171|Plasminogen|plasminogen|mesh-list
649319|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
649320|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
649321|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083032|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
2083033|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
2083034|NCT02107703|Fulvestrant|fulvestrant|mesh-list
2083035|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2083036|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649837|NCT03262688|Bupivacaine|bupivacaine|mesh-list
649838|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
649839|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
649840|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649841|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649842|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
649843|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650964|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
650965|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
650966|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
650967|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
2083037|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2083038|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2083039|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
2083040|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083041|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083042|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2083043|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
2083044|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083045|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
2083046|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2083047|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2083048|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083049|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2083050|NCT02108171|Analgesics|analgesics|mesh-ancestor
2083051|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
2083052|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
646695|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
646696|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
646697|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646698|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
646699|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
646811|NCT04416282|Terlipressin|terlipressin|mesh-list
646815|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
646816|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2083053|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2083054|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2083055|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2083056|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
2083057|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2083058|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083059|NCT02108288|Carteolol|carteolol|mesh-list
2083060|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2083061|NCT02108288|Latanoprost|latanoprost|mesh-list
2083062|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2083063|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2221338|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221339|NCT00041210|Prednisone|prednisone|mesh-list
2221340|NCT00041210|Doxorubicin|doxorubicin|mesh-list
2221341|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2221342|NCT00041210|Bleomycin|bleomycin|mesh-list
2221343|NCT00041210|Etoposide|etoposide|mesh-list
2221344|NCT00041210|Vincristine|vincristine|mesh-list
2221345|NCT00041210|Dacarbazine|dacarbazine|mesh-list
648023|NCT03384212|Cytarabine|cytarabine|mesh-list
648024|NCT03384212|Fludarabine|fludarabine|mesh-list
648025|NCT03384212|Busulfan|busulfan|mesh-list
648026|NCT03384212|Cladribine|cladribine|mesh-list
648027|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648028|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
648029|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
648030|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648031|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
648032|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
648033|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648034|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
648035|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
648036|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
648037|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
648038|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
648211|NCT03272347|Tenofovir|tenofovir|mesh-list
648212|NCT03272347|Lamivudine|lamivudine|mesh-list
648213|NCT03272347|Islatravir|islatravir|mesh-list
648214|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
648215|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
648216|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
648217|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
648218|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648219|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648220|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
648221|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
648301|NCT03272009|Interferons|interferons|mesh-list
648302|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
648303|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
648304|NCT03272009|Entecavir|entecavir|mesh-list
648305|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
648306|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648307|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
648308|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2751971|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
2751972|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2083064|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2083065|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
2083066|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2083067|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083068|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083069|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2083070|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2083071|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
2083072|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
2083073|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2751973|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
2751974|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751975|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648109|NCT03272685|Nicotine|nicotine|mesh-list
648110|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
648111|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
648112|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648113|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648114|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
648115|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
648116|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
648117|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
648118|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648227|NCT03272321|Oxytocin|oxytocin|mesh-list
648228|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
648229|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
648230|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083078|NCT02109029|Insulin|insulin|mesh-list
2083079|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2083080|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2083081|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083082|NCT02109133|Rocuronium|rocuronium|mesh-list
648418|NCT03270696|Propofol|propofol|mesh-list
648419|NCT03270696|Rocuronium|rocuronium|mesh-list
648420|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
648421|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
648422|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648423|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
648424|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
648425|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
648426|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
648427|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
648428|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
648429|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649643|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
649644|NCT03263520|Dexamethasone|dexamethasone|mesh-list
649645|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
649646|NCT03263520|Nandrolone|nandrolone|mesh-list
649647|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
649648|NCT03263520|BB 1101|bb 1101|mesh-list
649649|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
649650|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
649651|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
649652|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649653|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649654|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
649655|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
649656|NCT03263520|Hormones|hormones|mesh-ancestor
649657|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649658|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
649659|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649660|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
649661|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649662|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083083|NCT02109133|Atracurium|atracurium|mesh-list
646735|NCT04495452|Fentanyl|fentanyl|mesh-list
646736|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
646737|NCT04495452|Narcotics|narcotics|mesh-ancestor
646738|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
646739|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
646740|NCT04495452|Analgesics|analgesics|mesh-ancestor
646741|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
646742|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
646743|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
646744|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
646745|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
646746|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
2083084|NCT02109133|Neostigmine|neostigmine|mesh-list
2083085|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2083086|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2083087|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2083088|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083089|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083090|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2083091|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083092|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083093|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
647910|NCT03536520|Acetazolamide|acetazolamide|mesh-list
647911|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
647912|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
647913|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
647914|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
647915|NCT03536520|Diuretics|diuretics|mesh-ancestor
647916|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
647917|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083094|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2083095|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2083096|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
2083097|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
648257|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
648258|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
648259|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649476|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
649477|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
649478|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649494|NCT03263741|Paclitaxel|paclitaxel|mesh-list
649495|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
649496|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
649497|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
649498|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649499|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
649500|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
649501|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
649502|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649801|NCT03262545|Apatinib|apatinib|mesh-list
649802|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649803|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
649804|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649805|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650097|NCT03261193|Bupivacaine|bupivacaine|mesh-list
650098|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
650099|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
650100|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650101|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650102|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
2083098|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2083099|NCT02109445|Gemcitabine|gemcitabine|mesh-list
2083100|NCT02109445|Paclitaxel|paclitaxel|mesh-list
2083101|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2083102|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2083103|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083104|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
2083105|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
2083106|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
2083107|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083108|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2083109|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
2083110|NCT02109445|Antiviral Agents|antiviral agents|mesh-ancestor
2083111|NCT02109445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083112|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083113|NCT02109445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083114|NCT02109445|Immunologic Factors|immunologic factors|mesh-ancestor
2083115|NCT02109445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083116|NCT02109484|Vaccines|vaccines|mesh-list
2083117|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
2083118|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083119|NCT02109562|Risperidone|risperidone|mesh-list
2083120|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2083121|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
2083122|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2083123|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083124|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083125|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2083126|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2083127|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2083128|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2083129|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2083130|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
2083131|NCT02109640|Oxycodone|oxycodone|mesh-list
2083132|NCT02109640|Naloxone|naloxone|mesh-list
2083133|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2083134|NCT02109640|Narcotics|narcotics|mesh-ancestor
2083135|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2083136|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083137|NCT02109640|Analgesics|analgesics|mesh-ancestor
2083138|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
2083139|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083140|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2083141|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
2083142|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2083143|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2083144|NCT02110225|Mitogens|mitogens|mesh-list
2083145|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
2083146|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083147|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
2083148|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2083149|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
2083150|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083151|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
2083152|NCT02110238|Protective Agents|protective agents|mesh-ancestor
2083153|NCT02110264|Naltrexone|naltrexone|mesh-list
648450|NCT03270553|Metformin|metformin|mesh-list
648451|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
648452|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648586|NCT03269955|Thrombin|thrombin|mesh-list
648587|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
648588|NCT03269955|Coagulants|coagulants|mesh-ancestor
648838|NCT03268902|Niacinamide|niacinamide|mesh-list
648839|NCT03268902|Niacin|niacin|mesh-list
648840|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
648841|NCT03268902|Azithromycin|azithromycin|mesh-list
648842|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
648843|NCT03268902|Vitamins|vitamins|mesh-ancestor
648844|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
648845|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648846|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
648847|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
648848|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
648849|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
648850|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
648851|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648852|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
648853|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
648854|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
646814|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083154|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2083155|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2083156|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083157|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
2083158|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083159|NCT02110706|Rituximab|rituximab|mesh-list
2083160|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2083161|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083162|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
2083163|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083164|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2083165|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
2083166|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2083167|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647014|NCT04239040|Nivolumab|nivolumab|mesh-list
647015|NCT04239040|Ipilimumab|ipilimumab|mesh-list
647016|NCT04239040|Vaccines|vaccines|mesh-list
647017|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
647018|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647019|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
647020|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
647021|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
647022|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083168|NCT02111096|Metformin|metformin|mesh-list
2083169|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2083170|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2083171|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083172|NCT02111096|Incretins|incretins|mesh-ancestor
2083173|NCT02111096|Hormones|hormones|mesh-ancestor
2083174|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083175|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2083176|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
2083177|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083178|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083179|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
2083180|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2083181|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083182|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
2083183|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083184|NCT02111369|Propranolol|propranolol|mesh-list
2083185|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
2083186|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2083187|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2083188|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083189|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
2083190|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
649221|NCT03266081|Bupivacaine|bupivacaine|mesh-list
649222|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
649223|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
649224|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649225|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649226|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
649227|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649429|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
649430|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
649431|NCT03264118|Coagulants|coagulants|mesh-ancestor
649432|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
649433|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649577|NCT03263481|Secretin|secretin|mesh-list
649578|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
649579|NCT03263481|Hormones|hormones|mesh-ancestor
649580|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649581|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649882|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
649883|NCT03262142|Tazobactam|tazobactam|mesh-list
649884|NCT03262142|Piperacillin|piperacillin|mesh-list
649885|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
649886|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
649887|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649888|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
649889|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
649890|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649891|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649892|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
646825|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
646826|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
646827|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
646828|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
646829|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
646830|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
646831|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
646832|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
646833|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
646834|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
646835|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
646836|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
646837|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
646838|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
646839|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
646840|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
646841|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
646842|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
646843|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2083191|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083192|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2083193|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2221346|NCT00041210|Vinblastine|vinblastine|mesh-list
2221347|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
2221348|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2221349|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221350|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2221351|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2221352|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221353|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221354|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2221355|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
2221356|NCT00041210|Hormones|hormones|mesh-ancestor
2221357|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083194|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
2083195|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2083196|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2083197|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
2083198|NCT02111447|Propofol|propofol|mesh-list
2083199|NCT02111447|Sevoflurane|sevoflurane|mesh-list
2083200|NCT02111447|Isoflurane|isoflurane|mesh-list
647554|NCT03783286|Ivacaftor|ivacaftor|mesh-list
647555|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
647556|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
647557|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
647637|NCT03752684|Calcium|calcium|mesh-list
647638|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
647639|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221358|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221359|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2221360|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2221361|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
2221362|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
2221363|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
2221364|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
648281|NCT03271905|Bromides|bromides|mesh-list
648282|NCT03271905|Albuterol|albuterol|mesh-list
648283|NCT03271905|Ipratropium|ipratropium|mesh-list
648284|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
648285|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2083201|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2083202|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2083203|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083204|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2083205|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
2083206|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
2221365|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
2221366|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
2221367|NCT00041223|Procyanidin|procyanidin|mesh-list
2221368|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
2221369|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221370|NCT00041223|Protective Agents|protective agents|mesh-ancestor
2221371|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221372|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2221373|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2221374|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221375|NCT00041236|Exatecan|exatecan|mesh-list
2221376|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2221377|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2221378|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221379|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221380|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751976|NCT03754153|Atropine|atropine|mesh-list
2751977|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2751978|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2751979|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2751980|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
2751981|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
647412|NCT03902509|Pirfenidone|pirfenidone|mesh-list
647413|NCT03902509|Analgesics|analgesics|mesh-ancestor
647414|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
647415|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
647416|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647417|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
647418|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
647419|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
647420|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
647421|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083207|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2083208|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2083209|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
2083210|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2083211|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
2083212|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2083213|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
2083214|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083215|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083216|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
2083217|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2083218|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2083219|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2083220|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
2083221|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083222|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2083223|NCT02111746|Bupivacaine|bupivacaine|mesh-list
2083224|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
2083225|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
648238|NCT03272295|Menthol|menthol|mesh-list
648239|NCT03272295|Sorbitol|sorbitol|mesh-list
648240|NCT03272295|Glycerol|glycerol|mesh-list
648241|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
648242|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
648243|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
648244|NCT03272295|Protective Agents|protective agents|mesh-ancestor
648245|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648246|NCT03272295|Cathartics|cathartics|mesh-ancestor
648247|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
648343|NCT03271255|Bevacizumab|bevacizumab|mesh-list
648344|NCT03271255|Apatinib|apatinib|mesh-list
648345|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
648346|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648347|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
648348|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
648349|NCT03271255|Growth Substances|growth substances|mesh-ancestor
648350|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648351|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
648352|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
646876|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
646877|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
646878|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
646879|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083226|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2083227|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083228|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
2083229|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083230|NCT02111785|Dexamethasone|dexamethasone|mesh-list
2083231|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2083232|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
2083233|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
2083234|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083235|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083236|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2083237|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
2083238|NCT02111785|Hormones|hormones|mesh-ancestor
2083239|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083240|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2083241|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083242|NCT02111798|Bupropion|bupropion|mesh-list
2083243|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2083244|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
2083245|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2083246|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2083247|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2083248|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2083249|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083250|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
2083251|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2083252|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083253|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2083254|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2083255|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648606|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
648607|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
648608|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648609|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
648610|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
648611|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083256|NCT02111863|Aldesleukin|aldesleukin|mesh-list
2083257|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
2083258|NCT02111863|Fludarabine|fludarabine|mesh-list
2083259|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083260|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
2083261|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083262|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2083263|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2083264|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
2083265|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083266|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083267|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2083268|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2083269|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2083270|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
2083271|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083272|NCT02112045|Melphalan|melphalan|mesh-list
2083273|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
2083274|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083275|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2083276|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
2083277|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083278|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083279|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2083280|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083281|NCT02112370|Epinephrine|epinephrine|mesh-list
2083282|NCT02112370|Racepinephrine|racepinephrine|mesh-list
2083283|NCT02112370|Ropivacaine|ropivacaine|mesh-list
2221381|NCT00041262|Fluorouracil|fluorouracil|mesh-list
649148|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
649149|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
649150|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649328|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
2083284|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
2083285|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
2083286|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
2083287|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2083288|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083289|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
2083290|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083291|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2083292|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2083293|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
2083294|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2083295|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083296|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2083297|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2083298|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
2083299|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2083300|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
2083301|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
2083302|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
2083303|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2083304|NCT02112448|Acetaminophen|acetaminophen|mesh-list
2083305|NCT02112448|Ketorolac|ketorolac|mesh-list
2083306|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2083307|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
648314|NCT03271502|Anesthetics|anesthetics|mesh-list
648315|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
648316|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648373|NCT03271073|Apatinib|apatinib|mesh-list
648374|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648375|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
648376|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648377|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221382|NCT00041262|Epirubicin|epirubicin|mesh-list
2221383|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221384|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
2221385|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221386|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221387|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221388|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
2221389|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221390|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2221391|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2221392|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2221393|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221394|NCT00041275|Megestrol|megestrol|mesh-list
2221395|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
2221396|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
648540|NCT03269747|Prednisone|prednisone|mesh-list
648541|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
648542|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
648543|NCT03269747|Hormones|hormones|mesh-ancestor
648544|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
648545|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648546|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
648547|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649111|NCT03266991|Isoniazid|isoniazid|mesh-list
649112|NCT03266991|Rifapentine|rifapentine|mesh-list
649113|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
649114|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
649115|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649116|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
649117|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
649118|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
649119|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649120|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
649121|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
649122|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
649469|NCT03264274|Aflibercept|aflibercept|mesh-list
649470|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
649471|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
649472|NCT03264274|Growth Substances|growth substances|mesh-ancestor
649473|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649474|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
649475|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221397|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2083308|NCT02112448|Analgesics|analgesics|mesh-ancestor
2083309|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
2083310|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083311|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083312|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
2083313|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2083314|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2083315|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2083316|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2083317|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083318|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083321|NCT02113007|Rituximab|rituximab|mesh-list
2083322|NCT02113007|Temozolomide|temozolomide|mesh-list
2083323|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2083324|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083325|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
2083326|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083327|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2083328|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2083329|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
2083330|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083331|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
647969|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
647970|NCT03475134|Nivolumab|nivolumab|mesh-list
647971|NCT03475134|Fludarabine|fludarabine|mesh-list
647972|NCT03475134|Interleukin-2|interleukin-2|mesh-list
647973|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
647974|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
647975|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647976|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
647977|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
647978|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
647979|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
647980|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
647981|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
647982|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
647983|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
647984|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
647985|NCT03475134|Analgesics|analgesics|mesh-ancestor
647986|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
647987|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648095|NCT03272698|Ketamine|ketamine|mesh-list
648096|NCT03272698|Analgesics|analgesics|mesh-ancestor
648097|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
648098|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648099|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648100|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
648101|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
648102|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
648103|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
648104|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
648105|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
648106|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
648107|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
648108|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648131|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
648132|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
648133|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648263|NCT03271918|Cabergoline|cabergoline|mesh-list
648264|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
648265|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
648266|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
648267|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
648268|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
648269|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648270|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648595|NCT03269799|Ascorbic Acid|ascorbic acid|mesh-list
648596|NCT03269799|Vitamins|vitamins|mesh-ancestor
648597|NCT03269799|Micronutrients|micronutrients|mesh-ancestor
647087|NCT04149899|Timolol|timolol|mesh-list
647088|NCT04149899|Ophthalmic Solutions|ophthalmic solutions|mesh-list
647089|NCT04149899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
647090|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
647091|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
647092|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
647093|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
647094|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
647095|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647096|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
647097|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
647234|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
647235|NCT04046263|Hematinics|hematinics|mesh-ancestor
2083332|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2083333|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083334|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2083335|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083336|NCT02113579|Fluorides|fluorides|mesh-list
2083337|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
2083338|NCT02113579|Protective Agents|protective agents|mesh-ancestor
2083339|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083340|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
2083341|NCT02114151|Simeprevir|simeprevir|mesh-list
2083342|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
2083343|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083344|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
2083345|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083346|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083347|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
2083348|NCT02114177|Simeprevir|simeprevir|mesh-list
2083349|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
2083350|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083351|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
2083352|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083353|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083354|NCT02114385|Vaccines|vaccines|mesh-list
2083355|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
2083356|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083357|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
2083358|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2083359|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083360|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2083361|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2083362|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083363|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083364|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2751982|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751983|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2751984|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
2751985|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
2751986|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
2751987|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2751988|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2751989|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
2083373|NCT02114892|Resveratrol|resveratrol|mesh-list
2083374|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
2083375|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083376|NCT02114892|Protective Agents|protective agents|mesh-ancestor
2083377|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083378|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083379|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2083380|NCT02114931|Adalimumab|adalimumab|mesh-list
2083381|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2083382|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2083383|NCT02115048|Letrozole|letrozole|mesh-list
2083384|NCT02115048|Afatinib|afatinib|mesh-list
2083385|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083386|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2083387|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2083388|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083389|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083390|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2083391|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
2083392|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083393|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083394|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2083395|NCT02115113|Everolimus|everolimus|mesh-list
2083396|NCT02115113|Tacrolimus|tacrolimus|mesh-list
2083397|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083398|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
2083399|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083400|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2083401|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083402|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083403|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083404|NCT02115139|Ipilimumab|ipilimumab|mesh-list
2083405|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2083406|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221398|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2221399|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
2221400|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
648530|NCT03269786|Bilirubin|bilirubin|mesh-list
648536|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
648537|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648538|NCT03269786|Protective Agents|protective agents|mesh-ancestor
648539|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648780|NCT03268733|Folic Acid|folic acid|mesh-list
648781|NCT03268733|Hematinics|hematinics|mesh-ancestor
648782|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
648783|NCT03268733|Vitamins|vitamins|mesh-ancestor
648784|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
648785|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648999|NCT03267654|Apatinib|apatinib|mesh-list
649000|NCT03267654|Gefitinib|gefitinib|mesh-list
649001|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649002|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
649003|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649004|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649605|NCT03263533|Vorinostat|vorinostat|mesh-list
649606|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649607|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
649608|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649609|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649774|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
649775|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649776|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
649777|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
649778|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
649779|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649780|NCT03262961|Urological Agents|urological agents|mesh-ancestor
649806|NCT03262454|Atezolizumab|atezolizumab|mesh-list
649807|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650065|NCT03261791|Apatinib|apatinib|mesh-list
650066|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650067|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
650068|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650069|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221401|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221402|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2221403|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2221404|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2221405|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221406|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
651140|NCT03255642|Clonazepam|clonazepam|mesh-list
651141|NCT03255642|Melatonin|melatonin|mesh-list
651142|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
651143|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651144|NCT03255642|Protective Agents|protective agents|mesh-ancestor
651145|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651146|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
651147|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
651148|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
651149|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
651150|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
651319|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
651320|NCT03254589|Methotrexate|methotrexate|mesh-list
651321|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
651322|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
651323|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
651324|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651325|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221407|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2221408|NCT00041288|Cyclosporine|cyclosporine|mesh-list
2221409|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
2221410|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
2221411|NCT00041288|Methotrexate|methotrexate|mesh-list
2221412|NCT00041288|Fludarabine|fludarabine|mesh-list
2221413|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
2221414|NCT00041288|Tacrolimus|tacrolimus|mesh-list
2221415|NCT00041288|Cyclosporins|cyclosporins|mesh-list
2221416|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221417|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
2221418|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221419|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2221420|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2221421|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
2221422|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
647959|NCT03538938|Nicotine|nicotine|mesh-list
647960|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
647961|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
647962|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
647963|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647964|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
647965|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
647966|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
647967|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
647968|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083407|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2083408|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083409|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
2083410|NCT02115256|Terbutaline|terbutaline|mesh-list
2083411|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
648641|NCT03269591|Diclofenac|diclofenac|mesh-list
648642|NCT03269591|Progesterone|progesterone|mesh-list
648643|NCT03269591|Progestins|progestins|mesh-ancestor
648644|NCT03269591|Hormones|hormones|mesh-ancestor
648645|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
648646|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648647|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
648648|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
648649|NCT03269591|Analgesics|analgesics|mesh-ancestor
648650|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
648651|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648652|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
648653|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
648654|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
648655|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648656|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221423|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221424|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2221425|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2221426|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
2221427|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2221428|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221429|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
2221430|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
649414|NCT03264625|Vitamin D|vitamin d|mesh-list
649415|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
649416|NCT03264625|Vitamins|vitamins|mesh-ancestor
649417|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
649418|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649419|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
649420|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2221431|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221432|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2221433|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2221434|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2221435|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
2221436|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221437|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2221438|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2221439|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
2221440|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2221441|NCT00041314|Gemcitabine|gemcitabine|mesh-list
2083412|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2083413|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
2083414|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083415|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083416|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2083417|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
2083418|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
2083419|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
2083420|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2083421|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2083422|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2083423|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2083424|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
2083425|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2083426|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083427|NCT02115282|Exemestane|exemestane|mesh-list
2083428|NCT02115282|Goserelin|goserelin|mesh-list
2083429|NCT02115282|Entinostat|entinostat|mesh-list
2083430|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2083431|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083432|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2083433|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2083434|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648787|NCT03269162|Docetaxel|docetaxel|mesh-list
648788|NCT03269162|Pemetrexed|pemetrexed|mesh-list
648789|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648790|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
648791|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
648792|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
648793|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648794|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648795|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
648796|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
648947|NCT03267771|Progesterone|progesterone|mesh-list
648948|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
648949|NCT03267771|Progestins|progestins|mesh-ancestor
648950|NCT03267771|Hormones|hormones|mesh-ancestor
648951|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
648952|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649123|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
649124|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
649125|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649370|NCT03264651|Anastrozole|anastrozole|mesh-list
649371|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
649372|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649373|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
649374|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
649375|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649376|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649377|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
649378|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
649379|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649380|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649434|NCT03264430|Ketamine|ketamine|mesh-list
649435|NCT03264430|Bupivacaine|bupivacaine|mesh-list
649436|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
649437|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
649438|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649439|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649440|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
649441|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649442|NCT03264430|Analgesics|analgesics|mesh-ancestor
649443|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
649444|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
649445|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
649446|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
649447|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
649448|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
649449|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649677|NCT03263572|Cytarabine|cytarabine|mesh-list
649678|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
649679|NCT03263572|Methotrexate|methotrexate|mesh-list
649680|NCT03263572|Blinatumomab|blinatumomab|mesh-list
649681|NCT03263572|Ponatinib|ponatinib|mesh-list
649682|NCT03263572|Antibodies|antibodies|mesh-list
2221442|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
647314|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
647315|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
647316|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2221443|NCT00041314|Carboplatin|carboplatin|mesh-list
2221444|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221445|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221446|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
2221447|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221448|NCT00041314|Antiviral Agents|antiviral agents|mesh-ancestor
2221449|NCT00041314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
647626|NCT03765567|Vancomycin|vancomycin|mesh-list
647627|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
647628|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083435|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083436|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2083437|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
2083438|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083439|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083440|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2083441|NCT02115308|Regadenoson|regadenoson|mesh-list
2221450|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221451|NCT00041314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221452|NCT00041314|Immunologic Factors|immunologic factors|mesh-ancestor
2221453|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221454|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
648628|NCT03269383|Bupivacaine|bupivacaine|mesh-list
648629|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
648630|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
648631|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
648632|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648633|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
648634|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221455|NCT00041314|Protective Agents|protective agents|mesh-ancestor
2221456|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2221457|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2221458|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2221459|NCT00041314|Analgesics|analgesics|mesh-ancestor
2221460|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
2221461|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221462|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2221463|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2221464|NCT00041327|Interferons|interferons|mesh-list
2221465|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
2221466|NCT00041327|Lamivudine|lamivudine|mesh-list
649544|NCT03263650|Prednisone|prednisone|mesh-list
649545|NCT03263650|Carboplatin|carboplatin|mesh-list
649546|NCT03263650|Olaparib|olaparib|mesh-list
649547|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649548|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
649549|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
649550|NCT03263650|Hormones|hormones|mesh-ancestor
649551|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649552|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649553|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
649554|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
649555|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649556|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649583|NCT03263299|Aspirin|aspirin|mesh-list
649584|NCT03263299|Cabergoline|cabergoline|mesh-list
649585|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
649586|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
649587|NCT03263299|Analgesics|analgesics|mesh-ancestor
649588|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
649589|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649590|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649591|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
649592|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
649593|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
649594|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
649595|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649596|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
649597|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
649598|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649599|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
2083442|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2083443|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2083444|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
2083445|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
2083446|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2083447|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083448|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083449|NCT02115321|Grazoprevir|grazoprevir|mesh-list
2083450|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
2083451|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083452|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
2083453|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2083454|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083455|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2083456|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221467|NCT00041327|Zidovudine|zidovudine|mesh-list
2221468|NCT00041327|Prednisone|prednisone|mesh-list
2221469|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
2221470|NCT00041327|Doxorubicin|doxorubicin|mesh-list
2221471|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2221472|NCT00041327|Etoposide|etoposide|mesh-list
2221473|NCT00041327|Vincristine|vincristine|mesh-list
648384|NCT03270969|Tenofovir|tenofovir|mesh-list
648385|NCT03270969|Emtricitabine|emtricitabine|mesh-list
648386|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
648387|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
648388|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
648389|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
648390|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648391|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648392|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
648393|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
648430|NCT03270709|Vitamin D|vitamin d|mesh-list
648431|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
648432|NCT03270709|Vitamins|vitamins|mesh-ancestor
648433|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
648434|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648435|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
648436|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
649100|NCT03266926|Bupivacaine|bupivacaine|mesh-list
649101|NCT03266926|Estrogens|estrogens|mesh-list
649102|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
649103|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
649104|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
649105|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649106|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649107|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
649108|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649109|NCT03266926|Hormones|hormones|mesh-ancestor
649110|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649291|NCT03265899|Lactitol|lactitol|mesh-list
649292|NCT03265899|Oxytocin|oxytocin|mesh-list
649293|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
649294|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
649295|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649296|NCT03265899|Cathartics|cathartics|mesh-ancestor
649297|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2083457|NCT02115373|Tepotinib|tepotinib|mesh-list
2083458|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083459|NCT02115581|Ubiquinone|ubiquinone|mesh-list
2083460|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
2083461|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
2083462|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083463|NCT02115581|Vitamins|vitamins|mesh-ancestor
2083464|NCT02115750|Etanercept|etanercept|mesh-list
649613|NCT03263429|Irinotecan|irinotecan|mesh-list
649614|NCT03263429|Panitumumab|panitumumab|mesh-list
649615|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
649616|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
649617|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649618|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649619|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649620|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2102953|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2221474|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083465|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2083466|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2083467|NCT02115750|Analgesics|analgesics|mesh-ancestor
2083468|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
2083469|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083470|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083471|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2083472|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2083473|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2221475|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
2221476|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221477|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2221478|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2221479|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
2221480|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221481|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221482|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2221483|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
649228|NCT03266159|Trametinib|trametinib|mesh-list
649229|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649230|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
649231|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649232|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649262|NCT03265795|Ether|ether|mesh-list
649270|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
649271|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
649272|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
649273|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649274|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221484|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2221485|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2221486|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650222|NCT03260712|Gemcitabine|gemcitabine|mesh-list
650223|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
650224|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650225|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
650226|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
650227|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650228|NCT03260712|Antiviral Agents|antiviral agents|mesh-ancestor
650229|NCT03260712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650230|NCT03260712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650231|NCT03260712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
650232|NCT03260712|Immunologic Factors|immunologic factors|mesh-ancestor
650233|NCT03260712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650234|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
650476|NCT03259152|Denosumab|denosumab|mesh-list
650477|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
650478|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221487|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2221488|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
2221489|NCT00041327|Hormones|hormones|mesh-ancestor
2221490|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2221491|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2221492|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2221493|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
651408|NCT03254186|Propranolol|propranolol|mesh-list
651409|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
651410|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
651411|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
651412|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
651413|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651414|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651415|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
651416|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
651417|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
651879|NCT03251417|Irinotecan|irinotecan|mesh-list
651880|NCT03251417|Apatinib|apatinib|mesh-list
2083474|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083475|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
2083476|NCT02116205|Vaccines|vaccines|mesh-list
2083477|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
2083478|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083479|NCT02116309|Indomethacin|indomethacin|mesh-list
2083480|NCT02116309|Epinephrine|epinephrine|mesh-list
2083481|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2083482|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2083483|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
2083484|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2083485|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083486|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083487|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2102954|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
649398|NCT03264586|Lidocaine|lidocaine|mesh-list
649399|NCT03264586|Prilocaine|prilocaine|mesh-list
649400|NCT03264586|Mepivacaine|mepivacaine|mesh-list
649401|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
649402|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
649403|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
649404|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649405|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649406|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
649407|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649408|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
649409|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
649410|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
649411|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
649412|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649413|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
649744|NCT03262948|Paclitaxel|paclitaxel|mesh-list
649745|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
649746|NCT03262948|Carboplatin|carboplatin|mesh-list
649747|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
649748|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649749|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
649750|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
649751|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
649752|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650321|NCT03259958|Donepezil|donepezil|mesh-list
650322|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
650323|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650324|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650325|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
650326|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
650327|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650328|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
650535|NCT03259243|Bupivacaine|bupivacaine|mesh-list
650536|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
650537|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
650538|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650539|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650540|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
650541|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650589|NCT03258567|Nivolumab|nivolumab|mesh-list
650590|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
650591|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650592|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
650593|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221494|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221495|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
2221496|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
2221497|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
2083488|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2083489|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
2083490|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083491|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2083492|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
2083493|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
2083494|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
2083495|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2083496|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2083497|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2083498|NCT02116309|Analgesics|analgesics|mesh-ancestor
2083499|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
2083500|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2083501|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2083502|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
2083503|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
2083504|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2083505|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2083506|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083507|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
2083508|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2083509|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2083510|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2083511|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2083512|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083513|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
2083514|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2083515|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083516|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
648169|NCT03272477|Tamoxifen|tamoxifen|mesh-list
648170|NCT03272477|Paclitaxel|paclitaxel|mesh-list
648171|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
648172|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
648173|NCT03272477|Trastuzumab|trastuzumab|mesh-list
648174|NCT03272477|Letrozole|letrozole|mesh-list
648175|NCT03272477|Epirubicin|epirubicin|mesh-list
648176|NCT03272477|Anastrozole|anastrozole|mesh-list
648177|NCT03272477|Exemestane|exemestane|mesh-list
648178|NCT03272477|Goserelin|goserelin|mesh-list
648179|NCT03272477|Pertuzumab|pertuzumab|mesh-list
648180|NCT03272477|Leuprolide|leuprolide|mesh-list
648181|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
648182|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648183|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
648184|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
648185|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
648186|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648187|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
648188|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
648189|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648190|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
648191|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
648192|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
648193|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
648194|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
648195|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
648196|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
648197|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648198|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
648199|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
648200|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
648201|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
648202|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
648203|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
648204|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
648205|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
648206|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
648207|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
648208|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
648209|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
648210|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
648222|NCT03272126|Vitamin D|vitamin d|mesh-list
648223|NCT03272126|Vitamins|vitamins|mesh-ancestor
648224|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
648225|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648226|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2083517|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083518|NCT02116530|Dexamethasone|dexamethasone|mesh-list
2083519|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
2083520|NCT02116530|Doxorubicin|doxorubicin|mesh-list
2083521|NCT02116530|Ondansetron|ondansetron|mesh-list
2083522|NCT02116530|Olanzapine|olanzapine|mesh-list
2083523|NCT02116530|Aprepitant|aprepitant|mesh-list
2083524|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
2083525|NCT02116530|Palonosetron|palonosetron|mesh-list
2083526|NCT02116530|Granisetron|granisetron|mesh-list
2083527|NCT02116530|Antiemetics|antiemetics|mesh-list
2083528|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083529|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
2083530|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083531|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2083532|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2083533|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
2083534|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083535|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083536|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2083537|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2083538|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
2083539|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083540|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2083541|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
2083542|NCT02116530|Hormones|hormones|mesh-ancestor
2083543|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083544|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2083545|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
647918|NCT03536455|Acetazolamide|acetazolamide|mesh-list
647919|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
647920|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
647921|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
647922|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
647923|NCT03536455|Diuretics|diuretics|mesh-ancestor
647924|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
647925|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221498|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2221499|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2221500|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2221501|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2221502|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
2221503|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
2221504|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221505|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2221506|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
647998|NCT03461120|Anesthetics|anesthetics|mesh-list
647999|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
648000|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
648001|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648002|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
648003|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648164|NCT03272412|Progesterone|progesterone|mesh-list
648165|NCT03272412|Progestins|progestins|mesh-ancestor
648166|NCT03272412|Hormones|hormones|mesh-ancestor
648167|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
648168|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649334|NCT03265002|Psyllium|psyllium|mesh-list
649335|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
649336|NCT03265002|Cathartics|cathartics|mesh-ancestor
649337|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
649338|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
649479|NCT03264079|Itraconazole|itraconazole|mesh-list
649480|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
649481|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649482|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
649483|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
649484|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649485|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649486|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
649487|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
649488|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649489|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649490|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
649724|NCT03263052|Tacrolimus|tacrolimus|mesh-list
2083546|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2083547|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2083548|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083549|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
2083550|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
2083551|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2083552|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
2083553|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2083554|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2083555|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2083556|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2083557|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2083558|NCT02116530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2083559|NCT02116530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2083560|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2083561|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2083562|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2221507|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221508|NCT00041431|Hormones|hormones|mesh-list
648915|NCT03268226|Beclomethasone|beclomethasone|mesh-list
648916|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
648917|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
648918|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
648919|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
648920|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648921|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648922|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
648923|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
648924|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
648925|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
648926|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
648927|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
648928|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
648929|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648930|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
648931|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
648932|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
648933|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
648934|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
648935|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
648936|NCT03268226|Hormones|hormones|mesh-ancestor
648937|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2221509|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2221510|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221511|NCT00041483|Anecortave|anecortave|mesh-list
2221512|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2221513|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2221514|NCT00041483|Growth Substances|growth substances|mesh-ancestor
2221515|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221516|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
2221517|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221518|NCT00041535|Miglustat|miglustat|mesh-list
2221519|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649327|NCT03265223|Ropivacaine|ropivacaine|mesh-list
2751990|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2751991|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2751992|NCT03753074|Tenofovir|tenofovir|mesh-list
2751993|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
2751994|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2751995|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2751996|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2751997|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2751998|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648134|NCT03272503|Pimozide|pimozide|mesh-list
648135|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
648136|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
648137|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
648138|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648139|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
648140|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
648141|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
648142|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
648143|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648144|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
648311|NCT03271749|Anesthetics|anesthetics|mesh-list
648312|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
648313|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648394|NCT03270735|Thrombin|thrombin|mesh-list
648395|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
648396|NCT03270735|Coagulants|coagulants|mesh-ancestor
2221520|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221521|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2221522|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2221523|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
2221524|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221525|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2221526|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
648967|NCT03268018|Calcium|calcium|mesh-list
648968|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
648969|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649190|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
649191|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
649192|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
649193|NCT03266146|Prednisolone|prednisolone|mesh-list
649194|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
649195|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
649196|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
649197|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
649198|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
649199|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
649200|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649201|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649202|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
649203|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
649204|NCT03266146|Hormones|hormones|mesh-ancestor
649205|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649206|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
649207|NCT03266146|Protective Agents|protective agents|mesh-ancestor
649208|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
649209|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649359|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
649360|NCT03264638|Cyproterone|cyproterone|mesh-list
649361|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
649362|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
649363|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
649364|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649365|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649366|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649367|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
649368|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
649369|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
649582|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
650089|NCT03261284|Warfarin|warfarin|mesh-list
650090|NCT03261284|Dabigatran|dabigatran|mesh-list
650091|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
650092|NCT03261284|Antithrombins|antithrombins|mesh-ancestor
650093|NCT03261284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
650094|NCT03261284|Protease Inhibitors|protease inhibitors|mesh-ancestor
650095|NCT03261284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083563|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2083564|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
2083565|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
2083566|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
2083567|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
2083568|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2083569|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2083570|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083571|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
2083572|NCT02116660|Ritonavir|ritonavir|mesh-list
2083573|NCT02116660|Lopinavir|lopinavir|mesh-list
648055|NCT03384225|Cytarabine|cytarabine|mesh-list
648056|NCT03384225|Fludarabine|fludarabine|mesh-list
648057|NCT03384225|Busulfan|busulfan|mesh-list
648058|NCT03384225|Cladribine|cladribine|mesh-list
648059|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648060|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
648061|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
648062|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648063|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
648064|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
648065|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648066|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
648067|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
648068|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
648069|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
648070|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
648260|NCT03271866|Metformin|metformin|mesh-list
648261|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
648262|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648938|NCT03267836|Avelumab|avelumab|mesh-list
648939|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
648940|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649067|NCT03267316|Gemcitabine|gemcitabine|mesh-list
649068|NCT03267316|Paclitaxel|paclitaxel|mesh-list
649069|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
649070|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649071|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
649072|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
649073|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
649074|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649075|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
649076|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
649077|NCT03267316|Antiviral Agents|antiviral agents|mesh-ancestor
649078|NCT03267316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649079|NCT03267316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649080|NCT03267316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
649081|NCT03267316|Immunologic Factors|immunologic factors|mesh-ancestor
649082|NCT03267316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649167|NCT03266601|Interferons|interferons|mesh-list
649168|NCT03266601|Ribavirin|ribavirin|mesh-list
649169|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649170|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
649171|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649172|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
649173|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649187|NCT03266250|Anesthetics|anesthetics|mesh-list
649188|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649189|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649233|NCT03265886|Bupivacaine|bupivacaine|mesh-list
649234|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
649235|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
649236|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649237|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649238|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
649239|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649258|NCT03265470|Fentanyl|fentanyl|mesh-list
649259|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
649260|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
649261|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649263|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649264|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
649265|NCT03265470|Analgesics|analgesics|mesh-ancestor
649266|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
649267|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649268|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2083574|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2083575|NCT02116660|Darunavir|darunavir|mesh-list
647941|NCT03529825|Rifaximin|rifaximin|mesh-list
647942|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
647943|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
647944|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
648151|NCT03272425|Allopurinol|allopurinol|mesh-list
648152|NCT03272425|Lesinurad|lesinurad|mesh-list
648153|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
648154|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648155|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648156|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
648157|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
648158|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
648159|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
648160|NCT03272425|Protective Agents|protective agents|mesh-ancestor
648161|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648162|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
648163|NCT03272425|Renal Agents|renal agents|mesh-ancestor
648523|NCT03270020|Denosumab|denosumab|mesh-list
648524|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
648525|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648710|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
648711|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
648712|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648713|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
648714|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649030|NCT03267680|Indomethacin|indomethacin|mesh-list
649031|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
649032|NCT03267680|Omeprazole|omeprazole|mesh-list
649033|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
649034|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
649035|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649036|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
649037|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
649038|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
649039|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649040|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649041|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
649042|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
649043|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
649044|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
649045|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649046|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
649047|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
649048|NCT03267680|Analgesics|analgesics|mesh-ancestor
649049|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
649050|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649051|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
649052|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
649053|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
649054|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
649055|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
649160|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
649161|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
649162|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
649163|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649164|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
649165|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
649166|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649731|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
649732|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
649733|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221527|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221528|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
2221529|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2221530|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
2221531|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648271|NCT03271879|Empagliflozin|empagliflozin|mesh-list
648272|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
648273|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648274|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
648275|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648323|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
648324|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
648325|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
648326|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
648327|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648328|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
648329|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648330|NCT03271151|Analgesics|analgesics|mesh-ancestor
648331|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
648332|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648333|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
648334|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
648335|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
648491|NCT03269929|Midazolam|midazolam|mesh-list
648492|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
648493|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
648494|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
648495|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648496|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
648497|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
648498|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
648499|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
648500|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
648501|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
648502|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
648503|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
648504|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
648505|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648506|NCT03269760|Zolpidem|zolpidem|mesh-list
648507|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
648508|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
648509|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
648510|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648511|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
648512|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
648513|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
648514|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
648515|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648638|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
648639|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
648640|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649537|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
649538|NCT03263715|Hormones|hormones|mesh-ancestor
649539|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649540|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2751999|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2752000|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2752001|NCT03748784|Aflibercept|aflibercept|mesh-list
2752002|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2752003|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2752004|NCT03748784|Growth Substances|growth substances|mesh-ancestor
2752005|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752006|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
2752007|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650146|NCT03261102|Adalimumab|adalimumab|mesh-list
650147|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
650148|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2083576|NCT02116660|Tenofovir|tenofovir|mesh-list
2083577|NCT02116660|Lamivudine|lamivudine|mesh-list
2083578|NCT02116660|Emtricitabine|emtricitabine|mesh-list
650692|NCT03258294|Melatonin|melatonin|mesh-list
650693|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
650694|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650695|NCT03258294|Protective Agents|protective agents|mesh-ancestor
650696|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083579|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
648286|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
648287|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648288|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648289|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
648290|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
648291|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
648292|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
648293|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
648294|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
648295|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
648296|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
648297|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
648298|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648299|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
648300|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
2221532|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221533|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2221534|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
2221535|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2221536|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
2221537|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221538|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2221539|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2221540|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
2221541|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
2221542|NCT00041548|Protective Agents|protective agents|mesh-ancestor
2221543|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
2221544|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2221545|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
2221546|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221547|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221548|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2221549|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
2221550|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
648786|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2221551|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
2752008|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
649753|NCT03263065|Psyllium|psyllium|mesh-list
649754|NCT03263065|Cathartics|cathartics|mesh-ancestor
649755|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
650169|NCT03260920|Oxytocin|oxytocin|mesh-list
650170|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
650171|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
650172|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650446|NCT03259516|Cytarabine|cytarabine|mesh-list
650447|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
650448|NCT03259516|Melphalan|melphalan|mesh-list
650449|NCT03259516|Nivolumab|nivolumab|mesh-list
650450|NCT03259516|Fludarabine|fludarabine|mesh-list
650451|NCT03259516|Azacitidine|azacitidine|mesh-list
650452|NCT03259516|Tretinoin|tretinoin|mesh-list
650453|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
650454|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
650455|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
650456|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650457|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
650458|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
650459|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
650460|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650461|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650462|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
650463|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
650464|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
650465|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
650466|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
650467|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
650468|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650469|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650470|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
650471|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
650472|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
650473|NCT03259516|Urological Agents|urological agents|mesh-ancestor
650474|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
650475|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
650580|NCT03258866|Rituximab|rituximab|mesh-list
650581|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
650582|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648309|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
648310|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083580|NCT02116660|Nevirapine|nevirapine|mesh-list
2083581|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2083582|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2083583|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
2083584|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083585|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083586|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2083587|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2083588|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
2083589|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083590|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2083591|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2083592|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2083593|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2083594|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2083595|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2083596|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2083597|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2083598|NCT02116777|Temozolomide|temozolomide|mesh-list
2083599|NCT02116777|Talazoparib|talazoparib|mesh-list
2083600|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2083601|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
2083602|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083603|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083604|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2083605|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083606|NCT02116803|Fulvestrant|fulvestrant|mesh-list
2083607|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2083608|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083609|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2083610|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2083611|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
2083612|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083613|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083614|NCT02116972|FX006|fx006|mesh-list
2083615|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2083616|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
649830|NCT03262662|Varenicline|varenicline|mesh-list
649831|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
649832|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
649833|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
649834|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
649835|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649836|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650084|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
650085|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
650086|NCT03261349|Ledipasvir|ledipasvir|mesh-list
650087|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
650088|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650566|NCT03258684|Ascorbic Acid|ascorbic acid|mesh-list
650567|NCT03258684|Thiamine|thiamine|mesh-list
650568|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
650569|NCT03258684|Vitamins|vitamins|mesh-ancestor
650570|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
650571|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650572|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
650573|NCT03258684|Antioxidants|antioxidants|mesh-ancestor
650574|NCT03258684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650575|NCT03258684|Protective Agents|protective agents|mesh-ancestor
650576|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
650707|NCT03258398|Avelumab|avelumab|mesh-list
650708|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
650709|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650846|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
650847|NCT03257423|Metronidazole|metronidazole|mesh-list
650848|NCT03257423|Levofloxacin|levofloxacin|mesh-list
650849|NCT03257423|Ofloxacin|ofloxacin|mesh-list
650850|NCT03257423|Ertapenem|ertapenem|mesh-list
650851|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
650852|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650853|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
650854|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
650855|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650856|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648353|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648354|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648548|NCT03269916|Hormones|hormones|mesh-list
648549|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
648550|NCT03269916|Estrogens|estrogens|mesh-list
648551|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
648552|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648715|NCT03269318|Theophylline|theophylline|mesh-list
648716|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
648717|NCT03269318|Montelukast|montelukast|mesh-list
648718|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
648719|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
648720|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648721|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648722|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
648723|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
648724|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
648725|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
648726|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
648727|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
648728|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
648729|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648730|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
648731|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
648732|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
648733|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
648734|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
648735|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
648736|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648737|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
648738|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
648739|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
648740|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
648875|NCT03268499|Cisplatin|cisplatin|mesh-list
648876|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648941|NCT03268057|Avelumab|avelumab|mesh-list
648942|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
648943|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649012|NCT03267407|Fluconazole|fluconazole|mesh-list
649013|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
649014|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649015|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
649016|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
649017|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649018|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649019|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
649020|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
649021|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649022|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649023|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
649024|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
649174|NCT03266393|Tacrolimus|tacrolimus|mesh-list
649175|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
649176|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
649177|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649178|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
649179|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649180|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649395|NCT03264911|Amoxicillin|amoxicillin|mesh-list
649396|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
649397|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649503|NCT03263962|Canrenone|canrenone|mesh-list
649504|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
649505|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
649506|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649507|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649508|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
649509|NCT03263962|Diuretics|diuretics|mesh-ancestor
649510|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
649899|NCT03262363|Curcumin|curcumin|mesh-list
649900|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
649901|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
648355|NCT03271450|Warfarin|warfarin|mesh-list
648356|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
648357|NCT03271450|Dabigatran|dabigatran|mesh-list
648358|NCT03271450|Apixaban|apixaban|mesh-list
648359|NCT03271450|Edoxaban|edoxaban|mesh-list
648360|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
648361|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
648362|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
648363|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
648364|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
648365|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648366|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648397|NCT03270839|Meclizine|meclizine|mesh-list
648398|NCT03270839|Scopolamine|scopolamine|mesh-list
648399|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
648400|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
648401|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
648402|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648403|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648404|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
648405|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
648406|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
648407|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
648408|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
648409|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648410|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
648411|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
648412|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
648413|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
648414|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
648453|NCT03270462|Tacrolimus|tacrolimus|mesh-list
648454|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
648455|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
648456|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648457|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
648458|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648459|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648689|NCT03269279|Misoprostol|misoprostol|mesh-list
648690|NCT03269279|Mifepristone|mifepristone|mesh-list
648691|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
648692|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
648693|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
648694|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648695|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
648696|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
648697|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
648698|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
648699|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
648700|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
648701|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
648702|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
648703|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
648704|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
648705|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
648706|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
648707|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
648708|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
648709|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
648855|NCT03268525|Bupivacaine|bupivacaine|mesh-list
648856|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
648857|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
648858|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
648859|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648860|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
648861|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648885|NCT03268278|Lidocaine|lidocaine|mesh-list
648886|NCT03268278|Epinephrine|epinephrine|mesh-list
648887|NCT03268278|Buprenorphine|buprenorphine|mesh-list
648888|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
648889|NCT03268278|Anesthetics|anesthetics|mesh-list
648890|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
648891|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648892|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
648893|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648894|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
648895|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
649007|NCT03267498|Nivolumab|nivolumab|mesh-list
648598|NCT03269799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648599|NCT03269799|Antioxidants|antioxidants|mesh-ancestor
648600|NCT03269799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648601|NCT03269799|Protective Agents|protective agents|mesh-ancestor
649244|NCT03265782|Acetaminophen|acetaminophen|mesh-list
649245|NCT03265782|Ibuprofen|ibuprofen|mesh-list
649246|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
649247|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
649248|NCT03265782|Analgesics|analgesics|mesh-ancestor
649249|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
649250|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649251|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649252|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
649253|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
649254|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
649255|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649256|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649257|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
649345|NCT03265197|Lidocaine|lidocaine|mesh-list
649346|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
649347|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
649348|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649349|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649350|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
649351|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649352|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
649353|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
649354|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
649355|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
649356|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649896|NCT03262077|Methylene Blue|methylene blue|mesh-list
649897|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649898|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650214|NCT03260439|Tramadol|tramadol|mesh-list
650215|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
650216|NCT03260439|Narcotics|narcotics|mesh-ancestor
650217|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650218|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650219|NCT03260439|Analgesics|analgesics|mesh-ancestor
650220|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
650221|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650392|NCT03259607|Nicotine|nicotine|mesh-list
650393|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
650394|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
650395|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650396|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650397|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
650398|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
650399|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
650400|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
650401|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650671|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
650672|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
650673|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650674|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
650675|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
650676|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650677|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650678|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650733|NCT03257683|Ranolazine|ranolazine|mesh-list
650734|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
650735|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
650736|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221552|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221553|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2221554|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2221555|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
2221556|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
2221557|NCT00041561|Protective Agents|protective agents|mesh-ancestor
2221558|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
2221559|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2221560|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
2221561|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221562|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221563|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2221564|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
2221565|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2221566|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
2221567|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649610|NCT03263273|Minocycline|minocycline|mesh-list
649611|NCT03263273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
649612|NCT03263273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649705|NCT03262857|Lidocaine|lidocaine|mesh-list
649706|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
649707|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
649708|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
649709|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649710|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649711|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
649712|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649713|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
649714|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
649715|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
649716|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
649717|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649718|NCT03262857|Analgesics|analgesics|mesh-ancestor
649719|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
649720|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
649721|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
649722|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
649723|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
649853|NCT03262727|BMS-986165|bms-986165|mesh-list
649854|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
649855|NCT03262727|Norethindrone|norethindrone|mesh-list
649856|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
649857|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
649858|NCT03262727|Estradiol|estradiol|mesh-list
649859|NCT03262727|Estrogens|estrogens|mesh-ancestor
649860|NCT03262727|Hormones|hormones|mesh-ancestor
649861|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649862|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649863|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
649864|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
649865|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
649866|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
649867|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
649868|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
649869|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
649870|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
649871|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
649872|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649873|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649874|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
649875|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
650015|NCT03261921|Dexamethasone|dexamethasone|mesh-list
650016|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
650017|NCT03261921|Bupivacaine|bupivacaine|mesh-list
650018|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
650019|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
650020|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
650021|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650022|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650023|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
650024|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
650025|NCT03261921|Hormones|hormones|mesh-ancestor
650026|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
650027|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
650028|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650029|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
650030|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
650031|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649519|NCT03263871|Micronutrients|micronutrients|mesh-list
649520|NCT03263871|Trace Elements|trace elements|mesh-list
649521|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083617|NCT02116972|Hormones|hormones|mesh-ancestor
2083618|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083619|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083620|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083621|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
2083622|NCT02117024|Gemcitabine|gemcitabine|mesh-list
2221568|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2221569|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2221570|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
2221571|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
2221572|NCT00041574|Protective Agents|protective agents|mesh-ancestor
2221573|NCT00041639|Labetuzumab|labetuzumab|mesh-list
2221574|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2221575|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221576|NCT00041652|Labetuzumab|labetuzumab|mesh-list
2221577|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2221578|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221579|NCT00041665|Mitogens|mitogens|mesh-list
2221580|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
2221581|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221582|NCT00041678|Aripiprazole|aripiprazole|mesh-list
2221583|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
650004|NCT03261570|Digoxin|digoxin|mesh-list
650005|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
650006|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
650007|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
650008|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650009|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650010|NCT03261570|Protective Agents|protective agents|mesh-ancestor
650011|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650012|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
650013|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
650014|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
650127|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
650790|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
650791|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
650792|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650793|NCT03257514|Protective Agents|protective agents|mesh-ancestor
650794|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650795|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
650796|NCT03257514|Vitamins|vitamins|mesh-ancestor
650797|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
651504|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
651505|NCT03253224|Analgesics|analgesics|mesh-ancestor
651506|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
651507|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651508|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651509|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
651510|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
651511|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
651512|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
651513|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
651514|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
651515|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651516|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
651517|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
651518|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
652126|NCT03250143|Cyclosporine|cyclosporine|mesh-list
652127|NCT03250143|Azathioprine|azathioprine|mesh-list
652128|NCT03250143|Cyclosporins|cyclosporins|mesh-list
652129|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652296|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
648681|NCT03269214|Phenytoin|phenytoin|mesh-list
648682|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
648683|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
648684|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
648685|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
648686|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648687|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
648688|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
649025|NCT03267329|Telmisartan|telmisartan|mesh-list
649026|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
649027|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
649028|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
649029|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083623|NCT02117024|Paclitaxel|paclitaxel|mesh-list
2083624|NCT02117024|Vinorelbine|vinorelbine|mesh-list
2083625|NCT02117024|Docetaxel|docetaxel|mesh-list
2083626|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
2083627|NCT02117024|Pemetrexed|pemetrexed|mesh-list
2083628|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2083629|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2083630|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083631|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
2221584|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2221585|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
649925|NCT03262376|Vitamins|vitamins|mesh-list
649926|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
649927|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650070|NCT03261427|Pregabalin|pregabalin|mesh-list
650071|NCT03261427|Analgesics|analgesics|mesh-ancestor
650072|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
650073|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650074|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650075|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
650076|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
650077|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
650078|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650079|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
650080|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
650081|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
650082|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650083|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
650176|NCT03261024|Nickel|nickel|mesh-list
650177|NCT03261024|Trace Elements|trace elements|mesh-ancestor
650178|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
650179|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650384|NCT03259672|Sevoflurane|sevoflurane|mesh-list
650385|NCT03259672|Desflurane|desflurane|mesh-list
650386|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
650387|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
650388|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
650389|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
650390|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650391|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221586|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2221587|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2221588|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221589|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
2221590|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
2221591|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2221592|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221593|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2083632|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
648877|NCT03268382|Doxorubicin|doxorubicin|mesh-list
648878|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
648879|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
648880|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
648881|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
648882|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
648883|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
648884|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648970|NCT03267628|Morphine|morphine|mesh-list
648971|NCT03267628|Anesthetics|anesthetics|mesh-list
648972|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
648973|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
648974|NCT03267628|Narcotics|narcotics|mesh-ancestor
648975|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
648976|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
648977|NCT03267628|Analgesics|analgesics|mesh-ancestor
648978|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
648979|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221594|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2221595|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
2221596|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2221597|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2221598|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2221599|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2221600|NCT00041691|Labetuzumab|labetuzumab|mesh-list
2221601|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
650298|NCT03260166|Niacinamide|niacinamide|mesh-list
650299|NCT03260166|Niacin|niacin|mesh-list
650300|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
650301|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
650302|NCT03260166|Vitamins|vitamins|mesh-ancestor
650303|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
650304|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650305|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
650306|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
650307|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650308|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
650309|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
650884|NCT03257241|Cytarabine|cytarabine|mesh-list
650885|NCT03257241|Fludarabine|fludarabine|mesh-list
650886|NCT03257241|Daunorubicin|daunorubicin|mesh-list
650887|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
650888|NCT03257241|Idarubicin|idarubicin|mesh-list
650889|NCT03257241|Cladribine|cladribine|mesh-list
650890|NCT03257241|Lenograstim|lenograstim|mesh-list
650891|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650892|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
650893|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
650894|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650895|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
650896|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
650897|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650898|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
650899|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650900|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
650901|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
650902|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
650903|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
650904|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650905|NCT03257241|Analgesics|analgesics|mesh-ancestor
650906|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
650907|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650984|NCT03256864|Everolimus|everolimus|mesh-list
650985|NCT03256864|Tacrolimus|tacrolimus|mesh-list
650986|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
650987|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
650988|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650989|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
650990|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650991|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650992|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651219|NCT03255473|Dexamethasone|dexamethasone|mesh-list
651220|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
651221|NCT03255473|Prednisone|prednisone|mesh-list
651222|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
651223|NCT03255473|BB 1101|bb 1101|mesh-list
651224|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
651225|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
651226|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
648896|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
648897|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
648898|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
648899|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
648900|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
648901|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
648902|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
648903|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
648904|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
648905|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
648906|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
648907|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
648908|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
648909|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
648910|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
648911|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
648912|NCT03268278|Narcotics|narcotics|mesh-ancestor
648913|NCT03268278|Analgesics|analgesics|mesh-ancestor
648914|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
649083|NCT03267121|Apatinib|apatinib|mesh-list
649084|NCT03267121|Tegafur|tegafur|mesh-list
649085|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649086|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
649087|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649088|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649089|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
649090|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
649390|NCT03264794|Gefitinib|gefitinib|mesh-list
649391|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649392|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
649393|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649394|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083633|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
2083634|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221602|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649928|NCT03262116|Insulin|insulin|mesh-list
649929|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
649930|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
649931|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
649932|NCT03262116|Pancrelipase|pancrelipase|mesh-list
649933|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
649934|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649935|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2221603|NCT00041704|Anidulafungin|anidulafungin|mesh-list
2221604|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
2221605|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221606|NCT00041782|Dalteparin|dalteparin|mesh-list
2221607|NCT00041782|Tinzaparin|tinzaparin|mesh-list
2221608|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2221609|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
2221610|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2221611|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2221612|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221613|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
2221614|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2221615|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
650710|NCT03258320|Docetaxel|docetaxel|mesh-list
650711|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
650712|NCT03258320|Satraplatin|satraplatin|mesh-list
650713|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650714|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
650715|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
650716|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
650717|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650718|NCT03258320|Analgesics|analgesics|mesh-ancestor
650719|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
650720|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650721|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650722|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
650723|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
650724|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650730|NCT03257943|Ivermectin|ivermectin|mesh-list
650731|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
650732|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221616|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2221617|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221618|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2221619|NCT00041977|Doxycycline|doxycycline|mesh-list
649008|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649009|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
649010|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
649011|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649298|NCT03265405|Prednisolone|prednisolone|mesh-list
649299|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
649300|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
649301|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
649302|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
649303|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
649304|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
649305|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
649306|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
649307|NCT03265405|Hormones|hormones|mesh-ancestor
649308|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649309|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649310|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
649311|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649312|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
649313|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
649314|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649315|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
649316|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
649317|NCT03265405|Protective Agents|protective agents|mesh-ancestor
649381|NCT03264781|CycloProvera|cycloprovera|mesh-list
649382|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
649383|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
649384|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
649385|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
649386|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
649387|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649388|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
649389|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
649541|NCT03263624|Tazarotene|tazarotene|mesh-list
649542|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
649543|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
2083635|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083636|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
2083637|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083638|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2083639|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
650908|NCT03257163|Capecitabine|capecitabine|mesh-list
650909|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
650910|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
650911|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
650912|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650913|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650914|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
650954|NCT03256916|Nelfinavir|nelfinavir|mesh-list
650955|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
650956|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
650957|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
650958|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650959|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650960|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
650961|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
650962|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
650963|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651130|NCT03255915|Tenofovir|tenofovir|mesh-list
651131|NCT03255915|Emtricitabine|emtricitabine|mesh-list
651132|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
651133|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651134|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
651135|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
651136|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651137|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651138|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
651139|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
651668|NCT03252496|Ephedrine|ephedrine|mesh-list
651669|NCT03252496|Fentanyl|fentanyl|mesh-list
651670|NCT03252496|Bupivacaine|bupivacaine|mesh-list
651671|NCT03252496|Oxytocin|oxytocin|mesh-list
651672|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
651673|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
651674|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652435|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649092|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
649093|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
649094|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
649095|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
649096|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649097|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649098|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
649099|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649210|NCT03266445|Buprenorphine|buprenorphine|mesh-list
649211|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
649212|NCT03266445|Naloxone|naloxone|mesh-list
649213|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
649214|NCT03266445|Narcotics|narcotics|mesh-ancestor
649215|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649216|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649217|NCT03266445|Analgesics|analgesics|mesh-ancestor
649218|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
649219|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649220|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
649240|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
649241|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
649242|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649243|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
649285|NCT03265574|Enalapril|enalapril|mesh-list
649286|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
649287|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
649288|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649289|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649290|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
649511|NCT03263689|Morphine|morphine|mesh-list
649512|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
649513|NCT03263689|Narcotics|narcotics|mesh-ancestor
649514|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649515|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649516|NCT03263689|Analgesics|analgesics|mesh-ancestor
649517|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
649518|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649960|NCT03262103|Poly I-C|poly i-c|mesh-list
649961|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
649962|NCT03262103|Poly ICLC|poly iclc|mesh-list
649963|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
649964|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
649965|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649966|NCT03262103|Laxatives|laxatives|mesh-ancestor
649967|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
649968|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
649969|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649983|NCT03261635|Indomethacin|indomethacin|mesh-list
649984|NCT03261635|Ranibizumab|ranibizumab|mesh-list
649985|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
649986|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
649987|NCT03261635|Growth Substances|growth substances|mesh-ancestor
649988|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649989|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
649990|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649991|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
649992|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
649993|NCT03261635|Analgesics|analgesics|mesh-ancestor
649994|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
649995|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649996|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
649997|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
649998|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
649999|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
650000|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
650001|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
650002|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650003|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752009|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2752010|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
2752011|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2752012|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
2752013|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789038|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
2221620|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2221621|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649146|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
649147|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2752014|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752015|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
649911|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
649912|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
649913|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649914|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649915|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
649916|NCT03262090|Analgesics|analgesics|mesh-ancestor
649917|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
649918|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649919|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
649920|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
649921|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
649922|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
649923|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
649924|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221622|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
2221623|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2221624|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2221625|NCT00041990|Decitabine|decitabine|mesh-list
2221626|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221627|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
2221628|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221629|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221630|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650640|NCT03258372|Rifampin|rifampin|mesh-list
650641|NCT03258372|Mifepristone|mifepristone|mesh-list
650642|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
650643|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
650644|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
650645|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650646|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
650647|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
650648|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650649|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650650|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
650651|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
650652|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
650653|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
650654|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
650655|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
650656|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
650657|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
650658|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
650659|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650660|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
650661|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
650662|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
650663|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
650664|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
650665|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
650666|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
650667|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
650668|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
650669|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
650670|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
650767|NCT03257852|Methotrexate|methotrexate|mesh-list
650768|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
650769|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
650770|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
650771|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650772|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
650773|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
650774|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221631|NCT00042003|Decitabine|decitabine|mesh-list
2221632|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221633|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
2221634|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221635|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221636|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083640|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
2083641|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2083642|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2083643|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
2083644|NCT02117024|Antiviral Agents|antiviral agents|mesh-ancestor
2083645|NCT02117024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083646|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083647|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2083648|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2083649|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2083650|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2083651|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
2083652|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
2083653|NCT02117349|Coagulants|coagulants|mesh-ancestor
2083654|NCT02117479|Capecitabine|capecitabine|mesh-list
2083655|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2083656|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
649787|NCT03262792|Andrographolide|andrographolide|mesh-list
649788|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
649789|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
649790|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
649791|NCT03262792|Analgesics|analgesics|mesh-ancestor
649792|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
649793|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649794|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649795|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
649796|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
649797|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
649798|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649799|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
649800|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
650521|NCT03258931|Cytarabine|cytarabine|mesh-list
650522|NCT03258931|Midostaurin|midostaurin|mesh-list
650523|NCT03258931|Crenolanib|crenolanib|mesh-list
650524|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
650525|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
650526|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650527|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650528|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
650529|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650530|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
650531|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
650532|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650533|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
650534|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650749|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
650750|NCT03257722|Idelalisib|idelalisib|mesh-list
650751|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
650752|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650753|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650754|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650982|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
650983|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
651492|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
651493|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
651494|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
651495|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651496|NCT03253328|Expectorants|expectorants|mesh-ancestor
651497|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
651498|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
651499|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
651500|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651501|NCT03253328|Protective Agents|protective agents|mesh-ancestor
651502|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651503|NCT03253328|Antidotes|antidotes|mesh-ancestor
651846|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
651847|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
651848|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
651849|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651850|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
651851|NCT03251469|Coagulants|coagulants|mesh-ancestor
2221637|NCT00042016|Decitabine|decitabine|mesh-list
649269|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
649275|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
649276|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
649277|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
649278|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649279|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
649280|NCT03265470|Narcotics|narcotics|mesh-ancestor
649281|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
649282|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
649283|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
649284|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
649322|NCT03265288|Fenretinide|fenretinide|mesh-list
649323|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649324|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
649325|NCT03265288|Protective Agents|protective agents|mesh-ancestor
649326|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649458|NCT03264547|Paclitaxel|paclitaxel|mesh-list
649459|NCT03264547|Docetaxel|docetaxel|mesh-list
649460|NCT03264547|Trastuzumab|trastuzumab|mesh-list
649461|NCT03264547|Pertuzumab|pertuzumab|mesh-list
649462|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
649463|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649464|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
649465|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
649466|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
649467|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649468|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
649557|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
649558|NCT03263767|Fludarabine|fludarabine|mesh-list
649559|NCT03263767|Clofarabine|clofarabine|mesh-list
649560|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
649561|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
649562|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
649563|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649564|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
649565|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
649566|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
649567|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649568|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649569|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
649570|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
649571|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
650235|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
650236|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
650237|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
650238|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650239|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650240|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
650241|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
650242|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
650243|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
650244|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650245|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
650246|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
650247|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
650248|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
650249|NCT03260569|Protective Agents|protective agents|mesh-ancestor
2221638|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221639|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
650827|NCT03257800|Ketamine|ketamine|mesh-list
650828|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
650829|NCT03257800|Sevoflurane|sevoflurane|mesh-list
650830|NCT03257800|Analgesics|analgesics|mesh-ancestor
650831|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
650832|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650833|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650834|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
650835|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
650836|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
650837|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
650838|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650839|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
650840|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
650841|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
650842|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649329|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
649330|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
649331|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649332|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
649333|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221640|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221641|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221642|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649666|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
649667|NCT03263208|Fludarabine|fludarabine|mesh-list
649668|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
649669|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
649670|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649671|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
649672|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
649673|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
649674|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649675|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649676|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
650512|NCT03259165|Diuretics|diuretics|mesh-list
650513|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
650514|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
650515|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650516|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
650517|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221643|NCT00042029|Aprepitant|aprepitant|mesh-list
2221644|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
2221645|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
2221646|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221647|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221648|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2221649|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2083657|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083658|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083659|NCT02117570|Vaccines|vaccines|mesh-list
651991|NCT03250832|Bevacizumab|bevacizumab|mesh-list
651992|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
651993|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651994|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
651995|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
651996|NCT03250832|Growth Substances|growth substances|mesh-ancestor
651997|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651998|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
652638|NCT03248063|Cefazolin|cefazolin|mesh-list
652639|NCT03248063|Cloxacillin|cloxacillin|mesh-list
652640|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
652641|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
652855|NCT03246880|Tadalafil|tadalafil|mesh-list
652856|NCT03246880|Tamsulosin|tamsulosin|mesh-list
652857|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
652858|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
652859|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
652860|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652861|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652862|NCT03246880|Urological Agents|urological agents|mesh-ancestor
652863|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
652864|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
652865|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
652866|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
652867|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652868|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652941|NCT03246386|Posaconazole|posaconazole|mesh-list
649600|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
649601|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
649602|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
649603|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
649604|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2083660|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
2083661|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083662|NCT02117648|Clarithromycin|clarithromycin|mesh-list
2221650|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2221651|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221652|NCT00042068|Meloxicam|meloxicam|mesh-list
2221653|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2221654|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2221655|NCT00042068|Analgesics|analgesics|mesh-ancestor
2221656|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
2221657|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221658|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221659|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2221660|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2221661|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2221662|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2221663|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221664|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221665|NCT00042146|Zolpidem|zolpidem|mesh-list
2221666|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2221667|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2221668|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2221669|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221670|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2083663|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2083664|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083665|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
650484|NCT03259503|Gemcitabine|gemcitabine|mesh-list
650485|NCT03259503|Rituximab|rituximab|mesh-list
650486|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
650487|NCT03259503|Melphalan|melphalan|mesh-list
650488|NCT03259503|Busulfan|busulfan|mesh-list
650489|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
650490|NCT03259503|Olaparib|olaparib|mesh-list
650491|NCT03259503|Vorinostat|vorinostat|mesh-list
650492|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
650493|NCT03259503|Antibodies|antibodies|mesh-list
650494|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
650495|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
650496|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
650497|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650498|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650499|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
650500|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
650501|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
650502|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650503|NCT03259503|Antiviral Agents|antiviral agents|mesh-ancestor
650504|NCT03259503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650505|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650506|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
650507|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
650508|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
650509|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
650510|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
650511|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
650559|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
650560|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
650561|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
650562|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650563|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650564|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
650565|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650876|NCT03257319|Morphine|morphine|mesh-list
650877|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
650878|NCT03257319|Narcotics|narcotics|mesh-ancestor
650879|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650880|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650881|NCT03257319|Analgesics|analgesics|mesh-ancestor
650882|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
650883|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651042|NCT03256071|Decitabine|decitabine|mesh-list
649663|NCT03263520|Androgens|androgens|mesh-ancestor
649664|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
649665|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
650211|NCT03261115|Anesthetics|anesthetics|mesh-list
650212|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650213|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650427|NCT03259529|Gemcitabine|gemcitabine|mesh-list
650428|NCT03259529|Rituximab|rituximab|mesh-list
650429|NCT03259529|Nivolumab|nivolumab|mesh-list
650430|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
650431|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
650432|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650433|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
650434|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650435|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
650436|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
650437|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
650438|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650439|NCT03259529|Antiviral Agents|antiviral agents|mesh-ancestor
650440|NCT03259529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650441|NCT03259529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650442|NCT03259529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
650443|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
650444|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
650445|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
650679|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
650680|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
650681|NCT03258385|Vitamins|vitamins|mesh-ancestor
650682|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
650683|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650684|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
650685|NCT03258385|Hematinics|hematinics|mesh-ancestor
651555|NCT03253263|Mecasermin|mecasermin|mesh-list
651556|NCT03253263|Growth Substances|growth substances|mesh-ancestor
651557|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221671|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
2221672|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
2221673|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2221674|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221675|NCT00042172|Donepezil|donepezil|mesh-list
2221676|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2221677|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652376|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
652377|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
652378|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
652379|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
652380|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652381|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652382|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652383|NCT03249168|Analgesics|analgesics|mesh-ancestor
652384|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
652385|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652386|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
652387|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
652388|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
652569|NCT03248648|Ketamine|ketamine|mesh-list
652570|NCT03248648|Neostigmine|neostigmine|mesh-list
652571|NCT03248648|Analgesics|analgesics|mesh-ancestor
652572|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
652573|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652574|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652575|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
652576|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
652577|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
652578|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
652579|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652580|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
652581|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
652582|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652583|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652584|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
652585|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652586|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
652587|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
652588|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
649683|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
649684|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
649685|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
649686|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
649687|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
649688|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649689|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649690|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
649691|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
649692|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
649693|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
649694|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
649695|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
649696|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
649697|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649698|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
649699|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
649700|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
649701|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
649702|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
649703|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
649704|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
649808|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
649809|NCT03262740|Norethindrone|norethindrone|mesh-list
649810|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
649811|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
649812|NCT03262740|Estradiol|estradiol|mesh-list
649813|NCT03262740|Branebrutinib|branebrutinib|mesh-list
649814|NCT03262740|Estrogens|estrogens|mesh-ancestor
649815|NCT03262740|Hormones|hormones|mesh-ancestor
649816|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
649817|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649818|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
649819|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
649820|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
649821|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
649822|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
649823|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
649824|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
649825|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
649826|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
649827|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
649828|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649829|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083666|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083667|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083668|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2221678|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221679|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
2221680|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2221681|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221682|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
2221683|NCT00042289|Ritonavir|ritonavir|mesh-list
2221684|NCT00042289|Lopinavir|lopinavir|mesh-list
2083669|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2083670|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2221685|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
651008|NCT03256487|Morphine|morphine|mesh-list
651009|NCT03256487|Buprenorphine|buprenorphine|mesh-list
651010|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
651011|NCT03256487|Narcotics|narcotics|mesh-ancestor
651012|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
651013|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651014|NCT03256487|Analgesics|analgesics|mesh-ancestor
651015|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
651016|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651017|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
651193|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
651194|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651309|NCT03254654|Apatinib|apatinib|mesh-list
651310|NCT03254654|Vinorelbine|vinorelbine|mesh-list
651311|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651312|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
651313|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651326|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
649725|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
649726|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
649727|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649728|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
649729|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649730|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650250|NCT03260556|Pirfenidone|pirfenidone|mesh-list
650251|NCT03260556|Analgesics|analgesics|mesh-ancestor
650252|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
650253|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650254|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650255|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
650256|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
650257|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
650258|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
650259|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650310|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
650311|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
650312|NCT03260088|Antibodies|antibodies|mesh-list
650313|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
650314|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
650315|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083671|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
2083672|NCT02117687|Glycerol|glycerol|mesh-list
2083673|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2083674|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
2083675|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083676|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
2083677|NCT02117687|Protective Agents|protective agents|mesh-ancestor
2083678|NCT02117687|Laxatives|laxatives|mesh-ancestor
2083679|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2083680|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2083681|NCT02117934|Vaccines|vaccines|mesh-list
650479|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
650480|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
650481|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
650482|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
650483|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083682|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
2083683|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651465|NCT03253679|Adavosertib|adavosertib|mesh-list
651466|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651467|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752021|NCT03742518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
651750|NCT03252522|Micronutrients|micronutrients|mesh-list
651751|NCT03252522|Trace Elements|trace elements|mesh-list
651752|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651757|NCT03251690|Tenofovir|tenofovir|mesh-list
651758|NCT03251690|Emtricitabine|emtricitabine|mesh-list
651759|NCT03251690|Efavirenz|efavirenz|mesh-list
651760|NCT03251690|Rilpivirine|rilpivirine|mesh-list
651761|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
651762|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651763|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
651764|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
651765|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651766|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651767|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
651768|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
651769|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
651770|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
651771|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
651772|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
651773|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
651774|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
651945|NCT03251170|Fentanyl|fentanyl|mesh-list
651946|NCT03251170|Midazolam|midazolam|mesh-list
651947|NCT03251170|Ketamine|ketamine|mesh-list
651948|NCT03251170|Analgesics|analgesics|mesh-ancestor
2083684|NCT02118012|Ribavirin|ribavirin|mesh-list
2083685|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
2083686|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083687|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
2083688|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083689|NCT02118337|Nivolumab|nivolumab|mesh-list
2083690|NCT02118337|Durvalumab|durvalumab|mesh-list
2083691|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2083692|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083693|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2083694|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083695|NCT02118597|Interferons|interferons|mesh-list
2083696|NCT02118597|Ribavirin|ribavirin|mesh-list
2083697|NCT02118597|Simeprevir|simeprevir|mesh-list
2083698|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083699|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
650316|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
650317|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650915|NCT03257215|Vitamin D|vitamin d|mesh-list
650916|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
650917|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
650918|NCT03257215|Vitamins|vitamins|mesh-list
650919|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
650920|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650921|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
650922|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2083700|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083701|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
2083702|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083703|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
2083704|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651870|NCT03251300|Mirabegron|mirabegron|mesh-list
651871|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
651872|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
651873|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
651874|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
651875|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
651876|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651877|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651878|NCT03251300|Urological Agents|urological agents|mesh-ancestor
653170|NCT03245671|Dexamethasone|dexamethasone|mesh-list
653171|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
653172|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
653173|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
653174|NCT03245671|BB 1101|bb 1101|mesh-list
653175|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
653176|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
653177|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
653178|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653179|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653180|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
653181|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
653182|NCT03245671|Hormones|hormones|mesh-ancestor
653183|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
653184|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
653185|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653186|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
653187|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653188|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653189|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
653190|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
653418|NCT03244241|Insulin|insulin|mesh-list
653419|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
653420|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649893|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
649894|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
649895|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
650359|NCT03259542|Itraconazole|itraconazole|mesh-list
650360|NCT03259542|Mifepristone|mifepristone|mesh-list
650361|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
650362|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650363|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
650364|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
650365|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650366|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650367|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
650368|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
650369|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
650370|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650371|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
650372|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
650373|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
650374|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
650375|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
650376|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
650377|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
650378|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
650379|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
650380|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
650381|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
650382|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
650383|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2221686|NCT00042289|Darunavir|darunavir|mesh-list
2221687|NCT00042289|Tenofovir|tenofovir|mesh-list
2221688|NCT00042289|Nevirapine|nevirapine|mesh-list
2221689|NCT00042289|Dolutegravir|dolutegravir|mesh-list
2221690|NCT00042289|Cobicistat|cobicistat|mesh-list
2221691|NCT00042289|Elvitegravir|elvitegravir|mesh-list
2221692|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
2221693|NCT00042289|Efavirenz|efavirenz|mesh-list
2221694|NCT00042289|Levofloxacin|levofloxacin|mesh-list
2221695|NCT00042289|Ofloxacin|ofloxacin|mesh-list
2221696|NCT00042289|Rifampin|rifampin|mesh-list
2221697|NCT00042289|Isoniazid|isoniazid|mesh-list
2221698|NCT00042289|Cycloserine|cycloserine|mesh-list
2221699|NCT00042289|Linezolid|linezolid|mesh-list
2221700|NCT00042289|Amikacin|amikacin|mesh-list
2221701|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
2221702|NCT00042289|Ethambutol|ethambutol|mesh-list
2221703|NCT00042289|Etravirine|etravirine|mesh-list
2221704|NCT00042289|Bedaquiline|bedaquiline|mesh-list
2221705|NCT00042289|Clofazimine|clofazimine|mesh-list
2221706|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
2221707|NCT00042289|Kanamycin|kanamycin|mesh-list
2221708|NCT00042289|Ethionamide|ethionamide|mesh-list
2221709|NCT00042289|Capreomycin|capreomycin|mesh-list
2221710|NCT00042289|Prothionamide|prothionamide|mesh-list
2221711|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2221712|NCT00042289|Etonogestrel|etonogestrel|mesh-list
2221713|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-list
2221714|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-list
2221715|NCT00042289|Estradiol|estradiol|mesh-list
2221716|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2221717|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2221718|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
2221719|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649902|NCT03262363|Analgesics|analgesics|mesh-ancestor
649903|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
649904|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
649905|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
649906|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
649907|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
649908|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
649909|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
649910|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221720|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221721|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2221722|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2221723|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
2221724|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221725|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2221726|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2221727|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2221728|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2221729|NCT00042289|Estrogens|estrogens|mesh-ancestor
2221730|NCT00042289|Hormones|hormones|mesh-ancestor
2221731|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
650698|NCT03258476|Guanfacine|guanfacine|mesh-list
650699|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
650700|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
650701|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
650702|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
650703|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
650704|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
650705|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650706|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221732|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221733|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2221734|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
651186|NCT03255226|Tolvaptan|tolvaptan|mesh-list
651187|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
651188|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651189|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
651190|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651249|NCT03255148|Oxytocin|oxytocin|mesh-list
651250|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
651251|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
651252|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651344|NCT03254784|BMS-986165|bms-986165|mesh-list
651345|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
651346|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
651347|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651348|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651548|NCT03253198|Bupivacaine|bupivacaine|mesh-list
651549|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
651550|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
651551|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
651552|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651553|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
651554|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651605|NCT03252808|Gemcitabine|gemcitabine|mesh-list
651606|NCT03252808|Paclitaxel|paclitaxel|mesh-list
651607|NCT03252808|Tegafur|tegafur|mesh-list
651608|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
651609|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651610|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
651611|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
651612|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
651613|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651614|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
651615|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
651616|NCT03252808|Antiviral Agents|antiviral agents|mesh-ancestor
651617|NCT03252808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651618|NCT03252808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651619|NCT03252808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
651620|NCT03252808|Immunologic Factors|immunologic factors|mesh-ancestor
652453|NCT03248726|Bisacodyl|bisacodyl|mesh-list
650032|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
650033|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
650034|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
650035|NCT03261921|Analgesics|analgesics|mesh-ancestor
650036|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
650037|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
650038|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
650039|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
650040|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
650041|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650128|NCT03261310|Acetaminophen|acetaminophen|mesh-list
650129|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
650130|NCT03261310|Analgesics|analgesics|mesh-ancestor
650131|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
650132|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650133|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650134|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
650149|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
650150|NCT03260829|Vitamins|vitamins|mesh-ancestor
650151|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
650152|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650153|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
650154|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650155|NCT03260829|Protective Agents|protective agents|mesh-ancestor
650295|NCT03260010|Fosfomycin|fosfomycin|mesh-list
650296|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
650297|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650542|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
650543|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
650544|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
650545|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
650546|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650547|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650548|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
650549|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
650550|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
650551|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
650552|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
650553|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
650554|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
650555|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650556|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
650557|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
650558|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
650970|NCT03256721|Docetaxel|docetaxel|mesh-list
650971|NCT03256721|Pemetrexed|pemetrexed|mesh-list
650972|NCT03256721|Apatinib|apatinib|mesh-list
650973|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650974|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
650975|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
650976|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
650977|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650978|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650979|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
650980|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
650981|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
651195|NCT03255330|Dipyrone|dipyrone|mesh-list
651196|NCT03255330|Gabapentin|gabapentin|mesh-list
651197|NCT03255330|Tramadol|tramadol|mesh-list
651198|NCT03255330|Analgesics|analgesics|mesh-ancestor
651199|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
651200|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651201|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651202|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
651203|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
651204|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
651205|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
651206|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
651207|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
651208|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
651209|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
651210|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651211|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
651212|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
651213|NCT03255330|Narcotics|narcotics|mesh-ancestor
651214|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
650042|NCT03261596|Mebendazole|mebendazole|mesh-list
650043|NCT03261596|Piperazine|piperazine|mesh-list
650044|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
650045|NCT03261596|DMP 777|dmp 777|mesh-list
650046|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
650047|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
650048|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
650049|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650050|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
650051|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
650052|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
650053|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650054|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650055|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650737|NCT03257670|Lidocaine|lidocaine|mesh-list
650738|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
650739|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
650740|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650741|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650742|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
650743|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650744|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
650745|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
650746|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
650747|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
650748|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221735|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2221736|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2221737|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2221738|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2221739|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221740|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2221741|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2221742|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2221743|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2221744|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
651284|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
651285|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
651286|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651661|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
651662|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
651663|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651664|NCT03252418|Protective Agents|protective agents|mesh-ancestor
651665|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651666|NCT03252418|Vitamins|vitamins|mesh-ancestor
651667|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
652097|NCT03250117|Ropinirole|ropinirole|mesh-list
652098|NCT03250117|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
652099|NCT03250117|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
652100|NCT03250117|Dopamine Agonists|dopamine agonists|mesh-ancestor
652101|NCT03250117|Dopamine Agents|dopamine agents|mesh-ancestor
652102|NCT03250117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652103|NCT03250117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652104|NCT03250117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653299|NCT03245346|Anesthetics|anesthetics|mesh-list
653300|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
653301|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653539|NCT03243552|Levodopa|levodopa|mesh-list
653540|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
653541|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
653542|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
653543|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653544|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653545|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653602|NCT03243175|Apixaban|apixaban|mesh-list
653603|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
653604|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
653605|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
650096|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221745|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2221746|NCT00042289|Renal Agents|renal agents|mesh-ancestor
2221747|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2221748|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2221749|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
651786|NCT03251729|Progesterone|progesterone|mesh-list
651787|NCT03251729|Progestins|progestins|mesh-ancestor
651788|NCT03251729|Hormones|hormones|mesh-ancestor
651789|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
651790|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221750|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
2221751|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
2221752|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2221753|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2221754|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2221755|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2221756|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2221757|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
2221758|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2221759|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2221760|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2221761|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2221762|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2221763|NCT00042302|Paclitaxel|paclitaxel|mesh-list
2221764|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2221765|NCT00042302|Carboplatin|carboplatin|mesh-list
2221766|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2221767|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221768|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
652062|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
652063|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
652064|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
652065|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652066|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
652067|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
652068|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
652069|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652070|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652071|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
652251|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
652252|NCT03249506|Empagliflozin|empagliflozin|mesh-list
652253|NCT03249506|Canagliflozin|canagliflozin|mesh-list
652254|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
652255|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
652256|NCT03249506|Glucagon|glucagon|mesh-list
652257|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
652258|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
652259|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652260|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
652261|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652262|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
652263|NCT03249506|Hormones|hormones|mesh-ancestor
652264|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
652265|NCT03249506|Incretins|incretins|mesh-ancestor
652266|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
652267|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221769|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
2221770|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
2221771|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221772|NCT00042315|Vinorelbine|vinorelbine|mesh-list
2221773|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2221774|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221775|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
2221776|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
2221777|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
2221778|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221779|NCT00042328|Valacyclovir|valacyclovir|mesh-list
2221780|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
2221781|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221782|NCT00042341|Clofarabine|clofarabine|mesh-list
653872|NCT03241914|Megestrol|megestrol|mesh-list
653873|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
653874|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
650103|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650162|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
650163|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
650164|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
650165|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650166|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650167|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
650168|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650199|NCT03260634|Voriconazole|voriconazole|mesh-list
650200|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
650201|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650202|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
650203|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
650204|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650205|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650206|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
650207|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
650208|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
650209|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650210|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
650725|NCT03257930|Ethanol|ethanol|mesh-list
650726|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
650727|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
650728|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650729|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651468|NCT03253887|Ethanol|ethanol|mesh-list
651469|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
651470|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651471|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
651472|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221783|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221784|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
2221785|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221786|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221787|NCT00042354|Clofarabine|clofarabine|mesh-list
2221788|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221789|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
2221790|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221791|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221792|NCT00042367|Mafosfamide|mafosfamide|mesh-list
2221793|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
2221794|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2221795|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
2221796|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651781|NCT03251872|Olaparib|olaparib|mesh-list
651782|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
651783|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651784|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651785|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652389|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
652390|NCT03249012|Calcitriol|calcitriol|mesh-list
652391|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
652392|NCT03249012|Calcium|calcium|mesh-list
652393|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
652394|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652395|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
652396|NCT03249012|Antacids|antacids|mesh-ancestor
652397|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652398|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
652399|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
652400|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
652401|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
652402|NCT03249012|Vitamins|vitamins|mesh-ancestor
652403|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
653038|NCT03246451|Metformin|metformin|mesh-list
653039|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
653040|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653058|NCT03245853|Riboflavin|riboflavin|mesh-list
653059|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
2221797|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221798|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221799|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2221800|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2221801|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
2221802|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221803|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2221804|NCT00042393|Adefovir|adefovir|mesh-list
2221805|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2221806|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
2221807|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221808|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2221809|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2221810|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221811|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221812|NCT00042406|Zanolimumab|zanolimumab|mesh-list
2221813|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2221814|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221815|NCT00042458|Pramlintide|pramlintide|mesh-list
2221816|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2221817|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221818|NCT00042471|Pramlintide|pramlintide|mesh-list
2083725|NCT02118714|Atrasentan|atrasentan|mesh-list
650329|NCT03259919|Metformin|metformin|mesh-list
650330|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
650331|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083726|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083727|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2083728|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2083729|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083730|NCT02118831|Bevacizumab|bevacizumab|mesh-list
2083731|NCT02118831|Ranibizumab|ranibizumab|mesh-list
2083732|NCT02118831|Aflibercept|aflibercept|mesh-list
2083733|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2083734|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221819|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
651362|NCT03254485|Praliciguat|praliciguat|mesh-list
651363|NCT03254485|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
651364|NCT03254485|Enzyme Activators|enzyme activators|mesh-ancestor
651365|NCT03254485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651366|NCT03254485|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
651699|NCT03252600|Dexamethasone|dexamethasone|mesh-list
651700|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
651701|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
651702|NCT03252600|Lenalidomide|lenalidomide|mesh-list
651703|NCT03252600|Elotuzumab|elotuzumab|mesh-list
651704|NCT03252600|Ichthammol|ichthammol|mesh-list
651705|NCT03252600|BB 1101|bb 1101|mesh-list
651706|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
651707|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
651708|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651709|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
651710|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
651711|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
651712|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651713|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651714|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
651715|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
651716|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
651717|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
651718|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651719|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
651720|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
651721|NCT03252600|Hormones|hormones|mesh-ancestor
651722|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
651723|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
651724|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
651725|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
651726|NCT03252600|Growth Substances|growth substances|mesh-ancestor
651727|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
651728|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
651729|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651730|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
651791|NCT03251859|Ticagrelor|ticagrelor|mesh-list
651792|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2221820|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2221821|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221822|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
2221823|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2221824|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
2221825|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650280|NCT03260283|Fentanyl|fentanyl|mesh-list
650281|NCT03260283|Meperidine|meperidine|mesh-list
650282|NCT03260283|Ropivacaine|ropivacaine|mesh-list
650283|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
650284|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
650285|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650286|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650287|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
650288|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
650289|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
650290|NCT03260283|Narcotics|narcotics|mesh-ancestor
650291|NCT03260283|Analgesics|analgesics|mesh-ancestor
650292|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
650293|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
650294|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
650332|NCT03259867|Pembrolizumab|pembrolizumab|mesh-list
650333|NCT03259867|Tirapazamine|tirapazamine|mesh-list
650334|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
650335|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752047|NCT03731923|Liver Extracts|liver extracts|mesh-list
2752048|NCT03731923|Hematinics|hematinics|mesh-ancestor
2752049|NCT03727633|Idarubicin|idarubicin|mesh-list
2221826|NCT00042536|Naltrexone|naltrexone|mesh-list
2221827|NCT00042536|Yohimbine|yohimbine|mesh-list
2221828|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2221829|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2221830|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221831|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
2221832|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083735|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2083736|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2083737|NCT02118831|Growth Substances|growth substances|mesh-ancestor
2083738|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083739|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
2083740|NCT02118896|Tacrolimus|tacrolimus|mesh-list
2083741|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083742|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
2083743|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083744|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2083745|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083746|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083747|NCT02118961|Vaccines|vaccines|mesh-list
2083748|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
2083749|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651839|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
651840|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
651841|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
651842|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651843|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
651844|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
651845|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652045|NCT03250741|Rotigotine|rotigotine|mesh-list
652046|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
652047|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
652048|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652049|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652050|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652285|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
652286|NCT03249311|Milnacipran|milnacipran|mesh-list
652287|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
652288|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
652289|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
652290|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
652291|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652292|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652293|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652294|NCT03249311|Analgesics|analgesics|mesh-ancestor
652295|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
2083750|NCT02119026|Bevacizumab|bevacizumab|mesh-list
2221833|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
650583|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
650584|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
650585|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
650933|NCT03257124|Osimertinib|osimertinib|mesh-list
650934|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650935|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
650936|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650937|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651624|NCT03252938|Avelumab|avelumab|mesh-list
651625|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
651626|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651753|NCT03251911|Ivacaftor|ivacaftor|mesh-list
651754|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
651755|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
651756|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652145|NCT03250039|Abrocitinib|abrocitinib|mesh-list
652146|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
652147|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652148|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652506|NCT03248791|Phenylephrine|phenylephrine|mesh-list
652507|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
652508|NCT03248791|Norepinephrine|norepinephrine|mesh-list
652509|NCT03248791|Bupivacaine|bupivacaine|mesh-list
652510|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
652511|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
652512|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652513|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652514|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
652515|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652516|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
652517|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
652518|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
652519|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
652520|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
652521|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
652522|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
652523|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
652524|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
652525|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
652526|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
652527|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652528|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652529|NCT03248791|Protective Agents|protective agents|mesh-ancestor
652670|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
652671|NCT03247920|Amoxicillin|amoxicillin|mesh-list
652672|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
652673|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
652674|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
652675|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
652676|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
652677|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652678|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221834|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
2221835|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2221836|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2221837|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2221838|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
2221839|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2221840|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221841|NCT00042536|Urological Agents|urological agents|mesh-ancestor
2221842|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2221843|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2221844|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2221845|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2221846|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2221847|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2221848|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2221849|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221850|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653293|NCT03245333|Hormones|hormones|mesh-list
653294|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
653295|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653480|NCT03243864|Ceftazidime|ceftazidime|mesh-list
2221851|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221852|NCT00042562|Analgesics|analgesics|mesh-ancestor
2221853|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
2221854|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221855|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
2221856|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
651571|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
651572|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
651573|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
651574|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651575|NCT03252925|Expectorants|expectorants|mesh-ancestor
651576|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
651577|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
651578|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
651579|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651580|NCT03252925|Protective Agents|protective agents|mesh-ancestor
651581|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651582|NCT03252925|Antidotes|antidotes|mesh-ancestor
651731|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
651732|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
651733|NCT03252366|Coagulants|coagulants|mesh-ancestor
652023|NCT03250507|Bupivacaine|bupivacaine|mesh-list
652024|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
652025|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
652026|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652027|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652028|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
652029|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221857|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
2221858|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2221859|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2221860|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2221861|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2221862|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221863|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2221864|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221865|NCT00042575|Analgesics|analgesics|mesh-ancestor
2221866|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
2221867|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221868|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
2221869|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2221870|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
2221871|NCT00042588|Antibodies|antibodies|mesh-list
2221872|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2221873|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
2221874|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221875|NCT00042601|Pramlintide|pramlintide|mesh-list
2221876|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2221877|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221878|NCT00042653|Cinacalcet|cinacalcet|mesh-list
2221879|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
652239|NCT03249714|Ofatumumab|ofatumumab|mesh-list
652240|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
652241|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652242|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
652243|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653035|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
653036|NCT03246360|Cloxacillin|cloxacillin|mesh-list
653037|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
653287|NCT03245450|Irinotecan|irinotecan|mesh-list
653288|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
653289|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
653290|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653291|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653292|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654495|NCT03238560|Montelukast|montelukast|mesh-list
654496|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
654497|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
654498|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
654499|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
654500|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654501|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654502|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
654503|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
654504|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650697|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2221880|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221881|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2221882|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
651568|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
651569|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
651570|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221883|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2221884|NCT00042679|Gemcitabine|gemcitabine|mesh-list
2221885|NCT00042679|Carboplatin|carboplatin|mesh-list
2221886|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221887|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221888|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
652095|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
652096|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
652183|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
652184|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
652185|NCT03249831|Pentostatin|pentostatin|mesh-list
652186|NCT03249831|Tacrolimus|tacrolimus|mesh-list
652187|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
652188|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
652189|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
652190|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
652191|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652192|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
652193|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
652194|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
652195|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652196|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652197|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
652198|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
652199|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652200|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
652201|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
652202|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
652203|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
652204|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
652205|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
652301|NCT03249428|Nicotine|nicotine|mesh-list
652302|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
652303|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
652304|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652305|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652306|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
652307|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
652308|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
652309|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652310|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653202|NCT03245489|Aspirin|aspirin|mesh-list
653203|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
653204|NCT03245489|Clopidogrel|clopidogrel|mesh-list
653205|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
653206|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653207|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
653208|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
653209|NCT03245489|Analgesics|analgesics|mesh-ancestor
653210|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
653211|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653212|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653213|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
653214|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
653215|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
653216|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
653217|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653218|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
653219|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
653220|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653221|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
653222|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
653223|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
653224|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
653225|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
653226|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653254|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
653255|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
650775|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650776|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
650777|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
650778|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
650779|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
650780|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
650781|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
650782|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
651104|NCT03256045|Dexamethasone|dexamethasone|mesh-list
651105|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
651106|NCT03256045|Panobinostat|panobinostat|mesh-list
651107|NCT03256045|Ichthammol|ichthammol|mesh-list
651108|NCT03256045|BB 1101|bb 1101|mesh-list
651109|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
651110|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
651111|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
651112|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651113|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651114|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
651115|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
651116|NCT03256045|Hormones|hormones|mesh-ancestor
651117|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
651118|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
651119|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651120|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
651121|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651122|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651123|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
651124|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
651300|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
651301|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
651302|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652268|NCT03249558|Morphine|morphine|mesh-list
652269|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
652270|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
652271|NCT03249558|Narcotics|narcotics|mesh-ancestor
652272|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652273|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652274|NCT03249558|Analgesics|analgesics|mesh-ancestor
652275|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
652276|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652277|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
652278|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
652279|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
652280|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652281|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652282|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
652283|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
652284|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
652446|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
652447|NCT03248765|Narcotics|narcotics|mesh-ancestor
652448|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652449|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652450|NCT03248765|Analgesics|analgesics|mesh-ancestor
652451|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
652452|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083751|NCT02119026|Capecitabine|capecitabine|mesh-list
2083752|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
2083753|NCT02119026|Irinotecan|irinotecan|mesh-list
2083754|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2083755|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083756|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2083757|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2083758|NCT02119026|Growth Substances|growth substances|mesh-ancestor
2083759|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083760|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
2083761|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2083762|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
2083763|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083764|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2083765|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2083766|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653060|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
2221889|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221890|NCT00042679|Antiviral Agents|antiviral agents|mesh-ancestor
2221891|NCT00042679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221892|NCT00042679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221893|NCT00042679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221894|NCT00042679|Immunologic Factors|immunologic factors|mesh-ancestor
2221895|NCT00042679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221896|NCT00042718|Amoxicillin|amoxicillin|mesh-list
2221897|NCT00042718|Azithromycin|azithromycin|mesh-list
2221898|NCT00042718|Levofloxacin|levofloxacin|mesh-list
651179|NCT03255629|Glucagon|glucagon|mesh-list
651180|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
651181|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
651182|NCT03255629|Hormones|hormones|mesh-ancestor
651183|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
651184|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651185|NCT03255629|Incretins|incretins|mesh-ancestor
651241|NCT03255278|Vaccines|vaccines|mesh-list
651242|NCT03255278|Immunologic Factors|immunologic factors|mesh-ancestor
651243|NCT03255278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651253|NCT03254849|Empagliflozin|empagliflozin|mesh-list
651254|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
651255|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
651256|NCT03254849|Diuretics|diuretics|mesh-ancestor
651257|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
651258|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651259|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
651260|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
651261|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651262|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
651263|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
651909|NCT03250923|Acemannan|acemannan|mesh-list
651910|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
651911|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
651912|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651913|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651914|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
651915|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651916|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
652356|NCT03249181|Dolutegravir|dolutegravir|mesh-list
652357|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
652358|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
652359|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652360|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652361|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
652362|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
652363|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
652364|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
652745|NCT03247283|Linrodostat|linrodostat|mesh-list
652746|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652747|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652829|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
652830|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
652831|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652869|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
652870|NCT03246555|Perindopril|perindopril|mesh-list
652871|NCT03246555|Indapamide|indapamide|mesh-list
652872|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
652873|NCT03246555|Diuretics|diuretics|mesh-ancestor
652874|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
652875|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652876|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
652877|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
652878|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652879|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
652880|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
652881|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083767|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2083768|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
2083769|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083770|NCT02119156|Belimumab|belimumab|mesh-list
2083771|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083772|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
653066|NCT03245827|Clomiphene|clomiphene|mesh-list
653067|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2221899|NCT00042718|Ofloxacin|ofloxacin|mesh-list
2221900|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
2221901|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
2221902|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2221903|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2221904|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2221905|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2221906|NCT00042718|Renal Agents|renal agents|mesh-ancestor
2221907|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2221908|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2221909|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651264|NCT03254927|Cetuximab|cetuximab|mesh-list
651265|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
651266|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651418|NCT03254368|ZGN-1061|zgn-1061|mesh-list
651419|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651420|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651421|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
651600|NCT03252587|BMS-986165|bms-986165|mesh-list
651601|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
651602|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
651603|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651604|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652338|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
652339|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
652340|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
652341|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
652738|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
652739|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
652740|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652741|NCT03247452|Protective Agents|protective agents|mesh-ancestor
652742|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652743|NCT03247452|Vitamins|vitamins|mesh-ancestor
652744|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
653158|NCT03245892|Paclitaxel|paclitaxel|mesh-list
653159|NCT03245892|Carboplatin|carboplatin|mesh-list
653160|NCT03245892|Nivolumab|nivolumab|mesh-list
653161|NCT03245892|Ipilimumab|ipilimumab|mesh-list
653162|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
653163|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653164|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
653165|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
653166|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
653167|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653168|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
653169|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
653296|NCT03245281|Diuretics|diuretics|mesh-list
653297|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
653298|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653374|NCT03244488|Mecamylamine|mecamylamine|mesh-list
653375|NCT03244488|Scopolamine|scopolamine|mesh-list
653376|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
653377|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
653378|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
653379|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
653380|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653381|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653382|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
653383|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
653384|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
653385|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
653386|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653387|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653388|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
653389|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
653390|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
653391|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
653392|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
653813|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
653814|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2752050|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
2752051|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2752052|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752053|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2752054|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2752055|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752056|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
650843|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
650844|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
650845|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2221910|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221911|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221912|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2221913|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2221914|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2221915|NCT00042731|Lycopene|lycopene|mesh-list
2221916|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2221917|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
2221918|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221919|NCT00042731|Protective Agents|protective agents|mesh-ancestor
2221920|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221921|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2221922|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2221923|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651270|NCT03255044|Atorvastatin|atorvastatin|mesh-list
651271|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
651272|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
651273|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
651274|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
651275|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651276|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
651277|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
651278|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651388|NCT03254173|Mirtazapine|mirtazapine|mesh-list
651389|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
651390|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
651391|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
651392|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
651393|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
651394|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
651395|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651396|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651397|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
651398|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
651399|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
651400|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
651401|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
651402|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
651403|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
651404|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
651405|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
651406|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
651407|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
652006|NCT03250494|Dexamethasone|dexamethasone|mesh-list
652007|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
652008|NCT03250494|BB 1101|bb 1101|mesh-list
652009|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
652010|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
652011|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
652012|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652013|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652014|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
652015|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
652016|NCT03250494|Hormones|hormones|mesh-ancestor
652017|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
652018|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
652019|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652020|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
652021|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652022|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652169|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
652170|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
652171|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652172|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
652330|NCT03249259|Choline|choline|mesh-list
652331|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
652332|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
652333|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
652334|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652335|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
650857|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
650858|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
650859|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
650860|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
650861|NCT03257423|Renal Agents|renal agents|mesh-ancestor
650862|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
650863|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
651048|NCT03256292|Testosterone|testosterone|mesh-list
651049|NCT03256292|Androgens|androgens|mesh-ancestor
651050|NCT03256292|Hormones|hormones|mesh-ancestor
651051|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
651052|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651125|NCT03255811|Apatinib|apatinib|mesh-list
651126|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651127|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
651128|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651129|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651437|NCT03253913|Sirolimus|sirolimus|mesh-list
651438|NCT03253913|Resveratrol|resveratrol|mesh-list
651439|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
651440|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651441|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
651442|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651443|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
651444|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
651445|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
651446|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651447|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
651448|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651449|NCT03253913|Protective Agents|protective agents|mesh-ancestor
651450|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651451|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
651480|NCT03253289|Meclizine|meclizine|mesh-list
651481|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
651482|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
651483|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651484|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651485|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
651486|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
651487|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
651488|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
651489|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
651490|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651491|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
651693|NCT03252561|Anesthetics|anesthetics|mesh-list
651694|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
651695|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
651696|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651697|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
651698|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651737|NCT03252067|Azithromycin|azithromycin|mesh-list
651738|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
651739|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
651740|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651741|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
651863|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
651864|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
651906|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
651907|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
651908|NCT03251040|Coagulants|coagulants|mesh-ancestor
652424|NCT03248856|Triamcinolone|triamcinolone|mesh-list
652425|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
652426|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
652427|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
652428|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
652429|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
652430|NCT03248856|Hormones|hormones|mesh-ancestor
652431|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
652432|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652433|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
652434|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
650968|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
650969|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651303|NCT03254511|Enoxaparin|enoxaparin|mesh-list
651304|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
651305|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
651306|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
651307|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
651308|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651639|NCT03252457|Dexamethasone|dexamethasone|mesh-list
651640|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
651641|NCT03252457|Decitabine|decitabine|mesh-list
651642|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
651643|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
651644|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
651645|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651646|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651647|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
651648|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
651649|NCT03252457|Hormones|hormones|mesh-ancestor
651650|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
651651|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
651652|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651653|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
651654|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
651655|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651656|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652209|NCT03249740|Sunitinib|sunitinib|mesh-list
652210|NCT03249740|Aflibercept|aflibercept|mesh-list
652211|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652212|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
652213|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
652214|NCT03249740|Growth Substances|growth substances|mesh-ancestor
652215|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652216|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
652217|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
652218|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652219|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652311|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
652312|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
652503|NCT03248973|Ampicillin|ampicillin|mesh-list
652504|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
652505|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
652626|NCT03248297|Amoxicillin|amoxicillin|mesh-list
652627|NCT03248297|Azithromycin|azithromycin|mesh-list
652628|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
652629|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
653425|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
653426|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
653427|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
653428|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
653429|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
653430|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653431|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653432|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653598|NCT03243331|Gedatolisib|gedatolisib|mesh-list
653599|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
653600|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653601|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221924|NCT00042796|Decitabine|decitabine|mesh-list
2221925|NCT00042796|Azacitidine|azacitidine|mesh-list
2221926|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221927|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
2221928|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221929|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221930|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221931|NCT00042809|Paclitaxel|paclitaxel|mesh-list
2221932|NCT00042809|Trastuzumab|trastuzumab|mesh-list
2221933|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2221934|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2221935|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221936|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
2221937|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
2221938|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
2221939|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221940|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2221941|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2221942|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651030|NCT03256149|Dexamethasone|dexamethasone|mesh-list
651031|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
651032|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
651033|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
651034|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651035|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651036|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
651037|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
651038|NCT03256149|Hormones|hormones|mesh-ancestor
651039|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
651040|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
651041|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651297|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
651298|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
651299|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651376|NCT03254394|Lidocaine|lidocaine|mesh-list
651377|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
651378|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
651379|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
651380|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651381|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
651382|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651383|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
651384|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
651385|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
651386|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
651387|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651627|NCT03252665|Nicorandil|nicorandil|mesh-list
651628|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
651629|NCT03252665|Alprostadil|alprostadil|mesh-list
651630|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
651631|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
651632|NCT03252665|Urological Agents|urological agents|mesh-ancestor
651633|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
651634|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
651635|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
651636|NCT03252665|Vitamins|vitamins|mesh-ancestor
651637|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
651638|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651804|NCT03251924|Nivolumab|nivolumab|mesh-list
651805|NCT03251924|Ipilimumab|ipilimumab|mesh-list
651806|NCT03251924|Antibodies|antibodies|mesh-list
651807|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
651808|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
651809|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
651810|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651811|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
651812|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651813|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
651814|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651917|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
651918|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
651919|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
651920|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651921|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
651922|NCT03251222|Analgesics|analgesics|mesh-ancestor
651923|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
651924|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651925|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
651926|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
651927|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
651928|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
651929|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
651930|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221943|NCT00042822|Romidepsin|romidepsin|mesh-list
2221944|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2221945|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652444|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
652445|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
652543|NCT03248401|Aspirin|aspirin|mesh-list
652544|NCT03248401|Cilostazol|cilostazol|mesh-list
652545|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
652546|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2221946|NCT00042835|Paclitaxel|paclitaxel|mesh-list
651043|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
651044|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
651045|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651046|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651047|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221947|NCT00042835|Etoposide|etoposide|mesh-list
2221948|NCT00042835|Docetaxel|docetaxel|mesh-list
2221949|NCT00042835|Carboplatin|carboplatin|mesh-list
2221950|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2221951|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
2221952|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2221953|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221954|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
2221955|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
2221956|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
2221957|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221958|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2221959|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2221960|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221961|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2221962|NCT00042848|Modafinil|modafinil|mesh-list
2221963|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2221964|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221965|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2221966|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2221967|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2221968|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221969|NCT00042861|Leucovorin|leucovorin|mesh-list
2221970|NCT00042861|Fluorouracil|fluorouracil|mesh-list
2221971|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2221972|NCT00042861|Calcium|calcium|mesh-list
2221973|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
651583|NCT03253107|Trastuzumab|trastuzumab|mesh-list
651584|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
651585|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652244|NCT03249662|Bupivacaine|bupivacaine|mesh-list
652245|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
652246|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
652247|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652248|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652249|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
652250|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652704|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
652705|NCT03247595|Bisacodyl|bisacodyl|mesh-list
652706|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
652707|NCT03247595|Cathartics|cathartics|mesh-ancestor
652708|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
652709|NCT03247595|Laxatives|laxatives|mesh-ancestor
652760|NCT03247296|Ribavirin|ribavirin|mesh-list
652761|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
652762|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
652763|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652764|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
652765|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
653227|NCT03245554|Propranolol|propranolol|mesh-list
653228|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
653229|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
653230|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
653231|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653232|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653233|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653234|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
653235|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
653236|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
653412|NCT03244176|Avelumab|avelumab|mesh-list
653413|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
653414|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653645|NCT03243006|Acetaminophen|acetaminophen|mesh-list
653646|NCT03243006|Tramadol|tramadol|mesh-list
653647|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
653648|NCT03243006|Analgesics|analgesics|mesh-ancestor
653649|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
653650|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653651|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653652|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
653653|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
653654|NCT03243006|Narcotics|narcotics|mesh-ancestor
2221974|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2221975|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221976|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
2221977|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221978|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2221979|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221980|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2221981|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
2221982|NCT00042861|Antidotes|antidotes|mesh-ancestor
2221983|NCT00042861|Protective Agents|protective agents|mesh-ancestor
2221984|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
651294|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
651295|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
651296|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2221985|NCT00042861|Vitamins|vitamins|mesh-ancestor
2221986|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
2221987|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2221988|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2221989|NCT00042874|Leucovorin|leucovorin|mesh-list
2221990|NCT00042874|Fluorouracil|fluorouracil|mesh-list
2221991|NCT00042874|Irinotecan|irinotecan|mesh-list
2221992|NCT00042874|Alvocidib|alvocidib|mesh-list
651558|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
651559|NCT03253133|Oxycodone|oxycodone|mesh-list
651560|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651561|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
651562|NCT03253133|Narcotics|narcotics|mesh-ancestor
651563|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
651564|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651565|NCT03253133|Analgesics|analgesics|mesh-ancestor
651566|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
651567|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2221993|NCT00042874|Calcium|calcium|mesh-list
2221994|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
2221995|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2221996|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2221997|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
2221998|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2221999|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2222000|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222001|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2222002|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
652937|NCT03246529|Lenograstim|lenograstim|mesh-list
652938|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
652939|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
652940|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222003|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2222004|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2222005|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222006|NCT00042874|Antidotes|antidotes|mesh-ancestor
2222007|NCT00042874|Protective Agents|protective agents|mesh-ancestor
2222008|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
2222009|NCT00042874|Vitamins|vitamins|mesh-ancestor
2222010|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
2083773|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083774|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2083775|NCT02119468|Dexamethasone|dexamethasone|mesh-list
2083776|NCT02119468|Pomalidomide|pomalidomide|mesh-list
2083777|NCT02119468|Ixazomib|ixazomib|mesh-list
2083778|NCT02119468|Glycine|glycine|mesh-list
2083779|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
2083780|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2083781|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
2083782|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
2083783|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653257|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
653258|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
653259|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
653260|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
653261|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653262|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
653263|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
653264|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653312|NCT03245021|Rituximab|rituximab|mesh-list
653313|NCT03245021|Nivolumab|nivolumab|mesh-list
653314|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2083784|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222011|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
651215|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
651216|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
651217|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
651218|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
2222012|NCT00042874|Growth Substances|growth substances|mesh-ancestor
2222013|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2222014|NCT00042887|Mitomycins|mitomycins|mesh-list
2222015|NCT00042887|Mitomycin|mitomycin|mesh-list
2222016|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2222017|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222018|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
2222019|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222020|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2222021|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651422|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
651423|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
651424|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651865|NCT03251443|Apatinib|apatinib|mesh-list
651866|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651867|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
651868|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651869|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083785|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2083786|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
2083787|NCT02119468|Hormones|hormones|mesh-ancestor
2083788|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083789|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2083790|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083791|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083792|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
2083793|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2083794|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2083795|NCT02119468|Growth Substances|growth substances|mesh-ancestor
2083796|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
2083797|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
2083798|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083799|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
2083800|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2083801|NCT02119650|Pemetrexed|pemetrexed|mesh-list
2083802|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083803|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083804|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083805|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
652832|NCT03246776|Triclosan|triclosan|mesh-list
652833|NCT03246776|Halometasone|halometasone|mesh-list
652834|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
652835|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
652836|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
652837|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
652838|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
652839|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652840|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
652841|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
652842|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
652843|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
652844|NCT03246776|Hormones|hormones|mesh-ancestor
652845|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
652846|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653415|NCT03244358|Epalrestat|epalrestat|mesh-list
653416|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653417|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653488|NCT03243851|Metformin|metformin|mesh-list
653489|NCT03243851|Temozolomide|temozolomide|mesh-list
653490|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
653491|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653492|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
653493|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
653494|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653495|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653656|NCT03242772|Amphetamine|amphetamine|mesh-list
653657|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
653658|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653659|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
653660|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
651227|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651228|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651229|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
651230|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
651231|NCT03255473|Hormones|hormones|mesh-ancestor
651232|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
651233|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
651234|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651235|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
651236|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651237|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222022|NCT00042913|Epratuzumab|epratuzumab|mesh-list
2222023|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2222024|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222025|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2222026|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2222027|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222028|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
2222029|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222030|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2222031|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222032|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222033|NCT00042965|Gemcitabine|gemcitabine|mesh-list
2222034|NCT00042965|Capecitabine|capecitabine|mesh-list
2222035|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2222036|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
2222037|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652105|NCT03250338|Cytarabine|cytarabine|mesh-list
652106|NCT03250338|Fludarabine|fludarabine|mesh-list
652107|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
652108|NCT03250338|Idarubicin|idarubicin|mesh-list
652109|NCT03250338|Crenolanib|crenolanib|mesh-list
652110|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652111|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
652112|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
652113|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652114|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
652115|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
652116|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652117|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
652118|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
652119|NCT03250338|Analgesics|analgesics|mesh-ancestor
652120|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
652121|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652122|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
652123|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
652124|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652125|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2083806|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2083807|NCT02119663|Capecitabine|capecitabine|mesh-list
2083808|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2083809|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
2083810|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083811|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083812|NCT02119819|Metformin|metformin|mesh-list
2083813|NCT02119819|Exenatide|exenatide|mesh-list
2083814|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2083815|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083816|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2083817|NCT02119819|Incretins|incretins|mesh-ancestor
2083818|NCT02119819|Hormones|hormones|mesh-ancestor
2083819|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083820|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
2083821|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
2083822|NCT02120157|Busulfan|busulfan|mesh-list
2083823|NCT02120157|Tacrolimus|tacrolimus|mesh-list
2083824|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083825|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
651267|NCT03254810|Adalimumab|adalimumab|mesh-list
651268|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
651269|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
651528|NCT03253562|Metformin|metformin|mesh-list
651529|NCT03253562|Vildagliptin|vildagliptin|mesh-list
651530|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
651531|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651532|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
651533|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
651534|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651535|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652313|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
652314|NCT03249285|Perindopril|perindopril|mesh-list
652315|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
652316|NCT03249285|Diuretics|diuretics|mesh-ancestor
652317|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
652318|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652319|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
652320|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
652321|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652322|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
652323|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
652324|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652710|NCT03247712|Nivolumab|nivolumab|mesh-list
652711|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
652712|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652713|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
652714|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652797|NCT03247218|Memantine|memantine|mesh-list
652798|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
652799|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
652800|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
652801|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652802|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652803|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652804|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
652805|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
653049|NCT03246009|Lenograstim|lenograstim|mesh-list
653050|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
653051|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
653052|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653433|NCT03244462|Methotrexate|methotrexate|mesh-list
653434|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
653435|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
653436|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
653437|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653438|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
653439|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
653440|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653441|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653442|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
653443|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653444|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
653445|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
653446|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
653447|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
653448|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2222038|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222039|NCT00042965|Antiviral Agents|antiviral agents|mesh-ancestor
2222040|NCT00042965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222041|NCT00042965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222042|NCT00042965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2222043|NCT00042965|Immunologic Factors|immunologic factors|mesh-ancestor
2222044|NCT00042965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222045|NCT00042978|Carboplatin|carboplatin|mesh-list
2222046|NCT00042978|Etoposide|etoposide|mesh-list
2222047|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
2222048|NCT00042978|Oblimersen|oblimersen|mesh-list
2222049|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222050|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2222051|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2222052|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2222053|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222054|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651314|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651315|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
651316|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
651317|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
651318|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
651536|NCT03253250|Tenofovir|tenofovir|mesh-list
651537|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
651538|NCT03253250|Entecavir|entecavir|mesh-list
651539|NCT03253250|Adefovir|adefovir|mesh-list
651540|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
651541|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651542|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
651543|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
651544|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651545|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651546|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
651547|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
651742|NCT03252223|Hormones|hormones|mesh-list
651743|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
651744|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
651745|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083826|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083827|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2083828|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2083829|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
2083830|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083831|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083832|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2083833|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2083834|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083835|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2083836|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2083837|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
2083838|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2222055|NCT00043004|Leucovorin|leucovorin|mesh-list
652173|NCT03250052|Linagliptin|linagliptin|mesh-list
652174|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
652175|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652176|NCT03250052|Incretins|incretins|mesh-ancestor
652177|NCT03250052|Hormones|hormones|mesh-ancestor
652178|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
652179|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
652180|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
652181|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652182|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652496|NCT03248544|Vitamin D|vitamin d|mesh-list
652497|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
652498|NCT03248544|Vitamins|vitamins|mesh-ancestor
652499|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
652500|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652501|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
652502|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
652696|NCT03247582|Edoxaban|edoxaban|mesh-list
652697|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
652698|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
652699|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
652700|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
652701|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652702|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652703|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
653367|NCT03244592|Minocycline|minocycline|mesh-list
653368|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
653369|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
653628|NCT03243032|Ibuprofen|ibuprofen|mesh-list
653629|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
653630|NCT03243032|Anesthetics|anesthetics|mesh-list
653631|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
653632|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
653633|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653634|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
653635|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
653636|NCT03243032|Analgesics|analgesics|mesh-ancestor
653637|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
653638|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653639|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
651327|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651328|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651329|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
651330|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651331|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
651332|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
651333|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
651334|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
651335|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
651336|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651337|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
651338|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
651339|NCT03254589|Analgesics|analgesics|mesh-ancestor
651340|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
651341|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651342|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
651343|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
651525|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
651526|NCT03253276|Cathartics|cathartics|mesh-ancestor
651527|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
651976|NCT03250910|Ribavirin|ribavirin|mesh-list
651977|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
651978|NCT03250910|Velpatasvir|velpatasvir|mesh-list
651979|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
651980|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651981|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
651982|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651999|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
652000|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
652001|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
652002|NCT03250520|Protective Agents|protective agents|mesh-ancestor
652003|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652004|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
652005|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2222056|NCT00043004|Bevacizumab|bevacizumab|mesh-list
2222057|NCT00043004|Fluorouracil|fluorouracil|mesh-list
2222058|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
2222059|NCT00043004|Calcium|calcium|mesh-list
2222060|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
2222061|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2222062|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222063|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2222064|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2222065|NCT00043004|Growth Substances|growth substances|mesh-ancestor
2222066|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222067|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
2222068|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2222069|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
652473|NCT03248817|Phenylephrine|phenylephrine|mesh-list
652474|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
652475|NCT03248817|Bupivacaine|bupivacaine|mesh-list
652476|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
652477|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
652478|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652479|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652480|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
652481|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652482|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
652483|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
652484|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
652485|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
652486|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
652487|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
652488|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
652489|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
652490|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
652491|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
652492|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
652493|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652494|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652495|NCT03248817|Protective Agents|protective agents|mesh-ancestor
652882|NCT03246659|Polygeline|polygeline|mesh-list
652883|NCT03246659|Gastrins|gastrins|mesh-list
652884|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
652885|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
652886|NCT03246659|Hormones|hormones|mesh-ancestor
652887|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
651368|NCT03254628|Oxytocin|oxytocin|mesh-list
651369|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
651370|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
651371|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651372|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
651373|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
651374|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
651375|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
652030|NCT03250481|Oxycodone|oxycodone|mesh-list
652031|NCT03250481|Propofol|propofol|mesh-list
652032|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
652033|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652034|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652035|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
652036|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
652037|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
652038|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
652039|NCT03250481|Narcotics|narcotics|mesh-ancestor
652040|NCT03250481|Analgesics|analgesics|mesh-ancestor
652041|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
652042|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652437|NCT03249142|Durvalumab|durvalumab|mesh-list
652438|NCT03249142|Tremelimumab|tremelimumab|mesh-list
652439|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
652440|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
652441|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652442|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
652443|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652592|NCT03248531|Adalimumab|adalimumab|mesh-list
652593|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
652594|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2222070|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222071|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2222072|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2222073|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
2222074|NCT00043004|Antidotes|antidotes|mesh-ancestor
2222075|NCT00043004|Protective Agents|protective agents|mesh-ancestor
2222076|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
2222077|NCT00043004|Vitamins|vitamins|mesh-ancestor
2222078|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
652766|NCT03247140|Amlodipine|amlodipine|mesh-list
652767|NCT03247140|Telmisartan|telmisartan|mesh-list
652768|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
652769|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
652770|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
652771|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
652772|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
652773|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652774|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
652775|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652776|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
652777|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
652778|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
652779|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
652780|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
652781|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
652782|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652783|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
652784|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
652825|NCT03246919|Oxytocin|oxytocin|mesh-list
652826|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
652827|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
652828|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653032|NCT03246295|Insulin|insulin|mesh-list
653033|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
653034|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653111|NCT03245918|Aprepitant|aprepitant|mesh-list
653112|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
653113|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
653114|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
653115|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653116|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653117|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
653118|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
653119|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653256|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222079|NCT00043043|Celecoxib|celecoxib|mesh-list
651621|NCT03252808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651734|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
651735|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
651736|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
652059|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
652060|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
652061|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222080|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2222081|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
652223|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
652224|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
652225|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
652226|NCT03249402|Estradiol|estradiol|mesh-list
652227|NCT03249402|Estrogens|estrogens|mesh-ancestor
652228|NCT03249402|Hormones|hormones|mesh-ancestor
652229|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
652230|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652231|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
652232|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
652233|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
652234|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
652235|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
652236|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
652237|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
652238|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
653087|NCT03245970|Atenolol|atenolol|mesh-list
653088|NCT03245970|Labetalol|labetalol|mesh-list
653089|NCT03245970|Nifedipine|nifedipine|mesh-list
653090|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
653091|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
653092|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653093|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
653094|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653095|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
653096|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
653097|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
653098|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
653099|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
653100|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
653101|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
653102|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653103|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
653104|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
653105|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
653106|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
653107|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653108|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
653109|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
653110|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
653282|NCT03245190|Chiauranib|chiauranib|mesh-list
653283|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653284|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
653285|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653286|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083839|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083840|NCT02120261|Triamcinolone|triamcinolone|mesh-list
2083841|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2083842|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2083843|NCT02120261|Lidocaine|lidocaine|mesh-list
2083844|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2083845|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
2083846|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
2083847|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2083848|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083849|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
2083850|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653820|NCT03242239|Trastuzumab|trastuzumab|mesh-list
653821|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
653822|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653977|NCT03241602|Lidocaine|lidocaine|mesh-list
653978|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
653979|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
653980|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
653981|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651675|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651676|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
651677|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651678|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
651679|NCT03252496|Narcotics|narcotics|mesh-ancestor
651680|NCT03252496|Analgesics|analgesics|mesh-ancestor
651681|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
651682|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
651683|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
651684|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
651685|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
651686|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
651687|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
651688|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
651689|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
651690|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
651691|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
651692|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651800|NCT03251768|Lenograstim|lenograstim|mesh-list
651801|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
651802|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
651803|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652327|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
652328|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
652329|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
653191|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
653192|NCT03245528|Giapreza|giapreza|mesh-list
653193|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
654087|NCT03240809|Brodalumab|brodalumab|mesh-list
654088|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
654089|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
654090|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
654091|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654262|NCT03239860|Antibodies|antibodies|mesh-list
654263|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
654264|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
654265|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654355|NCT03239353|Entecavir|entecavir|mesh-list
654356|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
654357|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
655066|NCT03236584|Tenofovir|tenofovir|mesh-list
655067|NCT03236584|Lamivudine|lamivudine|mesh-list
655068|NCT03236584|Adefovir|adefovir|mesh-list
655069|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
655070|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
655071|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
655072|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
655073|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655074|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655075|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
655076|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
655121|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
655122|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
655123|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
655124|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
655125|NCT03236220|Expectorants|expectorants|mesh-ancestor
655126|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
655127|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
655128|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
655129|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655130|NCT03236220|Protective Agents|protective agents|mesh-ancestor
655131|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655132|NCT03236220|Antidotes|antidotes|mesh-ancestor
655342|NCT03234816|Norepinephrine|norepinephrine|mesh-list
655343|NCT03234816|Bupivacaine|bupivacaine|mesh-list
655344|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
655345|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
655346|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655347|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655348|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
655349|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655350|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
655351|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
655352|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
655353|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655354|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655355|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
655356|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
651793|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
651794|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
651795|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
651796|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
651797|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
651798|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651799|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651852|NCT03251365|Gemcitabine|gemcitabine|mesh-list
651853|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
651854|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
651855|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651856|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651857|NCT03251365|Antiviral Agents|antiviral agents|mesh-ancestor
651858|NCT03251365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
651859|NCT03251365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651860|NCT03251365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
651861|NCT03251365|Immunologic Factors|immunologic factors|mesh-ancestor
651862|NCT03251365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652325|NCT03249519|Cisplatin|cisplatin|mesh-list
652326|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083851|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2083852|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2083853|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2083854|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2083855|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083856|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2083857|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
2083858|NCT02120261|Hormones|hormones|mesh-ancestor
652681|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
652682|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
652683|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
652684|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652685|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
652686|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652687|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653347|NCT03244774|Paclitaxel|paclitaxel|mesh-list
653348|NCT03244774|Fluorouracil|fluorouracil|mesh-list
653349|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
653350|NCT03244774|Apatinib|apatinib|mesh-list
653351|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
653352|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653353|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
653354|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
653355|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
653356|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653357|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
653358|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
653359|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
653360|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
653361|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653362|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
653363|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083859|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083860|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083861|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
2222082|NCT00043043|Analgesics|analgesics|mesh-ancestor
2222083|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
2222084|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2222085|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222086|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2222087|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
651881|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
651882|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
651883|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
651884|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651885|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651886|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
651970|NCT03250962|Decitabine|decitabine|mesh-list
651971|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
651972|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
651973|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651974|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
651975|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652457|NCT03248713|Mifepristone|mifepristone|mesh-list
652458|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
652459|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
652460|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
652461|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652462|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
652463|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
652464|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
652465|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
652466|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
652467|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
652468|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
652469|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
652470|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
652471|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
652472|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
652600|NCT03248427|Paclitaxel|paclitaxel|mesh-list
652601|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
652602|NCT03248427|Doxorubicin|doxorubicin|mesh-list
652603|NCT03248427|Letrozole|letrozole|mesh-list
652604|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
652605|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652606|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
652607|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
652608|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
652609|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652610|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
652611|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
652612|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652613|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
652614|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
652615|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
652616|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
652617|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
652618|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
652619|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
652620|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652621|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
652622|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
652623|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
652624|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
652625|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
653336|NCT03244956|Trametinib|trametinib|mesh-list
653337|NCT03244956|Dabrafenib|dabrafenib|mesh-list
653338|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653339|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
653340|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653341|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653475|NCT03243838|Apatinib|apatinib|mesh-list
653476|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653477|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
653478|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653479|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222088|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2222089|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2222090|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222091|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222092|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
2222093|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
2222094|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
2222095|NCT00043069|Estrogens|estrogens|mesh-list
651949|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
651950|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
651951|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
651952|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
651953|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
651954|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
651955|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
651956|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
651957|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
651958|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
651959|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
651960|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
651961|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
651962|NCT03251170|Narcotics|narcotics|mesh-ancestor
651963|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
651964|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
651965|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
651966|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
651967|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
651968|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
651969|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
652595|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
652596|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
652662|NCT03247998|Remifentanil|remifentanil|mesh-list
652663|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652664|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652665|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
652666|NCT03247998|Narcotics|narcotics|mesh-ancestor
652667|NCT03247998|Analgesics|analgesics|mesh-ancestor
652668|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
652669|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652806|NCT03247257|Lidocaine|lidocaine|mesh-list
652807|NCT03247257|Anesthetics|anesthetics|mesh-list
652808|NCT03247257|Propofol|propofol|mesh-list
652809|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
652810|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652811|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652812|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
652813|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652814|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
652815|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
652816|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
652817|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
652818|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652819|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
652820|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
652821|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
652925|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
652926|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
652927|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
652928|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652929|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652930|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
652931|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
652932|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
652933|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
652934|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
652935|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652936|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083862|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083863|NCT02120287|Bevacizumab|bevacizumab|mesh-list
2083864|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2083865|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083866|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2083867|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2083868|NCT02120287|Growth Substances|growth substances|mesh-ancestor
2083869|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083870|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
653790|NCT03242317|Mitomycins|mitomycins|mesh-list
653791|NCT03242317|Mitomycin|mitomycin|mesh-list
653792|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
653793|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653794|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
653795|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654027|NCT03241706|Somatostatin|somatostatin|mesh-list
652130|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652131|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
652132|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
652133|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652134|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
652135|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
652136|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
652137|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
652138|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
652139|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
652140|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
652141|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652404|NCT03249025|Lidocaine|lidocaine|mesh-list
652405|NCT03249025|Ketamine|ketamine|mesh-list
652406|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
652407|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
652408|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652409|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652410|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
652411|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652412|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
652413|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
652414|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
652415|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
652416|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652417|NCT03249025|Analgesics|analgesics|mesh-ancestor
652418|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
652419|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
652420|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
652421|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
652422|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
652423|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652597|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
652598|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
652599|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652642|NCT03247972|Evolocumab|evolocumab|mesh-list
652643|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
652644|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
652645|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
652646|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652647|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
652748|NCT03247413|Dexamethasone|dexamethasone|mesh-list
652749|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
652750|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
652751|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
652752|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652753|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652754|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
652755|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
652756|NCT03247413|Hormones|hormones|mesh-ancestor
652757|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
652758|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
652759|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083871|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
2083872|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
2083873|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083874|NCT02120352|Rilpivirine|rilpivirine|mesh-list
2083875|NCT02120352|Cabotegravir|cabotegravir|mesh-list
2083876|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2083877|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2083878|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083879|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083880|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
655423|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
655424|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
655425|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655426|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655427|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
655428|NCT03234660|Analgesics|analgesics|mesh-ancestor
655429|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
655430|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655431|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
655432|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
655433|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
652297|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
652298|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
652299|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
652300|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2083881|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083882|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2083883|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
652650|NCT03248076|Fentanyl|fentanyl|mesh-list
652651|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
652652|NCT03248076|Narcotics|narcotics|mesh-ancestor
652653|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652654|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652655|NCT03248076|Analgesics|analgesics|mesh-ancestor
652656|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
652657|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652658|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
652659|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
652660|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
652661|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
2222096|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
2222097|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
2222098|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2222099|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222100|NCT00043069|Vitamins|vitamins|mesh-ancestor
2222101|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
2222102|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2222103|NCT00043069|Hormones|hormones|mesh-ancestor
2083884|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2083885|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2083886|NCT02120417|Capecitabine|capecitabine|mesh-list
2083887|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2083888|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
2083889|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083890|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653198|NCT03245424|Ivosidenib|ivosidenib|mesh-list
653199|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653200|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653201|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083891|NCT02120664|Corticosterone|corticosterone|mesh-list
2083892|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2083893|NCT02120794|Insulin|insulin|mesh-list
2083894|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2083895|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083896|NCT02120833|Decanoic acid|decanoic acid|mesh-list
2222104|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2222105|NCT00043069|Antacids|antacids|mesh-ancestor
2222106|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654153|NCT03240861|Aldesleukin|aldesleukin|mesh-list
654154|NCT03240861|Plerixafor|plerixafor|mesh-list
654155|NCT03240861|Fludarabine|fludarabine|mesh-list
654156|NCT03240861|Busulfan|busulfan|mesh-list
654157|NCT03240861|Interleukin-2|interleukin-2|mesh-list
654158|NCT03240861|Lenograstim|lenograstim|mesh-list
654159|NCT03240861|Sargramostim|sargramostim|mesh-list
654160|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654161|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654162|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
654163|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
654164|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654165|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
654166|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
654167|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
654168|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
654169|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
654170|NCT03240861|Analgesics|analgesics|mesh-ancestor
654171|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
654172|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654173|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
654174|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
654175|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
654176|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
654634|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
654635|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
652336|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
652337|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
2222107|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2222108|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2222109|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2222110|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
2222111|NCT00043082|Carboplatin|carboplatin|mesh-list
2222112|NCT00043082|Doxorubicin|doxorubicin|mesh-list
2222113|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2222114|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222115|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2222116|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2222117|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
652530|NCT03248700|Vitamins|vitamins|mesh-list
652531|NCT03248700|Vitamin A|vitamin a|mesh-list
652532|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
652533|NCT03248700|Retinol acetate|retinol acetate|mesh-list
652534|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
652535|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652536|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
652537|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652538|NCT03248700|Protective Agents|protective agents|mesh-ancestor
652539|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
652540|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652541|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
652542|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
652648|NCT03248167|Cannabidiol|cannabidiol|mesh-list
652649|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
652922|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
652923|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
652924|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222118|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222119|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222120|NCT00043095|Gemcitabine|gemcitabine|mesh-list
2222121|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2222122|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
2222123|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222124|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222125|NCT00043095|Antiviral Agents|antiviral agents|mesh-ancestor
2222126|NCT00043095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222127|NCT00043095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222128|NCT00043095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2222129|NCT00043095|Immunologic Factors|immunologic factors|mesh-ancestor
653549|NCT03243500|Lidocaine|lidocaine|mesh-list
653550|NCT03243500|Bupivacaine|bupivacaine|mesh-list
653551|NCT03243500|Atracurium|atracurium|mesh-list
653552|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
653553|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
653554|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
653555|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653556|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
653557|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653558|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
653559|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
653560|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
653561|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
653562|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653563|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
653564|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
653565|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
653566|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
653567|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
653568|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
653569|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653705|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
653706|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
653707|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
653708|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653709|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
653710|NCT03242707|Protective Agents|protective agents|mesh-ancestor
653715|NCT03242382|Palbociclib|palbociclib|mesh-list
653716|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653717|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
653718|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653719|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654026|NCT03241706|Glucagon|glucagon|mesh-list
652436|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652785|NCT03247400|Atorvastatin|atorvastatin|mesh-list
652786|NCT03247400|Simvastatin|simvastatin|mesh-list
652787|NCT03247400|Calcium|calcium|mesh-list
652788|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
652789|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652790|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
652791|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
652792|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
652793|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652794|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
652795|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
652796|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083897|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
2083898|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083899|NCT02120898|Imiquimod|imiquimod|mesh-list
652889|NCT03246620|Diazepam|diazepam|mesh-list
652890|NCT03246620|Haloperidol|haloperidol|mesh-list
652891|NCT03246620|Olanzapine|olanzapine|mesh-list
652892|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
652893|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
652894|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
652895|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652896|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652897|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
652898|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
652899|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
652900|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
652901|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
652902|NCT03246620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
652903|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
652904|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
652905|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652906|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
652907|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
652908|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
652909|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
652910|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
652911|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
652912|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
652913|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
652914|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
652915|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
652916|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
652917|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
652918|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
652919|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
652920|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
652921|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
653053|NCT03246113|Temozolomide|temozolomide|mesh-list
653054|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
653055|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
653056|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653057|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653850|NCT03242096|Sirolimus|sirolimus|mesh-list
653851|NCT03242096|Paclitaxel|paclitaxel|mesh-list
653852|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
653853|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653854|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
653855|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
653856|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
653857|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653858|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
653859|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
653860|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
653861|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
653862|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
653863|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
653864|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654140|NCT03240471|Calpastatin|calpastatin|mesh-list
654141|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
654142|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
654143|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654144|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654599|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
654636|NCT03238092|Estradiol|estradiol|mesh-list
652454|NCT03248726|Cathartics|cathartics|mesh-ancestor
652455|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
652456|NCT03248726|Laxatives|laxatives|mesh-ancestor
2083900|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2083901|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
2083902|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083903|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083904|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
2083905|NCT02120924|Azelaic acid|azelaic acid|mesh-list
2083906|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083907|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
652853|NCT03246750|Cisplatin|cisplatin|mesh-list
652854|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653496|NCT03244540|Acetaminophen|acetaminophen|mesh-list
653497|NCT03244540|Dipyrone|dipyrone|mesh-list
653498|NCT03244540|Ketoprofen|ketoprofen|mesh-list
653499|NCT03244540|Bupivacaine|bupivacaine|mesh-list
653500|NCT03244540|Ropivacaine|ropivacaine|mesh-list
653501|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
653502|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
653503|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
653504|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653505|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
653506|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653507|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
653508|NCT03244540|Analgesics|analgesics|mesh-ancestor
653509|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
653510|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
653511|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
653512|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
653513|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
653514|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653515|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653583|NCT03243461|Temozolomide|temozolomide|mesh-list
653584|NCT03243461|Valproic Acid|valproic acid|mesh-list
653585|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
653586|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
653587|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653588|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653589|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
653590|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653591|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
653592|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653593|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653594|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
653595|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
653596|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
653597|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
654048|NCT03241303|Acarbose|acarbose|mesh-list
654049|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
654050|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654051|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654052|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
654053|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654745|NCT03237533|Promethazine|promethazine|mesh-list
654746|NCT03237533|Doxycycline|doxycycline|mesh-list
654747|NCT03237533|Nystatin|nystatin|mesh-list
654748|NCT03237533|Dexamethasone|dexamethasone|mesh-list
654749|NCT03237533|Triamcinolone|triamcinolone|mesh-list
654750|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
654751|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
654752|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
654753|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654754|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654755|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
654756|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
652547|NCT03248401|Analgesics|analgesics|mesh-ancestor
652548|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
652549|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
652550|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652551|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
652552|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
652553|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
652554|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
652555|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652556|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
652557|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
652558|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652559|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
652560|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
652561|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
652562|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
652563|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
652564|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
652565|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
652566|NCT03248401|Protective Agents|protective agents|mesh-ancestor
652567|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
652568|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
653047|NCT03246399|Lorecivivint|lorecivivint|mesh-list
653048|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
653516|NCT03244020|Aspirin|aspirin|mesh-list
653517|NCT03244020|Enoxaparin|enoxaparin|mesh-list
653518|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
653519|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
653520|NCT03244020|Analgesics|analgesics|mesh-ancestor
653521|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
653522|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653523|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653524|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
653525|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
653526|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
653527|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
653528|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653529|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
653530|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
653531|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653532|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
653533|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
653720|NCT03242460|Dexamethasone|dexamethasone|mesh-list
653732|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
653733|NCT03242460|Pomalidomide|pomalidomide|mesh-list
653734|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
653735|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
653736|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653737|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
653738|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
653739|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
653740|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653741|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653742|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
653743|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
653744|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
653745|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
653746|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653747|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
653748|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
653749|NCT03242460|Hormones|hormones|mesh-ancestor
653750|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
653751|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
653752|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
653753|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
653754|NCT03242460|Growth Substances|growth substances|mesh-ancestor
653755|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
654023|NCT03241550|Isavuconazole|isavuconazole|mesh-list
654024|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
654025|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
654266|NCT03239743|Midazolam|midazolam|mesh-list
654267|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
654268|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
654269|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
654270|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
652847|NCT03246958|Nivolumab|nivolumab|mesh-list
652848|NCT03246958|Ipilimumab|ipilimumab|mesh-list
652849|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
652850|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
652851|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
652852|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653684|NCT03242915|Carboplatin|carboplatin|mesh-list
653685|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
653686|NCT03242915|Pemetrexed|pemetrexed|mesh-list
653687|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653688|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
653689|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653690|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653691|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
653692|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2222130|NCT00043095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222131|NCT00043108|Paclitaxel|paclitaxel|mesh-list
2222132|NCT00043108|Carboplatin|carboplatin|mesh-list
2222133|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2222134|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222135|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
2222136|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
2222137|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
2222138|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222139|NCT00043121|Leucovorin|leucovorin|mesh-list
2222140|NCT00043121|Fluorouracil|fluorouracil|mesh-list
2222141|NCT00043121|Capecitabine|capecitabine|mesh-list
654002|NCT03241641|Tenofovir|tenofovir|mesh-list
654003|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
654004|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
654005|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
654006|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
654007|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654008|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654009|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
654010|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
654678|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
654679|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
654680|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
654681|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654682|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
654683|NCT03238183|Protective Agents|protective agents|mesh-ancestor
654783|NCT03237611|Dexamethasone|dexamethasone|mesh-list
654784|NCT03237611|Ondansetron|ondansetron|mesh-list
654785|NCT03237611|Aprepitant|aprepitant|mesh-list
654786|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
654787|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
654788|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
654789|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
654790|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654791|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654792|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
654793|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
654794|NCT03237611|Hormones|hormones|mesh-ancestor
654795|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654796|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
654797|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654798|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
654799|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
654800|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
654801|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
654802|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
654803|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654804|NCT03237611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
654805|NCT03237611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
654806|NCT03237611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
654807|NCT03237611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
654808|NCT03237611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
654809|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2222142|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
2222143|NCT00043121|Calcium|calcium|mesh-list
655498|NCT03233828|Aldesleukin|aldesleukin|mesh-list
655499|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655500|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
655501|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
655502|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
655503|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222144|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
652888|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222145|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2222146|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222147|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
2222148|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222149|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2222150|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653534|NCT03243643|Apatinib|apatinib|mesh-list
653535|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653536|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
653537|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653538|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653622|NCT03242993|Folic Acid|folic acid|mesh-list
653623|NCT03242993|Hematinics|hematinics|mesh-ancestor
653624|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
653625|NCT03242993|Vitamins|vitamins|mesh-ancestor
653626|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
653627|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653865|NCT03241784|Interleukin-2|interleukin-2|mesh-list
653866|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653867|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
653868|NCT03241784|Analgesics|analgesics|mesh-ancestor
653869|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
653870|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653871|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083908|NCT02120950|Aflibercept|aflibercept|mesh-list
2083909|NCT02120950|Verteporfin|verteporfin|mesh-list
2083910|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2083911|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2083912|NCT02120950|Growth Substances|growth substances|mesh-ancestor
2083913|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083914|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
2083915|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654042|NCT03241173|Nivolumab|nivolumab|mesh-list
654043|NCT03241173|Ipilimumab|ipilimumab|mesh-list
654044|NCT03241173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
654045|NCT03241173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654046|NCT03241173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
654047|NCT03241173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222151|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2222152|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
2222153|NCT00043121|Antidotes|antidotes|mesh-ancestor
2222154|NCT00043121|Protective Agents|protective agents|mesh-ancestor
2222155|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
2222156|NCT00043121|Vitamins|vitamins|mesh-ancestor
2222157|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
2222158|NCT00043134|Decitabine|decitabine|mesh-list
2222159|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2222160|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
2222161|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222162|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222163|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222164|NCT00043147|Prednisone|prednisone|mesh-list
654831|NCT03237507|Paclitaxel|paclitaxel|mesh-list
654832|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
654833|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
654834|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654835|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
654836|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
654837|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
654838|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083916|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2083917|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
2083918|NCT02121002|Diclofenac|diclofenac|mesh-list
2083919|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2083920|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2083921|NCT02121002|Analgesics|analgesics|mesh-ancestor
2083922|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
2083923|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083924|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083925|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
655331|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
655332|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
655333|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655722|NCT03232710|Aripiprazole|aripiprazole|mesh-list
652942|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
652943|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
652944|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
652945|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
652946|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
652947|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
652948|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
652949|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
652950|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
652951|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
652952|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
652953|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
652954|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083926|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2083927|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2083928|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653265|NCT03245385|Halobetasol|halobetasol|mesh-list
653266|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
653342|NCT03244930|Plerixafor|plerixafor|mesh-list
653343|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
653344|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
653345|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
653346|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
653815|NCT03241771|Naloxone|naloxone|mesh-list
653816|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
653817|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653818|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
653819|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654145|NCT03240549|Bevacizumab|bevacizumab|mesh-list
654146|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
654147|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654148|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
654149|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
654150|NCT03240549|Growth Substances|growth substances|mesh-ancestor
654151|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654152|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
654200|NCT03240120|Tinzaparin|tinzaparin|mesh-list
654201|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
654202|NCT03240120|Dalteparin|dalteparin|mesh-list
654203|NCT03240120|Dabigatran|dabigatran|mesh-list
654204|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
654205|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
654206|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
654207|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654208|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654209|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
654210|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
654211|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
654301|NCT03239821|Codeine|codeine|mesh-list
654302|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
654303|NCT03239821|Narcotics|narcotics|mesh-ancestor
654304|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
654305|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654306|NCT03239821|Analgesics|analgesics|mesh-ancestor
654307|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
654308|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654309|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
654310|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
654342|NCT03239314|Dexamethasone|dexamethasone|mesh-list
654343|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
654344|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
654345|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
654346|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
654347|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654348|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654349|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
654350|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
654351|NCT03239314|Hormones|hormones|mesh-ancestor
654352|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654353|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
654354|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654410|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
654411|NCT03239145|Trebananib|trebananib|mesh-list
654412|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
654413|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654414|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2083929|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083930|NCT02121041|Losartan|losartan|mesh-list
2083931|NCT02121041|Amlodipine|amlodipine|mesh-list
653194|NCT03245515|Branebrutinib|branebrutinib|mesh-list
653195|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
653196|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653197|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222165|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
2222166|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2222167|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2222168|NCT00043147|Prednisolone|prednisolone|mesh-list
2222169|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
2222170|NCT00043147|Beclomethasone|beclomethasone|mesh-list
2222171|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
654864|NCT03237546|Anesthetics|anesthetics|mesh-list
654865|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
654866|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654965|NCT03236883|Gemcitabine|gemcitabine|mesh-list
654966|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
654967|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
654968|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654969|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654970|NCT03236883|Antiviral Agents|antiviral agents|mesh-ancestor
654971|NCT03236883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
654972|NCT03236883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654973|NCT03236883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
654974|NCT03236883|Immunologic Factors|immunologic factors|mesh-ancestor
654975|NCT03236883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655038|NCT03236493|PF-06700841|pf-06700841|mesh-list
655039|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
655040|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655041|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655531|NCT03234153|Durvalumab|durvalumab|mesh-list
655532|NCT03234153|Tremelimumab|tremelimumab|mesh-list
655533|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
655534|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
655535|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655536|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222172|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
2222173|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2222174|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
2222175|NCT00043147|Hormones|hormones|mesh-ancestor
2222176|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
655807|NCT03232216|Vitamin D|vitamin d|mesh-list
655808|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
655809|NCT03232216|Vitamins|vitamins|mesh-ancestor
655810|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
655811|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655812|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
655813|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
657171|NCT03224338|Dolutegravir|dolutegravir|mesh-list
657172|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
657173|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
657174|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657175|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657176|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
657177|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
657178|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
657179|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657762|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
657763|NCT03221309|Narcotics|narcotics|mesh-ancestor
657764|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657765|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657766|NCT03221309|Analgesics|analgesics|mesh-ancestor
657767|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
657768|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083932|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
2083933|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2083934|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2083935|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2083936|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083937|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2222177|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657983|NCT03220152|Tenofovir|tenofovir|mesh-list
2222178|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2083938|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083939|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
2083940|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2083941|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2083942|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2083943|NCT02121041|Diuretics|diuretics|mesh-ancestor
2083944|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
2752086|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
653135|NCT03245996|Atenolol|atenolol|mesh-list
653136|NCT03245996|Nebivolol|nebivolol|mesh-list
653137|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
653138|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
653139|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
653140|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
653141|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653142|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653143|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
653144|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
653145|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
653146|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
653147|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653148|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653149|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
653150|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
653151|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
653152|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
653302|NCT03245437|Oxytocin|oxytocin|mesh-list
653303|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
653304|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
653305|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653449|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
653450|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
653451|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
653452|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653453|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
653454|NCT03244423|Coagulants|coagulants|mesh-ancestor
653960|NCT03241563|Triamcinolone|triamcinolone|mesh-list
653961|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
653962|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
653963|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
653964|NCT03241563|Hormones|hormones|mesh-ancestor
653965|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
653966|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653967|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
653968|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
654037|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
654038|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654039|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
654040|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654041|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654101|NCT03240939|Tadalafil|tadalafil|mesh-list
654102|NCT03240939|Dutasteride|dutasteride|mesh-list
654103|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
654104|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
654105|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
654106|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654107|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654108|NCT03240939|Urological Agents|urological agents|mesh-ancestor
654109|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
654110|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
654111|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
654112|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654113|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654311|NCT03239600|Methotrexate|methotrexate|mesh-list
654312|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
654313|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
654314|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
654315|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654316|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
654317|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
654318|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654319|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654320|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
654321|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653061|NCT03245853|Vitamins|vitamins|mesh-ancestor
653062|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
653063|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653064|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
653065|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
653153|NCT03245658|Nabiximols|nabiximols|mesh-list
653154|NCT03245658|Analgesics|analgesics|mesh-ancestor
653155|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
653156|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653157|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653267|NCT03245307|Apatinib|apatinib|mesh-list
653268|NCT03245307|Nifedipine|nifedipine|mesh-list
653269|NCT03245307|Warfarin|warfarin|mesh-list
653270|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
653271|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653272|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
653273|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653274|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653275|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
653276|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
653277|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
653278|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653279|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
653280|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
653281|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
653364|NCT03244943|Anesthetics|anesthetics|mesh-list
653365|NCT03244943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
653366|NCT03244943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653610|NCT03243344|Surgiflo|surgiflo|mesh-list
653611|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
653612|NCT03243344|Coagulants|coagulants|mesh-ancestor
653756|NCT03242499|Lovastatin|lovastatin|mesh-list
653757|NCT03242499|L 647318|l 647318|mesh-list
653758|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
653759|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
653760|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
653761|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
653762|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653763|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
653764|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
653765|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654215|NCT03240055|Etomidate|etomidate|mesh-list
654217|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
654218|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
654219|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654220|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
654221|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
654222|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
654442|NCT03239015|Trastuzumab|trastuzumab|mesh-list
654443|NCT03239015|Everolimus|everolimus|mesh-list
654444|NCT03239015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
654445|NCT03239015|Olaparib|olaparib|mesh-list
654446|NCT03239015|Gefitinib|gefitinib|mesh-list
654447|NCT03239015|Palbociclib|palbociclib|mesh-list
654448|NCT03239015|Afatinib|afatinib|mesh-list
654449|NCT03239015|Vemurafenib|vemurafenib|mesh-list
654450|NCT03239015|Dabrafenib|dabrafenib|mesh-list
654451|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
654452|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654453|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
654454|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
654455|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654456|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
654457|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654458|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654459|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
654484|NCT03238365|Nivolumab|nivolumab|mesh-list
654485|NCT03238365|Tadalafil|tadalafil|mesh-list
654486|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
654487|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654488|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
654489|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654490|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
654491|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
654492|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
654493|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654494|NCT03238365|Urological Agents|urological agents|mesh-ancestor
654880|NCT03237260|Vedolizumab|vedolizumab|mesh-list
653068|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
653069|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
653070|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653071|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
653072|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
653073|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
653074|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
653075|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
653458|NCT03243903|Insulin|insulin|mesh-list
653459|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
653460|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
653461|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653613|NCT03243019|Sirolimus|sirolimus|mesh-list
653614|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
653615|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
653616|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
653617|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653618|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
653619|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
653620|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
653621|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654256|NCT03239691|ACT-709478|act-709478|mesh-list
654257|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
654258|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
654259|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654260|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
654261|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654298|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
654299|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
654300|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654882|NCT03237390|Gemcitabine|gemcitabine|mesh-list
654883|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
654884|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
654885|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654886|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654887|NCT03237390|Antiviral Agents|antiviral agents|mesh-ancestor
654888|NCT03237390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
654889|NCT03237390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654890|NCT03237390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
654891|NCT03237390|Immunologic Factors|immunologic factors|mesh-ancestor
654892|NCT03237390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654993|NCT03236610|Tenofovir|tenofovir|mesh-list
654994|NCT03236610|Entecavir|entecavir|mesh-list
654995|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
654996|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
654997|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
654998|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
654999|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655000|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655001|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
655002|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
655545|NCT03233750|Vaccines|vaccines|mesh-list
655546|NCT03233750|Immunologic Factors|immunologic factors|mesh-ancestor
655547|NCT03233750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655780|NCT03232398|Warfarin|warfarin|mesh-list
655781|NCT03232398|Apixaban|apixaban|mesh-list
655782|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
655783|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
655784|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
655785|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
655786|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
655787|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655788|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655841|NCT03232034|Calcium|calcium|mesh-list
655842|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
655843|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655973|NCT03231436|Bupivacaine|bupivacaine|mesh-list
655974|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
655975|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
655976|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655977|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655978|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
653120|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653237|NCT03245541|Durvalumab|durvalumab|mesh-list
653238|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
653239|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653402|NCT03244319|Warfarin|warfarin|mesh-list
653403|NCT03244319|Edoxaban|edoxaban|mesh-list
653404|NCT03244319|Anticoagulants|anticoagulants|mesh-list
653405|NCT03244319|Coagulants|coagulants|mesh-list
653406|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
653407|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
653408|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
653409|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
653410|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653411|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653805|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
653806|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
653807|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
653808|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
653809|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
653810|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653811|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653812|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
653890|NCT03241888|Megestrol|megestrol|mesh-list
653891|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
653892|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
653893|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
653894|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
653895|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
653896|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653897|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
653898|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
653899|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
653900|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
653901|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
653902|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653903|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
653904|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
654419|NCT03239236|Anesthetics|anesthetics|mesh-list
654420|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
654421|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654617|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
654618|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
654619|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
654620|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655183|NCT03235869|Durvalumab|durvalumab|mesh-list
655184|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
655185|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222179|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222180|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
2222181|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
656342|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
656343|NCT03229278|Nivolumab|nivolumab|mesh-list
656344|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
656345|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
656346|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656347|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
656348|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656419|NCT03228576|Everolimus|everolimus|mesh-list
656420|NCT03228576|Tacrolimus|tacrolimus|mesh-list
656421|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
656422|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
656423|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656424|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
656425|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656426|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656427|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222182|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2222183|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2222184|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2222185|NCT00043147|Protective Agents|protective agents|mesh-ancestor
2222186|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2222187|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
2222188|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
2222189|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222190|NCT00043264|Azithromycin|azithromycin|mesh-list
2222191|NCT00043264|Rifampin|rifampin|mesh-list
653315|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653316|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
653317|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653318|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
653319|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
653320|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654114|NCT03240835|Docetaxel|docetaxel|mesh-list
654115|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654116|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
654117|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
654118|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
654119|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654281|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
654282|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654283|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
654284|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654285|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654364|NCT03239457|Mitogens|mitogens|mesh-list
654365|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
654366|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654553|NCT03238482|Fluticasone|fluticasone|mesh-list
654554|NCT03238482|Xhance|xhance|mesh-list
654555|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
654556|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
654557|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
654558|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
654559|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
654560|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654561|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654562|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
654563|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
654564|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
654565|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
654566|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
654567|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
654568|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
654569|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
654570|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
654571|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654572|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
654573|NCT03238482|Hormones|hormones|mesh-ancestor
654574|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654575|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
654926|NCT03236974|Fulvestrant|fulvestrant|mesh-list
654927|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
654928|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654929|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
654930|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
654931|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
654932|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654933|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655798|NCT03232346|Buprenorphine|buprenorphine|mesh-list
655799|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
655800|NCT03232346|Narcotics|narcotics|mesh-ancestor
655801|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655802|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655803|NCT03232346|Analgesics|analgesics|mesh-ancestor
655804|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
655805|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655806|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
656322|NCT03229174|Droxidopa|droxidopa|mesh-list
656323|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
656324|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
656428|NCT03228771|Atorvastatin|atorvastatin|mesh-list
656429|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
656430|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
656431|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
656432|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656433|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
656434|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
656435|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656746|NCT03227016|Topotecan|topotecan|mesh-list
656747|NCT03227016|Veliparib|veliparib|mesh-list
656748|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
653393|NCT03244553|Prucalopride|prucalopride|mesh-list
653394|NCT03244553|Laxatives|laxatives|mesh-ancestor
653395|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
653396|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
653397|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
653398|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
653399|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653400|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653401|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653462|NCT03243890|Vitamin D|vitamin d|mesh-list
653463|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
653464|NCT03243890|Vitamin K|vitamin k|mesh-list
653465|NCT03243890|Vitamin MK 7|vitamin mk 7|mesh-list
653466|NCT03243890|Vitamins|vitamins|mesh-ancestor
653467|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
653468|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653469|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
653470|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
653471|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
653472|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653473|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
653474|NCT03243890|Coagulants|coagulants|mesh-ancestor
653923|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
653924|NCT03241940|Fludarabine|fludarabine|mesh-list
653925|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
653926|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
653927|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
653928|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653929|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
653930|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
653931|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
653932|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653933|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653934|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
653935|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
653936|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
654704|NCT03238027|Durvalumab|durvalumab|mesh-list
654705|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
654706|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655165|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
655166|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
655167|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
655168|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
655169|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
655170|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655171|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
655172|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655173|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655174|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
655175|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655511|NCT03233880|Azithromycin|azithromycin|mesh-list
655512|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
655513|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
655672|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
655673|NCT03233347|Nivolumab|nivolumab|mesh-list
655674|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
655675|NCT03233347|Doxorubicin|doxorubicin|mesh-list
655676|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
655677|NCT03233347|Daunorubicin|daunorubicin|mesh-list
655678|NCT03233347|Dacarbazine|dacarbazine|mesh-list
655679|NCT03233347|Vinblastine|vinblastine|mesh-list
655680|NCT03233347|Antibodies|antibodies|mesh-list
655681|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
655682|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
655683|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
655684|NCT03233347|Imidazole|imidazole|mesh-list
655685|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
655686|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655687|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655688|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
655689|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
655690|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
655691|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655692|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655693|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
655694|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
655695|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
653481|NCT03243864|Avibactam|avibactam|mesh-list
653482|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
653483|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
653484|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
653485|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
653486|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653487|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653546|NCT03243604|Hormones|hormones|mesh-list
653547|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
653548|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222192|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2222193|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222194|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2222195|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
2222196|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
2222197|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2222198|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222199|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083945|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2083946|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
2083947|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2083948|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
2083949|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2083950|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083951|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2083952|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2083953|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2083954|NCT02121262|Dexamethasone|dexamethasone|mesh-list
2083955|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2083956|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
2083957|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
2083958|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083959|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083960|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2083961|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
2222200|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2222201|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2222202|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
654422|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
654423|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
654424|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
654425|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
654426|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
654427|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654428|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
654429|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
654430|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654431|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
654432|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083962|NCT02121262|Hormones|hormones|mesh-ancestor
2083963|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083964|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2083965|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083966|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2083967|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2083968|NCT02121392|Bupivacaine|bupivacaine|mesh-list
2083969|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
2083970|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
2083971|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2083972|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083973|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
654870|NCT03237624|Chitosan|chitosan|mesh-list
654871|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
654872|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
654873|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
654874|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654875|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
654876|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
654877|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
654878|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
654879|NCT03237624|Coagulants|coagulants|mesh-ancestor
654936|NCT03236792|Dexamethasone|dexamethasone|mesh-list
654937|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
654938|NCT03236792|Ixazomib|ixazomib|mesh-list
2222203|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2222204|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2222205|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2222206|NCT00043277|Bivalirudin|bivalirudin|mesh-list
653721|NCT03242616|Pemetrexed|pemetrexed|mesh-list
653722|NCT03242616|Vinorelbine|vinorelbine|mesh-list
653723|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653724|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653725|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653726|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
653727|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
653728|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
653729|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
653730|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
653731|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
2222207|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
2222208|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2222209|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
654011|NCT03241407|Triclosan|triclosan|mesh-list
654012|NCT03241407|Fluorides|fluorides|mesh-list
654013|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
654014|NCT03241407|Protective Agents|protective agents|mesh-ancestor
654015|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654016|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
654017|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
654018|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
654019|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
654020|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
654021|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654022|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
654610|NCT03238248|Azacitidine|azacitidine|mesh-list
654611|NCT03238248|Pevonedistat|pevonedistat|mesh-list
654612|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
654613|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
654614|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654615|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654616|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655272|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
655273|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
655274|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
655275|NCT03235778|Analgesics|analgesics|mesh-ancestor
655276|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
655277|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655278|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655279|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
655280|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
655369|NCT03234673|Calcipotriene|calcipotriene|mesh-list
655370|NCT03234673|Tacrolimus|tacrolimus|mesh-list
655371|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
655372|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
655373|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655374|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
655375|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655376|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655377|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
2083974|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2083975|NCT02121418|Cytarabine|cytarabine|mesh-list
2083976|NCT02121418|Decitabine|decitabine|mesh-list
2083977|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2083978|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
2083979|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083980|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2083981|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
656220|NCT03229889|Tadalafil|tadalafil|mesh-list
656221|NCT03229889|Tamsulosin|tamsulosin|mesh-list
656222|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
656223|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
656224|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
656225|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656226|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656227|NCT03229889|Urological Agents|urological agents|mesh-ancestor
656228|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
656229|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
656230|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
656231|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
653606|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
653607|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653608|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653609|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
653711|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
653712|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
653713|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
653714|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653823|NCT03241875|Pregabalin|pregabalin|mesh-list
653824|NCT03241875|Gabapentin|gabapentin|mesh-list
653825|NCT03241875|Analgesics|analgesics|mesh-ancestor
653826|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
653827|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653828|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653829|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
653830|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
653831|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
653832|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653833|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
653834|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
653835|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
653836|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
653837|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
653838|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
653839|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
653840|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653841|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
2083982|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2083983|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2083984|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
2083985|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083986|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2083987|NCT02121483|Empagliflozin|empagliflozin|mesh-list
2083988|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2083989|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2083990|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2083991|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083992|NCT02121509|Metformin|metformin|mesh-list
2083993|NCT02121509|Linagliptin|linagliptin|mesh-list
654666|NCT03237936|Cyclosporine|cyclosporine|mesh-list
654667|NCT03237936|Cyclosporins|cyclosporins|mesh-list
654668|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654669|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654670|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
654671|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
654672|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654673|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
654674|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
654675|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
654676|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
654677|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
654714|NCT03237637|Propranolol|propranolol|mesh-list
654715|NCT03237637|Atenolol|atenolol|mesh-list
654716|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
654717|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
654718|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
654719|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
654720|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654721|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654722|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
654723|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
654724|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
654725|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
654726|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
654727|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654728|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2083994|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2083995|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2083996|NCT02121509|Incretins|incretins|mesh-ancestor
2083997|NCT02121509|Hormones|hormones|mesh-ancestor
2083998|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2083999|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
655475|NCT03234296|Metronidazole|metronidazole|mesh-list
655476|NCT03234296|Levofloxacin|levofloxacin|mesh-list
655477|NCT03234296|Ertapenem|ertapenem|mesh-list
653640|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
653641|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653642|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654092|NCT03240822|Antibodies|antibodies|mesh-list
654093|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
654094|NCT03240822|Tacrolimus|tacrolimus|mesh-list
654095|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
654096|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654097|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
654098|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
654099|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654100|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084000|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
2084001|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084002|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084003|NCT02121756|Dipyridamole|dipyridamole|mesh-list
2222210|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654460|NCT03238703|Tamoxifen|tamoxifen|mesh-list
654461|NCT03238703|Toremifene|toremifene|mesh-list
654462|NCT03238703|Letrozole|letrozole|mesh-list
654463|NCT03238703|Anastrozole|anastrozole|mesh-list
654464|NCT03238703|Exemestane|exemestane|mesh-list
654465|NCT03238703|Citric Acid|citric acid|mesh-list
654466|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
654467|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
654468|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
654469|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
654470|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
654471|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654472|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654473|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
654474|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
654475|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654476|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
654477|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
654478|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654479|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654480|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
654481|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
654482|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
654483|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2752087|NCT03713593|Lenvatinib|lenvatinib|mesh-list
2752088|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2752089|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752090|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2752091|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752092|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752093|NCT03713086|Vaccines|vaccines|mesh-list
2752094|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
2752095|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655063|NCT03236623|Menthol|menthol|mesh-list
655064|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
655065|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
2222211|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222212|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
2222213|NCT00043303|Interferons|interferons|mesh-list
2222214|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
2222215|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222216|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
2222217|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222218|NCT00043316|Interferons|interferons|mesh-list
2222219|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
2222220|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222221|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
655281|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
655282|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
655283|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
655284|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
655285|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
655286|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
655287|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653643|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
653644|NCT03242967|Hematinics|hematinics|mesh-ancestor
2084004|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2084005|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084006|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084007|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2084008|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
2084009|NCT02121795|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2084010|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2084011|NCT02121795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2084012|NCT02121795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2084013|NCT02121795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084014|NCT02121795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084015|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
2084016|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
654084|NCT03241017|Durvalumab|durvalumab|mesh-list
654085|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
654086|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654233|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
654234|NCT03240211|Decitabine|decitabine|mesh-list
654235|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
654236|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654237|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
654238|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
654239|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654240|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084017|NCT02121795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2084018|NCT02121847|Cyclosporine|cyclosporine|mesh-list
2084019|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
654576|NCT03238430|Morphine|morphine|mesh-list
654577|NCT03238430|Ropivacaine|ropivacaine|mesh-list
654578|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
654579|NCT03238430|Narcotics|narcotics|mesh-ancestor
654580|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
654581|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654582|NCT03238430|Analgesics|analgesics|mesh-ancestor
654583|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
654584|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654585|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
654586|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
655220|NCT03235531|Valproic Acid|valproic acid|mesh-list
655221|NCT03235531|Lorazepam|lorazepam|mesh-list
655222|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
655223|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655224|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655225|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
655226|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655227|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655228|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
655229|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
655230|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655231|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
655232|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
655233|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
655234|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655235|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
655236|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
655237|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
655238|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
655524|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
655525|NCT03233893|Calcium|calcium|mesh-list
655526|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
655527|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655528|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
655584|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
655585|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
655586|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
655587|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
655588|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655589|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
655590|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
655591|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653655|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
653842|NCT03241901|Lumefantrine|lumefantrine|mesh-list
653843|NCT03241901|Artemether|artemether|mesh-list
653844|NCT03241901|Primaquine|primaquine|mesh-list
653845|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
653846|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
653847|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
653848|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
653849|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
653937|NCT03241472|Letrozole|letrozole|mesh-list
653938|NCT03241472|Clomiphene|clomiphene|mesh-list
653939|NCT03241472|Enclomiphene|enclomiphene|mesh-list
653940|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
653941|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653942|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653943|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
653944|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
653945|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653946|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
653947|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
653948|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
653949|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653950|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
653951|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
653952|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
653953|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
653954|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
654032|NCT03241381|Vitamin D|vitamin d|mesh-list
654033|NCT03241381|Vitamins|vitamins|mesh-ancestor
654034|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
654035|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654036|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
654530|NCT03238612|Clarithromycin|clarithromycin|mesh-list
654531|NCT03238612|Oseltamivir|oseltamivir|mesh-list
654532|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
654533|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
654534|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
654535|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
654536|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654537|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654538|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
654539|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2222222|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222223|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
2222224|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
2222225|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222226|NCT00043342|Interferons|interferons|mesh-list
2222227|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
2222228|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222229|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
656328|NCT03228992|Ibuprofen|ibuprofen|mesh-list
656329|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
656330|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
656331|NCT03228992|Analgesics|analgesics|mesh-ancestor
656332|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
656333|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656334|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656335|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
656336|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
656337|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
656338|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656339|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656471|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
656472|NCT03228667|Nivolumab|nivolumab|mesh-list
656473|NCT03228667|Durvalumab|durvalumab|mesh-list
656474|NCT03228667|Avelumab|avelumab|mesh-list
656475|NCT03228667|Atezolizumab|atezolizumab|mesh-list
656476|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
656477|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
656478|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656479|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
656480|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656481|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
656482|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656636|NCT03228043|Apatinib|apatinib|mesh-list
656637|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222230|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
653661|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653662|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
653663|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
653664|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
653665|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
653666|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
653667|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
653668|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
653669|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
654286|NCT03239964|Dexamethasone|dexamethasone|mesh-list
654287|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
654288|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
654289|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
654290|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654291|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654292|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
654293|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
654294|NCT03239964|Hormones|hormones|mesh-ancestor
654295|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654296|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
654297|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655334|NCT03234842|Paclitaxel|paclitaxel|mesh-list
655335|NCT03234842|Carboplatin|carboplatin|mesh-list
655336|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
655337|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655338|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
655339|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
655340|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
655341|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655439|NCT03234400|Dapivirine|dapivirine|mesh-list
655471|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
655472|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
655473|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
655474|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
655831|NCT03232125|Ramosetron|ramosetron|mesh-list
655832|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
655833|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
655834|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655835|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655836|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
655837|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
655838|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
655839|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655840|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656459|NCT03228498|Choline|choline|mesh-list
656460|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
656461|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
656462|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
656463|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656464|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
656465|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
656466|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
656633|NCT03227926|Panitumumab|panitumumab|mesh-list
656634|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
656635|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222231|NCT00043355|Interferons|interferons|mesh-list
2222232|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
2222233|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653796|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
653797|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653955|NCT03241745|Nivolumab|nivolumab|mesh-list
653956|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
653957|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653958|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
653959|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654120|NCT03240783|Dexamethasone|dexamethasone|mesh-list
654121|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
654122|NCT03240783|Betamethasone|betamethasone|mesh-list
654123|NCT03240783|BB 1101|bb 1101|mesh-list
654124|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
654125|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
654126|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
654127|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654128|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654129|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
654130|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
654131|NCT03240783|Hormones|hormones|mesh-ancestor
654132|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654133|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
654134|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654135|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
654136|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654137|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654138|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
654139|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
654739|NCT03237741|Rabeprazole|rabeprazole|mesh-list
654740|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
654741|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
654742|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
654743|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654744|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655385|NCT03234517|Clindamycin|clindamycin|mesh-list
655386|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
655387|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
655388|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
655389|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
655390|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
655391|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655392|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655651|NCT03232918|Oxytocin|oxytocin|mesh-list
655652|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
655653|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
655654|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655764|NCT03232450|Aspirin|aspirin|mesh-list
655765|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
655766|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
655767|NCT03232450|Analgesics|analgesics|mesh-ancestor
655768|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
655769|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655770|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655771|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
655772|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
655773|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
655774|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
655775|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655776|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
655777|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
655778|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655779|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
656493|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
656494|NCT03228862|Vitamin D|vitamin d|mesh-list
656495|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
656496|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656497|NCT03228862|Vitamins|vitamins|mesh-ancestor
656498|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
656499|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
656668|NCT03227653|Ritonavir|ritonavir|mesh-list
656669|NCT03227653|Lopinavir|lopinavir|mesh-list
656670|NCT03227653|Nevirapine|nevirapine|mesh-list
656671|NCT03227653|Efavirenz|efavirenz|mesh-list
656672|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
656673|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
656674|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
656675|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
653875|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
653876|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
653877|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
653878|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
653879|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
653880|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
653881|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
653882|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
653883|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
653884|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
653885|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
653886|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
654712|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
654713|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2084020|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2084021|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
2084022|NCT02121847|Cyclosporins|cyclosporins|mesh-list
2084023|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222234|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
2222235|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222236|NCT00043381|Decitabine|decitabine|mesh-list
2222237|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2222238|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
2222239|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222240|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222241|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222242|NCT00043394|Trastuzumab|trastuzumab|mesh-list
656075|NCT03230604|Z 350|z 350|mesh-list
656076|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
656077|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
656078|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656079|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656080|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
656081|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
656082|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656837|NCT03226301|Venetoclax|venetoclax|mesh-list
656838|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657075|NCT03224923|Aspirin|aspirin|mesh-list
657076|NCT03224923|Clopidogrel|clopidogrel|mesh-list
657077|NCT03224923|Ticagrelor|ticagrelor|mesh-list
657078|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
657079|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
657080|NCT03224923|Analgesics|analgesics|mesh-ancestor
657081|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
657082|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657083|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657084|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
657085|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
657086|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
657087|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
657088|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657089|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
657090|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
657091|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657092|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
657093|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
657094|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
657095|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
657096|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
657097|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084024|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084025|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2084026|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
2084027|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084028|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
2084029|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084030|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
2084031|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2084032|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2084033|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2084034|NCT02121847|Laxatives|laxatives|mesh-ancestor
2084035|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084036|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
657444|NCT03222765|Metformin|metformin|mesh-list
2222243|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
653982|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
653996|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
653997|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
653998|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
653999|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
654000|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
654001|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654407|NCT03239080|Denosumab|denosumab|mesh-list
654408|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
654409|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655042|NCT03236987|Azithromycin|azithromycin|mesh-list
655043|NCT03236987|Clarithromycin|clarithromycin|mesh-list
655044|NCT03236987|Rifampin|rifampin|mesh-list
655045|NCT03236987|Ethambutol|ethambutol|mesh-list
655046|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
655047|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
655048|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
655049|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655050|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655051|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
655052|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
655053|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
655054|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
655055|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
655056|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
655057|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
655058|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
655059|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
655060|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
655061|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
655062|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
655176|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
655177|NCT03236155|Narcotics|narcotics|mesh-ancestor
655178|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655179|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655180|NCT03236155|Analgesics|analgesics|mesh-ancestor
655181|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
655182|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656791|NCT03226522|Bupropion|bupropion|mesh-list
656792|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
656793|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
656794|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
656795|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
656796|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
656797|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
656798|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656799|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
656800|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
656801|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656802|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
656803|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
656804|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657305|NCT03223896|Naloxone|naloxone|mesh-list
657306|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
657307|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657308|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
657309|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657364|NCT03223220|Midazolam|midazolam|mesh-list
657365|NCT03223220|Ketamine|ketamine|mesh-list
657366|NCT03223220|Analgesics|analgesics|mesh-ancestor
657367|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
657368|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657369|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657370|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
657371|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
657372|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
657373|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
654028|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654029|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
654030|NCT03241706|Hormones|hormones|mesh-ancestor
654031|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654054|NCT03241043|Tacrolimus|tacrolimus|mesh-list
654055|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
654056|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
654057|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654058|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
654059|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654060|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222244|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222245|NCT00043537|Fluoxetine|fluoxetine|mesh-list
2222246|NCT00043537|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2222247|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2222248|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2222249|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222250|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222251|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
2222252|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222253|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2222254|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
2222255|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2222256|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2222257|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2222258|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222259|NCT00043576|Calcitriol|calcitriol|mesh-list
2222260|NCT00043576|Docetaxel|docetaxel|mesh-list
2222261|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222262|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
2222263|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
2222264|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
2222265|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222266|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
654367|NCT03239210|Ondansetron|ondansetron|mesh-list
654368|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
654369|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
654370|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654371|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654372|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
654373|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
654374|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
654375|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
654376|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
654377|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
654378|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654379|NCT03239210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
654380|NCT03239210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
654381|NCT03239210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
654382|NCT03239210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
654383|NCT03239210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2222267|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222268|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
654907|NCT03236805|Morphine|morphine|mesh-list
654908|NCT03236805|Ketamine|ketamine|mesh-list
654909|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
654910|NCT03236805|Narcotics|narcotics|mesh-ancestor
654911|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
654912|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654913|NCT03236805|Analgesics|analgesics|mesh-ancestor
654914|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
654915|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654916|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
654917|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
654918|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
654919|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
654920|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
654921|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
654922|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
654923|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084037|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2084038|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084039|NCT02122380|Incretins|incretins|mesh-ancestor
2084040|NCT02122380|Hormones|hormones|mesh-ancestor
654330|NCT03239327|Alprostadil|alprostadil|mesh-list
654331|NCT03239327|Misoprostol|misoprostol|mesh-list
654332|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
654333|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
654334|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
654335|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654336|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
654337|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
654338|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
654339|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
654340|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
654341|NCT03239327|Urological Agents|urological agents|mesh-ancestor
654511|NCT03238625|Lidocaine|lidocaine|mesh-list
654512|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
654513|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
654514|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
654515|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654516|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
654517|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654518|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
654519|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
654520|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
654521|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
654522|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654621|NCT03238131|Ivermectin|ivermectin|mesh-list
654622|NCT03238131|Albendazole|albendazole|mesh-list
654623|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
654624|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
654625|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
654626|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
654627|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
654628|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
654629|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
654630|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
654631|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
654632|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654633|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084041|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2084042|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2084043|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
2084044|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084045|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084046|NCT02122471|Plecanatide|plecanatide|mesh-list
2084047|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2084048|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
2102955|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222269|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
655393|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
655394|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
655395|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
655396|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655397|NCT03234244|Vitamins|vitamins|mesh-ancestor
655398|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
655399|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
655400|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
655401|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
655402|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
655403|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2752102|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
2752103|NCT03704298|Fludarabine|fludarabine|mesh-list
2752104|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2752105|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
2752106|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752107|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2222270|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2752108|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2752109|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
2752110|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752111|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752112|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2752113|NCT03701282|Venetoclax|venetoclax|mesh-list
2752114|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
654777|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
654778|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
654779|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654867|NCT03237117|Hormones|hormones|mesh-list
654868|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654869|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655133|NCT03236233|PC-786|pc-786|mesh-list
655134|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
655135|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
655136|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655137|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222271|NCT00043576|Vitamins|vitamins|mesh-ancestor
2222272|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
2222273|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2222274|NCT00043589|Donepezil|donepezil|mesh-list
2222275|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2222276|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222277|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655577|NCT03233295|Vitamin D|vitamin d|mesh-list
655578|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
655579|NCT03233295|Vitamins|vitamins|mesh-ancestor
655580|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
655581|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655582|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
655583|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2222278|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
2222279|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222280|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222281|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
2222282|NCT00043654|Mifepristone|mifepristone|mesh-list
2222283|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2222284|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
2222285|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2222286|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222287|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2222288|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2222289|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2222290|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
2084049|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084050|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084051|NCT02122770|Itraconazole|itraconazole|mesh-list
2084052|NCT02122770|Fluconazole|fluconazole|mesh-list
2084053|NCT02122770|Paclitaxel|paclitaxel|mesh-list
2084054|NCT02122770|Docetaxel|docetaxel|mesh-list
2222291|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2222292|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2222293|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
2222294|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2222295|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
2222296|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2222297|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2222298|NCT00043667|Daclizumab|daclizumab|mesh-list
2222299|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2222300|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
2222301|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222302|NCT00043680|Celecoxib|celecoxib|mesh-list
2222303|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2222304|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2222305|NCT00043680|Analgesics|analgesics|mesh-ancestor
2222306|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
2222307|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2222308|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222309|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2222310|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2222311|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2222312|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2084055|NCT02122770|Carboplatin|carboplatin|mesh-list
2084056|NCT02122770|Pevonedistat|pevonedistat|mesh-list
2222313|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222314|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222315|NCT00043706|Antibodies|antibodies|mesh-list
2222316|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2222317|NCT00043706|Mitogens|mitogens|mesh-list
2222318|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
2222319|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222320|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
2222321|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222322|NCT00043719|Vitamin D|vitamin d|mesh-list
2222323|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
2222324|NCT00043719|Calcium|calcium|mesh-list
2222325|NCT00043719|Vitamins|vitamins|mesh-ancestor
2222326|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
2222327|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222328|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2222329|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2222330|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
2222331|NCT00043758|Tolvaptan|tolvaptan|mesh-list
654780|NCT03237312|Hormones|hormones|mesh-list
654781|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654782|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655415|NCT03234491|Insulin|insulin|mesh-list
655416|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
655417|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
655418|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084057|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2084058|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084059|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
2084060|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
2084061|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
2084062|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655814|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
655815|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
655816|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655817|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655818|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
655819|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
655820|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655821|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
655822|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655980|NCT03231176|Capecitabine|capecitabine|mesh-list
655981|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
655982|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
655983|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655984|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656012|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
656013|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
656014|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
656015|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656016|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
656097|NCT03230565|Ropivacaine|ropivacaine|mesh-list
656098|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
656099|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
656100|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
656101|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656102|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
656103|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656505|NCT03228394|Ganaxolone|ganaxolone|mesh-list
656506|NCT03228394|Neurosteroids|neurosteroids|mesh-ancestor
656507|NCT03228394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
656508|NCT03228394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656509|NCT03228394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656510|NCT03228394|GABA Modulators|gaba modulators|mesh-ancestor
656511|NCT03228394|GABA Agents|gaba agents|mesh-ancestor
2222332|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2222333|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222334|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
2222335|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222336|NCT00043771|Tolvaptan|tolvaptan|mesh-list
2222337|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
654271|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
654272|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
654273|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
654274|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
654275|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
654276|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
654277|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
654278|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
654279|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
654280|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654433|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
654434|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
654435|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654707|NCT03237715|Bilirubin|bilirubin|mesh-list
654708|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
654709|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654710|NCT03237715|Protective Agents|protective agents|mesh-ancestor
654711|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084063|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
2084064|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084065|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2084066|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2084067|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222338|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222339|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
2222340|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222341|NCT00043784|Enoxaparin|enoxaparin|mesh-list
2222342|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
2222343|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2222344|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2222345|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222346|NCT00043810|Vidarabine|vidarabine|mesh-list
2222347|NCT00043810|Fludarabine|fludarabine|mesh-list
2222348|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
2222349|NCT00043810|Busulfan|busulfan|mesh-list
2222350|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
655851|NCT03232021|Pregabalin|pregabalin|mesh-list
655852|NCT03232021|Analgesics|analgesics|mesh-ancestor
655853|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
655854|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655855|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655856|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
655857|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
655858|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
655859|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655860|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
655861|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
655862|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
655863|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655864|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
656010|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
656011|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
656091|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
656092|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
656093|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
656094|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
656095|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656096|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
656180|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
656181|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
656182|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656436|NCT03228732|Fluoxetine|fluoxetine|mesh-list
656437|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
656438|NCT03228732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
656439|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
656440|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
656441|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656442|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
656443|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
656444|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656445|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
656446|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
656447|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
656448|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
654322|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
654323|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
654324|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
654325|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
654326|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
654810|NCT03237416|Midazolam|midazolam|mesh-list
654811|NCT03237416|Dabigatran|dabigatran|mesh-list
654812|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
654813|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
654814|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
654815|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654816|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
654817|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
654818|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
654819|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
654820|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
654821|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
654822|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
654823|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
654824|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
654825|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654826|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
654827|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
654828|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
654829|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654830|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
655299|NCT03235037|Levodopa|levodopa|mesh-list
655300|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
655301|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
655302|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
655303|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655304|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655305|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084068|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2084069|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
2084070|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2084071|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084072|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2084073|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2084074|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2084075|NCT02123017|Lactulose|lactulose|mesh-list
2222351|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222352|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2222353|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
2222354|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222355|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2222356|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
2222357|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222358|NCT00043810|Antiviral Agents|antiviral agents|mesh-ancestor
2222359|NCT00043810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222360|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
2222361|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2222362|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2222363|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2222364|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2222365|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222366|NCT00043823|Bevacizumab|bevacizumab|mesh-list
2222367|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2222368|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2222369|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222370|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2222371|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2222372|NCT00043823|Growth Substances|growth substances|mesh-ancestor
2222373|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222374|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
2222375|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2222376|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222377|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222378|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2222379|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
656512|NCT03228355|Cromakalim|cromakalim|mesh-list
656513|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
656514|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
656515|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
654415|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
654416|NCT03239145|Growth Substances|growth substances|mesh-ancestor
654417|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654418|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
2084076|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084077|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
2084078|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2084079|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084080|NCT02123446|Cephalexin|cephalexin|mesh-list
2084081|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2084082|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084083|NCT02123459|Cephalexin|cephalexin|mesh-list
2084084|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2084085|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084086|NCT02123472|Cephalexin|cephalexin|mesh-list
2084087|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2084088|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084089|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
2084090|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2084091|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
2084092|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084093|NCT02123511|Expectorants|expectorants|mesh-ancestor
2084094|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
2084095|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2084096|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
2084097|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654893|NCT03236818|Bosentan|bosentan|mesh-list
654894|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
654895|NCT03236818|Tadalafil|tadalafil|mesh-list
654896|NCT03236818|Macitentan|macitentan|mesh-list
654897|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
654898|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
654899|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
654900|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654901|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654902|NCT03236818|Urological Agents|urological agents|mesh-ancestor
654903|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
654904|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
654905|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
654906|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
655017|NCT03236649|Sorafenib|sorafenib|mesh-list
655018|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655019|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
655020|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655021|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655149|NCT03235947|Trimethoprim|trimethoprim|mesh-list
655150|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
655151|NCT03235947|Fosfomycin|fosfomycin|mesh-list
655152|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
655153|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
655154|NCT03235947|Renal Agents|renal agents|mesh-ancestor
655155|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
655156|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
655157|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
655158|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
655159|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655160|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655161|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
655162|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
655163|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
655164|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
655293|NCT03235245|Nivolumab|nivolumab|mesh-list
655294|NCT03235245|Ipilimumab|ipilimumab|mesh-list
655295|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
655296|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655297|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
655298|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655592|NCT03233412|Imiquimod|imiquimod|mesh-list
655593|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
655594|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
655595|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655596|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655597|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
2222380|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2222381|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2084098|NCT02123511|Protective Agents|protective agents|mesh-ancestor
2084099|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654600|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
654601|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655202|NCT03235609|Fentanyl|fentanyl|mesh-list
655203|NCT03235609|Ketamine|ketamine|mesh-list
655204|NCT03235609|Analgesics|analgesics|mesh-ancestor
655205|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
655206|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655207|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655208|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
655209|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
655210|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
655211|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
655212|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655213|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
655214|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
655215|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655216|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655217|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
655218|NCT03235609|Narcotics|narcotics|mesh-ancestor
655219|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
655537|NCT03234062|Choline|choline|mesh-list
655538|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
655539|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
655540|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
655541|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655542|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
655543|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
655544|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
656043|NCT03230734|Docetaxel|docetaxel|mesh-list
656044|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656045|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
656046|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
656047|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
656048|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084100|NCT02123511|Antidotes|antidotes|mesh-ancestor
2084101|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
2084102|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2084103|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084104|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084105|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2084106|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
656618|NCT03228069|Vaccines|vaccines|mesh-list
656619|NCT03228069|Immunologic Factors|immunologic factors|mesh-ancestor
656620|NCT03228069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222382|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2222383|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2222384|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222385|NCT00043862|Topotecan|topotecan|mesh-list
2222386|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2222387|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2222388|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222389|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222390|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222391|NCT00043875|Lamotrigine|lamotrigine|mesh-list
657239|NCT03223779|Trifluridine|trifluridine|mesh-list
657240|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
657241|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657242|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
657243|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657256|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
657257|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084107|NCT02123576|Protective Agents|protective agents|mesh-ancestor
2084108|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084109|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
2084110|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2084111|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
2084112|NCT02123849|Aspirin|aspirin|mesh-list
2084113|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2084114|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2084115|NCT02123849|Analgesics|analgesics|mesh-ancestor
2084116|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
2084117|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657626|NCT03221907|Pregabalin|pregabalin|mesh-list
657627|NCT03221907|Analgesics|analgesics|mesh-ancestor
657628|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
2084118|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654637|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
654638|NCT03238092|Testosterone|testosterone|mesh-list
654639|NCT03238092|Estrogens|estrogens|mesh-ancestor
654640|NCT03238092|Hormones|hormones|mesh-ancestor
654641|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654642|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654643|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
654644|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
654645|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
654646|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
654647|NCT03238092|Androgens|androgens|mesh-ancestor
655022|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
655023|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
655024|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655025|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655026|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
655027|NCT03236727|Analgesics|analgesics|mesh-ancestor
655028|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
655029|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655030|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
655031|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
655032|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
655033|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
655034|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655035|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655082|NCT03236324|Epinephrine|epinephrine|mesh-list
655083|NCT03236324|Bupivacaine|bupivacaine|mesh-list
655084|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
655085|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
655086|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655087|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655088|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
655089|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655090|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
655091|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
655092|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
655093|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655094|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655095|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
655096|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
655097|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
655098|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
655099|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
655100|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
655101|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
655102|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
655138|NCT03235973|Fludarabine|fludarabine|mesh-list
655139|NCT03235973|Busulfan|busulfan|mesh-list
655140|NCT03235973|Cladribine|cladribine|mesh-list
655141|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655142|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655143|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
655144|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
655145|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655146|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
655147|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
655148|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
655625|NCT03233152|Nivolumab|nivolumab|mesh-list
655626|NCT03233152|Ipilimumab|ipilimumab|mesh-list
655627|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
655628|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
655629|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655630|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
655631|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656117|NCT03230227|Bupivacaine|bupivacaine|mesh-list
656118|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
656119|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
656120|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
656121|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656122|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
656123|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656183|NCT03230058|Voriconazole|voriconazole|mesh-list
656184|NCT03230058|Natamycin|natamycin|mesh-list
656185|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
656186|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
654648|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
654649|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
654650|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
654651|NCT03238157|Hormones|hormones|mesh-ancestor
654652|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654653|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655491|NCT03234387|Acetylcholine|acetylcholine|mesh-list
655492|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655493|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
655494|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
655495|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
655496|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655497|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655555|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
655556|NCT03233854|Fludarabine|fludarabine|mesh-list
655557|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
655558|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
655559|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
655560|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655561|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
655562|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
655563|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
655564|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655565|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655566|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
655567|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
655568|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
2222392|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
2222393|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2222394|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
655844|NCT03232112|Exenatide|exenatide|mesh-list
655845|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
655846|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655847|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
655848|NCT03232112|Incretins|incretins|mesh-ancestor
655849|NCT03232112|Hormones|hormones|mesh-ancestor
655850|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
655985|NCT03231215|Dexamethasone|dexamethasone|mesh-list
655986|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
655987|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
655988|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
655989|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655990|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655991|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
655992|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
655993|NCT03231215|Hormones|hormones|mesh-ancestor
655994|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
655995|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
655996|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656026|NCT03230851|Aspirin|aspirin|mesh-list
656027|NCT03230851|Indobufen|indobufen|mesh-list
656028|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
656029|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
656030|NCT03230851|Analgesics|analgesics|mesh-ancestor
656031|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
656032|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656033|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656034|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
656035|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
656036|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
656037|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
656038|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656039|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
656040|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
656041|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656042|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
656212|NCT03229798|Sumatriptan|sumatriptan|mesh-list
656213|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
656214|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
656215|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
656216|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
656217|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
656218|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656219|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656382|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
654757|NCT03237533|Hormones|hormones|mesh-ancestor
654758|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654759|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
654760|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654761|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654762|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
654763|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
654764|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
654765|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
654766|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
654767|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
654768|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
654769|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
654770|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
654771|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
654772|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
654773|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
654774|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
654775|NCT03237533|Ionophores|ionophores|mesh-ancestor
654776|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
654976|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
654977|NCT03236961|Metronidazole|metronidazole|mesh-list
654978|NCT03236961|Levofloxacin|levofloxacin|mesh-list
654979|NCT03236961|Ertapenem|ertapenem|mesh-list
654980|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
654981|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
654982|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
654983|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
654984|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
654985|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654986|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654987|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
654988|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
654989|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
654990|NCT03236961|Renal Agents|renal agents|mesh-ancestor
654991|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
654992|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
655437|NCT03234699|Midazolam|midazolam|mesh-list
655438|NCT03234699|Cenobamate|cenobamate|mesh-list
655440|NCT03234699|Bupropion|bupropion|mesh-list
655441|NCT03234699|Omeprazole|omeprazole|mesh-list
655442|NCT03234699|Warfarin|warfarin|mesh-list
655443|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
655444|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
655445|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655446|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655447|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
655448|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
655449|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
655450|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
655451|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
655452|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
655453|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
655454|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
655455|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655456|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655457|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
655458|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
655459|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
655460|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
655461|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655462|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
655463|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
655464|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
655465|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
655466|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
655467|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
655468|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
655469|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
655470|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
2084119|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2084120|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2084121|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2084122|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2084123|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084124|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
654881|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
655003|NCT03236740|Metformin|metformin|mesh-list
655004|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
655005|NCT03236740|Estradiol|estradiol|mesh-list
655006|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
655007|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655008|NCT03236740|Estrogens|estrogens|mesh-ancestor
655009|NCT03236740|Hormones|hormones|mesh-ancestor
655010|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
655011|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
655012|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
655013|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
655014|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
655015|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
655016|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2752115|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752116|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2752117|NCT03699540|Ethanol|ethanol|mesh-list
2752118|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2752119|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
655326|NCT03235141|Azithromycin|azithromycin|mesh-list
655327|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
655328|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
655329|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
655330|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
655655|NCT03233035|Ketamine|ketamine|mesh-list
655656|NCT03233035|Analgesics|analgesics|mesh-ancestor
655657|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
655658|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655659|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655660|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
655661|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
655662|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
655663|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
655664|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655665|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
655666|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
655667|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655668|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656207|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
656208|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084125|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2084126|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084127|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
2084128|NCT02123966|Sirolimus|sirolimus|mesh-list
2084129|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2084130|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222395|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222396|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2222397|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222398|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2084131|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2084132|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084133|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
2084134|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2084135|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
2084136|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084137|NCT02124044|Asunaprevir|asunaprevir|mesh-list
2084138|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
2084139|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084140|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084141|NCT02124083|Vorinostat|vorinostat|mesh-list
658592|NCT03218085|Tenofovir|tenofovir|mesh-list
658593|NCT03218085|Emtricitabine|emtricitabine|mesh-list
658594|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
658595|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658596|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
658597|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
658598|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658599|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658600|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
658601|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
658738|NCT03217734|Adalimumab|adalimumab|mesh-list
658739|NCT03217734|Methotrexate|methotrexate|mesh-list
658740|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
654939|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
654940|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
654941|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
654942|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
654943|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
654944|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
654945|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
654946|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
654947|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
654948|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
654949|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
654950|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
654951|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
654952|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
654953|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
654954|NCT03236792|Hormones|hormones|mesh-ancestor
654955|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
654956|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
654957|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
654958|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655188|NCT03235986|Poractant alfa|poractant alfa|mesh-list
655189|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
655190|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
2222399|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2752120|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655929|NCT03231683|Ketamine|ketamine|mesh-list
655930|NCT03231683|Remifentanil|remifentanil|mesh-list
655931|NCT03231683|Propofol|propofol|mesh-list
655932|NCT03231683|Esketamine|esketamine|mesh-list
655933|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
655934|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655935|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655936|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
655937|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
655938|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
655939|NCT03231683|Analgesics|analgesics|mesh-ancestor
655940|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
655941|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655942|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
655943|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
655944|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
655945|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655946|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655947|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
655948|NCT03231683|Narcotics|narcotics|mesh-ancestor
655949|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
655950|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
656261|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
656262|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
656263|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
656264|NCT03229408|Analgesics|analgesics|mesh-ancestor
656265|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
656266|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656267|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656268|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
656269|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
656405|NCT03228550|Evening primrose oil|evening primrose oil|mesh-list
656406|NCT03228550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
656407|NCT03228550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
656408|NCT03228550|Analgesics|analgesics|mesh-ancestor
656409|NCT03228550|Sensory System Agents|sensory system agents|mesh-ancestor
656410|NCT03228550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656411|NCT03228550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656412|NCT03228550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
656413|NCT03228550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
656414|NCT03228550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
656415|NCT03228550|Antimetabolites|antimetabolites|mesh-ancestor
656416|NCT03228550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656417|NCT03228550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
656418|NCT03228550|Dermatologic Agents|dermatologic agents|mesh-ancestor
657160|NCT03224871|Aldesleukin|aldesleukin|mesh-list
657161|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
657162|NCT03224871|Nivolumab|nivolumab|mesh-list
657163|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
657164|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222400|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2222401|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2222402|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
655239|NCT03235700|Nicorandil|nicorandil|mesh-list
655240|NCT03235700|Adenosine|adenosine|mesh-list
655241|NCT03235700|Analgesics|analgesics|mesh-ancestor
655242|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
655243|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655244|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655245|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
655246|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
655247|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
655248|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
655249|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
655250|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655251|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655252|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
655253|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
655254|NCT03235700|Vitamins|vitamins|mesh-ancestor
655255|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
2222403|NCT00043888|Ritonavir|ritonavir|mesh-list
2222404|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
2222405|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2222406|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
655514|NCT03233815|Propofol|propofol|mesh-list
655515|NCT03233815|Sevoflurane|sevoflurane|mesh-list
655516|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
655517|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655518|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655519|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
655520|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
655521|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
655522|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
655523|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
656277|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
656278|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
656279|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
656280|NCT03229538|Prednisolone|prednisolone|mesh-list
656281|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
656282|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
656283|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
656284|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
656285|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
656286|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
656287|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656288|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656289|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
656290|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
656291|NCT03229538|Hormones|hormones|mesh-ancestor
656292|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
656293|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
656294|NCT03229538|Protective Agents|protective agents|mesh-ancestor
656295|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
656296|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222407|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2222408|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
2222409|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222410|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222411|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2222412|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2222413|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
2222414|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222415|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2222416|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2222417|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2222418|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2222419|NCT00043901|Lamotrigine|lamotrigine|mesh-list
2222420|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
2222421|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2222422|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2222423|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657562|NCT03222089|Leucovorin|leucovorin|mesh-list
657563|NCT03222089|Fluorouracil|fluorouracil|mesh-list
657564|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
657565|NCT03222089|Irinotecan|irinotecan|mesh-list
657566|NCT03222089|Interleukin-2|interleukin-2|mesh-list
655186|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
655187|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
655504|NCT03233932|Leuprolide|leuprolide|mesh-list
655505|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
655506|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
655507|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
655508|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655509|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
655510|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655548|NCT03233633|Cannabidiol|cannabidiol|mesh-list
655549|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
2084142|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084143|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2084144|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084145|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084146|NCT02124161|Vaccines|vaccines|mesh-list
2084147|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2084148|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
2084149|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084150|NCT02124512|Rifaximin|rifaximin|mesh-list
656107|NCT03230474|Morphine|morphine|mesh-list
656108|NCT03230474|Naloxone|naloxone|mesh-list
656109|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
656110|NCT03230474|Narcotics|narcotics|mesh-ancestor
656111|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
656112|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656113|NCT03230474|Analgesics|analgesics|mesh-ancestor
656114|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
656115|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656116|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
656146|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
656147|NCT03229746|Vincristine|vincristine|mesh-list
656148|NCT03229746|Azathioprine|azathioprine|mesh-list
656149|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
656150|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656151|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
656152|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
656153|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
656154|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656155|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
656156|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
656157|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
656158|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
656159|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656160|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
656161|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
656162|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
656163|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
656164|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
656165|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656234|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
656235|NCT03229616|Busulfan|busulfan|mesh-list
656236|NCT03229616|Etoposide|etoposide|mesh-list
656237|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
656238|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
656239|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656240|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
656241|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
656242|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
656243|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656244|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656245|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
656246|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
656247|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
656248|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
656249|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656641|NCT03227705|Progesterone|progesterone|mesh-list
656642|NCT03227705|Progestins|progestins|mesh-ancestor
656643|NCT03227705|Hormones|hormones|mesh-ancestor
656644|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
656645|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752121|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752125|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
657604|NCT03221855|Domperidone|domperidone|mesh-list
655288|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655289|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655290|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
655291|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
655292|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2084151|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2084152|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084153|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084154|NCT02124564|Lacosamide|lacosamide|mesh-list
2084155|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
2084156|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2084157|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2084158|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2084159|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084160|NCT02124707|Paclitaxel|paclitaxel|mesh-list
2084161|NCT02124707|Carboplatin|carboplatin|mesh-list
2084162|NCT02124707|Cetuximab|cetuximab|mesh-list
2084163|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2084164|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655759|NCT03232424|Temozolomide|temozolomide|mesh-list
655760|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
655761|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
655762|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655763|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656325|NCT03229148|Anesthetics|anesthetics|mesh-list
656326|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
656327|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656602|NCT03228030|Thiamine|thiamine|mesh-list
656603|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
656604|NCT03228030|Vitamins|vitamins|mesh-ancestor
656605|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
656606|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656839|NCT03226210|Insulin|insulin|mesh-list
656840|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
656841|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
656842|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656964|NCT03225950|Antibodies|antibodies|mesh-list
656965|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
656966|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657200|NCT03224104|Temozolomide|temozolomide|mesh-list
657201|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
657202|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
657203|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657204|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657279|NCT03223506|Acetaminophen|acetaminophen|mesh-list
657280|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
657281|NCT03223506|Analgesics|analgesics|mesh-ancestor
657282|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
657283|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657284|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657285|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
657421|NCT03222960|Propolis|propolis|mesh-list
657422|NCT03222960|Fluorides|fluorides|mesh-list
657423|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
657424|NCT03222960|Protective Agents|protective agents|mesh-ancestor
657425|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657426|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657430|NCT03222544|Methylene Blue|methylene blue|mesh-list
657431|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657432|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657640|NCT03221946|Diclofenac|diclofenac|mesh-list
657641|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
657642|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
657643|NCT03221946|Analgesics|analgesics|mesh-ancestor
657644|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
657645|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657646|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657647|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
657648|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
657649|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
657650|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657651|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084165|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
2084166|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
2084167|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
2102956|NCT02415855|Dabigatran|dabigatran|mesh-list
655357|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
655404|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
655405|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
655406|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
655407|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
655408|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
655409|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655410|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
655411|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655412|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655413|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
655414|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2222424|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2222425|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222426|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
656140|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
656141|NCT03229954|Hematinics|hematinics|mesh-ancestor
2222427|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2222428|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2222429|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
657258|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
657259|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
657260|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657261|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
657262|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
657263|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
657264|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657265|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
657266|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222430|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2222431|NCT00043914|Lamotrigine|lamotrigine|mesh-list
2222432|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
2222433|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2222434|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2222435|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222436|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2222437|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222438|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2222439|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2222440|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2222441|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2222442|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
658188|NCT03220009|Nivolumab|nivolumab|mesh-list
658189|NCT03220009|Ipilimumab|ipilimumab|mesh-list
658190|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
658191|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658192|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
658193|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658281|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
658282|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
658283|NCT03219359|Vedolizumab|vedolizumab|mesh-list
658284|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
658285|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
658286|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
658287|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658288|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
658289|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
658290|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
658291|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658292|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658293|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
658294|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
658295|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
658296|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
658297|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
658298|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
658299|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
658300|NCT03219359|Hormones|hormones|mesh-ancestor
655434|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
655435|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655436|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655529|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
655530|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
655700|NCT03232957|Morphine|morphine|mesh-list
655701|NCT03232957|Bupivacaine|bupivacaine|mesh-list
655702|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
655703|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
655704|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655705|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655706|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
655707|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655708|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
655709|NCT03232957|Narcotics|narcotics|mesh-ancestor
655710|NCT03232957|Analgesics|analgesics|mesh-ancestor
656316|NCT03229057|Metformin|metformin|mesh-list
656317|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
656318|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656349|NCT03228901|Oxytocin|oxytocin|mesh-list
656350|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
656351|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
656352|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656719|NCT03227432|Dexamethasone|dexamethasone|mesh-list
656720|NCT03227432|Nivolumab|nivolumab|mesh-list
656721|NCT03227432|Pomalidomide|pomalidomide|mesh-list
656722|NCT03227432|Elotuzumab|elotuzumab|mesh-list
656723|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
656724|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
656725|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
656726|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656727|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656728|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
656729|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
656730|NCT03227432|Hormones|hormones|mesh-ancestor
656731|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
656732|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
656733|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656734|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
656735|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
656736|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656737|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
656738|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
656739|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
656740|NCT03227432|Growth Substances|growth substances|mesh-ancestor
656741|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
656932|NCT03226145|Scopolamine|scopolamine|mesh-list
656933|NCT03226145|Bisacodyl|bisacodyl|mesh-list
656934|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
656935|NCT03226145|Cathartics|cathartics|mesh-ancestor
656936|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
656937|NCT03226145|Laxatives|laxatives|mesh-ancestor
656938|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
656939|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
656940|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
656941|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656942|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656943|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
656944|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
656945|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
656946|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
656947|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656948|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
656949|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
657220|NCT03224416|Ethanol|ethanol|mesh-list
657221|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
657222|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657223|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657224|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658498|NCT03218800|Ertapenem|ertapenem|mesh-list
658499|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
658500|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222443|NCT00043927|Cisplatin|cisplatin|mesh-list
2222444|NCT00043927|Etoposide|etoposide|mesh-list
2222445|NCT00043927|Topotecan|topotecan|mesh-list
2222446|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222447|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2222448|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
655478|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
655479|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
655480|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
655481|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
655482|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
655483|NCT03234296|Renal Agents|renal agents|mesh-ancestor
655484|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
655485|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
655486|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655487|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655488|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655489|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
655490|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
655569|NCT03233321|Heparin|heparin|mesh-list
655570|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
655571|NCT03233321|Tinzaparin|tinzaparin|mesh-list
655572|NCT03233321|Dalteparin|dalteparin|mesh-list
655573|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
655574|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
655575|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
655576|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655742|NCT03232554|Iron|iron|mesh-list
655743|NCT03232554|Trace Elements|trace elements|mesh-ancestor
655744|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
655745|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655907|NCT03231722|Leucovorin|leucovorin|mesh-list
655908|NCT03231722|Fluorouracil|fluorouracil|mesh-list
655909|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
655910|NCT03231722|Irinotecan|irinotecan|mesh-list
655911|NCT03231722|Panitumumab|panitumumab|mesh-list
655912|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
655913|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
655914|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655915|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
655916|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655917|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
655918|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
655919|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655920|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
655921|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
655922|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655923|NCT03231722|Antidotes|antidotes|mesh-ancestor
655924|NCT03231722|Protective Agents|protective agents|mesh-ancestor
655925|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
655926|NCT03231722|Vitamins|vitamins|mesh-ancestor
655927|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
655928|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
656166|NCT03229668|Pregabalin|pregabalin|mesh-list
656167|NCT03229668|Analgesics|analgesics|mesh-ancestor
656168|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
656169|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656170|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656171|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
656172|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
656173|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
656174|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656175|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
656176|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
656177|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
656178|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
656179|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2084168|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084169|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2084170|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2084171|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2084172|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084173|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657267|NCT03223974|Paclitaxel|paclitaxel|mesh-list
657268|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
657269|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657270|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
657271|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
657272|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
657273|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657316|NCT03223402|Lamivudine|lamivudine|mesh-list
2084174|NCT02124759|Sevelamer|sevelamer|mesh-list
2084175|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
655823|NCT03231982|Amlodipine|amlodipine|mesh-list
655824|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
655825|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
655826|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
655827|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655828|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
655829|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655830|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
655905|NCT03231813|Emollients|emollients|mesh-list
655906|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
2222449|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2222450|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222451|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222452|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2222453|NCT00043940|Bivalirudin|bivalirudin|mesh-list
2222454|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
2222455|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2222456|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
2222457|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222458|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222459|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
2222460|NCT00043953|Ritonavir|ritonavir|mesh-list
656500|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
656501|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656502|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
656503|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656504|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222461|NCT00043953|Lopinavir|lopinavir|mesh-list
2222462|NCT00043953|Saquinavir|saquinavir|mesh-list
2222463|NCT00043953|Lamivudine|lamivudine|mesh-list
2222464|NCT00043953|Zidovudine|zidovudine|mesh-list
2222465|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2222466|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2084176|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
2084177|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084178|NCT02124772|Trametinib|trametinib|mesh-list
2084179|NCT02124772|Dabrafenib|dabrafenib|mesh-list
2084180|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084181|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2084182|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084183|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084184|NCT02124798|Belimumab|belimumab|mesh-list
2222467|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2222468|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
2222469|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222470|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222471|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2222472|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2222473|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
2222474|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222475|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2222476|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2222477|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2222478|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2222479|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
2222480|NCT00043966|Ritonavir|ritonavir|mesh-list
2222481|NCT00043966|Lopinavir|lopinavir|mesh-list
2222482|NCT00043966|Tenofovir|tenofovir|mesh-list
2222483|NCT00043966|Emtricitabine|emtricitabine|mesh-list
2222484|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2222485|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2222486|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
2222487|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222488|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657659|NCT03221569|Ketorolac|ketorolac|mesh-list
657660|NCT03221569|Ketamine|ketamine|mesh-list
657661|NCT03221569|Analgesics|analgesics|mesh-ancestor
657662|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
657663|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084185|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
655696|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
655697|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
655698|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
655699|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
2084186|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
2102957|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
656483|NCT03228368|Atezolizumab|atezolizumab|mesh-list
656484|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656904|NCT03225924|Prednisone|prednisone|mesh-list
656905|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
656906|NCT03225924|Rituximab|rituximab|mesh-list
656907|NCT03225924|Doxorubicin|doxorubicin|mesh-list
656908|NCT03225924|Vincristine|vincristine|mesh-list
656909|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
656910|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
656911|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656912|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
656913|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
656914|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
656915|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656916|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656917|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
656918|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
656919|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
656920|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
656921|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
656922|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656923|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
656924|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
656925|NCT03225924|Hormones|hormones|mesh-ancestor
656926|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
656927|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
656928|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
656929|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
656930|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
656931|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
2222489|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2222490|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
657386|NCT03223376|Paclitaxel|paclitaxel|mesh-list
657387|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
657388|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
657389|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657390|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
657391|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
657392|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
657393|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657614|NCT03221881|Docetaxel|docetaxel|mesh-list
657615|NCT03221881|Doxorubicin|doxorubicin|mesh-list
657616|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
657617|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657618|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
657619|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
657620|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
657621|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657622|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
657623|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
657624|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
657625|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657746|NCT03221166|Thalidomide|thalidomide|mesh-list
657747|NCT03221166|Infliximab|infliximab|mesh-list
657748|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
657749|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
657750|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
657751|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
657752|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
657753|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657754|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
657755|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
657756|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657757|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
657758|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
657759|NCT03221166|Growth Substances|growth substances|mesh-ancestor
657760|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
657761|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657835|NCT03220815|Methamphetamine|methamphetamine|mesh-list
657836|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
657889|NCT03220776|Protective Agents|protective agents|mesh-ancestor
2222491|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
2752126|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2752127|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
2752128|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752129|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
2752130|NCT03697876|Protective Agents|protective agents|mesh-ancestor
656007|NCT03231033|Pioglitazone|pioglitazone|mesh-list
656008|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
656009|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656020|NCT03230630|Melatonin|melatonin|mesh-list
656021|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
656022|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656023|NCT03230630|Protective Agents|protective agents|mesh-ancestor
656024|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656025|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2222492|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222493|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2222494|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2222495|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2222496|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2222497|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2222498|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
657473|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
657474|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
657475|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
657476|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657477|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
657478|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658626|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
658627|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
658628|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
658629|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658630|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
658631|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658632|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
658633|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658634|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
658635|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
658636|NCT03217916|Protective Agents|protective agents|mesh-ancestor
658726|NCT03217591|Praliciguat|praliciguat|mesh-list
658727|NCT03217591|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
658728|NCT03217591|Enzyme Activators|enzyme activators|mesh-ancestor
658729|NCT03217591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658730|NCT03217591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
658789|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
658790|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
658791|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
658792|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658793|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
658794|NCT03216759|Analgesics|analgesics|mesh-ancestor
658795|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
658796|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
658797|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
658798|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
658799|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
658800|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
658801|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
658802|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658940|NCT03216356|Cycloserine|cycloserine|mesh-list
658941|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
658942|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658943|NCT03216356|Renal Agents|renal agents|mesh-ancestor
658944|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
655719|NCT03232632|Flutemetamol|flutemetamol|mesh-list
655720|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
655721|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656124|NCT03230162|Heparin|heparin|mesh-list
656125|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
656126|NCT03230162|Tinzaparin|tinzaparin|mesh-list
656127|NCT03230162|Dalteparin|dalteparin|mesh-list
656128|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
656129|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
656130|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
656131|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
656132|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656133|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
656134|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
656135|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
656136|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656137|NCT03230162|Urological Agents|urological agents|mesh-ancestor
656340|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
656341|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
656707|NCT03227419|Abatacept|abatacept|mesh-list
656708|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
656709|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656710|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656711|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
656712|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
656713|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656714|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
656815|NCT03226340|Niacin|niacin|mesh-list
656816|NCT03226340|Amlodipine|amlodipine|mesh-list
656817|NCT03226340|Telmisartan|telmisartan|mesh-list
656818|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
656819|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
656820|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
656821|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
656822|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656823|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
656824|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656825|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
656826|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
656827|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
656828|NCT03226340|Diuretics|diuretics|mesh-ancestor
656829|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
656830|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
656831|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
656832|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
656833|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
656834|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
656835|NCT03226340|Vitamins|vitamins|mesh-ancestor
656836|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
656865|NCT03225937|Trastuzumab|trastuzumab|mesh-list
656866|NCT03225937|Pertuzumab|pertuzumab|mesh-list
656867|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
656868|NCT03225937|Lapatinib|lapatinib|mesh-list
656869|NCT03225937|Maytansine|maytansine|mesh-list
656870|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
656871|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656872|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
656873|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656874|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656875|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
656876|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
656877|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
656878|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
657044|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
657045|NCT03225664|Trametinib|trametinib|mesh-list
657046|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
657047|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657048|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
657049|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657050|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657493|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
657494|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
657495|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
657496|NCT03222206|Analgesics|analgesics|mesh-ancestor
657497|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
657498|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655723|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
655724|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
655725|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
655726|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
655727|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
655728|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655729|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
655730|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
655731|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
655732|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
655733|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
655734|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
655735|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
655736|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
655737|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
655738|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
655739|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
655876|NCT03232307|Dexamethasone|dexamethasone|mesh-list
655877|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
655878|NCT03232307|Rituximab|rituximab|mesh-list
655879|NCT03232307|Lenalidomide|lenalidomide|mesh-list
655880|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
655881|NCT03232307|Antibodies|antibodies|mesh-list
655882|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
655883|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
655884|NCT03232307|BB 1101|bb 1101|mesh-list
655885|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
655886|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
655887|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
655888|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
655889|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
655890|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655891|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
655892|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
655893|NCT03232307|Hormones|hormones|mesh-ancestor
655894|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
655895|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
655896|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
655897|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
655898|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
655899|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
655900|NCT03232307|Growth Substances|growth substances|mesh-ancestor
655901|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
655902|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
655903|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
655904|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656142|NCT03230097|BI 409306|bi 409306|mesh-list
656143|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
656144|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656145|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656879|NCT03226418|Cytarabine|cytarabine|mesh-list
656880|NCT03226418|Azacitidine|azacitidine|mesh-list
656881|NCT03226418|Decitabine|decitabine|mesh-list
656882|NCT03226418|Daunorubicin|daunorubicin|mesh-list
656883|NCT03226418|Venetoclax|venetoclax|mesh-list
656884|NCT03226418|Idarubicin|idarubicin|mesh-list
656885|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
656886|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
656887|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656888|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656889|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
656890|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
656891|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
656892|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
656893|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656894|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656895|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
656896|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
656897|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
656967|NCT03225690|Morphine|morphine|mesh-list
656968|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
656969|NCT03225690|Narcotics|narcotics|mesh-ancestor
656970|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
656971|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656972|NCT03225690|Analgesics|analgesics|mesh-ancestor
656973|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
656974|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
655979|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656017|NCT03230786|Metformin|metformin|mesh-list
656018|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
656019|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656200|NCT03230136|Anesthetics|anesthetics|mesh-list
656201|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
656202|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656392|NCT03228823|Amiodarone|amiodarone|mesh-list
656393|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
656394|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
656395|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
656396|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
656397|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656398|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
656399|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
656400|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
656401|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656402|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
656403|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
656404|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
657427|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
657428|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
657429|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084187|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084188|NCT02124811|Minocycline|minocycline|mesh-list
2084189|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2084190|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084191|NCT02125279|Calcitriol|calcitriol|mesh-list
2084192|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2084193|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084194|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2084195|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2084196|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084197|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2084198|NCT02125279|Vitamins|vitamins|mesh-ancestor
2084199|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
2084200|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2084201|NCT02125292|Mesalamine|mesalamine|mesh-list
2102958|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
658693|NCT03217292|Tramadol|tramadol|mesh-list
658694|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
658695|NCT03217292|Narcotics|narcotics|mesh-ancestor
658696|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
658697|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658698|NCT03217292|Analgesics|analgesics|mesh-ancestor
658699|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
658700|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2222499|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2222500|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222501|NCT00044135|Clevudine|clevudine|mesh-list
2222502|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
2222503|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222504|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
2222505|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659115|NCT03216070|Dasatinib|dasatinib|mesh-list
659116|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659117|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
659118|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659119|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659280|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
659281|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
659282|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659691|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
659692|NCT03212781|Dextrans|dextrans|mesh-list
659693|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
659694|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
659695|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
659696|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
659697|NCT03212781|Trace Elements|trace elements|mesh-ancestor
659698|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
659699|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659700|NCT03212781|Hematinics|hematinics|mesh-ancestor
659785|NCT03212469|Durvalumab|durvalumab|mesh-list
656187|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
656188|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
656189|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
656190|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
656191|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656192|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656193|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
656194|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
656195|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
656196|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656197|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
656198|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
656199|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2752131|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
2752132|NCT03690765|Progestins|progestins|mesh-ancestor
2752133|NCT03690765|Hormones|hormones|mesh-ancestor
2752134|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2752135|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752136|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
2752137|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752138|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
2752139|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2752140|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2752141|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656311|NCT03229096|Apatinib|apatinib|mesh-list
656312|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656313|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
656314|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656315|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656552|NCT03228108|Amoxicillin|amoxicillin|mesh-list
656553|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
656554|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
656555|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
656556|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
656557|NCT03228108|Fosfomycin|fosfomycin|mesh-list
656558|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
656559|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
656560|NCT03228108|Trimethoprim|trimethoprim|mesh-list
656561|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
656562|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
656563|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
656564|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
656565|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
656566|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656567|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656568|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656569|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
656570|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
656571|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
656572|NCT03228108|Renal Agents|renal agents|mesh-ancestor
656573|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
656574|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
656575|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
656576|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
656577|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
656578|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
656579|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
656607|NCT03227731|Tenofovir|tenofovir|mesh-list
656608|NCT03227731|Emtricitabine|emtricitabine|mesh-list
656609|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
656610|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
656611|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
656612|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
656613|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
656614|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656615|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656616|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
656617|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2222506|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222507|NCT00044187|Sibutramine|sibutramine|mesh-list
2222508|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
2752142|NCT03686813|Urological Agents|urological agents|mesh-ancestor
656203|NCT03229694|Bosentan|bosentan|mesh-list
656204|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
656205|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
656206|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657180|NCT03224208|Vemurafenib|vemurafenib|mesh-list
657181|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657182|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
657183|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657184|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657418|NCT03223025|Hormones|hormones|mesh-list
657419|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
657420|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084202|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2084203|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2084204|NCT02125292|Analgesics|analgesics|mesh-ancestor
2084205|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
2084206|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084207|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084208|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2084209|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2084210|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2084211|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
2084212|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2084213|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
2084214|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084215|NCT02125721|Penicillamine|penicillamine|mesh-list
2084216|NCT02125721|Antidotes|antidotes|mesh-ancestor
2084217|NCT02125721|Protective Agents|protective agents|mesh-ancestor
2084218|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084219|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
2084220|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
2084221|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084222|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2084223|NCT02125734|Bromides|bromides|mesh-list
2084224|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
2084225|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2084226|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
2084227|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084228|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658136|NCT03219983|Bupivacaine|bupivacaine|mesh-list
658137|NCT03219983|Ropivacaine|ropivacaine|mesh-list
658138|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
658139|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
658140|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
658141|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658142|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
658143|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084229|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
658521|NCT03218514|Dalteparin|dalteparin|mesh-list
658522|NCT03218514|Tinzaparin|tinzaparin|mesh-list
658523|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
658524|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
658525|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
658526|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
658527|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658560|NCT03218280|Ascorbic Acid|ascorbic acid|mesh-list
658561|NCT03218280|Vitamins|vitamins|mesh-ancestor
658562|NCT03218280|Micronutrients|micronutrients|mesh-ancestor
658563|NCT03218280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658564|NCT03218280|Antioxidants|antioxidants|mesh-ancestor
658565|NCT03218280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658566|NCT03218280|Protective Agents|protective agents|mesh-ancestor
659066|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
656232|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
656233|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656690|NCT03227484|Empagliflozin|empagliflozin|mesh-list
656691|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
656692|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656693|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
656694|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656761|NCT03226821|Tesamorelin|tesamorelin|mesh-list
656762|NCT03226821|Growth Substances|growth substances|mesh-ancestor
656763|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657135|NCT03224507|Dexamethasone|dexamethasone|mesh-list
657136|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
657137|NCT03224507|Lenalidomide|lenalidomide|mesh-list
657138|NCT03224507|Daratumumab|daratumumab|mesh-list
657139|NCT03224507|BB 1101|bb 1101|mesh-list
657140|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
657141|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
657142|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
657143|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
657144|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657145|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657146|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
657147|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
657148|NCT03224507|Hormones|hormones|mesh-ancestor
657149|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
657150|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
657151|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657152|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
657153|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657154|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657155|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
657156|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
657157|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
657158|NCT03224507|Growth Substances|growth substances|mesh-ancestor
657159|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
657652|NCT03221998|Acetaminophen|acetaminophen|mesh-list
657653|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
657654|NCT03221998|Analgesics|analgesics|mesh-ancestor
657655|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
657656|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657657|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657658|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
658009|NCT03220464|Interferons|interferons|mesh-list
658010|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
658011|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658012|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
658013|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658194|NCT03219554|Palbociclib|palbociclib|mesh-list
658195|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658196|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
658197|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658198|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658680|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
658681|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
658682|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222509|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2222510|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
2222511|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
659122|NCT03215602|Pyrantel|pyrantel|mesh-list
659123|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
659124|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
659125|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
659126|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
659127|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
659128|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
659129|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
659130|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
659131|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659132|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659244|NCT03215277|Certolizumab Pegol|certolizumab pegol|mesh-list
659245|NCT03215277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
659246|NCT03215277|Immunologic Factors|immunologic factors|mesh-ancestor
659247|NCT03215277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659248|NCT03215277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2222512|NCT00044265|Ramipril|ramipril|mesh-list
2222513|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2222514|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
2222515|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222516|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222517|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2222518|NCT00044278|Lamotrigine|lamotrigine|mesh-list
2222519|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
2222520|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2222521|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2222522|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222523|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2222524|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222525|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
656695|NCT03227562|Risperidone|risperidone|mesh-list
656696|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
656697|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
656698|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
656699|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656700|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656701|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
656702|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
656703|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
656704|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
656705|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
656706|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
657394|NCT03223155|Nivolumab|nivolumab|mesh-list
657395|NCT03223155|Ipilimumab|ipilimumab|mesh-list
657396|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
657397|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657398|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
657399|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657993|NCT03220425|Insulin|insulin|mesh-list
657994|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
657995|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
657996|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
657997|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
657998|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
657999|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
658000|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659417|NCT03214302|Tenofovir|tenofovir|mesh-list
659418|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
659419|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
659420|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
659421|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
659422|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659423|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659424|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
659425|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
659524|NCT03213639|Esomeprazole|esomeprazole|mesh-list
659525|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
659526|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
659527|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
659528|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659529|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659734|NCT03212599|Disulfiram|disulfiram|mesh-list
659735|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
659736|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
659737|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659738|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659958|NCT03211351|Dextrans|dextrans|mesh-list
659959|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
659960|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
659961|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
660258|NCT03209401|Carboplatin|carboplatin|mesh-list
660259|NCT03209401|Niraparib|niraparib|mesh-list
660260|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660261|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
660262|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660263|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660317|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
660318|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
660319|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660624|NCT03207542|Daratumumab|daratumumab|mesh-list
656375|NCT03228797|Ropivacaine|ropivacaine|mesh-list
656376|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
656377|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
656378|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
656379|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656380|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
656381|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656771|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
656772|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
656773|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656774|NCT03226431|Protective Agents|protective agents|mesh-ancestor
656775|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656776|NCT03226431|Vitamins|vitamins|mesh-ancestor
656777|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
656860|NCT03225963|Temozolomide|temozolomide|mesh-list
656861|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
656862|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
656863|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656864|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656975|NCT03225755|Hormones|hormones|mesh-list
656976|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
656977|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657833|NCT03221036|Vedolizumab|vedolizumab|mesh-list
657834|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084230|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
2084231|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
2084232|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2084233|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
2084234|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
659091|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
659092|NCT03215810|Nivolumab|nivolumab|mesh-list
659093|NCT03215810|Fludarabine|fludarabine|mesh-list
659094|NCT03215810|Interleukin-2|interleukin-2|mesh-list
659095|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
659096|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
659097|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659098|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
659099|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
659100|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
659101|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659102|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659103|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
659104|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
659105|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
659106|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
659107|NCT03215810|Analgesics|analgesics|mesh-ancestor
659108|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
659109|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659283|NCT03214731|Artesunate|artesunate|mesh-list
659284|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
659285|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
659286|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
659287|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
659288|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659289|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
659290|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
659291|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
659292|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
2222526|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2222527|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2222528|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2222529|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2222530|NCT00044291|Toremifene|toremifene|mesh-list
2222531|NCT00044291|Letrozole|letrozole|mesh-list
660042|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
660043|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
660044|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660349|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
660350|NCT03208972|Menotropins|menotropins|mesh-list
660351|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
660352|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660353|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
660354|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
660382|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
660383|NCT03208556|Fludarabine|fludarabine|mesh-list
660384|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
660385|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
2222532|NCT00044291|Hormones|hormones|mesh-list
656383|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
656384|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
656385|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
656386|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
656387|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656388|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
656389|NCT03228628|Analgesics|analgesics|mesh-ancestor
656390|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
656391|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656715|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
656716|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
656717|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
656718|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657003|NCT03225781|Bleomycin|bleomycin|mesh-list
657004|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
657005|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657068|NCT03225326|Carticaine|carticaine|mesh-list
657069|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
657070|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
657071|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657072|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657073|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
657074|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657928|NCT03220789|Methamphetamine|methamphetamine|mesh-list
657929|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
657930|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657931|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
657932|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
657933|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657934|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
657935|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
657936|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657937|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
657938|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
657939|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
657940|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
657941|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2222533|NCT00044291|Atamestane|atamestane|mesh-list
2222534|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
2222535|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
2222536|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
2222537|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2222538|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222539|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222540|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2222541|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2222542|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222543|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222544|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
658453|NCT03219086|Bupivacaine|bupivacaine|mesh-list
658454|NCT03219086|Prilocaine|prilocaine|mesh-list
658455|NCT03219086|Anesthetics|anesthetics|mesh-list
658456|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
658457|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
658458|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658459|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
658460|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
658470|NCT03218553|Dexamethasone|dexamethasone|mesh-list
658471|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
658472|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
658473|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
658474|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
658475|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658476|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
658477|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
658478|NCT03218553|Hormones|hormones|mesh-ancestor
658479|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
658480|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
658481|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658683|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
658684|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
658999|NCT03216395|Epinephrine|epinephrine|mesh-list
659000|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
659001|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
659002|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
656449|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
656450|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656451|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
656452|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
656533|NCT03228238|Vitamins|vitamins|mesh-list
656534|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
656535|NCT03228238|Vitamin E|vitamin e|mesh-list
656536|NCT03228238|Tocopherols|tocopherols|mesh-list
656537|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
656538|NCT03228238|Atorvastatin|atorvastatin|mesh-list
656539|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
656540|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656541|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
656542|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
656543|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
656544|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
656545|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656546|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
656547|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
656548|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656549|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
656550|NCT03228238|Protective Agents|protective agents|mesh-ancestor
656551|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2222545|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2222546|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2222547|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2222553|NCT00044343|Lapatinib|lapatinib|mesh-list
2222554|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222555|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2222556|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222557|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222558|NCT00044382|Lenalidomide|lenalidomide|mesh-list
2222559|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
2222560|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222561|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2222562|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2222563|NCT00044382|Growth Substances|growth substances|mesh-ancestor
2222564|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
2222565|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222566|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
657207|NCT03224039|Sufentanil|sufentanil|mesh-list
657208|NCT03224039|Morphine|morphine|mesh-list
657209|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
657210|NCT03224039|Narcotics|narcotics|mesh-ancestor
657211|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657212|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657213|NCT03224039|Analgesics|analgesics|mesh-ancestor
657214|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
657215|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657216|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
657217|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
657218|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
657219|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
657949|NCT03220555|Lidocaine|lidocaine|mesh-list
657950|NCT03220555|Prilocaine|prilocaine|mesh-list
657951|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
657952|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
657953|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657954|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657955|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
657956|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657957|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
657958|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
657959|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
657960|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
657961|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222567|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222568|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222569|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
2222570|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656516|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656528|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656529|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
656530|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
656531|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
656532|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
656621|NCT03227900|Lidocaine|lidocaine|mesh-list
656622|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
656623|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
656624|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
656625|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656626|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
656627|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656628|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
656629|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
656630|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
656631|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
656632|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084235|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084236|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
2084237|NCT02125877|Deferasirox|deferasirox|mesh-list
2084238|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2084239|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
657006|NCT03225456|Oxytocin|oxytocin|mesh-list
657007|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
657008|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
657009|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657185|NCT03224377|Antibodies|antibodies|mesh-list
657186|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
657187|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
657188|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657502|NCT03222310|Itraconazole|itraconazole|mesh-list
657503|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
657504|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657505|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
657506|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
657507|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657508|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657509|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
657510|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
657511|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
657512|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657513|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
657863|NCT03220841|Adalimumab|adalimumab|mesh-list
657864|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
657865|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
658229|NCT03219593|Apatinib|apatinib|mesh-list
658230|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658231|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
658232|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658233|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222571|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222572|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
2222573|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222574|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222575|NCT00044434|Bupropion|bupropion|mesh-list
2222576|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2222577|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
2222578|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2222579|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2222580|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2222581|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2222582|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222583|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
2222584|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222585|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222586|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
658660|NCT03217669|Sirolimus|sirolimus|mesh-list
658661|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
658662|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658663|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
658664|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222587|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2222588|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222589|NCT00044447|Glimepiride|glimepiride|mesh-list
2222590|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2222591|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2222592|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222593|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2222594|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
2222595|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
2222596|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2222597|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222598|NCT00044473|Levofloxacin|levofloxacin|mesh-list
656646|NCT03227679|Bupropion|bupropion|mesh-list
656647|NCT03227679|Nicotine|nicotine|mesh-list
656648|NCT03227679|Varenicline|varenicline|mesh-list
656649|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
656650|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
656651|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656652|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
656653|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
656654|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
656655|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
656656|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
656657|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656658|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
656659|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
656660|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
656661|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
656662|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
656663|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
656664|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
656665|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
656666|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
656667|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656759|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
656760|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657029|NCT03225417|Sirolimus|sirolimus|mesh-list
657030|NCT03225417|Ixazomib|ixazomib|mesh-list
657031|NCT03225417|Tacrolimus|tacrolimus|mesh-list
657032|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
657033|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
657034|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657035|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
657036|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657037|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657038|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
657039|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657040|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
657041|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657042|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
657043|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
657123|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
657124|NCT03224572|Vitamins|vitamins|mesh-ancestor
657125|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
657126|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657127|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
657128|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657129|NCT03224572|Protective Agents|protective agents|mesh-ancestor
657693|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
657694|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
657695|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
657696|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
657697|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
657698|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657699|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657700|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
657701|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
657702|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2222599|NCT00044473|Ofloxacin|ofloxacin|mesh-list
656638|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
656639|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656640|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656764|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
656765|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
656898|NCT03226080|Rocuronium|rocuronium|mesh-list
656899|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
656900|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
656901|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
656902|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
656903|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657286|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
657287|NCT03223961|Hematinics|hematinics|mesh-ancestor
657517|NCT03222076|Nivolumab|nivolumab|mesh-list
657518|NCT03222076|Ipilimumab|ipilimumab|mesh-list
657519|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
657520|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657521|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
657522|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657596|NCT03221816|Folic Acid|folic acid|mesh-list
657597|NCT03221816|Pyridoxine|pyridoxine|mesh-list
657598|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
657599|NCT03221816|Hematinics|hematinics|mesh-ancestor
657600|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
657601|NCT03221816|Vitamins|vitamins|mesh-ancestor
657602|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
657603|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657718|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
657719|NCT03221634|Daratumumab|daratumumab|mesh-list
657720|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
657721|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084240|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
2084241|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084242|NCT02126839|Albuterol|albuterol|mesh-list
2084243|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2084244|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
2084245|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2752158|NCT03679624|Daratumumab|daratumumab|mesh-list
2752159|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752160|NCT03658304|Mitomycins|mitomycins|mesh-list
2752161|NCT03658304|Mitomycin|mitomycin|mesh-list
2752162|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2752163|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752164|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
658467|NCT03218709|Vitamins|vitamins|mesh-list
658468|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
658469|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658812|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
658813|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
658879|NCT03216668|Silymarin|silymarin|mesh-list
2789039|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
656676|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656677|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
656678|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
656679|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
656680|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
656681|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
656682|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
656683|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
656684|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
656685|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
656686|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
656687|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
656688|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
656689|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
657189|NCT03224221|Fluorouracil|fluorouracil|mesh-list
657190|NCT03224221|Apatinib|apatinib|mesh-list
657191|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
657192|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657193|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
657194|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657195|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
657196|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
657197|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657198|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
657199|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084246|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084247|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2084248|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
2084249|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
2084250|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2084251|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2084252|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2084253|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2084254|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
2084255|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084256|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084257|NCT02126969|Carboplatin|carboplatin|mesh-list
2084258|NCT02126969|Docetaxel|docetaxel|mesh-list
2084259|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084260|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
2084261|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
2084262|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
657744|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
657745|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2752165|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752166|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2752167|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222600|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2222601|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222602|NCT00044473|Renal Agents|renal agents|mesh-ancestor
2222603|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2222604|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2222605|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2222606|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222607|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084263|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084264|NCT02127125|Sevelamer|sevelamer|mesh-list
2084265|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
2084266|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
2084267|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658701|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
658702|NCT03217409|Ezetimibe|ezetimibe|mesh-list
658703|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
658704|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
658705|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
658706|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658707|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
658708|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
658709|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658775|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
658776|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
658777|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
656749|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
656750|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
656751|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
656752|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
656753|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657334|NCT03223519|Ascorbic Acid|ascorbic acid|mesh-list
657335|NCT03223519|Ibuprofen|ibuprofen|mesh-list
657336|NCT03223519|Vitamins|vitamins|mesh-ancestor
657337|NCT03223519|Micronutrients|micronutrients|mesh-ancestor
657338|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657339|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
657340|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
657341|NCT03223519|Analgesics|analgesics|mesh-ancestor
657342|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
657343|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657344|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
657345|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
657346|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
657347|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657348|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657349|NCT03223519|Antioxidants|antioxidants|mesh-ancestor
657350|NCT03223519|Protective Agents|protective agents|mesh-ancestor
657459|NCT03222687|Prednisone|prednisone|mesh-list
657460|NCT03222687|Tacrolimus|tacrolimus|mesh-list
657461|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
657462|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
657463|NCT03222687|Hormones|hormones|mesh-ancestor
657464|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
657465|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657466|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
657467|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657468|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
657469|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
657470|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
657471|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657472|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657514|NCT03222167|Grazoprevir|grazoprevir|mesh-list
657515|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
657516|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658118|NCT03219970|Osimertinib|osimertinib|mesh-list
658119|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658120|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
658121|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658122|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658618|NCT03218124|Remifentanil|remifentanil|mesh-list
658619|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
658620|NCT03218124|Narcotics|narcotics|mesh-ancestor
658621|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
658622|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658623|NCT03218124|Analgesics|analgesics|mesh-ancestor
658624|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
658625|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660226|NCT03209648|Itraconazole|itraconazole|mesh-list
660227|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
660228|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660229|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
660230|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
660231|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660232|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660233|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
660234|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
660235|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
660236|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660237|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
660279|NCT03209180|Carvedilol|carvedilol|mesh-list
660280|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
660281|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
660282|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
660283|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
660284|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660285|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660286|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
660287|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
660288|NCT03209180|Protective Agents|protective agents|mesh-ancestor
2222608|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222609|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2222610|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2222611|NCT00044486|Posaconazole|posaconazole|mesh-list
2222612|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
2222613|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222614|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2222615|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2222616|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2084268|NCT02127372|Cisplatin|cisplatin|mesh-list
2084269|NCT02127372|Docetaxel|docetaxel|mesh-list
2084270|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
2084271|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084272|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
2084273|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
2084274|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
2084275|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084276|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2084277|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084278|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
2084279|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2084280|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
2084281|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084282|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
2084283|NCT02127723|Protective Agents|protective agents|mesh-ancestor
2084284|NCT02127970|Dalbavancin|dalbavancin|mesh-list
2084285|NCT02127970|Teicoplanin|teicoplanin|mesh-list
2084286|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
657414|NCT03223103|Poly ICLC|poly iclc|mesh-list
657415|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
657416|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
657417|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658123|NCT03219853|Selenium|selenium|mesh-list
658124|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
658125|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658126|NCT03219853|Protective Agents|protective agents|mesh-ancestor
658127|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658128|NCT03219853|Trace Elements|trace elements|mesh-ancestor
658129|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
658324|NCT03219645|Aspirin|aspirin|mesh-list
658325|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
658326|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
658327|NCT03219645|Analgesics|analgesics|mesh-ancestor
658328|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
658329|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
658330|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658331|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
658332|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
658333|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
658334|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
658335|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658336|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
658337|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
658338|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658339|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
658731|NCT03217474|Ganciclovir|ganciclovir|mesh-list
658732|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
658733|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
658734|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658735|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
658736|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658737|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658818|NCT03216967|Everolimus|everolimus|mesh-list
658819|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658820|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
658821|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
658822|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659135|NCT03215524|Thalidomide|thalidomide|mesh-list
659136|NCT03215524|Dexamethasone|dexamethasone|mesh-list
659137|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
659138|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
659139|NCT03215524|Pomalidomide|pomalidomide|mesh-list
659140|NCT03215524|Daratumumab|daratumumab|mesh-list
659141|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
659142|NCT03215524|BB 1101|bb 1101|mesh-list
2084287|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084288|NCT02128217|Ribavirin|ribavirin|mesh-list
2084289|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
2222617|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2222618|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2222619|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222620|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222621|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2222622|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
2222623|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2222624|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222625|NCT00044525|Taxane|taxane|mesh-list
2222626|NCT00044525|IDN 5109|idn 5109|mesh-list
2222627|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222628|NCT00044538|Taxane|taxane|mesh-list
2222629|NCT00044538|IDN 5109|idn 5109|mesh-list
2222630|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222631|NCT00044551|Taxane|taxane|mesh-list
2222632|NCT00044551|IDN 5109|idn 5109|mesh-list
2222633|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222634|NCT00044564|IDN 5109|idn 5109|mesh-list
2222635|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657051|NCT03225352|Aspirin|aspirin|mesh-list
657052|NCT03225352|Ibuprofen|ibuprofen|mesh-list
657053|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
657054|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
657055|NCT03225352|Analgesics|analgesics|mesh-ancestor
657056|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
657057|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657058|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657059|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
657060|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
657061|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
657062|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
657063|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657064|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
657065|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
657066|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657067|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
657108|NCT03224637|Acetaminophen|acetaminophen|mesh-list
657109|NCT03224637|Ketorolac|ketorolac|mesh-list
657110|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
657111|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
657112|NCT03224637|Analgesics|analgesics|mesh-ancestor
657113|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
657114|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657115|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657116|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
657117|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
657118|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
657119|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
657120|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
657121|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657122|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657769|NCT03221621|Adalimumab|adalimumab|mesh-list
657770|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
657771|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
657866|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
657867|NCT03220776|Gabapentin|gabapentin|mesh-list
657868|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
657869|NCT03220776|Analgesics|analgesics|mesh-ancestor
657870|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
657871|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657872|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657873|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
657874|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
657875|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
657876|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657877|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
657878|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
657879|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
657880|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
657881|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657882|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
657883|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
657884|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657885|NCT03220776|Expectorants|expectorants|mesh-ancestor
657886|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
657887|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
657888|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
2222636|NCT00044577|Tenofovir|tenofovir|mesh-list
2222637|NCT00044577|Lamivudine|lamivudine|mesh-list
657165|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
657166|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657167|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
657168|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
657169|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
657170|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657523|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
657524|NCT03222323|Ropivacaine|ropivacaine|mesh-list
657525|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
657526|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657527|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657528|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
657529|NCT03222323|Analgesics|analgesics|mesh-ancestor
657530|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
657531|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657532|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
657533|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
657534|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
657535|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
657536|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
657537|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657538|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
657539|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
657775|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
657776|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
657777|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
657778|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657779|NCT03221231|Expectorants|expectorants|mesh-ancestor
657780|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
657781|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
657782|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
657783|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657784|NCT03221231|Protective Agents|protective agents|mesh-ancestor
657785|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657786|NCT03221231|Antidotes|antidotes|mesh-ancestor
658242|NCT03219671|Nivolumab|nivolumab|mesh-list
658243|NCT03219671|Ipilimumab|ipilimumab|mesh-list
658244|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
658245|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658246|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
658247|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658461|NCT03218631|Oxandrolone|oxandrolone|mesh-list
658462|NCT03218631|Androgens|androgens|mesh-ancestor
658463|NCT03218631|Hormones|hormones|mesh-ancestor
658464|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
658465|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658466|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
658853|NCT03216876|Ursolic acid|ursolic acid|mesh-list
658854|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658855|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
658856|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658857|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
658858|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658859|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658860|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
658861|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
658862|NCT03216876|Analgesics|analgesics|mesh-ancestor
658863|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
658864|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
658865|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658866|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
658867|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
658966|NCT03216447|Tacrolimus|tacrolimus|mesh-list
658967|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
658968|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
658312|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
658313|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
658314|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
658315|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
658316|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658317|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
658318|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
658319|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
658320|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658321|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658322|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
658323|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
658501|NCT03218657|Cyclosporine|cyclosporine|mesh-list
658502|NCT03218657|Levamisole|levamisole|mesh-list
658503|NCT03218657|Cyclosporins|cyclosporins|mesh-list
658504|NCT03218657|Androgens|androgens|mesh-list
658505|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658506|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658507|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
658508|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
658509|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658510|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
658511|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658512|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
658513|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
658514|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
658515|NCT03218657|Hormones|hormones|mesh-ancestor
658516|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
658517|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
658518|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
658519|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
658520|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
658567|NCT03218254|Methylphenidate|methylphenidate|mesh-list
658568|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
658569|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658570|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
658571|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
658572|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
658573|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658574|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
658575|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
658654|NCT03217825|Losartan|losartan|mesh-list
658655|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
658656|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
658657|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
658658|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
658659|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658780|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
658781|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
658890|NCT03216707|Capsaicin|capsaicin|mesh-list
658891|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
658892|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
658893|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
658894|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
658895|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659249|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
659250|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
659251|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
659252|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
659253|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659254|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659619|NCT03213041|Carboplatin|carboplatin|mesh-list
659620|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
659621|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659622|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
660843|NCT03206320|Lidocaine|lidocaine|mesh-list
660844|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
660845|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
660846|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
660847|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660848|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
661380|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
657317|NCT03223402|Nevirapine|nevirapine|mesh-list
657318|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
657319|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
657320|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657321|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657322|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
657323|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657324|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
657325|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
657326|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
657327|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2084290|NCT02128217|Ledipasvir|ledipasvir|mesh-list
2084291|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2084292|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
657825|NCT03220932|Bevacizumab|bevacizumab|mesh-list
657826|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
657827|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657828|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
657829|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
657830|NCT03220932|Growth Substances|growth substances|mesh-ancestor
657831|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657832|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
658413|NCT03220022|Prednisone|prednisone|mesh-list
658414|NCT03220022|Cortisone|cortisone|mesh-list
658415|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
658416|NCT03220022|Rituximab|rituximab|mesh-list
658417|NCT03220022|Doxorubicin|doxorubicin|mesh-list
658418|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
658419|NCT03220022|Etoposide|etoposide|mesh-list
658420|NCT03220022|Vincristine|vincristine|mesh-list
658421|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
658422|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
658423|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
658424|NCT03220022|Antibodies|antibodies|mesh-list
658425|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
658426|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
658427|NCT03220022|Lenograstim|lenograstim|mesh-list
658428|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
658429|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
658430|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658431|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
658432|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
658433|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
658434|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658435|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658436|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
658437|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
658438|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
658439|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
658440|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658441|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
658442|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
658443|NCT03220022|Hormones|hormones|mesh-ancestor
658444|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
658445|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
658446|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
658447|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
658448|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
658449|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
658450|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
658451|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
658452|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
658848|NCT03217084|Fluorides|fluorides|mesh-list
658849|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
658850|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
658851|NCT03217084|Protective Agents|protective agents|mesh-ancestor
658852|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658918|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
658919|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
658920|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
658921|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
658922|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
658923|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658924|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
658925|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
658926|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657374|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657375|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
657376|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
657377|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
657378|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657379|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
657380|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
657381|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
657382|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
657383|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
657384|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
657385|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
657400|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
657401|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
657402|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657787|NCT03221400|Leucovorin|leucovorin|mesh-list
657788|NCT03221400|Folic Acid|folic acid|mesh-list
657789|NCT03221400|Fluorouracil|fluorouracil|mesh-list
657790|NCT03221400|Niraparib|niraparib|mesh-list
657791|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
657792|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
657793|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657794|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
657795|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657796|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
657797|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
657798|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657799|NCT03221400|Antidotes|antidotes|mesh-ancestor
657800|NCT03221400|Protective Agents|protective agents|mesh-ancestor
657801|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
657802|NCT03221400|Vitamins|vitamins|mesh-ancestor
657803|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
657804|NCT03221400|Hematinics|hematinics|mesh-ancestor
657805|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
657806|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658116|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
658117|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658353|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
658354|NCT03219177|Narcotics|narcotics|mesh-ancestor
658355|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
658356|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658357|NCT03219177|Analgesics|analgesics|mesh-ancestor
658358|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
658359|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659191|NCT03215446|Anesthetics|anesthetics|mesh-list
659192|NCT03215446|Propofol|propofol|mesh-list
659193|NCT03215446|Sevoflurane|sevoflurane|mesh-list
659194|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659195|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659196|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
659197|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
659198|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
659199|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
659200|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
659324|NCT03214354|Sirolimus|sirolimus|mesh-list
659325|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
659326|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
659327|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
659328|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
659329|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659330|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
659331|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
659332|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
659333|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659334|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
659492|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
659493|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
659494|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
659495|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659515|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
659516|NCT03213444|Fluorouracil|fluorouracil|mesh-list
659517|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659518|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
659519|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659520|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
659521|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
657445|NCT03222765|Linagliptin|linagliptin|mesh-list
657446|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
657447|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657448|NCT03222765|Incretins|incretins|mesh-ancestor
657449|NCT03222765|Hormones|hormones|mesh-ancestor
657450|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
657451|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
657452|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
657453|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657454|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657772|NCT03221023|Vancomycin|vancomycin|mesh-list
657773|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
657774|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658908|NCT03216525|Alvimopan|alvimopan|mesh-list
658909|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
659120|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
659121|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
659590|NCT03213249|Gentamicins|gentamicins|mesh-list
659591|NCT03213249|Cefazolin|cefazolin|mesh-list
659592|NCT03213249|Bacitracin|bacitracin|mesh-list
659593|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
659594|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
659595|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
659596|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659597|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659598|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
659871|NCT03211741|Bevacizumab|bevacizumab|mesh-list
659872|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
659873|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659874|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
659875|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
659876|NCT03211741|Growth Substances|growth substances|mesh-ancestor
659877|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659878|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
660295|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
660296|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660297|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
660298|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
660299|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
660458|NCT03208257|Esmolol|esmolol|mesh-list
660459|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
660460|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
660461|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
660462|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
660463|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
660464|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660465|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661225|NCT03204058|Metformin|metformin|mesh-list
661226|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
661227|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
661228|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661229|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
661230|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
661231|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
661232|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661233|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
661234|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
661235|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661341|NCT03203616|Trastuzumab|trastuzumab|mesh-list
661342|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
661343|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
661344|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661345|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
661346|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
661347|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
661348|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661533|NCT03202563|Metformin|metformin|mesh-list
661534|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
661535|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
661536|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661537|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
661538|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661605|NCT03202186|Progesterone|progesterone|mesh-list
661606|NCT03202186|Progestins|progestins|mesh-ancestor
661607|NCT03202186|Hormones|hormones|mesh-ancestor
657479|NCT03222518|Acetaminophen|acetaminophen|mesh-list
657480|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
657481|NCT03222518|Piroxicam|piroxicam|mesh-list
657482|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
657483|NCT03222518|Analgesics|analgesics|mesh-ancestor
657484|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
657485|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657486|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657487|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
657488|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
657489|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
657490|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
657491|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657492|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657891|NCT03220867|Risperidone|risperidone|mesh-list
657892|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
657893|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
657894|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
657895|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657896|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657897|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
657898|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
657899|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657900|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
657901|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
657902|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
658080|NCT03220126|Mirikizumab|mirikizumab|mesh-list
658081|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
658082|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
658083|NCT03220126|Analgesics|analgesics|mesh-ancestor
658084|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
658085|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
658086|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658087|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
658088|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
658089|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
658090|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
658913|NCT03216343|Chiauranib|chiauranib|mesh-list
658914|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658915|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
658916|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658917|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659239|NCT03215069|Empagliflozin|empagliflozin|mesh-list
659240|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
659241|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659242|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
659243|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659321|NCT03214393|Antibodies|antibodies|mesh-list
659322|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
659323|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659544|NCT03213392|Anesthetics|anesthetics|mesh-list
659545|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659546|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659770|NCT03212495|Neostigmine|neostigmine|mesh-list
659771|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659772|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659773|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
659774|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659775|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
659776|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659777|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
659778|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
659779|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
659844|NCT03211988|Entinostat|entinostat|mesh-list
659845|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659846|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
659847|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659848|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222638|NCT00044577|Abacavir|abacavir|mesh-list
2222639|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
2222640|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
2222641|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222642|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2222643|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
657499|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657500|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
657501|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
659034|NCT03215875|Torsemide|torsemide|mesh-list
659035|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
659036|NCT03215875|Diuretics|diuretics|mesh-ancestor
659037|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
659038|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659039|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
659040|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
659041|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659133|NCT03215719|Cisplatin|cisplatin|mesh-list
659134|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659310|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
659311|NCT03214770|Calcium|calcium|mesh-list
659312|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
659313|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659314|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
660183|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
660184|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
660185|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
660186|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660187|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
660188|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
661052|NCT03204877|Melatonin|melatonin|mesh-list
661053|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
661054|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661055|NCT03204877|Protective Agents|protective agents|mesh-ancestor
661056|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661057|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
661701|NCT03201796|Levofloxacin|levofloxacin|mesh-list
661702|NCT03201796|Ofloxacin|ofloxacin|mesh-list
661703|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
661704|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
661705|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
661706|NCT03201796|Renal Agents|renal agents|mesh-ancestor
661707|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
661708|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
661709|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
661710|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661711|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661712|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661713|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
661714|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2084293|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084294|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
2084295|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084296|NCT02128230|Thalidomide|thalidomide|mesh-list
2084297|NCT02128230|Dexamethasone|dexamethasone|mesh-list
2084298|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
2084299|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
2084300|NCT02128230|Melphalan|melphalan|mesh-list
2084301|NCT02128230|Cisplatin|cisplatin|mesh-list
2084302|NCT02128230|Doxorubicin|doxorubicin|mesh-list
2084303|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2084304|NCT02128230|Etoposide|etoposide|mesh-list
2084305|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
2084306|NCT02128230|Lenalidomide|lenalidomide|mesh-list
2084307|NCT02128230|Lenograstim|lenograstim|mesh-list
2084308|NCT02128230|BB 1101|bb 1101|mesh-list
2084309|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2084310|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
2084311|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084312|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2084313|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2084314|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
2084315|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084316|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084317|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2084318|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2084319|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
2084320|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
2084321|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084322|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084323|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
657567|NCT03222089|Molgramostim|molgramostim|mesh-list
657568|NCT03222089|Sargramostim|sargramostim|mesh-list
657569|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
657570|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
657571|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657572|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
657573|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657574|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
657575|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
657576|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657577|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
657578|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
657579|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657580|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
657581|NCT03222089|Analgesics|analgesics|mesh-ancestor
657582|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
657583|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657584|NCT03222089|Antidotes|antidotes|mesh-ancestor
657585|NCT03222089|Protective Agents|protective agents|mesh-ancestor
657586|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
657587|NCT03222089|Vitamins|vitamins|mesh-ancestor
657588|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
657962|NCT03220256|Lamotrigine|lamotrigine|mesh-list
657963|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
657964|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
657965|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
657966|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657967|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
657968|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657969|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
657970|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
657971|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657972|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
657973|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
658032|NCT03220113|Thiamine|thiamine|mesh-list
658033|NCT03220113|Dexamethasone|dexamethasone|mesh-list
658034|NCT03220113|Lidocaine|lidocaine|mesh-list
658035|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
658036|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
658037|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
658038|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
658039|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658040|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
658041|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
658042|NCT03220113|Hormones|hormones|mesh-ancestor
658043|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
658044|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
658045|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658046|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
658047|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
658048|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
658049|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
658050|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
658051|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
658052|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
658053|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
658054|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658055|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
658056|NCT03220113|Vitamins|vitamins|mesh-ancestor
658057|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
658108|NCT03219788|Remifentanil|remifentanil|mesh-list
658109|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
658110|NCT03219788|Narcotics|narcotics|mesh-ancestor
658111|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
658112|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658113|NCT03219788|Analgesics|analgesics|mesh-ancestor
658114|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
658115|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
658199|NCT03219710|Dexamethasone|dexamethasone|mesh-list
658200|NCT03219710|Ondansetron|ondansetron|mesh-list
658201|NCT03219710|Olanzapine|olanzapine|mesh-list
658202|NCT03219710|Aprepitant|aprepitant|mesh-list
658203|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
658204|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
658205|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
658206|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
658207|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657605|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
657606|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
657607|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657608|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657609|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
657610|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
657611|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
657612|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
657613|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657715|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
657716|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
657717|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657849|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
657850|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
657851|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657852|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657853|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
657854|NCT03220880|Analgesics|analgesics|mesh-ancestor
657855|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
657856|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657857|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
657858|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
657859|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
657860|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
657861|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
657862|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658672|NCT03217838|Azacitidine|azacitidine|mesh-list
658673|NCT03217838|Venetoclax|venetoclax|mesh-list
658674|NCT03217838|Pyrazole|pyrazole|mesh-list
658675|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
658676|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
658677|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658678|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658679|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658973|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
658974|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
658975|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
658976|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658977|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658978|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
658979|NCT03216538|Protective Agents|protective agents|mesh-ancestor
658980|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
658981|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
658982|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658983|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658984|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
658985|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
659050|NCT03215940|Dronabinol|dronabinol|mesh-list
659051|NCT03215940|Cannabidiol|cannabidiol|mesh-list
659052|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
659053|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
659054|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659055|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
659056|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
659057|NCT03215940|Analgesics|analgesics|mesh-ancestor
659058|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
659059|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659060|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
659061|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
659062|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
659063|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659064|NCT03215940|Hormones|hormones|mesh-ancestor
659065|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
660050|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
660051|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
660052|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660300|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
660301|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
660302|NCT03209115|Calcium|calcium|mesh-list
660303|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
660304|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660305|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
660306|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
660307|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657629|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657630|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657631|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
657632|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
657633|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
657634|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657635|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
657636|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
657637|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
657638|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657639|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
657722|NCT03221426|Leucovorin|leucovorin|mesh-list
657723|NCT03221426|Docetaxel|docetaxel|mesh-list
657724|NCT03221426|Fluorouracil|fluorouracil|mesh-list
657725|NCT03221426|Capecitabine|capecitabine|mesh-list
657726|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
657727|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
657728|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
657729|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
657730|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
657731|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
657732|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657733|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
657734|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
657735|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
657736|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
657737|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657738|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
657739|NCT03221426|Antidotes|antidotes|mesh-ancestor
657740|NCT03221426|Protective Agents|protective agents|mesh-ancestor
657741|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
657742|NCT03221426|Vitamins|vitamins|mesh-ancestor
657743|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
658071|NCT03220191|Palbociclib|palbociclib|mesh-list
658072|NCT03220191|Rabeprazole|rabeprazole|mesh-list
658073|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658074|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
658075|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658076|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658077|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
658078|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
658079|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
658718|NCT03217565|Tedizolid|tedizolid|mesh-list
658719|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
658720|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
658721|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
658722|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658723|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
658724|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658725|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658949|NCT03216278|Metformin|metformin|mesh-list
658950|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
658951|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
658952|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658953|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
658954|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659683|NCT03212742|Temozolomide|temozolomide|mesh-list
659684|NCT03212742|Olaparib|olaparib|mesh-list
659685|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
659686|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
659687|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659688|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659689|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
659690|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222644|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661115|NCT03204474|Lacosamide|lacosamide|mesh-list
661116|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
661117|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
661118|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
661119|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
661120|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661208|NCT03203967|Morphine|morphine|mesh-list
661209|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
661210|NCT03203967|Narcotics|narcotics|mesh-ancestor
661211|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789040|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
657664|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657665|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
657666|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
657667|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
657668|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
657669|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657670|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
657671|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
657672|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
657673|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657674|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
657675|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
657676|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
657677|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
657678|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
657679|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658264|NCT03219476|Tamoxifen|tamoxifen|mesh-list
658265|NCT03219476|Letrozole|letrozole|mesh-list
658266|NCT03219476|Anastrozole|anastrozole|mesh-list
658267|NCT03219476|Exemestane|exemestane|mesh-list
658268|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658269|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
658270|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
658271|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658272|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658273|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
658274|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
658275|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
658276|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658277|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
658278|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
658279|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
658280|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2084324|NCT02128230|Hormones|hormones|mesh-ancestor
2084325|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2084326|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2084327|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
2084328|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084329|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2084330|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2084331|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2084332|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2084333|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2084334|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2084335|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2084336|NCT02128230|Growth Substances|growth substances|mesh-ancestor
2084337|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
659110|NCT03215693|Ensartinib|ensartinib|mesh-list
659111|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659112|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
659113|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659114|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084338|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
2084339|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2084340|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084341|NCT02128490|Naproxen|naproxen|mesh-list
2084342|NCT02128490|Colchicine|colchicine|mesh-list
2084343|NCT02128490|Febuxostat|febuxostat|mesh-list
2084344|NCT02128490|Lansoprazole|lansoprazole|mesh-list
2084345|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
2084346|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2084347|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2084348|NCT02128490|Analgesics|analgesics|mesh-ancestor
2084349|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
657703|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
657704|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
657705|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
658014|NCT03220542|Amoxicillin|amoxicillin|mesh-list
658015|NCT03220542|Clarithromycin|clarithromycin|mesh-list
658016|NCT03220542|Sulforaphane|sulforaphane|mesh-list
658017|NCT03220542|Esomeprazole|esomeprazole|mesh-list
658018|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
658019|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658020|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
658021|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
658022|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
658023|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658024|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658025|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
658026|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
658027|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
658028|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
658029|NCT03220542|Protective Agents|protective agents|mesh-ancestor
658030|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658031|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222645|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222646|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2222647|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
658360|NCT03218969|Ecopipam|ecopipam|mesh-list
658361|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
658362|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
658363|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
658364|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658365|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
658366|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
658367|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
658368|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
658369|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658482|NCT03218852|Prednisone|prednisone|mesh-list
658483|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
658484|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
658485|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
658486|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658487|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
658488|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
658489|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
658490|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658491|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658492|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
658493|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
658494|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
658495|NCT03218852|Hormones|hormones|mesh-ancestor
658496|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
658497|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
659255|NCT03215017|Loperamide|loperamide|mesh-list
659256|NCT03215017|Sorbitol|sorbitol|mesh-list
659257|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
659258|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
659259|NCT03215017|Cathartics|cathartics|mesh-ancestor
659623|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
659624|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
659625|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
659626|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
659627|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660479|NCT03208335|Endostatins|endostatins|mesh-list
660480|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660481|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
660482|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
660483|NCT03208335|Growth Substances|growth substances|mesh-ancestor
660484|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660485|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
660605|NCT03207165|Dobutamine|dobutamine|mesh-list
660606|NCT03207165|Milrinone|milrinone|mesh-list
660607|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
660608|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
660609|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
660610|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
660611|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660612|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660613|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2084350|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084351|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084352|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2084353|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2084354|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
2084355|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2084356|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084357|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084358|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
2084359|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
2084360|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
2084361|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084362|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2084363|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
657974|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
657975|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
657976|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
657977|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657978|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657979|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
657980|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
657981|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
657982|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658669|NCT03217942|Mitogens|mitogens|mesh-list
658670|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
658671|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658884|NCT03216980|Antioxidants|antioxidants|mesh-list
658885|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658886|NCT03216980|Protective Agents|protective agents|mesh-ancestor
658887|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659535|NCT03213587|Apatinib|apatinib|mesh-list
659536|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659537|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
659538|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659539|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222648|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
2222649|NCT00044616|Fluoxetine|fluoxetine|mesh-list
2222650|NCT00044616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2222651|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2222652|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
660273|NCT03208985|Ulipristal acetate|ulipristal acetate|mesh-list
660274|NCT03208985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
660275|NCT03208985|Contraceptive Agents|contraceptive agents|mesh-ancestor
660276|NCT03208985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
660277|NCT03208985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660278|NCT03208985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
660438|NCT03208413|Thalidomide|thalidomide|mesh-list
660439|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
660440|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
660441|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660442|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
660443|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
660444|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660445|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
660446|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
660447|NCT03208413|Growth Substances|growth substances|mesh-ancestor
660448|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
660449|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660753|NCT03206671|Cytarabine|cytarabine|mesh-list
660754|NCT03206671|Dexamethasone|dexamethasone|mesh-list
660755|NCT03206671|Prednisolone|prednisolone|mesh-list
660756|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
660757|NCT03206671|Ifosfamide|ifosfamide|mesh-list
660758|NCT03206671|Rituximab|rituximab|mesh-list
660759|NCT03206671|Doxorubicin|doxorubicin|mesh-list
660760|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
660761|NCT03206671|Methotrexate|methotrexate|mesh-list
660762|NCT03206671|Etoposide|etoposide|mesh-list
660763|NCT03206671|Vincristine|vincristine|mesh-list
660764|NCT03206671|Vindesine|vindesine|mesh-list
660765|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
660766|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
660767|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660768|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
660769|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
660770|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
657837|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
657838|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
657839|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
657840|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
657841|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
657842|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
657843|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657844|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
657845|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
657846|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
657847|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
657848|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
658058|NCT03220490|Timolol|timolol|mesh-list
658059|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
658060|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
658061|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
658062|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
658063|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
658064|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658065|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658066|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
658067|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
658068|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
658069|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
658070|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
658234|NCT03219580|Fluorouracil|fluorouracil|mesh-list
658235|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
658236|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658237|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
658238|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658239|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
658240|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
658241|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658756|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
658757|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658758|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658759|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658760|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
658986|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
658987|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
658988|NCT03216304|Calcium|calcium|mesh-list
658989|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
658990|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658991|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
658992|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
658993|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
658994|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
658995|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658996|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
658997|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
658998|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084364|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2084365|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
2084366|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
659303|NCT03214536|Ropivacaine|ropivacaine|mesh-list
659304|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
659305|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659306|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659307|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
659308|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
659309|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659350|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
659351|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
659352|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
659353|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
659354|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
659355|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659356|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659357|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
659661|NCT03213002|Capecitabine|capecitabine|mesh-list
659662|NCT03213002|Temozolomide|temozolomide|mesh-list
659663|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
659664|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
2084367|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657890|NCT03220776|Antidotes|antidotes|mesh-ancestor
659760|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
659761|NCT03212456|Ropivacaine|ropivacaine|mesh-list
659762|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
659763|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
659764|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659765|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659766|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
659767|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659768|NCT03212456|Narcotics|narcotics|mesh-ancestor
659769|NCT03212456|Analgesics|analgesics|mesh-ancestor
659966|NCT03211143|Esomeprazole|esomeprazole|mesh-list
659967|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
659968|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
659969|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
659970|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659971|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660010|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
660011|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
660012|NCT03210688|Prednisone|prednisone|mesh-list
660013|NCT03210688|Prednisolone|prednisolone|mesh-list
660014|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
660015|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
660016|NCT03210688|Hormones|hormones|mesh-ancestor
660017|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
660018|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660019|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
660020|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660021|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
660022|NCT03210688|Vitamins|vitamins|mesh-ancestor
660023|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
660921|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
660922|NCT03205605|Oxybutynin|oxybutynin|mesh-list
660923|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
660924|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
660925|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660926|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660927|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
660928|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
660929|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
660930|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
660931|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660932|NCT03205605|Urological Agents|urological agents|mesh-ancestor
660933|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
660934|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660935|NCT03205605|Renal Agents|renal agents|mesh-ancestor
2222653|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222654|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222655|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
661094|NCT03204578|Midazolam|midazolam|mesh-list
661095|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
661096|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
661097|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
661098|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661099|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
661100|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
661101|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
661102|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
661103|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
661104|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
661105|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
661106|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
661107|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
661108|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661258|NCT03204019|Thalidomide|thalidomide|mesh-list
661259|NCT03204019|Temozolomide|temozolomide|mesh-list
661260|NCT03204019|Tegafur|tegafur|mesh-list
661261|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
661262|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
661263|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661264|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661265|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
661266|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
661267|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661268|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
661269|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
661270|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657984|NCT03220152|Emtricitabine|emtricitabine|mesh-list
657985|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
657986|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
657987|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
657988|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
657989|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
657990|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
657991|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
657992|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
658372|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
658373|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
658374|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658375|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
2084368|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
2084369|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
658576|NCT03218059|Methotrexate|methotrexate|mesh-list
658577|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
658578|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
658579|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
658580|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658581|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
658582|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
658583|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658584|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658585|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
658586|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658587|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
658588|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
658589|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
658590|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
658591|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2084370|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084371|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2084372|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2084373|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
2084374|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084375|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
2084376|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
658761|NCT03217201|Methamphetamine|methamphetamine|mesh-list
658762|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
658763|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658764|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
658765|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
658766|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
658767|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
658768|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
658769|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658770|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
658771|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
658772|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
658773|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
658774|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
659540|NCT03213548|Daminozide|daminozide|mesh-list
659541|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
659542|NCT03213548|Growth Substances|growth substances|mesh-ancestor
659543|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659604|NCT03213145|Rifampin|rifampin|mesh-list
659605|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
659606|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
659607|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
659608|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
659609|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
659610|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
659611|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659612|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659613|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
659614|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
659615|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
659616|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
659617|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
659618|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
659669|NCT03212820|Methamphetamine|methamphetamine|mesh-list
659786|NCT03212469|Tremelimumab|tremelimumab|mesh-list
2222656|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222657|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2222658|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
2222659|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2222660|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2222661|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2222662|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222663|NCT00044629|Zolpidem|zolpidem|mesh-list
2222664|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2222665|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2222666|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2222667|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222668|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2222669|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
2222670|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
658710|NCT03217448|Warfarin|warfarin|mesh-list
658711|NCT03217448|Dabigatran|dabigatran|mesh-list
658712|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
658713|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
658714|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
658715|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
658716|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658717|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658803|NCT03216733|Sirolimus|sirolimus|mesh-list
658804|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
658805|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
658806|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
658807|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658808|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
658809|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
658810|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
658811|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222671|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222672|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222673|NCT00044642|Lorazepam|lorazepam|mesh-list
2222674|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
2222675|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
660024|NCT03210766|Nabilone|nabilone|mesh-list
660025|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
660026|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
660027|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660028|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660029|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
660030|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
660031|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
660032|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
660033|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2222676|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
2222677|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2222678|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660221|NCT03209687|Menotropins|menotropins|mesh-list
660222|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
660223|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
660224|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
660225|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660380|NCT03208712|Atezolizumab|atezolizumab|mesh-list
660381|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660872|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
660873|NCT03206008|Analgesics|analgesics|mesh-ancestor
660874|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
660875|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660876|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660877|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
660878|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
660879|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
660880|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
660881|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
660882|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
660883|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660884|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
660885|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
660886|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
660936|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
660937|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
658208|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
658209|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
658210|NCT03219710|Hormones|hormones|mesh-ancestor
658211|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
658212|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
658213|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658214|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
658215|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
658216|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
658217|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
658218|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
658219|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658220|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
658221|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
658222|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
658223|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
658224|NCT03219710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
658225|NCT03219710|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
658226|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
658227|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
658228|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2222679|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2222680|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2222681|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2222682|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2222683|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2222684|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2222685|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
2222686|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
2222687|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222688|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222689|NCT00044668|Exenatide|exenatide|mesh-list
2222690|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2222691|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658528|NCT03218722|Thrombin|thrombin|mesh-list
658529|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
658530|NCT03218722|Coagulants|coagulants|mesh-ancestor
2084377|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084378|NCT02129075|Poly I-C|poly i-c|mesh-list
2084379|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2084380|NCT02129075|Poly ICLC|poly iclc|mesh-list
2084381|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
2084382|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
2084383|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
2084384|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084385|NCT02129075|Laxatives|laxatives|mesh-ancestor
2084386|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084387|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
2084388|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084389|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2084390|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2084391|NCT02129075|Protective Agents|protective agents|mesh-ancestor
2084392|NCT02129192|Amlodipine|amlodipine|mesh-list
2084393|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
658823|NCT03216941|Ketamine|ketamine|mesh-list
658824|NCT03216941|Olanzapine|olanzapine|mesh-list
658825|NCT03216941|Analgesics|analgesics|mesh-ancestor
658826|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
658827|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
658828|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658829|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
658830|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
658831|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
658832|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
658833|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
658834|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
658835|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
658836|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
658837|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658838|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
658839|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
658840|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
658841|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
658842|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
658843|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2084394|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2222692|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
658301|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
658310|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
658311|NCT03219359|Protective Agents|protective agents|mesh-ancestor
658376|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
658377|NCT03219008|Mirtazapine|mirtazapine|mesh-list
658378|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
658379|NCT03219008|Fluoxetine|fluoxetine|mesh-list
658380|NCT03219008|Bupropion|bupropion|mesh-list
658381|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
658382|NCT03219008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
658383|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
658384|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
658385|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658386|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
658387|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
658388|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658389|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
658390|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
658391|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
658392|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
658393|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
658394|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658395|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
658396|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
658397|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
658398|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
658399|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
658400|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
658401|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
658402|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
658403|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
658404|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
658405|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
658406|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
658407|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
658408|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
658409|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
658410|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
658411|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
658412|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
659260|NCT03214874|Torsemide|torsemide|mesh-list
659261|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
659262|NCT03214874|Diuretics|diuretics|mesh-ancestor
659263|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
659264|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659265|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
659266|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
659267|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659460|NCT03213769|Ubiquinone|ubiquinone|mesh-list
659461|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
659462|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
659463|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659464|NCT03213769|Vitamins|vitamins|mesh-ancestor
659719|NCT03212989|Vorinostat|vorinostat|mesh-list
659720|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659721|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
659722|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659723|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084395|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2084396|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084397|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2084398|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084399|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
2084400|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
2102959|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
659951|NCT03211052|Leuprolide|leuprolide|mesh-list
659952|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
659953|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
659954|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
659955|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659956|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
659957|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660497|NCT03208179|Azithromycin|azithromycin|mesh-list
658665|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
658666|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
658667|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
658668|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222693|NCT00044668|Incretins|incretins|mesh-ancestor
2222694|NCT00044668|Hormones|hormones|mesh-ancestor
2222695|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2222696|NCT00044681|Risperidone|risperidone|mesh-list
2222697|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2222698|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
2222699|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222700|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222701|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222702|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2222703|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2222704|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659435|NCT03214159|Ritonavir|ritonavir|mesh-list
659436|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
659437|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
659438|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
659439|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659440|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659441|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
659442|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
659443|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
659444|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
659445|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
659446|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
659789|NCT03212053|Hemostatics|hemostatics|mesh-list
659790|NCT03212053|Coagulants|coagulants|mesh-ancestor
660053|NCT03210532|Amlodipine|amlodipine|mesh-list
660054|NCT03210532|Telmisartan|telmisartan|mesh-list
660055|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
660056|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
660057|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
660058|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
660059|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
660060|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660061|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
660062|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660063|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
660064|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
660065|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
660066|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
660067|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
660068|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
660069|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660070|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
660071|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
660337|NCT03209232|Infliximab|infliximab|mesh-list
660338|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
660339|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
660340|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2222705|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2222706|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2222707|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
2222708|NCT00044694|Exenatide|exenatide|mesh-list
660720|NCT03206554|Ropivacaine|ropivacaine|mesh-list
660721|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
660722|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
660723|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
660724|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660725|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
660726|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660840|NCT03206255|Vaccines|vaccines|mesh-list
660841|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
660842|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752177|NCT03653247|Plerixafor|plerixafor|mesh-list
661327|NCT03203356|Hormones|hormones|mesh-list
661328|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
661329|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658741|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
658742|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
658743|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658744|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
658745|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
658746|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658747|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
658748|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
658749|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658750|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
658751|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
658752|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
658753|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
658754|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
658755|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
658888|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
658889|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
659335|NCT03214510|Fentanyl|fentanyl|mesh-list
659336|NCT03214510|Hydromorphone|hydromorphone|mesh-list
659337|NCT03214510|Bupivacaine|bupivacaine|mesh-list
659338|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
659339|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
659340|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659341|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659342|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
659343|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659344|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
659345|NCT03214510|Narcotics|narcotics|mesh-ancestor
659346|NCT03214510|Analgesics|analgesics|mesh-ancestor
659347|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
659348|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
659349|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
659447|NCT03213964|Interleukin-2|interleukin-2|mesh-list
659448|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659449|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
659450|NCT03213964|Analgesics|analgesics|mesh-ancestor
659451|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
659452|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659453|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752178|NCT03653247|Busulfan|busulfan|mesh-list
2752179|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
2752180|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752181|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2752182|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
2752183|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752184|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
660403|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
660404|NCT03208582|Diphosphonates|diphosphonates|mesh-list
660405|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
660406|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
660407|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660408|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
660409|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660410|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2222709|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2222710|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222711|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2222712|NCT00044694|Incretins|incretins|mesh-ancestor
2222713|NCT00044694|Hormones|hormones|mesh-ancestor
2222714|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
660956|NCT03205176|Olaparib|olaparib|mesh-list
660957|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
660958|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660959|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660960|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084401|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
2084402|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2084403|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084404|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084405|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
2084406|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2084407|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2084408|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222715|NCT00044707|Pramlintide|pramlintide|mesh-list
658814|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658815|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
658816|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
658817|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658955|NCT03216564|Vitamin D|vitamin d|mesh-list
658956|NCT03216564|Calcitriol|calcitriol|mesh-list
658957|NCT03216564|Vitamins|vitamins|mesh-ancestor
658958|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
658959|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658960|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
658961|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
658962|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
658963|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
658964|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658965|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
659231|NCT03215407|Betamethasone|betamethasone|mesh-list
659232|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
659233|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
659234|NCT03215407|Hormones|hormones|mesh-ancestor
659235|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
659236|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659237|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
659238|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
659293|NCT03214653|Propofol|propofol|mesh-list
659294|NCT03214653|Sevoflurane|sevoflurane|mesh-list
659295|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
659296|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659297|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659298|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
659299|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
659300|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
659301|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
659302|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
659701|NCT03212937|Carboplatin|carboplatin|mesh-list
659702|NCT03212937|Etoposide|etoposide|mesh-list
659703|NCT03212937|Ifosfamide|ifosfamide|mesh-list
659704|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659705|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
659706|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
659707|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
659708|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659709|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659710|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
659711|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
659932|NCT03211104|Curcumin|curcumin|mesh-list
659933|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
659934|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
659935|NCT03211104|Analgesics|analgesics|mesh-ancestor
659936|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
659937|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659938|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659939|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
659940|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
659941|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659942|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659943|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660151|NCT03210038|Lidocaine|lidocaine|mesh-list
660152|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
660153|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
660154|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
660155|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660156|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
660157|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660158|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
660159|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
660160|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
660161|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
660162|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222716|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2222717|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222718|NCT00044720|Sirolimus|sirolimus|mesh-list
2222719|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2222720|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222721|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
658844|NCT03216941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
658845|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
658846|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
658847|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
659177|NCT03215966|Tadalafil|tadalafil|mesh-list
659178|NCT03215966|Macitentan|macitentan|mesh-list
659179|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
659180|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
659181|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
659182|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659183|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659184|NCT03215966|Urological Agents|urological agents|mesh-ancestor
659185|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
659186|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
659187|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2084409|NCT02129426|Midazolam|midazolam|mesh-list
2084410|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
2084411|NCT02129426|Ketamine|ketamine|mesh-list
2084412|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2084413|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2084414|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084415|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2084416|NCT02129426|Analgesics|analgesics|mesh-ancestor
2084417|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
2084418|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084419|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2084420|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2084421|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2084422|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
2084423|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084424|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084425|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
659972|NCT03211338|Progesterone|progesterone|mesh-list
659973|NCT03211338|Mitogens|mitogens|mesh-list
659974|NCT03211338|Progestins|progestins|mesh-ancestor
659975|NCT03211338|Hormones|hormones|mesh-ancestor
659976|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
659977|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659978|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
659979|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660072|NCT03210324|Mifepristone|mifepristone|mesh-list
660073|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
660074|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
660075|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
660076|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660077|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
660078|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
660079|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
660080|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
660081|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
660082|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
660083|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
660084|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
660085|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
660086|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
660087|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2222722|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222723|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
2222724|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
660700|NCT03206658|Spironolactone|spironolactone|mesh-list
660701|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
660702|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
660703|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
660704|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660705|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
660706|NCT03206658|Diuretics|diuretics|mesh-ancestor
660707|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
2084426|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2084427|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
2084428|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
2084429|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2084430|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2222725|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
658880|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
658881|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658882|NCT03216668|Protective Agents|protective agents|mesh-ancestor
658883|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658929|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
658930|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
658931|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
658932|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
658933|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
658934|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
658935|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
658936|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
658937|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658938|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
658939|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659547|NCT03213353|Acetaminophen|acetaminophen|mesh-list
659548|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
659549|NCT03213353|Phenylephrine|phenylephrine|mesh-list
659550|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
659551|NCT03213353|Guaifenesin|guaifenesin|mesh-list
659552|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
659553|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
659554|NCT03213353|Analgesics|analgesics|mesh-ancestor
659555|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
659556|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659557|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659558|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
659559|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
659560|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
659561|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
659562|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
659563|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
659564|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
659565|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
659566|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
659567|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
659568|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
659569|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
659570|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
659571|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659572|NCT03213353|Protective Agents|protective agents|mesh-ancestor
659573|NCT03213353|Expectorants|expectorants|mesh-ancestor
659574|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
659575|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
660423|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
660424|NCT03208452|Analgesics|analgesics|mesh-ancestor
660425|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
660426|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660427|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660428|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
660429|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
660430|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
660431|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
660432|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
660433|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
660434|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660435|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
660436|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
660437|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
660486|NCT03208101|Vaccines|vaccines|mesh-list
660487|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
660488|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660566|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
660567|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660568|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660689|NCT03206957|Endostatins|endostatins|mesh-list
660690|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
660691|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660692|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
660693|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
660694|NCT03206957|Growth Substances|growth substances|mesh-ancestor
660695|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660696|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
2222726|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658927|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
658928|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659454|NCT03213886|Vitamin D|vitamin d|mesh-list
659455|NCT03213886|Calcifediol|calcifediol|mesh-list
659456|NCT03213886|Vitamins|vitamins|mesh-ancestor
659457|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
659458|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659459|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
659599|NCT03213158|Ixazomib|ixazomib|mesh-list
659600|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659601|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
659602|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659603|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659712|NCT03212950|Insulin|insulin|mesh-list
659713|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
659714|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
659715|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
659716|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
659717|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
659718|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659739|NCT03212352|Misoprostol|misoprostol|mesh-list
659740|NCT03212352|Mifepristone|mifepristone|mesh-list
659741|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
659742|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
659743|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
659744|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659745|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
659746|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
659747|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
659748|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
659749|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
659750|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
659751|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
659752|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
659753|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
659754|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
659755|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
659756|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
659757|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
659758|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
659759|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
659791|NCT03211949|Mepivacaine|mepivacaine|mesh-list
659792|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
659793|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
659794|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659795|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659796|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
659797|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2222727|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
2222728|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2222729|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222730|NCT00044746|Tazobactam|tazobactam|mesh-list
2222731|NCT00044746|Piperacillin|piperacillin|mesh-list
2222732|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2222733|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2222734|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660114|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
660115|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
660116|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660163|NCT03209856|Vitamin D|vitamin d|mesh-list
660164|NCT03209856|Calcitriol|calcitriol|mesh-list
660165|NCT03209856|Vitamins|vitamins|mesh-ancestor
660166|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
660167|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660168|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
660169|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
660170|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
660171|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
660172|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660173|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
660365|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
660366|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
660367|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
660368|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660369|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658945|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
658946|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
658947|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
658948|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659072|NCT03215797|Phenylephrine|phenylephrine|mesh-list
659073|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
659074|NCT03215797|Norepinephrine|norepinephrine|mesh-list
659075|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
659076|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
659077|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
659078|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
659079|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659080|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659081|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
659082|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
659083|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
659084|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
659085|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
659086|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
659087|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
659088|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
659089|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659090|NCT03215797|Protective Agents|protective agents|mesh-ancestor
659170|NCT03215498|Insulin|insulin|mesh-list
659171|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
659172|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
659173|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
659174|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
659175|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
659176|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659798|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
659799|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
659800|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659801|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659802|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
659803|NCT03211871|Analgesics|analgesics|mesh-ancestor
659804|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
659805|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659806|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
659807|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
659808|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
659809|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
659810|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
659811|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659857|NCT03211728|Pregabalin|pregabalin|mesh-list
659858|NCT03211728|Analgesics|analgesics|mesh-ancestor
659859|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
659860|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659861|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659862|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
659863|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
659864|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
659865|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659866|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
659867|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
659868|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
659869|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659870|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
659907|NCT03211455|Lidocaine|lidocaine|mesh-list
659908|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
659909|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
659910|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659911|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659912|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
659913|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659914|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
659915|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
659916|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
659917|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
659918|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659962|NCT03211013|Oxytocin|oxytocin|mesh-list
659963|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
659964|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
659965|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658969|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
658970|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
658971|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
658972|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659042|NCT03215927|Abatacept|abatacept|mesh-list
659043|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
659044|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659045|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659046|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
659047|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
659048|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659049|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
659315|NCT03214627|Iron|iron|mesh-list
659316|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
659317|NCT03214627|Hematinics|hematinics|mesh-list
659318|NCT03214627|Trace Elements|trace elements|mesh-ancestor
659319|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
659320|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659465|NCT03213977|Prednisone|prednisone|mesh-list
659466|NCT03213977|Cyclophosphamide|cyclophosphamide|mesh-list
659467|NCT03213977|Doxorubicin|doxorubicin|mesh-list
659468|NCT03213977|Etoposide|etoposide|mesh-list
659469|NCT03213977|Vincristine|vincristine|mesh-list
659470|NCT03213977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
659471|NCT03213977|Immunologic Factors|immunologic factors|mesh-ancestor
659472|NCT03213977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659473|NCT03213977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
659474|NCT03213977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
659475|NCT03213977|Alkylating Agents|alkylating agents|mesh-ancestor
659476|NCT03213977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659477|NCT03213977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659478|NCT03213977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
659479|NCT03213977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
659480|NCT03213977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
659481|NCT03213977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
659482|NCT03213977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659483|NCT03213977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
659484|NCT03213977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
659485|NCT03213977|Glucocorticoids|glucocorticoids|mesh-ancestor
659486|NCT03213977|Hormones|hormones|mesh-ancestor
659487|NCT03213977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
659488|NCT03213977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
659489|NCT03213977|Tubulin Modulators|tubulin modulators|mesh-ancestor
659490|NCT03213977|Antimitotic Agents|antimitotic agents|mesh-ancestor
659491|NCT03213977|Mitosis Modulators|mitosis modulators|mesh-ancestor
659646|NCT03212833|Insulin|insulin|mesh-list
659647|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
659648|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222735|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2222736|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222737|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222738|NCT00044759|Tazobactam|tazobactam|mesh-list
2222739|NCT00044759|Piperacillin|piperacillin|mesh-list
2222740|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2222741|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
660411|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
660412|NCT03208465|Empagliflozin|empagliflozin|mesh-list
660413|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
660414|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660415|NCT03208465|Incretins|incretins|mesh-ancestor
660416|NCT03208465|Hormones|hormones|mesh-ancestor
660417|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
660418|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
660419|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
660420|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660421|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660422|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2222742|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222743|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2222744|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222745|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222746|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2222747|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2084431|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
659003|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
659004|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659005|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659006|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
659007|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
659008|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
659009|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659010|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
659011|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
659012|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
659013|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
659014|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
659220|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
659221|NCT03215264|Entinostat|entinostat|mesh-list
659222|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
659223|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
659224|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
659225|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
659226|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659227|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659228|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
659229|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659230|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
659426|NCT03214003|Cisplatin|cisplatin|mesh-list
659427|NCT03214003|Etoposide|etoposide|mesh-list
659428|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
659429|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659430|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
659431|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
659432|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
659433|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659434|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222748|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2222749|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2222750|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222751|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222752|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659894|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
659895|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
659896|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
659897|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659898|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
659899|NCT03211650|Protective Agents|protective agents|mesh-ancestor
660139|NCT03210025|Methyldopa|methyldopa|mesh-list
660140|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
660141|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
660142|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
660143|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660144|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660145|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
660146|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
660147|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
660148|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
660149|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
660150|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660393|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
660394|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
660395|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660477|NCT03208309|Diacetylrhein|diacetylrhein|mesh-list
660478|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2084432|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2084433|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2084434|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2084435|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
2084436|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
2084437|NCT02129478|Olanzapine|olanzapine|mesh-list
2084438|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
2084439|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
659067|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
659068|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
659069|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659070|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
659071|NCT03216083|Coagulants|coagulants|mesh-ancestor
659367|NCT03214562|Cytarabine|cytarabine|mesh-list
659368|NCT03214562|Fludarabine|fludarabine|mesh-list
659369|NCT03214562|Venetoclax|venetoclax|mesh-list
659370|NCT03214562|Idarubicin|idarubicin|mesh-list
659371|NCT03214562|Lenograstim|lenograstim|mesh-list
659372|NCT03214562|Sargramostim|sargramostim|mesh-list
659373|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659374|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
659375|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
659376|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659377|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
659378|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
659379|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659380|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
659381|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
659382|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
659383|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
659384|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
659385|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
659386|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222753|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2222754|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
2222755|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2222756|NCT00044785|Leucovorin|leucovorin|mesh-list
2222757|NCT00044785|Fluorouracil|fluorouracil|mesh-list
2222758|NCT00044785|Irinotecan|irinotecan|mesh-list
2222759|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
2222760|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222761|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2222762|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222763|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2222764|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
2222765|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222766|NCT00044785|Antidotes|antidotes|mesh-ancestor
2222767|NCT00044785|Protective Agents|protective agents|mesh-ancestor
2222768|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
2222769|NCT00044785|Vitamins|vitamins|mesh-ancestor
2222770|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
2222771|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2222772|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2222773|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222774|NCT00044798|Citalopram|citalopram|mesh-list
660045|NCT03210558|Testosterone|testosterone|mesh-list
660046|NCT03210558|Androgens|androgens|mesh-ancestor
660047|NCT03210558|Hormones|hormones|mesh-ancestor
660048|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
660049|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660341|NCT03209206|Docetaxel|docetaxel|mesh-list
660342|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660343|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
660344|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
660345|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
660346|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660727|NCT03206866|Antibodies|antibodies|mesh-list
660728|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
660729|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084440|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084441|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084442|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084443|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2084444|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2084445|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2084446|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2084447|NCT02129478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2084448|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2084449|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2084450|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084451|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084452|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
2084453|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
2084454|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2222775|NCT00044798|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
659143|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
659144|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
659145|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659146|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
659147|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
659148|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
659149|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659150|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659151|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
659152|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
659153|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
659154|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
659155|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659156|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
659157|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
659158|NCT03215524|Hormones|hormones|mesh-ancestor
659159|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
659160|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
659161|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
659162|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659163|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
659164|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
659165|NCT03215524|Growth Substances|growth substances|mesh-ancestor
659166|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
659167|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
659168|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
659169|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
659724|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
659725|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
659726|NCT03212755|Antibodies|antibodies|mesh-list
659727|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
659728|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
659729|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659812|NCT03211897|Midazolam|midazolam|mesh-list
659813|NCT03211897|Haloperidol|haloperidol|mesh-list
659814|NCT03211897|Olanzapine|olanzapine|mesh-list
659815|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
659816|NCT03211897|Ziprasidone|ziprasidone|mesh-list
659817|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
659818|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
659819|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659820|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659821|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
659822|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
659823|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
659824|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
659825|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
659826|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
659827|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
659828|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
659829|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
659830|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659831|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
659832|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
659833|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659834|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
659835|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
659836|NCT03211897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
659837|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
659838|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
659839|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
659840|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
659841|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
659842|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
659843|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
659879|NCT03211572|Tamoxifen|tamoxifen|mesh-list
659880|NCT03211572|Anastrozole|anastrozole|mesh-list
659881|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
659882|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
659883|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
659884|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659885|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
659886|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659887|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
659888|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
659889|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2222776|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2222777|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2222778|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222779|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222780|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
2222781|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222782|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2222783|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
2222784|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
659412|NCT03214055|Mannitol|mannitol|mesh-list
659413|NCT03214055|Diuretics|diuretics|mesh-list
659414|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
659415|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
659416|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660088|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
660089|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
660090|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
660091|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660092|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660093|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
660094|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
660095|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
660096|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660196|NCT03209622|Nicotine|nicotine|mesh-list
660197|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
660198|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
660199|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660200|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660201|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
660202|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
660203|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
660204|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
660205|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660320|NCT03209219|Interferons|interferons|mesh-list
660321|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
660322|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
660323|NCT03209219|Cyclosporine|cyclosporine|mesh-list
660324|NCT03209219|Cyclosporins|cyclosporins|mesh-list
660325|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660326|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
660327|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660328|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660329|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660330|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
660331|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
660332|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660333|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
660334|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
660335|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
660336|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
660475|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
660476|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660582|NCT03207451|Aspirin|aspirin|mesh-list
660583|NCT03207451|Clopidogrel|clopidogrel|mesh-list
660584|NCT03207451|Vorapaxar|vorapaxar|mesh-list
660585|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
660586|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
660587|NCT03207451|Analgesics|analgesics|mesh-ancestor
660588|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
660589|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660590|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660591|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
660592|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
660593|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
660594|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
660595|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660596|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
660597|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
660598|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660599|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
660600|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
660601|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
660602|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
660603|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
660604|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222785|NCT00044811|Fexofenadine|fexofenadine|mesh-list
2222786|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2222787|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2222788|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2222789|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
2222790|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
659649|NCT03212716|Oseltamivir|oseltamivir|mesh-list
659650|NCT03212716|Diltiazem|diltiazem|mesh-list
659651|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
659652|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
659653|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659654|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659655|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
659656|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
659657|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
659658|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
659659|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659660|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
2222791|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222792|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222793|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660002|NCT03210610|Colchicine|colchicine|mesh-list
660003|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
660004|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
660005|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
660006|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
660007|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
660008|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660009|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222794|NCT00044824|Fexofenadine|fexofenadine|mesh-list
2222795|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2222796|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2222797|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2222798|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
2222799|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
2222800|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222801|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222802|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084455|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084456|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
2084457|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2084458|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2084459|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2084460|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
2084461|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084462|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084463|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084464|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
2084465|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084466|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
2084467|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2084468|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2084469|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084470|NCT02129725|Urological Agents|urological agents|mesh-ancestor
2084471|NCT02130024|Ranibizumab|ranibizumab|mesh-list
2084472|NCT02130024|Aflibercept|aflibercept|mesh-list
2084473|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2084474|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2084475|NCT02130024|Growth Substances|growth substances|mesh-ancestor
2084476|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084477|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
2084478|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084479|NCT02130063|Iron|iron|mesh-list
2084480|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2084481|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2084482|NCT02130063|Trace Elements|trace elements|mesh-ancestor
2084483|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
659501|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
659502|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
659503|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
659504|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659505|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
659506|NCT03213743|Analgesics|analgesics|mesh-ancestor
659507|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
659508|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659509|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
659510|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
659511|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
659512|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
659513|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
659514|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659628|NCT03212807|Lenalidomide|lenalidomide|mesh-list
659629|NCT03212807|Durvalumab|durvalumab|mesh-list
659630|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
659631|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659632|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
659633|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
659634|NCT03212807|Growth Substances|growth substances|mesh-ancestor
659635|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
659636|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659637|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
659944|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
659945|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
659946|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
659947|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
659948|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659949|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
659950|NCT03211286|Coagulants|coagulants|mesh-ancestor
2222803|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2222804|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
2222805|NCT00044837|Estradiol|estradiol|mesh-list
2222806|NCT00044837|Estrogens|estrogens|mesh-ancestor
2222807|NCT00044837|Hormones|hormones|mesh-ancestor
2222808|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2222809|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222810|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2222811|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
2222812|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
660531|NCT03207698|Metformin|metformin|mesh-list
660532|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
660533|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660644|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
660855|NCT03206203|Carboplatin|carboplatin|mesh-list
660856|NCT03206203|Atezolizumab|atezolizumab|mesh-list
660857|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661046|NCT03205033|Melatonin|melatonin|mesh-list
661047|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
661048|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661049|NCT03205033|Protective Agents|protective agents|mesh-ancestor
661050|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661051|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
661172|NCT03204097|Alendronate|alendronate|mesh-list
661173|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
661174|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661486|NCT03202875|Insulin|insulin|mesh-list
661487|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
661488|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
661489|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
661490|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
661491|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
661492|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661586|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
661587|NCT03202446|Chitosan|chitosan|mesh-list
661588|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
661589|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
659522|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
659523|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659730|NCT03212677|Iron|iron|mesh-list
659731|NCT03212677|Trace Elements|trace elements|mesh-ancestor
659732|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
659733|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084484|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084485|NCT02130063|Hematinics|hematinics|mesh-ancestor
2084486|NCT02130284|Insulin|insulin|mesh-list
2084487|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2084488|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
660097|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
660098|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
660099|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
660100|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
660101|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
660102|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660103|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
660104|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
660105|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
660106|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
660107|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
660108|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
660109|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
660110|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
660802|NCT03206138|Imiquimod|imiquimod|mesh-list
660803|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
660804|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
660805|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660806|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660807|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
660861|NCT03206021|Carboplatin|carboplatin|mesh-list
660862|NCT03206021|Azacitidine|azacitidine|mesh-list
660863|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660864|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
660865|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
660866|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660867|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661141|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
661142|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
661143|NCT03204318|Norethindrone|norethindrone|mesh-list
661144|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
661145|NCT03204318|Estradiol|estradiol|mesh-list
661146|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
661147|NCT03204318|Relugolix|relugolix|mesh-list
661148|NCT03204318|Estrogens|estrogens|mesh-ancestor
661149|NCT03204318|Hormones|hormones|mesh-ancestor
661150|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
661151|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661152|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
661153|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
661154|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
661155|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
661156|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
661157|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
661158|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
661159|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
661160|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
661758|NCT03201393|Acetaminophen|acetaminophen|mesh-list
661759|NCT03201393|Naltrexone|naltrexone|mesh-list
661760|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
661761|NCT03201393|Analgesics|analgesics|mesh-ancestor
661762|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
661763|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
661764|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661765|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
661766|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
661767|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2084489|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084490|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
2084491|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084492|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2084493|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084494|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084495|NCT02130635|Nemiralisib|nemiralisib|mesh-list
659665|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659666|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
659667|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
659668|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
659983|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
659984|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
659985|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659986|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
659987|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660174|NCT03209908|Tenofovir|tenofovir|mesh-list
660175|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
660176|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660177|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
660178|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
660179|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660180|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660181|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
660182|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
660450|NCT03208218|Lenalidomide|lenalidomide|mesh-list
660451|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
660452|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660453|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
660454|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
660455|NCT03208218|Growth Substances|growth substances|mesh-ancestor
660456|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
660457|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660569|NCT03207334|Cytarabine|cytarabine|mesh-list
660570|NCT03207334|Midostaurin|midostaurin|mesh-list
660571|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
660572|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
660573|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660574|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660575|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
660576|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660577|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
660578|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
660579|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660580|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
660581|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084496|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2084497|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084498|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084499|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2084500|NCT02130687|Aprepitant|aprepitant|mesh-list
661026|NCT03204786|Vasopressins|vasopressins|mesh-list
661027|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
661028|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
661029|NCT03204786|Coagulants|coagulants|mesh-ancestor
661030|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
661031|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
661032|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
661033|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222813|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2222814|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2222815|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2222816|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2222817|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2222818|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2222819|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222820|NCT00044863|Cetuximab|cetuximab|mesh-list
2222821|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2222822|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222823|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
2222824|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2222825|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
2222826|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
659670|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
659671|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
659672|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
659673|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
659674|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
659675|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
659676|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
659677|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
659678|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
659679|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
659680|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
659681|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
659682|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
659927|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
659928|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
659929|NCT03211065|Antibodies|antibodies|mesh-list
659930|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
659931|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084501|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2084502|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084503|NCT02130687|Incretins|incretins|mesh-ancestor
2084504|NCT02130687|Hormones|hormones|mesh-ancestor
2084505|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2084506|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2084507|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
2084508|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084509|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084510|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
2084511|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
2084512|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084513|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084514|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2084515|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084516|NCT02131064|Carboplatin|carboplatin|mesh-list
2084517|NCT02131064|Docetaxel|docetaxel|mesh-list
2084518|NCT02131064|Trastuzumab|trastuzumab|mesh-list
2084519|NCT02131064|Pertuzumab|pertuzumab|mesh-list
661374|NCT03203473|Nivolumab|nivolumab|mesh-list
661375|NCT03203473|Ipilimumab|ipilimumab|mesh-list
661376|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
661377|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661378|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
661379|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661647|NCT03202316|Atezolizumab|atezolizumab|mesh-list
661648|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
661649|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661650|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
661651|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084520|NCT02131064|Maytansine|maytansine|mesh-list
2084521|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2084522|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084523|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
2084524|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
2084525|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
2084526|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084527|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2084528|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2084529|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
2084530|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2084531|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2084532|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2084533|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
2084534|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084535|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2084536|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2084537|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084538|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084539|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2102960|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659787|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
659788|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660750|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
660751|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
660752|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
661109|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
661110|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
661111|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
661112|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661113|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
661114|NCT03204565|Protective Agents|protective agents|mesh-ancestor
661437|NCT03202849|Vitamin D|vitamin d|mesh-list
661438|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
661439|NCT03202849|Vitamins|vitamins|mesh-list
661440|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
661441|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661442|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
661443|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2084540|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2084541|NCT02131259|Afatinib|afatinib|mesh-list
2084542|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084543|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2084544|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084545|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084546|NCT02131272|Insulin|insulin|mesh-list
2084547|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2084548|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
2084549|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
2084550|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
2084551|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
2084552|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2084553|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084554|NCT02131324|Clobetasol|clobetasol|mesh-list
2084555|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2084556|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
2084557|NCT02131324|Hormones|hormones|mesh-ancestor
2084558|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2084559|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084560|NCT02132117|Phenylephrine|phenylephrine|mesh-list
2084561|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
2084562|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2084563|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2084564|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
2084565|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084566|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084567|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084568|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
2084569|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
2084570|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084571|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
2084572|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2084573|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
2084574|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2084575|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
2084576|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2084577|NCT02132117|Protective Agents|protective agents|mesh-ancestor
2084578|NCT02132169|Cetirizine|cetirizine|mesh-list
2084579|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2084580|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2084581|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2084582|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
2084583|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
2084584|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084585|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084586|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084587|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2084588|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2084589|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
2084590|NCT02132195|Hormones|hormones|mesh-ancestor
2084591|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2084592|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084593|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084594|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084595|NCT02132247|Diclofenac|diclofenac|mesh-list
2084596|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
659890|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
659891|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
659892|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
659893|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660128|NCT03210064|Fluorouracil|fluorouracil|mesh-list
660129|NCT03210064|Apatinib|apatinib|mesh-list
660130|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
660131|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660132|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
660133|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660134|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
660135|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
660136|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660137|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
660138|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660206|NCT03209427|Morphine|morphine|mesh-list
660207|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
660208|NCT03209427|Narcotics|narcotics|mesh-ancestor
660209|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
660210|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660211|NCT03209427|Analgesics|analgesics|mesh-ancestor
660212|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
660213|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660309|NCT03209193|Sevoflurane|sevoflurane|mesh-list
660310|NCT03209193|Desflurane|desflurane|mesh-list
660311|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
660312|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
660313|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
660314|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
660315|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
660316|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084597|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2084598|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2084599|NCT02132247|Analgesics|analgesics|mesh-ancestor
2084600|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
660640|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
660641|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
660642|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
660643|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
661618|NCT03202628|Dexamethasone|dexamethasone|mesh-list
661619|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
661620|NCT03202628|Pomalidomide|pomalidomide|mesh-list
661621|NCT03202628|Ixazomib|ixazomib|mesh-list
661622|NCT03202628|Ichthammol|ichthammol|mesh-list
661623|NCT03202628|BB 1101|bb 1101|mesh-list
661624|NCT03202628|Glycine|glycine|mesh-list
661625|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
661626|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
661627|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
661628|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
661629|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661630|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
661631|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
661632|NCT03202628|Hormones|hormones|mesh-ancestor
661633|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
661634|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
661635|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661636|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661637|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
661638|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661639|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
661640|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
661641|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
661642|NCT03202628|Growth Substances|growth substances|mesh-ancestor
661643|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
661644|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
661645|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
661646|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084601|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084602|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084603|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2084604|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2084605|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2084606|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084607|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084608|NCT02132312|Phenylephrine|phenylephrine|mesh-list
2084609|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
2222827|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222828|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2222829|NCT00044889|Clofarabine|clofarabine|mesh-list
2222830|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2222831|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
2222832|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222833|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660034|NCT03210545|Betamethasone|betamethasone|mesh-list
660035|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
660036|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
660037|NCT03210545|Hormones|hormones|mesh-ancestor
660038|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
660039|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660040|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
660041|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
660396|NCT03208894|Furosemide|furosemide|mesh-list
660397|NCT03208894|Diuretics|diuretics|mesh-ancestor
660398|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
660399|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660400|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
660401|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
660402|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660468|NCT03208270|Antithrombins|antithrombins|mesh-list
660469|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
660470|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
660471|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
660472|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660473|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660474|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
660832|NCT03206177|Paclitaxel|paclitaxel|mesh-list
660833|NCT03206177|Carboplatin|carboplatin|mesh-list
660834|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
660835|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660836|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
660837|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
660838|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
660839|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222834|NCT00044902|Epratuzumab|epratuzumab|mesh-list
2222835|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2222836|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222837|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
2222838|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
661360|NCT03203408|Hylan|hylan|mesh-list
661361|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
661362|NCT03203408|Protective Agents|protective agents|mesh-ancestor
661363|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661462|NCT03203070|Dipyrone|dipyrone|mesh-list
661463|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
661464|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
661465|NCT03203070|Analgesics|analgesics|mesh-ancestor
661466|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
661467|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
661468|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661469|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
661470|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
661471|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
2222839|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2222840|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
2222841|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222842|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222843|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222844|NCT00044928|Tazobactam|tazobactam|mesh-list
2222845|NCT00044928|Piperacillin|piperacillin|mesh-list
2222846|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2222847|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2222848|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222849|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2222850|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222851|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222852|NCT00044954|Cyclosporine|cyclosporine|mesh-list
661728|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
661729|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
661730|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084610|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2222853|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
660270|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
660271|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
660272|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660629|NCT03207477|Mydriatics|mydriatics|mesh-list
660630|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
660631|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660632|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661058|NCT03204760|Dexamethasone|dexamethasone|mesh-list
661059|NCT03204760|Prednisolone|prednisolone|mesh-list
661060|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
661061|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
661062|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
661063|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
661064|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661065|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
661066|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
661067|NCT03204760|Hormones|hormones|mesh-ancestor
661068|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
661069|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
661070|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661175|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
661176|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
661177|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
661178|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661179|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
661180|NCT03204006|Analgesics|analgesics|mesh-ancestor
661181|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
661182|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
661183|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
661184|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
661185|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
661186|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
661187|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
661188|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661472|NCT03202979|Trazodone|trazodone|mesh-list
661473|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
661474|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
661475|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
661476|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661477|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
661478|NCT03202979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
661479|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
661480|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
661481|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661482|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
661483|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
661484|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
661485|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
2084611|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
2084612|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
2084613|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084614|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084615|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
2084616|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2084617|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
2084618|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
2084619|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2084620|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2084621|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2084622|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
2084623|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084624|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084625|NCT02132312|Protective Agents|protective agents|mesh-ancestor
2084626|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
2084627|NCT02132468|Combretastatin|combretastatin|mesh-list
2084628|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2084629|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084630|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
2084631|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
2084632|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
2084633|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084634|NCT02132533|Nifedipine|nifedipine|mesh-list
2084635|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
660245|NCT03209661|Menthol|menthol|mesh-list
660246|NCT03209661|Nicotine|nicotine|mesh-list
660247|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
660248|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
660249|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660250|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660251|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
660252|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
660253|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
660254|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
660255|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660256|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
660257|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
660347|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
660348|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
660514|NCT03208426|Amoxicillin|amoxicillin|mesh-list
660515|NCT03208426|Metronidazole|metronidazole|mesh-list
660516|NCT03208426|Clarithromycin|clarithromycin|mesh-list
660517|NCT03208426|Tetracycline|tetracycline|mesh-list
660518|NCT03208426|Esomeprazole|esomeprazole|mesh-list
660519|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
660520|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660521|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
660522|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
660523|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
660524|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
660525|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
660526|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660527|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660528|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
660529|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
660530|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2222854|NCT00044954|Fludarabine|fludarabine|mesh-list
2222855|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
2222856|NCT00044954|Cyclosporins|cyclosporins|mesh-list
2222857|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222858|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2222859|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
2222860|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222861|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2222862|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
2222863|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222864|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222865|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
2222866|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
661252|NCT03203876|Nivolumab|nivolumab|mesh-list
661253|NCT03203876|Ipilimumab|ipilimumab|mesh-list
661254|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
661255|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661256|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
661257|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661514|NCT03202459|Pregabalin|pregabalin|mesh-list
661515|NCT03202459|Gabapentin|gabapentin|mesh-list
661516|NCT03202459|Analgesics|analgesics|mesh-ancestor
661517|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
661518|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
661519|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661520|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
661521|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
661522|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
661523|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661524|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
661525|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
661526|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
661527|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
661528|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
661529|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
661530|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
661531|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
661532|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
2084636|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2084637|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084638|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2084639|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084640|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
660289|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
660290|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
660291|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
660292|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
660293|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
660294|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2084641|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
2084642|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2084643|NCT02132637|Insulin|insulin|mesh-list
660563|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
660564|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
660565|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661236|NCT03204045|Fentanyl|fentanyl|mesh-list
661237|NCT03204045|Oxycodone|oxycodone|mesh-list
661238|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
661239|NCT03204045|Narcotics|narcotics|mesh-ancestor
661240|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
661241|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661242|NCT03204045|Analgesics|analgesics|mesh-ancestor
661243|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
661244|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
661245|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
661246|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
661247|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
661248|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
661731|NCT03201835|Nabiximols|nabiximols|mesh-list
661732|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661733|NCT03201835|Analgesics|analgesics|mesh-ancestor
661734|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
661735|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084644|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2084645|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
2084646|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2084647|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084648|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
2084649|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2084650|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084651|NCT02132767|Digoxin|digoxin|mesh-list
2084652|NCT02132767|Amiodarone|amiodarone|mesh-list
2084653|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
2084654|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2084655|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084656|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2084657|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2084658|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084659|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084660|NCT02132767|Protective Agents|protective agents|mesh-ancestor
2084661|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
2084662|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2084663|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2084664|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2084665|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2084666|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2084667|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2084668|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2084669|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2084670|NCT02132832|Buspirone|buspirone|mesh-list
2084671|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2084672|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2084673|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2084674|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084675|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2084676|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2084677|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
2084678|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084679|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084680|NCT02132936|Calcipotriene|calcipotriene|mesh-list
2084681|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
2084682|NCT02132949|Paclitaxel|paclitaxel|mesh-list
2084683|NCT02132949|Docetaxel|docetaxel|mesh-list
2084684|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
2084685|NCT02132949|Doxorubicin|doxorubicin|mesh-list
2084686|NCT02132949|Fluorouracil|fluorouracil|mesh-list
2084687|NCT02132949|Trastuzumab|trastuzumab|mesh-list
2084688|NCT02132949|Epirubicin|epirubicin|mesh-list
2084689|NCT02132949|Pertuzumab|pertuzumab|mesh-list
2222867|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
660308|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
660492|NCT03208361|Amoxicillin|amoxicillin|mesh-list
660493|NCT03208361|Penicillins|penicillins|mesh-list
660494|NCT03208361|Penicillin V|penicillin v|mesh-list
660495|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
660496|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660645|NCT03206944|Aspirin|aspirin|mesh-list
660646|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
660647|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
660648|NCT03206944|Analgesics|analgesics|mesh-ancestor
660649|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
660650|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660651|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660652|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
660653|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
660654|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
660655|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
660656|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660657|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
660658|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
660659|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660660|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
660939|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
660940|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
660941|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661364|NCT03203317|Insulin|insulin|mesh-list
661365|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
661366|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661690|NCT03201770|Artesunate|artesunate|mesh-list
661691|NCT03201770|Pyronaridine|pyronaridine|mesh-list
661692|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
661693|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
661694|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
661695|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
661696|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661697|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
661698|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
661699|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
661700|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
2084690|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2084691|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084692|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
2084693|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
2084694|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
2084695|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084696|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2084697|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
2084698|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084699|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2084700|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2084701|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
2084702|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2084703|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2084704|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2084705|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2084706|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084707|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
2084708|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2084709|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2084710|NCT02133001|Esketamine|esketamine|mesh-list
2084711|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
2084712|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2084713|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
2084714|NCT02133131|Grazoprevir|grazoprevir|mesh-list
2084715|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
2084716|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084717|NCT02133352|Ranolazine|ranolazine|mesh-list
2084718|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2084719|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2084720|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084721|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
2084722|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
2084723|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084724|NCT02133664|Protective Agents|protective agents|mesh-ancestor
2084725|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084726|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
2084727|NCT02133664|Vitamins|vitamins|mesh-ancestor
660370|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
660371|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
660372|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
660373|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
660374|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660375|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
660376|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
660377|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
660378|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
660379|NCT03208764|Protective Agents|protective agents|mesh-ancestor
660466|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
660467|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660554|NCT03207308|Vitamin A|vitamin a|mesh-list
660555|NCT03207308|Vitamins|vitamins|mesh-ancestor
660556|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
660557|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660708|NCT03206723|Hydrocodone|hydrocodone|mesh-list
660709|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
660710|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
660711|NCT03206723|Narcotics|narcotics|mesh-ancestor
660712|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
660713|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660714|NCT03206723|Analgesics|analgesics|mesh-ancestor
660715|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
660716|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660717|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
660718|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
660719|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
660906|NCT03205761|Olaparib|olaparib|mesh-list
660907|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
660908|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660909|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660910|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661071|NCT03204734|Capecitabine|capecitabine|mesh-list
661072|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
661073|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
661074|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661075|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661249|NCT03204071|Metformin|metformin|mesh-list
661250|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
661251|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661681|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
661682|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
661683|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
661684|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661685|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661686|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
661687|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
661688|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
661689|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084728|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
2084729|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
2084730|NCT02133742|Axitinib|axitinib|mesh-list
2084731|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2084732|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084733|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2084734|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084735|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084736|NCT02133781|Vaccines|vaccines|mesh-list
2084737|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
2084738|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084739|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2084740|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084741|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2084742|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084743|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084744|NCT02134184|Vaccines|vaccines|mesh-list
2084745|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
2084746|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084747|NCT02134210|Etanercept|etanercept|mesh-list
2084748|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2084749|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2084750|NCT02134210|Analgesics|analgesics|mesh-ancestor
2084751|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
2084752|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660386|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660387|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
660388|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
660389|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
660390|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660391|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660392|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2084753|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084754|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2084755|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2084756|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
660697|NCT03206931|Selitrectinib|selitrectinib|mesh-list
660698|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660699|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222868|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2222869|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2222870|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2222871|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2222872|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
2222873|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2222874|NCT00044993|Docetaxel|docetaxel|mesh-list
2222875|NCT00044993|Doxorubicin|doxorubicin|mesh-list
2222876|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2222877|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222878|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
2222879|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
661081|NCT03204799|Metformin|metformin|mesh-list
661082|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
661083|NCT03204799|Ezetimibe|ezetimibe|mesh-list
661084|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
661085|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661086|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
661087|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
661088|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
661089|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661090|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
661189|NCT03204032|Thalidomide|thalidomide|mesh-list
661190|NCT03204032|Temozolomide|temozolomide|mesh-list
661191|NCT03204032|Tegafur|tegafur|mesh-list
661192|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
661193|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
661194|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661195|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661196|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
661197|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
661198|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661199|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
661200|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
661201|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
661202|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
661203|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
661204|NCT03204032|Growth Substances|growth substances|mesh-ancestor
661205|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
661206|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
661207|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
661277|NCT03203668|Choline|choline|mesh-list
661278|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
661279|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
661280|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
661281|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661282|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
661283|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
661284|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
2222880|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
2222881|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222882|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2222883|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2222884|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2222885|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222886|NCT00045006|Vorinostat|vorinostat|mesh-list
2222887|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084757|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
660498|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
660499|NCT03208179|Piperaquine|piperaquine|mesh-list
660500|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
660501|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
660502|NCT03208179|Artenimol|artenimol|mesh-list
660503|NCT03208179|Artemisinins|artemisinins|mesh-list
660504|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
660505|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660506|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
660507|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
660508|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
660509|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
660510|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660511|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660512|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
660513|NCT03208179|Renal Agents|renal agents|mesh-ancestor
2222888|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2222889|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222890|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222891|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2222892|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2222893|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222894|NCT00045136|Melphalan|melphalan|mesh-list
2222895|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2222896|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
2222897|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222898|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222899|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2222900|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2222901|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
2222902|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222903|NCT00045149|Aldesleukin|aldesleukin|mesh-list
2222904|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752185|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661121|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
661122|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
661123|NCT03204331|Norethindrone|norethindrone|mesh-list
661124|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
661125|NCT03204331|Estradiol|estradiol|mesh-list
661126|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
661127|NCT03204331|Relugolix|relugolix|mesh-list
661128|NCT03204331|Estrogens|estrogens|mesh-ancestor
661129|NCT03204331|Hormones|hormones|mesh-ancestor
661130|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
661131|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661132|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
661133|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
661134|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
661135|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
661136|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
661137|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
661138|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
661139|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
661140|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
2084758|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
2084759|NCT02134314|Complement C1s|complement c1s|mesh-list
2084760|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2084761|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2084762|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
2084763|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084764|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2084765|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2084766|NCT02134353|Mannitol|mannitol|mesh-list
2084767|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2084768|NCT02134353|Diuretics|diuretics|mesh-ancestor
2084769|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
2084770|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752186|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2752187|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2752188|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2752189|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
2752190|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660614|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
660615|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
660616|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
660617|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
660618|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660619|NCT03207165|Protective Agents|protective agents|mesh-ancestor
660620|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
660621|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
660622|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
660623|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661349|NCT03203590|Carboplatin|carboplatin|mesh-list
661350|NCT03203590|Vinorelbine|vinorelbine|mesh-list
661351|NCT03203590|Gefitinib|gefitinib|mesh-list
661352|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661353|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
661354|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
661355|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
661356|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
661357|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661358|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
661359|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084784|NCT02134951|Ketamine|ketamine|mesh-list
2084785|NCT02134951|Analgesics|analgesics|mesh-ancestor
2084786|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
2084787|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084788|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084789|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2084790|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2084791|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
2084792|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
2084793|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2084794|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2084795|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2084796|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084797|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084798|NCT02134977|Leuprolide|leuprolide|mesh-list
2084799|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2084800|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
2084801|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2084802|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084803|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2084804|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084805|NCT02135016|Lidocaine|lidocaine|mesh-list
2084806|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
2084807|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
2084808|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2084809|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084810|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
2084811|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084812|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2084813|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2084814|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2084815|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2084816|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084826|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
2084827|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
660625|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660829|NCT03206411|Hormones|hormones|mesh-list
660830|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
660831|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661367|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
661368|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
661369|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
661370|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
661371|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661372|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661373|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
661427|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
661428|NCT03202836|Progesterone|progesterone|mesh-list
661429|NCT03202836|Progestins|progestins|mesh-ancestor
661430|NCT03202836|Hormones|hormones|mesh-ancestor
661431|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
661432|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661433|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2084828|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2084829|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
2084830|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084831|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084832|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084833|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
2084834|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
2084835|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084836|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
2084837|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2084838|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
2084839|NCT02135107|Rabeprazole|rabeprazole|mesh-list
2084840|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2084841|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084842|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2084843|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084844|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084845|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
2084846|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2084847|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2084848|NCT02135432|Ivacaftor|ivacaftor|mesh-list
2084849|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2084850|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2084851|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084852|NCT02135445|Relugolix|relugolix|mesh-list
2084853|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
2084854|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
2084855|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2084856|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752213|NCT03642028|Suvorexant|suvorexant|mesh-list
2752214|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2752215|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2752216|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2752217|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752218|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2752219|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2752220|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752227|NCT03636451|Lidocaine|lidocaine|mesh-list
2752228|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
2752229|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
2084878|NCT02136420|Promethazine|promethazine|mesh-list
2084879|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
2084880|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
2084881|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
2084882|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2084883|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
2084884|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
2084885|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2222905|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2222906|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2222907|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
2222908|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222909|NCT00045175|Topotecan|topotecan|mesh-list
660961|NCT03205228|Flupenthixol|flupenthixol|mesh-list
660962|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
660963|NCT03205228|Omeprazole|omeprazole|mesh-list
660964|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
660965|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
660966|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
660967|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660968|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660969|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
660970|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
660971|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
660972|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
660973|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
660974|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
660975|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
660976|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
661023|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
661024|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
661025|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2084886|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084887|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084888|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2084889|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2084890|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2084891|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2084892|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
2084893|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
2084894|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
2084895|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084896|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
2084897|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
2752230|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2752231|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752232|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
2752233|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2752234|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2752235|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2752236|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2084898|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084899|NCT02136498|Varenicline|varenicline|mesh-list
2084900|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2084901|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2084902|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
2084903|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084904|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084905|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084906|NCT02136576|Listerine|listerine|mesh-list
2084907|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
2084908|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
2084909|NCT02136576|Protective Agents|protective agents|mesh-ancestor
2084910|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084911|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2084912|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084913|NCT02136914|Amantadine|amantadine|mesh-list
2084914|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2084915|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2084916|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
2084917|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2084918|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
2084919|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084920|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084921|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084922|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2084923|NCT02136914|Analgesics|analgesics|mesh-ancestor
2084924|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
2084925|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084926|NCT02137226|Adalimumab|adalimumab|mesh-list
2084927|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2084928|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2752237|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2222910|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
660771|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
660772|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
660773|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
660774|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
660775|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
660776|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
660777|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660778|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
660779|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
660780|NCT03206671|Hormones|hormones|mesh-ancestor
660781|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
660782|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
660783|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
660784|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
660785|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
660786|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
660787|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
660788|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
660789|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
660790|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
660791|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
660792|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
660793|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
660794|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
660795|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
660796|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
660797|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
660798|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
660799|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
660800|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
660801|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
2752238|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752239|NCT03629340|Metformin|metformin|mesh-list
2752240|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2752241|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661336|NCT03203642|XL647|xl647|mesh-list
661337|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661338|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
661339|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661340|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661496|NCT03202758|Durvalumab|durvalumab|mesh-list
661497|NCT03202758|Tremelimumab|tremelimumab|mesh-list
661498|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
661499|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752242|NCT03629171|Cytarabine|cytarabine|mesh-list
2752243|NCT03629171|Daunorubicin|daunorubicin|mesh-list
2752244|NCT03629171|Venetoclax|venetoclax|mesh-list
2752245|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2752246|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
2752247|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752248|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752249|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
2752250|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2752251|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2752252|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
2752253|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752254|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2752255|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2752256|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2752257|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752258|NCT03626545|Docetaxel|docetaxel|mesh-list
2752259|NCT03626545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752260|NCT03626545|Tubulin Modulators|tubulin modulators|mesh-ancestor
2752261|NCT03626545|Antimitotic Agents|antimitotic agents|mesh-ancestor
2752262|NCT03626545|Mitosis Modulators|mitosis modulators|mesh-ancestor
2752263|NCT03626545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752264|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
2752265|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2084961|NCT02137369|Dexetimide|dexetimide|mesh-list
2084962|NCT02137369|Citalopram|citalopram|mesh-list
2084963|NCT02137369|Sertraline|sertraline|mesh-list
2084964|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
2084965|NCT02137369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2084966|NCT02137369|Serotonin|serotonin|mesh-list
2084967|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2084968|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2084969|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084970|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2084971|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
2084972|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084973|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2084974|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2084975|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2084976|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2084977|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
2084978|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
2084979|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2084980|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2222911|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
661285|NCT03203746|Lycopene|lycopene|mesh-list
661286|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
661287|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
661288|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661289|NCT03203746|Protective Agents|protective agents|mesh-ancestor
661290|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661291|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
661292|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
661293|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084981|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2084982|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
2084983|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2084984|NCT02137382|Pancrelipase|pancrelipase|mesh-list
2084985|NCT02137382|Pancreatin|pancreatin|mesh-list
2084986|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2084987|NCT02137538|Letrozole|letrozole|mesh-list
2084988|NCT02137538|Anastrozole|anastrozole|mesh-list
2084989|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2084990|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2084991|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2084992|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2084993|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2084994|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2084995|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
2084996|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2084997|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2084998|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2084999|NCT02137772|Letermovir|letermovir|mesh-list
2085000|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2085001|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085002|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085003|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085004|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
2085005|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085006|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2085007|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2085008|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2085009|NCT02137837|Everolimus|everolimus|mesh-list
2085010|NCT02137837|Fulvestrant|fulvestrant|mesh-list
2085011|NCT02137837|Anastrozole|anastrozole|mesh-list
2085012|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085013|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2085014|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
2085015|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085016|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2085017|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2085018|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2085019|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
2085020|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2085021|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2085022|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2085023|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085024|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085025|NCT02138006|Insulin|insulin|mesh-list
2085026|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2085027|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2085028|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085029|NCT02138136|Lubiprostone|lubiprostone|mesh-list
2085030|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2085031|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
660849|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
660850|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
660851|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
660852|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
660853|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
660854|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085032|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085033|NCT02138747|Mirabegron|mirabegron|mesh-list
2085034|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2085035|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2085036|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2085037|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2085038|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
2085039|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085040|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085041|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085042|NCT02138747|Urological Agents|urological agents|mesh-ancestor
2085043|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2085044|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2085045|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
2085046|NCT02138825|Riociguat|riociguat|mesh-list
2085047|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
2085048|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085049|NCT02138838|Cinacalcet|cinacalcet|mesh-list
2085050|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2085051|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085052|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2085053|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
2085054|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2085055|NCT02138916|Benralizumab|benralizumab|mesh-list
2085056|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2085057|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
2085058|NCT02139007|Alendronate|alendronate|mesh-list
2085059|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2085060|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085061|NCT02139046|Naproxen|naproxen|mesh-list
2085062|NCT02139046|Colchicine|colchicine|mesh-list
2085063|NCT02139046|Febuxostat|febuxostat|mesh-list
2085064|NCT02139046|Lansoprazole|lansoprazole|mesh-list
2085065|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
2085066|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2085067|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2085068|NCT02139046|Analgesics|analgesics|mesh-ancestor
2085069|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
2085070|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085071|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085072|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2085073|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2085074|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
2085075|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2085076|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085077|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085078|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
2085079|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
2085080|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
2085081|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085082|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2085083|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2085084|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2085085|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
2085086|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2085087|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
2085088|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085089|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2085090|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2085091|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
2085092|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085093|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085094|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2085095|NCT02139358|Gemcitabine|gemcitabine|mesh-list
2085096|NCT02139358|Trastuzumab|trastuzumab|mesh-list
2085097|NCT02139358|Pertuzumab|pertuzumab|mesh-list
2085098|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2085099|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
2085100|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085101|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661019|NCT03204929|Copper|copper|mesh-list
661020|NCT03204929|Trace Elements|trace elements|mesh-ancestor
661021|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
661022|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661078|NCT03204669|Trace Elements|trace elements|mesh-list
661079|NCT03204669|Micronutrients|micronutrients|mesh-list
661080|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661391|NCT03203525|Leucovorin|leucovorin|mesh-list
661392|NCT03203525|Sirolimus|sirolimus|mesh-list
661393|NCT03203525|Bevacizumab|bevacizumab|mesh-list
661394|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
661395|NCT03203525|Doxorubicin|doxorubicin|mesh-list
661396|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
661397|NCT03203525|Fluorouracil|fluorouracil|mesh-list
661398|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
661399|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
661400|NCT03203525|Antibodies|antibodies|mesh-list
661401|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
661402|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
661403|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
661404|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661405|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
661406|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
661407|NCT03203525|Growth Substances|growth substances|mesh-ancestor
661408|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661409|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
661410|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
661411|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
661412|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
661413|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
661414|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661415|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661416|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
661417|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
661418|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
661419|NCT03203525|Antidotes|antidotes|mesh-ancestor
661420|NCT03203525|Protective Agents|protective agents|mesh-ancestor
661421|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
661422|NCT03203525|Vitamins|vitamins|mesh-ancestor
661423|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
661424|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
661425|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
661426|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
2085102|NCT02139358|Antiviral Agents|antiviral agents|mesh-ancestor
2085103|NCT02139358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085104|NCT02139358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085105|NCT02139358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2085106|NCT02139358|Immunologic Factors|immunologic factors|mesh-ancestor
2085107|NCT02139358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085108|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2085109|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
2085110|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2085111|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
2085112|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
2085113|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2085114|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085115|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2085116|NCT02139540|Analgesics|analgesics|mesh-ancestor
2085117|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
2085118|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085119|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2085120|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2085121|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085122|NCT02139644|Fluticasone|fluticasone|mesh-list
2085123|NCT02139644|Xhance|xhance|mesh-list
2085124|NCT02139644|Beclomethasone|beclomethasone|mesh-list
2085125|NCT02139644|Albuterol|albuterol|mesh-list
2085126|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2085127|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
2085128|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2085129|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2085130|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
2085131|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085132|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085133|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2085134|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
2085135|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
2085136|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2085137|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2085138|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2085139|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
2085140|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085141|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085142|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
661434|NCT03203031|Anesthetics|anesthetics|mesh-list
661435|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
661436|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661670|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
661671|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
661672|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
661673|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661674|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
661675|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
661676|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
2222912|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2222913|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222914|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222915|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222916|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2222917|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
2222918|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222919|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2222920|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222921|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222922|NCT00045227|Docetaxel|docetaxel|mesh-list
2222923|NCT00045227|Vaccines|vaccines|mesh-list
2085143|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2085144|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
2085145|NCT02139644|Hormones|hormones|mesh-ancestor
2085146|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2085147|NCT02139943|Canagliflozin|canagliflozin|mesh-list
2085148|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2085149|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085150|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2085151|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085152|NCT02139982|Ropivacaine|ropivacaine|mesh-list
2085153|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
2085154|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
2085155|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2085156|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085157|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
2085158|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085159|NCT02140060|Travoprost|travoprost|mesh-list
2085160|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2085161|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2085162|NCT02140060|Brinzolamide|brinzolamide|mesh-list
2085163|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2085164|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2085165|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085166|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085167|NCT02140164|Minocycline|minocycline|mesh-list
2085168|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2085169|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085170|NCT02140372|Colchicine|colchicine|mesh-list
2085171|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
2085172|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
660938|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
661452|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
661453|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
661454|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
661455|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661456|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
661457|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
661458|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
661459|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661460|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661461|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
661652|NCT03201939|Lisinopril|lisinopril|mesh-list
661653|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
661654|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
661655|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661656|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661657|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
661658|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
661659|NCT03201939|Protective Agents|protective agents|mesh-ancestor
661660|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085173|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
2085174|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
2085175|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
2085176|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085177|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085178|NCT02140411|Ranibizumab|ranibizumab|mesh-list
2085179|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2085180|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2085181|NCT02140411|Growth Substances|growth substances|mesh-ancestor
2085182|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085183|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
2085184|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085185|NCT02140593|Rocuronium|rocuronium|mesh-list
2085186|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2085187|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2085188|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2085189|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085190|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085191|NCT02140645|Linagliptin|linagliptin|mesh-list
2085192|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2085193|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085194|NCT02140645|Incretins|incretins|mesh-ancestor
2085195|NCT02140645|Hormones|hormones|mesh-ancestor
2085196|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2085197|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2085198|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
2085199|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085200|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085201|NCT02140970|Ibuprofen|ibuprofen|mesh-list
2085202|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2085203|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2085204|NCT02140970|Analgesics|analgesics|mesh-ancestor
2085205|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
2085206|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085207|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085208|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2085209|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2085210|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2085211|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085212|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085213|NCT02141217|Amoxicillin|amoxicillin|mesh-list
2085214|NCT02141217|Clindamycin|clindamycin|mesh-list
2085215|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
2085216|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
2085217|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
2085218|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
2085219|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2085220|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2085221|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085222|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2085223|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085224|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085225|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2085226|NCT02141295|Leucovorin|leucovorin|mesh-list
2085227|NCT02141295|Folic Acid|folic acid|mesh-list
661034|NCT03204812|Durvalumab|durvalumab|mesh-list
661035|NCT03204812|Ipilimumab|ipilimumab|mesh-list
661036|NCT03204812|Tremelimumab|tremelimumab|mesh-list
661037|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
661038|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
661039|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
661040|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
661041|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661042|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
661043|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661044|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
661045|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661330|NCT03203304|Nivolumab|nivolumab|mesh-list
661331|NCT03203304|Ipilimumab|ipilimumab|mesh-list
661332|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
661333|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661334|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
661335|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661583|NCT03202719|Vaccines|vaccines|mesh-list
661584|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
661585|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085228|NCT02141295|Bevacizumab|bevacizumab|mesh-list
2085229|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
2085230|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
2085231|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2085232|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085233|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2085234|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2085235|NCT02141295|Growth Substances|growth substances|mesh-ancestor
2085236|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085237|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
2085238|NCT02141295|Antidotes|antidotes|mesh-ancestor
2085239|NCT02141295|Protective Agents|protective agents|mesh-ancestor
2085240|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
2085241|NCT02141295|Vitamins|vitamins|mesh-ancestor
2085242|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
2085243|NCT02141295|Hematinics|hematinics|mesh-ancestor
2085244|NCT02141451|Rituximab|rituximab|mesh-list
2085245|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2085246|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085247|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
2085248|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085249|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2085250|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2085251|NCT02141490|Hematinics|hematinics|mesh-ancestor
2085252|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2085253|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2085254|NCT02141555|Misoprostol|misoprostol|mesh-list
2085255|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2085256|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
2085257|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2085258|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085259|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2085260|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2085261|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
2085262|NCT02141581|Vaccines|vaccines|mesh-list
2085263|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
2085264|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085265|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
2085266|NCT02141620|Cocaine|cocaine|mesh-list
2085267|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2085268|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
2085269|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085270|NCT02141620|Expectorants|expectorants|mesh-ancestor
2085271|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
2085272|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2085273|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
2085274|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085275|NCT02141620|Protective Agents|protective agents|mesh-ancestor
2085276|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085277|NCT02141620|Antidotes|antidotes|mesh-ancestor
2085278|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
2085279|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
2085280|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2085281|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
2085282|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085283|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
661212|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661213|NCT03203967|Analgesics|analgesics|mesh-ancestor
661214|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
661215|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
661661|NCT03201861|Paclitaxel|paclitaxel|mesh-list
661662|NCT03201861|Docetaxel|docetaxel|mesh-list
661663|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
661664|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
661665|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661666|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
661667|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
661668|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
661669|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085284|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2085285|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2085286|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2085287|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
2085288|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085289|NCT02141633|Fluticasone|fluticasone|mesh-list
2085290|NCT02141633|Xhance|xhance|mesh-list
2085291|NCT02141633|Albuterol|albuterol|mesh-list
2085292|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2085293|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2085294|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
2085295|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085296|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085297|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2085298|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
2085299|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
2085300|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2085301|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
2085302|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2085303|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2085304|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2085305|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2085306|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
2085307|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085308|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085309|NCT02141659|Relugolix|relugolix|mesh-list
2085310|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
2085311|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
2085312|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2085313|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085314|NCT02141672|Cyclosporine|cyclosporine|mesh-list
2085315|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
2085316|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085317|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
2085318|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085319|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085320|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2085321|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
2085322|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085323|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2085324|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2085325|NCT02141854|Fluticasone|fluticasone|mesh-list
2085326|NCT02141854|Xhance|xhance|mesh-list
2085327|NCT02141854|Albuterol|albuterol|mesh-list
2085328|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2085329|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
2085330|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2085331|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2085332|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
2085333|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085334|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085335|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2085336|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
2085337|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
2085338|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2085339|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2085340|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2085341|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
2085342|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085343|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085344|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
2085345|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2085346|NCT02141997|Adalimumab|adalimumab|mesh-list
661271|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
661272|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
661273|NCT03204019|Growth Substances|growth substances|mesh-ancestor
661274|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
661275|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
661276|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
661444|NCT03202862|Fulvestrant|fulvestrant|mesh-list
661445|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
661446|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661447|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
661448|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
661449|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
661450|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
661451|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661512|NCT03202615|Lactoferrin|lactoferrin|mesh-list
661513|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085347|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2085348|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2085349|NCT02142049|Lenalidomide|lenalidomide|mesh-list
2085350|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
2085351|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085352|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2085353|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2085354|NCT02142049|Growth Substances|growth substances|mesh-ancestor
2085355|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
2085356|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085357|NCT02142153|Olorofim|olorofim|mesh-list
2085358|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
2085359|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085360|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
2085361|NCT02142712|Promethazine|promethazine|mesh-list
2085362|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
2085363|NCT02142712|Pantoprazole|pantoprazole|mesh-list
2085364|NCT02142712|Famotidine|famotidine|mesh-list
2085365|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2085366|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2085367|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2085368|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085369|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085370|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2085371|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2085372|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2085373|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085374|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
2085375|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
2085376|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
2085377|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085378|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
2085379|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
2085380|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2085381|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
2085382|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
2085383|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085384|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2085385|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
2085386|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
2085387|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
2085388|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
2085389|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2085390|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2085391|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2085392|NCT02142738|Gemcitabine|gemcitabine|mesh-list
2085393|NCT02142738|Paclitaxel|paclitaxel|mesh-list
2085394|NCT02142738|Carboplatin|carboplatin|mesh-list
2085395|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
2085396|NCT02142738|Pemetrexed|pemetrexed|mesh-list
2085397|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2085398|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085399|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
2085400|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
2085401|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
2085402|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085403|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2085404|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
2085405|NCT02142738|Antiviral Agents|antiviral agents|mesh-ancestor
2085406|NCT02142738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085407|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222924|NCT00045227|Sargramostim|sargramostim|mesh-list
2222925|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
2222926|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222927|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222928|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
2222929|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
2222930|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
2222931|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222932|NCT00045266|Aflibercept|aflibercept|mesh-list
2222933|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2222934|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2222935|NCT00045266|Growth Substances|growth substances|mesh-ancestor
2222936|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222937|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
2222938|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222939|NCT00045279|Interferons|interferons|mesh-list
2222940|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
2222941|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
2222942|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2085408|NCT02142738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2085409|NCT02142738|Immunologic Factors|immunologic factors|mesh-ancestor
2085410|NCT02142738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085411|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2085412|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2085413|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2085428|NCT02143141|Morphine|morphine|mesh-list
2085429|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2085430|NCT02143141|Narcotics|narcotics|mesh-ancestor
2085431|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2085432|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085433|NCT02143141|Analgesics|analgesics|mesh-ancestor
2085434|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
2085435|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085436|NCT02143648|Nalbuphine|nalbuphine|mesh-list
2085437|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2085438|NCT02143648|Narcotics|narcotics|mesh-ancestor
2085439|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2085440|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085441|NCT02143648|Analgesics|analgesics|mesh-ancestor
2085442|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
2085443|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085444|NCT02143843|Bimatoprost|bimatoprost|mesh-list
2085445|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2085446|NCT02143973|Nalbuphine|nalbuphine|mesh-list
2085447|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2085448|NCT02143973|Narcotics|narcotics|mesh-ancestor
2085449|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2085450|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085451|NCT02143973|Analgesics|analgesics|mesh-ancestor
2085452|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
2085453|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085454|NCT02144012|Docetaxel|docetaxel|mesh-list
2085455|NCT02144012|Trastuzumab|trastuzumab|mesh-list
2085456|NCT02144012|Maytansine|maytansine|mesh-list
2085457|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2085458|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085459|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
2085460|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
2085461|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
2085462|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085463|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2222943|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661381|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
661382|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
661383|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
661384|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
661385|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661386|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
661387|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
661388|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661389|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
661390|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
661493|NCT03202784|Berotralstat|berotralstat|mesh-list
661494|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661495|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661539|NCT03202407|Calcium|calcium|mesh-list
661540|NCT03202407|Sevelamer|sevelamer|mesh-list
661541|NCT03202407|Calcium acetate|calcium acetate|mesh-list
661542|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
661543|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661544|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
661545|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
661546|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085464|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2085465|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2085466|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2085467|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2085468|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
2085469|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
2085470|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085471|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
2085472|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
2085473|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
2085474|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2085475|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
2085476|NCT02144259|Etonogestrel|etonogestrel|mesh-list
2085477|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2085478|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2085479|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2085480|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
2085481|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2085482|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085483|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2085484|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2085485|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2085486|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2085487|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085488|NCT02144675|Cytarabine|cytarabine|mesh-list
2085489|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
2085490|NCT02144675|Salicylates|salicylates|mesh-list
2085491|NCT02144675|Idarubicin|idarubicin|mesh-list
2085492|NCT02144675|Choline|choline|mesh-list
2085493|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2085494|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
2085495|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085496|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085497|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
2085498|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085499|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2085500|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
2085501|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085502|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2085503|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2085504|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2085505|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085506|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
2085507|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2085508|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2085509|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2085510|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
2085511|NCT02144675|Analgesics|analgesics|mesh-ancestor
2085512|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
2085513|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085514|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2085515|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2085516|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2085517|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2222944|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
2222945|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222946|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
661677|NCT03201913|Estrogens|estrogens|mesh-list
661678|NCT03201913|Hormones|hormones|mesh-ancestor
661679|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
661680|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085518|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2085519|NCT02144714|Adalimumab|adalimumab|mesh-list
2085520|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2085521|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2085522|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
2085523|NCT02145026|Hematinics|hematinics|mesh-ancestor
2085524|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
2085525|NCT02145039|Fludarabine|fludarabine|mesh-list
2085526|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2085527|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
2085528|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085529|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2085530|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2085531|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
2085532|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085533|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085534|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2085535|NCT02145078|Gemcitabine|gemcitabine|mesh-list
2085536|NCT02145078|Docetaxel|docetaxel|mesh-list
2085537|NCT02145078|Pemetrexed|pemetrexed|mesh-list
2085538|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2085539|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
2085540|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085541|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085542|NCT02145078|Antiviral Agents|antiviral agents|mesh-ancestor
2085543|NCT02145078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085544|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085545|NCT02145078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2085546|NCT02145078|Immunologic Factors|immunologic factors|mesh-ancestor
2085547|NCT02145078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085548|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
2085549|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
2085550|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
2085551|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2085552|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2085553|NCT02145182|Eculizumab|eculizumab|mesh-list
2085554|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2085555|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2085556|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
2085557|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085558|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2085559|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2085560|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085568|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
2085569|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2085570|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2085571|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2085572|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2085573|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085574|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
2085575|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085576|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085577|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2085578|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085579|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2085580|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
2085581|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
2085582|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
2085583|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2085584|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2085585|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661590|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661591|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
661592|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
661593|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
661594|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661595|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661596|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
661597|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
661598|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
661599|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
661600|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
661601|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
661602|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
661603|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
661604|NCT03202446|Coagulants|coagulants|mesh-ancestor
2085586|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2085587|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2085588|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2085589|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2085590|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2085591|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2085592|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085593|NCT02146430|Pregabalin|pregabalin|mesh-list
2085594|NCT02146430|Analgesics|analgesics|mesh-ancestor
2085595|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
2085596|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085597|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085598|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
2085599|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2085600|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2085601|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085602|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2085603|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2085604|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2085605|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2085606|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2085607|NCT02147067|Ranolazine|ranolazine|mesh-list
2085608|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2085609|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2085610|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085611|NCT02147132|Nicotine|nicotine|mesh-list
2085612|NCT02147132|Varenicline|varenicline|mesh-list
2085613|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2085614|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
2085615|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085616|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085617|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2085618|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2085619|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
2085620|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085621|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085622|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
2085623|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2085624|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
2085625|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2085626|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085627|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2085628|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
2085629|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2085630|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
2085631|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2085632|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085633|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2085634|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
2085635|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2085636|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2085637|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2085638|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2085639|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085640|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
2085641|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085642|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085643|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
661608|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
661609|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661768|NCT03201185|Ramipril|ramipril|mesh-list
661769|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
661770|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
661771|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661772|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661773|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
661774|NCT03201380|Choline|choline|mesh-list
661775|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
661776|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
661777|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
661778|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661779|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
661780|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
661781|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
661782|NCT03201250|Dexamethasone|dexamethasone|mesh-list
661783|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
661784|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
661785|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
661786|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
661787|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661788|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
661789|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
661790|NCT03201250|Hormones|hormones|mesh-ancestor
661791|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
661792|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
661793|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661799|NCT03201601|Inositol|inositol|mesh-list
661800|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
661801|NCT03201601|Vitamins|vitamins|mesh-ancestor
661802|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
661803|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661804|NCT03201159|Pentamidine|pentamidine|mesh-list
661805|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
661806|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
661807|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
661808|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
661809|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
661810|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
661811|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
661812|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
661813|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
661814|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
661815|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661816|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661817|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
661818|NCT03200964|Anesthetics|anesthetics|mesh-list
661820|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2222947|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661821|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222948|NCT00045292|Valacyclovir|valacyclovir|mesh-list
2222949|NCT00045292|Acyclovir|acyclovir|mesh-list
661824|NCT03200938|Zinc|zinc|mesh-list
661825|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
661826|NCT03200938|Trace Elements|trace elements|mesh-ancestor
661827|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
661828|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661829|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
661830|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
661831|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
661832|NCT03200938|Protective Agents|protective agents|mesh-ancestor
661833|NCT03201146|Cisplatin|cisplatin|mesh-list
661834|NCT03201146|Carboplatin|carboplatin|mesh-list
661835|NCT03201146|Pemetrexed|pemetrexed|mesh-list
661836|NCT03201146|Apatinib|apatinib|mesh-list
661837|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661838|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661839|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661840|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
661841|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
661842|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
661843|NCT03200821|Gemcitabine|gemcitabine|mesh-list
661844|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
661845|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
661846|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661847|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661848|NCT03200821|Antiviral Agents|antiviral agents|mesh-ancestor
661849|NCT03200821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
661850|NCT03200821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661851|NCT03200821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
661852|NCT03200821|Immunologic Factors|immunologic factors|mesh-ancestor
661853|NCT03200821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661912|NCT03200600|Dexamethasone|dexamethasone|mesh-list
661913|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
661914|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
661915|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
661916|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
661917|NCT03200600|BB 1101|bb 1101|mesh-list
661918|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
661919|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
661920|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
661921|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
661922|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661923|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
661924|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
661925|NCT03200600|Hormones|hormones|mesh-ancestor
661926|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
661927|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
661928|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661929|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
661930|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661931|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661932|NCT03200600|Analgesics|analgesics|mesh-ancestor
661933|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
661934|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
661935|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
661936|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
661937|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
661961|NCT03200197|Menthol|menthol|mesh-list
661962|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
661963|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
662609|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
662610|NCT03197766|Natriuretic Agents|natriuretic agents|mesh-ancestor
662611|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664321|NCT03190304|Enalapril|enalapril|mesh-list
664322|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
664323|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
664324|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
664325|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664326|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2222950|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
2222951|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222952|NCT00045318|Exatecan|exatecan|mesh-list
2222953|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2222954|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2222955|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222956|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222957|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222958|NCT00045370|Interferons|interferons|mesh-list
2222959|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
2222960|NCT00045370|Sirolimus|sirolimus|mesh-list
2222961|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222962|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
2222963|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222964|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
2222965|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222966|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
665015|NCT03186742|Eplerenone|eplerenone|mesh-list
665016|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
665017|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
2222967|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
661854|NCT03200782|Empagliflozin|empagliflozin|mesh-list
661855|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
661856|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
661857|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661858|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
661859|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661860|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
661861|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
661862|NCT03200847|Tretinoin|tretinoin|mesh-list
661863|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
661864|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661865|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
661866|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
2085644|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085645|NCT02147587|Tofacitinib|tofacitinib|mesh-list
2085646|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2085647|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085648|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085649|NCT02147691|Azelaic acid|azelaic acid|mesh-list
661873|NCT03200808|Methylene Blue|methylene blue|mesh-list
661874|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661875|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661876|NCT03200587|Avelumab|avelumab|mesh-list
661877|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
661878|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661879|NCT03200691|Antibodies|antibodies|mesh-list
661880|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
661881|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661882|NCT03200886|Triamcinolone|triamcinolone|mesh-list
661883|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
661884|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
661885|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
661886|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
661887|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
661888|NCT03200886|Hormones|hormones|mesh-ancestor
661889|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
661890|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661891|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
661892|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
661893|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661894|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222968|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
2222969|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2222970|NCT00045396|Tipifarnib|tipifarnib|mesh-list
2222971|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222972|NCT00045422|Interferons|interferons|mesh-list
661900|NCT03200561|Prednisolone|prednisolone|mesh-list
661901|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
661902|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
661903|NCT03200561|Antibodies|antibodies|mesh-list
661904|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
661905|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
661906|NCT03200561|Hormones|hormones|mesh-ancestor
661907|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
661908|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661909|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
661910|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
661911|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
661938|NCT03200613|Heparin|heparin|mesh-list
661939|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
661940|NCT03200613|Tinzaparin|tinzaparin|mesh-list
661941|NCT03200613|Dalteparin|dalteparin|mesh-list
661942|NCT03200613|Apixaban|apixaban|mesh-list
661943|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
661944|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
661945|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
661946|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661947|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
661948|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
661949|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
661950|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
661951|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661952|NCT03200392|Chromium|chromium|mesh-list
661953|NCT03200392|Trace Elements|trace elements|mesh-ancestor
661954|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
661955|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222973|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
661956|NCT03200093|Vancomycin|vancomycin|mesh-list
661957|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
661958|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222974|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
2222975|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222976|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
2222977|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2222978|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
2222979|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222980|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2222981|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2222982|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662451|NCT03198949|Everolimus|everolimus|mesh-list
662452|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662453|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
662454|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
662455|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222983|NCT00045448|Docetaxel|docetaxel|mesh-list
2222984|NCT00045448|Alvocidib|alvocidib|mesh-list
2222985|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222986|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
2222987|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
2222988|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
2222989|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2222990|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
2222991|NCT00045448|Growth Substances|growth substances|mesh-ancestor
2222992|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2222993|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
663170|NCT03195543|Thrombin|thrombin|mesh-list
663171|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
663172|NCT03195543|Coagulants|coagulants|mesh-ancestor
663284|NCT03194906|Memantine|memantine|mesh-list
663285|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
663286|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
663287|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
663288|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
663289|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663290|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663291|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
663292|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
663381|NCT03194555|Acetaminophen|acetaminophen|mesh-list
663382|NCT03194555|Naltrexone|naltrexone|mesh-list
663383|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
663384|NCT03194555|Analgesics|analgesics|mesh-ancestor
663385|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
663386|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
663387|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663388|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
663389|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
663390|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
663872|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
663873|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
663874|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
663875|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
663876|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663877|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
663878|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
663879|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664163|NCT03191721|Triclosan|triclosan|mesh-list
664164|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
664165|NCT03191721|Fluorides|fluorides|mesh-list
664166|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
664167|NCT03191721|Protective Agents|protective agents|mesh-ancestor
664168|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664169|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
664170|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
664171|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
664172|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
664173|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664174|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
661959|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
661960|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085650|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2085651|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2085652|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2085653|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2085654|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2085655|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
2085656|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085657|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085658|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085659|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085660|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
2085661|NCT02147899|Secnidazole|secnidazole|mesh-list
2085662|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2085663|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2085664|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085665|NCT02148250|Insulin|insulin|mesh-list
2085666|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2085667|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2222994|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663676|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
663677|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
663678|NCT03193307|BI 409306|bi 409306|mesh-list
663679|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
663680|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663681|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663682|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
663683|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
663684|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
663685|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663686|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
663687|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
663688|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
663689|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
663690|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
663691|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
663692|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
663693|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2222995|NCT00045461|Carboplatin|carboplatin|mesh-list
2222996|NCT00045461|Ifosfamide|ifosfamide|mesh-list
2222997|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2222998|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2222999|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
2223000|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223001|NCT00045500|Prednisone|prednisone|mesh-list
2223002|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2223003|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
663998|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
663999|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
664000|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664255|NCT03190681|Methylphenidate|methylphenidate|mesh-list
664256|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
664257|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664258|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
664259|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
664260|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
664261|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664262|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
664263|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
664351|NCT03190239|Pemetrexed|pemetrexed|mesh-list
664352|NCT03190239|Apatinib|apatinib|mesh-list
664353|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664354|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664355|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664356|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
664357|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
664358|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
664451|NCT03189732|Metformin|metformin|mesh-list
664452|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
664453|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665151|NCT03186027|Ascorbic Acid|ascorbic acid|mesh-list
665152|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
665153|NCT03186027|Ubiquinone|ubiquinone|mesh-list
661964|NCT03200210|Febuxostat|febuxostat|mesh-list
661965|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
661966|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2085668|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085669|NCT02148445|Nicotine|nicotine|mesh-list
2085670|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2085671|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
2085672|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2223004|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
661973|NCT03200015|Metformin|metformin|mesh-list
661974|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
661975|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662213|NCT03199300|Trastuzumab|trastuzumab|mesh-list
662214|NCT03199300|Bleomycin|bleomycin|mesh-list
662215|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662216|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
662217|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
662364|NCT03198676|Poly I-C|poly i-c|mesh-list
662365|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
662366|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
662367|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
662368|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
662369|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223005|NCT00045500|Hormones|hormones|mesh-ancestor
2223006|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2223007|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223008|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2223009|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223010|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
662428|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
662429|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
662430|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662701|NCT03197584|Leucovorin|leucovorin|mesh-list
662702|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
662703|NCT03197584|Bevacizumab|bevacizumab|mesh-list
662704|NCT03197584|Fluorouracil|fluorouracil|mesh-list
662705|NCT03197584|Capecitabine|capecitabine|mesh-list
662706|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
662707|NCT03197584|Fulvestrant|fulvestrant|mesh-list
662708|NCT03197584|Avelumab|avelumab|mesh-list
662709|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662710|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662711|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
662712|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
662713|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662714|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
662715|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
662716|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
662717|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
662718|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
662719|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
662720|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
662721|NCT03197584|Growth Substances|growth substances|mesh-ancestor
662722|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
662723|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
662724|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
662725|NCT03197584|Antidotes|antidotes|mesh-ancestor
662726|NCT03197584|Protective Agents|protective agents|mesh-ancestor
662727|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
662728|NCT03197584|Vitamins|vitamins|mesh-ancestor
662729|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
662730|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
662731|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
662732|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
662733|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
662734|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
662833|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
662834|NCT03197077|Desogestrel|desogestrel|mesh-list
662835|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
662836|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
662837|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
662838|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
662839|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662840|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
662841|NCT03197077|Hormones|hormones|mesh-ancestor
662842|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
662847|NCT03196934|Cannabidiol|cannabidiol|mesh-list
661976|NCT03200236|Nicotine|nicotine|mesh-list
661977|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
661978|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
661979|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
661980|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
661981|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
661982|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
661983|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
661984|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
661985|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661986|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
661987|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
661988|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
662093|NCT03199664|Tacrolimus|tacrolimus|mesh-list
662094|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
662095|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
662096|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662097|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
662098|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
662099|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662100|NCT03199690|Rifampin|rifampin|mesh-list
662101|NCT03199690|Dolutegravir|dolutegravir|mesh-list
662102|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
662103|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
662104|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
662105|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
662106|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
662107|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
662108|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
662109|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662110|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
662111|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
662112|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
662113|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
662114|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
662115|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
662116|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
662117|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
662118|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
662119|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
662120|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
662187|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
662188|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
662189|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662190|NCT03199430|Protective Agents|protective agents|mesh-ancestor
662191|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662192|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
662193|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
662194|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662195|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2223011|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223012|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223013|NCT00045513|Fludarabine|fludarabine|mesh-list
2223014|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
2223015|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2223016|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223017|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2223018|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
2223019|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223020|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223021|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
2223022|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223023|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
662456|NCT03198728|Testosterone|testosterone|mesh-list
662457|NCT03198728|Androgens|androgens|mesh-ancestor
662458|NCT03198728|Hormones|hormones|mesh-ancestor
662459|NCT03198728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
662460|NCT03198728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662517|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
662518|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2223024|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223025|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2223026|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223027|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
661989|NCT03199989|Capecitabine|capecitabine|mesh-list
661990|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
661991|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
661992|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
661993|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
661994|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662293|NCT03199105|Tetracaine|tetracaine|mesh-list
662294|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
662295|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
662296|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
662297|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662298|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
662299|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662327|NCT03198741|Aspirin|aspirin|mesh-list
662328|NCT03198741|Clopidogrel|clopidogrel|mesh-list
662329|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
662330|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
662331|NCT03198741|Analgesics|analgesics|mesh-ancestor
662332|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
662333|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662334|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662335|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
662336|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
662337|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
662338|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
662339|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662340|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
662341|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
662342|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
662343|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
662344|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
662345|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
662346|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
662347|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
662348|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
663145|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
663146|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
663211|NCT03195257|Glucagon|glucagon|mesh-list
663212|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
663213|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
663214|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
663215|NCT03195257|Hormones|hormones|mesh-ancestor
663216|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
663217|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663218|NCT03195257|Incretins|incretins|mesh-ancestor
663265|NCT03195023|Amlodipine|amlodipine|mesh-list
663266|NCT03195023|Lisinopril|lisinopril|mesh-list
663267|NCT03195023|Lercanidipine|lercanidipine|mesh-list
663268|NCT03195023|Furosemide|furosemide|mesh-list
663269|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
663270|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
663271|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
663272|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
663273|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
663274|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663275|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
663276|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663277|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
663278|NCT03195023|Diuretics|diuretics|mesh-ancestor
663279|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
663280|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
663281|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
663282|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
663283|NCT03195023|Protective Agents|protective agents|mesh-ancestor
663391|NCT03194594|Dexamethasone|dexamethasone|mesh-list
663392|NCT03194594|Ketamine|ketamine|mesh-list
663393|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
663394|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
663395|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
663396|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
663397|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663398|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
663399|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
663400|NCT03194594|Hormones|hormones|mesh-ancestor
663401|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2223028|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
661995|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
661996|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
661997|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
661998|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
661999|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662000|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
662001|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
662002|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
662003|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662004|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662005|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
662006|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
662007|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
662008|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
662009|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
662010|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
662011|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
662012|NCT03200080|Amphetamine|amphetamine|mesh-list
662013|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
662014|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
662015|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662016|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
662017|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
662018|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662019|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
662020|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662021|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662022|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
662023|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
662024|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
662025|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
662026|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
662165|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
662166|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
662179|NCT03199261|Exenatide|exenatide|mesh-list
662180|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
662181|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662182|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
662183|NCT03199261|Incretins|incretins|mesh-ancestor
662184|NCT03199261|Hormones|hormones|mesh-ancestor
662185|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
662281|NCT03199157|Fentanyl|fentanyl|mesh-list
662282|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
662283|NCT03199157|Narcotics|narcotics|mesh-ancestor
662284|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
662285|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662286|NCT03199157|Analgesics|analgesics|mesh-ancestor
662287|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
662288|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662289|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
662290|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
662291|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
662292|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
662323|NCT03198819|Cefotaxime|cefotaxime|mesh-list
662324|NCT03198819|Cefoxitin|cefoxitin|mesh-list
662325|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
662326|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223029|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223030|NCT00045539|Leucovorin|leucovorin|mesh-list
2223031|NCT00045539|Methotrexate|methotrexate|mesh-list
2223032|NCT00045539|Thiotepa|thiotepa|mesh-list
2223033|NCT00045539|Calcium|calcium|mesh-list
2223034|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
2223035|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2223036|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223037|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2223038|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
2223039|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2223040|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
662642|NCT03197493|Levodopa|levodopa|mesh-list
662643|NCT03197493|Carbidopa|carbidopa|mesh-list
662644|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
662645|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
662646|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
662647|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
662648|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662735|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
662027|NCT03199794|Factor VIII|factor viii|mesh-list
662028|NCT03199794|Coagulants|coagulants|mesh-ancestor
2752266|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752267|NCT03622775|Daratumumab|daratumumab|mesh-list
2752268|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085673|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085674|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2085675|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2085676|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
2085677|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085678|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085679|NCT02148588|Lidocaine|lidocaine|mesh-list
2085680|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
2085681|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
2085682|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2085683|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662606|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
662607|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
662608|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662865|NCT03197012|Octreotide|octreotide|mesh-list
662866|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
662867|NCT03197012|Edotreotide|edotreotide|mesh-list
662868|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
662869|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
662870|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662871|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
662872|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
662873|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
662874|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223041|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
2223042|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223043|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223044|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
2223045|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223046|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
663517|NCT03194074|Propofol|propofol|mesh-list
663518|NCT03194074|Desflurane|desflurane|mesh-list
663519|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
663520|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
663521|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663522|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
663523|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
663524|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
663525|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
664145|NCT03191461|Adenosine|adenosine|mesh-list
664146|NCT03191461|Analgesics|analgesics|mesh-ancestor
664147|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
664148|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664149|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664150|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
664151|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
664152|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
664153|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
664154|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
664155|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
664156|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664500|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
664501|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
664502|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665893|NCT03182179|Ondansetron|ondansetron|mesh-list
665894|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
665895|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
665896|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665897|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665898|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
665899|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
665900|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
665901|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
665902|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
665903|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665904|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665905|NCT03182179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
665906|NCT03182179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
665907|NCT03182179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
665908|NCT03182179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
665909|NCT03182179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
662029|NCT03199976|Fluticasone|fluticasone|mesh-list
662030|NCT03199976|Xhance|xhance|mesh-list
662031|NCT03199976|Bromides|bromides|mesh-list
662032|NCT03199976|Albuterol|albuterol|mesh-list
662033|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
662034|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
662035|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
662036|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
662037|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662038|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662039|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
662040|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
662041|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
662042|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
662043|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
662044|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
662045|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
662046|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662047|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662048|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
662049|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
662050|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
662051|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
662052|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
662053|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
662054|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
662494|NCT03198338|Bupivacaine|bupivacaine|mesh-list
662495|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
662496|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
662497|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
662498|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662499|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
662500|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
663642|NCT03194009|Metformin|metformin|mesh-list
663643|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
663644|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664132|NCT03191539|Apremilast|apremilast|mesh-list
664133|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
664134|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
664135|NCT03191539|Analgesics|analgesics|mesh-ancestor
664136|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
664137|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664138|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664139|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
664140|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664141|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
664142|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
664143|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664144|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085684|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
2085685|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085686|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2085687|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2085688|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2085689|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2085690|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085691|NCT02148718|Adalimumab|adalimumab|mesh-list
2085692|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2223047|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
664702|NCT03188432|Carboplatin|carboplatin|mesh-list
664703|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223048|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
2223049|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2223050|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2223051|NCT00045539|Antidotes|antidotes|mesh-ancestor
2223052|NCT00045539|Protective Agents|protective agents|mesh-ancestor
2223053|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
2223054|NCT00045539|Vitamins|vitamins|mesh-ancestor
2223055|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
2223056|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2223057|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
664989|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
664990|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
664991|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085693|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2085694|NCT02148874|Vaccines|vaccines|mesh-list
2085695|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
2085696|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085697|NCT02149108|Nintedanib|nintedanib|mesh-list
2085698|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085699|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
662248|NCT03199170|Morphine|morphine|mesh-list
662249|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
662250|NCT03199170|Narcotics|narcotics|mesh-ancestor
662251|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
662252|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662253|NCT03199170|Analgesics|analgesics|mesh-ancestor
662254|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
662255|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662603|NCT03197623|Alendronate|alendronate|mesh-list
662604|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
662605|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662887|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
662888|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223058|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2223059|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
2223060|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223061|NCT00045591|Celecoxib|celecoxib|mesh-list
2223062|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2223063|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2223064|NCT00045591|Analgesics|analgesics|mesh-ancestor
2223065|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
2223066|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2752272|NCT03618134|Durvalumab|durvalumab|mesh-list
663239|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
663240|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
663241|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663484|NCT03194204|Doxycycline|doxycycline|mesh-list
663485|NCT03194204|Uric Acid|uric acid|mesh-list
663486|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
663487|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
663488|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
663489|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
663490|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
663491|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
663492|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
663493|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663494|NCT03194204|Protective Agents|protective agents|mesh-ancestor
663495|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663496|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
663543|NCT03193749|Amiodarone|amiodarone|mesh-list
663544|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
663545|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
663546|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
663547|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
663548|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663549|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
663550|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
663551|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
663552|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663553|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
663554|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
663555|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
663915|NCT03192449|Albendazole|albendazole|mesh-list
663916|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
663917|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
663918|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
663919|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
663920|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
663921|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
663922|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
663923|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
663924|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
663925|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663926|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664279|NCT03190603|Celecoxib|celecoxib|mesh-list
664280|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
662062|NCT03199924|Diclofenac|diclofenac|mesh-list
662063|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
662064|NCT03199924|Lidocaine|lidocaine|mesh-list
662065|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
662066|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
662067|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
662068|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
662069|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662070|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
662071|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662072|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
662073|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
662074|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
662075|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
662076|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662077|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
662078|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
662079|NCT03199924|Analgesics|analgesics|mesh-ancestor
662080|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
662081|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
662082|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
662083|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
662084|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
662085|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
662086|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
662087|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
662088|NCT03199677|Apatinib|apatinib|mesh-list
662089|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662090|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
662091|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
662092|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085700|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085701|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085702|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
2085703|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2085704|NCT02149173|Fluorides|fluorides|mesh-list
2085705|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2085706|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085707|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
2085708|NCT02149173|Protective Agents|protective agents|mesh-ancestor
2085709|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085710|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
662561|NCT03197818|Budesonide|budesonide|mesh-list
662562|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
662563|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
662564|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
662565|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
662566|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662567|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662568|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
662569|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
662570|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
662571|NCT03197818|Hormones|hormones|mesh-ancestor
662572|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
662573|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
662574|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
662575|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
662576|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
662577|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662578|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662782|NCT03197740|Donepezil|donepezil|mesh-list
2085711|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
662142|NCT03199950|Haloperidol|haloperidol|mesh-list
662143|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
662144|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
662145|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
662146|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662147|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662148|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
662149|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
662150|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
662151|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
662152|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
662153|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
662154|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
662155|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662156|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662157|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2085712|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085713|NCT02149199|Budesonide|budesonide|mesh-list
2085714|NCT02149199|Terbutaline|terbutaline|mesh-list
2085715|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
2085716|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2085717|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2085718|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
662164|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
662167|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
662168|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
662169|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
662170|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
662171|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662172|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
662173|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
662174|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085719|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085720|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085721|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2085722|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
662407|NCT03198403|Epinephrine|epinephrine|mesh-list
662408|NCT03198403|Bupivacaine|bupivacaine|mesh-list
662409|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
662410|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
662411|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
662412|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662413|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
662414|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662415|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
662416|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
662417|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
662418|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662419|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662420|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
662421|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
662422|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
662423|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
662424|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
662425|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
662426|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
662427|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2223067|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223068|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2223069|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2223070|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2223071|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2223072|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223073|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223074|NCT00045604|Irinotecan|irinotecan|mesh-list
2223075|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
2223076|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223077|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2752273|NCT03618134|Ipilimumab|ipilimumab|mesh-list
662612|NCT03198013|Prednisolone|prednisolone|mesh-list
662613|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
662614|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
662615|NCT03198013|Hormones|hormones|mesh-ancestor
662616|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
662617|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662736|NCT03197506|Temozolomide|temozolomide|mesh-list
662175|NCT03199820|Dinoprostone|dinoprostone|mesh-list
662176|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
662177|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
662178|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662186|NCT03199482|Dexamethasone|dexamethasone|mesh-list
662196|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
662197|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
662198|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
662199|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662200|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662201|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
662202|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
662203|NCT03199482|Hormones|hormones|mesh-ancestor
662204|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
662205|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
662206|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662320|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
662321|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
662322|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662484|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
662485|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
662486|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
662487|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662488|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
662489|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
662490|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
662491|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662492|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662493|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
662519|NCT03197961|Tenofovir|tenofovir|mesh-list
662520|NCT03197961|Emtricitabine|emtricitabine|mesh-list
662521|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
662522|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
662523|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
662524|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
662525|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
662526|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
662527|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
662528|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662529|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
662530|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
662531|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
662532|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
662533|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
662534|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
662535|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
662536|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662537|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
662538|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
662539|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
662540|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
662541|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662926|NCT03197064|Fosaprepitant|fosaprepitant|mesh-list
662927|NCT03197064|Aprepitant|aprepitant|mesh-list
662928|NCT03197064|Antiemetics|antiemetics|mesh-ancestor
662929|NCT03197064|Autonomic Agents|autonomic agents|mesh-ancestor
662930|NCT03197064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662931|NCT03197064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662932|NCT03197064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
662933|NCT03197064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
662934|NCT03197064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662935|NCT03197064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663008|NCT03196466|Topiramate|topiramate|mesh-list
663009|NCT03196466|Pregabalin|pregabalin|mesh-list
663010|NCT03196466|Lamotrigine|lamotrigine|mesh-list
663011|NCT03196466|Zonisamide|zonisamide|mesh-list
663012|NCT03196466|Lacosamide|lacosamide|mesh-list
663013|NCT03196466|Carbamazepine|carbamazepine|mesh-list
663014|NCT03196466|Phenytoin|phenytoin|mesh-list
663015|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
663016|NCT03196466|Rufinamide|rufinamide|mesh-list
663017|NCT03196466|Levetiracetam|levetiracetam|mesh-list
663018|NCT03196466|Cannabidiol|cannabidiol|mesh-list
663019|NCT03196466|Valproic Acid|valproic acid|mesh-list
663020|NCT03196466|Brivaracetam|brivaracetam|mesh-list
663021|NCT03196466|Phenobarbital|phenobarbital|mesh-list
663022|NCT03196466|Clobazam|clobazam|mesh-list
663023|NCT03196466|Ethosuximide|ethosuximide|mesh-list
662207|NCT03199547|Azithromycin|azithromycin|mesh-list
662208|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
662209|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
662315|NCT03198637|Cisatracurium|cisatracurium|mesh-list
662316|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
662317|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
662318|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662319|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223078|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2223079|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223080|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223081|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2223082|NCT00045617|Etoposide|etoposide|mesh-list
2223083|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2223084|NCT00045617|Vaccines|vaccines|mesh-list
2223085|NCT00045617|Antibodies|antibodies|mesh-list
2223086|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
662891|NCT03196817|Betamethasone|betamethasone|mesh-list
662892|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
662893|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
662894|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
662895|NCT03196817|Lidocaine|lidocaine|mesh-list
662896|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
662897|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
662898|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
662899|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
662900|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662901|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
662902|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662903|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
662904|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
662905|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
662906|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
662907|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662908|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
662909|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
662910|NCT03196817|Hormones|hormones|mesh-ancestor
662911|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
662912|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
662913|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
663242|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
663243|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
663244|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
663369|NCT03194724|Vitamin A|vitamin a|mesh-list
663370|NCT03194724|Vitamins|vitamins|mesh-ancestor
663371|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
663372|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663771|NCT03193112|S 20098|s 20098|mesh-list
663772|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
663773|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
663774|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085723|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
2085724|NCT02149199|Hormones|hormones|mesh-ancestor
2085725|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2085726|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2085727|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2085728|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2085729|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
2085730|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085731|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085732|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
2085733|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
2085734|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2085735|NCT02149264|Testosterone|testosterone|mesh-list
2085736|NCT02149264|Androgens|androgens|mesh-ancestor
2085737|NCT02149264|Hormones|hormones|mesh-ancestor
2085738|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2223087|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
662210|NCT03199521|Thrombin|thrombin|mesh-list
662211|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
662212|NCT03199521|Coagulants|coagulants|mesh-ancestor
662390|NCT03198585|Empagliflozin|empagliflozin|mesh-list
662391|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
662392|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662393|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
662394|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662978|NCT03196531|Loratadine|loratadine|mesh-list
662979|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
662980|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
662981|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
662982|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
662983|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
662984|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
662985|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
662986|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662987|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662988|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663339|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
663340|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
663341|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
663342|NCT03194620|Procyanidin|procyanidin|mesh-list
663343|NCT03194620|Theaflavin|theaflavin|mesh-list
663344|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
663345|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663346|NCT03194620|Protective Agents|protective agents|mesh-ancestor
663347|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663348|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
663349|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
663350|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
663351|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
663352|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
663353|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
663354|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
663355|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663356|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
663357|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
663358|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
663359|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663724|NCT03193606|Fluorides|fluorides|mesh-list
663725|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
663726|NCT03193606|Protective Agents|protective agents|mesh-ancestor
663727|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664327|NCT03190668|Cefazolin|cefazolin|mesh-list
664328|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
664329|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
664330|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664331|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
664736|NCT03187795|Mirabegron|mirabegron|mesh-list
664737|NCT03187795|Oxybutynin|oxybutynin|mesh-list
664738|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
664739|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
664740|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
664741|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
664742|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
664743|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664744|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664745|NCT03187795|Urological Agents|urological agents|mesh-ancestor
664746|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
664747|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
664748|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664749|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
664750|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
664751|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
664874|NCT03187392|Lidocaine|lidocaine|mesh-list
664875|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
664876|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
664877|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
664878|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664879|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
664880|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664881|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2223088|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
662218|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
662219|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
662220|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
662221|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
662222|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
662223|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662224|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
662225|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662226|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662227|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
662228|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085739|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085740|NCT02149303|Dabigatran|dabigatran|mesh-list
2085741|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
2085742|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2085743|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
2085744|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085745|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085746|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
2085747|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2085748|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2085749|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2085750|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
2085751|NCT02149524|Trastuzumab|trastuzumab|mesh-list
2085752|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2085753|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085754|NCT02149836|Ezogabine|ezogabine|mesh-list
2085755|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
2085756|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2085757|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662778|NCT03197662|Oxytocin|oxytocin|mesh-list
662779|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
662780|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
662781|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662951|NCT03196648|Fluorides|fluorides|mesh-list
662952|NCT03196648|Antioxidants|antioxidants|mesh-list
662953|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
662954|NCT03196648|Protective Agents|protective agents|mesh-ancestor
662955|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662956|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663100|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
663101|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
663102|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
663103|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
663104|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
663105|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
663423|NCT03194685|FF-10101|ff-10101|mesh-list
663424|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
663425|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663426|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663880|NCT03192644|Leucovorin|leucovorin|mesh-list
663881|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
663882|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
663883|NCT03192644|Epirubicin|epirubicin|mesh-list
663884|NCT03192644|Calcium|calcium|mesh-list
663885|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
663886|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663887|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
663888|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663889|NCT03192644|Antidotes|antidotes|mesh-ancestor
663890|NCT03192644|Protective Agents|protective agents|mesh-ancestor
663891|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
663892|NCT03192644|Vitamins|vitamins|mesh-ancestor
663893|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
663894|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
663895|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
663896|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
663897|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663898|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663945|NCT03192215|Aspirin|aspirin|mesh-list
663946|NCT03192215|Apixaban|apixaban|mesh-list
663947|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
663948|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
663949|NCT03192215|Analgesics|analgesics|mesh-ancestor
663950|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
663951|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085758|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
662256|NCT03199339|Midazolam|midazolam|mesh-list
662257|NCT03199339|Bupropion|bupropion|mesh-list
662258|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
662259|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
662260|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
662261|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662262|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
662263|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
662264|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
662265|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
662266|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
662267|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
662268|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
662269|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
662270|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662271|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662272|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
662273|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
662274|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
662275|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
662276|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
662277|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
662278|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
662279|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
662280|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
662349|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
662350|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
662351|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
662352|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
662353|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
662354|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662355|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
662356|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662357|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662358|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
662359|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085759|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
2085760|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2085761|NCT02149875|Protective Agents|protective agents|mesh-ancestor
2085762|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085763|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
2085764|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2085765|NCT02150213|Dexamethasone|dexamethasone|mesh-list
2085766|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
662472|NCT03198208|Fentanyl|fentanyl|mesh-list
662473|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
662474|NCT03198208|Narcotics|narcotics|mesh-ancestor
662475|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
662476|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662477|NCT03198208|Analgesics|analgesics|mesh-ancestor
662478|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
662479|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662480|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
662481|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
662482|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
662483|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
662656|NCT03197571|Leucovorin|leucovorin|mesh-list
662657|NCT03197571|Paclitaxel|paclitaxel|mesh-list
662658|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
662659|NCT03197571|Bevacizumab|bevacizumab|mesh-list
662660|NCT03197571|Fluorouracil|fluorouracil|mesh-list
662661|NCT03197571|Capecitabine|capecitabine|mesh-list
662662|NCT03197571|Fulvestrant|fulvestrant|mesh-list
662663|NCT03197571|Avelumab|avelumab|mesh-list
662664|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
662665|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662666|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
662667|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
662668|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
662669|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662670|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
662671|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
662672|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662673|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
662674|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
662675|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
2085767|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
2223089|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
2223090|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223091|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223092|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2223093|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2223094|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2223095|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223096|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223097|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
2223098|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223099|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2223100|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223101|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223102|NCT00045682|Paclitaxel|paclitaxel|mesh-list
2223103|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2223104|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2223105|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2223106|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223107|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
2223108|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
2223109|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
2223110|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223111|NCT00045695|Bortezomib|bortezomib|mesh-list
2223112|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223113|NCT00045721|Carmustine|carmustine|mesh-list
2223114|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2223115|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2223116|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
2223117|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223118|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223119|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223120|NCT00045747|Fluorouracil|fluorouracil|mesh-list
662889|NCT03196869|Cisplatin|cisplatin|mesh-list
662890|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663479|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
663480|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
663481|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663482|NCT03194139|Protective Agents|protective agents|mesh-ancestor
663483|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664714|NCT03188068|Sirolimus|sirolimus|mesh-list
664715|NCT03188068|Prednisolone|prednisolone|mesh-list
664716|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
664717|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664718|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
664719|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664720|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
664721|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
664722|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
664723|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664724|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
664725|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
664726|NCT03188068|Hormones|hormones|mesh-ancestor
665107|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
662514|NCT03198130|Cemiplimab|cemiplimab|mesh-list
662515|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
662516|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662579|NCT03197779|Aspirin|aspirin|mesh-list
662580|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
662581|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
662582|NCT03197779|Analgesics|analgesics|mesh-ancestor
662583|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
662584|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662585|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662586|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
662587|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
662588|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
662589|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
662590|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662591|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
662592|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
662593|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
662594|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
664292|NCT03190616|Apatinib|apatinib|mesh-list
664293|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664294|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
664295|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664296|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664474|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
664475|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
665555|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
665556|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
665557|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
665558|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666086|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
666087|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
666088|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666342|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
666343|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
666344|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223121|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2223122|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
2223123|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085768|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
2085769|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085770|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085771|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2085772|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
2085773|NCT02150213|Hormones|hormones|mesh-ancestor
2085774|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2085775|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2085776|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085777|NCT02150499|Albuterol|albuterol|mesh-list
2085778|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2085779|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
2085780|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085781|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662600|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
662601|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
662602|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662694|NCT03197480|Aflibercept|aflibercept|mesh-list
662695|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
662696|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
662697|NCT03197480|Growth Substances|growth substances|mesh-ancestor
662698|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662699|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
662700|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662792|NCT03197233|Vitamin D|vitamin d|mesh-list
662793|NCT03197233|Vitamins|vitamins|mesh-list
662794|NCT03197233|Vitamin A|vitamin a|mesh-list
662795|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
662796|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
662797|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662798|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
662799|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662800|NCT03197233|Protective Agents|protective agents|mesh-ancestor
662801|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
662802|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662803|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
663106|NCT03195946|Midazolam|midazolam|mesh-list
663107|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
663108|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
663109|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
663110|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663111|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
663112|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
663113|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
663114|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
663115|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
663116|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
663117|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
663118|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
663119|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
663120|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663336|NCT03194867|Cemiplimab|cemiplimab|mesh-list
663337|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
663338|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663599|NCT03193723|Anesthetics|anesthetics|mesh-list
663600|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
663601|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663665|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
663666|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
663667|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
663668|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
663669|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
663670|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663671|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
663672|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
663673|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663674|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
663675|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
663768|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
663769|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
663770|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663993|NCT03192332|Plasminogen|plasminogen|mesh-list
663994|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
663995|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
663996|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
663997|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664184|NCT03191240|Vasopressins|vasopressins|mesh-list
664185|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
664186|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
664187|NCT03191240|Coagulants|coagulants|mesh-ancestor
664188|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
664189|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
664190|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
664191|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223124|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2223125|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223126|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223127|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
2223128|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223129|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
662618|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
662619|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223130|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223131|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
2223132|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
663005|NCT03196154|Insulin|insulin|mesh-list
663006|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
663007|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663084|NCT03195634|Carvedilol|carvedilol|mesh-list
663085|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
663086|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
663087|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
663088|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
663089|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663090|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663091|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
663092|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
663093|NCT03195634|Protective Agents|protective agents|mesh-ancestor
663094|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
663095|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
663096|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
663097|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
663098|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
663099|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
663791|NCT03192943|Nivolumab|nivolumab|mesh-list
663792|NCT03192943|Linrodostat|linrodostat|mesh-list
663793|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
663794|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663795|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
663796|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663797|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085782|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2085783|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
2085784|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
2085785|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2085786|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2085787|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2085788|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2085789|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
2085790|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085791|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085792|NCT02150759|Fentanyl|fentanyl|mesh-list
2085793|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
2085794|NCT02150759|Ketamine|ketamine|mesh-list
2085795|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
665342|NCT03185143|Acetaminophen|acetaminophen|mesh-list
665343|NCT03185143|Sumatriptan|sumatriptan|mesh-list
665344|NCT03185143|Naltrexone|naltrexone|mesh-list
665345|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
665346|NCT03185143|Analgesics|analgesics|mesh-ancestor
665347|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
665348|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665349|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665350|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
665351|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
665352|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
665353|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
665354|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
665355|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
665356|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
665357|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665358|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665605|NCT03183752|Metformin|metformin|mesh-list
665606|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
665607|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665749|NCT03182504|Meropenem|meropenem|mesh-list
665750|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
665751|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085796|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2085797|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085798|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2085799|NCT02150759|Analgesics|analgesics|mesh-ancestor
2085800|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
2085801|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085802|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
662649|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662650|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662651|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
662652|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
662653|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
662654|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
662655|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
662749|NCT03197298|Clopidogrel|clopidogrel|mesh-list
662750|NCT03197298|Ticagrelor|ticagrelor|mesh-list
662751|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
662752|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
662753|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
662754|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
662755|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
662756|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662757|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662758|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663063|NCT03196180|Fluorouracil|fluorouracil|mesh-list
663064|NCT03196180|Imiquimod|imiquimod|mesh-list
663065|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
663066|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663067|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
663068|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663069|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
663070|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
663071|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663072|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
663073|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
663245|NCT03195309|Fentanyl|fentanyl|mesh-list
663246|NCT03195309|Ropivacaine|ropivacaine|mesh-list
663247|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
663248|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
663249|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
663250|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663251|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
663252|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
663253|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
663254|NCT03195309|Narcotics|narcotics|mesh-ancestor
663255|NCT03195309|Analgesics|analgesics|mesh-ancestor
663256|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
663257|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
663258|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
663373|NCT03194659|Choline|choline|mesh-list
663374|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
663375|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
663376|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
663377|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663378|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
663379|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
663380|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
664046|NCT03191903|Triamcinolone|triamcinolone|mesh-list
664047|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
664048|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
664049|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
664050|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
664051|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
664052|NCT03191903|Hormones|hormones|mesh-ancestor
664053|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
664054|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664055|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
664056|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
664057|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664058|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664175|NCT03191383|Vaccines|vaccines|mesh-list
664176|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
664177|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664770|NCT03187548|Calcium|calcium|mesh-list
664771|NCT03187548|Caseins|caseins|mesh-list
664772|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
664773|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664774|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
664775|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
664776|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665228|NCT03185624|Rifaximin|rifaximin|mesh-list
665229|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
662676|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
662677|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
662678|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
662679|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
662680|NCT03197571|Growth Substances|growth substances|mesh-ancestor
662681|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
662682|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
662683|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
662684|NCT03197571|Antidotes|antidotes|mesh-ancestor
662685|NCT03197571|Protective Agents|protective agents|mesh-ancestor
662686|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
662687|NCT03197571|Vitamins|vitamins|mesh-ancestor
662688|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
662689|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
662690|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
662691|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
662692|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
662693|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
662944|NCT03196843|Raltitrexed|raltitrexed|mesh-list
662945|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
662946|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
662947|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662948|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662949|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
662950|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
662959|NCT03196401|Durvalumab|durvalumab|mesh-list
662960|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
662961|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663360|NCT03194633|Nifedipine|nifedipine|mesh-list
663361|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
663362|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
663363|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663364|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
663365|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663366|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
663367|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
663368|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
663526|NCT03193957|Etanercept|etanercept|mesh-list
663527|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
663528|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
663529|NCT03193957|Analgesics|analgesics|mesh-ancestor
663530|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
663531|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
663532|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663533|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
663534|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
663535|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
663536|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
663537|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
663657|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
663658|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
663659|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
663660|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
663661|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
663662|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663663|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663664|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
663967|NCT03192371|Vaccines|vaccines|mesh-list
663968|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
663969|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664044|NCT03192033|Hemostatics|hemostatics|mesh-list
664045|NCT03192033|Coagulants|coagulants|mesh-ancestor
664239|NCT03190941|Aldesleukin|aldesleukin|mesh-list
664240|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
664241|NCT03190941|Fludarabine|fludarabine|mesh-list
664242|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
664243|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
664244|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664245|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664246|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
664247|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
664248|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664249|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664250|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
664251|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
662737|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
662738|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662739|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
662740|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
662741|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085803|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2085804|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2085805|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
2085806|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085807|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085808|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2085809|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2085810|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
2085811|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
2085812|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2085813|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2085814|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2085815|NCT02150759|Narcotics|narcotics|mesh-ancestor
2085816|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2085817|NCT02150954|Oxytocin|oxytocin|mesh-list
2085818|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
2085819|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
664264|NCT03190798|Canagliflozin|canagliflozin|mesh-list
664265|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
664266|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664267|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
664268|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664489|NCT03189069|Warfarin|warfarin|mesh-list
664490|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
664491|NCT03189069|Dabigatran|dabigatran|mesh-list
664492|NCT03189069|Apixaban|apixaban|mesh-list
664493|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
664494|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
664495|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
664496|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
664497|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
664498|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664499|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223133|NCT00045773|Sertraline|sertraline|mesh-list
2223134|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
2223135|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2223136|NCT00045773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2223137|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2223138|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2223139|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223140|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223141|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
2223142|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665120|NCT03186443|Pregabalin|pregabalin|mesh-list
665121|NCT03186443|Gabapentin|gabapentin|mesh-list
665122|NCT03186443|Analgesics|analgesics|mesh-ancestor
665123|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
665124|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665125|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665126|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
665127|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
665128|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
665129|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665130|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
665131|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
665132|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
665133|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
665134|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
665135|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
665136|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
665137|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665138|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
665262|NCT03185403|Sufentanil|sufentanil|mesh-list
665263|NCT03185403|Ropivacaine|ropivacaine|mesh-list
665264|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
665265|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
665266|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
665267|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665268|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
2085820|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662745|NCT03197402|Caseins|caseins|mesh-list
662746|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
662747|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
662748|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663602|NCT03193788|Folic Acid|folic acid|mesh-list
663603|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
663604|NCT03193788|Hydroxocobalamin|hydroxocobalamin|mesh-list
663605|NCT03193788|Dexamethasone|dexamethasone|mesh-list
663606|NCT03193788|Pemetrexed|pemetrexed|mesh-list
663607|NCT03193788|Vitamins|vitamins|mesh-ancestor
663608|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
663609|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663610|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
663611|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
663612|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
663613|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
663614|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
663615|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
663616|NCT03193788|Hormones|hormones|mesh-ancestor
663617|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
663618|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
663619|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663620|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663621|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663622|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
663623|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
663624|NCT03193788|Hematinics|hematinics|mesh-ancestor
663625|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
2085821|NCT02151058|Listerine|listerine|mesh-list
2085822|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
2085823|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
2085824|NCT02151058|Protective Agents|protective agents|mesh-ancestor
2085825|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085826|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2085827|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085828|NCT02151149|Paclitaxel|paclitaxel|mesh-list
2085829|NCT02151149|Carboplatin|carboplatin|mesh-list
2085830|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2085831|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085832|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
2085833|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
2085834|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
2085835|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085836|NCT02151253|Modafinil|modafinil|mesh-list
2085837|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2085838|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085839|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2085840|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2085841|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2085842|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085843|NCT02151448|Interferons|interferons|mesh-list
2085844|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
2085845|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
2085846|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2085847|NCT02151448|Celecoxib|celecoxib|mesh-list
2085848|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085849|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
2223143|NCT00045799|Omeprazole|omeprazole|mesh-list
2223144|NCT00045799|Cimetidine|cimetidine|mesh-list
663975|NCT03192293|Metformin|metformin|mesh-list
663976|NCT03192293|Fulvestrant|fulvestrant|mesh-list
663977|NCT03192293|Simvastatin|simvastatin|mesh-list
663978|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
663979|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663980|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
663981|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
663982|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
663983|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663984|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
663985|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
663986|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663987|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
663988|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663989|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
663990|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
663991|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
663992|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
662759|NCT03197207|Camphor|camphor|mesh-list
662760|NCT03197207|Salicylates|salicylates|mesh-list
662761|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
662762|NCT03197207|Menthol|menthol|mesh-list
662763|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
662764|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
662765|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
662766|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
662767|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
662768|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
662769|NCT03197207|Analgesics|analgesics|mesh-ancestor
662770|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
662771|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662772|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662773|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
662774|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
662775|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
662776|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
662777|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662857|NCT03196986|Bevacizumab|bevacizumab|mesh-list
662858|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
662859|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
662860|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
662861|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
662862|NCT03196986|Growth Substances|growth substances|mesh-ancestor
662863|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662864|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
663569|NCT03193853|Paclitaxel|paclitaxel|mesh-list
663570|NCT03193853|Serabelisib|serabelisib|mesh-list
663571|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
663572|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663573|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
663574|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
663575|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
663576|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663577|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663752|NCT03193203|Etanercept|etanercept|mesh-list
663753|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
663754|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
663755|NCT03193203|Analgesics|analgesics|mesh-ancestor
663756|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
663757|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
663758|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663759|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
663760|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
663761|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
663762|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
663763|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
2223145|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2223146|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2223147|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2223148|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223149|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223150|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2223151|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
2223152|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
2223153|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223154|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223155|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2223156|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2223157|NCT00045812|Ezetimibe|ezetimibe|mesh-list
2223158|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2223159|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2223160|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
2085850|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085851|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
2085852|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664400|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
664401|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664402|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
664403|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
664404|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
2223161|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223162|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2223163|NCT00045864|Aldesleukin|aldesleukin|mesh-list
2223164|NCT00045864|Rituximab|rituximab|mesh-list
662783|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
662784|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
662785|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662786|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
662787|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662788|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662789|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
663927|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
663928|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664130|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
664131|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664207|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
664208|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
664209|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664675|NCT03188289|Chitosan|chitosan|mesh-list
664676|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
664677|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
664678|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
664679|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664680|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
664681|NCT03188289|Protective Agents|protective agents|mesh-ancestor
664682|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
664683|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
664684|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
664685|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664686|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
664687|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
664688|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
664689|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
664690|NCT03188289|Coagulants|coagulants|mesh-ancestor
664840|NCT03187457|Metronidazole|metronidazole|mesh-list
664841|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664842|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
664843|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
664844|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
665117|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
665118|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
665119|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085853|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2085854|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2085855|NCT02151448|Analgesics|analgesics|mesh-ancestor
2085856|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
2085857|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085858|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2085859|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2085860|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2085861|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2085862|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085863|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085864|NCT02151461|Metformin|metformin|mesh-list
2085865|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2085866|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085867|NCT02151487|Dexamethasone|dexamethasone|mesh-list
2085868|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
2223165|NCT00045864|Interleukin-2|interleukin-2|mesh-list
2223166|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2223167|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665949|NCT03181685|Cetrorelix|cetrorelix|mesh-list
665950|NCT03181685|Progesterone|progesterone|mesh-list
665951|NCT03181685|Progestins|progestins|mesh-ancestor
665952|NCT03181685|Hormones|hormones|mesh-ancestor
665953|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
665954|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665955|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
665956|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
665957|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
665958|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
666189|NCT03180229|Granisetron|granisetron|mesh-list
666190|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
666191|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
666192|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666193|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666194|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
666195|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
666196|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
666197|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
666198|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223168|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
2223169|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662962|NCT03196479|Ketamine|ketamine|mesh-list
662963|NCT03196479|Propofol|propofol|mesh-list
662964|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
662965|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
662966|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662967|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
662968|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
662969|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
662970|NCT03196479|Analgesics|analgesics|mesh-ancestor
662971|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
662972|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
662973|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
662974|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
662975|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
662976|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
662977|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663165|NCT03195491|Nivolumab|nivolumab|mesh-list
663166|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
663167|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663168|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
663169|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663703|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
663704|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
663705|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
663706|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
663707|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
663708|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663709|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
663710|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
663711|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663712|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
663713|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2223170|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2223171|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2223172|NCT00045864|Analgesics|analgesics|mesh-ancestor
2223173|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
2223174|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664405|NCT03189901|Simendan|simendan|mesh-list
664406|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
664407|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
664408|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
664409|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
664410|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664411|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664412|NCT03189901|Protective Agents|protective agents|mesh-ancestor
664413|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664619|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
664620|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
664621|NCT03188276|Ledipasvir|ledipasvir|mesh-list
664622|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
664623|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
665193|NCT03185871|Celecoxib|celecoxib|mesh-list
665194|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
665195|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
665196|NCT03185871|Analgesics|analgesics|mesh-ancestor
665197|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
665198|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665199|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665200|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
665201|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
665202|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
665203|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
665204|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665205|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665628|NCT03183557|Vitamin D|vitamin d|mesh-list
665629|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
665630|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
665631|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
665632|NCT03183557|Vitamins|vitamins|mesh-ancestor
665633|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
665634|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665635|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
665985|NCT03181815|Cytarabine|cytarabine|mesh-list
662843|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
662844|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
662845|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
662846|NCT03197077|Progestins|progestins|mesh-ancestor
662957|NCT03196427|Vedolizumab|vedolizumab|mesh-list
662958|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
663201|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
663202|NCT03195374|Narcotics|narcotics|mesh-ancestor
663203|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
663204|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663205|NCT03195374|Analgesics|analgesics|mesh-ancestor
663206|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
663207|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
663578|NCT03193866|Interferons|interferons|mesh-list
663579|NCT03193866|Interferon-beta|interferon-beta|mesh-list
663580|NCT03193866|Rituximab|rituximab|mesh-list
663581|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
663582|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
663583|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
663584|NCT03193866|Natalizumab|natalizumab|mesh-list
663585|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
663586|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
663587|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
663588|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663589|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
663590|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663591|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
663592|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
663593|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
663594|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
663595|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
663596|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
663597|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
663598|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085869|NCT02151487|Clonidine|clonidine|mesh-list
2085870|NCT02151487|Ropivacaine|ropivacaine|mesh-list
2085871|NCT02151487|BB 1101|bb 1101|mesh-list
2085872|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2085873|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
2085874|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
2085875|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085876|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085877|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2085878|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
2223175|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2223176|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2223177|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
2223178|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223179|NCT00045877|Aldesleukin|aldesleukin|mesh-list
2223180|NCT00045877|Rituximab|rituximab|mesh-list
2223181|NCT00045877|Interleukin-2|interleukin-2|mesh-list
2223182|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2223183|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223184|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
2223185|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664845|NCT03187093|Vortioxetine|vortioxetine|mesh-list
664846|NCT03187093|Citalopram|citalopram|mesh-list
664847|NCT03187093|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
664848|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
664849|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
664850|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664851|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
664852|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
664853|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664854|NCT03187093|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
664855|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
664856|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
664857|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
664858|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
664859|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
664860|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
664861|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
664862|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
664863|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
665682|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
665683|NCT03182894|Azacitidine|azacitidine|mesh-list
2085879|NCT02151487|Hormones|hormones|mesh-ancestor
2223186|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
662848|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
2223187|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2223188|NCT00045877|Analgesics|analgesics|mesh-ancestor
2223189|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
663829|NCT03193073|Mitogens|mitogens|mesh-list
663830|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
663831|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663853|NCT03192566|Acetaminophen|acetaminophen|mesh-list
663854|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
663855|NCT03192566|Analgesics|analgesics|mesh-ancestor
663856|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
663857|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
663858|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663859|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
664009|NCT03192059|Aspirin|aspirin|mesh-list
664010|NCT03192059|Vitamin D|vitamin d|mesh-list
664011|NCT03192059|Curcumin|curcumin|mesh-list
664012|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
664013|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
664014|NCT03192059|Lansoprazole|lansoprazole|mesh-list
664015|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
664016|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
664017|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
664018|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664019|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664020|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
664021|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
664022|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664023|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664024|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
664025|NCT03192059|Vitamins|vitamins|mesh-ancestor
664026|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
664027|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
664028|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
664029|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
664030|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
664031|NCT03192059|Analgesics|analgesics|mesh-ancestor
664032|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
664033|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664034|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
664035|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
664036|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
664037|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
664038|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
664039|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664040|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
664041|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
664042|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
664043|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
664269|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
664270|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
664271|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223190|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2223191|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2223192|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2223193|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
665082|NCT03186482|Rifampin|rifampin|mesh-list
665083|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
665084|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
665085|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
665086|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
665087|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
665088|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
665089|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
665090|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665091|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665092|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
665093|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
665094|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
665095|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
665096|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
665097|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
665098|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
665099|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
665100|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
665101|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
662849|NCT03196921|Amphotericin B|amphotericin b|mesh-list
662850|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
662851|NCT03196921|Amebicides|amebicides|mesh-ancestor
662852|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
662853|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
662854|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
662855|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
662856|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
662996|NCT03196362|Metformin|metformin|mesh-list
662997|NCT03196362|Pioglitazone|pioglitazone|mesh-list
662998|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
662999|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752274|NCT03618134|Tremelimumab|tremelimumab|mesh-list
2752275|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
2752276|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2752277|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
2752278|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2752279|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663626|NCT03193710|Remifentanil|remifentanil|mesh-list
663627|NCT03193710|Propofol|propofol|mesh-list
663628|NCT03193710|Sevoflurane|sevoflurane|mesh-list
663629|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
663630|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
663631|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663632|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
663633|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
663634|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
663635|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
663636|NCT03193710|Narcotics|narcotics|mesh-ancestor
663637|NCT03193710|Analgesics|analgesics|mesh-ancestor
663638|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
663639|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
663640|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
663641|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
663714|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
663715|NCT03193281|Dasatinib|dasatinib|mesh-list
663716|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663717|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
663718|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663719|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663899|NCT03192657|Basiliximab|basiliximab|mesh-list
663900|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
663901|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
663902|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
663903|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663904|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663905|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664382|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
664383|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664589|NCT03188198|Prednisone|prednisone|mesh-list
664590|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
664591|NCT03188198|Rituximab|rituximab|mesh-list
664592|NCT03188198|Doxorubicin|doxorubicin|mesh-list
664593|NCT03188198|Etoposide|etoposide|mesh-list
664594|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
664595|NCT03188198|Vincristine|vincristine|mesh-list
664596|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
664597|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
664598|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664599|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664600|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
664601|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
664602|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664603|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664604|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
664605|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
664606|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
664607|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
664608|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
664609|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664610|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
664611|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
664612|NCT03188198|Hormones|hormones|mesh-ancestor
664613|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
664614|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
665108|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
662875|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
662876|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
662877|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
662878|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
662879|NCT03197103|Expectorants|expectorants|mesh-ancestor
662880|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
662881|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
662882|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
662883|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
662884|NCT03197103|Protective Agents|protective agents|mesh-ancestor
662885|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
662886|NCT03197103|Antidotes|antidotes|mesh-ancestor
663136|NCT03195673|Terazosin|terazosin|mesh-list
663137|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
663138|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
663139|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
663140|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
663141|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
663142|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663143|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663144|NCT03195673|Urological Agents|urological agents|mesh-ancestor
663325|NCT03194815|Rituximab|rituximab|mesh-list
663326|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
663327|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
663328|NCT03194815|Antibodies|antibodies|mesh-list
663329|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
663330|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
663331|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
663332|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663333|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
663334|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663335|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2752280|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
2752281|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752282|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2752283|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663556|NCT03193684|Dapagliflozin|dapagliflozin|mesh-list
663557|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
663558|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663559|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
663560|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663728|NCT03193463|Topotecan|topotecan|mesh-list
663729|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
663730|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
663731|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663732|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663733|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663764|NCT03192878|Infliximab|infliximab|mesh-list
663765|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
663766|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
663767|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664436|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
664437|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
664438|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664711|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
664712|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
664713|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
664777|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
664778|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
664779|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
664780|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
662937|NCT03196882|Trace Elements|trace elements|mesh-ancestor
662938|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
662939|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223194|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223195|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2223196|NCT00045916|Nortriptyline|nortriptyline|mesh-list
2223197|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
663154|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
663155|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
663156|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
663157|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
663158|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
663159|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
663160|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
663161|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
663162|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663163|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663164|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
663173|NCT03195413|Lidocaine|lidocaine|mesh-list
663174|NCT03195413|Epinephrine|epinephrine|mesh-list
663175|NCT03195413|Racepinephrine|racepinephrine|mesh-list
663176|NCT03195413|Bupivacaine|bupivacaine|mesh-list
663177|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
663178|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
663179|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
663180|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
663181|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663182|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
663183|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
663184|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
663185|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
663186|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
663187|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
663188|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663189|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
663190|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
663191|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
663192|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
663193|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
663194|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
663195|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
663196|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
663197|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
663198|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
663199|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
663200|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
663515|NCT03194061|Cisplatin|cisplatin|mesh-list
663516|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663694|NCT03193424|Docetaxel|docetaxel|mesh-list
663695|NCT03193424|Apatinib|apatinib|mesh-list
663696|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663697|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
663698|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
663699|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
663700|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663701|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
663702|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663832|NCT03192969|Abatacept|abatacept|mesh-list
663833|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
663834|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
663835|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663836|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663837|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
663838|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
663839|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663840|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
663841|NCT03192969|Hormones|hormones|mesh-ancestor
663842|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2223198|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2223199|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223200|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223201|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2223202|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2223203|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
664205|NCT03191305|Warfarin|warfarin|mesh-list
2223204|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223205|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2223206|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2223207|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2223208|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
2223209|NCT00045955|Fexofenadine|fexofenadine|mesh-list
2223210|NCT00045955|Montelukast|montelukast|mesh-list
663219|NCT03195049|Bilirubin|bilirubin|mesh-list
663220|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
663221|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663222|NCT03195049|Protective Agents|protective agents|mesh-ancestor
663223|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663293|NCT03194932|Cytarabine|cytarabine|mesh-list
663294|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
663295|NCT03194932|Methotrexate|methotrexate|mesh-list
663296|NCT03194932|Azacitidine|azacitidine|mesh-list
663297|NCT03194932|Venetoclax|venetoclax|mesh-list
663298|NCT03194932|Idarubicin|idarubicin|mesh-list
663299|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
663300|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
663301|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
663302|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663303|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
663304|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
663305|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663306|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663307|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
663308|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663309|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
663310|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
663311|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
663312|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
663313|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
663314|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
663315|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
663316|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
663317|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
663318|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
663319|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
664106|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
664107|NCT03192397|Sirolimus|sirolimus|mesh-list
664108|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
664109|NCT03192397|Melphalan|melphalan|mesh-list
664110|NCT03192397|Fludarabine|fludarabine|mesh-list
664111|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
664112|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
664113|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
664114|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664115|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664116|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
664117|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
664118|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664119|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664120|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
664121|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
664122|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
664123|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
664124|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
663003|NCT03196219|Anti-Infective Agents|anti-infective agents|mesh-list
663004|NCT03196219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
663224|NCT03195153|Allopurinol|allopurinol|mesh-list
663225|NCT03195153|Atorvastatin|atorvastatin|mesh-list
663226|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
663227|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
663228|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
663229|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663230|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
663231|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
663232|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663233|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
663234|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
663235|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
663236|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
663237|NCT03195153|Protective Agents|protective agents|mesh-ancestor
663238|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663645|NCT03193918|Paclitaxel|paclitaxel|mesh-list
663646|NCT03193918|Ramucirumab|ramucirumab|mesh-list
663647|NCT03193918|Crenolanib|crenolanib|mesh-list
663648|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
663649|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663650|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
663651|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
663652|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
663653|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664192|NCT03191162|Benzonidazole|benzonidazole|mesh-list
664193|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
664194|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
664195|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664196|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
664197|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
664198|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
664199|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664359|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
664360|NCT03190265|Nivolumab|nivolumab|mesh-list
664361|NCT03190265|Ipilimumab|ipilimumab|mesh-list
664362|NCT03190265|Pancrelipase|pancrelipase|mesh-list
664363|NCT03190265|Vaccines|vaccines|mesh-list
664364|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
664365|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664366|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
664367|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664368|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
664369|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
664370|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664371|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664372|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
664373|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
664374|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
664375|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
665053|NCT03186664|Nabiximols|nabiximols|mesh-list
665054|NCT03186664|Analgesics|analgesics|mesh-ancestor
665055|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
665056|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665057|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223211|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2223212|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
2223213|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2223214|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
2223215|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2223216|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223217|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2223218|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2223219|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223220|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2223221|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2223222|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2223223|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
665597|NCT03183843|Warfarin|warfarin|mesh-list
663024|NCT03196466|Tiagabine|tiagabine|mesh-list
663025|NCT03196466|Stiripentol|stiripentol|mesh-list
663026|NCT03196466|Primidone|primidone|mesh-list
663027|NCT03196466|Felbamate|felbamate|mesh-list
663028|NCT03196466|Analgesics|analgesics|mesh-ancestor
663029|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
663030|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
663031|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663032|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
663033|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
663034|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
663035|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663036|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
663037|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
663038|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
663039|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
663040|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
663041|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
663042|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
663043|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
663044|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
663045|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663046|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
663047|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
663048|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
663049|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
663050|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
663051|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
663052|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
663053|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
663054|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
663055|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
663056|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
663057|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
663058|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
663059|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
663060|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
663061|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
663062|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
663208|NCT03195205|Antibodies|antibodies|mesh-list
663209|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
663210|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663458|NCT03194126|Misoprostol|misoprostol|mesh-list
663459|NCT03194126|Mifepristone|mifepristone|mesh-list
663460|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
663461|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
663462|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
663463|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663464|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
663465|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
663466|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
663467|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
663468|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
663469|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
663470|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
663471|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
663472|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
663473|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
663474|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
663475|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
663476|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
663477|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
663478|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
663654|NCT03193372|Azelaic acid|azelaic acid|mesh-list
663655|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663656|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
663929|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
663930|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
663931|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
663932|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
663933|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663934|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663935|NCT03192709|Urological Agents|urological agents|mesh-ancestor
664376|NCT03189836|Rituximab|rituximab|mesh-list
665109|NCT03186053|Protective Agents|protective agents|mesh-ancestor
663121|NCT03195569|Paclitaxel|paclitaxel|mesh-list
663122|NCT03195569|Bevacizumab|bevacizumab|mesh-list
663123|NCT03195569|Carboplatin|carboplatin|mesh-list
663124|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
663125|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663126|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
663127|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
663128|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
663129|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663130|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
663131|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
663132|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
663133|NCT03195569|Growth Substances|growth substances|mesh-ancestor
663134|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663135|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
663860|NCT03192618|Leucovorin|leucovorin|mesh-list
663861|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
663862|NCT03192618|Calcium|calcium|mesh-list
663863|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
663864|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
663865|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663866|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663867|NCT03192618|Antidotes|antidotes|mesh-ancestor
663868|NCT03192618|Protective Agents|protective agents|mesh-ancestor
663869|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
663870|NCT03192618|Vitamins|vitamins|mesh-ancestor
663871|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
664095|NCT03191864|Fluticasone|fluticasone|mesh-list
664096|NCT03191864|Xhance|xhance|mesh-list
664097|NCT03191864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
664098|NCT03191864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
664099|NCT03191864|Autonomic Agents|autonomic agents|mesh-ancestor
664100|NCT03191864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664101|NCT03191864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664102|NCT03191864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
664103|NCT03191864|Respiratory System Agents|respiratory system agents|mesh-ancestor
664104|NCT03191864|Dermatologic Agents|dermatologic agents|mesh-ancestor
664105|NCT03191864|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
664178|NCT03191370|Anesthetics|anesthetics|mesh-list
664179|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
664180|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
664181|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664182|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
664183|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2752306|NCT03603509|Vaccines|vaccines|mesh-list
2752307|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
2752308|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664544|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
664545|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
664546|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
664547|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
664548|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664549|NCT03188445|Protective Agents|protective agents|mesh-ancestor
664550|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664551|NCT03188445|Vitamins|vitamins|mesh-ancestor
664552|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
664553|NCT03188445|Trace Elements|trace elements|mesh-ancestor
664554|NCT03188445|Hematinics|hematinics|mesh-ancestor
664752|NCT03187691|Amphotericin B|amphotericin b|mesh-list
664753|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
664754|NCT03187691|Amebicides|amebicides|mesh-ancestor
664755|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
664756|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
664757|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664758|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
664759|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
665160|NCT03186131|Vitamin D|vitamin d|mesh-list
665161|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
665162|NCT03186131|Vitamins|vitamins|mesh-ancestor
663147|NCT03195530|Propofol|propofol|mesh-list
663148|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
663149|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
663150|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663151|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
663152|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
663153|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
663561|NCT03193944|Vitamin D|vitamin d|mesh-list
663562|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
663563|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
663564|NCT03193944|Vitamins|vitamins|mesh-list
663565|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
663566|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663567|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
663568|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
664540|NCT03188835|Glycerol|glycerol|mesh-list
664541|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
664542|NCT03188835|Protective Agents|protective agents|mesh-ancestor
664543|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664816|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
664817|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
664818|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
664819|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664992|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
664993|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
664994|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
664995|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
664996|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
664997|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
664998|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664999|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
665000|NCT03186755|Protective Agents|protective agents|mesh-ancestor
665001|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
665002|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
665003|NCT03186755|Analgesics|analgesics|mesh-ancestor
665004|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
665005|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665006|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
665007|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
665008|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
665009|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
665010|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
665011|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
665012|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
665013|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665014|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665611|NCT03183596|Dexamethasone|dexamethasone|mesh-list
665612|NCT03183596|Bupivacaine|bupivacaine|mesh-list
665613|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
665614|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
665615|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
665616|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665617|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665618|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
665619|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
665620|NCT03183596|Hormones|hormones|mesh-ancestor
665621|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
665622|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
665623|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665624|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
665625|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
665626|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
665627|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
665706|NCT03183024|Benralizumab|benralizumab|mesh-list
665707|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
665708|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
2085880|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2085881|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2085882|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085883|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
2085884|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085885|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085886|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
2085887|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
2085888|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
663402|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
663403|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663404|NCT03194594|Analgesics|analgesics|mesh-ancestor
663405|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
663406|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
663407|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
663408|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
663409|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
663410|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
663411|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
663412|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
663413|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
663414|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663538|NCT03193814|Apatinib|apatinib|mesh-list
663539|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663540|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
663541|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663542|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663906|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
663907|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
663908|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
663909|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
663910|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
663911|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663912|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
663913|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
663914|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223224|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
2223225|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223226|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
669700|NCT03164447|UB-421|ub-421|mesh-list
669701|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
669702|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
669703|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669799|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
669800|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
669801|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669820|NCT03163277|Emtricitabine|emtricitabine|mesh-list
669821|NCT03163277|Maraviroc|maraviroc|mesh-list
669822|NCT03163277|Darunavir|darunavir|mesh-list
669823|NCT03163277|Cobicistat|cobicistat|mesh-list
669824|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
669825|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669826|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
669827|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
669828|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669829|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669830|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
669831|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
669832|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
669833|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
669834|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2223227|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
663970|NCT03192111|Entinostat|entinostat|mesh-list
663971|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
663972|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
663973|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663974|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664059|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
664060|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
664061|NCT03191981|Lenalidomide|lenalidomide|mesh-list
664062|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
664063|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
664064|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664065|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664066|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
664067|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
664068|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664069|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664070|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
664071|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
664072|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
664073|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
664074|NCT03191981|Growth Substances|growth substances|mesh-ancestor
664075|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
664332|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
664333|NCT03190447|Laxatives|laxatives|mesh-ancestor
664334|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
664582|NCT03188159|Vinorelbine|vinorelbine|mesh-list
664583|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
664584|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664585|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
664586|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
664587|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
664588|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665245|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
665246|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665247|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
665248|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
665249|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
665250|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665251|NCT03185364|Urological Agents|urological agents|mesh-ancestor
665310|NCT03185104|Fluorides|fluorides|mesh-list
665311|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
665312|NCT03185104|Protective Agents|protective agents|mesh-ancestor
665313|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665408|NCT03184805|Aspirin|aspirin|mesh-list
665409|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
665410|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
665411|NCT03184805|Analgesics|analgesics|mesh-ancestor
665412|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
665413|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665414|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665415|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
665416|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
665417|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
665418|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
665419|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665420|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
665421|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
665422|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665423|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
665910|NCT03182088|Norepinephrine|norepinephrine|mesh-list
665911|NCT03182088|Bupivacaine|bupivacaine|mesh-list
665912|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
665913|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
665914|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
665915|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665916|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
665917|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665918|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
665919|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
665920|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
665921|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665922|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663952|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
663953|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
663954|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
663955|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
663956|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
663957|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
663958|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
663959|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
663960|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
663961|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
663962|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
663963|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
663964|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
663965|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
663966|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
664274|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
664275|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
664276|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664277|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
664278|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664414|NCT03189641|Cilostazol|cilostazol|mesh-list
664415|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
664416|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
664417|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664418|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664419|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
664420|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
664421|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
664422|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
664423|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664424|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
664425|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
664426|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
664427|NCT03189641|Protective Agents|protective agents|mesh-ancestor
664428|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
664429|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
664430|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223228|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2223229|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2223230|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223231|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223232|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223233|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2223234|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
2223235|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2223236|NCT00046033|Ritonavir|ritonavir|mesh-list
2223237|NCT00046033|Lopinavir|lopinavir|mesh-list
665709|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
665710|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665711|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665712|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665827|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
665828|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
665829|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
665830|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
665831|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665832|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
665833|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
665834|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2085889|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
2085890|NCT02151487|Analgesics|analgesics|mesh-ancestor
666558|NCT03178747|Methylene Blue|methylene blue|mesh-list
666559|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666560|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666753|NCT03177850|Acetazolamide|acetazolamide|mesh-list
666754|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
666755|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
666756|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666757|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666758|NCT03177850|Diuretics|diuretics|mesh-ancestor
666759|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
666760|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666808|NCT03177317|Dexamethasone|dexamethasone|mesh-list
664125|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
664126|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
664127|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664128|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664129|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
2223238|NCT00046033|Saquinavir|saquinavir|mesh-list
2223239|NCT00046033|Amprenavir|amprenavir|mesh-list
2223240|NCT00046033|Tenofovir|tenofovir|mesh-list
2223241|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2223242|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2223243|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
664335|NCT03189953|Exenatide|exenatide|mesh-list
664336|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
664337|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664338|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
664339|NCT03189953|Incretins|incretins|mesh-ancestor
664340|NCT03189953|Hormones|hormones|mesh-ancestor
664341|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
664503|NCT03188978|Atorvastatin|atorvastatin|mesh-list
664504|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
664505|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
664506|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
664507|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664508|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
664509|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
664510|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664555|NCT03188471|Aspirin|aspirin|mesh-list
664556|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664557|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
664558|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
664559|NCT03188471|Analgesics|analgesics|mesh-ancestor
664560|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
664561|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664562|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
664563|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664564|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
664565|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
664566|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664567|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
664568|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
664569|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664570|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
665074|NCT03186404|Atorvastatin|atorvastatin|mesh-list
665075|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
665076|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
665077|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
665078|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665079|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
665080|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
665081|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665206|NCT03185988|Trastuzumab|trastuzumab|mesh-list
665207|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
665208|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665642|NCT03183297|Fexofenadine|fexofenadine|mesh-list
665643|NCT03183297|Naproxen|naproxen|mesh-list
665644|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
665645|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
665646|NCT03183297|Analgesics|analgesics|mesh-ancestor
665647|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
665648|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665649|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665650|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
665651|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
665652|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
665653|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
665654|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223244|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664206|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
664272|NCT03190733|Fludarabine|fludarabine|mesh-list
664273|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223245|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223246|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2223247|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2223248|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
2223249|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664939|NCT03187015|Entinostat|entinostat|mesh-list
664940|NCT03187015|Midazolam|midazolam|mesh-list
664941|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
664942|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
664943|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
664944|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664945|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
664946|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
664947|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
664948|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
664949|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
664950|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
664951|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
664952|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
664953|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
664954|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664955|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664956|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
664957|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223250|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2223251|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2223252|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2223253|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2223254|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2223255|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
2223256|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2223257|NCT00046111|Topotecan|topotecan|mesh-list
2223258|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
665314|NCT03185156|Propofol|propofol|mesh-list
665315|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
665316|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
665317|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665318|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
665319|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
665320|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
665531|NCT03184766|Ibuprofen|ibuprofen|mesh-list
665532|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
665533|NCT03184766|Ephedrine|ephedrine|mesh-list
665534|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
665535|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
665536|NCT03184766|Analgesics|analgesics|mesh-ancestor
665537|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
665538|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665539|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665540|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
665541|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
665542|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
665543|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665544|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665545|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
665546|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
665547|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
665548|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
665549|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
665550|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
665551|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
665552|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
665553|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
665554|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665697|NCT03182803|Antibodies|antibodies|mesh-list
665698|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
665699|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085891|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2085892|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
2085893|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
666202|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
666203|NCT03180346|Laxatives|laxatives|mesh-ancestor
666204|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
664297|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
664298|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
664299|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
664300|NCT03190642|Prednisolone|prednisolone|mesh-list
664301|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
664302|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
664303|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
664304|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
664305|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
664306|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
664307|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664308|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664309|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
664310|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
664311|NCT03190642|Hormones|hormones|mesh-ancestor
664312|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
664313|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
664314|NCT03190642|Protective Agents|protective agents|mesh-ancestor
664315|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
664316|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223259|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2223260|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664898|NCT03187106|Metronidazole|metronidazole|mesh-list
664899|NCT03187106|Cephalexin|cephalexin|mesh-list
664900|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664901|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
664902|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
664903|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2085894|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2085895|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2085896|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
665804|NCT03182322|Insulin|insulin|mesh-list
665805|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
665806|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665971|NCT03181243|Anesthetics|anesthetics|mesh-list
665972|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
665973|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666044|NCT03180970|Lugol's solution|lugol's solution|mesh-list
666045|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
666046|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
666047|NCT03180970|Coagulants|coagulants|mesh-ancestor
667172|NCT03175653|Oxycodone|oxycodone|mesh-list
667173|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
667174|NCT03175653|Narcotics|narcotics|mesh-ancestor
667175|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667176|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667177|NCT03175653|Analgesics|analgesics|mesh-ancestor
667178|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
667179|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667180|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
667181|NCT03175341|Vitamins|vitamins|mesh-ancestor
667182|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
667183|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667184|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
667185|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667186|NCT03175341|Protective Agents|protective agents|mesh-ancestor
2223261|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223262|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223263|NCT00046137|Teriparatide|teriparatide|mesh-list
669205|NCT03166787|Protective Agents|protective agents|mesh-ancestor
664252|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
664253|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
664254|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664476|NCT03189329|Lidocaine|lidocaine|mesh-list
664477|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
664478|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
664479|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
664480|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
664481|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664482|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
664483|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664484|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
664485|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
664486|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
664487|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
664488|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664704|NCT03187912|Riboflavin|riboflavin|mesh-list
664705|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
664706|NCT03187912|Vitamins|vitamins|mesh-ancestor
664707|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
664708|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664709|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
664710|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
2223264|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2223265|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2223266|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223267|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2223268|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2223269|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
2223270|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2085897|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085898|NCT02151591|Varenicline|varenicline|mesh-list
2085899|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
665381|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
665382|NCT03185130|Promethazine|promethazine|mesh-list
665383|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
665384|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
665385|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
665386|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
665387|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665388|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
665389|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
665390|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
665391|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665392|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
665393|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
665394|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
665395|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
665396|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
665397|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
665398|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665399|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665400|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
665401|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
665402|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
665403|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
665404|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
665405|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
665406|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
665407|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
665662|NCT03183492|Vaccines|vaccines|mesh-list
665663|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
665664|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223271|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2223272|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2223273|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
2223274|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
664281|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
664282|NCT03190603|Analgesics|analgesics|mesh-ancestor
664283|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
664284|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664285|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664286|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
664287|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664288|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
664289|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
664290|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664291|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085900|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2085901|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
2085902|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085903|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085904|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085905|NCT02151643|Iron|iron|mesh-list
2085906|NCT02151643|Trace Elements|trace elements|mesh-ancestor
2085907|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
2085908|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664632|NCT03188172|Dexamethasone|dexamethasone|mesh-list
664633|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
664634|NCT03188172|Melphalan|melphalan|mesh-list
664635|NCT03188172|Lenalidomide|lenalidomide|mesh-list
664636|NCT03188172|Bortezomib|bortezomib|mesh-list
664637|NCT03188172|Daratumumab|daratumumab|mesh-list
664638|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
664639|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
664640|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664641|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664642|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
664643|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
664644|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664645|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664646|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
664647|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
664648|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
664649|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
664650|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664651|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
664652|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
664653|NCT03188172|Hormones|hormones|mesh-ancestor
664654|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
664655|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
664656|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
664657|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
664658|NCT03188172|Growth Substances|growth substances|mesh-ancestor
664659|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
664911|NCT03187496|Midazolam|midazolam|mesh-list
664912|NCT03187496|Caffeine|caffeine|mesh-list
664913|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
664914|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
664915|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
664916|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
664917|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664918|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
664919|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
664920|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
664921|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
664922|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
664923|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
664924|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
664925|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
664926|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
664927|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664928|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
664929|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
664930|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
664931|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
665154|NCT03186027|Vitamins|vitamins|mesh-ancestor
664377|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
664378|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664379|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
664380|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664381|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664729|NCT03187899|Ropivacaine|ropivacaine|mesh-list
664730|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
664731|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
664732|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
664733|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664734|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
664735|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664830|NCT03187509|Torsemide|torsemide|mesh-list
664831|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
664832|NCT03187509|Diuretics|diuretics|mesh-ancestor
664833|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
664834|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664835|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
664836|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
664837|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665321|NCT03184844|Thalidomide|thalidomide|mesh-list
665322|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
665323|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
665324|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665325|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
665326|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
665327|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
665328|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
665329|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
665330|NCT03184844|Growth Substances|growth substances|mesh-ancestor
665331|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
665332|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666262|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
666263|NCT03180281|Glimepiride|glimepiride|mesh-list
666264|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
666265|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666266|NCT03180281|Incretins|incretins|mesh-ancestor
666267|NCT03180281|Hormones|hormones|mesh-ancestor
666268|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
666269|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
666270|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
666271|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666272|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666273|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
666274|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
666275|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
666345|NCT03179761|Vaccines|vaccines|mesh-list
666346|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
666347|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085909|NCT02151682|Morphine|morphine|mesh-list
2085910|NCT02151682|Tapentadol|tapentadol|mesh-list
2085911|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2085912|NCT02151682|Narcotics|narcotics|mesh-ancestor
2085913|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
668396|NCT03169751|Caffeine|caffeine|mesh-list
668397|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
668398|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668399|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
668400|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668401|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668402|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
668403|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
668404|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
668405|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
668518|NCT03169660|Aflibercept|aflibercept|mesh-list
668519|NCT03169660|Mitogens|mitogens|mesh-list
668520|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
668521|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
668522|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668523|NCT03169660|Growth Substances|growth substances|mesh-ancestor
2085914|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223275|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664571|NCT03188510|Mirikizumab|mirikizumab|mesh-list
664572|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
664573|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
664574|NCT03188510|Analgesics|analgesics|mesh-ancestor
664575|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
664576|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
664577|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664578|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
664579|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664580|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
664581|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
664804|NCT03187834|Amoxicillin|amoxicillin|mesh-list
664805|NCT03187834|Azithromycin|azithromycin|mesh-list
664806|NCT03187834|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
664807|NCT03187834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
664808|NCT03187834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
664809|NCT03187834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
664810|NCT03187834|Renal Agents|renal agents|mesh-ancestor
664811|NCT03187834|Antimalarials|antimalarials|mesh-ancestor
664812|NCT03187834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
664813|NCT03187834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
664864|NCT03187223|Melphalan|melphalan|mesh-list
664865|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
664866|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
664867|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
664868|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664869|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
664870|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
664871|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
664872|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
664873|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085915|NCT02151682|Analgesics|analgesics|mesh-ancestor
2085916|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
2085917|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085918|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2085919|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2085920|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2085921|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085922|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
2085923|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2085924|NCT02151773|Vaccines|vaccines|mesh-list
2085925|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
2085926|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665593|NCT03183674|Oxytocin|oxytocin|mesh-list
665594|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
665595|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
665596|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665636|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
665637|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665638|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
665639|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665640|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665641|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2223276|NCT00046163|Midodrine|midodrine|mesh-list
2223277|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
2223278|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
2223279|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2223280|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666690|NCT03178084|Lamivudine|lamivudine|mesh-list
666691|NCT03178084|Zidovudine|zidovudine|mesh-list
666692|NCT03178084|Efavirenz|efavirenz|mesh-list
666693|NCT03178084|Maraviroc|maraviroc|mesh-list
666694|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
666695|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
666696|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666697|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666698|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
666699|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666700|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
666701|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
666702|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
666703|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
666704|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
666730|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223281|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2223282|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
664886|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
664887|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
664888|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665024|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
665025|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
665026|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
665027|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
665028|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665029|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
665111|NCT03186313|Ribavirin|ribavirin|mesh-list
665112|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
665113|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
665114|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665115|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
665116|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
665209|NCT03185845|Warfarin|warfarin|mesh-list
665210|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
665252|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
665253|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
665254|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665255|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
665256|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
665257|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
665258|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
665259|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665260|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665261|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
665516|NCT03184493|Metformin|metformin|mesh-list
665517|NCT03184493|Celecoxib|celecoxib|mesh-list
665518|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
665519|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665520|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
665521|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
665522|NCT03184493|Analgesics|analgesics|mesh-ancestor
665523|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
665524|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665525|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
665526|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
665527|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
665528|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
665529|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665530|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665781|NCT03182218|Heparin|heparin|mesh-list
665782|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
665783|NCT03182218|Tinzaparin|tinzaparin|mesh-list
665784|NCT03182218|Dalteparin|dalteparin|mesh-list
665785|NCT03182218|Anticoagulants|anticoagulants|mesh-list
665786|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
665787|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
665788|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665814|NCT03181919|Letrozole|letrozole|mesh-list
665815|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665816|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
665817|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
665818|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665819|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665820|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
665821|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
665822|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
665823|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752348|NCT03580161|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
666392|NCT03179904|Paclitaxel|paclitaxel|mesh-list
666393|NCT03179904|Trastuzumab|trastuzumab|mesh-list
666394|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
666395|NCT03179904|Letrozole|letrozole|mesh-list
666396|NCT03179904|Fulvestrant|fulvestrant|mesh-list
666397|NCT03179904|Anastrozole|anastrozole|mesh-list
666398|NCT03179904|Exemestane|exemestane|mesh-list
666399|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
666400|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
666401|NCT03179904|Antibodies|antibodies|mesh-list
666402|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
664615|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
664616|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
664617|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
664618|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
664965|NCT03187080|Bupivacaine|bupivacaine|mesh-list
664966|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
664967|NCT03187080|Anesthetics|anesthetics|mesh-list
664968|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
664969|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664970|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
664971|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085927|NCT02151786|Lansoprazole|lansoprazole|mesh-list
2085928|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
2085929|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
665723|NCT03182634|Olaparib|olaparib|mesh-list
665724|NCT03182634|Fulvestrant|fulvestrant|mesh-list
665725|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
665726|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665727|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665728|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665729|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
665730|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
665731|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
665732|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
665733|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
665734|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666466|NCT03179280|Insulin|insulin|mesh-list
666467|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
666468|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
666469|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666806|NCT03177434|Lactulose|lactulose|mesh-list
666807|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2223283|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2223284|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2223285|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
2223286|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223287|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223288|NCT00046176|Lamivudine|lamivudine|mesh-list
2223289|NCT00046176|Abacavir|abacavir|mesh-list
2223290|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
2223291|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2223292|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2223293|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667276|NCT03174938|Flutemetamol|flutemetamol|mesh-list
667277|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
667278|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667331|NCT03174457|Micafungin|micafungin|mesh-list
667332|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
667333|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
667521|NCT03173781|Droxidopa|droxidopa|mesh-list
667522|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
667523|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
667653|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
667654|NCT03173066|Hematinics|hematinics|mesh-ancestor
667655|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
667656|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
668422|NCT03170479|Vitamin D|vitamin d|mesh-list
668423|NCT03170479|Vitamins|vitamins|mesh-ancestor
668424|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
668425|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668426|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
669292|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
669293|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
669294|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669295|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
669411|NCT03165500|Midazolam|midazolam|mesh-list
669412|NCT03165500|Diazepam|diazepam|mesh-list
669413|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
669414|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
669415|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
669416|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
669417|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669418|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
669419|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
669420|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
669421|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
669422|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
669423|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
2223294|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223295|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
2223296|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223297|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2223298|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2223299|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
2223300|NCT00046241|Bupropion|bupropion|mesh-list
2223301|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2223302|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
2223303|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2223304|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
665102|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
665103|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
665232|NCT03185611|Rifaximin|rifaximin|mesh-list
665233|NCT03185611|Azathioprine|azathioprine|mesh-list
665234|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
665235|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
665236|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
665237|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
665238|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665239|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
665240|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665241|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
665242|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
665243|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665244|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
665365|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
665564|NCT03184324|Esomeprazole|esomeprazole|mesh-list
665565|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
665566|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
665567|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
665568|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665569|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666041|NCT03180957|Adalimumab|adalimumab|mesh-list
666042|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
666043|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
666283|NCT03179995|Octreotide|octreotide|mesh-list
666284|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
666285|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
666286|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666424|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
666425|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
666426|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
666742|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
666743|NCT03177720|Imipenem|imipenem|mesh-list
666744|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
666745|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666746|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
666747|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
666748|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666749|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666750|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666751|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
666752|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
667036|NCT03176199|Oxycodone|oxycodone|mesh-list
667037|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
667038|NCT03176199|Narcotics|narcotics|mesh-ancestor
667039|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667040|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667041|NCT03176199|Analgesics|analgesics|mesh-ancestor
667042|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
667043|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2223305|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2223306|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2223307|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223308|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
2223309|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223310|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223311|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2223312|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
667842|NCT03172793|Telavancin|telavancin|mesh-list
667843|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
667844|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
667902|NCT03172299|Aflibercept|aflibercept|mesh-list
667903|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
664727|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
664728|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
665030|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
665031|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
665032|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
665033|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
665034|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
665035|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665036|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
665037|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665038|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665039|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
665040|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665139|NCT03186326|Bevacizumab|bevacizumab|mesh-list
665140|NCT03186326|Cetuximab|cetuximab|mesh-list
665141|NCT03186326|Panitumumab|panitumumab|mesh-list
665142|NCT03186326|Avelumab|avelumab|mesh-list
665143|NCT03186326|Aflibercept|aflibercept|mesh-list
665144|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
665145|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665146|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
665147|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
665148|NCT03186326|Growth Substances|growth substances|mesh-ancestor
665149|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665150|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
665281|NCT03185351|Midazolam|midazolam|mesh-list
665282|NCT03185351|Bupivacaine|bupivacaine|mesh-list
665283|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
665284|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
665285|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
665286|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665287|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
665288|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665289|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
665290|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
665291|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
665292|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
665293|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
665294|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
665295|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
665296|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
665297|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
665298|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665299|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665679|NCT03183115|Lugol's solution|lugol's solution|mesh-list
665680|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
665681|NCT03183115|Coagulants|coagulants|mesh-ancestor
665735|NCT03182595|Acetaminophen|acetaminophen|mesh-list
665736|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
665737|NCT03182595|Analgesics|analgesics|mesh-ancestor
665738|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
665739|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665740|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665741|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
665796|NCT03182257|ONO-7579|ono-7579|mesh-list
665797|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
665798|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665799|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223313|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666222|NCT03180255|Dexamethasone|dexamethasone|mesh-list
666223|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
666224|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
666225|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
666226|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
666227|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
666228|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666229|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666230|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
666231|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
666232|NCT03180255|Hormones|hormones|mesh-ancestor
666233|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
666234|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
666235|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666236|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
666606|NCT03178539|Diclofenac|diclofenac|mesh-list
666607|NCT03178539|Ketorolac|ketorolac|mesh-list
667213|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
664781|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
664782|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
664783|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
664784|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
664785|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
664786|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
664787|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665276|NCT03185793|Benzbromarone|benzbromarone|mesh-list
665277|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
665278|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
665279|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
665280|NCT03185793|Renal Agents|renal agents|mesh-ancestor
666063|NCT03180944|Lugol's solution|lugol's solution|mesh-list
666064|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
666065|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
666066|NCT03180944|Coagulants|coagulants|mesh-ancestor
2085930|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2085931|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2085932|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223314|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
2223315|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2223316|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223317|NCT00046267|Niacin|niacin|mesh-list
2223318|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2223319|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
2223320|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223321|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2223322|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
2223323|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
2223324|NCT00046267|Vitamins|vitamins|mesh-ancestor
2223325|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
2223326|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223327|NCT00046293|Abciximab|abciximab|mesh-list
2223328|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
2223329|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2223330|NCT00046306|Antioxidants|antioxidants|mesh-list
2223331|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223332|NCT00046306|Protective Agents|protective agents|mesh-ancestor
666977|NCT03176498|Aspirin|aspirin|mesh-list
666978|NCT03176498|Atorvastatin|atorvastatin|mesh-list
666979|NCT03176498|Calcium|calcium|mesh-list
666980|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
666981|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666982|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
666983|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
666984|NCT03176498|Analgesics|analgesics|mesh-ancestor
666985|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
666986|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666987|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
666988|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
666989|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
666990|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
666991|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666992|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
666993|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
666994|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666995|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
666996|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
666997|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
666998|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
666999|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
667000|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
667549|NCT03173235|Vitamin D|vitamin d|mesh-list
667550|NCT03173235|Vitamins|vitamins|mesh-ancestor
667551|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
667552|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667553|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2085933|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085934|NCT02151851|Methotrexate|methotrexate|mesh-list
2085935|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
2085936|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2085937|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
2085938|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2085939|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223333|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223334|NCT00046319|Ambrisentan|ambrisentan|mesh-list
664882|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
664883|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
664884|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
664885|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665166|NCT03186040|Lacosamide|lacosamide|mesh-list
665167|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
665168|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
665169|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
665170|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
665171|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752349|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
2752350|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
2752351|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
2752352|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
2752353|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2752354|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223335|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2223336|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2223337|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2223338|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2223339|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
2223340|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223341|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223342|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2223343|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2223344|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
2223345|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223346|NCT00046358|Ibuprofen|ibuprofen|mesh-list
2223347|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2223348|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2223349|NCT00046358|Analgesics|analgesics|mesh-ancestor
2223350|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
2223351|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2223352|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666431|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
666432|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
666433|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
666761|NCT03177980|Clonidine|clonidine|mesh-list
666762|NCT03177980|Fentanyl|fentanyl|mesh-list
666763|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
666764|NCT03177980|Narcotics|narcotics|mesh-ancestor
666765|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
666766|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666767|NCT03177980|Analgesics|analgesics|mesh-ancestor
666768|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
666769|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666770|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
666771|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
666772|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
666773|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
666774|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
666775|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
666776|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
666777|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
666778|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
666779|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
666780|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
666781|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
666782|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666918|NCT03177083|Interferons|interferons|mesh-list
666919|NCT03177083|Interferon-beta|interferon-beta|mesh-list
666920|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
666921|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
666922|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666923|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
666924|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666925|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
666926|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666927|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2752355|NCT03574571|Docetaxel|docetaxel|mesh-list
667786|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
667787|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
667788|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223353|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2223354|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
664932|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
664933|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
664934|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
664935|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
664936|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
664937|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
664938|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
665559|NCT03184090|Palbociclib|palbociclib|mesh-list
665560|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665561|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
665562|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665563|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665835|NCT03182192|Exenatide|exenatide|mesh-list
665836|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
665837|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665838|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
665839|NCT03182192|Incretins|incretins|mesh-ancestor
665840|NCT03182192|Hormones|hormones|mesh-ancestor
665841|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
666101|NCT03181100|Paclitaxel|paclitaxel|mesh-list
666102|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
666103|NCT03181100|Bevacizumab|bevacizumab|mesh-list
666104|NCT03181100|Atezolizumab|atezolizumab|mesh-list
666105|NCT03181100|Vemurafenib|vemurafenib|mesh-list
666106|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
666107|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
666108|NCT03181100|Antibodies|antibodies|mesh-list
666109|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
666110|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
666111|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
666112|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
666113|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666114|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
666115|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
666116|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
666117|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666118|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
666119|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
666120|NCT03181100|Growth Substances|growth substances|mesh-ancestor
666121|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666122|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
666123|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
666124|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
666125|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666330|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
666331|NCT03179930|Entinostat|entinostat|mesh-list
666332|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
666333|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666334|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
666335|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666336|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666420|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
666421|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
666422|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
666423|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666534|NCT03178721|Calcium|calcium|mesh-list
666535|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
666536|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223355|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2223356|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223357|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223358|NCT00046384|Aripiprazole|aripiprazole|mesh-list
2223359|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
2223360|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
667071|NCT03175978|Methotrexate|methotrexate|mesh-list
667072|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667073|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
667074|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
667075|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
667076|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
667077|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
667078|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667079|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667080|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
667081|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223361|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2223362|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2223363|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2223364|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223365|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
2223366|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
2223367|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223368|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223369|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2223370|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2223371|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
2223372|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2223373|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
665333|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
665334|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
665335|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
665336|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665337|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665338|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
665339|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
665340|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
665341|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666020|NCT03181178|Micronutrients|micronutrients|mesh-list
666021|NCT03181178|Trace Elements|trace elements|mesh-list
666022|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085940|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2085941|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
2085942|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085943|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667087|NCT03175939|Fluorouracil|fluorouracil|mesh-list
667088|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667089|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
667090|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667091|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
667092|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
667093|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
667094|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667140|NCT03175666|Leucovorin|leucovorin|mesh-list
667141|NCT03175666|Paclitaxel|paclitaxel|mesh-list
667142|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
667143|NCT03175666|Bevacizumab|bevacizumab|mesh-list
667144|NCT03175666|Fluorouracil|fluorouracil|mesh-list
667145|NCT03175666|Capecitabine|capecitabine|mesh-list
667146|NCT03175666|Avelumab|avelumab|mesh-list
667147|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
667148|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667149|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
667150|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
667151|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
667152|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667153|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
667154|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
667155|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667156|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
667157|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
667158|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
667159|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
667160|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
667161|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
667162|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
667163|NCT03175666|Growth Substances|growth substances|mesh-ancestor
667164|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
667165|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
667166|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
667167|NCT03175666|Antidotes|antidotes|mesh-ancestor
667168|NCT03175666|Protective Agents|protective agents|mesh-ancestor
667169|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
667170|NCT03175666|Vitamins|vitamins|mesh-ancestor
667171|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
667207|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
667208|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
667209|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
667210|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
667211|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
667212|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
665018|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
665019|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665020|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
665021|NCT03186742|Diuretics|diuretics|mesh-ancestor
665022|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
665023|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
665183|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
665184|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
665185|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
665186|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
665187|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665188|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
665189|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665190|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665191|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
665192|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665800|NCT03182374|Hylan|hylan|mesh-list
665801|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
665802|NCT03182374|Protective Agents|protective agents|mesh-ancestor
665803|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665848|NCT03181880|Bromides|bromides|mesh-list
665849|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
665850|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
665851|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
665852|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665853|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665854|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
665855|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
665856|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
665857|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
665858|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
665859|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
665860|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665861|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665862|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
666199|NCT03180359|Vaccines|vaccines|mesh-list
666200|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
666201|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666885|NCT03176849|Vitamin D|vitamin d|mesh-list
666886|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
666887|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
666888|NCT03176849|Vitamins|vitamins|mesh-list
666889|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
666890|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666891|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
666892|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2223374|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2223375|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2223376|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
667605|NCT03173339|Remifentanil|remifentanil|mesh-list
667606|NCT03173339|Sevoflurane|sevoflurane|mesh-list
667607|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
667608|NCT03173339|Narcotics|narcotics|mesh-ancestor
667609|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667610|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667611|NCT03173339|Analgesics|analgesics|mesh-ancestor
667612|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
667613|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667614|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
667615|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
667616|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
667617|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
667760|NCT03172910|Rivaroxaban|rivaroxaban|mesh-list
667761|NCT03172910|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
667762|NCT03172910|Antithrombins|antithrombins|mesh-ancestor
667763|NCT03172910|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
667764|NCT03172910|Protease Inhibitors|protease inhibitors|mesh-ancestor
667765|NCT03172910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667766|NCT03172910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667767|NCT03172910|Anticoagulants|anticoagulants|mesh-ancestor
665578|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
665579|NCT03184194|Nivolumab|nivolumab|mesh-list
665580|NCT03184194|Daratumumab|daratumumab|mesh-list
665581|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
665582|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
665583|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
665584|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665585|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
665586|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
665587|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
665588|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665589|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665590|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
665591|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
665592|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2752356|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752357|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
2752358|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
666434|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
666435|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
666436|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
667282|NCT03175432|Bevacizumab|bevacizumab|mesh-list
667283|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
667284|NCT03175432|Atezolizumab|atezolizumab|mesh-list
667285|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
667286|NCT03175432|Antibodies|antibodies|mesh-list
667287|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
667288|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
667289|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
667290|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667291|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
667292|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
667293|NCT03175432|Growth Substances|growth substances|mesh-ancestor
667294|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667295|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
667296|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
2085944|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
2085945|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085946|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
667693|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
667694|NCT03173131|Narcotics|narcotics|mesh-ancestor
667695|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667696|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667697|NCT03173131|Analgesics|analgesics|mesh-ancestor
667698|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
667699|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668698|NCT03169114|Amikacin|amikacin|mesh-list
668699|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
668700|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223377|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223378|NCT00046462|Metformin|metformin|mesh-list
2223379|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
668943|NCT03167853|Antibodies|antibodies|mesh-list
668944|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
668945|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
668946|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085947|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2085948|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
2085949|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2085950|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2085951|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
2085952|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2223380|NCT00046462|Glyburide|glyburide|mesh-list
665110|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665503|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
665504|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
665505|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
665506|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665507|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665508|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
665509|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
665510|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665511|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
665512|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665943|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
665944|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
665979|NCT03181360|Tenecteplase|tenecteplase|mesh-list
665980|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
665981|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
665982|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666276|NCT03180099|Bupivacaine|bupivacaine|mesh-list
666277|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
666278|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
666279|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
666280|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666281|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
666282|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666427|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
666428|NCT03179449|Hematinics|hematinics|mesh-ancestor
666429|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
666430|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
667595|NCT03173508|Acetazolamide|acetazolamide|mesh-list
667596|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
667597|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
667598|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667599|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667600|NCT03173508|Diuretics|diuretics|mesh-ancestor
667601|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
667602|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668068|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
668069|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
668070|NCT03171831|Busulfan|busulfan|mesh-list
668071|NCT03171831|Methotrexate|methotrexate|mesh-list
668072|NCT03171831|Fludarabine|fludarabine|mesh-list
668073|NCT03171831|Tacrolimus|tacrolimus|mesh-list
668074|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
668075|NCT03171831|Basiliximab|basiliximab|mesh-list
668076|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
668077|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
668078|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668079|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668080|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
668081|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
668082|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668083|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668084|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
668085|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
668086|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
668087|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
668088|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
668089|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
665155|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
665156|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665157|NCT03186027|Antioxidants|antioxidants|mesh-ancestor
665158|NCT03186027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665159|NCT03186027|Protective Agents|protective agents|mesh-ancestor
665424|NCT03184649|Acetaminophen|acetaminophen|mesh-list
665425|NCT03184649|Ibuprofen|ibuprofen|mesh-list
665426|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
665427|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
665428|NCT03184649|Analgesics|analgesics|mesh-ancestor
665429|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
665430|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665431|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665432|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
665433|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
665434|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
665435|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665436|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665437|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
665755|NCT03182426|Liraglutide|liraglutide|mesh-list
665756|NCT03182426|Plerixafor|plerixafor|mesh-list
665757|NCT03182426|Etanercept|etanercept|mesh-list
665758|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
665759|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
665760|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
665761|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665762|NCT03182426|Incretins|incretins|mesh-ancestor
665763|NCT03182426|Hormones|hormones|mesh-ancestor
665764|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
665765|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
665766|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
665767|NCT03182426|Analgesics|analgesics|mesh-ancestor
665768|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
665769|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665770|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
665771|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
665772|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
665773|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
665774|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
665775|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
665776|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665777|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
665778|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
665779|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
665780|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666386|NCT03179605|Clobetasol|clobetasol|mesh-list
666387|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
666388|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
666389|NCT03179605|Hormones|hormones|mesh-ancestor
666390|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
666391|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666588|NCT03178422|Nicotine|nicotine|mesh-list
666589|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
666590|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
666591|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666592|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666593|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
666594|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
666595|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
666596|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
666597|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666654|NCT03178123|Interferons|interferons|mesh-list
666655|NCT03178123|Antibodies|antibodies|mesh-list
666656|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
666657|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
666658|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666659|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666660|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
666661|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666893|NCT03177109|Fluorides|fluorides|mesh-list
666894|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
666895|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
666896|NCT03177109|Protective Agents|protective agents|mesh-ancestor
666897|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667511|NCT03173898|Anesthetics|anesthetics|mesh-list
667512|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2085953|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
665163|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
665164|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665165|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
665460|NCT03184870|Leucovorin|leucovorin|mesh-list
665461|NCT03184870|Gemcitabine|gemcitabine|mesh-list
665462|NCT03184870|Paclitaxel|paclitaxel|mesh-list
665463|NCT03184870|Fluorouracil|fluorouracil|mesh-list
665464|NCT03184870|Nivolumab|nivolumab|mesh-list
665465|NCT03184870|Irinotecan|irinotecan|mesh-list
665466|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
665467|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665468|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
665469|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
665470|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
665471|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665472|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
665473|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
665474|NCT03184870|Antiviral Agents|antiviral agents|mesh-ancestor
665475|NCT03184870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
665476|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665477|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
665478|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
665479|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665480|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
665481|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
665482|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
665483|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
665484|NCT03184870|Antidotes|antidotes|mesh-ancestor
665485|NCT03184870|Protective Agents|protective agents|mesh-ancestor
665486|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
665487|NCT03184870|Vitamins|vitamins|mesh-ancestor
665488|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
665665|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
665666|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
665667|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
665668|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665669|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665670|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
665671|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
665672|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
665673|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
665674|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
665675|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
665676|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
665677|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665678|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665713|NCT03182855|Ticagrelor|ticagrelor|mesh-list
665714|NCT03182855|Cangrelor|cangrelor|mesh-list
665715|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
665716|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
665717|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
665718|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
665719|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
665720|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665721|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665722|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666033|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
666034|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
666035|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
666036|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666048|NCT03180723|Cyclosporine|cyclosporine|mesh-list
666049|NCT03180723|Rituximab|rituximab|mesh-list
666050|NCT03180723|Cyclosporins|cyclosporins|mesh-list
666051|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
666052|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666053|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
666054|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666055|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
666056|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666057|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666058|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
666059|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
666060|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666061|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
666062|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2223381|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2223382|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
665230|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
665231|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
665492|NCT03184480|Fluticasone|fluticasone|mesh-list
665493|NCT03184480|Xhance|xhance|mesh-list
665494|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
665495|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
665496|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
665497|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665498|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665499|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
665500|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
665501|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
665502|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2085954|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085955|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085956|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2085957|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
2085958|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2223383|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223384|NCT00046501|Insulin|insulin|mesh-list
2223385|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
2223386|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
666067|NCT03180736|Dexamethasone|dexamethasone|mesh-list
666068|NCT03180736|Pomalidomide|pomalidomide|mesh-list
666069|NCT03180736|Daratumumab|daratumumab|mesh-list
666070|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
666071|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
666072|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
666073|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666074|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666075|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
666076|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
666077|NCT03180736|Hormones|hormones|mesh-ancestor
666078|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
666079|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
666080|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666081|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
666082|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
666083|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
666084|NCT03180736|Growth Substances|growth substances|mesh-ancestor
666085|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
666485|NCT03178955|Etanercept|etanercept|mesh-list
666486|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
666487|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
666488|NCT03178955|Analgesics|analgesics|mesh-ancestor
666489|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
666490|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666491|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666492|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
666493|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
666494|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
666495|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
666496|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
666561|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
666562|NCT03178591|Vildagliptin|vildagliptin|mesh-list
666563|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
666564|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666565|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
666566|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666567|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
666568|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
666569|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666832|NCT03177252|Lidocaine|lidocaine|mesh-list
666833|NCT03177252|Bupivacaine|bupivacaine|mesh-list
666834|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
666835|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
666836|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
666837|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666838|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
666839|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665269|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665270|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
665271|NCT03185403|Narcotics|narcotics|mesh-ancestor
665272|NCT03185403|Analgesics|analgesics|mesh-ancestor
665273|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
665274|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
665275|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
2223387|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
2223388|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
2223389|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2223390|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223391|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2223392|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223393|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2223394|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223395|NCT00046553|Mifepristone|mifepristone|mesh-list
2223396|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2223397|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
2223398|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2223399|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223400|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2223401|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2223402|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2223403|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
2223404|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2223405|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2223406|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
2223407|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
665752|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
665753|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
665754|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665932|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
665933|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
665934|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665935|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
665936|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
665937|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
665938|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665939|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
665940|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
665941|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
665942|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
665959|NCT03181464|Lidocaine|lidocaine|mesh-list
665960|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
665961|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
665962|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
665963|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665964|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
665965|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665966|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
665967|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
665968|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
665969|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
665970|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666155|NCT03180593|Valsartan|valsartan|mesh-list
666156|NCT03180593|Nebivolol|nebivolol|mesh-list
666157|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
666158|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
666159|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
666160|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666161|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
666162|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
666163|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
666164|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
666165|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
666166|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
666167|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666482|NCT03179254|Metformin|metformin|mesh-list
666483|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
666484|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666727|NCT03177811|Acetazolamide|acetazolamide|mesh-list
666728|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
666729|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
665598|NCT03183843|Dabigatran|dabigatran|mesh-list
665599|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
665600|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
665601|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
665602|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
665603|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665604|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665690|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
665742|NCT03182413|Modafinil|modafinil|mesh-list
665743|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
665744|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665745|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
665746|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
665747|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
665748|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665886|NCT03182114|Bupivacaine|bupivacaine|mesh-list
665887|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
665888|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
665889|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
665890|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665891|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
665892|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666139|NCT03180632|Lorazepam|lorazepam|mesh-list
666140|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
666141|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
666142|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
666143|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666144|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666145|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
666146|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
666147|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
666148|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
666149|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
666150|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
666151|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
666152|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
666153|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
666154|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666219|NCT03180242|Trastuzumab|trastuzumab|mesh-list
666220|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
666221|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223408|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
2223409|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2223410|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2223411|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
2223412|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2223413|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223414|NCT00046735|Lenalidomide|lenalidomide|mesh-list
2223415|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
2223416|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223417|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2223418|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2223419|NCT00046735|Growth Substances|growth substances|mesh-ancestor
2223420|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
2223421|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223422|NCT00046748|Omalizumab|omalizumab|mesh-list
2223423|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2223424|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2223425|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
2223426|NCT00046787|Lurtotecan|lurtotecan|mesh-list
2223427|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223428|NCT00046800|Lurtotecan|lurtotecan|mesh-list
2223429|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666437|NCT03179293|Propofol|propofol|mesh-list
666438|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
666439|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
666440|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666441|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
666442|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
666443|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
2223430|NCT00046813|Nicotine|nicotine|mesh-list
2223431|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2223432|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
667046|NCT03176446|Anesthetics|anesthetics|mesh-list
667047|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
667048|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2223433|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
665655|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665656|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
665657|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
665658|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
665659|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
665660|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
665661|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
666174|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
666175|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666176|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
666177|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
666178|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
2752359|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
2752360|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752361|NCT03572049|Itraconazole|itraconazole|mesh-list
667351|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
667352|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
667353|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
667354|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
667418|NCT03174067|Clonidine|clonidine|mesh-list
667419|NCT03174067|Buprenorphine|buprenorphine|mesh-list
667420|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
667421|NCT03174067|Narcotics|narcotics|mesh-ancestor
667422|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667423|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667424|NCT03174067|Analgesics|analgesics|mesh-ancestor
667425|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
667426|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667427|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
667428|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
667429|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
667430|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
667431|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
667432|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
667433|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
667434|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
667435|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
667436|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667533|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
667534|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
667535|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
667536|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
667537|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
667538|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
667539|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
667540|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667541|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667789|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
667790|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
667791|NCT03173053|Clarithromycin|clarithromycin|mesh-list
667792|NCT03173053|Doxycycline|doxycycline|mesh-list
667793|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
667794|NCT03173053|Rifampin|rifampin|mesh-list
667795|NCT03173053|Clindamycin|clindamycin|mesh-list
667796|NCT03173053|Trimethoprim|trimethoprim|mesh-list
667797|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
667798|NCT03173053|Mupirocin|mupirocin|mesh-list
667799|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
667800|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
667801|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
667802|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
667803|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
667804|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
667805|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
667806|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667807|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667808|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
667809|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
667810|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
667811|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
667812|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
667813|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
667814|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
667815|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667816|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
667817|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
665684|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
665685|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665686|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
665687|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
665688|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665689|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
665789|NCT03182296|Exenatide|exenatide|mesh-list
665790|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
665791|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665792|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
665793|NCT03182296|Incretins|incretins|mesh-ancestor
665794|NCT03182296|Hormones|hormones|mesh-ancestor
665795|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2085959|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
2085960|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085961|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
666134|NCT03180476|Apatinib|apatinib|mesh-list
666135|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666136|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
666137|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666138|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666205|NCT03180294|Bupropion|bupropion|mesh-list
666206|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
666207|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
666208|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
666209|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
666210|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
666211|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
666212|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666213|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
666214|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
666215|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666216|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
666217|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
666218|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666948|NCT03176524|Glucagon|glucagon|mesh-list
666949|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
666950|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
666951|NCT03176524|Hormones|hormones|mesh-ancestor
666952|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
666953|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666954|NCT03176524|Incretins|incretins|mesh-ancestor
2223434|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223435|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2223436|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2223437|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
2223438|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223439|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223440|NCT00046826|Thalidomide|thalidomide|mesh-list
2223441|NCT00046826|Docetaxel|docetaxel|mesh-list
2223442|NCT00046826|Estramustine|estramustine|mesh-list
2223443|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223444|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
2223445|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
2223446|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
667297|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
667298|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
667299|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667300|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
667301|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668221|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
668222|NCT03171220|Fludarabine|fludarabine|mesh-list
668223|NCT03171220|Interleukin-2|interleukin-2|mesh-list
668224|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
668225|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
668226|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668227|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668228|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
668229|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
668230|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668231|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752362|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
665807|NCT03182231|Exenatide|exenatide|mesh-list
665808|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
665809|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665810|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
665811|NCT03182231|Incretins|incretins|mesh-ancestor
665812|NCT03182231|Hormones|hormones|mesh-ancestor
665813|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2085962|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2085963|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
2085964|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
2085965|NCT02151877|Protective Agents|protective agents|mesh-ancestor
2085966|NCT02151981|Osimertinib|osimertinib|mesh-list
667132|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
667133|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
667134|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
667135|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
667136|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667137|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
667138|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
667139|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667302|NCT03174561|Choline|choline|mesh-list
667303|NCT03174561|Silymarin|silymarin|mesh-list
667304|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
667305|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
667306|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
667307|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667308|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
667309|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
667310|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
667311|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
667312|NCT03174561|Protective Agents|protective agents|mesh-ancestor
667313|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668183|NCT03170895|Sorafenib|sorafenib|mesh-list
668184|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
668185|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668186|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
668187|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668188|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668189|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
668190|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
668250|NCT03170596|Tazarotene|tazarotene|mesh-list
668251|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
668252|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
669539|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
669540|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
669541|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670063|NCT03162185|Citalopram|citalopram|mesh-list
670064|NCT03162185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
670065|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
670066|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
670114|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085967|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085968|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2085969|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085970|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085971|NCT02151994|Zamicastat|zamicastat|mesh-list
2085972|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2085973|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085974|NCT02152007|Sirolimus|sirolimus|mesh-list
2085975|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2085976|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085977|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2085978|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2085979|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
2085980|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223447|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752363|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
2752364|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2752365|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2752366|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2752367|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752368|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752369|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2752370|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
666619|NCT03178500|Clomiphene|clomiphene|mesh-list
666620|NCT03178500|Enclomiphene|enclomiphene|mesh-list
666621|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
666622|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
666623|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
666624|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
666625|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666626|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
666627|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
666628|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
666629|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
666630|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
666662|NCT03177993|Ivermectin|ivermectin|mesh-list
666663|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
666664|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
667019|NCT03176212|Milk fat globule|milk fat globule|mesh-list
667020|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
667269|NCT03174821|Insulin|insulin|mesh-list
667270|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
667271|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
667272|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223448|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223449|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
2223450|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223451|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
2223452|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2223453|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223454|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2223455|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2223456|NCT00046826|Growth Substances|growth substances|mesh-ancestor
2223457|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
2223458|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
667998|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
667999|NCT03171987|Lidocaine|lidocaine|mesh-list
668000|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
668001|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
668002|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
668003|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668004|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
668005|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668006|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
668007|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
668008|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
668009|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
668010|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668011|NCT03171987|Analgesics|analgesics|mesh-ancestor
668012|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
668013|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
668014|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
668015|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
665923|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
665924|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
665925|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
666089|NCT03180879|Ibuprofen|ibuprofen|mesh-list
666090|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
666091|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
666092|NCT03180879|Analgesics|analgesics|mesh-ancestor
666093|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
666094|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666095|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666096|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
666097|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
666098|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
666099|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666100|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666383|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
666384|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
666385|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666537|NCT03178656|Sorafenib|sorafenib|mesh-list
666538|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666539|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
666540|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666541|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666604|NCT03178409|Liver Extracts|liver extracts|mesh-list
666605|NCT03178409|Hematinics|hematinics|mesh-ancestor
666866|NCT03177460|Daratumumab|daratumumab|mesh-list
666867|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666928|NCT03176758|Anesthetics|anesthetics|mesh-list
666929|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
666930|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
666931|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667223|NCT03175016|Irinotecan|irinotecan|mesh-list
667224|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
667225|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
667226|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667227|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667228|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667279|NCT03174795|Meropenem|meropenem|mesh-list
667280|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
667281|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2085981|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
2085982|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085983|NCT02152137|Paclitaxel|paclitaxel|mesh-list
667603|NCT03173430|Blinatumomab|blinatumomab|mesh-list
667604|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668018|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
668019|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
668020|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
668021|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668022|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
668023|NCT03172065|Analgesics|analgesics|mesh-ancestor
668024|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
668025|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668026|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
668027|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
668028|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
668029|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
668030|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
668031|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668177|NCT03171090|Anesthetics|anesthetics|mesh-list
668178|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
668179|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
668180|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668181|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
668182|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668375|NCT03170115|Aspirin|aspirin|mesh-list
668376|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
668377|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
668378|NCT03170115|Analgesics|analgesics|mesh-ancestor
668379|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
668380|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668381|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668382|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
668383|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668384|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2085984|NCT02152137|Efatutazone|efatutazone|mesh-list
665986|NCT03181815|Cladribine|cladribine|mesh-list
665987|NCT03181815|Aclarubicin|aclarubicin|mesh-list
665988|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
665989|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
665990|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
665991|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
665992|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
665993|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
665994|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
665995|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
665996|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
665997|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
665998|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
665999|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
666000|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
666001|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666002|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
666237|NCT03180125|Lidocaine|lidocaine|mesh-list
666238|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
666239|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
666240|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
666241|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
666242|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666243|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
666244|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666245|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
666246|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
666247|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
666248|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
666249|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666250|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
666251|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
666252|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
666253|NCT03180125|Protective Agents|protective agents|mesh-ancestor
666337|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
666338|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
666470|NCT03178994|Ketoconazole|ketoconazole|mesh-list
666471|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
666472|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666473|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
666474|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
666475|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666476|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666477|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
666478|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
666479|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
666480|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666481|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
666510|NCT03178864|Heparin|heparin|mesh-list
666511|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
666512|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
666513|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
666514|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
666515|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666516|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
666517|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
666518|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
666519|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
666520|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666575|NCT03178292|Levofloxacin|levofloxacin|mesh-list
666576|NCT03178292|Ofloxacin|ofloxacin|mesh-list
666577|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
666578|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666579|NCT03178292|Renal Agents|renal agents|mesh-ancestor
666580|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
666581|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
666582|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
666583|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666584|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666585|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666586|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
666587|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2085985|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2085986|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666003|NCT03181386|Warfarin|warfarin|mesh-list
666004|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
666005|NCT03181386|Dabigatran|dabigatran|mesh-list
666006|NCT03181386|Apixaban|apixaban|mesh-list
666007|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
666008|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
666009|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
666010|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
666011|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
666012|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666013|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223459|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
2223460|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2223461|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
666254|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
666255|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
666256|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
666257|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
666258|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666259|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666260|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666261|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
666308|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
666309|NCT03179839|Sertraline|sertraline|mesh-list
666310|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
666311|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
666312|NCT03179839|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
666313|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
666314|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
666315|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666316|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
666317|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
666318|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666319|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
666320|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
666321|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
666322|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
666323|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
666324|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
666325|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666326|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
666497|NCT03178708|Amantadine|amantadine|mesh-list
666498|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
666499|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
666500|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
666501|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666502|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
666503|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
666504|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666505|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666506|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
666507|NCT03178708|Analgesics|analgesics|mesh-ancestor
666508|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
666509|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2752371|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2752372|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752373|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2752374|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2752375|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2752376|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667014|NCT03176537|Testosterone|testosterone|mesh-list
667015|NCT03176537|Androgens|androgens|mesh-ancestor
667016|NCT03176537|Hormones|hormones|mesh-ancestor
667017|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
667018|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223462|NCT00046852|Melphalan|melphalan|mesh-list
2223463|NCT00046852|Carmustine|carmustine|mesh-list
2223464|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2223465|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223466|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
2223467|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223468|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2223469|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
667513|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085987|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
2085988|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
2085989|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
2085990|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666129|NCT03180775|Glycine|glycine|mesh-list
666130|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
666131|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
666132|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666133|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666598|NCT03178396|Melatonin|melatonin|mesh-list
666599|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
666600|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666601|NCT03178396|Protective Agents|protective agents|mesh-ancestor
666602|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666603|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2223470|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
2223471|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223472|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223473|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2223474|NCT00046878|Carmustine|carmustine|mesh-list
2223475|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2223476|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2223477|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
2223478|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223479|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223480|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223481|NCT00046904|Etanercept|etanercept|mesh-list
2223482|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2223483|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2223484|NCT00046904|Analgesics|analgesics|mesh-ancestor
666820|NCT03177174|Docetaxel|docetaxel|mesh-list
666821|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666822|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
666823|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
666824|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
666825|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667459|NCT03174197|Temozolomide|temozolomide|mesh-list
667460|NCT03174197|Atezolizumab|atezolizumab|mesh-list
667461|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
667462|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
667463|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
667464|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667465|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667466|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
667467|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667649|NCT03172858|Oxytocin|oxytocin|mesh-list
667650|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
667651|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
667652|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667865|NCT03172741|Dronabinol|dronabinol|mesh-list
667866|NCT03172741|Cannabidiol|cannabidiol|mesh-list
667867|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
667868|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
667869|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667870|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
667871|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
667872|NCT03172741|Analgesics|analgesics|mesh-ancestor
667873|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
667874|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667875|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
667876|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
667877|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
667878|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667879|NCT03172741|Hormones|hormones|mesh-ancestor
667880|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
668317|NCT03170323|Cyclosporine|cyclosporine|mesh-list
668318|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
668319|NCT03170323|Cyclosporins|cyclosporins|mesh-list
668320|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668321|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668322|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
668323|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
668324|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668325|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
2223485|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
2223486|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2223487|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223488|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
666712|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
666713|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666714|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
666715|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
666716|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
666717|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666718|NCT03177824|Urological Agents|urological agents|mesh-ancestor
666911|NCT03176953|Topiramate|topiramate|mesh-list
666912|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
666913|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
666914|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667121|NCT03175705|Interleukin-2|interleukin-2|mesh-list
667122|NCT03175705|Tegafur|tegafur|mesh-list
667123|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667124|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
667125|NCT03175705|Analgesics|analgesics|mesh-ancestor
667126|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
667127|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667128|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667129|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
667130|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
667131|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667406|NCT03174353|Lanreotide|lanreotide|mesh-list
667407|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667562|NCT03173612|Cytarabine|cytarabine|mesh-list
667566|NCT03173612|Etoposide|etoposide|mesh-list
667567|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
667568|NCT03173612|Idarubicin|idarubicin|mesh-list
667569|NCT03173612|Dasatinib|dasatinib|mesh-list
667570|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
667571|NCT03173612|Sargramostim|sargramostim|mesh-list
667572|NCT03173612|Lenograstim|lenograstim|mesh-list
667573|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
667574|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667575|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
667576|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
667577|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667578|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667579|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
667580|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
667581|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
667582|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
667583|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
667584|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
667585|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667586|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
667587|NCT03173612|Analgesics|analgesics|mesh-ancestor
667588|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
667589|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667590|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
667591|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
667734|NCT03172988|Dexamethasone|dexamethasone|mesh-list
667735|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
667736|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
667737|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
667738|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
667739|NCT03172988|BB 1101|bb 1101|mesh-list
667740|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
667741|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
667742|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
667743|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667744|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667745|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
667746|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
667747|NCT03172988|Hormones|hormones|mesh-ancestor
667748|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
667749|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
667750|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667751|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
667752|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667753|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667754|NCT03172988|Analgesics|analgesics|mesh-ancestor
667755|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
667756|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
666403|NCT03179904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
666404|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
666405|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666406|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
666407|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
666408|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
666409|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666410|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
666411|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666412|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
666413|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
666414|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666415|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
666416|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
666417|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
666418|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
666419|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
666545|NCT03178643|Piperaquine|piperaquine|mesh-list
666546|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
666547|NCT03178643|Amodiaquine|amodiaquine|mesh-list
666548|NCT03178643|Artenimol|artenimol|mesh-list
666549|NCT03178643|Proguanil|proguanil|mesh-list
666550|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
666551|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
666552|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
666553|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
666554|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
666555|NCT03178643|Renal Agents|renal agents|mesh-ancestor
666556|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
666557|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223489|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2223490|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2223491|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223492|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
2223493|NCT00046917|Irinotecan|irinotecan|mesh-list
2223494|NCT00046917|Alvocidib|alvocidib|mesh-list
2223495|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223496|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2223497|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2223498|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223499|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223500|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
667006|NCT03176472|Ricolinostat|ricolinostat|mesh-list
667007|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667008|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
667009|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667010|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667110|NCT03175679|Interleukin-2|interleukin-2|mesh-list
667111|NCT03175679|Tegafur|tegafur|mesh-list
667112|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667113|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
667114|NCT03175679|Analgesics|analgesics|mesh-ancestor
667115|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
667116|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667117|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667118|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
667119|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
667120|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2085991|NCT02152163|Ibuprofen|ibuprofen|mesh-list
2085992|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2085993|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2085994|NCT02152163|Analgesics|analgesics|mesh-ancestor
666631|NCT03178526|Lovastatin|lovastatin|mesh-list
666632|NCT03178526|L 647318|l 647318|mesh-list
666633|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
666634|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
666635|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
666636|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
666637|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666638|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
666639|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
666640|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666966|NCT03176264|Bevacizumab|bevacizumab|mesh-list
666967|NCT03176264|Spartalizumab|spartalizumab|mesh-list
666968|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
666969|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666970|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
666971|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
666972|NCT03176264|Growth Substances|growth substances|mesh-ancestor
666973|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666974|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
666975|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
666976|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667021|NCT03176121|Oxycodone|oxycodone|mesh-list
667022|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
667023|NCT03176121|Narcotics|narcotics|mesh-ancestor
667024|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667025|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667026|NCT03176121|Analgesics|analgesics|mesh-ancestor
667027|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
667028|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2223501|NCT00046917|Growth Substances|growth substances|mesh-ancestor
2223502|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223503|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2223504|NCT00046943|Atrasentan|atrasentan|mesh-list
2223505|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223506|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2223507|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2223508|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223509|NCT00046969|Cisplatin|cisplatin|mesh-list
2223510|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223511|NCT00046995|Leucovorin|leucovorin|mesh-list
2223512|NCT00046995|Carboplatin|carboplatin|mesh-list
2223513|NCT00046995|Fluorouracil|fluorouracil|mesh-list
2223514|NCT00046995|Calcium|calcium|mesh-list
2223515|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
2223516|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223517|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2223518|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223519|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
2223520|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223521|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2223522|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223523|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
2223524|NCT00046995|Antidotes|antidotes|mesh-ancestor
2223525|NCT00046995|Protective Agents|protective agents|mesh-ancestor
2223526|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
2223527|NCT00046995|Vitamins|vitamins|mesh-ancestor
2223528|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
2223529|NCT00047021|Cytarabine|cytarabine|mesh-list
2223530|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
2223531|NCT00047021|Sargramostim|sargramostim|mesh-list
2223532|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
668164|NCT03171389|Ponatinib|ponatinib|mesh-list
668165|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668166|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
668167|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668168|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668271|NCT03170960|Atezolizumab|atezolizumab|mesh-list
668272|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668466|NCT03169738|Leucovorin|leucovorin|mesh-list
668467|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
668468|NCT03169738|Bevacizumab|bevacizumab|mesh-list
2223533|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
2223534|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223535|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666521|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
666522|NCT03179163|Enalapril|enalapril|mesh-list
666523|NCT03179163|Captopril|captopril|mesh-list
666524|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
666525|NCT03179163|Diuretics|diuretics|mesh-ancestor
666526|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
666527|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666528|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
666529|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
666530|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666531|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
666532|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
666533|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666783|NCT03177538|Menotropins|menotropins|mesh-list
666784|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
666785|NCT03177538|Hormones|hormones|mesh-ancestor
666786|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
666787|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666788|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
666789|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
666790|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
667052|NCT03176186|Xenon|xenon|mesh-list
667053|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
667054|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
667055|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
667056|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667057|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667392|NCT03174236|Metronidazole|metronidazole|mesh-list
667393|NCT03174236|Gentamicins|gentamicins|mesh-list
667394|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
667395|NCT03174236|Penicillins|penicillins|mesh-list
667396|NCT03174236|Penicillin G|penicillin g|mesh-list
667397|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
667398|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
667399|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
667400|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
667401|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
667402|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
667403|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
667404|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667405|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667896|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
667897|NCT03172416|Nivolumab|nivolumab|mesh-list
667898|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667899|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
667900|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
667901|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667986|NCT03171974|Dexamethasone|dexamethasone|mesh-list
667987|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
667988|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
667989|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
667990|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667991|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667992|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
667993|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
667994|NCT03171974|Hormones|hormones|mesh-ancestor
667995|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
667996|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
667997|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668710|NCT03169127|Ibuprofen|ibuprofen|mesh-list
668711|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
668712|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
668713|NCT03169127|Analgesics|analgesics|mesh-ancestor
668714|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
668715|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668716|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668717|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
668718|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668719|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
668720|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223536|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
666608|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
666609|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
666610|NCT03178539|Analgesics|analgesics|mesh-ancestor
666611|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
666612|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666613|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666614|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
666615|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
666616|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
666617|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666618|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666868|NCT03177122|Inositol|inositol|mesh-list
666869|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
666870|NCT03177122|Vitamins|vitamins|mesh-ancestor
666871|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
666872|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666943|NCT03176628|Niacinamide|niacinamide|mesh-list
666944|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
666945|NCT03176628|Vitamins|vitamins|mesh-ancestor
666946|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
666947|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667334|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
667335|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
667336|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667337|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667338|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
667339|NCT03174678|Analgesics|analgesics|mesh-ancestor
667340|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
667341|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667342|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
667343|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
667344|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
667345|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
667346|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
667347|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752377|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752378|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2752379|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2223537|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223538|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223539|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
2223540|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223541|NCT00047021|Analgesics|analgesics|mesh-ancestor
2223542|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
2223543|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2223544|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2223545|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2223546|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223547|NCT00047047|Gemcitabine|gemcitabine|mesh-list
2223548|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223549|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2223550|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
2223551|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223552|NCT00047047|Antiviral Agents|antiviral agents|mesh-ancestor
2223553|NCT00047047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223554|NCT00047047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223555|NCT00047047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223556|NCT00047047|Immunologic Factors|immunologic factors|mesh-ancestor
2223557|NCT00047047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223558|NCT00047073|Sirolimus|sirolimus|mesh-list
2223559|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2223560|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223561|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2223562|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223563|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
668169|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
668170|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
668171|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
668363|NCT03170050|Lidocaine|lidocaine|mesh-list
668364|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
668365|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
668366|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
668367|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668368|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
668369|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085995|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
2085996|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2085997|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2085998|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
666719|NCT03177837|Acetazolamide|acetazolamide|mesh-list
666720|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
666721|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
666722|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666723|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666724|NCT03177837|Diuretics|diuretics|mesh-ancestor
666725|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
666726|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666826|NCT03177239|Nivolumab|nivolumab|mesh-list
666827|NCT03177239|Ipilimumab|ipilimumab|mesh-list
666828|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
666829|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
666830|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
666831|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667099|NCT03175926|Budesonide|budesonide|mesh-list
667100|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
667101|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
667102|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
667103|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667104|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667105|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
667106|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
667107|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
667108|NCT03175926|Hormones|hormones|mesh-ancestor
667109|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
667187|NCT03175549|Apremilast|apremilast|mesh-list
667188|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
667189|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
667190|NCT03175549|Analgesics|analgesics|mesh-ancestor
667191|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
667192|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667193|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667194|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
667195|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
667196|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
667197|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
667198|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667199|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667712|NCT03173092|Dexamethasone|dexamethasone|mesh-list
667713|NCT03173092|Lenalidomide|lenalidomide|mesh-list
667714|NCT03173092|Ixazomib|ixazomib|mesh-list
667715|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
667716|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
667717|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
667718|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667719|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667720|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
667721|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
667722|NCT03173092|Hormones|hormones|mesh-ancestor
667723|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
667724|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
667725|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667726|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
667727|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
667728|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
667729|NCT03173092|Growth Substances|growth substances|mesh-ancestor
667730|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
667731|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
667732|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667733|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752380|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752381|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
2752382|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
668430|NCT03169764|Leucovorin|leucovorin|mesh-list
668431|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
668432|NCT03169764|Bevacizumab|bevacizumab|mesh-list
668433|NCT03169764|Fluorouracil|fluorouracil|mesh-list
668434|NCT03169764|Capecitabine|capecitabine|mesh-list
668435|NCT03169764|Nivolumab|nivolumab|mesh-list
2085999|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2086000|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2086001|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086002|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086003|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
2086004|NCT02152345|Abatacept|abatacept|mesh-list
2086005|NCT02152345|Tacrolimus|tacrolimus|mesh-list
2086006|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2086007|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
2223564|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223565|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
2223566|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223567|NCT00047099|Tamoxifen|tamoxifen|mesh-list
2223568|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
2223569|NCT00047099|Docetaxel|docetaxel|mesh-list
2223570|NCT00047099|Fluorouracil|fluorouracil|mesh-list
667314|NCT03174782|Bupivacaine|bupivacaine|mesh-list
667315|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
667316|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
667317|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667318|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667319|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
667320|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667359|NCT03174171|Everolimus|everolimus|mesh-list
667360|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667361|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
667362|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
667363|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667528|NCT03173963|Empagliflozin|empagliflozin|mesh-list
667529|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
667530|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667531|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
667532|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667592|NCT03173326|Anesthetics|anesthetics|mesh-list
667593|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667594|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668032|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
668033|NCT03171818|Hematinics|hematinics|mesh-ancestor
668781|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
668782|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
668783|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223571|NCT00047099|Epirubicin|epirubicin|mesh-list
2223572|NCT00047099|Goserelin|goserelin|mesh-list
2223573|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223574|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
2223575|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668947|NCT03167957|Amphotericin B|amphotericin b|mesh-list
668948|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
668949|NCT03167957|Amebicides|amebicides|mesh-ancestor
668950|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
668951|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
668952|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
668953|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
668954|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
2223576|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2223577|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2223578|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
2223579|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223580|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223581|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2223582|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
2086008|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223583|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
2223584|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
666705|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
666706|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
666707|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
666708|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
666709|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
666710|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
666711|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
666932|NCT03176693|Doxazosin|doxazosin|mesh-list
666933|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
666934|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
666935|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
666936|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
666937|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
666938|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
666939|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
666940|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666941|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666942|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
667001|NCT03176316|Naloxone|naloxone|mesh-list
667002|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
667003|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667004|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
667005|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667251|NCT03174847|Eplerenone|eplerenone|mesh-list
667252|NCT03174847|Amiloride|amiloride|mesh-list
667253|NCT03174847|Spironolactone|spironolactone|mesh-list
667254|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
667255|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
667256|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
667257|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
667258|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667259|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
667260|NCT03174847|Diuretics|diuretics|mesh-ancestor
667261|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
667262|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
667263|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
667264|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
667265|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
667266|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667267|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
667268|NCT03174847|Hormones|hormones|mesh-ancestor
2752386|NCT03570619|Nivolumab|nivolumab|mesh-list
2752387|NCT03570619|Ipilimumab|ipilimumab|mesh-list
2752388|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2752389|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752390|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2752391|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752392|NCT03565783|Cemiplimab|cemiplimab|mesh-list
2752393|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
668983|NCT03167619|Durvalumab|durvalumab|mesh-list
668984|NCT03167619|Olaparib|olaparib|mesh-list
668985|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
668986|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668987|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
668988|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668989|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669022|NCT03167216|Cetirizine|cetirizine|mesh-list
669023|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
669024|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
666731|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666732|NCT03177811|Diuretics|diuretics|mesh-ancestor
666733|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
666734|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666915|NCT03177070|Methylene Blue|methylene blue|mesh-list
666916|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
666917|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667216|NCT03175081|Ropivacaine|ropivacaine|mesh-list
667217|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
667218|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
667219|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667220|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667221|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
667222|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667239|NCT03174860|Diclofenac|diclofenac|mesh-list
667240|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
667241|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
667242|NCT03174860|Analgesics|analgesics|mesh-ancestor
667243|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
667244|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667245|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667246|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
667247|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
667248|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
667249|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667250|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667478|NCT03174041|Itraconazole|itraconazole|mesh-list
667479|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
667480|NCT03174041|Midazolam|midazolam|mesh-list
667481|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
667482|NCT03174041|Simvastatin|simvastatin|mesh-list
667483|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
667484|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
667485|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667486|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667487|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
667488|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
667489|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
667490|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
667491|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
667492|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
667493|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
667494|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
667495|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
667496|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667497|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
667498|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
667499|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
667500|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
667501|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
667502|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667503|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
667504|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
667505|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
667506|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
667507|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
667508|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
667509|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
667510|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
667909|NCT03172533|Dienogest|dienogest|mesh-list
667910|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
667911|NCT03172533|Estradiol|estradiol|mesh-list
667912|NCT03172533|Estrogens|estrogens|mesh-ancestor
667913|NCT03172533|Hormones|hormones|mesh-ancestor
667914|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
667915|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667916|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
667917|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
667918|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
667919|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
667920|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
667921|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
667922|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
667923|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
666809|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
666810|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
666811|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
666812|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
666813|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666814|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
666815|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
666816|NCT03177317|Hormones|hormones|mesh-ancestor
666817|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
666818|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
666819|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667011|NCT03176563|Fosfomycin|fosfomycin|mesh-list
667012|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
667013|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
667355|NCT03174080|Fluorides|fluorides|mesh-list
667356|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
667357|NCT03174080|Protective Agents|protective agents|mesh-ancestor
667358|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667542|NCT03173248|Azacitidine|azacitidine|mesh-list
667543|NCT03173248|Ivosidenib|ivosidenib|mesh-list
667544|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
667545|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
667546|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667547|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667548|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668278|NCT03170739|Dopamine|dopamine|mesh-list
668279|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
668280|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
668281|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
668282|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668283|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
668284|NCT03170739|Analgesics|analgesics|mesh-ancestor
668285|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
668286|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668287|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
668288|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
668289|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
668290|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
668291|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
668292|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668293|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
668294|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
668295|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
668296|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
668297|NCT03170739|Protective Agents|protective agents|mesh-ancestor
668541|NCT03169790|Leucovorin|leucovorin|mesh-list
668542|NCT03169790|Paclitaxel|paclitaxel|mesh-list
668543|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
668544|NCT03169790|Bevacizumab|bevacizumab|mesh-list
668545|NCT03169790|Rituximab|rituximab|mesh-list
668546|NCT03169790|Fluorouracil|fluorouracil|mesh-list
668547|NCT03169790|Capecitabine|capecitabine|mesh-list
668548|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
668549|NCT03169790|Avelumab|avelumab|mesh-list
668550|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
668551|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668552|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
668553|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
668554|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
668555|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668556|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
668557|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
668558|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668559|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668560|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
668561|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
668562|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
668563|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
666840|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
666841|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
666842|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
666843|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
666844|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666898|NCT03176966|Vitamin E|vitamin e|mesh-list
666899|NCT03176966|Ropinirole|ropinirole|mesh-list
666900|NCT03176966|Vitamins|vitamins|mesh-ancestor
666901|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
666902|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
666903|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
666904|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
666905|NCT03176966|Protective Agents|protective agents|mesh-ancestor
666906|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
666907|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
666908|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
666909|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
666910|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086009|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
2086010|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086011|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2086012|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667200|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
667201|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
667202|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
667203|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667675|NCT03172871|Aripiprazole|aripiprazole|mesh-list
667676|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
667677|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
667678|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
667679|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
667680|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667681|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667682|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
667683|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
667684|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
667685|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667686|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
667687|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
667688|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
667689|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
667690|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
667691|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
667692|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
667936|NCT03172234|Amantadine|amantadine|mesh-list
667937|NCT03172234|Gabapentin|gabapentin|mesh-list
667938|NCT03172234|Analgesics|analgesics|mesh-ancestor
667939|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
667940|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667941|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667942|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
667943|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
667944|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
667945|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667946|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
667947|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
667948|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
667949|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
667950|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667951|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
667952|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
667953|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
667954|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
667955|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
667956|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
667957|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
668110|NCT03171610|Fentanyl|fentanyl|mesh-list
668111|NCT03171610|Sufentanil|sufentanil|mesh-list
668112|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
668113|NCT03171610|Narcotics|narcotics|mesh-ancestor
668114|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
668115|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668116|NCT03171610|Analgesics|analgesics|mesh-ancestor
668117|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
668118|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668119|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
667049|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667050|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
667051|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667384|NCT03174288|Spironolactone|spironolactone|mesh-list
667385|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
667386|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
667387|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
667388|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667389|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
667390|NCT03174288|Diuretics|diuretics|mesh-ancestor
667391|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
667657|NCT03172936|Spartalizumab|spartalizumab|mesh-list
667658|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
667659|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667660|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667893|NCT03172377|Adalimumab|adalimumab|mesh-list
667894|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
667895|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668237|NCT03170713|Ibuprofen|ibuprofen|mesh-list
668238|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
668239|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
668240|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
668241|NCT03170713|Analgesics|analgesics|mesh-ancestor
668242|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
668243|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668244|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668245|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
668246|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668247|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
668248|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668249|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086013|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086014|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086015|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2086016|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
2086017|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
2086018|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086019|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086020|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
2086021|NCT02152345|Hormones|hormones|mesh-ancestor
668816|NCT03168256|Apremilast|apremilast|mesh-list
668817|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
668818|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
668819|NCT03168256|Analgesics|analgesics|mesh-ancestor
668820|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
668821|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668822|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668823|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
668824|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668825|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
668826|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
668827|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668828|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669516|NCT03165409|Nivolumab|nivolumab|mesh-list
669517|NCT03165409|Ipilimumab|ipilimumab|mesh-list
669518|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
669519|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669520|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
669521|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669558|NCT03164694|Carboplatin|carboplatin|mesh-list
669559|NCT03164694|Pemetrexed|pemetrexed|mesh-list
669560|NCT03164694|Apatinib|apatinib|mesh-list
669561|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669562|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669563|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669564|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
669565|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
669566|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
669879|NCT03163381|Apatinib|apatinib|mesh-list
669880|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669881|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
669882|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669883|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223585|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
667082|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
667083|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
667084|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
667085|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
667086|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
667321|NCT03174483|Fluticasone|fluticasone|mesh-list
667322|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
667323|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
667324|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
667325|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667326|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667327|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
667328|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
667329|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
667330|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2086022|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2086023|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2086024|NCT02152345|Protective Agents|protective agents|mesh-ancestor
2086025|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2086026|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2086027|NCT02152371|Metformin|metformin|mesh-list
2086028|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
2086029|NCT02152371|Dulaglutide|dulaglutide|mesh-list
2086030|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2086031|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086032|NCT02152384|Insulin|insulin|mesh-list
2086033|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2086034|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
2086035|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
2086036|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2086037|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086038|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2086039|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086040|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2086041|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086042|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086043|NCT02152696|Methotrexate|methotrexate|mesh-list
667887|NCT03172624|Nivolumab|nivolumab|mesh-list
667888|NCT03172624|Ipilimumab|ipilimumab|mesh-list
667889|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
667890|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667891|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
667892|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668640|NCT03169504|Fluticasone|fluticasone|mesh-list
668641|NCT03169504|Xhance|xhance|mesh-list
668642|NCT03169504|Bromides|bromides|mesh-list
668643|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
668644|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
668645|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
668646|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
668647|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668648|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668649|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
668650|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
668651|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
668652|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
668653|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
668654|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
668655|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
668656|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
668657|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668658|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
668890|NCT03168074|Lenvatinib|lenvatinib|mesh-list
668891|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668892|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
668893|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668894|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669196|NCT03166787|Ascorbic Acid|ascorbic acid|mesh-list
669197|NCT03166787|Tadalafil|tadalafil|mesh-list
669198|NCT03166787|Charcoal|charcoal|mesh-list
669199|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
669200|NCT03166787|Vitamins|vitamins|mesh-ancestor
669201|NCT03166787|Micronutrients|micronutrients|mesh-ancestor
669202|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669203|NCT03166787|Antioxidants|antioxidants|mesh-ancestor
669204|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086044|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
667214|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667215|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667881|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
667882|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
667883|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
667884|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
667885|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667886|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668811|NCT03168568|Valsartan|valsartan|mesh-list
668812|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
668813|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
668814|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
668815|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668898|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
668899|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
668900|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
669057|NCT03166891|Chiauranib|chiauranib|mesh-list
669058|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669059|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
669060|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669061|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669460|NCT03165123|Azithromycin|azithromycin|mesh-list
669461|NCT03165123|Dexamethasone|dexamethasone|mesh-list
669462|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
669463|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
669464|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
669465|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669466|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669467|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
669468|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
669469|NCT03165123|Hormones|hormones|mesh-ancestor
669470|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
669471|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
669472|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669473|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
669474|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669522|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
669523|NCT03164993|Doxorubicin|doxorubicin|mesh-list
669524|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
669525|NCT03164993|Atezolizumab|atezolizumab|mesh-list
669526|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
669527|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
669528|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669529|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
669530|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
669531|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
669532|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669533|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669534|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
669535|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
669536|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
669537|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
669538|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669791|NCT03164161|Endorphins|endorphins|mesh-list
669792|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
669793|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669794|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086045|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
2086046|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2086047|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086048|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2086049|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
2086050|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086051|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086052|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
2086053|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086054|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2086055|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2086056|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
2086057|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2086058|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2086059|NCT02153489|Bromides|bromides|mesh-list
670896|NCT03158025|Zolpidem|zolpidem|mesh-list
670897|NCT03158025|Suvorexant|suvorexant|mesh-list
2223586|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
667554|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
667555|NCT03173417|Fludarabine|fludarabine|mesh-list
667556|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
667557|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
667558|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667559|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
667560|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
667561|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
667563|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667564|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
667565|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
667832|NCT03172676|Amoxicillin|amoxicillin|mesh-list
667833|NCT03172676|Clarithromycin|clarithromycin|mesh-list
667834|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
667835|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
667836|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
667837|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
667838|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667839|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
667840|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
667841|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
668123|NCT03171584|Itraconazole|itraconazole|mesh-list
668124|NCT03171584|Fluconazole|fluconazole|mesh-list
668125|NCT03171584|Terbinafine|terbinafine|mesh-list
668126|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
668127|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
668128|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
668129|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
668130|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668131|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668132|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
668133|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
668134|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
668135|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668136|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
668137|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
668138|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
668309|NCT03170284|Bevacizumab|bevacizumab|mesh-list
668310|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
668311|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668312|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
668313|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
668314|NCT03170284|Growth Substances|growth substances|mesh-ancestor
668315|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668316|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
668901|NCT03168035|NC-4016|nc-4016|mesh-list
668902|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669276|NCT03165890|Acetazolamide|acetazolamide|mesh-list
669277|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
669278|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
669279|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669280|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669281|NCT03165890|Diuretics|diuretics|mesh-ancestor
669282|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
669283|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669977|NCT03162562|Oregovomab|oregovomab|mesh-list
669978|NCT03162562|Poly ICLC|poly iclc|mesh-list
669979|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
669980|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
669981|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669982|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
669983|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670398|NCT03161106|Lactulose|lactulose|mesh-list
670399|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
670581|NCT03159845|Levofloxacin|levofloxacin|mesh-list
670582|NCT03159845|Ofloxacin|ofloxacin|mesh-list
670583|NCT03159845|Fluconazole|fluconazole|mesh-list
670584|NCT03159845|Acyclovir|acyclovir|mesh-list
670585|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
670586|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
670587|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
670588|NCT03159845|Renal Agents|renal agents|mesh-ancestor
670589|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
670590|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
667661|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
667662|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
667663|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
667664|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667665|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
667666|NCT03172897|Analgesics|analgesics|mesh-ancestor
667667|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
667668|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
667669|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
667670|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
667671|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
667672|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
667673|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
667674|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668060|NCT03171727|Heparin|heparin|mesh-list
668061|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
668062|NCT03171727|Tinzaparin|tinzaparin|mesh-list
668063|NCT03171727|Dalteparin|dalteparin|mesh-list
668064|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
668065|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
668066|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
668067|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086060|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
2086061|NCT02153632|Amantadine|amantadine|mesh-list
2086062|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2086063|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2086064|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
2086065|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086066|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
2086067|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
668502|NCT03169933|Androgens|androgens|mesh-list
668503|NCT03169933|Hormones|hormones|mesh-ancestor
668504|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
668505|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668756|NCT03168828|Trospium chloride|trospium chloride|mesh-list
668757|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
668758|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
668759|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668760|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668761|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
668762|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
668763|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
668764|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
668765|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668766|NCT03168828|Urological Agents|urological agents|mesh-ancestor
2223587|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2223588|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2223589|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2223590|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223591|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2223592|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
2223593|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2223594|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2223595|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2223596|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2223597|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2223598|NCT00047112|Fluorouracil|fluorouracil|mesh-list
2223599|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223600|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
2223601|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223602|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2223603|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223604|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
2223605|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223606|NCT00047138|Dactinomycin|dactinomycin|mesh-list
669296|NCT03165942|Ethanol|ethanol|mesh-list
669297|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
669298|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669299|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086068|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086069|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086070|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2086071|NCT02153632|Analgesics|analgesics|mesh-ancestor
2086072|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
2086073|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086074|NCT02153645|Amantadine|amantadine|mesh-list
2086075|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2086076|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2086077|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
2086078|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086079|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
2086080|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086081|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086082|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086083|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2086084|NCT02153645|Analgesics|analgesics|mesh-ancestor
2086085|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
668253|NCT03170687|Calpastatin|calpastatin|mesh-list
668254|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
668255|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
668256|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668257|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668298|NCT03170310|Apatinib|apatinib|mesh-list
668299|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668300|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
668301|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668302|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223607|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
2223608|NCT00047138|Carboplatin|carboplatin|mesh-list
2223609|NCT00047138|Doxorubicin|doxorubicin|mesh-list
2223610|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2223611|NCT00047138|Etoposide|etoposide|mesh-list
2223612|NCT00047138|Vincristine|vincristine|mesh-list
2223613|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223614|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
2223615|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223616|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2223617|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2223618|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
2223619|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223620|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669215|NCT03166605|Simethicone|simethicone|mesh-list
669216|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
669217|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669218|NCT03166605|Emollients|emollients|mesh-ancestor
669219|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
2223621|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2223622|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2223623|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
669542|NCT03164889|Entecavir|entecavir|mesh-list
669543|NCT03164889|Molgramostim|molgramostim|mesh-list
669544|NCT03164889|Sargramostim|sargramostim|mesh-list
669545|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
669546|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669547|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
669548|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669549|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669804|NCT03163966|Methotrexate|methotrexate|mesh-list
669805|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
669806|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
669807|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
669808|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669809|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
669810|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
669811|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669812|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669813|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
669814|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669815|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
669816|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
669817|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
669818|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
669819|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
669915|NCT03163212|Lactoferrin|lactoferrin|mesh-list
2223624|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2223625|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667757|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
667758|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
667759|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2752394|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668534|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
668535|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
668536|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
668537|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
668538|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668539|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668540|NCT03169582|Urological Agents|urological agents|mesh-ancestor
668965|NCT03167905|Fentanyl|fentanyl|mesh-list
668966|NCT03167905|Meperidine|meperidine|mesh-list
668967|NCT03167905|Remifentanil|remifentanil|mesh-list
668968|NCT03167905|Ropivacaine|ropivacaine|mesh-list
668969|NCT03167905|Entonox|entonox|mesh-list
668970|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
668971|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
668972|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
668973|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668974|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
668975|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668976|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
668977|NCT03167905|Narcotics|narcotics|mesh-ancestor
668978|NCT03167905|Analgesics|analgesics|mesh-ancestor
668979|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
668980|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
668981|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
668982|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
669037|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
669038|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
669039|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
669040|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
669041|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669769|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
669770|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
669771|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
669772|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669773|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
669774|NCT03163693|Analgesics|analgesics|mesh-ancestor
669775|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
669776|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669777|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
669778|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
669779|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
669780|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
669781|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
669782|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223626|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2223627|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
2223628|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
2223629|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
2223630|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2223631|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669956|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
669957|NCT03162588|Hematinics|hematinics|mesh-ancestor
670361|NCT03161132|Doxorubicin|doxorubicin|mesh-list
670362|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
670363|NCT03161132|Olaparib|olaparib|mesh-list
670364|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
670365|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670366|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
670367|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
670368|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670369|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670370|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
670490|NCT03160521|Risperidone|risperidone|mesh-list
670491|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
670492|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
670493|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
670494|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670495|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670496|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
670497|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
670516|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
667818|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
667819|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
667820|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
667821|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
667822|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
667823|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
667824|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
667825|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
667826|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
667827|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
667828|NCT03173053|Renal Agents|renal agents|mesh-ancestor
667829|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
667830|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
667831|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
668053|NCT03172052|Streptokinase|streptokinase|mesh-list
668054|NCT03172052|Mesna|mesna|mesh-list
668055|NCT03172052|Protective Agents|protective agents|mesh-ancestor
668056|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668057|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
668058|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
668059|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668406|NCT03169959|Metformin|metformin|mesh-list
668407|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
668408|NCT03169959|Saxagliptin|saxagliptin|mesh-list
668409|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
668410|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668411|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
668412|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668413|NCT03169959|Incretins|incretins|mesh-ancestor
668414|NCT03169959|Hormones|hormones|mesh-ancestor
668415|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
668416|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
668417|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
668418|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668601|NCT03169569|Hemostatics|hemostatics|mesh-list
668602|NCT03169569|Coagulants|coagulants|mesh-ancestor
668801|NCT03168594|Cisplatin|cisplatin|mesh-list
668802|NCT03168594|Irinotecan|irinotecan|mesh-list
668803|NCT03168594|Etoposide|etoposide|mesh-list
668804|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668805|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
668806|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
668807|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668808|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668809|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
668810|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
668895|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
668896|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
668897|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669238|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
669239|NCT03166397|Fludarabine|fludarabine|mesh-list
669240|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
669241|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
669242|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669243|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
669244|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
669245|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
669246|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669247|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669248|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
669685|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
669686|NCT03164304|Analgesics|analgesics|mesh-ancestor
669687|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
669688|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669689|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669690|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
669691|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
669692|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
669693|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
669694|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
669695|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
669696|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669697|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
669698|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
667904|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
667905|NCT03172299|Growth Substances|growth substances|mesh-ancestor
667906|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
667907|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
667908|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668139|NCT03171740|Midazolam|midazolam|mesh-list
668140|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
668141|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
668142|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
668143|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
668144|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668145|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
668146|NCT03171740|Analgesics|analgesics|mesh-ancestor
668147|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
668148|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668149|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
668150|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
668151|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
668152|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
668153|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
668154|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668155|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
668156|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
668157|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
668158|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
668159|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
668160|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
668161|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
668162|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
668163|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
668258|NCT03170726|Ibuprofen|ibuprofen|mesh-list
668259|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
668260|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
668261|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
668262|NCT03170726|Analgesics|analgesics|mesh-ancestor
668263|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
668264|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668265|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668266|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
668267|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668268|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
668269|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668270|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086086|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086087|NCT02153671|Vaccines|vaccines|mesh-list
2086088|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
668736|NCT03168958|Methadone|methadone|mesh-list
668737|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
668738|NCT03168958|Narcotics|narcotics|mesh-ancestor
668739|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
668740|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668741|NCT03168958|Analgesics|analgesics|mesh-ancestor
668742|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
668743|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668744|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
668745|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
669594|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
669595|NCT03164590|Ketamine|ketamine|mesh-list
669596|NCT03164590|Bupivacaine|bupivacaine|mesh-list
669597|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
669598|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
669599|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
669600|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669601|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
669602|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669603|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
669604|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
669605|NCT03164590|Analgesics|analgesics|mesh-ancestor
669606|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
669607|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
669608|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
669609|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
669610|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
669611|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669612|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
670112|NCT03161977|Diuretics|diuretics|mesh-ancestor
667924|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
667925|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223632|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2223633|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2223634|NCT00047164|Ipilimumab|ipilimumab|mesh-list
2223635|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2223636|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223637|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
669050|NCT03166956|Ascorbic Acid|ascorbic acid|mesh-list
669051|NCT03166956|Vitamins|vitamins|mesh-ancestor
669052|NCT03166956|Micronutrients|micronutrients|mesh-ancestor
669053|NCT03166956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669054|NCT03166956|Antioxidants|antioxidants|mesh-ancestor
669055|NCT03166956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669056|NCT03166956|Protective Agents|protective agents|mesh-ancestor
669385|NCT03165591|Vaccines|vaccines|mesh-list
669386|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
669387|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086089|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086090|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
2086091|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
2086092|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2086093|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
2086094|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086095|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2086096|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
670005|NCT03162783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
670006|NCT03162783|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2223638|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223639|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
2223640|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223641|NCT00047190|Tipifarnib|tipifarnib|mesh-list
2223642|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223643|NCT00047203|Alvocidib|alvocidib|mesh-list
2223644|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223645|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
2223646|NCT00047203|Growth Substances|growth substances|mesh-ancestor
2223647|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223648|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2223649|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223650|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223651|NCT00047216|Tipifarnib|tipifarnib|mesh-list
2223652|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223653|NCT00047229|Doxorubicin|doxorubicin|mesh-list
2223654|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2223655|NCT00047229|Oblimersen|oblimersen|mesh-list
2223656|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2223657|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223658|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
671110|NCT03156322|Fentanyl|fentanyl|mesh-list
671111|NCT03156322|Bupivacaine|bupivacaine|mesh-list
671112|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
671113|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
671114|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
671115|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671116|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
671117|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671118|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
671119|NCT03156322|Narcotics|narcotics|mesh-ancestor
671120|NCT03156322|Analgesics|analgesics|mesh-ancestor
671121|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
671122|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
671123|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
671211|NCT03155646|Clonidine|clonidine|mesh-list
671212|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
671213|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
671214|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
671215|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
671216|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671217|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
671218|NCT03155646|Analgesics|analgesics|mesh-ancestor
671219|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
671220|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671221|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
671222|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
671223|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
671224|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
2223659|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2223660|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223661|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223662|NCT00047242|Irinotecan|irinotecan|mesh-list
2223663|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2223664|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2223665|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2223666|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668335|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
668336|NCT03170336|Amiloride|amiloride|mesh-list
668337|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
668338|NCT03170336|Diuretics|diuretics|mesh-ancestor
668339|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
668340|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668341|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
668342|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
668343|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668344|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
668345|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
668346|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
668347|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
668575|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
668576|NCT03169348|Ledipasvir|ledipasvir|mesh-list
668577|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
668578|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
668579|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
668776|NCT03168698|Oxytocin|oxytocin|mesh-list
668777|NCT03168698|Carbetocin|carbetocin|mesh-list
668778|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
668779|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
668780|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223667|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223668|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223669|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2223670|NCT00047255|Carboplatin|carboplatin|mesh-list
2223671|NCT00047255|Docetaxel|docetaxel|mesh-list
2223672|NCT00047255|Trastuzumab|trastuzumab|mesh-list
2223673|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223674|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
2223675|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
2223676|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
2223677|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223678|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2223679|NCT00047268|Cytarabine|cytarabine|mesh-list
2223680|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
2086097|NCT02153788|Temazepam|temazepam|mesh-list
2086098|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2086099|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086100|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086101|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2086102|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2086103|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2086104|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
2086105|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
2086106|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086107|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086108|NCT02153905|Aldesleukin|aldesleukin|mesh-list
2086109|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
2086110|NCT02153905|Fludarabine|fludarabine|mesh-list
2086111|NCT02153905|Interleukin-2|interleukin-2|mesh-list
2086112|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2086113|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
2086114|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086115|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2086116|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
670505|NCT03160248|Apremilast|apremilast|mesh-list
670506|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
670507|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
670508|NCT03160248|Analgesics|analgesics|mesh-ancestor
670509|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
670510|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670511|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670512|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
670513|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
670514|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
670515|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
668016|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
668017|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223681|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2223682|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
2223683|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223684|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223685|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
669257|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
669258|NCT03166527|Antibodies|antibodies|mesh-list
669259|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
669260|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
669261|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
669262|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
669263|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223686|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223687|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223688|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
2223689|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669646|NCT03164668|Menthol|menthol|mesh-list
669647|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
669648|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
669783|NCT03163667|Everolimus|everolimus|mesh-list
669784|NCT03163667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669785|NCT03163667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
669786|NCT03163667|Immunologic Factors|immunologic factors|mesh-ancestor
669787|NCT03163667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669894|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
669895|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
669896|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669897|NCT03163173|Protective Agents|protective agents|mesh-ancestor
669898|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669984|NCT03162406|Vitamin D|vitamin d|mesh-list
669985|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
669986|NCT03162406|Vitamins|vitamins|mesh-ancestor
669987|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
669988|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669989|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
669990|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
670413|NCT03161093|Naproxen|naproxen|mesh-list
670414|NCT03161093|Fasinumab|fasinumab|mesh-list
670415|NCT03161093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
670416|NCT03161093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
670417|NCT03161093|Analgesics|analgesics|mesh-ancestor
670418|NCT03161093|Sensory System Agents|sensory system agents|mesh-ancestor
670419|NCT03161093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670420|NCT03161093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670421|NCT03161093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
670422|NCT03161093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
670423|NCT03161093|Gout Suppressants|gout suppressants|mesh-ancestor
670424|NCT03161093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
670425|NCT03161093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670426|NCT03161093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671983|NCT03151720|Loratadine|loratadine|mesh-list
671984|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
671985|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
671986|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
671987|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
671988|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
671989|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
671990|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
671991|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671992|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671993|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672601|NCT03149432|Gabapentin|gabapentin|mesh-list
672602|NCT03149432|Analgesics|analgesics|mesh-ancestor
672603|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
672604|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
672605|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672606|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
672607|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
672608|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
672609|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672610|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
672611|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
672612|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
672613|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223690|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2223691|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223692|NCT00047281|Thalidomide|thalidomide|mesh-list
2223693|NCT00047281|Celecoxib|celecoxib|mesh-list
2223694|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
2223695|NCT00047281|Etoposide|etoposide|mesh-list
2223696|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223697|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
2086117|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
2086118|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086119|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086120|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2086121|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2086122|NCT02153905|Analgesics|analgesics|mesh-ancestor
2086123|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
2086124|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086125|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2086126|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2086127|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
2086128|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086129|NCT02153918|Metronidazole|metronidazole|mesh-list
2086130|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086131|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2086132|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2086133|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2086134|NCT02153983|Colchicine|colchicine|mesh-list
2086135|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
2086136|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2086137|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
2086138|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
668689|NCT03168997|Memantine|memantine|mesh-list
668690|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
668691|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
668692|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
668693|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
668694|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668695|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668696|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
668697|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
668767|NCT03168880|Paclitaxel|paclitaxel|mesh-list
668768|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
668769|NCT03168880|Carboplatin|carboplatin|mesh-list
668770|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
668771|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668772|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
668773|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
668774|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
668775|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668829|NCT03168464|Nivolumab|nivolumab|mesh-list
668830|NCT03168464|Ipilimumab|ipilimumab|mesh-list
668831|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
668832|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668833|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
668834|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669062|NCT03167034|Acetazolamide|acetazolamide|mesh-list
669063|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
669064|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
669065|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669066|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669067|NCT03167034|Diuretics|diuretics|mesh-ancestor
669068|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
669069|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669124|NCT03166644|Sufentanil|sufentanil|mesh-list
669125|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
669126|NCT03166644|Narcotics|narcotics|mesh-ancestor
669127|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
669128|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669129|NCT03166644|Analgesics|analgesics|mesh-ancestor
669130|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
669131|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669132|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
669133|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
669134|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
669135|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
669304|NCT03165825|Dexamethasone|dexamethasone|mesh-list
669305|NCT03165825|Betamethasone|betamethasone|mesh-list
2223698|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223699|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668090|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
668091|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668092|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
668093|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
668094|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
668095|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
668096|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
668097|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
668098|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
668099|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223700|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2223701|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
2223702|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668887|NCT03168412|Vaccines|vaccines|mesh-list
668888|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
668889|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086139|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
2086140|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086141|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223703|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223704|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2223705|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2223706|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2223707|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2223708|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223709|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2223710|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2223711|NCT00047281|Analgesics|analgesics|mesh-ancestor
2223712|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
2223713|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2223714|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
670618|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
670619|NCT03159754|Metronidazole|metronidazole|mesh-list
670620|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
670621|NCT03159754|Tazobactam|tazobactam|mesh-list
670622|NCT03159754|Piperacillin|piperacillin|mesh-list
670623|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
670624|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
670625|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
670626|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
670627|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
670628|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
670629|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670630|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670631|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670632|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
670633|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
670634|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
670835|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
670836|NCT03158168|Astringents|astringents|mesh-ancestor
670837|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670838|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
670940|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
670941|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671007|NCT03156907|Buprenorphine|buprenorphine|mesh-list
671008|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
671009|NCT03156907|Narcotics|narcotics|mesh-ancestor
671010|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
671011|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671012|NCT03156907|Analgesics|analgesics|mesh-ancestor
671013|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
671014|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671015|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
671205|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
671206|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
671207|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671208|NCT03155477|Vitamins|vitamins|mesh-ancestor
671209|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
671210|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
671448|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
671449|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
671816|NCT03152175|Propranolol|propranolol|mesh-list
668120|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
668121|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
668122|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
2223715|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2223716|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2223717|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
2223718|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2223719|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223720|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2223721|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
668603|NCT03169777|Leucovorin|leucovorin|mesh-list
668604|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
668605|NCT03169777|Bevacizumab|bevacizumab|mesh-list
668606|NCT03169777|Fluorouracil|fluorouracil|mesh-list
668607|NCT03169777|Capecitabine|capecitabine|mesh-list
668608|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
668609|NCT03169777|Nivolumab|nivolumab|mesh-list
668610|NCT03169777|Cetuximab|cetuximab|mesh-list
668611|NCT03169777|Fulvestrant|fulvestrant|mesh-list
668612|NCT03169777|Avelumab|avelumab|mesh-list
668613|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668614|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668615|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
668616|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
668617|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668618|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668619|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
668620|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
668621|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
668622|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
668623|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
668624|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
668625|NCT03169777|Growth Substances|growth substances|mesh-ancestor
668626|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
668627|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
668628|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
668629|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
668630|NCT03169777|Antidotes|antidotes|mesh-ancestor
668631|NCT03169777|Protective Agents|protective agents|mesh-ancestor
668632|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
668633|NCT03169777|Vitamins|vitamins|mesh-ancestor
668634|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
668635|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
668636|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
668637|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
668638|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
668639|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
668903|NCT03168100|Dexamethasone|dexamethasone|mesh-list
668904|NCT03168100|Lenalidomide|lenalidomide|mesh-list
668905|NCT03168100|Bortezomib|bortezomib|mesh-list
668906|NCT03168100|Elotuzumab|elotuzumab|mesh-list
668907|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
668908|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
668909|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
668910|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668911|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668912|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
668913|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
668914|NCT03168100|Hormones|hormones|mesh-ancestor
668915|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
668916|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
668917|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668918|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
668919|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
668920|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
668921|NCT03168100|Growth Substances|growth substances|mesh-ancestor
668922|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
669220|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
668232|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
668233|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
668234|NCT03171220|Analgesics|analgesics|mesh-ancestor
668235|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
668236|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668506|NCT03170180|Sunitinib|sunitinib|mesh-list
668507|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
668508|NCT03170180|Gefitinib|gefitinib|mesh-list
668509|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668510|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
668511|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
668512|NCT03170180|Growth Substances|growth substances|mesh-ancestor
668513|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668514|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
668515|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
668516|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668517|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668671|NCT03169335|Paclitaxel|paclitaxel|mesh-list
668672|NCT03169335|Bevacizumab|bevacizumab|mesh-list
668673|NCT03169335|Carboplatin|carboplatin|mesh-list
668674|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
668675|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668676|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
668677|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
668678|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
668679|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668680|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
668681|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
668682|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
668683|NCT03169335|Growth Substances|growth substances|mesh-ancestor
668684|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668685|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
669089|NCT03167164|Leucovorin|leucovorin|mesh-list
669090|NCT03167164|Paclitaxel|paclitaxel|mesh-list
669091|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
669092|NCT03167164|Bevacizumab|bevacizumab|mesh-list
669093|NCT03167164|Fluorouracil|fluorouracil|mesh-list
669094|NCT03167164|Capecitabine|capecitabine|mesh-list
669095|NCT03167164|Avelumab|avelumab|mesh-list
669096|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
669097|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669098|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
669099|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
669100|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
669101|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669102|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
669103|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
669104|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669105|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
669106|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
669107|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
669108|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
669109|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
669110|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
669111|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
669112|NCT03167164|Growth Substances|growth substances|mesh-ancestor
669113|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
669114|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
669115|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
669116|NCT03167164|Antidotes|antidotes|mesh-ancestor
669117|NCT03167164|Protective Agents|protective agents|mesh-ancestor
669118|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
669119|NCT03167164|Vitamins|vitamins|mesh-ancestor
669120|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
669230|NCT03166228|Glycine|glycine|mesh-list
669231|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
669232|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
669233|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669234|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669673|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
669674|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
669675|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
669676|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669677|NCT03164421|Expectorants|expectorants|mesh-ancestor
669678|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
669679|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
669680|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
670113|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
668326|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
668327|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
668328|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668329|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
668330|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
668331|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668332|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
668333|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
668334|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
668394|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
668395|NCT03169881|Hematinics|hematinics|mesh-ancestor
668996|NCT03167385|Apatinib|apatinib|mesh-list
668997|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668998|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
668999|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669000|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086142|NCT02154048|Dexamethasone|dexamethasone|mesh-list
2086143|NCT02154048|Ropivacaine|ropivacaine|mesh-list
2086144|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2086145|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
2086146|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
2086147|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086148|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086149|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086150|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
2086151|NCT02154048|Hormones|hormones|mesh-ancestor
2086152|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2086153|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2086154|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086155|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
2086156|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
2086157|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086158|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
2086159|NCT02154061|Metronidazole|metronidazole|mesh-list
2086160|NCT02154061|Vancomycin|vancomycin|mesh-list
2086161|NCT02154061|Neomycin|neomycin|mesh-list
669374|NCT03165383|Morphine|morphine|mesh-list
669375|NCT03165383|Bupivacaine|bupivacaine|mesh-list
669376|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
669377|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
669378|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
669379|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669380|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
669381|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669382|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
669383|NCT03165383|Narcotics|narcotics|mesh-ancestor
669384|NCT03165383|Analgesics|analgesics|mesh-ancestor
669550|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
669551|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
669552|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669662|NCT03164473|Rituximab|rituximab|mesh-list
669663|NCT03164473|Azathioprine|azathioprine|mesh-list
669664|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
669665|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669666|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
669667|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669668|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
669669|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
669670|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669671|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
669672|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
670200|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
670201|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
670202|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223722|NCT00047281|Growth Substances|growth substances|mesh-ancestor
2223723|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
2223724|NCT00047294|Thalidomide|thalidomide|mesh-list
2223725|NCT00047294|Celecoxib|celecoxib|mesh-list
2223726|NCT00047294|Temozolomide|temozolomide|mesh-list
2223727|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
670995|NCT03156855|Bismuth|bismuth|mesh-list
670996|NCT03156855|Antacids|antacids|mesh-ancestor
670997|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670998|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
671124|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
671125|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086162|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223728|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
668370|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
668371|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
668372|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
668373|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
668374|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669162|NCT03167177|Leucovorin|leucovorin|mesh-list
669163|NCT03167177|Paclitaxel|paclitaxel|mesh-list
669164|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
669165|NCT03167177|Bevacizumab|bevacizumab|mesh-list
669166|NCT03167177|Fluorouracil|fluorouracil|mesh-list
669167|NCT03167177|Capecitabine|capecitabine|mesh-list
669168|NCT03167177|Nivolumab|nivolumab|mesh-list
669169|NCT03167177|Avelumab|avelumab|mesh-list
669170|NCT03167177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
669171|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669172|NCT03167177|Tubulin Modulators|tubulin modulators|mesh-ancestor
669173|NCT03167177|Antimitotic Agents|antimitotic agents|mesh-ancestor
669174|NCT03167177|Mitosis Modulators|mitosis modulators|mesh-ancestor
669175|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669176|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
669177|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
669178|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669179|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
669180|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
669181|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
669182|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
669183|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
669184|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
669185|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
669186|NCT03167177|Growth Substances|growth substances|mesh-ancestor
669187|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
669188|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
669189|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
669190|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
669191|NCT03167177|Antidotes|antidotes|mesh-ancestor
669192|NCT03167177|Protective Agents|protective agents|mesh-ancestor
669193|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
669194|NCT03167177|Vitamins|vitamins|mesh-ancestor
669195|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
669235|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
669236|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
669237|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669958|NCT03162432|Vitamin D|vitamin d|mesh-list
669959|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
669960|NCT03162432|Vitamins|vitamins|mesh-ancestor
669961|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
669962|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669963|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
669964|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
670354|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
670355|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
670642|NCT03159559|Aspirin|aspirin|mesh-list
670643|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
670644|NCT03159559|Alprostadil|alprostadil|mesh-list
670645|NCT03159559|Clopidogrel|clopidogrel|mesh-list
670646|NCT03159559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
670647|NCT03159559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
670648|NCT03159559|Analgesics|analgesics|mesh-ancestor
670649|NCT03159559|Sensory System Agents|sensory system agents|mesh-ancestor
670650|NCT03159559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670651|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670652|NCT03159559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
670653|NCT03159559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
670654|NCT03159559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
670655|NCT03159559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
670656|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670657|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
670658|NCT03159559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
670659|NCT03159559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670660|NCT03159559|Antipyretics|antipyretics|mesh-ancestor
670661|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
670662|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
670663|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
670664|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
670665|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
670666|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
670667|NCT03159559|Urological Agents|urological agents|mesh-ancestor
668385|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
668386|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668387|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
668388|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
668389|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668390|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
668659|NCT03169413|Adenosine|adenosine|mesh-list
668660|NCT03169413|Analgesics|analgesics|mesh-ancestor
668661|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
668662|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668663|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668664|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
668665|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
668666|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
668667|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
668668|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
668669|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
668670|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668835|NCT03168191|Menthol|menthol|mesh-list
668836|NCT03168191|Nicotine|nicotine|mesh-list
668837|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
668838|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
668839|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
668840|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668841|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
668842|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
668843|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
668844|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
668845|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668846|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
668847|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
669070|NCT03167112|Leucovorin|leucovorin|mesh-list
669071|NCT03167112|Fluorouracil|fluorouracil|mesh-list
669072|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
669073|NCT03167112|Irinotecan|irinotecan|mesh-list
669074|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
669075|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669076|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
669077|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669078|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
669079|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
669080|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669081|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
669082|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
669083|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669084|NCT03167112|Antidotes|antidotes|mesh-ancestor
669085|NCT03167112|Protective Agents|protective agents|mesh-ancestor
669086|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
669087|NCT03167112|Vitamins|vitamins|mesh-ancestor
669088|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
669222|NCT03166306|Bevacizumab|bevacizumab|mesh-list
669223|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
669224|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669225|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
669226|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
669227|NCT03166306|Growth Substances|growth substances|mesh-ancestor
669228|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669229|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
669264|NCT03166111|Lidocaine|lidocaine|mesh-list
669265|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
669266|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
669267|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
669268|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669269|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
669270|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669271|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
669272|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
669273|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
669274|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
669275|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669350|NCT03165344|Prednisone|prednisone|mesh-list
669351|NCT03165344|Triamcinolone|triamcinolone|mesh-list
669352|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
669353|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
669354|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
669355|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
668419|NCT03169725|Vaccines|vaccines|mesh-list
668420|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
668421|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668686|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
668687|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
668688|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223729|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223730|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223731|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2223732|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2223733|NCT00047294|Analgesics|analgesics|mesh-ancestor
668955|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
668956|NCT03167918|Metformin|metformin|mesh-list
668957|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
668958|NCT03167918|Calcium|calcium|mesh-list
668959|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
668960|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668961|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
668962|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
668963|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
668964|NCT03167918|Coagulants|coagulants|mesh-ancestor
669008|NCT03167268|Lycopene|lycopene|mesh-list
669009|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
669010|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
669011|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669012|NCT03167268|Protective Agents|protective agents|mesh-ancestor
669013|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669014|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
669015|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
669016|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752401|NCT03554473|Temozolomide|temozolomide|mesh-list
2752402|NCT03554473|Topotecan|topotecan|mesh-list
2752403|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2752404|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
2752405|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752406|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670074|NCT03162120|Metoprolol|metoprolol|mesh-list
670075|NCT03162120|Flecainide|flecainide|mesh-list
670076|NCT03162120|Ranolazine|ranolazine|mesh-list
670077|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
670078|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
670079|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
670080|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
670081|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670082|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670083|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
670084|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
670085|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
670086|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
670087|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
670088|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670089|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
670090|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
670091|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2752407|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2752408|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2752409|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752416|NCT03530696|Palbociclib|palbociclib|mesh-list
2752417|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752418|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2752419|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
668436|NCT03169764|Cetuximab|cetuximab|mesh-list
668437|NCT03169764|Fulvestrant|fulvestrant|mesh-list
668438|NCT03169764|Avelumab|avelumab|mesh-list
668439|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668440|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668441|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
668442|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
668443|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668444|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668445|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
668446|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
668447|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
668448|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
668449|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
668450|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
668451|NCT03169764|Growth Substances|growth substances|mesh-ancestor
668452|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
668453|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
668454|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
668455|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
668456|NCT03169764|Antidotes|antidotes|mesh-ancestor
668457|NCT03169764|Protective Agents|protective agents|mesh-ancestor
668458|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
668459|NCT03169764|Vitamins|vitamins|mesh-ancestor
668460|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
668461|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
668462|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
668463|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
668464|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
668465|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2086163|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2086164|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2086165|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2086166|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2086167|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086168|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086169|NCT02154139|Leuprolide|leuprolide|mesh-list
2086170|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
669866|NCT03163407|Norepinephrine|norepinephrine|mesh-list
669867|NCT03163407|Ephedrine|ephedrine|mesh-list
669868|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
669869|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
669870|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
669871|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
669872|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669873|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669874|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
669875|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
669876|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669877|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
669878|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2086171|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
2086172|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2086173|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086174|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
671602|NCT03152942|Aminophylline|aminophylline|mesh-list
671603|NCT03152942|Progesterone|progesterone|mesh-list
671604|NCT03152942|Progestins|progestins|mesh-ancestor
671605|NCT03152942|Hormones|hormones|mesh-ancestor
671606|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
671607|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671608|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
671609|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
671610|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671611|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
671612|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
671613|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
671614|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
671615|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671616|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671617|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
671618|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
671619|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
671620|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671621|NCT03152942|Protective Agents|protective agents|mesh-ancestor
668469|NCT03169738|Fluorouracil|fluorouracil|mesh-list
668470|NCT03169738|Capecitabine|capecitabine|mesh-list
668471|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
668472|NCT03169738|Nivolumab|nivolumab|mesh-list
668473|NCT03169738|Fulvestrant|fulvestrant|mesh-list
668474|NCT03169738|Avelumab|avelumab|mesh-list
668475|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668476|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668477|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
668478|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
668479|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668480|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
668481|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
668482|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
668483|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
668484|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
668485|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
668486|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
668487|NCT03169738|Growth Substances|growth substances|mesh-ancestor
668488|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
668489|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
668490|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
668491|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
668492|NCT03169738|Antidotes|antidotes|mesh-ancestor
668493|NCT03169738|Protective Agents|protective agents|mesh-ancestor
668494|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
668495|NCT03169738|Vitamins|vitamins|mesh-ancestor
668496|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
668497|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
668498|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
668499|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
668500|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
668501|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
668585|NCT03169426|Carvedilol|carvedilol|mesh-list
668586|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
668587|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
668588|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
668589|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
668590|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
668591|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668592|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
668593|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
668594|NCT03169426|Protective Agents|protective agents|mesh-ancestor
668595|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
668596|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
668597|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
668598|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
668599|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
668600|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
669709|NCT03164291|Rifabutin|rifabutin|mesh-list
669710|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
669711|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669712|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
669713|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
669795|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
669796|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
669797|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669798|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
669944|NCT03162510|Paclitaxel|paclitaxel|mesh-list
669945|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
669946|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
669947|NCT03162510|Tegafur|tegafur|mesh-list
669948|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
669949|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669950|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
669951|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
669952|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
669953|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669954|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
669955|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
670060|NCT03162224|Durvalumab|durvalumab|mesh-list
670061|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
670062|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670448|NCT03160404|Zolpidem|zolpidem|mesh-list
670449|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
670450|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
668524|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668525|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
668526|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
668527|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
668528|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668990|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
668991|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
668992|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
668993|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668994|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
668995|NCT03167333|Protective Agents|protective agents|mesh-ancestor
669401|NCT03165396|Propofol|propofol|mesh-list
669402|NCT03165396|Sevoflurane|sevoflurane|mesh-list
669403|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
669404|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
669405|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669406|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
669407|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
669408|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
669409|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
669410|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
669475|NCT03165097|ACT-709478|act-709478|mesh-list
669476|NCT03165097|Midazolam|midazolam|mesh-list
669477|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
669478|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
669479|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
669480|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669481|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
669482|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
669483|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
669484|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
669485|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
669486|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
669487|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
669488|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
669489|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
669490|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669491|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
669492|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
669493|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
669927|NCT03163121|Vaccines|vaccines|mesh-list
669928|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
669929|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670125|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
670126|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
670335|NCT03161041|Bevacizumab|bevacizumab|mesh-list
670336|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
670337|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
670338|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670339|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
670340|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
670341|NCT03161041|Growth Substances|growth substances|mesh-ancestor
670342|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670343|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
671088|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
671089|NCT03156296|Bupivacaine|bupivacaine|mesh-list
671090|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
671091|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
671092|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
671093|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671094|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
671095|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671096|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
671097|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
671098|NCT03156296|Analgesics|analgesics|mesh-ancestor
671099|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
671100|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
671101|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
671102|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
668564|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
668565|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
668566|NCT03169790|Growth Substances|growth substances|mesh-ancestor
668567|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
668568|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
668569|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
668570|NCT03169790|Antidotes|antidotes|mesh-ancestor
668571|NCT03169790|Protective Agents|protective agents|mesh-ancestor
668572|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
668573|NCT03169790|Vitamins|vitamins|mesh-ancestor
668574|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
668883|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
668884|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
668885|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
668886|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
670227|NCT03161340|Sirolimus|sirolimus|mesh-list
670228|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
670229|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
670230|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
670231|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670232|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
670233|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
670234|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
670235|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670445|NCT03160638|Azithromycin|azithromycin|mesh-list
670446|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
670447|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
670760|NCT03158805|Liraglutide|liraglutide|mesh-list
670761|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
670762|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670763|NCT03158805|Incretins|incretins|mesh-ancestor
670764|NCT03158805|Hormones|hormones|mesh-ancestor
670765|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
670978|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
670979|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
670980|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
670981|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670982|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
670983|NCT03157193|Protective Agents|protective agents|mesh-ancestor
2223734|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
2223735|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2223736|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223737|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2223738|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2223739|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2223740|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2223741|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671478|NCT03154281|Everolimus|everolimus|mesh-list
671479|NCT03154281|Niraparib|niraparib|mesh-list
671480|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671481|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
671482|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
671483|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671484|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
671485|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671486|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671592|NCT03153163|Trastuzumab|trastuzumab|mesh-list
671593|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
671594|NCT03153163|Maytansine|maytansine|mesh-list
671595|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
671596|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671597|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
671598|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
671599|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
671600|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
672018|NCT03151499|Rifampin|rifampin|mesh-list
668701|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
668702|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
668703|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
668704|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
668705|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
668706|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
668707|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
668708|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
668709|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
668880|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
668881|NCT03168555|Cathartics|cathartics|mesh-ancestor
668882|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
669017|NCT03167372|Imidacloprid|imidacloprid|mesh-list
669018|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
669019|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
669020|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669021|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669326|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
669327|NCT03165929|Analgesics|analgesics|mesh-ancestor
669328|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
669329|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669330|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669331|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
669332|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
669333|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
669334|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
669335|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
669336|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669337|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669553|NCT03164980|Trabectedin|trabectedin|mesh-list
669554|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
669555|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
669556|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669557|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669763|NCT03163680|Omeprazole|omeprazole|mesh-list
669764|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
669765|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
669766|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
669767|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669768|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669884|NCT03163576|Niacin|niacin|mesh-list
669885|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
669886|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
669887|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669888|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
669889|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
669890|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
669891|NCT03163576|Vitamins|vitamins|mesh-ancestor
669892|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
669893|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669991|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
669992|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
669993|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669994|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
669995|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
669996|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669997|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669998|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670346|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
670347|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
670348|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670349|NCT03161028|Protective Agents|protective agents|mesh-ancestor
670350|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670351|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
670352|NCT03161028|Vitamins|vitamins|mesh-ancestor
670353|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
670635|NCT03159598|Urethane|urethane|mesh-list
670636|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670637|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
668721|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223742|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223743|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
2223744|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
2223745|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2223746|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223747|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2223748|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2223749|NCT00047294|Growth Substances|growth substances|mesh-ancestor
2752420|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752421|NCT03530683|Dexamethasone|dexamethasone|mesh-list
2752422|NCT03530683|Azacitidine|azacitidine|mesh-list
2752423|NCT03530683|Venetoclax|venetoclax|mesh-list
2752424|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2752425|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
669802|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
669803|NCT03163589|Hematinics|hematinics|mesh-ancestor
669840|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
669841|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
669842|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
669843|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669844|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
669845|NCT03163238|Analgesics|analgesics|mesh-ancestor
669846|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
669847|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669848|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
669849|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
669850|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
669851|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
669852|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
669853|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223750|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
2223751|NCT00047307|Gemcitabine|gemcitabine|mesh-list
2223752|NCT00047307|Alvocidib|alvocidib|mesh-list
2223753|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2223754|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
2223755|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223756|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223757|NCT00047307|Antiviral Agents|antiviral agents|mesh-ancestor
2223758|NCT00047307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223759|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223760|NCT00047307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223761|NCT00047307|Immunologic Factors|immunologic factors|mesh-ancestor
2223762|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223763|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
2223764|NCT00047307|Growth Substances|growth substances|mesh-ancestor
2223765|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2223766|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2223767|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670668|NCT03159403|Oritavancin|oritavancin|mesh-list
670669|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
670670|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671162|NCT03156231|Acetazolamide|acetazolamide|mesh-list
671163|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
671164|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
671165|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671166|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671167|NCT03156231|Diuretics|diuretics|mesh-ancestor
671168|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
671169|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672295|NCT03150836|Durvalumab|durvalumab|mesh-list
672296|NCT03150836|Tremelimumab|tremelimumab|mesh-list
672297|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
672298|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672464|NCT03149939|Febuxostat|febuxostat|mesh-list
672465|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
2752426|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
669025|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
669026|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
669027|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
669028|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
669029|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
669030|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669031|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669032|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
669033|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
669034|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
669035|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
669036|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
669136|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
669137|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
669138|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
669139|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669140|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
669141|NCT03166865|Protective Agents|protective agents|mesh-ancestor
2086175|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086176|NCT02154243|Midodrine|midodrine|mesh-list
2086177|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
2086178|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
2086179|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086180|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086181|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2086182|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2086183|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2086184|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2086185|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
2086186|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086187|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669788|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
669789|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
669790|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669854|NCT03163420|Diclofenac|diclofenac|mesh-list
669855|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
669856|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
669857|NCT03163420|Analgesics|analgesics|mesh-ancestor
669858|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
669859|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669860|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669861|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
669862|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
669863|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
669864|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669865|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670332|NCT03160872|Hormones|hormones|mesh-list
670333|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
670334|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670433|NCT03160729|Dexamethasone|dexamethasone|mesh-list
670434|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
670435|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
670436|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
670437|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670438|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670439|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
670440|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
670441|NCT03160729|Hormones|hormones|mesh-ancestor
670442|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
670443|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
670444|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670550|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
670551|NCT03160079|Blinatumomab|blinatumomab|mesh-list
670552|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
670553|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670777|NCT03158376|Gabapentin|gabapentin|mesh-list
670778|NCT03158376|Analgesics|analgesics|mesh-ancestor
670779|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
670780|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670781|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670782|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
670783|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
670784|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
670785|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
669206|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
669207|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
669208|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
669209|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669210|NCT03166787|Urological Agents|urological agents|mesh-ancestor
669211|NCT03166787|Antidotes|antidotes|mesh-ancestor
669212|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
669213|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
669214|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
670052|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
670053|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
670054|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
670055|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
670056|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
670057|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
670058|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
670059|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2223768|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2223769|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223770|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223771|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2223772|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223773|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2223774|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223775|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223776|NCT00047450|Citalopram|citalopram|mesh-list
670313|NCT03161522|Fluorouracil|fluorouracil|mesh-list
670314|NCT03161522|Capecitabine|capecitabine|mesh-list
670315|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
670316|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670317|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
670318|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670319|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
670320|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
670321|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671170|NCT03155971|Paclitaxel|paclitaxel|mesh-list
671171|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
671172|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671173|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
671174|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
671175|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
671176|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671350|NCT03154918|Gemcitabine|gemcitabine|mesh-list
671351|NCT03154918|Dexamethasone|dexamethasone|mesh-list
671352|NCT03154918|Etoposide|etoposide|mesh-list
671353|NCT03154918|Ifosfamide|ifosfamide|mesh-list
671354|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
671355|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
671356|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
671357|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671358|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671359|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
671360|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
671361|NCT03154918|Hormones|hormones|mesh-ancestor
671362|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
671363|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
671364|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671365|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671366|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671367|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
671368|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
671369|NCT03154918|Antiviral Agents|antiviral agents|mesh-ancestor
671370|NCT03154918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671371|NCT03154918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
671372|NCT03154918|Immunologic Factors|immunologic factors|mesh-ancestor
671373|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
671374|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
671375|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
671376|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
671377|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
671530|NCT03153852|Glycolic acid|glycolic acid|mesh-list
671531|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
671532|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
669221|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223777|NCT00047450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2223778|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2223779|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2223780|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223781|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223782|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
2223783|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669503|NCT03165292|Topotecan|topotecan|mesh-list
669504|NCT03165292|Thiotepa|thiotepa|mesh-list
669505|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
669506|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
669507|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669508|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669509|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669510|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
669511|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
669512|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
669513|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
669514|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
669515|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669704|NCT03164382|Sorafenib|sorafenib|mesh-list
669705|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669706|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
669707|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669708|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669930|NCT03162653|Allopurinol|allopurinol|mesh-list
669931|NCT03162653|Mannitol|mannitol|mesh-list
669932|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
669933|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669934|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669935|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
669936|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
669937|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
669938|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
669939|NCT03162653|Protective Agents|protective agents|mesh-ancestor
669940|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669941|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
669942|NCT03162653|Diuretics|diuretics|mesh-ancestor
669943|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
2223784|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2223785|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
2223786|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2223787|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
2223788|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2223789|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223790|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2223791|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2223792|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2223793|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086188|NCT02154347|Mitiglinide|mitiglinide|mesh-list
2086189|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2086190|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086191|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
2086192|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2086193|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
2086194|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086195|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2086196|NCT02154477|Insulin|insulin|mesh-list
2086197|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
671924|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
671925|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
671926|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
671927|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
671928|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671929|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
671930|NCT03151863|Analgesics|analgesics|mesh-ancestor
671931|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
671932|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671933|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
671934|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
671935|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
671936|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
671937|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
669249|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
669250|NCT03166254|Vaccines|vaccines|mesh-list
669251|NCT03166254|Poly ICLC|poly iclc|mesh-list
669252|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
669253|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669254|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
669255|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669256|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
669494|NCT03165240|Eplerenone|eplerenone|mesh-list
669495|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
669496|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
669497|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
669498|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669499|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
669500|NCT03165240|Diuretics|diuretics|mesh-ancestor
669501|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
669502|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
669917|NCT03162861|Anesthetics|anesthetics|mesh-list
669918|NCT03162861|Propofol|propofol|mesh-list
669919|NCT03162861|Sevoflurane|sevoflurane|mesh-list
669920|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
669921|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669922|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
669923|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
669924|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
669925|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
669926|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
670252|NCT03161353|Tamoxifen|tamoxifen|mesh-list
670253|NCT03161353|Carboplatin|carboplatin|mesh-list
670254|NCT03161353|Docetaxel|docetaxel|mesh-list
670255|NCT03161353|Trastuzumab|trastuzumab|mesh-list
670256|NCT03161353|Letrozole|letrozole|mesh-list
670257|NCT03161353|Pertuzumab|pertuzumab|mesh-list
670258|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670259|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
670260|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
670261|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
670262|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670263|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
670264|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
670265|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
670266|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670267|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
670268|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
670269|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
670270|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670271|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
670272|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
670273|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
670274|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2086198|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086199|NCT02154763|Ropivacaine|ropivacaine|mesh-list
2086200|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
2086201|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
2086202|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086203|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086204|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
2086205|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086206|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
2086207|NCT02155010|Bupivacaine|bupivacaine|mesh-list
2086208|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
2086209|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
2086210|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
670949|NCT03157479|Anesthetics|anesthetics|mesh-list
670950|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
670951|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
670952|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670953|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
671269|NCT03155048|Estradiol|estradiol|mesh-list
671270|NCT03155048|Estrogens|estrogens|mesh-list
671271|NCT03155048|Hormones|hormones|mesh-ancestor
671272|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
671273|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086211|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086212|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
2086213|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669300|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669644|NCT03164512|Cannabidiol|cannabidiol|mesh-list
669645|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
669721|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
669722|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
669723|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
669724|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669725|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
669726|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
669727|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669728|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669729|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669730|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669731|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
669732|NCT03164109|Protective Agents|protective agents|mesh-ancestor
2223794|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
670727|NCT03158935|Aldesleukin|aldesleukin|mesh-list
670728|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
670729|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
670730|NCT03158935|Fludarabine|fludarabine|mesh-list
670731|NCT03158935|Interleukin-2|interleukin-2|mesh-list
670732|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
670733|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
670734|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670735|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
670736|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
670737|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
670738|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670739|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670740|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
670741|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
670742|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
670743|NCT03158935|Analgesics|analgesics|mesh-ancestor
670744|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
670745|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670746|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
670747|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
670748|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
670749|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671049|NCT03156439|Huperzine A|huperzine a|mesh-list
671050|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
671051|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671052|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671053|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
671054|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671055|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671056|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
671057|NCT03156439|Protective Agents|protective agents|mesh-ancestor
672649|NCT03149575|Carboplatin|carboplatin|mesh-list
672650|NCT03149575|Temozolomide|temozolomide|mesh-list
672651|NCT03149575|Lomustine|lomustine|mesh-list
672652|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
672653|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672654|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
672655|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
672656|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086214|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2086215|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2086216|NCT02155010|Analgesics|analgesics|mesh-ancestor
2086217|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2086218|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2086219|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2086220|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
2086221|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672907|NCT03148288|Vitamin D|vitamin d|mesh-list
672908|NCT03148288|Vitamins|vitamins|mesh-ancestor
672909|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
672910|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672911|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
673059|NCT03147157|Tacrolimus|tacrolimus|mesh-list
673060|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
673061|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
673062|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673063|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
673064|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673065|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669306|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
669307|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
669308|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
669309|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669310|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669311|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
669312|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
669313|NCT03165825|Hormones|hormones|mesh-ancestor
669314|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
669315|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
669316|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669317|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
669318|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
2752427|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2752428|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752429|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
669714|NCT03164096|Bupivacaine|bupivacaine|mesh-list
669715|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
669716|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
669717|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
669718|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669719|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
669720|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669965|NCT03162497|Azithromycin|azithromycin|mesh-list
669966|NCT03162497|Doxycycline|doxycycline|mesh-list
669967|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
669968|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669969|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
669970|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
669971|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
670275|NCT03161574|Fluorouracil|fluorouracil|mesh-list
670276|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
670277|NCT03161574|Irinotecan|irinotecan|mesh-list
670278|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
670279|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670280|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
670281|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670282|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
670283|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
670284|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670285|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
670286|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
670287|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671105|NCT03156361|Insulin|insulin|mesh-list
671106|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
671107|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
671108|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
671109|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672120|NCT03151382|Tandospirone|tandospirone|mesh-list
672121|NCT03151382|Donepezil|donepezil|mesh-list
672122|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672123|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
672124|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672125|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
672126|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672127|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672128|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
672129|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
672130|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
672131|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672132|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
672133|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
672134|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
672407|NCT03150524|Verapamil|verapamil|mesh-list
672408|NCT03150524|Nimodipine|nimodipine|mesh-list
672409|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
672410|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
672411|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
672412|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672413|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
672414|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672415|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
672416|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
673508|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
673509|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
673510|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669356|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
669357|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
669358|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
669359|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
669360|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
669361|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
669362|NCT03165344|Hormones|hormones|mesh-ancestor
669363|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
669364|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669365|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
669366|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669367|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
669368|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
669369|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669370|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669371|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
669372|NCT03165344|Antacids|antacids|mesh-ancestor
669373|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
669439|NCT03165253|Amoxicillin|amoxicillin|mesh-list
669440|NCT03165253|Clarithromycin|clarithromycin|mesh-list
669441|NCT03165253|Omeprazole|omeprazole|mesh-list
669442|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
669443|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
669444|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
669445|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
669446|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
669447|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
669448|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669449|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
669450|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
669451|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2086222|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086223|NCT02155101|Ritonavir|ritonavir|mesh-list
2086224|NCT02155101|Lopinavir|lopinavir|mesh-list
2086225|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2086226|NCT02155101|Darunavir|darunavir|mesh-list
2086227|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2086228|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2086229|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
2086230|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086231|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086232|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2086233|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2086234|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
2086235|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086236|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2086237|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2086238|NCT02155257|Gabapentin|gabapentin|mesh-list
2086239|NCT02155257|Modafinil|modafinil|mesh-list
2086240|NCT02155257|Analgesics|analgesics|mesh-ancestor
2086241|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
2086242|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086243|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086244|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
2086245|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2086246|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2086247|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086248|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2086249|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2086250|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2086251|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086252|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086253|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
2086254|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2086255|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2086256|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2086257|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2086258|NCT02155309|Scopolamine|scopolamine|mesh-list
2086259|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2086260|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2086261|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
2086262|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
2086263|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670110|NCT03161977|Mannitol|mannitol|mesh-list
670111|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
669424|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
669425|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
669426|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
669427|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669428|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
669429|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
669430|NCT03165500|Analgesics|analgesics|mesh-ancestor
669431|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
669432|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669433|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
669434|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
669435|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
669436|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
669437|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
669438|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
670165|NCT03161509|Acetaminophen|acetaminophen|mesh-list
670166|NCT03161509|Lamotrigine|lamotrigine|mesh-list
670167|NCT03161509|Carbamazepine|carbamazepine|mesh-list
670168|NCT03161509|Phenytoin|phenytoin|mesh-list
670169|NCT03161509|Valproic Acid|valproic acid|mesh-list
670170|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
670171|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
670172|NCT03161509|Analgesics|analgesics|mesh-ancestor
670173|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
670174|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670175|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670176|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
670177|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
670178|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
670179|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670180|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
670181|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
670182|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
670183|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
670184|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
670185|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
670186|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670187|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
670188|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
670189|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
670190|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
670191|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
670192|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
670193|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
670288|NCT03161210|Anesthetics|anesthetics|mesh-list
670289|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
670290|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670344|NCT03160911|Hemostatics|hemostatics|mesh-list
670345|NCT03160911|Coagulants|coagulants|mesh-ancestor
670608|NCT03159702|Fludarabine|fludarabine|mesh-list
670609|NCT03159702|Melphalan|melphalan|mesh-list
670610|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670611|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670612|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
670613|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
670614|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670615|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
670616|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
670617|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2086264|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086265|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086266|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
670766|NCT03158610|Capecitabine|capecitabine|mesh-list
670767|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
670768|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
670769|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670770|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670909|NCT03158129|Cisplatin|cisplatin|mesh-list
670910|NCT03158129|Carboplatin|carboplatin|mesh-list
670911|NCT03158129|Docetaxel|docetaxel|mesh-list
670912|NCT03158129|Nivolumab|nivolumab|mesh-list
670913|NCT03158129|Pemetrexed|pemetrexed|mesh-list
670914|NCT03158129|Ipilimumab|ipilimumab|mesh-list
670915|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670916|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
670917|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
670918|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
671103|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
669613|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
669614|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
669615|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
669616|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
670194|NCT03161457|Rituximab|rituximab|mesh-list
670195|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
670196|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670197|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
670198|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670199|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
670502|NCT03160339|Vaccines|vaccines|mesh-list
670503|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
670504|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223795|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223796|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
2223797|NCT00047502|Lonafarnib|lonafarnib|mesh-list
2223798|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223799|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
671438|NCT03154385|Rituximab|rituximab|mesh-list
671439|NCT03154385|Belimumab|belimumab|mesh-list
671440|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
671441|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671442|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
671443|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671444|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
671445|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
671487|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
671488|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
671489|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
671490|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
671491|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
671492|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
671493|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
671494|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671495|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
671496|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
671497|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
671498|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
671499|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086267|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2086268|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
2086269|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086270|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086271|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2086272|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
2086273|NCT02155322|Interferons|interferons|mesh-list
2086274|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
2086275|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
672984|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
672985|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
672986|NCT03147066|Dezocine|dezocine|mesh-list
672987|NCT03147066|Analgesics|analgesics|mesh-ancestor
672988|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
672989|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
672990|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672991|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
672992|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
672993|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
672994|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
672995|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
672996|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672997|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672998|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
672999|NCT03147066|Narcotics|narcotics|mesh-ancestor
673000|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673257|NCT03145649|Insulin|insulin|mesh-list
673258|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
673259|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673326|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
673327|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
673328|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673376|NCT03145194|Ticagrelor|ticagrelor|mesh-list
673377|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
673378|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
673421|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
2223800|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670156|NCT03161756|Denosumab|denosumab|mesh-list
670157|NCT03161756|Nivolumab|nivolumab|mesh-list
670158|NCT03161756|Ipilimumab|ipilimumab|mesh-list
670159|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
670160|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670161|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
670162|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670163|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
670164|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223801|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223802|NCT00047554|Travoprost|travoprost|mesh-list
2223803|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2223804|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2223805|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
670525|NCT03160040|Minocycline|minocycline|mesh-list
670526|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
670527|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
670750|NCT03158584|Morphine|morphine|mesh-list
670751|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
670752|NCT03158584|Narcotics|narcotics|mesh-ancestor
670753|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
670754|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670755|NCT03158584|Analgesics|analgesics|mesh-ancestor
670756|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
670757|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670999|NCT03156920|Sumatriptan|sumatriptan|mesh-list
671000|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
671001|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
671002|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
671003|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
671004|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671005|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671006|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671127|NCT03156179|Calcium|calcium|mesh-list
671128|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
671129|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671421|NCT03154645|Ibuprofen|ibuprofen|mesh-list
671422|NCT03154645|Acetazolamide|acetazolamide|mesh-list
671423|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
671424|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
671425|NCT03154645|Analgesics|analgesics|mesh-ancestor
671426|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
671427|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671428|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671429|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
671430|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
671431|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
671432|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671433|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671434|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
671435|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
671436|NCT03154645|Diuretics|diuretics|mesh-ancestor
671437|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
669681|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669682|NCT03164421|Protective Agents|protective agents|mesh-ancestor
669683|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669684|NCT03164421|Antidotes|antidotes|mesh-ancestor
669733|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
669734|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
669735|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
669736|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223806|NCT00047567|Zonisamide|zonisamide|mesh-list
2223807|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
2223808|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2223809|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2223810|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223811|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2223812|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223813|NCT00047580|Tizanidine|tizanidine|mesh-list
2223814|NCT00047580|Analgesics|analgesics|mesh-ancestor
2223815|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
669999|NCT03162731|Nivolumab|nivolumab|mesh-list
670000|NCT03162731|Ipilimumab|ipilimumab|mesh-list
670001|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
670002|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670003|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
670004|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223816|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2223817|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223818|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
2223819|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2223820|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2223821|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
2223822|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
2223823|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2223824|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2223825|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2223826|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
2223827|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
670400|NCT03160807|Levofloxacin|levofloxacin|mesh-list
670401|NCT03160807|Ofloxacin|ofloxacin|mesh-list
670402|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
670403|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
670404|NCT03160807|Renal Agents|renal agents|mesh-ancestor
670405|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
670406|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
670407|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
670408|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670409|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670410|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670411|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
670412|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
670758|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
670759|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
670888|NCT03157843|Heparin|heparin|mesh-list
670889|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
670890|NCT03157843|Tinzaparin|tinzaparin|mesh-list
670891|NCT03157843|Dalteparin|dalteparin|mesh-list
670892|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
670893|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
670894|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
670895|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223828|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223829|NCT00047632|Interferons|interferons|mesh-list
2223830|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
2223831|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223832|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
2223833|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223834|NCT00047645|Interferons|interferons|mesh-list
671390|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
671391|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
671392|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
671393|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671394|NCT03154580|Expectorants|expectorants|mesh-ancestor
671395|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
671396|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
671397|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
2223835|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
2223836|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
669699|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
669740|NCT03163914|Phenylephrine|phenylephrine|mesh-list
669741|NCT03163914|Epinephrine|epinephrine|mesh-list
669742|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
669743|NCT03163914|Norepinephrine|norepinephrine|mesh-list
669744|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
669745|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
669746|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
669747|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
669748|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
669749|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
669750|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
669751|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
669752|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
669753|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
669754|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
669755|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
669756|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
669757|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
669758|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
669759|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
669760|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
669761|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
669762|NCT03163914|Protective Agents|protective agents|mesh-ancestor
671235|NCT03155100|Dexamethasone|dexamethasone|mesh-list
671236|NCT03155100|Elotuzumab|elotuzumab|mesh-list
671237|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
671238|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
671239|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
671240|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
671241|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671242|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671243|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
671244|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
671245|NCT03155100|Hormones|hormones|mesh-ancestor
671246|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
671247|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
671248|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671249|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
671250|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671251|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671334|NCT03154723|Vitamin A|vitamin a|mesh-list
671335|NCT03154723|Vitamins|vitamins|mesh-ancestor
671336|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
671337|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672267|NCT03150576|Paclitaxel|paclitaxel|mesh-list
672268|NCT03150576|Carboplatin|carboplatin|mesh-list
672269|NCT03150576|Olaparib|olaparib|mesh-list
672270|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
672271|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672272|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
672273|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
672274|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
672275|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672276|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
672277|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672354|NCT03150316|Dexamethasone|dexamethasone|mesh-list
672355|NCT03150316|Lenalidomide|lenalidomide|mesh-list
672356|NCT03150316|CKD-581|ckd-581|mesh-list
672357|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
672358|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
672359|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
672360|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
672361|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672362|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
672363|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
672364|NCT03150316|Hormones|hormones|mesh-ancestor
672365|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
672366|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
672367|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672368|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672369|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672370|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
672371|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
669835|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
669836|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
669837|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
669838|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
669839|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
670236|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
670237|NCT03161379|Nivolumab|nivolumab|mesh-list
670238|NCT03161379|Pancrelipase|pancrelipase|mesh-list
670239|NCT03161379|Vaccines|vaccines|mesh-list
670240|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
670241|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670242|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
670243|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
670244|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
670245|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
670246|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670247|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670248|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
670249|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
670250|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
670251|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
670322|NCT03160846|Milrinone|milrinone|mesh-list
670323|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
670324|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
670325|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
670326|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
670327|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
670328|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670329|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670330|NCT03160846|Protective Agents|protective agents|mesh-ancestor
670331|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670458|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
670459|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
670460|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
670461|NCT03160651|Prednisolone|prednisolone|mesh-list
670462|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
670463|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
670464|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
670465|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
670466|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
670467|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
670468|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670469|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670470|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
670471|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
670472|NCT03160651|Hormones|hormones|mesh-ancestor
670473|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
670474|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
670475|NCT03160651|Protective Agents|protective agents|mesh-ancestor
670476|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
670477|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223837|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
2223838|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223839|NCT00047658|Interferons|interferons|mesh-list
2223840|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
2223841|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223842|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
2223843|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671180|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
671181|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
671182|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
671183|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
671184|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671185|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
671186|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
671187|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671188|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671189|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671190|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
671191|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
671192|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
671193|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671194|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
671195|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2223844|NCT00047671|Citalopram|citalopram|mesh-list
669916|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671198|NCT03155568|Bupivacaine|bupivacaine|mesh-list
671199|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
671200|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
671201|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
671202|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671203|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
671204|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671509|NCT03154606|Calcium|calcium|mesh-list
671510|NCT03154606|Caseins|caseins|mesh-list
671511|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
671512|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671513|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
671514|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
671515|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223845|NCT00047671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2223846|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2223847|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2223848|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223849|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223850|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
672657|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
672658|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086276|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2086277|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086278|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
2086279|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086280|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
2086281|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086282|NCT02155335|Golimumab|golimumab|mesh-list
2086283|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
673120|NCT03146871|Azacitidine|azacitidine|mesh-list
673121|NCT03146871|Decitabine|decitabine|mesh-list
673122|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
673123|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
673124|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673125|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673126|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223851|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223852|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2223853|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
2223854|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2223855|NCT00047710|Bevacizumab|bevacizumab|mesh-list
2223856|NCT00047710|Capecitabine|capecitabine|mesh-list
2223857|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2223858|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223859|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2223860|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2223861|NCT00047710|Growth Substances|growth substances|mesh-ancestor
2223862|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223863|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
2752430|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
674174|NCT03140826|Meropenem|meropenem|mesh-list
674175|NCT03140826|Tazobactam|tazobactam|mesh-list
674176|NCT03140826|Piperacillin|piperacillin|mesh-list
674177|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
674178|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
674179|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
674180|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
674181|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674182|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674246|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
674247|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
674335|NCT03140033|Misoprostol|misoprostol|mesh-list
674336|NCT03140033|Ranitidine|ranitidine|mesh-list
674337|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
674338|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
674339|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
674340|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
674341|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674342|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
674343|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
674344|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
674345|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
674346|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
674347|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
670067|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670068|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
670069|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
670070|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670071|NCT03162185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
670072|NCT03162185|Antidepressive Agents|antidepressive agents|mesh-ancestor
670073|NCT03162185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2086284|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2086285|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2086286|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2086287|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
2086288|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086289|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2086290|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670846|NCT03158090|Lanreotide|lanreotide|mesh-list
670847|NCT03158090|Octreotide|octreotide|mesh-list
670848|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670849|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
670850|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
670925|NCT03157804|Plerixafor|plerixafor|mesh-list
670926|NCT03157804|Lenograstim|lenograstim|mesh-list
670927|NCT03157804|Sargramostim|sargramostim|mesh-list
670928|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
670929|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
670930|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670931|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
670932|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
670933|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
670934|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
670970|NCT03157388|Vancomycin|vancomycin|mesh-list
670971|NCT03157388|Gentamicins|gentamicins|mesh-list
670972|NCT03157388|Meropenem|meropenem|mesh-list
670973|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
670974|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
670975|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
670976|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670977|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671039|NCT03156790|Asparaginase|asparaginase|mesh-list
671040|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752431|NCT03530683|Hormones|hormones|mesh-ancestor
2752432|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2752433|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
672058|NCT03151460|Dopamine|dopamine|mesh-list
672059|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
672060|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
672061|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
672062|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
672063|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
672064|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672065|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672066|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672067|NCT03151460|Protective Agents|protective agents|mesh-ancestor
2223864|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2223865|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
2223866|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223867|NCT00047723|Minocycline|minocycline|mesh-list
2223868|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2223869|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223870|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2223871|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223872|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2223873|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223874|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223875|NCT00047749|Ziconotide|ziconotide|mesh-list
2223876|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2223877|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2223878|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223879|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2752434|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752435|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2752436|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
673417|NCT03144947|Docetaxel|docetaxel|mesh-list
673418|NCT03144947|Trastuzumab|trastuzumab|mesh-list
673419|NCT03144947|Pertuzumab|pertuzumab|mesh-list
673420|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670203|NCT03161652|Ranibizumab|ranibizumab|mesh-list
670204|NCT03161652|Dopamine|dopamine|mesh-list
670205|NCT03161652|Sulpiride|sulpiride|mesh-list
670206|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
670207|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
670208|NCT03161652|Growth Substances|growth substances|mesh-ancestor
670209|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670210|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
670211|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670212|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
670213|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
670214|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
670215|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670216|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
670217|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
670218|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670219|NCT03161652|Protective Agents|protective agents|mesh-ancestor
670220|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
670221|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
670222|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
670223|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
670224|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
670225|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
670226|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
670356|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
670357|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
670686|NCT03159234|Epinephrine|epinephrine|mesh-list
670687|NCT03159234|Racepinephrine|racepinephrine|mesh-list
670688|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
670689|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
670690|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
670691|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
670692|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
670693|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670694|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670695|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
670696|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
670697|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
670698|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670699|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
670700|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
670701|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
670702|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
670703|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
670819|NCT03158142|Atropine|atropine|mesh-list
670820|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
670821|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
670822|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
670823|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
670824|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670825|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670826|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
670827|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
670828|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
670829|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
670830|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
670831|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
670832|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
670833|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
670834|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223880|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223881|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
671771|NCT03152409|Aspirin|aspirin|mesh-list
671772|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
671773|NCT03152409|Salicylates|salicylates|mesh-list
671774|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
671775|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
671776|NCT03152409|Analgesics|analgesics|mesh-ancestor
671777|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
671778|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671779|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671780|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
671781|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
671782|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
671783|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
671784|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670291|NCT03161223|Azacitidine|azacitidine|mesh-list
670292|NCT03161223|Durvalumab|durvalumab|mesh-list
670293|NCT03161223|Romidepsin|romidepsin|mesh-list
670294|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
670295|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
670296|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670297|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670298|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670299|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
670300|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
670678|NCT03159078|Imipenem|imipenem|mesh-list
670679|NCT03159078|Polymyxins|polymyxins|mesh-list
670680|NCT03159078|Polymyxin B|polymyxin b|mesh-list
670681|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
670682|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223882|NCT00047749|Protective Agents|protective agents|mesh-ancestor
2223883|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2223884|NCT00047749|Analgesics|analgesics|mesh-ancestor
671024|NCT03156842|Amlodipine|amlodipine|mesh-list
671025|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
671026|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
671027|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
671028|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
671029|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671030|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
671031|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671032|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
671033|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
671034|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
671035|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
671036|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
671037|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
671038|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671072|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
671073|NCT03156452|Prednisolone|prednisolone|mesh-list
671074|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
671075|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671076|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
671077|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
671078|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
671079|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671080|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671081|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671082|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
671083|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
671084|NCT03156452|Hormones|hormones|mesh-ancestor
671085|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
671086|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671087|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
671130|NCT03156036|Capecitabine|capecitabine|mesh-list
671131|NCT03156036|Temozolomide|temozolomide|mesh-list
671132|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
671133|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
671134|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671135|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671136|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
671137|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
671562|NCT03153267|Doxycycline|doxycycline|mesh-list
671563|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
671564|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671565|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
671566|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
671567|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
671647|NCT03153111|Macitentan|macitentan|mesh-list
671648|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
671649|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
671650|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671651|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
671994|NCT03151681|Propranolol|propranolol|mesh-list
671995|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
671996|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
671997|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
671998|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671999|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672019|NCT03151499|BI 409306|bi 409306|mesh-list
2752437|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752438|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752439|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
2752440|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2752441|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
2752442|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752443|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2752444|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2752445|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
2752446|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752447|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752448|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
670771|NCT03158792|Enoxaparin|enoxaparin|mesh-list
670772|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
670773|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
670774|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
670775|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
670776|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670960|NCT03157310|Gefitinib|gefitinib|mesh-list
670961|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670962|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
670963|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670964|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671257|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
671258|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
671259|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
671260|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671261|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671262|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
671263|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
671264|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
671265|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
671266|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
671267|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671268|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671456|NCT03154528|Vitamin D|vitamin d|mesh-list
671457|NCT03154528|Vitamins|vitamins|mesh-ancestor
671458|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
671459|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671460|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
671667|NCT03152955|Sufentanil|sufentanil|mesh-list
671668|NCT03152955|Ketamine|ketamine|mesh-list
671669|NCT03152955|Ondansetron|ondansetron|mesh-list
671670|NCT03152955|Analgesics|analgesics|mesh-ancestor
671671|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
671672|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671673|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671674|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
671675|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
671676|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
671677|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
671678|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
671679|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
671680|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
671681|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671682|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671683|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
671684|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
671685|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
671686|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
671687|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
671688|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
671689|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
671690|NCT03152955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
671691|NCT03152955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
671692|NCT03152955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
671693|NCT03152955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
671694|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
671695|NCT03152955|Narcotics|narcotics|mesh-ancestor
671696|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
671715|NCT03152565|Avelumab|avelumab|mesh-list
671716|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
671717|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223885|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
670451|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
670452|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670453|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
670454|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
670455|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
670456|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
670457|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670518|NCT03160261|Exenatide|exenatide|mesh-list
670519|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
670520|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670521|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
670522|NCT03160261|Incretins|incretins|mesh-ancestor
670523|NCT03160261|Hormones|hormones|mesh-ancestor
670524|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2086291|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2086292|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086293|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086294|NCT02155647|Avelumab|avelumab|mesh-list
2086295|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2086296|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086297|NCT02155660|Benralizumab|benralizumab|mesh-list
2086298|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2086299|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
2086300|NCT02155738|Acetaminophen|acetaminophen|mesh-list
2086301|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2086302|NCT02155738|Analgesics|analgesics|mesh-ancestor
2086303|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
670984|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
670985|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
670986|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
670987|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672053|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
672054|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
672055|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672056|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672057|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672516|NCT03150004|Cytarabine|cytarabine|mesh-list
672517|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
672518|NCT03150004|Cladribine|cladribine|mesh-list
672519|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
672520|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
672521|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672522|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672523|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
672524|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
672525|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
672526|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
672527|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672528|NCT03150004|Analgesics|analgesics|mesh-ancestor
672529|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
672530|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
672531|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
672532|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
672533|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672636|NCT03149445|Metoprolol|metoprolol|mesh-list
672637|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
672638|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
672639|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
672640|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
672641|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
672642|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672643|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
672644|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
672645|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
672646|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
672647|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672648|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086304|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086305|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086306|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
672970|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
672971|NCT03146962|Vitamins|vitamins|mesh-ancestor
672972|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
670498|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
670499|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
670500|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
670501|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
670547|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
670548|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
670549|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
670673|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
670674|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
670675|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
670676|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670677|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671041|NCT03156829|Betamethasone|betamethasone|mesh-list
671042|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
671043|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
671044|NCT03156829|Hormones|hormones|mesh-ancestor
671045|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
671046|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671047|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
671048|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
671642|NCT03153085|Ipilimumab|ipilimumab|mesh-list
671643|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
671644|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671645|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
671646|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671721|NCT03152578|Capsaicin|capsaicin|mesh-list
671722|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
671723|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
671724|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
671725|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671726|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671826|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
671827|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
671828|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
671829|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671830|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
671831|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
671832|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
671833|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671834|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671835|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
672143|NCT03151174|Vitamin D|vitamin d|mesh-list
672144|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
672145|NCT03151174|Vitamins|vitamins|mesh-list
672146|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
672147|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672148|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
672149|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
672474|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
672475|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672932|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
672933|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
672934|NCT03147677|Irbesartan|irbesartan|mesh-list
672935|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
672936|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
672937|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
672938|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672939|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
672940|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672941|NCT03147677|Vitamins|vitamins|mesh-ancestor
672942|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
2223886|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2223887|NCT00047762|Bevacizumab|bevacizumab|mesh-list
2223888|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2223889|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2223890|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223891|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2223892|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2223893|NCT00047762|Growth Substances|growth substances|mesh-ancestor
2223894|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223895|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
2223896|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2223897|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673771|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
670517|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670528|NCT03160001|Niclosamide|niclosamide|mesh-list
670529|NCT03160001|Etanercept|etanercept|mesh-list
670530|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
670531|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
670532|NCT03160001|Analgesics|analgesics|mesh-ancestor
670533|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
670534|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
670535|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670536|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
670537|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
670538|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
670539|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
670540|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
670541|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
670542|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
670543|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
670544|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
670545|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
670546|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
670574|NCT03159741|Glucagon|glucagon|mesh-list
670575|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
670576|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
670577|NCT03159741|Hormones|hormones|mesh-ancestor
670578|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
670579|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670580|NCT03159741|Incretins|incretins|mesh-ancestor
670805|NCT03158389|Sirolimus|sirolimus|mesh-list
670806|NCT03158389|Atezolizumab|atezolizumab|mesh-list
670807|NCT03158389|Palbociclib|palbociclib|mesh-list
670808|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670809|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
670810|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670811|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670812|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
670813|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
670814|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
670815|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
670816|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
670817|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
670818|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670935|NCT03157791|Simethicone|simethicone|mesh-list
670936|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
670937|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670938|NCT03157791|Emollients|emollients|mesh-ancestor
670939|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
671402|NCT03154567|Yohimbine|yohimbine|mesh-list
671403|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
671404|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
671405|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671406|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671407|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
671408|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
671409|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
671410|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
671411|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671412|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671413|NCT03154567|Urological Agents|urological agents|mesh-ancestor
671697|NCT03153150|Warfarin|warfarin|mesh-list
671698|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
671699|NCT03153150|Dabigatran|dabigatran|mesh-list
671700|NCT03153150|Apixaban|apixaban|mesh-list
671701|NCT03153150|Edoxaban|edoxaban|mesh-list
671702|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
671703|NCT03153150|Phenindione|phenindione|mesh-list
671704|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
671705|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
671706|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
671707|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
671708|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
671709|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671710|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672047|NCT03151408|Azacitidine|azacitidine|mesh-list
672048|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
672049|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
672050|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672051|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670591|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
670592|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670593|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670594|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
670595|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
670596|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
670597|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
670598|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
670599|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
670600|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
670601|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
670602|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670603|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
670604|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
670605|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
670606|NCT03159845|Astringents|astringents|mesh-ancestor
670607|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
671058|NCT03156504|Ketamine|ketamine|mesh-list
671059|NCT03156504|Analgesics|analgesics|mesh-ancestor
671060|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
671061|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671062|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671063|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
671064|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
671065|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
671066|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
671067|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
671068|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
671069|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
671070|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671071|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671145|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
671146|NCT03156062|Salicylates|salicylates|mesh-list
671147|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671148|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
671149|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
671150|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
671151|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
671152|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
671153|NCT03156062|Analgesics|analgesics|mesh-ancestor
671154|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
671155|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671156|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671157|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
671158|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
671159|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
671160|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671161|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752454|NCT03511196|Prednisone|prednisone|mesh-list
2752455|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
2752456|NCT03511196|Androgens|androgens|mesh-list
2752457|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2752458|NCT03511196|Hormones|hormones|mesh-ancestor
671378|NCT03154814|Urinastatin|urinastatin|mesh-list
671379|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
671380|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
671381|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
671382|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671383|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671464|NCT03154372|Metronidazole|metronidazole|mesh-list
671465|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671466|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
671467|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
671468|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
671579|NCT03153072|Amiodarone|amiodarone|mesh-list
671580|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
671581|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
671582|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
671583|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
671584|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671585|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
671586|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2752459|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
670638|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
670639|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
670640|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
670641|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671293|NCT03154827|Atezolizumab|atezolizumab|mesh-list
671294|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223898|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223899|NCT00047801|Docetaxel|docetaxel|mesh-list
2223900|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223901|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
2223902|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
672232|NCT03150771|Aripiprazole|aripiprazole|mesh-list
672233|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
672234|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
672235|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
672236|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
672237|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672238|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672239|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
672240|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
672241|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672242|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672243|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
672244|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
672245|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
672246|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
672247|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
672248|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
672249|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
672417|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
672418|NCT03150420|Antidotes|antidotes|mesh-ancestor
672419|NCT03150420|Protective Agents|protective agents|mesh-ancestor
672420|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672421|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
672422|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672423|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
672424|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
672425|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
672426|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
672427|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
672749|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
672750|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
672751|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
672752|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672753|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672754|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
672755|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
672756|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672757|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223903|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
2223904|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223905|NCT00047827|Amphotericin B|amphotericin b|mesh-list
2223906|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2223907|NCT00047827|Micafungin|micafungin|mesh-list
2223908|NCT00047827|Amebicides|amebicides|mesh-ancestor
2223909|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2223910|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2223911|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223912|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2223913|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
670786|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
670787|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
670788|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
670789|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
670790|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670791|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
671138|NCT03156153|Bumetanide|bumetanide|mesh-list
671139|NCT03156153|Diuretics|diuretics|mesh-ancestor
671140|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
671141|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671142|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
671143|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
671144|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223914|NCT00047840|Docetaxel|docetaxel|mesh-list
2223915|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223916|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
2223917|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
2223918|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
2223919|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223920|NCT00048087|Docetaxel|docetaxel|mesh-list
671533|NCT03153657|Piroxicam|piroxicam|mesh-list
671534|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
671535|NCT03153657|Betadex|betadex|mesh-list
671536|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
671537|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
671538|NCT03153657|Analgesics|analgesics|mesh-ancestor
671539|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
671540|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671541|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671542|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
671543|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
671544|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
671545|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671546|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671547|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
671568|NCT03153280|Capecitabine|capecitabine|mesh-list
671569|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
671570|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
671571|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
671572|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671573|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671627|NCT03152981|Remifentanil|remifentanil|mesh-list
671628|NCT03152981|Propofol|propofol|mesh-list
671629|NCT03152981|Desflurane|desflurane|mesh-list
671630|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
671631|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
671632|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671633|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
671634|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
671635|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
671636|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
671637|NCT03152981|Narcotics|narcotics|mesh-ancestor
671638|NCT03152981|Analgesics|analgesics|mesh-ancestor
671639|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
671640|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671641|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2223921|NCT00048087|Gefitinib|gefitinib|mesh-list
2223922|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223923|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
2223924|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
2223925|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
2223926|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223927|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
671971|NCT03151707|Niacinamide|niacinamide|mesh-list
671972|NCT03151707|Niacin|niacin|mesh-list
671973|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
671974|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
671975|NCT03151707|Vitamins|vitamins|mesh-ancestor
671976|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
671977|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671978|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
671979|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
671980|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671981|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
671982|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
672073|NCT03151369|Morphine|morphine|mesh-list
2223928|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670875|NCT03158246|Vitamin D|vitamin d|mesh-list
670876|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
670877|NCT03158246|Calcium|calcium|mesh-list
670878|NCT03158246|Vitamins|vitamins|mesh-ancestor
670879|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
670880|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670881|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
670882|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
670954|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
670955|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
670956|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
670957|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670958|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
670959|NCT03157401|Coagulants|coagulants|mesh-ancestor
2223929|NCT00048113|Alicaforsen|alicaforsen|mesh-list
2223930|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2223931|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223932|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
2223933|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223934|NCT00048126|Capecitabine|capecitabine|mesh-list
2223935|NCT00048126|Irinotecan|irinotecan|mesh-list
671524|NCT03153813|Capsaicin|capsaicin|mesh-list
671525|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
671526|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
671527|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
671528|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671529|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671652|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
671653|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
671654|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672157|NCT03151096|Riboflavin|riboflavin|mesh-list
672158|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
672159|NCT03151096|Vitamins|vitamins|mesh-ancestor
672160|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
672161|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672162|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
672163|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
672216|NCT03150810|Temozolomide|temozolomide|mesh-list
672217|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
672218|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
672219|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672220|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672428|NCT03150134|Cyclosporine|cyclosporine|mesh-list
672429|NCT03150134|Cyclosporins|cyclosporins|mesh-list
672430|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
672431|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672432|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672433|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
672434|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672435|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
672436|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
672437|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
672438|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
672439|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
672587|NCT03149419|Paroxetine|paroxetine|mesh-list
672588|NCT03149419|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
672589|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
672590|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
672591|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672592|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672593|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
672594|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672595|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
672596|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
672597|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
672598|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
672599|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
672600|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672677|NCT03149250|Hemostatics|hemostatics|mesh-list
672678|NCT03149250|Coagulants|coagulants|mesh-ancestor
672885|NCT03148132|Bevacizumab|bevacizumab|mesh-list
672886|NCT03148132|Ranibizumab|ranibizumab|mesh-list
672887|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
672888|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672889|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
672890|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2223936|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
670898|NCT03158025|Lemborexant|lemborexant|mesh-list
670899|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
670900|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
670901|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
670902|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
670903|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
670904|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
670905|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
670906|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
670907|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670908|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
671338|NCT03154983|Docetaxel|docetaxel|mesh-list
671339|NCT03154983|Apatinib|apatinib|mesh-list
671340|NCT03154983|Tegafur|tegafur|mesh-list
671341|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671342|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
671343|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
671344|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
671345|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671346|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
671347|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671348|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
671349|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
672087|NCT03151603|Fosfomycin|fosfomycin|mesh-list
672088|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
672089|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
672221|NCT03150732|Nalbuphine|nalbuphine|mesh-list
672222|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
672223|NCT03150732|Narcotics|narcotics|mesh-ancestor
672224|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672225|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672226|NCT03150732|Analgesics|analgesics|mesh-ancestor
672227|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
672228|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
672672|NCT03149120|Nivolumab|nivolumab|mesh-list
672673|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
672674|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672675|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
672676|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086307|NCT02155829|Riluzole|riluzole|mesh-list
2086308|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
673755|NCT03142789|Cerivastatin|cerivastatin|mesh-list
673756|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
673757|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
673758|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
673759|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
673760|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673761|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673762|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2223937|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
2223938|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223939|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674098|NCT03141125|Ethanol|ethanol|mesh-list
674099|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
674100|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
674101|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674102|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674375|NCT03139474|Hormones|hormones|mesh-list
674376|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
674377|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
674378|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675023|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
675024|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
675025|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
675026|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675027|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
675028|NCT03136445|Coagulants|coagulants|mesh-ancestor
675181|NCT03135795|Parecoxib|parecoxib|mesh-list
675182|NCT03135795|Sufentanil|sufentanil|mesh-list
675183|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
675184|NCT03135795|Remifentanil|remifentanil|mesh-list
675185|NCT03135795|Dsuvia|dsuvia|mesh-list
675186|NCT03135795|Bromides|bromides|mesh-list
675187|NCT03135795|Propofol|propofol|mesh-list
675188|NCT03135795|Sevoflurane|sevoflurane|mesh-list
675189|NCT03135795|Citric Acid|citric acid|mesh-list
675190|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
675191|NCT03135795|Rocuronium|rocuronium|mesh-list
670919|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670920|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
670921|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
670922|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
670923|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
670924|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
670965|NCT03157414|Empagliflozin|empagliflozin|mesh-list
670966|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
670967|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
670968|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
670969|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671500|NCT03154294|Paclitaxel|paclitaxel|mesh-list
671501|NCT03154294|Serabelisib|serabelisib|mesh-list
671502|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
671503|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671504|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
671505|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
671506|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
671507|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671508|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671793|NCT03152474|Vitamin A|vitamin a|mesh-list
671794|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
671795|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
671796|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
671797|NCT03152474|Prednisolone|prednisolone|mesh-list
671798|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
671799|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
671800|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
671801|NCT03152474|Vitamins|vitamins|mesh-ancestor
671802|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
671803|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671804|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
671805|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
671806|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
671807|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671808|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
671809|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
671810|NCT03152474|Hormones|hormones|mesh-ancestor
671811|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
671812|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
671813|NCT03152474|Protective Agents|protective agents|mesh-ancestor
671814|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
671815|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672467|NCT03149913|Paclitaxel|paclitaxel|mesh-list
672468|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
672469|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672470|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
672471|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
672472|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
672473|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672899|NCT03148314|Misoprostol|misoprostol|mesh-list
672900|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
672901|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
672902|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
672903|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672904|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
672905|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
672906|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
672949|NCT03147404|Avelumab|avelumab|mesh-list
672950|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
672951|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223940|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2223941|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2223942|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223943|NCT00048139|Capecitabine|capecitabine|mesh-list
2223944|NCT00048139|Irinotecan|irinotecan|mesh-list
674195|NCT03140384|Misoprostol|misoprostol|mesh-list
674196|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
674197|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
674198|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
674199|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671104|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671177|NCT03155984|Antibodies|antibodies|mesh-list
671178|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
671179|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671732|NCT03152877|Bupivacaine|bupivacaine|mesh-list
671733|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
671734|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
671735|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
671736|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671737|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
671738|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671841|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
671842|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
671843|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
671844|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671845|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
671876|NCT03151772|Metformin|metformin|mesh-list
671877|NCT03151772|Disulfiram|disulfiram|mesh-list
671878|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
671879|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671880|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
671881|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
671882|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671883|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672229|NCT03150706|Avelumab|avelumab|mesh-list
672230|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
672231|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672484|NCT03149783|Ropivacaine|ropivacaine|mesh-list
672485|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
672486|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
672487|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672488|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672489|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
672490|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673242|NCT03146325|Metronidazole|metronidazole|mesh-list
673243|NCT03146325|Tetracycline|tetracycline|mesh-list
673244|NCT03146325|Omeprazole|omeprazole|mesh-list
673245|NCT03146325|Bismuth|bismuth|mesh-list
673246|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673247|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
673248|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
673249|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
673250|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
673251|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
673252|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
673253|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673254|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673255|NCT03146325|Antacids|antacids|mesh-ancestor
673256|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
673511|NCT03144453|Atropine|atropine|mesh-list
673512|NCT03144453|Neostigmine|neostigmine|mesh-list
673513|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
673514|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
673515|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
673516|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
673517|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673518|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673519|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
673520|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
673521|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
673522|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
673523|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
673524|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
673525|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
673526|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
673527|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673528|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
673529|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673530|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
674266|NCT03140358|Atropine|atropine|mesh-list
674267|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
674268|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
674269|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
674270|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
674271|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674272|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674273|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
671126|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671516|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
671517|NCT03153917|Melatonin|melatonin|mesh-list
671518|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
671519|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671520|NCT03153917|Protective Agents|protective agents|mesh-ancestor
671521|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671522|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
671523|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
671548|NCT03153527|Prednisone|prednisone|mesh-list
671549|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
671550|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
671551|NCT03153527|Hormones|hormones|mesh-ancestor
671552|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
671553|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671554|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
671555|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671718|NCT03152890|Insulin|insulin|mesh-list
671719|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
671720|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671888|NCT03152123|Phentermine|phentermine|mesh-list
671889|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
671890|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671891|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
671892|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
671893|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
671894|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
671895|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671896|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
671897|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671898|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672135|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
672136|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
672137|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
672138|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
672139|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
672140|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672141|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672142|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223945|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2223946|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
2223947|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223948|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223949|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2223950|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2223951|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223952|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
2223953|NCT00048152|Cyclosporine|cyclosporine|mesh-list
2223954|NCT00048152|Cyclosporins|cyclosporins|mesh-list
2223955|NCT00048152|Daclizumab|daclizumab|mesh-list
2223956|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2223957|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223958|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2223959|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
2223960|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2223961|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2223962|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223963|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223964|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
2223965|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
2223966|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223967|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
2223968|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223969|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2223970|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2223971|NCT00048204|Paroxetine|paroxetine|mesh-list
671196|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
671197|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
671232|NCT03155087|Metformin|metformin|mesh-list
671233|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
671234|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671315|NCT03155035|Vitamin D|vitamin d|mesh-list
671316|NCT03155035|Albendazole|albendazole|mesh-list
671317|NCT03155035|Calcium|calcium|mesh-list
671318|NCT03155035|Vitamins|vitamins|mesh-ancestor
671319|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
671320|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671321|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
671322|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
671323|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
671324|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
671325|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671326|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
671327|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
671328|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
671329|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
671330|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
671331|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
671332|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671333|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671461|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
671462|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
671463|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671574|NCT03153436|Inositol|inositol|mesh-list
671575|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
671576|NCT03153436|Vitamins|vitamins|mesh-ancestor
671577|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
671578|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671711|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
671712|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
671713|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
671714|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671836|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
671837|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
671838|NCT03152097|Protective Agents|protective agents|mesh-ancestor
671839|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671840|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223972|NCT00048204|Vestipitant|vestipitant|mesh-list
2223973|NCT00048204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2223974|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2223975|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
673127|NCT03146650|Nivolumab|nivolumab|mesh-list
673128|NCT03146650|Ipilimumab|ipilimumab|mesh-list
673129|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
673130|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673131|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
673132|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673616|NCT03143452|Lidocaine|lidocaine|mesh-list
673617|NCT03143452|Tetracaine|tetracaine|mesh-list
673618|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
673619|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
673620|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
673621|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673622|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673623|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
673624|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673625|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
673626|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
673627|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
673628|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
673629|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673630|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
674056|NCT03141268|Lactulose|lactulose|mesh-list
674057|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
674183|NCT03140787|Lidocaine|lidocaine|mesh-list
674184|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
674185|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
674186|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674187|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674188|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
674189|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674190|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
671225|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671226|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671227|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
671228|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
671229|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
671230|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
671231|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
671446|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
671447|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
671755|NCT03152370|Leucovorin|leucovorin|mesh-list
671756|NCT03152370|Folic Acid|folic acid|mesh-list
671757|NCT03152370|Capecitabine|capecitabine|mesh-list
671758|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
671759|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
671760|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
671761|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
671762|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671763|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671764|NCT03152370|Antidotes|antidotes|mesh-ancestor
671765|NCT03152370|Protective Agents|protective agents|mesh-ancestor
671766|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671767|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
671768|NCT03152370|Vitamins|vitamins|mesh-ancestor
671769|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
671770|NCT03152370|Hematinics|hematinics|mesh-ancestor
672035|NCT03151525|Azathioprine|azathioprine|mesh-list
672036|NCT03151525|Infliximab|infliximab|mesh-list
672037|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
672038|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
672039|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
672040|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
672041|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672042|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
672043|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672044|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
672045|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
672046|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672150|NCT03151161|Carboplatin|carboplatin|mesh-list
672151|NCT03151161|Pemetrexed|pemetrexed|mesh-list
672152|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672153|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672154|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672155|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
672156|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
672261|NCT03150797|Melatonin|melatonin|mesh-list
672262|NCT03150797|Antioxidants|antioxidants|mesh-ancestor
672263|NCT03150797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672264|NCT03150797|Protective Agents|protective agents|mesh-ancestor
672265|NCT03150797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672266|NCT03150797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672573|NCT03149653|SMOFlipid|smoflipid|mesh-list
672574|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
672575|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
672576|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
672629|NCT03149393|Mosapride|mosapride|mesh-list
672630|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672631|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
672632|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
672633|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
672634|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672635|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672807|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
672808|NCT03148522|Mirtazapine|mirtazapine|mesh-list
672809|NCT03148522|Citalopram|citalopram|mesh-list
672810|NCT03148522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
672811|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
672812|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
672813|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672814|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672815|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
672816|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672817|NCT03148522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
672818|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
672819|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
672820|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
672821|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2086309|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2086310|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2086311|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086312|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086313|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086314|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2086315|NCT02155829|Protective Agents|protective agents|mesh-ancestor
2086316|NCT02155881|Ciclesonide|ciclesonide|mesh-list
2086317|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
2086318|NCT02155881|Hormones|hormones|mesh-ancestor
2086319|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2086320|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086321|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2086322|NCT02155985|Aspirin|aspirin|mesh-list
2086323|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2086324|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2086325|NCT02155985|Analgesics|analgesics|mesh-ancestor
2223976|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223977|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2223978|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
2223979|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223980|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2223981|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
2223982|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
672004|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
672005|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
672006|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672007|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672008|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
672009|NCT03151668|Analgesics|analgesics|mesh-ancestor
672010|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
672011|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
672012|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
672013|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
672014|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
672015|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
672016|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672017|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672106|NCT03151213|Pregabalin|pregabalin|mesh-list
672107|NCT03151213|Analgesics|analgesics|mesh-ancestor
672108|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
672109|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
672110|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672111|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
672112|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
672113|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
672114|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672115|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
672116|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
672117|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
672118|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672119|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
672250|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
672616|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
672617|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
672618|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
672619|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672620|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
672621|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
672622|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
672623|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672624|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672625|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
673554|NCT03143816|Insulin|insulin|mesh-list
673555|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
673556|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223983|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2223984|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2223985|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2223986|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
673733|NCT03143023|Fluorides|fluorides|mesh-list
673734|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
671398|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671399|NCT03154580|Protective Agents|protective agents|mesh-ancestor
671400|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671401|NCT03154580|Antidotes|antidotes|mesh-ancestor
672577|NCT03149588|Propofol|propofol|mesh-list
672578|NCT03149588|Sevoflurane|sevoflurane|mesh-list
672579|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
672580|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672581|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672582|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
672583|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
672584|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
672585|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
672586|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
672758|NCT03148574|Misoprostol|misoprostol|mesh-list
672759|NCT03148574|Oxytocin|oxytocin|mesh-list
672760|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
672761|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
672762|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672763|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
672764|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
672765|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
672766|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086326|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
2086327|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086328|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086329|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2086330|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
673032|NCT03146858|Enoxaparin|enoxaparin|mesh-list
673033|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
673034|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
673035|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
673036|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673133|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
673134|NCT03146533|Fludarabine|fludarabine|mesh-list
673135|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
673136|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
673137|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673138|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
673139|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
673140|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
673141|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673142|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673143|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2086331|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2086332|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2086333|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086334|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2086335|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
673474|NCT03144843|Apatinib|apatinib|mesh-list
673475|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673476|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
673477|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673478|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673544|NCT03144115|Oxytocin|oxytocin|mesh-list
673545|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
673546|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
673547|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674222|NCT03140449|Calcitriol|calcitriol|mesh-list
674223|NCT03140449|Sirolimus|sirolimus|mesh-list
674224|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
674225|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
674226|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
674227|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674228|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
674229|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
674230|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
674231|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674232|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
674233|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
674234|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
674235|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674236|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
674237|NCT03140449|Vitamins|vitamins|mesh-ancestor
674238|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
671450|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
671451|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
671452|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671453|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
671454|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671455|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671622|NCT03153137|Macitentan|macitentan|mesh-list
671623|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
671624|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
671625|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671626|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
671955|NCT03151876|Gemcitabine|gemcitabine|mesh-list
671956|NCT03151876|Busulfan|busulfan|mesh-list
671957|NCT03151876|Cladribine|cladribine|mesh-list
671958|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
671959|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
671960|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671961|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
671962|NCT03151876|Antiviral Agents|antiviral agents|mesh-ancestor
671963|NCT03151876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671964|NCT03151876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671965|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
671966|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
671967|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671968|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
671969|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
671970|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
672193|NCT03151239|Niacinamide|niacinamide|mesh-list
672194|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
672195|NCT03151239|Vitamins|vitamins|mesh-ancestor
672196|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
672197|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672722|NCT03148704|Palonosetron|palonosetron|mesh-list
672723|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
672724|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
672725|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
672726|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672727|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
672728|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
672729|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
672730|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
672731|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672732|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673318|NCT03145558|Doxorubicin|doxorubicin|mesh-list
673319|NCT03145558|Tirapazamine|tirapazamine|mesh-list
673320|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
673321|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673322|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
673323|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
673324|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673325|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673557|NCT03143933|Fentanyl|fentanyl|mesh-list
673558|NCT03143933|Propofol|propofol|mesh-list
673559|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
673560|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673561|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673562|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
673563|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
673564|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
673565|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
673566|NCT03143933|Narcotics|narcotics|mesh-ancestor
673567|NCT03143933|Analgesics|analgesics|mesh-ancestor
673568|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
673569|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673570|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2086336|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086337|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
2086338|NCT02156154|Acetaminophen|acetaminophen|mesh-list
2086339|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2086340|NCT02156154|Analgesics|analgesics|mesh-ancestor
2086341|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
2086342|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086343|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086344|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
2086345|NCT02156492|Atorvastatin|atorvastatin|mesh-list
2086346|NCT02156492|Simvastatin|simvastatin|mesh-list
671587|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
671588|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671589|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
671590|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
671591|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
672164|NCT03151044|Rituximab|rituximab|mesh-list
672165|NCT03151044|Epirubicin|epirubicin|mesh-list
672166|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
672167|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672168|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
672169|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672170|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
672171|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
672172|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
672173|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
672174|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672175|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672838|NCT03148860|Methotrexate|methotrexate|mesh-list
672839|NCT03148860|Ustekinumab|ustekinumab|mesh-list
672840|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
672841|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
672842|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
672843|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672844|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
672845|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
672846|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672847|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672848|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
672849|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672850|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
672851|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
672852|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
672853|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
672854|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
673037|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
673038|NCT03146793|Antidotes|antidotes|mesh-ancestor
673039|NCT03146793|Protective Agents|protective agents|mesh-ancestor
673040|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673041|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
673042|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673043|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
673044|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
673045|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673046|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
673047|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
673813|NCT03142620|Vitamin D|vitamin d|mesh-list
673814|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
673815|NCT03142620|Amoxicillin|amoxicillin|mesh-list
673816|NCT03142620|Clarithromycin|clarithromycin|mesh-list
673817|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
673818|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
673819|NCT03142620|Esomeprazole|esomeprazole|mesh-list
673820|NCT03142620|Vitamins|vitamins|mesh-ancestor
673821|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
673822|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673823|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
673824|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
673825|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
673826|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673827|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
673828|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
673829|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
673830|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673831|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673832|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
673833|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
673834|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
673835|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
674458|NCT03139565|Vaccines|vaccines|mesh-list
674459|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
674460|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223987|NCT00048230|Bortezomib|bortezomib|mesh-list
2223988|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223989|NCT00048295|Alicaforsen|alicaforsen|mesh-list
2223990|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
671601|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671858|NCT03152149|Fluticasone|fluticasone|mesh-list
671859|NCT03152149|Xhance|xhance|mesh-list
671860|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
671861|NCT03152149|Olodaterol|olodaterol|mesh-list
671862|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
671863|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
671864|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
671865|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
671866|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671867|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
671868|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
671869|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
671870|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
671871|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
671872|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
671873|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
671874|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671875|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2223991|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2223992|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
2223993|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2223994|NCT00048334|Romidepsin|romidepsin|mesh-list
2223995|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2223996|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2223997|NCT00048360|Bupropion|bupropion|mesh-list
2223998|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2223999|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
2224000|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2224001|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
672388|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
672389|NCT03150329|Vorinostat|vorinostat|mesh-list
672390|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
672391|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672392|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
672393|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672394|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672479|NCT03149770|Naloxone|naloxone|mesh-list
672480|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
672481|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672482|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
672483|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
672663|NCT03148990|Vaccines|vaccines|mesh-list
672664|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
672665|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086347|NCT02156492|Evacetrapib|evacetrapib|mesh-list
2086348|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2086349|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2086350|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
2086351|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086352|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2086353|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2086354|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086355|NCT02156804|Nivolumab|nivolumab|mesh-list
673479|NCT03144713|Terlipressin|terlipressin|mesh-list
673480|NCT03144713|Midodrine|midodrine|mesh-list
673481|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
673482|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
673483|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673484|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673485|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
673486|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
673487|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
673488|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
673489|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
673490|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
673491|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673492|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
673789|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
673790|NCT03142776|Clarithromycin|clarithromycin|mesh-list
673791|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673792|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
673793|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673794|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673795|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
671785|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
671786|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
671787|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671788|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
671789|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
671790|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
671791|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
671792|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
671884|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
671885|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
671886|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
671887|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672090|NCT03151343|Empagliflozin|empagliflozin|mesh-list
672091|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
672092|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672093|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
672094|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672382|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
672383|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
672384|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224002|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2224003|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2224004|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224005|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
2224006|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2224007|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224008|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2224009|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2224010|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224011|NCT00048373|Etanercept|etanercept|mesh-list
672666|NCT03149159|Nivolumab|nivolumab|mesh-list
672667|NCT03149159|Ipilimumab|ipilimumab|mesh-list
672668|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
672669|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672670|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
672671|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224012|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2224013|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
672924|NCT03147859|Vedolizumab|vedolizumab|mesh-list
672925|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
672952|NCT03147287|Fulvestrant|fulvestrant|mesh-list
672953|NCT03147287|Palbociclib|palbociclib|mesh-list
672954|NCT03147287|Avelumab|avelumab|mesh-list
672955|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
672956|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672957|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
672958|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
672959|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
672960|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
672961|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672962|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
672963|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672964|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672965|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
673186|NCT03146390|Listerine|listerine|mesh-list
673187|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
673188|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
673189|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673190|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
673191|NCT03146390|Protective Agents|protective agents|mesh-ancestor
673192|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673307|NCT03145896|Vitamin D|vitamin d|mesh-list
673308|NCT03145896|Vitamins|vitamins|mesh-ancestor
673309|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
673310|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673311|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
673989|NCT03141645|Ondansetron|ondansetron|mesh-list
673990|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
673991|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
673992|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673993|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671817|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
671818|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
671819|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
671820|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
671821|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671822|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
671823|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
671824|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
671825|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
2086356|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2086357|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086358|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2086359|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086360|NCT02157103|Bevacizumab|bevacizumab|mesh-list
2086361|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2086362|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086363|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2086364|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2086365|NCT02157103|Growth Substances|growth substances|mesh-ancestor
2086366|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086367|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
2086368|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
2086369|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2086370|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086371|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2086372|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086373|NCT02157376|Esomeprazole|esomeprazole|mesh-list
2086374|NCT02157376|Cimetidine|cimetidine|mesh-list
2086375|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2086376|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086377|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2086378|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086379|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086380|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2224014|NCT00048373|Analgesics|analgesics|mesh-ancestor
2224015|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
2224016|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224017|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224018|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2224019|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2224020|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2224021|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224022|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
2224023|NCT00048399|Fludarabine|fludarabine|mesh-list
2224024|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
2224025|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224026|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2224027|NCT00048412|Fludarabine|fludarabine|mesh-list
2224028|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
2224029|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224030|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2086381|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
2086382|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
2086383|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086384|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086385|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2086386|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2224031|NCT00048425|Simendan|simendan|mesh-list
674034|NCT03141593|Vitamin D|vitamin d|mesh-list
674035|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
674036|NCT03141593|Vitamins|vitamins|mesh-list
674037|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
674038|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674039|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
674040|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
674591|NCT03138603|Metoprolol|metoprolol|mesh-list
674592|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
674593|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
674594|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
674595|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
674596|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674597|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674598|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
674599|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2224032|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2224033|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
2224034|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2224035|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
672180|NCT03151005|Metformin|metformin|mesh-list
672181|NCT03151005|Liraglutide|liraglutide|mesh-list
672182|NCT03151005|Exenatide|exenatide|mesh-list
672183|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
672184|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
672185|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
672186|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672187|NCT03151005|Incretins|incretins|mesh-ancestor
672188|NCT03151005|Hormones|hormones|mesh-ancestor
672189|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
672190|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
672191|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
672192|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
672251|NCT03150667|Clopidogrel|clopidogrel|mesh-list
672252|NCT03150667|Ticagrelor|ticagrelor|mesh-list
672253|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
672254|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
672255|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
672256|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
672257|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
672258|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672259|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672260|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086387|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2086388|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2086389|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
672780|NCT03148509|Risperidone|risperidone|mesh-list
672781|NCT03148509|Aripiprazole|aripiprazole|mesh-list
672782|NCT03148509|Bupropion|bupropion|mesh-list
672783|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
672784|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
672785|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672786|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672787|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672788|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
672789|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
672790|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672791|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
672792|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
672793|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
672794|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
672795|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
672796|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
672797|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
672798|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
672799|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
672800|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
672801|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672802|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
672803|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
672804|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
672805|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
672806|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
672912|NCT03148002|Lactulose|lactulose|mesh-list
672913|NCT03148002|Sennosides|sennosides|mesh-list
672914|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
672915|NCT03148002|Laxatives|laxatives|mesh-ancestor
673066|NCT03147612|Cytarabine|cytarabine|mesh-list
673067|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
673068|NCT03147612|Rituximab|rituximab|mesh-list
673069|NCT03147612|Methotrexate|methotrexate|mesh-list
673070|NCT03147612|Vincristine|vincristine|mesh-list
673071|NCT03147612|Blinatumomab|blinatumomab|mesh-list
673072|NCT03147612|Ponatinib|ponatinib|mesh-list
673073|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
673074|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
673075|NCT03147612|Antibodies|antibodies|mesh-list
673076|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
673077|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
673078|NCT03147612|Lenograstim|lenograstim|mesh-list
2224036|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
671938|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
671939|NCT03151863|Narcotics|narcotics|mesh-ancestor
2086405|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
2086406|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2086407|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2086408|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
2086409|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086410|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086411|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2086412|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
2086413|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2086414|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2086415|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2086416|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
2086417|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086418|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086419|NCT02157948|Denosumab|denosumab|mesh-list
2086420|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2086421|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086422|NCT02158039|Ethanol|ethanol|mesh-list
2086423|NCT02158039|Lidocaine|lidocaine|mesh-list
2086424|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
2086425|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
2086426|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086427|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086428|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
2086429|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086430|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2086431|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2086432|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2086433|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2086434|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086435|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2086436|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086437|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
2086438|NCT02158091|Rituximab|rituximab|mesh-list
2086439|NCT02158091|Fludarabine|fludarabine|mesh-list
2086440|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2086441|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
2086442|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224037|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224038|NCT00048425|Protective Agents|protective agents|mesh-ancestor
2224039|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674208|NCT03140709|Oxytocin|oxytocin|mesh-list
674209|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
674210|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
674211|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674466|NCT03139305|Glucagon|glucagon|mesh-list
674467|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
674468|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
674469|NCT03139305|Hormones|hormones|mesh-ancestor
674470|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
674471|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674472|NCT03139305|Incretins|incretins|mesh-ancestor
674678|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
674679|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
674680|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675496|NCT03134196|Valacyclovir|valacyclovir|mesh-list
675497|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
675498|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
672395|NCT03150459|Rifaximin|rifaximin|mesh-list
672396|NCT03150459|Simvastatin|simvastatin|mesh-list
672397|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
672398|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
672399|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
672400|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672401|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
672402|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
672403|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672404|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
672405|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
672406|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2224040|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2224041|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224042|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224043|NCT00048503|Tipifarnib|tipifarnib|mesh-list
2224044|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224045|NCT00048555|Galiximab|galiximab|mesh-list
2224046|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
672686|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
672691|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
672692|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
672693|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
672694|NCT03149107|Expectorants|expectorants|mesh-ancestor
672695|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
672696|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
672697|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
672698|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672699|NCT03149107|Protective Agents|protective agents|mesh-ancestor
672700|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672701|NCT03149107|Antidotes|antidotes|mesh-ancestor
672858|NCT03148444|Cephalexin|cephalexin|mesh-list
672859|NCT03148444|Roxithromycin|roxithromycin|mesh-list
672860|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
672861|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086443|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2086444|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2086445|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
673209|NCT03146000|Meloxicam|meloxicam|mesh-list
673210|NCT03146000|Lidocaine|lidocaine|mesh-list
673211|NCT03146000|Prilocaine|prilocaine|mesh-list
673212|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
673213|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
673214|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
673215|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673216|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673217|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
673218|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673219|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
673220|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
673221|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
673222|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
673223|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673224|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
673225|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
673226|NCT03146000|Analgesics|analgesics|mesh-ancestor
673227|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
673228|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
673229|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
673230|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
673231|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673232|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
673443|NCT03144596|Tamsulosin|tamsulosin|mesh-list
672000|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672001|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
672002|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
672003|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
672081|NCT03151304|Azacitidine|azacitidine|mesh-list
672082|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
672083|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
672084|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672085|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672086|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672207|NCT03150680|Clopidogrel|clopidogrel|mesh-list
672208|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
672209|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
672210|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
672211|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
672212|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
672213|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
672214|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672215|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086446|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086447|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086448|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2086449|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2086450|NCT02158273|Fenofibrate|fenofibrate|mesh-list
2086451|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2086452|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
2086453|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673293|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
673294|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673548|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
673549|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
673550|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674130|NCT03140943|Thalidomide|thalidomide|mesh-list
674131|NCT03140943|Dexamethasone|dexamethasone|mesh-list
674132|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
674133|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
674134|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
674135|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674136|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674137|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
674138|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
674139|NCT03140943|Hormones|hormones|mesh-ancestor
674140|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
674141|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
674142|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674143|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
674144|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
674145|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
674146|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
674147|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
674148|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
674149|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
674150|NCT03140943|Growth Substances|growth substances|mesh-ancestor
674151|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
2086454|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2086455|NCT02158364|Vaccines|vaccines|mesh-list
2086456|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
2224047|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224048|NCT00048594|Aprepitant|aprepitant|mesh-list
2224049|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
2224050|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
2224051|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224052|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224053|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2224054|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2224055|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2224056|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224057|NCT00048607|Aprepitant|aprepitant|mesh-list
2224058|NCT00048607|Paroxetine|paroxetine|mesh-list
2224059|NCT00048607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2224060|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2224061|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
675442|NCT03134573|Interferons|interferons|mesh-list
675443|NCT03134573|Interferon-beta|interferon-beta|mesh-list
675444|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
672020|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
672021|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
672022|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
672023|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
672024|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
672025|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
672026|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672027|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672028|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
672029|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
672030|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
672031|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
672032|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
672033|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
672034|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2224062|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224063|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2224064|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
2224065|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224066|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
672626|NCT03149640|Amikacin|amikacin|mesh-list
672627|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
672628|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
672733|NCT03148561|Misoprostol|misoprostol|mesh-list
672734|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
672735|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
672736|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
672737|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672738|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
672739|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
672740|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
672862|NCT03148366|Levofloxacin|levofloxacin|mesh-list
672863|NCT03148366|Ofloxacin|ofloxacin|mesh-list
672864|NCT03148366|Bismuth|bismuth|mesh-list
672865|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
672866|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
672867|NCT03148366|Renal Agents|renal agents|mesh-ancestor
672868|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
672869|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
672870|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
672871|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672872|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672873|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672874|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
672875|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
672876|NCT03148366|Antacids|antacids|mesh-ancestor
672877|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
673263|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
673264|NCT03145714|Anesthetics|anesthetics|mesh-list
673265|NCT03145714|Propofol|propofol|mesh-list
673266|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673267|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673268|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
673269|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
673270|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
673271|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
673272|NCT03145714|Analgesics|analgesics|mesh-ancestor
673273|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
673274|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673275|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
673276|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
673277|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
673278|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
673279|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
673280|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673462|NCT03144882|Curcumin|curcumin|mesh-list
673463|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
673464|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
673465|NCT03144882|Analgesics|analgesics|mesh-ancestor
673466|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
673467|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673468|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673469|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
672052|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
672916|NCT03147963|Docetaxel|docetaxel|mesh-list
672917|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
672918|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
672919|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
672920|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
672921|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672926|NCT03147599|Mebeverine|mebeverine|mesh-list
672927|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
672928|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
672929|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
672930|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
672931|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673144|NCT03146689|Ibuprofen|ibuprofen|mesh-list
673145|NCT03146689|Capsaicin|capsaicin|mesh-list
673146|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
673147|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
673148|NCT03146689|Analgesics|analgesics|mesh-ancestor
673149|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
673150|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673151|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673152|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
673153|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
673154|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
673155|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673156|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673157|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
673158|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
673196|NCT03146247|Apremilast|apremilast|mesh-list
673197|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
673198|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
673199|NCT03146247|Analgesics|analgesics|mesh-ancestor
673200|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
673201|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673202|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673203|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
673204|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
673205|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
673206|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
673207|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673208|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673426|NCT03145012|Ranitidine|ranitidine|mesh-list
673427|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
673428|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
673429|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
673430|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
673431|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
673432|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
673433|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
673434|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673435|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673803|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
673804|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
673805|NCT03142607|Metronidazole|metronidazole|mesh-list
673806|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
673807|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673808|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
673809|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
673810|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
673811|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
673812|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
673977|NCT03141918|Curcumin|curcumin|mesh-list
673978|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
673979|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
673980|NCT03141918|Analgesics|analgesics|mesh-ancestor
673981|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
673982|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673983|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673984|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
673985|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
673986|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673987|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673988|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224067|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
2224068|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
672074|NCT03151369|Analgesics|analgesics|mesh-list
672075|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
672076|NCT03151369|Narcotics|narcotics|mesh-ancestor
672077|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672078|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672079|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
672080|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086457|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086458|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
2086459|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
2086460|NCT02158442|Ticarcillin|ticarcillin|mesh-list
672741|NCT03148717|Misoprostol|misoprostol|mesh-list
672742|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
672743|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
672744|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
672745|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672746|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
672747|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
672748|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
673001|NCT03147092|Losartan|losartan|mesh-list
673002|NCT03147092|Atenolol|atenolol|mesh-list
673003|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
673004|NCT03147092|Clonidine|clonidine|mesh-list
673005|NCT03147092|Captopril|captopril|mesh-list
673006|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
673007|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
673008|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
673009|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
673010|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673011|NCT03147092|Diuretics|diuretics|mesh-ancestor
673012|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
673013|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673014|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
673015|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
673016|NCT03147092|Analgesics|analgesics|mesh-ancestor
673017|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
673018|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673019|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
673020|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
673021|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
673022|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
673023|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
673024|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
673025|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
673026|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
673027|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
673028|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
673029|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
673030|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
673031|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224069|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2224070|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2224071|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224072|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
2224073|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
2224074|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224075|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2224076|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
672372|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
672373|NCT03150316|Growth Substances|growth substances|mesh-ancestor
672374|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
672375|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
672659|NCT03149211|UB-421|ub-421|mesh-list
672660|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
672661|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
672662|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673048|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
673049|NCT03147196|Bicalutamide|bicalutamide|mesh-list
673050|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
673051|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
673052|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
673053|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673054|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673055|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
673056|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
673057|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
673058|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2224077|NCT00048646|Progesterone|progesterone|mesh-list
2224078|NCT00048646|Progestins|progestins|mesh-ancestor
2224079|NCT00048646|Hormones|hormones|mesh-ancestor
673551|NCT03143946|Vitamins|vitamins|mesh-list
673552|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
673553|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673775|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
673776|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
673777|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673778|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673779|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
673780|NCT03143010|Analgesics|analgesics|mesh-ancestor
673781|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
673782|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673783|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
673784|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
673785|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
673786|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
673787|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
673788|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673964|NCT03142035|Dienogest|dienogest|mesh-list
673965|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
673966|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
673967|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
673968|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673969|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
673970|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
673971|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
673972|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
673973|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
673974|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
673975|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
673976|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674079|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
674080|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
674081|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
674082|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
674083|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
674212|NCT03140488|Oxytocin|oxytocin|mesh-list
674213|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
674214|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
674215|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674573|NCT03138720|Gemcitabine|gemcitabine|mesh-list
674574|NCT03138720|Paclitaxel|paclitaxel|mesh-list
674575|NCT03138720|Cisplatin|cisplatin|mesh-list
674576|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
674577|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
674578|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674579|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
674580|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
674581|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
674582|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674583|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
674584|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
674585|NCT03138720|Antiviral Agents|antiviral agents|mesh-ancestor
674586|NCT03138720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
672466|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2224080|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2224081|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224082|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
2224083|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
672922|NCT03147638|Warfarin|warfarin|mesh-list
672923|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
673312|NCT03145675|Enoxaparin|enoxaparin|mesh-list
673313|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
673314|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
673315|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
673316|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
673317|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673329|NCT03145272|Oxycodone|oxycodone|mesh-list
673330|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
673331|NCT03145272|Narcotics|narcotics|mesh-ancestor
673332|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673333|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673334|NCT03145272|Analgesics|analgesics|mesh-ancestor
673335|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
673336|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673919|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
673920|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
673921|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
673922|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673923|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673924|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
673925|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673926|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
673927|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2086461|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2086462|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086463|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086464|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2086465|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086466|NCT02158520|Paclitaxel|paclitaxel|mesh-list
2086467|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2086468|NCT02158520|Bevacizumab|bevacizumab|mesh-list
2086469|NCT02158520|Ipilimumab|ipilimumab|mesh-list
2086470|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2086471|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
2086472|NCT02158520|Antibodies|antibodies|mesh-list
674461|NCT03139513|Vemurafenib|vemurafenib|mesh-list
674462|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674463|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
674464|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674465|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086473|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
2086474|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2086475|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
2086476|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2086477|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674843|NCT03137368|Tamoxifen|tamoxifen|mesh-list
674844|NCT03137368|Exemestane|exemestane|mesh-list
674845|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
674846|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
674847|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
674848|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674849|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
674850|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674851|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
674852|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
674853|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
674857|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
674858|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
674859|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674860|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675159|NCT03136120|Bromides|bromides|mesh-list
675160|NCT03136120|Ipratropium|ipratropium|mesh-list
675161|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
675162|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
675163|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
2086478|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
672614|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672615|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
672966|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
672967|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
672968|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672969|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
673162|NCT03146468|Nivolumab|nivolumab|mesh-list
673163|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
673164|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673165|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
673166|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673233|NCT03146052|Simethicone|simethicone|mesh-list
673234|NCT03146052|Bisacodyl|bisacodyl|mesh-list
673235|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673236|NCT03146052|Cathartics|cathartics|mesh-ancestor
673237|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
673238|NCT03146052|Laxatives|laxatives|mesh-ancestor
673239|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
673240|NCT03146052|Emollients|emollients|mesh-ancestor
673241|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
673438|NCT03144856|Apatinib|apatinib|mesh-list
673439|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673440|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
673441|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673442|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674103|NCT03141203|Romidepsin|romidepsin|mesh-list
674104|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
674105|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224084|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224085|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
2224086|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224087|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2224088|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674620|NCT03138785|Itraconazole|itraconazole|mesh-list
674621|NCT03138785|Voriconazole|voriconazole|mesh-list
674622|NCT03138785|Levofloxacin|levofloxacin|mesh-list
674623|NCT03138785|Ofloxacin|ofloxacin|mesh-list
674624|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
674625|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
674626|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
674627|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
674628|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674629|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674630|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
674631|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
674632|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
674633|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674634|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
674635|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
674636|NCT03138785|Renal Agents|renal agents|mesh-ancestor
674637|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
674638|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
674639|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
674640|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674641|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
674709|NCT03138161|Nivolumab|nivolumab|mesh-list
674710|NCT03138161|Ipilimumab|ipilimumab|mesh-list
674711|NCT03138161|Trabectedin|trabectedin|mesh-list
674712|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
674713|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674714|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
674715|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674716|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
674717|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
674833|NCT03137290|Neostigmine|neostigmine|mesh-list
674834|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
674835|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674836|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674837|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
674838|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
674839|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674840|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
674841|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
674842|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224089|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673281|NCT03145610|Triclosan|triclosan|mesh-list
673282|NCT03145610|Fluorides|fluorides|mesh-list
673283|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
673284|NCT03145610|Protective Agents|protective agents|mesh-ancestor
673285|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673286|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
673287|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673288|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
673289|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
673290|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
673291|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673292|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
673583|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
673584|NCT03143972|Remifentanil|remifentanil|mesh-list
673585|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
673586|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673587|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673588|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
673589|NCT03143972|Analgesics|analgesics|mesh-ancestor
673590|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
673591|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673592|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
673593|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
673594|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
673595|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
673596|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
673597|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673598|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
673599|NCT03143972|Narcotics|narcotics|mesh-ancestor
673763|NCT03142763|Choline|choline|mesh-list
673764|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
673765|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
673766|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
673767|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673768|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
673769|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
673770|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
2224090|NCT00048750|Micafungin|micafungin|mesh-list
2224091|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
2224092|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224093|NCT00048763|Cilostazol|cilostazol|mesh-list
2224094|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2224095|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
2224096|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224097|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224098|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2224099|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
2224100|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2224101|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2224102|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224103|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2224104|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
2224105|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2224106|NCT00048763|Protective Agents|protective agents|mesh-ancestor
2224107|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2086479|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
2086480|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
2086481|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086482|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2086483|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2086484|NCT02158520|Growth Substances|growth substances|mesh-ancestor
2224108|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2224109|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675635|NCT03133325|Lidocaine|lidocaine|mesh-list
675636|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
675637|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
675638|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675639|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675640|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
675641|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675642|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
675643|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
675644|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
672822|NCT03148522|Analgesics|analgesics|mesh-ancestor
672823|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
672824|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
672825|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
672826|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
672827|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
672828|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
672829|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
672830|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672831|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
672832|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
672833|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
672834|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
672835|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
672836|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
672837|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2224110|NCT00048776|Cilostazol|cilostazol|mesh-list
2224111|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2224112|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
673260|NCT03145623|Grazoprevir|grazoprevir|mesh-list
673261|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
673262|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673356|NCT03145467|Acetaminophen|acetaminophen|mesh-list
673357|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
673358|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
673359|NCT03145467|Analgesics|analgesics|mesh-ancestor
673360|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
673361|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673362|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673363|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
673364|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
673365|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
673366|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
673367|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
673368|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673436|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
673437|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2086485|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086486|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
2086487|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
2086488|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2086489|NCT02158533|Naltrexone|naltrexone|mesh-list
2086490|NCT02158533|Buprenorphine|buprenorphine|mesh-list
2086491|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2086492|NCT02158533|Narcotics|narcotics|mesh-ancestor
673631|NCT03143465|Calcitonin|calcitonin|mesh-list
673632|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
673633|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
673634|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
673635|NCT03143465|Katacalcin|katacalcin|mesh-list
673636|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
673637|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
673638|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
673639|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673640|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673641|NCT03143465|Urological Agents|urological agents|mesh-ancestor
673642|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
673643|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673644|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
673938|NCT03142542|Udenafil|udenafil|mesh-list
673939|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
673940|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
673941|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673942|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674120|NCT03140956|Levodopa|levodopa|mesh-list
674121|NCT03140956|Carbidopa|carbidopa|mesh-list
674122|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
674123|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
674124|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
674125|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
674126|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674127|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674128|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
674129|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086493|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
672891|NCT03148132|Growth Substances|growth substances|mesh-ancestor
672892|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672893|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
673167|NCT03146481|Aceclofenac|aceclofenac|mesh-list
673168|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
673169|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
673170|NCT03146481|Analgesics|analgesics|mesh-ancestor
673171|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
673172|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673173|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673174|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
673175|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
673304|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
673305|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
673306|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673385|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
673386|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673387|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
673388|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673389|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673390|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
673391|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
673392|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673393|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
673571|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
673572|NCT03143998|Grazoprevir|grazoprevir|mesh-list
673573|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
673574|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673645|NCT03143491|Paclitaxel|paclitaxel|mesh-list
673646|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
673647|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673648|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
673649|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
673650|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
673651|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673698|NCT03143036|Thalidomide|thalidomide|mesh-list
673699|NCT03143036|Dexamethasone|dexamethasone|mesh-list
673700|NCT03143036|Daratumumab|daratumumab|mesh-list
673701|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
673702|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
673703|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
673704|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673705|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673706|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
673707|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
673708|NCT03143036|Hormones|hormones|mesh-ancestor
673709|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
673710|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
673711|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673712|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
673713|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
673714|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
673715|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
673716|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673717|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
673718|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
673719|NCT03143036|Growth Substances|growth substances|mesh-ancestor
673720|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
2086494|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086495|NCT02158533|Analgesics|analgesics|mesh-ancestor
2086496|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
2086497|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086498|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2086499|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2086500|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
674248|NCT03140332|Sorafenib|sorafenib|mesh-list
674249|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674250|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
674251|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674252|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674544|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2224113|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224114|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224115|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
672973|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
672974|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
672975|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
672976|NCT03146962|Protective Agents|protective agents|mesh-ancestor
673859|NCT03142893|Ketoconazole|ketoconazole|mesh-list
673860|NCT03142893|Dexamethasone|dexamethasone|mesh-list
673861|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
673862|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
673863|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
673864|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
673865|NCT03142893|Hormones|hormones|mesh-list
673866|NCT03142893|Cosyntropin|cosyntropin|mesh-list
673867|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
673868|NCT03142893|BB 1101|bb 1101|mesh-list
673869|NCT03142893|Ganirelix|ganirelix|mesh-list
673870|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
673871|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
673872|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
673873|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673874|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673875|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
673876|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
673877|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
673878|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
673879|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673880|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
673881|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673882|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673883|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
673884|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673885|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
673886|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
673887|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
673888|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
673889|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
673928|NCT03142139|Vaccines|vaccines|mesh-list
673929|NCT03142139|Immunologic Factors|immunologic factors|mesh-ancestor
673930|NCT03142139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224116|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
2224117|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2224118|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2224119|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086501|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2086502|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086503|NCT02158806|Aspirin|aspirin|mesh-list
2086504|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2086505|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2086506|NCT02158806|Analgesics|analgesics|mesh-ancestor
2086507|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
674426|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
674427|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
674428|NCT03139422|Calcium|calcium|mesh-list
674429|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
674430|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674431|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
674432|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
674433|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674434|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
674435|NCT03139422|Coagulants|coagulants|mesh-ancestor
674613|NCT03138668|Ropivacaine|ropivacaine|mesh-list
674614|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
674615|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
674616|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674617|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674618|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
674619|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224120|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2224121|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
2224122|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2224123|NCT00048776|Protective Agents|protective agents|mesh-ancestor
2224124|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2224125|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2224126|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224127|NCT00048802|Valproic Acid|valproic acid|mesh-list
675235|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
673079|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
673080|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
673081|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
673082|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673083|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
673084|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
673085|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
673086|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673087|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673088|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
673089|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
673090|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
673091|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
673092|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
673093|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
673094|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
673095|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673096|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
673097|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
673098|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
673099|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
673100|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673101|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
673102|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
673103|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
673104|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
673105|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2224128|NCT00048802|Olanzapine|olanzapine|mesh-list
2224129|NCT00048802|Risperidone|risperidone|mesh-list
2224130|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2224131|NCT00048802|Ziprasidone|ziprasidone|mesh-list
2224132|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2224133|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
673892|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
673893|NCT03142165|Promethazine|promethazine|mesh-list
673894|NCT03142165|Famotidine|famotidine|mesh-list
673895|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
673896|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
673897|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673898|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673899|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
673900|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
673901|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
673902|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673903|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
673904|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
673905|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
673906|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
673907|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
673908|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
673909|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
673910|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673911|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
673912|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
673913|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
673914|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
673915|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2086508|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086509|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086510|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2086511|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2086512|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2086513|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2086514|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086515|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2086516|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2086517|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086518|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
2086519|NCT02158936|Azacitidine|azacitidine|mesh-list
2086520|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2086521|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
2224134|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2224135|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674305|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
674306|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
674307|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224136|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224137|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2224138|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2224139|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673295|NCT03146104|Propofol|propofol|mesh-list
673296|NCT03146104|Isoflurane|isoflurane|mesh-list
673297|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
673298|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673299|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673300|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
673301|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
673302|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
673303|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
673406|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
673407|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
673408|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
673409|NCT03145025|Hormones|hormones|mesh-ancestor
673410|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
673411|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673953|NCT03141970|Prednisone|prednisone|mesh-list
673954|NCT03141970|Prednisolone|prednisolone|mesh-list
673955|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
673956|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
673957|NCT03141970|Hormones|hormones|mesh-ancestor
673958|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
673959|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673960|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
673961|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674023|NCT03141671|Prednisone|prednisone|mesh-list
674024|NCT03141671|Bicalutamide|bicalutamide|mesh-list
674025|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
674026|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
674027|NCT03141671|Hormones|hormones|mesh-ancestor
674028|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
674029|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674030|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
674031|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674032|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
674033|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
2224140|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2224141|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2224142|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
2224143|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
2224144|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
2224145|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224146|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2224147|NCT00048802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2224148|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2224149|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2224150|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
2224151|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224152|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
2224153|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
2224154|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
2224155|NCT00048828|Olanzapine|olanzapine|mesh-list
2224156|NCT00048828|Clozapine|clozapine|mesh-list
2224157|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
2224158|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
2224159|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224160|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752460|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752461|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2752462|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224161|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2224162|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
675396|NCT03134612|Lidocaine|lidocaine|mesh-list
675397|NCT03134612|Ondansetron|ondansetron|mesh-list
675398|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
675399|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
675400|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675401|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675402|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
2224163|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2224164|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673176|NCT03146377|Capecitabine|capecitabine|mesh-list
673177|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
673178|NCT03146377|Irinotecan|irinotecan|mesh-list
673179|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
673180|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
673181|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673182|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673183|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
673184|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
673185|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673369|NCT03145584|Bupivacaine|bupivacaine|mesh-list
673370|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
673371|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
673372|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673373|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673374|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
673375|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224165|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2224166|NCT00048828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2224167|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2224168|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2224169|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224170|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2224171|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
2224172|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2224173|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
673916|NCT03142360|Beraprost|beraprost|mesh-list
673917|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
673918|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
673950|NCT03141827|Insulin|insulin|mesh-list
673951|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
673952|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674106|NCT03140982|Propofol|propofol|mesh-list
674107|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
674108|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674109|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674110|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
674111|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
674112|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
674282|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
674283|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
674284|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
674285|NCT03140397|Estrogens|estrogens|mesh-ancestor
674286|NCT03140397|Hormones|hormones|mesh-ancestor
674287|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
674288|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674735|NCT03137615|Anesthetics|anesthetics|mesh-list
674736|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
674737|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674738|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674739|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
674740|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675013|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
675014|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
675015|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
675016|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
675017|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675018|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
675019|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
675020|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675021|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2224174|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
2224175|NCT00048841|Alendronate|alendronate|mesh-list
2224176|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2224177|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224178|NCT00048854|Sertraline|sertraline|mesh-list
2224179|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
673668|NCT03143244|Ketorolac|ketorolac|mesh-list
673669|NCT03143244|Midazolam|midazolam|mesh-list
673670|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
673671|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
673672|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673673|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673674|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
673675|NCT03143244|Analgesics|analgesics|mesh-ancestor
673676|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
673677|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673678|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
673679|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
673680|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
673681|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
673682|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
673683|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673684|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
673685|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
673686|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
673687|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
673688|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
673689|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
673690|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
673691|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
673692|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
673693|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
673694|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
673695|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
673696|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
673697|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673890|NCT03142321|Vedolizumab|vedolizumab|mesh-list
673891|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
674009|NCT03141658|Ketamine|ketamine|mesh-list
674010|NCT03141658|Analgesics|analgesics|mesh-ancestor
674011|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
674012|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674013|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674014|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
674015|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
674016|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
674017|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
674018|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674019|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
674020|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
674021|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
674022|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674216|NCT03140423|Mupirocin|mupirocin|mesh-list
674217|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
674218|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
674219|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
674220|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674221|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674404|NCT03139591|Dexamethasone|dexamethasone|mesh-list
674405|NCT03139591|Lidocaine|lidocaine|mesh-list
674406|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
674407|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
674408|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
674409|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674410|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674411|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
674412|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
674413|NCT03139591|Hormones|hormones|mesh-ancestor
674414|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
674415|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
674416|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674417|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
674418|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
674419|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674420|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
2224180|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
673379|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
673380|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
673381|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
673382|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
673383|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673384|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673496|NCT03144778|Durvalumab|durvalumab|mesh-list
673497|NCT03144778|Ipilimumab|ipilimumab|mesh-list
673498|NCT03144778|Tremelimumab|tremelimumab|mesh-list
673499|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
673500|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
673501|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
673502|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
673503|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673504|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
673505|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673506|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
673507|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673539|NCT03144128|Vitamin D|vitamin d|mesh-list
673540|NCT03144128|Vitamins|vitamins|mesh-ancestor
673541|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
673542|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673543|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
673721|NCT03143153|Fluorouracil|fluorouracil|mesh-list
673722|NCT03143153|Nivolumab|nivolumab|mesh-list
673723|NCT03143153|Ipilimumab|ipilimumab|mesh-list
673724|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673725|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
673726|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673727|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
673728|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
673729|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
673730|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673731|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
673732|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2086522|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086523|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086524|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086525|NCT02158975|Ixazomib|ixazomib|mesh-list
2086526|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086527|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
2086528|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086529|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086530|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2086531|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
2086532|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086533|NCT02159352|Ritonavir|ritonavir|mesh-list
2086534|NCT02159352|Lopinavir|lopinavir|mesh-list
2086535|NCT02159352|Darunavir|darunavir|mesh-list
2086536|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2086537|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2086538|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
2086539|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086540|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086541|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2086542|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2086543|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
675435|NCT03134547|Sevoflurane|sevoflurane|mesh-list
675436|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
675437|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
675438|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
675439|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
675440|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675441|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675649|NCT03133221|Idelalisib|idelalisib|mesh-list
675650|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675651|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675652|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675679|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
675680|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
675681|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
675682|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
676015|NCT03131973|Leucovorin|leucovorin|mesh-list
676016|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
676017|NCT03131973|Methotrexate|methotrexate|mesh-list
676018|NCT03131973|Digoxin|digoxin|mesh-list
676019|NCT03131973|Midazolam|midazolam|mesh-list
673422|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
673423|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
673424|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673425|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
674075|NCT03141476|Cefuroxime|cefuroxime|mesh-list
674076|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
674077|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
674078|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
674436|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
674437|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
674438|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
674439|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
674568|NCT03138759|Probenecid|probenecid|mesh-list
674569|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
674570|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
674571|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
674572|NCT03138759|Renal Agents|renal agents|mesh-ancestor
674732|NCT03137667|Vaccines|vaccines|mesh-list
674733|NCT03137667|Immunologic Factors|immunologic factors|mesh-ancestor
674734|NCT03137667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675828|NCT03132233|Calcium|calcium|mesh-list
675829|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
675830|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676103|NCT03131622|Coal Tar|coal tar|mesh-list
676104|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
676105|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
2224181|NCT00048854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2224182|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2224183|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2224184|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224185|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
676299|NCT03130179|Nicotine|nicotine|mesh-list
676300|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
676301|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
676302|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676303|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676304|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
676305|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
676306|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
676307|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
676308|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224186|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
676951|NCT03126578|Midazolam|midazolam|mesh-list
676952|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
676953|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
676954|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676955|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676956|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
676957|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
676958|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
676959|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
676960|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
676961|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
676962|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
676963|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
676964|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
676965|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677095|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
677096|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
677097|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
677098|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677099|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
677100|NCT03126422|Analgesics|analgesics|mesh-ancestor
677101|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
677102|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
677103|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
677104|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
677105|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
677106|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
677107|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
677108|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677151|NCT03126123|Acetic Acid|acetic acid|mesh-list
677152|NCT03126123|Retinol acetate|retinol acetate|mesh-list
677153|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
677154|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
677155|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
673444|NCT03144596|Alfuzosin|alfuzosin|mesh-list
673445|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
673446|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
673447|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
673448|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
673449|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
673450|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673451|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673452|NCT03144596|Urological Agents|urological agents|mesh-ancestor
673607|NCT03143738|Anesthetics|anesthetics|mesh-list
673608|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673609|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674529|NCT03139500|Midazolam|midazolam|mesh-list
674530|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
674531|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
674532|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674533|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674534|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
674535|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
674536|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
674537|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
674538|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
674539|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
674540|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
674541|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
674542|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
674543|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674696|NCT03138356|Metformin|metformin|mesh-list
674697|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
674698|NCT03138356|Saxagliptin|saxagliptin|mesh-list
674699|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
674700|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674701|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
674702|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674703|NCT03138356|Incretins|incretins|mesh-ancestor
674704|NCT03138356|Hormones|hormones|mesh-ancestor
674705|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
674706|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
674707|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
674708|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224187|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224188|NCT00048880|Antibodies|antibodies|mesh-list
2224189|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2224190|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
2224191|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224192|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2224193|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
2224194|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224195|NCT00049023|Octreotide|octreotide|mesh-list
2224196|NCT00049023|Edotreotide|edotreotide|mesh-list
2224197|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2224198|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2224199|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224200|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2224201|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674942|NCT03136666|Candesartan|candesartan|mesh-list
674943|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
674944|NCT03136666|Nifedipine|nifedipine|mesh-list
674945|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
674946|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
674947|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
674948|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674949|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
674950|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
674951|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
674952|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674953|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
674954|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
674955|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
675230|NCT03135301|Metformin|metformin|mesh-list
675231|NCT03135301|Letrozole|letrozole|mesh-list
675232|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
675233|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675234|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224202|NCT00049062|Gefitinib|gefitinib|mesh-list
673470|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
673471|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673472|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673473|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673531|NCT03144401|Misoprostol|misoprostol|mesh-list
673532|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
673533|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
673534|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
673535|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673536|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
673537|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
673538|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
673600|NCT03143530|Ropivacaine|ropivacaine|mesh-list
673601|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
673602|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
673603|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673604|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673605|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
673606|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
673748|NCT03142880|Ropivacaine|ropivacaine|mesh-list
673749|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
673750|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
673751|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
673752|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673753|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
673754|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674727|NCT03137888|Temozolomide|temozolomide|mesh-list
674728|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
674729|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
674730|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674731|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674810|NCT03137407|Botulinum Toxins|botulinum toxins|mesh-list
674811|NCT03137407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
674812|NCT03137407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
674813|NCT03137407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
674814|NCT03137407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
674815|NCT03137407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674816|NCT03137407|Cholinergic Agents|cholinergic agents|mesh-ancestor
674817|NCT03137407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
674818|NCT03137407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674819|NCT03137407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
674820|NCT03137407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674923|NCT03137030|Acetaminophen|acetaminophen|mesh-list
674924|NCT03137030|Hydrocodone|hydrocodone|mesh-list
674925|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
674926|NCT03137030|Analgesics|analgesics|mesh-ancestor
674927|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
674928|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674929|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674930|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
674931|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
674932|NCT03137030|Narcotics|narcotics|mesh-ancestor
674933|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674934|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
674935|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
674973|NCT03136705|Niacinamide|niacinamide|mesh-list
674974|NCT03136705|Niacin|niacin|mesh-list
674975|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
674976|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
674977|NCT03136705|Vitamins|vitamins|mesh-ancestor
674978|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
674979|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674980|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
674981|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
674982|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674983|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
674984|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
2224203|NCT00049062|Anastrozole|anastrozole|mesh-list
2224204|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224205|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2224206|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224207|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224208|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2224209|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2224210|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
673735|NCT03143023|Protective Agents|protective agents|mesh-ancestor
673736|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673737|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
673738|NCT03142646|Fludarabine|fludarabine|mesh-list
673739|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
673740|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
673741|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673742|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
673743|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
673744|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
673745|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673746|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673747|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
674295|NCT03140176|Sunitinib|sunitinib|mesh-list
674296|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674297|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
674298|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
674299|NCT03140176|Growth Substances|growth substances|mesh-ancestor
674300|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674301|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
674302|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
674303|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674304|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674520|NCT03139331|Irinotecan|irinotecan|mesh-list
674521|NCT03139331|Temozolomide|temozolomide|mesh-list
674522|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
674523|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
674524|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674525|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674526|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674527|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
674528|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
674718|NCT03137966|Deferoxamine|deferoxamine|mesh-list
674719|NCT03137966|Siderophores|siderophores|mesh-ancestor
674720|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
674721|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
674722|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
674723|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674765|NCT03137498|Ketorolac|ketorolac|mesh-list
674766|NCT03137498|Lidocaine|lidocaine|mesh-list
674767|NCT03137498|Prilocaine|prilocaine|mesh-list
674768|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
674769|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
674770|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674771|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674772|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
674773|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674774|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
674775|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
674776|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
674777|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
674778|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674779|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
674780|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
674781|NCT03137498|Analgesics|analgesics|mesh-ancestor
674782|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
674783|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
674784|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
674785|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674990|NCT03136510|Apixaban|apixaban|mesh-list
674991|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
674992|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
674993|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
674994|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
674995|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674996|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674997|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
2224211|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
673772|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
673773|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673774|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
674006|NCT03141632|Dulaglutide|dulaglutide|mesh-list
674007|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
674008|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675227|NCT03135340|Anesthetics|anesthetics|mesh-list
675228|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675229|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675315|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
675316|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
675317|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675318|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
675319|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675320|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675361|NCT03134651|Propofol|propofol|mesh-list
675362|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
675363|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675364|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675365|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
675366|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
675367|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
675458|NCT03134417|Vitamin D|vitamin d|mesh-list
675459|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
675460|NCT03134417|Vitamins|vitamins|mesh-list
675461|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
675462|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675463|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
675464|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
675647|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
675648|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224212|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
2224213|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2224214|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224215|NCT00049075|Fludarabine|fludarabine|mesh-list
2224216|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
2224217|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676177|NCT03130855|Carticaine|carticaine|mesh-list
676178|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
676179|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
676180|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676181|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676182|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
676183|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676491|NCT03129009|Anesthetics|anesthetics|mesh-list
676492|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676493|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677002|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
677003|NCT03126656|Testosterone|testosterone|mesh-list
677004|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
677005|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
677006|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
677007|NCT03126656|Androgens|androgens|mesh-ancestor
677008|NCT03126656|Hormones|hormones|mesh-ancestor
677009|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
677010|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677011|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
677012|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677013|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
677335|NCT03125473|Vaccines|vaccines|mesh-list
677336|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
677337|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677579|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
677580|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
677581|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
677582|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677671|NCT03123445|Gemcitabine|gemcitabine|mesh-list
677672|NCT03123445|Endostar protein|endostar protein|mesh-list
677673|NCT03123445|Endostatins|endostatins|mesh-list
677674|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677675|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
677676|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
677677|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677678|NCT03123445|Antiviral Agents|antiviral agents|mesh-ancestor
677679|NCT03123445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
673796|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
674350|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
674351|NCT03139708|Phenylephrine|phenylephrine|mesh-list
674352|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
674353|NCT03139708|Tropicamide|tropicamide|mesh-list
674354|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
674355|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
674356|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
674357|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674358|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674359|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
674360|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
674361|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
674362|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
674363|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
674364|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
674365|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
674366|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
674367|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
674368|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674369|NCT03139708|Protective Agents|protective agents|mesh-ancestor
674370|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
674371|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
674372|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
674373|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
674374|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
674691|NCT03138031|Ethanol|ethanol|mesh-list
674692|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
674693|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
674694|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674695|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675128|NCT03136029|Antioxidants|antioxidants|mesh-list
675129|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675130|NCT03136029|Protective Agents|protective agents|mesh-ancestor
675131|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675246|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
675247|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675248|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675336|NCT03134872|Carboplatin|carboplatin|mesh-list
675337|NCT03134872|Pemetrexed|pemetrexed|mesh-list
675338|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675339|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675340|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675341|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
675342|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
675683|NCT03133299|Vitamin D|vitamin d|mesh-list
675684|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
675685|NCT03133299|Vitamins|vitamins|mesh-ancestor
675686|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
675687|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675688|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
675689|NCT03133299|Hormones|hormones|mesh-ancestor
675690|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
675923|NCT03132051|Triamcinolone|triamcinolone|mesh-list
675924|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
675925|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
675926|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
675927|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
675928|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
675929|NCT03132051|Hormones|hormones|mesh-ancestor
675930|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
675931|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675932|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
675933|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
675934|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675935|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676141|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
676142|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
676263|NCT03130452|Amoxicillin|amoxicillin|mesh-list
676264|NCT03130452|Metronidazole|metronidazole|mesh-list
676265|NCT03130452|Clarithromycin|clarithromycin|mesh-list
676266|NCT03130452|Lansoprazole|lansoprazole|mesh-list
676267|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
676268|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
676269|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
676270|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
673836|NCT03142516|Leucovorin|leucovorin|mesh-list
673837|NCT03142516|Folic Acid|folic acid|mesh-list
673838|NCT03142516|Fluorouracil|fluorouracil|mesh-list
673839|NCT03142516|Irinotecan|irinotecan|mesh-list
673840|NCT03142516|Panitumumab|panitumumab|mesh-list
673841|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
673842|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
673843|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
673844|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
673845|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
673846|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
673847|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
673848|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673849|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
673850|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
673851|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
673852|NCT03142516|Antidotes|antidotes|mesh-ancestor
673853|NCT03142516|Protective Agents|protective agents|mesh-ancestor
673854|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
673855|NCT03142516|Vitamins|vitamins|mesh-ancestor
673856|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
673857|NCT03142516|Hematinics|hematinics|mesh-ancestor
673858|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2086544|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086545|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2086546|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2086547|NCT02159365|Dexamethasone|dexamethasone|mesh-list
2086548|NCT02159365|Lenalidomide|lenalidomide|mesh-list
2086549|NCT02159365|Elotuzumab|elotuzumab|mesh-list
2086550|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2086551|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
2086552|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
675066|NCT03136406|Leucovorin|leucovorin|mesh-list
675067|NCT03136406|Paclitaxel|paclitaxel|mesh-list
675068|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
675069|NCT03136406|Bevacizumab|bevacizumab|mesh-list
675070|NCT03136406|Fluorouracil|fluorouracil|mesh-list
675071|NCT03136406|Capecitabine|capecitabine|mesh-list
675072|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
675073|NCT03136406|Avelumab|avelumab|mesh-list
675074|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
675075|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675076|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
675077|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
675078|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
675079|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675080|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
675081|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
675082|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675083|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
675084|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
675085|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
675086|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
675087|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675088|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
675089|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
675090|NCT03136406|Growth Substances|growth substances|mesh-ancestor
675091|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
675092|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
675093|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
675094|NCT03136406|Antidotes|antidotes|mesh-ancestor
675095|NCT03136406|Protective Agents|protective agents|mesh-ancestor
675096|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
675097|NCT03136406|Vitamins|vitamins|mesh-ancestor
675098|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
675242|NCT03135171|Trastuzumab|trastuzumab|mesh-list
675243|NCT03135171|Pertuzumab|pertuzumab|mesh-list
675244|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675245|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224218|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2224219|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
2224220|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224221|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224222|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
2224223|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224224|NCT00049088|Bevacizumab|bevacizumab|mesh-list
2086553|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086554|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
673994|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
673995|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
673996|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
673997|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
673998|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
673999|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
674000|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674001|NCT03141645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
674002|NCT03141645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
674003|NCT03141645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674004|NCT03141645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
674005|NCT03141645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
674058|NCT03141398|Pancrelipase|pancrelipase|mesh-list
674059|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
674152|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
674153|NCT03140553|Carboplatin|carboplatin|mesh-list
674154|NCT03140553|Docetaxel|docetaxel|mesh-list
674155|NCT03140553|Trastuzumab|trastuzumab|mesh-list
674156|NCT03140553|Epirubicin|epirubicin|mesh-list
674157|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
674158|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
674159|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674160|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
674161|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
674162|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
674163|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674164|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674165|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
674166|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
674167|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
674168|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
674169|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
674170|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
674171|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
674172|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
674173|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674609|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
674610|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
674611|NCT03138681|Protective Agents|protective agents|mesh-ancestor
674612|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674821|NCT03137316|Hormones|hormones|mesh-list
674822|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
674823|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
674824|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674825|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
674895|NCT03137017|Acetaminophen|acetaminophen|mesh-list
674896|NCT03137017|Hydrocodone|hydrocodone|mesh-list
674897|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
674898|NCT03137017|Analgesics|analgesics|mesh-ancestor
674899|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
674900|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674901|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674902|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
674903|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
674904|NCT03137017|Narcotics|narcotics|mesh-ancestor
674905|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674906|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
674907|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
675321|NCT03135106|Itraconazole|itraconazole|mesh-list
675322|NCT03135106|Fluconazole|fluconazole|mesh-list
675323|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
675324|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675325|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
675326|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
675327|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675328|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675329|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
675330|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
675331|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
675332|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675333|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
675334|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
675335|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
675539|NCT03133923|Vaccines|vaccines|mesh-list
675540|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
2086555|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086556|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
2086557|NCT02159365|Hormones|hormones|mesh-ancestor
2086558|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
674253|NCT03140293|Lidocaine|lidocaine|mesh-list
674254|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
674255|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
674256|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
674257|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674258|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674259|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
674260|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674261|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
674262|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
674263|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
674264|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
674265|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675172|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
675173|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
675174|NCT03136003|Coagulants|coagulants|mesh-ancestor
675175|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
675176|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
675177|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675509|NCT03133975|Vitamin D|vitamin d|mesh-list
675510|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
675511|NCT03133975|Vitamins|vitamins|mesh-ancestor
675512|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
675513|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675514|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
675515|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
676238|NCT03130634|Silymarin|silymarin|mesh-list
676239|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
676240|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676241|NCT03130634|Protective Agents|protective agents|mesh-ancestor
676242|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676378|NCT03129594|Glucagon|glucagon|mesh-list
676379|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
676380|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
676381|NCT03129594|Hormones|hormones|mesh-ancestor
676382|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
676383|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676384|NCT03129594|Incretins|incretins|mesh-ancestor
2086559|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2086560|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086561|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
2086562|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2086563|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2086564|NCT02159365|Growth Substances|growth substances|mesh-ancestor
2086565|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
2086566|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
2086567|NCT02159469|Testosterone|testosterone|mesh-list
2086568|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
2086569|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
2086570|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
676744|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
676745|NCT03127774|Antidotes|antidotes|mesh-ancestor
676746|NCT03127774|Protective Agents|protective agents|mesh-ancestor
676747|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676748|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
676749|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676750|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
676751|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
676752|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
676753|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
2086571|NCT02159469|Androgens|androgens|mesh-ancestor
674191|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
674192|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
674193|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
674194|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086572|NCT02159469|Hormones|hormones|mesh-ancestor
2086573|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2086574|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086575|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2086576|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086577|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
2086578|NCT02159482|Interferons|interferons|mesh-list
2086579|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
2086580|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
2086581|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086582|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
2086583|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086584|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
2086585|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086586|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
674962|NCT03136809|Copper|copper|mesh-list
674963|NCT03136809|Trace Elements|trace elements|mesh-ancestor
674964|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
674965|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675343|NCT03134729|Ropivacaine|ropivacaine|mesh-list
675344|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
675345|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
675346|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675347|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675348|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
675349|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675481|NCT03134339|Nicotine|nicotine|mesh-list
675482|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
675483|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
675484|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675485|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675486|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
675487|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
675488|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
675489|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
675490|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675595|NCT03133234|Osimertinib|osimertinib|mesh-list
675596|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675597|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
675598|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675599|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675737|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
675738|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
675739|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
675740|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
675741|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675742|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
675743|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
675744|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
675745|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675746|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675747|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
675748|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2086587|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2086588|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2086589|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086590|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2086591|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
677014|NCT03126812|Paclitaxel|paclitaxel|mesh-list
677015|NCT03126812|Carboplatin|carboplatin|mesh-list
677016|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
677017|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
677018|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677019|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
677020|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
677021|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
677022|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677023|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
677224|NCT03126084|Acetaminophen|acetaminophen|mesh-list
677225|NCT03126084|Tramadol|tramadol|mesh-list
674200|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
674201|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
674202|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
674379|NCT03139487|Dalteparin|dalteparin|mesh-list
674380|NCT03139487|Tinzaparin|tinzaparin|mesh-list
674381|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
674382|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
674383|NCT03139487|Apixaban|apixaban|mesh-list
674384|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
674385|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
674386|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
674387|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
674388|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674389|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674390|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
674391|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
674392|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
674886|NCT03137082|Guanfacine|guanfacine|mesh-list
674887|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
674888|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
674889|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
674890|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
674891|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
674892|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
674893|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674894|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675252|NCT03136146|Dexamethasone|dexamethasone|mesh-list
675253|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
675254|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
675255|NCT03136146|Rituximab|rituximab|mesh-list
675256|NCT03136146|Etoposide|etoposide|mesh-list
675257|NCT03136146|Vincristine|vincristine|mesh-list
675258|NCT03136146|Bortezomib|bortezomib|mesh-list
675259|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
675260|NCT03136146|Clofarabine|clofarabine|mesh-list
675261|NCT03136146|Ofatumumab|ofatumumab|mesh-list
675262|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
675263|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
675264|NCT03136146|Antibodies|antibodies|mesh-list
675265|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
675266|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
675267|NCT03136146|Lenograstim|lenograstim|mesh-list
675268|NCT03136146|BB 1101|bb 1101|mesh-list
675269|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
675270|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
675271|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675272|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
675273|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
675274|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
675275|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675276|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675277|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
675278|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
675279|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
675280|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
675281|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675282|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
675283|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
675284|NCT03136146|Hormones|hormones|mesh-ancestor
675285|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
675286|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
675287|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
675288|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675289|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
675290|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
675291|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
675292|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
675293|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
675294|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
675295|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
675296|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
675297|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
675298|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
675299|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
675542|NCT03133845|Fentanyl|fentanyl|mesh-list
675543|NCT03133845|Midazolam|midazolam|mesh-list
675544|NCT03133845|Morphine|morphine|mesh-list
675545|NCT03133845|Anesthetics|anesthetics|mesh-list
675546|NCT03133845|Propofol|propofol|mesh-list
675547|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
674239|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
674317|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
674318|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
674473|NCT03139253|Amoxicillin|amoxicillin|mesh-list
674474|NCT03139253|Clarithromycin|clarithromycin|mesh-list
674475|NCT03139253|Levofloxacin|levofloxacin|mesh-list
674476|NCT03139253|Ofloxacin|ofloxacin|mesh-list
674477|NCT03139253|Tetracycline|tetracycline|mesh-list
674478|NCT03139253|Tinidazole|tinidazole|mesh-list
674479|NCT03139253|Furazolidone|furazolidone|mesh-list
674480|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
674481|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
674482|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
674483|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674484|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674485|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
674486|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
674487|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
674488|NCT03139253|Renal Agents|renal agents|mesh-ancestor
674489|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
674490|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
674491|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674492|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
674493|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
674494|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
674495|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
674496|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
674497|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
674498|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2086592|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2086593|NCT02159547|Analgesics|analgesics|mesh-ancestor
2086594|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
2086595|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086596|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086597|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
675478|NCT03134846|Cetuximab|cetuximab|mesh-list
675479|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675480|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675507|NCT03133988|Margetuximab|margetuximab|mesh-list
675508|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675600|NCT03133260|Aspirin|aspirin|mesh-list
675601|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
675602|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
675603|NCT03133260|Analgesics|analgesics|mesh-ancestor
675604|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
675605|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675606|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675607|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
675608|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
675609|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
675610|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
675611|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675612|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
675613|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
675614|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675615|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
675705|NCT03132636|Cemiplimab|cemiplimab|mesh-list
675706|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675707|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675907|NCT03132103|Vitamin D|vitamin d|mesh-list
675908|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
675909|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
675910|NCT03132103|Vitamins|vitamins|mesh-list
675911|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
675912|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675913|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
675914|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2086598|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2086599|NCT02159807|Fentanyl|fentanyl|mesh-list
2086600|NCT02159807|Bupivacaine|bupivacaine|mesh-list
2086601|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
2086602|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
2086603|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086604|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086605|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
676106|NCT03131583|Colchicine|colchicine|mesh-list
2086606|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
674274|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
674275|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
674276|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
674277|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
674278|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
674279|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
674280|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
674281|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224225|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2224226|NCT00049088|Docetaxel|docetaxel|mesh-list
2224227|NCT00049088|Antibodies|antibodies|mesh-list
2224228|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
2224229|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2224230|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224231|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2086607|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2086608|NCT02159807|Narcotics|narcotics|mesh-ancestor
2086609|NCT02159807|Analgesics|analgesics|mesh-ancestor
2086610|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2086611|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2086612|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
2224232|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2224233|NCT00049088|Growth Substances|growth substances|mesh-ancestor
2224234|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224235|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
2224236|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
675465|NCT03134378|Amoxicillin|amoxicillin|mesh-list
675466|NCT03134378|Clarithromycin|clarithromycin|mesh-list
675467|NCT03134378|Rabeprazole|rabeprazole|mesh-list
675468|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
675469|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675470|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
675471|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675472|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675473|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
675474|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
675475|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
675476|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
675477|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
675522|NCT03134001|Analgesics|analgesics|mesh-list
675523|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
675524|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675525|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086613|NCT02159859|Ertapenem|ertapenem|mesh-list
2086614|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2086615|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086616|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
2086617|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2086618|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086619|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2086620|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676256|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
676257|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
676258|NCT03130517|Antibodies|antibodies|mesh-list
676259|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
676260|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
676261|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
676262|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676458|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
676459|NCT03129490|Apixaban|apixaban|mesh-list
676460|NCT03129490|Edoxaban|edoxaban|mesh-list
676461|NCT03129490|Dabigatran|dabigatran|mesh-list
676462|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
676463|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
676464|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
676465|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
676466|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676467|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676468|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
676711|NCT03127592|Etodolac|etodolac|mesh-list
676712|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
676713|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
676714|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
676715|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
676716|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
676717|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676718|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2086621|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674308|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
674309|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674310|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
674311|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
674312|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
674313|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674314|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674315|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
674316|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2224237|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
2224238|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
2224239|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
2224240|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224241|NCT00049101|Leucovorin|leucovorin|mesh-list
2224242|NCT00049101|Fluorouracil|fluorouracil|mesh-list
2224243|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
2224244|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2224245|NCT00049101|Calcium|calcium|mesh-list
2224246|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
2224247|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2224248|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224249|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
2224250|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224251|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2224252|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224253|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224254|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
2224255|NCT00049101|Antidotes|antidotes|mesh-ancestor
2224256|NCT00049101|Protective Agents|protective agents|mesh-ancestor
674936|NCT03137004|Docetaxel|docetaxel|mesh-list
674937|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674938|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
674939|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
674940|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
674941|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675036|NCT03136237|Cyclosporine|cyclosporine|mesh-list
675037|NCT03136237|Digoxin|digoxin|mesh-list
675038|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
675039|NCT03136237|Cyclosporins|cyclosporins|mesh-list
675040|NCT03136237|Berotralstat|berotralstat|mesh-list
675041|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675042|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675043|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
675044|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
675045|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675046|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
675047|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675048|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
675049|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
675050|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
675051|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
675052|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
675053|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
675054|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
675055|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
675056|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
675057|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
675058|NCT03136237|Protective Agents|protective agents|mesh-ancestor
675144|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
675145|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
675146|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
675147|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675148|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675149|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
675150|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
675151|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
675152|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
675153|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675154|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
675155|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
675156|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
675157|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
675158|NCT03135860|Protective Agents|protective agents|mesh-ancestor
2086622|NCT02159950|Vaccines|vaccines|mesh-list
2086623|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
2086624|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674348|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
674349|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674642|NCT03138616|Vitamin D|vitamin d|mesh-list
674643|NCT03138616|Vitamins|vitamins|mesh-ancestor
674644|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
674645|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674646|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
674681|NCT03138252|Oxytocin|oxytocin|mesh-list
674682|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
674683|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
674684|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086625|NCT02159976|Amoxicillin|amoxicillin|mesh-list
2086626|NCT02159976|Metronidazole|metronidazole|mesh-list
2086627|NCT02159976|Clarithromycin|clarithromycin|mesh-list
2086628|NCT02159976|Tetracycline|tetracycline|mesh-list
675110|NCT03135912|Terbinafine|terbinafine|mesh-list
675111|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
675112|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675113|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675114|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224257|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
2224258|NCT00049101|Vitamins|vitamins|mesh-ancestor
2224259|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
2224260|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2224261|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224262|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
2224263|NCT00049114|Doxorubicin|doxorubicin|mesh-list
2224264|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
675672|NCT03132688|Propofol|propofol|mesh-list
675673|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
675674|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675675|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675676|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
675677|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
675678|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
675798|NCT03132493|Nivolumab|nivolumab|mesh-list
675799|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675800|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675801|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
675802|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675952|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
675953|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
675954|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
675955|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
675956|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
675957|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675958|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
675959|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
675960|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675961|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
675962|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676480|NCT03129074|Capecitabine|capecitabine|mesh-list
676481|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
676482|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
676483|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676484|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676587|NCT03128216|Bupivacaine|bupivacaine|mesh-list
676588|NCT03128216|Ropivacaine|ropivacaine|mesh-list
676589|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
676590|NCT03128216|Anesthetics|anesthetics|mesh-list
676591|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676592|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676593|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
676594|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
677182|NCT03125980|Capecitabine|capecitabine|mesh-list
677183|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
677184|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
677185|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
677186|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677187|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224265|NCT00049114|Tipifarnib|tipifarnib|mesh-list
2224266|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224267|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
678032|NCT03122002|Aspirin|aspirin|mesh-list
678033|NCT03122002|Clopidogrel|clopidogrel|mesh-list
2086629|NCT02159976|Pantoprazole|pantoprazole|mesh-list
2224268|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224269|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
674421|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
674422|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
674423|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
674424|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
674425|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674969|NCT03136796|Meropenem|meropenem|mesh-list
674970|NCT03136796|Piperacillin|piperacillin|mesh-list
674971|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
674972|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675570|NCT03133780|Midazolam|midazolam|mesh-list
675571|NCT03133780|Ketamine|ketamine|mesh-list
675572|NCT03133780|Analgesics|analgesics|mesh-ancestor
675573|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
675574|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675575|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675576|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
675577|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
675578|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
675579|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
675580|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675581|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
675582|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
675583|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
675584|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675585|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
675586|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
675587|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
675588|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
675589|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
675590|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
675591|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
675783|NCT03132467|Durvalumab|durvalumab|mesh-list
675784|NCT03132467|Ipilimumab|ipilimumab|mesh-list
675785|NCT03132467|Tremelimumab|tremelimumab|mesh-list
675786|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
675787|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
675788|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
675789|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675790|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675791|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
675792|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675793|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
675794|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675904|NCT03132168|Anesthetics|anesthetics|mesh-list
675905|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675906|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676755|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
676756|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
676757|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
676758|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
676759|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676760|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676761|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
676762|NCT03127371|Analgesics|analgesics|mesh-ancestor
676763|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
676764|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676799|NCT03127137|Triamcinolone|triamcinolone|mesh-list
676800|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
676801|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
676802|NCT03127137|Lidocaine|lidocaine|mesh-list
676803|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
676804|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
676805|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
676806|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676807|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676808|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
676809|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676810|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
676811|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
676812|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
676813|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
676814|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676815|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
676816|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
676817|NCT03127137|Hormones|hormones|mesh-ancestor
677156|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
2224270|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2224271|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
2224272|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224273|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224274|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2224275|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2224276|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2224277|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2224278|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224279|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2224280|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224281|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2224282|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224283|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224284|NCT00049179|Cytarabine|cytarabine|mesh-list
2224285|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
2224286|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2224287|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
674808|NCT03137160|Ixekizumab|ixekizumab|mesh-list
674809|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
2224288|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224289|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224290|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
2224291|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224292|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224293|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
2224294|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675723|NCT03132610|Andrographolide|andrographolide|mesh-list
675724|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
675725|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
675726|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
675727|NCT03132610|Analgesics|analgesics|mesh-ancestor
675728|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
675729|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675730|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675731|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
675732|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
675733|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
675734|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675735|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
675736|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
675834|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
675835|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
675836|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675837|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675838|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
675839|NCT03132259|Analgesics|analgesics|mesh-ancestor
675840|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
675841|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675842|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
675843|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
675844|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
675845|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
675846|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
675847|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086630|NCT02159976|Bismuth|bismuth|mesh-list
2086631|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2086632|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086633|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2086634|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2086635|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2086636|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086637|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086638|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2086639|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2086640|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
676781|NCT03127267|Riluzole|riluzole|mesh-list
676782|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
676783|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
676784|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
676785|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
676786|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676787|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224295|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2224296|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
2224297|NCT00049192|Oblimersen|oblimersen|mesh-list
2224298|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224299|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
674667|NCT03138499|Nivolumab|nivolumab|mesh-list
674668|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
674669|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
674670|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674671|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
674672|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674724|NCT03137927|Vaccines|vaccines|mesh-list
674725|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
674726|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675178|NCT03135769|Avelumab|avelumab|mesh-list
675179|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675180|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675831|NCT03132311|Vaccines|vaccines|mesh-list
675832|NCT03132311|Immunologic Factors|immunologic factors|mesh-ancestor
675833|NCT03132311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224300|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224301|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224302|NCT00049218|Carboplatin|carboplatin|mesh-list
2224303|NCT00049218|Etoposide|etoposide|mesh-list
2224304|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676184|NCT03130842|Midazolam|midazolam|mesh-list
676185|NCT03130842|Alprazolam|alprazolam|mesh-list
676186|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
676187|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
676188|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676189|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676190|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
676191|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
676192|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
676193|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
676194|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
676195|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
676196|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
676197|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
676198|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
676199|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676229|NCT03130504|Progesterone|progesterone|mesh-list
676230|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
676231|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
676232|NCT03130504|Progestins|progestins|mesh-ancestor
676233|NCT03130504|Hormones|hormones|mesh-ancestor
676234|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
676235|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676236|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
676237|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
676453|NCT03129256|Apatinib|apatinib|mesh-list
676454|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676455|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
676456|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676457|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676546|NCT03128879|Venetoclax|venetoclax|mesh-list
676547|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676663|NCT03128034|Cyclosporine|cyclosporine|mesh-list
676664|NCT03128034|Sirolimus|sirolimus|mesh-list
676665|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
676666|NCT03128034|Fludarabine|fludarabine|mesh-list
676667|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
676668|NCT03128034|Cyclosporins|cyclosporins|mesh-list
676669|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676670|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
676671|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
676672|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676673|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
676674|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
676675|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676676|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674587|NCT03138720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674588|NCT03138720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
674589|NCT03138720|Immunologic Factors|immunologic factors|mesh-ancestor
674590|NCT03138720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674673|NCT03138447|Insulin|insulin|mesh-list
674674|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
674675|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
674854|NCT03137186|Metformin|metformin|mesh-list
674855|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
674856|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224305|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2224306|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2224307|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
675526|NCT03133897|Dexamethasone|dexamethasone|mesh-list
675527|NCT03133897|Prednisone|prednisone|mesh-list
675528|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
675529|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
675530|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
675531|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675532|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675533|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
675534|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
675535|NCT03133897|Hormones|hormones|mesh-ancestor
675536|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
675537|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
675538|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675771|NCT03132714|Amoxicillin|amoxicillin|mesh-list
675772|NCT03132714|Metronidazole|metronidazole|mesh-list
675773|NCT03132714|Clarithromycin|clarithromycin|mesh-list
675774|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
675775|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675776|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
675777|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
675778|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
675779|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675780|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675781|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
675782|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
675885|NCT03132181|Empagliflozin|empagliflozin|mesh-list
675886|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
675887|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675888|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
675889|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676115|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
676116|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
676117|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
676118|NCT03131336|Coagulants|coagulants|mesh-ancestor
676424|NCT03129646|Paromomycin|paromomycin|mesh-list
676425|NCT03129646|Miltefosine|miltefosine|mesh-list
676426|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
676427|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
676428|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
676429|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
676430|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
676431|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
676432|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676433|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
676434|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
676435|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
676603|NCT03128203|Oxytocin|oxytocin|mesh-list
676604|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
676605|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
676606|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677033|NCT03126864|Vidarabine|vidarabine|mesh-list
677034|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
677035|NCT03126864|Fludarabine|fludarabine|mesh-list
677036|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
677037|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
677038|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
677039|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677040|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
677041|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
677042|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
677043|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674600|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
674601|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
674602|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
674603|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674861|NCT03137134|Crizotinib|crizotinib|mesh-list
674862|NCT03137134|Esomeprazole|esomeprazole|mesh-list
674863|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
674864|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
674865|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
674866|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
674867|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
674868|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
674869|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
675592|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
675593|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
675594|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675653|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
675654|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
675655|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
675656|NCT03133312|Povidone|povidone|mesh-list
675657|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
675658|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675659|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
675660|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
675661|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
675662|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
676149|NCT03131050|Scopolamine|scopolamine|mesh-list
676150|NCT03131050|Citalopram|citalopram|mesh-list
676151|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
676152|NCT03131050|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
676153|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
676154|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
676155|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676156|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
676157|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
676158|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676159|NCT03131050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
676160|NCT03131050|Antidepressive Agents|antidepressive agents|mesh-ancestor
676161|NCT03131050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
676162|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
676163|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
676164|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676165|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
676166|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
676167|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
676168|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
676169|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
676170|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
676171|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
676405|NCT03129828|Bortezomib|bortezomib|mesh-list
676406|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676517|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
676518|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
676519|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
676520|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676521|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
676522|NCT03128866|Coagulants|coagulants|mesh-ancestor
677313|NCT03125486|Belimumab|belimumab|mesh-list
677314|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
677315|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
677316|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086641|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086642|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2086643|NCT02159976|Antacids|antacids|mesh-ancestor
2086644|NCT02160041|Infigratinib|infigratinib|mesh-list
2086645|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678245|NCT03121261|Clonidine|clonidine|mesh-list
678246|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
678247|NCT03121261|Analgesics|analgesics|mesh-ancestor
678248|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
678249|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086646|NCT02160145|Tolvaptan|tolvaptan|mesh-list
2224308|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224309|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224310|NCT00049244|Capecitabine|capecitabine|mesh-list
2224311|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2224312|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
2224313|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224314|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224315|NCT00049283|Docetaxel|docetaxel|mesh-list
2224316|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2224317|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675749|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
675750|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675751|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675898|NCT03132116|Gentamicins|gentamicins|mesh-list
675899|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
675900|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675901|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
675902|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675903|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676119|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
676120|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
676121|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676122|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676123|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
676124|NCT03131375|Analgesics|analgesics|mesh-ancestor
676125|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
676126|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676127|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
676128|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
676129|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
676130|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
676131|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
676132|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676172|NCT03130933|Amoxicillin|amoxicillin|mesh-list
676173|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
676174|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
676358|NCT03130348|Dexamethasone|dexamethasone|mesh-list
676359|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
676360|NCT03130348|Bortezomib|bortezomib|mesh-list
676361|NCT03130348|Ichthammol|ichthammol|mesh-list
676362|NCT03130348|BB 1101|bb 1101|mesh-list
676363|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
676364|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
676365|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
676366|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676367|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676368|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
676369|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
676370|NCT03130348|Hormones|hormones|mesh-ancestor
676371|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
676372|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
676373|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676374|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
676375|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676376|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676377|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
2224318|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
2224319|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
677292|NCT03125746|Exemestane|exemestane|mesh-list
677293|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677294|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
677295|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
677296|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677297|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677298|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
677299|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
677300|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
677301|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086647|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2086648|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086649|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
2086650|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086651|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
677856|NCT03122665|Nefopam|nefopam|mesh-list
2224320|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
675099|NCT03135977|Etoposide|etoposide|mesh-list
675100|NCT03135977|Apatinib|apatinib|mesh-list
675101|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
675102|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675103|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
675104|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
675105|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675106|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675107|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2224321|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224322|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2224323|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224324|NCT00049296|Thalidomide|thalidomide|mesh-list
2224325|NCT00049296|Docetaxel|docetaxel|mesh-list
2224326|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224327|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
2224328|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
2224329|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
2224330|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224331|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
676312|NCT03130218|Peppermint oil|peppermint oil|mesh-list
676313|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
676314|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
676315|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676316|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676317|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
676318|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
676686|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
676687|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
676688|NCT03128359|Melphalan|melphalan|mesh-list
676689|NCT03128359|Busulfan|busulfan|mesh-list
676690|NCT03128359|Fludarabine|fludarabine|mesh-list
676691|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
676692|NCT03128359|Tacrolimus|tacrolimus|mesh-list
676693|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
676694|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
676695|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676696|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
676697|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
676698|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
676699|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676700|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676701|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
676702|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
676703|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
676704|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
676705|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676706|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
676707|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
676708|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
676709|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
676710|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
676865|NCT03127189|Rilpivirine|rilpivirine|mesh-list
676866|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
676867|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
676868|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676869|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676870|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
676871|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
676872|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
676873|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
677329|NCT03125616|Vaccines|vaccines|mesh-list
677330|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
677331|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224332|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
2224333|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224334|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
2224335|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2224336|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224337|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2224338|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2224339|NCT00049296|Growth Substances|growth substances|mesh-ancestor
2224340|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
2224341|NCT00049335|Capecitabine|capecitabine|mesh-list
2224342|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
675022|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224343|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
2224344|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224345|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224346|NCT00049348|Gemcitabine|gemcitabine|mesh-list
2224347|NCT00049348|Fluorouracil|fluorouracil|mesh-list
2224348|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
2224349|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675421|NCT03134443|Andrographolide|andrographolide|mesh-list
675422|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
675423|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
675424|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
675425|NCT03134443|Analgesics|analgesics|mesh-ancestor
675426|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
675427|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675428|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675429|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
675430|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
675431|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
675432|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675433|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
675434|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
675518|NCT03133832|Praziquantel|praziquantel|mesh-list
675519|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
675520|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
675521|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675944|NCT03131700|Bevacizumab|bevacizumab|mesh-list
675945|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675946|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675947|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
675948|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
675949|NCT03131700|Growth Substances|growth substances|mesh-ancestor
675950|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675951|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
2224350|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2224351|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
2224352|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224353|NCT00049348|Antiviral Agents|antiviral agents|mesh-ancestor
2224354|NCT00049348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
676322|NCT03130153|Aspirin|aspirin|mesh-list
676323|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
676324|NCT03130153|Salicylates|salicylates|mesh-list
676325|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
676326|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
676327|NCT03130153|Analgesics|analgesics|mesh-ancestor
676328|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
676329|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676330|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676331|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
676332|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
676333|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
676334|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
676335|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676336|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
676337|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
676338|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676339|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
676340|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
676341|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
676342|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
676343|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
676849|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
676850|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
676851|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
676852|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2224355|NCT00049348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224356|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224357|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
2224358|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224359|NCT00049348|Hematinics|hematinics|mesh-ancestor
2224360|NCT00049361|Thalidomide|thalidomide|mesh-list
675451|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
675452|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675453|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675491|NCT03134118|Nivolumab|nivolumab|mesh-list
675492|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675493|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675494|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
675495|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675663|NCT03133195|Vitamin D|vitamin d|mesh-list
675664|NCT03133195|Teriparatide|teriparatide|mesh-list
675665|NCT03133195|Calcium|calcium|mesh-list
675666|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
675667|NCT03133195|Vitamins|vitamins|mesh-ancestor
675668|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
675669|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675670|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
675671|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
676200|NCT03130829|Fucoidan|fucoidan|mesh-list
676201|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
676202|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
676203|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
676204|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677161|NCT03126188|Sertraline|sertraline|mesh-list
677162|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
677163|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
677164|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
677165|NCT03126188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
677166|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
677167|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
677168|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677169|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
677170|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
677171|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677172|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
677173|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
677604|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
677605|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
677606|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224361|NCT00049361|Temozolomide|temozolomide|mesh-list
2224362|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2224363|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
678227|NCT03121547|Tramadol|tramadol|mesh-list
678228|NCT03121547|Tapentadol|tapentadol|mesh-list
678229|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678230|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
678231|NCT03121547|Narcotics|narcotics|mesh-ancestor
678232|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
678233|NCT03121547|Analgesics|analgesics|mesh-ancestor
678234|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
678235|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678236|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
678237|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
678238|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
678239|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678240|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
678241|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086652|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2086653|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2086654|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2086655|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2086656|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086657|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
2086658|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086659|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086660|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2086661|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086662|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2086663|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2224364|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224365|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675249|NCT03135184|Coal Tar|coal tar|mesh-list
675250|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
675251|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
675454|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
675455|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
675456|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
675457|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
675691|NCT03132623|Andrographolide|andrographolide|mesh-list
675692|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
675693|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
675694|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
675695|NCT03132623|Analgesics|analgesics|mesh-ancestor
675696|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
675697|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675698|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675699|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
675700|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
675701|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
675702|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675703|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
675704|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
676554|NCT03128528|Empagliflozin|empagliflozin|mesh-list
676555|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
676556|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676557|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
676558|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676855|NCT03127007|Atezolizumab|atezolizumab|mesh-list
676856|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086664|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2086665|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086666|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086667|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2086668|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2086669|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086670|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
2086671|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086672|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2086673|NCT02160730|Roscovitine|roscovitine|mesh-list
2086674|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224366|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224367|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
2224368|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224369|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
2224370|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2224371|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224372|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2224373|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2224374|NCT00049361|Growth Substances|growth substances|mesh-ancestor
2224375|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
2224376|NCT00049374|Thalidomide|thalidomide|mesh-list
2224377|NCT00049374|Dexamethasone|dexamethasone|mesh-list
2224378|NCT00049374|Oblimersen|oblimersen|mesh-list
2224379|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2224380|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
2224381|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
2224382|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224383|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224384|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
677633|NCT03123406|Cinacalcet|cinacalcet|mesh-list
677634|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
677635|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677636|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
677637|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
677638|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
677744|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
677745|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
677746|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
675164|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675165|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675166|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
675167|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
675168|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
675169|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
675170|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
675171|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675623|NCT03133546|Bevacizumab|bevacizumab|mesh-list
675624|NCT03133546|Osimertinib|osimertinib|mesh-list
675625|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675626|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675627|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
675628|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
675629|NCT03133546|Growth Substances|growth substances|mesh-ancestor
675630|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675631|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
675632|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
675633|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675634|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086675|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
2086676|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086677|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2224385|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
2224386|NCT00049374|Hormones|hormones|mesh-ancestor
2224387|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2224388|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2224389|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224390|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224391|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
2224392|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
2224393|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2224394|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224395|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2224396|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2224397|NCT00049374|Growth Substances|growth substances|mesh-ancestor
2224398|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
2224399|NCT00049387|Temozolomide|temozolomide|mesh-list
676407|NCT03129867|Ticagrelor|ticagrelor|mesh-list
676408|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
676409|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
676410|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
676411|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
676412|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
676413|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
676414|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676415|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224400|NCT00049387|Tipifarnib|tipifarnib|mesh-list
2224401|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2224402|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
2224403|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224404|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224405|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
2224406|NCT00049413|Rituximab|rituximab|mesh-list
2224407|NCT00049413|Pentostatin|pentostatin|mesh-list
2224408|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224409|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
2224410|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224411|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
677427|NCT03124524|Dienogest|dienogest|mesh-list
677428|NCT03124524|Drospirenone|drospirenone|mesh-list
677429|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
677430|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
677431|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
677432|NCT03124524|Estradiol|estradiol|mesh-list
677433|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
677434|NCT03124524|Estrogens|estrogens|mesh-ancestor
677435|NCT03124524|Hormones|hormones|mesh-ancestor
677436|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
677437|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677438|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
677439|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
2224412|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2224413|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
675192|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
675193|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675194|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675195|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
675196|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
675197|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
675198|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
675199|NCT03135795|Analgesics|analgesics|mesh-ancestor
675200|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
675201|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675202|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
675203|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
675204|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
675205|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
675206|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
675207|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675208|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
675209|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
675210|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
675211|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
675212|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
675213|NCT03135795|Narcotics|narcotics|mesh-ancestor
675214|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
675215|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
675216|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
675217|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
675218|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
675219|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
675220|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
675221|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
675222|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
675223|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675224|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
675225|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
675226|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
675379|NCT03134638|Carboplatin|carboplatin|mesh-list
675380|NCT03134638|Fulvestrant|fulvestrant|mesh-list
675381|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675382|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
675383|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
675384|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
675385|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
675386|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
675387|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676004|NCT03131765|Poly I-C|poly i-c|mesh-list
676005|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
676006|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
676007|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
676008|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
676009|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676146|NCT03131141|Lefamulin|lefamulin|mesh-list
676147|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
676148|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
676319|NCT03130114|Azithromycin|azithromycin|mesh-list
676320|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
676321|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224414|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224415|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224416|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2224417|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2224418|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2224419|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224420|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
2224421|NCT00049439|Lomustine|lomustine|mesh-list
2224422|NCT00049439|Etoposide|etoposide|mesh-list
2224423|NCT00049439|Procarbazine|procarbazine|mesh-list
2224424|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
676548|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
676549|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676550|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
676551|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676552|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676553|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
676736|NCT03127800|Morphine|morphine|mesh-list
2224425|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
675236|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
675237|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675238|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675239|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
675240|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
675241|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
675350|NCT03134677|Bupivacaine|bupivacaine|mesh-list
675351|NCT03134677|Sevoflurane|sevoflurane|mesh-list
675352|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
675353|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
675354|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675355|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675356|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
675357|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675358|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
675359|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
675360|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
2224426|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224427|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2224428|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
676441|NCT03129542|Midodrine|midodrine|mesh-list
676442|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
676443|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
676444|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676445|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676446|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
676447|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
676448|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
676449|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
676450|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
676451|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
676452|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676790|NCT03127319|Docetaxel|docetaxel|mesh-list
676791|NCT03127319|Apatinib|apatinib|mesh-list
676792|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676793|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
676794|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
676795|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
676796|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676797|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
676798|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224429|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
678413|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
678414|NCT03120728|Etonogestrel|etonogestrel|mesh-list
678415|NCT03120728|NuvaRing|nuvaring|mesh-list
678416|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
678417|NCT03120728|Estradiol|estradiol|mesh-list
678418|NCT03120728|Estrogens|estrogens|mesh-ancestor
678419|NCT03120728|Hormones|hormones|mesh-ancestor
678420|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
678421|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678422|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
678423|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
675403|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675404|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
675405|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
675406|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
675407|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
675408|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675409|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
675410|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
675411|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
675412|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
675413|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
675414|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
675415|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
675416|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
675417|NCT03134612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
675418|NCT03134612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
675419|NCT03134612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
675420|NCT03134612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
675565|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
675566|NCT03133793|Vitamins|vitamins|mesh-ancestor
675567|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
675568|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675708|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
675709|NCT03132701|Analgesics|analgesics|mesh-ancestor
675710|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
675711|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675712|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675713|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
675714|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675715|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
675716|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
675717|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
675718|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
675719|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675720|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
675721|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
675722|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
675795|NCT03132272|Autoantibodies|autoantibodies|mesh-list
675796|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
675797|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676309|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
676310|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
676311|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086678|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086679|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677139|NCT03126461|Nivolumab|nivolumab|mesh-list
677140|NCT03126461|Ipilimumab|ipilimumab|mesh-list
677141|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
677142|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677143|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
677144|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086680|NCT02160808|Secretin|secretin|mesh-list
2086681|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086682|NCT02160808|Hormones|hormones|mesh-ancestor
2086683|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2086684|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086685|NCT02160990|Exenatide|exenatide|mesh-list
2086686|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2086687|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086688|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2086689|NCT02160990|Incretins|incretins|mesh-ancestor
2086690|NCT02160990|Hormones|hormones|mesh-ancestor
2086691|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2086692|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
677732|NCT03123029|Venetoclax|venetoclax|mesh-list
677733|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677897|NCT03122769|Metformin|metformin|mesh-list
677898|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
677899|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677985|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
677986|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
677987|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675445|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675446|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
675447|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675448|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
675449|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675450|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
675516|NCT03134131|TIC10 compound|tic10 compound|mesh-list
675517|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675867|NCT03132519|Remifentanil|remifentanil|mesh-list
675868|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
675869|NCT03132519|Narcotics|narcotics|mesh-ancestor
675870|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675871|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675872|NCT03132519|Analgesics|analgesics|mesh-ancestor
675873|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
675874|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675970|NCT03131843|Ethanol|ethanol|mesh-list
675971|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
675972|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675973|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
675974|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676243|NCT03130556|Rabeprazole|rabeprazole|mesh-list
676244|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
676245|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
676246|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
676247|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676248|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676344|NCT03130270|Apatinib|apatinib|mesh-list
676345|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676346|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
676347|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676348|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676419|NCT03129698|Apatinib|apatinib|mesh-list
676420|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676421|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
676422|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676423|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086693|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2086694|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2086695|NCT02161146|Analgesics|analgesics|mesh-ancestor
2086696|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
2086697|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086698|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086699|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2086700|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2086701|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2086702|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2086703|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2086704|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
2086705|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
2086706|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2224430|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224431|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224432|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2224433|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2224434|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2224435|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2224436|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224437|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
2224438|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2224439|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224440|NCT00049556|Gefitinib|gefitinib|mesh-list
2224441|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224442|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2224443|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224444|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224445|NCT00049569|Leucovorin|leucovorin|mesh-list
2224446|NCT00049569|Cytarabine|cytarabine|mesh-list
2224447|NCT00049569|Prednisone|prednisone|mesh-list
2224448|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
2224449|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2224450|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2224451|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2224452|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
2224453|NCT00049569|Doxorubicin|doxorubicin|mesh-list
675541|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675875|NCT03132194|Dapsone|dapsone|mesh-list
675876|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
675877|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
675878|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
675879|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
675880|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
675881|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675882|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675883|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
675884|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
675975|NCT03131882|Triamcinolone|triamcinolone|mesh-list
675976|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
675977|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
675978|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
675979|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
675980|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
675981|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
675982|NCT03131882|Hormones|hormones|mesh-ancestor
675983|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
675984|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675985|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
675986|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
675987|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675988|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675989|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
675990|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
675991|NCT03131882|Protective Agents|protective agents|mesh-ancestor
676249|NCT03130582|Etoposide|etoposide|mesh-list
676250|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
676251|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676252|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
676253|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
676254|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676255|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676577|NCT03128398|Domperidone|domperidone|mesh-list
676578|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
676579|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
676580|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676581|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676582|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
676583|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
676584|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
676585|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
676586|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676777|NCT03127449|Aflutinib|aflutinib|mesh-list
676778|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
676779|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676780|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677206|NCT03126071|Bevacizumab|bevacizumab|mesh-list
677207|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
677208|NCT03126071|Irinotecan|irinotecan|mesh-list
677209|NCT03126071|Raltitrexed|raltitrexed|mesh-list
677210|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
677211|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677212|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
677213|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
677214|NCT03126071|Growth Substances|growth substances|mesh-ancestor
677215|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677216|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
677217|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
677218|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
677219|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677220|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677221|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
677222|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
677223|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
677541|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
677542|NCT03123913|Testosterone|testosterone|mesh-list
677543|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
677544|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
677545|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
677546|NCT03123913|Androgens|androgens|mesh-ancestor
677547|NCT03123913|Hormones|hormones|mesh-ancestor
677548|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
675548|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675549|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
675550|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
675551|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
675552|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
675553|NCT03133845|Narcotics|narcotics|mesh-ancestor
675554|NCT03133845|Analgesics|analgesics|mesh-ancestor
675555|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
675556|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675557|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
675558|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
675559|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
675560|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
675561|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
675562|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
675563|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
675564|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676293|NCT03130010|Nefopam|nefopam|mesh-list
676294|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
676295|NCT03130010|Analgesics|analgesics|mesh-ancestor
676296|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
676297|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676298|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676469|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
676470|NCT03129555|Apixaban|apixaban|mesh-list
676471|NCT03129555|Edoxaban|edoxaban|mesh-list
676472|NCT03129555|Dabigatran|dabigatran|mesh-list
676473|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
676474|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
676475|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
676476|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
676477|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676478|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676479|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
677373|NCT03126916|Vitamin A|vitamin a|mesh-list
677374|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
677375|NCT03126916|Melphalan|melphalan|mesh-list
677376|NCT03126916|Busulfan|busulfan|mesh-list
677377|NCT03126916|Thiotepa|thiotepa|mesh-list
677378|NCT03126916|Cisplatin|cisplatin|mesh-list
677379|NCT03126916|Carboplatin|carboplatin|mesh-list
677380|NCT03126916|Doxorubicin|doxorubicin|mesh-list
677381|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
677382|NCT03126916|Etoposide|etoposide|mesh-list
677383|NCT03126916|Vincristine|vincristine|mesh-list
677384|NCT03126916|Topotecan|topotecan|mesh-list
677385|NCT03126916|Tretinoin|tretinoin|mesh-list
677386|NCT03126916|Crizotinib|crizotinib|mesh-list
677387|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
677388|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
677389|NCT03126916|Dinutuximab|dinutuximab|mesh-list
677390|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
677391|NCT03126916|Razoxane|razoxane|mesh-list
677392|NCT03126916|Isotretinoin|isotretinoin|mesh-list
677393|NCT03126916|Sargramostim|sargramostim|mesh-list
677394|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
677395|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
677396|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677397|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
677398|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
677399|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
677400|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677401|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677402|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
677403|NCT03126916|Vitamins|vitamins|mesh-ancestor
677404|NCT03126916|Micronutrients|micronutrients|mesh-ancestor
677405|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
677406|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
677407|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
677408|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677409|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
677410|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
677411|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
677412|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
677413|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
677414|NCT03126916|Protective Agents|protective agents|mesh-ancestor
677415|NCT03126916|Keratolytic Agents|keratolytic agents|mesh-ancestor
677416|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
677417|NCT03126916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
677418|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
677419|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
677768|NCT03122938|Lactoferrin|lactoferrin|mesh-list
675645|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
675646|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675863|NCT03132376|Caseins|caseins|mesh-list
675864|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
675865|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
675866|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675963|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
675964|NCT03131908|GSK2636771|gsk2636771|mesh-list
675965|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
675966|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675967|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
675968|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
675969|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676205|NCT03130764|Durvalumab|durvalumab|mesh-list
676206|NCT03130764|Tremelimumab|tremelimumab|mesh-list
676207|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
676208|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224454|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2224455|NCT00049569|Methotrexate|methotrexate|mesh-list
2224456|NCT00049569|Etoposide|etoposide|mesh-list
2224457|NCT00049569|Vincristine|vincristine|mesh-list
2224458|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
2224459|NCT00049569|Asparaginase|asparaginase|mesh-list
2224460|NCT00049569|Pegaspargase|pegaspargase|mesh-list
2224461|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
2224462|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224463|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
2224464|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224465|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2224466|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2224467|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
2224468|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224469|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678058|NCT03122314|Acetaminophen|acetaminophen|mesh-list
678059|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
678060|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
678061|NCT03122314|Analgesics|analgesics|mesh-ancestor
678062|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
678063|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678064|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678065|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
678066|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
678067|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
678068|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
678427|NCT03120468|Topiramate|topiramate|mesh-list
678428|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
678429|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
678430|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
678431|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
678432|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678433|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
678434|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678435|NCT03120468|Expectorants|expectorants|mesh-ancestor
678436|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
678437|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
678438|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
678439|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678440|NCT03120468|Protective Agents|protective agents|mesh-ancestor
678441|NCT03120468|Antidotes|antidotes|mesh-ancestor
679052|NCT03118128|Metformin|metformin|mesh-list
679053|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
679054|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679324|NCT03116971|Etoposide|etoposide|mesh-list
679325|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679326|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
679327|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
679328|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
679329|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679330|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679598|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
679599|NCT03116087|Testosterone|testosterone|mesh-list
679600|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
679601|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
679602|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
679603|NCT03116087|Androgens|androgens|mesh-ancestor
2224470|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2224471|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2224472|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2224473|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2224474|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224475|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2224476|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
2224477|NCT00049569|Hormones|hormones|mesh-ancestor
2224478|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2224479|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2224480|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2224481|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
2224482|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2224483|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2224484|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
2224485|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
2224486|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2224487|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
675851|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
675852|NCT03132142|Capsaicin|capsaicin|mesh-list
675853|NCT03132142|Menthol|menthol|mesh-list
675854|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
675855|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
675856|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
675857|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
675858|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
675859|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
675860|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675861|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
675862|NCT03132142|Protective Agents|protective agents|mesh-ancestor
2086707|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086708|NCT02161185|Midazolam|midazolam|mesh-list
2086709|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
676923|NCT03126799|Bevacizumab|bevacizumab|mesh-list
676924|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
676925|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
676926|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676927|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
676928|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
676929|NCT03126799|Growth Substances|growth substances|mesh-ancestor
676930|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676931|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
676932|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
676933|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676934|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677302|NCT03125772|Paclitaxel|paclitaxel|mesh-list
677303|NCT03125772|Everolimus|everolimus|mesh-list
677304|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
677305|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677306|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
677307|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
677308|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
677309|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677310|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
677311|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
677312|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677802|NCT03122756|Dexamethasone|dexamethasone|mesh-list
677803|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
677804|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
677805|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
677806|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
677807|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677808|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
677809|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
677811|NCT03122756|Hormones|hormones|mesh-ancestor
677812|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
677813|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
677814|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677959|NCT03122262|Tenofovir|tenofovir|mesh-list
677960|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
677961|NCT03122262|Dolutegravir|dolutegravir|mesh-list
677962|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
677963|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
677964|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
677988|NCT03122041|Incretins|incretins|mesh-ancestor
2224488|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2086710|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2086711|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086712|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086713|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2086714|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2086715|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2086716|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2086717|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
2086718|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
2086719|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
2086720|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
2086721|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086722|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086723|NCT02161406|Abatacept|abatacept|mesh-list
2086724|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2086725|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086726|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086727|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2086728|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
2086729|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086730|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2224489|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
675936|NCT03132025|Capecitabine|capecitabine|mesh-list
675937|NCT03132025|Apatinib|apatinib|mesh-list
675938|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
675939|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
675940|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
675941|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
675942|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
675943|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676143|NCT03131037|Valacyclovir|valacyclovir|mesh-list
676144|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
676145|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
676436|NCT03129347|Nalmefene|nalmefene|mesh-list
676437|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
676438|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676439|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
676440|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678219|NCT03121690|Prednisone|prednisone|mesh-list
678220|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
678221|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
678222|NCT03121690|Hormones|hormones|mesh-ancestor
678223|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
678224|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678225|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
678226|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678399|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
678400|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678810|NCT03119064|Irinotecan|irinotecan|mesh-list
678811|NCT03119064|Temozolomide|temozolomide|mesh-list
678812|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
678813|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
678814|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678815|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678816|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678817|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
678818|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
2224490|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224491|NCT00049569|Antidotes|antidotes|mesh-ancestor
2224492|NCT00049569|Protective Agents|protective agents|mesh-ancestor
2224493|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
2224494|NCT00049569|Vitamins|vitamins|mesh-ancestor
2224495|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
679089|NCT03117855|Capecitabine|capecitabine|mesh-list
679090|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
679091|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
679092|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679093|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679704|NCT03115762|Bevacizumab|bevacizumab|mesh-list
679705|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
679706|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679707|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
679708|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
679709|NCT03115762|Growth Substances|growth substances|mesh-ancestor
679710|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679711|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
676020|NCT03131973|Caffeine|caffeine|mesh-list
676021|NCT03131973|Omeprazole|omeprazole|mesh-list
676022|NCT03131973|Pravastatin|pravastatin|mesh-list
676023|NCT03131973|Montelukast|montelukast|mesh-list
676024|NCT03131973|Branebrutinib|branebrutinib|mesh-list
676025|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
676026|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
676027|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
676028|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676029|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
676030|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
676031|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676032|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676033|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
676034|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676035|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
676036|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
676037|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
676038|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
676039|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
676040|NCT03131973|Antidotes|antidotes|mesh-ancestor
676041|NCT03131973|Protective Agents|protective agents|mesh-ancestor
676042|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
676043|NCT03131973|Vitamins|vitamins|mesh-ancestor
676044|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
676045|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
676046|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
676047|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676048|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
676049|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
676050|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
676051|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
676052|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
676053|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
676054|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
676055|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
676056|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
676057|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
676058|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
676059|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
676060|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
676061|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
676062|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
676063|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
676064|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
676065|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
676066|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
676067|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
676068|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
676069|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
676070|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
676071|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
676072|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
676073|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
676074|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
676075|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
676076|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
676077|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
676078|NCT03131973|Analgesics|analgesics|mesh-ancestor
676079|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
676080|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676081|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
676082|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
676083|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
676084|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
676085|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
676175|NCT03131154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
676176|NCT03131154|Ophthalmic Solutions|ophthalmic solutions|mesh-list
676286|NCT03130426|Insulin|insulin|mesh-list
676287|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
676288|NCT03130426|Metformin|metformin|mesh-list
676289|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
676290|NCT03130426|Lixisenatide|lixisenatide|mesh-list
676291|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
676292|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676607|NCT03128346|Aspirin|aspirin|mesh-list
676608|NCT03128346|Acetaminophen|acetaminophen|mesh-list
2224496|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
2224497|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
2224498|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
2224499|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2224500|NCT00049582|Decitabine|decitabine|mesh-list
2086731|NCT02161458|Dexetimide|dexetimide|mesh-list
2086732|NCT02161458|Citalopram|citalopram|mesh-list
2086733|NCT02161458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2086734|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2086735|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2086736|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086737|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086738|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
2086739|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086740|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2086741|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
2086742|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2086743|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2086744|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2086745|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
2086746|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
2086747|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086748|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2086749|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2086750|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
2086751|NCT02161484|Bupivacaine|bupivacaine|mesh-list
2086752|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
677583|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
677584|NCT03123770|Docetaxel|docetaxel|mesh-list
677585|NCT03123770|Doxorubicin|doxorubicin|mesh-list
677586|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
677587|NCT03123770|Epirubicin|epirubicin|mesh-list
677588|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
677589|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
677590|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677591|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
677592|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
677593|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
677594|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677595|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677596|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
677597|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
677598|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
677599|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
677600|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
677601|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
677602|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
677603|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086753|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
2086754|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086755|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086756|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
2086757|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086758|NCT02161562|Omalizumab|omalizumab|mesh-list
678054|NCT03122067|Oxytocin|oxytocin|mesh-list
678055|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
678056|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
678057|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752488|NCT03493126|Estradiol|estradiol|mesh-list
678201|NCT03121313|Tegafur|tegafur|mesh-list
678202|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
678203|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
678204|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678205|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224501|NCT00049582|Azacitidine|azacitidine|mesh-list
2752489|NCT03493126|Estrogens|estrogens|mesh-ancestor
676107|NCT03131583|Febuxostat|febuxostat|mesh-list
676108|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
676109|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
676110|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
676111|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
676112|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
676113|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676114|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676349|NCT03130127|Terlipressin|terlipressin|mesh-list
676350|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
676351|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
676538|NCT03128736|Esomeprazole|esomeprazole|mesh-list
676539|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
676540|NCT03128736|Lansoprazole|lansoprazole|mesh-list
676541|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
676542|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
676543|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
676544|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676545|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676822|NCT03127631|Aspirin|aspirin|mesh-list
676823|NCT03127631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
676824|NCT03127631|Atorvastatin|atorvastatin|mesh-list
676825|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
676826|NCT03127631|Simvastatin|simvastatin|mesh-list
676827|NCT03127631|Pravastatin|pravastatin|mesh-list
676828|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
676829|NCT03127631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
676830|NCT03127631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
676831|NCT03127631|Analgesics|analgesics|mesh-ancestor
676832|NCT03127631|Sensory System Agents|sensory system agents|mesh-ancestor
676833|NCT03127631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676834|NCT03127631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676835|NCT03127631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
676836|NCT03127631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
676837|NCT03127631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
676838|NCT03127631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
676839|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676840|NCT03127631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
676841|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676842|NCT03127631|Antipyretics|antipyretics|mesh-ancestor
676843|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
676844|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
676845|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
676846|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
676847|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
676848|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
677024|NCT03126708|Paclitaxel|paclitaxel|mesh-list
677025|NCT03126708|Cetuximab|cetuximab|mesh-list
677026|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
677027|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677028|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
677029|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
677030|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
677031|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677032|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
677188|NCT03126097|Drospirenone|drospirenone|mesh-list
677189|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
677190|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
677191|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
677192|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
677193|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
677194|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
677195|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
677196|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677197|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
677198|NCT03126097|Estrogens|estrogens|mesh-ancestor
677199|NCT03126097|Hormones|hormones|mesh-ancestor
677200|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
677201|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
677202|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
677203|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
677204|NCT03126097|Diuretics|diuretics|mesh-ancestor
677205|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
677607|NCT03123744|Palbociclib|palbociclib|mesh-list
677608|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677680|NCT03123445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676271|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
676272|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
676273|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676274|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676275|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
676276|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
676277|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
676278|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
676279|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
676352|NCT03130101|Insulin|insulin|mesh-list
676353|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
676354|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676488|NCT03129022|Anesthetics|anesthetics|mesh-list
676489|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676490|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676559|NCT03128242|Oxytocin|oxytocin|mesh-list
676560|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
676561|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
676562|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224502|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2224503|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
2224504|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224505|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224506|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224507|NCT00049595|Prednisone|prednisone|mesh-list
2224508|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
2224509|NCT00049595|Dacarbazine|dacarbazine|mesh-list
2224510|NCT00049595|Doxorubicin|doxorubicin|mesh-list
2224511|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2224512|NCT00049595|Etoposide|etoposide|mesh-list
2224513|NCT00049595|Vincristine|vincristine|mesh-list
2224514|NCT00049595|Bleomycin|bleomycin|mesh-list
2224515|NCT00049595|Vinblastine|vinblastine|mesh-list
2224516|NCT00049595|Procarbazine|procarbazine|mesh-list
2224517|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224518|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
2224519|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224520|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2224521|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2224522|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
2224523|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224524|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224525|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2224526|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2224527|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2224528|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
678242|NCT03121339|Vaccines|vaccines|mesh-list
678243|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
678244|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678376|NCT03120923|Triamcinolone|triamcinolone|mesh-list
678377|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
678378|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
678379|NCT03120923|Lidocaine|lidocaine|mesh-list
678380|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
678381|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
678382|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
678383|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
678384|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678385|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
678386|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678387|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
678388|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
678389|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
678390|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
678391|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678392|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
678393|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
678394|NCT03120923|Hormones|hormones|mesh-ancestor
678395|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
678396|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
678397|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
678398|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678442|NCT03120442|Fentanyl|fentanyl|mesh-list
678443|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
678444|NCT03120442|Propofol|propofol|mesh-list
2224529|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086759|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2086760|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2086761|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2086762|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
2086763|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
2086764|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086765|NCT02161575|Ranibizumab|ranibizumab|mesh-list
2086766|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2086767|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2086768|NCT02161575|Growth Substances|growth substances|mesh-ancestor
2086769|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086770|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
2086771|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086772|NCT02161705|Ropivacaine|ropivacaine|mesh-list
2086773|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
2086774|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
2086775|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086776|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086777|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
676732|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
676733|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
676734|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676735|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
676898|NCT03127046|Aceclofenac|aceclofenac|mesh-list
676899|NCT03127046|Diclofenac|diclofenac|mesh-list
676900|NCT03127046|Esomeprazole|esomeprazole|mesh-list
676901|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
676902|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
676903|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
676904|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676905|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676906|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
676907|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
676908|NCT03127046|Analgesics|analgesics|mesh-ancestor
676909|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
676910|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676911|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676912|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
676913|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
676914|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
677063|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
677064|NCT03126591|Olaratumab|olaratumab|mesh-list
677065|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
677066|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677470|NCT03124420|Amoxicillin|amoxicillin|mesh-list
677471|NCT03124420|Clarithromycin|clarithromycin|mesh-list
677472|NCT03124420|Lansoprazole|lansoprazole|mesh-list
677473|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
677474|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
677475|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
677476|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
677477|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677478|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677479|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
677480|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
677481|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2086778|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676609|NCT03128346|Fentanyl|fentanyl|mesh-list
676610|NCT03128346|Hydromorphone|hydromorphone|mesh-list
676611|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
676612|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
676613|NCT03128346|Analgesics|analgesics|mesh-ancestor
676614|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
676615|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676616|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676617|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
676618|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
676619|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
676620|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
676621|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676622|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
676623|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
676624|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676625|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
676626|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
676627|NCT03128346|Narcotics|narcotics|mesh-ancestor
676628|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676629|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
676630|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
676631|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
676632|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
677370|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
677371|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
677372|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
677829|NCT03122613|Curcumin|curcumin|mesh-list
677830|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
677831|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
677832|NCT03122613|Analgesics|analgesics|mesh-ancestor
677833|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
677834|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
677835|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677836|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
677837|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
677838|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677839|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677840|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678505|NCT03120663|Amoxicillin|amoxicillin|mesh-list
678506|NCT03120663|Clindamycin|clindamycin|mesh-list
678507|NCT03120663|Meropenem|meropenem|mesh-list
678508|NCT03120663|Tazobactam|tazobactam|mesh-list
678509|NCT03120663|Piperacillin|piperacillin|mesh-list
678510|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
678511|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
678512|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
678513|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
678514|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
678515|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678516|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
678517|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678518|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678519|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
678858|NCT03119324|Nimesulide|nimesulide|mesh-list
678859|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
678860|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
678861|NCT03119324|Analgesics|analgesics|mesh-ancestor
678862|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
678863|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678864|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678865|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
678866|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
678867|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
678868|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678869|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679290|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
679291|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
679292|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679293|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679294|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
679295|NCT03117023|Analgesics|analgesics|mesh-ancestor
679296|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
679297|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679298|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
676677|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
676678|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
676679|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
676680|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
676681|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
676682|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
676683|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
676684|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
676685|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
676874|NCT03127124|Leucovorin|leucovorin|mesh-list
676875|NCT03127124|Fluorouracil|fluorouracil|mesh-list
676876|NCT03127124|Bevacizumab|bevacizumab|mesh-list
676877|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
676878|NCT03127124|Calcium|calcium|mesh-list
676879|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
676880|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
676881|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676882|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
676883|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676884|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
676885|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676886|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
676887|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
676888|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
676889|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
676890|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
676891|NCT03127124|Growth Substances|growth substances|mesh-ancestor
676892|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
676893|NCT03127124|Antidotes|antidotes|mesh-ancestor
676894|NCT03127124|Protective Agents|protective agents|mesh-ancestor
676895|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
676896|NCT03127124|Vitamins|vitamins|mesh-ancestor
676897|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
676987|NCT03126721|Midazolam|midazolam|mesh-list
676988|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
676989|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
676990|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676991|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676992|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
676993|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
676994|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
676995|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
676996|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
676997|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
676998|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
676999|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
677000|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
677001|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677490|NCT03124082|Lidocaine|lidocaine|mesh-list
677491|NCT03124082|Clonidine|clonidine|mesh-list
677492|NCT03124082|Ketamine|ketamine|mesh-list
677493|NCT03124082|Remifentanil|remifentanil|mesh-list
677494|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
677495|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
677496|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
677497|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677498|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
677499|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
677500|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
677501|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
677502|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
677503|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
677504|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677505|NCT03124082|Analgesics|analgesics|mesh-ancestor
677506|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
677507|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
677508|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
677509|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
677510|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
677511|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
677512|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
677513|NCT03124082|Narcotics|narcotics|mesh-ancestor
677514|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
677515|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
677516|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
677517|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
677518|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
676719|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
676720|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
676721|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676722|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
676723|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
676724|NCT03127592|Analgesics|analgesics|mesh-ancestor
676725|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
676726|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
676727|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
676728|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
676729|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
676730|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676731|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677174|NCT03126214|Warfarin|warfarin|mesh-list
677175|NCT03126214|Anticoagulants|anticoagulants|mesh-list
677770|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
677771|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
677772|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
677773|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677774|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
677775|NCT03122782|Coagulants|coagulants|mesh-ancestor
2224530|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2224531|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
2224532|NCT00049595|Hormones|hormones|mesh-ancestor
2224533|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2224534|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2224535|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
678196|NCT03121417|Nivolumab|nivolumab|mesh-list
678197|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
678198|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678199|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
678200|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224536|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
2224537|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
2224538|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
2224539|NCT00049608|Gemcitabine|gemcitabine|mesh-list
2224540|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2224541|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
2224542|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224543|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224544|NCT00049608|Antiviral Agents|antiviral agents|mesh-ancestor
2224545|NCT00049608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224546|NCT00049608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224547|NCT00049608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
678600|NCT03119857|Docetaxel|docetaxel|mesh-list
678601|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
678602|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678603|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
678604|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
678605|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
678606|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678607|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
678608|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
678609|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678819|NCT03119038|Ketorolac|ketorolac|mesh-list
678820|NCT03119038|Clonidine|clonidine|mesh-list
678821|NCT03119038|Epinephrine|epinephrine|mesh-list
678822|NCT03119038|Bupivacaine|bupivacaine|mesh-list
678823|NCT03119038|Ropivacaine|ropivacaine|mesh-list
678824|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
678825|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
678826|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
678827|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678828|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
678829|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678830|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
678831|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
678832|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
678833|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678834|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678835|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
678836|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
678837|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
678838|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2224548|NCT00049608|Immunologic Factors|immunologic factors|mesh-ancestor
676737|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
676738|NCT03127800|Narcotics|narcotics|mesh-ancestor
676739|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
676740|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
676741|NCT03127800|Analgesics|analgesics|mesh-ancestor
676742|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
676743|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224549|NCT00049608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224550|NCT00049634|Cyclosporine|cyclosporine|mesh-list
2224551|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
2224552|NCT00049634|Busulfan|busulfan|mesh-list
2224553|NCT00049634|Methotrexate|methotrexate|mesh-list
2224554|NCT00049634|Cyclosporins|cyclosporins|mesh-list
2224555|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224556|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
2224557|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224558|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2224559|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2224560|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
2224561|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224562|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224563|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2224564|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2224565|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
2224566|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2224567|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2224568|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
2224569|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
2224570|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224571|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2224572|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2224573|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
2224574|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
677364|NCT03125187|Heparin|heparin|mesh-list
677365|NCT03125187|Calcium heparin|calcium heparin|mesh-list
677366|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
677367|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
677368|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
677369|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677667|NCT03123289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
677668|NCT03123289|Gallium citrate|gallium citrate|mesh-list
677669|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677670|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
677734|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
677735|NCT03123107|Vitamins|vitamins|mesh-ancestor
677736|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
677737|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677738|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
677739|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677740|NCT03123107|Protective Agents|protective agents|mesh-ancestor
678206|NCT03121599|Alovudine|alovudine|mesh-list
678207|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
678208|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086779|NCT02161718|Olanzapine|olanzapine|mesh-list
2086780|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
2086781|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
2086782|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086783|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086784|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086785|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2086786|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2086787|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086788|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2086789|NCT02161718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2086790|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2086791|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2086792|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086793|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086794|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
2086795|NCT02161731|Warfarin|warfarin|mesh-list
2086796|NCT02161731|Evacetrapib|evacetrapib|mesh-list
2086797|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
2086798|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2224575|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2224576|NCT00049660|Capecitabine|capecitabine|mesh-list
2224577|NCT00049660|Vinorelbine|vinorelbine|mesh-list
2224578|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
676754|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
2086799|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2086800|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
2086801|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086802|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2086803|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
2086804|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2086805|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086806|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224579|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
677948|NCT03122158|Citalopram|citalopram|mesh-list
677949|NCT03122158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
677950|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
677951|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
677952|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677953|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
677954|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
677955|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677956|NCT03122158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
677957|NCT03122158|Antidepressive Agents|antidepressive agents|mesh-ancestor
677958|NCT03122158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
678306|NCT03121079|Interferons|interferons|mesh-list
678307|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
678308|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678309|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
678310|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678311|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
678312|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224580|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224581|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224582|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2224583|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
2224584|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
2224585|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
2224586|NCT00049725|Daclizumab|daclizumab|mesh-list
2224587|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224588|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
2224589|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224590|NCT00049751|Adalimumab|adalimumab|mesh-list
2224591|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2224592|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2224593|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
2224594|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224595|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
2224596|NCT00049777|Heparin|heparin|mesh-list
2224597|NCT00049777|Calcium heparin|calcium heparin|mesh-list
2224598|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2224599|NCT00049777|Tinzaparin|tinzaparin|mesh-list
2224600|NCT00049777|Dalteparin|dalteparin|mesh-list
2224601|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
2224602|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2224603|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
679794|NCT03115034|Melatonin|melatonin|mesh-list
679795|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
679796|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679797|NCT03115034|Protective Agents|protective agents|mesh-ancestor
679798|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679799|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
680243|NCT03112785|Cimetidine|cimetidine|mesh-list
680244|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
680245|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
680246|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
680247|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
680248|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
680249|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680250|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680251|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680252|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
680253|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
680254|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680616|NCT03111420|Clopidogrel|clopidogrel|mesh-list
680617|NCT03111420|Ticagrelor|ticagrelor|mesh-list
680618|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
680619|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
680620|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
676788|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
676789|NCT03127267|Protective Agents|protective agents|mesh-ancestor
2086807|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2086808|NCT02162433|Analgesics|analgesics|mesh-ancestor
2086809|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
2086810|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086811|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
677261|NCT03125811|Ethanol|ethanol|mesh-list
677262|NCT03125811|Ondansetron|ondansetron|mesh-list
677263|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
677264|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
677265|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
677266|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677267|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
677268|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
677269|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
677270|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
677271|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
677272|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
677273|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
677274|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
677275|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
677276|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677277|NCT03125811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
677278|NCT03125811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
677279|NCT03125811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
677280|NCT03125811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2086812|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2086813|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2086814|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
2086815|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678480|NCT03120533|Treprostinil|treprostinil|mesh-list
678481|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
678575|NCT03120234|Fentanyl|fentanyl|mesh-list
678576|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
678577|NCT03120234|Ketamine|ketamine|mesh-list
678578|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
678579|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
678580|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678581|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
678582|NCT03120234|Analgesics|analgesics|mesh-ancestor
678583|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
678584|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678585|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
678586|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
678587|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
678588|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
678589|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678590|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678591|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
678592|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
678593|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
678594|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
678595|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
678596|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
678597|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
678598|NCT03120234|Narcotics|narcotics|mesh-ancestor
678599|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2224604|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224605|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224606|NCT00049790|Paclitaxel|paclitaxel|mesh-list
2224607|NCT00049790|Carboplatin|carboplatin|mesh-list
2224608|NCT00049790|Angiostatins|angiostatins|mesh-list
2224609|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2224610|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676818|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
676819|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
676820|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
676821|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
676915|NCT03126877|Mitomycins|mitomycins|mesh-list
676916|NCT03126877|Mitomycin|mitomycin|mesh-list
676917|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
676918|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
676919|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
676920|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
676921|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
676922|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224611|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
2224612|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
2224613|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
2224614|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224615|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2224616|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2224617|NCT00049790|Growth Substances|growth substances|mesh-ancestor
2224618|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224619|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
2224620|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
2224621|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2224622|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2224623|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
2224624|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
677281|NCT03125694|Pioglitazone|pioglitazone|mesh-list
677282|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
677283|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
677284|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677285|NCT03125694|Incretins|incretins|mesh-ancestor
677286|NCT03125694|Hormones|hormones|mesh-ancestor
677287|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
677288|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
677289|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
677290|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677291|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224625|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2224626|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224627|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
2224628|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
678083|NCT03121807|Leucovorin|leucovorin|mesh-list
678084|NCT03121807|Fluorouracil|fluorouracil|mesh-list
678085|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
678086|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
678087|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678088|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
678089|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678090|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
678091|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
678092|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678093|NCT03121807|Antidotes|antidotes|mesh-ancestor
678094|NCT03121807|Protective Agents|protective agents|mesh-ancestor
678095|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
678096|NCT03121807|Vitamins|vitamins|mesh-ancestor
678097|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
678729|NCT03118986|Olanzapine|olanzapine|mesh-list
678730|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
678731|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
678732|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678733|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678734|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
678735|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
678736|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
678737|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
678738|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
678739|NCT03118986|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
678740|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
678741|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
678742|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678743|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678744|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
680334|NCT03112603|Mycophenolic Acid|mycophenolic acid|mesh-list
680335|NCT03112603|Sirolimus|sirolimus|mesh-list
680336|NCT03112603|Rituximab|rituximab|mesh-list
2752490|NCT03493126|Hormones|hormones|mesh-ancestor
677086|NCT03126695|Ticagrelor|ticagrelor|mesh-list
677087|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
677088|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
677089|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
677090|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
677091|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
677092|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
677093|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677094|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677850|NCT03122717|Gefitinib|gefitinib|mesh-list
677851|NCT03122717|Osimertinib|osimertinib|mesh-list
677852|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677853|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
677854|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677855|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677933|NCT03122197|Letrozole|letrozole|mesh-list
677934|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677935|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
677936|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
677937|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677938|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677939|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
677940|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
677941|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
677942|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677995|NCT03121963|Acetaminophen|acetaminophen|mesh-list
677996|NCT03121963|Celecoxib|celecoxib|mesh-list
677997|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
677998|NCT03121963|Oxycodone|oxycodone|mesh-list
677999|NCT03121963|Gabapentin|gabapentin|mesh-list
678000|NCT03121963|Hydrocodone|hydrocodone|mesh-list
678001|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
678002|NCT03121963|Analgesics|analgesics|mesh-ancestor
678003|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
678004|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678005|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678006|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
678007|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
678008|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
678009|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
678010|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
678011|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
678012|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678013|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678014|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
678015|NCT03121963|Narcotics|narcotics|mesh-ancestor
678016|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
678017|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
678018|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
678019|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
678020|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
678021|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
678022|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
678023|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678024|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
678025|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
678026|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
678171|NCT03121716|Gemcitabine|gemcitabine|mesh-list
678172|NCT03121716|Cisplatin|cisplatin|mesh-list
678173|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
678174|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
678175|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678176|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678177|NCT03121716|Antiviral Agents|antiviral agents|mesh-ancestor
678178|NCT03121716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678179|NCT03121716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678180|NCT03121716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
678181|NCT03121716|Immunologic Factors|immunologic factors|mesh-ancestor
677044|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677045|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
677046|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
677047|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
677048|NCT03126864|Antiviral Agents|antiviral agents|mesh-ancestor
677049|NCT03126864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
677420|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
677421|NCT03124680|Narcotics|narcotics|mesh-ancestor
677422|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
677423|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677424|NCT03124680|Analgesics|analgesics|mesh-ancestor
677425|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
677426|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224629|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224630|NCT00049946|Risperidone|risperidone|mesh-list
2224631|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2224632|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
2224633|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2224634|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677810|NCT03122561|Acetaminophen|acetaminophen|mesh-list
677815|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
677816|NCT03122561|Analgesics|analgesics|mesh-ancestor
677817|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
677818|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
677819|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677820|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
678124|NCT03121521|Melatonin|melatonin|mesh-list
678125|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
678126|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678127|NCT03121521|Protective Agents|protective agents|mesh-ancestor
678128|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678129|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2224635|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224636|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2224637|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2224638|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679244|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
679245|NCT03117192|Astringents|astringents|mesh-ancestor
679246|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679247|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
679447|NCT03116659|Doxycycline|doxycycline|mesh-list
679448|NCT03116659|Imiquimod|imiquimod|mesh-list
679449|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
679450|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
679451|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
679452|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
679453|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
679454|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
679455|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
679456|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679457|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679458|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
679615|NCT03116295|Opicapone|opicapone|mesh-list
679616|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
679617|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679618|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679619|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
679620|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
679701|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
679702|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
679703|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679756|NCT03115086|Cholic Acids|cholic acids|mesh-list
679757|NCT03115086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2224639|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2224640|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2224641|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
2224642|NCT00049959|Verteporfin|verteporfin|mesh-list
2224643|NCT00049959|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2224644|NCT00049959|Dermatologic Agents|dermatologic agents|mesh-ancestor
2224645|NCT00049972|Paroxetine|paroxetine|mesh-list
677157|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677158|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
677159|NCT03126123|Protective Agents|protective agents|mesh-ancestor
677160|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677521|NCT03123978|Niclosamide|niclosamide|mesh-list
677522|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
677523|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
677524|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
677525|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
677526|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
677527|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
677778|NCT03122730|Epoprostenol|epoprostenol|mesh-list
677779|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
677780|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2086816|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086817|NCT02162667|Trastuzumab|trastuzumab|mesh-list
2224646|NCT00049972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
678263|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
678264|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
678265|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
678266|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678267|NCT03121222|Expectorants|expectorants|mesh-ancestor
678268|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
678269|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
678270|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
678271|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678272|NCT03121222|Protective Agents|protective agents|mesh-ancestor
678273|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678274|NCT03121222|Antidotes|antidotes|mesh-ancestor
678610|NCT03120182|Aspirin|aspirin|mesh-list
678611|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
678612|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
678613|NCT03120182|Analgesics|analgesics|mesh-ancestor
678614|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
678615|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678616|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678617|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
678618|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
678619|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
678620|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
678621|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678622|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
678623|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
678624|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678625|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
678642|NCT03119532|Metronidazole|metronidazole|mesh-list
678643|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678644|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
678645|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
678646|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2224647|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2224648|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2224649|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224650|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2224651|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
2224652|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224653|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2224654|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
2224655|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2224656|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2224657|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
679276|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
679277|NCT03116997|Neostigmine|neostigmine|mesh-list
679278|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
679279|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679280|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679281|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
679282|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679283|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679284|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
679285|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
679286|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679287|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
679288|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
677226|NCT03126084|Bupivacaine|bupivacaine|mesh-list
677227|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
677228|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
677229|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
677230|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677231|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
677232|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
677233|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
677234|NCT03126084|Analgesics|analgesics|mesh-ancestor
677235|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
677236|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
677237|NCT03126084|Narcotics|narcotics|mesh-ancestor
677841|NCT03122678|Thiamine|thiamine|mesh-list
677842|NCT03122678|Vitamins|vitamins|mesh-ancestor
677843|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
677844|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677845|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
678313|NCT03120962|Famciclovir|famciclovir|mesh-list
678314|NCT03120962|Oxycodone|oxycodone|mesh-list
678315|NCT03120962|Gabapentin|gabapentin|mesh-list
678316|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
678317|NCT03120962|Narcotics|narcotics|mesh-ancestor
678318|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
678319|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678320|NCT03120962|Analgesics|analgesics|mesh-ancestor
678321|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
678322|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678323|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
678324|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
678325|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
678326|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
678327|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
678328|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
678329|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678330|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678331|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
678332|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
678333|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678334|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
678335|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678527|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
678528|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
678529|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
678530|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678531|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
678532|NCT03120247|Analgesics|analgesics|mesh-ancestor
678533|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
678534|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678535|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
678536|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
678537|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
678538|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
678539|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678540|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678647|NCT03119584|Linaclotide|linaclotide|mesh-list
678648|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
678649|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
678650|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678651|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2752491|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2752492|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752496|NCT03483038|Irinotecan|irinotecan|mesh-list
2752497|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2752498|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2752499|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752500|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752501|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752502|NCT03483012|Atezolizumab|atezolizumab|mesh-list
2752503|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224658|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086818|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2224659|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
2224660|NCT00049985|Hematinics|hematinics|mesh-ancestor
2224661|NCT00049998|Topotecan|topotecan|mesh-list
2224662|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2224663|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2224664|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224665|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224666|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224667|NCT00050063|Vaccines|vaccines|mesh-list
2224668|NCT00050063|Immunologic Factors|immunologic factors|mesh-ancestor
2224669|NCT00050063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224670|NCT00050102|Ipilimumab|ipilimumab|mesh-list
2224671|NCT00050102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
677661|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
677662|NCT03123484|Gefitinib|gefitinib|mesh-list
677663|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677664|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
677665|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677666|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677910|NCT03122353|Calcitriol|calcitriol|mesh-list
677911|NCT03122353|Betamethasone|betamethasone|mesh-list
677912|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
677913|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
677914|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
677915|NCT03122353|Calcipotriene|calcipotriene|mesh-list
677916|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
677917|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
677918|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
677919|NCT03122353|Hormones|hormones|mesh-ancestor
677920|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
677921|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677922|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
677923|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
677924|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
677925|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
677926|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
677927|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
677928|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677929|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
677930|NCT03122353|Vitamins|vitamins|mesh-ancestor
677931|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
677932|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2086819|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086820|NCT02162680|Lidocaine|lidocaine|mesh-list
2086821|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
2086822|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
679388|NCT03117751|Cytarabine|cytarabine|mesh-list
679389|NCT03117751|Dexamethasone|dexamethasone|mesh-list
679390|NCT03117751|Prednisone|prednisone|mesh-list
679391|NCT03117751|Prednisolone|prednisolone|mesh-list
679392|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
679393|NCT03117751|Doxorubicin|doxorubicin|mesh-list
679394|NCT03117751|Methotrexate|methotrexate|mesh-list
679395|NCT03117751|Etoposide|etoposide|mesh-list
679396|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
679397|NCT03117751|Vincristine|vincristine|mesh-list
679398|NCT03117751|Bortezomib|bortezomib|mesh-list
679399|NCT03117751|Daunorubicin|daunorubicin|mesh-list
679400|NCT03117751|Asparaginase|asparaginase|mesh-list
679401|NCT03117751|Dasatinib|dasatinib|mesh-list
679402|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
679403|NCT03117751|Vorinostat|vorinostat|mesh-list
679404|NCT03117751|Idarubicin|idarubicin|mesh-list
679405|NCT03117751|Clofarabine|clofarabine|mesh-list
679406|NCT03117751|Thioguanine|thioguanine|mesh-list
679407|NCT03117751|Pegaspargase|pegaspargase|mesh-list
679408|NCT03117751|Blinatumomab|blinatumomab|mesh-list
679409|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
679410|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
679411|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679412|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
679413|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
679414|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
679415|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224672|NCT00050102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677440|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
677441|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
677442|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
677443|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
677444|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
677445|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
677446|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
677447|NCT03124524|Diuretics|diuretics|mesh-ancestor
677448|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
677449|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
677450|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
677451|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677701|NCT03123211|Veliparib|veliparib|mesh-list
677702|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
677703|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677704|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677705|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752518|NCT03474029|Rifampin|rifampin|mesh-list
2752519|NCT03474029|Rifapentine|rifapentine|mesh-list
2752520|NCT03474029|Isoniazid|isoniazid|mesh-list
2752521|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2752522|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
2752523|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2752524|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
679097|NCT03117894|Acetaminophen|acetaminophen|mesh-list
679098|NCT03117894|Etoricoxib|etoricoxib|mesh-list
679099|NCT03117894|Morphine|morphine|mesh-list
679100|NCT03117894|Remifentanil|remifentanil|mesh-list
679101|NCT03117894|Ondansetron|ondansetron|mesh-list
679102|NCT03117894|Propofol|propofol|mesh-list
679103|NCT03117894|Ropivacaine|ropivacaine|mesh-list
679104|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
679105|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679106|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679107|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
679108|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
679109|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
679110|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
679111|NCT03117894|Narcotics|narcotics|mesh-ancestor
679112|NCT03117894|Analgesics|analgesics|mesh-ancestor
679113|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
679114|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679115|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
679116|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
679117|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
679118|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
679119|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
679120|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
679121|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
679122|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
679123|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
679124|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
679125|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679126|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679127|NCT03117894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
679128|NCT03117894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
679129|NCT03117894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
679130|NCT03117894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
679131|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
679132|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
679133|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
679134|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
679135|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
679136|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224673|NCT00050102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
677482|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
677483|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2224674|NCT00050102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224675|NCT00050141|Tipifarnib|tipifarnib|mesh-list
2224676|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224677|NCT00050154|Tipifarnib|tipifarnib|mesh-list
677881|NCT03122444|Imipramine|imipramine|mesh-list
677882|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
677883|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
677884|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
677885|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
677886|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
677887|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
677888|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677889|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
677890|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
677891|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677973|NCT03122132|Ritonavir|ritonavir|mesh-list
677974|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
677975|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
677976|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
677977|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677978|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677979|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
677980|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
677981|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
677982|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
677983|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
677984|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
678500|NCT03120637|Methylene Blue|methylene blue|mesh-list
678501|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678502|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678661|NCT03119623|Valsartan|valsartan|mesh-list
678662|NCT03119623|Enalapril|enalapril|mesh-list
678663|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
678664|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
678665|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
678666|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678667|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
678668|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
678669|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678745|NCT03119194|Opicapone|opicapone|mesh-list
678746|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
678747|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678748|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678749|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
678750|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
679610|NCT03116282|Ethanol|ethanol|mesh-list
679611|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
679612|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
679613|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679614|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224678|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224679|NCT00050180|Indinavir|indinavir|mesh-list
2224680|NCT00050180|Saquinavir|saquinavir|mesh-list
2224681|NCT00050180|Midazolam|midazolam|mesh-list
2224682|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
680013|NCT03113773|Aldesleukin|aldesleukin|mesh-list
680014|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680015|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
680016|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
680017|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
680018|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
680060|NCT03113409|Naltrexone|naltrexone|mesh-list
680061|NCT03113409|Buprenorphine|buprenorphine|mesh-list
680062|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
680063|NCT03113409|Narcotics|narcotics|mesh-ancestor
680064|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
680065|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680066|NCT03113409|Analgesics|analgesics|mesh-ancestor
680067|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
680068|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680069|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
680070|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2224683|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
677519|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
677520|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
677612|NCT03123718|Methotrexate|methotrexate|mesh-list
677613|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
677614|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
677615|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
677616|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677617|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
677618|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
677619|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677620|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677621|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
677622|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677623|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
677624|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
677625|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
677626|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
677627|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
677706|NCT03123276|Gemcitabine|gemcitabine|mesh-list
677707|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
677708|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
677709|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
677710|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677711|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677712|NCT03123276|Antiviral Agents|antiviral agents|mesh-ancestor
677713|NCT03123276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
677714|NCT03123276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677715|NCT03123276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
677716|NCT03123276|Immunologic Factors|immunologic factors|mesh-ancestor
677717|NCT03123276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677718|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2224684|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2224685|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224686|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2224687|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2224688|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2086823|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086824|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086825|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
2086826|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086827|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2086828|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2086829|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2086830|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2086831|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086832|NCT02162719|Paclitaxel|paclitaxel|mesh-list
2086833|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2086834|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086835|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
2086836|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
2086837|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
2224689|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2224690|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
2224691|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
2224692|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
2224693|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
2224694|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679957|NCT03114215|Biotin|biotin|mesh-list
679958|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
679959|NCT03114215|Vitamins|vitamins|mesh-ancestor
679960|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
679961|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680262|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
680263|NCT03112551|Analgesics|analgesics|mesh-ancestor
680264|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
680265|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680266|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680267|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
680268|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
677549|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677550|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
677551|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677552|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
677719|NCT03123016|Apremilast|apremilast|mesh-list
677720|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
677721|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
677722|NCT03123016|Analgesics|analgesics|mesh-ancestor
677723|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
677724|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
677725|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677726|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
677727|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
677728|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
677729|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
677730|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677731|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224695|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224696|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2224697|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2224698|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
2224699|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678490|NCT03120494|Tenofovir|tenofovir|mesh-list
678491|NCT03120494|Emtricitabine|emtricitabine|mesh-list
678492|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
678493|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678494|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
678495|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
678496|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678497|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678498|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
678499|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2224700|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2224701|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2224702|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
2224703|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224704|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2224705|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2224706|NCT00050206|Olanzapine|olanzapine|mesh-list
2224707|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
2224708|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
678937|NCT03118479|Anastrozole|anastrozole|mesh-list
678938|NCT03118479|Testosterone|testosterone|mesh-list
678939|NCT03118479|Androgens|androgens|mesh-ancestor
678940|NCT03118479|Hormones|hormones|mesh-ancestor
678941|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
678942|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678943|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
678944|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678945|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
678946|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
678947|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678948|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678949|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
678950|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
679523|NCT03116347|Immunoglobulins|immunoglobulins|mesh-list
679524|NCT03116347|Antibodies|antibodies|mesh-list
679525|NCT03116347|gamma-Globulins|gamma-globulins|mesh-list
679526|NCT03116347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
679527|NCT03116347|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
679528|NCT03116347|Immunoglobulin G|immunoglobulin g|mesh-list
679529|NCT03116347|Immunologic Factors|immunologic factors|mesh-ancestor
679530|NCT03116347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224709|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224710|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224711|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2224712|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2224713|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2224714|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2224715|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2224716|NCT00050206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2224717|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2224718|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
680047|NCT03113708|Heparin|heparin|mesh-list
680048|NCT03113708|Calcium heparin|calcium heparin|mesh-list
677609|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
677610|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677611|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679380|NCT03116737|Benzocaine|benzocaine|mesh-list
679381|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
679382|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
679383|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
679384|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679385|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679386|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
679387|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224719|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224720|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2224721|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
2224722|NCT00050245|Rituximab|rituximab|mesh-list
2224723|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2224724|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224725|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
2224726|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224727|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2224728|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
679692|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
679693|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
679694|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
679695|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
679696|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
679697|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679698|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
679699|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
679700|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679919|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
679920|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
679921|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
679983|NCT03113851|Molgramostim|molgramostim|mesh-list
679984|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680720|NCT03111069|Doxorubicin|doxorubicin|mesh-list
680721|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
680722|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
680723|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680724|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
680725|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
680726|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680727|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681227|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
681228|NCT03108690|Meropenem|meropenem|mesh-list
681229|NCT03108690|Tazobactam|tazobactam|mesh-list
681230|NCT03108690|Piperacillin|piperacillin|mesh-list
681231|NCT03108690|Ampicillin|ampicillin|mesh-list
681232|NCT03108690|Cefuroxime|cefuroxime|mesh-list
681233|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
681234|NCT03108690|Lactams|lactams|mesh-list
681235|NCT03108690|beta-Lactams|beta-lactams|mesh-list
681236|NCT03108690|Penicillin G|penicillin g|mesh-list
681237|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
681238|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
681239|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
681240|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
681241|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
681242|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681243|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681269|NCT03108313|Fluorides|fluorides|mesh-list
681270|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
681271|NCT03108313|Protective Agents|protective agents|mesh-ancestor
681272|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681472|NCT03107481|Acetaminophen|acetaminophen|mesh-list
681473|NCT03107481|Hydromorphone|hydromorphone|mesh-list
681474|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
681475|NCT03107481|Analgesics|analgesics|mesh-ancestor
681476|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
681477|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681478|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681479|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
681480|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
681481|NCT03107481|Narcotics|narcotics|mesh-ancestor
681482|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681577|NCT03107169|Vancomycin|vancomycin|mesh-list
681578|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2224729|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
2224730|NCT00050271|Vitamins|vitamins|mesh-ancestor
2224731|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
2224732|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224733|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
2224734|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
2224735|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
678159|NCT03121664|Itraconazole|itraconazole|mesh-list
678160|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
678161|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678162|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
678163|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
678164|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678165|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678166|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
678167|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
678168|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
678169|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678170|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
678401|NCT03120780|Fentanyl|fentanyl|mesh-list
678402|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
678403|NCT03120780|Narcotics|narcotics|mesh-ancestor
678404|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
678405|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678406|NCT03120780|Analgesics|analgesics|mesh-ancestor
678407|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
678408|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678409|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
678410|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
678411|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
678412|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
678482|NCT03120403|Morphine|morphine|mesh-list
678483|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
678484|NCT03120403|Narcotics|narcotics|mesh-ancestor
678485|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
678486|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678487|NCT03120403|Analgesics|analgesics|mesh-ancestor
678488|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
678489|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678798|NCT03119077|Itraconazole|itraconazole|mesh-list
678799|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
678800|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678801|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
678802|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
678803|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678804|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678805|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
678806|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
678807|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
678808|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678809|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2224736|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224737|NCT00050336|Lonafarnib|lonafarnib|mesh-list
2224738|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224739|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224740|NCT00050349|Epothilones|epothilones|mesh-list
2224741|NCT00050349|Epothilone B|epothilone b|mesh-list
2224742|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
2224743|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
2224744|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
2224745|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224746|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224747|NCT00050362|Rofecoxib|rofecoxib|mesh-list
2224748|NCT00050362|Bupivacaine|bupivacaine|mesh-list
2224749|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
679304|NCT03116945|Gallium citrate|gallium citrate|mesh-list
679305|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679306|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
680397|NCT03112148|Tofacitinib|tofacitinib|mesh-list
680398|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
680399|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680400|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677681|NCT03123445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
677682|NCT03123445|Immunologic Factors|immunologic factors|mesh-ancestor
677683|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677684|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
677685|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
677686|NCT03123445|Growth Substances|growth substances|mesh-ancestor
677687|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
677791|NCT03122652|Teriflunomide|teriflunomide|mesh-list
677792|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
677793|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
677794|NCT03122652|Analgesics|analgesics|mesh-ancestor
677795|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
677796|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
677797|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677798|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
677799|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
677800|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
677801|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
678652|NCT03119454|Betamethasone|betamethasone|mesh-list
678653|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
678654|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
678655|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
678656|NCT03119454|Hormones|hormones|mesh-ancestor
678657|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
678658|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678659|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
678660|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
2224750|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
2224751|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2224752|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224753|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
2224754|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224755|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
679636|NCT03115697|Rifaximin|rifaximin|mesh-list
679637|NCT03115697|Lactulose|lactulose|mesh-list
679638|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
679639|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
679640|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
679734|NCT03115255|Ranibizumab|ranibizumab|mesh-list
679735|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
679736|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
679737|NCT03115255|Growth Substances|growth substances|mesh-ancestor
679738|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679739|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
679740|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679930|NCT03114072|Methamphetamine|methamphetamine|mesh-list
679931|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
679932|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679933|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
679934|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
679935|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679936|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
679937|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679938|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679939|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
679940|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
679941|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2224756|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2224757|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678209|NCT03121352|Paclitaxel|paclitaxel|mesh-list
678210|NCT03121352|Carboplatin|carboplatin|mesh-list
678211|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
678212|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
678213|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678214|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
678215|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
678216|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
678217|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678218|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
678520|NCT03120273|Lansoprazole|lansoprazole|mesh-list
678521|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
678522|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
678523|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
678524|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
678525|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678526|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678765|NCT03119012|Aspirin|aspirin|mesh-list
678766|NCT03119012|Clopidogrel|clopidogrel|mesh-list
678767|NCT03119012|Ticagrelor|ticagrelor|mesh-list
678768|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
678769|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
678770|NCT03119012|Analgesics|analgesics|mesh-ancestor
678771|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
678772|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678773|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678774|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
678775|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
678776|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
678777|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
678778|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678779|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
678780|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
678781|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678782|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
678783|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
678784|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
678785|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
678786|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
678787|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679562|NCT03116516|Amlodipine|amlodipine|mesh-list
679563|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
679564|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
679565|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
679566|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
679567|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679568|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
679569|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679570|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
679571|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
679572|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
679573|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
679574|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
679575|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
679576|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679712|NCT03115567|Triamcinolone|triamcinolone|mesh-list
679713|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
679714|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
679715|NCT03115567|Hormones|hormones|mesh-ancestor
679716|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
679717|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680156|NCT03112889|Valproic Acid|valproic acid|mesh-list
680157|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
680158|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680159|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680160|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
680161|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680162|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680163|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
680164|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
680165|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
680166|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2752525|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
677747|NCT03122847|Prednisolone|prednisolone|mesh-list
677748|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
677749|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
677750|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
677751|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
677752|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
677753|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
677754|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
677755|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
677756|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
677757|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
677758|NCT03122847|Hormones|hormones|mesh-ancestor
677759|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
677760|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
677761|NCT03122847|Protective Agents|protective agents|mesh-ancestor
677762|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
677763|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
677821|NCT03122639|Atorvastatin|atorvastatin|mesh-list
677822|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
677823|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
677824|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
677825|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677826|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
677827|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
677828|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678027|NCT03121846|Apatinib|apatinib|mesh-list
678028|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678029|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
678030|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678031|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086838|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086839|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
2086840|NCT02162758|Lansoprazole|lansoprazole|mesh-list
2086841|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2086842|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086843|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2086844|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086845|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086846|NCT02162771|Prednisone|prednisone|mesh-list
2086847|NCT02162771|Prednisolone|prednisolone|mesh-list
2086848|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
2086849|NCT02162771|Rituximab|rituximab|mesh-list
2086850|NCT02162771|Vincristine|vincristine|mesh-list
679137|NCT03117933|Paclitaxel|paclitaxel|mesh-list
679138|NCT03117933|Olaparib|olaparib|mesh-list
679139|NCT03117933|Cediranib|cediranib|mesh-list
679140|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
679141|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679142|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
679143|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
679144|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
679145|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679146|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
679147|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679148|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
679331|NCT03116893|Itraconazole|itraconazole|mesh-list
679332|NCT03116893|Rifampin|rifampin|mesh-list
679333|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
679334|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
679335|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
679336|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
679337|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679338|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679339|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
679340|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
679341|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
679342|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679343|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
679344|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
679345|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
679346|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
679347|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
679348|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2086851|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2086852|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
677769|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
677846|NCT03122509|Durvalumab|durvalumab|mesh-list
677847|NCT03122509|Tremelimumab|tremelimumab|mesh-list
677848|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
677849|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224758|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224759|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2224760|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2224761|NCT00050362|Analgesics|analgesics|mesh-ancestor
2224762|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2224763|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2224764|NCT00050375|Oregovomab|oregovomab|mesh-list
2224765|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2224766|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678296|NCT03120936|Tenofovir|tenofovir|mesh-list
678297|NCT03120936|Emtricitabine|emtricitabine|mesh-list
678298|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
678299|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678300|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
678301|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
678302|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678303|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678304|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
678305|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
678870|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
678871|NCT03118830|Cetrorelix|cetrorelix|mesh-list
678872|NCT03118830|Hormones|hormones|mesh-list
678873|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
678874|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
678875|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678876|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
678877|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
678878|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
678879|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
678880|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
678881|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
678882|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678883|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
678884|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
678885|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
679035|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
679036|NCT03118076|Ropivacaine|ropivacaine|mesh-list
679037|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
679038|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679039|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679040|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
679041|NCT03118076|Analgesics|analgesics|mesh-ancestor
679042|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
679043|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679044|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
679045|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
679046|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
679047|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
679048|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679049|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679050|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
679051|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
679515|NCT03116555|Irinotecan|irinotecan|mesh-list
679516|NCT03116555|Apatinib|apatinib|mesh-list
679517|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
679518|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
679519|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679520|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679521|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679522|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
679834|NCT03115151|Fentanyl|fentanyl|mesh-list
679835|NCT03115151|Hydromorphone|hydromorphone|mesh-list
679836|NCT03115151|Bupivacaine|bupivacaine|mesh-list
679837|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
679838|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
679839|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679840|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679841|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
679842|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679843|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
679844|NCT03115151|Narcotics|narcotics|mesh-ancestor
677857|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
677858|NCT03122665|Analgesics|analgesics|mesh-ancestor
677859|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
677860|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
677861|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678352|NCT03121014|Methotrexate|methotrexate|mesh-list
678353|NCT03121014|Fludarabine|fludarabine|mesh-list
678354|NCT03121014|Busulfan|busulfan|mesh-list
678355|NCT03121014|Tacrolimus|tacrolimus|mesh-list
678356|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
678357|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
678358|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
678359|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
678360|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678361|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
678362|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
678363|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678364|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678365|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
678366|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678367|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
678368|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
678369|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
678370|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
678371|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
678372|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
678373|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
678374|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
678375|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2224767|NCT00050401|Vancomycin|vancomycin|mesh-list
2224768|NCT00050401|Tobramycin|tobramycin|mesh-list
2224769|NCT00050401|Meropenem|meropenem|mesh-list
2224770|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2224771|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224772|NCT00050414|Dexamethasone|dexamethasone|mesh-list
2224773|NCT00050414|Trabectedin|trabectedin|mesh-list
2224774|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2224775|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
678981|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
678982|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
678983|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
678984|NCT03118232|Povidone|povidone|mesh-list
678985|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
678986|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678987|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
678988|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
678989|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
678990|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
679183|NCT03117595|Fentanyl|fentanyl|mesh-list
679184|NCT03117595|Morphine|morphine|mesh-list
679185|NCT03117595|Bupivacaine|bupivacaine|mesh-list
679186|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
679187|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
679188|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679189|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679190|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
679191|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679192|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
679193|NCT03117595|Narcotics|narcotics|mesh-ancestor
679194|NCT03117595|Analgesics|analgesics|mesh-ancestor
679195|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
679196|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
679197|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
679229|NCT03117257|Cisplatin|cisplatin|mesh-list
679230|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679586|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
679587|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
679588|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
679589|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
679590|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
679591|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679779|NCT03114865|Dexamethasone|dexamethasone|mesh-list
679780|NCT03114865|Blinatumomab|blinatumomab|mesh-list
679781|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
679782|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
679783|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
679784|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
679785|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679845|NCT03115151|Analgesics|analgesics|mesh-ancestor
2224776|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
677965|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
677966|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
677967|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677968|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
677969|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
677970|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
677971|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
677972|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
678075|NCT03121833|Endostar protein|endostar protein|mesh-list
678076|NCT03121833|Endostatins|endostatins|mesh-list
678077|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
678078|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
678079|NCT03121833|Growth Substances|growth substances|mesh-ancestor
678080|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678081|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
678082|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679493|NCT03116672|Diclofenac|diclofenac|mesh-list
679494|NCT03116672|Ketorolac|ketorolac|mesh-list
679495|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
679496|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
679497|NCT03116672|Analgesics|analgesics|mesh-ancestor
679498|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
679499|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679500|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679501|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
679502|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
679503|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
679504|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679505|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086853|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224777|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680382|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
680383|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
680384|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
680385|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
680386|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
2224778|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224779|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
681011|NCT03109756|Gaboxadol|gaboxadol|mesh-list
681012|NCT03109756|Analgesics|analgesics|mesh-ancestor
681013|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
681014|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681015|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681016|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
681017|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
681018|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
681019|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681020|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681177|NCT03108846|Citalopram|citalopram|mesh-list
681178|NCT03108846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
681179|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
681180|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
681181|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681182|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681183|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
681184|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681185|NCT03108846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
681186|NCT03108846|Antidepressive Agents|antidepressive agents|mesh-ancestor
681187|NCT03108846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
681299|NCT03108326|Infliximab|infliximab|mesh-list
681300|NCT03108326|Ustekinumab|ustekinumab|mesh-list
681301|NCT03108326|Vedolizumab|vedolizumab|mesh-list
681302|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
681303|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
681304|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
682094|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
682095|NCT03104855|Calcifediol|calcifediol|mesh-list
682096|NCT03104855|Vitamins|vitamins|mesh-ancestor
682097|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
682098|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682099|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
682145|NCT03104439|Nivolumab|nivolumab|mesh-list
682146|NCT03104439|Ipilimumab|ipilimumab|mesh-list
682147|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
682148|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682149|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
677989|NCT03122041|Hormones|hormones|mesh-ancestor
677990|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
677991|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
677992|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
677993|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
677994|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678464|NCT03120715|Heparin|heparin|mesh-list
678465|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
678466|NCT03120715|Tinzaparin|tinzaparin|mesh-list
678467|NCT03120715|Dalteparin|dalteparin|mesh-list
678468|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
678469|NCT03120715|Progesterone|progesterone|mesh-list
678470|NCT03120715|Estrogens|estrogens|mesh-list
678471|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
678472|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
678473|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
678474|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678475|NCT03120715|Progestins|progestins|mesh-ancestor
678476|NCT03120715|Hormones|hormones|mesh-ancestor
678477|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
678478|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678479|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
678626|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
678627|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
678628|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
678629|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678630|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
678631|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678632|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224780|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
2224781|NCT00050414|Hormones|hormones|mesh-ancestor
2224782|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
679512|NCT03116542|Alovudine|alovudine|mesh-list
679513|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
679514|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086854|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2086855|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2086856|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
2086857|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086858|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086859|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2086860|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
680123|NCT03113019|Vaccines|vaccines|mesh-list
680124|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
680125|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680463|NCT03112031|Tamoxifen|tamoxifen|mesh-list
680464|NCT03112031|Fluconazole|fluconazole|mesh-list
680465|NCT03112031|Amphotericin B|amphotericin b|mesh-list
680466|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
680467|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
680468|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
680469|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
680470|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680471|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
680472|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680473|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
680474|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
680475|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
680476|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
680477|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
680478|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
680479|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
680480|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680481|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680482|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
680483|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
680484|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
680485|NCT03112031|Amebicides|amebicides|mesh-ancestor
680486|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
680487|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
680488|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2086861|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2086862|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
678034|NCT03122002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
678035|NCT03122002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
678036|NCT03122002|Analgesics|analgesics|mesh-ancestor
678037|NCT03122002|Sensory System Agents|sensory system agents|mesh-ancestor
678038|NCT03122002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678039|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678040|NCT03122002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
678041|NCT03122002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
678042|NCT03122002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
678043|NCT03122002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
678044|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678045|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
678046|NCT03122002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
678047|NCT03122002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678048|NCT03122002|Antipyretics|antipyretics|mesh-ancestor
678049|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
678050|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
678051|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
678052|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
678053|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678183|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
678184|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
678185|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
678186|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
678187|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678188|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678189|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678190|NCT03121573|Analgesics|analgesics|mesh-ancestor
678191|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
678192|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678193|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
678194|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
678195|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
2224783|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2224784|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224785|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
679022|NCT03118037|Zaleplon|zaleplon|mesh-list
679023|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
679024|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
679025|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679026|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679027|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
679028|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
679029|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679030|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679307|NCT03117166|Lidocaine|lidocaine|mesh-list
679308|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
679309|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
679310|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679311|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679312|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
679313|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679314|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
679315|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
679316|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
679317|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
679318|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679903|NCT03114527|Everolimus|everolimus|mesh-list
679904|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679905|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
679906|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
679907|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086863|NCT02162771|Hormones|hormones|mesh-ancestor
2086864|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2086865|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2086866|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2086867|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
2086868|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
2086869|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
2086870|NCT02162862|Bupropion|bupropion|mesh-list
2086871|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2086872|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
678182|NCT03121716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224786|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
2224787|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224788|NCT00050427|Trabectedin|trabectedin|mesh-list
2224789|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2224790|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
678676|NCT03119428|Nivolumab|nivolumab|mesh-list
678677|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
678678|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
678679|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
678680|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679084|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
679085|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
679086|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
679087|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679088|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680299|NCT03112564|Fentanyl|fentanyl|mesh-list
680300|NCT03112564|Sevoflurane|sevoflurane|mesh-list
680301|NCT03112564|Rocuronium|rocuronium|mesh-list
680302|NCT03112564|Cisatracurium|cisatracurium|mesh-list
680303|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
680304|NCT03112564|Narcotics|narcotics|mesh-ancestor
680305|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
680306|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680307|NCT03112564|Analgesics|analgesics|mesh-ancestor
680308|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
680309|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680310|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
680311|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
680312|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
680313|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
680314|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
680315|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
680316|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
680317|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
680318|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
680909|NCT03109886|Maleic acid|maleic acid|mesh-list
680910|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680911|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224791|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224792|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224793|NCT00050440|Dexamethasone|dexamethasone|mesh-list
2224794|NCT00050440|Trabectedin|trabectedin|mesh-list
2224795|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2224796|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
2224797|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
2224798|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224799|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224800|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2224801|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
2224802|NCT00050440|Hormones|hormones|mesh-ancestor
2224803|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2224804|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2224805|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681553|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
681554|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
681555|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
681556|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
681557|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
681558|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681559|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681560|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
681561|NCT03107078|Hormones|hormones|mesh-ancestor
681562|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
681563|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
681564|NCT03107078|Protective Agents|protective agents|mesh-ancestor
682106|NCT03104842|Dexamethasone|dexamethasone|mesh-list
682107|NCT03104842|Lenalidomide|lenalidomide|mesh-list
678250|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678251|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
678252|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
678253|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
678254|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
678255|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
678256|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
678257|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
678258|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678259|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678260|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
678261|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
678262|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
678907|NCT03118713|Metformin|metformin|mesh-list
678908|NCT03118713|Glimepiride|glimepiride|mesh-list
678909|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
678910|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
678911|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678912|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
678913|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
678914|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
678915|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
678916|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679223|NCT03117725|Melatonin|melatonin|mesh-list
679224|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
679225|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679226|NCT03117725|Protective Agents|protective agents|mesh-ancestor
679227|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679228|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679577|NCT03116126|Guanfacine|guanfacine|mesh-list
679578|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
679579|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
679580|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
679581|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
679582|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
679583|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679584|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679585|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679761|NCT03115047|Meperidine|meperidine|mesh-list
679762|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
679763|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
679764|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679765|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679766|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
679767|NCT03115047|Analgesics|analgesics|mesh-ancestor
679768|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
679769|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679770|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
679771|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
679772|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
679773|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
679774|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679775|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679776|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
679777|NCT03115047|Narcotics|narcotics|mesh-ancestor
679778|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
679908|NCT03114371|Oxytocin|oxytocin|mesh-list
679909|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
679910|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
679911|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086873|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2086874|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2086875|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2086876|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2086877|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086878|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
2086879|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680255|NCT03112642|Anesthetics|anesthetics|mesh-list
680256|NCT03112642|Bupivacaine|bupivacaine|mesh-list
680257|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
680258|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
680259|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680260|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
680261|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086880|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086881|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2086882|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2224806|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2224807|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
2224808|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224809|NCT00050479|Celecoxib|celecoxib|mesh-list
2224810|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2224811|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2224812|NCT00050479|Analgesics|analgesics|mesh-ancestor
679258|NCT03117010|Dexamethasone|dexamethasone|mesh-list
679259|NCT03117010|Etoposide|etoposide|mesh-list
679260|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
679261|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
679262|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
679263|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679264|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679265|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
679266|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
679267|NCT03117010|Hormones|hormones|mesh-ancestor
679268|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
679269|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
679270|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679271|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679272|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679273|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
679274|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
679275|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
679372|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
679373|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
679374|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
679375|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
679376|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
679377|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679378|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
679379|NCT03116776|Protective Agents|protective agents|mesh-ancestor
679641|NCT03115736|Tenofovir|tenofovir|mesh-list
679642|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
679643|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
679644|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
679645|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
679646|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679647|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679648|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
679649|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
679819|NCT03115073|Clotrimazole|clotrimazole|mesh-list
679820|NCT03115073|Miconazole|miconazole|mesh-list
679821|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
679822|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
679823|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
679824|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
679825|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
679826|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679827|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679828|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
679829|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
679830|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
679831|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679832|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
679833|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
680378|NCT03112187|Iron|iron|mesh-list
680379|NCT03112187|Trace Elements|trace elements|mesh-ancestor
680380|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
680381|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680431|NCT03112005|Mydriatics|mydriatics|mesh-list
680432|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
680433|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680434|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680812|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
680813|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
680814|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
680815|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680816|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
680817|NCT03110679|Protective Agents|protective agents|mesh-ancestor
678424|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
678425|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
678426|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
679205|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
679206|NCT03117439|Clotrimazole|clotrimazole|mesh-list
679207|NCT03117439|Miconazole|miconazole|mesh-list
679208|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
679209|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
679210|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
679211|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
679212|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679213|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679214|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
679215|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
679216|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
679217|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679218|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
679219|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
679319|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
679320|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
679321|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
679322|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
679323|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
680757|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
680758|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
680759|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
680760|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680761|NCT03110757|Antacids|antacids|mesh-ancestor
680762|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680763|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
680936|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
680937|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
680938|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
681075|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
681076|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
681077|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
681078|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681079|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
681080|NCT03109652|Coagulants|coagulants|mesh-ancestor
2224813|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
2224814|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224815|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224816|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2224817|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2224818|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2224819|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2224820|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224821|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224822|NCT00050505|Vaccines|vaccines|mesh-list
681332|NCT03108131|Atezolizumab|atezolizumab|mesh-list
681333|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
681334|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681335|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
681336|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681501|NCT03107429|Acetazolamide|acetazolamide|mesh-list
681502|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
681503|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
681504|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681505|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681506|NCT03107429|Diuretics|diuretics|mesh-ancestor
681507|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
681508|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681929|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
681930|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
681931|NCT03105505|Permethrin|permethrin|mesh-list
681932|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
681933|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681934|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681935|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
681936|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
681937|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
682320|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
682321|NCT03103555|Bortezomib|bortezomib|mesh-list
682322|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
682323|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
678445|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
678446|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
678447|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678448|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
678449|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
678450|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
678451|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
678452|NCT03120442|Analgesics|analgesics|mesh-ancestor
678453|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
678454|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
678455|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
678456|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
678457|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
678458|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
678459|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678460|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678461|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
678462|NCT03120442|Narcotics|narcotics|mesh-ancestor
678463|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
679031|NCT03118167|Antioxidants|antioxidants|mesh-list
679032|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679033|NCT03118167|Protective Agents|protective agents|mesh-ancestor
679034|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679055|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
679056|NCT03117790|Morphine|morphine|mesh-list
679057|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
679058|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679059|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679060|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
679061|NCT03117790|Analgesics|analgesics|mesh-ancestor
679062|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
679063|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679064|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
679065|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
679066|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
679067|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
679068|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679069|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679070|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
679071|NCT03117790|Narcotics|narcotics|mesh-ancestor
2224823|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
2224824|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224825|NCT00050531|Interferons|interferons|mesh-list
2224826|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
2224827|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
2224828|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2224829|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2224830|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
2224831|NCT00050531|Molgramostim|molgramostim|mesh-list
2224832|NCT00050531|Sargramostim|sargramostim|mesh-list
2224833|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224834|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
2224835|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224836|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
2224837|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224838|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2224839|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224840|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224841|NCT00050596|Docetaxel|docetaxel|mesh-list
2224842|NCT00050596|Ipilimumab|ipilimumab|mesh-list
2224843|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224844|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
2224845|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
2224846|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
2224847|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224848|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2224849|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2224850|NCT00050609|Tadalafil|tadalafil|mesh-list
2224851|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
2224852|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2224853|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2752526|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2752527|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752528|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680049|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
678670|NCT03119714|Pemirolast|pemirolast|mesh-list
678671|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
678672|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
678673|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678674|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678675|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224854|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224855|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224856|NCT00050609|Urological Agents|urological agents|mesh-ancestor
2224857|NCT00050635|Octreotide|octreotide|mesh-list
2224858|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
679080|NCT03117660|Vitamin A|vitamin a|mesh-list
679081|NCT03117660|Vitamins|vitamins|mesh-ancestor
679082|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
679083|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679220|NCT03117530|Minocycline|minocycline|mesh-list
679221|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
679222|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
679355|NCT03117049|Paclitaxel|paclitaxel|mesh-list
679356|NCT03117049|Bevacizumab|bevacizumab|mesh-list
679357|NCT03117049|Carboplatin|carboplatin|mesh-list
679358|NCT03117049|Nivolumab|nivolumab|mesh-list
679359|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
679360|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679361|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
679362|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
679363|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
679364|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679365|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
679366|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
679367|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
679368|NCT03117049|Growth Substances|growth substances|mesh-ancestor
679369|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679370|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
679371|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
680295|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
680296|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
680297|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
680298|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
680422|NCT03112226|Estradiol|estradiol|mesh-list
680423|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
680424|NCT03112226|Estrogens|estrogens|mesh-ancestor
680425|NCT03112226|Hormones|hormones|mesh-ancestor
680426|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
680427|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680428|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
680828|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
680829|NCT03110432|Niacin|niacin|mesh-list
680830|NCT03110432|Ezetimibe|ezetimibe|mesh-list
680831|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
680832|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
680833|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
680834|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
680835|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680836|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
680837|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
680838|NCT03110432|Vitamins|vitamins|mesh-ancestor
680839|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
680840|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680841|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
681316|NCT03108287|Amoxicillin|amoxicillin|mesh-list
681317|NCT03108287|Clarithromycin|clarithromycin|mesh-list
681318|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
681319|NCT03108287|Rabeprazole|rabeprazole|mesh-list
681320|NCT03108287|Bismuth|bismuth|mesh-list
681321|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
681322|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
681323|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
681324|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681325|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681326|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
681327|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
681328|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
681329|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
681330|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
681331|NCT03108287|Antacids|antacids|mesh-ancestor
678681|NCT03119636|Levodopa|levodopa|mesh-list
678682|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
678683|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
678684|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
678685|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
678686|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678687|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
678788|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
678789|NCT03119116|Apixaban|apixaban|mesh-list
678790|NCT03119116|Dabigatran|dabigatran|mesh-list
678791|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
678792|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
678793|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
678794|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
678795|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678796|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678797|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
678999|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
679000|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
679001|NCT03118492|Melphalan|melphalan|mesh-list
679002|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
679003|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
679004|NCT03118492|Fludarabine|fludarabine|mesh-list
679005|NCT03118492|Tacrolimus|tacrolimus|mesh-list
679006|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
679007|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
679008|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679009|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
679010|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
679011|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
679012|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679013|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679014|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
679015|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
679016|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679017|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
679018|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
679019|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
679020|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
679021|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
679666|NCT03115489|Ketamine|ketamine|mesh-list
679667|NCT03115489|Propofol|propofol|mesh-list
679668|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
679669|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679670|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679671|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
679672|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
679673|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
679674|NCT03115489|Analgesics|analgesics|mesh-ancestor
679675|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
679676|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679677|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
679678|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
679679|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
679680|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679681|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679803|NCT03114813|Carvedilol|carvedilol|mesh-list
679804|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
679805|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
679806|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
679807|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679808|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679809|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679810|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
679811|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
679812|NCT03114813|Protective Agents|protective agents|mesh-ancestor
679813|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
679814|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
679815|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
679816|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
679817|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
679818|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
680945|NCT03110055|Grazoprevir|grazoprevir|mesh-list
680946|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
680947|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224859|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2224860|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224861|NCT00050648|Cyclosporine|cyclosporine|mesh-list
2224862|NCT00050648|Cyclosporins|cyclosporins|mesh-list
2224863|NCT00050648|Daclizumab|daclizumab|mesh-list
2224864|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2224865|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224866|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224867|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
2224868|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224869|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
2224870|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224871|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
2224872|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2224873|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2224874|NCT00050661|Daclizumab|daclizumab|mesh-list
2224875|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224876|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
2224877|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224878|NCT00050674|Lenograstim|lenograstim|mesh-list
2224879|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
678902|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
678903|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
678904|NCT03118674|Ledipasvir|ledipasvir|mesh-list
678905|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
678906|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
678994|NCT03118336|Empagliflozin|empagliflozin|mesh-list
678995|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
678996|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
678997|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
678998|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679094|NCT03117998|Volagidemab|volagidemab|mesh-list
679095|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
679096|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679198|NCT03117335|Endostatins|endostatins|mesh-list
679199|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679200|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
679201|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
679202|NCT03117335|Growth Substances|growth substances|mesh-ancestor
679203|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679204|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
679659|NCT03115775|Vitamin D|vitamin d|mesh-list
679660|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
679661|NCT03115775|Vitamins|vitamins|mesh-list
679662|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
679663|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679664|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
679665|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2224880|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
2224881|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224882|NCT00050713|Sirolimus|sirolimus|mesh-list
2224883|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2224884|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224885|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2224886|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224887|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
2224888|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2224889|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
2224890|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224891|NCT00050726|Interleukin-2|interleukin-2|mesh-list
2224892|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224893|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2224894|NCT00050726|Analgesics|analgesics|mesh-ancestor
2224895|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
2224896|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224897|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680077|NCT03113344|Amoxicillin|amoxicillin|mesh-list
680078|NCT03113344|Azithromycin|azithromycin|mesh-list
680079|NCT03113344|Meropenem|meropenem|mesh-list
680080|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
680081|NCT03113344|Imipenem|imipenem|mesh-list
680082|NCT03113344|Erythromycin|erythromycin|mesh-list
680083|NCT03113344|Penicillins|penicillins|mesh-list
680084|NCT03113344|Ceftazidime|ceftazidime|mesh-list
680085|NCT03113344|Ampicillin|ampicillin|mesh-list
680086|NCT03113344|Cephalosporins|cephalosporins|mesh-list
680087|NCT03113344|Acyclovir|acyclovir|mesh-list
680088|NCT03113344|Ganciclovir|ganciclovir|mesh-list
2224898|NCT00050804|Sertraline|sertraline|mesh-list
2224899|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
2224900|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
678839|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
678840|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
678841|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
678842|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
678843|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
678844|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
678845|NCT03119038|Analgesics|analgesics|mesh-ancestor
678846|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
678847|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
678848|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
678849|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
678850|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
678851|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
678852|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
678991|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
678992|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
678993|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
679149|NCT03117972|Leucovorin|leucovorin|mesh-list
679150|NCT03117972|Bevacizumab|bevacizumab|mesh-list
679151|NCT03117972|Fluorouracil|fluorouracil|mesh-list
679152|NCT03117972|Capecitabine|capecitabine|mesh-list
679153|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
679154|NCT03117972|Irinotecan|irinotecan|mesh-list
679155|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
679156|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
679157|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679158|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
679159|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
679160|NCT03117972|Growth Substances|growth substances|mesh-ancestor
679161|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679162|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
679163|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
679164|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679165|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
679166|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
679167|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
679168|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
679169|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
679170|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679171|NCT03117972|Antidotes|antidotes|mesh-ancestor
679172|NCT03117972|Protective Agents|protective agents|mesh-ancestor
679173|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
679174|NCT03117972|Vitamins|vitamins|mesh-ancestor
679175|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
2086883|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086884|NCT02163421|Vedolizumab|vedolizumab|mesh-list
2086885|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086886|NCT02163434|Gabapentin|gabapentin|mesh-list
2086887|NCT02163434|Metoclopramide|metoclopramide|mesh-list
2086888|NCT02163434|Analgesics|analgesics|mesh-ancestor
679531|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
679532|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
679533|NCT03116425|Vitamins|vitamins|mesh-ancestor
679534|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
679535|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679917|NCT03114280|Carboplatin|carboplatin|mesh-list
679918|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680071|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
680072|NCT03113487|Vaccines|vaccines|mesh-list
680073|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
680074|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680075|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
680076|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680573|NCT03111342|Lidocaine|lidocaine|mesh-list
680574|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
680575|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
680576|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
680577|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680578|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
680579|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680580|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
680581|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
680582|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
680583|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
680584|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680972|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
680973|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2086889|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
2086890|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086891|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086892|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
2086893|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2086894|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2086895|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2224901|NCT00050804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2224902|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2224903|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2224904|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224905|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2224906|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
2224907|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224908|NCT00050817|Clopidogrel|clopidogrel|mesh-list
679800|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
679801|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679802|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680227|NCT03112707|Aspirin|aspirin|mesh-list
680228|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
680229|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
680230|NCT03112707|Analgesics|analgesics|mesh-ancestor
680231|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
680232|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680233|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680234|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
680235|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
680236|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
680237|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
680238|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680239|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
680240|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
680241|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680242|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
680608|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
680609|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
680610|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680611|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680612|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
680613|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
680614|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
680615|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680928|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
680929|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
680930|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
680931|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
680932|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680933|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
680934|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
680935|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681051|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
681052|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681053|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681761|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
681762|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
681912|NCT03105765|Ketamine|ketamine|mesh-list
681913|NCT03105765|Analgesics|analgesics|mesh-ancestor
681914|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
681915|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681916|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681917|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
681918|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
681919|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
681920|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
681921|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681922|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
681923|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
681924|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681925|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682124|NCT03104634|Bromides|bromides|mesh-list
682125|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
682126|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
682127|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
2224909|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2224910|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2224911|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2224912|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2224913|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
2224914|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2224915|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224916|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224917|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
2224918|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
679536|NCT03116269|Aspirin|aspirin|mesh-list
679537|NCT03116269|Cilostazol|cilostazol|mesh-list
679538|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
679539|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
679540|NCT03116269|Analgesics|analgesics|mesh-ancestor
679541|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
679542|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679543|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679544|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
679545|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
679546|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
679547|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
679548|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679549|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
679550|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
679551|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679552|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
679553|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
679554|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
679555|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
679556|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
679557|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
679558|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
679559|NCT03116269|Protective Agents|protective agents|mesh-ancestor
679560|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
679561|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
680025|NCT03113695|Lenalidomide|lenalidomide|mesh-list
680026|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
680027|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
680028|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680029|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
680030|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
680031|NCT03113695|Growth Substances|growth substances|mesh-ancestor
680032|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
680033|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680034|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2086896|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2086897|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2086898|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
680442|NCT03111797|Morphine|morphine|mesh-list
680443|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
680444|NCT03111797|Narcotics|narcotics|mesh-ancestor
680445|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
680446|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680447|NCT03111797|Analgesics|analgesics|mesh-ancestor
680448|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
680449|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680988|NCT03109847|Metformin|metformin|mesh-list
680989|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
680990|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681443|NCT03107884|Metformin|metformin|mesh-list
681444|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
681445|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681509|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
681510|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
681511|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682335|NCT03103568|Tolbutamide|tolbutamide|mesh-list
682336|NCT03103568|Metoprolol|metoprolol|mesh-list
682337|NCT03103568|Furosemide|furosemide|mesh-list
682338|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
682339|NCT03103568|Nitisinone|nitisinone|mesh-list
682340|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
682341|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
682342|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
682343|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
682344|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679289|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
679592|NCT03116308|Opicapone|opicapone|mesh-list
679593|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
679594|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679595|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679596|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
679597|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
679682|NCT03115619|Pirfenidone|pirfenidone|mesh-list
679683|NCT03115619|Analgesics|analgesics|mesh-ancestor
679684|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
679685|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679686|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679687|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
679688|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
679689|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
679690|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
679691|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680517|NCT03111537|Nicotine|nicotine|mesh-list
680518|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
680519|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
680520|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680521|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680522|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
680523|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
680524|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
680525|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680526|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680842|NCT03110510|Leucovorin|leucovorin|mesh-list
680843|NCT03110510|Fluorouracil|fluorouracil|mesh-list
680844|NCT03110510|Irinotecan|irinotecan|mesh-list
680845|NCT03110510|Calcium|calcium|mesh-list
680846|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
680847|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
680848|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680849|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
680850|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680851|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
680852|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680853|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
680854|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
680855|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
680856|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
680857|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680858|NCT03110510|Antidotes|antidotes|mesh-ancestor
680859|NCT03110510|Protective Agents|protective agents|mesh-ancestor
680860|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
680861|NCT03110510|Vitamins|vitamins|mesh-ancestor
680862|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
2224919|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
2224920|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681396|NCT03107858|Dopamine|dopamine|mesh-list
681397|NCT03107858|Norepinephrine|norepinephrine|mesh-list
681398|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
681399|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
681400|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
681401|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681402|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681403|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681404|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
681405|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
681406|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681407|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
681408|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
681409|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
681410|NCT03107858|Protective Agents|protective agents|mesh-ancestor
681687|NCT03106740|Minocycline|minocycline|mesh-list
681688|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
681689|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
681800|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
681801|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
681802|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681853|NCT03105986|Probenecid|probenecid|mesh-list
681854|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
681855|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
681856|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
681857|NCT03105986|Renal Agents|renal agents|mesh-ancestor
682059|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
679299|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
679300|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
679301|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
679302|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679303|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679459|NCT03116490|Anesthetics|anesthetics|mesh-list
679460|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679461|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679758|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
679759|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
679760|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
679962|NCT03113968|Ketamine|ketamine|mesh-list
679963|NCT03113968|Analgesics|analgesics|mesh-ancestor
679964|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
679965|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679966|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679967|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
679968|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
679969|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
679970|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
679971|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
679972|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
679973|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
679974|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
679975|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680019|NCT03113448|Capsaicin|capsaicin|mesh-list
680020|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
680021|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
680022|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
680023|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680024|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680113|NCT03113084|Heparin|heparin|mesh-list
680114|NCT03113084|Calcium heparin|calcium heparin|mesh-list
680115|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
680116|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
680117|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
680118|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224921|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224922|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
2224923|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224924|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224925|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2224926|NCT00050830|Protective Agents|protective agents|mesh-ancestor
2224927|NCT00050843|Thalidomide|thalidomide|mesh-list
2224928|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
680754|NCT03110952|Vaccines|vaccines|mesh-list
680755|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
680756|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224929|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
2224930|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224931|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
2224932|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2224933|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224934|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2224935|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2224936|NCT00050843|Growth Substances|growth substances|mesh-ancestor
2224937|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
2224938|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224939|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
2224940|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2224941|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2224942|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224943|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2224944|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2224945|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
2224946|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224947|NCT00050895|Ritonavir|ritonavir|mesh-list
2224948|NCT00050895|Lopinavir|lopinavir|mesh-list
2224949|NCT00050895|Tenofovir|tenofovir|mesh-list
2224950|NCT00050895|Lamivudine|lamivudine|mesh-list
2224951|NCT00050895|Zidovudine|zidovudine|mesh-list
2224952|NCT00050895|Stavudine|stavudine|mesh-list
2224953|NCT00050895|Efavirenz|efavirenz|mesh-list
2224954|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2224955|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2224956|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
2224957|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679349|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
679350|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
679351|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
679352|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
679353|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
679354|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
679632|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
679633|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
679634|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
679635|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
679854|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
679855|NCT03115099|Liraglutide|liraglutide|mesh-list
679856|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
679857|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679858|NCT03115099|Incretins|incretins|mesh-ancestor
679859|NCT03115099|Hormones|hormones|mesh-ancestor
679860|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
679861|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
679862|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
679863|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679864|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679922|NCT03114085|Capecitabine|capecitabine|mesh-list
679923|NCT03114085|Apatinib|apatinib|mesh-list
679924|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
679925|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
679926|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679927|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679928|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
679929|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680458|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
680459|NCT03112044|Velpatasvir|velpatasvir|mesh-list
680460|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
680461|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086899|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086900|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086901|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
2086902|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
2086903|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
2086904|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086905|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2086906|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2086907|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
2086908|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
2086909|NCT02163447|Piperaquine|piperaquine|mesh-list
2086910|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
2086911|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
681207|NCT03108989|Neostigmine|neostigmine|mesh-list
681208|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
681209|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681210|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681211|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
681212|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681213|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681214|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
681215|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
681216|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681740|NCT03106545|Bupivacaine|bupivacaine|mesh-list
681741|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
681742|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
681743|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681744|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681745|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
681746|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682015|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
682016|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
682017|NCT03105466|Tacrolimus|tacrolimus|mesh-list
682018|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
682019|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
682020|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682021|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
682022|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682023|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682024|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
682025|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
682026|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
679416|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679417|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
679418|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
679419|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
679420|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
679421|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
679422|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
679423|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
679424|NCT03117751|Hormones|hormones|mesh-ancestor
679425|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
679426|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
679427|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
679428|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
679429|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
679430|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679431|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
679432|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
679433|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
679434|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
679435|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
679436|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
679437|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
679438|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
679439|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
679440|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
679441|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
679442|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
679443|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
679444|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
679445|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
679446|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2224958|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224959|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2224960|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2224961|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
2224962|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224963|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2224964|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2224965|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2224966|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2224967|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
679976|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
679977|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
679978|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
679979|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
679980|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679981|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
679982|NCT03114020|Protective Agents|protective agents|mesh-ancestor
680177|NCT03113500|Prednisone|prednisone|mesh-list
680178|NCT03113500|Cortisone|cortisone|mesh-list
680179|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
680180|NCT03113500|Doxorubicin|doxorubicin|mesh-list
680181|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
680182|NCT03113500|Etoposide|etoposide|mesh-list
680183|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
680184|NCT03113500|Daunorubicin|daunorubicin|mesh-list
680185|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
680186|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
680187|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
680188|NCT03113500|Antibodies|antibodies|mesh-list
680189|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
680190|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
680191|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
680192|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
680193|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
680194|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680195|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
680196|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
680197|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
680198|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680199|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680200|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
680201|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
680202|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
680203|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
680204|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679604|NCT03116087|Hormones|hormones|mesh-ancestor
679605|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
679606|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679607|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
679608|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679609|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
679912|NCT03114228|Midostaurin|midostaurin|mesh-list
679913|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679914|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
679915|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
679916|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
679944|NCT03113942|Thalidomide|thalidomide|mesh-list
679945|NCT03113942|Pomalidomide|pomalidomide|mesh-list
679946|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
679947|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679948|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
679949|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
679950|NCT03113942|Growth Substances|growth substances|mesh-ancestor
679951|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
679952|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679953|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
679954|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
679955|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
679956|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
680096|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
680097|NCT03113617|Bombesin|bombesin|mesh-list
680098|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680099|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680100|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680101|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
680435|NCT03111966|Grazoprevir|grazoprevir|mesh-list
680436|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
680437|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224968|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2224969|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2224970|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2224971|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
680818|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
680819|NCT03110341|Hematinics|hematinics|mesh-ancestor
680883|NCT03110094|Adalimumab|adalimumab|mesh-list
680884|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
680885|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2224972|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2224973|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2224974|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
681244|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
681245|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
681246|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
681247|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
681248|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
681249|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752529|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2752530|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2752531|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2752532|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2752533|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2752534|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2752535|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2224975|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
2224976|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2224977|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
2224978|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
2224979|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
681906|NCT03105674|Anesthetics|anesthetics|mesh-list
681907|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
681908|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681909|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681910|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
681911|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2752536|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2752537|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
2752538|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2752539|NCT03471364|Ketoconazole|ketoconazole|mesh-list
2752540|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
2752541|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2752542|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2752543|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2752544|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752545|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752546|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
680387|NCT03112382|Vitamins|vitamins|mesh-list
680388|NCT03112382|Vitamin A|vitamin a|mesh-list
680389|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
680390|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
680391|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680392|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
680393|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680394|NCT03112382|Protective Agents|protective agents|mesh-ancestor
680395|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
680396|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680790|NCT03110653|Remifentanil|remifentanil|mesh-list
680791|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
680792|NCT03110653|Narcotics|narcotics|mesh-ancestor
680793|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
680794|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680795|NCT03110653|Analgesics|analgesics|mesh-ancestor
680796|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
680797|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2224980|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2224981|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2224982|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224983|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2224984|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2224985|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
2224986|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
2224987|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2224988|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2224989|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2224990|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2224991|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2224992|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2224993|NCT00050973|Bexarotene|bexarotene|mesh-list
2224994|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2224995|NCT00051038|Entecavir|entecavir|mesh-list
2224996|NCT00051038|Antiviral Agents|antiviral agents|mesh-ancestor
2224997|NCT00051038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2224998|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
2224999|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
2225000|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
682062|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
682063|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
682064|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
682065|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
682066|NCT03104959|Expectorants|expectorants|mesh-ancestor
682067|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
682068|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
682069|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
682070|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682071|NCT03104959|Protective Agents|protective agents|mesh-ancestor
682072|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682073|NCT03104959|Antidotes|antidotes|mesh-ancestor
682534|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
682535|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
682536|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225001|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2225002|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225003|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
2225004|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2225005|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225006|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2225007|NCT00051051|Protective Agents|protective agents|mesh-ancestor
2225008|NCT00051077|Ribavirin|ribavirin|mesh-list
2086912|NCT02163447|Artenimol|artenimol|mesh-list
2086913|NCT02163447|Artemisinins|artemisinins|mesh-list
682800|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
679786|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
679787|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
679788|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
679789|NCT03114865|Hormones|hormones|mesh-ancestor
679790|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
679791|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
679792|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
679793|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
2752547|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
680627|NCT03111446|Anesthetics|anesthetics|mesh-list
680628|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
680629|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681347|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
681348|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
681349|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681434|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
681435|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
681436|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
681722|NCT03106610|Nivolumab|nivolumab|mesh-list
681723|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
681724|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681725|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
681726|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682004|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
682005|NCT03105336|Fludarabine|fludarabine|mesh-list
682006|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
682007|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
682008|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682009|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
682010|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
682011|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
682012|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682013|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682014|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
682485|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
682486|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
682531|NCT03102658|Micafungin|micafungin|mesh-list
682532|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
682533|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
682698|NCT03101579|Folic Acid|folic acid|mesh-list
682699|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
682700|NCT03101579|Hydroxocobalamin|hydroxocobalamin|mesh-list
682701|NCT03101579|Dexamethasone|dexamethasone|mesh-list
682702|NCT03101579|Pemetrexed|pemetrexed|mesh-list
682703|NCT03101579|Vitamins|vitamins|mesh-ancestor
682704|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
682705|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682706|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
682707|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
682708|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
682709|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682710|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
682711|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
682712|NCT03101579|Hormones|hormones|mesh-ancestor
682713|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
682714|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
682715|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682716|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682717|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682718|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
682719|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
682720|NCT03101579|Hematinics|hematinics|mesh-ancestor
682721|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
683133|NCT03099616|Propofol|propofol|mesh-list
679846|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
679847|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
679848|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
680119|NCT03113266|Antibodies|antibodies|mesh-list
680120|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
680121|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
680122|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680367|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
680368|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
680369|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
680370|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
680371|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
680372|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680373|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
680374|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680375|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680376|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
680377|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680728|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
680729|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
680730|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
680731|NCT03110822|Prednisolone|prednisolone|mesh-list
680732|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
680733|NCT03110822|Lenalidomide|lenalidomide|mesh-list
680734|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
680735|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
680736|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
680737|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680738|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
680739|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
680740|NCT03110822|Growth Substances|growth substances|mesh-ancestor
680741|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
680742|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680743|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
680744|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
680745|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
680746|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680747|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
680748|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
680749|NCT03110822|Hormones|hormones|mesh-ancestor
680750|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
680751|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
680752|NCT03110822|Protective Agents|protective agents|mesh-ancestor
680753|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
680820|NCT03110315|Suvorexant|suvorexant|mesh-list
680821|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
680822|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
680823|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
680824|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680825|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
680826|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680827|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680948|NCT03109964|Hemostatics|hemostatics|mesh-list
680949|NCT03109964|Surgiflo|surgiflo|mesh-list
680950|NCT03109964|Coagulants|coagulants|mesh-ancestor
681217|NCT03108963|Metformin|metformin|mesh-list
681218|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
681219|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225009|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2225010|NCT00051077|Adefovir|adefovir|mesh-list
2225011|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2225012|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
2225013|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225014|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
2225015|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225016|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2225017|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2225018|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681869|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
681870|NCT03105843|Miotics|miotics|mesh-ancestor
681871|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
681872|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681873|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681874|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
681875|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2225019|NCT00051090|Lamivudine|lamivudine|mesh-list
2225020|NCT00051090|Efavirenz|efavirenz|mesh-list
679942|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
679943|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
680126|NCT03113110|Empagliflozin|empagliflozin|mesh-list
680127|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
680128|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680129|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
680130|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680585|NCT03111485|Levodopa|levodopa|mesh-list
680586|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
680587|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
680588|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
680589|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
680590|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680591|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680592|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680593|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
680594|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
680595|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
2086914|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
2086915|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2086916|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2086917|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086918|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
681083|NCT03109379|Trospium chloride|trospium chloride|mesh-list
681084|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
681085|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
681086|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681087|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681088|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
681089|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
681090|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
681091|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681092|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681093|NCT03109379|Urological Agents|urological agents|mesh-ancestor
681668|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
681669|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
681670|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
681671|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681672|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
681673|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
681674|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
681675|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681676|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681677|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
681788|NCT03106402|Bromfenac|bromfenac|mesh-list
681789|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
681790|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
681791|NCT03106402|Analgesics|analgesics|mesh-ancestor
681792|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
681793|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681794|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681795|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
681796|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
682050|NCT03105375|Omeprazole|omeprazole|mesh-list
682051|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
682052|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
682053|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
682054|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682055|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682380|NCT03103334|Methotrexate|methotrexate|mesh-list
682381|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
682382|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
682383|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
682384|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682385|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
682386|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
682387|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682388|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682389|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
682390|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682391|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
682392|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
682393|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
2086919|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086920|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086921|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2086922|NCT02163447|Renal Agents|renal agents|mesh-ancestor
2086923|NCT02163759|Adalimumab|adalimumab|mesh-list
2086924|NCT02163759|Etrolizumab|etrolizumab|mesh-list
2086925|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2086926|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2086927|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086928|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
680037|NCT03113396|Baclofen|baclofen|mesh-list
680038|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
680039|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680040|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
680041|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680042|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
680043|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
680044|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
680045|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680046|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680131|NCT03113162|Cytarabine|cytarabine|mesh-list
680132|NCT03113162|Etoposide|etoposide|mesh-list
680133|NCT03113162|Melphalan|melphalan|mesh-list
680134|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
680135|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680136|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
680137|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
680138|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680139|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680140|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
680141|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
680142|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
680143|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
680144|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
680145|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
680146|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680147|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
680148|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
680149|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2225021|NCT00051090|Abacavir|abacavir|mesh-list
2225022|NCT00051090|Didanosine|didanosine|mesh-list
2225023|NCT00051090|Telbivudine|telbivudine|mesh-list
2225024|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2225025|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2225026|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225027|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681094|NCT03109158|Cetuximab|cetuximab|mesh-list
681095|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
681096|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086929|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086930|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2086931|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2086932|NCT02163837|Rifaximin|rifaximin|mesh-list
2086933|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2086934|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086935|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2086936|NCT02164240|Sunitinib|sunitinib|mesh-list
2086937|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2086938|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2086939|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2086940|NCT02164240|Growth Substances|growth substances|mesh-ancestor
2086941|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086942|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
2086943|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2086944|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086945|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086946|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
2086947|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
2086948|NCT02164383|Nicotine|nicotine|mesh-list
2086949|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2086950|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
2086951|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086952|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086953|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2086954|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2086955|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
2086956|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680050|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
680051|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
680052|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680102|NCT03113123|Tenofovir|tenofovir|mesh-list
680103|NCT03113123|Emtricitabine|emtricitabine|mesh-list
680104|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
680105|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
680106|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
680107|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
680108|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
680109|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680110|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680111|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
680112|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
680450|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
680451|NCT03111901|Interleukin-2|interleukin-2|mesh-list
680452|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
680453|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680454|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
680455|NCT03111901|Analgesics|analgesics|mesh-ancestor
680456|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
680457|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680462|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086957|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086958|NCT02164422|Guanfacine|guanfacine|mesh-list
2086959|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2086960|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2086961|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2086962|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2086963|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
2086964|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2086965|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086966|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086967|NCT02164513|Fluticasone|fluticasone|mesh-list
2086968|NCT02164513|Xhance|xhance|mesh-list
2086969|NCT02164513|Bromides|bromides|mesh-list
2086970|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2086971|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2225028|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
680875|NCT03110484|Pemetrexed|pemetrexed|mesh-list
680876|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
680877|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680878|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680879|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680880|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
680881|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
680882|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2225029|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225030|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2225031|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2225032|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2225033|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2225034|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2225035|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2225036|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2225037|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2225038|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
2225039|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
2225040|NCT00051116|Lenalidomide|lenalidomide|mesh-list
2225041|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
682167|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
682168|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
682169|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
682170|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
682171|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682172|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
682173|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
682174|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
682235|NCT03104010|Hormones|hormones|mesh-list
682236|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
682237|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682376|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
682377|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
680089|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
680090|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
680091|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
680092|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680093|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680094|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
680095|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
680568|NCT03111433|Ubiquinone|ubiquinone|mesh-list
680569|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
680570|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680571|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
680572|NCT03111433|Vitamins|vitamins|mesh-ancestor
680798|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
680799|NCT03110640|Fludarabine|fludarabine|mesh-list
680800|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
680801|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
680802|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680803|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
680804|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
680805|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
680806|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680807|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680808|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
680912|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
680913|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
680914|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
680915|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
680916|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680917|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680918|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680919|NCT03110172|Analgesics|analgesics|mesh-ancestor
680920|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
680921|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680922|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
680923|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
680924|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
681805|NCT03106389|Misoprostol|misoprostol|mesh-list
681806|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
681807|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
681808|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
681809|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681810|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
681811|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
681812|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
681954|NCT03105193|Lidocaine|lidocaine|mesh-list
681955|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
681956|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
681957|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681958|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681959|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
681960|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681961|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
681962|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
681963|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
681964|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
681965|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225042|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225043|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2225044|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2225045|NCT00051116|Growth Substances|growth substances|mesh-ancestor
2225046|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
2225047|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225048|NCT00051129|Hydrocortisone|hydrocortisone|mesh-list
2225049|NCT00051129|Anecortave|anecortave|mesh-list
2225050|NCT00051129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2225051|NCT00051129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2225052|NCT00051129|Growth Substances|growth substances|mesh-ancestor
2225053|NCT00051129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225054|NCT00051129|Growth Inhibitors|growth inhibitors|mesh-ancestor
2225055|NCT00051129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680438|NCT03111992|Spartalizumab|spartalizumab|mesh-list
680439|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
680440|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680441|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225056|NCT00051129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2225057|NCT00051142|Travoprost|travoprost|mesh-list
2225058|NCT00051142|Latanoprost|latanoprost|mesh-list
2225059|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
680951|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
680952|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
680953|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
680954|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680955|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
680956|NCT03109990|Analgesics|analgesics|mesh-ancestor
680957|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
680958|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680959|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
680960|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
680961|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
680962|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
680963|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680964|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681057|NCT03109600|Vaccines|vaccines|mesh-list
681058|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
681059|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
681060|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681109|NCT03109080|Olaparib|olaparib|mesh-list
681110|NCT03109080|Adenosine|adenosine|mesh-list
681111|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
681112|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681113|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681114|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681115|NCT03109080|Analgesics|analgesics|mesh-ancestor
681116|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
681117|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681118|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681119|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
681120|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
681121|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
681122|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
681123|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
681124|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2225060|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2225061|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2225062|NCT00051155|Timolol|timolol|mesh-list
2225063|NCT00051155|Travoprost|travoprost|mesh-list
2225064|NCT00051155|Latanoprost|latanoprost|mesh-list
2225065|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2225066|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2225067|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
2225068|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2225069|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225070|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225071|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2225072|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2225073|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2225074|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2225075|NCT00051181|Travoprost|travoprost|mesh-list
2225076|NCT00051181|Latanoprost|latanoprost|mesh-list
2225077|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2225078|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
680205|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
680206|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
680207|NCT03113500|Hormones|hormones|mesh-ancestor
680208|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
680209|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
680210|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
680211|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
680212|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
680213|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
680214|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
680215|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
680652|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
680653|NCT03111121|Neostigmine|neostigmine|mesh-list
680654|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
680655|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680656|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680657|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
680658|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680659|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680660|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
680661|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
680662|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680663|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
680664|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
680665|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
680925|NCT03109977|Pertuzumab|pertuzumab|mesh-list
680926|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
680927|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681021|NCT03109730|Tenofovir|tenofovir|mesh-list
681022|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
681023|NCT03109730|Entecavir|entecavir|mesh-list
681024|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
681025|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
681026|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
681027|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
681028|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681029|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681030|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
681031|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
681135|NCT03109314|Donepezil|donepezil|mesh-list
681136|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
681137|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681138|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681139|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
681140|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681141|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681142|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
681522|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
681523|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
681524|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681591|NCT03106831|Norepinephrine|norepinephrine|mesh-list
681592|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
681593|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
681594|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
681595|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681596|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681597|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681598|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
681599|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
681600|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681601|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
681831|NCT03106324|Lenalidomide|lenalidomide|mesh-list
681832|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
681833|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681834|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
681835|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
681836|NCT03106324|Growth Substances|growth substances|mesh-ancestor
681837|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
681838|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682056|NCT03105128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
682057|NCT03105128|Immunologic Factors|immunologic factors|mesh-ancestor
682058|NCT03105128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682741|NCT03101475|Durvalumab|durvalumab|mesh-list
682742|NCT03101475|Tremelimumab|tremelimumab|mesh-list
682743|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
682744|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225079|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2225080|NCT00051259|Bupropion|bupropion|mesh-list
2225081|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
680401|NCT03112135|Epinephrine|epinephrine|mesh-list
680402|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
680403|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
680404|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
680405|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
680406|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680407|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680408|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680409|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
680410|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
680411|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
680412|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680413|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
680414|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
680415|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
680416|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
680417|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
680418|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
680419|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
680420|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
680421|NCT03112135|Coagulants|coagulants|mesh-ancestor
680527|NCT03111511|Drospirenone|drospirenone|mesh-list
680528|NCT03111511|Midazolam|midazolam|mesh-list
680529|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
680530|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
680531|NCT03111511|Betadex|betadex|mesh-list
680532|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
680533|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
680534|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
680535|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680536|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
680537|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
680538|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
680539|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
680540|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
680541|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
680542|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
680543|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
680544|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680545|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680546|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
680547|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
680548|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
680549|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
680550|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
680551|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
680552|NCT03111511|Estrogens|estrogens|mesh-ancestor
680553|NCT03111511|Hormones|hormones|mesh-ancestor
680554|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
680555|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
680556|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
680557|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
680558|NCT03111511|Diuretics|diuretics|mesh-ancestor
680559|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
680560|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
681097|NCT03109392|Lidocaine|lidocaine|mesh-list
681098|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
681099|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
681100|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681101|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681102|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
681103|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681104|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
681105|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
681106|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
681107|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
681108|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681220|NCT03108872|Anticoagulants|anticoagulants|mesh-list
681803|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
681804|NCT03106298|Hematinics|hematinics|mesh-ancestor
681951|NCT03105583|Vitamins|vitamins|mesh-list
681952|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
681953|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680269|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
680270|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
680271|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
680272|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
680273|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680274|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
680275|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
680276|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
680630|NCT03111186|Acetaminophen|acetaminophen|mesh-list
680631|NCT03111186|Ibuprofen|ibuprofen|mesh-list
680632|NCT03111186|Oxycodone|oxycodone|mesh-list
680633|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
680634|NCT03111186|Analgesics|analgesics|mesh-ancestor
680635|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
680636|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680637|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680638|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
680639|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
680640|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
680641|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
680642|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
680643|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680644|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680645|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
680646|NCT03111186|Narcotics|narcotics|mesh-ancestor
680647|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2086972|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
2086973|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086974|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086975|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2086976|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
2086977|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
2086978|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
682808|NCT03100955|Cisplatin|cisplatin|mesh-list
682809|NCT03100955|Etoposide|etoposide|mesh-list
682810|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
682811|NCT03100955|Apatinib|apatinib|mesh-list
682812|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682813|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
682814|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
682815|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
682816|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682817|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682818|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
683115|NCT03099499|TIC10 compound|tic10 compound|mesh-list
683116|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683273|NCT03098875|Remifentanil|remifentanil|mesh-list
683274|NCT03098875|Propofol|propofol|mesh-list
683275|NCT03098875|Sevoflurane|sevoflurane|mesh-list
683276|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
683277|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
683278|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683279|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
683280|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
683281|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
683282|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
683283|NCT03098875|Narcotics|narcotics|mesh-ancestor
683284|NCT03098875|Analgesics|analgesics|mesh-ancestor
683285|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
683286|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683287|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
683288|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
683768|NCT03096405|Methicillin|methicillin|mesh-list
683769|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
683770|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
683901|NCT03096080|XL647|xl647|mesh-list
683902|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683903|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
683904|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683905|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086979|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
2086980|NCT02164864|Aspirin|aspirin|mesh-list
684532|NCT03092765|Quetmolimab|quetmolimab|mesh-list
684533|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
684811|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
684812|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086981|NCT02164864|Warfarin|warfarin|mesh-list
680291|NCT03112538|Insulin|insulin|mesh-list
680292|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
680293|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
680294|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086982|NCT02164864|Dabigatran|dabigatran|mesh-list
2086983|NCT02164864|Clopidogrel|clopidogrel|mesh-list
2086984|NCT02164864|Ticagrelor|ticagrelor|mesh-list
681081|NCT03109093|Blinatumomab|blinatumomab|mesh-list
681082|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681250|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
681251|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
681519|NCT03107247|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
681520|NCT03107247|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
681521|NCT03107247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681565|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
681566|NCT03106948|Penicillamine|penicillamine|mesh-list
681567|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
681568|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681569|NCT03106948|Protective Agents|protective agents|mesh-ancestor
681570|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681571|NCT03106948|Vitamins|vitamins|mesh-ancestor
681572|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
681573|NCT03106948|Antidotes|antidotes|mesh-ancestor
681574|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
681575|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
681576|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
681678|NCT03106597|Amlodipine|amlodipine|mesh-list
681679|NCT03106597|Manidipine|manidipine|mesh-list
681680|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
681681|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
681682|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
681683|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681684|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
681685|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681686|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
681877|NCT03105661|Atenolol|atenolol|mesh-list
681878|NCT03105661|Labetalol|labetalol|mesh-list
681879|NCT03105661|Nifedipine|nifedipine|mesh-list
681880|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
681881|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
681882|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681883|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
681884|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681885|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
681886|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
681887|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
681888|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
681889|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
681890|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
681891|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
681892|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681893|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
681894|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
681895|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
681896|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
681897|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681898|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
681899|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
681900|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
681938|NCT03105310|Interferons|interferons|mesh-list
681939|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
681940|NCT03105310|Ezetimibe|ezetimibe|mesh-list
681941|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681942|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
681943|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
681944|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
681945|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681946|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
681947|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
681948|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
681949|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681950|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
682194|NCT03104140|Ketamine|ketamine|mesh-list
682195|NCT03104140|Thiopental|thiopental|mesh-list
682196|NCT03104140|Analgesics|analgesics|mesh-ancestor
682197|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
682198|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680319|NCT03112577|Fluticasone|fluticasone|mesh-list
680320|NCT03112577|Xhance|xhance|mesh-list
680321|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
680322|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
680323|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
680324|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680325|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680326|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
680327|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
680328|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
680329|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2086985|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2086986|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2752548|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2752549|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681032|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
681033|NCT03109795|Clonidine|clonidine|mesh-list
681034|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
681035|NCT03109795|Diuretics|diuretics|mesh-ancestor
681036|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
681037|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681038|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
681039|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
681040|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681041|NCT03109795|Analgesics|analgesics|mesh-ancestor
681042|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
681043|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681044|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
681045|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
681046|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
681047|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
681048|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
681049|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
681050|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681421|NCT03107923|Dobutamine|dobutamine|mesh-list
681422|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
681423|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
681424|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
681425|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681426|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681427|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
681428|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
681429|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
681430|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
681431|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681432|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681433|NCT03107923|Protective Agents|protective agents|mesh-ancestor
682031|NCT03105349|Ribavirin|ribavirin|mesh-list
682032|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
682033|NCT03105349|Grazoprevir|grazoprevir|mesh-list
682034|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
682035|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682036|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
682037|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2086987|NCT02164864|Analgesics|analgesics|mesh-ancestor
2086988|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
2086989|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2086990|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2086991|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2086992|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2086993|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2086994|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2086995|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2086996|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
682331|NCT03103412|Tofacitinib|tofacitinib|mesh-list
682332|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
682333|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682334|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682794|NCT03101644|Darunavir|darunavir|mesh-list
682795|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
682796|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
682797|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
682798|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682799|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680337|NCT03112603|Methotrexate|methotrexate|mesh-list
680338|NCT03112603|Everolimus|everolimus|mesh-list
680339|NCT03112603|Imatinib Mesylate|imatinib mesylate|mesh-list
680340|NCT03112603|Pentostatin|pentostatin|mesh-list
680341|NCT03112603|Infliximab|infliximab|mesh-list
680342|NCT03112603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
680343|NCT03112603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680344|NCT03112603|Immunologic Factors|immunologic factors|mesh-ancestor
680345|NCT03112603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680346|NCT03112603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
680347|NCT03112603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
680348|NCT03112603|Abortifacient Agents|abortifacient agents|mesh-ancestor
680349|NCT03112603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
680350|NCT03112603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
680351|NCT03112603|Antimetabolites|antimetabolites|mesh-ancestor
680352|NCT03112603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680353|NCT03112603|Dermatologic Agents|dermatologic agents|mesh-ancestor
680354|NCT03112603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680355|NCT03112603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
680356|NCT03112603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
680357|NCT03112603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
680358|NCT03112603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
680359|NCT03112603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
680360|NCT03112603|Antitubercular Agents|antitubercular agents|mesh-ancestor
680361|NCT03112603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
680362|NCT03112603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
680363|NCT03112603|Antifungal Agents|antifungal agents|mesh-ancestor
680364|NCT03112603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
680365|NCT03112603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
680366|NCT03112603|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
680671|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
680672|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
680673|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
680674|NCT03110848|Prednisolone|prednisolone|mesh-list
680675|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
680676|NCT03110848|Atorvastatin|atorvastatin|mesh-list
680677|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
680678|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
680679|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
680680|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
680681|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
680682|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
680683|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680684|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
680685|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
680686|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
680687|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
680688|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
680689|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
680690|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680691|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680692|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
680693|NCT03110848|Hormones|hormones|mesh-ancestor
680694|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
680695|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
680696|NCT03110848|Protective Agents|protective agents|mesh-ancestor
680697|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
680698|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681202|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
681203|NCT03108833|Saruplase|saruplase|mesh-list
681204|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
681205|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
681206|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681305|NCT03108248|Doxorubicin|doxorubicin|mesh-list
681306|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
681307|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
681308|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
681309|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681310|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
681311|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
681312|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681313|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681314|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
681315|NCT03108248|Coagulants|coagulants|mesh-ancestor
681411|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
681412|NCT03107962|Antibodies|antibodies|mesh-list
680489|NCT03111810|Prednisolone|prednisolone|mesh-list
680490|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
680491|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
680492|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
680493|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
680494|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
680495|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
680496|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
680497|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
680498|NCT03111810|Hormones|hormones|mesh-ancestor
680499|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
680500|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680501|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
680502|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
680503|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
680504|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
680505|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680506|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
680507|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
680508|NCT03111810|Protective Agents|protective agents|mesh-ancestor
681188|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
681189|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
681190|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681191|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681192|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
681193|NCT03108937|Analgesics|analgesics|mesh-ancestor
681194|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
681195|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681196|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
681197|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
681198|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
681199|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
681200|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681201|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681690|NCT03106818|Ketorolac|ketorolac|mesh-list
681691|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
681692|NCT03106818|Bupivacaine|bupivacaine|mesh-list
681693|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
681694|NCT03106818|Anesthetics|anesthetics|mesh-list
681695|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681696|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681697|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
681698|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681699|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
681700|NCT03106818|Analgesics|analgesics|mesh-ancestor
681701|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
681702|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
681703|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
681704|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
681705|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681706|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681707|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
681708|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
681709|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
681710|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
681711|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
681712|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
681713|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
681846|NCT03105830|Acetaminophen|acetaminophen|mesh-list
681847|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
681848|NCT03105830|Analgesics|analgesics|mesh-ancestor
681849|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
681850|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681851|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681852|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
682157|NCT03104283|Apatinib|apatinib|mesh-list
682158|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682159|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
682160|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682161|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752550|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2752551|NCT03467789|Vitamin D|vitamin d|mesh-list
2752552|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
2752553|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
682625|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
2752554|NCT03467789|Vitamins|vitamins|mesh-list
2086997|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2086998|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2086999|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
2087000|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2087001|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2087002|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2087003|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
2087004|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087005|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
2087006|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
680886|NCT03110575|Cyclobenzaprine|cyclobenzaprine|mesh-list
680887|NCT03110575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
680888|NCT03110575|Antidepressive Agents|antidepressive agents|mesh-ancestor
680889|NCT03110575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
680890|NCT03110575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
680891|NCT03110575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680892|NCT03110575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
680893|NCT03110575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680894|NCT03110575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
680895|NCT03110575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681350|NCT03108274|Fexofenadine|fexofenadine|mesh-list
681351|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
681352|NCT03108274|Midazolam|midazolam|mesh-list
681353|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
681354|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
681355|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681356|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681357|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
681358|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
681359|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
681360|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
681361|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
681362|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
681363|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
681364|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
681365|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681366|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681367|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
681368|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681369|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
681370|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
681371|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
681372|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
681373|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681374|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
681375|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
681376|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
681377|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
681378|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
2225082|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
2225083|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2225084|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2225085|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2225086|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2225087|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225088|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
2225089|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2225090|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225091|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2225092|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2225093|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681747|NCT03106571|Methamphetamine|methamphetamine|mesh-list
681748|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
681749|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681750|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
681751|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
681752|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681753|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
681754|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681755|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681756|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
681757|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
681758|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2087007|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
680621|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
680622|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
680623|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
680624|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
680625|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
680626|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225094|NCT00051272|Bupropion|bupropion|mesh-list
2225095|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2225096|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
2225097|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2225098|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2225099|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2225100|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2225101|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225102|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
2225103|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2225104|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225105|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2225106|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2225107|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225108|NCT00051285|Enoximone|enoximone|mesh-list
2225109|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2225110|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
2225111|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2225112|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2225113|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225114|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225115|NCT00051285|Protective Agents|protective agents|mesh-ancestor
2225116|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680809|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
680810|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
680811|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681125|NCT03109119|Propofol|propofol|mesh-list
681126|NCT03109119|Sevoflurane|sevoflurane|mesh-list
681127|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
681128|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681129|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681130|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
681131|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
681132|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
681133|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
681134|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
681221|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
681222|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
681223|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
681224|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681225|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
681226|NCT03108807|Coagulants|coagulants|mesh-ancestor
681525|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
681526|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
681527|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
681528|NCT03107338|Analgesics|analgesics|mesh-ancestor
681529|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
681530|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681531|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681532|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
681533|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2225117|NCT00051298|Olanzapine|olanzapine|mesh-list
2225118|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
2225119|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
2225120|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682103|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
682104|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
682105|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
682682|NCT03101423|Interleukin-2|interleukin-2|mesh-list
682683|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087008|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
2087009|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2087010|NCT02164916|Cetuximab|cetuximab|mesh-list
2087011|NCT02164916|Irinotecan|irinotecan|mesh-list
2087012|NCT02164916|Camptothecin|camptothecin|mesh-list
2087013|NCT02164916|Vemurafenib|vemurafenib|mesh-list
2087014|NCT02164916|Antibodies|antibodies|mesh-list
2087015|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
2087016|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2087017|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
2087018|NCT02164916|Mitogens|mitogens|mesh-list
2087019|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
2087020|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087021|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087022|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2087023|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2087024|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087025|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087026|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
2087027|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2087028|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2087029|NCT02164929|Acetaminophen|acetaminophen|mesh-list
2087030|NCT02164929|Dexamethasone|dexamethasone|mesh-list
2087031|NCT02164929|Lidocaine|lidocaine|mesh-list
2087032|NCT02164929|Epinephrine|epinephrine|mesh-list
2087033|NCT02164929|Midazolam|midazolam|mesh-list
2087034|NCT02164929|Hydromorphone|hydromorphone|mesh-list
2087035|NCT02164929|Ropivacaine|ropivacaine|mesh-list
2087036|NCT02164929|Propofol|propofol|mesh-list
2087037|NCT02164929|Sevoflurane|sevoflurane|mesh-list
681273|NCT03108300|Doxorubicin|doxorubicin|mesh-list
681274|NCT03108300|Propranolol|propranolol|mesh-list
681275|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
681276|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681277|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
681278|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
681279|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681280|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681281|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
681282|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
681283|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
681284|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681285|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681286|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
681287|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
681288|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
2225121|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225122|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
681813|NCT03106363|Ethanol|ethanol|mesh-list
681814|NCT03106363|Dronabinol|dronabinol|mesh-list
681815|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
681816|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
681817|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681818|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681819|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
681820|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
681821|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
681822|NCT03106363|Analgesics|analgesics|mesh-ancestor
681823|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
681824|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681825|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
681826|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
681827|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681828|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681829|NCT03106363|Hormones|hormones|mesh-ancestor
681830|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2225123|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2225124|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
682635|NCT03102320|Gemcitabine|gemcitabine|mesh-list
682636|NCT03102320|Maytansine|maytansine|mesh-list
682637|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682638|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
682639|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
682640|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682641|NCT03102320|Antiviral Agents|antiviral agents|mesh-ancestor
2087038|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2087039|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
2087040|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
680974|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
680975|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
680976|NCT03110198|Mesalamine|mesalamine|mesh-list
680977|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
680978|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
680979|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
680980|NCT03110198|Analgesics|analgesics|mesh-ancestor
680981|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
680982|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
680983|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
680984|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
681289|NCT03108365|Hemostatics|hemostatics|mesh-list
681290|NCT03108365|Chitosan|chitosan|mesh-list
681291|NCT03108365|Coagulants|coagulants|mesh-ancestor
681292|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
681293|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
681294|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
681295|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681296|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
681297|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
681298|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
681446|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
681447|NCT03107988|Topotecan|topotecan|mesh-list
681448|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
681449|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
681450|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681451|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
681452|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
681453|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
681454|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681455|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681456|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
681457|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
681458|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
681459|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
681727|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
681728|NCT03106623|Mirabegron|mirabegron|mesh-list
681729|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
681730|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
681731|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
681732|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681733|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681734|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681735|NCT03106623|Urological Agents|urological agents|mesh-ancestor
681736|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
681737|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
681738|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
681739|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
682363|NCT03103646|Itraconazole|itraconazole|mesh-list
682364|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
682365|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
682366|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
682367|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
682368|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
682369|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682370|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682371|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
682372|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
682373|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
682374|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682375|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2225125|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2225126|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2225127|NCT00051298|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2225128|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2225129|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2225130|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225131|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2225132|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
2225133|NCT00051389|Fosinopril|fosinopril|mesh-list
2225134|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2225135|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
2225136|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752555|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
680994|NCT03109691|Dexamethasone|dexamethasone|mesh-list
680995|NCT03109691|Bupivacaine|bupivacaine|mesh-list
680996|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
680997|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
680998|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
680999|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681000|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681001|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
681002|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
681003|NCT03109691|Hormones|hormones|mesh-ancestor
681004|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
681005|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
681006|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681007|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
681008|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
681009|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681010|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
681252|NCT03108625|Vortioxetine|vortioxetine|mesh-list
681253|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
681254|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
681255|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
681256|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
681257|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681258|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681259|NCT03108625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
681260|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
681261|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
681262|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681263|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681264|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
681265|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
681266|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
681267|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
681268|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
681534|NCT03107507|Levetiracetam|levetiracetam|mesh-list
681535|NCT03107507|Phenobarbital|phenobarbital|mesh-list
681536|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
681537|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
681538|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
681539|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681540|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681541|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
681542|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
681543|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681544|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681545|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
681546|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
681547|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
681548|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
681549|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
681781|NCT03106519|Bupivacaine|bupivacaine|mesh-list
681782|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
681783|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
681784|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681785|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681786|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
681787|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681858|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
681859|NCT03105791|Narcotics|narcotics|mesh-ancestor
681860|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681861|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681862|NCT03105791|Analgesics|analgesics|mesh-ancestor
681863|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
681864|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2225137|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225138|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2225139|NCT00051441|Benzydamine|benzydamine|mesh-list
2225140|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2225141|NCT00051493|Carboplatin|carboplatin|mesh-list
2225142|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225143|NCT00051506|Carboplatin|carboplatin|mesh-list
2225144|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682591|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2225145|NCT00051532|Seocalcitol|seocalcitol|mesh-list
681413|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
681414|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
681415|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681416|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
681417|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
681763|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
681764|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
681765|NCT03106454|Norethindrone|norethindrone|mesh-list
681766|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
681767|NCT03106454|Estradiol|estradiol|mesh-list
681768|NCT03106454|Estrogens|estrogens|mesh-ancestor
681769|NCT03106454|Hormones|hormones|mesh-ancestor
681770|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
681771|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681772|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
681773|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
681774|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
681775|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
681776|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
681777|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
681778|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
681779|NCT03106454|Trace Elements|trace elements|mesh-ancestor
681780|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
682651|NCT03101800|Azathioprine|azathioprine|mesh-list
682652|NCT03101800|Allopurinol|allopurinol|mesh-list
682653|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
682654|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682655|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682656|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
682657|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
682658|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
682659|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
682660|NCT03101800|Protective Agents|protective agents|mesh-ancestor
682661|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682662|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
682663|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682664|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
682665|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
682826|NCT03101046|Docetaxel|docetaxel|mesh-list
682827|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682828|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
682829|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
682830|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
682831|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087041|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087042|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087043|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2087044|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
2087045|NCT02164929|Hormones|hormones|mesh-ancestor
2087046|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2087047|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2087048|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087049|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
2087050|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
2087051|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2087052|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
2087053|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2087054|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2225146|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225147|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225148|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
2225149|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225150|NCT00051545|Seocalcitol|seocalcitol|mesh-list
2225151|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225152|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225153|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
2225154|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225155|NCT00051571|Docetaxel|docetaxel|mesh-list
2225156|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225157|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
2225158|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
2225159|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
2225160|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683579|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
683580|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2225161|NCT00051584|Gemcitabine|gemcitabine|mesh-list
2087055|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2087056|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2087057|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225162|NCT00051584|Doxorubicin|doxorubicin|mesh-list
2225163|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
2225164|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225165|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
2225166|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225167|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225168|NCT00051584|Antiviral Agents|antiviral agents|mesh-ancestor
2225169|NCT00051584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225170|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225171|NCT00051584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225172|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
2225173|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225174|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2225175|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2225176|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2087058|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2087059|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2087060|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
2087061|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2087062|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2087063|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2087064|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2087065|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
2087066|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
2087067|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087068|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2087069|NCT02164929|Analgesics|analgesics|mesh-ancestor
683122|NCT03099590|Puerarin|puerarin|mesh-list
683123|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
683513|NCT03097601|Sunitinib|sunitinib|mesh-list
683514|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683515|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
683516|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
683517|NCT03097601|Growth Substances|growth substances|mesh-ancestor
683518|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683519|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
683520|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
683521|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683522|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683794|NCT03096223|KHK4083|khk4083|mesh-list
683795|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
684071|NCT03095079|Endostatins|endostatins|mesh-list
684072|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
684073|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
684074|NCT03095079|Growth Substances|growth substances|mesh-ancestor
684075|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684076|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
684077|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087070|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
2087071|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2087072|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2087073|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2087074|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2087075|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
2087076|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2087077|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2087078|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
684359|NCT03093129|Artesunate|artesunate|mesh-list
684360|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
684361|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
684362|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
684363|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
684364|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684365|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
684366|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
684367|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
684368|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
685105|NCT03089645|Docetaxel|docetaxel|mesh-list
685106|NCT03089645|Durvalumab|durvalumab|mesh-list
685107|NCT03089645|Tremelimumab|tremelimumab|mesh-list
685108|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
685109|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685110|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
685111|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
685112|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
681437|NCT03107702|Melatonin|melatonin|mesh-list
681438|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
681439|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681440|NCT03107702|Protective Agents|protective agents|mesh-ancestor
681441|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681442|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2752556|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752557|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2752558|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2752559|NCT03460015|Propofol|propofol|mesh-list
2752560|NCT03460015|Sevoflurane|sevoflurane|mesh-list
682213|NCT03104413|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
682214|NCT03104413|Immunologic Factors|immunologic factors|mesh-ancestor
682215|NCT03104413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682608|NCT03101995|Gemcitabine|gemcitabine|mesh-list
682609|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
682610|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
682611|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682612|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682613|NCT03101995|Antiviral Agents|antiviral agents|mesh-ancestor
682614|NCT03101995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
682615|NCT03101995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682616|NCT03101995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
682617|NCT03101995|Immunologic Factors|immunologic factors|mesh-ancestor
682618|NCT03101995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682733|NCT03101501|Mitomycins|mitomycins|mesh-list
682734|NCT03101501|Mitomycin|mitomycin|mesh-list
682735|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
682736|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682737|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
682738|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682739|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
682740|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683491|NCT03097939|Nivolumab|nivolumab|mesh-list
683492|NCT03097939|Ipilimumab|ipilimumab|mesh-list
683493|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
683494|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683495|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
683496|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683569|NCT03097445|Nicotine|nicotine|mesh-list
683570|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
683571|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
683572|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683573|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683574|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
683575|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
683576|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
683577|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
683578|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683609|NCT03097068|Ranibizumab|ranibizumab|mesh-list
683610|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
683611|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
683612|NCT03097068|Growth Substances|growth substances|mesh-ancestor
683613|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683614|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
683615|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683745|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
683746|NCT03096340|Irinotecan|irinotecan|mesh-list
683747|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
683748|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683749|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
683750|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
683751|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683752|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684289|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
684290|NCT03093883|Hematinics|hematinics|mesh-ancestor
684517|NCT03092856|Axitinib|axitinib|mesh-list
684518|NCT03092856|Antibodies|antibodies|mesh-list
684519|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
684520|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684521|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684522|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
684523|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684524|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752561|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2225177|NCT00051597|Antibodies|antibodies|mesh-list
2225178|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
682216|NCT03104270|Dexamethasone|dexamethasone|mesh-list
682217|NCT03104270|Pomalidomide|pomalidomide|mesh-list
682218|NCT03104270|Elotuzumab|elotuzumab|mesh-list
682219|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
682220|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
682221|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
682222|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682223|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682224|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
682225|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
682226|NCT03104270|Hormones|hormones|mesh-ancestor
682227|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
682228|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
682229|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682230|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
682231|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
682232|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
682233|NCT03104270|Growth Substances|growth substances|mesh-ancestor
682234|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
682622|NCT03102047|Durvalumab|durvalumab|mesh-list
682623|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
682624|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683008|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
683009|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
683010|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
683097|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
683098|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
683099|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683800|NCT03096457|Paromomycin|paromomycin|mesh-list
683801|NCT03096457|Pentamidine|pentamidine|mesh-list
683802|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
683803|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
683804|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
683805|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
683806|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
683807|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
684205|NCT03094533|Propofol|propofol|mesh-list
684206|NCT03094533|Sevoflurane|sevoflurane|mesh-list
684207|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
684208|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684209|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684210|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
684211|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
684212|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
684213|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
684214|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
684649|NCT03092076|Ticagrelor|ticagrelor|mesh-list
684650|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
684651|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
684652|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
684653|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
684654|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
684655|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684656|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684657|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684924|NCT03090880|Tinzaparin|tinzaparin|mesh-list
684925|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
684926|NCT03090880|Dalteparin|dalteparin|mesh-list
684927|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
684928|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
684929|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
684930|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685208|NCT03088670|Metformin|metformin|mesh-list
685209|NCT03088670|Vildagliptin|vildagliptin|mesh-list
685210|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
685211|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685212|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
685213|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
685214|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685215|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685412|NCT03088072|Aspirin|aspirin|mesh-list
685413|NCT03088072|Warfarin|warfarin|mesh-list
685414|NCT03088072|Edoxaban|edoxaban|mesh-list
685415|NCT03088072|Clopidogrel|clopidogrel|mesh-list
685416|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2225179|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
681579|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
681865|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
681866|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
681867|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
681868|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
681982|NCT03105180|Mannitol|mannitol|mesh-list
681983|NCT03105180|Sorbitol|sorbitol|mesh-list
681984|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
681985|NCT03105180|Diuretics|diuretics|mesh-ancestor
681986|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
681987|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681988|NCT03105180|Cathartics|cathartics|mesh-ancestor
681989|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2225180|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225181|NCT00051623|Infliximab|infliximab|mesh-list
2225182|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
2225183|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2225184|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2225185|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
2225186|NCT00051688|Tezacitabine|tezacitabine|mesh-list
2225187|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225188|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225189|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225190|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
2225191|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2225192|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225193|NCT00051753|Amoxicillin|amoxicillin|mesh-list
2225194|NCT00051753|Levofloxacin|levofloxacin|mesh-list
2225195|NCT00051753|Ofloxacin|ofloxacin|mesh-list
2225196|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
682481|NCT03103009|Pasireotide|pasireotide|mesh-list
682482|NCT03103009|Hormones|hormones|mesh-ancestor
682483|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
682484|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682577|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
682578|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
682579|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
682580|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682581|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
682582|NCT03102359|Analgesics|analgesics|mesh-ancestor
682583|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
682584|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682585|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
682586|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
682587|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
682588|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
682589|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
682590|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683056|NCT03100019|Resveratrol|resveratrol|mesh-list
683057|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
683058|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683059|NCT03100019|Protective Agents|protective agents|mesh-ancestor
683060|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683061|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683062|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
683181|NCT03099278|Ezetimibe|ezetimibe|mesh-list
683182|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
683183|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
683184|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
683185|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683186|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
683633|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
683634|NCT03097198|Tropicamide|tropicamide|mesh-list
683635|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
683636|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
683637|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
683638|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683639|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683640|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
683641|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
683642|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
683643|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
683644|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225197|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
2225198|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2225199|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2087079|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
2087080|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
2087081|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
2087082|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2087083|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2087084|NCT02164929|Narcotics|narcotics|mesh-ancestor
2087085|NCT02164981|Nitroprusside|nitroprusside|mesh-list
2087086|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2087087|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
2087088|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2087089|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087090|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
2087091|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2087092|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2087093|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2087094|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2087095|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
681990|NCT03105115|Fentanyl|fentanyl|mesh-list
681991|NCT03105115|Bupivacaine|bupivacaine|mesh-list
681992|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
681993|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
681994|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
681995|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
681996|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
681997|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
681998|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
681999|NCT03105115|Narcotics|narcotics|mesh-ancestor
682000|NCT03105115|Analgesics|analgesics|mesh-ancestor
682001|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
682002|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
682003|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
682079|NCT03104790|Vaccines|vaccines|mesh-list
682080|NCT03104790|Immunologic Factors|immunologic factors|mesh-ancestor
682081|NCT03104790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682139|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
682140|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
682141|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682142|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
682448|NCT03103087|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
682449|NCT03103087|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
682450|NCT03103087|Norethindrone|norethindrone|mesh-list
682451|NCT03103087|Norethindrone Acetate|norethindrone acetate|mesh-list
682452|NCT03103087|Estradiol|estradiol|mesh-list
682453|NCT03103087|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
682454|NCT03103087|Relugolix|relugolix|mesh-list
682455|NCT03103087|Estrogens|estrogens|mesh-ancestor
682456|NCT03103087|Hormones|hormones|mesh-ancestor
682457|NCT03103087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
682458|NCT03103087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682459|NCT03103087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
682460|NCT03103087|Contraceptive Agents|contraceptive agents|mesh-ancestor
682461|NCT03103087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
682462|NCT03103087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
682463|NCT03103087|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
682464|NCT03103087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
682465|NCT03103087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
682466|NCT03103087|Androgen Antagonists|androgen antagonists|mesh-ancestor
682467|NCT03103087|Hormone Antagonists|hormone antagonists|mesh-ancestor
682666|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
682667|NCT03101930|Liraglutide|liraglutide|mesh-list
682668|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
682669|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682670|NCT03101930|Incretins|incretins|mesh-ancestor
682671|NCT03101930|Hormones|hormones|mesh-ancestor
682672|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
682673|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
682674|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
682675|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682676|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225200|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225201|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2225202|NCT00051753|Renal Agents|renal agents|mesh-ancestor
683219|NCT03099408|Metronidazole|metronidazole|mesh-list
683220|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
683221|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
683222|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
683223|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
681759|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
681760|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2225203|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2225204|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225205|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225206|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225207|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225208|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2225209|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2225210|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2225211|NCT00051831|Ritonavir|ritonavir|mesh-list
2225212|NCT00051831|Saquinavir|saquinavir|mesh-list
2225213|NCT00051831|Tenofovir|tenofovir|mesh-list
2225214|NCT00051831|Emtricitabine|emtricitabine|mesh-list
2225215|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
2225216|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2225217|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2225218|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
2225219|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225220|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225221|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2225222|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2225223|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
682948|NCT03100786|Dexamethasone|dexamethasone|mesh-list
682949|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
682950|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
682951|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
682952|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682953|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682954|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
682955|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
682956|NCT03100786|Hormones|hormones|mesh-ancestor
682957|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
682958|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
682959|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683117|NCT03099785|Rifamycins|rifamycins|mesh-list
683118|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
683119|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
683120|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
683121|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
683257|NCT03099213|Ramipril|ramipril|mesh-list
683258|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
683259|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
683260|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683261|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683262|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
683486|NCT03098199|Menotropins|menotropins|mesh-list
683487|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683488|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
683489|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
683490|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
683700|NCT03096704|Vitamin D|vitamin d|mesh-list
683701|NCT03096704|Vitamins|vitamins|mesh-ancestor
683702|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
683703|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683704|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
683753|NCT03096327|Montelukast|montelukast|mesh-list
683754|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
683755|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
683756|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
683757|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
2087096|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
2087097|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
682143|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
682144|NCT03104426|Hematinics|hematinics|mesh-ancestor
2225224|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225225|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
683035|NCT03100422|Armin|armin|mesh-list
683036|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
683037|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683038|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683039|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
683040|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
683041|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087098|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087099|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2225226|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2225227|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2225228|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2225229|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2225230|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2225231|NCT00051844|Capravirine|capravirine|mesh-list
2225232|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2225233|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2225234|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225235|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225236|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
2225237|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225238|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2225239|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2225240|NCT00051896|Vanoxerine|vanoxerine|mesh-list
2225241|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2225242|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2225243|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2225244|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225245|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
685291|NCT03088540|Gemcitabine|gemcitabine|mesh-list
685292|NCT03088540|Paclitaxel|paclitaxel|mesh-list
685293|NCT03088540|Carboplatin|carboplatin|mesh-list
685294|NCT03088540|Pemetrexed|pemetrexed|mesh-list
685295|NCT03088540|Cemiplimab|cemiplimab|mesh-list
685296|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
685297|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685298|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
685299|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
685300|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
685301|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685302|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
685303|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
685304|NCT03088540|Antiviral Agents|antiviral agents|mesh-ancestor
685305|NCT03088540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
685306|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685307|NCT03088540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
685308|NCT03088540|Immunologic Factors|immunologic factors|mesh-ancestor
685309|NCT03088540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685310|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
685311|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
681876|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
681901|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
681902|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
681903|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
681904|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
681905|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682038|NCT03105245|Thiopental|thiopental|mesh-list
682039|NCT03105245|Anesthetics|anesthetics|mesh-list
682040|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
682041|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682042|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
682043|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
682044|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
682045|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
682046|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
682047|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
682048|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
682049|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225246|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2225247|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225248|NCT00051974|Bortezomib|bortezomib|mesh-list
682265|NCT03103867|Insulin|insulin|mesh-list
682266|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
682267|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682756|NCT03101319|Vitamin D|vitamin d|mesh-list
682757|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
682758|NCT03101319|Vitamins|vitamins|mesh-ancestor
682759|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
682760|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682761|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
682762|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
682926|NCT03100604|Sevoflurane|sevoflurane|mesh-list
682927|NCT03100604|Desflurane|desflurane|mesh-list
682928|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
682929|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
682930|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
682931|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
682932|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
682933|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225249|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225250|NCT00051987|Bortezomib|bortezomib|mesh-list
2225251|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683551|NCT03097835|Anesthetics|anesthetics|mesh-list
683552|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
683553|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683604|NCT03097406|Imidacloprid|imidacloprid|mesh-list
683605|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
683606|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
683607|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683608|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683862|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
683863|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
683864|NCT03096782|Melphalan|melphalan|mesh-list
683865|NCT03096782|Busulfan|busulfan|mesh-list
683866|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
683867|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
683868|NCT03096782|Rituximab|rituximab|mesh-list
683869|NCT03096782|Fludarabine|fludarabine|mesh-list
683870|NCT03096782|Clofarabine|clofarabine|mesh-list
683871|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
683872|NCT03096782|Tacrolimus|tacrolimus|mesh-list
683873|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
683874|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
683875|NCT03096782|Antibodies|antibodies|mesh-list
683876|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
683877|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
683878|NCT03096782|Lenograstim|lenograstim|mesh-list
683879|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
683880|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
683881|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683882|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
683883|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
683884|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
684494|NCT03092908|Acetic Acid|acetic acid|mesh-list
682027|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
682028|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
682029|NCT03105466|Hormones|hormones|mesh-ancestor
682030|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2225252|NCT00052000|Antibodies|antibodies|mesh-list
2225253|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2225254|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
2225255|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225256|NCT00052013|Vatalanib|vatalanib|mesh-list
2225257|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2225258|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225259|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225260|NCT00052026|Carvedilol|carvedilol|mesh-list
2225261|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2225262|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2225263|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
2225264|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2225265|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225266|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683029|NCT03100318|Dotinurad|dotinurad|mesh-list
683030|NCT03100318|Benzbromarone|benzbromarone|mesh-list
683031|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
683032|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
683033|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
683034|NCT03100318|Renal Agents|renal agents|mesh-ancestor
2225267|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2225268|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
2225269|NCT00052026|Protective Agents|protective agents|mesh-ancestor
2225270|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2225271|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2225272|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2225273|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
2225274|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2225275|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2225276|NCT00052039|Interferons|interferons|mesh-list
2225277|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
2225278|NCT00052039|Azathioprine|azathioprine|mesh-list
2225279|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225280|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
2225281|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225282|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
2225283|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225284|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225285|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225286|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
2225287|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225288|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2225289|NCT00052052|Interferons|interferons|mesh-list
684097|NCT03095040|Everolimus|everolimus|mesh-list
684098|NCT03095040|Vorolanib|vorolanib|mesh-list
684099|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684100|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
684101|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
684102|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684103|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
684104|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684105|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087100|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087101|NCT02165202|Rilpivirine|rilpivirine|mesh-list
2087102|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2087103|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2087104|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087105|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087106|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
2087107|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
684287|NCT03093805|Calcipotriene|calcipotriene|mesh-list
684288|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
684713|NCT03091699|Nicotine|nicotine|mesh-list
684714|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
684715|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
684716|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684717|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684718|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
684719|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
684720|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
684721|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
682060|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
682061|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087108|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2087109|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2752562|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2752563|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752564|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2752565|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
2087114|NCT02165397|Rituximab|rituximab|mesh-list
2087115|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2225290|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
2225291|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225292|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
2225293|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225294|NCT00052117|Capravirine|capravirine|mesh-list
2225295|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225296|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225297|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2225298|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2225299|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
2225300|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225301|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2225302|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2225303|NCT00052169|Docetaxel|docetaxel|mesh-list
2225304|NCT00052169|Gefitinib|gefitinib|mesh-list
2225305|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225306|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
2752566|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
2752567|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2752568|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2752569|NCT03459859|Cytarabine|cytarabine|mesh-list
2752570|NCT03459859|Pevonedistat|pevonedistat|mesh-list
2752571|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2752572|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
2752573|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752574|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752575|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
2752576|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2752577|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225307|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
2225308|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
2225309|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684583|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
684584|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
684585|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684696|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
684697|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
684698|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
684699|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684765|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
684766|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
684993|NCT03089866|Midazolam|midazolam|mesh-list
684994|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
684995|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
684996|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684997|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684998|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
684999|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
685000|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
685001|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
685002|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
685003|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
685004|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
685005|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
685006|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
685007|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225310|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2225311|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225312|NCT00052208|Gefitinib|gefitinib|mesh-list
2225313|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225314|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2225315|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225316|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225317|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
2087116|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682074|NCT03104998|Ubiquinone|ubiquinone|mesh-list
682075|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
682076|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
682077|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682078|NCT03104998|Vitamins|vitamins|mesh-ancestor
682251|NCT03104036|Mesalamine|mesalamine|mesh-list
682252|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
682253|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
682254|NCT03104036|Analgesics|analgesics|mesh-ancestor
682255|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
682256|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682257|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682258|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
682259|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
682518|NCT03102723|Cangrelor|cangrelor|mesh-list
682519|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
682520|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
682521|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
682522|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
682523|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
682524|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
682525|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682526|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682860|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
682861|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
682862|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
682863|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682864|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
682865|NCT03101124|Coagulants|coagulants|mesh-ancestor
683335|NCT03098407|Buprenorphine|buprenorphine|mesh-list
683336|NCT03098407|Methadone|methadone|mesh-list
683337|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
683338|NCT03098407|Narcotics|narcotics|mesh-ancestor
683339|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
683340|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683341|NCT03098407|Analgesics|analgesics|mesh-ancestor
683342|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
683343|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683344|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
683345|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
683346|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
2225318|NCT00052221|Hematinics|hematinics|mesh-ancestor
2225319|NCT00052273|Capecitabine|capecitabine|mesh-list
2225320|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225321|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
2225322|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225323|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225324|NCT00052286|Modafinil|modafinil|mesh-list
2752578|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
683906|NCT03096184|Apatinib|apatinib|mesh-list
683907|NCT03096184|Tegafur|tegafur|mesh-list
683908|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683909|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
683910|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683911|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683912|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
683913|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
684052|NCT03095352|Carboplatin|carboplatin|mesh-list
684054|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
684055|NCT03095352|Trastuzumab|trastuzumab|mesh-list
684056|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684057|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
684220|NCT03094403|Azelaic acid|azelaic acid|mesh-list
684221|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684222|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
684291|NCT03093909|Gemcitabine|gemcitabine|mesh-list
684292|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
684293|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
684294|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684295|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684296|NCT03093909|Antiviral Agents|antiviral agents|mesh-ancestor
684297|NCT03093909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
684298|NCT03093909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684299|NCT03093909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
684300|NCT03093909|Immunologic Factors|immunologic factors|mesh-ancestor
684301|NCT03093909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684626|NCT03092011|Clonidine|clonidine|mesh-list
684627|NCT03092011|Morphine|morphine|mesh-list
682108|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
682109|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
682110|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
682111|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682112|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682113|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
682114|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
682115|NCT03104842|Hormones|hormones|mesh-ancestor
682116|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
682117|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
682118|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682119|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
682120|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
682121|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
682122|NCT03104842|Growth Substances|growth substances|mesh-ancestor
682123|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
682162|NCT03104335|Apatinib|apatinib|mesh-list
682163|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682164|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
682165|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682166|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682268|NCT03103685|Clopidogrel|clopidogrel|mesh-list
682269|NCT03103685|Ticagrelor|ticagrelor|mesh-list
682270|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
682271|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
682272|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
682273|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
682274|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
682275|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
682276|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
682277|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682278|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682410|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
682411|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
682412|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
682413|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
682414|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682415|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
682416|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
682417|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682722|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
682723|NCT03101709|Fludarabine|fludarabine|mesh-list
682724|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
682725|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
682726|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682727|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
682728|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
682729|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
682730|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682731|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682732|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
683313|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
683314|NCT03098810|Astringents|astringents|mesh-ancestor
683315|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683316|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
2225325|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2225326|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225327|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2225328|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2225329|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2225330|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225331|NCT00052299|Cytarabine|cytarabine|mesh-list
2225332|NCT00052299|Etoposide|etoposide|mesh-list
2225333|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
2225334|NCT00052299|Idarubicin|idarubicin|mesh-list
2225335|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
2225336|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2225337|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682128|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682129|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682130|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
682131|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
682132|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
682133|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
682134|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
682135|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
682136|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
682137|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682138|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
2225338|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2225339|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225340|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225341|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225342|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
682360|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
682361|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
682362|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225343|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
2225344|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
682619|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
682620|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
682621|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
682843|NCT03101137|Dexamethasone|dexamethasone|mesh-list
682844|NCT03101137|Bupivacaine|bupivacaine|mesh-list
682845|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
682846|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
682847|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
682848|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682849|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682850|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
682851|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
682852|NCT03101137|Hormones|hormones|mesh-ancestor
682853|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
682854|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
682855|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682856|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
682857|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
682858|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
682859|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
2225345|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225346|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225347|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
2225348|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225349|NCT00052299|Analgesics|analgesics|mesh-ancestor
2225350|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
2225351|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2225352|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2225353|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2225354|NCT00052312|Paclitaxel|paclitaxel|mesh-list
2225355|NCT00052312|Doxorubicin|doxorubicin|mesh-list
2225356|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2225357|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2225358|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225359|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
2225360|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
2225361|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
2225362|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225363|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2225364|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2225365|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225366|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225367|NCT00052338|Gemcitabine|gemcitabine|mesh-list
2225368|NCT00052338|Carboplatin|carboplatin|mesh-list
2225369|NCT00052338|Bortezomib|bortezomib|mesh-list
2225370|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225371|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225372|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
2225373|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225374|NCT00052338|Antiviral Agents|antiviral agents|mesh-ancestor
2225375|NCT00052338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225376|NCT00052338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225377|NCT00052338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
684628|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
682150|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682396|NCT03103399|Levodopa|levodopa|mesh-list
682397|NCT03103399|Carbidopa|carbidopa|mesh-list
682398|NCT03103399|Entacapone|entacapone|mesh-list
682399|NCT03103399|Benserazide|benserazide|mesh-list
682400|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
682401|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
682402|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
682403|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
682404|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
682405|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
682406|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682407|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682408|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682409|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
682960|NCT03100565|Lidocaine|lidocaine|mesh-list
682961|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
682962|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
682963|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
682964|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682965|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
682966|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682967|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
682968|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
682969|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
682970|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
682971|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683187|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
683188|NCT03099122|Prednisone|prednisone|mesh-list
683189|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
683190|NCT03099122|Tacrolimus|tacrolimus|mesh-list
683191|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
683192|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
683193|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
683194|NCT03099122|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
683195|NCT03099122|Antibodies|antibodies|mesh-list
683196|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
683197|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
683198|NCT03099122|Hormones|hormones|mesh-ancestor
683199|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
683200|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683201|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
683202|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683203|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
683204|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
683205|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
683206|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683207|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683208|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
683209|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
683210|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
683211|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
683212|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
683213|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
683214|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
683215|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683216|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
683217|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
683218|NCT03099122|Protective Agents|protective agents|mesh-ancestor
683374|NCT03098680|Verapamil|verapamil|mesh-list
683375|NCT03098680|Nicardipine|nicardipine|mesh-list
683376|NCT03098680|Phentolamine|phentolamine|mesh-list
683377|NCT03098680|Phenylephrine|phenylephrine|mesh-list
683378|NCT03098680|Dobutamine|dobutamine|mesh-list
683379|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
683380|NCT03098680|Albuterol|albuterol|mesh-list
683381|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
683382|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
683383|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683384|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683385|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
683386|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
683387|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
683388|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
683389|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
683390|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
683391|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
682832|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
682833|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
682834|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
682835|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682836|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
682837|NCT03101163|Protective Agents|protective agents|mesh-ancestor
2752579|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752580|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752581|NCT03452865|Esomeprazole|esomeprazole|mesh-list
2752582|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2752583|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2752584|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2752585|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752586|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752587|NCT03452839|Meropenem|meropenem|mesh-list
2752588|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2752589|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2752590|NCT03435640|Nivolumab|nivolumab|mesh-list
2752591|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2752592|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752593|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2225378|NCT00052338|Immunologic Factors|immunologic factors|mesh-ancestor
2225379|NCT00052338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225380|NCT00052351|Metronidazole|metronidazole|mesh-list
2225381|NCT00052351|Paclitaxel|paclitaxel|mesh-list
684333|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
684334|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
684335|NCT03093545|Antibodies|antibodies|mesh-list
684336|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
684337|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225382|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
2225383|NCT00052351|Doxorubicin|doxorubicin|mesh-list
2225384|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2225385|NCT00052351|Vaccines|vaccines|mesh-list
2225386|NCT00052351|Sargramostim|sargramostim|mesh-list
2225387|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
2225388|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225389|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2225390|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225391|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
2225392|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
2225393|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
2225394|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225395|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225396|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2225397|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
684963|NCT03090165|Bicalutamide|bicalutamide|mesh-list
684964|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
684965|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
684966|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
684967|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684968|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685046|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
685047|NCT03089905|Remifentanil|remifentanil|mesh-list
685048|NCT03089905|Sevoflurane|sevoflurane|mesh-list
685049|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
685050|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
685051|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685052|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
685053|NCT03089905|Analgesics|analgesics|mesh-ancestor
685054|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
685055|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685056|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
685057|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
685058|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
685059|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
685060|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
685061|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685062|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
685063|NCT03089905|Narcotics|narcotics|mesh-ancestor
685064|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
685065|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2225398|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
2225399|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
682199|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682200|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
682201|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
682202|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
682203|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
682204|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
682205|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
682206|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
682207|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
682208|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682209|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
682210|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
682211|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
682212|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
682238|NCT03103893|Sirolimus|sirolimus|mesh-list
682239|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
682240|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
682241|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
682242|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682243|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
682244|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
682245|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
682246|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752594|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225400|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2225401|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2225402|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225403|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225404|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225405|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2225406|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2225407|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2225408|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
2225409|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225410|NCT00052377|Aldesleukin|aldesleukin|mesh-list
683128|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
683129|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
683130|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683131|NCT03099824|Protective Agents|protective agents|mesh-ancestor
683132|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683224|NCT03099265|Leucovorin|leucovorin|mesh-list
683225|NCT03099265|Fluorouracil|fluorouracil|mesh-list
683226|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
683227|NCT03099265|Irinotecan|irinotecan|mesh-list
683228|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
683229|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683230|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
683231|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683232|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
683233|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
683234|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683235|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
683236|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225411|NCT00052377|Interleukin-2|interleukin-2|mesh-list
2225412|NCT00052377|Interleukin-12|interleukin-12|mesh-list
682324|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682325|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
682326|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
682327|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
682328|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682329|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682330|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
682487|NCT03103022|Acetaminophen|acetaminophen|mesh-list
682488|NCT03103022|Ibuprofen|ibuprofen|mesh-list
682489|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
682490|NCT03103022|Analgesics|analgesics|mesh-ancestor
682491|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
682492|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682493|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682494|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
682495|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
682496|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
682497|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
682498|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
682499|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682500|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682934|NCT03100513|Lactulose|lactulose|mesh-list
682935|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
683050|NCT03100006|Nivolumab|nivolumab|mesh-list
683051|NCT03100006|Oregovomab|oregovomab|mesh-list
683052|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
683053|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683054|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
683055|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683164|NCT03099486|Leucovorin|leucovorin|mesh-list
683165|NCT03099486|Antidotes|antidotes|mesh-ancestor
683166|NCT03099486|Protective Agents|protective agents|mesh-ancestor
683167|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683168|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
683169|NCT03099486|Vitamins|vitamins|mesh-ancestor
683170|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
683363|NCT03098589|Lenalidomide|lenalidomide|mesh-list
683364|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
683365|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683366|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
683367|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
683368|NCT03098589|Growth Substances|growth substances|mesh-ancestor
683369|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
683370|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683616|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
683617|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
683618|NCT03097120|Estrogens|estrogens|mesh-list
683619|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
683620|NCT03097120|Hormones|hormones|mesh-ancestor
683621|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
683622|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683623|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
683624|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
683625|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
683626|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
683627|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
683628|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
683629|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
683630|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
683631|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
683632|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225413|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225414|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2225415|NCT00052377|Analgesics|analgesics|mesh-ancestor
2225416|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
2225417|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2225418|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225419|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2225420|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2225421|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
2225422|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225423|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2225424|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
2225425|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2225426|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
682345|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682346|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
682347|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
682348|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
682349|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
682350|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
682351|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682352|NCT03103568|Diuretics|diuretics|mesh-ancestor
682353|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
682354|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
682355|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
682356|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
682357|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682358|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
682359|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
682426|NCT03103152|Aspirin|aspirin|mesh-list
682427|NCT03103152|Vitamin D|vitamin d|mesh-list
682428|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
682429|NCT03103152|Vitamins|vitamins|mesh-list
682430|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
682431|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682432|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
682433|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
682434|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
682435|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
682436|NCT03103152|Analgesics|analgesics|mesh-ancestor
682437|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
682438|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682439|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
682440|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
682441|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
682442|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
682443|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682444|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
682445|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
682446|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682447|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
682527|NCT03102801|Insulin|insulin|mesh-list
682528|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
682529|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
682530|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682689|NCT03101722|Huperzine A|huperzine a|mesh-list
682690|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
682691|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682692|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682693|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
682694|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
682695|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682696|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
682697|NCT03101722|Protective Agents|protective agents|mesh-ancestor
682763|NCT03101280|Atezolizumab|atezolizumab|mesh-list
682764|NCT03101280|Rucaparib|rucaparib|mesh-list
682765|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682766|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
682767|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682768|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683511|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
683512|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
683665|NCT03096990|Apremilast|apremilast|mesh-list
683666|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
683667|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
683668|NCT03096990|Analgesics|analgesics|mesh-ancestor
683669|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
683670|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683671|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683672|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
683673|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
683674|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
683675|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
683676|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683677|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683717|NCT03096470|Anesthetics|anesthetics|mesh-list
683718|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
682378|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
682379|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
682606|NCT03102242|Atezolizumab|atezolizumab|mesh-list
682607|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682838|NCT03101254|Vemurafenib|vemurafenib|mesh-list
682839|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682840|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
682841|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682842|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683107|NCT03099759|Vitamin D|vitamin d|mesh-list
683108|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
683109|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
683110|NCT03099759|Vitamins|vitamins|mesh-ancestor
683111|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
683112|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683113|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
683114|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
683171|NCT03099382|Docetaxel|docetaxel|mesh-list
683172|NCT03099382|Irinotecan|irinotecan|mesh-list
683173|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683174|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
683175|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
683176|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
683177|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683178|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
683179|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
683180|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683289|NCT03098836|Prednisone|prednisone|mesh-list
683290|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
683291|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
683292|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
683293|NCT03098836|Hormones|hormones|mesh-ancestor
683294|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
683295|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683296|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
683297|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683298|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
683299|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683300|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683301|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
683302|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2225427|NCT00052377|Growth Substances|growth substances|mesh-ancestor
2225428|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
2225429|NCT00052390|Bevacizumab|bevacizumab|mesh-list
2225430|NCT00052390|Doxorubicin|doxorubicin|mesh-list
2225431|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2225432|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2225433|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225434|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2225435|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2225436|NCT00052390|Growth Substances|growth substances|mesh-ancestor
2225437|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225438|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
2225439|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2225440|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2225441|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225442|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225443|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225444|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2225445|NCT00052403|Antibodies|antibodies|mesh-list
2225446|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
2225447|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2225448|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
2225449|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
2225450|NCT00052403|Mitogens|mitogens|mesh-list
2225451|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225452|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225453|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
683695|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
683696|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
683697|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683698|NCT03096756|Protective Agents|protective agents|mesh-ancestor
683699|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225454|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225455|NCT00052416|Thalidomide|thalidomide|mesh-list
682394|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
682395|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
682896|NCT03101748|Paclitaxel|paclitaxel|mesh-list
682897|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
682898|NCT03101748|Doxorubicin|doxorubicin|mesh-list
682899|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
682900|NCT03101748|Trastuzumab|trastuzumab|mesh-list
682901|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
682902|NCT03101748|Daunorubicin|daunorubicin|mesh-list
682903|NCT03101748|Pertuzumab|pertuzumab|mesh-list
682904|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
682905|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
682906|NCT03101748|Antibodies|antibodies|mesh-list
682907|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
682908|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
682909|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
682910|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682911|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
682912|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
682913|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
682914|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682915|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
682916|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
682917|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682918|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
682919|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
682920|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
682921|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
682922|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
682923|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
682924|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
682925|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225456|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225457|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
2225458|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225459|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
2225460|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2225461|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
683763|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
683764|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
683765|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
683766|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
683767|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
684223|NCT03094507|Darunavir|darunavir|mesh-list
684224|NCT03094507|Dolutegravir|dolutegravir|mesh-list
684225|NCT03094507|Cobicistat|cobicistat|mesh-list
684226|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
684227|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
684228|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
684229|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684230|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684231|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
684232|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
684233|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
684234|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
684235|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
684236|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
684237|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
684238|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
684487|NCT03093090|Furosemide|furosemide|mesh-list
684488|NCT03093090|Diuretics|diuretics|mesh-ancestor
684489|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
684490|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684491|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
684492|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
684493|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225462|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2225463|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2225464|NCT00052416|Growth Substances|growth substances|mesh-ancestor
2225465|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
684831|NCT03091075|Oxandrolone|oxandrolone|mesh-list
684832|NCT03091075|Androgens|androgens|mesh-ancestor
684833|NCT03091075|Hormones|hormones|mesh-ancestor
684834|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
684835|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684836|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
2225466|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225467|NCT00052455|Vincristine|vincristine|mesh-list
2225468|NCT00052455|Temozolomide|temozolomide|mesh-list
2225469|NCT00052455|Lomustine|lomustine|mesh-list
2225470|NCT00052455|Procarbazine|procarbazine|mesh-list
2225471|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2225472|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225473|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
683528|NCT03097900|Caffeine|caffeine|mesh-list
683529|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
683530|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683531|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
683532|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683533|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
683534|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683535|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
683536|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
683537|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
683538|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684566|NCT03092193|Naproxen|naproxen|mesh-list
684567|NCT03092193|Esomeprazole|esomeprazole|mesh-list
684568|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
684569|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
684570|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
684571|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684572|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684573|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
684574|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
684575|NCT03092193|Analgesics|analgesics|mesh-ancestor
684576|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
684577|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684578|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684579|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
684580|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
684581|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
684582|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
684710|NCT03091712|Insulin|insulin|mesh-list
684711|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
684712|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087117|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
2087118|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087119|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2087120|NCT02166047|Vesatolimod|vesatolimod|mesh-list
2087121|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
2087122|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087123|NCT02166333|Vitamin D|vitamin d|mesh-list
2087124|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
2087125|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
2087126|NCT02166333|Vitamins|vitamins|mesh-list
684978|NCT03090087|Regadenoson|regadenoson|mesh-list
684979|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
684980|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
684981|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
684982|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
684983|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684984|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684985|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685193|NCT03088631|Metformin|metformin|mesh-list
685194|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
685195|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686173|NCT03084575|Glycerol|glycerol|mesh-list
686174|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
686175|NCT03084575|Protective Agents|protective agents|mesh-ancestor
686176|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225474|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
2225475|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
2225476|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225477|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2225478|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
2225479|NCT00052468|Gemcitabine|gemcitabine|mesh-list
2225480|NCT00052468|Paclitaxel|paclitaxel|mesh-list
2225481|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2225482|NCT00052468|Carboplatin|carboplatin|mesh-list
2087127|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
2087128|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225483|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2225484|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225485|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
2225486|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
2225487|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
2225488|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225489|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
682972|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
682973|NCT03100877|Melphalan|melphalan|mesh-list
682974|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
682975|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
682976|NCT03100877|Lenalidomide|lenalidomide|mesh-list
682977|NCT03100877|Lenograstim|lenograstim|mesh-list
682978|NCT03100877|Mitogens|mitogens|mesh-list
682979|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
682980|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
682981|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682982|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
682983|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
682984|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
682985|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682986|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
682987|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
682988|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
682989|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
682990|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
682991|NCT03100877|Growth Substances|growth substances|mesh-ancestor
682992|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
682993|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
683425|NCT03098342|Amorolfine|amorolfine|mesh-list
683426|NCT03098342|Methylene Blue|methylene blue|mesh-list
683427|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683428|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683429|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
683430|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
684121|NCT03094884|Paclitaxel|paclitaxel|mesh-list
684122|NCT03094884|Carboplatin|carboplatin|mesh-list
684123|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
684124|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684125|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
684126|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
684127|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
684128|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684184|NCT03094416|Esomeprazole|esomeprazole|mesh-list
684185|NCT03094416|Omeprazole|omeprazole|mesh-list
684186|NCT03094416|Rabeprazole|rabeprazole|mesh-list
684187|NCT03094416|Pantoprazole|pantoprazole|mesh-list
684188|NCT03094416|Lansoprazole|lansoprazole|mesh-list
684189|NCT03094416|Dexlansoprazole|dexlansoprazole|mesh-list
684190|NCT03094416|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
684191|NCT03094416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
684192|NCT03094416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
684193|NCT03094416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684194|NCT03094416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684326|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
684327|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
684328|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
684329|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
684745|NCT03091595|Drospirenone|drospirenone|mesh-list
684746|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
684747|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
684748|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
684749|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
684750|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
684751|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
684752|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684753|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
684754|NCT03091595|Estrogens|estrogens|mesh-ancestor
684755|NCT03091595|Hormones|hormones|mesh-ancestor
684756|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
684757|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
684758|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
684759|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
684760|NCT03091595|Diuretics|diuretics|mesh-ancestor
684761|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
685014|NCT03090035|Interferons|interferons|mesh-list
685015|NCT03090035|Ribavirin|ribavirin|mesh-list
682592|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
682593|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
682594|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
682595|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682596|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
682597|NCT03102398|Urological Agents|urological agents|mesh-ancestor
682866|NCT03100994|Bupivacaine|bupivacaine|mesh-list
682867|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
682868|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
682869|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
682870|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682871|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
682872|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683266|NCT03099031|Tinzaparin|tinzaparin|mesh-list
683267|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
683268|NCT03099031|Dalteparin|dalteparin|mesh-list
683269|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
683270|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
683271|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
683272|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683412|NCT03098368|Rotigotine|rotigotine|mesh-list
683413|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
683414|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
683415|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
683416|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683417|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225490|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
2225491|NCT00052468|Antiviral Agents|antiviral agents|mesh-ancestor
2225492|NCT00052468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225493|NCT00052468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225494|NCT00052468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225495|NCT00052468|Immunologic Factors|immunologic factors|mesh-ancestor
2225496|NCT00052468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225497|NCT00052494|Irinotecan|irinotecan|mesh-list
2225498|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
2225499|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225500|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2225501|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225502|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225503|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225504|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2225505|NCT00052507|Bortezomib|bortezomib|mesh-list
2225506|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225507|NCT00052520|Aldesleukin|aldesleukin|mesh-list
2225508|NCT00052520|Interleukin-2|interleukin-2|mesh-list
2225509|NCT00052520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225510|NCT00052520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2225511|NCT00052520|Analgesics|analgesics|mesh-ancestor
2225512|NCT00052520|Sensory System Agents|sensory system agents|mesh-ancestor
2225513|NCT00052520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2225514|NCT00052520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087129|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2087130|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2087131|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
2087132|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
683924|NCT03095703|Sirolimus|sirolimus|mesh-list
683925|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
683926|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
683927|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
683928|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683929|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
683930|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
683931|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
683932|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684181|NCT03094286|Durvalumab|durvalumab|mesh-list
684182|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
684183|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684404|NCT03093389|Resveratrol|resveratrol|mesh-list
684405|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
684406|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684407|NCT03093389|Protective Agents|protective agents|mesh-ancestor
684408|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684409|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684410|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
684817|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
684818|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
682626|NCT03102021|Hematinics|hematinics|mesh-ancestor
682677|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
682678|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
682679|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
682680|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
682681|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683645|NCT03097003|Apremilast|apremilast|mesh-list
683646|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
683647|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
683648|NCT03097003|Analgesics|analgesics|mesh-ancestor
683649|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
683650|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683651|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683652|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
683653|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
683654|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
683655|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
683656|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683657|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684040|NCT03095222|Ketamine|ketamine|mesh-list
684041|NCT03095222|Analgesics|analgesics|mesh-ancestor
684042|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
684043|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684044|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684045|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
684046|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
684047|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
684048|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
684049|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684050|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
684051|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
684053|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684058|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684129|NCT03094663|Cefazolin|cefazolin|mesh-list
684130|NCT03094663|Dexamethasone|dexamethasone|mesh-list
684131|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
684132|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
684133|NCT03094663|Epinephrine|epinephrine|mesh-list
684134|NCT03094663|Bupivacaine|bupivacaine|mesh-list
684135|NCT03094663|BB 1101|bb 1101|mesh-list
684136|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
684137|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
684138|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
684139|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684140|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684141|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
684142|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
684143|NCT03094663|Hormones|hormones|mesh-ancestor
684144|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
684145|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
684146|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684147|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
684148|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684149|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684150|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
684151|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
684152|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684153|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
684154|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
684155|NCT03094663|Protective Agents|protective agents|mesh-ancestor
684156|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
684157|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
684158|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
684159|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684160|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
684161|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
684162|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
684163|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
684164|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
684165|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
684166|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
684167|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
684168|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
684274|NCT03094247|Amoxicillin|amoxicillin|mesh-list
684275|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
684276|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
682642|NCT03102320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
682643|NCT03102320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
682644|NCT03102320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
682645|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
682646|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682647|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
682648|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
682649|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
682650|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
2225515|NCT00052520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2225516|NCT00052520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2225517|NCT00052520|Antiviral Agents|antiviral agents|mesh-ancestor
2225518|NCT00052520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225519|NCT00052559|Bevacizumab|bevacizumab|mesh-list
2225520|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2225521|NCT00052559|Fluorouracil|fluorouracil|mesh-list
2225522|NCT00052559|Antibodies|antibodies|mesh-list
683042|NCT03100071|Apixaban|apixaban|mesh-list
683043|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
683044|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
683045|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
683046|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
683047|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683048|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683049|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
683100|NCT03099720|Ropivacaine|ropivacaine|mesh-list
683101|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
683102|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
683103|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
683104|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683105|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
683106|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683790|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
683791|NCT03096275|Hormones|hormones|mesh-ancestor
683792|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
683793|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683898|NCT03095872|Petrolatum|petrolatum|mesh-list
683899|NCT03095872|Emollients|emollients|mesh-ancestor
683900|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
684059|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
684060|NCT03095378|Tetracycline|tetracycline|mesh-list
684061|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
684062|NCT03095378|Citric Acid|citric acid|mesh-list
684063|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
684064|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
684065|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684066|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684067|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
684068|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
684069|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
684070|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
684253|NCT03094481|Epinephrine|epinephrine|mesh-list
684254|NCT03094481|Bupivacaine|bupivacaine|mesh-list
684255|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
684256|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
684257|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684258|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684259|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
684260|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684261|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
684262|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
684263|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
684264|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684265|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684266|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
684267|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
684268|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
684269|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
684270|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
684271|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
684272|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
684273|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
684739|NCT03091491|Nivolumab|nivolumab|mesh-list
684740|NCT03091491|Ipilimumab|ipilimumab|mesh-list
684741|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
684742|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684743|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
684897|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
682684|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
682685|NCT03101423|Analgesics|analgesics|mesh-ancestor
682686|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
682687|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682688|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682819|NCT03101085|Equol|equol|mesh-list
682820|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
682821|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
682822|NCT03101085|Estrogens|estrogens|mesh-ancestor
682823|NCT03101085|Hormones|hormones|mesh-ancestor
682824|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
682825|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682936|NCT03100734|Etanercept|etanercept|mesh-list
682937|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
682938|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
682939|NCT03100734|Analgesics|analgesics|mesh-ancestor
682940|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
682941|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
682942|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
682943|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
682944|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
682945|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
682946|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
682947|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
683011|NCT03100253|Adalimumab|adalimumab|mesh-list
683012|NCT03100253|Etanercept|etanercept|mesh-list
683013|NCT03100253|Golimumab|golimumab|mesh-list
683014|NCT03100253|Infliximab|infliximab|mesh-list
683015|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
683016|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
683017|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
683018|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
683019|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
683020|NCT03100253|Analgesics|analgesics|mesh-ancestor
683021|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
683022|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683023|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683024|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
683025|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
683026|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
683027|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
683028|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2225523|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
2225524|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
683303|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
683304|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
683332|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
683333|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683334|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683458|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
683459|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
683460|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
683461|NCT03098225|Prednisolone|prednisolone|mesh-list
683462|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
683463|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
683464|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
683465|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
683466|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
683467|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
683468|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683469|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683470|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
683471|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
683472|NCT03098225|Hormones|hormones|mesh-ancestor
683473|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
683474|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
683475|NCT03098225|Protective Agents|protective agents|mesh-ancestor
683476|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
683477|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683980|NCT03095404|Lidocaine|lidocaine|mesh-list
683981|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
683982|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
683983|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
683984|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
683985|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683986|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
683987|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087133|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2087134|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087135|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2087136|NCT02166476|Levofloxacin|levofloxacin|mesh-list
2087137|NCT02166476|Ofloxacin|ofloxacin|mesh-list
2087138|NCT02166476|Meropenem|meropenem|mesh-list
682804|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
682805|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
682806|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
682807|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
2225525|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225526|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2225527|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2225528|NCT00052559|Growth Substances|growth substances|mesh-ancestor
2225529|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225530|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
2225531|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
2225532|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
2225533|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225534|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225535|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225536|NCT00052585|Leucovorin|leucovorin|mesh-list
2225537|NCT00052585|Fluorouracil|fluorouracil|mesh-list
2225538|NCT00052585|Irinotecan|irinotecan|mesh-list
683681|NCT03097211|Levodopa|levodopa|mesh-list
683682|NCT03097211|Benserazide|benserazide|mesh-list
683683|NCT03097211|Resveratrol|resveratrol|mesh-list
683684|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
683685|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
683686|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
683687|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
683688|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
683689|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683690|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683691|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
683692|NCT03097211|Protective Agents|protective agents|mesh-ancestor
683693|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683694|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
684023|NCT03095209|Paclitaxel|paclitaxel|mesh-list
684024|NCT03095209|Carboplatin|carboplatin|mesh-list
684025|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
684026|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684027|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
684028|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
684029|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
684030|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684215|NCT03094468|Terbinafine|terbinafine|mesh-list
684216|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
684217|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
684218|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684219|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225539|NCT00052585|Gefitinib|gefitinib|mesh-list
2225540|NCT00052585|Calcium|calcium|mesh-list
2225541|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
2225542|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2225543|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225544|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
2225545|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225546|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225547|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225548|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225549|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
2225550|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2225551|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225552|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225553|NCT00052585|Antidotes|antidotes|mesh-ancestor
2225554|NCT00052585|Protective Agents|protective agents|mesh-ancestor
684889|NCT03090776|Ketamine|ketamine|mesh-list
684890|NCT03090776|Analgesics|analgesics|mesh-ancestor
684891|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
684892|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684893|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684894|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
684895|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
684896|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
2087139|NCT02166476|Tazobactam|tazobactam|mesh-list
2225555|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
682801|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
682802|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
682803|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
683478|NCT03098160|Ipilimumab|ipilimumab|mesh-list
683479|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
683480|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683481|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
683482|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683796|NCT03096249|Oxytocin|oxytocin|mesh-list
683797|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
683798|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
683799|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684330|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
684331|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
684332|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684619|NCT03092466|Ropivacaine|ropivacaine|mesh-list
684620|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
684621|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
684622|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684623|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684624|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
684625|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684686|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
684687|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
684688|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
684689|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684690|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
684691|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
684692|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
684693|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
684694|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684695|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685117|NCT03089567|Listerine|listerine|mesh-list
685118|NCT03089567|Fluorides|fluorides|mesh-list
685119|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
685120|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
685121|NCT03089567|Protective Agents|protective agents|mesh-ancestor
685122|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685123|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
685124|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
685321|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
685322|NCT03088293|Infliximab|infliximab|mesh-list
685323|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
685324|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
685325|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685326|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
685327|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
685328|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
685329|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685330|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685331|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
685332|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
685333|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
685445|NCT03087877|Acetaminophen|acetaminophen|mesh-list
685446|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
685447|NCT03087877|Analgesics|analgesics|mesh-ancestor
685448|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
685449|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685450|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685451|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
2225556|NCT00052585|Vitamins|vitamins|mesh-ancestor
2225557|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
2225558|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2225559|NCT00052598|Aldesleukin|aldesleukin|mesh-list
2225560|NCT00052598|Interleukin-2|interleukin-2|mesh-list
2225561|NCT00052598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225562|NCT00052598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2225563|NCT00052598|Analgesics|analgesics|mesh-ancestor
2225564|NCT00052598|Sensory System Agents|sensory system agents|mesh-ancestor
2225565|NCT00052598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2225566|NCT00052598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225567|NCT00052598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2225568|NCT00052598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2225569|NCT00052598|Antiviral Agents|antiviral agents|mesh-ancestor
2225570|NCT00052598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225571|NCT00052611|Celecoxib|celecoxib|mesh-list
2225572|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2225573|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2225574|NCT00052611|Analgesics|analgesics|mesh-ancestor
2225575|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
684014|NCT03095274|Durvalumab|durvalumab|mesh-list
684015|NCT03095274|Tremelimumab|tremelimumab|mesh-list
684016|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
684017|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225576|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2225577|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225578|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2225579|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2225580|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2225581|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2225582|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225583|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225584|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2225585|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2225586|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225587|NCT00052689|Gemcitabine|gemcitabine|mesh-list
684969|NCT03090269|Methylphenidate|methylphenidate|mesh-list
684970|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
684971|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684972|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
684973|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
684974|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
684975|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684976|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
684977|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087140|NCT02166476|Piperacillin|piperacillin|mesh-list
2087141|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2087142|NCT02166476|Vaborbactam|vaborbactam|mesh-list
686855|NCT03081442|Misoprostol|misoprostol|mesh-list
686856|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
686857|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
686858|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
686859|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
686860|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686861|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
686862|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
686863|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
2087143|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
2087144|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087145|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2087146|NCT02166476|Renal Agents|renal agents|mesh-ancestor
2087147|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2087148|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2087149|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087150|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087151|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087152|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2087153|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2087154|NCT02166697|Candesartan|candesartan|mesh-list
2087155|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
2087156|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2087157|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
687145|NCT03079440|Capecitabine|capecitabine|mesh-list
687146|NCT03079440|Temozolomide|temozolomide|mesh-list
687147|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
687148|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
687149|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687150|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687151|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
687152|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
687278|NCT03078855|Vitamin D|vitamin d|mesh-list
687279|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
687280|NCT03078855|Rituximab|rituximab|mesh-list
687281|NCT03078855|Vitamins|vitamins|mesh-ancestor
687282|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
687283|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687284|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
687285|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687286|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
687287|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
687288|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
683134|NCT03099616|Desflurane|desflurane|mesh-list
683135|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
683136|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
683137|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683138|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
683139|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
683140|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
683141|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
683523|NCT03097848|Sorafenib|sorafenib|mesh-list
683524|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683525|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
683526|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683527|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225588|NCT00052689|Bortezomib|bortezomib|mesh-list
2225589|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225590|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
2225591|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225592|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225593|NCT00052689|Antiviral Agents|antiviral agents|mesh-ancestor
2225594|NCT00052689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
684564|NCT03092310|Pancrelipase|pancrelipase|mesh-list
684565|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2225595|NCT00052689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225596|NCT00052689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225597|NCT00052689|Immunologic Factors|immunologic factors|mesh-ancestor
2225598|NCT00052689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225599|NCT00052728|Tamoxifen|tamoxifen|mesh-list
2225600|NCT00052728|Tipifarnib|tipifarnib|mesh-list
2225601|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2225602|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
2225603|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2225604|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225605|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2225606|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225607|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2225608|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2225609|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
685238|NCT03088254|Amlodipine|amlodipine|mesh-list
685239|NCT03088254|Telmisartan|telmisartan|mesh-list
685240|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
685241|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
685242|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
685243|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
685244|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685245|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
685246|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685247|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
685248|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
685249|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
685250|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
685251|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
685252|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
685253|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685254|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
685255|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2225610|NCT00052754|Gefitinib|gefitinib|mesh-list
683237|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683238|NCT03099265|Antidotes|antidotes|mesh-ancestor
683239|NCT03099265|Protective Agents|protective agents|mesh-ancestor
683240|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
683241|NCT03099265|Vitamins|vitamins|mesh-ancestor
683242|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
683305|NCT03098823|Prednisone|prednisone|mesh-list
683306|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
683307|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
683308|NCT03098823|Hormones|hormones|mesh-ancestor
683309|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
683310|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683311|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
683312|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225611|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225612|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2225613|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225614|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225615|NCT00052780|Temozolomide|temozolomide|mesh-list
684351|NCT03093155|Bevacizumab|bevacizumab|mesh-list
684352|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
684353|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684354|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
684355|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
684356|NCT03093155|Growth Substances|growth substances|mesh-ancestor
684357|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684358|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
684525|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
684526|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
684527|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
684528|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
684529|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684931|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
684932|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
684933|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684934|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684935|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
685151|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
685152|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
685153|NCT03089073|Coagulants|coagulants|mesh-ancestor
685154|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
685155|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
685156|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225616|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2225617|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2225618|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
2225619|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685596|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
685597|NCT03087162|Lansoprazole|lansoprazole|mesh-list
685598|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
685599|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
685600|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
685601|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685602|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225620|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225621|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225622|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2225623|NCT00052832|Vitamins|vitamins|mesh-ancestor
2225624|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
2225625|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225626|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2225627|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
2225628|NCT00052845|Docetaxel|docetaxel|mesh-list
2225629|NCT00052845|Estramustine|estramustine|mesh-list
2225630|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225631|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
2225632|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
2225633|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
2225634|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225635|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2225636|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
2225637|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2225638|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2225639|NCT00052845|Protective Agents|protective agents|mesh-ancestor
2225640|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686506|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
683392|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
683393|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
683394|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683395|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
683396|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
683397|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
683398|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
683399|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
683400|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
683401|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
683402|NCT03098680|Protective Agents|protective agents|mesh-ancestor
683403|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
683404|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
683405|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
683406|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
683407|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
683408|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
683409|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
683410|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
683411|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
683483|NCT03098121|Grazoprevir|grazoprevir|mesh-list
683484|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
683485|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
683771|NCT03096392|Insulin|insulin|mesh-list
683772|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
683773|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
683774|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
683775|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683950|NCT03095547|Cyclosporine|cyclosporine|mesh-list
683951|NCT03095547|Posaconazole|posaconazole|mesh-list
683952|NCT03095547|Olorofim|olorofim|mesh-list
683953|NCT03095547|Pantoprazole|pantoprazole|mesh-list
683954|NCT03095547|Tacrolimus|tacrolimus|mesh-list
683955|NCT03095547|Cyclosporins|cyclosporins|mesh-list
683956|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
683957|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
683958|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683959|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
683960|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683961|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683962|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
683963|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
683964|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
683965|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
683966|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
683967|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
683968|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
683969|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
683970|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
683971|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
683972|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
683973|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
683974|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
683975|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
683976|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
684018|NCT03095144|Anesthetics|anesthetics|mesh-list
684019|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684020|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684478|NCT03092986|Paclitaxel|paclitaxel|mesh-list
684479|NCT03092986|Vinblastine|vinblastine|mesh-list
684480|NCT03092986|Carboplatin|carboplatin|mesh-list
684481|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
684482|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684483|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
684484|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
684485|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
684486|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685021|NCT03090048|Vitamin A|vitamin a|mesh-list
685022|NCT03090048|Azithromycin|azithromycin|mesh-list
685023|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
685024|NCT03090048|Vitamins|vitamins|mesh-ancestor
685025|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
685026|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685027|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
685028|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
685029|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
685030|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683418|NCT03098355|Interleukin-2|interleukin-2|mesh-list
683419|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683420|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
683421|NCT03098355|Analgesics|analgesics|mesh-ancestor
683422|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
683423|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683424|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683776|NCT03096522|Phenytoin|phenytoin|mesh-list
683777|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
683778|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
683779|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
683780|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
683781|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683782|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
683783|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
684106|NCT03095001|Paclitaxel|paclitaxel|mesh-list
684107|NCT03095001|Bevacizumab|bevacizumab|mesh-list
684108|NCT03095001|Carboplatin|carboplatin|mesh-list
684109|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
684110|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684111|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
684112|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
684113|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
684114|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684115|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
684116|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
684117|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
684118|NCT03095001|Growth Substances|growth substances|mesh-ancestor
684119|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684120|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
684338|NCT03093597|Petrolatum|petrolatum|mesh-list
684339|NCT03093597|Emollients|emollients|mesh-ancestor
684340|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
2225641|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2225642|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225643|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2225644|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2225645|NCT00052845|Analgesics|analgesics|mesh-ancestor
2225646|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
2225647|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2225648|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
685008|NCT03089957|Urinastatin|urinastatin|mesh-list
685009|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
685010|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
685011|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
685012|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685013|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685924|NCT03085771|Deferoxamine|deferoxamine|mesh-list
685925|NCT03085771|Siderophores|siderophores|mesh-ancestor
685926|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
685927|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
685928|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
685929|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752635|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
2752636|NCT03401710|Hematinics|hematinics|mesh-ancestor
2752637|NCT03389477|Cisplatin|cisplatin|mesh-list
2752638|NCT03389477|Cetuximab|cetuximab|mesh-list
2752639|NCT03389477|Palbociclib|palbociclib|mesh-list
2752640|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752641|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2752642|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2752643|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752644|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752645|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2752646|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2752647|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686337|NCT03083834|Cosyntropin|cosyntropin|mesh-list
686338|NCT03083834|Hormones|hormones|mesh-ancestor
686351|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
2225649|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
683581|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
683582|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683583|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683584|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
683585|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
683586|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
683587|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
683588|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
683589|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
683590|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683914|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
683915|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
683916|NCT03096028|Vitamins|vitamins|mesh-ancestor
683917|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
683918|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683919|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
683920|NCT03096028|Hematinics|hematinics|mesh-ancestor
2225650|NCT00052884|Melphalan|melphalan|mesh-list
2225651|NCT00052884|Amifostine|amifostine|mesh-list
2225652|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
685497|NCT03087669|Norepinephrine|norepinephrine|mesh-list
685498|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
685499|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
685500|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
685501|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
685502|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685503|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685504|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
685505|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
685506|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685507|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
685608|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
685609|NCT03087032|Liraglutide|liraglutide|mesh-list
685610|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
685611|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685612|NCT03087032|Incretins|incretins|mesh-ancestor
685613|NCT03087032|Hormones|hormones|mesh-ancestor
685614|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
685660|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
685661|NCT03086720|Eusol|eusol|mesh-list
685662|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
685663|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
686533|NCT03082677|Ixazomib|ixazomib|mesh-list
686534|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686535|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
686536|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686537|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686589|NCT03082352|Metoprolol|metoprolol|mesh-list
686590|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
686591|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
686592|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
686593|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
686594|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686595|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686596|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
686597|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
686598|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
686599|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
686600|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
686601|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687290|NCT03078829|Leuprolide|leuprolide|mesh-list
687291|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
687292|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
687293|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
687294|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687295|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
687296|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688059|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
688060|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
683719|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683784|NCT03096288|Evolocumab|evolocumab|mesh-list
683785|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
683786|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
683787|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
683788|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683789|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2225653|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225654|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2225655|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
2225656|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225657|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225658|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2225659|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225660|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2225661|NCT00052884|Protective Agents|protective agents|mesh-ancestor
684277|NCT03094156|Resveratrol|resveratrol|mesh-list
684278|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
684279|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
684280|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684281|NCT03094156|Protective Agents|protective agents|mesh-ancestor
684282|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684283|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684284|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
684285|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
684286|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684319|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
684320|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
684321|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
684322|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
684323|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
684324|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684325|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225662|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
2225663|NCT00052923|Carmustine|carmustine|mesh-list
2225664|NCT00052923|Rituximab|rituximab|mesh-list
2225665|NCT00052923|Etoposide|etoposide|mesh-list
2225666|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225667|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
2225668|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684880|NCT03090698|Triamcinolone|triamcinolone|mesh-list
684881|NCT03090698|Hylan|hylan|mesh-list
684882|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
684883|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
684884|NCT03090698|Hormones|hormones|mesh-ancestor
684885|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
684886|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684887|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
684888|NCT03090698|Protective Agents|protective agents|mesh-ancestor
685094|NCT03089671|Vitamins|vitamins|mesh-list
685095|NCT03089671|Riboflavin|riboflavin|mesh-list
685096|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
685097|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
685098|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685099|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
685100|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
685219|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
685220|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
685221|NCT03088709|Tacrolimus|tacrolimus|mesh-list
685222|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
685223|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
685224|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685225|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
685226|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
685227|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
685228|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685229|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685230|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
685231|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
685232|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685233|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
685234|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
685235|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
685236|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
685237|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
683758|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
683759|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683760|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
683761|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
683762|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684385|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
684386|NCT03093168|Fludarabine|fludarabine|mesh-list
684387|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
684388|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
684389|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684390|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
684391|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
684392|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
684393|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684394|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684395|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
684505|NCT03092817|Dexamethasone|dexamethasone|mesh-list
684506|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
684507|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
684508|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
684509|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684510|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684511|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
684512|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
684513|NCT03092817|Hormones|hormones|mesh-ancestor
684514|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
684515|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
684516|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684552|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
684553|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
684554|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
684555|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
684556|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684557|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
684558|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
684559|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
684560|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684561|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684562|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
684563|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2225669|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2225670|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2225671|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
2225672|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225673|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685585|NCT03087201|Nabiximols|nabiximols|mesh-list
685586|NCT03087201|Analgesics|analgesics|mesh-ancestor
685587|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
685588|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685589|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225674|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2225675|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2225676|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2225677|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2225678|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225679|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225680|NCT00052936|Prednisone|prednisone|mesh-list
2225681|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
2225682|NCT00052936|Rituximab|rituximab|mesh-list
2225683|NCT00052936|Doxorubicin|doxorubicin|mesh-list
2225684|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2225685|NCT00052936|Vincristine|vincristine|mesh-list
2225686|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225687|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
2225688|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225689|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2225690|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2225691|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
2225692|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225693|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225694|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2225695|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2225696|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2225697|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2225698|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225699|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225700|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2225701|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
2225702|NCT00052936|Hormones|hormones|mesh-ancestor
2225703|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2225704|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2225705|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2225706|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
2225707|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
2225708|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
2225709|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
2225710|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225711|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2225712|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225713|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225714|NCT00053001|Thalidomide|thalidomide|mesh-list
2225715|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
2225716|NCT00053001|Hematinics|hematinics|mesh-ancestor
2225717|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225718|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
2225719|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225720|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
2225721|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2225722|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225723|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
683936|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
683937|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
683938|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
683939|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
683940|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
683941|NCT03095469|Analgesics|analgesics|mesh-ancestor
683942|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
683943|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
683944|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
683945|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
683946|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
683947|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
683948|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
683949|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225724|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2225725|NCT00053001|Growth Substances|growth substances|mesh-ancestor
684857|NCT03091257|Trametinib|trametinib|mesh-list
684858|NCT03091257|Dabrafenib|dabrafenib|mesh-list
2225726|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
684031|NCT03095235|Riboflavin|riboflavin|mesh-list
684032|NCT03095235|Vitamins|vitamins|mesh-ancestor
684033|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
684034|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684035|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
684036|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
684037|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
684658|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
684659|NCT03091894|Propofol|propofol|mesh-list
684660|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
684661|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684662|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684663|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
684664|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
684665|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
684666|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
684667|NCT03091894|Analgesics|analgesics|mesh-ancestor
684668|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
684669|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684670|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
684671|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
684672|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
684673|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
684674|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684675|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684730|NCT03091569|Vitamin K|vitamin k|mesh-list
684731|NCT03091569|Vitamins|vitamins|mesh-ancestor
684732|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
684733|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684734|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
684735|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
684736|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684737|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
684738|NCT03091569|Coagulants|coagulants|mesh-ancestor
684936|NCT03090503|Risperidone|risperidone|mesh-list
684937|NCT03090503|Aripiprazole|aripiprazole|mesh-list
684938|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
684939|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
684940|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684941|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684942|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684943|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
684944|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
684945|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684946|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
684947|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
684948|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
684949|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
684950|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
684951|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
684952|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
684953|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
684954|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
685068|NCT03089983|Isoniazid|isoniazid|mesh-list
685069|NCT03089983|Rifapentine|rifapentine|mesh-list
685070|NCT03089983|Buprenorphine|buprenorphine|mesh-list
685071|NCT03089983|Methadone|methadone|mesh-list
685072|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
685073|NCT03089983|Naloxone|naloxone|mesh-list
685074|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
685075|NCT03089983|Narcotics|narcotics|mesh-ancestor
685076|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
685077|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685078|NCT03089983|Analgesics|analgesics|mesh-ancestor
685079|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
685080|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685081|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
685082|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
685083|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
685084|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
685085|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
685086|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
685185|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
683885|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
683886|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
683887|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
683888|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
683889|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
683890|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
683891|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
683892|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
683893|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
683894|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
683895|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
683896|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
683897|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
684078|NCT03095326|Zinc|zinc|mesh-list
684079|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
684080|NCT03095326|Vaccines|vaccines|mesh-list
684081|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
684082|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684083|NCT03095326|Trace Elements|trace elements|mesh-ancestor
684084|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
684085|NCT03095326|Astringents|astringents|mesh-ancestor
684086|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
684343|NCT03093402|Lenabasum|lenabasum|mesh-list
684344|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
684345|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
684346|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684347|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684348|NCT03093402|Hormones|hormones|mesh-ancestor
684349|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
684350|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684398|NCT03093103|Empagliflozin|empagliflozin|mesh-list
684400|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
684401|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684402|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
684403|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225727|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225728|NCT00053027|Rituximab|rituximab|mesh-list
2225729|NCT00053027|Cladribine|cladribine|mesh-list
685034|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
685035|NCT03090009|Analgesics|analgesics|mesh-ancestor
685036|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
685037|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685038|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685039|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
685040|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
685041|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
685042|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
685043|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
685044|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685045|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685334|NCT03088306|Acetaminophen|acetaminophen|mesh-list
685335|NCT03088306|Fentanyl|fentanyl|mesh-list
685336|NCT03088306|Ketamine|ketamine|mesh-list
685337|NCT03088306|Gabapentin|gabapentin|mesh-list
685338|NCT03088306|Hydromorphone|hydromorphone|mesh-list
685339|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
685340|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
685341|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685342|NCT03088306|Analgesics|analgesics|mesh-ancestor
685343|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
685344|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685345|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
685346|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
685347|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
685348|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
685349|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
685350|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
685351|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685352|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
685353|NCT03088306|Narcotics|narcotics|mesh-ancestor
685354|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
685355|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
685356|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
685357|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
685358|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
685359|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
683988|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
683989|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
683990|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
683991|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
683992|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684087|NCT03095105|Resveratrol|resveratrol|mesh-list
684088|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
684089|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684090|NCT03095105|Protective Agents|protective agents|mesh-ancestor
684091|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684092|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684093|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
684241|NCT03094442|Dexamethasone|dexamethasone|mesh-list
684242|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
684243|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
684244|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
684245|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684246|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684247|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
684248|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
684249|NCT03094442|Hormones|hormones|mesh-ancestor
684250|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
684251|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
684252|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684497|NCT03092895|Apatinib|apatinib|mesh-list
684498|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684499|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
684500|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684501|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087158|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2087159|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087160|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
2087161|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2087162|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2087163|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
2087164|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087165|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087166|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087167|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2087168|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2087169|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2087170|NCT02167139|Adalimumab|adalimumab|mesh-list
2087171|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2087172|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2087173|NCT02167204|Alovudine|alovudine|mesh-list
2087174|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
684586|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
684587|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
684588|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
684589|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
684590|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
684591|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
684592|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
684593|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
684594|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684595|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684767|NCT03091504|Albuterol|albuterol|mesh-list
684768|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
684769|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
684770|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684771|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684772|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
684773|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
684774|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
684775|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
684776|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
684777|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
684778|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
684779|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
684780|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684781|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225730|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2225731|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225732|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
684239|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
684240|NCT03094182|Hematinics|hematinics|mesh-ancestor
2225733|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225734|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2225735|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225736|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
2225737|NCT00053092|Rituximab|rituximab|mesh-list
684502|NCT03093064|Natalizumab|natalizumab|mesh-list
684503|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
684504|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685389|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
685390|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
685391|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685392|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
685393|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685394|NCT03087903|Protective Agents|protective agents|mesh-ancestor
685395|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225738|NCT00053092|Fludarabine|fludarabine|mesh-list
2225739|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
2225740|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
685942|NCT03085784|Aflibercept|aflibercept|mesh-list
685943|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
685944|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
685945|NCT03085784|Growth Substances|growth substances|mesh-ancestor
685946|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685947|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
685948|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225741|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
2225742|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225743|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2225744|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2225745|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
2225746|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225747|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225748|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2225749|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2225750|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225751|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
2752661|NCT03366142|Ustekinumab|ustekinumab|mesh-list
2752662|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
687261|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
687262|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
687263|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
687264|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687265|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687266|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
687267|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
687268|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
687269|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
687270|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687271|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687272|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
687273|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
687274|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
687275|NCT03078933|Protective Agents|protective agents|mesh-ancestor
687722|NCT03077828|Carboplatin|carboplatin|mesh-list
687723|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
687724|NCT03077828|Etoposide|etoposide|mesh-list
687725|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
687726|NCT03077828|Ifosfamide|ifosfamide|mesh-list
687727|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
687728|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
687729|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687730|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
687731|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
687732|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
687733|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
687734|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687748|NCT03077009|Protective Agents|protective agents|mesh-ancestor
2225752|NCT00053105|Cytarabine|cytarabine|mesh-list
2225753|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
2225754|NCT00053105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
685511|NCT03087578|Mirabegron|mirabegron|mesh-list
685512|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
685513|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
685514|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
685515|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
685516|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
685517|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685518|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685519|NCT03087578|Urological Agents|urological agents|mesh-ancestor
686113|NCT03084978|Anesthetics|anesthetics|mesh-list
686114|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
686115|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087175|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087176|NCT02167217|Prednisolone|prednisolone|mesh-list
2087177|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
686675|NCT03081949|Selenium|selenium|mesh-list
686676|NCT03081949|Selenious Acid|selenious acid|mesh-list
686677|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
686678|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
686679|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686680|NCT03081949|Protective Agents|protective agents|mesh-ancestor
686681|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686682|NCT03081949|Trace Elements|trace elements|mesh-ancestor
686683|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
2087178|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
2087179|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2087180|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
2087181|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2087182|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
2087183|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2087184|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
2087185|NCT02167217|Hormones|hormones|mesh-ancestor
687094|NCT03079973|Calcipotriene|calcipotriene|mesh-list
687095|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
687451|NCT03078257|Aspirin|aspirin|mesh-list
687452|NCT03078257|Tirofiban|tirofiban|mesh-list
687453|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
687454|NCT03078257|Clopidogrel|clopidogrel|mesh-list
687455|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
687456|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
687457|NCT03078257|Analgesics|analgesics|mesh-ancestor
687458|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
687459|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687460|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687461|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
687462|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
687463|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
687464|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
687465|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687466|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
687467|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
687468|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687469|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
687470|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
687471|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
687472|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
687473|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
687474|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688085|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
688086|NCT03074448|Cathartics|cathartics|mesh-ancestor
688087|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
688398|NCT03073018|Fosinopril|fosinopril|mesh-list
688399|NCT03073018|Pravastatin|pravastatin|mesh-list
688400|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
688401|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
688402|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
688403|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688404|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
688405|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
688406|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688407|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
688408|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
688409|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2225755|NCT00053105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
684495|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
684496|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225756|NCT00053105|Prednisolone|prednisolone|mesh-list
2225757|NCT00053105|Prednisolone acetate|prednisolone acetate|mesh-list
2225758|NCT00053105|Pixantrone|pixantrone|mesh-list
2225759|NCT00053105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2225760|NCT00053105|Prednisolone phosphate|prednisolone phosphate|mesh-list
684875|NCT03090737|Nivolumab|nivolumab|mesh-list
684876|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
684877|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684878|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
684879|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684986|NCT03090152|Bupivacaine|bupivacaine|mesh-list
684987|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
684988|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
684989|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684990|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684991|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
684992|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685101|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
686022|NCT03085485|Ivacaftor|ivacaftor|mesh-list
686023|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
686024|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
686025|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686528|NCT03082846|Temozolomide|temozolomide|mesh-list
686529|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
686530|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
686531|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686532|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686887|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
686888|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
686889|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
686890|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
686891|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686892|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686893|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
686894|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
686895|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
689201|NCT03070028|Phenol|phenol|mesh-list
2225761|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684615|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
684616|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
684617|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684618|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
684676|NCT03091881|Granisetron|granisetron|mesh-list
684677|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
684678|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
684679|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684680|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684681|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
684682|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
684683|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
684684|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684685|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685396|NCT03087890|Trimethoprim|trimethoprim|mesh-list
685397|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
685398|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
685399|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
685400|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
685401|NCT03087890|Renal Agents|renal agents|mesh-ancestor
685402|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
685403|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
685404|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
685405|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
685406|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685407|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685408|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
685409|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
685410|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
685411|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
685682|NCT03086759|Triamcinolone|triamcinolone|mesh-list
685683|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
685684|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
685685|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
685686|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
685687|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
685688|NCT03086759|Hormones|hormones|mesh-ancestor
685689|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
685690|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685691|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
685692|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
685693|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685694|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225762|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225763|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
2225764|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225765|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
2225766|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225767|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225768|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
685905|NCT03085680|Curcumin|curcumin|mesh-list
685906|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
685907|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
685908|NCT03085680|Analgesics|analgesics|mesh-ancestor
685909|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
685910|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685911|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685912|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
685913|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
685914|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685915|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685916|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686503|NCT03083080|Epinephrine|epinephrine|mesh-list
686504|NCT03083080|Ropivacaine|ropivacaine|mesh-list
686505|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
684629|NCT03092011|Narcotics|narcotics|mesh-ancestor
684630|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684631|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684632|NCT03092011|Analgesics|analgesics|mesh-ancestor
684633|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
684634|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684635|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
684636|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
684637|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
684638|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
684639|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
684640|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
684641|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
684642|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684643|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684955|NCT03090516|Donepezil|donepezil|mesh-list
684956|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
684957|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684958|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684959|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
684960|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684961|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684962|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
685256|NCT03088358|Enoxaparin|enoxaparin|mesh-list
685257|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
685258|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
685259|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
685260|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685381|NCT03087968|Prednisolone|prednisolone|mesh-list
685382|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
685383|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
685384|NCT03087968|Hormones|hormones|mesh-ancestor
685385|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
685386|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685387|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
685388|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685695|NCT03086785|Apatinib|apatinib|mesh-list
685696|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685697|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
685698|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685699|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685714|NCT03086291|Simvastatin|simvastatin|mesh-list
685715|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
685716|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
685717|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
685718|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685719|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
685720|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
685721|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685933|NCT03085823|Sirolimus|sirolimus|mesh-list
685934|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
685935|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
685936|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
685937|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685938|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
685939|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
685940|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
685941|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087186|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2087187|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686289|NCT03084237|Docetaxel|docetaxel|mesh-list
686290|NCT03084237|Trastuzumab|trastuzumab|mesh-list
686291|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686292|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
686293|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
686294|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
686295|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686296|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
686318|NCT03083782|Cyclosporine|cyclosporine|mesh-list
686319|NCT03083782|Apixaban|apixaban|mesh-list
686320|NCT03083782|Tacrolimus|tacrolimus|mesh-list
686321|NCT03083782|Cyclosporins|cyclosporins|mesh-list
686322|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
686323|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
684722|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685166|NCT03088813|Irinotecan|irinotecan|mesh-list
685167|NCT03088813|Topotecan|topotecan|mesh-list
685168|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
685169|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
685170|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685171|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685172|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685362|NCT03088046|Progesterone|progesterone|mesh-list
685363|NCT03088046|Progestins|progestins|mesh-ancestor
685364|NCT03088046|Hormones|hormones|mesh-ancestor
685365|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
685366|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685657|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
685658|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
685659|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686524|NCT03082885|Thymalfasin|thymalfasin|mesh-list
686525|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
686526|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
686527|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686699|NCT03082482|Nicotine|nicotine|mesh-list
686700|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
686701|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
686702|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686703|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686704|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
686705|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
686706|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
686707|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
686708|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687326|NCT03079011|Letrozole|letrozole|mesh-list
687327|NCT03079011|Fulvestrant|fulvestrant|mesh-list
687328|NCT03079011|Palbociclib|palbociclib|mesh-list
687329|NCT03079011|Anastrozole|anastrozole|mesh-list
687330|NCT03079011|Exemestane|exemestane|mesh-list
687331|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
687332|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687333|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
687334|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687335|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687336|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
687337|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
687338|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
687339|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687340|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
687341|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
687342|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
687612|NCT03077503|Fentanyl|fentanyl|mesh-list
687613|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
687614|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
687615|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687616|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687617|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
687618|NCT03077503|Analgesics|analgesics|mesh-ancestor
687619|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
687620|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687621|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
687622|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
687623|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
687624|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
687625|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687626|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687627|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
687628|NCT03077503|Narcotics|narcotics|mesh-ancestor
687629|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
687630|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
687631|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
687632|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
687743|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
687744|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
687745|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
687746|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687747|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
684744|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685278|NCT03088371|Lidocaine|lidocaine|mesh-list
685279|NCT03088371|Bupivacaine|bupivacaine|mesh-list
685280|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
685281|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
685282|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
685283|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685284|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
685285|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685286|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
685287|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
685288|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
685289|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
685290|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686184|NCT03084536|Acetaminophen|acetaminophen|mesh-list
686185|NCT03084536|Celecoxib|celecoxib|mesh-list
686186|NCT03084536|Fentanyl|fentanyl|mesh-list
686187|NCT03084536|Midazolam|midazolam|mesh-list
686188|NCT03084536|Gabapentin|gabapentin|mesh-list
686189|NCT03084536|Bupivacaine|bupivacaine|mesh-list
686190|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
686191|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
686192|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
686193|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686194|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
686195|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686196|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
686197|NCT03084536|Narcotics|narcotics|mesh-ancestor
686198|NCT03084536|Analgesics|analgesics|mesh-ancestor
686199|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
686200|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
686201|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
686202|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
686203|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
686204|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
686205|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
686206|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
686207|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
686208|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
686209|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686210|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
686211|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
686212|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
686213|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
686214|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
686215|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
686216|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
686217|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686218|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
686219|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
686220|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
686221|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
686308|NCT03084029|Oxytocin|oxytocin|mesh-list
686309|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
686310|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
686311|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686464|NCT03083184|Ethanol|ethanol|mesh-list
686465|NCT03083184|Enoxaparin|enoxaparin|mesh-list
686466|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
686467|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
686468|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
686469|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686470|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
686471|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
686472|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
686473|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225769|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225770|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2225771|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
2225772|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
2225773|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2225774|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2225775|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
2225776|NCT00053105|Hormones|hormones|mesh-ancestor
688549|NCT03071926|Doxorubicin|doxorubicin|mesh-list
688550|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
688551|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
684782|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
684783|NCT03091660|Vaccines|vaccines|mesh-list
684784|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
684785|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
684786|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684787|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2225777|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2225778|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2225779|NCT00053105|Protective Agents|protective agents|mesh-ancestor
2225780|NCT00053105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2225781|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2225782|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225783|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225784|NCT00053118|Carboplatin|carboplatin|mesh-list
2225785|NCT00053118|Etoposide|etoposide|mesh-list
2225786|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685737|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
685738|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
685739|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685740|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685865|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
685866|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
685867|NCT03086044|Velpatasvir|velpatasvir|mesh-list
685868|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
685869|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087188|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2087189|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087190|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
2087191|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
2087192|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087193|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2087194|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
687475|NCT03078062|Dexamethasone|dexamethasone|mesh-list
687476|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
687477|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
687478|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
687479|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687480|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687481|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
687482|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
687483|NCT03078062|Hormones|hormones|mesh-ancestor
687484|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
687485|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
687486|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225787|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2225788|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2225789|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
688293|NCT03073317|Mitogens|mitogens|mesh-list
688294|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
688295|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688349|NCT03073070|Biotin|biotin|mesh-list
688350|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
688351|NCT03073070|Vitamins|vitamins|mesh-ancestor
688352|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
688353|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689525|NCT03068650|Rindopepimut|rindopepimut|mesh-list
689526|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
689527|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225790|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225791|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225792|NCT00053131|Cytarabine|cytarabine|mesh-list
2225793|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
2225794|NCT00053131|Sargramostim|sargramostim|mesh-list
2225795|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
2225796|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225797|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225798|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
2225799|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225800|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225801|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
2225802|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225803|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
690015|NCT03066544|Dexamethasone|dexamethasone|mesh-list
690016|NCT03066544|Ketorolac|ketorolac|mesh-list
690017|NCT03066544|Naratriptan|naratriptan|mesh-list
690018|NCT03066544|Bupivacaine|bupivacaine|mesh-list
690019|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
684813|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
684814|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
684815|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684816|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684863|NCT03090971|Diclofenac|diclofenac|mesh-list
684864|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
684865|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
684866|NCT03090971|Analgesics|analgesics|mesh-ancestor
684867|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
684868|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684869|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684870|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
684871|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
684872|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
684873|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684874|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225804|NCT00053131|Analgesics|analgesics|mesh-ancestor
2225805|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
2225806|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2225807|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2225808|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225809|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225810|NCT00053144|Cytarabine|cytarabine|mesh-list
2225811|NCT00053144|Irinotecan|irinotecan|mesh-list
2225812|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2225813|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225814|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225815|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225816|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225817|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225818|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
2225819|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
2225820|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225821|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225822|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
2225823|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225824|NCT00053157|Sargramostim|sargramostim|mesh-list
685157|NCT03088930|Crizotinib|crizotinib|mesh-list
685158|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685159|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
685160|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685161|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685191|NCT03088605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
685192|NCT03088605|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2225825|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
2225826|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225827|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
2225828|NCT00053196|Methotrexate|methotrexate|mesh-list
2225829|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
2225830|NCT00053196|Fludarabine|fludarabine|mesh-list
2225831|NCT00053196|Busulfan|busulfan|mesh-list
2225832|NCT00053196|Allopurinol|allopurinol|mesh-list
685484|NCT03087864|Paclitaxel|paclitaxel|mesh-list
685485|NCT03087864|Carboplatin|carboplatin|mesh-list
685486|NCT03087864|Atezolizumab|atezolizumab|mesh-list
685487|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
685488|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685489|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
685490|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
685491|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
685492|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685859|NCT03086096|Irinotecan|irinotecan|mesh-list
685860|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
685861|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
685862|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685863|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685864|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087195|NCT02167217|Protective Agents|protective agents|mesh-ancestor
2087196|NCT02167256|Saracatinib|saracatinib|mesh-list
2087197|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225833|NCT00053196|Tacrolimus|tacrolimus|mesh-list
2225834|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2225835|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2225836|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
2225837|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2225838|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684819|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684820|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
684821|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
684822|NCT03091166|Analgesics|analgesics|mesh-ancestor
684823|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
684824|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
684825|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
684826|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
684827|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
684828|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
684829|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684830|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685274|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
685275|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
685276|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685277|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
685441|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
685442|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
685443|NCT03087942|Growth Substances|growth substances|mesh-ancestor
685444|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087198|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087199|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087200|NCT02167451|Maraviroc|maraviroc|mesh-list
686046|NCT03085056|Paclitaxel|paclitaxel|mesh-list
686047|NCT03085056|Trametinib|trametinib|mesh-list
686048|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
686049|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686050|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
686051|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
686052|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
686053|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686054|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
686055|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686864|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
686865|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
686866|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
686867|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686868|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686869|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
686870|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
686871|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
686872|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
686873|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686874|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
686875|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
686876|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
686877|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
686878|NCT03081052|Protective Agents|protective agents|mesh-ancestor
686955|NCT03080441|Midodrine|midodrine|mesh-list
686956|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
686957|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
686958|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686959|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686960|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
686961|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
686962|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
686963|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
686964|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
686965|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
686966|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687068|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
687069|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
687070|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
684859|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
684860|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
684861|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
684862|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685216|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
685217|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
685218|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225839|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225840|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
2225841|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225842|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225843|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
2225844|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225845|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2225846|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225847|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
2225848|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2225849|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2225850|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2225851|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2225852|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
685851|NCT03085992|Bevacizumab|bevacizumab|mesh-list
685852|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
685853|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685854|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
685855|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
685856|NCT03085992|Growth Substances|growth substances|mesh-ancestor
685857|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685858|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
686072|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
686073|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2225853|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
2225854|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2225855|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225856|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
2225857|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2225858|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2225859|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
2225860|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2225861|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
2225862|NCT00053196|Protective Agents|protective agents|mesh-ancestor
686602|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
686603|NCT03082534|Cetuximab|cetuximab|mesh-list
686604|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
686605|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686794|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
686795|NCT03081416|Dexamethasone|dexamethasone|mesh-list
686796|NCT03081416|Ketorolac|ketorolac|mesh-list
686797|NCT03081416|Ketamine|ketamine|mesh-list
686798|NCT03081416|Metoclopramide|metoclopramide|mesh-list
686799|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
686800|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
686801|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
686802|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686803|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686804|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
686805|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
686806|NCT03081416|Hormones|hormones|mesh-ancestor
686807|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
686808|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
686809|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686810|NCT03081416|Analgesics|analgesics|mesh-ancestor
686811|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
686812|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
686813|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
686814|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
686815|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
686816|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
686817|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
686818|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
686819|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
686820|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686821|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
686822|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2225863|NCT00053209|Gemcitabine|gemcitabine|mesh-list
684898|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
684899|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
684900|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
684901|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
684902|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685125|NCT03089658|Avelumab|avelumab|mesh-list
685126|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
685127|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685173|NCT03088826|Acetaminophen|acetaminophen|mesh-list
685174|NCT03088826|Morphine|morphine|mesh-list
685175|NCT03088826|Oxycodone|oxycodone|mesh-list
685176|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
685177|NCT03088826|Narcotics|narcotics|mesh-ancestor
685178|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
685179|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685180|NCT03088826|Analgesics|analgesics|mesh-ancestor
685181|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
685182|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685183|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
685184|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
685525|NCT03087539|Abciximab|abciximab|mesh-list
685526|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
685527|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
685879|NCT03086148|Ketamine|ketamine|mesh-list
685880|NCT03086148|Analgesics|analgesics|mesh-ancestor
685881|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
685882|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685883|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685884|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
685885|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
685886|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
685887|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
685888|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
685889|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
685890|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
685891|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
685892|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686116|NCT03085030|Antioxidants|antioxidants|mesh-list
686117|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686118|NCT03085030|Protective Agents|protective agents|mesh-ancestor
686119|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686297|NCT03084601|Calcium|calcium|mesh-list
686298|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
686299|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686730|NCT03082014|Losartan|losartan|mesh-list
686731|NCT03082014|Atenolol|atenolol|mesh-list
686732|NCT03082014|Amlodipine|amlodipine|mesh-list
686733|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
686734|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
686735|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
686736|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686737|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
686738|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686739|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
686740|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
686741|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
686742|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
686743|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
686744|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
686745|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686746|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
686747|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
686748|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
686749|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
686750|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
686879|NCT03081143|Paclitaxel|paclitaxel|mesh-list
686880|NCT03081143|Ramucirumab|ramucirumab|mesh-list
686881|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
686882|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686883|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
686884|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
686885|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
686886|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687352|NCT03079115|Atorvastatin|atorvastatin|mesh-list
685016|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685017|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
685018|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
685019|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
685020|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225864|NCT00053209|Pemetrexed|pemetrexed|mesh-list
2225865|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225866|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
686015|NCT03085225|Durvalumab|durvalumab|mesh-list
686016|NCT03085225|Trabectedin|trabectedin|mesh-list
686017|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
686018|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686019|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
686020|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
686021|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087201|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2087202|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2087203|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087204|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2087205|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
686151|NCT03084783|Dexamethasone|dexamethasone|mesh-list
686152|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
686153|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
686154|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
686155|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686156|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686157|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
686158|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
686159|NCT03084783|Hormones|hormones|mesh-ancestor
686160|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
686161|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
686162|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686366|NCT03083405|Opipramol|opipramol|mesh-list
686367|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
686368|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
686369|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
686370|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
686371|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
686372|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
686373|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686374|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
686375|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
686376|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686538|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
686539|NCT03082742|Furosemide|furosemide|mesh-list
686540|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
686541|NCT03082742|Diuretics|diuretics|mesh-ancestor
686542|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
686543|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686544|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
686545|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
686546|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686547|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
686580|NCT03082300|Naquotinib|naquotinib|mesh-list
686581|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686582|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
686583|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686584|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686930|NCT03080740|Metronidazole|metronidazole|mesh-list
686931|NCT03080740|Clindamycin|clindamycin|mesh-list
686932|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
686933|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
686934|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
686935|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
686936|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
686937|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
686938|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
686939|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686940|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686967|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
686968|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
686969|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
687032|NCT03080181|Pasireotide|pasireotide|mesh-list
687033|NCT03080181|Hormones|hormones|mesh-ancestor
685031|NCT03090048|Protective Agents|protective agents|mesh-ancestor
685032|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
685033|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685452|NCT03088176|Trametinib|trametinib|mesh-list
685453|NCT03088176|Dabrafenib|dabrafenib|mesh-list
685454|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
685455|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685456|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
685457|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685458|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685459|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
686033|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
686034|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
686109|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
686110|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
686111|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
686112|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
686312|NCT03083821|Entecavir|entecavir|mesh-list
686313|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
686314|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087206|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
2087207|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087208|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2087209|NCT02167893|Leuprolide|leuprolide|mesh-list
2087210|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2087211|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
2087212|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
686623|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
686624|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
686625|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
686626|NCT03082092|Prednisolone|prednisolone|mesh-list
686627|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
686628|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
686629|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
686630|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
686631|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
686632|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
686633|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686634|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686635|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
686636|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
686637|NCT03082092|Hormones|hormones|mesh-ancestor
686638|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
686639|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
686640|NCT03082092|Protective Agents|protective agents|mesh-ancestor
686641|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
686642|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686713|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
686714|NCT03081702|Itraconazole|itraconazole|mesh-list
686715|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
686716|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
686717|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
686718|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
686719|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686720|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686721|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
686722|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
686723|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
686724|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
686725|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
686726|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
686727|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
686728|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686729|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2225867|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225868|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225869|NCT00053209|Antiviral Agents|antiviral agents|mesh-ancestor
2225870|NCT00053209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225871|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225872|NCT00053209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225873|NCT00053209|Immunologic Factors|immunologic factors|mesh-ancestor
688047|NCT03074786|Tenofovir|tenofovir|mesh-list
688048|NCT03074786|Emtricitabine|emtricitabine|mesh-list
688049|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2087213|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685066|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
685067|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
685128|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
685129|NCT03089333|Glyburide|glyburide|mesh-list
685130|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
685131|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685132|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
685133|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685162|NCT03088891|Antioxidants|antioxidants|mesh-list
685163|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685164|NCT03088891|Protective Agents|protective agents|mesh-ancestor
685165|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685367|NCT03088384|Ketamine|ketamine|mesh-list
685368|NCT03088384|Analgesics|analgesics|mesh-ancestor
685369|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
685370|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685371|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685372|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
685373|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
685374|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
685375|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
685376|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
685377|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
685378|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
685379|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
685380|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225874|NCT00053209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225875|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2225876|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2225877|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
2225878|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225879|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
2225880|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
2225881|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225882|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2225883|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225884|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225885|NCT00053287|Thalidomide|thalidomide|mesh-list
2225886|NCT00053287|Carboplatin|carboplatin|mesh-list
686393|NCT03083704|Enoxaparin|enoxaparin|mesh-list
686394|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
686395|NCT03083704|Apixaban|apixaban|mesh-list
686396|NCT03083704|Edoxaban|edoxaban|mesh-list
686397|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
686398|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
686399|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
686400|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
686401|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
686402|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686403|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686404|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
686405|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
686406|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
686947|NCT03080805|Capecitabine|capecitabine|mesh-list
686948|NCT03080805|Lapatinib|lapatinib|mesh-list
686949|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
686950|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
686951|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686952|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686953|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
686954|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687571|NCT03077581|Anesthetics|anesthetics|mesh-list
687572|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687573|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688025|NCT03074825|Chiauranib|chiauranib|mesh-list
688026|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688027|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
688028|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688029|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225887|NCT00053287|Fludarabine|fludarabine|mesh-list
685087|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
685088|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
685089|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
685090|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685091|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
685092|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
685093|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
2225888|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
2225889|NCT00053287|Topotecan|topotecan|mesh-list
2225890|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225891|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2225892|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
2225893|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225894|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
685580|NCT03087708|Naloxegol|naloxegol|mesh-list
685581|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
685582|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685583|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
685584|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686358|NCT03083691|Nivolumab|nivolumab|mesh-list
686359|NCT03083691|Ipilimumab|ipilimumab|mesh-list
686360|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
686361|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686362|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
686363|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686836|NCT03081039|Gemcitabine|gemcitabine|mesh-list
686837|NCT03081039|Carboplatin|carboplatin|mesh-list
686838|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686839|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
686840|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
686841|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686842|NCT03081039|Antiviral Agents|antiviral agents|mesh-ancestor
686843|NCT03081039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
686844|NCT03081039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686845|NCT03081039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
686846|NCT03081039|Immunologic Factors|immunologic factors|mesh-ancestor
686847|NCT03081039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687360|NCT03078842|Zinc|zinc|mesh-list
687361|NCT03078842|Trace Elements|trace elements|mesh-ancestor
687362|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
687363|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225895|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
2225896|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225897|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2225898|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2225899|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687907|NCT03075462|Apatinib|apatinib|mesh-list
687908|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687909|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
687910|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687911|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687950|NCT03074942|Reslizumab|reslizumab|mesh-list
687951|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
687952|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
688376|NCT03073057|Budesonide|budesonide|mesh-list
688377|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
688378|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
688379|NCT03073057|Charcoal|charcoal|mesh-list
688380|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688381|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
688382|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
688383|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688384|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688385|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
688386|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
688387|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
688388|NCT03073057|Hormones|hormones|mesh-ancestor
688389|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
688390|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
688391|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
688392|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
688393|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
688394|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688395|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688396|NCT03073057|Antidotes|antidotes|mesh-ancestor
2087214|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2087215|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087216|NCT02168062|Leuprolide|leuprolide|mesh-list
2087217|NCT02168062|Goserelin|goserelin|mesh-list
2087218|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2087219|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2087220|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
685603|NCT03087149|Vitamin D|vitamin d|mesh-list
685604|NCT03087149|Vitamins|vitamins|mesh-ancestor
685605|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
685606|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685607|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
686026|NCT03085368|Trastuzumab|trastuzumab|mesh-list
686027|NCT03085368|Lapatinib|lapatinib|mesh-list
686028|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
686029|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686030|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
686031|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686032|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087221|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2087222|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087223|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2087224|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087225|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
2087226|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2087227|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
2087228|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2087229|NCT02168101|Ixazomib|ixazomib|mesh-list
2087230|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087231|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
2087232|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087233|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087234|NCT02168309|Labetalol|labetalol|mesh-list
2087235|NCT02168309|Nifedipine|nifedipine|mesh-list
2087236|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
686266|NCT03084328|Vitamin D|vitamin d|mesh-list
686267|NCT03084328|Vitamins|vitamins|mesh-ancestor
686268|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
686269|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686270|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
686407|NCT03083353|Isradipine|isradipine|mesh-list
686408|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
686409|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
686410|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
686411|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686412|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
686413|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686414|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
686916|NCT03080675|Vitamins|vitamins|mesh-list
686917|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
686918|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687003|NCT03080480|Pioglitazone|pioglitazone|mesh-list
687004|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
687005|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687319|NCT03079076|Bupivacaine|bupivacaine|mesh-list
687320|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
687321|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
687322|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687323|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687324|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
687325|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087237|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
685113|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685114|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
685115|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
685116|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685188|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
685189|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
685190|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685261|NCT03088410|Zidovudine|zidovudine|mesh-list
685262|NCT03088410|Nevirapine|nevirapine|mesh-list
685263|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
685264|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685265|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
685266|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
685267|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685268|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
685269|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
685270|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
685271|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
685272|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
685273|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
685590|NCT03087448|Trametinib|trametinib|mesh-list
685591|NCT03087448|Ceritinib|ceritinib|mesh-list
685592|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685593|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
685594|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685595|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685722|NCT03086226|Itraconazole|itraconazole|mesh-list
685723|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
685724|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
685725|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
685726|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
685727|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685728|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685729|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
685730|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
685731|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
685732|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685733|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
686684|NCT03081832|Oxytocin|oxytocin|mesh-list
686685|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
686686|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
686687|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686848|NCT03081169|Heparin|heparin|mesh-list
686849|NCT03081169|Enoxaparin|enoxaparin|mesh-list
686850|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
686851|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
686852|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
686853|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
686854|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687219|NCT03079271|Benzocaine|benzocaine|mesh-list
687220|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
687221|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
687222|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687223|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687224|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
687225|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687416|NCT03078374|Warfarin|warfarin|mesh-list
687417|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
687425|NCT03078192|Xenon|xenon|mesh-list
687426|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
687427|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
687428|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
687429|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687430|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687544|NCT03077698|Megestrol|megestrol|mesh-list
687545|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
687546|NCT03077698|Progestins|progestins|mesh-list
687547|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
687548|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
687549|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
687550|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
687551|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
687552|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
687553|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687554|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
685186|NCT03088852|Cathartics|cathartics|mesh-ancestor
685187|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
685670|NCT03086733|Metformin|metformin|mesh-list
685671|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
685672|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685700|NCT03086382|Lacosamide|lacosamide|mesh-list
685701|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
685702|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
685703|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
685704|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
685705|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686457|NCT03083197|Azithromycin|azithromycin|mesh-list
686458|NCT03083197|Doxycycline|doxycycline|mesh-list
686459|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
686460|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
686461|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
686462|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
686463|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
686548|NCT03082755|Gabapentin|gabapentin|mesh-list
686549|NCT03082755|Analgesics|analgesics|mesh-ancestor
686550|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
686551|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686552|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686553|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
686554|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
686555|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
686556|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
686557|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
686558|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
686559|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
686560|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
686561|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686562|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
686657|NCT03081923|Durvalumab|durvalumab|mesh-list
686658|NCT03081923|Tremelimumab|tremelimumab|mesh-list
686659|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
686660|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687407|NCT03078777|Fexofenadine|fexofenadine|mesh-list
687408|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
687409|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
687410|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
687411|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
687412|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
687413|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687414|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687415|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687793|NCT03076151|Tacrolimus|tacrolimus|mesh-list
687794|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
687795|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
687796|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687797|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
687798|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687799|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687835|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
687836|NCT03076021|Isotretinoin|isotretinoin|mesh-list
687837|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
687838|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
687839|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
687840|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
687841|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687842|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687843|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687844|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
688009|NCT03074994|Anesthetics|anesthetics|mesh-list
688010|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
688011|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
685312|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
685706|NCT03086538|Pemetrexed|pemetrexed|mesh-list
685707|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
685708|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685709|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685710|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685711|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
685712|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
685713|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
685796|NCT03086174|Antibodies|antibodies|mesh-list
685797|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
685798|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
685799|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685954|NCT03085563|Midazolam|midazolam|mesh-list
685955|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
685956|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
685957|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
685958|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
685959|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685960|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
685961|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
685962|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
685963|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
685964|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
685965|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
685966|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
685967|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
685968|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
685969|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685970|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
685971|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
685972|NCT03085563|Analgesics|analgesics|mesh-ancestor
685973|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
685974|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686041|NCT03085186|Crizotinib|crizotinib|mesh-list
686042|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686043|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
686044|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686045|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087238|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087239|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2225900|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
686377|NCT03083431|Propranolol|propranolol|mesh-list
686378|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
686379|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
686380|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
686381|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
686382|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686383|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686384|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
686385|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
686386|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
686667|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
686769|NCT03081689|Paclitaxel|paclitaxel|mesh-list
686770|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
686771|NCT03081689|Carboplatin|carboplatin|mesh-list
686772|NCT03081689|Nivolumab|nivolumab|mesh-list
686773|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
686774|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686775|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
686776|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
686777|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
686778|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686779|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
686780|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2225901|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2225902|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225903|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2225904|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2225905|NCT00053287|Growth Substances|growth substances|mesh-ancestor
2225906|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
2225907|NCT00053300|Thalidomide|thalidomide|mesh-list
687418|NCT03078309|Cannabidiol|cannabidiol|mesh-list
687419|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
687763|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
685360|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
685361|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
685673|NCT03086681|Cisplatin|cisplatin|mesh-list
685674|NCT03086681|Endostar protein|endostar protein|mesh-list
685675|NCT03086681|Endostatins|endostatins|mesh-list
685676|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685677|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
685678|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
685679|NCT03086681|Growth Substances|growth substances|mesh-ancestor
685680|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685681|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
685917|NCT03085628|Oxytocin|oxytocin|mesh-list
685918|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
685919|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
685920|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686035|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
686036|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
686037|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
686038|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686039|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
686040|NCT03085394|Coagulants|coagulants|mesh-ancestor
2225908|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225909|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
2225910|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225911|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
2225912|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2225913|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225914|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2225915|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2225916|NCT00053300|Growth Substances|growth substances|mesh-ancestor
2225917|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
2225918|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225919|NCT00053326|Fenretinide|fenretinide|mesh-list
2225920|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225921|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
687120|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
687121|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
687343|NCT03079141|Eplerenone|eplerenone|mesh-list
687344|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
687345|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
687346|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
687347|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687348|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
687349|NCT03079141|Diuretics|diuretics|mesh-ancestor
687350|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
687351|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
688004|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
688005|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688006|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
688007|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688008|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225922|NCT00053326|Protective Agents|protective agents|mesh-ancestor
2225923|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225924|NCT00053339|Tamoxifen|tamoxifen|mesh-list
2225925|NCT00053339|Trastuzumab|trastuzumab|mesh-list
2225926|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2225927|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225928|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2225929|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
2225930|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2225931|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225932|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2225933|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
688192|NCT03073863|Atorvastatin|atorvastatin|mesh-list
688193|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
688194|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
688195|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
688196|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688197|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
688198|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
688199|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688706|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
688707|NCT03071666|Vitamins|vitamins|mesh-ancestor
688708|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
688709|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685417|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
685418|NCT03088072|Analgesics|analgesics|mesh-ancestor
685419|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
685420|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
685421|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685422|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
685423|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
685424|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
685425|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
685426|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685427|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
685428|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
685429|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685430|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
685431|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
685432|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
685433|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
685434|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
685435|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
685436|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
685437|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
685438|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
685439|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
685440|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
685645|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
685646|NCT03087071|Panitumumab|panitumumab|mesh-list
685647|NCT03087071|Trametinib|trametinib|mesh-list
685648|NCT03087071|Antibodies|antibodies|mesh-list
685649|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
685650|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
685651|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
685652|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685653|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685654|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
685655|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685656|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685748|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
685749|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
685750|NCT03086564|Estrogens|estrogens|mesh-ancestor
685751|NCT03086564|Hormones|hormones|mesh-ancestor
685752|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
685753|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685754|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
685755|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685876|NCT03086005|Metformin|metformin|mesh-list
685877|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
685878|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686474|NCT03083041|Apatinib|apatinib|mesh-list
686475|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686476|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
686477|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686478|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687008|NCT03080324|Fentanyl|fentanyl|mesh-list
687009|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
687010|NCT03080324|Narcotics|narcotics|mesh-ancestor
687011|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687012|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687013|NCT03080324|Analgesics|analgesics|mesh-ancestor
687014|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
687015|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687016|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
687017|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
687018|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
687019|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
687082|NCT03079921|Propranolol|propranolol|mesh-list
687083|NCT03079921|Phentolamine|phentolamine|mesh-list
687084|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
687085|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
687086|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
687087|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687088|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687089|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687090|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
687091|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
687092|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
687226|NCT03079219|Dexamethasone|dexamethasone|mesh-list
2752705|NCT03358563|Docetaxel|docetaxel|mesh-list
2752706|NCT03358563|Bicalutamide|bicalutamide|mesh-list
2752707|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2752708|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752709|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
2752710|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
2752711|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
2752712|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685630|NCT03086993|Gemcitabine|gemcitabine|mesh-list
685631|NCT03086993|Melphalan|melphalan|mesh-list
685632|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685633|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
685634|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
685635|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685636|NCT03086993|Antiviral Agents|antiviral agents|mesh-ancestor
685637|NCT03086993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
685638|NCT03086993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685639|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
685640|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
685641|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685642|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
685643|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
685644|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
685734|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
685735|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
685736|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685870|NCT03086070|Omeprazole|omeprazole|mesh-list
685871|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
685872|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
685873|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
685874|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685875|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685901|NCT03085654|Oxytocin|oxytocin|mesh-list
685902|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
685903|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
685904|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686120|NCT03084809|Leucovorin|leucovorin|mesh-list
686121|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
686122|NCT03084809|Fluorouracil|fluorouracil|mesh-list
686123|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
686124|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686125|NCT03084809|Antidotes|antidotes|mesh-ancestor
686126|NCT03084809|Protective Agents|protective agents|mesh-ancestor
686127|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686128|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
686129|NCT03084809|Vitamins|vitamins|mesh-ancestor
686130|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
686131|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
686132|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686133|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
686134|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
686135|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
686163|NCT03084588|Methadone|methadone|mesh-list
686164|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
686165|NCT03084588|Narcotics|narcotics|mesh-ancestor
686166|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
686167|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686168|NCT03084588|Analgesics|analgesics|mesh-ancestor
686169|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
686170|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686171|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
686172|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
686346|NCT03083613|Paclitaxel|paclitaxel|mesh-list
686347|NCT03083613|Raltitrexed|raltitrexed|mesh-list
686348|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
686349|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686350|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
2225934|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2225935|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2225936|NCT00053378|Calcium|calcium|mesh-list
2225937|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2225938|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225939|NCT00053430|Thalidomide|thalidomide|mesh-list
2225940|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225941|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
2225942|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685615|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
685616|NCT03087136|Antibodies|antibodies|mesh-list
685617|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
685618|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685619|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
685620|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
685621|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
685622|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
685623|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
685624|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
685625|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
685626|NCT03087136|Protective Agents|protective agents|mesh-ancestor
685756|NCT03086473|Caffeine|caffeine|mesh-list
685757|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
685758|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685759|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
685760|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
685761|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
685762|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685763|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
685764|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
685765|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
685766|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
685893|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
685894|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
685895|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
685896|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
685897|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
685898|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
685899|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
685900|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
686248|NCT03084419|Abatacept|abatacept|mesh-list
686249|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
686250|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686251|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686252|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
686253|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
686254|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686255|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2087240|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687122|NCT03079895|Nicotine|nicotine|mesh-list
687123|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
687124|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
687125|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687126|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687127|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
687128|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
687129|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
687130|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687131|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687297|NCT03079102|Nitric Oxide|nitric oxide|mesh-list
687298|NCT03079102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
687299|NCT03079102|Autonomic Agents|autonomic agents|mesh-ancestor
687300|NCT03079102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687301|NCT03079102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687302|NCT03079102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
687303|NCT03079102|Respiratory System Agents|respiratory system agents|mesh-ancestor
687304|NCT03079102|Free Radical Scavengers|free radical scavengers|mesh-ancestor
687305|NCT03079102|Antioxidants|antioxidants|mesh-ancestor
687306|NCT03079102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687307|NCT03079102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687308|NCT03079102|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
687309|NCT03079102|Vasodilator Agents|vasodilator agents|mesh-ancestor
687310|NCT03079102|Gasotransmitters|gasotransmitters|mesh-ancestor
687311|NCT03079102|Protective Agents|protective agents|mesh-ancestor
2225943|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
2225944|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2225945|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225946|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2225947|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2225948|NCT00053430|Growth Substances|growth substances|mesh-ancestor
2225949|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
2225950|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225951|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2225952|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2225953|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
2225954|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225955|NCT00053599|Simvastatin|simvastatin|mesh-list
2225956|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2225957|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2225958|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
2225959|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225960|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2225961|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2225962|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225963|NCT00053612|Vitamin A|vitamin a|mesh-list
685949|NCT03085849|Durvalumab|durvalumab|mesh-list
685950|NCT03085849|Tremelimumab|tremelimumab|mesh-list
685951|NCT03085849|Guadecitabine|guadecitabine|mesh-list
685952|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
685953|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686278|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
686279|NCT03084380|Fludarabine|fludarabine|mesh-list
686280|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
686281|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
686282|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686283|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
686284|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
686285|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
686286|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686287|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686288|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
686433|NCT03083210|Lanreotide|lanreotide|mesh-list
686434|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687197|NCT03079388|Azithromycin|azithromycin|mesh-list
687198|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
687199|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
687200|NCT03079388|Albendazole|albendazole|mesh-list
687201|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
687202|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
687203|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
687204|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
687205|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
687206|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
687207|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
687208|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687209|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687210|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
687211|NCT03079388|Renal Agents|renal agents|mesh-ancestor
687212|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
687213|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
687214|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
687215|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
687216|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
687217|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
687218|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2225964|NCT00053612|Vitamins|vitamins|mesh-ancestor
2225965|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
2225966|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225967|NCT00053638|Tenofovir|tenofovir|mesh-list
2225968|NCT00053638|Lamivudine|lamivudine|mesh-list
2225969|NCT00053638|Efavirenz|efavirenz|mesh-list
2225970|NCT00053638|Abacavir|abacavir|mesh-list
2225971|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
2225972|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2225973|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2225974|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2225975|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2225976|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2225977|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2225978|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2225979|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2752713|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
2225980|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2225981|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2225982|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
686341|NCT03083678|Afatinib|afatinib|mesh-list
686342|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686343|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
686344|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686345|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686576|NCT03082339|Cortisone|cortisone|mesh-list
686577|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
687179|NCT03079505|Dasatinib|dasatinib|mesh-list
687180|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687181|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
687182|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687183|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687312|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
687313|NCT03079050|Lansoprazole|lansoprazole|mesh-list
687314|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
687315|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
687316|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
687317|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687318|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087241|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
2087242|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
2087243|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2087244|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2087245|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2087246|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
2087247|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087248|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
687868|NCT03075657|Haloperidol|haloperidol|mesh-list
687869|NCT03075657|Risperidone|risperidone|mesh-list
687870|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
687871|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
687872|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
687873|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687874|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687875|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687876|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
687877|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
687878|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687879|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
687880|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
687881|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
687882|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
687883|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
687884|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687885|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
687886|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2225983|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2225984|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2225985|NCT00053716|Alprostadil|alprostadil|mesh-list
688342|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
688343|NCT03073369|Vitamin D|vitamin d|mesh-list
688344|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
688345|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688346|NCT03073369|Vitamins|vitamins|mesh-ancestor
688347|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
688348|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
688557|NCT03072173|Xylometazoline|xylometazoline|mesh-list
688558|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
688559|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
688560|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
688880|NCT03071042|Docetaxel|docetaxel|mesh-list
688881|NCT03071042|Apatinib|apatinib|mesh-list
688882|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688883|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
688884|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
688885|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
688886|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688887|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
688888|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688985|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
688986|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
2087249|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
2225986|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2225987|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
2225988|NCT00053716|Urological Agents|urological agents|mesh-ancestor
2225989|NCT00053768|Prednisone|prednisone|mesh-list
2225990|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
2225991|NCT00053768|Doxorubicin|doxorubicin|mesh-list
2225992|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2225993|NCT00053768|Etoposide|etoposide|mesh-list
2225994|NCT00053768|Vincristine|vincristine|mesh-list
2225995|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2225996|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
686236|NCT03084250|Tenofovir|tenofovir|mesh-list
686237|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
686238|NCT03084250|Entecavir|entecavir|mesh-list
686239|NCT03084250|Adefovir|adefovir|mesh-list
686240|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
686241|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
686242|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
686243|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
686244|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686245|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686246|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
686247|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
687153|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
687154|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
687155|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
687156|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
687157|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
687158|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687159|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
687160|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687161|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687162|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
687163|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2752714|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
2752715|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2752716|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752717|NCT03358563|Hematinics|hematinics|mesh-ancestor
2752718|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2752719|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2752720|NCT03354728|Vaccines|vaccines|mesh-list
2752721|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
2752722|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752723|NCT03346135|Melphalan|melphalan|mesh-list
2752724|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
2752725|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2752726|NCT03346135|Daratumumab|daratumumab|mesh-list
2752727|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2752728|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
2752729|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752730|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752731|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2752732|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2752733|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
2752734|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752735|NCT03339284|Dexamethasone|dexamethasone|mesh-list
2752736|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
2225997|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2225998|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2225999|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2226000|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
2226001|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226002|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226003|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2226004|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2226005|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
687887|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
687888|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
687889|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
687890|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
687891|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687892|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
687893|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687894|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687917|NCT03075358|Lidocaine|lidocaine|mesh-list
686324|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686325|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
686326|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686327|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686328|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
686329|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
686330|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
686331|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
686332|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
686333|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
686334|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
686335|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
686336|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
686415|NCT03083457|Anesthetics|anesthetics|mesh-list
686416|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
686417|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
686418|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686606|NCT03082183|Rifampin|rifampin|mesh-list
686607|NCT03082183|BI 425809|bi 425809|mesh-list
686608|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
686609|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
686610|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
686611|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
686612|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
686613|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
686614|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686615|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686616|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
686617|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
686618|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
686619|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
686620|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
686621|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
686622|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
2226006|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2226007|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226008|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
687574|NCT03077516|Meloxicam|meloxicam|mesh-list
687575|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
687576|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
687577|NCT03077516|Analgesics|analgesics|mesh-ancestor
687578|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
687579|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687580|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687581|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
687582|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
687583|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
687584|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
687585|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687586|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687718|NCT03077217|Rifaximin|rifaximin|mesh-list
687719|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
687720|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
687721|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
687933|NCT03075423|Nivolumab|nivolumab|mesh-list
687934|NCT03075423|Ipilimumab|ipilimumab|mesh-list
687935|NCT03075423|Sunitinib|sunitinib|mesh-list
687936|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
687937|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687938|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
687939|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687940|NCT03075423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
687941|NCT03075423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
687942|NCT03075423|Growth Substances|growth substances|mesh-ancestor
687943|NCT03075423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687944|NCT03075423|Growth Inhibitors|growth inhibitors|mesh-ancestor
687945|NCT03075423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
687946|NCT03075423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688104|NCT03074435|Ivermectin|ivermectin|mesh-list
688105|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
688106|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087250|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
2087251|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087252|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
686339|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
686340|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686578|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
686579|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087253|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2087254|NCT02168361|Interferons|interferons|mesh-list
2087255|NCT02168361|Ribavirin|ribavirin|mesh-list
2087256|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
2087257|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
2087258|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
2087259|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2087260|NCT02168361|Simeprevir|simeprevir|mesh-list
2087261|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686709|NCT03081494|Spartalizumab|spartalizumab|mesh-list
686710|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
686711|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686712|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687276|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
687277|NCT03079167|Hematinics|hematinics|mesh-ancestor
687431|NCT03078231|Mydriatics|mydriatics|mesh-list
687432|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
687433|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687434|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687829|NCT03076203|Niraparib|niraparib|mesh-list
687830|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
687831|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
687832|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687833|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687834|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687955|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
687956|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
687957|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687958|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
687959|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687960|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688098|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
688099|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
688100|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
688101|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688102|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
688103|NCT03074344|Protective Agents|protective agents|mesh-ancestor
688561|NCT03072290|Triamcinolone|triamcinolone|mesh-list
688562|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
688563|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
688564|NCT03072290|Lidocaine|lidocaine|mesh-list
688565|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
688566|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
688567|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
688568|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
688569|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688570|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
688571|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688572|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
688573|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
688574|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
688575|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
688576|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688577|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688578|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
688579|NCT03072290|Hormones|hormones|mesh-ancestor
688580|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
688581|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
688582|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
688583|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688827|NCT03071705|Metformin|metformin|mesh-list
688828|NCT03071705|Gefitinib|gefitinib|mesh-list
688829|NCT03071705|Afatinib|afatinib|mesh-list
688830|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
688831|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688832|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688833|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
688834|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688835|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689282|NCT03069950|Leucovorin|leucovorin|mesh-list
689283|NCT03069950|Dexamethasone|dexamethasone|mesh-list
2087262|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
686352|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
686353|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686354|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
686355|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
686356|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
686357|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686479|NCT03083067|Budesonide|budesonide|mesh-list
686480|NCT03083067|Bromides|bromides|mesh-list
686481|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
686482|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
686483|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
686484|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
686485|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
686486|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686487|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686488|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
686489|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
686490|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
686491|NCT03083067|Hormones|hormones|mesh-ancestor
686492|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
686493|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
686494|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
686495|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
686496|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
686497|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
686498|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686499|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
686500|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
686501|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
686502|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
686643|NCT03082053|Capecitabine|capecitabine|mesh-list
686644|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
686645|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
686646|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686647|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686781|NCT03081676|Glimepiride|glimepiride|mesh-list
686782|NCT03081676|Glucagon|glucagon|mesh-list
686783|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
686784|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
686785|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
686786|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
686787|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686788|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
686789|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
686790|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
686791|NCT03081676|Hormones|hormones|mesh-ancestor
686792|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
686793|NCT03081676|Incretins|incretins|mesh-ancestor
686911|NCT03080974|Nivolumab|nivolumab|mesh-list
686912|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
686913|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686914|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
686915|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687184|NCT03079427|Gemcitabine|gemcitabine|mesh-list
687185|NCT03079427|Cisplatin|cisplatin|mesh-list
687186|NCT03079427|Capecitabine|capecitabine|mesh-list
687187|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687188|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
687189|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
687190|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687191|NCT03079427|Antiviral Agents|antiviral agents|mesh-ancestor
687192|NCT03079427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
687193|NCT03079427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687194|NCT03079427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
687195|NCT03079427|Immunologic Factors|immunologic factors|mesh-ancestor
687196|NCT03079427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687539|NCT03077633|Progesterone|progesterone|mesh-list
687540|NCT03077633|Progestins|progestins|mesh-ancestor
687541|NCT03077633|Hormones|hormones|mesh-ancestor
687542|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
687543|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687678|NCT03077451|Nelfinavir|nelfinavir|mesh-list
687679|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
687680|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
687681|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
687682|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226009|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
2226010|NCT00053768|Hormones|hormones|mesh-ancestor
2226011|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2226012|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2226013|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2226014|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
687020|NCT03080350|Fentanyl|fentanyl|mesh-list
687021|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
687022|NCT03080350|Narcotics|narcotics|mesh-ancestor
687023|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687024|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687025|NCT03080350|Analgesics|analgesics|mesh-ancestor
687026|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
687027|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687028|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
687029|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
687030|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
687031|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
687393|NCT03078725|Metformin|metformin|mesh-list
687394|NCT03078725|Glyburide|glyburide|mesh-list
687395|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
687396|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087263|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087264|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
2087265|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687953|NCT03074968|Benzydamine|benzydamine|mesh-list
687954|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688469|NCT03072485|Metformin|metformin|mesh-list
688470|NCT03072485|Sirolimus|sirolimus|mesh-list
688471|NCT03072485|Diclofenac|diclofenac|mesh-list
688472|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
688473|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688474|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
688475|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
688476|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
688477|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688478|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
688479|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
688480|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
688481|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
688482|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
688483|NCT03072485|Analgesics|analgesics|mesh-ancestor
688484|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
688485|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688486|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688487|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
688488|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
688489|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688490|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688588|NCT03072082|Aspirin|aspirin|mesh-list
688589|NCT03072082|Metoprolol|metoprolol|mesh-list
688590|NCT03072082|Isosorbide|isosorbide|mesh-list
688591|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
688592|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
688593|NCT03072082|Trimetazidine|trimetazidine|mesh-list
688594|NCT03072082|Clopidogrel|clopidogrel|mesh-list
688595|NCT03072082|Atorvastatin|atorvastatin|mesh-list
688596|NCT03072082|Calcium|calcium|mesh-list
688597|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
688598|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688599|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
688600|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
688601|NCT03072082|Analgesics|analgesics|mesh-ancestor
688602|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
688603|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688604|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688605|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
688606|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
688607|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
688608|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688609|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
688610|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
688611|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688612|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
688613|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
688614|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
688615|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
2226015|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226016|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226017|NCT00053807|Interferons|interferons|mesh-list
2226018|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
2226019|NCT00053807|Aldesleukin|aldesleukin|mesh-list
2226020|NCT00053807|Fluorouracil|fluorouracil|mesh-list
2226021|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
2226022|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226023|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226024|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226025|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226026|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
686941|NCT03080766|Decitabine|decitabine|mesh-list
686942|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
686943|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
686944|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686945|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
686946|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686970|NCT03080363|Lidocaine|lidocaine|mesh-list
686971|NCT03080363|Bupivacaine|bupivacaine|mesh-list
686972|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
686973|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
686974|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
686975|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686976|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
686977|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686978|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
686979|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
686980|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
686981|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
686982|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687167|NCT03079453|Dexamethasone|dexamethasone|mesh-list
687168|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
687169|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
687170|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
687171|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687172|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687173|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
687174|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
687175|NCT03079453|Hormones|hormones|mesh-ancestor
687176|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
687177|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
687178|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687854|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
687855|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
687856|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687857|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687858|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
687859|NCT03076099|Analgesics|analgesics|mesh-ancestor
687860|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
687861|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687862|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
687863|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
687864|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
687865|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
687866|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687867|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226027|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226028|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
2226029|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226030|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
686507|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
686508|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686509|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
686510|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686511|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
686512|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
686513|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
686514|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
686515|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686516|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
686517|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
686518|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
686519|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
686520|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
686521|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
686522|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
686523|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
686585|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
686586|NCT03082573|Hormones|hormones|mesh-ancestor
686587|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
686588|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686751|NCT03081728|Acetaminophen|acetaminophen|mesh-list
686752|NCT03081728|Diclofenac|diclofenac|mesh-list
686753|NCT03081728|Ropivacaine|ropivacaine|mesh-list
686754|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
686755|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
686756|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
686757|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686758|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
686759|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
686760|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
686761|NCT03081728|Analgesics|analgesics|mesh-ancestor
686762|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
686763|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
686764|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
686765|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
686766|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
686767|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686768|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087266|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
2087267|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087268|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
2087269|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087270|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
2087271|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2087272|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
687773|NCT03076684|Allopurinol|allopurinol|mesh-list
687774|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
687775|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687776|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687777|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
687778|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
687779|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
687780|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
687781|NCT03076684|Protective Agents|protective agents|mesh-ancestor
687782|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226031|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2226032|NCT00053820|Interferons|interferons|mesh-list
2226033|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
2226034|NCT00053820|Aldesleukin|aldesleukin|mesh-list
2226035|NCT00053820|Fluorouracil|fluorouracil|mesh-list
688279|NCT03073694|Melphalan|melphalan|mesh-list
688280|NCT03073694|Mitomycins|mitomycins|mesh-list
688281|NCT03073694|Mitomycin|mitomycin|mesh-list
688282|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
688283|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
688284|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688285|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688286|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
688287|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
688288|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
688289|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688290|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
688291|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2087273|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226036|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
686823|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
686824|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
686825|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686826|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
686827|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
686828|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
686829|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
686830|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
686831|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
686832|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
686833|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
686834|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
686835|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
686983|NCT03080545|Calcitriol|calcitriol|mesh-list
686984|NCT03080545|Betamethasone|betamethasone|mesh-list
686985|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
686986|NCT03080545|Calcipotriene|calcipotriene|mesh-list
686987|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
686988|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
686989|NCT03080545|Hormones|hormones|mesh-ancestor
686990|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
686991|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
686992|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
686993|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
686994|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
686995|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
686996|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
686997|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686998|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
686999|NCT03080545|Vitamins|vitamins|mesh-ancestor
687000|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
687001|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
687002|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
687164|NCT03079544|Asparaginase|asparaginase|mesh-list
687165|NCT03079544|Pegaspargase|pegaspargase|mesh-list
687166|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687420|NCT03078569|Testosterone|testosterone|mesh-list
687421|NCT03078569|Androgens|androgens|mesh-ancestor
687422|NCT03078569|Hormones|hormones|mesh-ancestor
687423|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
687424|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226037|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226038|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226039|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226040|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226041|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
2226042|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226043|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
2226044|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226045|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2226046|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2226047|NCT00053833|Irinotecan|irinotecan|mesh-list
2226048|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2226049|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2226050|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226051|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226052|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226053|NCT00053872|Vincristine|vincristine|mesh-list
688341|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2226054|NCT00053872|Lomustine|lomustine|mesh-list
2226055|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226056|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2226057|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226058|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226059|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
690641|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
690642|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
690643|NCT03063723|Ledipasvir|ledipasvir|mesh-list
690644|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
690645|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226060|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226061|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2226062|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
2226063|NCT00053885|Vatalanib|vatalanib|mesh-list
2226064|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2226065|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
686896|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
686897|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
686898|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
686899|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
686900|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
686901|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
686902|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
686903|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
686904|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
2226066|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226067|NCT00053911|Tamoxifen|tamoxifen|mesh-list
2226068|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
2226069|NCT00053911|Docetaxel|docetaxel|mesh-list
2226070|NCT00053911|Fluorouracil|fluorouracil|mesh-list
2226071|NCT00053911|Epirubicin|epirubicin|mesh-list
2226072|NCT00053911|Anastrozole|anastrozole|mesh-list
2226073|NCT00053911|Goserelin|goserelin|mesh-list
2226074|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226075|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
2226076|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226077|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2226078|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2226079|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
2226080|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226081|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226082|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2226083|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226084|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226085|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226086|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
2226087|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226088|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2226089|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2226090|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2226091|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226092|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2226093|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
2226094|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2226095|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2226096|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
688181|NCT03074123|Cosyntropin|cosyntropin|mesh-list
688182|NCT03074123|Hormones|hormones|mesh-ancestor
688183|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
688184|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688510|NCT03072264|Fluoxetine|fluoxetine|mesh-list
688511|NCT03072264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
688512|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
688513|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
688514|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688515|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688516|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
688517|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688518|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
688519|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
688520|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
688521|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
688522|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
688523|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689611|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
689612|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
689613|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
689614|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
689615|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689616|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689617|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689618|NCT03068247|Analgesics|analgesics|mesh-ancestor
689619|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
689620|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689621|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
689622|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
689623|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
689881|NCT03067415|Latanoprost|latanoprost|mesh-list
689882|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
687034|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
687035|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687112|NCT03079830|Pirinitramide|pirinitramide|mesh-list
687113|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
687114|NCT03079830|Narcotics|narcotics|mesh-ancestor
687115|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687116|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687117|NCT03079830|Analgesics|analgesics|mesh-ancestor
687118|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
687119|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226097|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2226098|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
687663|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
687664|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
687665|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
687666|NCT03077555|Estradiol|estradiol|mesh-list
687667|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
687668|NCT03077555|Estrogens|estrogens|mesh-ancestor
687669|NCT03077555|Hormones|hormones|mesh-ancestor
687670|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
687671|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687672|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
687673|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
687674|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
687675|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
687676|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
687677|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2226099|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2226100|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2226101|NCT00053937|Pirfenidone|pirfenidone|mesh-list
2226102|NCT00053937|Analgesics|analgesics|mesh-ancestor
2226103|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
2226104|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226105|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226106|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2226107|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2226108|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2226109|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2226110|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226111|NCT00053950|NSC 366140|nsc 366140|mesh-list
2226112|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226113|NCT00053963|Romidepsin|romidepsin|mesh-list
2226114|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2226115|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226116|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
2226117|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2226118|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2226119|NCT00053976|Prednisolone|prednisolone|mesh-list
2226120|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
2226121|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
688232|NCT03073889|Ropivacaine|ropivacaine|mesh-list
688233|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
688234|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
688235|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
688236|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688237|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
688238|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226122|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
2226123|NCT00053976|Daclizumab|daclizumab|mesh-list
2226124|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2226125|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
2226126|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
2226127|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688930|NCT03070951|OBE2109|obe2109|mesh-list
688931|NCT03070951|Hormone Antagonists|hormone antagonists|mesh-ancestor
688932|NCT03070951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
688933|NCT03070951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226128|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226129|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2226130|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
2226131|NCT00053976|Hormones|hormones|mesh-ancestor
2226132|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2226133|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2226134|NCT00053976|Protective Agents|protective agents|mesh-ancestor
689480|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
687071|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687072|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687073|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
687074|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
687075|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
687076|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
687077|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687078|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687079|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
687080|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
687081|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
2226135|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2226136|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226137|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226138|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
2226139|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2226140|NCT00054002|Trioxsalen|trioxsalen|mesh-list
2226141|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226142|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
2226143|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2226144|NCT00054041|Vaccines|vaccines|mesh-list
2226145|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
2226146|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226147|NCT00054054|Docetaxel|docetaxel|mesh-list
2226148|NCT00054054|Fluorouracil|fluorouracil|mesh-list
2226149|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226150|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226151|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226152|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226153|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226154|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
2226155|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226156|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226157|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
2226158|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226159|NCT00054067|Cisplatin|cisplatin|mesh-list
2226160|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226161|NCT00054106|Flutamide|flutamide|mesh-list
2226162|NCT00054106|Buserelin|buserelin|mesh-list
2226163|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
2226164|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
2226165|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2226166|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226167|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2226168|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226169|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2226170|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
2226171|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2226172|NCT00054158|Thalidomide|thalidomide|mesh-list
2226173|NCT00054158|Dexamethasone|dexamethasone|mesh-list
2226174|NCT00054158|Doxorubicin|doxorubicin|mesh-list
2226175|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2226176|NCT00054158|Vincristine|vincristine|mesh-list
2226177|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2226178|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
2226179|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
2226180|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226181|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226182|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2226183|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
2226184|NCT00054158|Hormones|hormones|mesh-ancestor
2226185|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2226186|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2226187|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688961|NCT03070899|OBE2109|obe2109|mesh-list
688962|NCT03070899|Hormone Antagonists|hormone antagonists|mesh-ancestor
688963|NCT03070899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
688964|NCT03070899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689230|NCT03069820|Docetaxel|docetaxel|mesh-list
689231|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689232|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
689233|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226188|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2226189|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2226190|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2226191|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687093|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
687140|NCT03079687|Olaparib|olaparib|mesh-list
687141|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
687142|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687143|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687144|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226192|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226193|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2226194|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226195|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226196|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226197|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226198|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
687783|NCT03076710|Bupivacaine|bupivacaine|mesh-list
687784|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
687785|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
687786|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687787|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687788|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
687789|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087274|NCT02168387|Expectorants|expectorants|mesh-ancestor
2087275|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
2087276|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
688174|NCT03073980|Acetaminophen|acetaminophen|mesh-list
688175|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
688176|NCT03073980|Analgesics|analgesics|mesh-ancestor
688177|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
688178|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688179|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688180|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
688272|NCT03073408|Propofol|propofol|mesh-list
688273|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
688274|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
688275|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688276|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
688277|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
688278|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
688836|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
688837|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
688838|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
688839|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688840|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688948|NCT03070665|Norepinephrine|norepinephrine|mesh-list
688949|NCT03070665|Ephedrine|ephedrine|mesh-list
688950|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
688951|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
688952|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
688953|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688954|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688955|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688956|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
688957|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
688958|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688959|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
688960|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2226199|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
2226200|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2226201|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226202|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2226203|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2226204|NCT00054158|Growth Substances|growth substances|mesh-ancestor
2226205|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
2226206|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2226207|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2226208|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
2226209|NCT00054184|Paclitaxel|paclitaxel|mesh-list
2226210|NCT00054184|Docetaxel|docetaxel|mesh-list
2226211|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2226212|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2226213|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226214|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226215|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226216|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226217|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226218|NCT00054197|Gemcitabine|gemcitabine|mesh-list
687227|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
687228|NCT03079219|Ondansetron|ondansetron|mesh-list
687229|NCT03079219|Olanzapine|olanzapine|mesh-list
687230|NCT03079219|Aprepitant|aprepitant|mesh-list
687231|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
687232|NCT03079219|BB 1101|bb 1101|mesh-list
687233|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
687234|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
687235|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
687236|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687237|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687238|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
687239|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
687240|NCT03079219|Hormones|hormones|mesh-ancestor
687241|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
687242|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
687243|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687244|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
687245|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687246|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687247|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
687248|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
687249|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
687250|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
687251|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687252|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
687253|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
687254|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687255|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
687256|NCT03079219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
687257|NCT03079219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
687258|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
687259|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
687260|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
687487|NCT03078101|Empagliflozin|empagliflozin|mesh-list
687488|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
687489|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687490|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
687491|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226219|NCT00054197|Paclitaxel|paclitaxel|mesh-list
2226220|NCT00054197|Vinorelbine|vinorelbine|mesh-list
2226221|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2226222|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2226223|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226224|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226225|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
2087277|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
2226226|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226227|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226228|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226229|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
2226230|NCT00054197|Antiviral Agents|antiviral agents|mesh-ancestor
2226231|NCT00054197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226232|NCT00054197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226233|NCT00054197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226234|NCT00054197|Immunologic Factors|immunologic factors|mesh-ancestor
2226235|NCT00054197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226236|NCT00054210|Paclitaxel|paclitaxel|mesh-list
2226237|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2226238|NCT00054210|Carboplatin|carboplatin|mesh-list
2226239|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
688786|NCT03071822|Gemcitabine|gemcitabine|mesh-list
688787|NCT03071822|Dexamethasone|dexamethasone|mesh-list
688788|NCT03071822|Etoposide|etoposide|mesh-list
688789|NCT03071822|Asparaginase|asparaginase|mesh-list
688790|NCT03071822|Ifosfamide|ifosfamide|mesh-list
688791|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688792|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688793|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
688794|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
688795|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688796|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688797|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
688798|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
688799|NCT03071822|Hormones|hormones|mesh-ancestor
688800|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
688801|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
687289|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2226240|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2226241|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226242|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226243|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226244|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226245|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226246|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
2226247|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
2226248|NCT00054236|Fludarabine|fludarabine|mesh-list
2226249|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
2226250|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2226251|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226252|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
2226253|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226254|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2226255|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2226256|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
2226257|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226258|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688030|NCT03074773|Dexamethasone|dexamethasone|mesh-list
688031|NCT03074773|Bupivacaine|bupivacaine|mesh-list
688032|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688033|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
688034|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
688035|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688036|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688037|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
688038|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
688039|NCT03074773|Hormones|hormones|mesh-ancestor
688040|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
688041|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
688042|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688043|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
688044|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
688045|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
688046|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
2226259|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2226260|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226261|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
2226262|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2226263|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
688316|NCT03073265|Apixaban|apixaban|mesh-list
688317|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
688318|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
688319|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
688320|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
688321|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688322|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688323|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
688543|NCT03072199|Rituximab|rituximab|mesh-list
688544|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
688545|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688546|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
688547|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688548|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
688702|NCT03071770|Ivosidenib|ivosidenib|mesh-list
688703|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688704|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688705|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688841|NCT03071289|Cisplatin|cisplatin|mesh-list
688842|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688869|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
688870|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2226264|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
2226265|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226266|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2226267|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
2226268|NCT00054236|Hormones|hormones|mesh-ancestor
2226269|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2226270|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2226271|NCT00054236|Protective Agents|protective agents|mesh-ancestor
2226272|NCT00054288|Gemcitabine|gemcitabine|mesh-list
2226273|NCT00054288|Irinotecan|irinotecan|mesh-list
2226274|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226275|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
687353|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
687354|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
687355|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
687356|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687357|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
687358|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
687359|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687397|NCT03078465|Clopidogrel|clopidogrel|mesh-list
687398|NCT03078465|Ticagrelor|ticagrelor|mesh-list
687399|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
687400|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
687401|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
687402|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
687403|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
687404|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
687405|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687406|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687895|NCT03075826|Guadecitabine|guadecitabine|mesh-list
687896|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688065|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
688066|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
688067|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
688068|NCT03074578|Hormones|hormones|mesh-ancestor
688069|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
688070|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688071|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688072|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226276|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226277|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226278|NCT00054288|Antiviral Agents|antiviral agents|mesh-ancestor
2226279|NCT00054288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226280|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226281|NCT00054288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226282|NCT00054288|Immunologic Factors|immunologic factors|mesh-ancestor
2226283|NCT00054288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226284|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2226285|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2226286|NCT00054314|IDN 5109|idn 5109|mesh-list
2226287|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688857|NCT03071055|Ranibizumab|ranibizumab|mesh-list
688858|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
688859|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
688860|NCT03071055|Growth Substances|growth substances|mesh-ancestor
688861|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688862|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
688863|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689018|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
689019|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
689020|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689021|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
689022|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
689023|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
689024|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689025|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
689026|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689494|NCT03069144|Calcitriol|calcitriol|mesh-list
689495|NCT03069144|Calcipotriene|calcipotriene|mesh-list
689496|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
689497|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
689498|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689499|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
689500|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
689501|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689502|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
689503|NCT03069144|Vitamins|vitamins|mesh-ancestor
689504|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
689505|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
689646|NCT03068208|Methylene Blue|methylene blue|mesh-list
689647|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689648|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689741|NCT03067571|Daratumumab|daratumumab|mesh-list
689742|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226288|NCT00054340|Cyclosporine|cyclosporine|mesh-list
2226289|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
2226290|NCT00054340|Busulfan|busulfan|mesh-list
2226291|NCT00054340|Methotrexate|methotrexate|mesh-list
2226292|NCT00054340|Cyclosporins|cyclosporins|mesh-list
2226293|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2226294|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226295|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
2226296|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226297|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2226298|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2226299|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
687812|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
687813|NCT03076164|Trametinib|trametinib|mesh-list
687814|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687815|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
687816|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687817|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688309|NCT03073343|Betaine|betaine|mesh-list
688310|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
688311|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
688312|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
688313|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
688314|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688315|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
689074|NCT03070379|Lidocaine|lidocaine|mesh-list
689075|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
689076|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
689077|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
689078|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689079|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
689080|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689081|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
689082|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
689083|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
689084|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
689085|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689506|NCT03068910|Spironolactone|spironolactone|mesh-list
689507|NCT03068910|Progesterone|progesterone|mesh-list
689508|NCT03068910|Progestins|progestins|mesh-ancestor
689509|NCT03068910|Hormones|hormones|mesh-ancestor
689510|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
689511|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689512|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
689513|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
689514|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
689515|NCT03068910|Diuretics|diuretics|mesh-ancestor
689516|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
689567|NCT03068442|Flutemetamol|flutemetamol|mesh-list
689568|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
689569|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689628|NCT03068065|Metformin|metformin|mesh-list
689629|NCT03068065|Liraglutide|liraglutide|mesh-list
689630|NCT03068065|Gliclazide|gliclazide|mesh-list
689631|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
689632|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689633|NCT03068065|Incretins|incretins|mesh-ancestor
689634|NCT03068065|Hormones|hormones|mesh-ancestor
689635|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2087278|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087279|NCT02168387|Protective Agents|protective agents|mesh-ancestor
2087280|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087281|NCT02168387|Antidotes|antidotes|mesh-ancestor
2087282|NCT02168439|Midazolam|midazolam|mesh-list
2087283|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
2087284|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2087285|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2087286|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690431|NCT03064568|Misoprostol|misoprostol|mesh-list
690432|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
690433|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
690434|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
690435|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690436|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
690437|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
690438|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
2226300|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226301|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226302|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2226303|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2226304|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
2226305|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2226306|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226307|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
2226308|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
2226309|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226310|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2226311|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2226312|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
2226313|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226314|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2226315|NCT00054392|Gemcitabine|gemcitabine|mesh-list
2226316|NCT00054392|Paclitaxel|paclitaxel|mesh-list
2226317|NCT00054392|Carboplatin|carboplatin|mesh-list
2226318|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2226319|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226320|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226321|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226322|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226323|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226324|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226325|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
2226326|NCT00054392|Antiviral Agents|antiviral agents|mesh-ancestor
2226327|NCT00054392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226328|NCT00054392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226329|NCT00054392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
688524|NCT03072394|Lidocaine|lidocaine|mesh-list
688525|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
688526|NCT03072394|Anesthetics|anesthetics|mesh-list
688527|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
688528|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688529|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
688530|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688531|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
688532|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
688533|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
688534|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
688535|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688714|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
688715|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
688716|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
688717|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
688718|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688719|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226330|NCT00054392|Immunologic Factors|immunologic factors|mesh-ancestor
2226331|NCT00054392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226332|NCT00054405|Aldesleukin|aldesleukin|mesh-list
2226333|NCT00054405|Interleukin-2|interleukin-2|mesh-list
2226334|NCT00054405|Interleukin-12|interleukin-12|mesh-list
2226335|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226336|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2226337|NCT00054405|Analgesics|analgesics|mesh-ancestor
2226338|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
2226339|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226340|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226341|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2226342|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2226343|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
2226344|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226345|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2226346|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
2226347|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2226348|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2226349|NCT00054405|Growth Substances|growth substances|mesh-ancestor
2226350|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
2226351|NCT00054418|Vitamin D|vitamin d|mesh-list
2226352|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
2226353|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
687555|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
687556|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
687557|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
687558|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
687559|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
687560|NCT03077698|Hormones|hormones|mesh-ancestor
687561|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
687562|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
687563|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
688720|NCT03071601|Lidocaine|lidocaine|mesh-list
688721|NCT03071601|Epinephrine|epinephrine|mesh-list
688722|NCT03071601|Prilocaine|prilocaine|mesh-list
688723|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
688724|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
688725|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
688726|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
688727|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688728|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
688729|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688730|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
688731|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
688732|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
688733|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
688734|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688735|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
688736|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
688737|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
688738|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688739|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
688740|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
688741|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
688742|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
688743|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
688744|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
688745|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
688746|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
688747|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
689050|NCT03070301|Everolimus|everolimus|mesh-list
689051|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689052|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
689053|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
689054|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689806|NCT03067727|Dinoprostone|dinoprostone|mesh-list
689807|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
689808|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
689809|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689920|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
689921|NCT03066817|Vitamin D|vitamin d|mesh-list
689922|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
689923|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689924|NCT03066817|Vitamins|vitamins|mesh-ancestor
689925|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
689926|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
690150|NCT03066154|Ritonavir|ritonavir|mesh-list
690151|NCT03066154|Docetaxel|docetaxel|mesh-list
690152|NCT03066154|Androgens|androgens|mesh-list
690153|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690154|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
690155|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
690156|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
690157|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690158|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
690159|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
690160|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
690161|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690162|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
690163|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
690164|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
690165|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
690166|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
690167|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
690168|NCT03066154|Hormones|hormones|mesh-ancestor
690169|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
690170|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690302|NCT03065309|Remifentanil|remifentanil|mesh-list
690303|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
687683|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687684|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
687685|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
687686|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
687687|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
687818|NCT03076320|Adapalene|adapalene|mesh-list
687819|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
687820|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
687821|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
687822|NCT03076320|Analgesics|analgesics|mesh-ancestor
687823|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
687824|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687825|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687826|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
687827|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
687828|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
688461|NCT03072589|Regadenoson|regadenoson|mesh-list
688462|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
688463|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
688464|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
688465|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
688466|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688467|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688468|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226354|NCT00054418|Calcium|calcium|mesh-list
2226355|NCT00054418|Vitamins|vitamins|mesh-ancestor
2226356|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
688843|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
688844|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
688845|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
688846|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
688847|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
688848|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688849|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688850|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
688965|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
688966|NCT03070574|Mesalamine|mesalamine|mesh-list
688967|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
688968|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
688969|NCT03070574|Analgesics|analgesics|mesh-ancestor
688970|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
688971|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688972|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688973|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688974|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
688975|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
688976|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
688977|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
689180|NCT03070054|Epinephrine|epinephrine|mesh-list
689181|NCT03070054|Bupivacaine|bupivacaine|mesh-list
689182|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
689183|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
689184|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
689185|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689186|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
689187|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689188|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
689189|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
689190|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
689191|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689192|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689193|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
689194|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
689195|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
689196|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
689197|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
689198|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
689199|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
689200|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2087287|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2087288|NCT02168439|Analgesics|analgesics|mesh-ancestor
2087289|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
2226357|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687735|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687736|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
687737|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
687738|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
687739|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
687740|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
687741|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
687742|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
687751|NCT03076905|Olorofim|olorofim|mesh-list
687752|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
687753|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
687800|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
687801|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
687802|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
687803|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687804|NCT03076112|Incretins|incretins|mesh-ancestor
687805|NCT03076112|Hormones|hormones|mesh-ancestor
687806|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
687807|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
687808|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
687809|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
687810|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687811|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2226358|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2226359|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2226360|NCT00054418|Antacids|antacids|mesh-ancestor
2226361|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226362|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2226363|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2226364|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2226365|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
2087290|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087291|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2087292|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2087293|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2087294|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
2087295|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087296|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087297|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2226366|NCT00054431|Decitabine|decitabine|mesh-list
2226367|NCT00054431|Azacitidine|azacitidine|mesh-list
2226368|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226369|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2226370|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226371|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689271|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
689272|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
689273|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
689274|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
689275|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
689276|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689277|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
689278|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689279|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689280|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
689281|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226372|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226373|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
2226374|NCT00054444|Topotecan|topotecan|mesh-list
2226375|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689684|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
689685|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
689686|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689878|NCT03067051|Verteporfin|verteporfin|mesh-list
689879|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
689880|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
690171|NCT03065868|Clarithromycin|clarithromycin|mesh-list
690172|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
690173|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
690174|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
690175|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690176|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690177|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2087298|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2087299|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2087300|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
688228|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
688229|NCT03074136|Eusol|eusol|mesh-list
688230|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
688231|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
688324|NCT03072992|Curcumin|curcumin|mesh-list
688325|NCT03072992|Paclitaxel|paclitaxel|mesh-list
688326|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
688327|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688328|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
688329|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
688330|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
688331|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688332|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
688333|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
688334|NCT03072992|Analgesics|analgesics|mesh-ancestor
688335|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
688336|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688337|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688338|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688339|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
688340|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688430|NCT03072771|Cytarabine|cytarabine|mesh-list
688431|NCT03072771|Etoposide|etoposide|mesh-list
688432|NCT03072771|Melphalan|melphalan|mesh-list
688433|NCT03072771|Carmustine|carmustine|mesh-list
688434|NCT03072771|Blinatumomab|blinatumomab|mesh-list
688435|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
688436|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688437|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
688438|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
688439|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688440|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688441|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
688442|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
688443|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
688444|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
688445|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
688446|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
688447|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688448|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
688449|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
688450|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
688536|NCT03072329|Bupivacaine|bupivacaine|mesh-list
688537|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
688538|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
688539|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
688540|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688541|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
688542|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688761|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
688762|NCT03071549|Salicylates|salicylates|mesh-list
688763|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
688764|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
688765|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
688766|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
688767|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
688768|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
688769|NCT03071549|Analgesics|analgesics|mesh-ancestor
688770|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
688771|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688772|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688773|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688774|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
688775|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
688776|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688777|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688927|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
688928|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
688929|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087301|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2087302|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
2087303|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
687764|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
687765|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
687766|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687767|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687768|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
687769|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
687770|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
687771|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
687772|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688162|NCT03073941|Cimetidine|cimetidine|mesh-list
688163|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
688164|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
688165|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
688166|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
688167|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
688168|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688169|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688170|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688171|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
688172|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
688173|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226376|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2226377|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2226378|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226379|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689699|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
689700|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
689701|NCT03067896|Bupivacaine|bupivacaine|mesh-list
689702|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
689703|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
689704|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
689705|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689706|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
689707|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689708|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
689709|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
689710|NCT03067896|Analgesics|analgesics|mesh-ancestor
689711|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
689712|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
689713|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
689714|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
689715|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689716|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689717|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
689718|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
689719|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
689720|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
689721|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
689722|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
689723|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
689840|NCT03067194|Celecoxib|celecoxib|mesh-list
689841|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
689842|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
689843|NCT03067194|Analgesics|analgesics|mesh-ancestor
689844|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
689845|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689846|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689847|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
689848|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
689849|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
689850|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
689851|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689852|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087304|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
2087305|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
2087306|NCT02168478|Neomycin|neomycin|mesh-list
2087307|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2087308|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087309|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2087310|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087311|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087312|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
690020|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
2226380|NCT00054457|Docetaxel|docetaxel|mesh-list
687845|NCT03076281|Metformin|metformin|mesh-list
687846|NCT03076281|Doxycycline|doxycycline|mesh-list
687847|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
687848|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687849|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
687850|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
687851|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
687852|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
687853|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
688015|NCT03075241|Zolpidem|zolpidem|mesh-list
688016|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
688017|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
688018|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
688019|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688020|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
688021|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
688022|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
688023|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688024|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688062|NCT03074539|Riociguat|riociguat|mesh-list
688063|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
688064|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688155|NCT03074097|Bupivacaine|bupivacaine|mesh-list
688156|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
688157|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
688158|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
688159|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688160|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
688161|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087313|NCT02168491|Lixisenatide|lixisenatide|mesh-list
2087314|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2087315|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087316|NCT02168660|Vitamin D|vitamin d|mesh-list
2087317|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
2087318|NCT02168660|Vitamins|vitamins|mesh-ancestor
689159|NCT03070223|Pitavastatin|pitavastatin|mesh-list
689160|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
689161|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
689162|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
689163|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
689164|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689165|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689166|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
689328|NCT03069703|Rituximab|rituximab|mesh-list
689329|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
689330|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689331|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
689332|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689333|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2226381|NCT00054457|Capecitabine|capecitabine|mesh-list
2226382|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226383|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226384|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226385|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226386|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226387|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226388|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
2226389|NCT00054470|Trastuzumab|trastuzumab|mesh-list
2226390|NCT00054470|Tipifarnib|tipifarnib|mesh-list
2226391|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2226392|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226393|NCT00054483|Bortezomib|bortezomib|mesh-list
2226394|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226395|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2226396|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226397|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2226398|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226399|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226400|NCT00054522|Calcitriol|calcitriol|mesh-list
2226401|NCT00054522|Dexamethasone|dexamethasone|mesh-list
2226402|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2226403|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
2226404|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
2226405|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226406|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226407|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2087319|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
687918|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
687919|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
687920|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
687921|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
687922|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
687923|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
687924|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
687925|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
687926|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
687927|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
687928|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226408|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
2226409|NCT00054522|Hormones|hormones|mesh-ancestor
2226410|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2226411|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2226412|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226413|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2226414|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2226415|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2226416|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226417|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2226418|NCT00054522|Vitamins|vitamins|mesh-ancestor
2226419|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
2226420|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2226421|NCT00054535|Aldesleukin|aldesleukin|mesh-list
2226422|NCT00054535|Vaccines|vaccines|mesh-list
2226423|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
2226424|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226425|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226426|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2226427|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2226428|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
2226429|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226430|NCT00054548|Paclitaxel|paclitaxel|mesh-list
2226431|NCT00054548|Oblimersen|oblimersen|mesh-list
2226432|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2226433|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691004|NCT03061838|Rituximab|rituximab|mesh-list
691005|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
691006|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691007|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
691008|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691009|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
691427|NCT03059849|Adalimumab|adalimumab|mesh-list
691428|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
691429|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
692187|NCT03056599|Gemcitabine|gemcitabine|mesh-list
692188|NCT03056599|Interferons|interferons|mesh-list
692189|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
692190|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
692191|NCT03056599|Aldesleukin|aldesleukin|mesh-list
692192|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
692193|NCT03056599|Docetaxel|docetaxel|mesh-list
692194|NCT03056599|Doxorubicin|doxorubicin|mesh-list
692195|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
692196|NCT03056599|Nivolumab|nivolumab|mesh-list
692197|NCT03056599|Bortezomib|bortezomib|mesh-list
692198|NCT03056599|Ipilimumab|ipilimumab|mesh-list
692199|NCT03056599|Durvalumab|durvalumab|mesh-list
692200|NCT03056599|Atezolizumab|atezolizumab|mesh-list
692201|NCT03056599|Avelumab|avelumab|mesh-list
692202|NCT03056599|Trabectedin|trabectedin|mesh-list
692203|NCT03056599|Olaratumab|olaratumab|mesh-list
692204|NCT03056599|Entrectinib|entrectinib|mesh-list
692205|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
692206|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
692207|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692208|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692209|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
692210|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
692211|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692212|NCT03056599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
692213|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
692214|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692215|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
692216|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
692217|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
692218|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
692219|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
688012|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688013|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
688014|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087320|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087321|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2087322|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2087323|NCT02168803|Evacetrapib|evacetrapib|mesh-list
2087324|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2087325|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2087326|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
2102968|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
688636|NCT03072121|Aspirin|aspirin|mesh-list
688637|NCT03072121|Metoprolol|metoprolol|mesh-list
688638|NCT03072121|Isosorbide|isosorbide|mesh-list
688639|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
688640|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
688641|NCT03072121|Trimetazidine|trimetazidine|mesh-list
688642|NCT03072121|Clopidogrel|clopidogrel|mesh-list
688643|NCT03072121|Atorvastatin|atorvastatin|mesh-list
688644|NCT03072121|Calcium|calcium|mesh-list
688645|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
688646|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688647|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
688648|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
688649|NCT03072121|Analgesics|analgesics|mesh-ancestor
688650|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
688651|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688652|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688653|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
688654|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
688655|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
688656|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688657|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
688658|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
688659|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688660|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
688661|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
688662|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
688663|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
688664|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
688665|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
688666|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
688667|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
688668|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
688669|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
688670|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688671|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
688672|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
688673|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
688674|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
688675|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
688676|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
688677|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
688678|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
688679|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
688680|NCT03072121|Diuretics|diuretics|mesh-ancestor
688681|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
688682|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
688683|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
688871|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
688872|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
688978|NCT03070704|Liraglutide|liraglutide|mesh-list
688979|NCT03070704|Xultophy|xultophy|mesh-list
688980|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
688981|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688982|NCT03070704|Incretins|incretins|mesh-ancestor
688983|NCT03070704|Hormones|hormones|mesh-ancestor
688984|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
689118|NCT03070405|Tenofovir|tenofovir|mesh-list
689119|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
689120|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
689121|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
689122|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
689123|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
689124|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689125|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688050|NCT03074786|Dapivirine|dapivirine|mesh-list
688051|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
688052|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
688053|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
688054|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
688055|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688056|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688057|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
688058|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
688088|NCT03074318|Avelumab|avelumab|mesh-list
688089|NCT03074318|Trabectedin|trabectedin|mesh-list
688090|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
688091|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
688092|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688093|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
688094|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
688095|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688096|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
688097|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087327|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087328|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2087329|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
2087330|NCT02168816|Metronidazole|metronidazole|mesh-list
2087331|NCT02168816|Vancomycin|vancomycin|mesh-list
2087332|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
2087333|NCT02168816|Clindamycin|clindamycin|mesh-list
2087334|NCT02168816|Meropenem|meropenem|mesh-list
2087335|NCT02168816|Tazobactam|tazobactam|mesh-list
2087336|NCT02168816|Linezolid|linezolid|mesh-list
2087337|NCT02168816|Piperacillin|piperacillin|mesh-list
2087338|NCT02168816|Daptomycin|daptomycin|mesh-list
2087339|NCT02168816|Cefepime|cefepime|mesh-list
2087340|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2087341|NCT02168816|Aztreonam|aztreonam|mesh-list
2087342|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2087343|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2087344|NCT02168816|Trimethoprim|trimethoprim|mesh-list
2087345|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
2087346|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
688296|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
688297|NCT03073785|Fluorouracil|fluorouracil|mesh-list
688298|NCT03073785|Capecitabine|capecitabine|mesh-list
688299|NCT03073785|Imidazole|imidazole|mesh-list
688300|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
688301|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688302|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
688303|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688304|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
688305|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
688306|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688307|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
688308|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226434|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226435|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226436|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226437|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226438|NCT00054561|Vitamin E|vitamin e|mesh-list
2226439|NCT00054561|Interferons|interferons|mesh-list
2226440|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
2226441|NCT00054561|Isotretinoin|isotretinoin|mesh-list
2226442|NCT00054561|Vitamins|vitamins|mesh-ancestor
2226443|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
2226444|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226445|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226446|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
2226447|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226448|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
2226449|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
2226450|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226451|NCT00054561|Protective Agents|protective agents|mesh-ancestor
2226452|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
2226453|NCT00054574|Panitumumab|panitumumab|mesh-list
2226454|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2226455|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226456|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
2226457|NCT00054587|Docetaxel|docetaxel|mesh-list
2087347|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2087348|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2226458|NCT00054587|Fluorouracil|fluorouracil|mesh-list
688061|NCT03074591|Hematinics|hematinics|mesh-ancestor
688185|NCT03073928|Ropivacaine|ropivacaine|mesh-list
688186|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
688187|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
688188|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
688189|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688190|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
688191|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688354|NCT03072849|Fluticasone|fluticasone|mesh-list
688355|NCT03072849|Azithromycin|azithromycin|mesh-list
688356|NCT03072849|Montelukast|montelukast|mesh-list
688357|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688358|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
688359|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
688360|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688361|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688362|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
688363|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
688364|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
688365|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
688366|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
688367|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
688368|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
688369|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
688370|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
688371|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
688372|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
688373|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688491|NCT03072511|Nicotine|nicotine|mesh-list
688492|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
688493|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
688494|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688495|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688496|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
688497|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
688498|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
688499|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688500|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689429|NCT03069131|Rifaximin|rifaximin|mesh-list
689430|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
689431|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
689432|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
690179|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
690180|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
690181|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690224|NCT03065504|Turmeric extract|turmeric extract|mesh-list
690225|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
690226|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690227|NCT03065504|Protective Agents|protective agents|mesh-ancestor
690228|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690890|NCT03063060|Vitamin D|vitamin d|mesh-list
690891|NCT03063060|Calcium|calcium|mesh-list
690892|NCT03063060|Vitamins|vitamins|mesh-ancestor
690893|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
690894|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690895|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
690896|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
690958|NCT03062462|Clopidogrel|clopidogrel|mesh-list
690959|NCT03062462|Ticagrelor|ticagrelor|mesh-list
690960|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
690961|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
690962|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
690963|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
690964|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
690965|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
690966|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690967|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691076|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
691077|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
691078|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
691079|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
691080|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
691081|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
691237|NCT03060707|Bromides|bromides|mesh-list
691238|NCT03060707|Rocuronium|rocuronium|mesh-list
691239|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
688200|NCT03073850|Aspirin|aspirin|mesh-list
688201|NCT03073850|Edoxaban|edoxaban|mesh-list
688202|NCT03073850|Anticoagulants|anticoagulants|mesh-list
688203|NCT03073850|Clopidogrel|clopidogrel|mesh-list
688204|NCT03073850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
688205|NCT03073850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
688206|NCT03073850|Analgesics|analgesics|mesh-ancestor
688207|NCT03073850|Sensory System Agents|sensory system agents|mesh-ancestor
688208|NCT03073850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688209|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688210|NCT03073850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688211|NCT03073850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
688212|NCT03073850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
688213|NCT03073850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
688214|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688215|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
688216|NCT03073850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
688217|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688218|NCT03073850|Antipyretics|antipyretics|mesh-ancestor
688219|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
688220|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
688221|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
688222|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
688223|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688224|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
688225|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
688226|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
688227|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
688693|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
688694|NCT03071861|Hematinics|hematinics|mesh-ancestor
689130|NCT03070353|Dextrans|dextrans|mesh-list
689131|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
689132|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
689133|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
689242|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
689243|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
689244|NCT03069781|Estradiol|estradiol|mesh-list
689245|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
689246|NCT03069781|Estrogens|estrogens|mesh-ancestor
689247|NCT03069781|Hormones|hormones|mesh-ancestor
689248|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
689249|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689250|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
689251|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
689252|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
689253|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
689444|NCT03069183|Ropivacaine|ropivacaine|mesh-list
689445|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
689446|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
689447|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
689448|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689449|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
689450|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689517|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
689518|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
689519|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
689905|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
689906|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
689907|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
689908|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
689909|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
689910|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688292|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688778|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
688779|NCT03071679|Imiquimod|imiquimod|mesh-list
688780|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
688781|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
688782|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688783|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688784|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
688785|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
688889|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
688890|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
688891|NCT03071172|Progesterone|progesterone|mesh-list
688892|NCT03071172|Hormones|hormones|mesh-ancestor
688893|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
688894|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688895|NCT03071172|Progestins|progestins|mesh-ancestor
688896|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
688897|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
688898|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
688899|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
688900|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
688901|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
688902|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689013|NCT03070613|Lectins|lectins|mesh-list
689014|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
689015|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
689016|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689017|NCT03070613|Coagulants|coagulants|mesh-ancestor
689754|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
689755|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
689756|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689757|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
689758|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689759|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689939|NCT03066700|Hemostatics|hemostatics|mesh-list
689940|NCT03066700|Coagulants|coagulants|mesh-ancestor
690067|NCT03066427|Sunitinib|sunitinib|mesh-list
690068|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690069|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
690070|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
690071|NCT03066427|Growth Substances|growth substances|mesh-ancestor
690072|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690073|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
690074|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
690075|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690076|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690253|NCT03065621|Palbociclib|palbociclib|mesh-list
690254|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690255|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
690256|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690257|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690620|NCT03063658|Acetaminophen|acetaminophen|mesh-list
690624|NCT03063658|Ibuprofen|ibuprofen|mesh-list
690625|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
690626|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
690627|NCT03063658|Analgesics|analgesics|mesh-ancestor
690628|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
690629|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690630|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690631|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
690632|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
690633|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
690634|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690635|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690636|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
690733|NCT03063307|Fluorides|fluorides|mesh-list
690734|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
690735|NCT03063307|Protective Agents|protective agents|mesh-ancestor
690736|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691002|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
691003|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691119|NCT03061630|Gemcitabine|gemcitabine|mesh-list
688397|NCT03073057|Protective Agents|protective agents|mesh-ancestor
688711|NCT03071575|Vaccines|vaccines|mesh-list
688712|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
688713|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087349|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087350|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087351|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087352|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2087353|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2087354|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2087355|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2087356|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2087357|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2087358|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2087359|NCT02168816|Renal Agents|renal agents|mesh-ancestor
2087360|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
2087361|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2087362|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2087363|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2087364|NCT02168842|Isradipine|isradipine|mesh-list
2087365|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2087366|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2087367|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2087368|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087369|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2087370|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087371|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
2087372|NCT02168855|Nicotine|nicotine|mesh-list
2087373|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2087374|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
2087375|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087376|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087377|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2087378|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2087379|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
2087380|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087381|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691178|NCT03061006|Warfarin|warfarin|mesh-list
691179|NCT03061006|Dabigatran|dabigatran|mesh-list
691180|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
691181|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
691182|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
691183|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
691184|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691185|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691279|NCT03060785|Tenofovir|tenofovir|mesh-list
691280|NCT03060785|Emtricitabine|emtricitabine|mesh-list
691281|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
691282|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
691283|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
691284|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
691285|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691286|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691287|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
691288|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
691375|NCT03060265|Acetaminophen|acetaminophen|mesh-list
691376|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
691377|NCT03060265|Analgesics|analgesics|mesh-ancestor
691378|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
691379|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691380|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691381|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
691764|NCT03058341|Propofol|propofol|mesh-list
691765|NCT03058341|Sevoflurane|sevoflurane|mesh-list
691766|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
691767|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
691768|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691769|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
691770|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
691771|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
691772|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
691773|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
691976|NCT03057483|Vaccines|vaccines|mesh-list
691977|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
691978|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752737|NCT03339284|Ropivacaine|ropivacaine|mesh-list
2752738|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2752739|NCT03339284|BB 1101|bb 1101|mesh-list
2752740|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2087382|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2087383|NCT02168946|Meropenem|meropenem|mesh-list
2087384|NCT02168946|Vaborbactam|vaborbactam|mesh-list
2087385|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2087386|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
2087387|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087388|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
2087389|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087390|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087391|NCT02169115|Omalizumab|omalizumab|mesh-list
2087392|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2087393|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2087394|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2087395|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
2087396|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
689236|NCT03069937|Docetaxel|docetaxel|mesh-list
689237|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689238|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
689239|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
689240|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
689241|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226459|NCT00054587|Trastuzumab|trastuzumab|mesh-list
2226460|NCT00054587|Epirubicin|epirubicin|mesh-list
2226461|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226462|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
2226463|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689764|NCT03067792|Leucovorin|leucovorin|mesh-list
689765|NCT03067792|Docetaxel|docetaxel|mesh-list
689766|NCT03067792|Fluorouracil|fluorouracil|mesh-list
689767|NCT03067792|Irinotecan|irinotecan|mesh-list
689768|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689769|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
689770|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
689771|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
689772|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689773|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
689774|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
689775|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
689776|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
689777|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689778|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
689779|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
689780|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689781|NCT03067792|Antidotes|antidotes|mesh-ancestor
689782|NCT03067792|Protective Agents|protective agents|mesh-ancestor
689783|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
689784|NCT03067792|Vitamins|vitamins|mesh-ancestor
689785|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
2087397|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087398|NCT02169219|Prednisone|prednisone|mesh-list
2087399|NCT02169219|Rituximab|rituximab|mesh-list
2087400|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
2087401|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2087402|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087403|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
2087404|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087405|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2752741|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
2752742|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
2752743|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2752744|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752745|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2752746|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
2752747|NCT03339284|Hormones|hormones|mesh-ancestor
2752748|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2752749|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2752750|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690459|NCT03064165|Epinephrine|epinephrine|mesh-list
690460|NCT03064165|Bupivacaine|bupivacaine|mesh-list
690461|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
690462|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
690463|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
690464|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690465|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
2087406|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688552|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
688553|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
688554|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
688555|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688556|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688748|NCT03071731|Bromides|bromides|mesh-list
688749|NCT03071731|Ipratropium|ipratropium|mesh-list
688750|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
688751|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
688752|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
688753|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688754|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688755|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
688756|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
688757|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688758|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688759|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
688760|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
688934|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
688935|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
688936|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
688937|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688938|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
688939|NCT03070847|Coagulants|coagulants|mesh-ancestor
689261|NCT03069924|Nicotine|nicotine|mesh-list
689262|NCT03069924|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
689263|NCT03069924|Autonomic Agents|autonomic agents|mesh-ancestor
689264|NCT03069924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689265|NCT03069924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689266|NCT03069924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
689267|NCT03069924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
689268|NCT03069924|Cholinergic Agents|cholinergic agents|mesh-ancestor
689269|NCT03069924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689270|NCT03069924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226464|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2226465|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2226466|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
2226467|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226468|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226469|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
690517|NCT03063944|Azacitidine|azacitidine|mesh-list
690518|NCT03063944|Decitabine|decitabine|mesh-list
690519|NCT03063944|Venetoclax|venetoclax|mesh-list
690520|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
690521|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
690522|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690523|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690524|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690607|NCT03063541|Aspirin|aspirin|mesh-list
690608|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
690609|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
690610|NCT03063541|Analgesics|analgesics|mesh-ancestor
690611|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
690612|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690613|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690614|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
690615|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
690616|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
690617|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
690618|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690619|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
690621|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
690622|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690623|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
691044|NCT03061734|Acetaminophen|acetaminophen|mesh-list
691045|NCT03061734|Naltrexone|naltrexone|mesh-list
691046|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
691047|NCT03061734|Analgesics|analgesics|mesh-ancestor
691048|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
691049|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691050|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691051|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
691052|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
691053|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2226470|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226471|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
688616|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
688617|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
688618|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
688619|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
688620|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
688621|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
688622|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
688623|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
688624|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
688625|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
688626|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
688627|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
688628|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
688629|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
688630|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
688631|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
688632|NCT03072082|Diuretics|diuretics|mesh-ancestor
688633|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
688634|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
688635|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
688695|NCT03071536|Furosemide|furosemide|mesh-list
688696|NCT03071536|Diuretics|diuretics|mesh-ancestor
688697|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
688698|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688699|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
688700|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
688701|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688873|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
688874|NCT03071068|Antibodies|antibodies|mesh-list
688875|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
688876|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
688877|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
688878|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688879|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689134|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
689135|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
689136|NCT03070275|Coagulants|coagulants|mesh-ancestor
689221|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
689222|NCT03069963|Antacids|antacids|mesh-ancestor
689223|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689224|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
689334|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
689335|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
689336|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
689337|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689338|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
689339|NCT03069638|Analgesics|analgesics|mesh-ancestor
689340|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
689341|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689342|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
689343|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
689344|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
689345|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
689346|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689347|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689570|NCT03068429|Sertraline|sertraline|mesh-list
689571|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
689572|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
689573|NCT03068429|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
689574|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
689575|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
689576|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689577|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689578|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
689579|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689743|NCT03067610|Paclitaxel|paclitaxel|mesh-list
689744|NCT03067610|Cisplatin|cisplatin|mesh-list
689745|NCT03067610|Carboplatin|carboplatin|mesh-list
689746|NCT03067610|Cetuximab|cetuximab|mesh-list
689747|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
689748|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689749|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
689750|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
689751|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
688710|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
2226472|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226473|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
2226474|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226475|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2226476|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2226477|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2226478|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2226479|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087407|NCT02169219|Hormones|hormones|mesh-ancestor
2087408|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2087409|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2087410|NCT02169271|Aspirin|aspirin|mesh-list
2087411|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2087412|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2087413|NCT02169271|Analgesics|analgesics|mesh-ancestor
2087414|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
2087415|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087416|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087417|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2087418|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2087419|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
689254|NCT03069768|Varenicline|varenicline|mesh-list
689255|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
689256|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
689257|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
689258|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689259|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689260|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689663|NCT03068260|Acetaminophen|acetaminophen|mesh-list
689664|NCT03068260|Ibuprofen|ibuprofen|mesh-list
689665|NCT03068260|Morphine|morphine|mesh-list
689666|NCT03068260|Ropivacaine|ropivacaine|mesh-list
689667|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
689668|NCT03068260|Narcotics|narcotics|mesh-ancestor
689669|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
689670|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689671|NCT03068260|Analgesics|analgesics|mesh-ancestor
689672|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
689673|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689674|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
689675|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
689676|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
689677|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
689678|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
689679|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
689680|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
689681|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
689682|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689683|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087420|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2087421|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087422|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
690083|NCT03066466|Methotrexate|methotrexate|mesh-list
690084|NCT03066466|Atorvastatin|atorvastatin|mesh-list
690085|NCT03066466|Tacrolimus|tacrolimus|mesh-list
690086|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
690087|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
690088|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
690089|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690090|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
690091|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
690092|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690093|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690094|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
690095|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690096|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
690097|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
690098|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
690099|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
690100|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
690101|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
690102|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
690103|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
690104|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
688802|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
688803|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
688804|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688805|NCT03071822|Antiviral Agents|antiviral agents|mesh-ancestor
688806|NCT03071822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
688807|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
688808|NCT03071822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
688809|NCT03071822|Immunologic Factors|immunologic factors|mesh-ancestor
688810|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
688811|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
688812|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
688813|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
688814|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
689482|NCT03068936|Cisplatin|cisplatin|mesh-list
689483|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689580|NCT03068624|Aldesleukin|aldesleukin|mesh-list
689581|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
689582|NCT03068624|Ipilimumab|ipilimumab|mesh-list
689583|NCT03068624|Interleukin-2|interleukin-2|mesh-list
689584|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
689585|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
689586|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689587|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
689588|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
689589|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
689590|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689591|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689592|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
689593|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
689594|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
689595|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
689596|NCT03068624|Analgesics|analgesics|mesh-ancestor
689597|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
689598|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689599|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
689600|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
689601|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
689602|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
689916|NCT03066661|Entrectinib|entrectinib|mesh-list
689917|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
689918|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689919|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690077|NCT03066518|Melatonin|melatonin|mesh-list
690078|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
690079|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690080|NCT03066518|Protective Agents|protective agents|mesh-ancestor
690081|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690082|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
690237|NCT03065660|Mifepristone|mifepristone|mesh-list
690238|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
690239|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
690240|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
690241|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690242|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
690243|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
690244|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
690245|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
690246|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
690247|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
690248|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
690249|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
690250|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
690251|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
690252|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
690340|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
690341|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
690395|NCT03064633|Dexamethasone|dexamethasone|mesh-list
690396|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
690397|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
690398|NCT03064633|Bupivacaine|bupivacaine|mesh-list
690399|NCT03064633|BB 1101|bb 1101|mesh-list
690400|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
690401|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
690402|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
690403|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087423|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2226480|NCT00054600|Methoxsalen|methoxsalen|mesh-list
2226481|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2226482|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
2226483|NCT00054613|Methoxsalen|methoxsalen|mesh-list
2226484|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2226485|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
2226486|NCT00054626|Gemcitabine|gemcitabine|mesh-list
2226487|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226488|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226489|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
689433|NCT03069248|Interferons|interferons|mesh-list
689434|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
689435|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
689436|NCT03069248|Rituximab|rituximab|mesh-list
689437|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
689438|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689439|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
689440|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689441|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
689442|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
689443|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226490|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226491|NCT00054626|Antiviral Agents|antiviral agents|mesh-ancestor
2226492|NCT00054626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226493|NCT00054626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226494|NCT00054626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226495|NCT00054626|Immunologic Factors|immunologic factors|mesh-ancestor
2226496|NCT00054626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226497|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
2226498|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226499|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2226500|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
2226501|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
2226502|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2226503|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226504|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226505|NCT00054834|Epratuzumab|epratuzumab|mesh-list
690769|NCT03063203|Decitabine|decitabine|mesh-list
690770|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
690771|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
690772|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690773|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690774|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690872|NCT03062800|Thalidomide|thalidomide|mesh-list
690873|NCT03062800|Carboplatin|carboplatin|mesh-list
690874|NCT03062800|Pemetrexed|pemetrexed|mesh-list
690875|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690876|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690877|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690878|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
690879|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
690880|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
690881|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
690882|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690883|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
690884|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
690885|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
690886|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
690887|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
690888|NCT03062800|Growth Substances|growth substances|mesh-ancestor
690889|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
691525|NCT03059277|Aflibercept|aflibercept|mesh-list
691526|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
691527|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
691528|NCT03059277|Growth Substances|growth substances|mesh-ancestor
691529|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691530|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
691531|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226506|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2226507|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226508|NCT00054873|Fluorouracil|fluorouracil|mesh-list
2226509|NCT00054873|Tezacitabine|tezacitabine|mesh-list
2226510|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
692880|NCT03053544|Metformin|metformin|mesh-list
2087424|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226511|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688987|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
688988|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
688989|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
688990|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
688991|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
688992|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
688993|NCT03070678|Analgesics|analgesics|mesh-ancestor
688994|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
688995|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
688996|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
688997|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
688998|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
688999|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226512|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226513|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226514|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226515|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
2226516|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226517|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226518|NCT00054886|Sunitinib|sunitinib|mesh-list
2087425|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
2087426|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2087427|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087428|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2087429|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087430|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087431|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
2087432|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2087433|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2087434|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087435|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
689451|NCT03069027|Lidocaine|lidocaine|mesh-list
689452|NCT03069027|Epinephrine|epinephrine|mesh-list
689453|NCT03069027|Racepinephrine|racepinephrine|mesh-list
689454|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
689455|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
689456|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
689457|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
689458|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689459|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
689460|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689461|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
689462|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
689463|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
689464|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
689465|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689466|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
689467|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
689468|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
689469|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689470|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
689471|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
689472|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
689473|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
689474|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
689475|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
689476|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
689477|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
689853|NCT03067103|Ketamine|ketamine|mesh-list
689854|NCT03067103|Tramadol|tramadol|mesh-list
689855|NCT03067103|Analgesics|analgesics|mesh-ancestor
689856|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
689857|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689858|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689859|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
689860|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
689861|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
689862|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
689863|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
689864|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
689865|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
689866|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689867|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689868|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
689000|NCT03070522|Prednisone|prednisone|mesh-list
689001|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
689002|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
689003|NCT03070522|Hormones|hormones|mesh-ancestor
689004|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
689005|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689006|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
689007|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689484|NCT03068832|Poly I-C|poly i-c|mesh-list
689485|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
689486|NCT03068832|Poly ICLC|poly iclc|mesh-list
689487|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
689488|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
689489|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689490|NCT03068832|Laxatives|laxatives|mesh-ancestor
689491|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
689492|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
689493|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
689786|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
689787|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
689788|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
689789|NCT03067753|Prednisolone|prednisolone|mesh-list
689790|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
689791|NCT03067753|Hormones|hormones|mesh-list
689792|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
689793|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
689794|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
689795|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689796|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
689797|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
689798|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
689799|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689800|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
689801|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
689802|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
689803|NCT03067753|Protective Agents|protective agents|mesh-ancestor
689804|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
689805|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690282|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
690283|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
690284|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690367|NCT03064854|Gemcitabine|gemcitabine|mesh-list
690368|NCT03064854|Paclitaxel|paclitaxel|mesh-list
690369|NCT03064854|Carboplatin|carboplatin|mesh-list
690370|NCT03064854|Pemetrexed|pemetrexed|mesh-list
690371|NCT03064854|Spartalizumab|spartalizumab|mesh-list
690372|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
690373|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690374|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
690375|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
690376|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
690377|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690378|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
690379|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
690380|NCT03064854|Antiviral Agents|antiviral agents|mesh-ancestor
690381|NCT03064854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
690382|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690383|NCT03064854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
690384|NCT03064854|Immunologic Factors|immunologic factors|mesh-ancestor
690385|NCT03064854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690386|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
690387|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
690388|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
690576|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
690577|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
690578|NCT03063775|Coagulants|coagulants|mesh-ancestor
691001|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
691100|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
691101|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
691102|NCT03061604|Octreotide|octreotide|mesh-list
691103|NCT03061604|Hemostatics|hemostatics|mesh-list
691104|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
691105|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
691106|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
691107|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691108|NCT03061604|Coagulants|coagulants|mesh-ancestor
691205|NCT03061136|Clonazepam|clonazepam|mesh-list
691206|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
691207|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
2226519|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226520|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2226521|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2226522|NCT00054886|Growth Substances|growth substances|mesh-ancestor
690133|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
690134|NCT03066115|Ketorolac|ketorolac|mesh-list
690135|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
690136|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
690137|NCT03066115|Analgesics|analgesics|mesh-ancestor
690138|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
690139|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690140|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690141|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
690142|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
690143|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
690144|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690145|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690146|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
690147|NCT03066115|Protective Agents|protective agents|mesh-ancestor
690148|NCT03066115|Vitamins|vitamins|mesh-ancestor
690149|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
690857|NCT03063112|Ethanol|ethanol|mesh-list
690858|NCT03063112|Lidocaine|lidocaine|mesh-list
690859|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
690860|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
690861|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
690862|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690863|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
690864|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690865|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
690866|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
690867|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
690868|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
690869|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690870|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
690871|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
690952|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
690953|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690954|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
690955|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690956|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690957|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2226523|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226524|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
2226525|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
691831|NCT03058263|Neostigmine|neostigmine|mesh-list
691832|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
691833|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691834|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691835|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
691836|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691837|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691838|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
691839|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
691840|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691998|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
691999|NCT03057574|Hormones|hormones|mesh-ancestor
692000|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
692001|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692270|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
692271|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
692272|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
692273|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
692274|NCT03056014|Expectorants|expectorants|mesh-ancestor
692275|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
692276|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
692277|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
692278|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692279|NCT03056014|Protective Agents|protective agents|mesh-ancestor
692280|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692281|NCT03056014|Antidotes|antidotes|mesh-ancestor
692382|NCT03055793|Budesonide|budesonide|mesh-list
692383|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
692384|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
692385|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2226526|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226527|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226528|NCT00054938|Aspirin|aspirin|mesh-list
2226529|NCT00054938|Ramipril|ramipril|mesh-list
2226530|NCT00054938|Pravastatin|pravastatin|mesh-list
2226531|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226532|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2226533|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2226534|NCT00054938|Analgesics|analgesics|mesh-ancestor
2226535|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
2226536|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689225|NCT03069976|Metronidazole|metronidazole|mesh-list
689226|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
689227|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
689228|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
689229|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2226537|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2226538|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2226539|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2226540|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2226541|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226542|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2226543|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2226544|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226545|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
2226546|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2226547|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
2226548|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2226549|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2226550|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
690480|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
690481|NCT03063983|Methotrexate|methotrexate|mesh-list
690482|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
690483|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
690484|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690485|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
690486|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
690487|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
690488|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690489|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690490|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
690491|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
690492|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
690493|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
690494|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
690495|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
690496|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
690497|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690498|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
690499|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
690737|NCT03063359|Fentanyl|fentanyl|mesh-list
690738|NCT03063359|Morphine|morphine|mesh-list
690739|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
690740|NCT03063359|Narcotics|narcotics|mesh-ancestor
690741|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
690742|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690743|NCT03063359|Analgesics|analgesics|mesh-ancestor
690744|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
690745|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690746|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
690747|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
690748|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
690749|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
690914|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
690915|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
690916|NCT03062436|Protective Agents|protective agents|mesh-ancestor
690917|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690992|NCT03062319|Anticoagulants|anticoagulants|mesh-list
690993|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
691488|NCT03059862|Tryptophan|tryptophan|mesh-list
691489|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
691490|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
691491|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
691603|NCT03059147|Nivolumab|nivolumab|mesh-list
691604|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2226551|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
689126|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
689127|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
689128|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
689129|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2226552|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2226553|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2226554|NCT00054977|Fluorouracil|fluorouracil|mesh-list
2226555|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
2226556|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226557|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226558|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226559|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226560|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
2226561|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689833|NCT03067168|Bupivacaine|bupivacaine|mesh-list
689834|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
689835|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
689836|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
689837|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689838|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
689839|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226562|NCT00055042|Vitamin E|vitamin e|mesh-list
2226563|NCT00055042|Vitamins|vitamins|mesh-ancestor
2226564|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
2226565|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226566|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
2226567|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226568|NCT00055042|Protective Agents|protective agents|mesh-ancestor
2226569|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
2226570|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2226571|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226572|NCT00055120|Ritonavir|ritonavir|mesh-list
691514|NCT03060005|Dextrans|dextrans|mesh-list
691515|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
691516|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
691517|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
2087436|NCT02169336|Analgesics|analgesics|mesh-ancestor
2087437|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
2087438|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087439|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2087440|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2087441|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2087442|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
2087443|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087444|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087445|NCT02169414|Levodopa|levodopa|mesh-list
2087446|NCT02169414|Carbidopa|carbidopa|mesh-list
2087447|NCT02169414|Opicapone|opicapone|mesh-list
692057|NCT03057015|Dexamethasone|dexamethasone|mesh-list
692058|NCT03057015|Clonidine|clonidine|mesh-list
692059|NCT03057015|Epinephrine|epinephrine|mesh-list
692060|NCT03057015|Ropivacaine|ropivacaine|mesh-list
692061|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
692062|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
692063|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
692064|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692065|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692066|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
692067|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
692068|NCT03057015|Hormones|hormones|mesh-ancestor
692069|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
692070|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
692071|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692072|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
692073|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
692074|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
692075|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
692076|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
692077|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
692078|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
2226573|NCT00055120|Lopinavir|lopinavir|mesh-list
2226574|NCT00055120|Tenofovir|tenofovir|mesh-list
689202|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
689203|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
689204|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
689205|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
689206|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
689383|NCT03069339|Carvedilol|carvedilol|mesh-list
689384|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
689385|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
689386|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
689387|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689388|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689389|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689390|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
689391|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
689392|NCT03069339|Protective Agents|protective agents|mesh-ancestor
689393|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
689394|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
689395|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
689396|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
689397|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
689398|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
689420|NCT03069001|Ribavirin|ribavirin|mesh-list
689421|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
689422|NCT03069001|Simeprevir|simeprevir|mesh-list
689423|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
689424|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689425|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
689426|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
689427|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
689428|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689603|NCT03068351|Daratumumab|daratumumab|mesh-list
689604|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689649|NCT03067974|Ketamine|ketamine|mesh-list
689650|NCT03067974|Analgesics|analgesics|mesh-ancestor
689651|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
689652|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689653|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689654|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
689655|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
689656|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
689657|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
689658|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
689659|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
689660|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
689661|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689662|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226575|NCT00055120|Emtricitabine|emtricitabine|mesh-list
2226576|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2226577|NCT00055120|Stavudine|stavudine|mesh-list
2226578|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2226579|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2226580|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
2226581|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226582|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226583|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2226584|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2226585|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
2226586|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226587|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2226588|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
690426|NCT03064542|Carbimazole|carbimazole|mesh-list
690427|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
690428|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
690429|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
690430|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690750|NCT03063190|Vitamin D|vitamin d|mesh-list
690751|NCT03063190|Vitamins|vitamins|mesh-ancestor
690752|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
690753|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087448|NCT02169414|Benserazide|benserazide|mesh-list
2087449|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2087450|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2087451|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
2087452|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087453|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087454|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087455|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
689371|NCT03069326|Thalidomide|thalidomide|mesh-list
689372|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
689373|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
689374|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689375|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
689376|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
689377|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
689378|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
689379|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
689380|NCT03069326|Growth Substances|growth substances|mesh-ancestor
689381|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
689382|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689478|NCT03068975|Alvimopan|alvimopan|mesh-list
689479|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
689927|NCT03066791|Curcumin|curcumin|mesh-list
689928|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
689929|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
689930|NCT03066791|Analgesics|analgesics|mesh-ancestor
689931|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
689932|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689933|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689934|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
689935|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
689936|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689937|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689938|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690579|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
690580|NCT03063580|Rifampin|rifampin|mesh-list
690581|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
690582|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
690583|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
690584|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
690585|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
690586|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
690587|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690588|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690589|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
690590|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
690591|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
690592|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
690593|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
690594|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
690595|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
690596|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
690597|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691455|NCT03060044|Fluticasone|fluticasone|mesh-list
691456|NCT03060044|Xhance|xhance|mesh-list
691457|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
691458|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
691459|NCT03060044|Charcoal|charcoal|mesh-list
691460|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
691461|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
691462|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
691463|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691464|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691465|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
691466|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
691467|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
691468|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
691469|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
691470|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
691471|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
691472|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
691473|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689234|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
689235|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689560|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
689561|NCT03068533|Calcium|calcium|mesh-list
689562|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
689563|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689564|NCT03068533|Antacids|antacids|mesh-ancestor
689565|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689566|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
690229|NCT03065569|Bupivacaine|bupivacaine|mesh-list
690230|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
690231|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
690232|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
690233|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690234|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
690235|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690445|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
690446|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
690447|NCT03064191|Calcium|calcium|mesh-list
690448|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
690449|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690450|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
690451|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
690452|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
690453|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
690549|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
690550|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
690551|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
690552|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690553|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
690554|NCT03063892|Coagulants|coagulants|mesh-ancestor
690679|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
690680|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
690681|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690682|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690683|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
690684|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
690685|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690766|NCT03063242|Sargramostim|sargramostim|mesh-list
690767|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
690768|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690813|NCT03062813|Entecavir|entecavir|mesh-list
690814|NCT03062813|Tacrolimus|tacrolimus|mesh-list
690815|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
690816|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
690817|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690818|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
690819|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690820|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690821|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
690822|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226589|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2226590|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2226591|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
691191|NCT03061058|Docetaxel|docetaxel|mesh-list
691192|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
691193|NCT03061058|Irinotecan|irinotecan|mesh-list
691194|NCT03061058|Pemetrexed|pemetrexed|mesh-list
691195|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691196|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
691197|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
691198|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
691199|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691200|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
691201|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
691202|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691203|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
691204|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
691302|NCT03060304|Tamoxifen|tamoxifen|mesh-list
691303|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
691304|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
691305|NCT03060304|Estradiol|estradiol|mesh-list
691306|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
691307|NCT03060304|Estrogens|estrogens|mesh-ancestor
691308|NCT03060304|Hormones|hormones|mesh-ancestor
691309|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
689284|NCT03069950|Fluorouracil|fluorouracil|mesh-list
689285|NCT03069950|Irinotecan|irinotecan|mesh-list
689286|NCT03069950|Panitumumab|panitumumab|mesh-list
689287|NCT03069950|Floxuridine|floxuridine|mesh-list
689288|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
689289|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
689290|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
689291|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689292|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689293|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
689294|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
689295|NCT03069950|Hormones|hormones|mesh-ancestor
689296|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
689297|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
689298|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689299|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
689300|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689301|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
689302|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
689303|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
689304|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
689305|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
689306|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689307|NCT03069950|Antidotes|antidotes|mesh-ancestor
689308|NCT03069950|Protective Agents|protective agents|mesh-ancestor
689309|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
689310|NCT03069950|Vitamins|vitamins|mesh-ancestor
689311|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
689312|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2752751|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
2752752|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
2752753|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2752754|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
689810|NCT03067688|Amlodipine|amlodipine|mesh-list
689811|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
689812|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
689813|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
689814|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
689815|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
689816|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689817|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
689818|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689819|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
689820|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
689821|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
689822|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
689823|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
689824|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
689825|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689826|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
689827|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
689828|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
689829|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226592|NCT00055133|Paclitaxel|paclitaxel|mesh-list
2226593|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2226594|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226595|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226596|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226597|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
690945|NCT03062631|Amifampridine|amifampridine|mesh-list
690946|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
690947|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690948|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752755|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
2226598|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226599|NCT00055159|Plasminogen|plasminogen|mesh-list
2226600|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
689760|NCT03067597|Dinoprostone|dinoprostone|mesh-list
689761|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
689762|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
689763|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226601|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2226602|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2226603|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226604|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
2226605|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
2226606|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226607|NCT00055198|Daptomycin|daptomycin|mesh-list
2226608|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2226609|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226610|NCT00055250|Gemcitabine|gemcitabine|mesh-list
2226611|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226612|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
2226613|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226614|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226615|NCT00055250|Antiviral Agents|antiviral agents|mesh-ancestor
2226616|NCT00055250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226617|NCT00055250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226618|NCT00055250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226619|NCT00055250|Immunologic Factors|immunologic factors|mesh-ancestor
2226620|NCT00055250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690667|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
690668|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2226621|NCT00055302|Anastrozole|anastrozole|mesh-list
2226622|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2226623|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226624|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2226625|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2226626|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226627|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226628|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2226629|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
2226630|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2226631|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226632|NCT00055341|Ribavirin|ribavirin|mesh-list
2226633|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2226634|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
2226635|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226636|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
2226637|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
691635|NCT03059303|Simeprevir|simeprevir|mesh-list
691636|NCT03059303|Odalasvir|odalasvir|mesh-list
691637|NCT03059303|Omeprazole|omeprazole|mesh-list
691638|NCT03059303|Lansoprazole|lansoprazole|mesh-list
691639|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
691640|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
691641|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
691642|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
691643|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691644|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691645|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
691646|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
691647|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
2226638|NCT00055367|Natalizumab|natalizumab|mesh-list
2226639|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
2226640|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226641|NCT00055393|Bupropion|bupropion|mesh-list
2226642|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2226643|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
2226644|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2226645|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2226646|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2226647|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2226648|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226649|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
2226650|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2226651|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226652|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
689481|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
689636|NCT03068234|Pirfenidone|pirfenidone|mesh-list
689637|NCT03068234|Analgesics|analgesics|mesh-ancestor
689638|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
689639|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689640|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689641|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
689642|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
689643|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
689644|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
689645|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689724|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
689725|NCT03067740|Bupivacaine|bupivacaine|mesh-list
689726|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
689727|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
689728|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
689729|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689730|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
689731|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
689732|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
689733|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
689734|NCT03067740|Analgesics|analgesics|mesh-ancestor
689735|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
689736|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
689737|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
689738|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
689739|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689740|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690064|NCT03066453|Tobramycin|tobramycin|mesh-list
690065|NCT03066453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
690066|NCT03066453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
690200|NCT03066011|Voriconazole|voriconazole|mesh-list
690201|NCT03066011|Posaconazole|posaconazole|mesh-list
690202|NCT03066011|Isavuconazole|isavuconazole|mesh-list
690203|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
690204|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
690205|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
690206|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
690207|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690208|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690209|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
690210|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
690211|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
690212|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690213|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
690214|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
690215|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
690216|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2087456|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087457|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2087458|NCT02169427|Opicapone|opicapone|mesh-list
690726|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
690727|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
691263|NCT03060850|Abivertinib|abivertinib|mesh-list
691264|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
691265|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691266|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691395|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
691396|NCT03060070|Ketamine|ketamine|mesh-list
691397|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
691398|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
691399|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691400|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
691401|NCT03060070|Analgesics|analgesics|mesh-ancestor
691402|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
691403|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691404|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
691405|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
691406|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
691407|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
691408|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691409|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691410|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
691411|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
689687|NCT03067883|Ritonavir|ritonavir|mesh-list
689688|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
689689|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
689690|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
689691|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689692|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689693|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
689694|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
689695|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
689696|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
689697|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
689698|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
689954|NCT03066557|Apatinib|apatinib|mesh-list
689955|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
689956|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
689957|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
689958|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
689959|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689960|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
689961|NCT03066557|Estrogens|estrogens|mesh-ancestor
689962|NCT03066557|Hormones|hormones|mesh-ancestor
689963|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
689964|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689965|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
690272|NCT03065387|Everolimus|everolimus|mesh-list
690273|NCT03065387|Palbociclib|palbociclib|mesh-list
690274|NCT03065387|Trametinib|trametinib|mesh-list
690275|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690276|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
690277|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
690278|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690279|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
690280|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690281|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690567|NCT03063762|Bevacizumab|bevacizumab|mesh-list
690568|NCT03063762|Atezolizumab|atezolizumab|mesh-list
690569|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
690570|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690571|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
690572|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
690573|NCT03063762|Growth Substances|growth substances|mesh-ancestor
690574|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690575|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
690795|NCT03062839|Melatonin|melatonin|mesh-list
690796|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
690797|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690798|NCT03062839|Protective Agents|protective agents|mesh-ancestor
690799|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690800|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
691082|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
691083|NCT03061656|Melphalan|melphalan|mesh-list
691084|NCT03061656|Thiotepa|thiotepa|mesh-list
691085|NCT03061656|Carboplatin|carboplatin|mesh-list
691086|NCT03061656|Etoposide|etoposide|mesh-list
691087|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
691088|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
691089|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691090|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
691091|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
691092|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
691093|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691094|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691095|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
691096|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
691097|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
691098|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
691099|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691872|NCT03058094|Pemetrexed|pemetrexed|mesh-list
691873|NCT03058094|Abivertinib|abivertinib|mesh-list
691874|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691875|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691876|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691877|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
691878|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
691879|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
689752|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
689753|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2226653|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2226654|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226655|NCT00055419|Cetuximab|cetuximab|mesh-list
2226656|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2226657|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226658|NCT00055432|Gemcitabine|gemcitabine|mesh-list
2226659|NCT00055432|Pemetrexed|pemetrexed|mesh-list
2226660|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226661|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
2226662|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226663|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226664|NCT00055432|Antiviral Agents|antiviral agents|mesh-ancestor
2226665|NCT00055432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226666|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226667|NCT00055432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226668|NCT00055432|Immunologic Factors|immunologic factors|mesh-ancestor
2226669|NCT00055432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226670|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
690686|NCT03063866|Fentanyl|fentanyl|mesh-list
690687|NCT03063866|Midazolam|midazolam|mesh-list
690688|NCT03063866|Propofol|propofol|mesh-list
690689|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
690690|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
690691|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690692|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
690693|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
690694|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
690695|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
690696|NCT03063866|Narcotics|narcotics|mesh-ancestor
690697|NCT03063866|Analgesics|analgesics|mesh-ancestor
690698|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
690699|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690700|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
690701|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
690702|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
690703|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
690704|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
690705|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
690706|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
690707|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691142|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
691143|NCT03061565|Hematinics|hematinics|mesh-ancestor
2226671|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2226672|NCT00055484|Zonisamide|zonisamide|mesh-list
2226673|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
2226674|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2226675|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2226676|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226677|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2226678|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691560|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
691561|NCT03059537|Cathartics|cathartics|mesh-ancestor
691562|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
691864|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
691865|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
691866|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
691867|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
691868|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
691869|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
691870|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691871|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226679|NCT00055523|Adalimumab|adalimumab|mesh-list
2226680|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2226681|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
692787|NCT03053830|Ketamine|ketamine|mesh-list
692788|NCT03053830|Analgesics|analgesics|mesh-ancestor
692789|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
692790|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692791|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692792|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
692793|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
692794|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
692795|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
692796|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
692838|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
689869|NCT03067103|Narcotics|narcotics|mesh-ancestor
2226682|NCT00055536|Natalizumab|natalizumab|mesh-list
2226683|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
2226684|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226685|NCT00055549|Lorazepam|lorazepam|mesh-list
2226686|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
2226687|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
690454|NCT03064243|Apatinib|apatinib|mesh-list
690455|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690456|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
690457|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690458|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226688|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
2226689|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2226690|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2226691|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2226692|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226693|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226694|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
2226695|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
2226696|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
2226697|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226698|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
691010|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
691011|NCT03062163|Resveratrol|resveratrol|mesh-list
691012|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
691013|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691014|NCT03062163|Protective Agents|protective agents|mesh-ancestor
691015|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691016|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691017|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
691018|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
691019|NCT03062163|Vitamins|vitamins|mesh-ancestor
691020|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
691382|NCT03060083|Nicotine|nicotine|mesh-list
691383|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
691384|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
691385|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691386|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691387|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
691388|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
691389|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
691390|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691391|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752756|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752757|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692367|NCT03055663|Midazolam|midazolam|mesh-list
692368|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
692369|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
692370|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
692371|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692372|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
692373|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
692374|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
692375|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
692376|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
692377|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
692378|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
692379|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
692380|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692381|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226699|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2226700|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2226701|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2226702|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2226703|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2226704|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
2226705|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
2226706|NCT00055562|Lenalidomide|lenalidomide|mesh-list
2226707|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
689883|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
690126|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
690127|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
690128|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
690129|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690130|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
690131|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
690132|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690217|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
690218|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
690219|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690500|NCT03064035|Thrombin|thrombin|mesh-list
690501|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
690502|NCT03064035|Coagulants|coagulants|mesh-ancestor
690708|NCT03063619|Tamoxifen|tamoxifen|mesh-list
690709|NCT03063619|Afimoxifene|afimoxifene|mesh-list
690710|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
690711|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
690712|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
690713|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690714|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
690715|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690716|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
690717|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
690718|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
691948|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
691949|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
692024|NCT03057106|Durvalumab|durvalumab|mesh-list
692025|NCT03057106|Tremelimumab|tremelimumab|mesh-list
692026|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
692027|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693191|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
693192|NCT03051698|Metronidazole|metronidazole|mesh-list
693193|NCT03051698|Vancomycin|vancomycin|mesh-list
693194|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
693195|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
693196|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
693197|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
693198|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
693199|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
693200|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693201|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693202|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693203|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
693204|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2226708|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226709|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2226710|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2226711|NCT00055562|Growth Substances|growth substances|mesh-ancestor
2226712|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
2226713|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226714|NCT00055575|Scopolamine|scopolamine|mesh-list
2226715|NCT00055575|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2226716|NCT00055575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2226717|NCT00055575|Antiemetics|antiemetics|mesh-ancestor
2226718|NCT00055575|Autonomic Agents|autonomic agents|mesh-ancestor
2226719|NCT00055575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226720|NCT00055575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226721|NCT00055575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2226722|NCT00055575|Mydriatics|mydriatics|mesh-ancestor
2226723|NCT00055575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2226724|NCT00055575|Cholinergic Agents|cholinergic agents|mesh-ancestor
2226725|NCT00055575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087459|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
689911|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
689912|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
689913|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
689914|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
689915|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690220|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
690221|NCT03065816|Antacids|antacids|mesh-ancestor
690222|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690223|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
690719|NCT03063632|Interferons|interferons|mesh-list
690720|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
690721|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
690722|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
690723|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690724|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
690725|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
690994|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
690995|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
691416|NCT03059888|Abatacept|abatacept|mesh-list
691417|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
691418|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691419|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691420|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
691421|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
691422|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691423|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
691571|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
691572|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
691573|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691574|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
691575|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
691576|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
691577|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
692316|NCT03056118|Aspirin|aspirin|mesh-list
692317|NCT03056118|Clopidogrel|clopidogrel|mesh-list
692318|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
692319|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
692320|NCT03056118|Analgesics|analgesics|mesh-ancestor
692321|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
692322|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692323|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692324|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
692325|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
692326|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
692327|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
692328|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692329|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
692330|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
692331|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692332|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
692333|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
692334|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
692335|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
692336|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
692337|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2226726|NCT00055575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226727|NCT00055575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2226728|NCT00055575|Parasympatholytics|parasympatholytics|mesh-ancestor
2226729|NCT00055614|Topotecan|topotecan|mesh-list
693612|NCT03049293|Midazolam|midazolam|mesh-list
693613|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
693614|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
693615|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693616|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693617|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
693618|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
693619|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
693620|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
693621|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
693622|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
693623|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
693624|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
693625|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693626|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087460|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690637|NCT03063788|Copper|copper|mesh-list
690638|NCT03063788|Trace Elements|trace elements|mesh-ancestor
690639|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
690640|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691164|NCT03060980|Empagliflozin|empagliflozin|mesh-list
691165|NCT03060980|Glimepiride|glimepiride|mesh-list
691166|NCT03060980|Exenatide|exenatide|mesh-list
691167|NCT03060980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
691168|NCT03060980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691169|NCT03060980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
691170|NCT03060980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691171|NCT03060980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
691172|NCT03060980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
691173|NCT03060980|Immunologic Factors|immunologic factors|mesh-ancestor
691174|NCT03060980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
691175|NCT03060980|Incretins|incretins|mesh-ancestor
691176|NCT03060980|Hormones|hormones|mesh-ancestor
691177|NCT03060980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
692110|NCT03056924|Vaccines|vaccines|mesh-list
692111|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
692112|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692163|NCT03056391|Acetaminophen|acetaminophen|mesh-list
692164|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
692165|NCT03056391|Analgesics|analgesics|mesh-ancestor
692166|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
692167|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692168|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692169|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
692551|NCT03054766|Ranibizumab|ranibizumab|mesh-list
692552|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
692553|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
692554|NCT03054766|Growth Substances|growth substances|mesh-ancestor
692555|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692556|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
692557|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226730|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2226731|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2226732|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226733|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693567|NCT03049930|Ketamine|ketamine|mesh-list
693568|NCT03049930|Analgesics|analgesics|mesh-ancestor
693569|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
693570|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693571|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693572|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
693573|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
693574|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
693575|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
693576|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693577|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
693578|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
693579|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693580|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226734|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226735|NCT00055640|Prednisone|prednisone|mesh-list
2226736|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
2226737|NCT00055640|Rituximab|rituximab|mesh-list
2226738|NCT00055640|Doxorubicin|doxorubicin|mesh-list
2226739|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2226740|NCT00055640|Vincristine|vincristine|mesh-list
693952|NCT03047538|Amlodipine|amlodipine|mesh-list
693953|NCT03047538|Perindopril|perindopril|mesh-list
693954|NCT03047538|Atorvastatin|atorvastatin|mesh-list
693955|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
693956|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
693957|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
693958|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693959|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
693960|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
693961|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693962|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
693963|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
693964|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
693965|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2226741|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
690021|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
690022|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690023|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690024|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
690025|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
690026|NCT03066544|Hormones|hormones|mesh-ancestor
690027|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
690028|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
690029|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690030|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
690031|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
690032|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
690033|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
690034|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
690035|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
690036|NCT03066544|Analgesics|analgesics|mesh-ancestor
690037|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
690038|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
690039|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690040|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690041|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
690042|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
690043|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
690044|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
690045|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
690503|NCT03064295|Adenosine|adenosine|mesh-list
690504|NCT03064295|Regadenoson|regadenoson|mesh-list
690505|NCT03064295|Analgesics|analgesics|mesh-ancestor
690506|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
690507|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690508|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690509|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
690510|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
690511|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
690512|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
690513|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
690514|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
690515|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690516|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
690823|NCT03062787|Triamcinolone|triamcinolone|mesh-list
690824|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
690825|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
690826|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
690827|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
690828|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
690829|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
690830|NCT03062787|Hormones|hormones|mesh-ancestor
690831|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
690832|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690833|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
690834|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
690835|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690836|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690837|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
690838|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
690839|NCT03062787|Protective Agents|protective agents|mesh-ancestor
690918|NCT03062540|Cyclobenzaprine|cyclobenzaprine|mesh-list
690919|NCT03062540|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
690920|NCT03062540|Antidepressive Agents|antidepressive agents|mesh-ancestor
690921|NCT03062540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
690922|NCT03062540|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
690923|NCT03062540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690924|NCT03062540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
690925|NCT03062540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690926|NCT03062540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
690927|NCT03062540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
691109|NCT03061643|Docetaxel|docetaxel|mesh-list
691110|NCT03061643|Androgens|androgens|mesh-list
691111|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691112|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
691113|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
691114|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
691115|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691116|NCT03061643|Hormones|hormones|mesh-ancestor
690105|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
690182|NCT03065998|Baclofen|baclofen|mesh-list
690183|NCT03065998|Opipramol|opipramol|mesh-list
690184|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
690185|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690186|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
690187|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690188|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
690189|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
690190|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
690191|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
690192|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690193|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
690194|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
690195|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
690196|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
690197|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
690198|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
690199|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
690439|NCT03064282|Papaverine|papaverine|mesh-list
690440|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
690441|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690442|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690443|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
690444|NCT03064282|Urological Agents|urological agents|mesh-ancestor
690775|NCT03062943|Nintedanib|nintedanib|mesh-list
690776|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690777|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
690778|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690779|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691648|NCT03058757|Mitomycins|mitomycins|mesh-list
691649|NCT03058757|Mitomycin|mitomycin|mesh-list
691650|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
691651|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691652|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
691653|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691654|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
691655|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691716|NCT03058666|Calfactant|calfactant|mesh-list
691717|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
691719|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
691857|NCT03058224|Acetaminophen|acetaminophen|mesh-list
691858|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
691859|NCT03058224|Analgesics|analgesics|mesh-ancestor
691860|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
691861|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691862|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691863|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
691969|NCT03057600|Paclitaxel|paclitaxel|mesh-list
691970|NCT03057600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
691971|NCT03057600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691972|NCT03057600|Tubulin Modulators|tubulin modulators|mesh-ancestor
691973|NCT03057600|Antimitotic Agents|antimitotic agents|mesh-ancestor
691974|NCT03057600|Mitosis Modulators|mitosis modulators|mesh-ancestor
691975|NCT03057600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692460|NCT03055442|Inositol|inositol|mesh-list
692461|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
692462|NCT03055442|Vitamins|vitamins|mesh-ancestor
692463|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
692464|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692662|NCT03054285|Levetiracetam|levetiracetam|mesh-list
692663|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
692664|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
2226742|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
2226743|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226744|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2226745|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2226746|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
2226747|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226748|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226749|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2226750|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2226751|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2226752|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2226753|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
690178|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
690236|NCT03065556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
690646|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
690647|NCT03063671|Ketamine|ketamine|mesh-list
690648|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
690649|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
690650|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690651|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
690652|NCT03063671|Analgesics|analgesics|mesh-ancestor
690653|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
690654|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690655|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
690656|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
690657|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
690658|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
690659|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
690660|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690661|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
690662|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
690663|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
690664|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
690665|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
690666|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
690840|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
690841|NCT03063073|Bupivacaine|bupivacaine|mesh-list
690842|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
690843|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
690844|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
690845|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690846|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
690847|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690848|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
690849|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
690850|NCT03063073|Analgesics|analgesics|mesh-ancestor
690851|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
690852|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
690853|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
690854|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
690855|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
690856|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691054|NCT03062150|Cycloserine|cycloserine|mesh-list
691055|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
691056|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
691057|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
691058|NCT03062150|Renal Agents|renal agents|mesh-ancestor
691059|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
691060|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
691061|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
691062|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
691063|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691064|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2226754|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226755|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2226756|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
2226757|NCT00055640|Hormones|hormones|mesh-ancestor
2226758|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2226759|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2226760|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2226761|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
691816|NCT03058536|Progesterone|progesterone|mesh-list
691817|NCT03058536|Progestins|progestins|mesh-ancestor
691818|NCT03058536|Hormones|hormones|mesh-ancestor
691819|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
691820|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692002|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
692003|NCT03057314|Calcium|calcium|mesh-list
692004|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
692005|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692006|NCT03057314|Antacids|antacids|mesh-ancestor
692007|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692008|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2226762|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226763|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226764|NCT00055653|Cyclosporine|cyclosporine|mesh-list
690304|NCT03065309|Narcotics|narcotics|mesh-ancestor
690305|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
690306|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690307|NCT03065309|Analgesics|analgesics|mesh-ancestor
690308|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
690309|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087461|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087462|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2087463|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2087464|NCT02169440|Opicapone|opicapone|mesh-list
2087465|NCT02169440|Warfarin|warfarin|mesh-list
2087466|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
2087467|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2087468|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690968|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
690969|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
690970|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
691492|NCT03060031|Oxytocin|oxytocin|mesh-list
691493|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
691494|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
691495|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087469|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087470|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2087471|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2087472|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2087473|NCT02169453|Opicapone|opicapone|mesh-list
2087474|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2087475|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
2087476|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692454|NCT03055312|Bicalutamide|bicalutamide|mesh-list
692455|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
692456|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
692457|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
692458|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692459|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692898|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
692899|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692900|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
692901|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692902|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693125|NCT03051932|Acetaminophen|acetaminophen|mesh-list
693126|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
693127|NCT03051932|Analgesics|analgesics|mesh-ancestor
693128|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
693129|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693130|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693131|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
693182|NCT03051529|Anesthetics|anesthetics|mesh-list
693183|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693184|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693440|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
693441|NCT03050411|Apatinib|apatinib|mesh-list
693442|NCT03050411|Gefitinib|gefitinib|mesh-list
693443|NCT03050411|Osimertinib|osimertinib|mesh-list
693444|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693445|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
693446|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693447|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693518|NCT03050177|Gefitinib|gefitinib|mesh-list
693519|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693520|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
693521|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693522|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693648|NCT03049059|Hydroquinone|hydroquinone|mesh-list
693649|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
693650|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693651|NCT03049059|Protective Agents|protective agents|mesh-ancestor
693652|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693653|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
694083|NCT03047330|Leuprolide|leuprolide|mesh-list
694084|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
694085|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
694086|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
694087|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694088|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2087477|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2087478|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2087479|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
2087480|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
2087481|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087482|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087483|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2087484|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087485|NCT02169466|Opicapone|opicapone|mesh-list
2087486|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
2087487|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2087488|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087489|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690348|NCT03064906|Pancrelipase|pancrelipase|mesh-list
690349|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
690669|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
690670|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
690671|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
690672|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690673|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690674|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
690675|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
690676|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690677|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
690678|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
690996|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
690997|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
691435|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
691436|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
691437|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
691438|NCT03059979|Prednisolone|prednisolone|mesh-list
691439|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
691440|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
691441|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
691442|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
691443|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
691444|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
691445|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691446|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691447|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
691448|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
691449|NCT03059979|Hormones|hormones|mesh-ancestor
691450|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
691451|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
691452|NCT03059979|Protective Agents|protective agents|mesh-ancestor
691453|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
691454|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691656|NCT03058978|Etonogestrel|etonogestrel|mesh-list
691657|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
691658|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
691659|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
691660|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691661|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
691937|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
691938|NCT03058237|Baclofen|baclofen|mesh-list
691939|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
691940|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691941|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
691942|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691943|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
691944|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
691945|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
691946|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691947|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226765|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
2226766|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
2226767|NCT00055653|Melphalan|melphalan|mesh-list
2226768|NCT00055653|Busulfan|busulfan|mesh-list
2226769|NCT00055653|Fludarabine|fludarabine|mesh-list
2226770|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
2226771|NCT00055653|Cyclosporins|cyclosporins|mesh-list
2226772|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2226773|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226774|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
2226775|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690564|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
690565|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
690566|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087490|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2087491|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2087492|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
2087493|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087494|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691065|NCT03062059|Gemcitabine|gemcitabine|mesh-list
691066|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
691067|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
691068|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691069|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691070|NCT03062059|Antiviral Agents|antiviral agents|mesh-ancestor
691071|NCT03062059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
691072|NCT03062059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691073|NCT03062059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
691074|NCT03062059|Immunologic Factors|immunologic factors|mesh-ancestor
691075|NCT03062059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226776|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2226777|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2226778|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
2226779|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691212|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
691213|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
691214|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
691215|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691216|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
691217|NCT03060889|Coagulants|coagulants|mesh-ancestor
691248|NCT03060681|Bupivacaine|bupivacaine|mesh-list
691249|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
691250|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
691251|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
691252|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691253|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
691254|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691496|NCT03059667|Carboplatin|carboplatin|mesh-list
691497|NCT03059667|Etoposide|etoposide|mesh-list
691498|NCT03059667|Atezolizumab|atezolizumab|mesh-list
691499|NCT03059667|Topotecan|topotecan|mesh-list
691500|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691501|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
691502|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
691503|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
691504|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691505|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691506|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
692019|NCT03057145|Olaparib|olaparib|mesh-list
692020|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
692021|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692022|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692023|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692260|NCT03056079|Aflibercept|aflibercept|mesh-list
692261|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
692262|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
692263|NCT03056079|Growth Substances|growth substances|mesh-ancestor
692264|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692265|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
692266|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692665|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
692666|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
692667|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690404|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690405|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
690406|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
690407|NCT03064633|Hormones|hormones|mesh-ancestor
690408|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
690409|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
690410|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690411|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
690412|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690413|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690414|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
690415|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
690416|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
690417|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
690418|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
690419|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
690420|NCT03064633|Analgesics|analgesics|mesh-ancestor
690421|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
690422|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
690423|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
690424|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
690425|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
690555|NCT03063905|Buprenorphine|buprenorphine|mesh-list
690556|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
690557|NCT03063905|Narcotics|narcotics|mesh-ancestor
690558|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
690559|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690560|NCT03063905|Analgesics|analgesics|mesh-ancestor
690561|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
690562|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690563|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
690780|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
690781|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
690782|NCT03062904|Miotics|miotics|mesh-ancestor
690783|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
690784|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690785|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690786|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
690787|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
690788|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
690789|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
690790|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
690791|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
690792|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
690793|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690794|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
690897|NCT03062644|Celecoxib|celecoxib|mesh-list
690898|NCT03062644|Tramadol|tramadol|mesh-list
690899|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
690900|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
690901|NCT03062644|Analgesics|analgesics|mesh-ancestor
690902|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
690903|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690904|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690905|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
690906|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
690907|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
690908|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
690909|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690910|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690911|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
690912|NCT03062644|Narcotics|narcotics|mesh-ancestor
690913|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
691024|NCT03061981|Metformin|metformin|mesh-list
691025|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
691026|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691186|NCT03061227|Glucagon|glucagon|mesh-list
691187|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
691188|NCT03061227|Hormones|hormones|mesh-ancestor
691189|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
691190|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690466|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
690467|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
690468|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
690469|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
690470|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
690471|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690472|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
690473|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
690474|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
690475|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
690476|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
690477|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
690478|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
690479|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
690544|NCT03063710|Olaparib|olaparib|mesh-list
690545|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
690546|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
690547|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
690548|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691218|NCT03061032|Ribavirin|ribavirin|mesh-list
691219|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
691220|NCT03061032|Ledipasvir|ledipasvir|mesh-list
691221|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
691222|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691223|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
691224|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
691273|NCT03060577|Evolocumab|evolocumab|mesh-list
691274|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
691275|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
691276|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
691277|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691278|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
691545|NCT03059316|Labetalol|labetalol|mesh-list
691546|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
691547|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
691548|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
691549|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
691550|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
691551|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691552|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691553|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691554|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
691555|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
691556|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
691557|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691558|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
691559|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
691917|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
691918|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
691919|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
692009|NCT03057470|Insulin|insulin|mesh-list
692010|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
692011|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
692012|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692042|NCT03056833|Paclitaxel|paclitaxel|mesh-list
692043|NCT03056833|Carboplatin|carboplatin|mesh-list
692044|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
692045|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692046|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
692047|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
692048|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
692049|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692973|NCT03052933|Gemcitabine|gemcitabine|mesh-list
692974|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
692975|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
692976|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692977|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692978|NCT03052933|Antiviral Agents|antiviral agents|mesh-ancestor
692979|NCT03052933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
692980|NCT03052933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692981|NCT03052933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
692982|NCT03052933|Immunologic Factors|immunologic factors|mesh-ancestor
692983|NCT03052933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693014|NCT03052660|Midazolam|midazolam|mesh-list
693015|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
693016|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
690598|NCT03063749|Sirolimus|sirolimus|mesh-list
690599|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
690600|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
690601|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
690602|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
690603|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
690604|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
690605|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
690606|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690971|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
690972|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
690973|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691353|NCT03060278|Nicotine|nicotine|mesh-list
691354|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
691355|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
691356|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691357|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691358|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
691359|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
691360|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
691361|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691362|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691672|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
691673|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
691674|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691841|NCT03058471|Methotrexate|methotrexate|mesh-list
691842|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
691843|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
691844|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
691845|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691846|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
691847|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
691848|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691849|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691850|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
691851|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691852|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
691853|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
691854|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
691855|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
691856|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
692013|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
692014|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
692015|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
692016|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692452|NCT03055234|Treprostinil|treprostinil|mesh-list
692453|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
692504|NCT03055091|Sorbitol|sorbitol|mesh-list
692505|NCT03055091|Cathartics|cathartics|mesh-ancestor
692506|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
692963|NCT03053167|Irinotecan|irinotecan|mesh-list
692964|NCT03053167|Raltitrexed|raltitrexed|mesh-list
692965|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
692966|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
692967|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692968|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692969|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692970|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
692971|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
692972|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2226780|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226781|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
693581|NCT03049878|Acetaminophen|acetaminophen|mesh-list
693582|NCT03049878|Codeine|codeine|mesh-list
693583|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
693584|NCT03049878|Analgesics|analgesics|mesh-ancestor
693585|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
693586|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693587|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693588|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
693589|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
693590|NCT03049878|Narcotics|narcotics|mesh-ancestor
693591|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693592|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
693593|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
690754|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
690998|NCT03061955|Vaccines|vaccines|mesh-list
690999|NCT03061955|Immunologic Factors|immunologic factors|mesh-ancestor
691000|NCT03061955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226782|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226783|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
2226784|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226785|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
2226786|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226787|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
2226788|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2226789|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2226790|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
2226791|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
692040|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
692041|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
692113|NCT03056495|Vorinostat|vorinostat|mesh-list
692114|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692115|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
692116|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692117|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692477|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
692478|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
692479|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
692480|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
692481|NCT03055377|Expectorants|expectorants|mesh-ancestor
692482|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
692483|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
692484|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
692485|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692486|NCT03055377|Protective Agents|protective agents|mesh-ancestor
692487|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692488|NCT03055377|Antidotes|antidotes|mesh-ancestor
692699|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
692700|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
692701|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
692702|NCT03054259|Prednisolone|prednisolone|mesh-list
692703|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
692704|NCT03054259|Rituximab|rituximab|mesh-list
692705|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
692706|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
692707|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
692708|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692709|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
692710|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692711|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
692712|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
692713|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
692714|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
692715|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692716|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
692717|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
692718|NCT03054259|Hormones|hormones|mesh-ancestor
692719|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
692720|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
692721|NCT03054259|Protective Agents|protective agents|mesh-ancestor
692722|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2226792|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226793|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2226794|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
2226795|NCT00055653|Hormones|hormones|mesh-ancestor
693405|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
693406|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
693407|NCT03051009|Coagulants|coagulants|mesh-ancestor
693408|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
693409|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
693410|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226796|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2226797|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2226798|NCT00055653|Protective Agents|protective agents|mesh-ancestor
2226799|NCT00055666|Beclomethasone|beclomethasone|mesh-list
2226800|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2226801|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
2226802|NCT00055666|Hormones|hormones|mesh-ancestor
2226803|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2226804|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226805|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2226806|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
2226807|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
2226808|NCT00055679|Fluorouracil|fluorouracil|mesh-list
2226809|NCT00055679|Epirubicin|epirubicin|mesh-list
2226810|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226811|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
2226812|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226813|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2226814|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
691021|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
691022|NCT03061903|Laxatives|laxatives|mesh-ancestor
691023|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2087495|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2087496|NCT02169479|Opicapone|opicapone|mesh-list
2087497|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2087498|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
2087499|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087500|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2087501|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2087502|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
2087503|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
2087504|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087505|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691322|NCT03060434|Acetaminophen|acetaminophen|mesh-list
691323|NCT03060434|Ibuprofen|ibuprofen|mesh-list
691324|NCT03060434|Pregabalin|pregabalin|mesh-list
691325|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
691326|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
691327|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
691328|NCT03060434|Analgesics|analgesics|mesh-ancestor
691329|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
691330|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691331|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691332|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
691333|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
691334|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
691335|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691336|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691337|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
691338|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
691339|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
691340|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
691341|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
691342|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
691343|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
691344|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
691345|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
691346|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
691347|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
691348|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
691349|NCT03060434|Protective Agents|protective agents|mesh-ancestor
691350|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
691351|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
691352|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
691711|NCT03059004|TEMPO|tempo|mesh-list
691712|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
691713|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691714|NCT03059004|Protective Agents|protective agents|mesh-ancestor
691715|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691821|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
691822|NCT03058289|Ipilimumab|ipilimumab|mesh-list
691823|NCT03058289|Antibodies|antibodies|mesh-list
691824|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
691825|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
691826|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691827|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
691828|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691829|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
691830|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691884|NCT03057951|Empagliflozin|empagliflozin|mesh-list
691885|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
691886|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691887|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
691888|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
690949|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
690950|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
690951|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691154|NCT03061253|Nicotine|nicotine|mesh-list
691155|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
691156|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
691157|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691158|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691159|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
691160|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
691161|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
691162|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691163|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691507|NCT03059563|Varenicline|varenicline|mesh-list
691508|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
691509|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
691510|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
691511|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691512|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691513|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691585|NCT03059238|Celecoxib|celecoxib|mesh-list
691586|NCT03059238|Parecoxib|parecoxib|mesh-list
691587|NCT03059238|Oxycodone|oxycodone|mesh-list
691588|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
691589|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
691590|NCT03059238|Analgesics|analgesics|mesh-ancestor
691591|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
691592|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691593|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691594|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
691595|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
691596|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
691597|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
691598|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691599|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691600|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
691601|NCT03059238|Narcotics|narcotics|mesh-ancestor
691602|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
691662|NCT03058835|Tenofovir|tenofovir|mesh-list
691663|NCT03058835|Emtricitabine|emtricitabine|mesh-list
691664|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
691665|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
691666|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
691667|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
691668|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691669|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691670|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
691671|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
691774|NCT03058419|Midazolam|midazolam|mesh-list
691775|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
691776|NCT03058419|Caffeine|caffeine|mesh-list
691777|NCT03058419|Bupropion|bupropion|mesh-list
691778|NCT03058419|Omeprazole|omeprazole|mesh-list
691779|NCT03058419|Warfarin|warfarin|mesh-list
691780|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
691781|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
691782|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
691783|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691784|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
691785|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
691786|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
691787|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
691788|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
691789|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
691790|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
691791|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
691792|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691793|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691794|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
691795|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
691796|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
691797|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
691798|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691799|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
691800|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
691801|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
691117|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
691118|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691235|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
691236|NCT03060603|Hematinics|hematinics|mesh-ancestor
691481|NCT03059719|Exenatide|exenatide|mesh-list
691482|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
691483|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691484|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
691485|NCT03059719|Incretins|incretins|mesh-ancestor
691486|NCT03059719|Hormones|hormones|mesh-ancestor
691487|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
691757|NCT03058354|Propofol|propofol|mesh-list
691758|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
691759|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
691760|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691761|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
691762|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
691763|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
692465|NCT03055247|Ibuprofen|ibuprofen|mesh-list
692466|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
692467|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
692468|NCT03055247|Analgesics|analgesics|mesh-ancestor
692469|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
692470|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692471|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692472|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
692473|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
692474|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
692475|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692476|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226815|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
2226816|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692676|NCT03054363|Letrozole|letrozole|mesh-list
692677|NCT03054363|Palbociclib|palbociclib|mesh-list
692678|NCT03054363|Tucatinib|tucatinib|mesh-list
692679|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692680|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
692681|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
692682|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692683|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692684|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
692685|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
692686|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
692687|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692688|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
693205|NCT03051503|Fentanyl|fentanyl|mesh-list
693206|NCT03051503|Morphine|morphine|mesh-list
693207|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
693208|NCT03051503|Narcotics|narcotics|mesh-ancestor
693209|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693210|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693211|NCT03051503|Analgesics|analgesics|mesh-ancestor
693212|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
693213|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693214|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
693215|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
693216|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
693217|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
693288|NCT03051243|Insulin|insulin|mesh-list
693289|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
693290|NCT03051243|Linagliptin|linagliptin|mesh-list
693291|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
693292|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693293|NCT03051243|Incretins|incretins|mesh-ancestor
693294|NCT03051243|Hormones|hormones|mesh-ancestor
693295|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
693296|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
693297|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
693298|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693299|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693882|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
693883|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
693884|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694032|NCT03047057|Lidocaine|lidocaine|mesh-list
694033|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
691120|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691121|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
691122|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
691123|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691124|NCT03061630|Antiviral Agents|antiviral agents|mesh-ancestor
691125|NCT03061630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
691126|NCT03061630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691127|NCT03061630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
691128|NCT03061630|Immunologic Factors|immunologic factors|mesh-ancestor
691129|NCT03061630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691532|NCT03059940|Nicotine|nicotine|mesh-list
691533|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
691534|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
691535|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
691536|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691537|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691538|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
691539|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
691540|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
691541|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691542|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691543|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
691544|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
691608|NCT03059134|Mirabegron|mirabegron|mesh-list
691609|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
691610|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
691611|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
691612|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
691613|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691614|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691615|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691616|NCT03059134|Urological Agents|urological agents|mesh-ancestor
691718|NCT03058744|Clobetasol|clobetasol|mesh-list
691720|NCT03058744|Halobetasol|halobetasol|mesh-list
691721|NCT03058744|Tazarotene|tazarotene|mesh-list
691722|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
691723|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
691724|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
691725|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
691726|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
691727|NCT03058744|Hormones|hormones|mesh-ancestor
691728|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
691729|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226817|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226818|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2226819|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
692141|NCT03056482|Haloperidol|haloperidol|mesh-list
692142|NCT03056482|Ondansetron|ondansetron|mesh-list
692143|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
692144|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
692145|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
692146|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692147|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692148|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
692149|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
692150|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
692151|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
692152|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
692153|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692154|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692155|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
692156|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
692157|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
692158|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
692159|NCT03056482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
692160|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
692161|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
692162|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
692723|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
692724|NCT03054220|Tramadol|tramadol|mesh-list
692725|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
692726|NCT03054220|Paroxetine|paroxetine|mesh-list
692727|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
692728|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
692729|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
692730|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691208|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
691209|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691210|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691211|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691430|NCT03060018|Oxitropium|oxitropium|mesh-list
691431|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
691432|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
691433|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691434|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691518|NCT03059615|Doxorubicin|doxorubicin|mesh-list
691519|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
691520|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691521|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
691522|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
691523|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691524|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691675|NCT03059056|Empagliflozin|empagliflozin|mesh-list
691676|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
691677|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691678|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
691679|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226820|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226821|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2226822|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2226823|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2226824|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226825|NCT00055718|Silymarin|silymarin|mesh-list
2226826|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
2226827|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226828|NCT00055718|Protective Agents|protective agents|mesh-ancestor
2226829|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226830|NCT00055731|Aspirin|aspirin|mesh-list
2226831|NCT00055731|Docetaxel|docetaxel|mesh-list
692615|NCT03054610|Betamethasone|betamethasone|mesh-list
692616|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
692617|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
692618|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
692619|NCT03054610|Ropivacaine|ropivacaine|mesh-list
692620|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
692621|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
692622|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
692623|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
692624|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
692625|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
692626|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
692627|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
692628|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692629|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
692630|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692631|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
692632|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
692633|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692634|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
692635|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692636|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
692637|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
692638|NCT03054610|Hormones|hormones|mesh-ancestor
692639|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
692640|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
692641|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
692642|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
692643|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
692644|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
692825|NCT03054038|Afatinib|afatinib|mesh-list
692826|NCT03054038|Necitumumab|necitumumab|mesh-list
692827|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692828|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
692829|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692830|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692831|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2226832|NCT00055731|Goserelin|goserelin|mesh-list
691240|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
691241|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
691242|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
691243|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691244|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226833|NCT00055731|Bicalutamide|bicalutamide|mesh-list
2226834|NCT00055731|Estramustine|estramustine|mesh-list
2226835|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226836|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
2752768|NCT03316586|Nivolumab|nivolumab|mesh-list
2752769|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2752770|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752771|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
691730|NCT03058939|Tamoxifen|tamoxifen|mesh-list
691731|NCT03058939|Paclitaxel|paclitaxel|mesh-list
691732|NCT03058939|Carboplatin|carboplatin|mesh-list
691733|NCT03058939|Trastuzumab|trastuzumab|mesh-list
691734|NCT03058939|Letrozole|letrozole|mesh-list
691735|NCT03058939|Pertuzumab|pertuzumab|mesh-list
691736|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
691737|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691738|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
691739|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
691740|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
691741|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691742|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
691743|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
691744|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
691745|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691746|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
691747|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
691748|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
691749|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691750|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
691751|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
691752|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
691753|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
691880|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
691881|NCT03057847|Velpatasvir|velpatasvir|mesh-list
691882|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
691883|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087506|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2087507|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087508|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2087509|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2087510|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087511|NCT02169791|Ixazomib|ixazomib|mesh-list
2087512|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087513|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
2087514|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087515|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087516|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
2087517|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2087518|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
2087519|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2087520|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087521|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2087522|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
692288|NCT03056053|Zolpidem|zolpidem|mesh-list
692289|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
692290|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
692291|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
692292|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692293|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
692294|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
692295|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
692296|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692297|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226837|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
2087523|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2087524|NCT02169895|Opicapone|opicapone|mesh-list
691267|NCT03060798|Desflurane|desflurane|mesh-list
691268|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
691269|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
691270|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
691271|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
691272|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691424|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
691425|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
691426|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087525|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
2087526|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2087527|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087528|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087529|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2087530|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2087531|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
2087532|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087533|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087534|NCT02170025|Riociguat|riociguat|mesh-list
2087535|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
2087536|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087537|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2087538|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
2087539|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2087540|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2226838|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226839|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692050|NCT03056846|Sulfalene|sulfalene|mesh-list
692051|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
692052|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
692053|NCT03056846|Renal Agents|renal agents|mesh-ancestor
692054|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
692055|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
692056|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2226840|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2226841|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2226842|NCT00055731|Analgesics|analgesics|mesh-ancestor
2226843|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
2226844|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226845|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226846|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2226847|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2226848|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2226849|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2226850|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2226851|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2226852|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226853|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
2226854|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2226855|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
2226856|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
2226857|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2226858|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2226859|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
2226860|NCT00055757|Gemcitabine|gemcitabine|mesh-list
2226861|NCT00055757|Tipifarnib|tipifarnib|mesh-list
693929|NCT03047993|Azacitidine|azacitidine|mesh-list
693930|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
693931|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
693932|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693933|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693934|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694378|NCT03045341|Naltrexone|naltrexone|mesh-list
694379|NCT03045341|Bupropion|bupropion|mesh-list
694380|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
694381|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
694382|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694383|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
691680|NCT03059017|Albuterol|albuterol|mesh-list
691681|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
691682|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
691683|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691684|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691685|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
691686|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
691687|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
691688|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
691689|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
691690|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
691691|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
691692|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
691693|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691694|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691889|NCT03057769|Indomethacin|indomethacin|mesh-list
691890|NCT03057769|Epinephrine|epinephrine|mesh-list
691891|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
691892|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
691893|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
691894|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
691895|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691896|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691897|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
691898|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
691899|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
691900|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
691901|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
691902|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
691903|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
691904|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
691905|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
691906|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
691907|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
691908|NCT03057769|Analgesics|analgesics|mesh-ancestor
691909|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
691910|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
691911|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
691912|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
691913|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
691914|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
691915|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
691916|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692529|NCT03054948|SMOFlipid|smoflipid|mesh-list
692530|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
692531|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
692532|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
692883|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
692884|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
692885|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
692886|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692887|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692888|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
692889|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
692890|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
692891|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
692892|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692893|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692894|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
692895|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
692896|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
692897|NCT03053388|Protective Agents|protective agents|mesh-ancestor
693179|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
693180|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
691310|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691311|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
691312|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
691313|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
691314|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
691315|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
691316|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
691317|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
691318|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691319|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
691320|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
691321|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
691695|NCT03058900|Methotrexate|methotrexate|mesh-list
691696|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
691697|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
691698|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
691699|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
691700|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
691701|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
691702|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691703|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691704|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
691705|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
691706|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
691707|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
691708|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
691709|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
691710|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2226862|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226863|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226864|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
2226865|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226866|NCT00055757|Antiviral Agents|antiviral agents|mesh-ancestor
2226867|NCT00055757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226868|NCT00055757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226869|NCT00055757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226870|NCT00055757|Immunologic Factors|immunologic factors|mesh-ancestor
2226871|NCT00055757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226872|NCT00055770|Docetaxel|docetaxel|mesh-list
692752|NCT03054168|Goserelin|goserelin|mesh-list
692753|NCT03054168|Testosterone|testosterone|mesh-list
692754|NCT03054168|Hormones|hormones|mesh-ancestor
692755|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
692756|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692757|NCT03054168|Androgens|androgens|mesh-ancestor
692758|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
692759|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693265|NCT03051282|Enalapril|enalapril|mesh-list
693266|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
693267|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
693268|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693269|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693270|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
693341|NCT03050827|Oxybutynin|oxybutynin|mesh-list
693342|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
693343|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
693344|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693345|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693346|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
693347|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
693348|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
693349|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693350|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693351|NCT03050827|Urological Agents|urological agents|mesh-ancestor
693502|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
693503|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
693504|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
693505|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
693506|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
693507|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693508|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693509|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087541|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
691412|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
691413|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
691414|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
691415|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2087542|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087543|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2087544|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
2087545|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2087546|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2087547|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2087548|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691965|NCT03057509|Octreotide|octreotide|mesh-list
691966|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
691967|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
691968|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226873|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2226874|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087549|NCT02170207|Lansoprazole|lansoprazole|mesh-list
2087550|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
2087551|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2087552|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2087553|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2087554|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087555|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087556|NCT02170220|Vortioxetine|vortioxetine|mesh-list
2087557|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
2087558|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2087559|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2087560|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2087561|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2087562|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087563|NCT02170220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2087564|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2087565|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2087566|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692645|NCT03054532|Durvalumab|durvalumab|mesh-list
692646|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
692647|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692929|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
692930|NCT03053284|Pasireotide|pasireotide|mesh-list
692931|NCT03053284|Hormones|hormones|mesh-ancestor
692932|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
692933|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692959|NCT03052998|Ivermectin|ivermectin|mesh-list
692960|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
692961|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
692962|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226875|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226876|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226877|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226878|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226879|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2226880|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226881|NCT00055809|Interferons|interferons|mesh-list
2226882|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
2226883|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
2226884|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2226885|NCT00055809|Bevacizumab|bevacizumab|mesh-list
2087567|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087568|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
2087569|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2087570|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2087571|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2087572|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2087573|NCT02170376|Levodopa|levodopa|mesh-list
2087574|NCT02170376|Carbidopa|carbidopa|mesh-list
2087575|NCT02170376|Opicapone|opicapone|mesh-list
2087576|NCT02170376|Entacapone|entacapone|mesh-list
2087577|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2087578|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2226886|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2226887|NCT00055809|Antibodies|antibodies|mesh-list
693919|NCT03048136|Nivolumab|nivolumab|mesh-list
691474|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
691475|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
691476|NCT03060044|Hormones|hormones|mesh-ancestor
691477|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
691478|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
691479|NCT03060044|Antidotes|antidotes|mesh-ancestor
691480|NCT03060044|Protective Agents|protective agents|mesh-ancestor
692028|NCT03057041|Fentanyl|fentanyl|mesh-list
692029|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
692030|NCT03057041|Narcotics|narcotics|mesh-ancestor
692031|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
692032|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692033|NCT03057041|Analgesics|analgesics|mesh-ancestor
692034|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
692035|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692036|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
692037|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
692038|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
692039|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
692118|NCT03056625|Vitamin A|vitamin a|mesh-list
692119|NCT03056625|Vitamins|vitamins|mesh-ancestor
692120|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
692121|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692267|NCT03056261|Anesthetics|anesthetics|mesh-list
692268|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
692269|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693367|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
693368|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
693369|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
693370|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693371|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693751|NCT03048825|Colchicine|colchicine|mesh-list
693752|NCT03048825|Spironolactone|spironolactone|mesh-list
693753|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
693754|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
693755|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
693756|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693757|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
693758|NCT03048825|Diuretics|diuretics|mesh-ancestor
693759|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
693760|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
693761|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
693762|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
693763|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
693764|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
693765|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693766|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694397|NCT03045393|Maytansine|maytansine|mesh-list
694398|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
694399|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694400|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
694401|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
694402|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
694403|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694492|NCT03044808|Lidocaine|lidocaine|mesh-list
694493|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
694494|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
694495|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694496|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694497|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
694498|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694499|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
694500|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
694501|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
694502|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
694503|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226888|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
2226889|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2226890|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226891|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2226892|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2226893|NCT00055809|Growth Substances|growth substances|mesh-ancestor
2226894|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226895|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
691605|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
691606|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
691607|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226896|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
2226897|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
2226898|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226899|NCT00055822|Leucovorin|leucovorin|mesh-list
2226900|NCT00055822|Fluorouracil|fluorouracil|mesh-list
2226901|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
2226902|NCT00055822|Oblimersen|oblimersen|mesh-list
2226903|NCT00055822|Calcium|calcium|mesh-list
2226904|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
2226905|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2226906|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226907|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
692253|NCT03056092|Ranibizumab|ranibizumab|mesh-list
692254|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
692255|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
692256|NCT03056092|Growth Substances|growth substances|mesh-ancestor
692257|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692258|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
692259|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692519|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
692520|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
692521|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
692522|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
692523|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
692524|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692525|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692526|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
2226908|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226909|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226910|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226911|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226912|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
2226913|NCT00055822|Antidotes|antidotes|mesh-ancestor
2226914|NCT00055822|Protective Agents|protective agents|mesh-ancestor
2226915|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
2226916|NCT00055822|Vitamins|vitamins|mesh-ancestor
2087579|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
2087580|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087581|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693176|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
693177|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
693178|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693372|NCT03051022|Dexamethasone|dexamethasone|mesh-list
693373|NCT03051022|Morphine|morphine|mesh-list
693374|NCT03051022|Bupivacaine|bupivacaine|mesh-list
693375|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
693376|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
693377|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
693378|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693379|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693380|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
693381|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
693382|NCT03051022|Hormones|hormones|mesh-ancestor
693383|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
693384|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
693385|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693386|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
693387|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
693388|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693389|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
693390|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
693391|NCT03051022|Narcotics|narcotics|mesh-ancestor
693392|NCT03051022|Analgesics|analgesics|mesh-ancestor
2226917|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
2226918|NCT00055835|Gemcitabine|gemcitabine|mesh-list
2226919|NCT00055835|Paclitaxel|paclitaxel|mesh-list
2226920|NCT00055835|Carboplatin|carboplatin|mesh-list
2226921|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2226922|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226923|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226924|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226925|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
694090|NCT03047005|Naltrexone|naltrexone|mesh-list
2226926|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226927|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
691802|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
691803|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
691804|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
691805|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
691806|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
691807|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
691808|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
691809|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
691810|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
691811|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
691812|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
691813|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
691814|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
691815|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
692122|NCT03056703|Aspirin|aspirin|mesh-list
692123|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
692124|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
692125|NCT03056703|Analgesics|analgesics|mesh-ancestor
692126|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
692127|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692128|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692129|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
692130|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
692131|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
692132|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
692133|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692134|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
692135|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
692136|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692137|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
692282|NCT03056274|Metformin|metformin|mesh-list
692283|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
692284|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
692285|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692286|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
692287|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
692422|NCT03055507|Acetaminophen|acetaminophen|mesh-list
692423|NCT03055507|Ibuprofen|ibuprofen|mesh-list
692424|NCT03055507|Oxycodone|oxycodone|mesh-list
692425|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
692426|NCT03055507|Analgesics|analgesics|mesh-ancestor
692427|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
692428|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692429|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692430|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
692431|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
692432|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
692433|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
692434|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
692435|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692436|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692437|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
692438|NCT03055507|Narcotics|narcotics|mesh-ancestor
692439|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2226928|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
2226929|NCT00055835|Antiviral Agents|antiviral agents|mesh-ancestor
2226930|NCT00055835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226931|NCT00055835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226932|NCT00055835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226933|NCT00055835|Immunologic Factors|immunologic factors|mesh-ancestor
2226934|NCT00055835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226935|NCT00055861|Bevacizumab|bevacizumab|mesh-list
2226936|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2226937|NCT00055861|Docetaxel|docetaxel|mesh-list
2226938|NCT00055861|Antibodies|antibodies|mesh-list
2226939|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
2226940|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2226941|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692832|NCT03053856|Paclitaxel|paclitaxel|mesh-list
692833|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
692834|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
692835|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
692836|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
692837|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226942|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2226943|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2226944|NCT00055861|Growth Substances|growth substances|mesh-ancestor
692668|NCT03054467|Amlodipine|amlodipine|mesh-list
692669|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
692670|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
692671|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
692672|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692673|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
692674|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692675|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
692996|NCT03052673|Fentanyl|fentanyl|mesh-list
692997|NCT03052673|Ketamine|ketamine|mesh-list
692998|NCT03052673|Analgesics|analgesics|mesh-ancestor
692999|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
693000|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693001|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693002|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
693003|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
693004|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
693005|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
693006|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693007|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
693008|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
693009|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693010|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693011|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
693012|NCT03052673|Narcotics|narcotics|mesh-ancestor
693013|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
693170|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
693171|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
693172|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693889|NCT03048019|Tirofiban|tirofiban|mesh-list
693890|NCT03048019|Cangrelor|cangrelor|mesh-list
693891|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
693892|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
693893|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693894|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
693895|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
693896|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
693897|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
693898|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
693899|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693900|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694520|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
694521|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694522|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
694523|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
694524|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
694525|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694526|NCT03044561|Urological Agents|urological agents|mesh-ancestor
694793|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
694794|NCT03043521|Lansoprazole|lansoprazole|mesh-list
694795|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
694796|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
694797|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
694798|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694799|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694924|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
694925|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
694926|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
694927|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
694928|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694929|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
694930|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
694931|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692079|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692080|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692081|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
692082|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
692083|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
692084|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
692085|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
692086|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
692087|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
692088|NCT03057015|Analgesics|analgesics|mesh-ancestor
692089|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
692090|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
692091|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2226945|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226946|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
2226947|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
2226948|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226949|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226950|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226951|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226952|NCT00055874|Interferons|interferons|mesh-list
2226953|NCT00055874|Cytarabine|cytarabine|mesh-list
2226954|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
2226955|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
2226956|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
693825|NCT03048214|Anesthetics|anesthetics|mesh-list
693826|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693827|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694044|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
694045|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
694046|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
694047|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694048|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
694049|NCT03047096|Protective Agents|protective agents|mesh-ancestor
694210|NCT03045783|Cefotiam|cefotiam|mesh-list
694211|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
694212|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694296|NCT03045471|Prednisolone|prednisolone|mesh-list
694297|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
694298|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
694299|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
694300|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
694301|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
694302|NCT03045471|Rituximab|rituximab|mesh-list
694303|NCT03045471|Etoposide|etoposide|mesh-list
694304|NCT03045471|Vincristine|vincristine|mesh-list
694305|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
694306|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
694307|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
694308|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
694309|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694310|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
694311|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
694312|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
694313|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694314|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694315|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
694316|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
694317|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
694318|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
694319|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
694320|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694321|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
694322|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
694323|NCT03045471|Hormones|hormones|mesh-ancestor
694324|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
694325|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
694326|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
694327|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
694328|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694329|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
694330|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
694331|NCT03045471|Protective Agents|protective agents|mesh-ancestor
694332|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
694333|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226957|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226958|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
692220|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
692221|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
692222|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
692223|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
692224|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
692225|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
692226|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
692227|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
692410|NCT03055741|Donepezil|donepezil|mesh-list
692411|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
692412|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692413|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692414|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
692415|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692416|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692417|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
2087582|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087583|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2087584|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692648|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
692649|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
692650|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
692651|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
692652|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
692653|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692654|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
692655|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692656|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692657|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
692658|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693087|NCT03052400|Mifepristone|mifepristone|mesh-list
693088|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
693089|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
693090|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
693091|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693092|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
693093|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
693094|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
693095|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
693096|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
693097|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
693098|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
693099|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
693100|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
693101|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
693102|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
693627|NCT03049306|Propranolol|propranolol|mesh-list
693628|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
693629|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
693630|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
693631|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693632|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693633|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693634|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
693635|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
693636|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
693730|NCT03048877|Apatinib|apatinib|mesh-list
693731|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693732|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
693733|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693734|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694015|NCT03046979|Apatinib|apatinib|mesh-list
694016|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694017|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
694018|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694019|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695152|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
695153|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
695154|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
695516|NCT03040219|Folic Acid|folic acid|mesh-list
695517|NCT03040219|Hematinics|hematinics|mesh-ancestor
695518|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
695519|NCT03040219|Vitamins|vitamins|mesh-ancestor
2226959|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226960|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226961|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
2226962|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2226963|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226964|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
2226965|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226966|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2226967|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226968|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
2226969|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2226970|NCT00055887|Gemcitabine|gemcitabine|mesh-list
2226971|NCT00055887|Paclitaxel|paclitaxel|mesh-list
2226972|NCT00055887|Vinorelbine|vinorelbine|mesh-list
2226973|NCT00055887|Carboplatin|carboplatin|mesh-list
2226974|NCT00055887|Efaproxiral|efaproxiral|mesh-list
2226975|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2226976|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226977|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
2226978|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
2226979|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
2226980|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692400|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
692401|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
692402|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
692403|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692404|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692405|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
692406|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
692407|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692408|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
692409|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692527|NCT03054896|Venetoclax|venetoclax|mesh-list
692528|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087585|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2087586|NCT02170519|Iloprost|iloprost|mesh-list
2087587|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
693271|NCT03051373|Gemcitabine|gemcitabine|mesh-list
693272|NCT03051373|Paclitaxel|paclitaxel|mesh-list
693273|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
693274|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
693275|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693276|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
693277|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
693278|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
693279|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693280|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
693281|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
693282|NCT03051373|Antiviral Agents|antiviral agents|mesh-ancestor
693283|NCT03051373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
693284|NCT03051373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693285|NCT03051373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
693286|NCT03051373|Immunologic Factors|immunologic factors|mesh-ancestor
693287|NCT03051373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693510|NCT03050086|Minocycline|minocycline|mesh-list
693511|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
693512|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
693749|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
693750|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694116|NCT03046901|Vancomycin|vancomycin|mesh-list
694117|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
694118|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694131|NCT03046511|Cefazolin|cefazolin|mesh-list
694132|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
694133|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694197|NCT03046290|Lidocaine|lidocaine|mesh-list
694198|NCT03046290|Ropivacaine|ropivacaine|mesh-list
694199|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
694200|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
694201|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694202|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694203|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
694204|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694205|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
694206|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
694207|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
692298|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
692299|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
692300|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
692301|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692302|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692303|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
692304|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
692305|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
692306|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692418|NCT03055546|Oxytocin|oxytocin|mesh-list
692419|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
692420|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
692421|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692543|NCT03054831|Oxycodone|oxycodone|mesh-list
692544|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
692545|NCT03054831|Narcotics|narcotics|mesh-ancestor
692546|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
692547|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692548|NCT03054831|Analgesics|analgesics|mesh-ancestor
692549|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
692550|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2226981|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2226982|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
2226983|NCT00055887|Antiviral Agents|antiviral agents|mesh-ancestor
2226984|NCT00055887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2226985|NCT00055887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2226986|NCT00055887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2226987|NCT00055887|Immunologic Factors|immunologic factors|mesh-ancestor
2226988|NCT00055887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2226989|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
2226990|NCT00055913|Bevacizumab|bevacizumab|mesh-list
2226991|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2226992|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2226993|NCT00055913|Antibodies|antibodies|mesh-list
2226994|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
2226995|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2226996|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2226997|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2226998|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2226999|NCT00055913|Growth Substances|growth substances|mesh-ancestor
2227000|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227001|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
2227002|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
2227003|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2227004|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227005|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227006|NCT00055939|Exatecan|exatecan|mesh-list
2227007|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
694168|NCT03046251|Natalizumab|natalizumab|mesh-list
694169|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
694170|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694445|NCT03044873|BMS-986165|bms-986165|mesh-list
694446|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
694447|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
694448|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
694449|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
694450|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694451|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
694452|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
694453|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694454|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
694455|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2227008|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2227009|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227010|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227011|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227012|NCT00055952|Exatecan|exatecan|mesh-list
2227013|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2227014|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2227015|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227016|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227017|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227018|NCT00055965|Gemcitabine|gemcitabine|mesh-list
2227019|NCT00055965|Carboplatin|carboplatin|mesh-list
2227020|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227021|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
692386|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
692387|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692388|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692389|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
692390|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
692391|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
692392|NCT03055793|Hormones|hormones|mesh-ancestor
692393|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
692394|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
692395|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
692396|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
692397|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
692398|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692399|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692571|NCT03054662|Hemostatics|hemostatics|mesh-list
692572|NCT03054662|Coagulants|coagulants|mesh-ancestor
693146|NCT03051906|Cetuximab|cetuximab|mesh-list
693147|NCT03051906|Durvalumab|durvalumab|mesh-list
693148|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
693149|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227022|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
2227023|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693260|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
693261|NCT03051269|Calcium|calcium|mesh-list
693262|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
693263|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693264|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
693523|NCT03050164|Gefitinib|gefitinib|mesh-list
693524|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693525|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
693526|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693527|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693767|NCT03048474|Nivolumab|nivolumab|mesh-list
693768|NCT03048474|Ipilimumab|ipilimumab|mesh-list
693769|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
693770|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693771|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
693772|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694165|NCT03046173|Mitogens|mitogens|mesh-list
694166|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
694167|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694626|NCT03044093|Misoprostol|misoprostol|mesh-list
694627|NCT03044093|Mifepristone|mifepristone|mesh-list
694628|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
694629|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
694630|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
694631|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694632|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
694633|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
694634|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
694635|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
694636|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
694637|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
694638|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
694639|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
694640|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
694641|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
694642|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
694643|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
694644|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
694645|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
694646|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
695145|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
695146|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
695147|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
695148|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695149|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
695150|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
695151|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695381|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
695382|NCT03041012|Romidepsin|romidepsin|mesh-list
695383|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
695384|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
692489|NCT03055390|Scopolamine|scopolamine|mesh-list
692490|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
692491|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
692492|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
692493|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
692494|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692495|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692496|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
692497|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
692498|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
692499|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
692500|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692501|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692502|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
692503|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
2227024|NCT00055965|Antiviral Agents|antiviral agents|mesh-ancestor
2227025|NCT00055965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227026|NCT00055965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227027|NCT00055965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227028|NCT00055965|Immunologic Factors|immunologic factors|mesh-ancestor
2227029|NCT00055965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227030|NCT00055978|Celecoxib|celecoxib|mesh-list
2227031|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2227032|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
693706|NCT03049085|Aspirin|aspirin|mesh-list
693707|NCT03049085|Ascorbic Acid|ascorbic acid|mesh-list
693708|NCT03049085|Vitamins|vitamins|mesh-ancestor
693709|NCT03049085|Micronutrients|micronutrients|mesh-ancestor
693710|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693711|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
693712|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
693713|NCT03049085|Analgesics|analgesics|mesh-ancestor
693714|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
693715|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693716|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
693717|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
693718|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
693719|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
693720|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693721|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
693722|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
693723|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693724|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
693725|NCT03049085|Antioxidants|antioxidants|mesh-ancestor
693726|NCT03049085|Protective Agents|protective agents|mesh-ancestor
693984|NCT03047733|Tacrolimus|tacrolimus|mesh-list
693985|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
693986|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
693987|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693988|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
693989|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693990|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694129|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
694130|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
694213|NCT03046108|Triamcinolone|triamcinolone|mesh-list
694214|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
694215|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
694216|NCT03046108|Mepivacaine|mepivacaine|mesh-list
694217|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
694218|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
694219|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
694220|NCT03046108|Hormones|hormones|mesh-ancestor
694221|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
694334|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
2227033|NCT00055978|Analgesics|analgesics|mesh-ancestor
2227034|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
2227035|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692763|NCT03053739|Bosentan|bosentan|mesh-list
692764|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
692765|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
692766|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
692767|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
692768|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692769|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692770|NCT03053739|Urological Agents|urological agents|mesh-ancestor
692771|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
692772|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
692992|NCT03052569|Agerafenib|agerafenib|mesh-list
692993|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
692994|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692995|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693352|NCT03050957|Menthol|menthol|mesh-list
693353|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
693354|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
693513|NCT03050229|Empagliflozin|empagliflozin|mesh-list
693514|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
693515|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693516|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
693517|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693695|NCT03049176|Tenofovir|tenofovir|mesh-list
693696|NCT03049176|Emtricitabine|emtricitabine|mesh-list
693697|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
693698|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
693699|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
693700|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
693701|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
693702|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
693703|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693704|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693705|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
693944|NCT03047772|Atorvastatin|atorvastatin|mesh-list
693945|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
693946|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
693947|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
693948|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693949|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
693950|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
693951|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693991|NCT03047278|Cetirizine|cetirizine|mesh-list
693992|NCT03047278|Gabapentin|gabapentin|mesh-list
693993|NCT03047278|Analgesics|analgesics|mesh-ancestor
693994|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
693995|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693996|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693997|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
693998|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
693999|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
694000|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694001|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
694002|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
694003|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
694004|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694005|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694006|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
694007|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
694008|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
694009|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
694010|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
694011|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
694432|NCT03044912|Mirabegron|mirabegron|mesh-list
694433|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
694434|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
694435|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
694436|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
694437|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694438|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694439|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227036|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227037|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2227038|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2227039|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2227040|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2227041|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227042|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227043|NCT00055991|Bexarotene|bexarotene|mesh-list
2227044|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227045|NCT00056004|Zileuton|zileuton|mesh-list
2227046|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2227047|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2227048|NCT00056004|Analgesics|analgesics|mesh-ancestor
2227049|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
2227050|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692689|NCT03054207|Clopidogrel|clopidogrel|mesh-list
692690|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
692691|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
692692|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
692693|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
692694|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
692695|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
692696|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692697|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692698|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692773|NCT03053947|Ketamine|ketamine|mesh-list
692774|NCT03053947|Analgesics|analgesics|mesh-ancestor
692775|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
692776|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692777|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692778|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
692779|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
692780|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
692781|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
692782|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
692783|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
692784|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
692785|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692786|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692955|NCT03053219|Abivertinib|abivertinib|mesh-list
692956|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
692957|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692958|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693393|NCT03050710|Lidocaine|lidocaine|mesh-list
693394|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
693395|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
693396|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693397|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693398|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
693399|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693400|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
693401|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
693402|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
693403|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
693404|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693434|NCT03050437|Pemetrexed|pemetrexed|mesh-list
693435|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693436|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693437|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693438|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
693439|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2227051|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227052|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2227053|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2227054|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2227055|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227056|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227057|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2227058|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
694426|NCT03045029|Treprostinil|treprostinil|mesh-list
694427|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
694977|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2087588|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
2087589|NCT02170532|Albuterol|albuterol|mesh-list
2087590|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
694078|NCT03047135|Olaparib|olaparib|mesh-list
694079|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
694080|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694081|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694082|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694171|NCT03046017|Lidocaine|lidocaine|mesh-list
694172|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
694173|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
694174|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694175|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694176|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
694177|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694178|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
694179|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
694180|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
694181|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
694182|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227059|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2227060|NCT00056030|Leucovorin|leucovorin|mesh-list
2227061|NCT00056030|Fluorouracil|fluorouracil|mesh-list
2227062|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
695084|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
695085|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
695086|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
695087|NCT03042377|Calcium|calcium|mesh-list
695088|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
695089|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695090|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
695091|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
695092|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
695419|NCT03040830|Progesterone|progesterone|mesh-list
695420|NCT03040830|Progestins|progestins|mesh-ancestor
695421|NCT03040830|Hormones|hormones|mesh-ancestor
695422|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
695423|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695557|NCT03040180|Bleomycin|bleomycin|mesh-list
695558|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
695559|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695778|NCT03039101|Montelukast|montelukast|mesh-list
695779|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
695780|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
695781|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
695782|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
695783|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
695784|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695785|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
695786|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
695787|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695951|NCT03038243|Vaccines|vaccines|mesh-list
695952|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
695953|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087591|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
2087592|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087593|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087594|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2087595|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
2087596|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
2087597|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2087598|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2087599|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2087600|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2087601|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
2087602|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087603|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087604|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2087605|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
2087606|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2087607|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2087608|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2227063|NCT00056030|Cetuximab|cetuximab|mesh-list
692731|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692732|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692733|NCT03054220|Analgesics|analgesics|mesh-ancestor
692734|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
692735|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692736|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
692737|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
692738|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
692739|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
692740|NCT03054220|Narcotics|narcotics|mesh-ancestor
692741|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
692742|NCT03054220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
692743|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
692744|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
692745|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
692746|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
692747|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
692748|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
692749|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
692750|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
692751|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
692801|NCT03053869|Diazepam|diazepam|mesh-list
692802|NCT03053869|Lorazepam|lorazepam|mesh-list
692803|NCT03053869|Alprazolam|alprazolam|mesh-list
692804|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
692805|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
692806|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
692807|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692808|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692809|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
692810|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
692811|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
692812|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
692813|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
692814|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
692815|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
692816|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
692817|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692818|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692819|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
692820|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
692821|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
692822|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
692823|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
692824|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
2227064|NCT00056030|Calcium|calcium|mesh-list
2227065|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
2227066|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2227067|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227068|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
2227069|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227070|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2227071|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227072|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227073|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
2227074|NCT00056030|Antidotes|antidotes|mesh-ancestor
2227075|NCT00056030|Protective Agents|protective agents|mesh-ancestor
2227076|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
2227077|NCT00056030|Vitamins|vitamins|mesh-ancestor
2227078|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
693185|NCT03051711|Pyrazole|pyrazole|mesh-list
693186|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693187|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693727|NCT03049345|Methylene Blue|methylene blue|mesh-list
693728|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693729|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694700|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
694701|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
694702|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
694703|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
694704|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694705|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
694706|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
694707|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
694889|NCT03043482|Calcitriol|calcitriol|mesh-list
692797|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
692798|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
692799|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
692800|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692925|NCT03053505|Vancomycin|vancomycin|mesh-list
692926|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
692927|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
692928|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
693103|NCT03052361|Ondansetron|ondansetron|mesh-list
693104|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
693105|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
693106|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693107|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693108|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
693109|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
693110|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
693111|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
693112|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
693113|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693114|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693115|NCT03052361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
693116|NCT03052361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
693117|NCT03052361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693118|NCT03052361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
693119|NCT03052361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
693132|NCT03051945|Ketamine|ketamine|mesh-list
693133|NCT03051945|Analgesics|analgesics|mesh-ancestor
693134|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
693135|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693136|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693137|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
693138|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
693139|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
693140|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
693141|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693142|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
693143|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
693144|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693145|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693448|NCT03050554|Avelumab|avelumab|mesh-list
693449|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
693450|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694461|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
694462|NCT03044665|Ezetimibe|ezetimibe|mesh-list
694463|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
694464|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
694465|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
694466|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694467|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
694468|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
694469|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694564|NCT03044379|Dapivirine|dapivirine|mesh-list
694565|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
694566|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
694567|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
694568|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694839|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
694840|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
694841|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
694842|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
694843|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
694844|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694845|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
694846|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694847|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694848|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
694849|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695012|NCT03043014|Misoprostol|misoprostol|mesh-list
695013|NCT03043014|Mifepristone|mifepristone|mesh-list
695014|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
695015|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
695016|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
695017|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695018|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
695019|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
692839|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
692840|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
692906|NCT03053414|Vitamin D|vitamin d|mesh-list
692907|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
692908|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
692909|NCT03053414|Vitamins|vitamins|mesh-ancestor
692910|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
692911|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692912|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
692913|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2227079|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227080|NCT00056056|Bexarotene|bexarotene|mesh-list
2227081|NCT00056056|Methoxsalen|methoxsalen|mesh-list
2227082|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227083|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2227084|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
2227085|NCT00056082|Celecoxib|celecoxib|mesh-list
2227086|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2227087|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2227088|NCT00056082|Analgesics|analgesics|mesh-ancestor
2227089|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
2227090|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227091|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227092|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2227093|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2227094|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
693256|NCT03051087|Ganirelix|ganirelix|mesh-list
693257|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
693258|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
693259|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693355|NCT03050866|Antiemetics|antiemetics|mesh-list
693356|NCT03050866|Histamine|histamine|mesh-list
693357|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
693358|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
693359|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
693360|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
693361|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693362|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693363|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693364|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
693365|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693366|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
693547|NCT03049735|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
693548|NCT03049735|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
693549|NCT03049735|Norethindrone|norethindrone|mesh-list
693550|NCT03049735|Norethindrone Acetate|norethindrone acetate|mesh-list
693551|NCT03049735|Estradiol|estradiol|mesh-list
693552|NCT03049735|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
693553|NCT03049735|Relugolix|relugolix|mesh-list
693554|NCT03049735|Estrogens|estrogens|mesh-ancestor
693555|NCT03049735|Hormones|hormones|mesh-ancestor
693556|NCT03049735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
693557|NCT03049735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693558|NCT03049735|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
693559|NCT03049735|Contraceptive Agents|contraceptive agents|mesh-ancestor
693560|NCT03049735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
693561|NCT03049735|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
693562|NCT03049735|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
693563|NCT03049735|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
693564|NCT03049735|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
693565|NCT03049735|Androgen Antagonists|androgen antagonists|mesh-ancestor
693566|NCT03049735|Hormone Antagonists|hormone antagonists|mesh-ancestor
693690|NCT03049046|Caffeic acid|caffeic acid|mesh-list
693691|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
693692|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693693|NCT03049046|Protective Agents|protective agents|mesh-ancestor
693694|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227095|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2227096|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227097|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227098|NCT00056095|Cyclosporine|cyclosporine|mesh-list
2227099|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
2227100|NCT00056095|Fludarabine|fludarabine|mesh-list
2227101|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
694034|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
2227102|NCT00056095|Cyclosporins|cyclosporins|mesh-list
693123|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
693124|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
693150|NCT03051841|Dexamethasone|dexamethasone|mesh-list
693151|NCT03051841|Bortezomib|bortezomib|mesh-list
693152|NCT03051841|CKD-581|ckd-581|mesh-list
693153|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
693154|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
693155|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
693156|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693157|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693158|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
693159|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
693160|NCT03051841|Hormones|hormones|mesh-ancestor
693161|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
693162|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
693163|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693164|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693165|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693166|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2087609|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087610|NCT02170662|Bimatoprost|bimatoprost|mesh-list
2087611|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2087612|NCT02171130|Glucagon|glucagon|mesh-list
2087613|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2087614|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
693604|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
693605|NCT03049163|Propoxycaine|propoxycaine|mesh-list
693606|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
693607|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693608|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693609|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
693610|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
693611|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694335|NCT03045484|Oxycodone|oxycodone|mesh-list
694336|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
694337|NCT03045484|Narcotics|narcotics|mesh-ancestor
694338|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694339|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694340|NCT03045484|Analgesics|analgesics|mesh-ancestor
694341|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
694342|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227103|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227104|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
2227105|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227106|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2227107|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2227108|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
2227109|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227110|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227111|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2227112|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2227113|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
2227114|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695849|NCT03038477|Durvalumab|durvalumab|mesh-list
695850|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
695851|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087615|NCT02171130|Hormones|hormones|mesh-ancestor
2087616|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2087617|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087618|NCT02171130|Incretins|incretins|mesh-ancestor
2087619|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
692881|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
692882|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693064|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
693065|NCT03052348|Betamethasone|betamethasone|mesh-list
693066|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
693067|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
693068|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
693069|NCT03052348|Ether|ether|mesh-list
693070|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
693071|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
693072|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
693073|NCT03052348|Hormones|hormones|mesh-ancestor
693074|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
693075|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693076|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
693077|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
693078|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
693079|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
693080|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
693081|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693082|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
693083|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
693084|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
693085|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693086|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752772|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752778|NCT03312907|Rituximab|rituximab|mesh-list
2752779|NCT03312907|Belimumab|belimumab|mesh-list
2752780|NCT03312907|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2227115|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
2227116|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227117|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
2227118|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2227119|NCT00056225|Vitamins|vitamins|mesh-list
2227120|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
2227121|NCT00056225|Hydroxocobalamin|hydroxocobalamin|mesh-list
2227122|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
2227123|NCT00056225|Pyridoxal|pyridoxal|mesh-list
2227124|NCT00056225|Pyridoxine|pyridoxine|mesh-list
693901|NCT03047837|Aspirin|aspirin|mesh-list
693902|NCT03047837|Metformin|metformin|mesh-list
693903|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
693904|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693905|NCT03047837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
693906|NCT03047837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
693907|NCT03047837|Analgesics|analgesics|mesh-ancestor
693908|NCT03047837|Sensory System Agents|sensory system agents|mesh-ancestor
693909|NCT03047837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693910|NCT03047837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
693911|NCT03047837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
693912|NCT03047837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
693913|NCT03047837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
693914|NCT03047837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693915|NCT03047837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
693916|NCT03047837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
693917|NCT03047837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693918|NCT03047837|Antipyretics|antipyretics|mesh-ancestor
694232|NCT03045770|Leucovorin|leucovorin|mesh-list
694233|NCT03045770|Paclitaxel|paclitaxel|mesh-list
694234|NCT03045770|Fluorouracil|fluorouracil|mesh-list
694235|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
694236|NCT03045770|Irinotecan|irinotecan|mesh-list
694237|NCT03045770|Calcium|calcium|mesh-list
694238|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
694239|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
694240|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694241|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
694242|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
694243|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
694244|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694245|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2227125|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
2227126|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
692903|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
692904|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
692905|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
693173|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
693174|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
693175|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693329|NCT03050905|Ritonavir|ritonavir|mesh-list
693330|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
693331|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
693332|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
693333|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693334|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693335|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
693336|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
693337|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
693338|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
693339|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
693340|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2227127|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227128|NCT00056225|Hematinics|hematinics|mesh-ancestor
2227129|NCT00056264|Infliximab|infliximab|mesh-list
2227130|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
2227131|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
693594|NCT03049540|Tadalafil|tadalafil|mesh-list
693595|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
693596|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
693597|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
693598|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693599|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693600|NCT03049540|Urological Agents|urological agents|mesh-ancestor
693742|NCT03048942|Paclitaxel|paclitaxel|mesh-list
693743|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
693744|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693745|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
693746|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
693747|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
693748|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693828|NCT03047928|Nivolumab|nivolumab|mesh-list
693829|NCT03047928|Vaccines|vaccines|mesh-list
693830|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
693831|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693832|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
693833|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693834|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
693835|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694050|NCT03047109|Phenylephrine|phenylephrine|mesh-list
694051|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
694052|NCT03047109|Ephedrine|ephedrine|mesh-list
694053|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
694054|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
694055|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
694056|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694057|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694058|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
694059|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
694060|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
694061|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
694062|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
694063|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
694064|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
694065|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
694066|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694067|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694068|NCT03047109|Protective Agents|protective agents|mesh-ancestor
694069|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
694183|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
694184|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
694185|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694186|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694187|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
694188|NCT03046238|Analgesics|analgesics|mesh-ancestor
694189|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
694190|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694191|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2227132|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
692914|NCT03053622|Mirikizumab|mirikizumab|mesh-list
692915|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
692916|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
692917|NCT03053622|Analgesics|analgesics|mesh-ancestor
692918|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
692919|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
692920|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
692921|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
692922|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
692923|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
692924|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
693224|NCT03051451|Metformin|metformin|mesh-list
693225|NCT03051451|Fluoxetine|fluoxetine|mesh-list
693226|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
693227|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693228|NCT03051451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
693229|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
693230|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
693231|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693232|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693233|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
693234|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
693235|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
693236|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
693237|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
693238|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
693239|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693528|NCT03050060|Nelfinavir|nelfinavir|mesh-list
693529|NCT03050060|Pembrolizumab|pembrolizumab|mesh-list
693530|NCT03050060|Nivolumab|nivolumab|mesh-list
693531|NCT03050060|Atezolizumab|atezolizumab|mesh-list
693532|NCT03050060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
693533|NCT03050060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
693534|NCT03050060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693535|NCT03050060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
693536|NCT03050060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693537|NCT03050060|Immunologic Factors|immunologic factors|mesh-ancestor
693538|NCT03050060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693539|NCT03050060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
693540|NCT03050060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
693541|NCT03050060|Protease Inhibitors|protease inhibitors|mesh-ancestor
693542|NCT03050060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693543|NCT03050060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
693544|NCT03050060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
693545|NCT03050060|Antiviral Agents|antiviral agents|mesh-ancestor
693546|NCT03050060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
693773|NCT03048578|Liraglutide|liraglutide|mesh-list
693774|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
693775|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693776|NCT03048578|Incretins|incretins|mesh-ancestor
693777|NCT03048578|Hormones|hormones|mesh-ancestor
693778|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
693836|NCT03048110|Itraconazole|itraconazole|mesh-list
693837|NCT03048110|Rifampin|rifampin|mesh-list
693838|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
693839|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
693840|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
693841|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
693842|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693843|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693844|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
693845|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
693846|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
693847|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693848|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
693849|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
693850|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
693851|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
693852|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
693853|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
693854|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
693855|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
693856|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
693017|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693018|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693019|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
693020|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
693021|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
693022|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
693023|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
693024|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
693025|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
693026|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
693027|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693028|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227133|NCT00056277|Lamotrigine|lamotrigine|mesh-list
2227134|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
2227135|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2227136|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2227137|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227138|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2227139|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227140|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2227141|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2227142|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2227143|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2227144|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2227145|NCT00056329|Vitamin E|vitamin e|mesh-list
2227146|NCT00056329|Tocopherols|tocopherols|mesh-list
2227147|NCT00056329|Vitamins|vitamins|mesh-ancestor
2227148|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
694012|NCT03046953|Avelumab|avelumab|mesh-list
694013|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
694014|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694119|NCT03046758|Metronidazole|metronidazole|mesh-list
694120|NCT03046758|Fosfomycin|fosfomycin|mesh-list
694121|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694122|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
694123|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
694124|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
694269|NCT03045627|Cytarabine|cytarabine|mesh-list
694270|NCT03045627|Aclarubicin|aclarubicin|mesh-list
694271|NCT03045627|Lenograstim|lenograstim|mesh-list
694272|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
694273|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
694274|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694275|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694276|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
694277|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694278|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
694279|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
694280|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694281|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
694282|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
694283|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
694284|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
694285|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694475|NCT03044587|Leucovorin|leucovorin|mesh-list
694476|NCT03044587|Gemcitabine|gemcitabine|mesh-list
694477|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694478|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
694479|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
694480|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694481|NCT03044587|Antiviral Agents|antiviral agents|mesh-ancestor
694482|NCT03044587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694483|NCT03044587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694484|NCT03044587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
694485|NCT03044587|Immunologic Factors|immunologic factors|mesh-ancestor
694486|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694487|NCT03044587|Antidotes|antidotes|mesh-ancestor
694488|NCT03044587|Protective Agents|protective agents|mesh-ancestor
694489|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
694490|NCT03044587|Vitamins|vitamins|mesh-ancestor
694491|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
695130|NCT03041883|Riboflavin|riboflavin|mesh-list
695131|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
695132|NCT03041883|Vitamins|vitamins|mesh-ancestor
695133|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
695134|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695135|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2227149|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693181|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752781|NCT03312907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2752782|NCT03312907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752783|NCT03312907|Immunologic Factors|immunologic factors|mesh-ancestor
2752784|NCT03312907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752785|NCT03312907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2752786|NCT03312400|Danazol|danazol|mesh-list
2752787|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2752788|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
2752789|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2752790|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752791|NCT03301857|Denosumab|denosumab|mesh-list
2752792|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
2752793|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
2752794|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
2752795|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752796|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2227150|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
2227151|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227152|NCT00056329|Protective Agents|protective agents|mesh-ancestor
2227153|NCT00056368|Fluconazole|fluconazole|mesh-list
2227154|NCT00056368|Anidulafungin|anidulafungin|mesh-list
2227155|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
2227156|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227157|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2227158|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
694125|NCT03046836|Oxytocin|oxytocin|mesh-list
694126|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
694127|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
694128|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227159|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227160|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227161|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2227162|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
2227163|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2227164|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227165|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2227166|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
694456|NCT03044795|Veliparib|veliparib|mesh-list
694457|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
694458|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694459|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694460|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227167|NCT00056381|Anidulafungin|anidulafungin|mesh-list
2227168|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
2227169|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227170|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
2227171|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
2227172|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
2227173|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2227174|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2227175|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695424|NCT03040752|Nifedipine|nifedipine|mesh-list
695425|NCT03040752|Ritodrine|ritodrine|mesh-list
695426|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
695427|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
695428|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695429|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
695430|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695431|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
695432|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
695433|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
695434|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
695435|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
695436|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695437|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
695438|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
695439|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2227176|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227177|NCT00056433|Urological Agents|urological agents|mesh-ancestor
694561|NCT03044366|Anesthetics|anesthetics|mesh-list
694562|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694563|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694687|NCT03043677|Adalimumab|adalimumab|mesh-list
694688|NCT03043677|Golimumab|golimumab|mesh-list
694689|NCT03043677|Infliximab|infliximab|mesh-list
694690|NCT03043677|Ustekinumab|ustekinumab|mesh-list
694691|NCT03043677|Vedolizumab|vedolizumab|mesh-list
694692|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
694693|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
694694|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
694695|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
694696|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
694697|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
694698|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
694699|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227178|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227179|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
2227180|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2227181|NCT00056446|Vatalanib|vatalanib|mesh-list
2227182|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2227183|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227184|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227185|NCT00056459|Vatalanib|vatalanib|mesh-list
2227186|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2227187|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227188|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695288|NCT03041740|Perflubron|perflubron|mesh-list
695289|NCT03041740|Bromides|bromides|mesh-list
695290|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
695291|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2227189|NCT00056576|Zonisamide|zonisamide|mesh-list
2227190|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
2227191|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2227192|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
695387|NCT03040778|Vitamin E|vitamin e|mesh-list
695388|NCT03040778|Tocopherols|tocopherols|mesh-list
695389|NCT03040778|Tocotrienols|tocotrienols|mesh-list
695390|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
695391|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
695392|NCT03040778|Vitamins|vitamins|mesh-ancestor
695393|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
695394|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695395|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
695396|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695397|NCT03040778|Protective Agents|protective agents|mesh-ancestor
695398|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
695399|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695400|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
695401|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
695402|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
695403|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2227193|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227194|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2227195|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227196|NCT00056641|Ritonavir|ritonavir|mesh-list
2227197|NCT00056641|Lopinavir|lopinavir|mesh-list
2227198|NCT00056641|Saquinavir|saquinavir|mesh-list
2227199|NCT00056641|Amprenavir|amprenavir|mesh-list
2227200|NCT00056641|Tipranavir|tipranavir|mesh-list
2227201|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2227202|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2227203|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
2227204|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227205|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227206|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
695852|NCT03038503|Terlipressin|terlipressin|mesh-list
695853|NCT03038503|Methylene Blue|methylene blue|mesh-list
695854|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695855|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695856|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
695857|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2087620|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
2087621|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2227207|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2227208|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
693654|NCT03049267|Apremilast|apremilast|mesh-list
693655|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
693656|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
693657|NCT03049267|Analgesics|analgesics|mesh-ancestor
693658|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
693659|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
693660|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693661|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
693662|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
693663|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
693664|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
693665|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693666|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227209|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227210|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
694667|NCT03043807|Docetaxel|docetaxel|mesh-list
694668|NCT03043807|Leuprolide|leuprolide|mesh-list
694669|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
694670|NCT03043807|Bicalutamide|bicalutamide|mesh-list
694671|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694672|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
694673|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
694674|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
694675|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694676|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
694677|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
694678|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
694679|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694680|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
694681|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
694682|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694683|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
694684|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
694685|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
694686|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
695137|NCT03042013|Naquotinib|naquotinib|mesh-list
695138|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695139|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
695140|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695141|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087622|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2087623|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2087624|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087625|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2087626|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
695639|NCT03039842|Valproic Acid|valproic acid|mesh-list
695640|NCT03039842|Memantine|memantine|mesh-list
695641|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
695642|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
695643|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
695644|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
695645|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
695646|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695647|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695648|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
695649|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
695650|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
695651|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
2227211|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2227212|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2227213|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
693925|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
693926|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
693927|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
693928|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693970|NCT03047473|Avelumab|avelumab|mesh-list
693971|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
693972|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227214|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2227215|NCT00056654|Leuprolide|leuprolide|mesh-list
2227216|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2227217|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
2227218|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2227219|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227220|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2227221|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227222|NCT00056693|Sunitinib|sunitinib|mesh-list
2227223|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694470|NCT03044626|Nivolumab|nivolumab|mesh-list
694471|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
694472|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694473|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
694474|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694762|NCT03043950|Panitumumab|panitumumab|mesh-list
694763|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
694764|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694800|NCT03043326|Tenofovir|tenofovir|mesh-list
694801|NCT03043326|Emtricitabine|emtricitabine|mesh-list
694802|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
694803|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694804|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
694805|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
694806|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694807|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694808|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
694809|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
695409|NCT03040934|Sirolimus|sirolimus|mesh-list
695410|NCT03040934|Everolimus|everolimus|mesh-list
695411|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695412|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
695413|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
695414|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695415|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
695416|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
695417|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
695418|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
695911|NCT03038295|Propranolol|propranolol|mesh-list
695912|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
695913|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
695914|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
695915|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
695916|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695917|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695918|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
695919|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
695920|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
2087627|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2087628|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2087629|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2087630|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087631|NCT02171429|Adalimumab|adalimumab|mesh-list
2087632|NCT02171429|Etrolizumab|etrolizumab|mesh-list
2087633|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2087634|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2087635|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2087636|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
2087637|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087638|NCT02171611|Dabigatran|dabigatran|mesh-list
2087639|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
2087640|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2087641|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
2087642|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227224|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2087643|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087644|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
2087645|NCT02172040|Celecoxib|celecoxib|mesh-list
2087646|NCT02172040|Amlodipine|amlodipine|mesh-list
2087647|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2087648|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2087649|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2087650|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087651|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2087652|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087653|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
2087654|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2087655|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2087656|NCT02172040|Analgesics|analgesics|mesh-ancestor
2087657|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
2087658|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087659|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2087660|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2087661|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2087662|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2087663|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087664|NCT02172742|Digoxin|digoxin|mesh-list
2227225|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2227226|NCT00056693|Growth Substances|growth substances|mesh-ancestor
2227227|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227228|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
2227229|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2227230|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227231|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227232|NCT00056758|Vaccines|vaccines|mesh-list
2227233|NCT00056758|Immunologic Factors|immunologic factors|mesh-ancestor
694576|NCT03044613|Paclitaxel|paclitaxel|mesh-list
694577|NCT03044613|Carboplatin|carboplatin|mesh-list
694578|NCT03044613|Nivolumab|nivolumab|mesh-list
694579|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
694580|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694581|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
694582|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
694583|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
694584|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694585|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
694586|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
694656|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
694657|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
694658|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
694659|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
694660|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694661|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694662|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
694663|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
694664|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694665|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
694666|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694906|NCT03043495|Dexamethasone|dexamethasone|mesh-list
694907|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
694908|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
694909|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
694910|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694911|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087665|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2087666|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
693857|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
693858|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
693859|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2087667|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2087668|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087669|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087670|NCT02172742|Protective Agents|protective agents|mesh-ancestor
2227234|NCT00056758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227235|NCT00056797|Interleukin-2|interleukin-2|mesh-list
2227236|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227237|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2227238|NCT00056797|Analgesics|analgesics|mesh-ancestor
2227239|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
2227240|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694620|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
694621|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
694622|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
694623|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694624|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
694625|NCT03044041|Coagulants|coagulants|mesh-ancestor
2087671|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087672|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
2087673|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2087674|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2087675|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2087676|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2087677|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
695175|NCT03042091|Metronidazole|metronidazole|mesh-list
695176|NCT03042091|Ethanol|ethanol|mesh-list
695177|NCT03042091|Neomycin|neomycin|mesh-list
695178|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
695179|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
695180|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
695181|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
695182|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
695183|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695184|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695185|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
695186|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695187|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695461|NCT03040596|Fluticasone|fluticasone|mesh-list
695462|NCT03040596|Xhance|xhance|mesh-list
695463|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
695464|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
695465|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
695466|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695467|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695468|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
695469|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
695470|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
695471|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
695843|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
695844|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
695845|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695846|NCT03038516|Vitamins|vitamins|mesh-ancestor
695847|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
695848|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2087678|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2087679|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2087680|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2087681|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087682|NCT02173054|Adapalene|adapalene|mesh-list
2087683|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2087684|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2087685|NCT02173054|Analgesics|analgesics|mesh-ancestor
2087686|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
2087687|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087688|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087689|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2087690|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2087691|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
2087692|NCT02173392|Brodalumab|brodalumab|mesh-list
2087693|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
2087694|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2087695|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2087696|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
2087697|NCT02173769|Olodaterol|olodaterol|mesh-list
2087698|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2087699|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
2087700|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087701|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694070|NCT03047265|Paclitaxel|paclitaxel|mesh-list
694071|NCT03047265|Cisplatin|cisplatin|mesh-list
694072|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
694073|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694074|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
694075|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
694076|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
694077|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694647|NCT03044171|Listerine|listerine|mesh-list
694648|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
694649|NCT03044171|Fluorides|fluorides|mesh-list
694650|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
694651|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
694652|NCT03044171|Protective Agents|protective agents|mesh-ancestor
694653|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694654|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
694655|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694765|NCT03043612|Doxazosin|doxazosin|mesh-list
694766|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
694767|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
694768|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
694769|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
694770|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
694771|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694772|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694773|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227241|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227242|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
2227243|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2227244|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2227245|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227246|NCT00056823|Ranibizumab|ranibizumab|mesh-list
2227247|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2227248|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2227249|NCT00056823|Growth Substances|growth substances|mesh-ancestor
2752821|NCT03287908|Dexamethasone|dexamethasone|mesh-list
2752822|NCT03287908|Pomalidomide|pomalidomide|mesh-list
695483|NCT03040531|Vitamin D|vitamin d|mesh-list
695484|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
695485|NCT03040531|Alendronate|alendronate|mesh-list
695486|NCT03040531|Genistein|genistein|mesh-list
695487|NCT03040531|Calcium|calcium|mesh-list
695488|NCT03040531|Vitamins|vitamins|mesh-ancestor
695489|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
695490|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695491|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
695492|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
695493|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
695494|NCT03040531|Protective Agents|protective agents|mesh-ancestor
695495|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695496|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
695497|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695498|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695499|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
695500|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
695501|NCT03040531|Estrogens|estrogens|mesh-ancestor
695502|NCT03040531|Hormones|hormones|mesh-ancestor
695503|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
696071|NCT03037593|Vitamin D|vitamin d|mesh-list
696072|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
696073|NCT03037593|Vitamins|vitamins|mesh-ancestor
696074|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
696075|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696076|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2752823|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
693869|NCT03048084|Levetiracetam|levetiracetam|mesh-list
693870|NCT03048084|Valproic Acid|valproic acid|mesh-list
693871|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
693872|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
693873|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
693874|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693875|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
693876|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693877|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693878|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
693879|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
693880|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
693881|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
693973|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
693974|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
693975|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
693976|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
693977|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
693978|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
693979|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
693980|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
693981|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693982|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
693983|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694134|NCT03046719|Bupivacaine|bupivacaine|mesh-list
694135|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
694136|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
694137|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694138|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694139|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
694140|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694417|NCT03045016|Prazosin|prazosin|mesh-list
694418|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
694419|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
694420|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
694421|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
694422|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
694423|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694424|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694425|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694504|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
694505|NCT03044743|Fludarabine|fludarabine|mesh-list
694506|NCT03044743|Interleukin-2|interleukin-2|mesh-list
694507|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
694508|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
694509|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694510|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
694511|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
694512|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
694513|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694514|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694515|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
694516|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
694517|NCT03044743|Analgesics|analgesics|mesh-ancestor
694518|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
694519|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695093|NCT03042325|Alogliptin|alogliptin|mesh-list
695094|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
695095|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695096|NCT03042325|Incretins|incretins|mesh-ancestor
695097|NCT03042325|Hormones|hormones|mesh-ancestor
695098|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
695099|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
695100|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
695101|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695102|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227250|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227251|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
2227252|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227253|NCT00056836|Ranibizumab|ranibizumab|mesh-list
695375|NCT03040973|Gefitinib|gefitinib|mesh-list
695376|NCT03040973|Nazartinib|nazartinib|mesh-list
695377|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695378|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2227254|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
693920|NCT03048136|Ipilimumab|ipilimumab|mesh-list
693921|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
693922|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
693923|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
693924|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694349|NCT03045406|Dalteparin|dalteparin|mesh-list
694350|NCT03045406|Tinzaparin|tinzaparin|mesh-list
694351|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
694352|NCT03045406|Apixaban|apixaban|mesh-list
694353|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
694354|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
694355|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
694356|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
694357|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694358|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694359|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
694360|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
694361|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
695194|NCT03041948|Acetaminophen|acetaminophen|mesh-list
695195|NCT03041948|Dexamethasone|dexamethasone|mesh-list
695196|NCT03041948|Ketorolac|ketorolac|mesh-list
695197|NCT03041948|Morphine|morphine|mesh-list
695198|NCT03041948|Remifentanil|remifentanil|mesh-list
695199|NCT03041948|Ondansetron|ondansetron|mesh-list
695200|NCT03041948|Propofol|propofol|mesh-list
695201|NCT03041948|Sevoflurane|sevoflurane|mesh-list
695202|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
695203|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
695204|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
695205|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695206|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695207|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
695208|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
695209|NCT03041948|Hormones|hormones|mesh-ancestor
695210|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
695211|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
695212|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695213|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
695214|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695215|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
695216|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
695217|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
695218|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
695219|NCT03041948|Narcotics|narcotics|mesh-ancestor
695220|NCT03041948|Analgesics|analgesics|mesh-ancestor
695221|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
695222|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
695223|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
695224|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
695225|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
695226|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
695227|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
695228|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
695229|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
695230|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
695231|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695232|NCT03041948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
695233|NCT03041948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
695234|NCT03041948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
695235|NCT03041948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
695236|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
695237|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
695238|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
695239|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695522|NCT03040401|Aldesleukin|aldesleukin|mesh-list
695523|NCT03040401|Interleukin-2|interleukin-2|mesh-list
695524|NCT03040401|Histamine|histamine|mesh-list
695525|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
695526|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695527|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
695528|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
695529|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
695530|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
695531|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
695532|NCT03040401|Analgesics|analgesics|mesh-ancestor
695533|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
695534|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695535|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695536|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
2227255|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2227256|NCT00056836|Growth Substances|growth substances|mesh-ancestor
694163|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
694164|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694375|NCT03045198|Azithromycin|azithromycin|mesh-list
694376|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
694377|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
695155|NCT03042000|Capecitabine|capecitabine|mesh-list
695156|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
695157|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
695158|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
695159|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695160|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695341|NCT03041311|Carboplatin|carboplatin|mesh-list
695342|NCT03041311|Etoposide|etoposide|mesh-list
695343|NCT03041311|Atezolizumab|atezolizumab|mesh-list
695344|NCT03041311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695345|NCT03041311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
695346|NCT03041311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
695347|NCT03041311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
695348|NCT03041311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695349|NCT03041311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695581|NCT03040128|Minocycline|minocycline|mesh-list
695582|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
695583|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
695865|NCT03038451|Amlodipine|amlodipine|mesh-list
695866|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
695867|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
695868|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
695869|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695870|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
695871|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695872|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
2087702|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2087703|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
2087704|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
2087705|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2087706|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
2087707|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087708|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087709|NCT02174276|Tenofovir|tenofovir|mesh-list
2087710|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
2087711|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087712|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2087713|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2087714|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087715|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087716|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2087717|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2087718|NCT02174419|Nalbuphine|nalbuphine|mesh-list
2087719|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2087720|NCT02174419|Narcotics|narcotics|mesh-ancestor
2087721|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2087722|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087723|NCT02174419|Analgesics|analgesics|mesh-ancestor
2087724|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
2087725|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087726|NCT02174432|Nalbuphine|nalbuphine|mesh-list
2087727|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2087728|NCT02174432|Narcotics|narcotics|mesh-ancestor
2087729|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2087730|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087731|NCT02174432|Analgesics|analgesics|mesh-ancestor
2087732|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
2087733|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087734|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2087735|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2087736|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2087737|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2087738|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087739|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2087740|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2087741|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2087742|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2752824|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
693966|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
693967|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
693968|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
693969|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
2087743|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
2087744|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087745|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087746|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2087747|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2087748|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
2087749|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2087750|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2087751|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
2087752|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2087753|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2087754|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2087755|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2087756|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227257|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227258|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
2227259|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227260|NCT00056875|Mitogens|mitogens|mesh-list
2227261|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
2227262|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227263|NCT00056966|Fludarabine|fludarabine|mesh-list
694832|NCT03043547|Leucovorin|leucovorin|mesh-list
694833|NCT03043547|Antidotes|antidotes|mesh-ancestor
694834|NCT03043547|Protective Agents|protective agents|mesh-ancestor
694835|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694836|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
694837|NCT03043547|Vitamins|vitamins|mesh-ancestor
694838|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
694981|NCT03043027|Bupivacaine|bupivacaine|mesh-list
694982|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
694983|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
694984|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694985|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694986|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
694987|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087757|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2087758|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2087759|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
695240|NCT03041935|Acetaminophen|acetaminophen|mesh-list
695241|NCT03041935|Dexamethasone|dexamethasone|mesh-list
695242|NCT03041935|Ketorolac|ketorolac|mesh-list
695243|NCT03041935|Morphine|morphine|mesh-list
695244|NCT03041935|Remifentanil|remifentanil|mesh-list
695245|NCT03041935|Ondansetron|ondansetron|mesh-list
695246|NCT03041935|Propofol|propofol|mesh-list
695247|NCT03041935|Ropivacaine|ropivacaine|mesh-list
695248|NCT03041935|Sevoflurane|sevoflurane|mesh-list
695249|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
695250|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
695251|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
695252|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695253|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695254|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
695255|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
695256|NCT03041935|Hormones|hormones|mesh-ancestor
695257|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
695258|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
695259|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695260|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
695261|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695262|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
695263|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
695264|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
695265|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
695266|NCT03041935|Narcotics|narcotics|mesh-ancestor
695267|NCT03041935|Analgesics|analgesics|mesh-ancestor
695268|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
695269|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
695270|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
695271|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
695272|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
695273|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
695274|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
695275|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
694035|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694036|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694037|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
694038|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694039|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
694040|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
694041|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
694042|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
694043|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694343|NCT03045510|Decitabine|decitabine|mesh-list
694344|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
694345|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
694346|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694347|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694348|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694404|NCT03045133|Morphine|morphine|mesh-list
694405|NCT03045133|Methadone|methadone|mesh-list
694406|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
694407|NCT03045133|Narcotics|narcotics|mesh-ancestor
694408|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694409|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694410|NCT03045133|Analgesics|analgesics|mesh-ancestor
694411|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
694412|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694413|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
694414|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
694810|NCT03043430|Midazolam|midazolam|mesh-list
694811|NCT03043430|Ketamine|ketamine|mesh-list
694812|NCT03043430|Analgesics|analgesics|mesh-ancestor
694813|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
694814|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694815|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694816|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
694817|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
694818|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
694819|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
694820|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694821|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
694822|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
694823|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694824|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694825|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
694826|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
694827|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
694828|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
694829|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
694830|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
694831|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
695043|NCT03042637|Tacrolimus|tacrolimus|mesh-list
695044|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
695045|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
695046|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695047|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
695048|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695049|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227264|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
2227265|NCT00056966|Tacrolimus|tacrolimus|mesh-list
2227266|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227267|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227268|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227269|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
2227270|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227271|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2227272|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227273|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227274|NCT00056979|Fludarabine|fludarabine|mesh-list
2227275|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
2227276|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227277|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227278|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
2227279|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
2227280|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227281|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
2227282|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227283|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
694089|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694722|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
694723|NCT03043664|Lanreotide|lanreotide|mesh-list
694724|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
694725|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694874|NCT03043443|Melatonin|melatonin|mesh-list
694875|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
694876|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694877|NCT03043443|Protective Agents|protective agents|mesh-ancestor
694878|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694879|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694935|NCT03042936|Insulin|insulin|mesh-list
694936|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
694937|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695142|NCT03042182|Vaccines|vaccines|mesh-list
695143|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
695144|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695453|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
695454|NCT03040765|Denosumab|denosumab|mesh-list
695455|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
695456|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695788|NCT03038802|Vaccines|vaccines|mesh-list
695789|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
695790|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695888|NCT03038425|Ropivacaine|ropivacaine|mesh-list
695889|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
695890|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
695891|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695892|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695893|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
695894|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695984|NCT03037944|Drospirenone|drospirenone|mesh-list
695985|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
695986|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
695987|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
695988|NCT03037944|Estradiol|estradiol|mesh-list
695989|NCT03037944|Estrogens|estrogens|mesh-ancestor
695990|NCT03037944|Hormones|hormones|mesh-ancestor
695991|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
695992|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695993|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
695994|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
695995|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
695996|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
695997|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
695998|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
695999|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
696000|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
696001|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
696002|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
696003|NCT03037944|Diuretics|diuretics|mesh-ancestor
696004|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
2087760|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2087761|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
2087762|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087763|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087764|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2087765|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2087766|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
2087767|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2087768|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2087769|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
2087770|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
2087771|NCT02174731|Hematinics|hematinics|mesh-ancestor
2087772|NCT02174848|Deferiprone|deferiprone|mesh-list
2087773|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2087774|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
2087775|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
2087776|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087777|NCT02174861|Erenumab|erenumab|mesh-list
2087778|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2087779|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087780|NCT02174861|Analgesics|analgesics|mesh-ancestor
2087781|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
2087782|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694091|NCT03047005|Bupropion|bupropion|mesh-list
694092|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
694093|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
694094|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694095|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
694096|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694097|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
694098|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
694099|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
694100|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
694101|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
694102|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
694103|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694104|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
694105|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694106|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
694107|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
694108|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694587|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
694588|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
694589|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2227284|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2227285|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
695126|NCT03042234|Insulin|insulin|mesh-list
695127|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
695128|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
695129|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087783|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087784|NCT02174913|Fentanyl|fentanyl|mesh-list
2087785|NCT02174913|Propofol|propofol|mesh-list
2087786|NCT02174913|Atracurium|atracurium|mesh-list
2087787|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2087788|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2087789|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087790|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2087791|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
2087792|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
2087793|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2087794|NCT02174913|Narcotics|narcotics|mesh-ancestor
2087795|NCT02174913|Analgesics|analgesics|mesh-ancestor
2087796|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
2087797|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087798|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2087799|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2087800|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2087801|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2087802|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2087803|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2087804|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
2087805|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087806|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087807|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
2087808|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
2087809|NCT02175212|Androgens|androgens|mesh-list
2087810|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2087811|NCT02175212|Hormones|hormones|mesh-ancestor
2087812|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2087813|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087814|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
2087815|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087816|NCT02175212|Protective Agents|protective agents|mesh-ancestor
2087817|NCT02175212|Vitamins|vitamins|mesh-ancestor
2087818|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
2087819|NCT02175212|Estrogens|estrogens|mesh-ancestor
2087820|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2087821|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087822|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
2087823|NCT02175225|Deferoxamine|deferoxamine|mesh-list
2087824|NCT02175225|Siderophores|siderophores|mesh-ancestor
2087825|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2087826|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
2087827|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
2087828|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087829|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
2087830|NCT02175277|Hematinics|hematinics|mesh-ancestor
2087831|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
694192|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
694193|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
694194|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
694195|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694196|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694362|NCT03045185|Metronidazole|metronidazole|mesh-list
694363|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
694364|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694365|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
694366|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
694367|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
694368|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
694369|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
694370|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694371|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694372|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694373|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
694374|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
694739|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
694740|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
694741|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
694742|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
694743|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
694744|NCT03043924|Estradiol|estradiol|mesh-list
694745|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
694746|NCT03043924|Cyproterone|cyproterone|mesh-list
694747|NCT03043924|Estrogens|estrogens|mesh-ancestor
694748|NCT03043924|Hormones|hormones|mesh-ancestor
694749|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
694750|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694751|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
694752|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
694753|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
694754|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
694755|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
694756|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
694757|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
694758|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
694759|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
694760|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694761|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
695103|NCT03042260|Trimethoprim|trimethoprim|mesh-list
695104|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
695105|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
695106|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
695107|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
695108|NCT03042260|Renal Agents|renal agents|mesh-ancestor
695109|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
695110|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
695111|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
695112|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
695113|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695114|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695115|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
695116|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
695117|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
695118|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2227286|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227287|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227288|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2227289|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227290|NCT00057031|Calcitriol|calcitriol|mesh-list
2227291|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2227292|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227293|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2227294|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2752825|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
2087832|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
2087833|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087834|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087835|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087836|NCT02175758|Ribavirin|ribavirin|mesh-list
2087837|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
2087838|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
694208|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
694209|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694850|NCT03043248|Digoxin|digoxin|mesh-list
694851|NCT03043248|Midazolam|midazolam|mesh-list
694852|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
694853|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
694854|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694855|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694856|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
694857|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
694858|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
694859|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
694860|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
694861|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
694862|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
694863|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
694864|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694865|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694866|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
694867|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
694868|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694869|NCT03043248|Protective Agents|protective agents|mesh-ancestor
694945|NCT03043053|Oxytocin|oxytocin|mesh-list
694946|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
694947|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
694948|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695457|NCT03040635|Risdiplam|risdiplam|mesh-list
695458|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
695459|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695460|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695761|NCT03039075|Metformin|metformin|mesh-list
695762|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
695763|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695903|NCT03038282|Chromium|chromium|mesh-list
695904|NCT03038282|Chromous chloride|chromous chloride|mesh-list
695905|NCT03038282|Trace Elements|trace elements|mesh-ancestor
695906|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
695907|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695908|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
695909|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695910|NCT03038282|Protective Agents|protective agents|mesh-ancestor
2087839|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087840|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
2087841|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087842|NCT02175771|Fluticasone|fluticasone|mesh-list
2087843|NCT02175771|Xhance|xhance|mesh-list
2087844|NCT02175771|Albuterol|albuterol|mesh-list
2087845|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2087846|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2087847|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
2087848|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2087849|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2087850|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
2087851|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087852|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087853|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2087854|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
2087855|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
2087856|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2087857|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2087858|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2087859|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
2087860|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087861|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087862|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
2087863|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2087864|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
2087865|NCT02175771|Hormones|hormones|mesh-ancestor
2087866|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2087867|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
2087868|NCT02175966|Ribavirin|ribavirin|mesh-list
2087869|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
2087870|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
2087871|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087872|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
2087873|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087874|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
694222|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694223|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
694224|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
694225|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694226|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694227|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
694228|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
694229|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694230|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
694231|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694546|NCT03044938|Albuterol|albuterol|mesh-list
694547|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
694548|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
694549|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694550|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694551|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
694552|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
694553|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
694554|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
694555|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
694556|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
694557|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
694558|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
694559|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694560|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694954|NCT03043001|Memantine|memantine|mesh-list
694955|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
694956|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
694957|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
694958|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694959|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694960|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694961|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
694962|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
695350|NCT03040999|Cisplatin|cisplatin|mesh-list
695351|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
695352|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695353|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
696023|NCT03037892|Fentanyl|fentanyl|mesh-list
696024|NCT03037892|Midazolam|midazolam|mesh-list
696025|NCT03037892|Remifentanil|remifentanil|mesh-list
696026|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
696027|NCT03037892|Narcotics|narcotics|mesh-ancestor
696028|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
696029|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696030|NCT03037892|Analgesics|analgesics|mesh-ancestor
696031|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
696032|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696033|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
696034|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
696035|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
696036|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
696037|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
696038|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
696039|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
696040|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
696041|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
696042|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
696043|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
696044|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087875|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2087876|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087877|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2087878|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2087879|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087880|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087881|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087882|NCT02176018|Quinidine|quinidine|mesh-list
2087883|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
2087884|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
2087885|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
2087886|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2087887|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2087888|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087889|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694246|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694247|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
694248|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
694249|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
694250|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
694251|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
694252|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
694253|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694254|NCT03045770|Antidotes|antidotes|mesh-ancestor
694255|NCT03045770|Protective Agents|protective agents|mesh-ancestor
694256|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
694257|NCT03045770|Vitamins|vitamins|mesh-ancestor
694258|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
694441|NCT03044964|Ranolazine|ranolazine|mesh-list
694442|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
694443|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
694444|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694932|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
694933|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
694934|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
695079|NCT03042611|Apatinib|apatinib|mesh-list
695080|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695081|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
695082|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695083|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695684|NCT03039257|Vitamin A|vitamin a|mesh-list
695685|NCT03039257|Vitamins|vitamins|mesh-ancestor
695686|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
695687|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087890|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087891|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2087892|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2087893|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
2087894|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2087895|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
2087896|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2087897|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2087898|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2087899|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087900|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2087901|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2087902|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
2087903|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2087904|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2087905|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2087906|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2087907|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2087908|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
2087909|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2087910|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2087911|NCT02176031|Prednisolone|prednisolone|mesh-list
2087912|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
2087913|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2087914|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
2087915|NCT02176031|Natalizumab|natalizumab|mesh-list
2087916|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2087917|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
2087918|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
2087919|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087920|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087921|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2087922|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
2087923|NCT02176031|Hormones|hormones|mesh-ancestor
2087924|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2087925|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2087926|NCT02176031|Protective Agents|protective agents|mesh-ancestor
2087927|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2087928|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087929|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
2087930|NCT02176291|Buprenorphine|buprenorphine|mesh-list
2087931|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2087932|NCT02176291|Narcotics|narcotics|mesh-ancestor
2087933|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2087934|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087935|NCT02176291|Analgesics|analgesics|mesh-ancestor
2087936|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
694384|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694385|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
694386|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
694387|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
694388|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
694389|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
694390|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
694391|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694392|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
694393|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
694394|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
694395|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
694396|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227295|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227296|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2227297|NCT00057031|Vitamins|vitamins|mesh-ancestor
2227298|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
695335|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
695336|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
695692|NCT03039205|Clopidogrel|clopidogrel|mesh-list
695693|NCT03039205|Ticagrelor|ticagrelor|mesh-list
695694|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
695695|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
695696|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
695697|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
695698|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
695699|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
695700|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695701|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695724|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
695725|NCT03038919|Testosterone|testosterone|mesh-list
695726|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
695727|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
695728|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
695729|NCT03038919|Androgens|androgens|mesh-ancestor
695730|NCT03038919|Hormones|hormones|mesh-ancestor
695731|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
695732|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695733|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
695734|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695735|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
695873|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
695874|NCT03038334|Analgesics|analgesics|mesh-ancestor
695875|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
695876|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695877|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695878|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
695879|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695880|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
695881|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
695882|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
695883|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
695884|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695885|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
695886|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
695887|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
696078|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
696079|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
696080|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
696081|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696082|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
696083|NCT03037515|Coagulants|coagulants|mesh-ancestor
2087937|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087938|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2087939|NCT02176356|Bimatoprost|bimatoprost|mesh-list
2087940|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2087941|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
2087942|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2087943|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2087944|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
2087945|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2087946|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2087947|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
694440|NCT03044912|Urological Agents|urological agents|mesh-ancestor
694527|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
694528|NCT03044522|Narcotics|narcotics|mesh-ancestor
694529|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694530|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694531|NCT03044522|Analgesics|analgesics|mesh-ancestor
694532|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
694533|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694726|NCT03043989|Clarithromycin|clarithromycin|mesh-list
694727|NCT03043989|Docetaxel|docetaxel|mesh-list
694728|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
694729|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
694730|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
694731|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
694732|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694733|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
694734|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694735|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
694736|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694737|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
694738|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
694918|NCT03043157|Rocuronium|rocuronium|mesh-list
694919|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
694920|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
694921|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
694922|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
694923|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695040|NCT03042546|Calcium|calcium|mesh-list
695041|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
695042|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227299|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2227300|NCT00057122|Rifampin|rifampin|mesh-list
2227301|NCT00057122|Rifapentine|rifapentine|mesh-list
695930|NCT03038321|Levofloxacin|levofloxacin|mesh-list
695931|NCT03038321|Lornoxicam|lornoxicam|mesh-list
695932|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
695933|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
695934|NCT03038321|Renal Agents|renal agents|mesh-ancestor
695935|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
695936|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
695937|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
695938|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695939|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695940|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695941|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
695942|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
695943|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
695944|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
695945|NCT03038321|Analgesics|analgesics|mesh-ancestor
695946|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
695947|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695948|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695949|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
695950|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2087948|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087949|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
2087950|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087951|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087952|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2087953|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087954|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2087955|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2087956|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
2087957|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
2087958|NCT02176356|Protective Agents|protective agents|mesh-ancestor
2087959|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
2087960|NCT02176382|Denosumab|denosumab|mesh-list
2087961|NCT02176382|Teriparatide|teriparatide|mesh-list
2087962|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2087963|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087964|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2087965|NCT02176421|Lidocaine|lidocaine|mesh-list
2087966|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
2087967|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
2227302|NCT00057122|Isoniazid|isoniazid|mesh-list
694605|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
694606|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
694607|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
694608|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
694609|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694610|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
694611|NCT03044184|Coagulants|coagulants|mesh-ancestor
694612|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
694613|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
694614|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
694615|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
694616|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
694617|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
694618|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
694619|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227303|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2227304|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
2227305|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2227306|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227307|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
2087968|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2087969|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087970|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
2087971|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087972|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2087973|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2087974|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2087975|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2087976|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087977|NCT02176486|Ixazomib|ixazomib|mesh-list
2087978|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2087979|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
2087980|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2087981|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087982|NCT02176642|Oxybutynin|oxybutynin|mesh-list
2087983|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
2087984|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
2087985|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2087986|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2087987|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2087988|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2087989|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
2087990|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2087991|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2087992|NCT02176642|Urological Agents|urological agents|mesh-ancestor
2087993|NCT02176655|Aspirin|aspirin|mesh-list
2087994|NCT02176655|Sumatriptan|sumatriptan|mesh-list
2087995|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2087996|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2087997|NCT02176655|Analgesics|analgesics|mesh-ancestor
2087998|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
2087999|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088000|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088001|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2088002|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2088003|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2088004|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2088005|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088006|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2088007|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2088008|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088009|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
2088010|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2088011|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2088012|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2088013|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
2088014|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2088015|NCT02177032|Vaccines|vaccines|mesh-list
2088016|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
2088017|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2088018|NCT02177032|Antibodies|antibodies|mesh-list
2088019|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
2088020|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088021|NCT02177786|Selonsertib|selonsertib|mesh-list
694890|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
694891|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694892|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
694893|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
694894|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
694895|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
694896|NCT03043482|Vitamins|vitamins|mesh-ancestor
694897|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
694898|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
694938|NCT03042923|Mannitol|mannitol|mesh-list
694939|NCT03042923|Lactulose|lactulose|mesh-list
694940|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
694941|NCT03042923|Diuretics|diuretics|mesh-ancestor
694942|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
694943|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
694944|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
695560|NCT03040167|Epinephrine|epinephrine|mesh-list
695561|NCT03040167|Bupivacaine|bupivacaine|mesh-list
695562|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
695563|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
695564|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695565|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695566|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
695567|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695568|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
695569|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
695570|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
695571|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
695572|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695573|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
695574|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
695575|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
695576|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
695577|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
695578|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
695579|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
695580|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
695752|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
695753|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
695754|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
695755|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
695756|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
695757|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695758|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
695759|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
695760|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695830|NCT03038594|Hormones|hormones|mesh-list
695831|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
695832|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695921|NCT03038256|Capecitabine|capecitabine|mesh-list
695922|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
695923|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
695924|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695925|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088022|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2088023|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088024|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088025|NCT02177838|Cetuximab|cetuximab|mesh-list
2088026|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2088027|NCT02177838|Antibodies|antibodies|mesh-list
2088028|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
2088029|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2088030|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
2088031|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088032|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088033|NCT02177942|Micronutrients|micronutrients|mesh-list
2088034|NCT02177942|Trace Elements|trace elements|mesh-list
2088035|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088036|NCT02178059|Terbutaline|terbutaline|mesh-list
2088037|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2088038|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
2088039|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088040|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088041|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2088042|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
694912|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
694913|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
694914|NCT03043495|Hormones|hormones|mesh-ancestor
694915|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
694916|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
694917|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695033|NCT03042871|Ranibizumab|ranibizumab|mesh-list
695034|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
695035|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
695036|NCT03042871|Growth Substances|growth substances|mesh-ancestor
695037|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695038|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
695039|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695161|NCT03041779|Acetaminophen|acetaminophen|mesh-list
695162|NCT03041779|Diclofenac|diclofenac|mesh-list
695163|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
695164|NCT03041779|Analgesics|analgesics|mesh-ancestor
695165|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
695166|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695167|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695168|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
695169|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
695170|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
695171|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
695172|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
695173|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695174|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695307|NCT03041506|Lidocaine|lidocaine|mesh-list
695308|NCT03041506|Midazolam|midazolam|mesh-list
695309|NCT03041506|Ketamine|ketamine|mesh-list
695310|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
695311|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
695312|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695313|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695314|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
695315|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695316|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
695317|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
695318|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
695319|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
695320|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695321|NCT03041506|Analgesics|analgesics|mesh-ancestor
695322|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
695323|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
695324|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
695325|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
695326|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
695327|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
695328|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
695329|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
695330|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
695331|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
695332|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
695333|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
695334|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
695610|NCT03039673|Interleukin-2|interleukin-2|mesh-list
695611|NCT03039673|Riluzole|riluzole|mesh-list
695612|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695613|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
695614|NCT03039673|Analgesics|analgesics|mesh-ancestor
695615|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
695616|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695617|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695618|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
695619|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
695620|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
695621|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
695622|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695623|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
695624|NCT03039673|Protective Agents|protective agents|mesh-ancestor
695795|NCT03038607|Aspirin|aspirin|mesh-list
695796|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
695797|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
695798|NCT03038607|Analgesics|analgesics|mesh-ancestor
695799|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
694978|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
694979|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
694980|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
695404|NCT03040791|Nivolumab|nivolumab|mesh-list
695405|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
695406|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695407|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
695408|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227308|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2227309|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227310|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227311|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2227312|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2227313|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2227314|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2227315|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
696088|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
696089|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
696090|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088043|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
2088044|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
2088045|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2088046|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2088047|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2088048|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2088049|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
2088050|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2088051|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088052|NCT02178241|Gemcitabine|gemcitabine|mesh-list
2088053|NCT02178241|Halichondrin B|halichondrin b|mesh-list
2088054|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2088055|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
2088056|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088057|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088058|NCT02178241|Antiviral Agents|antiviral agents|mesh-ancestor
2088059|NCT02178241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088060|NCT02178241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088061|NCT02178241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2088062|NCT02178241|Immunologic Factors|immunologic factors|mesh-ancestor
2088063|NCT02178241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088064|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
2088065|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
2088066|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
2088067|NCT02178358|Sorafenib|sorafenib|mesh-list
2088068|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088069|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2088070|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088071|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088072|NCT02178540|Tobramycin|tobramycin|mesh-list
2088073|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2088074|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088075|NCT02178553|Bupivacaine|bupivacaine|mesh-list
2088076|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
2088077|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
2088078|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2088079|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088080|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
2088081|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088082|NCT02178696|Citalopram|citalopram|mesh-list
2088083|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
2088084|NCT02178696|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2088085|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2088086|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088087|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088088|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2088089|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
2088090|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088091|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2088092|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2227316|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2227317|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2227318|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2227319|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
2227320|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2227321|NCT00057265|Lamivudine|lamivudine|mesh-list
2227322|NCT00057265|Telbivudine|telbivudine|mesh-list
2227323|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2227324|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2227325|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227326|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227327|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
2227328|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227329|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2227330|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
695442|NCT03040817|Esomeprazole|esomeprazole|mesh-list
695443|NCT03040817|Mosapride|mosapride|mesh-list
695444|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695445|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
695446|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
695447|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
695448|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695449|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
695450|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
695451|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
695452|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088108|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
2088109|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2088110|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088111|NCT02178800|Cabotegravir|cabotegravir|mesh-list
2088112|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2088113|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2088114|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088115|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088116|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2088117|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2088118|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
2088119|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088120|NCT02178956|Paclitaxel|paclitaxel|mesh-list
2088121|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2088122|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088123|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
2088124|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
2088125|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
2088126|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088127|NCT02178995|Methylphenidate|methylphenidate|mesh-list
2088128|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2088129|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088130|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2088131|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2088132|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088133|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088134|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
2088135|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2088136|NCT02179177|Apixaban|apixaban|mesh-list
2088137|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2088138|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
2088139|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2088140|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
2088141|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088142|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088143|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
2088144|NCT02179671|Docetaxel|docetaxel|mesh-list
2088145|NCT02179671|Gefitinib|gefitinib|mesh-list
2088146|NCT02179671|Tremelimumab|tremelimumab|mesh-list
2227331|NCT00057278|Gabapentin|gabapentin|mesh-list
695020|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
695021|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
695022|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
695023|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
695024|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
695025|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
695026|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
695027|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
695028|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
695029|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
695030|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
695031|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
695032|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
695054|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
695055|NCT03042429|Ifosfamide|ifosfamide|mesh-list
695056|NCT03042429|Cisplatin|cisplatin|mesh-list
695057|NCT03042429|Doxorubicin|doxorubicin|mesh-list
695058|NCT03042429|Etoposide|etoposide|mesh-list
695059|NCT03042429|Topotecan|topotecan|mesh-list
695060|NCT03042429|Vindesine|vindesine|mesh-list
695061|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
695062|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
695063|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695064|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
695065|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
695066|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
695067|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695068|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695069|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
695070|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
695071|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
695072|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
695073|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695074|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
695075|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
695076|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
695077|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
695078|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
2088147|NCT02179671|Osimertinib|osimertinib|mesh-list
2088148|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088149|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
2088150|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
2088151|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
2088152|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088153|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2088154|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088155|NCT02179788|Metformin|metformin|mesh-list
2088156|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2088157|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088158|NCT02179892|Acetaminophen|acetaminophen|mesh-list
2088159|NCT02179892|Dexamethasone|dexamethasone|mesh-list
2088160|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
2088161|NCT02179892|Bupivacaine|bupivacaine|mesh-list
2088162|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2088163|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
2088164|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
2088165|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088166|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088167|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2088168|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
2088169|NCT02179892|Hormones|hormones|mesh-ancestor
2088170|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2088171|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2088172|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088173|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
2088174|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
2088175|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2088176|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
2088177|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2088178|NCT02179892|Analgesics|analgesics|mesh-ancestor
2088179|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
2088180|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
2088181|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2088182|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088183|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
2088184|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227332|NCT00057278|Analgesics|analgesics|mesh-ancestor
695136|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
2088185|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088186|NCT02180100|Fluconazole|fluconazole|mesh-list
2088187|NCT02180100|Terconazole|terconazole|mesh-list
2088188|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
2088189|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227333|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
2227334|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227335|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227336|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
2227337|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2227338|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
695584|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
695585|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
695586|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
695587|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695588|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695589|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
695590|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
695591|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695592|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696045|NCT03037736|Bevacizumab|bevacizumab|mesh-list
696046|NCT03037736|Fluorouracil|fluorouracil|mesh-list
696047|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
696048|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
696049|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
696050|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
696051|NCT03037736|Growth Substances|growth substances|mesh-ancestor
696052|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696053|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
696054|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
696055|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696056|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
696057|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
696058|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
2088190|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2088191|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2088192|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088193|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088194|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2088195|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
2088196|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2088197|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088198|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2088199|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2088200|NCT02180165|Voriconazole|voriconazole|mesh-list
2088201|NCT02180165|Posaconazole|posaconazole|mesh-list
2088202|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
2088203|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088204|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2088205|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2088206|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088207|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088208|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2088209|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
2088210|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2088211|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088212|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2088213|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2088214|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2088215|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2088216|NCT02180438|Tenofovir|tenofovir|mesh-list
2088217|NCT02180438|Emtricitabine|emtricitabine|mesh-list
2088218|NCT02180438|Cobicistat|cobicistat|mesh-list
2088219|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2088220|NCT02180438|Elvitegravir|elvitegravir|mesh-list
2088221|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
2088222|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088223|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2088224|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2088225|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227339|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695276|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
695277|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
695278|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
695279|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695280|NCT03041935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
695281|NCT03041935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
695282|NCT03041935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
695283|NCT03041935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
695284|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
695285|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
695286|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
695287|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695710|NCT03039491|Vaccines|vaccines|mesh-list
695711|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
695712|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
695713|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695926|NCT03038230|Antibodies|antibodies|mesh-list
695927|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
695928|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
695929|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696013|NCT03037775|Nicotine|nicotine|mesh-list
696014|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
696015|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
696016|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696017|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696018|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
696019|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
696020|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
696021|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
696022|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088226|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088227|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2088228|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2088229|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2088230|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2088231|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2088232|NCT02180659|Buprenorphine|buprenorphine|mesh-list
2088233|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2088234|NCT02180659|Narcotics|narcotics|mesh-ancestor
2088235|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2088236|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088237|NCT02180659|Analgesics|analgesics|mesh-ancestor
2088238|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
2088239|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088240|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2088241|NCT02180672|Fluticasone|fluticasone|mesh-list
2088242|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2088243|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2088244|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
2088245|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088246|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088247|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2088248|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
2088249|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
2088250|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2752826|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088253|NCT02180828|Fluconazole|fluconazole|mesh-list
2088254|NCT02180828|Clotrimazole|clotrimazole|mesh-list
2088255|NCT02180828|Miconazole|miconazole|mesh-list
2088256|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
2088257|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088258|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2088259|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2088260|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088261|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088262|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2088263|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
2088264|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2088265|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088266|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2088267|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2088268|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2088269|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2227340|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2227341|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2227342|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2227343|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2227344|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227345|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
2227346|NCT00057304|Insulin|insulin|mesh-list
695545|NCT03040193|Lidocaine|lidocaine|mesh-list
695546|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
695547|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
695548|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695549|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695550|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
695551|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695552|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
695553|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
695554|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
695555|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
695556|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227347|NCT00057304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2227348|NCT00057304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227349|NCT00057343|Rituximab|rituximab|mesh-list
2227350|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227351|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227352|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
695791|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
695792|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
695793|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
695794|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696005|NCT03038048|Ranibizumab|ranibizumab|mesh-list
696006|NCT03038048|Aflibercept|aflibercept|mesh-list
696007|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
696008|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
696009|NCT03038048|Growth Substances|growth substances|mesh-ancestor
696010|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696011|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
696012|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088270|NCT02180867|Doxorubicin|doxorubicin|mesh-list
2088271|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2088272|NCT02180867|Daunorubicin|daunorubicin|mesh-list
2088273|NCT02180867|Ifosfamide|ifosfamide|mesh-list
2088274|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
2088275|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2088276|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088277|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2088278|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2088279|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088280|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088281|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2088282|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
2088283|NCT02181075|Doxorubicin|doxorubicin|mesh-list
2088284|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2088285|NCT02181075|Liver Extracts|liver extracts|mesh-list
2088286|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2088287|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088288|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2088289|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2088290|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088291|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088292|NCT02181075|Hematinics|hematinics|mesh-ancestor
2088293|NCT02181127|Glucagon|glucagon|mesh-list
2088294|NCT02181127|Pancrelipase|pancrelipase|mesh-list
2088295|NCT02181127|Pancreatin|pancreatin|mesh-list
2088296|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2088297|NCT02181127|Hormones|hormones|mesh-ancestor
2088298|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2088299|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088300|NCT02181231|Buprenorphine|buprenorphine|mesh-list
2088301|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2088302|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2088303|NCT02181231|Narcotics|narcotics|mesh-ancestor
2088304|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2088305|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088306|NCT02181231|Analgesics|analgesics|mesh-ancestor
2088307|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
2227353|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695379|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695380|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695540|NCT03040141|Oseltamivir|oseltamivir|mesh-list
695541|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
695542|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
695543|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695544|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088308|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088309|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2088310|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2088311|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2088312|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088313|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088314|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2088315|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2088316|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
2088317|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2088318|NCT02181296|Ropivacaine|ropivacaine|mesh-list
2088319|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
2088320|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
2088321|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2088322|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088323|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
2088324|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088325|NCT02181387|Acetaminophen|acetaminophen|mesh-list
2088326|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2088327|NCT02181387|Analgesics|analgesics|mesh-ancestor
2088328|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
2088329|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088330|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088331|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
2088332|NCT02181413|Ixazomib|ixazomib|mesh-list
2088333|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088334|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088335|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
2088336|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088337|NCT02181426|Ketorolac|ketorolac|mesh-list
2088338|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2088339|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2088340|NCT02181426|Analgesics|analgesics|mesh-ancestor
2088341|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
2088342|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088343|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088344|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2088345|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2088346|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2088347|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088348|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088349|NCT02181504|Ranibizumab|ranibizumab|mesh-list
2088350|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2088351|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2088352|NCT02181504|Growth Substances|growth substances|mesh-ancestor
2088353|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088354|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
2088355|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088356|NCT02181517|Ranibizumab|ranibizumab|mesh-list
2088357|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2088358|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2088359|NCT02181517|Growth Substances|growth substances|mesh-ancestor
2088360|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088361|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
2088362|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088363|NCT02181556|Aflibercept|aflibercept|mesh-list
2088364|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2088365|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2088366|NCT02181556|Growth Substances|growth substances|mesh-ancestor
2088367|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088368|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
2088369|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088370|NCT02181634|Gemcitabine|gemcitabine|mesh-list
2088371|NCT02181634|Paclitaxel|paclitaxel|mesh-list
2088372|NCT02181634|Antimetabolites|antimetabolites|mesh-list
2088373|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2088374|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695385|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
695386|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695708|NCT03039478|Erythritol|erythritol|mesh-list
695709|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
2227354|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2227355|NCT00057356|Conivaptan|conivaptan|mesh-list
2227356|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2227357|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227358|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
2227359|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227360|NCT00057369|Dalbavancin|dalbavancin|mesh-list
2227361|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2227362|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227363|NCT00057382|Doxorubicin|doxorubicin|mesh-list
2227364|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2227365|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227366|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2088375|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
2088376|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
2088377|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
2088378|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088379|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2088380|NCT02181634|Antiviral Agents|antiviral agents|mesh-ancestor
2088381|NCT02181634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088382|NCT02181634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088383|NCT02181634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2088384|NCT02181634|Immunologic Factors|immunologic factors|mesh-ancestor
2088385|NCT02181634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088386|NCT02181673|Golimumab|golimumab|mesh-list
2088387|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2088388|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2088389|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2088390|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
2088391|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088392|NCT02181738|Doxorubicin|doxorubicin|mesh-list
2088393|NCT02181738|Nivolumab|nivolumab|mesh-list
2088394|NCT02181738|Dacarbazine|dacarbazine|mesh-list
2088395|NCT02181738|Vinblastine|vinblastine|mesh-list
2088396|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2088397|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088398|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2088399|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2088400|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088401|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088402|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2088403|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2088404|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2088405|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
2088406|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2088407|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
2088408|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
2088409|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
2088410|NCT02181816|Amlodipine|amlodipine|mesh-list
2088411|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2088412|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2088413|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2088414|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088415|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088416|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2088417|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088418|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
2088419|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2088420|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2088421|NCT02181842|Pioglitazone|pioglitazone|mesh-list
2088422|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2088423|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088424|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2088425|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088426|NCT02182492|Clarithromycin|clarithromycin|mesh-list
2088427|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
2088428|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2088429|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088430|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2088431|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695440|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
695441|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
695668|NCT03039426|Diclofenac|diclofenac|mesh-list
695669|NCT03039426|Bupivacaine|bupivacaine|mesh-list
695670|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
695671|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
695672|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695673|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695674|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
695675|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695676|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
695677|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
695678|NCT03039426|Analgesics|analgesics|mesh-ancestor
695679|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
695680|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
695681|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
695682|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695683|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227367|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2227368|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227369|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227370|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
2227371|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227372|NCT00057408|Olanzapine|olanzapine|mesh-list
2227373|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
2227374|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
2088432|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088433|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2088434|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2088435|NCT02182492|Hormones|hormones|mesh-ancestor
2088436|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2088437|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088438|NCT02182830|Empagliflozin|empagliflozin|mesh-list
2088439|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2088440|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088441|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2088442|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088443|NCT02182895|Saxagliptin|saxagliptin|mesh-list
2088444|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2088445|NCT02182895|Incretins|incretins|mesh-ancestor
2088446|NCT02182895|Hormones|hormones|mesh-ancestor
2088447|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2088448|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088449|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
2088450|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088451|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088452|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2088453|NCT02182999|Ropivacaine|ropivacaine|mesh-list
2088454|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
2088455|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
2088456|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2088457|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088458|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
2088459|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088460|NCT02183519|Capsaicin|capsaicin|mesh-list
2088461|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
2088462|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
2088463|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
2088464|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088465|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088466|NCT02183675|Amlodipine|amlodipine|mesh-list
2088467|NCT02183675|Telmisartan|telmisartan|mesh-list
2088468|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2088469|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2088470|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2088471|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2088472|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088473|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088474|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2088475|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088476|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
2088477|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
695659|NCT03039608|Prednisone|prednisone|mesh-list
695660|NCT03039608|Triamcinolone|triamcinolone|mesh-list
695661|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
695662|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
695663|NCT03039608|Hormones|hormones|mesh-ancestor
695664|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
695665|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695666|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
695667|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
695954|NCT03038217|Capecitabine|capecitabine|mesh-list
695955|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
695956|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
695957|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
695958|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695959|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088478|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2088479|NCT02183675|Diuretics|diuretics|mesh-ancestor
2088480|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
2088481|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2088482|NCT02183792|Furosemide|furosemide|mesh-list
2088483|NCT02183792|Tolvaptan|tolvaptan|mesh-list
2088484|NCT02183792|Diuretics|diuretics|mesh-ancestor
2088485|NCT02183792|Natriuretic Agents|natriuretic agents|mesh-ancestor
2088486|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088487|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2088488|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088489|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088490|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2088491|NCT02184195|Olaparib|olaparib|mesh-list
2088492|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2088493|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088494|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088495|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088496|NCT02184572|Vaccines|vaccines|mesh-list
2088497|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
2088498|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088499|NCT02184611|Bromides|bromides|mesh-list
2088500|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
2088501|NCT02185014|Adalimumab|adalimumab|mesh-list
2088502|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2088503|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2088504|NCT02185131|Mirtazapine|mirtazapine|mesh-list
2088505|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
2088506|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2088507|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2088508|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
2088509|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
2088510|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2088511|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088512|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088513|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2088514|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2088515|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2088516|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2088517|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2088518|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2088519|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
2088520|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2088521|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2088522|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
2088523|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2088524|NCT02185339|Rocuronium|rocuronium|mesh-list
2088525|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2088526|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2088527|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2088528|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088529|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088530|NCT02185534|Clopidogrel|clopidogrel|mesh-list
2088531|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2088532|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2088533|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
695520|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
695521|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695688|NCT03039413|Copper|copper|mesh-list
695689|NCT03039413|Trace Elements|trace elements|mesh-ancestor
695690|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
695691|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695736|NCT03038958|Prilocaine|prilocaine|mesh-list
695737|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
695738|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
695739|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
695740|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695741|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695742|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
695743|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088534|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2088535|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
2088536|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2088537|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088538|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088539|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2088540|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2088541|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2088542|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2088543|NCT02186015|Vitamin D|vitamin d|mesh-list
2088544|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
2088545|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
2088546|NCT02186015|Vitamins|vitamins|mesh-list
2088547|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
2088548|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088549|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2088550|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2088551|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2088552|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088553|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2088554|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088555|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088556|NCT02186652|Pantoprazole|pantoprazole|mesh-list
2088557|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2088558|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2088559|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2088560|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088561|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088562|NCT02186665|Calcitriol|calcitriol|mesh-list
2088563|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2088564|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088565|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2088566|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088567|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088568|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2088569|NCT02186665|Vitamins|vitamins|mesh-ancestor
2088570|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
2088571|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2088572|NCT02186821|Ceritinib|ceritinib|mesh-list
2088573|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088574|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2088575|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088576|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695537|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
695538|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
695539|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227375|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
2227376|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227377|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227378|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2227379|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2227380|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695978|NCT03037970|Becaplermin|becaplermin|mesh-list
695979|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
695980|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
695981|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
695982|NCT03037970|Growth Substances|growth substances|mesh-ancestor
695983|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088596|NCT02186847|Metformin|metformin|mesh-list
2088597|NCT02186847|Paclitaxel|paclitaxel|mesh-list
2088598|NCT02186847|Carboplatin|carboplatin|mesh-list
2088599|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2088600|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088601|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
2088602|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
2088603|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
2088604|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088605|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2088606|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088607|NCT02186873|Golimumab|golimumab|mesh-list
2088608|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2088609|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2088610|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2088611|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
2088612|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088613|NCT02187016|Listerine|listerine|mesh-list
2088614|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2088615|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088616|NCT02187055|Adalimumab|adalimumab|mesh-list
2088617|NCT02187055|Methotrexate|methotrexate|mesh-list
2088618|NCT02187055|Tofacitinib|tofacitinib|mesh-list
2088619|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2088620|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
2088621|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2088622|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088623|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2088624|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
2088625|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088626|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088627|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
2088628|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088629|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2088630|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2088631|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
2088632|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2088633|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2088634|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2088635|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2088636|NCT02187159|Pregabalin|pregabalin|mesh-list
2088637|NCT02187159|Analgesics|analgesics|mesh-ancestor
2088638|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
2088639|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088640|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088641|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
2088642|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2088643|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088644|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088645|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2088646|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2088647|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2088648|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2088649|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2088650|NCT02187172|Ustekinumab|ustekinumab|mesh-list
2088651|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
2088652|NCT02187471|Pregabalin|pregabalin|mesh-list
2088653|NCT02187471|Analgesics|analgesics|mesh-ancestor
2088654|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
695652|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
695653|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695654|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
695655|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
695656|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
695657|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
695658|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2088655|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088656|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088657|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
2088658|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2088659|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088660|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088661|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
696065|NCT03037606|Rabeprazole|rabeprazole|mesh-list
696066|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
696067|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
696068|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
696069|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696070|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088662|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2088663|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2088664|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2088665|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2088666|NCT02187744|Carboplatin|carboplatin|mesh-list
2088667|NCT02187744|Docetaxel|docetaxel|mesh-list
2088668|NCT02187744|Trastuzumab|trastuzumab|mesh-list
2088669|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088670|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
2088671|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
2088672|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
2088673|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088674|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2088675|NCT02187809|Clobazam|clobazam|mesh-list
2088676|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
2088677|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2088678|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2088679|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2088680|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088681|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2088682|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2088683|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
2088684|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
2088685|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2088686|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088687|NCT02187861|Rituximab|rituximab|mesh-list
2088688|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2088689|NCT02187861|Venetoclax|venetoclax|mesh-list
2088690|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2088691|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088692|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
2088693|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088694|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2088695|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2088696|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
2088697|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088698|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2088699|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2088700|NCT02188459|Bupropion|bupropion|mesh-list
2088701|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2088702|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
2088703|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2088704|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2088705|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2088706|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088707|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088708|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
2088709|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2088710|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088711|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2088712|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2088713|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088714|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
2088715|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
695800|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
695801|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
695802|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
695803|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
695804|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
695805|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
695806|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
695807|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
695808|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
695809|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
695810|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
696059|NCT03038009|Pantoprazole|pantoprazole|mesh-list
696060|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
696061|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
696062|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
696063|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696064|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088716|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2088717|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088718|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
2088719|NCT02188576|Coagulants|coagulants|mesh-ancestor
2088720|NCT02188719|Acetaminophen|acetaminophen|mesh-list
2088721|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
2088722|NCT02188719|Promethazine|promethazine|mesh-list
2088723|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
2088724|NCT02188719|Valganciclovir|valganciclovir|mesh-list
2088725|NCT02188719|Ganciclovir|ganciclovir|mesh-list
2088726|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
2088727|NCT02188719|Prednisone|prednisone|mesh-list
2088728|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2088729|NCT02188719|Everolimus|everolimus|mesh-list
2088730|NCT02188719|Liver Extracts|liver extracts|mesh-list
2088731|NCT02188719|Tacrolimus|tacrolimus|mesh-list
2088732|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
2088733|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2088734|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2088735|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
2088736|NCT02188719|Hormones|hormones|mesh-ancestor
2088737|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2088738|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088739|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2088740|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088741|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2088742|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
2088743|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2088744|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088745|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088746|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2088747|NCT02188719|Analgesics|analgesics|mesh-ancestor
2088748|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
2088749|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088750|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
2088751|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2088752|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2088753|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
2088754|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2088755|NCT02188719|Hematinics|hematinics|mesh-ancestor
2088756|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2088757|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2088758|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2088759|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
2088760|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
2088761|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
2088762|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
2088763|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2088764|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2088765|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
2088766|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
2088767|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2088768|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2088769|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
2088770|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
2088771|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
2088772|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2088773|NCT02188719|Protective Agents|protective agents|mesh-ancestor
2088774|NCT02188784|Iron|iron|mesh-list
2088775|NCT02188784|Trace Elements|trace elements|mesh-ancestor
2088776|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
2227381|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2227382|NCT00057408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2227383|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2752827|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088777|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088778|NCT02189122|Aspirin|aspirin|mesh-list
2088779|NCT02189122|Bradykinin|bradykinin|mesh-list
2088780|NCT02189122|Kininogens|kininogens|mesh-list
2088781|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2088782|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2088783|NCT02189122|Analgesics|analgesics|mesh-ancestor
2088784|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
2088785|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088786|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088787|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2088788|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2088789|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2088790|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2088791|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088792|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2088793|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2088794|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088795|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
2088796|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
2088797|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2088798|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
2088799|NCT02189213|Sertraline|sertraline|mesh-list
2088800|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
2088801|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2088802|NCT02189213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2088803|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2088804|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088805|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088806|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2088807|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
2088808|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088809|NCT02189317|Bupivacaine|bupivacaine|mesh-list
2088810|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
2088811|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
2088812|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2088813|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088814|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
2088815|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088816|NCT02189629|Trifarotene|trifarotene|mesh-list
2088817|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
2088818|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2088819|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2088820|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088821|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2088822|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088823|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088824|NCT02189837|Atorvastatin|atorvastatin|mesh-list
2088825|NCT02189837|Evolocumab|evolocumab|mesh-list
2088826|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2088827|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2088828|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2088829|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
2088830|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088831|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2088832|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2088833|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088834|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
2088835|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088836|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2088837|NCT02189889|Hematinics|hematinics|mesh-ancestor
2088838|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2088839|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2088840|NCT02189941|Deferiprone|deferiprone|mesh-list
2088841|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2088842|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
2088843|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
2088844|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752828|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2752829|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
696077|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
696091|NCT03037372|Atorvastatin|atorvastatin|mesh-list
696092|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
696093|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
696094|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
696095|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
696096|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
696097|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696098|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
696099|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696100|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
696101|NCT03037437|Sorafenib|sorafenib|mesh-list
696102|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
696103|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
696104|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696105|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696106|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
696107|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
696108|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
696109|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
696110|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
696111|NCT03036995|Apremilast|apremilast|mesh-list
696112|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
696113|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
696114|NCT03036995|Analgesics|analgesics|mesh-ancestor
696115|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
696116|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696117|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696118|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
696119|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
696120|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
696121|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
696122|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696123|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696124|NCT03036826|Meropenem|meropenem|mesh-list
696125|NCT03036826|Tazobactam|tazobactam|mesh-list
696126|NCT03036826|Piperacillin|piperacillin|mesh-list
696127|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
696128|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
696129|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
696130|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
696131|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696132|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696133|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
696134|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
696135|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
696136|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
696137|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696138|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
696139|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696140|NCT03037073|Analgesics|analgesics|mesh-ancestor
696141|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
696142|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696143|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
696144|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
696145|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
696146|NCT03036800|Liraglutide|liraglutide|mesh-list
696148|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
696149|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696150|NCT03036800|Incretins|incretins|mesh-ancestor
696151|NCT03036800|Hormones|hormones|mesh-ancestor
696152|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
696147|NCT03036891|Naloxegol|naloxegol|mesh-list
696153|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
696154|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696155|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
696156|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696157|NCT03036748|Amiloride|amiloride|mesh-list
696158|NCT03036748|Diuretics|diuretics|mesh-ancestor
696159|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
696160|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696161|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
696162|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
696163|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
696164|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696165|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
696166|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2752830|NCT03287908|Hormones|hormones|mesh-ancestor
2088849|NCT02190903|Anesthetics|anesthetics|mesh-list
2088850|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2227384|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2227385|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227386|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2227387|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
2227388|NCT00057421|Prednisolone|prednisolone|mesh-list
696175|NCT03036904|Prednisone|prednisone|mesh-list
696176|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
696177|NCT03036904|Rituximab|rituximab|mesh-list
696178|NCT03036904|Doxorubicin|doxorubicin|mesh-list
696179|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
696180|NCT03036904|Etoposide|etoposide|mesh-list
696181|NCT03036904|Vincristine|vincristine|mesh-list
696182|NCT03036904|Venetoclax|venetoclax|mesh-list
696183|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
696184|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
696185|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696186|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
696187|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
696188|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
696189|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696190|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
696191|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
696192|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
696193|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
696194|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
696195|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
696196|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696197|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
696198|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
696199|NCT03036904|Hormones|hormones|mesh-ancestor
696200|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
696201|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
696202|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
696203|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
696204|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
696205|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
2227389|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2227390|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
2227391|NCT00057421|Hormones|hormones|mesh-ancestor
2227392|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2227393|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227394|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2227395|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227396|NCT00057447|Interferons|interferons|mesh-list
2227397|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
2227398|NCT00057447|Rituximab|rituximab|mesh-list
2227399|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227400|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
696498|NCT03035695|Hemostatics|hemostatics|mesh-list
696499|NCT03035695|Coagulants|coagulants|mesh-ancestor
2227401|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
2227402|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227403|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
696563|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
696564|NCT03035331|Vaccines|vaccines|mesh-list
696565|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
696566|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696567|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
696568|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
696569|NCT03034759|Insulin|insulin|mesh-list
696570|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
696571|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088851|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088852|NCT02191033|Nicotine|nicotine|mesh-list
2088853|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2088854|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
2088855|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088856|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088857|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
696749|NCT03034005|Budesonide|budesonide|mesh-list
696211|NCT03036501|Risdiplam|risdiplam|mesh-list
696212|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
696213|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696214|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696215|NCT03036605|Dexamethasone|dexamethasone|mesh-list
696216|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
696217|NCT03036605|Bupivacaine|bupivacaine|mesh-list
696218|NCT03036605|BB 1101|bb 1101|mesh-list
696219|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
696220|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
696221|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
696222|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696223|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696224|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
696225|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
696226|NCT03036605|Hormones|hormones|mesh-ancestor
696227|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
696228|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
696229|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
696230|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
696231|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696232|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696233|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
696234|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
696235|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
696236|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
696237|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
696238|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
696239|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
696240|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696241|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696242|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
696243|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
696244|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
696245|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696246|NCT03036514|Sufentanil|sufentanil|mesh-list
696247|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
696248|NCT03036514|Narcotics|narcotics|mesh-ancestor
696249|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
696250|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696251|NCT03036514|Analgesics|analgesics|mesh-ancestor
696252|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
696253|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696254|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
696255|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
696256|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
696257|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
696258|NCT03036488|Paclitaxel|paclitaxel|mesh-list
696259|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
696260|NCT03036488|Carboplatin|carboplatin|mesh-list
696261|NCT03036488|Doxorubicin|doxorubicin|mesh-list
696262|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
696263|NCT03036488|Epirubicin|epirubicin|mesh-list
696264|NCT03036488|Lenograstim|lenograstim|mesh-list
696265|NCT03036488|Sargramostim|sargramostim|mesh-list
696266|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
696267|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
696268|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
696269|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
696270|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
696271|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696272|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
696273|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
696274|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696275|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
696276|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
696277|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
696278|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
696279|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
696280|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
696281|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
696282|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696283|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
696284|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
696285|NCT03036644|Nicotine|nicotine|mesh-list
696286|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
696287|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
696295|NCT03036202|Epinephrine|epinephrine|mesh-list
696288|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696289|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696290|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
696291|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
696292|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
696293|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
696294|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227404|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
2227405|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227406|NCT00057473|Carboplatin|carboplatin|mesh-list
2227407|NCT00057473|Irinotecan|irinotecan|mesh-list
2227408|NCT00057473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227409|NCT00057473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2227410|NCT00057473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
696693|NCT03034382|Lidocaine|lidocaine|mesh-list
696694|NCT03034382|Epinephrine|epinephrine|mesh-list
696695|NCT03034382|Morphine|morphine|mesh-list
696696|NCT03034382|Nalbuphine|nalbuphine|mesh-list
696697|NCT03034382|Bupivacaine|bupivacaine|mesh-list
696698|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
696699|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
696700|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
696701|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696702|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
696703|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696704|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
696705|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
696706|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
696707|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
696708|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696709|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
696710|NCT03034382|Narcotics|narcotics|mesh-ancestor
696711|NCT03034382|Analgesics|analgesics|mesh-ancestor
696712|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
696713|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
696714|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
696715|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
696716|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
696717|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
696718|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
696719|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
696720|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
696721|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
696722|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
696723|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
696803|NCT03033537|Verapamil|verapamil|mesh-list
696804|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
696805|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
696806|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696807|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
696808|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
696809|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696810|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
697128|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
697129|NCT03032406|Everolimus|everolimus|mesh-list
697130|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697131|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
697132|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
697133|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697134|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
697135|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
697136|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
697137|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697138|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697139|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697140|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
697204|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
697205|NCT03032107|Trastuzumab|trastuzumab|mesh-list
697206|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
697207|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
697208|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697209|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
697210|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
697211|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
697212|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697553|NCT03030560|Lidocaine|lidocaine|mesh-list
2227411|NCT00057473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696296|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
696297|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
696298|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
696299|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
696300|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696301|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696302|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
696303|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
696304|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
696305|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696306|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
696307|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
696308|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
696309|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
696310|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
696311|NCT03036059|Ivermectin|ivermectin|mesh-list
696312|NCT03036059|Albendazole|albendazole|mesh-list
696313|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
696314|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
696315|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
696316|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
696317|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
696318|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
696319|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
696320|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
696321|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
696322|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696323|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
696368|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
696369|NCT03035838|Aprepitant|aprepitant|mesh-list
696370|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
696371|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
696372|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696373|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696374|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
696375|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
696376|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
696377|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696868|NCT03033446|Nivolumab|nivolumab|mesh-list
696869|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
696870|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
696871|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
696872|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752831|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2752832|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2752833|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752834|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
2752835|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2752836|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2752837|NCT03287908|Growth Substances|growth substances|mesh-ancestor
2752838|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
2752839|NCT03284385|Adavosertib|adavosertib|mesh-list
2752840|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752841|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697104|NCT03032458|Ketorolac|ketorolac|mesh-list
697105|NCT03032458|Lidocaine|lidocaine|mesh-list
697106|NCT03032458|Meperidine|meperidine|mesh-list
697107|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
697108|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
697109|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
697110|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697111|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
697112|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
697113|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
697114|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
697115|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
697116|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
697117|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697118|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
697119|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
697120|NCT03032458|Analgesics|analgesics|mesh-ancestor
696324|NCT03036046|Fluconazole|fluconazole|mesh-list
696325|NCT03036046|Posaconazole|posaconazole|mesh-list
696326|NCT03036046|Olorofim|olorofim|mesh-list
696327|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
696328|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
696329|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
696330|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
696331|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696332|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696333|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
696334|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
696335|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
696336|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696337|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
696338|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
696339|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
696340|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
696341|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2227412|NCT00057473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227413|NCT00057512|Masoprocol|masoprocol|mesh-list
2227414|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
2227415|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227416|NCT00057512|Protective Agents|protective agents|mesh-ancestor
2227417|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227418|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2227419|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227420|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2227421|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2227422|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2227423|NCT00057512|Analgesics|analgesics|mesh-ancestor
2227424|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
2227425|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227426|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2227427|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2227428|NCT00057564|Thalidomide|thalidomide|mesh-list
696359|NCT03036111|Trimebutine|trimebutine|mesh-list
696360|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
696361|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
696362|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
696363|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696364|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227429|NCT00057564|Dexamethasone|dexamethasone|mesh-list
2227430|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
2227431|NCT00057564|BB 1101|bb 1101|mesh-list
696378|NCT03036085|Epinephrine|epinephrine|mesh-list
696379|NCT03036085|Bupivacaine|bupivacaine|mesh-list
696380|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
696381|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
696382|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
696383|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696384|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
696385|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696386|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
696387|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
696388|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
696389|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
696390|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696391|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
696392|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
696393|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
696394|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
696395|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
696396|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
696397|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
696398|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2227432|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2227433|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
2227434|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
2227435|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227436|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227437|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2227438|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
2227439|NCT00057564|Hormones|hormones|mesh-ancestor
2227440|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2227441|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2227442|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227443|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
2227444|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227445|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696595|NCT03035045|Acetaminophen|acetaminophen|mesh-list
696596|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
696597|NCT03035045|Analgesics|analgesics|mesh-ancestor
696598|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
696599|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696600|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696601|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
698191|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
698192|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
698193|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
698194|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
698195|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698196|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
698197|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
698198|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
698556|NCT03025594|Ketorolac|ketorolac|mesh-list
698557|NCT03025594|Epinephrine|epinephrine|mesh-list
698558|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
698559|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
698560|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
698561|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
698562|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
698563|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698564|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698565|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
698566|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
698567|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
698568|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698569|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
698570|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
698571|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
698572|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
698573|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
698574|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
698575|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
698576|NCT03025594|Analgesics|analgesics|mesh-ancestor
698577|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
698578|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
698579|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
698580|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
698581|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698582|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
698583|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
698584|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
698945|NCT03023436|Fluorouracil|fluorouracil|mesh-list
698946|NCT03023436|Capecitabine|capecitabine|mesh-list
698947|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698948|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
698949|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698950|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
698951|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
698952|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
698953|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699022|NCT03023059|Levodopa|levodopa|mesh-list
699023|NCT03023059|Carbidopa|carbidopa|mesh-list
699024|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
699025|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
699026|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
699027|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
699028|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
699029|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699030|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699031|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
699032|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699033|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
699034|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
2088858|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2088859|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
2088860|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2088861|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088862|NCT02191137|Riociguat|riociguat|mesh-list
2088863|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
2088864|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088865|NCT02191397|Dexetimide|dexetimide|mesh-list
2088866|NCT02191397|Citalopram|citalopram|mesh-list
2088867|NCT02191397|Bupropion|bupropion|mesh-list
2088868|NCT02191397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2088869|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2088870|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088871|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088872|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2088873|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
2227446|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227447|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
2227448|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
2227449|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2227450|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227451|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2227452|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2227453|NCT00057564|Growth Substances|growth substances|mesh-ancestor
2227454|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
2227455|NCT00057616|Lenalidomide|lenalidomide|mesh-list
2227456|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
2227457|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227458|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2227459|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2227460|NCT00057616|Growth Substances|growth substances|mesh-ancestor
2227461|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
2227462|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227463|NCT00057642|Sertraline|sertraline|mesh-list
2227464|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2227465|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
2227466|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2227467|NCT00057642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2227468|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2227469|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2227470|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227471|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2227472|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
2227473|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227474|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2227475|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2227476|NCT00057707|Modafinil|modafinil|mesh-list
2227477|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2227478|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227479|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
696602|NCT03035058|Vedolizumab|vedolizumab|mesh-list
696603|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2088874|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088875|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2088876|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
2088877|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2088878|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2088879|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
696960|NCT03033095|Etanercept|etanercept|mesh-list
696961|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
696962|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
696963|NCT03033095|Analgesics|analgesics|mesh-ancestor
696964|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
696965|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696966|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696967|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
696968|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
696969|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
696970|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
696971|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
697007|NCT03033342|Omeprazole|omeprazole|mesh-list
697008|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
697009|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
697010|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
696471|NCT03035630|Sunitinib|sunitinib|mesh-list
696472|NCT03035630|Avelumab|avelumab|mesh-list
696473|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
696474|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
696475|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
696476|NCT03035630|Growth Substances|growth substances|mesh-ancestor
696477|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696478|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
696479|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
696480|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696481|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696482|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
696483|NCT03035656|Ropivacaine|ropivacaine|mesh-list
696484|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
696485|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
696486|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
696487|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696488|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
696489|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696942|NCT03033264|Dinoprostone|dinoprostone|mesh-list
696943|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
696944|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
696945|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696995|NCT03033316|Dexamethasone|dexamethasone|mesh-list
696996|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
696997|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
696998|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
696999|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
697000|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697001|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
697002|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
697003|NCT03033316|Hormones|hormones|mesh-ancestor
697004|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
697005|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
697006|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697098|NCT03032614|Carboplatin|carboplatin|mesh-list
697099|NCT03032614|Veliparib|veliparib|mesh-list
697100|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697101|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
697102|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697103|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697707|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
697708|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
697709|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
697710|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
697711|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697712|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
697713|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
697714|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697715|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697778|NCT03029442|Denosumab|denosumab|mesh-list
697779|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
697780|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697963|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
697964|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
697965|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697966|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
697967|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
697968|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
697969|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697985|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
697986|NCT03028298|Citric Acid|citric acid|mesh-list
697987|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
697988|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
697989|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
697990|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
697991|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
697992|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697993|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
697994|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
697995|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
697996|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697997|NCT03028298|Urological Agents|urological agents|mesh-ancestor
2227480|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2227481|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
696490|NCT03035578|Morphine|morphine|mesh-list
696491|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
696492|NCT03035578|Narcotics|narcotics|mesh-ancestor
696493|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
696494|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696495|NCT03035578|Analgesics|analgesics|mesh-ancestor
696496|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
696497|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696811|NCT03033758|Budesonide|budesonide|mesh-list
696812|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
696813|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
696814|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
696815|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
696816|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696817|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696818|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
696819|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
696820|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
696821|NCT03033758|Hormones|hormones|mesh-ancestor
696822|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
696823|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
696824|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
696825|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
696826|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
696827|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
696828|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696846|NCT03033472|Clindamycin|clindamycin|mesh-list
696847|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
696848|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
696849|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
696850|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
696851|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
696852|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696853|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697169|NCT03032315|Amlodipine|amlodipine|mesh-list
697170|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
697171|NCT03032315|Telmisartan|telmisartan|mesh-list
697172|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
697173|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
697174|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
697175|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
697176|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697177|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
697178|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697179|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
697180|NCT03032315|Diuretics|diuretics|mesh-ancestor
697181|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
697182|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
697183|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
697184|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
697525|NCT03031119|Atorvastatin|atorvastatin|mesh-list
697526|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
697527|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
697528|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
697529|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697530|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
697531|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
697532|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697608|NCT03030300|Metformin|metformin|mesh-list
697609|NCT03030300|Pioglitazone|pioglitazone|mesh-list
697610|NCT03030300|Insulin|insulin|mesh-list
697611|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
697612|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752851|NCT03277066|Diclofenac|diclofenac|mesh-list
2752852|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2752853|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
698290|NCT03027115|Tamsulosin|tamsulosin|mesh-list
698291|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
698292|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
698293|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
698294|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
698295|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
698296|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696500|NCT03035617|Bupivacaine|bupivacaine|mesh-list
696501|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
696502|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
696503|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
696504|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696505|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
696506|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227482|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227483|NCT00057720|Doxorubicin|doxorubicin|mesh-list
2227484|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2227485|NCT00057720|Topotecan|topotecan|mesh-list
2227486|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2227487|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227488|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
696552|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
696553|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
696554|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696676|NCT03034408|Mannitol|mannitol|mesh-list
696677|NCT03034408|Baclofen|baclofen|mesh-list
696678|NCT03034408|Nalmefene|nalmefene|mesh-list
696679|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
696680|NCT03034408|Diuretics|diuretics|mesh-ancestor
696681|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
696682|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696683|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
696684|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
696685|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696686|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
696687|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
696688|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
696689|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
696690|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696691|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
696692|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
696795|NCT03033589|Bupivacaine|bupivacaine|mesh-list
696796|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
696797|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
696798|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
696799|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
696800|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696801|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
696802|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088880|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
2088881|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
2227489|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
697067|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
697068|NCT03032666|Velpatasvir|velpatasvir|mesh-list
697069|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
697070|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697141|NCT03032536|Tenofovir|tenofovir|mesh-list
697142|NCT03032536|Entecavir|entecavir|mesh-list
697143|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
697144|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697145|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
697146|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
697147|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697148|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697149|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
697150|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
697289|NCT03031405|Oxytocin|oxytocin|mesh-list
697290|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
697291|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
697292|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697672|NCT03030105|Scopolamine|scopolamine|mesh-list
697673|NCT03030105|Donepezil|donepezil|mesh-list
697674|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
697675|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
697676|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697677|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697678|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
697679|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
697680|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696519|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
696951|NCT03033147|Amoxicillin|amoxicillin|mesh-list
696952|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
696953|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
696954|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
696955|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
696956|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
696957|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
696958|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696959|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697071|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
697072|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
697073|NCT03032783|Tacrolimus|tacrolimus|mesh-list
697074|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
697075|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
697076|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697077|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
697078|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
697079|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
697080|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697081|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697082|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
697083|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
697084|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697085|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
697086|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
697087|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
697088|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
697089|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088882|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088883|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2088884|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2088885|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
697229|NCT03031691|Trifluridine|trifluridine|mesh-list
697230|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
697231|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697232|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
697233|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697397|NCT03031353|Misoprostol|misoprostol|mesh-list
697398|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
697399|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
697400|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
697401|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697402|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
697403|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
697404|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
697626|NCT03030196|Denosumab|denosumab|mesh-list
697627|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
697628|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697873|NCT03029013|Apatinib|apatinib|mesh-list
697874|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697875|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
697876|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697877|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697970|NCT03028766|Adavosertib|adavosertib|mesh-list
697971|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697972|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698710|NCT03024905|Misoprostol|misoprostol|mesh-list
698711|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
698712|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
698713|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
698714|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698715|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
698716|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
698717|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
698735|NCT03024502|Clotrimazole|clotrimazole|mesh-list
698736|NCT03024502|Miconazole|miconazole|mesh-list
698737|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
698738|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
698739|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
698740|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
698741|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
698742|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698743|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698744|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
696520|NCT03035214|Dexamethasone|dexamethasone|mesh-list
696521|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
696522|NCT03035214|BB 1101|bb 1101|mesh-list
696523|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
696524|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
696525|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
696526|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696527|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696528|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
696529|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
696530|NCT03035214|Hormones|hormones|mesh-ancestor
696531|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
696533|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
696534|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
696535|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
696536|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696537|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696532|NCT03035357|Daratumumab|daratumumab|mesh-list
696538|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227490|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227491|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227492|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2227493|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
2227494|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227495|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
2227496|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2227497|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2227498|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227499|NCT00057759|Urological Agents|urological agents|mesh-ancestor
2227500|NCT00057798|Gemcitabine|gemcitabine|mesh-list
2227501|NCT00057798|Vinorelbine|vinorelbine|mesh-list
2227502|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
696651|NCT03034707|Biotin|biotin|mesh-list
696652|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
696653|NCT03034707|Vitamins|vitamins|mesh-ancestor
696654|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
696655|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696760|NCT03034304|Ifosfamide|ifosfamide|mesh-list
696761|NCT03034304|Antibodies|antibodies|mesh-list
696762|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
696763|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696764|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
696765|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
696766|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696767|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
696829|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
696830|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
696831|NCT03033654|Protective Agents|protective agents|mesh-ancestor
696832|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696833|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
2752854|NCT03277066|Analgesics|analgesics|mesh-ancestor
2752855|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
2752856|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2752857|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752858|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2752859|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2752860|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2752861|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752862|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227503|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
696539|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
696540|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
696541|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
696542|NCT03035305|Amodiaquine|amodiaquine|mesh-list
696543|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
696544|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
696545|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
696546|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
696547|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
696548|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696549|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696550|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
696551|NCT03035305|Renal Agents|renal agents|mesh-ancestor
696555|NCT03035084|Vitamin D|vitamin d|mesh-list
696556|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
696557|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
696558|NCT03035084|Vitamins|vitamins|mesh-list
696559|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
696560|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696561|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
696562|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
696579|NCT03034850|Doxorubicin|doxorubicin|mesh-list
696580|NCT03034850|Fluorouracil|fluorouracil|mesh-list
696581|NCT03034850|Ifosfamide|ifosfamide|mesh-list
696582|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
696583|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
696584|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
696585|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
696586|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696587|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696588|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
696589|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
696590|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
696591|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
696592|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696593|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
696594|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
2227504|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227505|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227506|NCT00057798|Antiviral Agents|antiviral agents|mesh-ancestor
2227507|NCT00057798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227508|NCT00057798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227509|NCT00057798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227510|NCT00057798|Immunologic Factors|immunologic factors|mesh-ancestor
2227511|NCT00057798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227512|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2227513|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
2227514|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
2227515|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
2227516|NCT00057850|Cisplatin|cisplatin|mesh-list
2227517|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227518|NCT00057889|Ipilimumab|ipilimumab|mesh-list
2227519|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227520|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227521|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2227522|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227523|NCT00057928|Gemcitabine|gemcitabine|mesh-list
2227524|NCT00057928|Paclitaxel|paclitaxel|mesh-list
2227525|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2227526|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227527|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
2227528|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
2227529|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
2227530|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227531|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2227532|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
2227533|NCT00057928|Antiviral Agents|antiviral agents|mesh-ancestor
2227534|NCT00057928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227535|NCT00057928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227536|NCT00057928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227537|NCT00057928|Immunologic Factors|immunologic factors|mesh-ancestor
2227538|NCT00057928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227539|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
2227540|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
696572|NCT03034941|Metformin|metformin|mesh-list
696573|NCT03034941|Liraglutide|liraglutide|mesh-list
696574|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
696575|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696576|NCT03034941|Incretins|incretins|mesh-ancestor
696577|NCT03034941|Hormones|hormones|mesh-ancestor
696578|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
696619|NCT03034733|Dexamethasone|dexamethasone|mesh-list
696620|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
696621|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
696622|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
696623|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696624|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696625|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
696626|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
696627|NCT03034733|Hormones|hormones|mesh-ancestor
696628|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
696629|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
696630|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088886|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2088887|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
2227541|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227542|NCT00057980|Celecoxib|celecoxib|mesh-list
2227543|NCT00057980|Epirubicin|epirubicin|mesh-list
2227544|NCT00057980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2227545|NCT00057980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2227546|NCT00057980|Analgesics|analgesics|mesh-ancestor
2227547|NCT00057980|Sensory System Agents|sensory system agents|mesh-ancestor
2227548|NCT00057980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227549|NCT00057980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227550|NCT00057980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2227551|NCT00057980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2227552|NCT00057980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2227553|NCT00057980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2227554|NCT00057980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227555|NCT00057980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227556|NCT00057980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2227557|NCT00057980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227558|NCT00057980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2227559|NCT00057980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2227560|NCT00057993|Trastuzumab|trastuzumab|mesh-list
2227561|NCT00057993|Exemestane|exemestane|mesh-list
2227562|NCT00057993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227563|NCT00057993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227564|NCT00057993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2227565|NCT00057993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2227566|NCT00057993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227567|NCT00057993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227568|NCT00057993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2227569|NCT00057993|Hormone Antagonists|hormone antagonists|mesh-ancestor
2227570|NCT00057993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2227571|NCT00057993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227572|NCT00058006|Celecoxib|celecoxib|mesh-list
2227573|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2227574|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2227575|NCT00058006|Analgesics|analgesics|mesh-ancestor
697293|NCT03031210|Amoxicillin|amoxicillin|mesh-list
697294|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
697295|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697405|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
697406|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
697407|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
697408|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697409|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
697410|NCT03031054|Protective Agents|protective agents|mesh-ancestor
697489|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
697490|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
697491|NCT03030716|Procyanidin|procyanidin|mesh-list
697492|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
697493|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697494|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
697495|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697496|NCT03030716|Protective Agents|protective agents|mesh-ancestor
697497|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697498|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2088888|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2088889|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2088890|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697166|NCT03032419|Vaccines|vaccines|mesh-list
697167|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
697168|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227576|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
2227577|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227578|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227579|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2227580|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
697381|NCT03031483|Clarithromycin|clarithromycin|mesh-list
697382|NCT03031483|Lenalidomide|lenalidomide|mesh-list
697383|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
697384|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697385|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
697386|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
697387|NCT03031483|Growth Substances|growth substances|mesh-ancestor
697388|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
697389|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697390|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
697391|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697392|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
697393|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697394|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697395|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
697396|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
697613|NCT03030287|Paclitaxel|paclitaxel|mesh-list
697614|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
697615|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
697616|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697617|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
697618|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
697619|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
697620|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697621|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
697622|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227581|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2088891|NCT02191579|Topiramate|topiramate|mesh-list
2088892|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
2088893|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2088894|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
698585|NCT03025477|Paclitaxel|paclitaxel|mesh-list
698586|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
698587|NCT03025477|Cisplatin|cisplatin|mesh-list
698588|NCT03025477|Carboplatin|carboplatin|mesh-list
698589|NCT03025477|Epirubicin|epirubicin|mesh-list
698590|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
698591|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698592|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
698593|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
698594|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
698595|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698596|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
698597|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
698598|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
698599|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088895|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2088896|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088897|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088898|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
2088899|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
698745|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
2227582|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2227583|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227584|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227585|NCT00058045|Aldesleukin|aldesleukin|mesh-list
697036|NCT03032848|Estrogens|estrogens|mesh-list
697037|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
697038|NCT03032848|Hormones|hormones|mesh-ancestor
697039|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
697040|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697541|NCT03030703|Inositol|inositol|mesh-list
697542|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
697543|NCT03030703|Vitamins|vitamins|mesh-ancestor
697544|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
697545|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697878|NCT03028883|Buprenorphine|buprenorphine|mesh-list
697879|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
697880|NCT03028883|Narcotics|narcotics|mesh-ancestor
697881|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
697882|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697883|NCT03028883|Analgesics|analgesics|mesh-ancestor
697884|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
697885|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
697886|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
698017|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
698018|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
698019|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
698020|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698021|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
698022|NCT03028428|Protective Agents|protective agents|mesh-ancestor
2227586|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227587|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
698775|NCT03024476|Olmesartan|olmesartan|mesh-list
698776|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
698777|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
698778|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
698779|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227588|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2227589|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
2227590|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227591|NCT00058071|Amifostine|amifostine|mesh-list
2227592|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2227593|NCT00058071|Protective Agents|protective agents|mesh-ancestor
2227594|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227595|NCT00058084|Prednisone|prednisone|mesh-list
2227596|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
2227597|NCT00058084|Epothilone B|epothilone b|mesh-list
2227598|NCT00058084|Epothilones|epothilones|mesh-list
2227599|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2227600|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
2227601|NCT00058084|Hormones|hormones|mesh-ancestor
699398|NCT03021694|Caseins|caseins|mesh-list
699399|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
699400|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
699401|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699875|NCT03019835|Neostigmine|neostigmine|mesh-list
699876|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
699877|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699878|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699879|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
699880|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
699881|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699882|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
699883|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
699884|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700409|NCT03017872|Ritonavir|ritonavir|mesh-list
700410|NCT03017872|Darunavir|darunavir|mesh-list
700411|NCT03017872|Dolutegravir|dolutegravir|mesh-list
700412|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
700413|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
700414|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
700415|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700416|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700417|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
700418|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
700419|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
696750|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
696751|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
696752|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
696753|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696754|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696755|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
696756|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
696757|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
696758|NCT03034005|Hormones|hormones|mesh-ancestor
696759|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
696854|NCT03033732|Buprenorphine|buprenorphine|mesh-list
696855|NCT03033732|Methadone|methadone|mesh-list
696856|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
696857|NCT03033732|Naloxone|naloxone|mesh-list
696858|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
696859|NCT03033732|Narcotics|narcotics|mesh-ancestor
696860|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
696861|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696862|NCT03033732|Analgesics|analgesics|mesh-ancestor
696863|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
696864|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696865|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
696866|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
696867|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
696907|NCT03033121|Hormones|hormones|mesh-list
696908|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
696909|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697565|NCT03031262|Cytarabine|cytarabine|mesh-list
697566|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
697567|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
697568|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697569|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697570|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
697571|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697572|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
697573|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
697574|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697773|NCT03029455|Ivacaftor|ivacaftor|mesh-list
697774|NCT03029455|VX-659|vx-659|mesh-list
697775|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
697776|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
697777|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698688|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
698691|NCT03024957|Morphine|morphine|mesh-list
698692|NCT03024957|Bupivacaine|bupivacaine|mesh-list
698693|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
698694|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
698695|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
698696|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698697|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
698698|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698699|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
698700|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
698701|NCT03024957|Analgesics|analgesics|mesh-ancestor
698702|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
698703|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
698704|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
698705|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
698706|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
698707|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698708|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
698709|NCT03024957|Narcotics|narcotics|mesh-ancestor
698750|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
698751|NCT03024515|Narcotics|narcotics|mesh-ancestor
698752|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
698753|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698754|NCT03024515|Analgesics|analgesics|mesh-ancestor
698755|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
698756|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699510|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
699511|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
699512|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699803|NCT03019809|Plerixafor|plerixafor|mesh-list
699804|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
699805|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
699806|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
2088900|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088901|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2088902|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088903|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
2088904|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2088905|NCT02191865|Nintedanib|nintedanib|mesh-list
2088906|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088907|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2227602|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2227603|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227604|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2227605|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227606|NCT00058084|Analgesics|analgesics|mesh-ancestor
2088908|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088909|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698089|NCT03027934|Ticagrelor|ticagrelor|mesh-list
698090|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
698091|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
698092|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
698093|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
698094|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
698095|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
698096|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
698097|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698098|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227607|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
2227608|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227609|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2227610|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2227611|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699080|NCT03023020|Aspirin|aspirin|mesh-list
699081|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
699082|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
699083|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
699084|NCT03023020|Analgesics|analgesics|mesh-ancestor
699085|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
699086|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699087|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699088|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
699089|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
699090|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
699091|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
699092|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699093|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
699094|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699095|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
700569|NCT03017430|Ketorolac|ketorolac|mesh-list
700570|NCT03017430|Phenazepam|phenazepam|mesh-list
700571|NCT03017430|Clonidine|clonidine|mesh-list
700572|NCT03017430|Pregabalin|pregabalin|mesh-list
700573|NCT03017430|Metoclopramide|metoclopramide|mesh-list
700574|NCT03017430|Loperamide|loperamide|mesh-list
700575|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
700576|NCT03017430|Analgesics|analgesics|mesh-ancestor
700577|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
700578|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700579|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700580|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
700581|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
700582|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
700583|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700584|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
700585|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
700586|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
700587|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700588|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
700589|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
700590|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
700591|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
700592|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
700593|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
700594|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088910|NCT02192190|Celecoxib|celecoxib|mesh-list
2088911|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2088912|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2088913|NCT02192190|Analgesics|analgesics|mesh-ancestor
2088914|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
2088915|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088916|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088917|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2088918|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2088919|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2088920|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2088921|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088922|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088923|NCT02192541|Aflibercept|aflibercept|mesh-list
2088924|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2088925|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2088926|NCT02192541|Growth Substances|growth substances|mesh-ancestor
2088927|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227612|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227613|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
2227614|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
2227615|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
2227616|NCT00058097|Tipifarnib|tipifarnib|mesh-list
2227617|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227618|NCT00058149|Gemcitabine|gemcitabine|mesh-list
2227619|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
2227620|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2227621|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
2227622|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227623|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227624|NCT00058149|Antiviral Agents|antiviral agents|mesh-ancestor
2227625|NCT00058149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227626|NCT00058149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227627|NCT00058149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227628|NCT00058149|Immunologic Factors|immunologic factors|mesh-ancestor
2227629|NCT00058149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227630|NCT00058201|Leucovorin|leucovorin|mesh-list
2227631|NCT00058201|Gemcitabine|gemcitabine|mesh-list
2227632|NCT00058201|Fluorouracil|fluorouracil|mesh-list
2227633|NCT00058201|Calcium|calcium|mesh-list
2227634|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
2227635|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2227636|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
2227637|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227638|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227639|NCT00058201|Antiviral Agents|antiviral agents|mesh-ancestor
2227640|NCT00058201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227641|NCT00058201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227642|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227643|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
2227644|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227645|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2227646|NCT00058201|Antidotes|antidotes|mesh-ancestor
2227647|NCT00058201|Protective Agents|protective agents|mesh-ancestor
2227648|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
2227649|NCT00058201|Vitamins|vitamins|mesh-ancestor
2227650|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
2227651|NCT00058227|Rituximab|rituximab|mesh-list
2227652|NCT00058227|Fludarabine|fludarabine|mesh-list
2227653|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
2227654|NCT00058227|Alvocidib|alvocidib|mesh-list
2227655|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227656|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227657|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
2227658|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227659|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2227660|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
697943|NCT03028701|Budesonide|budesonide|mesh-list
697944|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
698114|NCT03027908|Fluorides|fluorides|mesh-list
696834|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
696835|NCT03033836|Dolutegravir|dolutegravir|mesh-list
696836|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
696837|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
696838|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696839|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696840|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
696841|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
696842|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
696843|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
696844|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
696845|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
697185|NCT03032042|Azithromycin|azithromycin|mesh-list
697186|NCT03032042|Albendazole|albendazole|mesh-list
697187|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
697188|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697189|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
697190|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
697191|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
697192|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
697193|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
697194|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
697195|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
697196|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
697197|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697198|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697327|NCT03031184|Mirtazapine|mirtazapine|mesh-list
697328|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
697329|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
697330|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
697331|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
697332|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
697333|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
697334|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697335|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697336|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
697337|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
697338|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
697339|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
697340|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
697341|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
697342|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
697343|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
697344|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
697345|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
697346|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
697481|NCT03030937|Irinotecan|irinotecan|mesh-list
697482|NCT03030937|Apatinib|apatinib|mesh-list
697483|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
697484|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
697485|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697486|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697487|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697488|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2227661|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
2227662|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697862|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
697863|NCT03029273|Fludarabine|fludarabine|mesh-list
697864|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
697865|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
697866|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697867|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
697868|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
697869|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
697870|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697871|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697872|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2227663|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227664|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
2227665|NCT00058227|Growth Substances|growth substances|mesh-ancestor
2227666|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2227667|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227668|NCT00058253|Docetaxel|docetaxel|mesh-list
2227669|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697759|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
697760|NCT03029494|Vitamins|vitamins|mesh-ancestor
697761|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
697762|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697763|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
697764|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697765|NCT03029494|Protective Agents|protective agents|mesh-ancestor
698065|NCT03027960|Empagliflozin|empagliflozin|mesh-list
698066|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
698067|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698068|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
698069|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698170|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
698171|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
698172|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
698173|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
698174|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
698175|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698176|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698177|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698178|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
698179|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
698252|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
698253|NCT03026933|Calcium|calcium|mesh-list
698254|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
698255|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698256|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
698257|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
698258|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
698259|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698260|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
698261|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
698262|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698389|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
698390|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
698391|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
698469|NCT03026023|Ribavirin|ribavirin|mesh-list
698470|NCT03026023|Grazoprevir|grazoprevir|mesh-list
698471|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
698472|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698473|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
698474|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
698922|NCT03023527|Dexamethasone|dexamethasone|mesh-list
698923|NCT03023527|Nivolumab|nivolumab|mesh-list
698924|NCT03023527|Pomalidomide|pomalidomide|mesh-list
698925|NCT03023527|Elotuzumab|elotuzumab|mesh-list
698926|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
698927|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
698928|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
698929|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698930|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698931|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
698932|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
698933|NCT03023527|Hormones|hormones|mesh-ancestor
698934|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
698935|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
698936|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698937|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
698938|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
698939|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698940|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
698941|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
698942|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
698943|NCT03023527|Growth Substances|growth substances|mesh-ancestor
698944|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
2227670|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
2227671|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
2227672|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
2227673|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696910|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
696911|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
696912|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
696913|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
696914|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
696915|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696916|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
696917|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
696918|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696919|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
696920|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696985|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
696986|NCT03032978|Calcium|calcium|mesh-list
696987|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
696988|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696989|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2227674|NCT00058266|Genistein|genistein|mesh-list
2227675|NCT00058266|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2227676|NCT00058266|Protective Agents|protective agents|mesh-ancestor
2227677|NCT00058266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227678|NCT00058266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227679|NCT00058266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2227680|NCT00058266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227681|NCT00058266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227682|NCT00058266|Phytoestrogens|phytoestrogens|mesh-ancestor
2227683|NCT00058266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2227684|NCT00058266|Estrogens|estrogens|mesh-ancestor
2227685|NCT00058266|Hormones|hormones|mesh-ancestor
697745|NCT03029702|Metformin|metformin|mesh-list
697746|NCT03029702|Glyburide|glyburide|mesh-list
697747|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
697748|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697998|NCT03028519|Vitamin D|vitamin d|mesh-list
697999|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
698000|NCT03028519|Vitamins|vitamins|mesh-ancestor
698001|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
698002|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698003|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
698004|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
698524|NCT03025893|Sunitinib|sunitinib|mesh-list
698525|NCT03025893|Lomustine|lomustine|mesh-list
698526|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698527|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
698528|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
698529|NCT03025893|Growth Substances|growth substances|mesh-ancestor
698530|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698531|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
698532|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
698533|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698534|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698535|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
698536|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
698603|NCT03025256|Nivolumab|nivolumab|mesh-list
698604|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
698605|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698606|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
698607|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699135|NCT03022747|Allopurinol|allopurinol|mesh-list
699136|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
699137|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699138|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699139|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
699140|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
699141|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
699142|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
699143|NCT03022747|Protective Agents|protective agents|mesh-ancestor
699144|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699229|NCT03022318|Levodopa|levodopa|mesh-list
699230|NCT03022318|Carbidopa|carbidopa|mesh-list
699231|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
699232|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
699233|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
699234|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
699235|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
699236|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696921|NCT03033199|Dexamethasone|dexamethasone|mesh-list
696922|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
696923|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
696924|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
696925|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
696926|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
696927|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
696928|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
696929|NCT03033199|Hormones|hormones|mesh-ancestor
696930|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
696931|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
696932|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697234|NCT03031756|Glycine|glycine|mesh-list
697235|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
697236|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
697237|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697238|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227686|NCT00058266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2227687|NCT00058279|Aldesleukin|aldesleukin|mesh-list
2227688|NCT00058279|Ipilimumab|ipilimumab|mesh-list
2227689|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227690|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227691|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2227692|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227693|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2227694|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2227695|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
2227696|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227697|NCT00058292|Cytarabine|cytarabine|mesh-list
2227698|NCT00058292|Rituximab|rituximab|mesh-list
2227699|NCT00058292|Etoposide|etoposide|mesh-list
2227700|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
2227701|NCT00058292|Melphalan|melphalan|mesh-list
2227702|NCT00058292|Carmustine|carmustine|mesh-list
2227703|NCT00058292|Lenograstim|lenograstim|mesh-list
2227704|NCT00058292|Sargramostim|sargramostim|mesh-list
2227705|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227706|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227707|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
2227708|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227709|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2227710|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2227711|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2227712|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2227713|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227714|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227715|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2227716|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2227717|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
2227718|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
2227719|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227720|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227721|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2227722|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
2227723|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2227724|NCT00058305|Vincristine|vincristine|mesh-list
2227725|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
2227726|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2227727|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227728|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
2227729|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
2227730|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
2227731|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227732|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2227733|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
2227734|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227735|NCT00058318|Gemcitabine|gemcitabine|mesh-list
2227736|NCT00058318|Capecitabine|capecitabine|mesh-list
2227737|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2227738|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
2227739|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227740|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227741|NCT00058318|Antiviral Agents|antiviral agents|mesh-ancestor
2227742|NCT00058318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227743|NCT00058318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227744|NCT00058318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
696933|NCT03033368|Rilpivirine|rilpivirine|mesh-list
696934|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
696935|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
696936|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
696937|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
696938|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
696939|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
696940|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
696941|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
696990|NCT03033160|Estradiol|estradiol|mesh-list
696991|NCT03033160|Estrogens|estrogens|mesh-ancestor
696992|NCT03033160|Hormones|hormones|mesh-ancestor
696993|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
696994|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697151|NCT03032367|Bedaquiline|bedaquiline|mesh-list
697152|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
697153|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
697154|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088928|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
2088929|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088930|NCT02192684|Pioglitazone|pioglitazone|mesh-list
2088931|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2088932|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088933|NCT02192814|Lacosamide|lacosamide|mesh-list
2088934|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
2088935|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2088936|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2088937|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2088938|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088939|NCT02192970|Bevacizumab|bevacizumab|mesh-list
2088940|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2088941|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088942|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2088943|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2088944|NCT02192970|Growth Substances|growth substances|mesh-ancestor
2088945|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088946|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
2088947|NCT02193165|Triclosan|triclosan|mesh-list
2088948|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
2088949|NCT02193165|Fluorides|fluorides|mesh-list
697766|NCT03029390|Metformin|metformin|mesh-list
697767|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
697768|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697815|NCT03029429|Theophylline|theophylline|mesh-list
697816|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
697817|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
697818|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
697819|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697820|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
697821|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
697822|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
697823|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697824|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697825|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
697826|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
697827|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
697828|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
697829|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
698037|NCT03028350|Ifetroban|ifetroban|mesh-list
698038|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
698099|NCT03027843|Hormones|hormones|mesh-list
698100|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
698101|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227745|NCT00058318|Immunologic Factors|immunologic factors|mesh-ancestor
2227746|NCT00058318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227747|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
2227748|NCT00058331|Hematinics|hematinics|mesh-ancestor
2227749|NCT00058357|Lidocaine|lidocaine|mesh-list
2227750|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
2227751|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
2227752|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2227753|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227754|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
2227755|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227756|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
697011|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697012|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088950|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
2088951|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
2088952|NCT02193165|Protective Agents|protective agents|mesh-ancestor
2088953|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2088954|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2088955|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088956|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2088957|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2088958|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
2088959|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088960|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2088961|NCT02193347|Temozolomide|temozolomide|mesh-list
2088962|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2088963|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
2088964|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088965|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2088966|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
2227757|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2227758|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2227759|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2227760|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227761|NCT00058435|Abagovomab|abagovomab|mesh-list
2227762|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227763|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227764|NCT00058448|Docetaxel|docetaxel|mesh-list
2227765|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227766|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
2227767|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
2227768|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
2227769|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227770|NCT00058461|Cytarabine|cytarabine|mesh-list
2227771|NCT00058461|Rituximab|rituximab|mesh-list
2227772|NCT00058461|Carboplatin|carboplatin|mesh-list
2227773|NCT00058461|Methotrexate|methotrexate|mesh-list
2227774|NCT00058461|Etoposide|etoposide|mesh-list
2227775|NCT00058461|Ifosfamide|ifosfamide|mesh-list
2227776|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227777|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698459|NCT03026036|Raclopride|raclopride|mesh-list
698460|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
698461|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
698462|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
698463|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698464|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
698465|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
698466|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
698467|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
698468|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698618|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
698619|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
698620|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
698621|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698622|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
698623|NCT03025295|Analgesics|analgesics|mesh-ancestor
698624|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
698625|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698626|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
698627|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
698628|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
698629|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
698630|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
698631|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698728|NCT03024814|Acetaminophen|acetaminophen|mesh-list
698729|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
698730|NCT03024814|Analgesics|analgesics|mesh-ancestor
698731|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
698732|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698733|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698734|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
699053|NCT03023358|Prednisone|prednisone|mesh-list
699054|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
699055|NCT03023358|Doxorubicin|doxorubicin|mesh-list
699056|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
697090|NCT03032484|Bevacizumab|bevacizumab|mesh-list
697091|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
697092|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697093|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
697094|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
697095|NCT03032484|Growth Substances|growth substances|mesh-ancestor
697096|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697097|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
697239|NCT03031808|Lidocaine|lidocaine|mesh-list
697240|NCT03031808|Rocuronium|rocuronium|mesh-list
697241|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
697242|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
697243|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
697244|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697245|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
697246|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
697247|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
697248|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
697249|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
697250|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
697251|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697252|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
697253|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
697254|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
697373|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
697374|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
697375|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
697376|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
697377|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
697378|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697379|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
697380|NCT03031327|Protective Agents|protective agents|mesh-ancestor
697439|NCT03030911|Fentanyl|fentanyl|mesh-list
697440|NCT03030911|Midazolam|midazolam|mesh-list
697441|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
697442|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
697443|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
697444|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697445|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
697446|NCT03030911|Analgesics|analgesics|mesh-ancestor
697447|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
697448|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
697449|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
697450|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
697451|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
697452|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
697453|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
697454|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697455|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
697456|NCT03030911|Narcotics|narcotics|mesh-ancestor
697457|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
697458|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
697459|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
697460|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
697461|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
697462|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
697463|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
697464|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
697465|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
2088967|NCT02193776|Rifampin|rifampin|mesh-list
2088968|NCT02193776|Isoniazid|isoniazid|mesh-list
2088969|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
2088970|NCT02193776|Ethambutol|ethambutol|mesh-list
2088971|NCT02193776|Bedaquiline|bedaquiline|mesh-list
2088972|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2088973|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2088974|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2088975|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2088976|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2088977|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088978|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698213|NCT03027284|Gemcitabine|gemcitabine|mesh-list
698214|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698215|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
698216|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
2227778|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
2088979|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
697121|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
697122|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
697123|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
697124|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697125|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
697126|NCT03032458|Narcotics|narcotics|mesh-ancestor
697127|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
697213|NCT03031834|Quinapril|quinapril|mesh-list
697214|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
697215|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
697216|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697217|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697218|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
697425|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
697426|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
697427|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
697428|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697429|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
697430|NCT03030950|Analgesics|analgesics|mesh-ancestor
697431|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
697432|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
697433|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
697434|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
697435|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
697436|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
697437|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
697438|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697575|NCT03030677|Lidocaine|lidocaine|mesh-list
697576|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
697577|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
697578|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
697579|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697580|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
697581|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
697582|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
697583|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
697584|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
697585|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
697586|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697623|NCT03030001|Antibodies|antibodies|mesh-list
697624|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
697625|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698263|NCT03026842|Cytarabine|cytarabine|mesh-list
698264|NCT03026842|Decitabine|decitabine|mesh-list
698265|NCT03026842|Daunorubicin|daunorubicin|mesh-list
698266|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
698267|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
698268|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
698269|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
698270|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698271|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698272|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
698273|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
698274|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
698275|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
698276|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698277|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
698278|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
698279|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
698280|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698281|NCT03026842|Analgesics|analgesics|mesh-ancestor
698282|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
698283|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698284|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2227779|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227780|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2227781|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2227782|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
2227783|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2227784|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2227785|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
2227786|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227787|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
2227788|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227789|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2227790|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227791|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2227792|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2227793|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2227794|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
697716|NCT03029676|Fentanyl|fentanyl|mesh-list
697717|NCT03029676|Midazolam|midazolam|mesh-list
697718|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
697719|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
697720|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697721|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
697722|NCT03029676|Narcotics|narcotics|mesh-ancestor
697723|NCT03029676|Analgesics|analgesics|mesh-ancestor
697724|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
697725|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
697726|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
697727|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
697728|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
697729|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
697730|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
697731|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
697732|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
697733|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
697734|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
697735|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
697736|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697808|NCT03029351|Exenatide|exenatide|mesh-list
697809|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
697810|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697811|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
697812|NCT03029351|Incretins|incretins|mesh-ancestor
697813|NCT03029351|Hormones|hormones|mesh-ancestor
697814|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
698199|NCT03027674|Nifedipine|nifedipine|mesh-list
698200|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
698201|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
698202|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
698203|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
698204|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698205|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698206|NCT03027674|Urological Agents|urological agents|mesh-ancestor
698207|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
698208|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
698209|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
698210|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698211|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
698212|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
698299|NCT03026881|Paclitaxel|paclitaxel|mesh-list
698300|NCT03026881|Apatinib|apatinib|mesh-list
698301|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
698302|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698303|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
698304|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
698305|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
698306|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698307|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
698308|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698508|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
698509|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
698510|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698685|NCT03025009|Insulin|insulin|mesh-list
698686|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
698687|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
698689|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
698690|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699036|NCT03023111|Miltefosine|miltefosine|mesh-list
699037|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
699038|NCT03023111|Molgramostim|molgramostim|mesh-list
699039|NCT03023111|Sargramostim|sargramostim|mesh-list
699040|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
699041|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699042|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699043|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
699044|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
699045|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
699046|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
697296|NCT03031444|Leucovorin|leucovorin|mesh-list
697297|NCT03031444|Cetuximab|cetuximab|mesh-list
697298|NCT03031444|Fluorouracil|fluorouracil|mesh-list
697299|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
697300|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
697301|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697302|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
697303|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697304|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
697305|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
697306|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
697307|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697308|NCT03031444|Antidotes|antidotes|mesh-ancestor
697309|NCT03031444|Protective Agents|protective agents|mesh-ancestor
697310|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
697311|NCT03031444|Vitamins|vitamins|mesh-ancestor
697312|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
698232|NCT03027167|Aspirin|aspirin|mesh-list
698233|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
698234|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
698235|NCT03027167|Analgesics|analgesics|mesh-ancestor
698236|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
698237|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698238|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698239|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
698240|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
698241|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
698242|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
698243|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698244|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
698245|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
698246|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698247|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
2227795|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
2227796|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227797|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2227798|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
2227799|NCT00058474|Fluorouracil|fluorouracil|mesh-list
2227800|NCT00058474|Capecitabine|capecitabine|mesh-list
698537|NCT03025906|Valproic Acid|valproic acid|mesh-list
698538|NCT03025906|Phenobarbital|phenobarbital|mesh-list
698539|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
698540|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698541|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698542|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
698543|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
698544|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698545|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
698546|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
698547|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
698548|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
698549|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
698550|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
698551|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
698552|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
698553|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
698554|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
698555|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
698639|NCT03024879|Erythromycin|erythromycin|mesh-list
698640|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
698641|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
698642|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
698643|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
698644|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
698645|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
698646|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
698647|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698648|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699248|NCT03022500|Durvalumab|durvalumab|mesh-list
699249|NCT03022500|Tremelimumab|tremelimumab|mesh-list
699250|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2227801|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
2227802|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
2227803|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697267|NCT03031535|Octreotide|octreotide|mesh-list
697268|NCT03031535|Hormones|hormones|mesh-list
697269|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
697270|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
697271|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697272|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
697273|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
697274|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697313|NCT03031249|Cytarabine|cytarabine|mesh-list
697314|NCT03031249|Tretinoin|tretinoin|mesh-list
697315|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
697316|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
697317|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
697318|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697319|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697320|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
697321|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697322|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
697323|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
697324|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697325|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
697326|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
697501|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
697502|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
697503|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
697504|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697505|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
697506|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
697507|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
697508|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697509|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697510|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
697533|NCT03030430|Bevacizumab|bevacizumab|mesh-list
697534|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
697535|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697536|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
697537|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
697538|NCT03030430|Growth Substances|growth substances|mesh-ancestor
697539|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697540|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
697546|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
697547|NCT03030469|Analgesics|analgesics|mesh-list
697548|NCT03030469|Narcotics|narcotics|mesh-ancestor
697549|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
697550|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697551|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
697552|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2088980|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
2088981|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
2088982|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2088983|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2088984|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2088985|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2088986|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2227804|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2227805|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227806|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227807|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
2227808|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227809|NCT00058487|Thalidomide|thalidomide|mesh-list
2227810|NCT00058487|Epirubicin|epirubicin|mesh-list
2227811|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2227812|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227813|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2227814|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2227815|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227816|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227817|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227818|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
2227819|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698115|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
2227820|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
2227821|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2227822|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227823|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2227824|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2227825|NCT00058487|Growth Substances|growth substances|mesh-ancestor
2227826|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
2227827|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
2227828|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227829|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
2227830|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227831|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2227832|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2227833|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
2088987|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2088988|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2088989|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2088990|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2088991|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
2088992|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2088993|NCT02193815|Calcitriol|calcitriol|mesh-list
2088994|NCT02193815|Calcipotriene|calcipotriene|mesh-list
2088995|NCT02193815|Tofacitinib|tofacitinib|mesh-list
2088996|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2088997|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697979|NCT03028909|Oseltamivir|oseltamivir|mesh-list
697980|NCT03028909|MEDI8852|medi8852|mesh-list
697981|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
697982|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697983|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697984|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227834|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227835|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227836|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2227837|NCT00058682|Anidulafungin|anidulafungin|mesh-list
2227838|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
2227839|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227840|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
2227841|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227842|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2088998|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2088999|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
2089000|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2089001|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089002|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2089003|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2089004|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2089005|NCT02193815|Vitamins|vitamins|mesh-ancestor
2089006|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
2089007|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2089008|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
2089009|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2227843|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227844|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227845|NCT00058890|Gabapentin|gabapentin|mesh-list
2227846|NCT00058890|Analgesics|analgesics|mesh-ancestor
2227847|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
2227848|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227849|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227850|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
2227851|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2227852|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2227853|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2227854|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
699887|NCT03019666|Niacinamide|niacinamide|mesh-list
699888|NCT03019666|Niacin|niacin|mesh-list
699889|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
699890|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
699891|NCT03019666|Vitamins|vitamins|mesh-ancestor
699892|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
699893|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699894|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
699895|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
699896|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699897|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
699898|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
697472|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
697473|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
697474|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
697475|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697476|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697477|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
697478|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697479|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
697480|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
697639|NCT03030157|Pirarubicin|pirarubicin|mesh-list
697640|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698334|NCT03026972|Vaccines|vaccines|mesh-list
698335|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
698336|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698505|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
698506|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
698507|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
698816|NCT03024437|Bevacizumab|bevacizumab|mesh-list
698817|NCT03024437|Atezolizumab|atezolizumab|mesh-list
698818|NCT03024437|Entinostat|entinostat|mesh-list
698819|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
698820|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698821|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
698822|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
698823|NCT03024437|Growth Substances|growth substances|mesh-ancestor
698824|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698825|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
698826|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
698827|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698828|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698850|NCT03023774|Sargramostim|sargramostim|mesh-list
698851|NCT03023774|Lenograstim|lenograstim|mesh-list
698852|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
698853|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698854|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
699145|NCT03022565|Vorinostat|vorinostat|mesh-list
699146|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699147|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
699148|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699149|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699301|NCT03022253|Acetaminophen|acetaminophen|mesh-list
699302|NCT03022253|Ibuprofen|ibuprofen|mesh-list
699303|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
699304|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
699305|NCT03022253|Analgesics|analgesics|mesh-ancestor
699306|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
699307|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699308|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699309|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
699310|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
699311|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
699312|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699313|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699314|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
699579|NCT03020680|Ubiquinone|ubiquinone|mesh-list
699580|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
699581|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
699582|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699583|NCT03020680|Vitamins|vitamins|mesh-ancestor
2227855|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2227856|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2227857|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2227858|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227859|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
2227860|NCT00058903|Sertraline|sertraline|mesh-list
2227861|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
2227862|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2227863|NCT00058903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2227864|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2227865|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2227866|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227867|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2227868|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
700047|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
700048|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
697499|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
697500|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227869|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227870|NCT00058929|Treprostinil|treprostinil|mesh-list
2227871|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2227872|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
2227873|NCT00058955|Triazolam|triazolam|mesh-list
2227874|NCT00058955|Pentobarbital|pentobarbital|mesh-list
2227875|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2227876|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2227877|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
2227878|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
698757|NCT03024450|Trastuzumab|trastuzumab|mesh-list
698758|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
698759|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699133|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
699134|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
699674|NCT03020303|Spironolactone|spironolactone|mesh-list
699675|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
699676|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
699677|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
699678|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699679|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
699680|NCT03020303|Diuretics|diuretics|mesh-ancestor
699681|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
700125|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
700126|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
700127|NCT03018652|Antibodies|antibodies|mesh-list
700128|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
700129|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
700130|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
700131|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089010|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
2089011|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089012|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089013|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2089014|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
2089015|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089016|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227879|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2227880|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227881|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2227882|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
701014|NCT03015896|Nivolumab|nivolumab|mesh-list
701015|NCT03015896|Lenalidomide|lenalidomide|mesh-list
701016|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
701017|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701018|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
701019|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701020|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
701021|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701022|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
701023|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
701024|NCT03015896|Growth Substances|growth substances|mesh-ancestor
701025|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
701427|NCT03013491|Ipilimumab|ipilimumab|mesh-list
701428|NCT03013491|Vemurafenib|vemurafenib|mesh-list
701429|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
701430|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697511|NCT03030690|Methamphetamine|methamphetamine|mesh-list
697512|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
697513|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697514|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
697515|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
697516|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
697517|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
697518|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
697519|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697520|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
697521|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
697522|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
697523|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
697524|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
697598|NCT03030131|Durvalumab|durvalumab|mesh-list
697599|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
697600|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
697749|NCT03029845|Propranolol|propranolol|mesh-list
697750|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
697751|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
697752|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
697753|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
697754|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697755|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697756|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
697757|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
697758|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
697915|NCT03029169|Amiodarone|amiodarone|mesh-list
697916|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
697917|NCT03029169|Propafenone|propafenone|mesh-list
697918|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
697919|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
697920|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
697921|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
697922|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
697923|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
697924|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
697925|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
697926|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
697927|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
697928|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
697929|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
698023|NCT03028571|Trimethaphan|trimethaphan|mesh-list
698024|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
698025|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
698026|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
698027|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
698028|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
698029|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698030|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698031|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
698032|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
698033|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
698034|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
698035|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698036|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
699613|NCT03020602|Ubiquinone|ubiquinone|mesh-list
699614|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
699615|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
699616|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699617|NCT03020602|Vitamins|vitamins|mesh-ancestor
699751|NCT03019991|Ritonavir|ritonavir|mesh-list
699752|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
699753|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
699754|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
699755|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699756|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699757|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
699758|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
699759|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
699760|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
699761|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
699762|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
697554|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
697555|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
697556|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
697557|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697558|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
697559|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
697560|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
697561|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
697562|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
697563|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
697564|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698760|NCT03024684|Atorvastatin|atorvastatin|mesh-list
698761|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
698762|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
698763|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
698764|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698765|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
698766|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
698767|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698831|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
698832|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
698833|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
2089017|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2089018|NCT02194062|Fluticasone|fluticasone|mesh-list
2089019|NCT02194062|Xhance|xhance|mesh-list
2089020|NCT02194062|Budesonide|budesonide|mesh-list
2089021|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2089022|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2089023|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
2089024|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089025|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089026|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2089027|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
2089028|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
2089029|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2089030|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
2089031|NCT02194062|Hormones|hormones|mesh-ancestor
699099|NCT03023007|Anesthetics|anesthetics|mesh-list
699100|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
699101|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699908|NCT03019523|Caffeine|caffeine|mesh-list
699909|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
699910|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699911|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
699912|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699913|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699914|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
699915|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
699916|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
699917|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2227883|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2227884|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
2227885|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
2227886|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2227887|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227888|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2227889|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2227890|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2227891|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2227892|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2089032|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
697641|NCT03030248|Vancomycin|vancomycin|mesh-list
697642|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
697643|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
697665|NCT03029533|Leuprolide|leuprolide|mesh-list
697666|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
697667|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
697668|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
697669|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697670|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
697671|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089033|NCT02194088|Diclofenac|diclofenac|mesh-list
2089034|NCT02194088|Atropine|atropine|mesh-list
698041|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
698042|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
698043|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698323|NCT03026907|Azathioprine|azathioprine|mesh-list
698324|NCT03026907|Alitretinoin|alitretinoin|mesh-list
698325|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698326|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
698327|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
698328|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698329|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
698330|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
698331|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
698332|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698333|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
698366|NCT03026478|Betamethasone|betamethasone|mesh-list
698367|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
698368|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
698369|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
698370|NCT03026478|Clobetasol|clobetasol|mesh-list
698371|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
698372|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
698373|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
698374|NCT03026478|Hormones|hormones|mesh-ancestor
698375|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
698376|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698377|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
698378|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
2227893|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227894|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2227895|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227896|NCT00058968|Analgesics|analgesics|mesh-ancestor
2227897|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
2227898|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227899|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
2227900|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2227901|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
2227902|NCT00058994|Anecortave|anecortave|mesh-list
700005|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
700006|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
700007|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227903|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2227904|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2227905|NCT00058994|Growth Substances|growth substances|mesh-ancestor
700918|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
700919|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
700920|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701177|NCT03014947|Adalimumab|adalimumab|mesh-list
701178|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
701179|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
701843|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
701844|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
701845|NCT03012347|Protective Agents|protective agents|mesh-ancestor
701846|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701847|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
697681|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
697682|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
697683|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
697684|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
697685|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
697686|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
697687|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
697688|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
697689|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
697690|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
2089035|NCT02194088|Analgesics|analgesics|mesh-list
2089036|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2089037|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2089038|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
2089039|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089040|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089041|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2089042|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089043|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2089044|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089045|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089046|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2227906|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227907|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
2227908|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227909|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
2227910|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227911|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227912|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2227913|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2227914|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
699384|NCT03021785|Bevacizumab|bevacizumab|mesh-list
699385|NCT03021785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
699386|NCT03021785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699387|NCT03021785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
699388|NCT03021785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
699389|NCT03021785|Growth Substances|growth substances|mesh-ancestor
699390|NCT03021785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699391|NCT03021785|Growth Inhibitors|growth inhibitors|mesh-ancestor
2227915|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227916|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227917|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
2227918|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227919|NCT00059306|Aspirin|aspirin|mesh-list
2227920|NCT00059306|Clopidogrel|clopidogrel|mesh-list
2227921|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2227922|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2227923|NCT00059306|Analgesics|analgesics|mesh-ancestor
2227924|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
2227925|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227926|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227927|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2227928|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2227929|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2227930|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2227931|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227932|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2227933|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2227934|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227935|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
2227936|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2227937|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2227938|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2227939|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
2227940|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2227941|NCT00059358|Interferons|interferons|mesh-list
2227942|NCT00059358|Ribavirin|ribavirin|mesh-list
2227943|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
2227944|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
700198|NCT03018756|Fentanyl|fentanyl|mesh-list
700199|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
700200|NCT03018756|Narcotics|narcotics|mesh-ancestor
700201|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700202|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700203|NCT03018756|Analgesics|analgesics|mesh-ancestor
2089047|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2089048|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2089049|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
2089050|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2227945|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2227946|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227947|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
2227948|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227949|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
2227950|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227951|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
2227952|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227953|NCT00059462|Interleukin-2|interleukin-2|mesh-list
2227954|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227955|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2227956|NCT00059462|Analgesics|analgesics|mesh-ancestor
2227957|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
2227958|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227959|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227960|NCT00059592|Valacyclovir|valacyclovir|mesh-list
2227961|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
2227962|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2227963|NCT00059618|Carboplatin|carboplatin|mesh-list
698511|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
698512|NCT03025828|Hormones|hormones|mesh-ancestor
698513|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
698514|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698834|NCT03023982|Morphine|morphine|mesh-list
698835|NCT03023982|Bupivacaine|bupivacaine|mesh-list
698836|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
698837|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
698838|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
698839|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698840|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
698841|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698842|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
698843|NCT03023982|Narcotics|narcotics|mesh-ancestor
698844|NCT03023982|Analgesics|analgesics|mesh-ancestor
698862|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
698863|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
698864|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
698865|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227964|NCT00059618|Bortezomib|bortezomib|mesh-list
2227965|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227966|NCT00059631|Bortezomib|bortezomib|mesh-list
699434|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
699435|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
699436|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
699437|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
699438|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
699439|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699440|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699441|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227967|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
2227968|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227969|NCT00059631|Analgesics|analgesics|mesh-ancestor
2227970|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
2227971|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2227972|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699885|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
699886|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
700095|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
700096|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089051|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
2089052|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
2089053|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
2089054|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2089055|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2089056|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
2089057|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089058|NCT02194465|Spironolactone|spironolactone|mesh-list
2089059|NCT02194465|Tadalafil|tadalafil|mesh-list
2089060|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
2227973|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2227974|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2227975|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227976|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227977|NCT00059722|Gefitinib|gefitinib|mesh-list
2227978|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227979|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2227980|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227981|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227982|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
2227983|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227984|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2227985|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227986|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227987|NCT00059761|Irinotecan|irinotecan|mesh-list
698677|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
698678|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
698679|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
698680|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
698681|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
698682|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698683|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698684|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
698907|NCT03023501|Gabapentin|gabapentin|mesh-list
698908|NCT03023501|Analgesics|analgesics|mesh-ancestor
698909|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
698910|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698911|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698912|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
698913|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
698914|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
698915|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
698916|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
698917|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
698918|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
698919|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
698920|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698921|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
2227988|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2227989|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2227990|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2227991|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2227992|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2227993|NCT00059800|Boron|boron|mesh-list
2227994|NCT00059800|Trace Elements|trace elements|mesh-ancestor
2227995|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
2227996|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2227997|NCT00059813|Interferons|interferons|mesh-list
2227998|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
2227999|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
2228000|NCT00059813|Oblimersen|oblimersen|mesh-list
2228001|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228002|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
700042|NCT03018990|Ethanol|ethanol|mesh-list
700043|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
700044|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
700045|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700046|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700290|NCT03018236|Ethanol|ethanol|mesh-list
700291|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
700292|NCT03018236|Cocaine|cocaine|mesh-list
700293|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
700294|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
700295|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
700296|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700297|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700298|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
700299|NCT03018236|Expectorants|expectorants|mesh-ancestor
700300|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
700301|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
700302|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
700303|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700304|NCT03018236|Protective Agents|protective agents|mesh-ancestor
700305|NCT03018236|Antidotes|antidotes|mesh-ancestor
700306|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
700307|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
700308|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
700309|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700310|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
697945|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
697946|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
697947|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
697948|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
697949|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
697950|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
697951|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
697952|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
697953|NCT03028701|Hormones|hormones|mesh-ancestor
697954|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
697955|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
697956|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
697957|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
697958|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
697959|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
697960|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698005|NCT03028532|Clomiphene|clomiphene|mesh-list
698006|NCT03028532|Enclomiphene|enclomiphene|mesh-list
698007|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
698008|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
698009|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
698010|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
698011|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698012|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
698013|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
698014|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
698015|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
698016|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
698102|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
698103|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
698104|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
698105|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
698106|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698107|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
698108|NCT03027973|Coagulants|coagulants|mesh-ancestor
698109|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
698110|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
698111|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
698112|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698113|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
698413|NCT03026140|Celecoxib|celecoxib|mesh-list
698414|NCT03026140|Nivolumab|nivolumab|mesh-list
698415|NCT03026140|Ipilimumab|ipilimumab|mesh-list
698416|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
698417|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698418|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
698419|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698420|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
698421|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
698422|NCT03026140|Analgesics|analgesics|mesh-ancestor
698423|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
698424|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698425|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698426|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
698427|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
698428|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
698429|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
698430|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698489|NCT03025750|Vaccines|vaccines|mesh-list
698490|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
698491|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698845|NCT03023852|Oseltamivir|oseltamivir|mesh-list
698846|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
698847|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
698848|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698849|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698882|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
698883|NCT03023514|Progesterone|progesterone|mesh-list
698884|NCT03023514|Progestins|progestins|mesh-ancestor
698885|NCT03023514|Hormones|hormones|mesh-ancestor
698886|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
698887|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698888|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
698889|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228003|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228004|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
2228005|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698039|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
698040|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228006|NCT00059826|Interferons|interferons|mesh-list
2228007|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
2228008|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
2228009|NCT00059826|Fluorouracil|fluorouracil|mesh-list
2228010|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228011|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
2228012|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228013|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228014|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228015|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
2228016|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228017|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
698829|NCT03024216|Atezolizumab|atezolizumab|mesh-list
698830|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089061|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
2089062|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
2089063|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2089064|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089065|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2089066|NCT02194465|Diuretics|diuretics|mesh-ancestor
2089067|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
2089068|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
2089069|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2089070|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2089071|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089072|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089073|NCT02194465|Urological Agents|urological agents|mesh-ancestor
2089074|NCT02194465|Hormones|hormones|mesh-ancestor
2089075|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
2089076|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
2089077|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2228018|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
699518|NCT03020953|Estrogens|estrogens|mesh-list
699519|NCT03020953|Hormones|hormones|mesh-ancestor
699520|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
699521|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700470|NCT03017833|Metformin|metformin|mesh-list
700471|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
700472|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700739|NCT03016611|Ticagrelor|ticagrelor|mesh-list
700740|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
700741|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
700742|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
700743|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
700744|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
700745|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
700746|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
700747|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700748|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701026|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
701027|NCT03015675|Vitamins|vitamins|mesh-ancestor
701028|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
701029|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701030|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
701031|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701032|NCT03015675|Protective Agents|protective agents|mesh-ancestor
701816|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
701817|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
701818|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701878|NCT03011970|Oxytocin|oxytocin|mesh-list
701879|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
701880|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
701881|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701917|NCT03011684|Tamoxifen|tamoxifen|mesh-list
701918|NCT03011684|Letrozole|letrozole|mesh-list
701919|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701920|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
701921|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
701922|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701985|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
2228019|NCT00059852|Gemcitabine|gemcitabine|mesh-list
2228020|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
698116|NCT03027908|Protective Agents|protective agents|mesh-ancestor
698117|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698309|NCT03026946|Cyclosporine|cyclosporine|mesh-list
698310|NCT03026946|Alitretinoin|alitretinoin|mesh-list
698311|NCT03026946|Cyclosporins|cyclosporins|mesh-list
698312|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698313|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698314|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
698315|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
698316|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698317|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
698318|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
698319|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
698320|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
698321|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
698322|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698357|NCT03026517|Phenformin|phenformin|mesh-list
698358|NCT03026517|Trametinib|trametinib|mesh-list
698359|NCT03026517|Dabrafenib|dabrafenib|mesh-list
698360|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698361|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
698362|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698363|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698364|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
698365|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698392|NCT03026244|Vitamin D|vitamin d|mesh-list
698393|NCT03026244|Caseins|caseins|mesh-list
698394|NCT03026244|Vitamins|vitamins|mesh-ancestor
698395|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
698396|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698397|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
698398|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
698399|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
698400|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698608|NCT03025282|Betamethasone|betamethasone|mesh-list
698609|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
698610|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
698611|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
698612|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
698613|NCT03025282|Hormones|hormones|mesh-ancestor
698614|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
698615|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698616|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
698617|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
699187|NCT03023046|Prednisone|prednisone|mesh-list
699188|NCT03023046|Cortisone|cortisone|mesh-list
699189|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
699190|NCT03023046|Rituximab|rituximab|mesh-list
699191|NCT03023046|Doxorubicin|doxorubicin|mesh-list
699192|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
699193|NCT03023046|Etoposide|etoposide|mesh-list
699194|NCT03023046|Vincristine|vincristine|mesh-list
699195|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
699196|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
699197|NCT03023046|Daunorubicin|daunorubicin|mesh-list
699198|NCT03023046|Dasatinib|dasatinib|mesh-list
699199|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
699200|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
699201|NCT03023046|Antibodies|antibodies|mesh-list
699202|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
699203|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
699204|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
699205|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
699206|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699207|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
699208|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
699209|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
699210|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699211|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699212|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
699213|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
699214|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
699215|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
699216|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699217|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
699218|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
699219|NCT03023046|Hormones|hormones|mesh-ancestor
699220|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
699529|NCT03020914|Methamphetamine|methamphetamine|mesh-list
2228021|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228022|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
698484|NCT03025867|Niraparib|niraparib|mesh-list
698485|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
698486|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698487|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698488|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698649|NCT03025113|Ketoprofen|ketoprofen|mesh-list
698650|NCT03025113|Amitriptyline|amitriptyline|mesh-list
698651|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
698652|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
698653|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
698654|NCT03025113|Analgesics|analgesics|mesh-ancestor
698655|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
698656|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698657|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698658|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
698659|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
698660|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
698661|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698662|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698663|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
698664|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
698665|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
698666|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
698667|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
698668|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
698669|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
698670|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
698671|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
698672|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
698673|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
698674|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
698786|NCT03024580|Tamoxifen|tamoxifen|mesh-list
698787|NCT03024580|Letrozole|letrozole|mesh-list
698788|NCT03024580|Fulvestrant|fulvestrant|mesh-list
698789|NCT03024580|Anastrozole|anastrozole|mesh-list
698790|NCT03024580|Exemestane|exemestane|mesh-list
698791|NCT03024580|Megestrol|megestrol|mesh-list
698792|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
698793|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698794|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
698795|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
698796|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698797|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698798|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
698799|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
698800|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
698801|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698802|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
698803|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
698804|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
698805|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
698806|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
698807|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
698808|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
698809|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
698810|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
698811|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
698812|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
698813|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
698814|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
698815|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
699606|NCT03020589|Tacrolimus|tacrolimus|mesh-list
699607|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
699608|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
698217|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698218|NCT03027284|Antiviral Agents|antiviral agents|mesh-ancestor
698219|NCT03027284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
698220|NCT03027284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698221|NCT03027284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
698222|NCT03027284|Immunologic Factors|immunologic factors|mesh-ancestor
698223|NCT03027284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698285|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
698286|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
698287|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
698288|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
698289|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
698431|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
698432|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
699591|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
699592|NCT03020706|Analgesics|analgesics|mesh-ancestor
699593|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
699594|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699595|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699596|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
699597|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
699598|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
699599|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
699600|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
699601|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
699602|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699603|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
699604|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
699605|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2089078|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089079|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089080|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
2089081|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
2089082|NCT02194998|Ritonavir|ritonavir|mesh-list
2089083|NCT02194998|Ribavirin|ribavirin|mesh-list
2089084|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2089085|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
700694|NCT03016988|Cytarabine|cytarabine|mesh-list
700695|NCT03016988|Fludarabine|fludarabine|mesh-list
700696|NCT03016988|Bortezomib|bortezomib|mesh-list
700697|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700698|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
700699|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
700700|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700701|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
700702|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
700703|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700704|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
700705|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
700937|NCT03015857|Phenylephrine|phenylephrine|mesh-list
700938|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
700939|NCT03015857|Norepinephrine|norepinephrine|mesh-list
700940|NCT03015857|Fentanyl|fentanyl|mesh-list
700941|NCT03015857|Bupivacaine|bupivacaine|mesh-list
700942|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
700943|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
700944|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700945|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700946|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
700947|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700948|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
700949|NCT03015857|Narcotics|narcotics|mesh-ancestor
700950|NCT03015857|Analgesics|analgesics|mesh-ancestor
700951|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
700952|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
700953|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
700954|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
700955|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
700956|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
700957|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
700958|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
700959|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
700960|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
700961|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
700962|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
700963|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
700964|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
701477|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228023|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228024|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228025|NCT00059852|Antiviral Agents|antiviral agents|mesh-ancestor
2228026|NCT00059852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228027|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228028|NCT00059852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228029|NCT00059852|Immunologic Factors|immunologic factors|mesh-ancestor
698481|NCT03025841|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
698482|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
698483|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
698718|NCT03024840|Propofol|propofol|mesh-list
698719|NCT03024840|Sevoflurane|sevoflurane|mesh-list
698720|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
698721|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
698722|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698723|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
698724|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
698725|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
698726|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
698727|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
698768|NCT03024489|Cetuximab|cetuximab|mesh-list
698769|NCT03024489|Palbociclib|palbociclib|mesh-list
698770|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
698771|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698772|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
698773|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698774|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089086|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
2089087|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228030|NCT00059852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699047|NCT03023319|Pemetrexed|pemetrexed|mesh-list
699048|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699049|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699050|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699051|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
699052|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
699339|NCT03022006|Grazoprevir|grazoprevir|mesh-list
699340|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
699341|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
699845|NCT03019848|Curcumin|curcumin|mesh-list
699846|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
699847|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
699848|NCT03019848|Analgesics|analgesics|mesh-ancestor
699849|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
699850|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699851|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699852|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
699853|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
699854|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699855|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699856|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700016|NCT03018899|Anesthetics|anesthetics|mesh-list
700017|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700018|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700248|NCT03018301|Ketamine|ketamine|mesh-list
700249|NCT03018301|Analgesics|analgesics|mesh-ancestor
700250|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
700251|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700252|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700253|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
700254|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
700255|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
700256|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
700257|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700258|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
700259|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
700260|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
700261|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700434|NCT03017807|Antibodies|antibodies|mesh-list
700435|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
700436|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700647|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
700648|NCT03017404|Docetaxel|docetaxel|mesh-list
700649|NCT03017404|Doxorubicin|doxorubicin|mesh-list
700650|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
698248|NCT03027219|Alprostadil|alprostadil|mesh-list
698249|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
698250|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
698251|NCT03027219|Urological Agents|urological agents|mesh-ancestor
698354|NCT03026725|Calcium|calcium|mesh-list
698355|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
698356|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698492|NCT03025880|Gemcitabine|gemcitabine|mesh-list
698493|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
698494|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
698495|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
698496|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
698497|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698498|NCT03025880|Antiviral Agents|antiviral agents|mesh-ancestor
698499|NCT03025880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
698500|NCT03025880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
698501|NCT03025880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
698502|NCT03025880|Immunologic Factors|immunologic factors|mesh-ancestor
698503|NCT03025880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698504|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
699252|NCT03022240|Ondansetron|ondansetron|mesh-list
699253|NCT03022240|Propofol|propofol|mesh-list
699254|NCT03022240|Sevoflurane|sevoflurane|mesh-list
699255|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
699256|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
699257|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699258|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
699259|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
699260|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
699261|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
699262|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
699263|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
699264|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
699265|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699266|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
699267|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
699268|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
699269|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
699270|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
699271|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
699272|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699273|NCT03022240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
699274|NCT03022240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
699275|NCT03022240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
699276|NCT03022240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2228031|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2228032|NCT00059865|Gemcitabine|gemcitabine|mesh-list
699735|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
699736|NCT03020056|Antioxidants|antioxidants|mesh-list
699737|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
699738|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699739|NCT03020056|Protective Agents|protective agents|mesh-ancestor
699740|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228033|NCT00059865|Pemetrexed|pemetrexed|mesh-list
2228034|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228035|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
2228036|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228037|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228038|NCT00059865|Antiviral Agents|antiviral agents|mesh-ancestor
700367|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
700368|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
700369|NCT03018366|Estradiol|estradiol|mesh-list
700370|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
700371|NCT03018366|Progesterone|progesterone|mesh-list
700372|NCT03018366|Estrogens|estrogens|mesh-ancestor
700373|NCT03018366|Hormones|hormones|mesh-ancestor
700374|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
700375|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700376|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
700377|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
700378|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
698297|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698298|NCT03027115|Urological Agents|urological agents|mesh-ancestor
698600|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
698601|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
698602|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698780|NCT03024697|Anesthetics|anesthetics|mesh-list
698781|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
698782|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
698783|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698784|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
698785|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698869|NCT03023904|Nivolumab|nivolumab|mesh-list
698870|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
698871|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
698872|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
698873|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699291|NCT03022201|Domperidone|domperidone|mesh-list
699292|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
699293|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
699294|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699295|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699296|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
699297|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
699298|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
699299|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
699300|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699548|NCT03020875|Acetaminophen|acetaminophen|mesh-list
699549|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
699550|NCT03020875|Analgesics|analgesics|mesh-ancestor
699551|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
699552|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699553|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699554|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
699584|NCT03020563|Bupivacaine|bupivacaine|mesh-list
699585|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
699586|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
699587|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
699588|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699589|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
699590|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699781|NCT03019822|Amphetamine|amphetamine|mesh-list
699782|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
699783|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
699784|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
699785|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
699786|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699787|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
699788|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
699789|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699790|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
699791|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
699792|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699793|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
699794|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
699795|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
699796|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
699797|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
699798|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
699799|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
699800|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
699801|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
699802|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
699931|NCT03019536|Flutemetamol|flutemetamol|mesh-list
699932|NCT03019536|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
699933|NCT03019536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228039|NCT00059865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228040|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228041|NCT00059865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228042|NCT00059865|Immunologic Factors|immunologic factors|mesh-ancestor
700840|NCT03016871|Carboplatin|carboplatin|mesh-list
700841|NCT03016871|Nivolumab|nivolumab|mesh-list
700842|NCT03016871|Etoposide|etoposide|mesh-list
700843|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
700844|NCT03016871|Ifosfamide|ifosfamide|mesh-list
700845|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
700846|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
698343|NCT03026790|Buprenorphine|buprenorphine|mesh-list
698344|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
698345|NCT03026790|Naloxone|naloxone|mesh-list
698346|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
698347|NCT03026790|Narcotics|narcotics|mesh-ancestor
698348|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
698349|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698350|NCT03026790|Analgesics|analgesics|mesh-ancestor
698351|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
698352|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
698353|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
699457|NCT03021330|Cytarabine|cytarabine|mesh-list
699458|NCT03021330|Daunorubicin|daunorubicin|mesh-list
699459|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
699460|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
699461|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699462|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699463|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
699464|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
699465|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
699466|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
699467|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699468|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
699469|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
699470|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
699471|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089088|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089089|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2089090|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2089091|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
2089092|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089093|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2089094|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2089095|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
699011|NCT03023306|Antiemetics|antiemetics|mesh-list
699012|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
699013|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699014|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699015|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
699105|NCT03022838|Caffeine|caffeine|mesh-list
699106|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
699107|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699108|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
699109|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699110|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699111|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
699112|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
699113|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
699114|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
699408|NCT03021590|Amoxicillin|amoxicillin|mesh-list
699409|NCT03021590|Clarithromycin|clarithromycin|mesh-list
699410|NCT03021590|Levofloxacin|levofloxacin|mesh-list
699411|NCT03021590|Ofloxacin|ofloxacin|mesh-list
699412|NCT03021590|Tinidazole|tinidazole|mesh-list
699413|NCT03021590|Esomeprazole|esomeprazole|mesh-list
699414|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
699415|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
699416|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
699417|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
699418|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
699419|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699420|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699421|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
699422|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
699423|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
699424|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
699425|NCT03021590|Renal Agents|renal agents|mesh-ancestor
699426|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
699427|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
699428|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699429|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
699430|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
699431|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
699432|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
699433|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
699526|NCT03020901|Teicoplanin|teicoplanin|mesh-list
699527|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
699528|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
699618|NCT03020368|Diclofenac|diclofenac|mesh-list
699619|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
699620|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
699621|NCT03020368|Analgesics|analgesics|mesh-ancestor
699622|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
699623|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699624|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699625|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
699626|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
699627|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
699628|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699629|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228043|NCT00059865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228044|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2228045|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2228046|NCT00059878|Interferons|interferons|mesh-list
2228047|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
2228048|NCT00059878|Voriconazole|voriconazole|mesh-list
2228049|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228050|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
2228051|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228052|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
699918|NCT03019562|Fentanyl|fentanyl|mesh-list
2089096|NCT02195232|Quercetin|quercetin|mesh-list
698746|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
698747|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
698748|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
698749|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
699016|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
699017|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
699018|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
699019|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699020|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
699021|NCT03023189|Coagulants|coagulants|mesh-ancestor
699491|NCT03021421|Bupivacaine|bupivacaine|mesh-list
699492|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
699493|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
699494|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
699495|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699496|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
699497|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699522|NCT03020940|Cefuroxime|cefuroxime|mesh-list
699523|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
699524|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
699525|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
699659|NCT03020329|Paclitaxel|paclitaxel|mesh-list
699660|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
699661|NCT03020329|Cisplatin|cisplatin|mesh-list
699662|NCT03020329|Fluorouracil|fluorouracil|mesh-list
699663|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
699664|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699665|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
699666|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
699667|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
699668|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699669|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
699670|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
699671|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
699672|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
699673|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228053|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2228054|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2228055|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228056|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228057|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2228058|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
2228059|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2228060|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228061|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2228062|NCT00059904|Aldesleukin|aldesleukin|mesh-list
2228063|NCT00059904|Rituximab|rituximab|mesh-list
2228064|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2228065|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228066|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
2228067|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228068|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228069|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2228070|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2228071|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
2228072|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228073|NCT00059917|Camptothecin|camptothecin|mesh-list
2228074|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
700992|NCT03015701|Mifepristone|mifepristone|mesh-list
700993|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
700994|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
700995|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
700996|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700997|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
700998|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
700999|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
701000|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
701001|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
701002|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
701003|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
701004|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
701005|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
701006|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2228075|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228076|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2228077|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2228078|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228079|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699119|NCT03022877|Simendan|simendan|mesh-list
699120|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
699121|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
699122|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
699123|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
699124|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699125|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699126|NCT03022877|Protective Agents|protective agents|mesh-ancestor
699127|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699402|NCT03021629|Vitamin D|vitamin d|mesh-list
699403|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
699404|NCT03021629|Vitamins|vitamins|mesh-ancestor
699405|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
699406|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699407|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
699773|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
699774|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
699775|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
699776|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
699777|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
699778|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699779|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699780|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
699899|NCT03019588|Paclitaxel|paclitaxel|mesh-list
699900|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
699901|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
699902|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699903|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
699904|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
699905|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
699906|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699907|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
700218|NCT03018418|Mitomycins|mitomycins|mesh-list
700219|NCT03018418|Mitomycin|mitomycin|mesh-list
700220|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
700221|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700222|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
700223|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700224|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
700225|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089097|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
2089098|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089099|NCT02195232|Protective Agents|protective agents|mesh-ancestor
2089100|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700836|NCT03016468|Treprostinil|treprostinil|mesh-list
700837|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
701368|NCT03013933|Cyclosporine|cyclosporine|mesh-list
701369|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
701370|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
701371|NCT03013933|Verapamil|verapamil|mesh-list
701372|NCT03013933|Antibodies|antibodies|mesh-list
701373|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
701374|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
701375|NCT03013933|Cyclosporins|cyclosporins|mesh-list
701376|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
701377|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
701378|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701379|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701380|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701381|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701382|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
701383|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
701384|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
701385|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
701386|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
701387|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2228080|NCT00059930|Leucovorin|leucovorin|mesh-list
698890|NCT03023514|Protective Agents|protective agents|mesh-ancestor
698891|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
698892|NCT03023514|Vitamins|vitamins|mesh-ancestor
698893|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
2228081|NCT00059930|Dexamethasone|dexamethasone|mesh-list
2228082|NCT00059930|Fluorouracil|fluorouracil|mesh-list
2228083|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
2228084|NCT00059930|Floxuridine|floxuridine|mesh-list
2228085|NCT00059930|Calcium|calcium|mesh-list
2228086|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
2228087|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2228088|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
2228089|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
2228090|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228091|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228092|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2228093|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
700107|NCT03018665|Metformin|metformin|mesh-list
700108|NCT03018665|Exenatide|exenatide|mesh-list
700109|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
700110|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700111|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
700112|NCT03018665|Incretins|incretins|mesh-ancestor
700113|NCT03018665|Hormones|hormones|mesh-ancestor
700114|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2228094|NCT00059930|Hormones|hormones|mesh-ancestor
2228095|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2228096|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2228097|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228098|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2228099|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
2228100|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228101|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228102|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228103|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
701509|NCT03013218|Paclitaxel|paclitaxel|mesh-list
701510|NCT03013218|Rituximab|rituximab|mesh-list
701511|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
701512|NCT03013218|Trastuzumab|trastuzumab|mesh-list
701513|NCT03013218|Ramucirumab|ramucirumab|mesh-list
701514|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
701515|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701516|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
701517|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
701518|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
701519|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701520|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
701521|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
701522|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701523|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
702113|NCT03011567|Acetaminophen|acetaminophen|mesh-list
702114|NCT03011567|Ibuprofen|ibuprofen|mesh-list
702115|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
702116|NCT03011567|Analgesics|analgesics|mesh-ancestor
702117|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
702118|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702119|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702120|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
702121|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
702122|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
702123|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
702124|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
702125|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702126|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702290|NCT03010540|Fentanyl|fentanyl|mesh-list
702291|NCT03010540|Morphine|morphine|mesh-list
702292|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
702293|NCT03010540|Narcotics|narcotics|mesh-ancestor
702294|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
702295|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702296|NCT03010540|Analgesics|analgesics|mesh-ancestor
702297|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
702298|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228104|NCT00059930|Antidotes|antidotes|mesh-ancestor
2228105|NCT00059930|Protective Agents|protective agents|mesh-ancestor
700340|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
700341|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
700342|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
700827|NCT03016234|Propofol|propofol|mesh-list
700828|NCT03016234|Desflurane|desflurane|mesh-list
700829|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
700830|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700831|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700832|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
700833|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
700834|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
700835|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
700928|NCT03015922|Lenalidomide|lenalidomide|mesh-list
700929|NCT03015922|Pomalidomide|pomalidomide|mesh-list
700930|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
700931|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700932|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
700933|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
700934|NCT03015922|Growth Substances|growth substances|mesh-ancestor
700935|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
700936|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701095|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
701096|NCT03015519|Incretins|incretins|mesh-ancestor
701097|NCT03015519|Hormones|hormones|mesh-ancestor
701098|NCT03015519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
701099|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702583|NCT03009045|Tedizolid|tedizolid|mesh-list
702584|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
702585|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
702586|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
702587|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
702588|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
702589|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702590|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703047|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
703048|NCT03007537|Hematinics|hematinics|mesh-ancestor
703640|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
703641|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
703642|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
703643|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703644|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703645|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
703646|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
703647|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
703648|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
703649|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
703650|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
703651|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
703652|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703929|NCT03004248|Botulinum Toxins|botulinum toxins|mesh-list
703930|NCT03004248|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
703931|NCT03004248|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
703932|NCT03004248|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
703933|NCT03004248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
703934|NCT03004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703935|NCT03004248|Cholinergic Agents|cholinergic agents|mesh-ancestor
703936|NCT03004248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
703937|NCT03004248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703938|NCT03004248|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
703939|NCT03004248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228106|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
2228107|NCT00059930|Vitamins|vitamins|mesh-ancestor
2228108|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
2228109|NCT00059943|Docetaxel|docetaxel|mesh-list
2228110|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228111|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
2228112|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
2228113|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
2752902|NCT03268811|Teduglutide|teduglutide|mesh-list
2752903|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2752904|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2752905|NCT03268811|Protective Agents|protective agents|mesh-ancestor
2752906|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752907|NCT03267433|Rituximab|rituximab|mesh-list
2752908|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2752909|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752910|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
2752911|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752912|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089124|NCT02195518|Tenofovir|tenofovir|mesh-list
2089125|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
2089126|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089127|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2089128|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2089129|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089130|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089131|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2089132|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2089133|NCT02195583|Zinc|zinc|mesh-list
2089134|NCT02195583|Listerine|listerine|mesh-list
2089135|NCT02195583|Fluorides|fluorides|mesh-list
2089136|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
2089137|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
2089138|NCT02195583|Protective Agents|protective agents|mesh-ancestor
2089139|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089140|NCT02195583|Trace Elements|trace elements|mesh-ancestor
2089141|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
699128|NCT03022773|Carotenoids|carotenoids|mesh-list
699129|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
699130|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699131|NCT03022773|Protective Agents|protective agents|mesh-ancestor
699132|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699315|NCT03021772|Dexamethasone|dexamethasone|mesh-list
699316|NCT03021772|Neostigmine|neostigmine|mesh-list
699317|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
699318|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
699319|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
699320|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699321|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699322|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
699323|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
699324|NCT03021772|Hormones|hormones|mesh-ancestor
699325|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
699326|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
699327|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699328|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
699329|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699330|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699331|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
699332|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
699333|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
700441|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
700442|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
700443|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
700444|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
700445|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
700446|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700447|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
700448|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
700449|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700450|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
700451|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701008|NCT03015727|Docetaxel|docetaxel|mesh-list
701009|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701010|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
701011|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
701012|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
701013|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089142|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2089143|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089144|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
2089145|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
699035|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
699392|NCT03021395|Decitabine|decitabine|mesh-list
699393|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
699394|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
699395|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699396|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699397|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700226|NCT03018171|Clonidine|clonidine|mesh-list
700227|NCT03018171|Sufentanil|sufentanil|mesh-list
700228|NCT03018171|Analgesics|analgesics|mesh-ancestor
700229|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
700230|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700231|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700232|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
700233|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
700234|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
700235|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
700236|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
700237|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
700238|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
700239|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
700240|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700241|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
700242|NCT03018171|Narcotics|narcotics|mesh-ancestor
700243|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700244|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
700245|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
700246|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
700247|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
700706|NCT03017066|Anesthetics|anesthetics|mesh-list
700707|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700708|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701308|NCT03014323|Galantamine|galantamine|mesh-list
701309|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
701310|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701311|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701312|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
701313|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701314|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701315|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
701316|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
701317|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701318|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
701362|NCT03013790|Melatonin|melatonin|mesh-list
701363|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
701364|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701365|NCT03013790|Protective Agents|protective agents|mesh-ancestor
701366|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701367|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
702039|NCT03011671|Temozolomide|temozolomide|mesh-list
702040|NCT03011671|Acetazolamide|acetazolamide|mesh-list
702041|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
702042|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
702043|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702044|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702045|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
702046|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
702047|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702048|NCT03011671|Diuretics|diuretics|mesh-ancestor
702049|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
702050|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089146|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2089147|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2089148|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2089149|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089150|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
2089151|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089152|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089153|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2089154|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089155|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
2089156|NCT02195895|Vitamin D|vitamin d|mesh-list
2089157|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
2089158|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
2089159|NCT02195895|Alendronate|alendronate|mesh-list
2089160|NCT02195895|Vitamins|vitamins|mesh-list
699057|NCT03023358|Vincristine|vincristine|mesh-list
699058|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
699059|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
699060|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699061|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
699062|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
699063|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
699064|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699065|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699066|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
699067|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
699068|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
699069|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
699070|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699071|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
699072|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
699073|NCT03023358|Hormones|hormones|mesh-ancestor
699074|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
699075|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
699076|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
699077|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
699078|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
699079|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
699243|NCT03022409|Olaparib|olaparib|mesh-list
699244|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
699245|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699246|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699247|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699454|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
699455|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
699456|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228114|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228115|NCT00060112|Gemcitabine|gemcitabine|mesh-list
2228116|NCT00060112|Oblimersen|oblimersen|mesh-list
2228117|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228118|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
2228119|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228120|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228121|NCT00060112|Antiviral Agents|antiviral agents|mesh-ancestor
2228122|NCT00060112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228123|NCT00060112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228124|NCT00060112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228125|NCT00060112|Immunologic Factors|immunologic factors|mesh-ancestor
2228126|NCT00060112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228127|NCT00060125|Tipifarnib|tipifarnib|mesh-list
2228128|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228129|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
2228130|NCT00060138|Antibodies|antibodies|mesh-list
2228131|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2228132|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
2228133|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228134|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2228135|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
2228136|NCT00060242|Combretastatin|combretastatin|mesh-list
2228137|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2228138|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228139|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
2228140|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
2228141|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
2228142|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228143|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
2228144|NCT00060255|Melphalan|melphalan|mesh-list
700776|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
700777|NCT03016806|Melphalan|melphalan|mesh-list
700778|NCT03016806|Busulfan|busulfan|mesh-list
700779|NCT03016806|Fludarabine|fludarabine|mesh-list
700780|NCT03016806|Mesna|mesna|mesh-list
700781|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
700782|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
700783|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700784|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
700785|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
700786|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
700787|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700788|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700789|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2228145|NCT00060255|Busulfan|busulfan|mesh-list
2228146|NCT00060255|Thiotepa|thiotepa|mesh-list
2228147|NCT00060255|Carmustine|carmustine|mesh-list
2228148|NCT00060255|Carboplatin|carboplatin|mesh-list
2228149|NCT00060255|Etoposide|etoposide|mesh-list
2228150|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228151|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
2228152|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699450|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
699451|NCT03021317|Hormones|hormones|mesh-ancestor
699452|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
699453|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228153|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228154|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2228155|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
2228156|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228157|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228158|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2228159|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2228160|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2228161|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2228162|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228163|NCT00060294|Rituximab|rituximab|mesh-list
2228164|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2228165|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228166|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
2228167|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228168|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228169|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2228170|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228171|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2228172|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228173|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228174|NCT00060359|Paclitaxel|paclitaxel|mesh-list
2228175|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2228176|NCT00060359|Carboplatin|carboplatin|mesh-list
2228177|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2228178|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2228179|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228180|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
2228181|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
2228182|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
2228183|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228184|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2228185|NCT00060372|Ipilimumab|ipilimumab|mesh-list
2228186|NCT00060372|Antibodies|antibodies|mesh-list
2228187|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
2228188|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2228189|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
699942|NCT03019237|Omalizumab|omalizumab|mesh-list
699943|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
699944|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
699945|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
700452|NCT03017495|Midazolam|midazolam|mesh-list
700453|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
700454|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
700455|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700456|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700457|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
700458|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
700459|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
700460|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
700461|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
700462|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
700463|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
700464|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
700465|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
700466|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700551|NCT03017248|Morphine|morphine|mesh-list
700552|NCT03017248|Ketamine|ketamine|mesh-list
700553|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
700554|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
700555|NCT03017248|Narcotics|narcotics|mesh-ancestor
700556|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700557|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700558|NCT03017248|Analgesics|analgesics|mesh-ancestor
2228190|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699221|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
699222|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
699223|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
699224|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
699225|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
699226|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
699227|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
699228|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
699498|NCT03021083|Fentanyl|fentanyl|mesh-list
699499|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
699500|NCT03021083|Narcotics|narcotics|mesh-ancestor
699501|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
699502|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699503|NCT03021083|Analgesics|analgesics|mesh-ancestor
699504|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
699505|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699506|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
699507|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
699508|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
699509|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
700027|NCT03019081|Isoproterenol|isoproterenol|mesh-list
700028|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
700029|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
700030|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
700031|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
700032|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700033|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700034|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
700035|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
700036|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700037|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
700038|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
700039|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
700040|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
700041|NCT03019081|Protective Agents|protective agents|mesh-ancestor
700210|NCT03018444|Atorvastatin|atorvastatin|mesh-list
700211|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
700212|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
700213|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
700214|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700215|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
700216|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
700217|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701331|NCT03014076|Trastuzumab|trastuzumab|mesh-list
701332|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
701333|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701420|NCT03013387|Octreotide|octreotide|mesh-list
701421|NCT03013387|Edotreotide|edotreotide|mesh-list
701422|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
701423|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
701424|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701425|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
701426|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702168|NCT03011281|Tofacitinib|tofacitinib|mesh-list
702169|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
702170|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702171|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702303|NCT03011021|Liraglutide|liraglutide|mesh-list
702304|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
702305|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702306|NCT03011021|Incretins|incretins|mesh-ancestor
702307|NCT03011021|Hormones|hormones|mesh-ancestor
702308|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2228191|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228192|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2228193|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228194|NCT00060385|Prednisone|prednisone|mesh-list
2228195|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
2228196|NCT00060385|Doxorubicin|doxorubicin|mesh-list
2228197|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2228198|NCT00060385|Etoposide|etoposide|mesh-list
2228199|NCT00060385|Vincristine|vincristine|mesh-list
2228200|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228201|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
2228202|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228203|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
699237|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699238|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
699239|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699240|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
699241|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
699242|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
699357|NCT03022123|Prednisone|prednisone|mesh-list
699358|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
699359|NCT03022123|Doxorubicin|doxorubicin|mesh-list
699360|NCT03022123|Vincristine|vincristine|mesh-list
699361|NCT03022123|Epirubicin|epirubicin|mesh-list
699362|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
699363|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
699364|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699365|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
699366|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
699367|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
699368|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699369|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699370|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
699371|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
699372|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
699373|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
699374|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699375|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
699376|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
699377|NCT03022123|Hormones|hormones|mesh-ancestor
699378|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
699379|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
699380|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
699381|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
699382|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
699383|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor
699472|NCT03021486|Haloperidol|haloperidol|mesh-list
699473|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
699474|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
699475|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
699476|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
699477|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699478|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699479|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
699480|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
699481|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
699482|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
699483|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
699484|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
699485|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
699486|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
699487|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699488|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
699513|NCT03020979|Apatinib|apatinib|mesh-list
699514|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
699515|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
699516|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699517|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699694|NCT03020134|Ritonavir|ritonavir|mesh-list
699695|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
699696|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
699697|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
699698|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699699|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699700|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
699701|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
699702|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
699703|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
699704|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
699705|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
700013|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
700014|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700015|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700166|NCT03018626|Prednisone|prednisone|mesh-list
700167|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
700168|NCT03018626|Rituximab|rituximab|mesh-list
700169|NCT03018626|Doxorubicin|doxorubicin|mesh-list
700170|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
700171|NCT03018626|Etoposide|etoposide|mesh-list
699251|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700437|NCT03017768|Tryptophan|tryptophan|mesh-list
700438|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
700439|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
700440|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
700670|NCT03017131|Aldesleukin|aldesleukin|mesh-list
700671|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
700672|NCT03017131|Decitabine|decitabine|mesh-list
700673|NCT03017131|Interleukin-2|interleukin-2|mesh-list
700674|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
700675|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
700676|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700677|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
700678|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
700679|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
700680|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700681|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700682|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
700683|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
700684|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
700685|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700686|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
700687|NCT03017131|Analgesics|analgesics|mesh-ancestor
700688|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
700689|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700690|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
700691|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
700692|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
700693|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
702139|NCT03011463|Clarithromycin|clarithromycin|mesh-list
702140|NCT03011463|Ranitidine|ranitidine|mesh-list
699530|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
699531|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699532|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
699533|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
699534|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699535|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
699536|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
699537|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
699538|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
699539|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
699540|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
699541|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
699542|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2228204|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2228205|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
2228206|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228207|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228208|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2228209|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2228210|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2228211|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2228212|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228213|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
700271|NCT03018015|Ibuprofen|ibuprofen|mesh-list
700272|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
700273|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
700274|NCT03018015|Analgesics|analgesics|mesh-ancestor
700275|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
700276|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700277|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700278|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
700279|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
700280|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
700281|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700282|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701299|NCT03014440|Cannabidiol|cannabidiol|mesh-list
701300|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
2228214|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
2228215|NCT00060385|Hormones|hormones|mesh-ancestor
2228216|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
702438|NCT03009682|Olaparib|olaparib|mesh-list
702439|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
702440|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702441|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702442|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703232|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
703233|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
703234|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
703235|NCT03006757|Protective Agents|protective agents|mesh-ancestor
703236|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703237|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
703238|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
703304|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
703305|NCT03006419|Basiliximab|basiliximab|mesh-list
703306|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
703307|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703308|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
703436|NCT03006042|Bupivacaine|bupivacaine|mesh-list
703437|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
703438|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
703439|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
703440|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703441|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
703442|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704132|NCT03003637|Nivolumab|nivolumab|mesh-list
704133|NCT03003637|Ipilimumab|ipilimumab|mesh-list
704134|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
704135|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704136|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
704137|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704148|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
704149|NCT03003273|Amoxicillin|amoxicillin|mesh-list
704150|NCT03003273|Levofloxacin|levofloxacin|mesh-list
704151|NCT03003273|Ofloxacin|ofloxacin|mesh-list
699609|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699610|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
699611|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
699612|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089161|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
2089162|NCT02195895|Antacids|antacids|mesh-list
2089163|NCT02195895|Calcium|calcium|mesh-list
700132|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
700133|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
700134|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
700135|NCT03018535|Prednisolone|prednisolone|mesh-list
700136|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
700137|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
700138|NCT03018535|Rituximab|rituximab|mesh-list
700139|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
700140|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
700141|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
700142|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
700143|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700144|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
700145|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
700146|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
700147|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700148|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700149|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
700150|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
700151|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
700152|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
700153|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
700154|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700155|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
700156|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
700157|NCT03018535|Hormones|hormones|mesh-ancestor
700158|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
700159|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
700160|NCT03018535|Protective Agents|protective agents|mesh-ancestor
700161|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
700819|NCT03016208|Misoprostol|misoprostol|mesh-list
700820|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
700821|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
700822|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
700823|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700824|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
700825|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
700826|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
2228217|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2228218|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
701524|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
701525|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
701526|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701527|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701528|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
701529|NCT03013634|Analgesics|analgesics|mesh-ancestor
701530|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
701531|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701532|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
701533|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2089164|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
699807|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
700008|NCT03019120|Vitamin D|vitamin d|mesh-list
700009|NCT03019120|Vitamins|vitamins|mesh-ancestor
700010|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
700011|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700012|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
700162|NCT03018704|Topiramate|topiramate|mesh-list
700163|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
700164|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
700165|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700533|NCT03017820|Iodine|iodine|mesh-list
700534|NCT03017820|Interferons|interferons|mesh-list
700535|NCT03017820|Interferon-beta|interferon-beta|mesh-list
700536|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
700537|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
700538|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
700539|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700540|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
700541|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
700542|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
700543|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700544|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700545|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
700546|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
700547|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
700548|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
700549|NCT03017820|Trace Elements|trace elements|mesh-ancestor
700550|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
700667|NCT03016884|Vaccines|vaccines|mesh-list
700668|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
700669|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700892|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
700893|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700894|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700895|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700896|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
701585|NCT03013140|Anesthetics|anesthetics|mesh-list
701586|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701587|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701657|NCT03012646|Treprostinil|treprostinil|mesh-list
701658|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
702245|NCT03010995|Prazosin|prazosin|mesh-list
702246|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
702247|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
702248|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
702249|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
702250|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
702251|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702252|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702253|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702377|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
702378|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
702379|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
702380|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702576|NCT03009240|Decitabine|decitabine|mesh-list
702577|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
702578|NCT03009240|Pevonedistat|pevonedistat|mesh-list
702579|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
702580|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
702581|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702582|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702780|NCT03008317|Chromium|chromium|mesh-list
702781|NCT03008317|Trace Elements|trace elements|mesh-ancestor
702782|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
702783|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703083|NCT03007238|Aldesleukin|aldesleukin|mesh-list
703084|NCT03007238|Interleukin-2|interleukin-2|mesh-list
703085|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703086|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
703087|NCT03007238|Analgesics|analgesics|mesh-ancestor
703088|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
703089|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703090|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703091|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
699919|NCT03019562|Oxycodone|oxycodone|mesh-list
699920|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
699921|NCT03019562|Narcotics|narcotics|mesh-ancestor
699922|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
699923|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
699924|NCT03019562|Analgesics|analgesics|mesh-ancestor
699925|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
699926|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
699927|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
699928|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
699929|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
699930|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
700316|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
700317|NCT03017963|Antidotes|antidotes|mesh-ancestor
700318|NCT03017963|Protective Agents|protective agents|mesh-ancestor
700319|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700320|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
700321|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700322|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
700323|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
700324|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
700325|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
700326|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
700425|NCT03017703|Eplerenone|eplerenone|mesh-list
700426|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
700427|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
700428|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
700429|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700430|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
700431|NCT03017703|Diuretics|diuretics|mesh-ancestor
700432|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
700433|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
700512|NCT03017391|Dexamethasone|dexamethasone|mesh-list
700513|NCT03017391|Metoclopramide|metoclopramide|mesh-list
700514|NCT03017391|Granisetron|granisetron|mesh-list
700515|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
700516|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
700517|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
700518|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700519|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700520|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
700521|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
700522|NCT03017391|Hormones|hormones|mesh-ancestor
700523|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
700524|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
700525|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700526|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
700527|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
700528|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
700529|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
700530|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700531|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
700532|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
701435|NCT03013556|Tenofovir|tenofovir|mesh-list
701436|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
701437|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
701438|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
701439|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
701440|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
701441|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
701442|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701443|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701444|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
701445|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
701446|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
701447|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701761|NCT03012880|Dexamethasone|dexamethasone|mesh-list
701762|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
701763|NCT03012880|Lenalidomide|lenalidomide|mesh-list
701764|NCT03012880|Daratumumab|daratumumab|mesh-list
701765|NCT03012880|Ixazomib|ixazomib|mesh-list
701766|NCT03012880|Ichthammol|ichthammol|mesh-list
701767|NCT03012880|BB 1101|bb 1101|mesh-list
701768|NCT03012880|Glycine|glycine|mesh-list
701769|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
701770|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
701771|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
701772|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700115|NCT03018821|Tenofovir|tenofovir|mesh-list
700116|NCT03018821|Entecavir|entecavir|mesh-list
700117|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
700118|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
700119|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
700120|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
700121|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700122|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700123|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
700124|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2089165|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089166|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2089167|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2089168|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089169|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2089170|NCT02195921|Antiemetics|antiemetics|mesh-list
701579|NCT03013101|Antibodies|antibodies|mesh-list
701580|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
701581|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
701582|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702092|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
702093|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
702094|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
702095|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
702199|NCT03011177|Linagliptin|linagliptin|mesh-list
702200|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
702201|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702202|NCT03011177|Incretins|incretins|mesh-ancestor
702203|NCT03011177|Hormones|hormones|mesh-ancestor
702204|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
702205|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
702206|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
702207|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702208|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702336|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
702337|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
702338|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
702339|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
702340|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702341|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
702342|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
702343|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
702471|NCT03009838|Letrozole|letrozole|mesh-list
702472|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702473|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
702474|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
702475|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702476|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702477|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
702478|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
702479|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
702480|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703668|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
703669|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
703670|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
703772|NCT03004625|Ribavirin|ribavirin|mesh-list
703773|NCT03004625|Asunaprevir|asunaprevir|mesh-list
703774|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
703775|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703776|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
700049|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
700050|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700051|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
700052|NCT03019198|Coagulants|coagulants|mesh-ancestor
2228219|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
2228220|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
2228221|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
2228222|NCT00060398|Dexamethasone|dexamethasone|mesh-list
2228223|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
2228224|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2228225|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
2228226|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
2228227|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700749|NCT03016650|Acetaminophen|acetaminophen|mesh-list
700750|NCT03016650|Ibuprofen|ibuprofen|mesh-list
700751|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
700752|NCT03016650|Analgesics|analgesics|mesh-ancestor
700753|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
700754|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700755|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700756|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
700757|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
700758|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
700759|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
700760|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
700761|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700762|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700862|NCT03016260|Adalimumab|adalimumab|mesh-list
700863|NCT03016260|Etanercept|etanercept|mesh-list
700864|NCT03016260|Golimumab|golimumab|mesh-list
700865|NCT03016260|Infliximab|infliximab|mesh-list
700866|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
700867|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
700868|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
700869|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
700870|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
700871|NCT03016260|Analgesics|analgesics|mesh-ancestor
700872|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
700873|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700874|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700875|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
700876|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
700877|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
700878|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
700879|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
701180|NCT03015168|Capecitabine|capecitabine|mesh-list
701181|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
701182|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
701183|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701184|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701334|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
701335|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
701336|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
701337|NCT03013959|Analgesics|analgesics|mesh-ancestor
701338|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
701339|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701340|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701341|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
701342|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
701343|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
701358|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
701359|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
701360|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
701361|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
701393|NCT03013335|Nivolumab|nivolumab|mesh-list
701394|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
701395|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701396|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
701397|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701821|NCT03012321|Prednisone|prednisone|mesh-list
701822|NCT03012321|Olaparib|olaparib|mesh-list
701823|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
701824|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
701825|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
701826|NCT03012321|Hormones|hormones|mesh-ancestor
701827|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2228228|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700172|NCT03018626|Vincristine|vincristine|mesh-list
700173|NCT03018626|Bleomycin|bleomycin|mesh-list
700174|NCT03018626|Vindesine|vindesine|mesh-list
700175|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
700176|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
700177|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700178|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
700179|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
700180|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
700181|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700182|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700183|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
700184|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
700185|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
700186|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
700187|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
700188|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700189|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
700190|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
700191|NCT03018626|Hormones|hormones|mesh-ancestor
700192|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
700193|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
700194|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
700195|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
700196|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
700197|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
700619|NCT03017326|Gemcitabine|gemcitabine|mesh-list
700620|NCT03017326|Carboplatin|carboplatin|mesh-list
700621|NCT03017326|Doxorubicin|doxorubicin|mesh-list
700622|NCT03017326|Fluorouracil|fluorouracil|mesh-list
700623|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
700624|NCT03017326|Irinotecan|irinotecan|mesh-list
700625|NCT03017326|Etoposide|etoposide|mesh-list
700626|NCT03017326|Vincristine|vincristine|mesh-list
700627|NCT03017326|Sorafenib|sorafenib|mesh-list
700628|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700629|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
700630|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
700631|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700632|NCT03017326|Antiviral Agents|antiviral agents|mesh-ancestor
700633|NCT03017326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
700634|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700635|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
700636|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
700637|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700638|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
700639|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
700640|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
700641|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
700642|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
700643|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
700644|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
700645|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
700646|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2089171|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
2089172|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089173|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089174|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2089175|NCT02195986|Estradiol|estradiol|mesh-list
701288|NCT03014804|Nivolumab|nivolumab|mesh-list
701289|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
701290|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701291|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
701292|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701465|NCT03013205|Triamcinolone|triamcinolone|mesh-list
701466|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
701467|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
701468|NCT03013205|Lidocaine|lidocaine|mesh-list
701469|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
701470|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
701471|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
701472|NCT03013205|Hormones|hormones|mesh-ancestor
701473|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
701474|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701475|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
701476|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
2089176|NCT02195986|Estrogens|estrogens|mesh-ancestor
700204|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
700205|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700206|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
700207|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
700208|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
700209|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
701038|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
701039|NCT03015974|Prednisone|prednisone|mesh-list
701040|NCT03015974|Prednisolone|prednisolone|mesh-list
701041|NCT03015974|Deflazacort|deflazacort|mesh-list
701042|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
701043|NCT03015974|Dipyridamole|dipyridamole|mesh-list
701044|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
701045|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
701046|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
701047|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
701048|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701049|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
701050|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
701051|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
701052|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701053|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701054|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
701055|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
701056|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
701057|NCT03015974|Hormones|hormones|mesh-ancestor
701058|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
701059|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
701060|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
701061|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
701062|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
701063|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
701064|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
701065|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701066|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
701067|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
701068|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
701069|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
701571|NCT03013361|Bupivacaine|bupivacaine|mesh-list
701572|NCT03013361|Ropivacaine|ropivacaine|mesh-list
701573|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
701574|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
701575|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701576|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701577|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
701578|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702812|NCT03008408|Everolimus|everolimus|mesh-list
702813|NCT03008408|Letrozole|letrozole|mesh-list
702814|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702815|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
702816|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
702817|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702818|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
702819|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
702820|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702821|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702822|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
702823|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
702824|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2228229|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2228230|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
2228231|NCT00060398|Hormones|hormones|mesh-ancestor
703157|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
700311|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
700312|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
700313|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
700314|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
700315|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701115|NCT03015350|Sevoflurane|sevoflurane|mesh-list
701116|NCT03015350|Desflurane|desflurane|mesh-list
701117|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
701118|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
701119|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
701120|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
701121|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701122|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701583|NCT03013114|Bortezomib|bortezomib|mesh-list
701584|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702108|NCT03011450|Fenofibrate|fenofibrate|mesh-list
702109|NCT03011450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
702110|NCT03011450|Antimetabolites|antimetabolites|mesh-ancestor
702111|NCT03011450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702112|NCT03011450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2228232|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2228233|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2228234|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228235|NCT00060398|Hematinics|hematinics|mesh-ancestor
2228236|NCT00060411|Leucovorin|leucovorin|mesh-list
2228237|NCT00060411|Bevacizumab|bevacizumab|mesh-list
2228238|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2228239|NCT00060411|Fluorouracil|fluorouracil|mesh-list
2228240|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
2228241|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2228242|NCT00060411|Antibodies|antibodies|mesh-list
2228243|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
2228244|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2228245|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
2228246|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228247|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
703522|NCT03005704|Aspirin|aspirin|mesh-list
703523|NCT03005704|Ticagrelor|ticagrelor|mesh-list
703524|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
703525|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
703526|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
703527|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
703528|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
703529|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
703530|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703531|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703532|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
703533|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
703534|NCT03005704|Analgesics|analgesics|mesh-ancestor
703535|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
703536|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703537|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
703538|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
703539|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
703540|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
703541|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
703542|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703543|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
704079|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
704080|NCT03003832|Analgesics|analgesics|mesh-list
704081|NCT03003832|Narcotics|narcotics|mesh-ancestor
704082|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
704083|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704084|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
2228248|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2228249|NCT00060411|Growth Substances|growth substances|mesh-ancestor
2228250|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228251|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
2228252|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
2228253|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
2228254|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228255|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228256|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228257|NCT00060411|Antidotes|antidotes|mesh-ancestor
2228258|NCT00060411|Protective Agents|protective agents|mesh-ancestor
2228259|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
2228260|NCT00060411|Vitamins|vitamins|mesh-ancestor
700984|NCT03015831|Colchicine|colchicine|mesh-list
700985|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
700986|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
700987|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
700988|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
700989|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
700990|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700991|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701150|NCT03015246|Morphine|morphine|mesh-list
701151|NCT03015246|Buprenorphine|buprenorphine|mesh-list
701152|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
701153|NCT03015246|Naloxone|naloxone|mesh-list
701154|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
701155|NCT03015246|Narcotics|narcotics|mesh-ancestor
701156|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701157|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701158|NCT03015246|Analgesics|analgesics|mesh-ancestor
701159|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
701160|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701161|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
701203|NCT03014843|Bromides|bromides|mesh-list
701204|NCT03014843|Naloxone|naloxone|mesh-list
701205|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
701206|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
701207|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
701208|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701209|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
701210|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701355|NCT03013881|Trastuzumab|trastuzumab|mesh-list
701356|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
701357|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701606|NCT03013036|Fentanyl|fentanyl|mesh-list
701607|NCT03013036|Midazolam|midazolam|mesh-list
701608|NCT03013036|Propofol|propofol|mesh-list
701609|NCT03013036|Sevoflurane|sevoflurane|mesh-list
701610|NCT03013036|Rocuronium|rocuronium|mesh-list
701611|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
701612|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701613|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701614|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
701615|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
701616|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
701617|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
701618|NCT03013036|Narcotics|narcotics|mesh-ancestor
701619|NCT03013036|Analgesics|analgesics|mesh-ancestor
701620|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
701621|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701622|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
701623|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
701624|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
701625|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
701626|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
701627|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
701628|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701984|NCT03011775|Analgesics|analgesics|mesh-ancestor
2228261|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
700379|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
700380|NCT03018366|Progestins|progestins|mesh-ancestor
700482|NCT03017222|Ondansetron|ondansetron|mesh-list
700483|NCT03017222|Ramosetron|ramosetron|mesh-list
700484|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
700485|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
700486|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700487|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700488|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
700489|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
700490|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
700491|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
700492|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
700493|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
700494|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700495|NCT03017222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
700496|NCT03017222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
700497|NCT03017222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
700498|NCT03017222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
700499|NCT03017222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
700772|NCT03016442|Dinoprostone|dinoprostone|mesh-list
700773|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
700774|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
700775|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701070|NCT03015792|Dexamethasone|dexamethasone|mesh-list
701071|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
701072|NCT03015792|Lenalidomide|lenalidomide|mesh-list
701073|NCT03015792|Ichthammol|ichthammol|mesh-list
701074|NCT03015792|BB 1101|bb 1101|mesh-list
701075|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
701076|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
701077|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
701078|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701079|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701080|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
701081|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
701082|NCT03015792|Hormones|hormones|mesh-ancestor
701083|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
701084|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
701085|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701086|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
701087|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
701088|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
701089|NCT03015792|Growth Substances|growth substances|mesh-ancestor
701090|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
701091|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
701092|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701093|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701094|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
701123|NCT03015259|Budesonide|budesonide|mesh-list
701124|NCT03015259|Formoterol Fumarate|formoterol fumarate|mesh-list
701125|NCT03015259|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
701126|NCT03015259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
701127|NCT03015259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
701128|NCT03015259|Autonomic Agents|autonomic agents|mesh-ancestor
701129|NCT03015259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701130|NCT03015259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701131|NCT03015259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
701132|NCT03015259|Respiratory System Agents|respiratory system agents|mesh-ancestor
701133|NCT03015259|Glucocorticoids|glucocorticoids|mesh-ancestor
701134|NCT03015259|Hormones|hormones|mesh-ancestor
701135|NCT03015259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
701136|NCT03015259|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
701137|NCT03015259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
701138|NCT03015259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
701139|NCT03015259|Adrenergic Agents|adrenergic agents|mesh-ancestor
701140|NCT03015259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701141|NCT03015259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701538|NCT03013322|Physostigmine|physostigmine|mesh-list
701539|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
701540|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701541|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701542|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
701543|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701544|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701545|NCT03013322|Miotics|miotics|mesh-ancestor
2089177|NCT02195986|Hormones|hormones|mesh-ancestor
2089178|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2089179|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089180|NCT02196168|Cisplatin|cisplatin|mesh-list
2089181|NCT02196168|Adavosertib|adavosertib|mesh-list
2089182|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089183|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700906|NCT03016039|Curcumin|curcumin|mesh-list
700907|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
700908|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
700909|NCT03016039|Analgesics|analgesics|mesh-ancestor
700910|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
700911|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700912|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700913|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
700914|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
700915|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700916|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700917|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701185|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
701186|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
701265|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
701266|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
701267|NCT03014713|Dezocine|dezocine|mesh-list
701268|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
701269|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701270|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701271|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
701272|NCT03014713|Analgesics|analgesics|mesh-ancestor
701273|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
701274|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701275|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
701276|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
701277|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
701278|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
701279|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701280|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701281|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
701282|NCT03014713|Narcotics|narcotics|mesh-ancestor
701283|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
701284|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
701285|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
701286|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
701287|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701398|NCT03013998|Cytarabine|cytarabine|mesh-list
701399|NCT03013998|Azacitidine|azacitidine|mesh-list
701400|NCT03013998|Decitabine|decitabine|mesh-list
701401|NCT03013998|Daunorubicin|daunorubicin|mesh-list
701402|NCT03013998|Venetoclax|venetoclax|mesh-list
701403|NCT03013998|AZD5991|azd5991|mesh-list
701404|NCT03013998|Pevonedistat|pevonedistat|mesh-list
701405|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
701406|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
701407|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701408|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701409|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
701410|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
701411|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
701412|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
701413|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701414|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701415|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
701416|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
701417|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
701568|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
701569|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
701570|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701659|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
701660|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
701661|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701864|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
701865|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
701866|NCT03012360|Linezolid|linezolid|mesh-list
701867|NCT03012360|Imipenem|imipenem|mesh-list
701868|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
701869|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089184|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700420|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
700421|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
700422|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
700423|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
700424|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
700709|NCT03016715|Sirolimus|sirolimus|mesh-list
700710|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
700711|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
700712|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
700713|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700714|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
700715|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
700716|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
700717|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089185|NCT02196259|Ketamine|ketamine|mesh-list
2089186|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
2089187|NCT02196259|Anesthetics|anesthetics|mesh-list
2089188|NCT02196259|Analgesics|analgesics|mesh-ancestor
2089189|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
2089190|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089191|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089192|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
701191|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
701192|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
701193|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
701194|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
701195|NCT03014882|Expectorants|expectorants|mesh-ancestor
701196|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
701197|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
701198|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
701199|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701200|NCT03014882|Protective Agents|protective agents|mesh-ancestor
701201|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701202|NCT03014882|Antidotes|antidotes|mesh-ancestor
701488|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
701489|NCT03013504|Docetaxel|docetaxel|mesh-list
701490|NCT03013504|Trastuzumab|trastuzumab|mesh-list
701491|NCT03013504|Epirubicin|epirubicin|mesh-list
701492|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
701493|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
701494|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701495|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
701496|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
701497|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
701498|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701499|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701500|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
701501|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
701502|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
701503|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
701504|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
701505|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
701506|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
701507|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
701508|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701890|NCT03012113|Mirabegron|mirabegron|mesh-list
701891|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
701892|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
701893|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
701894|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
701895|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701896|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701897|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701898|NCT03012113|Urological Agents|urological agents|mesh-ancestor
2228262|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2228263|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228264|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
2228265|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2228266|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
2228267|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702481|NCT03009513|Glimepiride|glimepiride|mesh-list
702482|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
702483|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
702484|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702485|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2089193|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
2228268|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228269|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2228270|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
2228271|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2089194|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2228272|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
701238|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
701239|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
701240|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
701241|NCT03014778|Povidone|povidone|mesh-list
701242|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
701243|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
701244|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
701245|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
701246|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
701247|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
701418|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
701419|NCT03013439|Hematinics|hematinics|mesh-ancestor
701635|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
701636|NCT03012984|Morphine|morphine|mesh-list
701637|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
701638|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701639|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701640|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
701641|NCT03012984|Analgesics|analgesics|mesh-ancestor
701642|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
701643|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701644|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
701645|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
701646|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
701647|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
701648|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701649|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701650|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
701651|NCT03012984|Narcotics|narcotics|mesh-ancestor
702232|NCT03011008|Liraglutide|liraglutide|mesh-list
702233|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
702234|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702235|NCT03011008|Incretins|incretins|mesh-ancestor
702236|NCT03011008|Hormones|hormones|mesh-ancestor
702237|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
702383|NCT03009981|Prednisone|prednisone|mesh-list
702384|NCT03009981|Leuprolide|leuprolide|mesh-list
702385|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
702386|NCT03009981|Bicalutamide|bicalutamide|mesh-list
702387|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
702388|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
702389|NCT03009981|Hormones|hormones|mesh-ancestor
702390|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
702391|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702392|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
702393|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702394|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
702395|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
702396|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
702397|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
702398|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702399|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702400|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
702401|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
702402|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
2228273|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228274|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2228275|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2228276|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
2228277|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
703062|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
703063|NCT03007329|Exenatide|exenatide|mesh-list
703064|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
703065|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703066|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
703067|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703068|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
703069|NCT03007329|Incretins|incretins|mesh-ancestor
703070|NCT03007329|Hormones|hormones|mesh-ancestor
703092|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
700559|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
700560|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
700561|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
700562|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
700563|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
700564|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
700565|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
700566|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
700567|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
700568|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701216|NCT03014635|Botulinum Toxins|botulinum toxins|mesh-list
701217|NCT03014635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
701218|NCT03014635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
701219|NCT03014635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
701220|NCT03014635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
701221|NCT03014635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701222|NCT03014635|Cholinergic Agents|cholinergic agents|mesh-ancestor
701223|NCT03014635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701224|NCT03014635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701225|NCT03014635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
701226|NCT03014635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701899|NCT03011918|Vitamin D|vitamin d|mesh-list
701900|NCT03011918|Vitamins|vitamins|mesh-ancestor
701901|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
701902|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701903|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
702872|NCT03007992|Vinorelbine|vinorelbine|mesh-list
702873|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
702874|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702875|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
702876|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
702877|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
702878|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228278|NCT00060450|Protective Agents|protective agents|mesh-ancestor
2228279|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
2228280|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
2228281|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2228282|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228283|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2228284|NCT00060476|Rofecoxib|rofecoxib|mesh-list
703427|NCT03006003|Alendronate|alendronate|mesh-list
703428|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
703429|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
703430|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703431|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
703432|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
703433|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
703434|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
703435|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
703749|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
703750|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
703751|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
703752|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
703926|NCT03004066|Daptomycin|daptomycin|mesh-list
703927|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
703928|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
704092|NCT03004001|Atorvastatin|atorvastatin|mesh-list
704093|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
704094|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
704095|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
704096|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
704097|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704098|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
704099|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
704100|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704101|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
704102|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228285|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2228286|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2228287|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228288|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228289|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
704269|NCT03002805|Doxorubicin|doxorubicin|mesh-list
700595|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
700596|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
700597|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
700598|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
700599|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
700600|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
700601|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
700602|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
700603|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
700604|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
700605|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
700606|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
700607|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
700608|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
700609|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
700610|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
700611|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
700725|NCT03016741|Prednisone|prednisone|mesh-list
700726|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
700727|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
700728|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
700729|NCT03016741|Hormones|hormones|mesh-ancestor
700730|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
700731|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700732|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
700733|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700734|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
700735|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700736|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700737|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
700738|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
701033|NCT03015740|Nivolumab|nivolumab|mesh-list
701034|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
701035|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701036|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
701037|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701721|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
701722|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
701723|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702528|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
702529|NCT03009526|Piperaquine|piperaquine|mesh-list
702530|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
702531|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
702532|NCT03009526|Artenimol|artenimol|mesh-list
702533|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
702534|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
702535|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
702536|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
702537|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
702538|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702539|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702540|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
702541|NCT03009526|Renal Agents|renal agents|mesh-ancestor
702965|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
702966|NCT03007446|Apatinib|apatinib|mesh-list
702967|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702968|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
702969|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702970|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703125|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
703126|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
703127|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
703128|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
703129|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
703130|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
703131|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703132|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
703133|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
703134|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703135|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
703136|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703137|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
703391|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
703392|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
703393|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
703451|NCT03005860|Propofol|propofol|mesh-list
700612|NCT03017352|Exenatide|exenatide|mesh-list
700613|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
700614|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700615|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
700616|NCT03017352|Incretins|incretins|mesh-ancestor
700617|NCT03017352|Hormones|hormones|mesh-ancestor
700618|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
700718|NCT03016832|Irbesartan|irbesartan|mesh-list
700719|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
700720|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
700721|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
700722|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700880|NCT03016000|Thalidomide|thalidomide|mesh-list
700881|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
700882|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
700883|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700884|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
700885|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
700886|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
700887|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
700888|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
700889|NCT03016000|Growth Substances|growth substances|mesh-ancestor
700890|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
700891|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701227|NCT03014622|Botulinum Toxins|botulinum toxins|mesh-list
701228|NCT03014622|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
701229|NCT03014622|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
701230|NCT03014622|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
701231|NCT03014622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
701232|NCT03014622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701233|NCT03014622|Cholinergic Agents|cholinergic agents|mesh-ancestor
701234|NCT03014622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701235|NCT03014622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701236|NCT03014622|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
701237|NCT03014622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701448|NCT03013400|Ebselen|ebselen|mesh-list
701449|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
701450|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
701451|NCT03013400|Analgesics|analgesics|mesh-ancestor
701452|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
701453|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701454|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701455|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
701456|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
701457|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
701458|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
701459|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
701460|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701461|NCT03013400|Protective Agents|protective agents|mesh-ancestor
701462|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
701463|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701464|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
701565|NCT03012945|Anesthetics|anesthetics|mesh-list
701566|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701567|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701662|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
701663|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
701664|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
701665|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701666|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701667|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
701668|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
701669|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
701670|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2228290|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2228291|NCT00060476|Analgesics|analgesics|mesh-ancestor
2228292|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
2228293|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228294|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228295|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2228296|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228297|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2228298|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
700651|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
700652|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
700653|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700654|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
700655|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
700656|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
700657|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700658|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700659|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
700660|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
700661|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
700662|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
700663|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
700664|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
700665|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
700666|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700723|NCT03016793|Puerarin|puerarin|mesh-list
700724|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
701724|NCT03012763|Acetaminophen|acetaminophen|mesh-list
701725|NCT03012763|Fexofenadine|fexofenadine|mesh-list
701726|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
701727|NCT03012763|Valsartan|valsartan|mesh-list
701728|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
701729|NCT03012763|Analgesics|analgesics|mesh-ancestor
701730|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
701731|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701732|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701733|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
701734|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
701735|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
701736|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
701737|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701738|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
701739|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
701740|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
701741|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
701742|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
701743|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701744|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
701745|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
701746|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
701747|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
701748|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
701932|NCT03011905|Acetaminophen|acetaminophen|mesh-list
701933|NCT03011905|Dexamethasone|dexamethasone|mesh-list
701934|NCT03011905|Etoricoxib|etoricoxib|mesh-list
701935|NCT03011905|Oxycodone|oxycodone|mesh-list
701936|NCT03011905|Ropivacaine|ropivacaine|mesh-list
701937|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
701938|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
701939|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
701940|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701941|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701942|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
701943|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
701944|NCT03011905|Hormones|hormones|mesh-ancestor
701945|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
701946|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
701947|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701948|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
701949|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
701950|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701951|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
701952|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
701953|NCT03011905|Analgesics|analgesics|mesh-ancestor
701954|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
701955|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
701956|NCT03011905|Narcotics|narcotics|mesh-ancestor
701957|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
701958|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
701959|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
701960|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
701961|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701962|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228299|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2228300|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
700790|NCT03016806|Protective Agents|protective agents|mesh-ancestor
700897|NCT03015818|Calcium|calcium|mesh-list
700898|NCT03015818|Fluorides|fluorides|mesh-list
700899|NCT03015818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
700900|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
700901|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
700902|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
700903|NCT03015818|Protective Agents|protective agents|mesh-ancestor
700904|NCT03015818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
700905|NCT03015818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701319|NCT03014167|Albendazole|albendazole|mesh-list
701320|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
701321|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
701322|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
701323|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
701324|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
701325|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
701326|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
701327|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
701328|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
701329|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701330|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701346|NCT03013751|Udenafil|udenafil|mesh-list
701347|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
701348|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
701349|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701350|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701588|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
701589|NCT03013010|Tegafur|tegafur|mesh-list
701590|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701591|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
701592|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
701593|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228301|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2228302|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2228303|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228304|NCT00060502|Gemcitabine|gemcitabine|mesh-list
2228305|NCT00060502|Infliximab|infliximab|mesh-list
2228306|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228307|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
2228308|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089195|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2089196|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2089197|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2752934|NCT03234686|Deferiprone|deferiprone|mesh-list
702268|NCT03010761|Citalopram|citalopram|mesh-list
702269|NCT03010761|Moclobemide|moclobemide|mesh-list
702270|NCT03010761|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
702271|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
702272|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
702273|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702274|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702275|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
702276|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702277|NCT03010761|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
702278|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
702279|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
702280|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
702281|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702843|NCT03008148|Temozolomide|temozolomide|mesh-list
702844|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
702845|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
702846|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702847|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703049|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
703050|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
703051|NCT03007524|Calcium|calcium|mesh-list
703052|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
703053|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703054|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
703055|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
703056|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
703057|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
703058|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700847|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
700848|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
700849|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
700850|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700851|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
700852|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
700853|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
700854|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
700855|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
700856|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
700857|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
700858|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
700859|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
700860|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
700861|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
701108|NCT03015610|Lansoprazole|lansoprazole|mesh-list
701109|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
701110|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
701111|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
701112|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
701113|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701114|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089198|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228309|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228310|NCT00060502|Antiviral Agents|antiviral agents|mesh-ancestor
2228311|NCT00060502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228312|NCT00060502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228313|NCT00060502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228314|NCT00060502|Immunologic Factors|immunologic factors|mesh-ancestor
2228315|NCT00060502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701594|NCT03013075|Morphine|morphine|mesh-list
701595|NCT03013075|Bupivacaine|bupivacaine|mesh-list
701596|NCT03013075|Anesthetics|anesthetics|mesh-list
701597|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
701598|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
701599|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701600|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701601|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
701602|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701603|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
701604|NCT03013075|Narcotics|narcotics|mesh-ancestor
701605|NCT03013075|Analgesics|analgesics|mesh-ancestor
701652|NCT03012581|Nivolumab|nivolumab|mesh-list
701653|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
701654|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701655|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
701656|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701754|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
701755|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701756|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
701757|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
701758|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
701759|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701760|NCT03012386|Urological Agents|urological agents|mesh-ancestor
701963|NCT03011775|Aspirin|aspirin|mesh-list
701964|NCT03011775|Pioglitazone|pioglitazone|mesh-list
701965|NCT03011775|Ramipril|ramipril|mesh-list
701966|NCT03011775|Bisoprolol|bisoprolol|mesh-list
701967|NCT03011775|Isosorbide|isosorbide|mesh-list
701968|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
701969|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
701970|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
701971|NCT03011775|Calcium|calcium|mesh-list
701972|NCT03011775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
701973|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701974|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
701975|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
701976|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
701977|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701978|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
701979|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
701980|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701981|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
701982|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
701983|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
700965|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
700966|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
700967|NCT03015857|Protective Agents|protective agents|mesh-ancestor
701162|NCT03015090|Theophylline|theophylline|mesh-list
701163|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
701164|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
701165|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701166|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701167|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
701168|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
701169|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
701170|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701171|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701172|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
701173|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
701174|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
701175|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
701176|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701301|NCT03014297|Everolimus|everolimus|mesh-list
701302|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
701303|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701304|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
701305|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
701306|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701307|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2089199|NCT02196324|Serlopitant|serlopitant|mesh-list
2089200|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2228316|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
2228317|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2228318|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228319|NCT00060554|Heparin|heparin|mesh-list
2228320|NCT00060554|PENTA|penta|mesh-list
2228321|NCT00060554|Fondaparinux|fondaparinux|mesh-list
702406|NCT03009877|Fentanyl|fentanyl|mesh-list
702407|NCT03009877|Midazolam|midazolam|mesh-list
702408|NCT03009877|Propofol|propofol|mesh-list
702409|NCT03009877|Rocuronium|rocuronium|mesh-list
702410|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
702411|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
702412|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702413|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
702414|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
702415|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
702416|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
702417|NCT03009877|Narcotics|narcotics|mesh-ancestor
702418|NCT03009877|Analgesics|analgesics|mesh-ancestor
702419|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
702420|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702421|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
702422|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
702423|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
702424|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
702425|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
702426|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
702427|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702428|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702429|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
702430|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
702431|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2228322|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
701007|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
701248|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
701249|NCT03014687|Cefdinir|cefdinir|mesh-list
701250|NCT03014687|Cephalosporins|cephalosporins|mesh-list
701251|NCT03014687|Trimethoprim|trimethoprim|mesh-list
701252|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
701253|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
701254|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
701255|NCT03014687|Renal Agents|renal agents|mesh-ancestor
701256|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
701257|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
701258|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
701259|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
701260|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701261|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701262|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
701263|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
701264|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2228323|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2228324|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
701695|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
701696|NCT03012815|Gabapentin|gabapentin|mesh-list
701697|NCT03012815|Lorazepam|lorazepam|mesh-list
701698|NCT03012815|Valproic Acid|valproic acid|mesh-list
701699|NCT03012815|Analgesics|analgesics|mesh-ancestor
701700|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
701701|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701702|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701703|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
701704|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
701705|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
701706|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701707|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
701708|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
701709|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
701710|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701711|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701712|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
701713|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
701714|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
701715|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
701716|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
701717|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
701718|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
701719|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701720|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2228325|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228326|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2228327|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
2228328|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2228329|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
2228330|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228331|NCT00060567|Irinotecan|irinotecan|mesh-list
702381|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
702382|NCT03010072|Hematinics|hematinics|mesh-ancestor
702567|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
702568|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
702569|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
702570|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
702571|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
702572|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
702573|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
703263|NCT03006614|Gemcitabine|gemcitabine|mesh-list
703264|NCT03006614|Cisplatin|cisplatin|mesh-list
703265|NCT03006614|Docetaxel|docetaxel|mesh-list
703266|NCT03006614|Capecitabine|capecitabine|mesh-list
703267|NCT03006614|Trastuzumab|trastuzumab|mesh-list
703268|NCT03006614|Vinorelbine|vinorelbine|mesh-list
703269|NCT03006614|Epirubicin|epirubicin|mesh-list
703270|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703271|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
703272|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
703273|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703274|NCT03006614|Antiviral Agents|antiviral agents|mesh-ancestor
703275|NCT03006614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
703276|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703277|NCT03006614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
703278|NCT03006614|Immunologic Factors|immunologic factors|mesh-ancestor
703279|NCT03006614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701388|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
701389|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
701390|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
701391|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
701392|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
701548|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
701549|NCT03012971|Morphine|morphine|mesh-list
701550|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
701551|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701552|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701553|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
701554|NCT03012971|Analgesics|analgesics|mesh-ancestor
701555|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
701556|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701557|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
701558|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
701559|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
701560|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
701561|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701562|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701563|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
701564|NCT03012971|Narcotics|narcotics|mesh-ancestor
2089201|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089202|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089203|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089204|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
2089205|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
2089206|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089207|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089208|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089209|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
2089210|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
2089211|NCT02196558|Quetmolimab|quetmolimab|mesh-list
2089212|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089213|NCT02196701|Adalimumab|adalimumab|mesh-list
2089214|NCT02196701|Methotrexate|methotrexate|mesh-list
2089215|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2089216|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
2089217|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2089218|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089219|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2089220|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
702051|NCT03011996|Amoxicillin|amoxicillin|mesh-list
702052|NCT03011996|Clarithromycin|clarithromycin|mesh-list
702053|NCT03011996|Pantoprazole|pantoprazole|mesh-list
702054|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
702055|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
702056|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
702057|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702058|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702059|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
702060|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
702061|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
702062|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
702063|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
702254|NCT03011060|Capecitabine|capecitabine|mesh-list
702255|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
702256|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
702257|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702258|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702487|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
702488|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
702489|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
702490|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
702491|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
702492|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702493|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
702494|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
702495|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702496|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
703155|NCT03006835|Clopidogrel|clopidogrel|mesh-list
703156|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
703280|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
701431|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
701432|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701433|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
701434|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228332|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
2228333|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2228334|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2228335|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228336|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228337|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228338|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2228339|NCT00060632|Sirolimus|sirolimus|mesh-list
2228340|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2228341|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228342|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2228343|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228344|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
2228345|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228346|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
2228347|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228348|NCT00060645|Sirolimus|sirolimus|mesh-list
2228349|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2228350|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
702574|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
702575|NCT03009578|Hematinics|hematinics|mesh-ancestor
703077|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
703078|NCT03007160|Diuretics|diuretics|mesh-ancestor
703079|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
703080|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703081|NCT03007160|Expectorants|expectorants|mesh-ancestor
703082|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
703600|NCT03005496|Vitamin D|vitamin d|mesh-list
703601|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
703602|NCT03005496|Beta Carotene|beta carotene|mesh-list
703603|NCT03005496|Zinc|zinc|mesh-list
703604|NCT03005496|Dexamethasone|dexamethasone|mesh-list
703605|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
703606|NCT03005496|Nifedipine|nifedipine|mesh-list
703607|NCT03005496|BB 1101|bb 1101|mesh-list
703608|NCT03005496|Carotenoids|carotenoids|mesh-list
703609|NCT03005496|Picolinic acid|picolinic acid|mesh-list
703610|NCT03005496|Vitamins|vitamins|mesh-ancestor
703611|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
703612|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703613|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
703614|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
703615|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
703616|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703617|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
703618|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
703619|NCT03005496|Hormones|hormones|mesh-ancestor
703620|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
703621|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
703622|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703623|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
703624|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703625|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703626|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
703627|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
703628|NCT03005496|Trace Elements|trace elements|mesh-ancestor
703629|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
703630|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
703631|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
703632|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
703633|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
703634|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
703635|NCT03005496|Protective Agents|protective agents|mesh-ancestor
703636|NCT03005496|Provitamins|provitamins|mesh-ancestor
703637|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
703638|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
703639|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
703695|NCT03005171|Lidocaine|lidocaine|mesh-list
703696|NCT03005171|Bupivacaine|bupivacaine|mesh-list
703697|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
703698|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
703699|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
703700|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703701|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
701478|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701479|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
701480|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
701481|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
701482|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
701483|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701484|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
701485|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
701486|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
701487|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
701882|NCT03011931|Simvastatin|simvastatin|mesh-list
701883|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
701884|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
701885|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
701886|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701887|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
701888|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
701889|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702698|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
702699|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
702700|NCT03009006|Calcium|calcium|mesh-list
702701|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
702702|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702703|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
702704|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
702705|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
702706|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
702926|NCT03007797|Vaccines|vaccines|mesh-list
702927|NCT03007797|Immunologic Factors|immunologic factors|mesh-ancestor
702928|NCT03007797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089221|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089222|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089223|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
2089224|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703502|NCT03005639|Vemurafenib|vemurafenib|mesh-list
703503|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703504|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
703505|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703506|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704330|NCT03002961|Buprenorphine|buprenorphine|mesh-list
704331|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
704332|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
704333|NCT03002961|Narcotics|narcotics|mesh-ancestor
704334|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
704335|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704336|NCT03002961|Analgesics|analgesics|mesh-ancestor
704337|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
704338|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704339|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
704362|NCT03002493|Rifampin|rifampin|mesh-list
704363|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
704364|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
704365|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
704366|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
704367|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
704368|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
704369|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704370|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704371|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
704372|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
701534|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
701535|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
701536|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
701537|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701848|NCT03012165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
701849|NCT03012165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2089225|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2089226|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2089227|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
702497|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
702498|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
702499|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
702500|NCT03009500|Prednisolone|prednisolone|mesh-list
702501|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
702502|NCT03009500|Lidocaine|lidocaine|mesh-list
702503|NCT03009500|Bupivacaine|bupivacaine|mesh-list
702504|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
702505|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
702506|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
702507|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
702508|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
702509|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702510|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
702511|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702512|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
702513|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
702514|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
702515|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
702516|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702517|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
702518|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
702519|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
702520|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
702521|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
702522|NCT03009500|Hormones|hormones|mesh-ancestor
702523|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
702524|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
702525|NCT03009500|Protective Agents|protective agents|mesh-ancestor
702526|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
702527|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702591|NCT03009097|Atorvastatin|atorvastatin|mesh-list
702592|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
702593|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
702594|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
702595|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702596|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
702597|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
702598|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702983|NCT03007381|Ketorolac|ketorolac|mesh-list
702984|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
702985|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
702986|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
702987|NCT03007381|Analgesics|analgesics|mesh-ancestor
702988|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
702989|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702990|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702991|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
702992|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
702993|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
702994|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702995|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704252|NCT03003143|Vigabatrin|vigabatrin|mesh-list
704253|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
704254|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704255|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704256|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
704257|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
704258|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704431|NCT03002064|Docetaxel|docetaxel|mesh-list
704432|NCT03002064|Fluorouracil|fluorouracil|mesh-list
704433|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704434|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
704435|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
704436|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
704437|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701546|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
701547|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702619|NCT03009409|Ketamine|ketamine|mesh-list
702620|NCT03009409|Analgesics|analgesics|mesh-ancestor
702621|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
702622|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702623|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702624|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
702625|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
702626|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
702627|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
702628|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
702629|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
702630|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
702631|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702632|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702848|NCT03007927|Dexamethasone|dexamethasone|mesh-list
702849|NCT03007927|Bupivacaine|bupivacaine|mesh-list
702850|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
702851|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
702852|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
702853|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702854|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702855|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
702856|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
702857|NCT03007927|Hormones|hormones|mesh-ancestor
702858|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
702859|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
702860|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702861|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
702862|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
702863|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
702864|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
703244|NCT03006679|Meropenem|meropenem|mesh-list
703245|NCT03006679|Tazobactam|tazobactam|mesh-list
703246|NCT03006679|Piperacillin|piperacillin|mesh-list
703247|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
703248|NCT03006679|Vaborbactam|vaborbactam|mesh-list
703249|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
703250|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
703251|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
703252|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703253|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704528|NCT03001817|Fenofibrate|fenofibrate|mesh-list
704529|NCT03001817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
704530|NCT03001817|Antimetabolites|antimetabolites|mesh-ancestor
704531|NCT03001817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704532|NCT03001817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
704858|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
704859|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
704860|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
704861|NCT02999958|Antioxidants|antioxidants|mesh-list
704862|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
704863|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704864|NCT02999958|Protective Agents|protective agents|mesh-ancestor
704865|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704866|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
704867|NCT02999958|Vitamins|vitamins|mesh-ancestor
704868|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
704869|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
704870|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
704871|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
704872|NCT02999958|Expectorants|expectorants|mesh-ancestor
704873|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
704874|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
704875|NCT02999958|Antidotes|antidotes|mesh-ancestor
705236|NCT02997969|Vaccines|vaccines|mesh-list
705237|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
705238|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
705239|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705240|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
701629|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701630|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
701631|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
701632|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
701633|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
701634|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2089228|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089229|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2089230|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2089231|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
2089232|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
2089233|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2089234|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
2089235|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089236|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089237|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2089238|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
2089239|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2089240|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2089241|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2089242|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
2089243|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089244|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089245|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2089246|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2089247|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2089248|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
2089249|NCT02196831|Tesamorelin|tesamorelin|mesh-list
702084|NCT03011476|Donepezil|donepezil|mesh-list
702085|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
702086|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702087|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702088|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
702089|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702090|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702091|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
702265|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
702266|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
702267|NCT03010579|Hematinics|hematinics|mesh-list
2752935|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2752936|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
2752937|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
2752938|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752939|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
2752940|NCT03231085|Trace Elements|trace elements|mesh-ancestor
2752941|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
2752942|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228351|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2228352|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228353|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
2228354|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228355|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
702996|NCT03007303|Olanzapine|olanzapine|mesh-list
702997|NCT03007303|Risperidone|risperidone|mesh-list
702998|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
702999|NCT03007303|Ziprasidone|ziprasidone|mesh-list
703000|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
703001|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
703002|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
703003|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
703004|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703005|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703006|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
703007|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
703008|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
703009|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
703010|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
703011|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
703012|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
703013|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703014|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
703015|NCT03007303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
703016|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
703017|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2089250|NCT02196831|Growth Substances|growth substances|mesh-ancestor
701773|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701774|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
701775|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
701776|NCT03012880|Hormones|hormones|mesh-ancestor
701777|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
701778|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
701779|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701780|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
701781|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
701782|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
701783|NCT03012880|Growth Substances|growth substances|mesh-ancestor
701784|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
701785|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701786|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
701787|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701788|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
701789|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
701790|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702009|NCT03012009|Lidocaine|lidocaine|mesh-list
702010|NCT03012009|Epinephrine|epinephrine|mesh-list
702011|NCT03012009|Racepinephrine|racepinephrine|mesh-list
702012|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
702013|NCT03012009|Anesthetics|anesthetics|mesh-list
702014|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
702015|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
702016|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
702017|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702018|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
702019|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702020|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
702021|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
702022|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
702023|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
702024|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702025|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
702026|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
702027|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
702028|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702029|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
702030|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
702031|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
702032|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
702033|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
702034|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
702035|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
702036|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
702037|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
702038|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
702361|NCT03010202|Dexamethasone|dexamethasone|mesh-list
702362|NCT03010202|Rituximab|rituximab|mesh-list
702363|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
702364|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
702365|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
702366|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702367|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702368|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
702369|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
702370|NCT03010202|Hormones|hormones|mesh-ancestor
702371|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
702372|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
702373|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702374|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
702375|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
702376|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
703072|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
703073|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
703074|NCT03007589|Protective Agents|protective agents|mesh-ancestor
703075|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703076|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
2228356|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228357|NCT00060671|Rituximab|rituximab|mesh-list
2228358|NCT00060671|Pixantrone|pixantrone|mesh-list
703726|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
703727|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
703728|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
703886|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
701828|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701829|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
701830|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701831|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
701832|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701833|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701834|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
701835|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
701836|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
702209|NCT03011268|Adalimumab|adalimumab|mesh-list
702210|NCT03011268|Golimumab|golimumab|mesh-list
702211|NCT03011268|Infliximab|infliximab|mesh-list
702212|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
702213|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
702214|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
702215|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
702216|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
702217|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
702218|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
702219|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
702220|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702261|NCT03010670|Oxytocin|oxytocin|mesh-list
702262|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
702263|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
702264|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702323|NCT03010436|Benralizumab|benralizumab|mesh-list
702324|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
702325|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
703037|NCT03007654|Chitosan|chitosan|mesh-list
703038|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
703039|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
703040|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
703041|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703042|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
703043|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
703044|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
703045|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
703046|NCT03007654|Coagulants|coagulants|mesh-ancestor
703753|NCT03004833|Nivolumab|nivolumab|mesh-list
703754|NCT03004833|Doxorubicin|doxorubicin|mesh-list
703755|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
703756|NCT03004833|Dacarbazine|dacarbazine|mesh-list
703757|NCT03004833|Vinblastine|vinblastine|mesh-list
703758|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
703759|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703760|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
703761|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703762|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
703763|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
703764|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
703765|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703766|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
703767|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
703768|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
703769|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
703770|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
703771|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
703977|NCT03004105|Durvalumab|durvalumab|mesh-list
703978|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
703979|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089251|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089252|NCT02196857|Sorafenib|sorafenib|mesh-list
2089253|NCT02196857|Azacitidine|azacitidine|mesh-list
2089254|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089255|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2089256|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089257|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228359|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2228360|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228361|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
2228362|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702226|NCT03010865|Butyric Acid|butyric acid|mesh-list
702227|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
702228|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
702229|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702230|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702231|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702562|NCT03009292|Lenvatinib|lenvatinib|mesh-list
702563|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702564|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
702565|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702566|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702684|NCT03008876|Acetaminophen|acetaminophen|mesh-list
702685|NCT03008876|Ibuprofen|ibuprofen|mesh-list
702686|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
702687|NCT03008876|Analgesics|analgesics|mesh-ancestor
702688|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
702689|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702690|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702691|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
702692|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
702693|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
702694|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
702695|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
702696|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702697|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228363|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228364|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2228365|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2228366|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703296|NCT03006250|Sevoflurane|sevoflurane|mesh-list
703297|NCT03006250|Desflurane|desflurane|mesh-list
703298|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
703299|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
703300|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
703301|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
703302|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
703303|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703791|NCT03004443|Infliximab|infliximab|mesh-list
703792|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
703793|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
703794|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
704003|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
704004|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
704005|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
704006|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
2228367|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228368|NCT00060684|Dexamethasone|dexamethasone|mesh-list
2228369|NCT00060684|Rituximab|rituximab|mesh-list
2228370|NCT00060684|Fludarabine|fludarabine|mesh-list
2228371|NCT00060684|Pixantrone|pixantrone|mesh-list
2228372|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2228373|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
2228374|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
2228375|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228376|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228377|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2228378|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
2228379|NCT00060684|Hormones|hormones|mesh-ancestor
2228380|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2228381|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2228382|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228383|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2228384|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
2228385|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
704577|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
704578|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
704579|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
2228386|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228387|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2228388|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2228389|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228390|NCT00060866|Propranolol|propranolol|mesh-list
701870|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
701871|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
701872|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
701873|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701874|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
701875|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
701876|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
701877|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
702096|NCT03011645|Ziprasidone|ziprasidone|mesh-list
702097|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
702098|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
702099|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702100|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702101|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702102|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
702103|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
702104|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
702105|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
702106|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
702107|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
702326|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
702327|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
702328|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703028|NCT03007563|Bilirubin|bilirubin|mesh-list
703029|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
703030|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703031|NCT03007563|Protective Agents|protective agents|mesh-ancestor
703032|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228391|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2228392|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2228393|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
2228394|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2228395|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228396|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228397|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2228398|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2228399|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
2228400|NCT00060905|Valproic Acid|valproic acid|mesh-list
2228401|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
2228402|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703556|NCT03005483|Gabapentin|gabapentin|mesh-list
703557|NCT03005483|Analgesics|analgesics|mesh-ancestor
703558|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
703559|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703560|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703561|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
703562|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
703563|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
703564|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
703565|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
703566|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
703567|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
703568|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
703569|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703570|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
703795|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
703796|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
703797|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
703798|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
703799|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
703800|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
703801|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704072|NCT03004014|Propofol|propofol|mesh-list
704073|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
704074|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
704075|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704076|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
704077|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
704078|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
2228403|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228404|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
2228405|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2228406|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228407|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
702309|NCT03010475|Furosemide|furosemide|mesh-list
702310|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
702311|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
702312|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
702313|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
702314|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702315|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
702316|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
702317|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702318|NCT03010475|Diuretics|diuretics|mesh-ancestor
702319|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
702320|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702321|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
702322|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
702447|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
702449|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
702450|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
702451|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702452|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702453|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
702454|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
702455|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
702456|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
702457|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702458|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702459|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
702460|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
702461|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
702462|NCT03009643|Protective Agents|protective agents|mesh-ancestor
702808|NCT03008252|Caseins|caseins|mesh-list
702809|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
702810|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
702811|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703415|NCT03006107|Piroxicam|piroxicam|mesh-list
703416|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
703417|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
703418|NCT03006107|Analgesics|analgesics|mesh-ancestor
703419|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
703420|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703421|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703422|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
703423|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
703424|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
703425|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703426|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703653|NCT03005782|Cemiplimab|cemiplimab|mesh-list
703654|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
703655|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703714|NCT03005002|Durvalumab|durvalumab|mesh-list
703715|NCT03005002|Ipilimumab|ipilimumab|mesh-list
703716|NCT03005002|Tremelimumab|tremelimumab|mesh-list
703717|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
703718|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
703719|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
703720|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
703721|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703722|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
703723|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703724|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
703725|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704355|NCT03002675|Exenatide|exenatide|mesh-list
704356|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
704357|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704358|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
704359|NCT03002675|Incretins|incretins|mesh-ancestor
704360|NCT03002675|Hormones|hormones|mesh-ancestor
704361|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
704547|NCT03001570|Cetuximab|cetuximab|mesh-list
704548|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
704549|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704876|NCT02999776|Etanercept|etanercept|mesh-list
704877|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
701923|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
701924|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
701925|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
701926|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
701927|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
701928|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
701929|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
701930|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
701931|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
702466|NCT03009461|Sorafenib|sorafenib|mesh-list
702467|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702468|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
702469|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702470|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089258|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2089259|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
2089260|NCT02197065|Atorvastatin|atorvastatin|mesh-list
2089261|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2089262|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2089263|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
2089264|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089265|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2089266|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2089267|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089268|NCT02197234|Osimertinib|osimertinib|mesh-list
2089269|NCT02197234|Simvastatin|simvastatin|mesh-list
2089270|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
702971|NCT03007420|Lidocaine|lidocaine|mesh-list
702972|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
702973|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
702974|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
702975|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702976|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
702977|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702978|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
702979|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
702980|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
702981|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
702982|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089271|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2089272|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
2089273|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089274|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2089275|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2089276|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228408|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
703386|NCT03006146|Molgramostim|molgramostim|mesh-list
703387|NCT03006146|Sargramostim|sargramostim|mesh-list
703388|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
703389|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703390|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228409|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2228410|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2228411|NCT00060918|Metoprolol|metoprolol|mesh-list
2228412|NCT00060918|Carvedilol|carvedilol|mesh-list
2228413|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2228414|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2228415|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
2228416|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
2228417|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704550|NCT03001635|Oxytocin|oxytocin|mesh-list
704551|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
704552|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
704553|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228418|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228419|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2228420|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2228421|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2228422|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
2228423|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2228424|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228425|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
2228426|NCT00060918|Protective Agents|protective agents|mesh-ancestor
701986|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
701987|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
701988|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
701989|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
701990|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
701991|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
701992|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
701993|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
701994|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
701995|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
701996|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
701997|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
701998|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
701999|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
702000|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
702001|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
702002|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
702003|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702004|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
702005|NCT03011775|Diuretics|diuretics|mesh-ancestor
702006|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
702007|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-ancestor
702008|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
702221|NCT03010917|Ethanol|ethanol|mesh-list
702222|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
702223|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
702224|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
702225|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228427|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2228428|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2228429|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2228430|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
2228431|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2228432|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2228433|NCT00060931|Metoprolol|metoprolol|mesh-list
2228434|NCT00060931|Carvedilol|carvedilol|mesh-list
2228435|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2228436|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2228437|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
2228438|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
702900|NCT03008083|Clopidogrel|clopidogrel|mesh-list
702901|NCT03008083|Ticagrelor|ticagrelor|mesh-list
702902|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
702903|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
702904|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
702905|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
702906|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
702907|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702908|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702909|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703514|NCT03005665|Acetazolamide|acetazolamide|mesh-list
703515|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
703516|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
703517|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703518|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703519|NCT03005665|Diuretics|diuretics|mesh-ancestor
703520|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
703521|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228439|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228440|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228441|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2228442|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2228443|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2228444|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
2228445|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2228446|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228447|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
2228448|NCT00060931|Protective Agents|protective agents|mesh-ancestor
704657|NCT03000660|Dexamethasone|dexamethasone|mesh-list
704658|NCT03000660|Venetoclax|venetoclax|mesh-list
704659|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
704660|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
704661|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
704662|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704663|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702141|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
702142|NCT03011463|Trospium chloride|trospium chloride|mesh-list
702143|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
702144|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
702145|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
702146|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702147|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702148|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
702149|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
702150|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
702151|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
702152|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
702153|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
702154|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
702155|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702156|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702157|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
702158|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
702159|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702160|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
702161|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
702162|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
702163|NCT03011463|Urological Agents|urological agents|mesh-ancestor
702238|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
702239|NCT03011125|Lansoprazole|lansoprazole|mesh-list
702240|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
702241|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
702242|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
702243|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702244|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702348|NCT03010098|Remifentanil|remifentanil|mesh-list
702349|NCT03010098|Propofol|propofol|mesh-list
702350|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
702351|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
702352|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702353|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
702354|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
702355|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
702356|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
702357|NCT03010098|Narcotics|narcotics|mesh-ancestor
702358|NCT03010098|Analgesics|analgesics|mesh-ancestor
702359|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
702360|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702463|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
702464|NCT03009799|Laxatives|laxatives|mesh-ancestor
702465|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
703217|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
703223|NCT03006809|Metronidazole|metronidazole|mesh-list
703224|NCT03006809|Vancomycin|vancomycin|mesh-list
703225|NCT03006809|Neomycin|neomycin|mesh-list
703226|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
703227|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
703228|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
703229|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
703230|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703231|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703258|NCT03006445|Dotinurad|dotinurad|mesh-list
703259|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
703260|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
703261|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
703262|NCT03006445|Renal Agents|renal agents|mesh-ancestor
703358|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
703359|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
703360|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
703361|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
703362|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
703363|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
703364|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703365|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
703366|NCT03006211|Analgesics|analgesics|mesh-ancestor
703367|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
703368|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703369|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
703370|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
703371|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
703372|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
703373|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
703374|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
2089277|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089278|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2089279|NCT02197247|Rifampin|rifampin|mesh-list
2089280|NCT02197247|Osimertinib|osimertinib|mesh-list
2089281|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2089282|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
2228449|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2228450|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2228451|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2228452|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
702443|NCT03009604|Simethicone|simethicone|mesh-list
702444|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
702445|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702446|NCT03009604|Emollients|emollients|mesh-ancestor
702448|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
702768|NCT03008551|Metformin|metformin|mesh-list
702769|NCT03008551|Empagliflozin|empagliflozin|mesh-list
702770|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
702771|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702772|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
702773|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702929|NCT03007810|Hemay005|hemay005|mesh-list
702930|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
702931|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
702932|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
702933|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702934|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703033|NCT03007407|Durvalumab|durvalumab|mesh-list
703034|NCT03007407|Tremelimumab|tremelimumab|mesh-list
703035|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
703036|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703656|NCT03005522|Dexamethasone|dexamethasone|mesh-list
703657|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
703658|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
703659|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
703660|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703661|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703662|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
703663|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
703664|NCT03005522|Hormones|hormones|mesh-ancestor
703665|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
703666|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
703667|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704894|NCT02999841|Vildagliptin|vildagliptin|mesh-list
704895|NCT02999841|Acarbose|acarbose|mesh-list
704896|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
704897|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704898|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
704899|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
704900|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704901|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704902|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
705020|NCT02999230|Listerine|listerine|mesh-list
705021|NCT02999230|Fluorides|fluorides|mesh-list
705022|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
705023|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
705024|NCT02999230|Protective Agents|protective agents|mesh-ancestor
705025|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705026|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
705027|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705480|NCT02996318|Sirolimus|sirolimus|mesh-list
705481|NCT02996318|Paclitaxel|paclitaxel|mesh-list
705482|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
705483|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705484|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
705485|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
705486|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
705487|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705488|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
705489|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705490|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
705491|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
705492|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
705493|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
705494|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702299|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
702300|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
702301|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
702302|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
702432|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
702433|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
702434|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
702435|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
702436|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702437|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2089283|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2089284|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089285|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
2089286|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2089287|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089288|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089289|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2089290|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2089291|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2089292|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2089293|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2089294|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
702893|NCT03008057|Vitamin D|vitamin d|mesh-list
702894|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
702895|NCT03008057|Vitamins|vitamins|mesh-list
702896|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
702897|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702898|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
702899|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
703835|NCT03007147|Calcium, Dietary|calcium, dietary|mesh-list
703836|NCT03007147|Leucovorin|leucovorin|mesh-list
703837|NCT03007147|Folic Acid|folic acid|mesh-list
703838|NCT03007147|Cytarabine|cytarabine|mesh-list
703839|NCT03007147|Dexamethasone|dexamethasone|mesh-list
703840|NCT03007147|Dexamethasone acetate|dexamethasone acetate|mesh-list
703841|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
703842|NCT03007147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
703843|NCT03007147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
703844|NCT03007147|Prednisolone|prednisolone|mesh-list
703845|NCT03007147|Prednisolone acetate|prednisolone acetate|mesh-list
703846|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
703847|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
703848|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
703849|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
703850|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
703851|NCT03007147|Ifosfamide|ifosfamide|mesh-list
703852|NCT03007147|Isophosphamide mustard|isophosphamide mustard|mesh-list
703853|NCT03007147|Doxorubicin|doxorubicin|mesh-list
703854|NCT03007147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
703855|NCT03007147|Methotrexate|methotrexate|mesh-list
703856|NCT03007147|Etoposide|etoposide|mesh-list
703857|NCT03007147|Vincristine|vincristine|mesh-list
703858|NCT03007147|Etoposide phosphate|etoposide phosphate|mesh-list
703859|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
703860|NCT03007147|Daunorubicin|daunorubicin|mesh-list
703861|NCT03007147|Asparaginase|asparaginase|mesh-list
703862|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
703863|NCT03007147|Podophyllotoxin|podophyllotoxin|mesh-list
703864|NCT03007147|Thioguanine|thioguanine|mesh-list
703865|NCT03007147|Pegaspargase|pegaspargase|mesh-list
703866|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
703867|NCT03007147|Razoxane|razoxane|mesh-list
703868|NCT03007147|Azathioprine|azathioprine|mesh-list
703869|NCT03007147|Lenograstim|lenograstim|mesh-list
703870|NCT03007147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
703871|NCT03007147|Prednisolone phosphate|prednisolone phosphate|mesh-list
703872|NCT03007147|BB 1101|bb 1101|mesh-list
703873|NCT03007147|Calcium|calcium|mesh-list
703874|NCT03007147|2-Aminopurine|2-aminopurine|mesh-list
703875|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
703876|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
703877|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
703878|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703879|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
703880|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
703881|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
703882|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703883|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703884|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
703885|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
702486|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
2228453|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2228454|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2228455|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
2228456|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2228457|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2228458|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
702754|NCT03008512|Paclitaxel|paclitaxel|mesh-list
702755|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
702756|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702757|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
702758|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
702759|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
702760|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228459|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2228460|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228461|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
2228462|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2228463|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228464|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2228465|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228466|NCT00060996|Treprostinil|treprostinil|mesh-list
2228467|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2228468|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
2228469|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
2228470|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228471|NCT00061022|Protective Agents|protective agents|mesh-ancestor
2228472|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228473|NCT00061035|Vaccines|vaccines|mesh-list
2228474|NCT00061035|Immunologic Factors|immunologic factors|mesh-ancestor
2228475|NCT00061035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228476|NCT00061074|Nicotine|nicotine|mesh-list
2228477|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2228478|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
2228479|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228480|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228481|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2228482|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2228483|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
703313|NCT03006705|Capecitabine|capecitabine|mesh-list
703314|NCT03006705|Tegafur|tegafur|mesh-list
703315|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
703316|NCT03006705|Nivolumab|nivolumab|mesh-list
703317|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
703318|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
703319|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703320|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703321|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
703322|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
703583|NCT03005405|Methamphetamine|methamphetamine|mesh-list
703584|NCT03005405|Fluorides|fluorides|mesh-list
703585|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
703586|NCT03005405|Protective Agents|protective agents|mesh-ancestor
703587|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703588|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
703589|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
703590|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
703591|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703592|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
703593|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
703594|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703595|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
703596|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
703597|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
703598|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
703599|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
703975|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
703976|NCT03004209|Hematinics|hematinics|mesh-ancestor
704263|NCT03003039|Rituximab|rituximab|mesh-list
704264|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
704265|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704266|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
704267|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704268|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
704915|NCT02999919|Bupivacaine|bupivacaine|mesh-list
702633|NCT03009058|Leucovorin|leucovorin|mesh-list
702634|NCT03009058|Folic Acid|folic acid|mesh-list
702635|NCT03009058|Gemcitabine|gemcitabine|mesh-list
702636|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
702637|NCT03009058|Fluorouracil|fluorouracil|mesh-list
702638|NCT03009058|Capecitabine|capecitabine|mesh-list
702639|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
702640|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
702641|NCT03009058|Nivolumab|nivolumab|mesh-list
702642|NCT03009058|Irinotecan|irinotecan|mesh-list
702643|NCT03009058|Cetuximab|cetuximab|mesh-list
702644|NCT03009058|Ipilimumab|ipilimumab|mesh-list
702645|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
702646|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
702647|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
702648|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
702649|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702650|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
702651|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
702652|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
702653|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702654|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702655|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
702656|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
702657|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
702658|NCT03009058|Antiviral Agents|antiviral agents|mesh-ancestor
702659|NCT03009058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
702660|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702661|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
702662|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
702663|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
702664|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
702665|NCT03009058|Antidotes|antidotes|mesh-ancestor
702666|NCT03009058|Protective Agents|protective agents|mesh-ancestor
702667|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
702668|NCT03009058|Vitamins|vitamins|mesh-ancestor
702669|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
702670|NCT03009058|Hematinics|hematinics|mesh-ancestor
702761|NCT03008616|Digoxin|digoxin|mesh-list
702762|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
702763|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
702764|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
702765|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702766|NCT03008616|Protective Agents|protective agents|mesh-ancestor
702767|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702879|NCT03008005|Dronabinol|dronabinol|mesh-list
702880|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
702881|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702882|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
702883|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
702884|NCT03008005|Analgesics|analgesics|mesh-ancestor
702885|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
702886|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
702887|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
702888|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
702889|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
702890|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702891|NCT03008005|Hormones|hormones|mesh-ancestor
702892|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
703149|NCT03006874|Esomeprazole|esomeprazole|mesh-list
703150|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
703151|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
703152|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
703153|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703154|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703288|NCT03006627|Morphine|morphine|mesh-list
703289|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
703290|NCT03006627|Narcotics|narcotics|mesh-ancestor
703291|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
703292|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703293|NCT03006627|Analgesics|analgesics|mesh-ancestor
703294|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
703295|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703450|NCT03005860|Fentanyl|fentanyl|mesh-list
2228484|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2228485|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702715|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
702716|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
702717|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
702718|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
702719|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
702720|NCT03008655|Coagulants|coagulants|mesh-ancestor
2228486|NCT00061087|Methylphenidate|methylphenidate|mesh-list
2228487|NCT00061087|Bupropion|bupropion|mesh-list
2228488|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2228489|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228490|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2228491|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2228492|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2228493|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228494|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
2228495|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2228496|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2228497|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
2228498|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2228499|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2228500|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2228501|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703019|NCT03007342|Amoxicillin|amoxicillin|mesh-list
703020|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
703021|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
703022|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
703023|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
703024|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
703025|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
703026|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703027|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703544|NCT03005444|Enoxaparin|enoxaparin|mesh-list
703545|NCT03005444|Nadroparin|nadroparin|mesh-list
703546|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
703547|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
703548|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
703549|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
703550|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
703551|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703552|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703553|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
703554|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
703555|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2228502|NCT00061113|Fluoxetine|fluoxetine|mesh-list
2228503|NCT00061113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2228504|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2228505|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2228506|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228507|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2228508|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
2228509|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228510|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2228511|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
2228512|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2228513|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
705044|NCT02998970|Empagliflozin|empagliflozin|mesh-list
705045|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
705046|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705047|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
705048|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705166|NCT02998242|Apatinib|apatinib|mesh-list
705167|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705168|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
705169|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705170|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706212|NCT02993523|Azacitidine|azacitidine|mesh-list
706213|NCT02993523|Venetoclax|venetoclax|mesh-list
706214|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
706215|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
706216|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228514|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2228515|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228516|NCT00061126|Panitumumab|panitumumab|mesh-list
2228517|NCT00061126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2228518|NCT00061126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228519|NCT00061152|Capsaicin|capsaicin|mesh-list
2228520|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
2228521|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
2228522|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
2228523|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228524|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228525|NCT00061178|Bevacizumab|bevacizumab|mesh-list
2228526|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2228527|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228528|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2228529|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2228530|NCT00061178|Growth Substances|growth substances|mesh-ancestor
2228531|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228532|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
2228533|NCT00061243|Vaccines|vaccines|mesh-list
702865|NCT03008109|Endostatins|endostatins|mesh-list
702866|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
702867|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
702868|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
702869|NCT03008109|Growth Substances|growth substances|mesh-ancestor
702870|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
702871|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
703187|NCT03007121|Sufentanil|sufentanil|mesh-list
703188|NCT03007121|Morphine|morphine|mesh-list
703189|NCT03007121|Dsuvia|dsuvia|mesh-list
703190|NCT03007121|Bupivacaine|bupivacaine|mesh-list
703191|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
703192|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
703193|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
703194|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703195|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
703196|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703197|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
703198|NCT03007121|Narcotics|narcotics|mesh-ancestor
703199|NCT03007121|Analgesics|analgesics|mesh-ancestor
703200|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
703201|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
703202|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
2228534|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
2228535|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228536|NCT00061256|Vitamin D|vitamin d|mesh-list
2228537|NCT00061256|Alendronate|alendronate|mesh-list
2228538|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
704138|NCT03003611|Anesthetics|anesthetics|mesh-list
704139|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
704140|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704621|NCT03000946|Octreotide|octreotide|mesh-list
704622|NCT03000946|Somatostatin|somatostatin|mesh-list
704623|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
704624|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
704625|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704626|NCT03000946|Hormones|hormones|mesh-ancestor
704627|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
704628|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704815|NCT03000205|Lidocaine|lidocaine|mesh-list
704816|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
704817|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
704818|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
704819|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704820|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
704821|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704822|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
704823|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
704824|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
704825|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
704826|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705173|NCT02998528|Gemcitabine|gemcitabine|mesh-list
705174|NCT02998528|Paclitaxel|paclitaxel|mesh-list
705175|NCT02998528|Vinorelbine|vinorelbine|mesh-list
705176|NCT02998528|Docetaxel|docetaxel|mesh-list
705177|NCT02998528|Carboplatin|carboplatin|mesh-list
2228539|NCT00061256|Calcium|calcium|mesh-list
2228540|NCT00061256|Vitamins|vitamins|mesh-ancestor
2228541|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
703018|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
2089295|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089296|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2089297|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2089298|NCT02197273|Epinephrine|epinephrine|mesh-list
2089299|NCT02197273|Fentanyl|fentanyl|mesh-list
2089300|NCT02197273|Morphine|morphine|mesh-list
2089301|NCT02197273|Bupivacaine|bupivacaine|mesh-list
2089302|NCT02197273|Ropivacaine|ropivacaine|mesh-list
2089303|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
2089304|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
2089305|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2089306|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089307|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
704492|NCT03001882|Nivolumab|nivolumab|mesh-list
704493|NCT03001882|Ipilimumab|ipilimumab|mesh-list
704494|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
704495|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704496|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
704497|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704756|NCT03000374|Leucovorin|leucovorin|mesh-list
704757|NCT03000374|Fluorouracil|fluorouracil|mesh-list
704758|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
704759|NCT03000374|Panitumumab|panitumumab|mesh-list
704760|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
704761|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704762|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
704763|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704764|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
704765|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
704766|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704767|NCT03000374|Antidotes|antidotes|mesh-ancestor
704768|NCT03000374|Protective Agents|protective agents|mesh-ancestor
704769|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
704770|NCT03000374|Vitamins|vitamins|mesh-ancestor
704771|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
704772|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2228542|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228543|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2228544|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2228545|NCT00061256|Antacids|antacids|mesh-ancestor
705159|NCT02998424|Propofol|propofol|mesh-list
705160|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
705161|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
705162|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705163|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
705164|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
705165|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
705963|NCT02994719|Amantadine|amantadine|mesh-list
705964|NCT02994719|Levodopa|levodopa|mesh-list
705965|NCT02994719|Carbidopa|carbidopa|mesh-list
705966|NCT02994719|Pramipexole|pramipexole|mesh-list
705967|NCT02994719|Ropinirole|ropinirole|mesh-list
705968|NCT02994719|Entacapone|entacapone|mesh-list
705969|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
705970|NCT02994719|Tolcapone|tolcapone|mesh-list
705971|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
705972|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
705973|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
705974|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
705975|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705976|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705977|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
705978|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705979|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
705980|NCT02994719|Protective Agents|protective agents|mesh-ancestor
705981|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
705982|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
705983|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705984|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
705985|NCT02994719|Analgesics|analgesics|mesh-ancestor
705986|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
705987|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705988|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
705989|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
705990|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
2228546|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089308|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703059|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
703060|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
703061|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703138|NCT03006965|Factor VIII|factor viii|mesh-list
703139|NCT03006965|BAX 855|bax 855|mesh-list
703140|NCT03006965|Coagulants|coagulants|mesh-ancestor
703571|NCT03005678|Denosumab|denosumab|mesh-list
703572|NCT03005678|Alendronate|alendronate|mesh-list
703573|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
703574|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703742|NCT03005236|Tacrolimus|tacrolimus|mesh-list
703743|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
703744|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
703745|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703746|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
703747|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703748|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704103|NCT03003884|Propofol|propofol|mesh-list
704104|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
704105|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
704106|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704107|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
704108|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
704109|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
2228547|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2228548|NCT00061282|Clotrimazole|clotrimazole|mesh-list
2228549|NCT00061282|Miconazole|miconazole|mesh-list
2228550|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2228551|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228552|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
2228553|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2228554|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2228555|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228556|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228557|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2228558|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
2228559|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2228560|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228561|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2228562|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2228563|NCT00061308|Gemcitabine|gemcitabine|mesh-list
2228564|NCT00061308|Topotecan|topotecan|mesh-list
2228565|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228566|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
2228567|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228568|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228569|NCT00061308|Antiviral Agents|antiviral agents|mesh-ancestor
2228570|NCT00061308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228571|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704710|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
704711|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
704712|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
704713|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
704714|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
704715|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704716|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
704717|NCT03000556|Protective Agents|protective agents|mesh-ancestor
705007|NCT02999295|Nivolumab|nivolumab|mesh-list
705008|NCT02999295|Ramucirumab|ramucirumab|mesh-list
705009|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
705010|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705011|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
705012|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705784|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
705785|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705931|NCT02994888|Cetuximab|cetuximab|mesh-list
705932|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
705933|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706005|NCT02994576|Atezolizumab|atezolizumab|mesh-list
706006|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706394|NCT02992925|Vaccines|vaccines|mesh-list
706395|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
706396|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706488|NCT02992457|Interferons|interferons|mesh-list
706489|NCT02992457|Ribavirin|ribavirin|mesh-list
706490|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
703071|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
703206|NCT03006952|Losartan|losartan|mesh-list
703207|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
703208|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
703209|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
703210|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
703211|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
703212|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703213|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
703214|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703215|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
703216|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
703218|NCT03006952|Protective Agents|protective agents|mesh-ancestor
703219|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703220|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
703221|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
703222|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
2228572|NCT00061308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228573|NCT00061308|Immunologic Factors|immunologic factors|mesh-ancestor
2228574|NCT00061308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228575|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2228576|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2228577|NCT00061321|Nevirapine|nevirapine|mesh-list
2228578|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2228579|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2228580|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228581|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228582|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
2228583|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228584|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2228585|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2228586|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
704498|NCT03001960|Clopidogrel|clopidogrel|mesh-list
704499|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
704500|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
704501|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
704502|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
704503|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
704504|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
704505|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704506|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705078|NCT02998905|Aspirin|aspirin|mesh-list
705079|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
705080|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
705081|NCT02998905|Analgesics|analgesics|mesh-ancestor
705082|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
705083|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705084|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705085|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
705086|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
705087|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
705088|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
705089|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705090|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
705091|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
705092|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705093|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
2228587|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2228588|NCT00061360|Cyclosporine|cyclosporine|mesh-list
2228589|NCT00061360|Sirolimus|sirolimus|mesh-list
2228590|NCT00061360|Cyclosporins|cyclosporins|mesh-list
2228591|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228592|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705942|NCT02995005|Tenofovir|tenofovir|mesh-list
705943|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
705944|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705945|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
705946|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
705947|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705948|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705949|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
705950|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2228593|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
703093|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
703094|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
703336|NCT03006432|Leucovorin|leucovorin|mesh-list
703337|NCT03006432|Folic Acid|folic acid|mesh-list
703338|NCT03006432|Docetaxel|docetaxel|mesh-list
703339|NCT03006432|Fluorouracil|fluorouracil|mesh-list
703340|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
703341|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
703342|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703343|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
703344|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
703345|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
703346|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703347|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
703348|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
703349|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
703350|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
703351|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703352|NCT03006432|Antidotes|antidotes|mesh-ancestor
703353|NCT03006432|Protective Agents|protective agents|mesh-ancestor
703354|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
703355|NCT03006432|Vitamins|vitamins|mesh-ancestor
703356|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
703357|NCT03006432|Hematinics|hematinics|mesh-ancestor
703708|NCT03005366|Flecainide|flecainide|mesh-list
703709|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
703710|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
703711|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
703712|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
703713|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704007|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
704008|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
704009|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
704165|NCT03003416|Dexamethasone|dexamethasone|mesh-list
704166|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
704167|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
704168|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
704169|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704170|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704171|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
704172|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
704173|NCT03003416|Hormones|hormones|mesh-ancestor
704174|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
704175|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
704176|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704377|NCT03002428|Teriparatide|teriparatide|mesh-list
704378|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
704379|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704380|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2228594|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
2228595|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228596|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
2228597|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228598|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
2228599|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228600|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2228601|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2228602|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2228603|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228604|NCT00061425|Epratuzumab|epratuzumab|mesh-list
2228605|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2228606|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228607|NCT00061438|Meropenem|meropenem|mesh-list
2228608|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2228609|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228610|NCT00061451|Gemcitabine|gemcitabine|mesh-list
2228611|NCT00061451|Pemetrexed|pemetrexed|mesh-list
2228612|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228613|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
2228614|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704793|NCT03000127|Testosterone|testosterone|mesh-list
704794|NCT03000127|Androgens|androgens|mesh-ancestor
704795|NCT03000127|Hormones|hormones|mesh-ancestor
704796|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
704797|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228615|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228616|NCT00061451|Antiviral Agents|antiviral agents|mesh-ancestor
2089309|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2089310|NCT02197273|Narcotics|narcotics|mesh-ancestor
2089311|NCT02197273|Analgesics|analgesics|mesh-ancestor
2089312|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2089313|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2089314|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
2089315|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2089316|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2089317|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
2089318|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089319|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089320|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2089321|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2089322|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
2089323|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2089324|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
2089325|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
2089326|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
2089327|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2089328|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2089329|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
2089330|NCT02197273|Hormones|hormones|mesh-ancestor
2089331|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2089332|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2089333|NCT02197273|Protective Agents|protective agents|mesh-ancestor
2089334|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2089335|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703507|NCT03005808|Ropivacaine|ropivacaine|mesh-list
703508|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
703509|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
703510|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
703511|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703512|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
703513|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228617|NCT00061451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228618|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228619|NCT00061451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228620|NCT00061451|Immunologic Factors|immunologic factors|mesh-ancestor
2228621|NCT00061451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228622|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2228623|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2228624|NCT00061464|Gemcitabine|gemcitabine|mesh-list
2228625|NCT00061464|Pemetrexed|pemetrexed|mesh-list
2228626|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228627|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
2228628|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228629|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228630|NCT00061464|Antiviral Agents|antiviral agents|mesh-ancestor
2228631|NCT00061464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228632|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228633|NCT00061464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228634|NCT00061464|Immunologic Factors|immunologic factors|mesh-ancestor
2228635|NCT00061464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228636|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2228637|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2228638|NCT00061477|Gemcitabine|gemcitabine|mesh-list
2228639|NCT00061477|Pemetrexed|pemetrexed|mesh-list
2228640|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228641|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
2228642|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228643|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228644|NCT00061477|Antiviral Agents|antiviral agents|mesh-ancestor
2228645|NCT00061477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228646|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228647|NCT00061477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228648|NCT00061477|Immunologic Factors|immunologic factors|mesh-ancestor
2228649|NCT00061477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228650|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2228651|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2228652|NCT00061503|Travoprost|travoprost|mesh-list
2228653|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2228654|NCT00061516|Brinzolamide|brinzolamide|mesh-list
2228655|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
705094|NCT02998827|Thalidomide|thalidomide|mesh-list
705095|NCT02998827|Azathioprine|azathioprine|mesh-list
705096|NCT02998827|Infliximab|infliximab|mesh-list
705097|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
2228656|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228657|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228658|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2228659|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
703443|NCT03006081|Aflibercept|aflibercept|mesh-list
703444|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
703445|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
703446|NCT03006081|Growth Substances|growth substances|mesh-ancestor
703447|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703448|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
703449|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704010|NCT03004287|Thalidomide|thalidomide|mesh-list
704011|NCT03004287|Dexamethasone|dexamethasone|mesh-list
704012|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
704013|NCT03004287|Melphalan|melphalan|mesh-list
704014|NCT03004287|Doxorubicin|doxorubicin|mesh-list
704015|NCT03004287|Etoposide|etoposide|mesh-list
704016|NCT03004287|Lenalidomide|lenalidomide|mesh-list
704017|NCT03004287|Bortezomib|bortezomib|mesh-list
704018|NCT03004287|Daratumumab|daratumumab|mesh-list
704019|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
704020|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
704021|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704022|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
704023|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
704024|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
704025|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704026|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704027|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
704028|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
704029|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
704030|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
704031|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704032|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
704033|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
704034|NCT03004287|Hormones|hormones|mesh-ancestor
704035|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
704036|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
704037|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
704038|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
704039|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
704040|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704041|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
704042|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
704043|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
704044|NCT03004287|Growth Substances|growth substances|mesh-ancestor
704045|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
704046|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
704047|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
704048|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089336|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
2089337|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2089338|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089339|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
2089340|NCT02197416|Dabigatran|dabigatran|mesh-list
2089341|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
2089342|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2089343|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
2089344|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089345|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089346|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
2089347|NCT02197455|Tofacitinib|tofacitinib|mesh-list
704384|NCT03002649|Tofacitinib|tofacitinib|mesh-list
704385|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704386|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
704387|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704489|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
704490|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
704491|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228660|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2228661|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2228662|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2228663|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2228664|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2089348|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2228665|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
703158|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
703159|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
703160|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
703161|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
703162|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703163|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703254|NCT03006380|Oxytocin|oxytocin|mesh-list
703255|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
703256|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
703257|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703575|NCT03005548|Morphine|morphine|mesh-list
703576|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
703577|NCT03005548|Narcotics|narcotics|mesh-ancestor
703578|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
703579|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703580|NCT03005548|Analgesics|analgesics|mesh-ancestor
703581|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
703582|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703802|NCT03005184|Icatibant|icatibant|mesh-list
703803|NCT03005184|Valsartan|valsartan|mesh-list
703804|NCT03005184|Enalapril|enalapril|mesh-list
703805|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
703806|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
703807|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
703808|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
703809|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703810|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
703811|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
703812|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703813|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
703814|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
703815|NCT03005184|Analgesics|analgesics|mesh-ancestor
703816|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
703817|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703818|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703819|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
703820|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
703821|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
703822|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
703823|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
703824|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
703825|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
704086|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
704087|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
704088|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
704089|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
704090|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
704091|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
704428|NCT03002376|Cemiplimab|cemiplimab|mesh-list
704429|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
704430|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704608|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
704609|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
704903|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
704904|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
704905|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
704906|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704907|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
704908|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
704909|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
704910|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704911|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704912|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
705114|NCT02998736|Tadalafil|tadalafil|mesh-list
705115|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
705116|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
705117|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
705118|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705119|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705120|NCT02998736|Urological Agents|urological agents|mesh-ancestor
705218|NCT02998047|Lintuzumab|lintuzumab|mesh-list
705219|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
705220|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705408|NCT02996656|Cefazolin|cefazolin|mesh-list
703281|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
703282|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
703283|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
703284|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
703285|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
703286|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
703287|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2089349|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089350|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089351|NCT02197520|Insulin|insulin|mesh-list
2089352|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2089353|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
2089354|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
2089355|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2089356|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089357|NCT02197767|Rituximab|rituximab|mesh-list
2089358|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2089359|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089360|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
2089361|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089362|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089363|NCT02197897|Tamoxifen|tamoxifen|mesh-list
2089364|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2089365|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
2089366|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2089367|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089368|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
703940|NCT03004131|Fluticasone|fluticasone|mesh-list
703941|NCT03004131|Xhance|xhance|mesh-list
703942|NCT03004131|Loratadine|loratadine|mesh-list
703943|NCT03004131|Azelastine|azelastine|mesh-list
703944|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
703945|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
703946|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
703947|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703948|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703949|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
703950|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
703951|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
703952|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
703953|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
703954|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
703955|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
703956|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
703957|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
703958|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
703959|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703960|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
703961|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089369|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089370|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2089371|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2089372|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2089373|NCT02198235|Dexamethasone|dexamethasone|mesh-list
2089374|NCT02198235|Buprenorphine|buprenorphine|mesh-list
2089375|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2089376|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
2089377|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
2089378|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089379|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089380|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2089381|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
2089382|NCT02198235|Hormones|hormones|mesh-ancestor
2089383|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2089384|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2089385|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089386|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2089387|NCT02198235|Narcotics|narcotics|mesh-ancestor
2089388|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2089389|NCT02198235|Analgesics|analgesics|mesh-ancestor
2089390|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
2228666|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2228667|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228668|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228669|NCT00061542|Timolol|timolol|mesh-list
703375|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703376|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
703377|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
703378|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
703379|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
703380|NCT03006211|Protective Agents|protective agents|mesh-ancestor
703671|NCT03005353|Clotrimazole|clotrimazole|mesh-list
703672|NCT03005353|Miconazole|miconazole|mesh-list
703673|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
703674|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
703675|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
703676|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
703677|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
703678|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703679|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703680|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
703681|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
703682|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
703683|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703684|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
703685|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
703780|NCT03004612|Metformin|metformin|mesh-list
703781|NCT03004612|Linagliptin|linagliptin|mesh-list
703782|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
703783|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703784|NCT03004612|Incretins|incretins|mesh-ancestor
703785|NCT03004612|Hormones|hormones|mesh-ancestor
703786|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
703787|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
703788|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
703789|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703790|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703968|NCT03004222|Bupivacaine|bupivacaine|mesh-list
703969|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
703970|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
703971|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
703972|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703973|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
703974|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704194|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
704195|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
704196|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704726|NCT03000387|Nicotine|nicotine|mesh-list
704727|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
704728|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
704729|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704730|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704731|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
704732|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
704733|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
704734|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
704735|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704836|NCT03000036|Doxorubicin|doxorubicin|mesh-list
704837|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
704838|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
704839|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704840|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
704841|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
704842|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704843|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704844|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
704845|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
704922|NCT02999724|Gabapentin|gabapentin|mesh-list
704923|NCT02999724|Analgesics|analgesics|mesh-ancestor
704924|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
704925|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704926|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704927|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
704928|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
704929|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
704930|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
704931|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2228670|NCT00061542|Betaxolol|betaxolol|mesh-list
703394|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703395|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
703396|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
703397|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
703398|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
703399|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703400|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703401|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
703402|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
703989|NCT03004339|Betamethasone|betamethasone|mesh-list
703990|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
703991|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
703992|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
703993|NCT03004339|Calcipotriene|calcipotriene|mesh-list
703994|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
703995|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
703996|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
703997|NCT03004339|Hormones|hormones|mesh-ancestor
703998|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
703999|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704000|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
704001|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
704002|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
704110|NCT03003728|Melphalan|melphalan|mesh-list
704111|NCT03003728|Elotuzumab|elotuzumab|mesh-list
704112|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
704113|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
704114|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704115|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704116|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
704117|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
704118|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
704119|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704282|NCT03002831|Tegafur|tegafur|mesh-list
704283|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
704284|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
704285|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704286|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704443|NCT03002103|Gemcitabine|gemcitabine|mesh-list
704444|NCT03002103|Paclitaxel|paclitaxel|mesh-list
704445|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
704446|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704447|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
704448|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
704449|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
704450|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704451|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
704452|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
704453|NCT03002103|Antiviral Agents|antiviral agents|mesh-ancestor
704454|NCT03002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
704455|NCT03002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704456|NCT03002103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
704457|NCT03002103|Immunologic Factors|immunologic factors|mesh-ancestor
704458|NCT03002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704649|NCT03001193|Oxytocin|oxytocin|mesh-list
704650|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
704651|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
704652|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705049|NCT02999087|Cetuximab|cetuximab|mesh-list
705050|NCT02999087|Avelumab|avelumab|mesh-list
705051|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705052|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
706088|NCT02995096|Sirolimus|sirolimus|mesh-list
706089|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
706090|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
706091|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
706092|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706093|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
706094|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
706095|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
706096|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228671|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2228672|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2228673|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
2228674|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
703452|NCT03005860|Sevoflurane|sevoflurane|mesh-list
703453|NCT03005860|Atracurium|atracurium|mesh-list
703454|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
703455|NCT03005860|Narcotics|narcotics|mesh-ancestor
703456|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
703457|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703458|NCT03005860|Analgesics|analgesics|mesh-ancestor
703459|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
703460|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703461|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
703462|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
703463|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
703464|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
703465|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703466|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
703467|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
703468|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
703469|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
703470|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
703471|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
703472|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
703473|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
703474|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
703475|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
703686|NCT03005015|Doxorubicin|doxorubicin|mesh-list
703687|NCT03005015|Lenvatinib|lenvatinib|mesh-list
703688|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
703689|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703690|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
703691|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
703692|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703693|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703694|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
704259|NCT03003065|Temoporfin|temoporfin|mesh-list
704260|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704261|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
704262|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
704533|NCT03001661|Dinoprostone|dinoprostone|mesh-list
704534|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
704535|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
704536|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228675|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228676|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228677|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2228678|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2228679|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
2228680|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
2228681|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705328|NCT02997501|Osimertinib|osimertinib|mesh-list
705329|NCT02997501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705330|NCT02997501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
705331|NCT02997501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705332|NCT02997501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705865|NCT02994953|Avelumab|avelumab|mesh-list
705866|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
705867|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
705868|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705869|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
705870|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228682|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2228683|NCT00061594|Ranibizumab|ranibizumab|mesh-list
2228684|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2089391|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2089392|NCT02198651|Adalimumab|adalimumab|mesh-list
2089393|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2089394|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089395|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
2089396|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
2089397|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2089398|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2089399|NCT02199041|Prednisolone|prednisolone|mesh-list
2089400|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
2089401|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
2228685|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2228686|NCT00061594|Growth Substances|growth substances|mesh-ancestor
2089402|NCT02199041|Melphalan|melphalan|mesh-list
703702|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703703|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
703704|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
703705|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
703706|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
703707|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703737|NCT03004768|BMS-986165|bms-986165|mesh-list
703738|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
703739|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
703740|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703741|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703962|NCT03004183|Valacyclovir|valacyclovir|mesh-list
703963|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
703964|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
703965|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
703966|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
703967|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228687|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228688|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
2228689|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228690|NCT00061620|Tezacitabine|tezacitabine|mesh-list
2228691|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228692|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704287|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
704288|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
704289|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704290|NCT03002935|Vitamins|vitamins|mesh-ancestor
704405|NCT03002389|Fluticasone|fluticasone|mesh-list
704406|NCT03002389|Xhance|xhance|mesh-list
704407|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
704408|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
704409|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
704410|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704411|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704412|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
704413|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
704414|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
704415|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
704537|NCT03001726|Docetaxel|docetaxel|mesh-list
704538|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
704539|NCT03001726|Tegafur|tegafur|mesh-list
704540|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704541|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
704542|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
704543|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
704544|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704545|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
704546|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
2089403|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
2089404|NCT02199041|Thiotepa|thiotepa|mesh-list
2089405|NCT02199041|Fludarabine|fludarabine|mesh-list
2089406|NCT02199041|Tacrolimus|tacrolimus|mesh-list
705495|NCT02996409|Lidocaine|lidocaine|mesh-list
705496|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
705497|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
705498|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
705499|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705500|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
705501|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705502|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
705503|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
705504|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
705505|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
705506|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706007|NCT02994381|Ozanimod|ozanimod|mesh-list
706008|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
706009|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706010|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
706011|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
706012|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706195|NCT02993705|Trabectedin|trabectedin|mesh-list
706196|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
706197|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
706198|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089407|NCT02199041|Lenograstim|lenograstim|mesh-list
703729|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
703730|NCT03005340|Vitamins|vitamins|mesh-ancestor
703731|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
703732|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
703733|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
703734|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
703735|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
703736|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
703980|NCT03004261|Ganciclovir|ganciclovir|mesh-list
703981|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
703982|NCT03004261|Foscarnet|foscarnet|mesh-list
703983|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
703984|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
703985|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
703986|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703987|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
703988|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2228693|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228694|NCT00061646|Carboplatin|carboplatin|mesh-list
2228695|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705716|NCT02995746|Dexamethasone|dexamethasone|mesh-list
705717|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
705718|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
705719|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
705720|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705721|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705722|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
705723|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
705724|NCT02995746|Hormones|hormones|mesh-ancestor
705725|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
705726|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
705727|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228696|NCT00061711|Hormones|hormones|mesh-list
2228697|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
2228698|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2228699|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228700|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2228701|NCT00061711|Estrogens|estrogens|mesh-ancestor
2228702|NCT00061750|Deferasirox|deferasirox|mesh-list
2228703|NCT00061750|Deferoxamine|deferoxamine|mesh-list
2228704|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2228705|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
2228706|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
2228707|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228708|NCT00061750|Siderophores|siderophores|mesh-ancestor
706818|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
706819|NCT02990533|Testosterone|testosterone|mesh-list
706820|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
706821|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
706822|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
706823|NCT02990533|Androgens|androgens|mesh-ancestor
706824|NCT02990533|Hormones|hormones|mesh-ancestor
706825|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
706826|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706827|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
706828|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706829|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
707117|NCT02989467|Aprepitant|aprepitant|mesh-list
707118|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
707119|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
707120|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707121|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707122|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
707123|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
707124|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2228709|NCT00061763|Deferasirox|deferasirox|mesh-list
703777|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
703778|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
703779|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704398|NCT03002636|Anesthetics|anesthetics|mesh-list
704399|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
704400|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704601|NCT03001349|Octreotide|octreotide|mesh-list
704602|NCT03001349|Edotreotide|edotreotide|mesh-list
704603|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
704604|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
704605|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704606|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704607|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
704791|NCT03000257|Venetoclax|venetoclax|mesh-list
704792|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704888|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
704889|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
704890|NCT02999815|Antibodies|antibodies|mesh-list
704891|NCT02999815|Antitoxins|antitoxins|mesh-list
704892|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
704893|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705028|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
705029|NCT02999217|Hematinics|hematinics|mesh-ancestor
705129|NCT02998606|Naloxegol|naloxegol|mesh-list
705130|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
705131|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705132|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
705133|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705203|NCT02998268|Paclitaxel|paclitaxel|mesh-list
705204|NCT02998268|Carboplatin|carboplatin|mesh-list
705205|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
705206|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
705207|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705208|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
705209|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
705210|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
705211|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705212|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
705245|NCT02997800|Labetalol|labetalol|mesh-list
705246|NCT02997800|Fentanyl|fentanyl|mesh-list
705247|NCT02997800|Esmolol|esmolol|mesh-list
705248|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
705249|NCT02997800|Narcotics|narcotics|mesh-ancestor
705250|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
705251|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705252|NCT02997800|Analgesics|analgesics|mesh-ancestor
705253|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
705254|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705255|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
705256|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
705257|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
705258|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
705259|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
705260|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
705261|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
705262|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
705263|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
705264|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705265|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
705266|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
705267|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
705268|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
705269|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2089408|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2089409|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
2089410|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2089411|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
2089412|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089413|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089414|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2089415|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
2089416|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089417|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089418|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2089419|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2089420|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
703887|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
703888|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
703889|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
703890|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
703891|NCT03007147|Hormones|hormones|mesh-ancestor
703892|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
703893|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
703894|NCT03007147|Protease Inhibitors|protease inhibitors|mesh-ancestor
703895|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
703896|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
703897|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
703898|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
703899|NCT03007147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
703900|NCT03007147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
703901|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
703902|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
703903|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
703904|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
703905|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
703906|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
703907|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
703908|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
703909|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
703910|NCT03007147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
703911|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
703912|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
703913|NCT03007147|Antidotes|antidotes|mesh-ancestor
703914|NCT03007147|Protective Agents|protective agents|mesh-ancestor
703915|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
703916|NCT03007147|Vitamins|vitamins|mesh-ancestor
703917|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
703918|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
703919|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
703920|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
703921|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
703922|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
703923|NCT03007147|Hematinics|hematinics|mesh-ancestor
703924|NCT03007147|Keratolytic Agents|keratolytic agents|mesh-ancestor
703925|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
705270|NCT02997657|Nicotine|nicotine|mesh-list
705271|NCT02997657|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
705272|NCT02997657|Autonomic Agents|autonomic agents|mesh-ancestor
705273|NCT02997657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705274|NCT02997657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705275|NCT02997657|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
705276|NCT02997657|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
705277|NCT02997657|Cholinergic Agents|cholinergic agents|mesh-ancestor
705278|NCT02997657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
705279|NCT02997657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705338|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
705339|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228710|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2228711|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
2228712|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
2228713|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089421|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089422|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
706188|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
706189|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
706190|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
706191|NCT02993367|Protective Agents|protective agents|mesh-ancestor
706192|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706302|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
706303|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
706304|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706305|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
706306|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
706307|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
706308|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
706309|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706310|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706997|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
706998|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
706999|NCT02990013|Povidone|povidone|mesh-list
707000|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
704085|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2752948|NCT03207347|Niraparib|niraparib|mesh-list
2752949|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2752950|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752951|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752952|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704381|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
704382|NCT03002545|Cathartics|cathartics|mesh-ancestor
704383|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
704704|NCT03000777|Melatonin|melatonin|mesh-list
704705|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
704706|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704707|NCT03000777|Protective Agents|protective agents|mesh-ancestor
704708|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704709|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2228714|NCT00061776|Capsaicin|capsaicin|mesh-list
2228715|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
2228716|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
2228717|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
2228718|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228719|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228720|NCT00061789|Acetylcholine|acetylcholine|mesh-list
2228721|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
2228722|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2228723|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
2089423|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2089424|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
2089425|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2089426|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089427|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2089428|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
2089429|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
2089430|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089431|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2089432|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
2089433|NCT02199041|Hormones|hormones|mesh-ancestor
2089434|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2089435|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2089436|NCT02199041|Protective Agents|protective agents|mesh-ancestor
2089437|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2089438|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
2089439|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2089440|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2089441|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089442|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
2089443|NCT02199080|Coagulants|coagulants|mesh-ancestor
706031|NCT02994290|Vaccines|vaccines|mesh-list
2228724|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
704152|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
704153|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
704154|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
704155|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
704156|NCT03003273|Renal Agents|renal agents|mesh-ancestor
704157|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
704158|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
704159|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704160|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704161|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704162|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
704163|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
704164|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
704308|NCT03002792|Anesthetics|anesthetics|mesh-list
704309|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
704310|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704416|NCT03002259|Dexamethasone|dexamethasone|mesh-list
704417|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
704418|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
704419|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
704420|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704421|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704422|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
704423|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
704424|NCT03002259|Hormones|hormones|mesh-ancestor
704425|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
704426|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
704427|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704639|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
704640|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
704641|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
704642|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
704643|NCT03001102|Povidone|povidone|mesh-list
704644|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
704645|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
704646|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
704647|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
704648|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
2089444|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2089445|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089446|NCT02199314|Desflurane|desflurane|mesh-list
705066|NCT02998918|Curcumin|curcumin|mesh-list
705067|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
705068|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
705069|NCT02998918|Analgesics|analgesics|mesh-ancestor
705070|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
705071|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705072|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705073|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
705074|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
705075|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705076|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705077|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705340|NCT02997332|Docetaxel|docetaxel|mesh-list
705341|NCT02997332|Fluorouracil|fluorouracil|mesh-list
705342|NCT02997332|Durvalumab|durvalumab|mesh-list
705343|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705344|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
705345|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
705346|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
705347|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705348|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
705349|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
705350|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
705351|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
705352|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705353|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
705412|NCT02996721|Vitamin D|vitamin d|mesh-list
705413|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
705414|NCT02996721|Vitamins|vitamins|mesh-ancestor
705415|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
705416|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705417|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
705418|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
705668|NCT02996019|Etrolizumab|etrolizumab|mesh-list
705669|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2089447|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2089448|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
2089449|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
2089450|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2089451|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089452|NCT02199496|Ustekinumab|ustekinumab|mesh-list
2089453|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
2089454|NCT02199509|Levetiracetam|levetiracetam|mesh-list
2089455|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
2089456|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
2089457|NCT02199574|Bupivacaine|bupivacaine|mesh-list
2089458|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
704291|NCT03002844|Gemcitabine|gemcitabine|mesh-list
704292|NCT03002844|Carboplatin|carboplatin|mesh-list
704293|NCT03002844|Pemetrexed|pemetrexed|mesh-list
704294|NCT03002844|Gefitinib|gefitinib|mesh-list
704295|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704296|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
704297|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
704298|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704299|NCT03002844|Antiviral Agents|antiviral agents|mesh-ancestor
704300|NCT03002844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
704301|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704302|NCT03002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
704303|NCT03002844|Immunologic Factors|immunologic factors|mesh-ancestor
704304|NCT03002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704305|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
704306|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
704307|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2228725|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228726|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228727|NCT00061802|Risperidone|risperidone|mesh-list
2228728|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2228729|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
705595|NCT02996227|Bupivacaine|bupivacaine|mesh-list
705596|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
705597|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
705598|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
705599|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705600|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
705601|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706376|NCT02992886|Raltitrexed|raltitrexed|mesh-list
706377|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
706378|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
706379|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706380|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706381|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
706382|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707034|NCT02989571|Acivicin|acivicin|mesh-list
707035|NCT02989571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
707036|NCT02989571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707037|NCT02989571|Antifungal Agents|antifungal agents|mesh-ancestor
707038|NCT02989571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
707039|NCT02989571|Antimetabolites|antimetabolites|mesh-ancestor
707040|NCT02989571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707041|NCT02989571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
707042|NCT02989571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707140|NCT02989324|Misoprostol|misoprostol|mesh-list
707141|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
707142|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
707143|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
707144|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707145|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
707146|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
707147|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
707746|NCT02986659|Metformin|metformin|mesh-list
707747|NCT02986659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
707748|NCT02986659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707907|NCT02985749|Oxytocin|oxytocin|mesh-list
707908|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
707909|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
707910|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708224|NCT02985125|Everolimus|everolimus|mesh-list
708225|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708226|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
708227|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
2089459|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
2228730|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
704270|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
704271|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704272|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
704273|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
704274|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704275|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704459|NCT03002090|Iron|iron|mesh-list
704460|NCT03002090|Trace Elements|trace elements|mesh-ancestor
704461|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
704462|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704507|NCT03001687|Vitamin D|vitamin d|mesh-list
704508|NCT03001687|Vitamins|vitamins|mesh-ancestor
704509|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
704510|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704511|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
704554|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
704555|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
704618|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
704619|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
704620|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705368|NCT02996916|Amlodipine|amlodipine|mesh-list
705369|NCT02996916|Olmesartan|olmesartan|mesh-list
705370|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
705371|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
705372|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
705373|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705374|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
705375|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705376|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
705377|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
705378|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
705809|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
705810|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
705811|NCT02995330|Testosterone|testosterone|mesh-list
705812|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
705813|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
705814|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
705815|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
705816|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
705817|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705818|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
705819|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
705820|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
705821|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705822|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705823|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
705824|NCT02995330|Androgens|androgens|mesh-ancestor
705825|NCT02995330|Hormones|hormones|mesh-ancestor
705826|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
705827|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
705828|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
706166|NCT02993822|Maleic acid|maleic acid|mesh-list
706167|NCT02993822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706168|NCT02993822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706992|NCT02989701|Plerixafor|plerixafor|mesh-list
706993|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
706994|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
706995|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
706996|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708767|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
708768|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
708769|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
708770|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708771|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
708772|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
708773|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704373|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
704374|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
704375|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
704376|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
704827|NCT03000218|Metformin|metformin|mesh-list
704828|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
704829|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
704830|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704831|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
704832|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
704947|NCT02999594|Tramadol|tramadol|mesh-list
704948|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
704949|NCT02999594|Narcotics|narcotics|mesh-ancestor
704950|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
704951|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704952|NCT02999594|Analgesics|analgesics|mesh-ancestor
704953|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
704954|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705309|NCT02997605|Prednisone|prednisone|mesh-list
705310|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
705311|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
705312|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
705313|NCT02997605|Hormones|hormones|mesh-ancestor
705314|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
705315|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705316|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
705317|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705436|NCT02996513|Vitamin A|vitamin a|mesh-list
705437|NCT02996513|Vitamins|vitamins|mesh-ancestor
705438|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
705439|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705628|NCT02996214|Gemcitabine|gemcitabine|mesh-list
705629|NCT02996214|Paclitaxel|paclitaxel|mesh-list
705630|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
705631|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705632|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
705633|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
705634|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
705635|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705636|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
705637|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
705638|NCT02996214|Antiviral Agents|antiviral agents|mesh-ancestor
705639|NCT02996214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705640|NCT02996214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705641|NCT02996214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
705642|NCT02996214|Immunologic Factors|immunologic factors|mesh-ancestor
705643|NCT02996214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706599|NCT02991339|Dexamethasone|dexamethasone|mesh-list
706600|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
706601|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
706602|NCT02991339|BB 1101|bb 1101|mesh-list
706603|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
706604|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
706605|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
706606|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706607|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706608|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
706609|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
706610|NCT02991339|Hormones|hormones|mesh-ancestor
706611|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
706612|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
706613|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706614|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
706615|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706616|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706930|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
706931|NCT02990286|Rituximab|rituximab|mesh-list
706932|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2228731|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2228732|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228733|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228734|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2228735|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
704524|NCT03001609|Abivertinib|abivertinib|mesh-list
704525|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
704526|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
704527|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704736|NCT03000634|Dexamethasone|dexamethasone|mesh-list
704737|NCT03000634|Lenalidomide|lenalidomide|mesh-list
704738|NCT03000634|Bortezomib|bortezomib|mesh-list
704739|NCT03000634|Elotuzumab|elotuzumab|mesh-list
704740|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
704741|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
704742|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
704743|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704744|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704745|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
704746|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
704747|NCT03000634|Hormones|hormones|mesh-ancestor
704748|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
704749|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
704750|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704751|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
704752|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
704753|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
704754|NCT03000634|Growth Substances|growth substances|mesh-ancestor
704755|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
704913|NCT02999906|Treprostinil|treprostinil|mesh-list
704914|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
704998|NCT02999477|Paclitaxel|paclitaxel|mesh-list
704999|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
705000|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
705001|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705002|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
705003|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
705004|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
705005|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705006|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
705614|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
705615|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
705616|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
705617|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705618|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
705619|NCT02996058|Analgesics|analgesics|mesh-ancestor
705620|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
705621|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705622|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
705623|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
705624|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
705625|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
705626|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
705627|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705689|NCT02995720|Amlodipine|amlodipine|mesh-list
705690|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
705691|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
705692|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
705693|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
705694|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705695|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
705696|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705697|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
705698|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
705699|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
705700|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
705701|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
705702|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
705703|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705892|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
705893|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
705894|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
705895|NCT02995083|Prednisolone|prednisolone|mesh-list
705896|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
705897|NCT02995083|Lidocaine|lidocaine|mesh-list
704438|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
704439|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
704440|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
704441|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
704442|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704512|NCT03001739|Urapidil|urapidil|mesh-list
704513|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
704514|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
704515|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
704516|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
704517|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
704518|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704519|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704520|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
704521|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
704522|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
704523|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
704686|NCT03000413|Fentanyl|fentanyl|mesh-list
704687|NCT03000413|Ketamine|ketamine|mesh-list
704688|NCT03000413|Analgesics|analgesics|mesh-ancestor
704689|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
704690|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704691|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704692|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
704693|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
704694|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
704695|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
704696|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
704697|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
704698|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
704699|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
704700|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704701|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
704702|NCT03000413|Narcotics|narcotics|mesh-ancestor
704703|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2228736|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2228737|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2228738|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
704995|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
704996|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
704997|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705013|NCT02999204|Vitamin D|vitamin d|mesh-list
705014|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
705015|NCT02999204|Vitamins|vitamins|mesh-ancestor
705016|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
705017|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705018|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
705019|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
705171|NCT02998385|Cisplatin|cisplatin|mesh-list
705172|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228739|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
2228740|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
2228741|NCT00061815|Leucovorin|leucovorin|mesh-list
2228742|NCT00061815|Fluorouracil|fluorouracil|mesh-list
2228743|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
2228744|NCT00061815|Cetuximab|cetuximab|mesh-list
2228745|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
2228746|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228747|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228748|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228749|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228750|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
2228751|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228752|NCT00061815|Antidotes|antidotes|mesh-ancestor
705440|NCT02996825|Gemcitabine|gemcitabine|mesh-list
705441|NCT02996825|Maytansine|maytansine|mesh-list
705442|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
705443|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
705444|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705445|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705446|NCT02996825|Antiviral Agents|antiviral agents|mesh-ancestor
705447|NCT02996825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705448|NCT02996825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705449|NCT02996825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
705450|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
2228753|NCT00061815|Protective Agents|protective agents|mesh-ancestor
2228754|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
2228755|NCT00061815|Vitamins|vitamins|mesh-ancestor
2228756|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
2228757|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2228758|NCT00061854|Soblidotin|soblidotin|mesh-list
2228759|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228760|NCT00061867|Doxorubicin|doxorubicin|mesh-list
2228761|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2228762|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2228763|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228764|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2228765|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2228766|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228767|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228768|NCT00061906|Celecoxib|celecoxib|mesh-list
2228769|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2228770|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2089460|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2089461|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089462|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
2089463|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089464|NCT02199652|Prazosin|prazosin|mesh-list
2089465|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2089466|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2089467|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2089468|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2089469|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
2089470|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089471|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089472|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089473|NCT02199691|Vaccines|vaccines|mesh-list
2228771|NCT00061906|Analgesics|analgesics|mesh-ancestor
705333|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
705334|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705335|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
705336|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
705337|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
705680|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
705681|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
705682|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
705683|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
705684|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705685|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
705686|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
705687|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705688|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228772|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
2228773|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228774|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228775|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2228776|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228777|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2228778|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2228779|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707172|NCT02989311|Iron|iron|mesh-list
707173|NCT02989311|Trace Elements|trace elements|mesh-ancestor
707174|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
707175|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707501|NCT02987751|Insulin|insulin|mesh-list
707502|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
707503|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
707504|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708022|NCT02985619|Triamcinolone|triamcinolone|mesh-list
708023|NCT02985619|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
708024|NCT02985619|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
708025|NCT02985619|Bevacizumab|bevacizumab|mesh-list
708026|NCT02985619|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
708027|NCT02985619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
708028|NCT02985619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708029|NCT02985619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
708030|NCT02985619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
708031|NCT02985619|Growth Substances|growth substances|mesh-ancestor
708032|NCT02985619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708033|NCT02985619|Growth Inhibitors|growth inhibitors|mesh-ancestor
708034|NCT02985619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2228780|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704664|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
704665|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
704666|NCT03000660|Hormones|hormones|mesh-ancestor
704667|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
704668|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
704669|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228781|NCT00061919|Thalidomide|thalidomide|mesh-list
2228782|NCT00061919|Carboplatin|carboplatin|mesh-list
2228783|NCT00061919|Etoposide|etoposide|mesh-list
2228784|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
2089474|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
2089475|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089476|NCT02199743|Haloperidol|haloperidol|mesh-list
2089477|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
2089478|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2228785|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228786|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
706522|NCT02992028|Vitamins|vitamins|mesh-list
706523|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
706524|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706562|NCT02991612|Rifaximin|rifaximin|mesh-list
706563|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
706564|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
706565|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
706658|NCT02991131|Linezolid|linezolid|mesh-list
706659|NCT02991131|Tedizolid|tedizolid|mesh-list
706660|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
706661|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
706662|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
706663|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
706664|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706665|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706761|NCT02990806|Infliximab|infliximab|mesh-list
706762|NCT02990806|Dermatologic Agents|dermatologic agents|mesh-ancestor
706763|NCT02990806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
706764|NCT02990806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
707072|NCT02989558|Aspirin|aspirin|mesh-list
707073|NCT02989558|Clopidogrel|clopidogrel|mesh-list
707074|NCT02989558|Ticagrelor|ticagrelor|mesh-list
707075|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
707076|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
707077|NCT02989558|Analgesics|analgesics|mesh-ancestor
707078|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
707079|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707080|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707081|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
707082|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
707083|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
707084|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
707085|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707086|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
707087|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
707088|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707089|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
707090|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
707091|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
707092|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
707093|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
707094|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
707135|NCT02989259|Apatinib|apatinib|mesh-list
707136|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707137|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
707138|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707139|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228787|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2228788|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2228789|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228790|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228791|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228792|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
2228793|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228794|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
2228795|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2228796|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228797|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
707337|NCT02988063|Polidocanol|polidocanol|mesh-list
2228798|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2228799|NCT00061919|Growth Substances|growth substances|mesh-ancestor
2228800|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
2228801|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
2228802|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228803|NCT00061984|Doxorubicin|doxorubicin|mesh-list
2228804|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2228805|NCT00061984|Ifosfamide|ifosfamide|mesh-list
2228806|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2228807|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228808|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2228809|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2228810|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228811|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228812|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2228813|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
2228814|NCT00061997|Inositol|inositol|mesh-list
2228815|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
2228816|NCT00061997|Vitamins|vitamins|mesh-ancestor
2228817|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
2228818|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228819|NCT00062023|Aspirin|aspirin|mesh-list
2228820|NCT00062023|Sulindac|sulindac|mesh-list
2228821|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2228822|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2228823|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2228824|NCT00062023|Analgesics|analgesics|mesh-ancestor
2228825|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
2228826|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228827|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228828|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2228829|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228830|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2228831|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2228832|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228833|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2228834|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2228835|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228836|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
2228837|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2228838|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2228839|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228840|NCT00062036|Aldesleukin|aldesleukin|mesh-list
2228841|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
2228842|NCT00062036|Fludarabine|fludarabine|mesh-list
2228843|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
2228844|NCT00062036|Interleukin-2|interleukin-2|mesh-list
2228845|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
2228846|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228847|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
2228848|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228849|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228850|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2228851|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
2228852|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228853|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228854|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
705804|NCT02995187|Apatinib|apatinib|mesh-list
705805|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705806|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
705807|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705808|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705951|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
705952|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
705953|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
705954|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705955|NCT02994875|Expectorants|expectorants|mesh-ancestor
705956|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
705957|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
705958|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
705959|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705960|NCT02994875|Protective Agents|protective agents|mesh-ancestor
705961|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705962|NCT02994875|Antidotes|antidotes|mesh-ancestor
706063|NCT02994173|Ketamine|ketamine|mesh-list
706064|NCT02994173|Oxycodone|oxycodone|mesh-list
706065|NCT02994173|Esketamine|esketamine|mesh-list
2228855|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228856|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
2228857|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2228858|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2228859|NCT00062036|Analgesics|analgesics|mesh-ancestor
2228860|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
2228861|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228862|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
705704|NCT02995707|Thalidomide|thalidomide|mesh-list
705705|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
705706|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
705707|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705708|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
705709|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
705710|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705711|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
705712|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
705713|NCT02995707|Growth Substances|growth substances|mesh-ancestor
705714|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
705715|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705934|NCT02994745|Atorvastatin|atorvastatin|mesh-list
705935|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
705936|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
705937|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
705938|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705939|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
705940|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
705941|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706097|NCT02993991|Durvalumab|durvalumab|mesh-list
706098|NCT02993991|Mocetinostat|mocetinostat|mesh-list
706099|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
706100|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706101|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
706102|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706103|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228863|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2228864|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
2228865|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228866|NCT00062062|Paclitaxel|paclitaxel|mesh-list
2228867|NCT00062062|Carboplatin|carboplatin|mesh-list
2228868|NCT00062062|Gefitinib|gefitinib|mesh-list
2228869|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
706639|NCT02991196|Nivolumab|nivolumab|mesh-list
706640|NCT02991196|DS-8273a|ds-8273a|mesh-list
706641|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
706642|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706643|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
706644|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706790|NCT02990884|Ketamine|ketamine|mesh-list
706791|NCT02990884|Analgesics|analgesics|mesh-ancestor
706792|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
706793|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706794|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706795|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
706796|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
706797|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
706798|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
706799|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
706800|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
706801|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
706802|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
706803|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707218|NCT02989038|Nicotine|nicotine|mesh-list
707219|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
707220|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
707221|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707222|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707223|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
707224|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
707225|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
707226|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
707227|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707391|NCT02987907|Dexamethasone|dexamethasone|mesh-list
707392|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2228870|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704846|NCT02999984|Busulfan|busulfan|mesh-list
704847|NCT02999984|Alkylating Agents|alkylating agents|mesh-ancestor
704848|NCT02999984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704849|NCT02999984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
704850|NCT02999984|Immunologic Factors|immunologic factors|mesh-ancestor
704851|NCT02999984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704852|NCT02999984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
704853|NCT02999984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
704854|NCT02999984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
705053|NCT02999126|Remifentanil|remifentanil|mesh-list
705054|NCT02999126|Propofol|propofol|mesh-list
705055|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
705056|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
705057|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705058|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
705059|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
705060|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
705061|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
705062|NCT02999126|Narcotics|narcotics|mesh-ancestor
705063|NCT02999126|Analgesics|analgesics|mesh-ancestor
705064|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
705065|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705213|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
705214|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
705215|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
705216|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
705217|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228871|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
2228872|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
2228873|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
2228874|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228875|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
706145|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
706146|NCT02993718|Propofol|propofol|mesh-list
706147|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
706148|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
706149|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706150|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
706151|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
706152|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
706153|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
706154|NCT02993718|Analgesics|analgesics|mesh-ancestor
706155|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
706156|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706157|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
706158|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
706159|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
706160|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
706161|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
706162|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228876|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228877|NCT00062075|Romidepsin|romidepsin|mesh-list
2228878|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2228879|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228880|NCT00062101|Celecoxib|celecoxib|mesh-list
706459|NCT02992392|Dextrans|dextrans|mesh-list
706460|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
706461|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
706462|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
706571|NCT02991781|Varenicline|varenicline|mesh-list
706572|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
706573|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
706574|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
706575|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
706576|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706577|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706870|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
706871|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
706872|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089479|NCT02199743|Perphenazine|perphenazine|mesh-list
2089480|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
2089481|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
2089482|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089483|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089484|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2228881|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
704878|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
704879|NCT02999776|Analgesics|analgesics|mesh-ancestor
704880|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
704881|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
704882|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704883|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
704884|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
704885|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
704886|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
704887|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
705379|NCT02997059|Fluconazole|fluconazole|mesh-list
705380|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
705381|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705382|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
705383|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
705384|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705385|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705386|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
705387|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
705388|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
705389|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705390|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
705391|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2228882|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228883|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2228884|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228885|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228886|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2228887|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2228888|NCT00062101|Analgesics|analgesics|mesh-ancestor
2228889|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
2228890|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228891|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228892|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
706311|NCT02993029|Celecoxib|celecoxib|mesh-list
706312|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
706313|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
706314|NCT02993029|Analgesics|analgesics|mesh-ancestor
706315|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
706316|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706317|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706318|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
706319|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
706320|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
706321|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
706322|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706323|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706427|NCT02992548|Pravastatin|pravastatin|mesh-list
706428|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
706429|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
706430|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
706431|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706432|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
706433|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
706434|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706546|NCT02991768|Budesonide|budesonide|mesh-list
706547|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
706548|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
706549|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
706550|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706551|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706552|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
706553|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
706554|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
706555|NCT02991768|Hormones|hormones|mesh-ancestor
706556|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
706887|NCT02990364|Lidocaine|lidocaine|mesh-list
706888|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
706889|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
706890|NCT02990364|Anesthetics|anesthetics|mesh-list
706891|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
706892|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704916|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
704917|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
704918|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
704919|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
704920|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
704921|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228893|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228894|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2228895|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2228896|NCT00062114|Rituximab|rituximab|mesh-list
2228897|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
705829|NCT02995057|Nickel|nickel|mesh-list
705830|NCT02995057|Trace Elements|trace elements|mesh-ancestor
705831|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
705832|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706219|NCT02993315|Vaccines|vaccines|mesh-list
706220|NCT02993315|Immunologic Factors|immunologic factors|mesh-ancestor
706221|NCT02993315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706349|NCT02992756|Mitogens|mitogens|mesh-list
706350|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
706351|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706438|NCT02992652|Allopurinol|allopurinol|mesh-list
706439|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
706440|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706441|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706442|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
706443|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
706444|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
706445|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
706446|NCT02992652|Protective Agents|protective agents|mesh-ancestor
706447|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706636|NCT02991365|Insulin|insulin|mesh-list
706637|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
706638|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706744|NCT02990962|Triamcinolone|triamcinolone|mesh-list
706745|NCT02990962|Lidocaine|lidocaine|mesh-list
706746|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
706747|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
706748|NCT02990962|Hormones|hormones|mesh-ancestor
706749|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
706750|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706751|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706752|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
706753|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
706754|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
706755|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
706756|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706757|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
706758|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
706759|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
706760|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
707198|NCT02989129|Quercetin|quercetin|mesh-list
707199|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
707200|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707201|NCT02989129|Protective Agents|protective agents|mesh-ancestor
707202|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707281|NCT02988700|Bupivacaine|bupivacaine|mesh-list
707282|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
707283|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
707284|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
707285|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707286|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
707287|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707841|NCT02986269|Anesthetics|anesthetics|mesh-list
707842|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
707843|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228898|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228899|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
708665|NCT02982694|Bevacizumab|bevacizumab|mesh-list
708666|NCT02982694|Atezolizumab|atezolizumab|mesh-list
708667|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
708668|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708669|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
708670|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
708671|NCT02982694|Growth Substances|growth substances|mesh-ancestor
704932|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
704933|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
704934|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
704935|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
704936|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
705199|NCT02998398|Infliximab|infliximab|mesh-list
705200|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
705201|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
705202|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
705425|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
705426|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
705427|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
705428|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
705429|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705430|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
705431|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
705432|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
705433|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705434|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705435|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
706172|NCT02993640|Vasopressins|vasopressins|mesh-list
706173|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
706174|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
706175|NCT02993640|Coagulants|coagulants|mesh-ancestor
706176|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
706177|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
706178|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
706179|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706344|NCT02992964|Nivolumab|nivolumab|mesh-list
706345|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
706346|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706347|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
706348|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706383|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
706384|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
706385|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706386|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706387|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
706388|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
706389|NCT02992678|Protective Agents|protective agents|mesh-ancestor
706390|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706391|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
706392|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
706393|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
706474|NCT02992340|Gemcitabine|gemcitabine|mesh-list
706475|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706476|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
706477|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
706478|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706479|NCT02992340|Antiviral Agents|antiviral agents|mesh-ancestor
706480|NCT02992340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
706481|NCT02992340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706482|NCT02992340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
706483|NCT02992340|Immunologic Factors|immunologic factors|mesh-ancestor
706484|NCT02992340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707240|NCT02988921|Paclitaxel|paclitaxel|mesh-list
707241|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
707242|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707243|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
707244|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
707245|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
707246|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707340|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
707341|NCT02988089|Amoxicillin|amoxicillin|mesh-list
707342|NCT02988089|Metronidazole|metronidazole|mesh-list
707343|NCT02988089|Clarithromycin|clarithromycin|mesh-list
707344|NCT02988089|Levofloxacin|levofloxacin|mesh-list
707345|NCT02988089|Ofloxacin|ofloxacin|mesh-list
707346|NCT02988089|Tetracycline|tetracycline|mesh-list
707347|NCT02988089|Tinidazole|tinidazole|mesh-list
707348|NCT02988089|Furazolidone|furazolidone|mesh-list
707349|NCT02988089|Bismuth|bismuth|mesh-list
707350|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
707351|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
707352|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
707353|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
707354|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2228900|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228901|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228902|NCT00062127|Thalidomide|thalidomide|mesh-list
2228903|NCT00062127|Irinotecan|irinotecan|mesh-list
2228904|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2228905|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2228906|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228907|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228908|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228909|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228910|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
2228911|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228912|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
2228913|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2228914|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228915|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2228916|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2228917|NCT00062127|Growth Substances|growth substances|mesh-ancestor
2228918|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
2228919|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
2228920|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228921|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
2228922|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228923|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228924|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2228925|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
2228926|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228927|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228928|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2228929|NCT00062179|Celecoxib|celecoxib|mesh-list
2228930|NCT00062179|Paclitaxel|paclitaxel|mesh-list
2228931|NCT00062179|Carboplatin|carboplatin|mesh-list
2228932|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2228933|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228934|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
2228935|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
2228936|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
2228937|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228938|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
705134|NCT02998437|Amoxicillin|amoxicillin|mesh-list
705135|NCT02998437|Clarithromycin|clarithromycin|mesh-list
705136|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
705137|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705138|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
705139|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705140|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705141|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
705142|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
705241|NCT02997995|Durvalumab|durvalumab|mesh-list
705242|NCT02997995|Tremelimumab|tremelimumab|mesh-list
705243|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
705244|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705308|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
705354|NCT02997215|Lidocaine|lidocaine|mesh-list
705355|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
705356|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
705357|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
705358|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705359|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
705360|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705361|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
705362|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
705363|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
705364|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
705365|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705400|NCT02996760|Mitogens|mitogens|mesh-list
705401|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
705402|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228939|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2228940|NCT00062179|Analgesics|analgesics|mesh-ancestor
2228941|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
2228942|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228943|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228944|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
705098|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
705099|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
705100|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
705101|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
705102|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705103|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
705104|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
705105|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705106|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
705107|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
705108|NCT02998827|Growth Substances|growth substances|mesh-ancestor
705109|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
705110|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705111|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
705112|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705113|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
705143|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
705144|NCT02998567|Guadecitabine|guadecitabine|mesh-list
705145|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
705146|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705280|NCT02997982|Valacyclovir|valacyclovir|mesh-list
705281|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
705282|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705507|NCT02996305|Gaboxadol|gaboxadol|mesh-list
705508|NCT02996305|Analgesics|analgesics|mesh-ancestor
705509|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
705510|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705511|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705512|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
705513|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
705514|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
705515|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
705516|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705602|NCT02995954|Amlodipine|amlodipine|mesh-list
705603|NCT02995954|Perindopril|perindopril|mesh-list
705604|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
705605|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
705606|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
705607|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705608|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
705609|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705610|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
705611|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
705612|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
705613|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705796|NCT02995291|Phentolamine|phentolamine|mesh-list
705797|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
705798|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
705799|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
705800|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
705801|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705802|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705803|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
706013|NCT02994602|ST 1435|st 1435|mesh-list
706014|NCT02994602|Testosterone|testosterone|mesh-list
706015|NCT02994602|Androgens|androgens|mesh-ancestor
706016|NCT02994602|Hormones|hormones|mesh-ancestor
706017|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
706018|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706019|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
706020|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
706021|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
706022|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
706144|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
706365|NCT02993159|Tamoxifen|tamoxifen|mesh-list
706366|NCT02993159|Afimoxifene|afimoxifene|mesh-list
706367|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
706368|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
706369|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
706370|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706371|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
706372|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706373|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
706374|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
705178|NCT02998528|Nivolumab|nivolumab|mesh-list
705179|NCT02998528|Pemetrexed|pemetrexed|mesh-list
705180|NCT02998528|Ipilimumab|ipilimumab|mesh-list
705181|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
705182|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705183|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
705184|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
705185|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
705186|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705187|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
705188|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
705189|NCT02998528|Antiviral Agents|antiviral agents|mesh-ancestor
705190|NCT02998528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705191|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705192|NCT02998528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
705193|NCT02998528|Immunologic Factors|immunologic factors|mesh-ancestor
705194|NCT02998528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705195|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
705196|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
705197|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
705198|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
705397|NCT02996734|Denosumab|denosumab|mesh-list
705398|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
705399|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705456|NCT02996487|Vancomycin|vancomycin|mesh-list
705457|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
705458|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705998|NCT02994836|Adalimumab|adalimumab|mesh-list
705999|NCT02994836|Infliximab|infliximab|mesh-list
706000|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
706001|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
706002|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
706003|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
706004|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2228945|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228946|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2228947|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2228948|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228949|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
707016|NCT02989857|Ivosidenib|ivosidenib|mesh-list
707017|NCT02989857|Glycine|glycine|mesh-list
707018|NCT02989857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707019|NCT02989857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707020|NCT02989857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707021|NCT02989857|Glycine Agents|glycine agents|mesh-ancestor
707022|NCT02989857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
707023|NCT02989857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707256|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
707257|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
707258|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
707259|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
707260|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707261|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707262|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
707263|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
707264|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
707265|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
707266|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
707267|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
707268|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
707269|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707270|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
707271|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
707272|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
707440|NCT02987985|Acetaminophen|acetaminophen|mesh-list
707441|NCT02987985|Dexamethasone|dexamethasone|mesh-list
707442|NCT02987985|Lidocaine|lidocaine|mesh-list
707443|NCT02987985|Fentanyl|fentanyl|mesh-list
707444|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
707445|NCT02987985|Ketamine|ketamine|mesh-list
707446|NCT02987985|Gabapentin|gabapentin|mesh-list
707447|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
707448|NCT02987985|Ondansetron|ondansetron|mesh-list
707449|NCT02987985|Sevoflurane|sevoflurane|mesh-list
707450|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
707451|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
707452|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
707453|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2228950|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089485|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2089486|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2089487|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2089488|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2089489|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2089490|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
2089491|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089492|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089493|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2228951|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2228952|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705366|NCT02996942|Factor VIII|factor viii|mesh-list
705367|NCT02996942|Coagulants|coagulants|mesh-ancestor
705467|NCT02996695|Artesunate|artesunate|mesh-list
705468|NCT02996695|Chloroquine|chloroquine|mesh-list
705469|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
705470|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
705471|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
705472|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
705473|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705474|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
705475|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
705476|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
705477|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
705478|NCT02996695|Amebicides|amebicides|mesh-ancestor
705479|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2228953|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228954|NCT00062231|Amoxicillin|amoxicillin|mesh-list
2228955|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
2228956|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
2228957|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
2228958|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
2228959|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2228960|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2228961|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2228962|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228963|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2228964|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2228965|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228966|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228967|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228968|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2228969|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
2228970|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2228971|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705871|NCT02994927|Prednisone|prednisone|mesh-list
705872|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
705873|NCT02994927|Rituximab|rituximab|mesh-list
705874|NCT02994927|Azathioprine|azathioprine|mesh-list
705875|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
705876|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
705877|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705878|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
705879|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
705880|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
705881|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705882|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705883|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
705884|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
705885|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
705886|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
705887|NCT02994927|Hormones|hormones|mesh-ancestor
705888|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
705889|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
705890|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
705891|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
706463|NCT02992522|Lenalidomide|lenalidomide|mesh-list
706464|NCT02992522|Venetoclax|venetoclax|mesh-list
706465|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
706466|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
706467|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706468|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
706469|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
706470|NCT02992522|Growth Substances|growth substances|mesh-ancestor
706471|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
706472|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705409|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
705410|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
705411|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228972|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2228973|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2228974|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2228975|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2228976|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2228977|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2228978|NCT00062244|Oblimersen|oblimersen|mesh-list
2228979|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228980|NCT00062257|Irofulven|irofulven|mesh-list
2228981|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2228982|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
2228983|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228984|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228985|NCT00062270|Gemcitabine|gemcitabine|mesh-list
2228986|NCT00062270|Docetaxel|docetaxel|mesh-list
2228987|NCT00062270|Gefitinib|gefitinib|mesh-list
2228988|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2228989|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2228990|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
2228991|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2228992|NCT00062270|Antiviral Agents|antiviral agents|mesh-ancestor
2228993|NCT00062270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2228994|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2228995|NCT00062270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228996|NCT00062270|Immunologic Factors|immunologic factors|mesh-ancestor
707574|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
707575|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
707576|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707577|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
707578|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707733|NCT02986685|Rabeprazole|rabeprazole|mesh-list
707734|NCT02986685|Trimebutine|trimebutine|mesh-list
707735|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707736|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707737|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
707738|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
707739|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
707740|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
707741|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
707742|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707743|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707980|NCT02985697|Midazolam|midazolam|mesh-list
707997|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
707998|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
707999|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
708000|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708001|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708002|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
708003|NCT02985697|Analgesics|analgesics|mesh-ancestor
708004|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
708005|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708006|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
708007|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
708008|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
708009|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
708010|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
708011|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708012|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
708013|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
708014|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
708015|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
708016|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
708017|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
708018|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
708019|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
708020|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
708021|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2089494|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2089495|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
705451|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705452|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
705453|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
705454|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
705455|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
705776|NCT02995512|Colchicine|colchicine|mesh-list
705777|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
705778|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
705779|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
705780|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
705781|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
705782|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705783|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705833|NCT02995304|Midazolam|midazolam|mesh-list
705834|NCT02995304|Morphine|morphine|mesh-list
705835|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
705836|NCT02995304|Narcotics|narcotics|mesh-ancestor
705837|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
705838|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705839|NCT02995304|Analgesics|analgesics|mesh-ancestor
705840|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
705841|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705842|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
705843|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
705844|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
705845|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
705846|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
705847|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
705848|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
705849|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
705850|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
705851|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
705852|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
705853|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706118|NCT02994082|Bupropion|bupropion|mesh-list
706119|NCT02994082|Nicotine|nicotine|mesh-list
706120|NCT02994082|Varenicline|varenicline|mesh-list
706121|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
706122|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
706123|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706124|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706125|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
706126|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
706127|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
706128|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
706129|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706130|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
706131|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
706132|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
706133|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
706134|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
706135|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
706136|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
706137|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
706138|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
706139|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706405|NCT02992496|Midazolam|midazolam|mesh-list
706406|NCT02992496|Ketamine|ketamine|mesh-list
706407|NCT02992496|Analgesics|analgesics|mesh-ancestor
706408|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
706409|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706410|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706411|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
706412|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
706413|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
706414|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
706415|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
706416|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
706417|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
706418|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
706419|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706420|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
706421|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
706422|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
706423|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
706424|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2089496|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2089497|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
2089498|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2089499|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2089500|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
2089501|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2089502|NCT02199964|Cyclosporine|cyclosporine|mesh-list
2089503|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
2089504|NCT02199964|Cyclosporins|cyclosporins|mesh-list
2089505|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089506|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089507|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2228997|NCT00062270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2228998|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
2228999|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
2229000|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
2229001|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2229002|NCT00062283|Alanosine|alanosine|mesh-list
2229003|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2229004|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229005|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
2229006|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
2229007|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229008|NCT00062296|Rituximab|rituximab|mesh-list
2229009|NCT00062296|Epirubicin|epirubicin|mesh-list
2229010|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2229011|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707651|NCT02987400|Venetoclax|venetoclax|mesh-list
707652|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
707653|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707654|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
707815|NCT02986451|Clarithromycin|clarithromycin|mesh-list
707816|NCT02986451|Dexamethasone|dexamethasone|mesh-list
707817|NCT02986451|Lenalidomide|lenalidomide|mesh-list
707818|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
707819|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
707820|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
707821|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707822|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707823|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
707824|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
707825|NCT02986451|Hormones|hormones|mesh-ancestor
707826|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
707827|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
707828|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707829|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
707830|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
707831|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
707832|NCT02986451|Growth Substances|growth substances|mesh-ancestor
707833|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
707834|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
707835|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
707836|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
707837|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707838|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707839|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
707840|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2089508|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
2089509|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089510|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
2089511|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089512|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
2089513|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089514|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
708396|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
2229012|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
2229013|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229014|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2229015|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2229016|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2229017|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2229018|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229019|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229020|NCT00062322|Irinotecan|irinotecan|mesh-list
2229021|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229022|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2229023|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2229024|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229025|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229026|NCT00062426|Leucovorin|leucovorin|mesh-list
2229027|NCT00062426|Bevacizumab|bevacizumab|mesh-list
2229028|NCT00062426|Fluorouracil|fluorouracil|mesh-list
2229029|NCT00062426|Capecitabine|capecitabine|mesh-list
2229030|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
2229031|NCT00062426|Calcium|calcium|mesh-list
706169|NCT02993575|Floxacillin|floxacillin|mesh-list
706170|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
706171|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
706352|NCT02992808|Menotropins|menotropins|mesh-list
706353|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
706354|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
706355|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
706356|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706566|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
706567|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706568|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
706569|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706570|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229032|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
2229033|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2229034|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229035|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2229036|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2229037|NCT00062426|Growth Substances|growth substances|mesh-ancestor
2229038|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229039|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
708218|NCT02985281|Ribavirin|ribavirin|mesh-list
708219|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
708220|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
708221|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708222|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
708223|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708791|NCT02982148|Methylene Blue|methylene blue|mesh-list
708792|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708793|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709301|NCT02980276|Metformin|metformin|mesh-list
709302|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
709303|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709418|NCT02979405|Phenylephrine|phenylephrine|mesh-list
709419|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
709420|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
709421|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
709422|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
709423|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
709424|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709425|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
709426|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
709427|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
709428|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
709429|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
709430|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
709431|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
709432|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
709433|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
709434|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709435|NCT02979405|Protective Agents|protective agents|mesh-ancestor
709728|NCT02978040|Tirofiban|tirofiban|mesh-list
709729|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
709730|NCT02978040|Cangrelor|cangrelor|mesh-list
709731|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
709732|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2229040|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
705670|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
705671|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705786|NCT02995655|Azacitidine|azacitidine|mesh-list
705787|NCT02995655|Heparin|heparin|mesh-list
705788|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
705789|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
705790|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705791|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705792|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705793|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
705794|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
705795|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
706206|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
706207|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
706208|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
706209|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706210|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
706211|NCT02993341|Coagulants|coagulants|mesh-ancestor
706280|NCT02993094|Carboplatin|carboplatin|mesh-list
706281|NCT02993094|Ixazomib|ixazomib|mesh-list
706282|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706283|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
706284|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706285|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706804|NCT02990702|Bupivacaine|bupivacaine|mesh-list
706805|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
706806|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
706807|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
706808|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706809|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
706810|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229041|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
2229042|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229043|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2229044|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229045|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
2229046|NCT00062426|Antidotes|antidotes|mesh-ancestor
2229047|NCT00062426|Protective Agents|protective agents|mesh-ancestor
2229048|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
2229049|NCT00062426|Vitamins|vitamins|mesh-ancestor
2229050|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
707328|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
707329|NCT02987998|Etoposide|etoposide|mesh-list
707330|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707331|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
707332|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
707333|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
707334|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
707335|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707336|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229051|NCT00062478|Camptothecin|camptothecin|mesh-list
2229052|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2229053|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229054|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2229055|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2229056|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229057|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229058|NCT00062556|Niacin|niacin|mesh-list
2229059|NCT00062556|Lovastatin|lovastatin|mesh-list
2229060|NCT00062556|L 647318|l 647318|mesh-list
2229061|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
2229062|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2229063|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
2229064|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229065|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2229066|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
2229067|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
2229068|NCT00062556|Vitamins|vitamins|mesh-ancestor
2229069|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
2229070|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229071|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2229072|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2229073|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229074|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
2229075|NCT00062595|Vitamin K|vitamin k|mesh-list
2229076|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2229077|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
705672|NCT02996110|Nivolumab|nivolumab|mesh-list
705673|NCT02996110|Ipilimumab|ipilimumab|mesh-list
705674|NCT02996110|Linrodostat|linrodostat|mesh-list
705675|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
705676|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705677|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
705678|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705679|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706034|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
706035|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
706036|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
706037|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
706038|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
706039|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706040|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
706041|NCT02994433|Analgesics|analgesics|mesh-ancestor
706042|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
706043|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706140|NCT02993835|Iron|iron|mesh-list
706141|NCT02993835|Trace Elements|trace elements|mesh-ancestor
706142|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
706143|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706873|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
706874|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
706875|NCT02990507|Testosterone|testosterone|mesh-list
706876|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
706877|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
706878|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
706879|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706880|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
706881|NCT02990507|Hormones|hormones|mesh-ancestor
706882|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
706883|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706884|NCT02990507|Androgens|androgens|mesh-ancestor
2229078|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229079|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
2229080|NCT00062595|Coagulants|coagulants|mesh-ancestor
2229081|NCT00062595|Vitamins|vitamins|mesh-ancestor
2229082|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
2229083|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229084|NCT00062660|Tipranavir|tipranavir|mesh-list
2229085|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2229086|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2229087|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
2229088|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229089|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
707911|NCT02985736|Desoximetasone|desoximetasone|mesh-list
707912|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
707913|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
707914|NCT02985736|Hormones|hormones|mesh-ancestor
707915|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
707916|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229090|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2229091|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2229092|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2229093|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229094|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2229095|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229096|NCT00062673|Analgesics|analgesics|mesh-ancestor
708333|NCT02984345|Caseins|caseins|mesh-list
708334|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
708335|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
708336|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708368|NCT02984176|Simethicone|simethicone|mesh-list
708369|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
708370|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708371|NCT02984176|Emollients|emollients|mesh-ancestor
708372|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
708822|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
708823|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
708824|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708825|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
708826|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708851|NCT02981615|Levofloxacin|levofloxacin|mesh-list
708852|NCT02981615|Ofloxacin|ofloxacin|mesh-list
708853|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
705728|NCT02995772|Tamoxifen|tamoxifen|mesh-list
705729|NCT02995772|Fluorouracil|fluorouracil|mesh-list
705730|NCT02995772|Letrozole|letrozole|mesh-list
705731|NCT02995772|Anastrozole|anastrozole|mesh-list
705732|NCT02995772|Exemestane|exemestane|mesh-list
705733|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
705734|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
705735|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705736|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
705737|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
705738|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
705739|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
705740|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705741|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
705742|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
705743|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
705744|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
705745|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
705746|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
705747|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
705748|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
705749|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
706885|NCT02990468|Cisplatin|cisplatin|mesh-list
706886|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707048|NCT02989584|Gemcitabine|gemcitabine|mesh-list
707049|NCT02989584|Atezolizumab|atezolizumab|mesh-list
707050|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707051|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
707052|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
707053|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707054|NCT02989584|Antiviral Agents|antiviral agents|mesh-ancestor
707055|NCT02989584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
707056|NCT02989584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707057|NCT02989584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
707058|NCT02989584|Immunologic Factors|immunologic factors|mesh-ancestor
707059|NCT02989584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707315|NCT02988297|RNS60|rns60|mesh-list
707316|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
707317|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
707318|NCT02988297|Analgesics|analgesics|mesh-ancestor
707319|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
707320|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707321|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707322|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
707323|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
707324|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
707533|NCT02987920|Acetaminophen|acetaminophen|mesh-list
707534|NCT02987920|Celecoxib|celecoxib|mesh-list
707535|NCT02987920|Ketorolac|ketorolac|mesh-list
707536|NCT02987920|Oxycodone|oxycodone|mesh-list
707537|NCT02987920|Gabapentin|gabapentin|mesh-list
707538|NCT02987920|Hydromorphone|hydromorphone|mesh-list
707539|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
707540|NCT02987920|Pantoprazole|pantoprazole|mesh-list
707541|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
707542|NCT02987920|Analgesics|analgesics|mesh-ancestor
707543|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
707544|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707545|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707546|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
707547|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
707548|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
707549|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
707550|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
707551|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
707552|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707553|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707554|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
707555|NCT02987920|Narcotics|narcotics|mesh-ancestor
707556|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
707557|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
707558|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
707559|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
707560|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
707561|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
707562|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
707563|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
705898|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
705899|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
705900|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
705901|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
705902|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
705903|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
705904|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
705905|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
705906|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
705907|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
705908|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
705909|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
705910|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
705911|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
705912|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
705913|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
705914|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
705915|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
705916|NCT02995083|Hormones|hormones|mesh-ancestor
705917|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
705918|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
705919|NCT02995083|Protective Agents|protective agents|mesh-ancestor
705920|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
705921|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706286|NCT02993198|Carvedilol|carvedilol|mesh-list
706287|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
706288|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
706289|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
706290|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
706291|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706292|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706293|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
706294|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
706295|NCT02993198|Protective Agents|protective agents|mesh-ancestor
706296|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
706297|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
706298|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
706299|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
706300|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
706301|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
706357|NCT02992938|Acetazolamide|acetazolamide|mesh-list
706358|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
706359|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
706360|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706361|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706362|NCT02992938|Diuretics|diuretics|mesh-ancestor
706363|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
706364|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706765|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
706766|NCT02990845|Leuprolide|leuprolide|mesh-list
706767|NCT02990845|Exemestane|exemestane|mesh-list
706768|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
706769|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706770|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
706771|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
706772|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
706773|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706774|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
706775|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
706776|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
706777|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706778|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706779|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
706780|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
706781|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
706830|NCT02990455|Nicotine|nicotine|mesh-list
706831|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
706832|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
706833|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706834|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706835|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
706836|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
706837|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
707157|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
706023|NCT02994485|Simvastatin|simvastatin|mesh-list
706024|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
706025|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
706026|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
706027|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706028|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
706029|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
706030|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229097|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
2229098|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229099|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
2229100|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2229101|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
706698|NCT02990975|Ketamine|ketamine|mesh-list
706699|NCT02990975|Analgesics|analgesics|mesh-ancestor
706700|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
706701|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706702|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706703|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
706704|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
706705|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
706706|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
706707|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
706708|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
706709|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
706710|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
706711|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708161|NCT02985190|Azacitidine|azacitidine|mesh-list
708162|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
708163|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
708164|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708165|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708166|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229102|NCT00062686|Lapatinib|lapatinib|mesh-list
2229103|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229104|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2229105|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229106|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229107|NCT00062699|Calcitriol|calcitriol|mesh-list
2229108|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2229109|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229110|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2229111|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2229112|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229113|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2229114|NCT00062699|Vitamins|vitamins|mesh-ancestor
2229115|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
2229116|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2229117|NCT00062712|Sirolimus|sirolimus|mesh-list
2229118|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
709626|NCT02978313|Cetuximab|cetuximab|mesh-list
709627|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
709628|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709917|NCT02976909|Paclitaxel|paclitaxel|mesh-list
709918|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
709919|NCT02976909|Cisplatin|cisplatin|mesh-list
709920|NCT02976909|Fluorouracil|fluorouracil|mesh-list
709921|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
709922|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709923|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
709924|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
709925|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
709926|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709927|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
710002|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
706032|NCT02994290|Immunologic Factors|immunologic factors|mesh-ancestor
706033|NCT02994290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229119|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2229120|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229121|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2229122|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229123|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
2229124|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229125|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
2229126|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229127|NCT00062790|Dutasteride|dutasteride|mesh-list
2229128|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2229129|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2229130|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229131|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229132|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
2229133|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2229134|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229135|NCT00062803|Heparin|heparin|mesh-list
2229136|NCT00062803|Warfarin|warfarin|mesh-list
2229137|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
2229138|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
2229139|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2229140|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2229141|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229142|NCT00062816|Ribavirin|ribavirin|mesh-list
2229143|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
2229144|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229145|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
2229146|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229147|NCT00062842|Irinotecan|irinotecan|mesh-list
2229148|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2229149|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2229150|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229151|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229152|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229153|NCT00062881|Mafosfamide|mafosfamide|mesh-list
2229154|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2229155|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
2229156|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229157|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229158|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
2229159|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229160|NCT00062946|Fallypride|fallypride|mesh-list
706397|NCT02992912|Atezolizumab|atezolizumab|mesh-list
706398|NCT02992912|Antibodies|antibodies|mesh-list
706399|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
706400|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706401|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706581|NCT02991482|Gemcitabine|gemcitabine|mesh-list
706582|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
706583|NCT02991482|Vinorelbine|vinorelbine|mesh-list
706584|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
706585|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
706586|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706587|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706588|NCT02991482|Antiviral Agents|antiviral agents|mesh-ancestor
706589|NCT02991482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
706590|NCT02991482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706591|NCT02991482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
706592|NCT02991482|Immunologic Factors|immunologic factors|mesh-ancestor
706593|NCT02991482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706594|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
706595|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
706596|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
706597|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
706598|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
707288|NCT02988362|Amlodipine|amlodipine|mesh-list
707289|NCT02988362|Candesartan|candesartan|mesh-list
707290|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
707291|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
707292|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
707293|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707294|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
707295|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229161|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2229162|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2229163|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
2229164|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2229165|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229166|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229167|NCT00062972|Donepezil|donepezil|mesh-list
2229168|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2229169|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229170|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229171|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
2229172|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2229173|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229174|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
2229175|NCT00063011|Calcium|calcium|mesh-list
2229176|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
706200|NCT02993588|Melatonin|melatonin|mesh-list
706201|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
706202|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706203|NCT02993588|Protective Agents|protective agents|mesh-ancestor
706204|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706205|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
706402|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
706403|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
706404|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
706712|NCT02991053|Ketamine|ketamine|mesh-list
706713|NCT02991053|Analgesics|analgesics|mesh-ancestor
706714|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
706715|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706716|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706717|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
706718|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
706719|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
706720|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
706721|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
706722|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
706723|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
706724|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
706725|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706901|NCT02990312|Sirolimus|sirolimus|mesh-list
706902|NCT02990312|Maraviroc|maraviroc|mesh-list
706903|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
706904|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
706905|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
706906|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706907|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
706908|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
706909|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
706910|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706911|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
706912|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
706913|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706914|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
706915|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
706916|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
706917|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
706969|NCT02989870|Sorafenib|sorafenib|mesh-list
706970|NCT02989870|Bavituximab|bavituximab|mesh-list
706971|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706972|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
706973|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706974|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706975|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2089515|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2089516|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2089517|NCT02200445|Aldesleukin|aldesleukin|mesh-list
2089518|NCT02200445|Interleukin-2|interleukin-2|mesh-list
2089519|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089520|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2089521|NCT02200445|Analgesics|analgesics|mesh-ancestor
2089522|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
2089523|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089524|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707744|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
706066|NCT02994173|Analgesics|analgesics|mesh-ancestor
706067|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
706068|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706069|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706070|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
706071|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
706072|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
706073|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
706074|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
706075|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
706076|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
706077|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
706078|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706079|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
706080|NCT02994173|Narcotics|narcotics|mesh-ancestor
706081|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
706082|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2229177|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229178|NCT00063024|Calcium|calcium|mesh-list
2229179|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2229180|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229181|NCT00063076|Bexarotene|bexarotene|mesh-list
2229182|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229183|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
706180|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
706181|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
706182|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
706183|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706184|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
706185|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706186|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
706187|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708202|NCT02985203|Vinorelbine|vinorelbine|mesh-list
708203|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
708204|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708205|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
708206|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
708207|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
708208|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708270|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
708271|NCT02984865|Sufentanil|sufentanil|mesh-list
708272|NCT02984865|Nalbuphine|nalbuphine|mesh-list
708273|NCT02984865|Dsuvia|dsuvia|mesh-list
708274|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
708275|NCT02984865|Narcotics|narcotics|mesh-ancestor
708276|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708277|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708278|NCT02984865|Analgesics|analgesics|mesh-ancestor
708279|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
708280|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708281|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
708282|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
708283|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
708284|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
708285|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
708286|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
708287|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
708288|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
708289|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
708290|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708291|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708848|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
708849|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
708850|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709661|NCT02978495|Paclitaxel|paclitaxel|mesh-list
709662|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
709663|NCT02978495|Carboplatin|carboplatin|mesh-list
709664|NCT02978495|Doxorubicin|doxorubicin|mesh-list
709665|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
709666|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709667|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
709668|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
709669|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
709670|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709671|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
706199|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089525|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2089526|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
706435|NCT02992665|Ionophores|ionophores|mesh-list
706436|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
706437|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706918|NCT02990546|Midodrine|midodrine|mesh-list
706919|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
706920|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
706921|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706922|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706923|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
706924|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
706925|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
706926|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
706927|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
706928|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
706929|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706976|NCT02989662|Mifepristone|mifepristone|mesh-list
706977|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
706978|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
706979|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
706980|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706981|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
706982|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
706983|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
706984|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
706985|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
706986|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
706987|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
706988|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
706989|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
706990|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
706991|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
707299|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
707300|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
707301|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
707302|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
707303|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707304|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
707305|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707306|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
707307|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
707932|NCT02985983|Brodalumab|brodalumab|mesh-list
707933|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
708209|NCT02985242|Empagliflozin|empagliflozin|mesh-list
708210|NCT02985242|Glimepiride|glimepiride|mesh-list
708211|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
708212|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708213|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
708214|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708215|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
708216|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
708217|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
708360|NCT02984293|Atorvastatin|atorvastatin|mesh-list
708361|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
708362|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
708363|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
708364|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708365|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
708366|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
708367|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708441|NCT02983591|Misoprostol|misoprostol|mesh-list
708442|NCT02983591|Oxytocin|oxytocin|mesh-list
708443|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
708444|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
708445|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708446|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
708447|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
706217|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706218|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706650|NCT02991157|Nimodipine|nimodipine|mesh-list
706651|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
706652|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
706653|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
706654|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706655|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
706656|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706657|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
2229184|NCT00063089|Antibodies|antibodies|mesh-list
2229185|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
2229186|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2229187|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2229188|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
2229189|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229190|NCT00063128|Insulin|insulin|mesh-list
707095|NCT02989519|Progesterone|progesterone|mesh-list
707096|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
707097|NCT02989519|Progestins|progestins|mesh-ancestor
707098|NCT02989519|Hormones|hormones|mesh-ancestor
707099|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
707100|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707196|NCT02988999|Erythritol|erythritol|mesh-list
707197|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
2229191|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2229192|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2229193|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229194|NCT00063141|Irinotecan|irinotecan|mesh-list
2229195|NCT00063141|Cetuximab|cetuximab|mesh-list
2229196|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2229197|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2229198|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229199|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229200|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229201|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2229202|NCT00063193|Minocycline|minocycline|mesh-list
2229203|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2229204|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229205|NCT00063310|Leuprolide|leuprolide|mesh-list
2229206|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2229207|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
2229208|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2229209|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229210|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2229211|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229212|NCT00063323|Bupropion|bupropion|mesh-list
2229213|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2229214|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
2229215|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2229216|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2229217|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2229218|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
708065|NCT02985593|KHK4083|khk4083|mesh-list
708066|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
2229219|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229220|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
2229221|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2229222|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229223|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2229224|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2229225|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229226|NCT00063388|Cetuximab|cetuximab|mesh-list
2229227|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2229228|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229229|NCT00063401|Paclitaxel|paclitaxel|mesh-list
2229230|NCT00063401|Carboplatin|carboplatin|mesh-list
2229231|NCT00063401|Cetuximab|cetuximab|mesh-list
709149|NCT02980757|Gliclazide|gliclazide|mesh-list
709150|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
709151|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709232|NCT02980250|Domperidone|domperidone|mesh-list
709233|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
709234|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
709235|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
709236|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709237|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2229232|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2229233|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706840|NCT02990403|Aspirin|aspirin|mesh-list
706841|NCT02990403|Prednisone|prednisone|mesh-list
706842|NCT02990403|Heparin|heparin|mesh-list
706843|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
706844|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
706845|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
706846|NCT02990403|Antibodies|antibodies|mesh-list
706847|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
706848|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
706849|NCT02990403|Hormones|hormones|mesh-ancestor
706850|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
706851|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706852|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
706853|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706854|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
706855|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
706856|NCT02990403|Analgesics|analgesics|mesh-ancestor
706857|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
706858|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706859|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
706860|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
706861|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
706862|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706863|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
706864|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
706865|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706866|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
706867|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
706868|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
706869|NCT02990403|Progestins|progestins|mesh-ancestor
706962|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
706963|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706964|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
706965|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
706966|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
706967|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706968|NCT02990078|Urological Agents|urological agents|mesh-ancestor
2089527|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
2089528|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089529|NCT02201108|Teriflunomide|teriflunomide|mesh-list
2229234|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
708042|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
708043|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
708044|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
708045|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
708046|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708047|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
708048|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
708049|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
708170|NCT02985177|Ibuprofen|ibuprofen|mesh-list
708171|NCT02985177|Fentanyl|fentanyl|mesh-list
708172|NCT02985177|Hydromorphone|hydromorphone|mesh-list
708173|NCT02985177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
708174|NCT02985177|Narcotics|narcotics|mesh-ancestor
708175|NCT02985177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708176|NCT02985177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708177|NCT02985177|Analgesics|analgesics|mesh-ancestor
708178|NCT02985177|Sensory System Agents|sensory system agents|mesh-ancestor
708179|NCT02985177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708180|NCT02985177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
708181|NCT02985177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
708182|NCT02985177|Anesthetics, General|anesthetics, general|mesh-ancestor
708183|NCT02985177|Anesthetics|anesthetics|mesh-ancestor
708184|NCT02985177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
708185|NCT02985177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
708186|NCT02985177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
708187|NCT02985177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
708188|NCT02985177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
708189|NCT02985177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708190|NCT02985177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229235|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
2229236|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
2229237|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708395|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
706375|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
706741|NCT02990728|Metformin|metformin|mesh-list
706742|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
706743|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229238|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2229239|NCT00063414|Alicaforsen|alicaforsen|mesh-list
2229240|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2229241|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229242|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
2229243|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229244|NCT00063453|Vitamins|vitamins|mesh-list
2229245|NCT00063453|Vitamin E|vitamin e|mesh-list
2229246|NCT00063453|Tocopherols|tocopherols|mesh-list
2229247|NCT00063453|Tocotrienols|tocotrienols|mesh-list
2229248|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
2229249|NCT00063453|Selenium|selenium|mesh-list
707203|NCT02989012|Oseltamivir|oseltamivir|mesh-list
707204|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
707205|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
707206|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707207|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708342|NCT02984475|Metformin|metformin|mesh-list
708343|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
708344|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708403|NCT02984072|Menthol|menthol|mesh-list
708404|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
708405|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
708474|NCT02983734|Cycloserine|cycloserine|mesh-list
708475|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
708476|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708477|NCT02983734|Renal Agents|renal agents|mesh-ancestor
708478|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
708479|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
708480|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
708481|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
708482|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708632|NCT02982798|Metformin|metformin|mesh-list
708633|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
708634|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
708635|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708636|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
708637|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
708638|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
708639|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708640|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
708641|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
708642|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708811|NCT02982005|Brodalumab|brodalumab|mesh-list
708812|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
2229250|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
2229251|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229252|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
2229253|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229254|NCT00063453|Protective Agents|protective agents|mesh-ancestor
2229255|NCT00063453|Trace Elements|trace elements|mesh-ancestor
2229256|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
2229257|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2229258|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229259|NCT00063583|Pirfenidone|pirfenidone|mesh-list
2229260|NCT00063583|Analgesics|analgesics|mesh-ancestor
2229261|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
709459|NCT02979392|Paclitaxel|paclitaxel|mesh-list
709460|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
709461|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709462|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
709463|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
709464|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
709465|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709619|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
709620|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
709621|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
709622|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
709623|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
709624|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
709625|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710001|NCT02976337|Naloxone|naloxone|mesh-list
2229262|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706425|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
706426|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
706617|NCT02991456|Ondansetron|ondansetron|mesh-list
706618|NCT02991456|Rolapitant|rolapitant|mesh-list
706619|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
706620|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
706621|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706622|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706623|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
706624|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
706625|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
706626|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
706627|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
706628|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
706629|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706630|NCT02991456|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
706631|NCT02991456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
706632|NCT02991456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
706633|NCT02991456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
706634|NCT02991456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
706635|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2229263|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229264|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2229265|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2229266|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2229267|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2229268|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229269|NCT00063596|Vitamin A|vitamin a|mesh-list
2229270|NCT00063596|Vitamins|vitamins|mesh-ancestor
2229271|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
2229272|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229273|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
2229274|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2089530|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2089531|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2089532|NCT02201108|Analgesics|analgesics|mesh-ancestor
2089533|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
2089534|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089535|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089536|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2089537|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089538|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2089539|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
2089540|NCT02201212|Everolimus|everolimus|mesh-list
2089541|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089542|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2089543|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
2089544|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089545|NCT02201251|Topiramate|topiramate|mesh-list
2089546|NCT02201251|Levetiracetam|levetiracetam|mesh-list
2089547|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
2229275|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229276|NCT00063687|Oxypurinol|oxypurinol|mesh-list
2229277|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229278|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229279|NCT00063713|Bortezomib|bortezomib|mesh-list
2229280|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229281|NCT00063726|Bortezomib|bortezomib|mesh-list
2229282|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229283|NCT00063791|Bortezomib|bortezomib|mesh-list
2229284|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229285|NCT00063804|Ritonavir|ritonavir|mesh-list
2229286|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2229287|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2229288|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
2229289|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229290|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229291|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2229292|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2229293|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
2229294|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229295|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2229296|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2229297|NCT00063830|Alicaforsen|alicaforsen|mesh-list
2229298|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2229299|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229300|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
706473|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2089548|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2089549|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089550|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
2089551|NCT02201329|Azacitidine|azacitidine|mesh-list
2089552|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
706782|NCT02990858|Leronlimab|leronlimab|mesh-list
706783|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
706784|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
706785|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706786|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
706787|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
706788|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
706789|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
707101|NCT02989623|Copper|copper|mesh-list
707102|NCT02989623|Trace Elements|trace elements|mesh-ancestor
707103|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
707104|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707188|NCT02989207|Mitomycins|mitomycins|mesh-list
707189|NCT02989207|Mitomycin|mitomycin|mesh-list
707190|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
707191|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707192|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
707193|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707194|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
707195|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708191|NCT02985255|Docetaxel|docetaxel|mesh-list
708192|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708193|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
708194|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
708195|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
708196|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709776|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
709777|NCT02977611|Hematinics|hematinics|mesh-ancestor
710103|NCT02975882|Sirolimus|sirolimus|mesh-list
710104|NCT02975882|Irinotecan|irinotecan|mesh-list
710105|NCT02975882|Camptothecin|camptothecin|mesh-list
710106|NCT02975882|Temozolomide|temozolomide|mesh-list
710107|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
710108|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
710109|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710110|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710111|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710112|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
710113|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
710114|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
710115|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
710116|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
710117|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
710118|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
710119|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
710120|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710121|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
710246|NCT02975271|Serlopitant|serlopitant|mesh-list
710247|NCT02975271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
710248|NCT02975271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
706491|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
706492|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
706493|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
706494|NCT02992457|Ledipasvir|ledipasvir|mesh-list
706495|NCT02992457|Simeprevir|simeprevir|mesh-list
706496|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
706497|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706498|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
706499|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
706500|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
706501|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706502|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
706503|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706504|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
706505|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706517|NCT02991950|Parnaparin|parnaparin|mesh-list
706518|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
706519|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
706520|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
706521|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706645|NCT02991209|Testosterone|testosterone|mesh-list
706646|NCT02991209|Androgens|androgens|mesh-ancestor
706647|NCT02991209|Hormones|hormones|mesh-ancestor
706648|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
706649|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707273|NCT02988908|Donepezil|donepezil|mesh-list
707274|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
707275|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707276|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707277|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
707278|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
707279|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707280|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
707386|NCT02987946|Nadroparin|nadroparin|mesh-list
707387|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
707388|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
707389|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
707390|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707717|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
707718|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
707719|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707917|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
707918|NCT02985905|Astringents|astringents|mesh-ancestor
707919|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707920|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
708308|NCT02984696|Estradiol|estradiol|mesh-list
708309|NCT02984696|Estrogens|estrogens|mesh-ancestor
708310|NCT02984696|Hormones|hormones|mesh-ancestor
708311|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
708312|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708373|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
708374|NCT02984111|Hematinics|hematinics|mesh-ancestor
2229301|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229302|NCT00063869|Etanercept|etanercept|mesh-list
2229303|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2229304|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2229305|NCT00063869|Analgesics|analgesics|mesh-ancestor
2229306|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
2229307|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229308|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229309|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2229310|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
708827|NCT02981979|Prednisone|prednisone|mesh-list
708828|NCT02981979|Leflunomide|leflunomide|mesh-list
708829|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
708830|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
708831|NCT02981979|Hormones|hormones|mesh-ancestor
708832|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
708833|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708834|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
708835|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708836|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708837|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708838|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
708839|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
708970|NCT02981173|Psilocybin|psilocybin|mesh-list
708971|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
2089553|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
2089554|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089555|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089556|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089557|NCT02201394|Aspirin|aspirin|mesh-list
2089558|NCT02201394|Ticagrelor|ticagrelor|mesh-list
2089559|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2089560|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2089561|NCT02201394|Analgesics|analgesics|mesh-ancestor
2229311|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2229312|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229313|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
2229314|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2229315|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229316|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2229317|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229318|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229319|NCT00063947|Gemcitabine|gemcitabine|mesh-list
2229320|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2229321|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
707755|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
707756|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
707757|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
707758|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
707759|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
707760|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707761|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
707762|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
707763|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707764|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
707765|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707862|NCT02986321|Budesonide|budesonide|mesh-list
707863|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
707864|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
707865|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
707866|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707867|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707868|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
707869|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
707870|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
707871|NCT02986321|Hormones|hormones|mesh-ancestor
707872|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
707921|NCT02985658|Cisplatin|cisplatin|mesh-list
707922|NCT02985658|Vinorelbine|vinorelbine|mesh-list
707923|NCT02985658|Veliparib|veliparib|mesh-list
707924|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707925|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
707926|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
707927|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
707928|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
707929|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707930|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
707931|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708345|NCT02984397|Ketotifen|ketotifen|mesh-list
708346|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
708347|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
708348|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
708349|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
708350|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
708351|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
708352|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708353|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708354|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
708420|NCT02983682|Lidocaine|lidocaine|mesh-list
708421|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
708422|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
708423|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708424|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708425|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
708426|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708427|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
708428|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
706838|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
706839|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229322|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
2229323|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229324|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229325|NCT00063947|Antiviral Agents|antiviral agents|mesh-ancestor
2229326|NCT00063947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229327|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229328|NCT00063947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229329|NCT00063947|Immunologic Factors|immunologic factors|mesh-ancestor
2229330|NCT00063947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707308|NCT02988440|Sorafenib|sorafenib|mesh-list
707309|NCT02988440|Spartalizumab|spartalizumab|mesh-list
707310|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707311|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
707312|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707313|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707314|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
707690|NCT02987244|Prednisone|prednisone|mesh-list
707691|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
707692|NCT02987244|Etoposide|etoposide|mesh-list
707693|NCT02987244|Epirubicin|epirubicin|mesh-list
707694|NCT02987244|Vindesine|vindesine|mesh-list
707695|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
707696|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
707697|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707698|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
707699|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
707700|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
707701|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707702|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707703|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
707704|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
707705|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
707706|NCT02987244|Hormones|hormones|mesh-ancestor
707707|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
707708|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
707709|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
707710|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
707711|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
707712|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707713|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
707714|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
707715|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
707716|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
708412|NCT02983799|Olaparib|olaparib|mesh-list
708413|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
708414|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708415|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708416|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708980|NCT02981095|Bupivacaine|bupivacaine|mesh-list
708981|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
708982|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
708983|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708984|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708985|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
708986|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229331|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2229332|NCT00063960|Irinotecan|irinotecan|mesh-list
2229333|NCT00063960|Floxuridine|floxuridine|mesh-list
2229334|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2229335|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2229336|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229337|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229338|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229339|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2229340|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
2229341|NCT00064012|Docetaxel|docetaxel|mesh-list
2229342|NCT00064012|Bortezomib|bortezomib|mesh-list
709289|NCT02980094|Vitamins|vitamins|mesh-list
709290|NCT02980094|Vitamin E|vitamin e|mesh-list
709291|NCT02980094|Tocopherols|tocopherols|mesh-list
709292|NCT02980094|Tocotrienols|tocotrienols|mesh-list
709293|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
709294|NCT02980094|Selenium|selenium|mesh-list
709295|NCT02980094|Antioxidants|antioxidants|mesh-list
2229343|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706893|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
706894|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
706895|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
706896|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
706897|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
706898|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
706899|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
706900|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2229344|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
2229345|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
2229346|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
2229347|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229348|NCT00064051|Gemcitabine|gemcitabine|mesh-list
2229349|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2229350|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
707749|NCT02986906|Triamcinolone|triamcinolone|mesh-list
707750|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
707751|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
707752|NCT02986906|Hormones|hormones|mesh-ancestor
707753|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
707754|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707766|NCT02986347|Epinephrine|epinephrine|mesh-list
707767|NCT02986347|Racepinephrine|racepinephrine|mesh-list
707768|NCT02986347|Anesthetics|anesthetics|mesh-list
707769|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
707770|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
707771|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707772|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
707773|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
707774|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
707775|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
707776|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707777|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
707778|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
707779|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
707780|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707781|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
707782|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
707783|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
707784|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
707785|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2229351|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229352|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229353|NCT00064051|Antiviral Agents|antiviral agents|mesh-ancestor
2229354|NCT00064051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229355|NCT00064051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229356|NCT00064051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229357|NCT00064051|Immunologic Factors|immunologic factors|mesh-ancestor
2229358|NCT00064051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229359|NCT00064064|Gemcitabine|gemcitabine|mesh-list
2229360|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2229361|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
2229362|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708557|NCT02983084|Copper|copper|mesh-list
708558|NCT02983084|Nickel|nickel|mesh-list
708559|NCT02983084|Trace Elements|trace elements|mesh-ancestor
708560|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
708561|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2752972|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
2752973|NCT03199053|Saxagliptin|saxagliptin|mesh-list
2752974|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2752975|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752976|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2229363|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229364|NCT00064064|Antiviral Agents|antiviral agents|mesh-ancestor
709907|NCT02977052|Nivolumab|nivolumab|mesh-list
709908|NCT02977052|Ipilimumab|ipilimumab|mesh-list
709909|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
709910|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709911|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
709928|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
706933|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
706934|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
706935|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
706936|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
706937|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
706938|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
706939|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
706940|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
706941|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
706942|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
706943|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229365|NCT00064064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229366|NCT00064064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229367|NCT00064064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229368|NCT00064064|Immunologic Factors|immunologic factors|mesh-ancestor
2229369|NCT00064064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229370|NCT00064090|Cytarabine|cytarabine|mesh-list
2229371|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2229372|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
2229373|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229374|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229375|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
2229376|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708159|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
708160|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
708305|NCT02984722|Metformin|metformin|mesh-list
708306|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
708307|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708875|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
708876|NCT02981446|Latanoprost|latanoprost|mesh-list
708877|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
708967|NCT02981121|Metformin|metformin|mesh-list
708968|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
708969|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709013|NCT02980809|Topotecan|topotecan|mesh-list
709014|NCT02980809|Apatinib|apatinib|mesh-list
709015|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
709016|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
709017|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709018|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709019|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709020|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
709561|NCT02978716|Gemcitabine|gemcitabine|mesh-list
709562|NCT02978716|Carboplatin|carboplatin|mesh-list
709563|NCT02978716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709564|NCT02978716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
709565|NCT02978716|Antimetabolites|antimetabolites|mesh-ancestor
709566|NCT02978716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709567|NCT02978716|Antiviral Agents|antiviral agents|mesh-ancestor
709568|NCT02978716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
709569|NCT02978716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709570|NCT02978716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
709571|NCT02978716|Immunologic Factors|immunologic factors|mesh-ancestor
709572|NCT02978716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709750|NCT02977741|Olanzapine|olanzapine|mesh-list
709751|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
709752|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
709753|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
709754|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709755|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
709756|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
709757|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
709758|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
709759|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
709760|NCT02977741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
709761|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
709762|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
709763|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709764|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
709765|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
709870|NCT02977000|Propranolol|propranolol|mesh-list
709871|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
709872|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
709873|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
2229377|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229378|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
707001|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
707002|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
707003|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
707004|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
707623|NCT02987465|Norepinephrine|norepinephrine|mesh-list
707624|NCT02987465|Acetylcholine|acetylcholine|mesh-list
707625|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
707626|NCT02987465|Hematinics|hematinics|mesh-ancestor
707627|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
707628|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
707629|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
707630|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
707631|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707632|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707633|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
707634|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
707635|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707636|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
707637|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
707638|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
707639|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
707844|NCT02986594|Aspirin|aspirin|mesh-list
707845|NCT02986594|Heparin|heparin|mesh-list
707846|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
707847|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
707848|NCT02986594|Analgesics|analgesics|mesh-ancestor
707849|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
707850|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707851|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707852|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
707853|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
707854|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
707855|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
707856|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707857|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
707858|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
707859|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707860|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
707861|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
707934|NCT02985866|Pancrelipase|pancrelipase|mesh-list
707935|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
708507|NCT02983214|Cilostazol|cilostazol|mesh-list
708508|NCT02983214|Clopidogrel|clopidogrel|mesh-list
708509|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
708510|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
708511|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
708512|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
708513|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
708514|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
708515|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708516|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708517|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
708518|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
708519|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708520|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
708521|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
708522|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
708523|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
708524|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
708525|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
708526|NCT02983214|Protective Agents|protective agents|mesh-ancestor
708527|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
708528|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
708529|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229379|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229380|NCT00064116|Rituximab|rituximab|mesh-list
2229381|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2229382|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229383|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
2229384|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089562|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
2089563|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089564|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089565|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2089566|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089567|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
707125|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707661|NCT02987218|Propofol|propofol|mesh-list
707662|NCT02987218|Desflurane|desflurane|mesh-list
707663|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
707664|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
707665|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707666|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
707667|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
707668|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
707669|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2229385|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2229386|NCT00064129|Ipilimumab|ipilimumab|mesh-list
2229387|NCT00064129|Sargramostim|sargramostim|mesh-list
2229388|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2229389|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229390|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2229391|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229392|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
2229393|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229394|NCT00064142|Halofuginone|halofuginone|mesh-list
708258|NCT02985086|Cefoxitin|cefoxitin|mesh-list
708259|NCT02985086|Misoprostol|misoprostol|mesh-list
708260|NCT02985086|Oxytocin|oxytocin|mesh-list
708261|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
708262|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
708263|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708264|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
708265|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
708266|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
708267|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
708268|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
708269|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708840|NCT02981836|Vaccines|vaccines|mesh-list
708841|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
708842|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709045|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
709046|NCT02980965|Docetaxel|docetaxel|mesh-list
709047|NCT02980965|Fluorouracil|fluorouracil|mesh-list
709048|NCT02980965|Letrozole|letrozole|mesh-list
709049|NCT02980965|Epirubicin|epirubicin|mesh-list
709050|NCT02980965|Leuprolide|leuprolide|mesh-list
709051|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
709052|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
709053|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709054|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
709055|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
709056|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
709057|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709058|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709059|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
709060|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
709061|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
709062|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
709063|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
709064|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
709065|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
709066|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
709067|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709068|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
709069|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
709070|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
709071|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
709072|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
709073|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
709074|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
709075|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
709076|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
709077|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2229395|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229396|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
2229397|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
709588|NCT02978547|Metformin|metformin|mesh-list
709589|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
709590|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709816|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
2229398|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2229399|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
707158|NCT02989272|Analgesics|analgesics|mesh-ancestor
707159|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
707160|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707161|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707162|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
707163|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
707164|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
707165|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
707166|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
707167|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
707168|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707169|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
707170|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
707171|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2229400|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2229401|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229402|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708483|NCT02983773|Dronabinol|dronabinol|mesh-list
708484|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
708485|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708486|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
708487|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
708488|NCT02983773|Analgesics|analgesics|mesh-ancestor
708489|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
708490|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708491|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
708492|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
708493|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
708494|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708495|NCT02983773|Hormones|hormones|mesh-ancestor
708496|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
708684|NCT02982850|Aspirin|aspirin|mesh-list
708685|NCT02982850|Warfarin|warfarin|mesh-list
708686|NCT02982850|Dabigatran|dabigatran|mesh-list
708687|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
708688|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
708689|NCT02982850|Analgesics|analgesics|mesh-ancestor
708690|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
708691|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708692|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708693|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
708694|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
708695|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
708696|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
708697|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708698|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
708699|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
708700|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708701|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
708702|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
708703|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
708704|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
708705|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
708940|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
708941|NCT02981212|Prednisolone|prednisolone|mesh-list
708942|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
708943|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
708944|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708945|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
708946|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
708947|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
708948|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708949|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708950|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708951|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
708952|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
708953|NCT02981212|Hormones|hormones|mesh-ancestor
708954|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
708955|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708956|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
708957|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
709184|NCT02980510|Leucovorin|leucovorin|mesh-list
709185|NCT02980510|Folic Acid|folic acid|mesh-list
709186|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
707296|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
707297|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
707298|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
707720|NCT02987348|Insulin|insulin|mesh-list
707721|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
707722|NCT02987348|Exenatide|exenatide|mesh-list
707723|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
707724|NCT02987348|Glucagon|glucagon|mesh-list
707725|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
707726|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
707727|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707728|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
707729|NCT02987348|Incretins|incretins|mesh-ancestor
707730|NCT02987348|Hormones|hormones|mesh-ancestor
707731|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
707732|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
708167|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
708168|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
708169|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229403|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2229404|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2229405|NCT00064142|Growth Substances|growth substances|mesh-ancestor
2229406|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229407|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
2229408|NCT00064181|Leucovorin|leucovorin|mesh-list
2229409|NCT00064181|Celecoxib|celecoxib|mesh-list
2229410|NCT00064181|Fluorouracil|fluorouracil|mesh-list
2229411|NCT00064181|Capecitabine|capecitabine|mesh-list
2229412|NCT00064181|Irinotecan|irinotecan|mesh-list
2229413|NCT00064181|Calcium|calcium|mesh-list
2229414|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
2229415|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
708458|NCT02983630|Penicillins|penicillins|mesh-list
708459|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
708460|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089568|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2089569|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089570|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2089571|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2089572|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089573|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
708904|NCT02981329|Metformin|metformin|mesh-list
708914|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
708915|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709098|NCT02980835|Dexamethasone|dexamethasone|mesh-list
709099|NCT02980835|Epinephrine|epinephrine|mesh-list
709100|NCT02980835|Ropivacaine|ropivacaine|mesh-list
709101|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
709102|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
709103|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
709104|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
709105|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709106|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
709107|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
709108|NCT02980835|Hormones|hormones|mesh-ancestor
709109|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
709110|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
709111|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709112|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
709113|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
709114|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
709115|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
709116|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
709117|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
709118|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
709119|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
709120|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709121|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
709122|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
709123|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
709124|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
709125|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
709126|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
709127|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2229416|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229417|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
2229418|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707338|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
707339|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
707579|NCT02987699|Leucovorin|leucovorin|mesh-list
707580|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
707581|NCT02987699|Fluorouracil|fluorouracil|mesh-list
707582|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
707583|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707584|NCT02987699|Antidotes|antidotes|mesh-ancestor
707585|NCT02987699|Protective Agents|protective agents|mesh-ancestor
707586|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707587|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
707588|NCT02987699|Vitamins|vitamins|mesh-ancestor
707589|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
707590|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
707591|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707592|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
707593|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
707594|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
2089574|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2089575|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2089576|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2089577|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
2089578|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089579|NCT02201524|Abrocitinib|abrocitinib|mesh-list
2089580|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2089581|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089582|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089583|NCT02201771|Aspirin|aspirin|mesh-list
2089584|NCT02201771|Ticagrelor|ticagrelor|mesh-list
2089585|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2089586|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2089587|NCT02201771|Analgesics|analgesics|mesh-ancestor
2089588|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
2089589|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089590|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089591|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2089592|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2229419|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
708843|NCT02981784|Ponatinib|ponatinib|mesh-list
708844|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708845|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
708846|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708847|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229420|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229421|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229422|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
2229423|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2229424|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2229425|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229426|NCT00064181|Antidotes|antidotes|mesh-ancestor
2229427|NCT00064181|Protective Agents|protective agents|mesh-ancestor
2229428|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
2229429|NCT00064181|Vitamins|vitamins|mesh-ancestor
2229430|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
2229431|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
708974|NCT02980991|Pemetrexed|pemetrexed|mesh-list
708975|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708976|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708977|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708978|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
708979|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
709603|NCT02978391|Epinephrine|epinephrine|mesh-list
709604|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
709605|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
709606|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
709607|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
709608|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709609|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709610|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
709611|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
709612|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
709613|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
709614|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
709615|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
709616|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
709617|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
707355|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707356|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707357|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
707358|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
707359|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
707360|NCT02988089|Renal Agents|renal agents|mesh-ancestor
707361|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
707362|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
707363|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707364|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
707365|NCT02988089|Antacids|antacids|mesh-ancestor
707366|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
707367|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
707368|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
707369|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
707370|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
708087|NCT02985229|Misoprostol|misoprostol|mesh-list
708088|NCT02985229|Mifepristone|mifepristone|mesh-list
708089|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
708090|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
708091|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
708092|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708093|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
708094|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
708095|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
708096|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
708097|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
708098|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
708099|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
708100|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
708101|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
708102|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
708103|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
708104|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
708105|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
708106|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
708107|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
708313|NCT02984852|Tenofovir|tenofovir|mesh-list
708314|NCT02984852|Emtricitabine|emtricitabine|mesh-list
708315|NCT02984852|Darunavir|darunavir|mesh-list
708316|NCT02984852|Cobicistat|cobicistat|mesh-list
708317|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
708318|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708319|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
708320|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
708321|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708322|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708323|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
708324|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
708325|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
708326|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
708327|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
708328|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
708329|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
708375|NCT02984384|Aspirin|aspirin|mesh-list
708376|NCT02984384|Heparin|heparin|mesh-list
708377|NCT02984384|Enoxaparin|enoxaparin|mesh-list
708378|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
708379|NCT02984384|Tinzaparin|tinzaparin|mesh-list
708380|NCT02984384|Dalteparin|dalteparin|mesh-list
708381|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
708382|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
708383|NCT02984384|Analgesics|analgesics|mesh-ancestor
708384|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
708385|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708386|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708387|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
708388|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
708389|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
708390|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
708391|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708392|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
708393|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
708394|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707393|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
707394|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
707395|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707396|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707397|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
707398|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
707399|NCT02987907|Hormones|hormones|mesh-ancestor
707400|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
707401|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
707402|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707655|NCT02987270|Piperaquine|piperaquine|mesh-list
707656|NCT02987270|Artenimol|artenimol|mesh-list
707657|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
707658|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
707659|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
707660|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
707873|NCT02986334|Naproxen|naproxen|mesh-list
707874|NCT02986334|Omeprazole|omeprazole|mesh-list
707875|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
707876|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
707877|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
707878|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707879|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707880|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
707881|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
707882|NCT02986334|Analgesics|analgesics|mesh-ancestor
707883|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
707884|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707885|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707886|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
707887|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
707888|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
707889|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
708134|NCT02985333|Dexamethasone|dexamethasone|mesh-list
708135|NCT02985333|Paclitaxel|paclitaxel|mesh-list
708136|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
708137|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
708138|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708139|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
708140|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
708141|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
708142|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708143|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
708144|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
708145|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708146|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
708147|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
708148|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
708149|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
708150|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
708151|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
708152|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
708153|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708154|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
708155|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
708156|NCT02985333|Hormones|hormones|mesh-ancestor
708157|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
708158|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
708732|NCT02982889|Bupivacaine|bupivacaine|mesh-list
708733|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
708734|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
708735|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
708736|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708737|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708738|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
708739|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708740|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
708741|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
2229432|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2229433|NCT00064181|Analgesics|analgesics|mesh-ancestor
2229434|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
2229435|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229436|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2229437|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2229438|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2229439|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2229440|NCT00064194|Vitamin E|vitamin e|mesh-list
2229441|NCT00064194|Selenium|selenium|mesh-list
2229442|NCT00064194|Vitamins|vitamins|mesh-ancestor
2229443|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
707615|NCT02987556|Insulin|insulin|mesh-list
707616|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
707617|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707812|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
707813|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
707814|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708197|NCT02985554|Nivolumab|nivolumab|mesh-list
708198|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
708199|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708200|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
708201|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708430|NCT02983747|Loxoprofen|loxoprofen|mesh-list
708431|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
708432|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
708433|NCT02983747|Analgesics|analgesics|mesh-ancestor
708434|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
708435|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708436|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708437|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
708438|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
708565|NCT02983422|Aminophylline|aminophylline|mesh-list
708566|NCT02983422|Furosemide|furosemide|mesh-list
708567|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
708568|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
708569|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708570|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708571|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
708572|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
708573|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
708574|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
708575|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708576|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708577|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
708578|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
708579|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
708580|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
708581|NCT02983422|Protective Agents|protective agents|mesh-ancestor
708582|NCT02983422|Diuretics|diuretics|mesh-ancestor
708583|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
708584|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
708585|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2229444|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229445|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
2229446|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229447|NCT00064194|Protective Agents|protective agents|mesh-ancestor
2229448|NCT00064194|Trace Elements|trace elements|mesh-ancestor
2229449|NCT00064207|Gemcitabine|gemcitabine|mesh-list
2229450|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2229451|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
708916|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
708917|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
708918|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709175|NCT02980497|Ethanol|ethanol|mesh-list
709176|NCT02980497|Listerine|listerine|mesh-list
709177|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
709178|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
709179|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
709180|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
709181|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709182|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
709183|NCT02980497|Protective Agents|protective agents|mesh-ancestor
710228|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
710229|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
707454|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707455|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
707456|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
707457|NCT02987985|Hormones|hormones|mesh-ancestor
707458|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
707459|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
707460|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707461|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
707462|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
707463|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
707464|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
707465|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
707466|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
707467|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
707468|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
707469|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707470|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
707471|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
707472|NCT02987985|Analgesics|analgesics|mesh-ancestor
707473|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
707474|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
707475|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
707476|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
707477|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
707478|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
707479|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
707480|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
707481|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
707482|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
707483|NCT02987985|Narcotics|narcotics|mesh-ancestor
707484|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
707485|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
707486|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
707487|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
707488|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
707489|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
707490|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
707491|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
707492|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
707493|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
707494|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
707495|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
707496|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
707497|NCT02987985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2089593|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2089594|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2089595|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089596|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2089597|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2089598|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089599|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
2089600|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2089601|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2089602|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2089603|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
707902|NCT02986100|Rucaparib|rucaparib|mesh-list
707903|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
707904|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707905|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707906|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707939|NCT02985671|Acetaminophen|acetaminophen|mesh-list
707940|NCT02985671|Diclofenac|diclofenac|mesh-list
707941|NCT02985671|Orphenadrine|orphenadrine|mesh-list
707942|NCT02985671|Caffeine|caffeine|mesh-list
707943|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
707944|NCT02985671|Analgesics|analgesics|mesh-ancestor
707945|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
707946|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
707947|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707948|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
707949|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
707950|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
707951|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
707952|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2089604|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
707564|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
707565|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
707566|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
707567|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
707568|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
707569|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
2229452|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229453|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229454|NCT00064207|Antiviral Agents|antiviral agents|mesh-ancestor
708712|NCT02982486|Nivolumab|nivolumab|mesh-list
708713|NCT02982486|Ipilimumab|ipilimumab|mesh-list
708714|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
708715|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708716|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
708717|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709436|NCT02979548|Ondansetron|ondansetron|mesh-list
709437|NCT02979548|Aprepitant|aprepitant|mesh-list
709438|NCT02979548|Metoclopramide|metoclopramide|mesh-list
709439|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
709440|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
709441|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
709442|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709443|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
709444|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
709445|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
709446|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
709447|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
709448|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
709449|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709450|NCT02979548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
709451|NCT02979548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
709452|NCT02979548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
709453|NCT02979548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
709454|NCT02979548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
709455|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
709456|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
709457|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
709458|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
709517|NCT02978976|Betamethasone|betamethasone|mesh-list
709518|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
709519|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
709520|NCT02978976|Hormones|hormones|mesh-ancestor
709521|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
709522|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709523|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
709524|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
2089605|NCT02201784|Ropivacaine|ropivacaine|mesh-list
2089606|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
2089607|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
2089608|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
2089609|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2229455|NCT00064207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229456|NCT00064207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229457|NCT00064207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229458|NCT00064207|Immunologic Factors|immunologic factors|mesh-ancestor
2229459|NCT00064207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229460|NCT00064220|Soblidotin|soblidotin|mesh-list
2229461|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229462|NCT00064233|Dasatinib|dasatinib|mesh-list
2229463|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229464|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2229465|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229466|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710439|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
710440|NCT02974387|Fluorometholone|fluorometholone|mesh-list
710441|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
710442|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
710443|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
710444|NCT02974387|Hormones|hormones|mesh-ancestor
710445|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2089610|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707745|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
707786|NCT02986503|Cisplatin|cisplatin|mesh-list
707787|NCT02986503|Doxorubicin|doxorubicin|mesh-list
707788|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
707789|NCT02986503|Methotrexate|methotrexate|mesh-list
707790|NCT02986503|Ifosfamide|ifosfamide|mesh-list
707791|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
707792|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
707793|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
707794|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
707795|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
707796|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707797|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707798|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
707799|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
707800|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
707801|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707802|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
707803|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
707804|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
707805|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
707806|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
707807|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
707808|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
707809|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
707810|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
707811|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
708077|NCT02985606|Caffeine|caffeine|mesh-list
708078|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
708079|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708080|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
708081|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708082|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708083|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
708084|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
708085|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
708086|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
708120|NCT02985216|Pregabalin|pregabalin|mesh-list
708121|NCT02985216|Analgesics|analgesics|mesh-ancestor
708122|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
708123|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708124|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708125|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
708126|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
708127|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
708128|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708129|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
708130|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
708131|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
708132|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708133|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
708229|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
708230|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
708231|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
708232|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
708233|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708234|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
708235|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
708236|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708530|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
708531|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
708532|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708533|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708534|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
708718|NCT02982551|Insulin|insulin|mesh-list
708719|NCT02982551|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
708720|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
708721|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229467|NCT00064246|Rituximab|rituximab|mesh-list
2229468|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2229469|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2229470|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229471|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
2229472|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
707953|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
707954|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
707955|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
707956|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
707957|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
707958|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
707959|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
707960|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
707961|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
707962|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
707963|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
707964|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
707965|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
707966|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
707967|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
707968|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
707969|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
707970|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
707971|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
708108|NCT02985372|Cytarabine|cytarabine|mesh-list
708109|NCT02985372|Decitabine|decitabine|mesh-list
708110|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
708111|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
708112|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708113|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708114|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
708115|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708116|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
708117|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
708118|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708119|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708337|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
708338|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
708339|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708340|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
708341|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708417|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
708418|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
708419|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708794|NCT02982395|Ethanol|ethanol|mesh-list
708795|NCT02982395|Docetaxel|docetaxel|mesh-list
708796|NCT02982395|Mitomycins|mitomycins|mesh-list
708797|NCT02982395|Mitomycin|mitomycin|mesh-list
708798|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708799|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
708800|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
708801|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
708802|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708803|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
708804|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
708805|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
708806|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708807|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
708808|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708809|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708810|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229473|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2229474|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
2229475|NCT00064285|Alvocidib|alvocidib|mesh-list
2229476|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229477|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2229478|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229479|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229480|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
2229481|NCT00064285|Growth Substances|growth substances|mesh-ancestor
2229482|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229483|NCT00064389|Albuterol|albuterol|mesh-list
2229484|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2229485|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
2229486|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708244|NCT02984930|Esomeprazole|esomeprazole|mesh-list
708245|NCT02984930|Mosapride|mosapride|mesh-list
708246|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
708247|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
708248|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
708249|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708250|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708251|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
708252|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
708253|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
708254|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708330|NCT02984657|Anesthetics|anesthetics|mesh-list
708331|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708332|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229487|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229488|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2229489|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
2229490|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
2229491|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2229492|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2089611|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
2089612|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089613|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
708722|NCT02982577|Pilocarpine|pilocarpine|mesh-list
708723|NCT02982577|Miotics|miotics|mesh-ancestor
708724|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
708725|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708726|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708727|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
708728|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
708729|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
708730|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
708731|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709513|NCT02979093|Oxytocin|oxytocin|mesh-list
709514|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
709515|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
709516|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229493|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2229494|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2229495|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
2229496|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2229497|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229498|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2229499|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
2229500|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2229501|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
710767|NCT02973295|Silymarin|silymarin|mesh-list
710768|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
710769|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710770|NCT02973295|Protective Agents|protective agents|mesh-ancestor
710771|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089614|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2089615|NCT02201901|Velpatasvir|velpatasvir|mesh-list
2089616|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
2089617|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089618|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
2089619|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2089620|NCT02201940|Velpatasvir|velpatasvir|mesh-list
2089621|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
2089622|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089623|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
2089624|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
2089625|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
711159|NCT02971475|Analgesics|analgesics|mesh-list
711160|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
711161|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
711162|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089626|NCT02202135|Vancomycin|vancomycin|mesh-list
708035|NCT02985619|Glucocorticoids|glucocorticoids|mesh-ancestor
708036|NCT02985619|Hormones|hormones|mesh-ancestor
708037|NCT02985619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
708038|NCT02985619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
708039|NCT02985619|Immunologic Factors|immunologic factors|mesh-ancestor
708040|NCT02985619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708041|NCT02985619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708397|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
708398|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
708399|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
708400|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708401|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
708402|NCT02984228|Protective Agents|protective agents|mesh-ancestor
708821|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2089627|NCT02202135|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2089628|NCT02202135|Aztreonam|aztreonam|mesh-list
2089629|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2089630|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089631|NCT02202161|Metformin|metformin|mesh-list
2089632|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2089633|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2089634|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089635|NCT02202161|Incretins|incretins|mesh-ancestor
2089636|NCT02202161|Hormones|hormones|mesh-ancestor
2089637|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2089638|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2089639|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
2089640|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089641|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089642|NCT02202499|Varenicline|varenicline|mesh-list
2089643|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2089644|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2089645|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
2089646|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089647|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089648|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089649|NCT02202551|Amantadine|amantadine|mesh-list
2089650|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2089651|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2089652|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
2089653|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089654|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
2089655|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089656|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089657|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089658|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2089659|NCT02202551|Analgesics|analgesics|mesh-ancestor
2089660|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
2089661|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089662|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
2089663|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089664|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2089665|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2089666|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2089667|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
2089668|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089669|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089670|NCT02202837|Etanercept|etanercept|mesh-list
2229502|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
2229503|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229504|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709686|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
709687|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
709688|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
709689|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
709690|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709691|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
709692|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
709693|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2229505|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2229506|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
2229507|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2229508|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2229509|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2089671|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2089672|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2089673|NCT02202837|Analgesics|analgesics|mesh-ancestor
2089674|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
2089675|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
709152|NCT02980653|Megestrol|megestrol|mesh-list
709153|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
709154|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
709155|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
709156|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
709157|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
709158|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
709159|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709160|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
709161|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
709162|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
709163|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709164|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
709165|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2089676|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089677|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2089678|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2229510|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
2229511|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2752977|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709773|NCT02977533|Acyclovir|acyclovir|mesh-list
709774|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
709775|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
709826|NCT02977208|Gabapentin|gabapentin|mesh-list
709827|NCT02977208|Analgesics|analgesics|mesh-ancestor
709828|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
709829|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
709830|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709831|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
709832|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
709833|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
709834|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
709835|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
709836|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
709837|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
709838|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
709839|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709840|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
2752978|NCT03199053|Incretins|incretins|mesh-ancestor
710032|NCT02975843|Beclomethasone|beclomethasone|mesh-list
710033|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
710034|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
710035|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
710036|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
710037|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710038|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710039|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
710040|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
710041|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
710042|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
710043|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
710044|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
710045|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
710046|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710047|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
710048|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
710049|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
710050|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
710051|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
710052|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
710053|NCT02975843|Hormones|hormones|mesh-ancestor
710054|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
710851|NCT02972983|Daptomycin|daptomycin|mesh-list
710852|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
710853|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
710945|NCT02972333|Osimertinib|osimertinib|mesh-list
710946|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710947|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
710948|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089679|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
708228|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708497|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
708498|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
708499|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
708500|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
708501|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708502|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708503|NCT02983461|Urological Agents|urological agents|mesh-ancestor
708603|NCT02983097|Cytarabine|cytarabine|mesh-list
708604|NCT02983097|Dexamethasone|dexamethasone|mesh-list
708605|NCT02983097|Rituximab|rituximab|mesh-list
708606|NCT02983097|Carboplatin|carboplatin|mesh-list
708607|NCT02983097|Lenalidomide|lenalidomide|mesh-list
708608|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708609|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
708610|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
708611|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
708612|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708613|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708614|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
708615|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
708616|NCT02983097|Hormones|hormones|mesh-ancestor
708617|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
708618|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
708619|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
708620|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
708621|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
708622|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
708623|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
708624|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708625|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
708626|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708627|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
708628|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
708629|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
708630|NCT02983097|Growth Substances|growth substances|mesh-ancestor
708631|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
2089680|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2089681|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
2089682|NCT02202850|Etanercept|etanercept|mesh-list
2089683|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2089684|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2089685|NCT02202850|Analgesics|analgesics|mesh-ancestor
2089686|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
2089687|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089688|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089689|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
708753|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
708754|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
708755|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708756|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708757|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
708758|NCT02982512|Analgesics|analgesics|mesh-ancestor
708759|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
708760|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708761|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
708762|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
708763|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
708764|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
708765|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
708766|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708931|NCT02981459|Mirabegron|mirabegron|mesh-list
708932|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
708933|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
708934|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
708935|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
708936|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
708937|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708938|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708939|NCT02981459|Urological Agents|urological agents|mesh-ancestor
709078|NCT02980926|Bupivacaine|bupivacaine|mesh-list
709079|NCT02980926|Mepivacaine|mepivacaine|mesh-list
709080|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
709081|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
709082|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2229512|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708535|NCT02983344|Fentanyl|fentanyl|mesh-list
708536|NCT02983344|Ropivacaine|ropivacaine|mesh-list
708537|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
708538|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
708539|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708540|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708541|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
708542|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708543|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
708544|NCT02983344|Narcotics|narcotics|mesh-ancestor
708545|NCT02983344|Analgesics|analgesics|mesh-ancestor
708546|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
708547|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
708548|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
2089690|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089691|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2089692|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2089693|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
2089694|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
2089695|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
709366|NCT02980016|Isoniazid|isoniazid|mesh-list
709367|NCT02980016|Rifapentine|rifapentine|mesh-list
709368|NCT02980016|Rifampin|rifampin|mesh-list
709369|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
709370|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
709371|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
709372|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
709373|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
709374|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
709375|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709376|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
709377|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
709378|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
709379|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
709380|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709381|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
709382|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
709383|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
709384|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
709385|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
709386|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
709486|NCT02979327|Adderall|adderall|mesh-list
709487|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
709488|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710063|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
710064|NCT02975921|Povidone|povidone|mesh-list
710065|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
710066|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
710067|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
710068|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
710510|NCT02974166|Ibuprofen|ibuprofen|mesh-list
710511|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
710512|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
710513|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
710514|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
710515|NCT02974166|Analgesics|analgesics|mesh-ancestor
710516|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
710517|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710518|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710519|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
710520|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
710521|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710522|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710523|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
710524|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
710525|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
710526|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
708429|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
708439|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
708440|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752979|NCT03199053|Hormones|hormones|mesh-ancestor
2752980|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2752981|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2752982|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
2752983|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752984|NCT03194893|Crizotinib|crizotinib|mesh-list
2752985|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752986|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2752987|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2752988|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752989|NCT03193333|Timolol|timolol|mesh-list
2752990|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2752991|NCT03193333|Dorzolamide|dorzolamide|mesh-list
2752992|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2752993|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2752994|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2752995|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2752996|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
2752997|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793058|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
709208|NCT02980458|Deferiprone|deferiprone|mesh-list
709209|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
709210|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
709211|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
709212|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709394|NCT02979665|Ranibizumab|ranibizumab|mesh-list
709395|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
709396|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
709397|NCT02979665|Growth Substances|growth substances|mesh-ancestor
709398|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709399|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
709400|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709556|NCT02978612|Capecitabine|capecitabine|mesh-list
709557|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
709558|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
709559|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709560|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709894|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
709895|NCT02977286|Naloxegol|naloxegol|mesh-list
709896|NCT02977286|Bisacodyl|bisacodyl|mesh-list
709897|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
709898|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
709899|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
709900|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709901|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
709902|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
709903|NCT02977286|Cathartics|cathartics|mesh-ancestor
709904|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
709905|NCT02977286|Laxatives|laxatives|mesh-ancestor
709906|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
710011|NCT02976597|Morphine|morphine|mesh-list
710012|NCT02976597|Bupivacaine|bupivacaine|mesh-list
710013|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
710014|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
710015|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
710016|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710017|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
710018|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710019|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
710020|NCT02976597|Narcotics|narcotics|mesh-ancestor
710021|NCT02976597|Analgesics|analgesics|mesh-ancestor
710260|NCT02975037|Itraconazole|itraconazole|mesh-list
710261|NCT02975037|Erythromycin|erythromycin|mesh-list
710262|NCT02975037|Erythromycin Estolate|erythromycin estolate|mesh-list
710263|NCT02975037|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
710264|NCT02975037|Erythromycin stearate|erythromycin stearate|mesh-list
710265|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
710266|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
710267|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
710268|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
710269|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710270|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710271|NCT02975037|Urological Agents|urological agents|mesh-ancestor
710272|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
708448|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
708449|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
708562|NCT02983383|Anesthetics|anesthetics|mesh-list
708563|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708564|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709598|NCT02978404|Nivolumab|nivolumab|mesh-list
709599|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
709600|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709601|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
709602|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709741|NCT02978001|Glycerol|glycerol|mesh-list
709742|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
709743|NCT02978001|Protective Agents|protective agents|mesh-ancestor
709744|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229513|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
2229514|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2229515|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2229516|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
2229517|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229518|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710505|NCT02974257|Thiamine|thiamine|mesh-list
710506|NCT02974257|Vitamins|vitamins|mesh-ancestor
710507|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
710508|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710509|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
2089696|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089697|NCT02203019|Fentanyl|fentanyl|mesh-list
2089698|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
2089699|NCT02203019|Propofol|propofol|mesh-list
2089700|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2089701|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2089702|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089703|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2089704|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
2089705|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
2089706|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
711163|NCT02971696|Sorafenib|sorafenib|mesh-list
711164|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711165|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
711166|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711167|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712128|NCT02967289|Irinotecan|irinotecan|mesh-list
712129|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
712130|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
712131|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712132|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712133|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2752998|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2752999|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753000|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2753001|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2753002|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2753003|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2753004|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2753005|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2753006|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793059|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
712582|NCT02965963|Dopamine|dopamine|mesh-list
712583|NCT02965963|Metoclopramide|metoclopramide|mesh-list
712584|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
712585|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
712586|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712587|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712588|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
712589|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
712590|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
712591|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
712592|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
712729|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2089707|NCT02203019|Analgesics|analgesics|mesh-ancestor
2089708|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
2089709|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089710|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2089711|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2089712|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2089713|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
2089714|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089715|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089716|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2089717|NCT02203019|Narcotics|narcotics|mesh-ancestor
2089718|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2089719|NCT02203032|Ustekinumab|ustekinumab|mesh-list
2089720|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2089721|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
708958|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
708959|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
708960|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708961|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
708962|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
708963|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
708964|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708965|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708966|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709033|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
709034|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2089722|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
2089723|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089724|NCT02203149|Grazoprevir|grazoprevir|mesh-list
2089725|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
2089726|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089727|NCT02203331|Anastrozole|anastrozole|mesh-list
2089728|NCT02203331|Leuprolide|leuprolide|mesh-list
2089729|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
2089730|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2089731|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089732|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2089733|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2089734|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709885|NCT02977065|Atorvastatin|atorvastatin|mesh-list
709886|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
709887|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
709888|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
709889|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
709890|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709891|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
709892|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
709893|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710568|NCT02974049|Ivermectin|ivermectin|mesh-list
710569|NCT02974049|Albendazole|albendazole|mesh-list
710570|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
710571|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
710572|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
710573|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
710574|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
710575|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
710576|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
710577|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
710578|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
710579|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
710580|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710581|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710582|NCT02974049|Filaricides|filaricides|mesh-ancestor
710583|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
710584|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
710585|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710604|NCT02973763|Aflutinib|aflutinib|mesh-list
710605|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
710606|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710607|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711053|NCT02972216|Docetaxel|docetaxel|mesh-list
711054|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711055|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
711056|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
711057|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
711058|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711084|NCT02971982|Dexamethasone|dexamethasone|mesh-list
708672|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708673|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
708987|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
708988|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
708989|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
708990|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
708991|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709719|NCT02977832|Alfuzosin|alfuzosin|mesh-list
709720|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
709721|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
709722|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
709723|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
709724|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
709725|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709726|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709727|NCT02977832|Urological Agents|urological agents|mesh-ancestor
2229519|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2229520|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
2229521|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2229522|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2229523|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2229524|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
2229525|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2229526|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710284|NCT02975076|Aspirin|aspirin|mesh-list
710285|NCT02975076|Clopidogrel|clopidogrel|mesh-list
710286|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
710287|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
710288|NCT02975076|Analgesics|analgesics|mesh-ancestor
710289|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
710290|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710291|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710292|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
710293|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
710294|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
710295|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
710296|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710297|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
710298|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
710299|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710300|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
710301|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
710302|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
710303|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
710304|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
710305|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
710427|NCT02974439|Amlodipine|amlodipine|mesh-list
710428|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
710429|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
710430|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
710431|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710432|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
710433|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710434|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
710457|NCT02974244|Exenatide|exenatide|mesh-list
710458|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
710459|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710460|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
710461|NCT02974244|Incretins|incretins|mesh-ancestor
710462|NCT02974244|Hormones|hormones|mesh-ancestor
710463|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
711354|NCT02970643|Olanzapine|olanzapine|mesh-list
711355|NCT02970643|Palonosetron|palonosetron|mesh-list
711356|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
711357|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
711358|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
711359|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708742|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
708743|NCT02982889|Protective Agents|protective agents|mesh-ancestor
708774|NCT02982161|Celecoxib|celecoxib|mesh-list
708775|NCT02982161|Tramadol|tramadol|mesh-list
708776|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
708777|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
708778|NCT02982161|Analgesics|analgesics|mesh-ancestor
708779|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
708780|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708781|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708782|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
708783|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
708784|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
708785|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
708786|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708787|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708788|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
708789|NCT02982161|Narcotics|narcotics|mesh-ancestor
708790|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708864|NCT02981719|Gemcitabine|gemcitabine|mesh-list
708865|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
708866|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
708867|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708868|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708869|NCT02981719|Antiviral Agents|antiviral agents|mesh-ancestor
708870|NCT02981719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708871|NCT02981719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708872|NCT02981719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
708873|NCT02981719|Immunologic Factors|immunologic factors|mesh-ancestor
708874|NCT02981719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708919|NCT02981264|Lidocaine|lidocaine|mesh-list
708920|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
708921|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
708922|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
708923|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708924|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
708925|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
708926|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
708927|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
708928|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
708929|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
708930|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709591|NCT02978482|Durvalumab|durvalumab|mesh-list
709592|NCT02978482|Tremelimumab|tremelimumab|mesh-list
709593|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
709594|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
709595|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709596|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
709597|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709694|NCT02978066|Anesthetics|anesthetics|mesh-list
709695|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
709696|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709769|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
709770|NCT02977637|Hematinics|hematinics|mesh-ancestor
709771|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
709772|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
709841|NCT02977299|Aripiprazole|aripiprazole|mesh-list
709842|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
709843|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
709844|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
709845|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
709846|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
709847|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
709848|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709849|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
709850|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
709851|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
709852|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709853|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
709854|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
709855|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
709856|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
709857|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
709858|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
708854|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
708855|NCT02981615|Renal Agents|renal agents|mesh-ancestor
708856|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
708857|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
708858|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
708859|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
708860|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
708861|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
708862|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
708863|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
708992|NCT02981030|Misoprostol|misoprostol|mesh-list
708993|NCT02981030|Mifepristone|mifepristone|mesh-list
708994|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
708995|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
708996|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
708997|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708998|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
708999|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
709000|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
709001|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
709002|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
709003|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
709004|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
709005|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
709006|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
709007|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
709008|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
709009|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
709010|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
709011|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
709012|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2229527|NCT00064428|PENTA|penta|mesh-list
2229528|NCT00064428|Fondaparinux|fondaparinux|mesh-list
2229529|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2229530|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
2229531|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2229532|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
2229533|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229534|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229535|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
2229536|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
709629|NCT02978222|Molgramostim|molgramostim|mesh-list
709630|NCT02978222|Sargramostim|sargramostim|mesh-list
709631|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
709632|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709633|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709953|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
709954|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710060|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
710061|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
710062|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710530|NCT02974348|Acetaminophen|acetaminophen|mesh-list
710531|NCT02974348|Amoxicillin|amoxicillin|mesh-list
710532|NCT02974348|Artesunate|artesunate|mesh-list
710533|NCT02974348|Lumefantrine|lumefantrine|mesh-list
710534|NCT02974348|Piperaquine|piperaquine|mesh-list
710535|NCT02974348|Artenimol|artenimol|mesh-list
710536|NCT02974348|Mefloquine|mefloquine|mesh-list
710537|NCT02974348|Quinine|quinine|mesh-list
710538|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
710539|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
710540|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
710541|NCT02974348|Analgesics|analgesics|mesh-ancestor
710542|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
710543|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710544|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229537|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2229538|NCT00064467|Bupropion|bupropion|mesh-list
2753012|NCT03177291|Pirfenidone|pirfenidone|mesh-list
2753013|NCT03177291|Paclitaxel|paclitaxel|mesh-list
2753014|NCT03177291|Carboplatin|carboplatin|mesh-list
2753015|NCT03177291|Pemetrexed|pemetrexed|mesh-list
2753016|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
708972|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
708973|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2229539|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2229540|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
2229541|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2229542|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2229543|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
709410|NCT02979561|Warfarin|warfarin|mesh-list
709411|NCT02979561|Dabigatran|dabigatran|mesh-list
709412|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
709413|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
709414|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
709415|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
709416|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709417|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709502|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
709503|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
709504|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
709505|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709506|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
709507|NCT02979223|Protective Agents|protective agents|mesh-ancestor
709508|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709509|NCT02979223|Vitamins|vitamins|mesh-ancestor
709510|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
709511|NCT02979223|Cathartics|cathartics|mesh-ancestor
709512|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
709682|NCT02977897|Octreotide|octreotide|mesh-list
709683|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
709684|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
709685|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710069|NCT02975934|Docetaxel|docetaxel|mesh-list
710070|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
710071|NCT02975934|Rucaparib|rucaparib|mesh-list
710072|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710073|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
710074|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
710075|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
710076|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710077|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
710078|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710079|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
710080|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
710081|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710082|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
710083|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
710740|NCT02973542|Ethosuximide|ethosuximide|mesh-list
710741|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
2229544|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2229545|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711531|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
711532|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
711533|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
711534|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711535|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
711536|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
711537|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
711538|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711539|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711540|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
711834|NCT02968940|Avelumab|avelumab|mesh-list
711835|NCT02968940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
711836|NCT02968940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712150|NCT02967640|Ketamine|ketamine|mesh-list
712151|NCT02967640|Analgesics|analgesics|mesh-ancestor
712152|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
712153|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712154|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712155|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
712156|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
712157|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
712158|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
712159|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
712160|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
712161|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
712162|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
709083|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709084|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
709085|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
709171|NCT02980562|Bisacodyl|bisacodyl|mesh-list
709172|NCT02980562|Cathartics|cathartics|mesh-ancestor
709173|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
709174|NCT02980562|Laxatives|laxatives|mesh-ancestor
709955|NCT02976935|Xenon|xenon|mesh-list
709956|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
709957|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
709958|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
709959|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
709960|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710447|NCT02974504|Linagliptin|linagliptin|mesh-list
710448|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
710449|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710450|NCT02974504|Incretins|incretins|mesh-ancestor
710451|NCT02974504|Hormones|hormones|mesh-ancestor
710452|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
710453|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
710454|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
710455|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710456|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710734|NCT02973386|Cisplatin|cisplatin|mesh-list
710735|NCT02973386|Capecitabine|capecitabine|mesh-list
710736|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710737|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
710738|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
710739|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710920|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
710921|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
710922|NCT02972463|Antibodies|antibodies|mesh-list
710923|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
710924|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089735|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089736|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2089737|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
711258|NCT02971423|Imipenem|imipenem|mesh-list
711259|NCT02971423|Sulbactam|sulbactam|mesh-list
711260|NCT02971423|Cilastatin|cilastatin|mesh-list
711261|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
711262|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
711263|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
711264|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711265|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711266|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
711489|NCT02970383|Narcotics|narcotics|mesh-list
711490|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
711491|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711492|NCT02970383|Analgesics|analgesics|mesh-ancestor
711493|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
711494|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
711917|NCT02968394|Omalizumab|omalizumab|mesh-list
711918|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
711919|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
711920|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
2229546|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
2229547|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2229548|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229549|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2229550|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2229551|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229552|NCT00064610|Bortezomib|bortezomib|mesh-list
2229553|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229554|NCT00064623|Capsaicin|capsaicin|mesh-list
2229555|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
2229556|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
2229557|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
2229558|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229559|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712105|NCT02967432|Mupirocin|mupirocin|mesh-list
712106|NCT02967432|Petrolatum|petrolatum|mesh-list
712107|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
712108|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
712109|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
712110|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229560|NCT00064636|Bortezomib|bortezomib|mesh-list
2229561|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229562|NCT00064649|Finasteride|finasteride|mesh-list
2229563|NCT00064649|Alfuzosin|alfuzosin|mesh-list
2229564|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2229565|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2229566|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229567|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229568|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
2229569|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2229570|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229571|NCT00064649|Urological Agents|urological agents|mesh-ancestor
2229572|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
709401|NCT02979704|Atorvastatin|atorvastatin|mesh-list
709402|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
709403|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
709404|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
709405|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
709406|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709407|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
709408|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
709409|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709548|NCT02978755|Paclitaxel|paclitaxel|mesh-list
709549|NCT02978755|Carboplatin|carboplatin|mesh-list
709550|NCT02978755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
709551|NCT02978755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709552|NCT02978755|Tubulin Modulators|tubulin modulators|mesh-ancestor
709553|NCT02978755|Antimitotic Agents|antimitotic agents|mesh-ancestor
709554|NCT02978755|Mitosis Modulators|mitosis modulators|mesh-ancestor
709555|NCT02978755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710167|NCT02975583|Vorapaxar|vorapaxar|mesh-list
710168|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
710220|NCT02975219|Bevacizumab|bevacizumab|mesh-list
710221|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
710222|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710223|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
710224|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
710225|NCT02975219|Growth Substances|growth substances|mesh-ancestor
710226|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710227|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
710640|NCT02973958|Acetaminophen|acetaminophen|mesh-list
710641|NCT02973958|Ibuprofen|ibuprofen|mesh-list
710642|NCT02973958|Ketorolac|ketorolac|mesh-list
710643|NCT02973958|Bupivacaine|bupivacaine|mesh-list
710644|NCT02973958|Sevoflurane|sevoflurane|mesh-list
710645|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
710646|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
710647|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
710648|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710649|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
710650|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710651|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
710652|NCT02973958|Analgesics|analgesics|mesh-ancestor
710653|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
710654|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
710655|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
710656|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
710657|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
710658|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710659|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710660|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
710661|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
710662|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
710925|NCT02972450|Vedolizumab|vedolizumab|mesh-list
710926|NCT02972450|Vaccines|vaccines|mesh-list
710927|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
710928|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710929|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
711184|NCT02971254|Sevoflurane|sevoflurane|mesh-list
711185|NCT02971254|Desflurane|desflurane|mesh-list
711186|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
711187|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
711188|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
711189|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
711190|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
711191|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709187|NCT02980510|Irinotecan|irinotecan|mesh-list
709188|NCT02980510|Panitumumab|panitumumab|mesh-list
709189|NCT02980510|Fluorouracil|fluorouracil|mesh-list
709190|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
709191|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709192|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
709193|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
709194|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709195|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709196|NCT02980510|Antidotes|antidotes|mesh-ancestor
709197|NCT02980510|Protective Agents|protective agents|mesh-ancestor
709198|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709199|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
709200|NCT02980510|Vitamins|vitamins|mesh-ancestor
709201|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
709202|NCT02980510|Hematinics|hematinics|mesh-ancestor
709203|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
709204|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
709205|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
709206|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
709207|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
709544|NCT02979132|Iron|iron|mesh-list
709545|NCT02979132|Trace Elements|trace elements|mesh-ancestor
709546|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
709547|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709998|NCT02976467|Fulacimstat|fulacimstat|mesh-list
709999|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710000|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710130|NCT02975440|Rifampin|rifampin|mesh-list
710131|NCT02975440|Midazolam|midazolam|mesh-list
710132|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
710133|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
710134|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
710135|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710136|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
710137|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
710138|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
710139|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
710140|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
710141|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
710142|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
710143|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
710144|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
710145|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710146|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
710147|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
710148|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
710149|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
710150|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
710151|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
710152|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710153|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
710154|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
710155|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
710156|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
710157|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
710158|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
710620|NCT02973724|Remifentanil|remifentanil|mesh-list
710621|NCT02973724|Propofol|propofol|mesh-list
710622|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
710623|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
710624|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710625|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
710626|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
710627|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
710628|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
710629|NCT02973724|Narcotics|narcotics|mesh-ancestor
710630|NCT02973724|Analgesics|analgesics|mesh-ancestor
710631|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
710632|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710742|NCT02973451|Bupivacaine|bupivacaine|mesh-list
710743|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
710744|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
710745|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
710746|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710747|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
710748|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
709238|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
709239|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
709240|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
709241|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709325|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
709326|NCT02979886|Menotropins|menotropins|mesh-list
709327|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
709328|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
709329|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
709330|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
709331|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709332|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
709333|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
709334|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709335|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
709336|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
709579|NCT02978456|Sirolimus|sirolimus|mesh-list
709580|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
709581|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
709582|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
709583|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709584|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
709585|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
709586|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
709587|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709814|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
709815|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
709968|NCT02976623|Metronidazole|metronidazole|mesh-list
709969|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
709970|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
709971|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
709972|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
710251|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
710252|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
710253|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
710254|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710255|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
710256|NCT02974985|Protective Agents|protective agents|mesh-ancestor
710556|NCT02974361|Ibuprofen|ibuprofen|mesh-list
710557|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
710558|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
710559|NCT02974361|Analgesics|analgesics|mesh-ancestor
710560|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
710561|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710562|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710563|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
710564|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
710565|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
710566|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710567|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089738|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2089739|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089740|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2089741|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
2089742|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2089743|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2089744|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
2229573|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2229574|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2229575|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
2229576|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2229577|NCT00064714|Exenatide|exenatide|mesh-list
2229578|NCT00064714|Daclizumab|daclizumab|mesh-list
2229579|NCT00064714|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2229580|NCT00064714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2229581|NCT00064714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229582|NCT00064714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2229583|NCT00064714|Incretins|incretins|mesh-ancestor
2089745|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2089746|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2229584|NCT00064714|Hormones|hormones|mesh-ancestor
712040|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
712041|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
712042|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
712043|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753017|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709296|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
709297|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709298|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709299|NCT02980094|Protective Agents|protective agents|mesh-ancestor
709300|NCT02980094|Trace Elements|trace elements|mesh-ancestor
709880|NCT02976987|Cidofovir|cidofovir|mesh-list
709881|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
709882|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
709883|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709884|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709980|NCT02976272|Bortezomib|bortezomib|mesh-list
709981|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229585|NCT00064714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2229586|NCT00064714|Immunologic Factors|immunologic factors|mesh-ancestor
2229587|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
2229588|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2229589|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710699|NCT02973646|Tenofovir|tenofovir|mesh-list
710700|NCT02973646|Entecavir|entecavir|mesh-list
710701|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
710702|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
710703|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
710704|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
710705|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
710706|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710707|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710708|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
710709|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2229590|NCT00064766|Doxycycline|doxycycline|mesh-list
2229591|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2229592|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229593|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
2229594|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2229595|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2229596|NCT00064857|Pycnogenols|pycnogenols|mesh-list
710950|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
710951|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
710952|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
710953|NCT02972346|Hormones|hormones|mesh-ancestor
710954|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
710955|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710956|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
710957|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711423|NCT02970682|Tamoxifen|tamoxifen|mesh-list
711424|NCT02970682|Fulvestrant|fulvestrant|mesh-list
711425|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
711426|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
711427|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
711428|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
711429|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711430|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
711431|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711432|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
711433|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
711434|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
711435|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
711436|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
711437|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711438|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229597|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2229598|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
2229599|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229600|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
712287|NCT02966522|Thalidomide|thalidomide|mesh-list
712288|NCT02966522|Dexamethasone|dexamethasone|mesh-list
712289|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
712290|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
712291|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
712292|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712293|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712294|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
712295|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
712296|NCT02966522|Hormones|hormones|mesh-ancestor
712297|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2089747|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2089748|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2089749|NCT02203565|Eusol|eusol|mesh-list
2089750|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2089751|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
2089752|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089753|NCT02203578|Romidepsin|romidepsin|mesh-list
2089754|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2089755|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089756|NCT02203591|Ethanol|ethanol|mesh-list
2089757|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
709655|NCT02978443|Nivolumab|nivolumab|mesh-list
709656|NCT02978443|Ipilimumab|ipilimumab|mesh-list
709657|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
709658|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709659|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
709660|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709801|NCT02977169|Cisplatin|cisplatin|mesh-list
709802|NCT02977169|Carboplatin|carboplatin|mesh-list
709803|NCT02977169|Pemetrexed|pemetrexed|mesh-list
709804|NCT02977169|Vinorelbine|vinorelbine|mesh-list
709805|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709806|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709807|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709808|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
709809|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
709810|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
709811|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
709812|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
709813|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
710055|NCT02976116|Gefitinib|gefitinib|mesh-list
710056|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710057|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
710058|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710059|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710198|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
710199|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
710200|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
710201|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
710202|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710203|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710204|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
710205|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
710206|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
710207|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
710208|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710209|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
710210|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
710211|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
710212|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
710213|NCT02975258|Protective Agents|protective agents|mesh-ancestor
710214|NCT02975258|Miotics|miotics|mesh-ancestor
710215|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
710216|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
710217|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
710218|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
710219|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
2229601|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229602|NCT00064857|Protective Agents|protective agents|mesh-ancestor
2229603|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2229604|NCT00064974|Lenalidomide|lenalidomide|mesh-list
2229605|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
2229606|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229607|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2229608|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2229609|NCT00064974|Growth Substances|growth substances|mesh-ancestor
711138|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
711139|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
711140|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711785|NCT02969239|Phenylephrine|phenylephrine|mesh-list
711786|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
711787|NCT02969239|Norepinephrine|norepinephrine|mesh-list
711788|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
711789|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
711790|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
711791|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
2089758|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2089759|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2089760|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089761|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2089762|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089763|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
2089764|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
2089765|NCT02203630|Phenylephrine|phenylephrine|mesh-list
2089766|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
2089767|NCT02203630|Norepinephrine|norepinephrine|mesh-list
2089768|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2089769|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
2089770|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
2089771|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089772|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089773|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
2089774|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2089775|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
2089776|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
2089777|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2089778|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2089779|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2089780|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
2089781|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089782|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089783|NCT02203630|Protective Agents|protective agents|mesh-ancestor
2089784|NCT02203786|Haloperidol|haloperidol|mesh-list
2089785|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
2229610|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
2229611|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229612|NCT00065117|Leucovorin|leucovorin|mesh-list
2229613|NCT00065117|Fluorouracil|fluorouracil|mesh-list
2229614|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
2229615|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
2229616|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229617|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2229618|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229619|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229620|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
2229621|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229622|NCT00065117|Antidotes|antidotes|mesh-ancestor
2229623|NCT00065117|Protective Agents|protective agents|mesh-ancestor
2229624|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
2229625|NCT00065117|Vitamins|vitamins|mesh-ancestor
2229626|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
2229627|NCT00065130|Insulin|insulin|mesh-list
2229628|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2229629|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
2229630|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
2229631|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
709766|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
709767|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
709768|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709975|NCT02976896|Apatinib|apatinib|mesh-list
709976|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709977|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
709978|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709979|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710354|NCT02974920|Aspirin|aspirin|mesh-list
710355|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
710356|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
710357|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
710358|NCT02974920|Analgesics|analgesics|mesh-ancestor
710359|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
710360|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710361|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710362|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
710363|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
710364|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
710365|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
710366|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710367|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
710368|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
710369|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710370|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
710371|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
710372|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
710373|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2089786|NCT02203786|Fluphenazine|fluphenazine|mesh-list
2229632|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
2229633|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2229634|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229635|NCT00065143|Clofarabine|clofarabine|mesh-list
2229636|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2229637|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
2229638|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229639|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089787|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
2089788|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
2089789|NCT02203786|Amphetamine|amphetamine|mesh-list
2089790|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
2089791|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
2089792|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
710346|NCT02974933|Pemetrexed|pemetrexed|mesh-list
710347|NCT02974933|Apatinib|apatinib|mesh-list
710348|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710349|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710350|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710351|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
710352|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
710353|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
710402|NCT02974556|Capecitabine|capecitabine|mesh-list
710403|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
710404|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
710405|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
710406|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710407|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710586|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
710587|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
710878|NCT02972905|Nemiralisib|nemiralisib|mesh-list
710879|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
710880|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710881|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711075|NCT02971930|Factor VIII|factor viii|mesh-list
711076|NCT02971930|Coagulants|coagulants|mesh-ancestor
2089793|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089794|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089795|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2089796|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2089797|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2089798|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2089799|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2089800|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2089801|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
2089802|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089803|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089804|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2089805|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
713045|NCT02963194|Oxytocin|oxytocin|mesh-list
713046|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
713047|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
713048|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229640|NCT00065169|Celecoxib|celecoxib|mesh-list
2229641|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2229642|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2229643|NCT00065169|Analgesics|analgesics|mesh-ancestor
2229644|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
2229645|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229646|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229647|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2229648|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2229649|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2229650|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2229651|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229652|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229653|NCT00065273|Olanzapine|olanzapine|mesh-list
2229654|NCT00065273|Risperidone|risperidone|mesh-list
713724|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
713725|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
713726|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
713727|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
713728|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
2229655|NCT00065273|Clozapine|clozapine|mesh-list
2229656|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2229657|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
2229658|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089806|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
2229659|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229660|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229661|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2229662|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2229663|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2229664|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2229665|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2229666|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
2229667|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
2229668|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
2229669|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229670|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2229671|NCT00065273|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2229672|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2229673|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2229674|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
2229675|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
2229676|NCT00065325|Fulvestrant|fulvestrant|mesh-list
2229677|NCT00065325|Exemestane|exemestane|mesh-list
2229678|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2229679|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229680|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
709864|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
709865|NCT02977013|Dalteparin|dalteparin|mesh-list
709866|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
709867|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
709868|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
709869|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229681|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2229682|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
2229683|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2229684|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229685|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2229686|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2229687|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229688|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229689|NCT00065351|Lenalidomide|lenalidomide|mesh-list
2229690|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
2229691|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229692|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2229693|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2229694|NCT00065351|Growth Substances|growth substances|mesh-ancestor
2229695|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
2229696|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710749|NCT02973464|Valganciclovir|valganciclovir|mesh-list
710750|NCT02973464|Ganciclovir|ganciclovir|mesh-list
710751|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
710752|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
710753|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
710754|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
710755|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710756|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710997|NCT02972424|Teriparatide|teriparatide|mesh-list
710998|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
710999|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711000|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2229697|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
2229698|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
2229699|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2229700|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2229701|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229702|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
711653|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
711654|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711655|NCT02969681|Vitamins|vitamins|mesh-ancestor
711656|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
711657|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
711658|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711659|NCT02969681|Protective Agents|protective agents|mesh-ancestor
711765|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
711766|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
711767|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089807|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
2089808|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2229703|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709618|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
711144|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
711145|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
711146|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229704|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229705|NCT00065455|Vitamin A|vitamin a|mesh-list
2229706|NCT00065455|Vitamins|vitamins|mesh-ancestor
2229707|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
2229708|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711823|NCT02968901|Tadalafil|tadalafil|mesh-list
711824|NCT02968901|Macitentan|macitentan|mesh-list
711825|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
711826|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
711827|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
711828|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711829|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711830|NCT02968901|Urological Agents|urological agents|mesh-ancestor
711831|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
711832|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
711833|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
711904|NCT02968641|Ritonavir|ritonavir|mesh-list
711905|NCT02968641|Lonafarnib|lonafarnib|mesh-list
711906|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
711907|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
711908|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
711909|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711910|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711911|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
711912|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
711913|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
711914|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
711915|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
711916|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
712172|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
712173|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
712174|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229709|NCT00065533|Pemetrexed|pemetrexed|mesh-list
2229710|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229711|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229712|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229713|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2229714|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2229715|NCT00065546|Choline|choline|mesh-list
2229716|NCT00065546|Estrogens|estrogens|mesh-list
2229717|NCT00065546|Hormones|hormones|mesh-ancestor
712609|NCT02965859|Adefovir|adefovir|mesh-list
712610|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
712611|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
712612|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
712613|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
712614|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
712615|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712616|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712644|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
712645|NCT02965443|Saxagliptin|saxagliptin|mesh-list
712646|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
712647|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712648|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
712649|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712650|NCT02965443|Incretins|incretins|mesh-ancestor
712653|NCT02965443|Hormones|hormones|mesh-ancestor
712654|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
712655|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
712656|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
712657|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089809|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2089810|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2089811|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
712844|NCT02964195|Rifaximin|rifaximin|mesh-list
712845|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
712846|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
712847|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
712908|NCT02963896|Gentamicins|gentamicins|mesh-list
712909|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2753018|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
709672|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
709673|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709674|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
709675|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
709676|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
709677|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
709678|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
709679|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
709680|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
709681|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709778|NCT02977494|Dexamethasone|dexamethasone|mesh-list
709779|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
709780|NCT02977494|Bortezomib|bortezomib|mesh-list
709781|NCT02977494|Daratumumab|daratumumab|mesh-list
709782|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
709783|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
709784|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
709785|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
709786|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709787|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
709788|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
709789|NCT02977494|Hormones|hormones|mesh-ancestor
709790|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
709791|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
709792|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710006|NCT02976441|Temozolomide|temozolomide|mesh-list
710007|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
710008|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
710009|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710010|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710257|NCT02975310|Anesthetics|anesthetics|mesh-list
710258|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
710259|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229718|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2229719|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229720|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
2229721|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2229722|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
2229723|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229724|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2229725|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2229726|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
2229727|NCT00065559|Celecoxib|celecoxib|mesh-list
2229728|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2229729|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2229730|NCT00065559|Analgesics|analgesics|mesh-ancestor
710498|NCT02974270|Leuprolide|leuprolide|mesh-list
710499|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
710500|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
710501|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
710502|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710503|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
710504|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710835|NCT02973204|Everolimus|everolimus|mesh-list
710836|NCT02973204|Sorafenib|sorafenib|mesh-list
710837|NCT02973204|Octreotide|octreotide|mesh-list
710838|NCT02973204|Lanreotide|lanreotide|mesh-list
710839|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710840|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
710841|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
710842|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710843|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
710844|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710845|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710846|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
710847|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2229731|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
2229732|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229733|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229734|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2229735|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2229736|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2229737|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2229738|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753019|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
709733|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
709734|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709735|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
709736|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
709737|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
709738|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
709739|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
709740|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709932|NCT02976727|Vitamin D|vitamin d|mesh-list
709933|NCT02976727|Lidocaine|lidocaine|mesh-list
709934|NCT02976727|Prilocaine|prilocaine|mesh-list
709935|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
709936|NCT02976727|Calcipotriene|calcipotriene|mesh-list
709937|NCT02976727|Vitamins|vitamins|mesh-ancestor
709938|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
709939|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709940|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
709941|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
709942|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
709943|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
709944|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
709945|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
709946|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
709947|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
709948|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
709949|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709950|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
709951|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
709952|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
710022|NCT02976246|Vitamin K|vitamin k|mesh-list
710023|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
710024|NCT02976246|Vitamins|vitamins|mesh-ancestor
710025|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
710026|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710027|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
710028|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
710029|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710030|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
710031|NCT02976246|Coagulants|coagulants|mesh-ancestor
710181|NCT02975570|Levofloxacin|levofloxacin|mesh-list
710182|NCT02975570|Ofloxacin|ofloxacin|mesh-list
710183|NCT02975570|Linezolid|linezolid|mesh-list
710184|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
710185|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
710186|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
710187|NCT02975570|Renal Agents|renal agents|mesh-ancestor
710188|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
710189|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
710190|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
710191|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710192|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710193|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710194|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
710195|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
710196|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
710197|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
710958|NCT02972411|Acetazolamide|acetazolamide|mesh-list
710959|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
710960|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
710961|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710962|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710963|NCT02972411|Diuretics|diuretics|mesh-ancestor
710964|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
710965|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711222|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
711223|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
711224|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711583|NCT02969746|Charcoal|charcoal|mesh-list
711584|NCT02969746|Antidotes|antidotes|mesh-ancestor
711585|NCT02969746|Protective Agents|protective agents|mesh-ancestor
711586|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709817|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
709823|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
709824|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709825|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709913|NCT02976805|Bisacodyl|bisacodyl|mesh-list
709914|NCT02976805|Cathartics|cathartics|mesh-ancestor
709915|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
709916|NCT02976805|Laxatives|laxatives|mesh-ancestor
709961|NCT02976571|Bupivacaine|bupivacaine|mesh-list
709962|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
709963|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
709964|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
709965|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709966|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
709967|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229739|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229740|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
2229741|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
2229742|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229743|NCT00065624|Protective Agents|protective agents|mesh-ancestor
2229744|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229745|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
2229746|NCT00065624|Vitamins|vitamins|mesh-ancestor
2229747|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
2229748|NCT00065637|Teriparatide|teriparatide|mesh-list
2229749|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2229750|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229751|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2229752|NCT00065728|Anecortave|anecortave|mesh-list
2229753|NCT00065728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2229754|NCT00065728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2229755|NCT00065728|Growth Substances|growth substances|mesh-ancestor
2229756|NCT00065728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229757|NCT00065728|Growth Inhibitors|growth inhibitors|mesh-ancestor
2229758|NCT00065728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229759|NCT00065741|Silymarin|silymarin|mesh-list
2229760|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
2229761|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229762|NCT00065741|Protective Agents|protective agents|mesh-ancestor
2229763|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229764|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2229765|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2229766|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
2229767|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2229768|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229769|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2229770|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2229771|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2229772|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
2229773|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2229774|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229775|NCT00065884|Valproic Acid|valproic acid|mesh-list
2229776|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
711282|NCT02971033|Ezetimibe|ezetimibe|mesh-list
711283|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
711284|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
711285|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
711286|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711287|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2229777|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229778|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229779|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
2229780|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2229781|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229782|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
2229783|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2229784|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2229785|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2229786|NCT00065923|Topiramate|topiramate|mesh-list
2229787|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
2229788|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2229789|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229790|NCT00065936|Naltrexone|naltrexone|mesh-list
2229791|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2229792|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
709859|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
709860|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
709861|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
709862|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
709863|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
709991|NCT02976194|Ranibizumab|ranibizumab|mesh-list
709992|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
709993|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
709994|NCT02976194|Growth Substances|growth substances|mesh-ancestor
709995|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709996|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
709997|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710084|NCT02975999|Vasopressins|vasopressins|mesh-list
710085|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
710086|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
710087|NCT02975999|Coagulants|coagulants|mesh-ancestor
710088|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
710089|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
710090|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
710091|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710122|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
710123|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
710124|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
710125|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
710126|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
710127|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710128|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710129|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
710230|NCT02975323|Carvedilol|carvedilol|mesh-list
710231|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
710232|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
710233|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
710234|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
710235|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710236|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710237|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
710238|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
710239|NCT02975323|Protective Agents|protective agents|mesh-ancestor
710240|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
710241|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
710242|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
710243|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
710244|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
710245|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
711332|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
711333|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
711334|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
711335|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
711336|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
711337|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229793|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229794|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
2229795|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229796|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
2229797|NCT00065949|Analgesics|analgesics|mesh-ancestor
2229798|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
711998|NCT02968160|Telmisartan|telmisartan|mesh-list
709874|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
709875|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709876|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
709877|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
709878|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
709879|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
710092|NCT02976012|Aflibercept|aflibercept|mesh-list
710093|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
710094|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
710095|NCT02976012|Growth Substances|growth substances|mesh-ancestor
710096|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710097|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
710098|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711111|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
711112|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
711113|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
711114|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
711115|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
711117|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711118|NCT02971878|Protective Agents|protective agents|mesh-ancestor
711119|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711120|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
711121|NCT02971878|Vitamins|vitamins|mesh-ancestor
711122|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
711123|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
711124|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
711125|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
711126|NCT02971878|Expectorants|expectorants|mesh-ancestor
711127|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
711128|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
711129|NCT02971878|Antidotes|antidotes|mesh-ancestor
2229799|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229800|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229801|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
2229802|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2229803|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2229804|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
2229805|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2229806|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2229807|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229808|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2229809|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
2229810|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2229811|NCT00065962|Secretin|secretin|mesh-list
712058|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
712059|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
712060|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712238|NCT02966847|Anesthetics|anesthetics|mesh-list
712239|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
712240|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712505|NCT02966041|Ondansetron|ondansetron|mesh-list
712506|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
712507|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
712508|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712509|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712510|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
712511|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
712512|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
712513|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
712514|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
712515|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
712516|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712517|NCT02966041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
712518|NCT02966041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
712519|NCT02966041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
712520|NCT02966041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
712521|NCT02966041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2089812|NCT02203838|Risperidone|risperidone|mesh-list
2089813|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2089814|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
2089815|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
713447|NCT02962063|Paclitaxel|paclitaxel|mesh-list
713448|NCT02962063|Carboplatin|carboplatin|mesh-list
713449|NCT02962063|Durvalumab|durvalumab|mesh-list
713450|NCT02962063|Tremelimumab|tremelimumab|mesh-list
713451|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2753020|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
709912|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709982|NCT02976259|Dolutegravir|dolutegravir|mesh-list
709983|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
709984|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
709985|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
709986|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
709987|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
709988|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
709989|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
709990|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
710327|NCT02975141|Gemcitabine|gemcitabine|mesh-list
710328|NCT02975141|Paclitaxel|paclitaxel|mesh-list
710329|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
710330|NCT02975141|Afatinib|afatinib|mesh-list
710331|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
710332|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710333|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
710334|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
710335|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
710336|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710337|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
710338|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
710339|NCT02975141|Antiviral Agents|antiviral agents|mesh-ancestor
710340|NCT02975141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
710341|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710342|NCT02975141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
710343|NCT02975141|Immunologic Factors|immunologic factors|mesh-ancestor
710344|NCT02975141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710345|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
710477|NCT02974621|Bevacizumab|bevacizumab|mesh-list
710478|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
710479|NCT02974621|Olaparib|olaparib|mesh-list
710480|NCT02974621|Cediranib|cediranib|mesh-list
710481|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
710482|NCT02974621|Antibodies|antibodies|mesh-list
710483|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
710484|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
710485|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
710486|NCT02974621|Maleic acid|maleic acid|mesh-list
710487|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710488|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
710489|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
710490|NCT02974621|Growth Substances|growth substances|mesh-ancestor
710491|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710492|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
710493|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
710494|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710495|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710496|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
710497|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
710760|NCT02973776|Clobetasol|clobetasol|mesh-list
710761|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
710762|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
710763|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
710764|NCT02973776|Hormones|hormones|mesh-ancestor
710765|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
710766|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229812|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2229813|NCT00065962|Hormones|hormones|mesh-ancestor
2229814|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2229815|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229816|NCT00066001|Metronidazole|metronidazole|mesh-list
2229817|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229818|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2229819|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2229820|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2229821|NCT00066027|Doxycycline|doxycycline|mesh-list
2229822|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2229823|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229824|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
2229825|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2229826|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2229827|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
2229828|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
2229829|NCT00066040|Fluorides|fluorides|mesh-list
2229830|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
2229831|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
709929|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
709930|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
709931|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710398|NCT02974660|Protamines|protamines|mesh-list
710399|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
710400|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710401|NCT02974660|Coagulants|coagulants|mesh-ancestor
710464|NCT02974426|Cisplatin|cisplatin|mesh-list
710465|NCT02974426|Carboplatin|carboplatin|mesh-list
710466|NCT02974426|Pemetrexed|pemetrexed|mesh-list
710467|NCT02974426|Vinorelbine|vinorelbine|mesh-list
710468|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710469|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710470|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710471|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
710472|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
710473|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
710474|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
710475|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
710476|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
710710|NCT02973659|Oxybutynin|oxybutynin|mesh-list
710711|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
710712|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
710713|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710714|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710715|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
710716|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
710717|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
710718|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
710719|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710720|NCT02973659|Urological Agents|urological agents|mesh-ancestor
710824|NCT02973035|Amlodipine|amlodipine|mesh-list
710825|NCT02973035|Valsartan|valsartan|mesh-list
710826|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
710827|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
710828|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
710829|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710830|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
710831|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710832|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
710833|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
710834|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
711059|NCT02972294|Iron|iron|mesh-list
711060|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
711061|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
711062|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
711063|NCT02972294|Trace Elements|trace elements|mesh-ancestor
711064|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
711065|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711066|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
711067|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
711068|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711069|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
711070|NCT02972294|Coagulants|coagulants|mesh-ancestor
711071|NCT02972294|Hematinics|hematinics|mesh-ancestor
2229832|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
2229833|NCT00066040|Protective Agents|protective agents|mesh-ancestor
2229834|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229835|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2229836|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229837|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
2229838|NCT00066092|Lenograstim|lenograstim|mesh-list
2229839|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
711418|NCT02970409|Heparin|heparin|mesh-list
711419|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
711420|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
711421|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
711422|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711498|NCT02970084|Vitamin K|vitamin k|mesh-list
711499|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
711500|NCT02970084|Vitamins|vitamins|mesh-ancestor
711501|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
711502|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711503|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
711504|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
711505|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229840|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
710003|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710004|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
710005|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229841|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229842|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2229843|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2229844|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2229845|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
711192|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
711193|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
711194|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
711195|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
711196|NCT02971306|Expectorants|expectorants|mesh-ancestor
711197|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
711198|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
711199|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
711200|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711201|NCT02971306|Protective Agents|protective agents|mesh-ancestor
711202|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711203|NCT02971306|Antidotes|antidotes|mesh-ancestor
711402|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
711403|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229846|NCT00066157|Estradiol|estradiol|mesh-list
2229847|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2229848|NCT00066157|Estrogens|estrogens|mesh-list
2229849|NCT00066157|Progesterone|progesterone|mesh-list
2229850|NCT00066157|Hormones|hormones|mesh-ancestor
2229851|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2229852|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229853|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2229854|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
2229855|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2229856|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2229857|NCT00066157|Progestins|progestins|mesh-ancestor
2229858|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2229859|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2229860|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2229861|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2229862|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2229863|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229864|NCT00066196|Dacarbazine|dacarbazine|mesh-list
2229865|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
712175|NCT02967172|Epinephrine|epinephrine|mesh-list
712176|NCT02967172|Morphine|morphine|mesh-list
712177|NCT02967172|Ropivacaine|ropivacaine|mesh-list
712178|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
712179|NCT02967172|Narcotics|narcotics|mesh-ancestor
712180|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
712181|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712182|NCT02967172|Analgesics|analgesics|mesh-ancestor
712183|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
712184|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712185|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
712186|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
712187|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
712188|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
712189|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
712190|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
712191|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712192|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
712193|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
712194|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
712195|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
712196|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
712197|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
712198|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
712199|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
712361|NCT02966288|Ibuprofen|ibuprofen|mesh-list
712362|NCT02966288|Ketorolac|ketorolac|mesh-list
712363|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
712364|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
712365|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
712366|NCT02966288|Analgesics|analgesics|mesh-ancestor
712367|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
712368|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712369|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712370|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
710249|NCT02975271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710250|NCT02975271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710386|NCT02974712|Fentanyl|fentanyl|mesh-list
710387|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
710388|NCT02974712|Narcotics|narcotics|mesh-ancestor
710389|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
710390|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710391|NCT02974712|Analgesics|analgesics|mesh-ancestor
710392|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
710393|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710394|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
710395|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
710396|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
710397|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
710725|NCT02973620|Simendan|simendan|mesh-list
710726|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
710727|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
710728|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
710729|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
710730|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710731|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710732|NCT02973620|Protective Agents|protective agents|mesh-ancestor
710733|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710848|NCT02972957|Azithromycin|azithromycin|mesh-list
710849|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
710850|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229866|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
2229867|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229868|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229869|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
2229870|NCT00066248|Megestrol|megestrol|mesh-list
2229871|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
2229872|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2229873|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2229874|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2229875|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
2229876|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2229877|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229878|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2229879|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2229880|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2229881|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229882|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
711204|NCT02971540|Dipyrone|dipyrone|mesh-list
711205|NCT02971540|Tramadol|tramadol|mesh-list
711206|NCT02971540|Bupivacaine|bupivacaine|mesh-list
711207|NCT02971540|Ropivacaine|ropivacaine|mesh-list
711208|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
711209|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
711210|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
711211|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711212|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
711213|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
711214|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
711215|NCT02971540|Narcotics|narcotics|mesh-ancestor
711216|NCT02971540|Analgesics|analgesics|mesh-ancestor
711217|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
711218|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
711219|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
711220|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
711221|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
711345|NCT02970630|Everolimus|everolimus|mesh-list
711346|NCT02970630|Tacrolimus|tacrolimus|mesh-list
711347|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
711348|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
711349|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711350|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
711351|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711352|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711353|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229883|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2229884|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
2229885|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
2229886|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2229887|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2229888|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
710273|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
710274|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
710275|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
710276|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
710277|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
710278|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
710279|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710280|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
710281|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
710282|NCT02975037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
710283|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2089816|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089817|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089818|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2089819|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2089820|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2229889|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
2229890|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2229891|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229892|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2229893|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
2229894|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2229895|NCT00066274|Leucovorin|leucovorin|mesh-list
2229896|NCT00066274|Fluorouracil|fluorouracil|mesh-list
711176|NCT02971410|Simvastatin|simvastatin|mesh-list
711177|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
711178|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
711179|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
711180|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711181|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
711182|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
711183|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711594|NCT02969733|Lidocaine|lidocaine|mesh-list
711595|NCT02969733|Ketamine|ketamine|mesh-list
711596|NCT02969733|Analgesics|analgesics|mesh-ancestor
711597|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
711598|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
711599|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711600|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
711601|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
711602|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
711603|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
711604|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
711605|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
711606|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
711607|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
711608|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711609|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
711610|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
711611|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
711612|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
711613|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
712241|NCT02967133|Paclitaxel|paclitaxel|mesh-list
712242|NCT02967133|Nivolumab|nivolumab|mesh-list
712243|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
712244|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712245|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
712246|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
712247|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
712248|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712249|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
712250|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
713463|NCT02961660|Odalasvir|odalasvir|mesh-list
713464|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
713465|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
713769|NCT02959957|Cefotaxime|cefotaxime|mesh-list
713770|NCT02959957|Cefoxitin|cefoxitin|mesh-list
713771|NCT02959957|Temocillin|temocillin|mesh-list
713772|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
713773|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089821|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2089822|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2089823|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
2089824|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2229897|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
2229898|NCT00066274|Irinotecan|irinotecan|mesh-list
2229899|NCT00066274|Calcium|calcium|mesh-list
2229900|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
2229901|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2229902|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229903|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
710810|NCT02973113|Nivolumab|nivolumab|mesh-list
710811|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
710812|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710813|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
710814|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711072|NCT02972255|Meropenem|meropenem|mesh-list
711073|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
711074|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
711225|NCT02971345|Iodine|iodine|mesh-list
711226|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
711227|NCT02971345|Epirubicin|epirubicin|mesh-list
711228|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
711229|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
711230|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
711231|NCT02971345|Trace Elements|trace elements|mesh-ancestor
711232|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
711233|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711234|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
711235|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711236|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
711237|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
711238|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711239|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711381|NCT02970604|Aspirin|aspirin|mesh-list
711382|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
711383|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
711384|NCT02970604|Analgesics|analgesics|mesh-ancestor
711385|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
711386|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
711387|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711388|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
711389|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
711390|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
711391|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
711392|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711393|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
711394|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
711395|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711396|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
2089825|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2089826|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2089827|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089828|NCT02204410|Methylphenidate|methylphenidate|mesh-list
2089829|NCT02204410|Amphetamine|amphetamine|mesh-list
2089830|NCT02204410|Adderall|adderall|mesh-list
2089831|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
711921|NCT02968498|Methamphetamine|methamphetamine|mesh-list
711922|NCT02968498|Lactulose|lactulose|mesh-list
711923|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
711924|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
711925|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711926|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
711927|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
711928|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
711929|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
711930|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
711931|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711932|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
711933|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
711934|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
711935|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
711936|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2089832|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2229904|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229905|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2229906|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229907|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229908|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
710374|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
710375|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
2229909|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2229910|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2229911|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710815|NCT02972918|Simendan|simendan|mesh-list
710816|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
710817|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
710818|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
710819|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
710820|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
710821|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710822|NCT02972918|Protective Agents|protective agents|mesh-ancestor
710823|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710882|NCT02972723|Metformin|metformin|mesh-list
710883|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
710884|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089833|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089834|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2089835|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2229912|NCT00066274|Antidotes|antidotes|mesh-ancestor
2229913|NCT00066274|Protective Agents|protective agents|mesh-ancestor
2229914|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
2229915|NCT00066274|Vitamins|vitamins|mesh-ancestor
2229916|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
2229917|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
2229918|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229919|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2229920|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229921|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229922|NCT00066339|Gefitinib|gefitinib|mesh-list
2229923|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229924|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2229925|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229926|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229927|NCT00066352|Bortezomib|bortezomib|mesh-list
2229928|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713183|NCT02962921|Insulin|insulin|mesh-list
713184|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
713185|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
713186|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
713187|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713492|NCT02961634|Ciclopirox|ciclopirox|mesh-list
713493|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
713494|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229929|NCT00066378|Gefitinib|gefitinib|mesh-list
2229930|NCT00066378|Anastrozole|anastrozole|mesh-list
2229931|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229932|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2229933|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229934|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229935|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2229936|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2229937|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
714237|NCT02958631|Losartan|losartan|mesh-list
714238|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
714239|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
714240|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
714241|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
714242|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714710|NCT02956421|Vaccines|vaccines|mesh-list
714711|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
714712|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714867|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
714868|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
714869|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
714870|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
714871|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229938|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2229939|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
2229940|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2229941|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229942|NCT00066391|Irinotecan|irinotecan|mesh-list
716638|NCT02947880|Bumetanide|bumetanide|mesh-list
716639|NCT02947880|Diuretics|diuretics|mesh-ancestor
2229943|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711116|NCT02972125|Lacosamide|lacosamide|mesh-list
711130|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
711131|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
711132|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
711133|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
711134|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229944|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2229945|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2229946|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229947|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229948|NCT00066417|Cyclosporine|cyclosporine|mesh-list
2229949|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
2089836|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2089837|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089838|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
2089839|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089840|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
2089841|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
2089842|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712914|NCT02963779|Apremilast|apremilast|mesh-list
712915|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
712916|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
712917|NCT02963779|Analgesics|analgesics|mesh-ancestor
712918|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
712919|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712920|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712921|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
712922|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
712923|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
712924|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
712925|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712926|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229950|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
2229951|NCT00066417|Thiotepa|thiotepa|mesh-list
2229952|NCT00066417|Fludarabine|fludarabine|mesh-list
2229953|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
2229954|NCT00066417|Cyclosporins|cyclosporins|mesh-list
2229955|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2229956|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
2229957|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229958|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2229959|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2089843|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
2089844|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2089845|NCT02204982|Rituximab|rituximab|mesh-list
714374|NCT02958215|Phenylephrine|phenylephrine|mesh-list
714375|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
714376|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
714377|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
714378|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
714379|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714380|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714381|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
714382|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
714383|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
714384|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
714385|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
714386|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
714387|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
714388|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
714389|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714390|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714391|NCT02958215|Protective Agents|protective agents|mesh-ancestor
714499|NCT02957643|Iron|iron|mesh-list
714500|NCT02957643|Trace Elements|trace elements|mesh-ancestor
714501|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
2229960|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
710446|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710608|NCT02973737|Capecitabine|capecitabine|mesh-list
710609|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
710610|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
710611|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710612|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229961|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229962|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229963|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2229964|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2229965|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
2229966|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229967|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
2229968|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2229969|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
2229970|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2229971|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2229972|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
2229973|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
2229974|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2229975|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2229976|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
2229977|NCT00066417|Hormones|hormones|mesh-ancestor
2229978|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2229979|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2229980|NCT00066417|Protective Agents|protective agents|mesh-ancestor
2229981|NCT00066443|Docetaxel|docetaxel|mesh-list
2229982|NCT00066443|Epirubicin|epirubicin|mesh-list
2229983|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229984|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
2229985|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
2229986|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
2229987|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229988|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2229989|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2229990|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
711077|NCT02971891|Furosemide|furosemide|mesh-list
711078|NCT02971891|Diuretics|diuretics|mesh-ancestor
711079|NCT02971891|Natriuretic Agents|natriuretic agents|mesh-ancestor
711080|NCT02971891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711081|NCT02971891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
711082|NCT02971891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
711083|NCT02971891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711660|NCT02969798|Metformin|metformin|mesh-list
711661|NCT02969798|Pioglitazone|pioglitazone|mesh-list
711662|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
711663|NCT02969798|Saxagliptin|saxagliptin|mesh-list
711664|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
711665|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711666|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
711667|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711668|NCT02969798|Incretins|incretins|mesh-ancestor
711669|NCT02969798|Hormones|hormones|mesh-ancestor
711670|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
711671|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
711672|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
711673|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711882|NCT02968719|Donepezil|donepezil|mesh-list
711883|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
711884|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711885|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711886|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
711887|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
711888|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711889|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
712532|NCT02965911|Fenofibrate|fenofibrate|mesh-list
712533|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
712534|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
710527|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
710528|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
710529|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
710781|NCT02973581|Acetaminophen|acetaminophen|mesh-list
710782|NCT02973581|Dipyrone|dipyrone|mesh-list
710783|NCT02973581|Lidocaine|lidocaine|mesh-list
710784|NCT02973581|Bupivacaine|bupivacaine|mesh-list
710785|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
710786|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
710787|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
710788|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
710789|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710790|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
710791|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710792|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
710793|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
710794|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
710795|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
710796|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710797|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
710798|NCT02973581|Analgesics|analgesics|mesh-ancestor
710799|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
710800|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
710801|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
710802|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
711147|NCT02971644|Cobalt|cobalt|mesh-list
711148|NCT02971644|Trace Elements|trace elements|mesh-ancestor
711149|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
711150|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2229991|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2229992|NCT00066456|Docetaxel|docetaxel|mesh-list
2229993|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712221|NCT02967029|Remifentanil|remifentanil|mesh-list
712222|NCT02967029|Esmolol|esmolol|mesh-list
712223|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
712224|NCT02967029|Narcotics|narcotics|mesh-ancestor
712225|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
712226|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712227|NCT02967029|Analgesics|analgesics|mesh-ancestor
712228|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
712229|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712230|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
712231|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
712232|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
712233|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
712234|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
712235|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712349|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
712350|NCT02966652|Testosterone|testosterone|mesh-list
712351|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
712352|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
712353|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
712354|NCT02966652|Androgens|androgens|mesh-ancestor
712355|NCT02966652|Hormones|hormones|mesh-ancestor
712356|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
712357|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712358|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
712359|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712360|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
712562|NCT02966080|Heparin|heparin|mesh-list
712563|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
712564|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
712565|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
712566|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712718|NCT02965261|Fluoxetine|fluoxetine|mesh-list
712719|NCT02965261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
712720|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
712721|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
712722|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712723|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
712724|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
712725|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712726|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
712727|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
712728|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
712788|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
710545|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
710546|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
710547|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
710548|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
710549|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710550|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
710551|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
710552|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
710553|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
710554|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
710555|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
710940|NCT02972320|Temozolomide|temozolomide|mesh-list
710941|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
710942|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
710943|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710944|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2229994|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
2229995|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
2229996|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
2229997|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2229998|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
2229999|NCT00066482|Cisplatin|cisplatin|mesh-list
711650|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
711651|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
711652|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711716|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
711717|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
711718|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
711719|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
711720|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230000|NCT00066482|Etoposide|etoposide|mesh-list
2230001|NCT00066482|Bleomycin|bleomycin|mesh-list
2230002|NCT00066482|Lenograstim|lenograstim|mesh-list
2230003|NCT00066482|Sargramostim|sargramostim|mesh-list
2230004|NCT00066482|Mesna|mesna|mesh-list
712082|NCT02967302|Triamcinolone|triamcinolone|mesh-list
712083|NCT02967302|Morphine|morphine|mesh-list
712084|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
712085|NCT02967302|Narcotics|narcotics|mesh-ancestor
712086|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
712087|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712088|NCT02967302|Analgesics|analgesics|mesh-ancestor
712089|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
712090|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712091|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
712092|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
712093|NCT02967302|Hormones|hormones|mesh-ancestor
712094|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2230005|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230006|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
2230007|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230008|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230009|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2230010|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
2230011|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230012|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712651|NCT02965677|Paclitaxel|paclitaxel|mesh-list
712658|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
712659|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712660|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
712661|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
712662|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
712663|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712732|NCT02965053|Sevelamer|sevelamer|mesh-list
712733|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
712734|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
712735|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712863|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
712864|NCT02964091|Ledipasvir|ledipasvir|mesh-list
712865|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
712866|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
713478|NCT02962102|Calcitriol|calcitriol|mesh-list
713479|NCT02962102|Calcifediol|calcifediol|mesh-list
713480|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
713481|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713482|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
713483|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
710721|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
710722|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
710723|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
710724|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
710902|NCT02972762|Propofol|propofol|mesh-list
710903|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
710904|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
710905|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710906|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
710907|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
710908|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
711026|NCT02972476|Fluticasone|fluticasone|mesh-list
711027|NCT02972476|Xhance|xhance|mesh-list
711028|NCT02972476|Budesonide|budesonide|mesh-list
711029|NCT02972476|Bromides|bromides|mesh-list
711030|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
711031|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
711032|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
711033|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
711034|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
711035|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
711036|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
711037|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711038|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
711039|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
711040|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
711041|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
711042|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
711043|NCT02972476|Hormones|hormones|mesh-ancestor
711044|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
711045|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
711046|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
711047|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
711048|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
711049|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
711050|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711051|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
711052|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
711141|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
711142|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
711143|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711267|NCT02971397|Cytarabine|cytarabine|mesh-list
711268|NCT02971397|Daunorubicin|daunorubicin|mesh-list
711269|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
711270|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
711271|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711272|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711273|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
711274|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
711275|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
711276|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
711277|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711278|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
711279|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
711280|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
711281|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711305|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
711306|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
711307|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
711308|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
711309|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
711310|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711311|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711312|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
711373|NCT02970539|Paclitaxel|paclitaxel|mesh-list
711374|NCT02970539|Ramucirumab|ramucirumab|mesh-list
711375|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
711376|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711377|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
711378|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
711379|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
711380|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711703|NCT02969473|Cisplatin|cisplatin|mesh-list
711704|NCT02969473|Docetaxel|docetaxel|mesh-list
711705|NCT02969473|Fluorouracil|fluorouracil|mesh-list
711706|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
710862|NCT02972866|Budesonide|budesonide|mesh-list
710863|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
710864|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
710865|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
710866|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
710867|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
710868|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
710869|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
710870|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
710871|NCT02972866|Hormones|hormones|mesh-ancestor
710872|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
711013|NCT02972268|Tamsulosin|tamsulosin|mesh-list
711014|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
711015|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
711016|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
711017|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
711018|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
711019|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
711020|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711021|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711022|NCT02972268|Urological Agents|urological agents|mesh-ancestor
711023|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
711024|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
711025|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
2089846|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2089847|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089848|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
2089849|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089850|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089851|NCT02205333|Rituximab|rituximab|mesh-list
2089852|NCT02205333|Durvalumab|durvalumab|mesh-list
2089853|NCT02205333|Tremelimumab|tremelimumab|mesh-list
2089854|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2089855|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089856|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
2089857|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089858|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089859|NCT02205801|Bupivacaine|bupivacaine|mesh-list
2089860|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
2089861|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
2089862|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2089863|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089864|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
2230013|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2230014|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2230015|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2230016|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2230017|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230018|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2230019|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2230020|NCT00066482|Protective Agents|protective agents|mesh-ancestor
2230021|NCT00066508|Bortezomib|bortezomib|mesh-list
2230022|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230023|NCT00066547|Antibodies|antibodies|mesh-list
2230024|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2230025|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
2089865|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089866|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
2089867|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
2089868|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
2230026|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230027|NCT00066586|Exemestane|exemestane|mesh-list
710949|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230028|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230029|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2230030|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2230031|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711495|NCT02970175|Terlipressin|terlipressin|mesh-list
711496|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
711497|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
711587|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
711588|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
711589|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
711590|NCT02969720|Protective Agents|protective agents|mesh-ancestor
711591|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711592|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
711593|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
711684|NCT02969447|Oxytocin|oxytocin|mesh-list
711685|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
711686|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
711687|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711840|NCT02968927|Vitamin D|vitamin d|mesh-list
711841|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
711842|NCT02968927|Rifabutin|rifabutin|mesh-list
711843|NCT02968927|Everolimus|everolimus|mesh-list
711844|NCT02968927|Auranofin|auranofin|mesh-list
711845|NCT02968927|Vitamins|vitamins|mesh-ancestor
711846|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
711847|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711848|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
711849|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711850|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
711851|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
711852|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
711853|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
711854|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
711855|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
711856|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
711857|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
711965|NCT02968342|Progesterone|progesterone|mesh-list
711966|NCT02968342|Progestins|progestins|mesh-ancestor
711967|NCT02968342|Hormones|hormones|mesh-ancestor
711968|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
711969|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712263|NCT02967224|Insulin|insulin|mesh-list
712264|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
712265|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
712266|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
712267|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
712268|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
712269|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
712270|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
712271|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230032|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230033|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2230034|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
2230035|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2230036|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230037|NCT00066599|Voriconazole|voriconazole|mesh-list
712766|NCT02964715|Empagliflozin|empagliflozin|mesh-list
712767|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
712768|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712769|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
712770|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230038|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
2230039|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230040|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2230041|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
713237|NCT02962388|Anagrelide|anagrelide|mesh-list
713238|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
713239|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
713240|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713241|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
713377|NCT02962024|Morphine|morphine|mesh-list
713378|NCT02962024|Bupivacaine|bupivacaine|mesh-list
713379|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
713380|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
713381|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
711085|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
711086|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
711087|NCT02971982|Rituximab|rituximab|mesh-list
711088|NCT02971982|Bortezomib|bortezomib|mesh-list
711089|NCT02971982|BB 1101|bb 1101|mesh-list
711090|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
711091|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
711092|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711093|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
711094|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
711095|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
711096|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711097|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711098|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
711099|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
711100|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
711101|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
711102|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
711103|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
711104|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
711105|NCT02971982|Hormones|hormones|mesh-ancestor
711106|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
711107|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
711108|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
711109|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711110|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
711338|NCT02970916|Aflibercept|aflibercept|mesh-list
711339|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
711340|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
711341|NCT02970916|Growth Substances|growth substances|mesh-ancestor
711342|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711343|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
711344|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711768|NCT02969252|Rifamycins|rifamycins|mesh-list
711769|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
711770|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
711771|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
711772|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
712134|NCT02967614|Timolol|timolol|mesh-list
712135|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
712136|NCT02967614|Dorzolamide|dorzolamide|mesh-list
712137|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
712138|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
712139|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
712140|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
712141|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712142|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712143|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
712144|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
712145|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
712146|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
712147|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
712148|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
712149|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713219|NCT02962258|Amlodipine|amlodipine|mesh-list
713220|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
713221|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
713222|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
713223|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
713224|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713225|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
713226|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713227|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
713228|NCT02962258|Diuretics|diuretics|mesh-ancestor
713229|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
713230|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2230042|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230043|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230044|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
713721|NCT02960711|Metformin|metformin|mesh-list
713722|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
713723|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714352|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
714353|NCT02958059|Cefoxitin|cefoxitin|mesh-list
714354|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230045|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
2230046|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2230047|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711508|NCT02970097|Fentanyl|fentanyl|mesh-list
711509|NCT02970097|Midazolam|midazolam|mesh-list
711510|NCT02970097|Ropivacaine|ropivacaine|mesh-list
711511|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
711512|NCT02970097|Narcotics|narcotics|mesh-ancestor
711513|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
711514|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711515|NCT02970097|Analgesics|analgesics|mesh-ancestor
711516|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
711517|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
711518|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
711519|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
711520|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
711521|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
711522|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
711523|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
711524|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
711525|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
711526|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
711527|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
711528|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
711529|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711530|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
711614|NCT02969629|Apomorphine|apomorphine|mesh-list
711615|NCT02969629|Emetics|emetics|mesh-ancestor
711616|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711617|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
711618|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
711619|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
711620|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
711621|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
711622|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
711623|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089869|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089870|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2089871|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2089872|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
2089873|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089874|NCT02205983|Acetaminophen|acetaminophen|mesh-list
2089875|NCT02205983|Hydromorphone|hydromorphone|mesh-list
2089876|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2089877|NCT02205983|Analgesics|analgesics|mesh-ancestor
2089878|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
2089879|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089880|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089881|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
2089882|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2089883|NCT02205983|Narcotics|narcotics|mesh-ancestor
712031|NCT02967939|Tenofovir|tenofovir|mesh-list
712032|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
712033|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
712034|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
712035|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
712036|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712037|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712038|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
712039|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
712312|NCT02966587|Durvalumab|durvalumab|mesh-list
712313|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
712314|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
712315|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
712316|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
712317|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712318|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
712319|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712779|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
712780|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
712781|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
712782|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
712783|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
712784|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712785|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
712786|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
712787|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230048|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2230049|NCT00066612|Irinotecan|irinotecan|mesh-list
2230050|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2230051|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2230052|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230053|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230054|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230055|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
2230056|NCT00066625|Bortezomib|bortezomib|mesh-list
2230057|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230058|NCT00066638|Romidepsin|romidepsin|mesh-list
2230059|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2230060|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230061|NCT00066651|Immunotoxins|immunotoxins|mesh-list
2230062|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
2230063|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230064|NCT00066716|Celecoxib|celecoxib|mesh-list
2230065|NCT00066716|Paclitaxel|paclitaxel|mesh-list
2230066|NCT00066716|Carboplatin|carboplatin|mesh-list
2230067|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2230068|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230069|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
2230070|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
2230071|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
2230072|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230073|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2230074|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2230075|NCT00066716|Analgesics|analgesics|mesh-ancestor
2230076|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
712074|NCT02967653|Atorvastatin|atorvastatin|mesh-list
712075|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
712076|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
712077|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
712078|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712079|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
712080|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
712081|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712325|NCT02966743|Midazolam|midazolam|mesh-list
712326|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
712327|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
712328|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
712329|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712330|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
712331|NCT02966743|Analgesics|analgesics|mesh-ancestor
712332|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
712333|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712334|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
712335|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
712336|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
712337|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
712338|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
712339|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712340|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
712341|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
712342|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
712343|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
712344|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
712345|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
712346|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
712347|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
712348|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
712638|NCT02965768|Naltrexone|naltrexone|mesh-list
712639|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
712640|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
712641|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712642|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
712643|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712875|NCT02964104|Insulin|insulin|mesh-list
712876|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
712877|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
712878|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089884|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2089885|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
2089886|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2089887|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
2230077|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
711360|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
711361|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
711362|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
711363|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
711364|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
711365|NCT02970643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
711366|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
711367|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
711368|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711369|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
711370|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
711371|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
711372|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2089888|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089889|NCT02206152|Expectorants|expectorants|mesh-ancestor
2089890|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
2089891|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2089892|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
2089893|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089894|NCT02206152|Protective Agents|protective agents|mesh-ancestor
2089895|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089896|NCT02206152|Antidotes|antidotes|mesh-ancestor
2089897|NCT02206620|Donepezil|donepezil|mesh-list
2089898|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2089899|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089900|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711866|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
711867|NCT02968693|Vancomycin|vancomycin|mesh-list
711868|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
711869|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
711870|NCT02968693|Calcium|calcium|mesh-list
711871|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
711872|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711873|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
711874|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
711875|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
711876|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
711877|NCT02968693|Protective Agents|protective agents|mesh-ancestor
712046|NCT02967887|Fluorouracil|fluorouracil|mesh-list
712047|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712048|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
712049|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712050|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
712051|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
712052|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
712053|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712501|NCT02966067|Anesthetics|anesthetics|mesh-list
712502|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
712503|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
712504|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712829|NCT02964572|Empagliflozin|empagliflozin|mesh-list
712830|NCT02964572|Glimepiride|glimepiride|mesh-list
712831|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
712832|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712833|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
712834|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712835|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
712836|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
712837|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
2230078|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230079|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2230080|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230081|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2230082|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2230083|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230084|NCT00066768|Gemcitabine|gemcitabine|mesh-list
2230085|NCT00066768|Suramin|suramin|mesh-list
2230086|NCT00066768|Docetaxel|docetaxel|mesh-list
2230087|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2230088|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
2230089|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230090|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230091|NCT00066768|Antiviral Agents|antiviral agents|mesh-ancestor
2230092|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230093|NCT00066768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230094|NCT00066768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230095|NCT00066768|Immunologic Factors|immunologic factors|mesh-ancestor
711804|NCT02969083|Gemcitabine|gemcitabine|mesh-list
711805|NCT02969083|Cisplatin|cisplatin|mesh-list
711806|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711807|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
711808|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
711809|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711810|NCT02969083|Antiviral Agents|antiviral agents|mesh-ancestor
711811|NCT02969083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
711812|NCT02969083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711813|NCT02969083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
711814|NCT02969083|Immunologic Factors|immunologic factors|mesh-ancestor
711815|NCT02969083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711960|NCT02968303|Vemurafenib|vemurafenib|mesh-list
711961|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
711962|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
711963|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
711964|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712164|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
712165|NCT02967380|Antidotes|antidotes|mesh-ancestor
712166|NCT02967380|Protective Agents|protective agents|mesh-ancestor
712167|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712168|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
712169|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
712170|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712171|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
712272|NCT02966717|Rituximab|rituximab|mesh-list
712273|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
712274|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712275|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
712276|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712277|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230096|NCT00066768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230097|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
2230098|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
2230099|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
2230100|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
2230101|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
2230102|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2230103|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2230104|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2230105|NCT00066794|Cytarabine|cytarabine|mesh-list
2230106|NCT00066794|Cyclosporine|cyclosporine|mesh-list
2230107|NCT00066794|Daunorubicin|daunorubicin|mesh-list
2230108|NCT00066794|Cyclosporins|cyclosporins|mesh-list
2230109|NCT00066794|Sargramostim|sargramostim|mesh-list
2230110|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
2230111|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230112|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2230113|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
2089901|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
2089902|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089903|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230114|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713458|NCT02961803|Biotin|biotin|mesh-list
713459|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
713460|NCT02961803|Vitamins|vitamins|mesh-ancestor
713461|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
713462|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711506|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
711507|NCT02970084|Coagulants|coagulants|mesh-ancestor
2230115|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230116|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
2230117|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230118|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230119|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230120|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
2230121|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
712205|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
712206|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
712207|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2089904|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
2089905|NCT02206685|Methadone|methadone|mesh-list
2089906|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2089907|NCT02206685|Narcotics|narcotics|mesh-ancestor
2089908|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
712771|NCT02964949|Edoxaban|edoxaban|mesh-list
712772|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
712773|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
712774|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
712775|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
712776|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712777|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712778|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
713153|NCT02963324|Ivermectin|ivermectin|mesh-list
713154|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
713155|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
713269|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
713270|NCT02962323|Calcium|calcium|mesh-list
713271|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
713272|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713273|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
713274|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
713275|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
713276|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713277|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
713278|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
713279|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713495|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
713496|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
713497|NCT02961166|Antibodies|antibodies|mesh-list
713498|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
713499|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230122|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230123|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2230124|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2230125|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2230126|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2230127|NCT00066846|Leucovorin|leucovorin|mesh-list
2230128|NCT00066846|Bevacizumab|bevacizumab|mesh-list
2230129|NCT00066846|Fluorouracil|fluorouracil|mesh-list
2230130|NCT00066846|Calcium|calcium|mesh-list
2230131|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
2230132|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
714405|NCT02957903|Ropivacaine|ropivacaine|mesh-list
714406|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
714407|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
714408|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
714409|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714410|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
714411|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714545|NCT02957162|Atorvastatin|atorvastatin|mesh-list
714546|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
714547|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
714548|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
714549|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714550|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
714551|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
714552|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230133|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230134|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2230135|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2230136|NCT00066846|Growth Substances|growth substances|mesh-ancestor
2230137|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230138|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
2230139|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2230140|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
2230141|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230142|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2230143|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230144|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
2230145|NCT00066846|Antidotes|antidotes|mesh-ancestor
2230146|NCT00066846|Protective Agents|protective agents|mesh-ancestor
2230147|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
2230148|NCT00066846|Vitamins|vitamins|mesh-ancestor
2230149|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
2230150|NCT00066859|Sertraline|sertraline|mesh-list
2230151|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
711773|NCT02969265|Amlodipine|amlodipine|mesh-list
711774|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
711775|NCT02969265|Candesartan|candesartan|mesh-list
711776|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
711777|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
711778|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
711779|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711780|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
711781|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711782|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
711783|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
711784|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
712379|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
712380|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713007|NCT02963454|Simendan|simendan|mesh-list
713008|NCT02963454|Dobutamine|dobutamine|mesh-list
713009|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
713010|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
713011|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
713012|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
713013|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713014|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713015|NCT02963454|Protective Agents|protective agents|mesh-ancestor
713016|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713017|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
713018|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
713019|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713020|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
713021|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
713022|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
713023|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
713024|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
713147|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
713148|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
713149|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
713150|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
713151|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713152|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2230152|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2230153|NCT00066859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
713466|NCT02961608|Tacrolimus|tacrolimus|mesh-list
713467|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
713468|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
713469|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713470|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
713471|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713472|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713898|NCT02959918|Sirolimus|sirolimus|mesh-list
713899|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
713900|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
713901|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
713902|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713903|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
2230154|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2230155|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2230156|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230157|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230158|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
2230159|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230160|NCT00066872|Imiquimod|imiquimod|mesh-list
2230161|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2230162|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
2230163|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230164|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230165|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
2230166|NCT00066885|Calcitriol|calcitriol|mesh-list
2230167|NCT00066885|Docetaxel|docetaxel|mesh-list
2230168|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230169|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
2230170|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
2230171|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
2230172|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230173|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2230174|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230175|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2230176|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2230177|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
713098|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
713099|NCT02963090|Topotecan|topotecan|mesh-list
713100|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
713101|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713102|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
713103|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
713104|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713105|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089909|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089910|NCT02206685|Analgesics|analgesics|mesh-ancestor
2089911|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
2089912|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089913|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
713575|NCT02961101|Decitabine|decitabine|mesh-list
713576|NCT02961101|Antibodies|antibodies|mesh-list
713577|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
713578|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713579|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
713580|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
713581|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713582|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713583|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713789|NCT02960035|Etanercept|etanercept|mesh-list
713790|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
713791|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
713792|NCT02960035|Analgesics|analgesics|mesh-ancestor
713793|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
713794|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713795|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713796|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
713797|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
713798|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
713799|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
713800|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
713959|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
713960|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
713961|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
713962|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
713963|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714120|NCT02958878|Tamsulosin|tamsulosin|mesh-list
714121|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
714122|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
714123|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
714124|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
714125|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714126|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714127|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714128|NCT02958878|Urological Agents|urological agents|mesh-ancestor
2230178|NCT00066885|Vitamins|vitamins|mesh-ancestor
2230179|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
2230180|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2230181|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
711707|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
711708|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
711709|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
711710|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711711|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
711712|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
711713|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
711714|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
711715|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712054|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
712055|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
712056|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
712057|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
712208|NCT02967211|Insulin|insulin|mesh-list
712209|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
712210|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
712211|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
712212|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
712213|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
712214|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
712215|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
712216|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713071|NCT02963051|Copper|copper|mesh-list
713072|NCT02963051|Disulfiram|disulfiram|mesh-list
713073|NCT02963051|Trace Elements|trace elements|mesh-ancestor
713074|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
713075|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713076|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
713077|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
713078|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713079|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713166|NCT02962804|Nivolumab|nivolumab|mesh-list
713167|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
713168|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713169|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
713170|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713392|NCT02961829|Niacinamide|niacinamide|mesh-list
713393|NCT02961829|Maraviroc|maraviroc|mesh-list
713394|NCT02961829|Dolutegravir|dolutegravir|mesh-list
713395|NCT02961829|Auranofin|auranofin|mesh-list
713396|NCT02961829|Vaccines|vaccines|mesh-list
713397|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
713398|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
713399|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713400|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
713401|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
713402|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711792|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
711793|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711794|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
711795|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
711796|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
711797|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
711798|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
711799|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
711800|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
711801|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
711802|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711803|NCT02969239|Protective Agents|protective agents|mesh-ancestor
712095|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
712096|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
712097|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
712098|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
712099|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
712100|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712101|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712102|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712103|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
712104|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2230182|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2230183|NCT00066950|Fluorides|fluorides|mesh-list
2230184|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
2230185|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
2230186|NCT00066950|Protective Agents|protective agents|mesh-ancestor
2230187|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230188|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2230189|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230190|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
2230191|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
713938|NCT02959749|Bevacizumab|bevacizumab|mesh-list
713939|NCT02959749|Docetaxel|docetaxel|mesh-list
713940|NCT02959749|Osimertinib|osimertinib|mesh-list
713941|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
713942|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713943|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
713944|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
713945|NCT02959749|Growth Substances|growth substances|mesh-ancestor
713946|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713947|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
713948|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
713949|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
713950|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
713951|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713952|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
713953|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714574|NCT02957097|Gabapentin|gabapentin|mesh-list
714575|NCT02957097|Analgesics|analgesics|mesh-ancestor
714576|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
714577|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714578|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714579|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
714580|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
714581|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
714582|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
714583|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
714584|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
714585|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
714586|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714587|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714588|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
714648|NCT02956785|Dinoprostone|dinoprostone|mesh-list
714649|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
714650|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
714651|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714872|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
714873|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
714874|NCT02955706|Vitamins|vitamins|mesh-ancestor
714875|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
714876|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714877|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
2230192|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
2230193|NCT00066989|Antibodies|antibodies|mesh-list
2230194|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
2230195|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2230196|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2230197|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
2230198|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230199|NCT00067015|Goserelin|goserelin|mesh-list
711989|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
711990|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
711991|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
711992|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
711993|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
711994|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
711995|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
712309|NCT02966457|Colistin|colistin|mesh-list
712310|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
712311|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
712627|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
712628|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
712629|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
712630|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
712631|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712632|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
712633|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089914|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
2089915|NCT02206776|Midazolam|midazolam|mesh-list
2089916|NCT02206776|Ketamine|ketamine|mesh-list
713231|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
713232|NCT02962401|Idelalisib|idelalisib|mesh-list
713233|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
713234|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713235|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713236|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713371|NCT02962037|Melatonin|melatonin|mesh-list
713372|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
713373|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713374|NCT02962037|Protective Agents|protective agents|mesh-ancestor
713375|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713376|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2089917|NCT02206776|Analgesics|analgesics|mesh-ancestor
2089918|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
2089919|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2089920|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089921|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
713964|NCT02959762|Vitamins|vitamins|mesh-list
713965|NCT02959762|Vitamin K|vitamin k|mesh-list
713966|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
713967|NCT02959762|Vitamin MK 7|vitamin mk 7|mesh-list
713968|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
713969|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713970|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
713971|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
713972|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713973|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
713974|NCT02959762|Coagulants|coagulants|mesh-ancestor
2230200|NCT00067015|Bicalutamide|bicalutamide|mesh-list
2230201|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2230202|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714355|NCT02958111|Capecitabine|capecitabine|mesh-list
714356|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
714357|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
714358|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714359|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714825|NCT02955524|Lidocaine|lidocaine|mesh-list
714826|NCT02955524|Tetracaine|tetracaine|mesh-list
714827|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
714828|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
714829|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
714830|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714831|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
714832|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714833|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
714834|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
714835|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
714836|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
714837|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089922|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2230203|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
712010|NCT02968082|Scopolamine|scopolamine|mesh-list
712011|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
712012|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
712013|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
712014|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
712015|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712016|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712017|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
712018|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
712019|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
712020|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
712021|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
712022|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712023|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
712024|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
712025|NCT02967757|Liraglutide|liraglutide|mesh-list
712026|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
712027|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712028|NCT02967757|Incretins|incretins|mesh-ancestor
712029|NCT02967757|Hormones|hormones|mesh-ancestor
712030|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2230204|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
2230205|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2230206|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230207|NCT00067041|Treprostinil|treprostinil|mesh-list
2230208|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
713128|NCT02962986|Phenylephrine|phenylephrine|mesh-list
713129|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
713130|NCT02962986|Norepinephrine|norepinephrine|mesh-list
713131|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
713132|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
713133|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
713134|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713135|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713136|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
713137|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
713138|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
713139|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
713140|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
713141|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
713142|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
713143|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
713144|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
713145|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713146|NCT02962986|Protective Agents|protective agents|mesh-ancestor
2230209|NCT00067080|Deferasirox|deferasirox|mesh-list
2230210|NCT00067080|Deferoxamine|deferoxamine|mesh-list
2230211|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2230212|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
2230213|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
2230214|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230215|NCT00067080|Siderophores|siderophores|mesh-ancestor
2230216|NCT00067093|Vitamin K|vitamin k|mesh-list
2230217|NCT00067093|Heparin|heparin|mesh-list
2230218|NCT00067093|Calcium heparin|calcium heparin|mesh-list
714188|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
714189|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
714190|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
714191|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714192|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
714193|NCT02958761|Protective Agents|protective agents|mesh-ancestor
714328|NCT02957994|Tenofovir|tenofovir|mesh-list
714329|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
714330|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
714331|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
714332|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
714333|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714334|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714335|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
714336|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
714697|NCT02956408|Vitamin D|vitamin d|mesh-list
714698|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
714699|NCT02956408|Vitamins|vitamins|mesh-ancestor
714700|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
714701|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714702|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2230219|NCT00067093|Idraparinux|idraparinux|mesh-list
711999|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
712000|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
712001|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
712002|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
712003|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712004|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
712005|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
712006|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712007|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
712008|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
712009|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
712217|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
712218|NCT02966912|Antacids|antacids|mesh-ancestor
712219|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712220|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
712452|NCT02966665|Vitamins|vitamins|mesh-list
712453|NCT02966665|Vitamin E|vitamin e|mesh-list
712454|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
712455|NCT02966665|Fexofenadine|fexofenadine|mesh-list
712456|NCT02966665|Valsartan|valsartan|mesh-list
712457|NCT02966665|Nitroprusside|nitroprusside|mesh-list
712458|NCT02966665|Phentolamine|phentolamine|mesh-list
712459|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
712460|NCT02966665|Norepinephrine|norepinephrine|mesh-list
712461|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
712462|NCT02966665|Giapreza|giapreza|mesh-list
712463|NCT02966665|Acetylcholine|acetylcholine|mesh-list
712464|NCT02966665|Ranitidine|ranitidine|mesh-list
712465|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
712466|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
712467|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712468|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
712469|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
712470|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
712471|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712472|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
712473|NCT02966665|Protective Agents|protective agents|mesh-ancestor
712474|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
712475|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
712476|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
712477|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
712478|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
712479|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
712480|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712481|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
712482|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
712483|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
712484|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
712485|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
712486|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
712487|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
712488|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
712489|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
712490|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
712491|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
712492|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
712493|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
712494|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
712495|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712496|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
712497|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
712498|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
712499|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
712500|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
712736|NCT02965027|Prazosin|prazosin|mesh-list
712737|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
712738|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
712739|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
712740|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
712741|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
712742|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
712743|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712744|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712790|NCT02964689|Pemetrexed|pemetrexed|mesh-list
712791|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712792|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712793|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712044|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
712045|NCT02967874|Protective Agents|protective agents|mesh-ancestor
712236|NCT02967094|Expectorants|expectorants|mesh-list
712237|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
712692|NCT02965196|Dexamethasone|dexamethasone|mesh-list
712693|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
712694|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
712695|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
712696|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712697|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712698|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
712699|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
712700|NCT02965196|Hormones|hormones|mesh-ancestor
712701|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
712702|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
712703|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713055|NCT02963181|Melatonin|melatonin|mesh-list
713056|NCT02963181|Yohimbine|yohimbine|mesh-list
713057|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
713058|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713059|NCT02963181|Protective Agents|protective agents|mesh-ancestor
713060|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713061|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
713062|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
713063|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
713064|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713065|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
713066|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
713067|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
713068|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
713069|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
713070|NCT02963181|Urological Agents|urological agents|mesh-ancestor
713212|NCT02962232|Paclitaxel|paclitaxel|mesh-list
713213|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
713214|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713215|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
713216|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
713217|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
713218|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713505|NCT02961816|Pyridoxine|pyridoxine|mesh-list
713506|NCT02961816|Gemcitabine|gemcitabine|mesh-list
713507|NCT02961816|Dexamethasone|dexamethasone|mesh-list
713508|NCT02961816|Rituximab|rituximab|mesh-list
713509|NCT02961816|Melphalan|melphalan|mesh-list
713510|NCT02961816|Busulfan|busulfan|mesh-list
713511|NCT02961816|Panobinostat|panobinostat|mesh-list
713512|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
713513|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
713514|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
713515|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713516|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713517|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
713518|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
713519|NCT02961816|Hormones|hormones|mesh-ancestor
713520|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
713521|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
713522|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713523|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
713524|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
713525|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
713526|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
713527|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
713528|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713529|NCT02961816|Antiviral Agents|antiviral agents|mesh-ancestor
713530|NCT02961816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
713531|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713532|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
713533|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
713534|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
713535|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
713536|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
713537|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
713538|NCT02961816|Vitamins|vitamins|mesh-ancestor
713539|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
2230220|NCT00067093|Vitamins|vitamins|mesh-ancestor
2230221|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
2230222|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712111|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712112|NCT02967432|Emollients|emollients|mesh-ancestor
712113|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
712381|NCT02966704|Caseins|caseins|mesh-list
712382|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
712383|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
712384|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712522|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
712523|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
712524|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
712525|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712526|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
712527|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
712528|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
712529|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712530|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712531|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
713120|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
713121|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
713122|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
713123|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
713124|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713125|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
713126|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
713127|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230223|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
2230224|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2230225|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2230226|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230227|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
714040|NCT02959359|Ribavirin|ribavirin|mesh-list
714041|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
714042|NCT02959359|Ledipasvir|ledipasvir|mesh-list
714043|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
714044|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714045|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
714046|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
714337|NCT02958046|Domperidone|domperidone|mesh-list
714338|NCT02958046|Lansoprazole|lansoprazole|mesh-list
714339|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
714340|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
714341|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
714342|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
714343|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714344|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714345|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
714346|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
714347|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714348|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714349|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
714350|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
714351|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230228|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
2230229|NCT00067093|Coagulants|coagulants|mesh-ancestor
2230230|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2230231|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
2230232|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2230233|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
2230234|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230235|NCT00067119|Aspirin|aspirin|mesh-list
714620|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
714621|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753021|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753022|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715029|NCT02954991|Nivolumab|nivolumab|mesh-list
715030|NCT02954991|Mocetinostat|mocetinostat|mesh-list
715031|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
715032|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715033|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
715034|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715035|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
715036|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715085|NCT02954549|Vitamin D|vitamin d|mesh-list
715086|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
715087|NCT02954549|Vitamins|vitamins|mesh-ancestor
715088|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
2230236|NCT00067119|Dipyridamole|dipyridamole|mesh-list
712114|NCT02967276|Metformin|metformin|mesh-list
712115|NCT02967276|Dexamethasone|dexamethasone|mesh-list
712116|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
712117|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
712118|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
712119|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712120|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712121|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
712122|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
712123|NCT02967276|Hormones|hormones|mesh-ancestor
712124|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
712125|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
712126|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712127|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2230237|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2230238|NCT00067119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2230239|NCT00067119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2230240|NCT00067119|Analgesics|analgesics|mesh-ancestor
2230241|NCT00067119|Sensory System Agents|sensory system agents|mesh-ancestor
2230242|NCT00067119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230243|NCT00067119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230244|NCT00067119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2230245|NCT00067119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230246|NCT00067119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2230247|NCT00067119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2230248|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230249|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2230250|NCT00067119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
713080|NCT02963337|Remifentanil|remifentanil|mesh-list
713081|NCT02963337|Bupivacaine|bupivacaine|mesh-list
713082|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
713083|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
713084|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
713085|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713086|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
713087|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713088|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
713089|NCT02963337|Narcotics|narcotics|mesh-ancestor
713090|NCT02963337|Analgesics|analgesics|mesh-ancestor
713328|NCT02962141|Paclitaxel|paclitaxel|mesh-list
713329|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
713330|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713331|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
713332|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
713333|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
713334|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713695|NCT02960412|Furosemide|furosemide|mesh-list
713696|NCT02960412|Diuretics|diuretics|mesh-ancestor
713697|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
713698|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713699|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
713700|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
713701|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089923|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
2089924|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
2089925|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2089926|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
714609|NCT02957019|Rituximab|rituximab|mesh-list
714610|NCT02957019|Interleukin-2|interleukin-2|mesh-list
714611|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
714612|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714613|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
714614|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714615|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
714616|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
714617|NCT02957019|Analgesics|analgesics|mesh-ancestor
714618|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
714619|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714627|NCT02956538|Thalidomide|thalidomide|mesh-list
714628|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
714629|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
714630|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714631|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
714632|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
714633|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
712163|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712597|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
712598|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
712599|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
712600|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
712601|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
712602|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
712603|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712604|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
712605|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
712606|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712607|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
712608|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712745|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
712746|NCT02965248|Leucovorin|leucovorin|mesh-list
712747|NCT02965248|Capecitabine|capecitabine|mesh-list
712748|NCT02965248|Raltitrexed|raltitrexed|mesh-list
712749|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
712750|NCT02965248|Calcium|calcium|mesh-list
712751|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
712752|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
712753|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712754|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
712755|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
712756|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
712757|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712758|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712759|NCT02965248|Antidotes|antidotes|mesh-ancestor
712760|NCT02965248|Protective Agents|protective agents|mesh-ancestor
712761|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
712762|NCT02965248|Vitamins|vitamins|mesh-ancestor
712763|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
712764|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
712765|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713171|NCT02962830|Sufentanil|sufentanil|mesh-list
713172|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
713173|NCT02962830|Narcotics|narcotics|mesh-ancestor
713174|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
713175|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713176|NCT02962830|Analgesics|analgesics|mesh-ancestor
713177|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
713178|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713179|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
713180|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
713181|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
713182|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
713664|NCT02960919|Amoxicillin|amoxicillin|mesh-list
713665|NCT02960919|Gentamicins|gentamicins|mesh-list
713666|NCT02960919|Penicillins|penicillins|mesh-list
713667|NCT02960919|Ampicillin|ampicillin|mesh-list
713668|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
713669|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
713670|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
713671|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713672|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230251|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230252|NCT00067119|Antipyretics|antipyretics|mesh-ancestor
714439|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
714440|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
714441|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
714442|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
714443|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
714444|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714445|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
714446|NCT02957851|Analgesics|analgesics|mesh-ancestor
714447|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
714448|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
715283|NCT02954029|Hemostatics|hemostatics|mesh-list
715284|NCT02954029|Coagulants|coagulants|mesh-ancestor
2230253|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2230254|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
2230255|NCT00067158|Nicotine|nicotine|mesh-list
712298|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
712299|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712300|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
712301|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
712302|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
712303|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
712304|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
712305|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
712306|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
712307|NCT02966522|Growth Substances|growth substances|mesh-ancestor
712308|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
712409|NCT02966119|Aspirin|aspirin|mesh-list
712410|NCT02966119|Clopidogrel|clopidogrel|mesh-list
712411|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
712412|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
712413|NCT02966119|Analgesics|analgesics|mesh-ancestor
712414|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
712415|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712416|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712417|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
712418|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
712419|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
712420|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
712421|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712422|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
712423|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
712424|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712425|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
712426|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
712427|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
712428|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
712429|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
712430|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089927|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2089928|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089929|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230256|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
713322|NCT02962050|Capsaicin|capsaicin|mesh-list
713323|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
713324|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
713325|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
713326|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713327|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230257|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
2230258|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230259|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230260|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2230261|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2230262|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
2230263|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230264|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230265|NCT00067262|Valproic Acid|valproic acid|mesh-list
2230266|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
713907|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
713908|NCT02960646|Melphalan|melphalan|mesh-list
713909|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
713910|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
713911|NCT02960646|Rituximab|rituximab|mesh-list
713912|NCT02960646|Fludarabine|fludarabine|mesh-list
713913|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
713914|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
713915|NCT02960646|Tacrolimus|tacrolimus|mesh-list
713916|NCT02960646|Antibodies|antibodies|mesh-list
713917|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
713918|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
713919|NCT02960646|Lenograstim|lenograstim|mesh-list
713920|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
713921|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
713922|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713923|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
713924|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
713925|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
713926|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713927|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713928|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
714033|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2089930|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2089931|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2089932|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
712403|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
712404|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
712405|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
712406|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712407|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
712408|NCT02966236|Coagulants|coagulants|mesh-ancestor
712652|NCT02965404|Vaccines|vaccines|mesh-list
712664|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
712665|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712848|NCT02964403|Indomethacin|indomethacin|mesh-list
712849|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
712850|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
712851|NCT02964403|Analgesics|analgesics|mesh-ancestor
712852|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
712853|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
712854|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712855|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
712856|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
712857|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
712858|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
712859|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
712860|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
712861|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712862|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713731|NCT02960126|Aspirin|aspirin|mesh-list
713732|NCT02960126|Clopidogrel|clopidogrel|mesh-list
713733|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
713734|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
713735|NCT02960126|Analgesics|analgesics|mesh-ancestor
713736|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
713737|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713738|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713739|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
713740|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
713741|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
713742|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
713743|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713744|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
713745|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
713746|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713747|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
713748|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
713749|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
713750|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
713751|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
713752|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
713895|NCT02959775|Vaccines|vaccines|mesh-list
713896|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
713897|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714021|NCT02959541|Leucovorin|leucovorin|mesh-list
714022|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
714023|NCT02959541|Antidotes|antidotes|mesh-ancestor
714024|NCT02959541|Protective Agents|protective agents|mesh-ancestor
714025|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714026|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
714027|NCT02959541|Vitamins|vitamins|mesh-ancestor
714028|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
714639|NCT02957409|Valsartan|valsartan|mesh-list
714640|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
714641|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
714642|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
714643|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230267|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230268|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230269|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
2230270|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230271|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230272|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
2230273|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2230274|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2230275|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2230276|NCT00067301|Citalopram|citalopram|mesh-list
2089933|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
712371|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
712372|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
712373|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712374|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712704|NCT02965274|Fluoxetine|fluoxetine|mesh-list
712705|NCT02965274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
712706|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
712707|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
712708|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712709|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
712710|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
712711|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712712|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
712713|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
712714|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
712715|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
712716|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
712717|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230277|NCT00067301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2230278|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2230279|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2230280|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230281|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230282|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
2230283|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712933|NCT02963714|Vaccines|vaccines|mesh-list
712934|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
712935|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712985|NCT02963402|Adalimumab|adalimumab|mesh-list
712986|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
712987|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
713156|NCT02962947|Propranolol|propranolol|mesh-list
713157|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
713158|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
713159|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
713160|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
713161|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713162|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713163|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
713164|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
713165|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
2089934|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2089935|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
2089936|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
2089937|NCT02207088|Ritonavir|ritonavir|mesh-list
2089938|NCT02207088|Ribavirin|ribavirin|mesh-list
2089939|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2089940|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
713647|NCT02960828|Bevacizumab|bevacizumab|mesh-list
713648|NCT02960828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
713649|NCT02960828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713650|NCT02960828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
713651|NCT02960828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
713652|NCT02960828|Growth Substances|growth substances|mesh-ancestor
713653|NCT02960828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713654|NCT02960828|Growth Inhibitors|growth inhibitors|mesh-ancestor
713812|NCT02959905|Vidarabine|vidarabine|mesh-list
713813|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
713814|NCT02959905|Fludarabine|fludarabine|mesh-list
713815|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
713816|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
713817|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
713818|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713819|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
713820|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
713821|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
713822|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713823|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713824|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
713825|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
713826|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
713827|NCT02959905|Antiviral Agents|antiviral agents|mesh-ancestor
713828|NCT02959905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089941|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
712535|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712536|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2753023|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2753024|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2753025|NCT03177291|Analgesics|analgesics|mesh-ancestor
2753026|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
2753027|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2753028|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753029|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2753030|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2753031|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2753032|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
712824|NCT02964585|Canagliflozin|canagliflozin|mesh-list
712825|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
712826|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712827|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
712828|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713280|NCT02962518|Triamcinolone|triamcinolone|mesh-list
713281|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
713282|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
713283|NCT02962518|Hormones|hormones|mesh-ancestor
713284|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
713285|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713335|NCT02961855|Diclofenac|diclofenac|mesh-list
713336|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
713337|NCT02961855|Lidocaine|lidocaine|mesh-list
713338|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
713339|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
713340|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
713341|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713342|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
713343|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713344|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
713345|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
713346|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
713347|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
713348|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713349|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
713350|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
713351|NCT02961855|Analgesics|analgesics|mesh-ancestor
713352|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
713353|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
713354|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089942|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089943|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089944|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2089945|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2089946|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
2089947|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230284|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
713774|NCT02960113|Scopolamine|scopolamine|mesh-list
713775|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
713776|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
713777|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
713778|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
713779|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713780|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713781|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
713782|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
713783|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
713784|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
713785|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
713786|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713787|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
713788|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
2230285|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
2230286|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
712593|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
712594|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
712595|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
712596|NCT02965963|Protective Agents|protective agents|mesh-ancestor
2230287|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
2230288|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2230289|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230290|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
2230291|NCT00067353|Fluorides|fluorides|mesh-list
2230292|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
2089948|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2089949|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2089950|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
2089951|NCT02207231|Adalimumab|adalimumab|mesh-list
2089952|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
714644|NCT02956655|Insulin|insulin|mesh-list
714645|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
714646|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
714647|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089953|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2089954|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089955|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
2089956|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089957|NCT02207244|Adalimumab|adalimumab|mesh-list
2089958|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2089959|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2089960|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2089961|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
2089962|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089963|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2089964|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
2089965|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2089966|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089967|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2089968|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089969|NCT02207400|Listerine|listerine|mesh-list
2089970|NCT02207400|Fluorides|fluorides|mesh-list
2089971|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
2089972|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
2089973|NCT02207400|Protective Agents|protective agents|mesh-ancestor
2230293|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
2230294|NCT00067353|Protective Agents|protective agents|mesh-ancestor
2230295|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230296|NCT00067405|Micronutrients|micronutrients|mesh-list
2230297|NCT00067405|Trace Elements|trace elements|mesh-list
2230298|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230299|NCT00067431|Valproic Acid|valproic acid|mesh-list
716263|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
716264|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
716265|NCT02950051|Rituximab|rituximab|mesh-list
716266|NCT02950051|Fludarabine|fludarabine|mesh-list
716267|NCT02950051|Venetoclax|venetoclax|mesh-list
716268|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
716269|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
716270|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
716271|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716272|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
716273|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
716274|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
716275|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716276|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716277|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
716278|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
716796|NCT02947334|Bococizumab|bococizumab|mesh-list
716797|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
716798|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
716799|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
716800|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716801|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
717277|NCT02944981|Gabapentin|gabapentin|mesh-list
717278|NCT02944981|Analgesics|analgesics|mesh-ancestor
717279|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
717280|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717281|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717282|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
2089974|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
712730|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
712731|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712930|NCT02963766|Dulaglutide|dulaglutide|mesh-list
712931|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
712932|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713091|NCT02963103|Tacrolimus|tacrolimus|mesh-list
713092|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
713093|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
713094|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713095|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
713096|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713097|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230300|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
2230301|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713555|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
713556|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
713557|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
714105|NCT02959125|Micronutrients|micronutrients|mesh-list
714106|NCT02959125|Trace Elements|trace elements|mesh-list
714107|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714259|NCT02958566|Acetaminophen|acetaminophen|mesh-list
714260|NCT02958566|Ketorolac|ketorolac|mesh-list
714261|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
714262|NCT02958566|Lidocaine|lidocaine|mesh-list
714263|NCT02958566|Fentanyl|fentanyl|mesh-list
714264|NCT02958566|Morphine|morphine|mesh-list
714265|NCT02958566|Tramadol|tramadol|mesh-list
714266|NCT02958566|Methadone|methadone|mesh-list
714267|NCT02958566|Hydrocodone|hydrocodone|mesh-list
714268|NCT02958566|Hydromorphone|hydromorphone|mesh-list
714269|NCT02958566|Ketamine|ketamine|mesh-list
714270|NCT02958566|Gabapentin|gabapentin|mesh-list
714271|NCT02958566|Orphenadrine|orphenadrine|mesh-list
714272|NCT02958566|Bupivacaine|bupivacaine|mesh-list
714273|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
714274|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
714275|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
714276|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714277|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
714278|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714279|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
714280|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
714281|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
714282|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
714283|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714284|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
714285|NCT02958566|Narcotics|narcotics|mesh-ancestor
714286|NCT02958566|Analgesics|analgesics|mesh-ancestor
714287|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
714288|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
714289|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
714290|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
714291|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
714292|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714293|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
714294|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
714295|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
714296|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
714297|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
714298|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
714299|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
714300|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
714301|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
714302|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
714303|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
714304|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
714305|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714306|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
714307|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
714308|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
714309|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
714310|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
714311|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
714312|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
714313|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
714314|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
714315|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
714316|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
714317|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
712789|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713242|NCT02962336|Amlodipine|amlodipine|mesh-list
713243|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
713244|NCT02962336|Olmesartan|olmesartan|mesh-list
713245|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
713246|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
713247|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
713248|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
713249|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713250|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
713251|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713252|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
713253|NCT02962336|Diuretics|diuretics|mesh-ancestor
713254|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
713255|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
713256|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
713257|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2230302|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230303|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
714399|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
714400|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714401|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
714402|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714403|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714404|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2230304|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230305|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230306|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
2230307|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2230308|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2230309|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2230310|NCT00067444|Paroxetine|paroxetine|mesh-list
2230311|NCT00067444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2230312|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2230313|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2230314|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230315|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230316|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
2230317|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230318|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2230319|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
715147|NCT02954276|Sumatriptan|sumatriptan|mesh-list
715148|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
715149|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
715150|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
715151|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
715152|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
715153|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715154|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715547|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
715548|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
715549|NCT02953145|Coagulants|coagulants|mesh-ancestor
2230320|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2230321|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2230322|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2230323|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230324|NCT00067457|Alosetron|alosetron|mesh-list
2230325|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2230326|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2230327|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
716653|NCT02947516|Liver Extracts|liver extracts|mesh-list
716654|NCT02947516|Hematinics|hematinics|mesh-ancestor
716910|NCT02946684|Letrozole|letrozole|mesh-list
716911|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
712794|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
712805|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
713049|NCT02963129|Mupirocin|mupirocin|mesh-list
713050|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
713051|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
713052|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
713053|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713054|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713584|NCT02961257|Prednisone|prednisone|mesh-list
713585|NCT02961257|Sargramostim|sargramostim|mesh-list
713586|NCT02961257|Lenograstim|lenograstim|mesh-list
713587|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
713588|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
713589|NCT02961257|Hormones|hormones|mesh-ancestor
713590|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
713591|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713592|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
713593|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713594|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
713595|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
714808|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
714809|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
714810|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
714811|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714812|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
714813|NCT02955732|Analgesics|analgesics|mesh-ancestor
714814|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
714815|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714816|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
714817|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
714818|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
714819|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
714820|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714821|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715076|NCT02954692|Metformin|metformin|mesh-list
715077|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
715078|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
715079|NCT02954692|Meglitinide|meglitinide|mesh-list
715080|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
715081|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
715082|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715083|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715084|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715398|NCT02953405|Clopidogrel|clopidogrel|mesh-list
715399|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
715400|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
715401|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
715402|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
715403|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
715404|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
715405|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715406|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230328|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230329|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230330|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230331|NCT00067496|Modafinil|modafinil|mesh-list
2230332|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2230333|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230334|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
716228|NCT02950155|Rituximab|rituximab|mesh-list
716229|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
716230|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716231|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
716232|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716233|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
716926|NCT02946801|Listerine|listerine|mesh-list
716927|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
716928|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
716929|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
716930|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
716931|NCT02946801|Protective Agents|protective agents|mesh-ancestor
716932|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717538|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
717539|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
712806|NCT02964455|Docetaxel|docetaxel|mesh-list
712807|NCT02964455|Nedaplatin|nedaplatin|mesh-list
712808|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
712809|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
712810|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
712811|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
712812|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230335|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2230336|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2230337|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230338|NCT00067509|Progesterone|progesterone|mesh-list
2230339|NCT00067509|Estrogens|estrogens|mesh-list
2230340|NCT00067509|Progestins|progestins|mesh-ancestor
2230341|NCT00067509|Hormones|hormones|mesh-ancestor
2230342|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2230343|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714392|NCT02958163|Doxorubicin|doxorubicin|mesh-list
714393|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
714394|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714395|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
714396|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
714397|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714398|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230344|NCT00067535|Cocaine|cocaine|mesh-list
2230345|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
2230346|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
2230347|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2230348|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230349|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
2230350|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230351|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2230352|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2230353|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
715071|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
715072|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
715073|NCT02954588|Vitamins|vitamins|mesh-ancestor
715074|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
715075|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230354|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2230355|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230356|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
2230357|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
715996|NCT02951260|Metformin|metformin|mesh-list
715997|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
715998|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716082|NCT02950870|Ritonavir|ritonavir|mesh-list
716083|NCT02950870|Ribavirin|ribavirin|mesh-list
716084|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
716085|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
716086|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
716087|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716088|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716089|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
716090|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
716091|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
716092|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
716093|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
716094|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
716095|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
2230358|NCT00067548|EKB 569|ekb 569|mesh-list
2230359|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230360|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2230361|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230362|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230363|NCT00067561|Alosetron|alosetron|mesh-list
716584|NCT02948075|Paclitaxel|paclitaxel|mesh-list
716585|NCT02948075|Carboplatin|carboplatin|mesh-list
716586|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
716587|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716588|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
716589|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
716590|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
716591|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716806|NCT02947269|Prucalopride|prucalopride|mesh-list
716807|NCT02947269|Laxatives|laxatives|mesh-ancestor
716808|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
712910|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
712911|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
712912|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
712913|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713106|NCT02962999|Ketamine|ketamine|mesh-list
713107|NCT02962999|Analgesics|analgesics|mesh-ancestor
713108|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
713109|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713110|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713111|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
713112|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
713113|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
713114|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
713115|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
713116|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
713117|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
713118|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
713119|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713286|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
713287|NCT02962492|Exenatide|exenatide|mesh-list
713288|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
713289|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713290|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
713291|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713292|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
713293|NCT02962492|Incretins|incretins|mesh-ancestor
713294|NCT02962492|Hormones|hormones|mesh-ancestor
713295|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
713415|NCT02961842|Ephedrine|ephedrine|mesh-list
713416|NCT02961842|Fentanyl|fentanyl|mesh-list
713417|NCT02961842|Bupivacaine|bupivacaine|mesh-list
713418|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
713419|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
713420|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
713421|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713422|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
713423|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713424|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
713425|NCT02961842|Narcotics|narcotics|mesh-ancestor
713426|NCT02961842|Analgesics|analgesics|mesh-ancestor
713427|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
713428|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
713429|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
713430|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
713431|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
713432|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
713433|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
713434|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
713435|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
713436|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713473|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
713474|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713475|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713476|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713477|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2230364|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2230365|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2230366|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
2230367|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230368|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230369|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230370|NCT00067600|Calcium|calcium|mesh-list
2089975|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2230371|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2230372|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230373|NCT00067626|Chromium|chromium|mesh-list
2230374|NCT00067626|Trace Elements|trace elements|mesh-ancestor
2230375|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
2230376|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230377|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
2230378|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230379|NCT00067743|Lenalidomide|lenalidomide|mesh-list
2230380|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
2230381|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230382|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2230383|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2230384|NCT00067743|Growth Substances|growth substances|mesh-ancestor
2230385|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
2230386|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230387|NCT00067756|Butyric Acid|butyric acid|mesh-list
2230388|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
2230389|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
2230390|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230391|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230392|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713039|NCT02963168|Docetaxel|docetaxel|mesh-list
713040|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713041|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
713042|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
713043|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
713044|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713258|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
713259|NCT02962310|Calcium|calcium|mesh-list
713260|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
713261|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713262|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
713263|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
713264|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
713265|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713266|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
713267|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
713268|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713355|NCT02961998|Celecoxib|celecoxib|mesh-list
713356|NCT02961998|Sorafenib|sorafenib|mesh-list
713357|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713358|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
713359|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713360|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713361|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
713362|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
713363|NCT02961998|Analgesics|analgesics|mesh-ancestor
713364|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
713365|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713366|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713367|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
713368|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
713369|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
713370|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2230393|NCT00067782|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2230394|NCT00067782|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2230395|NCT00067782|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2230396|NCT00067782|Protease Inhibitors|protease inhibitors|mesh-ancestor
2230397|NCT00067782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713934|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
713935|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
713936|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
713937|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
714129|NCT02958917|Pirfenidone|pirfenidone|mesh-list
714130|NCT02958917|Analgesics|analgesics|mesh-ancestor
714131|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
714132|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714133|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714134|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
714135|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
714136|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
714137|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
714138|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089976|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089977|NCT02207413|Vaccines|vaccines|mesh-list
2089978|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
2089979|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089980|NCT02207491|Timolol|timolol|mesh-list
2089981|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2089982|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2089983|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2089984|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2089985|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
2089986|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2089987|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2089988|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2089989|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2089990|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2089991|NCT02207530|Durvalumab|durvalumab|mesh-list
2089992|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2089993|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089994|NCT02207556|Doxycycline|doxycycline|mesh-list
2089995|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2089996|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2089997|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
713596|NCT02961075|Anesthetics|anesthetics|mesh-list
713597|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
713598|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713599|NCT02960763|Aripiprazole|aripiprazole|mesh-list
713600|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
713601|NCT02960763|Bupropion|bupropion|mesh-list
713602|NCT02960763|Nortriptyline|nortriptyline|mesh-list
713603|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
713604|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
713605|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
713606|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
713607|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
713608|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
713609|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713610|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
713611|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
713612|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713613|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
713614|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
713615|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713616|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
713617|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
713618|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
713619|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
713620|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
713621|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
713622|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
713623|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
713624|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
713625|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
713626|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
713627|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
713628|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
713629|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
713630|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
713673|NCT02960503|Azithromycin|azithromycin|mesh-list
713674|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
713675|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
713975|NCT02959697|Lidocaine|lidocaine|mesh-list
713976|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
713977|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
713978|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
713979|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713980|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
713981|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713982|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
713983|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
713984|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
713985|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
713986|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714032|NCT02959255|Esomeprazole|esomeprazole|mesh-list
2089998|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
713382|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713383|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
713384|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713385|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
713386|NCT02962024|Narcotics|narcotics|mesh-ancestor
713387|NCT02962024|Analgesics|analgesics|mesh-ancestor
714001|NCT02959554|Nivolumab|nivolumab|mesh-list
714002|NCT02959554|Sunitinib|sunitinib|mesh-list
714003|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
714004|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714005|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
714006|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714007|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
714008|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
714009|NCT02959554|Growth Substances|growth substances|mesh-ancestor
714010|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714011|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
714012|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
714013|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714038|NCT02959229|Lactoferrin|lactoferrin|mesh-list
714039|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
714216|NCT02958514|Tobramycin|tobramycin|mesh-list
714217|NCT02958514|Dexamethasone|dexamethasone|mesh-list
714218|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
714219|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
714220|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
714221|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714222|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714223|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
714224|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
714225|NCT02958514|Hormones|hormones|mesh-ancestor
714226|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
714227|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
714228|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714229|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
714230|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
714503|NCT02957604|Evolocumab|evolocumab|mesh-list
714504|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
714505|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
714506|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
714507|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714508|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2230398|NCT00067782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230399|NCT00067782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
715253|NCT02954484|Acetaminophen|acetaminophen|mesh-list
715254|NCT02954484|Etoricoxib|etoricoxib|mesh-list
715255|NCT02954484|Pregabalin|pregabalin|mesh-list
715256|NCT02954484|Morphine|morphine|mesh-list
715257|NCT02954484|Ropivacaine|ropivacaine|mesh-list
715258|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
715259|NCT02954484|Narcotics|narcotics|mesh-ancestor
715260|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
715261|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715262|NCT02954484|Analgesics|analgesics|mesh-ancestor
715263|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
715264|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
715265|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
715266|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
715267|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
715268|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
715269|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
715270|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
715271|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
715272|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715273|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
715274|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
715275|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
715276|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
715277|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
715278|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
715279|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
715280|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
715281|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
715282|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715795|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
715796|NCT02952092|Hematinics|hematinics|mesh-ancestor
716038|NCT02950948|Progesterone|progesterone|mesh-list
713403|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
713404|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
713405|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
713406|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
713407|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
713408|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
713409|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
713410|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713411|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
713412|NCT02961829|Vitamins|vitamins|mesh-ancestor
713413|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
713414|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
713558|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
713559|NCT02961361|Ropivacaine|ropivacaine|mesh-list
713560|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
713561|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
713562|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713563|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
713564|NCT02961361|Analgesics|analgesics|mesh-ancestor
713565|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
713566|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
713567|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
713568|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
713569|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
713570|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
713571|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
713572|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713573|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
713574|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
713707|NCT02960906|Nivolumab|nivolumab|mesh-list
713708|NCT02960906|Ipilimumab|ipilimumab|mesh-list
713709|NCT02960906|Sunitinib|sunitinib|mesh-list
713710|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
713711|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713712|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
713713|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713714|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
713715|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
713716|NCT02960906|Growth Substances|growth substances|mesh-ancestor
713717|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713718|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
713719|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
713720|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713801|NCT02959879|Folfirinox|folfirinox|mesh-list
713802|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713987|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
713988|NCT02959606|Clopidogrel|clopidogrel|mesh-list
713989|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
713990|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
713991|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
713992|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
713993|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
713994|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
713995|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713996|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713997|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
713998|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
713999|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
714000|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
714429|NCT02957877|Heparin|heparin|mesh-list
714430|NCT02957877|Calcium heparin|calcium heparin|mesh-list
714431|NCT02957877|Nadroparin|nadroparin|mesh-list
714432|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
714433|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
714434|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
714435|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714484|NCT02957448|Rifampin|rifampin|mesh-list
714485|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
714486|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
714487|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
714488|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
714489|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
714490|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
714491|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714492|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714493|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
713452|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713453|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
713454|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
713455|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
713456|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713457|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
713686|NCT02960815|Imiquimod|imiquimod|mesh-list
713687|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
713688|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
713689|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
713690|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
713691|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
2230400|NCT00067782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2230401|NCT00067782|Antiviral Agents|antiviral agents|mesh-ancestor
2230402|NCT00067782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230403|NCT00067860|Hormones|hormones|mesh-list
2230404|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2230405|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230406|NCT00067899|Vitamins|vitamins|mesh-list
2230407|NCT00067899|Ascorbic Acid|ascorbic acid|mesh-list
2230408|NCT00067899|Vitamin E|vitamin e|mesh-list
2230409|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
2230410|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230411|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
2230412|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230413|NCT00067899|Protective Agents|protective agents|mesh-ancestor
2230414|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2230415|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
714047|NCT02959411|Tolvaptan|tolvaptan|mesh-list
714048|NCT02959411|Diuretics|diuretics|mesh-list
714049|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
714050|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714051|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
714052|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714691|NCT02956447|Hormones|hormones|mesh-list
714692|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
714693|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230416|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2230417|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2230418|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2230419|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230420|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230421|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230422|NCT00067912|Analgesics|analgesics|mesh-ancestor
2230423|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
2230424|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230425|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
2230426|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2230427|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
2230428|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2230429|NCT00067925|Calcium|calcium|mesh-list
2230430|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2230431|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230432|NCT00067938|Lamotrigine|lamotrigine|mesh-list
2230433|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
2230434|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2230435|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2230436|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230437|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2230438|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230439|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2230440|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2230441|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
715024|NCT02955251|Nivolumab|nivolumab|mesh-list
715025|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
715026|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715027|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
715028|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230442|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2230443|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2230444|NCT00067951|Metformin|metformin|mesh-list
2230445|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
713484|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713485|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
713486|NCT02962102|Vitamins|vitamins|mesh-ancestor
713487|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
713488|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
713655|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
713656|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
713657|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
713658|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
713659|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
713660|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
713661|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
713662|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
713663|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
2230446|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2230447|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230448|NCT00068029|Octreotide|octreotide|mesh-list
2230449|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2230450|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2230451|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230452|NCT00068042|Octreotide|octreotide|mesh-list
2230453|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2230454|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2230455|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230456|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
2230457|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2230458|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2230459|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
2230460|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230461|NCT00068068|Talaporfin|talaporfin|mesh-list
2230462|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230463|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2230464|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
2230465|NCT00068081|Capsaicin|capsaicin|mesh-list
2230466|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
2230467|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
2230468|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
2230469|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230470|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230471|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
2230472|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2230473|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230474|NCT00068276|Vitamins|vitamins|mesh-ancestor
2230475|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
2230476|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2230477|NCT00068289|Bortezomib|bortezomib|mesh-list
2230478|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230479|NCT00068302|Sirolimus|sirolimus|mesh-list
2230480|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2230481|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230482|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
716956|NCT02946294|Epinephrine|epinephrine|mesh-list
716957|NCT02946294|Racepinephrine|racepinephrine|mesh-list
716958|NCT02946294|Bupivacaine|bupivacaine|mesh-list
716959|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
716960|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
716961|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
716962|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
716963|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716964|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
716965|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717028|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2230483|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2089999|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2090000|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
2090001|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2090002|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
2090003|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090004|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
2090005|NCT02207608|Protective Agents|protective agents|mesh-ancestor
2090006|NCT02207621|Timolol|timolol|mesh-list
2090007|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2090008|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2090009|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2090010|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2090011|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
2090012|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714062|NCT02959060|Rifampin|rifampin|mesh-list
714063|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
714064|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
714065|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
714066|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
714067|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
714068|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
714069|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714070|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714071|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
714072|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
714073|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
714074|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
714075|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
714076|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
714166|NCT02958800|Olanzapine|olanzapine|mesh-list
714167|NCT02958800|Risperidone|risperidone|mesh-list
714168|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
714169|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
714170|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
714171|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
714172|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714173|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714174|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714175|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
714176|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
714177|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
714178|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
714179|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
714180|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
714181|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
714182|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714183|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
714184|NCT02958800|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
714185|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
714186|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
714187|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
714555|NCT02957266|Gemcitabine|gemcitabine|mesh-list
714556|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714557|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
714558|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
714559|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714560|NCT02957266|Antiviral Agents|antiviral agents|mesh-ancestor
714561|NCT02957266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
714562|NCT02957266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714563|NCT02957266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
714564|NCT02957266|Immunologic Factors|immunologic factors|mesh-ancestor
714565|NCT02957266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230484|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
2230485|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230486|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
2230487|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230488|NCT00068315|Rituximab|rituximab|mesh-list
2230489|NCT00068315|Fludarabine|fludarabine|mesh-list
2230490|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
2230491|NCT00068315|Bortezomib|bortezomib|mesh-list
2230492|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2230493|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090013|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230494|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
2230495|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230496|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230497|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2230498|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
2230499|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230500|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230501|NCT00068432|Gemcitabine|gemcitabine|mesh-list
2230502|NCT00068432|Celecoxib|celecoxib|mesh-list
2230503|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2230504|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
2230505|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230506|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230507|NCT00068432|Antiviral Agents|antiviral agents|mesh-ancestor
2230508|NCT00068432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230509|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715866|NCT02951962|Amlodipine|amlodipine|mesh-list
715867|NCT02951962|Telmisartan|telmisartan|mesh-list
715868|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
715869|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
715870|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
715871|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
715872|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
715873|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715874|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
715875|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715876|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
715877|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
715878|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
715879|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
715880|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
715881|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
715882|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715883|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
715884|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2230510|NCT00068432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230511|NCT00068432|Immunologic Factors|immunologic factors|mesh-ancestor
2230512|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230513|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2230514|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2230515|NCT00068432|Analgesics|analgesics|mesh-ancestor
2230516|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
2230517|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230518|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
716611|NCT02948283|Metformin|metformin|mesh-list
716612|NCT02948283|Ritonavir|ritonavir|mesh-list
716613|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
716614|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716615|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
716616|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
716617|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
716618|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716619|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716620|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
716621|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
716622|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
716623|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
716624|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
716625|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
716920|NCT02946671|Nivolumab|nivolumab|mesh-list
716921|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
716922|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
716923|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716924|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
716925|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717675|NCT02943135|Lidocaine|lidocaine|mesh-list
717676|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
717677|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
717678|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
717679|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717680|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
717681|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230519|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230520|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2230521|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2230522|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
2230523|NCT00068458|Calcium|calcium|mesh-list
2230524|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2230525|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230526|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2230527|NCT00068471|Anidulafungin|anidulafungin|mesh-list
2230528|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
2230529|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230530|NCT00068484|Bortezomib|bortezomib|mesh-list
2230531|NCT00068484|Topotecan|topotecan|mesh-list
2230532|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230533|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2230534|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2230535|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714077|NCT02959112|Indomethacin|indomethacin|mesh-list
714078|NCT02959112|Epinephrine|epinephrine|mesh-list
714079|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
714080|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
714081|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
714082|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714083|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714084|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714085|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
714086|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
714087|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
714088|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714089|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
714090|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
714091|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
714092|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
714093|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
714094|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
714095|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
714096|NCT02959112|Analgesics|analgesics|mesh-ancestor
714097|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
714098|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
714099|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
714100|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
714101|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
714102|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
714103|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
714104|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714694|NCT02956252|Anesthetics|anesthetics|mesh-list
714695|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
714696|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230536|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230537|NCT00068497|Gefitinib|gefitinib|mesh-list
2230538|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230539|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2230540|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230541|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230542|NCT00068523|Cyclosporine|cyclosporine|mesh-list
2230543|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
2230544|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
2230545|NCT00068523|Fludarabine|fludarabine|mesh-list
2230546|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
2230547|NCT00068523|Cyclosporins|cyclosporins|mesh-list
2230548|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2230549|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230550|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
2230551|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230552|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230553|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2230554|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
2230555|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230556|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230557|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2230558|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2230559|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
2230560|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230561|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
2230562|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
715391|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
715392|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
2230563|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
713904|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
713905|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
713906|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714029|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
714030|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
714031|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714231|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
714232|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
714233|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714234|NCT02958501|Vitamins|vitamins|mesh-ancestor
714235|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
714236|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
714360|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
714361|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
714362|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
714363|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714364|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
714365|NCT02958150|Analgesics|analgesics|mesh-ancestor
714366|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
714367|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714368|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
714369|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
714370|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
714371|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
714372|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714373|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714534|NCT02957656|Vaccines|vaccines|mesh-list
714535|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
714536|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714948|NCT02955654|Aripiprazole|aripiprazole|mesh-list
714949|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
714950|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
714951|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
714952|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
714953|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
714954|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714955|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
714956|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
714957|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714958|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714959|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
714960|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
714961|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
714962|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
714963|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
714964|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
714965|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
715006|NCT02955056|Teriparatide|teriparatide|mesh-list
715007|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715008|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
715009|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
715065|NCT02954822|Glimepiride|glimepiride|mesh-list
715066|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
715067|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
715068|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715069|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
715070|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
2230564|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2230565|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2230566|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
2230567|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
2230568|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230569|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2230570|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
2230571|NCT00068523|Hormones|hormones|mesh-ancestor
2230572|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2230573|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2230574|NCT00068523|Protective Agents|protective agents|mesh-ancestor
2230575|NCT00068549|Gemcitabine|gemcitabine|mesh-list
2230576|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230577|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2230578|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
2230579|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230580|NCT00068549|Antiviral Agents|antiviral agents|mesh-ancestor
713929|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
713930|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
713931|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
713932|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
713933|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714014|NCT02959476|Ropivacaine|ropivacaine|mesh-list
714015|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
714016|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
714017|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
714018|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714019|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
714020|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714139|NCT02958852|Letrozole|letrozole|mesh-list
714140|NCT02958852|Fulvestrant|fulvestrant|mesh-list
714141|NCT02958852|Atorvastatin|atorvastatin|mesh-list
714142|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
714143|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
714144|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
714145|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714146|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
714147|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
714148|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714149|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714150|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
714151|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
714152|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
714153|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
714154|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
714155|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714156|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
714157|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2230581|NCT00068549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230582|NCT00068549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230583|NCT00068549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230584|NCT00068549|Immunologic Factors|immunologic factors|mesh-ancestor
2230585|NCT00068549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230586|NCT00068653|Celecoxib|celecoxib|mesh-list
2230587|NCT00068653|Gefitinib|gefitinib|mesh-list
2230588|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2230589|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2230590|NCT00068653|Analgesics|analgesics|mesh-ancestor
714412|NCT02957864|Tenofovir|tenofovir|mesh-list
714413|NCT02957864|Abacavir|abacavir|mesh-list
714414|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
714415|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
714416|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
714417|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
714418|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714419|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714420|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
714421|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
714622|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
714623|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
714624|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714625|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
714626|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230591|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
2230592|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230593|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230594|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2230595|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230596|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2230597|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2230598|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715515|NCT02953106|Fluticasone|fluticasone|mesh-list
715516|NCT02953106|Azelastine|azelastine|mesh-list
715517|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
715518|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
715519|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
715520|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
715521|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715522|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2230599|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230600|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090014|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230601|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2230602|NCT00068666|Temozolomide|temozolomide|mesh-list
2230603|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2230604|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
2230605|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230606|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230607|NCT00068731|Lycopene|lycopene|mesh-list
2230608|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
714243|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
714244|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
714245|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
714246|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714247|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714248|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714726|NCT02955810|Dexamethasone|dexamethasone|mesh-list
714727|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
714728|NCT02955810|Bortezomib|bortezomib|mesh-list
714729|NCT02955810|Daratumumab|daratumumab|mesh-list
714730|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
714731|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
714732|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714733|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
714734|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
714735|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
714736|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714737|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714738|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
714739|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
714740|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
714741|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
714742|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714743|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
714744|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
714745|NCT02955810|Hormones|hormones|mesh-ancestor
714746|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
714747|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2230609|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
2230610|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230611|NCT00068731|Protective Agents|protective agents|mesh-ancestor
2230612|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716719|NCT02947672|Dexamethasone|dexamethasone|mesh-list
716720|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
716721|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
716722|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
716723|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
716724|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716725|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
716726|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
716727|NCT02947672|Hormones|hormones|mesh-ancestor
716728|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
716729|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
716730|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717266|NCT02945020|Simeprevir|simeprevir|mesh-list
717267|NCT02945020|Odalasvir|odalasvir|mesh-list
717268|NCT02945020|Dabigatran|dabigatran|mesh-list
717269|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
717270|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
717271|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
717272|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717273|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717274|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
717275|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
717276|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
717789|NCT02942550|Bromides|bromides|mesh-list
717790|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
717791|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
717792|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
717793|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717794|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
717795|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714034|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
714035|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
714036|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714037|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714509|NCT02957630|Drospirenone|drospirenone|mesh-list
714510|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
714511|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
714512|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
714513|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
714514|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
714515|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714516|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
714517|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
714518|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
714519|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
714520|NCT02957630|Estrogens|estrogens|mesh-ancestor
714521|NCT02957630|Hormones|hormones|mesh-ancestor
714522|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
714523|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
714524|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
714525|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
714526|NCT02957630|Diuretics|diuretics|mesh-ancestor
714527|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
714755|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
714756|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
714878|NCT02955602|Seladelpar|seladelpar|mesh-list
714879|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
714880|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
714881|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714882|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
715354|NCT02953743|Lenvatinib|lenvatinib|mesh-list
715355|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715356|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
715357|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715358|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230613|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2230614|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2230615|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230616|NCT00068744|Fluorouracil|fluorouracil|mesh-list
716461|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
716462|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
716463|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716563|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
716564|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716565|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
716566|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
716567|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
716568|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
716765|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
716766|NCT02947438|Hematinics|hematinics|mesh-ancestor
716863|NCT02946970|Quinine|quinine|mesh-list
716864|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
716865|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
716866|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
716867|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
716868|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
716869|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716870|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
716871|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
716872|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
716873|NCT02946970|Analgesics|analgesics|mesh-ancestor
716874|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
2230617|NCT00068744|Mitomycins|mitomycins|mesh-list
2230618|NCT00068744|Mitomycin|mitomycin|mesh-list
717836|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
717837|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
717838|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
717839|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717840|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
717841|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
717842|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718704|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
718705|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
718706|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718707|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
718726|NCT02938507|Solabegron|solabegron|mesh-list
2090015|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2090016|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2090017|NCT02207634|Evolocumab|evolocumab|mesh-list
2090018|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2090019|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2090020|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
2090021|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090022|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2090023|NCT02207816|Vaccines|vaccines|mesh-list
2090024|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
2090025|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090026|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
2090027|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2090028|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
714528|NCT02957474|Omeprazole|omeprazole|mesh-list
714529|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
714530|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
714531|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
714532|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714533|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714652|NCT02956590|Pitavastatin|pitavastatin|mesh-list
714653|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
714654|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
714655|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
714656|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
714657|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714658|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
714659|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
714704|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
714705|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
714706|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714707|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
714708|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
714709|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714757|NCT02955940|Capecitabine|capecitabine|mesh-list
714758|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
714759|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
714760|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714761|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714945|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
714946|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
714947|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
2090029|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090030|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090031|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2090032|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
2090033|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
2090034|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2090035|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
2090036|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090037|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090038|NCT02207907|Listerine|listerine|mesh-list
2090039|NCT02207907|Fluorides|fluorides|mesh-list
2090040|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
2090041|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
2090042|NCT02207907|Protective Agents|protective agents|mesh-ancestor
2090043|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090044|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2090045|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090046|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
715999|NCT02951377|Dexamethasone|dexamethasone|mesh-list
716000|NCT02951377|Lidocaine|lidocaine|mesh-list
716001|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
716002|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
716003|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
716004|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
716005|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716006|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
716007|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
716008|NCT02951377|Hormones|hormones|mesh-ancestor
716009|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
716010|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
716011|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090047|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2090048|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
714318|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
714436|NCT02957890|Vaccines|vaccines|mesh-list
714437|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
714438|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714475|NCT02957435|Eplerenone|eplerenone|mesh-list
714476|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
714477|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
714478|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
714479|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714480|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
714481|NCT02957435|Diuretics|diuretics|mesh-ancestor
714482|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
714483|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2090049|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2090050|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2090051|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2090052|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090053|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
2090054|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090055|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230619|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715012|NCT02954939|Prednisone|prednisone|mesh-list
715013|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
715014|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
715015|NCT02954939|Hormones|hormones|mesh-ancestor
715016|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
715017|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715018|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
715019|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715097|NCT02954536|Fluorouracil|fluorouracil|mesh-list
715098|NCT02954536|Capecitabine|capecitabine|mesh-list
715099|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
715100|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
715101|NCT02954536|Trastuzumab|trastuzumab|mesh-list
715102|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715103|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
715104|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715105|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
715106|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
715107|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
715108|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715109|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2230620|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
2230621|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230622|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2230623|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230624|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
715457|NCT02953340|Cyclophosphamide|cyclophosphamide|mesh-list
715458|NCT02953340|Docetaxel|docetaxel|mesh-list
715459|NCT02953340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
715460|NCT02953340|Immunologic Factors|immunologic factors|mesh-ancestor
715461|NCT02953340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715462|NCT02953340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
715463|NCT02953340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
715464|NCT02953340|Alkylating Agents|alkylating agents|mesh-ancestor
715465|NCT02953340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715466|NCT02953340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715467|NCT02953340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
715468|NCT02953340|Tubulin Modulators|tubulin modulators|mesh-ancestor
715469|NCT02953340|Antimitotic Agents|antimitotic agents|mesh-ancestor
715470|NCT02953340|Mitosis Modulators|mitosis modulators|mesh-ancestor
715556|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
715557|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
715558|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
715559|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
715560|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715561|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
715562|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
715563|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715564|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
715565|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
715835|NCT02951728|Prednisone|prednisone|mesh-list
715836|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
714422|NCT02957786|Varenicline|varenicline|mesh-list
714423|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
714424|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
714425|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
714426|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714427|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714428|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230625|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230626|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2230627|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
2230628|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2230629|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090056|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2090057|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090058|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
2090059|NCT02208037|Maraviroc|maraviroc|mesh-list
2090060|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
716199|NCT02950259|Indomethacin|indomethacin|mesh-list
716200|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
716201|NCT02950259|Omeprazole|omeprazole|mesh-list
716202|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
716203|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
716204|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716205|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
716206|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
716207|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
716208|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716209|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716210|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
716211|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
716212|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
716213|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
716214|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716215|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
716216|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
716217|NCT02950259|Analgesics|analgesics|mesh-ancestor
716218|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
716219|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
716220|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
716221|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
716222|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
716223|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
716224|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
716305|NCT02949765|Iron|iron|mesh-list
716306|NCT02949765|Trace Elements|trace elements|mesh-ancestor
716307|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
716308|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716875|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
716876|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
716877|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
716878|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716879|NCT02947126|Antidotes|antidotes|mesh-ancestor
716880|NCT02947126|Protective Agents|protective agents|mesh-ancestor
716881|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716882|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
716883|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
716884|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
717093|NCT02946060|TEMPO|tempo|mesh-list
717094|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
717095|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717096|NCT02946060|Protective Agents|protective agents|mesh-ancestor
717097|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717200|NCT02945280|Apixaban|apixaban|mesh-list
717201|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
717202|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
717203|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
717204|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
717205|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717206|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717207|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
717653|NCT02943642|Vorinostat|vorinostat|mesh-list
717654|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717655|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
717656|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717657|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717950|NCT02941575|Methamphetamine|methamphetamine|mesh-list
2090061|NCT02208037|Methotrexate|methotrexate|mesh-list
2090062|NCT02208037|Bortezomib|bortezomib|mesh-list
2090063|NCT02208037|Tacrolimus|tacrolimus|mesh-list
2090064|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2090065|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
2090066|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090067|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2090068|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2090069|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
2090070|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090071|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090072|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2090073|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2090074|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
2090075|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2090076|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2090077|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
2090078|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
2090079|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090080|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2090081|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2090082|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2090083|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2090084|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2230630|NCT00068757|Paclitaxel|paclitaxel|mesh-list
714599|NCT02957032|Cytarabine|cytarabine|mesh-list
714600|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
714601|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
714602|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714603|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714604|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
714605|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
714606|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
714607|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
714608|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714922|NCT02955641|Dexamethasone|dexamethasone|mesh-list
714923|NCT02955641|Nepafenac|nepafenac|mesh-list
714924|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
714925|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
714926|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
714927|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
714928|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714929|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714930|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
714931|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
714932|NCT02955641|Hormones|hormones|mesh-ancestor
714933|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
714934|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
714935|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
714936|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
714937|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
714938|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
714939|NCT02955641|Analgesics|analgesics|mesh-ancestor
714940|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
714941|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230631|NCT00068757|Trastuzumab|trastuzumab|mesh-list
2230632|NCT00068757|Lonafarnib|lonafarnib|mesh-list
2230633|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2230634|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230635|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
2230636|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
2230637|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
2230638|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230639|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2230640|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230641|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
2230642|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230643|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2230644|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230645|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230646|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2230647|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
2230648|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230649|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
2230650|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
714494|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
714495|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
714496|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
714497|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
714498|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
714553|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
714554|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
714904|NCT02955927|Atropine|atropine|mesh-list
714905|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
714906|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
714907|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
714908|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
714909|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
714910|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
714911|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714912|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714913|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
714914|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
714915|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
714916|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
714917|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
714918|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
714919|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
714920|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714921|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715020|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
715021|NCT02955134|Antacids|antacids|mesh-ancestor
715022|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715023|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2230651|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2230652|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230653|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2230654|NCT00068861|Metformin|metformin|mesh-list
2230655|NCT00068861|Clomiphene|clomiphene|mesh-list
2230656|NCT00068861|Enclomiphene|enclomiphene|mesh-list
2230657|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
2230658|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2230659|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230660|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2230661|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
2230662|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2230663|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2230664|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
2230665|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2230666|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
715363|NCT02953847|Rifampin|rifampin|mesh-list
715364|NCT02953847|Isoniazid|isoniazid|mesh-list
715365|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
715366|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
715367|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
715368|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
715369|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
715370|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
715371|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715372|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715373|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
715374|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
715375|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
715376|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
715377|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
715378|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
715379|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
715380|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
715381|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
715382|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
715434|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
715435|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
715436|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
715437|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
715783|NCT02952157|Lidocaine|lidocaine|mesh-list
715784|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
715785|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
715786|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
715787|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714502|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230667|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2230668|NCT00068952|Temozolomide|temozolomide|mesh-list
2230669|NCT00068952|Carmustine|carmustine|mesh-list
2230670|NCT00068952|Lomustine|lomustine|mesh-list
2230671|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2230672|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
2230673|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715168|NCT02954406|Gemcitabine|gemcitabine|mesh-list
715169|NCT02954406|Rituximab|rituximab|mesh-list
715170|NCT02954406|Lenalidomide|lenalidomide|mesh-list
715171|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
715172|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
715173|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715174|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
715175|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715176|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
715177|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
715178|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
715179|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715180|NCT02954406|Antiviral Agents|antiviral agents|mesh-ancestor
715181|NCT02954406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
715182|NCT02954406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715183|NCT02954406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
715184|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
715185|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
715186|NCT02954406|Growth Substances|growth substances|mesh-ancestor
715187|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
715188|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
715189|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
715383|NCT02953522|Folic Acid|folic acid|mesh-list
715384|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
715385|NCT02953522|Hematinics|hematinics|mesh-ancestor
715386|NCT02953522|Vitamins|vitamins|mesh-ancestor
715387|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
715388|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715809|NCT02951975|Dexamethasone|dexamethasone|mesh-list
715810|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
715811|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
715812|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
715813|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
715814|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715815|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
715816|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
715817|NCT02951975|Hormones|hormones|mesh-ancestor
715818|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
715819|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
715820|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230674|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230675|NCT00069251|Bupropion|bupropion|mesh-list
2230676|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2230677|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
2230678|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2230679|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2230680|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2230681|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2230682|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230683|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
2230684|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230685|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230686|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2230687|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2230688|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230689|NCT00069355|Propranolol|propranolol|mesh-list
2230690|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
716645|NCT02947711|Diltiazem|diltiazem|mesh-list
716646|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
716647|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
716648|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2230691|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2230692|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
2230693|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230694|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230695|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230696|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2230697|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2230698|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
2230699|NCT00069446|Bevacizumab|bevacizumab|mesh-list
2230700|NCT00069446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2230701|NCT00069446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230702|NCT00069446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2230703|NCT00069446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2230704|NCT00069446|Growth Substances|growth substances|mesh-ancestor
2090085|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
2090086|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2090087|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090088|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2090089|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2090090|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2090091|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2090092|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
2090093|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2090094|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
2230705|NCT00069446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715693|NCT02952599|Edoxaban|edoxaban|mesh-list
715694|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
715695|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
715696|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
715697|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
715698|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715699|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715700|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
716096|NCT02950766|Ipilimumab|ipilimumab|mesh-list
716097|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
716098|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716099|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
716100|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716234|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
716235|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
716236|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
716237|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
716238|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716239|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230706|NCT00069446|Growth Inhibitors|growth inhibitors|mesh-ancestor
2230707|NCT00069459|Bupropion|bupropion|mesh-list
2230708|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2230709|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
2230710|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2230711|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
717192|NCT02945293|Oxycodone|oxycodone|mesh-list
717193|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
717194|NCT02945293|Narcotics|narcotics|mesh-ancestor
717195|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
717196|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717197|NCT02945293|Analgesics|analgesics|mesh-ancestor
717198|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
717199|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
714634|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
714635|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
714636|NCT02956538|Growth Substances|growth substances|mesh-ancestor
714637|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
714638|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715010|NCT02955082|Carboplatin|carboplatin|mesh-list
715011|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715442|NCT02953457|Durvalumab|durvalumab|mesh-list
715443|NCT02953457|Ipilimumab|ipilimumab|mesh-list
715444|NCT02953457|Olaparib|olaparib|mesh-list
715445|NCT02953457|Tremelimumab|tremelimumab|mesh-list
715446|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
715447|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
715448|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
715449|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
715450|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
715451|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715452|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
715453|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715454|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715455|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715456|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
715537|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
715538|NCT02953041|Bromides|bromides|mesh-list
715539|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
715540|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
715541|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
715542|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
715543|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
715544|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
715545|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715546|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715723|NCT02952807|Misoprostol|misoprostol|mesh-list
715724|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
715725|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
715726|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
715727|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715728|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
715729|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
715730|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
2230712|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2230713|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2230714|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230715|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
2230716|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230717|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230718|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2230719|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2230720|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230721|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
2230722|NCT00069498|Mesalamine|mesalamine|mesh-list
2230723|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
2230724|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2230725|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230726|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2230727|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2230728|NCT00069498|Analgesics|analgesics|mesh-ancestor
2230729|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
2230730|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717493|NCT02944175|Neostigmine|neostigmine|mesh-list
717494|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
717495|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717496|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717497|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
717498|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
717499|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717500|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
717501|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
717502|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717645|NCT02943252|Apatinib|apatinib|mesh-list
717646|NCT02943252|Tegafur|tegafur|mesh-list
717647|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717648|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
717649|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717650|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714703|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
714854|NCT02955719|Sertraline|sertraline|mesh-list
714855|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
714856|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
714857|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
714858|NCT02955719|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
714859|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
714860|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
714861|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
714862|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
714863|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
714864|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
714865|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
714866|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
714942|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
714943|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
714944|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715141|NCT02954393|Amoxicillin|amoxicillin|mesh-list
715142|NCT02954393|Metronidazole|metronidazole|mesh-list
715143|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
715144|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
715145|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
715146|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2230731|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230732|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2230733|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230734|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
2230735|NCT00069550|Donepezil|donepezil|mesh-list
2230736|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2230737|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230738|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230739|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
2230740|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230741|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230742|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
2230743|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
2230744|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
2230745|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2230746|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2230747|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2230748|NCT00069706|Latanoprost|latanoprost|mesh-list
2230749|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2230750|NCT00069745|Prednisone|prednisone|mesh-list
2230751|NCT00069745|Satraplatin|satraplatin|mesh-list
2230752|NCT00069745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
716464|NCT02948920|Ephedrine|ephedrine|mesh-list
716465|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
716466|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716467|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
716468|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
716469|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
716470|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
716471|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
716472|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
716473|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716626|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
716627|NCT02948101|Antibodies|antibodies|mesh-list
716628|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
716629|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
716630|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
716631|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716632|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
716633|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
716634|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
716635|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716636|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716637|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
716655|NCT02947503|Metformin|metformin|mesh-list
716656|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
716657|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230753|NCT00069745|Glucocorticoids|glucocorticoids|mesh-ancestor
715575|NCT02953210|Dexamethasone|dexamethasone|mesh-list
715576|NCT02953210|Ketorolac|ketorolac|mesh-list
715577|NCT02953210|Lidocaine|lidocaine|mesh-list
715578|NCT02953210|Clonidine|clonidine|mesh-list
715579|NCT02953210|Fentanyl|fentanyl|mesh-list
715580|NCT02953210|Midazolam|midazolam|mesh-list
715581|NCT02953210|Ketamine|ketamine|mesh-list
715582|NCT02953210|Ondansetron|ondansetron|mesh-list
715583|NCT02953210|Bupivacaine|bupivacaine|mesh-list
715584|NCT02953210|Propofol|propofol|mesh-list
715585|NCT02953210|Isoflurane|isoflurane|mesh-list
715586|NCT02953210|Ranitidine|ranitidine|mesh-list
715587|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
715588|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
715589|NCT02953210|Rocuronium|rocuronium|mesh-list
715590|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
715591|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
715592|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
715593|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
715594|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715595|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
715596|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
715597|NCT02953210|Hormones|hormones|mesh-ancestor
715598|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
715599|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
715600|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715601|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
715602|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
715603|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
715604|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
715605|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
715606|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
715607|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
715608|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
715609|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715610|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
715611|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
715612|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
715613|NCT02953210|Analgesics|analgesics|mesh-ancestor
715614|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
715615|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
715616|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
715617|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
715618|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
715619|NCT02953210|Narcotics|narcotics|mesh-ancestor
715620|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
715621|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
715622|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
715623|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
715624|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
715625|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
715626|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
715627|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
715628|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
715629|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
715630|NCT02953210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
715631|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
715632|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
715633|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
715634|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
715635|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715636|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
715637|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
715638|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
715639|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
715640|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
715641|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
715642|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
715643|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
715644|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
715645|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
715646|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
715647|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
715648|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
715649|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
716132|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
716133|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
716134|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2230754|NCT00069745|Hormones|hormones|mesh-ancestor
2230755|NCT00069745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2230756|NCT00069745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230757|NCT00069745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2230758|NCT00069745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230759|NCT00069836|Metformin|metformin|mesh-list
2230760|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
2230761|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2230762|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715037|NCT02954913|Liver Extracts|liver extracts|mesh-list
715038|NCT02954913|Hematinics|hematinics|mesh-ancestor
2090095|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2090096|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2090097|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230763|NCT00069875|Gemcitabine|gemcitabine|mesh-list
2753063|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
2753064|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2753065|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753066|NCT03141359|Paclitaxel|paclitaxel|mesh-list
2230764|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230765|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2230766|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
2230767|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715566|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
715567|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
715568|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
715569|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
715570|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
715571|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715572|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
715573|NCT02952963|Cathartics|cathartics|mesh-ancestor
715574|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
715759|NCT02952469|Edetic Acid|edetic acid|mesh-list
715760|NCT02952469|Chelating Agents|chelating agents|mesh-ancestor
715761|NCT02952469|Sequestering Agents|sequestering agents|mesh-ancestor
715762|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715763|NCT02952469|Anticoagulants|anticoagulants|mesh-ancestor
715764|NCT02952469|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
715937|NCT02951897|Pemetrexed|pemetrexed|mesh-list
715938|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715939|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715940|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715941|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
715942|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2230768|NCT00069875|Antiviral Agents|antiviral agents|mesh-ancestor
2230769|NCT00069875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753067|NCT03141359|Etoposide|etoposide|mesh-list
2753068|NCT03141359|Carboplatin|carboplatin|mesh-list
716309|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
716310|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
716311|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
716312|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
716353|NCT02949232|Prednisolone|prednisolone|mesh-list
716354|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
716355|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
716356|NCT02949232|Hormones|hormones|mesh-ancestor
716357|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
716358|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716359|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
716360|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717124|NCT02945696|Ropivacaine|ropivacaine|mesh-list
717125|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
717126|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
717127|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
717128|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717129|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
717130|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230770|NCT00069875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230771|NCT00069875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230772|NCT00069875|Immunologic Factors|immunologic factors|mesh-ancestor
2230773|NCT00069875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090098|NCT02208063|Vancomycin|vancomycin|mesh-list
2090099|NCT02208063|Cefazolin|cefazolin|mesh-list
2090100|NCT02208063|Daptomycin|daptomycin|mesh-list
2090101|NCT02208063|Penicillins|penicillins|mesh-list
2090102|NCT02208063|Cloxacillin|cloxacillin|mesh-list
2090103|NCT02208063|Telavancin|telavancin|mesh-list
716347|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
716348|NCT02949843|Nivolumab|nivolumab|mesh-list
716349|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
716350|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716351|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
716352|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230774|NCT00069888|Docetaxel|docetaxel|mesh-list
2230775|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230776|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
2230777|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
2230778|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
2230779|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230780|NCT00069901|Paclitaxel|paclitaxel|mesh-list
2230781|NCT00069901|Carboplatin|carboplatin|mesh-list
2230782|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2230783|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2230784|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230785|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
2230786|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
2230787|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
2230788|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230789|NCT00069927|Methylphenidate|methylphenidate|mesh-list
2230790|NCT00069927|Amphetamine|amphetamine|mesh-list
2230791|NCT00069927|Adderall|adderall|mesh-list
2230792|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
2230793|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2230794|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718329|NCT02940366|Atorvastatin|atorvastatin|mesh-list
718330|NCT02940366|Pitavastatin|pitavastatin|mesh-list
718331|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
718332|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
718333|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
718334|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718335|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
718336|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
718337|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719073|NCT02936895|Vitamin D|vitamin d|mesh-list
719074|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
719075|NCT02936895|Vitamins|vitamins|mesh-ancestor
719076|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
719077|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719078|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
719079|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
719606|NCT02935075|Tenofovir|tenofovir|mesh-list
719607|NCT02935075|Lamivudine|lamivudine|mesh-list
719608|NCT02935075|Efavirenz|efavirenz|mesh-list
719609|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
719610|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
719611|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
719612|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
719613|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719614|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719615|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
719616|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
719617|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
719618|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
719619|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
719620|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
719621|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
719622|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2230795|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2230796|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2230797|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2230798|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090104|NCT02208063|Oxacillin|oxacillin|mesh-list
2090105|NCT02208063|Nafcillin|nafcillin|mesh-list
2230799|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
715089|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715090|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
715091|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
715297|NCT02954055|Paclitaxel|paclitaxel|mesh-list
715298|NCT02954055|Vinorelbine|vinorelbine|mesh-list
715299|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
715300|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
715301|NCT02954055|Capecitabine|capecitabine|mesh-list
715302|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
715303|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715304|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
715305|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
715306|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
715307|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715308|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
715309|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
715310|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715311|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
715312|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
715313|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
715314|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
715315|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
715316|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
715800|NCT02951754|Methylphenidate|methylphenidate|mesh-list
715801|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
715802|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715803|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
715804|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
715805|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
715806|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715807|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
715808|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
716240|NCT02950038|Nivolumab|nivolumab|mesh-list
716241|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
716242|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716243|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
716244|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716447|NCT02948985|Cetuximab|cetuximab|mesh-list
716448|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
716449|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716739|NCT02947750|Folic Acid|folic acid|mesh-list
716740|NCT02947750|Hematinics|hematinics|mesh-ancestor
716741|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
716742|NCT02947750|Vitamins|vitamins|mesh-ancestor
716743|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
716744|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716844|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
716845|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
716846|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
716847|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
716848|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716849|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716942|NCT02946359|Bevacizumab|bevacizumab|mesh-list
716945|NCT02946359|Crizotinib|crizotinib|mesh-list
716946|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
716947|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716948|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
716949|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
716950|NCT02946359|Growth Substances|growth substances|mesh-ancestor
716951|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716952|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
716953|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
716954|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716955|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717098|NCT02946125|Phenylephrine|phenylephrine|mesh-list
717099|NCT02946125|Oxymetazoline|oxymetazoline|mesh-list
717100|NCT02946125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
717101|NCT02946125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
717102|NCT02946125|Mydriatics|mydriatics|mesh-ancestor
717103|NCT02946125|Autonomic Agents|autonomic agents|mesh-ancestor
717104|NCT02946125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717105|NCT02946125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717106|NCT02946125|Sympathomimetics|sympathomimetics|mesh-ancestor
717107|NCT02946125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
717108|NCT02946125|Nasal Decongestants|nasal decongestants|mesh-ancestor
2090106|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
716367|NCT02949466|Triamcinolone|triamcinolone|mesh-list
716368|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
716369|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
716370|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
716371|NCT02949466|Hormones|hormones|mesh-ancestor
716372|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
716373|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716374|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
716375|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
716376|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
716377|NCT02949466|Protective Agents|protective agents|mesh-ancestor
2090107|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090108|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2090109|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2090110|NCT02208310|Vitamin D|vitamin d|mesh-list
2090111|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
2090112|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
2090113|NCT02208310|Vitamins|vitamins|mesh-list
2230800|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230801|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
718343|NCT02940301|Nivolumab|nivolumab|mesh-list
718344|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
718345|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718346|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
718347|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230802|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
2230803|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230804|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
2230805|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2230806|NCT00069940|Sargramostim|sargramostim|mesh-list
2230807|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
2230808|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230809|NCT00069966|Cytarabine|cytarabine|mesh-list
2230810|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
2230811|NCT00069966|Rituximab|rituximab|mesh-list
2230812|NCT00069966|Pixantrone|pixantrone|mesh-list
2230813|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719653|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
719654|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
719655|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
719656|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
719657|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719658|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
719909|NCT02933697|Apixaban|apixaban|mesh-list
719910|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
719911|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
719912|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
719913|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
719914|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
719915|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719916|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719917|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
720062|NCT02933099|Dexamethasone|dexamethasone|mesh-list
720063|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
720064|NCT02933099|Aprepitant|aprepitant|mesh-list
720065|NCT02933099|Palonosetron|palonosetron|mesh-list
720066|NCT02933099|BB 1101|bb 1101|mesh-list
720067|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
720068|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
720069|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
720070|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720071|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720072|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
720073|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
720074|NCT02933099|Hormones|hormones|mesh-ancestor
720075|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
720076|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
720077|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720078|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
720079|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230814|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2090114|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
2230815|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
2230816|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230817|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230818|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2230819|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
2230820|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230821|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
2230822|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230823|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230824|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2230825|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
2230826|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
2230827|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230828|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2230829|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
2090115|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090116|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2090117|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2090118|NCT02208466|Fluoxetine|fluoxetine|mesh-list
2090119|NCT02208466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2090120|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2090121|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2090122|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090123|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090124|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
2090125|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090126|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2090127|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
2090128|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2090129|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2230830|NCT00069966|Hormones|hormones|mesh-ancestor
2753069|NCT03141359|Durvalumab|durvalumab|mesh-list
2753070|NCT03141359|Cisplatin|cisplatin|mesh-list
2753071|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2753072|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753073|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
2753074|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
2753075|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
2753076|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753077|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2753078|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2753079|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753080|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2753081|NCT03138889|Paclitaxel|paclitaxel|mesh-list
2753082|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2753083|NCT03138889|Carboplatin|carboplatin|mesh-list
2753084|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
2753085|NCT03138889|Pemetrexed|pemetrexed|mesh-list
716187|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
716188|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
716189|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
716190|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
716381|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
716382|NCT02949349|Prednisolone|prednisolone|mesh-list
716383|NCT02949349|Azathioprine|azathioprine|mesh-list
716384|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
716385|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716386|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
716387|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
716388|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
716389|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
716390|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716391|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716392|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
716393|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
716394|NCT02949349|Hormones|hormones|mesh-ancestor
716395|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
716396|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716397|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
716398|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
716399|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
716400|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
716401|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
716402|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2753086|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
717229|NCT02945163|Tenofovir|tenofovir|mesh-list
2230831|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2230832|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2230833|NCT00069966|Protective Agents|protective agents|mesh-ancestor
2230834|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2230835|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2230836|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230837|NCT00069992|Fludarabine|fludarabine|mesh-list
2230838|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
2230839|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230840|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2230841|NCT00070057|Celecoxib|celecoxib|mesh-list
715324|NCT02953834|Insulin|insulin|mesh-list
715325|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
715326|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715471|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
715472|NCT02953275|Vedolizumab|vedolizumab|mesh-list
715473|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
715474|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715475|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715476|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
715477|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
715478|NCT02953275|Protective Agents|protective agents|mesh-ancestor
715479|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715480|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
715481|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
715482|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
715483|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
715534|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
715535|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
715536|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715915|NCT02951637|Carboplatin|carboplatin|mesh-list
715916|NCT02951637|Pemetrexed|pemetrexed|mesh-list
715917|NCT02951637|Gefitinib|gefitinib|mesh-list
715918|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715919|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715920|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715921|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
715922|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
715923|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
716051|NCT02951117|Dexamethasone|dexamethasone|mesh-list
716052|NCT02951117|Venetoclax|venetoclax|mesh-list
716053|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
716054|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
716055|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
716056|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
716057|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716058|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
716059|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
716060|NCT02951117|Hormones|hormones|mesh-ancestor
716061|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
716062|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
716063|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716191|NCT02950168|Edoxaban|edoxaban|mesh-list
716192|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
716193|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
716194|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
716195|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
716196|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716197|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716198|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
716458|NCT02949206|Thrombin|thrombin|mesh-list
716459|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
716460|NCT02949206|Coagulants|coagulants|mesh-ancestor
716555|NCT02948543|Mitomycins|mitomycins|mesh-list
716556|NCT02948543|Mitomycin|mitomycin|mesh-list
716557|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
716558|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716559|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
716560|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716561|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
716562|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716774|NCT02947347|Rituximab|rituximab|mesh-list
716775|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
716776|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716777|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
716778|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716779|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
715249|NCT02954068|Oxytocin|oxytocin|mesh-list
715250|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
715251|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
715252|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090130|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2090131|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090132|NCT02208843|Afatinib|afatinib|mesh-list
2090133|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090134|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2090135|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090136|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090137|NCT02209181|Acetaminophen|acetaminophen|mesh-list
2090138|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2090139|NCT02209181|Analgesics|analgesics|mesh-ancestor
2090140|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
2090141|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090142|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090143|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
2090144|NCT02209272|Lidocaine|lidocaine|mesh-list
2090145|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
2090146|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
2090147|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
2090148|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090149|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090150|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
715754|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
715755|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
715756|NCT02952235|Protective Agents|protective agents|mesh-ancestor
715757|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715758|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
716043|NCT02951039|Edoxaban|edoxaban|mesh-list
716044|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
716045|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
716046|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
716047|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
716048|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716049|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716050|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
2230842|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2230843|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2230844|NCT00070057|Analgesics|analgesics|mesh-ancestor
2230845|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
2230846|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230847|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230848|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
716480|NCT02949284|Prednisone|prednisone|mesh-list
716481|NCT02949284|Cortisone|cortisone|mesh-list
716482|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
716483|NCT02949284|Hormones|hormones|mesh-list
716484|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
716485|NCT02949284|Androgens|androgens|mesh-list
716486|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
716487|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
716488|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
716489|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
716490|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716491|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
716492|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716493|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
716494|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716495|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716496|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
716497|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
716498|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
716731|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
716732|NCT02947854|Poly ICLC|poly iclc|mesh-list
716733|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
716734|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
716735|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
716736|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716737|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
716738|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
716780|NCT02947113|Etoposide|etoposide|mesh-list
716781|NCT02947113|Pemetrexed|pemetrexed|mesh-list
716782|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716783|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2230849|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230850|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2230851|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2230852|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230853|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230854|NCT00070083|Prednisone|prednisone|mesh-list
2230855|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
2230856|NCT00070083|Rituximab|rituximab|mesh-list
2230857|NCT00070083|Doxorubicin|doxorubicin|mesh-list
2230858|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
715438|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
715439|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
715440|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
715441|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
715650|NCT02953184|Vitamins|vitamins|mesh-list
715651|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
715652|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
715653|NCT02953184|Docetaxel|docetaxel|mesh-list
715654|NCT02953184|Doxorubicin|doxorubicin|mesh-list
715655|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
715656|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
715657|NCT02953184|Razoxane|razoxane|mesh-list
715658|NCT02953184|Pirarubicin|pirarubicin|mesh-list
715659|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
715660|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
715661|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715662|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
715663|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
715664|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
715665|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715666|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715667|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
715668|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
715669|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
715670|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
715671|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
715672|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
715673|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
715674|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
715675|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715676|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
715677|NCT02953184|Protective Agents|protective agents|mesh-ancestor
715701|NCT02952573|Dexamethasone|dexamethasone|mesh-list
715702|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
715703|NCT02952573|BB 1101|bb 1101|mesh-list
715704|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
715705|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
715706|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
715707|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
715708|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715709|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
715710|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
715711|NCT02952573|Hormones|hormones|mesh-ancestor
715712|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
715713|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
715714|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715715|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
715716|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715717|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715954|NCT02951234|Aspirin|aspirin|mesh-list
715955|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
715956|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
715957|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
715958|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
715959|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
715960|NCT02951234|Analgesics|analgesics|mesh-ancestor
715961|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
715962|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
715963|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715964|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
715965|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
715966|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
715967|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
715968|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715969|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
715970|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
715971|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230859|NCT00070083|Vincristine|vincristine|mesh-list
715393|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230860|NCT00070083|Oblimersen|oblimersen|mesh-list
2230861|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230862|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
2230863|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230864|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230865|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2230866|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
2230867|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230868|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230869|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2230870|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2230871|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2230872|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2230873|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2230874|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230875|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2230876|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
2230877|NCT00070083|Hormones|hormones|mesh-ancestor
2230878|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2230879|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2230880|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2230881|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
2230882|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
2230883|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
2230884|NCT00070122|Leucovorin|leucovorin|mesh-list
2230885|NCT00070122|Bevacizumab|bevacizumab|mesh-list
2230886|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2230887|NCT00070122|Fluorouracil|fluorouracil|mesh-list
2230888|NCT00070122|Capecitabine|capecitabine|mesh-list
2230889|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
2230890|NCT00070122|Antibodies|antibodies|mesh-list
2230891|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
2230892|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2230893|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
2230894|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230895|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2230896|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2230897|NCT00070122|Growth Substances|growth substances|mesh-ancestor
2230898|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230899|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
2230900|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
2230901|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
2230902|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230903|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2230904|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230905|NCT00070122|Antidotes|antidotes|mesh-ancestor
716437|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
716438|NCT02949258|Etoposide|etoposide|mesh-list
716439|NCT02949258|Epirubicin|epirubicin|mesh-list
716440|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716441|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
716442|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
716443|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
716444|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716445|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716446|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
716508|NCT02948660|Melatonin|melatonin|mesh-list
716509|NCT02948660|Zolpidem|zolpidem|mesh-list
716510|NCT02948660|Antioxidants|antioxidants|mesh-ancestor
716511|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716512|NCT02948660|Protective Agents|protective agents|mesh-ancestor
716513|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716514|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
716515|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
716516|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
716517|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
716518|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
716519|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
716520|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090151|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090152|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2090153|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2090154|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2090155|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2230906|NCT00070122|Protective Agents|protective agents|mesh-ancestor
2230907|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
2230908|NCT00070122|Vitamins|vitamins|mesh-ancestor
2230909|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
2230910|NCT00070148|Megestrol|megestrol|mesh-list
2230911|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
2230912|NCT00070148|Oxandrolone|oxandrolone|mesh-list
2230913|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2230914|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2230915|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2230916|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
2230917|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2230918|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230919|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2230920|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2230921|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2230922|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230923|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
2230924|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
715943|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
715944|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
715945|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715946|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715947|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
715948|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
715949|NCT02951299|Protective Agents|protective agents|mesh-ancestor
715950|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715951|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
715952|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
715953|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
2090156|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090157|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2090158|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2090159|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2090160|NCT02209454|Analgesics|analgesics|mesh-ancestor
2090161|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
2090162|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090163|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090164|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2090165|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
716158|NCT02950441|Niacinamide|niacinamide|mesh-list
716159|NCT02950441|Niacin|niacin|mesh-list
716160|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
716161|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
716162|NCT02950441|Vitamins|vitamins|mesh-ancestor
716163|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
716164|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716165|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
716166|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
716167|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716168|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
716169|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
716245|NCT02949752|Aripiprazole|aripiprazole|mesh-list
716246|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
716247|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
716248|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
716249|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
716250|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
716251|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716252|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
716253|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
716254|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
716255|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716256|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
716257|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
716258|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
716259|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
716260|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
716261|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
716262|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
716313|NCT02949492|Interleukin-2|interleukin-2|mesh-list
716314|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716315|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
716316|NCT02949492|Analgesics|analgesics|mesh-ancestor
716317|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
716318|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
715523|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
715524|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
715525|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
715526|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
715527|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715528|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715529|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
715530|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
715531|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
715532|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
715533|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
715718|NCT02952534|Rucaparib|rucaparib|mesh-list
715719|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
715720|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715721|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715722|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715821|NCT02951806|Fentanyl|fentanyl|mesh-list
715822|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
715823|NCT02951806|Narcotics|narcotics|mesh-ancestor
715824|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
715825|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715826|NCT02951806|Analgesics|analgesics|mesh-ancestor
715827|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
715828|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
715829|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
715830|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
715831|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
715832|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
716225|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
716226|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
716227|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716320|NCT02949778|Ropivacaine|ropivacaine|mesh-list
716321|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
716322|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
716323|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
716324|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716325|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
716326|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230925|NCT00070148|Androgens|androgens|mesh-ancestor
2230926|NCT00070148|Hormones|hormones|mesh-ancestor
2230927|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2230928|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
2230929|NCT00070161|Donepezil|donepezil|mesh-list
2230930|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2230931|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230932|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230933|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
2230934|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2230935|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2230936|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
2230937|NCT00070174|Cytarabine|cytarabine|mesh-list
2230938|NCT00070174|Cyclosporine|cyclosporine|mesh-list
2230939|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
2230940|NCT00070174|Busulfan|busulfan|mesh-list
2230941|NCT00070174|Methotrexate|methotrexate|mesh-list
2230942|NCT00070174|Etoposide|etoposide|mesh-list
2230943|NCT00070174|Daunorubicin|daunorubicin|mesh-list
716702|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
716703|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
716704|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
716705|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716706|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
716707|NCT02947529|Coagulants|coagulants|mesh-ancestor
2230944|NCT00070174|Asparaginase|asparaginase|mesh-list
2230945|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
2230946|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
2230947|NCT00070174|Cyclosporins|cyclosporins|mesh-list
2230948|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2230949|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
2230950|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717694|NCT02942888|Niacinamide|niacinamide|mesh-list
717695|NCT02942888|Niacin|niacin|mesh-list
717696|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
717697|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
717698|NCT02942888|Vitamins|vitamins|mesh-ancestor
717699|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
717812|NCT02942329|Apatinib|apatinib|mesh-list
2230951|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2230952|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
715788|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
715789|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
715790|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
715791|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
715792|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
715793|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
715794|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715885|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
716125|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
716126|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
716127|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
716128|NCT02950623|Protective Agents|protective agents|mesh-ancestor
716129|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716130|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
716131|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
716286|NCT02949648|Nicotine|nicotine|mesh-list
716287|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
716288|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
716289|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
716290|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716291|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
716292|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
716293|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
716294|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
716295|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716546|NCT02948348|Capecitabine|capecitabine|mesh-list
716547|NCT02948348|Nivolumab|nivolumab|mesh-list
716548|NCT02948348|Ipilimumab|ipilimumab|mesh-list
716549|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
716550|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
716551|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716552|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716553|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
716554|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
716658|NCT02947763|Metronidazole|metronidazole|mesh-list
716659|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
716660|NCT02947763|Minocycline|minocycline|mesh-list
716661|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
716662|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
716663|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
716664|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
716665|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
716666|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
716667|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716668|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716669|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716670|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
716671|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2230953|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
2230954|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230955|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230956|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2230957|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2230958|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
2230959|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2230960|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2230961|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
2230962|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
2230963|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230964|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2230965|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2230966|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2230967|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2230968|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
717018|NCT02946437|Midazolam|midazolam|mesh-list
717019|NCT02946437|Propofol|propofol|mesh-list
717020|NCT02946437|Sevoflurane|sevoflurane|mesh-list
717021|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
717022|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
717023|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717024|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
717025|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
717026|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
717027|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
715837|NCT02951728|Rituximab|rituximab|mesh-list
715838|NCT02951728|Doxorubicin|doxorubicin|mesh-list
715839|NCT02951728|Vincristine|vincristine|mesh-list
715840|NCT02951728|Decitabine|decitabine|mesh-list
715841|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
715842|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
715843|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715844|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
715845|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
715846|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
715847|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
715848|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
715849|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
715850|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
715851|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
715852|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
715853|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
715854|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
715855|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
715856|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
715857|NCT02951728|Hormones|hormones|mesh-ancestor
715858|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
715859|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
715860|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
715861|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
715862|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
715863|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
715864|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
715865|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
716422|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
716423|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
716424|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716425|NCT02949193|Incretins|incretins|mesh-ancestor
716426|NCT02949193|Hormones|hormones|mesh-ancestor
716427|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
716428|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
716429|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
716430|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716431|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230969|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
2230970|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230971|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
2230972|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2230973|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2230974|NCT00070174|Analgesics|analgesics|mesh-ancestor
2230975|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
2230976|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2230977|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2230978|NCT00070187|Interferons|interferons|mesh-list
2230979|NCT00070187|Cytarabine|cytarabine|mesh-list
2230980|NCT00070187|Aldesleukin|aldesleukin|mesh-list
2230981|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
2230982|NCT00070187|Cyclosporine|cyclosporine|mesh-list
2230983|NCT00070187|Etoposide|etoposide|mesh-list
2230984|NCT00070187|Melphalan|melphalan|mesh-list
2230985|NCT00070187|Interleukin-2|interleukin-2|mesh-list
2230986|NCT00070187|Carmustine|carmustine|mesh-list
2230987|NCT00070187|Cyclosporins|cyclosporins|mesh-list
2230988|NCT00070187|Lenograstim|lenograstim|mesh-list
2230989|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2230990|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2230991|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2230992|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2230993|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2230994|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2230995|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
718583|NCT02939287|Olanzapine|olanzapine|mesh-list
718584|NCT02939287|Aprepitant|aprepitant|mesh-list
718585|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
718586|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
718587|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
718588|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718589|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718590|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
718591|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
718592|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
718841|NCT02937662|Idarubicin|idarubicin|mesh-list
2230996|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2230997|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2230998|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
2230999|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231000|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2231001|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
2231002|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231003|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
2231004|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
2231005|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231006|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2231007|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
716064|NCT02950935|Progesterone|progesterone|mesh-list
716065|NCT02950935|Progestins|progestins|mesh-ancestor
716066|NCT02950935|Hormones|hormones|mesh-ancestor
716067|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
716068|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716299|NCT02949934|Tolcapone|tolcapone|mesh-list
716300|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
716301|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
716302|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
716303|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716304|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716450|NCT02948998|Spironolactone|spironolactone|mesh-list
716451|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
716452|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
716453|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
716454|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716455|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
716456|NCT02948998|Diuretics|diuretics|mesh-ancestor
716457|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
716745|NCT02947685|Trastuzumab|trastuzumab|mesh-list
716746|NCT02947685|Pertuzumab|pertuzumab|mesh-list
716747|NCT02947685|Letrozole|letrozole|mesh-list
716748|NCT02947685|Fulvestrant|fulvestrant|mesh-list
716749|NCT02947685|Palbociclib|palbociclib|mesh-list
716750|NCT02947685|Anastrozole|anastrozole|mesh-list
716751|NCT02947685|Exemestane|exemestane|mesh-list
716752|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
716753|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716754|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
716755|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
716756|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716757|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716758|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
716759|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
716760|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
716761|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716762|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
716763|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
716764|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2090166|NCT02209519|Metronidazole|metronidazole|mesh-list
2090167|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090168|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2090169|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2090170|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2090171|NCT02209597|Bupropion|bupropion|mesh-list
2090172|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2090173|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
2090174|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
717215|NCT02945241|Vancomycin|vancomycin|mesh-list
717216|NCT02945241|Cystatins|cystatins|mesh-list
717217|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
717218|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
717219|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
717220|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
717221|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717222|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717363|NCT02944617|Micronutrients|micronutrients|mesh-list
717364|NCT02944617|Trace Elements|trace elements|mesh-list
717365|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717383|NCT02944227|Ranibizumab|ranibizumab|mesh-list
717384|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
717385|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
717386|NCT02944227|Growth Substances|growth substances|mesh-ancestor
717387|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
715972|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
715973|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
2231008|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
2231009|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2231010|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2231011|NCT00070187|Analgesics|analgesics|mesh-ancestor
2231012|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
2231013|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2231014|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2231015|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2231016|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
2231017|NCT00070200|Melphalan|melphalan|mesh-list
2231018|NCT00070200|Doxorubicin|doxorubicin|mesh-list
2231019|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
716708|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
716709|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
716710|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
716711|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
716712|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
716713|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716714|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
716715|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
716716|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716717|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
716718|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
716993|NCT02946814|Listerine|listerine|mesh-list
716994|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
716995|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
716996|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
716997|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
716998|NCT02946814|Protective Agents|protective agents|mesh-ancestor
716999|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717173|NCT02945527|Dexamethasone|dexamethasone|mesh-list
717174|NCT02945527|Acetazolamide|acetazolamide|mesh-list
717175|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
717176|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
717177|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
717178|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717179|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717180|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
717181|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
717182|NCT02945527|Hormones|hormones|mesh-ancestor
717183|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
717184|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
717185|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717186|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
717187|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
717188|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717189|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717190|NCT02945527|Diuretics|diuretics|mesh-ancestor
717191|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
717421|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
717422|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
717423|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
717424|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717425|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
717687|NCT02943057|Ganciclovir|ganciclovir|mesh-list
717688|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
717689|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
717690|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
717691|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
717692|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717693|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717725|NCT02942693|Apatinib|apatinib|mesh-list
717726|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717727|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
717728|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717729|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717773|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
717774|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
717775|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
717776|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
717777|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
717778|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231020|NCT00070200|Etoposide|etoposide|mesh-list
2231021|NCT00070200|Vincristine|vincristine|mesh-list
2231022|NCT00070200|Topotecan|topotecan|mesh-list
716012|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
716013|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
716014|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
716015|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
716016|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
716017|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
716018|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
716019|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
716020|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716279|NCT02949895|Etoposide|etoposide|mesh-list
716280|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716281|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
716282|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
716283|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
716284|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716285|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717408|NCT02944526|Ropivacaine|ropivacaine|mesh-list
717409|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
717410|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
717411|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
717412|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717413|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
717414|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717530|NCT02943993|Edoxaban|edoxaban|mesh-list
717531|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
717532|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
717533|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
717534|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
717535|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717536|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717537|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
717826|NCT02942602|Atorvastatin|atorvastatin|mesh-list
717827|NCT02942602|Ezetimibe|ezetimibe|mesh-list
717828|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
717829|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
717830|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
717831|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
717832|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717833|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
717834|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
717835|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717975|NCT02941731|Oseltamivir|oseltamivir|mesh-list
717976|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
717977|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
717978|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717979|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718043|NCT02941367|Metformin|metformin|mesh-list
718044|NCT02941367|Lixisenatide|lixisenatide|mesh-list
718045|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
718046|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231023|NCT00070200|Isotretinoin|isotretinoin|mesh-list
2231024|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231025|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
2231026|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231027|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231028|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
718551|NCT02939274|Verteporfin|verteporfin|mesh-list
718552|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
718553|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
718708|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
718709|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
718710|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718977|NCT02937519|Cisplatin|cisplatin|mesh-list
718978|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719378|NCT02935725|Ketamine|ketamine|mesh-list
719379|NCT02935725|Analgesics|analgesics|mesh-ancestor
719380|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
719381|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719382|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719383|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
719384|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
719385|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
719386|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
719387|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
719388|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
716039|NCT02950948|Progestins|progestins|mesh-ancestor
716040|NCT02950948|Hormones|hormones|mesh-ancestor
716041|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
716042|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716361|NCT02949310|Nefopam|nefopam|mesh-list
716362|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
716363|NCT02949310|Analgesics|analgesics|mesh-ancestor
716364|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
716365|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
716366|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090175|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2090176|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2090177|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2090178|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090179|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
2090180|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090181|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090182|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
716592|NCT02947932|Indomethacin|indomethacin|mesh-list
716593|NCT02947932|Resveratrol|resveratrol|mesh-list
716594|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
716595|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716596|NCT02947932|Protective Agents|protective agents|mesh-ancestor
716597|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716598|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716599|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
716600|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
716601|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
716602|NCT02947932|Analgesics|analgesics|mesh-ancestor
716603|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
716604|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
716605|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
716606|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
716607|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
716608|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
716609|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
716610|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
716678|NCT02947620|Metformin|metformin|mesh-list
716679|NCT02947620|Atorvastatin|atorvastatin|mesh-list
716680|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
716681|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716682|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
716683|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
716684|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
716685|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716686|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
716687|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
716688|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716818|NCT02947243|Morphine|morphine|mesh-list
716819|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
716820|NCT02947243|Narcotics|narcotics|mesh-ancestor
716821|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
716822|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716823|NCT02947243|Analgesics|analgesics|mesh-ancestor
716824|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
716825|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
716941|NCT02946788|Minocycline|minocycline|mesh-list
716943|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
716944|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
717136|NCT02945839|Topiramate|topiramate|mesh-list
717137|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
717138|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
717139|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717351|NCT02944734|Amlodipine|amlodipine|mesh-list
717352|NCT02944734|Candesartan|candesartan|mesh-list
717353|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
717354|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
717355|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
717356|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
717357|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717358|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
717359|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717360|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
717361|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
716135|NCT02950584|Protective Agents|protective agents|mesh-ancestor
716136|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716137|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
716138|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
716296|NCT02949700|Metformin|metformin|mesh-list
716297|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
716298|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231029|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
2231030|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231031|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231032|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2231033|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2231034|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2231035|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2231036|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231037|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2231038|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
2231039|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
2231040|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
2231041|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2231042|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
2231043|NCT00070213|Leucovorin|leucovorin|mesh-list
2231044|NCT00070213|Fluorouracil|fluorouracil|mesh-list
2231045|NCT00070213|Capecitabine|capecitabine|mesh-list
717037|NCT02946268|Ropivacaine|ropivacaine|mesh-list
717038|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
717039|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
717040|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
717041|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717042|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
717043|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717121|NCT02945956|Entecavir|entecavir|mesh-list
717122|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
717123|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753087|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753088|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
2753089|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
2753090|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
2753091|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753092|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2753093|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753094|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2753095|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2753096|NCT03126110|Nivolumab|nivolumab|mesh-list
2753097|NCT03126110|Ipilimumab|ipilimumab|mesh-list
2753098|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2231046|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
2231047|NCT00070213|Calcium|calcium|mesh-list
718196|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
718197|NCT02940821|Fluorides|fluorides|mesh-list
718198|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
718199|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
718200|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
718201|NCT02940821|Protective Agents|protective agents|mesh-ancestor
718202|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718203|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
718204|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
718513|NCT02939365|Abatacept|abatacept|mesh-list
718514|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
718515|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718516|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718517|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
718518|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
718519|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718520|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
716319|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231048|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
2231049|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2231050|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090183|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2090184|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090185|NCT02209610|Fentanyl|fentanyl|mesh-list
2090186|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2090187|NCT02209610|Narcotics|narcotics|mesh-ancestor
2090188|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
716581|NCT02947945|Reslizumab|reslizumab|mesh-list
716582|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
716583|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
716672|NCT02947737|Gentamicins|gentamicins|mesh-list
716673|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
716674|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
716675|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
716676|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716677|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716850|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
716851|NCT02946944|Apixaban|apixaban|mesh-list
716852|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
716853|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
716854|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
716855|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716856|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716857|NCT02946944|Urological Agents|urological agents|mesh-ancestor
716858|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
716859|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
716860|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
716861|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
716862|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
2231051|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
2231052|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231053|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2231054|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718734|NCT02938442|Paclitaxel|paclitaxel|mesh-list
718735|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
718736|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
718737|NCT02938442|Doxorubicin|doxorubicin|mesh-list
718738|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
718739|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
718740|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
718741|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718742|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
718743|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
718744|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
718745|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718746|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
718747|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
718748|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718749|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
718750|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
718751|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
718752|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
718753|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
718754|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
718755|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
718756|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718757|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
718864|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
718865|NCT02937844|Fludarabine|fludarabine|mesh-list
718866|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
718867|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
718868|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718869|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
718870|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
718871|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
718872|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718873|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718874|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
719195|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
719196|NCT02936375|Azathioprine|azathioprine|mesh-list
719197|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
719198|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
716640|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
716641|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716642|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
716643|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
716644|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717428|NCT02944396|Paclitaxel|paclitaxel|mesh-list
717429|NCT02944396|Carboplatin|carboplatin|mesh-list
717430|NCT02944396|Nivolumab|nivolumab|mesh-list
717431|NCT02944396|Pemetrexed|pemetrexed|mesh-list
717432|NCT02944396|Veliparib|veliparib|mesh-list
717433|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
717434|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717435|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
717436|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
717437|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
717438|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717439|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
717440|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
717441|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717442|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
717443|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
717444|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
717605|NCT02943902|Vaccines|vaccines|mesh-list
717606|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
717607|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
717608|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231055|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231056|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
2231057|NCT00070213|Antidotes|antidotes|mesh-ancestor
2231058|NCT00070213|Protective Agents|protective agents|mesh-ancestor
2231059|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
2231060|NCT00070213|Vitamins|vitamins|mesh-ancestor
2231061|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
2231062|NCT00070239|Alvocidib|alvocidib|mesh-list
2231063|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2231064|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2231065|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231066|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231067|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231068|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
2231069|NCT00070239|Growth Substances|growth substances|mesh-ancestor
719057|NCT02937272|Gemcitabine|gemcitabine|mesh-list
719058|NCT02937272|Paclitaxel|paclitaxel|mesh-list
719059|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
719060|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719061|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
719062|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
719063|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
719064|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719065|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
719066|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
719067|NCT02937272|Antiviral Agents|antiviral agents|mesh-ancestor
719068|NCT02937272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
719069|NCT02937272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719070|NCT02937272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
719071|NCT02937272|Immunologic Factors|immunologic factors|mesh-ancestor
719072|NCT02937272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231070|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2231071|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231072|NCT00070252|Docetaxel|docetaxel|mesh-list
2231073|NCT00070252|Capecitabine|capecitabine|mesh-list
2231074|NCT00070252|Tipifarnib|tipifarnib|mesh-list
2231075|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231076|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
2231077|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
2231078|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
2231079|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231080|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2231081|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
719569|NCT02935361|Atezolizumab|atezolizumab|mesh-list
719570|NCT02935361|Guadecitabine|guadecitabine|mesh-list
719571|NCT02935361|Azacitidine|azacitidine|mesh-list
719572|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
719573|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231082|NCT00070265|Capecitabine|capecitabine|mesh-list
2231083|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
2231084|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
716649|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716650|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
716651|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716652|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
2090189|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090190|NCT02209610|Analgesics|analgesics|mesh-ancestor
2090191|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
2090192|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090193|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2090194|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
717223|NCT02945215|Rituximab|rituximab|mesh-list
717224|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
717225|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717226|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
717227|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717228|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231085|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
2231086|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231087|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231088|NCT00070278|Gemcitabine|gemcitabine|mesh-list
2231089|NCT00070278|Paclitaxel|paclitaxel|mesh-list
717672|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
717673|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
717674|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717706|NCT02942810|Cefepime|cefepime|mesh-list
717707|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
717708|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
717781|NCT02942498|Vitamins|vitamins|mesh-list
717782|NCT02942498|Ascorbic Acid|ascorbic acid|mesh-list
717783|NCT02942498|Vitamin E|vitamin e|mesh-list
717784|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
717785|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717786|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
717787|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717788|NCT02942498|Protective Agents|protective agents|mesh-ancestor
717980|NCT02941562|Leucovorin|leucovorin|mesh-list
717981|NCT02941562|Fluorouracil|fluorouracil|mesh-list
717982|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
717983|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
717984|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717985|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
717986|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717987|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
717988|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
717989|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717990|NCT02941562|Antidotes|antidotes|mesh-ancestor
717991|NCT02941562|Protective Agents|protective agents|mesh-ancestor
717992|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
717993|NCT02941562|Vitamins|vitamins|mesh-ancestor
717994|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
718065|NCT02941315|Captopril|captopril|mesh-list
718066|NCT02941315|Spironolactone|spironolactone|mesh-list
718067|NCT02941315|Furosemide|furosemide|mesh-list
718068|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
718069|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
718071|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
718072|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
718073|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718074|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
718075|NCT02941315|Diuretics|diuretics|mesh-ancestor
718076|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
718077|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
718078|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
718079|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718080|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718081|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
718082|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
718083|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718084|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
718085|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
718086|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
718383|NCT02940496|Ribavirin|ribavirin|mesh-list
718384|NCT02940496|Grazoprevir|grazoprevir|mesh-list
718385|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
718386|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
718387|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090195|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
2090196|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
2090197|NCT02209948|Temozolomide|temozolomide|mesh-list
2090198|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2090199|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
2090200|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090201|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090202|NCT02210091|Factor VIII|factor viii|mesh-list
2090203|NCT02210091|BAX 855|bax 855|mesh-list
2090204|NCT02210091|Coagulants|coagulants|mesh-ancestor
2090205|NCT02210195|Aprepitant|aprepitant|mesh-list
2090206|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
716767|NCT02947178|Bupivacaine|bupivacaine|mesh-list
716768|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
716769|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
716770|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
716771|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
716772|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
716773|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
716901|NCT02947061|Docetaxel|docetaxel|mesh-list
716902|NCT02947061|Capecitabine|capecitabine|mesh-list
716903|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716904|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
716905|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
716906|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
716907|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716908|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
716909|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
2231090|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
2231091|NCT00070278|Epirubicin|epirubicin|mesh-list
2231092|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2231093|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231094|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
2231095|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
2231096|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
2231097|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231098|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231099|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
2231100|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231101|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231102|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2090207|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
2090208|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090209|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090210|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2090211|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2090212|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090213|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090214|NCT02210247|Bupivacaine|bupivacaine|mesh-list
717964|NCT02941822|Ambroxol|ambroxol|mesh-list
717965|NCT02941822|Expectorants|expectorants|mesh-ancestor
717966|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
2231103|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
2231104|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2231105|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2231106|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
718367|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
718368|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
718369|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
718370|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
718371|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718372|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718373|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718374|NCT02940314|Urological Agents|urological agents|mesh-ancestor
2231107|NCT00070278|Antiviral Agents|antiviral agents|mesh-ancestor
2231108|NCT00070278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231109|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231110|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2090215|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
716784|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
716785|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
716786|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716787|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716788|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
716789|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2231111|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2231112|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2231113|NCT00070304|Gemcitabine|gemcitabine|mesh-list
717552|NCT02943798|Paclitaxel|paclitaxel|mesh-list
717553|NCT02943798|Etoposide|etoposide|mesh-list
717554|NCT02943798|Carboplatin|carboplatin|mesh-list
717555|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
717556|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717557|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
717558|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
717559|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
717560|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717561|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
717562|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
717563|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717627|NCT02943356|Tadalafil|tadalafil|mesh-list
717628|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
717629|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
717630|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
717631|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717632|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717633|NCT02943356|Urological Agents|urological agents|mesh-ancestor
2231114|NCT00070304|Vinorelbine|vinorelbine|mesh-list
2231115|NCT00070304|Lenograstim|lenograstim|mesh-list
2231116|NCT00070304|Sargramostim|sargramostim|mesh-list
2231117|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2231118|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
2231119|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231120|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231121|NCT00070304|Antiviral Agents|antiviral agents|mesh-ancestor
2231122|NCT00070304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
718182|NCT02941068|Fluconazole|fluconazole|mesh-list
718183|NCT02941068|Caspofungin|caspofungin|mesh-list
718184|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
718185|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
718186|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
718187|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
718188|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718189|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718190|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
718191|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
718192|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
718193|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718194|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
718195|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
718348|NCT02940483|Azacitidine|azacitidine|mesh-list
718349|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
718350|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
718351|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718352|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718353|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718446|NCT02939833|Ropivacaine|ropivacaine|mesh-list
718447|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
718448|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
718449|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
718450|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718451|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
718452|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719080|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
719081|NCT02937012|Bezafibrate|bezafibrate|mesh-list
719082|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
719083|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
719084|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
719085|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
719086|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719087|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
719456|NCT02935582|Betamethasone|betamethasone|mesh-list
719457|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
716809|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
716810|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
716811|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
716812|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
716813|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716814|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717000|NCT02946632|Metformin|metformin|mesh-list
717001|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
717002|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
717003|NCT02946632|Glimepiride|glimepiride|mesh-list
717004|NCT02946632|Saxagliptin|saxagliptin|mesh-list
717005|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
717006|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717007|NCT02946632|Incretins|incretins|mesh-ancestor
717008|NCT02946632|Hormones|hormones|mesh-ancestor
717009|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
717010|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
717011|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
717012|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717013|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717014|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
717015|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
717016|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
717017|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
717065|NCT02945982|Entecavir|entecavir|mesh-list
717066|NCT02945982|Carvedilol|carvedilol|mesh-list
717067|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
717068|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
717069|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
717070|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
717071|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
717072|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
717073|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717074|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717075|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
717076|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
717077|NCT02945982|Protective Agents|protective agents|mesh-ancestor
717078|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
717079|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
717080|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
717081|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
717082|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
717083|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
717642|NCT02943317|Avelumab|avelumab|mesh-list
717643|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
717644|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717770|NCT02942706|Cetuximab|cetuximab|mesh-list
717771|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
717772|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231123|NCT00070304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231124|NCT00070304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231125|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
2231126|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231127|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
718047|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
718048|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
718049|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718050|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718051|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
718052|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718053|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718438|NCT02939742|Betamethasone|betamethasone|mesh-list
718439|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
718440|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
718441|NCT02939742|Hormones|hormones|mesh-ancestor
718442|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
718443|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718444|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
718445|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
718548|NCT02939547|Betadex|betadex|mesh-list
718549|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
718550|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718839|NCT02937662|Cytarabine|cytarabine|mesh-list
718840|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
716912|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
716913|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
716914|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
716915|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716916|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
716917|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
716918|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
716919|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717208|NCT02945267|Tegafur|tegafur|mesh-list
717209|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
717210|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
717211|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
717212|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717213|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717214|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
717445|NCT02944201|Carvedilol|carvedilol|mesh-list
717446|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
717447|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
717448|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
717449|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
717450|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717451|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717452|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
717453|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
717454|NCT02944201|Protective Agents|protective agents|mesh-ancestor
717455|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
717456|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
717457|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
717458|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
717459|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
717460|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
717609|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
717610|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
717611|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718272|NCT02940561|Methotrexate|methotrexate|mesh-list
718273|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
718274|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
718275|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
718276|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718277|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
718278|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
718279|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718280|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718281|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
718282|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718283|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
718284|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
718285|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
718286|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
718287|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
719022|NCT02937285|Interferons|interferons|mesh-list
719023|NCT02937285|Interferon-beta|interferon-beta|mesh-list
719024|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
719025|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
719026|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719027|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
719028|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
719029|NCT02937285|Analgesics|analgesics|mesh-ancestor
719030|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
719031|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719032|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719033|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
719034|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
719035|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719036|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719037|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
719038|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2231128|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2231129|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
2231130|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
2231131|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
2231132|NCT00070343|Dacarbazine|dacarbazine|mesh-list
2231133|NCT00070343|Oblimersen|oblimersen|mesh-list
2753099|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753100|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2753101|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753104|NCT03110744|Palbociclib|palbociclib|mesh-list
2753105|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717156|NCT02945813|Metformin|metformin|mesh-list
717157|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
717158|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717485|NCT02944019|Edoxaban|edoxaban|mesh-list
717486|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
717487|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
717488|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
717489|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
717490|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717491|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717492|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
717871|NCT02942043|Bevacizumab|bevacizumab|mesh-list
717872|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
717873|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717874|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
717875|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
717876|NCT02942043|Growth Substances|growth substances|mesh-ancestor
717877|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717878|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
718090|NCT02940990|Gemcitabine|gemcitabine|mesh-list
718091|NCT02940990|Paclitaxel|paclitaxel|mesh-list
718092|NCT02940990|Etoposide|etoposide|mesh-list
718093|NCT02940990|Vinorelbine|vinorelbine|mesh-list
718094|NCT02940990|Docetaxel|docetaxel|mesh-list
718095|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
718096|NCT02940990|Carboplatin|carboplatin|mesh-list
718097|NCT02940990|Pemetrexed|pemetrexed|mesh-list
718098|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
718099|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718100|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
718101|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
718102|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
718103|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718104|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
718105|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
718106|NCT02940990|Antiviral Agents|antiviral agents|mesh-ancestor
718107|NCT02940990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
718108|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718109|NCT02940990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
718110|NCT02940990|Immunologic Factors|immunologic factors|mesh-ancestor
718111|NCT02940990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718112|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
718113|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
718114|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
718115|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
718165|NCT02940808|Caffeine|caffeine|mesh-list
718166|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
718167|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718168|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
718169|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718170|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718171|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
718172|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
718173|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
718174|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718288|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
718289|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
718290|NCT02940535|Menotropins|menotropins|mesh-list
718291|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
718292|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
718293|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
718294|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
718295|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718296|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
718297|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
718298|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718299|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
718300|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
718400|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
716966|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
716967|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
716968|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
716969|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
716970|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
716971|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
716972|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
716973|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
716974|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
716975|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
716976|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
716977|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
716978|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2090216|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
2090217|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090218|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090219|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
2090220|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717415|NCT02944500|Liraglutide|liraglutide|mesh-list
717416|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
717417|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717418|NCT02944500|Incretins|incretins|mesh-ancestor
717419|NCT02944500|Hormones|hormones|mesh-ancestor
717420|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
717612|NCT02943369|Ticagrelor|ticagrelor|mesh-list
717613|NCT02943369|Cangrelor|cangrelor|mesh-list
717614|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
717615|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
717616|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
717617|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
717618|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
717619|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
717620|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717621|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717709|NCT02942680|Aspirin|aspirin|mesh-list
717710|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
717711|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
717712|NCT02942680|Analgesics|analgesics|mesh-ancestor
717713|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
717714|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717715|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717716|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
717717|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
717718|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
717719|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
717720|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717721|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
717722|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
717723|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717724|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
2090221|NCT02210689|Clindamycin|clindamycin|mesh-list
2090222|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
2231134|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2231135|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
2231136|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718875|NCT02937792|Bupivacaine|bupivacaine|mesh-list
718876|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
718877|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
718878|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
718879|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718880|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
718881|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090223|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
2090224|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2090225|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090226|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2090227|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090228|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090229|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
2090230|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090231|NCT02211638|Candesartan|candesartan|mesh-list
2090232|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
720674|NCT02929706|Azathioprine|azathioprine|mesh-list
720675|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
717029|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
717030|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
717031|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
717032|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
717033|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
717034|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717035|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
717036|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
717249|NCT02945072|Sevoflurane|sevoflurane|mesh-list
717250|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
717251|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
717252|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
717253|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
717254|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
717255|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090233|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2090234|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2090235|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2090236|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090237|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2090238|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2090239|NCT02212106|Vaccines|vaccines|mesh-list
2090240|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
717461|NCT02944357|Gemcitabine|gemcitabine|mesh-list
717462|NCT02944357|Cisplatin|cisplatin|mesh-list
717463|NCT02944357|Vaccines|vaccines|mesh-list
717464|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717465|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
717466|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
717467|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717468|NCT02944357|Antiviral Agents|antiviral agents|mesh-ancestor
717469|NCT02944357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
717470|NCT02944357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717471|NCT02944357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
717472|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
717473|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718354|NCT02940405|Ketorolac|ketorolac|mesh-list
718355|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
718356|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
718357|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
718358|NCT02940405|Analgesics|analgesics|mesh-ancestor
718359|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
718360|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718361|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718362|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
718363|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
718364|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
718365|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718366|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090241|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090242|NCT02212197|Leuprolide|leuprolide|mesh-list
2090243|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2090244|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
2231137|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231138|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
718699|NCT02938923|Testosterone|testosterone|mesh-list
718700|NCT02938923|Androgens|androgens|mesh-ancestor
718701|NCT02938923|Hormones|hormones|mesh-ancestor
718702|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
718703|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231139|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
2231140|NCT00070382|Hematinics|hematinics|mesh-ancestor
2231141|NCT00070434|Leucovorin|leucovorin|mesh-list
719315|NCT02935790|Nivolumab|nivolumab|mesh-list
719316|NCT02935790|Ipilimumab|ipilimumab|mesh-list
719317|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
719318|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719319|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
719320|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719546|NCT02935335|Menotropins|menotropins|mesh-list
719547|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
719548|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
719549|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
719550|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719861|NCT02933905|Ranibizumab|ranibizumab|mesh-list
719862|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
717131|NCT02945852|Apatinib|apatinib|mesh-list
717132|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717133|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
717134|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717135|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717748|NCT02942563|Capecitabine|capecitabine|mesh-list
717749|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
717750|NCT02942563|Irinotecan|irinotecan|mesh-list
717751|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
717752|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
717753|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717754|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717755|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
717756|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
717757|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717900|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
717901|NCT02942095|Ixazomib|ixazomib|mesh-list
717902|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717903|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
717904|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717905|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717906|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
2231142|NCT00070434|Pyridoxine|pyridoxine|mesh-list
2231143|NCT00070434|Fluorouracil|fluorouracil|mesh-list
2231144|NCT00070434|Capecitabine|capecitabine|mesh-list
2231145|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
2231146|NCT00070434|Irinotecan|irinotecan|mesh-list
2231147|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
2231148|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231149|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
718453|NCT02939872|Aspirin|aspirin|mesh-list
718454|NCT02939872|Clopidogrel|clopidogrel|mesh-list
718455|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
718456|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
718457|NCT02939872|Analgesics|analgesics|mesh-ancestor
718458|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
718459|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718460|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718461|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
718462|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
718463|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
718464|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
718465|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718466|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
718467|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
718468|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718469|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
718470|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
718471|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
718472|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
718473|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
718474|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718891|NCT02937896|Ketorolac|ketorolac|mesh-list
718892|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
718893|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
718894|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
718895|NCT02937896|Analgesics|analgesics|mesh-ancestor
718896|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
718897|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718898|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718899|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
718900|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
718901|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
718902|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718903|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718904|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
718905|NCT02937896|Coagulants|coagulants|mesh-ancestor
718906|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
718907|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
719134|NCT02936622|Paclitaxel|paclitaxel|mesh-list
2231150|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717109|NCT02946125|Respiratory System Agents|respiratory system agents|mesh-ancestor
717110|NCT02946125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
717111|NCT02946125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
717112|NCT02946125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
717113|NCT02946125|Adrenergic Agents|adrenergic agents|mesh-ancestor
717114|NCT02946125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
717115|NCT02946125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717116|NCT02946125|Protective Agents|protective agents|mesh-ancestor
717117|NCT02946125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
717159|NCT02945644|Trazodone|trazodone|mesh-list
717160|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
717161|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
717162|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
717163|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717164|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
717165|NCT02945644|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
717166|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
717167|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
717168|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717169|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
717170|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
717171|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
717172|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
717320|NCT02945033|Aspirin|aspirin|mesh-list
717321|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
717322|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
717323|NCT02945033|Analgesics|analgesics|mesh-ancestor
717324|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
717325|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717326|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717327|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
717328|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
717329|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
717330|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
717331|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717332|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
717333|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
717334|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717335|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
717376|NCT02944292|Propofol|propofol|mesh-list
717377|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
717378|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
717379|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717380|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
717381|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
717382|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
2231151|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2231152|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231153|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231154|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
2231155|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2231156|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2231157|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231158|NCT00070434|Antidotes|antidotes|mesh-ancestor
2231159|NCT00070434|Protective Agents|protective agents|mesh-ancestor
2231160|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
2231161|NCT00070434|Vitamins|vitamins|mesh-ancestor
2231162|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
2231163|NCT00070447|Prednisone|prednisone|mesh-list
2231164|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
717736|NCT02942758|Pioglitazone|pioglitazone|mesh-list
717737|NCT02942758|Azacitidine|azacitidine|mesh-list
717738|NCT02942758|Tretinoin|tretinoin|mesh-list
717739|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
717740|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
717741|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717742|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717743|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717744|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
717745|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717746|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
717747|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
2090245|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2090246|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231165|NCT00070447|Rituximab|rituximab|mesh-list
2231166|NCT00070447|Doxorubicin|doxorubicin|mesh-list
717230|NCT02945163|Lamivudine|lamivudine|mesh-list
717231|NCT02945163|Efavirenz|efavirenz|mesh-list
717232|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
717233|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
717234|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
717235|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
717236|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717237|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717238|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
717239|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
717240|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
717241|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
717242|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
717243|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
717244|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
717245|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
717300|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
717301|NCT02944825|Trimethoprim|trimethoprim|mesh-list
717302|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
717303|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
717304|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
717305|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
717306|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
717307|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717308|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717309|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717310|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
717311|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
717312|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
717313|NCT02944825|Renal Agents|renal agents|mesh-ancestor
717314|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
717315|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
717316|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
717317|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
717318|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
717319|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
717547|NCT02944110|Glucagon|glucagon|mesh-list
717548|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
717549|NCT02944110|Hormones|hormones|mesh-ancestor
717550|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
717551|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718116|NCT02940925|Cisplatin|cisplatin|mesh-list
718117|NCT02940925|Fluorouracil|fluorouracil|mesh-list
718118|NCT02940925|Capecitabine|capecitabine|mesh-list
718119|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718120|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
718121|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718122|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
718123|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
718124|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
718125|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718649|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
718650|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
718651|NCT02938988|Methylene Blue|methylene blue|mesh-list
718652|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718653|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719411|NCT02935829|Locust bean gum|locust bean gum|mesh-list
719412|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
719413|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
719725|NCT02934464|Leucovorin|leucovorin|mesh-list
719726|NCT02934464|Paclitaxel|paclitaxel|mesh-list
719727|NCT02934464|Ramucirumab|ramucirumab|mesh-list
719728|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
719729|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
719730|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
719731|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719732|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
719733|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
719734|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
719735|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719736|NCT02934464|Antidotes|antidotes|mesh-ancestor
719737|NCT02934464|Protective Agents|protective agents|mesh-ancestor
719738|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719739|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
719740|NCT02934464|Vitamins|vitamins|mesh-ancestor
719741|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
717263|NCT02944942|Anesthetics|anesthetics|mesh-list
717264|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
717265|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717390|NCT02944214|Febuxostat|febuxostat|mesh-list
717391|NCT02944214|Benzbromarone|benzbromarone|mesh-list
717392|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
717393|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
717394|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
717395|NCT02944214|Renal Agents|renal agents|mesh-ancestor
717577|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
717578|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
717579|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
717580|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
717581|NCT02943655|Progesterone|progesterone|mesh-list
717582|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
717583|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717584|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
717585|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
717586|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
717587|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
717588|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
717589|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
717590|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
717591|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717592|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
717593|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
717594|NCT02943655|Analgesics|analgesics|mesh-ancestor
717595|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
717596|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717597|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
717598|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
717599|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
717600|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717601|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717602|NCT02943655|Progestins|progestins|mesh-ancestor
717603|NCT02943655|Hormones|hormones|mesh-ancestor
717604|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
717969|NCT02941744|Nivolumab|nivolumab|mesh-list
717970|NCT02941744|Ipilimumab|ipilimumab|mesh-list
717971|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
717972|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717973|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
717974|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718392|NCT02940262|Edetic Acid|edetic acid|mesh-list
718393|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
718394|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
718395|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
718396|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718397|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
718398|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
718399|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
718882|NCT02937779|Tenofovir|tenofovir|mesh-list
718883|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
718884|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
718885|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
718886|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
718887|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718888|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718889|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
718890|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
718969|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
718970|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
718971|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718972|NCT02937363|Protective Agents|protective agents|mesh-ancestor
718973|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718974|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
718975|NCT02937363|Vitamins|vitamins|mesh-ancestor
718976|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
2090247|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2090248|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090249|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
2090250|NCT02212379|Etravirine|etravirine|mesh-list
2090251|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2090252|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
719628|NCT02934945|Budesonide|budesonide|mesh-list
719629|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
717283|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
717284|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
717285|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
717286|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
717287|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
717288|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
717289|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
717290|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717291|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
717544|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
717545|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
717546|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
718338|NCT02940444|Heparin|heparin|mesh-list
718339|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
718340|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
718341|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
718342|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718666|NCT02938975|Permethrin|permethrin|mesh-list
718667|NCT02938975|Insect Repellents|insect repellents|mesh-list
718668|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718669|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718670|NCT02938975|Protective Agents|protective agents|mesh-ancestor
718671|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753106|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2753107|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753108|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719048|NCT02936934|Morphine|morphine|mesh-list
719049|NCT02936934|Oxycodone|oxycodone|mesh-list
719050|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
719051|NCT02936934|Narcotics|narcotics|mesh-ancestor
719052|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
719053|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719054|NCT02936934|Analgesics|analgesics|mesh-ancestor
719055|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
719056|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719174|NCT02936505|Cyclosporine|cyclosporine|mesh-list
719175|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
719176|NCT02936505|Tacrolimus|tacrolimus|mesh-list
719177|NCT02936505|Cyclosporins|cyclosporins|mesh-list
719178|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
719179|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
719180|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
719181|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
719182|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719183|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
719184|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719185|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719186|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
719187|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
719188|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
719189|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
719190|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
719191|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719192|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
719193|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
719194|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
719285|NCT02935998|Ziprasidone|ziprasidone|mesh-list
719286|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
719287|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
719288|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
719289|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719290|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719291|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
719292|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
719293|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
719294|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
719295|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
719296|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
717362|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2090253|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
2090254|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090255|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2090256|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2090257|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717852|NCT02942290|Azacitidine|azacitidine|mesh-list
717853|NCT02942290|Venetoclax|venetoclax|mesh-list
717854|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
717855|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
717856|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717857|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717858|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718156|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
718157|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
718158|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
718159|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718160|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718161|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
718162|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
718163|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
718164|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718602|NCT02939248|Morphine|morphine|mesh-list
718603|NCT02939248|Naloxone|naloxone|mesh-list
718604|NCT02939248|Ticagrelor|ticagrelor|mesh-list
718605|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
718606|NCT02939248|Narcotics|narcotics|mesh-ancestor
718607|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
718608|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718609|NCT02939248|Analgesics|analgesics|mesh-ancestor
718610|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
718611|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718612|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
718613|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
718614|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
718615|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
718616|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
718617|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718618|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718619|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
719144|NCT02936427|Dexamethasone|dexamethasone|mesh-list
719145|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
719146|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
719147|NCT02936427|BB 1101|bb 1101|mesh-list
719148|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
719149|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
719150|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
719151|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719152|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719153|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
719154|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
719155|NCT02936427|Hormones|hormones|mesh-ancestor
719156|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
719157|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
719158|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719159|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
719160|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719161|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719969|NCT02933658|Amlodipine|amlodipine|mesh-list
719970|NCT02933658|Telmisartan|telmisartan|mesh-list
719971|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
719972|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
719973|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
719974|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
719975|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719976|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
719977|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719978|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
719979|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
719980|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
719981|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
719982|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
719983|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
719984|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231167|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
717388|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
717389|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717474|NCT02944123|Clopidogrel|clopidogrel|mesh-list
717475|NCT02944123|Ticagrelor|ticagrelor|mesh-list
717476|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
717477|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
717478|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
717479|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
717480|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
717481|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
717482|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
717483|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717484|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717564|NCT02943785|Edoxaban|edoxaban|mesh-list
717565|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
717566|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
717567|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
717568|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
717569|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717570|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717571|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
718021|NCT02941601|Gemcitabine|gemcitabine|mesh-list
718022|NCT02941601|Carboplatin|carboplatin|mesh-list
718023|NCT02941601|Necitumumab|necitumumab|mesh-list
718024|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718025|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
718026|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
718027|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718028|NCT02941601|Antiviral Agents|antiviral agents|mesh-ancestor
718029|NCT02941601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
718030|NCT02941601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718031|NCT02941601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
718032|NCT02941601|Immunologic Factors|immunologic factors|mesh-ancestor
718033|NCT02941601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718034|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
718126|NCT02941016|Evolocumab|evolocumab|mesh-list
718127|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
718128|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
718129|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
718130|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718131|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
718208|NCT02940756|Artesunate|artesunate|mesh-list
718209|NCT02940756|Lumefantrine|lumefantrine|mesh-list
718210|NCT02940756|Artemether|artemether|mesh-list
718211|NCT02940756|Piperaquine|piperaquine|mesh-list
718212|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
718213|NCT02940756|Amodiaquine|amodiaquine|mesh-list
718214|NCT02940756|Artenimol|artenimol|mesh-list
718215|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
718216|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
718217|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
718218|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
718219|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718220|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
718221|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
718222|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
718223|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
718301|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
718302|NCT02940379|Metoprolol|metoprolol|mesh-list
718303|NCT02940379|Midazolam|midazolam|mesh-list
718304|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
718305|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
718306|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
718307|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718308|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
718309|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
718310|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
718311|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
718312|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
718313|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
718314|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
718315|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
718316|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718317|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718318|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
718319|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
717510|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
717511|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
717512|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
717513|NCT02944045|Prednisolone|prednisolone|mesh-list
717514|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
717515|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
717516|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
717517|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
717518|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
717519|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
717520|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717521|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717522|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
717523|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
717524|NCT02944045|Hormones|hormones|mesh-ancestor
717525|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
717526|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
717527|NCT02944045|Protective Agents|protective agents|mesh-ancestor
717528|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
717529|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717879|NCT02942212|Nicotine|nicotine|mesh-list
717880|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
717881|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
717882|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717883|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717884|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
717885|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
717886|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
717887|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
717888|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231168|NCT00070447|Vincristine|vincristine|mesh-list
2231169|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231170|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
2231171|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231172|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231173|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2231174|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
2231175|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231176|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231177|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2231178|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2231179|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2231180|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2231181|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2231182|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718490|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
718491|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
718492|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
718493|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
718494|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718495|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718496|NCT02939495|Urological Agents|urological agents|mesh-ancestor
718554|NCT02939300|Nivolumab|nivolumab|mesh-list
718555|NCT02939300|Ipilimumab|ipilimumab|mesh-list
718556|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
718557|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718558|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
718559|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718711|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
718712|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
718713|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090258|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090259|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2090260|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2090261|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
2090262|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2090263|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
2090264|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090265|NCT02212678|Expectorants|expectorants|mesh-ancestor
2090266|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
719349|NCT02935972|Lidocaine|lidocaine|mesh-list
719350|NCT02935972|Diazepam|diazepam|mesh-list
719351|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
719352|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
719353|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
717540|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
717541|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
717542|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
717543|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
2090267|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2090268|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
2090269|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090270|NCT02212678|Protective Agents|protective agents|mesh-ancestor
2090271|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090272|NCT02212678|Antidotes|antidotes|mesh-ancestor
2090273|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
2090274|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2090275|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090276|NCT02213042|Trastuzumab|trastuzumab|mesh-list
2090277|NCT02213042|Lapatinib|lapatinib|mesh-list
2090278|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2090279|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2090280|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090281|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2090282|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718626|NCT02939235|Morphine|morphine|mesh-list
718627|NCT02939235|Metoclopramide|metoclopramide|mesh-list
718628|NCT02939235|Ticagrelor|ticagrelor|mesh-list
718629|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
718630|NCT02939235|Narcotics|narcotics|mesh-ancestor
718631|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
718632|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718633|NCT02939235|Analgesics|analgesics|mesh-ancestor
718634|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
718635|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718636|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
718637|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
718638|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
718639|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
718640|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
718641|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718642|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718643|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
718644|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
718645|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
718646|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
718647|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
718648|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
718818|NCT02938286|Epinephrine|epinephrine|mesh-list
718819|NCT02938286|Carticaine|carticaine|mesh-list
718820|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
718821|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
718822|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
718823|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718824|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718825|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718826|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
718827|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
718828|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
718829|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718830|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
718831|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
718832|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
718833|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
718834|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
718835|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
718836|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
718837|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
718838|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
2231183|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2231184|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
2231185|NCT00070447|Hormones|hormones|mesh-ancestor
719111|NCT02936830|Listerine|listerine|mesh-list
719112|NCT02936830|Fluorides|fluorides|mesh-list
719113|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
719114|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
719115|NCT02936830|Glycerol|glycerol|mesh-list
719116|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
719117|NCT02936830|Protective Agents|protective agents|mesh-ancestor
719118|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719119|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
719120|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753109|NCT03093246|Aspirin|aspirin|mesh-list
717651|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
717652|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
717730|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
717731|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
717732|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717733|NCT02942732|Vitamins|vitamins|mesh-ancestor
717734|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
717735|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
718235|NCT02940548|Amlodipine|amlodipine|mesh-list
718236|NCT02940548|Nifedipine|nifedipine|mesh-list
718237|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
718238|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
718239|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
718240|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718241|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
718242|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718243|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
718244|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
718245|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
718475|NCT02939898|Letrozole|letrozole|mesh-list
718476|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
718477|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718478|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
718479|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718480|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718481|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
718482|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
718483|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
718484|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718521|NCT02939430|Atropine|atropine|mesh-list
718522|NCT02939430|Neostigmine|neostigmine|mesh-list
718523|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
718524|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
718525|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
718526|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
718527|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718528|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718529|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
718530|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
718531|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
718532|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
718533|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
718534|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
718535|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
718536|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718537|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718538|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
718539|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718540|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
718662|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
718663|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
718664|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
718665|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
2231186|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2231187|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2231188|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
719122|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
719123|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
719124|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
719125|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719126|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
719127|NCT02936661|Coagulants|coagulants|mesh-ancestor
719277|NCT02935751|Apixaban|apixaban|mesh-list
719278|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
719279|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
719280|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
719281|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
719282|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719283|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719284|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
719586|NCT02935101|Prednisolone|prednisolone|mesh-list
719587|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
719588|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
719589|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
717682|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
717683|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
717684|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
717685|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
717686|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717758|NCT02942420|Bucillamine|bucillamine|mesh-list
717759|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
717760|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
717761|NCT02942420|Analgesics|analgesics|mesh-ancestor
717762|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
717763|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717764|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717765|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
717766|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
717767|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
717768|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717769|NCT02942420|Protective Agents|protective agents|mesh-ancestor
2231189|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
2231190|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
2231191|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
2231192|NCT00070473|Pemetrexed|pemetrexed|mesh-list
718146|NCT02940912|Apomorphine|apomorphine|mesh-list
718147|NCT02940912|Emetics|emetics|mesh-ancestor
718148|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718149|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
718150|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718151|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
718152|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
718153|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
718154|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718155|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718250|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
718251|NCT02940509|Ketamine|ketamine|mesh-list
718252|NCT02940509|Analgesics|analgesics|mesh-ancestor
718253|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
718254|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718255|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718256|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
718257|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
718258|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
718259|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
718260|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
718261|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
718262|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
718263|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718264|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718265|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
718266|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
718267|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
718268|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
718269|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
718270|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
718271|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2231193|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231194|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231195|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231196|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2231197|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2231198|NCT00070486|Gemcitabine|gemcitabine|mesh-list
718792|NCT02938182|Clopidogrel|clopidogrel|mesh-list
718793|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
718794|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
718795|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
718796|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
718797|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
718798|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718799|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718800|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090283|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231199|NCT00070486|Celecoxib|celecoxib|mesh-list
720168|NCT02932397|Propofol|propofol|mesh-list
720169|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
720170|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
717700|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717701|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
717702|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
717703|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717704|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
717705|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
2231200|NCT00070486|Zileuton|zileuton|mesh-list
2231201|NCT00070486|Carboplatin|carboplatin|mesh-list
2231202|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231203|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2231204|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
2231205|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231206|NCT00070486|Antiviral Agents|antiviral agents|mesh-ancestor
2231207|NCT00070486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231208|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717889|NCT02941913|Palonosetron|palonosetron|mesh-list
717890|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
717891|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
717892|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717893|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717894|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
717895|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
717896|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
717897|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
717898|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
717899|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719252|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
719253|NCT02935933|Morphine|morphine|mesh-list
719254|NCT02935933|Bupivacaine|bupivacaine|mesh-list
719255|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
719256|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
719257|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
719258|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719259|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
719260|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719261|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
719262|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
719263|NCT02935933|Analgesics|analgesics|mesh-ancestor
719264|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
719265|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
719266|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
719267|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
719268|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
719269|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719270|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
719271|NCT02935933|Narcotics|narcotics|mesh-ancestor
719623|NCT02934919|Nalmefene|nalmefene|mesh-list
719624|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
719625|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719626|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
719627|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719801|NCT02934022|Maraviroc|maraviroc|mesh-list
719802|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
719803|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
719804|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719805|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
719806|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
719807|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
719808|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
719809|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
720113|NCT02932774|Cetirizine|cetirizine|mesh-list
720114|NCT02932774|Loratadine|loratadine|mesh-list
720115|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
720116|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
720117|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
720118|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
720119|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
720120|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
720121|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720122|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720123|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
720124|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
720278|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
720279|NCT02932254|Analgesics|analgesics|mesh-ancestor
720280|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
720281|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717779|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717780|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
718005|NCT02941510|Budesonide|budesonide|mesh-list
718006|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
718007|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
718008|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
718009|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718010|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718011|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
718012|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
718013|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
718014|NCT02941510|Hormones|hormones|mesh-ancestor
718015|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
718054|NCT02941224|Sirolimus|sirolimus|mesh-list
718055|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
718056|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
718057|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
718058|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718059|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
718060|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
718061|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
718062|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231209|NCT00070486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231210|NCT00070486|Immunologic Factors|immunologic factors|mesh-ancestor
2231211|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231212|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2231213|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2231214|NCT00070486|Analgesics|analgesics|mesh-ancestor
2231215|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
2231216|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2231217|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
719233|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
719234|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
719235|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
719519|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
719520|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
719521|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
719522|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
719987|NCT02933593|Hydralazine|hydralazine|mesh-list
719988|NCT02933593|Labetalol|labetalol|mesh-list
719989|NCT02933593|Nifedipine|nifedipine|mesh-list
719990|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
719991|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
719992|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719993|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
719994|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719995|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
719996|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
719997|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
719998|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
719999|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
720000|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
720001|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
720002|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
720003|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
720004|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
720005|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720006|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
720007|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
720318|NCT02931877|Propofol|propofol|mesh-list
720319|NCT02931877|Sevoflurane|sevoflurane|mesh-list
720320|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
720321|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720322|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720323|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
720324|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
720325|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
720326|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
720327|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
720492|NCT02930902|Gemcitabine|gemcitabine|mesh-list
720493|NCT02930902|Paclitaxel|paclitaxel|mesh-list
720494|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
720495|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
720496|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
720497|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720498|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
2090284|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2090285|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2090286|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
2090287|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2090288|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090289|NCT02213055|Permethrin|permethrin|mesh-list
2090290|NCT02213055|Malathion|malathion|mesh-list
2090291|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090292|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090293|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
717999|NCT02941445|Metformin|metformin|mesh-list
718000|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
718001|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
718002|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718003|NCT02941445|Incretins|incretins|mesh-ancestor
718004|NCT02941445|Hormones|hormones|mesh-ancestor
718016|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
718017|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
718018|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
718019|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718020|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718070|NCT02941198|Copper|copper|mesh-list
718087|NCT02941198|Trace Elements|trace elements|mesh-ancestor
718088|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
718089|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231218|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231219|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2231220|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
718541|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
718542|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
718543|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718544|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
718545|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718546|NCT02939417|Protective Agents|protective agents|mesh-ancestor
718547|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231221|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2231222|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2231223|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
2231224|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2231225|NCT00070525|Tipifarnib|tipifarnib|mesh-list
2231226|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718714|NCT02938468|Dexamethasone|dexamethasone|mesh-list
718715|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
718716|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
718717|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
718718|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718719|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718720|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
718721|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
718722|NCT02938468|Hormones|hormones|mesh-ancestor
718723|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
718724|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
718725|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231227|NCT00070538|Cytarabine|cytarabine|mesh-list
2231228|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2231229|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
2231230|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231231|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231232|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
2231233|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753110|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2753111|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2753112|NCT03093246|Analgesics|analgesics|mesh-ancestor
2753113|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
2753114|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2753115|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753116|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2753117|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2753118|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2090294|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
2090295|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
719321|NCT02935959|Midazolam|midazolam|mesh-list
719322|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
719323|NCT02935959|Ketamine|ketamine|mesh-list
2231234|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
717813|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
717814|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
717815|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
717816|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231235|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
2231236|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231237|NCT00070551|Cytarabine|cytarabine|mesh-list
2231238|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2231239|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
2231240|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231241|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231242|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
2231243|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231244|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
719470|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
719471|NCT02935530|Tinzaparin|tinzaparin|mesh-list
719472|NCT02935530|Dalteparin|dalteparin|mesh-list
719473|NCT02935530|Argatroban|argatroban|mesh-list
719474|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
719475|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
719476|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
719477|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719478|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
719479|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
719480|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
719481|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719482|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
720400|NCT02931136|Huperzine A|huperzine a|mesh-list
720401|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
720402|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720403|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720404|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
720405|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
720406|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720407|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
720408|NCT02931136|Protective Agents|protective agents|mesh-ancestor
720720|NCT02929524|Ketamine|ketamine|mesh-list
720721|NCT02929524|Analgesics|analgesics|mesh-ancestor
720722|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
720723|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720724|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720725|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
720726|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
720727|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
720728|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
720729|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720730|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
720731|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
720732|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
720733|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722825|NCT02919579|Esketamine|esketamine|mesh-list
722826|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
722827|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2231245|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
2231246|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231247|NCT00070590|Bosentan|bosentan|mesh-list
2231248|NCT00070590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2231249|NCT00070590|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
717951|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
717952|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
717953|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
717954|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
717955|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
717956|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
717957|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
717958|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
717959|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
717960|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
717961|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
717962|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
717963|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2231250|NCT00070590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231251|NCT00070629|Paclitaxel|paclitaxel|mesh-list
2231252|NCT00070629|Docetaxel|docetaxel|mesh-list
2231253|NCT00070629|Cisplatin|cisplatin|mesh-list
2231254|NCT00070629|Carboplatin|carboplatin|mesh-list
2231255|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2231256|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231257|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
718788|NCT02938273|Cetuximab|cetuximab|mesh-list
718789|NCT02938273|Avelumab|avelumab|mesh-list
718790|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
718791|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718859|NCT02937857|Antipyretics|antipyretics|mesh-list
718860|NCT02937857|Expectorants|expectorants|mesh-list
718861|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
718862|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718863|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
2231258|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
2231259|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
2231260|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231261|NCT00070642|Dacarbazine|dacarbazine|mesh-list
2231262|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2231263|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
2231264|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231265|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231266|NCT00070655|Vitamin K|vitamin k|mesh-list
2231267|NCT00070655|Warfarin|warfarin|mesh-list
2231268|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
2231269|NCT00070655|Idraparinux|idraparinux|mesh-list
2231270|NCT00070655|Vitamins|vitamins|mesh-ancestor
2231271|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
2231272|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231273|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
2231274|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2231275|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2231276|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231277|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
2231278|NCT00070655|Coagulants|coagulants|mesh-ancestor
2231279|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2090296|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090297|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
2090298|NCT02213068|Abatacept|abatacept|mesh-list
2090299|NCT02213068|Tacrolimus|tacrolimus|mesh-list
2090300|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2090301|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
2231280|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
2231281|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2231282|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
2231283|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231284|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
2231285|NCT00070733|Testosterone|testosterone|mesh-list
2231286|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
2231287|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
2231288|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2231289|NCT00070733|Androgens|androgens|mesh-ancestor
2231290|NCT00070733|Hormones|hormones|mesh-ancestor
2231291|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2231292|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231293|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2231294|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231295|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
2231296|NCT00070759|Daclizumab|daclizumab|mesh-list
2231297|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231298|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
2231299|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718132|NCT02940769|Methamphetamine|methamphetamine|mesh-list
718133|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
718134|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718135|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
718136|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
718137|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718138|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
718139|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718140|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718141|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
718142|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
718143|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
718144|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
718145|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2231300|NCT00070837|Antibodies|antibodies|mesh-list
2231301|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2231302|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
2231303|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231304|NCT00071071|Zanolimumab|zanolimumab|mesh-list
2231305|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2231306|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231307|NCT00071084|Zanolimumab|zanolimumab|mesh-list
2231308|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2231309|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231310|NCT00071097|Darunavir|darunavir|mesh-list
2231311|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2090302|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090303|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
720175|NCT02932566|Pirfenidone|pirfenidone|mesh-list
720176|NCT02932566|Analgesics|analgesics|mesh-ancestor
720177|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
720178|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720179|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720180|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
720181|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
720182|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
720183|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
720184|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720523|NCT02930434|Vitamin D|vitamin d|mesh-list
720524|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
720525|NCT02930434|Vitamins|vitamins|mesh-ancestor
720526|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
720527|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720528|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
720529|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
720590|NCT02930109|Cytarabine|cytarabine|mesh-list
720591|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
720592|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
720593|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720594|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720595|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
720596|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720597|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
718320|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
718321|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
718322|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718323|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
718324|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
718325|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
718326|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
718327|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
718328|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
718485|NCT02939846|Trametinib|trametinib|mesh-list
718486|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718487|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
718488|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718489|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718620|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
718621|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
718622|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
718623|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718624|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
718625|NCT02938962|Coagulants|coagulants|mesh-ancestor
718758|NCT02938793|Durvalumab|durvalumab|mesh-list
718759|NCT02938793|Tremelimumab|tremelimumab|mesh-list
718760|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
718761|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231312|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2231313|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
2231314|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231315|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231316|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2231317|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2231318|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
719449|NCT02935647|Propofol|propofol|mesh-list
719450|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
719451|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
719452|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719453|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
719454|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
719455|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
720485|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
720486|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
720487|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231319|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231320|NCT00071136|Gemcitabine|gemcitabine|mesh-list
2231321|NCT00071136|Pemetrexed|pemetrexed|mesh-list
2231322|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2231323|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
2231324|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231325|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231326|NCT00071136|Antiviral Agents|antiviral agents|mesh-ancestor
2231327|NCT00071136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231328|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231329|NCT00071136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231330|NCT00071136|Immunologic Factors|immunologic factors|mesh-ancestor
2231331|NCT00071136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231332|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2231333|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2231334|NCT00071188|Paclitaxel|paclitaxel|mesh-list
2231335|NCT00071188|Carboplatin|carboplatin|mesh-list
2231336|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2231337|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231338|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
2231339|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
2231340|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
2231341|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231342|NCT00071201|Adefovir|adefovir|mesh-list
2231343|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2231344|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
2231345|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231346|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2231347|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2231348|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231349|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231350|NCT00071227|Triamcinolone|triamcinolone|mesh-list
2231351|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2231352|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
718388|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
718389|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718390|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
718391|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
718418|NCT02940002|Betamethasone|betamethasone|mesh-list
718419|NCT02940002|Clobetasol|clobetasol|mesh-list
718420|NCT02940002|Calcipotriene|calcipotriene|mesh-list
718421|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
718422|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
718423|NCT02940002|Hormones|hormones|mesh-ancestor
718424|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
718425|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718426|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
718427|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
718428|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
718500|NCT02939482|Triamcinolone|triamcinolone|mesh-list
718501|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
718502|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
718503|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
718504|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
718505|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
718506|NCT02939482|Hormones|hormones|mesh-ancestor
718507|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
718508|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718509|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
718510|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
718511|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718512|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718654|NCT02939209|Hydromorphone|hydromorphone|mesh-list
718655|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
718656|NCT02939209|Narcotics|narcotics|mesh-ancestor
718657|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
718658|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718659|NCT02939209|Analgesics|analgesics|mesh-ancestor
718660|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
718661|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719297|NCT02935764|Leucovorin|leucovorin|mesh-list
719298|NCT02935764|Fluorouracil|fluorouracil|mesh-list
719299|NCT02935764|Irinotecan|irinotecan|mesh-list
719300|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
719301|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719302|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
719303|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719304|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
719305|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
719306|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719307|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
719308|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
719309|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719310|NCT02935764|Antidotes|antidotes|mesh-ancestor
719311|NCT02935764|Protective Agents|protective agents|mesh-ancestor
719312|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
719313|NCT02935764|Vitamins|vitamins|mesh-ancestor
719314|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
719580|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
719581|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
719582|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
719583|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
719584|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
719585|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
719666|NCT02934763|Propranolol|propranolol|mesh-list
719667|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
719668|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
719669|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
719670|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
719671|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719672|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719673|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
719674|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
719675|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
719829|NCT02934152|Amoxicillin|amoxicillin|mesh-list
719830|NCT02934152|Clarithromycin|clarithromycin|mesh-list
719831|NCT02934152|Rabeprazole|rabeprazole|mesh-list
719832|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
719833|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
719834|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
719835|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718401|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
718402|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718403|NCT02940184|Incretins|incretins|mesh-ancestor
718404|NCT02940184|Hormones|hormones|mesh-ancestor
718405|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
718406|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
718407|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
718408|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
718409|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718770|NCT02938260|Metoprolol|metoprolol|mesh-list
718771|NCT02938260|Diltiazem|diltiazem|mesh-list
718772|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
718773|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
718774|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
718775|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
718776|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
718777|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718778|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
718779|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
718780|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
718781|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
718782|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718783|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718784|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
718785|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
718786|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
718787|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
2231353|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2231354|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2231355|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
2231356|NCT00071227|Hormones|hormones|mesh-ancestor
2231357|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2231358|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231359|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231360|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
719676|NCT02935010|Amoxicillin|amoxicillin|mesh-list
719677|NCT02935010|Metronidazole|metronidazole|mesh-list
719678|NCT02935010|Clarithromycin|clarithromycin|mesh-list
719679|NCT02935010|Levofloxacin|levofloxacin|mesh-list
719680|NCT02935010|Ofloxacin|ofloxacin|mesh-list
719681|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
719682|NCT02935010|Esomeprazole|esomeprazole|mesh-list
719683|NCT02935010|Bismuth|bismuth|mesh-list
719684|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719685|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
719686|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
719687|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
719688|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
719689|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
719690|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
719691|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
719692|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719693|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
719694|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
719695|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
719696|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
719697|NCT02935010|Renal Agents|renal agents|mesh-ancestor
719698|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
719699|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
719700|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719701|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
719702|NCT02935010|Antacids|antacids|mesh-ancestor
719703|NCT02935010|Diuretics|diuretics|mesh-ancestor
719704|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
719705|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719706|NCT02935010|Expectorants|expectorants|mesh-ancestor
719707|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
720161|NCT02932644|Vitamin D|vitamin d|mesh-list
720162|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
720163|NCT02932644|Vitamins|vitamins|mesh-list
720164|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
720165|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720166|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
720167|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
720389|NCT02931123|Rifaximin|rifaximin|mesh-list
720390|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
718593|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
718594|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
718595|NCT02939287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
718596|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
718597|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
718598|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718599|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718600|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
718601|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2231361|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231362|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719538|NCT02935374|Amoxicillin|amoxicillin|mesh-list
719539|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
719540|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
719541|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
719542|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
719543|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
719544|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719545|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720017|NCT02933645|Insulin|insulin|mesh-list
720018|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
720019|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
720020|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720396|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
720397|NCT02931175|Hormones|hormones|mesh-ancestor
720398|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
720399|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231363|NCT00071240|Hormones|hormones|mesh-list
2231364|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2231365|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720658|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
720659|NCT02929927|Eusol|eusol|mesh-list
720660|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
720661|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720783|NCT02929576|Paclitaxel|paclitaxel|mesh-list
720784|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
720785|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720786|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
720787|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
720788|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
720789|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720877|NCT02928679|Liraglutide|liraglutide|mesh-list
720878|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
720879|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720880|NCT02928679|Incretins|incretins|mesh-ancestor
720881|NCT02928679|Hormones|hormones|mesh-ancestor
720882|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
721649|NCT02924532|Hormones|hormones|mesh-list
721650|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
721651|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
721652|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721653|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
721886|NCT02924090|Ketamine|ketamine|mesh-list
721887|NCT02924090|Etomidate|etomidate|mesh-list
721888|NCT02924090|Analgesics|analgesics|mesh-ancestor
721889|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
721890|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
721891|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721892|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2231366|NCT00071253|Valproic Acid|valproic acid|mesh-list
2231367|NCT00071253|Olanzapine|olanzapine|mesh-list
2231368|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
718979|NCT02937415|Antioxidants|antioxidants|mesh-list
718980|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
718981|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718982|NCT02937415|Protective Agents|protective agents|mesh-ancestor
718983|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718984|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
718985|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
718986|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2231369|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
2231370|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2231371|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231372|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2231373|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2231374|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2231375|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2231376|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2231377|NCT00071253|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2231378|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2231379|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2231380|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231381|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2231382|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
2231383|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
2231384|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231385|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
2231386|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
2231387|NCT00071266|Niacin|niacin|mesh-list
2231388|NCT00071266|Lovastatin|lovastatin|mesh-list
2231389|NCT00071266|L 647318|l 647318|mesh-list
2231390|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
2231391|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
719509|NCT02935634|Nivolumab|nivolumab|mesh-list
719510|NCT02935634|Ipilimumab|ipilimumab|mesh-list
719511|NCT02935634|Rucaparib|rucaparib|mesh-list
719512|NCT02935634|Linrodostat|linrodostat|mesh-list
719513|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
719514|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719515|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
719516|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719517|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
719518|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719646|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
719647|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
719648|NCT02934906|Antibodies|antibodies|mesh-list
719649|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
719650|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
719651|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
719652|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719810|NCT02934204|Methotrexate|methotrexate|mesh-list
719811|NCT02934204|Temozolomide|temozolomide|mesh-list
719812|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
719813|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
719814|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
719815|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719816|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
719817|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
719818|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719819|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719820|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
719821|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719822|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
719823|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
719824|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
719825|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
719826|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
719827|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
719828|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
720008|NCT02933684|Cycloserine|cycloserine|mesh-list
2231392|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
718727|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
718728|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
718729|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
718730|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
718731|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
718732|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718733|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719483|NCT02935855|Warfarin|warfarin|mesh-list
719484|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
719485|NCT02935855|Dabigatran|dabigatran|mesh-list
719486|NCT02935855|Apixaban|apixaban|mesh-list
719487|NCT02935855|Edoxaban|edoxaban|mesh-list
719488|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
719489|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
719490|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
719491|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
719492|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
719493|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719494|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719742|NCT02934321|Erythritol|erythritol|mesh-list
719743|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
719962|NCT02933853|Insulin|insulin|mesh-list
719963|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
719964|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
719965|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
719966|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
719967|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
719968|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753119|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2753120|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720932|NCT02928575|Temozolomide|temozolomide|mesh-list
720933|NCT02928575|Sunitinib|sunitinib|mesh-list
720934|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
720935|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
720936|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720937|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720938|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
720939|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
720940|NCT02928575|Growth Substances|growth substances|mesh-ancestor
720941|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720942|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
720943|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
720944|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721126|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
721127|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
721377|NCT02926196|Avelumab|avelumab|mesh-list
721378|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
721379|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721481|NCT02925416|Oritavancin|oritavancin|mesh-list
721482|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
721483|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
722236|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
722392|NCT02921204|Vitamin D|vitamin d|mesh-list
722393|NCT02921204|Vitamins|vitamins|mesh-ancestor
722394|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
722395|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722396|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2231393|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231394|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2231395|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
2231396|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
2231397|NCT00071266|Vitamins|vitamins|mesh-ancestor
2231398|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
2231399|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231400|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2231401|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2231402|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231403|NCT00071279|Idraparinux|idraparinux|mesh-list
2231404|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2231405|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
2231406|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2231407|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
2231408|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231409|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723636|NCT02916121|Folic Acid|folic acid|mesh-list
723637|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
723638|NCT02916121|Vitamins|vitamins|mesh-ancestor
718842|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
718843|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
718844|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
718845|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
718846|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
718847|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
718848|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
718849|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
718850|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
718851|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
718852|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
718853|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
718854|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
718855|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
718856|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
718857|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
718858|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090304|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090305|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090306|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2090307|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090308|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2090309|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
2090310|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2090311|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090312|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2090313|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2090314|NCT02213094|Vitamins|vitamins|mesh-list
2090315|NCT02213094|Niacinamide|niacinamide|mesh-list
2090316|NCT02213094|Niacin|niacin|mesh-list
2090317|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
2090318|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
2090319|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
2090320|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090321|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
719045|NCT02937181|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
719046|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
719047|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
719168|NCT02936492|Clobetasol|clobetasol|mesh-list
719169|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
719170|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
719171|NCT02936492|Hormones|hormones|mesh-ancestor
719172|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
719173|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231410|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
2231411|NCT00071331|Tolvaptan|tolvaptan|mesh-list
2231412|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2231413|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090322|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
2090323|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090324|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2090325|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
2090326|NCT02213263|Rituximab|rituximab|mesh-list
2090327|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2090328|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090329|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
2090330|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090331|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2090332|NCT02213289|Nivolumab|nivolumab|mesh-list
2090333|NCT02213289|Trastuzumab|trastuzumab|mesh-list
2090334|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
2090335|NCT02213289|Ramucirumab|ramucirumab|mesh-list
2090336|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2090337|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090338|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2090339|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090340|NCT02213380|Anesthetics|anesthetics|mesh-list
2090341|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090342|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722125|NCT02922686|Floxacillin|floxacillin|mesh-list
722126|NCT02922686|Penicillin V|penicillin v|mesh-list
722127|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
722128|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
722499|NCT02920801|Metformin|metformin|mesh-list
722500|NCT02920801|Saxagliptin|saxagliptin|mesh-list
722501|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
719121|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2231414|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
2231415|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231416|NCT00071448|Insulin|insulin|mesh-list
2231417|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2231418|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
2231419|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
2231420|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2231421|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231422|NCT00071461|Bosentan|bosentan|mesh-list
2231423|NCT00071461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2231424|NCT00071461|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2231425|NCT00071461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231426|NCT00071539|Immunotoxins|immunotoxins|mesh-list
2231427|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
2090343|NCT02213900|Haloperidol|haloperidol|mesh-list
2090344|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
2090345|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
2090346|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
2090347|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720052|NCT02932930|Ropivacaine|ropivacaine|mesh-list
720053|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
720054|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
720055|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720056|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720057|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
720058|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720100|NCT02932761|Goserelin|goserelin|mesh-list
720101|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
720102|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720210|NCT02932436|Empagliflozin|empagliflozin|mesh-list
720211|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
720212|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720213|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
720214|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721076|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
721077|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
721078|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
721079|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721080|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
721081|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
721082|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231428|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231429|NCT00071643|Citalopram|citalopram|mesh-list
2231430|NCT00071643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2231431|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2231432|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
721799|NCT02924246|Vaccines|vaccines|mesh-list
721800|NCT02924246|Immunologic Factors|immunologic factors|mesh-ancestor
721801|NCT02924246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722772|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
722831|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
722832|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
722833|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
722834|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722835|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
722836|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
722837|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
723183|NCT02918136|Cortisone|cortisone|mesh-list
723184|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
723314|NCT02917512|Cyclosporine|cyclosporine|mesh-list
723315|NCT02917512|Cyclosporins|cyclosporins|mesh-list
723316|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723317|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723318|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
723319|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
723320|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723321|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
723322|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
723323|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
723324|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
723325|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
723563|NCT02916602|Losartan|losartan|mesh-list
723564|NCT02916602|Amlodipine|amlodipine|mesh-list
723565|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
2090348|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719135|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
719136|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
719137|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719138|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
719139|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
719140|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
719141|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231433|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231434|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2231435|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
2231436|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231437|NCT00071643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2231438|NCT00071643|Antidepressive Agents|antidepressive agents|mesh-ancestor
2231439|NCT00071643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2231440|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2231441|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2231442|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2231443|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2231444|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2231445|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231446|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2231447|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231448|NCT00071695|Analgesics|analgesics|mesh-ancestor
2231449|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
2231450|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2231451|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
2231452|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2231453|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
719523|NCT02935205|Indomethacin|indomethacin|mesh-list
719524|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
719525|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
719526|NCT02935205|Analgesics|analgesics|mesh-ancestor
719527|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
719528|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719529|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719530|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
719531|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
719532|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
719533|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
719534|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
719535|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
719536|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719537|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231454|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2231455|NCT00071747|Lamotrigine|lamotrigine|mesh-list
2231456|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
2231457|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
719773|NCT02934295|Antibodies|antibodies|mesh-list
719774|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
719775|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719936|NCT02933788|Aspirin|aspirin|mesh-list
719937|NCT02933788|Cilostazol|cilostazol|mesh-list
719938|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
719939|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
719940|NCT02933788|Analgesics|analgesics|mesh-ancestor
719941|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
719942|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719943|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719944|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
719945|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
719946|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
719947|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
719948|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719949|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
719950|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
719951|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719952|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
719953|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
719199|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719200|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
719201|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
719202|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
719203|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719204|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719205|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
719206|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
719207|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
719414|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
719415|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
719416|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
719417|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719418|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
719419|NCT02935985|Coagulants|coagulants|mesh-ancestor
2753121|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2753122|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2753123|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753124|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
2753125|NCT03090997|Vitamins|vitamins|mesh-list
2753126|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
2753127|NCT03090997|Resveratrol|resveratrol|mesh-list
2753128|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
2753129|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753130|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
2753131|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753132|NCT03090997|Protective Agents|protective agents|mesh-ancestor
2753133|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753134|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2753144|NCT03077542|Sirolimus|sirolimus|mesh-list
2753145|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
2753146|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
2753147|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
2753148|NCT03077542|Pentostatin|pentostatin|mesh-list
719902|NCT02933814|Bupivacaine|bupivacaine|mesh-list
719903|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
719904|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
719905|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
719906|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719907|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
719908|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720686|NCT02929693|Gefitinib|gefitinib|mesh-list
720694|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720695|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
720696|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720697|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720828|NCT02929251|Adalimumab|adalimumab|mesh-list
720829|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
720830|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
720831|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
720868|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
720869|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
720870|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720915|NCT02928601|Ondansetron|ondansetron|mesh-list
720916|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
719324|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
719325|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
719326|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719327|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
719328|NCT02935959|Analgesics|analgesics|mesh-ancestor
719329|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
719330|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719331|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
719332|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
719333|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
719334|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
719335|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
719336|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719337|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
719338|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
719339|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
719340|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
719341|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
719342|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
719343|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
719344|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
719345|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
719346|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
719347|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
719348|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
720021|NCT02933437|Ajmaline|ajmaline|mesh-list
720022|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
720023|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
720024|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
720025|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
720026|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720346|NCT02931383|Liraglutide|liraglutide|mesh-list
720347|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
720348|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720349|NCT02931383|Incretins|incretins|mesh-ancestor
720350|NCT02931383|Hormones|hormones|mesh-ancestor
720351|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
720874|NCT02928692|Minocycline|minocycline|mesh-list
720875|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
720876|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
721057|NCT02927769|Nivolumab|nivolumab|mesh-list
721058|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
721059|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
721060|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
721061|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721062|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
721063|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721064|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
721065|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
721354|NCT02926183|Gemcitabine|gemcitabine|mesh-list
721355|NCT02926183|Paclitaxel|paclitaxel|mesh-list
721356|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
721357|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721358|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
721359|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
721360|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
721361|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721362|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
721363|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
721364|NCT02926183|Antiviral Agents|antiviral agents|mesh-ancestor
721365|NCT02926183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
721366|NCT02926183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721367|NCT02926183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
721368|NCT02926183|Immunologic Factors|immunologic factors|mesh-ancestor
721369|NCT02926183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721418|NCT02925832|Bupivacaine|bupivacaine|mesh-list
721419|NCT02925832|Ropivacaine|ropivacaine|mesh-list
721420|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
721421|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
721422|NCT02925832|Anesthetics|anesthetics|mesh-list
721423|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
721424|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721425|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
721426|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719354|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719355|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
719356|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719357|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
719358|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
719359|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
719360|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
719361|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719362|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
719363|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
719364|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
719365|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
719366|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
719367|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
719368|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
719369|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
719370|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
719371|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
719372|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
719373|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
719374|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
719375|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
719376|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
719377|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
720302|NCT02931786|Ketamine|ketamine|mesh-list
720303|NCT02931786|Propofol|propofol|mesh-list
720304|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
720305|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720306|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720307|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
720308|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
720309|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
720310|NCT02931786|Analgesics|analgesics|mesh-ancestor
720311|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
720312|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720313|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
720314|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
720315|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
720316|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
720317|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720832|NCT02929316|Vedolizumab|vedolizumab|mesh-list
720833|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
721146|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
721147|NCT02927379|Ketamine|ketamine|mesh-list
721148|NCT02927379|Bupivacaine|bupivacaine|mesh-list
721149|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
721150|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
721151|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
721152|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721153|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
721154|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
721155|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
721156|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
721157|NCT02927379|Analgesics|analgesics|mesh-ancestor
721158|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
721159|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
721160|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
721161|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
721162|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
721163|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721164|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
721165|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
721166|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
721167|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
721168|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2231458|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2231459|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231460|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2231461|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231462|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
722093|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
722094|NCT02922803|Vitamin D|vitamin d|mesh-list
722095|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
722096|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
722097|NCT02922803|Vitamins|vitamins|mesh-list
719389|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
719390|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
719391|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231463|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2231464|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2231465|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2231466|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2231467|NCT00071838|Daclizumab|daclizumab|mesh-list
2231468|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231469|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
2231470|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231471|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
2231472|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231473|NCT00071942|Metronidazole|metronidazole|mesh-list
2231474|NCT00071942|Vaccines|vaccines|mesh-list
2231475|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
2231476|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231477|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231478|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2231479|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2231480|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2231481|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
2231482|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2231483|NCT00071955|Antibodies|antibodies|mesh-list
2231484|NCT00071955|Sargramostim|sargramostim|mesh-list
720293|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
720294|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
720295|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
720296|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720297|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720298|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
720299|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
720300|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720301|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720383|NCT02931526|Tigecycline|tigecycline|mesh-list
720384|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
720385|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720386|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
720387|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720388|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090349|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2090350|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2231485|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2231486|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
2231487|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231488|NCT00071968|Sirolimus|sirolimus|mesh-list
2231489|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2231490|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231491|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2231492|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231493|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
2231494|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231495|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
2231496|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231497|NCT00071994|Gefitinib|gefitinib|mesh-list
2231498|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090351|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2090352|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090353|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
721104|NCT02927392|Leuprolide|leuprolide|mesh-list
721105|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
721106|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
721107|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
721108|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721109|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
721110|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722129|NCT02922699|Omeprazole|omeprazole|mesh-list
722130|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
722131|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
722132|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
722133|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722153|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2231499|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2231500|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231501|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231502|NCT00072007|Prednisone|prednisone|mesh-list
2231503|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
2231504|NCT00072007|Rituximab|rituximab|mesh-list
719559|NCT02935231|Nicotine|nicotine|mesh-list
719560|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
719561|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
719562|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719563|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719564|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
719565|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
719566|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
719567|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
719568|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719868|NCT02934217|Cyclosporine|cyclosporine|mesh-list
719869|NCT02934217|Cyclosporins|cyclosporins|mesh-list
719870|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719871|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719872|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
719873|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
719874|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719875|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
719876|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
719877|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
719878|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
719879|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2231505|NCT00072007|Doxorubicin|doxorubicin|mesh-list
2231506|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2231507|NCT00072007|Vincristine|vincristine|mesh-list
2231508|NCT00072007|Cladribine|cladribine|mesh-list
2231509|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
720511|NCT02930551|Lidocaine|lidocaine|mesh-list
720512|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
720513|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
720514|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720515|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720516|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
720517|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720518|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
720519|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
720520|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
720521|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
720522|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720698|NCT02929563|Pantoprazole|pantoprazole|mesh-list
720699|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
720700|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
720701|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
720702|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720703|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721083|NCT02927587|Propofol|propofol|mesh-list
721084|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
721085|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
721086|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721087|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
721088|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
721089|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
2231510|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
2231511|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231512|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231513|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2231514|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
2231515|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721388|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
721389|NCT02926053|Fludarabine|fludarabine|mesh-list
721390|NCT02926053|Interleukin-2|interleukin-2|mesh-list
721391|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
721392|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
721393|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721394|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
721395|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
721396|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
721397|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721398|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721399|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
721400|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
721401|NCT02926053|Analgesics|analgesics|mesh-ancestor
721402|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
721403|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719458|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
719459|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
719460|NCT02935582|Calcipotriene|calcipotriene|mesh-list
719461|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
719462|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
719463|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
719464|NCT02935582|Hormones|hormones|mesh-ancestor
719465|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
719466|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719467|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
719468|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
719469|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
720253|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
720254|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
720255|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
720256|NCT02932020|Prednisolone|prednisolone|mesh-list
720257|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
720258|NCT02932020|Bupivacaine|bupivacaine|mesh-list
720259|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
720260|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
720261|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
720262|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
720263|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720264|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720265|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
720266|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720267|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
720268|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
720269|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
720270|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
720271|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
720272|NCT02932020|Hormones|hormones|mesh-ancestor
720273|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
720274|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
720275|NCT02932020|Protective Agents|protective agents|mesh-ancestor
720276|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
720277|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720452|NCT02930954|Gemcitabine|gemcitabine|mesh-list
720453|NCT02930954|Bevacizumab|bevacizumab|mesh-list
720454|NCT02930954|Carboplatin|carboplatin|mesh-list
720455|NCT02930954|Pemetrexed|pemetrexed|mesh-list
720456|NCT02930954|Gefitinib|gefitinib|mesh-list
720457|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
720458|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720459|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
720460|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
720461|NCT02930954|Growth Substances|growth substances|mesh-ancestor
720462|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720463|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
720464|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
720465|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
720466|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720467|NCT02930954|Antiviral Agents|antiviral agents|mesh-ancestor
720468|NCT02930954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720469|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720470|NCT02930954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
720471|NCT02930954|Immunologic Factors|immunologic factors|mesh-ancestor
720472|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
720473|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
720474|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2090354|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2090355|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
2090356|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090357|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090358|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2090361|NCT02214121|Ticagrelor|ticagrelor|mesh-list
2090362|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2090363|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2090364|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2090365|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2090366|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
719574|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
719575|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719576|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
719577|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
719578|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719579|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090367|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090368|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090369|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090370|NCT02214225|Vaccines|vaccines|mesh-list
2090371|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
720600|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
720601|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
720602|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
720603|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720604|NCT02930031|Expectorants|expectorants|mesh-ancestor
720605|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
720606|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
720607|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
720608|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720609|NCT02930031|Protective Agents|protective agents|mesh-ancestor
720610|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720611|NCT02930031|Antidotes|antidotes|mesh-ancestor
720704|NCT02929888|Aspirin|aspirin|mesh-list
720705|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
720706|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
720707|NCT02929888|Analgesics|analgesics|mesh-ancestor
720708|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
720709|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720710|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720711|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
720712|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
720713|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
720714|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
720715|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720716|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
720717|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
720718|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720719|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
2231516|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231517|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2231518|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2231519|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2231520|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2231521|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2231522|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231523|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2231524|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
2231525|NCT00072007|Hormones|hormones|mesh-ancestor
2231526|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2231527|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2231528|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2231529|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
2231530|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
2231531|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
2231532|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
2231533|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2231534|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231535|NCT00072033|Docetaxel|docetaxel|mesh-list
2231536|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231537|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
2231538|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
2231539|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
2231540|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231541|NCT00072046|Interferons|interferons|mesh-list
2231542|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
2231543|NCT00072046|Bevacizumab|bevacizumab|mesh-list
2231544|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2231545|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721370|NCT02926326|Azithromycin|azithromycin|mesh-list
721371|NCT02926326|Acumapimod|acumapimod|mesh-list
721372|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
721373|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
721374|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2231546|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
719590|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
719591|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
719592|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
719593|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
719594|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
719595|NCT02935101|Hormones|hormones|mesh-ancestor
719596|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
719597|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719598|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
719599|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719600|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
719601|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
719602|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719603|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
719604|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
719605|NCT02935101|Protective Agents|protective agents|mesh-ancestor
719842|NCT02934061|Tizanidine|tizanidine|mesh-list
719843|NCT02934061|Analgesics|analgesics|mesh-ancestor
719844|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
719845|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719846|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719847|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
719848|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
719849|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
719850|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
719851|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
719852|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
719853|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
719854|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
719855|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
719856|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
719857|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720103|NCT02932722|Anesthetics|anesthetics|mesh-list
720104|NCT02932722|Propofol|propofol|mesh-list
720105|NCT02932722|Sevoflurane|sevoflurane|mesh-list
720106|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720107|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720108|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
720109|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
720110|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
720111|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
720112|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
720810|NCT02929394|Trabectedin|trabectedin|mesh-list
720811|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
720812|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
720813|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720814|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720901|NCT02928614|Liraglutide|liraglutide|mesh-list
720902|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
720903|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720904|NCT02928614|Incretins|incretins|mesh-ancestor
720905|NCT02928614|Hormones|hormones|mesh-ancestor
720906|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
721281|NCT02926690|OTS167|ots167|mesh-list
721282|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
721283|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721284|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231547|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2231548|NCT00072046|Growth Substances|growth substances|mesh-ancestor
2231549|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231550|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
2231551|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
2231552|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231553|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
2231554|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
2231555|NCT00072059|Hematinics|hematinics|mesh-ancestor
2231556|NCT00072072|Celecoxib|celecoxib|mesh-list
2231557|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2231558|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231559|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2231560|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231561|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231562|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2231563|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2231564|NCT00072072|Analgesics|analgesics|mesh-ancestor
719630|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
719631|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
719632|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
719633|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719634|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719635|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
719636|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
719637|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
719638|NCT02934945|Hormones|hormones|mesh-ancestor
719639|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
719640|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
719641|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
719642|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
719643|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
719644|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
719645|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719712|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
719713|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
719714|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
720662|NCT02929901|Caffeine|caffeine|mesh-list
720663|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
720664|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720665|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
720666|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720667|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720668|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
720669|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
720670|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
720671|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2231565|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
2231566|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2231567|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231568|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2231569|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231570|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2231571|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2231572|NCT00072085|Aldesleukin|aldesleukin|mesh-list
2231573|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
2231574|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231575|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2231576|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2231577|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
2231578|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231579|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2231580|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
2231581|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231582|NCT00072098|Interleukin-12|interleukin-12|mesh-list
2231583|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2231584|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
721111|NCT02927405|Gabapentin|gabapentin|mesh-list
721112|NCT02927405|Analgesics|analgesics|mesh-ancestor
721113|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
721114|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
721115|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721116|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
721117|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
721118|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
721119|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
721120|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
721121|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
721122|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
721123|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
721124|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721125|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
721297|NCT02926586|Cytarabine|cytarabine|mesh-list
721298|NCT02926586|Fludarabine|fludarabine|mesh-list
721299|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721300|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
721301|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
721302|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721303|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
721304|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
721305|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231585|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719918|NCT02933671|Ropivacaine|ropivacaine|mesh-list
719919|NCT02933671|Anesthetics, Local|anesthetics, local|mesh-ancestor
719920|NCT02933671|Anesthetics|anesthetics|mesh-ancestor
719921|NCT02933671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
719922|NCT02933671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719923|NCT02933671|Sensory System Agents|sensory system agents|mesh-ancestor
719924|NCT02933671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2231586|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2231587|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2231588|NCT00072098|Growth Substances|growth substances|mesh-ancestor
2231589|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
2231590|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231591|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2231592|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
720059|NCT02932826|Insulin|insulin|mesh-list
720060|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
720061|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720187|NCT02932579|Acetaminophen|acetaminophen|mesh-list
720188|NCT02932579|Ibuprofen|ibuprofen|mesh-list
720189|NCT02932579|Oxycodone|oxycodone|mesh-list
720190|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
720191|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
720192|NCT02932579|Analgesics|analgesics|mesh-ancestor
720193|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
720194|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720195|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720196|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
720197|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
720198|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
720199|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720200|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720201|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
720202|NCT02932579|Narcotics|narcotics|mesh-ancestor
720203|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720204|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
720236|NCT02932137|Interleukin-2|interleukin-2|mesh-list
720237|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720238|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
720239|NCT02932137|Analgesics|analgesics|mesh-ancestor
720240|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
720241|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720242|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720352|NCT02931474|Tesamorelin|tesamorelin|mesh-list
720353|NCT02931474|Growth Substances|growth substances|mesh-ancestor
720354|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720883|NCT02928991|Vidarabine|vidarabine|mesh-list
720884|NCT02928991|Fludarabine|fludarabine|mesh-list
720885|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
720886|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720887|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
720888|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
720889|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720890|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
720891|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
720892|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720893|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
720894|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720945|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
720946|NCT02928315|Analgesics|analgesics|mesh-ancestor
720947|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
720948|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720949|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720950|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
720951|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720952|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
720953|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
720954|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
720955|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
720956|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720957|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
720958|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
720959|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
721380|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
721381|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
721382|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
719778|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
719779|NCT02934035|Citalopram|citalopram|mesh-list
719780|NCT02934035|Fluoxetine|fluoxetine|mesh-list
719781|NCT02934035|Paroxetine|paroxetine|mesh-list
719782|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
719783|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
719784|NCT02934035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
719785|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
719786|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
719787|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719788|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
719789|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
719790|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719791|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
719792|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
719793|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
719794|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
719795|NCT02934035|Analgesics|analgesics|mesh-ancestor
719796|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
719797|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
719798|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
719799|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
719800|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
719925|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
719926|NCT02933775|Fludarabine|fludarabine|mesh-list
719927|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
719928|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
719929|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719930|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
719931|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
719932|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
719933|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719934|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
719935|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
720341|NCT02931591|Metformin|metformin|mesh-list
720342|NCT02931591|Hormones|hormones|mesh-list
720343|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
720344|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720345|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
720421|NCT02931188|Anacetrapib|anacetrapib|mesh-list
720422|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
720423|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
720424|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
720425|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720426|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
720445|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
720446|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
720447|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
720448|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
720449|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720450|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720451|NCT02930811|Urological Agents|urological agents|mesh-ancestor
2231593|NCT00072124|Dacarbazine|dacarbazine|mesh-list
2231594|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231595|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2231596|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
2231597|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231598|NCT00072137|Metronidazole|metronidazole|mesh-list
2231599|NCT00072137|Molgramostim|molgramostim|mesh-list
2231600|NCT00072137|Vaccines|vaccines|mesh-list
2231601|NCT00072137|Sargramostim|sargramostim|mesh-list
2231602|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
2231603|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231604|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231605|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231606|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
721134|NCT02927353|Adalimumab|adalimumab|mesh-list
721135|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
721136|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231607|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2231608|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2231609|NCT00072150|Bortezomib|bortezomib|mesh-list
2231610|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231611|NCT00072163|Thalidomide|thalidomide|mesh-list
2231612|NCT00072163|Temozolomide|temozolomide|mesh-list
719836|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
719837|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
719838|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
719839|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
719840|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
719841|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
720159|NCT02932605|Cannabidiol|cannabidiol|mesh-list
720160|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
720547|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
2231613|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2231614|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
2231615|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231616|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231617|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231618|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
721867|NCT02923869|Bupivacaine|bupivacaine|mesh-list
721868|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
721869|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
721870|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
721871|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
721872|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721873|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
721874|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722002|NCT02923258|Docetaxel|docetaxel|mesh-list
722003|NCT02923258|Cisplatin|cisplatin|mesh-list
722004|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722005|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
722006|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
722007|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
722008|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231619|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231620|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
2231621|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2231622|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231623|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2231624|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2231625|NCT00072163|Growth Substances|growth substances|mesh-ancestor
2231626|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
2231627|NCT00072215|Paclitaxel|paclitaxel|mesh-list
2231628|NCT00072215|Vinblastine|vinblastine|mesh-list
2231629|NCT00072215|Ifosfamide|ifosfamide|mesh-list
2231630|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2231631|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231632|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
2231633|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
2231634|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
2231635|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231636|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
722231|NCT02922166|SRX246|srx246|mesh-list
722232|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
722233|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722234|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
722235|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722593|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
722594|NCT02920710|Hormones|hormones|mesh-ancestor
722595|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
722596|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722702|NCT02919917|Midodrine|midodrine|mesh-list
722703|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
722704|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
722705|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722706|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722707|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
722708|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
722709|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
722710|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
722711|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
722712|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722713|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231637|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
2231638|NCT00072228|Gemcitabine|gemcitabine|mesh-list
2231639|NCT00072228|Soblidotin|soblidotin|mesh-list
2231640|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2231641|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
719863|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
719864|NCT02933905|Growth Substances|growth substances|mesh-ancestor
719865|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
719866|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
719867|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231642|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231643|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231644|NCT00072228|Antiviral Agents|antiviral agents|mesh-ancestor
2231645|NCT00072228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720358|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
720359|NCT02931357|Lidocaine|lidocaine|mesh-list
720360|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
720361|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
720362|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
720363|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720364|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720365|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
720366|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720367|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
720368|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
720369|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
720370|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
720371|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720372|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
720373|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
720374|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
720375|NCT02931357|Protective Agents|protective agents|mesh-ancestor
720376|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
720377|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231646|NCT00072228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231647|NCT00072228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231648|NCT00072228|Immunologic Factors|immunologic factors|mesh-ancestor
2231649|NCT00072228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231650|NCT00072267|Topotecan|topotecan|mesh-list
2231651|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2231652|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2231653|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2231654|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231655|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720548|NCT02930317|Factor VIII|factor viii|mesh-list
720549|NCT02930317|Coagulants|coagulants|mesh-ancestor
2231656|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231657|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
720907|NCT02928419|Lenalidomide|lenalidomide|mesh-list
720908|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
720909|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720910|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
720911|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
720912|NCT02928419|Growth Substances|growth substances|mesh-ancestor
720913|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
720914|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721137|NCT02927496|Doxycycline|doxycycline|mesh-list
721138|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
721139|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
721140|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
721141|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
721142|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
721782|NCT02924233|Nivolumab|nivolumab|mesh-list
721783|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
721784|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721785|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
721786|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231658|NCT00072319|Paclitaxel|paclitaxel|mesh-list
2231659|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
2231660|NCT00072319|Epirubicin|epirubicin|mesh-list
2231661|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2231662|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231663|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
2231664|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
2231665|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
722366|NCT02921360|Aspirin|aspirin|mesh-list
722367|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
722368|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
722369|NCT02921360|Analgesics|analgesics|mesh-ancestor
722370|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
722371|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2231666|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231667|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231668|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
2231669|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231670|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231671|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2231672|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
2231673|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2231674|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2231675|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2231676|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2231677|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231678|NCT00072332|Cisplatin|cisplatin|mesh-list
2231679|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231680|NCT00072345|Thalidomide|thalidomide|mesh-list
2231681|NCT00072345|Temozolomide|temozolomide|mesh-list
2231682|NCT00072345|Lomustine|lomustine|mesh-list
2231683|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2231684|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
2231685|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231686|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720634|NCT02930265|Liraglutide|liraglutide|mesh-list
720635|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
720636|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720637|NCT02930265|Incretins|incretins|mesh-ancestor
720638|NCT02930265|Hormones|hormones|mesh-ancestor
720639|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
720798|NCT02929121|Doxycycline|doxycycline|mesh-list
720799|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
720800|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720801|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
720802|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
720803|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2231687|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231688|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
2231689|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231690|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
2231691|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
721466|NCT02925351|Clofarabine|clofarabine|mesh-list
721467|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
721468|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
721469|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721470|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721774|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
721775|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
721776|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
721777|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
721778|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
721779|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721780|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721781|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722453|NCT02921165|Aspirin|aspirin|mesh-list
722454|NCT02921165|Analgesics|analgesics|mesh-list
722455|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
722456|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
722457|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
722458|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722459|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722460|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
722461|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
722462|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
722463|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
722464|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722465|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
722466|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
722467|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722468|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
2231692|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231693|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2231694|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2231695|NCT00072345|Growth Substances|growth substances|mesh-ancestor
2231696|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
2231697|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
2231698|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2231699|NCT00072358|Irinotecan|irinotecan|mesh-list
719954|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
719955|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
719956|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
719957|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
719958|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
719959|NCT02933788|Protective Agents|protective agents|mesh-ancestor
719960|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
719961|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
720032|NCT02933333|Molgramostim|molgramostim|mesh-list
720033|NCT02933333|Lenograstim|lenograstim|mesh-list
720034|NCT02933333|Sargramostim|sargramostim|mesh-list
720035|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
720036|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
720037|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720038|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720672|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
720673|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
720871|NCT02928965|Minocycline|minocycline|mesh-list
720872|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
720873|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090372|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090373|NCT02214290|Caffeine|caffeine|mesh-list
721475|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
721476|NCT02925559|Gliclazide|gliclazide|mesh-list
721477|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
721478|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721479|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
721480|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231700|NCT00072358|Temozolomide|temozolomide|mesh-list
2231701|NCT00072358|Molgramostim|molgramostim|mesh-list
2231702|NCT00072358|Isotretinoin|isotretinoin|mesh-list
2231703|NCT00072358|Antibodies|antibodies|mesh-list
2231704|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
2231705|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2231706|NCT00072358|Sargramostim|sargramostim|mesh-list
2231707|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
2231708|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
2231709|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231710|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231711|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2231712|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2231713|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231714|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231715|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2231716|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
2231717|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
2231718|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2231719|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231724|NCT00072436|Gemcitabine|gemcitabine|mesh-list
2231725|NCT00072436|Alvocidib|alvocidib|mesh-list
2231726|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2231727|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
2231728|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231729|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231730|NCT00072436|Antiviral Agents|antiviral agents|mesh-ancestor
2231731|NCT00072436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231732|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231733|NCT00072436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231734|NCT00072436|Immunologic Factors|immunologic factors|mesh-ancestor
2231735|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724892|NCT02909751|Tocotrienols|tocotrienols|mesh-list
724893|NCT02909751|Vitamin E|vitamin e|mesh-list
724894|NCT02909751|Tocopherols|tocopherols|mesh-list
724895|NCT02909751|Docetaxel|docetaxel|mesh-list
724896|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
724897|NCT02909751|Trastuzumab|trastuzumab|mesh-list
724898|NCT02909751|Epirubicin|epirubicin|mesh-list
724899|NCT02909751|Pertuzumab|pertuzumab|mesh-list
724900|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724901|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
724902|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
724903|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
724904|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231736|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
2231737|NCT00072436|Growth Substances|growth substances|mesh-ancestor
719985|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
719986|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
720151|NCT02932488|Sumatriptan|sumatriptan|mesh-list
720152|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
720153|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
720154|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
720155|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
720156|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
720157|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720158|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231738|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2231739|NCT00072462|Tamoxifen|tamoxifen|mesh-list
2231740|NCT00072462|Anastrozole|anastrozole|mesh-list
2231741|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231742|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2231743|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
2231744|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2231745|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231746|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2231747|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090374|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2090375|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090376|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2090377|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090378|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090379|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2090380|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2090381|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
2090382|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090383|NCT02214420|Ribavirin|ribavirin|mesh-list
2090384|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
2231748|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
721429|NCT02925975|Carvedilol|carvedilol|mesh-list
721430|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
721431|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
721432|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
721433|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
721434|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721435|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721436|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
721437|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
721438|NCT02925975|Protective Agents|protective agents|mesh-ancestor
721439|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
721440|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
721441|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
721442|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
721443|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
721444|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
721536|NCT02925130|Albuterol|albuterol|mesh-list
721537|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
721538|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
721539|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
721540|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721541|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
721542|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
721543|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
721544|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
721545|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
721546|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
721547|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
721548|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
721549|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
721550|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721875|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
721876|NCT02923999|Antibodies|antibodies|mesh-list
721877|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
721878|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
721879|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
721880|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721881|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231749|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2231750|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
720009|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
720010|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720011|NCT02933684|Renal Agents|renal agents|mesh-ancestor
720012|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
720013|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
720014|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
720015|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
720016|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720218|NCT02932007|Chloroquine|chloroquine|mesh-list
720219|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
720220|NCT02932007|Amebicides|amebicides|mesh-ancestor
720221|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
720222|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
720223|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720224|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
720225|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
720226|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
720227|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
720228|NCT02932007|Analgesics|analgesics|mesh-ancestor
720229|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
720230|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720231|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720232|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
720233|NCT02932007|Filaricides|filaricides|mesh-ancestor
720234|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
720235|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
720433|NCT02931071|Plerixafor|plerixafor|mesh-list
720434|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
720435|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
720436|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
720437|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720530|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
720531|NCT02930707|Bupivacaine|bupivacaine|mesh-list
720532|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
720533|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
720534|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720535|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720536|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
720537|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720538|NCT02930707|Analgesics|analgesics|mesh-ancestor
720539|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
720540|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
720541|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
720542|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
720543|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720544|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
720545|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
720546|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
720841|NCT02929095|Midazolam|midazolam|mesh-list
720842|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
720843|NCT02929095|Remifentanil|remifentanil|mesh-list
720844|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
720845|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720846|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720847|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
720848|NCT02929095|Analgesics|analgesics|mesh-ancestor
720849|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
720850|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720851|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
720852|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
720853|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
720854|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
720855|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
720856|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720857|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
720858|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
720859|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
720860|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
720861|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
720862|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
720863|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
720864|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
720865|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
720866|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
720867|NCT02929095|Narcotics|narcotics|mesh-ancestor
2090385|NCT02214420|Simeprevir|simeprevir|mesh-list
2090386|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
2231751|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2231752|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2231753|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231754|NCT00072527|Carboplatin|carboplatin|mesh-list
2231755|NCT00072527|Etoposide|etoposide|mesh-list
2231756|NCT00072527|Irinotecan|irinotecan|mesh-list
2090387|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090388|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
2090389|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090390|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
2090391|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090392|NCT02214615|Carbamazepine|carbamazepine|mesh-list
720612|NCT02930057|Betamethasone|betamethasone|mesh-list
720613|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
720614|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
720615|NCT02930057|Hormones|hormones|mesh-ancestor
720616|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
720617|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720618|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
720619|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
720991|NCT02927951|Pregabalin|pregabalin|mesh-list
720992|NCT02927951|Analgesics|analgesics|mesh-ancestor
720993|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
720994|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720995|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720996|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
720997|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
720998|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
720999|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721000|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
721001|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
721002|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
721003|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
721004|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
721667|NCT02924675|Pregabalin|pregabalin|mesh-list
721668|NCT02924675|Analgesics|analgesics|mesh-ancestor
721669|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
721670|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
721671|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721672|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
721673|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
721674|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
721675|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721676|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
721677|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
721678|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
721679|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
721680|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2090393|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
2090394|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
2090395|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2090396|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090397|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721855|NCT02923986|Dasatinib|dasatinib|mesh-list
721856|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721857|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
721858|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721859|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722302|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
722303|NCT02921763|Progestins|progestins|mesh-ancestor
722304|NCT02921763|Hormones|hormones|mesh-ancestor
722305|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
722306|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723172|NCT02918006|Vaccines|vaccines|mesh-list
723173|NCT02918006|Immunologic Factors|immunologic factors|mesh-ancestor
723174|NCT02918006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723244|NCT02917772|Nivolumab|nivolumab|mesh-list
723245|NCT02917772|Ipilimumab|ipilimumab|mesh-list
723246|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
723247|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723248|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
723249|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231757|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231758|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2231759|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
720080|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720081|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
720082|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
720083|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
720084|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
720085|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
720640|NCT02930044|Insulin|insulin|mesh-list
720641|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
720642|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
720643|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
720644|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720683|NCT02929719|Dapsone|dapsone|mesh-list
720684|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720685|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
720687|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
720688|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
720689|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
720690|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720691|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720692|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
720693|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
721681|NCT02924766|Prednisone|prednisone|mesh-list
721682|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
721683|NCT02924766|Niraparib|niraparib|mesh-list
721684|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
721685|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
721686|NCT02924766|Hormones|hormones|mesh-ancestor
721687|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
721688|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721689|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
721690|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721691|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
721692|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721693|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721694|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
721695|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
721696|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
722160|NCT02922660|Remifentanil|remifentanil|mesh-list
722161|NCT02922660|Anesthetics|anesthetics|mesh-list
722162|NCT02922660|Propofol|propofol|mesh-list
722163|NCT02922660|Desflurane|desflurane|mesh-list
722164|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
722165|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722166|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
722167|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
722168|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
722169|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
722170|NCT02922660|Narcotics|narcotics|mesh-ancestor
722171|NCT02922660|Analgesics|analgesics|mesh-ancestor
722172|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
722173|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722174|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
722312|NCT02921984|Docetaxel|docetaxel|mesh-list
722313|NCT02921984|Pemetrexed|pemetrexed|mesh-list
722314|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722315|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
722316|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
722317|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
722318|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722319|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722320|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
722321|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
722867|NCT02919202|Listerine|listerine|mesh-list
722868|NCT02919202|Fluorides|fluorides|mesh-list
722869|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
722870|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
722871|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
722872|NCT02919202|Protective Agents|protective agents|mesh-ancestor
722873|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722874|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
722875|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
723844|NCT02914886|Insulin|insulin|mesh-list
723845|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
723846|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
723847|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720171|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720172|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
720173|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
720174|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
720355|NCT02931695|Hormones|hormones|mesh-list
720356|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
720357|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720647|NCT02929797|Gemcitabine|gemcitabine|mesh-list
720648|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
720649|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
720650|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720651|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720652|NCT02929797|Antiviral Agents|antiviral agents|mesh-ancestor
720653|NCT02929797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720654|NCT02929797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720655|NCT02929797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
720656|NCT02929797|Immunologic Factors|immunologic factors|mesh-ancestor
720657|NCT02929797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720804|NCT02929134|Doxycycline|doxycycline|mesh-list
720805|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
720806|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720807|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
720808|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
720809|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2090398|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2090399|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2090400|NCT02214615|Analgesics|analgesics|mesh-ancestor
2090401|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
2090402|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090403|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2090404|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2090405|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090406|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2090407|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2090408|NCT02214628|Bevacizumab|bevacizumab|mesh-list
721529|NCT02925000|Vinorelbine|vinorelbine|mesh-list
721530|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
721531|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721532|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
721533|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
721534|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
721535|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721644|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
721645|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721646|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
721647|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721648|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721732|NCT02924324|Propofol|propofol|mesh-list
721733|NCT02924324|Ropivacaine|ropivacaine|mesh-list
721734|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
721735|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
721736|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721737|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
721738|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
721739|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
721740|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
721741|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
721742|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722237|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
720282|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720283|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
720284|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720285|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
720286|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
720287|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
720288|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
720289|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720290|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
720291|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
720292|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
720734|NCT02929459|Vitamins|vitamins|mesh-list
720735|NCT02929459|Riboflavin|riboflavin|mesh-list
720736|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
720737|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
720738|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720739|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
720740|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
720815|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
720816|NCT02929147|Morphine|morphine|mesh-list
720817|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
720818|NCT02929147|Narcotics|narcotics|mesh-ancestor
720819|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720820|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720821|NCT02929147|Analgesics|analgesics|mesh-ancestor
720822|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
720823|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720824|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
720825|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
720826|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
720827|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
721143|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
721144|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
721145|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721228|NCT02926859|Cannabidiol|cannabidiol|mesh-list
721229|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
721762|NCT02924480|Lidocaine|lidocaine|mesh-list
721763|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
721764|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
721765|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
721766|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721767|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
721768|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
721769|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
721770|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
721771|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
721772|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
721773|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722252|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
722253|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
722254|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
722255|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
722256|NCT02922348|Norgestimate|norgestimate|mesh-list
722257|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
722258|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
722259|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
722260|NCT02922348|Hormones|hormones|mesh-list
722261|NCT02922348|Estradiol|estradiol|mesh-list
722262|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
722263|NCT02922348|Progestins|progestins|mesh-list
722264|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
722265|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722266|NCT02922348|Estrogens|estrogens|mesh-ancestor
722267|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
722268|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
722269|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
722270|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
722271|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2231760|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2231761|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753149|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
722422|NCT02921191|Lenograstim|lenograstim|mesh-list
722423|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
722424|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
722425|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720391|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720392|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
721128|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
721129|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
721130|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
721131|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
721132|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721133|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721237|NCT02926846|Vancomycin|vancomycin|mesh-list
721238|NCT02926846|Gentamicins|gentamicins|mesh-list
721239|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
721240|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
721241|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
721242|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721243|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721341|NCT02926222|Lomustine|lomustine|mesh-list
721342|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
721343|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
721344|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721345|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721427|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
721428|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721802|NCT02924454|Metoprolol|metoprolol|mesh-list
721803|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
721804|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
721805|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
721806|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
721807|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
721808|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
721809|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
721810|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
721811|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721812|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
721813|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
721814|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
721815|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
721816|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
721817|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721818|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
721920|NCT02923856|Clarithromycin|clarithromycin|mesh-list
721921|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
721922|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
721923|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
721924|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721925|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721926|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
721927|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
722107|NCT02922712|Nimesulide|nimesulide|mesh-list
722108|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
722109|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
722110|NCT02922712|Analgesics|analgesics|mesh-ancestor
722111|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
722112|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722113|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722114|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
722115|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
722116|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
722117|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722118|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722245|NCT02922387|Varenicline|varenicline|mesh-list
722246|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
722247|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
722248|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
722249|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722250|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722251|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722515|NCT02921035|Interferons|interferons|mesh-list
722516|NCT02921035|Interferon-beta|interferon-beta|mesh-list
722517|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
722518|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722519|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
722520|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
722521|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
2231762|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231763|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
720438|NCT02930733|Bupivacaine|bupivacaine|mesh-list
720439|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
720440|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
720441|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720442|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720443|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
720444|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720834|NCT02929212|Acetaminophen|acetaminophen|mesh-list
720835|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
720836|NCT02929212|Analgesics|analgesics|mesh-ancestor
720837|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
720838|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720839|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720840|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
720960|NCT02928328|Lidocaine|lidocaine|mesh-list
720961|NCT02928328|Lorazepam|lorazepam|mesh-list
720962|NCT02928328|Capsaicin|capsaicin|mesh-list
720963|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
720964|NCT02928328|Butyric Acid|butyric acid|mesh-list
720965|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
720966|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
720967|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720968|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720969|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
720970|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720971|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
720972|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
720973|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
720974|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
720975|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720976|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
720977|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
720978|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
720979|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
720980|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
720981|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
720982|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
720983|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
720984|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
720985|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
720986|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
720987|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
720988|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
720989|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
720990|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
721066|NCT02927847|Nicotine|nicotine|mesh-list
721067|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
721068|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
721069|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
721070|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721071|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
721072|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
721073|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
721074|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
721075|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231764|NCT00072540|Celecoxib|celecoxib|mesh-list
2231765|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2231766|NCT00072540|Mitogens|mitogens|mesh-list
2231767|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
721515|NCT02925026|Lactoferrin|lactoferrin|mesh-list
721516|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
721743|NCT02924389|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
721744|NCT02924389|Dolutegravir|dolutegravir|mesh-list
721745|NCT02924389|Triumeq|triumeq|mesh-list
721746|NCT02924389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
721747|NCT02924389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
721748|NCT02924389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721749|NCT02924389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721750|NCT02924389|Antiviral Agents|antiviral agents|mesh-ancestor
721751|NCT02924389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
721752|NCT02924389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
721753|NCT02924389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
721754|NCT02924389|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
721755|NCT02924389|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
721985|NCT02923388|Vitamins|vitamins|mesh-list
720499|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
720500|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
720501|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720502|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
720503|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
720504|NCT02930902|Antiviral Agents|antiviral agents|mesh-ancestor
720505|NCT02930902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
720506|NCT02930902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720507|NCT02930902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
720508|NCT02930902|Immunologic Factors|immunologic factors|mesh-ancestor
720509|NCT02930902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720510|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
720895|NCT02928510|Idelalisib|idelalisib|mesh-list
720896|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720897|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
720898|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231768|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2231769|NCT00072540|Analgesics|analgesics|mesh-ancestor
721230|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
721231|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
721232|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2231770|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
2231771|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2231772|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231773|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2231774|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231775|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2231776|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2231777|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231778|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
2231779|NCT00072553|Leucovorin|leucovorin|mesh-list
2231780|NCT00072553|Celecoxib|celecoxib|mesh-list
2231781|NCT00072553|Fluorouracil|fluorouracil|mesh-list
722135|NCT02922465|Clopidogrel|clopidogrel|mesh-list
722136|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
722137|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
722138|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
722139|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
722140|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
722141|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722142|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722143|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722307|NCT02921919|Talazoparib|talazoparib|mesh-list
722308|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
722309|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722310|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722311|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090409|NCT02214628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2090410|NCT02214628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090411|NCT02214628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2090412|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2090413|NCT02214628|Growth Substances|growth substances|mesh-ancestor
2090414|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090415|NCT02214628|Growth Inhibitors|growth inhibitors|mesh-ancestor
2090416|NCT02215070|Pasireotide|pasireotide|mesh-list
2090417|NCT02215070|Hormones|hormones|mesh-ancestor
2090418|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2090419|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753150|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
2753151|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753152|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2753153|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2753154|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
2090425|NCT02215200|Sargramostim|sargramostim|mesh-list
2090426|NCT02215200|Lenograstim|lenograstim|mesh-list
2090427|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
2090428|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
723579|NCT02916381|Anesthetics|anesthetics|mesh-list
723580|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
723581|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724374|NCT02912182|Prednisolone|prednisolone|mesh-list
724375|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
724376|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
724377|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2231782|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
2231783|NCT00072553|Calcium|calcium|mesh-list
2231784|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
2231785|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2231786|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721472|NCT02925299|Insulin|insulin|mesh-list
721473|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
721474|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721551|NCT02924974|Lidocaine|lidocaine|mesh-list
721552|NCT02924974|Morphine|morphine|mesh-list
721553|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
721554|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
721555|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
721556|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721557|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
721558|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
721559|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
721560|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
721561|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
721562|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
721563|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721564|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
721565|NCT02924974|Narcotics|narcotics|mesh-ancestor
721566|NCT02924974|Analgesics|analgesics|mesh-ancestor
2090429|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
2090430|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090431|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2090432|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2090433|NCT02215252|Pregabalin|pregabalin|mesh-list
2090434|NCT02215252|Analgesics|analgesics|mesh-ancestor
2090435|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
2090436|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090437|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090438|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
2090439|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2090440|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2231787|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
2231788|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231789|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2231790|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231791|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231792|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
721977|NCT02923466|Interferon-beta|interferon-beta|mesh-list
721978|NCT02923466|Avelumab|avelumab|mesh-list
721979|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
721980|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721981|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
721982|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
721983|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
721984|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722009|NCT02923128|Sufentanil|sufentanil|mesh-list
722010|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
722011|NCT02923128|Dsuvia|dsuvia|mesh-list
722012|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
722013|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
722014|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722015|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
722016|NCT02923128|Analgesics|analgesics|mesh-ancestor
722017|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
722018|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722019|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
722020|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
722021|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
722022|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
722023|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722024|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722025|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
722026|NCT02923128|Narcotics|narcotics|mesh-ancestor
722027|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
720598|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
720599|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231793|NCT00072553|Antidotes|antidotes|mesh-ancestor
2231794|NCT00072553|Protective Agents|protective agents|mesh-ancestor
2231795|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
2231796|NCT00072553|Vitamins|vitamins|mesh-ancestor
2231797|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
2231798|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2231799|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2231800|NCT00072553|Analgesics|analgesics|mesh-ancestor
2231801|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
2231802|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
721175|NCT02927522|Donepezil|donepezil|mesh-list
721176|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
721177|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721178|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721179|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
721180|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
721181|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721182|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
721250|NCT02926976|Valproic Acid|valproic acid|mesh-list
721251|NCT02926976|Risperidone|risperidone|mesh-list
721252|NCT02926976|Aripiprazole|aripiprazole|mesh-list
721253|NCT02926976|Clozapine|clozapine|mesh-list
721254|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
721255|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
721256|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
721257|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721258|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721259|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
721260|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
721261|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
721262|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
721263|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
721264|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
721265|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
721266|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
721267|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
721268|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
721269|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
721270|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
721271|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
721272|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721273|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
721274|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
721275|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
2231803|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2231804|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231805|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2231806|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2231807|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231808|NCT00072579|Sargramostim|sargramostim|mesh-list
2231809|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
2231810|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231811|NCT00072592|Rituximab|rituximab|mesh-list
2231812|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2231813|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231814|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
2231815|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231816|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
721471|NCT02925247|Anticoagulants|anticoagulants|mesh-list
721508|NCT02925195|Vitamin D|vitamin d|mesh-list
721509|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
721510|NCT02925195|Vitamins|vitamins|mesh-ancestor
721511|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
721512|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721513|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
721514|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
721712|NCT02924311|Aflibercept|aflibercept|mesh-list
721713|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
721714|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
721715|NCT02924311|Growth Substances|growth substances|mesh-ancestor
721716|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721717|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
721718|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721992|NCT02923336|Propranolol|propranolol|mesh-list
2231817|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
2231818|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720676|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720677|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
720678|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
720679|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
720680|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
720681|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720682|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2090441|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090442|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2090443|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2090444|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2090445|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090446|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2090447|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
2090448|NCT02215967|Fludarabine|fludarabine|mesh-list
2090449|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2090450|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
2090451|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090452|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2090453|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2090454|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
2090455|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090456|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090457|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2090458|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
2090459|NCT02216071|Dexamethasone|dexamethasone|mesh-list
2090460|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
2090461|NCT02216071|BB 1101|bb 1101|mesh-list
2090462|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2090463|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
2090464|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
2090465|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090466|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090467|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2231819|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2231820|NCT00072618|Protective Agents|protective agents|mesh-ancestor
2231821|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231822|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2753155|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753156|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722936|NCT02918825|Olanzapine|olanzapine|mesh-list
722937|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
722938|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
722939|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
722940|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722941|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722942|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
722943|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
722944|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
722945|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
722946|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
722947|NCT02918825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
722948|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
722949|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
722950|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722951|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722952|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
722953|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
722954|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
722955|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
722956|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
722957|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
2753157|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2753158|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2753159|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753160|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2753161|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
2753162|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2753163|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
723175|NCT02918110|Misoprostol|misoprostol|mesh-list
723176|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
723177|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
723178|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
720917|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
720918|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
720919|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
720920|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
720921|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
720922|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
720923|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
720924|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
720925|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
720926|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
720927|NCT02928601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
720928|NCT02928601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
720929|NCT02928601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
720930|NCT02928601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
720931|NCT02928601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
721233|NCT02926885|Liver Extracts|liver extracts|mesh-list
721234|NCT02926885|Hematinics|hematinics|mesh-ancestor
2090468|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
2090469|NCT02216071|Hormones|hormones|mesh-ancestor
2090470|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2090471|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2090472|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721969|NCT02923583|Abatacept|abatacept|mesh-list
721970|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
721971|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721972|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721973|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
721974|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
721975|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721976|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
722103|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
722104|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
722105|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
722106|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
722572|NCT02920567|Octreotide|octreotide|mesh-list
722573|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
722574|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
722575|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722660|NCT02920359|Leuprolide|leuprolide|mesh-list
722661|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
722662|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
722663|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
722664|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722665|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
722666|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723409|NCT02916979|Methotrexate|methotrexate|mesh-list
723410|NCT02916979|Fludarabine|fludarabine|mesh-list
723411|NCT02916979|Busulfan|busulfan|mesh-list
723412|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
723413|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
723414|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
723415|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
723416|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723417|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
723418|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
723419|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723420|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723421|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
723422|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723423|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
723424|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
723425|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
723426|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
723427|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
723428|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
723429|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
723430|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
723888|NCT02914405|Nivolumab|nivolumab|mesh-list
723889|NCT02914405|Dinutuximab|dinutuximab|mesh-list
723890|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
723891|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
723892|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
723893|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723894|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
723895|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090473|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
721484|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
721485|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
721486|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721522|NCT02924987|Aflibercept|aflibercept|mesh-list
721523|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
721524|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
721525|NCT02924987|Growth Substances|growth substances|mesh-ancestor
721526|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721527|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
721528|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721697|NCT02924727|Valsartan|valsartan|mesh-list
721698|NCT02924727|Ramipril|ramipril|mesh-list
721699|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
721700|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
721701|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
721702|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
721703|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721704|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
721705|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
721706|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722438|NCT02921269|Bevacizumab|bevacizumab|mesh-list
722439|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
722440|NCT02921269|Atezolizumab|atezolizumab|mesh-list
722441|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
722442|NCT02921269|Antibodies|antibodies|mesh-list
722443|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
722444|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
722445|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
722446|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722447|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
722448|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
722449|NCT02921269|Growth Substances|growth substances|mesh-ancestor
722450|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722451|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
722452|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
723553|NCT02916511|Paclitaxel|paclitaxel|mesh-list
723554|NCT02916511|Carboplatin|carboplatin|mesh-list
723555|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
723556|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723557|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
723558|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
723559|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
723560|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723602|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
723603|NCT02916173|Hormones|hormones|mesh-list
723604|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723605|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723606|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
723792|NCT02915055|Acetaminophen|acetaminophen|mesh-list
723793|NCT02915055|Ibuprofen|ibuprofen|mesh-list
723794|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
723795|NCT02915055|Oxycodone|oxycodone|mesh-list
723796|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
723797|NCT02915055|Analgesics|analgesics|mesh-ancestor
723798|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
723799|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723800|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723801|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
723802|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
723803|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
723804|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
723805|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
723806|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723807|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723808|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
723809|NCT02915055|Narcotics|narcotics|mesh-ancestor
723810|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2231823|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231824|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231825|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2231826|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2231827|NCT00072618|Analgesics|analgesics|mesh-ancestor
2231828|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
721235|NCT02927015|Iproplatin|iproplatin|mesh-list
721236|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721567|NCT02924909|Paclitaxel|paclitaxel|mesh-list
721568|NCT02924909|Carboplatin|carboplatin|mesh-list
721569|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
721570|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721571|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
721572|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
721573|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
721574|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231829|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2231830|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2231831|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231832|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2231833|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231834|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
722055|NCT02922933|Entinostat|entinostat|mesh-list
722056|NCT02922933|Omeprazole|omeprazole|mesh-list
722057|NCT02922933|Famotidine|famotidine|mesh-list
722058|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
722059|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
722060|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
722061|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722062|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722063|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
722064|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
722065|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
722066|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722067|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722068|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722069|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
722191|NCT02922426|Olanzapine|olanzapine|mesh-list
722192|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
722193|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
722194|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722195|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722196|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
722197|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
722198|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
722199|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
722200|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
722201|NCT02922426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
722202|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
722203|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
722204|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722205|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722206|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
722272|NCT02922075|Amoxicillin|amoxicillin|mesh-list
722273|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
722274|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
722275|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
722276|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
722277|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
722695|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
722696|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
722697|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722893|NCT02919072|Ropivacaine|ropivacaine|mesh-list
722894|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
722895|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
722896|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
722897|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
722898|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722899|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
722900|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723022|NCT02918747|Gemcitabine|gemcitabine|mesh-list
723023|NCT02918747|Dexamethasone|dexamethasone|mesh-list
723024|NCT02918747|Prednisone|prednisone|mesh-list
723025|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
723026|NCT02918747|Doxorubicin|doxorubicin|mesh-list
723027|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
723028|NCT02918747|Vincristine|vincristine|mesh-list
723029|NCT02918747|Pegaspargase|pegaspargase|mesh-list
723030|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
723031|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
723032|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723033|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
723034|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
723035|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
721306|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
721307|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
721346|NCT02926248|Colchicine|colchicine|mesh-list
721347|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
721348|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
721349|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
721350|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
721351|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
721352|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721353|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090474|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090475|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090476|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
721575|NCT02924857|Paclitaxel|paclitaxel|mesh-list
721576|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
721577|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721578|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
721579|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
721580|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
721581|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721654|NCT02924506|Meloxicam|meloxicam|mesh-list
721655|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
721656|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
721657|NCT02924506|Analgesics|analgesics|mesh-ancestor
721658|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
721659|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
721660|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721661|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
721662|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
721663|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
721664|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
721665|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721666|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721967|NCT02923557|Pirarubicin|pirarubicin|mesh-list
721968|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090477|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090478|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2090479|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2090480|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2090481|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2090482|NCT02216123|Chloroquine|chloroquine|mesh-list
2090483|NCT02216123|Primaquine|primaquine|mesh-list
2090484|NCT02216123|Tafenoquine|tafenoquine|mesh-list
2090485|NCT02216123|Amebicides|amebicides|mesh-ancestor
2090486|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2090487|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2090488|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090489|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
2090490|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2090491|NCT02216214|Mirabegron|mirabegron|mesh-list
2090492|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
722746|NCT02919878|Gemcitabine|gemcitabine|mesh-list
722747|NCT02919878|Capecitabine|capecitabine|mesh-list
722748|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
722749|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
722750|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722751|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722752|NCT02919878|Antiviral Agents|antiviral agents|mesh-ancestor
722753|NCT02919878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
722754|NCT02919878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722755|NCT02919878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
722756|NCT02919878|Immunologic Factors|immunologic factors|mesh-ancestor
722757|NCT02919878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231835|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231836|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231837|NCT00072670|Trabectedin|trabectedin|mesh-list
2231838|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2231839|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
2231840|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231841|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231842|NCT00072683|Tolvaptan|tolvaptan|mesh-list
2231843|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
724281|NCT02912702|Dexamethasone|dexamethasone|mesh-list
724282|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
724283|NCT02912702|Doxorubicin|doxorubicin|mesh-list
724284|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2231844|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231845|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
2231846|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231847|NCT00072722|Pomalidomide|pomalidomide|mesh-list
2231848|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
2231849|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231850|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2231851|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2231852|NCT00072722|Growth Substances|growth substances|mesh-ancestor
2231853|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
2231854|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231855|NCT00072748|EKB 569|ekb 569|mesh-list
2231856|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231857|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2231858|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231859|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231860|NCT00072787|Cisplatin|cisplatin|mesh-list
2231861|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231862|NCT00072826|Acetylcholine|acetylcholine|mesh-list
2231863|NCT00072826|Oxypurinol|oxypurinol|mesh-list
2231864|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
2231865|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2231866|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
2231867|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2231868|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231869|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231870|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231871|NCT00072839|Teduglutide|teduglutide|mesh-list
722036|NCT02922894|Trazodone|trazodone|mesh-list
722037|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
722038|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
722039|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
722040|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722041|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
722042|NCT02922894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
722043|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
722044|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
722045|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722046|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722047|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
722048|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
722049|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
722144|NCT02922673|Aspirin|aspirin|mesh-list
722145|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
722146|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
722147|NCT02922673|Analgesics|analgesics|mesh-ancestor
722148|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
722149|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722150|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722151|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
722152|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
721375|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721376|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231872|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2231873|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2231874|NCT00072839|Protective Agents|protective agents|mesh-ancestor
2231875|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231876|NCT00072852|Irinotecan|irinotecan|mesh-list
2231877|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2231878|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2231879|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231880|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231881|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231882|NCT00072865|Carboplatin|carboplatin|mesh-list
2231883|NCT00072865|Pemetrexed|pemetrexed|mesh-list
2231884|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231885|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721719|NCT02924285|Amiodarone|amiodarone|mesh-list
721720|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
721721|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
721722|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
721723|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
721724|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721725|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
721726|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
721727|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
721728|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721729|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
721730|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
721731|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
721882|NCT02923791|Lenograstim|lenograstim|mesh-list
721883|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
721884|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
721885|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722397|NCT02921555|Prednisone|prednisone|mesh-list
722398|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
722399|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
722400|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
722401|NCT02921555|Prednisolone|prednisolone|mesh-list
722402|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
722403|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
722404|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
722405|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
722406|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
722407|NCT02921555|Hormones|hormones|mesh-ancestor
722408|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
722409|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722410|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
722411|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722412|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
722413|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
722414|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722415|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
722416|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
722417|NCT02921555|Protective Agents|protective agents|mesh-ancestor
2231886|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231887|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2231888|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2231889|NCT00072904|Repaglinide|repaglinide|mesh-list
2231890|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2231891|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090493|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2090494|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2090495|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
2090496|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090497|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090498|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090499|NCT02216214|Urological Agents|urological agents|mesh-ancestor
2090500|NCT02216357|Ifetroban|ifetroban|mesh-list
2090501|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2090502|NCT02216422|Ritonavir|ritonavir|mesh-list
2090503|NCT02216422|Ribavirin|ribavirin|mesh-list
2231892|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
2231893|NCT00072930|Prednisone|prednisone|mesh-list
2231894|NCT00072930|Docetaxel|docetaxel|mesh-list
2090504|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
721383|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
721384|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
721385|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721386|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721387|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
2090505|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2090506|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
2090507|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090508|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090509|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2090510|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2090511|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
2090512|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090513|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2090514|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2090515|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
2090516|NCT02216812|Ascorbic Acid|ascorbic acid|mesh-list
2090517|NCT02216812|Vitamins|vitamins|mesh-ancestor
2090518|NCT02216812|Micronutrients|micronutrients|mesh-ancestor
2090519|NCT02216812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090520|NCT02216812|Antioxidants|antioxidants|mesh-ancestor
2090521|NCT02216812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090522|NCT02216812|Protective Agents|protective agents|mesh-ancestor
2090523|NCT02217332|Pramipexole|pramipexole|mesh-list
2090524|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
2090525|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090526|NCT02217332|Protective Agents|protective agents|mesh-ancestor
2090527|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090528|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2090529|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2090530|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
2090531|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
2090532|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090533|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
2231895|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231896|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
2231897|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
2231898|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
2231899|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721863|NCT02924038|Poly ICLC|poly iclc|mesh-list
721864|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
721865|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
721866|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722213|NCT02922491|Vitamin E|vitamin e|mesh-list
722214|NCT02922491|Vitamins|vitamins|mesh-ancestor
722215|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
722216|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722217|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
722218|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722219|NCT02922491|Protective Agents|protective agents|mesh-ancestor
723107|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
723108|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
723109|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
723110|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723111|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
723112|NCT02918201|Coagulants|coagulants|mesh-ancestor
723227|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
723228|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
723229|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
723230|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723231|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
723232|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
723233|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723972|NCT02913885|Fluorides|fluorides|mesh-list
723973|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
723974|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
723975|NCT02913885|Protective Agents|protective agents|mesh-ancestor
723976|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724798|NCT02909972|Cytarabine|cytarabine|mesh-list
724799|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
724800|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
724801|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724802|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724803|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
724804|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724805|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
721517|NCT02924922|Mannitol|mannitol|mesh-list
721518|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
721519|NCT02924922|Diuretics|diuretics|mesh-ancestor
721520|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
721521|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721633|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
721634|NCT02924753|Fludarabine|fludarabine|mesh-list
721635|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
721636|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
721637|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721638|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
721639|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
721640|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
721641|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721642|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721643|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
721849|NCT02923934|Nivolumab|nivolumab|mesh-list
721850|NCT02923934|Ipilimumab|ipilimumab|mesh-list
721851|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
721852|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721853|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
721854|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090534|NCT02217410|Tacrolimus|tacrolimus|mesh-list
2090535|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2090536|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
722119|NCT02922777|Docetaxel|docetaxel|mesh-list
722120|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722121|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
722122|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
722123|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
722124|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722322|NCT02921659|Niacinamide|niacinamide|mesh-list
722323|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
722324|NCT02921659|Vitamins|vitamins|mesh-ancestor
722325|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
722326|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722586|NCT02920515|Leuprolide|leuprolide|mesh-list
722587|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
722588|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
722589|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
722590|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722591|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
722592|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722790|NCT02919787|Irinotecan|irinotecan|mesh-list
722791|NCT02919787|Fluorouracil|fluorouracil|mesh-list
722792|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
722793|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
722794|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
722795|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722796|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722797|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722798|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
722799|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
722800|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
722801|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
722802|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231900|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2231901|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
2231902|NCT00072930|Hormones|hormones|mesh-ancestor
2231903|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2231904|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231905|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
724082|NCT02913300|Lidocaine|lidocaine|mesh-list
724083|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
724084|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
724085|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
724086|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
724087|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724088|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
724089|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724090|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
724091|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
724092|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
724093|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
724094|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724198|NCT02912988|Letrozole|letrozole|mesh-list
2231906|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2231907|NCT00072943|Interferons|interferons|mesh-list
2231908|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
2231909|NCT00072943|Antibodies|antibodies|mesh-list
2231910|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2231911|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
2231912|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231913|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231914|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
2231915|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2231916|NCT00072969|Daclizumab|daclizumab|mesh-list
2231917|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2231918|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
2231919|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231920|NCT00072982|Borage oil|borage oil|mesh-list
2231921|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2231922|NCT00073047|Daclizumab|daclizumab|mesh-list
2231923|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
722418|NCT02921178|Omalizumab|omalizumab|mesh-list
722419|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
722420|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
722421|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
722490|NCT02920931|Tenofovir|tenofovir|mesh-list
722491|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
722492|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
722493|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
722494|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
722495|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722496|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722497|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
722498|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
722733|NCT02920060|Levetiracetam|levetiracetam|mesh-list
722734|NCT02920060|Valproic Acid|valproic acid|mesh-list
722735|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
722736|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
722737|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722738|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722739|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
722740|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722741|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722742|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
722743|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
722744|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
722745|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2231924|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
2231925|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231926|NCT00073164|Valproic Acid|valproic acid|mesh-list
2231927|NCT00073164|Olanzapine|olanzapine|mesh-list
2231928|NCT00073164|Risperidone|risperidone|mesh-list
2231929|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2231930|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
2231931|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2231932|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723748|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
723749|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2090537|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090538|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2090539|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090540|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090541|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2090542|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090543|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2090544|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
2090545|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2090546|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090547|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
2090548|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2090549|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090550|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2090551|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2090552|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
2090553|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090554|NCT02217501|Aspirin|aspirin|mesh-list
2090555|NCT02217501|Clopidogrel|clopidogrel|mesh-list
2231933|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724285|NCT02912702|Etoposide|etoposide|mesh-list
2231934|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2231935|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2090556|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2090557|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2090558|NCT02217501|Analgesics|analgesics|mesh-ancestor
2090559|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
721928|NCT02923687|Ketorolac|ketorolac|mesh-list
721929|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
721930|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
721931|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
721932|NCT02923687|Analgesics|analgesics|mesh-ancestor
721933|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
721934|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
721935|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721936|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
721937|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
721938|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
721939|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
721940|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722050|NCT02922946|Entinostat|entinostat|mesh-list
722051|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722052|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
722053|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722054|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722620|NCT02920593|Vitamin D|vitamin d|mesh-list
722621|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
722622|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
722623|NCT02920593|Vitamins|vitamins|mesh-list
722624|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
722625|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722626|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
722627|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
722714|NCT02920190|Liraglutide|liraglutide|mesh-list
722715|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
722716|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722717|NCT02920190|Incretins|incretins|mesh-ancestor
722718|NCT02920190|Hormones|hormones|mesh-ancestor
722719|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2231936|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2231937|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2231938|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
723699|NCT02915796|Lenograstim|lenograstim|mesh-list
723700|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
723701|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
723702|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724061|NCT02913430|Tamoxifen|tamoxifen|mesh-list
724062|NCT02913430|Fulvestrant|fulvestrant|mesh-list
724063|NCT02913430|Palbociclib|palbociclib|mesh-list
724064|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
724065|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
724066|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
724067|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724068|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
724069|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724070|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
724071|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
724072|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
724073|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
721893|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
721894|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
721895|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
721896|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
721897|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
721898|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
721899|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
721900|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721901|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
721941|NCT02923531|Nivolumab|nivolumab|mesh-list
721942|NCT02923531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
721943|NCT02923531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
721944|NCT02923531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
721945|NCT02923531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231939|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
2231940|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
2231941|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
2231942|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2231943|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2231944|NCT00073164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2231945|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2231946|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2231947|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
2231948|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231949|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
2231950|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
2231951|NCT00073203|Paroxetine|paroxetine|mesh-list
2231952|NCT00073203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2231953|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2231954|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2231955|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231956|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2231957|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
2231958|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231959|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2231960|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
2231961|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2231962|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2231963|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2231964|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2231965|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2231966|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2231967|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2231968|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2231969|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231970|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2231971|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2231972|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2231973|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
2231974|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2231975|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231976|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2231977|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2231978|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
2231979|NCT00073372|Abciximab|abciximab|mesh-list
723733|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
723734|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
723735|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723832|NCT02914678|Fentanyl|fentanyl|mesh-list
723833|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
723834|NCT02914678|Narcotics|narcotics|mesh-ancestor
723835|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
723836|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723837|NCT02914678|Analgesics|analgesics|mesh-ancestor
723838|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
723839|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723840|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
723841|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
723842|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
723843|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
724208|NCT02913066|Cisplatin|cisplatin|mesh-list
724209|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724210|NCT02912715|Paclitaxel|paclitaxel|mesh-list
724211|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
721986|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
721987|NCT02923388|Pyridoxine|pyridoxine|mesh-list
721988|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
721989|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
721990|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
721991|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231980|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
2231981|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2231982|NCT00073385|Docetaxel|docetaxel|mesh-list
2231983|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2231984|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
2231985|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
722382|NCT02921282|Dopamine|dopamine|mesh-list
722383|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
722384|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
722385|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
722386|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722387|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722388|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
722389|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722390|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722391|NCT02921282|Protective Agents|protective agents|mesh-ancestor
2231986|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
2231987|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231988|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2231989|NCT00073411|Citalopram|citalopram|mesh-list
2231990|NCT00073411|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2231991|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2231992|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2231993|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2231994|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2231995|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
2231996|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2231997|NCT00073411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2231998|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
2231999|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2232000|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232001|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2232002|NCT00073411|Analgesics|analgesics|mesh-ancestor
2232003|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
2232004|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
723689|NCT02915809|Vaccines|vaccines|mesh-list
723690|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
723691|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232005|NCT00073437|Infliximab|infliximab|mesh-list
2232006|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
2232007|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
723869|NCT02914652|Albuterol|albuterol|mesh-list
723870|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
723871|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
723872|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723873|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723874|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
723875|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
723876|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
723877|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
723878|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
723879|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
723880|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
723881|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
723882|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
723883|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232008|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232009|NCT00073580|Hirudins|hirudins|mesh-list
2232010|NCT00073580|Anticoagulants|anticoagulants|mesh-list
2232011|NCT00073580|Bivalirudin|bivalirudin|mesh-list
2232012|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
2232013|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
724048|NCT02913417|Nivolumab|nivolumab|mesh-list
724049|NCT02913417|Ipilimumab|ipilimumab|mesh-list
724050|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
724051|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724052|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
724074|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
721993|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
721994|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
721995|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
721996|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
721997|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
721998|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
721999|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
722000|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
722001|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
722327|NCT02921906|Acetaminophen|acetaminophen|mesh-list
722328|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
722329|NCT02921906|Analgesics|analgesics|mesh-ancestor
722330|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
722331|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722332|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722333|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
2232014|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
2232015|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232016|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232017|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2232018|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2232019|NCT00073593|Heparin|heparin|mesh-list
2232020|NCT00073593|Bivalirudin|bivalirudin|mesh-list
2232021|NCT00073593|Protamines|protamines|mesh-list
2232022|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
2232023|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2232024|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2232025|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722510|NCT02920827|Dapivirine|dapivirine|mesh-list
722511|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
722512|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
722513|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
722514|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
722634|NCT02920658|Betamethasone|betamethasone|mesh-list
722635|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
722636|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
722637|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
722638|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
722639|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
722640|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
722641|NCT02920658|Hormones|hormones|mesh-ancestor
722642|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
722643|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722644|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
722645|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
723465|NCT02916771|Dexamethasone|dexamethasone|mesh-list
723466|NCT02916771|Lenalidomide|lenalidomide|mesh-list
723467|NCT02916771|Ixazomib|ixazomib|mesh-list
723468|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
723469|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
723470|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
723471|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723472|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723473|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
723474|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
723475|NCT02916771|Hormones|hormones|mesh-ancestor
723476|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723477|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
723478|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723479|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
723480|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
723481|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
723482|NCT02916771|Growth Substances|growth substances|mesh-ancestor
723483|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
723484|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
723485|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723486|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723753|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
723754|NCT02915224|Chlorambucil|chlorambucil|mesh-list
723755|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
723756|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723757|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
723758|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
723759|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090560|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232026|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
722028|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
722029|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
722030|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
722224|NCT02922283|Interleukin-2|interleukin-2|mesh-list
722225|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722226|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
722227|NCT02922283|Analgesics|analgesics|mesh-ancestor
722228|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
722229|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722230|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722728|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
722729|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
722730|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722828|NCT02919293|Vaccines|vaccines|mesh-list
722829|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
722830|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722901|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
722902|NCT02919059|Glimepiride|glimepiride|mesh-list
722903|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
722904|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722905|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
722906|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722907|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
722908|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
722909|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
2232027|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2232028|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
2232029|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232030|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
2232031|NCT00073593|Coagulants|coagulants|mesh-ancestor
2232032|NCT00073658|Risperidone|risperidone|mesh-list
2232033|NCT00073658|Citalopram|citalopram|mesh-list
2232034|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2232035|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
2232036|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2232037|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232038|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232039|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2232040|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2232041|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2232042|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2232043|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2232044|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
2232045|NCT00073658|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2232046|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
724147|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
724148|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
724149|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
724150|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
724151|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724152|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724153|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724154|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232047|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2232048|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2232049|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
2232050|NCT00073697|Dexetimide|dexetimide|mesh-list
2232051|NCT00073697|Citalopram|citalopram|mesh-list
2232052|NCT00073697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2232053|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2232054|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2232055|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232056|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2232057|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
2232058|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232059|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2232060|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
2232061|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2232062|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2232063|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2232064|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
2232065|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
2232066|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232067|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2232068|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2232069|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
2232070|NCT00073710|Calcitriol|calcitriol|mesh-list
2232071|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2232072|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232073|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2232074|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2232075|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232076|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2232077|NCT00073710|Vitamins|vitamins|mesh-ancestor
2232078|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
2232079|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
722847|NCT02919371|Bevacizumab|bevacizumab|mesh-list
722848|NCT02919371|Sunitinib|sunitinib|mesh-list
722849|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
722850|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722851|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
722852|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
722853|NCT02919371|Growth Substances|growth substances|mesh-ancestor
722854|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722855|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
722856|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
722857|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722858|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722910|NCT02918955|Cisplatin|cisplatin|mesh-list
722911|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232080|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2232081|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232082|NCT00073736|Cytarabine|cytarabine|mesh-list
2232083|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2090561|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090562|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2090563|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2090564|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2090565|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2090566|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090567|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2090568|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2090569|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090570|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
2090571|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2090572|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2090573|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2090574|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
2090575|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090576|NCT02217566|Prednisone|prednisone|mesh-list
2090577|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
2090578|NCT02217566|Androgens|androgens|mesh-list
2090579|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2090580|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
2090581|NCT02217566|Hormones|hormones|mesh-ancestor
2090582|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2090583|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090584|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2090585|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090586|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2232084|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
2232085|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753164|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753165|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2753166|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
723665|NCT02915731|Vitamin A|vitamin a|mesh-list
723666|NCT02915731|Vitamins|vitamins|mesh-ancestor
723667|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
723668|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724436|NCT02912026|Olorofim|olorofim|mesh-list
724437|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
724438|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724501|NCT02911792|Metformin|metformin|mesh-list
724502|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
724503|NCT02911792|Glipizide|glipizide|mesh-list
724504|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
722098|NCT02922803|Calcium|calcium|mesh-list
722099|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
722100|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722101|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
722102|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2090587|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090588|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090589|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
2090590|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2090591|NCT02217800|Octreotide|octreotide|mesh-list
2090592|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2090593|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2090594|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090595|NCT02217878|Morphine|morphine|mesh-list
2090596|NCT02217878|Ticagrelor|ticagrelor|mesh-list
2090597|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2090598|NCT02217878|Narcotics|narcotics|mesh-ancestor
2090599|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090600|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090601|NCT02217878|Analgesics|analgesics|mesh-ancestor
2090602|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
2090603|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090604|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2090605|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2090606|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2090607|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
722731|NCT02920008|Guadecitabine|guadecitabine|mesh-list
722732|NCT02920008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723064|NCT02918591|Empagliflozin|empagliflozin|mesh-list
723065|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
723066|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723067|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
723068|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090608|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
2090609|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090610|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090611|NCT02217904|Islatravir|islatravir|mesh-list
2090612|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
2090613|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090614|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090615|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090616|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2232086|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723616|NCT02916238|Fluoxetine|fluoxetine|mesh-list
723617|NCT02916238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
723618|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
723619|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
723620|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723621|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
723622|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
723623|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723624|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
723625|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
723626|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
723627|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
723628|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
723629|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232087|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
2232088|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232089|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232090|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
724439|NCT02911961|Acetaminophen|acetaminophen|mesh-list
724440|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
724441|NCT02911961|Analgesics|analgesics|mesh-ancestor
724442|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
724443|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724444|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724445|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
722134|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723000|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
723001|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
723002|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723144|NCT02918331|Dexamethasone|dexamethasone|mesh-list
723145|NCT02918331|Lenalidomide|lenalidomide|mesh-list
723146|NCT02918331|Daratumumab|daratumumab|mesh-list
723147|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
723148|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
723149|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
723150|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723151|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723152|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
723153|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
723154|NCT02918331|Hormones|hormones|mesh-ancestor
723155|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723156|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
723157|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723158|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
723159|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
723160|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
723161|NCT02918331|Growth Substances|growth substances|mesh-ancestor
723162|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
723326|NCT02917564|Triamcinolone|triamcinolone|mesh-list
723327|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
723328|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
723329|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
723330|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
723331|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
723332|NCT02917564|Hormones|hormones|mesh-ancestor
723333|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723334|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723335|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
723336|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
723337|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723338|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723372|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
723373|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
723374|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
723375|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723376|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
723377|NCT02917018|Analgesics|analgesics|mesh-ancestor
723378|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
723379|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723380|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
723381|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
723382|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
723383|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
723384|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
723385|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723461|NCT02916654|Iron|iron|mesh-list
723462|NCT02916654|Trace Elements|trace elements|mesh-ancestor
723463|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
723464|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723607|NCT02916251|Glucagon|glucagon|mesh-list
723608|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
723609|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
723610|NCT02916251|Hormones|hormones|mesh-ancestor
723611|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723612|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723613|NCT02916251|Incretins|incretins|mesh-ancestor
2232091|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232092|NCT00073814|Albuterol|albuterol|mesh-list
2232093|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2232094|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
2232095|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232096|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232097|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2232098|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
2232099|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
2232100|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2232101|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2232102|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2232103|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
722154|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
722155|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722156|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
722157|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
722158|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722159|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
722220|NCT02922179|Insulin|insulin|mesh-list
722221|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
722222|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
722223|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232104|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
2232105|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2232106|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232107|NCT00073827|Albuterol|albuterol|mesh-list
2232108|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2232109|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
2232110|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232111|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232112|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2232113|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
2232114|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
2232115|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2232116|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2232117|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
722720|NCT02920047|Amlodipine|amlodipine|mesh-list
722721|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
722722|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
722723|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
722724|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722725|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
722726|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722727|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
722876|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
722877|NCT02919345|Glyburide|glyburide|mesh-list
722878|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
722879|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722880|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
722881|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722932|NCT02918864|Oxytocin|oxytocin|mesh-list
722933|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
722934|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
722935|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723209|NCT02918084|Letrozole|letrozole|mesh-list
723210|NCT02918084|Anastrozole|anastrozole|mesh-list
723211|NCT02918084|Exemestane|exemestane|mesh-list
723212|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723213|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
723214|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
723215|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723216|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723217|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
723218|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
723219|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723220|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723221|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
723431|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
723432|NCT02916862|Calcium|calcium|mesh-list
723433|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
723434|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723435|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
723692|NCT02915523|Avelumab|avelumab|mesh-list
723693|NCT02915523|Entinostat|entinostat|mesh-list
723694|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
723695|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723696|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
723697|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723698|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232118|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2232119|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
2232120|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2232121|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232122|NCT00073840|Albuterol|albuterol|mesh-list
2232123|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
725947|NCT02904538|Dexamethasone|dexamethasone|mesh-list
722238|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
722239|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
722240|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
722241|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
722242|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722243|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
722244|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
722524|NCT02921022|Gemcitabine|gemcitabine|mesh-list
722525|NCT02921022|Paclitaxel|paclitaxel|mesh-list
722526|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
722527|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722528|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
722529|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
722530|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
722531|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722532|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
722533|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
722534|NCT02921022|Antiviral Agents|antiviral agents|mesh-ancestor
722535|NCT02921022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
722536|NCT02921022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722537|NCT02921022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
722538|NCT02921022|Immunologic Factors|immunologic factors|mesh-ancestor
722539|NCT02921022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722680|NCT02920489|Sufentanil|sufentanil|mesh-list
722681|NCT02920489|Dsuvia|dsuvia|mesh-list
722682|NCT02920489|Ropivacaine|ropivacaine|mesh-list
722683|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
722684|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
722685|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
722686|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722687|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
722688|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722689|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
722690|NCT02920489|Narcotics|narcotics|mesh-ancestor
722691|NCT02920489|Analgesics|analgesics|mesh-ancestor
722692|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
722693|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
722694|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
722773|NCT02919501|Vortioxetine|vortioxetine|mesh-list
722774|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
722775|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
722776|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
722777|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
722778|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
722779|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722780|NCT02919501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
722781|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
722782|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
722783|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722784|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722785|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
722786|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
722787|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
722788|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
722789|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2232124|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
2232125|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232126|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232127|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2232128|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
2232129|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
2232130|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2232131|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2232132|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
723234|NCT02917889|Caffeine|caffeine|mesh-list
723235|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
723236|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723237|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
723238|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723239|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723240|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
723241|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
723242|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
723243|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722372|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722373|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
722374|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
722375|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
722376|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
722377|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722378|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
722379|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
722380|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722381|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
722667|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
722668|NCT02920372|Hematinics|hematinics|mesh-ancestor
722766|NCT02919605|Pentamidine|pentamidine|mesh-list
722767|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
722768|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
722769|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
722770|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
722771|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
723544|NCT02916485|Sirolimus|sirolimus|mesh-list
723545|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
723546|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
723547|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
723548|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723549|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
723550|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
723551|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
723552|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723655|NCT02916147|Propofol|propofol|mesh-list
723656|NCT02916147|Sevoflurane|sevoflurane|mesh-list
723657|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
723658|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
723659|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723660|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
723661|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
723662|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
723663|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
723664|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
723981|NCT02914028|Acetaminophen|acetaminophen|mesh-list
723982|NCT02914028|Tramadol|tramadol|mesh-list
723983|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
723984|NCT02914028|Analgesics|analgesics|mesh-ancestor
723985|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
723986|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723987|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723988|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
723989|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
723990|NCT02914028|Narcotics|narcotics|mesh-ancestor
723991|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2232133|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2232134|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
2232135|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2232136|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232137|NCT00073866|Celecoxib|celecoxib|mesh-list
2232138|NCT00073866|Docetaxel|docetaxel|mesh-list
2232139|NCT00073866|Irinotecan|irinotecan|mesh-list
2232140|NCT00073866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724217|NCT02912637|Xenon|xenon|mesh-list
724218|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
724219|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
724220|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
724221|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
724222|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232141|NCT00073866|Tubulin Modulators|tubulin modulators|mesh-ancestor
2232142|NCT00073866|Antimitotic Agents|antimitotic agents|mesh-ancestor
2232143|NCT00073866|Mitosis Modulators|mitosis modulators|mesh-ancestor
2232144|NCT00073866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232145|NCT00073866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
724990|NCT02909413|Sevoflurane|sevoflurane|mesh-list
724991|NCT02909413|Desflurane|desflurane|mesh-list
724992|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
724993|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
724994|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
724995|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
724996|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
724997|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722502|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722503|NCT02920801|Incretins|incretins|mesh-ancestor
722504|NCT02920801|Hormones|hormones|mesh-ancestor
722505|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
722506|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
722507|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
722508|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722509|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722838|NCT02919436|Tamsulosin|tamsulosin|mesh-list
722839|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
722840|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
722841|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
722842|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
722843|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722844|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722845|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722846|NCT02919436|Urological Agents|urological agents|mesh-ancestor
2232146|NCT00073866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2232147|NCT00073866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232148|NCT00073866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2232149|NCT00073866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2232150|NCT00073866|Analgesics|analgesics|mesh-ancestor
2232151|NCT00073866|Sensory System Agents|sensory system agents|mesh-ancestor
2232152|NCT00073866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232153|NCT00073866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232154|NCT00073866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2232155|NCT00073866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232156|NCT00073866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2232157|NCT00073866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2232158|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
2232159|NCT00073879|Fludarabine|fludarabine|mesh-list
2232160|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
2232161|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
2232162|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232163|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
2232164|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232165|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232166|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2232167|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
2232168|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232169|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723678|NCT02915666|Trametinib|trametinib|mesh-list
723679|NCT02915666|Dabrafenib|dabrafenib|mesh-list
723680|NCT02915666|Digoxin|digoxin|mesh-list
723681|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723682|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
723683|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723684|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723685|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
723686|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
723687|NCT02915666|Protective Agents|protective agents|mesh-ancestor
723688|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723773|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
723774|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
723775|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723938|NCT02914015|Morphine|morphine|mesh-list
723939|NCT02914015|Ropivacaine|ropivacaine|mesh-list
723940|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
723941|NCT02914015|Anesthetics|anesthetics|mesh-list
723942|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
723943|NCT02914015|Narcotics|narcotics|mesh-ancestor
723944|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
723945|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723946|NCT02914015|Analgesics|analgesics|mesh-ancestor
723947|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
723948|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723999|NCT02913768|Ondansetron|ondansetron|mesh-list
724000|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
724001|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
724002|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724003|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724004|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
724005|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
724006|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
724007|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
724008|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
722522|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722523|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
722859|NCT02919449|Atezolizumab|atezolizumab|mesh-list
722860|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723278|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
723279|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
723280|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
723281|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
723403|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
723404|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
723405|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
723406|NCT02916940|Hormones|hormones|mesh-ancestor
723407|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723408|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723736|NCT02915354|Etanercept|etanercept|mesh-list
723737|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
723738|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
723739|NCT02915354|Analgesics|analgesics|mesh-ancestor
723740|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
723741|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723742|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723743|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
723744|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
723745|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
723746|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
723747|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
724095|NCT02913690|Vitamin E|vitamin e|mesh-list
724096|NCT02913690|Vitamins|vitamins|mesh-ancestor
724097|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
724098|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724099|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
724100|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724101|NCT02913690|Protective Agents|protective agents|mesh-ancestor
2232170|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2232171|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232172|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
2232173|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
724689|NCT02910414|Ethanol|ethanol|mesh-list
724690|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
724691|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724692|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
724693|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724756|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
724757|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
724758|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
724759|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
724760|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724761|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724762|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724763|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
724998|NCT02909465|Midazolam|midazolam|mesh-list
724999|NCT02909465|Ketamine|ketamine|mesh-list
725000|NCT02909465|Haloperidol|haloperidol|mesh-list
725001|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
725002|NCT02909465|Analgesics|analgesics|mesh-ancestor
725003|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
725004|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725005|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725006|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
725007|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
722552|NCT02920905|Lidocaine|lidocaine|mesh-list
722553|NCT02920905|Atracurium|atracurium|mesh-list
722554|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
722555|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
722556|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
722557|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722558|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
722559|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722560|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
722561|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
722562|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
722563|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
722564|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722565|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
722566|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
722567|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
722568|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
722569|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
722570|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
722571|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722628|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
722629|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
722630|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722631|NCT02920502|Vitamins|vitamins|mesh-ancestor
722632|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
722633|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2232174|NCT00073905|Gemcitabine|gemcitabine|mesh-list
2232175|NCT00073905|Capecitabine|capecitabine|mesh-list
2232176|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232177|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
2232178|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232179|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232180|NCT00073905|Antiviral Agents|antiviral agents|mesh-ancestor
2232181|NCT00073905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
722813|NCT02919462|Cisplatin|cisplatin|mesh-list
722814|NCT02919462|Pemetrexed|pemetrexed|mesh-list
722815|NCT02919462|Vinorelbine|vinorelbine|mesh-list
722816|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
722817|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
722818|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722819|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
722820|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
722821|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
722822|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
722823|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
722824|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
722882|NCT02919176|Pioglitazone|pioglitazone|mesh-list
722883|NCT02919176|Mirabegron|mirabegron|mesh-list
722884|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
722885|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722886|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
722887|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
722888|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
722889|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
722890|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722891|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722892|NCT02919176|Urological Agents|urological agents|mesh-ancestor
722958|NCT02918760|Gabapentin|gabapentin|mesh-list
722959|NCT02918760|Analgesics|analgesics|mesh-ancestor
722960|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
722961|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722962|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722963|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
722964|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
722965|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
722966|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
722967|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
722968|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
722969|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
722970|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
722971|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722972|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
723097|NCT02918409|Tobramycin|tobramycin|mesh-list
723098|NCT02918409|Colistin|colistin|mesh-list
723099|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2232182|NCT00073905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232183|NCT00073905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232184|NCT00073905|Immunologic Factors|immunologic factors|mesh-ancestor
2232185|NCT00073905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232186|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
2232187|NCT00073931|Sargramostim|sargramostim|mesh-list
2232188|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
2232189|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232190|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232191|NCT00073970|Celecoxib|celecoxib|mesh-list
2232192|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2232193|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2232194|NCT00073970|Analgesics|analgesics|mesh-ancestor
2232195|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
2232196|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232197|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232198|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2232199|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232200|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2232201|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2232202|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232203|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232204|NCT00074009|Bortezomib|bortezomib|mesh-list
2232205|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232206|NCT00074022|Docetaxel|docetaxel|mesh-list
2232207|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723358|NCT02917005|Palbociclib|palbociclib|mesh-list
723359|NCT02917005|Exemestane|exemestane|mesh-list
723360|NCT02917005|Goserelin|goserelin|mesh-list
723361|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723362|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
723363|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723364|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723365|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
723366|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
723367|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
723368|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
723369|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723370|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723371|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
723901|NCT02914158|Tamoxifen|tamoxifen|mesh-list
723902|NCT02914158|Goserelin|goserelin|mesh-list
723903|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
723904|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
723905|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
723906|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723907|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723908|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
723909|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723910|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
723911|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
723912|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
723913|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
723914|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723915|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724307|NCT02912572|Avelumab|avelumab|mesh-list
724308|NCT02912572|Axitinib|axitinib|mesh-list
724309|NCT02912572|Talazoparib|talazoparib|mesh-list
724310|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
724311|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724312|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
724313|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724314|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724315|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
724367|NCT02912247|Adalimumab|adalimumab|mesh-list
724368|NCT02912247|Antibodies|antibodies|mesh-list
724369|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
724370|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
724371|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724372|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
724373|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
724978|NCT02909322|Hydromorphone|hydromorphone|mesh-list
724979|NCT02909322|Bupivacaine|bupivacaine|mesh-list
724980|NCT02909322|Ropivacaine|ropivacaine|mesh-list
724981|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
2232208|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
2232209|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
722912|NCT02918812|Diclofenac|diclofenac|mesh-list
722913|NCT02918812|Lidocaine|lidocaine|mesh-list
722914|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
722915|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
722916|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
722917|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
722918|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
722919|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
722920|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
722921|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
722922|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
722923|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
722924|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
722925|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
722926|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
722927|NCT02918812|Analgesics|analgesics|mesh-ancestor
722928|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
722929|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
722930|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
722931|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090617|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2090618|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2090619|NCT02217982|Simethicone|simethicone|mesh-list
2090620|NCT02217982|Loperamide|loperamide|mesh-list
2090621|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
2232210|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
2232211|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724102|NCT02913469|Morphine|morphine|mesh-list
724103|NCT02913469|Metoclopramide|metoclopramide|mesh-list
724104|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
724105|NCT02913469|Narcotics|narcotics|mesh-ancestor
724106|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
724107|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724108|NCT02913469|Analgesics|analgesics|mesh-ancestor
724109|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
724110|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724111|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
724112|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
724113|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
724114|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
724115|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
724116|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
724117|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
724118|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724475|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
724476|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
724477|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
724478|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724479|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
724480|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
2232212|NCT00074074|Infliximab|infliximab|mesh-list
2232213|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
2232214|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2232215|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232216|NCT00074087|Doxorubicin|doxorubicin|mesh-list
2232217|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2232218|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2232219|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232220|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2232221|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2232222|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232223|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232224|NCT00074100|Amonafide|amonafide|mesh-list
2232225|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232226|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
2232227|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232228|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232229|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725969|NCT02904291|Amlodipine|amlodipine|mesh-list
725970|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
725971|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
725972|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
725973|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090622|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2232230|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
2232231|NCT00074139|Docetaxel|docetaxel|mesh-list
2232232|NCT00074139|Doxorubicin|doxorubicin|mesh-list
2232233|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
723561|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
723562|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
723614|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
723615|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
723862|NCT02914626|Ranibizumab|ranibizumab|mesh-list
723863|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
723864|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
723865|NCT02914626|Growth Substances|growth substances|mesh-ancestor
723866|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723867|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
723868|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723919|NCT02914145|Piperaquine|piperaquine|mesh-list
723920|NCT02914145|Artenimol|artenimol|mesh-list
723921|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
723922|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
723923|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
723924|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232234|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232235|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
2232236|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232237|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
724590|NCT02911272|Oxytocin|oxytocin|mesh-list
724591|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
724592|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
724593|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724649|NCT02910817|Metformin|metformin|mesh-list
724650|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
724651|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724728|NCT02910518|Insulin|insulin|mesh-list
724729|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
724730|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
724731|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
724732|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
724733|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
724734|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
724735|NCT02910518|Heparin|heparin|mesh-list
724736|NCT02910518|Calcium heparin|calcium heparin|mesh-list
724737|NCT02910518|Glucagon|glucagon|mesh-list
724738|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
724739|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724740|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
724741|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
724742|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
724743|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724744|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
724745|NCT02910518|Hormones|hormones|mesh-ancestor
724746|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
725278|NCT02908412|Bupivacaine|bupivacaine|mesh-list
725279|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
725280|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
725281|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
725282|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725283|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
725284|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725494|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
725495|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
725496|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725706|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
725707|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
725708|NCT02905682|Coagulants|coagulants|mesh-ancestor
725709|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
725710|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
725711|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725843|NCT02905045|Ketoprofen|ketoprofen|mesh-list
725844|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
725845|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
725846|NCT02905045|Analgesics|analgesics|mesh-ancestor
725847|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
725848|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725849|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725850|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
725851|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
725852|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
725853|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723036|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723037|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723038|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
723039|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
723040|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
723041|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
723042|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723043|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
723044|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
723045|NCT02918747|Hormones|hormones|mesh-ancestor
723046|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723047|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
723048|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
723049|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
723050|NCT02918747|Antiviral Agents|antiviral agents|mesh-ancestor
723051|NCT02918747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
723052|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723053|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
723054|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
723055|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
723056|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
723057|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
723058|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
723059|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
2090623|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
2090624|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090625|NCT02217982|Emollients|emollients|mesh-ancestor
2090626|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
2090627|NCT02218164|Interferons|interferons|mesh-list
2090628|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
2090629|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
2090630|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2090631|NCT02218164|Fluorouracil|fluorouracil|mesh-list
2090632|NCT02218164|Capecitabine|capecitabine|mesh-list
2090633|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
2090634|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090635|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2090636|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090637|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2090638|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
2090639|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090640|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
2090641|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090642|NCT02218190|Alvimopan|alvimopan|mesh-list
2090643|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2090644|NCT02218203|Lidocaine|lidocaine|mesh-list
723282|NCT02917629|Pioglitazone|pioglitazone|mesh-list
723283|NCT02917629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
723284|NCT02917629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723396|NCT02917057|Exenatide|exenatide|mesh-list
723397|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
723398|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723399|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
723400|NCT02917057|Incretins|incretins|mesh-ancestor
723401|NCT02917057|Hormones|hormones|mesh-ancestor
723402|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723630|NCT02916160|Valsartan|valsartan|mesh-list
723631|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
723632|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
723633|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
723634|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
723635|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723776|NCT02915172|Capecitabine|capecitabine|mesh-list
723777|NCT02915172|Lenvatinib|lenvatinib|mesh-list
723778|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
723779|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
723780|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723781|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723782|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
723783|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723860|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
723861|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2090645|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
723100|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
723163|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
723164|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
723165|NCT02918045|Coagulants|coagulants|mesh-ancestor
723304|NCT02917525|Vitamin K|vitamin k|mesh-list
723305|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
723306|NCT02917525|Vitamins|vitamins|mesh-ancestor
723307|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
723308|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723309|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
723310|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
723311|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723312|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
723313|NCT02917525|Coagulants|coagulants|mesh-ancestor
2090646|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
2090647|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
2090648|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090649|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090650|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
2090651|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090652|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2090653|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2090654|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2090655|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2753183|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
723811|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
723812|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
723813|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
723814|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723815|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
723816|NCT02915042|Analgesics|analgesics|mesh-ancestor
723817|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
723818|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723819|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
723820|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
723821|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
723822|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
723823|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
723824|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753184|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2753185|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753186|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2753187|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724878|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
724879|NCT02909712|Piperaquine|piperaquine|mesh-list
724880|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
724881|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
724882|NCT02909712|Artenimol|artenimol|mesh-list
724883|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
724884|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
724885|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
724886|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724887|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
724888|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724889|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724890|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
724891|NCT02909712|Renal Agents|renal agents|mesh-ancestor
725043|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
725044|NCT02909335|Prednisone|prednisone|mesh-list
725045|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
725046|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
725047|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
725048|NCT02909335|Prednisolone|prednisolone|mesh-list
725049|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
725050|NCT02909335|Everolimus|everolimus|mesh-list
725051|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
725052|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
725053|NCT02909335|Tacrolimus|tacrolimus|mesh-list
725054|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
725055|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
725056|NCT02909335|Hormones|hormones|mesh-ancestor
725057|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723179|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723180|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
723181|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
723182|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
723272|NCT02917746|Imiquimod|imiquimod|mesh-list
723273|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
723274|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
723275|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723276|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723277|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
723339|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
723340|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
723341|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
723342|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
723343|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
723344|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
723345|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723346|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723526|NCT02916420|Dexamethasone|dexamethasone|mesh-list
723527|NCT02916420|Pomalidomide|pomalidomide|mesh-list
723528|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
723529|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
723530|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
723531|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723532|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723533|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
723534|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
723535|NCT02916420|Hormones|hormones|mesh-ancestor
723536|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723537|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
723538|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
723539|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
723540|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
723541|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
723542|NCT02916420|Growth Substances|growth substances|mesh-ancestor
723543|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
724487|NCT02911701|Acetaminophen|acetaminophen|mesh-list
724488|NCT02911701|Ibuprofen|ibuprofen|mesh-list
724489|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
724490|NCT02911701|Analgesics|analgesics|mesh-ancestor
724491|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
724492|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724493|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724494|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
724495|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
724496|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
724497|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
724498|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
724499|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724500|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724828|NCT02910050|Letrozole|letrozole|mesh-list
724829|NCT02910050|Anastrozole|anastrozole|mesh-list
724830|NCT02910050|Exemestane|exemestane|mesh-list
724831|NCT02910050|Bicalutamide|bicalutamide|mesh-list
724832|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
724833|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724834|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
724835|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724836|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724837|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
724838|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
724839|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
724840|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724841|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
724842|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
724958|NCT02909478|Dexamethasone|dexamethasone|mesh-list
724959|NCT02909478|Aprepitant|aprepitant|mesh-list
724960|NCT02909478|Tropisetron|tropisetron|mesh-list
724961|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2232238|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2232239|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
2232240|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232241|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232242|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2232243|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
2232244|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
2232245|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
2232246|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2232247|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2232248|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2232249|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232250|NCT00074178|Cytarabine|cytarabine|mesh-list
2232251|NCT00074178|Dexamethasone|dexamethasone|mesh-list
2232252|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
2232253|NCT00074178|Methotrexate|methotrexate|mesh-list
2232254|NCT00074178|Etoposide|etoposide|mesh-list
2232255|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
2232256|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232257|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
2232258|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232259|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232260|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2232261|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
724054|NCT02913573|Bupivacaine|bupivacaine|mesh-list
724055|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
724056|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
724057|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
724058|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724059|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
724060|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
726145|NCT02903485|Anesthetics|anesthetics|mesh-list
726146|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
726147|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726190|NCT02903251|Oxytocin|oxytocin|mesh-list
726191|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
726192|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
726193|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232262|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232263|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232264|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2232265|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2232266|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
2232267|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
2232268|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232269|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2232270|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
2232271|NCT00074178|Hormones|hormones|mesh-ancestor
2232272|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2232273|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2232274|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2232275|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
2232276|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2232277|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232278|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
2232279|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
727107|NCT02898961|Gentamicins|gentamicins|mesh-list
727108|NCT02898961|Amikacin|amikacin|mesh-list
727109|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
727110|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727111|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
727112|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727113|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727690|NCT02895659|Norepinephrine|norepinephrine|mesh-list
727691|NCT02895659|Epinephrine|epinephrine|mesh-list
727692|NCT02895659|Racepinephrine|racepinephrine|mesh-list
727693|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
727694|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
727695|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
727696|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
727697|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
727739|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
723566|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
723567|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
723568|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
723569|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
723570|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
723571|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723572|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
723573|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
723574|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
723575|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
723576|NCT02916602|Diuretics|diuretics|mesh-ancestor
723577|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
723578|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2090656|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090657|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
2090658|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
2090659|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2090660|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2232280|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724586|NCT02911480|Oxytocin|oxytocin|mesh-list
724587|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
724588|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
724589|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724855|NCT02910245|Prednisone|prednisone|mesh-list
724856|NCT02910245|Mesalamine|mesalamine|mesh-list
724857|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
724858|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
724859|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
724860|NCT02910245|Hormones|hormones|mesh-ancestor
724861|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
724862|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724863|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
724864|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724865|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
724866|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724867|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
724868|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
724869|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
724870|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
724871|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724872|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
724873|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
724874|NCT02910245|Analgesics|analgesics|mesh-ancestor
724875|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
724876|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724877|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
725213|NCT02908711|Ropivacaine|ropivacaine|mesh-list
725214|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
725215|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
725216|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
725217|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725218|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
725219|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232281|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2232282|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2232283|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2232284|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2232285|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2232286|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
2232287|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725813|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
725814|NCT02905188|Fludarabine|fludarabine|mesh-list
725815|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
725816|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
725817|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725818|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
725819|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
725820|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
725821|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725822|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725823|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2232288|NCT00074191|Cytarabine|cytarabine|mesh-list
2232289|NCT00074191|Dexamethasone|dexamethasone|mesh-list
2232290|NCT00074191|Methotrexate|methotrexate|mesh-list
2232291|NCT00074191|Lomustine|lomustine|mesh-list
2232292|NCT00074191|Procarbazine|procarbazine|mesh-list
2232293|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2232294|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
2232295|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
2232296|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723750|NCT02915198|Metformin|metformin|mesh-list
723751|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
723752|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232297|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232298|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2232299|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
2232300|NCT00074191|Hormones|hormones|mesh-ancestor
725171|NCT02909049|Midazolam|midazolam|mesh-list
725172|NCT02909049|Ketamine|ketamine|mesh-list
725173|NCT02909049|Mepivacaine|mepivacaine|mesh-list
725174|NCT02909049|Analgesics|analgesics|mesh-ancestor
725175|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
725176|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725177|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725178|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
725179|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
725180|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
725181|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
725182|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
725183|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
725184|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
725185|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
725186|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725187|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
725188|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
725189|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
725190|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
725191|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
725192|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
725193|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
725194|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
725551|NCT02906800|Digoxin|digoxin|mesh-list
725552|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
725553|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
725554|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725555|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725556|NCT02906800|Protective Agents|protective agents|mesh-ancestor
725557|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726128|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
726129|NCT02903524|Doxorubicin|doxorubicin|mesh-list
726130|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
726131|NCT02903524|Pirarubicin|pirarubicin|mesh-list
726132|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
726133|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
726134|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726135|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
726136|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
726137|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
726138|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726139|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726140|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
726141|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
726142|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
726143|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
726144|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726575|NCT02901977|Ramipril|ramipril|mesh-list
726576|NCT02901977|Doxazosin|doxazosin|mesh-list
726577|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
726578|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
726579|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726580|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726581|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
726582|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
726583|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
726584|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
726585|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
726586|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
726587|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726635|NCT02901561|Misoprostol|misoprostol|mesh-list
723639|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
723640|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723641|NCT02916121|Hematinics|hematinics|mesh-ancestor
723642|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
723760|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
723761|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
723762|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
723763|NCT02915289|Povidone|povidone|mesh-list
723764|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
723765|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
723766|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
723767|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
723768|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
723769|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
723898|NCT02914366|Ambroxol|ambroxol|mesh-list
723899|NCT02914366|Expectorants|expectorants|mesh-ancestor
723900|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
724131|NCT02913508|Vedolizumab|vedolizumab|mesh-list
724132|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
724576|NCT02911350|Paclitaxel|paclitaxel|mesh-list
724577|NCT02911350|Hormones|hormones|mesh-list
724578|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
724579|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724580|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
724581|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
724582|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
724583|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724584|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
724585|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232301|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2232302|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2232303|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232304|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2232305|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
2232306|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2232307|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232308|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
2232309|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232310|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
2232311|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232312|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2232313|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232314|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
2232315|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232316|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2232317|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
726317|NCT02903004|Gemcitabine|gemcitabine|mesh-list
726318|NCT02903004|Paclitaxel|paclitaxel|mesh-list
726319|NCT02903004|Carboplatin|carboplatin|mesh-list
726320|NCT02903004|Doxorubicin|doxorubicin|mesh-list
726321|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
726322|NCT02903004|Topotecan|topotecan|mesh-list
726323|NCT02903004|Trabectedin|trabectedin|mesh-list
726324|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
726325|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726326|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
726327|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
2232318|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232319|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2232320|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
2232321|NCT00074204|Gemcitabine|gemcitabine|mesh-list
2232322|NCT00074204|Carboplatin|carboplatin|mesh-list
2232323|NCT00074204|Docetaxel|docetaxel|mesh-list
2232324|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232325|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
723858|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
723859|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
723977|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
723978|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
723979|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723980|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724353|NCT02912234|Clarithromycin|clarithromycin|mesh-list
724354|NCT02912234|Apixaban|apixaban|mesh-list
724355|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
724356|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724357|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
724358|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724359|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724360|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
724361|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
724362|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
724363|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
724364|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
724365|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
724366|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
724694|NCT02910570|Liraglutide|liraglutide|mesh-list
724695|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
724696|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724697|NCT02910570|Incretins|incretins|mesh-ancestor
724698|NCT02910570|Hormones|hormones|mesh-ancestor
724699|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
724810|NCT02910206|Sufentanil|sufentanil|mesh-list
724811|NCT02910206|Propofol|propofol|mesh-list
724812|NCT02910206|Etomidate|etomidate|mesh-list
724813|NCT02910206|Cisatracurium|cisatracurium|mesh-list
724814|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
724815|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
724816|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724817|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
724818|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
724819|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
724820|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
724821|NCT02910206|Narcotics|narcotics|mesh-ancestor
724822|NCT02910206|Analgesics|analgesics|mesh-ancestor
724823|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
724824|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724825|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
724826|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
724827|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2090661|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090662|NCT02218307|Mupirocin|mupirocin|mesh-list
2090663|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2090664|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090665|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2090666|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725318|NCT02908152|Curcumin|curcumin|mesh-list
725319|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
725320|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
725321|NCT02908152|Analgesics|analgesics|mesh-ancestor
725322|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
725323|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725324|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725325|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
725326|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
725327|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725328|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232326|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
723896|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
723897|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723925|NCT02914054|Dexamethasone|dexamethasone|mesh-list
723926|NCT02914054|Prednisone|prednisone|mesh-list
723927|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
723928|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
723929|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
723930|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
723931|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
723932|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
723933|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
723934|NCT02914054|Hormones|hormones|mesh-ancestor
723935|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
723936|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
723937|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724332|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
724333|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232327|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232328|NCT00074204|Antiviral Agents|antiviral agents|mesh-ancestor
2232329|NCT00074204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232330|NCT00074204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232331|NCT00074204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232332|NCT00074204|Immunologic Factors|immunologic factors|mesh-ancestor
2232333|NCT00074204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232334|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
2232335|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
2232336|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
2232337|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
2232338|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2232339|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
2232340|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232341|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232342|NCT00074321|Capecitabine|capecitabine|mesh-list
2232343|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
2232344|NCT00074321|Irinotecan|irinotecan|mesh-list
2232345|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232346|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
2232347|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232348|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232349|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2232350|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2232351|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725792|NCT02905214|Sirolimus|sirolimus|mesh-list
725793|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
725794|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725795|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
725796|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725797|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
725798|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
725799|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
725800|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232352|NCT00074334|Immunotoxins|immunotoxins|mesh-list
2232353|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
2232354|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726074|NCT02904109|Mannitol|mannitol|mesh-list
726075|NCT02904109|Triflusal|triflusal|mesh-list
726076|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
726077|NCT02904109|Diuretics|diuretics|mesh-ancestor
726078|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
726079|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726080|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
726643|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
726644|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
726645|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
726646|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
726823|NCT02900976|Rituximab|rituximab|mesh-list
726824|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
726825|NCT02900976|Antibodies|antibodies|mesh-list
726826|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
726827|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
726828|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
726829|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726830|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726831|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232355|NCT00074399|Nevirapine|nevirapine|mesh-list
2232356|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2232357|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
724009|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
724010|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724011|NCT02913768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
724012|NCT02913768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
724013|NCT02913768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
724014|NCT02913768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
724015|NCT02913768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
724223|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
724224|NCT02912663|Verapamil|verapamil|mesh-list
724225|NCT02912663|Analgesics|analgesics|mesh-ancestor
724226|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
724227|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724229|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724230|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
724231|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
724232|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
724233|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
724234|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
724235|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
724236|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724237|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
724240|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
724241|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
724242|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
724508|NCT02911662|Cephalexin|cephalexin|mesh-list
724509|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
724510|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
724511|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724512|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
724513|NCT02911662|Renal Agents|renal agents|mesh-ancestor
724708|NCT02910596|Bethanechol|bethanechol|mesh-list
724709|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
724710|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
724711|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724712|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724713|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
724714|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
724715|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
724716|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
724717|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724764|NCT02910141|Insulin|insulin|mesh-list
724765|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
724766|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
724767|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232358|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232359|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232360|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
2232361|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232362|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2232363|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2232364|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2232365|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2232366|NCT00074438|Rituximab|rituximab|mesh-list
2232367|NCT00074438|Methotrexate|methotrexate|mesh-list
2232368|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2232369|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232370|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
2232371|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232372|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232373|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2232374|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
2232375|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2232376|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232377|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
2232378|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232379|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
2232380|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232381|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2232382|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232383|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2232384|NCT00074607|Gemcitabine|gemcitabine|mesh-list
2232385|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232386|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
2232387|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090667|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090668|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
2090669|NCT02218320|Dolutegravir|dolutegravir|mesh-list
2090670|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2090671|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2090672|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
2090673|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090674|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2090675|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2090676|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090677|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090678|NCT02218372|Vancomycin|vancomycin|mesh-list
2090679|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
2090680|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2090681|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090682|NCT02218463|Estradiol|estradiol|mesh-list
2090683|NCT02218463|Estrogens|estrogens|mesh-ancestor
2090684|NCT02218463|Hormones|hormones|mesh-ancestor
2090685|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2090686|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090687|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2090688|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
726530|NCT02902315|Vitamins|vitamins|mesh-list
726531|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
726532|NCT02902315|Tocopherols|tocopherols|mesh-list
726533|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
726534|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
726535|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726536|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
726537|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726538|NCT02902315|Protective Agents|protective agents|mesh-ancestor
726757|NCT02901236|Bevacizumab|bevacizumab|mesh-list
726758|NCT02901236|Mitomycins|mitomycins|mesh-list
726759|NCT02901236|Mitomycin|mitomycin|mesh-list
726760|NCT02901236|Antimetabolites|antimetabolites|mesh-list
726761|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
726762|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726763|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
726764|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
726765|NCT02901236|Growth Substances|growth substances|mesh-ancestor
726766|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726767|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
726768|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
726769|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
726770|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726771|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
726772|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726989|NCT02899507|Amoxicillin|amoxicillin|mesh-list
726990|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
726991|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
726992|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
726993|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
726994|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
726995|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
726996|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726997|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727153|NCT02899078|Nivolumab|nivolumab|mesh-list
727154|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
724053|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724228|NCT02912793|Betadex|betadex|mesh-list
724238|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
724239|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724673|NCT02910882|Gemcitabine|gemcitabine|mesh-list
724674|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
724675|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
724676|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724677|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724678|NCT02910882|Antiviral Agents|antiviral agents|mesh-ancestor
724679|NCT02910882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724680|NCT02910882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724681|NCT02910882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
724682|NCT02910882|Immunologic Factors|immunologic factors|mesh-ancestor
724683|NCT02910882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725440|NCT02907710|Endostar protein|endostar protein|mesh-list
725441|NCT02907710|Endostatins|endostatins|mesh-list
725442|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
725443|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
725444|NCT02907710|Growth Substances|growth substances|mesh-ancestor
725445|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725446|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
725447|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725777|NCT02905760|Furosemide|furosemide|mesh-list
725778|NCT02905760|Diuretics|diuretics|mesh-list
725779|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
725780|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725781|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
725782|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
725783|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232388|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232389|NCT00074607|Antiviral Agents|antiviral agents|mesh-ancestor
2232390|NCT00074607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232391|NCT00074607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232392|NCT00074607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232393|NCT00074607|Immunologic Factors|immunologic factors|mesh-ancestor
2232394|NCT00074607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232395|NCT00074620|Hirudins|hirudins|mesh-list
2232396|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
2232397|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2232398|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
2232399|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232400|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232401|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
2232402|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2232403|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2232404|NCT00074737|Cytarabine|cytarabine|mesh-list
2232405|NCT00074737|Idarubicin|idarubicin|mesh-list
2232406|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232407|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
2232408|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232409|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232410|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
2232411|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232412|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232413|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
2232414|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232415|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2232416|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2232417|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2232418|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232419|NCT00074750|Molgramostim|molgramostim|mesh-list
2232420|NCT00074750|Sargramostim|sargramostim|mesh-list
2232421|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
2232422|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232423|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727732|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
727733|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
727734|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
727735|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727736|NCT02895061|Vitamins|vitamins|mesh-ancestor
727737|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
728099|NCT02893384|Anesthetics|anesthetics|mesh-list
2232424|NCT00074776|Lamotrigine|lamotrigine|mesh-list
2232425|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2232426|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724075|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724076|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724162|NCT02913196|Prednisone|prednisone|mesh-list
724163|NCT02913196|Docetaxel|docetaxel|mesh-list
724164|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
724165|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724166|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
724167|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
724168|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
724169|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724170|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
724171|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
724172|NCT02913196|Hormones|hormones|mesh-ancestor
724173|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
724174|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724175|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
724176|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
724177|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724178|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
724179|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
724243|NCT02912910|Labetalol|labetalol|mesh-list
724244|NCT02912910|Nifedipine|nifedipine|mesh-list
724245|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
724246|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
724247|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724248|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
724249|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724250|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
724251|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
724252|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
724253|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
724254|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
724255|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
724256|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
724257|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
724258|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
724259|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
724260|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724261|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
724262|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
724350|NCT02912169|Anesthetics|anesthetics|mesh-list
724351|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
724352|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232427|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2232428|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2232429|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232430|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
2232431|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2232432|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2232433|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2232434|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2232435|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
725404|NCT02907749|Carvedilol|carvedilol|mesh-list
725405|NCT02907749|Spironolactone|spironolactone|mesh-list
725406|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
725407|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
725408|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
725409|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725410|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
725411|NCT02907749|Diuretics|diuretics|mesh-ancestor
725412|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
725413|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
725414|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
725415|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
725416|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
725417|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725418|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
725419|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
725420|NCT02907749|Protective Agents|protective agents|mesh-ancestor
725421|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
725422|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
725423|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
725424|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
2090692|NCT02218736|Aticaprant|aticaprant|mesh-list
724184|NCT02913118|Amoxicillin|amoxicillin|mesh-list
724185|NCT02913118|Azithromycin|azithromycin|mesh-list
724186|NCT02913118|Doxycycline|doxycycline|mesh-list
724187|NCT02913118|Minocycline|minocycline|mesh-list
724188|NCT02913118|Cephalosporins|cephalosporins|mesh-list
724189|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
724190|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
724191|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724192|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
724193|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
724194|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
724195|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
724196|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724197|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232436|NCT00074828|Enoxaparin|enoxaparin|mesh-list
2232437|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
2232438|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2232439|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2232440|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232441|NCT00074841|Azithromycin|azithromycin|mesh-list
2232442|NCT00074841|Chloroquine|chloroquine|mesh-list
2232443|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2232444|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
2232445|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
2232446|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2232447|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2232448|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232449|NCT00074841|Amebicides|amebicides|mesh-ancestor
2232450|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2232451|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2232452|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
2232453|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232454|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2232455|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2232456|NCT00074841|Analgesics|analgesics|mesh-ancestor
2232457|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
2232458|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232459|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232460|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2232461|NCT00074841|Filaricides|filaricides|mesh-ancestor
2232462|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
2232463|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
2753215|NCT02991599|Vaccines|vaccines|mesh-list
2753216|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
2753217|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753218|NCT02983578|Durvalumab|durvalumab|mesh-list
2753219|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
2753220|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
725784|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
725785|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
725786|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725932|NCT02904564|Fluorouracil|fluorouracil|mesh-list
725933|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
725934|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725935|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
725936|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725937|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
725938|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
725939|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232464|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2232465|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232466|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232467|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2232468|NCT00074841|Renal Agents|renal agents|mesh-ancestor
2232469|NCT00075010|Decitabine|decitabine|mesh-list
2232470|NCT00075010|Valproic Acid|valproic acid|mesh-list
2232471|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232472|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
2232473|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232474|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232475|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232476|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
2232477|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
2753221|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
2753222|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2232478|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2232479|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232480|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
2232481|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2232482|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2232483|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2232484|NCT00075075|Infliximab|infliximab|mesh-list
2232485|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
2232486|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2232487|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232488|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
724263|NCT02912676|Methotrexate|methotrexate|mesh-list
724264|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
724265|NCT02912676|Thioguanine|thioguanine|mesh-list
724266|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
724267|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
724268|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
724269|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724270|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
724271|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
724272|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724273|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724274|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
724275|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724276|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
724277|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
724278|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
724279|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
724280|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
724948|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
724949|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
724950|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725541|NCT02906995|Nicotine|nicotine|mesh-list
725542|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
725543|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
725544|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725545|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725546|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
725547|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
725548|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
725549|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
725550|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726165|NCT02903719|Ropivacaine|ropivacaine|mesh-list
726166|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
726167|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
726168|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
726169|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726170|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
726171|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
726488|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
726489|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
726490|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
726491|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726492|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
726493|NCT02902380|Analgesics|analgesics|mesh-ancestor
726494|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
726495|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
726496|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
726497|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
726498|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
726499|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
726500|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
726501|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726890|NCT02900352|Zonisamide|zonisamide|mesh-list
726891|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
726892|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
726893|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
726894|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726895|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
726896|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232489|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2090693|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
724338|NCT02912156|Voriconazole|voriconazole|mesh-list
724339|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
724340|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724341|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
724342|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
724343|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724344|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724345|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
724346|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
724347|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
724348|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724349|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
725334|NCT02908191|Tenofovir|tenofovir|mesh-list
725335|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
725336|NCT02908191|Entecavir|entecavir|mesh-list
725337|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
725338|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725339|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
725340|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
725341|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725342|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725343|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
725344|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
725427|NCT02907593|Budesonide|budesonide|mesh-list
725428|NCT02907593|Calfactant|calfactant|mesh-list
725429|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
725430|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
725431|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
725432|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725433|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725434|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
725435|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
725436|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
725437|NCT02907593|Hormones|hormones|mesh-ancestor
725438|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
725439|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
725627|NCT02906059|Irinotecan|irinotecan|mesh-list
725628|NCT02906059|Adavosertib|adavosertib|mesh-list
725629|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
725630|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
725631|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725632|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725633|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726554|NCT02902133|Acetazolamide|acetazolamide|mesh-list
726555|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
726556|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
726557|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726558|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726559|NCT02902133|Diuretics|diuretics|mesh-ancestor
726560|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
726561|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726852|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
726853|NCT02900560|Azacitidine|azacitidine|mesh-list
726854|NCT02900560|Cc-486|cc-486|mesh-list
726855|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
726856|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726857|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
726858|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
726859|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726860|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727163|NCT02898571|Ascorbic Acid|ascorbic acid|mesh-list
727164|NCT02898571|Vitamins|vitamins|mesh-ancestor
727165|NCT02898571|Micronutrients|micronutrients|mesh-ancestor
727166|NCT02898571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727167|NCT02898571|Antioxidants|antioxidants|mesh-ancestor
727168|NCT02898571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727169|NCT02898571|Protective Agents|protective agents|mesh-ancestor
727433|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
727434|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
727435|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727436|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
727437|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
727438|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090694|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724199|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724200|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
724201|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
724202|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724203|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724204|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
724205|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
724206|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
724207|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724330|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
724331|NCT02912494|Hematinics|hematinics|mesh-ancestor
2232490|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232491|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232492|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
2232493|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2232494|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232495|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2232496|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
2232497|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232498|NCT00075192|Leuprolide|leuprolide|mesh-list
2232499|NCT00075192|Bicalutamide|bicalutamide|mesh-list
2232500|NCT00075192|Tremelimumab|tremelimumab|mesh-list
724726|NCT02910583|Venetoclax|venetoclax|mesh-list
724727|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232501|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2232502|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
2232503|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2232504|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725138|NCT02908945|Ketamine|ketamine|mesh-list
725139|NCT02908945|Analgesics|analgesics|mesh-ancestor
725140|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
725141|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725142|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725143|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
725144|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
725145|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
725146|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
725147|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
725148|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
725149|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
725150|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
725151|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725220|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
725221|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
725222|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
725223|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725479|NCT02907307|Clotrimazole|clotrimazole|mesh-list
725480|NCT02907307|Miconazole|miconazole|mesh-list
725481|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
725482|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725483|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
725484|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
725485|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
725486|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725487|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725488|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
725489|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
725490|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
725491|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725492|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
725493|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
725583|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
725584|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
725585|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
725940|NCT02904499|Dabigatran|dabigatran|mesh-list
725941|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
725942|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
725943|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
725944|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725945|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725946|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
726148|NCT02903680|Dexamethasone|dexamethasone|mesh-list
726149|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
726150|NCT02903680|BB 1101|bb 1101|mesh-list
724212|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724213|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
724214|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
724215|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
724216|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232505|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2232506|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232507|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
2232508|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
2232509|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2232510|NCT00075205|Rimonabant|rimonabant|mesh-list
2232511|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2232512|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2232513|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2232514|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2232515|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232516|NCT00075205|Hormones|hormones|mesh-ancestor
2232517|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2232518|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232519|NCT00075231|Ritonavir|ritonavir|mesh-list
2232520|NCT00075231|Lopinavir|lopinavir|mesh-list
725210|NCT02908438|Hormones|hormones|mesh-list
725211|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
725212|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090695|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
2090696|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090697|NCT02219009|Aripiprazole|aripiprazole|mesh-list
2090698|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
2090699|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2090700|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2090701|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2090702|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090703|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090704|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
2090705|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
2090706|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090707|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090708|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2090709|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2090710|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
725615|NCT02906150|Cisplatin|cisplatin|mesh-list
725616|NCT02906150|Carboplatin|carboplatin|mesh-list
725617|NCT02906150|Pemetrexed|pemetrexed|mesh-list
725618|NCT02906150|Thymalfasin|thymalfasin|mesh-list
725619|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725620|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725621|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725622|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
725623|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
725624|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
725625|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
725626|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232521|NCT00075231|Lamivudine|lamivudine|mesh-list
2232522|NCT00075231|Zidovudine|zidovudine|mesh-list
2232523|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2232524|NCT00075231|Efavirenz|efavirenz|mesh-list
2090711|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2090712|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2090713|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2232525|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2232526|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2232527|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
2232528|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232529|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232530|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
728119|NCT02893254|Adalimumab|adalimumab|mesh-list
728120|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
728121|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
728286|NCT02892591|Oxycodone|oxycodone|mesh-list
728287|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
728288|NCT02892591|Narcotics|narcotics|mesh-ancestor
728289|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
728290|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728291|NCT02892591|Analgesics|analgesics|mesh-ancestor
724286|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
724287|NCT02912702|Pegaspargase|pegaspargase|mesh-list
724288|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
724289|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
724290|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
724291|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724292|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724293|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
724294|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
724295|NCT02912702|Hormones|hormones|mesh-ancestor
724296|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
724297|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
724298|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724299|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
724300|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
724301|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
724302|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724303|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724304|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
724305|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
724306|NCT02912702|Protective Agents|protective agents|mesh-ancestor
724481|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
724482|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
724483|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
724484|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724485|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
724486|NCT02911831|Coagulants|coagulants|mesh-ancestor
724700|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
724701|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
724702|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724703|NCT02910531|Protective Agents|protective agents|mesh-ancestor
724704|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724705|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
724706|NCT02910531|Vitamins|vitamins|mesh-ancestor
724707|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
724768|NCT02910115|Oxytocin|oxytocin|mesh-list
724769|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
724770|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
724771|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724951|NCT02909257|Bupivacaine|bupivacaine|mesh-list
724952|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
724953|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
724954|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
724955|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724956|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
724957|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725233|NCT02908698|Prednisone|prednisone|mesh-list
725234|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
725235|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
725236|NCT02908698|Hormones|hormones|mesh-ancestor
725237|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
725238|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725239|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
725240|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725657|NCT02905994|Cytarabine|cytarabine|mesh-list
725658|NCT02905994|Idarubicin|idarubicin|mesh-list
725659|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
725660|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
725661|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725662|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725663|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
725664|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725665|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
725666|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
725667|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725668|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
725669|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
725670|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
725671|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753223|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753224|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
2753225|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753226|NCT02970500|Methylphenidate|methylphenidate|mesh-list
2753227|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
725959|NCT02904369|Tenofovir|tenofovir|mesh-list
725960|NCT02904369|Emtricitabine|emtricitabine|mesh-list
724378|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
724379|NCT02912182|Betamethasone|betamethasone|mesh-list
724380|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
724381|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
724382|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
724383|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
724384|NCT02912182|Hormones|hormones|mesh-ancestor
724385|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
724386|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724387|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
724388|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724389|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
724390|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
724391|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724392|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
724393|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
724394|NCT02912182|Protective Agents|protective agents|mesh-ancestor
724395|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
724396|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
724459|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
724460|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
724461|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724462|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
724463|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
724464|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724465|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724466|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725195|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
725196|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2232531|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2232532|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
2232533|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725716|NCT02905799|Resveratrol|resveratrol|mesh-list
725717|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
725718|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725719|NCT02905799|Protective Agents|protective agents|mesh-ancestor
725720|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725721|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725722|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
725801|NCT02905305|Dexamethasone|dexamethasone|mesh-list
725802|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
725803|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
725804|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
725805|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725806|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725807|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
725808|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
725809|NCT02905305|Hormones|hormones|mesh-ancestor
725810|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
725811|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
725812|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232534|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2232535|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2232536|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2232537|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2232538|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
2232539|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2232540|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2232541|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2232542|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2232543|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2232544|NCT00075374|Docetaxel|docetaxel|mesh-list
2232545|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726344|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
726345|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
726346|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
726347|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726348|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
726349|NCT02903017|Coagulants|coagulants|mesh-ancestor
726562|NCT02902029|Atezolizumab|atezolizumab|mesh-list
726563|NCT02902029|Vemurafenib|vemurafenib|mesh-list
726564|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726565|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
726566|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726617|NCT02902198|Analgesics|analgesics|mesh-ancestor
2232546|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
2232547|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
2232548|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
2232549|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232550|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
2232551|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
2232552|NCT00075387|Carboplatin|carboplatin|mesh-list
2232553|NCT00075387|Etoposide|etoposide|mesh-list
2232554|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
2232555|NCT00075387|Antidotes|antidotes|mesh-list
2232556|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232557|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
2232558|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232559|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232560|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2232561|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
724538|NCT02911597|Naltrexone|naltrexone|mesh-list
724539|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
724540|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
724541|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724542|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
724543|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724571|NCT02911298|Metronidazole|metronidazole|mesh-list
724572|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
724573|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
724574|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
724575|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2090714|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2090715|NCT02219087|Bupivacaine|bupivacaine|mesh-list
2090716|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
2090717|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
2090718|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090719|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090720|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
2090721|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090722|NCT02219321|Lidocaine|lidocaine|mesh-list
2090723|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
2090724|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
2090725|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090726|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090727|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
2090728|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090729|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2090730|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2090731|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2090732|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2090733|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090734|NCT02219477|Ritonavir|ritonavir|mesh-list
2090735|NCT02219477|Ribavirin|ribavirin|mesh-list
2090736|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2090737|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2090738|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
2090739|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090740|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090741|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2090742|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2090743|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
2090744|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090745|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2232562|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725094|NCT02909361|Fulvestrant|fulvestrant|mesh-list
725095|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
725096|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725097|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
725098|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
725099|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
725100|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
725101|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232563|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232564|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2232565|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2232566|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2232567|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2232568|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724505|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724506|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
724507|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232569|NCT00075387|Protective Agents|protective agents|mesh-ancestor
2232570|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
2232571|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
2232572|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2232573|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232574|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
2232575|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
2232576|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
2232577|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232578|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
2232579|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232580|NCT00075439|Gefitinib|gefitinib|mesh-list
724686|NCT02910765|Methylene Blue|methylene blue|mesh-list
724687|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724688|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725029|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
725030|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
725031|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725032|NCT02909400|Protective Agents|protective agents|mesh-ancestor
725033|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725285|NCT02908334|Sertraline|sertraline|mesh-list
725286|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
725287|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
725288|NCT02908334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
725289|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
725290|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
725291|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725292|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
725293|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
725294|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232581|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232582|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2232583|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232584|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232585|NCT00075452|Gemcitabine|gemcitabine|mesh-list
2232586|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
2232587|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232588|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
2232589|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232590|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232591|NCT00075452|Antiviral Agents|antiviral agents|mesh-ancestor
2232592|NCT00075452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232593|NCT00075452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232594|NCT00075452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232595|NCT00075452|Immunologic Factors|immunologic factors|mesh-ancestor
2232596|NCT00075452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232597|NCT00075465|Docetaxel|docetaxel|mesh-list
2232598|NCT00075465|Epirubicin|epirubicin|mesh-list
726358|NCT02902666|Acetaminophen|acetaminophen|mesh-list
726359|NCT02902666|Codeine|codeine|mesh-list
726360|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
726361|NCT02902666|Analgesics|analgesics|mesh-ancestor
726362|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
726363|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
726364|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726365|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
726366|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
726367|NCT02902666|Narcotics|narcotics|mesh-ancestor
726368|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
726369|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
726370|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
726607|NCT02902198|Quinine|quinine|mesh-list
726608|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
726609|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
726610|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
726611|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
726612|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
726613|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726614|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
726615|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
726616|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2232599|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232600|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
2232601|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
2232602|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
724657|NCT02910778|Ticagrelor|ticagrelor|mesh-list
724658|NCT02910778|Atorvastatin|atorvastatin|mesh-list
724659|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
724660|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
724661|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
724662|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724663|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
724664|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
724665|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724666|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
724667|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
724668|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
724669|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
724670|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
724671|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
724672|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724843|NCT02909933|Metformin|metformin|mesh-list
724844|NCT02909933|Liraglutide|liraglutide|mesh-list
724845|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
724846|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724847|NCT02909933|Incretins|incretins|mesh-ancestor
724848|NCT02909933|Hormones|hormones|mesh-ancestor
724849|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2090746|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2090747|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
2090748|NCT02219503|Ritonavir|ritonavir|mesh-list
2090749|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2090750|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2090751|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
2090752|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090753|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090754|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2090755|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2090756|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
2090757|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090758|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2090759|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2090760|NCT02219516|Verinurad|verinurad|mesh-list
2090761|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
2090762|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2090763|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
2090764|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
725298|NCT02908165|Sorafenib|sorafenib|mesh-list
725299|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
725300|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725301|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
725302|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725303|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725304|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
725305|NCT02908165|Estrogens|estrogens|mesh-ancestor
725306|NCT02908165|Hormones|hormones|mesh-ancestor
725307|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
725308|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725309|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
725363|NCT02907957|Anesthetics|anesthetics|mesh-list
725364|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
725365|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725728|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
725729|NCT02905591|Paclitaxel|paclitaxel|mesh-list
725730|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
725731|NCT02905591|Carboplatin|carboplatin|mesh-list
725732|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
725733|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725734|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
725735|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
725736|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
725737|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725738|NCT02905591|Vitamins|vitamins|mesh-ancestor
725739|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
725740|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725741|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
725742|NCT02905591|Protective Agents|protective agents|mesh-ancestor
2232603|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232604|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2232605|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2232606|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2232607|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232608|NCT00075491|Fenretinide|fenretinide|mesh-list
2232609|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725634|NCT02906176|Voriconazole|voriconazole|mesh-list
725635|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
725636|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725637|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
725638|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
725639|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725640|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725641|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
725642|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
725643|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
725644|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725645|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
726350|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
726351|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
726475|NCT02902432|Endostar protein|endostar protein|mesh-list
726476|NCT02902432|Endostatins|endostatins|mesh-list
726477|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
726478|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
726479|NCT02902432|Growth Substances|growth substances|mesh-ancestor
726480|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726481|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
726482|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726568|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
726569|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
726570|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232610|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2232611|NCT00075491|Protective Agents|protective agents|mesh-ancestor
2232612|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232613|NCT00075517|Gemcitabine|gemcitabine|mesh-list
2232614|NCT00075517|Docetaxel|docetaxel|mesh-list
2232615|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232616|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
2232617|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232618|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232619|NCT00075517|Antiviral Agents|antiviral agents|mesh-ancestor
2232620|NCT00075517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232621|NCT00075517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232622|NCT00075517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232623|NCT00075517|Immunologic Factors|immunologic factors|mesh-ancestor
2232624|NCT00075517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232625|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
2232626|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
2232627|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
2232628|NCT00075543|Docetaxel|docetaxel|mesh-list
2232629|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
2232630|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727303|NCT02897557|Pancrelipase|pancrelipase|mesh-list
727304|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
727709|NCT02895529|Itraconazole|itraconazole|mesh-list
727710|NCT02895529|Caspofungin|caspofungin|mesh-list
727711|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
727712|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727713|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
727714|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
727715|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727716|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727717|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
727718|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
727719|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
727720|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727721|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2232631|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
2232632|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
724806|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
724807|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725161|NCT02909088|Ecopipam|ecopipam|mesh-list
725162|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
725163|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
725164|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
725165|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725166|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
725167|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
725168|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
725169|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
725170|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726298|NCT02902861|Methotrexate|methotrexate|mesh-list
726299|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
726300|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
726301|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
726302|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726303|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
726304|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
726305|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726306|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726307|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
726308|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726309|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
726310|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
726311|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
726312|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
726313|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
726571|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
726572|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
726573|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
726574|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726750|NCT02901041|Zonisamide|zonisamide|mesh-list
726751|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
726752|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
726753|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
726754|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726755|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
726756|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726929|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
726930|NCT02900430|Clotrimazole|clotrimazole|mesh-list
726931|NCT02900430|Miconazole|miconazole|mesh-list
726932|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
726933|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
726934|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
726935|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
726936|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726937|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726938|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
726939|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
726940|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
726941|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726942|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
726943|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
726975|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
726976|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
726977|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727145|NCT02898792|Remifentanil|remifentanil|mesh-list
727146|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
727147|NCT02898792|Narcotics|narcotics|mesh-ancestor
727148|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
727149|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727150|NCT02898792|Analgesics|analgesics|mesh-ancestor
727151|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
727152|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727557|NCT02896582|Cytarabine|cytarabine|mesh-list
727558|NCT02896582|Dexamethasone|dexamethasone|mesh-list
727559|NCT02896582|Etoposide|etoposide|mesh-list
727560|NCT02896582|Melphalan|melphalan|mesh-list
727561|NCT02896582|Cisplatin|cisplatin|mesh-list
727562|NCT02896582|Carmustine|carmustine|mesh-list
727563|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
727564|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
727565|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
727566|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
724905|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
724906|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
724907|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724908|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
724909|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
724910|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
724911|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
724912|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
724913|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
724914|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
724915|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
724916|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
724917|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
724918|NCT02909751|Protective Agents|protective agents|mesh-ancestor
724919|NCT02909751|Vitamins|vitamins|mesh-ancestor
724920|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
2232633|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
2232634|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232635|NCT00075556|Capecitabine|capecitabine|mesh-list
2232636|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232637|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
2232638|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232639|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232640|NCT00075595|Leucovorin|leucovorin|mesh-list
2232641|NCT00075595|Fluorouracil|fluorouracil|mesh-list
2232642|NCT00075595|Irinotecan|irinotecan|mesh-list
2232643|NCT00075595|Calcium|calcium|mesh-list
2232644|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
2232645|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2232646|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232647|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
2232648|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725538|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
725539|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
725540|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725693|NCT02905864|Liraglutide|liraglutide|mesh-list
725694|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
725695|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725696|NCT02905864|Incretins|incretins|mesh-ancestor
725697|NCT02905864|Hormones|hormones|mesh-ancestor
725698|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
725723|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
725724|NCT02905539|Hematinics|hematinics|mesh-ancestor
725831|NCT02905058|Ketoprofen|ketoprofen|mesh-list
725832|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
725833|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
725834|NCT02905058|Analgesics|analgesics|mesh-ancestor
725835|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
725836|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725837|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725838|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
725839|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
725840|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
725841|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725842|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726008|NCT02904304|Ibuprofen|ibuprofen|mesh-list
726009|NCT02904304|Phenylephrine|phenylephrine|mesh-list
726010|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
726011|NCT02904304|Desloratadine|desloratadine|mesh-list
726012|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
726013|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
726014|NCT02904304|Analgesics|analgesics|mesh-ancestor
726015|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
726016|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
726017|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726018|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
726019|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
726020|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
726021|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726022|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726023|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
726024|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
726025|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
726026|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
726027|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2232649|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
724962|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
724963|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
724964|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724965|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724966|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
724967|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
724968|NCT02909478|Hormones|hormones|mesh-ancestor
724969|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
724970|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
724971|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
724972|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
724973|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
724974|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
724975|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
724976|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
724977|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
2090765|NCT02219685|Ledipasvir|ledipasvir|mesh-list
2090766|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
2090767|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090768|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
2232650|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232651|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232652|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
2232653|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2232654|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2232655|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232656|NCT00075595|Antidotes|antidotes|mesh-ancestor
2232657|NCT00075595|Protective Agents|protective agents|mesh-ancestor
2232658|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
2232659|NCT00075595|Vitamins|vitamins|mesh-ancestor
725676|NCT02906163|Gefitinib|gefitinib|mesh-list
725677|NCT02906163|Afatinib|afatinib|mesh-list
725678|NCT02906163|Thymalfasin|thymalfasin|mesh-list
725679|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725680|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
725681|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725682|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725683|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
725684|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
725685|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232660|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
2232661|NCT00075621|Melphalan|melphalan|mesh-list
2232662|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
2232663|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232664|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2232665|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
2232666|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232667|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232668|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2232669|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232670|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
2232671|NCT00075634|Doxorubicin|doxorubicin|mesh-list
2232672|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2232673|NCT00075634|Decitabine|decitabine|mesh-list
726454|NCT02902302|Ibuprofen|ibuprofen|mesh-list
726455|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
726456|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
726457|NCT02902302|Analgesics|analgesics|mesh-ancestor
726458|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
726459|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
726460|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726461|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
726462|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
726463|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
726464|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726465|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726628|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
726629|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
726630|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
726631|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
726632|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
726633|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
726634|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726712|NCT02901184|Spironolactone|spironolactone|mesh-list
2232674|NCT00075634|Azacitidine|azacitidine|mesh-list
2232675|NCT00075634|Lenograstim|lenograstim|mesh-list
724982|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
724983|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
724984|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
724985|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
724986|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
724987|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
724988|NCT02909322|Narcotics|narcotics|mesh-ancestor
724989|NCT02909322|Analgesics|analgesics|mesh-ancestor
2090769|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2090770|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2090771|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090772|NCT02219997|Methamphetamine|methamphetamine|mesh-list
2090773|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
2090774|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2090775|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2090776|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2090777|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725330|NCT02908126|Oxytocin|oxytocin|mesh-list
725331|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
725332|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
725333|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725460|NCT02907632|Metoclopramide|metoclopramide|mesh-list
725461|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
725462|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
725463|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725464|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725465|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
725466|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
725467|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
725468|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
725469|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
725470|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232676|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232677|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
2232678|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232679|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232680|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2232681|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
2232682|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232683|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232684|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2232685|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2232686|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2232687|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
725743|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
725744|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
725745|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090778|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
2090779|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
2090780|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090781|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
2090782|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090783|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727484|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
727485|NCT02897050|Docetaxel|docetaxel|mesh-list
727486|NCT02897050|Fluorouracil|fluorouracil|mesh-list
727487|NCT02897050|Capecitabine|capecitabine|mesh-list
727488|NCT02897050|Epirubicin|epirubicin|mesh-list
727489|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
727490|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
727491|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727492|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
727493|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
727494|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
727495|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727496|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727497|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
727498|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
727499|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
727500|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
727501|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
727502|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
727503|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
727504|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
725008|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
725009|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
725010|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
725011|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
725012|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
725013|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
725014|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725015|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
725016|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
725017|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
725018|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
725019|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
725020|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
725021|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
725022|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
725023|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
725024|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
725025|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
725026|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
725027|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
725028|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
725379|NCT02908035|Sirolimus|sirolimus|mesh-list
725380|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
725381|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725382|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
725383|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725384|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
725385|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
725386|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
725387|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725448|NCT02907554|Cyclosporine|cyclosporine|mesh-list
725449|NCT02907554|Cyclosporins|cyclosporins|mesh-list
725450|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725451|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725452|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
725453|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
725454|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725455|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
725456|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725457|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
725458|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
725459|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
725586|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
725587|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
2232688|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232689|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2232690|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232691|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
2232692|NCT00075647|Sirolimus|sirolimus|mesh-list
2232693|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2232694|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232695|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2232696|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232697|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
2232698|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232699|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
2232700|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232701|NCT00075673|Celecoxib|celecoxib|mesh-list
2232702|NCT00075673|Vinorelbine|vinorelbine|mesh-list
2232703|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2232704|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2232705|NCT00075673|Analgesics|analgesics|mesh-ancestor
2232706|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
2232707|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232708|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232709|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2232710|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232711|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2232712|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2232713|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726400|NCT02903069|Temozolomide|temozolomide|mesh-list
726401|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
726402|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
726403|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726404|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726887|NCT02900209|Vaccines|vaccines|mesh-list
726888|NCT02900209|Immunologic Factors|immunologic factors|mesh-ancestor
725058|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725059|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
725060|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725061|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
725062|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
725063|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
725064|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725065|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725066|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
725067|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
725068|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
725069|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
725070|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725071|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
725072|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
725073|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725074|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
725075|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
725076|NCT02909335|Protective Agents|protective agents|mesh-ancestor
725310|NCT02908295|Misoprostol|misoprostol|mesh-list
725311|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
725312|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
725313|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
725314|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725315|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
725316|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
725317|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
2232714|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232715|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2232716|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232717|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
2232718|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
2232719|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
2232720|NCT00075686|Gemcitabine|gemcitabine|mesh-list
2232721|NCT00075686|Cetuximab|cetuximab|mesh-list
2232722|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232723|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
2232724|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232725|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232726|NCT00075686|Antiviral Agents|antiviral agents|mesh-ancestor
2232727|NCT00075686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232728|NCT00075686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232729|NCT00075686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
725513|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
725514|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
725515|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
725516|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
725517|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725518|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725712|NCT02905708|Charcoal|charcoal|mesh-list
725713|NCT02905708|Antidotes|antidotes|mesh-ancestor
725714|NCT02905708|Protective Agents|protective agents|mesh-ancestor
725715|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090784|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
2090785|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2090786|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2090787|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2090788|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2090789|NCT02219997|Hormones|hormones|mesh-ancestor
2090790|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2090791|NCT02220712|Aripiprazole|aripiprazole|mesh-list
2090792|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
2090793|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2090794|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2090795|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2090796|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090797|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090798|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
2090799|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
2090800|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090801|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090802|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2232730|NCT00075686|Immunologic Factors|immunologic factors|mesh-ancestor
726050|NCT02904031|Leucovorin|leucovorin|mesh-list
2232731|NCT00075686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232732|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2232733|NCT00075699|Vincristine|vincristine|mesh-list
2232734|NCT00075699|Vinorelbine|vinorelbine|mesh-list
2232735|NCT00075699|Mitomycins|mitomycins|mesh-list
2232736|NCT00075699|Mitomycin|mitomycin|mesh-list
2232737|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232738|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2232739|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
2232740|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
2232741|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
2232742|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725295|NCT02908282|Povidone|povidone|mesh-list
725296|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
725297|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
725473|NCT02907437|Minocycline|minocycline|mesh-list
725474|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
725475|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232743|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2232744|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
2232745|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2232746|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232747|NCT00075712|Paclitaxel|paclitaxel|mesh-list
2232748|NCT00075712|Carboplatin|carboplatin|mesh-list
2232749|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2753228|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725746|NCT02905734|Nicotine|nicotine|mesh-list
725747|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
725748|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
725749|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725750|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725751|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
725752|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
725753|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
725754|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
725755|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090803|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2090804|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
2090805|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
726650|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
726651|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
726652|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726720|NCT02901067|Aspirin|aspirin|mesh-list
726721|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
726722|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
726723|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
726724|NCT02901067|Analgesics|analgesics|mesh-ancestor
726725|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
726726|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
726727|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726728|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
726729|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
726730|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
726731|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
726732|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726733|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
726734|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
726735|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726736|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
726737|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
726738|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
726739|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
726740|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
726741|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
727408|NCT02897375|Carboplatin|carboplatin|mesh-list
727409|NCT02897375|Palbociclib|palbociclib|mesh-list
727410|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727411|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
727412|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727413|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090806|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2090807|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2090808|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2753229|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
727738|NCT02895191|Urinastatin|urinastatin|mesh-list
725197|NCT02908581|Folic Acid|folic acid|mesh-list
725198|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
725199|NCT02908581|Hematinics|hematinics|mesh-ancestor
725200|NCT02908581|Vitamins|vitamins|mesh-ancestor
725201|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
725202|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725471|NCT02907359|Guadecitabine|guadecitabine|mesh-list
725472|NCT02907359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725646|NCT02905890|Norethindrone|norethindrone|mesh-list
725647|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
725648|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
725649|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
725650|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
725651|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
725652|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
725653|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
725654|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725655|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
725656|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2232750|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232751|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
2232752|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
2232753|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
2232754|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232755|NCT00075738|Leucovorin|leucovorin|mesh-list
726669|NCT02901379|Atorvastatin|atorvastatin|mesh-list
726670|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
726671|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
726672|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
726673|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726674|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
726675|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
726676|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726836|NCT02900729|Losartan|losartan|mesh-list
726837|NCT02900729|Amlodipine|amlodipine|mesh-list
726838|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
726839|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
726840|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
726841|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
726842|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726843|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
726844|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726845|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
726846|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
726847|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
726848|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
726849|NCT02900729|Diuretics|diuretics|mesh-ancestor
726850|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
726851|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2232756|NCT00075738|Fluorouracil|fluorouracil|mesh-list
2232757|NCT00075738|Irinotecan|irinotecan|mesh-list
2232758|NCT00075738|Calcium|calcium|mesh-list
2232759|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
2232760|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232761|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2232762|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232763|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
2232764|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232765|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232766|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232767|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
2232768|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2232769|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2232770|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232771|NCT00075738|Antidotes|antidotes|mesh-ancestor
2232772|NCT00075738|Protective Agents|protective agents|mesh-ancestor
2232773|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
2232774|NCT00075738|Vitamins|vitamins|mesh-ancestor
2232775|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
2232776|NCT00075751|Gemcitabine|gemcitabine|mesh-list
725329|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232777|NCT00075751|Carboplatin|carboplatin|mesh-list
2232778|NCT00075751|Bortezomib|bortezomib|mesh-list
2232779|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232780|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232781|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
2232782|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232783|NCT00075751|Antiviral Agents|antiviral agents|mesh-ancestor
2232784|NCT00075751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232785|NCT00075751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232786|NCT00075751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
725535|NCT02906722|Colistin|colistin|mesh-list
725536|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
725537|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725608|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
725609|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725699|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
725700|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
725701|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
725702|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
725703|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725704|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
725705|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725725|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
725726|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
725727|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725824|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
725825|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
725826|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
725827|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
725828|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
725829|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725830|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725884|NCT02904772|Cyclosporine|cyclosporine|mesh-list
725885|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
725886|NCT02904772|Prednisolone|prednisolone|mesh-list
725887|NCT02904772|Cyclosporins|cyclosporins|mesh-list
725888|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725889|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725890|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
725891|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
725892|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725893|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
725894|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725895|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
725896|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
725897|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
725898|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
725899|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725900|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
725901|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
725902|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
725903|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
725904|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
725905|NCT02904772|Hormones|hormones|mesh-ancestor
725906|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
725907|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2232787|NCT00075751|Immunologic Factors|immunologic factors|mesh-ancestor
2753230|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2753231|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2753232|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725756|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
725757|NCT02905578|Gemcitabine|gemcitabine|mesh-list
725758|NCT02905578|Paclitaxel|paclitaxel|mesh-list
725759|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
725760|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
725761|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
725762|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
725763|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
725764|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725765|NCT02905578|Vitamins|vitamins|mesh-ancestor
725766|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
725767|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725768|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
725769|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
725770|NCT02905578|Antiviral Agents|antiviral agents|mesh-ancestor
725771|NCT02905578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725772|NCT02905578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725773|NCT02905578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
725774|NCT02905578|Immunologic Factors|immunologic factors|mesh-ancestor
725775|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
725776|NCT02905578|Protective Agents|protective agents|mesh-ancestor
2232788|NCT00075751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232789|NCT00075777|Valproic Acid|valproic acid|mesh-list
2232790|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
2232791|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232792|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232793|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
2232794|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
726944|NCT02900105|Letrozole|letrozole|mesh-list
726945|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726946|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
726947|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
726948|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726949|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726950|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
726951|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
726952|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
726953|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727025|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
727026|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
727027|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
727028|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
727029|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
727030|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727031|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
727032|NCT02899182|Analgesics|analgesics|mesh-ancestor
727033|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
727034|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727625|NCT02896270|Valproic Acid|valproic acid|mesh-list
727626|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
727627|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727628|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727629|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
727630|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
727631|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727632|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
727633|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
727634|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
727635|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
727844|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
727845|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
727846|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727855|NCT02894554|Lamivudine|lamivudine|mesh-list
727856|NCT02894554|Telbivudine|telbivudine|mesh-list
727857|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
727858|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
727859|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727860|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725425|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
725426|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2232795|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232796|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
2232797|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2232798|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2232799|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
726414|NCT02902640|Trimethoprim|trimethoprim|mesh-list
726415|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
726416|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
726417|NCT02902640|Guaifenesin|guaifenesin|mesh-list
726418|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
726419|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
726420|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
726421|NCT02902640|Renal Agents|renal agents|mesh-ancestor
726422|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
726423|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
726424|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
726425|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
726426|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726427|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726428|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
726429|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
726430|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
726431|NCT02902640|Expectorants|expectorants|mesh-ancestor
726432|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
726433|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
726434|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
726435|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
726436|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
726437|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726438|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
726439|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
726440|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
726441|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
726442|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
726443|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
726444|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
726539|NCT02902289|Ibuprofen|ibuprofen|mesh-list
726540|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
726541|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
726542|NCT02902289|Analgesics|analgesics|mesh-ancestor
726543|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
726544|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
726545|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726546|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
726547|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
726548|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
726549|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726550|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726879|NCT02900664|Trametinib|trametinib|mesh-list
726880|NCT02900664|Spartalizumab|spartalizumab|mesh-list
726881|NCT02900664|Nazartinib|nazartinib|mesh-list
726882|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726883|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
726884|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726885|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726886|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
727675|NCT02896023|Menotropins|menotropins|mesh-list
727676|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
727677|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
727678|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
727679|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232800|NCT00075855|Testosterone|testosterone|mesh-list
2232801|NCT00075855|Androgens|androgens|mesh-ancestor
2232802|NCT00075855|Hormones|hormones|mesh-ancestor
2232803|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2232804|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232805|NCT00075868|Octreotide|octreotide|mesh-list
725854|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725908|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
725909|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
725910|NCT02904759|Coagulants|coagulants|mesh-ancestor
725911|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
725912|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
725913|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726042|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
726043|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
726044|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
726045|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
726046|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726047|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
726048|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
726049|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
726483|NCT02902484|Nintedanib|nintedanib|mesh-list
726484|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726485|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
726486|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726487|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726792|NCT02901288|Levofloxacin|levofloxacin|mesh-list
726793|NCT02901288|Ofloxacin|ofloxacin|mesh-list
726794|NCT02901288|Rifampin|rifampin|mesh-list
726795|NCT02901288|Isoniazid|isoniazid|mesh-list
726796|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
726797|NCT02901288|Ethambutol|ethambutol|mesh-list
726798|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
726799|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
726800|NCT02901288|Renal Agents|renal agents|mesh-ancestor
726801|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
726802|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
726803|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
726804|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726805|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726806|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726807|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
726808|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
726809|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
726810|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
726811|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
726812|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
726813|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
726814|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
726815|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
726816|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
726817|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
726818|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
726819|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
726820|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
726821|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
726822|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
727135|NCT02899026|Prednisone|prednisone|mesh-list
727136|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
727137|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
727138|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
727139|NCT02899026|Hormones|hormones|mesh-ancestor
727140|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
727141|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725948|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
725949|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
725950|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
725951|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
725952|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725953|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
725954|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
725955|NCT02904538|Hormones|hormones|mesh-ancestor
725956|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
725957|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
725958|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232806|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2232807|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2232808|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232809|NCT00075894|Alanosine|alanosine|mesh-list
2232810|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2232811|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232812|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
2232813|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
2232814|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726664|NCT02901366|Dotinurad|dotinurad|mesh-list
726665|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
726666|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
726667|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
726668|NCT02901366|Renal Agents|renal agents|mesh-ancestor
2232815|NCT00075907|Ritonavir|ritonavir|mesh-list
2232816|NCT00075907|Lopinavir|lopinavir|mesh-list
2232817|NCT00075907|Efavirenz|efavirenz|mesh-list
2232818|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2232819|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2232820|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
2232821|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232822|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232823|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2232824|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2232825|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
727636|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
727637|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
727638|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727639|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
727640|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
727641|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
727642|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727643|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727644|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729282|NCT02887625|Insulin|insulin|mesh-list
729283|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
729284|NCT02887625|Pioglitazone|pioglitazone|mesh-list
729285|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
729286|NCT02887625|Exenatide|exenatide|mesh-list
729287|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
729288|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729289|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
729290|NCT02887625|Incretins|incretins|mesh-ancestor
729291|NCT02887625|Hormones|hormones|mesh-ancestor
729292|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
730299|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
730300|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
730301|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730505|NCT02880085|Lidocaine|lidocaine|mesh-list
730506|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
730507|NCT02880085|Anesthetics|anesthetics|mesh-list
730508|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
730509|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730510|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
730511|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730512|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
730513|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
730514|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
730515|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
730516|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731174|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
2232826|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725961|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
725962|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
725963|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
725964|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
725965|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
725966|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725967|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
725968|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
726068|NCT02903901|Melatonin|melatonin|mesh-list
726069|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
726070|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726071|NCT02903901|Protective Agents|protective agents|mesh-ancestor
726072|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726073|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2232827|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2232828|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2232829|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2232830|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2232831|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2232832|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2232833|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2232834|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2232835|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2232836|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
2232837|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232838|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2232839|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2232840|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232841|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232842|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
2232843|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
2232844|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
2232845|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232846|NCT00075959|Protective Agents|protective agents|mesh-ancestor
726900|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
726901|NCT02900443|Azathioprine|azathioprine|mesh-list
726902|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
726903|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726904|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
726905|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
726906|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
726907|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
726908|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726909|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726910|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
726911|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
726912|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
726913|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
726914|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726915|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
727014|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
727015|NCT02899364|Antidotes|antidotes|mesh-ancestor
727016|NCT02899364|Protective Agents|protective agents|mesh-ancestor
727017|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727018|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
727019|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727020|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
727021|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
727022|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727023|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
727024|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
727294|NCT02897778|Entinostat|entinostat|mesh-list
727295|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727296|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
727297|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727298|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728300|NCT02892357|Omeprazole|omeprazole|mesh-list
728301|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
728302|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
728303|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
728304|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728305|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
725974|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
725975|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
725976|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
726123|NCT02903498|Tegafur|tegafur|mesh-list
726124|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
726125|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
726126|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726127|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726742|NCT02901301|Capecitabine|capecitabine|mesh-list
726743|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
726744|NCT02901301|Trastuzumab|trastuzumab|mesh-list
726745|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726746|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
726747|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
726748|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726749|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
726861|NCT02900742|Gemcitabine|gemcitabine|mesh-list
726862|NCT02900742|Docetaxel|docetaxel|mesh-list
726863|NCT02900742|Pemetrexed|pemetrexed|mesh-list
726864|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
726865|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
726866|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726867|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726868|NCT02900742|Antiviral Agents|antiviral agents|mesh-ancestor
726869|NCT02900742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
726870|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726871|NCT02900742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
726872|NCT02900742|Immunologic Factors|immunologic factors|mesh-ancestor
726873|NCT02900742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726874|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
726875|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
726876|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
726877|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
726878|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2232847|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232848|NCT00075972|Nicotine|nicotine|mesh-list
2232849|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2232850|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
2232851|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232852|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232853|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2232854|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2232855|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
2232856|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2232857|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232858|NCT00075998|Interferons|interferons|mesh-list
2232859|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
2232860|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232861|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
2232862|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232863|NCT00076115|Risperidone|risperidone|mesh-list
2232864|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2232865|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
2232866|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2232867|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232868|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232869|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2232870|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2232871|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2232872|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2232873|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2232874|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
2232875|NCT00076206|Sirolimus|sirolimus|mesh-list
727654|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
727655|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
727656|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727729|NCT02895750|Metformin|metformin|mesh-list
727730|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
727731|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727744|NCT02895113|Aspirin|aspirin|mesh-list
727745|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
727746|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
727747|NCT02895113|Analgesics|analgesics|mesh-ancestor
727748|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
727749|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727750|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726028|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
726029|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
726030|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
726031|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
726032|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
726033|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
726034|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
726035|NCT02904304|Protective Agents|protective agents|mesh-ancestor
726036|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
726037|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
726038|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
726039|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
726040|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
726041|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
2232876|NCT00076206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2232877|NCT00076206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232878|NCT00076206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2232879|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232880|NCT00076206|Antifungal Agents|antifungal agents|mesh-ancestor
2232881|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2232882|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
2232883|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232884|NCT00076232|Acyclovir|acyclovir|mesh-list
2232885|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
2232886|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232887|NCT00076284|Aplaviroc|aplaviroc|mesh-list
2232888|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2232889|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2232890|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232891|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2232892|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2232893|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
727009|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
727010|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
727011|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727105|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
727106|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727305|NCT02897830|Dexamethasone|dexamethasone|mesh-list
727306|NCT02897830|Lenalidomide|lenalidomide|mesh-list
727307|NCT02897830|Ixazomib|ixazomib|mesh-list
727308|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
727309|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
727310|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
727311|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727312|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727313|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
727314|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
727315|NCT02897830|Hormones|hormones|mesh-ancestor
727316|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
727317|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
727318|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727319|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
727320|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
727321|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
727322|NCT02897830|Growth Substances|growth substances|mesh-ancestor
727323|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
727324|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
727325|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727326|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727444|NCT02896803|Fluorouracil|fluorouracil|mesh-list
727445|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
727446|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
727447|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727448|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
727449|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727450|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
727451|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
727452|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727990|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
727991|NCT02894268|Doxycycline|doxycycline|mesh-list
727992|NCT02894268|Furazolidone|furazolidone|mesh-list
727993|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
727994|NCT02894268|Esomeprazole|esomeprazole|mesh-list
727995|NCT02894268|Bismuth|bismuth|mesh-list
727996|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727997|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
726051|NCT02904031|Fluorouracil|fluorouracil|mesh-list
726052|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
726053|NCT02904031|Panitumumab|panitumumab|mesh-list
726054|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
726055|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
726056|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726057|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
726058|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726059|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
726060|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
726061|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726062|NCT02904031|Antidotes|antidotes|mesh-ancestor
726063|NCT02904031|Protective Agents|protective agents|mesh-ancestor
726064|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
726065|NCT02904031|Vitamins|vitamins|mesh-ancestor
726066|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
726067|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
726466|NCT02902523|Tenofovir|tenofovir|mesh-list
726467|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
726468|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
726469|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
726470|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
726471|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726472|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726473|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
726474|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
727327|NCT02897765|Nivolumab|nivolumab|mesh-list
727328|NCT02897765|Poly ICLC|poly iclc|mesh-list
727329|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
727330|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727331|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
727332|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727333|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
727334|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727335|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
2232894|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232895|NCT00076310|Cisplatin|cisplatin|mesh-list
2232896|NCT00076310|Docetaxel|docetaxel|mesh-list
2232897|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2232898|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232899|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
2232900|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
2232901|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
2232902|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727870|NCT02894710|Lidocaine|lidocaine|mesh-list
727871|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
727872|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
727873|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
727874|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727875|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
727876|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727877|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
727878|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
727879|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
727880|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
727881|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728197|NCT02893371|Lamotrigine|lamotrigine|mesh-list
728198|NCT02893371|Carbamazepine|carbamazepine|mesh-list
728199|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
728200|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
728201|NCT02893371|Valproic Acid|valproic acid|mesh-list
728202|NCT02893371|Haloperidol|haloperidol|mesh-list
728203|NCT02893371|Olanzapine|olanzapine|mesh-list
728204|NCT02893371|Risperidone|risperidone|mesh-list
728205|NCT02893371|Aripiprazole|aripiprazole|mesh-list
728206|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
728207|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
728208|NCT02893371|Ziprasidone|ziprasidone|mesh-list
728209|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
728210|NCT02893371|Clozapine|clozapine|mesh-list
728211|NCT02893371|Asenapine|asenapine|mesh-list
728212|NCT02893371|Perphenazine|perphenazine|mesh-list
728213|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
728214|NCT02893371|Mirtazapine|mirtazapine|mesh-list
728215|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
728216|NCT02893371|Doxepin|doxepin|mesh-list
728217|NCT02893371|Citalopram|citalopram|mesh-list
728218|NCT02893371|Bupropion|bupropion|mesh-list
728219|NCT02893371|Sertraline|sertraline|mesh-list
728220|NCT02893371|Fluoxetine|fluoxetine|mesh-list
2753233|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
2232903|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2753234|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2753235|NCT02969928|Amoxicillin|amoxicillin|mesh-list
2753236|NCT02969928|Metronidazole|metronidazole|mesh-list
726655|NCT02901353|Sirolimus|sirolimus|mesh-list
726656|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
726657|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
726658|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
726659|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726660|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
726661|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
726662|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
726663|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727176|NCT02898610|Colchicine|colchicine|mesh-list
727177|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
727178|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
727179|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
727180|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
727181|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
727182|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727183|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727368|NCT02897206|Imipenem|imipenem|mesh-list
727369|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
727370|NCT02897206|Cilastatin|cilastatin|mesh-list
727371|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
727372|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727373|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
727374|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727375|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727439|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
727440|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727441|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
727442|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727443|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232904|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2232905|NCT00076323|Primaquine|primaquine|mesh-list
2232906|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
2232907|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2232908|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2232909|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232910|NCT00076349|Rituximab|rituximab|mesh-list
2232911|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2232912|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2232913|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232914|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
2232915|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232916|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2232917|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2232918|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
2753237|NCT02969928|Clarithromycin|clarithromycin|mesh-list
728991|NCT02889159|Imiquimod|imiquimod|mesh-list
728992|NCT02889159|Histamine|histamine|mesh-list
728993|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
728994|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
728995|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
728996|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728997|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728998|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
2753238|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
726151|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
726152|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
726153|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
726154|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
726155|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726156|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
726157|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
726158|NCT02903680|Hormones|hormones|mesh-ancestor
726159|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
726160|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
726161|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726162|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
726163|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726164|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232919|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232920|NCT00076362|Octreotide|octreotide|mesh-list
2232921|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2232922|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2232923|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232924|NCT00076388|Docetaxel|docetaxel|mesh-list
2232925|NCT00076388|Gefitinib|gefitinib|mesh-list
2232926|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232927|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
2232928|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
2232929|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
2232930|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232931|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2232932|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726677|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
726678|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
726679|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
726680|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
726681|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727038|NCT02899169|Tretinoin|tretinoin|mesh-list
727039|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
727040|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
727041|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727042|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
727043|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
727044|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
727045|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727046|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727047|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
727403|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
727404|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
727405|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727406|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
727407|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727764|NCT02895321|Listerine|listerine|mesh-list
727765|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
727766|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
727767|NCT02895321|Protective Agents|protective agents|mesh-ancestor
727768|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727769|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
727770|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729335|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
729336|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
729337|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
729338|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
729339|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
729340|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729341|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
729342|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729343|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729344|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
729345|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729528|NCT02885688|Insulin|insulin|mesh-list
729529|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
729530|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729769|NCT02884635|Methotrexate|methotrexate|mesh-list
729770|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
729771|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
729772|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
729773|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726172|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
726173|NCT02903537|Interferons|interferons|mesh-list
726174|NCT02903537|Interferon-beta|interferon-beta|mesh-list
726175|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726176|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
726177|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
726178|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
726179|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726180|NCT02903537|Vitamins|vitamins|mesh-ancestor
726181|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
726182|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
726183|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2232933|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
2232934|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232935|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2232936|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
2232937|NCT00076414|Acetylcholine|acetylcholine|mesh-list
2232938|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
2232939|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2232940|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
2232941|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2232942|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232943|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232944|NCT00076440|Leuprolide|leuprolide|mesh-list
726445|NCT02902354|Nifedipine|nifedipine|mesh-list
726446|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
726447|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
726448|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726449|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
726450|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726451|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
726452|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
726453|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2753239|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753240|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2753241|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
727299|NCT02897869|Amikacin|amikacin|mesh-list
727300|NCT02897869|Murepavadin|murepavadin|mesh-list
727301|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
727302|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232945|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2232946|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
2232947|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2232948|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232949|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2232950|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232951|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
2232952|NCT00076492|Vitamins|vitamins|mesh-ancestor
2232953|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
2232954|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232955|NCT00076518|Fenofibrate|fenofibrate|mesh-list
2232956|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2232957|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
2232958|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232959|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2232960|NCT00076531|Leuprolide|leuprolide|mesh-list
2232961|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2232962|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
2232963|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
727776|NCT02895022|Lidocaine|lidocaine|mesh-list
727777|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
727778|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
727779|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
727780|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727781|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
727782|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727783|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
727784|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
727785|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
727786|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
727787|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727895|NCT02894684|Aztreonam|aztreonam|mesh-list
727896|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
727897|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727988|NCT02893995|Treprostinil|treprostinil|mesh-list
2232964|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726405|NCT02902653|Misoprostol|misoprostol|mesh-list
726406|NCT02902653|Dinoprostone|dinoprostone|mesh-list
726407|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
726408|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
726409|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
726410|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726411|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
726412|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
726413|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
2232965|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2232966|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232967|NCT00076544|Ziconotide|ziconotide|mesh-list
2232968|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2232969|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2232970|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232971|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
728017|NCT02893618|Diazoxide|diazoxide|mesh-list
728018|NCT02893618|Choline|choline|mesh-list
728019|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
728020|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
728021|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
728022|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728023|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
728024|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
728025|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
728026|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
728027|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
728494|NCT02891603|Sirolimus|sirolimus|mesh-list
728495|NCT02891603|Tacrolimus|tacrolimus|mesh-list
728496|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
728497|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
728498|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728499|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
728500|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728501|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728502|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
728503|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
728504|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
728505|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728506|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
2232972|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232973|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
728921|NCT02889523|Prednisolone|prednisolone|mesh-list
728922|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
728923|NCT02889523|Rituximab|rituximab|mesh-list
728924|NCT02889523|Doxorubicin|doxorubicin|mesh-list
728925|NCT02889523|Vincristine|vincristine|mesh-list
728926|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
728927|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
728928|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728929|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
728930|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
728931|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
728932|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728933|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728934|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
728935|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
728936|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
728937|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
728938|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
728939|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728940|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
728941|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
728942|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
728943|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
728944|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
728945|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
728946|NCT02889523|Hormones|hormones|mesh-ancestor
728947|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
728948|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
729416|NCT02886299|Simvastatin|simvastatin|mesh-list
2232974|NCT00076544|Protective Agents|protective agents|mesh-ancestor
2232975|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2232976|NCT00076544|Analgesics|analgesics|mesh-ancestor
2232977|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
2232978|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2232979|NCT00076609|Capecitabine|capecitabine|mesh-list
2232980|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2232981|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
2232982|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2232983|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232984|NCT00076635|Interferons|interferons|mesh-list
2232985|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
2232986|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2232987|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
2232988|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2232989|NCT00076674|Levodopa|levodopa|mesh-list
2232990|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2232991|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2232992|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
2232993|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2232994|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726832|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
726833|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
726834|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
726835|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
2232995|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2232996|NCT00076726|Infliximab|infliximab|mesh-list
2232997|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
2232998|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2232999|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2233000|NCT00076791|Tenofovir|tenofovir|mesh-list
2233001|NCT00076791|Emtricitabine|emtricitabine|mesh-list
2233002|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
727523|NCT02896621|Amlodipine|amlodipine|mesh-list
727524|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
727525|NCT02896621|Amiloride|amiloride|mesh-list
727526|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
727527|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
727528|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
727529|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727530|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
727531|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727532|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
727533|NCT02896621|Diuretics|diuretics|mesh-ancestor
727534|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
727535|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
727536|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
727537|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
727538|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
727539|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
728076|NCT02893540|Capecitabine|capecitabine|mesh-list
728077|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
728078|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
728079|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728080|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233003|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
2233004|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233005|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2233006|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2233007|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233008|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233009|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2233010|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2233011|NCT00076856|Temozolomide|temozolomide|mesh-list
2233012|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2233013|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
2233014|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233015|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233016|NCT00076869|Amphotericin B|amphotericin b|mesh-list
729058|NCT02888574|Oxytocin|oxytocin|mesh-list
729059|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
729060|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
729061|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729400|NCT02886377|Antibodies|antibodies|mesh-list
729401|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
2233017|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2233018|NCT00076869|Caspofungin|caspofungin|mesh-list
2233019|NCT00076869|Amebicides|amebicides|mesh-ancestor
2233020|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2233021|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2233022|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233023|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2233024|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
2233025|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233026|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726352|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
726353|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
726354|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
726355|NCT02902744|Hormones|hormones|mesh-ancestor
726356|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
726357|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233027|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
2233028|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233029|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233030|NCT00076973|Montelukast|montelukast|mesh-list
2233031|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2233032|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
2233033|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2233034|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
2233035|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2233036|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233037|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2233038|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2233039|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233040|NCT00076986|Carmustine|carmustine|mesh-list
2233041|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2233042|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
2233043|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233044|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233045|NCT00077025|Gefitinib|gefitinib|mesh-list
726926|NCT02900469|Denosumab|denosumab|mesh-list
726927|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
726928|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726978|NCT02899611|Valproic Acid|valproic acid|mesh-list
726979|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
726980|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726981|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726982|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
726983|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
726984|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726985|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
726986|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
726987|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
726988|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2233046|NCT00077025|Anastrozole|anastrozole|mesh-list
2233047|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233048|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2233049|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233050|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233051|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2233052|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2233053|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2233054|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2233055|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
727453|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
727454|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727455|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
727456|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727457|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727771|NCT02894983|Calpastatin|calpastatin|mesh-list
727772|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
727773|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
727774|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727775|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727927|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
727928|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
727929|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
727930|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
726328|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
726329|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726330|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
726331|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
726332|NCT02903004|Antiviral Agents|antiviral agents|mesh-ancestor
726333|NCT02903004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
726334|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726335|NCT02903004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
726336|NCT02903004|Immunologic Factors|immunologic factors|mesh-ancestor
726337|NCT02903004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726338|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
726339|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
726340|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
726341|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
726342|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
726343|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
727227|NCT02897986|Vinorelbine|vinorelbine|mesh-list
727228|NCT02897986|Propranolol|propranolol|mesh-list
727229|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
727230|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727231|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
727232|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
727233|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
727234|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727235|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
727236|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
727237|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
727238|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
727239|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727240|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
727241|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
727242|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
727458|NCT02897037|Heparin|heparin|mesh-list
727459|NCT02897037|Bivalirudin|bivalirudin|mesh-list
727460|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
727461|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
727462|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
727463|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727464|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
727465|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
727466|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
727467|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727826|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
727827|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
727828|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
728092|NCT02893423|Ropivacaine|ropivacaine|mesh-list
728093|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
728094|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
728095|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
728096|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728097|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
728098|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2233056|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2233057|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233058|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
2233059|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
2233060|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233061|NCT00077077|Capecitabine|capecitabine|mesh-list
2753242|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2090823|NCT02220907|Canagliflozin|canagliflozin|mesh-list
2090824|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2090825|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090826|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2090827|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090828|NCT02220920|Canagliflozin|canagliflozin|mesh-list
2090829|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2090830|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090831|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
726567|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726699|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
726700|NCT02901145|Nivolumab|nivolumab|mesh-list
726701|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
726702|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
726703|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726704|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
726705|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
726706|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
726707|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726708|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
726709|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
726710|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
726711|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
727086|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
727087|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727184|NCT02898376|Tocopherols|tocopherols|mesh-list
727185|NCT02898376|Vitamin E|vitamin e|mesh-list
727186|NCT02898376|Tocotrienols|tocotrienols|mesh-list
727187|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
727188|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
727189|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
727190|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727191|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727192|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
727193|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
727194|NCT02898376|Protective Agents|protective agents|mesh-ancestor
727195|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727196|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
727197|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
727198|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
727199|NCT02898376|Vitamins|vitamins|mesh-ancestor
727200|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
727279|NCT02897856|Midazolam|midazolam|mesh-list
727280|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
727281|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
727282|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
727283|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727284|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
727285|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
727286|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
727287|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
727288|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
727289|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
727290|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
727291|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
727292|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
727293|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728011|NCT02893709|Omeprazole|omeprazole|mesh-list
728012|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
728013|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
728014|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
728015|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728016|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233062|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233063|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
2233064|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233065|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233066|NCT00077103|Doxorubicin|doxorubicin|mesh-list
2233067|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2233068|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
2233069|NCT00077103|Combretastatin|combretastatin|mesh-list
2233070|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233071|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2233072|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2233073|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2233074|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233075|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233076|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2233077|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
2233078|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
2233079|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
2233080|NCT00077116|Cytarabine|cytarabine|mesh-list
2233081|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
2233082|NCT00077116|Busulfan|busulfan|mesh-list
2233083|NCT00077116|Idarubicin|idarubicin|mesh-list
2233084|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
726618|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
726972|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
726973|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
726974|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090832|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090833|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
2090834|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
727388|NCT02897063|Midodrine|midodrine|mesh-list
727389|NCT02897063|Droxidopa|droxidopa|mesh-list
727390|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
727391|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
727392|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727393|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727394|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
727395|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
727396|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
727397|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
727398|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
727399|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
727400|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727401|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
727402|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2233085|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233086|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
2233087|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090835|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090836|NCT02221219|Indomethacin|indomethacin|mesh-list
2090837|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2090838|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2090839|NCT02221219|Analgesics|analgesics|mesh-ancestor
2090840|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
2090841|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
728620|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
728621|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
728622|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728623|NCT02890823|Vitamins|vitamins|mesh-ancestor
728624|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
728625|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
728857|NCT02889666|Gemcitabine|gemcitabine|mesh-list
728858|NCT02889666|Cisplatin|cisplatin|mesh-list
728859|NCT02889666|Carboplatin|carboplatin|mesh-list
728860|NCT02889666|Docetaxel|docetaxel|mesh-list
728861|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
728862|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728863|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
728864|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
728865|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728866|NCT02889666|Antiviral Agents|antiviral agents|mesh-ancestor
728867|NCT02889666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
728868|NCT02889666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728869|NCT02889666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
728870|NCT02889666|Immunologic Factors|immunologic factors|mesh-ancestor
728871|NCT02889666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728872|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
728873|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
728874|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
729254|NCT02887534|Tizanidine|tizanidine|mesh-list
729255|NCT02887534|Analgesics|analgesics|mesh-ancestor
729256|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
729257|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729258|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729259|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
729260|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
729261|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
729262|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
729263|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
729264|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
729265|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
729266|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
729267|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
729268|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729269|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233088|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2233089|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2233090|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
2233091|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
726636|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
726637|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
726638|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
726639|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726640|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
726641|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
726642|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
726916|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
726917|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
726918|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726919|NCT02900417|Incretins|incretins|mesh-ancestor
726920|NCT02900417|Hormones|hormones|mesh-ancestor
726921|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
726922|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
726923|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
726924|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
726925|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090842|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090843|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2090844|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2090845|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
2090846|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
2090847|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2090848|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2090849|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090850|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090851|NCT02221284|Alogliptin|alogliptin|mesh-list
2090852|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2090853|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090854|NCT02221284|Incretins|incretins|mesh-ancestor
727243|NCT02898012|Bevacizumab|bevacizumab|mesh-list
727244|NCT02898012|Temozolomide|temozolomide|mesh-list
727245|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
727246|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727247|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
727248|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
727249|NCT02898012|Growth Substances|growth substances|mesh-ancestor
727250|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727251|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
727252|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
727253|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
727254|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727760|NCT02895373|Alprostadil|alprostadil|mesh-list
727761|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
727762|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
727763|NCT02895373|Urological Agents|urological agents|mesh-ancestor
727915|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
727916|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
727917|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
727918|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728324|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
728325|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
728326|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233092|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233093|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2233094|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233095|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
2233096|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
2233097|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233098|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2233099|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2233100|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2233101|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233102|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2233103|NCT00077129|Paclitaxel|paclitaxel|mesh-list
2233104|NCT00077129|Carboplatin|carboplatin|mesh-list
2233105|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2233106|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233107|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
2233108|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
2233109|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
2233110|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233111|NCT00077168|Tamoxifen|tamoxifen|mesh-list
2233112|NCT00077168|Anastrozole|anastrozole|mesh-list
726713|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
726714|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
726715|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
726716|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
726717|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
726718|NCT02901184|Diuretics|diuretics|mesh-ancestor
726719|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
726897|NCT02900157|Durvalumab|durvalumab|mesh-list
726898|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
726899|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753243|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753244|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753245|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2753246|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
727363|NCT02897596|Grazoprevir|grazoprevir|mesh-list
727364|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
727365|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727540|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
727541|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
727542|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
727543|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727544|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
727545|NCT02896413|Analgesics|analgesics|mesh-ancestor
727546|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
727547|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727548|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
727549|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
727550|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
727551|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
727552|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
727553|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727722|NCT02895672|Exenatide|exenatide|mesh-list
727723|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
727724|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727725|NCT02895672|Incretins|incretins|mesh-ancestor
727726|NCT02895672|Hormones|hormones|mesh-ancestor
727727|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
727728|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
727940|NCT02894645|Cytarabine|cytarabine|mesh-list
727941|NCT02894645|Dexamethasone|dexamethasone|mesh-list
727942|NCT02894645|Prednisolone|prednisolone|mesh-list
727943|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
727944|NCT02894645|Doxorubicin|doxorubicin|mesh-list
727945|NCT02894645|Methotrexate|methotrexate|mesh-list
727946|NCT02894645|Fludarabine|fludarabine|mesh-list
727947|NCT02894645|Vincristine|vincristine|mesh-list
727948|NCT02894645|Daunorubicin|daunorubicin|mesh-list
727949|NCT02894645|Asparaginase|asparaginase|mesh-list
727950|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
727951|NCT02894645|Thioguanine|thioguanine|mesh-list
727952|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
727953|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
727954|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727955|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
727956|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
727957|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
727958|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727959|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727960|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
727961|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
727962|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
727963|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
727964|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727965|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
727966|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
727967|NCT02894645|Hormones|hormones|mesh-ancestor
727968|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
727969|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
727970|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
727971|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
727972|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
727973|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727974|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
727975|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
727976|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
726889|NCT02900209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727012|NCT02899286|BCT-100|bct-100|mesh-list
727013|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727336|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
727337|NCT02897700|Doxorubicin|doxorubicin|mesh-list
727338|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
727339|NCT02897700|Fluorouracil|fluorouracil|mesh-list
727340|NCT02897700|Methotrexate|methotrexate|mesh-list
727341|NCT02897700|Epirubicin|epirubicin|mesh-list
727342|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
727343|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
727344|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727345|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
727346|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
727347|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
727348|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727349|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727350|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
727351|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
727352|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
727353|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
727354|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727355|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
727356|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
727357|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
727358|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
727359|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
727360|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
727361|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
727362|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
727376|NCT02897076|Betamethasone|betamethasone|mesh-list
727377|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
727378|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
727379|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
727380|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
727381|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
727382|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
727383|NCT02897076|Hormones|hormones|mesh-ancestor
727384|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
727385|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727386|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
727387|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
727819|NCT02894957|Varenicline|varenicline|mesh-list
727820|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
727821|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
727822|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
727823|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
727824|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727825|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728043|NCT02893826|Nimodipine|nimodipine|mesh-list
728044|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
728045|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
728046|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
728047|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728048|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
728049|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728050|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
728087|NCT02893176|Macitentan|macitentan|mesh-list
728088|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
728089|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
728090|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728091|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
728587|NCT02891083|Paclitaxel|paclitaxel|mesh-list
728588|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
728589|NCT02891083|Cisplatin|cisplatin|mesh-list
728590|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
728591|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728592|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
728593|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
728594|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
728595|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090855|NCT02221284|Hormones|hormones|mesh-ancestor
2090856|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2753247|NCT02968446|Vitamin D|vitamin d|mesh-list
2233113|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233114|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2233115|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
727158|NCT02898779|Primaquine|primaquine|mesh-list
727159|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
727160|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
727161|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
727162|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727366|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
727367|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
727919|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
727920|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
727921|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
727922|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
727923|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
727924|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727925|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727926|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
728507|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
728508|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
728509|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728743|NCT02890212|Selenium|selenium|mesh-list
728744|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
728745|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728746|NCT02890212|Protective Agents|protective agents|mesh-ancestor
728747|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728748|NCT02890212|Trace Elements|trace elements|mesh-ancestor
728749|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
729087|NCT02888561|Dobutamine|dobutamine|mesh-list
729088|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
729089|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
729090|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
729091|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729092|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729093|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
729094|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
729095|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
729096|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
729097|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729098|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729099|NCT02888561|Protective Agents|protective agents|mesh-ancestor
2233116|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2233117|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233118|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2233119|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233120|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2233121|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2233122|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
730208|NCT02882230|Dolutegravir|dolutegravir|mesh-list
730209|NCT02882230|Rilpivirine|rilpivirine|mesh-list
730210|NCT02882230|Elvitegravir|elvitegravir|mesh-list
730211|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
730212|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
730213|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730214|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730215|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
730216|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
730217|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
730218|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
730219|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
730220|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
730286|NCT02881619|Etodolac|etodolac|mesh-list
730287|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
730288|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
730289|NCT02881619|Analgesics|analgesics|mesh-ancestor
730290|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
730291|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730292|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730293|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
730294|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
730295|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
730296|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
730297|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730298|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727088|NCT02899000|Doxycycline|doxycycline|mesh-list
727089|NCT02899000|Adapalene|adapalene|mesh-list
727090|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
727091|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
727092|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727093|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
727094|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
727095|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
727096|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
727097|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
727098|NCT02899000|Analgesics|analgesics|mesh-ancestor
727099|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
727100|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727101|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727102|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
727103|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
727104|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
727220|NCT02897934|Bupivacaine|bupivacaine|mesh-list
727221|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
727222|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
727223|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
727224|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727225|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
727226|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727657|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
727658|NCT02896101|Tacrolimus|tacrolimus|mesh-list
727659|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
727660|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
727661|NCT02896101|Analgesics|analgesics|mesh-ancestor
727662|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
727663|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727664|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727665|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
727666|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
727667|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
727668|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
727669|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
727670|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
727671|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727672|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727882|NCT02894593|Ethanol|ethanol|mesh-list
727883|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
727884|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
727885|NCT02894593|Listerine|listerine|mesh-list
727886|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
727887|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
727888|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727889|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
727890|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727891|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
727892|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
727893|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
727894|NCT02894593|Protective Agents|protective agents|mesh-ancestor
728614|NCT02890719|Ribavirin|ribavirin|mesh-list
728615|NCT02890719|Grazoprevir|grazoprevir|mesh-list
728616|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
728617|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728618|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
728619|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729100|NCT02888301|Clofarabine|clofarabine|mesh-list
729101|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
729102|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
729103|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729104|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729144|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
729145|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
729146|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
729147|NCT02887976|Prednisolone|prednisolone|mesh-list
729148|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
729149|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
729150|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
729151|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
729152|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
729153|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
729154|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
729155|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729156|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729171|NCT02888223|Coagulants|coagulants|mesh-ancestor
727142|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
727143|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727144|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
727468|NCT02897011|Methotrexate|methotrexate|mesh-list
727469|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
727470|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
727471|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
727472|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727473|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
727474|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
727475|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727476|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727477|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
727478|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727479|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
727480|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
727481|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
727482|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
727483|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
728081|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
728082|NCT02893332|Gefitinib|gefitinib|mesh-list
728083|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728084|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
728085|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728086|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728187|NCT02892942|Cetrorelix|cetrorelix|mesh-list
728188|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
728189|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
728190|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
728191|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728192|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
728193|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
728682|NCT02890589|Chromium|chromium|mesh-list
728683|NCT02890589|Everolimus|everolimus|mesh-list
728684|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728685|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
728686|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
728687|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728688|NCT02890589|Trace Elements|trace elements|mesh-ancestor
728689|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
728776|NCT02890082|Tamoxifen|tamoxifen|mesh-list
728777|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
728778|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
728779|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
728780|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728781|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
728782|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728783|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
728784|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
728785|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2233123|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2233124|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2233125|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233126|NCT00077181|Cytarabine|cytarabine|mesh-list
2233127|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
729015|NCT02888990|Dasatinib|dasatinib|mesh-list
729016|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729017|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
729018|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729019|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233128|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
2233129|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233130|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729516|NCT02885441|Ketorolac|ketorolac|mesh-list
729517|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
729518|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
729519|NCT02885441|Analgesics|analgesics|mesh-ancestor
729520|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
729521|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729522|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729523|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
729524|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
729525|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
729526|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727155|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727156|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
727157|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233131|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
2233132|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233133|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233134|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
727847|NCT02894892|Esomeprazole|esomeprazole|mesh-list
727848|NCT02894892|Bismuth|bismuth|mesh-list
727849|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
727850|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
727851|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
727852|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727853|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727854|NCT02894892|Antacids|antacids|mesh-ancestor
728157|NCT02893488|Lamivudine|lamivudine|mesh-list
728158|NCT02893488|Dolutegravir|dolutegravir|mesh-list
728159|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
728160|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
728161|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728162|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728163|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
728164|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
728165|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
728166|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
728167|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
728168|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
728480|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
728481|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728482|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
728483|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728484|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728580|NCT02891005|Paclitaxel|paclitaxel|mesh-list
728581|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
728582|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728583|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
728584|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
728585|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
728586|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233135|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233136|NCT00077194|Romidepsin|romidepsin|mesh-list
2233137|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2233138|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233139|NCT00077220|Paclitaxel|paclitaxel|mesh-list
2233140|NCT00077220|Carboplatin|carboplatin|mesh-list
2233141|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2233142|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233143|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
2233144|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
729560|NCT02885545|Anticoagulants|anticoagulants|mesh-list
2233145|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
2233146|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233147|NCT00077233|Leucovorin|leucovorin|mesh-list
2233148|NCT00077233|Fluorouracil|fluorouracil|mesh-list
2233149|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
2233150|NCT00077233|Irinotecan|irinotecan|mesh-list
2233151|NCT00077233|Cetuximab|cetuximab|mesh-list
2233152|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233153|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
2233154|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233155|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233156|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233157|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233158|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
2233159|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2233160|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
729809|NCT02884219|Ibuprofen|ibuprofen|mesh-list
729810|NCT02884219|Indomethacin|indomethacin|mesh-list
729811|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
729812|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
729813|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
729814|NCT02884219|Analgesics|analgesics|mesh-ancestor
729815|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
729816|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729817|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233161|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233162|NCT00077233|Antidotes|antidotes|mesh-ancestor
2233163|NCT00077233|Protective Agents|protective agents|mesh-ancestor
727829|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
727830|NCT02895074|Tropicamide|tropicamide|mesh-list
727831|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
727832|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
727833|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727834|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727835|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
727836|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
727837|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
727838|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
727839|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727840|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
727841|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
727842|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
727843|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
728051|NCT02893280|Aspirin|aspirin|mesh-list
728052|NCT02893280|Enoxaparin|enoxaparin|mesh-list
728053|NCT02893280|Streptokinase|streptokinase|mesh-list
728054|NCT02893280|Clopidogrel|clopidogrel|mesh-list
728055|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
728056|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
728057|NCT02893280|Analgesics|analgesics|mesh-ancestor
728058|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
728059|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
728060|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728061|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
728062|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
728063|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
728064|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
728065|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728066|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
728067|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
728068|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728069|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
728070|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
728071|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
728072|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
728073|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
728074|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
728075|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
2753248|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
2753249|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
2753250|NCT02968446|Vitamins|vitamins|mesh-ancestor
728546|NCT02891226|Mirikizumab|mirikizumab|mesh-list
728547|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
728548|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
728549|NCT02891226|Analgesics|analgesics|mesh-ancestor
728550|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
728551|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
728552|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728553|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
728554|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
728555|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
728556|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
729020|NCT02889003|Pioglitazone|pioglitazone|mesh-list
729021|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
729022|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729270|NCT02887365|Tegafur|tegafur|mesh-list
729271|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
729272|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
729273|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729274|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729497|NCT02885948|Naloxone|naloxone|mesh-list
729498|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
729499|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729500|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
729501|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090857|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2090858|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
2090859|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090860|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090861|NCT02221349|Listerine|listerine|mesh-list
2090862|NCT02221349|Fluorides|fluorides|mesh-list
2090863|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
2090864|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
2753251|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
727505|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
727506|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233164|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
2233165|NCT00077233|Vitamins|vitamins|mesh-ancestor
2233166|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
2233167|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2233168|NCT00077246|Paclitaxel|paclitaxel|mesh-list
2233169|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2233170|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2233171|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233172|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
2233173|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
727865|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
727866|NCT02894606|Basiliximab|basiliximab|mesh-list
727867|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
727868|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727869|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2753252|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753253|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2753254|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2753255|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
2753256|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753257|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2753258|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753259|NCT02960022|Prednisone|prednisone|mesh-list
728675|NCT02890459|Denatonium|denatonium|mesh-list
728676|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
728677|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728678|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
728679|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728680|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
728681|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
728909|NCT02889432|Melatonin|melatonin|mesh-list
728910|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
728911|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728912|NCT02889432|Protective Agents|protective agents|mesh-ancestor
728913|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728914|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729005|NCT02889133|Iron|iron|mesh-list
729006|NCT02889133|Dextrans|dextrans|mesh-list
729007|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
729008|NCT02889133|Trace Elements|trace elements|mesh-ancestor
729009|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
729010|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729011|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
729012|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
729013|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
729014|NCT02889133|Hematinics|hematinics|mesh-ancestor
729029|NCT02888704|Remestemcel-l|remestemcel-l|mesh-list
729030|NCT02888704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
729031|NCT02888704|Antiviral Agents|antiviral agents|mesh-ancestor
729032|NCT02888704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729313|NCT02887313|Leucovorin|leucovorin|mesh-list
729314|NCT02887313|Fluorouracil|fluorouracil|mesh-list
729315|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
729316|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
729317|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729318|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
729319|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729320|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
729321|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
729322|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729323|NCT02887313|Antidotes|antidotes|mesh-ancestor
729324|NCT02887313|Protective Agents|protective agents|mesh-ancestor
729325|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
729326|NCT02887313|Vitamins|vitamins|mesh-ancestor
729327|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
729531|NCT02885558|Efonidipine|efonidipine|mesh-list
729532|NCT02885558|Nifedipine|nifedipine|mesh-list
729533|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
729534|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
729535|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729536|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
729537|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729538|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
729539|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
2233174|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
2090865|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
2090866|NCT02221349|Protective Agents|protective agents|mesh-ancestor
2090867|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090868|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2090869|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090870|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2090871|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2090872|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
728173|NCT02892916|Ketamine|ketamine|mesh-list
728174|NCT02892916|Analgesics|analgesics|mesh-ancestor
728175|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
728176|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
728177|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728178|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
728179|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
728180|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
728181|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
728182|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
728183|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
728184|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
728185|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
728186|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753260|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
2753261|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2753262|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
2753263|NCT02960022|Hormones|hormones|mesh-ancestor
2753264|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
728706|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
728707|NCT02890238|Citric Acid|citric acid|mesh-list
728708|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
728709|NCT02890238|Clomiphene|clomiphene|mesh-list
728710|NCT02890238|Enclomiphene|enclomiphene|mesh-list
728711|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
728712|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
728713|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
728714|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
728715|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
728716|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728717|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
728718|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
728719|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
728720|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728721|NCT02890238|Urological Agents|urological agents|mesh-ancestor
728722|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
728723|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
728724|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
728725|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728726|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
728727|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
728728|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
728729|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
728730|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2233175|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233176|NCT00077259|Epothilones|epothilones|mesh-list
2233177|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
2233178|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
2233179|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
2233180|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
729134|NCT02888444|Varenicline|varenicline|mesh-list
729135|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
729136|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
729137|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
729138|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729139|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729140|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729197|NCT02887807|Cyclosporine|cyclosporine|mesh-list
729198|NCT02887807|Cyclosporins|cyclosporins|mesh-list
729199|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729200|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729201|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
729202|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
729203|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729204|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
729205|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753265|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727567|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727568|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727569|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
727570|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
727571|NCT02896582|Hormones|hormones|mesh-ancestor
727572|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
727573|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
727574|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
727575|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
727576|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
727577|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
727578|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727579|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727580|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
727581|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
727582|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
727583|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727584|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
727585|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
727586|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
727587|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
727588|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
727589|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
728528|NCT02891278|Cytarabine|cytarabine|mesh-list
728529|NCT02891278|Sertraline|sertraline|mesh-list
728530|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
728531|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
728532|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728533|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728534|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
728535|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
728536|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
728537|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
728538|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728539|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
728540|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
728541|NCT02891278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
728542|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
728543|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
728544|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
728545|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
728731|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
728732|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
728733|NCT02890277|Chitosan|chitosan|mesh-list
728734|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
728735|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
728736|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
728737|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728738|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
728739|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
728740|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
728741|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
728742|NCT02890277|Coagulants|coagulants|mesh-ancestor
729076|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
729077|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
729078|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
729079|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
729080|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
729081|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729082|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
729083|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729084|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729085|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
729086|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729236|NCT02887443|Midazolam|midazolam|mesh-list
729237|NCT02887443|Idebenone|idebenone|mesh-list
727698|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727699|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727700|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
727701|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
727702|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
727703|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
727704|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
727705|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
727706|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
727707|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
727708|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
728028|NCT02893722|Oxytocin|oxytocin|mesh-list
728029|NCT02893722|Atosiban|atosiban|mesh-list
728030|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
728031|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
728032|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728033|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
728034|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
728035|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
728520|NCT02891018|Paclitaxel|paclitaxel|mesh-list
728521|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
728522|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
728523|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728524|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
728525|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
728526|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
728527|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728763|NCT02890186|Remifentanil|remifentanil|mesh-list
728764|NCT02890186|Propofol|propofol|mesh-list
728765|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
728766|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
728767|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728768|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
728769|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
728770|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
728771|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
728772|NCT02890186|Narcotics|narcotics|mesh-ancestor
728773|NCT02890186|Analgesics|analgesics|mesh-ancestor
728774|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
728775|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
728817|NCT02889822|Alprostadil|alprostadil|mesh-list
728818|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
728819|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
728820|NCT02889822|Urological Agents|urological agents|mesh-ancestor
729502|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
729503|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729580|NCT02885454|Simeprevir|simeprevir|mesh-list
729581|NCT02885454|Odalasvir|odalasvir|mesh-list
729582|NCT02885454|Drospirenone|drospirenone|mesh-list
729583|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
729584|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
729585|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
729586|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
729587|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
727740|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
727741|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
727742|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727743|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090873|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2090874|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090875|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
2090876|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090877|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090878|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2090879|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090880|NCT02221674|Tapentadol|tapentadol|mesh-list
2090881|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2090882|NCT02221674|Narcotics|narcotics|mesh-ancestor
2090883|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090884|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090885|NCT02221674|Analgesics|analgesics|mesh-ancestor
2090886|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
2090887|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090888|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2233181|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728133|NCT02893553|Midodrine|midodrine|mesh-list
728134|NCT02893553|Bromides|bromides|mesh-list
728135|NCT02893553|Mirabegron|mirabegron|mesh-list
728136|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
728137|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
728138|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
728139|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
728140|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
728141|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
728142|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
728143|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728144|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728145|NCT02893553|Urological Agents|urological agents|mesh-ancestor
728146|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
728147|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
728148|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
728149|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
728150|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
728151|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
728152|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
728153|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728154|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
728194|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
728195|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
728196|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728348|NCT02892123|Paclitaxel|paclitaxel|mesh-list
728349|NCT02892123|Vinorelbine|vinorelbine|mesh-list
728350|NCT02892123|Capecitabine|capecitabine|mesh-list
728351|NCT02892123|Tucatinib|tucatinib|mesh-list
728352|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
728353|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728354|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
728355|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
728356|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
728357|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728358|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
728359|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
728360|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
728361|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728699|NCT02890511|Paclitaxel|paclitaxel|mesh-list
728700|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
728701|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728702|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
728703|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
728704|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
728705|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233182|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233183|NCT00077298|Bevacizumab|bevacizumab|mesh-list
2233184|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2233185|NCT00077298|Cetuximab|cetuximab|mesh-list
2233186|NCT00077298|Irinotecan|irinotecan|mesh-list
2233187|NCT00077298|Antibodies|antibodies|mesh-list
2233188|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
727751|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
727752|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
727753|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
727754|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
727755|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
727756|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
727757|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
727758|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
727759|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
2090889|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2090890|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2090891|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090892|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
2090893|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2090894|NCT02221739|Ipilimumab|ipilimumab|mesh-list
2090895|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2090896|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090897|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2090898|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090899|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
2090900|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
728631|NCT02890602|Prednisolone|prednisolone|mesh-list
728632|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
728633|NCT02890602|Vincristine|vincristine|mesh-list
728634|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
728635|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
728636|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
728637|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728638|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
728639|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
728640|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
728641|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728642|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728643|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
728644|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
728645|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
728646|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
728647|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
728648|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
728649|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
728650|NCT02890602|Hormones|hormones|mesh-ancestor
728651|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
728652|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
728653|NCT02890602|Hematinics|hematinics|mesh-ancestor
728750|NCT02890199|Lidocaine|lidocaine|mesh-list
728751|NCT02890199|Bupivacaine|bupivacaine|mesh-list
728752|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
728753|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
728754|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
728755|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728756|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
728757|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
728758|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
728759|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
728760|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
728761|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
728762|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728821|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
728822|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
728823|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
728824|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
729170|NCT02888223|Factor VIII|factor viii|mesh-list
2233189|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2233190|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233191|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2233192|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2233193|NCT00077298|Growth Substances|growth substances|mesh-ancestor
2233194|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233195|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
2233196|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
2233197|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2233198|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2233199|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233200|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233201|NCT00077311|Docetaxel|docetaxel|mesh-list
2233202|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
2233203|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
2233204|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233205|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
2233206|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
2233207|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
2233208|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233209|NCT00077311|Hematinics|hematinics|mesh-ancestor
2233210|NCT00077311|Protective Agents|protective agents|mesh-ancestor
2233211|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233212|NCT00077337|Romidepsin|romidepsin|mesh-list
2233213|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2233214|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233215|NCT00077350|Gemcitabine|gemcitabine|mesh-list
2233216|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
728155|NCT02893111|Bortezomib|bortezomib|mesh-list
728156|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233217|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
2233218|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233219|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233220|NCT00077350|Antiviral Agents|antiviral agents|mesh-ancestor
2233221|NCT00077350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233222|NCT00077350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728654|NCT02890784|Dasatinib|dasatinib|mesh-list
728655|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728656|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
728657|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728658|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729193|NCT02888041|Dinoprostone|dinoprostone|mesh-list
729194|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
729195|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
729196|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729544|NCT02885597|Methotrexate|methotrexate|mesh-list
729545|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
729546|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
729547|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
729548|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729549|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
729550|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
729551|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729552|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729553|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
729554|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729555|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
729556|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
729557|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
729558|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
729559|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
729620|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
729621|NCT02885168|Phenylephrine|phenylephrine|mesh-list
729622|NCT02885168|Protein C|protein c|mesh-list
729623|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
729624|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
729625|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
729626|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
729627|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729628|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729629|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
729630|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
729631|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
729632|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
729633|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
729634|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
727861|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
727862|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727863|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
727864|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
728949|NCT02889549|Clopidogrel|clopidogrel|mesh-list
728950|NCT02889549|Ticagrelor|ticagrelor|mesh-list
728951|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
728952|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
728953|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
728954|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
728955|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
728956|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
728957|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728958|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729328|NCT02887222|Bupivacaine|bupivacaine|mesh-list
729329|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
729330|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
729331|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729332|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729333|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
729334|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729346|NCT02886897|Antibodies|antibodies|mesh-list
729347|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
729348|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729477|NCT02886065|Lenalidomide|lenalidomide|mesh-list
729478|NCT02886065|Poly ICLC|poly iclc|mesh-list
729479|NCT02886065|Citarinostat|citarinostat|mesh-list
729480|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
729481|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729482|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
729483|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
729484|NCT02886065|Growth Substances|growth substances|mesh-ancestor
729485|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
729486|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729487|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
729488|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
729489|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729490|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729792|NCT02884544|Dextroamphetamine|dextroamphetamine|mesh-list
729793|NCT02884544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
729794|NCT02884544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729795|NCT02884544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
729796|NCT02884544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
729797|NCT02884544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
729798|NCT02884544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729799|NCT02884544|Dopamine Agents|dopamine agents|mesh-ancestor
729800|NCT02884544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729839|NCT02884050|Topiramate|topiramate|mesh-list
729840|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
729841|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
729842|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233223|NCT00077350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233224|NCT00077350|Immunologic Factors|immunologic factors|mesh-ancestor
2233225|NCT00077350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233226|NCT00077363|Capecitabine|capecitabine|mesh-list
2233227|NCT00077363|Tipifarnib|tipifarnib|mesh-list
2233228|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233229|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
2233230|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233231|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730265|NCT02881346|Betamethasone|betamethasone|mesh-list
730266|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
730267|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
730268|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
730269|NCT02881346|Calcipotriene|calcipotriene|mesh-list
730270|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
730271|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
730272|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
730273|NCT02881346|Hormones|hormones|mesh-ancestor
730274|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
730275|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730276|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
730277|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
730278|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
730316|NCT02880956|Tilavonemab|tilavonemab|mesh-list
727931|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
727932|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
727933|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
727934|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
727935|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
727936|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
727937|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
727938|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
727939|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728510|NCT02891161|Durvalumab|durvalumab|mesh-list
728511|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
728512|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728596|NCT02890875|Ethanol|ethanol|mesh-list
728597|NCT02890875|Heparin|heparin|mesh-list
728598|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
728599|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
728600|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
728601|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728602|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
728603|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
728604|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
728605|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233232|NCT00077389|Carboplatin|carboplatin|mesh-list
2233233|NCT00077389|Doxorubicin|doxorubicin|mesh-list
2233234|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
729993|NCT02883023|Bleomycin|bleomycin|mesh-list
729994|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
729995|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233235|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233236|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2233237|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2233238|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2233239|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233240|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233241|NCT00077402|Fenretinide|fenretinide|mesh-list
2233242|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233243|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2233244|NCT00077402|Protective Agents|protective agents|mesh-ancestor
2233245|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233246|NCT00077415|Gemcitabine|gemcitabine|mesh-list
2233247|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233248|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
730334|NCT02881125|Paclitaxel|paclitaxel|mesh-list
730335|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
730336|NCT02881125|Nortriptyline|nortriptyline|mesh-list
730337|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
730338|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730339|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
730340|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
730341|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
730342|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730343|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
730344|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
730345|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
730346|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
730347|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
730348|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
730349|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
730350|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
730351|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730415|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
730416|NCT02880280|Menotropins|menotropins|mesh-list
730417|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
730418|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730419|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
730420|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
730571|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
730572|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
730573|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
730574|NCT02879942|Growth Substances|growth substances|mesh-ancestor
730575|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730576|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
730577|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730727|NCT02879513|Paclitaxel|paclitaxel|mesh-list
2753266|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
727977|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
727978|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
727979|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
727980|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
727981|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
727982|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
727983|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
727984|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
727985|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
727986|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
727987|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
728169|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
728170|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
728171|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
728172|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
728327|NCT02892318|Atezolizumab|atezolizumab|mesh-list
728328|NCT02892318|Guadecitabine|guadecitabine|mesh-list
728329|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728443|NCT02891785|Antipain|antipain|mesh-list
728444|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
728445|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728446|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729990|NCT02883426|Vaccines|vaccines|mesh-list
729991|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
729992|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730023|NCT02882737|Glucagon|glucagon|mesh-list
730024|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
730025|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
730026|NCT02882737|Hormones|hormones|mesh-ancestor
730027|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
730028|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730029|NCT02882737|Incretins|incretins|mesh-ancestor
730249|NCT02882087|Methotrexate|methotrexate|mesh-list
730250|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
730251|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
730252|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
730253|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730254|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
730255|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
730256|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730257|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730258|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
730259|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730260|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
730261|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
730262|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
730263|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
730264|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
731554|NCT02876107|Paclitaxel|paclitaxel|mesh-list
731555|NCT02876107|Carboplatin|carboplatin|mesh-list
731556|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
731557|NCT02876107|Panitumumab|panitumumab|mesh-list
731558|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
731559|NCT02876107|Antibodies|antibodies|mesh-list
731560|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
731561|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
731562|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
731563|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731564|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
731565|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
731566|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
731567|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731568|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
731569|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233249|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233250|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233251|NCT00077415|Antiviral Agents|antiviral agents|mesh-ancestor
2233252|NCT00077415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233253|NCT00077415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233254|NCT00077415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233255|NCT00077415|Immunologic Factors|immunologic factors|mesh-ancestor
2233256|NCT00077415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233257|NCT00077428|Doxorubicin|doxorubicin|mesh-list
2233258|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
731729|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
731730|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
2233259|NCT00077428|Bortezomib|bortezomib|mesh-list
727989|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
728122|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
728123|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
728124|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
728125|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
728126|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728127|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
728128|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2753267|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753268|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2753269|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753270|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753271|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
2753272|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2753273|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
2753274|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2753275|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753276|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
2753277|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2753278|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753279|NCT02939183|Dexamethasone|dexamethasone|mesh-list
2753280|NCT02939183|Pomalidomide|pomalidomide|mesh-list
2753281|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2753282|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
2753283|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
2753284|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2753285|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753286|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2753287|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
2753288|NCT02939183|Hormones|hormones|mesh-ancestor
2753289|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2753290|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2753291|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753292|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
2753293|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2753294|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2753295|NCT02939183|Growth Substances|growth substances|mesh-ancestor
2753296|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
2753297|NCT02935309|Capecitabine|capecitabine|mesh-list
2753298|NCT02935309|Lenvatinib|lenvatinib|mesh-list
2753299|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2753300|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
2233260|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2233261|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233262|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2233263|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
729763|NCT02884479|Docetaxel|docetaxel|mesh-list
729764|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729765|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
729766|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
729767|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
729768|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730191|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
730192|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
730193|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
730194|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
730195|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730196|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
730197|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
730198|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
730499|NCT02879955|Acarbose|acarbose|mesh-list
730500|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
730501|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730502|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730503|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
730504|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090901|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
2090902|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090903|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090904|NCT02222129|Bupivacaine|bupivacaine|mesh-list
2090905|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
2090906|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
2090907|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090908|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730850|NCT02878837|Analgesics|analgesics|mesh-ancestor
727998|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
727999|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
728000|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728001|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728002|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
728003|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
728004|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
728005|NCT02894268|Antacids|antacids|mesh-ancestor
728006|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
728007|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
728008|NCT02894268|Renal Agents|renal agents|mesh-ancestor
728009|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
728010|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
728129|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
728130|NCT02893293|Hematinics|hematinics|mesh-ancestor
728131|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
728132|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
728374|NCT02891967|Z 350|z 350|mesh-list
728375|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
728376|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
728377|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728378|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728379|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
728380|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
728381|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728571|NCT02891447|Cisplatin|cisplatin|mesh-list
728572|NCT02891447|Mitomycins|mitomycins|mesh-list
728573|NCT02891447|Mitomycin|mitomycin|mesh-list
728574|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728575|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
728576|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
728577|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728578|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
728579|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728626|NCT02890771|Turmeric extract|turmeric extract|mesh-list
728627|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
728628|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728629|NCT02890771|Protective Agents|protective agents|mesh-ancestor
728630|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728690|NCT02890173|Eplerenone|eplerenone|mesh-list
728691|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
728692|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
728693|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
728694|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728695|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
728696|NCT02890173|Diuretics|diuretics|mesh-ancestor
728697|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
728698|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
728959|NCT02889497|Vaccines|vaccines|mesh-list
728960|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
728961|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729141|NCT02888392|Psyllium|psyllium|mesh-list
729142|NCT02888392|Cathartics|cathartics|mesh-ancestor
729143|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
729425|NCT02886195|Pemetrexed|pemetrexed|mesh-list
729426|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
729427|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729428|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729429|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729430|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
729431|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
729432|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
729659|NCT02884986|Etoricoxib|etoricoxib|mesh-list
729660|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
729661|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
729662|NCT02884986|Analgesics|analgesics|mesh-ancestor
729663|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
729664|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729665|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729666|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
729667|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
729668|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
729669|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
729670|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233264|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728100|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
728101|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
728102|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728103|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
728104|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
728386|NCT02891980|Vaccines|vaccines|mesh-list
728387|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
728389|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729105|NCT02888327|Oseltamivir|oseltamivir|mesh-list
729106|NCT02888327|Digoxin|digoxin|mesh-list
729107|NCT02888327|Midazolam|midazolam|mesh-list
729108|NCT02888327|Pitavastatin|pitavastatin|mesh-list
729109|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
729110|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
729111|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729112|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729113|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
729114|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
729115|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
729116|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
729117|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
729118|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
729119|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
729120|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
729121|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729122|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729123|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
729124|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
729125|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729126|NCT02888327|Protective Agents|protective agents|mesh-ancestor
729127|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
729128|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729129|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
729130|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
729131|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
729132|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
729133|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2233265|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233266|NCT00077441|Bortezomib|bortezomib|mesh-list
2233267|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233268|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2233269|NCT00077454|Temozolomide|temozolomide|mesh-list
2233270|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233271|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
728221|NCT02893371|Paroxetine|paroxetine|mesh-list
728225|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
728226|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
728227|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
728228|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
728229|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
728230|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
728231|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728232|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728233|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
728234|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
728235|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
728236|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
728237|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
728238|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
728239|NCT02893371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
728240|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
728241|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
728242|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
728243|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
728244|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
728245|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
728246|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
728247|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
728248|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
728249|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
728250|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
728251|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
728252|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728253|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
728254|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
728255|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
728256|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
728257|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
728258|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
728259|NCT02893371|Analgesics|analgesics|mesh-ancestor
728260|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
728261|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
728262|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
728263|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
728264|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
728265|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
728266|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
728267|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
728268|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
728269|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
728270|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
728271|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
728272|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
728273|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
728274|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
728275|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
728276|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
728277|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
728278|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
728279|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
728280|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
728281|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
728282|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
728283|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
728284|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
728285|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2233272|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233273|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233274|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2233275|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
2233276|NCT00077467|Bortezomib|bortezomib|mesh-list
2233277|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233278|NCT00077493|Antibodies|antibodies|mesh-list
2233279|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
2233280|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2233281|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
2233282|NCT00077493|Immunotoxins|immunotoxins|mesh-list
728292|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
728293|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
728346|NCT02892149|Darbepoetin alfa|darbepoetin alfa|mesh-list
728347|NCT02892149|Hematinics|hematinics|mesh-ancestor
728977|NCT02889081|Vitamin D|vitamin d|mesh-list
728978|NCT02889081|Vitamins|vitamins|mesh-ancestor
728979|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
728980|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728981|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
729433|NCT02886286|Fentanyl|fentanyl|mesh-list
729434|NCT02886286|Morphine|morphine|mesh-list
729435|NCT02886286|Hydromorphone|hydromorphone|mesh-list
729436|NCT02886286|Bupivacaine|bupivacaine|mesh-list
729437|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
729438|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
729439|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729440|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729441|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
729442|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729443|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
729444|NCT02886286|Narcotics|narcotics|mesh-ancestor
729445|NCT02886286|Analgesics|analgesics|mesh-ancestor
729446|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
729447|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
729448|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
729491|NCT02885727|Durvalumab|durvalumab|mesh-list
729492|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
729493|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090909|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
2090910|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090911|NCT02222207|Ranibizumab|ranibizumab|mesh-list
2090912|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2090913|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2090914|NCT02222207|Growth Substances|growth substances|mesh-ancestor
730152|NCT02882594|Anesthetics|anesthetics|mesh-list
730153|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
730154|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730279|NCT02881528|Metformin|metformin|mesh-list
730280|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
730281|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730365|NCT02880800|Morphine|morphine|mesh-list
730366|NCT02880800|Hydromorphone|hydromorphone|mesh-list
730367|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
730368|NCT02880800|Narcotics|narcotics|mesh-ancestor
730369|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
730370|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730371|NCT02880800|Analgesics|analgesics|mesh-ancestor
730372|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
730373|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730517|NCT02880033|Deferiprone|deferiprone|mesh-list
730518|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
730519|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
730520|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
730521|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730656|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
730657|NCT02879669|Carboplatin|carboplatin|mesh-list
730658|NCT02879669|Pemetrexed|pemetrexed|mesh-list
730659|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
730660|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
730661|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730662|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
730663|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
730664|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
730665|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730666|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730667|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
730668|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730669|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
730670|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2233283|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
2233284|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233285|NCT00077519|Tipifarnib|tipifarnib|mesh-list
2233286|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233287|NCT00077532|Ipilimumab|ipilimumab|mesh-list
2233288|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
2233289|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2233290|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090915|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233291|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2233292|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233293|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2233294|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
2233295|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233296|NCT00077545|Cisplatin|cisplatin|mesh-list
2233297|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233298|NCT00077558|Fludarabine|fludarabine|mesh-list
2233299|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
2233300|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233301|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233302|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
2233303|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233304|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233305|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
2233306|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233307|NCT00077584|Bosentan|bosentan|mesh-list
2233308|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2233309|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
729023|NCT02888899|Loperamide|loperamide|mesh-list
729024|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
729025|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
729026|NCT02888899|Psyllium|psyllium|mesh-list
729027|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
729028|NCT02888899|Cathartics|cathartics|mesh-ancestor
2233310|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233311|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
2233312|NCT00077597|Hematinics|hematinics|mesh-ancestor
2233313|NCT00077688|Paclitaxel|paclitaxel|mesh-list
2233314|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2233315|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729831|NCT02884245|Estrogens|estrogens|mesh-list
729832|NCT02884245|Hormones|hormones|mesh-ancestor
729833|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
729834|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729892|NCT02883595|Thymalfasin|thymalfasin|mesh-list
729893|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
729894|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
729895|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730067|NCT02883062|Paclitaxel|paclitaxel|mesh-list
730068|NCT02883062|Carboplatin|carboplatin|mesh-list
730069|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
730070|NCT02883062|Atezolizumab|atezolizumab|mesh-list
730071|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
730072|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
730073|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730074|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
730075|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
730076|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
730077|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730078|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
730079|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730162|NCT02882100|Vaccines|vaccines|mesh-list
730163|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
730164|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730979|NCT02878018|Hormones|hormones|mesh-list
730980|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
730981|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
730982|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
730983|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
730984|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730985|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
730986|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730987|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
730988|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
730989|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233316|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
2233317|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
2233318|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
2233319|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233320|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2233321|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2233322|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
728795|NCT02890368|Interferons|interferons|mesh-list
728796|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
728797|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
728798|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
728799|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728800|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
728801|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
728802|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
728803|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
728804|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
728805|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728851|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
728852|NCT02889692|Gefitinib|gefitinib|mesh-list
728853|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
728854|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
728855|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
728856|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728974|NCT02889367|Odalasvir|odalasvir|mesh-list
728975|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
728976|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729048|NCT02888652|Clopidogrel|clopidogrel|mesh-list
729049|NCT02888652|Ticagrelor|ticagrelor|mesh-list
729050|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
729051|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
729052|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
729053|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
729054|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
729055|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729056|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729057|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729062|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
729063|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
729064|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729065|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729066|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
729067|NCT02888275|Analgesics|analgesics|mesh-ancestor
729068|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
729069|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729070|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
729071|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
729072|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
729073|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
729074|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729075|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730409|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
730410|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
730411|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233323|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2233324|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233325|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
731678|NCT02875002|Belinostat|belinostat|mesh-list
731679|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731680|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
731681|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731682|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731865|NCT02874248|Drospirenone|drospirenone|mesh-list
731866|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
731867|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
731868|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
731869|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731870|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
731871|NCT02874248|Diuretics|diuretics|mesh-ancestor
731872|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
732199|NCT02872649|Warfarin|warfarin|mesh-list
732200|NCT02872649|Dabigatran|dabigatran|mesh-list
732201|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
732202|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
732203|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
728609|NCT02890745|Empagliflozin|empagliflozin|mesh-list
728610|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
728611|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
728612|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
728613|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233326|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2233327|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2233328|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
2233329|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2233330|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233331|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2233332|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2233333|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
2233334|NCT00077727|Galantamine|galantamine|mesh-list
729172|NCT02888054|Allopurinol|allopurinol|mesh-list
729173|NCT02888054|Lesinurad|lesinurad|mesh-list
729174|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
729175|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729176|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729177|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
729178|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
729179|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
729180|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
729181|NCT02888054|Protective Agents|protective agents|mesh-ancestor
729182|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729183|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
729184|NCT02888054|Renal Agents|renal agents|mesh-ancestor
729413|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
729414|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
729415|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729494|NCT02885909|Insulin|insulin|mesh-list
729495|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
729496|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730173|NCT02882217|Histamine|histamine|mesh-list
730174|NCT02882217|Glutarimide|glutarimide|mesh-list
730175|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
730176|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
730177|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
730178|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730179|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730180|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
730181|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730309|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
730310|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731005|NCT02878122|Carboplatin|carboplatin|mesh-list
731006|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233335|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2233336|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233337|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233338|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
2233339|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2233340|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233341|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2233342|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
2233343|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731904|NCT02873650|Dabrafenib|dabrafenib|mesh-list
731905|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731906|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
731907|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731908|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233344|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
2233345|NCT00077753|Enoxaparin|enoxaparin|mesh-list
2233346|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
2233347|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
2233348|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2233349|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2233350|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233351|NCT00077779|Adalimumab|adalimumab|mesh-list
2233352|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2233353|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2233354|NCT00077792|Enoxaparin|enoxaparin|mesh-list
2233355|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
2233356|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
2233357|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2233358|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2090916|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
2233359|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233360|NCT00077805|Enoxaparin|enoxaparin|mesh-list
2233361|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
728850|NCT02889653|Anticoagulants|anticoagulants|mesh-list
729003|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
729004|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
729275|NCT02887573|Mosapride|mosapride|mesh-list
729276|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729277|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
729278|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
729279|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
729280|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729281|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729719|NCT02884596|Serotonin|serotonin|mesh-list
729720|NCT02884596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
729721|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
729722|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
729723|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729724|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729725|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729726|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
729727|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
730578|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
730579|NCT02883049|Leucovorin|leucovorin|mesh-list
730580|NCT02883049|Folic Acid|folic acid|mesh-list
730581|NCT02883049|Cytarabine|cytarabine|mesh-list
730582|NCT02883049|Dexamethasone|dexamethasone|mesh-list
730583|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
730584|NCT02883049|Prednisone|prednisone|mesh-list
730585|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
730586|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
730587|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
730588|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
730589|NCT02883049|Cortisone|cortisone|mesh-list
730590|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
730591|NCT02883049|Doxorubicin|doxorubicin|mesh-list
730592|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
730593|NCT02883049|Methotrexate|methotrexate|mesh-list
730594|NCT02883049|Etoposide|etoposide|mesh-list
730595|NCT02883049|Vincristine|vincristine|mesh-list
730596|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
730597|NCT02883049|Daunorubicin|daunorubicin|mesh-list
730598|NCT02883049|Asparaginase|asparaginase|mesh-list
730599|NCT02883049|Dasatinib|dasatinib|mesh-list
730600|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
730601|NCT02883049|Clofarabine|clofarabine|mesh-list
730602|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
730603|NCT02883049|Thioguanine|thioguanine|mesh-list
730604|NCT02883049|Pegaspargase|pegaspargase|mesh-list
730605|NCT02883049|BB 1101|bb 1101|mesh-list
730606|NCT02883049|Calcium|calcium|mesh-list
730607|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
730608|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
730609|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
730610|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
730611|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730612|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
730613|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
730614|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
730615|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730616|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730617|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
730618|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
730619|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
730620|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
730621|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730622|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
730623|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
730624|NCT02883049|Hormones|hormones|mesh-ancestor
730625|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
730626|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
730627|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
730628|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730629|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
730630|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
730631|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
730632|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
730633|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
730634|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2090917|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090918|NCT02222246|Morphine|morphine|mesh-list
2090919|NCT02222246|Hydromorphone|hydromorphone|mesh-list
2090920|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2090921|NCT02222246|Narcotics|narcotics|mesh-ancestor
2090922|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2090923|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090924|NCT02222246|Analgesics|analgesics|mesh-ancestor
2090925|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
2090926|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2090927|NCT02222493|Infliximab|infliximab|mesh-list
2090928|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
2090929|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2090930|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2090931|NCT02222558|Testosterone|testosterone|mesh-list
729185|NCT02888067|Bromides|bromides|mesh-list
729186|NCT02888067|Rocuronium|rocuronium|mesh-list
729187|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
729188|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
729189|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
729190|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
729191|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729192|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729355|NCT02886962|Vitamin K|vitamin k|mesh-list
729356|NCT02886962|Vitamins|vitamins|mesh-ancestor
729357|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
729358|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729359|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
729360|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
729361|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729362|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
729363|NCT02886962|Coagulants|coagulants|mesh-ancestor
729504|NCT02885740|Adenosine|adenosine|mesh-list
729505|NCT02885740|Analgesics|analgesics|mesh-ancestor
729506|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
729507|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729508|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729509|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
729510|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
729511|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
729512|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
729513|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
729514|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729515|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729978|NCT02883114|Itraconazole|itraconazole|mesh-list
729979|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
729980|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729981|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
729982|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
729983|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729984|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729985|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
729986|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
729987|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
729988|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729989|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
730149|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
730150|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
730151|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730718|NCT02879721|Candesartan|candesartan|mesh-list
730719|NCT02879721|Enalapril|enalapril|mesh-list
730720|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
730721|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
730722|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
730723|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730724|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
730725|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
730726|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730844|NCT02878837|Midazolam|midazolam|mesh-list
730845|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
730846|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
730847|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
730848|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730849|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2090932|NCT02222558|Androgens|androgens|mesh-ancestor
2090933|NCT02222558|Hormones|hormones|mesh-ancestor
2233362|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
2233363|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2233364|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2233365|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233366|NCT00077818|Enoxaparin|enoxaparin|mesh-list
2233367|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
2233368|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
2233369|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2233370|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2233371|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730030|NCT02882789|Delpazolid|delpazolid|mesh-list
730031|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
730032|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
730033|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
730034|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
730035|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730036|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730155|NCT02882113|Tacrolimus|tacrolimus|mesh-list
730156|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
730157|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
730158|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730159|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
730160|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730161|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730563|NCT02880007|Cisplatin|cisplatin|mesh-list
730564|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730768|NCT02879227|Cisplatin|cisplatin|mesh-list
730769|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
730770|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730948|NCT02878421|Nicotine|nicotine|mesh-list
730949|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
730950|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
730951|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730952|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730953|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
730954|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
730955|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
730956|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
730957|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730974|NCT02878083|Adalimumab|adalimumab|mesh-list
730975|NCT02878083|Vedolizumab|vedolizumab|mesh-list
730976|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
730977|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
730978|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
731200|NCT02876679|Cyclosporine|cyclosporine|mesh-list
731201|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
731202|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
731203|NCT02876679|Cyclosporins|cyclosporins|mesh-list
731204|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
731205|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
731206|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
731207|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731208|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731209|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
731210|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
731211|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731212|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731213|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
731214|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731215|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
731216|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
731217|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
731218|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
731219|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
731220|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
731221|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
731222|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
732239|NCT02872116|Leucovorin|leucovorin|mesh-list
732240|NCT02872116|Fluorouracil|fluorouracil|mesh-list
732241|NCT02872116|Capecitabine|capecitabine|mesh-list
732242|NCT02872116|Oxaliplatin|oxaliplatin|mesh-list
732243|NCT02872116|Nivolumab|nivolumab|mesh-list
732244|NCT02872116|Ipilimumab|ipilimumab|mesh-list
732245|NCT02872116|Antimetabolites|antimetabolites|mesh-ancestor
732246|NCT02872116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732247|NCT02872116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
732248|NCT02872116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732249|NCT02872116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
728999|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
729000|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
729001|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729002|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729033|NCT02888730|Tobramycin|tobramycin|mesh-list
729034|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
729035|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729231|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
729232|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
729233|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729234|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
729235|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729383|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
729384|NCT02886429|Bupivacaine|bupivacaine|mesh-list
729385|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
729386|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
729387|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729388|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729389|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
729390|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729391|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
729392|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
729393|NCT02886429|Analgesics|analgesics|mesh-ancestor
729394|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
729395|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
729396|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
729397|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
729398|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729399|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729561|NCT02885753|Leucovorin|leucovorin|mesh-list
729562|NCT02885753|Folic Acid|folic acid|mesh-list
729563|NCT02885753|Bevacizumab|bevacizumab|mesh-list
729564|NCT02885753|Panitumumab|panitumumab|mesh-list
729565|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
729566|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
729567|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
729568|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729569|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
729570|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
729571|NCT02885753|Growth Substances|growth substances|mesh-ancestor
729572|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729573|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
729574|NCT02885753|Antidotes|antidotes|mesh-ancestor
729575|NCT02885753|Protective Agents|protective agents|mesh-ancestor
729576|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
729577|NCT02885753|Vitamins|vitamins|mesh-ancestor
729578|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
729579|NCT02885753|Hematinics|hematinics|mesh-ancestor
729949|NCT02883569|Ibuprofen|ibuprofen|mesh-list
729950|NCT02883569|Aceclofenac|aceclofenac|mesh-list
729951|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
729952|NCT02883569|Tramadol|tramadol|mesh-list
729953|NCT02883569|Codeine|codeine|mesh-list
729954|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
729955|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
729956|NCT02883569|Analgesics|analgesics|mesh-ancestor
729957|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
729958|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729959|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729960|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
729961|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
729962|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
729963|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729964|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729965|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
729966|NCT02883569|Narcotics|narcotics|mesh-ancestor
729967|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729968|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
729969|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
730010|NCT02882828|Tacrolimus|tacrolimus|mesh-list
730011|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
730012|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
730013|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730014|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
730015|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730016|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233372|NCT00077844|Enoxaparin|enoxaparin|mesh-list
729157|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
729158|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
729159|NCT02887976|Hormones|hormones|mesh-ancestor
729160|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
729161|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
729162|NCT02887976|Protective Agents|protective agents|mesh-ancestor
729163|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
729164|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729165|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
729166|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729167|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729168|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
729169|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
729403|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
729404|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
729405|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
729406|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
729407|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729408|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729409|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
729410|NCT02886351|Analgesics|analgesics|mesh-ancestor
729411|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
729412|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2233373|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
2233374|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
2233375|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2233376|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2233377|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233378|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
2233379|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
2233380|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233381|NCT00077883|Cisplatin|cisplatin|mesh-list
2233382|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233383|NCT00077948|Metoprolol|metoprolol|mesh-list
2233384|NCT00077948|Enoximone|enoximone|mesh-list
2233385|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2233386|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2233387|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
729731|NCT02884713|Doxycycline|doxycycline|mesh-list
729732|NCT02884713|Levofloxacin|levofloxacin|mesh-list
729733|NCT02884713|Ofloxacin|ofloxacin|mesh-list
729734|NCT02884713|Esomeprazole|esomeprazole|mesh-list
729735|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
729736|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
729737|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
729738|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729739|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729740|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
729741|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729742|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
729743|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
729744|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
729745|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
729746|NCT02884713|Renal Agents|renal agents|mesh-ancestor
729747|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
729748|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
729749|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729750|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
729751|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2233388|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
2233389|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2233390|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729931|NCT02883478|Riboflavin|riboflavin|mesh-list
729932|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
729933|NCT02883478|Vitamins|vitamins|mesh-ancestor
729934|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
729935|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729936|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
729937|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
730182|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
730183|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2233391|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2233392|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2233393|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2233394|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
2233395|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729206|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
729207|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
729208|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2233396|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233397|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2233398|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
2233399|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2233400|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2233401|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233402|NCT00077948|Protective Agents|protective agents|mesh-ancestor
2233403|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
730240|NCT02881762|Maraviroc|maraviroc|mesh-list
730241|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
730242|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
730243|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730244|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
730245|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
730246|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
730247|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
730248|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2233404|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2233405|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730671|NCT02879435|Bupivacaine|bupivacaine|mesh-list
730672|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
730673|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
730674|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
730675|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730676|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
730677|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731256|NCT02876354|Vitamin K|vitamin k|mesh-list
731257|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
731258|NCT02876354|Vitamins|vitamins|mesh-ancestor
731259|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
731260|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731261|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
731262|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
731263|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731264|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
731265|NCT02876354|Coagulants|coagulants|mesh-ancestor
731605|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
731606|NCT02875314|Thiotepa|thiotepa|mesh-list
731607|NCT02875314|Cisplatin|cisplatin|mesh-list
731608|NCT02875314|Carboplatin|carboplatin|mesh-list
731609|NCT02875314|Methotrexate|methotrexate|mesh-list
731610|NCT02875314|Etoposide|etoposide|mesh-list
731611|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
731612|NCT02875314|Vincristine|vincristine|mesh-list
731613|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
731614|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
731615|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731616|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731617|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
731618|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
731619|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731620|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731621|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
731622|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
731623|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
731624|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
731625|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
731626|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
731627|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
731628|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731629|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
731630|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
731631|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
731632|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
731633|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
731634|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
731635|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
731636|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
732443|NCT02871518|Cisplatin|cisplatin|mesh-list
732444|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732580|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
732581|NCT02870907|Thiotepa|thiotepa|mesh-list
732582|NCT02870907|Carboplatin|carboplatin|mesh-list
732583|NCT02870907|Etoposide|etoposide|mesh-list
732584|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
2233406|NCT00077987|Sunitinib|sunitinib|mesh-list
2233407|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233408|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2233409|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
729449|NCT02885974|Gemcitabine|gemcitabine|mesh-list
729450|NCT02885974|Celecoxib|celecoxib|mesh-list
729451|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729452|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
729453|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
729454|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729455|NCT02885974|Antiviral Agents|antiviral agents|mesh-ancestor
729456|NCT02885974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729457|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729458|NCT02885974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
729459|NCT02885974|Immunologic Factors|immunologic factors|mesh-ancestor
729460|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729461|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
729462|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
729463|NCT02885974|Analgesics|analgesics|mesh-ancestor
729464|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
729465|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729466|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
729467|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
729468|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
729469|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
729843|NCT02884180|Dexamethasone|dexamethasone|mesh-list
729844|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
729845|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
729846|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
729847|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729848|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729849|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
729850|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
729851|NCT02884180|Hormones|hormones|mesh-ancestor
729852|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
729853|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
729854|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729896|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
729897|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
729898|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753301|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753302|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753303|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2753304|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233410|NCT00077987|Growth Substances|growth substances|mesh-ancestor
2233411|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233412|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
2233413|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2233414|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233415|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233416|NCT00078000|Sunitinib|sunitinib|mesh-list
2233417|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233418|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2233419|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2233420|NCT00078000|Growth Substances|growth substances|mesh-ancestor
2233421|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730728|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
730729|NCT02879513|Epirubicin|epirubicin|mesh-list
729238|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
729239|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
729240|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729241|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729242|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
729243|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
729244|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
729245|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
729246|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
729247|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
729248|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
729249|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
729250|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729251|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729252|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
729253|NCT02887443|Protective Agents|protective agents|mesh-ancestor
729728|NCT02884817|Listerine|listerine|mesh-list
729729|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
729730|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729801|NCT02884310|Remifentanil|remifentanil|mesh-list
729802|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
729803|NCT02884310|Narcotics|narcotics|mesh-ancestor
729804|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729805|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729806|NCT02884310|Analgesics|analgesics|mesh-ancestor
729807|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
729808|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730140|NCT02882425|Selexipag|selexipag|mesh-list
730141|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
730765|NCT02879292|Anesthetics|anesthetics|mesh-list
730766|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
730767|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730971|NCT02878291|Vaccines|vaccines|mesh-list
730972|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
730973|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731189|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
731190|NCT02876978|Fludarabine|fludarabine|mesh-list
731191|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
731192|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
731193|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731194|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731195|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
731196|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
731197|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731198|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731199|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
731372|NCT02876081|Afatinib|afatinib|mesh-list
731373|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731374|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
731375|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731376|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731533|NCT02875717|Aspirin|aspirin|mesh-list
731534|NCT02875717|Heparin|heparin|mesh-list
731535|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
731536|NCT02875717|Tinzaparin|tinzaparin|mesh-list
731537|NCT02875717|Dalteparin|dalteparin|mesh-list
731538|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
731539|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
731540|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
731541|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731542|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
731543|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
731544|NCT02875717|Analgesics|analgesics|mesh-ancestor
731545|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
731546|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731547|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731548|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
731549|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731550|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
731551|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
731552|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731553|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
731595|NCT02875093|Cytarabine|cytarabine|mesh-list
731596|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
731597|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
731598|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731600|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
729644|NCT02885311|Naltrexone|naltrexone|mesh-list
729645|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
729646|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
729647|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729648|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
729649|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730110|NCT02882477|Metformin|metformin|mesh-list
730111|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
730112|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
730113|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
730114|NCT02882477|Deferiprone|deferiprone|mesh-list
730115|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
730116|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730117|NCT02882477|Incretins|incretins|mesh-ancestor
730118|NCT02882477|Hormones|hormones|mesh-ancestor
730119|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
730120|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
730121|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
730122|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730123|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730124|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
730125|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
730126|NCT02882477|Expectorants|expectorants|mesh-ancestor
730127|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
730128|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
730129|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
730130|NCT02882477|Protective Agents|protective agents|mesh-ancestor
730131|NCT02882477|Antidotes|antidotes|mesh-ancestor
730132|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
730133|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
730134|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
2233422|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
2233423|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2233424|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233425|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233426|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2233427|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2233428|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2233429|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2233430|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233431|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2233432|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2233433|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2233434|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
730412|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
730413|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
730414|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730889|NCT02878785|Decitabine|decitabine|mesh-list
730890|NCT02878785|Talazoparib|talazoparib|mesh-list
730891|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
730892|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
730893|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730894|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730895|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730896|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
731168|NCT02876770|Melatonin|melatonin|mesh-list
731169|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
731170|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731171|NCT02876770|Protective Agents|protective agents|mesh-ancestor
731172|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731173|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732585|NCT02870907|Vincristine|vincristine|mesh-list
2233435|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2233436|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233437|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2233438|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2233439|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
2233440|NCT00078117|Buprenorphine|buprenorphine|mesh-list
2233441|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2233442|NCT00078117|Narcotics|narcotics|mesh-ancestor
2233443|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2233444|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233445|NCT00078117|Analgesics|analgesics|mesh-ancestor
2233446|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
2233447|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2233448|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2233449|NCT00078130|Buprenorphine|buprenorphine|mesh-list
2233450|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2233451|NCT00078130|Naloxone|naloxone|mesh-list
2233452|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2233453|NCT00078130|Narcotics|narcotics|mesh-ancestor
2233454|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
730199|NCT02881866|Furosemide|furosemide|mesh-list
730200|NCT02881866|Diuretics|diuretics|mesh-ancestor
730201|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
730202|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730203|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
730204|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
730205|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233455|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233456|NCT00078130|Analgesics|analgesics|mesh-ancestor
2233457|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
2233458|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2233459|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2233460|NCT00078182|Tenofovir|tenofovir|mesh-list
2233461|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
2233462|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233463|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2233464|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2233465|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233466|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233467|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2233468|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2233469|NCT00078195|Omalizumab|omalizumab|mesh-list
2233470|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
2233471|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
2233472|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2233473|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233474|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2233475|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
731390|NCT02875743|Posaconazole|posaconazole|mesh-list
731391|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
731392|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
731393|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
731394|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
731395|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
731396|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
731397|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
731398|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731399|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731400|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
731401|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
731402|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
731403|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090934|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2090935|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090936|NCT02222610|Ranibizumab|ranibizumab|mesh-list
2090937|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2090938|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2090939|NCT02222610|Growth Substances|growth substances|mesh-ancestor
2090940|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090941|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
2090942|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732025|NCT02873351|Levodopa|levodopa|mesh-list
732026|NCT02873351|Carbidopa|carbidopa|mesh-list
732250|NCT02872116|Immunologic Factors|immunologic factors|mesh-ancestor
729402|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729835|NCT02884037|Rifaximin|rifaximin|mesh-list
729836|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
729837|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729838|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
729882|NCT02883647|Tenofovir|tenofovir|mesh-list
729883|NCT02883647|Entecavir|entecavir|mesh-list
729884|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
729885|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729886|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
729887|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
729888|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729889|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729890|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
729891|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
729938|NCT02883439|Fluticasone|fluticasone|mesh-list
729939|NCT02883439|Xhance|xhance|mesh-list
729940|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
729941|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
729942|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
729943|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729944|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729945|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
729946|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
729947|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
729948|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
730000|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
730001|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
730002|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
730003|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730004|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730005|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
730006|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
730007|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730008|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
730009|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
730083|NCT02882347|Somatostatin|somatostatin|mesh-list
730084|NCT02882347|Hormones|hormones|mesh-ancestor
730085|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
730086|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730404|NCT02880410|Temozolomide|temozolomide|mesh-list
730405|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
730406|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
730407|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730408|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730868|NCT02879006|Omalizumab|omalizumab|mesh-list
730869|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
730870|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
730871|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
730919|NCT02878564|Praziquantel|praziquantel|mesh-list
730920|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
730921|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
730922|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
731083|NCT02877550|Venetoclax|venetoclax|mesh-list
731084|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
731085|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731086|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
731377|NCT02876146|Albendazole|albendazole|mesh-list
731378|NCT02876146|Benzimidazole|benzimidazole|mesh-list
731379|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
731380|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
731381|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
731382|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
731383|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
731384|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
731385|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
731386|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
731387|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
731388|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731389|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731577|NCT02875262|Deferoxamine|deferoxamine|mesh-list
731578|NCT02875262|Siderophores|siderophores|mesh-ancestor
731579|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
731580|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
731581|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
731582|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731923|NCT02873806|Tobramycin|tobramycin|mesh-list
729417|NCT02886299|Fenofibrate|fenofibrate|mesh-list
729418|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
729419|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
729420|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
729421|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729422|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
729423|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
729424|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730103|NCT02882308|Durvalumab|durvalumab|mesh-list
730104|NCT02882308|Olaparib|olaparib|mesh-list
730105|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730106|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
730107|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
730108|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730109|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730958|NCT02878538|Deferiprone|deferiprone|mesh-list
730959|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
730960|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
730961|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
730962|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731075|NCT02877771|Insulin|insulin|mesh-list
731076|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
731077|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731703|NCT02874963|Ethanol|ethanol|mesh-list
731704|NCT02874963|Listerine|listerine|mesh-list
731705|NCT02874963|Eucalyptol|eucalyptol|mesh-list
731706|NCT02874963|Salicylates|salicylates|mesh-list
731707|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
731708|NCT02874963|Menthol|menthol|mesh-list
731709|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
731710|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
731711|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
731712|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731713|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
731714|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
731715|NCT02874963|Protective Agents|protective agents|mesh-ancestor
731716|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
731717|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
731718|NCT02874963|Analgesics|analgesics|mesh-ancestor
731719|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
731720|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731721|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
731722|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731723|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
731724|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731725|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731726|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
731727|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
731728|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
732208|NCT02872389|Sevoflurane|sevoflurane|mesh-list
732209|NCT02872389|Desflurane|desflurane|mesh-list
732210|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
732211|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
732212|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
732213|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
732214|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732215|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090943|NCT02222714|Protein C|protein c|mesh-list
2090944|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
2090945|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2090946|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2090947|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090948|NCT02222870|Vaccines|vaccines|mesh-list
2090949|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
2090950|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090951|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
2090952|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2090953|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2090954|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090955|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
2090956|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
2090957|NCT02222922|Fluconazole|fluconazole|mesh-list
2090958|NCT02222922|Avelumab|avelumab|mesh-list
2090959|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2090960|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090961|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
2090962|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729470|NCT02885961|Dabigatran|dabigatran|mesh-list
729471|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
729472|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
729473|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
729474|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729475|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729476|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
729650|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
729651|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
729652|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
729653|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729654|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
729655|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
729656|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
730046|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2233476|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
2233477|NCT00078234|Rituximab|rituximab|mesh-list
2233478|NCT00078234|Fludarabine|fludarabine|mesh-list
2233479|NCT00078234|Oblimersen|oblimersen|mesh-list
730937|NCT02878512|Anesthetics|anesthetics|mesh-list
730938|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
730939|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731147|NCT02876991|Listerine|listerine|mesh-list
731148|NCT02876991|Fluorides|fluorides|mesh-list
731149|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
731150|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
731151|NCT02876991|Protective Agents|protective agents|mesh-ancestor
731152|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731153|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
731154|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
731225|NCT02876549|Chloroquine|chloroquine|mesh-list
731226|NCT02876549|Primaquine|primaquine|mesh-list
731227|NCT02876549|Amebicides|amebicides|mesh-ancestor
731228|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
731229|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
731230|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
731231|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
731232|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731574|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
731575|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
731576|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233480|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2233481|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233482|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
2233483|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233484|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2233485|NCT00078247|Lamivudine|lamivudine|mesh-list
2233486|NCT00078247|Zidovudine|zidovudine|mesh-list
2233487|NCT00078247|Abacavir|abacavir|mesh-list
2233488|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
732115|NCT02872818|Metformin|metformin|mesh-list
732116|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
732117|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
732118|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
732119|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
732120|NCT02872818|Estradiol|estradiol|mesh-list
732121|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
732122|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
732123|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732124|NCT02872818|Estrogens|estrogens|mesh-ancestor
732125|NCT02872818|Hormones|hormones|mesh-ancestor
732126|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
732127|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
732128|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
732129|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
732130|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
732131|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
732132|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
732133|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
732134|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
732135|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
732136|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732328|NCT02871869|Buformin|buformin|mesh-list
732329|NCT02871869|Prednisone|prednisone|mesh-list
732330|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
732331|NCT02871869|Rituximab|rituximab|mesh-list
732332|NCT02871869|Epirubicin|epirubicin|mesh-list
732333|NCT02871869|Vindesine|vindesine|mesh-list
732334|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233489|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
729527|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233490|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729914|NCT02883192|Ondansetron|ondansetron|mesh-list
729915|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
729916|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
729917|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729918|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729919|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
729920|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
729921|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
729922|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
729923|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
729924|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729925|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729926|NCT02883192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
729927|NCT02883192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
729928|NCT02883192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729929|NCT02883192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
729930|NCT02883192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
730017|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
730018|NCT02882984|Gefitinib|gefitinib|mesh-list
730019|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730020|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
730021|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730022|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730235|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
730236|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
730237|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730238|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
730239|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730525|NCT02879981|Trimethoprim|trimethoprim|mesh-list
730526|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
730527|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
730528|NCT02879981|Guaifenesin|guaifenesin|mesh-list
730529|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
730530|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
730531|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
730532|NCT02879981|Renal Agents|renal agents|mesh-ancestor
730533|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
730534|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
730535|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
730536|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
730537|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730538|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730539|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
730540|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
730541|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
730542|NCT02879981|Expectorants|expectorants|mesh-ancestor
730543|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
730544|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
730545|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
730546|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
730547|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
730548|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730549|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
730550|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
730551|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
730552|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
730553|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730554|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
730555|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
731143|NCT02877173|Alprostadil|alprostadil|mesh-list
731144|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
731145|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
731146|NCT02877173|Urological Agents|urological agents|mesh-ancestor
731182|NCT02876822|Vitamin D|vitamin d|mesh-list
731183|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
731184|NCT02876822|Vitamins|vitamins|mesh-ancestor
731185|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
731186|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731187|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
731188|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
731501|NCT02875587|Cabergoline|cabergoline|mesh-list
731502|NCT02875587|Calcium|calcium|mesh-list
731503|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
729540|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
729541|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
729542|NCT02885558|Diuretics|diuretics|mesh-ancestor
729543|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
729760|NCT02884388|Anesthetics|anesthetics|mesh-list
729761|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729762|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729825|NCT02884115|Penicillins|penicillins|mesh-list
729826|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
729827|NCT02884115|Penicillin G|penicillin g|mesh-list
729828|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
729829|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
729830|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
730080|NCT02882581|Metformin|metformin|mesh-list
730081|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
730082|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730330|NCT02881177|Oxytocin|oxytocin|mesh-list
730331|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
730332|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
730333|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090963|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2090964|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2090965|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090966|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090967|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2090968|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
2090969|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2090970|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090971|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2090972|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2090973|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
2090974|NCT02223065|Saxagliptin|saxagliptin|mesh-list
2090975|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2090976|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090977|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2090978|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2090979|NCT02223065|Incretins|incretins|mesh-ancestor
2090980|NCT02223065|Hormones|hormones|mesh-ancestor
2233491|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233492|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
2233493|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233494|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
730711|NCT02879643|Vincristine|vincristine|mesh-list
730712|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
730713|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730714|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
730715|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
730716|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
730717|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731354|NCT02876211|Vitamin D|vitamin d|mesh-list
731355|NCT02876211|Vitamins|vitamins|mesh-ancestor
731356|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
731357|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731358|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
731737|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
731738|NCT02874768|Propofol|propofol|mesh-list
731739|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
731740|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
731741|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731742|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
731743|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
731744|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
731745|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
731746|NCT02874768|Analgesics|analgesics|mesh-ancestor
731747|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
731748|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731749|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
731750|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
731751|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
731752|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
731753|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
731754|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233495|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2233496|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
2233497|NCT00078260|Pemetrexed|pemetrexed|mesh-list
729588|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
729589|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
729590|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729591|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
729592|NCT02885454|Estrogens|estrogens|mesh-ancestor
729593|NCT02885454|Hormones|hormones|mesh-ancestor
729594|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
729595|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
729596|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
729597|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
729598|NCT02885454|Diuretics|diuretics|mesh-ancestor
729599|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
729600|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
729601|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729602|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
729603|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729604|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729855|NCT02884128|Leucovorin|leucovorin|mesh-list
729856|NCT02884128|Fluorouracil|fluorouracil|mesh-list
729857|NCT02884128|Irinotecan|irinotecan|mesh-list
729858|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
729859|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729860|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
729861|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729862|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
729863|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
729864|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729865|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
729866|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
729867|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729868|NCT02884128|Antidotes|antidotes|mesh-ancestor
729869|NCT02884128|Protective Agents|protective agents|mesh-ancestor
729870|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
729871|NCT02884128|Vitamins|vitamins|mesh-ancestor
729872|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
730087|NCT02882451|Ascorbic Acid|ascorbic acid|mesh-list
730088|NCT02882451|Pinaverium|pinaverium|mesh-list
730089|NCT02882451|Bromides|bromides|mesh-list
730090|NCT02882451|Vitamins|vitamins|mesh-ancestor
730091|NCT02882451|Micronutrients|micronutrients|mesh-ancestor
730092|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730093|NCT02882451|Antioxidants|antioxidants|mesh-ancestor
730094|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730095|NCT02882451|Protective Agents|protective agents|mesh-ancestor
730096|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
730097|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
730098|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
730099|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
730100|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
730101|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
730102|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730318|NCT02880995|Amisulpride|amisulpride|mesh-list
730319|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
730320|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
730321|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
730322|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730323|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
730324|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
730325|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
730326|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
730327|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730328|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
730329|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
730678|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
730679|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
730680|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731245|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
731246|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
729635|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
729636|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
729637|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
729638|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729639|NCT02885168|Protective Agents|protective agents|mesh-ancestor
729640|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
729641|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
729642|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
729643|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
729702|NCT02884921|Acetaminophen|acetaminophen|mesh-list
729703|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
729704|NCT02884921|Analgesics|analgesics|mesh-ancestor
729705|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
729706|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729707|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729708|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
729785|NCT02884440|Ropivacaine|ropivacaine|mesh-list
729786|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
729787|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729788|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729789|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
729790|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
729791|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730771|NCT02879409|Insulin|insulin|mesh-list
730772|NCT02879409|Metformin|metformin|mesh-list
730773|NCT02879409|Pioglitazone|pioglitazone|mesh-list
730774|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
730775|NCT02879409|Liraglutide|liraglutide|mesh-list
730776|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
730777|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
730778|NCT02879409|Gliclazide|gliclazide|mesh-list
730779|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
730780|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730781|NCT02879409|Incretins|incretins|mesh-ancestor
730782|NCT02879409|Hormones|hormones|mesh-ancestor
730783|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
730784|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
730785|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
730786|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730787|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730788|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
730963|NCT02878200|Piperaquine|piperaquine|mesh-list
730964|NCT02878200|Artenimol|artenimol|mesh-list
730965|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
730966|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
730967|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
730968|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233498|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233499|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233500|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233501|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2233502|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2233503|NCT00078351|Hylan|hylan|mesh-list
2233504|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
2233505|NCT00078351|Protective Agents|protective agents|mesh-ancestor
2233506|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233507|NCT00078390|S 3304|s 3304|mesh-list
2233508|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
2233509|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
2233510|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731278|NCT02876250|Cyclosporine|cyclosporine|mesh-list
731279|NCT02876250|Cyclosporins|cyclosporins|mesh-list
731280|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731281|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731282|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
731283|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
731284|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731285|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
731286|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
731287|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
731288|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731289|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2233511|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233512|NCT00078442|Interferons|interferons|mesh-list
2233513|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
2233514|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
731599|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233515|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
729671|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729899|NCT02883179|Lidocaine|lidocaine|mesh-list
729900|NCT02883179|Prilocaine|prilocaine|mesh-list
729901|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
729902|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
729903|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
729904|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
729905|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
729906|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
729907|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
729908|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
729909|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
729910|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
729911|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
729912|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729913|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
730047|NCT02882555|Capsaicin|capsaicin|mesh-list
730048|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
730049|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
730050|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
730051|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730052|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730135|NCT02882269|Capecitabine|capecitabine|mesh-list
730136|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
730137|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
730138|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730139|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730789|NCT02879110|Sulforaphane|sulforaphane|mesh-list
730790|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
730791|NCT02879110|Protective Agents|protective agents|mesh-ancestor
730792|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730793|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2090981|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2090982|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2090983|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
2090984|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731732|NCT02874807|Empagliflozin|empagliflozin|mesh-list
731733|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
731734|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731735|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
731736|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731947|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
731948|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233516|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233517|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
2233518|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233519|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
2233520|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233521|NCT00078481|Idebenone|idebenone|mesh-list
2233522|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
2233523|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233524|NCT00078481|Protective Agents|protective agents|mesh-ancestor
2233525|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233526|NCT00078546|Antibodies|antibodies|mesh-list
2233527|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2090985|NCT02223260|Dabigatran|dabigatran|mesh-list
2090986|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
2090987|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2090988|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
2090989|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090990|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090991|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
2090992|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
2090993|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2090994|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2090995|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2090996|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2090997|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2090998|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2090999|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091000|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2091001|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2233528|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
2091002|NCT02223351|Ritonavir|ritonavir|mesh-list
2091003|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2091004|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2091005|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
2091006|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091007|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233529|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233530|NCT00078572|Capecitabine|capecitabine|mesh-list
2233531|NCT00078572|Lapatinib|lapatinib|mesh-list
2233532|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
730206|NCT02882126|Treprostinil|treprostinil|mesh-list
730207|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2233533|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
2233534|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233535|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730399|NCT02880462|Sulforaphane|sulforaphane|mesh-list
730400|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
730401|NCT02880462|Protective Agents|protective agents|mesh-ancestor
730402|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730403|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091008|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2091009|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2091010|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
2091011|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091012|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2091013|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2091014|NCT02223364|Bupivacaine|bupivacaine|mesh-list
2091015|NCT02223364|Ropivacaine|ropivacaine|mesh-list
2091016|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
2091017|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
2091018|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2091019|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091020|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
2091021|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091022|NCT02223429|Vasopressins|vasopressins|mesh-list
2091023|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
2091024|NCT02223429|Oxytocin|oxytocin|mesh-list
2091025|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091026|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
2091027|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
731637|NCT02875288|Bupivacaine|bupivacaine|mesh-list
731638|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
731639|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
731640|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
731641|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731642|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
731643|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091028|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
2091029|NCT02223429|Coagulants|coagulants|mesh-ancestor
2091030|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2091031|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2091032|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
2091044|NCT02223702|Amoxicillin|amoxicillin|mesh-list
2091045|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
2091046|NCT02223702|Metronidazole|metronidazole|mesh-list
2091047|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
731886|NCT02873598|Gemcitabine|gemcitabine|mesh-list
731887|NCT02873598|Paclitaxel|paclitaxel|mesh-list
731888|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
731889|NCT02873598|Folfirinox|folfirinox|mesh-list
731890|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
731891|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731892|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
731893|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
731894|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
2091048|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091049|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
729774|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
729775|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
729776|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729777|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
729778|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
729779|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729780|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
729781|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
729782|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
729783|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
729784|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
730556|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
730557|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
730558|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
730559|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
730560|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730561|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
730562|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730832|NCT02879136|Methylphenidate|methylphenidate|mesh-list
730833|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
730834|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
730835|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730836|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
730837|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
730838|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
730839|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730840|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
730841|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
730842|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
730843|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
731477|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
731478|NCT02875886|Amiloride|amiloride|mesh-list
731479|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
731480|NCT02875886|Diuretics|diuretics|mesh-ancestor
731481|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
731482|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731483|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
731484|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
731485|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731486|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
731487|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
731488|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
731489|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
732017|NCT02873364|Vitamin D|vitamin d|mesh-list
732018|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
732019|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
732020|NCT02873364|Vitamins|vitamins|mesh-list
732021|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
732022|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732023|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
732024|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2233536|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2233537|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233538|NCT00078598|Rituximab|rituximab|mesh-list
2233539|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
2233540|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2233541|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233542|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
2233543|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091050|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2091051|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091052|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091053|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091054|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2091055|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2091056|NCT02223871|Lumefantrine|lumefantrine|mesh-list
2091057|NCT02223871|Artemether|artemether|mesh-list
729818|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
729819|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
729820|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
729821|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
729822|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
729823|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
729824|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
730311|NCT02881242|Trametinib|trametinib|mesh-list
730312|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730313|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
730314|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730315|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731102|NCT02877641|Vitamin D|vitamin d|mesh-list
731103|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
731104|NCT02877641|Vitamins|vitamins|mesh-list
731105|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
731106|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731107|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
731108|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2233544|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2233545|NCT00078611|Natalizumab|natalizumab|mesh-list
2233546|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
2233547|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233548|NCT00078689|Daclizumab|daclizumab|mesh-list
2233549|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233550|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
2233551|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233552|NCT00078793|Etanercept|etanercept|mesh-list
2233553|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2233554|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2233555|NCT00078793|Analgesics|analgesics|mesh-ancestor
2233556|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
2233557|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2233558|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233559|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
731658|NCT02875015|Lidocaine|lidocaine|mesh-list
731659|NCT02875015|Bupivacaine|bupivacaine|mesh-list
731660|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
731661|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
731662|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
731663|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731664|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
731665|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731666|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
731667|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
731668|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
731669|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
731670|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731755|NCT02874690|Methylphenidate|methylphenidate|mesh-list
731756|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
731757|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731758|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
731759|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
731760|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
731761|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731762|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
731763|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
731833|NCT02874326|Octreotide|octreotide|mesh-list
731834|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
731835|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
731836|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732282|NCT02871791|Everolimus|everolimus|mesh-list
732283|NCT02871791|Palbociclib|palbociclib|mesh-list
732284|NCT02871791|Exemestane|exemestane|mesh-list
732285|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732286|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
732287|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
732288|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732289|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
732290|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732291|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732292|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
732293|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
732294|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2233560|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2233561|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2233562|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233563|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
2233564|NCT00078806|Etanercept|etanercept|mesh-list
2233565|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2233566|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2233567|NCT00078806|Analgesics|analgesics|mesh-ancestor
731007|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
731008|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
731009|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
731010|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
731011|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
731012|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731013|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731014|NCT02877901|Urological Agents|urological agents|mesh-ancestor
731122|NCT02877238|Sevoflurane|sevoflurane|mesh-list
731123|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
731124|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
731125|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731126|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
731127|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
731128|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
731873|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
731874|NCT02873819|Sargramostim|sargramostim|mesh-list
731875|NCT02873819|Poly ICLC|poly iclc|mesh-list
731876|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
731877|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
731878|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731879|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731880|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
731881|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
731882|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731883|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731884|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
731885|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
731940|NCT02873559|Testosterone|testosterone|mesh-list
731941|NCT02873559|Androgens|androgens|mesh-ancestor
731942|NCT02873559|Hormones|hormones|mesh-ancestor
731943|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
731944|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233568|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
2233569|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2233570|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233571|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2233572|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2233573|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2233574|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233575|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
2233576|NCT00078832|Anastrozole|anastrozole|mesh-list
2233577|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2233578|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233579|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2233580|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2233581|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233582|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233583|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2233584|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
2233585|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
732397|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
732398|NCT02871648|Eplerenone|eplerenone|mesh-list
732399|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
732400|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
732401|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
732402|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732403|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
732404|NCT02871648|Diuretics|diuretics|mesh-ancestor
732405|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
732406|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
732407|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2091058|NCT02223871|Primaquine|primaquine|mesh-list
2091059|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
2091060|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2091061|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2091062|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091063|NCT02224053|Osimertinib|osimertinib|mesh-list
730317|NCT02880956|Nootropic Agents|nootropic agents|mesh-ancestor
730817|NCT02879097|Paclitaxel|paclitaxel|mesh-list
730818|NCT02879097|Carboplatin|carboplatin|mesh-list
730819|NCT02879097|Bevacizumab|bevacizumab|mesh-list
730820|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
730821|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730822|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
730823|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
730824|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
730825|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730826|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
730827|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
730828|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
730829|NCT02879097|Growth Substances|growth substances|mesh-ancestor
730830|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730831|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
730897|NCT02878772|Aspirin|aspirin|mesh-list
730898|NCT02878772|Vinpocetine|vinpocetine|mesh-list
730899|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
730900|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
730901|NCT02878772|Analgesics|analgesics|mesh-ancestor
730902|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
730903|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730904|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730905|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
730906|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
730907|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
730908|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
730909|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730910|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
730911|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
730912|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730913|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
730914|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
730915|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
730916|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
730917|NCT02878772|Protective Agents|protective agents|mesh-ancestor
730918|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
730990|NCT02878031|Amoxicillin|amoxicillin|mesh-list
730991|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
730992|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091064|NCT02224053|Omeprazole|omeprazole|mesh-list
2091065|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
731790|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
731791|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
731792|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
731793|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731794|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
731795|NCT02874378|Analgesics|analgesics|mesh-ancestor
731796|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
731797|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731798|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
731799|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
731800|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
731801|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
731802|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
731803|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732279|NCT02872064|Verteporfin|verteporfin|mesh-list
732280|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
732281|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
2091066|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2091067|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2091068|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091069|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091070|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091071|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2091072|NCT02224157|Budesonide|budesonide|mesh-list
2091073|NCT02224157|Terbutaline|terbutaline|mesh-list
2091074|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
2091075|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2091076|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2091077|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
2091078|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091079|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091080|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
730356|NCT02880787|Rocuronium|rocuronium|mesh-list
730357|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
730358|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
730359|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
730360|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730361|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731068|NCT02877615|S44819|s44819|mesh-list
731069|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
731070|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
731071|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
731072|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
731073|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731074|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731266|NCT02876432|Diclofenac|diclofenac|mesh-list
731267|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
731268|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
731269|NCT02876432|Analgesics|analgesics|mesh-ancestor
731270|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
731271|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731272|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731273|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
731274|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731275|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
731276|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731277|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233586|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233587|NCT00078845|Amifostine|amifostine|mesh-list
732539|NCT02870478|Atropine|atropine|mesh-list
732540|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
732541|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
732542|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
732543|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
732544|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
732545|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
732546|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732547|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732548|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
732549|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
732550|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
732551|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
732552|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
732553|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
732554|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
732555|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
732556|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091081|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
2091082|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
2091083|NCT02224157|Hormones|hormones|mesh-ancestor
2091084|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091085|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2091086|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2091087|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2091088|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
2091089|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091090|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091091|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
2091092|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
2091093|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2091094|NCT02224274|Clopidogrel|clopidogrel|mesh-list
2091095|NCT02224274|Ticagrelor|ticagrelor|mesh-list
2091096|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2091097|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2091098|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2091099|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2091100|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
2091101|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091102|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091103|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731490|NCT02875457|Cisplatin|cisplatin|mesh-list
731491|NCT02875457|Etoposide|etoposide|mesh-list
731492|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
731493|NCT02875457|Apatinib|apatinib|mesh-list
731494|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731495|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
731496|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
731497|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
731498|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731499|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731500|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2233588|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2233589|NCT00078845|Protective Agents|protective agents|mesh-ancestor
2091104|NCT02224313|Estradiol|estradiol|mesh-list
2091105|NCT02224313|Progesterone|progesterone|mesh-list
2091106|NCT02224313|Estrogens|estrogens|mesh-ancestor
2091107|NCT02224313|Hormones|hormones|mesh-ancestor
2091108|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091109|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091110|NCT02224313|Progestins|progestins|mesh-ancestor
2091111|NCT02224560|Cannabidiol|cannabidiol|mesh-list
2091112|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
2091113|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
2091114|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2091115|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2091116|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091117|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
731996|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
731997|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233590|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233591|NCT00078858|Cyclosporine|cyclosporine|mesh-list
2091118|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
2091119|NCT02224690|Cannabidiol|cannabidiol|mesh-list
2091120|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
2091121|NCT02224703|Cannabidiol|cannabidiol|mesh-list
2091122|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
2091123|NCT02224729|Dexamethasone|dexamethasone|mesh-list
2091124|NCT02224729|Bortezomib|bortezomib|mesh-list
2091125|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2091126|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2091127|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
2091128|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
2091129|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091130|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091131|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2091132|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
2091133|NCT02224729|Hormones|hormones|mesh-ancestor
2091134|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091135|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2091136|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091137|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2091138|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
2091139|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091140|NCT02224846|Tadalafil|tadalafil|mesh-list
2091141|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
2091142|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2091143|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2091144|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091145|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091146|NCT02224846|Urological Agents|urological agents|mesh-ancestor
2091147|NCT02225106|Methylphenidate|methylphenidate|mesh-list
730708|NCT02879617|Durvalumab|durvalumab|mesh-list
730709|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
730710|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730872|NCT02878863|Peoniflorin|peoniflorin|mesh-list
730873|NCT02878863|Silymarin|silymarin|mesh-list
730874|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
730875|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730876|NCT02878863|Protective Agents|protective agents|mesh-ancestor
730877|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730878|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
730879|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
730880|NCT02878863|Analgesics|analgesics|mesh-ancestor
730881|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
730882|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730883|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
730884|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731031|NCT02878161|Prednisone|prednisone|mesh-list
731032|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
731033|NCT02878161|Adalimumab|adalimumab|mesh-list
731034|NCT02878161|Etanercept|etanercept|mesh-list
731035|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
731036|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
731037|NCT02878161|Methotrexate|methotrexate|mesh-list
731038|NCT02878161|Infliximab|infliximab|mesh-list
731039|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
731040|NCT02878161|Leflunomide|leflunomide|mesh-list
731041|NCT02878161|Hormones|hormones|mesh-ancestor
731042|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
731043|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731044|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
731045|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731046|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
731047|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
731048|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
731049|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
731050|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
731051|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731052|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
731053|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731054|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
731055|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
731056|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
731057|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731058|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
731059|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
731060|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
731061|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731062|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
731063|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
731064|NCT02878161|Protective Agents|protective agents|mesh-ancestor
731065|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
731066|NCT02878161|Analgesics|analgesics|mesh-ancestor
731067|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
731223|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
731224|NCT02876835|Hematinics|hematinics|mesh-ancestor
2233592|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
2233593|NCT00078858|Fludarabine|fludarabine|mesh-list
2233594|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
2233595|NCT00078858|Cyclosporins|cyclosporins|mesh-list
2233596|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233597|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233598|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
2233599|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233600|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233601|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
2233602|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732358|NCT02871713|Morphine|morphine|mesh-list
732359|NCT02871713|Ropivacaine|ropivacaine|mesh-list
732360|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
732361|NCT02871713|Narcotics|narcotics|mesh-ancestor
732362|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732363|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091148|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
730635|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
730636|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
730637|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
730638|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
730639|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
730640|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
730641|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
730642|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
730643|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
730644|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
730645|NCT02883049|Antidotes|antidotes|mesh-ancestor
730646|NCT02883049|Protective Agents|protective agents|mesh-ancestor
730647|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
730648|NCT02883049|Vitamins|vitamins|mesh-ancestor
730649|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
730650|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
730651|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
730652|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
730653|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
730654|NCT02883049|Hematinics|hematinics|mesh-ancestor
730655|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
2233603|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233604|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
2233605|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233606|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
2233607|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731078|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
731079|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
731080|NCT02877511|Protective Agents|protective agents|mesh-ancestor
731081|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731082|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
731136|NCT02877277|Ascorbic Acid|ascorbic acid|mesh-list
731137|NCT02877277|Vitamins|vitamins|mesh-ancestor
731138|NCT02877277|Micronutrients|micronutrients|mesh-ancestor
731139|NCT02877277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731140|NCT02877277|Antioxidants|antioxidants|mesh-ancestor
731141|NCT02877277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731142|NCT02877277|Protective Agents|protective agents|mesh-ancestor
2233608|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2233609|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2233610|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2233611|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
2233612|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2233613|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
2233614|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091149|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091150|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2091151|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2091152|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2091153|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091154|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
2091155|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091156|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
2091157|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091158|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
2091159|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091160|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091161|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2091162|NCT02225353|Progesterone|progesterone|mesh-list
2091163|NCT02225353|Progestins|progestins|mesh-ancestor
2091164|NCT02225353|Hormones|hormones|mesh-ancestor
2091165|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091166|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091167|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2091168|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
2091169|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091170|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
2091171|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2091172|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
2091173|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091174|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2091175|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2091176|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
2091177|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233615|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2233616|NCT00078910|Protective Agents|protective agents|mesh-ancestor
2233617|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233618|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2233619|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233620|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233621|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2233622|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2233623|NCT00078910|Analgesics|analgesics|mesh-ancestor
2233624|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
2233625|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2233626|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2233627|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2233628|NCT00078962|Gemcitabine|gemcitabine|mesh-list
730993|NCT02878265|Vitamins|vitamins|mesh-list
730994|NCT02878265|Vitamin A|vitamin a|mesh-list
730995|NCT02878265|Zinc|zinc|mesh-list
730996|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
730997|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
730998|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730999|NCT02878265|Trace Elements|trace elements|mesh-ancestor
731000|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
731001|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731002|NCT02878265|Protective Agents|protective agents|mesh-ancestor
731003|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
731004|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731415|NCT02877303|Cytarabine|cytarabine|mesh-list
731416|NCT02877303|Dexamethasone|dexamethasone|mesh-list
731417|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
731418|NCT02877303|Prednisone|prednisone|mesh-list
731419|NCT02877303|Cortisone|cortisone|mesh-list
731420|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
731421|NCT02877303|Rituximab|rituximab|mesh-list
731422|NCT02877303|Doxorubicin|doxorubicin|mesh-list
731423|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
731424|NCT02877303|Methotrexate|methotrexate|mesh-list
731425|NCT02877303|Vincristine|vincristine|mesh-list
731426|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
731427|NCT02877303|Ofatumumab|ofatumumab|mesh-list
731428|NCT02877303|Blinatumomab|blinatumomab|mesh-list
731429|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
731430|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
731431|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
731432|NCT02877303|Antibodies|antibodies|mesh-list
731433|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
731434|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
731435|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
731436|NCT02877303|BB 1101|bb 1101|mesh-list
731437|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
731438|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
731439|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731440|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731441|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
731442|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
731443|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731444|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731445|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
731446|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
731447|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
731448|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
731449|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731450|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
731451|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
731452|NCT02877303|Hormones|hormones|mesh-ancestor
731453|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
731454|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
731455|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
731456|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731457|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
731458|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
731459|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
731460|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
731461|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
731462|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
731463|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
731464|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
731465|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
731466|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
731467|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2233629|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
730730|NCT02879513|Fluorouracil|fluorouracil|mesh-list
730731|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
730732|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
730733|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
730734|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
730735|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
730736|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730737|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
730738|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
730739|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730740|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
730741|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
730742|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
730743|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
730744|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
730745|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
730746|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
730747|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
730748|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
730749|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
730923|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
730924|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
730925|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
730926|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730927|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
730928|NCT02878707|Analgesics|analgesics|mesh-ancestor
730929|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
730930|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730931|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
730932|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
730933|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
730934|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
730935|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
730936|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731325|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
731326|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
731327|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
731328|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
731329|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
731330|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731331|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
731332|NCT02876484|Cathartics|cathartics|mesh-ancestor
731333|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
732039|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
732040|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
732156|NCT02872584|Prednisone|prednisone|mesh-list
732157|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
732158|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
732159|NCT02872584|Hormones|hormones|mesh-ancestor
732160|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
732161|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732162|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
732163|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732231|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
732232|NCT02872259|Trametinib|trametinib|mesh-list
732233|NCT02872259|Dabrafenib|dabrafenib|mesh-list
732234|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
732235|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732236|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
732237|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732238|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732321|NCT02871765|Warfarin|warfarin|mesh-list
732322|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
2091178|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091179|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2091180|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2091181|NCT02226003|Glimepiride|glimepiride|mesh-list
2091182|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
2091183|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2091184|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091185|NCT02226003|Incretins|incretins|mesh-ancestor
2091186|NCT02226003|Hormones|hormones|mesh-ancestor
2091187|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091188|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2091189|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
2091190|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091191|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091192|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2091193|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2091194|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
731026|NCT02877888|Fluorides|fluorides|mesh-list
731027|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
731028|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
731029|NCT02877888|Protective Agents|protective agents|mesh-ancestor
731030|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731087|NCT02877537|Albuterol|albuterol|mesh-list
731088|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
731089|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
731090|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731091|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731092|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
731093|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
731094|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
731095|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
731096|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
731097|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
731098|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
731099|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
731100|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
731101|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233630|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
2233631|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233632|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233633|NCT00078962|Antiviral Agents|antiviral agents|mesh-ancestor
2233634|NCT00078962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233635|NCT00078962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233636|NCT00078962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233637|NCT00078962|Immunologic Factors|immunologic factors|mesh-ancestor
2233638|NCT00078962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233639|NCT00078975|Gemcitabine|gemcitabine|mesh-list
732102|NCT02873026|Triamcinolone|triamcinolone|mesh-list
732103|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
732104|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
732105|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
732106|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
732107|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
732108|NCT02873026|Hormones|hormones|mesh-ancestor
732109|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
732110|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732111|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
732112|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
732113|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732114|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732262|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
732263|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2233640|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233641|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
2233642|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233643|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233644|NCT00078975|Antiviral Agents|antiviral agents|mesh-ancestor
2233645|NCT00078975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233646|NCT00078975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233647|NCT00078975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233648|NCT00078975|Immunologic Factors|immunologic factors|mesh-ancestor
2233649|NCT00078975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233650|NCT00078988|Carboplatin|carboplatin|mesh-list
2233651|NCT00078988|Etoposide|etoposide|mesh-list
2233652|NCT00078988|Thiotepa|thiotepa|mesh-list
2233653|NCT00078988|Isotretinoin|isotretinoin|mesh-list
2233654|NCT00078988|Lenograstim|lenograstim|mesh-list
2091195|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2091196|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2091197|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2091198|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091199|NCT02226159|Dexamethasone|dexamethasone|mesh-list
2091200|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
2091201|NCT02226159|Lidocaine|lidocaine|mesh-list
2091202|NCT02226159|BB 1101|bb 1101|mesh-list
2091203|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2233655|NCT00078988|Sargramostim|sargramostim|mesh-list
730851|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
730852|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
730853|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
730854|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
730855|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
730856|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
730857|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
730858|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
730859|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
730860|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
730861|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
730862|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
730863|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
730864|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
730865|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
730866|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
730867|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
730940|NCT02878681|Ranibizumab|ranibizumab|mesh-list
730941|NCT02878681|Aflibercept|aflibercept|mesh-list
730942|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
730943|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
730944|NCT02878681|Growth Substances|growth substances|mesh-ancestor
730945|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
730946|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
730947|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731359|NCT02876094|Celecoxib|celecoxib|mesh-list
731360|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
731361|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
731362|NCT02876094|Analgesics|analgesics|mesh-ancestor
731363|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
731364|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731365|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731366|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
731367|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
731368|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
731369|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
731370|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731371|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731408|NCT02875821|Metformin|metformin|mesh-list
731409|NCT02875821|Pioglitazone|pioglitazone|mesh-list
731410|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
731411|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
731412|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731413|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
731414|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731685|NCT02874989|Dasatinib|dasatinib|mesh-list
731686|NCT02874989|Quercetin|quercetin|mesh-list
731687|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731688|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
731689|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731690|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731691|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
731692|NCT02874989|Protective Agents|protective agents|mesh-ancestor
731693|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731857|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
731858|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
731859|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
731860|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
731861|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
731862|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731863|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731864|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2091204|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
2091205|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
2091206|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091207|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091208|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2091209|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
2091210|NCT02226159|Hormones|hormones|mesh-ancestor
2091211|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091212|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2091213|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091214|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
2091215|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091216|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233656|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233657|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2233658|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2233659|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2233660|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731233|NCT02876796|Firsocostat|firsocostat|mesh-list
731234|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731235|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731316|NCT02876224|Bevacizumab|bevacizumab|mesh-list
731317|NCT02876224|Atezolizumab|atezolizumab|mesh-list
731318|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
731319|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731320|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
731321|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
731322|NCT02876224|Growth Substances|growth substances|mesh-ancestor
731323|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731324|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
731511|NCT02875873|Methamphetamine|methamphetamine|mesh-list
731512|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
731513|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
731514|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731515|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
731516|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
731517|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731518|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
731519|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
731520|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731521|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
731522|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
731523|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
731524|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
731525|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
731526|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
731527|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
731769|NCT02874820|Idazoxan|idazoxan|mesh-list
731770|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
731771|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
731772|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
731773|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
731774|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
731775|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731776|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091217|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
2091218|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
2091219|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2091220|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
2091221|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2091222|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2091223|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2091224|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2091225|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2091226|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2091227|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2091228|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
2091229|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091230|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2091231|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2091232|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091233|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
2091234|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2091235|NCT02226549|Ledipasvir|ledipasvir|mesh-list
2091236|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
2091237|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091238|NCT02226562|Listerine|listerine|mesh-list
2091239|NCT02226562|Fluorides|fluorides|mesh-list
2091240|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
2091241|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
2091242|NCT02226562|Protective Agents|protective agents|mesh-ancestor
2091243|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091244|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2091245|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091246|NCT02226653|Evacetrapib|evacetrapib|mesh-list
2091247|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2091248|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
731175|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
731176|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
731177|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
731178|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
731179|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731180|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731181|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
731404|NCT02875756|Ivermectin|ivermectin|mesh-list
731405|NCT02875756|Selamectin|selamectin|mesh-list
731406|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
731407|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233661|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233662|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2233663|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
2233664|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731945|NCT02873871|Hemostatics|hemostatics|mesh-list
731946|NCT02873871|Coagulants|coagulants|mesh-ancestor
732216|NCT02872467|Oxytocin|oxytocin|mesh-list
732217|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
732218|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
732219|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091249|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
2091250|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091251|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2091252|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
2091253|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091281|NCT02227316|Acetaminophen|acetaminophen|mesh-list
2091282|NCT02227316|Ibuprofen|ibuprofen|mesh-list
2091283|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2091284|NCT02227316|Analgesics|analgesics|mesh-ancestor
2091285|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
2091286|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091287|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091288|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
2091289|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2091290|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2091291|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2091292|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2091293|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091294|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091295|NCT02227329|Ethanol|ethanol|mesh-list
2091296|NCT02227329|Heparin|heparin|mesh-list
2091297|NCT02227329|Calcium heparin|calcium heparin|mesh-list
2091298|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
2091299|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2091300|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2091301|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091302|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2091303|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091304|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
731247|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
731248|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731249|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
731250|NCT02876276|Protective Agents|protective agents|mesh-ancestor
2233665|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2233666|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
2233667|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2233668|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
732297|NCT02871986|Estrogens|estrogens|mesh-list
732298|NCT02871986|Hormones|hormones|mesh-ancestor
732299|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
732300|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091305|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091306|NCT02227368|Aspirin|aspirin|mesh-list
2091307|NCT02227368|Ticagrelor|ticagrelor|mesh-list
2091308|NCT02227368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2091309|NCT02227368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2091310|NCT02227368|Analgesics|analgesics|mesh-ancestor
2091311|NCT02227368|Sensory System Agents|sensory system agents|mesh-ancestor
2091312|NCT02227368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091313|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091314|NCT02227368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2091315|NCT02227368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2091316|NCT02227368|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2091317|NCT02227368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2091318|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091319|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2091320|NCT02227368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2091321|NCT02227368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091322|NCT02227368|Antipyretics|antipyretics|mesh-ancestor
2091323|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2091324|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2091325|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2091326|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
2091327|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091328|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2091329|NCT02227446|Vancomycin|vancomycin|mesh-list
2091330|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091331|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
2091332|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2091333|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091334|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
2091335|NCT02227667|Durvalumab|durvalumab|mesh-list
2091336|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2091337|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091338|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2091339|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
2091340|NCT02227706|Coagulants|coagulants|mesh-ancestor
2091341|NCT02227784|Atorvastatin|atorvastatin|mesh-list
2091342|NCT02227784|Ezetimibe|ezetimibe|mesh-list
2091343|NCT02227784|Evacetrapib|evacetrapib|mesh-list
2091344|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2091345|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2091346|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
2091347|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091348|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2091349|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2091350|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091351|NCT02227849|Canagliflozin|canagliflozin|mesh-list
2091352|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2091353|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091354|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2091355|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091356|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
2091357|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2091358|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091359|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
2091360|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2091361|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091362|NCT02228408|Hydralazine|hydralazine|mesh-list
2091363|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2091364|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
2091365|NCT02228590|Apomorphine|apomorphine|mesh-list
2091366|NCT02228590|Emetics|emetics|mesh-ancestor
2091367|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091368|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
2233669|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
2233670|NCT00079014|Doxorubicin|doxorubicin|mesh-list
2233671|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2233672|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2233673|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233674|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2233675|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2233676|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233677|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233678|NCT00079027|Doxorubicin|doxorubicin|mesh-list
2233679|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2091369|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091370|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2091371|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
2091372|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
2091373|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091374|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091375|NCT02228681|Tamoxifen|tamoxifen|mesh-list
2091376|NCT02228681|Everolimus|everolimus|mesh-list
2091377|NCT02228681|Letrozole|letrozole|mesh-list
2091378|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2091379|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
2091380|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091381|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2091382|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
2091383|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091384|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2091385|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2091386|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091387|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091388|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2091389|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
2091390|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091391|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2091392|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2091393|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2091394|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2091395|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2091396|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2091397|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2091398|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
2091399|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2091400|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2091401|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2091402|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2091403|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
2091404|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2091405|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
2091406|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2091407|NCT02228824|Nicotine|nicotine|mesh-list
2091408|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2091409|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
2091410|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091411|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091412|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2091413|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2091414|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
2233680|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
731468|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
731469|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
731470|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
731471|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
731472|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
731473|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
732388|NCT02871687|Simvastatin|simvastatin|mesh-list
732389|NCT02871687|Pravastatin|pravastatin|mesh-list
732390|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
732391|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
732392|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
732393|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732394|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
732395|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
732396|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091415|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091416|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091417|NCT02228980|Vaccines|vaccines|mesh-list
2091418|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
2091419|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091420|NCT02229214|Topiramate|topiramate|mesh-list
2091421|NCT02229214|Phentermine|phentermine|mesh-list
2091422|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
2091423|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2091424|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091425|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2091426|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
2091427|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2091428|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
2091429|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
2091430|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091431|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
2091432|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091433|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091434|NCT02229227|Insulin|insulin|mesh-list
2091435|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
2091436|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
2091437|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
2091438|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2091439|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091440|NCT02229227|Incretins|incretins|mesh-ancestor
2091441|NCT02229227|Hormones|hormones|mesh-ancestor
2091442|NCT02229227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091443|NCT02229383|Exenatide|exenatide|mesh-list
2091444|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2091445|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091446|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2091447|NCT02229383|Incretins|incretins|mesh-ancestor
2091448|NCT02229383|Hormones|hormones|mesh-ancestor
2091449|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091450|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
2091451|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2091452|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091453|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2091454|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091455|NCT02229461|Aspirin|aspirin|mesh-list
2091456|NCT02229461|Naproxen|naproxen|mesh-list
2091457|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2091458|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2091459|NCT02229461|Analgesics|analgesics|mesh-ancestor
2091460|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
2091461|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091462|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091463|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2091464|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2091465|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2091466|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2091467|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091468|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2091469|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2091470|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091471|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
2091472|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
2091473|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
2091474|NCT02229539|Promethazine|promethazine|mesh-list
2091475|NCT02229539|Lidocaine|lidocaine|mesh-list
2091476|NCT02229539|Doxepin|doxepin|mesh-list
731504|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731505|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
731506|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
731507|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
731508|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
731509|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
731510|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233681|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731837|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
731838|NCT02874144|Fluticasone|fluticasone|mesh-list
731839|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
731840|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
731841|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
731842|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
731843|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
731844|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731845|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731846|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
731847|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
731984|NCT02873273|Dexamethasone|dexamethasone|mesh-list
731985|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
731986|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
731987|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
731988|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731989|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731990|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
731991|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
731992|NCT02873273|Hormones|hormones|mesh-ancestor
731993|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
731994|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
731995|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732301|NCT02871843|Temozolomide|temozolomide|mesh-list
732302|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
732303|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
732304|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732305|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732415|NCT02871401|Valganciclovir|valganciclovir|mesh-list
732416|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
732417|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
732511|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
732512|NCT02870829|Vitamin K|vitamin k|mesh-list
732513|NCT02870829|Vitamin MK 7|vitamin mk 7|mesh-list
732514|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
732515|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
732516|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732517|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
732518|NCT02870829|Coagulants|coagulants|mesh-ancestor
732519|NCT02870829|Vitamins|vitamins|mesh-ancestor
732520|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
732521|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091477|NCT02229539|Antacids|antacids|mesh-list
2091478|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
2091479|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
2091480|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2091481|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091482|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
2091483|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091484|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2091485|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2091486|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2091487|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2091488|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091489|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2091490|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2091491|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
2091492|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
2091493|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2091494|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2091495|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
2091496|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
2091497|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2233682|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2233683|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2233684|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233685|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233686|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2233687|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233688|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
732070|NCT02873091|Sufentanil|sufentanil|mesh-list
732071|NCT02873091|Ropivacaine|ropivacaine|mesh-list
732072|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
732073|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
732074|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732075|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732076|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
732077|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732078|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
732079|NCT02873091|Narcotics|narcotics|mesh-ancestor
732080|NCT02873091|Analgesics|analgesics|mesh-ancestor
732081|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
732082|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
732083|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
732196|NCT02872272|Amikacin|amikacin|mesh-list
732197|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
732198|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
732369|NCT02871661|Amitriptyline|amitriptyline|mesh-list
732370|NCT02871661|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
732371|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
732372|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
732373|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
732374|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
732375|NCT02871661|Analgesics|analgesics|mesh-ancestor
732376|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
732377|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732378|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732379|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
732380|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
732381|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
732382|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732383|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
732384|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
732385|NCT02871661|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
732386|NCT02871661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
732387|NCT02871661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2753329|NCT02908685|Risdiplam|risdiplam|mesh-list
2753330|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2753331|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2753332|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753333|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
2753334|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
2753335|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
732535|NCT02870634|Copper|copper|mesh-list
732536|NCT02870634|Trace Elements|trace elements|mesh-ancestor
732537|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
732538|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091498|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2091499|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
2091500|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
2091501|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2091502|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
2091503|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2091504|NCT02230306|Vemurafenib|vemurafenib|mesh-list
2091505|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091506|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2091507|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731601|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
731602|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
731603|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
731604|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091508|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091509|NCT02230332|Alendronate|alendronate|mesh-list
2091510|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2091511|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091512|NCT02230527|Clopidogrel|clopidogrel|mesh-list
2091513|NCT02230527|Ticagrelor|ticagrelor|mesh-list
2091514|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2091515|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2091516|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2091517|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2091518|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
2091519|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091520|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091521|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091522|NCT02230696|Fluticasone|fluticasone|mesh-list
2091523|NCT02230696|Xhance|xhance|mesh-list
2091524|NCT02230696|Azelastine|azelastine|mesh-list
2091525|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2091526|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2091527|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
2091528|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091529|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091530|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2091531|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
2091532|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
2091533|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2091534|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2091535|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091536|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091537|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2091538|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2091539|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
2091540|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
2091541|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091542|NCT02230904|Rotigotine|rotigotine|mesh-list
2091543|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
2091544|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
2091545|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091546|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091547|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091548|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
2091549|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2091550|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2091551|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2091552|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2091553|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091554|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
2091555|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091556|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091557|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2091558|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091559|NCT02230995|Metformin|metformin|mesh-list
2091560|NCT02230995|Empagliflozin|empagliflozin|mesh-list
2091561|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2091562|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091563|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2091564|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091565|NCT02231086|Leucovorin|leucovorin|mesh-list
2091566|NCT02231086|Fluorouracil|fluorouracil|mesh-list
2091567|NCT02231086|Capecitabine|capecitabine|mesh-list
2091568|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
2091569|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
2091570|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091571|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2091572|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091573|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2091574|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
2091575|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091576|NCT02231086|Antidotes|antidotes|mesh-ancestor
2091577|NCT02231086|Protective Agents|protective agents|mesh-ancestor
731731|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731848|NCT02874430|Metformin|metformin|mesh-list
731849|NCT02874430|Doxycycline|doxycycline|mesh-list
731850|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
731851|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731852|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
731853|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
731854|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
731855|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
731856|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2233689|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233690|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233691|NCT00079066|Cetuximab|cetuximab|mesh-list
2233692|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2233693|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233694|NCT00079079|Gemcitabine|gemcitabine|mesh-list
2233695|NCT00079079|Carboplatin|carboplatin|mesh-list
732084|NCT02873065|Amoxicillin|amoxicillin|mesh-list
732085|NCT02873065|Clarithromycin|clarithromycin|mesh-list
732086|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
732087|NCT02873065|Bismuth|bismuth|mesh-list
732088|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732089|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
732090|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
732091|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
732092|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732093|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
732094|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
732095|NCT02873065|Antacids|antacids|mesh-ancestor
732096|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
732097|NCT02873065|Diuretics|diuretics|mesh-ancestor
732098|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
732099|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732100|NCT02873065|Expectorants|expectorants|mesh-ancestor
732101|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
732164|NCT02872597|Dexamethasone|dexamethasone|mesh-list
732165|NCT02872597|Prednisone|prednisone|mesh-list
732166|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
732167|NCT02872597|Prednisolone|prednisolone|mesh-list
732168|NCT02872597|Albuterol|albuterol|mesh-list
732169|NCT02872597|Ipratropium|ipratropium|mesh-list
732170|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
732171|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
732172|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
732173|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732174|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732175|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
732176|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
732177|NCT02872597|Hormones|hormones|mesh-ancestor
732178|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
732179|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
732180|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732181|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732182|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
732183|NCT02872597|Protective Agents|protective agents|mesh-ancestor
732184|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
732185|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
732186|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
732187|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
732188|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
732189|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
732190|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
732191|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
732192|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
732193|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
732194|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
732195|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
732488|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
732489|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2091578|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
2091579|NCT02231086|Vitamins|vitamins|mesh-ancestor
2091580|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
2091581|NCT02231164|Docetaxel|docetaxel|mesh-list
2091582|NCT02231164|Nintedanib|nintedanib|mesh-list
2091583|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091584|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
2091585|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
2091586|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
2233696|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731895|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
731896|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
731897|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
731898|NCT02873598|Antiviral Agents|antiviral agents|mesh-ancestor
731899|NCT02873598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
731900|NCT02873598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
731901|NCT02873598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
731902|NCT02873598|Immunologic Factors|immunologic factors|mesh-ancestor
731903|NCT02873598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732306|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
732307|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
732308|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
732309|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
732310|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732311|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732312|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
732313|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
732314|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
732315|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
732316|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
732317|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
732318|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732319|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
732320|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2233697|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233698|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
2233699|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091587|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091588|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2091589|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091590|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
2091591|NCT02231177|Olodaterol|olodaterol|mesh-list
2091592|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2091593|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
2091594|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091595|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091596|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2091597|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
2091598|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
2091599|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2091600|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
2091601|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091602|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091603|NCT02231749|Nivolumab|nivolumab|mesh-list
2091604|NCT02231749|Ipilimumab|ipilimumab|mesh-list
2091605|NCT02231749|Sunitinib|sunitinib|mesh-list
2091606|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2091607|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091608|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2091609|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091610|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2091611|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2091612|NCT02231749|Growth Substances|growth substances|mesh-ancestor
2091613|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091614|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
2091615|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2091616|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091623|NCT02231918|Pramipexole|pramipexole|mesh-list
2091624|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
2091625|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091626|NCT02231918|Protective Agents|protective agents|mesh-ancestor
2091627|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091628|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2091629|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2091630|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
2091631|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
2091632|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091633|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
731924|NCT02873806|Dexamethasone|dexamethasone|mesh-list
731925|NCT02873806|Travoprost|travoprost|mesh-list
731926|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
731927|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
731928|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
731929|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
731930|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
731931|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
731932|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
731933|NCT02873806|Hormones|hormones|mesh-ancestor
731934|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
731935|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
731936|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
731937|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
731938|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
731939|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091634|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2091635|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091636|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2091637|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
2091638|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091639|NCT02232087|Fluticasone|fluticasone|mesh-list
2091640|NCT02232087|Xhance|xhance|mesh-list
2091641|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2091642|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2091643|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2091644|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2091645|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
2091646|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091647|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091648|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2091649|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
2091650|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
2091651|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2091652|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
732220|NCT02872428|Valproic Acid|valproic acid|mesh-list
732221|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
732222|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732223|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732224|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
732225|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
732226|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732227|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
732228|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
732229|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732230|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2091653|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2091654|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2091655|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
2091656|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091657|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091658|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
2091659|NCT02232087|Hormones|hormones|mesh-ancestor
2091660|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091661|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
2091662|NCT02232178|Bupivacaine|bupivacaine|mesh-list
2091663|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
2091664|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
2091665|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2091666|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091667|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
2091668|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091669|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
2091670|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
2091671|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2091672|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2091673|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091674|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091675|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091676|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2091677|NCT02232802|Enoxaparin|enoxaparin|mesh-list
2091678|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
2091679|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
2091680|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2091681|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2233700|NCT00079079|Antiviral Agents|antiviral agents|mesh-ancestor
2233701|NCT00079079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233702|NCT00079079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233703|NCT00079079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233704|NCT00079079|Immunologic Factors|immunologic factors|mesh-ancestor
2233705|NCT00079079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233706|NCT00079092|Thalidomide|thalidomide|mesh-list
2233707|NCT00079092|Procarbazine|procarbazine|mesh-list
2233708|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233709|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
2233710|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233711|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
2233712|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2233713|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233714|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
732323|NCT02872038|Cefazolin|cefazolin|mesh-list
732324|NCT02872038|Ceftazidime|ceftazidime|mesh-list
732325|NCT02872038|Cefepime|cefepime|mesh-list
732326|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
732327|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091682|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091683|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
2091684|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2091685|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2091686|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091687|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
2091688|NCT02233101|Coagulants|coagulants|mesh-ancestor
2091689|NCT02233296|Lasmiditan|lasmiditan|mesh-list
2091690|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2091691|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
2091692|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091693|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091694|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091695|NCT02233309|Anesthetics|anesthetics|mesh-list
2091696|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2091697|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091698|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
2091699|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2091700|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2091701|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2091702|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
2091703|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091704|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091705|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091706|NCT02233647|Cocaine|cocaine|mesh-list
2091707|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
2091708|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
2091709|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2091710|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091711|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
2091712|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091713|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2091714|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2091715|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2091716|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2091717|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091718|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
2091719|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091720|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
2091721|NCT02233751|Testosterone|testosterone|mesh-list
2091722|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
2091723|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
2091724|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2091725|NCT02233751|Androgens|androgens|mesh-ancestor
2091726|NCT02233751|Hormones|hormones|mesh-ancestor
2091727|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091728|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091729|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2091730|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091731|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
2091732|NCT02233803|Budesonide|budesonide|mesh-list
2091733|NCT02233803|Albuterol|albuterol|mesh-list
2091734|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2091735|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2233715|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
732027|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
732028|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
732029|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
732030|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
732031|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
732032|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732033|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732034|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
732035|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732036|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
732037|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
732038|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
2091736|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2091737|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
2091738|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091739|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091740|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2091741|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
2091742|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
2091743|NCT02233803|Hormones|hormones|mesh-ancestor
2091744|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091745|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
2091746|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2091747|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2091748|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2091749|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2091750|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
2091751|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091752|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091753|NCT02233998|Listerine|listerine|mesh-list
2091754|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
2091755|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2091756|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091757|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
2091758|NCT02233998|Protective Agents|protective agents|mesh-ancestor
2091759|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091760|NCT02234115|Leuprolide|leuprolide|mesh-list
2091761|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2091762|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
2091763|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2091764|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091765|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2091766|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091767|NCT02234141|Selonsertib|selonsertib|mesh-list
2091768|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2091769|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091770|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091771|NCT02234323|Factor VIII|factor viii|mesh-list
2091772|NCT02234323|Coagulants|coagulants|mesh-ancestor
2091773|NCT02234362|Vortioxetine|vortioxetine|mesh-list
2091774|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
2091775|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2091776|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2091777|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2091778|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2091779|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091780|NCT02234362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2091781|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2091782|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2091783|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091784|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091785|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
2091786|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2091787|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2091788|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2091789|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2091790|NCT02234427|Aspirin|aspirin|mesh-list
2091791|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2091792|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2091793|NCT02234427|Analgesics|analgesics|mesh-ancestor
2091794|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
2091795|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091796|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732204|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
732205|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
732206|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732207|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732445|NCT02871219|Lenalidomide|lenalidomide|mesh-list
732446|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
732447|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
732448|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732449|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
732450|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
732451|NCT02871219|Growth Substances|growth substances|mesh-ancestor
732452|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
732453|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732454|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
732557|NCT02870673|Triamcinolone|triamcinolone|mesh-list
732558|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
732559|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
732560|NCT02870673|Lidocaine|lidocaine|mesh-list
732561|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
732562|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
732563|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
732564|NCT02870673|Hormones|hormones|mesh-ancestor
732565|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
732566|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732567|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
732568|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
732569|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732570|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732571|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
732572|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
732573|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732574|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
732575|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732576|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
732577|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
732578|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
732579|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2091797|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2091798|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2091799|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2091800|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2091801|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091802|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2091803|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2091804|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091805|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
2091806|NCT02234570|Oxfendazole|oxfendazole|mesh-list
2091807|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
2091808|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2091809|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091810|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
2091811|NCT02234596|Nintedanib|nintedanib|mesh-list
2091812|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091813|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2091814|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091815|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091816|NCT02234752|Memantine|memantine|mesh-list
2091817|NCT02234752|Galantamine|galantamine|mesh-list
2091818|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2091819|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2091820|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
2091821|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091822|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091823|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091824|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2091825|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2091826|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2091827|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091828|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
2091829|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2091830|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
2091831|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091832|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
732251|NCT02872116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732252|NCT02872116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
732253|NCT02872116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
732254|NCT02872116|Antidotes|antidotes|mesh-ancestor
732255|NCT02872116|Protective Agents|protective agents|mesh-ancestor
732256|NCT02872116|Vitamin B Complex|vitamin b complex|mesh-ancestor
732257|NCT02872116|Vitamins|vitamins|mesh-ancestor
732258|NCT02872116|Micronutrients|micronutrients|mesh-ancestor
2091841|NCT02235064|Sertraline|sertraline|mesh-list
2091842|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
2091843|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2091844|NCT02235064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2091845|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2091846|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2091847|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091848|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091849|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
2091850|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091851|NCT02235077|Spironolactone|spironolactone|mesh-list
2091852|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2091853|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
2091854|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091855|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091856|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2091857|NCT02235077|Diuretics|diuretics|mesh-ancestor
2091858|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
2091859|NCT02235298|Metformin|metformin|mesh-list
2091860|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
2091861|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2091862|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091863|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2091864|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091865|NCT02235311|Pantoprazole|pantoprazole|mesh-list
2091866|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2091867|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2091868|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2091869|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091870|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091871|NCT02235987|Octreotide|octreotide|mesh-list
2091872|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2091873|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2091874|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091875|NCT02236130|Acetaminophen|acetaminophen|mesh-list
2091876|NCT02236130|Morphine|morphine|mesh-list
2091877|NCT02236130|Hydrocodone|hydrocodone|mesh-list
2091878|NCT02236130|Analgesics|analgesics|mesh-list
2091879|NCT02236130|Anesthetics|anesthetics|mesh-list
2091880|NCT02236130|Ropivacaine|ropivacaine|mesh-list
2091881|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
2091882|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2091883|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091884|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2091885|NCT02236130|Narcotics|narcotics|mesh-ancestor
2091886|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
2091887|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091888|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2091889|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
2091890|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
2091891|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
2091892|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
2091893|NCT02236520|Spironolactone|spironolactone|mesh-list
2091894|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2091895|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
2091896|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2091897|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091898|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2091899|NCT02236520|Diuretics|diuretics|mesh-ancestor
2091900|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
2091901|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2233716|NCT00079092|Growth Substances|growth substances|mesh-ancestor
732295|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
732296|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
732455|NCT02871505|Penicillins|penicillins|mesh-list
732456|NCT02871505|Penicillin G|penicillin g|mesh-list
732457|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
732458|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
732459|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
732460|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091902|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2091903|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2091904|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091905|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
2091906|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2091907|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2091908|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2091909|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
2091910|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091911|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091912|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091913|NCT02236988|Thalidomide|thalidomide|mesh-list
2091914|NCT02236988|Apremilast|apremilast|mesh-list
2091915|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2091916|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2091917|NCT02236988|Analgesics|analgesics|mesh-ancestor
2091918|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
2091919|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091920|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091921|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2091922|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2091923|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2091924|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2091925|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091926|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091927|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2091928|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
2091929|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
2091930|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2091931|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091932|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2091933|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2091934|NCT02236988|Growth Substances|growth substances|mesh-ancestor
2091935|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
2091936|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091937|NCT02237157|Gemcitabine|gemcitabine|mesh-list
2091938|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2091939|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
2091940|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091941|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2091942|NCT02237157|Antiviral Agents|antiviral agents|mesh-ancestor
2091943|NCT02237157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091944|NCT02237157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091945|NCT02237157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2091946|NCT02237157|Immunologic Factors|immunologic factors|mesh-ancestor
2091947|NCT02237157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091948|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
2091949|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091950|NCT02237417|Aripiprazole|aripiprazole|mesh-list
2091951|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
2091952|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
2091953|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2091954|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2091955|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2091956|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091957|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
2091958|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
2091959|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091960|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091961|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2091962|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2091963|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
2091964|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2091965|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2091966|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
732335|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
732336|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732337|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
732338|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
732339|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
732340|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732341|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732342|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
732343|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
732344|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
732345|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
732346|NCT02871869|Hormones|hormones|mesh-ancestor
732347|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
732348|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
732349|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
732350|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
732351|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
732352|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732353|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
732354|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
732355|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
732356|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
732357|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
732418|NCT02871323|Durvalumab|durvalumab|mesh-list
732419|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
732420|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
732421|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
732422|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
732423|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732424|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
732425|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091967|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2091968|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
2091969|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
2091970|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091971|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
2091972|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2091973|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091974|NCT02237950|Metronidazole|metronidazole|mesh-list
2091975|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2091976|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2091977|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2091978|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2091979|NCT02237989|Acetaminophen|acetaminophen|mesh-list
2091980|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2091981|NCT02237989|Analgesics|analgesics|mesh-ancestor
2091982|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
2091983|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2091984|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091985|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
2091986|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
2091987|NCT02238080|Hematinics|hematinics|mesh-ancestor
2091988|NCT02238379|Oxytocin|oxytocin|mesh-list
2091989|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
2091990|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2091991|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2091992|NCT02238483|AZD7624|azd7624|mesh-list
2091993|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2091994|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2091995|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2091996|NCT02238626|Ibudilast|ibudilast|mesh-list
2091997|NCT02238626|Riluzole|riluzole|mesh-list
2091998|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
2091999|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2092000|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2092001|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092002|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092003|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092004|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2092005|NCT02238626|Protective Agents|protective agents|mesh-ancestor
2092006|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2092007|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
2092008|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092009|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2092010|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
2233717|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
732364|NCT02871713|Analgesics|analgesics|mesh-ancestor
732365|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
732366|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732367|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
732368|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
732461|NCT02871349|Propranolol|propranolol|mesh-list
732462|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
732463|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
732464|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
732465|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
732466|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732467|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732468|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
732469|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
732470|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
732605|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
732606|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
732607|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
732608|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732609|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732610|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
732611|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
732612|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
732613|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2092011|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2092012|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092013|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2092014|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
2092015|NCT02238977|Bupropion|bupropion|mesh-list
2092016|NCT02238977|Fluoxetine|fluoxetine|mesh-list
2092017|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2092018|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
2092019|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2092020|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2092021|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2092022|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2092023|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092024|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
2092025|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092026|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092027|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2092028|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2092029|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092030|NCT02238977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2092031|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
2092032|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2092033|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2092034|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2092035|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2092036|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092037|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2092038|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2092039|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2092040|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2092041|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
2092042|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092043|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092044|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2092045|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2092046|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
2092047|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2092048|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2092049|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
2092050|NCT02239120|Dabigatran|dabigatran|mesh-list
2092051|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
2092052|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2092053|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
2092054|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092055|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092056|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
2092057|NCT02239380|Lorazepam|lorazepam|mesh-list
2092058|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
2092059|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
732471|NCT02871193|Dexamethasone|dexamethasone|mesh-list
732472|NCT02871193|Ropivacaine|ropivacaine|mesh-list
732473|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
732474|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
732475|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
732476|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732477|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732478|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
732479|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
732480|NCT02871193|Hormones|hormones|mesh-ancestor
732481|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
732482|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
732483|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732484|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
732485|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
732486|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732487|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
732602|NCT02870361|Insulin|insulin|mesh-list
732603|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
732604|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092060|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
2092061|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092062|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092063|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2092064|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2092065|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2092066|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2092067|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2092068|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2092069|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
2092070|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
2092071|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092072|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092073|NCT02239510|Linaclotide|linaclotide|mesh-list
2092074|NCT02239510|Sennosides|sennosides|mesh-list
2092075|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2092076|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
2092077|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092078|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2092079|NCT02239510|Laxatives|laxatives|mesh-ancestor
2092080|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2092081|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2092082|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
2092083|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
2092084|NCT02239692|Cathartics|cathartics|mesh-ancestor
2092085|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2092086|NCT02239770|Nicotine|nicotine|mesh-list
2092087|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2092088|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
2092089|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092090|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092091|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2092092|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2092093|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
2092094|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092095|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092096|NCT02240030|Levodopa|levodopa|mesh-list
2092097|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2092098|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2092099|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
2092100|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092101|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092102|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092103|NCT02240108|Rifaximin|rifaximin|mesh-list
2092104|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2092105|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092106|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2092107|NCT02240121|Rifaximin|rifaximin|mesh-list
2092108|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2092109|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092110|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2092111|NCT02240329|Capsaicin|capsaicin|mesh-list
2092112|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
2092113|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
732586|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
732587|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
732588|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732589|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
732590|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
732591|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
732592|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732593|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732594|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
732595|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
732596|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
732597|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
732598|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732599|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
732600|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
732601|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
732614|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
732615|NCT02870231|Liraglutide|liraglutide|mesh-list
2092114|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
732617|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
732618|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
732619|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
732620|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732621|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732622|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
732623|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732624|NCT02870231|Incretins|incretins|mesh-ancestor
732625|NCT02870231|Hormones|hormones|mesh-ancestor
732626|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2092115|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092116|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092117|NCT02240589|Memantine|memantine|mesh-list
2092118|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2092119|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2233718|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233719|NCT00079105|Prednisolone|prednisolone|mesh-list
2233720|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
2233721|NCT00079105|Etoposide|etoposide|mesh-list
2233722|NCT00079105|Vincristine|vincristine|mesh-list
2233723|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
2233724|NCT00079105|Bleomycin|bleomycin|mesh-list
2233725|NCT00079105|Vinblastine|vinblastine|mesh-list
2233726|NCT00079105|Procarbazine|procarbazine|mesh-list
2233727|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
2233728|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233729|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
2233730|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233731|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2233732|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2233733|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
2233734|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233735|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233736|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2233737|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
732662|NCT02869984|Ramosetron|ramosetron|mesh-list
732663|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
732664|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
732665|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732666|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732667|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
732668|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
732669|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
732670|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
732671|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092120|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
2233738|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
732672|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
732673|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732674|NCT02869815|Methylene Blue|methylene blue|mesh-list
732675|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732676|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732934|NCT02868606|Insulin|insulin|mesh-list
732935|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
732936|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
732937|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732948|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
732949|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
732950|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
732951|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732952|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
732953|NCT02868437|Protective Agents|protective agents|mesh-ancestor
733068|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
733069|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733070|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
733071|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733072|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733073|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
733074|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
733075|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733076|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
733257|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
733258|NCT02867332|Interleukin-2|interleukin-2|mesh-list
733259|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
733260|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
733261|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733262|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
733263|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
733264|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
733265|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733266|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733267|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
733268|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
733269|NCT02867332|Analgesics|analgesics|mesh-ancestor
733270|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
733271|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2753365|NCT02857426|Nivolumab|nivolumab|mesh-list
2753366|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2753367|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753368|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
733432|NCT02866448|Aspirin|aspirin|mesh-list
733433|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
733434|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
733435|NCT02866448|Analgesics|analgesics|mesh-ancestor
733436|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
733437|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733438|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733439|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
733440|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
733441|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
733442|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
733443|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733444|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
733445|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
733446|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733447|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
2233739|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2233740|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233741|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
2233742|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
2233743|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
2233744|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2233745|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
2233746|NCT00079105|Hormones|hormones|mesh-ancestor
732677|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
732678|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
732679|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
732680|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732681|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732682|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
732683|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2753369|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753370|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
2753371|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2753372|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753373|NCT02835222|Cytarabine|cytarabine|mesh-list
2753374|NCT02835222|Daunorubicin|daunorubicin|mesh-list
732690|NCT02870036|Leucovorin|leucovorin|mesh-list
732691|NCT02870036|Thalidomide|thalidomide|mesh-list
732692|NCT02870036|Fluorouracil|fluorouracil|mesh-list
732693|NCT02870036|Calcium|calcium|mesh-list
732694|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
732695|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
732696|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732697|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
732698|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732699|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
732700|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732701|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
732702|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
732703|NCT02870036|Antidotes|antidotes|mesh-ancestor
732704|NCT02870036|Protective Agents|protective agents|mesh-ancestor
732705|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
732706|NCT02870036|Vitamins|vitamins|mesh-ancestor
732707|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
732708|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
732709|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
732710|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
732711|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
732712|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
732713|NCT02870036|Growth Substances|growth substances|mesh-ancestor
732714|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
732723|NCT02869347|Complement C1s|complement c1s|mesh-list
732724|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
732725|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
732726|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
732727|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732728|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
732729|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
732825|NCT02868931|Insulin|insulin|mesh-list
732826|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
732827|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233747|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2233748|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2233749|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2233750|NCT00079105|Analgesics|analgesics|mesh-ancestor
2233751|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
2233752|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2233753|NCT00079118|Docetaxel|docetaxel|mesh-list
2233754|NCT00079118|Irinotecan|irinotecan|mesh-list
733109|NCT02867800|Acetaminophen|acetaminophen|mesh-list
733110|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
733111|NCT02867800|Promethazine|promethazine|mesh-list
733112|NCT02867800|Cyclosporine|cyclosporine|mesh-list
733113|NCT02867800|Sirolimus|sirolimus|mesh-list
733114|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
733115|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
733116|NCT02867800|Methotrexate|methotrexate|mesh-list
733117|NCT02867800|Fludarabine|fludarabine|mesh-list
733118|NCT02867800|Melphalan|melphalan|mesh-list
733119|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
733120|NCT02867800|Thiotepa|thiotepa|mesh-list
733121|NCT02867800|Abatacept|abatacept|mesh-list
733122|NCT02867800|Meperidine|meperidine|mesh-list
733123|NCT02867800|Tacrolimus|tacrolimus|mesh-list
733124|NCT02867800|Cyclosporins|cyclosporins|mesh-list
733125|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
733126|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
733127|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
733128|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
733129|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733130|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
733131|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
2233755|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732715|NCT02869763|Ethanol|ethanol|mesh-list
732716|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
732717|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
732718|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732719|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732720|NCT02869672|Vaccines|vaccines|mesh-list
732721|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
732722|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732730|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
732731|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
732732|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
732733|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
732764|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
732765|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
732766|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233756|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
2233757|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
2233758|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
732885|NCT02868814|Pregabalin|pregabalin|mesh-list
732886|NCT02868814|Analgesics|analgesics|mesh-ancestor
732887|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
732888|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732889|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732890|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
732891|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
732892|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
732893|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732894|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
732895|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
732896|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
732897|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732898|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
733422|NCT02866383|Nivolumab|nivolumab|mesh-list
733423|NCT02866383|Ipilimumab|ipilimumab|mesh-list
733424|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
733425|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733426|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
733427|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733550|NCT02866071|Ketamine|ketamine|mesh-list
733551|NCT02866071|Analgesics|analgesics|mesh-ancestor
733552|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
733553|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733554|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733555|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
733556|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
733557|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
733558|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
733559|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
733560|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
733561|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
733562|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
733563|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233759|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233760|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2233761|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2233762|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233763|NCT00079131|Oblimersen|oblimersen|mesh-list
733751|NCT02864927|Vaccines|vaccines|mesh-list
733752|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
733753|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233764|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233765|NCT00079144|Aldesleukin|aldesleukin|mesh-list
2233766|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
2233767|NCT00079144|Fludarabine|fludarabine|mesh-list
2233768|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
2092121|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092122|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092123|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092124|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2092125|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2092126|NCT02240628|Lidocaine|lidocaine|mesh-list
2092127|NCT02240628|Tetracaine|tetracaine|mesh-list
2092128|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
2092129|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
733948|NCT02864147|Imiquimod|imiquimod|mesh-list
2233769|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
2233770|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233771|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
2233772|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233773|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
732739|NCT02869204|Ascorbic Acid|ascorbic acid|mesh-list
732740|NCT02869204|Vitamins|vitamins|mesh-ancestor
732741|NCT02869204|Micronutrients|micronutrients|mesh-ancestor
732742|NCT02869204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732743|NCT02869204|Antioxidants|antioxidants|mesh-ancestor
732744|NCT02869204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732745|NCT02869204|Protective Agents|protective agents|mesh-ancestor
732746|NCT02869321|Fentanyl|fentanyl|mesh-list
732747|NCT02869321|Morphine|morphine|mesh-list
732748|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
732749|NCT02869321|Narcotics|narcotics|mesh-ancestor
732750|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732751|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732752|NCT02869321|Analgesics|analgesics|mesh-ancestor
732753|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
732754|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732755|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
732756|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
732757|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
732758|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
732759|NCT02869165|Estrogens|estrogens|mesh-list
732760|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
732761|NCT02869165|Hormones|hormones|mesh-ancestor
732762|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
732763|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732767|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
732769|NCT02869217|Fludarabine|fludarabine|mesh-list
732770|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
732771|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
732772|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732773|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
732774|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
732775|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
732776|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732777|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732778|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
732768|NCT02869100|Listerine|listerine|mesh-list
732780|NCT02869100|Fluorides|fluorides|mesh-list
732781|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
732782|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
732783|NCT02869100|Protective Agents|protective agents|mesh-ancestor
732784|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732785|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
732786|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233774|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2233775|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
2233776|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233777|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233778|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2233779|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233780|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
2233781|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2233782|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2233783|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2233784|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
2233785|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233786|NCT00079157|Sargramostim|sargramostim|mesh-list
2233787|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
2233788|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
2233789|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233790|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2233791|NCT00079170|Docetaxel|docetaxel|mesh-list
2233792|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233793|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
2233794|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
732810|NCT02868944|Sufentanil|sufentanil|mesh-list
732811|NCT02868944|Morphine|morphine|mesh-list
732812|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
732813|NCT02868944|Anesthetics|anesthetics|mesh-list
732814|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
732815|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
732816|NCT02868944|Narcotics|narcotics|mesh-ancestor
732920|NCT02868801|Pregabalin|pregabalin|mesh-list
2233795|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
732817|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732818|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732819|NCT02868944|Analgesics|analgesics|mesh-ancestor
732820|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
732821|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732822|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
732823|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
732824|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
733211|NCT02867306|Methotrexate|methotrexate|mesh-list
733212|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
733213|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
733214|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
733215|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733216|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
733217|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
733218|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733219|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733220|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
733221|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733222|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
733223|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
733224|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
733225|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
733226|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
733311|NCT02866955|Tamoxifen|tamoxifen|mesh-list
733312|NCT02866955|Estramustine|estramustine|mesh-list
733313|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
733314|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
733315|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
733316|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733317|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
733318|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733319|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
733320|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
733321|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
733322|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
733323|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
733324|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733575|NCT02865733|Treprostinil|treprostinil|mesh-list
733576|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
734056|NCT02863471|Gemcitabine|gemcitabine|mesh-list
734057|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
734058|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
734059|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734060|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734061|NCT02863471|Antiviral Agents|antiviral agents|mesh-ancestor
734062|NCT02863471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
734063|NCT02863471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734064|NCT02863471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
734065|NCT02863471|Immunologic Factors|immunologic factors|mesh-ancestor
734066|NCT02863471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233796|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233797|NCT00079222|Itraconazole|itraconazole|mesh-list
2233798|NCT00079222|Voriconazole|voriconazole|mesh-list
2233799|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
2233800|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
734430|NCT02862015|Gemcitabine|gemcitabine|mesh-list
734431|NCT02862015|Folfirinox|folfirinox|mesh-list
734432|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
734433|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
734434|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734435|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734436|NCT02862015|Antiviral Agents|antiviral agents|mesh-ancestor
734437|NCT02862015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
734438|NCT02862015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734439|NCT02862015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
734440|NCT02862015|Immunologic Factors|immunologic factors|mesh-ancestor
734441|NCT02862015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732828|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
732829|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
732830|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
732831|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732832|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
732833|NCT02868749|Protective Agents|protective agents|mesh-ancestor
732834|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
732835|NCT02869035|Citalopram|citalopram|mesh-list
732836|NCT02869035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
732837|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
732838|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
732839|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732840|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
732841|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
732842|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732843|NCT02869035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
732844|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
732845|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
732846|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732847|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
732848|NCT02869035|Analgesics|analgesics|mesh-ancestor
732849|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
732850|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
732857|NCT02868996|Kallikreins|kallikreins|mesh-list
732858|NCT02868996|Coagulants|coagulants|mesh-ancestor
732859|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
732860|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
732861|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
732862|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732863|NCT02869009|Aspirin|aspirin|mesh-list
732864|NCT02869009|Clopidogrel|clopidogrel|mesh-list
732865|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
732866|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
732867|NCT02869009|Analgesics|analgesics|mesh-ancestor
732868|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
732869|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732870|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732871|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
732872|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
732873|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
732874|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
732875|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732876|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
732877|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
732878|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732879|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
732880|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
732881|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
732882|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
732883|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
732884|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
732899|NCT02868580|Lamivudine|lamivudine|mesh-list
732901|NCT02868580|Abacavir|abacavir|mesh-list
732902|NCT02868580|Dolutegravir|dolutegravir|mesh-list
732903|NCT02868580|Triumeq|triumeq|mesh-list
732904|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
732905|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
732906|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732907|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732908|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
732909|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
732910|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
732911|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
732912|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
732913|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
732900|NCT02868827|Vitamin D|vitamin d|mesh-list
732914|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
732915|NCT02868827|Vitamins|vitamins|mesh-ancestor
732916|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
732917|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732918|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
732919|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
732979|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
732980|NCT02867930|Ketamine|ketamine|mesh-list
732981|NCT02867930|Propofol|propofol|mesh-list
732982|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
732921|NCT02868801|Analgesics|analgesics|mesh-ancestor
732922|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
732923|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732924|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732925|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
732926|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
732927|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
732928|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732929|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
732930|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
732931|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
732932|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732933|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
733107|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
733108|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733573|NCT02865850|Darbepoetin alfa|darbepoetin alfa|mesh-list
733574|NCT02865850|Hematinics|hematinics|mesh-ancestor
2233801|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2233802|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2233803|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736244|NCT02852837|Daratumumab|daratumumab|mesh-list
736245|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736522|NCT02850887|Anesthetics|anesthetics|mesh-list
736523|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736524|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736805|NCT02849236|Ropivacaine|ropivacaine|mesh-list
736806|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
736807|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
736808|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736809|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736810|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
736811|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737354|NCT02846376|Nivolumab|nivolumab|mesh-list
737355|NCT02846376|Ipilimumab|ipilimumab|mesh-list
737356|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
737357|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737358|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
737359|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233804|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233805|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2233806|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
2233807|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2233808|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233809|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2233810|NCT00079235|Sirolimus|sirolimus|mesh-list
2233811|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2233812|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233813|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2233814|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233815|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
2233816|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2092130|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2092131|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092132|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
2092133|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738332|NCT02840708|Sargramostim|sargramostim|mesh-list
738333|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
738334|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738461|NCT02840006|Anesthetics|anesthetics|mesh-list
738462|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
738463|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738525|NCT02839694|Celecoxib|celecoxib|mesh-list
738526|NCT02839694|Decitabine|decitabine|mesh-list
738527|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
738528|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
738529|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
738530|NCT02839694|Analgesics|analgesics|mesh-ancestor
738531|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
738532|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738533|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738534|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
738535|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
738536|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
732938|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
732939|NCT02868372|Povidone|povidone|mesh-list
732940|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
732941|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
732942|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
732943|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
732967|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
732968|NCT02868151|Vitamins|vitamins|mesh-ancestor
732969|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
732970|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732971|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
732972|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732973|NCT02868151|Protective Agents|protective agents|mesh-ancestor
733325|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
733326|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233817|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
2233818|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233819|NCT00079248|Progesterone|progesterone|mesh-list
2233820|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2233821|NCT00079248|Estrogens|estrogens|mesh-list
2233822|NCT00079248|Progestins|progestins|mesh-ancestor
733800|NCT02864849|Capecitabine|capecitabine|mesh-list
733801|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
733802|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
733803|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
733804|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733805|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734803|NCT02860221|Epinephrine|epinephrine|mesh-list
734804|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
734805|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
734806|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
734807|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
734808|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734809|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734810|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734811|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
734812|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
734813|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
734814|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734815|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
734816|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
734817|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
734818|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
734819|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
734820|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
734821|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
734822|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
734823|NCT02860221|Coagulants|coagulants|mesh-ancestor
734897|NCT02859402|Fludarabine|fludarabine|mesh-list
734903|NCT02859402|Busulfan|busulfan|mesh-list
734904|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734905|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734907|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
734908|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
734909|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734910|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
734911|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
734912|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2092134|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2092135|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2092136|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2092137|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2233823|NCT00079248|Hormones|hormones|mesh-ancestor
2233824|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2233825|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233826|NCT00079261|Gemcitabine|gemcitabine|mesh-list
2233827|NCT00079261|Prednisone|prednisone|mesh-list
2233828|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
2233829|NCT00079261|Doxorubicin|doxorubicin|mesh-list
2233830|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
736438|NCT02851459|Vaccines|vaccines|mesh-list
736439|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
736440|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736581|NCT02850289|Interferons|interferons|mesh-list
736582|NCT02850289|Ribavirin|ribavirin|mesh-list
736583|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736584|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
2233831|NCT00079261|Vincristine|vincristine|mesh-list
732944|NCT02868385|Praziquantel|praziquantel|mesh-list
732945|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
732946|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
732947|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092138|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092139|NCT02240667|Vitamin K|vitamin k|mesh-list
2092140|NCT02240667|Dabigatran|dabigatran|mesh-list
2092141|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
2092142|NCT02240667|Vitamins|vitamins|mesh-ancestor
2092143|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
733916|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
733917|NCT02863861|Ketamine|ketamine|mesh-list
733918|NCT02863861|Propofol|propofol|mesh-list
733919|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
733920|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
733921|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733922|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
733923|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
733924|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
733925|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
733926|NCT02863861|Analgesics|analgesics|mesh-ancestor
733927|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
733928|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733929|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
733930|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
733931|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
733932|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
733933|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
733934|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733935|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
733936|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
733937|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
734074|NCT02863705|Timolol|timolol|mesh-list
734075|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
734076|NCT02863705|Bimatoprost|bimatoprost|mesh-list
734077|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
734078|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
734079|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
734080|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
734081|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
734082|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734083|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734084|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734085|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
734086|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
734087|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
734088|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
734089|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
734226|NCT02862873|Ondansetron|ondansetron|mesh-list
734227|NCT02862873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734228|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734229|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
734230|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
734231|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734232|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
734233|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
734234|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
734235|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
734236|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
734237|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734238|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734239|NCT02862873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
734240|NCT02862873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
734241|NCT02862873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
734242|NCT02862873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
734398|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
734399|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
734400|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
734401|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
732954|NCT02868632|Durvalumab|durvalumab|mesh-list
732955|NCT02868632|Tremelimumab|tremelimumab|mesh-list
732956|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
732957|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
732958|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
732959|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
732960|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
732961|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733003|NCT02867956|Etoposide|etoposide|mesh-list
733004|NCT02867956|Apatinib|apatinib|mesh-list
733005|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
733006|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733007|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
733008|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
733009|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733010|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733011|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
733012|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
733013|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
733014|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
733015|NCT02867904|Prednisolone|prednisolone|mesh-list
733016|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
733017|NCT02867904|Bupivacaine|bupivacaine|mesh-list
733018|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
733019|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
733020|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
733021|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
733022|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
733023|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733024|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733025|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
733026|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
733027|NCT02867904|Hormones|hormones|mesh-ancestor
733028|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
733029|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
733031|NCT02867904|Protective Agents|protective agents|mesh-ancestor
733032|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
733033|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733034|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
733035|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
733036|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
733037|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
733081|NCT02867566|Rituximab|rituximab|mesh-list
733082|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
733083|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733084|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
733085|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733086|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
733227|NCT02867267|Thymalfasin|thymalfasin|mesh-list
733228|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
733229|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
733230|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733290|NCT02867046|Dexamethasone|dexamethasone|mesh-list
733291|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
733292|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
733293|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
733294|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733295|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733296|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
733297|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
733298|NCT02867046|Hormones|hormones|mesh-ancestor
733299|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
733300|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
733301|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733327|NCT02866786|Metformin|metformin|mesh-list
733328|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
733329|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
733330|NCT02866786|Estradiol|estradiol|mesh-list
733331|NCT02866786|Cyproterone|cyproterone|mesh-list
733332|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
733333|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733334|NCT02866786|Estrogens|estrogens|mesh-ancestor
733335|NCT02866786|Hormones|hormones|mesh-ancestor
733336|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
733337|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
733339|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
733382|NCT02866214|Febuxostat|febuxostat|mesh-list
2233832|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233833|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
2233834|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233835|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2233836|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
732974|NCT02868073|Vaccines|vaccines|mesh-list
732975|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
732976|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733272|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
733273|NCT02867345|Interleukin-2|interleukin-2|mesh-list
733274|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
733275|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
733276|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733277|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
733278|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
733279|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
733280|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733281|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733282|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
733283|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
733284|NCT02867345|Analgesics|analgesics|mesh-ancestor
733285|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
733286|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733385|NCT02866227|TOL-463|tol-463|mesh-list
733386|NCT02866227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
733497|NCT02866136|Carboplatin|carboplatin|mesh-list
733498|NCT02866136|Etoposide|etoposide|mesh-list
733499|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
733500|NCT02866136|Melphalan|melphalan|mesh-list
733501|NCT02866136|Vincristine|vincristine|mesh-list
733502|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733503|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
733504|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
733505|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
733506|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733507|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733508|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
733509|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
733510|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
733511|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
733512|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
733513|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733514|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
733515|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
733516|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
733540|NCT02866032|Ciclopirox|ciclopirox|mesh-list
733541|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
733542|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
733674|NCT02865551|Anesthetics|anesthetics|mesh-list
733675|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
733676|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733969|NCT02864095|Epinephrine|epinephrine|mesh-list
733970|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
733971|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
733972|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
733973|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
733974|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
733975|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733976|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733977|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
733978|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
733979|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
733980|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733981|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
733982|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
733983|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
733984|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
733985|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
733986|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
733987|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
733988|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
733989|NCT02864095|Coagulants|coagulants|mesh-ancestor
734090|NCT02863276|Insulin|insulin|mesh-list
734091|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
734092|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
734093|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233837|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
732983|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
732984|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
732985|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
732986|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
732987|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
732988|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
732989|NCT02867930|Analgesics|analgesics|mesh-ancestor
732990|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
732991|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
732992|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
732993|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
732994|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
732995|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
732996|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
732997|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
732998|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
732999|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
733000|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
733001|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
733002|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233838|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233839|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233840|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2233841|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233842|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
733203|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
733204|NCT02867397|Epirubicin|epirubicin|mesh-list
733205|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733206|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
733207|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
733208|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
733209|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733210|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733287|NCT02866747|Durvalumab|durvalumab|mesh-list
733288|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
733289|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733387|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
733388|NCT02866409|Bupivacaine|bupivacaine|mesh-list
733389|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
733390|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
733391|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
733392|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733393|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
733394|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733395|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
733396|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
733397|NCT02866409|Analgesics|analgesics|mesh-ancestor
733398|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
733399|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
733400|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
733401|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
733402|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
733403|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733408|NCT02866396|Pregabalin|pregabalin|mesh-list
733409|NCT02866396|Analgesics|analgesics|mesh-ancestor
733410|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
733411|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733412|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733413|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
733414|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
733415|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
733416|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733417|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
733418|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
733419|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
733420|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
733421|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
733665|NCT02865616|Vancomycin|vancomycin|mesh-list
733666|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
733667|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
733748|NCT02865135|Vaccines|vaccines|mesh-list
733749|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
733750|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733030|NCT02867878|Adenosine|adenosine|mesh-list
733038|NCT02867878|Analgesics|analgesics|mesh-ancestor
733039|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
733040|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733041|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733042|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
733043|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
733044|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
733045|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
733046|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
733047|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
733048|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733087|NCT02867553|Rituximab|rituximab|mesh-list
733088|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
733089|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733090|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
733091|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733092|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
733231|NCT02867293|Anesthetics|anesthetics|mesh-list
733232|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
733233|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733517|NCT02865824|Aspirin|aspirin|mesh-list
733518|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
733519|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
733520|NCT02865824|Analgesics|analgesics|mesh-ancestor
733521|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
733522|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733523|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733524|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
733525|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
733526|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
733527|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
733528|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733529|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
733530|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
733531|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733532|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
733648|NCT02865668|Metformin|metformin|mesh-list
733649|NCT02865668|Canagliflozin|canagliflozin|mesh-list
733650|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
733651|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733652|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
733653|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092144|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092145|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
2092146|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2092147|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
2092148|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092149|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092150|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
2092151|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
733863|NCT02864550|Doxycycline|doxycycline|mesh-list
733864|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
733865|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
733866|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
733867|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
733868|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2233843|NCT00079261|Antiviral Agents|antiviral agents|mesh-ancestor
2233844|NCT00079261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233845|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233846|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2233847|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2233848|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2233849|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2233850|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
2233851|NCT00079261|Hormones|hormones|mesh-ancestor
2233852|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2233853|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2233854|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2233855|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
2233856|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
734268|NCT02862509|Budesonide|budesonide|mesh-list
734269|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
734270|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
734283|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
733049|NCT02867865|Gemcitabine|gemcitabine|mesh-list
733050|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733051|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
733052|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
733053|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733054|NCT02867865|Antiviral Agents|antiviral agents|mesh-ancestor
733055|NCT02867865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
733056|NCT02867865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733057|NCT02867865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
733058|NCT02867865|Immunologic Factors|immunologic factors|mesh-ancestor
733059|NCT02867865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733066|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
733067|NCT02867917|Psyllium|psyllium|mesh-list
733077|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
733078|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
733079|NCT02867917|Cathartics|cathartics|mesh-ancestor
733080|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2092152|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2092153|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
2092154|NCT02240667|Coagulants|coagulants|mesh-ancestor
2092155|NCT02240680|Linagliptin|linagliptin|mesh-list
2092156|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2092157|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092158|NCT02240680|Incretins|incretins|mesh-ancestor
2092159|NCT02240680|Hormones|hormones|mesh-ancestor
733181|NCT02867176|Ketorolac|ketorolac|mesh-list
733182|NCT02867176|Gabapentin|gabapentin|mesh-list
733183|NCT02867176|Analgesics|analgesics|mesh-ancestor
733184|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
733185|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733186|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733187|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
733188|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
733189|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
733190|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
733191|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
733192|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
733193|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
733194|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
733195|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733196|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
733197|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
733198|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
733199|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
733200|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
733201|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
733202|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733533|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
733534|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
733535|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
733564|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
733565|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
733566|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
733567|NCT02866006|Topotecan|topotecan|mesh-list
733568|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
733569|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
733570|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733571|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733572|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733604|NCT02865642|Citalopram|citalopram|mesh-list
733605|NCT02865642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
733606|NCT02865642|Serotonin|serotonin|mesh-list
733607|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
733608|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
733609|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733610|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
733611|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
733612|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733613|NCT02865642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
733614|NCT02865642|Antidepressive Agents|antidepressive agents|mesh-ancestor
733615|NCT02865642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
733616|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
733654|NCT02865473|Pilocarpine|pilocarpine|mesh-list
733655|NCT02865473|Miotics|miotics|mesh-ancestor
733656|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
733692|NCT02865356|Cyclosporine|cyclosporine|mesh-list
2233857|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
733132|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733133|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733134|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
733135|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733136|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
733137|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
733138|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
733139|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
733140|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
733141|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
733142|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
733143|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
733144|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
733145|NCT02867800|Analgesics|analgesics|mesh-ancestor
733146|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
733147|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733148|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
733149|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
733150|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
733151|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
733152|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
733153|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
733154|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
733155|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
733156|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
733157|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
733158|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
733159|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
733160|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
733161|NCT02867800|Hormones|hormones|mesh-ancestor
733162|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
733163|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
733164|NCT02867800|Protective Agents|protective agents|mesh-ancestor
733165|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
733166|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
733167|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
733168|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
733169|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
733170|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
733171|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
733172|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
733173|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
733174|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
733175|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
733176|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
733177|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
733178|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
733179|NCT02867800|Narcotics|narcotics|mesh-ancestor
733180|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
733251|NCT02867124|Naltrexone|naltrexone|mesh-list
733252|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
733253|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
733254|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733255|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
733256|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2233858|NCT00079287|Gemcitabine|gemcitabine|mesh-list
2233859|NCT00079287|Paclitaxel|paclitaxel|mesh-list
2233860|NCT00079287|Vinorelbine|vinorelbine|mesh-list
2233861|NCT00079287|Docetaxel|docetaxel|mesh-list
2233862|NCT00079287|Carboplatin|carboplatin|mesh-list
2233863|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2233864|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233865|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
2233866|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
2233867|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
2233868|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233869|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233870|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
2233871|NCT00079287|Antiviral Agents|antiviral agents|mesh-ancestor
2233872|NCT00079287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233873|NCT00079287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233874|NCT00079287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233875|NCT00079287|Immunologic Factors|immunologic factors|mesh-ancestor
2233876|NCT00079287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233877|NCT00079300|Imiquimod|imiquimod|mesh-list
2233878|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2233879|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
2233880|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233881|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233882|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
2233883|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
2233884|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233885|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2233886|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233887|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233888|NCT00079352|Gemcitabine|gemcitabine|mesh-list
2233889|NCT00079352|Irinotecan|irinotecan|mesh-list
2233890|NCT00079352|Alvocidib|alvocidib|mesh-list
2233891|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233892|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
2233893|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233894|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233895|NCT00079352|Antiviral Agents|antiviral agents|mesh-ancestor
2233896|NCT00079352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233897|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733536|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
733537|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
733538|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
733539|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
733793|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
733794|NCT02864784|Calcium|calcium|mesh-list
733795|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
733796|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733797|NCT02864784|Antacids|antacids|mesh-ancestor
733798|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733799|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2092160|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2092161|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2092162|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
2092163|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092164|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092165|NCT02240693|BI 409306|bi 409306|mesh-list
2092166|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2092167|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734216|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
734217|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
734218|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
734219|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
734220|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
734221|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
734222|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734223|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
734224|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
734225|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734445|NCT02861859|Olanzapine|olanzapine|mesh-list
734446|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
734447|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
734448|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734449|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734450|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
734451|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
734452|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
734453|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734454|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
734455|NCT02861859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
734456|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
734457|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
734458|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734459|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734460|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
734653|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
734654|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
734655|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
734656|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734657|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
734658|NCT02861183|Protective Agents|protective agents|mesh-ancestor
734842|NCT02860039|Vaccines|vaccines|mesh-list
734843|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
734844|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092168|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733404|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
733405|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
733406|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
733407|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733587|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
733588|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
733589|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
733590|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
733591|NCT02865629|Expectorants|expectorants|mesh-ancestor
733592|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
733593|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
733594|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
733595|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733596|NCT02865629|Protective Agents|protective agents|mesh-ancestor
733597|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733598|NCT02865629|Antidotes|antidotes|mesh-ancestor
733715|NCT02865174|Heparin|heparin|mesh-list
733716|NCT02865174|Enoxaparin|enoxaparin|mesh-list
733717|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
733718|NCT02865174|Tinzaparin|tinzaparin|mesh-list
733719|NCT02865174|Dalteparin|dalteparin|mesh-list
733720|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
733721|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
733722|NCT02865174|Thrombin|thrombin|mesh-list
733723|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
733724|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
733725|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
733726|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733727|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
733728|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
733729|NCT02865174|Coagulants|coagulants|mesh-ancestor
733730|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
733731|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
733732|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
733733|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733734|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
733735|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
733736|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
733737|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733776|NCT02864758|Vitamin K|vitamin k|mesh-list
733777|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
733778|NCT02864758|Dabigatran|dabigatran|mesh-list
733779|NCT02864758|Vitamins|vitamins|mesh-ancestor
733780|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
733781|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733782|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
733783|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
733784|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
733785|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
733786|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733787|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733788|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
733789|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
733790|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
733791|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
733792|NCT02864758|Coagulants|coagulants|mesh-ancestor
733843|NCT02864472|Ranibizumab|ranibizumab|mesh-list
733844|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
733845|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
733846|NCT02864472|Growth Substances|growth substances|mesh-ancestor
733847|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733848|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
733849|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734191|NCT02863120|Bupivacaine|bupivacaine|mesh-list
734192|NCT02863120|Ropivacaine|ropivacaine|mesh-list
734193|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
734194|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
734195|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734196|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734197|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
734198|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734838|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
734839|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
734840|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
734841|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735304|NCT02857361|Analgesics|analgesics|mesh-ancestor
733243|NCT02867280|Sorafenib|sorafenib|mesh-list
733244|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733245|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
733246|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733247|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733302|NCT02866903|Bevacizumab|bevacizumab|mesh-list
733303|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
733304|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
733305|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733306|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
733307|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
733308|NCT02866903|Growth Substances|growth substances|mesh-ancestor
733309|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733310|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
733428|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
733429|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733430|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
733431|NCT02866435|Protective Agents|protective agents|mesh-ancestor
733869|NCT02864264|Interferons|interferons|mesh-list
733870|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
733871|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733872|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
733873|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092169|NCT02241486|Fentanyl|fentanyl|mesh-list
2092170|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2092171|NCT02241486|Narcotics|narcotics|mesh-ancestor
2092172|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2092173|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734636|NCT02860858|Aflibercept|aflibercept|mesh-list
734637|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
734638|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
734639|NCT02860858|Growth Substances|growth substances|mesh-ancestor
734640|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734641|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
734642|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092174|NCT02241486|Analgesics|analgesics|mesh-ancestor
2092175|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
735185|NCT02858037|Dapivirine|dapivirine|mesh-list
735186|NCT02858037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
735187|NCT02858037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
735188|NCT02858037|Antiviral Agents|antiviral agents|mesh-ancestor
735189|NCT02858037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
735292|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
735293|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
735294|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
735295|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735296|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
735297|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735298|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735299|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
735300|NCT02857309|Diuretics|diuretics|mesh-ancestor
735301|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
735302|NCT02857309|Hormones|hormones|mesh-ancestor
735444|NCT02856893|Gefitinib|gefitinib|mesh-list
735445|NCT02856893|Osimertinib|osimertinib|mesh-list
735446|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735447|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
735448|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735449|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233898|NCT00079352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233899|NCT00079352|Immunologic Factors|immunologic factors|mesh-ancestor
2233900|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233901|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2233902|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2233903|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
2233904|NCT00079352|Growth Substances|growth substances|mesh-ancestor
2233905|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2233906|NCT00079365|Gemcitabine|gemcitabine|mesh-list
2233907|NCT00079365|Fluorouracil|fluorouracil|mesh-list
2233908|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233909|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
2233910|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233911|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233912|NCT00079365|Antiviral Agents|antiviral agents|mesh-ancestor
2233913|NCT00079365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233914|NCT00079365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233915|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233916|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
2233917|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092176|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092177|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2092178|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2092179|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
2092180|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
2092181|NCT02241512|Ibuprofen|ibuprofen|mesh-list
2092182|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
734043|NCT02863367|Gemcitabine|gemcitabine|mesh-list
734044|NCT02863367|Apatinib|apatinib|mesh-list
734045|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
734046|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
734047|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734048|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734049|NCT02863367|Antiviral Agents|antiviral agents|mesh-ancestor
734050|NCT02863367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
734051|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734052|NCT02863367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
734053|NCT02863367|Immunologic Factors|immunologic factors|mesh-ancestor
734054|NCT02863367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734055|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
734550|NCT02860936|Lenvatinib|lenvatinib|mesh-list
734551|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734552|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
734553|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734554|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233918|NCT00079378|Decitabine|decitabine|mesh-list
2233919|NCT00079378|Azacitidine|azacitidine|mesh-list
2233920|NCT00079378|Valproic Acid|valproic acid|mesh-list
2233921|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233922|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
2233923|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233924|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233925|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736501|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
736502|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
736503|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092183|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2092184|NCT02241512|Analgesics|analgesics|mesh-ancestor
2092185|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
2092186|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092187|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092188|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2092189|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2092190|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2092191|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092192|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092193|NCT02241655|Anesthetics|anesthetics|mesh-list
2092194|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2092195|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092196|NCT02241785|Natalizumab|natalizumab|mesh-list
2092197|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
2233926|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
2233927|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
2233928|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2233929|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233930|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
2233931|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2233932|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2233933|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2233934|NCT00079430|Paclitaxel|paclitaxel|mesh-list
2233935|NCT00079430|Bevacizumab|bevacizumab|mesh-list
2233936|NCT00079430|Carboplatin|carboplatin|mesh-list
2233937|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2233938|NCT00079430|Antibodies|antibodies|mesh-list
2233939|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
2233940|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2233941|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2233942|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233943|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
2233944|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
2233945|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
2233946|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233947|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
733340|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
733346|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
733347|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
733348|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
733349|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
733350|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
733351|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733352|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2233948|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2233949|NCT00079430|Growth Substances|growth substances|mesh-ancestor
2233950|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233951|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
2233952|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
2233953|NCT00079443|Rituximab|rituximab|mesh-list
2233954|NCT00079443|Fludarabine|fludarabine|mesh-list
2233955|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
2233956|NCT00079443|Romidepsin|romidepsin|mesh-list
2233957|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2233958|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233959|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
2233960|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736078|NCT02853799|Insulin|insulin|mesh-list
736079|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
736080|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736092|NCT02853526|Propranolol|propranolol|mesh-list
736093|NCT02853526|Warfarin|warfarin|mesh-list
736094|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
736095|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
736096|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
736097|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
736098|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
736099|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736100|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736101|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
736102|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
736103|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
736328|NCT02852083|Pioglitazone|pioglitazone|mesh-list
736329|NCT02852083|Clarithromycin|clarithromycin|mesh-list
736330|NCT02852083|Nivolumab|nivolumab|mesh-list
736331|NCT02852083|Treosulfan|treosulfan|mesh-list
736332|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
736333|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736334|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
736335|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736336|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
736337|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736338|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
736339|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
736340|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
736341|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736342|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
736343|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
736344|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
736345|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
2233961|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2233962|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2233963|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
2233964|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233965|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233966|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2233967|NCT00079456|Sirolimus|sirolimus|mesh-list
2233968|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2233969|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233970|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2233971|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233972|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
2233973|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2233974|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
2233975|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233976|NCT00079469|Bupropion|bupropion|mesh-list
2233977|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2233978|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
2233979|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
737160|NCT02847338|Amlodipine|amlodipine|mesh-list
2233980|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
733353|NCT02867020|Prednisone|prednisone|mesh-list
733354|NCT02867020|Goserelin|goserelin|mesh-list
733355|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
733356|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
733357|NCT02867020|Hormones|hormones|mesh-ancestor
733358|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
733359|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733360|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
733361|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733756|NCT02865018|Cetirizine|cetirizine|mesh-list
733757|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
733758|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
733759|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
733760|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
733761|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
733762|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
733763|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733764|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733954|NCT02863835|Albuterol|albuterol|mesh-list
733955|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
733956|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
733957|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733958|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733959|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
733960|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
733961|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
733962|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
733963|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
733964|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
733965|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
733966|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
733967|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
733968|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233981|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2233982|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2233983|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233984|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
2233985|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734555|NCT02860923|Exenatide|exenatide|mesh-list
734556|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
734557|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734558|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
734559|NCT02860923|Incretins|incretins|mesh-ancestor
734560|NCT02860923|Hormones|hormones|mesh-ancestor
734561|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735555|NCT02856789|Hemostatics|hemostatics|mesh-list
735556|NCT02856789|Coagulants|coagulants|mesh-ancestor
735975|NCT02854787|Phenylephrine|phenylephrine|mesh-list
735976|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
735977|NCT02854787|Norepinephrine|norepinephrine|mesh-list
735978|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
735979|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
735980|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
735981|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735982|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735983|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
735984|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
735985|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
735986|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
735987|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
735988|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
733383|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
733384|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
733629|NCT02865681|Letrozole|letrozole|mesh-list
733630|NCT02865681|Clomiphene|clomiphene|mesh-list
733631|NCT02865681|Enclomiphene|enclomiphene|mesh-list
733632|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
733633|NCT02865681|Menotropins|menotropins|mesh-list
733634|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733635|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733636|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
733637|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
733638|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733639|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
733640|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
733641|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
733642|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733643|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
733644|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
733645|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
733646|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
733647|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
733685|NCT02865304|Endostar protein|endostar protein|mesh-list
733686|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
733687|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
733688|NCT02865304|Growth Substances|growth substances|mesh-ancestor
733689|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733690|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
733691|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733738|NCT02865005|Dapsone|dapsone|mesh-list
733739|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
733740|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
733741|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
733742|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
733743|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
733744|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733745|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733746|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
733747|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
734291|NCT02862483|Tadalafil|tadalafil|mesh-list
734292|NCT02862483|Tamsulosin|tamsulosin|mesh-list
734293|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
734294|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
734295|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
734296|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734297|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734298|NCT02862483|Urological Agents|urological agents|mesh-ancestor
734299|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
734300|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
734301|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
734302|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
734303|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734304|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734776|NCT02860299|Heparin|heparin|mesh-list
734777|NCT02860299|Calcium heparin|calcium heparin|mesh-list
734778|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
734779|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734780|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
734781|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2092198|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092199|NCT02241889|Pancrelipase|pancrelipase|mesh-list
2092200|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
735194|NCT02858024|Dapivirine|dapivirine|mesh-list
735195|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
735196|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
735197|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
735198|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2233986|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2233987|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2233988|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
735615|NCT02856295|Enoxaparin|enoxaparin|mesh-list
735616|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
735617|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
735618|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
735619|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735685|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
2092201|NCT02242045|Idelalisib|idelalisib|mesh-list
733454|NCT02866370|Paclitaxel|paclitaxel|mesh-list
733455|NCT02866370|Carboplatin|carboplatin|mesh-list
733456|NCT02866370|Doxorubicin|doxorubicin|mesh-list
733457|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
733458|NCT02866370|Topotecan|topotecan|mesh-list
733459|NCT02866370|Nintedanib|nintedanib|mesh-list
733460|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
733461|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733462|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
733463|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
733464|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
733465|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733466|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
733467|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
733468|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
733469|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733470|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
733471|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
733681|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
733682|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
733683|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733684|NCT02865460|Vitamins|vitamins|mesh-ancestor
733825|NCT02864602|Dexamethasone|dexamethasone|mesh-list
733826|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
733827|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
733828|NCT02864602|BB 1101|bb 1101|mesh-list
733829|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
733830|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
733831|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
733832|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733833|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733834|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
733835|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
733836|NCT02864602|Hormones|hormones|mesh-ancestor
733837|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
733838|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
733839|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733840|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
733841|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733842|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092202|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092203|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092204|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092205|NCT02242201|Ketorolac|ketorolac|mesh-list
2092206|NCT02242201|Epinephrine|epinephrine|mesh-list
2233989|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233990|NCT00079482|Cytarabine|cytarabine|mesh-list
2233991|NCT00079482|Etoposide|etoposide|mesh-list
2233992|NCT00079482|Mitoxantrone|mitoxantrone|mesh-list
2233993|NCT00079482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2233994|NCT00079482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2233995|NCT00079482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
735031|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
735032|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735033|NCT02858856|Mitogens|mitogens|mesh-ancestor
735034|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
735035|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735270|NCT02857686|Anesthetics|anesthetics|mesh-list
735271|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
735272|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735903|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
735904|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
735905|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
735906|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735907|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
2233996|NCT00079482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2233997|NCT00079482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2233998|NCT00079482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2233999|NCT00079482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2234000|NCT00079482|Antimetabolites|antimetabolites|mesh-ancestor
733914|NCT02863991|TIC10 compound|tic10 compound|mesh-list
733915|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734415|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
734416|NCT02861976|Narcotics|narcotics|mesh-ancestor
734417|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734418|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734419|NCT02861976|Analgesics|analgesics|mesh-ancestor
734420|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
734421|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734743|NCT02860624|Esomeprazole|esomeprazole|mesh-list
734744|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
734745|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
734746|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
734747|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734748|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734929|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
734930|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
734931|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
734932|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
734933|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
735610|NCT02856451|Nivolumab|nivolumab|mesh-list
735611|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
735612|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735613|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
735614|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234001|NCT00079482|Antiviral Agents|antiviral agents|mesh-ancestor
2234002|NCT00079482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234003|NCT00079482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2234004|NCT00079482|Immunologic Factors|immunologic factors|mesh-ancestor
2234005|NCT00079482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234006|NCT00079482|Analgesics|analgesics|mesh-ancestor
2234007|NCT00079482|Sensory System Agents|sensory system agents|mesh-ancestor
2234008|NCT00079482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2234009|NCT00079508|Bivalirudin|bivalirudin|mesh-list
2234010|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
2234011|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2234012|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
2234013|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234014|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234015|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
2234016|NCT00079560|Dronabinol|dronabinol|mesh-list
2234017|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
2234018|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234019|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2234020|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2234021|NCT00079560|Analgesics|analgesics|mesh-ancestor
2234022|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
2234023|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2234024|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2234025|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2234026|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2234027|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234028|NCT00079560|Hormones|hormones|mesh-ancestor
2092207|NCT02242201|Bupivacaine|bupivacaine|mesh-list
2092208|NCT02242201|Ropivacaine|ropivacaine|mesh-list
2092209|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
2092210|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
2234029|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2234030|NCT00079586|Heparin|heparin|mesh-list
2234031|NCT00079586|Bivalirudin|bivalirudin|mesh-list
2234032|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
2234033|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2234034|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2234035|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734067|NCT02863679|Tetracaine|tetracaine|mesh-list
734068|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
734069|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
734070|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734071|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734072|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
734073|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734145|NCT02863055|Nintedanib|nintedanib|mesh-list
734146|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734147|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
734148|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734149|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234036|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
2234037|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
734484|NCT02861482|Oxytocin|oxytocin|mesh-list
734485|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
734486|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
734487|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
734488|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734523|NCT02861261|Promethazine|promethazine|mesh-list
734524|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
734525|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
734526|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
734527|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
734528|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
734529|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
734530|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734531|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734532|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734533|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
734534|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
734535|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
734536|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734537|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
734538|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
734539|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
734540|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734541|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
734542|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
734543|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
734659|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
734660|NCT02860897|Estrogens|estrogens|mesh-ancestor
734661|NCT02860897|Hormones|hormones|mesh-ancestor
734662|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
734663|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734971|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
734972|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
734973|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
734974|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
734975|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734976|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734977|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734978|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
734979|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
734980|NCT02859259|Fostemsavir|fostemsavir|mesh-list
734981|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
734982|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
734983|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
734984|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
734985|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
734986|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
734987|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735285|NCT02857491|Ranibizumab|ranibizumab|mesh-list
735286|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
735287|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
735288|NCT02857491|Growth Substances|growth substances|mesh-ancestor
735303|NCT02857361|Ketamine|ketamine|mesh-list
2234038|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
2234039|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234040|NCT00079612|Sorafenib|sorafenib|mesh-list
2234041|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234042|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2234043|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234044|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234045|NCT00079638|Niacin|niacin|mesh-list
2234046|NCT00079638|Atorvastatin|atorvastatin|mesh-list
2234047|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2234048|NCT00079638|Simvastatin|simvastatin|mesh-list
2234049|NCT00079638|Ezetimibe|ezetimibe|mesh-list
2234050|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2234051|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2234052|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
2234053|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234054|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
734030|NCT02863809|Riboflavin|riboflavin|mesh-list
734031|NCT02863809|Dextrans|dextrans|mesh-list
734032|NCT02863809|Vitamins|vitamins|mesh-ancestor
734033|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
734034|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734035|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
734036|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
734037|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
734038|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
734039|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
734040|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
734150|NCT02862977|Ketoprofen|ketoprofen|mesh-list
734151|NCT02862977|Amitriptyline|amitriptyline|mesh-list
734152|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
734153|NCT02862977|Caffeine|caffeine|mesh-list
734154|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
734155|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734156|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
734157|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734158|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734159|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
734160|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
734161|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
734162|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734163|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
734164|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
734165|NCT02862977|Analgesics|analgesics|mesh-ancestor
734166|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
734167|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734168|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
734169|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
734170|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
734171|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
734172|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
734173|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
734174|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
734175|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
734176|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
734177|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734178|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
734179|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
734180|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
734181|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
2234055|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
733657|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
733658|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733659|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
733660|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
733661|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
733662|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
733663|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733664|NCT02865564|Gentamicins|gentamicins|mesh-list
733668|NCT02865564|Ampicillin|ampicillin|mesh-list
733669|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
733670|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
733671|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
733672|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733673|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734005|NCT02863614|Ibuprofen|ibuprofen|mesh-list
734006|NCT02863614|Lorazepam|lorazepam|mesh-list
734007|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
734008|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
734009|NCT02863614|Analgesics|analgesics|mesh-ancestor
734010|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
734011|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734012|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734013|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
734014|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
734015|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
734016|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734017|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734018|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
734019|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
734020|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
734021|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
734022|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
734023|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734024|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
734025|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
734026|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
734027|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
734028|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
734029|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2753375|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2234056|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234057|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
2234058|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
2234059|NCT00079638|Vitamins|vitamins|mesh-ancestor
2234060|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
2234061|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234062|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
2092211|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2234063|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
734667|NCT02860819|Gemcitabine|gemcitabine|mesh-list
734668|NCT02860819|Carboplatin|carboplatin|mesh-list
734669|NCT02860819|Veliparib|veliparib|mesh-list
734670|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734671|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
734672|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
734673|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734674|NCT02860819|Antiviral Agents|antiviral agents|mesh-ancestor
734675|NCT02860819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
734676|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734677|NCT02860819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
734678|NCT02860819|Immunologic Factors|immunologic factors|mesh-ancestor
734679|NCT02860819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734925|NCT02859571|Oxytocin|oxytocin|mesh-list
733677|NCT02865369|Asunaprevir|asunaprevir|mesh-list
733678|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
733679|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733680|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734824|NCT02860234|Capecitabine|capecitabine|mesh-list
734825|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
734826|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
734827|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
734828|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734829|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234064|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234065|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2234066|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2234067|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234068|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
2234069|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2234070|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234071|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
2234072|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
2234073|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234074|NCT00079807|Protective Agents|protective agents|mesh-ancestor
735421|NCT02857166|Antibodies|antibodies|mesh-list
735422|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
735423|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
735424|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735763|NCT02855788|Leucovorin|leucovorin|mesh-list
735764|NCT02855788|Paclitaxel|paclitaxel|mesh-list
735765|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
735766|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
735767|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735768|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
735769|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
735770|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
735771|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735772|NCT02855788|Antidotes|antidotes|mesh-ancestor
735773|NCT02855788|Protective Agents|protective agents|mesh-ancestor
735774|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735775|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
735776|NCT02855788|Vitamins|vitamins|mesh-ancestor
735777|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
735827|NCT02855346|Dapivirine|dapivirine|mesh-list
735828|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
735829|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
735830|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
735831|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
735832|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735833|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
735834|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
735835|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
735836|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
735837|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
735838|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
735839|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234075|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234076|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
2234077|NCT00079807|Vitamins|vitamins|mesh-ancestor
2234078|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
2234079|NCT00079820|Vaccines|vaccines|mesh-list
2234080|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
2234081|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234082|NCT00079833|Esomeprazole|esomeprazole|mesh-list
735953|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
735954|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
733693|NCT02865356|Cyclosporins|cyclosporins|mesh-list
733694|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
733695|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733696|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
733697|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
733698|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733699|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
733700|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
733701|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
733702|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
733703|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2234083|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2234084|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2234085|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2234086|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234087|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234088|NCT00079872|Pemetrexed|pemetrexed|mesh-list
2234089|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234090|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734182|NCT02863185|Atorvastatin|atorvastatin|mesh-list
734183|NCT02863185|Pitavastatin|pitavastatin|mesh-list
734184|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
734185|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
734186|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
734187|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734188|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
734189|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
734190|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234091|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234092|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2234093|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2234094|NCT00079885|Tigecycline|tigecycline|mesh-list
2234095|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2234096|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234097|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2234098|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234099|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234100|NCT00079911|Valacyclovir|valacyclovir|mesh-list
2234101|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
2234102|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234103|NCT00079924|Teriparatide|teriparatide|mesh-list
2234104|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2234105|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2234106|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234107|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2234108|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2234109|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
2234110|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
734643|NCT02861040|Vincristine|vincristine|mesh-list
734644|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
734645|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734646|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
734647|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
734648|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
734649|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734749|NCT02860663|Vitamin D|vitamin d|mesh-list
734750|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
734751|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
734752|NCT02860663|Vitamins|vitamins|mesh-list
734753|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
734754|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734755|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
734756|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2092212|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092213|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
2092214|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092215|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2092216|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2753376|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
2753377|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753378|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753379|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
2753380|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753381|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2753382|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
2753383|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753384|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2234111|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2234112|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2234113|NCT00079963|Vitamins|vitamins|mesh-list
2234114|NCT00079963|Ascorbic Acid|ascorbic acid|mesh-list
2234115|NCT00079963|Vitamin E|vitamin e|mesh-list
2234116|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
2234117|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735648|NCT02856568|Gemcitabine|gemcitabine|mesh-list
735649|NCT02856568|Cisplatin|cisplatin|mesh-list
735650|NCT02856568|Ricolinostat|ricolinostat|mesh-list
735651|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735652|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
735653|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
735654|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735655|NCT02856568|Antiviral Agents|antiviral agents|mesh-ancestor
735656|NCT02856568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
735657|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735658|NCT02856568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
735659|NCT02856568|Immunologic Factors|immunologic factors|mesh-ancestor
735660|NCT02856568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735661|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
736048|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
736049|NCT02853864|Propofol|propofol|mesh-list
736050|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
736051|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736052|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736053|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
736054|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
736055|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
736056|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
736057|NCT02853864|Analgesics|analgesics|mesh-ancestor
736058|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
736059|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736060|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
736061|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
736062|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
736063|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
736064|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
736065|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736604|NCT02850211|Ibuprofen|ibuprofen|mesh-list
736605|NCT02850211|Celecoxib|celecoxib|mesh-list
736606|NCT02850211|Tramadol|tramadol|mesh-list
736607|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
736608|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
736609|NCT02850211|Analgesics|analgesics|mesh-ancestor
736610|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
736611|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736612|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736613|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
736614|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
736615|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
736616|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736617|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736618|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
736619|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
736620|NCT02850211|Narcotics|narcotics|mesh-ancestor
736621|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2234118|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
2234119|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234120|NCT00079963|Protective Agents|protective agents|mesh-ancestor
2234121|NCT00079976|Tigecycline|tigecycline|mesh-list
2234122|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2234123|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234124|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2234125|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753385|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
733773|NCT02864953|Glyburide|glyburide|mesh-list
733774|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
733775|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734271|NCT02862769|Lidocaine|lidocaine|mesh-list
734272|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
734273|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
734274|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734275|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734276|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
734277|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734278|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
734279|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
734280|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
734281|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
734282|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734352|NCT02862171|Dapivirine|dapivirine|mesh-list
734353|NCT02862171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
734354|NCT02862171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
734355|NCT02862171|Antiviral Agents|antiviral agents|mesh-ancestor
734356|NCT02862171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
735036|NCT02858817|Atovaquone|atovaquone|mesh-list
735037|NCT02858817|Proguanil|proguanil|mesh-list
735038|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
735039|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
735040|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
735041|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
735042|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
735043|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735044|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735045|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
735279|NCT02857582|Metronidazole|metronidazole|mesh-list
735280|NCT02857582|Vancomycin|vancomycin|mesh-list
735281|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
735282|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
735283|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
735284|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
735557|NCT02856750|Gabapentin|gabapentin|mesh-list
735558|NCT02856750|Analgesics|analgesics|mesh-ancestor
735559|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
735560|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735561|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735562|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
735563|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
735564|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
735565|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
735566|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
735567|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
735568|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
735569|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735570|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735571|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
736089|NCT02853539|Denosumab|denosumab|mesh-list
736090|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
736091|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736132|NCT02853253|SMOFlipid|smoflipid|mesh-list
736133|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
736134|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
736135|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
736467|NCT02851303|Morphine|morphine|mesh-list
736468|NCT02851303|Methadone|methadone|mesh-list
736469|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
736470|NCT02851303|Narcotics|narcotics|mesh-ancestor
736471|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736472|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736473|NCT02851303|Analgesics|analgesics|mesh-ancestor
736474|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
736475|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736476|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
736477|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
736751|NCT02849483|Ramosetron|ramosetron|mesh-list
736752|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
736753|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
736754|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736755|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736756|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
736757|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
736758|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
2234126|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234127|NCT00079989|Tigecycline|tigecycline|mesh-list
2234128|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2234129|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234130|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2234131|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234132|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234133|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
2234134|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234135|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2234136|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
2234137|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
2234138|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234139|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2234140|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
2234141|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
2234142|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234143|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2234144|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
2753386|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2753387|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753394|NCT02831764|Tenofovir|tenofovir|mesh-list
2753395|NCT02831764|Lamivudine|lamivudine|mesh-list
2753396|NCT02831764|Emtricitabine|emtricitabine|mesh-list
2234145|NCT00080080|Docetaxel|docetaxel|mesh-list
2234146|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234147|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
2234148|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
2234149|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
2234150|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735161|NCT02858297|Triamcinolone|triamcinolone|mesh-list
735162|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
735163|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
735164|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
735165|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
735166|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
735167|NCT02858297|Hormones|hormones|mesh-ancestor
735168|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735169|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735170|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
735171|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
735172|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735173|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735273|NCT02857569|Nivolumab|nivolumab|mesh-list
735274|NCT02857569|Ipilimumab|ipilimumab|mesh-list
735275|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
735276|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735277|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
735278|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735425|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
735426|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
735427|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
735428|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
735429|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
736257|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
736258|NCT02852564|Diuretics|diuretics|mesh-ancestor
736259|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
736260|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736261|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736262|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736783|NCT02849548|Suvorexant|suvorexant|mesh-list
736784|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
736785|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
736786|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736787|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736788|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
736789|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
736790|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736902|NCT02848560|Xenon|xenon|mesh-list
2753397|NCT02831764|Dolutegravir|dolutegravir|mesh-list
733908|NCT02864199|Ribavirin|ribavirin|mesh-list
733909|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
733910|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
733911|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733912|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
733913|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
734214|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
734215|NCT02862665|Hematinics|hematinics|mesh-ancestor
734357|NCT02862145|Dexamethasone|dexamethasone|mesh-list
734358|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
734359|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
734360|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
734361|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734362|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734363|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
734364|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
734365|NCT02862145|Hormones|hormones|mesh-ancestor
734366|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
734367|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
734368|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734509|NCT02861378|Phentolamine|phentolamine|mesh-list
734510|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
734511|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
734512|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
734513|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734514|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734515|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734516|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
734594|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
734595|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
734596|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
734597|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
734598|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
734599|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734600|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734601|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734757|NCT02860494|Everolimus|everolimus|mesh-list
734758|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734759|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
734760|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
734761|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092217|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
2092218|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092219|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092220|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2092221|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2092222|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
735174|NCT02858258|Rituximab|rituximab|mesh-list
735175|NCT02858258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
735176|NCT02858258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735177|NCT02858258|Immunologic Factors|immunologic factors|mesh-ancestor
735178|NCT02858258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735179|NCT02858258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
735713|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
735714|NCT02856425|Nintedanib|nintedanib|mesh-list
735715|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
735716|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735717|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
735718|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735719|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234151|NCT00080145|Risperidone|risperidone|mesh-list
2234152|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2234153|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
2234154|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2234155|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234156|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234157|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2234158|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2234159|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2234160|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2234161|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2234162|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
2234163|NCT00080158|Mirtazapine|mirtazapine|mesh-list
2234164|NCT00080158|Citalopram|citalopram|mesh-list
2092223|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2092224|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
2092225|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
2092226|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
2092227|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2092228|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2092229|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2092230|NCT02242201|Analgesics|analgesics|mesh-ancestor
2092231|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2092232|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2234165|NCT00080158|Bupropion|bupropion|mesh-list
2234166|NCT00080158|Fluoxetine|fluoxetine|mesh-list
2234167|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2234168|NCT00080158|Sertraline|sertraline|mesh-list
2234169|NCT00080158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2234170|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2234171|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2234172|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234173|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2234174|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
2234175|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234176|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2234177|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
2234178|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2234179|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2234180|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
2234181|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2234182|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
735019|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
735020|NCT02858921|Trametinib|trametinib|mesh-list
735021|NCT02858921|Dabrafenib|dabrafenib|mesh-list
735022|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
735023|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735024|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
735025|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735026|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735081|NCT02858505|Iron|iron|mesh-list
735082|NCT02858505|Trace Elements|trace elements|mesh-ancestor
735083|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
735084|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735180|NCT02858193|Carbocysteine|carbocysteine|mesh-list
735181|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
735182|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
735183|NCT02858193|Expectorants|expectorants|mesh-ancestor
735184|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
735260|NCT02857829|Caffeine|caffeine|mesh-list
735261|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
735262|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735263|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
735264|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735265|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735266|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
735267|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
735268|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
735269|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735861|NCT02855307|Insulin|insulin|mesh-list
735862|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
735863|NCT02855307|Hormones|hormones|mesh-list
735864|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
735865|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735866|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735929|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
735930|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
735931|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
735932|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735933|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
735934|NCT02854904|Analgesics|analgesics|mesh-ancestor
735935|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
735936|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735937|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
735938|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
735939|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
735940|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
735941|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735942|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733949|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
733950|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
733951|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733952|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
733953|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
2234183|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234184|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2234185|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2234186|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2234187|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2234188|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
2234189|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
2234190|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2234191|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2234192|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2234193|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2234194|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
2234195|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2234196|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2234197|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2234198|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
2234199|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234200|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2234201|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734716|NCT02861417|Vidarabine|vidarabine|mesh-list
734717|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
734718|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
734719|NCT02861417|Busulfan|busulfan|mesh-list
734720|NCT02861417|Thiotepa|thiotepa|mesh-list
734721|NCT02861417|Fludarabine|fludarabine|mesh-list
734722|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
734723|NCT02861417|Tacrolimus|tacrolimus|mesh-list
734724|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
734725|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
734726|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734727|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
734728|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
734729|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
734730|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734731|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734732|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
734733|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
734734|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
734735|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
734736|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
734737|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
734738|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734739|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
734740|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
734741|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
734742|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2234202|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234203|NCT00080275|Niacin|niacin|mesh-list
2234204|NCT00080275|Simvastatin|simvastatin|mesh-list
2234205|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2234206|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2234207|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
2234208|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234209|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2234210|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2234211|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234212|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
2234213|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
2234214|NCT00080275|Vitamins|vitamins|mesh-ancestor
2234215|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
2234216|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234217|NCT00080314|Aripiprazole|aripiprazole|mesh-list
2234218|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
2234219|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2234220|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2234221|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2234222|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2753398|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
735572|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
735573|NCT02856685|Analgesics|analgesics|mesh-ancestor
735574|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
733990|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
733991|NCT02863913|Interleukin-2|interleukin-2|mesh-list
733992|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
733993|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
733994|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
733995|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
733996|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
733997|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
733998|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
733999|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734000|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
734001|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
734002|NCT02863913|Analgesics|analgesics|mesh-ancestor
734003|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
734004|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734371|NCT02862327|Dexamethasone|dexamethasone|mesh-list
734372|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
734373|NCT02862327|Ropivacaine|ropivacaine|mesh-list
734374|NCT02862327|BB 1101|bb 1101|mesh-list
734375|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
734376|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
734377|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
734378|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734379|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734380|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
734381|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
734382|NCT02862327|Hormones|hormones|mesh-ancestor
734383|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
734384|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
734385|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734386|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
734387|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734388|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734389|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
734390|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
734391|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734392|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
734502|NCT02861222|Doxorubicin|doxorubicin|mesh-list
734503|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
734504|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734505|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
734506|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
734507|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734508|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734562|NCT02860949|Ketorolac|ketorolac|mesh-list
734563|NCT02860949|Epinephrine|epinephrine|mesh-list
734564|NCT02860949|Morphine|morphine|mesh-list
734565|NCT02860949|Bupivacaine|bupivacaine|mesh-list
734566|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
734567|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
734568|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734569|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734570|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
734571|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734572|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
734573|NCT02860949|Narcotics|narcotics|mesh-ancestor
734574|NCT02860949|Analgesics|analgesics|mesh-ancestor
734575|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
734576|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
734577|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
734578|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734579|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734580|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
734581|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
734582|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
734583|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
734584|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
734585|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
734586|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
734587|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
734588|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
734589|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
734590|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
734591|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
734592|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
734593|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735788|NCT02855684|Insulin|insulin|mesh-list
2234223|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234224|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
2234225|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
2234226|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734489|NCT02861690|Paclitaxel|paclitaxel|mesh-list
734490|NCT02861690|Nedaplatin|nedaplatin|mesh-list
734491|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
734492|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734493|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
734494|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
734495|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
734496|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734544|NCT02861105|Enoxaparin|enoxaparin|mesh-list
734545|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
734546|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
734547|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
734548|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
734549|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234227|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234228|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2234229|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2234230|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
2234231|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2234232|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2234233|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2234234|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2234235|NCT00080327|Aripiprazole|aripiprazole|mesh-list
2234236|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
2234237|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2234238|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2234239|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2234240|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2234241|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234242|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
2234243|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
2234244|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2234245|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234246|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
735419|NCT02857062|Emollients|emollients|mesh-list
735420|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
735551|NCT02856724|Dinoprostone|dinoprostone|mesh-list
735552|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
735553|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
735554|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736354|NCT02852239|Dabrafenib|dabrafenib|mesh-list
736355|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736356|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
736357|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736358|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092233|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2092234|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092235|NCT02242305|Scopolamine|scopolamine|mesh-list
2092236|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2092237|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2092238|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
2092239|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
2092240|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092241|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736649|NCT02850081|Atorvastatin|atorvastatin|mesh-list
736650|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
736651|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
736652|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
736653|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
736654|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736655|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
736656|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736892|NCT02848768|Sunitinib|sunitinib|mesh-list
736893|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736894|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
736895|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
736896|NCT02848768|Growth Substances|growth substances|mesh-ancestor
736897|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736898|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
736899|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
736900|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734250|NCT02862691|Acetaminophen|acetaminophen|mesh-list
734251|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
734252|NCT02862691|Oxycodone|oxycodone|mesh-list
734253|NCT02862691|Analgesics|analgesics|mesh-list
734254|NCT02862691|Bupivacaine|bupivacaine|mesh-list
734255|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
734256|NCT02862691|Anesthetics|anesthetics|mesh-list
734257|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734258|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734259|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
734260|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734261|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
734262|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
734263|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
734264|NCT02862691|Narcotics|narcotics|mesh-ancestor
734265|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
734266|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
734267|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2092242|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2092243|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
2092244|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2092245|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
2092246|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092247|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092248|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2092249|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
2092250|NCT02242487|Levodopa|levodopa|mesh-list
2092251|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2092252|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2092253|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
2092254|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092255|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092256|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092257|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
2092258|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2092259|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2092260|NCT02242630|Prednisolone|prednisolone|mesh-list
2092261|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
2092262|NCT02242630|Triamcinolone|triamcinolone|mesh-list
2092263|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2092264|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2092265|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2092266|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
2092267|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2092268|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2092269|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
2092270|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
2092271|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092272|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092273|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2092274|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
2092275|NCT02242630|Hormones|hormones|mesh-ancestor
734898|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
734906|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
734913|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
734914|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
734915|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734916|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
734917|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
734918|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734988|NCT02859077|Gemcitabine|gemcitabine|mesh-list
734989|NCT02859077|Carboplatin|carboplatin|mesh-list
734990|NCT02859077|Pemetrexed|pemetrexed|mesh-list
734991|NCT02859077|Gefitinib|gefitinib|mesh-list
734992|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734993|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
734994|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
734995|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734996|NCT02859077|Antiviral Agents|antiviral agents|mesh-ancestor
734997|NCT02859077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
734998|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734999|NCT02859077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
735000|NCT02859077|Immunologic Factors|immunologic factors|mesh-ancestor
735001|NCT02859077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735002|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
735003|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
735004|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
734284|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734285|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734286|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
734287|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
734288|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
734289|NCT02862509|Hormones|hormones|mesh-ancestor
734290|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2234247|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2234248|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
2234249|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
734961|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
734962|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
734963|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
734964|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
734965|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
734966|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734967|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
734968|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
734969|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734970|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
737000|NCT02848183|Cytarabine|cytarabine|mesh-list
737001|NCT02848183|Etoposide|etoposide|mesh-list
737002|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
737003|NCT02848183|Idarubicin|idarubicin|mesh-list
737004|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
737005|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737006|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
737007|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
737008|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737009|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737010|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
737011|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
737012|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
737013|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737014|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
737015|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
737016|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737017|NCT02848183|Analgesics|analgesics|mesh-ancestor
737018|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
737019|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737020|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
737802|NCT02844933|Cannabidiol|cannabidiol|mesh-list
737803|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
738211|NCT02841488|Fentanyl|fentanyl|mesh-list
738212|NCT02841488|Ropivacaine|ropivacaine|mesh-list
738213|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
738214|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
738215|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
738216|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738217|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
738218|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738219|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
738220|NCT02841488|Narcotics|narcotics|mesh-ancestor
738221|NCT02841488|Analgesics|analgesics|mesh-ancestor
738222|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
738223|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
738224|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
738824|NCT02838589|Exenatide|exenatide|mesh-list
738825|NCT02838589|Glucagon|glucagon|mesh-list
738826|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
738827|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
738828|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738829|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
738830|NCT02838589|Incretins|incretins|mesh-ancestor
738831|NCT02838589|Hormones|hormones|mesh-ancestor
738832|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738833|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
739202|NCT02836743|Melatonin|melatonin|mesh-list
734402|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734403|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
734404|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
734405|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734406|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734461|NCT02861716|Fentanyl|fentanyl|mesh-list
734462|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
734463|NCT02861716|Bupivacaine|bupivacaine|mesh-list
734464|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
734465|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
734466|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734467|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734468|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
734469|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734470|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
734471|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
734472|NCT02861716|Analgesics|analgesics|mesh-ancestor
734473|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
734474|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
734475|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
734476|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
734477|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734478|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734479|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
734480|NCT02861716|Narcotics|narcotics|mesh-ancestor
734481|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
734482|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
734483|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
2092276|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2092277|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2092278|NCT02242630|Protective Agents|protective agents|mesh-ancestor
2092279|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2092280|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092281|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2092282|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
2092283|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092284|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092285|NCT02242942|Venetoclax|venetoclax|mesh-list
2092286|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
734934|NCT02859285|Estradiol|estradiol|mesh-list
734935|NCT02859285|Estrogens|estrogens|mesh-ancestor
734936|NCT02859285|Hormones|hormones|mesh-ancestor
734937|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
734938|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735027|NCT02858843|Ivacaftor|ivacaftor|mesh-list
735028|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
735029|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
735030|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735388|NCT02857270|Gemcitabine|gemcitabine|mesh-list
735389|NCT02857270|Paclitaxel|paclitaxel|mesh-list
735390|NCT02857270|Cetuximab|cetuximab|mesh-list
735391|NCT02857270|Midazolam|midazolam|mesh-list
735392|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
735393|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735394|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
735395|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
735396|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
735397|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735398|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
735399|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
735400|NCT02857270|Antiviral Agents|antiviral agents|mesh-ancestor
735401|NCT02857270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
735402|NCT02857270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735403|NCT02857270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
735404|NCT02857270|Immunologic Factors|immunologic factors|mesh-ancestor
735405|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735406|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
735407|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
735408|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
735409|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
735410|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
735411|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
735412|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
735413|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
735414|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
2092287|NCT02242942|Chlorambucil|chlorambucil|mesh-list
734422|NCT02861950|Bupivacaine|bupivacaine|mesh-list
734423|NCT02861950|Ropivacaine|ropivacaine|mesh-list
734424|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
734425|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
734426|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734427|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734428|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
734429|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092288|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092289|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2234250|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
735046|NCT02858895|Interleukin-4|interleukin-4|mesh-list
735047|NCT02858895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
735048|NCT02858895|Immunologic Factors|immunologic factors|mesh-ancestor
735049|NCT02858895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735050|NCT02858895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735051|NCT02858895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
735213|NCT02858206|Paclitaxel|paclitaxel|mesh-list
735214|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
735215|NCT02858206|Nedaplatin|nedaplatin|mesh-list
735216|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
735217|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735218|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
735219|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
735220|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
735221|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735222|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
735706|NCT02856230|Paclitaxel|paclitaxel|mesh-list
735707|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
735708|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735709|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
735710|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
735711|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
735712|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735824|NCT02855515|Anesthetics|anesthetics|mesh-list
735825|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
735826|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735870|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
735871|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
735872|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234251|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2234252|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2234253|NCT00080340|Gefitinib|gefitinib|mesh-list
2234254|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234255|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2234256|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234257|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234258|NCT00080405|Bortezomib|bortezomib|mesh-list
2234259|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234260|NCT00080418|Paclitaxel|paclitaxel|mesh-list
2234261|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2234262|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736308|NCT02852486|Pioglitazone|pioglitazone|mesh-list
736309|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
736310|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
736311|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736312|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736313|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
736314|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736315|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736346|NCT02852122|Choline|choline|mesh-list
736347|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
736348|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
736349|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
736350|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736351|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
736352|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
736353|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
736391|NCT02851888|Ropivacaine|ropivacaine|mesh-list
736392|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
736393|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736394|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736395|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
736396|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
736397|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736504|NCT02851212|Metformin|metformin|mesh-list
734680|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
734782|NCT02860117|Ketamine|ketamine|mesh-list
734783|NCT02860117|Analgesics|analgesics|mesh-ancestor
734784|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
734785|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
734786|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734787|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
734788|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
734789|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
734790|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
734791|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
734792|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
734793|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
734794|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734795|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735345|NCT02857465|Dexamethasone|dexamethasone|mesh-list
735346|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
735347|NCT02857465|Sufentanil|sufentanil|mesh-list
735348|NCT02857465|Dsuvia|dsuvia|mesh-list
735349|NCT02857465|Ropivacaine|ropivacaine|mesh-list
735350|NCT02857465|BB 1101|bb 1101|mesh-list
735351|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
735352|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
735353|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
735354|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735355|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735356|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
735357|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
735358|NCT02857465|Hormones|hormones|mesh-ancestor
735359|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735360|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
735361|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735362|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
735363|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735364|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735365|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
735366|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
735367|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
735368|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
735369|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
735370|NCT02857465|Narcotics|narcotics|mesh-ancestor
735371|NCT02857465|Analgesics|analgesics|mesh-ancestor
735372|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
735373|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
735374|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
735474|NCT02856867|Leucovorin|leucovorin|mesh-list
735475|NCT02856867|Fluorouracil|fluorouracil|mesh-list
735476|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
735477|NCT02856867|Nintedanib|nintedanib|mesh-list
735478|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
735479|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735480|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
735481|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735482|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
735483|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
735484|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735485|NCT02856867|Antidotes|antidotes|mesh-ancestor
735486|NCT02856867|Protective Agents|protective agents|mesh-ancestor
735487|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
735488|NCT02856867|Vitamins|vitamins|mesh-ancestor
735489|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
735490|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
735491|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735665|NCT02856542|Betamethasone|betamethasone|mesh-list
735666|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
735667|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
735668|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
735669|NCT02856542|Calcipotriene|calcipotriene|mesh-list
735670|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
735671|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
735672|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
735673|NCT02856542|Hormones|hormones|mesh-ancestor
735674|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735675|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735676|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
735677|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
735678|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
2234263|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
2234264|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
2234265|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
2234266|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234267|NCT00080431|Daclizumab|daclizumab|mesh-list
2234268|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2234269|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
2234270|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234271|NCT00080444|Dexamethasone|dexamethasone|mesh-list
2234272|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
735134|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
735135|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
735136|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
735137|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
735138|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
735139|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735140|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
735141|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735142|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735143|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
735144|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735207|NCT02857959|Penicillins|penicillins|mesh-list
735208|NCT02857959|Penicillin G|penicillin g|mesh-list
735209|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
735210|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
735211|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
735212|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
735518|NCT02856698|Midazolam|midazolam|mesh-list
735519|NCT02856698|Morphine|morphine|mesh-list
735520|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
735521|NCT02856698|Narcotics|narcotics|mesh-ancestor
735522|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
735523|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735524|NCT02856698|Analgesics|analgesics|mesh-ancestor
735525|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
735526|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735527|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
735528|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
735529|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
735530|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
735531|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
735532|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
735533|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
735534|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
735535|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
735536|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
735537|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735538|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092290|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2092291|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
2092292|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092293|NCT02243007|Gemcitabine|gemcitabine|mesh-list
2092294|NCT02243007|Paclitaxel|paclitaxel|mesh-list
2092295|NCT02243007|Capecitabine|capecitabine|mesh-list
2092296|NCT02243007|Folfirinox|folfirinox|mesh-list
2092297|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2092298|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092299|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
2092300|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
2092301|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
2092302|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092303|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2092304|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
2092305|NCT02243007|Antiviral Agents|antiviral agents|mesh-ancestor
2092306|NCT02243007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092307|NCT02243007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092308|NCT02243007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
736111|NCT02853552|Misoprostol|misoprostol|mesh-list
736112|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
736113|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
736114|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
736115|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736116|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
736117|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
736118|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
2092309|NCT02243007|Immunologic Factors|immunologic factors|mesh-ancestor
2234273|NCT00080444|Ondansetron|ondansetron|mesh-list
2092310|NCT02243007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734856|NCT02859792|Riluzole|riluzole|mesh-list
734857|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
734858|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
734859|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
734860|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
734861|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
734862|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
734863|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
734864|NCT02859792|Protective Agents|protective agents|mesh-ancestor
735088|NCT02858804|Cytarabine|cytarabine|mesh-list
735089|NCT02858804|Thalidomide|thalidomide|mesh-list
735090|NCT02858804|Dexamethasone|dexamethasone|mesh-list
735091|NCT02858804|Prednisone|prednisone|mesh-list
735092|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
735093|NCT02858804|Rituximab|rituximab|mesh-list
735094|NCT02858804|Doxorubicin|doxorubicin|mesh-list
735095|NCT02858804|Etoposide|etoposide|mesh-list
735096|NCT02858804|Vincristine|vincristine|mesh-list
735097|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
735098|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
735099|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735100|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
735101|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
735102|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
735103|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735104|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735105|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
735106|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
735107|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
735108|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
735109|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735110|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
735111|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
735112|NCT02858804|Hormones|hormones|mesh-ancestor
735113|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735114|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
735115|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
735116|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
735117|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
735118|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
735119|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735120|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
735121|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
735122|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
735123|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
735124|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
735125|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
735126|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
735127|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
735128|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
735129|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
735130|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
735131|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
735132|NCT02858804|Growth Substances|growth substances|mesh-ancestor
735133|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
735233|NCT02857712|Axitinib|axitinib|mesh-list
735234|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735235|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
735236|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735237|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735375|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
735376|NCT02857218|Hematinics|hematinics|mesh-ancestor
735377|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
735378|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
735596|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
735597|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
735598|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
735599|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735600|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
735601|NCT02856594|Analgesics|analgesics|mesh-ancestor
735602|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
735603|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735604|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
735605|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
735606|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
734954|NCT02859012|Axitinib|axitinib|mesh-list
734955|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
734956|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
734957|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
734958|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092311|NCT02243176|Saxagliptin|saxagliptin|mesh-list
2092312|NCT02243176|Acarbose|acarbose|mesh-list
2092313|NCT02243176|Incretins|incretins|mesh-ancestor
735252|NCT02857920|Bevacizumab|bevacizumab|mesh-list
735253|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
735254|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735255|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
735256|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
735257|NCT02857920|Growth Substances|growth substances|mesh-ancestor
735258|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735259|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
735492|NCT02857153|Urapidil|urapidil|mesh-list
735493|NCT02857153|Phenylephrine|phenylephrine|mesh-list
735494|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
735495|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
735496|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
735497|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
735498|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735499|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735500|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
735501|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
735502|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
735503|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
735504|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
735505|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
735506|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
735507|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
735508|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735509|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735510|NCT02857153|Protective Agents|protective agents|mesh-ancestor
735511|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
735512|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
735513|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
735514|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
735515|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
735516|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
735517|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
735687|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
735688|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
735689|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
735690|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
735691|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
735692|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735693|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
735694|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
735695|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092314|NCT02243176|Hormones|hormones|mesh-ancestor
2092315|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2092316|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234274|NCT00080444|Aprepitant|aprepitant|mesh-list
2234275|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
2234276|NCT00080444|BB 1101|bb 1101|mesh-list
2234277|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2234278|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
2234279|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
2234280|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2234281|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234282|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2234283|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
2234284|NCT00080444|Hormones|hormones|mesh-ancestor
2234285|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2234286|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2234287|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234288|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
2234289|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234290|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234291|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
735241|NCT02857777|Esketamine|esketamine|mesh-list
735242|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
735243|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
735430|NCT02856932|Methamphetamine|methamphetamine|mesh-list
735431|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
735432|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735433|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
735434|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
735435|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735436|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
735437|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735438|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735439|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
735440|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
735441|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
735442|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
735443|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
735999|NCT02854748|Empagliflozin|empagliflozin|mesh-list
736000|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
736001|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736002|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
736003|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736081|NCT02853630|Metformin|metformin|mesh-list
736082|NCT02853630|Vildagliptin|vildagliptin|mesh-list
736083|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
736084|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736085|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
736086|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
736087|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736088|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736515|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
736516|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
736517|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
736518|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
736519|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736520|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736521|NCT02850718|Urological Agents|urological agents|mesh-ancestor
736657|NCT02849873|Tazarotene|tazarotene|mesh-list
736658|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
736659|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
737834|NCT02844530|Epratuzumab|epratuzumab|mesh-list
737835|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
737836|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
737837|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737838|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
737839|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
737840|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737871|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
737872|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
737873|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234292|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
2234293|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2234294|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
2234295|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2234296|NCT00080444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2234297|NCT00080444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2234298|NCT00080444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2234299|NCT00080444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2234300|NCT00080444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2234301|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2234302|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
2234303|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2234304|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092317|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2092318|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
2092319|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092320|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092321|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2234305|NCT00080496|Imipenem|imipenem|mesh-list
2234306|NCT00080496|Tigecycline|tigecycline|mesh-list
2234307|NCT00080496|Cilastatin|cilastatin|mesh-list
2234308|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
739329|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
734926|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
734927|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
734928|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735052|NCT02858622|Fentanyl|fentanyl|mesh-list
735053|NCT02858622|Meperidine|meperidine|mesh-list
735054|NCT02858622|Bupivacaine|bupivacaine|mesh-list
735055|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
735056|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
735057|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
735058|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735059|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
735060|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735061|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
735062|NCT02858622|Narcotics|narcotics|mesh-ancestor
735063|NCT02858622|Analgesics|analgesics|mesh-ancestor
735064|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
735065|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
735066|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
735244|NCT02857842|Prednisolone|prednisolone|mesh-list
735245|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
735246|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
735247|NCT02857842|Hormones|hormones|mesh-ancestor
735248|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735249|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735250|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
735251|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735778|NCT02855632|Hormones|hormones|mesh-list
735779|NCT02855632|Progesterone|progesterone|mesh-list
735780|NCT02855632|Sargramostim|sargramostim|mesh-list
735781|NCT02855632|Lenograstim|lenograstim|mesh-list
735782|NCT02855632|Estrogens|estrogens|mesh-list
735783|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735784|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735785|NCT02855632|Progestins|progestins|mesh-ancestor
735786|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
735787|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
735873|NCT02855138|Isotretinoin|isotretinoin|mesh-list
735874|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
735923|NCT02854670|Capsaicin|capsaicin|mesh-list
735924|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
735925|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
735926|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
735927|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735928|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736136|NCT02853578|Budesonide|budesonide|mesh-list
736137|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
736138|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
736139|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
736140|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736141|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736142|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
736143|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
736144|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
736145|NCT02853578|Hormones|hormones|mesh-ancestor
736146|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
736398|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
736399|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
736400|NCT02851914|Serotonin|serotonin|mesh-list
736401|NCT02851914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
736402|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
736403|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
736404|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
736405|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
736406|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736407|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736408|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
736409|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
737549|NCT02845778|Melatonin|melatonin|mesh-list
737550|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
737551|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737552|NCT02845778|Protective Agents|protective agents|mesh-ancestor
737553|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737554|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
737812|NCT02845050|Cisplatin|cisplatin|mesh-list
737813|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234309|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234310|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2234311|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234312|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735622|NCT02856503|Vitamin D|vitamin d|mesh-list
735623|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
735624|NCT02856503|Vitamins|vitamins|mesh-ancestor
735625|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
735626|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735627|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
735628|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
735816|NCT02855502|Prednisolone|prednisolone|mesh-list
735817|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
735818|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
735819|NCT02855502|Hormones|hormones|mesh-ancestor
735820|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735821|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735822|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
735823|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735972|NCT02854696|Insulin|insulin|mesh-list
735973|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
735974|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234313|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
2234314|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
2234315|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
2234316|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
2234317|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
2234318|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234319|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234320|NCT00080522|Ritonavir|ritonavir|mesh-list
2234321|NCT00080522|Lopinavir|lopinavir|mesh-list
2234322|NCT00080522|Lamivudine|lamivudine|mesh-list
2234323|NCT00080522|Zidovudine|zidovudine|mesh-list
2234324|NCT00080522|Stavudine|stavudine|mesh-list
736483|NCT02851290|Anesthetics|anesthetics|mesh-list
736484|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736485|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736568|NCT02850250|Cefuroxime|cefuroxime|mesh-list
736569|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
736570|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
736571|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
736935|NCT02848443|Trifluridine|trifluridine|mesh-list
736936|NCT02848443|Bevacizumab|bevacizumab|mesh-list
736937|NCT02848443|Nivolumab|nivolumab|mesh-list
736938|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
736939|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
736940|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736941|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
736942|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
736943|NCT02848443|Growth Substances|growth substances|mesh-ancestor
736944|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736945|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
736946|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
736947|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736948|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
736949|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
736950|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737194|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
737195|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
737196|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737197|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
737198|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737389|NCT02846155|Simethicone|simethicone|mesh-list
737390|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
737391|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737392|NCT02846155|Emollients|emollients|mesh-ancestor
737393|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
2234325|NCT00080522|Didanosine|didanosine|mesh-list
2234326|NCT00080522|Efavirenz|efavirenz|mesh-list
2234327|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2234328|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2234329|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
2234330|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234331|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234332|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2234333|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2234334|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
2092322|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2092323|NCT02243202|Canagliflozin|canagliflozin|mesh-list
2092324|NCT02243202|Phentermine|phentermine|mesh-list
2092325|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2092326|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735223|NCT02857946|Linagliptin|linagliptin|mesh-list
735224|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
735225|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735226|NCT02857946|Incretins|incretins|mesh-ancestor
735227|NCT02857946|Hormones|hormones|mesh-ancestor
735228|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735229|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
735230|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
735231|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735232|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735322|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
735323|NCT02857244|Modafinil|modafinil|mesh-list
735324|NCT02857244|Donepezil|donepezil|mesh-list
735325|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
735326|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
735327|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
735328|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735329|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735330|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735331|NCT02857244|Analgesics|analgesics|mesh-ancestor
735332|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
735333|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735334|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
735335|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
735336|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
735337|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
735338|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735339|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
735340|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
735341|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
735342|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
735343|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
735344|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
735450|NCT02856854|Cocaine|cocaine|mesh-list
735451|NCT02856854|Oxazepam|oxazepam|mesh-list
735452|NCT02856854|Metyrapone|metyrapone|mesh-list
735453|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
735454|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
735455|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
735456|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735457|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
735458|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735459|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
735460|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
735461|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
735462|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
735463|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735464|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
735465|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735466|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
735467|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735468|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
735469|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
735470|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
735471|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
735472|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
735473|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
735720|NCT02856126|Sorafenib|sorafenib|mesh-list
735721|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735722|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
735723|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735724|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735735|NCT02855697|Olaparib|olaparib|mesh-list
735736|NCT02855697|Cediranib|cediranib|mesh-list
735737|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
735738|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735739|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735740|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735741|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
735289|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735290|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
735291|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234335|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234336|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2234337|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2234338|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2234339|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2234340|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
2234341|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2234342|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2234343|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2234344|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2234345|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2234346|NCT00080613|Exemestane|exemestane|mesh-list
2234347|NCT00080613|Hormones|hormones|mesh-list
2234348|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2234349|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234350|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234351|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2234352|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2234353|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234354|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736222|NCT02852798|Docetaxel|docetaxel|mesh-list
736223|NCT02852798|Apatinib|apatinib|mesh-list
736224|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736225|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
736226|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
736227|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
736228|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736229|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
736230|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737109|NCT02847455|Rabeprazole|rabeprazole|mesh-list
737110|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
737111|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
737112|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
737113|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737114|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234355|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2234356|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
2234357|NCT00080626|Docetaxel|docetaxel|mesh-list
2234358|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234359|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
2234360|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
2234361|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
2234362|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234363|NCT00080665|Docetaxel|docetaxel|mesh-list
737752|NCT02845024|Doxycycline|doxycycline|mesh-list
737753|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
737754|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737755|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
737756|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
737757|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
737881|NCT02844309|Thalidomide|thalidomide|mesh-list
737882|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
737883|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
737884|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737885|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
737886|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
737887|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737888|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
737889|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
737890|NCT02844309|Growth Substances|growth substances|mesh-ancestor
737891|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
737892|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738788|NCT02838992|Cyclosporine|cyclosporine|mesh-list
738789|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
738790|NCT02838992|Cyclosporins|cyclosporins|mesh-list
738791|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
738792|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
738793|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
738794|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738795|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
738796|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
738797|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
735305|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
735306|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735307|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735308|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
735309|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
735310|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
735311|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
735312|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
735313|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
735314|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
735315|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735316|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735379|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
735380|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
735381|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
735382|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
735383|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
735384|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
735385|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735386|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735387|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735582|NCT02856776|Vitamin D|vitamin d|mesh-list
735583|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
735584|NCT02856776|Vitamins|vitamins|mesh-ancestor
735585|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
735586|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735587|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
735588|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
735620|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
735621|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
735725|NCT02856087|Remifentanil|remifentanil|mesh-list
735726|NCT02856087|Naloxone|naloxone|mesh-list
735727|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
735728|NCT02856087|Narcotics|narcotics|mesh-ancestor
735729|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
735730|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735731|NCT02856087|Analgesics|analgesics|mesh-ancestor
735732|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
735733|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735734|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
735853|NCT02855294|Drospirenone|drospirenone|mesh-list
735854|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
735855|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
735856|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735857|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735858|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
735859|NCT02855294|Diuretics|diuretics|mesh-ancestor
735860|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
736122|NCT02853370|Rituximab|rituximab|mesh-list
736123|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
736124|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
736125|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736126|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
736127|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736128|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
736129|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
736130|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
736131|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736359|NCT02852382|Morphine|morphine|mesh-list
736360|NCT02852382|Bupivacaine|bupivacaine|mesh-list
736361|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
736362|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
736363|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736364|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736365|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
736366|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736367|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
736368|NCT02852382|Narcotics|narcotics|mesh-ancestor
736369|NCT02852382|Analgesics|analgesics|mesh-ancestor
736534|NCT02850848|Entecavir|entecavir|mesh-list
736535|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
736536|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234364|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
2234365|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737095|NCT02847429|Crenolanib|crenolanib|mesh-list
735415|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
735416|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
735417|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735418|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
735589|NCT02856581|Varenicline|varenicline|mesh-list
735590|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
735591|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
735592|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
735593|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735594|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735595|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736800|NCT02849470|Complement Factor H|complement factor h|mesh-list
736801|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
736802|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
736803|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
736804|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234366|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
2234367|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
737281|NCT02846493|Dexamethasone|dexamethasone|mesh-list
737282|NCT02846493|Bromocriptine|bromocriptine|mesh-list
737283|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
737284|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
737285|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
737286|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737287|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737288|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
737289|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
737290|NCT02846493|Hormones|hormones|mesh-ancestor
737291|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
737292|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
737293|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737294|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
737295|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
737296|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
737297|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
737298|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
737299|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
737300|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737545|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
737546|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
737547|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737548|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737992|NCT02843126|Trastuzumab|trastuzumab|mesh-list
737993|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
737994|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738278|NCT02841332|Misonidazole|misonidazole|mesh-list
738279|NCT02841332|Bevacizumab|bevacizumab|mesh-list
738280|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
738281|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738282|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
738283|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
738284|NCT02841332|Growth Substances|growth substances|mesh-ancestor
738285|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738286|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
738287|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
738288|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
738289|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
738942|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
738943|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
738944|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739140|NCT02836977|Tegafur|tegafur|mesh-list
739141|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
739142|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
739143|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739144|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739811|NCT02833480|Fluticasone|fluticasone|mesh-list
739812|NCT02833480|Budesonide|budesonide|mesh-list
739813|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
739814|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
739815|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
739816|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
739817|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739818|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739819|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
739820|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
735575|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735576|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735577|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735578|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
735579|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
735580|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735581|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735696|NCT02856113|Alogliptin|alogliptin|mesh-list
735697|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
735698|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735699|NCT02856113|Incretins|incretins|mesh-ancestor
735700|NCT02856113|Hormones|hormones|mesh-ancestor
735701|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735702|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
735703|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
735704|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735705|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234368|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
2234369|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234370|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2234371|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234372|NCT00080678|Docetaxel|docetaxel|mesh-list
2234373|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
2234374|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234375|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
2234376|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
2234377|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
2234378|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234379|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2234380|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736979|NCT02848209|Phenol|phenol|mesh-list
736980|NCT02848209|Croton Oil|croton oil|mesh-list
736981|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
736982|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
736983|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
736984|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
736985|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
736986|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
737146|NCT02847559|Bevacizumab|bevacizumab|mesh-list
737147|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
737148|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
737149|NCT02847559|Antibodies|antibodies|mesh-list
737150|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
737151|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
737152|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
737153|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737154|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
737155|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
737156|NCT02847559|Growth Substances|growth substances|mesh-ancestor
737157|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737158|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
737159|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
737211|NCT02847000|Decitabine|decitabine|mesh-list
737212|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
737213|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
737214|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
737215|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737216|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737217|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737341|NCT02846623|Atezolizumab|atezolizumab|mesh-list
737342|NCT02846623|Venetoclax|venetoclax|mesh-list
737343|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
737344|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
737345|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737346|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
737347|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737348|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
737804|NCT02844712|beta-Lactams|beta-lactams|mesh-list
737805|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
737806|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234381|NCT00080743|Tamoxifen|tamoxifen|mesh-list
2234382|NCT00080743|Gefitinib|gefitinib|mesh-list
2234383|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738180|NCT02841982|Morphine|morphine|mesh-list
738181|NCT02841982|Ropivacaine|ropivacaine|mesh-list
738182|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
738183|NCT02841982|Narcotics|narcotics|mesh-ancestor
735607|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
735608|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735609|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735793|NCT02855866|Acetaminophen|acetaminophen|mesh-list
735794|NCT02855866|Dexamethasone|dexamethasone|mesh-list
735795|NCT02855866|Cortisone|cortisone|mesh-list
735796|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
735797|NCT02855866|BB 1101|bb 1101|mesh-list
735798|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
735799|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
735800|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
735801|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735802|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735803|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
735804|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
735805|NCT02855866|Hormones|hormones|mesh-ancestor
735806|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735807|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
735808|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735809|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
735810|NCT02855866|Analgesics|analgesics|mesh-ancestor
735811|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
735812|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
735813|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
735814|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735815|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092327|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2092328|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092329|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2092330|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
2092331|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
736560|NCT02850419|Doxorubicin|doxorubicin|mesh-list
736561|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
736562|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
736563|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736564|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
736565|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
736566|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736567|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736737|NCT02849730|Fentanyl|fentanyl|mesh-list
736738|NCT02849730|Analgesics|analgesics|mesh-list
736739|NCT02849730|Ropivacaine|ropivacaine|mesh-list
736740|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
736741|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
736742|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736743|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736744|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
736745|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736746|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
736747|NCT02849730|Narcotics|narcotics|mesh-ancestor
736748|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
736749|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
736750|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
736867|NCT02848612|Heparin|heparin|mesh-list
736868|NCT02848612|Calcium heparin|calcium heparin|mesh-list
736869|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
736870|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
736871|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
736872|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737703|NCT02845466|Becaplermin|becaplermin|mesh-list
737704|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
737705|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
737706|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
737707|NCT02845466|Growth Substances|growth substances|mesh-ancestor
737708|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737776|NCT02844907|Dexamethasone|dexamethasone|mesh-list
737777|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
737778|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
737779|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
737780|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
735679|NCT02856178|Caspofungin|caspofungin|mesh-list
735680|NCT02856178|Olorofim|olorofim|mesh-list
735681|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
735682|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
735683|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735684|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735867|NCT02855190|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
735868|NCT02855190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735869|NCT02855190|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
736283|NCT02852720|Anesthetics|anesthetics|mesh-list
736284|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
736285|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736286|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736287|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
736288|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
736289|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737394|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
737395|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
737396|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
737397|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737398|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
737399|NCT02846090|Analgesics|analgesics|mesh-ancestor
737400|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
737401|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737402|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
737403|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
737404|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
737405|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
737406|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
737407|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737867|NCT02844153|Metformin|metformin|mesh-list
737868|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
737869|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738307|NCT02841137|Progesterone|progesterone|mesh-list
738308|NCT02841137|Progestins|progestins|mesh-ancestor
738309|NCT02841137|Hormones|hormones|mesh-ancestor
738310|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738311|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753399|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753400|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2753401|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2753402|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793060|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
739092|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
739093|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
739094|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739169|NCT02836821|Rifampin|rifampin|mesh-list
739170|NCT02836821|Apatinib|apatinib|mesh-list
739171|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739172|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
739173|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739174|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739175|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
739176|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
739177|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
739178|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
739179|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
739180|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
739181|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
739182|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
739183|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
739184|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
739185|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
739186|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
739268|NCT02836483|Linezolid|linezolid|mesh-list
739269|NCT02836483|Delpazolid|delpazolid|mesh-list
739270|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
739271|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
739272|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
739273|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
739274|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739275|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739581|NCT02834637|Vaccines|vaccines|mesh-list
739582|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
735686|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736263|NCT02852694|Adalimumab|adalimumab|mesh-list
736264|NCT02852694|Methotrexate|methotrexate|mesh-list
736265|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
736266|NCT02852694|Azathioprine|azathioprine|mesh-list
736267|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
736268|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
736269|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
736270|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736271|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
736272|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
736273|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736274|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736275|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
736276|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736277|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
736278|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
736279|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
736280|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
736281|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
736282|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2234384|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2234385|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
2234386|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2234387|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234388|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2234389|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736812|NCT02849132|Entecavir|entecavir|mesh-list
736813|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
736814|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234390|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2234391|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2234392|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2234393|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2234394|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234395|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2234396|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2234397|NCT00080756|Estradiol|estradiol|mesh-list
2234398|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
737199|NCT02846909|Progesterone|progesterone|mesh-list
737200|NCT02846909|Progestins|progestins|mesh-ancestor
737201|NCT02846909|Hormones|hormones|mesh-ancestor
737202|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
737203|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737264|NCT02846766|Lenvatinib|lenvatinib|mesh-list
737265|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737266|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
737267|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737268|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737419|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
737420|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
737421|NCT02846142|Estradiol|estradiol|mesh-list
737422|NCT02846142|Estrogens|estrogens|mesh-ancestor
737423|NCT02846142|Hormones|hormones|mesh-ancestor
737424|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
737425|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737426|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
737427|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
737428|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
737429|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
737430|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
737431|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
737432|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
738017|NCT02842749|Everolimus|everolimus|mesh-list
738018|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738019|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
738020|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
738021|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738579|NCT02839668|Acetaminophen|acetaminophen|mesh-list
738580|NCT02839668|Lidocaine|lidocaine|mesh-list
738581|NCT02839668|Atropine|atropine|mesh-list
738582|NCT02839668|Tramadol|tramadol|mesh-list
738583|NCT02839668|Sevoflurane|sevoflurane|mesh-list
738584|NCT02839668|Neostigmine|neostigmine|mesh-list
738585|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
738586|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
2092332|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
2092333|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
2092334|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092335|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
2092336|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092337|NCT02243293|Ribavirin|ribavirin|mesh-list
2092338|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
2092339|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092340|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
2092341|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092342|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
2092343|NCT02243371|Nivolumab|nivolumab|mesh-list
2092344|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
2092345|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092346|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2092347|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2092348|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2092349|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
2092350|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735943|NCT02854761|Vitamin D|vitamin d|mesh-list
735944|NCT02854761|Vitamins|vitamins|mesh-ancestor
735945|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
735946|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735947|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
736043|NCT02854241|Liver Extracts|liver extracts|mesh-list
736044|NCT02854241|Hematinics|hematinics|mesh-ancestor
736423|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
736424|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
736425|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
736426|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736427|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736428|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
736429|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
736430|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
736431|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
736432|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736433|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
736434|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
736435|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
736436|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
736437|NCT02851472|Protective Agents|protective agents|mesh-ancestor
736670|NCT02849899|Vildagliptin|vildagliptin|mesh-list
736671|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
736672|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736673|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
736674|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
736675|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736676|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737275|NCT02846831|Insulin|insulin|mesh-list
737276|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
737277|NCT02846831|Hormones|hormones|mesh-list
737278|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
737279|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737280|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
737491|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
737492|NCT02845999|Fludarabine|fludarabine|mesh-list
737493|NCT02845999|Cetuximab|cetuximab|mesh-list
737494|NCT02845999|Interleukin-2|interleukin-2|mesh-list
737495|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
737496|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
737497|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737498|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
737499|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
737500|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
737501|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737502|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737503|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
737504|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
737505|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
737506|NCT02845999|Analgesics|analgesics|mesh-ancestor
737507|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
737508|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2234399|NCT00080756|Testosterone|testosterone|mesh-list
2234400|NCT00080756|Deslorelin|deslorelin|mesh-list
2234401|NCT00080756|Estrogens|estrogens|mesh-ancestor
2234402|NCT00080756|Hormones|hormones|mesh-ancestor
2793061|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
735789|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
735790|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
735791|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
735792|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736410|NCT02851745|Linagliptin|linagliptin|mesh-list
736411|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
736412|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736413|NCT02851745|Incretins|incretins|mesh-ancestor
736414|NCT02851745|Hormones|hormones|mesh-ancestor
736415|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
736416|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
736417|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
736418|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736419|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736510|NCT02850744|Temozolomide|temozolomide|mesh-list
736511|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
736512|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
736513|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736514|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737021|NCT02848287|Ropivacaine|ropivacaine|mesh-list
737022|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
737023|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
737024|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
737025|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737026|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
737027|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737825|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
737826|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737827|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
737828|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737829|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737830|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
737951|NCT02843633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
738870|NCT02838342|Interferons|interferons|mesh-list
738871|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
738872|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
738873|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
738874|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
738875|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738876|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
738877|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
738878|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
738879|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738880|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738881|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
738882|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
738883|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
739058|NCT02837770|Diclofenac|diclofenac|mesh-list
739059|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
739060|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
739061|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
739062|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
739063|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
739064|NCT02837770|Analgesics|analgesics|mesh-ancestor
739065|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
739066|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739067|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739068|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
739069|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
739070|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
739071|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739072|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739089|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
739090|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
739091|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739198|NCT02836795|Antibodies|antibodies|mesh-list
739199|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
739200|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
739201|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739307|NCT02836288|Ketamine|ketamine|mesh-list
739308|NCT02836288|Analgesics|analgesics|mesh-ancestor
2793062|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
735908|NCT02855073|Protective Agents|protective agents|mesh-ancestor
735957|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
735958|NCT02854722|Vitamin D|vitamin d|mesh-list
735959|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
735960|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
735961|NCT02854722|Vitamins|vitamins|mesh-list
735962|NCT02854722|Calcium|calcium|mesh-list
735963|NCT02854722|Deferasirox|deferasirox|mesh-list
735964|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
735965|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
735966|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
735967|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
735968|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
735969|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
735970|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
735971|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736174|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
736175|NCT02853136|BI 409306|bi 409306|mesh-list
736176|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
736177|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
736178|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736179|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736180|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
736181|NCT02853136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
736182|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
736183|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
736184|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736185|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
736186|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
736187|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
736188|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
736189|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
736190|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
736191|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736192|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
736193|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
736290|NCT02852577|Clonazepam|clonazepam|mesh-list
736291|NCT02852577|Paroxetine|paroxetine|mesh-list
736292|NCT02852577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
736293|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
736294|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
736295|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736296|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
736297|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
736298|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736299|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
736300|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
736301|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
736302|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
736303|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
736304|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736305|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
736306|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
736307|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
736537|NCT02850874|Gemcitabine|gemcitabine|mesh-list
736538|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
736539|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
736540|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736541|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736542|NCT02850874|Antiviral Agents|antiviral agents|mesh-ancestor
736543|NCT02850874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
736544|NCT02850874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736545|NCT02850874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
736546|NCT02850874|Immunologic Factors|immunologic factors|mesh-ancestor
736547|NCT02850874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736834|NCT02848937|Citric Acid|citric acid|mesh-list
736835|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
736836|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
736837|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
736838|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
736839|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
736840|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736994|NCT02848170|Olmesartan|olmesartan|mesh-list
736995|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
736996|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
735917|NCT02854995|Triamcinolone|triamcinolone|mesh-list
735918|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
735919|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
735920|NCT02854995|Hormones|hormones|mesh-ancestor
735921|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
735922|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234403|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2234404|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234405|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2234406|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
2234407|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2234408|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2234409|NCT00080756|Androgens|androgens|mesh-ancestor
2234410|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234411|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234412|NCT00080782|Celecoxib|celecoxib|mesh-list
2234413|NCT00080782|Doxorubicin|doxorubicin|mesh-list
2234414|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2234415|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2234416|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234417|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2234418|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2234419|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234420|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234421|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2234422|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2234423|NCT00080782|Analgesics|analgesics|mesh-ancestor
2234424|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
736486|NCT02851095|Metformin|metformin|mesh-list
736487|NCT02851095|Canagliflozin|canagliflozin|mesh-list
736488|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
736489|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736490|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
736491|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736588|NCT02850445|Olanzapine|olanzapine|mesh-list
736589|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
736590|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
736591|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736592|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736593|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
736594|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
736595|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
736596|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736597|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
736598|NCT02850445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
736599|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
736600|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
736601|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736602|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
736603|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
736664|NCT02850016|Romidepsin|romidepsin|mesh-list
736665|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
736666|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
736667|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736668|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736669|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234425|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2234426|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234427|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2234428|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2234429|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2234430|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2234431|NCT00080795|Gemcitabine|gemcitabine|mesh-list
2234432|NCT00080795|Doxorubicin|doxorubicin|mesh-list
2234433|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2234434|NCT00080795|Ifosfamide|ifosfamide|mesh-list
2234435|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234436|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2234437|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
2234438|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234439|NCT00080795|Antiviral Agents|antiviral agents|mesh-ancestor
2234440|NCT00080795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234441|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
735948|NCT02854488|Ipilimumab|ipilimumab|mesh-list
735949|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
735950|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
735951|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
735952|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736045|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
736046|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
736047|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736194|NCT02853071|Estramustine|estramustine|mesh-list
736195|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
736196|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
736197|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736198|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736199|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
736246|NCT02852681|Drospirenone|drospirenone|mesh-list
736247|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
736248|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
736249|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
736250|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736251|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
736252|NCT02852681|Diuretics|diuretics|mesh-ancestor
736253|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
736462|NCT02851407|Defibrotide|defibrotide|mesh-list
736463|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
736464|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
736465|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736466|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
737251|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
737252|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
737253|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
737254|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
737255|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737256|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
737257|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737258|NCT02846701|Analgesics|analgesics|mesh-ancestor
737259|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
737260|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737261|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
737262|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
737263|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
737360|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
737361|NCT02846428|Docetaxel|docetaxel|mesh-list
737362|NCT02846428|Fluorouracil|fluorouracil|mesh-list
737363|NCT02846428|Capecitabine|capecitabine|mesh-list
737364|NCT02846428|Epirubicin|epirubicin|mesh-list
737365|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
737366|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
737367|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737368|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
737369|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
737370|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
737371|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737372|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737373|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
737374|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
737375|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
737376|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
737377|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
737378|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
737379|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
737380|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
737381|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
737382|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737714|NCT02845349|Vortioxetine|vortioxetine|mesh-list
737715|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
737716|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
737717|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
737718|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
737719|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
737720|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737721|NCT02845349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
737722|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
735955|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
735956|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736254|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
736255|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
736256|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234442|NCT00080795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2234443|NCT00080795|Immunologic Factors|immunologic factors|mesh-ancestor
2234444|NCT00080795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234445|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2234446|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2234447|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2234448|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2234449|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
737243|NCT02846857|Insulin|insulin|mesh-list
737244|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
737245|NCT02846857|Glucagon|glucagon|mesh-list
737246|NCT02846857|Hormones|hormones|mesh-list
737247|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
737248|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737249|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
737250|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
737383|NCT02846506|Metformin|metformin|mesh-list
737384|NCT02846506|Canagliflozin|canagliflozin|mesh-list
737385|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
737386|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737387|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
737388|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737470|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
737471|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
737472|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
737473|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737474|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737904|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
737905|NCT02844062|Fludarabine|fludarabine|mesh-list
737906|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
737907|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
737908|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737909|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
737910|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
737911|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
737912|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737913|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737914|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
738022|NCT02842931|Prednisone|prednisone|mesh-list
738023|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
738024|NCT02842931|Doxorubicin|doxorubicin|mesh-list
738025|NCT02842931|Etoposide|etoposide|mesh-list
738026|NCT02842931|Vincristine|vincristine|mesh-list
738027|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
738028|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
738029|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738030|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
738031|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
738032|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
738033|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738034|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738035|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
738036|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
738037|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
738038|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
738039|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738040|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
738041|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
738042|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
738043|NCT02842931|Hormones|hormones|mesh-ancestor
738044|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738045|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
738046|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
738047|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
738048|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
2234450|NCT00080808|Phentolamine|phentolamine|mesh-list
2234451|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
2234452|NCT00080808|Alprostadil|alprostadil|mesh-list
2234453|NCT00080808|Papaverine|papaverine|mesh-list
735989|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
735990|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
735991|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
735992|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
735993|NCT02854787|Protective Agents|protective agents|mesh-ancestor
736066|NCT02854072|Gemcitabine|gemcitabine|mesh-list
736067|NCT02854072|Capecitabine|capecitabine|mesh-list
736068|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
736069|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
736070|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736071|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736072|NCT02854072|Antiviral Agents|antiviral agents|mesh-ancestor
736073|NCT02854072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
736074|NCT02854072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736075|NCT02854072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
736076|NCT02854072|Immunologic Factors|immunologic factors|mesh-ancestor
736077|NCT02854072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736451|NCT02851394|Tramadol|tramadol|mesh-list
736452|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
736453|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
736454|NCT02851394|Narcotics|narcotics|mesh-ancestor
736455|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736456|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736457|NCT02851394|Analgesics|analgesics|mesh-ancestor
736458|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
736459|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736460|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
736461|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
736528|NCT02850913|Doxycycline|doxycycline|mesh-list
736529|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
736530|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
736531|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
736532|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
736533|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
736677|NCT02849743|Oxytocin|oxytocin|mesh-list
736678|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
736679|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
736680|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736851|NCT02849171|Choline|choline|mesh-list
736852|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
736853|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
736854|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
736855|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736856|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
736857|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
736858|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
737037|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
737038|NCT02848157|Ropivacaine|ropivacaine|mesh-list
737039|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
737040|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
737041|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737042|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
737043|NCT02848157|Analgesics|analgesics|mesh-ancestor
737044|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
737045|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737046|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
737047|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
737048|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
737049|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
737050|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
737051|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737052|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
737053|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
737054|NCT02847884|Infliximab|infliximab|mesh-list
737055|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
737056|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
737057|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
737070|NCT02847702|Naproxen|naproxen|mesh-list
737071|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
737072|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
737073|NCT02847702|Analgesics|analgesics|mesh-ancestor
737074|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
737075|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737076|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737077|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
737078|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
737079|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
2092351|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092352|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2092353|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2092354|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2092355|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
2092356|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2092357|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092358|NCT02243943|Neostigmine|neostigmine|mesh-list
2092359|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2092360|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092361|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234454|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736967|NCT02848417|Curcumin|curcumin|mesh-list
736968|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
736969|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
736970|NCT02848417|Analgesics|analgesics|mesh-ancestor
736971|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
736972|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736973|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736974|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
736975|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
736976|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736977|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736978|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737220|NCT02847286|Dapivirine|dapivirine|mesh-list
737221|NCT02847286|Clotrimazole|clotrimazole|mesh-list
737222|NCT02847286|Miconazole|miconazole|mesh-list
737223|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
737224|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
737225|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
737226|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737227|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
737228|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
737229|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
737230|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
737231|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737232|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737233|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
737234|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
737235|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
737236|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737237|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
737238|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
737798|NCT02844790|Insulin|insulin|mesh-list
737799|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
737800|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
737801|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737959|NCT02843451|Silymarin|silymarin|mesh-list
737960|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
737961|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737962|NCT02843451|Protective Agents|protective agents|mesh-ancestor
737963|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738239|NCT02841800|Phenobarbital|phenobarbital|mesh-list
738240|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
738241|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
738242|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
738243|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738244|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
738245|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
738246|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
738247|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738248|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
738249|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
738250|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
738251|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
738252|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
738290|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
738291|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
738292|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
738293|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
738294|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738295|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2092362|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
736441|NCT02851433|Anesthetics|anesthetics|mesh-list
736442|NCT02851433|Propofol|propofol|mesh-list
736443|NCT02851433|Sevoflurane|sevoflurane|mesh-list
736444|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736445|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736446|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
736447|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
736448|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
736449|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
736450|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2234455|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
2234456|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2234457|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
736776|NCT02849457|Vigabatrin|vigabatrin|mesh-list
736777|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
736778|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736779|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736780|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
736781|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
736782|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736815|NCT02848950|Metformin|metformin|mesh-list
736816|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
736817|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737301|NCT02846519|Rifampin|rifampin|mesh-list
737302|NCT02846519|Esketamine|esketamine|mesh-list
737303|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
737304|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
737305|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
737306|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737307|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
737308|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
737309|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737310|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737311|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
737312|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
737313|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
737314|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
737315|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
737316|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
737317|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
737318|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
737814|NCT02844621|Omeprazole|omeprazole|mesh-list
737815|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
737816|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
737817|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
737818|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737819|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737870|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2753403|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753404|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2753405|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2753406|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2753407|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2753408|NCT02823002|Lidocaine|lidocaine|mesh-list
2753409|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
2753410|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
2753411|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2753412|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739507|NCT02835404|Nedaplatin|nedaplatin|mesh-list
739508|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234458|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234459|NCT00080808|Urological Agents|urological agents|mesh-ancestor
2234460|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2234461|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2234462|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
2234463|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2234464|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234465|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2234466|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2234467|NCT00080847|Prednisone|prednisone|mesh-list
2234468|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
2234469|NCT00080847|Rituximab|rituximab|mesh-list
2234470|NCT00080847|Doxorubicin|doxorubicin|mesh-list
2234471|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2234472|NCT00080847|Vincristine|vincristine|mesh-list
2234473|NCT00080847|Oblimersen|oblimersen|mesh-list
2092363|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
736631|NCT02850484|Budesonide|budesonide|mesh-list
736632|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
736633|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
736634|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
736635|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
736636|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736637|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736638|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
736639|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
736640|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
736641|NCT02850484|Hormones|hormones|mesh-ancestor
736642|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
736643|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
736644|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
736645|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
736646|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
736647|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
736648|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736660|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
736661|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
736662|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
736663|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736818|NCT02848963|Ketamine|ketamine|mesh-list
736819|NCT02848963|Propofol|propofol|mesh-list
736820|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
736821|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736822|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736823|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
736824|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
736825|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
736826|NCT02848963|Analgesics|analgesics|mesh-ancestor
736827|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
736828|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736829|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
736830|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
736831|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
736832|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
736833|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737183|NCT02847104|Insulin|insulin|mesh-list
737184|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
737185|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
737186|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737204|NCT02846935|Decitabine|decitabine|mesh-list
737205|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
737206|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
737207|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
737208|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737209|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737210|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737475|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
737476|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
737477|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
737478|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737479|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
737480|NCT02845661|Analgesics|analgesics|mesh-ancestor
737481|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
737482|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737483|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
737484|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
737485|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
737486|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
737487|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
737488|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737893|NCT02844270|Sirolimus|sirolimus|mesh-list
737894|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
737895|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737896|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
737897|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737898|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
737899|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
737900|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
737901|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738094|NCT02842281|Levan|levan|mesh-list
2234474|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2234475|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
2234476|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234477|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
736873|NCT02848794|Irinotecan|irinotecan|mesh-list
736874|NCT02848794|Apatinib|apatinib|mesh-list
736875|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
736876|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
736877|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736878|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736879|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
736880|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
737058|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
737059|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
737239|NCT02847143|Oxytocin|oxytocin|mesh-list
737240|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
737241|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
737242|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737319|NCT02846532|Aspirin|aspirin|mesh-list
737320|NCT02846532|Rivaroxaban|rivaroxaban|mesh-list
737321|NCT02846532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
737322|NCT02846532|Antithrombins|antithrombins|mesh-ancestor
737323|NCT02846532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
737324|NCT02846532|Protease Inhibitors|protease inhibitors|mesh-ancestor
737325|NCT02846532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737326|NCT02846532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737327|NCT02846532|Anticoagulants|anticoagulants|mesh-ancestor
737328|NCT02846532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
737329|NCT02846532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
737330|NCT02846532|Analgesics|analgesics|mesh-ancestor
737331|NCT02846532|Sensory System Agents|sensory system agents|mesh-ancestor
737332|NCT02846532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737333|NCT02846532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737334|NCT02846532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
737335|NCT02846532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
737336|NCT02846532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
737337|NCT02846532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
737338|NCT02846532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
737339|NCT02846532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
737340|NCT02846532|Antipyretics|antipyretics|mesh-ancestor
737509|NCT02845908|Leucovorin|leucovorin|mesh-list
737510|NCT02845908|Fluorouracil|fluorouracil|mesh-list
737511|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
737512|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
737513|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737514|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
737515|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737516|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
737517|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
737518|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737519|NCT02845908|Antidotes|antidotes|mesh-ancestor
737520|NCT02845908|Protective Agents|protective agents|mesh-ancestor
737521|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
737522|NCT02845908|Vitamins|vitamins|mesh-ancestor
737523|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
2092364|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092365|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2092366|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
2092367|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092368|NCT02244619|Acetaminophen|acetaminophen|mesh-list
738146|NCT02842424|Ramipril|ramipril|mesh-list
738147|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
738148|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
738149|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738150|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738151|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2753413|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
2753414|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2753415|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
738380|NCT02840409|Bevacizumab|bevacizumab|mesh-list
738381|NCT02840409|Vinblastine|vinblastine|mesh-list
738382|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
738383|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738384|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
738385|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
738386|NCT02840409|Growth Substances|growth substances|mesh-ancestor
2092369|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
736505|NCT02851212|Canagliflozin|canagliflozin|mesh-list
736506|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
736507|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736508|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
736509|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092370|NCT02244619|Analgesics|analgesics|mesh-ancestor
2092371|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
2092372|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092373|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092374|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
2092375|NCT02244918|Nicotine|nicotine|mesh-list
2092376|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2092377|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
2092378|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736908|NCT02848508|Metformin|metformin|mesh-list
736909|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
736910|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737083|NCT02847442|Levodopa|levodopa|mesh-list
737084|NCT02847442|Opicapone|opicapone|mesh-list
737085|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
737086|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
737087|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
737088|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
737089|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
737090|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
737091|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737092|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737093|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
737094|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737542|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
737543|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
737544|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234478|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2234479|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
2234480|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234481|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234482|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
738757|NCT02838940|Cefazolin|cefazolin|mesh-list
738758|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
738759|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
738834|NCT02838576|Estrogens|estrogens|mesh-list
738835|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
738836|NCT02838576|Hormones|hormones|mesh-ancestor
738837|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738838|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738884|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
738885|NCT02838225|Docetaxel|docetaxel|mesh-list
738886|NCT02838225|Doxorubicin|doxorubicin|mesh-list
738887|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
738888|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
738889|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
738890|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738891|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
738892|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
738893|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
738894|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738895|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738896|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
738897|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
738898|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
738899|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
738900|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
738901|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
738902|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
738903|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234483|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2234484|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2234485|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2234486|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2234487|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740429|NCT02831231|Xanomeline|xanomeline|mesh-list
740430|NCT02831231|Trospium chloride|trospium chloride|mesh-list
740431|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
740432|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
740433|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736585|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
736586|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
736587|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234488|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2234489|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
2234490|NCT00080847|Hormones|hormones|mesh-ancestor
2234491|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2234492|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2234493|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2234494|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
2234495|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
2234496|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
2234497|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2234498|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2234499|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234500|NCT00080886|Cytarabine|cytarabine|mesh-list
736881|NCT02848820|Amoxicillin|amoxicillin|mesh-list
736882|NCT02848820|Gentamicins|gentamicins|mesh-list
736883|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
736884|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
736885|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
736886|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
736887|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
736888|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
736889|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736890|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736891|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
737028|NCT02848131|Dasatinib|dasatinib|mesh-list
737029|NCT02848131|Quercetin|quercetin|mesh-list
737030|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737031|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
737032|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737033|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737034|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
737035|NCT02848131|Protective Agents|protective agents|mesh-ancestor
737036|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737097|NCT02847624|Tolvaptan|tolvaptan|mesh-list
737098|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
737099|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737100|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
737101|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737670|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
737671|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
737672|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
737673|NCT02845388|Estradiol|estradiol|mesh-list
737674|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
737675|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737676|NCT02845388|Estrogens|estrogens|mesh-ancestor
737677|NCT02845388|Hormones|hormones|mesh-ancestor
737678|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
737679|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737680|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
737681|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
737682|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
737683|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
737684|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
737685|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
737686|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
737687|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737688|NCT02845388|Urological Agents|urological agents|mesh-ancestor
737874|NCT02844322|Rituximab|rituximab|mesh-list
737875|NCT02844322|Bortezomib|bortezomib|mesh-list
737876|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
737877|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737878|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
737879|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737880|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
737948|NCT02843321|Vaccines|vaccines|mesh-list
737949|NCT02843321|Immunologic Factors|immunologic factors|mesh-ancestor
737950|NCT02843321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738491|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
738492|NCT02839941|Tacrolimus|tacrolimus|mesh-list
738493|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
738494|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
738495|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
2234501|NCT00080886|Rituximab|rituximab|mesh-list
2234502|NCT00080886|Etoposide|etoposide|mesh-list
2234503|NCT00080886|Melphalan|melphalan|mesh-list
2234504|NCT00080886|Carmustine|carmustine|mesh-list
2234505|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2234506|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234507|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
2234508|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234509|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2234510|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2234511|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2234512|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2234513|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234514|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234515|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2234516|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
2234517|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
2234518|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234519|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2234520|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2234521|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
2234522|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2234523|NCT00080925|Cytarabine|cytarabine|mesh-list
2234524|NCT00080925|Cyclosporine|cyclosporine|mesh-list
2234525|NCT00080925|Prednisone|prednisone|mesh-list
2234526|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
2234527|NCT00080925|Rituximab|rituximab|mesh-list
2234528|NCT00080925|Doxorubicin|doxorubicin|mesh-list
737060|NCT02847806|Insulin|insulin|mesh-list
737061|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
737062|NCT02847806|Estradiol|estradiol|mesh-list
737063|NCT02847806|Testosterone|testosterone|mesh-list
737064|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
737065|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737066|NCT02847806|Estrogens|estrogens|mesh-ancestor
737067|NCT02847806|Hormones|hormones|mesh-ancestor
737068|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
737069|NCT02847806|Androgens|androgens|mesh-ancestor
737102|NCT02847403|Exenatide|exenatide|mesh-list
737103|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
737104|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737105|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
737106|NCT02847403|Incretins|incretins|mesh-ancestor
737107|NCT02847403|Hormones|hormones|mesh-ancestor
737108|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
737489|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
737490|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738846|NCT02838238|Capecitabine|capecitabine|mesh-list
738847|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
738848|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
738849|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738850|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738985|NCT02838030|Aspirin|aspirin|mesh-list
738986|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
738987|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
738988|NCT02838030|Analgesics|analgesics|mesh-ancestor
738989|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
738990|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738991|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738992|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
738993|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
738994|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
738995|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
738996|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738997|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
738998|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
738999|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739000|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
739073|NCT02837146|Methotrexate|methotrexate|mesh-list
739074|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
739075|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
739076|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
739077|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739078|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
739079|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
739203|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
2234529|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2234530|NCT00080925|Fludarabine|fludarabine|mesh-list
736759|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
736760|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737142|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
737143|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
737144|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737145|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
737447|NCT02845856|Cetuximab|cetuximab|mesh-list
737448|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
737449|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737831|NCT02844803|Metformin|metformin|mesh-list
737832|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
737833|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738011|NCT02843061|Rituximab|rituximab|mesh-list
738012|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
738013|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738014|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
738015|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738016|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
738120|NCT02842359|Irbesartan|irbesartan|mesh-list
738121|NCT02842359|Atorvastatin|atorvastatin|mesh-list
738122|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
738123|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
738124|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
738125|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738126|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
738127|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
738128|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738129|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
738130|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
738131|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2092379|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092380|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2092381|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2092382|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
2092383|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092384|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738513|NCT02839785|Ibuprofen|ibuprofen|mesh-list
738514|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
738515|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
738516|NCT02839785|Analgesics|analgesics|mesh-ancestor
738517|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
738518|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738519|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738520|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
738521|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
738522|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
738523|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738524|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738806|NCT02838758|Lidocaine|lidocaine|mesh-list
738807|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
738808|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
738809|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
738810|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738811|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
738812|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738813|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
738814|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
738815|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
738816|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
738817|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738973|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
738974|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
739187|NCT02836548|Vorinostat|vorinostat|mesh-list
739188|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
739189|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739190|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739191|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739591|NCT02834559|Fluorouracil|fluorouracil|mesh-list
739592|NCT02834559|Heparin|heparin|mesh-list
2234531|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
2234532|NCT00080925|Etoposide|etoposide|mesh-list
2234533|NCT00080925|Vincristine|vincristine|mesh-list
736987|NCT02848300|Bimatoprost|bimatoprost|mesh-list
736988|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
737442|NCT02845804|Everolimus|everolimus|mesh-list
737443|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737444|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
737445|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
737446|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737841|NCT02844517|Pancrelipase|pancrelipase|mesh-list
737842|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
737920|NCT02844114|Gemcitabine|gemcitabine|mesh-list
737921|NCT02844114|Cisplatin|cisplatin|mesh-list
737922|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737923|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
737924|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
737925|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737926|NCT02844114|Antiviral Agents|antiviral agents|mesh-ancestor
737927|NCT02844114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737928|NCT02844114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737929|NCT02844114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
737930|NCT02844114|Immunologic Factors|immunologic factors|mesh-ancestor
737931|NCT02844114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092406|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2234534|NCT00080925|Cyclosporins|cyclosporins|mesh-list
2234535|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
738225|NCT02841579|Osimertinib|osimertinib|mesh-list
738226|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738227|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
738228|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738229|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738275|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
738276|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
738277|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
738543|NCT02839642|Rivastigmine|rivastigmine|mesh-list
738544|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
738545|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738546|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738547|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
738548|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
738549|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738550|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
738551|NCT02839642|Protective Agents|protective agents|mesh-ancestor
739253|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
739254|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
739255|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
739256|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739257|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739258|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
739259|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
739260|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
739261|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
739262|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739263|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
739264|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
736901|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736951|NCT02848339|Aspirin|aspirin|mesh-list
736952|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
736953|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
736954|NCT02848339|Analgesics|analgesics|mesh-ancestor
736955|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
736956|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
736957|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
736958|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
736959|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
736960|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
736961|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
736962|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736963|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
736964|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
736965|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
736966|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
737524|NCT02845713|Ivermectin|ivermectin|mesh-list
737525|NCT02845713|Albendazole|albendazole|mesh-list
737526|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
737527|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
737528|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737529|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
737530|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
737531|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
737532|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
737533|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
737534|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
737535|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
737536|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737537|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737538|NCT02845713|Filaricides|filaricides|mesh-ancestor
737539|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
737540|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
737541|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737689|NCT02845271|Acetaminophen|acetaminophen|mesh-list
737690|NCT02845271|Tramadol|tramadol|mesh-list
737691|NCT02845271|Codeine|codeine|mesh-list
737692|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
737693|NCT02845271|Analgesics|analgesics|mesh-ancestor
737694|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
737695|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737696|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737697|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
737698|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
737699|NCT02845271|Narcotics|narcotics|mesh-ancestor
737700|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
737701|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
737702|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
737758|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
737759|NCT02844894|Esmolol|esmolol|mesh-list
737760|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
737761|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
737762|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737763|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
737764|NCT02844894|Analgesics|analgesics|mesh-ancestor
737765|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
737766|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737767|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
737768|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
737769|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
737770|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
737771|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
737772|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737773|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
737774|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
737775|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
737852|NCT02844634|Tenofovir|tenofovir|mesh-list
737853|NCT02844634|Emtricitabine|emtricitabine|mesh-list
737854|NCT02844634|Doxycycline|doxycycline|mesh-list
737855|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
737856|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737857|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
737858|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
737859|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737860|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736903|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
736904|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
736905|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
736906|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
736907|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738230|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
738231|NCT02841774|Pravastatin|pravastatin|mesh-list
738232|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
738233|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
738234|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
738235|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738236|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
738237|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
738238|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234536|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
2234537|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234538|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2234539|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2234540|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
2234541|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234542|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234543|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2234544|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2234545|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
739321|NCT02836353|Rifaximin|rifaximin|mesh-list
739322|NCT02836353|Somatostatin|somatostatin|mesh-list
739323|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
739324|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
739325|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
739326|NCT02836353|Hormones|hormones|mesh-ancestor
739327|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
739328|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739447|NCT02835469|Menotropins|menotropins|mesh-list
739448|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
739449|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
739450|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
739451|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739942|NCT02833155|Exemestane|exemestane|mesh-list
739943|NCT02833155|Entinostat|entinostat|mesh-list
739944|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739945|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
739946|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
739947|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739948|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739949|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
739950|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
739951|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
739952|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739953|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
740353|NCT02831374|Anesthetics|anesthetics|mesh-list
740354|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
740355|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234546|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2234547|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2234548|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234549|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2234550|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
2234551|NCT00080925|Hormones|hormones|mesh-ancestor
2234552|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
740807|NCT02829060|Gentamicins|gentamicins|mesh-list
740808|NCT02829060|Ampicillin|ampicillin|mesh-list
740809|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
740810|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
740811|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
740812|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
740813|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740814|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
736997|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
736998|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
736999|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737738|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
737739|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
737740|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
737741|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
737742|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
737743|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737744|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
737745|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
737746|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
737747|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
737748|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
737749|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
737750|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
737751|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
738362|NCT02840240|Gabapentin|gabapentin|mesh-list
738363|NCT02840240|Analgesics|analgesics|mesh-ancestor
738364|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
738365|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738366|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738367|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
738368|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
738369|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
738370|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
738371|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
738372|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
738373|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
738374|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
738375|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738376|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
738751|NCT02838745|Pemetrexed|pemetrexed|mesh-list
738752|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738753|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738754|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738755|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
738756|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
738912|NCT02838264|Itraconazole|itraconazole|mesh-list
738913|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
738914|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
738915|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
738916|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
738917|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738918|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738919|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
738920|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
738921|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738922|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738923|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
738975|NCT02837835|Ceftazidime|ceftazidime|mesh-list
738976|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
738977|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
739132|NCT02837198|Dotinurad|dotinurad|mesh-list
739133|NCT02837198|FYX-051|fyx-051|mesh-list
739134|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
739135|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
739136|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
739137|NCT02837198|Renal Agents|renal agents|mesh-ancestor
739138|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739139|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739153|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
739427|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
739428|NCT02836002|Piperaquine|piperaquine|mesh-list
739429|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
739430|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
739431|NCT02836002|Atovaquone|atovaquone|mesh-list
739432|NCT02836002|Proguanil|proguanil|mesh-list
739433|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
739434|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
739435|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
739436|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
737080|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
737081|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737082|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737598|NCT02845882|Cytarabine|cytarabine|mesh-list
737599|NCT02845882|Dexamethasone|dexamethasone|mesh-list
737600|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
737601|NCT02845882|Prednisone|prednisone|mesh-list
737602|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
737603|NCT02845882|Ifosfamide|ifosfamide|mesh-list
737604|NCT02845882|Doxorubicin|doxorubicin|mesh-list
737605|NCT02845882|Methotrexate|methotrexate|mesh-list
737606|NCT02845882|Etoposide|etoposide|mesh-list
737607|NCT02845882|Vincristine|vincristine|mesh-list
737608|NCT02845882|Daunorubicin|daunorubicin|mesh-list
737609|NCT02845882|Asparaginase|asparaginase|mesh-list
737610|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
737611|NCT02845882|Vindesine|vindesine|mesh-list
737612|NCT02845882|Pegaspargase|pegaspargase|mesh-list
737613|NCT02845882|BB 1101|bb 1101|mesh-list
737614|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
737615|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
737616|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737617|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
737618|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
737619|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
737620|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737621|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737622|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
737623|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
737624|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
737625|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
737626|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737627|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
737628|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
737629|NCT02845882|Hormones|hormones|mesh-ancestor
737630|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
737631|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
737632|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
737633|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737634|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
737635|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
737636|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
737637|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
737638|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
737639|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
737640|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
737641|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
737642|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
737643|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
737644|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
737645|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
737646|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
737647|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737648|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
737649|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
737650|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
737964|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
738692|NCT02839486|Vancomycin|vancomycin|mesh-list
738693|NCT02839486|Cefoxitin|cefoxitin|mesh-list
738694|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
738695|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234553|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2234554|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2234555|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
2234556|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2234557|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
739859|NCT02833233|Nivolumab|nivolumab|mesh-list
739860|NCT02833233|Ipilimumab|ipilimumab|mesh-list
739861|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
739862|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739863|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
739864|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740141|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
740142|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
740143|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
740144|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
740145|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740374|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
737096|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737187|NCT02847013|Bupivacaine|bupivacaine|mesh-list
737188|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
737189|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
737190|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
737191|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737192|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
737193|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737433|NCT02846025|Folic Acid|folic acid|mesh-list
737434|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
737435|NCT02846025|Antioxidants|antioxidants|mesh-list
737436|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737437|NCT02846025|Protective Agents|protective agents|mesh-ancestor
737438|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737439|NCT02846025|Hematinics|hematinics|mesh-ancestor
737440|NCT02846025|Vitamins|vitamins|mesh-ancestor
737441|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
737570|NCT02845596|Cyclosporine|cyclosporine|mesh-list
737571|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
737572|NCT02845596|Methotrexate|methotrexate|mesh-list
737573|NCT02845596|Fludarabine|fludarabine|mesh-list
737574|NCT02845596|Cyclosporins|cyclosporins|mesh-list
737575|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
737576|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
737577|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
737578|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
737579|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737580|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
737581|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
737582|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
737583|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737584|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737585|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
737586|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
737587|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
737588|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
737589|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
737590|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
737591|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
737592|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737593|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
737594|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
737595|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
737596|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737597|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
737952|NCT02843490|Ranibizumab|ranibizumab|mesh-list
737953|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
737954|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
737955|NCT02843490|Growth Substances|growth substances|mesh-ancestor
737956|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737957|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
737958|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738068|NCT02842567|Vitamin E|vitamin e|mesh-list
738069|NCT02842567|Tocopherols|tocopherols|mesh-list
738070|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
738071|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
738072|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
738073|NCT02842567|Vitamins|vitamins|mesh-ancestor
738074|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
738075|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738076|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
738077|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738078|NCT02842567|Protective Agents|protective agents|mesh-ancestor
738079|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
738080|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
738081|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
738082|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
738335|NCT02840539|Cytarabine|cytarabine|mesh-list
738336|NCT02840539|Dexamethasone|dexamethasone|mesh-list
738337|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
738338|NCT02840539|Bortezomib|bortezomib|mesh-list
738339|NCT02840539|BB 1101|bb 1101|mesh-list
738340|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
738341|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
738342|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
738343|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738344|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738345|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
738346|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
2234558|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234559|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
2234560|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
2234561|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
2234562|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
2234563|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
737450|NCT02845843|Interferons|interferons|mesh-list
737451|NCT02845843|Ritonavir|ritonavir|mesh-list
737452|NCT02845843|Lopinavir|lopinavir|mesh-list
737453|NCT02845843|Interferon-beta|interferon-beta|mesh-list
737454|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
737455|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737456|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
737457|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737458|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
737459|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
737460|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
737461|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737462|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737463|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
737464|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
737465|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
737466|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
737467|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
737468|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737469|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
737731|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
737732|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
737733|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
737734|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
737735|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
737736|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
737737|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739100|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
739101|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
739102|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
739103|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739104|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
739105|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
739106|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739223|NCT02836704|Metformin|metformin|mesh-list
739224|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
739225|NCT02836704|Acarbose|acarbose|mesh-list
739226|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
739227|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739228|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
739229|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739230|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234564|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
740083|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
740084|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
740085|NCT02832726|Vitamins|vitamins|mesh-ancestor
740086|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
740087|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740088|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
740089|NCT02832726|Hematinics|hematinics|mesh-ancestor
740758|NCT02829268|Dantrolene|dantrolene|mesh-list
740759|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
740760|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740761|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
740762|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740957|NCT02827578|Tamsulosin|tamsulosin|mesh-list
740958|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
740959|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
740960|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
740961|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
740962|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
740963|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740964|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740965|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740966|NCT02827578|Urological Agents|urological agents|mesh-ancestor
740967|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
740968|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
740969|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
741152|NCT02826434|Durvalumab|durvalumab|mesh-list
741153|NCT02826434|Poly ICLC|poly iclc|mesh-list
2234565|NCT00080951|Leucovorin|leucovorin|mesh-list
737161|NCT02847338|Lisinopril|lisinopril|mesh-list
737162|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
737163|NCT02847338|Amiloride|amiloride|mesh-list
737164|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
737165|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
737166|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
737167|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737168|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
737169|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737170|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
737171|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
737172|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
737173|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737174|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
737175|NCT02847338|Protective Agents|protective agents|mesh-ancestor
737176|NCT02847338|Diuretics|diuretics|mesh-ancestor
737177|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
737178|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
737179|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
737180|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
737181|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
737182|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
737932|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
737933|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
737934|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
737935|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737936|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
737937|NCT02843698|Analgesics|analgesics|mesh-ancestor
737938|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
737939|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
737940|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
737941|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
737942|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
737943|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
737944|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
737945|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738206|NCT02841722|Sargramostim|sargramostim|mesh-list
738207|NCT02841722|Lenograstim|lenograstim|mesh-list
738208|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
738209|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738210|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
738256|NCT02841371|Edetic Acid|edetic acid|mesh-list
738257|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
738258|NCT02841371|Antidotes|antidotes|mesh-ancestor
738259|NCT02841371|Protective Agents|protective agents|mesh-ancestor
738260|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738261|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
738262|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
738263|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738264|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
738265|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
738266|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
738439|NCT02840526|Acetaminophen|acetaminophen|mesh-list
738440|NCT02840526|Fentanyl|fentanyl|mesh-list
738441|NCT02840526|Bupivacaine|bupivacaine|mesh-list
738442|NCT02840526|Propofol|propofol|mesh-list
738443|NCT02840526|Sevoflurane|sevoflurane|mesh-list
738444|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
738445|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
738446|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
738447|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738448|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
738449|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738450|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
738451|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
738452|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
738453|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
738454|NCT02840526|Narcotics|narcotics|mesh-ancestor
738455|NCT02840526|Analgesics|analgesics|mesh-ancestor
738456|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
738457|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
738458|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
738459|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
738460|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
738618|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
738619|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
738620|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234566|NCT00080951|Fluorouracil|fluorouracil|mesh-list
737902|NCT02843984|Lactoferrin|lactoferrin|mesh-list
737903|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
737946|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
737947|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
738049|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
738050|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
738051|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
738052|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
738053|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
738054|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
738055|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738056|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738057|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
738058|NCT02842814|Hormones|hormones|mesh-ancestor
738059|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738060|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738312|NCT02841176|Golimumab|golimumab|mesh-list
738313|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
738314|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
738315|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
738316|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
738317|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738474|NCT02839928|Ketamine|ketamine|mesh-list
738475|NCT02839928|Analgesics|analgesics|mesh-list
738476|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
738477|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
738478|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738479|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738480|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
738481|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
738482|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
738483|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
738484|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
738485|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
738486|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
738487|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
738488|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738489|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
738490|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
738978|NCT02838173|Ropivacaine|ropivacaine|mesh-list
738979|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
738980|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
738981|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
738982|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738983|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
738984|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2234567|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
2234568|NCT00080951|Irinotecan|irinotecan|mesh-list
2234569|NCT00080951|Calcium|calcium|mesh-list
2234570|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
2234571|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2234572|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234573|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
2234574|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234575|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2234576|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234577|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2234578|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
2234579|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2234580|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2234581|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234582|NCT00080951|Antidotes|antidotes|mesh-ancestor
739850|NCT02833506|Sirolimus|sirolimus|mesh-list
739851|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
739852|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
739853|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
739854|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739855|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
739856|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2234583|NCT00080951|Protective Agents|protective agents|mesh-ancestor
2234584|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
2234585|NCT00080951|Vitamins|vitamins|mesh-ancestor
2234586|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
2234587|NCT00080977|Aldesleukin|aldesleukin|mesh-list
2234588|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234589|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2234590|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
737807|NCT02844881|Apatinib|apatinib|mesh-list
737808|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737809|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
737810|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737811|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738132|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
738133|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
738134|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
738135|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738136|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
738137|NCT02842437|Analgesics|analgesics|mesh-ancestor
738138|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
738139|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738140|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
738141|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
738142|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
738143|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
738144|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
738145|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738267|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
738268|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
738269|NCT02841280|Diuretics|diuretics|mesh-ancestor
738270|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
738271|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738272|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
738273|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
738274|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738299|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
738300|NCT02840994|Nivolumab|nivolumab|mesh-list
738301|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
738302|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738303|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
738304|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738360|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
738361|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
738730|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
738731|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
738732|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
738733|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738734|NCT02839161|Antacids|antacids|mesh-ancestor
738735|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738736|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
739379|NCT02836028|Temozolomide|temozolomide|mesh-list
739380|NCT02836028|Talazoparib|talazoparib|mesh-list
739381|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
739382|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
739383|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739384|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739385|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
739386|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739575|NCT02834754|Vedolizumab|vedolizumab|mesh-list
739576|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
740275|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
740276|NCT02831712|Trace Elements|trace elements|mesh-ancestor
740277|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
740278|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234591|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
2234592|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
740571|NCT02830126|Anesthetics|anesthetics|mesh-list
740572|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
740573|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740763|NCT02829281|Triamcinolone|triamcinolone|mesh-list
740764|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
740765|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
740766|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
740767|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2234593|NCT00080990|Leucovorin|leucovorin|mesh-list
2234594|NCT00080990|Fluorouracil|fluorouracil|mesh-list
737723|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
737724|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737725|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
737726|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
737727|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
737728|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
737729|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
737730|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
737995|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
737996|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
737997|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234595|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
2234596|NCT00080990|Alvocidib|alvocidib|mesh-list
2234597|NCT00080990|Calcium|calcium|mesh-list
2234598|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
2234599|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2234600|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739032|NCT02837640|Levodopa|levodopa|mesh-list
739033|NCT02837640|Carbidopa|carbidopa|mesh-list
739034|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
739035|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
739036|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
739037|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
739038|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
739039|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739040|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739041|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
739042|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739043|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
739044|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
739045|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
739544|NCT02835183|Insulin|insulin|mesh-list
739545|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
739546|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739547|NCT02834676|Ethanol|ethanol|mesh-list
739548|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
739549|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
739550|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
739551|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739718|NCT02833766|Doxorubicin|doxorubicin|mesh-list
739719|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
739720|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739721|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
739722|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
739723|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739724|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739954|NCT02833103|Pinaverium|pinaverium|mesh-list
739955|NCT02833103|Bromides|bromides|mesh-list
739956|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
739957|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
739958|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
739959|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739960|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
739961|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739962|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
739963|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
739964|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740350|NCT02831361|Metformin|metformin|mesh-list
740351|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
740352|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740970|NCT02827682|Anesthetics|anesthetics|mesh-list
740971|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
740972|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092407|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2092408|NCT02245672|Fluticasone|fluticasone|mesh-list
2092409|NCT02245672|Xhance|xhance|mesh-list
2092410|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2092411|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
741622|NCT02824458|Apatinib|apatinib|mesh-list
741623|NCT02824458|Gefitinib|gefitinib|mesh-list
741624|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741625|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
741626|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741627|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092412|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
737781|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737782|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
737783|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
737784|NCT02844907|Hormones|hormones|mesh-ancestor
737785|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
737786|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
737787|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737998|NCT02843230|Bevacizumab|bevacizumab|mesh-list
737999|NCT02843230|Temozolomide|temozolomide|mesh-list
738000|NCT02843230|Lomustine|lomustine|mesh-list
738001|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
738002|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738003|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
738004|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
738005|NCT02843230|Growth Substances|growth substances|mesh-ancestor
738006|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738007|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
738008|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
738009|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
738010|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738096|NCT02842580|Leucovorin|leucovorin|mesh-list
738097|NCT02842580|Bevacizumab|bevacizumab|mesh-list
738098|NCT02842580|Capecitabine|capecitabine|mesh-list
738099|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
738100|NCT02842580|Irinotecan|irinotecan|mesh-list
738101|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
738102|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
738103|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738104|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
738105|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
738106|NCT02842580|Growth Substances|growth substances|mesh-ancestor
738107|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738108|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
738109|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
738110|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
738111|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738112|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
738113|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
738114|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738115|NCT02842580|Antidotes|antidotes|mesh-ancestor
738116|NCT02842580|Protective Agents|protective agents|mesh-ancestor
738117|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
738118|NCT02842580|Vitamins|vitamins|mesh-ancestor
738119|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
738201|NCT02841839|Fluorides|fluorides|mesh-list
738202|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
738203|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
738204|NCT02841839|Protective Agents|protective agents|mesh-ancestor
738205|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738572|NCT02839538|Anesthetics|anesthetics|mesh-list
738573|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
738574|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738851|NCT02838615|Dexamethasone|dexamethasone|mesh-list
738852|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
738853|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
738854|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
738855|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738856|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738857|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
738858|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
738859|NCT02838615|Hormones|hormones|mesh-ancestor
738860|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738861|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
738862|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739095|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
739096|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2092413|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
2234601|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
2234602|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234603|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2234604|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234605|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2234606|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
2234607|NCT00080990|Antidotes|antidotes|mesh-ancestor
2234608|NCT00080990|Protective Agents|protective agents|mesh-ancestor
2234609|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
2234610|NCT00080990|Vitamins|vitamins|mesh-ancestor
2234611|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
2234612|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
2234613|NCT00080990|Growth Substances|growth substances|mesh-ancestor
2234614|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2234615|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
737965|NCT02842983|Esmolol|esmolol|mesh-list
737966|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
737967|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
737968|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
737969|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
737970|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
737971|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
737972|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2092414|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092415|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092416|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2092417|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
2092418|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
2092419|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2092420|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2092421|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2092422|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2092423|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
2092424|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092425|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092426|NCT02246218|Glycerol|glycerol|mesh-list
2092427|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2092428|NCT02246218|Protective Agents|protective agents|mesh-ancestor
2092429|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092430|NCT02246582|Insulin|insulin|mesh-list
2092431|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2092432|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753416|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2753417|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
740539|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
740540|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
740541|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740981|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
740982|NCT02827266|Hematinics|hematinics|mesh-ancestor
741224|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
741225|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
741226|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
741227|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741228|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
741229|NCT02826031|Protective Agents|protective agents|mesh-ancestor
2234616|NCT00081042|Paclitaxel|paclitaxel|mesh-list
2234617|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2234618|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2234619|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234620|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
2234621|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
2234622|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
741488|NCT02824926|Ketoconazole|ketoconazole|mesh-list
741489|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
741490|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
741491|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
741492|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
741493|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741494|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741495|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
741496|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
741791|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
737861|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
737862|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
737863|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
737864|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
737865|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
737866|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
738086|NCT02842294|Bevacizumab|bevacizumab|mesh-list
738087|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
738088|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738089|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
738090|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
738091|NCT02842294|Growth Substances|growth substances|mesh-ancestor
738092|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738093|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
2234623|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234624|NCT00081055|Cyclosporine|cyclosporine|mesh-list
2234625|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
2234626|NCT00081055|Busulfan|busulfan|mesh-list
2234627|NCT00081055|Methotrexate|methotrexate|mesh-list
2234628|NCT00081055|Cyclosporins|cyclosporins|mesh-list
2234629|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2234630|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
738702|NCT02839135|Scopolamine|scopolamine|mesh-list
738703|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
738704|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
738705|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
738706|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
738707|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738708|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738709|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
738710|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
738711|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
738712|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
738713|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
738714|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738715|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
738716|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
2234631|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234632|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
739107|NCT02837003|Aspirin|aspirin|mesh-list
739108|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
739109|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
739110|NCT02837003|Analgesics|analgesics|mesh-ancestor
739111|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
739112|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739113|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739114|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
739115|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
739116|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
739117|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
739118|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739119|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
739120|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
739121|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739122|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
739808|NCT02833610|Denosumab|denosumab|mesh-list
739809|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
739810|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740030|NCT02832778|Tenofovir|tenofovir|mesh-list
740031|NCT02832778|Lamivudine|lamivudine|mesh-list
740032|NCT02832778|Zidovudine|zidovudine|mesh-list
740033|NCT02832778|Emtricitabine|emtricitabine|mesh-list
740034|NCT02832778|Efavirenz|efavirenz|mesh-list
740035|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
740036|NCT02832778|Isoniazid|isoniazid|mesh-list
740037|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
740038|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
740039|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
740040|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
740041|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740042|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740043|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
740044|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
740045|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
740046|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
740047|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
738152|NCT02842125|Capecitabine|capecitabine|mesh-list
738153|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
738154|NCT02842125|Nivolumab|nivolumab|mesh-list
738155|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
738156|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
738157|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738158|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738159|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
738160|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
738664|NCT02839408|Azithromycin|azithromycin|mesh-list
738665|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
738666|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234633|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2234634|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
2234635|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234636|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234637|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2234638|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
739097|NCT02837094|Insulin|insulin|mesh-list
739098|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
739099|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739239|NCT02836509|Acetaminophen|acetaminophen|mesh-list
739240|NCT02836509|Ibuprofen|ibuprofen|mesh-list
739241|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
739242|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
739243|NCT02836509|Analgesics|analgesics|mesh-ancestor
739244|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
739245|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739246|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739247|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
739248|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
739249|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
739250|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739251|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739252|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
739276|NCT02836171|Itraconazole|itraconazole|mesh-list
739277|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
739278|NCT02836171|Apatinib|apatinib|mesh-list
739279|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739280|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
739281|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739282|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739283|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
739284|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
739285|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
739286|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
739287|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
739288|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
739289|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
739290|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739291|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
739475|NCT02835664|Niacinamide|niacinamide|mesh-list
739476|NCT02835664|Niacin|niacin|mesh-list
739477|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
739478|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
739479|NCT02835664|Vitamins|vitamins|mesh-ancestor
739480|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
739481|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739482|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
739483|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
739484|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739485|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
739486|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
739846|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
739847|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
739848|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
739849|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
2753418|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2753419|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753420|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
2753421|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753422|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
740375|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
738095|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234639|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
2234640|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2234641|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2234642|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
2234643|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
2234644|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234645|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2234646|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2234647|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
2234648|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234649|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2234650|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
2234651|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2234652|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234653|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2234654|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2234655|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234656|NCT00081107|Epothilones|epothilones|mesh-list
2234657|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
738326|NCT02840929|Esomeprazole|esomeprazole|mesh-list
738327|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
738328|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
738329|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
738330|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738331|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738394|NCT02840162|Celecoxib|celecoxib|mesh-list
738395|NCT02840162|Benzenesulfonamide|benzenesulfonamide|mesh-list
738396|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
738397|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
738398|NCT02840162|Analgesics|analgesics|mesh-ancestor
738399|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
738400|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738401|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738402|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
738403|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
738404|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
738405|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
738406|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738407|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738408|NCT02840162|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
738747|NCT02838823|Antibodies|antibodies|mesh-list
738748|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
738749|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
738750|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740224|NCT02831842|Bevacizumab|bevacizumab|mesh-list
740225|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
740226|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740227|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
740228|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
740229|NCT02831842|Growth Substances|growth substances|mesh-ancestor
740230|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740231|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
2234658|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
2234659|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
2234660|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
2234661|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234662|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234663|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
2234664|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
2234665|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234666|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2234667|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234668|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234669|NCT00081172|Antibodies|antibodies|mesh-list
740365|NCT02831218|Aspirin|aspirin|mesh-list
740366|NCT02831218|Clopidogrel|clopidogrel|mesh-list
740367|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
740368|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
740369|NCT02831218|Analgesics|analgesics|mesh-ancestor
740370|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
740371|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740372|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740373|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2234670|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
738184|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
738185|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738186|NCT02841982|Analgesics|analgesics|mesh-ancestor
738187|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
738188|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738189|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
738190|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
2234671|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
2234672|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234673|NCT00081224|Celecoxib|celecoxib|mesh-list
2234674|NCT00081224|Capecitabine|capecitabine|mesh-list
2234675|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2234676|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
2234677|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234678|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234679|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2234680|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2234681|NCT00081224|Analgesics|analgesics|mesh-ancestor
2234682|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
2234683|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2234684|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234685|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2234686|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2234687|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2234688|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2234689|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234690|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
2234691|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234692|NCT00081276|Cisplatin|cisplatin|mesh-list
2234693|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234694|NCT00081302|Paclitaxel|paclitaxel|mesh-list
2234695|NCT00081302|Carboplatin|carboplatin|mesh-list
2234696|NCT00081302|Cetuximab|cetuximab|mesh-list
2234697|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2234698|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234699|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
2234700|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
2234701|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
2234702|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739408|NCT02835729|Cytarabine|cytarabine|mesh-list
739409|NCT02835729|Idarubicin|idarubicin|mesh-list
739410|NCT02835729|Tryptophan|tryptophan|mesh-list
739411|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
739412|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
739413|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739414|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739415|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
739416|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
739417|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
739418|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
739419|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739420|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
739421|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
739422|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
739423|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739424|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
739425|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
739426|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2753423|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
2753424|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
2753425|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
739965|NCT02832973|Ramipril|ramipril|mesh-list
739966|NCT02832973|Bisoprolol|bisoprolol|mesh-list
739967|NCT02832973|Amiloride|amiloride|mesh-list
739968|NCT02832973|Furosemide|furosemide|mesh-list
739969|NCT02832973|Spironolactone|spironolactone|mesh-list
739970|NCT02832973|Diuretics|diuretics|mesh-list
739971|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
739972|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
739973|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739974|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
739975|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
739976|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739977|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
739978|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
739979|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738347|NCT02840539|Hormones|hormones|mesh-ancestor
738348|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738349|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
738350|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738351|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
738352|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738353|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738354|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
738355|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
738356|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
738357|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
738358|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
738359|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
738422|NCT02840175|Adalimumab|adalimumab|mesh-list
738423|NCT02840175|Etanercept|etanercept|mesh-list
738424|NCT02840175|Abatacept|abatacept|mesh-list
738425|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
738426|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
738427|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
738428|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
738429|NCT02840175|Analgesics|analgesics|mesh-ancestor
738430|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
738431|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738432|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738433|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
738434|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
738435|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
738436|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
738437|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738438|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234703|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2234704|NCT00081315|Amifostine|amifostine|mesh-list
2234705|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2234706|NCT00081315|Protective Agents|protective agents|mesh-ancestor
2234707|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234708|NCT00081380|Valproic Acid|valproic acid|mesh-list
2234709|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2234710|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
2234711|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
2234712|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2234713|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2234714|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2234715|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739154|NCT02836639|Etoposide|etoposide|mesh-list
739155|NCT02836639|Busulfan|busulfan|mesh-list
739156|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
739157|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
739158|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739159|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
739160|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
739161|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739162|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739163|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
739164|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
739165|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
739166|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739167|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
739168|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2234716|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234717|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234718|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
2234719|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
2234720|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
2234721|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2234722|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
2234723|NCT00081471|Hematinics|hematinics|mesh-ancestor
2234724|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
2234725|NCT00081484|Hematinics|hematinics|mesh-ancestor
2234726|NCT00081510|Anastrozole|anastrozole|mesh-list
2234727|NCT00081510|Lonafarnib|lonafarnib|mesh-list
2234728|NCT00081510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2234729|NCT00081510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234730|NCT00081510|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2234731|NCT00081510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
739885|NCT02833584|Acetaminophen|acetaminophen|mesh-list
2234732|NCT00081510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738387|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738388|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
738389|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
738390|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
738391|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
738392|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
738393|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753426|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753427|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2092445|NCT02246647|Mannitol|mannitol|mesh-list
2092446|NCT02246647|Lactulose|lactulose|mesh-list
2092447|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
739406|NCT02835716|Ustekinumab|ustekinumab|mesh-list
739407|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
740511|NCT02830932|Vaccines|vaccines|mesh-list
740512|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
740513|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092448|NCT02246647|Diuretics|diuretics|mesh-ancestor
2092449|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
2092450|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092451|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2092452|NCT02246660|Resveratrol|resveratrol|mesh-list
2092453|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
2092454|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092455|NCT02246660|Protective Agents|protective agents|mesh-ancestor
2092456|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092457|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092458|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2092459|NCT02246673|Febuxostat|febuxostat|mesh-list
2092460|NCT02246673|Verinurad|verinurad|mesh-list
2092461|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
2092462|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2092463|NCT02246764|Timolol|timolol|mesh-list
2092464|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2092465|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2092466|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2092467|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2092468|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
2092469|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092470|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092471|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092472|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2092473|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2092474|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2092475|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
2092476|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092477|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2092478|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2092479|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
2092480|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2092481|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2092482|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2092483|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2092484|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092485|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
2092486|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092487|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092488|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2092489|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092490|NCT02247440|Interferons|interferons|mesh-list
2092491|NCT02247440|Ribavirin|ribavirin|mesh-list
2092492|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092493|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
2092494|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092495|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
2092496|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092497|NCT02247466|Rocuronium|rocuronium|mesh-list
2092498|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2092499|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2092500|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2092501|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092502|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092503|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2092504|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
738496|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738497|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
738498|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738499|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738500|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
738501|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738502|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
738503|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
738504|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
738505|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
738506|NCT02839941|Hormones|hormones|mesh-ancestor
738507|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738818|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
738819|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
738820|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
738821|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
738822|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738823|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234733|NCT00081510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234734|NCT00081510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2234735|NCT00081510|Hormone Antagonists|hormone antagonists|mesh-ancestor
739390|NCT02835833|Bevacizumab|bevacizumab|mesh-list
739391|NCT02835833|Nintedanib|nintedanib|mesh-list
739392|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
739393|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739394|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
739395|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
739396|NCT02835833|Growth Substances|growth substances|mesh-ancestor
739397|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739398|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
739399|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
739400|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739401|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739509|NCT02835391|Surgiflo|surgiflo|mesh-list
739510|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
739511|NCT02835391|Coagulants|coagulants|mesh-ancestor
2092505|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2092506|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
2092507|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092508|NCT02247804|Timolol|timolol|mesh-list
2092509|NCT02247804|Bimatoprost|bimatoprost|mesh-list
2092510|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2092511|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2092512|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
2092513|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092514|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092515|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092516|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2092517|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2092518|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
2092519|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2092520|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092521|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2092522|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2092523|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092524|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092525|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092526|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2092527|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2092528|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2092529|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2092530|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
740216|NCT02831933|Valacyclovir|valacyclovir|mesh-list
740217|NCT02831933|Nivolumab|nivolumab|mesh-list
740218|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
740219|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740220|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
740221|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740222|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
740223|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
740598|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
740599|NCT02829957|Apixaban|apixaban|mesh-list
740600|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2234736|NCT00081510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738771|NCT02838719|Dexamethasone|dexamethasone|mesh-list
738772|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
738773|NCT02838719|BB 1101|bb 1101|mesh-list
738774|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
738775|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
738776|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
738777|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738778|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738779|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
738780|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
738781|NCT02838719|Hormones|hormones|mesh-ancestor
738782|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738783|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
738784|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738785|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
738786|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738787|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739231|NCT02836457|Apixaban|apixaban|mesh-list
739232|NCT02836457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
739233|NCT02836457|Antithrombins|antithrombins|mesh-ancestor
739234|NCT02836457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
739235|NCT02836457|Protease Inhibitors|protease inhibitors|mesh-ancestor
739236|NCT02836457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739237|NCT02836457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739238|NCT02836457|Anticoagulants|anticoagulants|mesh-ancestor
739292|NCT02836184|Niacin|niacin|mesh-list
739293|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
739294|NCT02836184|Niacinamide|niacinamide|mesh-list
739295|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
739296|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739297|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
739298|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
739299|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739300|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
739301|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
739302|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
739303|NCT02836184|Vitamins|vitamins|mesh-ancestor
739304|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
739305|NCT02836184|Antacids|antacids|mesh-ancestor
739306|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2234737|NCT00081510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234738|NCT00081536|Capecitabine|capecitabine|mesh-list
2234739|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2234740|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
2234741|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234742|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234743|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
2234744|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234745|NCT00081575|Levofloxacin|levofloxacin|mesh-list
2234746|NCT00081575|Ofloxacin|ofloxacin|mesh-list
2234747|NCT00081575|Tigecycline|tigecycline|mesh-list
2234748|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2234749|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234750|NCT00081575|Renal Agents|renal agents|mesh-ancestor
2234751|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2234752|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2234753|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2234754|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234755|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234756|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234757|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2234758|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
739627|NCT02834260|Dexamethasone|dexamethasone|mesh-list
739628|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
739629|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
739630|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
739631|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739632|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739633|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
739634|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
739635|NCT02834260|Hormones|hormones|mesh-ancestor
739636|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
739637|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
739638|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738537|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
738538|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738539|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738540|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
738541|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
738542|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738626|NCT02839356|Epinephrine|epinephrine|mesh-list
738627|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
738628|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
738629|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
738630|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
738631|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738632|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738633|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
738634|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
738635|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
738636|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738637|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
738638|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
738639|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
738640|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
738641|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
738717|NCT02839122|Tadalafil|tadalafil|mesh-list
738718|NCT02839122|Dutasteride|dutasteride|mesh-list
738719|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
738720|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
738721|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
738722|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738723|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738724|NCT02839122|Urological Agents|urological agents|mesh-ancestor
738725|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
738726|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
738727|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
738728|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738729|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092531|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2092532|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092533|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092534|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092535|NCT02248480|Analgesics|analgesics|mesh-ancestor
2234759|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2234760|NCT00081588|Darunavir|darunavir|mesh-list
2234761|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
739704|NCT02834052|Poly I-C|poly i-c|mesh-list
739705|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
739706|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
739707|NCT02834052|Poly ICLC|poly iclc|mesh-list
739708|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
739709|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739710|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
739711|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
739712|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739713|NCT02834052|Laxatives|laxatives|mesh-ancestor
739714|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
739715|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
739716|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
740187|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
740188|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
740189|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740478|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
740479|NCT02831023|Piperaquine|piperaquine|mesh-list
740480|NCT02831023|Primaquine|primaquine|mesh-list
740481|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
740482|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
740483|NCT02831023|Amodiaquine|amodiaquine|mesh-list
740484|NCT02831023|Artenimol|artenimol|mesh-list
740485|NCT02831023|Methylene Blue|methylene blue|mesh-list
740486|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
740487|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
740488|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
740489|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
740490|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
740491|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740492|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740493|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
738587|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
738588|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738589|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
738590|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738591|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
738592|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
738593|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
738594|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
738595|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738596|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
738597|NCT02839668|Analgesics|analgesics|mesh-ancestor
738598|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
738599|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
738600|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
738601|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
738602|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
738603|NCT02839668|Narcotics|narcotics|mesh-ancestor
738604|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
738605|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
738606|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
738607|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
738608|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
738609|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
738610|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
738611|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
738612|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
738613|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
738614|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
738615|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
738616|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738617|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
738667|NCT02839213|Scopolamine|scopolamine|mesh-list
738668|NCT02839213|Bromides|bromides|mesh-list
738669|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
738670|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
738671|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
738672|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
738673|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
738674|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
738675|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738676|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
738677|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
738678|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
738679|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
738680|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
738681|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738682|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
738683|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
738839|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
738840|NCT02838472|Vitamins|vitamins|mesh-ancestor
738841|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
738842|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738843|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
738844|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738845|NCT02838472|Protective Agents|protective agents|mesh-ancestor
739622|NCT02834546|Sorafenib|sorafenib|mesh-list
739623|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739624|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
739625|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739626|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739725|NCT02833987|Warfarin|warfarin|mesh-list
739726|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
739727|NCT02833987|Dabigatran|dabigatran|mesh-list
739728|NCT02833987|Apixaban|apixaban|mesh-list
739729|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
739730|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
739731|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
739732|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
739733|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
739734|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739735|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234762|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2234763|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
2234764|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234765|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234766|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2234767|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
738621|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
738622|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
738623|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738624|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738625|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738684|NCT02839239|Vitamin D|vitamin d|mesh-list
738685|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
738686|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
738687|NCT02839239|Vitamins|vitamins|mesh-list
738688|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
738689|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738690|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
738691|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
738760|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
738761|NCT02839044|Vitamin K|vitamin k|mesh-list
738762|NCT02839044|Vitamin MK 7|vitamin mk 7|mesh-list
738763|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
738764|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
738765|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738766|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
738767|NCT02839044|Coagulants|coagulants|mesh-ancestor
738768|NCT02839044|Vitamins|vitamins|mesh-ancestor
738769|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
738770|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738863|NCT02838329|Ropivacaine|ropivacaine|mesh-list
738864|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
738865|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
738866|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
738867|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738868|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
738869|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739452|NCT02835586|Paclitaxel|paclitaxel|mesh-list
739453|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
739454|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739455|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
739456|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
739457|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
739458|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739909|NCT02833025|Thrombin|thrombin|mesh-list
739910|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
739911|NCT02833025|Coagulants|coagulants|mesh-ancestor
740317|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
740318|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
740319|NCT02831478|Protective Agents|protective agents|mesh-ancestor
740320|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740321|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
740394|NCT02831101|Sufentanil|sufentanil|mesh-list
740395|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
740396|NCT02831101|Narcotics|narcotics|mesh-ancestor
740397|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
740398|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740399|NCT02831101|Analgesics|analgesics|mesh-ancestor
740400|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
740401|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740402|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
740403|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
740404|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
740405|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
740623|NCT02830139|Capecitabine|capecitabine|mesh-list
740624|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
740625|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740626|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
740627|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
738798|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738799|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738800|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
738801|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738802|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
738803|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
738804|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
738805|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
738945|NCT02837965|Doxycycline|doxycycline|mesh-list
738946|NCT02837965|Prednisone|prednisone|mesh-list
738947|NCT02837965|Methotrexate|methotrexate|mesh-list
738948|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
738949|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
738950|NCT02837965|Hormones|hormones|mesh-ancestor
738951|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
738952|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738953|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
738954|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738955|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
738956|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
738957|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
738958|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
738959|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
738960|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738961|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
738962|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738963|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
738964|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
738965|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
738966|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
738967|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
738968|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
738969|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
738970|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
738971|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
738972|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
739007|NCT02837614|Acetaminophen|acetaminophen|mesh-list
739008|NCT02837614|Amoxicillin|amoxicillin|mesh-list
739009|NCT02837614|Dexamethasone|dexamethasone|mesh-list
739010|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
739011|NCT02837614|BB 1101|bb 1101|mesh-list
739012|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
739013|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
739014|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
739015|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739016|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739017|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
739018|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
739019|NCT02837614|Hormones|hormones|mesh-ancestor
739020|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
739021|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
739022|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739023|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
739024|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739025|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739026|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
739027|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
739028|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
739029|NCT02837614|Analgesics|analgesics|mesh-ancestor
739030|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
739031|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
739208|NCT02836847|Trastuzumab|trastuzumab|mesh-list
739209|NCT02836847|Cetuximab|cetuximab|mesh-list
739210|NCT02836847|Everolimus|everolimus|mesh-list
739211|NCT02836847|Sorafenib|sorafenib|mesh-list
739212|NCT02836847|Lapatinib|lapatinib|mesh-list
739213|NCT02836847|Gefitinib|gefitinib|mesh-list
739214|NCT02836847|Crizotinib|crizotinib|mesh-list
739215|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
739216|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739217|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
739218|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
739219|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739220|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
739221|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739222|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739736|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
738924|NCT02837978|Methotrexate|methotrexate|mesh-list
738925|NCT02837978|Tacrolimus|tacrolimus|mesh-list
738926|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
738927|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
738928|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
738929|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
738930|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
738931|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
738932|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
738933|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
738934|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
738935|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
738936|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
738937|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
738938|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
738939|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
738940|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
738941|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
739487|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
739488|NCT02835534|Plasminogen|plasminogen|mesh-list
739489|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
739490|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
739491|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739567|NCT02834845|Sevoflurane|sevoflurane|mesh-list
739568|NCT02834845|Desflurane|desflurane|mesh-list
739569|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
739570|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
739571|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
739572|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
739573|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
739574|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739865|NCT02833701|Vitamins|vitamins|mesh-list
739866|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
739867|NCT02833701|Bevacizumab|bevacizumab|mesh-list
739868|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
739869|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
739870|NCT02833701|Antibodies|antibodies|mesh-list
739871|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
739872|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
739873|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
739874|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739875|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
739876|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
739877|NCT02833701|Growth Substances|growth substances|mesh-ancestor
739878|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739879|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
739880|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
739881|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
739882|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739883|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
739884|NCT02833701|Protective Agents|protective agents|mesh-ancestor
739995|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
739996|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
739997|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
739998|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
739999|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
740000|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740001|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740002|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
740514|NCT02830360|Amiodarone|amiodarone|mesh-list
740515|NCT02830360|Sotalol|sotalol|mesh-list
740516|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
740517|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
740518|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
740519|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
740520|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740521|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
740522|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
740523|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
740524|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740525|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
740526|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
740527|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
740528|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
740529|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
739080|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739081|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739082|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
739083|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739084|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
739085|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
739086|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
739087|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
739088|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
739462|NCT02835521|Triamcinolone|triamcinolone|mesh-list
739463|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
739464|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
739465|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
739466|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
739467|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
739468|NCT02835521|Hormones|hormones|mesh-ancestor
739469|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
739470|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739471|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
739472|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
739473|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739474|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739532|NCT02835131|Pasireotide|pasireotide|mesh-list
739533|NCT02835131|Hormones|hormones|mesh-ancestor
739534|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
739535|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234768|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
2234769|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234770|NCT00081614|Bevacizumab|bevacizumab|mesh-list
2234771|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2234772|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2234773|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234774|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2234775|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2234776|NCT00081614|Growth Substances|growth substances|mesh-ancestor
2234777|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234778|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
2234779|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2234780|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234781|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234782|NCT00081744|Tigecycline|tigecycline|mesh-list
2234783|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2234784|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234785|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2234786|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234787|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234788|NCT00081757|Thalidomide|thalidomide|mesh-list
2234789|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2234790|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
2234791|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234792|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
2234793|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2234794|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234795|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
739927|NCT02833116|Dexamethasone|dexamethasone|mesh-list
739928|NCT02833116|Betamethasone|betamethasone|mesh-list
739929|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
739930|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
739931|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
739932|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739933|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739934|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
739935|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
739936|NCT02833116|Hormones|hormones|mesh-ancestor
739937|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
739938|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
739939|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739940|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
739941|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
740057|NCT02832700|Caseins|caseins|mesh-list
740058|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
740059|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
740060|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234796|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
739204|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739205|NCT02836743|Protective Agents|protective agents|mesh-ancestor
739206|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739207|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
739912|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
739913|NCT02833038|Analgesics|analgesics|mesh-ancestor
739914|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
739915|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739916|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739917|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
739918|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
739919|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
739920|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
739921|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
739922|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
739923|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739924|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
739925|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
739926|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
740014|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
740015|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
740016|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
740017|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
740018|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
740019|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
740020|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740021|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
740022|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740023|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740024|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
740025|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
740026|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
740027|NCT02832713|Protective Agents|protective agents|mesh-ancestor
740028|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
740029|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2234797|NCT00081757|Growth Substances|growth substances|mesh-ancestor
2234798|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
2234799|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234800|NCT00081796|Capecitabine|capecitabine|mesh-list
2234801|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2234802|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
2234803|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234804|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234805|NCT00081822|Cytarabine|cytarabine|mesh-list
2234806|NCT00081822|Clofarabine|clofarabine|mesh-list
2234807|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2234808|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
2234809|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234810|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234811|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
2234812|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234813|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
740682|NCT02829372|Antibodies|antibodies|mesh-list
740683|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
740684|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
740685|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
740686|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741076|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
741077|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
741078|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741705|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
741706|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
742349|NCT02820922|Anesthetics|anesthetics|mesh-list
742350|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742351|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743298|NCT02817243|Simvastatin|simvastatin|mesh-list
743299|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
743300|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
743301|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
743302|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743303|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
743304|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
743305|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743415|NCT02816164|Lenograstim|lenograstim|mesh-list
739265|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
739266|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
739267|NCT02836899|Protective Agents|protective agents|mesh-ancestor
740148|NCT02832401|Caffeine|caffeine|mesh-list
740149|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
740150|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740151|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
740152|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740153|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740154|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
740155|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
740156|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
740157|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740314|NCT02831751|Vaccines|vaccines|mesh-list
740315|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
740316|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740418|NCT02831179|Capecitabine|capecitabine|mesh-list
740419|NCT02831179|Temozolomide|temozolomide|mesh-list
740420|NCT02831179|Veliparib|veliparib|mesh-list
740421|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
740422|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
740423|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740424|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740425|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
740426|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
740427|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
740428|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740829|NCT02828384|Psyllium|psyllium|mesh-list
740830|NCT02828384|Cathartics|cathartics|mesh-ancestor
740831|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
740862|NCT02828059|Ropivacaine|ropivacaine|mesh-list
740863|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
740864|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
740865|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
740866|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740867|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
740868|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741189|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
741190|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
741191|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741192|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741193|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
741194|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
741861|NCT02823106|Verapamil|verapamil|mesh-list
741862|NCT02823106|Choline|choline|mesh-list
741863|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
741864|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
741865|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
741866|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
741867|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741868|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
741869|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
741870|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
741871|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
741872|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
741873|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
741874|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
741875|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741876|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
2234814|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
2234815|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234816|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
2234817|NCT00081835|Antibodies|antibodies|mesh-list
2234818|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
2234819|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2234820|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2234821|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
2234822|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234823|NCT00081848|Metronidazole|metronidazole|mesh-list
2234824|NCT00081848|Celecoxib|celecoxib|mesh-list
2234825|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2234826|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2234827|NCT00081848|Analgesics|analgesics|mesh-ancestor
2234828|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
742862|NCT02818582|Remdesivir|remdesivir|mesh-list
2234829|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739309|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
739310|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739311|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739312|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
739313|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
739314|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
739315|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
739316|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
739317|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
739318|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
739319|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
739320|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739370|NCT02835794|Azacitidine|azacitidine|mesh-list
739371|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
739372|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
739373|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
739374|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739375|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739376|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739377|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
739378|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
739387|NCT02835742|Sargramostim|sargramostim|mesh-list
739388|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
739389|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739606|NCT02834507|Levodopa|levodopa|mesh-list
739607|NCT02834507|Carbidopa|carbidopa|mesh-list
739608|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
739609|NCT02834507|Entacapone|entacapone|mesh-list
739610|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
739611|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
739612|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
739613|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
739614|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739615|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739616|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
739617|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739618|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
739619|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
739620|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
739621|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
739832|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
739833|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
739834|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
739835|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739836|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
739837|NCT02833688|Analgesics|analgesics|mesh-ancestor
739838|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
739839|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739840|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
739841|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
739842|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
739843|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
739844|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
739845|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740356|NCT02831205|Cobalt|cobalt|mesh-list
740357|NCT02831205|Chromium|chromium|mesh-list
740358|NCT02831205|Everolimus|everolimus|mesh-list
740359|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740360|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
740361|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
740362|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740363|NCT02831205|Trace Elements|trace elements|mesh-ancestor
740364|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
740495|NCT02830724|Aldesleukin|aldesleukin|mesh-list
740496|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
740497|NCT02830724|Fludarabine|fludarabine|mesh-list
740498|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
740499|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
740500|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740501|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
740502|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
740503|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
740504|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740505|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739330|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
739331|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
739332|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739333|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
739334|NCT02836431|Analgesics|analgesics|mesh-ancestor
739335|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
739336|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739337|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
739338|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
739339|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
739340|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
739341|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
739342|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739459|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
739460|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739461|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739536|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
739537|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
739538|NCT02835170|Antibodies|antibodies|mesh-list
739539|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
739540|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740061|NCT02832531|Aspirin|aspirin|mesh-list
740062|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
740063|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
740064|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
740065|NCT02832531|Analgesics|analgesics|mesh-ancestor
740066|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
740067|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740068|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740069|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
740070|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
740071|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
740072|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
740073|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740074|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
740075|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
740076|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740077|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
740078|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
740079|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
740080|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
740081|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
740082|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
740195|NCT02831972|Itraconazole|itraconazole|mesh-list
740196|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
740197|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
740198|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
740199|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
740200|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740201|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740202|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
740203|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
740204|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
740205|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740206|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
740748|NCT02829177|Allopurinol|allopurinol|mesh-list
740749|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
740750|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740751|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740752|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
740753|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
740754|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
740755|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
740756|NCT02829177|Protective Agents|protective agents|mesh-ancestor
740757|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740832|NCT02828566|Ketamine|ketamine|mesh-list
740833|NCT02828566|Analgesics|analgesics|mesh-ancestor
740834|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
740835|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740836|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740837|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
740838|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
740839|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
740840|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
739437|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
739438|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
739439|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739440|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739441|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
739442|NCT02836002|Renal Agents|renal agents|mesh-ancestor
739443|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
739522|NCT02835079|Tamoxifen|tamoxifen|mesh-list
739523|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
739524|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
739525|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
739526|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739527|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
739528|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739529|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
739530|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
739531|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
739800|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
739801|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
739802|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
739803|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
739804|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
739805|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739806|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739807|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234830|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234831|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2234832|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2234833|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2234834|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2234835|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234836|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234837|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234838|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2234839|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
741124|NCT02826759|Insulin|insulin|mesh-list
741125|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
741126|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741359|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
741360|NCT02825797|Antibodies|antibodies|mesh-list
741361|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
741362|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
741363|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
741364|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741365|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741438|NCT02825121|Iodine|iodine|mesh-list
741439|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
741440|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
741441|NCT02825121|Trace Elements|trace elements|mesh-ancestor
741443|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
741444|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092536|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
2092537|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092538|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
2092539|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2092540|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
2092541|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
2092542|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092543|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092544|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
2092545|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092546|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741885|NCT02823366|Fenofibrate|fenofibrate|mesh-list
741886|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
741887|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
741888|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741889|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
741990|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
741991|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
741992|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234840|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2234841|NCT00081874|Everolimus|everolimus|mesh-list
2234842|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234843|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
739583|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739639|NCT02834286|Dexamethasone|dexamethasone|mesh-list
739640|NCT02834286|Rituximab|rituximab|mesh-list
739641|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
739642|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
739643|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
739644|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739645|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739646|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
739647|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
739648|NCT02834286|Hormones|hormones|mesh-ancestor
739649|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
739650|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
739651|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739652|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
739653|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
739654|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
739744|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
739745|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
739746|NCT02833805|Fludarabine|fludarabine|mesh-list
739747|NCT02833805|Tacrolimus|tacrolimus|mesh-list
739748|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
739749|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
739750|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
739751|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
739752|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739753|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
739754|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
739755|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
739756|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739757|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739758|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
739759|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
739760|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739761|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
739762|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
739763|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
739764|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
739765|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
740136|NCT02832635|Temozolomide|temozolomide|mesh-list
740137|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
740138|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
740139|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740140|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740568|NCT02830048|Glyburide|glyburide|mesh-list
740569|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
740570|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092547|NCT02248961|Losartan|losartan|mesh-list
2092548|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2092549|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2092550|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2092551|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
741037|NCT02827942|Amoxicillin|amoxicillin|mesh-list
741038|NCT02827942|Metronidazole|metronidazole|mesh-list
741039|NCT02827942|Clarithromycin|clarithromycin|mesh-list
741040|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
741041|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
741042|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
741043|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
741044|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
741045|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741046|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741047|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
741048|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2234844|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
2234845|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742072|NCT02822157|Gemcitabine|gemcitabine|mesh-list
742073|NCT02822157|Paclitaxel|paclitaxel|mesh-list
742074|NCT02822157|Carboplatin|carboplatin|mesh-list
742075|NCT02822157|Doxorubicin|doxorubicin|mesh-list
742076|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
742077|NCT02822157|Topotecan|topotecan|mesh-list
742078|NCT02822157|Olaparib|olaparib|mesh-list
742079|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
742080|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742081|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
742082|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
739593|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
739594|NCT02834559|Tinzaparin|tinzaparin|mesh-list
739595|NCT02834559|Dalteparin|dalteparin|mesh-list
739596|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
739597|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
739598|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
739599|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
739600|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
739601|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
739602|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739603|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
739604|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
739605|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
741180|NCT02826070|Adefovir|adefovir|mesh-list
741181|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
741182|NCT02826070|Telbivudine|telbivudine|mesh-list
741183|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
741184|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
741185|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
741186|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
741187|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741188|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741970|NCT02822482|Cetuximab|cetuximab|mesh-list
741971|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
741972|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742460|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
742461|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
742462|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
742463|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
742464|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
742465|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742466|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742467|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234846|NCT00081887|Clofarabine|clofarabine|mesh-list
2234847|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
743311|NCT02817256|Vitamins|vitamins|mesh-list
743312|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
743313|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743440|NCT02815657|Valsartan|valsartan|mesh-list
743441|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
743442|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
743443|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
743444|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743656|NCT02814500|Amlodipine|amlodipine|mesh-list
743657|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
743658|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
743659|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
743660|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
743661|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743662|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
743663|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743664|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
743665|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
743666|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
743667|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
743668|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
743669|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
743670|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234848|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
2234849|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234850|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234851|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
2234852|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2234853|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234854|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
2234855|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744030|NCT02812602|Lidocaine|lidocaine|mesh-list
2234856|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
739737|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740125|NCT02832336|Caffeine|caffeine|mesh-list
740126|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
740127|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740128|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
740129|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740130|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
740131|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740132|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
740133|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
740134|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
740135|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740171|NCT02832089|Carvedilol|carvedilol|mesh-list
740172|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
740173|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
740174|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
740175|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740176|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740177|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740178|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
740179|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
740180|NCT02832089|Protective Agents|protective agents|mesh-ancestor
740181|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
740182|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
740183|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
740184|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
740185|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
740186|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2092552|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092553|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2092554|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2092555|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2092556|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2092557|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2092558|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
2092559|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092560|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092561|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092562|NCT02249091|Cytarabine|cytarabine|mesh-list
2092563|NCT02249091|Idarubicin|idarubicin|mesh-list
2092564|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
740687|NCT02829359|Entecavir|entecavir|mesh-list
740688|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
740689|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
741061|NCT02826902|Remifentanil|remifentanil|mesh-list
741062|NCT02826902|Propofol|propofol|mesh-list
741063|NCT02826902|Desflurane|desflurane|mesh-list
741064|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
741065|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741066|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741067|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
741068|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
741069|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
741070|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
741071|NCT02826902|Narcotics|narcotics|mesh-ancestor
741072|NCT02826902|Analgesics|analgesics|mesh-ancestor
741073|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
741074|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741075|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
741133|NCT02826486|Leucovorin|leucovorin|mesh-list
741134|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
741135|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
741136|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741137|NCT02826486|Antidotes|antidotes|mesh-ancestor
741138|NCT02826486|Protective Agents|protective agents|mesh-ancestor
741139|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741140|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
741141|NCT02826486|Vitamins|vitamins|mesh-ancestor
741142|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
742007|NCT02821897|Anesthetics|anesthetics|mesh-list
742008|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742009|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742298|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
742299|NCT02821026|Sirolimus|sirolimus|mesh-list
742300|NCT02821026|Etanercept|etanercept|mesh-list
742301|NCT02821026|Tacrolimus|tacrolimus|mesh-list
742302|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
2092565|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
2092566|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092567|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092568|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
741752|NCT02823665|Atropine|atropine|mesh-list
741753|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
741754|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
741755|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
741756|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
741757|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741758|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741759|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
741760|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
741761|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
741762|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
741763|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
741764|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
741765|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
741766|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741767|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742005|NCT02821923|Erythritol|erythritol|mesh-list
742006|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
742143|NCT02821689|Pirfenidone|pirfenidone|mesh-list
742144|NCT02821689|Analgesics|analgesics|mesh-ancestor
742145|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
742146|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742147|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742148|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
742149|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
742150|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
742151|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
742152|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742266|NCT02821377|Furosemide|furosemide|mesh-list
742267|NCT02821377|Diuretics|diuretics|mesh-ancestor
742268|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
742269|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742270|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
742271|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
742272|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234857|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234858|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234859|NCT00081978|Etravirine|etravirine|mesh-list
2234860|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2234861|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2234862|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092569|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092570|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2092571|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
2092572|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092573|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2234863|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234864|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
2234865|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234866|NCT00082043|Dutasteride|dutasteride|mesh-list
2234867|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2234868|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2234869|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234870|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234871|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
744875|NCT02808325|Polygeline|polygeline|mesh-list
744876|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
744877|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
745218|NCT02807194|Anesthetics|anesthetics|mesh-list
745219|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
745220|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745393|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
745394|NCT02806375|Busulfan|busulfan|mesh-list
745395|NCT02806375|Fludarabine|fludarabine|mesh-list
739821|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
739822|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
739823|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
739824|NCT02833480|Hormones|hormones|mesh-ancestor
739825|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
739826|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
739827|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
739828|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
739829|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
739830|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
739831|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740447|NCT02830906|Ondansetron|ondansetron|mesh-list
740448|NCT02830906|Ramosetron|ramosetron|mesh-list
740449|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
740450|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
740451|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740452|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740453|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
740454|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
740455|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
740456|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
740457|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
740458|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740459|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740460|NCT02830906|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
740461|NCT02830906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
740462|NCT02830906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
740463|NCT02830906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
740464|NCT02830906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
740950|NCT02827747|Vitamin A|vitamin a|mesh-list
740951|NCT02827747|Antioxidants|antioxidants|mesh-list
740952|NCT02827747|Vitamins|vitamins|mesh-ancestor
740953|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
740954|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740955|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740956|NCT02827747|Protective Agents|protective agents|mesh-ancestor
741314|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
741315|NCT02826174|Anesthetics|anesthetics|mesh-list
741316|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741317|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741336|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
741337|NCT02825576|Neostigmine|neostigmine|mesh-list
741338|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
741339|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741340|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741341|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
741342|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741343|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741344|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
741345|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
741346|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741347|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
741348|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
741349|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
741500|NCT02825056|Morphine|morphine|mesh-list
741501|NCT02825056|Bupivacaine|bupivacaine|mesh-list
741502|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
741503|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
741504|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741505|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741506|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
741507|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741508|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
741509|NCT02825056|Narcotics|narcotics|mesh-ancestor
741510|NCT02825056|Analgesics|analgesics|mesh-ancestor
741553|NCT02824627|Oxytocin|oxytocin|mesh-list
741554|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
741555|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
741556|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741964|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
741965|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741966|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742029|NCT02822144|Lidocaine|lidocaine|mesh-list
742030|NCT02822144|Remifentanil|remifentanil|mesh-list
742031|NCT02822144|Propofol|propofol|mesh-list
742032|NCT02822144|Etomidate|etomidate|mesh-list
742033|NCT02822144|Succinylcholine|succinylcholine|mesh-list
742034|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
739857|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
739858|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740003|NCT02832999|Liraglutide|liraglutide|mesh-list
740004|NCT02832999|Vildagliptin|vildagliptin|mesh-list
740005|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
740006|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740007|NCT02832999|Incretins|incretins|mesh-ancestor
740008|NCT02832999|Hormones|hormones|mesh-ancestor
740009|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
740010|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
740011|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
740012|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740013|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741430|NCT02825225|Anesthetics|anesthetics|mesh-list
741431|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741432|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234872|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2234873|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234874|NCT00082082|Thymalfasin|thymalfasin|mesh-list
2234875|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2234876|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
2234877|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234878|NCT00082095|Doxorubicin|doxorubicin|mesh-list
2234879|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
742434|NCT02820493|Vedolizumab|vedolizumab|mesh-list
742435|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
742687|NCT02819115|Vaccines|vaccines|mesh-list
742688|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
742689|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742878|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
742879|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
742880|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
742881|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
742882|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
742883|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
742884|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
742885|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
742886|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
742887|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742888|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742889|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742890|NCT02818816|Laxatives|laxatives|mesh-ancestor
742891|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2092574|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2092575|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2092576|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092577|NCT02249104|Adapalene|adapalene|mesh-list
2092578|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
2092579|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2092580|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
2092581|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
743811|NCT02813382|Bupivacaine|bupivacaine|mesh-list
743812|NCT02813382|Prilocaine|prilocaine|mesh-list
743813|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
743814|NCT02813382|Procaine|procaine|mesh-list
743815|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
743816|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
743817|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
743818|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743819|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
743820|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743874|NCT02813018|Ropivacaine|ropivacaine|mesh-list
743875|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
743876|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
743877|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
743878|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743879|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
743880|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744607|NCT02809963|Eplerenone|eplerenone|mesh-list
744608|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
744609|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
744610|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
744611|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744612|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
744613|NCT02809963|Diuretics|diuretics|mesh-ancestor
739886|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
739887|NCT02833584|Analgesics|analgesics|mesh-ancestor
739888|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
739889|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739890|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
739891|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
740097|NCT02832544|Vitamin K|vitamin k|mesh-list
740098|NCT02832544|Warfarin|warfarin|mesh-list
740099|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
740100|NCT02832544|Vitamins|vitamins|mesh-ancestor
740101|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
740102|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740103|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
740104|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
740105|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
740106|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
740107|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
740108|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740109|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740110|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
740111|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
740112|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
740113|NCT02832544|Coagulants|coagulants|mesh-ancestor
740544|NCT02830230|Azithromycin|azithromycin|mesh-list
740545|NCT02830230|Cefixime|cefixime|mesh-list
740546|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
740547|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234880|NCT00082095|Capecitabine|capecitabine|mesh-list
2234881|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2234882|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234883|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2234884|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2234885|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234886|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234887|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
741175|NCT02826252|Iloprost|iloprost|mesh-list
741176|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
741177|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
741469|NCT02825095|Lidocaine|lidocaine|mesh-list
741470|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
741471|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
741472|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741473|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741474|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
741475|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741476|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
741477|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
741478|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
741479|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
741480|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741519|NCT02824666|Fallypride|fallypride|mesh-list
741520|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
741521|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
741522|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
741523|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741524|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741525|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741890|NCT02823249|Erythritol|erythritol|mesh-list
741891|NCT02823249|Tryptophan|tryptophan|mesh-list
741892|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
741893|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
741894|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2234888|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
2234889|NCT00082186|Bosentan|bosentan|mesh-list
740869|NCT02828228|Vitamin D|vitamin d|mesh-list
740870|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
740871|NCT02828228|Vitamins|vitamins|mesh-ancestor
740872|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
740873|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740874|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
740875|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
741744|NCT02823626|Spironolactone|spironolactone|mesh-list
741745|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
741746|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
741747|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
741748|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741749|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
741750|NCT02823626|Diuretics|diuretics|mesh-ancestor
741751|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
741925|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
741926|NCT02822742|Latanoprost|latanoprost|mesh-list
741927|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
742409|NCT02820714|Laxatives|laxatives|mesh-list
742410|NCT02820714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2234890|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2234891|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2234892|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234893|NCT00082199|Aripiprazole|aripiprazole|mesh-list
2234894|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
2234895|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2234896|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2234897|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
742643|NCT02819570|Ampicillin|ampicillin|mesh-list
742644|NCT02819570|Cefuroxime|cefuroxime|mesh-list
742645|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
742646|NCT02819570|Roxithromycin|roxithromycin|mesh-list
742647|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
742648|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
742867|NCT02818751|Citalopram|citalopram|mesh-list
742868|NCT02818751|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
742869|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
742870|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
742871|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742872|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742873|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
742874|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742875|NCT02818751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
742876|NCT02818751|Antidepressive Agents|antidepressive agents|mesh-ancestor
742877|NCT02818751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
743000|NCT02818348|Darunavir|darunavir|mesh-list
743001|NCT02818348|Cobicistat|cobicistat|mesh-list
743002|NCT02818348|Etravirine|etravirine|mesh-list
743003|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
743004|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
743005|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
743006|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743007|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743008|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
743009|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
743010|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
743011|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
743012|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
743013|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
743014|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
743015|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
743123|NCT02817477|Morphine|morphine|mesh-list
743124|NCT02817477|Ketamine|ketamine|mesh-list
743125|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
743126|NCT02817477|Narcotics|narcotics|mesh-ancestor
743127|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
743128|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743129|NCT02817477|Analgesics|analgesics|mesh-ancestor
743130|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
743131|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743132|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
743133|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
743134|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
743135|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
743136|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
739980|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
739981|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
739982|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
739983|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
739984|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
739985|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
739986|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
739987|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
739988|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
739989|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
739990|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
739991|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
739992|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
739993|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
739994|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
740114|NCT02832596|Norepinephrine|norepinephrine|mesh-list
740115|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
740116|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
740117|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
740118|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740119|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740120|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740121|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
740122|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
740123|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740124|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2234898|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2234899|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234900|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
2234901|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
2234902|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2234903|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234904|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2234905|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
740387|NCT02831491|Docetaxel|docetaxel|mesh-list
740388|NCT02831491|Ramucirumab|ramucirumab|mesh-list
740389|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740390|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
740391|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
740392|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
740393|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740548|NCT02830243|Sevoflurane|sevoflurane|mesh-list
740549|NCT02830243|Desflurane|desflurane|mesh-list
740550|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
740551|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
740552|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
740553|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
740554|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
740555|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740876|NCT02828033|Rilonacept|rilonacept|mesh-list
740877|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
740941|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
740942|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
740943|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
740944|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
740945|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
740946|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740947|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
740948|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
740949|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741081|NCT02826772|Androgens|androgens|mesh-list
741082|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
741083|NCT02826772|Hormones|hormones|mesh-ancestor
741084|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
741085|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741086|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
741087|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
741159|NCT02826343|Xenon|xenon|mesh-list
741160|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
741161|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
741162|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
741163|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741164|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741165|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
740048|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
740049|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
740050|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
740051|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
740052|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
740053|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
740054|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
740055|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
740056|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
740657|NCT02829385|Apatinib|apatinib|mesh-list
740658|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740659|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
740660|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740661|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740878|NCT02827903|Metformin|metformin|mesh-list
740879|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
740880|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
740881|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740882|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
740883|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
740884|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
740885|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740886|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
740887|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
740888|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741000|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
741001|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
741002|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
741003|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
741004|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741005|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741006|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
741442|NCT02825186|Dexamethasone|dexamethasone|mesh-list
741445|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
741446|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
741447|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
741448|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741449|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741450|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
741451|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
741452|NCT02825186|Hormones|hormones|mesh-ancestor
741453|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
741454|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
741455|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741699|NCT02823808|Glimepiride|glimepiride|mesh-list
741700|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
741701|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
741702|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741703|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
741704|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
741777|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
741778|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
741779|NCT02823483|Protective Agents|protective agents|mesh-ancestor
741780|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741781|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
741835|NCT02823236|Triamcinolone|triamcinolone|mesh-list
741836|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
741837|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
741838|NCT02823236|Pirfenidone|pirfenidone|mesh-list
741839|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
741840|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
741841|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
741842|NCT02823236|Hormones|hormones|mesh-ancestor
741843|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
741844|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741845|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
741846|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
741847|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741848|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741849|NCT02823236|Analgesics|analgesics|mesh-ancestor
741850|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
741851|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741852|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
741853|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2753428|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
2753429|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2753430|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2753431|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
2753432|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753433|NCT02710331|Ethanol|ethanol|mesh-list
740279|NCT02831686|Dexamethasone|dexamethasone|mesh-list
740280|NCT02831686|Ixazomib|ixazomib|mesh-list
740281|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
740282|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
740283|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
740284|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740285|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740286|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
740288|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
740289|NCT02831686|Hormones|hormones|mesh-ancestor
740290|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
740291|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
740292|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740293|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
740294|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740295|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740690|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
740691|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
740692|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
740693|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740694|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
740695|NCT02829346|Coagulants|coagulants|mesh-ancestor
2753434|NCT02710331|Dronabinol|dronabinol|mesh-list
2753435|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2753436|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753437|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2753438|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753439|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
2753440|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2753441|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
740983|NCT02827487|Celecoxib|celecoxib|mesh-list
740984|NCT02827487|Tramadol|tramadol|mesh-list
740985|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
740986|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
740987|NCT02827487|Analgesics|analgesics|mesh-ancestor
740988|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
740989|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740990|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740991|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
740992|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
740993|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
740994|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
740995|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740996|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740997|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
740998|NCT02827487|Narcotics|narcotics|mesh-ancestor
740999|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741049|NCT02827136|Lidocaine|lidocaine|mesh-list
741050|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
741051|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
741052|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741053|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741054|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
741055|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741056|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
741057|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
741058|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
741059|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
741060|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741332|NCT02825914|Caseins|caseins|mesh-list
741333|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
741334|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
741335|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741355|NCT02825394|Ecarin|ecarin|mesh-list
741356|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
741357|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
741358|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741373|NCT02825147|Dexamethasone|dexamethasone|mesh-list
741374|NCT02825147|Methotrexate|methotrexate|mesh-list
741375|NCT02825147|Etoposide|etoposide|mesh-list
740146|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740147|NCT02832570|Urological Agents|urological agents|mesh-ancestor
2234906|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
2234907|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2234908|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2234909|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2234910|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2234911|NCT00082212|Cetuximab|cetuximab|mesh-list
2234912|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2234913|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234914|NCT00082225|Antibodies|antibodies|mesh-list
2234915|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
2234916|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234917|NCT00082251|Niacin|niacin|mesh-list
2234918|NCT00082251|Simvastatin|simvastatin|mesh-list
2234919|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2234920|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2234921|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
740889|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
740890|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
740891|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740892|NCT02827890|Incretins|incretins|mesh-ancestor
740893|NCT02827890|Hormones|hormones|mesh-ancestor
740894|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
740895|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
740896|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
740897|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740898|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741542|NCT02824770|Tramadol|tramadol|mesh-list
741543|NCT02824770|Bupivacaine|bupivacaine|mesh-list
741544|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
741545|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
741546|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741547|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741548|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
741549|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741550|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
741551|NCT02824770|Narcotics|narcotics|mesh-ancestor
741552|NCT02824770|Analgesics|analgesics|mesh-ancestor
741782|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
741783|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
741784|NCT02823496|Protective Agents|protective agents|mesh-ancestor
741785|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741786|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
742391|NCT02820519|Loxapine|loxapine|mesh-list
742392|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
742393|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
742394|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742395|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742396|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
742397|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
742398|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
742399|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742400|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742481|NCT02820025|Doxapram|doxapram|mesh-list
742482|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
742483|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742484|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
742754|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
742755|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
742756|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742757|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742758|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
742759|NCT02819089|Analgesics|analgesics|mesh-ancestor
742760|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
742761|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742762|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
742763|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
742764|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
742765|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
742766|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742767|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743435|NCT02815865|Oxytocin|oxytocin|mesh-list
743436|NCT02815865|Dinoprostone|dinoprostone|mesh-list
743437|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
2753442|NCT02710331|Analgesics|analgesics|mesh-ancestor
2234922|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234923|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2234924|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2234925|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234926|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
2234927|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
2234928|NCT00082251|Vitamins|vitamins|mesh-ancestor
740287|NCT02831543|Mosapride|mosapride|mesh-list
740296|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740297|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
740298|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
740299|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
740300|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740301|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740469|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
740470|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
740471|NCT02830789|Calcium|calcium|mesh-list
740472|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
740473|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740474|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
740475|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740476|NCT02830789|Antacids|antacids|mesh-ancestor
740477|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
740574|NCT02829879|Listerine|listerine|mesh-list
740575|NCT02829879|Fluorides|fluorides|mesh-list
740576|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
740577|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
740578|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
740579|NCT02829879|Protective Agents|protective agents|mesh-ancestor
740580|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740581|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
740582|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
740696|NCT02829333|Anesthetics|anesthetics|mesh-list
740697|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
740698|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234929|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
2234930|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234931|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
2234932|NCT00082277|Anastrozole|anastrozole|mesh-list
741079|NCT02826616|Trimetazidine|trimetazidine|mesh-list
741080|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
741127|NCT02826408|Rabeprazole|rabeprazole|mesh-list
741128|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
741129|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
741130|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
741131|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741132|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741178|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
741179|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
741414|NCT02825342|Citalopram|citalopram|mesh-list
741415|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
741416|NCT02825342|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
741417|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
741418|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
741419|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741420|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741421|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
741422|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741423|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
741424|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
741425|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
741426|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741628|NCT02824094|Crizotinib|crizotinib|mesh-list
741629|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741630|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
741631|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741632|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234933|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2234934|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234935|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2234936|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
742098|NCT02821858|Odalasvir|odalasvir|mesh-list
742099|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
742100|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
742532|NCT02819869|Metformin|metformin|mesh-list
2234937|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234938|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234939|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2234940|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
2234941|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2234942|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234943|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2234944|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2234945|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2234946|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2234947|NCT00082316|Capsaicin|capsaicin|mesh-list
2234948|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
2234949|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
2234950|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
740556|NCT02829931|Bevacizumab|bevacizumab|mesh-list
740557|NCT02829931|Nivolumab|nivolumab|mesh-list
740558|NCT02829931|Ipilimumab|ipilimumab|mesh-list
740559|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
740560|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740561|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
740562|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
740563|NCT02829931|Growth Substances|growth substances|mesh-ancestor
740564|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740565|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
740566|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
740567|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740789|NCT02829008|Bevacizumab|bevacizumab|mesh-list
740790|NCT02829008|Pemetrexed|pemetrexed|mesh-list
740791|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
740792|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740793|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
740794|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
740795|NCT02829008|Growth Substances|growth substances|mesh-ancestor
740796|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740797|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
740798|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740799|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740800|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
740801|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
740912|NCT02827877|Copper|copper|mesh-list
740913|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
740914|NCT02827877|Trastuzumab|trastuzumab|mesh-list
740915|NCT02827877|Pertuzumab|pertuzumab|mesh-list
740916|NCT02827877|Antibodies|antibodies|mesh-list
740917|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
740918|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
740919|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
740920|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740921|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740922|NCT02827877|Trace Elements|trace elements|mesh-ancestor
740923|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
742168|NCT02821533|Cisplatin|cisplatin|mesh-list
742169|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
2092582|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2092583|NCT02249104|Analgesics|analgesics|mesh-ancestor
2092584|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
2092585|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092586|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092587|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2092588|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2092589|NCT02249182|Ribavirin|ribavirin|mesh-list
2092590|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
2092591|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2092592|NCT02249182|Ledipasvir|ledipasvir|mesh-list
2092593|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
2092594|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092595|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
2092596|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092597|NCT02249585|Iodine|iodine|mesh-list
2092598|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2092599|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092600|NCT02249585|Trace Elements|trace elements|mesh-ancestor
2092601|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
2092602|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092603|NCT02249767|Tretinoin|tretinoin|mesh-list
2092604|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092605|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
2092606|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
2092607|NCT02249949|Efatutazone|efatutazone|mesh-list
2092608|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740588|NCT02829814|Cyclobenzaprine|cyclobenzaprine|mesh-list
740589|NCT02829814|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
740590|NCT02829814|Antidepressive Agents|antidepressive agents|mesh-ancestor
740591|NCT02829814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
740592|NCT02829814|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
740593|NCT02829814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740594|NCT02829814|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
740595|NCT02829814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740596|NCT02829814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
740597|NCT02829814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
740662|NCT02829424|Methotrexate|methotrexate|mesh-list
740663|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
740664|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
740665|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
740666|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740667|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
740668|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
740669|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740670|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740671|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
740672|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740673|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
740674|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
740675|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
740676|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
740677|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
740846|NCT02828163|Triamcinolone|triamcinolone|mesh-list
740847|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
740848|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
740849|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
740850|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
740851|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
740852|NCT02828163|Hormones|hormones|mesh-ancestor
740853|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
740854|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740855|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
740856|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
740857|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740858|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741588|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
741589|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
741590|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741591|NCT02824874|Incretins|incretins|mesh-ancestor
741592|NCT02824874|Hormones|hormones|mesh-ancestor
741593|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
741594|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
741595|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
741596|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741597|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234951|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2234952|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234953|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2234954|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2234955|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2234956|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2234957|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
2234958|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234959|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234960|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
741787|NCT02823691|Metformin|metformin|mesh-list
741788|NCT02823691|Lanreotide|lanreotide|mesh-list
741789|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
741790|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740376|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
740377|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740378|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
740379|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
740380|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740381|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
740382|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
740383|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
740384|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
740385|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
740386|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740406|NCT02831088|Salicylates|salicylates|mesh-list
740407|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
740408|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
740409|NCT02831088|Analgesics|analgesics|mesh-ancestor
740410|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
740411|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740412|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740413|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
740414|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
740415|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
740416|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740417|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753443|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
740709|NCT02829697|Ropivacaine|ropivacaine|mesh-list
740710|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
740711|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
740712|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
740713|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740714|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
740715|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741320|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
741321|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
741322|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
741323|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
741324|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741325|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
741326|NCT02825719|Coagulants|coagulants|mesh-ancestor
741327|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
741328|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
741329|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
741330|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741331|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
741612|NCT02824575|Paclitaxel|paclitaxel|mesh-list
741613|NCT02824575|Rebastinib|rebastinib|mesh-list
741614|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
741615|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741616|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
741617|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
741618|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
741619|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741620|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
741621|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741768|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
741769|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
741770|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
741771|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
741772|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234961|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2234962|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
2234963|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234964|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2234965|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2234966|NCT00082446|Vaccines|vaccines|mesh-list
2234967|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
2234968|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742188|NCT02821676|Anesthetics|anesthetics|mesh-list
742189|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742190|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742291|NCT02821169|Ropivacaine|ropivacaine|mesh-list
742292|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
742293|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
742294|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742303|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
740434|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740435|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
740436|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
740437|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
740438|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740439|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740440|NCT02831231|Urological Agents|urological agents|mesh-ancestor
740441|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
740442|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
740443|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
740444|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2234969|NCT00082472|Docetaxel|docetaxel|mesh-list
2234970|NCT00082472|Doxorubicin|doxorubicin|mesh-list
2234971|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2234972|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2234973|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
2234974|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
741598|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
741599|NCT02824536|Antibodies|antibodies|mesh-list
741600|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
741601|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
741602|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
741603|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741604|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741792|NCT02824042|Itraconazole|itraconazole|mesh-list
741793|NCT02824042|Maytansine|maytansine|mesh-list
741794|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
741795|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
741796|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
741797|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
741798|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741799|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741800|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
741801|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
741802|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
741803|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741804|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
741805|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
741806|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741807|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
741808|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
741809|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
2234975|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
2234976|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743336|NCT02816905|Fluorometholone|fluorometholone|mesh-list
743337|NCT02816905|Dexamethasone|dexamethasone|mesh-list
743338|NCT02816905|Rimexolone|rimexolone|mesh-list
743339|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
743340|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
743341|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
743342|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743343|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743344|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
743345|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
743346|NCT02816905|Hormones|hormones|mesh-ancestor
743347|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
743348|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
743349|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743350|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
743383|NCT02816567|Sufentanil|sufentanil|mesh-list
743384|NCT02816567|Propofol|propofol|mesh-list
743385|NCT02816567|Cisatracurium|cisatracurium|mesh-list
743386|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
743387|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
743388|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743389|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
743390|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
743391|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
743392|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
743393|NCT02816567|Narcotics|narcotics|mesh-ancestor
743394|NCT02816567|Analgesics|analgesics|mesh-ancestor
743395|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
743396|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743397|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
743398|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
743399|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
740494|NCT02831023|Renal Agents|renal agents|mesh-ancestor
740646|NCT02829840|Azacitidine|azacitidine|mesh-list
740647|NCT02829840|Ponatinib|ponatinib|mesh-list
740648|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
740649|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
740650|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740651|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740652|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740653|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
741088|NCT02826837|Bevacizumab|bevacizumab|mesh-list
741089|NCT02826837|Cetuximab|cetuximab|mesh-list
741090|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
741091|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741092|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
741093|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
741094|NCT02826837|Growth Substances|growth substances|mesh-ancestor
741095|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741096|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
742067|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
742068|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
742069|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
742070|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
742071|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742170|NCT02821520|Verteporfin|verteporfin|mesh-list
742171|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
742172|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
742388|NCT02820883|Vaccines|vaccines|mesh-list
742389|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
742390|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234977|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2234978|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2234979|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2234980|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2234981|NCT00082485|Baclofen|baclofen|mesh-list
2234982|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2234983|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234984|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2234985|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2234986|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2234987|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
2234988|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
2234989|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2234990|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2234991|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2234992|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2234993|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
2234994|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234995|NCT00082524|Caspofungin|caspofungin|mesh-list
2234996|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
2234997|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2234998|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743550|NCT02815332|Minocycline|minocycline|mesh-list
743551|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
743552|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
744323|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
744324|NCT02811263|Hematinics|hematinics|mesh-ancestor
744698|NCT02809404|Everolimus|everolimus|mesh-list
744699|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744700|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
744701|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
744702|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2234999|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235000|NCT00082537|Caspofungin|caspofungin|mesh-list
2235001|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
745487|NCT02805842|Tacrolimus|tacrolimus|mesh-list
745488|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
745489|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
745490|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745491|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
745492|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745493|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745649|NCT02804711|Vaccines|vaccines|mesh-list
745650|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
745651|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745841|NCT02803216|Amoxicillin|amoxicillin|mesh-list
745842|NCT02803216|Clarithromycin|clarithromycin|mesh-list
745843|NCT02803216|Omeprazole|omeprazole|mesh-list
2235002|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
740506|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
740507|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
740508|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
740509|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
740510|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
740536|NCT02830347|Amoxicillin|amoxicillin|mesh-list
740537|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
740538|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
740716|NCT02829151|Aspirin|aspirin|mesh-list
740717|NCT02829151|Cilostazol|cilostazol|mesh-list
740718|NCT02829151|Clopidogrel|clopidogrel|mesh-list
740719|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
740720|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
740721|NCT02829151|Analgesics|analgesics|mesh-ancestor
740722|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
740723|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740724|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740725|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
740726|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
740727|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
740728|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
740729|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740730|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
740731|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
740732|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740733|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
740734|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
740735|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
740736|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
740737|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
740738|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740739|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
740740|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
740741|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
740742|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
740743|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
740744|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
740745|NCT02829151|Protective Agents|protective agents|mesh-ancestor
740746|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
740747|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2235003|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235004|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235005|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235006|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2235007|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
741648|NCT02824354|Nalmefene|nalmefene|mesh-list
741649|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
741650|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741651|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
741652|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743201|NCT02817360|Losartan|losartan|mesh-list
743202|NCT02817360|Valsartan|valsartan|mesh-list
743203|NCT02817360|Carvedilol|carvedilol|mesh-list
743204|NCT02817360|Candesartan|candesartan|mesh-list
743205|NCT02817360|Ramipril|ramipril|mesh-list
743206|NCT02817360|Enalapril|enalapril|mesh-list
743207|NCT02817360|Lisinopril|lisinopril|mesh-list
743208|NCT02817360|Irbesartan|irbesartan|mesh-list
743209|NCT02817360|Nebivolol|nebivolol|mesh-list
743210|NCT02817360|Bisoprolol|bisoprolol|mesh-list
743211|NCT02817360|Perindopril|perindopril|mesh-list
743212|NCT02817360|Captopril|captopril|mesh-list
743213|NCT02817360|Quinapril|quinapril|mesh-list
743214|NCT02817360|Trandolapril|trandolapril|mesh-list
743215|NCT02817360|Fosinopril|fosinopril|mesh-list
743216|NCT02817360|Eprosartan|eprosartan|mesh-list
743217|NCT02817360|Zofenopril|zofenopril|mesh-list
743218|NCT02817360|Spirapril|spirapril|mesh-list
743219|NCT02817360|Cilazapril|cilazapril|mesh-list
740530|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
740531|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740532|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740533|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
740534|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
740535|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092621|NCT02250612|Timolol|timolol|mesh-list
2092622|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
740817|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
740818|NCT02828592|Fludarabine|fludarabine|mesh-list
740819|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
740820|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
740821|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
740822|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740823|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
740824|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
740825|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
740826|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740827|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
740828|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
740859|NCT02828176|Anesthetics|anesthetics|mesh-list
740860|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
740861|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741097|NCT02826876|Ropivacaine|ropivacaine|mesh-list
741098|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
741099|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
741100|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741101|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741102|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
741103|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092623|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2092624|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
2092625|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092626|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092627|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741456|NCT02825199|Caffeine|caffeine|mesh-list
741457|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
741458|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741459|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
741460|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741461|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741462|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
741463|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
741464|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
741465|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741605|NCT02824510|Insulin|insulin|mesh-list
741606|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
741607|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
741608|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
741609|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741877|NCT02823145|Fenfluramine|fenfluramine|mesh-list
741878|NCT02823145|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
741879|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
741880|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
741881|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741882|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741883|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
741884|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742054|NCT02822196|Lidocaine|lidocaine|mesh-list
742055|NCT02822196|Bupivacaine|bupivacaine|mesh-list
742056|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
742057|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
742058|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742059|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742060|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
742061|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742062|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
742063|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
742064|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
742065|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
742066|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742447|NCT02820688|Bupivacaine|bupivacaine|mesh-list
740601|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
740602|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
740603|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
740604|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740605|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740606|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
2092628|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2092629|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2092630|NCT02250651|Timolol|timolol|mesh-list
2092631|NCT02250651|Bimatoprost|bimatoprost|mesh-list
2092632|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2092633|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2092634|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
2092635|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092636|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235008|NCT00082563|Azithromycin|azithromycin|mesh-list
740924|NCT02827643|Vitamin D|vitamin d|mesh-list
740925|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
740926|NCT02827643|Lamivudine|lamivudine|mesh-list
740927|NCT02827643|Calcium|calcium|mesh-list
740928|NCT02827643|Vitamins|vitamins|mesh-ancestor
740929|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
740930|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740931|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
740932|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
740933|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
740934|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
740935|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740936|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740937|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
740938|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
740939|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
740940|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
740973|NCT02827435|Bromides|bromides|mesh-list
740974|NCT02827435|Rocuronium|rocuronium|mesh-list
740975|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
740976|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
740977|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
740978|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
740979|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
740980|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235009|NCT00082563|Chloroquine|chloroquine|mesh-list
2235010|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2235011|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235012|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235013|NCT00082563|Amebicides|amebicides|mesh-ancestor
2235014|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2235015|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
741557|NCT02824718|Teriparatide|teriparatide|mesh-list
741558|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
741559|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
741560|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
741561|NCT02824718|Diuretics|diuretics|mesh-list
741562|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
741563|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
741564|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741565|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
741566|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
741567|NCT02824718|Vitamins|vitamins|mesh-ancestor
741568|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
741569|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
741570|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741707|NCT02823912|Capsaicin|capsaicin|mesh-list
741708|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
741709|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
741710|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
741711|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
741712|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741713|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741714|NCT02823912|Antacids|antacids|mesh-ancestor
741715|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741716|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
741816|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
741817|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
741818|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235016|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
2235017|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
740628|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753444|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2753445|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2753446|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2753447|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2753448|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753449|NCT02710331|Hormones|hormones|mesh-ancestor
2753450|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2753451|NCT02705300|Leucovorin|leucovorin|mesh-list
2753452|NCT02705300|Tocotrienols|tocotrienols|mesh-list
2753453|NCT02705300|Vitamin E|vitamin e|mesh-list
2753454|NCT02705300|Tocopherols|tocopherols|mesh-list
2753455|NCT02705300|Fluorouracil|fluorouracil|mesh-list
2753456|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
2753457|NCT02705300|Irinotecan|irinotecan|mesh-list
2753458|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
2753459|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741104|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
741105|NCT02826746|Analgesics|analgesics|mesh-ancestor
741106|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
741107|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741108|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741109|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
741110|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741111|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
741112|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
741113|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
741114|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
741115|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741116|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
741117|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
741118|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
741195|NCT02825940|Gemcitabine|gemcitabine|mesh-list
741196|NCT02825940|Atezolizumab|atezolizumab|mesh-list
741197|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741198|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
741199|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
741200|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741201|NCT02825940|Antiviral Agents|antiviral agents|mesh-ancestor
741202|NCT02825940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
741203|NCT02825940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741204|NCT02825940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
741205|NCT02825940|Immunologic Factors|immunologic factors|mesh-ancestor
741206|NCT02825940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741672|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
741673|NCT02823977|Ketamine|ketamine|mesh-list
741674|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
741675|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741676|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741677|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
741678|NCT02823977|Analgesics|analgesics|mesh-ancestor
741679|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
741680|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741681|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
741682|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
741683|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
741684|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
741685|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741686|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741687|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
741688|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
741689|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
741690|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
741691|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
741692|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
741810|NCT02823574|Nivolumab|nivolumab|mesh-list
741811|NCT02823574|Ipilimumab|ipilimumab|mesh-list
741812|NCT02823574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
741813|NCT02823574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741814|NCT02823574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
741815|NCT02823574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741983|NCT02822378|Vitamin D|vitamin d|mesh-list
741984|NCT02822378|Calcium|calcium|mesh-list
741985|NCT02822378|Vitamins|vitamins|mesh-ancestor
741986|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
740768|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
740769|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
740770|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
740771|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
740772|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
740773|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
740774|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740775|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740776|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
740777|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
740778|NCT02829281|Hormones|hormones|mesh-ancestor
740779|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
740780|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
740781|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
740782|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
740783|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
740784|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092637|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092638|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2092639|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2092640|NCT02250703|Midazolam|midazolam|mesh-list
2092641|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
741404|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
741405|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
741406|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
741407|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
741408|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
741409|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
741410|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741411|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
741412|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
741413|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753460|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
2753461|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753462|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2753463|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753464|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2753465|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
2753466|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2753467|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2753468|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753469|NCT02705300|Antidotes|antidotes|mesh-ancestor
2753470|NCT02705300|Protective Agents|protective agents|mesh-ancestor
2753471|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
2753472|NCT02705300|Vitamins|vitamins|mesh-ancestor
2753473|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
2753474|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
2235018|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2235019|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2235020|NCT00082563|Analgesics|analgesics|mesh-ancestor
2235021|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
2235022|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235023|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235024|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2235025|NCT00082563|Filaricides|filaricides|mesh-ancestor
2235026|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
2235027|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
2235028|NCT00082576|Azithromycin|azithromycin|mesh-list
2235029|NCT00082576|Chloroquine|chloroquine|mesh-list
741967|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
741968|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
741969|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235030|NCT00082576|Mefloquine|mefloquine|mesh-list
2235031|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235032|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235033|NCT00082576|Amebicides|amebicides|mesh-ancestor
742471|NCT02820077|Hemostatics|hemostatics|mesh-list
742472|NCT02820077|Coagulants|coagulants|mesh-ancestor
2235034|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2235035|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2235036|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
2235037|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2235038|NCT00082589|Eplerenone|eplerenone|mesh-list
2092642|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2235039|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2235040|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
2753475|NCT02678533|Plerixafor|plerixafor|mesh-list
2753476|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
740815|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
740816|NCT02829060|Renal Agents|renal agents|mesh-ancestor
741318|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
741319|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
2235041|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2235042|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235043|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2235044|NCT00082589|Diuretics|diuretics|mesh-ancestor
2235045|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
2235046|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2235047|NCT00082602|Galantamine|galantamine|mesh-list
742332|NCT02820948|Vitamins|vitamins|mesh-list
742333|NCT02820948|Vitamin E|vitamin e|mesh-list
742334|NCT02820948|Tocopherols|tocopherols|mesh-list
742335|NCT02820948|Tocotrienols|tocotrienols|mesh-list
742336|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
742337|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
742338|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742339|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
742340|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742341|NCT02820948|Protective Agents|protective agents|mesh-ancestor
742593|NCT02819596|Durvalumab|durvalumab|mesh-list
742594|NCT02819596|Tremelimumab|tremelimumab|mesh-list
742595|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
742596|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742892|NCT02818738|Levamisole|levamisole|mesh-list
742893|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
742894|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
742895|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742896|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
742897|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
742898|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
742899|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
742900|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
743140|NCT02817503|Folic Acid|folic acid|mesh-list
743141|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
743142|NCT02817503|Amlodipine|amlodipine|mesh-list
743143|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
743144|NCT02817503|Enalapril|enalapril|mesh-list
743145|NCT02817503|Enalaprilat|enalaprilat|mesh-list
743146|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
743147|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
743148|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
743149|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743150|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
743151|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743152|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
743153|NCT02817503|Diuretics|diuretics|mesh-ancestor
743154|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
743155|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
743156|NCT02817503|Hematinics|hematinics|mesh-ancestor
743157|NCT02817503|Vitamins|vitamins|mesh-ancestor
743158|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
743159|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
743160|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
743161|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743326|NCT02817113|Fluorouracil|fluorouracil|mesh-list
743327|NCT02817113|Cetuximab|cetuximab|mesh-list
743328|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
743329|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743330|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
743331|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743332|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
743333|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
743334|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
740841|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
740842|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
740843|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
740844|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
740845|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235048|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2235049|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235050|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235051|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
2235052|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2235053|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235054|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
741526|NCT02824523|Aspirin|aspirin|mesh-list
741527|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
741528|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
741529|NCT02824523|Analgesics|analgesics|mesh-ancestor
741530|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
741531|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741532|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741533|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
741534|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
741535|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
741536|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
741537|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741538|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
741539|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
741540|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741541|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
741641|NCT02824315|Simeprevir|simeprevir|mesh-list
741642|NCT02824315|Odalasvir|odalasvir|mesh-list
741643|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
741644|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
741645|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
741646|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741647|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741773|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
741774|NCT02823925|Pamidronate|pamidronate|mesh-list
741775|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
741776|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235055|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
2235056|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2753477|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
742237|NCT02821312|DA-8010|da-8010|mesh-list
742238|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
742239|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
742240|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
742241|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742242|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742243|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753478|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
2753479|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753480|NCT02675452|Itraconazole|itraconazole|mesh-list
2753481|NCT02675452|Azacitidine|azacitidine|mesh-list
2753482|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2753483|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
2753484|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753485|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753486|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753487|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
2753488|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753489|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
743190|NCT02817321|Morphine|morphine|mesh-list
743191|NCT02817321|Ropivacaine|ropivacaine|mesh-list
743192|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
743193|NCT02817321|Narcotics|narcotics|mesh-ancestor
743194|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
743195|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743196|NCT02817321|Analgesics|analgesics|mesh-ancestor
743197|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
743198|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743199|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
743200|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
743264|NCT02816970|Vildagliptin|vildagliptin|mesh-list
743265|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
743266|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741154|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
741155|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741156|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
741157|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
741158|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741653|NCT02824276|Morphine|morphine|mesh-list
741654|NCT02824276|Oxycodone|oxycodone|mesh-list
741655|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
741656|NCT02824276|Narcotics|narcotics|mesh-ancestor
741657|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741658|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741659|NCT02824276|Analgesics|analgesics|mesh-ancestor
741660|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
741661|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741947|NCT02822937|Triazolam|triazolam|mesh-list
741948|NCT02822937|Methylphenidate|methylphenidate|mesh-list
741949|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
741950|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741951|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
741952|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
741953|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
741954|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741955|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
741956|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741957|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
741958|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
741959|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
741960|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741961|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
741962|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
741963|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
742520|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
742521|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
742522|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
742523|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
742524|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742525|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742526|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742527|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
742528|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
742820|NCT02818725|Cisplatin|cisplatin|mesh-list
742821|NCT02818725|Doxorubicin|doxorubicin|mesh-list
742822|NCT02818725|Methotrexate|methotrexate|mesh-list
742823|NCT02818725|Panitumumab|panitumumab|mesh-list
742824|NCT02818725|Vinblastine|vinblastine|mesh-list
742825|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742826|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
742827|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
742828|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
742829|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742830|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742831|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
742832|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
742833|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
742834|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742835|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
742836|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
742837|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
742838|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
742839|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
742840|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
742841|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
742842|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
742843|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
742844|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
742845|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
742846|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
742847|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
2092643|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2092644|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092645|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2092646|NCT02250703|Analgesics|analgesics|mesh-ancestor
2092647|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
2092648|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741166|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
741167|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
741168|NCT02826343|Hormones|hormones|mesh-ancestor
741169|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
741170|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
741171|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
741172|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
741173|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
741174|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
741207|NCT02825979|Sotalol|sotalol|mesh-list
741208|NCT02825979|Flecainide|flecainide|mesh-list
741209|NCT02825979|Dronedarone|dronedarone|mesh-list
741210|NCT02825979|Propafenone|propafenone|mesh-list
741211|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
741212|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
741213|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
741214|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
741215|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741216|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741217|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741218|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
741219|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
741220|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741221|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
741222|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
741223|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
741466|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
741467|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
741468|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741633|NCT02824406|Acetazolamide|acetazolamide|mesh-list
741634|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
741635|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
741636|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741637|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741638|NCT02824406|Diuretics|diuretics|mesh-ancestor
741639|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
741640|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741693|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
741694|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
741695|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741696|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
741697|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741698|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741856|NCT02823353|Fenofibrate|fenofibrate|mesh-list
741857|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
741858|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
741859|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741860|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
741975|NCT02822573|Donepezil|donepezil|mesh-list
741976|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
741977|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741978|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741979|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
741980|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741981|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741982|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
742436|NCT02820441|Zopiclone|zopiclone|mesh-list
742437|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
742438|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742439|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743591|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
743592|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
743711|NCT02814110|Lenograstim|lenograstim|mesh-list
743712|NCT02814110|Sargramostim|sargramostim|mesh-list
743713|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
743714|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
743715|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743932|NCT02812979|Albuterol|albuterol|mesh-list
743933|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
743934|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
743935|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743936|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743937|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
743938|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
743939|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
743940|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2092649|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2092650|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2092651|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2092652|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
2092653|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092654|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092655|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2092656|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2092657|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2092658|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2092659|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2092660|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
2092661|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
2092662|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
741586|NCT02824614|Erythritol|erythritol|mesh-list
741587|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
741896|NCT02823028|Nicotine|nicotine|mesh-list
741897|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
741898|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
741899|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741900|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741901|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
741902|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
741903|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
741904|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741905|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742529|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
742530|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
742531|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742617|NCT02819414|Acetaminophen|acetaminophen|mesh-list
742618|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
742619|NCT02819414|Analgesics|analgesics|mesh-ancestor
742620|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
742621|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742622|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742623|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
742901|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
742902|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
742903|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742904|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742905|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
742906|NCT02818621|Analgesics|analgesics|mesh-ancestor
742907|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
741376|NCT02825147|Pegaspargase|pegaspargase|mesh-list
741377|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
741378|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
741379|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
741380|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741381|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741382|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
741383|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
741384|NCT02825147|Hormones|hormones|mesh-ancestor
741385|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
741386|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
741387|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
741388|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
741389|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
741390|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
741391|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
741392|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
741393|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741394|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
741395|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741396|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
741397|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
741398|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
741399|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
741400|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
741401|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
741402|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
741403|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2092663|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
2092664|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
2092665|NCT02250807|Simeprevir|simeprevir|mesh-list
2092666|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
2092667|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
741516|NCT02824601|Calcium|calcium|mesh-list
741517|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
741518|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741728|NCT02823743|Aspirin|aspirin|mesh-list
741729|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
741730|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
741731|NCT02823743|Analgesics|analgesics|mesh-ancestor
741732|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
741733|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
741734|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741735|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
741736|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
741737|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
741738|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
741739|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741740|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
741741|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
741742|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
741743|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
742153|NCT02821507|Sirolimus|sirolimus|mesh-list
742154|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
742155|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
742156|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
742157|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742158|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
742159|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
742160|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
742161|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742162|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742163|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
742164|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
742165|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
742166|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
742167|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
2235057|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
2235058|NCT00082667|Gefitinib|gefitinib|mesh-list
2235059|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235060|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2235061|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235062|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092668|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
2235063|NCT00082706|Leucovorin|leucovorin|mesh-list
741497|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
741498|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741499|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
742557|NCT02819648|Prednisolone|prednisolone|mesh-list
742558|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
742559|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
742560|NCT02819648|Hormones|hormones|mesh-ancestor
742561|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
742562|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742563|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
742564|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235064|NCT00082706|Gemcitabine|gemcitabine|mesh-list
2235065|NCT00082706|Cisplatin|cisplatin|mesh-list
2235066|NCT00082706|Fluorouracil|fluorouracil|mesh-list
2235067|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235068|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2235069|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
2235070|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743353|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
743354|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
743355|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
743579|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
743580|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
743581|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
743582|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
743583|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
743584|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743585|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
743586|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743587|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743588|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
743589|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744245|NCT02811679|Blinatumomab|blinatumomab|mesh-list
744246|NCT02811679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744369|NCT02810886|Edetic Acid|edetic acid|mesh-list
744370|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
744371|NCT02810886|Anticoagulants|anticoagulants|mesh-ancestor
744372|NCT02810886|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
744373|NCT02810886|Chelating Agents|chelating agents|mesh-ancestor
744374|NCT02810886|Sequestering Agents|sequestering agents|mesh-ancestor
744375|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744376|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2235071|NCT00082706|Antiviral Agents|antiviral agents|mesh-ancestor
2235072|NCT00082706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235073|NCT00082706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235074|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
744628|NCT02809677|Aripiprazole|aripiprazole|mesh-list
744629|NCT02809677|Quetiapine Fumarate|quetiapine fumarate|mesh-list
744630|NCT02809677|Mirtazapine|mirtazapine|mesh-list
744631|NCT02809677|Buspirone|buspirone|mesh-list
744632|NCT02809677|Citalopram|citalopram|mesh-list
744633|NCT02809677|Bupropion|bupropion|mesh-list
744634|NCT02809677|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
744635|NCT02809677|Sertraline|sertraline|mesh-list
744636|NCT02809677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
744637|NCT02809677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
744638|NCT02809677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
744639|NCT02809677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744640|NCT02809677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744641|NCT02809677|Serotonin Agents|serotonin agents|mesh-ancestor
744642|NCT02809677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744643|NCT02809677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
744644|NCT02809677|Antidepressive Agents|antidepressive agents|mesh-ancestor
744645|NCT02809677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
744646|NCT02809677|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
744647|NCT02809677|Dopamine Agents|dopamine agents|mesh-ancestor
744648|NCT02809677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
744649|NCT02809677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
744650|NCT02809677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
744651|NCT02809677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
744652|NCT02809677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
744653|NCT02809677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
744654|NCT02809677|Dopamine Agonists|dopamine agonists|mesh-ancestor
744655|NCT02809677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
744656|NCT02809677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
741854|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
741855|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742173|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
742492|NCT02820051|Lidocaine|lidocaine|mesh-list
742493|NCT02820051|Midazolam|midazolam|mesh-list
742494|NCT02820051|Nalbuphine|nalbuphine|mesh-list
742495|NCT02820051|Propofol|propofol|mesh-list
742496|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
742497|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
742498|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742499|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742500|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
742501|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742502|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
742503|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
742504|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
742505|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
742506|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742507|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
742508|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
742509|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
742510|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
742511|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
742512|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
742513|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
742514|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
742515|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
742516|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742517|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
742518|NCT02820051|Narcotics|narcotics|mesh-ancestor
742519|NCT02820051|Analgesics|analgesics|mesh-ancestor
742848|NCT02818803|Propolis|propolis|mesh-list
742849|NCT02818803|Miconazole|miconazole|mesh-list
742850|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
742851|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
742852|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
742853|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
742854|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742855|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742856|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
742857|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
742858|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
742859|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742860|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
742861|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
743016|NCT02818387|Midazolam|midazolam|mesh-list
743017|NCT02818387|Remifentanil|remifentanil|mesh-list
743018|NCT02818387|Propofol|propofol|mesh-list
743019|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
743020|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
743021|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743022|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
743023|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
743024|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
743025|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
743026|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
743027|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
743028|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
743029|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
743030|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
743031|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743032|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743033|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
743034|NCT02818387|Narcotics|narcotics|mesh-ancestor
743035|NCT02818387|Analgesics|analgesics|mesh-ancestor
743036|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
743037|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743072|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
743073|NCT02817789|Clopidogrel|clopidogrel|mesh-list
743074|NCT02817789|Ticagrelor|ticagrelor|mesh-list
743075|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
743076|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
743077|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
743078|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
743079|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
743080|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741895|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
741928|NCT02822729|Timolol|timolol|mesh-list
741929|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
741930|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
741931|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
741932|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
741933|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
741934|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
741935|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
741936|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741937|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
741938|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
741973|NCT02822508|Laxatives|laxatives|mesh-list
741974|NCT02822508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2092669|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092670|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092671|NCT02251236|Tenofovir|tenofovir|mesh-list
2092672|NCT02251236|Emtricitabine|emtricitabine|mesh-list
742256|NCT02820987|Meropenem|meropenem|mesh-list
742257|NCT02820987|Tazobactam|tazobactam|mesh-list
742258|NCT02820987|Piperacillin|piperacillin|mesh-list
742259|NCT02820987|Cefepime|cefepime|mesh-list
742260|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
742261|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
742262|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
742263|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
742264|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742265|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235075|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
2235076|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753490|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2753491|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2753492|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
2753493|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2753494|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753495|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2235077|NCT00082706|Antidotes|antidotes|mesh-ancestor
2235078|NCT00082706|Protective Agents|protective agents|mesh-ancestor
2235079|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
2092673|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2092674|NCT02251236|Cobicistat|cobicistat|mesh-list
2235080|NCT00082706|Vitamins|vitamins|mesh-ancestor
743684|NCT02814630|Omalizumab|omalizumab|mesh-list
743685|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
743686|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
743687|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
743839|NCT02813486|Vaccines|vaccines|mesh-list
743840|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
743841|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744105|NCT02812199|Lidocaine|lidocaine|mesh-list
744106|NCT02812199|Epinephrine|epinephrine|mesh-list
744107|NCT02812199|Racepinephrine|racepinephrine|mesh-list
744108|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
744109|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
744110|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
2235081|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
2235082|NCT00082719|Interferons|interferons|mesh-list
2235083|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
2235084|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
2235085|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742001|NCT02822131|Sevelamer|sevelamer|mesh-list
742002|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
742003|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
742004|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092675|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2092676|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2092677|NCT02251236|Elvitegravir|elvitegravir|mesh-list
2092678|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
2092679|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092680|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2092681|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2092682|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092683|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092684|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2092685|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2092686|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2092687|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2092688|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2092689|NCT02251275|Tolvaptan|tolvaptan|mesh-list
2092690|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2092691|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092692|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
2092693|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092694|NCT02251379|Fluticasone|fluticasone|mesh-list
2092695|NCT02251379|Xhance|xhance|mesh-list
2235086|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
742690|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
742691|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
742692|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742693|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742694|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
742695|NCT02819141|Analgesics|analgesics|mesh-ancestor
742696|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
742697|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742698|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
742699|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
742700|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
742701|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
742702|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742703|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235087|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235088|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
743306|NCT02817217|Valsartan|valsartan|mesh-list
743307|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
743308|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
743309|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
743310|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743466|NCT02816203|Hemostatics|hemostatics|mesh-list
743467|NCT02816203|Coagulants|coagulants|mesh-ancestor
2235089|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235090|NCT00082784|Bortezomib|bortezomib|mesh-list
2235091|NCT00082784|Alvocidib|alvocidib|mesh-list
743900|NCT02813044|Anesthetics|anesthetics|mesh-list
743901|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
743902|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743957|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
743958|NCT02812719|Salicylates|salicylates|mesh-list
743959|NCT02812719|Glycolic acid|glycolic acid|mesh-list
743960|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
743961|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
743962|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
743963|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
743964|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
743965|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
743966|NCT02812719|Analgesics|analgesics|mesh-ancestor
743967|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
743968|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743969|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743970|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
741987|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
741988|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
741989|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2235092|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235093|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235094|NCT00082784|Growth Substances|growth substances|mesh-ancestor
742352|NCT02820935|Itraconazole|itraconazole|mesh-list
742353|NCT02820935|Rifampin|rifampin|mesh-list
742354|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
742355|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
742356|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
742357|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
742358|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742359|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742360|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
742361|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
742362|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
742363|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742364|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
742365|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
742366|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
742367|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
742368|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
742369|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
742370|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
742371|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
742372|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
742373|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
742374|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
742375|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
742455|NCT02820558|Substance P|substance p|mesh-list
742456|NCT02820558|Neurokinin A|neurokinin a|mesh-list
742457|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742458|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742459|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742649|NCT02819375|Ketamine|ketamine|mesh-list
742650|NCT02819375|Remifentanil|remifentanil|mesh-list
742651|NCT02819375|Propofol|propofol|mesh-list
742652|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
742653|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742654|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742655|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
742656|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
742657|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
742658|NCT02819375|Analgesics|analgesics|mesh-ancestor
742659|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
742660|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742661|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
742662|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
742663|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
742664|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742665|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742666|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
742667|NCT02819375|Narcotics|narcotics|mesh-ancestor
742707|NCT02818985|Dexamethasone|dexamethasone|mesh-list
742708|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
742709|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
742710|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
742711|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
742712|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742713|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742714|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
742715|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
742716|NCT02818985|Hormones|hormones|mesh-ancestor
742717|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
742718|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
742719|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742720|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
742721|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742722|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
742723|NCT02818985|Analgesics|analgesics|mesh-ancestor
742724|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
742863|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
742035|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
742036|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742037|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742038|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
742039|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742040|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
742041|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
742042|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
742043|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
742044|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742045|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
742046|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
742047|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
742048|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
742049|NCT02822144|Narcotics|narcotics|mesh-ancestor
742050|NCT02822144|Analgesics|analgesics|mesh-ancestor
742051|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
742052|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
742053|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
742191|NCT02821559|Bevacizumab|bevacizumab|mesh-list
742192|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
742193|NCT02821559|Raltitrexed|raltitrexed|mesh-list
742194|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
742195|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742196|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
742197|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
742198|NCT02821559|Growth Substances|growth substances|mesh-ancestor
742199|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742200|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
742201|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
742202|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
742203|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742204|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
742205|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235095|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235096|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2235097|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235098|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235099|NCT00082797|Leucovorin|leucovorin|mesh-list
2235100|NCT00082797|Methotrexate|methotrexate|mesh-list
2235101|NCT00082797|Calcium|calcium|mesh-list
2235102|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
2235103|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2235104|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235105|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
742816|NCT02818660|Cosyntropin|cosyntropin|mesh-list
742817|NCT02818660|Hormones|hormones|mesh-ancestor
742818|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
742819|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743773|NCT02813824|Aspirin|aspirin|mesh-list
743774|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
743775|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
743776|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
743777|NCT02813824|Analgesics|analgesics|mesh-ancestor
743778|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
743779|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743780|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743781|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
743782|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
743783|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
743784|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
743785|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743786|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
743787|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
743788|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742083|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
742084|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742085|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
742086|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
742087|NCT02822157|Antiviral Agents|antiviral agents|mesh-ancestor
742088|NCT02822157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
742089|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742090|NCT02822157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
742091|NCT02822157|Immunologic Factors|immunologic factors|mesh-ancestor
742092|NCT02822157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742093|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
742094|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
742095|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
742096|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
742097|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
742174|NCT02821468|Acetaminophen|acetaminophen|mesh-list
742175|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
742176|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
742177|NCT02821468|Analgesics|analgesics|mesh-ancestor
742178|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
742179|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742180|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742181|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
742182|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
742183|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742184|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742185|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
742186|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
742187|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
742273|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
742274|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
742275|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
742276|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742277|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742278|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
742279|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
742280|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
742281|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
742282|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742283|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742284|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
742285|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
742286|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
742287|NCT02821156|Protective Agents|protective agents|mesh-ancestor
742631|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
742632|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
742633|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742768|NCT02819024|Alovudine|alovudine|mesh-list
742769|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
742770|NCT02819024|Dexamethasone|dexamethasone|mesh-list
742771|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
742772|NCT02819024|Ichthammol|ichthammol|mesh-list
742773|NCT02819024|BB 1101|bb 1101|mesh-list
742774|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
742775|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
742776|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
742777|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742778|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742779|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
742780|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
742781|NCT02819024|Hormones|hormones|mesh-ancestor
742782|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
742783|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
742784|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742785|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
742786|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742787|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742788|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
742789|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
742790|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
742791|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
742792|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
742793|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
742917|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
742918|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2235106|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
2235107|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2235108|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2235109|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
2235110|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235111|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235112|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
2235113|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742325|NCT02821052|Insulin|insulin|mesh-list
742326|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
742327|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
742328|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742571|NCT02819661|Morphine|morphine|mesh-list
742572|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742573|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742574|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
742575|NCT02819661|Narcotics|narcotics|mesh-ancestor
742576|NCT02819661|Analgesics|analgesics|mesh-ancestor
742577|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
742578|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235114|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2235115|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235116|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
2235117|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2235118|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2235119|NCT00082797|Antidotes|antidotes|mesh-ancestor
2235120|NCT00082797|Protective Agents|protective agents|mesh-ancestor
2235121|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
2235122|NCT00082797|Vitamins|vitamins|mesh-ancestor
2235123|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
2235124|NCT00082823|Aflibercept|aflibercept|mesh-list
2235125|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
743419|NCT02816411|Caseins|caseins|mesh-list
743420|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
743421|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
743422|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743590|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
744215|NCT02811991|Acetaminophen|acetaminophen|mesh-list
744216|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
744217|NCT02811991|Analgesics|analgesics|mesh-ancestor
744218|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
744219|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744220|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744221|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
744868|NCT02808533|Topiramate|topiramate|mesh-list
744869|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
744870|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
744871|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744961|NCT02808104|Mazindol|mazindol|mesh-list
744962|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
744963|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744964|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
744965|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
744966|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
744967|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744968|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
744969|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744970|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
744971|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
745226|NCT02807051|Clarithromycin|clarithromycin|mesh-list
745227|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
745228|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745229|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
745230|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745231|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745232|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
745233|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2092696|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2092697|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2092698|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
2235126|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
742206|NCT02821390|Nepafenac|nepafenac|mesh-list
742207|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
742208|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
742209|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
742210|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
742211|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
742212|NCT02821390|Analgesics|analgesics|mesh-ancestor
742213|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
742214|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742215|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742216|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
742217|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2235127|NCT00082823|Growth Substances|growth substances|mesh-ancestor
2235128|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235129|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
742540|NCT02819856|Ebselen|ebselen|mesh-list
742541|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
742542|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
742543|NCT02819856|Analgesics|analgesics|mesh-ancestor
742544|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
742545|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742546|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742547|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
742548|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
742549|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
742550|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
742551|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
742552|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742553|NCT02819856|Protective Agents|protective agents|mesh-ancestor
742554|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
742555|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742556|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
742731|NCT02819180|Vaccines|vaccines|mesh-list
742732|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
742733|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742970|NCT02818309|Lesogaberan|lesogaberan|mesh-list
742971|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
742972|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
742973|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
742974|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
742975|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742976|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742977|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743162|NCT02817451|Vaccines|vaccines|mesh-list
743163|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
743164|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743630|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
743631|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
743632|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744151|NCT02812043|Amorolfine|amorolfine|mesh-list
744152|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
744153|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
744270|NCT02811497|Azacitidine|azacitidine|mesh-list
744271|NCT02811497|Durvalumab|durvalumab|mesh-list
744272|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
744273|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
744274|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744275|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744276|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
744277|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
744848|NCT02808676|Vitamin D|vitamin d|mesh-list
744849|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
744850|NCT02808676|Vitamins|vitamins|mesh-ancestor
744851|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
744852|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744853|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
744854|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
745242|NCT02806791|Lenograstim|lenograstim|mesh-list
745243|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
745244|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
745245|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745607|NCT02804815|Aspirin|aspirin|mesh-list
745608|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
745609|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
745610|NCT02804815|Analgesics|analgesics|mesh-ancestor
745611|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
2235130|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235131|NCT00082836|Rituximab|rituximab|mesh-list
2235132|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2235133|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235134|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
2235135|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235136|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2235137|NCT00082862|Gemcitabine|gemcitabine|mesh-list
2235138|NCT00082862|Interferons|interferons|mesh-list
2235139|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
2235140|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235141|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2235142|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
2235143|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235144|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
2235145|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235146|NCT00082862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235147|NCT00082862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
743351|NCT02816476|Daratumumab|daratumumab|mesh-list
743352|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743531|NCT02815475|Curcumin|curcumin|mesh-list
743532|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
743533|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
743534|NCT02815475|Analgesics|analgesics|mesh-ancestor
743535|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
743536|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743537|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743538|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
743539|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
743540|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743541|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743542|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743975|NCT02812992|Gemcitabine|gemcitabine|mesh-list
743976|NCT02812992|Paclitaxel|paclitaxel|mesh-list
743977|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
743978|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743979|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
743980|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
743981|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
743982|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743983|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
743984|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
743985|NCT02812992|Antiviral Agents|antiviral agents|mesh-ancestor
743986|NCT02812992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
743987|NCT02812992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743988|NCT02812992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
743989|NCT02812992|Immunologic Factors|immunologic factors|mesh-ancestor
743990|NCT02812992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092699|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092700|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092701|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2092702|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
2092703|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
744827|NCT02808767|Ticagrelor|ticagrelor|mesh-list
744828|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
744829|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
744830|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
744831|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
744832|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
744833|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
744834|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744835|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744836|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745089|NCT02807415|Ivacaftor|ivacaftor|mesh-list
745090|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
745091|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
745092|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745276|NCT02806817|Bevacizumab|bevacizumab|mesh-list
745277|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
745278|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745279|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
745280|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
745281|NCT02806817|Growth Substances|growth substances|mesh-ancestor
745282|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742295|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742296|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
742297|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743092|NCT02817750|Zolpidem|zolpidem|mesh-list
743093|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
743094|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
743095|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
743096|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743097|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
743098|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
743099|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
743100|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743101|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743271|NCT02817191|Tobramycin|tobramycin|mesh-list
743272|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
743273|NCT02817191|Dexamethasone|dexamethasone|mesh-list
743274|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
743275|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
743276|NCT02817191|BB 1101|bb 1101|mesh-list
743277|NCT02817191|Dipivefrin|dipivefrin|mesh-list
743278|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
743279|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
743280|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
743281|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743282|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743283|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
743284|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
743285|NCT02817191|Hormones|hormones|mesh-ancestor
743286|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
743287|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
743288|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743289|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
743290|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743291|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743292|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
743293|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
743294|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
743295|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
743296|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
743297|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743508|NCT02815319|Dexamethasone|dexamethasone|mesh-list
743509|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
743510|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
743511|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
743512|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743513|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743514|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
743515|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
743516|NCT02815319|Hormones|hormones|mesh-ancestor
743517|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
743518|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
743519|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235148|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
2235149|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235150|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
2235151|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235152|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
2235153|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2235154|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235155|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
2235156|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235157|NCT00082966|Bortezomib|bortezomib|mesh-list
743799|NCT02813356|Naloxegol|naloxegol|mesh-list
743800|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
743801|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743802|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
743803|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092704|NCT02251379|Hormones|hormones|mesh-ancestor
2092705|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2092706|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
744136|NCT02812147|Droxidopa|droxidopa|mesh-list
744137|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
744138|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
744208|NCT02811809|Leuprolide|leuprolide|mesh-list
744209|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
744210|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
742304|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
742305|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
742306|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742307|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
742308|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742309|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742310|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
742311|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742312|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
742313|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
742314|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
742315|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
742316|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
742317|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
742318|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
742319|NCT02821026|Analgesics|analgesics|mesh-ancestor
742320|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
742321|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742322|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
742323|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
742324|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
742624|NCT02819544|Ropivacaine|ropivacaine|mesh-list
742625|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
742626|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
742627|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742628|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742629|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
742630|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742684|NCT02819102|Berotralstat|berotralstat|mesh-list
742685|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742686|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742802|NCT02818881|Methamphetamine|methamphetamine|mesh-list
742803|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
742804|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742805|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
742806|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
742807|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742808|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
742809|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742810|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742811|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
742812|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
742813|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
742814|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
742815|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
743753|NCT02813863|Metformin|metformin|mesh-list
743754|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
743755|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744056|NCT02812641|Bevacizumab|bevacizumab|mesh-list
744057|NCT02812641|Cisplatin|cisplatin|mesh-list
744058|NCT02812641|Fluorouracil|fluorouracil|mesh-list
744059|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
744060|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744061|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
744062|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
744063|NCT02812641|Growth Substances|growth substances|mesh-ancestor
744064|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744065|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
744066|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
744067|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744068|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
744069|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
744070|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
744977|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
744978|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
744979|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
744980|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2235158|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235159|NCT00083005|Thalidomide|thalidomide|mesh-list
2235160|NCT00083005|Docetaxel|docetaxel|mesh-list
2235161|NCT00083005|Estramustine|estramustine|mesh-list
2235162|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235163|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
2235164|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
742342|NCT02821247|Aflibercept|aflibercept|mesh-list
742343|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
742344|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
742345|NCT02821247|Growth Substances|growth substances|mesh-ancestor
742346|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742347|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
742348|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742411|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
742412|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
742413|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
742414|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742415|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742416|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
742417|NCT02820610|Analgesics|analgesics|mesh-ancestor
742418|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
742419|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742420|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
742421|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
742422|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
742423|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
742424|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742425|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742426|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
742427|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
742428|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
742429|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
742430|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
742431|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
742432|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
742433|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
742440|NCT02820259|Tacrolimus|tacrolimus|mesh-list
742441|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
742442|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
742443|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742444|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
742445|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742446|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742485|NCT02819999|Etoposide|etoposide|mesh-list
742486|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742487|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
742488|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
742489|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
742490|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742491|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742978|NCT02818491|Dexamethasone|dexamethasone|mesh-list
742979|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
742980|NCT02818491|Ropivacaine|ropivacaine|mesh-list
742981|NCT02818491|BB 1101|bb 1101|mesh-list
742982|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
742983|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
742984|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
742985|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742986|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742987|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
742988|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
742989|NCT02818491|Hormones|hormones|mesh-ancestor
742990|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
742991|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
742992|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
742993|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
742994|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
742995|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742996|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
742997|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
742998|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742999|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
743400|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
742448|NCT02820688|Prilocaine|prilocaine|mesh-list
742449|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
742450|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
742451|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
742452|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742453|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
742454|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235165|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
2235166|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235167|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235168|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
2235169|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235170|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
2235171|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235172|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235173|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2235174|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2092707|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2092708|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
2092709|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2092710|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
2092711|NCT02251548|Rituximab|rituximab|mesh-list
2235175|NCT00083005|Growth Substances|growth substances|mesh-ancestor
2235176|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235177|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
744172|NCT02811939|Dronabinol|dronabinol|mesh-list
744173|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
744174|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744175|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
744176|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
744177|NCT02811939|Analgesics|analgesics|mesh-ancestor
744178|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
744179|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744180|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
744181|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
744182|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744183|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744184|NCT02811939|Hormones|hormones|mesh-ancestor
744185|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2235178|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
2235179|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2235180|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
2235181|NCT00083031|Bevacizumab|bevacizumab|mesh-list
2235182|NCT00083031|Methotrexate|methotrexate|mesh-list
2235183|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235184|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
2235185|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745339|NCT02806492|Phenylephrine|phenylephrine|mesh-list
745340|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
745341|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
745342|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
745343|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
745344|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
745345|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745346|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
745347|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
745348|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
745349|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
745350|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
745351|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
745352|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
745353|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
745354|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
745355|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745356|NCT02806492|Protective Agents|protective agents|mesh-ancestor
2092712|NCT02251548|Fludarabine|fludarabine|mesh-list
2092713|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2092714|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
2092715|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746104|NCT02802072|Aspirin|aspirin|mesh-list
746105|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
746106|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
746107|NCT02802072|Analgesics|analgesics|mesh-ancestor
746108|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
746109|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092716|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
742533|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
742534|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743038|NCT02818140|Ropivacaine|ropivacaine|mesh-list
743039|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
743040|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
743041|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
743042|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743043|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
743044|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743498|NCT02815566|Tenofovir|tenofovir|mesh-list
743499|NCT02815566|Emtricitabine|emtricitabine|mesh-list
743500|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
743501|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
743502|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
743503|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
743504|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743505|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743506|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
743507|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2092717|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2092718|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
2092719|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744477|NCT02810483|Topiramate|topiramate|mesh-list
744478|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
744479|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
744480|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744537|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
744538|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
744539|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
744540|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744541|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
744542|NCT02809937|Analgesics|analgesics|mesh-ancestor
744543|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
744544|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744545|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
744546|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
744547|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
744548|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
744549|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744550|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745307|NCT02806752|Triamcinolone|triamcinolone|mesh-list
745308|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
745309|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
745310|NCT02806752|Ranibizumab|ranibizumab|mesh-list
745311|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
745312|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
745313|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
745314|NCT02806752|Growth Substances|growth substances|mesh-ancestor
745315|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745316|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
745317|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745318|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
745319|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
745320|NCT02806752|Hormones|hormones|mesh-ancestor
745321|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
745322|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
745323|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
745324|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745325|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745417|NCT02806115|Acetic Acid|acetic acid|mesh-list
745418|NCT02806115|Retinol acetate|retinol acetate|mesh-list
745419|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
745420|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745421|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
745422|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
745423|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745424|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2235186|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2235187|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2235188|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
2235189|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235190|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235191|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
743423|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
743424|NCT02816021|Azacitidine|azacitidine|mesh-list
743425|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
743426|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743427|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
743428|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
743429|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743430|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743458|NCT02815722|Simvastatin|simvastatin|mesh-list
743459|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
743460|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
743461|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
743462|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743463|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
743464|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
743465|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743520|NCT02815410|Levetiracetam|levetiracetam|mesh-list
743521|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
743522|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
743601|NCT02815111|Acetaminophen|acetaminophen|mesh-list
743602|NCT02815111|Lidocaine|lidocaine|mesh-list
743603|NCT02815111|Ketamine|ketamine|mesh-list
743604|NCT02815111|Gabapentin|gabapentin|mesh-list
743605|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
743606|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
743607|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
743608|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743609|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
743610|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743611|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
743612|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
743613|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
743614|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
743615|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743616|NCT02815111|Analgesics|analgesics|mesh-ancestor
743617|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
743618|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
743619|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
743620|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
743621|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
743622|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743623|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
743624|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
743625|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
743626|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
743627|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
743628|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
743629|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
2235192|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2235193|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2235194|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2235195|NCT00083031|Growth Substances|growth substances|mesh-ancestor
2235196|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235197|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2235198|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
2235199|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2235200|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2235201|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
2235202|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
2235203|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235204|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2235205|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2235206|NCT00083057|Paclitaxel|paclitaxel|mesh-list
2235207|NCT00083057|Gefitinib|gefitinib|mesh-list
744616|NCT02809755|Lidocaine|lidocaine|mesh-list
744617|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
744618|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
744619|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
744620|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744621|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
742725|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
742726|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
742727|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
742728|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
742729|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742730|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742923|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
742924|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
742925|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
742926|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
742927|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742928|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742929|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742930|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
742931|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743045|NCT02817932|Ranolazine|ranolazine|mesh-list
743046|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
743047|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
743048|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743314|NCT02817100|Itraconazole|itraconazole|mesh-list
743315|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
743316|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
743317|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
743318|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
743319|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743320|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743321|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
743322|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
743323|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
743324|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743325|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
744461|NCT02810444|Immunoglobulins|immunoglobulins|mesh-list
744462|NCT02810444|gamma-Globulins|gamma-globulins|mesh-list
744463|NCT02810444|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
744464|NCT02810444|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
744465|NCT02810444|Immunologic Factors|immunologic factors|mesh-ancestor
744466|NCT02810444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235208|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2235209|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235210|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
745070|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
745071|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
745072|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235211|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
2235212|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
2235213|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235214|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2235215|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235216|NCT00083070|Temozolomide|temozolomide|mesh-list
2235217|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2235218|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
2235219|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235220|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235221|NCT00083083|Paclitaxel|paclitaxel|mesh-list
2235222|NCT00083083|Etoposide|etoposide|mesh-list
2235223|NCT00083083|Vinorelbine|vinorelbine|mesh-list
2235224|NCT00083083|Vinblastine|vinblastine|mesh-list
2235225|NCT00083083|Docetaxel|docetaxel|mesh-list
2235226|NCT00083083|Carboplatin|carboplatin|mesh-list
746047|NCT02802215|Folic Acid|folic acid|mesh-list
746048|NCT02802215|Metformin|metformin|mesh-list
746049|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
746050|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746051|NCT02802215|Hematinics|hematinics|mesh-ancestor
746052|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
746053|NCT02802215|Vitamins|vitamins|mesh-ancestor
746054|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
746349|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
746350|NCT02801188|Bupivacaine|bupivacaine|mesh-list
746351|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
746352|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
746353|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746354|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746355|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
2235227|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
742864|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742865|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
742866|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235228|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2235229|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235230|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
2235231|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
2235232|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
2235233|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235234|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2235235|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
743543|NCT02815449|Iron|iron|mesh-list
743544|NCT02815449|Trace Elements|trace elements|mesh-ancestor
743545|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
743546|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743922|NCT02812667|Nivolumab|nivolumab|mesh-list
743923|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
743924|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743925|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
743926|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744192|NCT02811731|Amlodipine|amlodipine|mesh-list
744193|NCT02811731|Candesartan|candesartan|mesh-list
744194|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
744195|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
744196|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
744197|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744198|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
744199|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744200|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
744201|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
744202|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
744585|NCT02809820|Metoprolol|metoprolol|mesh-list
744586|NCT02809820|Carvedilol|carvedilol|mesh-list
744587|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
744588|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
744589|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
744590|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
744591|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
744592|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744593|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744594|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
744595|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
744596|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
744597|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744598|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744599|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
744600|NCT02809820|Protective Agents|protective agents|mesh-ancestor
744601|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
744602|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
744603|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
744604|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
744605|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
744606|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
744855|NCT02808611|Propranolol|propranolol|mesh-list
744856|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
744857|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
744858|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
744859|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744860|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744861|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744862|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
744863|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
744864|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
744878|NCT02808247|Ifosfamide|ifosfamide|mesh-list
744879|NCT02808247|Nintedanib|nintedanib|mesh-list
744880|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
744881|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
744882|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744883|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744884|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
744885|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745018|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
745019|NCT02807467|Propofol|propofol|mesh-list
742908|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742909|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
742910|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
742911|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
742912|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
742913|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
742914|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742946|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
742947|NCT02818270|Albuterol|albuterol|mesh-list
742948|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
742949|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
742950|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
742951|NCT02818270|Expectorants|expectorants|mesh-ancestor
742952|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
742953|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
742954|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
742955|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
742956|NCT02818270|Protective Agents|protective agents|mesh-ancestor
742957|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742958|NCT02818270|Antidotes|antidotes|mesh-ancestor
742959|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
742960|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
742961|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
742962|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
742963|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
742964|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
742965|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
742966|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
742967|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
742968|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
742969|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743362|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
743363|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
743364|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
743365|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
743445|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
743446|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
743447|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
743448|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743449|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743450|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
743451|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
743452|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743453|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
743454|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743804|NCT02813369|Naloxegol|naloxegol|mesh-list
743805|NCT02813369|Laxatives|laxatives|mesh-list
743806|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
743807|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743808|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
743809|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743810|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
743869|NCT02813148|Naloxegol|naloxegol|mesh-list
743870|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
743871|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743872|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
743873|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744102|NCT02812212|Diuretics|diuretics|mesh-list
744103|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
744104|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235236|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235237|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2235238|NCT00083096|Temozolomide|temozolomide|mesh-list
2235239|NCT00083096|Lonafarnib|lonafarnib|mesh-list
2235240|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2235241|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
745095|NCT02807454|Dexamethasone|dexamethasone|mesh-list
745096|NCT02807454|Durvalumab|durvalumab|mesh-list
745097|NCT02807454|Pomalidomide|pomalidomide|mesh-list
745098|NCT02807454|Daratumumab|daratumumab|mesh-list
745099|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
745100|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
745101|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
745102|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
745103|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745104|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
745105|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
742919|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
742920|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
742921|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
742922|NCT02818556|Protective Agents|protective agents|mesh-ancestor
743645|NCT02814461|Axitinib|axitinib|mesh-list
743646|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743647|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
743648|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743649|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235242|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235243|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235244|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235245|NCT00083109|Suramin|suramin|mesh-list
2235246|NCT00083109|Fluorouracil|fluorouracil|mesh-list
2235247|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
2235248|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235249|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2235250|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235251|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235252|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
744238|NCT02811692|Aflibercept|aflibercept|mesh-list
744239|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
744240|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
744241|NCT02811692|Growth Substances|growth substances|mesh-ancestor
744242|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744243|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
744244|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744315|NCT02811354|Osimertinib|osimertinib|mesh-list
744316|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744317|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
744318|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
744319|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744886|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
744887|NCT02808065|Tacrolimus|tacrolimus|mesh-list
744888|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
744889|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
744890|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744891|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
744892|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
744893|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744894|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
744895|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744896|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
744897|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
744898|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
744899|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092720|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092721|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2092722|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2092723|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2092724|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2092725|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2092726|NCT02251613|Epinastine|epinastine|mesh-list
2092727|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2092728|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2092729|NCT02251613|Analgesics|analgesics|mesh-ancestor
2092730|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
2092731|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092732|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092733|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2092734|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
745408|NCT02806141|Colistin|colistin|mesh-list
745409|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
745410|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745463|NCT02805738|Tenofovir|tenofovir|mesh-list
745464|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
745465|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745466|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
745467|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
745468|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743366|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
743367|NCT02816853|Domperidone|domperidone|mesh-list
743368|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
743369|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
743370|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
743371|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
743372|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743373|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743374|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743375|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743376|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
743377|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
743378|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743379|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
743380|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
743381|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
743382|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743561|NCT02815189|Acetaminophen|acetaminophen|mesh-list
743562|NCT02815189|Ibuprofen|ibuprofen|mesh-list
743563|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
743564|NCT02815189|Analgesics|analgesics|mesh-ancestor
743565|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
743566|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743567|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743568|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
743569|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
743570|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
743571|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
743572|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
743573|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743574|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235253|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235254|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
2235255|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
2235256|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2235257|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235258|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2235259|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2235260|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2235261|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235262|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235263|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235264|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2235265|NCT00083148|Capecitabine|capecitabine|mesh-list
2235266|NCT00083148|Irinotecan|irinotecan|mesh-list
743770|NCT02813642|Mitogens|mitogens|mesh-list
743771|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
743772|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743903|NCT02812888|Propranolol|propranolol|mesh-list
743904|NCT02812888|Methimazole|methimazole|mesh-list
743905|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
743906|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
743907|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
743908|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
743909|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743910|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743911|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743912|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
743913|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
743914|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
743915|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
743916|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
743917|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
743918|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
743947|NCT02812654|Doxorubicin|doxorubicin|mesh-list
743948|NCT02812654|Ifosfamide|ifosfamide|mesh-list
743949|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
743950|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743951|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
743952|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
743953|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743971|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
743081|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743082|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743083|NCT02817789|Analgesics|analgesics|mesh-ancestor
743084|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
743085|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743086|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
743087|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
743088|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
743089|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
743090|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
743091|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743410|NCT02816424|TEMPO|tempo|mesh-list
743411|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
743412|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743413|NCT02816424|Protective Agents|protective agents|mesh-ancestor
743414|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743633|NCT02815059|Prednisone|prednisone|mesh-list
743634|NCT02815059|Dasatinib|dasatinib|mesh-list
743635|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
743636|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
743637|NCT02815059|Hormones|hormones|mesh-ancestor
743638|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
743639|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743640|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
743641|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743642|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
743643|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743644|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743927|NCT02812940|Everolimus|everolimus|mesh-list
743928|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743929|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
743930|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
743931|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744023|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
744024|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
744025|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
744026|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
744027|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
744028|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744029|NCT02812433|Urological Agents|urological agents|mesh-ancestor
744278|NCT02811523|Doxorubicin|doxorubicin|mesh-list
744279|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
744280|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744281|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
744282|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
744283|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
744284|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744337|NCT02811055|Aprepitant|aprepitant|mesh-list
744338|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
744339|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
744340|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744341|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744342|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
744343|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
744344|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744345|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744671|NCT02809729|Cefazolin|cefazolin|mesh-list
744672|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
744673|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
744790|NCT02808949|Dapivirine|dapivirine|mesh-list
744791|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
744792|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
744793|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
744794|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
744846|NCT02808585|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
744847|NCT02808585|Vasodilator Agents|vasodilator agents|mesh-ancestor
745499|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
745500|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
745501|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745748|NCT02803944|Azithromycin|azithromycin|mesh-list
745749|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
745750|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745935|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
745936|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
743137|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
743138|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743139|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743431|NCT02815995|Durvalumab|durvalumab|mesh-list
743432|NCT02815995|Tremelimumab|tremelimumab|mesh-list
743433|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
743434|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235267|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2235268|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
2235269|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235270|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235271|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2235272|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2235273|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235274|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
2235275|NCT00083161|Etoposide|etoposide|mesh-list
2235276|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235277|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
2235278|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235279|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2235280|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2235281|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
2235282|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235283|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235284|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2235285|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2235286|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
743852|NCT02813135|Carboplatin|carboplatin|mesh-list
743853|NCT02813135|Nivolumab|nivolumab|mesh-list
743854|NCT02813135|Irinotecan|irinotecan|mesh-list
743855|NCT02813135|Temozolomide|temozolomide|mesh-list
743856|NCT02813135|Topotecan|topotecan|mesh-list
743857|NCT02813135|Olaparib|olaparib|mesh-list
743858|NCT02813135|Adavosertib|adavosertib|mesh-list
743859|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743860|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
743861|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
743862|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743863|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
743864|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
743865|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743866|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
743867|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
743868|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
744420|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
744421|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
744806|NCT02808871|Pirfenidone|pirfenidone|mesh-list
744807|NCT02808871|Analgesics|analgesics|mesh-ancestor
744808|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
744809|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744810|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744811|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
744812|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
744813|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
744814|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
744815|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744975|NCT02807883|Blinatumomab|blinatumomab|mesh-list
744976|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745284|NCT02806648|Palbociclib|palbociclib|mesh-list
745285|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745286|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
745287|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745288|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745427|NCT02806050|Letrozole|letrozole|mesh-list
745428|NCT02806050|Palbociclib|palbociclib|mesh-list
745429|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745430|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
745431|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
745432|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745433|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745434|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
745435|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
745436|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
745437|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743220|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
743221|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
743222|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
743223|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
743224|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743225|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
743226|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
743227|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
743228|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743229|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743230|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
743231|NCT02817360|Protective Agents|protective agents|mesh-ancestor
743232|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
743233|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
743234|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
743235|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
743236|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
743237|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
743238|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
743239|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
743240|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743241|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
743242|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
743243|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
743244|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
743245|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
743246|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
743247|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743248|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
743249|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
2235287|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2235288|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235289|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
2235290|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235291|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
2235292|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235293|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743650|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
743651|NCT02814409|Plasminogen|plasminogen|mesh-list
743652|NCT02814409|Tenecteplase|tenecteplase|mesh-list
743653|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
743654|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
743655|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744674|NCT02809573|Prednisone|prednisone|mesh-list
744675|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
744676|NCT02809573|Vincristine|vincristine|mesh-list
744677|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
744678|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
744679|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744680|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
744681|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
744682|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
744683|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744684|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744685|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
744686|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
744687|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
744688|NCT02809573|Hormones|hormones|mesh-ancestor
744689|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
744690|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
744691|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
744692|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
744693|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
744694|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
745575|NCT02805049|Caspofungin|caspofungin|mesh-list
745576|NCT02805049|Micafungin|micafungin|mesh-list
745577|NCT02805049|Echinocandins|echinocandins|mesh-list
745578|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
745579|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745580|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745581|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745737|NCT02804165|Vaccines|vaccines|mesh-list
745738|NCT02804165|Immunologic Factors|immunologic factors|mesh-ancestor
2092735|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2092736|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2092737|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2092738|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
2092739|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
2092740|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092741|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743455|NCT02815787|Glyburide|glyburide|mesh-list
743456|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
743457|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743821|NCT02813447|Sertraline|sertraline|mesh-list
743822|NCT02813447|Antidepressive Agents|antidepressive agents|mesh-ancestor
743823|NCT02813447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
743824|NCT02813447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
743825|NCT02813447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
743826|NCT02813447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
743827|NCT02813447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743828|NCT02813447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743829|NCT02813447|Serotonin Agents|serotonin agents|mesh-ancestor
743830|NCT02813447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744551|NCT02809768|Itraconazole|itraconazole|mesh-list
744552|NCT02809768|Fluconazole|fluconazole|mesh-list
744553|NCT02809768|Rifampin|rifampin|mesh-list
744554|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
744555|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
744556|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
744557|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
744558|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
744559|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744560|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
744561|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
744562|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
744563|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744564|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
744565|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
744566|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
744567|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
744568|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
744569|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
744570|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
744571|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
744572|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
744573|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
744574|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
744575|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
744576|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
744577|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
744981|NCT02807870|Methylphenidate|methylphenidate|mesh-list
744982|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
744983|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744984|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
744985|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
744986|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
744987|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744988|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
744989|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
745128|NCT02807298|Lidocaine|lidocaine|mesh-list
745129|NCT02807298|Epinephrine|epinephrine|mesh-list
745130|NCT02807298|Carticaine|carticaine|mesh-list
745131|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
745132|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
745133|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
745134|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
745135|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745136|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745137|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
745138|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
745139|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
745140|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
745141|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
745142|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
743267|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
743268|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
743269|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743270|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092742|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
2092743|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2092744|NCT02251717|Ledipasvir|ledipasvir|mesh-list
2092745|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
2092746|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092747|NCT02251912|Oxytocin|oxytocin|mesh-list
2092748|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
2092749|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2092750|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092751|NCT02251938|Sirolimus|sirolimus|mesh-list
2235294|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2235295|NCT00083213|Aflibercept|aflibercept|mesh-list
2235296|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2235297|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2235298|NCT00083213|Growth Substances|growth substances|mesh-ancestor
2235299|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235300|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235301|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235302|NCT00083252|Cisplatin|cisplatin|mesh-list
744071|NCT02812524|Ipilimumab|ipilimumab|mesh-list
744072|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
744073|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744074|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
744075|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744517|NCT02809781|Etanercept|etanercept|mesh-list
744518|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
744519|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
744520|NCT02809781|Analgesics|analgesics|mesh-ancestor
744521|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
744522|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744523|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744524|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
744525|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
744526|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
744527|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
744528|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
744764|NCT02809105|Linaclotide|linaclotide|mesh-list
744765|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
744766|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
744767|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744768|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
744872|NCT02808364|Vaccines|vaccines|mesh-list
744873|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
744874|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744900|NCT02808091|Bortezomib|bortezomib|mesh-list
744901|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745048|NCT02807805|Niclosamide|niclosamide|mesh-list
745049|NCT02807805|Prednisone|prednisone|mesh-list
745050|NCT02807805|Cortisone|cortisone|mesh-list
745051|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
745052|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
745053|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
745054|NCT02807805|Hormones|hormones|mesh-ancestor
745055|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
745056|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745057|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
745058|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745059|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
745060|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745061|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745062|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
745063|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
745064|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
745065|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
745066|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
745067|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
745068|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745069|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
745705|NCT02804360|Dexamethasone|dexamethasone|mesh-list
745706|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
745707|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
745708|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
743335|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
743842|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
743843|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
743844|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
743845|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
743846|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
743847|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
743848|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743849|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
743850|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
743851|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744819|NCT02808728|Bupivacaine|bupivacaine|mesh-list
744820|NCT02808728|Ropivacaine|ropivacaine|mesh-list
744821|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
744822|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
744823|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
744824|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744825|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
744826|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744916|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
744917|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
744918|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
744919|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
744920|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744921|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
744922|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
744923|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745173|NCT02807181|Gemcitabine|gemcitabine|mesh-list
745174|NCT02807181|Cisplatin|cisplatin|mesh-list
745175|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745176|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
745177|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
745178|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745179|NCT02807181|Antiviral Agents|antiviral agents|mesh-ancestor
745180|NCT02807181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745181|NCT02807181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745182|NCT02807181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
745183|NCT02807181|Immunologic Factors|immunologic factors|mesh-ancestor
745184|NCT02807181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745387|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
745388|NCT02806349|Cathartics|cathartics|mesh-ancestor
745389|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2235303|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235304|NCT00083278|Ipilimumab|ipilimumab|mesh-list
2235305|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2235306|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235307|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
745740|NCT02804035|Furosemide|furosemide|mesh-list
745741|NCT02804035|Diuretics|diuretics|mesh-ancestor
745742|NCT02804035|Natriuretic Agents|natriuretic agents|mesh-ancestor
745743|NCT02804035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745744|NCT02804035|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
745745|NCT02804035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
745746|NCT02804035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745975|NCT02802683|Phenylephrine|phenylephrine|mesh-list
745976|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
745977|NCT02802683|Bupivacaine|bupivacaine|mesh-list
745978|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
745979|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
745980|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
745981|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
745982|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745983|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
745984|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
745985|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
745986|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
745987|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
745988|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
745989|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
745990|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
745991|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
745992|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
745993|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
745994|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
745995|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
745996|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743401|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
743402|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
743403|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
743404|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
743405|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743406|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743407|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
743408|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
743409|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
743593|NCT02815033|Choline|choline|mesh-list
743594|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
743595|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
743596|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
743597|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743598|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
743599|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
743600|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
744016|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
744017|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
744018|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
744019|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744020|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
744021|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
744022|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235308|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235309|NCT00083304|Efaproxiral|efaproxiral|mesh-list
2235310|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
2235311|NCT00083343|Caspofungin|caspofungin|mesh-list
2235312|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
2235313|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235314|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235315|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235316|NCT00083408|Pamidronate|pamidronate|mesh-list
2235317|NCT00083408|Thalidomide|thalidomide|mesh-list
2235318|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235319|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
2235320|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235321|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
744837|NCT02808741|Olorofim|olorofim|mesh-list
744838|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
744839|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
744924|NCT02807909|Itraconazole|itraconazole|mesh-list
744925|NCT02807909|Diltiazem|diltiazem|mesh-list
744926|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
744927|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
744928|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
744929|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
744930|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
744931|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744932|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
744933|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
744934|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
744935|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744936|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
744937|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
744938|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
744939|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
744940|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2235322|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
743416|NCT02816164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
743417|NCT02816164|Immunologic Factors|immunologic factors|mesh-ancestor
743418|NCT02816164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743701|NCT02814058|Zolpidem|zolpidem|mesh-list
743702|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
743703|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
743704|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
743705|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743706|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
743707|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
743708|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
743709|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743710|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743991|NCT02812615|Micronutrients|micronutrients|mesh-list
743992|NCT02812615|Trace Elements|trace elements|mesh-list
743993|NCT02812615|Albendazole|albendazole|mesh-list
743994|NCT02812615|Pyrantel|pyrantel|mesh-list
743995|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
743996|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
743997|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
743998|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
743999|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
744000|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
744001|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
744002|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
744003|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
744004|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
744005|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744006|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744007|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744008|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
744009|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
744010|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
744011|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
744012|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744346|NCT02811016|Budesonide|budesonide|mesh-list
744347|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
744348|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
744349|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
744350|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744351|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744352|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
744353|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
744354|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
744355|NCT02811016|Hormones|hormones|mesh-ancestor
744356|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
744506|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
744507|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
744508|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
744509|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
744510|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
744511|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744512|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
744513|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744514|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744515|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
744516|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744695|NCT02809690|Clevudine|clevudine|mesh-list
744696|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
744697|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745191|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
745192|NCT02807103|Rituximab|rituximab|mesh-list
745193|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
745194|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
745195|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745196|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
745197|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
745198|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
745199|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745200|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745201|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
745202|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
745378|NCT02806206|Prucalopride|prucalopride|mesh-list
745379|NCT02806206|Laxatives|laxatives|mesh-ancestor
745380|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
743438|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
743439|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092752|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2092753|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092754|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2092755|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092756|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
2092757|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2092758|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
2092759|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092760|NCT02251990|Grazoprevir|grazoprevir|mesh-list
2092761|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
743881|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
743882|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
743883|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
743884|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
743885|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
743886|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
743887|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
743888|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
743889|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
743890|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
743891|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
743892|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743893|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743894|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
743895|NCT02813200|Hormones|hormones|mesh-ancestor
743896|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
743897|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
744042|NCT02812368|Clonidine|clonidine|mesh-list
744043|NCT02812368|Analgesics|analgesics|mesh-ancestor
744044|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
744045|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744046|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744047|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
744048|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
744049|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
744050|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
744051|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
744052|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
744053|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
744054|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744055|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744310|NCT02811133|Inositol|inositol|mesh-list
744311|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
744312|NCT02811133|Vitamins|vitamins|mesh-ancestor
744313|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
744314|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744377|NCT02810782|Morphine|morphine|mesh-list
744378|NCT02810782|Phenobarbital|phenobarbital|mesh-list
744379|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
744380|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
744381|NCT02810782|Narcotics|narcotics|mesh-ancestor
744382|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
744383|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744384|NCT02810782|Analgesics|analgesics|mesh-ancestor
744385|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
744386|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744387|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
744388|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
744389|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
744390|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
744391|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744392|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744393|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
744394|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
744395|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
744396|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
744397|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
744398|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
744399|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
744400|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
744401|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
744402|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2235323|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235324|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2235325|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2235326|NCT00083408|Growth Substances|growth substances|mesh-ancestor
2235327|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235328|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235329|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2235330|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
2235331|NCT00083434|Hematinics|hematinics|mesh-ancestor
2235332|NCT00083460|Thalidomide|thalidomide|mesh-list
743671|NCT02814669|Atezolizumab|atezolizumab|mesh-list
743672|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
743673|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744972|NCT02807571|Anesthetics|anesthetics|mesh-list
744973|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
744974|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745073|NCT02807441|Aspirin|aspirin|mesh-list
745074|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
745075|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
745076|NCT02807441|Analgesics|analgesics|mesh-ancestor
745077|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
745078|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
745079|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745080|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
745081|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
745082|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
745083|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
745084|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745085|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
745086|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
745087|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745088|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
2092762|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092763|NCT02252016|Grazoprevir|grazoprevir|mesh-list
2092764|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
2092765|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092766|NCT02252042|Docetaxel|docetaxel|mesh-list
745755|NCT02804126|Acetaminophen|acetaminophen|mesh-list
745756|NCT02804126|Dipyrone|dipyrone|mesh-list
745757|NCT02804126|Ketoprofen|ketoprofen|mesh-list
745758|NCT02804126|Morphine|morphine|mesh-list
745759|NCT02804126|Bupivacaine|bupivacaine|mesh-list
745760|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
745761|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
745762|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
745763|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745764|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
745765|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
745766|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
745767|NCT02804126|Narcotics|narcotics|mesh-ancestor
745768|NCT02804126|Analgesics|analgesics|mesh-ancestor
745769|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
745770|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
745771|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
745772|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
745773|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
745774|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
745775|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745776|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235333|NCT00083460|Dexamethasone|dexamethasone|mesh-list
2235334|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2235335|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
2235336|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
2235337|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235338|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235339|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2235340|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
2235341|NCT00083460|Hormones|hormones|mesh-ancestor
2235342|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2235343|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2235344|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235345|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235346|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
2235347|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
746256|NCT02801383|Interferons|interferons|mesh-list
2092767|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
2235348|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235349|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
743789|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
2235350|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
744154|NCT02812355|Heparin|heparin|mesh-list
744155|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
744156|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
744157|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
744158|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744247|NCT02811627|Memantine|memantine|mesh-list
744248|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
744249|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
744250|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
744251|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744252|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744253|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744254|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
744255|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
744325|NCT02811289|Mirabegron|mirabegron|mesh-list
744326|NCT02811289|Glycerol|glycerol|mesh-list
744327|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
744328|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
744329|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
744330|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
744331|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744332|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744333|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744334|NCT02811289|Urological Agents|urological agents|mesh-ancestor
744335|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
744336|NCT02811289|Protective Agents|protective agents|mesh-ancestor
744427|NCT02810704|Aspirin|aspirin|mesh-list
744428|NCT02810704|Warfarin|warfarin|mesh-list
744429|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
744430|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
744431|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
744432|NCT02810704|Analgesics|analgesics|mesh-ancestor
744433|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
744434|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744435|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744436|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
744437|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
744438|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
744439|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
744440|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744441|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
744442|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
744443|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
744444|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
744445|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
744446|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
744447|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
744448|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
744449|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
744748|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
744749|NCT02809079|Prednisone|prednisone|mesh-list
744750|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
744751|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
744752|NCT02809079|Hormones|hormones|mesh-ancestor
744753|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
744754|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744755|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
744756|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744757|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
744758|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
744759|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
744760|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
744761|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
744762|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
744763|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744942|NCT02807922|Zopiclone|zopiclone|mesh-list
744943|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
744944|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
744945|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744990|NCT02807610|Propofol|propofol|mesh-list
744991|NCT02807610|Etomidate|etomidate|mesh-list
744992|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
744993|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
743941|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
743942|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
743943|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
743944|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
743945|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
743946|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092768|NCT02252042|Methotrexate|methotrexate|mesh-list
2092769|NCT02252042|Cetuximab|cetuximab|mesh-list
2092770|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092771|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
2092772|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
2092773|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
2092774|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092775|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2092776|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2092777|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
2092778|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2235351|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
744406|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
744407|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
744408|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
744409|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744410|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
744411|NCT02810899|Analgesics|analgesics|mesh-ancestor
744412|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
744413|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744414|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
744415|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
744416|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
744417|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
744418|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744419|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744467|NCT02810275|Leucovorin|leucovorin|mesh-list
744468|NCT02810275|Folic Acid|folic acid|mesh-list
744469|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
744470|NCT02810275|Antidotes|antidotes|mesh-ancestor
744471|NCT02810275|Protective Agents|protective agents|mesh-ancestor
744472|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744473|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
744474|NCT02810275|Vitamins|vitamins|mesh-ancestor
744475|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
744476|NCT02810275|Hematinics|hematinics|mesh-ancestor
744732|NCT02809456|Nicorandil|nicorandil|mesh-list
744733|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
744734|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
744735|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
744736|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
744737|NCT02809456|Vitamins|vitamins|mesh-ancestor
744738|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
744739|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744800|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
744801|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
744802|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235352|NCT00083460|Growth Substances|growth substances|mesh-ancestor
2235353|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235354|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
2235355|NCT00083486|Hematinics|hematinics|mesh-ancestor
2235356|NCT00083525|Capecitabine|capecitabine|mesh-list
2235357|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2235358|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
2235359|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235360|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235361|NCT00083538|Thalidomide|thalidomide|mesh-list
2235362|NCT00083538|Dexamethasone|dexamethasone|mesh-list
2235363|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
745366|NCT02806362|Ritonavir|ritonavir|mesh-list
745367|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
745368|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
745369|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
745370|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745371|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745372|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
745373|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2235364|NCT00083538|Etoposide|etoposide|mesh-list
743954|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
743955|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
743956|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
744076|NCT02812394|Levodopa|levodopa|mesh-list
744077|NCT02812394|Carbidopa|carbidopa|mesh-list
744078|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
744079|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
744080|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
744081|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
744082|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744083|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744084|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744085|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
744086|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
744087|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
744088|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
744089|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
744159|NCT02811978|Dexamethasone|dexamethasone|mesh-list
744160|NCT02811978|Bortezomib|bortezomib|mesh-list
744161|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
744162|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
744163|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
744164|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744165|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744166|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
744167|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
744168|NCT02811978|Hormones|hormones|mesh-ancestor
744169|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
744170|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
744171|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744295|NCT02811341|Scopolamine|scopolamine|mesh-list
744296|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
744297|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
744298|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
744299|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
744300|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744301|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744302|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
744303|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
744304|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
744305|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
744306|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744307|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744308|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
744309|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
2235365|NCT00083538|Doxorubicin|doxorubicin|mesh-list
2235366|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2235367|NCT00083538|Cisplatin|cisplatin|mesh-list
2235368|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235369|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
2235370|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235371|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
746529|NCT02800135|Furosemide|furosemide|mesh-list
746530|NCT02800135|Diuretics|diuretics|mesh-ancestor
746531|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
746532|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746533|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
746534|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
746535|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235372|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2235373|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
2235374|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747350|NCT02796105|Ganirelix|ganirelix|mesh-list
747351|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
747352|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
747353|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092779|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092780|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
747948|NCT02792816|Artesunate|artesunate|mesh-list
747949|NCT02792816|Artemether|artemether|mesh-list
747950|NCT02792816|Piperaquine|piperaquine|mesh-list
747951|NCT02792816|Artenimol|artenimol|mesh-list
747952|NCT02792816|Mefloquine|mefloquine|mesh-list
747953|NCT02792816|Antimalarials|antimalarials|mesh-list
747954|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
743972|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
743973|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
743974|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235375|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235376|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2235377|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2235378|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
744357|NCT02810808|Ranibizumab|ranibizumab|mesh-list
744358|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
744359|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
744360|NCT02810808|Growth Substances|growth substances|mesh-ancestor
744361|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744362|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
744363|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744481|NCT02810548|Mitogens|mitogens|mesh-list
744482|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
744483|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744998|NCT02807558|Azacitidine|azacitidine|mesh-list
744999|NCT02807558|Daratumumab|daratumumab|mesh-list
745000|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
745001|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
745002|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745003|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745004|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745449|NCT02805946|Posaconazole|posaconazole|mesh-list
745450|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
745451|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745452|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
745453|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
745454|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
745455|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
745456|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
745457|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745458|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745459|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
745460|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
745461|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
745462|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745518|NCT02805556|Fostemsavir|fostemsavir|mesh-list
745519|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
745520|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
745521|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
745522|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745523|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
745524|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
745525|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745582|NCT02805153|Lenograstim|lenograstim|mesh-list
745583|NCT02805153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
745584|NCT02805153|Immunologic Factors|immunologic factors|mesh-ancestor
745585|NCT02805153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745805|NCT02803892|Vildagliptin|vildagliptin|mesh-list
745806|NCT02803892|Sirolimus|sirolimus|mesh-list
745807|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
745808|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745809|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
745810|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745811|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
745812|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
745813|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
745814|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745815|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
745816|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
745817|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
745818|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745819|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745895|NCT02802995|Thrombin|thrombin|mesh-list
745896|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
745897|NCT02802995|Coagulants|coagulants|mesh-ancestor
745968|NCT02802722|Vitamin D|vitamin d|mesh-list
745969|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
745970|NCT02802722|Vitamins|vitamins|mesh-ancestor
745971|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
745972|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745973|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
745974|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
744031|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
744032|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
744033|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
744034|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744035|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
744036|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744037|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
744038|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
744039|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
744040|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
744041|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744740|NCT02809469|Apixaban|apixaban|mesh-list
744741|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
744742|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
744743|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
744744|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
744745|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
744746|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744747|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
744902|NCT02808117|Micronutrients|micronutrients|mesh-list
744903|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092781|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
2092782|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
2092783|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092784|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2092785|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2092786|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
2092787|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2092788|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2092789|NCT02252081|Metformin|metformin|mesh-list
2092790|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2092791|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745203|NCT02807116|Rifampin|rifampin|mesh-list
745204|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
745205|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
745206|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
745207|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745208|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
745209|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
745210|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745211|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745212|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
745213|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
745214|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
745215|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
745216|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
745217|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
745357|NCT02806440|Naltrexone|naltrexone|mesh-list
745358|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
745359|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
745360|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745361|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
745362|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235379|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
2235380|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235381|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2235382|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
2235383|NCT00083538|Hormones|hormones|mesh-ancestor
745959|NCT02802605|Bemiparin|bemiparin|mesh-list
745960|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
746435|NCT02800694|Fentanyl|fentanyl|mesh-list
746436|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
746437|NCT02800694|Narcotics|narcotics|mesh-ancestor
746438|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746439|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746440|NCT02800694|Analgesics|analgesics|mesh-ancestor
746441|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
746442|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746443|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
746444|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
746445|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
746446|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
746490|NCT02800174|Aspirin|aspirin|mesh-list
744111|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
744112|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744113|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
744114|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744115|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
744116|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
744117|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
744118|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
744119|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744120|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
744121|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
744122|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
744123|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744124|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
744125|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
744126|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
744127|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
744128|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
744129|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
744130|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
744131|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
744285|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
744286|NCT02811484|Exenatide|exenatide|mesh-list
744287|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
744288|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744289|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
744290|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744291|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
744292|NCT02811484|Incretins|incretins|mesh-ancestor
744293|NCT02811484|Hormones|hormones|mesh-ancestor
744294|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
744499|NCT02810132|Metformin|metformin|mesh-list
744500|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
744501|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744578|NCT02809742|Ropivacaine|ropivacaine|mesh-list
744579|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
744580|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
744581|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
744582|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744583|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
744584|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744703|NCT02809378|Remifentanil|remifentanil|mesh-list
744704|NCT02809378|Thiopental|thiopental|mesh-list
744705|NCT02809378|Palonosetron|palonosetron|mesh-list
744706|NCT02809378|Propofol|propofol|mesh-list
744707|NCT02809378|Sevoflurane|sevoflurane|mesh-list
744708|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
744709|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
744710|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744711|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
744712|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
744713|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
744714|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
744715|NCT02809378|Narcotics|narcotics|mesh-ancestor
744716|NCT02809378|Analgesics|analgesics|mesh-ancestor
744717|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
744718|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744719|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
744720|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
744721|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
744722|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
744723|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
744724|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
744725|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
744726|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
744727|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744728|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
744729|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
744730|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
744731|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
744795|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
744796|NCT02809066|Calcium|calcium|mesh-list
744797|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
744798|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744799|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
744211|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
744212|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744213|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
744214|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
744320|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
744321|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
744322|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235384|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2235385|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2235386|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2235387|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2235388|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2235389|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235390|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2235391|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
2235392|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235393|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235394|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2235395|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2235396|NCT00083538|Growth Substances|growth substances|mesh-ancestor
2235397|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235398|NCT00083577|Thalidomide|thalidomide|mesh-list
745363|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
745364|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
745365|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746301|NCT02801227|Oxytocin|oxytocin|mesh-list
746302|NCT02801227|Dinoprostone|dinoprostone|mesh-list
746303|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
746304|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
746305|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753529|NCT02626455|Prednisone|prednisone|mesh-list
2753530|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
2753531|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2753532|NCT02626455|Rituximab|rituximab|mesh-list
2753533|NCT02626455|Doxorubicin|doxorubicin|mesh-list
2753534|NCT02626455|Vincristine|vincristine|mesh-list
2092812|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2092813|NCT02252354|Relugolix|relugolix|mesh-list
2092814|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
2092815|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
2753535|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2753536|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
744403|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
744404|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
744405|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
2092816|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2092817|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092818|NCT02252406|Ranolazine|ranolazine|mesh-list
2092819|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2092820|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2092821|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092822|NCT02252445|Propofol|propofol|mesh-list
2092823|NCT02252445|Sevoflurane|sevoflurane|mesh-list
2092824|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2092825|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2092826|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092827|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2092828|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
745479|NCT02805829|Trastuzumab|trastuzumab|mesh-list
745480|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
745481|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745948|NCT02802813|Piperaquine|piperaquine|mesh-list
745949|NCT02802813|Primaquine|primaquine|mesh-list
745950|NCT02802813|Artenimol|artenimol|mesh-list
745951|NCT02802813|Artemisinins|artemisinins|mesh-list
745952|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
745953|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
745954|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
745955|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235399|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235400|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
2235401|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746366|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
746367|NCT02800785|Metronidazole|metronidazole|mesh-list
746368|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
746369|NCT02800785|Levofloxacin|levofloxacin|mesh-list
746370|NCT02800785|Cefazolin|cefazolin|mesh-list
746371|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
746372|NCT02800785|Ertapenem|ertapenem|mesh-list
746373|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
746374|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
746375|NCT02800785|Cefuroxime|cefuroxime|mesh-list
746376|NCT02800785|Tigecycline|tigecycline|mesh-list
746377|NCT02800785|Cefotaxime|cefotaxime|mesh-list
746378|NCT02800785|Cefoxitin|cefoxitin|mesh-list
746379|NCT02800785|Ticarcillin|ticarcillin|mesh-list
746380|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
746381|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
746382|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
746383|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
746384|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
746385|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746386|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746387|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746388|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
746389|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
746390|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
746391|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
746392|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
746393|NCT02800785|Renal Agents|renal agents|mesh-ancestor
746394|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
746395|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
746703|NCT02799316|Antibodies|antibodies|mesh-list
746704|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
746705|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092829|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
2092830|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2092831|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2092832|NCT02252536|Gabapentin|gabapentin|mesh-list
2092833|NCT02252536|Analgesics|analgesics|mesh-ancestor
2092834|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
2092835|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092836|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092837|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
2092838|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2092839|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2092840|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2092841|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2092842|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2092843|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2092844|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
744614|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
744615|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2753537|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753538|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2753539|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2753540|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
2753541|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753542|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753543|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2753544|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2753545|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2753546|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2753547|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2753548|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753549|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2753550|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
745726|NCT02804373|Oxytocin|oxytocin|mesh-list
745727|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
745728|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
745729|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745751|NCT02803918|Metformin|metformin|mesh-list
745752|NCT02803918|Lixisenatide|lixisenatide|mesh-list
745753|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
745754|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235402|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
2235403|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235404|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235405|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2235406|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2235407|NCT00083577|Growth Substances|growth substances|mesh-ancestor
2235408|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235409|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235410|NCT00083590|Huperzine A|huperzine a|mesh-list
2235411|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2235412|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235413|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235414|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
2235415|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2235416|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746409|NCT02800902|Atorvastatin|atorvastatin|mesh-list
746410|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
746411|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
746412|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
746413|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
746414|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746415|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
746416|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
746417|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746466|NCT02800486|Cetuximab|cetuximab|mesh-list
746467|NCT02800486|Mannitol|mannitol|mesh-list
746468|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
746469|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746470|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
746471|NCT02800486|Diuretics|diuretics|mesh-ancestor
746472|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
744622|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
744623|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
744624|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
744625|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
744626|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
744627|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745116|NCT02807363|Leuprolide|leuprolide|mesh-list
745117|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
745118|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
745119|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
745120|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745121|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
745122|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745718|NCT02804022|Morphine|morphine|mesh-list
745719|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
745720|NCT02804022|Narcotics|narcotics|mesh-ancestor
745721|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
745722|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745723|NCT02804022|Analgesics|analgesics|mesh-ancestor
745724|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
745725|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746461|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
746462|NCT02800408|Provitamins|provitamins|mesh-ancestor
746463|NCT02800408|Vitamins|vitamins|mesh-ancestor
746464|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
746465|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747724|NCT02794220|Nicotine|nicotine|mesh-list
747725|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
747726|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
747727|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
747728|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747729|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
747730|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
747731|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
747732|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
747733|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747793|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
747794|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
747795|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747796|NCT02793687|Protective Agents|protective agents|mesh-ancestor
747797|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747798|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
747799|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2235417|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2235418|NCT00083590|Protective Agents|protective agents|mesh-ancestor
2235419|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2235420|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2235421|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2235422|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2235423|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235424|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2235425|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2235426|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2235427|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
2235428|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2235429|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235430|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2235431|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2235432|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
2753551|NCT02626455|Hormones|hormones|mesh-ancestor
2753552|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2753553|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
748268|NCT02791256|Ribavirin|ribavirin|mesh-list
748269|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
748270|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
748271|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748272|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
748273|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748489|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
748490|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
748491|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
748492|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744657|NCT02809677|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
744658|NCT02809677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
744659|NCT02809677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
744660|NCT02809677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
744661|NCT02809677|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
744662|NCT02809677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
744663|NCT02809677|Histamine Antagonists|histamine antagonists|mesh-ancestor
744664|NCT02809677|Histamine Agents|histamine agents|mesh-ancestor
744665|NCT02809677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
744666|NCT02809677|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
744667|NCT02809677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
744668|NCT02809677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
744669|NCT02809677|Adrenergic Agents|adrenergic agents|mesh-ancestor
744670|NCT02809677|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
745472|NCT02805920|Bupivacaine|bupivacaine|mesh-list
745473|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
745474|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
745475|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
745476|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745477|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
745478|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
745567|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
745568|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
745569|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
745570|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
745571|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
745572|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745573|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745574|NCT02805452|Urological Agents|urological agents|mesh-ancestor
745599|NCT02804841|Vitamin D|vitamin d|mesh-list
745600|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
745601|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
745602|NCT02804841|Vitamins|vitamins|mesh-list
745603|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
745604|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745605|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
745606|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2235433|NCT00083681|Thalidomide|thalidomide|mesh-list
2235434|NCT00083681|Dexamethasone|dexamethasone|mesh-list
2235435|NCT00083681|Etoposide|etoposide|mesh-list
2235436|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
2235437|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235438|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2235439|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
2235440|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
2235441|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746539|NCT02799901|Nivolumab|nivolumab|mesh-list
746540|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
746541|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746542|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
746543|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235442|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235443|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2235444|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
746909|NCT02798367|Melatonin|melatonin|mesh-list
746910|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
746911|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746912|NCT02798367|Protective Agents|protective agents|mesh-ancestor
746913|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746914|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746984|NCT02797977|Gemcitabine|gemcitabine|mesh-list
746985|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746986|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
746987|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
746988|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746989|NCT02797977|Antiviral Agents|antiviral agents|mesh-ancestor
746990|NCT02797977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
746991|NCT02797977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746992|NCT02797977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
746993|NCT02797977|Immunologic Factors|immunologic factors|mesh-ancestor
746994|NCT02797977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747229|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
747230|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
747231|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2235445|NCT00083681|Hormones|hormones|mesh-ancestor
2092845|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092846|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
2092847|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
2092848|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2092849|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092850|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
2092851|NCT02252965|Metformin|metformin|mesh-list
2092852|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2092853|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092854|NCT02253160|Sargramostim|sargramostim|mesh-list
745161|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
745162|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
745163|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745164|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
745165|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
745166|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745167|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745168|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745548|NCT02805426|Misoprostol|misoprostol|mesh-list
745549|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
745550|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
745551|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
745552|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745553|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
745554|NCT02805426|Coagulants|coagulants|mesh-ancestor
745555|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
745556|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
745557|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
745558|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745559|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
745560|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
745561|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
2235446|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2235447|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2235448|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2235449|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2235450|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2235451|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235452|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235453|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235454|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
2235455|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
746628|NCT02799758|Pitavastatin|pitavastatin|mesh-list
746629|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
746630|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
746631|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
746632|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
746633|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746634|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746635|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
747082|NCT02797340|Metformin|metformin|mesh-list
747083|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
747084|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747134|NCT02797041|Bortezomib|bortezomib|mesh-list
747135|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235456|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2235457|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
2235458|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2235459|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
2235460|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235461|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235462|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2235463|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2235464|NCT00083681|Growth Substances|growth substances|mesh-ancestor
2235465|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235466|NCT00083694|Thalidomide|thalidomide|mesh-list
2235467|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235468|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
2235469|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235470|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
2235471|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235472|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235473|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2235474|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2235475|NCT00083694|Growth Substances|growth substances|mesh-ancestor
744941|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
745093|NCT02807272|Tipifarnib|tipifarnib|mesh-list
745094|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745273|NCT02806804|Vaccines|vaccines|mesh-list
745274|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
745275|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746120|NCT02802137|Timolol|timolol|mesh-list
746121|NCT02802137|Dorzolamide|dorzolamide|mesh-list
746122|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
746123|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
746124|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
746125|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
746126|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746127|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746128|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
746129|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
746130|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
746131|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235476|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235477|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235478|NCT00083707|Thalidomide|thalidomide|mesh-list
2235479|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235480|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
746544|NCT02800265|Sulforaphane|sulforaphane|mesh-list
746545|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
746546|NCT02800265|Protective Agents|protective agents|mesh-ancestor
746547|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746548|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753554|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2753555|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
2753556|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
2753557|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
747347|NCT02796196|Coal Tar|coal tar|mesh-list
747348|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
747349|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
747474|NCT02795143|Isotretinoin|isotretinoin|mesh-list
747475|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
747543|NCT02794896|Fentanyl|fentanyl|mesh-list
747544|NCT02794896|Propofol|propofol|mesh-list
747545|NCT02794896|Sevoflurane|sevoflurane|mesh-list
747546|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
747547|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
747548|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747549|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
747550|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
747551|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
747552|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
747553|NCT02794896|Narcotics|narcotics|mesh-ancestor
747554|NCT02794896|Analgesics|analgesics|mesh-ancestor
747555|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
747556|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
747557|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
747558|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
747559|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2235481|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235482|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
2235483|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235484|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235485|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2235486|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2235487|NCT00083707|Growth Substances|growth substances|mesh-ancestor
2235488|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235489|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235490|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2235491|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
2235492|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235493|NCT00083785|Talaporfin|talaporfin|mesh-list
2235494|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235495|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
744994|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
744995|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
744996|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
744997|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
2235496|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2235497|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2235498|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
2235499|NCT00083824|Estrogens|estrogens|mesh-list
2235500|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
745945|NCT02802631|Minocycline|minocycline|mesh-list
745946|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
745947|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
746725|NCT02799277|Testosterone|testosterone|mesh-list
746726|NCT02799277|Androgens|androgens|mesh-ancestor
746727|NCT02799277|Hormones|hormones|mesh-ancestor
746728|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
746729|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235501|NCT00083824|Hormones|hormones|mesh-ancestor
2235502|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2235503|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235504|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2235505|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2235506|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2235507|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
2235508|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2235509|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2235510|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
747060|NCT02797249|Aspirin|aspirin|mesh-list
747061|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
747062|NCT02797249|Salicylates|salicylates|mesh-list
747063|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
747064|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
747065|NCT02797249|Analgesics|analgesics|mesh-ancestor
747066|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
747067|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
747068|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747069|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
747070|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
747071|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
747072|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
747073|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747074|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
747075|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
747076|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747077|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
747078|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
747079|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
747080|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
747081|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
747529|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
747530|NCT02794922|Vitamins|vitamins|mesh-ancestor
747531|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
747532|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747734|NCT02794155|Insulin|insulin|mesh-list
747735|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
747736|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
747737|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
747738|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747876|NCT02793466|Durvalumab|durvalumab|mesh-list
747877|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
747878|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
747879|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747880|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
747881|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748406|NCT02790450|Benzbromarone|benzbromarone|mesh-list
748407|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
748408|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
748409|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
748410|NCT02790450|Renal Agents|renal agents|mesh-ancestor
748756|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
748757|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
748758|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
748759|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
748760|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748761|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
748762|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
749312|NCT02786264|Propofol|propofol|mesh-list
745020|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
745021|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
745022|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745023|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
745024|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
745025|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
745026|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
745027|NCT02807467|Analgesics|analgesics|mesh-ancestor
745028|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
745029|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
745030|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
745031|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
745032|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
745033|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
745034|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
745035|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235511|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2235512|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2235513|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235514|NCT00083876|Thalidomide|thalidomide|mesh-list
2235515|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235516|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
2235517|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235518|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
2235519|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235520|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235521|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2235522|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2235523|NCT00083876|Growth Substances|growth substances|mesh-ancestor
2235524|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235525|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745642|NCT02804633|Acetaminophen|acetaminophen|mesh-list
745643|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
745644|NCT02804633|Analgesics|analgesics|mesh-ancestor
745645|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
745646|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
745647|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745648|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
745898|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
745899|NCT02803073|Testosterone|testosterone|mesh-list
745900|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
745901|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
745902|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
745903|NCT02803073|Androgens|androgens|mesh-ancestor
745904|NCT02803073|Hormones|hormones|mesh-ancestor
745905|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
745906|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745907|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
745908|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745909|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
745961|NCT02802696|Furosemide|furosemide|mesh-list
745962|NCT02802696|Diuretics|diuretics|mesh-ancestor
745963|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
745964|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745965|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
745966|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
745967|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235526|NCT00083902|Thalidomide|thalidomide|mesh-list
2235527|NCT00083902|Dexamethasone|dexamethasone|mesh-list
2235528|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2235529|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
2235530|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
2235531|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235532|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746758|NCT02798874|Clopidogrel|clopidogrel|mesh-list
746759|NCT02798874|Ticagrelor|ticagrelor|mesh-list
746760|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
746761|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
746762|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
746763|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
746764|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
746765|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
746766|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235533|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2235534|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
745106|NCT02807454|Hormones|hormones|mesh-ancestor
745107|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
745108|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
745109|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745110|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
745111|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
745112|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
745113|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
745114|NCT02807454|Growth Substances|growth substances|mesh-ancestor
745115|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
745239|NCT02806882|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
745240|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
745241|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745300|NCT02806596|Sevoflurane|sevoflurane|mesh-list
745301|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
745302|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
745303|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
745304|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
745305|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
745306|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745820|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
745821|NCT02803385|Anesthetics|anesthetics|mesh-list
745822|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
745823|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
745824|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745825|NCT02803385|Narcotics|narcotics|mesh-ancestor
745826|NCT02803385|Analgesics|analgesics|mesh-ancestor
745827|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
745828|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235535|NCT00083902|Hormones|hormones|mesh-ancestor
2235536|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2235537|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2235538|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235539|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235540|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
747656|NCT02794571|Paclitaxel|paclitaxel|mesh-list
747657|NCT02794571|Etoposide|etoposide|mesh-list
747658|NCT02794571|Bevacizumab|bevacizumab|mesh-list
747659|NCT02794571|Carboplatin|carboplatin|mesh-list
747660|NCT02794571|Capecitabine|capecitabine|mesh-list
747661|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
747662|NCT02794571|Pemetrexed|pemetrexed|mesh-list
747663|NCT02794571|Atezolizumab|atezolizumab|mesh-list
747664|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
747665|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747666|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
747667|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
747668|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
747669|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747670|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
747671|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
747672|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
747673|NCT02794571|Growth Substances|growth substances|mesh-ancestor
747674|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747675|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
747676|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
747677|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
747678|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
747679|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
747680|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747681|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
747682|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2092855|NCT02253160|Lenograstim|lenograstim|mesh-list
2092856|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
748547|NCT02789930|Anesthetics|anesthetics|mesh-list
748548|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
745143|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
745144|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
745145|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
745146|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
745147|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
745148|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
745149|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
745150|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
745151|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
745152|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
745153|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
745169|NCT02806999|Insulin|insulin|mesh-list
745170|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
745171|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
745172|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235541|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
2235542|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
746474|NCT02800252|Aspirin|aspirin|mesh-list
746475|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
746476|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
746477|NCT02800252|Analgesics|analgesics|mesh-ancestor
746478|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
746479|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746480|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746481|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
746482|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
746483|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
746484|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
746485|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746486|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
746487|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
746488|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746489|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
746536|NCT02799927|Calcium|calcium|mesh-list
746537|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
746538|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746938|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
746939|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746940|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
746941|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
746942|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
746943|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746944|NCT02798159|Urological Agents|urological agents|mesh-ancestor
746968|NCT02797704|Aflibercept|aflibercept|mesh-list
746969|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
746970|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
746971|NCT02797704|Growth Substances|growth substances|mesh-ancestor
746972|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746973|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
746974|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747448|NCT02795858|Octreotide|octreotide|mesh-list
747449|NCT02795858|Ramucirumab|ramucirumab|mesh-list
747450|NCT02795858|Lanreotide|lanreotide|mesh-list
747451|NCT02795858|Somatostatin|somatostatin|mesh-list
747452|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
747453|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
747454|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747455|NCT02795858|Hormones|hormones|mesh-ancestor
747456|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
747457|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747857|NCT02793440|Cortivazol|cortivazol|mesh-list
747858|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
747977|NCT02792491|Prednisone|prednisone|mesh-list
747978|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
747979|NCT02792491|Rituximab|rituximab|mesh-list
747980|NCT02792491|Doxorubicin|doxorubicin|mesh-list
747981|NCT02792491|Vincristine|vincristine|mesh-list
747982|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
747983|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
747984|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747985|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
747986|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
745283|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
745411|NCT02806128|Kallikreins|kallikreins|mesh-list
745412|NCT02806128|Coagulants|coagulants|mesh-ancestor
745413|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
745414|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
745415|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
745416|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745502|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
745503|NCT02805725|Trabectedin|trabectedin|mesh-list
745504|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
745505|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
745506|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745507|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
745508|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
745509|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
745510|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745511|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745512|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
745533|NCT02805257|Mitomycins|mitomycins|mesh-list
745534|NCT02805257|Mitomycin|mitomycin|mesh-list
745535|NCT02805257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
745536|NCT02805257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745537|NCT02805257|Alkylating Agents|alkylating agents|mesh-ancestor
745538|NCT02805257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745539|NCT02805257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
745540|NCT02805257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745591|NCT02805010|Abatacept|abatacept|mesh-list
745592|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
745593|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745594|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745595|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
745596|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
745597|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745598|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
745730|NCT02804282|Furosemide|furosemide|mesh-list
745731|NCT02804282|Diuretics|diuretics|mesh-ancestor
745732|NCT02804282|Natriuretic Agents|natriuretic agents|mesh-ancestor
745733|NCT02804282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745734|NCT02804282|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
745735|NCT02804282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
745736|NCT02804282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235543|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235544|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2235545|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2235546|NCT00083902|Growth Substances|growth substances|mesh-ancestor
2235547|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235548|NCT00083941|Interleukin-2|interleukin-2|mesh-list
2235549|NCT00083941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235550|NCT00083941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2235551|NCT00083941|Analgesics|analgesics|mesh-ancestor
2235552|NCT00083941|Sensory System Agents|sensory system agents|mesh-ancestor
2235553|NCT00083941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235554|NCT00083941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235555|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2235556|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
2235557|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2235558|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2235559|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2235560|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2235561|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235562|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2235563|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2235564|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2235565|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2235566|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235567|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2235568|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235569|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
746164|NCT02802098|Bevacizumab|bevacizumab|mesh-list
746165|NCT02802098|Durvalumab|durvalumab|mesh-list
746166|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
746167|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746168|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2235570|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
2235571|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
745513|NCT02805868|Siltuximab|siltuximab|mesh-list
745514|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
745515|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745516|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
745517|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745586|NCT02805231|Vitamin D|vitamin d|mesh-list
745587|NCT02805231|Vitamins|vitamins|mesh-ancestor
745588|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
745589|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745590|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
745802|NCT02803502|Thrombin|thrombin|mesh-list
745803|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
745804|NCT02803502|Coagulants|coagulants|mesh-ancestor
745956|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
745957|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
745958|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753578|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
2753579|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2753580|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753581|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
2753582|NCT02593123|Molgramostim|molgramostim|mesh-list
2753583|NCT02593123|Lenograstim|lenograstim|mesh-list
2753584|NCT02593123|Sargramostim|sargramostim|mesh-list
2753585|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2753586|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
2753587|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753588|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2753589|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753590|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2753591|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
2753592|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2753593|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753594|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747110|NCT02797067|Indomethacin|indomethacin|mesh-list
747111|NCT02797067|Glycerol|glycerol|mesh-list
747112|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
747113|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
747114|NCT02797067|Analgesics|analgesics|mesh-ancestor
747115|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
747116|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
747117|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747118|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
747119|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
747120|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
747121|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
747122|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
747123|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
747124|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747125|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747126|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
747127|NCT02797067|Protective Agents|protective agents|mesh-ancestor
747253|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
747254|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
747255|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747256|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747257|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
747258|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
747259|NCT02796469|Protective Agents|protective agents|mesh-ancestor
747260|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747261|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
747262|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
747263|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
747342|NCT02796170|Dapagliflozin|dapagliflozin|mesh-list
745374|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
745375|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745376|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
745377|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
746035|NCT02802540|Nabilone|nabilone|mesh-list
746036|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
746037|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
746038|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746039|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746040|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
746041|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
746042|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
746043|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746044|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
746209|NCT02801487|Cisplatin|cisplatin|mesh-list
746210|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746423|NCT02800447|Procarbazine|procarbazine|mesh-list
746424|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235572|NCT00083993|Sirolimus|sirolimus|mesh-list
2235573|NCT00083993|Letrozole|letrozole|mesh-list
2235574|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235575|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2235576|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2235577|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235578|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235579|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2235580|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
2235581|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2235582|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235583|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235584|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235585|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
747744|NCT02793843|Dexamethasone|dexamethasone|mesh-list
747745|NCT02793843|Ondansetron|ondansetron|mesh-list
747746|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
747747|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
747748|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
747749|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
747750|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747751|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
747752|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
747753|NCT02793843|Hormones|hormones|mesh-ancestor
747754|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
747755|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
747756|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747757|NCT02793843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
747758|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747759|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
747760|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
747761|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
747762|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
747763|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
747764|NCT02793843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
747765|NCT02793843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
747766|NCT02793843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
747767|NCT02793843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
747892|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
747893|NCT02793544|Sirolimus|sirolimus|mesh-list
747894|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
747895|NCT02793544|Busulfan|busulfan|mesh-list
747896|NCT02793544|Fludarabine|fludarabine|mesh-list
747897|NCT02793544|Mesna|mesna|mesh-list
747898|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
747899|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
747900|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747901|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
747902|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
747903|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
747904|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747905|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747906|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
747907|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
747908|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
747909|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
747910|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
747911|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745381|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
745382|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
745383|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
745384|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
745385|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745386|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235586|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
2235587|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235588|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
2235589|NCT00084019|Ritonavir|ritonavir|mesh-list
2235590|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2235591|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2235592|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2235593|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
2235594|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235595|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235596|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2235597|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2235598|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
2235599|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235600|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2235601|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2235602|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2235603|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
2235604|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235605|NCT00084058|Ritonavir|ritonavir|mesh-list
2235606|NCT00084058|Lopinavir|lopinavir|mesh-list
2235607|NCT00084058|Saquinavir|saquinavir|mesh-list
2235608|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2235609|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2235610|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
746403|NCT02800889|Pixantrone|pixantrone|mesh-list
746404|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
746405|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
746406|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746407|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746408|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746447|NCT02800590|Abp-700|abp-700|mesh-list
746448|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
746449|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
746450|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
746451|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
746452|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746453|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746578|NCT02799615|Infliximab|infliximab|mesh-list
746579|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
746580|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
746581|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
746881|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
746882|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
746883|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746884|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
746885|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746927|NCT02798172|Metformin|metformin|mesh-list
746928|NCT02798172|Alogliptin|alogliptin|mesh-list
746929|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
746930|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746931|NCT02798172|Incretins|incretins|mesh-ancestor
746932|NCT02798172|Hormones|hormones|mesh-ancestor
746933|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
746934|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
746935|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
746936|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746937|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747146|NCT02797015|Ozanimod|ozanimod|mesh-list
747147|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
747148|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747149|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
747150|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
747151|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747483|NCT02795429|Spartalizumab|spartalizumab|mesh-list
747484|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
747912|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235611|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235612|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745396|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
745397|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
745398|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
745399|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745400|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
745401|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
745402|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
745403|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745404|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745405|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
745406|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
745407|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
745665|NCT02804490|Vitamin A|vitamin a|mesh-list
745666|NCT02804490|Beta Carotene|beta carotene|mesh-list
745667|NCT02804490|Provitamins|provitamins|mesh-list
745668|NCT02804490|Carotenoids|carotenoids|mesh-list
745669|NCT02804490|Vitamins|vitamins|mesh-ancestor
745670|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
745671|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745672|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
745673|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745674|NCT02804490|Protective Agents|protective agents|mesh-ancestor
2092857|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235613|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
746777|NCT02798913|Clopidogrel|clopidogrel|mesh-list
746778|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
746779|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
746780|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
746781|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
746782|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
746783|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
746784|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746785|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235614|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2235615|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
2235616|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235617|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2235618|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
747915|NCT02793050|Trabectedin|trabectedin|mesh-list
747916|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
747917|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
747918|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747919|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748011|NCT02792413|Denosumab|denosumab|mesh-list
748012|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
748013|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748147|NCT02792036|Carboplatin|carboplatin|mesh-list
748148|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748315|NCT02790853|Proflavine|proflavine|mesh-list
748316|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
748317|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235619|NCT00084097|Omalizumab|omalizumab|mesh-list
2235620|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2235621|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2235622|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
2235623|NCT00084201|Amoxicillin|amoxicillin|mesh-list
2235624|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235625|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235626|NCT00084214|Paclitaxel|paclitaxel|mesh-list
2235627|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2235628|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235629|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
2235630|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
2235631|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
2235632|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235633|NCT00084227|Azithromycin|azithromycin|mesh-list
2235634|NCT00084227|Chloroquine|chloroquine|mesh-list
2235635|NCT00084227|Atovaquone|atovaquone|mesh-list
2235636|NCT00084227|Proguanil|proguanil|mesh-list
2235637|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2235638|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235639|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235640|NCT00084227|Amebicides|amebicides|mesh-ancestor
749529|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
749530|NCT02785146|Leucovorin|leucovorin|mesh-list
749531|NCT02785146|Fluorouracil|fluorouracil|mesh-list
2235641|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
745425|NCT02806115|Protective Agents|protective agents|mesh-ancestor
745426|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745652|NCT02804646|Carboplatin|carboplatin|mesh-list
745653|NCT02804646|Pemetrexed|pemetrexed|mesh-list
745654|NCT02804646|Endostatins|endostatins|mesh-list
745655|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745656|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745657|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745658|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
745659|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
745660|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
745661|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
745662|NCT02804646|Growth Substances|growth substances|mesh-ancestor
745663|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745664|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
745914|NCT02802943|Imiquimod|imiquimod|mesh-list
745915|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
745916|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
745917|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745918|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745919|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
746582|NCT02799797|Sufentanil|sufentanil|mesh-list
746583|NCT02799797|Dsuvia|dsuvia|mesh-list
746584|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
746585|NCT02799797|Narcotics|narcotics|mesh-ancestor
746586|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746587|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746588|NCT02799797|Analgesics|analgesics|mesh-ancestor
746589|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
746590|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746591|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
746592|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
746593|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
746594|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
746841|NCT02798744|Empagliflozin|empagliflozin|mesh-list
746842|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
746843|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746844|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
746845|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747174|NCT02797470|Cytarabine|cytarabine|mesh-list
747175|NCT02797470|Etoposide|etoposide|mesh-list
747176|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
747177|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
747178|NCT02797470|Melphalan|melphalan|mesh-list
747179|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
747180|NCT02797470|Carmustine|carmustine|mesh-list
747181|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
747182|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
747183|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747184|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
747185|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
747186|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747187|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747188|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
747189|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
747190|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
747191|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
747192|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
747193|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
747194|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747195|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
747196|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
747197|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
747198|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
747199|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
747200|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
747201|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
747202|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
747533|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
747534|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
747535|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
747536|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748043|NCT02792803|Latanoprost|latanoprost|mesh-list
748044|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
748045|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
748328|NCT02790996|Vancomycin|vancomycin|mesh-list
748329|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
748330|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745438|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2235642|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2235643|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
2235644|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2235645|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235646|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235647|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
2235648|NCT00084240|Azithromycin|azithromycin|mesh-list
745687|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
745688|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
745689|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
746149|NCT02801838|Morphine|morphine|mesh-list
746150|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
746151|NCT02801838|Narcotics|narcotics|mesh-ancestor
746152|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746153|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746154|NCT02801838|Analgesics|analgesics|mesh-ancestor
746155|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
746156|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746277|NCT02801656|Vancomycin|vancomycin|mesh-list
746278|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
746279|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
746345|NCT02800941|Warfarin|warfarin|mesh-list
746346|NCT02800941|Anticoagulants|anticoagulants|mesh-list
746347|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
746348|NCT02800941|Fluindione|fluindione|mesh-list
2235649|NCT00084240|Chloroquine|chloroquine|mesh-list
2235650|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2235651|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
2235652|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
2235653|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2235654|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235655|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235656|NCT00084240|Amebicides|amebicides|mesh-ancestor
2235657|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2235658|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2235659|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
2235660|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2235661|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2235662|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
747594|NCT02794610|Tacrolimus|tacrolimus|mesh-list
747595|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
747596|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
747597|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747598|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
747599|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747600|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235663|NCT00084240|Analgesics|analgesics|mesh-ancestor
2235664|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
2235665|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235666|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235667|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2235668|NCT00084240|Filaricides|filaricides|mesh-ancestor
2235669|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
2235670|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
2235671|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2235672|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235673|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235674|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2235675|NCT00084240|Renal Agents|renal agents|mesh-ancestor
2235676|NCT00084253|Ritonavir|ritonavir|mesh-list
2235677|NCT00084253|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2235678|NCT00084253|Lamivudine|lamivudine|mesh-list
2235679|NCT00084253|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2235680|NCT00084253|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2235681|NCT00084253|Protease Inhibitors|protease inhibitors|mesh-ancestor
2235682|NCT00084253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235683|NCT00084253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745469|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745470|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
745471|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2235684|NCT00084253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2235685|NCT00084253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2235686|NCT00084253|Antiviral Agents|antiviral agents|mesh-ancestor
2235687|NCT00084253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235688|NCT00084253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2235689|NCT00084253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2235690|NCT00084253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2235691|NCT00084253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2235692|NCT00084279|Interferons|interferons|mesh-list
2235693|NCT00084279|Ribavirin|ribavirin|mesh-list
2235694|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
2235695|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
2235696|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
2235697|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235698|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
2235699|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235700|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
2235701|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235702|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
2235703|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746222|NCT02801357|Lofexidine|lofexidine|mesh-list
746223|NCT02801357|Buprenorphine|buprenorphine|mesh-list
746224|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
746225|NCT02801357|Narcotics|narcotics|mesh-ancestor
746226|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746227|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746228|NCT02801357|Analgesics|analgesics|mesh-ancestor
746229|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
746230|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746231|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
746232|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
746233|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
746234|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
746235|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
746236|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
746237|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
746238|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747103|NCT02797145|Digoxin|digoxin|mesh-list
747104|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
747105|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
747106|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747107|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747108|NCT02797145|Protective Agents|protective agents|mesh-ancestor
747109|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235704|NCT00084344|Afimoxifene|afimoxifene|mesh-list
2235705|NCT00084344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747693|NCT02794337|Sorafenib|sorafenib|mesh-list
747694|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747695|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
747696|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747697|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235706|NCT00084344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2235707|NCT00084344|Hormone Antagonists|hormone antagonists|mesh-ancestor
2235708|NCT00084344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
748602|NCT02789579|Levofloxacin|levofloxacin|mesh-list
748603|NCT02789579|Ofloxacin|ofloxacin|mesh-list
748604|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
748605|NCT02789579|Cefuroxime|cefuroxime|mesh-list
748606|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
748607|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
748608|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748609|NCT02789579|Renal Agents|renal agents|mesh-ancestor
748610|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
748611|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
748612|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
748613|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748614|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748615|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748616|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
748617|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
748888|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
2092858|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2092859|NCT02253173|Estradiol|estradiol|mesh-list
2092860|NCT02253173|Estrogens|estrogens|mesh-ancestor
745623|NCT02804776|Gefitinib|gefitinib|mesh-list
745624|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745625|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
745626|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745627|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235709|NCT00084344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235710|NCT00084344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2235711|NCT00084344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2235712|NCT00084370|Celecoxib|celecoxib|mesh-list
2235713|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2235714|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2235715|NCT00084370|Analgesics|analgesics|mesh-ancestor
2235716|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
2235717|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235718|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235719|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2235720|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2235721|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2235722|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2235723|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235724|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235725|NCT00084396|Letrozole|letrozole|mesh-list
2235726|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235727|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2235728|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2235729|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235730|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235731|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2235732|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
2235733|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2235734|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235735|NCT00084435|Docetaxel|docetaxel|mesh-list
2235736|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235737|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
2235738|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
2235739|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
2235740|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235741|NCT00084448|Celecoxib|celecoxib|mesh-list
746082|NCT02802163|Dexamethasone|dexamethasone|mesh-list
746083|NCT02802163|Lenalidomide|lenalidomide|mesh-list
746084|NCT02802163|Panobinostat|panobinostat|mesh-list
746085|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
746086|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
746087|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
746088|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746089|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746090|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
746091|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
746092|NCT02802163|Hormones|hormones|mesh-ancestor
746093|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
746094|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
746095|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746096|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
746097|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
746098|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
746099|NCT02802163|Growth Substances|growth substances|mesh-ancestor
746100|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
746101|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
746102|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746103|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746157|NCT02801799|Ropivacaine|ropivacaine|mesh-list
746158|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
746159|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
746160|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746161|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746162|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
746163|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746265|NCT02801305|Diltiazem|diltiazem|mesh-list
746266|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
746267|NCT02801305|Petrolatum|petrolatum|mesh-list
746268|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
2092861|NCT02253173|Hormones|hormones|mesh-ancestor
2235742|NCT00084448|Paclitaxel|paclitaxel|mesh-list
745612|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
745613|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745614|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
745615|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
745616|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
745617|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
745618|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745619|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
745620|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
745621|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745622|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
2235743|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2235744|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235745|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
2235746|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
2235747|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
2235748|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235749|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2235750|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2235751|NCT00084448|Analgesics|analgesics|mesh-ancestor
2235752|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
745920|NCT02802748|Letrozole|letrozole|mesh-list
745921|NCT02802748|Vinorelbine|vinorelbine|mesh-list
745922|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745923|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
745924|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
745925|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745926|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745927|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
745928|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
745929|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
745930|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745931|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
745932|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
745933|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
745934|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
746309|NCT02801201|Midazolam|midazolam|mesh-list
746310|NCT02801201|Bupivacaine|bupivacaine|mesh-list
746311|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
746312|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
746313|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746314|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746315|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
746316|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746317|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
746318|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
746319|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
746320|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
746321|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
746322|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
746323|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
746324|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
746325|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
746326|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
746327|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746549|NCT02799888|Cyclosporine|cyclosporine|mesh-list
746550|NCT02799888|Maraviroc|maraviroc|mesh-list
746551|NCT02799888|Methotrexate|methotrexate|mesh-list
746552|NCT02799888|Tacrolimus|tacrolimus|mesh-list
746553|NCT02799888|Cyclosporins|cyclosporins|mesh-list
746554|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
746555|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
746556|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
746557|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746558|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
746559|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
746560|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746561|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746562|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
746563|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746564|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
746565|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
746566|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
746567|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
746568|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
745709|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
745710|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
745711|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745712|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
745713|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
745714|NCT02804360|Hormones|hormones|mesh-ancestor
745715|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
745716|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
745717|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753595|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753596|NCT02591147|Fluorides|fluorides|mesh-list
747088|NCT02797275|Albuterol|albuterol|mesh-list
747089|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
747090|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
747091|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
747092|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747093|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
747094|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
747095|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
747096|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
747097|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
747098|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
747099|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
747100|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
747101|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
747102|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747157|NCT02796833|SMOFlipid|smoflipid|mesh-list
747158|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
747159|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
747160|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
747617|NCT02794506|Propolis|propolis|mesh-list
747618|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748102|NCT02792257|Dronabinol|dronabinol|mesh-list
748103|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
748104|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748105|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
748106|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
748107|NCT02792257|Analgesics|analgesics|mesh-ancestor
748108|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
748109|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
748110|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
748111|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
748112|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
748113|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748114|NCT02792257|Hormones|hormones|mesh-ancestor
748115|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
748274|NCT02791373|Gemcitabine|gemcitabine|mesh-list
748275|NCT02791373|Vinorelbine|vinorelbine|mesh-list
748276|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
748277|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
748278|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748279|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748280|NCT02791373|Antiviral Agents|antiviral agents|mesh-ancestor
748281|NCT02791373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748282|NCT02791373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748283|NCT02791373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
748284|NCT02791373|Immunologic Factors|immunologic factors|mesh-ancestor
748285|NCT02791373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748286|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
748287|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
748288|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
748289|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
748411|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
748412|NCT02790580|Doxorubicin|doxorubicin|mesh-list
748413|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
748414|NCT02790580|Sunitinib|sunitinib|mesh-list
748415|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
748416|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
748417|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748418|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
748419|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
748420|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
748421|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748422|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745739|NCT02804165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745777|NCT02803788|Dexamethasone|dexamethasone|mesh-list
745778|NCT02803788|Ondansetron|ondansetron|mesh-list
745779|NCT02803788|Ramosetron|ramosetron|mesh-list
745780|NCT02803788|Antiemetics|antiemetics|mesh-list
745781|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
745782|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
745783|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
745784|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745785|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
745786|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
745787|NCT02803788|Hormones|hormones|mesh-ancestor
745788|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
745789|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
745790|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
745791|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
745792|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
745793|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
745794|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
745795|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
745796|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745797|NCT02803788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
745798|NCT02803788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
745799|NCT02803788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
745800|NCT02803788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
745801|NCT02803788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
746211|NCT02801526|Amlodipine|amlodipine|mesh-list
746212|NCT02801526|Candesartan|candesartan|mesh-list
746213|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
746214|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
746215|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
746216|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746217|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
746218|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746219|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
746220|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
746221|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
746306|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
746307|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
746308|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746425|NCT02800772|Acetic Acid|acetic acid|mesh-list
746426|NCT02800772|Retinol acetate|retinol acetate|mesh-list
746427|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
746428|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
746429|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
746430|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
746431|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746432|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
746433|NCT02800772|Protective Agents|protective agents|mesh-ancestor
746434|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746691|NCT02799498|Etanercept|etanercept|mesh-list
746692|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
746693|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
746694|NCT02799498|Analgesics|analgesics|mesh-ancestor
746695|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
746696|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746697|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746698|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
746699|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
746700|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
746701|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
746702|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
2235753|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235754|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235755|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2235756|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2235757|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2235758|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2235759|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235760|NCT00084461|Romidepsin|romidepsin|mesh-list
2235761|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2235762|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235763|NCT00084513|Trastuzumab|trastuzumab|mesh-list
2235764|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
2235765|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
745844|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
745845|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
745846|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
745847|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
745848|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
745849|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745850|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745851|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
745852|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
745853|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
746239|NCT02801292|Ketamine|ketamine|mesh-list
746240|NCT02801292|Analgesics|analgesics|mesh-ancestor
746241|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
746242|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746243|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746244|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
746245|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
746246|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
746247|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
746248|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746249|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
746250|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
746251|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
746252|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746639|NCT02799446|Reslizumab|reslizumab|mesh-list
746640|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
746641|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
746737|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
746738|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
746739|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747458|NCT02795546|Alendronate|alendronate|mesh-list
747459|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
747460|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747608|NCT02794428|Eflornithine|eflornithine|mesh-list
747609|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747610|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
747611|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
747612|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
747613|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
747614|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
747615|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747616|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747882|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
747883|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
747884|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
747885|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
748020|NCT02792621|Acipimox|acipimox|mesh-list
748021|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
748022|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
748023|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748024|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
748087|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
748088|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
748089|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
748090|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748091|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
748092|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
748093|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
748094|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748095|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748096|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2235766|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235767|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2235768|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235769|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235770|NCT00084565|Paclitaxel|paclitaxel|mesh-list
2235771|NCT00084565|Topotecan|topotecan|mesh-list
2235772|NCT00084565|Estramustine|estramustine|mesh-list
2235773|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2235774|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235775|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
2235776|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
2235777|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
2753597|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
745937|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
745938|NCT02802644|Incretins|incretins|mesh-ancestor
745939|NCT02802644|Hormones|hormones|mesh-ancestor
745940|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
745941|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
745942|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
745943|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
745944|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235778|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235779|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2235780|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2235781|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235782|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2235783|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
2235784|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2235785|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
2235786|NCT00084578|Celecoxib|celecoxib|mesh-list
2235787|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2235788|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2235789|NCT00084578|Analgesics|analgesics|mesh-ancestor
2235790|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
2235791|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235792|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235793|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2235794|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2235795|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2235796|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2235797|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235798|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235799|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2235800|NCT00084591|Capecitabine|capecitabine|mesh-list
746730|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
746731|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
746732|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
747246|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
747247|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
747248|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
747249|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
747250|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747251|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
747252|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
747859|NCT02793505|Metformin|metformin|mesh-list
747860|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
747861|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748259|NCT02791243|Finasteride|finasteride|mesh-list
748260|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
748261|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
748262|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748263|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748264|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
748265|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
748266|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748267|NCT02791243|Urological Agents|urological agents|mesh-ancestor
748506|NCT02790164|Rocuronium|rocuronium|mesh-list
748507|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
748508|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
748509|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
748510|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
748511|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753598|NCT02591147|Protective Agents|protective agents|mesh-ancestor
2753599|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753600|NCT02574455|Gemcitabine|gemcitabine|mesh-list
2753601|NCT02574455|Capecitabine|capecitabine|mesh-list
2753602|NCT02574455|Vinorelbine|vinorelbine|mesh-list
2753603|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2753604|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
2753605|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748763|NCT02788851|Guanfacine|guanfacine|mesh-list
748764|NCT02788851|Methylphenidate|methylphenidate|mesh-list
748765|NCT02788851|Amphetamine|amphetamine|mesh-list
748766|NCT02788851|Adderall|adderall|mesh-list
748767|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
748768|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
748769|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
745997|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
745998|NCT02802683|Protective Agents|protective agents|mesh-ancestor
746396|NCT02801032|Tadalafil|tadalafil|mesh-list
746397|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
746398|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
746399|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
746400|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746401|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746402|NCT02801032|Urological Agents|urological agents|mesh-ancestor
747329|NCT02796157|Everolimus|everolimus|mesh-list
747330|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747331|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
747332|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
747333|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235801|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2235802|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
2235803|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235804|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235805|NCT00084604|Bevacizumab|bevacizumab|mesh-list
2235806|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2235807|NCT00084604|Irinotecan|irinotecan|mesh-list
2235808|NCT00084604|Antibodies|antibodies|mesh-list
748149|NCT02791958|Ramipril|ramipril|mesh-list
748150|NCT02791958|Atorvastatin|atorvastatin|mesh-list
748151|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
748152|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
748153|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
748154|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748155|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
748156|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
748157|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748158|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
748159|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
748160|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
748392|NCT02790671|Firuglipel|firuglipel|mesh-list
748393|NCT02790671|Itraconazole|itraconazole|mesh-list
748394|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
748395|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748396|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
748397|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
748398|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748399|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748400|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
748401|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
748402|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
748403|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748404|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
748405|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
748679|NCT02789202|Fluorides|fluorides|mesh-list
748680|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
748681|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
748682|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
748683|NCT02789202|Protective Agents|protective agents|mesh-ancestor
748684|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748839|NCT02788552|Vitamins|vitamins|mesh-list
748840|NCT02788552|Thiamine|thiamine|mesh-list
748841|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
748842|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748843|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
2235809|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
2235810|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2235811|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235812|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
749109|NCT02787226|Bupivacaine|bupivacaine|mesh-list
749110|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
749111|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
749112|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749113|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749114|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
749115|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749252|NCT02786667|Rotigotine|rotigotine|mesh-list
749253|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
749254|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
749255|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749256|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746110|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746111|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
746112|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
746113|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
746114|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
746115|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746116|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
746117|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
746118|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746119|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
746173|NCT02801786|Tamoxifen|tamoxifen|mesh-list
746174|NCT02801786|Lidocaine|lidocaine|mesh-list
746175|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
746176|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
746177|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746178|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746179|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
746180|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746181|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
746182|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
746183|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
746184|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
746185|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746186|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
746187|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
746188|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
746189|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
746190|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746191|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
746192|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
746193|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
746339|NCT02801097|Irinotecan|irinotecan|mesh-list
746340|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
746341|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
746342|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746343|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746344|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747487|NCT02795156|Afatinib|afatinib|mesh-list
747488|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747489|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
747490|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747491|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747834|NCT02793648|Vitamins|vitamins|mesh-list
747835|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
747836|NCT02793648|Vitamin E|vitamin e|mesh-list
747837|NCT02793648|Tocopherols|tocopherols|mesh-list
747838|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
747839|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
747840|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747841|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
747842|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747843|NCT02793648|Protective Agents|protective agents|mesh-ancestor
748495|NCT02790099|Morphine|morphine|mesh-list
748496|NCT02790099|Bupivacaine|bupivacaine|mesh-list
748497|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
748498|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
748499|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
748500|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748501|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
748502|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
748503|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
748504|NCT02790099|Narcotics|narcotics|mesh-ancestor
748505|NCT02790099|Analgesics|analgesics|mesh-ancestor
2235813|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2235814|NCT00084604|Growth Substances|growth substances|mesh-ancestor
2235815|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235816|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
2235817|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
2235818|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2235819|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2235820|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235821|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235822|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
2235823|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746169|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
746170|NCT02802098|Growth Substances|growth substances|mesh-ancestor
746171|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746172|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
746253|NCT02801409|Anesthetics|anesthetics|mesh-list
746254|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746255|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746919|NCT02798250|Insulin|insulin|mesh-list
746920|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
746921|NCT02798250|Glucagon|glucagon|mesh-list
746922|NCT02798250|Hormones|hormones|mesh-list
746923|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
746924|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746925|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
746926|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
746978|NCT02797860|Rocuronium|rocuronium|mesh-list
746979|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
746980|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
746981|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
746982|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746983|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235824|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2235825|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235826|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235827|NCT00084643|Capecitabine|capecitabine|mesh-list
2235828|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
2235829|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2235830|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
2235831|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235832|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235833|NCT00084656|Ipilimumab|ipilimumab|mesh-list
2235834|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2235835|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235836|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2235837|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235838|NCT00084669|Zolpidem|zolpidem|mesh-list
2235839|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2235840|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2235841|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2235842|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
747698|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
747699|NCT02793986|Propofol|propofol|mesh-list
747700|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
747701|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
747702|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747703|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
747704|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
747705|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
747706|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
747707|NCT02793986|Analgesics|analgesics|mesh-ancestor
747708|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
747709|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
747710|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
747711|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
747712|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
747713|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
747714|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
747715|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748226|NCT02791919|Cytarabine|cytarabine|mesh-list
748227|NCT02791919|Fludarabine|fludarabine|mesh-list
748228|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
748229|NCT02791919|Lenograstim|lenograstim|mesh-list
748230|NCT02791919|Sargramostim|sargramostim|mesh-list
748231|NCT02791919|Adavosertib|adavosertib|mesh-list
748232|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748233|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
748234|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
748235|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748236|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
748237|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
748238|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748239|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
748240|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
748241|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
746257|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746258|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
746259|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
746806|NCT02798653|Progesterone|progesterone|mesh-list
746807|NCT02798653|Progestins|progestins|mesh-ancestor
746808|NCT02798653|Hormones|hormones|mesh-ancestor
746809|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
746810|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747203|NCT02796950|Acipimox|acipimox|mesh-list
747204|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
747205|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
747206|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747207|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2235843|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235844|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2235845|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235846|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2235847|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
2235848|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2235849|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2235850|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2235851|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2235852|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2235853|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
2235854|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
2235855|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
2235856|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
2235857|NCT00084695|Melphalan|melphalan|mesh-list
2235858|NCT00084695|Busulfan|busulfan|mesh-list
2235859|NCT00084695|Fludarabine|fludarabine|mesh-list
748014|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
748015|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
748016|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
748017|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748018|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
748019|NCT02792673|Protective Agents|protective agents|mesh-ancestor
748125|NCT02792140|Naltrexone|naltrexone|mesh-list
748126|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
748127|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
748128|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748129|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
748130|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235860|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
2235861|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
748331|NCT02790775|Bevacizumab|bevacizumab|mesh-list
748332|NCT02790775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
748333|NCT02790775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748334|NCT02790775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
748335|NCT02790775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
748336|NCT02790775|Growth Substances|growth substances|mesh-ancestor
748337|NCT02790775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748338|NCT02790775|Growth Inhibitors|growth inhibitors|mesh-ancestor
748576|NCT02789813|Valproic Acid|valproic acid|mesh-list
748577|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
748578|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748579|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748580|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
748581|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
748582|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748583|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
748584|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
748585|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
748586|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
748964|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
748965|NCT02788123|Pantoprazole|pantoprazole|mesh-list
748966|NCT02788123|Bismuth|bismuth|mesh-list
748967|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
748968|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
748969|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
748970|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748971|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748972|NCT02788123|Antacids|antacids|mesh-ancestor
748973|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092862|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2092863|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092864|NCT02253316|Dexamethasone|dexamethasone|mesh-list
746515|NCT02800330|Esomeprazole|esomeprazole|mesh-list
746516|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
746517|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
746518|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
746519|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746520|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746768|NCT02799264|Cabotegravir|cabotegravir|mesh-list
746769|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
746770|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
746771|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746772|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746773|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
746774|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
746775|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
746776|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
747128|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
747129|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
747130|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
747131|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747132|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
747133|NCT02797119|Coagulants|coagulants|mesh-ancestor
2235862|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235863|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
2235864|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748350|NCT02790710|Propranolol|propranolol|mesh-list
748351|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
748352|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
748353|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
748354|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
748355|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748356|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748357|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
748358|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
748359|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
2235865|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2235866|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2235867|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
2235868|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235869|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235870|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2235871|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2235872|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
2235873|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
749230|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
749231|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
749232|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
749233|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
749234|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
749235|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749236|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
749237|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749238|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749239|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
749240|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750016|NCT02783638|Pregabalin|pregabalin|mesh-list
750017|NCT02783638|Analgesics|analgesics|mesh-ancestor
750018|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
750019|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750020|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750021|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
750022|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
750023|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
750024|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750025|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
750026|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
750027|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
750028|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
750029|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2235874|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
2235875|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
746269|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
746270|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
746271|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
746272|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746273|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
746274|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746275|NCT02801305|Emollients|emollients|mesh-ancestor
746276|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
2092865|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
2092866|NCT02253316|Lenalidomide|lenalidomide|mesh-list
2092867|NCT02253316|Ixazomib|ixazomib|mesh-list
746642|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
746643|NCT02799589|Remifentanil|remifentanil|mesh-list
746644|NCT02799589|Ropivacaine|ropivacaine|mesh-list
746645|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
746646|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746647|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746648|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
746649|NCT02799589|Analgesics|analgesics|mesh-ancestor
746650|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
746651|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746652|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
746653|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
746654|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
746655|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
746656|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
746657|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746658|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
746659|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
746660|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
746661|NCT02799589|Narcotics|narcotics|mesh-ancestor
746786|NCT02799147|Fludarabine|fludarabine|mesh-list
746787|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
746788|NCT02799147|Busulfan|busulfan|mesh-list
746789|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
746790|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746791|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
746792|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
746793|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746794|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
746795|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
746796|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746797|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
746798|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
746799|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
746975|NCT02797782|Antibodies|antibodies|mesh-list
746976|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
746977|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747033|NCT02797548|Aspirin|aspirin|mesh-list
747034|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
747035|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
747036|NCT02797548|Analgesics|analgesics|mesh-ancestor
747037|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
747038|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
747039|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747040|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
747041|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
747042|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
747043|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
747044|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747045|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
747046|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
747047|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747048|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
2753606|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753607|NCT02574455|Antiviral Agents|antiviral agents|mesh-ancestor
2092868|NCT02253316|BB 1101|bb 1101|mesh-list
746356|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746357|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
746358|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
746359|NCT02801188|Analgesics|analgesics|mesh-ancestor
746360|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
746361|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
746362|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
746363|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
746364|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
746365|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746720|NCT02799238|Temozolomide|temozolomide|mesh-list
746721|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
746722|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
746723|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746724|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746886|NCT02798510|Gemcitabine|gemcitabine|mesh-list
746887|NCT02798510|Capecitabine|capecitabine|mesh-list
746888|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
746889|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
746890|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746891|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746892|NCT02798510|Antiviral Agents|antiviral agents|mesh-ancestor
746893|NCT02798510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
746894|NCT02798510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746895|NCT02798510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
746896|NCT02798510|Immunologic Factors|immunologic factors|mesh-ancestor
746897|NCT02798510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746945|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
746946|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
746947|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
746948|NCT02798068|Prednisolone|prednisolone|mesh-list
746949|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
746950|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
746951|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
746952|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
746953|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
746954|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
746955|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746956|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746957|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
746958|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
746959|NCT02798068|Hormones|hormones|mesh-ancestor
746960|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
746961|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
746962|NCT02798068|Protective Agents|protective agents|mesh-ancestor
746963|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
746964|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747334|NCT02796183|Bevacizumab|bevacizumab|mesh-list
747335|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
747336|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747337|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
747338|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
747339|NCT02796183|Growth Substances|growth substances|mesh-ancestor
747340|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747341|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
747739|NCT02793908|Progesterone|progesterone|mesh-list
747740|NCT02793908|Progestins|progestins|mesh-ancestor
747741|NCT02793908|Hormones|hormones|mesh-ancestor
747742|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
747743|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235876|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235877|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2235878|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
2235879|NCT00084695|Hormones|hormones|mesh-ancestor
748433|NCT02790632|Nimodipine|nimodipine|mesh-list
748434|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
748435|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
748436|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
748437|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748438|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
748439|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748440|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
748629|NCT02789150|Norepinephrine|norepinephrine|mesh-list
2235880|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
746473|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746620|NCT02799355|Interferons|interferons|mesh-list
746621|NCT02799355|Ribavirin|ribavirin|mesh-list
746622|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
746623|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746624|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
746625|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
746626|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
746627|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747492|NCT02795039|Fulvestrant|fulvestrant|mesh-list
747493|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
747494|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747495|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
747496|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
747497|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
747498|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
747499|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092869|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2092870|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
2092871|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
2092872|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092873|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092874|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2092875|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
2092876|NCT02253316|Hormones|hormones|mesh-ancestor
2092877|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2092878|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2092879|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092880|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
2092881|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092882|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092883|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
2235881|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2235882|NCT00084695|Protective Agents|protective agents|mesh-ancestor
2235883|NCT00084708|Calcitriol|calcitriol|mesh-list
2235884|NCT00084708|Dexamethasone|dexamethasone|mesh-list
2235885|NCT00084708|Gefitinib|gefitinib|mesh-list
2235886|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2235887|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
2235888|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
748992|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
748993|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
749355|NCT02785978|Levodopa|levodopa|mesh-list
749356|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
749357|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
749358|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
749359|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749360|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749361|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749460|NCT02785549|Acetaminophen|acetaminophen|mesh-list
749461|NCT02785549|Amoxicillin|amoxicillin|mesh-list
749462|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
749463|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
749464|NCT02785549|Ibuprofen|ibuprofen|mesh-list
749465|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
749466|NCT02785549|Analgesics|analgesics|mesh-ancestor
749467|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
749468|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749469|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749470|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
749471|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
749472|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
749473|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
749474|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
749475|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749476|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749477|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
749478|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
749479|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2235889|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235890|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235891|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2235892|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
2235893|NCT00084708|Hormones|hormones|mesh-ancestor
2235894|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2235895|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
746491|NCT02800174|Clopidogrel|clopidogrel|mesh-list
746492|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
746493|NCT02800174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
746494|NCT02800174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
746495|NCT02800174|Analgesics|analgesics|mesh-ancestor
746496|NCT02800174|Sensory System Agents|sensory system agents|mesh-ancestor
746497|NCT02800174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746498|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746499|NCT02800174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
746500|NCT02800174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
746501|NCT02800174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
746502|NCT02800174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
746503|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746504|NCT02800174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
746505|NCT02800174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
746506|NCT02800174|Antipyretics|antipyretics|mesh-ancestor
746507|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
746508|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
746509|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
746510|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
746511|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
746521|NCT02799862|Paclitaxel|paclitaxel|mesh-list
746522|NCT02799862|Carboplatin|carboplatin|mesh-list
746523|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
746524|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746525|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
746526|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
746527|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
746528|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746906|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
746907|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
746908|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747235|NCT02796859|Siltuximab|siltuximab|mesh-list
747236|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747500|NCT02795299|Folic Acid|folic acid|mesh-list
747501|NCT02795299|Methotrexate|methotrexate|mesh-list
747502|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
747503|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
747504|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
747505|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747506|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
747507|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
747508|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747509|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747510|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
747511|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747512|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
747513|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
747514|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
747515|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
747516|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
747517|NCT02795299|Hematinics|hematinics|mesh-ancestor
747518|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
747519|NCT02795299|Vitamins|vitamins|mesh-ancestor
747520|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
747563|NCT02794779|Oxytocin|oxytocin|mesh-list
747564|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
747565|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
747566|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748056|NCT02792465|Fulvestrant|fulvestrant|mesh-list
748057|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
748058|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748059|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
748060|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
748061|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
748062|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
748063|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748618|NCT02789592|Clonazepam|clonazepam|mesh-list
748619|NCT02789592|Melatonin|melatonin|mesh-list
748620|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
748621|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748622|NCT02789592|Protective Agents|protective agents|mesh-ancestor
748623|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748624|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
748625|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
746569|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
746570|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
746571|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
746572|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
746573|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
746574|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
746575|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
746576|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
746577|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
746636|NCT02799459|Anesthetics|anesthetics|mesh-list
746637|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
746638|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746740|NCT02799134|Ascorbic Acid|ascorbic acid|mesh-list
746741|NCT02799134|Dexamethasone|dexamethasone|mesh-list
746742|NCT02799134|Vitamins|vitamins|mesh-ancestor
746743|NCT02799134|Micronutrients|micronutrients|mesh-ancestor
746744|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746745|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
746746|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
746747|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
746748|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
746749|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
746750|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
746751|NCT02799134|Hormones|hormones|mesh-ancestor
746752|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
746753|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
746754|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
746755|NCT02799134|Antioxidants|antioxidants|mesh-ancestor
746756|NCT02799134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
746757|NCT02799134|Protective Agents|protective agents|mesh-ancestor
747085|NCT02797236|Vaccines|vaccines|mesh-list
747086|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
747087|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235896|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235897|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2235898|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235899|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235900|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2235901|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
747379|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
747380|NCT02795949|Amoxicillin|amoxicillin|mesh-list
747381|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
747382|NCT02795949|Meropenem|meropenem|mesh-list
747383|NCT02795949|Tazobactam|tazobactam|mesh-list
747384|NCT02795949|Piperacillin|piperacillin|mesh-list
747385|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
747386|NCT02795949|Imipenem|imipenem|mesh-list
747387|NCT02795949|Ceftazidime|ceftazidime|mesh-list
747388|NCT02795949|Ampicillin|ampicillin|mesh-list
747389|NCT02795949|Ertapenem|ertapenem|mesh-list
747390|NCT02795949|Cefuroxime|cefuroxime|mesh-list
747391|NCT02795949|Cefepime|cefepime|mesh-list
747392|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
747393|NCT02795949|Lactams|lactams|mesh-list
747394|NCT02795949|Aztreonam|aztreonam|mesh-list
747395|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
747396|NCT02795949|beta-Lactams|beta-lactams|mesh-list
747397|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
747398|NCT02795949|Trimethoprim|trimethoprim|mesh-list
747399|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
747400|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
747401|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
747402|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
747403|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
747404|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747405|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747406|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747407|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
747408|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
747409|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
747410|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
747411|NCT02795949|Renal Agents|renal agents|mesh-ancestor
747412|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
747413|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
747414|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
747415|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
747416|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
747417|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
746767|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
746995|NCT02797717|Prednisone|prednisone|mesh-list
746996|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
746997|NCT02797717|Dacarbazine|dacarbazine|mesh-list
746998|NCT02797717|Doxorubicin|doxorubicin|mesh-list
746999|NCT02797717|Etoposide|etoposide|mesh-list
747000|NCT02797717|Vincristine|vincristine|mesh-list
747001|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
747002|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
747003|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747004|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
747005|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
747006|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
747007|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747008|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747009|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
747010|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
747011|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
747012|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
747013|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747014|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
747015|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
747016|NCT02797717|Hormones|hormones|mesh-ancestor
747017|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
747018|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
747019|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
747020|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
747021|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
747022|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
747161|NCT02796794|Genistein|genistein|mesh-list
747162|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
747163|NCT02796794|Protective Agents|protective agents|mesh-ancestor
747164|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747165|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747166|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
747167|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747168|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747169|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
747170|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
747171|NCT02796794|Estrogens|estrogens|mesh-ancestor
747172|NCT02796794|Hormones|hormones|mesh-ancestor
747173|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
747537|NCT02795065|Enoxaparin|enoxaparin|mesh-list
747538|NCT02795065|Bemiparin|bemiparin|mesh-list
747539|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
747540|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
747541|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
747542|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747619|NCT02794584|Sufentanil|sufentanil|mesh-list
747620|NCT02794584|Dsuvia|dsuvia|mesh-list
747621|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
747622|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
747623|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747624|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
747625|NCT02794584|Narcotics|narcotics|mesh-ancestor
747626|NCT02794584|Analgesics|analgesics|mesh-ancestor
747627|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
747628|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
747629|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
747630|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
747631|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
747802|NCT02793765|Docetaxel|docetaxel|mesh-list
747803|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747804|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
747805|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
747806|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
747807|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747854|NCT02793323|Anesthetics|anesthetics|mesh-list
747855|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
747856|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235902|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2235903|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2235904|NCT00084708|Vitamins|vitamins|mesh-ancestor
2235905|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
2235906|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2235907|NCT00084721|Celecoxib|celecoxib|mesh-list
747955|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2235908|NCT00084721|Irinotecan|irinotecan|mesh-list
2235909|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2235910|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2235911|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235912|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235913|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235914|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2235915|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2235916|NCT00084721|Analgesics|analgesics|mesh-ancestor
2235917|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
2235918|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2235919|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235920|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2235921|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2235922|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2235923|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
746915|NCT02798055|Bosentan|bosentan|mesh-list
746916|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
746917|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
746918|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235924|NCT00084734|Docetaxel|docetaxel|mesh-list
2235925|NCT00084734|Capecitabine|capecitabine|mesh-list
2235926|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235927|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
2235928|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
2235929|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
2235930|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235931|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2235932|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
2235933|NCT00084773|Fluorouracil|fluorouracil|mesh-list
2235934|NCT00084773|Cetuximab|cetuximab|mesh-list
2235935|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
2235936|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235937|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2235938|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235939|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235940|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
2235941|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235942|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2235943|NCT00084786|Docetaxel|docetaxel|mesh-list
2235944|NCT00084786|Gefitinib|gefitinib|mesh-list
2235945|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235946|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
2235947|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
2092884|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2092885|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2092886|NCT02253316|Growth Substances|growth substances|mesh-ancestor
2092887|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
2092888|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
748318|NCT02790957|Plerixafor|plerixafor|mesh-list
748319|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
748320|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
748321|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
748322|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748786|NCT02788981|Paclitaxel|paclitaxel|mesh-list
748787|NCT02788981|Mifepristone|mifepristone|mesh-list
748788|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
748789|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748790|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
748791|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
748792|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
748793|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748794|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
748795|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
748796|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
748797|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748798|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
748799|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
748800|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
748801|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
748802|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
748803|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
748804|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
748805|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2092889|NCT02253654|Hematinics|hematinics|mesh-ancestor
2092890|NCT02253992|Nivolumab|nivolumab|mesh-list
2092891|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2092892|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747136|NCT02797028|Allopurinol|allopurinol|mesh-list
747137|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
747138|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747139|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747140|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
747141|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
747142|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
747143|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
747144|NCT02797028|Protective Agents|protective agents|mesh-ancestor
747145|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747297|NCT02796378|Ubiquinone|ubiquinone|mesh-list
747298|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
747299|NCT02796378|Simvastatin|simvastatin|mesh-list
747300|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
747301|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
747302|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
747303|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747304|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
747305|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
747306|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747307|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
747308|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747309|NCT02796378|Vitamins|vitamins|mesh-ancestor
747844|NCT02793375|Montelukast|montelukast|mesh-list
747845|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
747846|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
747847|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
747848|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
747849|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
747850|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747851|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
747852|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
747853|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747962|NCT02792712|Clopidogrel|clopidogrel|mesh-list
747963|NCT02792712|Ticagrelor|ticagrelor|mesh-list
747964|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
747965|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
747966|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
747967|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
747968|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
747969|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
747970|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747971|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235948|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
2235949|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235950|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2235951|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235952|NCT00084799|Antibodies|antibodies|mesh-list
748441|NCT02790528|Atorvastatin|atorvastatin|mesh-list
748442|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
748443|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
748444|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
748445|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748446|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
748447|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
748448|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748476|NCT02790203|Celecoxib|celecoxib|mesh-list
748477|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
748478|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
748479|NCT02790203|Analgesics|analgesics|mesh-ancestor
748480|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
748481|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
748482|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748483|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
748484|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
748485|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
748486|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
748487|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748488|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748744|NCT02788864|Piperaquine|piperaquine|mesh-list
747049|NCT02797587|Nicotine|nicotine|mesh-list
747050|NCT02797587|Varenicline|varenicline|mesh-list
747051|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
747052|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
747053|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
747054|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747055|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
747056|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
747057|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
747058|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
747059|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747461|NCT02795754|Ritonavir|ritonavir|mesh-list
747462|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
747463|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
747464|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
747465|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
747466|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747467|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747468|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
747469|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
747470|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
747471|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
747472|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
747473|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
747524|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
747525|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747526|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
747527|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747528|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747886|NCT02793219|Docetaxel|docetaxel|mesh-list
747887|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747888|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
747889|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
747890|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
747891|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748046|NCT02792426|Nicotine|nicotine|mesh-list
748047|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
748048|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
748049|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
748050|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748051|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
748052|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
748053|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
748054|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
748055|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748116|NCT02792088|Tenofovir|tenofovir|mesh-list
748117|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
748118|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748119|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
748120|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
748121|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748122|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748123|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
748124|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
748223|NCT02791737|Coal Tar|coal tar|mesh-list
748224|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
748225|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
748344|NCT02790840|Omeprazole|omeprazole|mesh-list
748345|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
748346|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
748347|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
748348|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748349|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748591|NCT02789657|Paclitaxel|paclitaxel|mesh-list
748592|NCT02789657|Carboplatin|carboplatin|mesh-list
748593|NCT02789657|Trastuzumab|trastuzumab|mesh-list
748594|NCT02789657|Pertuzumab|pertuzumab|mesh-list
748595|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
748596|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748597|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
748598|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
748599|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
748600|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748601|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2235953|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2235954|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
747232|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
747233|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747234|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747432|NCT02795572|Vitamin D|vitamin d|mesh-list
747433|NCT02795572|Vitamins|vitamins|mesh-list
747434|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
747435|NCT02795572|Hydroxocobalamin|hydroxocobalamin|mesh-list
747436|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
747437|NCT02795572|Pyridoxal|pyridoxal|mesh-list
747438|NCT02795572|Pyridoxine|pyridoxine|mesh-list
747439|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
747440|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
747441|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747442|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
747443|NCT02795572|Hematinics|hematinics|mesh-ancestor
747644|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
747645|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
747646|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
747647|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
747648|NCT02794389|Expectorants|expectorants|mesh-ancestor
747649|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
747650|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
747651|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
747652|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747653|NCT02794389|Protective Agents|protective agents|mesh-ancestor
747654|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747655|NCT02794389|Antidotes|antidotes|mesh-ancestor
747716|NCT02794025|Esmolol|esmolol|mesh-list
747717|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
747718|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
747719|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
747720|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
747721|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
747722|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747723|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747928|NCT02793011|Dexamethasone|dexamethasone|mesh-list
747929|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
747930|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
747931|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
747932|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
747933|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747934|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
747935|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
747936|NCT02793011|Hormones|hormones|mesh-ancestor
747937|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
747938|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
747939|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092893|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2092894|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092895|NCT02254252|Nicorandil|nicorandil|mesh-list
2092896|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
2092897|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
2092898|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2092899|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
749152|NCT02787031|Anesthetics|anesthetics|mesh-list
749153|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749154|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749636|NCT02785003|Acetaminophen|acetaminophen|mesh-list
749637|NCT02785003|Morphine|morphine|mesh-list
749638|NCT02785003|Narcotics|narcotics|mesh-list
749639|NCT02785003|Ketamine|ketamine|mesh-list
749640|NCT02785003|Alvimopan|alvimopan|mesh-list
749641|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
749642|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749643|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749644|NCT02785003|Analgesics|analgesics|mesh-ancestor
749645|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
749646|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749647|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
749648|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
749649|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
749650|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
749651|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
749652|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
749653|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749654|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749655|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
747343|NCT02796170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
747344|NCT02796170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747345|NCT02796170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
747346|NCT02796170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747418|NCT02795884|Cisplatin|cisplatin|mesh-list
747419|NCT02795884|Pemetrexed|pemetrexed|mesh-list
747420|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
747421|NCT02795884|Vinorelbine|vinorelbine|mesh-list
747422|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747423|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747424|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747425|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
747426|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
747427|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
747428|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
747429|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
747430|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
747431|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
747813|NCT02793388|Primaquine|primaquine|mesh-list
747814|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
747815|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
747816|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
747817|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092900|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
2092901|NCT02254252|Vitamins|vitamins|mesh-ancestor
2092902|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
2092903|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092904|NCT02254278|Cisplatin|cisplatin|mesh-list
2092905|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092906|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2092907|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2092908|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092909|NCT02254291|Incretins|incretins|mesh-ancestor
2092910|NCT02254291|Hormones|hormones|mesh-ancestor
2092911|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2092912|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2092913|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
2092914|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092915|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092916|NCT02254304|Interferons|interferons|mesh-list
2092917|NCT02254304|Interferon-beta|interferon-beta|mesh-list
2092918|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
2092919|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092920|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
2092921|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748685|NCT02789189|Gemcitabine|gemcitabine|mesh-list
748686|NCT02789189|Nedaplatin|nedaplatin|mesh-list
748687|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
748688|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
748689|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748690|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748691|NCT02789189|Antiviral Agents|antiviral agents|mesh-ancestor
748692|NCT02789189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748693|NCT02789189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748694|NCT02789189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
748695|NCT02789189|Immunologic Factors|immunologic factors|mesh-ancestor
748696|NCT02789189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748961|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
748962|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
748963|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748987|NCT02787642|Olaparib|olaparib|mesh-list
748988|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
748989|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748990|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748991|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749073|NCT02787369|Idelalisib|idelalisib|mesh-list
749074|NCT02787369|Ricolinostat|ricolinostat|mesh-list
749075|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749076|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749077|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749078|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2235955|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235956|NCT00084812|Safingol|safingol|mesh-list
749309|NCT02786264|Fentanyl|fentanyl|mesh-list
749310|NCT02786264|Midazolam|midazolam|mesh-list
749311|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
2753608|NCT02574455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2753609|NCT02574455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753610|NCT02574455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2753611|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
2753612|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753613|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2753614|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
2753615|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
2753616|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
747576|NCT02794792|Metformin|metformin|mesh-list
747577|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
747578|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
747579|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747580|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
747581|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747683|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
747684|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
747685|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
747686|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747687|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
747688|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
747689|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
747690|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747691|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747692|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2235957|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235958|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235959|NCT00084825|Docetaxel|docetaxel|mesh-list
2235960|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
2235961|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235962|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
2235963|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
2235964|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
2235965|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235966|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2235967|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235968|NCT00084877|Irinotecan|irinotecan|mesh-list
2235969|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
748550|NCT02789865|Metronidazole|metronidazole|mesh-list
748551|NCT02789865|Levofloxacin|levofloxacin|mesh-list
748552|NCT02789865|Ofloxacin|ofloxacin|mesh-list
748553|NCT02789865|Ertapenem|ertapenem|mesh-list
748554|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748555|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
748556|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
748557|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
748558|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
748559|NCT02789865|Renal Agents|renal agents|mesh-ancestor
748560|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
748561|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
748562|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748563|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748564|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748565|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
748566|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
749200|NCT02786732|Ustekinumab|ustekinumab|mesh-list
749201|NCT02786732|Brodalumab|brodalumab|mesh-list
749202|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
749203|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
749204|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
749205|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749417|NCT02785601|Trazodone|trazodone|mesh-list
749418|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
749419|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
749420|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749421|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749422|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
749423|NCT02785601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
749424|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
749425|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
749426|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749427|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749428|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
749429|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2092922|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
2092923|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092924|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2092925|NCT02254551|Bortezomib|bortezomib|mesh-list
2092926|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092927|NCT02254681|Gemcitabine|gemcitabine|mesh-list
2092928|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092929|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2092930|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
2092931|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747582|NCT02794883|Durvalumab|durvalumab|mesh-list
747583|NCT02794883|Ipilimumab|ipilimumab|mesh-list
747584|NCT02794883|Tremelimumab|tremelimumab|mesh-list
747585|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
747586|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
747587|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
747588|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
747589|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747590|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
747591|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747592|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
747593|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747601|NCT02794402|Exenatide|exenatide|mesh-list
747602|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
747603|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747604|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
747605|NCT02794402|Incretins|incretins|mesh-ancestor
747606|NCT02794402|Hormones|hormones|mesh-ancestor
747607|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
747828|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
747829|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
747830|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
747831|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747832|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
747833|NCT02793739|Protective Agents|protective agents|mesh-ancestor
748064|NCT02792335|Warfarin|warfarin|mesh-list
748065|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
748066|NCT02792335|Dabigatran|dabigatran|mesh-list
748067|NCT02792335|Apixaban|apixaban|mesh-list
748068|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
748069|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
748070|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
748071|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
748072|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
748073|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748074|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235970|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
749160|NCT02786992|Misoprostol|misoprostol|mesh-list
749161|NCT02786992|Oxytocin|oxytocin|mesh-list
749162|NCT02786992|Carbetocin|carbetocin|mesh-list
749163|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
749164|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
749165|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749166|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
749167|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
749168|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
749169|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
749337|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
749338|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
749339|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749340|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749341|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
749342|NCT02786212|Analgesics|analgesics|mesh-ancestor
749343|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
749344|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749345|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
749346|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
749347|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
749348|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
749349|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749350|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749488|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
749489|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
749490|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
749491|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749492|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2092932|NCT02254681|Antiviral Agents|antiviral agents|mesh-ancestor
747485|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747486|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747570|NCT02794714|Rocuronium|rocuronium|mesh-list
747571|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
747572|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
747573|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
747574|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
747575|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235971|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235972|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235973|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235974|NCT00084890|Carboplatin|carboplatin|mesh-list
2235975|NCT00084890|Docetaxel|docetaxel|mesh-list
2235976|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235977|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
2235978|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
2235979|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
2235980|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235981|NCT00084916|Sirolimus|sirolimus|mesh-list
2235982|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2235983|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235984|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2235985|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235986|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
2235987|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2235988|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
2235989|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2235990|NCT00084942|Gemcitabine|gemcitabine|mesh-list
2235991|NCT00084942|Capecitabine|capecitabine|mesh-list
2235992|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
748097|NCT02792153|Estradiol|estradiol|mesh-list
748098|NCT02792153|Estrogens|estrogens|mesh-ancestor
748099|NCT02792153|Hormones|hormones|mesh-ancestor
748100|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
748101|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748202|NCT02791815|Selexipag|selexipag|mesh-list
748203|NCT02791815|Midazolam|midazolam|mesh-list
748204|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
748205|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
748206|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
748207|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748208|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
748209|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
748210|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
748211|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
748212|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
748213|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
748214|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
748215|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
748216|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
748217|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748218|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
748313|NCT02791334|Ramucirumab|ramucirumab|mesh-list
748314|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748709|NCT02789332|Paclitaxel|paclitaxel|mesh-list
748710|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
748711|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
748712|NCT02789332|Carboplatin|carboplatin|mesh-list
748713|NCT02789332|Epirubicin|epirubicin|mesh-list
748714|NCT02789332|Olaparib|olaparib|mesh-list
748715|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
748716|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748717|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
748718|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
748719|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
748720|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748721|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
748722|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
748723|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748724|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
748725|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
748726|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
748727|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
748728|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
748729|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
748745|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
2235993|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
2235994|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2235995|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2235996|NCT00084942|Antiviral Agents|antiviral agents|mesh-ancestor
2235997|NCT00084942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2235998|NCT00084942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2235999|NCT00084942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236000|NCT00084942|Immunologic Factors|immunologic factors|mesh-ancestor
2236001|NCT00084942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236002|NCT00084981|Decitabine|decitabine|mesh-list
748199|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
748200|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
748201|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748974|NCT02788058|Gefitinib|gefitinib|mesh-list
748975|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748976|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
748977|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748978|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749051|NCT02787356|Lidocaine|lidocaine|mesh-list
749052|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
749053|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
749054|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749055|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749056|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
749057|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749058|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
749059|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
749060|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
749061|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
749062|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749614|NCT02785068|Leucovorin|leucovorin|mesh-list
749615|NCT02785068|Fluorouracil|fluorouracil|mesh-list
749616|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
749617|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749618|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
749619|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749620|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
749621|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
749622|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749623|NCT02785068|Antidotes|antidotes|mesh-ancestor
749624|NCT02785068|Protective Agents|protective agents|mesh-ancestor
749625|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
749626|NCT02785068|Vitamins|vitamins|mesh-ancestor
749627|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
2092933|NCT02254681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2092934|NCT02254681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092935|NCT02254681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236003|NCT00084981|Azacitidine|azacitidine|mesh-list
2236004|NCT00084981|Valproic Acid|valproic acid|mesh-list
2236005|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2236006|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
2236007|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236008|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236009|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236010|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
751015|NCT02778399|OBE2109|obe2109|mesh-list
751016|NCT02778399|Hormone Antagonists|hormone antagonists|mesh-ancestor
751017|NCT02778399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
751018|NCT02778399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236011|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
2236012|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
751577|NCT02776163|Docetaxel|docetaxel|mesh-list
751578|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751579|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
751580|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
751581|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
751582|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751928|NCT02774811|Bimatoprost|bimatoprost|mesh-list
751929|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
752126|NCT02774291|Aldesleukin|aldesleukin|mesh-list
752127|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
752128|NCT02774291|Fludarabine|fludarabine|mesh-list
752129|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
752130|NCT02774291|Interleukin-2|interleukin-2|mesh-list
752131|NCT02774291|Lenograstim|lenograstim|mesh-list
752132|NCT02774291|Sargramostim|sargramostim|mesh-list
752133|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
752134|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
747913|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
747914|NCT02793544|Protective Agents|protective agents|mesh-ancestor
2236013|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236014|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
2236015|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2236016|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2236017|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236018|NCT00085020|Trastuzumab|trastuzumab|mesh-list
2236019|NCT00085020|Lapatinib|lapatinib|mesh-list
2236020|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2236021|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236022|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2236023|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236024|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236025|NCT00085111|Bevacizumab|bevacizumab|mesh-list
2236026|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2236027|NCT00085111|Antibodies|antibodies|mesh-list
2236028|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
2236029|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2236030|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236031|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2236032|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
749087|NCT02787278|Otaplimastat|otaplimastat|mesh-list
749088|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
749089|NCT02787278|Protective Agents|protective agents|mesh-ancestor
749090|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749401|NCT02785757|Thrombin|thrombin|mesh-list
749402|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
749403|NCT02785757|Coagulants|coagulants|mesh-ancestor
2236033|NCT00085111|Growth Substances|growth substances|mesh-ancestor
2236034|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236035|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
2236036|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
2236037|NCT00085124|Cytarabine|cytarabine|mesh-list
2236038|NCT00085124|Daunorubicin|daunorubicin|mesh-list
2236039|NCT00085124|Oblimersen|oblimersen|mesh-list
2236040|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
749658|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
749659|NCT02784821|Gentamicins|gentamicins|mesh-list
749660|NCT02784821|Ampicillin|ampicillin|mesh-list
749661|NCT02784821|Cefotaxime|cefotaxime|mesh-list
749662|NCT02784821|Cefoxitin|cefoxitin|mesh-list
749663|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
749664|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
749665|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
749666|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
749667|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749668|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749831|NCT02784080|Isoantibodies|isoantibodies|mesh-list
749832|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
749833|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236041|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
2236042|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236043|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236044|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
2236045|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236046|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236047|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
2236048|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236049|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2236050|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2236051|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2236052|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750678|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
750679|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
750680|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
750681|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750682|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
750683|NCT02780427|Analgesics|analgesics|mesh-ancestor
750684|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
750685|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750686|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
750687|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
750688|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
750689|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
750690|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
751195|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
2236053|NCT00085150|Immunotoxins|immunotoxins|mesh-list
2236054|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
2236055|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748075|NCT02792400|Empagliflozin|empagliflozin|mesh-list
748076|NCT02792400|Linagliptin|linagliptin|mesh-list
748077|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
748078|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748079|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
748080|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748081|NCT02792400|Incretins|incretins|mesh-ancestor
748082|NCT02792400|Hormones|hormones|mesh-ancestor
748083|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
748084|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
748085|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
748086|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748323|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
748324|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
748325|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748326|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
748327|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749409|NCT02785718|Hemostatics|hemostatics|mesh-list
749410|NCT02785718|Coagulants|coagulants|mesh-ancestor
749887|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
749888|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
749889|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
749890|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749891|NCT02783989|Protective Agents|protective agents|mesh-ancestor
749892|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750095|NCT02783144|Dexamethasone|dexamethasone|mesh-list
750096|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
750097|NCT02783144|BB 1101|bb 1101|mesh-list
750098|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
750099|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
750100|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
750101|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750102|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750103|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
750104|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
750105|NCT02783144|Hormones|hormones|mesh-ancestor
750106|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
750107|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
750108|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750109|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
750110|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750111|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236056|NCT00085163|Leucovorin|leucovorin|mesh-list
2236057|NCT00085163|Celecoxib|celecoxib|mesh-list
2236058|NCT00085163|Fluorouracil|fluorouracil|mesh-list
2236059|NCT00085163|Calcium|calcium|mesh-list
2236060|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
2236061|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
750328|NCT02782208|Acipimox|acipimox|mesh-list
750329|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
750330|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
750331|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750332|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2236062|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
747956|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
747957|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747958|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
747959|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
747960|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
747961|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
748512|NCT02789969|Fentanyl|fentanyl|mesh-list
748513|NCT02789969|Hydromorphone|hydromorphone|mesh-list
748514|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
748515|NCT02789969|Narcotics|narcotics|mesh-ancestor
748516|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
748517|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748518|NCT02789969|Analgesics|analgesics|mesh-ancestor
748519|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
748520|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
748521|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
748522|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
748523|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
748524|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
748645|NCT02789475|Amlodipine|amlodipine|mesh-list
748646|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
748647|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
748648|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
748649|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
748650|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748651|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
748652|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748653|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
748654|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
748655|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
748656|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
748657|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
748658|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
748659|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236063|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
2236064|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236065|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2236066|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236067|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236068|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
2236069|NCT00085163|Antidotes|antidotes|mesh-ancestor
2236070|NCT00085163|Protective Agents|protective agents|mesh-ancestor
2236071|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
2236072|NCT00085163|Vitamins|vitamins|mesh-ancestor
2236073|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
2236074|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2236075|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
749007|NCT02787798|Valsartan|valsartan|mesh-list
749008|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
749009|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
749010|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
749011|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
749012|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749183|NCT02786875|Vitamin D|vitamin d|mesh-list
749184|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
749185|NCT02786875|Vitamins|vitamins|mesh-list
749186|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
749187|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749188|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
749189|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2236076|NCT00085163|Analgesics|analgesics|mesh-ancestor
2236077|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
2236078|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2236079|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2236080|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
750740|NCT02780024|Metformin|metformin|mesh-list
750741|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
750742|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751186|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
751187|NCT02779283|Leucovorin|leucovorin|mesh-list
751188|NCT02779283|Folic Acid|folic acid|mesh-list
751189|NCT02779283|Cytarabine|cytarabine|mesh-list
751190|NCT02779283|Dexamethasone|dexamethasone|mesh-list
751191|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
751192|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
751193|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
747987|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
747988|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
747989|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
747990|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
747991|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
747992|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
747993|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
747994|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
747995|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
747996|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
747997|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
747998|NCT02792491|Hormones|hormones|mesh-ancestor
747999|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
748000|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
748001|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
748002|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
748003|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
748004|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
748567|NCT02789878|Prednisone|prednisone|mesh-list
748568|NCT02789878|Goserelin|goserelin|mesh-list
748569|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
748570|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
748571|NCT02789878|Hormones|hormones|mesh-ancestor
748572|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
748573|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748574|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
748575|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748590|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
748994|NCT02787746|Donepezil|donepezil|mesh-list
748995|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
748996|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748997|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748998|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
748999|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749000|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749001|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
2236081|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2236082|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2236083|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236084|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
2236085|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2236086|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
749670|NCT02784457|Cetrorelix|cetrorelix|mesh-list
749671|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
749672|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
749673|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
749674|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749675|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
750249|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236087|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236088|NCT00085228|Docetaxel|docetaxel|mesh-list
2236089|NCT00085228|Oblimersen|oblimersen|mesh-list
2236090|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236091|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
2236092|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
2236093|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
2236094|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236095|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2236096|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236097|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2236098|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236099|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236100|NCT00085306|Interferons|interferons|mesh-list
2236101|NCT00085306|Interferon-beta|interferon-beta|mesh-list
2236102|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236103|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
748341|NCT02790684|Firuglipel|firuglipel|mesh-list
748342|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
748343|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749022|NCT02787473|Docetaxel|docetaxel|mesh-list
749023|NCT02787473|Pemetrexed|pemetrexed|mesh-list
749024|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749025|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
749026|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
749027|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
749028|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749029|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749030|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
749031|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2236104|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236105|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
2236106|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236107|NCT00085332|Docetaxel|docetaxel|mesh-list
2236108|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236109|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
2236110|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
2236111|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
2236112|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236113|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
2236114|NCT00085345|Melphalan|melphalan|mesh-list
2236115|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
2236116|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2236117|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
2236118|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236119|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236120|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2236121|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236122|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
2236123|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236124|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
2236125|NCT00085345|Protective Agents|protective agents|mesh-ancestor
2236126|NCT00085345|Vitamins|vitamins|mesh-ancestor
2236127|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
2236128|NCT00085358|Paclitaxel|paclitaxel|mesh-list
2236129|NCT00085358|Docetaxel|docetaxel|mesh-list
2236130|NCT00085358|Bevacizumab|bevacizumab|mesh-list
2236131|NCT00085358|Carboplatin|carboplatin|mesh-list
2236132|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2236133|NCT00085358|Antibodies|antibodies|mesh-list
2236134|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
748242|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748537|NCT02789982|Propranolol|propranolol|mesh-list
748538|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
748539|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
748540|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
748541|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
748542|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748543|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748544|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
748545|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
748546|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
748587|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
748588|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
748589|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
748926|NCT02787928|Hydromorphone|hydromorphone|mesh-list
748927|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
748928|NCT02787928|Narcotics|narcotics|mesh-ancestor
748929|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
748930|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748931|NCT02787928|Analgesics|analgesics|mesh-ancestor
748932|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
748933|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749125|NCT02787018|Dexamethasone|dexamethasone|mesh-list
749126|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
749127|NCT02787018|Ropivacaine|ropivacaine|mesh-list
749128|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
749129|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
749130|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
749131|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749132|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749133|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
749134|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
749135|NCT02787018|Hormones|hormones|mesh-ancestor
749136|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
749137|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
749138|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749139|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
749140|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749141|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
749142|NCT02787018|Analgesics|analgesics|mesh-ancestor
749143|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
749144|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
749145|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
749146|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
749147|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
749148|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749149|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749150|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
749151|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
749431|NCT02785614|Trazodone|trazodone|mesh-list
749432|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
749433|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
749434|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749435|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749436|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
749437|NCT02785614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
749438|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
749439|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
749440|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749441|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749442|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
749443|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
749444|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
749628|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
749629|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
749630|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
749631|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
749632|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
749633|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749634|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749635|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
749733|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
749734|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
749735|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236135|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2236136|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2236137|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236138|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
2236139|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
2236140|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
2236141|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236142|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2236143|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2236144|NCT00085358|Growth Substances|growth substances|mesh-ancestor
2236145|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236146|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
2236147|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
2236148|NCT00085384|Interferons|interferons|mesh-list
2236149|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
2236150|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
2236151|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2236152|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236153|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
2236154|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236155|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
2236156|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236157|NCT00085449|Cyclosporine|cyclosporine|mesh-list
2236158|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
2236159|NCT00085449|Fludarabine|fludarabine|mesh-list
2236160|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
751097|NCT02778191|Carboplatin|carboplatin|mesh-list
751098|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751513|NCT02776527|Apatinib|apatinib|mesh-list
751514|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751515|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
751516|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751517|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751636|NCT02776228|Brotizolam|brotizolam|mesh-list
751637|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
751638|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
751639|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751687|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
751688|NCT02775773|Oxytocin|oxytocin|mesh-list
751689|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
751690|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
751691|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751692|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
751693|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
751694|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751695|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
751696|NCT02775773|Coagulants|coagulants|mesh-ancestor
751823|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
751824|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
751825|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751826|NCT02775266|Protective Agents|protective agents|mesh-ancestor
751827|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751828|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
751829|NCT02775266|Vitamins|vitamins|mesh-ancestor
751830|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
752103|NCT02773875|Pancrelipase|pancrelipase|mesh-list
752104|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
752236|NCT02773472|Morphine|morphine|mesh-list
752237|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
752238|NCT02773472|Narcotics|narcotics|mesh-ancestor
752239|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752240|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752241|NCT02773472|Analgesics|analgesics|mesh-ancestor
752242|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
752243|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752446|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
752447|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
752448|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236161|NCT00085449|Melphalan|melphalan|mesh-list
2236162|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
2236163|NCT00085449|Cyclosporins|cyclosporins|mesh-list
2236164|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236165|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
748423|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
748424|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
748425|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
748426|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
748427|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748428|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
748429|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
748430|NCT02790580|Growth Substances|growth substances|mesh-ancestor
748431|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
748432|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
748697|NCT02789358|Adenosine|adenosine|mesh-list
748698|NCT02789358|Analgesics|analgesics|mesh-ancestor
748699|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
748700|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
748701|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748702|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
748703|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
748704|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
748705|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
748706|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
748707|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
748708|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748749|NCT02788877|Aflibercept|aflibercept|mesh-list
748750|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
748751|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
748752|NCT02788877|Growth Substances|growth substances|mesh-ancestor
748753|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748754|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
748755|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749445|NCT02785653|Sevoflurane|sevoflurane|mesh-list
749446|NCT02785653|Rocuronium|rocuronium|mesh-list
749447|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
749448|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
749449|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
749450|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
749451|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749452|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749453|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
749454|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
749455|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
749456|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749549|NCT02785276|Ropivacaine|ropivacaine|mesh-list
749550|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
749551|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
749552|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749553|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749554|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
749555|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749583|NCT02784899|Iloprost|iloprost|mesh-list
749584|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
749585|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
2092936|NCT02254681|Immunologic Factors|immunologic factors|mesh-ancestor
2092937|NCT02254681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092938|NCT02254772|Ipilimumab|ipilimumab|mesh-list
2092939|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2092940|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092941|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2092942|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092943|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
2236166|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
2236167|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236168|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
750306|NCT02782403|Axitinib|axitinib|mesh-list
750307|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750308|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
750309|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750310|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236169|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
2236170|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236171|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236172|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
751909|NCT02774837|Tenofovir|tenofovir|mesh-list
751910|NCT02774837|Telbivudine|telbivudine|mesh-list
751911|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
751912|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748493|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
748494|NCT02790177|Protective Agents|protective agents|mesh-ancestor
2092944|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2092945|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092946|NCT02255110|Doxorubicin|doxorubicin|mesh-list
2092947|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2092948|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092949|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2092950|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2092951|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092952|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092953|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
748913|NCT02788240|Meropenem|meropenem|mesh-list
748914|NCT02788240|Terlipressin|terlipressin|mesh-list
748915|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
748916|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748917|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
748918|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2236173|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236174|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
2236175|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
749279|NCT02786641|Cisplatin|cisplatin|mesh-list
749280|NCT02786641|Docetaxel|docetaxel|mesh-list
749281|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749282|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
749283|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
749284|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
749285|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749842|NCT02784392|Metoclopramide|metoclopramide|mesh-list
749843|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
749844|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
749845|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749846|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749847|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
749848|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
749849|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
749850|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
749851|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749852|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750081|NCT02783222|Paclitaxel|paclitaxel|mesh-list
750082|NCT02783222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
750083|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
750084|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750085|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
750086|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
750087|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
750088|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092954|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2092955|NCT02255175|Estradiol|estradiol|mesh-list
2092956|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2092957|NCT02255175|Progesterone|progesterone|mesh-list
2092958|NCT02255175|Estrogens|estrogens|mesh-ancestor
2092959|NCT02255175|Hormones|hormones|mesh-ancestor
2092960|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
750454|NCT02781805|Alendronate|alendronate|mesh-list
750455|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
750456|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092961|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092962|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2092963|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
2092964|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2092965|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2092966|NCT02255175|Progestins|progestins|mesh-ancestor
2092967|NCT02255279|Vaccines|vaccines|mesh-list
2092968|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
2092969|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092970|NCT02255357|Oxytocin|oxytocin|mesh-list
2092971|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
2092972|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2092973|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092974|NCT02255461|Palbociclib|palbociclib|mesh-list
2092975|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2092976|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2092977|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2092978|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092979|NCT02255500|Bupivacaine|bupivacaine|mesh-list
748549|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748640|NCT02789566|Primaquine|primaquine|mesh-list
748641|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
748642|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
748643|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
748644|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236176|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2236177|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2236178|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2236179|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
2236180|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2236181|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2236182|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
2236183|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2236184|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
750743|NCT02779881|Caseins|caseins|mesh-list
750744|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
750745|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
750746|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750842|NCT02779192|Ebselen|ebselen|mesh-list
750843|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
750844|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
750845|NCT02779192|Analgesics|analgesics|mesh-ancestor
750846|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
750847|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750848|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750849|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
750850|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
750851|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
750852|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
750853|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
750854|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750855|NCT02779192|Protective Agents|protective agents|mesh-ancestor
750856|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
750857|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750858|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
751046|NCT02778308|Gemcitabine|gemcitabine|mesh-list
751047|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751048|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
751049|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
751050|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751051|NCT02778308|Antiviral Agents|antiviral agents|mesh-ancestor
751052|NCT02778308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751053|NCT02778308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751054|NCT02778308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
751055|NCT02778308|Immunologic Factors|immunologic factors|mesh-ancestor
751056|NCT02778308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751288|NCT02777411|Vaccines|vaccines|mesh-list
751289|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
751290|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092980|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
2092981|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
2092982|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2092983|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092984|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
2092985|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2092986|NCT02255513|Methylphenidate|methylphenidate|mesh-list
2092987|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2092988|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092989|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2092990|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
752208|NCT02773459|Capecitabine|capecitabine|mesh-list
752209|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
752210|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
752211|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752212|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752269|NCT02773199|Bupivacaine|bupivacaine|mesh-list
752270|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
752271|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
752272|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752273|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752274|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
752275|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752382|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
752383|NCT02772640|Ezetimibe|ezetimibe|mesh-list
748626|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
748627|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
748628|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749091|NCT02786979|Aspirin|aspirin|mesh-list
749092|NCT02786979|Beraprost|beraprost|mesh-list
749093|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
749094|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
749095|NCT02786979|Analgesics|analgesics|mesh-ancestor
749096|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
749097|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749098|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749099|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
749100|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
749101|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
749102|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
749103|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749104|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
749105|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
749106|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749107|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
749108|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
749241|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
749242|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
749243|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
749244|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
749245|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
749246|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749247|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
749248|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749249|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749250|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
749251|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2236185|NCT00085462|Aldesleukin|aldesleukin|mesh-list
2236186|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
2236187|NCT00085462|Fludarabine|fludarabine|mesh-list
749669|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
749896|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
749897|NCT02784015|Melphalan|melphalan|mesh-list
749898|NCT02784015|Ifosfamide|ifosfamide|mesh-list
749899|NCT02784015|Thiotepa|thiotepa|mesh-list
749900|NCT02784015|Carboplatin|carboplatin|mesh-list
749901|NCT02784015|Doxorubicin|doxorubicin|mesh-list
749902|NCT02784015|Etoposide|etoposide|mesh-list
749903|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
749904|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
749905|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749906|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
749907|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
749908|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
749909|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749910|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749911|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
749912|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
749913|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
749914|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
749915|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749916|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
750503|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
750504|NCT02781467|Fludarabine|fludarabine|mesh-list
750505|NCT02781467|Interleukin-2|interleukin-2|mesh-list
750506|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
750507|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
750508|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750509|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
750510|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
750511|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
750512|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750513|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750514|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
750515|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
750516|NCT02781467|Analgesics|analgesics|mesh-ancestor
750517|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
750518|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750940|NCT02778776|Metformin|metformin|mesh-list
750941|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
750942|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236188|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
748630|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
748631|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
748632|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
748633|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
748634|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748635|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748636|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
748637|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
748638|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
748639|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2236189|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236190|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
2236191|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236192|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2236193|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
749190|NCT02786823|Folic Acid|folic acid|mesh-list
749191|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
749192|NCT02786823|Hydroxocobalamin|hydroxocobalamin|mesh-list
749193|NCT02786823|Metformin|metformin|mesh-list
749194|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
749195|NCT02786823|Vitamins|vitamins|mesh-ancestor
749196|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
749197|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749198|NCT02786823|Hematinics|hematinics|mesh-ancestor
749199|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
749351|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
749352|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
749353|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
749354|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749411|NCT02785666|Ribavirin|ribavirin|mesh-list
749412|NCT02785666|Grazoprevir|grazoprevir|mesh-list
749413|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
749414|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749415|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
749416|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
749893|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
749894|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
749895|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
750262|NCT02782429|Ketamine|ketamine|mesh-list
750263|NCT02782429|Analgesics|analgesics|mesh-ancestor
750264|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
750265|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750266|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750267|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
750268|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
750269|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
750270|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
750271|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
750272|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
750273|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
750274|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
750275|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750487|NCT02781753|Interferons|interferons|mesh-list
750488|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
750489|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
750490|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750491|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
750492|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
750493|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
750494|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750800|NCT02779387|Goserelin|goserelin|mesh-list
750801|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
750802|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751282|NCT02777489|Perindopril|perindopril|mesh-list
751283|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
751284|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
751285|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751286|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751287|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
751443|NCT02776917|Paclitaxel|paclitaxel|mesh-list
751444|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
751445|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751446|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
751447|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
751448|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
751449|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748660|NCT02789397|Rituximab|rituximab|mesh-list
748661|NCT02789397|Azathioprine|azathioprine|mesh-list
748662|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
748663|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748664|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
748665|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748666|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
748667|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
748668|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748669|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
748670|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2092991|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2092992|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2092993|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
2092994|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2092995|NCT02255565|Methylphenidate|methylphenidate|mesh-list
2092996|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2092997|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2092998|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2092999|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2093000|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2236194|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
749960|NCT02783547|Azacitidine|azacitidine|mesh-list
749961|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
749962|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
749963|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749964|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749965|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750089|NCT02783196|Liraglutide|liraglutide|mesh-list
750090|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
750091|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750092|NCT02783196|Incretins|incretins|mesh-ancestor
750093|NCT02783196|Hormones|hormones|mesh-ancestor
750094|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
750387|NCT02781909|Ibuprofen|ibuprofen|mesh-list
750388|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
750389|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
750390|NCT02781909|Analgesics|analgesics|mesh-ancestor
750391|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
750392|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750393|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750394|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
750395|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
750396|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
750397|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750398|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236195|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236196|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750792|NCT02779608|Docetaxel|docetaxel|mesh-list
750793|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750794|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
750795|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
750796|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
750797|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236197|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2236198|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2236199|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
2236200|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2236201|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2236202|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
751461|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
751462|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
751463|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
751464|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751465|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751466|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
751467|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751468|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
751469|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
751780|NCT02775539|Mirabegron|mirabegron|mesh-list
751781|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
751782|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
748730|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
748731|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
748732|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2236203|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236204|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
2236205|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236206|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2236207|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236208|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236209|NCT00085501|Paclitaxel|paclitaxel|mesh-list
2236210|NCT00085501|Carboplatin|carboplatin|mesh-list
748934|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
748935|NCT02787824|Hematinics|hematinics|mesh-ancestor
749063|NCT02787317|Heparin|heparin|mesh-list
749064|NCT02787317|Bivalirudin|bivalirudin|mesh-list
749065|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
749066|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
749067|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
749068|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749069|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
749070|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
749071|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
749072|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750065|NCT02783092|Cannabidiol|cannabidiol|mesh-list
750066|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
750333|NCT02782182|Leucovorin|leucovorin|mesh-list
750334|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
750335|NCT02782182|Irinotecan|irinotecan|mesh-list
750336|NCT02782182|Folfirinox|folfirinox|mesh-list
750337|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750338|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
750339|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
750340|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750341|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750342|NCT02782182|Antidotes|antidotes|mesh-ancestor
750343|NCT02782182|Protective Agents|protective agents|mesh-ancestor
750344|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750345|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
750346|NCT02782182|Vitamins|vitamins|mesh-ancestor
750347|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
2236211|NCT00085501|Cetuximab|cetuximab|mesh-list
2236212|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2236213|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236214|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
2236215|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
2236216|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
2236217|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236218|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
751434|NCT02777073|Liraglutide|liraglutide|mesh-list
751435|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
751436|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
751437|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751438|NCT02777073|Incretins|incretins|mesh-ancestor
751439|NCT02777073|Hormones|hormones|mesh-ancestor
751440|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
751441|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
751442|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751543|NCT02776605|Prednisone|prednisone|mesh-list
751544|NCT02776605|Methotrexate|methotrexate|mesh-list
751545|NCT02776605|Vincristine|vincristine|mesh-list
751546|NCT02776605|Daunorubicin|daunorubicin|mesh-list
751547|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
751548|NCT02776605|Ponatinib|ponatinib|mesh-list
751549|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
751550|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
751551|NCT02776605|Hormones|hormones|mesh-ancestor
751552|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
751553|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751554|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
751555|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751556|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
751557|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
751558|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
751583|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
748746|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
748747|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
748748|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748943|NCT02787967|Beclomethasone|beclomethasone|mesh-list
748944|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
748945|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
748946|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
748947|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
748948|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748949|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
748950|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
748951|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
748952|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
748953|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
748954|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
748955|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
748956|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748957|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
748958|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
748959|NCT02787967|Hormones|hormones|mesh-ancestor
748960|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
749931|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
749932|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
749933|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749934|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749935|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
749936|NCT02783846|Analgesics|analgesics|mesh-ancestor
749937|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
749938|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749939|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
749940|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
749941|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
749942|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
749943|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749944|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750030|NCT02783586|Bupivacaine|bupivacaine|mesh-list
750031|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
750032|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
750033|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
750034|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750035|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
750036|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750210|NCT02782338|Diclofenac|diclofenac|mesh-list
750211|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
750212|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
750213|NCT02782338|Analgesics|analgesics|mesh-ancestor
750214|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
750215|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750216|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750217|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
750218|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
750219|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
750220|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750221|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750482|NCT02781792|Temozolomide|temozolomide|mesh-list
750483|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
750484|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
750485|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750486|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750671|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
750672|NCT02780505|Vitamins|vitamins|mesh-ancestor
750673|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
750674|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750675|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
750676|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750677|NCT02780505|Protective Agents|protective agents|mesh-ancestor
750759|NCT02779777|Tipifarnib|tipifarnib|mesh-list
750760|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751269|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
751270|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
751271|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
751272|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751273|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
751274|NCT02777723|Protective Agents|protective agents|mesh-ancestor
748770|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748771|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
748772|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
748773|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
748774|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748775|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
748776|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
748777|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
748778|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
748779|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
748780|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
748781|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
748782|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
748783|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
748784|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
748785|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
749457|NCT02785705|Vaccines|vaccines|mesh-list
749458|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
749459|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749707|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
749708|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
749709|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750251|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
750252|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
750253|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
750254|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750255|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750256|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
750257|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
750258|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
750259|NCT02782312|Hormones|hormones|mesh-ancestor
750260|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
750261|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
750435|NCT02781766|Thrombin|thrombin|mesh-list
750436|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
750437|NCT02781766|Coagulants|coagulants|mesh-ancestor
2236219|NCT00085527|Romidepsin|romidepsin|mesh-list
2236220|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2236221|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236222|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2236223|NCT00085553|Tipifarnib|tipifarnib|mesh-list
2236224|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750733|NCT02780128|Ceritinib|ceritinib|mesh-list
750734|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750735|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
750736|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750737|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750818|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
750819|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
750820|NCT02779270|Protective Agents|protective agents|mesh-ancestor
750821|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750822|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
2236225|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2236226|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236227|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236228|NCT00085579|Aldesleukin|aldesleukin|mesh-list
2236229|NCT00085579|Sargramostim|sargramostim|mesh-list
2236230|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
2236231|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236232|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236233|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2236234|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2236235|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
2236236|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236237|NCT00085696|Rituximab|rituximab|mesh-list
2236238|NCT00085696|Bortezomib|bortezomib|mesh-list
2236239|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2236240|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236241|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
2236242|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236243|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
751930|NCT02774876|Insulin|insulin|mesh-list
751931|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
751932|NCT02774876|Hormones|hormones|mesh-list
751933|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2236244|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
748806|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
748807|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
748808|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2236245|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2236246|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2236247|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2236248|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236249|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236250|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2236251|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2236252|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
2236253|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236254|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236255|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2236256|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2236257|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
2236258|NCT00085761|Capsaicin|capsaicin|mesh-list
2236259|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
2236260|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
2236261|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
2236262|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2236263|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236264|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
2236265|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236266|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2236267|NCT00085826|Protective Agents|protective agents|mesh-ancestor
749768|NCT02784223|Choline|choline|mesh-list
749769|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
749770|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
749771|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
749772|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749773|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
749774|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
749775|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
750443|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
750444|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
750445|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
750446|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750447|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
750448|NCT02781597|Coagulants|coagulants|mesh-ancestor
750581|NCT02780882|Pasireotide|pasireotide|mesh-list
750582|NCT02780882|Hormones|hormones|mesh-ancestor
750583|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
750584|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750830|NCT02779530|Diclofenac|diclofenac|mesh-list
750831|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
750832|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
750833|NCT02779530|Analgesics|analgesics|mesh-ancestor
750834|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
750835|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750836|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750837|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
750838|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
750839|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
750840|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750841|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751183|NCT02777710|Durvalumab|durvalumab|mesh-list
751184|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
751185|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751398|NCT02777190|Misoprostol|misoprostol|mesh-list
751399|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
751400|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
751401|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
751402|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751403|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
751404|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
751405|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
751498|NCT02776761|Vaccines|vaccines|mesh-list
751499|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
751500|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093001|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093002|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
2093003|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
752395|NCT02773030|Dexamethasone|dexamethasone|mesh-list
752396|NCT02773030|Bortezomib|bortezomib|mesh-list
2236268|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236269|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2236270|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236271|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236272|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2236273|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2236274|NCT00085826|Analgesics|analgesics|mesh-ancestor
748854|NCT02788305|Misoprostol|misoprostol|mesh-list
748855|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
748856|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
748857|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
748858|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748859|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
748860|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
748861|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
2236275|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
2236276|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2236277|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2236278|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2236279|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2236280|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
2236281|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
749966|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
749967|NCT02783378|Antacids|antacids|mesh-ancestor
749968|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749969|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
750295|NCT02782481|Levodopa|levodopa|mesh-list
750296|NCT02782481|Carbidopa|carbidopa|mesh-list
750297|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
750298|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
750299|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
750300|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
750301|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
750302|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750303|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750304|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
750305|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750495|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
750496|NCT02781779|Laxatives|laxatives|mesh-ancestor
750497|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
750594|NCT02780804|Entinostat|entinostat|mesh-list
750595|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
750596|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750597|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750598|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750943|NCT02778893|Thalidomide|thalidomide|mesh-list
750944|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
750945|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
750946|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750947|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
750948|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
750949|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
750950|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
750951|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
750952|NCT02778893|Growth Substances|growth substances|mesh-ancestor
750953|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
750954|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751037|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
751038|NCT02778425|Somatostatin|somatostatin|mesh-list
751039|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
751040|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
751041|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
751042|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751043|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751044|NCT02778425|Hormones|hormones|mesh-ancestor
751045|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
751479|NCT02776813|Rituximab|rituximab|mesh-list
751480|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
751481|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748862|NCT02788708|Paclitaxel|paclitaxel|mesh-list
748863|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
748864|NCT02788708|Lenvatinib|lenvatinib|mesh-list
748865|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
748866|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
748867|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
748868|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
748869|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
748870|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748871|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
748872|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749079|NCT02787239|Rituximab|rituximab|mesh-list
749080|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
749081|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749082|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
749083|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749084|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
750292|NCT02782221|Hormones|hormones|mesh-list
750293|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
750294|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236282|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2236283|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2236284|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2236285|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236286|NCT00085943|Ritonavir|ritonavir|mesh-list
750696|NCT02780310|Lenvatinib|lenvatinib|mesh-list
750697|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750698|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
750699|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750700|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750879|NCT02779569|Decitabine|decitabine|mesh-list
750880|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
750881|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
750882|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750883|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750884|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751158|NCT02777736|Methotrexate|methotrexate|mesh-list
751159|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
751160|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
751161|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
751162|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751163|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
751164|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
751165|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751166|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751167|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
751168|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751169|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
751170|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
751171|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
751172|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
751173|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
748889|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
748890|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
748891|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
748892|NCT02788292|Expectorants|expectorants|mesh-ancestor
748893|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
748894|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
748895|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
748896|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
748897|NCT02788292|Protective Agents|protective agents|mesh-ancestor
748898|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
748899|NCT02788292|Antidotes|antidotes|mesh-ancestor
749013|NCT02787447|Gefitinib|gefitinib|mesh-list
749014|NCT02787447|Thymalfasin|thymalfasin|mesh-list
749015|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749016|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
749017|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749018|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749019|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
749020|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
749021|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236287|NCT00085943|Lopinavir|lopinavir|mesh-list
2236288|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
2236289|NCT00085943|Lamivudine|lamivudine|mesh-list
2236290|NCT00085943|Abacavir|abacavir|mesh-list
2236291|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2236292|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2236293|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
2236294|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236295|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750761|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
750762|NCT02779751|Anastrozole|anastrozole|mesh-list
750763|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
750764|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750765|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
750766|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
750767|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
750768|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750769|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750770|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
750771|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
750772|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
750773|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750806|NCT02779257|Diazoxide|diazoxide|mesh-list
750807|NCT02779257|Pasireotide|pasireotide|mesh-list
750808|NCT02779257|Hormones|hormones|mesh-ancestor
750809|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
750810|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750811|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
750812|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
751028|NCT02778360|Methylphenidate|methylphenidate|mesh-list
751029|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
751030|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751031|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
751032|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
751033|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
751034|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751035|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
751036|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236296|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2236297|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2236298|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
2236299|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236300|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2236301|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2236302|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2236303|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
751881|NCT02775292|Aldesleukin|aldesleukin|mesh-list
751882|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
751883|NCT02775292|Nivolumab|nivolumab|mesh-list
751884|NCT02775292|Fludarabine|fludarabine|mesh-list
751885|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
751886|NCT02775292|Interleukin-2|interleukin-2|mesh-list
751887|NCT02775292|Vaccines|vaccines|mesh-list
751888|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
751889|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236304|NCT00085969|Exenatide|exenatide|mesh-list
2093004|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
2093005|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2093006|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093007|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
749586|NCT02784860|Lidocaine|lidocaine|mesh-list
749587|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
749588|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
749589|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749590|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749591|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
749592|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749593|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
749594|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
749595|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
749596|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
749597|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749761|NCT02784327|Ropivacaine|ropivacaine|mesh-list
749762|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
749763|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
749764|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749765|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749766|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
749767|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749919|NCT02783937|Lenograstim|lenograstim|mesh-list
749927|NCT02783937|Sargramostim|sargramostim|mesh-list
749928|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
749929|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
749930|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236305|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2236306|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236307|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2236308|NCT00085969|Incretins|incretins|mesh-ancestor
2236309|NCT00085969|Hormones|hormones|mesh-ancestor
2236310|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2236311|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
2236312|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750156|NCT02782624|Empagliflozin|empagliflozin|mesh-list
750157|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
750158|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750159|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
750160|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750701|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
750702|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
750703|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
750704|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750705|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
750706|NCT02780245|Coagulants|coagulants|mesh-ancestor
2093008|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
2093009|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093010|NCT02256111|Androgens|androgens|mesh-list
2093011|NCT02256111|Hormones|hormones|mesh-ancestor
2093012|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2093013|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093014|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2093015|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2093016|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750823|NCT02779465|Vitamin D|vitamin d|mesh-list
750824|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
750825|NCT02779465|Vitamins|vitamins|mesh-ancestor
750826|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
750827|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750828|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
750829|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
750891|NCT02778958|Acetaminophen|acetaminophen|mesh-list
750892|NCT02778958|Ibuprofen|ibuprofen|mesh-list
750893|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
750894|NCT02778958|Analgesics|analgesics|mesh-ancestor
750895|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
750896|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750897|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750898|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
750899|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
750900|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
750901|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093017|NCT02256189|Incretins|incretins|mesh-ancestor
2236313|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2236314|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
2236315|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
2236316|NCT00086086|Hematinics|hematinics|mesh-ancestor
2236317|NCT00086099|Amifostine|amifostine|mesh-list
2236318|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2236319|NCT00086099|Protective Agents|protective agents|mesh-ancestor
2236320|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236321|NCT00086112|Risperidone|risperidone|mesh-list
2236322|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2236323|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
2236324|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236325|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236326|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236327|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2236328|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
749677|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
749678|NCT02784626|Propofol|propofol|mesh-list
749679|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
749680|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749681|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749682|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
749683|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
749684|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
749685|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
749686|NCT02784626|Analgesics|analgesics|mesh-ancestor
749687|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
749688|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749689|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
749690|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
749691|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
749692|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
749693|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749694|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749797|NCT02784340|Dexamethasone|dexamethasone|mesh-list
749798|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
749799|NCT02784340|Bupivacaine|bupivacaine|mesh-list
749800|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
749801|NCT02784340|BB 1101|bb 1101|mesh-list
749802|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
749803|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
749804|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
749805|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749806|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749807|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
749808|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
749809|NCT02784340|Hormones|hormones|mesh-ancestor
749810|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
749811|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
749812|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749813|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
749814|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749815|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749816|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
749817|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
749818|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749819|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
750062|NCT02783053|Metformin|metformin|mesh-list
750063|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
750064|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750235|NCT02782273|Ketorolac|ketorolac|mesh-list
750236|NCT02782273|Morphine|morphine|mesh-list
750237|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
750238|NCT02782273|Narcotics|narcotics|mesh-ancestor
750239|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
750240|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750241|NCT02782273|Analgesics|analgesics|mesh-ancestor
750242|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
750243|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750244|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
750245|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
750246|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
750247|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
750248|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2236329|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749258|NCT02786446|Naproxen|naproxen|mesh-list
749259|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
749260|NCT02786446|Lidocaine|lidocaine|mesh-list
749261|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
749262|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
749263|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749264|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749265|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
749266|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749267|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
749268|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
749269|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
749270|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
749271|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749272|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
749273|NCT02786446|Analgesics|analgesics|mesh-ancestor
749274|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
749275|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
749276|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
749277|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
749278|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749498|NCT02785393|Doxazosin|doxazosin|mesh-list
749499|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
749500|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
749501|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
749502|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
749503|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
749504|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749505|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749506|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749737|NCT02784561|Vidarabine|vidarabine|mesh-list
749738|NCT02784561|Cytarabine|cytarabine|mesh-list
749739|NCT02784561|Fludarabine|fludarabine|mesh-list
749740|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
749741|NCT02784561|Busulfan|busulfan|mesh-list
749742|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
749743|NCT02784561|Sargramostim|sargramostim|mesh-list
749744|NCT02784561|Lenograstim|lenograstim|mesh-list
749745|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749746|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
749747|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
749748|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749749|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
749750|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
749751|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749752|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
749753|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
749754|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
749755|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
749756|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
749757|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
749970|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
749971|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
749972|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
749973|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
749974|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
749975|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750747|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
750748|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
750749|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236330|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236331|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2236332|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
2236333|NCT00086125|Sirolimus|sirolimus|mesh-list
2236334|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2236335|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236336|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2236337|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236338|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
2236339|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236340|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
751099|NCT02777814|Entecavir|entecavir|mesh-list
751100|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
751101|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236341|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749257|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093018|NCT02256189|Hormones|hormones|mesh-ancestor
2093019|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2093020|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2093021|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
2093022|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093023|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093024|NCT02256267|Rifampin|rifampin|mesh-list
2093025|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2093026|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
2093027|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2093028|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093029|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
2093030|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2093031|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093032|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093033|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2093034|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2093035|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2093036|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
749994|NCT02783430|Ketamine|ketamine|mesh-list
749995|NCT02783430|Milnacipran|milnacipran|mesh-list
749996|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
749997|NCT02783430|Analgesics|analgesics|mesh-ancestor
749998|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
749999|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750000|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750001|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
750002|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
750003|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
750004|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
750005|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
750006|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
750007|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
750008|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
750009|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750010|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
750011|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
750012|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
750013|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
750014|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
750015|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
750174|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
750175|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
750176|NCT02782897|Antibodies|antibodies|mesh-list
750177|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
750178|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750774|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
750775|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
750776|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
750777|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750778|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749313|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
749314|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749315|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749316|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
749317|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
749318|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
749319|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
749320|NCT02786264|Analgesics|analgesics|mesh-ancestor
749321|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
749322|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749323|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
749324|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
749325|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
749326|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
749327|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749328|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749329|NCT02786264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
749330|NCT02786264|Narcotics|narcotics|mesh-ancestor
749331|NCT02786264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
749332|NCT02786264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
749333|NCT02786264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
749334|NCT02786264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
749335|NCT02786264|GABA Modulators|gaba modulators|mesh-ancestor
749336|NCT02786264|GABA Agents|gaba agents|mesh-ancestor
749404|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
749405|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
749406|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
749407|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749408|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
749598|NCT02785055|Hydromorphone|hydromorphone|mesh-list
749599|NCT02785055|Bupivacaine|bupivacaine|mesh-list
749600|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
749601|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
749602|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749603|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749604|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
749605|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749606|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
749607|NCT02785055|Narcotics|narcotics|mesh-ancestor
749608|NCT02785055|Analgesics|analgesics|mesh-ancestor
749725|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
749726|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
749727|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
749728|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
749729|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749730|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
749731|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
749732|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750067|NCT02783183|Pregabalin|pregabalin|mesh-list
750068|NCT02783183|Analgesics|analgesics|mesh-ancestor
750069|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
750070|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750071|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750072|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
750073|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
750074|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
750075|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750076|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
750077|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
750078|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
750079|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
750080|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
750473|NCT02781493|Prucalopride|prucalopride|mesh-list
750474|NCT02781493|Laxatives|laxatives|mesh-ancestor
750475|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
750476|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
750477|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
750478|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
750479|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
750480|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750481|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236342|NCT00086177|Progesterone|progesterone|mesh-list
2236343|NCT00086177|Progestins|progestins|mesh-ancestor
2236344|NCT00086177|Hormones|hormones|mesh-ancestor
749430|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
749710|NCT02784743|Ivermectin|ivermectin|mesh-list
749711|NCT02784743|Albendazole|albendazole|mesh-list
749712|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
749713|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
749714|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
749715|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
749716|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
749717|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
749718|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
749719|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
749720|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
749721|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749722|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749990|NCT02783625|Bortezomib|bortezomib|mesh-list
749991|NCT02783625|Romidepsin|romidepsin|mesh-list
749992|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749993|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
750550|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
750551|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
750552|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
750553|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750554|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
750555|NCT02781246|Analgesics|analgesics|mesh-ancestor
750556|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
750557|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750558|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
750559|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
750560|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
750561|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
750562|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
750563|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236345|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2236346|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236347|NCT00086203|Rituximab|rituximab|mesh-list
2236348|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2236349|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751872|NCT02775006|Docetaxel|docetaxel|mesh-list
751873|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
751874|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751875|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
751876|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
751877|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
751878|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751879|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
751880|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093037|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2093038|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2093039|NCT02256358|Midazolam|midazolam|mesh-list
2093040|NCT02256358|Ketamine|ketamine|mesh-list
2093041|NCT02256358|Analgesics|analgesics|mesh-ancestor
2093042|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
2093043|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093044|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093045|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
752023|NCT02774096|Xenon|xenon|mesh-list
752024|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
752025|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
752026|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
752027|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752028|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752253|NCT02773550|Prednisone|prednisone|mesh-list
752254|NCT02773550|Bortezomib|bortezomib|mesh-list
752255|NCT02773550|Melphalan|melphalan|mesh-list
752256|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
752257|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
752258|NCT02773550|Hormones|hormones|mesh-ancestor
752259|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
752260|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752261|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
752262|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752263|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
752264|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
752265|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093046|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2236350|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
2236351|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749723|NCT02784483|Atezolizumab|atezolizumab|mesh-list
749724|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749861|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
749862|NCT02784054|Melphalan|melphalan|mesh-list
749863|NCT02784054|Thiotepa|thiotepa|mesh-list
749864|NCT02784054|Carboplatin|carboplatin|mesh-list
749865|NCT02784054|Etoposide|etoposide|mesh-list
749866|NCT02784054|Bleomycin|bleomycin|mesh-list
749867|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
749868|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
749869|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749870|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
749871|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
749872|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
749873|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749874|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749875|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
749876|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
749877|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
749878|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
749879|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749880|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
749976|NCT02783508|Meperidine|meperidine|mesh-list
749977|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
749978|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
749979|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
749980|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
749981|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
749982|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749983|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
749984|NCT02783508|Analgesics|analgesics|mesh-ancestor
749985|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
749986|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
749987|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
749988|NCT02783508|Narcotics|narcotics|mesh-ancestor
749989|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
750155|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
750311|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
750312|NCT02782546|Tacrolimus|tacrolimus|mesh-list
750313|NCT02782546|Sargramostim|sargramostim|mesh-list
750314|NCT02782546|Lenograstim|lenograstim|mesh-list
750315|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
750316|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
750317|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750318|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
750319|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750320|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750321|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
750322|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750323|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
750324|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
750325|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
750326|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
750327|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
750519|NCT02781584|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
750520|NCT02781584|Fenofibrate|fenofibrate|mesh-list
750521|NCT02781584|Firsocostat|firsocostat|mesh-list
750522|NCT02781584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
750523|NCT02781584|Antimetabolites|antimetabolites|mesh-ancestor
750524|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750525|NCT02781584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
750526|NCT02781584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
750527|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236352|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2236353|NCT00086255|Tiagabine|tiagabine|mesh-list
2236354|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
2236355|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
2236356|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2236357|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2236358|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236359|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
2236360|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236361|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236362|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
2236363|NCT00086268|Carboplatin|carboplatin|mesh-list
749493|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
749494|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
749495|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749496|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749497|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
750037|NCT02783404|Amoxicillin|amoxicillin|mesh-list
750038|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
750039|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
750040|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
750041|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
750042|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
750043|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750044|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750124|NCT02783040|Digoxin|digoxin|mesh-list
750125|NCT02783040|Midazolam|midazolam|mesh-list
750126|NCT02783040|BI 425809|bi 425809|mesh-list
750127|NCT02783040|Omeprazole|omeprazole|mesh-list
750128|NCT02783040|Warfarin|warfarin|mesh-list
750129|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
750130|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
750131|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
750132|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750133|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
750134|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
750135|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
750136|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
750137|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
750138|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
750139|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
750140|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
750141|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
750142|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750143|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
750144|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
750145|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
750146|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
750147|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750148|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
750149|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
750150|NCT02783040|Protective Agents|protective agents|mesh-ancestor
750151|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
750803|NCT02779413|Insulin|insulin|mesh-list
750804|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
750805|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750905|NCT02778789|Adalimumab|adalimumab|mesh-list
750906|NCT02778789|Etanercept|etanercept|mesh-list
750907|NCT02778789|Golimumab|golimumab|mesh-list
750908|NCT02778789|Infliximab|infliximab|mesh-list
750909|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
750910|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
750911|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
750912|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
750913|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
750914|NCT02778789|Analgesics|analgesics|mesh-ancestor
750915|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
750916|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750917|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750918|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
750919|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
750920|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
750921|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
750922|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
751306|NCT02777671|Gliclazide|gliclazide|mesh-list
751307|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
751308|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
751309|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
751310|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
751311|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
751312|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751313|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
751314|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751470|NCT02776891|Citric Acid|citric acid|mesh-list
751471|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
751472|NCT02776891|Gallium citrate|gallium citrate|mesh-list
751473|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
751474|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
751475|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
751476|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
751482|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
749532|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
749533|NCT02785146|Calcium|calcium|mesh-list
749534|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
749535|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
749536|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749537|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
749538|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
749539|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749540|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
749541|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749542|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
749543|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
749544|NCT02785146|Antidotes|antidotes|mesh-ancestor
749545|NCT02785146|Protective Agents|protective agents|mesh-ancestor
749546|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
749547|NCT02785146|Vitamins|vitamins|mesh-ancestor
749548|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
750056|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
750057|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
750058|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
750059|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750060|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750061|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750203|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
750204|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
750205|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
750206|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
750207|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750208|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750209|NCT02782559|Urological Agents|urological agents|mesh-ancestor
750276|NCT02782286|Ketorolac|ketorolac|mesh-list
750277|NCT02782286|Morphine|morphine|mesh-list
750278|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
750279|NCT02782286|Narcotics|narcotics|mesh-ancestor
750280|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
750281|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750282|NCT02782286|Analgesics|analgesics|mesh-ancestor
750283|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
750284|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750285|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
750286|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
750287|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
750288|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
750289|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
750290|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750291|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750367|NCT02782052|Bromides|bromides|mesh-list
750368|NCT02782052|Albuterol|albuterol|mesh-list
750369|NCT02782052|Ipratropium|ipratropium|mesh-list
750370|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
750371|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
750372|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
750373|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750374|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750375|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
750376|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
750377|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
750378|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
750379|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
750380|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
750381|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
750382|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
750383|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
750384|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750385|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
750386|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
2236364|NCT00086268|Docetaxel|docetaxel|mesh-list
2236365|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236366|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
749695|NCT02784795|Gemcitabine|gemcitabine|mesh-list
749696|NCT02784795|Carboplatin|carboplatin|mesh-list
749697|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
749698|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
749699|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
749700|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749701|NCT02784795|Antiviral Agents|antiviral agents|mesh-ancestor
749702|NCT02784795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
749703|NCT02784795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749704|NCT02784795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
749705|NCT02784795|Immunologic Factors|immunologic factors|mesh-ancestor
749706|NCT02784795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749945|NCT02784002|Fidaxomicin|fidaxomicin|mesh-list
749946|NCT02784002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
749947|NCT02784002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751291|NCT02777580|Tenecteplase|tenecteplase|mesh-list
751292|NCT02777580|Clopidogrel|clopidogrel|mesh-list
751293|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
751294|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
751295|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
751296|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
751297|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
751298|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
751299|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751300|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751301|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
751302|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
751630|NCT02776137|Docetaxel|docetaxel|mesh-list
751631|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751632|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
751633|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
751634|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
751635|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752322|NCT02773095|Lactitol|lactitol|mesh-list
752323|NCT02773095|Cathartics|cathartics|mesh-ancestor
752324|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
752581|NCT02771860|Denosumab|denosumab|mesh-list
752582|NCT02771860|Calcium|calcium|mesh-list
752583|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
752584|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752585|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
752736|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
752737|NCT02771197|Fludarabine|fludarabine|mesh-list
752738|NCT02771197|Melphalan|melphalan|mesh-list
752739|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
752740|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752741|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752742|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
752743|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
752744|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752745|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
752746|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
752747|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
753174|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
753175|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753176|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236367|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
2236368|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
2236369|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236370|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2236371|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236372|NCT00086294|Levodopa|levodopa|mesh-list
2236373|NCT00086294|Pimavanserin|pimavanserin|mesh-list
2236374|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2236375|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2236376|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
2236377|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236378|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236379|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236380|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2236381|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2236382|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2236383|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236384|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
749656|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
749657|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
750179|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
750180|NCT02782754|Carboplatin|carboplatin|mesh-list
750181|NCT02782754|Etoposide|etoposide|mesh-list
750182|NCT02782754|Bleomycin|bleomycin|mesh-list
750183|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
750184|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
750185|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750186|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
750187|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
750188|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
750189|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750190|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750191|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
750192|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
750193|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
750194|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
750195|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750196|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2236385|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2236386|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
2236387|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2236388|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2236389|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2236390|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2236391|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236392|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236393|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2236394|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2236395|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
2236396|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236397|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750542|NCT02781415|Morphine|morphine|mesh-list
750543|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
750544|NCT02781415|Narcotics|narcotics|mesh-ancestor
750545|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
750546|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750547|NCT02781415|Analgesics|analgesics|mesh-ancestor
750548|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
750549|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750813|NCT02779582|Progesterone|progesterone|mesh-list
750814|NCT02779582|Progestins|progestins|mesh-ancestor
750815|NCT02779582|Hormones|hormones|mesh-ancestor
750816|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
750817|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750873|NCT02778971|Flutemetamol|flutemetamol|mesh-list
750874|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
750875|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751342|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
751343|NCT02777619|Propofol|propofol|mesh-list
751344|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
751345|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
751346|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751347|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
751348|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
751349|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
751350|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
751351|NCT02777619|Analgesics|analgesics|mesh-ancestor
751352|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
751353|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
751354|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
751355|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
751356|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
751357|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
751358|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
751359|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751426|NCT02776956|Atorvastatin|atorvastatin|mesh-list
751427|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
751428|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
751429|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
751430|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751431|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
751432|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
751433|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749676|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
749917|NCT02783859|Amoxicillin|amoxicillin|mesh-list
749918|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
749920|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
749921|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
749922|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
749923|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
749924|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
749925|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749926|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
750222|NCT02782260|Dipyridamole|dipyridamole|mesh-list
750223|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
750224|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750225|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750226|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
750227|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
750585|NCT02780778|Docetaxel|docetaxel|mesh-list
750586|NCT02780778|Apatinib|apatinib|mesh-list
750587|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750588|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
750589|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
750590|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
750591|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750592|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
750593|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750885|NCT02778945|Rocuronium|rocuronium|mesh-list
750886|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
750887|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
750888|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
750889|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750890|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751057|NCT02778178|Clonidine|clonidine|mesh-list
751058|NCT02778178|Ropivacaine|ropivacaine|mesh-list
751059|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
751060|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
751061|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
751062|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751063|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
751064|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
751065|NCT02778178|Analgesics|analgesics|mesh-ancestor
751066|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
751067|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
751068|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
751069|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
751070|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
751071|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
751072|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
751073|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
751074|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751450|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
751451|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
751452|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
751453|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751454|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
751455|NCT02776943|Protective Agents|protective agents|mesh-ancestor
2236398|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2236399|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2236400|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
2236401|NCT00086333|Docetaxel|docetaxel|mesh-list
2236402|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236403|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
2236404|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
2236405|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
752164|NCT02773927|Metformin|metformin|mesh-list
752165|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
752166|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236406|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236407|NCT00086359|Ritonavir|ritonavir|mesh-list
2236408|NCT00086359|Lopinavir|lopinavir|mesh-list
753428|NCT02768493|Ropivacaine|ropivacaine|mesh-list
753429|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
753430|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
753431|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
753432|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753433|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
753444|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
749736|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
749881|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
749882|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
749883|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
749884|NCT02783924|Vitamins|vitamins|mesh-ancestor
749885|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
749886|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
750348|NCT02782078|Clindamycin|clindamycin|mesh-list
750349|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
750350|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
750351|NCT02782078|Rifampin|rifampin|mesh-list
750352|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
750353|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
750354|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
750355|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750356|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750357|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
750358|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
750359|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
750360|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
750361|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
750362|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
750363|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
750364|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
750365|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
750366|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
750658|NCT02780479|Dexamethasone|dexamethasone|mesh-list
750659|NCT02780479|Prednisone|prednisone|mesh-list
750660|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
750661|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
750662|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
750663|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750664|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750665|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
750666|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
750667|NCT02780479|Hormones|hormones|mesh-ancestor
750668|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
750669|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
750670|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750707|NCT02780102|Methylphenidate|methylphenidate|mesh-list
750708|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
750709|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750710|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
750711|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
750712|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
750713|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750714|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
750715|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236409|NCT00086359|Lamivudine|lamivudine|mesh-list
2236410|NCT00086359|Zidovudine|zidovudine|mesh-list
2236411|NCT00086359|Abacavir|abacavir|mesh-list
2236412|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2236413|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2236414|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2236415|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
2236416|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236417|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236418|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2236419|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2236420|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
2236421|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236422|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2236423|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2236424|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
751194|NCT02779283|Prednisolone|prednisolone|mesh-list
750250|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750859|NCT02778906|Abatacept|abatacept|mesh-list
750860|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
750861|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750862|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750863|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
750864|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
750865|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750866|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
751134|NCT02777788|Gemcitabine|gemcitabine|mesh-list
751135|NCT02777788|Paclitaxel|paclitaxel|mesh-list
751136|NCT02777788|Vinorelbine|vinorelbine|mesh-list
751137|NCT02777788|Docetaxel|docetaxel|mesh-list
751138|NCT02777788|Carboplatin|carboplatin|mesh-list
751139|NCT02777788|Pemetrexed|pemetrexed|mesh-list
751140|NCT02777788|Cisplatin|cisplatin|mesh-list
751141|NCT02777788|Nedaplatin|nedaplatin|mesh-list
751142|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
751143|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751144|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
751145|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
751146|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
751147|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751148|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
751149|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
751150|NCT02777788|Antiviral Agents|antiviral agents|mesh-ancestor
751151|NCT02777788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751152|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751153|NCT02777788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
751154|NCT02777788|Immunologic Factors|immunologic factors|mesh-ancestor
751155|NCT02777788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751156|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
751157|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2236425|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2236426|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
2236427|NCT00086463|Iloprost|iloprost|mesh-list
2236428|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2236429|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
2236430|NCT00086489|Tremelimumab|tremelimumab|mesh-list
2236431|NCT00086489|Ipilimumab|ipilimumab|mesh-list
2236432|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236433|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2236434|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2236435|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236436|NCT00086528|XL647|xl647|mesh-list
2236437|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236438|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2236439|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236440|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236441|NCT00086541|Interferons|interferons|mesh-list
2236442|NCT00086541|Ribavirin|ribavirin|mesh-list
2236443|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
2236444|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236445|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
2236446|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236447|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
2236448|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236449|NCT00086593|Lamotrigine|lamotrigine|mesh-list
2236450|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
2236451|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2236452|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
752533|NCT02772029|Apatinib|apatinib|mesh-list
752534|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752535|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
752536|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752537|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752665|NCT02771626|Nivolumab|nivolumab|mesh-list
752666|NCT02771626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
752667|NCT02771626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752668|NCT02771626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
752669|NCT02771626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753035|NCT02770105|Caffeine|caffeine|mesh-list
753036|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
753193|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
2236453|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236454|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2236455|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236456|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2236457|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2236458|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2236459|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236460|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2236461|NCT00086606|Omalizumab|omalizumab|mesh-list
2236462|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2236463|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2236464|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
750498|NCT02781506|Nivolumab|nivolumab|mesh-list
750499|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
750500|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
750501|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
750502|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750876|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
750877|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
750878|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093047|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
2093048|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
2093049|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
751518|NCT02776540|Aspirin|aspirin|mesh-list
751519|NCT02776540|Clopidogrel|clopidogrel|mesh-list
751520|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
751521|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
751522|NCT02776540|Analgesics|analgesics|mesh-ancestor
751523|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
751524|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
751525|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751526|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
751527|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
751528|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
751529|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
751530|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751531|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
751532|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
751533|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751534|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
751535|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
751536|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
751537|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
751538|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
751539|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
751605|NCT02776189|Midazolam|midazolam|mesh-list
751606|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
751607|NCT02776189|Propofol|propofol|mesh-list
751608|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
751609|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
751610|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751611|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
751612|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
751613|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
751614|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
751615|NCT02776189|Analgesics|analgesics|mesh-ancestor
751616|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
751617|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
751618|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
751619|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
751620|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
751621|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
751622|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
751623|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751624|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
751625|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
751626|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
751627|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
751628|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
751629|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
751813|NCT02775318|Bupivacaine|bupivacaine|mesh-list
751814|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
751815|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
751816|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2236465|NCT00086632|Oregovomab|oregovomab|mesh-list
750573|NCT02781064|Atorvastatin|atorvastatin|mesh-list
750574|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
750575|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
750576|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
750577|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750578|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
750579|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
750580|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750788|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
750789|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
750790|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750791|NCT02779634|Vitamins|vitamins|mesh-ancestor
750955|NCT02778919|Leuprolide|leuprolide|mesh-list
750956|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
750957|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
750958|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
750959|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750960|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
750961|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751325|NCT02777424|Thrombin|thrombin|mesh-list
751326|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
751327|NCT02777424|Coagulants|coagulants|mesh-ancestor
751501|NCT02776865|Lidocaine|lidocaine|mesh-list
751502|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
751503|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
751504|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
751505|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751506|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
751507|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
751508|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
751509|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
751510|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
751511|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
751512|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751802|NCT02775370|Apatinib|apatinib|mesh-list
751803|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751804|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
751805|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751806|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752298|NCT02773212|Amphetamine|amphetamine|mesh-list
752299|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
752300|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
752301|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752302|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
752303|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
752304|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752305|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
752306|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
752307|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752308|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
752309|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
752310|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
752311|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
752312|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
752501|NCT02772237|Riboflavin|riboflavin|mesh-list
752502|NCT02772237|Vitamins|vitamins|mesh-ancestor
752503|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
752504|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752505|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
752506|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
752507|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
752568|NCT02771795|Trastuzumab|trastuzumab|mesh-list
752569|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
752570|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752932|NCT02770378|Ritonavir|ritonavir|mesh-list
752933|NCT02770378|Itraconazole|itraconazole|mesh-list
752934|NCT02770378|Minocycline|minocycline|mesh-list
752935|NCT02770378|Celecoxib|celecoxib|mesh-list
752936|NCT02770378|Temozolomide|temozolomide|mesh-list
752937|NCT02770378|Auranofin|auranofin|mesh-list
752938|NCT02770378|Captopril|captopril|mesh-list
752939|NCT02770378|Disulfiram|disulfiram|mesh-list
752940|NCT02770378|Aprepitant|aprepitant|mesh-list
752941|NCT02770378|Sertraline|sertraline|mesh-list
752942|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
752943|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2236466|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2236467|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236468|NCT00086645|Dexetimide|dexetimide|mesh-list
2236469|NCT00086645|Citalopram|citalopram|mesh-list
2236470|NCT00086645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2093050|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2093051|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2093052|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093053|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093054|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2093055|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2093056|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2093057|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2093058|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236471|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
751001|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
751002|NCT02778685|Letrozole|letrozole|mesh-list
751003|NCT02778685|Palbociclib|palbociclib|mesh-list
751004|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
751005|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751006|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
751007|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
751008|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751009|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751010|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
751011|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
751012|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
751013|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751014|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
751131|NCT02777801|Entecavir|entecavir|mesh-list
751132|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
751133|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751664|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
751665|NCT02775734|Clomiphene|clomiphene|mesh-list
751666|NCT02775734|Enclomiphene|enclomiphene|mesh-list
751667|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
751668|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
751669|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751670|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
751671|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
751672|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
751673|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751674|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
751675|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
751676|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
751677|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
751678|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
751679|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
751680|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751681|NCT02775734|Expectorants|expectorants|mesh-ancestor
751682|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
751683|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
751684|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
751685|NCT02775734|Protective Agents|protective agents|mesh-ancestor
751686|NCT02775734|Antidotes|antidotes|mesh-ancestor
2236472|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2236473|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236474|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236475|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
2236476|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236477|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2236478|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
2236479|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236480|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2236481|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2236482|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
752511|NCT02772211|Cycloserine|cycloserine|mesh-list
752512|NCT02772211|Ketamine|ketamine|mesh-list
752513|NCT02772211|Analgesics|analgesics|mesh-ancestor
752514|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
752515|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752516|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752517|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
752518|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
752519|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
2236483|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
2236484|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2236485|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2236486|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2236487|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
2236488|NCT00086671|Antibodies|antibodies|mesh-list
2236489|NCT00086671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2236490|NCT00086671|Immunologic Factors|immunologic factors|mesh-ancestor
2236491|NCT00086671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236492|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
2236493|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2236494|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2236495|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236496|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2236497|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2236498|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
2236499|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236500|NCT00086723|Captopril|captopril|mesh-list
2236501|NCT00086723|Plasminogen|plasminogen|mesh-list
2236502|NCT00086723|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2236503|NCT00086723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2236504|NCT00086723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2236505|NCT00086723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236506|NCT00086723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2236507|NCT00086723|Protease Inhibitors|protease inhibitors|mesh-ancestor
2236508|NCT00086723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236509|NCT00086723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
751730|NCT02776397|Vitamin E|vitamin e|mesh-list
751731|NCT02776397|Tocopherols|tocopherols|mesh-list
751732|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
751733|NCT02776397|Vitamins|vitamins|mesh-ancestor
751734|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
751735|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751736|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
751737|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751738|NCT02776397|Protective Agents|protective agents|mesh-ancestor
752576|NCT02771834|Vitamin D|vitamin d|mesh-list
752577|NCT02771834|Vitamins|vitamins|mesh-ancestor
752578|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
752579|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752580|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
752660|NCT02771314|Osimertinib|osimertinib|mesh-list
752661|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752662|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
752663|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752664|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753806|NCT02767102|Melatonin|melatonin|mesh-list
753807|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
753808|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753809|NCT02767102|Protective Agents|protective agents|mesh-ancestor
753810|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753811|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754006|NCT02766478|Genistein|genistein|mesh-list
754007|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
754008|NCT02766478|Protective Agents|protective agents|mesh-ancestor
754009|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754010|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754011|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
754012|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754013|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754014|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
754015|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
754016|NCT02766478|Estrogens|estrogens|mesh-ancestor
754017|NCT02766478|Hormones|hormones|mesh-ancestor
754018|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2236510|NCT00086736|Eflornithine|eflornithine|mesh-list
2236511|NCT00086736|Bicalutamide|bicalutamide|mesh-list
2236512|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
2236513|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
2236514|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2236515|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755317|NCT02760316|Prednisolone|prednisolone|mesh-list
755318|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
755319|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
755320|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
755321|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
2093059|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
2093060|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
2093061|NCT02256436|Paclitaxel|paclitaxel|mesh-list
750716|NCT02780323|Celecoxib|celecoxib|mesh-list
750717|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
750718|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
750719|NCT02780323|Analgesics|analgesics|mesh-ancestor
750720|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
750721|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
750722|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750723|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
750724|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
750725|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
750726|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
750727|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750728|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750867|NCT02778828|Linezolid|linezolid|mesh-list
750868|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
750869|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
750870|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
750871|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750872|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750991|NCT02778659|Zolpidem|zolpidem|mesh-list
750992|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
750993|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
750994|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
750995|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
750996|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
750997|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
750998|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
750999|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
751000|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751328|NCT02777320|Acetaminophen|acetaminophen|mesh-list
751329|NCT02777320|Ibuprofen|ibuprofen|mesh-list
751330|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
751331|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
751332|NCT02777320|Analgesics|analgesics|mesh-ancestor
751333|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
751334|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
751335|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751336|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
751337|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
751338|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
751339|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751340|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751341|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
2236516|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236517|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2236518|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
751858|NCT02774993|Doxycycline|doxycycline|mesh-list
751859|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
751860|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751861|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
751862|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
751863|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
752055|NCT02774005|Idebenone|idebenone|mesh-list
752056|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
752057|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752058|NCT02774005|Protective Agents|protective agents|mesh-ancestor
752059|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752612|NCT02771379|Idebenone|idebenone|mesh-list
752613|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
752614|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752615|NCT02771379|Protective Agents|protective agents|mesh-ancestor
752616|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093062|NCT02256436|Docetaxel|docetaxel|mesh-list
2093063|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
2093064|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2093065|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093066|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
2093067|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
2093068|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
2093069|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093070|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2093071|NCT02256540|Resveratrol|resveratrol|mesh-list
2093072|NCT02256540|Estradiol|estradiol|mesh-list
750691|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751019|NCT02778594|Levodopa|levodopa|mesh-list
751020|NCT02778594|Benserazide|benserazide|mesh-list
751021|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
751022|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
751023|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
751024|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
751025|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751026|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751027|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236519|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2236520|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236521|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2236522|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236523|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236524|NCT00086775|Rituximab|rituximab|mesh-list
2236525|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
2236526|NCT00086775|Fludarabine|fludarabine|mesh-list
2236527|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
2236528|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2236529|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236530|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
2236531|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236532|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2236533|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2236534|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
2236535|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236536|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236537|NCT00086801|Gemcitabine|gemcitabine|mesh-list
2236538|NCT00086801|Doxorubicin|doxorubicin|mesh-list
2236539|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2236540|NCT00086801|Vinblastine|vinblastine|mesh-list
2236541|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2236542|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
751708|NCT02775695|Doxycycline|doxycycline|mesh-list
751709|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
751710|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751711|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
751712|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
751713|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
751807|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
751808|NCT02775227|Pasireotide|pasireotide|mesh-list
751809|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
751810|NCT02775227|Hormones|hormones|mesh-ancestor
751811|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
751812|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236543|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
2236544|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236545|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236546|NCT00086801|Antiviral Agents|antiviral agents|mesh-ancestor
2236547|NCT00086801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236548|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236549|NCT00086801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236550|NCT00086801|Immunologic Factors|immunologic factors|mesh-ancestor
2236551|NCT00086801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236552|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2236553|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2236554|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2236555|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2236556|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2236557|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
2236558|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
2236559|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
2236560|NCT00086827|Romidepsin|romidepsin|mesh-list
2236561|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2236562|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236563|NCT00086840|Sirolimus|sirolimus|mesh-list
752325|NCT02772926|Benphothiamine|benphothiamine|mesh-list
752326|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
752327|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
752328|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752329|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
752330|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
752331|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752571|NCT02771782|Vaccines|vaccines|mesh-list
752572|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
750779|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
750780|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
750781|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
750782|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
750783|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
750784|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
750785|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
750786|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
750787|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
750798|NCT02779348|Warfarin|warfarin|mesh-list
750799|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
750936|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
750937|NCT02779153|Hormones|hormones|mesh-ancestor
750938|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
750939|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751109|NCT02777866|Bupivacaine|bupivacaine|mesh-list
751110|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
751111|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
751112|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
751113|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751114|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
751115|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
751651|NCT02776436|Dexamethasone|dexamethasone|mesh-list
751652|NCT02776436|Prednisone|prednisone|mesh-list
751653|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
751654|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
751655|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
751656|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
751657|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751658|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
751659|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
751660|NCT02776436|Hormones|hormones|mesh-ancestor
751661|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
751662|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
751663|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751789|NCT02775500|Apremilast|apremilast|mesh-list
751790|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
751791|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
751792|NCT02775500|Analgesics|analgesics|mesh-ancestor
751793|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
751794|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
751795|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751796|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
751797|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
751798|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
751799|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
751800|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751801|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751820|NCT02775110|Natalizumab|natalizumab|mesh-list
751821|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
751822|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751864|NCT02774902|Clarithromycin|clarithromycin|mesh-list
751865|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
751866|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751867|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
751868|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751869|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751870|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
751871|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
751983|NCT02774460|Amlodipine|amlodipine|mesh-list
751984|NCT02774460|Candesartan|candesartan|mesh-list
751985|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
751986|NCT02774460|Lisinopril|lisinopril|mesh-list
751987|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
751988|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
751989|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
751990|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751991|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
751992|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751993|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
751994|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
751995|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
751996|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
750902|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
750903|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
750904|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752153|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
752154|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
752155|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
752156|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
752157|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
752158|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752159|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
752160|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
752161|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752162|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
752163|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752724|NCT02771158|Midodrine|midodrine|mesh-list
752725|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
752726|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
752727|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752728|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752729|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
752730|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
752731|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
752732|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
752733|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
752734|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
752735|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752830|NCT02770690|Lidocaine|lidocaine|mesh-list
752831|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
752832|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
752833|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
752834|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752835|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752836|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
752837|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752838|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
752839|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
752840|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
752841|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
752842|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236564|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2236565|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236566|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2236567|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236568|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
2236569|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236570|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
2236571|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236572|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2236573|NCT00086879|Temozolomide|temozolomide|mesh-list
2236574|NCT00086879|Carmustine|carmustine|mesh-list
2236575|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236576|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2236577|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753261|NCT02769130|Losartan|losartan|mesh-list
753262|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
753263|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
753264|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
753265|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
753266|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753465|NCT02768376|Fentanyl|fentanyl|mesh-list
753466|NCT02768376|Bupivacaine|bupivacaine|mesh-list
753467|NCT02768376|Anesthetics|anesthetics|mesh-list
753468|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
753469|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
753470|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753471|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
753472|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753473|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
753474|NCT02768376|Narcotics|narcotics|mesh-ancestor
753475|NCT02768376|Analgesics|analgesics|mesh-ancestor
753476|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
753477|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
753478|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
753530|NCT02767999|Fluoxetine|fluoxetine|mesh-list
2236578|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236579|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2236580|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
2236581|NCT00086892|Carboplatin|carboplatin|mesh-list
2236582|NCT00086892|Cetuximab|cetuximab|mesh-list
2236583|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236584|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2236585|NCT00086931|Capecitabine|capecitabine|mesh-list
2236586|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
2236587|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2236588|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
2236589|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236590|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236591|NCT00086944|Rituximab|rituximab|mesh-list
2236592|NCT00086944|Carboplatin|carboplatin|mesh-list
2236593|NCT00086944|Etoposide|etoposide|mesh-list
751493|NCT02776878|Dasatinib|dasatinib|mesh-list
751494|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751495|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
751496|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751497|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751714|NCT02775877|Letrozole|letrozole|mesh-list
751715|NCT02775877|Clomiphene|clomiphene|mesh-list
751716|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751717|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
751718|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
751719|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751720|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751721|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
751722|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
751723|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
751724|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751725|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
751726|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
751727|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
751728|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
751729|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
751978|NCT02774525|Ethanol|ethanol|mesh-list
751979|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
751980|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751981|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
751982|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752699|NCT02771405|Ribavirin|ribavirin|mesh-list
752700|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
752701|NCT02771405|Simeprevir|simeprevir|mesh-list
752702|NCT02771405|Ledipasvir|ledipasvir|mesh-list
752703|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
752704|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752705|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
752706|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752707|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
752708|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752806|NCT02770651|Everolimus|everolimus|mesh-list
752807|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752808|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
752809|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
752810|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753575|NCT02767596|Lixisenatide|lixisenatide|mesh-list
753576|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
753577|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753826|NCT02767479|Esomeprazole|esomeprazole|mesh-list
753827|NCT02767479|Rabeprazole|rabeprazole|mesh-list
753828|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
753829|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
753830|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
753831|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753832|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753884|NCT02766803|Resveratrol|resveratrol|mesh-list
753885|NCT02766803|Simvastatin|simvastatin|mesh-list
753886|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
753887|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
753888|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
753889|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753890|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
753891|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
753892|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093073|NCT02256540|Estrogens|estrogens|mesh-ancestor
2093074|NCT02256540|Hormones|hormones|mesh-ancestor
2093075|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2093076|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093077|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
2093078|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093079|NCT02256540|Protective Agents|protective agents|mesh-ancestor
2093080|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752455|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
752456|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
752457|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236594|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
2236595|NCT00086944|Ifosfamide|ifosfamide|mesh-list
2236596|NCT00086944|Oblimersen|oblimersen|mesh-list
2236597|NCT00086944|Lenograstim|lenograstim|mesh-list
2236598|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2236599|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236600|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
753332|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
753333|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
753334|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
753335|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753336|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
753337|NCT02768688|Analgesics|analgesics|mesh-ancestor
753338|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
753339|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753340|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
753341|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
753342|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
753343|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
753344|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753345|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753426|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
753427|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
753521|NCT02768116|Sirolimus|sirolimus|mesh-list
753522|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
753523|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
753524|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
753525|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753526|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
753527|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
753528|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
753529|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236601|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236602|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
754215|NCT02765347|Metformin|metformin|mesh-list
754216|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
754217|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754751|NCT02762942|Misoprostol|misoprostol|mesh-list
754752|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
754753|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
754754|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
754755|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754756|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
754757|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
754758|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
2236603|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2236604|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2236605|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2236606|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236607|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236608|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2236609|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2236610|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
2236611|NCT00086970|Ifosfamide|ifosfamide|mesh-list
2236612|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2236613|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2236614|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
2236615|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755118|NCT02761291|Gemcitabine|gemcitabine|mesh-list
755119|NCT02761291|Valganciclovir|valganciclovir|mesh-list
755120|NCT02761291|Valproic Acid|valproic acid|mesh-list
755121|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
755122|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
755123|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751196|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
751197|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
751198|NCT02779283|Rituximab|rituximab|mesh-list
751199|NCT02779283|Doxorubicin|doxorubicin|mesh-list
751200|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
751201|NCT02779283|Methotrexate|methotrexate|mesh-list
751202|NCT02779283|Vincristine|vincristine|mesh-list
751203|NCT02779283|Sorafenib|sorafenib|mesh-list
751204|NCT02779283|Sunitinib|sunitinib|mesh-list
751205|NCT02779283|Dasatinib|dasatinib|mesh-list
751206|NCT02779283|Idarubicin|idarubicin|mesh-list
751207|NCT02779283|Ponatinib|ponatinib|mesh-list
751208|NCT02779283|Idelalisib|idelalisib|mesh-list
751209|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
751210|NCT02779283|Antibodies|antibodies|mesh-list
751211|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
751212|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
751213|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
751214|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
751215|NCT02779283|BB 1101|bb 1101|mesh-list
751216|NCT02779283|Calcium|calcium|mesh-list
751217|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
751218|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
751219|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
751220|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751221|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
751222|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
751223|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
751224|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751225|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751226|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
751227|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
751228|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
751229|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
751230|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
751231|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
751232|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
751233|NCT02779283|Hormones|hormones|mesh-ancestor
751234|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
751235|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
751236|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
751237|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
751238|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
751239|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751240|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
751241|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
751242|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
751243|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
751244|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
751245|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
751246|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
751247|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
751248|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
751249|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
751250|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
751251|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751252|NCT02779283|Antidotes|antidotes|mesh-ancestor
751253|NCT02779283|Protective Agents|protective agents|mesh-ancestor
751254|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
751255|NCT02779283|Vitamins|vitamins|mesh-ancestor
751256|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
751257|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
751258|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
751259|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
751260|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
751261|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
751262|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
751263|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
751264|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
751265|NCT02779283|Growth Substances|growth substances|mesh-ancestor
751266|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
751267|NCT02779283|Hematinics|hematinics|mesh-ancestor
751268|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
751406|NCT02777229|Tenofovir|tenofovir|mesh-list
751407|NCT02777229|Lamivudine|lamivudine|mesh-list
751408|NCT02777229|Efavirenz|efavirenz|mesh-list
751409|NCT02777229|Dolutegravir|dolutegravir|mesh-list
751410|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
751411|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751412|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
751456|NCT02776722|Tagatose|tagatose|mesh-list
751457|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
751458|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
751459|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
751460|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236616|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236617|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236618|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
2236619|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236620|NCT00087009|Rituximab|rituximab|mesh-list
752173|NCT02773602|Dexamethasone|dexamethasone|mesh-list
752174|NCT02773602|Clonidine|clonidine|mesh-list
752175|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
752176|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
752177|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
752178|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752179|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752180|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
752181|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
752182|NCT02773602|Hormones|hormones|mesh-ancestor
752183|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
752184|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
752185|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752186|NCT02773602|Analgesics|analgesics|mesh-ancestor
752187|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
752188|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
752189|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
752190|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
752191|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
752192|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
752193|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
752194|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
752195|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752597|NCT02771912|Propofol|propofol|mesh-list
752598|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
752599|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
752600|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752601|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752602|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
752603|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
752604|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
752605|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
752606|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
752607|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
752758|NCT02770885|Dulaglutide|dulaglutide|mesh-list
752759|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
752760|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752912|NCT02770430|Infliximab|infliximab|mesh-list
752913|NCT02770430|Basiliximab|basiliximab|mesh-list
752914|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
752915|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
752916|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
752917|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
752918|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
752919|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753376|NCT02769013|Praziquantel|praziquantel|mesh-list
753377|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
753378|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
753379|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093081|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2093082|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
2093083|NCT02256969|Prednisolone|prednisolone|mesh-list
2093084|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2093085|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
2093086|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2093087|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
2093088|NCT02256969|Mineral Oil|mineral oil|mesh-list
2236621|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2236622|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093089|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2236623|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
751413|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
751414|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751415|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751416|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
751417|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
751418|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
751419|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
751420|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
751421|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
751422|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
751423|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
751424|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
751425|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2236624|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236625|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2236626|NCT00087035|Docetaxel|docetaxel|mesh-list
2236627|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
752617|NCT02771392|Tetracaine|tetracaine|mesh-list
752618|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
752619|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
752620|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
752621|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752622|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752623|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
752624|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093090|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
2093091|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093092|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
2093093|NCT02256969|Hormones|hormones|mesh-ancestor
2093094|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2093095|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093096|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2093097|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093098|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
2093099|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
2093100|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093101|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
753634|NCT02767713|Dexamethasone|dexamethasone|mesh-list
753635|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
753636|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
753637|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
753638|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753639|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753640|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
753641|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
753642|NCT02767713|Hormones|hormones|mesh-ancestor
753643|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
753644|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
753645|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754385|NCT02764619|Spironolactone|spironolactone|mesh-list
754386|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
754387|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
754388|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
754389|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754390|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
754391|NCT02764619|Diuretics|diuretics|mesh-ancestor
754392|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
754547|NCT02763761|Prednisone|prednisone|mesh-list
754548|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
754549|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
754550|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
754551|NCT02763761|Prednisolone|prednisolone|mesh-list
754552|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
754553|NCT02763761|Infliximab|infliximab|mesh-list
754554|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
751477|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751478|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
751640|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
751641|NCT02775968|Azithromycin|azithromycin|mesh-list
751642|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
751643|NCT02775968|Erythromycin|erythromycin|mesh-list
751644|NCT02775968|Cephalosporins|cephalosporins|mesh-list
751645|NCT02775968|Cefamandole|cefamandole|mesh-list
751646|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751647|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
751648|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
751649|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751650|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752449|NCT02772744|Ribavirin|ribavirin|mesh-list
752450|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
752451|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
752452|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752453|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
752454|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093102|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2093103|NCT02256969|Protective Agents|protective agents|mesh-ancestor
2093104|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
753361|NCT02768805|Vaccines|vaccines|mesh-list
753362|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
753363|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236628|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236629|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
2236630|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
2236631|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
2236632|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236633|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2236634|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236635|NCT00087048|Topotecan|topotecan|mesh-list
2236636|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2236637|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2236638|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236639|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236640|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236641|NCT00087074|Sirolimus|sirolimus|mesh-list
2236642|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2236643|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236644|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2236645|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236646|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
2236647|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236648|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
2236649|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236650|NCT00087087|Pemetrexed|pemetrexed|mesh-list
2236651|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236652|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236653|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236654|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2236655|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2236656|NCT00087100|Pemetrexed|pemetrexed|mesh-list
2236657|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236658|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236659|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236660|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2236661|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2236662|NCT00087113|Pemetrexed|pemetrexed|mesh-list
2236663|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236664|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236665|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236666|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2236667|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2236668|NCT00087165|Prednisone|prednisone|mesh-list
2236669|NCT00087165|Docetaxel|docetaxel|mesh-list
2236670|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236671|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
2236672|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
2236673|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
2236674|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236675|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2236676|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
2236677|NCT00087165|Hormones|hormones|mesh-ancestor
755179|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
751483|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751484|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093105|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093106|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2093107|NCT02256969|Renal Agents|renal agents|mesh-ancestor
2236678|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
752060|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
752061|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
752062|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752063|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752064|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
752065|NCT02773797|Analgesics|analgesics|mesh-ancestor
752066|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
752067|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752068|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
752069|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
752070|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
752071|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
752072|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
752073|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752221|NCT02773355|Liraglutide|liraglutide|mesh-list
752222|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
752223|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752224|NCT02773355|Incretins|incretins|mesh-ancestor
752225|NCT02773355|Hormones|hormones|mesh-ancestor
752226|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
752628|NCT02771587|Ethanol|ethanol|mesh-list
752629|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
752630|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752631|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752632|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236679|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236680|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2236681|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
2236682|NCT00087178|Doxorubicin|doxorubicin|mesh-list
2236683|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2236684|NCT00087178|Fluorouracil|fluorouracil|mesh-list
2236685|NCT00087178|Epirubicin|epirubicin|mesh-list
2236686|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
753729|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
753730|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
753731|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
753904|NCT02767024|Nitroprusside|nitroprusside|mesh-list
753905|NCT02767024|Dobutamine|dobutamine|mesh-list
753906|NCT02767024|Furosemide|furosemide|mesh-list
753907|NCT02767024|Diuretics|diuretics|mesh-ancestor
753908|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
753909|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753910|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
753911|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
753912|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753913|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
753914|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
753915|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
753916|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753917|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
753918|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
753919|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
753920|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
753921|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753922|NCT02767024|Protective Agents|protective agents|mesh-ancestor
753923|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
753924|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
753925|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
754363|NCT02764749|Phenol|phenol|mesh-list
754364|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
754365|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
754366|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
754367|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
754368|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
754525|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
754526|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754527|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754528|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
754529|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
751559|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
751560|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
751561|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751562|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
751563|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751564|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
751565|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
751566|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
751567|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
751568|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
751569|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
751570|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
751571|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
751572|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
751573|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
751574|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
751575|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
751576|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
751697|NCT02776059|Prednisolone|prednisolone|mesh-list
751698|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
751699|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
751700|NCT02776059|Hormones|hormones|mesh-ancestor
751701|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
751702|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751703|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
751704|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751965|NCT02774382|Vancomycin|vancomycin|mesh-list
751966|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
751967|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752356|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
752357|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
752358|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752359|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752360|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
752361|NCT02773017|Analgesics|analgesics|mesh-ancestor
752362|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
752363|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752364|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
752365|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
752366|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
752367|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
752368|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
752369|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753045|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
753046|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
753047|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
753048|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753049|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753050|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753110|NCT02769494|Riboflavin|riboflavin|mesh-list
753111|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
753112|NCT02769494|Mesalamine|mesalamine|mesh-list
753113|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
753114|NCT02769494|Vitamins|vitamins|mesh-ancestor
753115|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
753116|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753117|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
753118|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
753119|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
753120|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
753121|NCT02769494|Analgesics|analgesics|mesh-ancestor
753122|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
753123|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753124|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
753125|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
753435|NCT02768415|Apatinib|apatinib|mesh-list
753436|NCT02768415|Vinorelbine|vinorelbine|mesh-list
753437|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753438|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
753439|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753440|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753441|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
753442|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
753443|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
751584|NCT02776202|Sirolimus|sirolimus|mesh-list
751585|NCT02776202|Fludarabine|fludarabine|mesh-list
751586|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
751587|NCT02776202|Melphalan|melphalan|mesh-list
751588|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751589|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
751590|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
751591|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751592|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
751593|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
751594|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751595|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
751596|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
751597|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
751598|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
751599|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
751600|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751601|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
751602|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
751603|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
751604|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
751753|NCT02775474|Fentanyl|fentanyl|mesh-list
751754|NCT02775474|Methadone|methadone|mesh-list
751755|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
751756|NCT02775474|Narcotics|narcotics|mesh-ancestor
751757|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
751758|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751759|NCT02775474|Analgesics|analgesics|mesh-ancestor
751760|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
751761|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
751762|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
751763|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
751764|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
751765|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
751766|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
751767|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
2236687|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
2236688|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236689|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2236690|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2236691|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
2236692|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236693|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236694|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2236695|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2236696|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2236697|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
752376|NCT02772822|Rituximab|rituximab|mesh-list
752377|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
752378|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752379|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
752380|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752381|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
752411|NCT02772497|Aflibercept|aflibercept|mesh-list
752412|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
752413|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
752414|NCT02772497|Growth Substances|growth substances|mesh-ancestor
752415|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752416|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
752417|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753177|NCT02769390|Clonidine|clonidine|mesh-list
753178|NCT02769390|Diazepam|diazepam|mesh-list
753179|NCT02769390|Analgesics|analgesics|mesh-ancestor
753180|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
753181|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753182|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753183|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
753184|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
753185|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
753186|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
753187|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
753188|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
753189|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
753190|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753191|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753192|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2236698|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236699|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
2236700|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2236701|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
2236702|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2236703|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
752425|NCT02772419|Benralizumab|benralizumab|mesh-list
752426|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
752427|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
752538|NCT02772120|Progesterone|progesterone|mesh-list
752539|NCT02772120|Progestins|progestins|mesh-ancestor
752540|NCT02772120|Hormones|hormones|mesh-ancestor
752541|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
752542|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753460|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
753461|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
753462|NCT02768571|Protective Agents|protective agents|mesh-ancestor
753463|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753464|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
753708|NCT02767245|Thiamine|thiamine|mesh-list
753709|NCT02767245|Vitamins|vitamins|mesh-ancestor
753710|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
753711|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753712|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
753857|NCT02767076|Anesthetics|anesthetics|mesh-list
753858|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
753859|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754330|NCT02765126|Vaccines|vaccines|mesh-list
754331|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
754332|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754476|NCT02764281|Dexamethasone|dexamethasone|mesh-list
754477|NCT02764281|Methotrexate|methotrexate|mesh-list
754478|NCT02764281|Etoposide|etoposide|mesh-list
754479|NCT02764281|Pegaspargase|pegaspargase|mesh-list
754480|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
754481|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
754482|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
754483|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754484|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754485|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
754486|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
754487|NCT02764281|Hormones|hormones|mesh-ancestor
754488|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
754489|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
754490|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754491|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754492|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754493|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
754494|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
754495|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
754496|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
754497|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
754498|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
754499|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
754500|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
754501|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
754502|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
754503|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
754504|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
754505|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
754506|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
755161|NCT02760953|Epirubicin|epirubicin|mesh-list
755162|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
755163|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755164|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2236704|NCT00087217|Paclitaxel|paclitaxel|mesh-list
751783|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
751784|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
751785|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
751786|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751787|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751788|NCT02775539|Urological Agents|urological agents|mesh-ancestor
751968|NCT02774499|Methadone|methadone|mesh-list
751969|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
751970|NCT02774499|Narcotics|narcotics|mesh-ancestor
751971|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
751972|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751973|NCT02774499|Analgesics|analgesics|mesh-ancestor
751974|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
751975|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
751976|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
751977|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
752019|NCT02774044|Beractant|beractant|mesh-list
752020|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
752021|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
752022|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
752670|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
752671|NCT02771743|Ifosfamide|ifosfamide|mesh-list
752672|NCT02771743|Carboplatin|carboplatin|mesh-list
752673|NCT02771743|Doxorubicin|doxorubicin|mesh-list
752674|NCT02771743|Etoposide|etoposide|mesh-list
752675|NCT02771743|Interleukin-2|interleukin-2|mesh-list
752676|NCT02771743|Isotretinoin|isotretinoin|mesh-list
752677|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
752678|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
752679|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752680|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
752681|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
752682|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
752683|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752684|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752685|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
752686|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
752687|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
752688|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
752689|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752690|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
752691|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
752692|NCT02771743|Analgesics|analgesics|mesh-ancestor
752693|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
752694|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752695|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
752811|NCT02770716|Terlipressin|terlipressin|mesh-list
752812|NCT02770716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
752813|NCT02770716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
753082|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
753083|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753084|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
753085|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753086|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753087|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
753397|NCT02768519|OTS167|ots167|mesh-list
753398|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
753399|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753400|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753509|NCT02768220|Empagliflozin|empagliflozin|mesh-list
753510|NCT02768220|Linagliptin|linagliptin|mesh-list
753511|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
753512|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753513|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
753514|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753515|NCT02768220|Incretins|incretins|mesh-ancestor
753516|NCT02768220|Hormones|hormones|mesh-ancestor
753517|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
753518|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
753519|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
753520|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754104|NCT02766322|Ethanol|ethanol|mesh-list
754105|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
754106|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
754107|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754221|NCT02765399|Incretins|incretins|mesh-ancestor
751817|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751818|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
751819|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2236705|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2236706|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236707|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
2236708|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
2236709|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
2236710|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236711|NCT00087256|Celecoxib|celecoxib|mesh-list
2236712|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2236713|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
752213|NCT02773316|Morphine|morphine|mesh-list
752214|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
752215|NCT02773316|Narcotics|narcotics|mesh-ancestor
752216|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752217|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752218|NCT02773316|Analgesics|analgesics|mesh-ancestor
752219|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
752220|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753256|NCT02769286|Osimertinib|osimertinib|mesh-list
753257|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753258|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
753259|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753260|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236714|NCT00087256|Analgesics|analgesics|mesh-ancestor
2236715|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
2236716|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754464|NCT02764125|Levodopa|levodopa|mesh-list
754465|NCT02764125|Carbidopa|carbidopa|mesh-list
754466|NCT02764125|Entacapone|entacapone|mesh-list
754467|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
754468|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
754469|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
754470|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
754471|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754472|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754473|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
754474|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754475|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
755057|NCT02761317|Bisacodyl|bisacodyl|mesh-list
755058|NCT02761317|Cathartics|cathartics|mesh-ancestor
755059|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
755060|NCT02761317|Laxatives|laxatives|mesh-ancestor
756209|NCT02756715|Propofol|propofol|mesh-list
756210|NCT02756715|Desflurane|desflurane|mesh-list
756211|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
756212|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
756213|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756214|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
756215|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
756216|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
756217|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
756287|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
756288|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
756289|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
756290|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
756291|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756292|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
756293|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
756775|NCT02754011|Capecitabine|capecitabine|mesh-list
756776|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
756777|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
756778|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756779|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756876|NCT02753712|Fluticasone|fluticasone|mesh-list
756877|NCT02753712|Xhance|xhance|mesh-list
756878|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
756879|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
756880|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
756881|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
756882|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756883|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236717|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236718|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2236719|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2236720|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2236721|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
751936|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
751937|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
751938|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
751939|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751940|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
751941|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
751942|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
751943|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
751944|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
751945|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236722|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236723|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236724|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2236725|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236726|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2236727|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236728|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236729|NCT00087282|Irinotecan|irinotecan|mesh-list
2236730|NCT00087282|Alvocidib|alvocidib|mesh-list
2236731|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
752639|NCT02771704|Iodine|iodine|mesh-list
752640|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
752641|NCT02771704|Fluorides|fluorides|mesh-list
752642|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
752643|NCT02771704|Protective Agents|protective agents|mesh-ancestor
752644|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752645|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
752646|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752647|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
752648|NCT02771704|Trace Elements|trace elements|mesh-ancestor
752649|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
752802|NCT02770794|Infliximab|infliximab|mesh-list
752803|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
752804|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
752805|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
752854|NCT02770391|Leuprolide|leuprolide|mesh-list
752855|NCT02770391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
752856|NCT02770391|Fertility Agents|fertility agents|mesh-ancestor
752857|NCT02770391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
752858|NCT02770391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752859|NCT02770391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
752860|NCT02770391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753126|NCT02769793|Levodopa|levodopa|mesh-list
753127|NCT02769793|Benserazide|benserazide|mesh-list
753128|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
753129|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
753130|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
753131|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
753132|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753133|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753134|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753135|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236732|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2236733|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236734|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236735|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236736|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
2236737|NCT00087282|Growth Substances|growth substances|mesh-ancestor
2236738|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236739|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2236740|NCT00087295|Romidepsin|romidepsin|mesh-list
2236741|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2236742|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236743|NCT00087334|Capecitabine|capecitabine|mesh-list
2236744|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
2236745|NCT00087334|Gefitinib|gefitinib|mesh-list
2236746|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2236747|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
2236748|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236749|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236750|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
751890|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
751891|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
751892|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
751893|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
751894|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751895|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
751896|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
751897|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
751898|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
751899|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
751900|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
751901|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
751902|NCT02775292|Analgesics|analgesics|mesh-ancestor
751903|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
751904|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
751905|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
751906|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
751907|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
751908|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236751|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236752|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2236753|NCT00087347|Hematinics|hematinics|mesh-ancestor
752244|NCT02773407|Azithromycin|azithromycin|mesh-list
752245|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
752246|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
752247|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752248|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
752249|NCT02773407|Renal Agents|renal agents|mesh-ancestor
752250|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
752251|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
752252|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
752458|NCT02772601|Metoprolol|metoprolol|mesh-list
752459|NCT02772601|Midazolam|midazolam|mesh-list
752460|NCT02772601|Caffeine|caffeine|mesh-list
752461|NCT02772601|Omeprazole|omeprazole|mesh-list
752462|NCT02772601|Warfarin|warfarin|mesh-list
752463|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
752464|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
752465|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752466|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752467|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
752468|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
752469|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
752470|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
752471|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
752472|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
752473|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
752474|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
752475|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
752476|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752477|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
752478|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
752479|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
752480|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
752481|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752482|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
752483|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
752484|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
752485|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
752486|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
752487|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
752488|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
752489|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
752490|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
752491|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752492|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
752493|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
752494|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
752495|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
752633|NCT02771600|Anesthetics|anesthetics|mesh-list
752634|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
752635|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752636|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752637|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
752638|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753088|NCT02769936|Cycloserine|cycloserine|mesh-list
751913|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
751914|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
751915|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751916|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
751917|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
751918|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
752034|NCT02774187|Leucovorin|leucovorin|mesh-list
752035|NCT02774187|Fluorouracil|fluorouracil|mesh-list
752036|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
752037|NCT02774187|Sorafenib|sorafenib|mesh-list
752038|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
752039|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752040|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
752041|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752042|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
752043|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
752044|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752045|NCT02774187|Antidotes|antidotes|mesh-ancestor
752046|NCT02774187|Protective Agents|protective agents|mesh-ancestor
752047|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
752048|NCT02774187|Vitamins|vitamins|mesh-ancestor
752049|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
752050|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
752051|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236754|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2236755|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2236756|NCT00087373|Metronidazole|metronidazole|mesh-list
2236757|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236758|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2236759|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2236760|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2236761|NCT00087399|Gabapentin|gabapentin|mesh-list
2236762|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
2236763|NCT00087399|Analgesics|analgesics|mesh-ancestor
2236764|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
2236765|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754807|NCT02762617|Tenofovir|tenofovir|mesh-list
754808|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
754809|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
754810|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
754811|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
754812|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754813|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754814|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
754815|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
755640|NCT02758990|Vitamin D|vitamin d|mesh-list
755641|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
755642|NCT02758990|Vitamins|vitamins|mesh-list
755643|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
755644|NCT02758990|Vitamin E|vitamin e|mesh-list
755645|NCT02758990|Tocopherols|tocopherols|mesh-list
755646|NCT02758990|Vitamin A|vitamin a|mesh-list
755647|NCT02758990|Niacinamide|niacinamide|mesh-list
755648|NCT02758990|Niacin|niacin|mesh-list
755649|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
755650|NCT02758990|Pyridoxine|pyridoxine|mesh-list
755651|NCT02758990|Pyridoxal|pyridoxal|mesh-list
755652|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
755653|NCT02758990|Caffeine|caffeine|mesh-list
755654|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
755655|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755656|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
755657|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
755658|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
755659|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755660|NCT02758990|Protective Agents|protective agents|mesh-ancestor
755661|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
755662|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
755663|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755664|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
755665|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
755666|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
755667|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
755668|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
755669|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
755670|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
755671|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
755672|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
2236766|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751934|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751935|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
752006|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
752007|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
752008|NCT02774239|Antibodies|antibodies|mesh-list
752009|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
752010|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
752011|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752276|NCT02773485|Gemcitabine|gemcitabine|mesh-list
752277|NCT02773485|Cisplatin|cisplatin|mesh-list
752278|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752279|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
752280|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
752281|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752282|NCT02773485|Antiviral Agents|antiviral agents|mesh-ancestor
752283|NCT02773485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752284|NCT02773485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752285|NCT02773485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
752286|NCT02773485|Immunologic Factors|immunologic factors|mesh-ancestor
752287|NCT02773485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752428|NCT02772354|Metoprolol|metoprolol|mesh-list
752429|NCT02772354|Verapamil|verapamil|mesh-list
752430|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
752431|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
752432|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
752433|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
752434|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752435|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752436|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
752437|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
752438|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
752439|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
752440|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
752441|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752442|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
752443|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
752444|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
752445|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
752625|NCT02771509|Mitogens|mitogens|mesh-list
752626|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
752627|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752709|NCT02770950|Indomethacin|indomethacin|mesh-list
752710|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
752711|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
752712|NCT02770950|Analgesics|analgesics|mesh-ancestor
752713|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
752714|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752715|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752716|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
752717|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
752718|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
752719|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
752720|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
752721|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
752722|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752723|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753395|NCT02768532|Vedolizumab|vedolizumab|mesh-list
753396|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
753496|NCT02768168|Dezocine|dezocine|mesh-list
753497|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
753498|NCT02768168|Narcotics|narcotics|mesh-ancestor
753499|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
753500|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753501|NCT02768168|Analgesics|analgesics|mesh-ancestor
753502|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
753503|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754218|NCT02765399|Liraglutide|liraglutide|mesh-list
754219|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
754220|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
751997|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
751998|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
751999|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
752000|NCT02774460|Protective Agents|protective agents|mesh-ancestor
752096|NCT02773979|Chloroquine|chloroquine|mesh-list
752097|NCT02773979|Amebicides|amebicides|mesh-ancestor
752098|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
752099|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
752100|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752101|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
752102|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
752227|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
752228|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
752229|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
752230|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
752231|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752232|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
752233|NCT02773251|Protective Agents|protective agents|mesh-ancestor
752234|NCT02773251|Laxatives|laxatives|mesh-ancestor
752235|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
752868|NCT02770508|Ritonavir|ritonavir|mesh-list
752869|NCT02770508|Darunavir|darunavir|mesh-list
752870|NCT02770508|Tenofovir|tenofovir|mesh-list
752871|NCT02770508|Lamivudine|lamivudine|mesh-list
752872|NCT02770508|Emtricitabine|emtricitabine|mesh-list
752873|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
752874|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
752875|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
752876|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752877|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752878|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
752879|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
752880|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
752881|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752882|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
752883|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
752884|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
752885|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
753488|NCT02768389|Bevacizumab|bevacizumab|mesh-list
753489|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
753490|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753491|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
753492|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
753493|NCT02768389|Growth Substances|growth substances|mesh-ancestor
753494|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753495|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
753875|NCT02766855|Cysteamine|cysteamine|mesh-list
753876|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
753877|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753933|NCT02766582|Paclitaxel|paclitaxel|mesh-list
753934|NCT02766582|Carboplatin|carboplatin|mesh-list
753935|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
753936|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
753937|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753938|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
753939|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
753940|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
753941|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753942|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
754444|NCT02764268|Apatinib|apatinib|mesh-list
754445|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754446|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
754447|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754448|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754507|NCT02763969|Interferons|interferons|mesh-list
754508|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
754509|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
754510|NCT02763969|Ustekinumab|ustekinumab|mesh-list
754511|NCT02763969|Famotidine|famotidine|mesh-list
754512|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754513|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
754514|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
754515|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
754516|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754517|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
754518|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
754519|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
754520|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
752001|NCT02774200|Apatinib|apatinib|mesh-list
752002|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752003|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
752004|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752005|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752496|NCT02772107|Temozolomide|temozolomide|mesh-list
752497|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
752498|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
752499|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752500|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752650|NCT02771418|Anesthetics|anesthetics|mesh-list
752651|NCT02771418|Propofol|propofol|mesh-list
752652|NCT02771418|Sevoflurane|sevoflurane|mesh-list
752653|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752654|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752655|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
752656|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
752657|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
752658|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
752659|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
752843|NCT02770404|Nafithromycin|nafithromycin|mesh-list
752844|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
752845|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752846|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
752847|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752848|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753065|NCT02769832|Gemcitabine|gemcitabine|mesh-list
753066|NCT02769832|Paclitaxel|paclitaxel|mesh-list
753067|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
753068|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
753069|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753070|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
753071|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
753072|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
753073|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753074|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
753075|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
753076|NCT02769832|Antiviral Agents|antiviral agents|mesh-ancestor
753077|NCT02769832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
753078|NCT02769832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753079|NCT02769832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
753080|NCT02769832|Immunologic Factors|immunologic factors|mesh-ancestor
753081|NCT02769832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236767|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
2236768|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2236769|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2236770|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2236771|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236772|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2236773|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2236774|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236775|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753953|NCT02766634|Lenograstim|lenograstim|mesh-list
753954|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
753955|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
753956|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754031|NCT02766140|Docetaxel|docetaxel|mesh-list
754032|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754033|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
754034|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
754035|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
754036|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236776|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
2236777|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2236778|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752135|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752136|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
752137|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
752138|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
752139|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752140|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752141|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
752142|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
752143|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
752144|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
752145|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
752146|NCT02774291|Analgesics|analgesics|mesh-ancestor
752147|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
752148|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752149|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
752150|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
752151|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
752152|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752332|NCT02773147|Pyridoxine|pyridoxine|mesh-list
752333|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
752334|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
752335|NCT02773147|Hematinics|hematinics|mesh-ancestor
752336|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
752337|NCT02773147|Vitamins|vitamins|mesh-ancestor
752338|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
752339|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093108|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2093109|NCT02256969|Emollients|emollients|mesh-ancestor
2093110|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
2093111|NCT02256982|Gemcitabine|gemcitabine|mesh-list
2093112|NCT02256982|Cisplatin|cisplatin|mesh-list
2093113|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093114|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2093115|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
2093116|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093117|NCT02256982|Antiviral Agents|antiviral agents|mesh-ancestor
2093118|NCT02256982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093119|NCT02256982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093120|NCT02256982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2093121|NCT02256982|Immunologic Factors|immunologic factors|mesh-ancestor
2093122|NCT02256982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093123|NCT02257372|Albuterol|albuterol|mesh-list
2093124|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2093125|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
2093126|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093127|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093128|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2093129|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
2093130|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
2093131|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2093132|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2093133|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2093134|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2093135|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
2093136|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236779|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
753327|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
753328|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
753329|NCT02768961|Ledipasvir|ledipasvir|mesh-list
753330|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
753331|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
753586|NCT02767635|Triamcinolone|triamcinolone|mesh-list
753587|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
753588|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
753589|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
753590|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
753591|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
753592|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
753593|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753594|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753595|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
753596|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
753597|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753598|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
753599|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753600|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
753601|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
752266|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
752267|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
752268|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
752340|NCT02772965|Methotrexate|methotrexate|mesh-list
752341|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
752342|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
752343|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
752344|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752345|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
752346|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
752347|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752348|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752349|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
752350|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752351|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
752352|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
752353|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
752354|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
752355|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
752814|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
752815|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
752816|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
752817|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752818|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
752819|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
752820|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752821|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752822|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752823|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
752824|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
752825|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
752826|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752827|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
752828|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
752829|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
752886|NCT02770274|Aspirin|aspirin|mesh-list
752887|NCT02770274|Cilostazol|cilostazol|mesh-list
752888|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
752889|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
752890|NCT02770274|Analgesics|analgesics|mesh-ancestor
752891|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
752892|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752893|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752894|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
752895|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
752896|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
752897|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
752898|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752899|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
752900|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
752901|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752902|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
752903|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
752904|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
752905|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
752906|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
752907|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
752908|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
752909|NCT02770274|Protective Agents|protective agents|mesh-ancestor
752910|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
752911|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
753097|NCT02769910|Capsaicin|capsaicin|mesh-list
753098|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
753099|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
753100|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
753101|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753102|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093137|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093138|NCT02257385|Albuterol|albuterol|mesh-list
2093139|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
2093140|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2093141|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
2093142|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093143|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752384|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
752385|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
752386|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
752387|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752388|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
752389|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
752390|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752553|NCT02771925|Gabapentin|gabapentin|mesh-list
752554|NCT02771925|Analgesics|analgesics|mesh-ancestor
752555|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
752556|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752557|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752558|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
752559|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
752560|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
752561|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752562|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
752563|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
752564|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
752565|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
752566|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752567|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
2093144|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2093145|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
2093146|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
753136|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
753137|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
753138|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
753139|NCT02769689|Prednisolone|prednisolone|mesh-list
753140|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
753141|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
753142|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
753143|NCT02769689|Natalizumab|natalizumab|mesh-list
753144|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
753145|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
753146|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
753147|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753148|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753149|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
753150|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
753151|NCT02769689|Hormones|hormones|mesh-ancestor
753152|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
753153|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
753154|NCT02769689|Protective Agents|protective agents|mesh-ancestor
753155|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
753156|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753157|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
753364|NCT02768649|Risperidone|risperidone|mesh-list
753365|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
753366|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
753367|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753368|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753369|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753370|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
753371|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
753372|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
753373|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
753374|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
753375|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
753622|NCT02767752|Gemcitabine|gemcitabine|mesh-list
753623|NCT02767752|Capecitabine|capecitabine|mesh-list
753624|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
753625|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
753626|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753627|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753628|NCT02767752|Antiviral Agents|antiviral agents|mesh-ancestor
753629|NCT02767752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
753630|NCT02767752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753631|NCT02767752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
753632|NCT02767752|Immunologic Factors|immunologic factors|mesh-ancestor
753633|NCT02767752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753713|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
753714|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
753715|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
753716|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
752397|NCT02773030|Daratumumab|daratumumab|mesh-list
752398|NCT02773030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
752399|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
752400|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
752401|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
752402|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752403|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752404|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
752405|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
752406|NCT02773030|Hormones|hormones|mesh-ancestor
752407|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
752408|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
752409|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752410|NCT02773030|Immunologic Factors|immunologic factors|mesh-ancestor
2236780|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236781|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236782|NCT00087425|Rituximab|rituximab|mesh-list
2236783|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
2236784|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2236785|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236786|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
2236787|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236788|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2236789|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
753022|NCT02770261|Candesartan|candesartan|mesh-list
753023|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
753024|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
753025|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
753026|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
753027|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
753028|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753029|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
753030|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
753031|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753032|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
753033|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
753034|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2236790|NCT00087451|Sirolimus|sirolimus|mesh-list
2236791|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2236792|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
755260|NCT02760381|Acetic Acid|acetic acid|mesh-list
755261|NCT02760381|Retinol acetate|retinol acetate|mesh-list
755262|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
755263|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
755264|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
755265|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
755266|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755267|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
755268|NCT02760381|Protective Agents|protective agents|mesh-ancestor
755269|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755390|NCT02760030|Fulvestrant|fulvestrant|mesh-list
755391|NCT02760030|Palbociclib|palbociclib|mesh-list
755392|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
755393|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
755394|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755395|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
755396|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
755397|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
755398|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
755399|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755400|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
755401|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752418|NCT02772588|Leuprolide|leuprolide|mesh-list
752419|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
752420|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
752421|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
752422|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752423|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
752424|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752543|NCT02772003|Interleukin-12|interleukin-12|mesh-list
752544|NCT02772003|Vaccines|vaccines|mesh-list
752545|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
752546|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752547|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
752548|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
752549|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
752550|NCT02772003|Growth Substances|growth substances|mesh-ancestor
752551|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
752552|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752987|NCT02770222|Rifampin|rifampin|mesh-list
752988|NCT02770222|Selexipag|selexipag|mesh-list
752989|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
752990|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
752991|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
752992|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
752993|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752994|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
752995|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
752996|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752997|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752998|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
752999|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
753000|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
753001|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
753002|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
753003|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
753004|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
753005|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
753006|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
753007|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
753008|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
753009|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2236793|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2236794|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236795|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
2236796|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236797|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
2236798|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236799|NCT00087464|Tenofovir|tenofovir|mesh-list
2236800|NCT00087464|Emtricitabine|emtricitabine|mesh-list
2236801|NCT00087464|Nevirapine|nevirapine|mesh-list
2236802|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
753559|NCT02767661|Capecitabine|capecitabine|mesh-list
753560|NCT02767661|Letrozole|letrozole|mesh-list
753561|NCT02767661|Anastrozole|anastrozole|mesh-list
753562|NCT02767661|Exemestane|exemestane|mesh-list
753563|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
753564|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
753565|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
753566|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753567|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753568|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
753569|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753570|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
753571|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
753572|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
753573|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753574|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
753972|NCT02766439|Etanercept|etanercept|mesh-list
753973|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
753974|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
753975|NCT02766439|Analgesics|analgesics|mesh-ancestor
753976|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
753977|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753978|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753979|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2236803|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752520|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
752521|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
752522|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
752523|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
752524|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
752525|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752526|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
752527|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752528|NCT02772211|Renal Agents|renal agents|mesh-ancestor
752529|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
752530|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
752531|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
752532|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
752586|NCT02771717|Budesonide|budesonide|mesh-list
752587|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
752588|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
752589|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
752590|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752591|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752592|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
752593|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
752594|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
752595|NCT02771717|Hormones|hormones|mesh-ancestor
752596|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
752608|NCT02771457|Infliximab|infliximab|mesh-list
752609|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
752610|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
752611|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2236804|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2236805|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2236806|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236807|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236808|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2236809|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2236810|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2236811|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2236812|NCT00087542|Pimavanserin|pimavanserin|mesh-list
2236813|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
753380|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
753381|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
753382|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753383|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
753384|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
753385|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
753386|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753387|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
753388|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236814|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2236815|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2236816|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2236817|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
753797|NCT02767154|Mannitol|mannitol|mesh-list
753798|NCT02767154|Dextrans|dextrans|mesh-list
753799|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
753800|NCT02767154|Diuretics|diuretics|mesh-ancestor
753801|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
753802|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753803|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
753804|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
753805|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
754316|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
754317|NCT02765009|Furosemide|furosemide|mesh-list
754318|NCT02765009|Bumetanide|bumetanide|mesh-list
754319|NCT02765009|Diuretics|diuretics|mesh-list
754320|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
754321|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
754322|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754323|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
754324|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
754325|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754326|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
754650|NCT02762955|Adalimumab|adalimumab|mesh-list
754651|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
754652|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
752573|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
752574|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752575|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2236818|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236819|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236820|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2236821|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2236822|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
2236823|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753281|NCT02769169|Ranibizumab|ranibizumab|mesh-list
753282|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
753283|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
753284|NCT02769169|Growth Substances|growth substances|mesh-ancestor
753285|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753286|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
753287|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753322|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
753323|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
753324|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
753325|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
753326|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
753389|NCT02768545|Ezetimibe|ezetimibe|mesh-list
753390|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
753391|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
753392|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
753393|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753394|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
753504|NCT02768207|Vemurafenib|vemurafenib|mesh-list
753505|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753506|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
753507|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753508|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753666|NCT02767674|Gemcitabine|gemcitabine|mesh-list
753667|NCT02767674|Prednisone|prednisone|mesh-list
753668|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
753669|NCT02767674|Rituximab|rituximab|mesh-list
753670|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
753671|NCT02767674|Epirubicin|epirubicin|mesh-list
753672|NCT02767674|Vindesine|vindesine|mesh-list
753673|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
753674|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
753675|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753676|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
753677|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
753678|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
753679|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753680|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753681|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
753682|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
753683|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
753684|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
753685|NCT02767674|Antiviral Agents|antiviral agents|mesh-ancestor
753686|NCT02767674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
753687|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753688|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
753689|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
753690|NCT02767674|Hormones|hormones|mesh-ancestor
753691|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
753692|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
753693|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
753694|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
753695|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
753696|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
753697|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
753698|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
753699|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
754571|NCT02764008|Bupivacaine|bupivacaine|mesh-list
754572|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
754573|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
754574|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754575|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754576|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
754577|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754718|NCT02762851|Vaccines|vaccines|mesh-list
754719|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
2093147|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2093148|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
2236824|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236825|NCT00087581|Cyclosporine|cyclosporine|mesh-list
2236826|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
2236827|NCT00087581|Tacrolimus|tacrolimus|mesh-list
2236828|NCT00087581|Cyclosporins|cyclosporins|mesh-list
753162|NCT02769572|Diclofenac|diclofenac|mesh-list
753163|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
753164|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
753165|NCT02769572|Analgesics|analgesics|mesh-ancestor
753166|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
753167|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753168|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753169|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
753170|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
753171|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
753172|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753173|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753897|NCT02766764|Hormones|hormones|mesh-list
753898|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
753899|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753984|NCT02766192|Ketamine|ketamine|mesh-list
753985|NCT02766192|Analgesics|analgesics|mesh-ancestor
753986|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
753987|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753988|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753989|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
753990|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
753991|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
753992|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
753993|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
753994|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
753995|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
753996|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753997|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236829|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236830|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
2236831|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236832|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2236833|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754338|NCT02764736|Atorvastatin|atorvastatin|mesh-list
754339|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
754340|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
754341|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
754342|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754343|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
754344|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
754345|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754721|NCT02762981|Paclitaxel|paclitaxel|mesh-list
754722|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
754723|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
754724|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754725|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
754726|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
754727|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
754728|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236834|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236835|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
2236836|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236837|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
2236838|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2236839|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2236840|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755148|NCT02760979|Denosumab|denosumab|mesh-list
755149|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
755150|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755366|NCT02759991|Vaccines|vaccines|mesh-list
755367|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
755368|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755440|NCT02759614|Bevacizumab|bevacizumab|mesh-list
755441|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
755442|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
755443|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752944|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
752945|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
752946|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
752947|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
752948|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
752949|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
752950|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
752951|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
752952|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
752953|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
752954|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
752955|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
752956|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
752957|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
752958|NCT02770378|Analgesics|analgesics|mesh-ancestor
752959|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
752960|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
752961|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
752962|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
752963|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
752964|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
752965|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
752966|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
752967|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
752968|NCT02770378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
752969|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
752970|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
752971|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
752972|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
752973|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
752974|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
752975|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
752976|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
752977|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
752978|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
752979|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
752980|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
752981|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
752982|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
752983|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
752984|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
752985|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
752986|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
753106|NCT02769884|Pancrelipase|pancrelipase|mesh-list
753107|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
753215|NCT02769325|Ketorolac|ketorolac|mesh-list
753216|NCT02769325|Atropine|atropine|mesh-list
753217|NCT02769325|Morphine|morphine|mesh-list
753218|NCT02769325|Propofol|propofol|mesh-list
753219|NCT02769325|Sevoflurane|sevoflurane|mesh-list
753220|NCT02769325|Rocuronium|rocuronium|mesh-list
753221|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
753222|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
753223|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753224|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
753225|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
753226|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
753227|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
753228|NCT02769325|Narcotics|narcotics|mesh-ancestor
753229|NCT02769325|Analgesics|analgesics|mesh-ancestor
753230|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
753231|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753232|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
753233|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
753234|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
753235|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
753236|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
753237|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
753238|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
753239|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753240|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753241|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
753242|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
753243|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
753037|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753038|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
753039|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753040|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753041|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
753042|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
753043|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
753044|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753412|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
753413|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
753414|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
753415|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753416|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
753417|NCT02768610|Analgesics|analgesics|mesh-ancestor
753418|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
753419|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753420|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
753421|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
753422|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
753423|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
753424|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753425|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236841|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2236842|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
2236843|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2236844|NCT00087620|Capecitabine|capecitabine|mesh-list
2236845|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2236846|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
754128|NCT02766036|Propolis|propolis|mesh-list
754129|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
754984|NCT02761512|Lansoprazole|lansoprazole|mesh-list
754985|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
754986|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
754987|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
754988|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
754989|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754990|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755033|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
755034|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
755035|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
755036|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
755037|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
755038|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
755039|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
755040|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755041|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755187|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
755188|NCT02760901|Mannitol|mannitol|mesh-list
755189|NCT02760901|Acetazolamide|acetazolamide|mesh-list
755190|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
755191|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
755192|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
755193|NCT02760901|Expectorants|expectorants|mesh-ancestor
755194|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
755195|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
755196|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
755197|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755198|NCT02760901|Protective Agents|protective agents|mesh-ancestor
755199|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755200|NCT02760901|Antidotes|antidotes|mesh-ancestor
755201|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
755202|NCT02760901|Diuretics|diuretics|mesh-ancestor
755203|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
755204|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
755205|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
755206|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755233|NCT02760342|Metformin|metformin|mesh-list
755234|NCT02760342|Peficitinib|peficitinib|mesh-list
755235|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
755236|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755237|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755238|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755239|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
755240|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
755551|NCT02758925|Cytarabine|cytarabine|mesh-list
755552|NCT02758925|Rituximab|rituximab|mesh-list
753089|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
753090|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
753091|NCT02769936|Renal Agents|renal agents|mesh-ancestor
753092|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
753093|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
753094|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
753095|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
753096|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753267|NCT02769104|Docetaxel|docetaxel|mesh-list
753268|NCT02769104|Letrozole|letrozole|mesh-list
753269|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
753270|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753271|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
753272|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
753273|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
753274|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753275|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
753276|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753277|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
753278|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
753279|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
753280|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753607|NCT02767882|Dexamethasone|dexamethasone|mesh-list
753608|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
753609|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
753610|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
753611|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753612|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753613|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
753614|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
753615|NCT02767882|Hormones|hormones|mesh-ancestor
753616|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
753617|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
753618|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753860|NCT02767089|Prednisone|prednisone|mesh-list
753861|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
753862|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
753863|NCT02767089|Hormones|hormones|mesh-ancestor
753864|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
753865|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753866|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
753867|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236847|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236848|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236849|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
2236850|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2236851|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236852|NCT00087711|Gemcitabine|gemcitabine|mesh-list
2236853|NCT00087711|Pemetrexed|pemetrexed|mesh-list
2236854|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236855|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2236856|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
2236857|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236858|NCT00087711|Antiviral Agents|antiviral agents|mesh-ancestor
2236859|NCT00087711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236860|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236861|NCT00087711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
754296|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
754297|NCT02765204|Saxagliptin|saxagliptin|mesh-list
754298|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
754299|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754300|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
754301|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754302|NCT02765204|Incretins|incretins|mesh-ancestor
754303|NCT02765204|Hormones|hormones|mesh-ancestor
754304|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
754305|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
754306|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
754307|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754455|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
754456|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
754457|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
754458|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
754459|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2236862|NCT00087711|Immunologic Factors|immunologic factors|mesh-ancestor
753401|NCT02769078|Warfarin|warfarin|mesh-list
753402|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
753403|NCT02769078|Dabigatran|dabigatran|mesh-list
753404|NCT02769078|Apixaban|apixaban|mesh-list
753405|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
753406|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
753407|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
753408|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
753409|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
753410|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753411|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236863|NCT00087711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236864|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2236865|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2236866|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2236867|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
754421|NCT02764541|Tamoxifen|tamoxifen|mesh-list
754422|NCT02764541|Letrozole|letrozole|mesh-list
754423|NCT02764541|Palbociclib|palbociclib|mesh-list
754424|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754425|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
754426|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
754427|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754428|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754429|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
754430|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
754431|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
754432|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754433|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
754434|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
754435|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
754436|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
754437|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
754626|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
754627|NCT02763137|Carbidopa|carbidopa|mesh-list
754628|NCT02763137|Levodopa|levodopa|mesh-list
754629|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
754630|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
754631|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754632|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
754633|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
754634|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
754635|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
754636|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
754637|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754638|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
754639|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754729|NCT02762890|Iodine|iodine|mesh-list
754730|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
754731|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
754732|NCT02762890|Trace Elements|trace elements|mesh-ancestor
754733|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
754734|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754843|NCT02762474|Paclitaxel|paclitaxel|mesh-list
754844|NCT02762474|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
754845|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
754846|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754847|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
754848|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
754849|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
754850|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755042|NCT02761161|Mianserin|mianserin|mesh-list
755043|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
755044|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
755045|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
755046|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
755047|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755048|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755049|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
755050|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
755051|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
755052|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
755053|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
753194|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
753195|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
753196|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
753197|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
753198|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
753199|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
753200|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
753201|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
753202|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
753203|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
753204|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
753205|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
753206|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
753207|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
2236868|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2236869|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2236870|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236871|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236872|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236873|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2236874|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
2093149|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093150|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093151|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
2093152|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2093153|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2093154|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2093155|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2093156|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
2093162|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
2093163|NCT02257541|Infigratinib|infigratinib|mesh-list
2093164|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093165|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2093166|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093167|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093168|NCT02257632|Ranibizumab|ranibizumab|mesh-list
2093169|NCT02257632|Aflibercept|aflibercept|mesh-list
2093170|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2093171|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2093172|NCT02257632|Growth Substances|growth substances|mesh-ancestor
2093173|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093174|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
2093175|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236875|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236876|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
754531|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
754532|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755241|NCT02760355|Ribavirin|ribavirin|mesh-list
755242|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
755243|NCT02760355|Ledipasvir|ledipasvir|mesh-list
755244|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
755245|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755246|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
755247|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236877|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
2236878|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236879|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2236880|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2236881|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2236882|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236883|NCT00087802|Gemcitabine|gemcitabine|mesh-list
2236884|NCT00087802|Paclitaxel|paclitaxel|mesh-list
2236885|NCT00087802|Carboplatin|carboplatin|mesh-list
2236886|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
2236887|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
753244|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
753245|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
753246|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
753247|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
753248|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
753249|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
753250|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
753251|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
753252|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
753253|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
753254|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
753255|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753288|NCT02768948|Losartan|losartan|mesh-list
753289|NCT02768948|Telmisartan|telmisartan|mesh-list
753290|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
753291|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
753292|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
753293|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
753294|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753316|NCT02768727|Xenon|xenon|mesh-list
753317|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
753318|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
753319|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
753320|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
753321|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753445|NCT02768337|Afatinib|afatinib|mesh-list
753446|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753447|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
753448|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753449|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236888|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236889|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
2236890|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
2236891|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
754037|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
754038|NCT02766556|Ropivacaine|ropivacaine|mesh-list
754039|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
754040|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754041|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754042|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
754043|NCT02766556|Analgesics|analgesics|mesh-ancestor
754044|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
754045|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754046|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
754047|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
754048|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
754049|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
754050|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
754051|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754052|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
754053|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
754203|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
754204|NCT02765594|Valsartan|valsartan|mesh-list
754205|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
754206|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
754207|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
754208|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754209|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
754210|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
754211|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
754212|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
754213|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754214|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
754244|NCT02765217|Amoxicillin|amoxicillin|mesh-list
754245|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
754246|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
754247|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
754248|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
754249|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
754250|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754251|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754252|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
754859|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
754860|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755207|NCT02760667|Cisplatin|cisplatin|mesh-list
755208|NCT02760667|Carboplatin|carboplatin|mesh-list
2236892|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753732|NCT02767362|Atorvastatin|atorvastatin|mesh-list
753733|NCT02767362|Ezetimibe|ezetimibe|mesh-list
753734|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
753735|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
753736|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
753737|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753738|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
753739|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
753740|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753998|NCT02766257|Anesthetics|anesthetics|mesh-list
753999|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754000|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754438|NCT02764593|Nivolumab|nivolumab|mesh-list
754439|NCT02764593|Cetuximab|cetuximab|mesh-list
754440|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754441|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
754442|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
754443|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754836|NCT02762929|Bupivacaine|bupivacaine|mesh-list
754837|NCT02762929|Anesthetics, Local|anesthetics, local|mesh-ancestor
754838|NCT02762929|Anesthetics|anesthetics|mesh-ancestor
754839|NCT02762929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754840|NCT02762929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754841|NCT02762929|Sensory System Agents|sensory system agents|mesh-ancestor
754842|NCT02762929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755066|NCT02761070|Bevacizumab|bevacizumab|mesh-list
755067|NCT02761070|Temozolomide|temozolomide|mesh-list
755068|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
755069|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755070|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
755071|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
755072|NCT02761070|Growth Substances|growth substances|mesh-ancestor
755073|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755074|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
755075|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
755076|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
755077|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755274|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
755275|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
755276|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755482|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
755483|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
755484|NCT02759380|Estrogens|estrogens|mesh-ancestor
755485|NCT02759380|Hormones|hormones|mesh-ancestor
755486|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
755487|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755949|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
755950|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
755951|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
755952|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755953|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
755954|NCT02757495|Analgesics|analgesics|mesh-ancestor
755955|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
755956|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755957|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
755958|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
755959|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
755960|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
755961|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
755962|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756609|NCT02755064|Erythromycin|erythromycin|mesh-list
756610|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
756611|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
756612|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
756613|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
756614|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
756615|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756616|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
756617|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
756618|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753485|NCT02768363|Valacyclovir|valacyclovir|mesh-list
753486|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
753487|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236893|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2236894|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
2236895|NCT00087802|Antiviral Agents|antiviral agents|mesh-ancestor
753815|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
753816|NCT02767232|Plasminogen|plasminogen|mesh-list
753817|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
753818|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
753819|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754167|NCT02765633|Cangrelor|cangrelor|mesh-list
754168|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
754169|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
754170|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
754171|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
754172|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
754173|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
754174|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754175|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754661|NCT02763059|Acetaminophen|acetaminophen|mesh-list
754662|NCT02763059|Dexamethasone|dexamethasone|mesh-list
754663|NCT02763059|Ibuprofen|ibuprofen|mesh-list
754664|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
754665|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
754666|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
754667|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754668|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754669|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
754670|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
754671|NCT02763059|Hormones|hormones|mesh-ancestor
754672|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
754673|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
754674|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754675|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
754676|NCT02763059|Analgesics|analgesics|mesh-ancestor
754677|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
754678|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
754679|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
754680|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
754681|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
754682|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754683|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236896|NCT00087802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236897|NCT00087802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236898|NCT00087802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2236899|NCT00087802|Immunologic Factors|immunologic factors|mesh-ancestor
2236900|NCT00087802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236901|NCT00087815|Dexamethasone|dexamethasone|mesh-list
2236902|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2236903|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
2236904|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
2236905|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2236906|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236907|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2236908|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
2236909|NCT00087815|Hormones|hormones|mesh-ancestor
2236910|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2236911|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2236912|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236913|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2236914|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2236915|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236916|NCT00087854|Amonafide|amonafide|mesh-list
755758|NCT02758444|Micronutrients|micronutrients|mesh-list
753434|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753479|NCT02768077|Melatonin|melatonin|mesh-list
753480|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
753481|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753482|NCT02768077|Protective Agents|protective agents|mesh-ancestor
753483|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753484|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
753650|NCT02767557|Gemcitabine|gemcitabine|mesh-list
753651|NCT02767557|Paclitaxel|paclitaxel|mesh-list
753652|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
753653|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753654|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
753655|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
753656|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
753657|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753658|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
753659|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
753660|NCT02767557|Antiviral Agents|antiviral agents|mesh-ancestor
753661|NCT02767557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
753662|NCT02767557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753663|NCT02767557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
753664|NCT02767557|Immunologic Factors|immunologic factors|mesh-ancestor
753665|NCT02767557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753833|NCT02767219|Dexamethasone|dexamethasone|mesh-list
753834|NCT02767219|Bevacizumab|bevacizumab|mesh-list
753835|NCT02767219|Fluorouracil|fluorouracil|mesh-list
753836|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
753837|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753838|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
753839|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
753840|NCT02767219|Growth Substances|growth substances|mesh-ancestor
753841|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753842|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
753843|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
753844|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
753845|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
753846|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753847|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
753848|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
753849|NCT02767219|Hormones|hormones|mesh-ancestor
753850|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
753851|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
753852|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
753853|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753854|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
753855|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
753856|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
754130|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
754131|NCT02765971|Cathartics|cathartics|mesh-ancestor
754132|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
754369|NCT02764515|Methotrexate|methotrexate|mesh-list
754370|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
754371|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
754372|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
754373|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754374|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
754375|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
754376|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754377|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754378|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
754379|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754380|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
754381|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
754382|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
754383|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
754384|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2236917|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236918|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
2236919|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236920|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236921|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236922|NCT00087867|Bortezomib|bortezomib|mesh-list
2236923|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755061|NCT02761395|Deferasirox|deferasirox|mesh-list
755062|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
753531|NCT02767999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
753532|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
753533|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
753534|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753535|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753536|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
753537|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753538|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
753539|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
753540|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
753541|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
753542|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
753543|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236924|NCT00087880|Bupropion|bupropion|mesh-list
2236925|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
753926|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
753927|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
753928|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
753929|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
753930|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753931|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753932|NCT02766725|Urological Agents|urological agents|mesh-ancestor
754019|NCT02766348|Gemcitabine|gemcitabine|mesh-list
754020|NCT02766348|Cisplatin|cisplatin|mesh-list
754021|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
754022|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
754023|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754024|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754025|NCT02766348|Antiviral Agents|antiviral agents|mesh-ancestor
754026|NCT02766348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
754027|NCT02766348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754028|NCT02766348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
754029|NCT02766348|Immunologic Factors|immunologic factors|mesh-ancestor
754030|NCT02766348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754133|NCT02765815|Ketorolac|ketorolac|mesh-list
754134|NCT02765815|Epinephrine|epinephrine|mesh-list
754135|NCT02765815|Racepinephrine|racepinephrine|mesh-list
754136|NCT02765815|Morphine|morphine|mesh-list
754137|NCT02765815|Bupivacaine|bupivacaine|mesh-list
754138|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
754139|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
754140|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
754141|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754142|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754143|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
754144|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754145|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
754146|NCT02765815|Narcotics|narcotics|mesh-ancestor
754147|NCT02765815|Analgesics|analgesics|mesh-ancestor
754148|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
754149|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
754150|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
754151|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
754152|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754153|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
754154|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
754155|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
754156|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
754157|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
754158|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
754159|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
754160|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
754161|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
754162|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
754163|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
754164|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
754165|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
754166|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755138|NCT02760992|Baclofen|baclofen|mesh-list
755139|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
755140|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755141|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
755142|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755143|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
755144|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
753602|NCT02767635|Hormones|hormones|mesh-ancestor
753603|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
753604|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
753605|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
753606|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753758|NCT02767401|Aspirin|aspirin|mesh-list
753759|NCT02767401|Metoprolol|metoprolol|mesh-list
753760|NCT02767401|Clopidogrel|clopidogrel|mesh-list
753761|NCT02767401|Ticagrelor|ticagrelor|mesh-list
753762|NCT02767401|Atorvastatin|atorvastatin|mesh-list
753763|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
753764|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
753765|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
753766|NCT02767401|Analgesics|analgesics|mesh-ancestor
753767|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
753768|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753769|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753770|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
753771|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
753772|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
753773|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
753774|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753775|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
753776|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
753777|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753778|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
753779|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
753780|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
753781|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
753782|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
753783|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
753784|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
753785|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
753786|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
753787|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
753788|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
753789|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
753790|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
753791|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
753792|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
753793|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
753794|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
753795|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
753796|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
754355|NCT02764723|Bupivacaine|bupivacaine|mesh-list
754356|NCT02764723|Ropivacaine|ropivacaine|mesh-list
754357|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
754358|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
754359|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754360|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754361|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
754362|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754735|NCT02762812|Infliximab|infliximab|mesh-list
754736|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
754737|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
754738|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
754868|NCT02762448|Asunaprevir|asunaprevir|mesh-list
754869|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
754870|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754871|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754893|NCT02762006|Durvalumab|durvalumab|mesh-list
754894|NCT02762006|Tremelimumab|tremelimumab|mesh-list
754895|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
754896|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753717|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753718|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
753719|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
753720|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
753878|NCT02767063|Pioglitazone|pioglitazone|mesh-list
753879|NCT02767063|Avelumab|avelumab|mesh-list
753880|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
753881|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753882|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
753883|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754001|NCT02766270|Temozolomide|temozolomide|mesh-list
754002|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
754003|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
754004|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754005|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2236926|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
2236927|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236928|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2236929|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2236930|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
754533|NCT02763722|Emollients|emollients|mesh-list
754534|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
754684|NCT02763007|Pioglitazone|pioglitazone|mesh-list
754685|NCT02763007|Alogliptin|alogliptin|mesh-list
754686|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
754687|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754688|NCT02763007|Incretins|incretins|mesh-ancestor
754689|NCT02763007|Hormones|hormones|mesh-ancestor
754690|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
754691|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
754692|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
754693|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754694|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754739|NCT02762656|Lidocaine|lidocaine|mesh-list
754740|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
754741|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
754742|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754743|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754744|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
754745|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754746|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
754747|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
754748|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
754749|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
754750|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236931|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236932|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
2236933|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236934|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236935|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2236936|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2236937|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236938|NCT00087945|Lamivudine|lamivudine|mesh-list
2236939|NCT00087945|Zidovudine|zidovudine|mesh-list
2236940|NCT00087945|Abacavir|abacavir|mesh-list
2236941|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
2236942|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
755859|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
755860|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
755861|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236943|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2236944|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2236945|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236946|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
2236947|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2236948|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2236949|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2236950|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
756658|NCT02754726|Gemcitabine|gemcitabine|mesh-list
756659|NCT02754726|Paclitaxel|paclitaxel|mesh-list
756660|NCT02754726|Nivolumab|nivolumab|mesh-list
756661|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
756662|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
756663|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753749|NCT02767375|Fluorouracil|fluorouracil|mesh-list
753750|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
753751|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
753752|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753753|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
753754|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
753755|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
753756|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
753757|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753943|NCT02766647|Lenograstim|lenograstim|mesh-list
753944|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
753945|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
753946|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754224|NCT02765373|Letrozole|letrozole|mesh-list
754225|NCT02765373|Anastrozole|anastrozole|mesh-list
754226|NCT02765373|Exemestane|exemestane|mesh-list
754227|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754228|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
754229|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
754230|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754231|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754232|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
754233|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
754234|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
754235|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754236|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
754346|NCT02764710|Amoxicillin|amoxicillin|mesh-list
754347|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
754348|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
754349|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
754350|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
754351|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
754352|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
754353|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754354|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754449|NCT02764359|Vancomycin|vancomycin|mesh-list
754450|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
754451|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
754653|NCT02763098|Remifentanil|remifentanil|mesh-list
754654|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
754655|NCT02763098|Narcotics|narcotics|mesh-ancestor
754656|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754657|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754658|NCT02763098|Analgesics|analgesics|mesh-ancestor
754659|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
754660|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2236951|NCT00088036|Olanzapine|olanzapine|mesh-list
2236952|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
2236953|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
2236954|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2236955|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236956|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2236957|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2236958|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2236959|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2236960|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236961|NCT00088036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2236962|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2236963|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2236964|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755576|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
755577|NCT02758873|Montelukast|montelukast|mesh-list
755578|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
755579|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
755580|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755581|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755582|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
755583|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
755584|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
755585|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
755586|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
755587|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
755588|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
755589|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
753893|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
753894|NCT02766803|Protective Agents|protective agents|mesh-ancestor
753895|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
753896|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2236965|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236966|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
2236967|NCT00088049|Olanzapine|olanzapine|mesh-list
2236968|NCT00088049|Aripiprazole|aripiprazole|mesh-list
2236969|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
2236970|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
754588|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
754589|NCT02763475|Fludarabine|fludarabine|mesh-list
754590|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
754591|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
754592|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754593|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
754594|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
754595|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
754596|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754597|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754598|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
755452|NCT02759588|Bevacizumab|bevacizumab|mesh-list
755453|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
755454|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755455|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
755456|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
755457|NCT02759588|Growth Substances|growth substances|mesh-ancestor
755458|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755459|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
755796|NCT02758405|Fentanyl|fentanyl|mesh-list
755797|NCT02758405|Bupivacaine|bupivacaine|mesh-list
755798|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
755799|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
755800|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
755801|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755802|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
755803|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755804|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
755805|NCT02758405|Narcotics|narcotics|mesh-ancestor
755806|NCT02758405|Analgesics|analgesics|mesh-ancestor
755807|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
755808|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
755809|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
756493|NCT02755597|Dexamethasone|dexamethasone|mesh-list
756494|NCT02755597|Bortezomib|bortezomib|mesh-list
756495|NCT02755597|Venetoclax|venetoclax|mesh-list
756496|NCT02755597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
756497|NCT02755597|Antiemetics|antiemetics|mesh-ancestor
756498|NCT02755597|Autonomic Agents|autonomic agents|mesh-ancestor
756499|NCT02755597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756500|NCT02755597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756501|NCT02755597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
756502|NCT02755597|Glucocorticoids|glucocorticoids|mesh-ancestor
756503|NCT02755597|Hormones|hormones|mesh-ancestor
756504|NCT02755597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2236971|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
753980|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
753981|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
753982|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
753983|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
754795|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
754796|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
754797|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
754798|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
754799|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754800|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
754801|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
754802|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2236972|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236973|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2236974|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2236975|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2236976|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2236977|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2236978|NCT00088049|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2236979|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2236980|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2236981|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236982|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236983|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
2236984|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
2236985|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
2236986|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
756239|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
756240|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
756241|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
756242|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
756243|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
756244|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756245|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
756246|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
756247|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
756248|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756249|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756250|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
756251|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
756252|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
756253|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
756254|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
756255|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756256|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756284|NCT02756312|Anesthetics|anesthetics|mesh-list
756285|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
756286|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756294|NCT02756104|Vitamin D|vitamin d|mesh-list
756295|NCT02756104|Vitamins|vitamins|mesh-ancestor
756296|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
756297|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756298|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2236987|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2236988|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2236989|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2236990|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
756575|NCT02754856|Durvalumab|durvalumab|mesh-list
756576|NCT02754856|Ipilimumab|ipilimumab|mesh-list
756577|NCT02754856|Tremelimumab|tremelimumab|mesh-list
756578|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
756579|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
756580|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
756581|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
756582|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756583|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
756584|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756585|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
756586|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756796|NCT02754154|Warfarin|warfarin|mesh-list
756797|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
756798|NCT02754154|Dabigatran|dabigatran|mesh-list
756799|NCT02754154|Apixaban|apixaban|mesh-list
756800|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
756801|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
754108|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754308|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
754309|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
754310|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
754311|NCT02765022|Hormones|hormones|mesh-ancestor
754312|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
754313|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754314|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
754315|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093193|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2093194|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
2093195|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2093196|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2093197|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
2093198|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093199|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
2093200|NCT02257957|Protective Agents|protective agents|mesh-ancestor
2093201|NCT02257970|Ketoprofen|ketoprofen|mesh-list
2093202|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2093203|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2093204|NCT02257970|Analgesics|analgesics|mesh-ancestor
2093205|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
2093206|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093207|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754578|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
754579|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
754580|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
754581|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754582|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
754583|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
754584|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
754585|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
754586|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
754587|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755623|NCT02758782|Celecoxib|celecoxib|mesh-list
755624|NCT02758782|Golimumab|golimumab|mesh-list
755625|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
755626|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
755627|NCT02758782|Analgesics|analgesics|mesh-ancestor
755628|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
755629|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755630|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755631|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
755632|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
755633|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
755634|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
755635|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755636|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755637|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
755638|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
755639|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
2093208|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093209|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093210|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2093211|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093212|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093213|NCT02258074|Niacinamide|niacinamide|mesh-list
2093214|NCT02258074|Niacin|niacin|mesh-list
2093215|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
2093216|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
2093217|NCT02258074|Vitamins|vitamins|mesh-ancestor
2093218|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
2093219|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093220|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2093221|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
2093222|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093223|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2093224|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
2093225|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2093226|NCT02258217|Hormones|hormones|mesh-ancestor
2236991|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2236992|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2236993|NCT00088075|Risperidone|risperidone|mesh-list
2236994|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2236995|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
2236996|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2236997|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2236998|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2236999|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2237000|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2237001|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2237002|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2237003|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2237004|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
2237005|NCT00088088|Paclitaxel|paclitaxel|mesh-list
2237006|NCT00088088|Carboplatin|carboplatin|mesh-list
2237007|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
754535|NCT02763592|Lidocaine|lidocaine|mesh-list
754536|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
754537|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
754538|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754539|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754540|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
754541|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754542|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
754543|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
754544|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
754545|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
754546|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093227|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2093228|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093229|NCT02258334|Vaccines|vaccines|mesh-list
2237008|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755248|NCT02760459|Dexamethasone|dexamethasone|mesh-list
755249|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
755250|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
755251|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
755252|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755253|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755254|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
755255|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
755256|NCT02760459|Hormones|hormones|mesh-ancestor
755257|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
755258|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
755259|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755345|NCT02760043|Dexamethasone|dexamethasone|mesh-list
755346|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
755347|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
755348|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
755349|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755350|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755351|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
755352|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
755353|NCT02760043|Hormones|hormones|mesh-ancestor
755354|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
755355|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
755356|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756042|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
756043|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
756044|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756045|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756046|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
756047|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
756048|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756049|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
756050|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
756257|NCT02756663|Dexamethasone|dexamethasone|mesh-list
756258|NCT02756663|Panobinostat|panobinostat|mesh-list
756259|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
756260|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
756261|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
756262|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756263|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237009|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
754222|NCT02765399|Hormones|hormones|mesh-ancestor
754223|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2237010|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
2237011|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
2237012|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093230|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
2093231|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093232|NCT02258412|Ethanol|ethanol|mesh-list
2093233|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2093234|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
2093235|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093236|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2093237|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093238|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
2093239|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2093240|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093241|NCT02258529|Rituximab|rituximab|mesh-list
2093242|NCT02258529|Idelalisib|idelalisib|mesh-list
2093243|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2093244|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093245|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
2093246|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093247|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093248|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093249|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753677|NCT02527798|Furosemide|furosemide|mesh-list
2753678|NCT02527798|Diuretics|diuretics|mesh-ancestor
2093253|NCT02258659|Paclitaxel|paclitaxel|mesh-list
2093254|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2093255|NCT02258659|Carboplatin|carboplatin|mesh-list
2093256|NCT02258659|Fluorouracil|fluorouracil|mesh-list
2093257|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
755102|NCT02760888|Diclofenac|diclofenac|mesh-list
755103|NCT02760888|Tramadol|tramadol|mesh-list
755104|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
755105|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
755106|NCT02760888|Analgesics|analgesics|mesh-ancestor
755107|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
755108|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755109|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755110|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
755111|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
755112|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
755113|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755114|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755115|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
755116|NCT02760888|Narcotics|narcotics|mesh-ancestor
755117|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
755357|NCT02760121|Acetazolamide|acetazolamide|mesh-list
755358|NCT02760121|Methazolamide|methazolamide|mesh-list
755359|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
755360|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
755361|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755362|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755363|NCT02760121|Diuretics|diuretics|mesh-ancestor
755364|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
755365|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755781|NCT02758470|Acetazolamide|acetazolamide|mesh-list
755782|NCT02758470|Methazolamide|methazolamide|mesh-list
755783|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
755784|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
755785|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755786|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755787|NCT02758470|Diuretics|diuretics|mesh-ancestor
755788|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
755789|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756112|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
756113|NCT02757443|Anesthetics|anesthetics|mesh-list
756114|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2093258|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2093259|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754460|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
754461|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
754462|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754463|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237013|NCT00088114|Paclitaxel|paclitaxel|mesh-list
2237014|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2237015|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237016|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
2237017|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
2237018|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
2237019|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237020|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
2237021|NCT00088231|Vatalanib|vatalanib|mesh-list
2237022|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755790|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
755791|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
755792|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
755793|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
755794|NCT02758327|Laxatives|laxatives|mesh-ancestor
755795|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
755901|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
755902|NCT02757885|Thiotepa|thiotepa|mesh-list
755903|NCT02757885|Fludarabine|fludarabine|mesh-list
755904|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
755905|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
755906|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
755907|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
755908|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
755909|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
755910|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755911|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
755912|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
755913|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
755914|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755915|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755916|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
755917|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
755918|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
755919|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
755920|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755921|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2237023|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2237024|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237025|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237026|NCT00088270|Leucovorin|leucovorin|mesh-list
2237027|NCT00088270|Fluorouracil|fluorouracil|mesh-list
2237028|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
2237029|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237030|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2237031|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237032|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
756529|NCT02755311|Cisplatin|cisplatin|mesh-list
756530|NCT02755311|Carboplatin|carboplatin|mesh-list
756531|NCT02755311|Fluorouracil|fluorouracil|mesh-list
756532|NCT02755311|Epirubicin|epirubicin|mesh-list
756533|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
756534|NCT02755311|Pirarubicin|pirarubicin|mesh-list
756535|NCT02755311|Doxorubicin|doxorubicin|mesh-list
756536|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
756537|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756538|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
756539|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756540|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
756541|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
756542|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
756543|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756544|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
756545|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
756546|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
756547|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756548|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
756549|NCT02755311|Coagulants|coagulants|mesh-ancestor
756678|NCT02754739|Pravastatin|pravastatin|mesh-list
756679|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
756680|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
756681|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
2237033|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
2753679|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
754521|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
754522|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
754523|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
754524|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237034|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237035|NCT00088270|Antidotes|antidotes|mesh-ancestor
2237036|NCT00088270|Protective Agents|protective agents|mesh-ancestor
2237037|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
2237038|NCT00088270|Vitamins|vitamins|mesh-ancestor
2237039|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
2237040|NCT00088387|Valproic Acid|valproic acid|mesh-list
2237041|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2237042|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237043|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237044|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
2237045|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2237046|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754782|NCT02762591|Pimavanserin|pimavanserin|mesh-list
754783|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
754784|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
754785|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
754786|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
754787|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754788|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754789|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
754790|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
754791|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
754792|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
754793|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
754794|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754856|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
754857|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
754858|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
754991|NCT02761486|Aspirin|aspirin|mesh-list
754992|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
754993|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
754994|NCT02761486|Analgesics|analgesics|mesh-ancestor
754995|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
754996|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754997|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754998|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
754999|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
755000|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
755001|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
755002|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755003|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
755004|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
755005|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755006|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
755520|NCT02758951|Bevacizumab|bevacizumab|mesh-list
755521|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
755522|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755523|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
755524|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
755525|NCT02758951|Growth Substances|growth substances|mesh-ancestor
755526|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755527|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
756158|NCT02757391|Aldesleukin|aldesleukin|mesh-list
756159|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
756160|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
756161|NCT02757391|Interleukin-2|interleukin-2|mesh-list
756162|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
756163|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
756164|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756165|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
756166|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
756167|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
756168|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756169|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756170|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
756171|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
756172|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
756173|NCT02757391|Analgesics|analgesics|mesh-ancestor
756174|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
756175|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754530|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754695|NCT02762838|Folic Acid|folic acid|mesh-list
754696|NCT02762838|Methotrexate|methotrexate|mesh-list
754697|NCT02762838|Infliximab|infliximab|mesh-list
754698|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
754699|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
754700|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
754701|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754702|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
754703|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
754704|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754705|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754706|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
754707|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754708|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
754709|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
754710|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
754711|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
754712|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
754713|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
754714|NCT02762838|Hematinics|hematinics|mesh-ancestor
754715|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
754716|NCT02762838|Vitamins|vitamins|mesh-ancestor
754717|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
754861|NCT02762253|Riboflavin|riboflavin|mesh-list
754862|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
754863|NCT02762253|Vitamins|vitamins|mesh-ancestor
754864|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
754865|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754866|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
754867|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
2237047|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237048|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
2237049|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
2237050|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237051|NCT00088478|Olanzapine|olanzapine|mesh-list
2237052|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
2237053|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
2237054|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237055|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237056|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2237057|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
755270|NCT02760472|SMOFlipid|smoflipid|mesh-list
755271|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
755272|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
755273|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
755867|NCT02757534|Domperidone|domperidone|mesh-list
755868|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
755869|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
755870|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755871|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755872|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
755873|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
755874|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
755875|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
755876|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756463|NCT02755532|Bupivacaine|bupivacaine|mesh-list
756464|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
756465|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
756466|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
756467|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756468|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
756469|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756550|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
756551|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
756552|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
756553|NCT02754817|Liraglutide|liraglutide|mesh-list
756554|NCT02754817|Xultophy|xultophy|mesh-list
756555|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
756556|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756557|NCT02754817|Incretins|incretins|mesh-ancestor
756558|NCT02754817|Hormones|hormones|mesh-ancestor
756559|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
756765|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
756766|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
756767|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2237058|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
754555|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
754556|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
754557|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
754558|NCT02763761|Hormones|hormones|mesh-ancestor
754559|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
754560|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754561|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
754562|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
754563|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
754564|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
754565|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754566|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
754567|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
754568|NCT02763761|Protective Agents|protective agents|mesh-ancestor
754569|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
754570|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
754759|NCT02762864|Aspirin|aspirin|mesh-list
754760|NCT02762864|Clopidogrel|clopidogrel|mesh-list
754761|NCT02762864|Ticagrelor|ticagrelor|mesh-list
754762|NCT02762864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
754763|NCT02762864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
754764|NCT02762864|Analgesics|analgesics|mesh-ancestor
754765|NCT02762864|Sensory System Agents|sensory system agents|mesh-ancestor
754766|NCT02762864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754767|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754768|NCT02762864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
754769|NCT02762864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
754770|NCT02762864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
754771|NCT02762864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
754772|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754773|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
754774|NCT02762864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
754775|NCT02762864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754776|NCT02762864|Antipyretics|antipyretics|mesh-ancestor
754777|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
754778|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
754779|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
754780|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
754781|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
754823|NCT02762344|Heparin|heparin|mesh-list
754824|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
754825|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
754826|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
754827|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754897|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
754898|NCT02762123|Digoxin|digoxin|mesh-list
754899|NCT02762123|Midazolam|midazolam|mesh-list
754900|NCT02762123|Omeprazole|omeprazole|mesh-list
754901|NCT02762123|Montelukast|montelukast|mesh-list
754902|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
754903|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
754904|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
754905|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
754906|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
754907|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
754908|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
754909|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
754910|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
754911|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
754912|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
754913|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
754914|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
754915|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
754916|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
754917|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
754918|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
754919|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
754920|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
754921|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
754922|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
754923|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
754924|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
754925|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
754926|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
754927|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
754928|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
754720|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755215|NCT02760420|Amoxicillin|amoxicillin|mesh-list
755216|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
755217|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
755421|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
755422|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
755423|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755531|NCT02759107|Dulaglutide|dulaglutide|mesh-list
755532|NCT02759107|Tirzepatide|tirzepatide|mesh-list
755533|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
755534|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755535|NCT02759107|Incretins|incretins|mesh-ancestor
755536|NCT02759107|Hormones|hormones|mesh-ancestor
755537|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2237059|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2237060|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
756807|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
756808|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
756809|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237061|NCT00088478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2237062|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2237063|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
757236|NCT02752204|Rituximab|rituximab|mesh-list
757237|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
757238|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757239|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
757240|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757241|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237064|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237065|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237066|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
2237067|NCT00088491|Olanzapine|olanzapine|mesh-list
2237068|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
2237069|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
2237070|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237071|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237072|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
757765|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
757766|NCT02749890|Lixisenatide|lixisenatide|mesh-list
757767|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
757768|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237073|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2237074|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2237075|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
758431|NCT02746380|Adalimumab|adalimumab|mesh-list
758432|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
758433|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
758498|NCT02745756|Vaccines|vaccines|mesh-list
758499|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
758500|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758710|NCT02744339|Riociguat|riociguat|mesh-list
758711|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
758712|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758877|NCT02744183|Benzocaine|benzocaine|mesh-list
758878|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
758879|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
758880|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
758881|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758882|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
758883|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237076|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
759644|NCT02740803|Listerine|listerine|mesh-list
759645|NCT02740803|Fluorides|fluorides|mesh-list
759646|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
759647|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
759648|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
759649|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
759650|NCT02740803|Protective Agents|protective agents|mesh-ancestor
759651|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759652|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
759653|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760058|NCT02739204|Celecoxib|celecoxib|mesh-list
760059|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
760060|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
760061|NCT02739204|Analgesics|analgesics|mesh-ancestor
760062|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
2237077|NCT00088491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2093260|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
2093261|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
2093262|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
2093263|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093264|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
2093265|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2093266|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2093267|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
2093268|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093269|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
2093270|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093271|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2093272|NCT02259010|Itraconazole|itraconazole|mesh-list
2093273|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
2093274|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
755751|NCT02758366|Doxorubicin|doxorubicin|mesh-list
755752|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
755753|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755754|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
755755|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
755756|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755757|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756146|NCT02757144|Esomeprazole|esomeprazole|mesh-list
756147|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
756148|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
756149|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
756150|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756151|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756318|NCT02756130|Carboplatin|carboplatin|mesh-list
756319|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756382|NCT02755714|Bromides|bromides|mesh-list
756383|NCT02755714|Ipratropium|ipratropium|mesh-list
756384|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
756385|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
756386|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
756387|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756388|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756389|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
756390|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
756391|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
756392|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
756393|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
756394|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237078|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2237079|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2237080|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237081|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237082|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
2237083|NCT00088504|Interferons|interferons|mesh-list
2237084|NCT00088504|Ribavirin|ribavirin|mesh-list
2237085|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
2237086|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
2237087|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
756733|NCT02754362|Bevacizumab|bevacizumab|mesh-list
756734|NCT02754362|Poly ICLC|poly iclc|mesh-list
756735|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
756736|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
756737|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
756738|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756739|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
756740|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
756741|NCT02754362|Growth Substances|growth substances|mesh-ancestor
756742|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756743|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
756744|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
756745|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
757009|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
757010|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
757011|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757012|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757013|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
757014|NCT02753205|Analgesics|analgesics|mesh-ancestor
757015|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
757016|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754929|NCT02762123|Protective Agents|protective agents|mesh-ancestor
754930|NCT02762123|Analgesics|analgesics|mesh-ancestor
754931|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
754932|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
754933|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
754934|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
754935|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
754936|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
754937|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
755009|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
755010|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
755011|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
755012|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
755013|NCT02761577|Expectorants|expectorants|mesh-ancestor
755014|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
755015|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
755016|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
755017|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755018|NCT02761577|Protective Agents|protective agents|mesh-ancestor
755019|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755020|NCT02761577|Antidotes|antidotes|mesh-ancestor
755595|NCT02758769|Abatacept|abatacept|mesh-list
755596|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
755597|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755598|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755599|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
755600|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
755601|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755602|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
755743|NCT02758340|Misoprostol|misoprostol|mesh-list
755744|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
755745|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
755746|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
755747|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755748|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
755749|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
755750|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
755845|NCT02758067|Risperidone|risperidone|mesh-list
755846|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
755847|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
755848|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
755849|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
755850|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755851|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755852|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
755853|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
755854|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
755855|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
755856|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
755857|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
755858|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
756560|NCT02754882|Paclitaxel|paclitaxel|mesh-list
756561|NCT02754882|Bevacizumab|bevacizumab|mesh-list
756562|NCT02754882|Carboplatin|carboplatin|mesh-list
756563|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
756564|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756565|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
756566|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
756567|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
756568|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756569|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
756570|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
756571|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
756572|NCT02754882|Growth Substances|growth substances|mesh-ancestor
756573|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756574|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
757197|NCT02752724|Ketamine|ketamine|mesh-list
757198|NCT02752724|Methohexital|methohexital|mesh-list
757199|NCT02752724|Analgesics|analgesics|mesh-ancestor
757200|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
757201|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757202|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757203|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
757204|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
757205|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
757206|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
2237088|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237089|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
2237090|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237091|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
2237092|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237093|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
2237094|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237095|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
2237096|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2237097|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
2237098|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237099|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237100|NCT00088556|Paclitaxel|paclitaxel|mesh-list
2237101|NCT00088556|Carboplatin|carboplatin|mesh-list
755369|NCT02760095|Vitamin A|vitamin a|mesh-list
755370|NCT02760095|Acetic Acid|acetic acid|mesh-list
755371|NCT02760095|Retinol acetate|retinol acetate|mesh-list
755372|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
755373|NCT02760095|Vitamins|vitamins|mesh-ancestor
755374|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
755375|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755376|NCT02760095|Protective Agents|protective agents|mesh-ancestor
755377|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
755378|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755379|NCT02760095|Astringents|astringents|mesh-ancestor
755380|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
755381|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
755382|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
755383|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
755384|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093275|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2093276|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2093277|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093278|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093279|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2093280|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
2093281|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2237102|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2237103|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237104|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
2237105|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
2237106|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
2237107|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237108|NCT00088582|Octreotide|octreotide|mesh-list
2237109|NCT00088582|Pasireotide|pasireotide|mesh-list
2237110|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2237111|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
757305|NCT02751918|Doxorubicin|doxorubicin|mesh-list
757306|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
757307|NCT02751918|Maytansine|maytansine|mesh-list
757308|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
757309|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757310|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
757311|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
757312|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757313|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757314|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
757315|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
757316|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
757317|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
757363|NCT02751593|Dexamethasone|dexamethasone|mesh-list
757364|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
757365|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
757366|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
757367|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757368|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757369|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
757370|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
757371|NCT02751593|Hormones|hormones|mesh-ancestor
757372|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
757373|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
757374|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757954|NCT02749162|Acetaminophen|acetaminophen|mesh-list
757955|NCT02749162|Dexamethasone|dexamethasone|mesh-list
757956|NCT02749162|Lidocaine|lidocaine|mesh-list
757957|NCT02749162|Morphine|morphine|mesh-list
757958|NCT02749162|Ropivacaine|ropivacaine|mesh-list
755054|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
755055|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
755056|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2237112|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237113|NCT00088582|Hormones|hormones|mesh-ancestor
2237114|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2237115|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237116|NCT00088608|Pasireotide|pasireotide|mesh-list
2237117|NCT00088608|Hormones|hormones|mesh-ancestor
2237118|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2237119|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237120|NCT00088686|Capsaicin|capsaicin|mesh-list
756152|NCT02757066|Melatonin|melatonin|mesh-list
756153|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
756154|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756155|NCT02757066|Protective Agents|protective agents|mesh-ancestor
756156|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756157|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2237121|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
2237122|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
2237123|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
2237124|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237125|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237126|NCT00088816|Tegafur|tegafur|mesh-list
2237127|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237128|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2237129|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
756485|NCT02755298|Acetazolamide|acetazolamide|mesh-list
756486|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
756487|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
756488|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756489|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756490|NCT02755298|Diuretics|diuretics|mesh-ancestor
756491|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
756492|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756698|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
756699|NCT02754687|Nandrolone|nandrolone|mesh-list
756700|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
756701|NCT02754687|Androgens|androgens|mesh-ancestor
756702|NCT02754687|Hormones|hormones|mesh-ancestor
756703|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
756704|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756705|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
756706|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
757421|NCT02751268|Ropivacaine|ropivacaine|mesh-list
757422|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
757423|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
757424|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757425|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757426|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
757427|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237130|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237131|NCT00088855|Doxorubicin|doxorubicin|mesh-list
2237132|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2237133|NCT00088855|Bortezomib|bortezomib|mesh-list
2237134|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2237135|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237136|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2237137|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2237138|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237139|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237140|NCT00088894|Gemcitabine|gemcitabine|mesh-list
2237141|NCT00088894|Bevacizumab|bevacizumab|mesh-list
2237142|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2237143|NCT00088894|Antibodies|antibodies|mesh-list
2237144|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
2237145|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2237146|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759468|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
759469|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
759470|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237147|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
755063|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
755064|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
755065|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237148|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2237149|NCT00088894|Growth Substances|growth substances|mesh-ancestor
2237150|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237151|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
2237152|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
2237153|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2237154|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
2237155|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237156|NCT00088894|Antiviral Agents|antiviral agents|mesh-ancestor
2237157|NCT00088894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237158|NCT00088894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237159|NCT00088894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237160|NCT00088933|Metronidazole|metronidazole|mesh-list
2237161|NCT00088933|Docetaxel|docetaxel|mesh-list
2237162|NCT00088933|Vaccines|vaccines|mesh-list
2237163|NCT00088933|Sargramostim|sargramostim|mesh-list
756963|NCT02753283|Vitamin D|vitamin d|mesh-list
756964|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
756965|NCT02753283|Denosumab|denosumab|mesh-list
756966|NCT02753283|Calcium|calcium|mesh-list
756967|NCT02753283|Vitamins|vitamins|mesh-ancestor
756968|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
756969|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756970|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
756971|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
757136|NCT02752763|Dextrans|dextrans|mesh-list
757137|NCT02752763|Povidone|povidone|mesh-list
757138|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
757139|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
757140|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
757141|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
757142|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
757143|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
757614|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
757615|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
757616|NCT02750475|Protective Agents|protective agents|mesh-ancestor
757617|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757618|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
758049|NCT02748265|Epoprostenol|epoprostenol|mesh-list
758050|NCT02748265|Phenylephrine|phenylephrine|mesh-list
758051|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
758052|NCT02748265|Tezosentan|tezosentan|mesh-list
758053|NCT02748265|Propofol|propofol|mesh-list
758054|NCT02748265|Sevoflurane|sevoflurane|mesh-list
758055|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
758056|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
758057|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758058|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
758059|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
758060|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
758061|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
758062|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
758063|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
758064|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
758065|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
758066|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758067|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
758068|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
758069|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
758070|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
758071|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
758072|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
758073|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
758074|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
758075|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
758076|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758077|NCT02748265|Protective Agents|protective agents|mesh-ancestor
758078|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
758079|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
758679|NCT02744638|Metronidazole|metronidazole|mesh-list
758680|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
758681|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
758682|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
758683|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2237164|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
2237165|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755124|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755125|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
755126|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
755127|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755128|NCT02761291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
755129|NCT02761291|Immunologic Factors|immunologic factors|mesh-ancestor
755130|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755131|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
755132|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
755133|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
755134|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
755135|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
755136|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
755137|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
756102|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
756103|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756104|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
756105|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
756106|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
756810|NCT02754180|Gemcitabine|gemcitabine|mesh-list
756811|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
756812|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
756813|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756814|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756815|NCT02754180|Antiviral Agents|antiviral agents|mesh-ancestor
756816|NCT02754180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756817|NCT02754180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756818|NCT02754180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
756819|NCT02754180|Immunologic Factors|immunologic factors|mesh-ancestor
756820|NCT02754180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756954|NCT02753309|Sirolimus|sirolimus|mesh-list
756955|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
756956|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756957|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
756958|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756959|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
756960|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
756961|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
756962|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757512|NCT02751034|Lidocaine|lidocaine|mesh-list
757513|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
757514|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
757515|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757516|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757517|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
757518|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757519|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
757520|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
757521|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
757522|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
757523|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758310|NCT02747316|Iron|iron|mesh-list
758311|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
758312|NCT02747316|Trace Elements|trace elements|mesh-ancestor
758313|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
758314|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237166|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237167|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
2237168|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
2237169|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
2237170|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237171|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237172|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2237173|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2237174|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2237175|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2237176|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237177|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2237178|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758909|NCT02743975|Bevacizumab|bevacizumab|mesh-list
758910|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
758911|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758912|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
758913|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
758914|NCT02743975|Growth Substances|growth substances|mesh-ancestor
759430|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
755145|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
755146|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
755147|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755280|NCT02760615|Losartan|losartan|mesh-list
755281|NCT02760615|Midazolam|midazolam|mesh-list
755282|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
755283|NCT02760615|Caffeine|caffeine|mesh-list
755284|NCT02760615|Omeprazole|omeprazole|mesh-list
755285|NCT02760615|Vedolizumab|vedolizumab|mesh-list
755286|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
755287|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
755288|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
755289|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755290|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
755291|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
755292|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
755293|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
755294|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
755295|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
755296|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
755297|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
755298|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
755299|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755300|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
755301|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
755302|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
755303|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
755304|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
755305|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
755306|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
755307|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755308|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
755309|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
755310|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
755311|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
755312|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
755313|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
755314|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
755315|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
755316|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
755512|NCT02759042|Leronlimab|leronlimab|mesh-list
755513|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
755514|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
755515|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755516|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
755517|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
755518|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
755519|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
755822|NCT02758145|Vaccines|vaccines|mesh-list
755823|NCT02758145|Immunologic Factors|immunologic factors|mesh-ancestor
755824|NCT02758145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756051|NCT02757365|Aspirin|aspirin|mesh-list
756052|NCT02757365|Levofloxacin|levofloxacin|mesh-list
756053|NCT02757365|Ofloxacin|ofloxacin|mesh-list
756054|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
756055|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
756056|NCT02757365|Analgesics|analgesics|mesh-ancestor
756057|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
756058|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756059|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756060|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
756061|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
756062|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
756063|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
756064|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756065|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
756066|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
756067|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756068|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
756069|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
756070|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756071|NCT02757365|Renal Agents|renal agents|mesh-ancestor
756072|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
756073|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
756074|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
756075|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237179|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237180|NCT00088959|Celecoxib|celecoxib|mesh-list
755340|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
755341|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
755342|NCT02759861|Ledipasvir|ledipasvir|mesh-list
755343|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
755344|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237181|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2237182|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237183|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2237184|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093282|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093283|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2093284|NCT02259088|Ranibizumab|ranibizumab|mesh-list
2093285|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2093286|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2093287|NCT02259088|Growth Substances|growth substances|mesh-ancestor
2093288|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093289|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
756107|NCT02757248|Romidepsin|romidepsin|mesh-list
756108|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
756109|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753680|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753681|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2753682|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
756751|NCT02754258|Methylphenidate|methylphenidate|mesh-list
756752|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
756753|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756754|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
756755|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
756756|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
756757|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756758|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
756759|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
756995|NCT02753114|Ketamine|ketamine|mesh-list
756996|NCT02753114|Analgesics|analgesics|mesh-ancestor
756997|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
756998|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756999|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757000|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
757001|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
757002|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
757003|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
757004|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757005|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
757006|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
757007|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
757008|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757056|NCT02752828|Insulin|insulin|mesh-list
757057|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
757058|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
757059|NCT02752828|Lixisenatide|lixisenatide|mesh-list
757060|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
757061|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093290|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093291|NCT02259231|Nivolumab|nivolumab|mesh-list
2093292|NCT02259231|Ipilimumab|ipilimumab|mesh-list
2093293|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2093294|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093295|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
757711|NCT02749968|Bupivacaine|bupivacaine|mesh-list
757712|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
757713|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
757714|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757715|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757716|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
757717|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237185|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758735|NCT02744378|Clobetasol|clobetasol|mesh-list
758736|NCT02744378|Tacrolimus|tacrolimus|mesh-list
758737|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
758738|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
758739|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758740|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
755165|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
755166|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755167|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755424|NCT02759926|Quinine|quinine|mesh-list
755425|NCT02759926|Denatonium|denatonium|mesh-list
755426|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
755427|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
755428|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
755429|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
755430|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
755431|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755432|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
755433|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755434|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
755435|NCT02759926|Analgesics|analgesics|mesh-ancestor
755436|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
755437|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
755438|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755439|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
755685|NCT02758522|Insulin|insulin|mesh-list
755686|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
755687|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
755688|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755733|NCT02758249|Propofol|propofol|mesh-list
755734|NCT02758249|Sevoflurane|sevoflurane|mesh-list
755735|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
755736|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
755737|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755738|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
755739|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
755740|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
755741|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
755742|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
755877|NCT02757703|Terlipressin|terlipressin|mesh-list
755878|NCT02757703|Pantoprazole|pantoprazole|mesh-list
755879|NCT02757703|Somatostatin|somatostatin|mesh-list
755880|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
755881|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
755882|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
755883|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755884|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755885|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
755886|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
755887|NCT02757703|Hormones|hormones|mesh-ancestor
755888|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
755889|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237186|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2237187|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2237188|NCT00088959|Analgesics|analgesics|mesh-ancestor
2237189|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
2237190|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237191|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237192|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2237193|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237194|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2237195|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2237196|NCT00088998|Bevacizumab|bevacizumab|mesh-list
2237197|NCT00088998|Docetaxel|docetaxel|mesh-list
2237198|NCT00088998|Capecitabine|capecitabine|mesh-list
2237199|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2237200|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237201|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
756724|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
756725|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
756726|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757153|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
757154|NCT02753088|Mannitol|mannitol|mesh-list
757155|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
757156|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
757157|NCT02753088|Diuretics|diuretics|mesh-ancestor
757158|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
757159|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757160|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
757161|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
757162|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
757163|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
755898|NCT02757508|Vitamins|vitamins|mesh-list
755899|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
755900|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237202|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2237203|NCT00088998|Growth Substances|growth substances|mesh-ancestor
2237204|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237205|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
2237206|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
2237207|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
2237208|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
2237209|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237210|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2237211|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
2237212|NCT00089037|Sirolimus|sirolimus|mesh-list
2237213|NCT00089037|Methotrexate|methotrexate|mesh-list
2237214|NCT00089037|Tacrolimus|tacrolimus|mesh-list
2237215|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2237216|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
2237217|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2237218|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756833|NCT02753803|Pioglitazone|pioglitazone|mesh-list
756834|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
756835|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757127|NCT02752685|Paclitaxel|paclitaxel|mesh-list
757128|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
757129|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
757130|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757131|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
757132|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
757133|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
757134|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757135|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2237219|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2237220|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
2237221|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237222|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237223|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
2237224|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237225|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2237226|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237227|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
2237228|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237229|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2237230|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2237231|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2237232|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237233|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2237234|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
2237235|NCT00089050|Cyclosporine|cyclosporine|mesh-list
2753683|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758434|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
758435|NCT02745990|Hematinics|hematinics|mesh-ancestor
758533|NCT02745769|Ramucirumab|ramucirumab|mesh-list
758534|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755180|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
755181|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755182|NCT02760823|Protective Agents|protective agents|mesh-ancestor
755183|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755184|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
755185|NCT02760823|Vitamins|vitamins|mesh-ancestor
755186|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
2093296|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093297|NCT02259348|Aldesleukin|aldesleukin|mesh-list
2093298|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
755987|NCT02757287|Desogestrel|desogestrel|mesh-list
755988|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
755989|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
755990|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
755991|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
755992|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
755993|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755994|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
755995|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
755996|NCT02757287|Progestins|progestins|mesh-ancestor
755997|NCT02757287|Hormones|hormones|mesh-ancestor
755998|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
756120|NCT02757079|Melatonin|melatonin|mesh-list
756121|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
756122|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756123|NCT02757079|Protective Agents|protective agents|mesh-ancestor
756124|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756125|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
756200|NCT02756728|Melphalan|melphalan|mesh-list
756201|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
756202|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
756203|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756204|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756205|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
756206|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
756207|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
756208|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237236|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
2237237|NCT00089050|Cyclosporins|cyclosporins|mesh-list
2237238|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237239|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237240|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237241|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
2237242|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237243|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
756746|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
756747|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
756748|NCT02754102|Protective Agents|protective agents|mesh-ancestor
756749|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756750|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
2237244|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237245|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
2237246|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237247|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2237248|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2237249|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237250|NCT00089063|Sargramostim|sargramostim|mesh-list
2237251|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
757414|NCT02751476|Disinfectants|disinfectants|mesh-list
757415|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
759157|NCT02742805|Vitamin D|vitamin d|mesh-list
759158|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
759159|NCT02742805|Vitamins|vitamins|mesh-list
759160|NCT02742805|Omalizumab|omalizumab|mesh-list
759161|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
759162|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759163|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
759164|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
759165|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
759166|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
759167|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
759215|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
759216|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
759217|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
759218|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
2237252|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
755209|NCT02760667|Docetaxel|docetaxel|mesh-list
755210|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755211|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
755212|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
755213|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
755214|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093299|NCT02259348|Melphalan|melphalan|mesh-list
2093300|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
2093301|NCT02259348|Thiotepa|thiotepa|mesh-list
2237253|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237254|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2237255|NCT00089089|Decitabine|decitabine|mesh-list
2093302|NCT02259348|Rituximab|rituximab|mesh-list
2093303|NCT02259348|Fludarabine|fludarabine|mesh-list
2237256|NCT00089089|Azacitidine|azacitidine|mesh-list
2237257|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2237258|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
2237259|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237260|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237261|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756980|NCT02753218|Midazolam|midazolam|mesh-list
756981|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
756982|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
756983|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
756984|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756985|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
756986|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
756987|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
756988|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
756989|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
756990|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
756991|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
756992|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
756993|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
756994|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757416|NCT02751294|Tafenoquine|tafenoquine|mesh-list
757417|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
757418|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
757419|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
757420|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
757536|NCT02750995|Azacitidine|azacitidine|mesh-list
757537|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
757538|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
757539|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757540|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757541|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757739|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
757740|NCT02749994|Ezetimibe|ezetimibe|mesh-list
757741|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
757742|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
757743|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
757744|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757745|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
757746|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
757747|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757838|NCT02749292|Rituximab|rituximab|mesh-list
757839|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
757840|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757841|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
757842|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757843|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
758490|NCT02745639|Capecitabine|capecitabine|mesh-list
758491|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
758492|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
758493|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
758494|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758495|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093304|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
755322|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
755323|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
755324|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
755325|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
755326|NCT02760316|Hormones|hormones|mesh-ancestor
755327|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
755328|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755329|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
755330|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755331|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
755332|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
755333|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755334|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
755335|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
755336|NCT02760316|Protective Agents|protective agents|mesh-ancestor
755491|NCT02759224|Irsogladine|irsogladine|mesh-list
755492|NCT02759224|Lafutidine|lafutidine|mesh-list
755493|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755494|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
755495|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
755496|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
755497|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
755498|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
755499|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
755500|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755501|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755502|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
755503|NCT02759224|Protective Agents|protective agents|mesh-ancestor
755504|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
755693|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
755694|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
755695|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237262|NCT00089115|Rituximab|rituximab|mesh-list
2237263|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
2237264|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2237265|NCT00089115|Antibodies|antibodies|mesh-list
2237266|NCT00089115|Sargramostim|sargramostim|mesh-list
2237267|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2237268|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2237269|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237270|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
2237271|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756078|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
756079|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
756080|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
756081|NCT02757196|Prednisolone|prednisolone|mesh-list
756082|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
756083|NCT02757196|Rituximab|rituximab|mesh-list
756084|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
756085|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
756086|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
756087|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756088|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
756089|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756090|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
756091|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
756092|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
756093|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
756094|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756095|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
756096|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
756097|NCT02757196|Hormones|hormones|mesh-ancestor
756098|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
756099|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
756100|NCT02757196|Protective Agents|protective agents|mesh-ancestor
756101|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
756220|NCT02756598|Sufentanil|sufentanil|mesh-list
756221|NCT02756598|Dsuvia|dsuvia|mesh-list
756222|NCT02756598|Propofol|propofol|mesh-list
756223|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
756224|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
756225|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756226|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
756227|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
756228|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
756229|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
756230|NCT02756598|Narcotics|narcotics|mesh-ancestor
2237272|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
755402|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755403|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
755460|NCT02759510|Phenylephrine|phenylephrine|mesh-list
755461|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
755462|NCT02759510|Norepinephrine|norepinephrine|mesh-list
755463|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
755464|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
755465|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
755466|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755467|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755468|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
755469|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
755470|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
755471|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
755472|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
755473|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
755474|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
755475|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
755476|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
755477|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755478|NCT02759510|Protective Agents|protective agents|mesh-ancestor
755689|NCT02758691|Insulin|insulin|mesh-list
755690|NCT02758691|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
755691|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
755692|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755999|NCT02757469|Drospirenone|drospirenone|mesh-list
756000|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
756001|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
756002|NCT02757469|Estradiol|estradiol|mesh-list
756003|NCT02757469|Estrogens|estrogens|mesh-ancestor
756004|NCT02757469|Hormones|hormones|mesh-ancestor
756005|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
756006|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756007|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
756008|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
756009|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
756010|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
756011|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
756012|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
756013|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
756014|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
756015|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
756016|NCT02757469|Diuretics|diuretics|mesh-ancestor
756017|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
756427|NCT02755857|Itraconazole|itraconazole|mesh-list
756428|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
756429|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756430|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
756431|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
756432|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756433|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756434|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
756435|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
756436|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
756437|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756438|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
757182|NCT02752555|Antioxidants|antioxidants|mesh-list
757183|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757184|NCT02752555|Protective Agents|protective agents|mesh-ancestor
757185|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757524|NCT02750969|Lidocaine|lidocaine|mesh-list
757525|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
757526|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
757527|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757528|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757529|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
757530|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757531|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
757532|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
757533|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
757534|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
757535|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757873|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
2237273|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2237274|NCT00089154|Antibodies|antibodies|mesh-list
2237275|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
755505|NCT02759393|Lansoprazole|lansoprazole|mesh-list
755506|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
755507|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
755508|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
755509|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
755510|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755511|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756180|NCT02756962|Cytarabine|cytarabine|mesh-list
756181|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
756182|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
756183|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756184|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756185|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
756186|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756187|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
756188|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
756189|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093305|NCT02259348|Interleukin-2|interleukin-2|mesh-list
2093306|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2093307|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
756865|NCT02753738|Citalopram|citalopram|mesh-list
756866|NCT02753738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
756867|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
756868|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
756869|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756870|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
756871|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
756872|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756873|NCT02753738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
756874|NCT02753738|Antidepressive Agents|antidepressive agents|mesh-ancestor
756875|NCT02753738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
757148|NCT02752841|Vitamin D|vitamin d|mesh-list
757149|NCT02752841|Vitamins|vitamins|mesh-ancestor
757150|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
757151|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757152|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
757331|NCT02752412|Insulin|insulin|mesh-list
757332|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
757333|NCT02752412|Metformin|metformin|mesh-list
757334|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
757335|NCT02752412|Lixisenatide|lixisenatide|mesh-list
757336|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
757337|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237276|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2237277|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
2237278|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237279|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237280|NCT00089167|Thalidomide|thalidomide|mesh-list
2237281|NCT00089167|Dexamethasone|dexamethasone|mesh-list
2237282|NCT00089167|Melphalan|melphalan|mesh-list
2237283|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2237284|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
2237285|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
2237286|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237287|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237288|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2237289|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
2237290|NCT00089167|Hormones|hormones|mesh-ancestor
2237291|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2237292|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2237293|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237294|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
2237295|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2237296|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
2237297|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237298|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2237299|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237300|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
2237301|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
758448|NCT02745912|Metformin|metformin|mesh-list
758449|NCT02745912|Naltrexone|naltrexone|mesh-list
758450|NCT02745912|Bupropion|bupropion|mesh-list
758451|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
758452|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755444|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
755445|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
755446|NCT02759614|Growth Substances|growth substances|mesh-ancestor
755447|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755448|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
755449|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
755450|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755451|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755538|NCT02759198|Celecoxib|celecoxib|mesh-list
755539|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
755540|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
755541|NCT02759198|Analgesics|analgesics|mesh-ancestor
755542|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
755543|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755544|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755545|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
755546|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
755547|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
755548|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
755549|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755550|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093308|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093309|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093310|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2093311|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
2093312|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093313|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093314|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2093315|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2093316|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2093317|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
2093318|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
2093319|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093320|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2093321|NCT02259348|Analgesics|analgesics|mesh-ancestor
2093322|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
2093323|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093324|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2093325|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2093326|NCT02259582|Carboplatin|carboplatin|mesh-list
2093327|NCT02259582|Pemetrexed|pemetrexed|mesh-list
2093328|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093329|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093330|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093331|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2093332|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2093333|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
2093334|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2093335|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
2093336|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093337|NCT02260154|Mebeverine|mebeverine|mesh-list
2093338|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
2093339|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
2093340|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
2093341|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093342|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093343|NCT02260258|Rocuronium|rocuronium|mesh-list
2093344|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2093345|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
756636|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
756637|NCT02754765|Levofloxacin|levofloxacin|mesh-list
756638|NCT02754765|Ofloxacin|ofloxacin|mesh-list
756639|NCT02754765|Linezolid|linezolid|mesh-list
756640|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
756641|NCT02754765|Bedaquiline|bedaquiline|mesh-list
756642|NCT02754765|Clofazimine|clofazimine|mesh-list
756643|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
756644|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756645|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
756646|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
756647|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756648|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756649|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756650|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
756651|NCT02754765|Renal Agents|renal agents|mesh-ancestor
755553|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
755554|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
755555|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755556|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
755557|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755558|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
755559|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
755560|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
755561|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755562|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
755563|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
755564|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
755565|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
755566|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
755681|NCT02758665|Venetoclax|venetoclax|mesh-list
755682|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
755683|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755684|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
756845|NCT02753764|Prednisone|prednisone|mesh-list
756846|NCT02753764|AZD7624|azd7624|mesh-list
756847|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
756848|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
756849|NCT02753764|Hormones|hormones|mesh-ancestor
756850|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
756851|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756852|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
756853|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756854|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
756855|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756856|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756950|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
756951|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
756952|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756953|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
757117|NCT02753062|Rituximab|rituximab|mesh-list
757118|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
757119|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
757120|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757121|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
757122|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757123|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
757124|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
757125|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
757126|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237302|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237303|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2237304|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2237305|NCT00089167|Growth Substances|growth substances|mesh-ancestor
2237306|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
2237307|NCT00089193|Sargramostim|sargramostim|mesh-list
2237308|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
2237309|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
2237310|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237311|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2237312|NCT00089206|Sargramostim|sargramostim|mesh-list
2237313|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
2237314|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
2237315|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237316|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2237317|NCT00089219|Sargramostim|sargramostim|mesh-list
2237318|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
2237319|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
2237320|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237321|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2237322|NCT00089245|Iodine|iodine|mesh-list
2237323|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
2237324|NCT00089245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2237325|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2237326|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237327|NCT00089245|Trace Elements|trace elements|mesh-ancestor
2237328|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
2237329|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237330|NCT00089245|Immunologic Factors|immunologic factors|mesh-ancestor
759938|NCT02739672|Amlodipine|amlodipine|mesh-list
759939|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2237331|NCT00089258|Isotretinoin|isotretinoin|mesh-list
2237332|NCT00089258|Antibodies|antibodies|mesh-list
755590|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
755591|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
755592|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
755593|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
755594|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2237333|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2237334|NCT00089258|Sargramostim|sargramostim|mesh-list
2237335|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
2237336|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237337|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
2237338|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2237339|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
2237340|NCT00089349|Methotrexate|methotrexate|mesh-list
2237341|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
2237342|NCT00089349|Antibodies|antibodies|mesh-list
2237343|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
2237344|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2237345|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
2237346|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756686|NCT02754596|Timolol|timolol|mesh-list
756687|NCT02754596|Travoprost|travoprost|mesh-list
756688|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
756689|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
756690|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
756691|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
756692|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
756693|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
756694|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756695|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756696|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
756697|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
757223|NCT02752113|Metformin|metformin|mesh-list
757224|NCT02752113|Empagliflozin|empagliflozin|mesh-list
757225|NCT02752113|Linagliptin|linagliptin|mesh-list
757226|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
757227|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757228|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
757229|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757230|NCT02752113|Incretins|incretins|mesh-ancestor
757231|NCT02752113|Hormones|hormones|mesh-ancestor
757232|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
757233|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
757234|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
757235|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757322|NCT02751996|Tenofovir|tenofovir|mesh-list
757323|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
757324|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
757325|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
757326|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
757327|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757328|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757329|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
757330|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2237347|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237348|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2237349|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
2237350|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2237351|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2237352|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
2237353|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237354|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
758237|NCT02747823|Bevacizumab|bevacizumab|mesh-list
758238|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
758239|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758240|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
758241|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
758242|NCT02747823|Growth Substances|growth substances|mesh-ancestor
758243|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758244|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
759031|NCT02743455|Vaccines|vaccines|mesh-list
759032|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
759033|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759200|NCT02742285|Lumefantrine|lumefantrine|mesh-list
759201|NCT02742285|Artemether|artemether|mesh-list
2237355|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237356|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2237357|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237358|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237359|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2237360|NCT00089401|Melphalan|melphalan|mesh-list
755708|NCT02758509|Interferons|interferons|mesh-list
755709|NCT02758509|Ritonavir|ritonavir|mesh-list
755710|NCT02758509|Ribavirin|ribavirin|mesh-list
755711|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
755712|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
755713|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
755714|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
755715|NCT02758509|Ledipasvir|ledipasvir|mesh-list
755716|NCT02758509|Simeprevir|simeprevir|mesh-list
755717|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
755718|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
755719|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
755720|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
755721|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
755722|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
755723|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
755724|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
755725|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755726|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
755727|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
755728|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
755729|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
755730|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
755731|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
755732|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755973|NCT02757313|Dronabinol|dronabinol|mesh-list
755974|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
755975|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755976|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
755977|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
755978|NCT02757313|Analgesics|analgesics|mesh-ancestor
755979|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
755980|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
755981|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
755982|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
755983|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
755984|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755985|NCT02757313|Hormones|hormones|mesh-ancestor
755986|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
756470|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
756471|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
756472|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
756473|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756474|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756475|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
756476|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756477|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
756478|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
756597|NCT02754960|Thalidomide|thalidomide|mesh-list
756598|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
756599|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
756600|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756601|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
756602|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
756603|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756604|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
756605|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
756606|NCT02754960|Growth Substances|growth substances|mesh-ancestor
756607|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
756608|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757039|NCT02753166|Dexamethasone|dexamethasone|mesh-list
757040|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
757041|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
757042|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
757043|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757044|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757045|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
757046|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
757047|NCT02753166|Hormones|hormones|mesh-ancestor
757207|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
755759|NCT02758444|Trace Elements|trace elements|mesh-list
755760|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
755835|NCT02758015|Betaine|betaine|mesh-list
755836|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
755837|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
755838|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
755839|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
755840|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
755841|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2237361|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2237362|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
2237363|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237364|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237365|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2237366|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237367|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
2237368|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237369|NCT00089427|Temozolomide|temozolomide|mesh-list
2237370|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2237371|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
2237372|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237373|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237374|NCT00089440|Aripiprazole|aripiprazole|mesh-list
756408|NCT02755753|Lansoprazole|lansoprazole|mesh-list
756409|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
756410|NCT02755753|Rebamipide|rebamipide|mesh-list
756411|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
756412|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
756413|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
756414|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756415|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756416|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
756417|NCT02755753|Protective Agents|protective agents|mesh-ancestor
756418|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756507|NCT02755259|Acetazolamide|acetazolamide|mesh-list
756508|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
756509|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
756510|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756511|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756512|NCT02755259|Diuretics|diuretics|mesh-ancestor
756513|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
756514|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756717|NCT02754583|Azithromycin|azithromycin|mesh-list
756718|NCT02754583|Tetracycline|tetracycline|mesh-list
756719|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
756720|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756721|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
756722|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756723|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756821|NCT02753725|Fentanyl|fentanyl|mesh-list
756822|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
756823|NCT02753725|Narcotics|narcotics|mesh-ancestor
756824|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
756825|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756826|NCT02753725|Analgesics|analgesics|mesh-ancestor
756827|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
756828|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756829|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
756830|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
756831|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
756832|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
756916|NCT02753426|Doxycycline|doxycycline|mesh-list
756917|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
756918|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756919|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
756920|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
756921|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2237375|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
2237376|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2237377|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2237378|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2237379|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2237380|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237381|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
2237382|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
2237383|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093346|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2093347|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756018|NCT02757209|Fluticasone|fluticasone|mesh-list
756019|NCT02757209|Xhance|xhance|mesh-list
756020|NCT02757209|Budesonide|budesonide|mesh-list
756021|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
756022|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
756023|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
756024|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
756025|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
756026|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
756027|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756028|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756029|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
756030|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
756031|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
756032|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
756033|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
756034|NCT02757209|Hormones|hormones|mesh-ancestor
756035|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
756036|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
756037|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
756038|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
756039|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
756040|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
756041|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756110|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
756111|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756299|NCT02756403|Azithromycin|azithromycin|mesh-list
756300|NCT02756403|Metronidazole|metronidazole|mesh-list
756301|NCT02756403|Doxycycline|doxycycline|mesh-list
756302|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
756303|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756304|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
756305|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
756306|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
2093348|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093349|NCT02260388|Mexiletine|mexiletine|mesh-list
2093350|NCT02260388|Pregabalin|pregabalin|mesh-list
2093351|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2093352|NCT02260388|Nortriptyline|nortriptyline|mesh-list
2093353|NCT02260388|Analgesics|analgesics|mesh-ancestor
2093354|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
2093355|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093356|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093357|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
2093358|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2093359|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2093360|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093361|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2237384|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237385|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2237386|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2237387|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
2237388|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2237389|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
757164|NCT02752646|Ketorolac|ketorolac|mesh-list
757165|NCT02752646|Nepafenac|nepafenac|mesh-list
757166|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
757167|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
757168|NCT02752646|Analgesics|analgesics|mesh-ancestor
757169|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
757170|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757171|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757172|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
757173|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
757174|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
757175|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757176|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757568|NCT02750670|Gemcitabine|gemcitabine|mesh-list
757569|NCT02750670|Dexamethasone|dexamethasone|mesh-list
757570|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
757571|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757572|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
757573|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
757574|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
756076|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
756077|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
757086|NCT02752815|Prednisone|prednisone|mesh-list
757087|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
757088|NCT02752815|Rituximab|rituximab|mesh-list
757089|NCT02752815|Vincristine|vincristine|mesh-list
757090|NCT02752815|Epirubicin|epirubicin|mesh-list
757091|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
757092|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
757093|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757094|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
757095|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
757096|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
757097|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757098|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757099|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
757100|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
757101|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
757102|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
757103|NCT02752815|Hormones|hormones|mesh-ancestor
757104|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
757105|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
757106|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
757107|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
757108|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
757109|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
757110|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
757111|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
757112|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
757113|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757318|NCT02752477|Anesthetics|anesthetics|mesh-list
757319|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
757320|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757321|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757392|NCT02751632|Fluoxetine|fluoxetine|mesh-list
757393|NCT02751632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
757394|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
757395|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
757396|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757397|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
757398|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
757399|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757400|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
757401|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-ancestor
757402|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
757403|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
757404|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
757405|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757805|NCT02749526|Tegafur|tegafur|mesh-list
757806|NCT02749526|Endostar protein|endostar protein|mesh-list
757807|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757808|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
757809|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
757810|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757811|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
757812|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
757813|NCT02749526|Growth Substances|growth substances|mesh-ancestor
757814|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757815|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
2237390|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2237391|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2237392|NCT00089453|Dexamethasone|dexamethasone|mesh-list
2237393|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
2237394|NCT00089453|Melphalan|melphalan|mesh-list
2237395|NCT00089453|Fludarabine|fludarabine|mesh-list
2237396|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237397|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
2237398|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237399|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237400|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2237401|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
2237402|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237403|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237404|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
756115|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756116|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
756117|NCT02757443|Protective Agents|protective agents|mesh-ancestor
756395|NCT02756000|Dobutamine|dobutamine|mesh-list
756396|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
756397|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
756398|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
756399|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756400|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756401|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
756402|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
756403|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
756404|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
756405|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
756406|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756407|NCT02756000|Protective Agents|protective agents|mesh-ancestor
756780|NCT02753855|Telavancin|telavancin|mesh-list
756781|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
756782|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756972|NCT02753140|Docetaxel|docetaxel|mesh-list
756973|NCT02753140|Cetuximab|cetuximab|mesh-list
756974|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756975|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
756976|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
756977|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
756978|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756979|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
757212|NCT02752529|Tacrolimus|tacrolimus|mesh-list
757213|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
757214|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
757215|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757216|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
757217|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757218|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757718|NCT02750059|Tenofovir|tenofovir|mesh-list
757719|NCT02750059|Lamivudine|lamivudine|mesh-list
757720|NCT02750059|Efavirenz|efavirenz|mesh-list
757721|NCT02750059|Telmisartan|telmisartan|mesh-list
757722|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
757723|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
757724|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
757725|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
757726|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757727|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757728|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
757729|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
757730|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
757731|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
757732|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
757733|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
757734|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
757735|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
757736|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
757737|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
757738|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2093362|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2093363|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2093364|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2093365|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2093366|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2093367|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2093368|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093369|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
2093370|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
2093371|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2093372|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2093373|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
757930|NCT02749032|Metformin|metformin|mesh-list
757931|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
757932|NCT02749032|Vildagliptin|vildagliptin|mesh-list
757933|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
757934|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757935|NCT02749032|Incretins|incretins|mesh-ancestor
757936|NCT02749032|Hormones|hormones|mesh-ancestor
2093374|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
756176|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
756177|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
756178|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
756179|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756445|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
756446|NCT02755545|Adapalene|adapalene|mesh-list
756447|NCT02755545|Salicylates|salicylates|mesh-list
756448|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
756449|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
756450|NCT02755545|Analgesics|analgesics|mesh-ancestor
756451|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
756452|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756453|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756454|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
756455|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
756456|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
756457|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756458|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
756459|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
756460|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
756461|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756462|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757177|NCT02752503|Nalmefene|nalmefene|mesh-list
757178|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
757179|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757180|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
757181|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757285|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
757286|NCT02752334|Bupivacaine|bupivacaine|mesh-list
757287|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
757288|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
757289|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757290|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757291|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
757292|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757293|NCT02752334|Analgesics|analgesics|mesh-ancestor
757294|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
757295|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
757296|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
757297|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
757298|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757299|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
757300|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
757301|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
757344|NCT02751840|Caffeine|caffeine|mesh-list
757345|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
757346|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757347|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
757348|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757349|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757350|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
757351|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
757352|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
757353|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237405|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2237406|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
2237407|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
2237408|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237409|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
757708|NCT02750202|Vaccines|vaccines|mesh-list
756231|NCT02756598|Analgesics|analgesics|mesh-ancestor
756232|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
756233|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
756234|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
756361|NCT02756026|Micronutrients|micronutrients|mesh-list
756362|NCT02756026|Trace Elements|trace elements|mesh-list
756363|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757432|NCT02751307|Metformin|metformin|mesh-list
757433|NCT02751307|Clozapine|clozapine|mesh-list
757434|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
757435|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757436|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
757437|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
757438|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
757439|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757440|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
757441|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
757442|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757443|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
757444|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
757445|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
2237410|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
2237411|NCT00089453|Hormones|hormones|mesh-ancestor
2237412|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2237413|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2237414|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
757748|NCT02749825|Goserelin|goserelin|mesh-list
757749|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
757750|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
757751|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757752|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
757753|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757754|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
757755|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
757756|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
757757|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
759149|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
759150|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
759151|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
759152|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
759153|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
759154|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759155|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759156|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
759267|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
759268|NCT02742051|Fluorouracil|fluorouracil|mesh-list
759269|NCT02742051|Everolimus|everolimus|mesh-list
759270|NCT02742051|Letrozole|letrozole|mesh-list
759271|NCT02742051|Epirubicin|epirubicin|mesh-list
759272|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
759273|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
759274|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759275|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
759276|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
759277|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
759278|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759279|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759280|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
759281|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
759282|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
759283|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
759284|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
759285|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759286|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
759287|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
759288|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
759289|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
759290|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
759291|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
759998|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
759999|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
760000|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
760001|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
760002|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760003|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760338|NCT02737774|Carboplatin|carboplatin|mesh-list
756264|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
756265|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
756266|NCT02756663|Hormones|hormones|mesh-ancestor
756267|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
756268|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
756269|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756270|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
756271|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756272|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756364|NCT02755909|Anesthetics|anesthetics|mesh-list
756365|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
756366|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756479|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
756480|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
756481|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
756482|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756483|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
756484|NCT02755376|Protective Agents|protective agents|mesh-ancestor
757062|NCT02753127|Leucovorin|leucovorin|mesh-list
757063|NCT02753127|Bevacizumab|bevacizumab|mesh-list
757064|NCT02753127|Fluorouracil|fluorouracil|mesh-list
757065|NCT02753127|Irinotecan|irinotecan|mesh-list
757066|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
757067|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757068|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
757069|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
757070|NCT02753127|Growth Substances|growth substances|mesh-ancestor
757071|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757072|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
757073|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
757074|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757075|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
757076|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
757077|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
757078|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
757079|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
757080|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757081|NCT02753127|Antidotes|antidotes|mesh-ancestor
757082|NCT02753127|Protective Agents|protective agents|mesh-ancestor
757083|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
757084|NCT02753127|Vitamins|vitamins|mesh-ancestor
757085|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
2237415|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2237416|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2237417|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237418|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2237419|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2237420|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
2237421|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237422|NCT00089518|Valsartan|valsartan|mesh-list
2237423|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2237424|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2237425|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2237426|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758411|NCT02746185|Heparin|heparin|mesh-list
758412|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
758413|NCT02746185|Tinzaparin|tinzaparin|mesh-list
758414|NCT02746185|Dalteparin|dalteparin|mesh-list
758415|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
758416|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
758417|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
758418|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
758419|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758420|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
758421|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
758422|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
758423|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
758424|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758469|NCT02745886|Metformin|metformin|mesh-list
758470|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
758471|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758551|NCT02745054|Anticoagulants|anticoagulants|mesh-list
758596|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
758597|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
758598|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093375|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
756505|NCT02755597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
756506|NCT02755597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756894|NCT02753686|Tamoxifen|tamoxifen|mesh-list
756895|NCT02753686|Everolimus|everolimus|mesh-list
756896|NCT02753686|Letrozole|letrozole|mesh-list
756897|NCT02753686|Fulvestrant|fulvestrant|mesh-list
756898|NCT02753686|Anastrozole|anastrozole|mesh-list
756899|NCT02753686|Exemestane|exemestane|mesh-list
756900|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756901|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
756902|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
756903|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756904|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
756905|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
756906|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756907|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756908|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
756909|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
756910|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
756911|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
756912|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
756913|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
756914|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
756915|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2237427|NCT00089557|Capsaicin|capsaicin|mesh-list
2237428|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
2237429|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
2237430|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
2237431|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757473|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
757474|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
757475|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
757488|NCT02750904|Nicotine|nicotine|mesh-list
757489|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
757490|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
757491|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757492|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757493|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
757494|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
757495|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
757496|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
757497|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237432|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237433|NCT00089570|Terlipressin|terlipressin|mesh-list
2237434|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2237435|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2237436|NCT00089622|Levodopa|levodopa|mesh-list
2237437|NCT00089622|Lisuride|lisuride|mesh-list
2237438|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2237439|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2237440|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
2237441|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237442|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237443|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237444|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2237445|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
2237446|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
757905|NCT02749396|Interferons|interferons|mesh-list
757906|NCT02749396|Interferon-beta|interferon-beta|mesh-list
757907|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
757908|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
757909|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757910|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
757911|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
757912|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
757913|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757914|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
757985|NCT02748772|Thalidomide|thalidomide|mesh-list
757986|NCT02748772|Endostar protein|endostar protein|mesh-list
757987|NCT02748772|Endostatins|endostatins|mesh-list
757988|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237447|NCT00089687|Vanoxerine|vanoxerine|mesh-list
756619|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237448|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2237449|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2237450|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2237451|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237452|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
2237453|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237454|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237455|NCT00089700|Ibalizumab|ibalizumab|mesh-list
2237456|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2237457|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
757999|NCT02748707|Celecoxib|celecoxib|mesh-list
758000|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
758001|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758002|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
758003|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758004|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758005|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
758006|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
758007|NCT02748707|Analgesics|analgesics|mesh-ancestor
758008|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
758009|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758010|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758011|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
758012|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
758013|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
758014|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
758080|NCT02748395|Triamcinolone|triamcinolone|mesh-list
758081|NCT02748395|Lidocaine|lidocaine|mesh-list
758082|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
758083|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
758084|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
758085|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758086|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
758087|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758088|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
758089|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
758090|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
758091|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
758092|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758093|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
758094|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
758095|NCT02748395|Hormones|hormones|mesh-ancestor
758096|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2237458|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
2237459|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237460|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
2237461|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237462|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
758713|NCT02744417|Bupropion|bupropion|mesh-list
758714|NCT02744417|Nicotine|nicotine|mesh-list
758715|NCT02744417|Varenicline|varenicline|mesh-list
758716|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
758717|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
758718|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758719|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758720|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
758721|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
758722|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
758723|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
758724|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758725|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
758726|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
758727|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
758728|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
758729|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
758730|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
758731|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
758732|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
758733|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
758734|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759126|NCT02743065|Doxorubicin|doxorubicin|mesh-list
759127|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
756652|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
756653|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
756654|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
756655|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
756656|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
756657|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
2237463|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237464|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237465|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2237466|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
2237467|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237468|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237469|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2237470|NCT00089765|Ranibizumab|ranibizumab|mesh-list
2237471|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
757219|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
757220|NCT02752191|Hematinics|hematinics|mesh-ancestor
757221|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
757222|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
757663|NCT02750254|Plerixafor|plerixafor|mesh-list
757664|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
757665|NCT02750254|Melphalan|melphalan|mesh-list
757666|NCT02750254|Busulfan|busulfan|mesh-list
757667|NCT02750254|Fludarabine|fludarabine|mesh-list
757668|NCT02750254|Azacitidine|azacitidine|mesh-list
757669|NCT02750254|Lenograstim|lenograstim|mesh-list
757670|NCT02750254|Sargramostim|sargramostim|mesh-list
757671|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
757672|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
757673|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757674|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
757675|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
757676|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
757677|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757678|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757679|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
757680|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
757681|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
757682|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
757683|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757684|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
757685|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
757686|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
757687|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237472|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2237473|NCT00089765|Growth Substances|growth substances|mesh-ancestor
2237474|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237475|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
2237476|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237477|NCT00089804|Abetimus|abetimus|mesh-list
2237478|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237479|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
758260|NCT02747511|Haloperidol|haloperidol|mesh-list
758261|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
758262|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
758263|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
758264|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758265|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758266|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
758267|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
758268|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
758269|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
758270|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
758271|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
758272|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
758273|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
758274|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758275|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2237480|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237481|NCT00089830|Squalamine|squalamine|mesh-list
2237482|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2237483|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237484|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
758605|NCT02744833|Enoxaparin|enoxaparin|mesh-list
758606|NCT02744833|Enoxaparin sodium|enoxaparin sodium|mesh-list
758607|NCT02744833|Anticoagulants|anticoagulants|mesh-ancestor
758608|NCT02744833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
756664|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
756665|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
756666|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
756667|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756668|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
756669|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
756670|NCT02754726|Antiviral Agents|antiviral agents|mesh-ancestor
756671|NCT02754726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
756672|NCT02754726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756673|NCT02754726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
756674|NCT02754726|Immunologic Factors|immunologic factors|mesh-ancestor
756675|NCT02754726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756676|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
756677|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2237485|NCT00089830|Protective Agents|protective agents|mesh-ancestor
2237486|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237487|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237488|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2237489|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
757793|NCT02749747|Sulpiride|sulpiride|mesh-list
757794|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
757795|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
757796|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757797|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757798|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
757799|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
757800|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
757801|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
757802|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757803|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
757804|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
2237490|NCT00089830|Growth Substances|growth substances|mesh-ancestor
2237491|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
2237492|NCT00089856|Prednisone|prednisone|mesh-list
2237493|NCT00089856|Docetaxel|docetaxel|mesh-list
758097|NCT02748564|Aldesleukin|aldesleukin|mesh-list
758098|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
758099|NCT02748564|Interleukin-2|interleukin-2|mesh-list
758100|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
758101|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758102|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
758103|NCT02748564|Analgesics|analgesics|mesh-ancestor
758104|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
758105|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758106|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758107|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
758108|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
758109|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
758110|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
758547|NCT02745431|Oxytocin|oxytocin|mesh-list
758548|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
758549|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
758550|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758593|NCT02744976|Metformin|metformin|mesh-list
758594|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
758595|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758765|NCT02744430|Mirabegron|mirabegron|mesh-list
758766|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
758767|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
758768|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
758769|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
758770|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
758771|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758772|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758773|NCT02744430|Urological Agents|urological agents|mesh-ancestor
758958|NCT02743663|Albuterol|albuterol|mesh-list
758959|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
758960|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
2237494|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
756682|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756683|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
756684|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
756685|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756922|NCT02753647|Prednisone|prednisone|mesh-list
756923|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
756924|NCT02753647|Rituximab|rituximab|mesh-list
756925|NCT02753647|Doxorubicin|doxorubicin|mesh-list
756926|NCT02753647|Vincristine|vincristine|mesh-list
756927|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
756928|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
756929|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756930|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
756931|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
756932|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
756933|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
756934|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
756935|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
756936|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
756937|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
756938|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
756939|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
756940|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756941|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
756942|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
756943|NCT02753647|Hormones|hormones|mesh-ancestor
756944|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
756945|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
756946|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
756947|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
756948|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
756949|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
757375|NCT02751619|Lidocaine|lidocaine|mesh-list
757376|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
757377|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
757378|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757379|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757380|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
757381|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757382|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
757383|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
757384|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
757385|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
757386|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757428|NCT02751255|Tretinoin|tretinoin|mesh-list
757429|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757430|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
757431|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
2237495|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
2237496|NCT00089856|Hormones|hormones|mesh-ancestor
2237497|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
757758|NCT02750163|Acetaminophen|acetaminophen|mesh-list
757759|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
757760|NCT02750163|Analgesics|analgesics|mesh-ancestor
757761|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
757762|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757763|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757764|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
757942|NCT02749136|Gemcitabine|gemcitabine|mesh-list
757943|NCT02749136|Folfirinox|folfirinox|mesh-list
757944|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
757945|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
757946|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757947|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757948|NCT02749136|Antiviral Agents|antiviral agents|mesh-ancestor
757949|NCT02749136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
757950|NCT02749136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757951|NCT02749136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
757952|NCT02749136|Immunologic Factors|immunologic factors|mesh-ancestor
757953|NCT02749136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758117|NCT02748304|Aspirin|aspirin|mesh-list
758118|NCT02748304|Sorafenib|sorafenib|mesh-list
758119|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
758120|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
758121|NCT02748304|Analgesics|analgesics|mesh-ancestor
756768|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
756769|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
756770|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
756771|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
756772|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
756773|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
756774|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757023|NCT02752971|Diclofenac|diclofenac|mesh-list
757024|NCT02752971|Bupivacaine|bupivacaine|mesh-list
757025|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
757026|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
757027|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757028|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757029|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
757030|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757031|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
757032|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
757033|NCT02752971|Analgesics|analgesics|mesh-ancestor
757034|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
757035|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
757036|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
757037|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757038|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237498|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237499|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2237500|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237501|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
2237502|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
2237503|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
2237504|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237505|NCT00089869|Olanzapine|olanzapine|mesh-list
2237506|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2237507|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
757387|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
757388|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
757389|NCT02751541|Protective Agents|protective agents|mesh-ancestor
757390|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757391|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
757498|NCT02750917|Etoricoxib|etoricoxib|mesh-list
757499|NCT02750917|Lornoxicam|lornoxicam|mesh-list
757500|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
757501|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
757502|NCT02750917|Analgesics|analgesics|mesh-ancestor
757503|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
757504|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757505|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757506|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
757507|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
757508|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
757509|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
757510|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757511|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758136|NCT02748330|Aspirin|aspirin|mesh-list
758137|NCT02748330|Clopidogrel|clopidogrel|mesh-list
758138|NCT02748330|Ticagrelor|ticagrelor|mesh-list
758139|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
758140|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
758141|NCT02748330|Analgesics|analgesics|mesh-ancestor
758142|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
758143|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758144|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758145|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
758146|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
758147|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
758148|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
758149|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758150|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
758151|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
758152|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758153|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
758154|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
758155|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
758156|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
758157|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
756802|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
756803|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
756804|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
756805|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756806|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757247|NCT02752308|Atropine|atropine|mesh-list
757248|NCT02752308|Epinephrine|epinephrine|mesh-list
757249|NCT02752308|Fentanyl|fentanyl|mesh-list
757250|NCT02752308|Bupivacaine|bupivacaine|mesh-list
757251|NCT02752308|Neostigmine|neostigmine|mesh-list
757252|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
757253|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
757254|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757255|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757256|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
757257|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757258|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
757259|NCT02752308|Narcotics|narcotics|mesh-ancestor
757260|NCT02752308|Analgesics|analgesics|mesh-ancestor
757261|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
757262|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
757263|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
757264|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
757265|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
757266|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
757267|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
757268|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757269|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
757270|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
757271|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
757272|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
757273|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
757274|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
757275|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
757276|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
757277|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
757278|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
757279|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
757280|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
757281|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
757282|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
757283|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757284|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2237508|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
2237509|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237510|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237511|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2237512|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2237513|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
757548|NCT02750748|Naltrexone|naltrexone|mesh-list
757549|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
757550|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
757551|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757552|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
757553|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237514|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2237515|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2237516|NCT00089869|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2237517|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2237518|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2237519|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237520|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237521|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
2237522|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
758276|NCT02747537|Irinotecan|irinotecan|mesh-list
758277|NCT02747537|Sorafenib|sorafenib|mesh-list
758278|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
758279|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
758280|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758281|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758282|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758283|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
758509|NCT02745717|Cyclosporine|cyclosporine|mesh-list
758510|NCT02745717|Cyclosporins|cyclosporins|mesh-list
758511|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
758512|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
758513|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
756884|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
756885|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
756886|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
756887|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
756888|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
756889|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
756890|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
756891|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
756892|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
756893|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757409|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
757410|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
757411|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757412|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
757413|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757554|NCT02750696|Acetaminophen|acetaminophen|mesh-list
757555|NCT02750696|Tramadol|tramadol|mesh-list
757556|NCT02750696|Codeine|codeine|mesh-list
757557|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
757558|NCT02750696|Analgesics|analgesics|mesh-ancestor
757559|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
757560|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757561|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757562|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
757563|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
757564|NCT02750696|Narcotics|narcotics|mesh-ancestor
757565|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757566|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
757567|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
757619|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
757620|NCT02750319|Amiodarone|amiodarone|mesh-list
757621|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
757622|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
757623|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
757624|NCT02750319|Expectorants|expectorants|mesh-ancestor
757625|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
757626|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
757627|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
757628|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757629|NCT02750319|Protective Agents|protective agents|mesh-ancestor
757630|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757631|NCT02750319|Antidotes|antidotes|mesh-ancestor
757632|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
757633|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
757634|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
757635|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
757636|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
757637|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
757638|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
757639|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757640|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
757641|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
757642|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2237523|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
2237524|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
2237525|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2237526|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
2237527|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237528|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237529|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
2237530|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2237531|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237532|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237533|NCT00090012|Olanzapine|olanzapine|mesh-list
2237534|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2237535|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
2237536|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
2237537|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237538|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237539|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2237540|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2237541|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2237542|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2237543|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2237544|NCT00090012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
757017|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
757018|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
757019|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
757020|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
757021|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
757022|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757406|NCT02751528|Vaccines|vaccines|mesh-list
757407|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
757408|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757643|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
757644|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
757645|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757646|NCT02750293|Vitamins|vitamins|mesh-ancestor
757647|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
757648|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
759136|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
759137|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
759138|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237545|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2237546|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2237547|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237548|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237549|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
2237550|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
2237551|NCT00090025|Leucovorin|leucovorin|mesh-list
2237552|NCT00090025|Fluorouracil|fluorouracil|mesh-list
2237553|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
2237554|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237555|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2237556|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237557|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237558|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
2237559|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237560|NCT00090025|Antidotes|antidotes|mesh-ancestor
2237561|NCT00090025|Protective Agents|protective agents|mesh-ancestor
2237562|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
2237563|NCT00090025|Vitamins|vitamins|mesh-ancestor
2237564|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
2237565|NCT00090038|Rituximab|rituximab|mesh-list
760795|NCT02735902|Aspirin|aspirin|mesh-list
760796|NCT02735902|Vitamin K|vitamin k|mesh-list
760797|NCT02735902|Anticoagulants|anticoagulants|mesh-list
760798|NCT02735902|Vitamins|vitamins|mesh-ancestor
760799|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
760800|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760801|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
760802|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
760803|NCT02735902|Analgesics|analgesics|mesh-ancestor
760804|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
760805|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760806|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
760807|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
760808|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
760809|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
760810|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760811|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
760812|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
760813|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760814|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
760815|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
760816|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
760817|NCT02735902|Coagulants|coagulants|mesh-ancestor
2237566|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2237567|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237568|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
2237569|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237570|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237571|NCT00090090|Elsamicin A|elsamicin a|mesh-list
757048|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
757049|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
757050|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237572|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2237573|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757832|NCT02749656|Desoximetasone|desoximetasone|mesh-list
757833|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
757834|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
757835|NCT02749656|Hormones|hormones|mesh-ancestor
757836|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
757837|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237574|NCT00090155|Ondansetron|ondansetron|mesh-list
2237575|NCT00090155|Aprepitant|aprepitant|mesh-list
2237576|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
2237577|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
2237578|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237579|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237580|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2237581|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
2237582|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
2237583|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2237584|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
758523|NCT02745522|Oxytocin|oxytocin|mesh-list
758524|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
758525|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
758526|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758644|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
758646|NCT02744742|Busulfan|busulfan|mesh-list
758647|NCT02744742|Decitabine|decitabine|mesh-list
758648|NCT02744742|Sargramostim|sargramostim|mesh-list
758649|NCT02744742|Lenograstim|lenograstim|mesh-list
758650|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
758651|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
758652|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758653|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
758654|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
758655|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
758656|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758657|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758658|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
758659|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
758660|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
758661|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758662|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
758996|NCT02743429|Dinutuximab|dinutuximab|mesh-list
758997|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759825|NCT02740166|Propranolol|propranolol|mesh-list
759826|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
759827|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
759828|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
759829|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
759830|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759831|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759832|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
759833|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
759834|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
759988|NCT02739477|Favipiravir|favipiravir|mesh-list
759989|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
759990|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093376|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2093377|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
2093378|NCT02260440|Azacitidine|azacitidine|mesh-list
2093379|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2093380|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093381|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2093382|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
2093383|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093384|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093385|NCT02260492|Fluticasone|fluticasone|mesh-list
2093386|NCT02260492|Xhance|xhance|mesh-list
2093387|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2093388|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2093389|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093390|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2093391|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
2093392|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093393|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757208|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
757209|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
757210|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
757211|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237585|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237586|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237587|NCT00090155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2237588|NCT00090155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2237589|NCT00090155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2237590|NCT00090155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2237591|NCT00090155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2237592|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2237593|NCT00090168|Atorvastatin|atorvastatin|mesh-list
757856|NCT02749409|Parecoxib|parecoxib|mesh-list
757857|NCT02749409|Morphine|morphine|mesh-list
757858|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
757859|NCT02749409|Narcotics|narcotics|mesh-ancestor
757860|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757861|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757862|NCT02749409|Analgesics|analgesics|mesh-ancestor
757863|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
757864|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757865|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
757866|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
757867|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757868|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757869|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
757870|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
757871|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
757872|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
758111|NCT02748369|Glucagon|glucagon|mesh-list
758112|NCT02748369|Hormones|hormones|mesh-list
758113|NCT02748369|Somatostatin|somatostatin|mesh-list
758114|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
758115|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758116|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
758209|NCT02747940|Pregabalin|pregabalin|mesh-list
758210|NCT02747940|Flunarizine|flunarizine|mesh-list
758211|NCT02747940|Analgesics|analgesics|mesh-ancestor
758212|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
758213|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758214|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758215|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
758216|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
758217|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
758218|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758219|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
758220|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
758221|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
758222|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
758223|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
758224|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
758225|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
758226|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
758227|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
758228|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
758379|NCT02746783|Vaccines|vaccines|mesh-list
758380|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
758381|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758425|NCT02746276|Metronidazole|metronidazole|mesh-list
758426|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
758427|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
758428|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
758429|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
758430|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
758436|NCT02745925|Ibuprofen|ibuprofen|mesh-list
758437|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
758438|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
758439|NCT02745925|Analgesics|analgesics|mesh-ancestor
758440|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
758441|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758442|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758443|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
758444|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
758445|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2237594|NCT00090168|Simvastatin|simvastatin|mesh-list
2237595|NCT00090168|Ezetimibe|ezetimibe|mesh-list
2237596|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2237597|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2237598|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
2237599|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237600|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2237601|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2237602|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237603|NCT00090181|Diclofenac|diclofenac|mesh-list
2237604|NCT00090181|Etoricoxib|etoricoxib|mesh-list
2237605|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2237606|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2237607|NCT00090181|Analgesics|analgesics|mesh-ancestor
2237608|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
2237609|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237610|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237611|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2237612|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237613|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2093394|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2093395|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
2093396|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
2237614|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237615|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758701|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
758702|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
758703|NCT02744612|Antibodies|antibodies|mesh-list
758704|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
758705|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
758706|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
758707|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
758708|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758709|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758843|NCT02744196|Methotrexate|methotrexate|mesh-list
758844|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758845|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
758846|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758847|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
758848|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
758849|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
758850|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
758851|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
758852|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
758853|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758854|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
758855|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758856|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
758857|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
758858|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
758935|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
758936|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
758937|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759804|NCT02740101|Oxytocin|oxytocin|mesh-list
759805|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
759806|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
759807|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759916|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
759917|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
759918|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
759919|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759920|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
759921|NCT02739880|Protective Agents|protective agents|mesh-ancestor
760041|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
760042|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760043|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
760044|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760045|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760145|NCT02738814|Propofol|propofol|mesh-list
760146|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
760147|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
760148|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760149|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2237616|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2237617|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
757575|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757576|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757577|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
757578|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
757579|NCT02750670|Hormones|hormones|mesh-ancestor
757580|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
757581|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
757582|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
757583|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
757584|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757585|NCT02750670|Antiviral Agents|antiviral agents|mesh-ancestor
757586|NCT02750670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
757587|NCT02750670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757588|NCT02750670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
757589|NCT02750670|Immunologic Factors|immunologic factors|mesh-ancestor
757590|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2237618|NCT00090194|Antibodies|antibodies|mesh-list
2237619|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
2237620|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2237621|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2237622|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
2237623|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237624|NCT00090207|Ondansetron|ondansetron|mesh-list
2237625|NCT00090207|Aprepitant|aprepitant|mesh-list
757816|NCT02749578|Atorvastatin|atorvastatin|mesh-list
757817|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
757818|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
757819|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
757820|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757821|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
757822|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
757823|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758342|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
758343|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
758527|NCT02745691|Gefitinib|gefitinib|mesh-list
758528|NCT02745691|Crizotinib|crizotinib|mesh-list
758529|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758530|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
758531|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758532|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758663|NCT02744937|Aspirin|aspirin|mesh-list
758664|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
758665|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
758666|NCT02744937|Analgesics|analgesics|mesh-ancestor
758667|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
758668|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758669|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758670|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
758671|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
758672|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
758673|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
758674|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758675|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
758676|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
758677|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758678|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
758906|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
758907|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
758908|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758952|NCT02743572|Iron|iron|mesh-list
758953|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
758954|NCT02743572|Trace Elements|trace elements|mesh-ancestor
758955|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
758956|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758957|NCT02743572|Hematinics|hematinics|mesh-ancestor
759034|NCT02743260|Metformin|metformin|mesh-list
759035|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
759036|NCT02743260|Adefovir|adefovir|mesh-list
759037|NCT02743260|Digoxin|digoxin|mesh-list
759038|NCT02743260|Pitavastatin|pitavastatin|mesh-list
759039|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
759040|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759041|NCT02743260|Incretins|incretins|mesh-ancestor
759042|NCT02743260|Hormones|hormones|mesh-ancestor
759128|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237626|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
2237627|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
757701|NCT02750137|Tetracaine|tetracaine|mesh-list
757702|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
757703|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
757704|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757705|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757706|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
757707|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757915|NCT02749123|Lidocaine|lidocaine|mesh-list
757916|NCT02749123|Menthol|menthol|mesh-list
757917|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
757918|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
757919|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757920|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757921|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
757922|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757923|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
757924|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
757925|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
757926|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
757927|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757928|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
757929|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
2237628|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237629|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237630|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2237631|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
2237632|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
2237633|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2237634|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
2237635|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237636|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237637|NCT00090207|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2237638|NCT00090207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2237639|NCT00090207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2237640|NCT00090207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2237641|NCT00090207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2237642|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2237643|NCT00090246|Ondansetron|ondansetron|mesh-list
2237644|NCT00090246|Aprepitant|aprepitant|mesh-list
2237645|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
2237646|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
2237647|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237648|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237649|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2237650|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
2237651|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
2237652|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2237653|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
2237654|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237655|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237656|NCT00090246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
758483|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
758484|NCT02745873|Vitamins|vitamins|mesh-ancestor
758485|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
758486|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758487|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
758488|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758489|NCT02745873|Protective Agents|protective agents|mesh-ancestor
758501|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
758502|NCT02745561|Endostatins|endostatins|mesh-list
758503|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758504|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
758505|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
758506|NCT02745561|Growth Substances|growth substances|mesh-ancestor
758507|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758508|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
758585|NCT02744690|Mitomycins|mitomycins|mesh-list
758586|NCT02744690|Mitomycin|mitomycin|mesh-list
758587|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
758588|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758589|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
758590|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758591|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
758592|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758693|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2237657|NCT00090246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
757709|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
757710|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758201|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
758202|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
758203|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758232|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
758233|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758234|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
758235|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
758236|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758304|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
758305|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
758306|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
758307|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758308|NCT02747381|Vitamins|vitamins|mesh-ancestor
758309|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
2237658|NCT00090246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2237659|NCT00090246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2237660|NCT00090246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2237661|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2093397|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2093398|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2093399|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2093400|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2093401|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
2093402|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093403|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093404|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
2093405|NCT02260492|Hormones|hormones|mesh-ancestor
759582|NCT02740894|Gefitinib|gefitinib|mesh-list
759583|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759584|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
759585|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759586|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093406|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2093407|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
2093408|NCT02260531|Trastuzumab|trastuzumab|mesh-list
2093409|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2093410|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093411|NCT02260622|Aspirin|aspirin|mesh-list
2093412|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
2093413|NCT02260622|Clopidogrel|clopidogrel|mesh-list
2093414|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2237662|NCT00090272|Ertapenem|ertapenem|mesh-list
2237663|NCT00090272|Cefotetan|cefotetan|mesh-list
2237664|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2237665|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237666|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2237667|NCT00090298|Simvastatin|simvastatin|mesh-list
2237668|NCT00090298|Ezetimibe|ezetimibe|mesh-list
2237669|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2237670|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2237671|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
2237672|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237673|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2237674|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2237675|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237676|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2237677|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
2237678|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2237679|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2237680|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2237681|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761579|NCT02733432|Fluconazole|fluconazole|mesh-list
761580|NCT02733432|Rezafungin|rezafungin|mesh-list
761581|NCT02733432|Antifungal Agents|antifungal agents|mesh-ancestor
761582|NCT02733432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
761583|NCT02733432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2237682|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237683|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
757874|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
757875|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
757876|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
757877|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
757878|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757879|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
757880|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
757881|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757882|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
757883|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758539|NCT02745470|Lixisenatide|lixisenatide|mesh-list
758540|NCT02745470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
758541|NCT02745470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758611|NCT02744872|Felodipine|felodipine|mesh-list
758612|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
758613|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
758614|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
758615|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
758616|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758617|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
758618|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758619|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
759480|NCT02741219|Sufentanil|sufentanil|mesh-list
759481|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
759482|NCT02741219|Dsuvia|dsuvia|mesh-list
759483|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
759484|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
759485|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759486|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
759487|NCT02741219|Analgesics|analgesics|mesh-ancestor
759488|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
759489|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
759490|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
759491|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
759492|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
759493|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
759494|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
759495|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759496|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
759497|NCT02741219|Narcotics|narcotics|mesh-ancestor
759498|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
759499|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
759500|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
759501|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
2093415|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2093416|NCT02260622|Analgesics|analgesics|mesh-ancestor
2093417|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
2093418|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093419|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093420|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093421|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093422|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2093423|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2093424|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093425|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2093426|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2093427|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093428|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
2093429|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
760486|NCT02737254|Oxytocin|oxytocin|mesh-list
760487|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
760488|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
760489|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237684|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
2237685|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2237686|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2237687|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2237688|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2237689|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237690|NCT00090428|Caseins|caseins|mesh-list
2237691|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
2237692|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
2237693|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760890|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
757937|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
757938|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
757939|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
757940|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
757941|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093430|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2093431|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2237694|NCT00090480|Vaccines|vaccines|mesh-list
758382|NCT02746796|Capecitabine|capecitabine|mesh-list
758383|NCT02746796|Tegafur|tegafur|mesh-list
758384|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
758385|NCT02746796|Nivolumab|nivolumab|mesh-list
758386|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
758387|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
758388|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758389|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758390|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
758391|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2237695|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
2237696|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237697|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
2237698|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
2237699|NCT00090623|Ranibizumab|ranibizumab|mesh-list
2237700|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2237701|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2237702|NCT00090623|Growth Substances|growth substances|mesh-ancestor
2237703|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237704|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
2237705|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237706|NCT00090675|Gefitinib|gefitinib|mesh-list
2237707|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237708|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2237709|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237710|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237711|NCT00090727|AQ4N|aq4n|mesh-list
2237712|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237713|NCT00090896|Ipilimumab|ipilimumab|mesh-list
2237714|NCT00090896|Antibodies|antibodies|mesh-list
2237715|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2237716|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
2237717|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237718|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2237719|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237720|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2237721|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237722|NCT00090909|Gemcitabine|gemcitabine|mesh-list
2237723|NCT00090909|Dexamethasone|dexamethasone|mesh-list
2237724|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237725|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
759680|NCT02740595|Nicotine|nicotine|mesh-list
759681|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
759682|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
759683|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
759684|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759685|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
759686|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
759687|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
759688|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
759689|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237726|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
2237727|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
2237728|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760764|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
757959|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
757960|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
757961|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
757962|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
757963|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
757964|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757965|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
757966|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
757967|NCT02749162|Hormones|hormones|mesh-ancestor
757968|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
757969|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
757970|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
757971|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
757972|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
757973|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
757974|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
757975|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
757976|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
757977|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
757978|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
757979|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
757980|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
757981|NCT02749162|Narcotics|narcotics|mesh-ancestor
757982|NCT02749162|Analgesics|analgesics|mesh-ancestor
757983|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
757984|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
2237729|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237730|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2237731|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
2237732|NCT00090909|Hormones|hormones|mesh-ancestor
2237733|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2237734|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2237735|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2237736|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
2237737|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758811|NCT02744222|Interferons|interferons|mesh-list
758812|NCT02744222|Interferon-beta|interferon-beta|mesh-list
758813|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
758814|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758815|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
758816|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
758817|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
758818|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758819|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2237738|NCT00090909|Antiviral Agents|antiviral agents|mesh-ancestor
2237739|NCT00090909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237740|NCT00090909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237741|NCT00090909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237742|NCT00090909|Immunologic Factors|immunologic factors|mesh-ancestor
2237743|NCT00091039|Metronidazole|metronidazole|mesh-list
2093432|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
2093433|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093434|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2093435|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
2093436|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2093437|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
2093438|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
2093439|NCT02260635|Evacetrapib|evacetrapib|mesh-list
2093440|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2093441|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2093442|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
2093443|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093444|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2093445|NCT02260648|Atorvastatin|atorvastatin|mesh-list
2093446|NCT02260648|Ezetimibe|ezetimibe|mesh-list
2237744|NCT00091039|Paclitaxel|paclitaxel|mesh-list
2237745|NCT00091039|Carboplatin|carboplatin|mesh-list
2237746|NCT00091039|Vaccines|vaccines|mesh-list
2237747|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
2237748|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237749|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2237750|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237751|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
2237752|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
2237753|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
760271|NCT02738177|Isosorbide|isosorbide|mesh-list
760272|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
757989|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
757990|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
757991|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
757992|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
757993|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
757994|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
757995|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
757996|NCT02748772|Growth Substances|growth substances|mesh-ancestor
757997|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
757998|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758204|NCT02747953|Afatinib|afatinib|mesh-list
758205|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758206|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
758207|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758208|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759006|NCT02743234|Vancomycin|vancomycin|mesh-list
759007|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
759008|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
759009|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237754|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237755|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237756|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2237757|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2237758|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2237759|NCT00091052|Sargramostim|sargramostim|mesh-list
2237760|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
2237761|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237762|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
2237763|NCT00091078|Oblimersen|oblimersen|mesh-list
2237764|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759927|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
759928|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
759929|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
759930|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759931|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
759932|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759933|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
759934|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
759935|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
759936|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
759937|NCT02739711|Protective Agents|protective agents|mesh-ancestor
2237765|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2237766|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237767|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237768|NCT00091104|Aldesleukin|aldesleukin|mesh-list
760188|NCT02738658|Everolimus|everolimus|mesh-list
760189|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760190|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
760191|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
760192|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760535|NCT02737150|Anesthetics|anesthetics|mesh-list
760536|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
760537|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237769|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
2237770|NCT00091104|Fludarabine|fludarabine|mesh-list
2237771|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
2237772|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
2237773|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237774|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
2237775|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237776|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237777|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2237778|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
761188|NCT02734771|Prednisone|prednisone|mesh-list
761189|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
761190|NCT02734771|Rituximab|rituximab|mesh-list
761191|NCT02734771|Doxorubicin|doxorubicin|mesh-list
761192|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
761193|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
761194|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
761195|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761196|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
761197|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
761198|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
761199|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761200|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758122|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
758123|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758124|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758125|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
758126|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
758127|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
758128|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
758129|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758130|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
758131|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
758132|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758133|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
758134|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758135|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2237779|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237780|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237781|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2237782|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2237783|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
2237784|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2237785|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2237786|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2237787|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
2237788|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237789|NCT00091117|Bortezomib|bortezomib|mesh-list
2237790|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758357|NCT02746744|Rituximab|rituximab|mesh-list
758358|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
758359|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
758360|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758361|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
758362|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758363|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
758364|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
758365|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
758392|NCT02746250|Amitriptyline|amitriptyline|mesh-list
758393|NCT02746250|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
758394|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
758395|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
758396|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
758397|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
758398|NCT02746250|Analgesics|analgesics|mesh-ancestor
758399|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
758400|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758401|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758402|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
758403|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
758404|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
758405|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758406|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
758407|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
758408|NCT02746250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
758409|NCT02746250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
758410|NCT02746250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
758496|NCT02745860|Selexipag|selexipag|mesh-list
758497|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
758684|NCT02744703|Capecitabine|capecitabine|mesh-list
758685|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
758686|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
758687|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
758688|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758689|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237791|NCT00091130|Vaccines|vaccines|mesh-list
2237792|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
758158|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237793|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237794|NCT00091143|Fludarabine|fludarabine|mesh-list
2237795|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
2237796|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
2237797|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2237798|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237799|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2237800|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
2237801|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237802|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237803|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
2237804|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237805|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2237806|NCT00091156|Gefitinib|gefitinib|mesh-list
758747|NCT02744508|Dexamethasone|dexamethasone|mesh-list
758748|NCT02744508|Palonosetron|palonosetron|mesh-list
758749|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
758750|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
758751|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
758752|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758753|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758754|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
758755|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
758756|NCT02744508|Hormones|hormones|mesh-ancestor
758757|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
758758|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
758759|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758760|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
758761|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
758762|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
758763|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
758764|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759292|NCT02741947|Levodopa|levodopa|mesh-list
759293|NCT02741947|Benserazide|benserazide|mesh-list
759294|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
759295|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
759296|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
759297|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
759298|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
759299|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759300|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759301|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759414|NCT02741232|Lidocaine|lidocaine|mesh-list
759415|NCT02741232|Epinephrine|epinephrine|mesh-list
759416|NCT02741232|Racepinephrine|racepinephrine|mesh-list
759417|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
759418|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
759419|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
759420|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
759421|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759422|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
759423|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
759424|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
759425|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
759426|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
759427|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
759428|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759429|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2237807|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758820|NCT02744495|Betamethasone|betamethasone|mesh-list
758821|NCT02744495|Droperidol|droperidol|mesh-list
758822|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
758823|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
758824|NCT02744495|Hormones|hormones|mesh-ancestor
758825|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
758826|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758827|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
758828|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
758829|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
758830|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
758831|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
758832|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758833|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
758834|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
758835|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
758836|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
758837|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
758838|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
758839|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
758840|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
758841|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
758842|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758946|NCT02743598|Liraglutide|liraglutide|mesh-list
758947|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
758948|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758949|NCT02743598|Incretins|incretins|mesh-ancestor
758950|NCT02743598|Hormones|hormones|mesh-ancestor
758951|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
759079|NCT02743104|Lidocaine|lidocaine|mesh-list
759080|NCT02743104|Atropine|atropine|mesh-list
759081|NCT02743104|Midazolam|midazolam|mesh-list
759082|NCT02743104|Ketamine|ketamine|mesh-list
759083|NCT02743104|Propofol|propofol|mesh-list
759084|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
759085|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
759086|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
759087|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759088|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
759089|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
759090|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
759091|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
759092|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
759093|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
759094|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759095|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
759096|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
759097|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
759098|NCT02743104|Analgesics|analgesics|mesh-ancestor
759099|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
759100|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
759101|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
759102|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
759103|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
759104|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
759105|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
759106|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
759107|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
759108|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
759109|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
759110|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
759111|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
759112|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
759113|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
759114|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
759115|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
759116|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
759117|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
759302|NCT02741960|Metformin|metformin|mesh-list
759303|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
759304|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759603|NCT02741063|Oxytocin|oxytocin|mesh-list
759604|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
759605|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
759606|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759816|NCT02740179|Eplerenone|eplerenone|mesh-list
758446|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758447|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758797|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
758798|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
758799|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
758800|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758801|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
758802|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758803|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2237808|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2237809|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237810|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237811|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
2237812|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237813|NCT00091195|Romidepsin|romidepsin|mesh-list
2237814|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2237815|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237816|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
2237817|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2237818|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237819|NCT00091247|Tetracycline|tetracycline|mesh-list
2237820|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2237821|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237822|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2237823|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237824|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237825|NCT00091299|Warfarin|warfarin|mesh-list
2237826|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
2237827|NCT00091312|Leucovorin|leucovorin|mesh-list
2237828|NCT00091312|Fluorouracil|fluorouracil|mesh-list
2237829|NCT00091312|Irinotecan|irinotecan|mesh-list
2237830|NCT00091312|Calcium|calcium|mesh-list
2237831|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
2237832|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2237833|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237834|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
2237835|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237836|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2237837|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237838|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
760038|NCT02739295|Sargramostim|sargramostim|mesh-list
760039|NCT02739295|Immunologic Factors|immunologic factors|mesh-ancestor
760040|NCT02739295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760363|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
760364|NCT02737696|Narcotics|narcotics|mesh-ancestor
760365|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
760366|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760367|NCT02737696|Analgesics|analgesics|mesh-ancestor
760368|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
760369|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237839|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
2237840|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2237841|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2237842|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237843|NCT00091312|Antidotes|antidotes|mesh-ancestor
2237844|NCT00091312|Protective Agents|protective agents|mesh-ancestor
2237845|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
2237846|NCT00091312|Vitamins|vitamins|mesh-ancestor
2237847|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
2237848|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2237849|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
2237850|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760649|NCT02736435|Leuprolide|leuprolide|mesh-list
760650|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
760651|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
760652|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
760653|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760654|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
760655|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760947|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
760948|NCT02735603|Naltrexone|naltrexone|mesh-list
760949|NCT02735603|Bupropion|bupropion|mesh-list
760950|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
760951|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760952|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2237851|NCT00091325|Protective Agents|protective agents|mesh-ancestor
758453|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
758454|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
758455|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
758456|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758457|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
758458|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
758459|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
758460|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
758461|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
758462|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
758463|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758464|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
758465|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
758466|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
758467|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
758468|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758552|NCT02745093|Misoprostol|misoprostol|mesh-list
758553|NCT02745093|Mifepristone|mifepristone|mesh-list
758554|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
758555|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
758556|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
758557|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758558|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
758559|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
758560|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
758561|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
758562|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
758563|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
758564|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
758565|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
758566|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
758567|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
758568|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
758569|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
758570|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
758571|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
758572|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
758620|NCT02744716|Aspirin|aspirin|mesh-list
758621|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
758622|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
758623|NCT02744716|Analgesics|analgesics|mesh-ancestor
758624|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
758625|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758626|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758627|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
758628|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
758629|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
758630|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
758631|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758632|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
758633|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
758634|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758635|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
2237852|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237853|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2237854|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2237855|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237856|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2237857|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
2237858|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2093447|NCT02260648|Evacetrapib|evacetrapib|mesh-list
2093448|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2093449|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
759060|NCT02743390|Infliximab|infliximab|mesh-list
759061|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
759062|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
759063|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237859|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
2237860|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237861|NCT00091377|Paclitaxel|paclitaxel|mesh-list
2237862|NCT00091377|Cisplatin|cisplatin|mesh-list
759592|NCT02741115|Udenafil|udenafil|mesh-list
759593|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2237863|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
758514|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758515|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
758516|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
758517|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758518|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
758519|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
758520|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
758521|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
758522|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
758599|NCT02744768|Dasatinib|dasatinib|mesh-list
758600|NCT02744768|Blinatumomab|blinatumomab|mesh-list
758601|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758602|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
758603|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758604|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759252|NCT02742181|Alvimopan|alvimopan|mesh-list
759253|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
759319|NCT02741817|Aspirin|aspirin|mesh-list
759320|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
759321|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
759322|NCT02741817|Analgesics|analgesics|mesh-ancestor
759323|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
759324|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
759325|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759326|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
759327|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
759328|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
759329|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
759330|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759331|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
759332|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
759333|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759334|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
759627|NCT02741154|Letrozole|letrozole|mesh-list
759628|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
759629|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759630|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
759631|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
759632|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759633|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759634|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
759635|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
759636|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
759637|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759638|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
759639|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
759640|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
759641|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
759642|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
759643|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2237864|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237865|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
2237866|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
2237867|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
2237868|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237869|NCT00091429|Ranolazine|ranolazine|mesh-list
2237870|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2237871|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2237872|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237873|NCT00091468|Nicotine|nicotine|mesh-list
2237874|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2237875|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
2237876|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237877|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237878|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2237879|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2237880|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
2237881|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237882|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237883|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2237884|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
2237885|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237886|NCT00091559|Vorinostat|vorinostat|mesh-list
2237887|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758781|NCT02744456|Losartan|losartan|mesh-list
758782|NCT02744456|Amlodipine|amlodipine|mesh-list
758783|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
758784|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
758785|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
758786|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
758787|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758788|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
758789|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758790|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
758791|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
758792|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
758793|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
758794|NCT02744456|Diuretics|diuretics|mesh-ancestor
758795|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
758796|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
758938|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
758939|NCT02743819|Ipilimumab|ipilimumab|mesh-list
758940|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
758941|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758942|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
758943|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759168|NCT02742675|Leuprolide|leuprolide|mesh-list
759169|NCT02742675|Goserelin|goserelin|mesh-list
759170|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
759171|NCT02742675|Flutamide|flutamide|mesh-list
759172|NCT02742675|Bicalutamide|bicalutamide|mesh-list
759173|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
759174|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
759175|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
759176|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759177|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
759178|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759179|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
759180|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
759181|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
759182|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
759183|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
759184|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
759185|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
759254|NCT02742142|Fluorides|fluorides|mesh-list
759255|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
759256|NCT02742142|Protective Agents|protective agents|mesh-ancestor
759257|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759305|NCT02741791|Bupropion|bupropion|mesh-list
759306|NCT02741791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
759307|NCT02741791|Antidepressive Agents|antidepressive agents|mesh-ancestor
759308|NCT02741791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
759309|NCT02741791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
759310|NCT02741791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
759311|NCT02741791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
759312|NCT02741791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759313|NCT02741791|Dopamine Agents|dopamine agents|mesh-ancestor
759314|NCT02741791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
759315|NCT02741791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759316|NCT02741791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
759317|NCT02741791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
759318|NCT02741791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759690|NCT02740647|Amoxicillin|amoxicillin|mesh-list
759691|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
759692|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
759693|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
759694|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
759695|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
759696|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
759697|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759698|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760322|NCT02737813|Bupivacaine|bupivacaine|mesh-list
760323|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
760324|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
760325|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
760326|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760327|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
758609|NCT02744833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
758610|NCT02744833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237888|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2237889|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237890|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237891|NCT00091598|Ambrisentan|ambrisentan|mesh-list
2237892|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2237893|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
2237894|NCT00091611|Fludarabine|fludarabine|mesh-list
759249|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
759250|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
759251|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760412|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
760413|NCT02737371|Clotrimazole|clotrimazole|mesh-list
760414|NCT02737371|Miconazole|miconazole|mesh-list
760415|NCT02737371|Olorofim|olorofim|mesh-list
760416|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760417|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
760418|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
760419|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
760420|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760421|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760422|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
760423|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
760424|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
760425|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760426|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
760427|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
760543|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
760544|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
760545|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
760621|NCT02736513|Osimertinib|osimertinib|mesh-list
760622|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760623|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
760624|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760625|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761374|NCT02733835|Remifentanil|remifentanil|mesh-list
761375|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
761376|NCT02733835|Narcotics|narcotics|mesh-ancestor
761377|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761378|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761379|NCT02733835|Analgesics|analgesics|mesh-ancestor
761380|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
761381|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761608|NCT02733380|Thalidomide|thalidomide|mesh-list
761609|NCT02733380|Dexamethasone|dexamethasone|mesh-list
761610|NCT02733380|Doxorubicin|doxorubicin|mesh-list
761611|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
761612|NCT02733380|Vinorelbine|vinorelbine|mesh-list
761613|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
761614|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
761615|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
761616|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
761617|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761618|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761619|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
761620|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
761621|NCT02733380|Hormones|hormones|mesh-ancestor
761622|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
761623|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
761624|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761625|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
761626|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
761627|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
761628|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
761629|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761630|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
761631|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
761632|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
761633|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
761634|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
761635|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
761636|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
761637|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2237895|NCT00091611|Interleukin-2|interleukin-2|mesh-list
2237896|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237897|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
759017|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
759018|NCT02743247|Tacrolimus|tacrolimus|mesh-list
759019|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
759020|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
759021|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759022|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
759023|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759024|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759025|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
759026|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759027|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
759028|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
759029|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
759030|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
759233|NCT02742467|Amlodipine|amlodipine|mesh-list
759234|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
759235|NCT02742467|Perindopril|perindopril|mesh-list
759236|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
759237|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
759238|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
759239|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759240|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
759241|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759242|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
759243|NCT02742467|Diuretics|diuretics|mesh-ancestor
759244|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
759245|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
759246|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
759247|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
759248|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760026|NCT02739516|Letrozole|letrozole|mesh-list
760027|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
760028|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760029|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
760030|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
760031|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760032|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760033|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
760034|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
760035|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
760036|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760037|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
760626|NCT02736591|Hormones|hormones|mesh-list
760627|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
760628|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
760629|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237898|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237899|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237900|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2237901|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
2237902|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237903|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237904|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2237905|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2237906|NCT00091611|Analgesics|analgesics|mesh-ancestor
2237907|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
761443|NCT02733705|Fentanyl|fentanyl|mesh-list
761444|NCT02733705|Propofol|propofol|mesh-list
761445|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
761446|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761447|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761448|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
761449|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
758694|NCT02744625|Propofol|propofol|mesh-list
758695|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
758696|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
758697|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758698|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
758699|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
758700|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
758944|NCT02743806|Vedolizumab|vedolizumab|mesh-list
758945|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
759223|NCT02742233|Saxagliptin|saxagliptin|mesh-list
759224|NCT02742233|Incretins|incretins|mesh-ancestor
759225|NCT02742233|Hormones|hormones|mesh-ancestor
759226|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
759227|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759228|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
759229|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
759230|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759231|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759232|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2237908|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237909|NCT00091624|Lenalidomide|lenalidomide|mesh-list
2237910|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
2237911|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093450|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
2093451|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093452|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2093453|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2093454|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093455|NCT02260791|Adalimumab|adalimumab|mesh-list
2093456|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093457|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093458|NCT02260804|Rituximab|rituximab|mesh-list
2093459|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2093460|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093461|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
2093462|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093463|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
760314|NCT02737709|Paclitaxel|paclitaxel|mesh-list
760315|NCT02737709|Carboplatin|carboplatin|mesh-list
760316|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
760317|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760318|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
760319|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
760320|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
760321|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237912|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2237913|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2237914|NCT00091624|Growth Substances|growth substances|mesh-ancestor
760663|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
760664|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
760665|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
760666|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
760667|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237915|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
2237916|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237917|NCT00091650|Olanzapine|olanzapine|mesh-list
2237918|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
2237919|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
2237920|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237921|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237922|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
761322|NCT02734173|Ritonavir|ritonavir|mesh-list
761323|NCT02734173|Ribavirin|ribavirin|mesh-list
761324|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
761325|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
761326|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
761327|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093464|NCT02260817|Choline|choline|mesh-list
2237923|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
758741|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
758742|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
758743|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
758744|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
758745|NCT02744378|Hormones|hormones|mesh-ancestor
758746|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
758859|NCT02744131|Metformin|metformin|mesh-list
758860|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
758861|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
758862|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
758863|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
758864|NCT02744131|Estradiol|estradiol|mesh-list
758865|NCT02744131|Cyproterone|cyproterone|mesh-list
758866|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
758867|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758868|NCT02744131|Estrogens|estrogens|mesh-ancestor
758869|NCT02744131|Hormones|hormones|mesh-ancestor
758870|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
758871|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
758872|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
758873|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
758874|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
758875|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758876|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2237924|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2237925|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2237926|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2237927|NCT00091650|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2237928|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2237929|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2237930|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237931|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2237932|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
2237933|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
759587|NCT02740829|Glucagon|glucagon|mesh-list
759588|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
759589|NCT02740829|Hormones|hormones|mesh-ancestor
759590|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
759591|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237934|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237935|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2237936|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2237937|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237938|NCT00091702|Vaccines|vaccines|mesh-list
2237939|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
2237940|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237941|NCT00091715|Bosentan|bosentan|mesh-list
2237942|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2237943|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2237944|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237945|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2237946|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
2237947|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
2237948|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
2237949|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2237950|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2237951|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237952|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2237953|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2237954|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
760193|NCT02738502|Ritonavir|ritonavir|mesh-list
760194|NCT02738502|Darunavir|darunavir|mesh-list
760195|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
760196|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
760197|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
760198|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760199|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760200|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
760201|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
760202|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
760203|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760204|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
760205|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
759369|NCT02741856|Paclitaxel|paclitaxel|mesh-list
759370|NCT02741856|Carboplatin|carboplatin|mesh-list
759371|NCT02741856|Capecitabine|capecitabine|mesh-list
759372|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
759373|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759374|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
759375|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
759376|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
759377|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759378|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
759379|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
759621|NCT02740868|Xenon|xenon|mesh-list
759622|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
759623|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
759624|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
759625|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
759626|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760046|NCT02739412|Aldesleukin|aldesleukin|mesh-list
760047|NCT02739412|Interleukin-2|interleukin-2|mesh-list
760048|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760049|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
760050|NCT02739412|Analgesics|analgesics|mesh-ancestor
760051|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
760052|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760053|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760054|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
760055|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
760056|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
760057|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760288|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
760289|NCT02737943|Analgesics|analgesics|mesh-list
760290|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760291|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
760292|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760293|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760428|NCT02737436|Oxytocin|oxytocin|mesh-list
760429|NCT02737436|Oxytocics|oxytocics|mesh-ancestor
760430|NCT02737436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
760431|NCT02737436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760747|NCT02736019|Celecoxib|celecoxib|mesh-list
760748|NCT02736019|Tramadol|tramadol|mesh-list
760749|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
760750|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
760751|NCT02736019|Analgesics|analgesics|mesh-ancestor
760752|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
760753|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760754|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760755|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
760756|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
760757|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
760758|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
760759|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760760|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760761|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
760762|NCT02736019|Narcotics|narcotics|mesh-ancestor
760763|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761294|NCT02734290|Paclitaxel|paclitaxel|mesh-list
761295|NCT02734290|Capecitabine|capecitabine|mesh-list
761296|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
761297|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
761298|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761299|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
761300|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
761301|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
761302|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761303|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
761304|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
761305|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
761363|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
758915|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758916|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
758987|NCT02743182|Interferons|interferons|mesh-list
758988|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
758989|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
758990|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
758991|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
758992|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
758993|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
758994|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
758995|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237955|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2237956|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2237957|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2237958|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237959|NCT00091741|Etanercept|etanercept|mesh-list
2237960|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2237961|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2237962|NCT00091741|Analgesics|analgesics|mesh-ancestor
760075|NCT02739035|Dexamethasone|dexamethasone|mesh-list
760076|NCT02739035|Celecoxib|celecoxib|mesh-list
760077|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
760078|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
760079|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
760080|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760081|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760082|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
760083|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
760084|NCT02739035|Hormones|hormones|mesh-ancestor
760085|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
760086|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
760087|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760088|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
760089|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
760090|NCT02739035|Analgesics|analgesics|mesh-ancestor
760091|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
760092|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
760093|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
760094|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
760095|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760096|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237963|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
2237964|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2237965|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237966|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2237967|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237968|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2237969|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2237970|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
2237971|NCT00091806|Panitumumab|panitumumab|mesh-list
2237972|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2237973|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237974|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
758961|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
758962|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
758963|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
758964|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
758965|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
758966|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
758967|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
758968|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
758969|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
758970|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
758971|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
758972|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759800|NCT02740270|Spartalizumab|spartalizumab|mesh-list
759801|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
759802|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759803|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759954|NCT02739685|Everolimus|everolimus|mesh-list
759955|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759956|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
759957|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
759958|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760168|NCT02738931|Lamivudine|lamivudine|mesh-list
760169|NCT02738931|Dolutegravir|dolutegravir|mesh-list
760170|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
760171|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
760172|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760173|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760174|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
760175|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760176|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
760177|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
760178|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
760179|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
760206|NCT02738346|Carboplatin|carboplatin|mesh-list
760207|NCT02738346|Etoposide|etoposide|mesh-list
760208|NCT02738346|Topotecan|topotecan|mesh-list
760209|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760210|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
760211|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
760212|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
760213|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760214|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760215|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2237975|NCT00091858|Hematinics|hematinics|mesh-ancestor
2237976|NCT00091897|Rituximab|rituximab|mesh-list
2237977|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2237978|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2237979|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
2237980|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237981|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2237982|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
2237983|NCT00091910|Hematinics|hematinics|mesh-ancestor
2237984|NCT00091936|Lamivudine|lamivudine|mesh-list
2237985|NCT00091936|Efavirenz|efavirenz|mesh-list
2237986|NCT00091936|Didanosine|didanosine|mesh-list
2237987|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2237988|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2237989|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760509|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
760510|NCT02737605|Esketamine|esketamine|mesh-list
760511|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
760512|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760513|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
760514|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
760515|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760516|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760517|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760518|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
760519|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2237990|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2237991|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
2237992|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2237993|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2237994|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2237995|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2237996|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
759467|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
759607|NCT02741024|Artesunate|artesunate|mesh-list
759608|NCT02741024|Lumefantrine|lumefantrine|mesh-list
759609|NCT02741024|Artemether|artemether|mesh-list
759610|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
759611|NCT02741024|Amodiaquine|amodiaquine|mesh-list
759612|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
759613|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
759614|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
759615|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
759616|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759617|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
759618|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
759619|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
759620|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
760116|NCT02738918|Abatacept|abatacept|mesh-list
760117|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
760118|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760119|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760120|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
760121|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
760122|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760123|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
760216|NCT02738632|Amlodipine|amlodipine|mesh-list
760217|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
760218|NCT02738632|Telmisartan|telmisartan|mesh-list
760219|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
760220|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
760221|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
760222|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
760223|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760224|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
760225|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760226|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
760227|NCT02738632|Diuretics|diuretics|mesh-ancestor
760228|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
760229|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
760230|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
760231|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
760329|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
760330|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
760331|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
760332|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
760333|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760334|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
760335|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
760336|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
760337|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
760339|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2237997|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2237998|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2237999|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2238000|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2238001|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
760924|NCT02735330|Ethanol|ethanol|mesh-list
760925|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
760926|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760927|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
760928|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761258|NCT02734524|Carboplatin|carboplatin|mesh-list
761269|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761719|NCT02732405|Grazoprevir|grazoprevir|mesh-list
761720|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
761721|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2238002|NCT00092001|Sunitinib|sunitinib|mesh-list
2238003|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238004|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2238005|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2238006|NCT00092001|Growth Substances|growth substances|mesh-ancestor
2238007|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238008|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
2238009|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2238010|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238011|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759043|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
759044|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
759045|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
759046|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759047|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759048|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
759049|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
759050|NCT02743260|Protective Agents|protective agents|mesh-ancestor
759051|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
759052|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
759053|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
759054|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
759055|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
759056|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
759057|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
759058|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
759059|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
759133|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
759134|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
759135|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759743|NCT02740712|Vitamin K|vitamin k|mesh-list
759744|NCT02740712|Rucaparib|rucaparib|mesh-list
759745|NCT02740712|Digoxin|digoxin|mesh-list
759746|NCT02740712|Midazolam|midazolam|mesh-list
759747|NCT02740712|Caffeine|caffeine|mesh-list
759748|NCT02740712|Omeprazole|omeprazole|mesh-list
759749|NCT02740712|Warfarin|warfarin|mesh-list
759750|NCT02740712|Vitamins|vitamins|mesh-ancestor
759751|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
759752|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759753|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
759754|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
759755|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
759756|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
759757|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
759758|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
759759|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
759760|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
759761|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
759762|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
759763|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
759764|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
759765|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759766|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
759767|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
759768|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
759769|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
759770|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759771|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
759772|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
759773|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
759774|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
759775|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
759776|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
759777|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
759778|NCT02740712|Protective Agents|protective agents|mesh-ancestor
759779|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
759780|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
759781|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
759782|NCT02740712|Coagulants|coagulants|mesh-ancestor
759783|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
759784|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238012|NCT00092014|Vitamin D|vitamin d|mesh-list
2238013|NCT00092014|Alendronate|alendronate|mesh-list
2238014|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
2238015|NCT00092014|Calcium|calcium|mesh-list
2238016|NCT00092014|Vitamins|vitamins|mesh-ancestor
759129|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
759130|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
759131|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759132|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759207|NCT02742480|Dabigatran|dabigatran|mesh-list
759208|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
759209|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
759210|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
759211|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
759212|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759213|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759214|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
2238017|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
2238018|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238019|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2238020|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2238021|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2238022|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2238023|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238024|NCT00092027|Alendronate|alendronate|mesh-list
2238025|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238026|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2238027|NCT00092040|Alendronate|alendronate|mesh-list
2238028|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
2238029|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759959|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
759960|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
759961|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
759962|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
759963|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
759964|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759965|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
759966|NCT02739815|Coagulants|coagulants|mesh-ancestor
760180|NCT02738619|Vitamin D|vitamin d|mesh-list
760181|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
760182|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
760183|NCT02738619|Vitamins|vitamins|mesh-list
760184|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
760185|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760186|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
760187|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2238030|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760656|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
760657|NCT02736682|Metronidazole|metronidazole|mesh-list
760658|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
760659|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760660|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
760661|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
760662|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
760782|NCT02735928|Doxorubicin|doxorubicin|mesh-list
760783|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760784|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
760785|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
760786|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
760787|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760788|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760872|NCT02735343|Ketamine|ketamine|mesh-list
760873|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
760874|NCT02735343|Analgesics|analgesics|mesh-ancestor
760875|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
760876|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760877|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760878|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
760879|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
760880|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
760881|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
760882|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
760883|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
760884|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
760885|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
760886|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760887|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
760888|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
760889|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
759202|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
759203|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
759204|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
759205|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
759206|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
759262|NCT02742038|Fluorides|fluorides|mesh-list
759263|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
759264|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
759265|NCT02742038|Protective Agents|protective agents|mesh-ancestor
759266|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238031|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2238032|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2238033|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2238034|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2238035|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
2238036|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2238037|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238038|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
2238039|NCT00092066|Alendronate|alendronate|mesh-list
2238040|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2238041|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238042|NCT00092066|Vitamins|vitamins|mesh-ancestor
2238043|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
2238044|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2238045|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
2238046|NCT00092079|Alendronate|alendronate|mesh-list
2238047|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2238048|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238049|NCT00092079|Vitamins|vitamins|mesh-ancestor
2238050|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
2238051|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2238052|NCT00092092|Budesonide|budesonide|mesh-list
2238053|NCT00092092|Montelukast|montelukast|mesh-list
2238054|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238055|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2238056|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
2238057|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238058|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238059|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2238060|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
2238061|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
2238062|NCT00092092|Hormones|hormones|mesh-ancestor
2238063|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2238064|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
759579|NCT02740933|Demeclocycline|demeclocycline|mesh-list
759580|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
759581|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
759922|NCT02739906|Insulin|insulin|mesh-list
759923|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
759924|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
759925|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
759926|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760140|NCT02739386|Ipilimumab|ipilimumab|mesh-list
760141|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
760142|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760143|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
760144|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760592|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
760593|NCT02736604|Anesthetics|anesthetics|mesh-list
760594|NCT02736604|Sevoflurane|sevoflurane|mesh-list
760595|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
760596|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760597|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
760598|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
760599|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
760600|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
760601|NCT02736604|Analgesics|analgesics|mesh-ancestor
760602|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
760603|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238065|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
2238066|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2238067|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2238068|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238069|NCT00092105|Montelukast|montelukast|mesh-list
2238070|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
759219|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
759220|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
759221|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759222|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759502|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
759503|NCT02741414|Amoxicillin|amoxicillin|mesh-list
759504|NCT02741414|Metronidazole|metronidazole|mesh-list
759505|NCT02741414|Clarithromycin|clarithromycin|mesh-list
759506|NCT02741414|Levofloxacin|levofloxacin|mesh-list
759507|NCT02741414|Ofloxacin|ofloxacin|mesh-list
759508|NCT02741414|Tetracycline|tetracycline|mesh-list
759509|NCT02741414|Furazolidone|furazolidone|mesh-list
759510|NCT02741414|Esomeprazole|esomeprazole|mesh-list
759511|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
759512|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
759513|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
759514|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
759515|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
759516|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
759517|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759518|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759519|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
759520|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
759521|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
759522|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
759523|NCT02741414|Renal Agents|renal agents|mesh-ancestor
759524|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
759525|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
759526|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759527|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
759528|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
759529|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
759530|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2238071|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
2238072|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2238073|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
760152|NCT02738970|Trastuzumab|trastuzumab|mesh-list
760153|NCT02738970|Pertuzumab|pertuzumab|mesh-list
760154|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
760155|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760251|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
760252|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
760253|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
760254|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760255|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
760256|NCT02738073|Coagulants|coagulants|mesh-ancestor
760671|NCT02736240|Vaccines|vaccines|mesh-list
760672|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
760673|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
760674|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760821|NCT02735876|Rituximab|rituximab|mesh-list
760822|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
760823|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
760824|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760825|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
760826|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760827|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
761232|NCT02734511|Propofol|propofol|mesh-list
761233|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
761234|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761235|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761236|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
761237|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
761238|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
762544|NCT02729935|Parecoxib|parecoxib|mesh-list
762545|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
762546|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
762547|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762548|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762549|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
762550|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
762551|NCT02729935|Analgesics|analgesics|mesh-ancestor
762552|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
762553|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
762554|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762555|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
759431|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
759432|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
759433|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
759434|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
759435|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
759436|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
759437|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
759438|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
759439|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
759440|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2093465|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
2093466|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2093467|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
2238074|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2238075|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238076|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2238077|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2238078|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238079|NCT00092144|Montelukast|montelukast|mesh-list
2238080|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238081|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238082|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
2238083|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2238084|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
759808|NCT02740192|Bupivacaine|bupivacaine|mesh-list
759809|NCT02740192|Ropivacaine|ropivacaine|mesh-list
759810|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
759811|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
759812|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
759813|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759814|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
759815|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760354|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
760355|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
760356|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
760357|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
760358|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
760359|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760360|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
760361|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
760362|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760392|NCT02737423|Vitamin D|vitamin d|mesh-list
760393|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
760394|NCT02737423|Vitamins|vitamins|mesh-ancestor
760395|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
760396|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760397|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
760398|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2238085|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
2238086|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2238087|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2238088|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2238089|NCT00092157|Simvastatin|simvastatin|mesh-list
2238090|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238091|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238092|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
2238093|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238094|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238095|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
761275|NCT02734407|Aflibercept|aflibercept|mesh-list
761276|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
761277|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
761278|NCT02734407|Growth Substances|growth substances|mesh-ancestor
761279|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761280|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
761281|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093468|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093469|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2093470|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2093471|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
2093472|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2093473|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
759972|NCT02739633|Gemcitabine|gemcitabine|mesh-list
759973|NCT02739633|Paclitaxel|paclitaxel|mesh-list
759974|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
759975|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
759976|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
759977|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
759978|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
759979|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759980|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
759981|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
759982|NCT02739633|Antiviral Agents|antiviral agents|mesh-ancestor
759983|NCT02739633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
759984|NCT02739633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759985|NCT02739633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
759986|NCT02739633|Immunologic Factors|immunologic factors|mesh-ancestor
759987|NCT02739633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760468|NCT02737228|Gemcitabine|gemcitabine|mesh-list
760469|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
760470|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
760471|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
760472|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760473|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760474|NCT02737228|Antiviral Agents|antiviral agents|mesh-ancestor
760475|NCT02737228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760476|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760477|NCT02737228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
760478|NCT02737228|Immunologic Factors|immunologic factors|mesh-ancestor
760479|NCT02737228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760480|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
760687|NCT02736149|Ubenimex|ubenimex|mesh-list
760688|NCT02736149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
760689|NCT02736149|Immunologic Factors|immunologic factors|mesh-ancestor
760690|NCT02736149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760691|NCT02736149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
760692|NCT02736149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760693|NCT02736149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
760694|NCT02736149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760695|NCT02736149|Protease Inhibitors|protease inhibitors|mesh-ancestor
760696|NCT02736149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760697|NCT02736149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760698|NCT02736149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
760699|NCT02736149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
760700|NCT02736149|Antiviral Agents|antiviral agents|mesh-ancestor
761412|NCT02733874|Betamethasone|betamethasone|mesh-list
761413|NCT02733874|Clobetasol|clobetasol|mesh-list
761414|NCT02733874|Calcipotriene|calcipotriene|mesh-list
761415|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
761416|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
761417|NCT02733874|Hormones|hormones|mesh-ancestor
761418|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
761419|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761420|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
761421|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
761422|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
762223|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
762224|NCT02730689|Ezetimibe|ezetimibe|mesh-list
762225|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
762226|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
762227|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
762228|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762229|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
762230|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
762231|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238096|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238097|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
2238098|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
2238099|NCT00092170|Ertapenem|ertapenem|mesh-list
2238100|NCT00092170|Ticarcillin|ticarcillin|mesh-list
2238101|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2238102|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238103|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238104|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
759594|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
759595|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
759596|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759741|NCT02740426|Pirarubicin|pirarubicin|mesh-list
759742|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760346|NCT02737787|Nivolumab|nivolumab|mesh-list
760347|NCT02737787|Vaccines|vaccines|mesh-list
760348|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
760349|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760350|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
760351|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760352|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
760353|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760789|NCT02735837|Doxycycline|doxycycline|mesh-list
760790|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
760791|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760792|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
760793|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
760794|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2093474|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093475|NCT02260934|Acetaminophen|acetaminophen|mesh-list
2093476|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
2093477|NCT02260934|Promethazine|promethazine|mesh-list
2093478|NCT02260934|Prednisone|prednisone|mesh-list
761593|NCT02733341|Ticagrelor|ticagrelor|mesh-list
761594|NCT02733341|Cangrelor|cangrelor|mesh-list
761595|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
761596|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
761597|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
761598|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
761599|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
761600|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
761601|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761602|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761751|NCT02732067|Anesthetics|anesthetics|mesh-list
761752|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761753|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762158|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
762159|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762160|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
762161|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762162|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762163|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
762164|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
762165|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762166|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
762646|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
762647|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
762648|NCT02728856|Protective Agents|protective agents|mesh-ancestor
762649|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762650|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
762742|NCT02728622|Tamoxifen|tamoxifen|mesh-list
762743|NCT02728622|Paclitaxel|paclitaxel|mesh-list
762744|NCT02728622|Doxorubicin|doxorubicin|mesh-list
762745|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
762746|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
762747|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762748|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
762749|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
762750|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
762751|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762752|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
762753|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
762754|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
762755|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762756|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
762757|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
762758|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
762759|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762760|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
762761|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
762762|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2093479|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
2238105|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2238106|NCT00092183|Ondansetron|ondansetron|mesh-list
2238107|NCT00092183|Aprepitant|aprepitant|mesh-list
2238108|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
759845|NCT02739958|Propofol|propofol|mesh-list
759846|NCT02739958|Isoflurane|isoflurane|mesh-list
759847|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
759848|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
759849|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759850|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
759851|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
759852|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
759853|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
760136|NCT02738905|Rifaximin|rifaximin|mesh-list
760137|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
760138|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760139|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2238109|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
2238110|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238111|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760895|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
760896|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
760897|NCT02735317|Gentamicins|gentamicins|mesh-list
760898|NCT02735317|Dexamethasone|dexamethasone|mesh-list
760899|NCT02735317|Procaine|procaine|mesh-list
760900|NCT02735317|Vitamins|vitamins|mesh-ancestor
760901|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
760902|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760903|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
760904|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
760905|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
760906|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760907|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
760908|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
760909|NCT02735317|Hormones|hormones|mesh-ancestor
760910|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
760911|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
760912|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760913|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
760914|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
760915|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760916|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
760917|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760918|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760919|NCT02735317|Hematinics|hematinics|mesh-ancestor
760920|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
760921|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
760922|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
760923|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
2238112|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2238113|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
2238114|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
2238115|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2238116|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
2238117|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2238118|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238119|NCT00092183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2238120|NCT00092183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2238121|NCT00092183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2238122|NCT00092183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2238123|NCT00092183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2238124|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2238125|NCT00092196|Aprepitant|aprepitant|mesh-list
2238126|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
2238127|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
2238128|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238129|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238130|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2238131|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2238132|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2238133|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238134|NCT00092209|Losartan|losartan|mesh-list
2238135|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2238136|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2238137|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2238138|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2238139|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
759817|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
759818|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
759819|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
759820|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759821|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
759822|NCT02740179|Diuretics|diuretics|mesh-ancestor
759823|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
759824|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
760008|NCT02739399|Phenylephrine|phenylephrine|mesh-list
760009|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
760010|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
760011|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
760012|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
760013|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760014|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760015|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
760016|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
760017|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
760018|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
760019|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
760020|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
760021|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
760022|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
760023|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
760024|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760025|NCT02739399|Protective Agents|protective agents|mesh-ancestor
760444|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
760445|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
760446|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
760447|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
760448|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760449|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
760450|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
760451|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760566|NCT02737059|Codeine|codeine|mesh-list
760567|NCT02737059|Naloxegol|naloxegol|mesh-list
760568|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
760569|NCT02737059|Narcotics|narcotics|mesh-ancestor
760570|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
760571|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760572|NCT02737059|Analgesics|analgesics|mesh-ancestor
760573|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
760574|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760575|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
760576|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
760577|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
760972|NCT02735031|Exenatide|exenatide|mesh-list
760973|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
760974|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760975|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
760976|NCT02735031|Incretins|incretins|mesh-ancestor
760977|NCT02735031|Hormones|hormones|mesh-ancestor
760978|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2238140|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238141|NCT00092209|Diuretics|diuretics|mesh-ancestor
2238142|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
2238143|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238144|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2238145|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2753770|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
2753771|NCT02457598|Idelalisib|idelalisib|mesh-list
2753772|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2753773|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753774|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753775|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753776|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
2753777|NCT02451982|Nivolumab|nivolumab|mesh-list
2753778|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
2753779|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753780|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2753781|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
759967|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
759968|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
759969|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
759970|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
759971|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753782|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2753783|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
2753784|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753785|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761004|NCT02735122|Acetaminophen|acetaminophen|mesh-list
761005|NCT02735122|Ibuprofen|ibuprofen|mesh-list
761006|NCT02735122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
761007|NCT02735122|Analgesics|analgesics|mesh-ancestor
761008|NCT02735122|Sensory System Agents|sensory system agents|mesh-ancestor
761009|NCT02735122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761010|NCT02735122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761011|NCT02735122|Antipyretics|antipyretics|mesh-ancestor
761012|NCT02735122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
761013|NCT02735122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
761014|NCT02735122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
761015|NCT02735122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
761016|NCT02735122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
761017|NCT02735122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761516|NCT02733445|Dasatinib|dasatinib|mesh-list
761517|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761518|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
761519|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
761520|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761680|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
761681|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
761682|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
761683|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
761684|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
761685|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761686|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761687|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
761688|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
761689|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761690|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
761691|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
761692|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
761933|NCT02731846|Fluticasone|fluticasone|mesh-list
761934|NCT02731846|Xhance|xhance|mesh-list
761935|NCT02731846|Albuterol|albuterol|mesh-list
761936|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
761937|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
761938|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
761939|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761940|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761941|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
761942|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
761943|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
761944|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
761945|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
761946|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
761947|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
761948|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
761949|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
761950|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
761951|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
761952|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763599|NCT02725489|Durvalumab|durvalumab|mesh-list
2093480|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2093481|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2093482|NCT02260934|Prednisolone|prednisolone|mesh-list
2093483|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
2093484|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
2093485|NCT02260934|Rituximab|rituximab|mesh-list
2093486|NCT02260934|Belimumab|belimumab|mesh-list
2093487|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2093488|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
760097|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
760098|NCT02739061|Sertraline|sertraline|mesh-list
760099|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
760100|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
760101|NCT02739061|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
760102|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
760103|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
760104|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760105|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
760106|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
760107|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760108|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
760109|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
760110|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
760111|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
760112|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
760113|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
760114|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760115|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2753786|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2753787|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2753788|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
761558|NCT02733250|Paclitaxel|paclitaxel|mesh-list
761559|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
761560|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
761561|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761562|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
761563|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
761564|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
761565|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761566|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
762127|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
762128|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
762506|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
762507|NCT02729870|Laxatives|laxatives|mesh-ancestor
762508|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
762728|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
762729|NCT02728700|Sirolimus|sirolimus|mesh-list
762730|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
762731|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762732|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
762733|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
762734|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
762735|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
762736|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762737|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762738|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
762739|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
762740|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
762741|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763248|NCT02726581|Dexamethasone|dexamethasone|mesh-list
763249|NCT02726581|Nivolumab|nivolumab|mesh-list
763250|NCT02726581|Pomalidomide|pomalidomide|mesh-list
763251|NCT02726581|Elotuzumab|elotuzumab|mesh-list
763252|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
763253|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
763254|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
763255|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763256|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763257|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
763258|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
763259|NCT02726581|Hormones|hormones|mesh-ancestor
763260|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
759940|NCT02739672|Telmisartan|telmisartan|mesh-list
759941|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
759942|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
759943|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
759944|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
759945|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
759946|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
759947|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
759948|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
759949|NCT02739672|Diuretics|diuretics|mesh-ancestor
759950|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
759951|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
759952|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
759953|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2238191|NCT00092274|Ofatumumab|ofatumumab|mesh-list
2238192|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238193|NCT00092287|Lanreotide|lanreotide|mesh-list
2238194|NCT00092287|Octreotide|octreotide|mesh-list
2238195|NCT00092287|Somatostatin|somatostatin|mesh-list
2238196|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238197|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2238198|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2238199|NCT00092287|Hormones|hormones|mesh-ancestor
760389|NCT02738229|Valacyclovir|valacyclovir|mesh-list
760390|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
760391|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760440|NCT02737202|Saracatinib|saracatinib|mesh-list
760441|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760442|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760443|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093489|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2238200|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
760724|NCT02736123|Nivolumab|nivolumab|mesh-list
760725|NCT02736123|Ipilimumab|ipilimumab|mesh-list
760726|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
760727|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760728|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
760729|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760941|NCT02735395|Amoxicillin|amoxicillin|mesh-list
760942|NCT02735395|Metronidazole|metronidazole|mesh-list
760943|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
760944|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760945|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
760946|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
761254|NCT02734602|Ketamine|ketamine|mesh-list
761255|NCT02734602|Analgesics|analgesics|mesh-ancestor
761256|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
761257|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761259|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761260|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
761261|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
761262|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
761263|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
761264|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761265|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
761266|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
761267|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
761268|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761336|NCT02734186|Praziquantel|praziquantel|mesh-list
761337|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
761338|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
761339|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
761828|NCT02732093|Lidocaine|lidocaine|mesh-list
761829|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
761830|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
761831|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761832|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761833|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
761834|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760063|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760064|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760065|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
760066|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
760067|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
760068|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
760069|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760070|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093490|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
2093491|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093492|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093493|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2093494|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
2093495|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093496|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093497|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2093498|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
760616|NCT02736448|Capecitabine|capecitabine|mesh-list
760617|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
760618|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
760619|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760620|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760864|NCT02735473|Choline|choline|mesh-list
760865|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
760866|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
760867|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
760868|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760869|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
760870|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
760871|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
761407|NCT02733822|Naloxone|naloxone|mesh-list
761408|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
761409|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761410|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
761411|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761567|NCT02733237|Oxytocin|oxytocin|mesh-list
761568|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
761569|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
761570|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761697|NCT02732522|Misoprostol|misoprostol|mesh-list
761698|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
761699|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
761700|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
761701|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761702|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
761703|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
761704|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
761788|NCT02732288|Melatonin|melatonin|mesh-list
761789|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
761790|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761791|NCT02732288|Protective Agents|protective agents|mesh-ancestor
761792|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761793|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2238201|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238202|NCT00092300|Valdecoxib|valdecoxib|mesh-list
2238203|NCT00092300|Rofecoxib|rofecoxib|mesh-list
2238204|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2238205|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238206|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238207|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762719|NCT02728453|Empagliflozin|empagliflozin|mesh-list
762720|NCT02728453|Glimepiride|glimepiride|mesh-list
762721|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
762722|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762723|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
762724|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762725|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
762726|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
762727|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
763283|NCT02726490|Metformin|metformin|mesh-list
763284|NCT02726490|Glyburide|glyburide|mesh-list
763285|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
763286|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238208|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
760150|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
760151|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
2238209|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238210|NCT00092300|Analgesics|analgesics|mesh-ancestor
2238211|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
760828|NCT02735590|Isoniazid|isoniazid|mesh-list
760829|NCT02735590|Rifapentine|rifapentine|mesh-list
760830|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
760831|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
760832|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760833|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
760834|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
760835|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
760836|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760837|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
760838|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
760839|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
761270|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
761271|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
761272|NCT02734420|Coagulants|coagulants|mesh-ancestor
761273|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
761274|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761320|NCT02734069|Carboplatin|carboplatin|mesh-list
761321|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761490|NCT02733458|Gemcitabine|gemcitabine|mesh-list
761491|NCT02733458|Dexamethasone|dexamethasone|mesh-list
761492|NCT02733458|Etoposide|etoposide|mesh-list
761493|NCT02733458|Pegaspargase|pegaspargase|mesh-list
761494|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
761495|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
761496|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
761497|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761498|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761499|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
761500|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
761501|NCT02733458|Hormones|hormones|mesh-ancestor
761502|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
761503|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
761504|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761505|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
761506|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761507|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
761508|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
761509|NCT02733458|Antiviral Agents|antiviral agents|mesh-ancestor
761510|NCT02733458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
761511|NCT02733458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
761512|NCT02733458|Immunologic Factors|immunologic factors|mesh-ancestor
761513|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
761514|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
761515|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2238212|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238213|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238214|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238215|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238216|NCT00092313|Acetaminophen|acetaminophen|mesh-list
764155|NCT02723578|Pemetrexed|pemetrexed|mesh-list
764156|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
764157|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764158|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764159|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764160|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
764161|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
764162|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
764433|NCT02722694|Methotrexate|methotrexate|mesh-list
764434|NCT02722694|Abatacept|abatacept|mesh-list
764435|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
764436|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
764437|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
764438|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764439|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
764440|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
764441|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764442|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764443|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
764444|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238217|NCT00092313|Rofecoxib|rofecoxib|mesh-list
2238218|NCT00092313|Oxycodone|oxycodone|mesh-list
760273|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
760274|NCT02738177|Misoprostol|misoprostol|mesh-list
760275|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
760276|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
760277|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
760278|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760279|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
760280|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
760281|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
760282|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
760283|NCT02738177|Diuretics|diuretics|mesh-ancestor
760284|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
760285|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
760286|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
760287|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760675|NCT02736227|Everolimus|everolimus|mesh-list
760676|NCT02736227|Tacrolimus|tacrolimus|mesh-list
760677|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
760678|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
760679|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760680|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
760681|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760682|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760683|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761340|NCT02734160|Durvalumab|durvalumab|mesh-list
761341|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
761342|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761895|NCT02731911|Dexamethasone|dexamethasone|mesh-list
761896|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
761897|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
761898|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
761899|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761900|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761901|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
761902|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
761903|NCT02731911|Hormones|hormones|mesh-ancestor
761904|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
761905|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
761906|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238219|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238220|NCT00092313|Analgesics|analgesics|mesh-ancestor
2238221|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
2238222|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238223|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238224|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
763113|NCT02727205|Rotigotine|rotigotine|mesh-list
763114|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
763115|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
763116|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763117|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763118|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763221|NCT02726503|Lenvatinib|lenvatinib|mesh-list
763222|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763223|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
763224|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
763225|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763332|NCT02726126|Fentanyl|fentanyl|mesh-list
763333|NCT02726126|Melatonin|melatonin|mesh-list
763334|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
763335|NCT02726126|Narcotics|narcotics|mesh-ancestor
763336|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
763337|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763338|NCT02726126|Analgesics|analgesics|mesh-ancestor
763339|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
763340|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763341|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
763342|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
763343|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
763344|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
763345|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
763346|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763347|NCT02726126|Protective Agents|protective agents|mesh-ancestor
763617|NCT02725359|Tizanidine|tizanidine|mesh-list
763618|NCT02725359|Bupivacaine|bupivacaine|mesh-list
763619|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
763620|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
763621|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
760328|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760461|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
760462|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
760463|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
760464|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
760465|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760466|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
760467|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760668|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
760669|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
760670|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760929|NCT02735356|Itraconazole|itraconazole|mesh-list
760930|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
760931|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760932|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
760933|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
760934|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760935|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760936|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
760937|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
760938|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
760939|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760940|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
761369|NCT02733809|Sorafenib|sorafenib|mesh-list
761370|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761371|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
761372|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
761373|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238225|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2238226|NCT00092313|Narcotics|narcotics|mesh-ancestor
2238227|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2238228|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
761840|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
761841|NCT02731950|Bupivacaine|bupivacaine|mesh-list
761842|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
761843|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
761844|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761845|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761846|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
761847|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761848|NCT02731950|Analgesics|analgesics|mesh-ancestor
761849|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
761850|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
761851|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
761852|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
761853|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761854|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
761855|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
761856|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
762181|NCT02730923|Anastrozole|anastrozole|mesh-list
762182|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
762183|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762184|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
762185|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
762186|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762187|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762188|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
762189|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
762190|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
762191|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760340|NCT02737774|Pemetrexed|pemetrexed|mesh-list
760341|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760342|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760343|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760344|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
760345|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
760490|NCT02737124|Acetaminophen|acetaminophen|mesh-list
760491|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
760492|NCT02737124|Analgesics|analgesics|mesh-ancestor
760493|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
760494|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760495|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760496|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
761400|NCT02733679|Metformin|metformin|mesh-list
761401|NCT02733679|Pioglitazone|pioglitazone|mesh-list
761402|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
761403|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761857|NCT02732314|Desonide|desonide|mesh-list
761858|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
762142|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
762143|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
762144|NCT02731040|Diphosphonates|diphosphonates|mesh-list
762145|NCT02731040|Etidronic Acid|etidronic acid|mesh-list
762146|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
762147|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238229|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238230|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238231|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238232|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2238233|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238234|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238235|NCT00092326|Acetaminophen|acetaminophen|mesh-list
762947|NCT02727712|Anesthetics|anesthetics|mesh-list
762948|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
762949|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763119|NCT02726919|Clobazam|clobazam|mesh-list
763120|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
763121|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
763122|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
763123|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
763124|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763125|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
763126|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
763127|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
763128|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
763129|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763130|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763935|NCT02724293|Pregabalin|pregabalin|mesh-list
763936|NCT02724293|Analgesics|analgesics|mesh-ancestor
763937|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
763938|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763939|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763940|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
763941|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
763942|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
763943|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763944|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
763945|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
763946|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
763947|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
763948|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
764652|NCT02721537|Niacinamide|niacinamide|mesh-list
764653|NCT02721537|Niacin|niacin|mesh-list
764654|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
764655|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
764656|NCT02721537|Vitamins|vitamins|mesh-ancestor
764657|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
764658|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764659|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238236|NCT00092326|Rofecoxib|rofecoxib|mesh-list
2238237|NCT00092326|Oxycodone|oxycodone|mesh-list
2238238|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238239|NCT00092326|Analgesics|analgesics|mesh-ancestor
2238240|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
2238241|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238242|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238243|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
2238244|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2238245|NCT00092326|Narcotics|narcotics|mesh-ancestor
2238246|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2238247|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2238248|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238249|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238250|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238251|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2238252|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238253|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238254|NCT00092339|Valdecoxib|valdecoxib|mesh-list
760546|NCT02737046|Interferons|interferons|mesh-list
760547|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
760548|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
760549|NCT02737046|Zidovudine|zidovudine|mesh-list
760550|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
760551|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
760552|NCT02737046|Belinostat|belinostat|mesh-list
760553|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760554|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
760555|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760556|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
760557|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760558|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
760559|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760560|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
760561|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
760562|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760563|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
760564|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
760565|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
760613|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
760614|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
760615|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760730|NCT02736071|Celecoxib|celecoxib|mesh-list
760731|NCT02736071|Tramadol|tramadol|mesh-list
760732|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
760733|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
760734|NCT02736071|Analgesics|analgesics|mesh-ancestor
760735|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
760736|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760737|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760738|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
760739|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
760740|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
760741|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
760742|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760743|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760744|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
760745|NCT02736071|Narcotics|narcotics|mesh-ancestor
760746|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
760840|NCT02735694|Cycloserine|cycloserine|mesh-list
760841|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
760842|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
760843|NCT02735694|Renal Agents|renal agents|mesh-ancestor
760844|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
760845|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
760846|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
760847|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
760848|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093499|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093500|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
2093501|NCT02260934|Hormones|hormones|mesh-ancestor
2093502|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2093503|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2093504|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2093505|NCT02260934|Analgesics|analgesics|mesh-ancestor
2093506|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
2238255|NCT00092339|Rofecoxib|rofecoxib|mesh-list
2238256|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2238257|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238258|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238259|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761524|NCT02733107|Etoposide|etoposide|mesh-list
761525|NCT02733107|Apatinib|apatinib|mesh-list
761526|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
761527|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761528|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
761529|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
761530|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
761531|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761532|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2238260|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2238261|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238262|NCT00092339|Analgesics|analgesics|mesh-ancestor
2238263|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
2238264|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238265|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763050|NCT02727296|Propofol|propofol|mesh-list
763051|NCT02727296|Sevoflurane|sevoflurane|mesh-list
763052|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
763053|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
763054|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763055|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
763056|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
763057|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
763058|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
763059|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
763177|NCT02726997|Paclitaxel|paclitaxel|mesh-list
763178|NCT02726997|Carboplatin|carboplatin|mesh-list
763179|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
763180|NCT02726997|Durvalumab|durvalumab|mesh-list
763181|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
763182|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
763183|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
763184|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
763185|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763186|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
763187|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
763188|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
763189|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763190|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
763191|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
763192|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764245|NCT02723383|Baclofen|baclofen|mesh-list
764246|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
764247|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764248|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
764249|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764250|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
764251|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
764252|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
764253|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
764254|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238266|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238267|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238268|NCT00092352|Celecoxib|celecoxib|mesh-list
2238269|NCT00092352|Rofecoxib|rofecoxib|mesh-list
764625|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
764626|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
764627|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764637|NCT02721511|Furosemide|furosemide|mesh-list
764638|NCT02721511|Diuretics|diuretics|mesh-ancestor
764639|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
764640|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764641|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
764642|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
764643|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764749|NCT02721082|Nicotine|nicotine|mesh-list
2238270|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
760818|NCT02735798|Trastuzumab|trastuzumab|mesh-list
760819|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
760820|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238271|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238272|NCT00092352|Analgesics|analgesics|mesh-ancestor
2238273|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
2238274|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238275|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238276|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238277|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238278|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2238279|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238280|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238281|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238282|NCT00092365|Celecoxib|celecoxib|mesh-list
2238283|NCT00092365|Rofecoxib|rofecoxib|mesh-list
2238284|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2238285|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238286|NCT00092365|Analgesics|analgesics|mesh-ancestor
762764|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
762765|NCT02728466|Procyanidin|procyanidin|mesh-list
762766|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
762767|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762768|NCT02728466|Protective Agents|protective agents|mesh-ancestor
762769|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762770|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
762771|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
762772|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
762950|NCT02727907|Interferons|interferons|mesh-list
762951|NCT02727907|Interferon-beta|interferon-beta|mesh-list
762952|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
762953|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762954|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
762955|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
762956|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
762957|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762958|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2093507|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093508|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
2093509|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
2093510|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
2093511|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2093512|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2093513|NCT02260934|Protective Agents|protective agents|mesh-ancestor
2093514|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2093515|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2093516|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2093517|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
2093518|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
2093519|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2093520|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
2093521|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
2093522|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093523|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2093524|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
2093525|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
2093526|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2093527|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
2093528|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093529|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
2093530|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2093531|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
763360|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
763361|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
763362|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763487|NCT02725541|Trastuzumab|trastuzumab|mesh-list
763488|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
763489|NCT02725541|Maytansine|maytansine|mesh-list
763490|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
763491|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763492|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
763493|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
763494|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
763495|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
763496|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763741|NCT02725060|Phenylephrine|phenylephrine|mesh-list
2093532|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2093533|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2238287|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
2238288|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238289|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238290|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238291|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238292|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2238293|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238294|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238295|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238296|NCT00092378|Diclofenac|diclofenac|mesh-list
761044|NCT02735057|Paclitaxel|paclitaxel|mesh-list
761045|NCT02735057|Carboplatin|carboplatin|mesh-list
761046|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
761047|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761048|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
761049|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
761050|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
761051|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761212|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
761213|NCT02734732|Trimethoprim|trimethoprim|mesh-list
761214|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
761215|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
761216|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
761217|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
761218|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
761219|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
761220|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761221|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761222|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
761223|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
761224|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
761225|NCT02734732|Renal Agents|renal agents|mesh-ancestor
761226|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
761227|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
761228|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
761229|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
761230|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
761231|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2238297|NCT00092378|Rofecoxib|rofecoxib|mesh-list
2238298|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2238299|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238300|NCT00092378|Analgesics|analgesics|mesh-ancestor
2238301|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
2238302|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238303|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238304|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238305|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238306|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238307|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238308|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238309|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2238310|NCT00092391|Vaccines|vaccines|mesh-list
2238311|NCT00092391|Immunoglobulins|immunoglobulins|mesh-list
2238312|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
2238313|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238314|NCT00092404|Vaccines|vaccines|mesh-list
2238315|NCT00092404|Immunoglobulins|immunoglobulins|mesh-list
2238316|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
2238317|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238318|NCT00092508|Mesalamine|mesalamine|mesh-list
2238319|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2238320|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238321|NCT00092508|Analgesics|analgesics|mesh-ancestor
2238322|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
2238323|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238324|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238325|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
762522|NCT02729714|Suvorexant|suvorexant|mesh-list
762523|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
762524|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
762525|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
762526|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760765|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
760766|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
760767|NCT02736032|Estradiol|estradiol|mesh-list
760768|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
760769|NCT02736032|Progesterone|progesterone|mesh-list
760770|NCT02736032|Estrogens|estrogens|mesh-ancestor
760771|NCT02736032|Hormones|hormones|mesh-ancestor
760772|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
760773|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760774|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
760775|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
760776|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
760777|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
760778|NCT02736032|Progestins|progestins|mesh-ancestor
760779|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
760780|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
760781|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093534|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093535|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
2238326|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238327|NCT00092560|Ezetimibe|ezetimibe|mesh-list
2238328|NCT00092560|Fenofibrate|fenofibrate|mesh-list
2238329|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238330|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238331|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
2238332|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238333|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238334|NCT00092573|Ezetimibe|ezetimibe|mesh-list
2238335|NCT00092573|Fenofibrate|fenofibrate|mesh-list
2238336|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238337|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238338|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
2238339|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238340|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238341|NCT00092586|Ezetimibe|ezetimibe|mesh-list
2238342|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238343|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238344|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
2238345|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238346|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238347|NCT00092599|Ezetimibe|ezetimibe|mesh-list
2238348|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
763371|NCT02726035|Naltrexone|naltrexone|mesh-list
763372|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
763373|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
763374|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763375|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
763376|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763557|NCT02725255|Albendazole|albendazole|mesh-list
763558|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
763559|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
763560|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
763561|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
763562|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
763563|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
763564|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
763565|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
763566|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
763567|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763568|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238349|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238350|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
2238351|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238352|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238353|NCT00092612|Ezetimibe|ezetimibe|mesh-list
2238354|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238355|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238356|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
2238357|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238358|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238359|NCT00092625|Ezetimibe|ezetimibe|mesh-list
2238360|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238361|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238362|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
2238363|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238364|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238365|NCT00092638|Ezetimibe|ezetimibe|mesh-list
760891|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
760892|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
760893|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
760894|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
761053|NCT02735018|Epinephrine|epinephrine|mesh-list
761054|NCT02735018|Racepinephrine|racepinephrine|mesh-list
761055|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
761056|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
761057|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
761058|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
761059|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
761060|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761061|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761062|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
761063|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
761064|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
761065|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761066|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
761067|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
761068|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
761069|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
761070|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
761404|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
761405|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
761406|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761705|NCT02732678|Propranolol|propranolol|mesh-list
761706|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
761707|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
761708|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
761709|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
761710|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761711|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761712|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
761713|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
761714|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
761770|NCT02732197|Thiopental|thiopental|mesh-list
761771|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
761772|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
761773|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761774|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761775|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
761776|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
761777|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
761778|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
761779|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
761780|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
761781|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238366|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238367|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238368|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
2238369|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762486|NCT02729662|Tolvaptan|tolvaptan|mesh-list
762487|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
762488|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762489|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
762490|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762820|NCT02728492|Gemcitabine|gemcitabine|mesh-list
762821|NCT02728492|Paclitaxel|paclitaxel|mesh-list
762822|NCT02728492|Carboplatin|carboplatin|mesh-list
762823|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
762824|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762825|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
762826|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
762827|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
762828|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762829|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
762830|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
762831|NCT02728492|Antiviral Agents|antiviral agents|mesh-ancestor
762832|NCT02728492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
762833|NCT02728492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762834|NCT02728492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
762835|NCT02728492|Immunologic Factors|immunologic factors|mesh-ancestor
762836|NCT02728492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762920|NCT02727647|Factor VIII|factor viii|mesh-list
762921|NCT02727647|Coagulants|coagulants|mesh-ancestor
763032|NCT02727504|Dobutamine|dobutamine|mesh-list
760953|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
760954|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
760955|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
760956|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
760957|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
760958|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
760959|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
760960|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
760961|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
760962|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
760963|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
760964|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
760965|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
760966|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
760967|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
760968|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
760969|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
760970|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
760971|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
761052|NCT02734875|Anticoagulants|anticoagulants|mesh-list
761382|NCT02733640|Pantoprazole|pantoprazole|mesh-list
761383|NCT02733640|Ranitidine|ranitidine|mesh-list
761384|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
761385|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
761386|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
761387|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
761388|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
761389|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761390|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
761391|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
761392|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
761393|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
761394|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761571|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
761572|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
761573|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
761574|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
761575|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
761576|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
761577|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761578|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
761859|NCT02732249|Metronidazole|metronidazole|mesh-list
761860|NCT02732249|Clarithromycin|clarithromycin|mesh-list
761861|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
761862|NCT02732249|Esomeprazole|esomeprazole|mesh-list
761863|NCT02732249|Bismuth|bismuth|mesh-list
761864|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761865|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
761866|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
761867|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
761868|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
761869|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
761870|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
761871|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
761872|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
761873|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
761874|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
761875|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
761876|NCT02732249|Antacids|antacids|mesh-ancestor
761877|NCT02732249|Diuretics|diuretics|mesh-ancestor
761878|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
761879|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761880|NCT02732249|Expectorants|expectorants|mesh-ancestor
761881|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
761920|NCT02731664|Glucagon|glucagon|mesh-list
761921|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
761922|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
761923|NCT02731664|Hormones|hormones|mesh-ancestor
761924|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
761925|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761926|NCT02731664|Incretins|incretins|mesh-ancestor
762028|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
762029|NCT02731534|Hematinics|hematinics|mesh-ancestor
762104|NCT02731105|Clindamycin|clindamycin|mesh-list
762105|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
762106|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
2093536|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093537|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093538|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2093539|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093540|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
2093541|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2093542|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2093543|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2093544|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2093545|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093546|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
2093547|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093548|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093549|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2093550|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093551|NCT02261727|Prednisone|prednisone|mesh-list
761782|NCT02732236|Rituximab|rituximab|mesh-list
761783|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
761784|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761785|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
761786|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761787|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238370|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238371|NCT00092651|Simvastatin|simvastatin|mesh-list
2238372|NCT00092651|Ezetimibe|ezetimibe|mesh-list
762373|NCT02730026|Ketoprofen|ketoprofen|mesh-list
762374|NCT02730026|Omeprazole|omeprazole|mesh-list
762375|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
762376|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
762377|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
762378|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762379|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762380|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
762381|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
762382|NCT02730026|Analgesics|analgesics|mesh-ancestor
762383|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
762384|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
762385|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762386|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
762387|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
762388|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238373|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2238374|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
763193|NCT02726828|Morphine|morphine|mesh-list
763194|NCT02726828|Ketamine|ketamine|mesh-list
763195|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
763196|NCT02726828|Narcotics|narcotics|mesh-ancestor
763197|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
763198|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763199|NCT02726828|Analgesics|analgesics|mesh-ancestor
763200|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
763201|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763202|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
763203|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
763204|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
763205|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
763206|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
763207|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
763208|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763209|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093552|NCT02261727|Cortisone|cortisone|mesh-list
2093553|NCT02261727|Theophylline|theophylline|mesh-list
2093554|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093555|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
2093556|NCT02261727|Hormones|hormones|mesh-ancestor
2093557|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2093558|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093559|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
764222|NCT02723487|Bupivacaine|bupivacaine|mesh-list
764223|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
764224|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
764225|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764226|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764227|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
764228|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761794|NCT02732132|Fentanyl|fentanyl|mesh-list
761795|NCT02732132|Midazolam|midazolam|mesh-list
761796|NCT02732132|Ketamine|ketamine|mesh-list
761797|NCT02732132|Propofol|propofol|mesh-list
761798|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
761799|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761800|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761801|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
761802|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
761803|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
761804|NCT02732132|Analgesics|analgesics|mesh-ancestor
761805|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
761806|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761807|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
761808|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
761809|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
761810|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
761811|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761812|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
761813|NCT02732132|Narcotics|narcotics|mesh-ancestor
761814|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
761815|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
761816|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
761817|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2238375|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238376|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
2238377|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238378|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238379|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2238380|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238381|NCT00092664|Simvastatin|simvastatin|mesh-list
2238382|NCT00092664|Ezetimibe|ezetimibe|mesh-list
2238383|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238384|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238385|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
2238386|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238387|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238388|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2238389|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238390|NCT00092690|Atorvastatin|atorvastatin|mesh-list
2238391|NCT00092690|Simvastatin|simvastatin|mesh-list
2238392|NCT00092690|Ezetimibe|ezetimibe|mesh-list
2238393|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238394|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238395|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
2238396|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238397|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238398|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2238399|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238400|NCT00092703|Diclofenac|diclofenac|mesh-list
2238401|NCT00092703|Etoricoxib|etoricoxib|mesh-list
2238402|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2238403|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238404|NCT00092703|Analgesics|analgesics|mesh-ancestor
2238405|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
2238406|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
762015|NCT02731430|Morphine|morphine|mesh-list
762016|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
762017|NCT02731430|Narcotics|narcotics|mesh-ancestor
762018|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
762019|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762020|NCT02731430|Analgesics|analgesics|mesh-ancestor
762021|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
762022|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238407|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238408|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238409|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238410|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238411|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238412|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238413|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2238414|NCT00092716|Atorvastatin|atorvastatin|mesh-list
2238415|NCT00092716|Ezetimibe|ezetimibe|mesh-list
2238416|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238417|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238418|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
2238419|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238420|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238421|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2238422|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238423|NCT00092729|Naproxen|naproxen|mesh-list
2238424|NCT00092729|Etoricoxib|etoricoxib|mesh-list
2238425|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2238426|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
762790|NCT02728531|Cytarabine|cytarabine|mesh-list
762791|NCT02728531|Rituximab|rituximab|mesh-list
762792|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
762793|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
762794|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762795|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
762796|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762797|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
762798|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
762799|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
762800|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762801|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
762802|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
762803|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
763033|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
761201|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
761202|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
761203|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
761204|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
761205|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
761206|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
761207|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
761208|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
761209|NCT02734771|Hormones|hormones|mesh-ancestor
761210|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
761211|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
761546|NCT02733393|Lidocaine|lidocaine|mesh-list
761547|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
761548|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
761549|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761550|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761551|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
761552|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761553|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
761554|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
761555|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
761556|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
761557|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238427|NCT00092729|Analgesics|analgesics|mesh-ancestor
2238428|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
2238429|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238430|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238431|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238432|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
762665|NCT02728869|Vaccines|vaccines|mesh-list
762666|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
762667|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763301|NCT02726646|Doxycycline|doxycycline|mesh-list
763302|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
763303|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
763304|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
763305|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
763306|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
763511|NCT02725502|Linagliptin|linagliptin|mesh-list
763512|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
763513|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763514|NCT02725502|Incretins|incretins|mesh-ancestor
763515|NCT02725502|Hormones|hormones|mesh-ancestor
763516|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
763517|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
763518|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
763519|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
763520|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238433|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
2238434|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238435|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238436|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238437|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
764451|NCT02722603|Gabapentin|gabapentin|mesh-list
764452|NCT02722603|Tramadol|tramadol|mesh-list
764453|NCT02722603|Analgesics|analgesics|mesh-ancestor
764454|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
764455|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764456|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764457|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
764458|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
764459|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
764460|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764461|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
764462|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
764463|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
764464|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
764465|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764466|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
764467|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
764468|NCT02722603|Narcotics|narcotics|mesh-ancestor
764562|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
764563|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764564|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
2238438|NCT00092742|Diclofenac|diclofenac|mesh-list
2238439|NCT00092742|Etoricoxib|etoricoxib|mesh-list
2238440|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2238441|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238442|NCT00092742|Analgesics|analgesics|mesh-ancestor
2238443|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
2238444|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238445|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238446|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238447|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238448|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238449|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238450|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761820|NCT02732262|Oxycodone|oxycodone|mesh-list
761821|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
761822|NCT02732262|Narcotics|narcotics|mesh-ancestor
761823|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761824|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761825|NCT02732262|Analgesics|analgesics|mesh-ancestor
761826|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
761827|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238451|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2238452|NCT00092755|Ibuprofen|ibuprofen|mesh-list
2238453|NCT00092755|Etoricoxib|etoricoxib|mesh-list
762681|NCT02728843|Deferiprone|deferiprone|mesh-list
762682|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
762683|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
762684|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
762685|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093560|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093561|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2093562|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
2093563|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093564|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2093565|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
2093566|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2093567|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093568|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093569|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
2093570|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2093571|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2093572|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
2093573|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093574|NCT02261805|Doxorubicin|doxorubicin|mesh-list
2093575|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2093576|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093577|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2093578|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2238454|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
763085|NCT02727348|Anesthetics|anesthetics|mesh-list
763086|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
763087|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238455|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238456|NCT00092755|Analgesics|analgesics|mesh-ancestor
2238457|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
2238458|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238459|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238460|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238461|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238462|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238463|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238464|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238465|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2238466|NCT00092768|Celecoxib|celecoxib|mesh-list
2238467|NCT00092768|Etoricoxib|etoricoxib|mesh-list
2238468|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2238469|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238470|NCT00092768|Analgesics|analgesics|mesh-ancestor
2238471|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
2238472|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238473|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238474|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238475|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238476|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
763925|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
2238477|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238478|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238479|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238480|NCT00092781|Celecoxib|celecoxib|mesh-list
2238481|NCT00092781|Etoricoxib|etoricoxib|mesh-list
2238482|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2238483|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238484|NCT00092781|Analgesics|analgesics|mesh-ancestor
2238485|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
2238486|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238487|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238488|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238489|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238490|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2238491|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2238492|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238493|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238494|NCT00092807|Ezetimibe|ezetimibe|mesh-list
2238495|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
762009|NCT02731560|Rituximab|rituximab|mesh-list
762010|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
762011|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762012|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
762013|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762014|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
762044|NCT02731287|Timolol|timolol|mesh-list
762045|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
762046|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
762047|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
762048|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
762049|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762050|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762051|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
762052|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
762310|NCT02730676|Menthol|menthol|mesh-list
762311|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
762312|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
763287|NCT02726711|Trimethaphan|trimethaphan|mesh-list
763288|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
763289|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
763290|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
763291|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
763292|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
763293|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763294|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763295|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
763296|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
763297|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
763298|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763299|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763300|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
763637|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
763638|NCT02725177|Hormones|hormones|mesh-ancestor
763639|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
763640|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764578|NCT02722096|Lidocaine|lidocaine|mesh-list
764579|NCT02722096|Ropivacaine|ropivacaine|mesh-list
764580|NCT02722096|Anesthetics|anesthetics|mesh-list
764581|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
764582|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764583|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764584|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
764585|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764586|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2238496|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
761328|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761329|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
761330|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
761331|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
761332|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
761333|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
761334|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
761335|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
761464|NCT02733471|Lidocaine|lidocaine|mesh-list
761465|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
761466|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
761467|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761468|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761469|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
761470|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761471|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
761472|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
761473|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
761474|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
761475|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093579|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093580|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093581|NCT02261948|Simendan|simendan|mesh-list
2093582|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2093583|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
761671|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
761672|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
761673|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
761674|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
761675|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761676|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
761677|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
761678|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
761679|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
761738|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
761739|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
761740|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
761741|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
761742|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761743|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
761744|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
761745|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
761746|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
761747|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761748|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
761749|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
761750|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2238497|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
2238498|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238499|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238500|NCT00092820|Ezetimibe|ezetimibe|mesh-list
2238501|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238502|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238503|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
2238504|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238505|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238506|NCT00092833|Ezetimibe|ezetimibe|mesh-list
2238507|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238508|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238509|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
2238510|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238511|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238512|NCT00092846|Lovastatin|lovastatin|mesh-list
2238513|NCT00092846|L 647318|l 647318|mesh-list
2238514|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
2238515|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238516|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238517|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
2238518|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238519|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238520|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2238521|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093584|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2093585|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2093586|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093587|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093588|NCT02261948|Protective Agents|protective agents|mesh-ancestor
2093589|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761423|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
761424|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
761425|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
761426|NCT02733510|Prednisolone|prednisolone|mesh-list
761427|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
761428|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
761429|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
761430|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
761431|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
761432|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
761433|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761434|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761435|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
761436|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
761437|NCT02733510|Hormones|hormones|mesh-ancestor
761438|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
761439|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
761440|NCT02733510|Protective Agents|protective agents|mesh-ancestor
761441|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
761442|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761521|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
761522|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
761523|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
761645|NCT02732795|Morphine|morphine|mesh-list
761646|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
761647|NCT02732795|Narcotics|narcotics|mesh-ancestor
761648|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761649|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761650|NCT02732795|Analgesics|analgesics|mesh-ancestor
761651|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
761652|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238522|NCT00092885|Montelukast|montelukast|mesh-list
2238523|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2238524|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
762238|NCT02730624|Tazobactam|tazobactam|mesh-list
762239|NCT02730624|Piperacillin|piperacillin|mesh-list
762240|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
762241|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
762242|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
762243|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
762244|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762245|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762491|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
762492|NCT02729701|Estrogens|estrogens|mesh-list
762493|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
762494|NCT02729701|Hormones|hormones|mesh-ancestor
762495|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
762496|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762497|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
762498|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
762499|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
762500|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
762608|NCT02729467|Itraconazole|itraconazole|mesh-list
762609|NCT02729467|Rifampin|rifampin|mesh-list
762610|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
762611|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
762612|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
762613|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
762614|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762615|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762616|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
762617|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
762618|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
762619|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762620|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
762621|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
762622|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
761364|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
761365|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
761366|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761367|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
761368|NCT02733952|Coagulants|coagulants|mesh-ancestor
761533|NCT02733185|Vitamins|vitamins|mesh-list
761534|NCT02733185|Edetic Acid|edetic acid|mesh-list
761535|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
761536|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
761537|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761538|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
761539|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
761540|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
761541|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
761542|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761543|NCT02733185|Antidotes|antidotes|mesh-ancestor
761544|NCT02733185|Protective Agents|protective agents|mesh-ancestor
761545|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
762030|NCT02731378|Iron|iron|mesh-list
762031|NCT02731378|Dextrans|dextrans|mesh-list
762032|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
762033|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
762034|NCT02731378|Trace Elements|trace elements|mesh-ancestor
762035|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
762036|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762037|NCT02731378|Hematinics|hematinics|mesh-ancestor
762038|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
762039|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
762040|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
762455|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
762456|NCT02730546|Leucovorin|leucovorin|mesh-list
762457|NCT02730546|Folic Acid|folic acid|mesh-list
762458|NCT02730546|Paclitaxel|paclitaxel|mesh-list
762459|NCT02730546|Carboplatin|carboplatin|mesh-list
762460|NCT02730546|Fluorouracil|fluorouracil|mesh-list
762461|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
762462|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
762463|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
762464|NCT02730546|Calcium|calcium|mesh-list
762465|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
762466|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
762467|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762468|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
762469|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
762470|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
762471|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762472|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
762473|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762474|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
762475|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
762476|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
762477|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
762478|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
762479|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
762480|NCT02730546|Antidotes|antidotes|mesh-ancestor
762481|NCT02730546|Protective Agents|protective agents|mesh-ancestor
762482|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
762483|NCT02730546|Vitamins|vitamins|mesh-ancestor
762484|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
762485|NCT02730546|Hematinics|hematinics|mesh-ancestor
2238525|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2238526|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
2238527|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2238528|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238529|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2238530|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2238531|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238532|NCT00092898|Ezetimibe|ezetimibe|mesh-list
2238533|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
763521|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
763522|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
763523|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
763524|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763525|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763526|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
763527|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
763528|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
763529|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
763530|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761450|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
761451|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
761452|NCT02733705|Narcotics|narcotics|mesh-ancestor
761453|NCT02733705|Analgesics|analgesics|mesh-ancestor
761454|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
761455|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
761456|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2238534|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238535|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
2238536|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238537|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238538|NCT00092924|Mapatumumab|mapatumumab|mesh-list
2238539|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762102|NCT02731092|Lactoferrin|lactoferrin|mesh-list
762103|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2238540|NCT00092937|Busulfan|busulfan|mesh-list
2238541|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
2238542|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238543|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2238544|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
2238545|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238546|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2238547|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238548|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2238549|NCT00092963|Rizatriptan|rizatriptan|mesh-list
2238550|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2238551|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238552|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238553|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
762781|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
762785|NCT02728440|Menotropins|menotropins|mesh-list
762786|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
762787|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762788|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
762789|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
762922|NCT02727881|Squalamine|squalamine|mesh-list
762923|NCT02727881|Ranibizumab|ranibizumab|mesh-list
762924|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
762925|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
762926|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
762927|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
762928|NCT02727881|Growth Substances|growth substances|mesh-ancestor
762929|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762930|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
762931|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762932|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
762933|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
762934|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
762935|NCT02727881|Protective Agents|protective agents|mesh-ancestor
2238554|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
2238555|NCT00092976|Factor VIII|factor viii|mesh-list
2238556|NCT00092976|Coagulants|coagulants|mesh-ancestor
2238557|NCT00092989|Montelukast|montelukast|mesh-list
2238558|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2238559|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
2238560|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2238561|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
2238562|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2238563|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238564|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
763390|NCT02725736|Nifedipine|nifedipine|mesh-list
763391|NCT02725736|Atosiban|atosiban|mesh-list
763392|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
763393|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
763394|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763395|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
763396|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763397|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
763398|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
763399|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
761584|NCT02733432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
761585|NCT02733432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
761586|NCT02733432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761587|NCT02733432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
761588|NCT02733432|Hormone Antagonists|hormone antagonists|mesh-ancestor
761589|NCT02733432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
761590|NCT02733432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761591|NCT02733432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
761592|NCT02733432|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
762392|NCT02730117|Cephalosporins|cephalosporins|mesh-list
762393|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
762394|NCT02730117|Dobutamine|dobutamine|mesh-list
762395|NCT02730117|Dopamine|dopamine|mesh-list
762396|NCT02730117|Milrinone|milrinone|mesh-list
762397|NCT02730117|Norepinephrine|norepinephrine|mesh-list
762398|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
762399|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
762400|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
762401|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
762402|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
762403|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762404|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762405|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
762406|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
762407|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
762408|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
762409|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
762410|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
762411|NCT02730117|Protective Agents|protective agents|mesh-ancestor
762412|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
762413|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
762414|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
762415|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
762416|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
762417|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762418|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
763574|NCT02725242|Budesonide|budesonide|mesh-list
763575|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
763576|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
763577|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
763578|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
763579|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763580|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763581|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
763582|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
763583|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
763584|NCT02725242|Hormones|hormones|mesh-ancestor
763585|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
763586|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
763587|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
763588|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
763589|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
763590|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763591|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763859|NCT02724410|Amoxicillin|amoxicillin|mesh-list
763860|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
763861|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
763862|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
763863|NCT02724410|Ertapenem|ertapenem|mesh-list
763864|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
763865|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
763866|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
763867|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
761638|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
761639|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
761640|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
761641|NCT02733380|Growth Substances|growth substances|mesh-ancestor
761642|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
761643|NCT02733380|Analgesics|analgesics|mesh-ancestor
761644|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
762197|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
762198|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
762199|NCT02730715|Basiliximab|basiliximab|mesh-list
762200|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
762201|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762202|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2093590|NCT02261961|Vaccines|vaccines|mesh-list
2093591|NCT02261961|Immunologic Factors|immunologic factors|mesh-ancestor
2093592|NCT02261961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093593|NCT02262130|Omalizumab|omalizumab|mesh-list
2093594|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
762657|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
762658|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238565|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2238566|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238567|NCT00093002|Fulvestrant|fulvestrant|mesh-list
2238568|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2238569|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238570|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2238571|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
763019|NCT02727608|Eculizumab|eculizumab|mesh-list
763020|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
763021|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
763022|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
763023|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238572|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
2238573|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2238574|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238575|NCT00093028|Bortezomib|bortezomib|mesh-list
2238576|NCT00093028|Lenalidomide|lenalidomide|mesh-list
2238577|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238578|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
2238579|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238580|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2238581|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2238582|NCT00093028|Growth Substances|growth substances|mesh-ancestor
764474|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
764475|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
764476|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
764477|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
764478|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
764479|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764480|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764481|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
2238583|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
764742|NCT02721290|Ropivacaine|ropivacaine|mesh-list
764743|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
764744|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
764745|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764746|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764747|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
764748|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765152|NCT02719405|Caseins|caseins|mesh-list
765153|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
765154|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
765155|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765214|NCT02719132|Metformin|metformin|mesh-list
765215|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
765216|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
765217|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765218|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
765219|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765465|NCT02717858|Liraglutide|liraglutide|mesh-list
765466|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
765467|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765468|NCT02717858|Incretins|incretins|mesh-ancestor
765469|NCT02717858|Hormones|hormones|mesh-ancestor
765470|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
765549|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
761818|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
761819|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
762167|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
762168|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
762169|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
762170|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762171|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
762172|NCT02730845|Analgesics|analgesics|mesh-ancestor
762173|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
762174|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
762175|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
762176|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
762177|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
762178|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
762179|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
762180|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762232|NCT02730533|Esomeprazole|esomeprazole|mesh-list
762233|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
762234|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
762235|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
762236|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762237|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238584|NCT00093067|Daptomycin|daptomycin|mesh-list
2238585|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2238586|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2238587|NCT00093093|Interferons|interferons|mesh-list
2238588|NCT00093093|Ribavirin|ribavirin|mesh-list
2238589|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
2238590|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
2238591|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2093595|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2093596|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
2093597|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
2093598|NCT02262728|Simeprevir|simeprevir|mesh-list
2093599|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
2093600|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093601|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
2093602|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764347|NCT02722811|Etanercept|etanercept|mesh-list
764348|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
764349|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
764350|NCT02722811|Analgesics|analgesics|mesh-ancestor
764351|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
764352|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764353|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764354|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
764355|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
764356|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
764357|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
764358|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
764503|NCT02722369|Gemcitabine|gemcitabine|mesh-list
764504|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
764505|NCT02722369|Carboplatin|carboplatin|mesh-list
764506|NCT02722369|Etoposide|etoposide|mesh-list
764507|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764508|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
764509|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
764510|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764511|NCT02722369|Antiviral Agents|antiviral agents|mesh-ancestor
764512|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764513|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764514|NCT02722369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
764515|NCT02722369|Immunologic Factors|immunologic factors|mesh-ancestor
764516|NCT02722369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764517|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
764518|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
764519|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
764520|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
764521|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
764522|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
764523|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
765175|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
765176|NCT02719392|Minocycline|minocycline|mesh-list
765177|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
765178|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
765179|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093603|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238592|NCT00093093|Taribavirin|taribavirin|mesh-list
761835|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
761836|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
761837|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
761838|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
761839|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238593|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238594|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
762313|NCT02730442|Fluconazole|fluconazole|mesh-list
762314|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
762315|NCT02730442|Clotrimazole|clotrimazole|mesh-list
762316|NCT02730442|Miconazole|miconazole|mesh-list
762317|NCT02730442|Olorofim|olorofim|mesh-list
762318|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
762319|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
762320|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
762321|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762322|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762323|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
762324|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
762325|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
762326|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762327|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
762328|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
762329|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
762330|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
762427|NCT02730091|Letrozole|letrozole|mesh-list
762428|NCT02730091|Vinorelbine|vinorelbine|mesh-list
762429|NCT02730091|Anastrozole|anastrozole|mesh-list
762430|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762431|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
762432|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
762433|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762434|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762435|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
762436|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
762437|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
762438|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762439|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
762440|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
762441|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
762442|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
762443|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2238595|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2238596|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
2238597|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238598|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
2238599|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238600|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2238601|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763592|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
763593|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
763594|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
763595|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
763596|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763597|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
763598|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093604|NCT02262754|Naproxen|naproxen|mesh-list
2093605|NCT02262754|PF-06372865|pf-06372865|mesh-list
2093606|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2093607|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2093608|NCT02262754|Analgesics|analgesics|mesh-ancestor
2093609|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
2093610|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093611|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238602|NCT00093132|Satraplatin|satraplatin|mesh-list
2238603|NCT00093132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238604|NCT00093158|Anticoagulants|anticoagulants|mesh-list
2238605|NCT00093158|Bivalirudin|bivalirudin|mesh-list
2238606|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
2238607|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2238608|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
761959|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
761960|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
761961|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
761962|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
761963|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
761964|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
761965|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
761966|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
761967|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
761968|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
761969|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
761970|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
761971|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
761972|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
761973|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
761974|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
761975|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
761976|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
2238609|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238610|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238611|NCT00093184|Anticoagulants|anticoagulants|mesh-list
2238612|NCT00093184|Bivalirudin|bivalirudin|mesh-list
2238613|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
2238614|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2238615|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
2238616|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238617|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238618|NCT00093223|Paclitaxel|paclitaxel|mesh-list
2238619|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2238620|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2238621|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238622|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
2238623|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
2238624|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
2238625|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762605|NCT02729324|Protective Agents|protective agents|mesh-list
762606|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
762607|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762668|NCT02728934|Golimumab|golimumab|mesh-list
762669|NCT02728934|Infliximab|infliximab|mesh-list
762670|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
762671|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
762672|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
762673|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
762674|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
762675|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
762676|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
762677|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763271|NCT02726737|Lidocaine|lidocaine|mesh-list
763272|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
763273|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
763274|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
763275|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763276|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
763277|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763278|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
763279|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
763280|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
763281|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
763282|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763706|NCT02724904|Methotrexate|methotrexate|mesh-list
763707|NCT02724904|Fludarabine|fludarabine|mesh-list
2238626|NCT00093249|Clevidipine|clevidipine|mesh-list
2238627|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2238628|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
762129|NCT02730949|Folic Acid|folic acid|mesh-list
762130|NCT02730949|Inositol|inositol|mesh-list
762131|NCT02730949|Hematinics|hematinics|mesh-ancestor
762132|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
762133|NCT02730949|Vitamins|vitamins|mesh-ancestor
762134|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
762135|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762246|NCT02730481|Paclitaxel|paclitaxel|mesh-list
762247|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
762248|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762249|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
762250|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
762251|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
762252|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762509|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
762510|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
762511|NCT02729961|Ceritinib|ceritinib|mesh-list
762512|NCT02729961|Antibodies|antibodies|mesh-list
762513|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
762514|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
762515|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
762516|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
762517|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762518|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762519|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
762520|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762521|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238629|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238630|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2238631|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238632|NCT00093262|Clevidipine|clevidipine|mesh-list
2238633|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
763024|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
763025|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
763026|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
763027|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
763028|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
763029|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763030|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763031|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763781|NCT02724618|Curcumin|curcumin|mesh-list
763782|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
763783|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
763784|NCT02724618|Analgesics|analgesics|mesh-ancestor
763785|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
763786|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763787|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763788|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
763789|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
763790|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763791|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
763792|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764622|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
764623|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
764624|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2238634|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2238635|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238636|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2238637|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238638|NCT00093288|Bupropion|bupropion|mesh-list
2238639|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2238640|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
2238641|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2238642|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
764982|NCT02720367|Gemcitabine|gemcitabine|mesh-list
764983|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
764984|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
764985|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764986|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764987|NCT02720367|Antiviral Agents|antiviral agents|mesh-ancestor
764988|NCT02720367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764989|NCT02720367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238643|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2238644|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2238645|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238646|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
2238647|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2238648|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238649|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2238650|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2238651|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238652|NCT00093301|Simendan|simendan|mesh-list
2238653|NCT00093301|Dobutamine|dobutamine|mesh-list
2238654|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2238655|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
2238656|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2238657|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
762501|NCT02729766|Empagliflozin|empagliflozin|mesh-list
762502|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
762503|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762504|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
762505|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762578|NCT02729441|Ramipril|ramipril|mesh-list
762579|NCT02729441|Perindopril|perindopril|mesh-list
762580|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
762581|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
762582|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762583|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762584|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
762641|NCT02729064|Insulin|insulin|mesh-list
762642|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
762643|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
762644|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762813|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
762814|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
762815|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
762816|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
762817|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762818|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
762819|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
762849|NCT02727998|Midazolam|midazolam|mesh-list
762850|NCT02727998|Ketamine|ketamine|mesh-list
762851|NCT02727998|Analgesics|analgesics|mesh-ancestor
762852|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
762853|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
762854|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762855|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
762856|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
762857|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
762858|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
762859|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
762860|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
762861|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
762862|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
762863|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762864|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
762865|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
762866|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
762867|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
762868|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
762869|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
762870|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
2238658|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238659|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238660|NCT00093301|Protective Agents|protective agents|mesh-ancestor
2238661|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238662|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
2238663|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
2238664|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238665|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2238666|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2238667|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2238668|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
2238669|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2238670|NCT00093314|Ofatumumab|ofatumumab|mesh-list
2238671|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238672|NCT00093353|Cefixime|cefixime|mesh-list
2238673|NCT00093353|Irinotecan|irinotecan|mesh-list
2238674|NCT00093353|Temozolomide|temozolomide|mesh-list
2238675|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2238676|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2238677|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238678|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238679|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238680|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2238681|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
2238682|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2238683|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2238684|NCT00093366|Etanercept|etanercept|mesh-list
2238685|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
2238686|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2238687|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238688|NCT00093366|Analgesics|analgesics|mesh-ancestor
2238689|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
2238690|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238691|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238692|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238693|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238694|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2238695|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2238696|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
2238697|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238698|NCT00093418|Tipifarnib|tipifarnib|mesh-list
762253|NCT02730364|Acetaminophen|acetaminophen|mesh-list
762254|NCT02730364|Ascorbic Acid|ascorbic acid|mesh-list
762255|NCT02730364|Pheniramine|pheniramine|mesh-list
762256|NCT02730364|Phenylephrine|phenylephrine|mesh-list
762257|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
762258|NCT02730364|Vitamins|vitamins|mesh-ancestor
762259|NCT02730364|Micronutrients|micronutrients|mesh-ancestor
762260|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762261|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
762262|NCT02730364|Analgesics|analgesics|mesh-ancestor
762263|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
762264|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
762265|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
762266|NCT02730364|Antioxidants|antioxidants|mesh-ancestor
762267|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762268|NCT02730364|Protective Agents|protective agents|mesh-ancestor
762269|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
762270|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
762271|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
762272|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
762273|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
762274|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
762275|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
762276|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
762277|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
762278|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
762279|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
762280|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
762281|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
762282|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
762283|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
762284|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
762285|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
762286|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
763088|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
763089|NCT02727803|Melphalan|melphalan|mesh-list
763090|NCT02727803|Busulfan|busulfan|mesh-list
763091|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
763092|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
763093|NCT02727803|Rituximab|rituximab|mesh-list
763094|NCT02727803|Fludarabine|fludarabine|mesh-list
763095|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
763096|NCT02727803|Clofarabine|clofarabine|mesh-list
763097|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
763098|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
763099|NCT02727803|Antibodies|antibodies|mesh-list
763100|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
763101|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
763102|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
763103|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
763104|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763105|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
763106|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2238699|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762107|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
762108|NCT02731105|Tretinoin|tretinoin|mesh-list
762109|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
762110|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
762111|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
762112|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762113|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762114|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762115|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
762116|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
762117|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
762118|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
762119|NCT02731105|Analgesics|analgesics|mesh-ancestor
762120|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
762121|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
762122|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762123|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
762124|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
762331|NCT02730572|Methylphenidate|methylphenidate|mesh-list
762332|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
762333|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762334|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
762335|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
762336|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
762337|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762338|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
762339|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
762530|NCT02729805|Ketamine|ketamine|mesh-list
762531|NCT02729805|Analgesics|analgesics|mesh-ancestor
762532|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
762533|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
762534|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762535|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
762536|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
762537|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
762538|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
762539|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
762540|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
762541|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
762542|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
762543|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762806|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
762807|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
762808|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
762809|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
762810|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762811|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
762812|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763045|NCT02727309|Apatinib|apatinib|mesh-list
763046|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763047|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
763048|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
763049|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763536|NCT02725398|Scopolamine|scopolamine|mesh-list
763537|NCT02725398|Bromides|bromides|mesh-list
763538|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
763539|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
763540|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
763541|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
763542|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
763543|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763544|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763545|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
763546|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
763547|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
763548|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
763549|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763550|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763551|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
763552|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
763685|NCT02725099|Ticagrelor|ticagrelor|mesh-list
763686|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
763687|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2238700|NCT00093444|Doxorubicin|doxorubicin|mesh-list
2238701|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2238702|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2238703|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238704|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2238705|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2238706|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238707|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238708|NCT00093457|Sorafenib|sorafenib|mesh-list
2238709|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238710|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2238711|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238712|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238713|NCT00093483|Cytarabine|cytarabine|mesh-list
2238714|NCT00093483|Idarubicin|idarubicin|mesh-list
2238715|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
2238716|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
763001|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
763002|NCT02727621|Propofol|propofol|mesh-list
763003|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
763004|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
763005|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763006|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
763007|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
763008|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
763009|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
763010|NCT02727621|Analgesics|analgesics|mesh-ancestor
763011|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
763012|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763013|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
763014|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
763015|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
763016|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
763017|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763018|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763727|NCT02725112|Pregabalin|pregabalin|mesh-list
763728|NCT02725112|Analgesics|analgesics|mesh-ancestor
763729|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
763730|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763731|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763732|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
763733|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
763734|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
763735|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763736|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
763737|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
763738|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
763739|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
763740|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2093612|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093613|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093614|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
2093615|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2093616|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093617|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093618|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
2093619|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
2093620|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093621|NCT02263079|Interferons|interferons|mesh-list
2093622|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
2093623|NCT02263079|Lamivudine|lamivudine|mesh-list
2093624|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
2093625|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2093626|NCT02263079|Entecavir|entecavir|mesh-list
2093627|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093628|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
764856|NCT02720744|Sodium Oxybate|sodium oxybate|mesh-list
764857|NCT02720744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
764858|NCT02720744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
764859|NCT02720744|Anesthetics, General|anesthetics, general|mesh-ancestor
764860|NCT02720744|Anesthetics|anesthetics|mesh-ancestor
764861|NCT02720744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764862|NCT02720744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093629|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093630|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
2093631|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762527|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
762528|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
762529|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762602|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
762603|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762604|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762645|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
762773|NCT02728687|Mannitol|mannitol|mesh-list
762774|NCT02728687|Menthol|menthol|mesh-list
762775|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
762776|NCT02728687|Diuretics|diuretics|mesh-ancestor
762777|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
762778|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762779|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
762780|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
762936|NCT02727738|Selenium|selenium|mesh-list
762937|NCT02727738|Methimazole|methimazole|mesh-list
762938|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
762939|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762940|NCT02727738|Protective Agents|protective agents|mesh-ancestor
762941|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762942|NCT02727738|Trace Elements|trace elements|mesh-ancestor
762943|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
762944|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
762945|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
762946|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2238717|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238718|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2238719|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
2238720|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238721|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238722|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
2238723|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2238724|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2238725|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2238726|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2238727|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2238728|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238729|NCT00093509|Doxorubicin|doxorubicin|mesh-list
2238730|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2238731|NCT00093509|Ifosfamide|ifosfamide|mesh-list
2238732|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
2238733|NCT00093509|Mesna|mesna|mesh-list
2238734|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2238735|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238736|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2238737|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2238738|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238739|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238740|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2238741|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
2238742|NCT00093509|Protective Agents|protective agents|mesh-ancestor
2238743|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238744|NCT00093522|Fludarabine|fludarabine|mesh-list
2238745|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
2238746|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2238747|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238748|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2238749|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
2238750|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238751|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2238752|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
2238753|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238754|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2238755|NCT00093548|Vaccines|vaccines|mesh-list
2238756|NCT00093548|Sargramostim|sargramostim|mesh-list
2238757|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
2238758|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238759|NCT00093561|Lycopene|lycopene|mesh-list
2238760|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238761|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
2238762|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238763|NCT00093561|Protective Agents|protective agents|mesh-ancestor
2238764|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762556|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
762565|NCT02729285|Ketorolac|ketorolac|mesh-list
762566|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
762567|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
762568|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
762569|NCT02729285|Analgesics|analgesics|mesh-ancestor
762570|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
762571|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
762572|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762573|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
762574|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
762575|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
762576|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762577|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763320|NCT02726308|Dexamethasone|dexamethasone|mesh-list
763321|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
763322|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
763323|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
763324|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763325|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763326|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
763327|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
763328|NCT02726308|Hormones|hormones|mesh-ancestor
763329|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
763330|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
763331|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238765|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2238766|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2238767|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238768|NCT00093587|Cyclosporine|cyclosporine|mesh-list
2238769|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
2238770|NCT00093587|Busulfan|busulfan|mesh-list
2238771|NCT00093587|Cyclosporins|cyclosporins|mesh-list
2238772|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2238773|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2238774|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
2238775|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238776|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238777|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2238778|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
2238779|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238780|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238781|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2238782|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238783|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
2238784|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2238785|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
2238786|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2238787|NCT00093600|Cytarabine|cytarabine|mesh-list
764234|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
764235|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
764236|NCT02723266|Protective Agents|protective agents|mesh-ancestor
764237|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238788|NCT00093600|Daunorubicin|daunorubicin|mesh-list
2238789|NCT00093600|Midostaurin|midostaurin|mesh-list
2238790|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2238791|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
2238792|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238793|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238794|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
2238795|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2238796|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2753820|NCT02422641|Methotrexate|methotrexate|mesh-list
2753821|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2753822|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
2753823|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2238797|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
762623|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
762624|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
762625|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
762626|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
762627|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
762628|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
762629|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
762630|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
762631|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
762651|NCT02728947|Rotigotine|rotigotine|mesh-list
762652|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
762653|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
762654|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
762655|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762656|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762703|NCT02728518|Amikacin|amikacin|mesh-list
762704|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
762705|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
763641|NCT02725424|Docetaxel|docetaxel|mesh-list
763642|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
763643|NCT02725424|Trastuzumab|trastuzumab|mesh-list
763644|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763645|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
763646|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
763647|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
763648|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763649|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
763851|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
763852|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
763853|NCT02724358|Estrogens|estrogens|mesh-ancestor
763854|NCT02724358|Hormones|hormones|mesh-ancestor
763855|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
763856|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763857|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
763858|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764057|NCT02723955|Gemcitabine|gemcitabine|mesh-list
764058|NCT02723955|Paclitaxel|paclitaxel|mesh-list
764059|NCT02723955|Docetaxel|docetaxel|mesh-list
764060|NCT02723955|Carboplatin|carboplatin|mesh-list
764061|NCT02723955|Fluorouracil|fluorouracil|mesh-list
764062|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
764063|NCT02723955|Pemetrexed|pemetrexed|mesh-list
764064|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
764065|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764066|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
764067|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
764068|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
764069|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764070|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
764071|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
764072|NCT02723955|Antiviral Agents|antiviral agents|mesh-ancestor
764073|NCT02723955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764074|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764075|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
764076|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
764077|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764078|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
764079|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
764080|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
764211|NCT02723448|Aclarubicin|aclarubicin|mesh-list
764212|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
764213|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
764214|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764215|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
764216|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
764217|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764218|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764219|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
764220|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
764221|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238798|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238799|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2238800|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2238801|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2238802|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762632|NCT02729116|Ertapenem|ertapenem|mesh-list
762633|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
762634|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
762635|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
762636|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
762637|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
762638|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
762639|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762640|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
762871|NCT02728037|Lidocaine|lidocaine|mesh-list
762872|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
762873|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
762874|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
762875|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
762876|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762877|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
762878|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
762879|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
762880|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
762881|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
762882|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
762883|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
762884|NCT02728037|Analgesics|analgesics|mesh-ancestor
762885|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
762886|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
762887|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
762888|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
762889|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
764138|NCT02723838|Gemcitabine|gemcitabine|mesh-list
764139|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764140|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
764141|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
764142|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764143|NCT02723838|Antiviral Agents|antiviral agents|mesh-ancestor
764144|NCT02723838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764145|NCT02723838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764146|NCT02723838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
764147|NCT02723838|Immunologic Factors|immunologic factors|mesh-ancestor
764148|NCT02723838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765546|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
765547|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
765548|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238803|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2238804|NCT00093613|Sorafenib|sorafenib|mesh-list
2238805|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238806|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2238807|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238808|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238809|NCT00093626|Sorafenib|sorafenib|mesh-list
2238810|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238811|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2238812|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238813|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238814|NCT00093639|Everolimus|everolimus|mesh-list
765801|NCT02716285|Peppermint oil|peppermint oil|mesh-list
765802|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
765803|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
765804|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765805|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765806|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
765807|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
762763|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
762890|NCT02728245|Dienogest|dienogest|mesh-list
762891|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
762892|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
762893|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
762894|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
762895|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
762896|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
762897|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
762898|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
762899|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
762900|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
762901|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
762902|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238815|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
2238816|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238817|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2238818|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
2238819|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238820|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2238821|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238822|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238823|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
2238824|NCT00093652|Gefitinib|gefitinib|mesh-list
2238825|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238826|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
764303|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
764304|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
764305|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093632|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2093633|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2093634|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093635|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093636|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2093637|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2093638|NCT02263326|Lamivudine|lamivudine|mesh-list
2093639|NCT02263326|Dolutegravir|dolutegravir|mesh-list
2093640|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2093641|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2093642|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2093643|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093644|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093645|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
2093646|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093647|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2093648|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2093649|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2093650|NCT02263547|Teriflunomide|teriflunomide|mesh-list
2093651|NCT02263547|Colestipol|colestipol|mesh-list
2238827|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238828|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238829|NCT00093665|Fluorouracil|fluorouracil|mesh-list
2238830|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764895|NCT02720601|Capecitabine|capecitabine|mesh-list
764896|NCT02720601|Irinotecan|irinotecan|mesh-list
764897|NCT02720601|Camptothecin|camptothecin|mesh-list
764898|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
764899|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
764900|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764901|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764902|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
764903|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
764904|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764905|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
762804|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
762805|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
2093652|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2093653|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2093654|NCT02263547|Analgesics|analgesics|mesh-ancestor
2093655|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
2093656|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093657|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093658|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093659|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093660|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2093661|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
2093662|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2093663|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
2093664|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093665|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2093666|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
2093667|NCT02264353|Donepezil|donepezil|mesh-list
2093668|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2093669|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093670|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093671|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
2093672|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093673|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093674|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
763131|NCT02726984|Listerine|listerine|mesh-list
763132|NCT02726984|Fluorides|fluorides|mesh-list
763133|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
763134|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
763135|NCT02726984|Protective Agents|protective agents|mesh-ancestor
763136|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763137|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
763138|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
763307|NCT02726269|Ofloxacin|ofloxacin|mesh-list
763308|NCT02726269|Levofloxacin|levofloxacin|mesh-list
763309|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
763310|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
763311|NCT02726269|Renal Agents|renal agents|mesh-ancestor
763312|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
763313|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
763314|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
763315|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
763316|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763317|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763318|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
763319|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
763481|NCT02725918|Pemetrexed|pemetrexed|mesh-list
763482|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763483|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
763484|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763485|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
763486|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
765994|NCT02715531|Leucovorin|leucovorin|mesh-list
765995|NCT02715531|Gemcitabine|gemcitabine|mesh-list
765996|NCT02715531|Paclitaxel|paclitaxel|mesh-list
765997|NCT02715531|Bevacizumab|bevacizumab|mesh-list
765998|NCT02715531|Capecitabine|capecitabine|mesh-list
765999|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
766000|NCT02715531|Atezolizumab|atezolizumab|mesh-list
766001|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
766002|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766003|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
766004|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
766005|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
766006|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766007|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
766008|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
766009|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
766010|NCT02715531|Growth Substances|growth substances|mesh-ancestor
766011|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766012|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
766013|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
766014|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
766015|NCT02715531|Antiviral Agents|antiviral agents|mesh-ancestor
766016|NCT02715531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
766017|NCT02715531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
763034|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
763035|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
763036|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763037|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763038|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
763039|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
763040|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
763041|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
763042|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763043|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763044|NCT02727504|Protective Agents|protective agents|mesh-ancestor
763167|NCT02726854|Apatinib|apatinib|mesh-list
763168|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763169|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
763170|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
763171|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763226|NCT02726555|Atorvastatin|atorvastatin|mesh-list
763227|NCT02726555|Red yeast rice|red yeast rice|mesh-list
763228|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
763229|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
763230|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
763231|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763232|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
763233|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
763234|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238831|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
2238832|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238833|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2238834|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2238835|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
2238836|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238837|NCT00093678|Celecoxib|celecoxib|mesh-list
2238838|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2238839|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2238840|NCT00093678|Analgesics|analgesics|mesh-ancestor
2238841|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
2238842|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238843|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238844|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2238845|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238846|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2238847|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
765191|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
765192|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
765193|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238848|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238849|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765891|NCT02715960|Vitamin A|vitamin a|mesh-list
765892|NCT02715960|Tretinoin|tretinoin|mesh-list
765893|NCT02715960|Acitretin|acitretin|mesh-list
765894|NCT02715960|Vitamins|vitamins|mesh-ancestor
765895|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
765896|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765897|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765898|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
765899|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
766306|NCT02714361|Vitamin D|vitamin d|mesh-list
766307|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
766308|NCT02714361|Vitamins|vitamins|mesh-ancestor
766309|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
766310|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766311|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
766312|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2238850|NCT00093704|Ganciclovir|ganciclovir|mesh-list
2238851|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2238852|NCT00093704|Bortezomib|bortezomib|mesh-list
2238853|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238854|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
766971|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
766972|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
766973|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
766974|NCT02711449|Prednisolone|prednisolone|mesh-list
766975|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
766976|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
766977|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
766978|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
763107|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
763108|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763109|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763110|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
763111|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
763112|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
763139|NCT02726867|Lacosamide|lacosamide|mesh-list
763140|NCT02726867|Ketamine|ketamine|mesh-list
763141|NCT02726867|Levetiracetam|levetiracetam|mesh-list
763142|NCT02726867|Phenobarbital|phenobarbital|mesh-list
763143|NCT02726867|Analgesics|analgesics|mesh-ancestor
763144|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
763145|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763146|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763147|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
763148|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
763149|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
763150|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
763151|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
763152|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
763153|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
763154|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763155|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763156|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
763157|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
763158|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
763159|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
763160|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
763161|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
763162|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
763163|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
763164|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
763165|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
763166|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2238855|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2238856|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2238857|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238858|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238859|NCT00093743|Cyclosporine|cyclosporine|mesh-list
763763|NCT02724761|Epinephrine|epinephrine|mesh-list
763764|NCT02724761|Racepinephrine|racepinephrine|mesh-list
763765|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
763766|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
763767|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
763768|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
763769|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763770|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763771|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763772|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
763773|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
763774|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
763775|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763776|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
763777|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
763778|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
763779|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
763780|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
763839|NCT02724202|Curcumin|curcumin|mesh-list
763840|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
763841|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
763842|NCT02724202|Analgesics|analgesics|mesh-ancestor
763843|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
763844|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763845|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763846|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
763847|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
763848|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763849|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
763850|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763949|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
764169|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
764170|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
764171|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
764172|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764173|NCT02723669|Expectorants|expectorants|mesh-ancestor
763261|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
763262|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763263|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
763264|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
763265|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763266|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
763267|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
763268|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
763269|NCT02726581|Growth Substances|growth substances|mesh-ancestor
763270|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
2238860|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
2238861|NCT00093743|Fludarabine|fludarabine|mesh-list
2238862|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
2238863|NCT00093743|Cyclosporins|cyclosporins|mesh-list
2238864|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238865|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2238866|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
2238867|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238868|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2238869|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
2238870|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238871|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238872|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
2238873|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764759|NCT02721173|Clindamycin|clindamycin|mesh-list
764760|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
764761|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
764762|NCT02721173|Adapalene|adapalene|mesh-list
764763|NCT02721173|Tazarotene|tazarotene|mesh-list
764764|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
764765|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764766|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
764767|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764768|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764769|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
764770|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
764771|NCT02721173|Analgesics|analgesics|mesh-ancestor
764772|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
764773|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764774|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764775|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
764776|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
764777|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
764778|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
766115|NCT02714894|Clozapine|clozapine|mesh-list
766116|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
766117|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
766118|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
766119|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766120|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766121|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
766122|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
766123|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
766124|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
766125|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
766126|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
766717|NCT02712801|Ritonavir|ritonavir|mesh-list
766718|NCT02712801|Lopinavir|lopinavir|mesh-list
766719|NCT02712801|Lamivudine|lamivudine|mesh-list
766720|NCT02712801|Zidovudine|zidovudine|mesh-list
766721|NCT02712801|Nevirapine|nevirapine|mesh-list
766722|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
766723|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
766724|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
766725|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766726|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766727|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
766728|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
766729|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
766730|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
766731|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
766732|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
766733|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
766734|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
766735|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
2238874|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
2238875|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238876|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2238877|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2238878|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2238879|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
2238880|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
763650|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
763651|NCT02725164|Sevoflurane|sevoflurane|mesh-list
763652|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
763653|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
763654|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
763655|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
763656|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
763657|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763658|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
763659|NCT02725164|Analgesics|analgesics|mesh-ancestor
763660|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
763661|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2238881|NCT00093769|Rituximab|rituximab|mesh-list
2238882|NCT00093769|Bortezomib|bortezomib|mesh-list
2238883|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2238884|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238885|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
2238886|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238887|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238888|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
2238889|NCT00093834|Doxorubicin|doxorubicin|mesh-list
2238890|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2238891|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2238892|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
2238893|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238894|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2238895|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2238896|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
2238897|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238898|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238899|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2238900|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2238901|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2238902|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2238903|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238904|NCT00093860|Propranolol|propranolol|mesh-list
2238905|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2238906|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2238907|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
764269|NCT02723331|Gemcitabine|gemcitabine|mesh-list
764270|NCT02723331|Paclitaxel|paclitaxel|mesh-list
764271|NCT02723331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
764272|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
764273|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764274|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
764275|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
764276|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
764277|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764278|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
764279|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
764280|NCT02723331|Antiviral Agents|antiviral agents|mesh-ancestor
764281|NCT02723331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764282|NCT02723331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764283|NCT02723331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
764284|NCT02723331|Immunologic Factors|immunologic factors|mesh-ancestor
764285|NCT02723331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764431|NCT02722616|Pancrelipase|pancrelipase|mesh-list
764432|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
764664|NCT02721342|Ramipril|ramipril|mesh-list
764665|NCT02721342|Irbesartan|irbesartan|mesh-list
764666|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
764667|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
764668|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764669|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764670|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
764671|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
764672|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
764889|NCT02720471|Anesthetics|anesthetics|mesh-list
764890|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
765026|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
763400|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
763401|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
764163|NCT02723513|Xenon|xenon|mesh-list
764164|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
764165|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
764166|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
764167|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764168|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764238|NCT02723253|Raltitrexed|raltitrexed|mesh-list
764239|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764240|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
764241|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
764242|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764243|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
764244|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764306|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
764307|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
764308|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238908|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2238909|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238910|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238911|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2238912|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2238913|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
764694|NCT02721329|Acetaminophen|acetaminophen|mesh-list
764695|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
764696|NCT02721329|Analgesics|analgesics|mesh-ancestor
764697|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
764698|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764699|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764700|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
764709|NCT02721043|Lenalidomide|lenalidomide|mesh-list
764710|NCT02721043|Vaccines|vaccines|mesh-list
764711|NCT02721043|Poly ICLC|poly iclc|mesh-list
764712|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
764713|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764714|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
764715|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
764716|NCT02721043|Growth Substances|growth substances|mesh-ancestor
764717|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
764718|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764719|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
765114|NCT02719808|Tenofovir|tenofovir|mesh-list
765115|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
765116|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
765117|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
765118|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
765119|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765120|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765121|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
765122|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2238914|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
2238915|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2238916|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238917|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238918|NCT00093886|Clevidipine|clevidipine|mesh-list
2238919|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
2238920|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
2238921|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2238922|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2238923|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238924|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2238925|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766182|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
766183|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766184|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
766185|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766186|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766252|NCT02714231|Diclofenac|diclofenac|mesh-list
766253|NCT02714231|Scopolamine|scopolamine|mesh-list
766254|NCT02714231|Bromides|bromides|mesh-list
766255|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
766256|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
766257|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
766258|NCT02714231|Analgesics|analgesics|mesh-ancestor
2238926|NCT00093899|Simvastatin|simvastatin|mesh-list
2238927|NCT00093899|Ezetimibe|ezetimibe|mesh-list
2238928|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2238929|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238930|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
2238931|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238932|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2238933|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2238934|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238935|NCT00093912|Nitroprusside|nitroprusside|mesh-list
2238936|NCT00093912|Clevidipine|clevidipine|mesh-list
2238937|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2238938|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
2238939|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2238940|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238941|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2238942|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2238943|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2238944|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238945|NCT00093925|Nicardipine|nicardipine|mesh-list
2238946|NCT00093925|Clevidipine|clevidipine|mesh-list
2238947|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2238948|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
763869|NCT02724150|Omeprazole|omeprazole|mesh-list
763870|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
763871|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
763872|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
763873|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
763874|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763979|NCT02723903|Fluoxetine|fluoxetine|mesh-list
763980|NCT02723903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
763981|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
763982|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
763983|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763984|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763985|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
763986|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763987|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
763988|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
763989|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
763990|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
763991|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
763992|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764482|NCT02722421|Efavirenz|efavirenz|mesh-list
764483|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
764484|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
764485|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
764486|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764487|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764488|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
764489|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764490|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
764491|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
764492|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
764493|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
764494|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
764495|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
764496|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
764497|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
764498|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
764499|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764500|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
764501|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
764502|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
764682|NCT02721368|Lidocaine|lidocaine|mesh-list
764683|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
764684|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
764685|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764686|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764687|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
764688|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764689|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
763531|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763532|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
763533|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
763534|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
763535|NCT02725372|Protective Agents|protective agents|mesh-ancestor
764135|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
764136|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
764137|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764200|NCT02723461|Oxytocin|oxytocin|mesh-list
764201|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
764202|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
764203|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764367|NCT02722538|Gemcitabine|gemcitabine|mesh-list
764368|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
764369|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
764370|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764371|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764372|NCT02722538|Antiviral Agents|antiviral agents|mesh-ancestor
764373|NCT02722538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764374|NCT02722538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764375|NCT02722538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
764376|NCT02722538|Immunologic Factors|immunologic factors|mesh-ancestor
764377|NCT02722538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764524|NCT02722356|Oxytocin|oxytocin|mesh-list
764525|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
764526|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
764527|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764673|NCT02721420|Piperaquine|piperaquine|mesh-list
764674|NCT02721420|Artenimol|artenimol|mesh-list
764675|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
764676|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
764677|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
764678|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2238949|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2238950|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238951|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2238952|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238953|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
2238954|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
765270|NCT02718976|Lidocaine|lidocaine|mesh-list
765271|NCT02718976|Epinephrine|epinephrine|mesh-list
765272|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
765273|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
765274|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
765275|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
765276|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765277|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
765278|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765279|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
765280|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
765281|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
765282|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
765283|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765284|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
765285|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
765286|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
765287|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
765288|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
765289|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
765290|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
765291|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
765292|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
765293|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
765294|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
765295|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
765296|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
765297|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
2238955|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2238956|NCT00093951|Protective Agents|protective agents|mesh-ancestor
2238957|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238958|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
2238959|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
765827|NCT02716129|Morphine|morphine|mesh-list
765828|NCT02716129|Nalbuphine|nalbuphine|mesh-list
765829|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
765830|NCT02716129|Narcotics|narcotics|mesh-ancestor
763600|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
763601|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764029|NCT02724163|Cytarabine|cytarabine|mesh-list
764030|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
764031|NCT02724163|Busulfan|busulfan|mesh-list
764032|NCT02724163|Fludarabine|fludarabine|mesh-list
764033|NCT02724163|Daunorubicin|daunorubicin|mesh-list
764034|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
764035|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
764036|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
764037|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
764038|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764039|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
764040|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
764041|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
764042|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764043|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764044|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
764045|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
764046|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
764047|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
764048|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764049|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
764050|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
764051|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
764052|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764053|NCT02724163|Analgesics|analgesics|mesh-ancestor
764054|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
764055|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764056|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
764332|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
764333|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
764334|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
764335|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2238960|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2238961|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238962|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
2238963|NCT00093977|Hematinics|hematinics|mesh-ancestor
2238964|NCT00093990|Tipifarnib|tipifarnib|mesh-list
2238965|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093675|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
2093676|NCT02264574|Chlorambucil|chlorambucil|mesh-list
2093677|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2093678|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093679|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
765560|NCT02717780|Fentanyl|fentanyl|mesh-list
765561|NCT02717780|Remifentanil|remifentanil|mesh-list
765562|NCT02717780|Sevoflurane|sevoflurane|mesh-list
765563|NCT02717780|Desflurane|desflurane|mesh-list
765564|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
765565|NCT02717780|Narcotics|narcotics|mesh-ancestor
765566|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
765567|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765568|NCT02717780|Analgesics|analgesics|mesh-ancestor
765569|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
765570|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765571|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
765572|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
765573|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
765574|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
765575|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
765576|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
765963|NCT02715479|Dolutegravir|dolutegravir|mesh-list
765964|NCT02715479|BMS-955176|bms-955176|mesh-list
765965|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
765966|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
765967|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765968|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765969|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
765970|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
765971|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
765972|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
766161|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
766162|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
766163|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
766343|NCT02713945|Simvastatin|simvastatin|mesh-list
766344|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
766345|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2238966|NCT00094003|Poly I-C|poly i-c|mesh-list
764875|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
764876|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
764877|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764878|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764879|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
764880|NCT02720705|Analgesics|analgesics|mesh-ancestor
764881|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
764882|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764883|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
764884|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
764885|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
764886|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
764887|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
764888|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764940|NCT02720406|Ketamine|ketamine|mesh-list
764941|NCT02720406|Analgesics|analgesics|mesh-ancestor
764942|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
764943|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764944|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764945|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
764946|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
764947|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
764948|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
764949|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764950|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
764951|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
764952|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
764953|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238967|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
2238968|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2238969|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
2238970|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
2238971|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238972|NCT00094029|Sunitinib|sunitinib|mesh-list
2238973|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238974|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2238975|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2238976|NCT00094029|Growth Substances|growth substances|mesh-ancestor
2238977|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238978|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
2238979|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2238980|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2238981|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2238982|NCT00094081|Tirapazamine|tirapazamine|mesh-list
2238983|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238984|NCT00094120|Squalamine|squalamine|mesh-list
2238985|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2238986|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2238987|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
765350|NCT02718482|Gemcitabine|gemcitabine|mesh-list
765351|NCT02718482|Docetaxel|docetaxel|mesh-list
765352|NCT02718482|Ifosfamide|ifosfamide|mesh-list
765353|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
765354|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
765355|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
765356|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765357|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765358|NCT02718482|Antiviral Agents|antiviral agents|mesh-ancestor
765359|NCT02718482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
765360|NCT02718482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765361|NCT02718482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
765362|NCT02718482|Immunologic Factors|immunologic factors|mesh-ancestor
765363|NCT02718482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765364|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
765365|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
765366|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
765367|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
765368|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
765868|NCT02715947|Methotrexate|methotrexate|mesh-list
765869|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
765870|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
765871|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
765872|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238988|NCT00094120|Protective Agents|protective agents|mesh-ancestor
763622|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763623|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
763624|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763625|NCT02725359|Analgesics|analgesics|mesh-ancestor
763626|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
763627|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
763628|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
763629|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
763630|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
763631|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
763632|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
763633|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
763634|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
763635|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763636|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763830|NCT02724332|Sirolimus|sirolimus|mesh-list
763831|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
763832|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
763833|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
763834|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763835|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
763836|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
763837|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
763838|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764081|NCT02723994|Leucovorin|leucovorin|mesh-list
764082|NCT02723994|Cytarabine|cytarabine|mesh-list
764083|NCT02723994|Dexamethasone|dexamethasone|mesh-list
764084|NCT02723994|Prednisone|prednisone|mesh-list
764085|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
764086|NCT02723994|Doxorubicin|doxorubicin|mesh-list
764087|NCT02723994|Methotrexate|methotrexate|mesh-list
764088|NCT02723994|Vincristine|vincristine|mesh-list
764089|NCT02723994|Asparaginase|asparaginase|mesh-list
764090|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
764091|NCT02723994|Thioguanine|thioguanine|mesh-list
764092|NCT02723994|Pegaspargase|pegaspargase|mesh-list
764093|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
764094|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
764095|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
764096|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764097|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
764098|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
764099|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
764100|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764101|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764102|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
764103|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
764104|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
764105|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
764106|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764107|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
764108|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
764109|NCT02723994|Hormones|hormones|mesh-ancestor
764110|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
764111|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
764112|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
764113|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
764114|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
764115|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764116|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
764117|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
764118|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
764119|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
764120|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
764121|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
764122|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
764123|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
764124|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
764125|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764126|NCT02723994|Antidotes|antidotes|mesh-ancestor
764127|NCT02723994|Protective Agents|protective agents|mesh-ancestor
764128|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
764129|NCT02723994|Vitamins|vitamins|mesh-ancestor
764130|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
764131|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
764132|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
764133|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
764134|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
763688|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
763689|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
763690|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
763691|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763692|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763693|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763901|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
763902|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
763903|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
763904|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763905|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
763906|NCT02724098|Analgesics|analgesics|mesh-ancestor
763907|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
763908|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763909|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
763910|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
763911|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
763912|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
763913|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763914|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764255|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
764256|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
764257|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
764258|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
764259|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
764260|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764261|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764262|NCT02723279|Urological Agents|urological agents|mesh-ancestor
2238989|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2238990|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238991|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2238992|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2238993|NCT00094120|Growth Substances|growth substances|mesh-ancestor
2093680|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
2093681|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093682|NCT02264821|Morphine|morphine|mesh-list
764824|NCT02720926|Capecitabine|capecitabine|mesh-list
764825|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
764826|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
764827|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
764828|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764829|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2238994|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
2238995|NCT00094146|Octreotide|octreotide|mesh-list
2238996|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2238997|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2238998|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765209|NCT02719210|Mannitol|mannitol|mesh-list
765210|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
765211|NCT02719210|Diuretics|diuretics|mesh-ancestor
765212|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
765213|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765375|NCT02718261|Pantoprazole|pantoprazole|mesh-list
765376|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
765377|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
765378|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
765379|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765380|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765423|NCT02717923|Capecitabine|capecitabine|mesh-list
765424|NCT02717923|Cetuximab|cetuximab|mesh-list
765425|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
765426|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
765427|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765428|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765429|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
766057|NCT02715167|Budesonide|budesonide|mesh-list
766058|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
766059|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
766060|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
766061|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766062|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766063|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
766064|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
2238999|NCT00094289|Disulfiram|disulfiram|mesh-list
763708|NCT02724904|Thiotepa|thiotepa|mesh-list
763709|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
763710|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
763711|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
763712|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763713|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
763714|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
763715|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763716|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763717|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
763718|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
763719|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
763720|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
763721|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
763722|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
763723|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
763724|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
763725|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
763726|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2239000|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2239001|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2239002|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239003|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239004|NCT00094315|Cocaine|cocaine|mesh-list
2239005|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
2239006|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
2239007|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239008|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239009|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
2239010|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239011|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2239012|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2239013|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2239014|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2239015|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239016|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
2239017|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239018|NCT00094341|Etanercept|etanercept|mesh-list
764616|NCT02721888|Liraglutide|liraglutide|mesh-list
764617|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
764618|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764619|NCT02721888|Incretins|incretins|mesh-ancestor
764620|NCT02721888|Hormones|hormones|mesh-ancestor
764621|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
764830|NCT02720783|Econazole|econazole|mesh-list
764831|NCT02720783|Benzydamine|benzydamine|mesh-list
764832|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
764833|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
764834|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764835|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
764836|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
764837|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764838|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764839|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
764840|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
764841|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
764842|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765372|NCT02718469|Vaccines|vaccines|mesh-list
765373|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
765374|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765430|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
765431|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
765432|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
765433|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765434|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239019|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2239020|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2239021|NCT00094341|Analgesics|analgesics|mesh-ancestor
2239022|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
2239023|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239024|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239025|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
763742|NCT02725060|Isoproterenol|isoproterenol|mesh-list
763743|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
763744|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
763745|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
763746|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
763747|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
763748|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763749|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
763750|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
763751|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
763752|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
763753|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
763754|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
763755|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
763756|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
763757|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763758|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763759|NCT02725060|Protective Agents|protective agents|mesh-ancestor
763760|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
763761|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
763762|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
763950|NCT02723981|Vitamins|vitamins|mesh-list
763951|NCT02723981|Vitamin K|vitamin k|mesh-list
763952|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
763953|NCT02723981|Dabigatran|dabigatran|mesh-list
763954|NCT02723981|Anticoagulants|anticoagulants|mesh-list
763955|NCT02723981|Clopidogrel|clopidogrel|mesh-list
763956|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
763957|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
763958|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
763959|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
763960|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
763961|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
763962|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
763963|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
763964|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763965|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
763966|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
763967|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
763968|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
763969|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
763970|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
763971|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
763972|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
763973|NCT02723981|Coagulants|coagulants|mesh-ancestor
764286|NCT02723162|Acetylcysteine|acetylcysteine|mesh-list
764287|NCT02723162|Varenicline|varenicline|mesh-list
764288|NCT02723162|N-monoacetylcystine|n-monoacetylcystine|mesh-list
764289|NCT02723162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
764290|NCT02723162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
764291|NCT02723162|Cholinergic Agents|cholinergic agents|mesh-ancestor
764292|NCT02723162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
764293|NCT02723162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764294|NCT02723162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764295|NCT02723162|Antiviral Agents|antiviral agents|mesh-ancestor
764296|NCT02723162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764297|NCT02723162|Expectorants|expectorants|mesh-ancestor
764298|NCT02723162|Respiratory System Agents|respiratory system agents|mesh-ancestor
764299|NCT02723162|Free Radical Scavengers|free radical scavengers|mesh-ancestor
764300|NCT02723162|Antioxidants|antioxidants|mesh-ancestor
764301|NCT02723162|Protective Agents|protective agents|mesh-ancestor
764302|NCT02723162|Antidotes|antidotes|mesh-ancestor
764419|NCT02722772|Etanercept|etanercept|mesh-list
764420|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
764421|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
764422|NCT02722772|Analgesics|analgesics|mesh-ancestor
764423|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
764424|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764425|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764426|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
764427|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
764428|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
764429|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
764430|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
2093683|NCT02264821|Ropivacaine|ropivacaine|mesh-list
2093684|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
2093685|NCT02264821|Anesthetics|anesthetics|mesh-list
2093686|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2093687|NCT02264821|Narcotics|narcotics|mesh-ancestor
763868|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764149|NCT02723500|Xenon|xenon|mesh-list
764150|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
764151|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
764152|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
764153|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764154|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764378|NCT02722746|Epinephrine|epinephrine|mesh-list
764379|NCT02722746|Ropivacaine|ropivacaine|mesh-list
764380|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
764381|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
764382|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764383|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764384|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
764385|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764386|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
764387|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
764388|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
764389|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
764390|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764391|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
764392|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
764393|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
764394|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
764395|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
764396|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
764397|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
764398|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
764815|NCT02720770|Hormones|hormones|mesh-list
764816|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
764817|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239026|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2239027|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2239028|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2239029|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
2239030|NCT00094367|Lamivudine|lamivudine|mesh-list
2239031|NCT00094367|Abacavir|abacavir|mesh-list
765316|NCT02718677|Factor VIII|factor viii|mesh-list
765317|NCT02718677|Coagulants|coagulants|mesh-ancestor
766213|NCT02714842|Diclofenac|diclofenac|mesh-list
766214|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
766215|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
766216|NCT02714842|Analgesics|analgesics|mesh-ancestor
766217|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
766218|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766219|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766220|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
766221|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
766222|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
766223|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766224|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766395|NCT02713893|Econazole|econazole|mesh-list
766396|NCT02713893|Benzydamine|benzydamine|mesh-list
766397|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
766398|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
766399|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
766400|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
766401|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
766402|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766403|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766404|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
766405|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
766406|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
766407|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766806|NCT02712307|Penicillins|penicillins|mesh-list
766807|NCT02712307|Penicillin V|penicillin v|mesh-list
766808|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
766809|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767109|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
767110|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
767111|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767331|NCT02710305|Lidocaine|lidocaine|mesh-list
767332|NCT02710305|Scopolamine|scopolamine|mesh-list
767333|NCT02710305|Bromides|bromides|mesh-list
767334|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
763926|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
763927|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
763928|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
763929|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
763930|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
763931|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
763932|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
763933|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
763934|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
764263|NCT02723435|Midostaurin|midostaurin|mesh-list
764264|NCT02723435|Staurosporine|staurosporine|mesh-list
764265|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764266|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
764267|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764268|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093688|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2093689|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093690|NCT02264821|Analgesics|analgesics|mesh-ancestor
2093691|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
2093692|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093693|NCT02264990|Paclitaxel|paclitaxel|mesh-list
2093694|NCT02264990|Carboplatin|carboplatin|mesh-list
2093695|NCT02264990|Pemetrexed|pemetrexed|mesh-list
2093696|NCT02264990|Veliparib|veliparib|mesh-list
2093697|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
765206|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
765207|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
765208|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2093698|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093699|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
2093700|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
2093701|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
2093702|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093703|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093704|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2093705|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2093706|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2093707|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
2093708|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2093709|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
2093710|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093711|NCT02265224|Expectorants|expectorants|mesh-ancestor
2093712|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
2093713|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2093714|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
2093715|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093716|NCT02265224|Protective Agents|protective agents|mesh-ancestor
2239032|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
765577|NCT02717819|Vitamin D|vitamin d|mesh-list
765578|NCT02717819|Vitamins|vitamins|mesh-ancestor
765579|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
765580|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765581|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
765739|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
765740|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
765741|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765836|NCT02716233|Pegaspargase|pegaspargase|mesh-list
765837|NCT02716233|Asparaginase|asparaginase|mesh-list
765838|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239033|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2239034|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239035|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239036|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
2239037|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239038|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
766632|NCT02712866|Vedolizumab|vedolizumab|mesh-list
766633|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
766674|NCT02712658|Terbutaline|terbutaline|mesh-list
766675|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
766676|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
766677|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766678|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766679|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
766680|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
766681|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
764174|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
764175|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
764176|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
764177|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764178|NCT02723669|Protective Agents|protective agents|mesh-ancestor
764179|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764180|NCT02723669|Antidotes|antidotes|mesh-ancestor
764407|NCT02722733|Cytarabine|cytarabine|mesh-list
764408|NCT02722733|Lenograstim|lenograstim|mesh-list
764409|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
764410|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
764411|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764412|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
764413|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
764414|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764415|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764416|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
764417|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764418|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2239039|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2239040|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
2239041|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2239042|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
2239043|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239044|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2239045|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2239046|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
2239047|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239048|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239049|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2239050|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
2239051|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
2239052|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239053|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
2239054|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239055|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239056|NCT00094432|Aripiprazole|aripiprazole|mesh-list
2239057|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
2239058|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239059|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2239060|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2239061|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
765298|NCT02718911|Durvalumab|durvalumab|mesh-list
765299|NCT02718911|Tremelimumab|tremelimumab|mesh-list
765300|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
765301|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093717|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093718|NCT02265224|Antidotes|antidotes|mesh-ancestor
2093719|NCT02265237|Ritonavir|ritonavir|mesh-list
2093720|NCT02265237|Ribavirin|ribavirin|mesh-list
2093721|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
765761|NCT02716415|Menthol|menthol|mesh-list
765762|NCT02716415|Petrolatum|petrolatum|mesh-list
765763|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
765764|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
765765|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
765766|NCT02716415|Emollients|emollients|mesh-ancestor
765767|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
765768|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
765769|NCT02716415|Protective Agents|protective agents|mesh-ancestor
765770|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239062|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239063|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
2239064|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
2239065|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239066|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239067|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2239068|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2239069|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
2239070|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2239071|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2239072|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2093722|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2093723|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
766979|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
2093724|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239073|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2239074|NCT00094484|Cinacalcet|cinacalcet|mesh-list
2239075|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2239076|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239077|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2239078|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
2239079|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2239080|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
2239081|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2239082|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2239083|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
2239084|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239085|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239086|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2239087|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2239088|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
2239089|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239090|NCT00094549|Valproic Acid|valproic acid|mesh-list
2239091|NCT00094549|Olanzapine|olanzapine|mesh-list
2239092|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
764528|NCT02722343|Tenofovir|tenofovir|mesh-list
764529|NCT02722343|Emtricitabine|emtricitabine|mesh-list
764530|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
764531|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
764532|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
764533|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
764534|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
764535|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764536|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764537|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
764538|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
764790|NCT02720991|Misoprostol|misoprostol|mesh-list
764791|NCT02720991|Mifepristone|mifepristone|mesh-list
764792|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
764793|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
764794|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
764795|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764796|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
764797|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
764798|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
764799|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
764800|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
764801|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
764802|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
764803|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
764804|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
764805|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
764806|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
764807|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
764808|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
764809|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
764810|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
765334|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
765335|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
765336|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
765337|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239093|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
2239094|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239095|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239096|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2239097|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2239098|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2239099|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239100|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239101|NCT00094549|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2239102|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2239103|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2239104|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239105|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239106|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
2239107|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
2239108|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766980|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
2239109|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
2239110|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
2239111|NCT00094614|Atropine|atropine|mesh-list
2239112|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2239113|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2239114|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2239115|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
2239116|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239117|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765168|NCT02719418|Tinzaparin|tinzaparin|mesh-list
765169|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
765170|NCT02719418|Dalteparin|dalteparin|mesh-list
765171|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
765172|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
765173|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
765174|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765302|NCT02718755|Vidarabine|vidarabine|mesh-list
765303|NCT02718755|Cytarabine|cytarabine|mesh-list
765304|NCT02718755|Fludarabine|fludarabine|mesh-list
765305|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
765306|NCT02718755|Asparaginase|asparaginase|mesh-list
765307|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765308|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
765309|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
765310|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765311|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
765312|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
765313|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765314|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
765315|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
766088|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
766089|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
766090|NCT02715232|Lynestrenol|lynestrenol|mesh-list
766091|NCT02715232|Estradiol|estradiol|mesh-list
766092|NCT02715232|Testosterone|testosterone|mesh-list
766093|NCT02715232|Cyproterone|cyproterone|mesh-list
766094|NCT02715232|Estrogens|estrogens|mesh-ancestor
766095|NCT02715232|Hormones|hormones|mesh-ancestor
766096|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
766097|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766098|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
766099|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
766100|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
766101|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
766102|NCT02715232|Androgens|androgens|mesh-ancestor
766103|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
766104|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766105|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
766106|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
766107|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
766108|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
766109|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
766110|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
766111|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2239118|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2239119|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
2239120|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
2239121|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
2239122|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2239123|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2239124|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
2239125|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239126|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767363|NCT02710318|Vaccines|vaccines|mesh-list
767364|NCT02710318|Immunologic Factors|immunologic factors|mesh-ancestor
767365|NCT02710318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239127|NCT00094627|Gaboxadol|gaboxadol|mesh-list
764445|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
764446|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
764447|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
764448|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
764449|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
764450|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
764634|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
764635|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
764636|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764704|NCT02721433|Denosumab|denosumab|mesh-list
764705|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
764706|NCT02721433|Pamidronate|pamidronate|mesh-list
764707|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
764708|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764916|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
764917|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764918|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765189|NCT02719431|Warfarin|warfarin|mesh-list
765190|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
2239128|NCT00094627|Analgesics|analgesics|mesh-ancestor
2239129|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
2239130|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239131|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239132|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
2239133|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
2239134|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
2239135|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239136|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239137|NCT00094640|Olanzapine|olanzapine|mesh-list
766390|NCT02713841|Insulin|insulin|mesh-list
766391|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
766392|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
766393|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
766394|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766578|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
766579|NCT02713074|Povidone|povidone|mesh-list
766580|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
766581|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
766582|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
766583|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239138|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
2239139|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
2239140|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239141|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239142|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2239143|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2239144|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2239145|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239146|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239147|NCT00094640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2239148|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
767511|NCT02709590|Diclofenac|diclofenac|mesh-list
767512|NCT02709590|Lidocaine|lidocaine|mesh-list
767513|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
767514|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
767515|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767516|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767517|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
767518|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767519|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
767520|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
767521|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
767522|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
767523|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767524|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
767525|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
767526|NCT02709590|Analgesics|analgesics|mesh-ancestor
767527|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
767528|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
767529|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
767530|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767938|NCT02707913|Amlodipine|amlodipine|mesh-list
767939|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
767940|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
767941|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
768093|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
764560|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
764561|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
764818|NCT02720965|Anesthetics|anesthetics|mesh-list
764819|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
764820|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764821|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764822|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
764823|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239149|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2239150|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239151|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239152|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
2239153|NCT00094666|Gaboxadol|gaboxadol|mesh-list
2239154|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239155|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239156|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239157|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239158|NCT00094666|Analgesics|analgesics|mesh-ancestor
2239159|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
2239160|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
2239161|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
2239162|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
2239163|NCT00094692|Atropine|atropine|mesh-list
2239164|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2239165|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2239166|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
765440|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
765441|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
765442|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
765443|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093725|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093726|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2239167|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
765771|NCT02716428|Ribavirin|ribavirin|mesh-list
765772|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
765773|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765774|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
765775|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
765839|NCT02716090|Adapalene|adapalene|mesh-list
765840|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
765841|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
765842|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
765843|NCT02716090|Analgesics|analgesics|mesh-ancestor
765844|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
765845|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765846|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765847|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
765848|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
765849|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
766763|NCT02712502|Amoxicillin|amoxicillin|mesh-list
766764|NCT02712502|Levofloxacin|levofloxacin|mesh-list
766765|NCT02712502|Ofloxacin|ofloxacin|mesh-list
766766|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
766767|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
766768|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
766769|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
766770|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
766771|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
766772|NCT02712502|Renal Agents|renal agents|mesh-ancestor
766773|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
766774|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
766775|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766776|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766777|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766778|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
766779|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
766780|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
766836|NCT02711943|Levofloxacin|levofloxacin|mesh-list
766837|NCT02711943|Ofloxacin|ofloxacin|mesh-list
766838|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
766839|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
766840|NCT02711943|Renal Agents|renal agents|mesh-ancestor
766841|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
767162|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
764565|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
764566|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
764567|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
764568|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
764569|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
764570|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764571|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
764786|NCT02720978|Oxytocin|oxytocin|mesh-list
764787|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
764788|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
764789|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765017|NCT02720094|Cabotegravir|cabotegravir|mesh-list
765018|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
765019|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
765020|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765021|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765022|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
765023|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
765024|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
765025|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
765471|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
765472|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
765473|NCT02717871|Levofloxacin|levofloxacin|mesh-list
765474|NCT02717871|Ofloxacin|ofloxacin|mesh-list
765475|NCT02717871|Gentamicins|gentamicins|mesh-list
765476|NCT02717871|Cefazolin|cefazolin|mesh-list
765477|NCT02717871|Tobramycin|tobramycin|mesh-list
765478|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
765479|NCT02717871|Besifloxacin|besifloxacin|mesh-list
765480|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
765481|NCT02717871|Prednisolone|prednisolone|mesh-list
765482|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
765483|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
765484|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
765485|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
765486|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
765487|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
765488|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
765489|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
765490|NCT02717871|Mydriatics|mydriatics|mesh-list
765491|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
765492|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
765493|NCT02717871|Hormones|hormones|mesh-ancestor
765494|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
765495|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765496|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
765497|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765498|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
765499|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
765500|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765501|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
765502|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
765503|NCT02717871|Protective Agents|protective agents|mesh-ancestor
765504|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
765505|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
765506|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
765507|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
765508|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765509|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765510|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
765511|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
765512|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
765513|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
765514|NCT02717871|Renal Agents|renal agents|mesh-ancestor
765515|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
765516|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
765517|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
765518|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
765519|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
765520|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
765521|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
765603|NCT02717364|Ipilimumab|ipilimumab|mesh-list
765604|NCT02717364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
765605|NCT02717364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765606|NCT02717364|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
765607|NCT02717364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765661|NCT02716974|Docetaxel|docetaxel|mesh-list
765662|NCT02716974|Leuprolide|leuprolide|mesh-list
764587|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
764588|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
764589|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
764590|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764701|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
764702|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
764703|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
764924|NCT02720575|Vitamin D|vitamin d|mesh-list
764925|NCT02720575|Vitamins|vitamins|mesh-ancestor
764926|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
764927|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764928|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
765107|NCT02719834|Acetaminophen|acetaminophen|mesh-list
765108|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
765109|NCT02719834|Analgesics|analgesics|mesh-ancestor
765110|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
765111|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765112|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765113|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
2239168|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239169|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239170|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2239171|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
2239172|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
2239173|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
2239174|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2239175|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2239176|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
2239177|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
765346|NCT02718404|Analgesics|analgesics|mesh-list
765347|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
765348|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765349|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093727|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2093728|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
2093729|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093730|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2093731|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2239178|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239179|NCT00094848|Mapatumumab|mapatumumab|mesh-list
2239180|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239181|NCT00094926|Risperidone|risperidone|mesh-list
2239182|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2239183|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
2239184|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239185|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239186|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239187|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2239188|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2239189|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239190|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239191|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2239192|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
2239193|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
766408|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
766409|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
766410|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766584|NCT02713087|Phenylephrine|phenylephrine|mesh-list
766585|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
766586|NCT02713087|Ephedrine|ephedrine|mesh-list
766587|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
766588|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
766589|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
766590|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766591|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766592|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
766593|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
766594|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
766595|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
766596|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
766597|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
766598|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
766599|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
766600|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239194|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239195|NCT00094978|Alvocidib|alvocidib|mesh-list
2093732|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
764929|NCT02720822|Morphine|morphine|mesh-list
764930|NCT02720822|Laxatives|laxatives|mesh-list
764931|NCT02720822|Cathartics|cathartics|mesh-list
764932|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
764933|NCT02720822|Narcotics|narcotics|mesh-ancestor
764934|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764935|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764936|NCT02720822|Analgesics|analgesics|mesh-ancestor
764937|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
764938|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764939|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2239196|NCT00094978|Romidepsin|romidepsin|mesh-list
2239197|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239198|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
765444|NCT02717884|Cytarabine|cytarabine|mesh-list
765445|NCT02717884|Tretinoin|tretinoin|mesh-list
765446|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
765447|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
765448|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
765449|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765450|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765451|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
765452|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
765453|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
765454|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
765455|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765456|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
765457|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
765458|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
765459|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
765460|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
765461|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765462|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
765463|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
765464|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2093733|NCT02265341|Ponatinib|ponatinib|mesh-list
2093734|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093735|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2093736|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093737|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093738|NCT02265510|Gemcitabine|gemcitabine|mesh-list
2093739|NCT02265510|Dexamethasone|dexamethasone|mesh-list
2093740|NCT02265510|Paclitaxel|paclitaxel|mesh-list
2093741|NCT02265510|Lenalidomide|lenalidomide|mesh-list
2093742|NCT02265510|Bortezomib|bortezomib|mesh-list
2093743|NCT02265510|Azacitidine|azacitidine|mesh-list
2093744|NCT02265510|Pomalidomide|pomalidomide|mesh-list
2093745|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
766025|NCT02714998|Methotrexate|methotrexate|mesh-list
766026|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
766027|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
766028|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
766029|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766030|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
766031|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
766032|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766033|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766034|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
766035|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766036|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
766037|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
766038|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
766039|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
766040|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
766331|NCT02714036|Ibudilast|ibudilast|mesh-list
766332|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
766333|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
766334|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766335|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766336|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
766337|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
766338|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
766339|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766340|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766346|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
2093746|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239199|NCT00094978|Growth Substances|growth substances|mesh-ancestor
764660|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
764661|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764662|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
764663|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
764779|NCT02721186|Piperaquine|piperaquine|mesh-list
764780|NCT02721186|Primaquine|primaquine|mesh-list
764781|NCT02721186|Artenimol|artenimol|mesh-list
764782|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
764783|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
764784|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
764785|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
765094|NCT02719756|Metformin|metformin|mesh-list
765095|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
765096|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
765097|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765098|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
765099|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765338|NCT02718742|Paclitaxel|paclitaxel|mesh-list
765339|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
765340|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
765341|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765342|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
765343|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
765344|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
765345|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239200|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239201|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
766787|NCT02712476|Furosemide|furosemide|mesh-list
766788|NCT02712476|Mannitol|mannitol|mesh-list
766789|NCT02712476|Diuretics|diuretics|mesh-ancestor
766790|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
766791|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766792|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
766793|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
766794|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766795|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
766880|NCT02711735|Vaccines|vaccines|mesh-list
766881|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
766882|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767271|NCT02710552|Amlodipine|amlodipine|mesh-list
767272|NCT02710552|Perindopril|perindopril|mesh-list
767273|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
767274|NCT02710552|Indapamide|indapamide|mesh-list
767275|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
767276|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
767277|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767278|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
767279|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767280|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
767281|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
767282|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
767283|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767284|NCT02710552|Diuretics|diuretics|mesh-ancestor
767285|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
767286|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2239202|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239203|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239204|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
767631|NCT02709265|Amikacin|amikacin|mesh-list
767632|NCT02709265|Fosfomycin|fosfomycin|mesh-list
767633|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
767634|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767967|NCT02707458|Probucol|probucol|mesh-list
767968|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
767969|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
767970|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
767971|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767972|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
767973|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
767974|NCT02707458|Protective Agents|protective agents|mesh-ancestor
767975|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768089|NCT02707315|Gemcitabine|gemcitabine|mesh-list
768090|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
768091|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
768092|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764690|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
764691|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
764692|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
764693|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765004|NCT02720341|Armin|armin|mesh-list
765005|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
765006|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765007|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765008|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
765009|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
765010|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765677|NCT02717052|Ketamine|ketamine|mesh-list
765678|NCT02717052|Esketamine|esketamine|mesh-list
765679|NCT02717052|Analgesics|analgesics|mesh-ancestor
765680|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
765681|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765682|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765683|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
765684|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
765685|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
765686|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
765687|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
765688|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
765689|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
765690|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
765691|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765692|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
765693|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
765913|NCT02716012|Sorafenib|sorafenib|mesh-list
765914|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765915|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
765916|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765917|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766054|NCT02715193|Volagidemab|volagidemab|mesh-list
766055|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
766056|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766164|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
766165|NCT02714725|Propofol|propofol|mesh-list
766166|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
766167|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
766168|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766169|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
766170|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
766171|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
766172|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
766173|NCT02714725|Analgesics|analgesics|mesh-ancestor
766174|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
766175|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766176|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
766177|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
766178|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
766179|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
766180|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
766181|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239205|NCT00095004|Rizatriptan|rizatriptan|mesh-list
2239206|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239207|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239208|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239209|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2239210|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
2239211|NCT00095017|Etoricoxib|etoricoxib|mesh-list
2239212|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2239213|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2239214|NCT00095017|Analgesics|analgesics|mesh-ancestor
2239215|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
2239216|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239217|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239218|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
766634|NCT02712944|Testosterone|testosterone|mesh-list
766635|NCT02712944|Androgens|androgens|mesh-ancestor
766636|NCT02712944|Hormones|hormones|mesh-ancestor
766637|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
766638|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239219|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2239220|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2239221|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2239222|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239223|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239224|NCT00095043|Gaboxadol|gaboxadol|mesh-list
2239225|NCT00095043|Analgesics|analgesics|mesh-ancestor
2239226|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
2239227|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239228|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239229|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
2239230|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
765850|NCT02716038|Paclitaxel|paclitaxel|mesh-list
765851|NCT02716038|Carboplatin|carboplatin|mesh-list
765852|NCT02716038|Atezolizumab|atezolizumab|mesh-list
765853|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
765854|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765855|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
765856|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
765857|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
765858|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239231|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
2239232|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239233|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239234|NCT00095069|Gaboxadol|gaboxadol|mesh-list
2239235|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239236|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239237|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239238|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239239|NCT00095069|Analgesics|analgesics|mesh-ancestor
2239240|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
2239241|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
2239242|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
2239243|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
766225|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
766226|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
766227|NCT02714543|Antioxidants|antioxidants|mesh-list
766228|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
766229|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
766230|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
766231|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766232|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
766233|NCT02714543|Protective Agents|protective agents|mesh-ancestor
766234|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766296|NCT02714179|Acetaminophen|acetaminophen|mesh-list
766297|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
766298|NCT02714179|Analgesics|analgesics|mesh-ancestor
766299|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
766300|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766301|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766302|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
766738|NCT02712723|Letrozole|letrozole|mesh-list
766739|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766740|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
766741|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
766742|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766743|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766744|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
766745|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
766746|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
766747|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766796|NCT02712125|Isosorbide|isosorbide|mesh-list
766797|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
764750|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
764751|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
764752|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764753|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764754|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
764755|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
764756|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
764757|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
764758|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
764843|NCT02720692|Meloxicam|meloxicam|mesh-list
764844|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
764845|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
764846|NCT02720692|Analgesics|analgesics|mesh-ancestor
764847|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
764848|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
764849|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764850|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
764851|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
764852|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
764853|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
764854|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
764855|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765100|NCT02719795|Ropivacaine|ropivacaine|mesh-list
765101|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
765102|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
765103|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
765104|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765105|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
765106|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765194|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
765195|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
765196|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
765197|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
765198|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
765199|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765200|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765201|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
765202|NCT02719314|Hormones|hormones|mesh-ancestor
765203|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
765204|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
765205|NCT02719314|Protective Agents|protective agents|mesh-ancestor
2239244|NCT00095082|Insulin|insulin|mesh-list
2239245|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2239246|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
2239247|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
2239248|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
2239249|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2239250|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239251|NCT00095134|Risperidone|risperidone|mesh-list
2239252|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2239253|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
2239254|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239255|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239256|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239257|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2239258|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2239259|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239260|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239261|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2239262|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
2239263|NCT00095186|Lactoferrin|lactoferrin|mesh-list
2239264|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239265|NCT00095225|Bevacizumab|bevacizumab|mesh-list
2239266|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2239267|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2239268|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239269|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2239270|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2239271|NCT00095225|Growth Substances|growth substances|mesh-ancestor
2239272|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239273|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
2239274|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2239275|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239276|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239277|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
764891|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
764892|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
764893|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
764894|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765253|NCT02718950|Liraglutide|liraglutide|mesh-list
765254|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
765255|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765256|NCT02718950|Incretins|incretins|mesh-ancestor
765257|NCT02718950|Hormones|hormones|mesh-ancestor
765258|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
765369|NCT02718599|Terlipressin|terlipressin|mesh-list
765370|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
765371|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
765742|NCT02716766|Capecitabine|capecitabine|mesh-list
765743|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
765744|NCT02716766|Sorafenib|sorafenib|mesh-list
765745|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
765746|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
765747|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765748|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765749|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
765750|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766433|NCT02713776|Pasireotide|pasireotide|mesh-list
766434|NCT02713776|Somatostatin|somatostatin|mesh-list
766435|NCT02713776|Hormones|hormones|mesh-ancestor
766436|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
766437|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239278|NCT00095251|Lorazepam|lorazepam|mesh-list
2239279|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2239280|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239281|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239282|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2239283|NCT00095251|Analgesics|analgesics|mesh-ancestor
2239284|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
766962|NCT02711410|Clopidogrel|clopidogrel|mesh-list
766963|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
766964|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
766965|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
766966|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
766967|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
766968|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
766969|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766970|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239285|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239286|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2239287|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2239288|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2239289|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
2239290|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
767483|NCT02709954|Ethanol|ethanol|mesh-list
767484|NCT02709954|Dronabinol|dronabinol|mesh-list
767485|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
767486|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767487|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767488|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767489|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
767490|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
767491|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
767492|NCT02709954|Analgesics|analgesics|mesh-ancestor
767493|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
767494|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767495|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
767496|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
767497|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
767498|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767499|NCT02709954|Hormones|hormones|mesh-ancestor
767500|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2239291|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239292|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
2239293|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
2239294|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
2239295|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2239296|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2239297|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
764990|NCT02720367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
764991|NCT02720367|Immunologic Factors|immunologic factors|mesh-ancestor
764992|NCT02720367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765859|NCT02716116|Carboplatin|carboplatin|mesh-list
765860|NCT02716116|Pemetrexed|pemetrexed|mesh-list
765861|NCT02716116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765862|NCT02716116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765863|NCT02716116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765864|NCT02716116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
765865|NCT02716116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
766475|NCT02713607|Doxycycline|doxycycline|mesh-list
766476|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
766477|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
766478|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
766479|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
766480|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
766517|NCT02713139|Metronidazole|metronidazole|mesh-list
766518|NCT02713139|Clotrimazole|clotrimazole|mesh-list
766519|NCT02713139|Miconazole|miconazole|mesh-list
766520|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
766521|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
766522|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
766523|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
766524|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
766525|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
766526|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
766527|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
766528|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766529|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766530|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
766531|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
766532|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
766533|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766534|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
766535|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
766828|NCT02711865|Antibodies|antibodies|mesh-list
766829|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
766830|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093747|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
2093748|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
2093749|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
2093750|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093751|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093752|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
2093753|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
2093754|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093755|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093756|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2093757|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
2093758|NCT02265510|Hormones|hormones|mesh-ancestor
2093759|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2093760|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2093761|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2093762|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
2093763|NCT02265510|Antiviral Agents|antiviral agents|mesh-ancestor
2093764|NCT02265510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093765|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093766|NCT02265510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
765027|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
765028|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765156|NCT02719574|Cytarabine|cytarabine|mesh-list
765157|NCT02719574|Azacitidine|azacitidine|mesh-list
765158|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
765159|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
765160|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765161|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765162|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
765163|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
765164|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
765165|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
765166|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765167|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239298|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239299|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
2239300|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
2239301|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
2239302|NCT00095264|Hematinics|hematinics|mesh-ancestor
2239303|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
2239304|NCT00095277|Hematinics|hematinics|mesh-ancestor
765608|NCT02717091|Gemcitabine|gemcitabine|mesh-list
765609|NCT02717091|Paclitaxel|paclitaxel|mesh-list
765610|NCT02717091|Folfirinox|folfirinox|mesh-list
765611|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
765612|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765613|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
765614|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
765615|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
765616|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765617|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
765618|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
765619|NCT02717091|Antiviral Agents|antiviral agents|mesh-ancestor
765620|NCT02717091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
765621|NCT02717091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765622|NCT02717091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
765623|NCT02717091|Immunologic Factors|immunologic factors|mesh-ancestor
765624|NCT02717091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765719|NCT02716857|Oxycodone|oxycodone|mesh-list
765720|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
765721|NCT02716857|Narcotics|narcotics|mesh-ancestor
765722|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
765723|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765724|NCT02716857|Analgesics|analgesics|mesh-ancestor
765725|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
765726|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765794|NCT02716311|Cetuximab|cetuximab|mesh-list
765795|NCT02716311|Afatinib|afatinib|mesh-list
765796|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
765797|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765798|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
765799|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765800|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765900|NCT02715687|Amiodarone|amiodarone|mesh-list
765901|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
765902|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
765903|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
765904|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
765905|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765906|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
765907|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
765908|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
765909|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765910|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
765911|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
765912|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
766235|NCT02714439|Proflavine|proflavine|mesh-list
766236|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
766237|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767501|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
767502|NCT02709668|Vitamins|vitamins|mesh-ancestor
767503|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
767504|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767696|NCT02709382|Tazobactam|tazobactam|mesh-list
767697|NCT02709382|Cefepime|cefepime|mesh-list
767698|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2239305|NCT00095290|Ramipril|ramipril|mesh-list
2239306|NCT00095290|Irbesartan|irbesartan|mesh-list
2093767|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
2093768|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2093769|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2093770|NCT02265510|Growth Substances|growth substances|mesh-ancestor
2093771|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
2093772|NCT02265744|Antibodies|antibodies|mesh-list
2093773|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
2093774|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093775|NCT02265796|Ranolazine|ranolazine|mesh-list
2093776|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2093777|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2093778|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093779|NCT02265913|Acyclovir|acyclovir|mesh-list
2093780|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
2093781|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093782|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
2093783|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
2093784|NCT02266433|Dexamethasone|dexamethasone|mesh-list
2093785|NCT02266433|Ketorolac|ketorolac|mesh-list
2093786|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093787|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
2093788|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
2093789|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
765259|NCT02718820|Docetaxel|docetaxel|mesh-list
765260|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
765261|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765262|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
765263|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
765264|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
765265|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765266|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
765318|NCT02718547|Timolol|timolol|mesh-list
765319|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
765320|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
765321|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
765322|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
765323|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
765324|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
765325|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
765326|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
765327|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765328|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765329|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
765330|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
765331|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
765332|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
765333|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
765822|NCT02716259|Fluorides|fluorides|mesh-list
765823|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
765824|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
765825|NCT02716259|Protective Agents|protective agents|mesh-ancestor
765826|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765884|NCT02715869|Sevoflurane|sevoflurane|mesh-list
765885|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
765886|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
765887|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
765888|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
765889|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
765890|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765993|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
766247|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
766248|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
766249|NCT02714166|Protective Agents|protective agents|mesh-ancestor
766250|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766251|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
766443|NCT02714075|Zinc|zinc|mesh-list
766444|NCT02714075|Iron|iron|mesh-list
766445|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
766446|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
766447|NCT02714075|Citric Acid|citric acid|mesh-list
766448|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
766449|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
766450|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
766451|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
766452|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
766453|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766454|NCT02714075|Trace Elements|trace elements|mesh-ancestor
766455|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
2753824|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753825|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2753826|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
2753827|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753828|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753829|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
2753830|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2753831|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2753832|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2753833|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
2753834|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2753835|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
765529|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
765530|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
765531|NCT02718079|Mannitol|mannitol|mesh-list
765532|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
765533|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
765534|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
765535|NCT02718079|Diuretics|diuretics|mesh-ancestor
765536|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
765537|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765538|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
765539|NCT02718079|Expectorants|expectorants|mesh-ancestor
765540|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
765541|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
765542|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
765543|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765544|NCT02718079|Protective Agents|protective agents|mesh-ancestor
765545|NCT02718079|Antidotes|antidotes|mesh-ancestor
765986|NCT02715336|Leuprolide|leuprolide|mesh-list
765987|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
765988|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
765989|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
765990|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765991|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
765992|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766082|NCT02714959|Aldesleukin|aldesleukin|mesh-list
766083|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766084|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
766085|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
766086|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
766087|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767875|NCT02708459|Morphine|morphine|mesh-list
767876|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
767877|NCT02708459|Narcotics|narcotics|mesh-ancestor
767878|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767879|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767880|NCT02708459|Analgesics|analgesics|mesh-ancestor
767881|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
767882|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768884|NCT02703857|Cefoxitin|cefoxitin|mesh-list
768885|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
768886|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
769029|NCT02703376|Prednisone|prednisone|mesh-list
769030|NCT02703376|Prednisolone|prednisolone|mesh-list
769031|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769032|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
769033|NCT02703376|Hormones|hormones|mesh-ancestor
769034|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
769035|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769036|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
769037|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093790|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093791|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2093792|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
2093793|NCT02266433|Hormones|hormones|mesh-ancestor
2093794|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2093795|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2093796|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765180|NCT02719392|Expectorants|expectorants|mesh-ancestor
765181|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
765182|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
765183|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
765184|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765185|NCT02719392|Protective Agents|protective agents|mesh-ancestor
765186|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765187|NCT02719392|Antidotes|antidotes|mesh-ancestor
765188|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
765267|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
765268|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
765269|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765381|NCT02718521|Isosorbide|isosorbide|mesh-list
765382|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
765383|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
765384|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
765385|NCT02718521|Diuretics|diuretics|mesh-ancestor
765386|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
765387|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765388|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
765389|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
765390|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239307|NCT00095290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2239308|NCT00095290|Protease Inhibitors|protease inhibitors|mesh-ancestor
2239309|NCT00095290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239310|NCT00095290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765808|NCT02716142|Misoprostol|misoprostol|mesh-list
765809|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
765810|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
765811|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
765812|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765813|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
765814|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
765815|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
766351|NCT02713997|Etanercept|etanercept|mesh-list
766352|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
766353|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
766354|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
766355|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
766356|NCT02713997|Analgesics|analgesics|mesh-ancestor
766357|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
766358|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766359|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766360|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
766361|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
766362|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
766363|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
766364|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
766365|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
766366|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
766367|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
766368|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766369|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766781|NCT02712814|Estrogens|estrogens|mesh-list
766782|NCT02712814|Hormones|hormones|mesh-ancestor
766783|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
766784|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239311|NCT00095290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2239312|NCT00095290|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2239313|NCT00095290|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2239314|NCT00095316|Caspofungin|caspofungin|mesh-list
2239315|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
2239316|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239317|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239318|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239319|NCT00095329|Sirolimus|sirolimus|mesh-list
2239320|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2239321|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239322|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2239323|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239324|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
2239325|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2239326|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
2239327|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239328|NCT00095355|Valproic Acid|valproic acid|mesh-list
765550|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765647|NCT02716961|Gemcitabine|gemcitabine|mesh-list
765648|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765649|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
765650|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
765651|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765652|NCT02716961|Antiviral Agents|antiviral agents|mesh-ancestor
765653|NCT02716961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
765654|NCT02716961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765655|NCT02716961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
765656|NCT02716961|Immunologic Factors|immunologic factors|mesh-ancestor
765657|NCT02716961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766156|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
766157|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
766158|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
766159|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766160|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
766495|NCT02713477|Insulin|insulin|mesh-list
766496|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
766497|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
766498|NCT02713477|Lixisenatide|lixisenatide|mesh-list
766499|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
766500|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767017|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
767018|NCT02711683|Donepezil|donepezil|mesh-list
767019|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
767020|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767021|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767022|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
767023|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
767024|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767025|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
767026|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
767027|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
767028|NCT02711683|Protective Agents|protective agents|mesh-ancestor
767661|NCT02709473|Remifentanil|remifentanil|mesh-list
767662|NCT02709473|Propofol|propofol|mesh-list
767663|NCT02709473|Rocuronium|rocuronium|mesh-list
767664|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
767665|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767666|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767667|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
767668|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
767669|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
767670|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
767671|NCT02709473|Narcotics|narcotics|mesh-ancestor
767672|NCT02709473|Analgesics|analgesics|mesh-ancestor
767673|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
767674|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767675|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
767676|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
767677|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2239329|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239330|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239331|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239332|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
2239333|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2239334|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239335|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239336|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
2239337|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
2239338|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239339|NCT00095368|Amoxicillin|amoxicillin|mesh-list
2239340|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
768214|NCT02707081|Lidocaine|lidocaine|mesh-list
768215|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
768216|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
768217|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
768218|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768219|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
768220|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768221|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
768222|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
768223|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
768224|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
768225|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239341|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239342|NCT00095394|Irbesartan|irbesartan|mesh-list
2239343|NCT00095394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2239344|NCT00095394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2239345|NCT00095394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2239346|NCT00095394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239347|NCT00095433|Ranibizumab|ranibizumab|mesh-list
2239348|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2239349|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
765958|NCT02715492|Enoxaparin|enoxaparin|mesh-list
765959|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
765960|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
765961|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
765962|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766127|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
766128|NCT02714634|Methotrexate|methotrexate|mesh-list
766129|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
766130|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
766131|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
766132|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766133|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
766134|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
766135|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766136|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766137|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
766138|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766139|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
766140|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
766141|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
766142|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
766143|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
766144|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
766145|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
766146|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
766147|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239350|NCT00095433|Growth Substances|growth substances|mesh-ancestor
2239351|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239352|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
2239353|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239354|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
2239355|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2239356|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239357|NCT00095459|Bevacizumab|bevacizumab|mesh-list
2239358|NCT00095459|Sorafenib|sorafenib|mesh-list
2239359|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2239360|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239361|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2239362|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2239363|NCT00095459|Growth Substances|growth substances|mesh-ancestor
2239364|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239365|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
2239366|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2239367|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239368|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239369|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2239370|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239371|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239372|NCT00095511|Aripiprazole|aripiprazole|mesh-list
767578|NCT02709564|Misoprostol|misoprostol|mesh-list
767579|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
767580|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
767581|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
767582|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767583|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
767584|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
767585|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
767801|NCT02708680|Atezolizumab|atezolizumab|mesh-list
767802|NCT02708680|Entinostat|entinostat|mesh-list
767803|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
767804|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
767805|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767806|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768267|NCT02706704|Adalimumab|adalimumab|mesh-list
768268|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
768269|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
765663|NCT02716974|Bicalutamide|bicalutamide|mesh-list
765664|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765665|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
765666|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
765667|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
765668|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765669|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
765670|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
765671|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
765672|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765673|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
765674|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
765675|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
765676|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
765751|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
765752|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
765753|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765816|NCT02716272|Nivolumab|nivolumab|mesh-list
765817|NCT02716272|Ipilimumab|ipilimumab|mesh-list
765818|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
765819|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765820|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
765821|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239373|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
2239374|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239375|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2239376|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2239377|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239378|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239379|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
766701|NCT02712528|Sufentanil|sufentanil|mesh-list
766702|NCT02712528|Remifentanil|remifentanil|mesh-list
766703|NCT02712528|Sevoflurane|sevoflurane|mesh-list
766704|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
766705|NCT02712528|Narcotics|narcotics|mesh-ancestor
766706|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
766707|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766708|NCT02712528|Analgesics|analgesics|mesh-ancestor
766709|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
766710|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766711|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
766712|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
766713|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
766714|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
766715|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
766716|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
767099|NCT02711280|Propofol|propofol|mesh-list
767100|NCT02711280|Sevoflurane|sevoflurane|mesh-list
767101|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
767102|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767103|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767104|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
767105|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
767106|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
767107|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
767108|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2239380|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
2239381|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239382|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239383|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2239384|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2239385|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
2239386|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2239387|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2239388|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2239389|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2239390|NCT00095524|Aripiprazole|aripiprazole|mesh-list
2239391|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
2239392|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239393|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2239394|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
767713|NCT02709031|Cicletanine|cicletanine|mesh-list
767714|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
767715|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2239395|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239396|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239397|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
2239398|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
2239399|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239400|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239401|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2239402|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2239403|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
2239404|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2239405|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2239406|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2239407|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2239408|NCT00095550|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2239409|NCT00095550|Irbesartan|irbesartan|mesh-list
2239410|NCT00095550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2239411|NCT00095550|Diuretics|diuretics|mesh-ancestor
2239412|NCT00095550|Natriuretic Agents|natriuretic agents|mesh-ancestor
2239413|NCT00095550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239414|NCT00095550|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2239415|NCT00095550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2239416|NCT00095550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239417|NCT00095550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2239418|NCT00095550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2239419|NCT00095641|Capecitabine|capecitabine|mesh-list
2239420|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2239421|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
2239422|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239423|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239424|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
766481|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
766482|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
766483|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
766484|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
766485|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766486|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
766487|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
766488|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
766489|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
766490|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
766491|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766492|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
766493|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
766494|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
2239425|NCT00095654|Ramipril|ramipril|mesh-list
2239426|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2239427|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239428|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2239429|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
2239430|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239431|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239432|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
766924|NCT02711826|Acetaminophen|acetaminophen|mesh-list
766925|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
766926|NCT02711826|Promethazine|promethazine|mesh-list
766927|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
766928|NCT02711826|Everolimus|everolimus|mesh-list
766929|NCT02711826|Tacrolimus|tacrolimus|mesh-list
766930|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
766931|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
766932|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766933|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
766934|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766935|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766936|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
766937|NCT02711826|Analgesics|analgesics|mesh-ancestor
766938|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
766939|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766940|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
766941|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766942|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
766943|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
765831|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
765832|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
765833|NCT02716129|Analgesics|analgesics|mesh-ancestor
765834|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
765835|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766041|NCT02715024|Tamsulosin|tamsulosin|mesh-list
766042|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
766043|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
766044|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
766045|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
766046|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
766047|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
766048|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766049|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766050|NCT02715024|Urological Agents|urological agents|mesh-ancestor
766051|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
766052|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
766053|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
2239433|NCT00095667|Lapatinib|lapatinib|mesh-list
2239434|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239435|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2239436|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239437|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239438|NCT00095680|Bortezomib|bortezomib|mesh-list
2239439|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239440|NCT00095693|Sorafenib|sorafenib|mesh-list
2239441|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2239442|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
767709|NCT02708992|Azithromycin|azithromycin|mesh-list
767710|NCT02708992|Cefixime|cefixime|mesh-list
767711|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
767712|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239443|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2239444|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239445|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239446|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2239447|NCT00095706|Bevacizumab|bevacizumab|mesh-list
2239448|NCT00095706|Trastuzumab|trastuzumab|mesh-list
767946|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
767947|NCT02707666|Pemetrexed|pemetrexed|mesh-list
767948|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
767949|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
767950|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767951|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767952|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
767953|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2093797|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2093798|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2093799|NCT02266433|Analgesics|analgesics|mesh-ancestor
2239449|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
768401|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
768402|NCT02706405|Fludarabine|fludarabine|mesh-list
768403|NCT02706405|Durvalumab|durvalumab|mesh-list
768404|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
768405|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
768406|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
768407|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
768408|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
768409|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768410|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
768411|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
768412|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
768413|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768414|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768415|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
768416|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2239450|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765873|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
765874|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
765875|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
765876|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
765877|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
765878|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
765879|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
765880|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
765881|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
765882|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
765883|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
766068|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
766069|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
766070|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
766071|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766072|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
766073|NCT02715154|Analgesics|analgesics|mesh-ancestor
766074|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
766075|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766076|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
766077|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
766078|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
766079|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
766080|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
766081|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766187|NCT02714699|Diclofenac|diclofenac|mesh-list
766188|NCT02714699|Scopolamine|scopolamine|mesh-list
766189|NCT02714699|Bromides|bromides|mesh-list
766190|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
766191|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
766192|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
766193|NCT02714699|Analgesics|analgesics|mesh-ancestor
766194|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
766195|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766196|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766197|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
766198|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
766199|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
766200|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766201|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766202|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
766203|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
766204|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
766205|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
766206|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
766207|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
766208|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
766209|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
766210|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
766211|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
766212|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
2239451|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2239452|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2239453|NCT00095706|Growth Substances|growth substances|mesh-ancestor
2239454|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239455|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
2239456|NCT00095719|Aripiprazole|aripiprazole|mesh-list
766690|NCT02712775|Minocycline|minocycline|mesh-list
766691|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
766692|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767147|NCT02711176|Amoxicillin|amoxicillin|mesh-list
767148|NCT02711176|Clarithromycin|clarithromycin|mesh-list
767149|NCT02711176|Tinidazole|tinidazole|mesh-list
767150|NCT02711176|Esomeprazole|esomeprazole|mesh-list
767151|NCT02711176|Lansoprazole|lansoprazole|mesh-list
767152|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
767153|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767154|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
767155|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
767156|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
767157|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767158|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767159|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
767160|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
767161|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2239457|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
2239458|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239459|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
766421|NCT02713802|Propofol|propofol|mesh-list
766422|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
766423|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
766424|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766425|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
766426|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
766427|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
766671|NCT02712619|Metformin|metformin|mesh-list
766672|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
766673|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239460|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2239461|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239462|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239463|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
2239464|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
2239465|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239466|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239467|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2239468|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
767678|NCT02709187|Candesartan|candesartan|mesh-list
767679|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
767680|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
767681|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
767682|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
767683|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
767684|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767685|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
767686|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
767687|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767688|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
767689|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
767690|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2239469|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
2239470|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2239471|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
768661|NCT02705287|Vitamin D|vitamin d|mesh-list
768662|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
768663|NCT02705287|Vitamins|vitamins|mesh-list
768664|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
768665|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768666|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
768667|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
770155|NCT02698969|Atropine|atropine|mesh-list
770156|NCT02698969|Fentanyl|fentanyl|mesh-list
770157|NCT02698969|Propofol|propofol|mesh-list
770158|NCT02698969|Sevoflurane|sevoflurane|mesh-list
770159|NCT02698969|Rocuronium|rocuronium|mesh-list
770160|NCT02698969|Neostigmine|neostigmine|mesh-list
770161|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
770162|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770163|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770164|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
770165|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
770166|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
770167|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
770168|NCT02698969|Narcotics|narcotics|mesh-ancestor
770169|NCT02698969|Analgesics|analgesics|mesh-ancestor
770170|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
770171|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770172|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
770173|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
770174|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
770175|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
770176|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
770177|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
770178|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
770179|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
770180|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
770181|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
770182|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
770183|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
770184|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
770185|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
770186|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
766018|NCT02715531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
766019|NCT02715531|Immunologic Factors|immunologic factors|mesh-ancestor
766020|NCT02715531|Antidotes|antidotes|mesh-ancestor
766021|NCT02715531|Protective Agents|protective agents|mesh-ancestor
766022|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
766023|NCT02715531|Vitamins|vitamins|mesh-ancestor
766024|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
766411|NCT02713763|Sunitinib|sunitinib|mesh-list
766412|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766413|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
766414|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
766415|NCT02713763|Growth Substances|growth substances|mesh-ancestor
766416|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766417|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
766418|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
766419|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766420|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753846|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2753847|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2753848|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
766536|NCT02713009|Vitamin D|vitamin d|mesh-list
766537|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
766538|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
766539|NCT02713009|Vitamins|vitamins|mesh-list
766540|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
766541|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766542|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
766543|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2239472|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2239473|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2239474|NCT00095745|Aripiprazole|aripiprazole|mesh-list
2239475|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
2239476|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239477|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2239478|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2239479|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239480|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767459|NCT02710162|Capsaicin|capsaicin|mesh-list
767460|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
767461|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
767462|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
767463|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767464|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767807|NCT02708836|Anesthetics|anesthetics|mesh-list
767808|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767809|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767954|NCT02707653|Misoprostol|misoprostol|mesh-list
767955|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
767956|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
767957|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
767958|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767959|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
767960|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
767961|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
768461|NCT02706067|Orlistat|orlistat|mesh-list
768462|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768463|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768464|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
768465|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
768571|NCT02705534|Ribavirin|ribavirin|mesh-list
768572|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
768573|NCT02705534|Ledipasvir|ledipasvir|mesh-list
768574|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
768575|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239481|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
766065|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
766066|NCT02715167|Hormones|hormones|mesh-ancestor
766067|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2239482|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
2239483|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239484|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239485|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2239486|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2239487|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
767067|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
767068|NCT02711215|Mirtazapine|mirtazapine|mesh-list
767069|NCT02711215|Citalopram|citalopram|mesh-list
767070|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
767071|NCT02711215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
767072|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
767073|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
767074|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767075|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
767076|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
767077|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767078|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
767079|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
767080|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
767081|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767082|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
767083|NCT02711215|Analgesics|analgesics|mesh-ancestor
767084|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
767085|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
767086|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
767087|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
767088|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
767089|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
767090|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
767091|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767092|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
767093|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
767094|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
767095|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
767096|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
767097|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
767098|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
767212|NCT02710851|Vaccines|vaccines|mesh-list
767213|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
767214|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767325|NCT02710448|Metformin|metformin|mesh-list
767326|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
767327|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767413|NCT02710097|Ethanol|ethanol|mesh-list
767414|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
767415|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767416|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767417|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768027|NCT02707328|Gemcitabine|gemcitabine|mesh-list
768028|NCT02707328|Paclitaxel|paclitaxel|mesh-list
768029|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
768030|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768031|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
768032|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
768033|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
768034|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768035|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
768036|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
768037|NCT02707328|Antiviral Agents|antiviral agents|mesh-ancestor
768038|NCT02707328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
768039|NCT02707328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768040|NCT02707328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
768041|NCT02707328|Immunologic Factors|immunologic factors|mesh-ancestor
768042|NCT02707328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768732|NCT02704754|Suvorexant|suvorexant|mesh-list
768733|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
768734|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
768735|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
768736|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766148|NCT02714855|Apixaban|apixaban|mesh-list
766149|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
766150|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
766151|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
766152|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
766153|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766154|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766155|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
766303|NCT02714322|Adalimumab|adalimumab|mesh-list
766304|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
766305|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093800|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
2093801|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093802|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2093803|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093804|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093805|NCT02266472|Metformin|metformin|mesh-list
2093806|NCT02266472|Empagliflozin|empagliflozin|mesh-list
2093807|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2093808|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766818|NCT02712151|Ropivacaine|ropivacaine|mesh-list
766819|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
766820|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
766821|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
766822|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766823|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
766824|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767041|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
767042|NCT02711228|Antibodies|antibodies|mesh-list
767043|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
767044|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
767045|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
767046|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
767047|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767249|NCT02710539|Amlodipine|amlodipine|mesh-list
767250|NCT02710539|Perindopril|perindopril|mesh-list
767251|NCT02710539|Indapamide|indapamide|mesh-list
767252|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
767253|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
767254|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
767255|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767256|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
767257|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767258|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
767259|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
767260|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
767261|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767262|NCT02710539|Diuretics|diuretics|mesh-ancestor
767263|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
767264|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
767505|NCT02709616|Vaccines|vaccines|mesh-list
767506|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
767507|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767778|NCT02708693|Triamcinolone|triamcinolone|mesh-list
767779|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
767780|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
767781|NCT02708693|Lidocaine|lidocaine|mesh-list
767782|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
767783|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
767784|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
767785|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767786|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767787|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
767788|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767789|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
767790|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
767791|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
767792|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
767793|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767794|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
767795|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
767796|NCT02708693|Hormones|hormones|mesh-ancestor
767797|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
767798|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
767799|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
767800|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766259|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
766260|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766261|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766262|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
766263|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
766264|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
766265|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766266|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766267|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
766268|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
766269|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
766270|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
766271|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
766272|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
766273|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
766274|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
766275|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
766276|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
766277|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
766428|NCT02714010|Gefitinib|gefitinib|mesh-list
766429|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766430|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
766431|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766432|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766544|NCT02713191|Fentanyl|fentanyl|mesh-list
766545|NCT02713191|Midazolam|midazolam|mesh-list
766546|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
766547|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
766548|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
766549|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766550|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
766551|NCT02713191|Analgesics|analgesics|mesh-ancestor
766552|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
766553|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766554|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
766555|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
766556|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
766557|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
766558|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
766559|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766560|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
766561|NCT02713191|Narcotics|narcotics|mesh-ancestor
766562|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
766563|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
766564|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
766565|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
766566|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
766567|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
766568|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
766569|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
766570|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
2239488|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2239489|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2239490|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2239491|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2239492|NCT00095758|Aripiprazole|aripiprazole|mesh-list
2239493|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
2239494|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
767221|NCT02710656|Paclitaxel|paclitaxel|mesh-list
767222|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
767223|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
767224|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
767225|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
767226|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
767227|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766341|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
766342|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
766758|NCT02712671|Interferons|interferons|mesh-list
766759|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
766760|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766761|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
766762|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
766831|NCT02711969|Apatinib|apatinib|mesh-list
766832|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766833|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
766834|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766835|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767197|NCT02710877|Sufentanil|sufentanil|mesh-list
767198|NCT02710877|Dsuvia|dsuvia|mesh-list
767199|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
767200|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
767201|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
767202|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767203|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767204|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
767205|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767206|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
767207|NCT02710877|Narcotics|narcotics|mesh-ancestor
767208|NCT02710877|Analgesics|analgesics|mesh-ancestor
767209|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
767210|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
767211|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
767548|NCT02709720|Cisplatin|cisplatin|mesh-list
767549|NCT02709720|Vinorelbine|vinorelbine|mesh-list
767550|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
767551|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
767552|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
767553|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
767554|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
767555|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239495|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2239496|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2239497|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239498|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768151|NCT02707159|Gemcitabine|gemcitabine|mesh-list
768152|NCT02707159|Paclitaxel|paclitaxel|mesh-list
768153|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
768154|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
768155|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768156|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
768157|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
768158|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
768159|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768160|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
768161|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
768162|NCT02707159|Antiviral Agents|antiviral agents|mesh-ancestor
768163|NCT02707159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
768164|NCT02707159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768165|NCT02707159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
768166|NCT02707159|Immunologic Factors|immunologic factors|mesh-ancestor
768167|NCT02707159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239499|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
2239500|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
2239501|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239502|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239503|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
769270|NCT02702622|Provitamins|provitamins|mesh-list
769271|NCT02702622|Beta Carotene|beta carotene|mesh-list
769272|NCT02702622|Vitamins|vitamins|mesh-ancestor
769273|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
769274|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769521|NCT02701517|Cyclosporine|cyclosporine|mesh-list
769522|NCT02701517|Methotrexate|methotrexate|mesh-list
769523|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
769524|NCT02701517|Cyclosporins|cyclosporins|mesh-list
769525|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
769526|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
769527|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
769528|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769529|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
769530|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
769531|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766347|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766348|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
766349|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
766350|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766911|NCT02711917|Propofol|propofol|mesh-list
766912|NCT02711917|Etomidate|etomidate|mesh-list
766913|NCT02711917|Rocuronium|rocuronium|mesh-list
766914|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
766915|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
766916|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766917|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
766918|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
766919|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
766920|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
766921|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
766922|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
766923|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768064|NCT02707393|Cyclosporine|cyclosporine|mesh-list
768065|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
768066|NCT02707393|Fludarabine|fludarabine|mesh-list
768067|NCT02707393|Melphalan|melphalan|mesh-list
768068|NCT02707393|Thiotepa|thiotepa|mesh-list
768069|NCT02707393|Cyclosporins|cyclosporins|mesh-list
768070|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
768071|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768072|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768073|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
768074|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
768075|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768076|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768077|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
768078|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
768079|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
768080|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
768081|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
768082|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
768083|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
768084|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
768085|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
768086|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
768087|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
768088|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
768277|NCT02706769|Acetaminophen|acetaminophen|mesh-list
768278|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
768279|NCT02706769|Analgesics|analgesics|mesh-ancestor
768280|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
768281|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768282|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768283|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
768300|NCT02706470|Cyclosporine|cyclosporine|mesh-list
768301|NCT02706470|Cyclosporins|cyclosporins|mesh-list
768302|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
768303|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768304|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768305|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
768306|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
768307|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768308|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
768309|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
768310|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
768311|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
768312|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
768313|NCT02706470|Progestins|progestins|mesh-ancestor
768314|NCT02706470|Hormones|hormones|mesh-ancestor
768315|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
768417|NCT02705859|Trastuzumab|trastuzumab|mesh-list
768418|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
768419|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768622|NCT02705651|Somatostatin|somatostatin|mesh-list
768623|NCT02705651|Hormones|hormones|mesh-ancestor
768624|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
768625|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768668|NCT02705053|Insulin|insulin|mesh-list
768669|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
768670|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768771|NCT02704780|Misoprostol|misoprostol|mesh-list
768772|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
766456|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766457|NCT02714075|Astringents|astringents|mesh-ancestor
766458|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
766459|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
766460|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
766461|NCT02714075|Protective Agents|protective agents|mesh-ancestor
766658|NCT02712957|Naproxen|naproxen|mesh-list
766659|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
766660|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
766661|NCT02712957|Analgesics|analgesics|mesh-ancestor
766662|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
766663|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766664|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766665|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
766666|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
766667|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
766668|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
766669|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766670|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767194|NCT02711267|Acyclovir|acyclovir|mesh-list
767195|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
767196|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767357|NCT02710266|Gabexate|gabexate|mesh-list
767358|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
767359|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
767360|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
767361|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767362|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239504|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2239505|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
2239506|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2239507|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2239508|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2239509|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2239510|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
2239511|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239512|NCT00095810|Aripiprazole|aripiprazole|mesh-list
2239513|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
2239514|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239515|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
767988|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
767989|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
767990|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768376|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
768377|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
768378|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768582|NCT02705508|Gemcitabine|gemcitabine|mesh-list
768583|NCT02705508|Etoposide|etoposide|mesh-list
768584|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
768585|NCT02705508|Pegaspargase|pegaspargase|mesh-list
768586|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
768587|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
768588|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768589|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768590|NCT02705508|Antiviral Agents|antiviral agents|mesh-ancestor
768591|NCT02705508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
768592|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768593|NCT02705508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
768594|NCT02705508|Immunologic Factors|immunologic factors|mesh-ancestor
768595|NCT02705508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768596|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
768597|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
768598|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2239516|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2239517|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239518|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239519|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
2239520|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
769468|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2239521|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
766601|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766602|NCT02713087|Protective Agents|protective agents|mesh-ancestor
766603|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
766693|NCT02712697|Prednisone|prednisone|mesh-list
766694|NCT02712697|Hormones|hormones|mesh-list
766695|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
766696|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
766697|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
766698|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766699|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
766700|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766852|NCT02711904|Remifentanil|remifentanil|mesh-list
766853|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
766854|NCT02711904|Narcotics|narcotics|mesh-ancestor
766855|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
766856|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766857|NCT02711904|Analgesics|analgesics|mesh-ancestor
766858|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
766859|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767004|NCT02711579|Celecoxib|celecoxib|mesh-list
767005|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
767006|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
767007|NCT02711579|Analgesics|analgesics|mesh-ancestor
767008|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
767009|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767010|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767011|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
767012|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
767013|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
767014|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
767015|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767016|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767703|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
767704|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
767705|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
767706|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767707|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
767708|NCT02709525|Protective Agents|protective agents|mesh-ancestor
767922|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
767923|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
767924|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
767925|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239522|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239523|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2239524|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2239525|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
2239526|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2239527|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2239528|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2239529|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
768538|NCT02705729|Methamphetamine|methamphetamine|mesh-list
768539|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
768540|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768541|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
768542|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
768543|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768544|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
768545|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
768546|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768547|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
768548|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
768549|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
768550|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
768551|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
768602|NCT02705378|Naloxegol|naloxegol|mesh-list
768603|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
768604|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768605|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
768606|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093809|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2093810|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093811|NCT02266706|Tazobactam|tazobactam|mesh-list
2093812|NCT02266706|Ceftolozane|ceftolozane|mesh-list
766682|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
766683|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
766684|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
766685|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
766686|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
766687|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
766688|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
766689|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766785|NCT02712346|Ambrisentan|ambrisentan|mesh-list
766786|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
766860|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
766861|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
766862|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
766863|NCT02711982|Prednisolone|prednisolone|mesh-list
766864|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
766865|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
766866|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
766867|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
766868|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
766869|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
766870|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766871|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766872|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
766873|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
766874|NCT02711982|Hormones|hormones|mesh-ancestor
766875|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
766876|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
766877|NCT02711982|Protective Agents|protective agents|mesh-ancestor
766878|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
766879|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768007|NCT02707484|Thalidomide|thalidomide|mesh-list
768008|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
768009|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
768010|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768011|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
768012|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
768013|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
768014|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
768015|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
768016|NCT02707484|Growth Substances|growth substances|mesh-ancestor
768017|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
768018|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768207|NCT02707016|Sevoflurane|sevoflurane|mesh-list
768208|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
768209|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
768210|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
768211|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
768212|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
768213|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239530|NCT00095823|Aripiprazole|aripiprazole|mesh-list
2239531|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
2239532|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239533|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2239534|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
769356|NCT02702076|Apomorphine|apomorphine|mesh-list
769357|NCT02702076|Emetics|emetics|mesh-ancestor
769358|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769359|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
769360|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769361|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
769362|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
769363|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
769364|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
769365|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769455|NCT02701673|Pyridoxine|pyridoxine|mesh-list
769456|NCT02701673|Gemcitabine|gemcitabine|mesh-list
769457|NCT02701673|Azacitidine|azacitidine|mesh-list
769458|NCT02701673|Melphalan|melphalan|mesh-list
769459|NCT02701673|Busulfan|busulfan|mesh-list
769460|NCT02701673|Belinostat|belinostat|mesh-list
769461|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
769462|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
769463|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769464|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769465|NCT02701673|Antiviral Agents|antiviral agents|mesh-ancestor
769466|NCT02701673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
769467|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766736|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
766737|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
766810|NCT02712203|Vaccines|vaccines|mesh-list
766811|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
766812|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766849|NCT02711891|Loperamide|loperamide|mesh-list
766850|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
766851|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
766991|NCT02711592|Analgesics|analgesics|mesh-list
766992|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
766993|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766994|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767048|NCT02711189|Oxytocin|oxytocin|mesh-list
767049|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
767050|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
767051|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239535|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239536|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239537|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
2239538|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
2239539|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239540|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239541|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2239542|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2239543|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
2239544|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2239545|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2239546|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2239547|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2239548|NCT00095862|Interferons|interferons|mesh-list
2239549|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
2239550|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
2239551|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2239552|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
2239553|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239554|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2239555|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2239556|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
767850|NCT02708160|Fluorides|fluorides|mesh-list
767851|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
767852|NCT02708160|Protective Agents|protective agents|mesh-ancestor
767853|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767908|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
767909|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
767910|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767911|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767912|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
767913|NCT02707809|Analgesics|analgesics|mesh-ancestor
767914|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
767915|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767916|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
767917|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
767918|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
767919|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
767920|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
767921|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239557|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239558|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239559|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2239560|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
2239561|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239562|NCT00095888|Gemcitabine|gemcitabine|mesh-list
768991|NCT02703740|Lidocaine|lidocaine|mesh-list
768992|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
768993|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
768994|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
768995|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
768996|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768997|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
768998|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768999|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
769000|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
769001|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
769136|NCT02703194|Prednisone|prednisone|mesh-list
2239563|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
766798|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
766799|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
766800|NCT02712125|Diuretics|diuretics|mesh-ancestor
766801|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
766802|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766803|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
766804|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
766805|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767112|NCT02711241|Dipyrone|dipyrone|mesh-list
767113|NCT02711241|Papaverine|papaverine|mesh-list
767114|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
767115|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
767116|NCT02711241|Analgesics|analgesics|mesh-ancestor
767117|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
767118|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767119|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767120|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
767121|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
767122|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
767123|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
767124|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767125|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767126|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
767127|NCT02711241|Urological Agents|urological agents|mesh-ancestor
767315|NCT02710604|Tenofovir|tenofovir|mesh-list
767316|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
767317|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
767318|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767319|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
767320|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
767321|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767322|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767323|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
767324|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2239564|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
2239565|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239566|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239567|NCT00095888|Antiviral Agents|antiviral agents|mesh-ancestor
2239568|NCT00095888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239569|NCT00095888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239570|NCT00095888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2239571|NCT00095888|Immunologic Factors|immunologic factors|mesh-ancestor
2239572|NCT00095888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239573|NCT00095901|Capecitabine|capecitabine|mesh-list
2239574|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2239575|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
767826|NCT02708511|Copper|copper|mesh-list
767827|NCT02708511|Trace Elements|trace elements|mesh-ancestor
767828|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
767829|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239576|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239577|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239578|NCT00095914|Paclitaxel|paclitaxel|mesh-list
2239579|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2239580|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2239581|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239582|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
2239583|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
2239584|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
2239585|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239586|NCT00095927|Paclitaxel|paclitaxel|mesh-list
2239587|NCT00095927|Carboplatin|carboplatin|mesh-list
2239588|NCT00095927|Amifostine|amifostine|mesh-list
2239589|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2239590|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239591|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
2239592|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
2239593|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
2239594|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768673|NCT02705274|Bevacizumab|bevacizumab|mesh-list
768674|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
768675|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768676|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
768677|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
768678|NCT02705274|Growth Substances|growth substances|mesh-ancestor
2093813|NCT02266706|Cephalosporins|cephalosporins|mesh-list
2093814|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2093815|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
2239595|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2239596|NCT00095927|Protective Agents|protective agents|mesh-ancestor
2239597|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239598|NCT00095966|Gemcitabine|gemcitabine|mesh-list
2239599|NCT00095966|Sorafenib|sorafenib|mesh-list
2239600|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2239601|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
2239602|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239603|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239604|NCT00095966|Antiviral Agents|antiviral agents|mesh-ancestor
2239605|NCT00095966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239606|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239607|NCT00095966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2239608|NCT00095966|Immunologic Factors|immunologic factors|mesh-ancestor
2239609|NCT00095966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239610|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2239611|NCT00096005|Bortezomib|bortezomib|mesh-list
2239612|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239613|NCT00096057|Antibodies|antibodies|mesh-list
2239614|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2239615|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
2239616|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239617|NCT00096070|Gemcitabine|gemcitabine|mesh-list
2239618|NCT00096070|Fluorouracil|fluorouracil|mesh-list
2239619|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
2239620|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
767810|NCT02708394|Olanzapine|olanzapine|mesh-list
767811|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
767812|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
767813|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767814|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767815|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
767816|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
767817|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
767818|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767819|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
767820|NCT02708394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
767821|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
767822|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
767823|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767824|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
767825|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
768019|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
768020|NCT02707588|Cetuximab|cetuximab|mesh-list
768021|NCT02707588|Antibodies|antibodies|mesh-list
768022|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
768023|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
768024|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768025|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
768026|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768205|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
768206|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768396|NCT02706119|Insulin|insulin|mesh-list
768397|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
768398|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
768399|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
768400|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768844|NCT02704481|Misoprostol|misoprostol|mesh-list
768845|NCT02704481|Mifepristone|mifepristone|mesh-list
768846|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
768847|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
768848|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
768849|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768850|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
768851|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
768852|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
768853|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
768854|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
768855|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
768856|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
768857|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
768858|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2093816|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2239621|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
766825|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
766826|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
766827|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766995|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
766996|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
766997|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
766998|NCT02711670|Diuretics|diuretics|mesh-ancestor
766999|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
767000|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767001|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
767002|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
767003|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767174|NCT02711137|Gemcitabine|gemcitabine|mesh-list
767175|NCT02711137|Paclitaxel|paclitaxel|mesh-list
767176|NCT02711137|Azacitidine|azacitidine|mesh-list
767177|NCT02711137|Rucaparib|rucaparib|mesh-list
767178|NCT02711137|INCB057643|incb057643|mesh-list
767179|NCT02711137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
767180|NCT02711137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
767181|NCT02711137|Tubulin Modulators|tubulin modulators|mesh-ancestor
767182|NCT02711137|Antimitotic Agents|antimitotic agents|mesh-ancestor
767183|NCT02711137|Mitosis Modulators|mitosis modulators|mesh-ancestor
767184|NCT02711137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767185|NCT02711137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
767186|NCT02711137|Antimetabolites|antimetabolites|mesh-ancestor
767187|NCT02711137|Antiviral Agents|antiviral agents|mesh-ancestor
767188|NCT02711137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767189|NCT02711137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767190|NCT02711137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
767191|NCT02711137|Immunologic Factors|immunologic factors|mesh-ancestor
767192|NCT02711137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767193|NCT02711137|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2239622|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239623|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239624|NCT00096070|Antiviral Agents|antiviral agents|mesh-ancestor
2239625|NCT00096070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239626|NCT00096070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239627|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2239628|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
2239629|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239630|NCT00096083|Melphalan|melphalan|mesh-list
2239631|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2239632|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
2239633|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768191|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
768192|NCT02706977|Carbidopa|carbidopa|mesh-list
768193|NCT02706977|Levodopa|levodopa|mesh-list
768194|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
768195|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
768196|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768197|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
768198|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
768199|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
768200|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
768201|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
768202|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768203|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
768204|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239634|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239635|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2239636|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2239637|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
2239638|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768445|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
768446|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
768447|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768779|NCT02704767|Apatinib|apatinib|mesh-list
768780|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
768781|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768782|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
768783|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768784|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769191|NCT02703623|Prednisone|prednisone|mesh-list
769192|NCT02703623|Cortisone|cortisone|mesh-list
769193|NCT02703623|Carboplatin|carboplatin|mesh-list
766842|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
766843|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
766844|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
766845|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
766846|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
766847|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
766848|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
767166|NCT02711007|Apatinib|apatinib|mesh-list
767167|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
767168|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
767169|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767170|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767531|NCT02709603|Scopolamine|scopolamine|mesh-list
767532|NCT02709603|Bromides|bromides|mesh-list
767533|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
767534|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
767535|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
767536|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
767537|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
767538|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767539|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767540|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
767541|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
767542|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
767543|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
767544|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
767545|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767546|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
767547|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
767612|NCT02709304|Lidocaine|lidocaine|mesh-list
767613|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
767614|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
767615|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767616|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767617|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
767618|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767619|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
767620|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
767621|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
767622|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
767623|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239639|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
2239640|NCT00096096|Tacrolimus|tacrolimus|mesh-list
2239641|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
768178|NCT02707224|Candesartan|candesartan|mesh-list
768179|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
768180|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
768181|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
768182|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
768183|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
768184|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768185|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
768186|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
768187|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768188|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
768189|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
768190|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
769399|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
769400|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
769401|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770330|NCT02698098|Methadone|methadone|mesh-list
770331|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
770332|NCT02698098|Narcotics|narcotics|mesh-ancestor
770333|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770334|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770335|NCT02698098|Analgesics|analgesics|mesh-ancestor
770336|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
770337|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770338|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
770339|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
770406|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
770407|NCT02697851|Cobicistat|cobicistat|mesh-list
770408|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
770409|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2239642|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
2239643|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239644|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2239645|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239646|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239647|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2239648|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239649|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
767052|NCT02711358|Indomethacin|indomethacin|mesh-list
767053|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
767054|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
767055|NCT02711358|Analgesics|analgesics|mesh-ancestor
767056|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
767057|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767058|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767059|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
767060|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
767061|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
767062|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
767063|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
767064|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
767065|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767066|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767448|NCT02709863|Propofol|propofol|mesh-list
767449|NCT02709863|Sevoflurane|sevoflurane|mesh-list
767450|NCT02709863|Desflurane|desflurane|mesh-list
767451|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
767452|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767453|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767454|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
767455|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
767456|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
767457|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
767458|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
768168|NCT02707263|Heparin|heparin|mesh-list
768169|NCT02707263|Calcium heparin|calcium heparin|mesh-list
768170|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
768171|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
768172|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
768173|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768491|NCT02705963|Trametinib|trametinib|mesh-list
768492|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
768493|NCT02705963|Norethindrone|norethindrone|mesh-list
768494|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
768495|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
768496|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
768497|NCT02705963|Estradiol|estradiol|mesh-list
768498|NCT02705963|Estrogens|estrogens|mesh-ancestor
768499|NCT02705963|Hormones|hormones|mesh-ancestor
768500|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
768501|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768502|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
768503|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
768504|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
768505|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768506|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
768507|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768508|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768509|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
768510|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
769307|NCT02702778|Prednisone|prednisone|mesh-list
769308|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769309|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
769310|NCT02702778|Hormones|hormones|mesh-ancestor
769311|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
769312|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769313|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
769314|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769599|NCT02701179|Lidocaine|lidocaine|mesh-list
769600|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
769601|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
769602|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
769603|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769604|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769605|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
766944|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
766945|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
766946|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
766947|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
766948|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
766949|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
766950|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
766951|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
766952|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
766953|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
766954|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
766955|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
766956|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
766957|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
766958|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
766959|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
766960|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
766961|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
767366|NCT02710396|Paclitaxel|paclitaxel|mesh-list
767367|NCT02710396|Carboplatin|carboplatin|mesh-list
767368|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
767369|NCT02710396|Pemetrexed|pemetrexed|mesh-list
767370|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
767371|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
767372|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
767373|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
767374|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
767375|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767376|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
767377|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767378|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
767379|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
768284|NCT02706860|Atorvastatin|atorvastatin|mesh-list
768285|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
768286|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
768287|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
768288|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768289|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
768290|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
768291|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768448|NCT02706054|Meloxicam|meloxicam|mesh-list
768449|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
768450|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
768451|NCT02706054|Analgesics|analgesics|mesh-ancestor
768452|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
768453|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768454|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768455|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
768456|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
768457|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
768458|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
768459|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768460|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768793|NCT02704546|Methylphenidate|methylphenidate|mesh-list
768794|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
768795|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768796|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
768797|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
768798|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
768799|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768800|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
768801|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
768988|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
768989|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
768990|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769900|NCT02700022|Prednisone|prednisone|mesh-list
769901|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
769902|NCT02700022|Doxorubicin|doxorubicin|mesh-list
769903|NCT02700022|Etoposide|etoposide|mesh-list
769904|NCT02700022|Vincristine|vincristine|mesh-list
769905|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
769906|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
769907|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769908|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
769909|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
766981|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
766982|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
766983|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
766984|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
766985|NCT02711449|Hormones|hormones|mesh-ancestor
766986|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
766987|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
766988|NCT02711449|Protective Agents|protective agents|mesh-ancestor
766989|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
766990|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
767128|NCT02711202|Sirolimus|sirolimus|mesh-list
767129|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
767130|NCT02711202|Infliximab|infliximab|mesh-list
767131|NCT02711202|Tacrolimus|tacrolimus|mesh-list
767132|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
767133|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
767134|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767135|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
767136|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767137|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767138|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
767139|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767140|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
767141|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
767142|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
767143|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
767144|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
767145|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
767146|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
767328|NCT02710409|Vaccines|vaccines|mesh-list
767329|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
767330|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239650|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
2239651|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2239652|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239653|NCT00096148|Cytarabine|cytarabine|mesh-list
2239654|NCT00096148|Bevacizumab|bevacizumab|mesh-list
768958|NCT02703961|Cisplatin|cisplatin|mesh-list
768959|NCT02703961|Docetaxel|docetaxel|mesh-list
768960|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768961|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
768962|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
768963|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
768964|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239655|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2239656|NCT00096148|Idarubicin|idarubicin|mesh-list
2239657|NCT00096148|Antibodies|antibodies|mesh-list
2239658|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
2239659|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2239660|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239661|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2239662|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2239663|NCT00096148|Growth Substances|growth substances|mesh-ancestor
2239664|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239665|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
2239666|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
2239667|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2239668|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
2239669|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239670|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
2239671|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239672|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2239673|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2239674|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2239675|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2239676|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239677|NCT00096187|Pemetrexed|pemetrexed|mesh-list
2239678|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239679|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239680|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769698|NCT02700529|Ubenimex|ubenimex|mesh-list
769699|NCT02700529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
769700|NCT02700529|Immunologic Factors|immunologic factors|mesh-ancestor
769701|NCT02700529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769702|NCT02700529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
769703|NCT02700529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
769910|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
767163|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
767164|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
767165|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
767442|NCT02710110|Capsaicin|capsaicin|mesh-list
767443|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
767444|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
767445|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
767446|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767447|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753857|NCT02346630|Levodopa|levodopa|mesh-list
2753858|NCT02346630|Carbidopa|carbidopa|mesh-list
2753859|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2753860|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2753861|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
2753862|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2753863|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753864|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753865|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2753866|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767762|NCT02708628|Heparin|heparin|mesh-list
767763|NCT02708628|Allantoin|allantoin|mesh-list
767764|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
767765|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
767766|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
767767|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767768|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
767836|NCT02708251|Lidocaine|lidocaine|mesh-list
767837|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
767838|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
767839|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
767840|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767841|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767842|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
767843|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767844|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
767845|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
767846|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
767847|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
767848|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767849|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
2239681|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2239682|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2239683|NCT00096291|Paclitaxel|paclitaxel|mesh-list
2239684|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2239685|NCT00096291|Doxorubicin|doxorubicin|mesh-list
2239686|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2239687|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2239688|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239689|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
2239690|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
2239691|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
2239692|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239693|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2239694|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2239695|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2239696|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239697|NCT00096304|Docetaxel|docetaxel|mesh-list
2239698|NCT00096304|Epirubicin|epirubicin|mesh-list
2239699|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239700|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
2239701|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
2239702|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
2239703|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239704|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2239705|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2239706|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
767833|NCT02708173|Vaccines|vaccines|mesh-list
767834|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
767835|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767926|NCT02707900|Vorinostat|vorinostat|mesh-list
767927|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
767928|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
767929|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767930|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768148|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
768149|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
768150|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
768257|NCT02706795|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
768258|NCT02706795|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
768259|NCT02706795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
768260|NCT02706795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768261|NCT02706795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768262|NCT02706795|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
768263|NCT02706795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
768264|NCT02706795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768265|NCT02706795|Cholinergic Agents|cholinergic agents|mesh-ancestor
768266|NCT02706795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
768566|NCT02705573|Mannitol|mannitol|mesh-list
768567|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
768568|NCT02705573|Diuretics|diuretics|mesh-ancestor
768569|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
768570|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239707|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239708|NCT00096317|Ketoconazole|ketoconazole|mesh-list
2239709|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
2239710|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239711|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2239712|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2239713|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239714|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768865|NCT02704520|Leucovorin|leucovorin|mesh-list
768866|NCT02704520|Folic Acid|folic acid|mesh-list
768867|NCT02704520|Fluorouracil|fluorouracil|mesh-list
768868|NCT02704520|Capecitabine|capecitabine|mesh-list
768869|NCT02704520|Oxaliplatin|oxaliplatin|mesh-list
768870|NCT02704520|Levoleucovorin|levoleucovorin|mesh-list
768871|NCT02704520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768872|NCT02704520|Antimetabolites|antimetabolites|mesh-ancestor
768873|NCT02704520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768874|NCT02704520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
768875|NCT02704520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768876|NCT02704520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
768877|NCT02704520|Immunologic Factors|immunologic factors|mesh-ancestor
768878|NCT02704520|Antidotes|antidotes|mesh-ancestor
768879|NCT02704520|Protective Agents|protective agents|mesh-ancestor
768880|NCT02704520|Vitamin B Complex|vitamin b complex|mesh-ancestor
768881|NCT02704520|Vitamins|vitamins|mesh-ancestor
768882|NCT02704520|Micronutrients|micronutrients|mesh-ancestor
768883|NCT02704520|Hematinics|hematinics|mesh-ancestor
2239715|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2239716|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
2239717|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2239718|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239719|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2239720|NCT00096330|Folic Acid|folic acid|mesh-list
2239721|NCT00096330|Hematinics|hematinics|mesh-ancestor
2239722|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
2239723|NCT00096330|Vitamins|vitamins|mesh-ancestor
2239724|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
770352|NCT02698228|Morphine|morphine|mesh-list
770353|NCT02698228|Bupivacaine|bupivacaine|mesh-list
770354|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
770355|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
770356|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770357|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770358|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
770359|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770360|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
770361|NCT02698228|Narcotics|narcotics|mesh-ancestor
2093817|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2093818|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2093819|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093820|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093821|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2093822|NCT02266706|Renal Agents|renal agents|mesh-ancestor
2093823|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
2093824|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
767477|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
767478|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
767479|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
767480|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767481|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
767482|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
2239725|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239726|NCT00096343|Paclitaxel|paclitaxel|mesh-list
2239727|NCT00096343|Carboplatin|carboplatin|mesh-list
2239728|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2239729|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239730|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
768174|NCT02707211|Antibodies|antibodies|mesh-list
768175|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
768176|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
768177|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239731|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
2239732|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
2239733|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239734|NCT00096369|Tamoxifen|tamoxifen|mesh-list
2239735|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2239736|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
768684|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
769366|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
769367|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
769368|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
769369|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769370|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
769371|NCT02702128|Coagulants|coagulants|mesh-ancestor
769488|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
769489|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
769490|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
769491|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
769492|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769493|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769494|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
769495|NCT02701478|Analgesics|analgesics|mesh-ancestor
769496|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
769497|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770225|NCT02698514|Sevoflurane|sevoflurane|mesh-list
770226|NCT02698514|Desflurane|desflurane|mesh-list
770227|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
770228|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
770229|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
770230|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
770231|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770232|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770438|NCT02697929|Neostigmine|neostigmine|mesh-list
770439|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
770440|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
770441|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770442|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
770443|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770444|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770445|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
770446|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
770447|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770656|NCT02696733|Cephalosporins|cephalosporins|mesh-list
770657|NCT02696733|Lidocaine|lidocaine|mesh-list
770658|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
770659|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
770660|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770661|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770662|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
770663|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767335|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
767336|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
767337|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767338|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767339|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
767340|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767341|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
767342|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
767343|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
767344|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
767345|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767346|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
767347|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
767348|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
767349|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
767350|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
767351|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
767352|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
767353|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
767354|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
767355|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
767356|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
768000|NCT02707575|Ranibizumab|ranibizumab|mesh-list
768001|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
768002|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
768003|NCT02707575|Growth Substances|growth substances|mesh-ancestor
768004|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768005|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
768006|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768511|NCT02705989|Branebrutinib|branebrutinib|mesh-list
768512|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
768513|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768514|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768887|NCT02704013|Oxybutynin|oxybutynin|mesh-list
768888|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
768889|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
768890|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768891|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768892|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
768893|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
768894|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
768895|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
768896|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768897|NCT02704013|Urological Agents|urological agents|mesh-ancestor
769793|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
769794|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
770048|NCT02699138|Trazodone|trazodone|mesh-list
770049|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
770050|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
770051|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770052|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770053|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
770054|NCT02699138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
770055|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
770056|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
770057|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770058|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770059|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
770060|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
770061|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
770764|NCT02696564|Losartan|losartan|mesh-list
770765|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
770766|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
770767|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
770768|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
770769|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771031|NCT02695563|Lactoferrin|lactoferrin|mesh-list
771032|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239737|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2239738|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239739|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2239740|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
767465|NCT02709902|Adapalene|adapalene|mesh-list
767466|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
767467|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
767468|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
767469|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
767470|NCT02709902|Analgesics|analgesics|mesh-ancestor
767471|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
767472|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767473|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767474|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
767475|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
767476|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
2239741|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2239742|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2239743|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
767991|NCT02707445|Clopidogrel|clopidogrel|mesh-list
767992|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
767993|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
767994|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
767995|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
767996|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
767997|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
767998|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767999|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768226|NCT02707250|Meperidine|meperidine|mesh-list
768227|NCT02707250|Bupivacaine|bupivacaine|mesh-list
768228|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
768229|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
768230|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
768231|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768232|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
768233|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768234|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
768235|NCT02707250|Narcotics|narcotics|mesh-ancestor
768236|NCT02707250|Analgesics|analgesics|mesh-ancestor
768237|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
768515|NCT02705768|Carbamazepine|carbamazepine|mesh-list
768516|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
768517|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
768518|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
768519|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
768520|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
768521|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768522|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
768523|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
768524|NCT02705768|Analgesics|analgesics|mesh-ancestor
768525|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
768526|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768527|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
768528|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
768529|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768530|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
768531|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
768532|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
768833|NCT02704507|Triamcinolone|triamcinolone|mesh-list
768834|NCT02704507|Tretinoin|tretinoin|mesh-list
768835|NCT02704507|Emollients|emollients|mesh-list
768836|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
768837|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
768838|NCT02704507|Hormones|hormones|mesh-ancestor
768839|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
768840|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768841|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768842|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
768843|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
768931|NCT02703896|Esomeprazole|esomeprazole|mesh-list
768932|NCT02703896|Omeprazole|omeprazole|mesh-list
768933|NCT02703896|Pantoprazole|pantoprazole|mesh-list
2239744|NCT00096395|Gemcitabine|gemcitabine|mesh-list
2239745|NCT00096395|Sorafenib|sorafenib|mesh-list
2239746|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
767647|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
767648|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
767649|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767650|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767651|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
767652|NCT02709200|Analgesics|analgesics|mesh-ancestor
767653|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
767654|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
767655|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
767656|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
767657|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
767658|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
767659|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
767660|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239747|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
2239748|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239749|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239750|NCT00096395|Antiviral Agents|antiviral agents|mesh-ancestor
2239751|NCT00096395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239752|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239753|NCT00096395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2239754|NCT00096395|Immunologic Factors|immunologic factors|mesh-ancestor
2239755|NCT00096395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239756|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2239757|NCT00096434|Sorafenib|sorafenib|mesh-list
2239758|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239759|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2239760|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239761|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239762|NCT00096473|Donepezil|donepezil|mesh-list
2239763|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2239764|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239765|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239766|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
2239767|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239768|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239769|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
2239770|NCT00096512|Sorafenib|sorafenib|mesh-list
2239771|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239772|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2239773|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239774|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239775|NCT00096525|Lenalidomide|lenalidomide|mesh-list
2239776|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
2239777|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239778|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2239779|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2239780|NCT00096525|Growth Substances|growth substances|mesh-ancestor
2239781|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
2239782|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239783|NCT00096551|Metronidazole|metronidazole|mesh-list
2239784|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239785|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
768389|NCT02706158|Vitamin D|vitamin d|mesh-list
768390|NCT02706158|Calcium|calcium|mesh-list
768391|NCT02706158|Vitamins|vitamins|mesh-ancestor
768392|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
768393|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768394|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
768395|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2239786|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2239787|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2239788|NCT00096616|Albuterol|albuterol|mesh-list
2239789|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2239790|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
2239791|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239792|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239793|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2239794|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
2239795|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
2239796|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2239797|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
767699|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
767700|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
767701|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767702|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767854|NCT02708446|Misoprostol|misoprostol|mesh-list
767855|NCT02708446|Mifepristone|mifepristone|mesh-list
767856|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
767857|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
767858|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
767859|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767860|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
767861|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
767862|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
767863|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
767864|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
767865|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
767866|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
767867|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
767868|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
767869|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
767870|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
767871|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
767872|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
767873|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
767874|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
768740|NCT02704923|Atropine|atropine|mesh-list
768741|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
768742|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
768743|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
768744|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
768745|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
768746|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
768747|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768748|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768749|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
768750|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
768751|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
768752|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
768753|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
768754|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
768755|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
768756|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
768757|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753884|NCT02264678|Carboplatin|carboplatin|mesh-list
2753885|NCT02264678|Durvalumab|durvalumab|mesh-list
2753886|NCT02264678|Olaparib|olaparib|mesh-list
2753887|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753888|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2753889|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
769084|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
769085|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
769086|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
770004|NCT02699281|Palmidrol|palmidrol|mesh-list
770005|NCT02699281|Analgesics|analgesics|mesh-ancestor
770006|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
770007|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770008|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770009|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
770010|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
770011|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
770012|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
770013|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
770014|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
770015|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
770016|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
770017|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770018|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770019|NCT02699281|Hormones|hormones|mesh-ancestor
770020|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
771293|NCT02693769|Xhance|xhance|mesh-list
2753890|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
767716|NCT02709031|Diuretics|diuretics|mesh-ancestor
767717|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
767718|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767769|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
767770|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
767771|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
767772|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767773|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
767774|NCT02708706|Protective Agents|protective agents|mesh-ancestor
2239798|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2239799|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2239800|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
2239801|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239802|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768365|NCT02706509|Tramadol|tramadol|mesh-list
768366|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
768367|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768368|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
768369|NCT02706509|Narcotics|narcotics|mesh-ancestor
768370|NCT02706509|Analgesics|analgesics|mesh-ancestor
768371|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
768372|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768430|NCT02705872|Sufentanil|sufentanil|mesh-list
768431|NCT02705872|Dsuvia|dsuvia|mesh-list
768432|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
768433|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
768434|NCT02705872|Narcotics|narcotics|mesh-ancestor
768435|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
768436|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768437|NCT02705872|Analgesics|analgesics|mesh-ancestor
768438|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
768439|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768440|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
768441|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
768442|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
768443|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
768444|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
768599|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
768600|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768601|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
768685|NCT02705196|Gemcitabine|gemcitabine|mesh-list
768686|NCT02705196|Paclitaxel|paclitaxel|mesh-list
768687|NCT02705196|Atezolizumab|atezolizumab|mesh-list
768688|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
768689|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768690|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
768691|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
768692|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
768693|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768694|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
768695|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
768696|NCT02705196|Antiviral Agents|antiviral agents|mesh-ancestor
768697|NCT02705196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
768698|NCT02705196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768699|NCT02705196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
768700|NCT02705196|Immunologic Factors|immunologic factors|mesh-ancestor
768701|NCT02705196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769823|NCT02700087|Famotidine|famotidine|mesh-list
769824|NCT02700087|Ranitidine|ranitidine|mesh-list
769825|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
769826|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
769827|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
769828|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
769829|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
769830|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
769831|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
769832|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769833|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239803|NCT00096629|Vaccines|vaccines|mesh-list
2239804|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
2239805|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239806|NCT00096655|Infliximab|infliximab|mesh-list
2239807|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
2239808|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2239809|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2239810|NCT00096668|Paclitaxel|paclitaxel|mesh-list
2239811|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2239812|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
767931|NCT02707874|Ropivacaine|ropivacaine|mesh-list
767932|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
767933|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
767934|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
767935|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767936|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
767937|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768607|NCT02705664|Amorolfine|amorolfine|mesh-list
768608|NCT02705664|Bifonazole|bifonazole|mesh-list
768609|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
768610|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239813|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
2239814|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
2239815|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
2239816|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239817|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
2239818|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2239819|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
2239820|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2239821|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239822|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2239823|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2239824|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
769073|NCT02703415|Tramadol|tramadol|mesh-list
769074|NCT02703415|Bupivacaine|bupivacaine|mesh-list
769075|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
769076|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
769077|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769078|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769079|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
769080|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769081|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
769082|NCT02703415|Narcotics|narcotics|mesh-ancestor
769083|NCT02703415|Analgesics|analgesics|mesh-ancestor
769278|NCT02702739|Ribavirin|ribavirin|mesh-list
769279|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
769280|NCT02702739|Simeprevir|simeprevir|mesh-list
769281|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
769282|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769283|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
769284|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
769285|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
769286|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769340|NCT02702323|Apatinib|apatinib|mesh-list
769341|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769342|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
769343|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769344|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769811|NCT02701205|Etanercept|etanercept|mesh-list
769812|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
769813|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
769814|NCT02701205|Analgesics|analgesics|mesh-ancestor
769815|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
769816|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769817|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769818|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769819|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
769820|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
769821|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
769822|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
770286|NCT02698280|Bevacizumab|bevacizumab|mesh-list
770287|NCT02698280|Nimustine|nimustine|mesh-list
770288|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
770289|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770290|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
770291|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
770292|NCT02698280|Growth Substances|growth substances|mesh-ancestor
770293|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770294|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
2239825|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
2239826|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
2239827|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239828|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
2239829|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239830|NCT00096720|Levodopa|levodopa|mesh-list
2239831|NCT00096720|Pramipexole|pramipexole|mesh-list
2239832|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2239833|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
767942|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
767943|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
767944|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
767945|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
2239834|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
2239835|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2239836|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239837|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239838|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
2239839|NCT00096720|Protective Agents|protective agents|mesh-ancestor
2239840|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
2239841|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2239842|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2239843|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2239844|NCT00096811|Entecavir|entecavir|mesh-list
2239845|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
2239846|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239847|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
2239848|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239849|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2239850|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
2239851|NCT00096850|Ritonavir|ritonavir|mesh-list
2239852|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
769385|NCT02701933|Ketamine|ketamine|mesh-list
769386|NCT02701933|Analgesics|analgesics|mesh-ancestor
769387|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
769388|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769389|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769390|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
769391|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
769392|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
769393|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
769394|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769395|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
769396|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
769397|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
769398|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239853|NCT00096850|Rifampin|rifampin|mesh-list
2239854|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2239855|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2239856|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
2239857|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239858|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239859|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
769612|NCT02700893|Atropine|atropine|mesh-list
769613|NCT02700893|Sufentanil|sufentanil|mesh-list
769614|NCT02700893|Propofol|propofol|mesh-list
769615|NCT02700893|Atracurium|atracurium|mesh-list
769616|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
769617|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769618|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769619|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
769620|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
769621|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
769622|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
769623|NCT02700893|Narcotics|narcotics|mesh-ancestor
769624|NCT02700893|Analgesics|analgesics|mesh-ancestor
769625|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
769626|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769627|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
769628|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
769629|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
769630|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
769631|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
769632|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
769633|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
769634|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
769635|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
769636|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
769637|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
769638|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
769639|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769640|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
769641|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
769642|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2239860|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
768094|NCT02707315|Antiviral Agents|antiviral agents|mesh-ancestor
768098|NCT02707315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
768099|NCT02707315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768100|NCT02707315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
768101|NCT02707315|Immunologic Factors|immunologic factors|mesh-ancestor
768102|NCT02707315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768341|NCT02706535|Itraconazole|itraconazole|mesh-list
768342|NCT02706535|Rifampin|rifampin|mesh-list
768343|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
768344|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
768345|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
768346|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
768347|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768348|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768349|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
768350|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
768351|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
768352|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768353|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
768354|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
768355|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
768356|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
768357|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
768358|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
768359|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
768360|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
768361|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
768362|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
768363|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
768364|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
768578|NCT02705482|Durvalumab|durvalumab|mesh-list
768579|NCT02705482|Tremelimumab|tremelimumab|mesh-list
768580|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
768581|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768702|NCT02704962|Olanzapine|olanzapine|mesh-list
768703|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
768704|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
768705|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768706|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768707|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
768708|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
768709|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
768710|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
768711|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
768712|NCT02704962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
768713|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
768714|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
768715|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768716|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
768717|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
768762|NCT02704598|Warfarin|warfarin|mesh-list
768763|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
768764|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
768765|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
768766|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
768767|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
768768|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
768769|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768770|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769287|NCT02702661|Anesthetics|anesthetics|mesh-list
769288|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
769289|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
769290|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769291|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769292|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
769293|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769834|NCT02700048|Naloxone|naloxone|mesh-list
769835|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
769836|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769837|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
769838|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769855|NCT02699658|Levofloxacin|levofloxacin|mesh-list
769856|NCT02699658|Ofloxacin|ofloxacin|mesh-list
769857|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
768270|NCT02706678|Tacrolimus|tacrolimus|mesh-list
768271|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
768272|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
768273|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768274|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
768275|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768276|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768466|NCT02706015|Dipyrone|dipyrone|mesh-list
768467|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
768468|NCT02706015|Caffeine|caffeine|mesh-list
768469|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
768470|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768471|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
768472|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768473|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768474|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
768475|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
768476|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
768477|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
768478|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
768479|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
768480|NCT02706015|Analgesics|analgesics|mesh-ancestor
768481|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
768482|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768483|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
768484|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
768485|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
768486|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
768487|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
768488|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
768558|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
768559|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
768560|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
768561|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
768562|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768563|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
768564|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
768565|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768967|NCT02703649|Letrozole|letrozole|mesh-list
768968|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768969|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
768970|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
768971|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768972|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768973|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
768974|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
768975|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
768976|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769057|NCT02703363|Minocycline|minocycline|mesh-list
769058|NCT02703363|Celecoxib|celecoxib|mesh-list
769059|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
769060|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
769061|NCT02703363|Analgesics|analgesics|mesh-ancestor
769062|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
769063|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769064|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769065|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769066|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
769067|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
769068|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
769069|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769070|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769071|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
769072|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
769210|NCT02703051|Lenograstim|lenograstim|mesh-list
769211|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
769212|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
769213|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239861|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
2239862|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239863|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2239864|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2239865|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
768373|NCT02706236|Pancrelipase|pancrelipase|mesh-list
768374|NCT02706236|Pancreatin|pancreatin|mesh-list
768375|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
768489|NCT02705976|Warfarin|warfarin|mesh-list
768490|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
768611|NCT02705638|Rituximab|rituximab|mesh-list
768612|NCT02705638|Lenalidomide|lenalidomide|mesh-list
768613|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
768614|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768615|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
768616|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768617|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
768618|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
768619|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
768620|NCT02705638|Growth Substances|growth substances|mesh-ancestor
768621|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
768671|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
768672|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
768811|NCT02704208|Nicotine|nicotine|mesh-list
768812|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
768813|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
768814|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768815|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768816|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
768817|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
768818|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
768819|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
768820|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768983|NCT02703571|Trametinib|trametinib|mesh-list
768984|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
768985|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
768986|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768987|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769241|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
769242|NCT02702960|Prednisone|prednisone|mesh-list
769243|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
769244|NCT02702960|Fludarabine|fludarabine|mesh-list
769245|NCT02702960|Tacrolimus|tacrolimus|mesh-list
769246|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
769247|NCT02702960|Mesna|mesna|mesh-list
769248|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
769249|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
769250|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769251|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
769252|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
769253|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
769254|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769255|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769256|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
769257|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769258|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
769259|NCT02702960|Hormones|hormones|mesh-ancestor
769260|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
769261|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
769262|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
769263|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769264|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
769265|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
769266|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
769267|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
769268|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
769269|NCT02702960|Protective Agents|protective agents|mesh-ancestor
769315|NCT02702492|Niacin|niacin|mesh-list
769316|NCT02702492|Nivolumab|nivolumab|mesh-list
769317|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
769318|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769319|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
769320|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769321|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
769322|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
769323|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
769324|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
769325|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
769326|NCT02702492|Vitamins|vitamins|mesh-ancestor
769327|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
769328|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769995|NCT02699528|Methylphenidate|methylphenidate|mesh-list
770187|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
768420|NCT02705950|Baclofen|baclofen|mesh-list
768421|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
768422|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768423|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
768424|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768425|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
768426|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
768427|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
768428|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
768429|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239866|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
2239867|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2239868|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
2239869|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2239870|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2239871|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2239872|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2239873|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2239874|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2239875|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2239876|NCT00096863|Haloperidol|haloperidol|mesh-list
2239877|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
2239878|NCT00096863|Ziprasidone|ziprasidone|mesh-list
2239879|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
2239880|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
2239881|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2239882|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239883|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2239884|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2239885|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2239886|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239887|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239888|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2239889|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
2239890|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
769228|NCT02702817|Naproxen|naproxen|mesh-list
769229|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
769230|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
769231|NCT02702817|Analgesics|analgesics|mesh-ancestor
769232|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
769233|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769234|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769235|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769236|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
769237|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
769238|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
769239|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769240|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769478|NCT02701348|Letrozole|letrozole|mesh-list
769479|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
769480|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769481|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
769482|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769483|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769484|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
769485|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
769486|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
769487|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769644|NCT02701166|Bezafibrate|bezafibrate|mesh-list
769645|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
769646|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
769647|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769648|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
770062|NCT02698982|Anesthetics|anesthetics|mesh-list
770063|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770064|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093825|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
2093826|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2093827|NCT02266888|Rituximab|rituximab|mesh-list
2093828|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2093829|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093830|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
2093831|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770474|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
768576|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
768577|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
768658|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
768659|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
768660|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768821|NCT02704494|Losartan|losartan|mesh-list
768822|NCT02704494|Resveratrol|resveratrol|mesh-list
768823|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
768824|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
768825|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
768826|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
768827|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768828|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
768829|NCT02704494|Protective Agents|protective agents|mesh-ancestor
768830|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768831|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768832|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2239891|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239892|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2239893|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2239894|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
2239895|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
2239896|NCT00096915|Hematinics|hematinics|mesh-ancestor
769345|NCT02702349|Penicillins|penicillins|mesh-list
769346|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
769347|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239897|NCT00096967|Bevacizumab|bevacizumab|mesh-list
2239898|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2239899|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239900|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2239901|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2239902|NCT00096967|Growth Substances|growth substances|mesh-ancestor
2239903|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239904|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
2239905|NCT00097019|Bevacizumab|bevacizumab|mesh-list
2239906|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2239907|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239908|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2239909|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2239910|NCT00097019|Growth Substances|growth substances|mesh-ancestor
2239911|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239912|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
2239913|NCT00097032|Risperidone|risperidone|mesh-list
2239914|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2239915|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2239916|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
2239917|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
769868|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
769869|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
769870|NCT02699827|Analgesics|analgesics|mesh-ancestor
769871|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
769872|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769873|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769874|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
769875|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769876|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
769877|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
769878|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
769879|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
769880|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769881|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
769882|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
769883|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
769884|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
2093832|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093833|NCT02267083|Doxorubicin|doxorubicin|mesh-list
2093834|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2093835|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093836|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2093837|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
771121|NCT02695355|Methylphenidate|methylphenidate|mesh-list
771122|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
771123|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771124|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
771294|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
768681|NCT02705014|Hormones|hormones|mesh-list
768682|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
768683|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768727|NCT02704624|Vitamin D|vitamin d|mesh-list
768728|NCT02704624|Vitamins|vitamins|mesh-ancestor
768729|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
768730|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768731|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2753891|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753902|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2753903|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
2753904|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769661|NCT02701127|Niacinamide|niacinamide|mesh-list
769662|NCT02701127|Niacin|niacin|mesh-list
769663|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
769664|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
769665|NCT02701127|Vitamins|vitamins|mesh-ancestor
769666|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
769667|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769668|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
769669|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
769670|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769671|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
769672|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
770448|NCT02697838|Paclitaxel|paclitaxel|mesh-list
770449|NCT02697838|Apatinib|apatinib|mesh-list
770450|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
770451|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770452|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
770453|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
770454|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
770455|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770456|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
770457|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239918|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239919|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239920|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2239921|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2093838|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093839|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093840|NCT02267187|Anesthetics|anesthetics|mesh-list
2093841|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2093842|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093843|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
2093844|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2093845|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2093846|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093847|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2093848|NCT02267538|Analgesics|analgesics|mesh-ancestor
2093849|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
2093850|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
768679|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768680|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
768724|NCT02704715|Anesthetics|anesthetics|mesh-list
768725|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
768726|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768898|NCT02704052|Enoxaparin|enoxaparin|mesh-list
768899|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
768900|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
768901|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
768902|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
768903|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239922|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239923|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239924|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2239925|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
2239926|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
2239927|NCT00097045|Interferons|interferons|mesh-list
2239928|NCT00097045|Ribavirin|ribavirin|mesh-list
2239929|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
2239930|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769430|NCT02701608|Levofloxacin|levofloxacin|mesh-list
769431|NCT02701608|Ofloxacin|ofloxacin|mesh-list
769432|NCT02701608|Rifampin|rifampin|mesh-list
769433|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
769434|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
769435|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
769436|NCT02701608|Renal Agents|renal agents|mesh-ancestor
769437|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
769438|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
769439|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
769440|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769441|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769442|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769443|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
769444|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
769445|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
769446|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
769447|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
769448|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
769449|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
769450|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
769451|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
769452|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
769453|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
769454|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2239931|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
2239932|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239933|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
2239934|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239935|NCT00097071|Insulin|insulin|mesh-list
2239936|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2239937|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
2239938|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
2239939|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2239940|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239941|NCT00097084|Insulin|insulin|mesh-list
2239942|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2239943|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
2239944|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
2239945|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
769959|NCT02699710|Folic Acid|folic acid|mesh-list
769960|NCT02699710|Methotrexate|methotrexate|mesh-list
769961|NCT02699710|Rabeprazole|rabeprazole|mesh-list
769962|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
769963|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
769964|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
769965|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769966|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
769967|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
769968|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769969|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769970|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
769971|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769972|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2239946|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2239947|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239948|NCT00097110|Ascorbic Acid|ascorbic acid|mesh-list
768737|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
768738|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
768739|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239949|NCT00097110|Vitamins|vitamins|mesh-ancestor
2239950|NCT00097110|Micronutrients|micronutrients|mesh-ancestor
2239951|NCT00097110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239952|NCT00097110|Antioxidants|antioxidants|mesh-ancestor
2239953|NCT00097110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239954|NCT00097110|Protective Agents|protective agents|mesh-ancestor
2239955|NCT00097123|Misoprostol|misoprostol|mesh-list
2239956|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2239957|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
2239958|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2239959|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239960|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2239961|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2239962|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
2239963|NCT00097188|Rituximab|rituximab|mesh-list
2239964|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2239965|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239966|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
770716|NCT02697344|Acetic Acid|acetic acid|mesh-list
770717|NCT02697344|Dexamethasone|dexamethasone|mesh-list
770718|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
770719|NCT02697344|Lenalidomide|lenalidomide|mesh-list
770720|NCT02697344|Retinol acetate|retinol acetate|mesh-list
770721|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
770722|NCT02697344|Gossypol|gossypol|mesh-list
770723|NCT02697344|BB 1101|bb 1101|mesh-list
770724|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
770725|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
770726|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
770727|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770728|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770729|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
770730|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
770731|NCT02697344|Hormones|hormones|mesh-ancestor
770732|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
770733|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
770734|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770735|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
770736|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
770737|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
770738|NCT02697344|Growth Substances|growth substances|mesh-ancestor
770739|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
770740|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
770741|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
770742|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770743|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
770744|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
770745|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
770746|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
770747|NCT02697344|Protective Agents|protective agents|mesh-ancestor
770748|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
770749|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
770750|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
770751|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
770752|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
770753|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
770754|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
770958|NCT02696122|Anesthetics|anesthetics|mesh-list
770959|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770960|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770990|NCT02695654|Clonidine|clonidine|mesh-list
770991|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
770992|NCT02695654|Analgesics|analgesics|mesh-ancestor
770993|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
770994|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770995|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770996|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
770997|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
770998|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
770999|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
771000|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
771001|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
771002|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
768773|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
768774|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
768775|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768776|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
768777|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
768778|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
769038|NCT02703610|Acetaminophen|acetaminophen|mesh-list
769039|NCT02703610|Ibuprofen|ibuprofen|mesh-list
769040|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
769041|NCT02703610|Oxycodone|oxycodone|mesh-list
769042|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
769043|NCT02703610|Analgesics|analgesics|mesh-ancestor
769044|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
769045|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769046|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769047|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
769048|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
769049|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769050|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
769051|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
769052|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769053|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769054|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
769055|NCT02703610|Narcotics|narcotics|mesh-ancestor
769056|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769220|NCT02703090|Remifentanil|remifentanil|mesh-list
769221|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
769222|NCT02703090|Narcotics|narcotics|mesh-ancestor
769223|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769224|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769225|NCT02703090|Analgesics|analgesics|mesh-ancestor
769226|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
769227|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769774|NCT02700451|Acetaminophen|acetaminophen|mesh-list
769775|NCT02700451|Ketorolac|ketorolac|mesh-list
769776|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
769777|NCT02700451|Analgesics|analgesics|mesh-ancestor
769778|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
769779|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769780|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769781|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
769782|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
769783|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769784|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
769785|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
769786|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769787|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239967|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239968|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2239969|NCT00097214|Carboplatin|carboplatin|mesh-list
2239970|NCT00097214|Cetuximab|cetuximab|mesh-list
2239971|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771355|NCT02693574|Amoxicillin|amoxicillin|mesh-list
771356|NCT02693574|Clarithromycin|clarithromycin|mesh-list
771357|NCT02693574|Levofloxacin|levofloxacin|mesh-list
771358|NCT02693574|Ofloxacin|ofloxacin|mesh-list
771359|NCT02693574|Esomeprazole|esomeprazole|mesh-list
771360|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
771361|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
771362|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
771363|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
771364|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
771365|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771366|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771367|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
771368|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
771369|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
771370|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
771371|NCT02693574|Renal Agents|renal agents|mesh-ancestor
771372|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
771373|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
771374|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771375|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
771414|NCT02692989|Anesthetics|anesthetics|mesh-list
771415|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
771416|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768859|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
768860|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
768861|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
768862|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
768863|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
768864|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2239972|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2239973|NCT00097227|Paclitaxel|paclitaxel|mesh-list
2239974|NCT00097227|Carboplatin|carboplatin|mesh-list
769214|NCT02702843|Xenon|xenon|mesh-list
769215|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
769216|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
769217|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
769218|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769219|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769984|NCT02699840|Vaccines|vaccines|mesh-list
769985|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
769986|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093851|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2093852|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2093853|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
771323|NCT02694224|Paclitaxel|paclitaxel|mesh-list
771324|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
771325|NCT02694224|Epirubicin|epirubicin|mesh-list
771326|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
771327|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771328|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
771329|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
771330|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
771331|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771332|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
771333|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
771334|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771335|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
771336|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
771337|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
771338|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
771339|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
771340|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
771341|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
771342|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771411|NCT02693392|Metformin|metformin|mesh-list
771412|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
771413|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771818|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
771819|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
771820|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771821|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771822|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
771823|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
771824|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
771825|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2239975|NCT00097227|Cetuximab|cetuximab|mesh-list
2239976|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2239977|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2239978|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
2239979|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
2093854|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
2093855|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093856|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093857|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
2093858|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2093859|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093860|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
2093861|NCT02267746|Tazarotene|tazarotene|mesh-list
2093862|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
2093863|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
2093864|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
2093865|NCT02267746|Vitamins|vitamins|mesh-ancestor
2093866|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
2093867|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093868|NCT02267772|Acetaminophen|acetaminophen|mesh-list
2093869|NCT02267772|Morphine|morphine|mesh-list
2093870|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2093871|NCT02267772|Narcotics|narcotics|mesh-ancestor
2093872|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2093873|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768934|NCT02703896|Lansoprazole|lansoprazole|mesh-list
768935|NCT02703896|Famotidine|famotidine|mesh-list
768936|NCT02703896|Ranitidine|ranitidine|mesh-list
768937|NCT02703896|Cimetidine|cimetidine|mesh-list
768938|NCT02703896|Nizatidine|nizatidine|mesh-list
768939|NCT02703896|Lafutidine|lafutidine|mesh-list
768940|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
768941|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
768942|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
768943|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
768944|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
768945|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
768946|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
768947|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
768948|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
768949|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
768950|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
768951|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
769275|NCT02702700|Verteporfin|verteporfin|mesh-list
769276|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
769277|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
2093874|NCT02267772|Analgesics|analgesics|mesh-ancestor
2093875|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
2093876|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093877|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2093878|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
2093879|NCT02268045|Rituximab|rituximab|mesh-list
2093880|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2093881|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093882|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
2093883|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093884|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093885|NCT02268058|Acetaminophen|acetaminophen|mesh-list
2093886|NCT02268058|Ibuprofen|ibuprofen|mesh-list
2093887|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2093888|NCT02268058|Analgesics|analgesics|mesh-ancestor
769795|NCT02700217|Remifentanil|remifentanil|mesh-list
769796|NCT02700217|Heroin|heroin|mesh-list
769797|NCT02700217|Bupivacaine|bupivacaine|mesh-list
769798|NCT02700217|Propofol|propofol|mesh-list
769799|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
769800|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
769801|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769802|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769803|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
769804|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769805|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
769806|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
769807|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
769808|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
769809|NCT02700217|Narcotics|narcotics|mesh-ancestor
769810|NCT02700217|Analgesics|analgesics|mesh-ancestor
770079|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
770080|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
770081|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
770082|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770083|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
770084|NCT02698813|Protective Agents|protective agents|mesh-ancestor
770477|NCT02697474|Vaccines|vaccines|mesh-list
770478|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
770479|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770671|NCT02696837|Rocuronium|rocuronium|mesh-list
770672|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
770673|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
770674|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
770675|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770676|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771221|NCT02694588|Infliximab|infliximab|mesh-list
771222|NCT02694588|Vedolizumab|vedolizumab|mesh-list
771223|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
771224|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
771225|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
771320|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
771321|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
771322|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239980|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
2239981|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239982|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2093889|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
769002|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
769003|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769004|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
769005|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
769006|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
769007|NCT02703740|Protective Agents|protective agents|mesh-ancestor
769087|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
769088|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
769089|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
769090|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
769091|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769092|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769093|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
769094|NCT02703233|Analgesics|analgesics|mesh-ancestor
769095|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
769096|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093890|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093891|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093892|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
769845|NCT02699879|Pirfenidone|pirfenidone|mesh-list
769846|NCT02699879|Analgesics|analgesics|mesh-ancestor
769847|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
769848|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769849|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769850|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
769851|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
769852|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769853|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
769854|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770085|NCT02698891|Paclitaxel|paclitaxel|mesh-list
770086|NCT02698891|Cyclophosphamide|cyclophosphamide|mesh-list
770087|NCT02698891|Doxorubicin|doxorubicin|mesh-list
770088|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
770089|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770090|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
770091|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
770092|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
770093|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770094|NCT02698891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
770095|NCT02698891|Immunologic Factors|immunologic factors|mesh-ancestor
770096|NCT02698891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770097|NCT02698891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
770098|NCT02698891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
770099|NCT02698891|Alkylating Agents|alkylating agents|mesh-ancestor
770100|NCT02698891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
770101|NCT02698891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
770102|NCT02698891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
770103|NCT02698891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
770104|NCT02698891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
770280|NCT02698124|Decitabine|decitabine|mesh-list
770281|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
770282|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
770283|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770284|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770285|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2239983|NCT00097266|Haloperidol|haloperidol|mesh-list
2239984|NCT00097266|Aripiprazole|aripiprazole|mesh-list
2239985|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
2239986|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
2239987|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239988|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2239989|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2239990|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2239991|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239992|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
2239993|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
2239994|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770645|NCT02696694|Progesterone|progesterone|mesh-list
770646|NCT02696694|Progestins|progestins|mesh-ancestor
770647|NCT02696694|Hormones|hormones|mesh-ancestor
770648|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
770649|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2239995|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2239996|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2239997|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
769137|NCT02703194|Prednisolone|prednisolone|mesh-list
769138|NCT02703194|Leflunomide|leflunomide|mesh-list
769139|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769140|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
769141|NCT02703194|Hormones|hormones|mesh-ancestor
769142|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
769143|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769144|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
769145|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769146|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769147|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769148|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
769149|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
769348|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
769349|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
769350|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769727|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
769728|NCT02700711|Methylphenidate|methylphenidate|mesh-list
769729|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
769730|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769731|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
769732|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
769733|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
769734|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769735|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
769736|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
769737|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
769738|NCT02700711|Analgesics|analgesics|mesh-ancestor
769739|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
769740|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769741|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
769742|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2239998|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
2239999|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2240000|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2240001|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2240002|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2240003|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
2240004|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
2240005|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2240006|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2240007|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2240008|NCT00097279|Metformin|metformin|mesh-list
2240009|NCT00097279|Pioglitazone|pioglitazone|mesh-list
2240010|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
2240011|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
770865|NCT02696330|Enoxaparin|enoxaparin|mesh-list
770866|NCT02696330|Clopidogrel|clopidogrel|mesh-list
770867|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
770868|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
770869|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
770870|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
770871|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
770872|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770873|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770874|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770875|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
770876|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
770877|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
770984|NCT02695810|Metformin|metformin|mesh-list
770985|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
770986|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
770987|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770988|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
770989|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771226|NCT02694653|Acetaminophen|acetaminophen|mesh-list
771227|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
771228|NCT02694653|Analgesics|analgesics|mesh-ancestor
771229|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
771230|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771231|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771232|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
771292|NCT02693769|Fluticasone|fluticasone|mesh-list
2240012|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
769156|NCT02703272|Dexamethasone|dexamethasone|mesh-list
769157|NCT02703272|Rituximab|rituximab|mesh-list
769158|NCT02703272|Carboplatin|carboplatin|mesh-list
769159|NCT02703272|Etoposide|etoposide|mesh-list
769160|NCT02703272|Vincristine|vincristine|mesh-list
769161|NCT02703272|Ifosfamide|ifosfamide|mesh-list
769162|NCT02703272|Idarubicin|idarubicin|mesh-list
769163|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769164|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
769165|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
769166|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769167|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769168|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
769169|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
769170|NCT02703272|Hormones|hormones|mesh-ancestor
769171|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
769172|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
769173|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769174|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
769175|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
769176|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
769177|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
769178|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
769179|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
769180|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769181|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769182|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
769183|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
769184|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
769185|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
769186|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
769187|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
769329|NCT02702206|Triamcinolone|triamcinolone|mesh-list
769330|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
769331|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769332|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
769333|NCT02702206|Hormones|hormones|mesh-ancestor
769334|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
769335|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769336|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
769337|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
769338|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
769339|NCT02702206|Protective Agents|protective agents|mesh-ancestor
2093893|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2240013|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240014|NCT00097318|Interferons|interferons|mesh-list
2240015|NCT00097318|Interferon-beta|interferon-beta|mesh-list
2240016|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
2240017|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770065|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
770066|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
770067|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770068|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770069|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
770070|NCT02698930|Analgesics|analgesics|mesh-ancestor
770071|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
770072|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770073|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
770074|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
770075|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
770076|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
770077|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770078|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770199|NCT02698553|Bupropion|bupropion|mesh-list
770200|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
770201|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
770202|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
770203|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
770204|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
770205|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
770206|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770207|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
770208|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770209|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770210|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
769194|NCT02703623|Ipilimumab|ipilimumab|mesh-list
769195|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
769196|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769197|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769198|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
769199|NCT02703623|Hormones|hormones|mesh-ancestor
769200|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
769201|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769202|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
769203|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
769204|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
769205|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769206|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
769207|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769208|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
769209|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
769294|NCT02702674|Propranolol|propranolol|mesh-list
769295|NCT02702674|Oxytocin|oxytocin|mesh-list
769296|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
769297|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
769298|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769299|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
769300|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
769301|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
769302|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
769303|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769304|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
769305|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
769306|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
2240018|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
2240019|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240020|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
2240021|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240022|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2240023|NCT00097344|Toremifene|toremifene|mesh-list
769991|NCT02699437|Antibodies|antibodies|mesh-list
769992|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
769993|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
769994|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770505|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
770506|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
770507|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770508|NCT02697253|Incretins|incretins|mesh-ancestor
770509|NCT02697253|Hormones|hormones|mesh-ancestor
770510|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
770511|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
770512|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
770513|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
770514|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770600|NCT02697032|Bicalutamide|bicalutamide|mesh-list
770601|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
770602|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
770603|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
770604|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770605|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770878|NCT02696369|Lidocaine|lidocaine|mesh-list
770879|NCT02696369|Epinephrine|epinephrine|mesh-list
770880|NCT02696369|Racepinephrine|racepinephrine|mesh-list
770881|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
770882|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
770883|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
770884|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770885|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770886|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
770887|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770888|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
770889|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
770890|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
770891|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
770892|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770893|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
770894|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
770895|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
771295|NCT02693769|Bromides|bromides|mesh-list
769351|NCT02702180|Molgramostim|molgramostim|mesh-list
769352|NCT02702180|Sargramostim|sargramostim|mesh-list
769353|NCT02702180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769354|NCT02702180|Immunologic Factors|immunologic factors|mesh-ancestor
769355|NCT02702180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769402|NCT02701595|Amoxicillin|amoxicillin|mesh-list
769403|NCT02701595|Vancomycin|vancomycin|mesh-list
769404|NCT02701595|Gentamicins|gentamicins|mesh-list
769405|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
769406|NCT02701595|Penicillins|penicillins|mesh-list
769407|NCT02701595|Penicillin G|penicillin g|mesh-list
769408|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
769409|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
769410|NCT02701595|Netilmicin|netilmicin|mesh-list
769411|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
769412|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
769413|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
769414|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769415|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769649|NCT02700906|Lidocaine|lidocaine|mesh-list
769650|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
769651|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
769652|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769653|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769654|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
769655|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769656|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
769657|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
769658|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
769659|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
769660|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769712|NCT02700685|Methylphenidate|methylphenidate|mesh-list
769713|NCT02700685|Pycnogenols|pycnogenols|mesh-list
769714|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
769715|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769716|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
769717|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
769718|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
769719|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769720|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
769721|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
769722|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
769723|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
769724|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
769725|NCT02700685|Protective Agents|protective agents|mesh-ancestor
769726|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
769927|NCT02699723|Itraconazole|itraconazole|mesh-list
769928|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
769929|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
769930|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
769931|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
769932|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
769933|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769934|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769935|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
769936|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
769937|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
769938|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769939|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
769940|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770021|NCT02699385|Domperidone|domperidone|mesh-list
770022|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
770023|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
770024|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770025|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770026|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
770027|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
770028|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
770029|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770030|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770268|NCT02698267|Itraconazole|itraconazole|mesh-list
770269|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
770270|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
770271|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
770362|NCT02698228|Analgesics|analgesics|mesh-ancestor
2240024|NCT00097344|Letrozole|letrozole|mesh-list
2240025|NCT00097344|Hormones|hormones|mesh-list
2240026|NCT00097344|Atamestane|atamestane|mesh-list
769760|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
769761|NCT02700347|Allopurinol|allopurinol|mesh-list
769762|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
769763|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769764|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769765|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
769766|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
769767|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
769768|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
769769|NCT02700347|Protective Agents|protective agents|mesh-ancestor
769770|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769771|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
769772|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
769773|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
770125|NCT02698995|Acetaminophen|acetaminophen|mesh-list
770126|NCT02698995|Dexamethasone|dexamethasone|mesh-list
770127|NCT02698995|Lidocaine|lidocaine|mesh-list
770128|NCT02698995|Morphine|morphine|mesh-list
770129|NCT02698995|Ropivacaine|ropivacaine|mesh-list
770130|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
770131|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
770132|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
770133|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770134|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770135|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
770136|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
770137|NCT02698995|Hormones|hormones|mesh-ancestor
770138|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
770139|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
770140|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770141|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
770142|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
770143|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770144|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
770145|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
770146|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
770147|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
770148|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
770149|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770150|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
770151|NCT02698995|Narcotics|narcotics|mesh-ancestor
770152|NCT02698995|Analgesics|analgesics|mesh-ancestor
770153|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
770154|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
2093894|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2240027|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
2240028|NCT00097344|Estrogens|estrogens|mesh-list
2240029|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
2240030|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
2240031|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2240032|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240033|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240034|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2240035|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2240036|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240037|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240038|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
770976|NCT02695797|Prednisolone|prednisolone|mesh-list
770977|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
770978|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
770979|NCT02695797|Hormones|hormones|mesh-ancestor
770980|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
770981|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770982|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
770983|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240039|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2240040|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2240041|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2240042|NCT00097357|Enoxaparin|enoxaparin|mesh-list
2240043|NCT00097357|Warfarin|warfarin|mesh-list
2240044|NCT00097357|Enoxaparin sodium|enoxaparin sodium|mesh-list
2240045|NCT00097357|Apixaban|apixaban|mesh-list
2240046|NCT00097357|Anticoagulants|anticoagulants|mesh-ancestor
2240047|NCT00097357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
769469|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
769470|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769471|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
769472|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
769473|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
769474|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
769475|NCT02701673|Vitamins|vitamins|mesh-ancestor
769476|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
769477|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
769544|NCT02701309|Iron|iron|mesh-list
769545|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
769546|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
769547|NCT02701309|Trace Elements|trace elements|mesh-ancestor
769548|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
769549|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769550|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
769551|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
769552|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769553|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770523|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
770524|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
770525|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
770526|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
770843|NCT02696642|Maytansine|maytansine|mesh-list
770844|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
770845|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770846|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
770847|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
770848|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
770849|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771242|NCT02694289|Metformin|metformin|mesh-list
771243|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
771244|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771510|NCT02692534|Cocaine|cocaine|mesh-list
771511|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
771512|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
771513|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
771514|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771515|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
771516|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771517|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
771518|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
771519|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
771520|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
771521|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771522|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
771523|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
771544|NCT02692248|Gemcitabine|gemcitabine|mesh-list
771545|NCT02692248|Dexamethasone|dexamethasone|mesh-list
771546|NCT02692248|Rituximab|rituximab|mesh-list
771547|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
771548|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
771549|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
771550|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
771551|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771552|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771553|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
771554|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
771555|NCT02692248|Hormones|hormones|mesh-ancestor
771556|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
771557|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
771558|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771559|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
771560|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
771561|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
771562|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
771563|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
771564|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771565|NCT02692248|Antiviral Agents|antiviral agents|mesh-ancestor
771566|NCT02692248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
771567|NCT02692248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771568|NCT02692248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240048|NCT00097357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2240049|NCT00097357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772120|NCT02689388|Anesthetics|anesthetics|mesh-list
2240050|NCT00097357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2240051|NCT00097357|Antithrombins|antithrombins|mesh-ancestor
2240052|NCT00097357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2240053|NCT00097357|Protease Inhibitors|protease inhibitors|mesh-ancestor
2240054|NCT00097357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240055|NCT00097383|Epirubicin|epirubicin|mesh-list
2240056|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2240057|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240058|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2240059|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2240060|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240061|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240062|NCT00097435|Ribavirin|ribavirin|mesh-list
2240063|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
2240064|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240065|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
2240066|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
771049|NCT02695641|Bevacizumab|bevacizumab|mesh-list
771050|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
771051|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771052|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
771053|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
771054|NCT02695641|Growth Substances|growth substances|mesh-ancestor
771055|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771056|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
771135|NCT02695212|Apremilast|apremilast|mesh-list
771136|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
771137|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
771138|NCT02695212|Analgesics|analgesics|mesh-ancestor
771139|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
771140|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771141|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771142|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
771143|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
771144|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
771145|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
771146|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771147|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240075|NCT00097734|Ertapenem|ertapenem|mesh-list
2240076|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2240077|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240078|NCT00097760|Natalizumab|natalizumab|mesh-list
2240079|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
2240080|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240081|NCT00097799|Ritonavir|ritonavir|mesh-list
2240082|NCT00097799|Tipranavir|tipranavir|mesh-list
2240083|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2240084|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2240085|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
771645|NCT02691754|Acetaminophen|acetaminophen|mesh-list
771646|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
771647|NCT02691754|Analgesics|analgesics|mesh-ancestor
771648|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
771649|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771650|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771651|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
771862|NCT02690883|Exenatide|exenatide|mesh-list
771863|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
771864|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771865|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
771866|NCT02690883|Incretins|incretins|mesh-ancestor
771867|NCT02690883|Hormones|hormones|mesh-ancestor
771868|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
772386|NCT02688881|Sirolimus|sirolimus|mesh-list
772387|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
772388|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240086|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240087|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769532|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769533|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
769534|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769535|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
769536|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
769537|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
769538|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
769539|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
769540|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
769541|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
769542|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
769543|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
769675|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
769676|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
769677|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769688|NCT02700568|Axitinib|axitinib|mesh-list
769689|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769690|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
769691|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769692|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769941|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
769942|NCT02699801|Propofol|propofol|mesh-list
769943|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
769944|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
769945|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769946|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
769947|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
769948|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
769949|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
769950|NCT02699801|Analgesics|analgesics|mesh-ancestor
769951|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
769952|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769953|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
769954|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
769955|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
769956|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
769957|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
769958|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770363|NCT02698254|Bevacizumab|bevacizumab|mesh-list
770364|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
770365|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
770366|NCT02698254|Antibodies|antibodies|mesh-list
770367|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
770368|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
770369|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
770370|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770371|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
770372|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
770373|NCT02698254|Growth Substances|growth substances|mesh-ancestor
770374|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770375|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
770376|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
770490|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
770491|NCT02697630|Entinostat|entinostat|mesh-list
770492|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
770493|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770494|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
770495|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
770496|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770755|NCT02696954|Lumefantrine|lumefantrine|mesh-list
770756|NCT02696954|Artemether|artemether|mesh-list
770757|NCT02696954|Primaquine|primaquine|mesh-list
770758|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
770759|NCT02696954|Amodiaquine|amodiaquine|mesh-list
770760|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
770761|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
770762|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
770763|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
769606|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
769607|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
769608|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
769609|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
769610|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
769611|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769693|NCT02700763|Dabrafenib|dabrafenib|mesh-list
769694|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769695|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
769696|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769697|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769885|NCT02699645|Amlodipine|amlodipine|mesh-list
769886|NCT02699645|Telmisartan|telmisartan|mesh-list
769887|NCT02699645|Indapamide|indapamide|mesh-list
769888|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
769889|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
769890|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
769891|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769892|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
769893|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769894|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
769895|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
769896|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
769897|NCT02699645|Diuretics|diuretics|mesh-ancestor
769898|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
769899|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
770618|NCT02697227|Nicotine|nicotine|mesh-list
770619|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
770620|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
770621|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770622|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770623|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
770624|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
770625|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
770626|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770627|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771988|NCT02690103|Ribavirin|ribavirin|mesh-list
771989|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
771990|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771991|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
771992|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772169|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
772170|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
772171|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772761|NCT02687425|Pioglitazone|pioglitazone|mesh-list
772762|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
772763|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
772764|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772765|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772766|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
772767|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772768|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093895|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093896|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2093897|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093898|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093899|NCT02268175|Prednisone|prednisone|mesh-list
2093900|NCT02268175|Leuprolide|leuprolide|mesh-list
2093901|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
2093902|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093903|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
2093904|NCT02268175|Hormones|hormones|mesh-ancestor
2093905|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2093906|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093907|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2093908|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2093909|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2093910|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
2093911|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2093912|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2093913|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093914|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093915|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
769643|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2240088|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2240089|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2240090|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
2240091|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240092|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
770563|NCT02697318|Timolol|timolol|mesh-list
770564|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
770565|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
770566|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
770567|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
770568|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
770569|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770570|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770571|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770572|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
770573|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
771008|NCT02695771|Gemcitabine|gemcitabine|mesh-list
771009|NCT02695771|Mitomycins|mitomycins|mesh-list
771010|NCT02695771|Mitomycin|mitomycin|mesh-list
771011|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
771012|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
771013|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771014|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771015|NCT02695771|Antiviral Agents|antiviral agents|mesh-ancestor
771016|NCT02695771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
771017|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771018|NCT02695771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
771019|NCT02695771|Immunologic Factors|immunologic factors|mesh-ancestor
771020|NCT02695771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771021|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
771022|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
771023|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
771895|NCT02690792|Vitamin E|vitamin e|mesh-list
771896|NCT02690792|Vitamins|vitamins|mesh-ancestor
771897|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
771898|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771899|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
771900|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771901|NCT02690792|Protective Agents|protective agents|mesh-ancestor
772179|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
772180|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
772181|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772182|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
772459|NCT02688595|Anesthetics|anesthetics|mesh-list
772460|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
772461|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772578|NCT02688140|Cytarabine|cytarabine|mesh-list
772579|NCT02688140|Methotrexate|methotrexate|mesh-list
772580|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
772581|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
772582|NCT02688140|Idarubicin|idarubicin|mesh-list
772583|NCT02688140|Tretinoin|tretinoin|mesh-list
772584|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
772585|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
772586|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
772587|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
772588|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772589|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
772590|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
772591|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772592|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772593|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
772594|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772595|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
772596|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
772597|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
772598|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
772599|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
772600|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
772601|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772602|NCT02688140|Analgesics|analgesics|mesh-ancestor
772603|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
772604|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772605|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
772606|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
769704|NCT02700529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
769705|NCT02700529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769706|NCT02700529|Protease Inhibitors|protease inhibitors|mesh-ancestor
769707|NCT02700529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769708|NCT02700529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769709|NCT02700529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
769710|NCT02700529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
769711|NCT02700529|Antiviral Agents|antiviral agents|mesh-ancestor
770377|NCT02697955|Epinephrine|epinephrine|mesh-list
770378|NCT02697955|Bupivacaine|bupivacaine|mesh-list
770379|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
770380|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
770381|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770382|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770383|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
770384|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770385|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
770386|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
770387|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
770388|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770389|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770390|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
770391|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
770392|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
770393|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
770394|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
770395|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
770396|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
770397|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2240093|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2240094|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
770527|NCT02697045|Aripiprazole|aripiprazole|mesh-list
770528|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
770529|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
770530|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
770531|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
770532|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770533|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770534|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
770535|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
770536|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770537|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770538|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
770539|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
770540|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
770541|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
770542|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
770543|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
770544|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
771378|NCT02693444|Lidocaine|lidocaine|mesh-list
771379|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
771380|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
771381|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
771382|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771383|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
771384|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771385|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
771386|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
771387|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
771388|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
771389|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772287|NCT02689024|Acetaminophen|acetaminophen|mesh-list
772288|NCT02689024|Dipyrone|dipyrone|mesh-list
772289|NCT02689024|Ibuprofen|ibuprofen|mesh-list
772290|NCT02689024|Diclofenac|diclofenac|mesh-list
772291|NCT02689024|Naproxen|naproxen|mesh-list
772292|NCT02689024|Fentanyl|fentanyl|mesh-list
772293|NCT02689024|Morphine|morphine|mesh-list
772294|NCT02689024|Bupivacaine|bupivacaine|mesh-list
772295|NCT02689024|Ropivacaine|ropivacaine|mesh-list
772296|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
772297|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
772298|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
772299|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
772300|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772301|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
769858|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
769859|NCT02699658|Renal Agents|renal agents|mesh-ancestor
769860|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
769861|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
769862|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
769863|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769864|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769865|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769866|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
769867|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2240095|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2240096|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240097|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
2240098|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2240099|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240100|NCT00097851|Docetaxel|docetaxel|mesh-list
2240101|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240102|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
2240103|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
2240104|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
2240105|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240106|NCT00097877|Insulin|insulin|mesh-list
2240107|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2240108|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
770574|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
770575|NCT02697058|Leucovorin|leucovorin|mesh-list
770576|NCT02697058|Fluorouracil|fluorouracil|mesh-list
770577|NCT02697058|Calcium|calcium|mesh-list
770578|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
770579|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
770580|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770581|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
770582|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
770583|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770584|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
770585|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770586|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
770587|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
770588|NCT02697058|Antidotes|antidotes|mesh-ancestor
770589|NCT02697058|Protective Agents|protective agents|mesh-ancestor
770590|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
770591|NCT02697058|Vitamins|vitamins|mesh-ancestor
770592|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
770628|NCT02696720|Lidocaine|lidocaine|mesh-list
770629|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
770630|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
770631|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770632|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770633|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
770634|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770635|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
770636|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
770637|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
770638|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
770639|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770827|NCT02696577|Aspirin|aspirin|mesh-list
770828|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
770829|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
770830|NCT02696577|Analgesics|analgesics|mesh-ancestor
770831|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
770832|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770833|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770834|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
770835|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
770836|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
770837|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
770838|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770839|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
770840|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
770841|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
770842|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
2240109|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
2240110|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
2240111|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
769911|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
769912|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
769913|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
769914|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
769915|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
769916|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
769917|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
769918|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
769919|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
769920|NCT02700022|Hormones|hormones|mesh-ancestor
769921|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
769922|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
769923|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
769924|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
769925|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
769926|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
2240112|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240113|NCT00097903|Camptothecin|camptothecin|mesh-list
2240114|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2240115|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240116|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2240117|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
770770|NCT02696590|Vitamin D|vitamin d|mesh-list
770771|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
770772|NCT02696590|Vitamins|vitamins|mesh-ancestor
770773|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
770774|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770775|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
770776|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
770967|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
770968|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
770969|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
770970|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
770971|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
770972|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
2240118|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240119|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240120|NCT00097916|Memantine|memantine|mesh-list
771417|NCT02692963|Vaccines|vaccines|mesh-list
771418|NCT02692963|Immunologic Factors|immunologic factors|mesh-ancestor
771419|NCT02692963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771687|NCT02691403|Bupivacaine|bupivacaine|mesh-list
771688|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
771689|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
771690|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
771691|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
771692|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771693|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
771694|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771765|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
771766|NCT02691156|Bilirubin|bilirubin|mesh-list
771767|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
771768|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771769|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
771770|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
771771|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771772|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
771773|NCT02691156|Protective Agents|protective agents|mesh-ancestor
772039|NCT02690064|Vitamins|vitamins|mesh-list
772040|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
772041|NCT02690064|Vitamin E|vitamin e|mesh-list
769973|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
769974|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
769975|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
769976|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
769977|NCT02699710|Hematinics|hematinics|mesh-ancestor
769978|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
769979|NCT02699710|Vitamins|vitamins|mesh-ancestor
769980|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
769981|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
769982|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
769983|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
770240|NCT02698748|Chloroquine|chloroquine|mesh-list
770241|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
770242|NCT02698748|Amebicides|amebicides|mesh-ancestor
770243|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
770244|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
770245|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
770246|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
770247|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
770248|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
770249|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
770250|NCT02698748|Analgesics|analgesics|mesh-ancestor
770251|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
770252|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770253|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770254|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
770255|NCT02698748|Filaricides|filaricides|mesh-ancestor
770256|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
770257|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
770301|NCT02698306|Dexamethasone|dexamethasone|mesh-list
770302|NCT02698306|Diclofenac|diclofenac|mesh-list
770303|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
770304|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
770305|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
770306|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770307|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770308|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
770309|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
770310|NCT02698306|Hormones|hormones|mesh-ancestor
770311|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
770312|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
770313|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770314|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
770315|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
770316|NCT02698306|Analgesics|analgesics|mesh-ancestor
770317|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
770318|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
770319|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
770320|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
770321|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770398|NCT02697877|Regadenoson|regadenoson|mesh-list
770399|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
770400|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
770401|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
770402|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
770403|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770404|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770405|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771662|NCT02691871|Docetaxel|docetaxel|mesh-list
771663|NCT02691871|Apatinib|apatinib|mesh-list
771664|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771665|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
771666|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
771667|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
771668|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771669|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
771670|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240121|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2240122|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2240123|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
2240124|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2240125|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240126|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240127|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2240128|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2240129|NCT00097929|Vorinostat|vorinostat|mesh-list
769996|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
769997|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
769998|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
769999|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
770000|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
770001|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770002|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
770003|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770031|NCT02699008|Clopidogrel|clopidogrel|mesh-list
770032|NCT02699008|Ticagrelor|ticagrelor|mesh-list
770033|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
770034|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
770035|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
770036|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
770037|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
770038|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770039|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770040|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240130|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240131|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2240132|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240133|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240134|NCT00097942|Memantine|memantine|mesh-list
2240135|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
770850|NCT02696460|Lidocaine|lidocaine|mesh-list
770851|NCT02696460|Prilocaine|prilocaine|mesh-list
770852|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
770853|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
770854|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
770855|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770856|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770857|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
770858|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770859|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
770860|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
770861|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
770862|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
770863|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770864|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
771040|NCT02695459|Everolimus|everolimus|mesh-list
771041|NCT02695459|Cisplatin|cisplatin|mesh-list
771042|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771043|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
771044|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
771045|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771172|NCT02694848|Aspirin|aspirin|mesh-list
771173|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
771174|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
771175|NCT02694848|Analgesics|analgesics|mesh-ancestor
771176|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
771177|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771178|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771179|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
771180|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
771181|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
771182|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
771183|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771184|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
771185|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
771186|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771187|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
771703|NCT02691442|Epinephrine|epinephrine|mesh-list
771704|NCT02691442|Ropivacaine|ropivacaine|mesh-list
771705|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
771706|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
771707|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
771708|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
771709|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771710|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
771711|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771712|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
771713|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
771714|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
770188|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770189|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770190|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
770191|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
770192|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
770784|NCT02696993|Nivolumab|nivolumab|mesh-list
770785|NCT02696993|Ipilimumab|ipilimumab|mesh-list
770786|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
770787|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770788|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
770789|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240136|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2240137|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
771459|NCT02692599|Vaccines|vaccines|mesh-list
771460|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
771461|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771588|NCT02692313|Epinephrine|epinephrine|mesh-list
771589|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
771590|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
771591|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
771592|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
771593|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771594|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771595|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
771596|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
771597|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
771598|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771599|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
771600|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
771601|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
771602|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
771603|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
771671|NCT02691897|Melatonin|melatonin|mesh-list
771672|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
771673|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771674|NCT02691897|Protective Agents|protective agents|mesh-ancestor
771675|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771676|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
771910|NCT02690506|Pregabalin|pregabalin|mesh-list
771911|NCT02690506|Analgesics|analgesics|mesh-ancestor
771912|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
771913|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771914|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771915|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
771916|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
771917|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
771918|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771919|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
771920|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
771921|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
771922|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
771923|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
772097|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
772098|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
772099|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
772100|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
772101|NCT02689856|Lidocaine|lidocaine|mesh-list
772102|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
772103|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
772104|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
772105|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772106|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
772107|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772108|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
772109|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
772110|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
772111|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
772112|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772113|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772423|NCT02688907|Adavosertib|adavosertib|mesh-list
772424|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772425|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093916|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
770211|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
770212|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093917|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
2093918|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2093919|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093920|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2093921|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093922|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
2093923|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
2093924|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2093925|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
2093926|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093927|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093928|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2093929|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
2093930|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2093931|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2093932|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2240138|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2240139|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240140|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240141|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2240142|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2240143|NCT00097968|Everolimus|everolimus|mesh-list
2240144|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240145|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240146|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
2240147|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240148|NCT00098007|Everolimus|everolimus|mesh-list
2240149|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240150|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240151|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
2240152|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240153|NCT00098033|Clofarabine|clofarabine|mesh-list
771618|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
771619|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
771620|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2240154|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2240155|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
2240156|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240157|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240158|NCT00098046|Famciclovir|famciclovir|mesh-list
2240159|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
2240160|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240161|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2240162|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240163|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240164|NCT00098111|Azathioprine|azathioprine|mesh-list
2240165|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
2240166|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240167|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2240168|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240169|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240170|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
2240171|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240172|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2240173|NCT00098124|Milnacipran|milnacipran|mesh-list
2240174|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
2240175|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2240176|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2240177|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2240178|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240179|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2240180|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240181|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2240182|NCT00098124|Analgesics|analgesics|mesh-ancestor
2240183|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
2240184|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2240185|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
2240186|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2240187|NCT00098137|Olmesartan|olmesartan|mesh-list
2240188|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
770213|NCT02698527|Lidocaine|lidocaine|mesh-list
770214|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
770215|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
770216|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770217|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770218|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
770219|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770220|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
770221|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
770222|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
770223|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
770224|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770906|NCT02696096|Buprenorphine|buprenorphine|mesh-list
770907|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
770908|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
770909|NCT02696096|Narcotics|narcotics|mesh-ancestor
770910|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770911|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770912|NCT02696096|Analgesics|analgesics|mesh-ancestor
770913|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
770914|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770915|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
771033|NCT02695758|Bupivacaine|bupivacaine|mesh-list
771034|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
771035|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
771036|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
771037|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771038|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
771039|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771163|NCT02694692|Vaccines|vaccines|mesh-list
771164|NCT02694692|Immunologic Factors|immunologic factors|mesh-ancestor
771165|NCT02694692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771683|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
771684|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
771685|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
771686|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
771798|NCT02691078|Octreotide|octreotide|mesh-list
771799|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
771800|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
771801|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771872|NCT02690844|Clonazepam|clonazepam|mesh-list
771873|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
771874|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
771875|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
771876|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
771877|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771878|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772165|NCT02689596|Oxytocin|oxytocin|mesh-list
772166|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
772167|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
772168|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093933|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
2093934|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2093935|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093936|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2093937|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2093938|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2093939|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
2093940|NCT02268864|Simeprevir|simeprevir|mesh-list
2093941|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
2093942|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772346|NCT02688803|Paclitaxel|paclitaxel|mesh-list
772347|NCT02688803|Docetaxel|docetaxel|mesh-list
772348|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
772349|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
772350|NCT02688803|Doxorubicin|doxorubicin|mesh-list
772351|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
772352|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
772353|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772354|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
772355|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
772356|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
772357|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772358|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
772359|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
2093943|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
2240189|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2240190|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2240191|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240192|NCT00098241|Everolimus|everolimus|mesh-list
2240193|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240194|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240195|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
2240196|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240197|NCT00098280|Eculizumab|eculizumab|mesh-list
2240198|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2240199|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240200|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
2240201|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240202|NCT00098319|Folic Acid|folic acid|mesh-list
2240203|NCT00098319|Hematinics|hematinics|mesh-ancestor
2240204|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
2240205|NCT00098319|Vitamins|vitamins|mesh-ancestor
2240206|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
2240207|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770702|NCT02696915|Fentanyl|fentanyl|mesh-list
770703|NCT02696915|Bupivacaine|bupivacaine|mesh-list
770704|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
770705|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
770706|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770707|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770708|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
770709|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
770710|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
770711|NCT02696915|Narcotics|narcotics|mesh-ancestor
770712|NCT02696915|Analgesics|analgesics|mesh-ancestor
770713|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
770714|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
770715|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
771160|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
771161|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
771162|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240208|NCT00098358|Zileuton|zileuton|mesh-list
2240209|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2240210|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2240211|NCT00098358|Analgesics|analgesics|mesh-ancestor
2240212|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
2240213|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771967|NCT02690155|Vitamin K|vitamin k|mesh-list
771968|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
771969|NCT02690155|Vitamins|vitamins|mesh-ancestor
771970|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
771971|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771972|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
771973|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
771974|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
771975|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
771976|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771977|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771978|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
771979|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
771980|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
771981|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
771982|NCT02690155|Coagulants|coagulants|mesh-ancestor
772217|NCT02689089|Rifapentine|rifapentine|mesh-list
772218|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
772219|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
772220|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
772221|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772222|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
2240214|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240215|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2240216|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2240217|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2240218|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240219|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240220|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2240221|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
772521|NCT02688322|Sulbactam|sulbactam|mesh-list
772522|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
772523|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772524|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
772525|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772942|NCT02686476|Empagliflozin|empagliflozin|mesh-list
770272|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
770273|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
770274|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770275|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
770276|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
770277|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
770278|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770279|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
770480|NCT02697448|Propofol|propofol|mesh-list
770481|NCT02697448|Sevoflurane|sevoflurane|mesh-list
770482|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
770483|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770484|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770485|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
770486|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
770487|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
770488|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
770489|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
770515|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
770516|NCT02697162|Octenidine|octenidine|mesh-list
770517|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
770650|NCT02696928|Lumefantrine|lumefantrine|mesh-list
770651|NCT02696928|Primaquine|primaquine|mesh-list
770652|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
770653|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
770654|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
770655|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
771061|NCT02695745|Celecoxib|celecoxib|mesh-list
771062|NCT02695745|Capsaicin|capsaicin|mesh-list
771063|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
771064|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
771065|NCT02695745|Analgesics|analgesics|mesh-ancestor
771066|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
771067|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771068|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771069|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
771070|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
771071|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
771072|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
771073|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771074|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771075|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
771076|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
2240222|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2240223|NCT00098384|Rifaximin|rifaximin|mesh-list
2240224|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2240225|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240226|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2240227|NCT00098397|Romidepsin|romidepsin|mesh-list
2240228|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2240229|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240230|NCT00098423|Cytarabine|cytarabine|mesh-list
2240231|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2240232|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
2240233|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240234|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240235|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
2240236|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772183|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
772184|NCT02689401|Hematinics|hematinics|mesh-ancestor
772185|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
772186|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
772255|NCT02689037|Aspirin|aspirin|mesh-list
772256|NCT02689037|Clopidogrel|clopidogrel|mesh-list
772257|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
772258|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
772259|NCT02689037|Analgesics|analgesics|mesh-ancestor
772260|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
772261|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772262|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772263|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772264|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
772265|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
772266|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
772267|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770410|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
770411|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
770412|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
770413|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
770414|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
770415|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770416|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
770417|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
770418|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
770419|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
770420|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
770421|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
770422|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
770423|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770424|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
770425|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
770426|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
770427|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
770428|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
770429|NCT02697851|Estrogens|estrogens|mesh-ancestor
770430|NCT02697851|Hormones|hormones|mesh-ancestor
770431|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
770432|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
770433|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
770434|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
770435|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
770436|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
770437|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
770545|NCT02697370|Factor VIII|factor viii|mesh-list
770546|NCT02697370|Coagulants|coagulants|mesh-ancestor
771233|NCT02694458|Vancomycin|vancomycin|mesh-list
771234|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
771235|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
771343|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
771344|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
771345|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
771346|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771347|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
771348|NCT02693808|Protective Agents|protective agents|mesh-ancestor
772022|NCT02689960|Prednisone|prednisone|mesh-list
772023|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772024|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
772025|NCT02689960|Hormones|hormones|mesh-ancestor
772026|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
772027|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772028|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
772029|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772404|NCT02688712|Fluorouracil|fluorouracil|mesh-list
772405|NCT02688712|Capecitabine|capecitabine|mesh-list
772406|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
772407|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772408|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
772409|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772410|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
772411|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
772412|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772731|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
772732|NCT02687386|Analgesics|analgesics|mesh-ancestor
772733|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
772734|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772735|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772736|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772737|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
772738|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
772739|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772740|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093944|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093945|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093946|NCT02268955|Ibuprofen|ibuprofen|mesh-list
2093947|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2093948|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2093949|NCT02268955|Analgesics|analgesics|mesh-ancestor
2093950|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
2240237|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240238|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
2240239|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240240|NCT00098436|Temozolomide|temozolomide|mesh-list
2240241|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2240242|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
2240243|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240244|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771077|NCT02695381|Etodolac|etodolac|mesh-list
771078|NCT02695381|Lidocaine|lidocaine|mesh-list
771079|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
771080|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
771081|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
771082|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771083|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
771084|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771085|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
771086|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
771087|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
771088|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
771089|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771090|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
771091|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
771092|NCT02695381|Analgesics|analgesics|mesh-ancestor
771093|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
771094|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
771095|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
771096|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
771097|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771188|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
771189|NCT02694809|Estrogens|estrogens|mesh-list
771190|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
771191|NCT02694809|Hormones|hormones|mesh-ancestor
771192|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
771193|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771194|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
771195|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
771196|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
771197|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2093951|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093952|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240245|NCT00098462|Sirolimus|sirolimus|mesh-list
2240246|NCT00098462|Gefitinib|gefitinib|mesh-list
2240247|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
772133|NCT02689713|Voriconazole|voriconazole|mesh-list
772134|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
772135|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772136|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
772137|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
772138|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772139|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772140|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
772141|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
772142|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
772143|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772144|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2093953|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093954|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2093955|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2093956|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093957|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093958|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
2093959|NCT02269163|Antibodies|antibodies|mesh-list
2093960|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
2093961|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2093962|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2093963|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
2093964|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
2093965|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093966|NCT02269241|Drospirenone|drospirenone|mesh-list
2093967|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2093968|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
2240248|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
770475|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
770476|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240249|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2240250|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240251|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
2240252|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240253|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
2240254|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240255|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
771098|NCT02695732|Carvedilol|carvedilol|mesh-list
771099|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
771100|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
771101|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
771102|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
771103|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771104|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771105|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
771106|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
771107|NCT02695732|Protective Agents|protective agents|mesh-ancestor
771108|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
771109|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
771110|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
771111|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
771112|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
771113|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2240256|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240257|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240258|NCT00098488|Rituximab|rituximab|mesh-list
2240259|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2240260|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771273|NCT02694146|Hylan|hylan|mesh-list
771274|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
771275|NCT02694146|Protective Agents|protective agents|mesh-ancestor
771276|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771402|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
771403|NCT02693483|Povidone|povidone|mesh-list
771404|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
771405|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
771406|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
771407|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772568|NCT02688374|Nicotine|nicotine|mesh-list
772569|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
772570|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
772571|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772572|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772573|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
772574|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
772575|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
772576|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
772577|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772773|NCT02687269|Ranolazine|ranolazine|mesh-list
772774|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
772775|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
772776|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093969|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2093970|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2093971|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2093972|NCT02269241|Diuretics|diuretics|mesh-ancestor
2093973|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
2753916|NCT02214550|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2753917|NCT02214550|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2753918|NCT02214550|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2753919|NCT02214550|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2093983|NCT02269943|Azacitidine|azacitidine|mesh-list
2093984|NCT02269943|Cc-486|cc-486|mesh-list
2093985|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2093986|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
2093987|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093988|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
770518|NCT02697331|Progesterone|progesterone|mesh-list
770519|NCT02697331|Progestins|progestins|mesh-ancestor
770520|NCT02697331|Hormones|hormones|mesh-ancestor
770521|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
770522|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770640|NCT02696941|Metformin|metformin|mesh-list
770641|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
770642|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
770643|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770644|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770790|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
770791|NCT02696512|Minocycline|minocycline|mesh-list
770792|NCT02696512|Lamotrigine|lamotrigine|mesh-list
770793|NCT02696512|Flumazenil|flumazenil|mesh-list
770794|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
770795|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
770796|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
770797|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
770798|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
770799|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770800|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
770801|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770802|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
770803|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
770804|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
770805|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
770806|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
770807|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
770808|NCT02696512|Protective Agents|protective agents|mesh-ancestor
770809|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
770810|NCT02696512|Vitamins|vitamins|mesh-ancestor
770811|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
770812|NCT02696512|Antidotes|antidotes|mesh-ancestor
770813|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
770814|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
770815|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
771423|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
771424|NCT02693210|Rituximab|rituximab|mesh-list
771425|NCT02693210|Methotrexate|methotrexate|mesh-list
771426|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
771427|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
771428|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771429|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
771430|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
771431|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
771432|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771433|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771434|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
771435|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
771436|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
771437|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
771438|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
771439|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
771440|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
771441|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
771442|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771443|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
771444|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
771526|NCT02692339|Dexamethasone|dexamethasone|mesh-list
771527|NCT02692339|Lenalidomide|lenalidomide|mesh-list
771528|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
771529|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
771530|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
771531|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771532|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771533|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
771534|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
771535|NCT02692339|Hormones|hormones|mesh-ancestor
771536|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
771537|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
771538|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771539|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
771540|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
771541|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
771542|NCT02692339|Growth Substances|growth substances|mesh-ancestor
771543|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
770664|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
770665|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
770666|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
770667|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
770668|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
770669|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
770670|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
770961|NCT02696148|Liraglutide|liraglutide|mesh-list
770962|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
770963|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
770964|NCT02696148|Incretins|incretins|mesh-ancestor
770965|NCT02696148|Hormones|hormones|mesh-ancestor
770966|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
771027|NCT02695550|Conteltinib|conteltinib|mesh-list
771028|NCT02695550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
771029|NCT02695550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771030|NCT02695550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240261|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
2240262|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240263|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2240264|NCT00098501|Sirolimus|sirolimus|mesh-list
2240265|NCT00098501|EKB 569|ekb 569|mesh-list
2240266|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2240267|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240268|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2240269|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240270|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
2240271|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240272|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
2240273|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240274|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2240275|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771569|NCT02692365|Manganese|manganese|mesh-list
771570|NCT02692365|Trace Elements|trace elements|mesh-ancestor
771571|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
771572|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240276|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240277|NCT00098527|Romidepsin|romidepsin|mesh-list
2240278|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2240279|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240280|NCT00098540|Sorafenib|sorafenib|mesh-list
2240281|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772036|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
772037|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
772038|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772155|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
772156|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
772157|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772158|NCT02689362|Incretins|incretins|mesh-ancestor
772159|NCT02689362|Hormones|hormones|mesh-ancestor
772160|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
772161|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
772162|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
772163|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772164|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772413|NCT02688465|Apomorphine|apomorphine|mesh-list
772414|NCT02688465|Emetics|emetics|mesh-ancestor
772415|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772416|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
772417|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772418|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
772419|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
772420|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
772421|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
772422|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2093989|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2093990|NCT02270242|Aspirin|aspirin|mesh-list
2093991|NCT02270242|Ticagrelor|ticagrelor|mesh-list
2093992|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2093993|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2093994|NCT02270242|Analgesics|analgesics|mesh-ancestor
2093995|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
2093996|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2093997|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240282|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2240283|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240284|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240285|NCT00098553|Everolimus|everolimus|mesh-list
2240286|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240287|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240288|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
2240289|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240290|NCT00098579|Doxorubicin|doxorubicin|mesh-list
2240291|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2240292|NCT00098579|Alvocidib|alvocidib|mesh-list
2240293|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2240294|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771148|NCT02695004|Donepezil|donepezil|mesh-list
771149|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
771150|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771151|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771152|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
771153|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
771154|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771155|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
771392|NCT02693184|Vitamin D|vitamin d|mesh-list
771393|NCT02693184|Calcium|calcium|mesh-list
771394|NCT02693184|Vitamins|vitamins|mesh-ancestor
771395|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
771396|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771397|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
771398|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
771936|NCT02690480|Fulvestrant|fulvestrant|mesh-list
771937|NCT02690480|Palbociclib|palbociclib|mesh-list
771938|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
771939|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771940|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
771941|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
771942|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
771943|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
771944|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771945|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
771946|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771947|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772123|NCT02689778|Pirfenidone|pirfenidone|mesh-list
772124|NCT02689778|Analgesics|analgesics|mesh-ancestor
772125|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
772126|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772127|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772128|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
772129|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
772130|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772131|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
772132|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772280|NCT02689258|Bupivacaine|bupivacaine|mesh-list
772281|NCT02689258|Anesthetics, Local|anesthetics, local|mesh-ancestor
772282|NCT02689258|Anesthetics|anesthetics|mesh-ancestor
772283|NCT02689258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
772284|NCT02689258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772285|NCT02689258|Sensory System Agents|sensory system agents|mesh-ancestor
772286|NCT02689258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772661|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
772662|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
772663|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772664|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772665|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
772666|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
772667|NCT02687841|Protective Agents|protective agents|mesh-ancestor
772668|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772669|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
772670|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
772671|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
2093998|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2093999|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2094000|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2094001|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2094002|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094003|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2240295|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
770896|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
770897|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
770898|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
770899|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
770900|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
770901|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
770902|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
770903|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
770904|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
771024|NCT02695862|Terlipressin|terlipressin|mesh-list
771025|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
771026|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
771261|NCT02694263|Pioglitazone|pioglitazone|mesh-list
771262|NCT02694263|Glimepiride|glimepiride|mesh-list
771263|NCT02694263|Canagliflozin|canagliflozin|mesh-list
771264|NCT02694263|Repaglinide|repaglinide|mesh-list
771265|NCT02694263|Gliclazide|gliclazide|mesh-list
771266|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
771267|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771268|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
771269|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
771270|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
771271|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
771272|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240296|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2240297|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240298|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240299|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
2240300|NCT00098579|Growth Substances|growth substances|mesh-ancestor
2240301|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240302|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2240303|NCT00098605|Lapatinib|lapatinib|mesh-list
2240304|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240305|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2240306|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240307|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240308|NCT00098618|Interferons|interferons|mesh-list
2240309|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
2240310|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
771652|NCT02691793|Sunitinib|sunitinib|mesh-list
771653|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771654|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
771655|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
771656|NCT02691793|Growth Substances|growth substances|mesh-ancestor
771657|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771658|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
771659|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
771660|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771661|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771826|NCT02690922|Dexamethasone|dexamethasone|mesh-list
771827|NCT02690922|Prednisone|prednisone|mesh-list
771828|NCT02690922|Methotrexate|methotrexate|mesh-list
771829|NCT02690922|Dasatinib|dasatinib|mesh-list
771830|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
771831|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
771832|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
771833|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771834|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771835|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
771836|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
771837|NCT02690922|Hormones|hormones|mesh-ancestor
771838|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
771839|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
771840|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771841|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
771842|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
771843|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
771844|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
771845|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
771846|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771847|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
771848|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771849|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
771850|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
771851|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
771852|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2240311|NCT00098618|Sorafenib|sorafenib|mesh-list
2240312|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240313|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
2240314|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240315|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2240316|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240317|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240318|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
2240319|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240320|NCT00098631|Lapatinib|lapatinib|mesh-list
2240321|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240322|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2240323|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240324|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240325|NCT00098683|Amifostine|amifostine|mesh-list
2240326|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2240327|NCT00098683|Protective Agents|protective agents|mesh-ancestor
2240328|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240329|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2240330|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2240331|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240332|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
771420|NCT02692976|Vaccines|vaccines|mesh-list
771421|NCT02692976|Immunologic Factors|immunologic factors|mesh-ancestor
771422|NCT02692976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240333|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
2240334|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240335|NCT00098800|Fenretinide|fenretinide|mesh-list
2240336|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771961|NCT02689999|Rabeprazole|rabeprazole|mesh-list
771962|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
771963|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
771964|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
771965|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771966|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240337|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2240338|NCT00098800|Protective Agents|protective agents|mesh-ancestor
2240339|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772618|NCT02688023|Leucovorin|leucovorin|mesh-list
772619|NCT02688023|Fluorouracil|fluorouracil|mesh-list
772620|NCT02688023|Capecitabine|capecitabine|mesh-list
772621|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
772622|NCT02688023|Irinotecan|irinotecan|mesh-list
772623|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
772624|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772625|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
772626|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772627|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
772628|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
772629|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772630|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
772631|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
772632|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772633|NCT02688023|Antidotes|antidotes|mesh-ancestor
772634|NCT02688023|Protective Agents|protective agents|mesh-ancestor
772635|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
772636|NCT02688023|Vitamins|vitamins|mesh-ancestor
772637|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
2094004|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2094005|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094006|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
2094007|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2094008|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2094009|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2094010|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
2094011|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2094012|NCT02270255|Lidocaine|lidocaine|mesh-list
2094013|NCT02270255|Ropivacaine|ropivacaine|mesh-list
2094014|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
2094015|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
2094016|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2094017|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094018|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
2094019|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094020|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2094021|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2240340|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
771317|NCT02693951|Cefotiam|cefotiam|mesh-list
771318|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
771319|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
771376|NCT02693470|Ustekinumab|ustekinumab|mesh-list
771377|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
771408|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
771409|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
771410|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
771621|NCT02691910|Chloroquine|chloroquine|mesh-list
771622|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
771623|NCT02691910|Primaquine|primaquine|mesh-list
771624|NCT02691910|Amebicides|amebicides|mesh-ancestor
771625|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
771626|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
771627|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
771628|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
771629|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
771630|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
771631|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
771632|NCT02691910|Analgesics|analgesics|mesh-ancestor
771633|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
771634|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771635|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771636|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
771637|NCT02691910|Filaricides|filaricides|mesh-ancestor
771638|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
771639|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
771879|NCT02690870|Tamoxifen|tamoxifen|mesh-list
771880|NCT02690870|Clomiphene|clomiphene|mesh-list
771881|NCT02690870|Enclomiphene|enclomiphene|mesh-list
771882|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
771883|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
771884|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
771885|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
771886|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771887|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
771888|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771889|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
771890|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
771891|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
771892|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
771893|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
771894|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2240341|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2240342|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240343|NCT00098878|Carboplatin|carboplatin|mesh-list
2240344|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240345|NCT00098891|Entinostat|entinostat|mesh-list
2094022|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2094023|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094024|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094025|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
2094026|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2094027|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2094028|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2094029|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2094030|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094031|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094032|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
2094033|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2094034|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094035|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2094036|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094037|NCT02270944|Vaccines|vaccines|mesh-list
2094038|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
2094039|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240346|NCT00098891|Isotretinoin|isotretinoin|mesh-list
771003|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
771004|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771005|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
771006|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
771007|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2240347|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2240348|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
2240349|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240350|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240351|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771802|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
771803|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
771804|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772012|NCT02689986|Rituximab|rituximab|mesh-list
772013|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
772014|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
772015|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772016|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
772017|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772018|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
772019|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
772020|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
772021|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240352|NCT00098917|Vaccines|vaccines|mesh-list
2240353|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
2240354|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240355|NCT00098969|Resveratrol|resveratrol|mesh-list
2240356|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
2240357|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240358|NCT00098969|Protective Agents|protective agents|mesh-ancestor
2240359|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240360|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240361|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2240362|NCT00098982|Leucovorin|leucovorin|mesh-list
2240363|NCT00098982|Fluorouracil|fluorouracil|mesh-list
2240364|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
2240365|NCT00098982|Bortezomib|bortezomib|mesh-list
772513|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
772514|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
772649|NCT02687984|Risperidone|risperidone|mesh-list
772650|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
772651|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
772652|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
772653|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772654|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772655|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
772656|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
772657|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
772658|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
772659|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
772660|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
772729|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
772730|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094048|NCT02270983|Linaclotide|linaclotide|mesh-list
2094049|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2094050|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
2094051|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094052|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2094053|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
2094054|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2094055|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094056|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094057|NCT02271425|Evacetrapib|evacetrapib|mesh-list
2094058|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2094059|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2094060|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
2240366|NCT00098982|Calcium|calcium|mesh-list
2240367|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
771125|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
771126|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
771127|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771128|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
771129|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
771640|NCT02691780|Sorafenib|sorafenib|mesh-list
771641|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771642|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
771643|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771644|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771928|NCT02690389|Flumazenil|flumazenil|mesh-list
771929|NCT02690389|Antidotes|antidotes|mesh-ancestor
771930|NCT02690389|Protective Agents|protective agents|mesh-ancestor
771931|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771932|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
771933|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
771934|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
771935|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771993|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
771994|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
771995|NCT02690038|Antibodies|antibodies|mesh-list
771996|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
771997|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
771998|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
771999|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772223|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
772224|NCT02689284|Margetuximab|margetuximab|mesh-list
772225|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
772226|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772707|NCT02687854|Vitamin K|vitamin k|mesh-list
772708|NCT02687854|Apixaban|apixaban|mesh-list
772709|NCT02687854|Vitamins|vitamins|mesh-ancestor
772710|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
772711|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772712|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
772713|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
772714|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
772715|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
772716|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772717|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772718|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
772719|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
772720|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
772721|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
772722|NCT02687854|Coagulants|coagulants|mesh-ancestor
2094061|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094062|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2094063|NCT02271698|Dexamethasone|dexamethasone|mesh-list
2094064|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
2094065|NCT02271698|BB 1101|bb 1101|mesh-list
2094066|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2094067|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
2094068|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
2094069|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094070|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094071|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2094072|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
2094073|NCT02271698|Hormones|hormones|mesh-ancestor
2094074|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094075|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2094076|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094077|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
2094078|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094079|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094080|NCT02271854|Diclofenac|diclofenac|mesh-list
2094081|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2094082|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2094083|NCT02271854|Analgesics|analgesics|mesh-ancestor
2094084|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
2094085|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094086|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094087|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2094088|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2094089|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2094090|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094091|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240368|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2240369|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240370|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
2240371|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753920|NCT02214550|Contraceptive Agents|contraceptive agents|mesh-ancestor
771399|NCT02693288|Anesthetics|anesthetics|mesh-list
771400|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
771401|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772193|NCT02689427|Paclitaxel|paclitaxel|mesh-list
772194|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
772195|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
772196|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772197|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
772198|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
772199|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
772200|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772432|NCT02688530|Dexamethasone|dexamethasone|mesh-list
772433|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
772434|NCT02688530|BB 1101|bb 1101|mesh-list
772435|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772436|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
772437|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
772438|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772439|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772440|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
772441|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
772442|NCT02688530|Hormones|hormones|mesh-ancestor
772443|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
772444|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
772445|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772446|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
772447|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772448|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094092|NCT02271906|Afatinib|afatinib|mesh-list
2094093|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094094|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2094095|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094096|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094097|NCT02271984|Praziquantel|praziquantel|mesh-list
2094098|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
2094099|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2094100|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094101|NCT02272413|Bevacizumab|bevacizumab|mesh-list
2094102|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2094103|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094104|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2094105|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2094106|NCT02272413|Growth Substances|growth substances|mesh-ancestor
2094107|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094108|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
2094109|NCT02272725|Ibuprofen|ibuprofen|mesh-list
2094110|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2094111|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2094112|NCT02272725|Analgesics|analgesics|mesh-ancestor
2094113|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
2094114|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094115|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094116|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2094117|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2094118|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2094119|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094120|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094121|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
2094122|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094123|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2094124|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094125|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094126|NCT02272790|Gemcitabine|gemcitabine|mesh-list
2094127|NCT02272790|Paclitaxel|paclitaxel|mesh-list
2094128|NCT02272790|Carboplatin|carboplatin|mesh-list
2094129|NCT02272790|Adavosertib|adavosertib|mesh-list
2094130|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2094131|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094132|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
2094133|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
2240372|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2240373|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240374|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240375|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
2240376|NCT00098982|Antidotes|antidotes|mesh-ancestor
2240377|NCT00098982|Protective Agents|protective agents|mesh-ancestor
2240378|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
2240379|NCT00098982|Vitamins|vitamins|mesh-ancestor
771462|NCT02692651|Vancomycin|vancomycin|mesh-list
771463|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
771464|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
771465|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
771680|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
771681|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
771682|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
771695|NCT02691325|Charcoal|charcoal|mesh-list
771696|NCT02691325|Nemiralisib|nemiralisib|mesh-list
771697|NCT02691325|Antidotes|antidotes|mesh-ancestor
771698|NCT02691325|Protective Agents|protective agents|mesh-ancestor
771699|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771700|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
771701|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771702|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772077|NCT02689921|Trastuzumab|trastuzumab|mesh-list
772078|NCT02689921|Pertuzumab|pertuzumab|mesh-list
772079|NCT02689921|Letrozole|letrozole|mesh-list
772080|NCT02689921|Anastrozole|anastrozole|mesh-list
772081|NCT02689921|Leuprolide|leuprolide|mesh-list
772082|NCT02689921|Exemestane|exemestane|mesh-list
772083|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
772084|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772085|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
772086|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
772087|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772088|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772089|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
772090|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
772091|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
772092|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772093|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
772094|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
772095|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
772096|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
772500|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
772501|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
772502|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
772503|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
772504|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772505|NCT02688361|Expectorants|expectorants|mesh-ancestor
772506|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
772507|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
772508|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
772509|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772510|NCT02688361|Protective Agents|protective agents|mesh-ancestor
772511|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772512|NCT02688361|Antidotes|antidotes|mesh-ancestor
772644|NCT02687958|Everolimus|everolimus|mesh-list
772645|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772646|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
772647|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
772648|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772769|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
772770|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772771|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
772772|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2094134|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
2094135|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094136|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2094137|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
2094138|NCT02272790|Antiviral Agents|antiviral agents|mesh-ancestor
2094139|NCT02272790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094140|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094141|NCT02272790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2094142|NCT02272790|Immunologic Factors|immunologic factors|mesh-ancestor
2094143|NCT02272790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240380|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
2240381|NCT00098995|Tirapazamine|tirapazamine|mesh-list
771296|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
771297|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
771298|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
771299|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
771300|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
771301|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771302|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
771303|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
771304|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
771305|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
771306|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
771307|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
771308|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
771309|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
771310|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
771311|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771312|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
771313|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
771314|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
771315|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
771316|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
771604|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
771605|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
771606|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771607|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
771608|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
771609|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
771610|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
771611|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
771612|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771677|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
771678|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
771679|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
771924|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
771925|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
771926|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
771927|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
772030|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
772031|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
772032|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772033|NCT02690012|Cathartics|cathartics|mesh-ancestor
772034|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
772035|NCT02690012|Antacids|antacids|mesh-ancestor
772201|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
772202|NCT02689141|Ofatumumab|ofatumumab|mesh-list
772203|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
772204|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
772205|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772206|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240382|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240383|NCT00099008|Genistein|genistein|mesh-list
2240384|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2240385|NCT00099008|Protective Agents|protective agents|mesh-ancestor
2240386|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240387|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240388|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2240389|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240390|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094163|NCT02272816|Carboplatin|carboplatin|mesh-list
2094164|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094165|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
2094166|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
2094167|NCT02272842|Vitamins|vitamins|mesh-ancestor
2094168|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
2094169|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094170|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
2094171|NCT02272842|Hematinics|hematinics|mesh-ancestor
2094172|NCT02273050|Metformin|metformin|mesh-list
2094173|NCT02273050|Saxagliptin|saxagliptin|mesh-list
771811|NCT02691195|Ropivacaine|ropivacaine|mesh-list
771812|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
771813|NCT02691195|Anesthetics|anesthetics|mesh-list
771814|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
771815|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771816|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
771817|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094174|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2094175|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094176|NCT02273050|Incretins|incretins|mesh-ancestor
2094177|NCT02273050|Hormones|hormones|mesh-ancestor
2094178|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094179|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2094180|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
2094181|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094182|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094183|NCT02273115|Oxytocin|oxytocin|mesh-list
2094184|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
2094185|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2094186|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772059|NCT02689843|Metformin|metformin|mesh-list
772060|NCT02689843|Pioglitazone|pioglitazone|mesh-list
772061|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
772062|NCT02689843|Spironolactone|spironolactone|mesh-list
772063|NCT02689843|Cyproterone|cyproterone|mesh-list
772064|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
772065|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772066|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
772067|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
772068|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
772069|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
772070|NCT02689843|Diuretics|diuretics|mesh-ancestor
772071|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
772072|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
772073|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772074|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
772075|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
772076|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2240391|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
2240392|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2240393|NCT00099008|Estrogens|estrogens|mesh-ancestor
2240394|NCT00099008|Hormones|hormones|mesh-ancestor
2240395|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2240396|NCT00099060|Lapatinib|lapatinib|mesh-list
2240397|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772539|NCT02688088|Midazolam|midazolam|mesh-list
772540|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
772541|NCT02688088|Caffeine|caffeine|mesh-list
772542|NCT02688088|Warfarin|warfarin|mesh-list
772543|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
772544|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
772545|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
772546|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772547|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
772548|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
772549|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
772550|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
772551|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
772552|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
772553|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
772554|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
772555|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
772556|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772557|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
772558|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2094187|NCT02273180|Insulin|insulin|mesh-list
2094188|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2094189|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
771715|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
771716|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
771717|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
771718|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
771719|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
771720|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
771721|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
771722|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
771723|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
771724|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
771855|NCT02690987|Exenatide|exenatide|mesh-list
771856|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
771857|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
771858|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
771859|NCT02690987|Incretins|incretins|mesh-ancestor
771860|NCT02690987|Hormones|hormones|mesh-ancestor
771861|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094190|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
2094191|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2094192|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094193|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
2094194|NCT02273726|Hematinics|hematinics|mesh-ancestor
2094195|NCT02273973|Letrozole|letrozole|mesh-list
2094196|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094197|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2094198|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2094199|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094200|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094201|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2094202|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
2094203|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094204|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094205|NCT02274038|Pemetrexed|pemetrexed|mesh-list
2094206|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094207|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094208|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094209|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2094210|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2094211|NCT02274311|Clomiphene|clomiphene|mesh-list
2094212|NCT02274311|Enclomiphene|enclomiphene|mesh-list
2094213|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
2094214|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2094215|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
2094216|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094217|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094218|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2094219|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
2094220|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2094221|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2094222|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2094223|NCT02274766|Amantadine|amantadine|mesh-list
2094224|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2094225|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2094226|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
2094227|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094228|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
2094229|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2094230|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094231|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094232|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2094233|NCT02274766|Analgesics|analgesics|mesh-ancestor
2094234|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
2094235|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094236|NCT02274792|Etanercept|etanercept|mesh-list
2094237|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2094238|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2094239|NCT02274792|Analgesics|analgesics|mesh-ancestor
2094240|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
2094241|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094242|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094243|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2094244|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2094245|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2094246|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2094247|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
772449|NCT02688491|Sunitinib|sunitinib|mesh-list
772450|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772451|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
772452|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
772453|NCT02688491|Growth Substances|growth substances|mesh-ancestor
772454|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772455|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
772456|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
772457|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772458|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094248|NCT02274870|Bupivacaine|bupivacaine|mesh-list
2094249|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
2094250|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
2094251|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2094252|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094253|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
2094254|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094255|NCT02274948|Metformin|metformin|mesh-list
2094256|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2094257|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094258|NCT02275052|Albuterol|albuterol|mesh-list
2094259|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2094260|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
2094261|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094262|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094263|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2094264|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
2094265|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
2094266|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2094267|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2094268|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2094269|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2094270|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
2094271|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2094272|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094273|NCT02275156|Evolocumab|evolocumab|mesh-list
2094274|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2094275|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2094276|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
2094277|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094278|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2094279|NCT02275338|Lanreotide|lanreotide|mesh-list
2094280|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094281|NCT02275546|NuvaRing|nuvaring|mesh-list
2094282|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2094283|NCT02275546|Desogestrel|desogestrel|mesh-list
2094284|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2094285|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
2094286|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2094287|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094288|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2094289|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2094290|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2094291|NCT02275546|Estrogens|estrogens|mesh-ancestor
2094292|NCT02275546|Hormones|hormones|mesh-ancestor
2094293|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094294|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2094295|NCT02275546|Progestins|progestins|mesh-ancestor
2094296|NCT02275611|Oxytocin|oxytocin|mesh-list
2094297|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
2094298|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2094299|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094300|NCT02275780|Ritonavir|ritonavir|mesh-list
2094301|NCT02275780|Darunavir|darunavir|mesh-list
2094302|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2094303|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2094304|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2094305|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
2094306|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240398|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2240399|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240400|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772056|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
772057|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
772058|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094307|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094308|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2094309|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2094310|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
2094311|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094312|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2094313|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2094314|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2094315|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2094316|NCT02276027|Ceritinib|ceritinib|mesh-list
2094317|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094318|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2094319|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094320|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094321|NCT02276040|Bupivacaine|bupivacaine|mesh-list
2094322|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
2094323|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
2094324|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2094325|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094326|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
2094327|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094328|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
2094329|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
2094330|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2094331|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
2094332|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094333|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094334|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2094335|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
2094336|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
2094337|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2094338|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
2094339|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2094340|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094341|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2094342|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2094343|NCT02276274|Alogliptin|alogliptin|mesh-list
2094344|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2094345|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094346|NCT02276274|Incretins|incretins|mesh-ancestor
2094347|NCT02276274|Hormones|hormones|mesh-ancestor
2094348|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094349|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2094350|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
2094351|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094352|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094353|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2094354|NCT02276482|Metronidazole|metronidazole|mesh-list
2094355|NCT02276482|Vancomycin|vancomycin|mesh-list
2094356|NCT02276482|Clindamycin|clindamycin|mesh-list
2094357|NCT02276482|Cefazolin|cefazolin|mesh-list
2240418|NCT00099125|Irinotecan|irinotecan|mesh-list
2240419|NCT00099125|Temozolomide|temozolomide|mesh-list
2240420|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2240421|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2240422|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240423|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240424|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
771983|NCT02690129|Progesterone|progesterone|mesh-list
771984|NCT02690129|Progestins|progestins|mesh-ancestor
771985|NCT02690129|Hormones|hormones|mesh-ancestor
771986|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
771987|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772114|NCT02689726|Imiquimod|imiquimod|mesh-list
772115|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
772116|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
772117|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772118|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772119|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
772251|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
772252|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
772253|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
772254|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094358|NCT02276482|Linezolid|linezolid|mesh-list
2094359|NCT02276482|Cephalexin|cephalexin|mesh-list
2094360|NCT02276482|Aztreonam|aztreonam|mesh-list
2094361|NCT02276482|Tedizolid|tedizolid|mesh-list
2094362|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094363|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2094364|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2094365|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2094366|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094367|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094368|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2094369|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2094370|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2094371|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
2094372|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094373|NCT02276872|Treprostinil|treprostinil|mesh-list
2094374|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2094375|NCT02277249|Digoxin|digoxin|mesh-list
2094376|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2094377|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2094378|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094379|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094380|NCT02277249|Protective Agents|protective agents|mesh-ancestor
2094381|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753921|NCT02214550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2753922|NCT02214550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753923|NCT02214550|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2753924|NCT02214550|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2753925|NCT02214550|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2753926|NCT02214550|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2094401|NCT02277548|Pregabalin|pregabalin|mesh-list
2094402|NCT02277548|Analgesics|analgesics|mesh-ancestor
2094403|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
2094404|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094405|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094406|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
2094407|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2094408|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094409|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094410|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2240425|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
771853|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
771854|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
772227|NCT02689245|Tenofovir|tenofovir|mesh-list
772228|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
772229|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772230|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
772231|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
772232|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772233|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772234|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
772235|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
772777|NCT02687204|Enoxaparin|enoxaparin|mesh-list
772778|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
772779|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
772780|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
772781|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
772782|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094411|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2094412|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2094413|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2094414|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2094415|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2094416|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2094417|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2094418|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094419|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2094420|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
2094421|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094422|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2094423|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
2094424|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094425|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2094426|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094427|NCT02278003|Propofol|propofol|mesh-list
2094428|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2094429|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2094430|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094431|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2094432|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
2094433|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
2094451|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
2094452|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2094453|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2094454|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094455|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
2094456|NCT02278263|Coagulants|coagulants|mesh-ancestor
2094457|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
2094458|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
2094459|NCT02278341|Hematinics|hematinics|mesh-ancestor
2094460|NCT02278471|Losartan|losartan|mesh-list
2094461|NCT02278471|Amlodipine|amlodipine|mesh-list
2094462|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2094463|NCT02278471|Atorvastatin|atorvastatin|mesh-list
2094464|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2094465|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2094466|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
2094467|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094468|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
772000|NCT02689882|Niacinamide|niacinamide|mesh-list
772001|NCT02689882|Niacin|niacin|mesh-list
772002|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
772003|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
772004|NCT02689882|Vitamins|vitamins|mesh-ancestor
772005|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
772006|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772007|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
772008|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
772009|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772010|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
772011|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
772486|NCT02688400|Celecoxib|celecoxib|mesh-list
772487|NCT02688400|Diacetylrhein|diacetylrhein|mesh-list
772488|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
772489|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
772490|NCT02688400|Analgesics|analgesics|mesh-ancestor
772491|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
772492|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772493|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772494|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772495|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
772496|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
772497|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
772498|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772499|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094469|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2094470|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094471|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2094472|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2094473|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094474|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2094475|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094476|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
2094477|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2094478|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2094479|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2094480|NCT02278471|Diuretics|diuretics|mesh-ancestor
2094481|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
2094482|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2094483|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2094484|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2094485|NCT02278614|Timolol|timolol|mesh-list
2094486|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2094487|NCT02278614|Latanoprost|latanoprost|mesh-list
2094488|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2094489|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2094490|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2094491|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
2094492|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2094493|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094494|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094495|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2094496|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2094497|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
2094498|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2094499|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094500|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2094501|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094502|NCT02279641|Allopurinol|allopurinol|mesh-list
2094503|NCT02279641|Verinurad|verinurad|mesh-list
2094504|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
2094505|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094506|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094507|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
2094508|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2094509|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2094510|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
2094511|NCT02279641|Protective Agents|protective agents|mesh-ancestor
2094512|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094513|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2094514|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
2094515|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2094516|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
772042|NCT02690064|Tocopherols|tocopherols|mesh-list
772043|NCT02690064|Tocotrienols|tocotrienols|mesh-list
772044|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
772045|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
772046|NCT02690064|Ubiquinone|ubiquinone|mesh-list
772047|NCT02690064|Resveratrol|resveratrol|mesh-list
772048|NCT02690064|Antioxidants|antioxidants|mesh-list
772049|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
772050|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772051|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772052|NCT02690064|Protective Agents|protective agents|mesh-ancestor
772053|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772054|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
772055|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
772244|NCT02689180|Furosemide|furosemide|mesh-list
772245|NCT02689180|Diuretics|diuretics|mesh-ancestor
772246|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
772247|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772248|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
772249|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
772250|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240426|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
2240427|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2240428|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2240429|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2240430|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
2240431|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094517|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094518|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094519|NCT02279719|Sorafenib|sorafenib|mesh-list
2094520|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094521|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2094522|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094523|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094524|NCT02279732|Paclitaxel|paclitaxel|mesh-list
2094525|NCT02279732|Carboplatin|carboplatin|mesh-list
2094526|NCT02279732|Ipilimumab|ipilimumab|mesh-list
2094527|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2094528|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094529|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
2094530|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
2094531|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
2094532|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094533|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2094534|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2094535|NCT02279862|Ipilimumab|ipilimumab|mesh-list
2094536|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2094537|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094538|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2094539|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094540|NCT02280044|Rifaximin|rifaximin|mesh-list
2094541|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2094542|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094543|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2094544|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
2094545|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2094546|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094547|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094548|NCT02280421|Cyclosporine|cyclosporine|mesh-list
2094549|NCT02280421|Cyclosporins|cyclosporins|mesh-list
2094550|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094551|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094552|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2094553|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
2094554|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094555|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
2094556|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094557|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
2094558|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2094559|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2094560|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2094561|NCT02280473|Laxatives|laxatives|mesh-ancestor
2094562|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2094563|NCT02280811|Aldesleukin|aldesleukin|mesh-list
772121|NCT02689388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
772122|NCT02689388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772236|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
772237|NCT02689336|Temozolomide|temozolomide|mesh-list
772238|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772239|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
772240|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772241|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772242|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
772243|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
772343|NCT02688790|Dalbavancin|dalbavancin|mesh-list
772344|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
772345|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772692|NCT02687867|Vitamin K|vitamin k|mesh-list
772693|NCT02687867|Dabigatran|dabigatran|mesh-list
772694|NCT02687867|Vitamins|vitamins|mesh-ancestor
772695|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
772696|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772697|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
772698|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
772699|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
772700|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772701|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772702|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
772703|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
772704|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
772705|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
772706|NCT02687867|Coagulants|coagulants|mesh-ancestor
2094564|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
2094565|NCT02280811|Fludarabine|fludarabine|mesh-list
2094566|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2094567|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
2094568|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094569|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2094570|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2094571|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
2094572|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094573|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094574|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2094575|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2094576|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2094577|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
2094578|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094587|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2094588|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2094589|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
2094590|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
2094591|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094592|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2094593|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
2094594|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2094595|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2094596|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094597|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094598|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2094599|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
2094600|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
2094601|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2094602|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2094603|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094604|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
2094605|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2094606|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2094607|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094608|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094609|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2094610|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
772268|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
772269|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
772270|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772271|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
772272|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
772273|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
772274|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
772275|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
772276|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
772318|NCT02688738|Doxycycline|doxycycline|mesh-list
772319|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
772320|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772321|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
772322|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
772323|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
772429|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
772430|NCT02688634|Amoxicillin|amoxicillin|mesh-list
772431|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094611|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
2094612|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2094613|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2094614|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094615|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094616|NCT02281552|Tofacitinib|tofacitinib|mesh-list
2094617|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2094618|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094619|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094620|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2094621|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
2094622|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2094623|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2094624|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094625|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094626|NCT02281760|Trametinib|trametinib|mesh-list
2094627|NCT02281760|Dabrafenib|dabrafenib|mesh-list
2094628|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2094629|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094630|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2094631|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094632|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094633|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2094634|NCT02281760|Protective Agents|protective agents|mesh-ancestor
2094635|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094636|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2094637|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
2094638|NCT02281773|BI 409306|bi 409306|mesh-list
2094639|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2094640|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094641|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094644|NCT02282293|Piperaquine|piperaquine|mesh-list
2094645|NCT02282293|Trimethoprim|trimethoprim|mesh-list
2094646|NCT02282293|Artenimol|artenimol|mesh-list
2094647|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
2094648|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
2094649|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2094650|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2094651|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094652|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2094653|NCT02282293|Renal Agents|renal agents|mesh-ancestor
2094654|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2094655|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094656|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094657|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2094658|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2094659|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2094660|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
2094661|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2094662|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
2094663|NCT02282514|Rituximab|rituximab|mesh-list
2094664|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
2094665|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2094666|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
2094667|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094668|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
772302|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772303|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
772304|NCT02689024|Narcotics|narcotics|mesh-ancestor
772305|NCT02689024|Analgesics|analgesics|mesh-ancestor
772306|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
772307|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
772308|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
772309|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
772310|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
772311|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
772312|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772313|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
772314|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
772315|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772316|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772317|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
772426|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
772427|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
772428|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094669|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2094670|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
2094671|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094672|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094673|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2094674|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2094675|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2094676|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
2094677|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
2094678|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094679|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2094680|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
2094681|NCT02282514|Hormones|hormones|mesh-ancestor
2094682|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094683|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2094684|NCT02282514|Protective Agents|protective agents|mesh-ancestor
2094685|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2094686|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2094687|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2094688|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2094689|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
2094690|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094691|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094692|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
2094693|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2094694|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2094695|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094696|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
2094697|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
2094698|NCT02282813|Calcitriol|calcitriol|mesh-list
2094699|NCT02282813|Calcifediol|calcifediol|mesh-list
2094700|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2094701|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2094702|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094703|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2094704|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094705|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094706|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2094707|NCT02282813|Vitamins|vitamins|mesh-ancestor
2094708|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
2094709|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2094710|NCT02282904|Sirolimus|sirolimus|mesh-list
2094711|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
2094712|NCT02282904|Busulfan|busulfan|mesh-list
2094713|NCT02282904|Fludarabine|fludarabine|mesh-list
2094714|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2094715|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
2094716|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094717|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2094718|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2094719|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
2094720|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094721|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094722|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2094723|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2094724|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772360|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772363|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
772364|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
772365|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
772366|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
772367|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
772368|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
772369|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
772370|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094725|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2094726|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
2094727|NCT02283294|Warfarin|warfarin|mesh-list
2094728|NCT02283294|Apixaban|apixaban|mesh-list
2094729|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
2094730|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2094731|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
2094732|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2094733|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
2094734|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094735|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094736|NCT02283658|Everolimus|everolimus|mesh-list
2094737|NCT02283658|Letrozole|letrozole|mesh-list
2094738|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094739|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2094740|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
2094741|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094742|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2094743|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2094744|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094745|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094746|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2094747|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
2094748|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094749|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2094750|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094751|NCT02283762|Riociguat|riociguat|mesh-list
2094752|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
2094753|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094754|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
2094755|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2094756|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2094757|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094758|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2094759|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2094760|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094761|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094762|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094763|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
2094764|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2094765|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2094766|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094767|NCT02283814|Topiramate|topiramate|mesh-list
2094768|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2094769|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
2094770|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2094771|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094772|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2094773|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2094774|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094775|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094776|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2094777|NCT02283827|Phenytoin|phenytoin|mesh-list
2094778|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
2094779|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2094780|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2094781|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094782|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094783|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2094784|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2094785|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2094786|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
2094787|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2094788|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
772389|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
772390|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772391|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
772392|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
772393|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
772394|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772515|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
772516|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
772517|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
772518|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772519|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
772520|NCT02688127|Coagulants|coagulants|mesh-ancestor
772638|NCT02687971|Miltefosine|miltefosine|mesh-list
772639|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
772640|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772641|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772642|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
772643|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
772943|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
772944|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772945|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
772946|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773011|NCT02686086|Albuterol|albuterol|mesh-list
773012|NCT02686086|Ipratropium|ipratropium|mesh-list
773013|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
773014|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
773015|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
773016|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773017|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
773018|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
773019|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
773020|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
773021|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
773022|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
773023|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
773024|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
773025|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
773026|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773027|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
773028|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
773142|NCT02685709|Octreotide|octreotide|mesh-list
773143|NCT02685709|Lanreotide|lanreotide|mesh-list
773144|NCT02685709|Cabergoline|cabergoline|mesh-list
773145|NCT02685709|Somatostatin|somatostatin|mesh-list
773146|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
773147|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
773148|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773149|NCT02685709|Hormones|hormones|mesh-ancestor
773150|NCT02685709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
773151|NCT02685709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773152|NCT02685709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
773153|NCT02685709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
773154|NCT02685709|Dopamine Agonists|dopamine agonists|mesh-ancestor
773155|NCT02685709|Dopamine Agents|dopamine agents|mesh-ancestor
773156|NCT02685709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
773157|NCT02685709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773517|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
773518|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
773519|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
773520|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
773521|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773522|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
773523|NCT02684019|Analgesics|analgesics|mesh-ancestor
773524|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
773525|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
773526|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
773527|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
773528|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
773529|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
773530|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
773531|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773532|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
773533|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
773534|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
773535|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
772526|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772723|NCT02687932|Valsartan|valsartan|mesh-list
772724|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
772725|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
772726|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
772727|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
772728|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772741|NCT02687347|Morphine|morphine|mesh-list
772742|NCT02687347|Methadone|methadone|mesh-list
772743|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
772744|NCT02687347|Narcotics|narcotics|mesh-ancestor
772745|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
772746|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772747|NCT02687347|Analgesics|analgesics|mesh-ancestor
772748|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
772749|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772750|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
772751|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
773004|NCT02686177|Metformin|metformin|mesh-list
773005|NCT02686177|Liraglutide|liraglutide|mesh-list
773006|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
773007|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773008|NCT02686177|Incretins|incretins|mesh-ancestor
773009|NCT02686177|Hormones|hormones|mesh-ancestor
773010|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
773319|NCT02685150|Omeprazole|omeprazole|mesh-list
773320|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
773321|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
773322|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
773323|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773324|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240432|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240433|NCT00099164|Progestins|progestins|mesh-ancestor
2240434|NCT00099164|Hormones|hormones|mesh-ancestor
2240435|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
2240436|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
2240437|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2240438|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240439|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
2240440|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240441|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2240442|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2240443|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240444|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240445|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
2240446|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
2240447|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
2240448|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2240449|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774160|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774161|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774162|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
774163|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774189|NCT02681783|Aflibercept|aflibercept|mesh-list
774190|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
774191|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
774192|NCT02681783|Growth Substances|growth substances|mesh-ancestor
774193|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774194|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
774195|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774207|NCT02681562|Olaparib|olaparib|mesh-list
774208|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
774209|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774210|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774211|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774218|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774219|NCT02681653|Atorvastatin|atorvastatin|mesh-list
774220|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2094789|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094790|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094791|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
2094792|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094793|NCT02284009|Incretins|incretins|mesh-ancestor
2094794|NCT02284009|Hormones|hormones|mesh-ancestor
2094795|NCT02284009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094796|NCT02284126|Vancomycin|vancomycin|mesh-list
2094797|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2094798|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
773048|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
773049|NCT02686047|Hylan|hylan|mesh-list
773050|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
773051|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
773052|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773053|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
773054|NCT02686047|Protective Agents|protective agents|mesh-ancestor
773309|NCT02685111|Lenograstim|lenograstim|mesh-list
773310|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
773311|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
773312|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773575|NCT02684123|Apremilast|apremilast|mesh-list
773576|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
773577|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
773578|NCT02684123|Analgesics|analgesics|mesh-ancestor
773579|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
773580|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
773581|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773582|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
773583|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
773584|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
773585|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
773586|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773587|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773711|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
773712|NCT02683733|Curcumin|curcumin|mesh-list
773713|NCT02683733|Mesalamine|mesalamine|mesh-list
773714|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
773715|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
773716|NCT02683733|Analgesics|analgesics|mesh-ancestor
773717|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
773718|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
773719|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773720|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
773721|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
773722|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773723|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773724|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773725|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
773726|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
773727|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094799|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
2240450|NCT00099216|Rivastigmine|rivastigmine|mesh-list
773919|NCT02682862|Bromides|bromides|mesh-list
773920|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
773921|NCT02682862|Olodaterol|olodaterol|mesh-list
773922|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
773923|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
773924|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
773925|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773926|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
773927|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
773928|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
773929|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
773930|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
773931|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
773932|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773933|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
2240451|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2240452|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240453|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240454|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
2240455|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2240456|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240457|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
772559|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
772560|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772561|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
772562|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
772563|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
772564|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
772565|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
772566|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
772567|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
773059|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
773060|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
773061|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
773062|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
2240458|NCT00099216|Protective Agents|protective agents|mesh-ancestor
2240459|NCT00099242|Rivastigmine|rivastigmine|mesh-list
2240460|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2240461|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240462|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240463|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
2240464|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2240465|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240466|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2240467|NCT00099242|Protective Agents|protective agents|mesh-ancestor
2240468|NCT00099320|Exenatide|exenatide|mesh-list
2240469|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2240470|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240471|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
773380|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
773381|NCT02684799|Omeprazole|omeprazole|mesh-list
773382|NCT02684799|Famotidine|famotidine|mesh-list
773383|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
773384|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
773385|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
773386|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773387|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773388|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
773389|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
773390|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
773391|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
773392|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773393|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
773394|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
773395|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
773396|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
773397|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
773457|NCT02684474|HBOC 201|hboc 201|mesh-list
773458|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
773672|NCT02683837|Remifentanil|remifentanil|mesh-list
773673|NCT02683837|Sevoflurane|sevoflurane|mesh-list
773674|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
773675|NCT02683837|Narcotics|narcotics|mesh-ancestor
773676|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
773677|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773678|NCT02683837|Analgesics|analgesics|mesh-ancestor
773679|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
773680|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
773681|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
773682|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
773683|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
773684|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
773792|NCT02683603|Imipenem|imipenem|mesh-list
773793|NCT02683603|Colistin|colistin|mesh-list
773794|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
773795|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
773853|NCT02683070|Ropivacaine|ropivacaine|mesh-list
773854|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
773855|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
773856|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
773857|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773858|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
773859|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
773860|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
773861|NCT02683070|Narcotics|narcotics|mesh-ancestor
773862|NCT02683070|Analgesics|analgesics|mesh-ancestor
774078|NCT02682134|Dexamethasone|dexamethasone|mesh-list
774079|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
774080|NCT02682134|Lidocaine|lidocaine|mesh-list
774081|NCT02682134|BB 1101|bb 1101|mesh-list
774082|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772607|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
772608|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
772672|NCT02687724|Golimumab|golimumab|mesh-list
772673|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
772674|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772675|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
772676|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
772677|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094800|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2094801|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2094802|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094803|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2094804|NCT02284243|Analgesics|analgesics|mesh-ancestor
2094805|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
2094806|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094807|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2094808|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
773063|NCT02686008|Olaparib|olaparib|mesh-list
773064|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
773065|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773066|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773067|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773563|NCT02684162|Guadecitabine|guadecitabine|mesh-list
773564|NCT02684162|Azacitidine|azacitidine|mesh-list
773565|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773566|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
773567|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
773568|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773569|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094809|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2094810|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
2094811|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2094812|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094813|NCT02284386|Bupivacaine|bupivacaine|mesh-list
2094814|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
2094815|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
2094816|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2094817|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094818|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
2094819|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094820|NCT02284464|Prednisone|prednisone|mesh-list
2094821|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2094822|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
774083|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
774084|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
774085|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774086|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774087|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
774088|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
774089|NCT02682134|Hormones|hormones|mesh-ancestor
774090|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
774091|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
774092|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774093|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
774094|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774095|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774096|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
774097|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
774098|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774099|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
774100|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
774101|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
774102|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
774103|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2240472|NCT00099320|Incretins|incretins|mesh-ancestor
2240473|NCT00099320|Hormones|hormones|mesh-ancestor
2240474|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2240475|NCT00099333|Exenatide|exenatide|mesh-list
2240476|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
774169|NCT02681913|Adenosine|adenosine|mesh-list
774170|NCT02681913|Analgesics|analgesics|mesh-ancestor
774171|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
774172|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774197|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
772678|NCT02687906|Meropenem|meropenem|mesh-list
772679|NCT02687906|Vaborbactam|vaborbactam|mesh-list
772680|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
772681|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
772682|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772683|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772684|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773072|NCT02686021|Dipyrone|dipyrone|mesh-list
773081|NCT02686021|Ibuprofen|ibuprofen|mesh-list
773082|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
773083|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
773084|NCT02686021|Analgesics|analgesics|mesh-ancestor
773085|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
773086|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
773087|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773088|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
773089|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
773090|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
773091|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773092|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773093|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
773277|NCT02685228|Gemcitabine|gemcitabine|mesh-list
773278|NCT02685228|Decitabine|decitabine|mesh-list
773279|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
773280|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
773281|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773282|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773283|NCT02685228|Antiviral Agents|antiviral agents|mesh-ancestor
773284|NCT02685228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
773285|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773286|NCT02685228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
773287|NCT02685228|Immunologic Factors|immunologic factors|mesh-ancestor
773288|NCT02685228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773325|NCT02684786|Lidocaine|lidocaine|mesh-list
773326|NCT02684786|Reserpine|reserpine|mesh-list
773327|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
773328|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
773329|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
773330|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773331|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
773332|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
773333|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
773334|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
773335|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
773336|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
773337|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773338|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
773339|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
773340|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
773341|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
773342|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
773343|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
773344|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
773345|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
773648|NCT02684032|Letrozole|letrozole|mesh-list
773649|NCT02684032|Fulvestrant|fulvestrant|mesh-list
773650|NCT02684032|Palbociclib|palbociclib|mesh-list
773651|NCT02684032|Gedatolisib|gedatolisib|mesh-list
773652|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773653|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
773654|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
773655|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773656|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773657|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
773658|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
773659|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
773660|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773661|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
773662|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
773663|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
773899|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
773900|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
773901|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773982|NCT02682680|Ezetimibe|ezetimibe|mesh-list
773983|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
772783|NCT02687256|Heparin|heparin|mesh-list
772784|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
772785|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
772786|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
772787|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772876|NCT02686853|Amphotericin B|amphotericin b|mesh-list
772877|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
772878|NCT02686853|Amebicides|amebicides|mesh-ancestor
772879|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
772880|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
772881|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772882|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
772883|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
772947|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
772948|NCT02686385|Prednisolone|prednisolone|mesh-list
772949|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
772950|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772951|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
772952|NCT02686385|Hormones|hormones|mesh-ancestor
772953|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
772954|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772955|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
772956|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772957|NCT02686385|Protective Agents|protective agents|mesh-ancestor
772958|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
772959|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772960|NCT02686385|Expectorants|expectorants|mesh-ancestor
772961|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
772962|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
772963|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
772964|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772965|NCT02686385|Antidotes|antidotes|mesh-ancestor
2753965|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
2753966|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753967|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
2753968|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2753969|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2753970|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2753971|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2753972|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753973|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
2753974|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2753975|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753976|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2753977|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2753978|NCT02067975|Tryptophan|tryptophan|mesh-list
773237|NCT02685397|Leuprolide|leuprolide|mesh-list
773238|NCT02685397|Goserelin|goserelin|mesh-list
773239|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
773240|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
773241|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
773242|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
773243|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773244|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
773245|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773246|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
773247|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
773248|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
773249|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2240477|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240478|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2240479|NCT00099333|Incretins|incretins|mesh-ancestor
773507|NCT02684669|Naloxone|naloxone|mesh-list
773508|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
773509|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773510|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
773511|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2240480|NCT00099333|Hormones|hormones|mesh-ancestor
2240481|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2240482|NCT00099450|INS 50589|ins 50589|mesh-list
2240483|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2240484|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2240485|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
2240486|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2240487|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772788|NCT02686983|Betamethasone|betamethasone|mesh-list
772790|NCT02686983|Anesthetics|anesthetics|mesh-list
772791|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
772792|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
772793|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772794|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
772795|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772796|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772797|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
772798|NCT02686983|Hormones|hormones|mesh-ancestor
772799|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
772800|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
772801|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
773055|NCT02685969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
773056|NCT02685969|Flutemetamol|flutemetamol|mesh-list
773057|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
773058|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773131|NCT02685852|Exenatide|exenatide|mesh-list
773132|NCT02685852|Acarbose|acarbose|mesh-list
773133|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
773134|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773135|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
773136|NCT02685852|Incretins|incretins|mesh-ancestor
773137|NCT02685852|Hormones|hormones|mesh-ancestor
773138|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
773139|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
773140|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773141|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773200|NCT02685345|Firuglipel|firuglipel|mesh-list
773201|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
773202|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773346|NCT02685176|Charcoal|charcoal|mesh-list
773347|NCT02685176|Antidotes|antidotes|mesh-ancestor
773348|NCT02685176|Protective Agents|protective agents|mesh-ancestor
773349|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773375|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
773376|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773377|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
773378|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773379|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773822|NCT02682953|Plerixafor|plerixafor|mesh-list
773823|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
773824|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
773825|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
773826|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
773938|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
773939|NCT02683291|Sirolimus|sirolimus|mesh-list
773940|NCT02683291|Prednisone|prednisone|mesh-list
773941|NCT02683291|Tacrolimus|tacrolimus|mesh-list
773942|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
773943|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
773944|NCT02683291|Basiliximab|basiliximab|mesh-list
773945|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
773946|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
773947|NCT02683291|Hormones|hormones|mesh-ancestor
773948|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
773949|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773950|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
773951|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773952|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
773953|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
773954|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
773955|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773956|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773957|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
773958|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
773959|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
773960|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
773961|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
773962|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
774104|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
774105|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
774106|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
774107|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
774129|NCT02682225|Ketamine|ketamine|mesh-list
774130|NCT02682225|Esketamine|esketamine|mesh-list
774131|NCT02682225|Analgesics|analgesics|mesh-ancestor
774132|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
772789|NCT02687178|Canrenone|canrenone|mesh-list
772802|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
772803|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
772804|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
772805|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772806|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
772807|NCT02687178|Diuretics|diuretics|mesh-ancestor
772808|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
773158|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
773159|NCT02685657|Docetaxel|docetaxel|mesh-list
773160|NCT02685657|Doxorubicin|doxorubicin|mesh-list
773161|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
773162|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
773163|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773164|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
773165|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
773166|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
773167|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773168|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773169|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
773170|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
773171|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
773172|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
773173|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
773174|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
773175|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
773176|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773203|NCT02685306|Paclitaxel|paclitaxel|mesh-list
773204|NCT02685306|Taxane|taxane|mesh-list
773205|NCT02685306|Bavituximab|bavituximab|mesh-list
773206|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
773207|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773208|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
773209|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
773210|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
773211|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773212|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
773306|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
773307|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773308|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773401|NCT02685059|Paclitaxel|paclitaxel|mesh-list
773402|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
773403|NCT02685059|Durvalumab|durvalumab|mesh-list
773404|NCT02685059|Epirubicin|epirubicin|mesh-list
773405|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
773406|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773407|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
773408|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
773409|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
773410|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773411|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
773412|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
773413|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773414|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
773415|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
773416|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
773417|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
773418|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
773419|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
773420|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
773421|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
773422|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773699|NCT02683759|Curcumin|curcumin|mesh-list
773700|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
773701|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
773702|NCT02683759|Analgesics|analgesics|mesh-ancestor
773703|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
773704|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
773705|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773706|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
773707|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
773708|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773709|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773710|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773898|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
772809|NCT02687009|Niclosamide|niclosamide|mesh-list
772810|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
772811|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
772812|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
772813|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
772814|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772815|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
772894|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
772979|NCT02686242|Anesthetics|anesthetics|mesh-list
772980|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
772981|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773177|NCT02685618|Iloprost|iloprost|mesh-list
773178|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
773179|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
773250|NCT02685605|Temozolomide|temozolomide|mesh-list
773251|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
773252|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
773253|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773254|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773302|NCT02685163|Antioxidants|antioxidants|mesh-list
773303|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773304|NCT02685163|Protective Agents|protective agents|mesh-ancestor
773305|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753979|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2753980|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
2753981|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2753982|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
2753983|NCT02048813|Rituximab|rituximab|mesh-list
2753984|NCT02048813|Fludarabine|fludarabine|mesh-list
2753985|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
2753986|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2753987|NCT02048813|Antibodies|antibodies|mesh-list
2094823|NCT02284464|Hormones|hormones|mesh-ancestor
2094824|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094825|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094826|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2094827|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094828|NCT02284516|Lifitegrast|lifitegrast|mesh-list
2094829|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2094830|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2094831|NCT02284555|Mupirocin|mupirocin|mesh-list
2094832|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2094833|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094834|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
773934|NCT02682888|Oxytocin|oxytocin|mesh-list
773935|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
773936|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
773937|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094835|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094836|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753988|NCT02048813|Immunoglobulins|immunoglobulins|mesh-list
774030|NCT02682485|Metronidazole|metronidazole|mesh-list
774031|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
774032|NCT02682485|Neomycin|neomycin|mesh-list
774033|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
774034|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
774035|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
774036|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
774037|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
774038|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
774039|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774040|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774041|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774042|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
774043|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
774044|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
774063|NCT02682459|Lisinopril|lisinopril|mesh-list
774064|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
774065|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
774066|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774067|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774068|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
774069|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
774070|NCT02682459|Protective Agents|protective agents|mesh-ancestor
774071|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772816|NCT02687100|Beclomethasone|beclomethasone|mesh-list
772817|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772818|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
772819|NCT02687100|Hormones|hormones|mesh-ancestor
772820|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
772821|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772822|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
772823|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
773108|NCT02685774|Metformin|metformin|mesh-list
773109|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
773110|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773213|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
773214|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
773215|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
773372|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
773373|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773374|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240488|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240489|NCT00099489|Interferons|interferons|mesh-list
2240490|NCT00099489|Interferon-beta|interferon-beta|mesh-list
2094837|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2094838|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
2094839|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2240491|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
2240492|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240493|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
2240494|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240495|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
2240496|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240497|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2240498|NCT00099502|Interferons|interferons|mesh-list
2240499|NCT00099502|Interferon-beta|interferon-beta|mesh-list
773595|NCT02684084|Dexamethasone|dexamethasone|mesh-list
773596|NCT02684084|Ranibizumab|ranibizumab|mesh-list
773597|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
773598|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
773599|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
773600|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
773601|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773602|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
773603|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
773604|NCT02684084|Hormones|hormones|mesh-ancestor
773605|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
773606|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
773607|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773608|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
773609|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
773610|NCT02684084|Growth Substances|growth substances|mesh-ancestor
773611|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
2094840|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2094841|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094842|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094843|NCT02284854|Carbamazepine|carbamazepine|mesh-list
2094844|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2094845|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
773832|NCT02683213|Fluoxetine|fluoxetine|mesh-list
773833|NCT02683213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
773834|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
773835|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
773836|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773837|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
773838|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
773839|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773840|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
773841|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
773842|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
773843|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
773844|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
773845|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094846|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
2094847|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2094848|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2094849|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240500|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
2240501|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
2240502|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240503|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
2240504|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240505|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
2240506|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240507|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2240508|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240509|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2240510|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
2240511|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2240512|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240513|NCT00099554|Etanercept|etanercept|mesh-list
2240514|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2240515|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2240516|NCT00099554|Analgesics|analgesics|mesh-ancestor
2240517|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
2240518|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2240519|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240520|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2240521|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2240522|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2240523|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
772982|NCT02686151|Dexamethasone|dexamethasone|mesh-list
772983|NCT02686151|Letrozole|letrozole|mesh-list
772984|NCT02686151|Polygeline|polygeline|mesh-list
772985|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772986|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
772987|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
772988|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772989|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772990|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
772991|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
772992|NCT02686151|Hormones|hormones|mesh-ancestor
772993|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
772994|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
772995|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772996|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
772997|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
772998|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772999|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773000|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
773001|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
773002|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
773003|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
773111|NCT02685748|Aspirin|aspirin|mesh-list
773112|NCT02685748|Pantoprazole|pantoprazole|mesh-list
773113|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
773114|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
773115|NCT02685748|Analgesics|analgesics|mesh-ancestor
773116|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
773117|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
773118|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773119|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
773120|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
773121|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
773122|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
773123|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773124|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
773125|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
773126|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773127|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
773128|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
773129|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
773130|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2240524|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
2240525|NCT00099606|Dasatinib|dasatinib|mesh-list
2240526|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240527|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2240528|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240529|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240530|NCT00099619|Insulin|insulin|mesh-list
2240531|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2240532|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
2240533|NCT00099619|Exenatide|exenatide|mesh-list
2240534|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
773363|NCT02685085|Misoprostol|misoprostol|mesh-list
2240535|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772846|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
772847|NCT02686905|Vitamin D|vitamin d|mesh-list
772848|NCT02686905|Vitamins|vitamins|mesh-list
772849|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
772850|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
772851|NCT02686905|Calcium|calcium|mesh-list
772852|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
772853|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772854|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
772855|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
772856|NCT02686905|Hematinics|hematinics|mesh-ancestor
772857|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
2753989|NCT02048813|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2753990|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2753991|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
2753992|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2753993|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2753994|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2753995|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
2753996|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2753997|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2753998|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2753999|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2754000|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
2754001|NCT02035137|Irinotecan|irinotecan|mesh-list
773230|NCT02685449|Insulin|insulin|mesh-list
773231|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
773232|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
773233|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
773234|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
773235|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
773236|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240536|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2240537|NCT00099619|Incretins|incretins|mesh-ancestor
773313|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
773314|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
773315|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
773316|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773317|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
773318|NCT02684812|Coagulants|coagulants|mesh-ancestor
2240538|NCT00099619|Hormones|hormones|mesh-ancestor
2240539|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2240540|NCT00099645|Mifepristone|mifepristone|mesh-list
2240541|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2240542|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
2240543|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2240544|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240545|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2240546|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2240547|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2240548|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
2240549|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2240550|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
773570|NCT02684253|Nivolumab|nivolumab|mesh-list
773571|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
773572|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773573|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
773574|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754002|NCT02035137|Vincristine|vincristine|mesh-list
2754003|NCT02035137|Vorinostat|vorinostat|mesh-list
2754004|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2754005|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2754006|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2754007|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754008|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754009|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754010|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2754011|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
2240551|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
2240552|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2240553|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
2240554|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2240555|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2754012|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
773967|NCT02682524|Aceclofenac|aceclofenac|mesh-list
773968|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
772858|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
772859|NCT02686593|Clofarabine|clofarabine|mesh-list
772860|NCT02686593|Analgesics|analgesics|mesh-ancestor
772861|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
772862|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
772863|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772864|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772865|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
772866|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
772867|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772868|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772869|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
772870|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
773068|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
773069|NCT02685670|Fludarabine|fludarabine|mesh-list
773070|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
773071|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
773073|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773074|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
773075|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
773076|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
773077|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773078|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773079|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
773364|NCT02685085|Dinoprostone|dinoprostone|mesh-list
773365|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
773366|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
773367|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
773368|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773369|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
773370|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
773371|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
773470|NCT02684487|Vitamin D|vitamin d|mesh-list
773471|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
773472|NCT02684487|Vitamins|vitamins|mesh-ancestor
773473|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
773474|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773475|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
773476|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
773592|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
773593|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
773594|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240556|NCT00099684|Ezetimibe|ezetimibe|mesh-list
2240557|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2240558|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2240559|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
2240560|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240561|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
773877|NCT02682927|Fenfluramine|fenfluramine|mesh-list
773878|NCT02682927|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
773879|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
773880|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
773881|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773882|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
773883|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
773884|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773969|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
773970|NCT02682524|Analgesics|analgesics|mesh-ancestor
773971|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
773972|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
773973|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773974|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
773975|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
774021|NCT02682511|Ifetroban|ifetroban|mesh-list
774022|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
774108|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
774109|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
774110|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
774111|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
774112|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774113|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774114|NCT02682147|Urological Agents|urological agents|mesh-ancestor
774156|NCT02682082|Bupivacaine|bupivacaine|mesh-list
774158|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
774159|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
774196|NCT02681679|Bromfenac|bromfenac|mesh-list
772871|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
772872|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
772873|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
772874|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
772875|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240562|NCT00099710|Curcumin|curcumin|mesh-list
2240563|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2240564|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2240565|NCT00099710|Analgesics|analgesics|mesh-ancestor
2240566|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
2240567|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2240568|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240569|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2240570|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2240571|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240572|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240573|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240574|NCT00099736|Cyclosporine|cyclosporine|mesh-list
2240575|NCT00099736|Cyclosporins|cyclosporins|mesh-list
2240576|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2240577|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
2240578|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240579|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
2240580|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240581|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240582|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240583|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
773819|NCT02683031|Ionophores|ionophores|mesh-list
773820|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
773821|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773976|NCT02682758|Xenon|xenon|mesh-list
773977|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
773978|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
773979|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773980|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
773981|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
773984|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
773985|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
773986|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
773987|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773988|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
774056|NCT02682186|Ropivacaine|ropivacaine|mesh-list
774057|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
774058|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
774059|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774060|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774061|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
774062|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774118|NCT02682004|Serotonin|serotonin|mesh-list
774119|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
774120|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
774121|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
774122|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774123|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774124|NCT02682017|Fucoidan|fucoidan|mesh-list
774125|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
774126|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
774127|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
774128|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774173|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774174|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
774175|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
774176|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
774177|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
774178|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
774179|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
774180|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774198|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
774199|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
774200|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
774201|NCT02681679|Analgesics|analgesics|mesh-ancestor
774202|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
774203|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774204|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774295|NCT02681263|Temocillin|temocillin|mesh-list
772884|NCT02686710|Propofol|propofol|mesh-list
772885|NCT02686710|Sevoflurane|sevoflurane|mesh-list
772886|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
772887|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
772888|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772889|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
772890|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
772891|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
772892|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
772893|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
773255|NCT02685462|Digoxin|digoxin|mesh-list
773256|NCT02685462|Caffeine|caffeine|mesh-list
773257|NCT02685462|Atorvastatin|atorvastatin|mesh-list
773258|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
773259|NCT02685462|Simvastatin|simvastatin|mesh-list
773260|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
773261|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
773262|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
773263|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773264|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
773265|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
773266|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773267|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
773268|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773269|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
773270|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
773271|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
773272|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
773273|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
773274|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
773275|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
773276|NCT02685462|Protective Agents|protective agents|mesh-ancestor
773459|NCT02684409|Sumatriptan|sumatriptan|mesh-list
773460|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
773461|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
773462|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
773463|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
773464|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
773465|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773466|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773637|NCT02684318|Olaparib|olaparib|mesh-list
773638|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
773639|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773640|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773641|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240584|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240585|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2240586|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2240587|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2240588|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2240589|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2240590|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240591|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240592|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
2240593|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240594|NCT00099775|Caspofungin|caspofungin|mesh-list
2240595|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
2240596|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240597|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240598|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240599|NCT00099788|Ranolazine|ranolazine|mesh-list
772895|NCT02686840|Misoprostol|misoprostol|mesh-list
772896|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
772897|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
772898|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
772899|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772900|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
772901|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
772902|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
2240600|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2240601|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2240602|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240603|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2240604|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
773489|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
773490|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
773491|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
773492|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773540|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
773541|NCT02684071|Methotrexate|methotrexate|mesh-list
773542|NCT02684071|Topotecan|topotecan|mesh-list
773543|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
773544|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
773545|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773546|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
773547|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
773548|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
773549|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773550|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773551|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
773552|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
773553|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
773554|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
773555|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
773556|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
773557|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
773558|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773559|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
773560|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
773561|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
773562|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
773734|NCT02683655|Apatinib|apatinib|mesh-list
773735|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773736|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
773737|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
773738|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773796|NCT02683369|Iron|iron|mesh-list
773797|NCT02683369|Trace Elements|trace elements|mesh-ancestor
773798|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
773799|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773827|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
773828|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
773829|NCT02683005|Ledipasvir|ledipasvir|mesh-list
773830|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
773831|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2754013|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
774115|NCT02682121|Metformin|metformin|mesh-list
774116|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
774117|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774133|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774134|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774135|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
774136|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
774137|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
774138|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
774139|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774140|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
774141|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
774142|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
774143|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774144|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
774145|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
774146|NCT02681848|Nicotine|nicotine|mesh-list
774147|NCT02681848|Varenicline|varenicline|mesh-list
774148|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
774149|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
772903|NCT02686645|Metronidazole|metronidazole|mesh-list
772904|NCT02686645|Vancomycin|vancomycin|mesh-list
772905|NCT02686645|Loperamide|loperamide|mesh-list
772906|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
772907|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772908|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
772909|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
772910|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
772911|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2240605|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240606|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240607|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
2240608|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240609|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2240610|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240611|NCT00099853|Pioglitazone|pioglitazone|mesh-list
2240612|NCT00099853|Vildagliptin|vildagliptin|mesh-list
2240613|NCT00099853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2240614|NCT00099853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240615|NCT00099853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2240616|NCT00099853|Protease Inhibitors|protease inhibitors|mesh-ancestor
2240617|NCT00099853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240618|NCT00099853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240619|NCT00099866|Metformin|metformin|mesh-list
2240620|NCT00099866|Vildagliptin|vildagliptin|mesh-list
2240621|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2240622|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240623|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2240624|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
773435|NCT02684708|Prednisone|prednisone|mesh-list
773436|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
773437|NCT02684708|Dacarbazine|dacarbazine|mesh-list
773438|NCT02684708|Vincristine|vincristine|mesh-list
773439|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
773440|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
773441|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773442|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
773443|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
773444|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
773445|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
773446|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
773447|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
773448|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
773449|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
773450|NCT02684708|Hormones|hormones|mesh-ancestor
773451|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
773452|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
773453|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
773454|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
773455|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
773456|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
2240625|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240626|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240627|NCT00099892|Vildagliptin|vildagliptin|mesh-list
2240628|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2240629|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094850|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2094851|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2094852|NCT02284854|Analgesics|analgesics|mesh-ancestor
2094853|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
2094854|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094855|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2094856|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094857|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240630|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
773778|NCT02683564|Infliximab|infliximab|mesh-list
773779|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
773780|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
773781|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2240631|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
2240632|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240633|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240634|NCT00099905|Vildagliptin|vildagliptin|mesh-list
2240635|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2240636|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773852|NCT02683070|Tramadol|tramadol|mesh-list
772912|NCT02686827|Vitamin D|vitamin d|mesh-list
772913|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
772914|NCT02686827|Vitamins|vitamins|mesh-ancestor
772915|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
772916|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772917|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
772918|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
773536|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
773537|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
773538|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
773539|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
773588|NCT02684305|Oxytocin|oxytocin|mesh-list
773589|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
773590|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
773591|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773694|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
773695|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
773696|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
773697|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
773698|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
773995|NCT02682693|Denosumab|denosumab|mesh-list
773996|NCT02682693|Paclitaxel|paclitaxel|mesh-list
773997|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
773998|NCT02682693|Carboplatin|carboplatin|mesh-list
773999|NCT02682693|Trastuzumab|trastuzumab|mesh-list
774000|NCT02682693|Epirubicin|epirubicin|mesh-list
774001|NCT02682693|Pertuzumab|pertuzumab|mesh-list
774002|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
774003|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774004|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
774005|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
774006|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
774007|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774008|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
774009|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
774010|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774011|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
774012|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
774013|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
774014|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
774015|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
774016|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
774017|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
774018|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
774019|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774020|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2240637|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2240638|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
2240639|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240640|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240641|NCT00099918|Vildagliptin|vildagliptin|mesh-list
2240642|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2240643|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774150|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774151|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774152|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
774153|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
774154|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
774155|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
774157|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240644|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
774183|NCT02681887|Melatonin|melatonin|mesh-list
774184|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
774185|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774186|NCT02681887|Protective Agents|protective agents|mesh-ancestor
774187|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774188|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774205|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
774206|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
774212|NCT02681796|Bupivacaine|bupivacaine|mesh-list
774213|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
774214|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
774215|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774216|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774217|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
772919|NCT02686619|Cyclosporine|cyclosporine|mesh-list
772920|NCT02686619|Sirolimus|sirolimus|mesh-list
772921|NCT02686619|Prednisolone|prednisolone|mesh-list
772922|NCT02686619|Cyclosporins|cyclosporins|mesh-list
772923|NCT02686619|Daclizumab|daclizumab|mesh-list
772924|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
772925|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
772926|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
772927|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
772928|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
772929|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
772930|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
772931|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
772932|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
772933|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
772934|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
772935|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
772936|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
772937|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
772938|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
772939|NCT02686619|Hormones|hormones|mesh-ancestor
772940|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
772941|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2240645|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
2240646|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240647|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240648|NCT00099931|Vildagliptin|vildagliptin|mesh-list
2240649|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2240650|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240651|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2240652|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
2240653|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240654|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240655|NCT00099944|Glimepiride|glimepiride|mesh-list
2240656|NCT00099944|Vildagliptin|vildagliptin|mesh-list
2240657|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2240658|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2240659|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240660|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240661|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
2240662|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2240663|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
2240664|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240665|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240666|NCT00099957|Vildagliptin|vildagliptin|mesh-list
2240667|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2240668|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240669|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2240670|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
2240671|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240672|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240673|NCT00099970|Dacarbazine|dacarbazine|mesh-list
2240674|NCT00099970|Volociximab|volociximab|mesh-list
2240675|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2240676|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
2240677|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240678|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240679|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2240680|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2240681|NCT00099970|Growth Substances|growth substances|mesh-ancestor
2240682|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240683|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
2240684|NCT00099996|Ezetimibe|ezetimibe|mesh-list
2240685|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2240686|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2240687|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
2240688|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094858|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2094859|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2094860|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2094861|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2094862|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
2094863|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2094864|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2240689|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2240690|NCT00100009|Triamcinolone|triamcinolone|mesh-list
2240691|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2240692|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2240693|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2240694|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2240695|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
2240696|NCT00100009|Hormones|hormones|mesh-ancestor
2240697|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094865|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094866|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094867|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2094868|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
2094869|NCT02284893|Saxagliptin|saxagliptin|mesh-list
2094870|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2094871|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094872|NCT02284893|Incretins|incretins|mesh-ancestor
2094873|NCT02284893|Hormones|hormones|mesh-ancestor
2094874|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094875|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2094876|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
2094877|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094878|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094879|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2094880|NCT02285010|Pregabalin|pregabalin|mesh-list
2094881|NCT02285010|Analgesics|analgesics|mesh-ancestor
2094882|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
2094883|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094884|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094885|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
2094886|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2094887|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094888|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094889|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2094890|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2094891|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2094892|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2094893|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2094894|NCT02285062|Prednisone|prednisone|mesh-list
2094895|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
2094896|NCT02285062|Rituximab|rituximab|mesh-list
2094897|NCT02285062|Doxorubicin|doxorubicin|mesh-list
2094898|NCT02285062|Vincristine|vincristine|mesh-list
2094899|NCT02285062|Lenalidomide|lenalidomide|mesh-list
2094900|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2094901|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
2094902|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094903|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2094904|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2094905|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
2094906|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094907|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2094908|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2094909|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2094910|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2094911|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2094912|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2094913|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094914|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2094915|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
2094916|NCT02285062|Hormones|hormones|mesh-ancestor
2094917|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094918|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2094919|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2094920|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
2094921|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
2094922|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
774221|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
774222|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
774223|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774224|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
774225|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
774226|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774382|NCT02680717|Clobetasol|clobetasol|mesh-list
774383|NCT02680717|Calcipotriene|calcipotriene|mesh-list
774384|NCT02680717|Tacrolimus|tacrolimus|mesh-list
774385|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
774386|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
774387|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774388|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
774389|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774390|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774391|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
774392|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
774393|NCT02680717|Hormones|hormones|mesh-ancestor
774394|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
774395|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
2240698|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240699|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240700|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
2240701|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774748|NCT02679144|Eflornithine|eflornithine|mesh-list
774749|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774750|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
774751|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
774752|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
774753|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
774754|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
774755|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774756|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776131|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
776132|NCT02671864|Incretins|incretins|mesh-list
776133|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776134|NCT02671864|Hormones|hormones|mesh-ancestor
776135|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
776756|NCT02668666|Tamoxifen|tamoxifen|mesh-list
776757|NCT02668666|Palbociclib|palbociclib|mesh-list
776758|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
776759|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
776760|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
776761|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776762|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
776763|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776764|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
776765|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
776766|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
776767|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
776768|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776769|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777055|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
777056|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
777057|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
777058|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
777059|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
777060|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777061|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777062|NCT02667470|Urological Agents|urological agents|mesh-ancestor
777460|NCT02665637|Trastuzumab|trastuzumab|mesh-list
777461|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
777462|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777702|NCT02664558|Ubenimex|ubenimex|mesh-list
777703|NCT02664558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
777704|NCT02664558|Immunologic Factors|immunologic factors|mesh-ancestor
777705|NCT02664558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777706|NCT02664558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
777707|NCT02664558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
777708|NCT02664558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
777709|NCT02664558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777710|NCT02664558|Protease Inhibitors|protease inhibitors|mesh-ancestor
777711|NCT02664558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774227|NCT02681705|Temozolomide|temozolomide|mesh-list
774228|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
774229|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
774230|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774231|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774272|NCT02681198|Lofexidine|lofexidine|mesh-list
774273|NCT02681198|Paroxetine|paroxetine|mesh-list
774274|NCT02681198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
774275|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
774276|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
774277|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774278|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
774279|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
774280|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774281|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
774282|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
774283|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
774284|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
774285|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
774286|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774287|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
774288|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
774289|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
774290|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774291|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
774292|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
774293|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
774294|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
774628|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
774629|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
774630|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
774631|NCT02679833|Vitamins|vitamins|mesh-ancestor
774632|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
774633|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774634|NCT02679833|Hematinics|hematinics|mesh-ancestor
2240702|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240703|NCT00100074|Lobeline|lobeline|mesh-list
2240704|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2240705|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
2240706|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2240707|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240708|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2240709|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2240710|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
2240711|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2240712|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774978|NCT02678234|Acetaminophen|acetaminophen|mesh-list
774979|NCT02678234|Ascorbic Acid|ascorbic acid|mesh-list
774980|NCT02678234|Phenylephrine|phenylephrine|mesh-list
774981|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
774982|NCT02678234|Vitamins|vitamins|mesh-ancestor
774983|NCT02678234|Micronutrients|micronutrients|mesh-ancestor
774984|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774985|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
774986|NCT02678234|Analgesics|analgesics|mesh-ancestor
774987|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
774988|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774989|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
774990|NCT02678234|Antioxidants|antioxidants|mesh-ancestor
774991|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774992|NCT02678234|Protective Agents|protective agents|mesh-ancestor
774993|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
774994|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
774995|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
774996|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
774997|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
774998|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
774999|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
775000|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
775001|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
775002|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
775003|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
775004|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775351|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
775352|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
775353|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
2240713|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
2240714|NCT00100100|Modafinil|modafinil|mesh-list
2240715|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2240716|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774404|NCT02680951|Cytarabine|cytarabine|mesh-list
774405|NCT02680951|Fludarabine|fludarabine|mesh-list
774406|NCT02680951|Dasatinib|dasatinib|mesh-list
774407|NCT02680951|Idarubicin|idarubicin|mesh-list
774408|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774409|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
774410|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
774411|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774412|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
774413|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
774414|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774415|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
774416|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
774417|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
774418|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774419|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
774420|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
774421|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2240717|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2240718|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2240719|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2240720|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240721|NCT00100113|Vanoxerine|vanoxerine|mesh-list
2240722|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2240723|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2240724|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2240725|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240726|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
2240727|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2240728|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240729|NCT00100126|Amoxicillin|amoxicillin|mesh-list
774624|NCT02679820|Copper|copper|mesh-list
774625|NCT02679820|Trace Elements|trace elements|mesh-ancestor
774626|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
774627|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240730|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
775451|NCT02675829|Trastuzumab|trastuzumab|mesh-list
775452|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
775453|NCT02675829|Maytansine|maytansine|mesh-list
775454|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
775455|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775456|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
775457|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
775458|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
775459|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
775460|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776302|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
776303|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
776304|NCT02670954|Tramadol|tramadol|mesh-list
776305|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
776306|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776307|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776308|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
776309|NCT02670954|Analgesics|analgesics|mesh-ancestor
776310|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
776311|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776312|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
776313|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
776314|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
776315|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
776316|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
776317|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776318|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
776319|NCT02670954|Narcotics|narcotics|mesh-ancestor
776320|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
774236|NCT02681549|Bevacizumab|bevacizumab|mesh-list
774237|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
774238|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
774239|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774240|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
774241|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
774242|NCT02681549|Growth Substances|growth substances|mesh-ancestor
774243|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774244|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
774676|NCT02679339|Lidocaine|lidocaine|mesh-list
774677|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
774678|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
774679|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774680|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774681|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
774682|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774683|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
774684|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
774685|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
774686|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
774687|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774939|NCT02678260|Spartalizumab|spartalizumab|mesh-list
774940|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
774941|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774942|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775281|NCT02676934|Anesthetics|anesthetics|mesh-list
775282|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
775283|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775638|NCT02675205|Aspirin|aspirin|mesh-list
775639|NCT02675205|Clopidogrel|clopidogrel|mesh-list
775640|NCT02675205|Ticagrelor|ticagrelor|mesh-list
775641|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
775642|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
775643|NCT02675205|Analgesics|analgesics|mesh-ancestor
775644|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
775645|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775646|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775647|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
775648|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
775649|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
775650|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
775651|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775652|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
775653|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
775654|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775655|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
775656|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
775657|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
775658|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
775659|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
775660|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775882|NCT02674191|Clindamycin|clindamycin|mesh-list
775883|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
775884|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
775885|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
775886|NCT02674191|Mepivacaine|mepivacaine|mesh-list
775887|NCT02674191|Benzocaine|benzocaine|mesh-list
775888|NCT02674191|Povidone|povidone|mesh-list
775889|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
775890|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775891|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
775892|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775893|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775894|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
775895|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
775896|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
775897|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
775898|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
775899|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
775900|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775901|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
775902|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094923|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
776043|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
774245|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
774247|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
774248|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
774249|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
774250|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
774251|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774252|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
774253|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
774254|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
774255|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
774256|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774571|NCT02680132|Esomeprazole|esomeprazole|mesh-list
774572|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
774573|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
774574|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
774575|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774576|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774757|NCT02679040|Trastuzumab|trastuzumab|mesh-list
774758|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
774759|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774887|NCT02678598|Micafungin|micafungin|mesh-list
774888|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
774889|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
776102|NCT02672202|Pregabalin|pregabalin|mesh-list
776103|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
776104|NCT02672202|Analgesics|analgesics|mesh-ancestor
776105|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
776106|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776107|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776108|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
776109|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
776110|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
776111|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776112|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
776113|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
776114|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
776115|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776116|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
776117|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
776118|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
776119|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
776120|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
776121|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
776518|NCT02670018|Metformin|metformin|mesh-list
776519|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
776520|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776726|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
776727|NCT02669368|Rocuronium|rocuronium|mesh-list
776728|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
776729|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
776730|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
776731|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776732|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776733|NCT02669368|Analgesics|analgesics|mesh-ancestor
776734|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
776735|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
776736|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776737|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
776738|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
776739|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
776740|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
776741|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776742|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
776743|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
776744|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
776960|NCT02668172|Pasireotide|pasireotide|mesh-list
776961|NCT02668172|Hormones|hormones|mesh-ancestor
776962|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2240731|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240732|NCT00100139|Paclitaxel|paclitaxel|mesh-list
2240733|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2240734|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2240735|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240736|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
2240737|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
2240738|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
2240739|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240740|NCT00100243|Abarelix|abarelix|mesh-list
774356|NCT02680977|Levodopa|levodopa|mesh-list
774357|NCT02680977|Benserazide|benserazide|mesh-list
774358|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
774359|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
774360|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
774361|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
774362|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774363|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774364|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775083|NCT02677584|Caffeine|caffeine|mesh-list
775084|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
775085|NCT02677584|Citric Acid|citric acid|mesh-list
775086|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
775087|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
775088|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
775089|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
775090|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
775091|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775092|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
775093|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775094|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
775095|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775096|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
775097|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
775098|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
775099|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775185|NCT02677415|Anesthetics|anesthetics|mesh-list
775186|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
775187|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
775188|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775189|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
775258|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
775259|NCT02677181|Methotrexate|methotrexate|mesh-list
775260|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
775261|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
775262|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
775263|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
775264|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775265|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
775266|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
775267|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775268|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775269|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
775270|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775271|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
775272|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
775273|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
775274|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
775275|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
775276|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
775277|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
775278|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
775279|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
775280|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775284|NCT02676609|Insulin|insulin|mesh-list
775285|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
775286|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775583|NCT02675400|Methylphenidate|methylphenidate|mesh-list
775584|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
775585|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
774296|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
774297|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240741|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
2240742|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2240743|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240744|NCT00100269|Antioxidants|antioxidants|mesh-list
2240745|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240746|NCT00100269|Protective Agents|protective agents|mesh-ancestor
2240747|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240748|NCT00100308|Heparin|heparin|mesh-list
2240749|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
2240750|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2240751|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2240752|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774788|NCT02679092|Misoprostol|misoprostol|mesh-list
774789|NCT02679092|Mifepristone|mifepristone|mesh-list
774790|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
774791|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
774792|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
774793|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774794|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
774795|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
774796|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
774797|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
774798|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
774799|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
774800|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
774801|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
774802|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
774803|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
774804|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
774805|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
774806|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
774807|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
774808|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2240753|NCT00100412|Phenylephrine|phenylephrine|mesh-list
2240754|NCT00100412|Dobutamine|dobutamine|mesh-list
2240755|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
2240756|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2240757|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
2240758|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
2240759|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2240760|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240761|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
2240762|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2240763|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
2240764|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
2240765|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
775149|NCT02677519|Methylphenidate|methylphenidate|mesh-list
775150|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
775151|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775152|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
775153|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
775154|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
775155|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775156|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
775157|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775198|NCT02677155|Rituximab|rituximab|mesh-list
775199|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
775200|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
775201|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775202|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
775203|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775204|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
775676|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
775677|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
775678|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
775679|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
776122|NCT02672241|Temozolomide|temozolomide|mesh-list
2094924|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2094925|NCT02285062|Growth Substances|growth substances|mesh-ancestor
2094926|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
2094927|NCT02285153|Aspirin|aspirin|mesh-list
2094928|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
2094929|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2094930|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
774396|NCT02680795|Belinostat|belinostat|mesh-list
774397|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774398|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
774399|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774400|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774541|NCT02680379|Minocycline|minocycline|mesh-list
774542|NCT02680379|Lovastatin|lovastatin|mesh-list
774543|NCT02680379|L 647318|l 647318|mesh-list
774544|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
774545|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
774546|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
774547|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
774548|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
774549|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
774550|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774551|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
774552|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
774553|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240766|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2240767|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2240768|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
2240769|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2240770|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240771|NCT00100412|Protective Agents|protective agents|mesh-ancestor
2240772|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2240773|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
774760|NCT02679131|Belinostat|belinostat|mesh-list
774761|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774762|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
774763|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774764|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774828|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
774829|NCT02678767|Hematinics|hematinics|mesh-ancestor
774830|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
774831|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
774842|NCT02678338|Magrolimab|magrolimab|mesh-list
774843|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
774844|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774933|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
774934|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
774935|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
774936|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774937|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
774938|NCT02678208|Coagulants|coagulants|mesh-ancestor
2240774|NCT00100464|Paroxetine|paroxetine|mesh-list
2240775|NCT00100464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
775365|NCT02676336|Iodine|iodine|mesh-list
775366|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
775367|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
775368|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775369|NCT02676336|Trace Elements|trace elements|mesh-ancestor
775370|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
775371|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094931|NCT02285153|Analgesics|analgesics|mesh-ancestor
2094932|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
2094933|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094934|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094935|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2094936|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2094937|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2094938|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2094939|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094940|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2094941|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2094942|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094943|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
2094944|NCT02285283|Itraconazole|itraconazole|mesh-list
2094945|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
2754014|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2754015|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
774732|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
774733|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
774832|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
774833|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
774834|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
774835|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774836|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774837|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
774838|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
774839|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774840|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
774841|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
774845|NCT02678572|Melphalan|melphalan|mesh-list
774846|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
774847|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
774848|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774849|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774850|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
774851|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
774852|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
774853|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774957|NCT02678221|Aspirin|aspirin|mesh-list
774958|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
774959|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
774960|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
774961|NCT02678221|Analgesics|analgesics|mesh-ancestor
774962|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
774963|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774964|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774965|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
774966|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
774967|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
774968|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
774969|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774970|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
774971|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
774972|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774973|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
774974|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
774975|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
774976|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
774977|NCT02678221|Urological Agents|urological agents|mesh-ancestor
775303|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
775304|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
775305|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775372|NCT02676323|Leucovorin|leucovorin|mesh-list
775373|NCT02676323|Cytarabine|cytarabine|mesh-list
775374|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
775375|NCT02676323|Methotrexate|methotrexate|mesh-list
775376|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
775377|NCT02676323|Fludarabine|fludarabine|mesh-list
775378|NCT02676323|Panobinostat|panobinostat|mesh-list
775379|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
775380|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775381|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
775382|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
775383|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
775384|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
775385|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
775386|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775387|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775388|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
775389|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775390|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
775391|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
775392|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
775393|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
775394|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
775395|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
774311|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
774312|NCT02681211|Promethazine|promethazine|mesh-list
774313|NCT02681211|Ketorolac|ketorolac|mesh-list
774314|NCT02681211|Metoclopramide|metoclopramide|mesh-list
774315|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
774316|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
774317|NCT02681211|Analgesics|analgesics|mesh-ancestor
774318|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
774319|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774320|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774321|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
774322|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
774323|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
774324|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774325|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774326|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
774327|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
774328|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774329|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
774330|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
774331|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
774332|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
774333|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
774334|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
774335|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
774336|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
774337|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
774338|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
774339|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
774340|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
774341|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
774342|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
774343|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
774423|NCT02680574|Darbepoetin alfa|darbepoetin alfa|mesh-list
774424|NCT02680574|Hematinics|hematinics|mesh-ancestor
774911|NCT02678364|Vitamin D|vitamin d|mesh-list
774912|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
774913|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
774914|NCT02678364|Calcifediol|calcifediol|mesh-list
774915|NCT02678364|Vitamins|vitamins|mesh-ancestor
774916|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
774917|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774918|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
774919|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
775126|NCT02677545|Aspirin|aspirin|mesh-list
775127|NCT02677545|Clopidogrel|clopidogrel|mesh-list
775128|NCT02677545|Ticagrelor|ticagrelor|mesh-list
775129|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
775130|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
775131|NCT02677545|Analgesics|analgesics|mesh-ancestor
775132|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
775133|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775134|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775135|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
775136|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
775137|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
775138|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
775139|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775140|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
775141|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
775142|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775143|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
775144|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
775145|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
775146|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
775147|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
775148|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775343|NCT02676154|Fesoterodine|fesoterodine|mesh-list
775344|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
775345|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
775346|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
775347|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775348|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775349|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775350|NCT02676154|Urological Agents|urological agents|mesh-ancestor
775475|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
775476|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2240776|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2240777|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2240778|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240779|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2240780|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
2240781|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240782|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2240783|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
2240784|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2240785|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2240786|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2240787|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240788|NCT00100477|Etoposide|etoposide|mesh-list
2240789|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
2240790|NCT00100477|Topotecan|topotecan|mesh-list
2240791|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2240792|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240793|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2240794|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2240795|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240796|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240797|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2240798|NCT00100477|Analgesics|analgesics|mesh-ancestor
2240799|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
2240800|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775013|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
775014|NCT02678117|Pregabalin|pregabalin|mesh-list
775015|NCT02678117|Analgesics|analgesics|mesh-ancestor
775016|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
775017|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775018|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775019|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
775020|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
775021|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
775022|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775023|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
775024|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
775025|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
775026|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
775027|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
775028|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
775029|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
775030|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
775031|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
775730|NCT02674906|Calcium heparin|calcium heparin|mesh-list
775731|NCT02674906|Anticoagulants|anticoagulants|mesh-list
775732|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775733|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
775734|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
775796|NCT02674581|Fostemsavir|fostemsavir|mesh-list
775797|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
775798|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
775799|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
775800|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775801|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
775802|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
775803|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775864|NCT02674113|Bupivacaine|bupivacaine|mesh-list
775865|NCT02674113|Anesthetics|anesthetics|mesh-list
775866|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
775867|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
775868|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775869|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
775870|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775928|NCT02673840|Ketotifen|ketotifen|mesh-list
775929|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
775930|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
775931|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
775932|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
775933|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
775934|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775935|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775936|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775937|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
774365|NCT02680938|Oxytocin|oxytocin|mesh-list
774366|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
774367|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
774368|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774554|NCT02680119|Esomeprazole|esomeprazole|mesh-list
774555|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
774556|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
774557|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
774558|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774559|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774785|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
774786|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
774787|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774854|NCT02678650|Anesthetics|anesthetics|mesh-list
774855|NCT02678650|Propofol|propofol|mesh-list
774856|NCT02678650|Isoflurane|isoflurane|mesh-list
774857|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774858|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774859|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
774860|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
774861|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
774862|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
774954|NCT02678195|Amoxicillin|amoxicillin|mesh-list
774955|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
774956|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775354|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775355|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775356|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
775357|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
775358|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
775359|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
775360|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
775361|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775362|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240801|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240802|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
2240803|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2240804|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240805|NCT00100568|Lamivudine|lamivudine|mesh-list
2240806|NCT00100568|Zidovudine|zidovudine|mesh-list
775547|NCT02675647|Heparin|heparin|mesh-list
775548|NCT02675647|Protamines|protamines|mesh-list
775549|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
775550|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
775551|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
775552|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775553|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
775554|NCT02675647|Coagulants|coagulants|mesh-ancestor
775616|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
775617|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
775618|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775619|NCT02675335|Incretins|incretins|mesh-ancestor
775620|NCT02675335|Hormones|hormones|mesh-ancestor
775621|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
775622|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
775623|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
775624|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775625|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775735|NCT02674997|Factor VIII|factor viii|mesh-list
775736|NCT02674997|Coagulants|coagulants|mesh-ancestor
775871|NCT02673931|Exenatide|exenatide|mesh-list
775872|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
775873|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775874|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
775875|NCT02673931|Incretins|incretins|mesh-ancestor
775876|NCT02673931|Hormones|hormones|mesh-ancestor
775877|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
775951|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
775952|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
775953|NCT02673606|Estradiol|estradiol|mesh-list
775954|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
775955|NCT02673606|Estrogens|estrogens|mesh-ancestor
775956|NCT02673606|Hormones|hormones|mesh-ancestor
775957|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
775958|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776047|NCT02672839|Betadex|betadex|mesh-list
2240807|NCT00100568|Efavirenz|efavirenz|mesh-list
2240808|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2240809|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2240810|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2240811|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240812|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240813|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
2240814|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240815|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2240816|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2240817|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
2240818|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
775011|NCT02678052|Vedolizumab|vedolizumab|mesh-list
775012|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2240819|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2240820|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2240821|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2240822|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2240823|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2240824|NCT00100581|Interferons|interferons|mesh-list
2240825|NCT00100581|Ritonavir|ritonavir|mesh-list
2240826|NCT00100581|Tenofovir|tenofovir|mesh-list
2240827|NCT00100581|Ribavirin|ribavirin|mesh-list
2240828|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
2240829|NCT00100581|Lamivudine|lamivudine|mesh-list
2240830|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
2240831|NCT00100581|Efavirenz|efavirenz|mesh-list
2240832|NCT00100581|Lopinavir|lopinavir|mesh-list
2240833|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2240834|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240835|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
2240836|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775396|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775397|NCT02676323|Antidotes|antidotes|mesh-ancestor
775398|NCT02676323|Protective Agents|protective agents|mesh-ancestor
775399|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
775400|NCT02676323|Vitamins|vitamins|mesh-ancestor
775401|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
775402|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
775403|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
775555|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
775556|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
775557|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
775558|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
775559|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240837|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2240838|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2240839|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
2240840|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240841|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775695|NCT02675140|Vitamins|vitamins|mesh-list
775696|NCT02675140|Vitamin A|vitamin a|mesh-list
775697|NCT02675140|Albendazole|albendazole|mesh-list
775698|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
775699|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
775700|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775701|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
775702|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775703|NCT02675140|Protective Agents|protective agents|mesh-ancestor
775704|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
775705|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775706|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
775707|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
775708|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775709|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
775710|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
775711|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
775712|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
775713|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
775714|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
775766|NCT02674958|Aspirin|aspirin|mesh-list
775767|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
775768|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
775769|NCT02674958|Analgesics|analgesics|mesh-ancestor
775770|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
775771|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775772|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775773|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
775774|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2240842|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2240843|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2240844|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2240845|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2240846|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2240847|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
774823|NCT02678780|Lenvatinib|lenvatinib|mesh-list
774824|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774825|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
774826|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774827|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775231|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
775232|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
775233|NCT02677259|Estradiol|estradiol|mesh-list
775236|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
775237|NCT02677259|Progesterone|progesterone|mesh-list
775238|NCT02677259|Estrogens|estrogens|mesh-ancestor
775239|NCT02677259|Hormones|hormones|mesh-ancestor
775240|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
775241|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775242|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
775243|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
775244|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
775245|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
775246|NCT02677259|Progestins|progestins|mesh-ancestor
775293|NCT02676674|Vitamin D|vitamin d|mesh-list
775294|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
775295|NCT02676674|Vitamins|vitamins|mesh-ancestor
775296|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
775297|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775298|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
775299|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
775477|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
775478|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775479|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775480|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
775481|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
775482|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
775483|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
775484|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
775485|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775486|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775775|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
775776|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
775777|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775778|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
775779|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
775780|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775781|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
775838|NCT02674139|Copper|copper|mesh-list
775839|NCT02674139|Trace Elements|trace elements|mesh-ancestor
775840|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
775841|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240848|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
2240849|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
2240850|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775959|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
775960|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
775961|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
775962|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2240851|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
776012|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
776013|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
776014|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
776015|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
776016|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
776017|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776018|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
776019|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
776020|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776021|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
776022|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776029|NCT02672995|Bevacizumab|bevacizumab|mesh-list
776030|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
774401|NCT02680600|Cefepime|cefepime|mesh-list
774402|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
774403|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240852|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2240853|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2240854|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2240855|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2240856|NCT00100594|Lamivudine|lamivudine|mesh-list
2240857|NCT00100594|Zidovudine|zidovudine|mesh-list
2240858|NCT00100594|Efavirenz|efavirenz|mesh-list
2240859|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2240860|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2240861|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2240862|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240863|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240864|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
2240865|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240866|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2240867|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2240868|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
2240869|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2240870|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2240871|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2240872|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2240873|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2240874|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2240875|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
775560|NCT02675530|Ketamine|ketamine|mesh-list
775561|NCT02675530|Analgesics|analgesics|mesh-ancestor
775562|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
775563|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775564|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775565|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
775566|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
775567|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
775568|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
775569|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
775570|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
775571|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
775572|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775573|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775782|NCT02674529|Citalopram|citalopram|mesh-list
775783|NCT02674529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
775784|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
775785|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
775786|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775787|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775788|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
775789|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775790|NCT02674529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
775791|NCT02674529|Antidepressive Agents|antidepressive agents|mesh-ancestor
775792|NCT02674529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2240876|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2240877|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240878|NCT00100646|Ritonavir|ritonavir|mesh-list
2240879|NCT00100646|Lopinavir|lopinavir|mesh-list
2240880|NCT00100646|Lamivudine|lamivudine|mesh-list
2240881|NCT00100646|Stavudine|stavudine|mesh-list
2240882|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2240883|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2240884|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
2240885|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240886|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240887|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
775842|NCT02673996|Phenylephrine|phenylephrine|mesh-list
775843|NCT02673996|Isoproterenol|isoproterenol|mesh-list
775844|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
775845|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
775846|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
775847|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
775848|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775849|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775850|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
775851|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
776088|NCT02672475|Paclitaxel|paclitaxel|mesh-list
774422|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
774577|NCT02679963|Olaparib|olaparib|mesh-list
774578|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
774579|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774580|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774581|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774601|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
774602|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
774603|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
774604|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
774605|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774606|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
774607|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
774608|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094946|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2094947|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2094948|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2094949|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2094950|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094951|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2094952|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
2094953|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094954|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094955|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2094956|NCT02285634|Lidocaine|lidocaine|mesh-list
2094957|NCT02285634|Phenylephrine|phenylephrine|mesh-list
2094958|NCT02285634|Epinephrine|epinephrine|mesh-list
2094959|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
2094960|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
2094961|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
2094962|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2094963|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094964|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
2094965|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2240888|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2240889|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
2240890|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775235|NCT02676986|Exemestane|exemestane|mesh-list
775249|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775250|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
775251|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
775252|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775253|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775254|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
775255|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
775256|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
775257|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775426|NCT02675868|Phenylephrine|phenylephrine|mesh-list
775427|NCT02675868|Vasopressins|vasopressins|mesh-list
775428|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
775429|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
775430|NCT02675868|Norepinephrine|norepinephrine|mesh-list
775431|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
775432|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
775433|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
775434|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775435|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775436|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
775437|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
775438|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
775439|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
775440|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
775441|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
775442|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
775443|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
775444|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775445|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775446|NCT02675868|Protective Agents|protective agents|mesh-ancestor
775447|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
775448|NCT02675868|Coagulants|coagulants|mesh-ancestor
775449|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
775450|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
775586|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775729|NCT02674906|Heparin|heparin|mesh-list
774425|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
774426|NCT02680626|Ropivacaine|ropivacaine|mesh-list
774427|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
774428|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
774429|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774430|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774431|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
774432|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774433|NCT02680626|Analgesics|analgesics|mesh-ancestor
774434|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
774435|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
774436|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
774437|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
774438|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774439|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
774440|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
774441|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2240891|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2240892|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2240893|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2240894|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
774734|NCT02678975|Copper|copper|mesh-list
774735|NCT02678975|Temozolomide|temozolomide|mesh-list
774736|NCT02678975|Lomustine|lomustine|mesh-list
774737|NCT02678975|Disulfiram|disulfiram|mesh-list
774738|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
774739|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
774740|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774741|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774742|NCT02678975|Trace Elements|trace elements|mesh-ancestor
774743|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
774744|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774745|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
774746|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
774747|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774809|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
774810|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
774811|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774812|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774813|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
774814|NCT02678728|Analgesics|analgesics|mesh-ancestor
774815|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
774816|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774817|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
774818|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
774819|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
774820|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
774821|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
774822|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775574|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
775575|NCT02675309|Simvastatin|simvastatin|mesh-list
775576|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
775577|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
775578|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
775579|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775580|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
775581|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
775582|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775587|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
775588|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
775589|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
775590|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775591|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
775592|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775692|NCT02675023|Adalimumab|adalimumab|mesh-list
775693|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
775694|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
775831|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
775832|NCT02674243|Povidone|povidone|mesh-list
775833|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
775834|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
775835|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
775836|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
775837|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
774442|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
774443|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
774444|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
774445|NCT02680548|Prednisolone|prednisolone|mesh-list
774446|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
774447|NCT02680548|Bupivacaine|bupivacaine|mesh-list
774448|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
774449|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
774450|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
774451|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
774452|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774453|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774454|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
774455|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774456|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
774457|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
774458|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
774459|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
774460|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
774461|NCT02680548|Hormones|hormones|mesh-ancestor
774462|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
774463|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
774464|NCT02680548|Protective Agents|protective agents|mesh-ancestor
774465|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
774466|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240895|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
2240896|NCT00100685|Volociximab|volociximab|mesh-list
2240897|NCT00100685|Antibodies|antibodies|mesh-list
2240898|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
775100|NCT02677805|Botulinum Toxins|botulinum toxins|mesh-list
775101|NCT02677805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
775102|NCT02677805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
775103|NCT02677805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
775104|NCT02677805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
775105|NCT02677805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775106|NCT02677805|Cholinergic Agents|cholinergic agents|mesh-ancestor
775107|NCT02677805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775108|NCT02677805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775109|NCT02677805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
775110|NCT02677805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775190|NCT02677376|Listerine|listerine|mesh-list
775191|NCT02677376|Fluorides|fluorides|mesh-list
775192|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
775193|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
775194|NCT02677376|Protective Agents|protective agents|mesh-ancestor
775195|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775196|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
775197|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775234|NCT02677077|Natalizumab|natalizumab|mesh-list
775247|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
775248|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775324|NCT02676622|Aldesleukin|aldesleukin|mesh-list
775325|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
775326|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
775327|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
775328|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
775329|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775330|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
775331|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
775332|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
775333|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775334|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775335|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
775336|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
775337|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
775338|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
775339|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775593|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
775594|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
775595|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
774467|NCT02680808|Olorofim|olorofim|mesh-list
774468|NCT02680808|Midazolam|midazolam|mesh-list
774469|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
774470|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
774471|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774472|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774473|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
774474|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
774475|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
774476|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
774477|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
774478|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
774479|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
774480|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
774481|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
774482|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774483|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
774484|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
774765|NCT02678949|Fluticasone|fluticasone|mesh-list
774766|NCT02678949|Xhance|xhance|mesh-list
774767|NCT02678949|Albuterol|albuterol|mesh-list
774768|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
774769|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
774770|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
774771|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774772|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774773|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
774774|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
774775|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
774776|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
774777|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
774778|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
774779|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
774780|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
774781|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
774782|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
774783|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
774784|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775032|NCT02677922|Azacitidine|azacitidine|mesh-list
775033|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
775034|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
775035|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775036|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775037|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240899|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
2240900|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240901|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
775596|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
775597|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775598|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775599|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775626|NCT02675387|Lidocaine|lidocaine|mesh-list
775627|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
775628|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
775629|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
775630|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775631|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
775632|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775633|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
775634|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
775635|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
775636|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
775637|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775760|NCT02674893|Liraglutide|liraglutide|mesh-list
775761|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
775762|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775763|NCT02674893|Incretins|incretins|mesh-ancestor
775764|NCT02674893|Hormones|hormones|mesh-ancestor
775765|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094966|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2094967|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2094968|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2094969|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2094970|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2094971|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2094972|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2094973|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
2094974|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2094975|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2094976|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2094977|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
2094978|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2094979|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
2094980|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
2094981|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
2094982|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2094983|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2094984|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
2094985|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2094986|NCT02285634|Protective Agents|protective agents|mesh-ancestor
2094987|NCT02285855|Metformin|metformin|mesh-list
2094988|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
774895|NCT02678585|Lidocaine|lidocaine|mesh-list
774896|NCT02678585|Nalbuphine|nalbuphine|mesh-list
774897|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
774898|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
774899|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774900|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774901|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
774902|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
774903|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
774904|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
774905|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
774906|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
774907|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774908|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
774909|NCT02678585|Narcotics|narcotics|mesh-ancestor
774910|NCT02678585|Analgesics|analgesics|mesh-ancestor
2240902|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2240903|NCT00100685|Growth Substances|growth substances|mesh-ancestor
2240904|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
2240905|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240906|NCT00100711|Motexafin gadolinium|motexafin gadolinium|mesh-list
775205|NCT02677051|Sulforaphane|sulforaphane|mesh-list
775206|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
775207|NCT02677051|Protective Agents|protective agents|mesh-ancestor
775208|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775209|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240907|NCT00100711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240908|NCT00100711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2240909|NCT00100711|Dermatologic Agents|dermatologic agents|mesh-ancestor
2240910|NCT00100737|Rituximab|rituximab|mesh-list
2240911|NCT00100737|Interleukin-2|interleukin-2|mesh-list
2240912|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2240913|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240914|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
2240915|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240916|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2240917|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2240918|NCT00100737|Analgesics|analgesics|mesh-ancestor
2240919|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
2240920|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2094989|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094990|NCT02285920|Spironolactone|spironolactone|mesh-list
2094991|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2094992|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
2094993|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2094994|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2094995|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2094996|NCT02285920|Diuretics|diuretics|mesh-ancestor
2094997|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
2094998|NCT02285998|Vaccines|vaccines|mesh-list
2094999|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
2240921|NCT00100750|Gemcitabine|gemcitabine|mesh-list
2240922|NCT00100750|Tipifarnib|tipifarnib|mesh-list
774560|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
774561|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
774562|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774880|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
774881|NCT02678507|Narcotics|narcotics|mesh-ancestor
774882|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
774883|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774884|NCT02678507|Analgesics|analgesics|mesh-ancestor
774885|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
774886|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095000|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095001|NCT02286726|Cytarabine|cytarabine|mesh-list
2095002|NCT02286726|Daunorubicin|daunorubicin|mesh-list
2095003|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2095004|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
775737|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
775738|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
775739|NCT02674737|Tramadol|tramadol|mesh-list
775740|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
775741|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
775742|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775743|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
775744|NCT02674737|Analgesics|analgesics|mesh-ancestor
775745|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
775746|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775747|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
775748|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
775749|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
775750|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
775751|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775752|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775753|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
775754|NCT02674737|Narcotics|narcotics|mesh-ancestor
775755|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
775756|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
775757|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
775758|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
775759|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775793|NCT02674295|Esketamine|esketamine|mesh-list
775794|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
775795|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
775828|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
775829|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
775830|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
775852|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
775853|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
775854|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
775855|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
775856|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
775857|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
775858|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775859|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775860|NCT02673996|Protective Agents|protective agents|mesh-ancestor
775861|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
775862|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
775863|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
775963|NCT02673463|Spironolactone|spironolactone|mesh-list
775964|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
775965|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
775966|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
775967|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775968|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
775969|NCT02673463|Diuretics|diuretics|mesh-ancestor
775970|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
776031|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776032|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
776033|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
776034|NCT02672995|Growth Substances|growth substances|mesh-ancestor
2240923|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
774563|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
774564|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
774565|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
774566|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
774567|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
774568|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774569|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774570|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775075|NCT02677597|Paclitaxel|paclitaxel|mesh-list
775076|NCT02677597|Cisplatin|cisplatin|mesh-list
775077|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
775078|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775079|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
775080|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
775081|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
775082|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240924|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
2240925|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240926|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240927|NCT00100750|Antiviral Agents|antiviral agents|mesh-ancestor
2240928|NCT00100750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240929|NCT00100750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240930|NCT00100750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2240931|NCT00100750|Immunologic Factors|immunologic factors|mesh-ancestor
2240932|NCT00100750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240933|NCT00100776|Olanzapine|olanzapine|mesh-list
2240934|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
2240935|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
2240936|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775672|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
775673|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
775674|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
775675|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775807|NCT02674308|Vedolizumab|vedolizumab|mesh-list
775808|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
775878|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
775879|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
775880|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
775881|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095005|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095006|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095007|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
2095008|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2095009|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2095010|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
2240937|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240938|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2240939|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2240940|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2240941|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2240942|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2240943|NCT00100776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2240944|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2240945|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2240946|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240947|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2240948|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
2240949|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2240950|NCT00100854|Fulvestrant|fulvestrant|mesh-list
776044|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774591|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
774592|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
774593|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
774594|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774595|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
774596|NCT02679924|Protective Agents|protective agents|mesh-ancestor
2240951|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240952|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2240953|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240954|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240955|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2240956|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2240957|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2240958|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
2240959|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
775158|NCT02677532|Acetaminophen|acetaminophen|mesh-list
775159|NCT02677532|Sufentanil|sufentanil|mesh-list
775160|NCT02677532|Morphine|morphine|mesh-list
775161|NCT02677532|Dsuvia|dsuvia|mesh-list
775162|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
775163|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
775164|NCT02677532|Narcotics|narcotics|mesh-ancestor
775165|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
775166|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775167|NCT02677532|Analgesics|analgesics|mesh-ancestor
775168|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
775169|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775170|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
775171|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
775172|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
775173|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
775174|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
775175|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
775176|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
775300|NCT02676739|Adderall|adderall|mesh-list
775301|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
775302|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775487|NCT02676011|Atropine|atropine|mesh-list
775488|NCT02676011|Succinylcholine|succinylcholine|mesh-list
775489|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
775490|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
775491|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
775492|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
775493|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775494|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775495|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
775496|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
775497|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
775498|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
775499|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
775500|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
775501|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
775502|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775503|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775504|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
775505|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
775506|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2095011|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095012|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2095013|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2095014|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2095015|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095016|NCT02286843|Trastuzumab|trastuzumab|mesh-list
2095017|NCT02286843|Pertuzumab|pertuzumab|mesh-list
2095018|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2095019|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095020|NCT02286895|Vaccines|vaccines|mesh-list
775667|NCT02675153|Sirolimus|sirolimus|mesh-list
775668|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
775669|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775670|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
775671|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774693|NCT02679456|Fluconazole|fluconazole|mesh-list
774694|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
774695|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
774696|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
774697|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
774698|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
774699|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
774700|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774701|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
774702|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
774703|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
774704|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774705|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
774706|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
774863|NCT02678520|Goserelin|goserelin|mesh-list
774864|NCT02678520|Bicalutamide|bicalutamide|mesh-list
774865|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
774866|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
774867|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
774868|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
774869|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
774870|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
775005|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
775006|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
775007|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
775008|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775009|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
775010|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
775680|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775681|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
775809|NCT02674555|Naquotinib|naquotinib|mesh-list
775810|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775811|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
775812|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775813|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240960|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240961|NCT00100880|Lenalidomide|lenalidomide|mesh-list
2240962|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
2240963|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240964|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2240965|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2240966|NCT00100880|Growth Substances|growth substances|mesh-ancestor
2240967|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
2240968|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240969|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
2240970|NCT00100893|Procyanidin|procyanidin|mesh-list
2240971|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
775942|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
775943|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
775944|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
775945|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
775946|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
775947|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775948|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
775949|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
775950|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240972|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240973|NCT00100893|Protective Agents|protective agents|mesh-ancestor
2240974|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776035|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776036|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
776045|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776046|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
776048|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
776049|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776050|NCT02672527|Dexamethasone|dexamethasone|mesh-list
776051|NCT02672527|Trabectedin|trabectedin|mesh-list
776052|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
776053|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
776054|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
776055|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776056|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240975|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
774707|NCT02679261|Atorvastatin|atorvastatin|mesh-list
774708|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
774709|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
774710|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
774711|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
774712|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
774713|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
774714|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775038|NCT02678182|Capecitabine|capecitabine|mesh-list
775039|NCT02678182|Trastuzumab|trastuzumab|mesh-list
775040|NCT02678182|Durvalumab|durvalumab|mesh-list
775041|NCT02678182|Ramucirumab|ramucirumab|mesh-list
775042|NCT02678182|Rucaparib|rucaparib|mesh-list
775043|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
775044|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
775045|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775046|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775047|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
775048|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
775049|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
775111|NCT02677571|Morphine|morphine|mesh-list
775112|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
775113|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
775114|NCT02677571|Narcotics|narcotics|mesh-ancestor
775115|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
775116|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775117|NCT02677571|Analgesics|analgesics|mesh-ancestor
775118|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
775119|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775120|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
775121|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
775223|NCT02677246|Denosumab|denosumab|mesh-list
775224|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
775225|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775287|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
775288|NCT02676791|Povidone|povidone|mesh-list
775289|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
775290|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
775291|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
775292|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
775363|NCT02676310|Bimatoprost|bimatoprost|mesh-list
775364|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
775715|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
775716|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
775717|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
775718|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775719|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
775720|NCT02675049|Analgesics|analgesics|mesh-ancestor
775721|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
775722|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775723|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
775724|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
775725|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
775726|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
775727|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775728|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775938|NCT02673814|Durvalumab|durvalumab|mesh-list
775939|NCT02673814|Bavituximab|bavituximab|mesh-list
775940|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
775941|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
775978|NCT02673359|Progesterone|progesterone|mesh-list
775979|NCT02673359|Progestins|progestins|mesh-ancestor
775980|NCT02673359|Hormones|hormones|mesh-ancestor
775981|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
775982|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776003|NCT02673229|Bacitracin|bacitracin|mesh-list
776004|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
776005|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
776006|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2095021|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
2095022|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095023|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
776039|NCT02672709|Apixaban|apixaban|mesh-list
776040|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
776041|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
776042|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2240976|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
774246|NCT02681471|Mannitol|mannitol|mesh-list
774257|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
774258|NCT02681471|Diuretics|diuretics|mesh-ancestor
774259|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
774260|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095024|NCT02286921|Testosterone|testosterone|mesh-list
2095025|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
2095026|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
2095027|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2095028|NCT02286921|Androgens|androgens|mesh-ancestor
2095029|NCT02286921|Hormones|hormones|mesh-ancestor
2095030|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2095031|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095032|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
775210|NCT02677298|Botulinum Toxins|botulinum toxins|mesh-list
775211|NCT02677298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
775212|NCT02677298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
775213|NCT02677298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
775214|NCT02677298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
775215|NCT02677298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775216|NCT02677298|Cholinergic Agents|cholinergic agents|mesh-ancestor
775217|NCT02677298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
775218|NCT02677298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775219|NCT02677298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
775220|NCT02677298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2240977|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240978|NCT00100906|Aldesleukin|aldesleukin|mesh-list
2240979|NCT00100906|Interleukin-2|interleukin-2|mesh-list
2240980|NCT00100906|Tretinoin|tretinoin|mesh-list
2240981|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240982|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2240983|NCT00100906|Analgesics|analgesics|mesh-ancestor
2240984|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
2240985|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2240986|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775914|NCT02673866|Pregabalin|pregabalin|mesh-list
775915|NCT02673866|Analgesics|analgesics|mesh-ancestor
775916|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
775917|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
775918|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
775919|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
775920|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
775921|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
775922|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
775923|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
775924|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
775925|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
775926|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
775927|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
776037|NCT02672917|Folfirinox|folfirinox|mesh-list
776038|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776191|NCT02671695|Amlodipine|amlodipine|mesh-list
776192|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
776193|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
776194|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
776195|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776196|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
776197|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776198|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
776537|NCT02670135|Triclosan|triclosan|mesh-list
776538|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
776539|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
776540|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
776541|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
776542|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
776543|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776544|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
776583|NCT02669732|Firuglipel|firuglipel|mesh-list
776584|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
776585|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2240987|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2240988|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
776057|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
776058|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
776059|NCT02672527|Hormones|hormones|mesh-ancestor
776060|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
776061|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
776062|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776063|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
776064|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
776065|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095033|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095034|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
2095035|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2095036|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2095037|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2095038|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2095039|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095040|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
2095041|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095042|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095043|NCT02287350|Diclofenac|diclofenac|mesh-list
2095044|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2095045|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2095046|NCT02287350|Analgesics|analgesics|mesh-ancestor
776280|NCT02671084|Sevoflurane|sevoflurane|mesh-list
776281|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
776282|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
776283|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
776284|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
776285|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776286|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777139|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
777140|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
777141|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240989|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
2240990|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2240991|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
2240992|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
2240993|NCT00100945|Gefitinib|gefitinib|mesh-list
2240994|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2240995|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2240996|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2240997|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2240998|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
2240999|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2241000|NCT00100958|Protective Agents|protective agents|mesh-ancestor
2241001|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095047|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
2095048|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095049|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095050|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2095051|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2095052|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2095053|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095054|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095055|NCT02287376|Diclofenac|diclofenac|mesh-list
2095056|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2095057|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2095058|NCT02287376|Analgesics|analgesics|mesh-ancestor
2095059|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
2241002|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241003|NCT00100971|Vaccines|vaccines|mesh-list
778923|NCT02659254|Sirolimus|sirolimus|mesh-list
778924|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
778925|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778926|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
778927|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778928|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
778929|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
778930|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
778931|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241004|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
2241005|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241006|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
2241007|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
776066|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
776067|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
776595|NCT02669719|Carboplatin|carboplatin|mesh-list
776596|NCT02669719|Pemetrexed|pemetrexed|mesh-list
776597|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776598|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776599|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776600|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
776601|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
777338|NCT02666105|Exemestane|exemestane|mesh-list
777339|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777340|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
777341|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
777342|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777343|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777344|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
777345|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
777346|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
777347|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778001|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
778165|NCT02662426|Oseltamivir|oseltamivir|mesh-list
778166|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
778167|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778168|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778169|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095060|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095061|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241008|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
778699|NCT02660177|Dipyrone|dipyrone|mesh-list
778700|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
778701|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
778702|NCT02660177|Analgesics|analgesics|mesh-ancestor
778703|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
778704|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
778705|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778706|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
778707|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
778708|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
2241009|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241010|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2241011|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2241012|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
2241013|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241014|NCT00101062|Celecoxib|celecoxib|mesh-list
2241015|NCT00101062|Letrozole|letrozole|mesh-list
2241016|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241017|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2241018|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2241019|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779036|NCT02658864|Lafutidine|lafutidine|mesh-list
779037|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
779038|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
779039|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
779040|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
779041|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
779042|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
779043|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779044|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779659|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
779660|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779661|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
779662|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779663|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779664|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
779665|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
779666|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779667|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
779773|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
779774|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
779775|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779776|NCT02655757|Incretins|incretins|mesh-ancestor
779777|NCT02655757|Hormones|hormones|mesh-ancestor
779778|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
776068|NCT02672488|Metformin|metformin|mesh-list
776070|NCT02672488|Sorafenib|sorafenib|mesh-list
776071|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
776072|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776073|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776074|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
776075|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776076|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776389|NCT02670642|Esomeprazole|esomeprazole|mesh-list
776390|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
776391|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
776392|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
776393|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776394|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776578|NCT02669901|Naloxone|naloxone|mesh-list
776579|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
776580|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776581|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
776582|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776661|NCT02669173|Bevacizumab|bevacizumab|mesh-list
776662|NCT02669173|Capecitabine|capecitabine|mesh-list
776663|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
776664|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776665|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
776666|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
776667|NCT02669173|Growth Substances|growth substances|mesh-ancestor
776668|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776669|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
776670|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
776671|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
776672|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776964|NCT02668094|Lidocaine|lidocaine|mesh-list
776965|NCT02668094|Pregabalin|pregabalin|mesh-list
776966|NCT02668094|Propofol|propofol|mesh-list
776967|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
776968|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
776969|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776970|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776971|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
776972|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776973|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
776974|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
776975|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
776976|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
776977|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776978|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
776979|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
776980|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
776981|NCT02668094|Analgesics|analgesics|mesh-ancestor
776982|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
776983|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
776984|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
776985|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
776986|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
776987|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
777328|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
777329|NCT02666157|Apixaban|apixaban|mesh-list
777330|NCT02666157|Dabigatran|dabigatran|mesh-list
777331|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
777332|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
777333|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
777334|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
777335|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777336|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777337|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
777466|NCT02665702|Cisplatin|cisplatin|mesh-list
777467|NCT02665702|Vinorelbine|vinorelbine|mesh-list
777468|NCT02665702|Endostar protein|endostar protein|mesh-list
777469|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777470|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
777471|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
777472|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
777473|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
777474|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777475|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
777476|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
776081|NCT02672345|Sevoflurane|sevoflurane|mesh-list
776082|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
776083|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
776084|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
776085|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
776086|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776087|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776129|NCT02672098|Carboplatin|carboplatin|mesh-list
776130|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776545|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
776546|NCT02670252|Busulfan|busulfan|mesh-list
776547|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
776548|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
776549|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776550|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
776551|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
776552|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
776553|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776554|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776555|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
776558|NCT02669953|Aflibercept|aflibercept|mesh-list
776559|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
776560|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
776561|NCT02669953|Growth Substances|growth substances|mesh-ancestor
776562|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776563|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
776564|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241020|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241021|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2241022|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
2241023|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2241024|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241025|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2241026|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2241027|NCT00101062|Analgesics|analgesics|mesh-ancestor
776679|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
776680|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
776681|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
776682|NCT02669303|Prednisolone|prednisolone|mesh-list
776683|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
776684|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
776685|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
776686|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
776687|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
776688|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
776689|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776690|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776691|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
776692|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
776693|NCT02669303|Hormones|hormones|mesh-ancestor
776694|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
776695|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
776696|NCT02669303|Protective Agents|protective agents|mesh-ancestor
776697|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
776698|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776770|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
776771|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
776772|NCT02668796|Estradiol|estradiol|mesh-list
776773|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
776774|NCT02668796|Estrogens|estrogens|mesh-ancestor
776775|NCT02668796|Hormones|hormones|mesh-ancestor
776776|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
776777|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776778|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
776779|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
776780|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
776782|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
776988|NCT02667743|Paclitaxel|paclitaxel|mesh-list
776989|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
776990|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
776991|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776992|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
776993|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
776994|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
777918|NCT02663323|Sirolimus|sirolimus|mesh-list
776089|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
776090|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
776091|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776092|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
776093|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
776094|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
776095|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776586|NCT02669706|Pentamidine|pentamidine|mesh-list
776587|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
776588|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
776589|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
776590|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
776591|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2241028|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
2241029|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2241030|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2241031|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2241032|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2241033|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2241034|NCT00101075|Capecitabine|capecitabine|mesh-list
2241035|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
2241036|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2241037|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
2241038|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241039|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241040|NCT00101088|Sirolimus|sirolimus|mesh-list
776699|NCT02669030|Suvorexant|suvorexant|mesh-list
776700|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
776701|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
776702|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776703|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776704|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
776705|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
776706|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776785|NCT02668926|Amphetamine|amphetamine|mesh-list
776786|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
776787|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
776788|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
776789|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776790|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
776791|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
776792|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776793|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
776794|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
776795|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776796|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
776797|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
776798|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
776799|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
776800|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2241041|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
2241042|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241043|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2241044|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241045|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241046|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2241047|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241048|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2241049|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
2241050|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2241051|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
2241052|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241053|NCT00101114|Interferons|interferons|mesh-list
777041|NCT02667535|Isosorbide|isosorbide|mesh-list
777042|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
777043|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
777044|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
777045|NCT02667535|Diuretics|diuretics|mesh-ancestor
777046|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
777047|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777048|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
777049|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
777096|NCT02667496|Sargramostim|sargramostim|mesh-list
2241054|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
2241055|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
776096|NCT02672358|Trametinib|trametinib|mesh-list
776097|NCT02672358|Dabrafenib|dabrafenib|mesh-list
776098|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776099|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
776100|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776101|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241056|NCT00101114|Sorafenib|sorafenib|mesh-list
2241057|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241058|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
2241059|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241060|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
776616|NCT02669680|Lenograstim|lenograstim|mesh-list
776617|NCT02669680|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
776618|NCT02669680|Immunologic Factors|immunologic factors|mesh-ancestor
776619|NCT02669680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776819|NCT02668653|Cytarabine|cytarabine|mesh-list
776820|NCT02668653|Daunorubicin|daunorubicin|mesh-list
776821|NCT02668653|Idarubicin|idarubicin|mesh-list
776822|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
776823|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
776824|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776825|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776826|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
776827|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
776828|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
776829|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
776830|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776831|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
776832|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
776833|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
776834|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241061|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241062|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241063|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
2241064|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241065|NCT00101127|Gemcitabine|gemcitabine|mesh-list
2241066|NCT00101127|Docetaxel|docetaxel|mesh-list
2241067|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2241068|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
2241069|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241070|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241071|NCT00101127|Antiviral Agents|antiviral agents|mesh-ancestor
2241072|NCT00101127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241073|NCT00101127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241074|NCT00101127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
777390|NCT02666040|Anesthetics|anesthetics|mesh-list
777391|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777392|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777417|NCT02665845|Mesalamine|mesalamine|mesh-list
777418|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
777419|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
777420|NCT02665845|Analgesics|analgesics|mesh-ancestor
777421|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
777422|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777423|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777424|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
777425|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
777558|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
777559|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777727|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
777728|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777729|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777812|NCT02663999|Diazepam|diazepam|mesh-list
777813|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
777814|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
777815|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
777816|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
777817|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777818|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777819|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
777820|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
777821|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777822|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
777823|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
777824|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
776123|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
776124|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
776125|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
776126|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776127|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776128|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
776145|NCT02671851|Acetaminophen|acetaminophen|mesh-list
776146|NCT02671851|Dipyrone|dipyrone|mesh-list
776147|NCT02671851|Fentanyl|fentanyl|mesh-list
776148|NCT02671851|Tramadol|tramadol|mesh-list
776149|NCT02671851|Bupivacaine|bupivacaine|mesh-list
776150|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
776151|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
776152|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776153|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776154|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
776155|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776156|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
776157|NCT02671851|Narcotics|narcotics|mesh-ancestor
776158|NCT02671851|Analgesics|analgesics|mesh-ancestor
776159|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
776160|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
776161|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
776162|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
776163|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
776164|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
776165|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
776166|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
776262|NCT02671318|Sirolimus|sirolimus|mesh-list
776263|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
776264|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
776265|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
776266|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776267|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
776268|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
776269|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
776270|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776346|NCT02670564|Busulfan|busulfan|mesh-list
776347|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
776348|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776349|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
776350|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
776351|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776352|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
776353|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776354|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2241075|NCT00101127|Immunologic Factors|immunologic factors|mesh-ancestor
2241076|NCT00101127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241077|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
776647|NCT02669186|Fentanyl|fentanyl|mesh-list
776648|NCT02669186|Bupivacaine|bupivacaine|mesh-list
776649|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
776650|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
776651|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776652|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776653|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
776654|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776655|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
776656|NCT02669186|Narcotics|narcotics|mesh-ancestor
776657|NCT02669186|Analgesics|analgesics|mesh-ancestor
776658|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
776659|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
776660|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
2095062|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2095063|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2095064|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2095065|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095066|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777004|NCT02667730|Acetaminophen|acetaminophen|mesh-list
777005|NCT02667730|Celecoxib|celecoxib|mesh-list
777006|NCT02667730|Naproxen|naproxen|mesh-list
777007|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
777008|NCT02667730|Analgesics|analgesics|mesh-ancestor
777009|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
777010|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777011|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777012|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
2095067|NCT02287402|Voglibose|voglibose|mesh-list
2241078|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
2241079|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
2241080|NCT00101140|Fludarabine|fludarabine|mesh-list
2241081|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
2241082|NCT00101140|Thiotepa|thiotepa|mesh-list
2241083|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2241084|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241085|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
776221|NCT02671383|Lopinavir|lopinavir|mesh-list
776222|NCT02671383|Darunavir|darunavir|mesh-list
776223|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
776224|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
776225|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
776226|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776227|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776228|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
776229|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
776230|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
776231|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
776232|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
776233|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
776603|NCT02669641|Choline|choline|mesh-list
776604|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
776605|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
776606|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
776607|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776608|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
776609|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
776610|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
776707|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
776708|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
776709|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
776710|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
776711|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241086|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
2241087|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241088|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
777078|NCT02667353|Anesthetics|anesthetics|mesh-list
777079|NCT02667353|Etomidate|etomidate|mesh-list
777080|NCT02667353|Succinylcholine|succinylcholine|mesh-list
777081|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777082|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777083|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
777084|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
777085|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
777086|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
777087|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
777088|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
777089|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777432|NCT02665832|Amlodipine|amlodipine|mesh-list
777433|NCT02665832|Olmesartan|olmesartan|mesh-list
777434|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
777435|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
777436|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
777437|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
777438|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777439|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
777440|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777441|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
777442|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
777443|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
777444|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
777445|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
777446|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
777447|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777448|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
777449|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2241089|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
2241090|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241091|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2241092|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
777635|NCT02665039|Gemcitabine|gemcitabine|mesh-list
777636|NCT02665039|Carboplatin|carboplatin|mesh-list
777637|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777638|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
776181|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
776182|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
776183|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
776184|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
776185|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776186|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776187|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
776188|NCT02671578|Analgesics|analgesics|mesh-ancestor
776189|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
776190|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776801|NCT02668861|Vitamin D|vitamin d|mesh-list
776802|NCT02668861|Budesonide|budesonide|mesh-list
776803|NCT02668861|Vitamins|vitamins|mesh-ancestor
776804|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
776805|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776806|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
776807|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
776808|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
776809|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
776810|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776811|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
776812|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
776813|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
776814|NCT02668861|Hormones|hormones|mesh-ancestor
776815|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
776963|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777029|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
777030|NCT02667561|Testosterone|testosterone|mesh-list
777031|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
777032|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
777033|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
777034|NCT02667561|Androgens|androgens|mesh-ancestor
777035|NCT02667561|Hormones|hormones|mesh-ancestor
777036|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
777037|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777038|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
777039|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777040|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
2241093|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
777090|NCT02667223|Bococizumab|bococizumab|mesh-list
777091|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
777092|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
777093|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
777094|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777095|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
777155|NCT02666768|Interferons|interferons|mesh-list
777156|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
777157|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777158|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
777159|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
777185|NCT02666534|Lidocaine|lidocaine|mesh-list
777186|NCT02666534|Prilocaine|prilocaine|mesh-list
777187|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
777188|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
777189|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
777190|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
777191|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
777192|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777193|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777194|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
777195|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777196|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
777197|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
777198|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
777199|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
777200|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777201|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
777202|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
777203|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
777522|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
777523|NCT02665624|Sennosides|sennosides|mesh-list
777524|NCT02665624|Senna Extract|senna extract|mesh-list
777525|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
777526|NCT02665624|Calcium|calcium|mesh-list
777527|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
777528|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241094|NCT00101153|Cytarabine|cytarabine|mesh-list
776199|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
776200|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
776201|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
776202|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776203|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
776204|NCT02671565|Protective Agents|protective agents|mesh-ancestor
776361|NCT02670759|Bupivacaine|bupivacaine|mesh-list
776362|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
776363|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
776364|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776365|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776366|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
776367|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776454|NCT02670317|Prednisone|prednisone|mesh-list
776455|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
776456|NCT02670317|Doxorubicin|doxorubicin|mesh-list
776457|NCT02670317|Vincristine|vincristine|mesh-list
776458|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
776459|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
776460|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
776461|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776462|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
776463|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
776464|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
776465|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776466|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776467|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
776468|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
776469|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
776470|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
776471|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776472|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
776473|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
776474|NCT02670317|Hormones|hormones|mesh-ancestor
776475|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
776476|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
776477|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
776478|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
776479|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
776480|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
776481|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
776925|NCT02668289|Anesthetics|anesthetics|mesh-list
776926|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776927|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776995|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241095|NCT00101153|Daunorubicin|daunorubicin|mesh-list
777163|NCT02666651|Tolvaptan|tolvaptan|mesh-list
777164|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
777165|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777166|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
777167|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777279|NCT02666209|Dexamethasone|dexamethasone|mesh-list
777280|NCT02666209|Lenalidomide|lenalidomide|mesh-list
777281|NCT02666209|Bortezomib|bortezomib|mesh-list
777282|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
777283|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
777284|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
777285|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777286|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777287|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
777288|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
777289|NCT02666209|Hormones|hormones|mesh-ancestor
777290|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
777291|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
777292|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777293|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
777294|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
777295|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
777296|NCT02666209|Growth Substances|growth substances|mesh-ancestor
777297|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
2241096|NCT00101153|Tipifarnib|tipifarnib|mesh-list
2241097|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2241098|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
777426|NCT02665871|Vaccines|vaccines|mesh-list
777427|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
776205|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
776206|NCT02671708|Busulfan|busulfan|mesh-list
776207|NCT02671708|Idarubicin|idarubicin|mesh-list
776208|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
776209|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
776210|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776211|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
776212|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
776213|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
776214|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776215|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776216|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
776217|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
776218|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
776219|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
776220|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776418|NCT02670434|Pitavastatin|pitavastatin|mesh-list
776419|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
776420|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
776421|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
776422|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
776423|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776424|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776425|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2241099|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241100|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241101|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
776947|NCT02667886|Axitinib|axitinib|mesh-list
776948|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776949|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
776950|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776951|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777013|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
777014|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
777015|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
777016|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
777017|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
777018|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777019|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777020|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
777063|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
777064|NCT02667197|Narcotics|narcotics|mesh-ancestor
777065|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777066|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777067|NCT02667197|Analgesics|analgesics|mesh-ancestor
777068|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
777069|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2241102|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241103|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2241104|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
2241105|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777560|NCT02665143|Nintedanib|nintedanib|mesh-list
777561|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777562|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
777563|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777564|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777628|NCT02664857|Vitamin D|vitamin d|mesh-list
777629|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
777630|NCT02664857|Vitamins|vitamins|mesh-list
777631|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
777632|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777633|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
777634|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2241106|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2241107|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2241108|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2241109|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241110|NCT00101179|Azacitidine|azacitidine|mesh-list
777744|NCT02664142|Anesthetics|anesthetics|mesh-list
777745|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777746|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095068|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2095069|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095070|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2241111|NCT00101179|Entinostat|entinostat|mesh-list
2241112|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2241113|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2241114|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
2241115|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241116|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241117|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241118|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
2241119|NCT00101205|Etoposide|etoposide|mesh-list
2241120|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
2241121|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241122|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2241123|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2241124|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2241125|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241126|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241127|NCT00101231|Alvocidib|alvocidib|mesh-list
2241128|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241129|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
2241130|NCT00101231|Growth Substances|growth substances|mesh-ancestor
2241131|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241132|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2241133|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241134|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241135|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
2241136|NCT00101270|Irinotecan|irinotecan|mesh-list
2241137|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241138|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2241139|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2241140|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241141|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241142|NCT00101296|Tipifarnib|tipifarnib|mesh-list
2241143|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241144|NCT00101309|Aldesleukin|aldesleukin|mesh-list
2095071|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095072|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095073|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2095074|NCT02287415|Warfarin|warfarin|mesh-list
2095075|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
2095076|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
2095077|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
777267|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
777268|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
777269|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777270|NCT02666170|Protective Agents|protective agents|mesh-ancestor
777271|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777272|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
777273|NCT02666170|Vitamins|vitamins|mesh-ancestor
777274|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
777429|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
777430|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
777431|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
777463|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
777464|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
777465|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777639|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
777640|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777641|NCT02665039|Antiviral Agents|antiviral agents|mesh-ancestor
777642|NCT02665039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
777643|NCT02665039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777644|NCT02665039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
777645|NCT02665039|Immunologic Factors|immunologic factors|mesh-ancestor
777646|NCT02665039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777716|NCT02664116|Diclofenac|diclofenac|mesh-list
777717|NCT02664116|Ketorolac|ketorolac|mesh-list
777718|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
777719|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
777720|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
777721|NCT02664116|Analgesics|analgesics|mesh-ancestor
777722|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
777723|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777724|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777725|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
777726|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2095078|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2241145|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776255|NCT02671227|Bupivacaine|bupivacaine|mesh-list
776256|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
776257|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
776258|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776259|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776260|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
776261|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2241146|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2241147|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2241148|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
2241149|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241150|NCT00101335|Celecoxib|celecoxib|mesh-list
2241151|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2241152|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2241153|NCT00101335|Analgesics|analgesics|mesh-ancestor
2241154|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
2241155|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2241156|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241157|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2241158|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2241159|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
776939|NCT02668016|Atorvastatin|atorvastatin|mesh-list
776940|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
776941|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
776942|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
776943|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
776944|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776945|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
776946|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777050|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777070|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
777071|NCT02667262|Narcotics|narcotics|mesh-ancestor
777072|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777073|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777074|NCT02667262|Analgesics|analgesics|mesh-ancestor
777075|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
777076|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777298|NCT02666365|Cefazolin|cefazolin|mesh-list
777299|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
777300|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
777393|NCT02665936|Dexamethasone|dexamethasone|mesh-list
777394|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
777395|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
777396|NCT02665936|BB 1101|bb 1101|mesh-list
777397|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
777398|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
777399|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
777400|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777401|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777402|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
777403|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
777404|NCT02665936|Hormones|hormones|mesh-ancestor
777405|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
777406|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
777407|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777408|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
777409|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777410|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777411|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
777412|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
777413|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777414|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
777568|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
777569|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
777570|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777571|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
777572|NCT02665117|Diuretics|diuretics|mesh-ancestor
777573|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
777574|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777575|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
777576|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
777577|NCT02665117|Cathartics|cathartics|mesh-ancestor
777578|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
777656|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
777657|NCT02664649|Anticoagulants|anticoagulants|mesh-list
2241160|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2241161|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241162|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776325|NCT02670707|Cytarabine|cytarabine|mesh-list
776326|NCT02670707|Prednisone|prednisone|mesh-list
776327|NCT02670707|Vinblastine|vinblastine|mesh-list
776328|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
776329|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
776330|NCT02670707|Hormones|hormones|mesh-ancestor
776331|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
776332|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776333|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
776334|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776335|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
776336|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
776337|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776338|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
776339|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
776340|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
776341|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
776342|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
776343|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
776344|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
776345|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
777097|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
777098|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777142|NCT02666716|Fluconazole|fluconazole|mesh-list
777143|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
777144|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
777145|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
777146|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
777147|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777148|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777149|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
777150|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
777151|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
777152|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777153|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
777154|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2241163|NCT00101348|Bevacizumab|bevacizumab|mesh-list
2241164|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2241165|NCT00101348|Cetuximab|cetuximab|mesh-list
2241166|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2241167|NCT00101348|Antibodies|antibodies|mesh-list
2241168|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
2241169|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2241170|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241171|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2241172|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2241173|NCT00101348|Growth Substances|growth substances|mesh-ancestor
2241174|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241175|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
2241176|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
2241177|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2241178|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241179|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241180|NCT00101374|Leflunomide|leflunomide|mesh-list
2241181|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241182|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241183|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2241184|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
2241185|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777322|NCT02666092|Antibodies|antibodies|mesh-list
777323|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
777324|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777550|NCT02665208|Nicotine|nicotine|mesh-list
777551|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
777552|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
777553|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777554|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777555|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
777556|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
777557|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
777658|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
776275|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
776276|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
776277|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
776278|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
776279|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
776395|NCT02670772|Tenofovir|tenofovir|mesh-list
776396|NCT02670772|Stavudine|stavudine|mesh-list
776397|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
776398|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
776399|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
776400|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
776401|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776402|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776403|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
776404|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
776405|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
776565|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
776566|NCT02670109|Busulfan|busulfan|mesh-list
776567|NCT02670109|Carmustine|carmustine|mesh-list
776568|NCT02670109|Carboplatin|carboplatin|mesh-list
776569|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
776570|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
776571|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776572|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
776573|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
776574|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
776575|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776576|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776577|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
776611|NCT02669589|Heparin|heparin|mesh-list
776612|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
776613|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776614|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
776615|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
777113|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
777114|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
777115|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
777116|NCT02666703|Prednisolone|prednisolone|mesh-list
777117|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
777118|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
777119|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
777120|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
777121|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
777122|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
777123|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777124|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777125|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
777126|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
777127|NCT02666703|Hormones|hormones|mesh-ancestor
777128|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
777129|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
777130|NCT02666703|Protective Agents|protective agents|mesh-ancestor
777131|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
777132|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777160|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
777161|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
777162|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777370|NCT02666001|Fostemsavir|fostemsavir|mesh-list
777371|NCT02666001|Buprenorphine|buprenorphine|mesh-list
777372|NCT02666001|Methadone|methadone|mesh-list
777373|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
777374|NCT02666001|Narcotics|narcotics|mesh-ancestor
777375|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777376|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777377|NCT02666001|Analgesics|analgesics|mesh-ancestor
777378|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
777379|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777380|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
777381|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
777382|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
777383|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
777384|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
777385|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
777386|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
777387|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
777388|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
777825|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
776287|NCT02671175|Piperaquine|piperaquine|mesh-list
776288|NCT02671175|Artenimol|artenimol|mesh-list
776289|NCT02671175|Artemisinins|artemisinins|mesh-list
776290|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
776291|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
776292|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
776293|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
776388|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
776835|NCT02668679|Hormones|hormones|mesh-list
776836|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
776837|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777100|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
777101|NCT02666898|Fludarabine|fludarabine|mesh-list
777102|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
777103|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
777104|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
777105|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777106|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
777107|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
777108|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
777109|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777110|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777111|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
777112|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
777389|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241186|NCT00101426|Ranirestat|ranirestat|mesh-list
2241187|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241188|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241189|NCT00101569|Aripiprazole|aripiprazole|mesh-list
2241190|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
2241191|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2241192|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
777659|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
777660|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
777661|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777662|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095079|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2095080|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095081|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
2095082|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2095083|NCT02287467|Antibodies|antibodies|mesh-list
2095084|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
2095085|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2095086|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
2095087|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095088|NCT02287610|Prednisone|prednisone|mesh-list
2095089|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2095090|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
2095091|NCT02287610|Hormones|hormones|mesh-ancestor
777775|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
777776|NCT02664103|Capecitabine|capecitabine|mesh-list
777777|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
777778|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
777779|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777780|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
777781|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
777782|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
777783|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777784|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777785|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
777786|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
777787|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
777826|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
777827|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
777828|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
777829|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
777830|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
777831|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
777832|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
777833|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777846|NCT02664012|Menthol|menthol|mesh-list
777847|NCT02664012|Nicotine|nicotine|mesh-list
777848|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
777849|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
777850|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777851|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776294|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
776295|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
776296|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
776297|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
776298|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776299|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
776300|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
776301|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776368|NCT02670655|Lidocaine|lidocaine|mesh-list
776369|NCT02670655|Prilocaine|prilocaine|mesh-list
776370|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
776371|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
776372|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
776373|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776374|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776375|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
776376|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776377|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
776378|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
776379|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
776380|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
776381|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776382|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
776521|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
776522|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
776523|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
776524|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
776525|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776526|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
776527|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
776528|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776748|NCT02669004|Morphine|morphine|mesh-list
776749|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
776750|NCT02669004|Narcotics|narcotics|mesh-ancestor
776751|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
776752|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776753|NCT02669004|Analgesics|analgesics|mesh-ancestor
776754|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
776755|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777305|NCT02666443|Dexamethasone|dexamethasone|mesh-list
777306|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
777307|NCT02666443|BB 1101|bb 1101|mesh-list
777308|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
777309|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
777310|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
777311|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777312|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777313|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
777314|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
777315|NCT02666443|Hormones|hormones|mesh-ancestor
777316|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
777317|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
777318|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777319|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
777320|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777321|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777428|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095092|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2095093|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095094|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2095095|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777753|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
777754|NCT02664168|Laxatives|laxatives|mesh-ancestor
777755|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2095096|NCT02287623|Bupivacaine|bupivacaine|mesh-list
2095097|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
2095098|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
2095099|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2095100|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095101|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
2241193|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2241194|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2241195|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776321|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
776322|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
776323|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
776324|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776482|NCT02670304|Aspirin|aspirin|mesh-list
776483|NCT02670304|Letrozole|letrozole|mesh-list
776484|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
776485|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
776486|NCT02670304|Analgesics|analgesics|mesh-ancestor
776487|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
776488|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
776489|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776490|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
776491|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
776492|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
776493|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
776494|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776495|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
776496|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
776497|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776498|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
776499|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776500|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
776501|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
776502|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
776503|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
776504|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
776781|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
776783|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
776784|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776896|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
776897|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
776898|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
776899|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
776900|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
776901|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
776902|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776903|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
776904|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
776905|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776906|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
776907|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777301|NCT02666417|Iron|iron|mesh-list
777302|NCT02666417|Trace Elements|trace elements|mesh-ancestor
777303|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
777304|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777356|NCT02665806|Fluticasone|fluticasone|mesh-list
777357|NCT02665806|Ciclesonide|ciclesonide|mesh-list
777358|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
777359|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
777360|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
777361|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777362|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777363|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
777364|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
777365|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
777366|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
777367|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
777368|NCT02665806|Hormones|hormones|mesh-ancestor
777369|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
777477|NCT02665702|Growth Substances|growth substances|mesh-ancestor
777478|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777479|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
777517|NCT02665351|Peramivir|peramivir|mesh-list
777518|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
777519|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
777520|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777521|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241196|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
2241197|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
2241198|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241199|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777655|NCT02664649|Apixaban|apixaban|mesh-list
776383|NCT02670785|Estradiol|estradiol|mesh-list
776384|NCT02670785|Estrogens|estrogens|mesh-ancestor
776385|NCT02670785|Hormones|hormones|mesh-ancestor
776386|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
776387|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776908|NCT02668588|Octreotide|octreotide|mesh-list
776909|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
776910|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
776911|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776937|NCT02667925|Cisplatin|cisplatin|mesh-list
776938|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241200|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2241201|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2241202|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
2241203|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2241204|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2241205|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2241206|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2241207|NCT00101595|Dasatinib|dasatinib|mesh-list
777168|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
777169|NCT02666794|Sufentanil|sufentanil|mesh-list
777170|NCT02666794|Morphine|morphine|mesh-list
777171|NCT02666794|Dsuvia|dsuvia|mesh-list
777172|NCT02666794|Bupivacaine|bupivacaine|mesh-list
777173|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
777174|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
777175|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777176|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777177|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
777178|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777179|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
777180|NCT02666794|Narcotics|narcotics|mesh-ancestor
777181|NCT02666794|Analgesics|analgesics|mesh-ancestor
777182|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
777183|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
777184|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
777516|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
2241208|NCT00101595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241209|NCT00101595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2241210|NCT00101595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241211|NCT00101595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241212|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2241213|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2241214|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2241215|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2241216|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241217|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2241218|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
777682|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
777683|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
777684|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
777685|NCT02664493|Prednisolone|prednisolone|mesh-list
777686|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
777687|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
777688|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
777689|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
777690|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
777691|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
777692|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777693|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777694|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
777695|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
777696|NCT02664493|Hormones|hormones|mesh-ancestor
777697|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
777698|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
777699|NCT02664493|Protective Agents|protective agents|mesh-ancestor
777700|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
777701|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241219|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2241220|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
2241221|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241222|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241223|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2241224|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2241225|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
2241226|NCT00101673|Vildagliptin|vildagliptin|mesh-list
2241227|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2241228|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241229|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2241230|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
2241231|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241232|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241233|NCT00101712|Vildagliptin|vildagliptin|mesh-list
2241234|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2241235|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241236|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2241237|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
2241238|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241239|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776529|NCT02670096|Acetazolamide|acetazolamide|mesh-list
776530|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
776531|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
776532|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776533|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776534|NCT02670096|Diuretics|diuretics|mesh-ancestor
776535|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
776536|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776879|NCT02668562|Ticagrelor|ticagrelor|mesh-list
776880|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
776881|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
776882|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
776883|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
776884|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
776885|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
776886|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776887|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241240|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
2241241|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2241242|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241243|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2241244|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
2241245|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2241246|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241247|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241248|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241249|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
2241250|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
2241251|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2241252|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241253|NCT00101764|Triamcinolone|triamcinolone|mesh-list
2241254|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2241255|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
777487|NCT02665533|Dexamethasone|dexamethasone|mesh-list
777488|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
777489|NCT02665533|Diclofenac|diclofenac|mesh-list
777490|NCT02665533|Codeine|codeine|mesh-list
777491|NCT02665533|BB 1101|bb 1101|mesh-list
777492|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
777493|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
777494|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
777495|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777496|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777497|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
777498|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
777499|NCT02665533|Hormones|hormones|mesh-ancestor
777500|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
777501|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
777502|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777503|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
777504|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777505|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777506|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
777507|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
777508|NCT02665533|Analgesics|analgesics|mesh-ancestor
777509|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
777510|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
777511|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
777512|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
777513|NCT02665533|Narcotics|narcotics|mesh-ancestor
777514|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777515|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
776426|NCT02670616|Prednisolone|prednisolone|mesh-list
776427|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
776428|NCT02670616|Rituximab|rituximab|mesh-list
776429|NCT02670616|Doxorubicin|doxorubicin|mesh-list
776430|NCT02670616|Vincristine|vincristine|mesh-list
776431|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
776432|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
776433|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776434|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
776435|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
776436|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
776437|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776438|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776439|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
776440|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
776441|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
776442|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
776443|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
776444|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
776445|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
776446|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
776447|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
776448|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
776449|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
776450|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
776451|NCT02670616|Hormones|hormones|mesh-ancestor
776452|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
776453|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
776629|NCT02669459|Imiquimod|imiquimod|mesh-list
776630|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
776631|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
776632|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776633|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
776634|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
2241256|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2241257|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2241258|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
2241259|NCT00101764|Hormones|hormones|mesh-ancestor
2241260|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2241261|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241262|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2241263|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
2241264|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777133|NCT02667054|Anesthetics|anesthetics|mesh-list
777134|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
777135|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777136|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777137|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
777138|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777529|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
777530|NCT02665624|Laxatives|laxatives|mesh-ancestor
777531|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
777532|NCT02665624|Cathartics|cathartics|mesh-ancestor
2241265|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241266|NCT00101790|Pamidronate|pamidronate|mesh-list
2241267|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2241268|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241269|NCT00101803|Vildagliptin|vildagliptin|mesh-list
2241270|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2241271|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241272|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2241273|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
2241274|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241275|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241276|NCT00101829|Rituximab|rituximab|mesh-list
2241277|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2241278|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241279|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
2241280|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241281|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2241282|NCT00101842|Gemcitabine|gemcitabine|mesh-list
2241283|NCT00101842|Pemetrexed|pemetrexed|mesh-list
2241284|NCT00101842|Cisplatin|cisplatin|mesh-list
2241285|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2241286|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
2241287|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241288|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241289|NCT00101842|Antiviral Agents|antiviral agents|mesh-ancestor
2241290|NCT00101842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241291|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241292|NCT00101842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2241293|NCT00101842|Immunologic Factors|immunologic factors|mesh-ancestor
2241294|NCT00101842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241295|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2241296|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2241297|NCT00101894|Panitumumab|panitumumab|mesh-list
2241298|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
2241299|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2241300|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241301|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2241302|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241303|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241304|NCT00101920|Panitumumab|panitumumab|mesh-list
2241305|NCT00101920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2241306|NCT00101920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241307|NCT00101972|Antibodies|antibodies|mesh-list
2241308|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2241309|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
2241310|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241311|NCT00101998|Alvimopan|alvimopan|mesh-list
2241312|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2241313|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
2241314|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241315|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241316|NCT00102115|Talaporfin|talaporfin|mesh-list
777450|NCT02666014|Neostigmine|neostigmine|mesh-list
777451|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
777452|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777453|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777454|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
777455|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
777456|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777457|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
777458|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
777459|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2241317|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241318|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2241319|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
2241320|NCT00102141|Drospirenone|drospirenone|mesh-list
2241321|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2241322|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2241323|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2241324|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2241325|NCT00102141|Estradiol|estradiol|mesh-list
2241326|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2241327|NCT00102141|Estrogens|estrogens|mesh-ancestor
2241328|NCT00102141|Hormones|hormones|mesh-ancestor
2241329|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2241330|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241331|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2241332|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
2241333|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2241334|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2241335|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2241336|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
2241337|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2241338|NCT00102141|Diuretics|diuretics|mesh-ancestor
2241339|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
2241340|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2095102|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095103|NCT02287779|Volixibat|volixibat|mesh-list
2095104|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2095105|NCT02287818|Febuxostat|febuxostat|mesh-list
2095106|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
2095107|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2095108|NCT02287909|Clopidogrel|clopidogrel|mesh-list
2095109|NCT02287909|Ticagrelor|ticagrelor|mesh-list
2241341|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2241342|NCT00102154|Gaboxadol|gaboxadol|mesh-list
2241343|NCT00102154|Analgesics|analgesics|mesh-ancestor
2241344|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
2241345|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2241346|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241347|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
777348|NCT02666053|Fostemsavir|fostemsavir|mesh-list
777349|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
777350|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
777351|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
777352|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
777353|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
777354|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
777355|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241348|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
2241349|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
777540|NCT02665416|Bevacizumab|bevacizumab|mesh-list
777541|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
777542|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777543|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
777544|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
777545|NCT02665416|Growth Substances|growth substances|mesh-ancestor
777546|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777547|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
777548|NCT02665234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
777549|NCT02665234|Ophthalmic Solutions|ophthalmic solutions|mesh-list
777712|NCT02664558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777713|NCT02664558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
777714|NCT02664558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
777715|NCT02664558|Antiviral Agents|antiviral agents|mesh-ancestor
777737|NCT02664441|Exenatide|exenatide|mesh-list
777738|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
777739|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777740|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
777741|NCT02664441|Incretins|incretins|mesh-ancestor
777742|NCT02664441|Hormones|hormones|mesh-ancestor
777743|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2241350|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241351|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241352|NCT00102167|Gaboxadol|gaboxadol|mesh-list
2241353|NCT00102167|Analgesics|analgesics|mesh-ancestor
2241354|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
2241355|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
777836|NCT02663713|Clopidogrel|clopidogrel|mesh-list
777837|NCT02663713|Ticagrelor|ticagrelor|mesh-list
777838|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
777839|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
777840|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
777841|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
777842|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
777843|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
777844|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777845|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777852|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
777853|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
777854|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
777855|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
777856|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777857|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
777858|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
777859|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
777860|NCT02663830|Clomiphene|clomiphene|mesh-list
777861|NCT02663830|Enclomiphene|enclomiphene|mesh-list
777862|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
777863|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777864|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
777865|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
777866|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
777867|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
777868|NCT02663830|Urological Agents|urological agents|mesh-ancestor
777869|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
777870|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
777871|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
777878|NCT02663596|Vancomycin|vancomycin|mesh-list
776069|NCT02672566|Enoxaparin|enoxaparin|mesh-list
776077|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
776078|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
776079|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
776080|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
776673|NCT02669238|Etonogestrel|etonogestrel|mesh-list
776674|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
776675|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
776676|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
776677|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776678|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
776891|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
776892|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
776893|NCT02668536|Protective Agents|protective agents|mesh-ancestor
776894|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776895|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
776952|NCT02668159|Vitamin D|vitamin d|mesh-list
776953|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
776954|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
776955|NCT02668159|Vitamins|vitamins|mesh-list
776956|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
776957|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
776958|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
776959|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2241356|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241357|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
2241358|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
2241359|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
2241360|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241361|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241362|NCT00102206|Ritonavir|ritonavir|mesh-list
2241363|NCT00102206|Lopinavir|lopinavir|mesh-list
777730|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
777731|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
777732|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
777733|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777734|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
777735|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
777736|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
777788|NCT02663960|Citric Acid|citric acid|mesh-list
777789|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
777790|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
777791|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
777792|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
777793|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
777794|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241364|NCT00102206|Saquinavir|saquinavir|mesh-list
2241365|NCT00102206|Tenofovir|tenofovir|mesh-list
2241366|NCT00102206|Lamivudine|lamivudine|mesh-list
2241367|NCT00102206|Zidovudine|zidovudine|mesh-list
2241368|NCT00102206|Emtricitabine|emtricitabine|mesh-list
2241369|NCT00102206|Abacavir|abacavir|mesh-list
2241370|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2241371|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2241372|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
2241373|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241374|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241375|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2241376|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2241377|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
2241378|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241379|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
778732|NCT02660008|Glucagon|glucagon|mesh-list
778733|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
778734|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
778735|NCT02660008|Hormones|hormones|mesh-ancestor
778736|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
778737|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778738|NCT02660008|Incretins|incretins|mesh-ancestor
2241380|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2241381|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2241382|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2241383|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
779483|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
779484|NCT02657512|Charcoal|charcoal|mesh-list
779485|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2241384|NCT00102219|Doxorubicin|doxorubicin|mesh-list
2241385|NCT00102219|Pemetrexed|pemetrexed|mesh-list
777872|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777873|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
777874|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
777875|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
777876|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
777877|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
777902|NCT02663440|Temozolomide|temozolomide|mesh-list
777903|NCT02663440|Molgramostim|molgramostim|mesh-list
777904|NCT02663440|Sargramostim|sargramostim|mesh-list
777905|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
777906|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
777907|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777908|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777909|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
777910|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241386|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2241387|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241388|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2241389|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2241390|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241391|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241392|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2241393|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2241394|NCT00102258|Hormones|hormones|mesh-list
2241395|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2241396|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241397|NCT00102271|Oxypurinol|oxypurinol|mesh-list
778247|NCT02661932|Letrozole|letrozole|mesh-list
778248|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778249|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
778250|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
778251|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778252|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778253|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
778254|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
778255|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
778256|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241398|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778874|NCT02659384|Aspirin|aspirin|mesh-list
778875|NCT02659384|Bevacizumab|bevacizumab|mesh-list
778876|NCT02659384|Atezolizumab|atezolizumab|mesh-list
778877|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
778878|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778879|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
778880|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
778881|NCT02659384|Growth Substances|growth substances|mesh-ancestor
778882|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778883|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
778884|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
778885|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
778886|NCT02659384|Analgesics|analgesics|mesh-ancestor
778887|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
778888|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
778889|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
778890|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
778891|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
778892|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
778893|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778894|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
778895|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
778896|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778897|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
779306|NCT02658292|Naftifine|naftifine|mesh-list
779307|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
779308|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
779472|NCT02657486|Infigratinib|infigratinib|mesh-list
779473|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779511|NCT02657213|Insulin|insulin|mesh-list
779512|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
779513|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
779514|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779706|NCT02656342|Cycloserine|cycloserine|mesh-list
779707|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
779708|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
777879|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
777881|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778064|NCT02662647|Cytarabine|cytarabine|mesh-list
778065|NCT02662647|Decitabine|decitabine|mesh-list
778066|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
778067|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
778068|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
778069|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778070|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778071|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
778072|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778073|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
778074|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
778075|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778076|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778077|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
778078|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2241399|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241400|NCT00102284|Levodopa|levodopa|mesh-list
2241401|NCT00102284|Modafinil|modafinil|mesh-list
779668|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
779669|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
779670|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
779671|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
779672|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779673|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
779674|NCT02656472|Coagulants|coagulants|mesh-ancestor
780572|NCT02653196|Cyclosporine|cyclosporine|mesh-list
780573|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
780574|NCT02653196|Fludarabine|fludarabine|mesh-list
780575|NCT02653196|Etoposide|etoposide|mesh-list
780576|NCT02653196|Melphalan|melphalan|mesh-list
780577|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
780578|NCT02653196|Thiotepa|thiotepa|mesh-list
780579|NCT02653196|Tacrolimus|tacrolimus|mesh-list
780580|NCT02653196|Cyclosporins|cyclosporins|mesh-list
780581|NCT02653196|Mitogens|mitogens|mesh-list
780582|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
780583|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780584|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
780585|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
780586|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780587|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
780588|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
780589|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
780590|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780591|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
780592|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
780593|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
780594|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
780595|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
780596|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
780597|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
780598|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
780599|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
780600|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
780601|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
780602|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
780603|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
780604|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
781046|NCT02651727|Gemcitabine|gemcitabine|mesh-list
781047|NCT02651727|Paclitaxel|paclitaxel|mesh-list
781048|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
781049|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
781050|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781051|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
781052|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
781053|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
781054|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781055|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
781056|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
781057|NCT02651727|Antiviral Agents|antiviral agents|mesh-ancestor
781058|NCT02651727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781059|NCT02651727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781060|NCT02651727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
781061|NCT02651727|Immunologic Factors|immunologic factors|mesh-ancestor
781087|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
2241402|NCT00102284|Rivastigmine|rivastigmine|mesh-list
2241403|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2241404|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2241405|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
2241406|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
778044|NCT02662894|Valsartan|valsartan|mesh-list
778045|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
778046|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
778047|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
778048|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
778049|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778050|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
778051|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
778052|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778053|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
778054|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
778055|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
778170|NCT02662309|Atezolizumab|atezolizumab|mesh-list
778171|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778301|NCT02661789|Goserelin|goserelin|mesh-list
778302|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
778303|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778391|NCT02661347|Risperidone|risperidone|mesh-list
778392|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
778393|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
778394|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
778395|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778396|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778397|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
778398|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
778399|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
778400|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
778401|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
778402|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
778564|NCT02660684|Cyclosporine|cyclosporine|mesh-list
778565|NCT02660684|Methotrexate|methotrexate|mesh-list
778566|NCT02660684|Tacrolimus|tacrolimus|mesh-list
778567|NCT02660684|Cyclosporins|cyclosporins|mesh-list
778568|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
778569|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
778570|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
778571|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778572|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
778573|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
778574|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778575|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778576|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
778577|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778578|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
778579|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
778580|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
778581|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
778582|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
778583|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
778584|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
778585|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241407|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241408|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241409|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2241410|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2241411|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2241412|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2241413|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
778827|NCT02659657|Interleukin-2|interleukin-2|mesh-list
778828|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778829|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
778830|NCT02659657|Analgesics|analgesics|mesh-ancestor
778831|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
778832|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
778833|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778851|NCT02659917|Methamphetamine|methamphetamine|mesh-list
778852|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
778853|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778854|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
778855|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
777892|NCT02663700|Artesunate|artesunate|mesh-list
777893|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
777894|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
777895|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
777896|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
777897|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777898|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
777899|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
777900|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
777901|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
778056|NCT02662855|Favipiravir|favipiravir|mesh-list
778057|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
778058|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778106|NCT02662504|Cisplatin|cisplatin|mesh-list
778107|NCT02662504|Pemetrexed|pemetrexed|mesh-list
778108|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
778109|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778110|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778111|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778112|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
778113|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
778114|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
778115|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
778403|NCT02661477|Interferons|interferons|mesh-list
778404|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
778405|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
778406|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778407|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
778408|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778409|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
778410|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778518|NCT02660905|Tenofovir|tenofovir|mesh-list
778519|NCT02660905|Emtricitabine|emtricitabine|mesh-list
778520|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
778521|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
778522|NCT02660905|Rilpivirine|rilpivirine|mesh-list
778523|NCT02660905|Ledipasvir|ledipasvir|mesh-list
778524|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
778525|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778526|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
778527|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
778528|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778529|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778530|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
778531|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
778532|NCT02660866|Vorapaxar|vorapaxar|mesh-list
778533|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
778998|NCT02659293|Dexamethasone|dexamethasone|mesh-list
778999|NCT02659293|Lenalidomide|lenalidomide|mesh-list
779000|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
779001|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
779002|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
779003|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779004|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779005|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
779006|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
779007|NCT02659293|Hormones|hormones|mesh-ancestor
779008|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
779009|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
779010|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779011|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
779012|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
779013|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
779014|NCT02659293|Growth Substances|growth substances|mesh-ancestor
779015|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
779077|NCT02658838|Heparin|heparin|mesh-list
779078|NCT02658838|Calcium heparin|calcium heparin|mesh-list
779079|NCT02658838|Enoxaparin|enoxaparin|mesh-list
777919|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
777920|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
777921|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
777922|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777923|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
777924|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
777925|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
777926|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778324|NCT02661373|Cobicistat|cobicistat|mesh-list
778325|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
778326|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
778327|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
778328|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778329|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
778330|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
778331|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778332|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241414|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241415|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
2241416|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
778443|NCT02661282|Temozolomide|temozolomide|mesh-list
778444|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
778445|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
778446|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778447|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778617|NCT02660762|Cytarabine|cytarabine|mesh-list
778618|NCT02660762|Dexamethasone|dexamethasone|mesh-list
778619|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
778620|NCT02660762|Prednisone|prednisone|mesh-list
778621|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
778622|NCT02660762|Methotrexate|methotrexate|mesh-list
778623|NCT02660762|Etoposide|etoposide|mesh-list
778624|NCT02660762|Vincristine|vincristine|mesh-list
778625|NCT02660762|Daunorubicin|daunorubicin|mesh-list
778626|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
778627|NCT02660762|Thioguanine|thioguanine|mesh-list
778628|NCT02660762|Pegaspargase|pegaspargase|mesh-list
778629|NCT02660762|BB 1101|bb 1101|mesh-list
778630|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
778631|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
778632|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778633|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
778634|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
778635|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
778636|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778637|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778638|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
778639|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
778640|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
778641|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
778642|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
778643|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
778644|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
778645|NCT02660762|Hormones|hormones|mesh-ancestor
778646|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
778647|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
778648|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
778649|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778650|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
778651|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
778652|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
778653|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
778654|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
778655|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
778656|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
778657|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
778658|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
778659|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
778660|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
778661|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
778662|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778663|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
778664|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
778665|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
778666|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2095110|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2241417|NCT00102284|Protective Agents|protective agents|mesh-ancestor
2241418|NCT00102310|Z 338|z 338|mesh-list
2241419|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2241420|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241421|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241422|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
2241423|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241424|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241425|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2241426|NCT00102375|Topotecan|topotecan|mesh-list
2241427|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2241428|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2241429|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241430|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241431|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241432|NCT00102388|Vildagliptin|vildagliptin|mesh-list
2241433|NCT00102388|Gliclazide|gliclazide|mesh-list
2241434|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2241435|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778259|NCT02661893|Rifampin|rifampin|mesh-list
778260|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
778261|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
778262|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
778263|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778264|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
778265|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
778266|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778267|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778268|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
778269|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
778270|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
778271|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
778272|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
778273|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2241436|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2241437|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
2241438|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241439|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241440|NCT00102414|Gemcitabine|gemcitabine|mesh-list
2241441|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2241442|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
2241443|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241444|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241445|NCT00102414|Antiviral Agents|antiviral agents|mesh-ancestor
2241446|NCT00102414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241447|NCT00102414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241448|NCT00102414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2241449|NCT00102414|Immunologic Factors|immunologic factors|mesh-ancestor
2241450|NCT00102414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241451|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
2241452|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2241453|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241454|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241455|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2241456|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2241457|NCT00102453|Protective Agents|protective agents|mesh-ancestor
2241458|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241459|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
2241460|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2241461|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
2241462|NCT00102466|Metformin|metformin|mesh-list
2241463|NCT00102466|Vildagliptin|vildagliptin|mesh-list
2241464|NCT00102466|Gliclazide|gliclazide|mesh-list
2241465|NCT00102466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2241466|NCT00102466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241467|NCT00102466|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2241468|NCT00102466|Protease Inhibitors|protease inhibitors|mesh-ancestor
2241469|NCT00102466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241470|NCT00102466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241471|NCT00102479|Aripiprazole|aripiprazole|mesh-list
2241472|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
2241473|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2241474|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2241475|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2241476|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777945|NCT02663284|Ropivacaine|ropivacaine|mesh-list
777946|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
777947|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
777948|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
777949|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777950|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
777951|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754023|NCT01999179|Heparin|heparin|mesh-list
2754024|NCT01999179|Enoxaparin|enoxaparin|mesh-list
778079|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
778080|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
778081|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
778082|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
778083|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
778084|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778085|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
778086|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
778087|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778088|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
778089|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
778162|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
778163|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
778164|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778451|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
778452|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
778453|NCT02661035|Fludarabine|fludarabine|mesh-list
778454|NCT02661035|Allopurinol|allopurinol|mesh-list
778455|NCT02661035|Tacrolimus|tacrolimus|mesh-list
778456|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
778457|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
778458|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
778459|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778460|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
778461|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
778462|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
778463|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778464|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778465|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
778466|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
778467|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
778468|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778469|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
778470|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
778471|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
778472|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
778473|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778474|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
778475|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
778476|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
778477|NCT02661035|Protective Agents|protective agents|mesh-ancestor
778553|NCT02660840|Flupenthixol|flupenthixol|mesh-list
778554|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
778555|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
778556|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
778557|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
778558|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778559|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
778560|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
778561|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
778562|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
778563|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241477|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241478|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
2241479|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
2241480|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241481|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241482|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2241483|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2241484|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
2241485|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2754025|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
779298|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
779299|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
779300|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777952|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
777953|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
777954|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778027|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
778028|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
778029|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
778030|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
778031|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
778032|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778033|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
778034|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
778035|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778036|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
778037|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095111|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2095112|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2095113|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2095114|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
2095115|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095116|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778697|NCT02660255|Cannabidiol|cannabidiol|mesh-list
778698|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
2095117|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095118|NCT02288156|Capsaicin|capsaicin|mesh-list
2095119|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
2095120|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
2095121|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
2095122|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095123|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095124|NCT02288273|Exenatide|exenatide|mesh-list
2095125|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2095126|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095127|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2095128|NCT02288273|Incretins|incretins|mesh-ancestor
2241486|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2241487|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2241488|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2241489|NCT00102492|Casopitant|casopitant|mesh-list
2241490|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
2241491|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
2241492|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2241493|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241494|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2241495|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
779191|NCT02658526|Anesthetics|anesthetics|mesh-list
779193|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779194|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779283|NCT02658188|Gabapentin|gabapentin|mesh-list
779284|NCT02658188|Analgesics|analgesics|mesh-ancestor
779285|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
779286|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779287|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779288|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
779289|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
779290|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
779291|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779292|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
779293|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
779294|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
779295|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
779296|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779297|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
2241496|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241497|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241498|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
2241499|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241500|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2241501|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
2241502|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
2241503|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
2241504|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2241505|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2241506|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241507|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779458|NCT02657603|Lidocaine|lidocaine|mesh-list
777955|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
777956|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
777957|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
777958|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777959|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
777960|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
777961|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778038|NCT02662959|Irinotecan|irinotecan|mesh-list
778039|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
778040|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
778041|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778042|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778043|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778237|NCT02662374|Nystatin|nystatin|mesh-list
778238|NCT02662374|Calcium|calcium|mesh-list
778239|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
778240|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778241|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
778242|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778243|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
778244|NCT02662374|Ionophores|ionophores|mesh-ancestor
778245|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
778246|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241508|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241509|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2241510|NCT00102583|Cyclosporine|cyclosporine|mesh-list
2241511|NCT00102583|Cyclosporins|cyclosporins|mesh-list
2241512|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241513|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241514|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2241515|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
2241516|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241517|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
2241518|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241519|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
2241520|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2241521|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2241522|NCT00102609|Dexamethasone|dexamethasone|mesh-list
2241523|NCT00102609|Doxorubicin|doxorubicin|mesh-list
2241524|NCT00102609|Trabectedin|trabectedin|mesh-list
2241525|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2241526|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
778547|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
778548|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
778549|NCT02660736|Incretins|incretins|mesh-ancestor
778550|NCT02660736|Hormones|hormones|mesh-ancestor
778551|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
778552|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778856|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
778857|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
778858|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
778859|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778860|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
778861|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
778862|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
778863|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
778864|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
779192|NCT02658422|Montelukast|montelukast|mesh-list
779195|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
779196|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
779197|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
779198|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
779199|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2241527|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
2241528|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2241529|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241530|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2241531|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
2241532|NCT00102609|Hormones|hormones|mesh-ancestor
778059|NCT02662725|Ipilimumab|ipilimumab|mesh-list
778060|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
778061|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778062|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
778063|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241533|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2241534|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2241535|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241536|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2241537|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2241538|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2241539|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241540|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241541|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2241542|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
2241543|NCT00102622|Paclitaxel|paclitaxel|mesh-list
2241544|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2241545|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241546|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
778865|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
778866|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
778867|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778868|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
778869|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
778870|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
778871|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778872|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
778873|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
779045|NCT02658799|Diclofenac|diclofenac|mesh-list
779046|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
779047|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
779048|NCT02658799|Analgesics|analgesics|mesh-ancestor
779049|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
779050|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779051|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779052|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
779053|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
779054|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
779055|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779056|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241547|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
2241548|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
2241549|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241550|NCT00102635|Fenretinide|fenretinide|mesh-list
2241551|NCT00102635|Lonafarnib|lonafarnib|mesh-list
2241552|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241553|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
777987|NCT02663141|Bevacizumab|bevacizumab|mesh-list
777988|NCT02663141|Losartan|losartan|mesh-list
777989|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
777990|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
777991|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
777992|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
777993|NCT02663141|Growth Substances|growth substances|mesh-ancestor
777994|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777995|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
777996|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
777997|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
777998|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
777999|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
778000|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778333|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
778334|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
778335|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778336|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
778337|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
778338|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778339|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778340|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778341|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
778342|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2095129|NCT02288273|Hormones|hormones|mesh-ancestor
2095130|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2095131|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
778834|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
778835|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
778836|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778912|NCT02659397|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
778913|NCT02659397|Atorvastatin|atorvastatin|mesh-list
778914|NCT02659397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
778915|NCT02659397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
778916|NCT02659397|Antimetabolites|antimetabolites|mesh-ancestor
778917|NCT02659397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778918|NCT02659397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
778919|NCT02659397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
778920|NCT02659397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778921|NCT02659397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
778922|NCT02659397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779030|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
779031|NCT02659033|Cefotaxime|cefotaxime|mesh-list
779032|NCT02659033|Cefoxitin|cefoxitin|mesh-list
779033|NCT02659033|Cephalosporins|cephalosporins|mesh-list
779034|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
779035|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2095132|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
2095133|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2095134|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2095135|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2095136|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095137|NCT02288325|Milnacipran|milnacipran|mesh-list
2095138|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
2241554|NCT00102635|Protective Agents|protective agents|mesh-ancestor
2095139|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2095140|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2095141|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2095142|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095143|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095144|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095145|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
2095146|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2095147|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2095148|NCT02288325|Analgesics|analgesics|mesh-ancestor
778589|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
778590|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
778591|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
778592|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778593|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
778594|NCT02660658|Analgesics|analgesics|mesh-ancestor
778595|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
778596|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
778597|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
778598|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
778599|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
778600|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
778601|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
778602|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778675|NCT02660411|Propofol|propofol|mesh-list
778676|NCT02660411|Sevoflurane|sevoflurane|mesh-list
778677|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
778678|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
778679|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778680|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
778681|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
778682|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
778683|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
778684|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
778943|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
778944|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
778945|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241555|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241556|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241557|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241565|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
2241566|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2241567|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241568|NCT00102674|Cangrelor|cangrelor|mesh-list
2241569|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2241570|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
779301|NCT02658396|Bortezomib|bortezomib|mesh-list
779302|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241571|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2241572|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2241573|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
2241574|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241575|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241576|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241577|NCT00102700|Gemcitabine|gemcitabine|mesh-list
2241578|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
2241579|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2241580|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
2241581|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241582|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241583|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
2241584|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241585|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095149|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
2095150|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095151|NCT02288364|Lidocaine|lidocaine|mesh-list
778015|NCT02663050|Diclofenac|diclofenac|mesh-list
778016|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
778017|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
778018|NCT02663050|Analgesics|analgesics|mesh-ancestor
778019|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
778020|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
778021|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778022|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
778023|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
778024|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
778025|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778026|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778141|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
778142|NCT02662491|Vitamin D|vitamin d|mesh-list
778143|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
778144|NCT02662491|Vitamins|vitamins|mesh-list
778145|NCT02662491|Calcium|calcium|mesh-list
778146|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
778147|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778148|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
778149|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
778414|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
778415|NCT02661100|Poly ICLC|poly iclc|mesh-list
778416|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
778417|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778418|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
778419|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
778420|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778932|NCT02659228|Anesthetics|anesthetics|mesh-list
778933|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
778934|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
778935|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778936|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
2241586|NCT00102700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2241587|NCT00102700|Immunologic Factors|immunologic factors|mesh-ancestor
2241588|NCT00102700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241589|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2241590|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2241591|NCT00102713|Valproic Acid|valproic acid|mesh-list
2241592|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
2241593|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241594|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241595|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
2241596|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241597|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241598|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
779215|NCT02658721|Diclofenac|diclofenac|mesh-list
779216|NCT02658721|Lidocaine|lidocaine|mesh-list
779217|NCT02658721|Atropine|atropine|mesh-list
779218|NCT02658721|Ephedrine|ephedrine|mesh-list
779219|NCT02658721|Fentanyl|fentanyl|mesh-list
779220|NCT02658721|Midazolam|midazolam|mesh-list
779221|NCT02658721|Tramadol|tramadol|mesh-list
779222|NCT02658721|Ondansetron|ondansetron|mesh-list
779223|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
779224|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
779225|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779226|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779227|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
779228|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779229|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
779230|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
779231|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
779232|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
779233|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779234|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
779235|NCT02658721|Narcotics|narcotics|mesh-ancestor
779236|NCT02658721|Analgesics|analgesics|mesh-ancestor
779237|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
779238|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
779239|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
779240|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
779241|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
779242|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
779243|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
779244|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
779245|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
779246|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
778090|NCT02662660|Acetaminophen|acetaminophen|mesh-list
778091|NCT02662660|Dipyrone|dipyrone|mesh-list
778092|NCT02662660|Bupivacaine|bupivacaine|mesh-list
778093|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
778094|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
778095|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
778096|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
778097|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778098|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
778099|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
778100|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
778101|NCT02662660|Analgesics|analgesics|mesh-ancestor
778102|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
778103|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
778104|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
778105|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
778226|NCT02662296|Idelalisib|idelalisib|mesh-list
778227|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778228|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778229|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241599|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2241600|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2241601|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2241602|NCT00102752|Gemcitabine|gemcitabine|mesh-list
2241603|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2241604|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
2241605|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241606|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241607|NCT00102752|Antiviral Agents|antiviral agents|mesh-ancestor
2241608|NCT00102752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241609|NCT00102752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241610|NCT00102752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2241611|NCT00102752|Immunologic Factors|immunologic factors|mesh-ancestor
2241612|NCT00102752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241613|NCT00102765|Fluticasone|fluticasone|mesh-list
2241614|NCT00102765|Xhance|xhance|mesh-list
2241615|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
778909|NCT02659306|Metformin|metformin|mesh-list
778910|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
778911|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779016|NCT02659085|Ketamine|ketamine|mesh-list
779017|NCT02659085|Analgesics|analgesics|mesh-ancestor
779018|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
779019|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779020|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779021|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
779022|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
779023|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
779024|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
779025|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779026|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
779027|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
779028|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
779029|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779080|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
779081|NCT02658838|Tinzaparin|tinzaparin|mesh-list
779082|NCT02658838|Dalteparin|dalteparin|mesh-list
779083|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
779084|NCT02658838|Ticagrelor|ticagrelor|mesh-list
779085|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
779086|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
779087|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
779088|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
779089|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779090|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
779092|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
779093|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
779094|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
779095|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
779096|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779113|NCT02658773|Lidocaine|lidocaine|mesh-list
779114|NCT02658773|Prilocaine|prilocaine|mesh-list
779115|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
779116|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
779117|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
779118|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2754026|NCT01999179|Tinzaparin|tinzaparin|mesh-list
778150|NCT02662348|Aldesleukin|aldesleukin|mesh-list
778151|NCT02662348|Interleukin-2|interleukin-2|mesh-list
778152|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778153|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
778154|NCT02662348|Analgesics|analgesics|mesh-ancestor
778155|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
778156|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
778157|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778158|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
778159|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
778160|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
778161|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241616|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2241617|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2241618|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2241619|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
2241620|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2241621|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779119|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779120|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
779121|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779122|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
779123|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
779124|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
779125|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
779126|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779127|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
779385|NCT02658214|Leucovorin|leucovorin|mesh-list
779386|NCT02658214|Folic Acid|folic acid|mesh-list
779387|NCT02658214|Gemcitabine|gemcitabine|mesh-list
779388|NCT02658214|Paclitaxel|paclitaxel|mesh-list
779389|NCT02658214|Etoposide|etoposide|mesh-list
779390|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
779391|NCT02658214|Carboplatin|carboplatin|mesh-list
779392|NCT02658214|Fluorouracil|fluorouracil|mesh-list
779393|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
779394|NCT02658214|Durvalumab|durvalumab|mesh-list
779395|NCT02658214|Tremelimumab|tremelimumab|mesh-list
779396|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
779397|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
779398|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779399|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
779400|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
779401|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
779402|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779403|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
779404|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
779405|NCT02658214|Antiviral Agents|antiviral agents|mesh-ancestor
779406|NCT02658214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
779407|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779408|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
779409|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
779410|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779411|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
779412|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
779413|NCT02658214|Antidotes|antidotes|mesh-ancestor
779414|NCT02658214|Protective Agents|protective agents|mesh-ancestor
779415|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
779416|NCT02658214|Vitamins|vitamins|mesh-ancestor
779417|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
779418|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
779419|NCT02658214|Hematinics|hematinics|mesh-ancestor
2095152|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
2095153|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
2095154|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2095155|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095156|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
779499|NCT02657291|Ropivacaine|ropivacaine|mesh-list
779500|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
779501|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
779502|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779503|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779504|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
779505|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779528|NCT02657187|Rocuronium|rocuronium|mesh-list
779529|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2095157|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
778172|NCT02662283|Acteoside|acteoside|mesh-list
778173|NCT02662283|Prednisolone|prednisolone|mesh-list
778174|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
778175|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
778176|NCT02662283|Hormones|hormones|mesh-ancestor
778177|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
778178|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778179|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
778180|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778181|NCT02662283|Protective Agents|protective agents|mesh-ancestor
778182|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778183|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
778184|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
778185|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778186|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
778187|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
778188|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
778189|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
2095158|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2095159|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2095160|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2095161|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2241622|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
779132|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
779133|NCT02658760|Bupivacaine|bupivacaine|mesh-list
779134|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
779135|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
779136|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779137|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779138|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
779139|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779140|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
779141|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
779142|NCT02658760|Analgesics|analgesics|mesh-ancestor
779143|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
779144|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
779145|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
779146|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
779147|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
779148|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779204|NCT02658435|Tafenoquine|tafenoquine|mesh-list
779205|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
779206|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
779207|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
779208|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
779303|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
779304|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
779305|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779448|NCT02657616|Vitamin K|vitamin k|mesh-list
779449|NCT02657616|Anticoagulants|anticoagulants|mesh-list
779450|NCT02657616|Vitamins|vitamins|mesh-ancestor
779451|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
779452|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779453|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
779454|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
779455|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779456|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
779457|NCT02657616|Coagulants|coagulants|mesh-ancestor
779459|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
779460|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
779461|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779462|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779463|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
779464|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779465|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
779466|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
779467|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
779468|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
779469|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241623|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
2241624|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
2241625|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2241626|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2241627|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2241628|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
778190|NCT02662257|Propofol|propofol|mesh-list
778191|NCT02662257|Sevoflurane|sevoflurane|mesh-list
778192|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
778193|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
778194|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778195|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
778196|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
778197|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
778198|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
778199|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2241629|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
2241630|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241631|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241632|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
2241633|NCT00102765|Hormones|hormones|mesh-ancestor
2241634|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2241635|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
2241636|NCT00102778|Ritonavir|ritonavir|mesh-list
2241637|NCT00102778|Lopinavir|lopinavir|mesh-list
2241638|NCT00102778|Aplaviroc|aplaviroc|mesh-list
2241639|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2241640|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2241641|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
2241642|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241643|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241644|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2241645|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2241646|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
2241647|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241648|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2241649|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2241650|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2241651|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2241652|NCT00102830|Trebananib|trebananib|mesh-list
2241653|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2241654|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2241655|NCT00102830|Growth Substances|growth substances|mesh-ancestor
2241656|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241657|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
2241658|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241659|NCT00102843|Folic Acid|folic acid|mesh-list
2241660|NCT00102843|Betaine|betaine|mesh-list
2241661|NCT00102843|Hematinics|hematinics|mesh-ancestor
2241662|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
2241663|NCT00102843|Vitamins|vitamins|mesh-ancestor
2241664|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
2095162|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095163|NCT02288377|Lanreotide|lanreotide|mesh-list
2095164|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095165|NCT02288819|Diuretics|diuretics|mesh-list
2095166|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
2095167|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
2095168|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095169|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2095170|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095171|NCT02289079|Bupivacaine|bupivacaine|mesh-list
2095172|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
2095173|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
2095174|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2095175|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241665|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779200|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779201|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
779202|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
779203|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779470|NCT02657460|Cisplatin|cisplatin|mesh-list
779471|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779515|NCT02657343|Trastuzumab|trastuzumab|mesh-list
779516|NCT02657343|Fulvestrant|fulvestrant|mesh-list
779517|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
779518|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779519|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
779520|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
779521|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
779522|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
778209|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
778210|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778211|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
778739|NCT02660060|Pramipexole|pramipexole|mesh-list
778740|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
778741|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778742|NCT02660060|Protective Agents|protective agents|mesh-ancestor
778743|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778744|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
778745|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
778746|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
778747|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
778748|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241666|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2241667|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
2241668|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
779212|NCT02658409|Vaccines|vaccines|mesh-list
779213|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
779214|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241669|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
2241670|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241671|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2241672|NCT00102856|Pramipexole|pramipexole|mesh-list
2241673|NCT00102856|Rivastigmine|rivastigmine|mesh-list
2241674|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
2241675|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241676|NCT00102856|Protective Agents|protective agents|mesh-ancestor
2241677|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241678|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2241679|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
779474|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
779475|NCT02657694|Ledipasvir|ledipasvir|mesh-list
779476|NCT02657694|Velpatasvir|velpatasvir|mesh-list
779477|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
779478|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
779523|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
779524|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779542|NCT02657161|Vaccines|vaccines|mesh-list
779543|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
779544|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779559|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
779560|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
779561|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241680|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
2241681|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
2241682|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241683|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2241684|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241685|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
2241686|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2241687|NCT00102869|Levodopa|levodopa|mesh-list
2241688|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2241689|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2241690|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
2241691|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241692|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241693|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241694|NCT00102882|Fluticasone|fluticasone|mesh-list
2241695|NCT00102882|Xhance|xhance|mesh-list
2241696|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2241697|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2241698|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2241699|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2241700|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
2241701|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2241702|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241703|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2241704|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
2241705|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
2241706|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2241707|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2241708|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2241709|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2241710|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
2241711|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
779622|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
779623|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
778212|NCT02662634|Paclitaxel|paclitaxel|mesh-list
778213|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
778214|NCT02662634|Cisplatin|cisplatin|mesh-list
778215|NCT02662634|Carboplatin|carboplatin|mesh-list
778216|NCT02662634|Pemetrexed|pemetrexed|mesh-list
778217|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
778218|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778219|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
778220|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
778221|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
778222|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778223|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778224|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
778225|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2241712|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241713|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
778667|NCT02660502|Insulin|insulin|mesh-list
778668|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
778669|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
778670|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
778671|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241714|NCT00102882|Hormones|hormones|mesh-ancestor
2241715|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2241716|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
2241717|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
2241718|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2241719|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241720|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
2241721|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2241722|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
779159|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
779160|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
779161|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
779162|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
779163|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
779164|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
779165|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779166|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779167|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779168|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
779169|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
779170|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
779171|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779172|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
779173|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
779174|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
779247|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
779248|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
779249|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
779250|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
779251|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
779252|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
779253|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
779254|NCT02658721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
779255|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
779256|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
779257|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
779258|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
779259|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
779260|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779261|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
779262|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
779263|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
779264|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
779265|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
779266|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
779267|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
779268|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
779269|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
779270|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
779271|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
779272|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
2241723|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779479|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
778294|NCT02661711|Aflibercept|aflibercept|mesh-list
778295|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
778296|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
778297|NCT02661711|Growth Substances|growth substances|mesh-ancestor
778298|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778299|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
778300|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778807|NCT02659761|Lamivudine|lamivudine|mesh-list
778808|NCT02659761|Abacavir|abacavir|mesh-list
778809|NCT02659761|Dolutegravir|dolutegravir|mesh-list
778810|NCT02659761|Triumeq|triumeq|mesh-list
778811|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
778812|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
778813|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778814|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778815|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
778816|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778817|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
778818|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
778819|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
778820|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2241724|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2241725|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2241726|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
2241727|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241728|NCT00102947|Daptomycin|daptomycin|mesh-list
2241729|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2241730|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241731|NCT00102973|Carboplatin|carboplatin|mesh-list
2241732|NCT00102973|Doxorubicin|doxorubicin|mesh-list
2241733|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2241734|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241735|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2241736|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2241737|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2241738|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241739|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779480|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
779481|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
779482|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241740|NCT00102986|Ritonavir|ritonavir|mesh-list
779545|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
779546|NCT02657148|Etonogestrel|etonogestrel|mesh-list
779547|NCT02657148|Desogestrel|desogestrel|mesh-list
779548|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
779549|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779550|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
779551|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
779552|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
779553|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
779554|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
779555|NCT02657148|Progestins|progestins|mesh-ancestor
779556|NCT02657148|Hormones|hormones|mesh-ancestor
779557|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
779562|NCT02656901|Anesthetics|anesthetics|mesh-list
779563|NCT02656901|Sevoflurane|sevoflurane|mesh-list
779564|NCT02656901|Desflurane|desflurane|mesh-list
779565|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779566|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779567|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
779568|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
779569|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
779573|NCT02656810|Teriparatide|teriparatide|mesh-list
779574|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
779575|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779576|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
779582|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
779583|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779624|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779625|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
779634|NCT02656511|Tenofovir|tenofovir|mesh-list
779635|NCT02656511|Emtricitabine|emtricitabine|mesh-list
779636|NCT02656511|Dolutegravir|dolutegravir|mesh-list
779637|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
779638|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
779639|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2241741|NCT00102986|Lopinavir|lopinavir|mesh-list
778343|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
778344|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
778345|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778346|NCT02661191|Vitamins|vitamins|mesh-ancestor
778347|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
778348|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2241742|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2241743|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2241744|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
2241745|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241746|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241747|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2241748|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2241749|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
2241750|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241751|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2241752|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2241753|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2241754|NCT00103038|Hematinics|hematinics|mesh-ancestor
2241755|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2241756|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2241757|NCT00103051|Gemcitabine|gemcitabine|mesh-list
2241758|NCT00103051|Gefitinib|gefitinib|mesh-list
2241759|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241760|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2241761|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
2241762|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241763|NCT00103051|Antiviral Agents|antiviral agents|mesh-ancestor
2241764|NCT00103051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
779378|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
779379|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
779380|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
779381|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779382|NCT02658253|Antacids|antacids|mesh-ancestor
779383|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779384|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
779486|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
779487|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
779488|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
779489|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779490|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779491|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
779492|NCT02657512|Antidotes|antidotes|mesh-ancestor
779493|NCT02657512|Protective Agents|protective agents|mesh-ancestor
779494|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779530|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
779531|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
779532|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779533|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779570|NCT02656979|Latanoprost|latanoprost|mesh-list
779571|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
779572|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
779577|NCT02656771|Metronidazole|metronidazole|mesh-list
779578|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
779579|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
779580|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
779581|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
779626|NCT02656797|Amphotericin B|amphotericin b|mesh-list
779627|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
779628|NCT02656797|Amebicides|amebicides|mesh-ancestor
779629|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
779630|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
779631|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
779632|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
779633|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
779640|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
779641|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779642|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779643|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
779644|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
779645|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
779646|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
779647|NCT02656706|Nivolumab|nivolumab|mesh-list
779648|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
779649|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779652|NCT02656589|Capecitabine|capecitabine|mesh-list
778354|NCT02661503|Dexamethasone|dexamethasone|mesh-list
778355|NCT02661503|Prednisone|prednisone|mesh-list
778356|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
778357|NCT02661503|Dacarbazine|dacarbazine|mesh-list
778358|NCT02661503|Doxorubicin|doxorubicin|mesh-list
778359|NCT02661503|Etoposide|etoposide|mesh-list
778360|NCT02661503|Vincristine|vincristine|mesh-list
778361|NCT02661503|Bleomycin|bleomycin|mesh-list
778362|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
778363|NCT02661503|Procarbazine|procarbazine|mesh-list
778364|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
778365|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
778366|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778367|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
778368|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
778369|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
778370|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778371|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
778372|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
778373|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
778374|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
778375|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
778376|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
778377|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
778378|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
778379|NCT02661503|Hormones|hormones|mesh-ancestor
778380|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
778381|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
778382|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
778383|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
778384|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
778385|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778386|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
778387|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
778388|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
778389|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
778390|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2241765|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241766|NCT00103051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2241767|NCT00103051|Immunologic Factors|immunologic factors|mesh-ancestor
2241768|NCT00103051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241769|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2241770|NCT00103103|Leucovorin|leucovorin|mesh-list
2241771|NCT00103103|Fluorouracil|fluorouracil|mesh-list
778692|NCT02660346|Vancomycin|vancomycin|mesh-list
778693|NCT02660346|Daptomycin|daptomycin|mesh-list
778694|NCT02660346|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
778695|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
778696|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241772|NCT00103103|Bortezomib|bortezomib|mesh-list
2241773|NCT00103103|Calcium|calcium|mesh-list
2241774|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
2241775|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2241776|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095176|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
2095177|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095178|NCT02289222|Dexamethasone|dexamethasone|mesh-list
2095179|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
2095180|NCT02289222|Pomalidomide|pomalidomide|mesh-list
2095181|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2095182|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
779495|NCT02657473|Tobramycin|tobramycin|mesh-list
779496|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
779497|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
779498|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241777|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
2241778|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241779|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2241780|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241781|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2241782|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
2241783|NCT00103103|Antidotes|antidotes|mesh-ancestor
2241784|NCT00103103|Protective Agents|protective agents|mesh-ancestor
2241785|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
2241786|NCT00103103|Vitamins|vitamins|mesh-ancestor
2241787|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
2241788|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
2241789|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241790|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2095183|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
777880|NCT02663570|Melatonin|melatonin|mesh-list
777882|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
777883|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
777884|NCT02663570|Protective Agents|protective agents|mesh-ancestor
777885|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
777886|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2241791|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241792|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241793|NCT00103233|Trastuzumab|trastuzumab|mesh-list
2241794|NCT00103233|Vinorelbine|vinorelbine|mesh-list
2241795|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2241796|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241797|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2241798|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
2241799|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
2241800|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
2241801|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
778321|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
778322|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
778323|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778349|NCT02661152|Nimorazole|nimorazole|mesh-list
778350|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
778351|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
778352|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
778353|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
778685|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
778686|NCT02660606|Narcotics|narcotics|mesh-ancestor
778687|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
778688|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778689|NCT02660606|Analgesics|analgesics|mesh-ancestor
778690|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
778691|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
778749|NCT02660047|Liraglutide|liraglutide|mesh-list
778750|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
778751|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
778752|NCT02660047|Incretins|incretins|mesh-ancestor
778753|NCT02660047|Hormones|hormones|mesh-ancestor
778754|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
778821|NCT02659683|Esomeprazole|esomeprazole|mesh-list
778822|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
778823|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
778824|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
778825|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
778826|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779728|NCT02656017|Metformin|metformin|mesh-list
779729|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
779730|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095184|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095185|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095186|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2095187|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
2095188|NCT02289222|Hormones|hormones|mesh-ancestor
2095189|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2095190|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2095191|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095192|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2095193|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
780223|NCT02654171|Ziresovir|ziresovir|mesh-list
780224|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
780225|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
780753|NCT02652234|Endostar protein|endostar protein|mesh-list
780754|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
780755|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
780756|NCT02652234|Growth Substances|growth substances|mesh-ancestor
780757|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780758|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
780759|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781352|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
781353|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
781354|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
781355|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779650|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
779651|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779906|NCT02655562|Montelukast|montelukast|mesh-list
779907|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
779908|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
779909|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
779910|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
779911|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
779912|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779913|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
779914|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
779915|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780006|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
780007|NCT02655146|Progesterone|progesterone|mesh-list
780008|NCT02655146|Estradiol|estradiol|mesh-list
780009|NCT02655146|Progestins|progestins|mesh-ancestor
780010|NCT02655146|Hormones|hormones|mesh-ancestor
780011|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
780012|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780013|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
780014|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
780015|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
780016|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
780017|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
780018|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
780019|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
780020|NCT02655146|Estrogens|estrogens|mesh-ancestor
2241802|NCT00103246|Silicon|silicon|mesh-list
2241803|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
2241804|NCT00103246|Trace Elements|trace elements|mesh-ancestor
2241805|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
2241806|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241807|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
2241808|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2241809|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2241810|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241811|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
2241812|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2241813|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
2241814|NCT00103272|Bortezomib|bortezomib|mesh-list
2241815|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241816|NCT00103298|Leucovorin|leucovorin|mesh-list
2241817|NCT00103298|Fluorouracil|fluorouracil|mesh-list
2241818|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
2241819|NCT00103298|Melphalan|melphalan|mesh-list
2241820|NCT00103298|Calcium|calcium|mesh-list
2241821|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
2241822|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2241823|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241824|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
2241825|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241826|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2241827|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241828|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2241829|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
2241830|NCT00103298|Antidotes|antidotes|mesh-ancestor
2241831|NCT00103298|Protective Agents|protective agents|mesh-ancestor
2241832|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
2241833|NCT00103298|Vitamins|vitamins|mesh-ancestor
780961|NCT02651792|Meperidine|meperidine|mesh-list
780962|NCT02651792|Ketamine|ketamine|mesh-list
780963|NCT02651792|Propofol|propofol|mesh-list
780964|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
780965|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
780966|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780967|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
780968|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
780969|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
780970|NCT02651792|Analgesics|analgesics|mesh-ancestor
780971|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
780972|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
780973|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
780974|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
780975|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
781253|NCT02650752|Lapatinib|lapatinib|mesh-list
2241834|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
2241835|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
779653|NCT02656589|Trastuzumab|trastuzumab|mesh-list
779654|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
779655|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
779656|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779657|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779658|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2241836|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
2241837|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2241838|NCT00103324|Lapatinib|lapatinib|mesh-list
2241839|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779819|NCT02655705|Cyclosporine|cyclosporine|mesh-list
779820|NCT02655705|Methotrexate|methotrexate|mesh-list
779821|NCT02655705|Cyclosporins|cyclosporins|mesh-list
779822|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
779823|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
779824|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
779825|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779826|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
779827|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
779828|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779829|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779830|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
779831|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779832|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
779833|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
779834|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
779835|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
779836|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
779837|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
779838|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
779839|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
780078|NCT02655029|Amlodipine|amlodipine|mesh-list
780079|NCT02655029|Perindopril|perindopril|mesh-list
780080|NCT02655029|Indapamide|indapamide|mesh-list
780081|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
780082|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
780083|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
780084|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780085|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
780086|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780087|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
780088|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
780089|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
780090|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780091|NCT02655029|Diuretics|diuretics|mesh-ancestor
780092|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
780093|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
780159|NCT02654665|Liraglutide|liraglutide|mesh-list
780160|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
780161|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780162|NCT02654665|Incretins|incretins|mesh-ancestor
780163|NCT02654665|Hormones|hormones|mesh-ancestor
780164|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
780207|NCT02654405|Butyric Acid|butyric acid|mesh-list
780208|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
780209|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
780210|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
780211|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780212|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095194|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2095195|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2095196|NCT02289222|Growth Substances|growth substances|mesh-ancestor
780380|NCT02653742|Ketorolac|ketorolac|mesh-list
780381|NCT02653742|Fentanyl|fentanyl|mesh-list
780382|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
780383|NCT02653742|Narcotics|narcotics|mesh-ancestor
780384|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
780385|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780386|NCT02653742|Analgesics|analgesics|mesh-ancestor
780387|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
780388|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
780389|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
780390|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
780391|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
780392|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
2754027|NCT01999179|Dalteparin|dalteparin|mesh-list
779675|NCT02656095|Heparin|heparin|mesh-list
779676|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
779677|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
779678|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
779679|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779792|NCT02655965|Clonidine|clonidine|mesh-list
779793|NCT02655965|Ropivacaine|ropivacaine|mesh-list
779794|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
779795|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
779796|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779797|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779798|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
779799|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779800|NCT02655965|Analgesics|analgesics|mesh-ancestor
779801|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
779802|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
779803|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
779804|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
779805|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
779806|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
779807|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
779808|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
779809|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779941|NCT02655380|Ketamine|ketamine|mesh-list
779942|NCT02655380|Remifentanil|remifentanil|mesh-list
779943|NCT02655380|Analgesics|analgesics|mesh-ancestor
779944|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
779945|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779946|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779947|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
779948|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
779949|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
779950|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
779951|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779952|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
779953|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
779954|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
779955|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779956|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
779957|NCT02655380|Narcotics|narcotics|mesh-ancestor
2241840|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2241841|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241842|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241843|NCT00103389|Docetaxel|docetaxel|mesh-list
2241844|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241845|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
2241846|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
2241847|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
2241848|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241849|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
2241850|NCT00103519|Hormones|hormones|mesh-ancestor
2241851|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2241852|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241853|NCT00103545|Abagovomab|abagovomab|mesh-list
2241854|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2241855|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241856|NCT00103571|Olanzapine|olanzapine|mesh-list
2241857|NCT00103571|Aripiprazole|aripiprazole|mesh-list
2241858|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
2241859|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
781302|NCT02650713|Atezolizumab|atezolizumab|mesh-list
781303|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781522|NCT02649829|Vaccines|vaccines|mesh-list
781523|NCT02649829|Immunologic Factors|immunologic factors|mesh-ancestor
781524|NCT02649829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095197|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
2095198|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2241860|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2241861|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241862|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2241863|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2241864|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
779680|NCT02656082|Etanercept|etanercept|mesh-list
779681|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
779682|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
779683|NCT02656082|Analgesics|analgesics|mesh-ancestor
779684|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
779685|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779686|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779687|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
779688|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
779689|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
779690|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
779691|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
779856|NCT02655614|Midazolam|midazolam|mesh-list
779857|NCT02655614|Caffeine|caffeine|mesh-list
779858|NCT02655614|Rabeprazole|rabeprazole|mesh-list
779859|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
779860|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
779861|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779862|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779863|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
779864|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
779865|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
779866|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
779867|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
779868|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
779869|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
779870|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
779871|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
779872|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779873|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
779874|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
779875|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779876|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
779877|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
779878|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
779879|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
779880|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
779881|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2241865|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2241866|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2241867|NCT00103571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2241868|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2241869|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
780218|NCT02654106|Temozolomide|temozolomide|mesh-list
780219|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
780220|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
780221|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780222|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241870|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241871|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241872|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
2241873|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
2241874|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
2241875|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
2241876|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2241877|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2241878|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2241879|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2241880|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2241881|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2241882|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
2241883|NCT00103597|Domperidone|domperidone|mesh-list
2241884|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
2241885|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
2241886|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2241887|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241888|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2241889|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2241890|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
2241891|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241892|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241893|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2241894|NCT00103623|Abarelix|abarelix|mesh-list
2241895|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
2754028|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
779692|NCT02656121|Vitamin D|vitamin d|mesh-list
779693|NCT02656121|Clomiphene|clomiphene|mesh-list
779694|NCT02656121|Vitamins|vitamins|mesh-ancestor
779695|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
779696|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779697|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
779698|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
779699|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
779700|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
779701|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
779702|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
779703|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
779704|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
779705|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2241896|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2241897|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780738|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
780739|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
780740|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
780741|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
780742|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780743|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
780744|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
780745|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
780746|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
780747|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780748|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
780749|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
780750|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
780751|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
780752|NCT02652429|Protective Agents|protective agents|mesh-ancestor
781139|NCT02651324|Ketamine|ketamine|mesh-list
781140|NCT02651324|Analgesics|analgesics|mesh-ancestor
781141|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
781142|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781143|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781144|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
781145|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
781146|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
781147|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
781148|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
781149|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
781150|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
781151|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
781152|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781810|NCT02648412|Ketamine|ketamine|mesh-list
781811|NCT02648412|Analgesics|analgesics|mesh-ancestor
781812|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
781813|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781814|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781815|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
781816|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
781817|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
781818|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
781819|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
781820|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
781821|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
781822|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
781823|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782004|NCT02647385|Lidocaine|lidocaine|mesh-list
782005|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
782006|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
782007|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782008|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782009|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
782010|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782011|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
782012|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
782013|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
782014|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
782015|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782318|NCT02646670|Ranibizumab|ranibizumab|mesh-list
782319|NCT02646670|Aflibercept|aflibercept|mesh-list
779709|NCT02656342|Renal Agents|renal agents|mesh-ancestor
779710|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
779711|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
779712|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
779713|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
779714|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779916|NCT02655536|Bevacizumab|bevacizumab|mesh-list
779917|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
779918|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
779919|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779920|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
779921|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
779922|NCT02655536|Growth Substances|growth substances|mesh-ancestor
779923|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779924|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
779925|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
779926|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779927|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780237|NCT02654041|Methimazole|methimazole|mesh-list
780238|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
780239|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
780240|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
780241|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241898|NCT00103649|Xaliproden|xaliproden|mesh-list
2241899|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2241900|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2241901|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
2241902|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241903|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241904|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241905|NCT00103701|Dasatinib|dasatinib|mesh-list
2095199|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2095200|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2095201|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2095202|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2095203|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
2095204|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095205|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095206|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095207|NCT02289417|Apremilast|apremilast|mesh-list
2095208|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2095209|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2241906|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781635|NCT02649140|Acetic Acid|acetic acid|mesh-list
781636|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
781637|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781688|NCT02648906|Choline|choline|mesh-list
781689|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
781690|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
781691|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
781692|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781693|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
781694|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
781695|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
2241907|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
782155|NCT02646904|Beclomethasone|beclomethasone|mesh-list
782156|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
782157|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
782158|NCT02646904|Hormones|hormones|mesh-ancestor
782159|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
782160|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782161|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
782162|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
782264|NCT02646592|Alfentanil|alfentanil|mesh-list
782265|NCT02646592|Propofol|propofol|mesh-list
782266|NCT02646592|Sevoflurane|sevoflurane|mesh-list
782267|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
782268|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782269|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782270|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
782271|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
782272|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
782273|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
782274|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
779719|NCT02656251|Ethanol|ethanol|mesh-list
779720|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
779721|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
779722|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
779723|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
779724|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779725|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779726|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
779727|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
779783|NCT02655770|Liraglutide|liraglutide|mesh-list
779784|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
779785|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779786|NCT02655770|Incretins|incretins|mesh-ancestor
779787|NCT02655770|Hormones|hormones|mesh-ancestor
779788|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
779966|NCT02655458|Lenalidomide|lenalidomide|mesh-list
779967|NCT02655458|Elotuzumab|elotuzumab|mesh-list
779968|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
779969|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779970|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
779971|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
779972|NCT02655458|Growth Substances|growth substances|mesh-ancestor
779973|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
779974|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
780104|NCT02654990|Dexamethasone|dexamethasone|mesh-list
780105|NCT02654990|Bortezomib|bortezomib|mesh-list
780106|NCT02654990|Panobinostat|panobinostat|mesh-list
780107|NCT02654990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
780108|NCT02654990|Antiemetics|antiemetics|mesh-ancestor
780109|NCT02654990|Autonomic Agents|autonomic agents|mesh-ancestor
780110|NCT02654990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
780111|NCT02654990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780112|NCT02654990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
780113|NCT02654990|Glucocorticoids|glucocorticoids|mesh-ancestor
780114|NCT02654990|Hormones|hormones|mesh-ancestor
780115|NCT02654990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
780116|NCT02654990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
780117|NCT02654990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
780118|NCT02654990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
780119|NCT02654990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780120|NCT02654990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780366|NCT02653703|Ethanol|ethanol|mesh-list
780367|NCT02653703|Menthol|menthol|mesh-list
780368|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
780369|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
780370|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
780371|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780372|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
780373|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
780519|NCT02653209|Pioglitazone|pioglitazone|mesh-list
780520|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
780521|NCT02653209|Canagliflozin|canagliflozin|mesh-list
780522|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
780523|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780524|NCT02653209|Incretins|incretins|mesh-ancestor
780525|NCT02653209|Hormones|hormones|mesh-ancestor
780526|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
780527|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
780528|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
780529|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780530|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780531|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
780676|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
780677|NCT02652806|Hematinics|hematinics|mesh-ancestor
2241908|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241909|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241910|NCT00103727|Risperidone|risperidone|mesh-list
781304|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
781305|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
781306|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
781307|NCT02650609|Prednisolone|prednisolone|mesh-list
781308|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
781309|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
781310|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
781311|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
781312|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
781313|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
2241911|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2241912|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
2241913|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241914|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241915|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241916|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2241917|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
779847|NCT02655601|Manganese|manganese|mesh-list
779848|NCT02655601|Temozolomide|temozolomide|mesh-list
779849|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
779850|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
779851|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779852|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779853|NCT02655601|Trace Elements|trace elements|mesh-ancestor
779854|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
779855|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241918|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2241919|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2241920|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2241921|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
2241922|NCT00103753|Deferiprone|deferiprone|mesh-list
2241923|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2241924|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
2241925|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
2241926|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241927|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
780321|NCT02653898|Artesunate|artesunate|mesh-list
780322|NCT02653898|Piperaquine|piperaquine|mesh-list
780323|NCT02653898|Primaquine|primaquine|mesh-list
780324|NCT02653898|Artenimol|artenimol|mesh-list
780325|NCT02653898|Mefloquine|mefloquine|mesh-list
780326|NCT02653898|Permethrin|permethrin|mesh-list
780327|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
780328|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
780329|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
780330|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
780331|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
780332|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
780333|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
780334|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
780335|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
780336|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780337|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780638|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
780639|NCT02652650|Norethindrone|norethindrone|mesh-list
780640|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
780641|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
780642|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
780643|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
780644|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
780645|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
780646|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780647|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
780648|NCT02652650|Estrogens|estrogens|mesh-ancestor
780649|NCT02652650|Hormones|hormones|mesh-ancestor
780650|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
780651|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2095210|NCT02289417|Analgesics|analgesics|mesh-ancestor
2095211|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
2095212|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095213|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095214|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2095215|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2095216|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2095217|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2095218|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095219|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095220|NCT02289456|Paclitaxel|paclitaxel|mesh-list
2095221|NCT02289456|Carboplatin|carboplatin|mesh-list
2095222|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2095223|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095224|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
2095225|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
2095226|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
2095227|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095228|NCT02289690|Carboplatin|carboplatin|mesh-list
2241928|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2241929|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2241930|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241931|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
2241932|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2241933|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241934|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
2241935|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
2241936|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2241937|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
2241938|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241939|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2241940|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2241941|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
2241942|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241943|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241944|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2241945|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2241946|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2241947|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
2241948|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2241949|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2241950|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241951|NCT00103805|Levodopa|levodopa|mesh-list
2241952|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2241953|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2241954|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
2241955|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241956|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241957|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241958|NCT00103818|Gaboxadol|gaboxadol|mesh-list
2241959|NCT00103818|Analgesics|analgesics|mesh-ancestor
2241960|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
2241961|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2241962|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241963|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
781539|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
781540|NCT02649504|Dexamethasone|dexamethasone|mesh-list
781541|NCT02649504|Rituximab|rituximab|mesh-list
781542|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
781543|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
781544|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
781545|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781546|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781547|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
781548|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
781549|NCT02649504|Hormones|hormones|mesh-ancestor
781550|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
781551|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
781552|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781553|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
781554|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
781555|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
781556|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
781557|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
781558|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
781559|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
781560|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781561|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781562|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781618|NCT02649179|Ropivacaine|ropivacaine|mesh-list
781619|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
781620|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
781621|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
781622|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781623|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
781624|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781743|NCT02648711|Leucovorin|leucovorin|mesh-list
781744|NCT02648711|Bevacizumab|bevacizumab|mesh-list
781745|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
781746|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
781747|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781748|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
781749|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
781750|NCT02648711|Growth Substances|growth substances|mesh-ancestor
2241964|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
2241965|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
2241966|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241967|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241968|NCT00103831|Taxane|taxane|mesh-list
2241969|NCT00103831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2241970|NCT00103922|Cilomilast|cilomilast|mesh-list
2241971|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
780730|NCT02652273|Abatacept|abatacept|mesh-list
780731|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
780732|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780733|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
780734|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
780735|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
780736|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780737|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
780919|NCT02652091|Interferons|interferons|mesh-list
780920|NCT02652091|Interferon-beta|interferon-beta|mesh-list
780921|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
780922|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
780923|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
780924|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
780925|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
780926|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780927|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2241972|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2241973|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241974|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241975|NCT00103935|Exenatide|exenatide|mesh-list
2241976|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2241977|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241978|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2241979|NCT00103935|Incretins|incretins|mesh-ancestor
2241980|NCT00103935|Hormones|hormones|mesh-ancestor
2241981|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
781372|NCT02650544|Mirtazapine|mirtazapine|mesh-list
781373|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
781374|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
781375|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
781376|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
781377|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
781378|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
781379|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781380|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781381|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
781382|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
781383|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
781384|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
781385|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
781386|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
781387|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
781388|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
781389|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
781390|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
781391|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
781517|NCT02649582|Temozolomide|temozolomide|mesh-list
781518|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
781519|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
781520|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781521|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781891|NCT02648048|Pirfenidone|pirfenidone|mesh-list
781892|NCT02648048|Analgesics|analgesics|mesh-ancestor
781893|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
781894|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781895|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781896|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
781897|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
781898|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
781899|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
781900|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782016|NCT02647437|Levetiracetam|levetiracetam|mesh-list
782017|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
782018|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
2241982|NCT00103948|Donepezil|donepezil|mesh-list
2241983|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
779759|NCT02655692|Ketamine|ketamine|mesh-list
779760|NCT02655692|Analgesics|analgesics|mesh-ancestor
779761|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
779762|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779763|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779764|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
779765|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
779766|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
779767|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
779768|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779769|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
779770|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
779771|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
779772|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779928|NCT02655471|Zidovudine|zidovudine|mesh-list
779929|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
779930|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
779931|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779932|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
779933|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
779934|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779935|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
779936|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
779937|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
779938|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
779939|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
779940|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
780180|NCT02654730|Piperaquine|piperaquine|mesh-list
780181|NCT02654730|Primaquine|primaquine|mesh-list
780182|NCT02654730|Artenimol|artenimol|mesh-list
780183|NCT02654730|Artemisinins|artemisinins|mesh-list
780184|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
780185|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
780186|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
780187|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
780226|NCT02654288|Gemcitabine|gemcitabine|mesh-list
780227|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
780228|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
780229|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780230|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
780231|NCT02654288|Antiviral Agents|antiviral agents|mesh-ancestor
780232|NCT02654288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
780233|NCT02654288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780234|NCT02654288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
780235|NCT02654288|Immunologic Factors|immunologic factors|mesh-ancestor
780236|NCT02654288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780338|NCT02653833|Tadalafil|tadalafil|mesh-list
780339|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
780340|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
780341|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
780342|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780343|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780344|NCT02653833|Urological Agents|urological agents|mesh-ancestor
780605|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
780606|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
780607|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
780608|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
780609|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780610|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
780611|NCT02653014|Diuretics|diuretics|mesh-ancestor
780612|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
780613|NCT02653014|Hormones|hormones|mesh-ancestor
781074|NCT02651844|Mifepristone|mifepristone|mesh-list
781075|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
781076|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
781077|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
781078|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781079|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
781080|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
781081|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
781082|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
781083|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
781084|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
781085|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
781086|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
779779|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
779780|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
779781|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
779782|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780684|NCT02652598|Tolcapone|tolcapone|mesh-list
780685|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
780686|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
780687|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
780688|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780689|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781090|NCT02651662|Cemiplimab|cemiplimab|mesh-list
781091|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
781092|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781513|NCT02649686|Trastuzumab|trastuzumab|mesh-list
781514|NCT02649686|Durvalumab|durvalumab|mesh-list
781515|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
781516|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782037|NCT02647554|Urinastatin|urinastatin|mesh-list
782038|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
782039|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
782040|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
782041|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782042|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782104|NCT02646982|Candesartan|candesartan|mesh-list
782105|NCT02646982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
782106|NCT02646982|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
782107|NCT02646982|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
782108|NCT02646982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782233|NCT02646709|Ketamine|ketamine|mesh-list
782234|NCT02646709|Rocuronium|rocuronium|mesh-list
782235|NCT02646709|Analgesics|analgesics|mesh-ancestor
782236|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
782237|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782238|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782239|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
782240|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
782241|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
782242|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
782243|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782244|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
782245|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
782246|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
782247|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782248|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
782249|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
782250|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
782482|NCT02645981|Sorafenib|sorafenib|mesh-list
782483|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782484|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
782485|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782486|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782926|NCT02644057|Dobutamine|dobutamine|mesh-list
782927|NCT02644057|Milrinone|milrinone|mesh-list
782928|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
782929|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
782930|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
782931|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782932|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782933|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
782934|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
782935|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
782936|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
782937|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
782938|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782939|NCT02644057|Protective Agents|protective agents|mesh-ancestor
779789|NCT02655874|Vaccines|vaccines|mesh-list
779790|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
779791|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241984|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2241985|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241986|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
2241987|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241988|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241989|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
2241990|NCT00104013|Xaliproden|xaliproden|mesh-list
2241991|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2241992|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2241993|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
2241994|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2241995|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2241996|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2241997|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
2241998|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
2241999|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
2242000|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
2242001|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242002|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242003|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
2242004|NCT00104169|Hematinics|hematinics|mesh-ancestor
781824|NCT02648490|Acetaminophen|acetaminophen|mesh-list
781825|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
781826|NCT02648490|Promethazine|promethazine|mesh-list
781827|NCT02648490|Dexamethasone|dexamethasone|mesh-list
781828|NCT02648490|Cetuximab|cetuximab|mesh-list
781829|NCT02648490|Ondansetron|ondansetron|mesh-list
781830|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
781831|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
781832|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
781833|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781834|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781835|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
781836|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
781837|NCT02648490|Hormones|hormones|mesh-ancestor
781838|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
781839|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
781840|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781841|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
781842|NCT02648490|Analgesics|analgesics|mesh-ancestor
781843|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
781844|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
781845|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
781846|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
781847|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
781848|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
781849|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
781850|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781851|NCT02648490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
781852|NCT02648490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
781853|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
781854|NCT02648490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
781855|NCT02648490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
781856|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
781857|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
781858|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
781859|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
781860|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
781861|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
781862|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
781863|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
781864|NCT02648490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
782447|NCT02645747|Aflibercept|aflibercept|mesh-list
782448|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
782449|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
782450|NCT02645747|Growth Substances|growth substances|mesh-ancestor
782451|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782452|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
782453|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782604|NCT02645240|Heparin|heparin|mesh-list
782605|NCT02645240|Calcium heparin|calcium heparin|mesh-list
782606|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
782607|NCT02645240|Tinzaparin|tinzaparin|mesh-list
782608|NCT02645240|Dalteparin|dalteparin|mesh-list
782609|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
779810|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
779811|NCT02655913|Vitamins|vitamins|mesh-ancestor
779812|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
779813|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779814|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
779815|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779816|NCT02655913|Protective Agents|protective agents|mesh-ancestor
2242005|NCT00104182|Insulin|insulin|mesh-list
2242006|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2242007|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
2242008|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
2242009|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
2242010|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
2242011|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2242012|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242013|NCT00104260|Verapamil|verapamil|mesh-list
2242014|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2242015|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2242016|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2242017|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242018|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2242019|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242020|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
2242021|NCT00104273|Rasagiline|rasagiline|mesh-list
2242022|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2242023|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242024|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242025|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2242026|NCT00104273|Protective Agents|protective agents|mesh-ancestor
2242027|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242028|NCT00104286|Troxacitabine|troxacitabine|mesh-list
2242029|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242030|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2242031|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2242032|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
2242033|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2242034|NCT00104403|Dexamethasone|dexamethasone|mesh-list
2242035|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
2242036|NCT00104403|Ondansetron|ondansetron|mesh-list
2242037|NCT00104403|Casopitant|casopitant|mesh-list
2242038|NCT00104403|BB 1101|bb 1101|mesh-list
2242039|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2242040|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
2242041|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
2242042|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242043|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242044|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2242045|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
2242046|NCT00104403|Hormones|hormones|mesh-ancestor
2242047|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2242048|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2242049|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242050|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
2242051|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242052|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242053|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
2242054|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
2242055|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2242056|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
2242057|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242058|NCT00104403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2242059|NCT00104403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2242060|NCT00104403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2242061|NCT00104403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2242062|NCT00104403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2242063|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2242064|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2242065|NCT00104429|Aplaviroc|aplaviroc|mesh-list
2242066|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2242067|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2242068|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242069|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242070|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
2242071|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2242072|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2242073|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
779817|NCT02655822|Atezolizumab|atezolizumab|mesh-list
779818|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779980|NCT02655276|Glycine|glycine|mesh-list
779981|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
779982|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
779983|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779984|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780420|NCT02653638|Indomethacin|indomethacin|mesh-list
780421|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
780422|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
780423|NCT02653638|Analgesics|analgesics|mesh-ancestor
780424|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
780425|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
780426|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780427|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
780428|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
780429|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
780430|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
780431|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
780432|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
780433|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780434|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780505|NCT02653339|Loratadine|loratadine|mesh-list
780506|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
780507|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
780508|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
780509|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
780510|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
780511|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
780512|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
780513|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
780514|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780515|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242074|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2242075|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2242076|NCT00104442|Rivastigmine|rivastigmine|mesh-list
2242077|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2242078|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242079|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242080|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
2242081|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242082|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242083|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2242084|NCT00104442|Protective Agents|protective agents|mesh-ancestor
2242085|NCT00104468|Troxacitabine|troxacitabine|mesh-list
2242086|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242087|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2242088|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2242089|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
2242090|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2242091|NCT00104546|Vitamin K|vitamin k|mesh-list
781483|NCT02649998|Furosemide|furosemide|mesh-list
781484|NCT02649998|Isosorbide|isosorbide|mesh-list
781485|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
781486|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
781487|NCT02649998|Diuretics|diuretics|mesh-ancestor
781488|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
781489|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781490|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
781491|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
781492|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781493|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
781494|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
781495|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2242092|NCT00104546|Vitamins|vitamins|mesh-ancestor
2242093|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
2242094|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242095|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2242096|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2242097|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242098|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
2242099|NCT00104546|Coagulants|coagulants|mesh-ancestor
782052|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
782053|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2242100|NCT00104598|Bupropion|bupropion|mesh-list
2242101|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2242102|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
2242103|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2242104|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2242105|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2242106|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2242107|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242108|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
779958|NCT02655198|Fenfluramine|fenfluramine|mesh-list
779959|NCT02655198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
779960|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
779961|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
779962|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
779963|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
779964|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
779965|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095229|NCT02289690|Etoposide|etoposide|mesh-list
2095230|NCT02289690|Veliparib|veliparib|mesh-list
2095231|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095232|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2095233|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
781680|NCT02648854|Metformin|metformin|mesh-list
781681|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
781682|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782354|NCT02646319|Sirolimus|sirolimus|mesh-list
782355|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
782356|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
782357|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
782358|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782359|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
782360|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
782361|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
782362|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782987|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
782988|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
782989|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
782990|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
782991|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782992|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
782993|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
782994|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242109|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242110|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242111|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2242112|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2242113|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242114|NCT00104624|Docetaxel|docetaxel|mesh-list
2242115|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242116|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
2242117|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
783734|NCT02641236|Vancomycin|vancomycin|mesh-list
783735|NCT02641236|Polymyxins|polymyxins|mesh-list
783736|NCT02641236|Polymyxin B|polymyxin b|mesh-list
783737|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
783738|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784093|NCT02639806|Lidocaine|lidocaine|mesh-list
784094|NCT02639806|Sevoflurane|sevoflurane|mesh-list
784095|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
784096|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
784097|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784098|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784099|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
784100|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
784101|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
784102|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
784103|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
784104|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
784105|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784106|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
784107|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
784108|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
784169|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
784170|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
784171|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
784172|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
779882|NCT02655523|Dexamethasone|dexamethasone|mesh-list
779883|NCT02655523|Triamcinolone|triamcinolone|mesh-list
779884|NCT02655523|Bupivacaine|bupivacaine|mesh-list
779885|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
779886|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
779887|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
779888|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
779889|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
779890|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
779891|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
779892|NCT02655523|Hormones|hormones|mesh-ancestor
779893|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
779894|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
779895|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
779896|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
779897|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
779898|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
779899|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
2242118|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
2242119|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242120|NCT00104663|Quinacrine|quinacrine|mesh-list
2242121|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
2242122|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2242123|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
2242124|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2242125|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
780191|NCT02654379|Rituximab|rituximab|mesh-list
780192|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
780193|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
780194|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
780195|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780196|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
780652|NCT02652637|Metronidazole|metronidazole|mesh-list
780653|NCT02652637|Neomycin|neomycin|mesh-list
780654|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
780655|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
780656|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
780657|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
780658|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
780659|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780660|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781450|NCT02649920|Dinoprostone|dinoprostone|mesh-list
781451|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
781452|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
781453|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781528|NCT02649673|Topotecan|topotecan|mesh-list
781529|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
781530|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
781531|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781532|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781533|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754029|NCT01999179|Dabigatran|dabigatran|mesh-list
2754030|NCT01999179|Apixaban|apixaban|mesh-list
2754031|NCT01999179|Edoxaban|edoxaban|mesh-list
2754032|NCT01999179|Anticoagulants|anticoagulants|mesh-list
2754033|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2754034|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2754035|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754036|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2754037|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
2754038|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
783037|NCT02643732|Methylphenidate|methylphenidate|mesh-list
783038|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
783039|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783040|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
783041|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
783042|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
783043|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783044|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
783045|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242126|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
2242127|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2242128|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
2242129|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242130|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754039|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
2754040|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242131|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242132|NCT00104689|Capecitabine|capecitabine|mesh-list
2242133|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
2242134|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2242135|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
780153|NCT02654561|Heparin|heparin|mesh-list
780154|NCT02654561|Calcium heparin|calcium heparin|mesh-list
780155|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
780156|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
780157|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
780158|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780486|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
780487|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
780488|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
780489|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780490|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
780491|NCT02653261|Coagulants|coagulants|mesh-ancestor
780907|NCT02652169|Amikacin|amikacin|mesh-list
780908|NCT02652169|Teicoplanin|teicoplanin|mesh-list
780909|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
780910|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781717|NCT02648425|Leucovorin|leucovorin|mesh-list
781718|NCT02648425|Cisplatin|cisplatin|mesh-list
781719|NCT02648425|Fluorouracil|fluorouracil|mesh-list
781720|NCT02648425|Capecitabine|capecitabine|mesh-list
781721|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781722|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
781723|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781724|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
781725|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
781726|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
781727|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781728|NCT02648425|Antidotes|antidotes|mesh-ancestor
781729|NCT02648425|Protective Agents|protective agents|mesh-ancestor
781730|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
781731|NCT02648425|Vitamins|vitamins|mesh-ancestor
781732|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
2242136|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242137|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242138|NCT00104715|Docetaxel|docetaxel|mesh-list
2242139|NCT00104715|Goserelin|goserelin|mesh-list
2242140|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
2242141|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242142|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
2242143|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
2242144|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
2242145|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242146|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2242147|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
2242148|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2242149|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242150|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2242151|NCT00104741|Flutamide|flutamide|mesh-list
2242152|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
2242153|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2242154|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
782019|NCT02647424|Letrozole|letrozole|mesh-list
782020|NCT02647424|Clomiphene|clomiphene|mesh-list
782021|NCT02647424|Enclomiphene|enclomiphene|mesh-list
782022|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
782023|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782024|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
782025|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
782026|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782027|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782028|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
782029|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
782030|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
782031|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782032|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
782033|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
782034|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
782035|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
782036|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
782163|NCT02647099|Aspirin|aspirin|mesh-list
782164|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
782275|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
779975|NCT02655315|Deferiprone|deferiprone|mesh-list
779976|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
779977|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
779978|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
779979|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242155|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2242156|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242157|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2242158|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2242159|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754041|NCT01979536|Cytarabine|cytarabine|mesh-list
2095234|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2095235|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095236|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095237|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2095238|NCT02289833|Trastuzumab|trastuzumab|mesh-list
2095239|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2095240|NCT02289833|Maytansine|maytansine|mesh-list
2095241|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2095242|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095243|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2095244|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
2095245|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
2095246|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
2095247|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780858|NCT02652312|Diclofenac|diclofenac|mesh-list
780859|NCT02652312|Fentanyl|fentanyl|mesh-list
780860|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
780861|NCT02652312|Ondansetron|ondansetron|mesh-list
780862|NCT02652312|Propofol|propofol|mesh-list
780863|NCT02652312|Desflurane|desflurane|mesh-list
780864|NCT02652312|Atracurium|atracurium|mesh-list
780865|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
780866|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
780867|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780868|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
780869|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
780870|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
780871|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
780872|NCT02652312|Analgesics|analgesics|mesh-ancestor
780873|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
780874|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
780875|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
780876|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
780877|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
780878|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
780879|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
780880|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780881|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
780882|NCT02652312|Narcotics|narcotics|mesh-ancestor
780883|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
780884|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
780885|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
780886|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
780887|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
780888|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
780889|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
780890|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
780891|NCT02652312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
780892|NCT02652312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
780893|NCT02652312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
780894|NCT02652312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
780895|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
780896|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
780897|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
780898|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
780899|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780900|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
780901|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
780902|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
780903|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
780904|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
780905|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
780906|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
2754042|NCT01979536|Dexamethasone|dexamethasone|mesh-list
2754043|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
2754044|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
780094|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
780095|NCT02654834|Anesthetics|anesthetics|mesh-list
780096|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
780097|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780098|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
780099|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
780100|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
780101|NCT02654834|Analgesics|analgesics|mesh-ancestor
780102|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
780103|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
780345|NCT02654119|Paclitaxel|paclitaxel|mesh-list
780346|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
780347|NCT02654119|Trastuzumab|trastuzumab|mesh-list
780348|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
780349|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
780350|NCT02654119|Antibodies|antibodies|mesh-list
780351|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
780352|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
780353|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
780354|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
780355|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
780356|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
780357|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
780358|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780359|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
780360|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
780361|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780362|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
780363|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
780364|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
780365|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
781597|NCT02649465|Glimepiride|glimepiride|mesh-list
781598|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
781599|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
781600|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
781601|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781602|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
781603|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
781604|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
781605|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782192|NCT02647086|Metoprolol|metoprolol|mesh-list
782193|NCT02647086|Midazolam|midazolam|mesh-list
782194|NCT02647086|Caffeine|caffeine|mesh-list
782195|NCT02647086|Omeprazole|omeprazole|mesh-list
782196|NCT02647086|Warfarin|warfarin|mesh-list
782197|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
782198|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
782199|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782200|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782201|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
782202|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
782203|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
782204|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
782205|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
782206|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
782207|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
782208|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
782209|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
782210|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782211|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
782212|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
782213|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
782214|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
782215|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782216|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
782217|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
782218|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
782219|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
782220|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
782221|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
782222|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
782223|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
782224|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
782225|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782226|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
780121|NCT02654847|Norepinephrine|norepinephrine|mesh-list
780122|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
780123|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
780124|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
780125|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
780126|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780127|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780128|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
780129|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
780130|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
780131|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
780251|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
780252|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
780253|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
780254|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780255|NCT02654093|Vitamins|vitamins|mesh-ancestor
780256|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
780257|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
780258|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
780259|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
780260|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
780261|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
780262|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
781173|NCT02651311|Ibuprofen|ibuprofen|mesh-list
781174|NCT02651311|Fentanyl|fentanyl|mesh-list
781175|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
781176|NCT02651311|Narcotics|narcotics|mesh-ancestor
781177|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
781178|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781179|NCT02651311|Analgesics|analgesics|mesh-ancestor
781180|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
781181|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781182|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
781183|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
781184|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
781185|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
781186|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
781187|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
781188|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
781189|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
781190|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
781191|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781192|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781683|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
781684|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
781685|NCT02649075|Antibodies|antibodies|mesh-list
781686|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
781687|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095248|NCT02289898|Gemcitabine|gemcitabine|mesh-list
2095249|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2095250|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2095251|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
2095252|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095253|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095254|NCT02289898|Antiviral Agents|antiviral agents|mesh-ancestor
2095255|NCT02289898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2095256|NCT02289898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095257|NCT02289898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2095258|NCT02289898|Immunologic Factors|immunologic factors|mesh-ancestor
2095259|NCT02289898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095260|NCT02289950|Farletuzumab|farletuzumab|mesh-list
2095261|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095262|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2095263|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
2095264|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095265|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
2095266|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2095267|NCT02290106|Pitavastatin|pitavastatin|mesh-list
782637|NCT02645032|Vaccines|vaccines|mesh-list
782638|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
782639|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783424|NCT02642315|Gabapentin|gabapentin|mesh-list
783425|NCT02642315|Analgesics|analgesics|mesh-ancestor
783426|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
783427|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242160|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
780132|NCT02654743|Sulforaphane|sulforaphane|mesh-list
780133|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
780134|NCT02654743|Protective Agents|protective agents|mesh-ancestor
780135|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780136|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242161|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
2242162|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2242163|NCT00104767|Celecoxib|celecoxib|mesh-list
2242164|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2242165|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2242166|NCT00104767|Analgesics|analgesics|mesh-ancestor
2242167|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
2242168|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242169|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242170|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2242171|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2242172|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2242173|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2242174|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754045|NCT01979536|Ifosfamide|ifosfamide|mesh-list
2754046|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
780941|NCT02652065|Acetylcholine|acetylcholine|mesh-list
780942|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
780943|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
780944|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
780945|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
780946|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780947|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781063|NCT02651636|Folic Acid|folic acid|mesh-list
781064|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
781065|NCT02651636|Inositol|inositol|mesh-list
781066|NCT02651636|Hematinics|hematinics|mesh-ancestor
781067|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
781068|NCT02651636|Vitamins|vitamins|mesh-ancestor
781069|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
781070|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781071|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
781072|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781073|NCT02651636|Protective Agents|protective agents|mesh-ancestor
2095268|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2095269|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2095270|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2095271|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
2095272|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095273|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095274|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2754047|NCT01979536|Doxorubicin|doxorubicin|mesh-list
2754048|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2754049|NCT01979536|Methotrexate|methotrexate|mesh-list
2754050|NCT01979536|Etoposide|etoposide|mesh-list
2754051|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
2754052|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2754053|NCT01979536|Crizotinib|crizotinib|mesh-list
2754054|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
2754055|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2754056|NCT01979536|Antibodies|antibodies|mesh-list
2754057|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
2754058|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2754059|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
781506|NCT02649751|Roscovitine|roscovitine|mesh-list
781507|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781508|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
781509|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781510|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
781511|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781512|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781758|NCT02648503|Atropine|atropine|mesh-list
781759|NCT02648503|Rocuronium|rocuronium|mesh-list
781760|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
781761|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
781762|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
781763|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
781764|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781765|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781766|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
781767|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
781768|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
781769|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
780173|NCT02654678|Enalapril|enalapril|mesh-list
780174|NCT02654678|Enalaprilat|enalaprilat|mesh-list
780175|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
780176|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
780177|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780178|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780179|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
780374|NCT02653963|Triamcinolone|triamcinolone|mesh-list
780375|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
780376|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
780377|NCT02653963|Hormones|hormones|mesh-ancestor
780378|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
780379|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780780|NCT02652325|Iodine|iodine|mesh-list
780781|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
780782|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
780783|NCT02652325|Povidone|povidone|mesh-list
780784|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
780785|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
780786|NCT02652325|Trace Elements|trace elements|mesh-ancestor
780787|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
780788|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780789|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
780790|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
781288|NCT02650804|Coenzyme Q10|coenzyme q10|mesh-list
781289|NCT02650804|Gemcitabine|gemcitabine|mesh-list
781290|NCT02650804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
781291|NCT02650804|Antimetabolites|antimetabolites|mesh-ancestor
781292|NCT02650804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781293|NCT02650804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781294|NCT02650804|Antiviral Agents|antiviral agents|mesh-ancestor
781295|NCT02650804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781296|NCT02650804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781297|NCT02650804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
781298|NCT02650804|Immunologic Factors|immunologic factors|mesh-ancestor
781299|NCT02650804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781300|NCT02650804|Vitamins|vitamins|mesh-ancestor
781301|NCT02650804|Micronutrients|micronutrients|mesh-ancestor
2754060|NCT01979536|BB 1101|bb 1101|mesh-list
2754061|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2754062|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
2754063|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781795|NCT02648633|Nivolumab|nivolumab|mesh-list
781796|NCT02648633|Valproic Acid|valproic acid|mesh-list
781797|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
781798|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781799|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
781800|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781801|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
781802|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781803|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
781804|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
781805|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781806|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
781807|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
781808|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
781809|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
782072|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
782073|NCT02647268|Oxytocin|oxytocin|mesh-list
782074|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
782075|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
782076|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782077|NCT02647268|Analgesics|analgesics|mesh-ancestor
782078|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
782079|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782080|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
782081|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782082|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
782083|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
782084|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
782085|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
782086|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782087|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
782088|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
782144|NCT02646839|Biotin|biotin|mesh-list
782145|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
782146|NCT02646839|Vitamins|vitamins|mesh-ancestor
782147|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
780188|NCT02654704|Vaccines|vaccines|mesh-list
780189|NCT02654704|Immunologic Factors|immunologic factors|mesh-ancestor
780190|NCT02654704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242175|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242176|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
2242177|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2242178|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
2242179|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242180|NCT00104793|Carboplatin|carboplatin|mesh-list
2242181|NCT00104793|Irinotecan|irinotecan|mesh-list
2242182|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242183|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2242184|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2242185|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242186|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781975|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
781976|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
781977|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781978|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
781979|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782302|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
782303|NCT02646397|Fosinopril|fosinopril|mesh-list
782304|NCT02646397|Benidipine|benidipine|mesh-list
782305|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
782306|NCT02646397|Diuretics|diuretics|mesh-ancestor
782307|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
782308|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782309|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
782310|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
782311|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782312|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
782313|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
782314|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782315|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
782316|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
782317|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
782474|NCT02645903|Morphine|morphine|mesh-list
782475|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782476|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782477|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
782478|NCT02645903|Narcotics|narcotics|mesh-ancestor
782479|NCT02645903|Analgesics|analgesics|mesh-ancestor
782480|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
782481|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782622|NCT02645279|Midazolam|midazolam|mesh-list
782623|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
782624|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
782625|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782626|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782627|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
782628|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
782629|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
782630|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
782631|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
782632|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
782633|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
782634|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
782635|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
782636|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782757|NCT02644811|Anesthetics|anesthetics|mesh-list
782758|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782759|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782921|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
782922|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
782923|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
784438|NCT02638376|Riboflavin|riboflavin|mesh-list
784439|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
784440|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
784441|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
784442|NCT02638376|Vitamins|vitamins|mesh-ancestor
784443|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
784444|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784445|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
784446|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
780197|NCT02654587|Docetaxel|docetaxel|mesh-list
780198|NCT02654587|Pemetrexed|pemetrexed|mesh-list
780199|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
780200|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
780201|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
780202|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
780203|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780204|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780205|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
780206|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
780400|NCT02653651|Lidocaine|lidocaine|mesh-list
780401|NCT02653651|Ketamine|ketamine|mesh-list
780402|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
780403|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
780404|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
780405|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780406|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
780407|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
780408|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
780409|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
780410|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
780411|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
780412|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780413|NCT02653651|Analgesics|analgesics|mesh-ancestor
780414|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
780415|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
780416|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
780417|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
780418|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
780419|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
780697|NCT02652741|Enalapril|enalapril|mesh-list
780698|NCT02652741|Enalaprilat|enalaprilat|mesh-list
780699|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
780700|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
780701|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780702|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780703|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2242187|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
2242188|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
2242189|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2242190|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242191|NCT00104806|Vitamins|vitamins|mesh-ancestor
2242192|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
2242193|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2242194|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242195|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
2242196|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2242197|NCT00104819|Antibodies|antibodies|mesh-list
781093|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
781094|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
781095|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
781096|NCT02651350|Prednisolone|prednisolone|mesh-list
781097|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
781098|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
781099|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
781100|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
781101|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
781102|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
781103|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781104|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781105|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
781106|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
781107|NCT02651350|Hormones|hormones|mesh-ancestor
781108|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
781109|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
781110|NCT02651350|Protective Agents|protective agents|mesh-ancestor
781111|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
781112|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781260|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
781261|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
781262|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
781263|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781264|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
781265|NCT02650791|Coagulants|coagulants|mesh-ancestor
781392|NCT02650479|Exenatide|exenatide|mesh-list
2242198|NCT00104819|Sargramostim|sargramostim|mesh-list
2242199|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2242200|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
2242201|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242202|NCT00104845|Vaccines|vaccines|mesh-list
2242203|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
2242204|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242205|NCT00104910|Cetuximab|cetuximab|mesh-list
2242206|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242207|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2242208|NCT00104923|Fenretinide|fenretinide|mesh-list
2242209|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242210|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2242211|NCT00104923|Protective Agents|protective agents|mesh-ancestor
2242212|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242213|NCT00104949|Trastuzumab|trastuzumab|mesh-list
781980|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
781981|NCT02647671|Calcium|calcium|mesh-list
781982|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
781983|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781984|NCT02647671|Antacids|antacids|mesh-ancestor
781985|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781986|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
782569|NCT02645370|Topiramate|topiramate|mesh-list
782570|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
782571|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
782572|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783568|NCT02641899|Acetaminophen|acetaminophen|mesh-list
783569|NCT02641899|Exenatide|exenatide|mesh-list
783570|NCT02641899|Digoxin|digoxin|mesh-list
783571|NCT02641899|Lisinopril|lisinopril|mesh-list
783572|NCT02641899|Warfarin|warfarin|mesh-list
783573|NCT02641899|Atorvastatin|atorvastatin|mesh-list
783574|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
783575|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
783576|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
783577|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783578|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
783579|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
783580|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783581|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
783582|NCT02641899|Analgesics|analgesics|mesh-ancestor
783583|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
783584|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783585|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783586|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
783587|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
783588|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
783589|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
783590|NCT02641899|Protective Agents|protective agents|mesh-ancestor
783591|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
783592|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
783593|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
783594|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
783595|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
783596|NCT02641899|Incretins|incretins|mesh-ancestor
783597|NCT02641899|Hormones|hormones|mesh-ancestor
783598|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
783956|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
783957|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784081|NCT02639702|Clozapine|clozapine|mesh-list
784082|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
784083|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
784084|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
784085|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784086|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784087|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
784088|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
784089|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784090|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
784091|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
784092|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
2242214|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2242215|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242216|NCT00104962|Lenalidomide|lenalidomide|mesh-list
2242217|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
2242218|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242219|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2754064|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2242220|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2242221|NCT00104962|Growth Substances|growth substances|mesh-ancestor
2242222|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
2242223|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242224|NCT00104975|Fludarabine|fludarabine|mesh-list
780661|NCT02652871|Cytarabine|cytarabine|mesh-list
780662|NCT02652871|Idarubicin|idarubicin|mesh-list
780663|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
780664|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
780665|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780666|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
780667|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
780668|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
780669|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
780670|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
780671|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780672|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
780673|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
780674|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
780675|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242225|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
2242226|NCT00104975|Melphalan|melphalan|mesh-list
2242227|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
2242228|NCT00104975|Thiotepa|thiotepa|mesh-list
2242229|NCT00104975|Tacrolimus|tacrolimus|mesh-list
2242230|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242231|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2242232|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
2242233|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242234|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2242235|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
2242236|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242237|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2242238|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242239|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2242240|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
2242241|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2242242|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2242243|NCT00104988|Thalidomide|thalidomide|mesh-list
2242244|NCT00104988|Temozolomide|temozolomide|mesh-list
780949|NCT02651870|Amlodipine|amlodipine|mesh-list
780950|NCT02651870|Candesartan|candesartan|mesh-list
780951|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
780952|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
780953|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
780954|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780955|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
780956|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780957|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
780958|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
780959|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
781039|NCT02651519|Ropivacaine|ropivacaine|mesh-list
781040|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
781041|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
781042|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
781043|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781044|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
781045|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781201|NCT02651207|Lidocaine|lidocaine|mesh-list
781202|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
781203|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
781204|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
781205|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
781206|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
781207|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781208|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
781209|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781210|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
781211|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
781212|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
781213|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
781214|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781215|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
781252|NCT02650752|Capecitabine|capecitabine|mesh-list
2242245|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
780393|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
780394|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
780395|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
780396|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
780397|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
780398|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780399|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780614|NCT02652793|Lamivudine|lamivudine|mesh-list
780615|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
780616|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
780617|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
780618|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780619|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780620|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
780621|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
780622|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
780623|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
780624|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
780625|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
780626|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
780709|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
780710|NCT02652507|Ketamine|ketamine|mesh-list
780711|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
780712|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
780713|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780714|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
780715|NCT02652507|Analgesics|analgesics|mesh-ancestor
780716|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
780717|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
780718|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
780719|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
780720|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
780721|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
780722|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
780723|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780724|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
780725|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
780726|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
780727|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
780728|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
780729|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
780928|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
780929|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
780930|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
780931|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781122|NCT02651441|Gemcitabine|gemcitabine|mesh-list
781123|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781124|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
781125|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
781126|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781127|NCT02651441|Antiviral Agents|antiviral agents|mesh-ancestor
781128|NCT02651441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781129|NCT02651441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781130|NCT02651441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
781131|NCT02651441|Immunologic Factors|immunologic factors|mesh-ancestor
781132|NCT02651441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781350|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
781351|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
782251|NCT02646683|Vedolizumab|vedolizumab|mesh-list
782252|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
782363|NCT02646267|Warfarin|warfarin|mesh-list
782364|NCT02646267|Dabigatran|dabigatran|mesh-list
782365|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
782366|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
782367|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
782368|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
782369|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782370|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783017|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
783018|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
783019|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
783020|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
2242246|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
2242247|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242248|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242249|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2242250|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
2242251|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242252|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
2242253|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2242254|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2242255|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2242256|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2242257|NCT00104988|Growth Substances|growth substances|mesh-ancestor
2242258|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
2242259|NCT00105040|Levetiracetam|levetiracetam|mesh-list
2242260|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
2242261|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
2242262|NCT00105105|Mifepristone|mifepristone|mesh-list
2242263|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2242264|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
2242265|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2242266|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242267|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2242268|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
780678|NCT02652585|Naltrexone|naltrexone|mesh-list
780679|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
780680|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
780681|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780682|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
780683|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
780999|NCT02651610|Paclitaxel|paclitaxel|mesh-list
781000|NCT02651610|Docetaxel|docetaxel|mesh-list
781001|NCT02651610|Taxane|taxane|mesh-list
781002|NCT02651610|Bavituximab|bavituximab|mesh-list
781003|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
781004|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781005|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
781006|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
781007|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
781008|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781009|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2242269|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2242270|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
2242271|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2242272|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2242273|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
781454|NCT02650102|Olanzapine|olanzapine|mesh-list
781455|NCT02650102|Risperidone|risperidone|mesh-list
781456|NCT02650102|Aripiprazole|aripiprazole|mesh-list
781457|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
781458|NCT02650102|Ziprasidone|ziprasidone|mesh-list
781459|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
781460|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
781461|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
781462|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781463|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781464|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
781465|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
781466|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
781467|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
781468|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
781469|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
781470|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
781471|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
781472|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781473|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
781474|NCT02650102|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
781475|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
781476|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
781477|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
781478|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
781479|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
781480|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
781481|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
781482|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
781534|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
781535|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2242274|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2242275|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
780483|NCT02653235|Vaccines|vaccines|mesh-list
780484|NCT02653235|Immunologic Factors|immunologic factors|mesh-ancestor
780485|NCT02653235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780532|NCT02653027|Ivacaftor|ivacaftor|mesh-list
780533|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
780534|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
780535|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780690|NCT02652728|Enalapril|enalapril|mesh-list
780691|NCT02652728|Enalaprilat|enalaprilat|mesh-list
780692|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
780693|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
780694|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780695|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780696|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
780981|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
780982|NCT02651753|Atorvastatin|atorvastatin|mesh-list
780983|NCT02651753|Fenofibrate|fenofibrate|mesh-list
780984|NCT02651753|Calcium|calcium|mesh-list
780985|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
780986|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780987|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
780988|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
780989|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
780990|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
780991|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780992|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
780993|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
780994|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781362|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
781363|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
781364|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781365|NCT02650427|Incretins|incretins|mesh-ancestor
781366|NCT02650427|Hormones|hormones|mesh-ancestor
781367|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
781368|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
781369|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
781370|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781371|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781434|NCT02650206|Liraglutide|liraglutide|mesh-list
781435|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
781436|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781437|NCT02650206|Incretins|incretins|mesh-ancestor
781438|NCT02650206|Hormones|hormones|mesh-ancestor
781439|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
781921|NCT02647892|Lidocaine|lidocaine|mesh-list
781922|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
781923|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
781924|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
781925|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781926|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
781927|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781928|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
781929|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
781930|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
781931|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
781932|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781994|NCT02647567|Caffeine|caffeine|mesh-list
781995|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
781996|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781997|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
781998|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781999|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782000|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
782001|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
782002|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
782003|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
782300|NCT02646657|Vedolizumab|vedolizumab|mesh-list
782301|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
782338|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
782339|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
782340|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782902|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
782903|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
780492|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
780493|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
780494|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
780495|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780496|NCT02653131|Incretins|incretins|mesh-ancestor
780497|NCT02653131|Hormones|hormones|mesh-ancestor
780498|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
780499|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
780500|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
780501|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780629|NCT02652884|Betamethasone|betamethasone|mesh-list
780630|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
780631|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
780632|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
780633|NCT02652884|Hormones|hormones|mesh-ancestor
780634|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
780635|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
780636|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
780637|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
2242276|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2242277|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2242278|NCT00105144|Caspofungin|caspofungin|mesh-list
2242279|NCT00105144|Micafungin|micafungin|mesh-list
2242280|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
2242281|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2242282|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242283|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242284|NCT00105209|Aspirin|aspirin|mesh-list
2242285|NCT00105209|Clopidogrel|clopidogrel|mesh-list
2242286|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2242287|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2242288|NCT00105209|Analgesics|analgesics|mesh-ancestor
2242289|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
2242290|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242291|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242292|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
781416|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
781417|NCT02650635|Lenograstim|lenograstim|mesh-list
781418|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
781419|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
781420|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781421|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
781422|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
781423|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
781424|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781425|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781426|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
781427|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
781865|NCT02648659|Amoxicillin|amoxicillin|mesh-list
781866|NCT02648659|Metronidazole|metronidazole|mesh-list
781867|NCT02648659|Clarithromycin|clarithromycin|mesh-list
781868|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
781869|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781870|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
781871|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
781872|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
781873|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781874|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781875|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
781876|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
782043|NCT02647632|Ribavirin|ribavirin|mesh-list
782044|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
782045|NCT02647632|Grazoprevir|grazoprevir|mesh-list
782046|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
782047|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782048|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
782049|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
782620|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
782621|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
782860|NCT02644044|Methotrexate|methotrexate|mesh-list
782861|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
782862|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
782863|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
782864|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782865|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2242293|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2242294|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2242295|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2242296|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242297|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
781170|NCT02651038|Micafungin|micafungin|mesh-list
781171|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
781172|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781638|NCT02649413|Prednisone|prednisone|mesh-list
781639|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
781640|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
781641|NCT02649413|Hormones|hormones|mesh-ancestor
781642|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
781643|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781644|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
781645|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781877|NCT02648347|Darbepoetin alfa|darbepoetin alfa|mesh-list
781878|NCT02648347|Hematinics|hematinics|mesh-ancestor
782573|NCT02645461|Palmidrol|palmidrol|mesh-list
782574|NCT02645461|Riluzole|riluzole|mesh-list
782575|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
782576|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
782577|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
782578|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
782579|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782580|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782581|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
782582|NCT02645461|Protective Agents|protective agents|mesh-ancestor
782583|NCT02645461|Analgesics|analgesics|mesh-ancestor
782584|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
782585|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782586|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
782587|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
782588|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
782589|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
782590|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
782591|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
782592|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
782593|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
782594|NCT02645461|Hormones|hormones|mesh-ancestor
782595|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
782675|NCT02644694|Dexamethasone|dexamethasone|mesh-list
782676|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
782677|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
782678|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
782679|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
782680|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
782681|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782682|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782683|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
782684|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
782685|NCT02644694|Hormones|hormones|mesh-ancestor
782686|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
782687|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
782688|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782689|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
782838|NCT02644486|Irbesartan|irbesartan|mesh-list
782839|NCT02644486|Sevelamer|sevelamer|mesh-list
782840|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
782841|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
782842|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
782843|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782844|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
782845|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
783241|NCT02642900|Nystatin|nystatin|mesh-list
783242|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
783243|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
783244|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
783245|NCT02642900|Ionophores|ionophores|mesh-ancestor
783246|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
783247|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783439|NCT02642601|Indomethacin|indomethacin|mesh-list
783440|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
783441|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2754065|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2095292|NCT02290444|Hormones|hormones|mesh-list
2095293|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2095294|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2095295|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
2242298|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2242299|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781022|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
781023|NCT02651623|Sertraline|sertraline|mesh-list
781024|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
781025|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781026|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
781027|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
781028|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781029|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781030|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781031|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781032|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
781033|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
781034|NCT02651623|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
781035|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
781036|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
781037|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
781038|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
782152|NCT02646774|Micafungin|micafungin|mesh-list
782153|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
782154|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2242300|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
2242301|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2242302|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2242303|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2242304|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
2242305|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242306|NCT00105287|Fentanyl|fentanyl|mesh-list
2242307|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2242308|NCT00105287|Narcotics|narcotics|mesh-ancestor
2242309|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2242310|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242311|NCT00105287|Analgesics|analgesics|mesh-ancestor
2242312|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
2242313|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242314|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2242315|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2242316|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
2242317|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
2242318|NCT00105300|Adalimumab|adalimumab|mesh-list
2242319|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2242320|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2242321|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2242322|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2242323|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2242324|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2242325|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242326|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2242327|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2242328|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2242329|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
2242330|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242331|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242332|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2242333|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2242334|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
2242335|NCT00105352|Glucagon|glucagon|mesh-list
2242336|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2242337|NCT00105352|Hormones|hormones|mesh-ancestor
2242338|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2242339|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242340|NCT00105404|Triamcinolone|triamcinolone|mesh-list
2242341|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2242342|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2242343|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2242344|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2242345|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
2242346|NCT00105404|Hormones|hormones|mesh-ancestor
2242347|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2754066|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
2242348|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242349|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
781708|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
781710|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
781711|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781987|NCT02647515|Ranibizumab|ranibizumab|mesh-list
781988|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
781989|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
781990|NCT02647515|Growth Substances|growth substances|mesh-ancestor
781991|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781992|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
781993|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782050|NCT02647190|Asparaginase|asparaginase|mesh-list
782051|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782487|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
782488|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
782489|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
782490|NCT02645565|Prednisolone|prednisolone|mesh-list
782491|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
782492|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
782493|NCT02645565|Azathioprine|azathioprine|mesh-list
782494|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
782495|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
782496|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
782497|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
782498|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782499|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
782500|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
782501|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
782502|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782503|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782504|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
782505|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
782506|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
782507|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
782508|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782509|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
782510|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
782511|NCT02645565|Hormones|hormones|mesh-ancestor
782512|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
782513|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
782514|NCT02645565|Protective Agents|protective agents|mesh-ancestor
782515|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
782516|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
782517|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
782640|NCT02644967|Pembrolizumab|pembrolizumab|mesh-list
782641|NCT02644967|Ipilimumab|ipilimumab|mesh-list
782642|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
782643|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782644|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
782645|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782717|NCT02644616|Torsemide|torsemide|mesh-list
782718|NCT02644616|Tolvaptan|tolvaptan|mesh-list
782719|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
782720|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782721|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
782722|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782723|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
782724|NCT02644616|Diuretics|diuretics|mesh-ancestor
782725|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
782726|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
782808|NCT02644304|Cabergoline|cabergoline|mesh-list
782809|NCT02644304|Clomiphene|clomiphene|mesh-list
782810|NCT02644304|Enclomiphene|enclomiphene|mesh-list
782811|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
782812|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782813|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
782814|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
782815|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
782816|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782817|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
782818|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
782819|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
782820|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
780976|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
780977|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
780978|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
780979|NCT02651792|Narcotics|narcotics|mesh-ancestor
780980|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
781606|NCT02649764|Cytarabine|cytarabine|mesh-list
781607|NCT02649764|Fludarabine|fludarabine|mesh-list
781608|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
781609|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781610|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
781611|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
781612|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781613|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
781614|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
781615|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781616|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
781617|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
782109|NCT02647047|Acetaminophen|acetaminophen|mesh-list
782110|NCT02647047|Ketorolac|ketorolac|mesh-list
782111|NCT02647047|Sufentanil|sufentanil|mesh-list
782112|NCT02647047|Ropivacaine|ropivacaine|mesh-list
782113|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
782114|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
782115|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782116|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782117|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
782118|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782119|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
782120|NCT02647047|Analgesics|analgesics|mesh-ancestor
782121|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
782122|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
782123|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
782124|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
782125|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
782126|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782127|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782128|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
782129|NCT02647047|Narcotics|narcotics|mesh-ancestor
782130|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
782131|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
782132|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
782563|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
782564|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
782565|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
782566|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782567|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
782568|NCT02645552|Coagulants|coagulants|mesh-ancestor
782664|NCT02644954|Metformin|metformin|mesh-list
782665|NCT02644954|Calcipotriene|calcipotriene|mesh-list
782666|NCT02644954|Coal Tar|coal tar|mesh-list
782667|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
782668|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782669|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
782670|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
782793|NCT02644551|Ciclopirox|ciclopirox|mesh-list
782794|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
782795|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
783504|NCT02642003|Sargramostim|sargramostim|mesh-list
783505|NCT02642003|Lenograstim|lenograstim|mesh-list
783506|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
783507|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783508|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2242350|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
2242351|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242352|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242353|NCT00105495|Deferiprone|deferiprone|mesh-list
2242354|NCT00105495|Deferoxamine|deferoxamine|mesh-list
2242355|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
781062|NCT02651727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781163|NCT02651168|Aflibercept|aflibercept|mesh-list
781164|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
781165|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
781166|NCT02651168|Growth Substances|growth substances|mesh-ancestor
781167|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781168|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
781169|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781344|NCT02650596|Liraglutide|liraglutide|mesh-list
781345|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
781346|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781347|NCT02650596|Incretins|incretins|mesh-ancestor
781348|NCT02650596|Hormones|hormones|mesh-ancestor
781349|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
781432|NCT02650245|Lactulose|lactulose|mesh-list
781433|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2242356|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
2242357|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
2242358|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242359|NCT00105495|Siderophores|siderophores|mesh-ancestor
2242360|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
2242361|NCT00105547|Analgesics|analgesics|mesh-ancestor
782371|NCT02646189|Interferons|interferons|mesh-list
782372|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
782373|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
782374|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
782375|NCT02646189|REP 2139|rep 2139|mesh-list
782376|NCT02646189|Thymalfasin|thymalfasin|mesh-list
782377|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782378|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
782379|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
782380|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
782381|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782382|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2095296|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2095297|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095298|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095299|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782748|NCT02644590|Melatonin|melatonin|mesh-list
782749|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
782750|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782751|NCT02644590|Protective Agents|protective agents|mesh-ancestor
782752|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782753|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782961|NCT02644252|Tocotrienols|tocotrienols|mesh-list
782962|NCT02644252|Vitamin E|vitamin e|mesh-list
782963|NCT02644252|Tocopherols|tocopherols|mesh-list
782964|NCT02644252|Carboplatin|carboplatin|mesh-list
782965|NCT02644252|Vinorelbine|vinorelbine|mesh-list
782966|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782967|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
782968|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
782969|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
782970|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
782971|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782972|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
782973|NCT02644252|Protective Agents|protective agents|mesh-ancestor
782974|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782975|NCT02644252|Vitamins|vitamins|mesh-ancestor
782976|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
783264|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
783265|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
783266|NCT02642861|Calcium|calcium|mesh-list
783267|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
783268|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783269|NCT02642861|Antacids|antacids|mesh-ancestor
783270|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783271|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
783272|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
783273|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
783274|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
781088|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
781089|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2242362|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
2242363|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242364|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242365|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
781525|NCT02649530|LGK974|lgk974|mesh-list
781526|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781527|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781625|NCT02649335|Propranolol|propranolol|mesh-list
781626|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
781627|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
781628|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
781629|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
781630|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781631|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781632|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
781633|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
781634|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
781666|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
781667|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
781668|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
781669|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781670|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
781671|NCT02648958|Analgesics|analgesics|mesh-ancestor
781672|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
781673|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781674|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
781675|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
781676|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
781677|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
781678|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
781679|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782089|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
782090|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
782091|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
782092|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
782326|NCT02646540|Metolazone|metolazone|mesh-list
782327|NCT02646540|Furosemide|furosemide|mesh-list
782328|NCT02646540|Tolvaptan|tolvaptan|mesh-list
782329|NCT02646540|Diuretics|diuretics|mesh-list
782330|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
782331|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782332|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
782333|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
782334|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782335|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
782336|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
782337|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
782341|NCT02646111|Ribavirin|ribavirin|mesh-list
782342|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
782343|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782344|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
782345|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
782709|NCT02644863|Paclitaxel|paclitaxel|mesh-list
782710|NCT02644863|Cisplatin|cisplatin|mesh-list
782711|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
782712|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782713|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
782714|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
782715|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
782716|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782995|NCT02643563|Epinephrine|epinephrine|mesh-list
782996|NCT02643563|Bupivacaine|bupivacaine|mesh-list
782997|NCT02643563|Ropivacaine|ropivacaine|mesh-list
782998|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
782999|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
783000|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
783001|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783002|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
783003|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783004|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
783005|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
783006|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
781254|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
781255|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
781256|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781257|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781258|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
781259|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781941|NCT02647827|Metformin|metformin|mesh-list
781942|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
781943|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782827|NCT02644408|Megestrol|megestrol|mesh-list
782828|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
782829|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
782830|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
782831|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
782832|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
782833|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782834|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
782835|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
782836|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
782837|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242366|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2242367|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2242368|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2242369|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2242370|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242371|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242372|NCT00105937|Fentanyl|fentanyl|mesh-list
2242373|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2242374|NCT00105937|Narcotics|narcotics|mesh-ancestor
2242375|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2242376|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242377|NCT00105937|Analgesics|analgesics|mesh-ancestor
2242378|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
2242379|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242380|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2242381|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
783204|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
783205|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
783206|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
783207|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
783208|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
783209|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783210|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783211|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
2242382|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
2242383|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
2242384|NCT00105950|Lapatinib|lapatinib|mesh-list
2242385|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242386|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2242387|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242388|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242389|NCT00106054|Leucovorin|leucovorin|mesh-list
2242390|NCT00106054|Bevacizumab|bevacizumab|mesh-list
2242391|NCT00106054|Irinotecan|irinotecan|mesh-list
2242392|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2242393|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242394|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2242395|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2242396|NCT00106054|Growth Substances|growth substances|mesh-ancestor
2242397|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242398|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
2242399|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2242400|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2242401|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242402|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242403|NCT00106054|Antidotes|antidotes|mesh-ancestor
784229|NCT02639143|Clopidogrel|clopidogrel|mesh-list
784230|NCT02639143|Ticagrelor|ticagrelor|mesh-list
784231|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
784232|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
784233|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
784234|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
784235|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
784236|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242404|NCT00106054|Protective Agents|protective agents|mesh-ancestor
781314|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781315|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781316|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
781317|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
781318|NCT02650609|Hormones|hormones|mesh-ancestor
781319|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
781320|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
781321|NCT02650609|Protective Agents|protective agents|mesh-ancestor
781322|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
781323|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781696|NCT02649101|Thalidomide|thalidomide|mesh-list
781697|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
781698|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
781699|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781700|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
781701|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
781702|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781703|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
781704|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
781705|NCT02649101|Growth Substances|growth substances|mesh-ancestor
781706|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
781707|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781879|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
781880|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
781881|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
781882|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781883|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
781884|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
781885|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
781886|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
781887|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781888|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781889|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
781890|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
782179|NCT02646735|Fulvestrant|fulvestrant|mesh-list
782180|NCT02646735|Exemestane|exemestane|mesh-list
782181|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
782182|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782183|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
782184|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
782185|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
782186|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
782187|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782188|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
782189|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
782190|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782191|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782346|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
782347|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
782348|NCT02646137|Estrogens|estrogens|mesh-ancestor
782349|NCT02646137|Hormones|hormones|mesh-ancestor
782350|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
782351|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782352|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
782353|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754067|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754068|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754069|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2754070|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2754071|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
2754072|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
2754073|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754074|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2754075|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
2754076|NCT01979536|Hormones|hormones|mesh-ancestor
2754077|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2754078|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2754079|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
2754080|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754081|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2754082|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
783182|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
783183|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2754083|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2754084|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2754085|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
2754086|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2754087|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2754088|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
2754089|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
2754090|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2754091|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2754092|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2754093|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
781563|NCT02649478|Fluticasone|fluticasone|mesh-list
781564|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
781565|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
781566|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
781567|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
781568|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
781569|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781570|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781571|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
781572|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
781573|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
781574|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
781575|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
781576|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
781577|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
781578|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
781579|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
781580|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781581|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
781582|NCT02649478|Hormones|hormones|mesh-ancestor
781583|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
781584|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
781733|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
781734|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
781735|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
781736|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
781737|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781738|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781739|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781740|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
782097|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
782098|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
782099|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
782100|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782101|NCT02647489|Antacids|antacids|mesh-ancestor
782102|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782103|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
782230|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
782231|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
782232|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782537|NCT02646020|Loratadine|loratadine|mesh-list
782538|NCT02646020|Aprepitant|aprepitant|mesh-list
782539|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
782540|NCT02646020|Desloratadine|desloratadine|mesh-list
782541|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
782542|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
782543|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782544|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782545|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
782546|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
782547|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
782548|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782549|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
782550|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
782551|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
782552|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
782553|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
782554|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
782555|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
782556|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
782557|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
783125|NCT02643420|Cyclophosphamide|cyclophosphamide|mesh-list
783126|NCT02643420|Docetaxel|docetaxel|mesh-list
783127|NCT02643420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
781356|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
781357|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
781358|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
781359|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781360|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781361|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2242405|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
2242406|NCT00106054|Vitamins|vitamins|mesh-ancestor
2242407|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
2242408|NCT00106132|Triamcinolone|triamcinolone|mesh-list
2242409|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2242410|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2242411|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2242412|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2242413|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
2242414|NCT00106132|Hormones|hormones|mesh-ancestor
2242415|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2242416|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242417|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2242418|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
782518|NCT02645656|Curcumin|curcumin|mesh-list
782519|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
782520|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
782521|NCT02645656|Analgesics|analgesics|mesh-ancestor
782522|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
782523|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782524|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782525|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
782526|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
782527|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782528|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782529|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783102|NCT02643407|Docetaxel|docetaxel|mesh-list
783103|NCT02643407|Nedaplatin|nedaplatin|mesh-list
783104|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783105|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
783106|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
783107|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
783108|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783773|NCT02641132|Mitomycins|mitomycins|mesh-list
783774|NCT02641132|Mitomycin|mitomycin|mesh-list
783775|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
783776|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783777|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
783778|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783779|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
783780|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783958|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
783959|NCT02640417|Vitamins|vitamins|mesh-ancestor
783960|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
783961|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784026|NCT02640222|Vitamin K|vitamin k|mesh-list
784027|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
784028|NCT02640222|Apixaban|apixaban|mesh-list
784029|NCT02640222|Dabigatran|dabigatran|mesh-list
784030|NCT02640222|Vitamins|vitamins|mesh-ancestor
784031|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
784032|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784033|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
784034|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
784035|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
784036|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
784037|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784038|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784039|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
784040|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
784041|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
784042|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
784043|NCT02640222|Coagulants|coagulants|mesh-ancestor
784868|NCT02636101|Betamethasone|betamethasone|mesh-list
784869|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
784870|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
784871|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
784872|NCT02636101|Calcipotriene|calcipotriene|mesh-list
784873|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
784874|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
784875|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
2242419|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781393|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
781394|NCT02650479|Palonosetron|palonosetron|mesh-list
781395|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
781396|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
781397|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
781398|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
781399|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
781400|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781401|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
781402|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781403|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
781404|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
781405|NCT02650479|Incretins|incretins|mesh-ancestor
781406|NCT02650479|Hormones|hormones|mesh-ancestor
781407|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
781408|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
781409|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
781410|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
781411|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
781412|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
781413|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
781414|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
781415|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242420|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242421|NCT00106158|Vaccines|vaccines|mesh-list
2242422|NCT00106158|Immunologic Factors|immunologic factors|mesh-ancestor
2242423|NCT00106158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242424|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2242425|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
2242426|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2242427|NCT00106197|Bupropion|bupropion|mesh-list
2242428|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2242429|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
2242430|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2242431|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2242432|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2242433|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2242434|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242435|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
2242436|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
782924|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
782925|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2242437|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242438|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2242439|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2242440|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242441|NCT00106262|Irinotecan|irinotecan|mesh-list
2242442|NCT00106262|Bortezomib|bortezomib|mesh-list
2242443|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2242444|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2242445|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095300|NCT02290613|Ambrisentan|ambrisentan|mesh-list
2095301|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2095302|NCT02290873|Midazolam|midazolam|mesh-list
2095303|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2095304|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2095305|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2242446|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242447|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242448|NCT00106288|Amphotericin B|amphotericin b|mesh-list
2242449|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2242450|NCT00106288|Micafungin|micafungin|mesh-list
2242451|NCT00106288|Amebicides|amebicides|mesh-ancestor
2242452|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2242453|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2242454|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2242455|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2242456|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
2242457|NCT00106301|Romidepsin|romidepsin|mesh-list
784173|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
781751|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781752|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
781753|NCT02648711|Antidotes|antidotes|mesh-ancestor
781754|NCT02648711|Protective Agents|protective agents|mesh-ancestor
781755|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
781756|NCT02648711|Vitamins|vitamins|mesh-ancestor
781757|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
782383|NCT02646072|Ketorolac|ketorolac|mesh-list
782384|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
782385|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
782386|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
782387|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
782388|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
782389|NCT02646072|Analgesics|analgesics|mesh-ancestor
782390|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
782391|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782392|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782393|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
782394|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
782395|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
782396|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782397|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782465|NCT02645734|Bevacizumab|bevacizumab|mesh-list
782466|NCT02645734|Aflibercept|aflibercept|mesh-list
782467|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
782468|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782469|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
782470|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
782471|NCT02645734|Growth Substances|growth substances|mesh-ancestor
782472|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782473|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
782727|NCT02644915|Edaravone|edaravone|mesh-list
782728|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
782729|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
782730|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782731|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
782732|NCT02644915|Protective Agents|protective agents|mesh-ancestor
782733|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782907|NCT02644291|Mebendazole|mebendazole|mesh-list
782908|NCT02644291|Piperazine|piperazine|mesh-list
782909|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
782910|NCT02644291|DMP 777|dmp 777|mesh-list
782911|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
782912|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
782913|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
782914|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
782915|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
782916|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
782917|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
782918|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782919|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782920|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783146|NCT02643329|Gliclazide|gliclazide|mesh-list
783147|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
783148|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783663|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
783664|NCT02641639|Combretastatin|combretastatin|mesh-list
783665|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
783666|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783667|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
783668|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
783669|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
783670|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783885|NCT02640833|Venetoclax|venetoclax|mesh-list
783886|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784246|NCT02639091|Pemetrexed|pemetrexed|mesh-list
784247|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784248|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784249|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784250|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
784251|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2242458|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2242459|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242460|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2242461|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2242462|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
2242463|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
781770|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
781771|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
781772|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
781773|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
781774|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
781775|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
781776|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
781777|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
782697|NCT02644720|Dexamethasone|dexamethasone|mesh-list
782698|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
782699|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
782700|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
782701|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782702|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782703|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
782704|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
782705|NCT02644720|Hormones|hormones|mesh-ancestor
782706|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
782707|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
782708|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783081|NCT02643602|Theophylline|theophylline|mesh-list
783082|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
783083|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
783084|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783085|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783086|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
783087|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
783088|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
783089|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783090|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783091|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
783092|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
783093|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
783094|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
783095|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783554|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
783555|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
783556|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
783557|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783558|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
783559|NCT02641938|Analgesics|analgesics|mesh-ancestor
783560|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
783561|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783562|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
783563|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
783564|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
783565|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
783566|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783567|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242464|NCT00106340|Metformin|metformin|mesh-list
2242465|NCT00106340|Glimepiride|glimepiride|mesh-list
2242466|NCT00106340|Vildagliptin|vildagliptin|mesh-list
2242467|NCT00106340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2242468|NCT00106340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242469|NCT00106340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2242470|NCT00106340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2242471|NCT00106340|Immunologic Factors|immunologic factors|mesh-ancestor
2242472|NCT00106340|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2242473|NCT00106340|Protease Inhibitors|protease inhibitors|mesh-ancestor
2242474|NCT00106340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242475|NCT00106340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242476|NCT00106366|Insulin|insulin|mesh-list
2242477|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2242478|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
784239|NCT02639039|Cortisone|cortisone|mesh-list
784240|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
784322|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
784323|NCT02638896|Celecoxib|celecoxib|mesh-list
784324|NCT02638896|Etanercept|etanercept|mesh-list
784325|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
784326|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
784327|NCT02638896|Analgesics|analgesics|mesh-ancestor
784328|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
784329|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242479|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
2242480|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
2242481|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2242482|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242483|NCT00106379|Tenofovir|tenofovir|mesh-list
2242484|NCT00106379|Emtricitabine|emtricitabine|mesh-list
2242485|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2242486|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
2242487|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2242488|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2242489|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2242490|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242491|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242492|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2242493|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2242494|NCT00106405|Memantine|memantine|mesh-list
2242495|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2242496|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2242497|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
2242498|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242499|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782613|NCT02645266|Aflibercept|aflibercept|mesh-list
782614|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
782615|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
782616|NCT02645266|Growth Substances|growth substances|mesh-ancestor
782617|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782618|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
782619|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783285|NCT02642874|Methocarbamol|methocarbamol|mesh-list
783286|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
783287|NCT02642874|Calcium|calcium|mesh-list
783288|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
783289|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783290|NCT02642874|Antacids|antacids|mesh-ancestor
783291|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783292|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
783293|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
783294|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
783295|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783387|NCT02642523|Insulin|insulin|mesh-list
783388|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
783389|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
783390|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
783391|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783392|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
783890|NCT02641054|Levodopa|levodopa|mesh-list
783891|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
783892|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
783893|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
783894|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783895|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783896|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783968|NCT02640508|Lenvatinib|lenvatinib|mesh-list
783969|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783970|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
783971|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783972|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784020|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
784021|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
784022|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
784023|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784024|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
784025|NCT02640144|Protective Agents|protective agents|mesh-ancestor
2242500|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242501|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2242502|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2242503|NCT00106418|Romidepsin|romidepsin|mesh-list
2242504|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2242505|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242506|NCT00106496|Tacrolimus|tacrolimus|mesh-list
2242507|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2242508|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
2242509|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242510|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2242511|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784606|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
782054|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
782055|NCT02647255|Prednisolone|prednisolone|mesh-list
782056|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
782057|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
782058|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
782059|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
782060|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
782061|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
782062|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782063|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782064|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
782065|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
782066|NCT02647255|Hormones|hormones|mesh-ancestor
782067|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
782068|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
782069|NCT02647255|Protective Agents|protective agents|mesh-ancestor
782070|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
782071|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782149|NCT02646800|Micafungin|micafungin|mesh-list
782150|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
782151|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
782263|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
782876|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
782877|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
782878|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783021|NCT02643823|Methotrexate|methotrexate|mesh-list
783022|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
783023|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
783024|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
783025|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
783026|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783027|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
783028|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
783029|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783030|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783031|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
783032|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783033|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
783034|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
783035|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
783036|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
783248|NCT02642939|Mifepristone|mifepristone|mesh-list
783249|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
783250|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
783251|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
783252|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783253|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
783254|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
783255|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
783256|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
783257|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
783258|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
783259|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
783260|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
783261|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
783262|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
783263|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
783495|NCT02642094|Sirolimus|sirolimus|mesh-list
783496|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
783497|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
783498|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
783499|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783500|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
783501|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
783502|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
783503|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242512|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242513|NCT00106522|Methotrexate|methotrexate|mesh-list
2242514|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2242515|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
2242516|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2242517|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242518|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2242519|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
782148|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782852|NCT02644577|Metformin|metformin|mesh-list
782853|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
782854|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242520|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242521|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242522|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
2242523|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242524|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2242525|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2242526|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
2242527|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2242528|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2242529|NCT00106548|Methotrexate|methotrexate|mesh-list
2242530|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2242531|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
2242532|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2242533|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242534|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2242535|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
2242536|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242537|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242538|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
2242539|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242540|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2242541|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2242542|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
2242543|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2242544|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
784063|NCT02639858|Docetaxel|docetaxel|mesh-list
784064|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784065|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
784066|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
784067|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
784068|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784118|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
784119|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
784241|NCT02639234|Nivolumab|nivolumab|mesh-list
784242|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
784243|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784244|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
784245|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784490|NCT02638428|Cytarabine|cytarabine|mesh-list
784491|NCT02638428|Carboplatin|carboplatin|mesh-list
784492|NCT02638428|Fludarabine|fludarabine|mesh-list
784493|NCT02638428|Etoposide|etoposide|mesh-list
784494|NCT02638428|Trastuzumab|trastuzumab|mesh-list
784495|NCT02638428|Everolimus|everolimus|mesh-list
784496|NCT02638428|Sorafenib|sorafenib|mesh-list
784497|NCT02638428|Ifosfamide|ifosfamide|mesh-list
784498|NCT02638428|Dasatinib|dasatinib|mesh-list
784499|NCT02638428|Axitinib|axitinib|mesh-list
784500|NCT02638428|Vemurafenib|vemurafenib|mesh-list
784501|NCT02638428|Crizotinib|crizotinib|mesh-list
784502|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784503|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
784504|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
784505|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784506|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
784507|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
784508|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784509|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
784510|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
784511|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
784512|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784513|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
784514|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
784515|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784516|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
784517|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
784518|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
2242545|NCT00106561|Irbesartan|irbesartan|mesh-list
2242546|NCT00106561|Spironolactone|spironolactone|mesh-list
784853|NCT02636582|Molgramostim|molgramostim|mesh-list
784854|NCT02636582|Vaccines|vaccines|mesh-list
784855|NCT02636582|Sargramostim|sargramostim|mesh-list
784856|NCT02636582|Immunologic Factors|immunologic factors|mesh-ancestor
782165|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
782166|NCT02647099|Analgesics|analgesics|mesh-ancestor
782167|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
782168|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782169|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782170|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
782171|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
782172|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
782173|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
782174|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782175|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
782176|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
782177|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782178|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
782462|NCT02645994|Anesthetics|anesthetics|mesh-list
782463|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782464|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782690|NCT02644707|Selenium|selenium|mesh-list
782691|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
782692|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782693|NCT02644707|Protective Agents|protective agents|mesh-ancestor
782694|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782695|NCT02644707|Trace Elements|trace elements|mesh-ancestor
782696|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
782879|NCT02644421|Lidocaine|lidocaine|mesh-list
782880|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
782881|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
782882|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782883|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782884|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
782885|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782886|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
782887|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
782888|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
782889|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
782890|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783484|NCT02642263|Carbetocin|carbetocin|mesh-list
783485|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
783486|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
783487|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783643|NCT02641782|Aldesleukin|aldesleukin|mesh-list
783644|NCT02641782|Interleukin-2|interleukin-2|mesh-list
783645|NCT02641782|Tretinoin|tretinoin|mesh-list
783646|NCT02641782|Dinutuximab|dinutuximab|mesh-list
783647|NCT02641782|Isotretinoin|isotretinoin|mesh-list
783648|NCT02641782|Antibodies|antibodies|mesh-list
783649|NCT02641782|Sargramostim|sargramostim|mesh-list
783650|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
783651|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783652|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783653|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
783654|NCT02641782|Analgesics|analgesics|mesh-ancestor
783655|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
783656|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783657|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
783658|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
783659|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
783660|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
783661|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
783662|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
783766|NCT02641288|Ropivacaine|ropivacaine|mesh-list
783767|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
783768|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
783769|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
783770|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783771|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
783772|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
784000|NCT02640313|Choline|choline|mesh-list
784001|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
784002|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
784003|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
784004|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784005|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
784006|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
784007|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
784175|NCT02639598|Topiramate|topiramate|mesh-list
784176|NCT02639598|Flunarizine|flunarizine|mesh-list
784177|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
782227|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
782228|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
782229|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
782454|NCT02645864|Irinotecan|irinotecan|mesh-list
782455|NCT02645864|Apatinib|apatinib|mesh-list
782456|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
782457|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
782458|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782459|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782460|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782461|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
782846|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
782847|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
782848|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
782849|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782850|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
782851|NCT02644473|Coagulants|coagulants|mesh-ancestor
783212|NCT02643186|Misoprostol|misoprostol|mesh-list
783213|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
783214|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
783215|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
783216|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783217|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
783218|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
783219|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
783296|NCT02642718|Ketorolac|ketorolac|mesh-list
783297|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
783298|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
783299|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
783300|NCT02642718|Analgesics|analgesics|mesh-ancestor
783301|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
783302|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783303|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783304|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
783305|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
783306|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
783307|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783308|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783470|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
783471|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
783472|NCT02642146|Calcium|calcium|mesh-list
783473|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
783474|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
783475|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783476|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
783477|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783478|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783897|NCT02640794|Aspirin|aspirin|mesh-list
783898|NCT02640794|Clopidogrel|clopidogrel|mesh-list
783899|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
783900|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
783901|NCT02640794|Analgesics|analgesics|mesh-ancestor
783902|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
783903|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783904|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783905|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
783906|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
783907|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
783908|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
783909|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783910|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
783911|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
783912|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783913|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
783914|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
783915|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
783916|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
783917|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
783918|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
782276|NCT02646592|Narcotics|narcotics|mesh-ancestor
782277|NCT02646592|Analgesics|analgesics|mesh-ancestor
782278|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
782279|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754094|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2754095|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2754096|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
2754097|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
2754098|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
2754099|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
2754100|NCT01964807|Nicotine|nicotine|mesh-list
782671|NCT02644785|Protamines|protamines|mesh-list
782672|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
782673|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782674|NCT02644785|Coagulants|coagulants|mesh-ancestor
782754|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
782755|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
782756|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
782894|NCT02644226|Sevoflurane|sevoflurane|mesh-list
782895|NCT02644226|Desflurane|desflurane|mesh-list
782896|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
782897|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
782898|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
782899|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
782900|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782901|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783280|NCT02642913|Sorafenib|sorafenib|mesh-list
783281|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783282|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
783283|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783284|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783393|NCT02642497|Ketamine|ketamine|mesh-list
783394|NCT02642497|Analgesics|analgesics|mesh-ancestor
783395|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
783396|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783397|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783398|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
783399|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
783400|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
783401|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
783402|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
783403|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
783404|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
783405|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783406|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783739|NCT02641314|Celecoxib|celecoxib|mesh-list
783740|NCT02641314|Propranolol|propranolol|mesh-list
783741|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783742|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
783743|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783744|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
783745|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
783746|NCT02641314|Analgesics|analgesics|mesh-ancestor
783747|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
783748|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783749|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
783750|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
783751|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
783752|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783753|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
783754|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
783755|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
783756|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783757|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
783758|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
783759|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
783973|NCT02640534|Metformin|metformin|mesh-list
783974|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
783975|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242547|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2242548|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
2242549|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2242550|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242551|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2242552|NCT00106561|Diuretics|diuretics|mesh-ancestor
782320|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
782321|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
782322|NCT02646670|Growth Substances|growth substances|mesh-ancestor
782323|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782324|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
782325|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782760|NCT02644499|Folic Acid|folic acid|mesh-list
782761|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
782762|NCT02644499|Prednisolone|prednisolone|mesh-list
782763|NCT02644499|Methotrexate|methotrexate|mesh-list
782764|NCT02644499|Leflunomide|leflunomide|mesh-list
782765|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
782766|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
782767|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
782768|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
782769|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782770|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
782771|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
782772|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782773|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782774|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
782775|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782776|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
782777|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
782778|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
782779|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
782780|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
782781|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
782782|NCT02644499|Hormones|hormones|mesh-ancestor
782783|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
782784|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
782785|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
782786|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
782787|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
782788|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
782789|NCT02644499|Hematinics|hematinics|mesh-ancestor
782790|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
782791|NCT02644499|Vitamins|vitamins|mesh-ancestor
782792|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
783488|NCT02641990|Exenatide|exenatide|mesh-list
783489|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
783490|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783491|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
783492|NCT02641990|Incretins|incretins|mesh-ancestor
783493|NCT02641990|Hormones|hormones|mesh-ancestor
783494|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2242553|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
2242554|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2242555|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2242556|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
784535|NCT02637973|Empagliflozin|empagliflozin|mesh-list
784536|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
784537|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784538|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
784539|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242557|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242558|NCT00106587|Paclitaxel|paclitaxel|mesh-list
2242559|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2242560|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242561|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
785246|NCT02634723|Factor VIII|factor viii|mesh-list
785247|NCT02634723|Coagulants|coagulants|mesh-ancestor
2095306|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095307|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2095308|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2095309|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2095310|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2095311|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
2095312|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
2095313|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
2095314|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
2095315|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095316|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785693|NCT02633579|Erythromycin|erythromycin|mesh-list
785694|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
785695|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2242562|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
2242563|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
2242564|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782596|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
782597|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
782598|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
782599|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
782600|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782601|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
782602|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
782603|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782650|NCT02644980|Anesthetics|anesthetics|mesh-list
782651|NCT02644980|Propofol|propofol|mesh-list
782652|NCT02644980|Etomidate|etomidate|mesh-list
782653|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782654|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782655|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
782656|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
782657|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
783760|NCT02641431|Ajmaline|ajmaline|mesh-list
783761|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
783762|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
783763|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
783764|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
783765|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095317|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
2095318|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2095319|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
2095320|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095321|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095322|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2242565|NCT00106600|Pixantrone|pixantrone|mesh-list
784069|NCT02639767|Pemetrexed|pemetrexed|mesh-list
784070|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784071|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784072|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784073|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
784074|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2242566|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2242567|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2242568|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242569|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242570|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242571|NCT00106613|Romidepsin|romidepsin|mesh-list
2242572|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2242573|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784303|NCT02638870|Amitriptyline|amitriptyline|mesh-list
784304|NCT02638870|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
784305|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
784306|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
784307|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
784308|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
784309|NCT02638870|Analgesics|analgesics|mesh-ancestor
784310|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
784311|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
784312|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784313|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
784314|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
784315|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
784316|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784317|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
784318|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
784319|NCT02638870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
784320|NCT02638870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
784321|NCT02638870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784341|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
784342|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
784343|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784344|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784345|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
784346|NCT02638545|Analgesics|analgesics|mesh-ancestor
784347|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
784348|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242574|NCT00106691|Toremifene|toremifene|mesh-list
2242575|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2242576|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242577|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2242578|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2242579|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
2242580|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2242581|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242582|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2242583|NCT00106808|Pioglitazone|pioglitazone|mesh-list
2242584|NCT00106808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2242585|NCT00106808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242586|NCT00106821|Bromides|bromides|mesh-list
2242587|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
782646|NCT02645058|Analgesics|analgesics|mesh-list
782647|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782648|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
782649|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782734|NCT02644629|Ketamine|ketamine|mesh-list
782735|NCT02644629|Analgesics|analgesics|mesh-ancestor
782736|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
782737|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782738|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782739|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
782740|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
782741|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
782742|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
782743|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
782744|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
782745|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
782746|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
782747|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782891|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
782892|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
782893|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
783046|NCT02643719|Topiramate|topiramate|mesh-list
783047|NCT02643719|Naproxen|naproxen|mesh-list
783048|NCT02643719|Sumatriptan|sumatriptan|mesh-list
783049|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
783050|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
783051|NCT02643719|Analgesics|analgesics|mesh-ancestor
783052|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
783053|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783054|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783055|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
783056|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
783057|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
783058|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
783059|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783060|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783061|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
783062|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
783063|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
783064|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
783065|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
783066|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
783067|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783332|NCT02642640|Melatonin|melatonin|mesh-list
783333|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
783334|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783335|NCT02642640|Protective Agents|protective agents|mesh-ancestor
783336|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783337|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
783633|NCT02641652|Sertraline|sertraline|mesh-list
783634|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
783635|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
783636|NCT02641652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
783637|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
783638|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
783639|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783640|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783641|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
783642|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783816|NCT02641340|Fentanyl|fentanyl|mesh-list
2242588|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2242589|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
782796|NCT02644395|Amlodipine|amlodipine|mesh-list
782797|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
782798|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
782799|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
782800|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
782801|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782802|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
782803|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782804|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
782805|NCT02644395|Diuretics|diuretics|mesh-ancestor
782806|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
782807|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2095323|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
2095324|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2095325|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2095326|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2095327|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
2095328|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242590|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242591|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242592|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2242593|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
2242594|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
2242595|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2242596|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
2242597|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242598|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242599|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
2242600|NCT00106834|Infliximab|infliximab|mesh-list
2242601|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
2242602|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2242603|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2242604|NCT00106847|Infliximab|infliximab|mesh-list
2242605|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
2242606|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2242607|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2242608|NCT00106886|Folic Acid|folic acid|mesh-list
2242609|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
2242610|NCT00106886|Pyridoxal|pyridoxal|mesh-list
2242611|NCT00106886|Pyridoxine|pyridoxine|mesh-list
2242612|NCT00106886|Vitamins|vitamins|mesh-ancestor
2242613|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
784801|NCT02636569|Diclofenac|diclofenac|mesh-list
784802|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
784803|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
784804|NCT02636569|Analgesics|analgesics|mesh-ancestor
784805|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
784806|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
784807|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784808|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
784809|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
784810|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
784811|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784812|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784888|NCT02635841|Deferiprone|deferiprone|mesh-list
784889|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
784890|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
784891|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
784892|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785068|NCT02635230|Aspirin|aspirin|mesh-list
785069|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
785070|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
785071|NCT02635230|Analgesics|analgesics|mesh-ancestor
785072|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
785073|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785074|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785075|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
785076|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
785077|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
785078|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
785079|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785080|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2242614|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242615|NCT00106886|Hematinics|hematinics|mesh-ancestor
782610|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
782611|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
782612|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782855|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
782856|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
782857|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
782858|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
782859|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782977|NCT02643914|Nicotine|nicotine|mesh-list
782978|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
782979|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
782980|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
782981|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
782982|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
782983|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
782984|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
782985|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
782986|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783096|NCT02643550|Cetuximab|cetuximab|mesh-list
783097|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
783098|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242616|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
2242617|NCT00107003|Lapatinib|lapatinib|mesh-list
784044|NCT02640118|Lixisenatide|lixisenatide|mesh-list
784045|NCT02640118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
784046|NCT02640118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784387|NCT02638857|Epirubicin|epirubicin|mesh-list
784388|NCT02638857|Mitomycins|mitomycins|mesh-list
784389|NCT02638857|Mitomycin|mitomycin|mesh-list
784390|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
784391|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
784392|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784393|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
784394|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
784395|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784396|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784397|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
784398|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
784640|NCT02637726|Remifentanil|remifentanil|mesh-list
784641|NCT02637726|Propofol|propofol|mesh-list
784642|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
784643|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784644|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784645|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
784646|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
784647|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
784648|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
784649|NCT02637726|Narcotics|narcotics|mesh-ancestor
784650|NCT02637726|Analgesics|analgesics|mesh-ancestor
784651|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
784652|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
784725|NCT02637128|Artesunate|artesunate|mesh-list
784726|NCT02637128|Lumefantrine|lumefantrine|mesh-list
784727|NCT02637128|Artemether|artemether|mesh-list
784728|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
784729|NCT02637128|Amodiaquine|amodiaquine|mesh-list
784730|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
784731|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
784732|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
784733|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784734|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784735|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
784736|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
784737|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
784738|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
784774|NCT02636803|Albendazole|albendazole|mesh-list
784775|NCT02636803|Oxfendazole|oxfendazole|mesh-list
784776|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
784777|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
784778|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784779|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
784780|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
784781|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
784782|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
784783|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
784784|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
784785|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784786|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784787|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
782821|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
782822|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
782823|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
782824|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
782825|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
782826|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783199|NCT02643173|Anesthetics|anesthetics|mesh-list
783200|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
783201|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
783202|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783203|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
783367|NCT02642484|Gabapentin|gabapentin|mesh-list
783368|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
783369|NCT02642484|Calcium|calcium|mesh-list
783370|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
783371|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783372|NCT02642484|Analgesics|analgesics|mesh-ancestor
783373|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
783374|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783375|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
783376|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
783377|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
783378|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
783379|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
783380|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
783381|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
783382|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783383|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783384|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
783385|NCT02642484|Antacids|antacids|mesh-ancestor
783386|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
783671|NCT02641457|Ranibizumab|ranibizumab|mesh-list
783672|NCT02641457|Aflibercept|aflibercept|mesh-list
783673|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
783674|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
783675|NCT02641457|Growth Substances|growth substances|mesh-ancestor
783676|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783677|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
783678|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783887|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
783888|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
783889|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783946|NCT02640495|Artesunate|artesunate|mesh-list
783947|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
783948|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
783949|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
783950|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
783951|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783952|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
783953|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
783954|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
783955|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
2242618|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242619|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2242620|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242621|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242622|NCT00107016|Letrozole|letrozole|mesh-list
2242623|NCT00107016|Everolimus|everolimus|mesh-list
2242624|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242625|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2242626|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2242627|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242628|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242629|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2242630|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
2242631|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2242632|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242633|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2242634|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
2242635|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2242636|NCT00107081|Amoxicillin|amoxicillin|mesh-list
2242637|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
2242638|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2242639|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2242640|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2242641|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782866|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
782867|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
782868|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
782869|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
782870|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782871|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
782872|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
782873|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
782874|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
782875|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2242642|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242643|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242644|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2242645|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
783220|NCT02643147|Furosemide|furosemide|mesh-list
783221|NCT02643147|Diuretics|diuretics|mesh-list
783222|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
783223|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
783224|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783225|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
783226|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242646|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2242647|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242648|NCT00107107|Pramlintide|pramlintide|mesh-list
2242649|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2242650|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242651|NCT00107237|Everolimus|everolimus|mesh-list
2242652|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242653|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2242654|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
2242655|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242656|NCT00107250|Paclitaxel|paclitaxel|mesh-list
2242657|NCT00107250|Carboplatin|carboplatin|mesh-list
2242658|NCT00107250|Capecitabine|capecitabine|mesh-list
2242659|NCT00107250|Cediranib|cediranib|mesh-list
2242660|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2242661|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242662|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
2242663|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
783813|NCT02640989|Vaccines|vaccines|mesh-list
783814|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
783815|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242664|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
784748|NCT02636842|Aripiprazole|aripiprazole|mesh-list
784749|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
784750|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
784751|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
784752|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
784753|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
784754|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784755|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784756|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
784757|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
784758|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
784759|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784760|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
784761|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
784762|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
784763|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
784764|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
784765|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
784766|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
784825|NCT02636218|Ketamine|ketamine|mesh-list
784826|NCT02636218|Analgesics|analgesics|mesh-ancestor
784827|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
784828|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
784829|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784830|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
784831|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
784832|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
784833|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
784834|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784835|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
784836|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
782904|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
782905|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
782906|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242665|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242666|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2242667|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
2242668|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242669|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2242670|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
2242671|NCT00107263|Letrozole|letrozole|mesh-list
783407|NCT02642380|Dexamethasone|dexamethasone|mesh-list
783408|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
783409|NCT02642380|BB 1101|bb 1101|mesh-list
783410|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
783411|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
783412|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
783413|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783414|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783415|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
783416|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
783417|NCT02642380|Hormones|hormones|mesh-ancestor
783418|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
783419|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
783420|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783421|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
783422|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783423|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783879|NCT02640898|Docetaxel|docetaxel|mesh-list
783880|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783881|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
783882|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
783883|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
783884|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242672|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242673|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2242674|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
784434|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
784435|NCT02638233|Ledipasvir|ledipasvir|mesh-list
784436|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
784437|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784519|NCT02638064|Surgiflo|surgiflo|mesh-list
784520|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
784521|NCT02638064|Coagulants|coagulants|mesh-ancestor
784599|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
784600|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
784601|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
784602|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
784603|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
784604|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784605|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784818|NCT02636491|Insulin|insulin|mesh-list
784819|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
784820|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
784821|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785520|NCT02634008|Ritonavir|ritonavir|mesh-list
785521|NCT02634008|Ribavirin|ribavirin|mesh-list
785522|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
785523|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
785524|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
785525|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785526|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785527|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
785528|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
785529|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
785530|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
785531|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
785532|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
785533|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
785846|NCT02632877|Pirfenidone|pirfenidone|mesh-list
785847|NCT02632877|Ketanserin|ketanserin|mesh-list
785848|NCT02632877|Analgesics|analgesics|mesh-ancestor
785849|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
785850|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785851|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785852|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
785853|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
785854|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
782940|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
782941|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
782942|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
782943|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
782944|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783479|NCT02642250|Metronidazole|metronidazole|mesh-list
783480|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
783481|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
783482|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
783483|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
783608|NCT02641847|Gemcitabine|gemcitabine|mesh-list
783609|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
783610|NCT02641847|Docetaxel|docetaxel|mesh-list
783611|NCT02641847|Doxorubicin|doxorubicin|mesh-list
783612|NCT02641847|Epirubicin|epirubicin|mesh-list
783613|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
783614|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
783615|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783616|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
783617|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
783618|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
783619|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783620|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783621|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
783622|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
783623|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
783624|NCT02641847|Antiviral Agents|antiviral agents|mesh-ancestor
783625|NCT02641847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
783626|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783627|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
783628|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
783629|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
783630|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
783631|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
783632|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
783810|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
783811|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783812|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
784120|NCT02639533|Pregabalin|pregabalin|mesh-list
784121|NCT02639533|Analgesics|analgesics|mesh-ancestor
784122|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
784123|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
784124|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784125|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
784126|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
784127|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
784128|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784129|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
784130|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
784131|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
784132|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784133|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2095329|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095330|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2095331|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
2095332|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095333|NCT02291133|Bleomycin|bleomycin|mesh-list
2242675|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785084|NCT02636322|Prednisone|prednisone|mesh-list
785085|NCT02636322|Cortisone|cortisone|mesh-list
785086|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
785087|NCT02636322|Rituximab|rituximab|mesh-list
785088|NCT02636322|Doxorubicin|doxorubicin|mesh-list
785089|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
785090|NCT02636322|Etoposide|etoposide|mesh-list
785091|NCT02636322|Vincristine|vincristine|mesh-list
785092|NCT02636322|Lenalidomide|lenalidomide|mesh-list
785093|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
785094|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
785095|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
785096|NCT02636322|Antibodies|antibodies|mesh-list
785097|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
785098|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
785099|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
785100|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
785101|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785102|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
785674|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
783007|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783008|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783009|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
783010|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
783011|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
783012|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
783013|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
783014|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
783015|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
783016|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
783099|NCT02643433|Vaccines|vaccines|mesh-list
783100|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
783101|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783338|NCT02642419|Aspirin|aspirin|mesh-list
783339|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
783340|NCT02642419|Clopidogrel|clopidogrel|mesh-list
783341|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
783342|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
783343|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
783344|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
783345|NCT02642419|Analgesics|analgesics|mesh-ancestor
783346|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
783347|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783348|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783349|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
783350|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
783351|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
783352|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
783353|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783354|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
783355|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783356|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
783357|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
783358|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
783359|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
783360|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
783361|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783362|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
783363|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
783364|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
783365|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
783366|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
2242676|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242677|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2242678|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
2242679|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2242680|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242681|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2242687|NCT00107341|Paclitaxel|paclitaxel|mesh-list
2242688|NCT00107341|Carboplatin|carboplatin|mesh-list
2242689|NCT00107341|Bortezomib|bortezomib|mesh-list
2242690|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2242691|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784413|NCT02638506|Fentanyl|fentanyl|mesh-list
784414|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
784415|NCT02638506|Narcotics|narcotics|mesh-ancestor
784416|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784417|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784418|NCT02638506|Analgesics|analgesics|mesh-ancestor
784419|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
784420|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
784421|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
784422|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
784423|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
784424|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
2242692|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
2242693|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
2242694|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
2242695|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242696|NCT00107354|Cytarabine|cytarabine|mesh-list
2242697|NCT00107354|Aldesleukin|aldesleukin|mesh-list
783128|NCT02643420|Immunologic Factors|immunologic factors|mesh-ancestor
783129|NCT02643420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783130|NCT02643420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
783131|NCT02643420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
783132|NCT02643420|Alkylating Agents|alkylating agents|mesh-ancestor
783133|NCT02643420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783134|NCT02643420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783135|NCT02643420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
783136|NCT02643420|Tubulin Modulators|tubulin modulators|mesh-ancestor
783137|NCT02643420|Antimitotic Agents|antimitotic agents|mesh-ancestor
783138|NCT02643420|Mitosis Modulators|mitosis modulators|mesh-ancestor
784382|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
784383|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
784384|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784385|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
784386|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784522|NCT02638116|Omeprazole|omeprazole|mesh-list
784523|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
784524|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
784525|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
784526|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784527|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242698|NCT00107354|Etoposide|etoposide|mesh-list
2242699|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
2242700|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2242701|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242702|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2242703|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2242704|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242705|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242706|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2242707|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
2242708|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
2242709|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
787053|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
787054|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
787055|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787111|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
787112|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
787387|NCT02627430|Talazoparib|talazoparib|mesh-list
787388|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
787389|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787390|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787391|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787509|NCT02626559|Bupivacaine|bupivacaine|mesh-list
787510|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
787511|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
787512|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
787513|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787514|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
787515|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242710|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2242711|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
2242712|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242713|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2242714|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2242715|NCT00107354|Analgesics|analgesics|mesh-ancestor
2242716|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
2242717|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242718|NCT00107393|Capecitabine|capecitabine|mesh-list
2242719|NCT00107393|Trastuzumab|trastuzumab|mesh-list
2242720|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2242721|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
2242722|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242723|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242724|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2242725|NCT00107419|Pemetrexed|pemetrexed|mesh-list
2242726|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242727|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242728|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242729|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2242730|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2242731|NCT00107432|Sorafenib|sorafenib|mesh-list
783184|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
783185|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783186|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
783187|NCT02643017|Analgesics|analgesics|mesh-ancestor
783188|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
783189|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783190|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
783191|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
783192|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
783193|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
783194|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783195|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783454|NCT02642367|Rocuronium|rocuronium|mesh-list
783455|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
783456|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
783457|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
783458|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783459|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242732|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242733|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2242734|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242735|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242736|NCT00107458|Valproic Acid|valproic acid|mesh-list
2242737|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
2242738|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242739|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242740|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
784613|NCT02637466|Vortioxetine|vortioxetine|mesh-list
784614|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
784615|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
784616|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
784617|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
784618|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784619|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784620|NCT02637466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
784621|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
784622|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
784623|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784624|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
784625|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
784626|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
784627|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
784628|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
784629|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
784695|NCT02637167|Rifaximin|rifaximin|mesh-list
784696|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
784697|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784698|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
785031|NCT02635555|Phenylephrine|phenylephrine|mesh-list
785032|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
785033|NCT02635555|Ephedrine|ephedrine|mesh-list
785034|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
785035|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
785036|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
785037|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785038|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785039|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
785040|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
785041|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
785042|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
785043|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
785044|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
785045|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
785046|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
785047|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
785048|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785049|NCT02635555|Protective Agents|protective agents|mesh-ancestor
785050|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
785166|NCT02635191|Amoxicillin|amoxicillin|mesh-list
785167|NCT02635191|Metronidazole|metronidazole|mesh-list
785168|NCT02635191|Clarithromycin|clarithromycin|mesh-list
785169|NCT02635191|Esomeprazole|esomeprazole|mesh-list
785170|NCT02635191|Omeprazole|omeprazole|mesh-list
785171|NCT02635191|Rabeprazole|rabeprazole|mesh-list
785172|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2242741|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242742|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242743|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
2242744|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2242745|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2242746|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2242747|NCT00107471|Topotecan|topotecan|mesh-list
2242748|NCT00107471|Lenograstim|lenograstim|mesh-list
2242749|NCT00107471|Sargramostim|sargramostim|mesh-list
783714|NCT02641210|Albendazole|albendazole|mesh-list
783715|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
783716|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
783717|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
783718|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
783719|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
783720|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
783721|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
783722|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
783723|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
783724|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783725|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783805|NCT02641028|Aticaprant|aticaprant|mesh-list
783806|NCT02641028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
783807|NCT02641028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783808|NCT02641028|Sensory System Agents|sensory system agents|mesh-ancestor
783809|NCT02641028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
784197|NCT02639520|Fosfomycin|fosfomycin|mesh-list
784198|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
784199|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2095334|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2095335|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095336|NCT02291289|Bevacizumab|bevacizumab|mesh-list
2095337|NCT02291289|Trastuzumab|trastuzumab|mesh-list
784542|NCT02637830|Fluorides|fluorides|mesh-list
784543|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
784544|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
784545|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
784546|NCT02637830|Protective Agents|protective agents|mesh-ancestor
784547|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095338|NCT02291289|Cetuximab|cetuximab|mesh-list
2095339|NCT02291289|Pertuzumab|pertuzumab|mesh-list
2095340|NCT02291289|Capecitabine|capecitabine|mesh-list
2095341|NCT02291289|Fluorouracil|fluorouracil|mesh-list
2095342|NCT02291289|Atezolizumab|atezolizumab|mesh-list
2095343|NCT02291289|Vemurafenib|vemurafenib|mesh-list
2095344|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2242750|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2242751|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
2242752|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785632|NCT02633813|Naftifine|naftifine|mesh-list
785633|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
785634|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
786406|NCT02630888|Memantine|memantine|mesh-list
786407|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
786408|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
786409|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
786410|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
786411|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786412|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786413|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
786414|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
786666|NCT02630264|Paclitaxel|paclitaxel|mesh-list
786667|NCT02630264|Endostatins|endostatins|mesh-list
786668|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
786669|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786670|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
786671|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
786672|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
786673|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786674|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
786675|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
786676|NCT02630264|Growth Substances|growth substances|mesh-ancestor
786677|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786678|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
2095345|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095346|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2095347|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2242753|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
783275|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
783276|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
783277|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783278|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
783279|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
783545|NCT02641821|Nifedipine|nifedipine|mesh-list
783546|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
783547|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
783548|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783549|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
783550|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783551|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
783552|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
783553|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
784075|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
784076|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
784077|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
784078|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784079|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
784080|NCT02639819|Coagulants|coagulants|mesh-ancestor
784653|NCT02637531|Nivolumab|nivolumab|mesh-list
784654|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
784655|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784656|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
784657|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784822|NCT02636270|Mecasermin|mecasermin|mesh-list
784823|NCT02636270|Growth Substances|growth substances|mesh-ancestor
784824|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242754|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2242755|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242756|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242757|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242758|NCT00107510|Carboplatin|carboplatin|mesh-list
2242759|NCT00107510|Docetaxel|docetaxel|mesh-list
2242760|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242761|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
2242762|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
2242763|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
2242764|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242765|NCT00107523|Cytarabine|cytarabine|mesh-list
2242766|NCT00107523|Idarubicin|idarubicin|mesh-list
2242767|NCT00107523|Pravastatin|pravastatin|mesh-list
2242768|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2242769|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
2242770|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785782|NCT02633176|Docetaxel|docetaxel|mesh-list
785783|NCT02633176|Capecitabine|capecitabine|mesh-list
785784|NCT02633176|Cetuximab|cetuximab|mesh-list
785785|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785786|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
785787|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
785788|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
785789|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785790|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
785791|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
785792|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2242771|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242772|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
2242773|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2242774|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2242775|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
2242776|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242777|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2242778|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2242779|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2242780|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786399|NCT02631174|Antithrombins|antithrombins|mesh-list
786400|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
786401|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
786402|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
786403|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786404|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786405|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
786852|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
786853|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2242781|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2242782|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2242783|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2242784|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2242785|NCT00107601|Insulin|insulin|mesh-list
2242786|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2242787|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242788|NCT00107731|Valproic Acid|valproic acid|mesh-list
2242789|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2242790|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
2242791|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2242792|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2242793|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2242794|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2242795|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242796|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783853|NCT02640846|Simendan|simendan|mesh-list
783854|NCT02640846|Milrinone|milrinone|mesh-list
783855|NCT02640846|Norepinephrine|norepinephrine|mesh-list
783856|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
783857|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
783858|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
783859|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783860|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783861|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783862|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
783863|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
783864|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783865|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
783866|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
783867|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
783868|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
783869|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
783870|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783871|NCT02640846|Protective Agents|protective agents|mesh-ancestor
783872|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
784008|NCT02640300|Clozapine|clozapine|mesh-list
784009|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
784010|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
784011|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
784012|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784013|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784014|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
784015|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
784016|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784017|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
784018|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
784019|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
2242797|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242798|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
2242799|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
2242800|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
784453|NCT02638415|Carvedilol|carvedilol|mesh-list
784454|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
784455|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
784456|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
784457|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
784458|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784459|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784460|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
784461|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
784462|NCT02638415|Protective Agents|protective agents|mesh-ancestor
784463|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
784464|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
784465|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
784466|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
784467|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
784468|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
784988|NCT02635750|Donepezil|donepezil|mesh-list
784989|NCT02635750|BI 409306|bi 409306|mesh-list
784990|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
784991|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784992|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784993|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
784998|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
783428|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783429|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
783430|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
783431|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
783432|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
783433|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
783434|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
783435|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
783436|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
783437|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783438|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
783525|NCT02641873|Leucovorin|leucovorin|mesh-list
783526|NCT02641873|Bevacizumab|bevacizumab|mesh-list
783527|NCT02641873|Irinotecan|irinotecan|mesh-list
783528|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
783529|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
783530|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783531|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
783532|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
783533|NCT02641873|Growth Substances|growth substances|mesh-ancestor
783534|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783535|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
783536|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
783537|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
783538|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783539|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783540|NCT02641873|Antidotes|antidotes|mesh-ancestor
783541|NCT02641873|Protective Agents|protective agents|mesh-ancestor
783542|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
783543|NCT02641873|Vitamins|vitamins|mesh-ancestor
783544|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
783726|NCT02641301|Morphine|morphine|mesh-list
783727|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
783728|NCT02641301|Narcotics|narcotics|mesh-ancestor
783729|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
783730|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783731|NCT02641301|Analgesics|analgesics|mesh-ancestor
783732|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
783733|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783844|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
783845|NCT02640976|Cetrorelix|cetrorelix|mesh-list
783846|NCT02640976|Menotropins|menotropins|mesh-list
783847|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
783848|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783849|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
783850|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
783851|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
783852|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
783962|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
783963|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
783964|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
783965|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
783966|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
783967|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
2242801|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242802|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2242803|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242804|NCT00107796|Modafinil|modafinil|mesh-list
2242805|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2242806|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242807|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2242808|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2242809|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2242810|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242811|NCT00107809|Modafinil|modafinil|mesh-list
2242812|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2242813|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242814|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2242815|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
784739|NCT02636946|Bimatoprost|bimatoprost|mesh-list
784740|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2095348|NCT02291289|Growth Substances|growth substances|mesh-ancestor
2095349|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095350|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
2095351|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
783442|NCT02642601|Analgesics|analgesics|mesh-ancestor
783443|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
783444|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783445|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783446|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
783447|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
783448|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
783449|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
783450|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
783451|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
783452|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783453|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242816|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2242817|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242818|NCT00107822|Lidocaine|lidocaine|mesh-list
784355|NCT02638701|Infliximab|infliximab|mesh-list
784356|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
784357|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
784358|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2242819|NCT00107822|Tetracaine|tetracaine|mesh-list
2242820|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
2242821|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
2242822|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2242823|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242824|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
2242825|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242826|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2242827|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2242828|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2242829|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2242830|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242831|NCT00107835|Lidocaine|lidocaine|mesh-list
2242832|NCT00107835|Tetracaine|tetracaine|mesh-list
2242833|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
2242834|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
2242835|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
786076|NCT02631928|Insulin|insulin|mesh-list
786077|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
786078|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
786079|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
786080|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786174|NCT02631603|Prednisolone|prednisolone|mesh-list
786175|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
786176|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
786177|NCT02631603|Hormones|hormones|mesh-ancestor
786178|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
786179|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786180|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
786181|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242836|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242837|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
2242838|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242839|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2242840|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2242841|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2242842|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2242843|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242844|NCT00107848|Modafinil|modafinil|mesh-list
2242845|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
786909|NCT02629224|Gabapentin|gabapentin|mesh-list
786910|NCT02629224|Analgesics|analgesics|mesh-ancestor
786911|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
786912|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
786913|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786914|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
786915|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
786916|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
786917|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
786918|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
786919|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
786920|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
786921|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
786922|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786923|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
2242846|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242847|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2242848|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2242849|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2242850|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242851|NCT00107874|Misoprostol|misoprostol|mesh-list
2242852|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2242853|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
2242854|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2242855|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242856|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2242857|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2242858|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
2242859|NCT00108004|Pramlintide|pramlintide|mesh-list
2242860|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2242861|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784528|NCT02638142|Furosemide|furosemide|mesh-list
784529|NCT02638142|Diuretics|diuretics|mesh-ancestor
784530|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
784531|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784532|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
784533|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
784534|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784658|NCT02637284|BPC 157|bpc 157|mesh-list
784659|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
784660|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
785058|NCT02635334|Montelukast|montelukast|mesh-list
785059|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
785060|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
785061|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
785062|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
785063|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
785064|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785065|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
785066|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
785067|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785225|NCT02635061|Nivolumab|nivolumab|mesh-list
785226|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
785227|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785228|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
785229|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095352|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
2095353|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095354|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2095355|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
2095356|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2242862|NCT00108017|Timolol|timolol|mesh-list
2242863|NCT00108017|Dorzolamide|dorzolamide|mesh-list
2242864|NCT00108017|Maleic acid|maleic acid|mesh-list
2242865|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
786686|NCT02630160|Epinephrine|epinephrine|mesh-list
786687|NCT02630160|Bupivacaine|bupivacaine|mesh-list
786688|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
786689|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
786690|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
786691|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786692|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
786693|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
786694|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
786695|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
786696|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
786697|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
786698|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786699|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
786700|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
786701|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
786702|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
786703|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
786704|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
786705|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
786706|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
783817|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
783818|NCT02641340|Narcotics|narcotics|mesh-ancestor
783819|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
783820|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783821|NCT02641340|Analgesics|analgesics|mesh-ancestor
783822|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
783823|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
783824|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
783825|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
783826|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
783827|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
783979|NCT02640365|Leucovorin|leucovorin|mesh-list
783980|NCT02640365|Bevacizumab|bevacizumab|mesh-list
783981|NCT02640365|Irinotecan|irinotecan|mesh-list
783982|NCT02640365|Camptothecin|camptothecin|mesh-list
783983|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
783984|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
783985|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
783986|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
783987|NCT02640365|Growth Substances|growth substances|mesh-ancestor
783988|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
783989|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
783990|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
783991|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
783992|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
783993|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
783994|NCT02640365|Antidotes|antidotes|mesh-ancestor
783995|NCT02640365|Protective Agents|protective agents|mesh-ancestor
783996|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
783997|NCT02640365|Vitamins|vitamins|mesh-ancestor
783998|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
783999|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
784134|NCT02639650|Dactinomycin|dactinomycin|mesh-list
784135|NCT02639650|Paclitaxel|paclitaxel|mesh-list
784136|NCT02639650|Etoposide|etoposide|mesh-list
784137|NCT02639650|Vincristine|vincristine|mesh-list
784138|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
784139|NCT02639650|Carboplatin|carboplatin|mesh-list
784140|NCT02639650|Methotrexate|methotrexate|mesh-list
784141|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
784142|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784143|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
784144|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
784145|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
784146|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784147|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
784148|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
784149|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784150|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
784151|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
784152|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
784153|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
784154|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
784155|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
784156|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
784157|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
784158|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
784159|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
784160|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784161|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
784162|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
784163|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
784164|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
784165|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
784166|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784167|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
784168|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
784359|NCT02638805|Metformin|metformin|mesh-list
784360|NCT02638805|Liraglutide|liraglutide|mesh-list
784361|NCT02638805|Exenatide|exenatide|mesh-list
784362|NCT02638805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
784363|NCT02638805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784364|NCT02638805|Incretins|incretins|mesh-ancestor
784365|NCT02638805|Hormones|hormones|mesh-ancestor
784366|NCT02638805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
784367|NCT02638805|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2242866|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2242867|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
2242868|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242869|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784109|NCT02639741|Vitamins|vitamins|mesh-list
784110|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
784111|NCT02639741|Melatonin|melatonin|mesh-list
784112|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
784113|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784114|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
784115|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784116|NCT02639741|Protective Agents|protective agents|mesh-ancestor
784117|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2095357|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095358|NCT02291419|Aspirin|aspirin|mesh-list
2095359|NCT02291419|Ticagrelor|ticagrelor|mesh-list
2095360|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2095361|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
784633|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
784634|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
784635|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
784636|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784637|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
784638|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784639|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
784846|NCT02636348|Vitamin D|vitamin d|mesh-list
784847|NCT02636348|Calcium|calcium|mesh-list
784848|NCT02636348|Vitamins|vitamins|mesh-ancestor
784849|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
784850|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784851|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
784852|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
785475|NCT02634203|Riociguat|riociguat|mesh-list
785476|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
785477|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785640|NCT02633761|Misoprostol|misoprostol|mesh-list
785641|NCT02633761|Mifepristone|mifepristone|mesh-list
785642|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
785643|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
785644|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
785645|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785646|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
785647|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
785648|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
785649|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
785650|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
785651|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
785652|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
785653|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
785654|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
785655|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
785656|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
785657|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
785658|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
785659|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
785660|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
785722|NCT02633384|Sorbitol|sorbitol|mesh-list
785723|NCT02633384|SMOFlipid|smoflipid|mesh-list
785724|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
785725|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
785726|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
785727|NCT02633384|Cathartics|cathartics|mesh-ancestor
785728|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
786072|NCT02632279|Tryptophan|tryptophan|mesh-list
786073|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
786074|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
786075|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
786128|NCT02631616|Somatostatin|somatostatin|mesh-list
786129|NCT02631616|Hormones|hormones|mesh-ancestor
786130|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
786131|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242870|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242871|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2242872|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2242873|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242874|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2242875|NCT00108095|Ondansetron|ondansetron|mesh-list
2242876|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
2242877|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
784226|NCT02639065|Durvalumab|durvalumab|mesh-list
784227|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
784228|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784282|NCT02638909|Ceritinib|ceritinib|mesh-list
784283|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784284|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
784285|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784286|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784447|NCT02638584|Rabeprazole|rabeprazole|mesh-list
784448|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
784449|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
784450|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
784451|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784452|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242878|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242879|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242880|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2242881|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
2242882|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
2242883|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2242884|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
2242885|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242886|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242887|NCT00108095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2242888|NCT00108095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2242889|NCT00108095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2242890|NCT00108095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2242891|NCT00108095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2242892|NCT00108186|Celecoxib|celecoxib|mesh-list
2242893|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
785676|NCT02633618|Neurotropin|neurotropin|mesh-list
785677|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
785678|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
785679|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785680|NCT02633618|Analgesics|analgesics|mesh-ancestor
785681|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
785682|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785683|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
785823|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
785824|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
785825|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785994|NCT02632331|Gabapentin|gabapentin|mesh-list
785995|NCT02632331|Analgesics|analgesics|mesh-ancestor
785996|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
785997|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785998|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785999|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
786000|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
786001|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
786002|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
786003|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
786004|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
786005|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
786006|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
786007|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786008|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
786132|NCT02631668|Ascorbic Acid|ascorbic acid|mesh-list
786133|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
786134|NCT02631668|Vitamins|vitamins|mesh-ancestor
786135|NCT02631668|Micronutrients|micronutrients|mesh-ancestor
786136|NCT02631668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786137|NCT02631668|Antioxidants|antioxidants|mesh-ancestor
786138|NCT02631668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786139|NCT02631668|Protective Agents|protective agents|mesh-ancestor
786140|NCT02631668|Hematinics|hematinics|mesh-ancestor
2242894|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2242895|NCT00108186|Analgesics|analgesics|mesh-ancestor
2242896|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
2242897|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242898|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242899|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2242900|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2242901|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2242902|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2242903|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784174|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
784661|NCT02637375|Paclitaxel|paclitaxel|mesh-list
784662|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
784663|NCT02637375|Doxorubicin|doxorubicin|mesh-list
784664|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
784665|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784666|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
784667|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
784668|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
784669|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784670|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
784671|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
784672|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784673|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
784674|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
784675|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
784676|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
784677|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
784678|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
784679|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
784680|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784973|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
784974|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
784975|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242904|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242905|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2242906|NCT00108238|Estradiol|estradiol|mesh-list
2242907|NCT00108238|Progesterone|progesterone|mesh-list
2242908|NCT00108238|Estrogens|estrogens|mesh-ancestor
2242909|NCT00108238|Hormones|hormones|mesh-ancestor
2242910|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2242911|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242912|NCT00108238|Progestins|progestins|mesh-ancestor
2242913|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
786057|NCT02632136|Bupivacaine|bupivacaine|mesh-list
786058|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
786059|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
786060|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
786061|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786062|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
786063|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242914|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
2242915|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2242916|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2242917|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2242918|NCT00108251|Eplerenone|eplerenone|mesh-list
2242919|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2242920|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
2242921|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2242922|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787170|NCT02628080|Atovaquone|atovaquone|mesh-list
787171|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
787172|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
787173|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
787174|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
787175|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787176|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787503|NCT02626845|Rituximab|rituximab|mesh-list
787504|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
787505|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787506|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
787507|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787508|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
787516|NCT02626364|Crenolanib|crenolanib|mesh-list
787517|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242923|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2242924|NCT00108251|Diuretics|diuretics|mesh-ancestor
787793|NCT02625558|Riociguat|riociguat|mesh-list
787794|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
787795|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788239|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
788240|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
788241|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
788242|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
2242925|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
784178|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
784179|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784180|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
784181|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
784182|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784183|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
784184|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
784185|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
784186|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
784187|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
784188|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
784368|NCT02638831|Ketorolac|ketorolac|mesh-list
784369|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
784370|NCT02638831|Ketoprofen|ketoprofen|mesh-list
784371|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
784372|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
784373|NCT02638831|Analgesics|analgesics|mesh-ancestor
784374|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
784375|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
784376|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784377|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
784378|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
784379|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
784380|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784381|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784839|NCT02636231|Endostatins|endostatins|mesh-list
784840|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
784841|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
784842|NCT02636231|Growth Substances|growth substances|mesh-ancestor
784843|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784844|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
784845|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785260|NCT02634489|Tamsulosin|tamsulosin|mesh-list
785261|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
785262|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
785263|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
785264|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
785265|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
785266|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
785267|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785268|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785269|NCT02634489|Urological Agents|urological agents|mesh-ancestor
785270|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
785271|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
785272|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
785478|NCT02633969|Indomethacin|indomethacin|mesh-list
785479|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
785480|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
785481|NCT02633969|Analgesics|analgesics|mesh-ancestor
785482|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
785483|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785484|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785485|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
785486|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
785487|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
785488|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
785489|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
785490|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
785491|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785492|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785661|NCT02633709|Itraconazole|itraconazole|mesh-list
785662|NCT02633709|Risdiplam|risdiplam|mesh-list
785663|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
785664|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
785665|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
785666|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
785667|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785668|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785669|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
785670|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
785671|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
785672|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785673|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
784237|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784238|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784265|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
784266|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
784267|NCT02638922|Trisequens|trisequens|mesh-list
784268|NCT02638922|Norethindrone|norethindrone|mesh-list
784269|NCT02638922|Estradiol|estradiol|mesh-list
784270|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
784271|NCT02638922|Estrogens|estrogens|mesh-ancestor
784272|NCT02638922|Hormones|hormones|mesh-ancestor
784273|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
784274|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784275|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
784276|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
784277|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
784278|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
784279|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
784280|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
784281|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
784469|NCT02638285|Clomiphene|clomiphene|mesh-list
784470|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
784471|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
784472|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
784473|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784474|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
784475|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
784476|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
784477|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
784478|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2242926|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2242927|NCT00108316|Fluoxetine|fluoxetine|mesh-list
2242928|NCT00108316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2242929|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2242930|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2242931|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242932|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242933|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
2242934|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242935|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2242936|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
2242937|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2242938|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
784909|NCT02635802|Lidocaine|lidocaine|mesh-list
784910|NCT02635802|Midazolam|midazolam|mesh-list
784911|NCT02635802|Remifentanil|remifentanil|mesh-list
784912|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
784913|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
784914|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784915|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784916|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
784917|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
784918|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
784919|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
784920|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
784921|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
784922|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784923|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
784924|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
784925|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
784926|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
784927|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
784928|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
784929|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
784930|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
784931|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
784932|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
784933|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
784934|NCT02635802|Narcotics|narcotics|mesh-ancestor
784935|NCT02635802|Analgesics|analgesics|mesh-ancestor
785003|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
785004|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
785005|NCT02635607|Ganirelix|ganirelix|mesh-list
785006|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
785007|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
784330|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784331|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
784332|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
784333|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
784334|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
784335|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784336|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784337|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
784338|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
784339|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
784340|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784407|NCT02638519|Xenon|xenon|mesh-list
784408|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
784409|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
784410|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
784411|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
784412|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784862|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
784863|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
784864|NCT02636387|Coagulants|coagulants|mesh-ancestor
784865|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
784866|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
784867|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242939|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2242940|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2242941|NCT00108368|Olanzapine|olanzapine|mesh-list
2242942|NCT00108368|Risperidone|risperidone|mesh-list
2242943|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2242944|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
2242945|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242946|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242947|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242948|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2242949|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2242950|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2242951|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2242952|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2242953|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
2242954|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
2242955|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
2242956|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242957|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2242958|NCT00108368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2242959|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2242960|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2242961|NCT00108394|Pamidronate|pamidronate|mesh-list
2242962|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2242963|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242964|NCT00108420|Prazosin|prazosin|mesh-list
2242965|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2242966|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2242967|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2242968|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2242969|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
2242970|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2242971|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242972|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242973|NCT00108446|Lidocaine|lidocaine|mesh-list
2242974|NCT00108446|Fentanyl|fentanyl|mesh-list
2242975|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
2242976|NCT00108446|Naloxone|naloxone|mesh-list
2242977|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
2242978|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
2242979|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2242980|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242981|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
2242982|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2242983|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2242984|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2242985|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2242986|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2242987|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2242988|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
785887|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
785888|NCT02632760|Hematinics|hematinics|mesh-ancestor
784349|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
784350|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
784351|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
784352|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
784353|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
784354|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784425|NCT02638389|Sirolimus|sirolimus|mesh-list
784426|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
784427|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784428|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
784429|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784430|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
784431|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
784432|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
784433|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2242989|NCT00108446|Narcotics|narcotics|mesh-ancestor
2242990|NCT00108446|Analgesics|analgesics|mesh-ancestor
2242991|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2242992|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2242993|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
2242994|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2242995|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
2242996|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
784882|NCT02636088|Cetuximab|cetuximab|mesh-list
784883|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
784884|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785306|NCT02634476|Ethanol|ethanol|mesh-list
785307|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
785308|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
785309|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
785310|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785605|NCT02633696|Silybin|silybin|mesh-list
785606|NCT02633696|Silymarin|silymarin|mesh-list
785607|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
785608|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785609|NCT02633696|Protective Agents|protective agents|mesh-ancestor
785610|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785611|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
785612|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2242997|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2242998|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2242999|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
785797|NCT02633137|Cytarabine|cytarabine|mesh-list
785798|NCT02633137|Lenalidomide|lenalidomide|mesh-list
785799|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
785800|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
785801|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785802|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785803|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
785804|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
785805|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
785806|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
785807|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785808|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
785809|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
785810|NCT02633137|Growth Substances|growth substances|mesh-ancestor
785811|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
786601|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
786602|NCT02630368|Avelumab|avelumab|mesh-list
786603|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
786604|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
786605|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786606|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
786607|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
786608|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
786609|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786610|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786611|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
786612|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2243000|NCT00108498|Mirtazapine|mirtazapine|mesh-list
2243001|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
2243002|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2243003|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
787229|NCT02627846|Lidocaine|lidocaine|mesh-list
787230|NCT02627846|Epinephrine|epinephrine|mesh-list
787231|NCT02627846|Racepinephrine|racepinephrine|mesh-list
2243004|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
785570|NCT02633683|Gabapentin|gabapentin|mesh-list
785571|NCT02633683|Analgesics|analgesics|mesh-ancestor
785572|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
785573|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785574|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785575|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
785576|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
785577|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
785578|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
785579|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
785580|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
785581|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
785582|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
785583|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785584|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
786050|NCT02631993|Furocoumarins|furocoumarins|mesh-list
786051|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
786052|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
786210|NCT02631499|Epirubicin|epirubicin|mesh-list
786211|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
786212|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
786213|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786214|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
786215|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
786216|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786217|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786839|NCT02629718|Paclitaxel|paclitaxel|mesh-list
786840|NCT02629718|Carboplatin|carboplatin|mesh-list
786841|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
786842|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786843|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
786844|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
786845|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
786846|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243005|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
2243006|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243007|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787315|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
787316|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
787947|NCT02624830|Glyburide|glyburide|mesh-list
787948|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
787949|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788204|NCT02624518|Bombesin|bombesin|mesh-list
788205|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
788206|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788207|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788331|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
788332|NCT02624141|Hematinics|hematinics|mesh-ancestor
788657|NCT02622854|Insulin|insulin|mesh-list
788658|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
788659|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788719|NCT02622386|Riboflavin|riboflavin|mesh-list
788720|NCT02622386|Vitamins|vitamins|mesh-ancestor
788721|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
788722|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788723|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
788724|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
788725|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
788801|NCT02621905|Itraconazole|itraconazole|mesh-list
788802|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
788803|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
788804|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
788805|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
788806|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
788807|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788808|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788809|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
788810|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
788811|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
788812|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788813|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
784630|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
784631|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
784632|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785367|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
785368|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
785369|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
785370|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
785371|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785372|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
785467|NCT02634034|Pitavastatin|pitavastatin|mesh-list
785468|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
785469|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
785470|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
785471|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
785472|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785473|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785474|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
785927|NCT02632708|Cytarabine|cytarabine|mesh-list
785928|NCT02632708|Etoposide|etoposide|mesh-list
785929|NCT02632708|Daunorubicin|daunorubicin|mesh-list
785930|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
785931|NCT02632708|Idarubicin|idarubicin|mesh-list
785932|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
785933|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785934|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
785935|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
785936|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785937|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785938|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
785939|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
785940|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
785941|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
785942|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
785943|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
785944|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785945|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
785946|NCT02632708|Analgesics|analgesics|mesh-ancestor
785947|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
785948|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
786431|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
786432|NCT02631109|Doxorubicin|doxorubicin|mesh-list
786433|NCT02631109|Etoposide|etoposide|mesh-list
786434|NCT02631109|Pegaspargase|pegaspargase|mesh-list
786435|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
786436|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786437|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
786438|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
786439|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786440|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786441|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
786442|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
786443|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
786444|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
786445|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
786446|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786447|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
786448|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
786449|NCT02631109|Hormones|hormones|mesh-ancestor
786450|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
786451|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
786452|NCT02631109|Protective Agents|protective agents|mesh-ancestor
2243008|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243009|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2243010|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2243011|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243012|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
784708|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
784709|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
784710|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
784711|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784712|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
784713|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
784714|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784715|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784716|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784717|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784718|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
784719|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
784720|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
784721|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
784722|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
784723|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
784724|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
784767|NCT02636816|Carbetocin|carbetocin|mesh-list
784768|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
784769|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
784770|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243013|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2243014|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2243015|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
2243016|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2243017|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2243018|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
2243019|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2243020|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
2243021|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2243022|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
2243023|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243024|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2243025|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
785793|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
785794|NCT02632916|Denosumab|denosumab|mesh-list
785795|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
785796|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243026|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2243027|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243028|NCT00108537|Bupropion|bupropion|mesh-list
2243029|NCT00108537|Nicotine|nicotine|mesh-list
2243030|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2243031|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
2243032|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243033|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754101|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2095362|NCT02291419|Analgesics|analgesics|mesh-ancestor
2095363|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
2095364|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754102|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
2754103|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
787518|NCT02626507|Fulvestrant|fulvestrant|mesh-list
787519|NCT02626507|Goserelin|goserelin|mesh-list
787520|NCT02626507|Palbociclib|palbociclib|mesh-list
787521|NCT02626507|Gedatolisib|gedatolisib|mesh-list
787522|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
787523|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787524|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
787525|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
787526|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
787527|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
787528|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787529|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
787530|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787531|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787749|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
787750|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
787751|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
787752|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787753|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
2243034|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2243035|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2243036|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
2243037|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243038|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243039|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
784813|NCT02636426|Sorafenib|sorafenib|mesh-list
784814|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784815|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
784816|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784817|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785393|NCT02634515|Insulin|insulin|mesh-list
785394|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
785395|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
785396|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785493|NCT02634021|Midazolam|midazolam|mesh-list
785494|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
785495|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
785496|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
785497|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785498|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
785499|NCT02634021|Analgesics|analgesics|mesh-ancestor
785500|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
785501|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785502|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
785503|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
785504|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
785505|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
785506|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
785507|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785508|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
785509|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
785510|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
785511|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
785512|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
785513|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
785514|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
785515|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
785516|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
2095365|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095366|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2095367|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2095368|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2095369|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2095370|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095371|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2095372|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2095373|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095374|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
786053|NCT02632032|Insulin|insulin|mesh-list
786054|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
786055|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
786056|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786125|NCT02631759|Levetiracetam|levetiracetam|mesh-list
786126|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
786127|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
786287|NCT02631473|Ritonavir|ritonavir|mesh-list
786288|NCT02631473|Lopinavir|lopinavir|mesh-list
786289|NCT02631473|Efavirenz|efavirenz|mesh-list
786290|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
786291|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
786292|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
786293|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786294|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786295|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
786296|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
786297|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
786298|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
786299|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
786300|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
786301|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
786302|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
786303|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
786304|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
786305|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
784607|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
784608|NCT02637700|Antibodies|antibodies|mesh-list
784609|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
784610|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
784611|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
784612|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784771|NCT02636829|Calcium|calcium|mesh-list
784772|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
784773|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784976|NCT02635971|Gemcitabine|gemcitabine|mesh-list
784977|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
784978|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
784979|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
784980|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
784981|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
784982|NCT02635971|Antiviral Agents|antiviral agents|mesh-ancestor
784983|NCT02635971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784984|NCT02635971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
784985|NCT02635971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
784986|NCT02635971|Immunologic Factors|immunologic factors|mesh-ancestor
784987|NCT02635971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785208|NCT02635074|Cytarabine|cytarabine|mesh-list
785209|NCT02635074|Idarubicin|idarubicin|mesh-list
785210|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
785211|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
785212|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785213|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785214|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
785215|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
785216|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
785217|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
785218|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785219|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
785220|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
785221|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
785222|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785684|NCT02633839|Carbidopa|carbidopa|mesh-list
785685|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
785686|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
785687|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
785688|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
785689|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785690|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785691|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
785692|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095375|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2095376|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2095377|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2095378|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
2095379|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095380|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
2095381|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2095382|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
2095383|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2754104|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754105|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2754106|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2754107|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
786639|NCT02630303|Coal Tar|coal tar|mesh-list
786640|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
786641|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
786770|NCT02629913|Methaqualone|methaqualone|mesh-list
786771|NCT02629913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
786772|NCT02629913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
786773|NCT02629913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787011|NCT02628951|Paclitaxel|paclitaxel|mesh-list
787012|NCT02628951|Ramucirumab|ramucirumab|mesh-list
787013|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
787014|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787015|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
787016|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
787017|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
787018|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787162|NCT02628002|Regadenoson|regadenoson|mesh-list
787163|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
787164|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2243040|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
2243041|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2243042|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2243043|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2243044|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2243045|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
2243046|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2243047|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2243048|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785426|NCT02634281|Varenicline|varenicline|mesh-list
785427|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
785428|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
785429|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
785430|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
785431|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785432|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785517|NCT02633995|Anesthetics|anesthetics|mesh-list
785518|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
785519|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243049|NCT00108563|Citalopram|citalopram|mesh-list
2243050|NCT00108563|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2243051|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2243052|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2243053|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786380|NCT02630862|Aspirin|aspirin|mesh-list
786381|NCT02630862|Dipyridamole|dipyridamole|mesh-list
786382|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
786383|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
786384|NCT02630862|Analgesics|analgesics|mesh-ancestor
786385|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
786386|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
786387|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786388|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
786389|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
786390|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
786391|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
786392|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786393|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
786394|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
786395|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786396|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
786397|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
786398|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
786483|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
786484|NCT02630628|Tacrolimus|tacrolimus|mesh-list
786485|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
786486|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
786487|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786488|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
786489|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786490|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786491|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
786492|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786493|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
786494|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
786495|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
786496|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
786803|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
786804|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
786963|NCT02629146|Fentanyl|fentanyl|mesh-list
786964|NCT02629146|Midazolam|midazolam|mesh-list
786965|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
786966|NCT02629146|Narcotics|narcotics|mesh-ancestor
786967|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
786968|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786969|NCT02629146|Analgesics|analgesics|mesh-ancestor
786970|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
786971|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
786972|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
786973|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
786974|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
786975|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
786976|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
786977|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
786978|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2243054|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243055|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
2243056|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243057|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
785132|NCT02635282|Fentanyl|fentanyl|mesh-list
785133|NCT02635282|Midazolam|midazolam|mesh-list
785134|NCT02635282|Ketamine|ketamine|mesh-list
785135|NCT02635282|Analgesics|analgesics|mesh-ancestor
785136|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
785137|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785138|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785139|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
785140|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
785141|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
785142|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
785143|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
785144|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
785145|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
785146|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
785147|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785148|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
785149|NCT02635282|Narcotics|narcotics|mesh-ancestor
785150|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
785151|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
785152|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
785153|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
785154|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
785155|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
785156|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
785339|NCT02634463|Olanzapine|olanzapine|mesh-list
785340|NCT02634463|Risperidone|risperidone|mesh-list
785341|NCT02634463|Aripiprazole|aripiprazole|mesh-list
785342|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
785343|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
785344|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
785345|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
785346|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785347|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785348|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
785349|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
785350|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
785351|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
785352|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
785353|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
785354|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
785355|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
785356|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785357|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
785358|NCT02634463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
785359|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
785360|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
785361|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
785362|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
785363|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
785364|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
785365|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
785366|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
785585|NCT02633852|Aflibercept|aflibercept|mesh-list
785586|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
785587|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
785588|NCT02633852|Growth Substances|growth substances|mesh-ancestor
785589|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785590|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
785591|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785812|NCT02633514|Etoposide|etoposide|mesh-list
785813|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785814|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
785815|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
785816|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
785817|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785818|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095384|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
2095385|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2095386|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2095387|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
784837|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
784838|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095388|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
2095389|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
2095390|NCT02291679|Linaclotide|linaclotide|mesh-list
2095391|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2095392|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
2095393|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095394|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2095395|NCT02291913|Tamoxifen|tamoxifen|mesh-list
2095396|NCT02291913|Everolimus|everolimus|mesh-list
2754108|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2754109|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786081|NCT02632071|Paclitaxel|paclitaxel|mesh-list
786082|NCT02632071|Ricolinostat|ricolinostat|mesh-list
786083|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
786084|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786085|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
786086|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
786087|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
786088|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786089|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
786090|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095397|NCT02291913|Letrozole|letrozole|mesh-list
2095398|NCT02291913|Fulvestrant|fulvestrant|mesh-list
2095399|NCT02291913|Anastrozole|anastrozole|mesh-list
2095400|NCT02291913|Exemestane|exemestane|mesh-list
2095401|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095402|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2095403|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
2095404|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095405|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2095406|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2095407|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243058|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
2243059|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2243060|NCT00108576|Valproic Acid|valproic acid|mesh-list
2243061|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
2243062|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243063|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243064|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
2243065|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243066|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243067|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
2243068|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2243069|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243070|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2243071|NCT00108602|Acetazolamide|acetazolamide|mesh-list
2243072|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
2243073|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2243074|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243075|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243076|NCT00108602|Diuretics|diuretics|mesh-ancestor
2243077|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
2243078|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243079|NCT00108615|Metformin|metformin|mesh-list
2243080|NCT00108615|Pioglitazone|pioglitazone|mesh-list
2243081|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2243082|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243083|NCT00108667|Levodopa|levodopa|mesh-list
2243084|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2243085|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2243086|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
2243087|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243088|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787326|NCT02627469|Listerine|listerine|mesh-list
787327|NCT02627469|Fluorides|fluorides|mesh-list
787328|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
787329|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
787330|NCT02627469|Protective Agents|protective agents|mesh-ancestor
787331|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787332|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2095408|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095409|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2095410|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
2243089|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243090|NCT00108706|Candesartan|candesartan|mesh-list
784857|NCT02636582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784858|NCT02636582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785022|NCT02635893|Cycloserine|cycloserine|mesh-list
785023|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
785024|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
785025|NCT02635893|Renal Agents|renal agents|mesh-ancestor
785026|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
785027|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
785028|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
785029|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
785030|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243091|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2243092|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2243093|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2243094|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243095|NCT00108771|Fentanyl|fentanyl|mesh-list
2243096|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2243097|NCT00108771|Narcotics|narcotics|mesh-ancestor
2243098|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243099|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243100|NCT00108771|Analgesics|analgesics|mesh-ancestor
2243101|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
2243102|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243103|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2243104|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2243105|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
2243106|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
2243107|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
2243108|NCT00108797|Coagulants|coagulants|mesh-ancestor
2243109|NCT00108810|Ketoprofen|ketoprofen|mesh-list
785617|NCT02633657|Gabapentin|gabapentin|mesh-list
785618|NCT02633657|Analgesics|analgesics|mesh-ancestor
785619|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
785620|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785621|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785622|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
785623|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
785624|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
785625|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
785626|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
785627|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
785628|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
785629|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
785630|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785631|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
785836|NCT02633007|Levodopa|levodopa|mesh-list
785837|NCT02633007|Carbidopa|carbidopa|mesh-list
785838|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
785839|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
785840|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
785841|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
785842|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785843|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785844|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
785845|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785897|NCT02632565|Lidocaine|lidocaine|mesh-list
785913|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
785914|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
785915|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
785916|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785917|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
785918|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785919|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
785920|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
785921|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
785922|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
785923|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786259|NCT02631408|Vancomycin|vancomycin|mesh-list
786260|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
786261|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243110|NCT00108810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2243111|NCT00108810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2243112|NCT00108810|Analgesics|analgesics|mesh-ancestor
2243113|NCT00108810|Sensory System Agents|sensory system agents|mesh-ancestor
784876|NCT02636101|Hormones|hormones|mesh-ancestor
784877|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
784878|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784879|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
784880|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
784881|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
2243114|NCT00108810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243115|NCT00108810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243116|NCT00108810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2243117|NCT00108810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243118|NCT00108810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2243119|NCT00108810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243120|NCT00108810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243121|NCT00108849|Estradiol|estradiol|mesh-list
2243122|NCT00108849|Estrogens|estrogens|mesh-ancestor
2243123|NCT00108849|Hormones|hormones|mesh-ancestor
2243124|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2243125|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243126|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
2243127|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2243128|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
2243129|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243130|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243131|NCT00108979|Citalopram|citalopram|mesh-list
2243132|NCT00108979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2243133|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2243134|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2754110|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
785433|NCT02634255|Fentanyl|fentanyl|mesh-list
785434|NCT02634255|Propofol|propofol|mesh-list
785435|NCT02634255|Rocuronium|rocuronium|mesh-list
785436|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
785437|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
785438|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785439|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
785440|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
785441|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
785442|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
785443|NCT02634255|Narcotics|narcotics|mesh-ancestor
785444|NCT02634255|Analgesics|analgesics|mesh-ancestor
785445|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
785446|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785447|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
785448|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
785449|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
785450|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
785766|NCT02633202|Cisplatin|cisplatin|mesh-list
785767|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786148|NCT02631694|Propranolol|propranolol|mesh-list
786149|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
786150|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
786151|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
786152|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
786153|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786154|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786155|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
786156|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
786157|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
2095411|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2095412|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2095413|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2095414|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2095415|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2095416|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
787281|NCT02627807|Gemcitabine|gemcitabine|mesh-list
787282|NCT02627807|Cisplatin|cisplatin|mesh-list
787283|NCT02627807|Docetaxel|docetaxel|mesh-list
787284|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787285|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
787286|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
787287|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787288|NCT02627807|Antiviral Agents|antiviral agents|mesh-ancestor
787289|NCT02627807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
787290|NCT02627807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243135|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243136|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243137|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
2243138|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243139|NCT00108979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2243140|NCT00108979|Antidepressive Agents|antidepressive agents|mesh-ancestor
2243141|NCT00108979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2243142|NCT00108992|Diclofenac|diclofenac|mesh-list
2243143|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2243144|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
785127|NCT02635243|Glucagon|glucagon|mesh-list
785128|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785129|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
785130|NCT02635243|Hormones|hormones|mesh-ancestor
785131|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2243145|NCT00108992|Analgesics|analgesics|mesh-ancestor
2243146|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
2243147|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243148|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243149|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2243150|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243151|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2243152|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243153|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243154|NCT00109044|Citalopram|citalopram|mesh-list
2243155|NCT00109044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2243156|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2243157|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2243158|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243159|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243160|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
2243161|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243162|NCT00109044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
786459|NCT02630823|Paclitaxel|paclitaxel|mesh-list
786460|NCT02630823|Carboplatin|carboplatin|mesh-list
786461|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
786462|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
786463|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786464|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
786465|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
786466|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
786467|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786468|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2243163|NCT00109044|Antidepressive Agents|antidepressive agents|mesh-ancestor
2243164|NCT00109044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2243165|NCT00109057|Bevacizumab|bevacizumab|mesh-list
2243166|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2243167|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243168|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2243169|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2243170|NCT00109057|Growth Substances|growth substances|mesh-ancestor
2243171|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787667|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
787668|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
787669|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788208|NCT02624453|Fluconazole|fluconazole|mesh-list
788209|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
788210|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
788211|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
788212|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
788213|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
788214|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788215|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788216|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
788217|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
788218|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
788219|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788220|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
788221|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
788222|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
788314|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
788315|NCT02624063|Simeprevir|simeprevir|mesh-list
2095417|NCT02292082|Cefazolin|cefazolin|mesh-list
785373|NCT02634294|Interferons|interferons|mesh-list
785374|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
785375|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
785376|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
785377|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785378|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
785379|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
785380|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
785381|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785635|NCT02633878|Progesterone|progesterone|mesh-list
785636|NCT02633878|Progestins|progestins|mesh-ancestor
785637|NCT02633878|Hormones|hormones|mesh-ancestor
785638|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
785639|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095418|NCT02292082|Dexamethasone|dexamethasone|mesh-list
2095419|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
2095420|NCT02292082|Midazolam|midazolam|mesh-list
2095421|NCT02292082|Morphine|morphine|mesh-list
2095422|NCT02292082|Bupivacaine|bupivacaine|mesh-list
2095423|NCT02292082|Propofol|propofol|mesh-list
2095424|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2095425|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
2095426|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
2095427|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095428|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095429|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2095430|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
2095431|NCT02292082|Hormones|hormones|mesh-ancestor
2095432|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2095433|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2095434|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095435|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
2243172|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
2243173|NCT00109070|Bevacizumab|bevacizumab|mesh-list
786892|NCT02629419|Amphotericin B|amphotericin b|mesh-list
786893|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
786894|NCT02629419|Amebicides|amebicides|mesh-ancestor
786895|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
786896|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
786897|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
786898|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
786899|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
786933|NCT02629042|Prednisolone|prednisolone|mesh-list
786934|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786935|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
786936|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
786937|NCT02629042|Hormones|hormones|mesh-ancestor
786938|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
786939|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
786940|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787152|NCT02628197|Vitamin D|vitamin d|mesh-list
787153|NCT02628197|Calcium|calcium|mesh-list
787154|NCT02628197|Vitamins|vitamins|mesh-ancestor
787155|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
787156|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787157|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
787158|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
787929|NCT02624817|Glyburide|glyburide|mesh-list
787930|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
787931|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095436|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
2095437|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2095438|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
2095439|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2095440|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2095441|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
2095442|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2095443|NCT02292082|Narcotics|narcotics|mesh-ancestor
788476|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
788477|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
788478|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
788479|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788480|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
788481|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
788482|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
788483|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095444|NCT02292082|Analgesics|analgesics|mesh-ancestor
2095445|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
784994|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
784995|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
784996|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
784997|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
785949|NCT02632474|Tenofovir|tenofovir|mesh-list
785950|NCT02632474|Lamivudine|lamivudine|mesh-list
785951|NCT02632474|Efavirenz|efavirenz|mesh-list
785952|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
785953|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
785954|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
785955|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
785956|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785957|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785958|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
785959|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
785960|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
785961|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
785962|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
785963|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
785964|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
785965|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2243174|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2243175|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243176|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2243177|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2243178|NCT00109070|Growth Substances|growth substances|mesh-ancestor
2243179|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786339|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
786340|NCT02631135|Remifentanil|remifentanil|mesh-list
786341|NCT02631135|Propofol|propofol|mesh-list
786342|NCT02631135|Rocuronium|rocuronium|mesh-list
786343|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
786344|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
786345|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786346|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
786347|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
786348|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
786349|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
786350|NCT02631135|Analgesics|analgesics|mesh-ancestor
786351|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
786352|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
786353|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
786354|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
786355|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
786356|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
786357|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
786358|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786359|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
786360|NCT02631135|Narcotics|narcotics|mesh-ancestor
786361|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
786362|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
786363|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
786544|NCT02630511|Mannitol|mannitol|mesh-list
786545|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
786546|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
786547|NCT02630511|Diuretics|diuretics|mesh-ancestor
786548|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
786549|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786550|NCT02630511|Miotics|miotics|mesh-ancestor
786551|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
786552|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
786553|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
786554|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
786555|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
786556|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
786557|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
786558|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
786559|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
786560|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786709|NCT02630121|Phenylephrine|phenylephrine|mesh-list
786710|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
786711|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
786712|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
786713|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
786714|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
786854|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
784999|NCT02635867|Calcium|calcium|mesh-list
785000|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
785001|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785002|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
785157|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
785158|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785159|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
785747|NCT02633462|Inositol|inositol|mesh-list
785748|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
785749|NCT02633462|Vitamins|vitamins|mesh-ancestor
785750|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
785751|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786269|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
786270|NCT02631252|Etoposide|etoposide|mesh-list
786271|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
786272|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
786273|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786274|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
786275|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
786276|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786277|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786278|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
786279|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
786280|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
786281|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
786282|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
786283|NCT02631252|Analgesics|analgesics|mesh-ancestor
786284|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
786285|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
786286|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786824|NCT02629744|Etrolizumab|etrolizumab|mesh-list
786825|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
786826|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
786827|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786924|NCT02629315|Formaldehyde|formaldehyde|mesh-list
786925|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
786926|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
787021|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
787022|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787023|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
787024|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
787025|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
787026|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787027|NCT02628847|Urological Agents|urological agents|mesh-ancestor
787141|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
787142|NCT02628392|Firuglipel|firuglipel|mesh-list
787143|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
787144|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787145|NCT02628392|Incretins|incretins|mesh-ancestor
787146|NCT02628392|Hormones|hormones|mesh-ancestor
787147|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
787148|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
787149|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
787150|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787151|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787417|NCT02627092|Copper|copper|mesh-list
787418|NCT02627092|Trace Elements|trace elements|mesh-ancestor
787419|NCT02627092|Micronutrients|micronutrients|mesh-ancestor
787420|NCT02627092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787596|NCT02626208|ST 1435|st 1435|mesh-list
787597|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
787598|NCT02626208|Estradiol|estradiol|mesh-list
787599|NCT02626208|Estrogens|estrogens|mesh-ancestor
787600|NCT02626208|Hormones|hormones|mesh-ancestor
787601|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
787602|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787603|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
787604|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
787605|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2095446|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2095447|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2095448|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2243180|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
2243181|NCT00109096|Pemetrexed|pemetrexed|mesh-list
2243182|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243183|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787969|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
785008|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
785009|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
785010|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785011|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
785012|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
785013|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785014|NCT02635607|Hormones|hormones|mesh-ancestor
785015|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
785016|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
785223|NCT02634853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
785224|NCT02634853|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2243184|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243185|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2243186|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2243187|NCT00109109|Vorinostat|vorinostat|mesh-list
2243188|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243189|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2243190|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243191|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243192|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
2243193|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2243194|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2243195|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243196|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243197|NCT00109135|Hormones|hormones|mesh-ancestor
785592|NCT02633774|Propafenone|propafenone|mesh-list
785593|NCT02633774|Apixaban|apixaban|mesh-list
785594|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
785595|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
785596|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
785597|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
785598|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785599|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785600|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
785601|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
785602|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
785603|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
785604|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
786020|NCT02632019|Gemcitabine|gemcitabine|mesh-list
786021|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
786022|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
786023|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786024|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786025|NCT02632019|Antiviral Agents|antiviral agents|mesh-ancestor
786026|NCT02632019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
786027|NCT02632019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786028|NCT02632019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
786029|NCT02632019|Immunologic Factors|immunologic factors|mesh-ancestor
786030|NCT02632019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243198|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2243199|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785311|NCT02634528|Insulin|insulin|mesh-list
785312|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
785313|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
785314|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
785315|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
785316|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
785317|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095449|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
2095450|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
786009|NCT02632448|Gemcitabine|gemcitabine|mesh-list
786010|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
786011|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
786012|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786013|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786014|NCT02632448|Antiviral Agents|antiviral agents|mesh-ancestor
786015|NCT02632448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
786016|NCT02632448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786017|NCT02632448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
786018|NCT02632448|Immunologic Factors|immunologic factors|mesh-ancestor
786019|NCT02632448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786453|NCT02631447|Nivolumab|nivolumab|mesh-list
786454|NCT02631447|Ipilimumab|ipilimumab|mesh-list
786455|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
786456|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786457|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
786458|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786743|NCT02630004|Melatonin|melatonin|mesh-list
786744|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
786745|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786746|NCT02630004|Protective Agents|protective agents|mesh-ancestor
786747|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786748|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
786889|NCT02629627|Metformin|metformin|mesh-list
786890|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
786891|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787670|NCT02626065|Nivolumab|nivolumab|mesh-list
787671|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
787672|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787673|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
787674|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788321|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
788322|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
788814|NCT02621827|Calcifediol|calcifediol|mesh-list
788815|NCT02621827|Vitamins|vitamins|mesh-ancestor
788816|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
788817|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788818|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
789037|NCT02620800|Leucovorin|leucovorin|mesh-list
789038|NCT02620800|Paclitaxel|paclitaxel|mesh-list
789039|NCT02620800|Bevacizumab|bevacizumab|mesh-list
789040|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
789041|NCT02620800|Calcium|calcium|mesh-list
789042|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
789043|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
789044|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789045|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
789046|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
789047|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
789048|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789049|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
789050|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
789051|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
789052|NCT02620800|Growth Substances|growth substances|mesh-ancestor
789053|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789054|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
789055|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
789056|NCT02620800|Antidotes|antidotes|mesh-ancestor
789057|NCT02620800|Protective Agents|protective agents|mesh-ancestor
789058|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
789059|NCT02620800|Vitamins|vitamins|mesh-ancestor
789060|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
789246|NCT02619929|Vinorelbine|vinorelbine|mesh-list
789247|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
789248|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785081|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
785082|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785083|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
2095451|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095452|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095453|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2243200|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
785924|NCT02632578|Vaccines|vaccines|mesh-list
785925|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
785926|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786679|NCT02630277|Aflibercept|aflibercept|mesh-list
786680|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
786681|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
786682|NCT02630277|Growth Substances|growth substances|mesh-ancestor
786683|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786684|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
786685|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786792|NCT02629848|Paclitaxel|paclitaxel|mesh-list
786793|NCT02629848|Carboplatin|carboplatin|mesh-list
786794|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
786795|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
786796|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786797|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
786798|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
786799|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
786800|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786801|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
786802|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786880|NCT02629575|Sirolimus|sirolimus|mesh-list
786881|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
786882|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
786883|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
786884|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786885|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
786886|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
786887|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
786888|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787764|NCT02625519|Hormones|hormones|mesh-list
787765|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
787766|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
787767|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788084|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
788085|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
788086|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
788087|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
788088|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
788089|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
788986|NCT02621398|Paclitaxel|paclitaxel|mesh-list
788987|NCT02621398|Carboplatin|carboplatin|mesh-list
788988|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
788989|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
788990|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
788991|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788992|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
788993|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
788994|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
788995|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788996|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
789205|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
789206|NCT02620124|Hormones|hormones|mesh-list
789207|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
789208|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789209|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
789210|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
789211|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
789212|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
789213|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
789214|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
789215|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243201|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2243202|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
790019|NCT02617290|Clopidogrel|clopidogrel|mesh-list
790020|NCT02617290|Ticagrelor|ticagrelor|mesh-list
790085|NCT02616874|Romidepsin|romidepsin|mesh-list
785103|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
785104|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
785105|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785106|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785107|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
785108|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
785109|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
785110|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
785111|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785112|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
785113|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
785114|NCT02636322|Hormones|hormones|mesh-ancestor
785115|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
785116|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
785117|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
785118|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
785119|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
785120|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
785121|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
785122|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
785123|NCT02636322|Growth Substances|growth substances|mesh-ancestor
785124|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
785125|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
785126|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
785239|NCT02634970|Ranibizumab|ranibizumab|mesh-list
785240|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
785241|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
785242|NCT02634970|Growth Substances|growth substances|mesh-ancestor
785243|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785244|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
785245|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785257|NCT02634541|Adalimumab|adalimumab|mesh-list
785258|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
785259|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243203|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243204|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243205|NCT00109148|Hormones|hormones|mesh-ancestor
2243206|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2243207|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243208|NCT00109161|Antibodies|antibodies|mesh-list
2243209|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2243210|NCT00109161|Daclizumab|daclizumab|mesh-list
2243211|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
2243212|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243213|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243214|NCT00109187|Omalizumab|omalizumab|mesh-list
2243215|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2243216|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2243217|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
2243218|NCT00109200|Omalizumab|omalizumab|mesh-list
2243219|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2243220|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2243221|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
2243222|NCT00109226|Bevacizumab|bevacizumab|mesh-list
2243223|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2243224|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243225|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2243226|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2243227|NCT00109226|Growth Substances|growth substances|mesh-ancestor
2243228|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243229|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
2243230|NCT00109239|Bevacizumab|bevacizumab|mesh-list
2243231|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2095454|NCT02292082|Protective Agents|protective agents|mesh-ancestor
2095455|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2095456|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2095457|NCT02292719|Ritonavir|ritonavir|mesh-list
2095458|NCT02292719|Ribavirin|ribavirin|mesh-list
2243232|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243233|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2243234|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2243235|NCT00109239|Growth Substances|growth substances|mesh-ancestor
2243236|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243237|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
2095459|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
2095460|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
785173|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
785174|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
785175|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
785176|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
785177|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
785178|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
785179|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785180|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785181|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
785182|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
785183|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2243238|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2243239|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243240|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2243241|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243242|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243243|NCT00109278|Vaccines|vaccines|mesh-list
2243244|NCT00109278|Immunoglobulins|immunoglobulins|mesh-list
2243245|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
2754111|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
785534|NCT02633930|Amoxicillin|amoxicillin|mesh-list
785535|NCT02633930|Clarithromycin|clarithromycin|mesh-list
785536|NCT02633930|Lansoprazole|lansoprazole|mesh-list
785537|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
785538|NCT02633930|Bismuth|bismuth|mesh-list
785539|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
785540|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
785541|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
785542|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785543|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785544|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
785545|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
785546|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
785547|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
785548|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
785549|NCT02633930|Antacids|antacids|mesh-ancestor
785768|NCT02633189|Bevacizumab|bevacizumab|mesh-list
785769|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
785770|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
785771|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785772|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
785773|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
785774|NCT02633189|Growth Substances|growth substances|mesh-ancestor
785775|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785776|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
785777|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
785778|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785779|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786366|NCT02631031|Valsartan|valsartan|mesh-list
786367|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
786368|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
786369|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
786370|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786749|NCT02630108|Epirubicin|epirubicin|mesh-list
786750|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
786751|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
786752|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786753|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
786754|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
786755|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786756|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754112|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2754113|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2754114|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2754115|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754116|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754117|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754118|NCT01940809|Nivolumab|nivolumab|mesh-list
2754119|NCT01940809|Ipilimumab|ipilimumab|mesh-list
2754120|NCT01940809|Trametinib|trametinib|mesh-list
2754121|NCT01940809|Dabrafenib|dabrafenib|mesh-list
2754122|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2754123|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754124|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
785675|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243246|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243247|NCT00109356|AQ4N|aq4n|mesh-list
2243248|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243249|NCT00109382|Aspirin|aspirin|mesh-list
2243250|NCT00109382|Clopidogrel|clopidogrel|mesh-list
2243251|NCT00109382|Simvastatin|simvastatin|mesh-list
2243252|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2243253|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2243254|NCT00109382|Analgesics|analgesics|mesh-ancestor
2243255|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
2243256|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243257|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243258|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2243259|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243260|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2243261|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2243262|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243263|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2243264|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2243265|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786541|NCT02630394|Azithromycin|azithromycin|mesh-list
786542|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
786543|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
786727|NCT02630095|Nadroparin|nadroparin|mesh-list
786728|NCT02630095|Warfarin|warfarin|mesh-list
786729|NCT02630095|Calcium|calcium|mesh-list
786730|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
786731|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786732|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
786733|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
786734|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
786735|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787019|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
787020|NCT02628860|Hematinics|hematinics|mesh-ancestor
2243266|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
2243267|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2243268|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2243269|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2243270|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
2243271|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243272|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2243273|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2243274|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
2243275|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2243276|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2243277|NCT00109395|Midazolam|midazolam|mesh-list
2243278|NCT00109395|Lorazepam|lorazepam|mesh-list
2243279|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2243280|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2243281|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243282|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788619|NCT02623049|Anticoagulants|anticoagulants|mesh-list
788707|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
788708|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
788709|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095461|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2095462|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
2095463|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095464|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095465|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2095466|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2095467|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
2095468|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2095469|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2095470|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2243283|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2243284|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2243285|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2243286|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2243287|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
2243288|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
2243289|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
2243290|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
2243291|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243292|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785696|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
785697|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
785698|NCT02633579|Atropine|atropine|mesh-list
785699|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
785700|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
785701|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
785702|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
785703|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785704|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785705|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
785706|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
785707|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
785708|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
785709|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
785710|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
785711|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
785712|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
785713|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785714|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
785715|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
785716|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
785717|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
785718|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785889|NCT02633059|Dexamethasone|dexamethasone|mesh-list
785890|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
785891|NCT02633059|Ixazomib|ixazomib|mesh-list
785892|NCT02633059|Ichthammol|ichthammol|mesh-list
785893|NCT02633059|BB 1101|bb 1101|mesh-list
785894|NCT02633059|Glycine|glycine|mesh-list
785895|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
785896|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
785898|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
785899|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
785900|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
785901|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
785902|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
785903|NCT02633059|Hormones|hormones|mesh-ancestor
785904|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
785905|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
785906|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785907|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
785908|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
785909|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
785910|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
785911|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
785912|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243293|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
2243294|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
2243295|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
2243296|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243297|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2243298|NCT00109408|Methotrexate|methotrexate|mesh-list
2243299|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2243300|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
2243301|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2243302|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243303|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2095471|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
2243304|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
2243305|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243306|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243307|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
2243308|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787932|NCT02624908|Canagliflozin|canagliflozin|mesh-list
787933|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
787934|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787935|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
787936|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788176|NCT02624544|Desonide|desonide|mesh-list
788177|NCT02624544|Esomeprazole|esomeprazole|mesh-list
788178|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
788179|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
788180|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
785855|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
785856|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
785857|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
785858|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
785859|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
785860|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
785861|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
785862|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243309|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2243310|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243311|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
2243312|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243313|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2243314|NCT00109538|Lonafarnib|lonafarnib|mesh-list
2243315|NCT00109538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243316|NCT00109538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243317|NCT00109551|Folic Acid|folic acid|mesh-list
2243318|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
2095492|NCT02292771|Vasotocin|vasotocin|mesh-list
2095493|NCT02292771|Atosiban|atosiban|mesh-list
2095494|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
2095495|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
787820|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
787821|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788428|NCT02623621|Bevacizumab|bevacizumab|mesh-list
788429|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
788430|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788431|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
788432|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
788433|NCT02623621|Growth Substances|growth substances|mesh-ancestor
788434|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788435|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
788598|NCT02623036|Enalapril|enalapril|mesh-list
788599|NCT02623036|Lisinopril|lisinopril|mesh-list
788600|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
788601|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
788602|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788603|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788604|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
788605|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
788606|NCT02623036|Protective Agents|protective agents|mesh-ancestor
788607|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788685|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
788686|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
788687|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788688|NCT02622672|Vitamins|vitamins|mesh-ancestor
2243319|NCT00109551|Hematinics|hematinics|mesh-ancestor
2243320|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
2243321|NCT00109551|Vitamins|vitamins|mesh-ancestor
2243322|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
2243323|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243324|NCT00109551|Astringents|astringents|mesh-ancestor
2243325|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
2243326|NCT00109564|Acetylcholine|acetylcholine|mesh-list
2243327|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
2243328|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
789820|NCT02617862|Anesthetics|anesthetics|mesh-list
2243329|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2243330|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
786031|NCT02632305|Gemcitabine|gemcitabine|mesh-list
786032|NCT02632305|Paclitaxel|paclitaxel|mesh-list
786033|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
786034|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786035|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
786036|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
786037|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
786038|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786039|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
786040|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
786041|NCT02632305|Antiviral Agents|antiviral agents|mesh-ancestor
786042|NCT02632305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
786043|NCT02632305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786044|NCT02632305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
786045|NCT02632305|Immunologic Factors|immunologic factors|mesh-ancestor
786046|NCT02632305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786262|NCT02631460|Carboplatin|carboplatin|mesh-list
786263|NCT02631460|Pemetrexed|pemetrexed|mesh-list
786264|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786265|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786266|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786267|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
786268|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2243331|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243332|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243333|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243334|NCT00109603|Tenofovir|tenofovir|mesh-list
2243335|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
2243336|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243337|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2243338|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2243339|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786480|NCT02630420|Cetuximab|cetuximab|mesh-list
786481|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
786482|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786642|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
786643|NCT02630290|Ropivacaine|ropivacaine|mesh-list
786644|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
786645|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
786646|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786647|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
786648|NCT02630290|Analgesics|analgesics|mesh-ancestor
786649|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
786650|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
786651|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
786652|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
786653|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
786654|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
786655|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
786656|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786657|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
786658|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
787177|NCT02627989|Diflucortolone|diflucortolone|mesh-list
787178|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
787179|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
787180|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
787181|NCT02627989|Hormones|hormones|mesh-ancestor
787182|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
787183|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787297|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
787298|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
787299|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
787300|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
787301|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787302|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
787303|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
787304|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
787305|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
787306|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
787307|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
787308|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243340|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243341|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2243342|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2095496|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095497|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
2095498|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2095499|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
2095500|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2095501|NCT02292784|Atosiban|atosiban|mesh-list
2095502|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
2095503|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
786308|NCT02631239|Dexamethasone|dexamethasone|mesh-list
786309|NCT02631239|Methotrexate|methotrexate|mesh-list
786310|NCT02631239|Etoposide|etoposide|mesh-list
786311|NCT02631239|Pegaspargase|pegaspargase|mesh-list
786312|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
786313|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
786314|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
786315|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
786316|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786317|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
786318|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
786319|NCT02631239|Hormones|hormones|mesh-ancestor
786320|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
786321|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
786322|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786323|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
786324|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
786325|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
786326|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
786327|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
786328|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786329|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
786330|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786331|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
786332|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
786333|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
786334|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
786335|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
786336|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
786337|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
786338|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
786959|NCT02629289|Lenograstim|lenograstim|mesh-list
786960|NCT02629289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
786961|NCT02629289|Immunologic Factors|immunologic factors|mesh-ancestor
786962|NCT02629289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787056|NCT02628704|Dexamethasone|dexamethasone|mesh-list
787057|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
787058|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
787059|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
787060|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
787061|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787062|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
787063|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
787064|NCT02628704|Hormones|hormones|mesh-ancestor
787065|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
787066|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
787067|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095504|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095505|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
2095506|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2095507|NCT02293096|Metoprolol|metoprolol|mesh-list
2095508|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
2095509|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2095510|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2095511|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
2095512|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
2095513|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095514|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095515|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2095516|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2095517|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2095518|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
2095519|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095520|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788400|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
788401|NCT02623972|Doxorubicin|doxorubicin|mesh-list
788402|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
786306|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
786307|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2243343|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
2243344|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2243345|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2243346|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2243347|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243348|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
2243349|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
2754125|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754126|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2754127|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754128|NCT01921335|Trastuzumab|trastuzumab|mesh-list
2754129|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2754130|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754131|NCT01907360|Methylphenidate|methylphenidate|mesh-list
2243358|NCT00109681|Iloprost|iloprost|mesh-list
2243359|NCT00109681|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2243360|NCT00109681|Vasodilator Agents|vasodilator agents|mesh-ancestor
786622|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
786623|NCT02630043|Tolcapone|tolcapone|mesh-list
786624|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786625|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
786626|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
786627|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
786628|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786629|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243361|NCT00109746|Chromium|chromium|mesh-list
2243362|NCT00109746|Picolinic acid|picolinic acid|mesh-list
2243363|NCT00109746|Trace Elements|trace elements|mesh-ancestor
2243364|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
2243365|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243366|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2243367|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
2243368|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
2243369|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243370|NCT00109785|Idoxuridine|idoxuridine|mesh-list
2243371|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2243372|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2243373|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243374|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
2243375|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243376|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2243377|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243378|NCT00109798|Temozolomide|temozolomide|mesh-list
2243379|NCT00109798|Topotecan|topotecan|mesh-list
787087|NCT02628587|Clopidogrel|clopidogrel|mesh-list
787088|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
787089|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
787090|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
787091|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
787092|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
787093|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
787094|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787095|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095521|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
2095522|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
2095523|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2095524|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2095525|NCT02293395|Aspirin|aspirin|mesh-list
2095526|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
2095527|NCT02293395|Clopidogrel|clopidogrel|mesh-list
2095528|NCT02293395|Ticagrelor|ticagrelor|mesh-list
2095529|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2095530|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2095531|NCT02293395|Analgesics|analgesics|mesh-ancestor
2095532|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
2095533|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095534|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095535|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2095536|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2095537|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2095538|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2243380|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2243381|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
2243382|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243383|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243384|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2243385|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
786515|NCT02630485|Inositol|inositol|mesh-list
786516|NCT02630485|Letrozole|letrozole|mesh-list
786517|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786518|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
786519|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
786520|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786521|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786522|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
786523|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
786524|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
786525|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786526|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
786527|NCT02630485|Vitamins|vitamins|mesh-ancestor
786528|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
786659|NCT02630199|Paclitaxel|paclitaxel|mesh-list
786660|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
786661|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786662|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
786663|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
786664|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
786665|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786774|NCT02629835|Dexamethasone|dexamethasone|mesh-list
786775|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
786776|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
786777|NCT02629835|BB 1101|bb 1101|mesh-list
786778|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
786779|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
786780|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
786781|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
786782|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786783|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
786784|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
786785|NCT02629835|Hormones|hormones|mesh-ancestor
786786|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
786787|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
786788|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786789|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
786790|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786791|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787652|NCT02626481|Dexamethasone|dexamethasone|mesh-list
787653|NCT02626481|Daratumumab|daratumumab|mesh-list
787654|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
787655|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
787656|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
787657|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
787658|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787659|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
787660|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
787661|NCT02626481|Hormones|hormones|mesh-ancestor
787662|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
787663|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
787664|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788246|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
788247|NCT02624401|Ketamine|ketamine|mesh-list
788248|NCT02624401|Propofol|propofol|mesh-list
788249|NCT02624401|Sevoflurane|sevoflurane|mesh-list
788250|NCT02624401|Esketamine|esketamine|mesh-list
788251|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
788252|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
788253|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788254|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
788255|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
788256|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
788257|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
788258|NCT02624401|Analgesics|analgesics|mesh-ancestor
788259|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
788260|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
788261|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
788262|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
788263|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
788264|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
788265|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243386|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243387|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
2243388|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2243389|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
2243390|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243391|NCT00109824|Decitabine|decitabine|mesh-list
786847|NCT02629523|Afatinib|afatinib|mesh-list
786848|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786849|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
786850|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
786851|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243392|NCT00109824|Azacitidine|azacitidine|mesh-list
2243393|NCT00109824|Valproic Acid|valproic acid|mesh-list
2243394|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2243395|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
2243396|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243397|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243398|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243399|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
2243400|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
2243401|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243402|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243403|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
2243404|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2243405|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243406|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2243407|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
787993|NCT02624661|Glycerol|glycerol|mesh-list
787994|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
787995|NCT02624661|Protective Agents|protective agents|mesh-ancestor
787996|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788274|NCT02624440|Clarithromycin|clarithromycin|mesh-list
788275|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
788276|NCT02624440|Trimethoprim|trimethoprim|mesh-list
788277|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
788278|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
788279|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
788280|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
788281|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788282|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788283|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
788284|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
788285|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
788286|NCT02624440|Renal Agents|renal agents|mesh-ancestor
788287|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
788288|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
788289|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
788290|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
788291|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
788292|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
788620|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
788621|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
788622|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
788623|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
788624|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
788625|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788626|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788627|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
788628|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
788629|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2243408|NCT00109941|Mitogens|mitogens|mesh-list
2243409|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
2243410|NCT00109941|Narcotics|narcotics|mesh-ancestor
2243411|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243412|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243413|NCT00109941|Analgesics|analgesics|mesh-ancestor
2243414|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
2243415|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243416|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
2243417|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789244|NCT02620293|Emollients|emollients|mesh-list
789245|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
789418|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
2243418|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243419|NCT00109954|Cisplatin|cisplatin|mesh-list
2243420|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243421|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
2243422|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2243423|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2243424|NCT00109993|Prednisolone|prednisolone|mesh-list
2243425|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
2243426|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
2243427|NCT00109993|Tacrolimus|tacrolimus|mesh-list
2243428|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2243429|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
2243430|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
787047|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
787048|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
787049|NCT02628665|Trioxsalen|trioxsalen|mesh-list
787050|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
787051|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787052|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
787184|NCT02628132|Paclitaxel|paclitaxel|mesh-list
787185|NCT02628132|Durvalumab|durvalumab|mesh-list
787186|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
787187|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787188|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
787189|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
787190|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
787191|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787192|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
787755|NCT02625805|Methylphenidate|methylphenidate|mesh-list
787756|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
787757|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787758|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
787759|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
787760|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
787761|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787762|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
787763|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
788338|NCT02624089|Ropivacaine|ropivacaine|mesh-list
788339|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
788340|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
788341|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
788342|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788343|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
788344|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
788486|NCT02623569|Atenolol|atenolol|mesh-list
788487|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
788488|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
788489|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
788490|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
788491|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
788492|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788493|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
788494|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
788495|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
788496|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
788497|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
788498|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243431|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
2243432|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243433|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2243434|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243435|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243436|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2243437|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
2243438|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
2243439|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243440|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
790099|NCT02616848|Everolimus|everolimus|mesh-list
790100|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790101|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
790102|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
790103|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790140|NCT02616354|Imipenem|imipenem|mesh-list
790141|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2243441|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
2243442|NCT00109993|Hormones|hormones|mesh-ancestor
2243443|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2243444|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2243445|NCT00109993|Protective Agents|protective agents|mesh-ancestor
2243446|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2243447|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
786613|NCT02630069|Choline|choline|mesh-list
786614|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
786615|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
786616|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
786617|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
786618|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786619|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
786620|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
786621|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
787071|NCT02628613|Paclitaxel|paclitaxel|mesh-list
787072|NCT02628613|Vinorelbine|vinorelbine|mesh-list
787073|NCT02628613|Epirubicin|epirubicin|mesh-list
787074|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
787075|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787076|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
787077|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
787078|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
787079|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787080|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
787081|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
787082|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
787083|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787626|NCT02626338|Vidarabine|vidarabine|mesh-list
787627|NCT02626338|Cytarabine|cytarabine|mesh-list
787628|NCT02626338|Fludarabine|fludarabine|mesh-list
787629|NCT02626338|Fludarabine phosphate|fludarabine phosphate|mesh-list
787630|NCT02626338|Etoposide|etoposide|mesh-list
787631|NCT02626338|Etoposide phosphate|etoposide phosphate|mesh-list
787632|NCT02626338|Mitoxantrone|mitoxantrone|mesh-list
787633|NCT02626338|Idarubicin|idarubicin|mesh-list
787634|NCT02626338|Crenolanib|crenolanib|mesh-list
787635|NCT02626338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787636|NCT02626338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
787637|NCT02626338|Antimetabolites|antimetabolites|mesh-ancestor
787638|NCT02626338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787639|NCT02626338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
787640|NCT02626338|Immunologic Factors|immunologic factors|mesh-ancestor
787641|NCT02626338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787642|NCT02626338|Antiviral Agents|antiviral agents|mesh-ancestor
787643|NCT02626338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
787644|NCT02626338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
787645|NCT02626338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
787646|NCT02626338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
787647|NCT02626338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787648|NCT02626338|Analgesics|analgesics|mesh-ancestor
787649|NCT02626338|Sensory System Agents|sensory system agents|mesh-ancestor
787650|NCT02626338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
787651|NCT02626338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2243448|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2243449|NCT00110006|Prednisone|prednisone|mesh-list
2243450|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
2243451|NCT00110006|Rituximab|rituximab|mesh-list
2243452|NCT00110006|Doxorubicin|doxorubicin|mesh-list
2243453|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
787950|NCT02624726|Leucovorin|leucovorin|mesh-list
787951|NCT02624726|Fluorouracil|fluorouracil|mesh-list
787952|NCT02624726|Irinotecan|irinotecan|mesh-list
787953|NCT02624726|Aflibercept|aflibercept|mesh-list
787954|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
787955|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
787956|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787957|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
787958|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787959|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
787960|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
787961|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787962|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
787963|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
787964|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787965|NCT02624726|Antidotes|antidotes|mesh-ancestor
787966|NCT02624726|Protective Agents|protective agents|mesh-ancestor
787967|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
787968|NCT02624726|Vitamins|vitamins|mesh-ancestor
2243454|NCT00110006|Vincristine|vincristine|mesh-list
786715|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786716|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786717|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
786718|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
786719|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
786720|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
786721|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
786722|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
786723|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
786724|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
786725|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
786726|NCT02630121|Protective Agents|protective agents|mesh-ancestor
2095539|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095540|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2095541|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2095542|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095543|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
2095544|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2095545|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2095546|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2095547|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
2095548|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095549|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2095550|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
2095551|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2095552|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
2095553|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
2095554|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2095555|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2095556|NCT02293863|Oseltamivir|oseltamivir|mesh-list
787428|NCT02626962|Nivolumab|nivolumab|mesh-list
787429|NCT02626962|Ipilimumab|ipilimumab|mesh-list
787430|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
787431|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787432|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
787433|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787852|NCT02625376|Resveratrol|resveratrol|mesh-list
787853|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
787854|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787855|NCT02625376|Protective Agents|protective agents|mesh-ancestor
787856|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787857|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787858|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
788223|NCT02624531|Cisplatin|cisplatin|mesh-list
788224|NCT02624531|Taxane|taxane|mesh-list
788225|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243455|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2243456|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243457|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
2243458|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243459|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243460|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2243461|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
2243462|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789001|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
789002|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2243463|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243464|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2243465|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2243466|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2243467|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2243468|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2243469|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790115|NCT02616640|Dexamethasone|dexamethasone|mesh-list
790116|NCT02616640|Durvalumab|durvalumab|mesh-list
790117|NCT02616640|Pomalidomide|pomalidomide|mesh-list
790118|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
790119|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
790120|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
790121|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790122|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790123|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
790124|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
790125|NCT02616640|Hormones|hormones|mesh-ancestor
790126|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2095557|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
2095558|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2095559|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095560|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095561|NCT02293902|Folic Acid|folic acid|mesh-list
2095562|NCT02293902|Methotrexate|methotrexate|mesh-list
2095563|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
786927|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
786928|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
786929|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
786930|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786931|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
786932|NCT02629380|Protective Agents|protective agents|mesh-ancestor
787675|NCT02626104|Lactoferrin|lactoferrin|mesh-list
787676|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
787822|NCT02625415|Vitamins|vitamins|mesh-list
787823|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
787824|NCT02625415|Pyridoxal|pyridoxal|mesh-list
787825|NCT02625415|Pyridoxine|pyridoxine|mesh-list
787826|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
787827|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
787828|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787879|NCT02624999|Cisplatin|cisplatin|mesh-list
787880|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243470|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2243471|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
2243472|NCT00110006|Hormones|hormones|mesh-ancestor
2243473|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2243474|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2243475|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2243476|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
788819|NCT02621970|Cisplatin|cisplatin|mesh-list
788820|NCT02621970|Docetaxel|docetaxel|mesh-list
788821|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788822|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
788823|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
788824|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
788825|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788903|NCT02621489|Metformin|metformin|mesh-list
788904|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
788905|NCT02621489|Exenatide|exenatide|mesh-list
788906|NCT02621489|Biguanides|biguanides|mesh-list
788907|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
788908|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788909|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
788910|NCT02621489|Incretins|incretins|mesh-ancestor
788911|NCT02621489|Hormones|hormones|mesh-ancestor
2095564|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
786855|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
786856|NCT02629536|Expectorants|expectorants|mesh-ancestor
786857|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
786858|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
786859|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
786860|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
786861|NCT02629536|Protective Agents|protective agents|mesh-ancestor
786862|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
786863|NCT02629536|Antidotes|antidotes|mesh-ancestor
787113|NCT02628522|Lidocaine|lidocaine|mesh-list
787114|NCT02628522|Epinephrine|epinephrine|mesh-list
787115|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
787116|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
787117|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
787118|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787119|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
787120|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
787121|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
787122|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
787123|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
787124|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
787125|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787126|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
787127|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
787128|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
787129|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
787130|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
787131|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
787132|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
787133|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
787134|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
787135|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
787136|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
787137|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
787561|NCT02626247|Vitamin A|vitamin a|mesh-list
787562|NCT02626247|Vitamins|vitamins|mesh-ancestor
787563|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
787564|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787768|NCT02625740|Paclitaxel|paclitaxel|mesh-list
787769|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
787770|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787771|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
787772|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
787773|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
787774|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243477|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
2243478|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
2243479|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2243480|NCT00110032|Etanidazole|etanidazole|mesh-list
2243481|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243482|NCT00110045|Caspofungin|caspofungin|mesh-list
2243483|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
2243484|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243485|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243486|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243487|NCT00110058|Interferons|interferons|mesh-list
2243488|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
2243489|NCT00110058|Cyclosporine|cyclosporine|mesh-list
2243490|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
2243491|NCT00110058|Fludarabine|fludarabine|mesh-list
2243492|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
2243493|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
2243494|NCT00110058|Cyclosporins|cyclosporins|mesh-list
2243495|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243496|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2243497|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
2243498|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243499|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243500|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
2243501|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243502|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
2243503|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2095565|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2095566|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095567|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2243504|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243505|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
787725|NCT02625779|Valproic Acid|valproic acid|mesh-list
787726|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
787727|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787728|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787729|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
787730|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
787731|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787732|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
787733|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
787734|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
787735|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
788389|NCT02623920|Rituximab|rituximab|mesh-list
788390|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
788391|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
788392|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
788393|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788394|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
788395|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788396|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
788397|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
788398|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
788399|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788563|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
788564|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
788565|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
788566|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788567|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
788568|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
788569|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
788570|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788571|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788572|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
788793|NCT02621957|Pravastatin|pravastatin|mesh-list
788794|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
788795|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
788796|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
788797|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788798|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
788799|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
788800|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095568|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
2095569|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095570|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095571|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
2095572|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095573|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2095574|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
789655|NCT02618824|Tryptophan|tryptophan|mesh-list
789656|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
789657|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
789658|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
789900|NCT02617654|Liraglutide|liraglutide|mesh-list
789901|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
789902|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789903|NCT02617654|Incretins|incretins|mesh-ancestor
789904|NCT02617654|Hormones|hormones|mesh-ancestor
789905|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
790438|NCT02615288|Vitamin D|vitamin d|mesh-list
790439|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
790440|NCT02615288|Vitamins|vitamins|mesh-ancestor
790441|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
786979|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
786980|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
786981|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
786982|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
786983|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787364|NCT02627417|Dapsone|dapsone|mesh-list
787365|NCT02627417|Prednisone|prednisone|mesh-list
787366|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
787367|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
787368|NCT02627417|Hormones|hormones|mesh-ancestor
787369|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
787370|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787371|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
787372|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787373|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
787374|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
787375|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
787376|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
787377|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
787378|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787379|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787380|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
787381|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
787392|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
787393|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
787394|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
787395|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
787396|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
787397|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787398|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787399|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
787434|NCT02626936|Insulin|insulin|mesh-list
787435|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
787436|NCT02626936|Glucagon|glucagon|mesh-list
787437|NCT02626936|Hormones|hormones|mesh-list
787438|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
787439|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787440|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
787441|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
788184|NCT02624570|Midostaurin|midostaurin|mesh-list
788185|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788186|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
788187|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788188|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788630|NCT02623114|Methylphenidate|methylphenidate|mesh-list
788631|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
788632|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
788633|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788634|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
788635|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
788636|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
788637|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788638|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
788639|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
788640|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
788641|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
788713|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
788714|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
788715|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
789112|NCT02620618|Infliximab|infliximab|mesh-list
789113|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
789114|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
789115|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
789345|NCT02620280|Paclitaxel|paclitaxel|mesh-list
789346|NCT02620280|Carboplatin|carboplatin|mesh-list
789347|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
789348|NCT02620280|Atezolizumab|atezolizumab|mesh-list
789349|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
789350|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789351|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
789352|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
789353|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
2243506|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
2243507|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243508|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2243509|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
787613|NCT02626234|Digoxin|digoxin|mesh-list
787614|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
787615|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
787616|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
787617|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
787618|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787619|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
787620|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
787621|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787622|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
787623|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
787624|NCT02626234|Protective Agents|protective agents|mesh-ancestor
787625|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787736|NCT02625753|Acetaminophen|acetaminophen|mesh-list
787737|NCT02625753|Codeine|codeine|mesh-list
787738|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
787739|NCT02625753|Analgesics|analgesics|mesh-ancestor
787740|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
787741|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
787742|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787743|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
787744|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
787745|NCT02625753|Narcotics|narcotics|mesh-ancestor
787746|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
787747|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
787748|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
788243|NCT02624310|Droxidopa|droxidopa|mesh-list
788244|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
788245|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
788369|NCT02623998|Metformin|metformin|mesh-list
788370|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
788371|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
788372|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
788373|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788374|NCT02623998|Incretins|incretins|mesh-ancestor
788375|NCT02623998|Hormones|hormones|mesh-ancestor
788376|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
788377|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
788378|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
788379|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788380|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788560|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
788561|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
788562|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788594|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
788595|NCT02623062|Antacids|antacids|mesh-ancestor
788596|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788597|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
788716|NCT02622334|Latanoprost|latanoprost|mesh-list
788717|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
788718|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
789260|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
789261|NCT02620865|Leucovorin|leucovorin|mesh-list
789262|NCT02620865|Folic Acid|folic acid|mesh-list
789263|NCT02620865|Gemcitabine|gemcitabine|mesh-list
789264|NCT02620865|Aldesleukin|aldesleukin|mesh-list
789265|NCT02620865|Paclitaxel|paclitaxel|mesh-list
789266|NCT02620865|Camptothecin|camptothecin|mesh-list
789267|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
789268|NCT02620865|Fluorouracil|fluorouracil|mesh-list
789269|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
789270|NCT02620865|Irinotecan|irinotecan|mesh-list
789271|NCT02620865|Interleukin-2|interleukin-2|mesh-list
789272|NCT02620865|Antibodies|antibodies|mesh-list
789273|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
789274|NCT02620865|Sargramostim|sargramostim|mesh-list
789275|NCT02620865|Calcium|calcium|mesh-list
789276|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
789277|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
789278|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789279|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
789280|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
789281|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
789282|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754132|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2754133|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754134|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2754135|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
787264|NCT02627950|Metoclopramide|metoclopramide|mesh-list
787265|NCT02627950|Ticagrelor|ticagrelor|mesh-list
787266|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
787267|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
787268|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
787269|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
787270|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
787271|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
787272|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787273|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787274|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
787275|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
787276|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
787277|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
787278|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
787279|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
787280|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
787317|NCT02627521|Ticagrelor|ticagrelor|mesh-list
787318|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
787319|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
787320|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
787321|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
787322|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
787323|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
787324|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787325|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787833|NCT02625454|Acetaminophen|acetaminophen|mesh-list
787834|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
787835|NCT02625454|Analgesics|analgesics|mesh-ancestor
787836|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
787837|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
787838|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787839|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
2243510|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2243511|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
2243512|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2243513|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2243514|NCT00110071|Iodine|iodine|mesh-list
2243515|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
2243516|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
788584|NCT02623127|Sunitinib|sunitinib|mesh-list
788585|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788586|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
788587|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
788588|NCT02623127|Growth Substances|growth substances|mesh-ancestor
788589|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788590|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
788591|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
788592|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788593|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788826|NCT02621944|Melatonin|melatonin|mesh-list
788827|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
788828|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788829|NCT02621944|Protective Agents|protective agents|mesh-ancestor
788830|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788831|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789382|NCT02619669|Letrozole|letrozole|mesh-list
789383|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789384|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
789385|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
789386|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
789387|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789388|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
789389|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
789390|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
789391|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789788|NCT02618317|Minocycline|minocycline|mesh-list
789789|NCT02618317|Heparin|heparin|mesh-list
789790|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
787096|NCT02628574|Gemcitabine|gemcitabine|mesh-list
787097|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
787098|NCT02628574|Nivolumab|nivolumab|mesh-list
787099|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
787100|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
787101|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787102|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787103|NCT02628574|Antiviral Agents|antiviral agents|mesh-ancestor
787104|NCT02628574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
787105|NCT02628574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787106|NCT02628574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
787107|NCT02628574|Immunologic Factors|immunologic factors|mesh-ancestor
787108|NCT02628574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787109|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
787110|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
787339|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
787340|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
787341|NCT02627573|Busulfan|busulfan|mesh-list
787342|NCT02627573|Fludarabine|fludarabine|mesh-list
787343|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
787344|NCT02627573|Tacrolimus|tacrolimus|mesh-list
787345|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
787346|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
787347|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
787348|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787349|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
787350|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
787351|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
787352|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787353|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787354|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
787355|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
787356|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
787357|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
787358|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787359|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
787360|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
787361|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
787362|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
787363|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
787691|NCT02626130|Tremelimumab|tremelimumab|mesh-list
787692|NCT02626130|Ipilimumab|ipilimumab|mesh-list
787693|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787694|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
787695|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
787696|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787775|NCT02625636|Glucagon|glucagon|mesh-list
787776|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
787777|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
787778|NCT02625636|Hormones|hormones|mesh-ancestor
787779|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
787780|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787781|NCT02625636|Incretins|incretins|mesh-ancestor
788120|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
788121|NCT02624479|Antidotes|antidotes|mesh-ancestor
788122|NCT02624479|Protective Agents|protective agents|mesh-ancestor
788123|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788124|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
788125|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788126|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
788127|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
788128|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
788129|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
788130|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
788416|NCT02623751|Exemestane|exemestane|mesh-list
788417|NCT02623751|Entinostat|entinostat|mesh-list
788418|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788419|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
788420|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
788421|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788422|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788423|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
788424|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
788425|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
788426|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788427|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2243517|NCT00110071|Fludarabine|fludarabine|mesh-list
787412|NCT02627222|Vitamin A|vitamin a|mesh-list
787413|NCT02627222|Provitamins|provitamins|mesh-list
787414|NCT02627222|Vitamins|vitamins|mesh-ancestor
787415|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
787416|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787782|NCT02625506|Tramadol|tramadol|mesh-list
787783|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
787784|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
787785|NCT02625506|Narcotics|narcotics|mesh-ancestor
787786|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
787787|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787788|NCT02625506|Analgesics|analgesics|mesh-ancestor
787789|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
787790|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
787791|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
787792|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
788541|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
788542|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
788543|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788735|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
788736|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
788737|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
788738|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
788739|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
788740|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788741|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
788742|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
788743|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
788744|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
788745|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
788746|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
788747|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788748|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
788749|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
788960|NCT02621112|Imiquimod|imiquimod|mesh-list
788961|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
788962|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
788963|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788964|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788965|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
789104|NCT02620605|Cabergoline|cabergoline|mesh-list
789105|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
789106|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
789107|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
789108|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
789109|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789110|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789111|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789339|NCT02620306|Losartan|losartan|mesh-list
789340|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
789341|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
789342|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
789343|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
789344|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095575|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
2095576|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2095577|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2095578|NCT02293902|Hematinics|hematinics|mesh-ancestor
2095579|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
2095580|NCT02293902|Vitamins|vitamins|mesh-ancestor
790334|NCT02615847|Memantine|memantine|mesh-list
790335|NCT02615847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
790336|NCT02615847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
790337|NCT02615847|Dopamine Agents|dopamine agents|mesh-ancestor
790338|NCT02615847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
790339|NCT02615847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790340|NCT02615847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790341|NCT02615847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
790342|NCT02615847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2243518|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
2243519|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
2243520|NCT00110071|Antibodies|antibodies|mesh-list
2243521|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
790706|NCT02614508|Ofatumumab|ofatumumab|mesh-list
790707|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
790708|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243522|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
787165|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
787166|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
787167|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
787168|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787169|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754136|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2754137|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754138|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
2754139|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2754140|NCT01886872|Rituximab|rituximab|mesh-list
2754141|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2754142|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2754143|NCT01886872|Antibodies|antibodies|mesh-list
2754144|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
2754145|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2754146|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
2754147|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787677|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
787678|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
787679|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
787680|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787681|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
787682|NCT02625948|Coagulants|coagulants|mesh-ancestor
787859|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
787860|NCT02625168|Afatinib|afatinib|mesh-list
787861|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787862|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
787863|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787864|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787912|NCT02624856|Dexamethasone|dexamethasone|mesh-list
787913|NCT02624856|Bupivacaine|bupivacaine|mesh-list
787914|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
787915|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
787916|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
787917|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
787918|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787919|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
787920|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
787921|NCT02624856|Hormones|hormones|mesh-ancestor
787922|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
787923|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
787924|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787925|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
787926|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
787927|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
787928|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
2095581|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
2095582|NCT02293993|Guadecitabine|guadecitabine|mesh-list
2095583|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095584|NCT02294019|Ibuprofen|ibuprofen|mesh-list
2095585|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2095586|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2095587|NCT02294019|Analgesics|analgesics|mesh-ancestor
2095588|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
2095589|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095590|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095591|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2095592|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2095593|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2095594|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095595|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095596|NCT02294058|Interferons|interferons|mesh-list
2095597|NCT02294058|Interferon-beta|interferon-beta|mesh-list
2095598|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
2095599|NCT02294058|Ozanimod|ozanimod|mesh-list
2095600|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095601|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
2095602|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
788345|NCT02623816|Omeprazole|omeprazole|mesh-list
788346|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
788347|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
788348|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
788349|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788350|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788922|NCT02621320|Vitamin D|vitamin d|mesh-list
788923|NCT02621320|Vitamins|vitamins|mesh-ancestor
2095603|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
787232|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
787233|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
787234|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
787235|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
787236|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
787237|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
787238|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787239|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
787240|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
787241|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
787242|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
787243|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
787244|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
787245|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787246|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
787247|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
787248|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
787249|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
787250|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
787251|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
787252|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
787253|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
787254|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
787255|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
787256|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
787257|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
787258|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
787309|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
787310|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
787311|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
787312|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787313|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
787314|NCT02627560|Coagulants|coagulants|mesh-ancestor
787456|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
787457|NCT02627248|Docetaxel|docetaxel|mesh-list
787458|NCT02627248|Epirubicin|epirubicin|mesh-list
787459|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
787460|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
787461|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787462|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
787463|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
787464|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
787465|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787466|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787467|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
787468|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
787469|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
787470|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
787471|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
787472|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
787473|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
787474|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243523|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
2243524|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243525|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243526|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2243527|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
2243528|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243529|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243530|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2243531|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243532|NCT00110071|Trace Elements|trace elements|mesh-ancestor
2243533|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
2243534|NCT00110110|Cyclosporine|cyclosporine|mesh-list
789319|NCT02620072|Insulin|insulin|mesh-list
789320|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
789321|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790150|NCT02616289|Emollients|emollients|mesh-list
790151|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
790997|NCT02612649|Ramosetron|ramosetron|mesh-list
787291|NCT02627807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
787292|NCT02627807|Immunologic Factors|immunologic factors|mesh-ancestor
787293|NCT02627807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787294|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
787295|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
787296|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
787382|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
787383|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
787384|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
787385|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
787386|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
787421|NCT02627027|Metformin|metformin|mesh-list
787422|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
787423|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787475|NCT02626754|Sunitinib|sunitinib|mesh-list
787476|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787477|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
787478|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
787479|NCT02626754|Growth Substances|growth substances|mesh-ancestor
787480|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787481|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
787482|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
787483|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787484|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787586|NCT02626169|Clopidogrel|clopidogrel|mesh-list
787587|NCT02626169|Ticagrelor|ticagrelor|mesh-list
787588|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
787589|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
787590|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
787591|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
787592|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
787593|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
787594|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787595|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095604|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095605|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2095606|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2095607|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095608|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2095609|NCT02294253|Buprenorphine|buprenorphine|mesh-list
2095610|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2095611|NCT02294253|Naloxone|naloxone|mesh-list
2095612|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2095613|NCT02294253|Narcotics|narcotics|mesh-ancestor
2095614|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2095615|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095616|NCT02294253|Analgesics|analgesics|mesh-ancestor
2095617|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
2095618|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095619|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2095620|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
2095621|NCT02294396|Mirabegron|mirabegron|mesh-list
2754148|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788689|NCT02622802|Acetaminophen|acetaminophen|mesh-list
788690|NCT02622802|Azithromycin|azithromycin|mesh-list
788691|NCT02622802|Erythromycin|erythromycin|mesh-list
788692|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
788693|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
788694|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
788695|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
788696|NCT02622802|Analgesics|analgesics|mesh-ancestor
788697|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
788698|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
788699|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788700|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
788701|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
788702|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
788703|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
788704|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
788705|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788706|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754149|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2754150|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2754151|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
789249|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
787333|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243535|NCT00110110|Carboplatin|carboplatin|mesh-list
2243536|NCT00110110|Etoposide|etoposide|mesh-list
2243537|NCT00110110|Vincristine|vincristine|mesh-list
2243538|NCT00110110|Cyclosporins|cyclosporins|mesh-list
2243539|NCT00110110|Lenograstim|lenograstim|mesh-list
2243540|NCT00110110|Sargramostim|sargramostim|mesh-list
2243541|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243542|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2243543|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2243544|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2243545|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243546|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243547|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2243548|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
2243549|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243550|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
2243551|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
2243552|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
2243553|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243554|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
2243555|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243556|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
2243557|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243558|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2243559|NCT00110123|Fotemustine|fotemustine|mesh-list
2243560|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243561|NCT00110162|Hormones|hormones|mesh-list
2243562|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
2243563|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2243564|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243565|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
2243566|NCT00110188|Sirolimus|sirolimus|mesh-list
2243567|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2243568|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243569|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2243570|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243571|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
2243572|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243573|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
788138|NCT02624973|Tamoxifen|tamoxifen|mesh-list
788139|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
788140|NCT02624973|Docetaxel|docetaxel|mesh-list
788141|NCT02624973|Trastuzumab|trastuzumab|mesh-list
788142|NCT02624973|Letrozole|letrozole|mesh-list
788143|NCT02624973|Epirubicin|epirubicin|mesh-list
788144|NCT02624973|Olaparib|olaparib|mesh-list
788145|NCT02624973|Palbociclib|palbociclib|mesh-list
788146|NCT02624973|Goserelin|goserelin|mesh-list
788147|NCT02624973|Pertuzumab|pertuzumab|mesh-list
788148|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
788149|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
788150|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788151|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
788152|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
788153|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
788154|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788155|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788156|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
788157|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
788158|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
788159|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
788160|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
788161|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
788162|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
788163|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788164|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
788165|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
788166|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
788167|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
788168|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
788169|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
788170|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
788171|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
788172|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
788173|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
788174|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2095622|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2095623|NCT02294396|Propiverine|propiverine|mesh-list
2095624|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2095625|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2095626|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
2095627|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095628|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095629|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095630|NCT02294396|Urological Agents|urological agents|mesh-ancestor
2095631|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2243574|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787840|NCT02625103|Clozapine|clozapine|mesh-list
787841|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
787842|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
787843|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
787844|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787845|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787846|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
787847|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
787848|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
787849|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
787850|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
787851|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
788499|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
788500|NCT02623738|Latanoprost|latanoprost|mesh-list
788501|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
789008|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
789009|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
789010|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
789011|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789012|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
789013|NCT02620748|Coagulants|coagulants|mesh-ancestor
789128|NCT02620553|Insulin|insulin|mesh-list
789129|NCT02620553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
789130|NCT02620553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
789131|NCT02620553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789612|NCT02618876|Nalbuphine|nalbuphine|mesh-list
789613|NCT02618876|Bupivacaine|bupivacaine|mesh-list
789614|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
789615|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
789616|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789617|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789618|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
789619|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789620|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
789621|NCT02618876|Narcotics|narcotics|mesh-ancestor
789622|NCT02618876|Analgesics|analgesics|mesh-ancestor
790077|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
790078|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
790079|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790518|NCT02614937|Squalamine|squalamine|mesh-list
790519|NCT02614937|Ranibizumab|ranibizumab|mesh-list
790520|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
790521|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
790522|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
790523|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
790524|NCT02614937|Growth Substances|growth substances|mesh-ancestor
790525|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790526|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
790527|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790528|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
790529|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
790530|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
790531|NCT02614937|Protective Agents|protective agents|mesh-ancestor
2243575|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2243576|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
2243577|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243578|NCT00110240|Vildagliptin|vildagliptin|mesh-list
2243579|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2243580|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243581|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2243582|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
2243583|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790897|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
790898|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
790899|NCT02613039|Estrogens|estrogens|mesh-list
790900|NCT02613039|Progestins|progestins|mesh-list
2243584|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095632|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2095633|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2095634|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
2095635|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
2095636|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
2095637|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095638|NCT02294474|Insulin|insulin|mesh-list
2095639|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2095640|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
2095641|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
2095642|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
788226|NCT02624388|Genistein|genistein|mesh-list
788227|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
788228|NCT02624388|Protective Agents|protective agents|mesh-ancestor
788229|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788230|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788231|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
788232|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788233|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788234|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
788235|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
788236|NCT02624388|Estrogens|estrogens|mesh-ancestor
788237|NCT02624388|Hormones|hormones|mesh-ancestor
788238|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
789147|NCT02620423|Leucovorin|leucovorin|mesh-list
789148|NCT02620423|Gemcitabine|gemcitabine|mesh-list
789149|NCT02620423|Fluorouracil|fluorouracil|mesh-list
789150|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
789151|NCT02620423|Irinotecan|irinotecan|mesh-list
789152|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
789153|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
789154|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789155|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789156|NCT02620423|Antiviral Agents|antiviral agents|mesh-ancestor
789157|NCT02620423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
789158|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
789159|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
789160|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
789161|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789162|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
789163|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
789164|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
789165|NCT02620423|Antidotes|antidotes|mesh-ancestor
789166|NCT02620423|Protective Agents|protective agents|mesh-ancestor
789167|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
789168|NCT02620423|Vitamins|vitamins|mesh-ancestor
789169|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
789714|NCT02618720|Ornidazole|ornidazole|mesh-list
789715|NCT02618720|Amebicides|amebicides|mesh-ancestor
789716|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
789717|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
789718|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
789719|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
790453|NCT02615041|Meropenem|meropenem|mesh-list
790454|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
790455|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243585|NCT00110253|Lidocaine|lidocaine|mesh-list
2243586|NCT00110253|Tetracaine|tetracaine|mesh-list
2243587|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
2243588|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
2243589|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243590|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243591|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
2243592|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243593|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2243594|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2243595|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2243596|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
791196|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
791197|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
791198|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
791243|NCT02611596|Ranolazine|ranolazine|mesh-list
791244|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
791245|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
791246|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791366|NCT02611258|Tadalafil|tadalafil|mesh-list
2095643|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
787754|NCT02625727|Protective Agents|protective agents|mesh-ancestor
787871|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
787872|NCT02625337|Trametinib|trametinib|mesh-list
787873|NCT02625337|Dabrafenib|dabrafenib|mesh-list
787874|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
787875|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
787876|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
787877|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
787878|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788189|NCT02624505|Albuterol|albuterol|mesh-list
788190|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
788191|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
788192|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
788193|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788194|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
788195|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
788196|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
788197|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
788198|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
788199|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
788200|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
788201|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
788202|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
788203|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788710|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
788711|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
788712|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
789132|NCT02620566|Bupivacaine|bupivacaine|mesh-list
789133|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
789134|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
789135|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789136|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789137|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
789138|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789191|NCT02620189|Adalimumab|adalimumab|mesh-list
789192|NCT02620189|Etanercept|etanercept|mesh-list
789193|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
789194|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
789195|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
789196|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
789197|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
789198|NCT02620189|Analgesics|analgesics|mesh-ancestor
789199|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
789200|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789201|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789202|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
789203|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
789204|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
789422|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
789423|NCT02619513|Ropivacaine|ropivacaine|mesh-list
789424|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
789425|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789426|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789427|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
789428|NCT02619513|Analgesics|analgesics|mesh-ancestor
789429|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
789430|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789431|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
789432|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
789433|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
789434|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
789435|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789436|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789437|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
789438|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
789541|NCT02619162|Letrozole|letrozole|mesh-list
789542|NCT02619162|Nintedanib|nintedanib|mesh-list
789543|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789544|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
789545|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
789546|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
789547|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789548|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
789549|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
789550|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2243597|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243598|NCT00110344|Sorafenib|sorafenib|mesh-list
2243599|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243600|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2243601|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788533|NCT02623595|Molgramostim|molgramostim|mesh-list
788534|NCT02623595|Sargramostim|sargramostim|mesh-list
788535|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
788536|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788537|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788660|NCT02622503|Rituximab|rituximab|mesh-list
788661|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
788662|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788663|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
788664|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788665|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2095644|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
2095645|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2095646|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
2095647|NCT02294604|Povidone|povidone|mesh-list
2095648|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2095649|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2095650|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
2095651|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
2095652|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
2095653|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
2095654|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2095655|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
2095656|NCT02294734|Nemiralisib|nemiralisib|mesh-list
789253|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
789254|NCT02620345|Progestins|progestins|mesh-ancestor
789255|NCT02620345|Hormones|hormones|mesh-ancestor
789256|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
789257|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095657|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2095658|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790088|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
790089|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
790090|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
790091|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790092|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
790093|NCT02616731|Coagulants|coagulants|mesh-ancestor
790177|NCT02616419|Lidocaine|lidocaine|mesh-list
790178|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
790179|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
790180|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
790181|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790182|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
790183|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790184|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
790185|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
790186|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
790187|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
790188|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790269|NCT02615977|Ethanol|ethanol|mesh-list
790270|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
790271|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
790272|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
790273|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790656|NCT02614404|Piperaquine|piperaquine|mesh-list
790657|NCT02614404|Artenimol|artenimol|mesh-list
790658|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
790659|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790660|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
790661|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790662|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790663|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
790664|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
790665|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
790666|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
790769|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
790770|NCT02613494|Scopolamine|scopolamine|mesh-list
790771|NCT02613494|Bromides|bromides|mesh-list
790772|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
790773|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
2095659|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
787970|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
787971|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
787972|NCT02624726|Growth Substances|growth substances|mesh-ancestor
787973|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
788750|NCT02622126|Atropine|atropine|mesh-list
788751|NCT02622126|Ephedrine|ephedrine|mesh-list
788752|NCT02622126|Morphine|morphine|mesh-list
788753|NCT02622126|Bupivacaine|bupivacaine|mesh-list
788754|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
788755|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
788756|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
788757|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788758|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
788759|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
788760|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
788761|NCT02622126|Narcotics|narcotics|mesh-ancestor
788762|NCT02622126|Analgesics|analgesics|mesh-ancestor
788763|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
788764|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
788765|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
788766|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
788767|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
788768|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
788769|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
788770|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
788771|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
788772|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
788773|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
788774|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
788775|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788776|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
788777|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
788778|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
788779|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
788927|NCT02621359|Doxycycline|doxycycline|mesh-list
788928|NCT02621359|Levofloxacin|levofloxacin|mesh-list
788929|NCT02621359|Ofloxacin|ofloxacin|mesh-list
788930|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
788931|NCT02621359|Omeprazole|omeprazole|mesh-list
788932|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
788933|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
788934|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
788935|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788936|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788937|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
788938|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
788939|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
788940|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
788941|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
788942|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
788943|NCT02621359|Renal Agents|renal agents|mesh-ancestor
788944|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
788945|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
788946|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788947|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
788948|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2243602|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243603|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
2243604|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2243605|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243606|NCT00110422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2243607|NCT00110422|Irbesartan|irbesartan|mesh-list
2243608|NCT00110422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2243609|NCT00110422|Diuretics|diuretics|mesh-ancestor
2243610|NCT00110422|Natriuretic Agents|natriuretic agents|mesh-ancestor
2243611|NCT00110422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243612|NCT00110422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2243613|NCT00110422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2243614|NCT00110422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243615|NCT00110422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2243616|NCT00110422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2243617|NCT00110435|Atorvastatin|atorvastatin|mesh-list
789258|NCT02620046|Vedolizumab|vedolizumab|mesh-list
789259|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2243618|NCT00110435|Simvastatin|simvastatin|mesh-list
2243619|NCT00110435|Ezetimibe|ezetimibe|mesh-list
2243620|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2243621|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2243622|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
2243623|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243624|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2243625|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2243626|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243627|NCT00110448|Aspirin|aspirin|mesh-list
2243628|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2243629|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2243630|NCT00110448|Analgesics|analgesics|mesh-ancestor
2243631|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
2243632|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243633|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243634|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2243635|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243636|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2243637|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2243638|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243639|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2243640|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2243641|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243642|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
2243643|NCT00110474|Acetaminophen|acetaminophen|mesh-list
2243644|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2243645|NCT00110474|Analgesics|analgesics|mesh-ancestor
2243646|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
2243647|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243648|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243649|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
2243650|NCT00110578|Aldesleukin|aldesleukin|mesh-list
2243651|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243652|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2243653|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2243654|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
2243655|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243656|NCT00110591|Leronlimab|leronlimab|mesh-list
2243657|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2243658|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2243659|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243660|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2243661|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2243662|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
2243663|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243664|NCT00110604|Folic Acid|folic acid|mesh-list
2243665|NCT00110604|Hematinics|hematinics|mesh-ancestor
2243666|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
2243667|NCT00110604|Vitamins|vitamins|mesh-ancestor
2243668|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
2243669|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243670|NCT00110630|Nicotine|nicotine|mesh-list
2243671|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2243672|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
2243673|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243674|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243675|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2243676|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2243677|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
2243678|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243679|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243680|NCT00110669|Prednisone|prednisone|mesh-list
2243681|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2243682|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
2243683|NCT00110669|Hormones|hormones|mesh-ancestor
2243684|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2243685|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788436|NCT02623673|Dexamethasone|dexamethasone|mesh-list
788437|NCT02623673|Bevacizumab|bevacizumab|mesh-list
788438|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
788439|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788440|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
788441|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
788442|NCT02623673|Growth Substances|growth substances|mesh-ancestor
788443|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788444|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
788445|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
788446|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
788175|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2095660|NCT02294773|Letrozole|letrozole|mesh-list
2095661|NCT02294773|Clomiphene|clomiphene|mesh-list
2095662|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095663|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2095664|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2095665|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095666|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095667|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2095668|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
2095669|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2095670|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095671|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2095672|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
2095673|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
788333|NCT02623881|Progesterone|progesterone|mesh-list
788334|NCT02623881|Progestins|progestins|mesh-ancestor
788335|NCT02623881|Hormones|hormones|mesh-ancestor
788336|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
788337|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788646|NCT02623153|Docetaxel|docetaxel|mesh-list
788647|NCT02623153|Capecitabine|capecitabine|mesh-list
788648|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
788649|NCT02623153|Tegafur|tegafur|mesh-list
788650|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788651|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
788652|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
788653|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
788654|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788655|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
788656|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
789102|NCT02620839|Cisplatin|cisplatin|mesh-list
789103|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789322|NCT02619994|Levofloxacin|levofloxacin|mesh-list
789323|NCT02619994|Ofloxacin|ofloxacin|mesh-list
789324|NCT02619994|Linezolid|linezolid|mesh-list
789325|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
789326|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
789327|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
789328|NCT02619994|Renal Agents|renal agents|mesh-ancestor
789329|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
789330|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
789331|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
789332|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
789333|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789334|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789335|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
789336|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
789337|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
789338|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
789623|NCT02619019|Dexamethasone|dexamethasone|mesh-list
789624|NCT02619019|Meperidine|meperidine|mesh-list
789625|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
789626|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
789627|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
789628|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789629|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789630|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
789631|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
789632|NCT02619019|Hormones|hormones|mesh-ancestor
789633|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
789634|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
789635|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789636|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
789637|NCT02619019|Narcotics|narcotics|mesh-ancestor
789638|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789639|NCT02619019|Analgesics|analgesics|mesh-ancestor
789640|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
789641|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2095674|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2095675|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2095676|NCT02294786|Capecitabine|capecitabine|mesh-list
2095677|NCT02294786|Lapatinib|lapatinib|mesh-list
2754152|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754153|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2754154|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
2754155|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
788181|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788182|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788183|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
788544|NCT02623504|Carbamazepine|carbamazepine|mesh-list
788545|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
788546|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
788547|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
788548|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
788549|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788550|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
788551|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
788552|NCT02623504|Analgesics|analgesics|mesh-ancestor
788553|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
788554|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
788555|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
788556|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
788557|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788558|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
788559|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2243686|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2243687|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243688|NCT00110682|Imiquimod|imiquimod|mesh-list
2243689|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2243690|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
789450|NCT02619448|Paclitaxel|paclitaxel|mesh-list
789451|NCT02619448|Carboplatin|carboplatin|mesh-list
789452|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
789453|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789454|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
789455|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
789456|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
789457|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789596|NCT02619266|Megestrol|megestrol|mesh-list
789597|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
789598|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
789599|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
789600|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
789601|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
789602|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
789603|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789604|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
789605|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
789606|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
789607|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789608|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
789609|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2243691|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243692|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243693|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
2243694|NCT00110695|Paclitaxel|paclitaxel|mesh-list
789977|NCT02617121|Gabapentin|gabapentin|mesh-list
789978|NCT02617121|Ramosetron|ramosetron|mesh-list
789979|NCT02617121|Analgesics|analgesics|mesh-ancestor
789980|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
789981|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789982|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789983|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
789984|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
789985|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
789986|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789987|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
789988|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
789989|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
789990|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789991|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789992|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
789993|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
789994|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
789995|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
789996|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
789997|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
790094|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
790095|NCT02616965|Romidepsin|romidepsin|mesh-list
790096|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2243695|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
788266|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788267|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
788268|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
788269|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
788270|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
788271|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
788272|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
788273|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2243696|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2243697|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243698|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
2243699|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
2243700|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
2243701|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243702|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
2243703|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2243704|NCT00110708|Antibodies|antibodies|mesh-list
2243705|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
2243706|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243707|NCT00110721|Fluorouracil|fluorouracil|mesh-list
2243708|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
2243709|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243710|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2243711|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754156|NCT01873170|Etonogestrel|etonogestrel|mesh-list
788538|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
788539|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
788540|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788863|NCT02621515|Nivolumab|nivolumab|mesh-list
788864|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
788865|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788866|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
788867|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788913|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
788914|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
788915|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
788916|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788917|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788918|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
788919|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
788920|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
788921|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
789307|NCT02619981|Lidocaine|lidocaine|mesh-list
789308|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
789309|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
789310|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789311|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789312|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
789313|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789314|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
789315|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
789316|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
789317|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
789318|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095678|NCT02294786|Octreotide|octreotide|mesh-list
2095679|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2095680|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
2095681|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095682|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095683|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2095684|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095685|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2095686|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2095687|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
2095688|NCT02295280|Promethazine|promethazine|mesh-list
2095689|NCT02295280|Codeine|codeine|mesh-list
2095690|NCT02295280|Metoclopramide|metoclopramide|mesh-list
2095691|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2095692|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
789642|NCT02619032|Fentanyl|fentanyl|mesh-list
789643|NCT02619032|Remifentanil|remifentanil|mesh-list
789644|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
789645|NCT02619032|Narcotics|narcotics|mesh-ancestor
788316|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
788317|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
788318|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
788319|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788320|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788608|NCT02623231|Citalopram|citalopram|mesh-list
788609|NCT02623231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
788610|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
788611|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
788612|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788613|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
788614|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
788615|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788616|NCT02623231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
788617|NCT02623231|Antidepressive Agents|antidepressive agents|mesh-ancestor
788618|NCT02623231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
788979|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
788980|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788981|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
788982|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
788983|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
788984|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788985|NCT02620995|Urological Agents|urological agents|mesh-ancestor
789116|NCT02620501|Lidocaine|lidocaine|mesh-list
789117|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
789118|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
789119|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789120|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789121|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
789122|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789123|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
789124|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
789125|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
789126|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
789127|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789240|NCT02620215|Dinoprostone|dinoprostone|mesh-list
789241|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
789242|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
789243|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789367|NCT02619773|Mupirocin|mupirocin|mesh-list
789368|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
789369|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
789370|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
789371|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
789372|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754157|NCT01873170|Desogestrel|desogestrel|mesh-list
2754158|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
790361|NCT02615496|Aflibercept|aflibercept|mesh-list
790362|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
790363|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
790364|NCT02615496|Growth Substances|growth substances|mesh-ancestor
790365|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790366|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
790367|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790799|NCT02613455|Triamcinolone|triamcinolone|mesh-list
790800|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
790801|NCT02613455|Lidocaine|lidocaine|mesh-list
790802|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
790803|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
790804|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
790805|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790806|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
790807|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790808|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
790809|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
790810|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
790811|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
790812|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790813|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
790814|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
790815|NCT02613455|Hormones|hormones|mesh-ancestor
790816|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
790817|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
788403|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
788404|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
788405|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788406|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
788407|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
788408|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
788409|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788410|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788411|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
788412|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
788413|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
788414|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
788415|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788502|NCT02623426|Dexamethasone|dexamethasone|mesh-list
788503|NCT02623426|Methotrexate|methotrexate|mesh-list
788504|NCT02623426|Ranibizumab|ranibizumab|mesh-list
788505|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
788506|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
788507|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
788508|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
788509|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788510|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
788511|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
788512|NCT02623426|Hormones|hormones|mesh-ancestor
788513|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
788514|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
788515|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788516|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
788517|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
788518|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
788519|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
788520|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
788521|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788522|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
788523|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788524|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
788525|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
788526|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
788527|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
788528|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
788529|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
788530|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
788531|NCT02623426|Growth Substances|growth substances|mesh-ancestor
788532|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
790474|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
790475|NCT02615184|Lansoprazole|lansoprazole|mesh-list
790476|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
790477|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
790478|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
790479|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790480|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790759|NCT02613585|Permethrin|permethrin|mesh-list
790760|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790761|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791315|NCT02611505|Esketamine|esketamine|mesh-list
791316|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
791317|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
791578|NCT02609932|Interferons|interferons|mesh-list
791579|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
791580|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
791581|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
791582|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
791661|NCT02609646|Vancomycin|vancomycin|mesh-list
791662|NCT02609646|Meropenem|meropenem|mesh-list
791663|NCT02609646|Tazobactam|tazobactam|mesh-list
791664|NCT02609646|Linezolid|linezolid|mesh-list
791665|NCT02609646|Piperacillin|piperacillin|mesh-list
791666|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
791667|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
791668|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
791669|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
791670|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791671|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791672|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2243712|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243713|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
788447|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
788448|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
788449|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
788450|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
788451|NCT02623673|Hormones|hormones|mesh-ancestor
788452|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
788453|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
788848|NCT02621385|Midazolam|midazolam|mesh-list
788849|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
788850|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
788851|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
788852|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788853|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
788854|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
788855|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
788856|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
788857|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
788858|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
788859|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
788860|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
788861|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
788862|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788949|NCT02621255|Bupivacaine|bupivacaine|mesh-list
788950|NCT02621255|Anesthetics|anesthetics|mesh-list
788951|NCT02621255|Sevoflurane|sevoflurane|mesh-list
788952|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
788953|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
788954|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788955|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
788956|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
788957|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
788958|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
788959|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
2243714|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243715|NCT00110734|Lidocaine|lidocaine|mesh-list
789949|NCT02617485|Prednisone|prednisone|mesh-list
789950|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
789951|NCT02617485|Rituximab|rituximab|mesh-list
789952|NCT02617485|Doxorubicin|doxorubicin|mesh-list
789953|NCT02617485|Vincristine|vincristine|mesh-list
789954|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
789955|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
789956|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789957|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
789958|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
789959|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
789960|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789961|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789962|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
789963|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
789964|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
789965|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
789966|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
789967|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
789968|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
789969|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
789970|NCT02617485|Hormones|hormones|mesh-ancestor
789971|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
789972|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
789973|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
789974|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
789975|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
789976|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
790387|NCT02615691|Factor VIII|factor viii|mesh-list
790388|NCT02615691|BAX 855|bax 855|mesh-list
790389|NCT02615691|Coagulants|coagulants|mesh-ancestor
2243716|NCT00110734|Tetracaine|tetracaine|mesh-list
2243717|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
2243718|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
2243719|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243720|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243721|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
2243722|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790843|NCT02613247|Hylan|hylan|mesh-list
790844|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
790845|NCT02613247|Protective Agents|protective agents|mesh-ancestor
790846|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243723|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2243724|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2243725|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2243726|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2243727|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243728|NCT00110747|Lidocaine|lidocaine|mesh-list
2243729|NCT00110747|Tetracaine|tetracaine|mesh-list
2243730|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
788573|NCT02623205|Citalopram|citalopram|mesh-list
788574|NCT02623205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
788575|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
788576|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
788577|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788578|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
788579|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
788580|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788581|NCT02623205|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
788582|NCT02623205|Antidepressive Agents|antidepressive agents|mesh-ancestor
788583|NCT02623205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
788642|NCT02622906|Pasireotide|pasireotide|mesh-list
788643|NCT02622906|Hormones|hormones|mesh-ancestor
788644|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
788645|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788676|NCT02622555|Mirabegron|mirabegron|mesh-list
788677|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
788678|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
788679|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
788680|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
788681|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
788682|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788683|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788684|NCT02622555|Urological Agents|urological agents|mesh-ancestor
788785|NCT02622022|Morphine|morphine|mesh-list
788786|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
788787|NCT02622022|Narcotics|narcotics|mesh-ancestor
788788|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
788789|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788790|NCT02622022|Analgesics|analgesics|mesh-ancestor
788791|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
788792|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789003|NCT02620813|Tretinoin|tretinoin|mesh-list
789004|NCT02620813|Isotretinoin|isotretinoin|mesh-list
789005|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
789006|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789007|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
2243731|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
2243732|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243733|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790047|NCT02617017|Buspirone|buspirone|mesh-list
790048|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
790049|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
790050|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
790051|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790052|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
790053|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
790054|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
790055|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
790056|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790348|NCT02615912|Castor Oil|castor oil|mesh-list
790349|NCT02615912|Cathartics|cathartics|mesh-ancestor
790350|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
790572|NCT02614833|Paclitaxel|paclitaxel|mesh-list
790573|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
790574|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790575|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
790576|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
790577|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
790578|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790929|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
790930|NCT02613026|Docetaxel|docetaxel|mesh-list
790931|NCT02613026|Pirarubicin|pirarubicin|mesh-list
790932|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
790933|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
790934|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790935|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
788484|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
788485|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
788666|NCT02622477|Pirfenidone|pirfenidone|mesh-list
788667|NCT02622477|Analgesics|analgesics|mesh-ancestor
788668|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
788669|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
788670|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788671|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
788672|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
788673|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
788674|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
788675|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243734|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
2243735|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243736|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2243737|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2243738|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2243739|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2243740|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243741|NCT00110760|Lidocaine|lidocaine|mesh-list
2243742|NCT00110760|Tetracaine|tetracaine|mesh-list
2243743|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
2243744|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
2243745|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243746|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243747|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
2243748|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243749|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2243750|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2243751|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2243752|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2243753|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243754|NCT00110773|Lidocaine|lidocaine|mesh-list
2243755|NCT00110773|Tetracaine|tetracaine|mesh-list
2243756|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
2243757|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
2243758|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243759|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243760|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
2243761|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243762|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2243763|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2243764|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2243765|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2243766|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243767|NCT00110851|Metformin|metformin|mesh-list
2243768|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
789373|NCT02619786|Colistin|colistin|mesh-list
789374|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
789375|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
789500|NCT02619578|Remifentanil|remifentanil|mesh-list
789501|NCT02619578|Propofol|propofol|mesh-list
789502|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
789503|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
789504|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789505|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789506|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
789507|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
789508|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
789509|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
789510|NCT02619578|Narcotics|narcotics|mesh-ancestor
789511|NCT02619578|Analgesics|analgesics|mesh-ancestor
789512|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
789513|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789514|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
789515|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
789516|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
789517|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
789518|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
789519|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
789520|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789521|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790189|NCT02616315|Naltrexone|naltrexone|mesh-list
790190|NCT02616315|Bupropion|bupropion|mesh-list
790191|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2095693|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2095694|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095695|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
2243769|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2243770|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243771|NCT00110864|Insulin|insulin|mesh-list
2243772|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2243773|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243774|NCT00110877|Darunavir|darunavir|mesh-list
790042|NCT02616692|Sorafenib|sorafenib|mesh-list
790043|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790044|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
790045|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790046|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243775|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2243776|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2243777|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
2243778|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243779|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243780|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2243781|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2243782|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
2243783|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243784|NCT00110903|Etanercept|etanercept|mesh-list
2243785|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2243786|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2243787|NCT00110903|Analgesics|analgesics|mesh-ancestor
2243788|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
2243789|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791364|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
791365|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
791834|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
791835|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
791836|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792090|NCT02608073|Capecitabine|capecitabine|mesh-list
792091|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792092|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
792093|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
792094|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243790|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243791|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2243792|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243793|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2243794|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243795|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
2243796|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2243797|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243798|NCT00110929|Cinacalcet|cinacalcet|mesh-list
2243799|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2243800|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243801|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2243802|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
2243803|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
792481|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
792482|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
792483|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
792484|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
2754159|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2754160|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2754161|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754162|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2754163|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2754164|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2754165|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2754166|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2754167|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754168|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2754169|NCT01873170|Progestins|progestins|mesh-ancestor
2754170|NCT01873170|Hormones|hormones|mesh-ancestor
2754171|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2754172|NCT01835041|Leucovorin|leucovorin|mesh-list
2754173|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
2754174|NCT01835041|Fluorouracil|fluorouracil|mesh-list
2754175|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
788841|NCT02621554|Resveratrol|resveratrol|mesh-list
788842|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
788843|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788844|NCT02621554|Protective Agents|protective agents|mesh-ancestor
788845|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788846|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
788847|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
789139|NCT02620631|Morphine|morphine|mesh-list
789140|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
789141|NCT02620631|Narcotics|narcotics|mesh-ancestor
789142|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789143|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789144|NCT02620631|Analgesics|analgesics|mesh-ancestor
789145|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
789146|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789180|NCT02620150|Citalopram|citalopram|mesh-list
789181|NCT02620150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
789182|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
789183|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
789184|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789185|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789186|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
789187|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789188|NCT02620150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
789189|NCT02620150|Antidepressive Agents|antidepressive agents|mesh-ancestor
789190|NCT02620150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
789355|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
789356|NCT02620007|Rifaximin|rifaximin|mesh-list
789357|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
789358|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
789359|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
789360|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
789361|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
789362|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789363|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789364|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
789365|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
789366|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
789478|NCT02619552|Prednisone|prednisone|mesh-list
789479|NCT02619552|Budesonide|budesonide|mesh-list
789480|NCT02619552|Adalimumab|adalimumab|mesh-list
789481|NCT02619552|Infliximab|infliximab|mesh-list
789482|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
789483|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
789484|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
789485|NCT02619552|Hormones|hormones|mesh-ancestor
789486|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
789487|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789488|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
789489|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789490|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
789491|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
789492|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789493|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
789494|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
789495|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
789496|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
789497|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
789498|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
789499|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
790432|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
790433|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
790434|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
790435|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790436|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
790437|NCT02615366|Coagulants|coagulants|mesh-ancestor
790654|NCT02614248|Protective Agents|protective agents|mesh-list
790655|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243804|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
2243805|NCT00110955|Hematinics|hematinics|mesh-ancestor
2243806|NCT00110981|Etanercept|etanercept|mesh-list
2243807|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2243808|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2243809|NCT00110981|Analgesics|analgesics|mesh-ancestor
2243810|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
2243811|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243812|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243813|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2243814|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243815|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2243816|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243817|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
2243818|NCT00111020|Sorafenib|sorafenib|mesh-list
2243819|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243820|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2243821|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243822|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243823|NCT00111046|Ibuprofen|ibuprofen|mesh-list
2243824|NCT00111046|Tramadol|tramadol|mesh-list
2243825|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2243826|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2243827|NCT00111046|Analgesics|analgesics|mesh-ancestor
2243828|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
2243829|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243830|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790495|NCT02615301|Vitamin D|vitamin d|mesh-list
790496|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
790497|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
790498|NCT02615301|Vitamins|vitamins|mesh-list
790499|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
790500|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790501|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
790502|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
790840|NCT02613416|Denosumab|denosumab|mesh-list
790841|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
790842|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790925|NCT02612896|Praziquantel|praziquantel|mesh-list
790926|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
790927|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
790928|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
790990|NCT02612545|Piperaquine|piperaquine|mesh-list
790991|NCT02612545|Artenimol|artenimol|mesh-list
790992|NCT02612545|Mefloquine|mefloquine|mesh-list
790993|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
790994|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
790995|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
790996|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243831|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2243832|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243833|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2243834|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243835|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243836|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2243837|NCT00111046|Narcotics|narcotics|mesh-ancestor
2243838|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243839|NCT00111072|Dexamethasone|dexamethasone|mesh-list
2243840|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2243841|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
2243842|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
2243843|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791837|NCT02609334|Pemirolast|pemirolast|mesh-list
791838|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
791839|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
791840|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791841|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791842|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792061|NCT02608034|Itraconazole|itraconazole|mesh-list
792062|NCT02608034|Rifampin|rifampin|mesh-list
792063|NCT02608034|Vemurafenib|vemurafenib|mesh-list
792064|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
792065|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
792066|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
792067|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
792068|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792069|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
788912|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
789778|NCT02618733|Clopidogrel|clopidogrel|mesh-list
789779|NCT02618733|Ticagrelor|ticagrelor|mesh-list
789780|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
789781|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
789782|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
789783|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
789784|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
789785|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789786|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789787|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789840|NCT02617771|Vitamin D|vitamin d|mesh-list
789841|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
789842|NCT02617771|Vitamins|vitamins|mesh-ancestor
789843|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
789844|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789845|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
789846|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
790468|NCT02615080|Pemirolast|pemirolast|mesh-list
790469|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
790470|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
790471|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
790472|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790473|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095696|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
2095697|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
2095698|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095699|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
2095700|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
2095701|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2095702|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2095703|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
2095704|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
2095705|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095706|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095707|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2095708|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
2095709|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
2095710|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2095711|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2095712|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
2095713|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2095714|NCT02295280|Narcotics|narcotics|mesh-ancestor
2095715|NCT02295280|Analgesics|analgesics|mesh-ancestor
2095716|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
2095717|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
2095718|NCT02295553|Ketamine|ketamine|mesh-list
2095719|NCT02295553|Propofol|propofol|mesh-list
2095720|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2095721|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
791540|NCT02610348|Vaccines|vaccines|mesh-list
791541|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
791542|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
791543|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791583|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
791584|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
791585|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
791586|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
791587|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
791588|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791589|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791590|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791591|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
791592|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
791593|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243844|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243845|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2243846|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
792185|NCT02607774|Midazolam|midazolam|mesh-list
792186|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
792187|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
792188|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
792317|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
2095722|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095723|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
788924|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
788925|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
788926|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2243847|NCT00111072|Hormones|hormones|mesh-ancestor
2243848|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2243849|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2243850|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243851|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
2243852|NCT00111098|Hematinics|hematinics|mesh-ancestor
2243853|NCT00111111|Etanercept|etanercept|mesh-list
2243854|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2243855|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2243856|NCT00111111|Analgesics|analgesics|mesh-ancestor
2243857|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
2243858|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243859|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243860|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2243861|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243862|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2243863|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243864|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
2243865|NCT00111124|Etanercept|etanercept|mesh-list
2243866|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2243867|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2243868|NCT00111124|Analgesics|analgesics|mesh-ancestor
2243869|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
2243870|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243871|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243872|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
789659|NCT02618668|Ketamine|ketamine|mesh-list
789660|NCT02618668|Propofol|propofol|mesh-list
789661|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
789662|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789663|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789664|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
789665|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
789666|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
789667|NCT02618668|Analgesics|analgesics|mesh-ancestor
789668|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
789669|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789670|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
789671|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
789672|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
789673|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789674|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789698|NCT02618395|Hydrocodone|hydrocodone|mesh-list
789699|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
789700|NCT02618395|Narcotics|narcotics|mesh-ancestor
789701|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789702|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789703|NCT02618395|Analgesics|analgesics|mesh-ancestor
789704|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
789705|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789706|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
789707|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
790069|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
790070|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
790071|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
790072|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
790073|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
790074|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790075|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790076|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243873|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243874|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2243875|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243876|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
2243877|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
2243878|NCT00111137|Hematinics|hematinics|mesh-ancestor
2243879|NCT00111150|Tenofovir|tenofovir|mesh-list
2243880|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
2243881|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243882|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2243883|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2243884|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754176|NCT01835041|Irinotecan|irinotecan|mesh-list
2754177|NCT01835041|Calcium|calcium|mesh-list
2754178|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
2754179|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2754180|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754181|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
2754182|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754183|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2754184|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789027|NCT02620761|Fenoldopam|fenoldopam|mesh-list
789028|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
789029|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
789030|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
789031|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
789032|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789033|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789034|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789216|NCT02620163|Amlodipine|amlodipine|mesh-list
789217|NCT02620163|Telmisartan|telmisartan|mesh-list
789218|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
789219|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
789220|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
789221|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
789222|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
789223|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789224|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
789225|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789226|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
789227|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
789228|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
789229|NCT02620163|Diuretics|diuretics|mesh-ancestor
789230|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
789231|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
789458|NCT02619526|Carvedilol|carvedilol|mesh-list
789459|NCT02619526|Nebivolol|nebivolol|mesh-list
789460|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
789461|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
789462|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
789463|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789464|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789465|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789466|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
789467|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
789468|NCT02619526|Protective Agents|protective agents|mesh-ancestor
789469|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
789470|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
789471|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
789472|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
789473|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
789474|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
789475|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
789476|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
789477|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
789800|NCT02618057|Levofloxacin|levofloxacin|mesh-list
789801|NCT02618057|Ofloxacin|ofloxacin|mesh-list
789802|NCT02618057|Prednisolone|prednisolone|mesh-list
789803|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
789804|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
789805|NCT02618057|Hormones|hormones|mesh-ancestor
789806|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
789807|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789808|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
789809|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789810|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
789811|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
789812|NCT02618057|Renal Agents|renal agents|mesh-ancestor
789813|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
789814|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
789815|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
789816|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
789817|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789818|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
789819|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
789250|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
789251|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
789252|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789690|NCT02618577|Edoxaban|edoxaban|mesh-list
789691|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
789692|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
789693|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
789694|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
789695|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
789696|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789697|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
789847|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
789848|NCT02617680|Desflurane|desflurane|mesh-list
789849|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
789850|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
789851|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789852|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789853|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
789854|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
789855|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
789856|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
789857|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789858|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789859|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
789860|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
789861|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
789862|NCT02617680|Protective Agents|protective agents|mesh-ancestor
789863|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
789864|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
789865|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
789866|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
790538|NCT02614859|Metformin|metformin|mesh-list
790539|NCT02614859|Bicalutamide|bicalutamide|mesh-list
790540|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
790541|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790542|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
790543|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
790544|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
790545|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790604|NCT02614482|Fesoterodine|fesoterodine|mesh-list
790605|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
790606|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
790607|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
790608|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
790609|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790610|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790611|NCT02614482|Urological Agents|urological agents|mesh-ancestor
791199|NCT02611921|Ketamine|ketamine|mesh-list
791200|NCT02611921|Analgesics|analgesics|mesh-ancestor
791201|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
791202|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791203|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791204|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
791205|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
791206|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
791207|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
791208|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
791209|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
791210|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
791211|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791212|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791561|NCT02610075|Adavosertib|adavosertib|mesh-list
791562|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791563|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789283|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
789284|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789285|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
789286|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
789287|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
789288|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
789289|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
789290|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
789291|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
789292|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
789293|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
789294|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
789295|NCT02620865|Antidotes|antidotes|mesh-ancestor
789296|NCT02620865|Protective Agents|protective agents|mesh-ancestor
789297|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
789298|NCT02620865|Vitamins|vitamins|mesh-ancestor
789299|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
789300|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
789301|NCT02620865|Analgesics|analgesics|mesh-ancestor
789302|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
789303|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789304|NCT02620865|Hematinics|hematinics|mesh-ancestor
789305|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
789306|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
789588|NCT02619149|Tazobactam|tazobactam|mesh-list
789589|NCT02619149|Piperacillin|piperacillin|mesh-list
789590|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
789591|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
789592|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
789593|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
789594|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
789595|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789752|NCT02618499|Oxytocin|oxytocin|mesh-list
789753|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
789754|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
789755|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789884|NCT02617459|Betaxolol|betaxolol|mesh-list
789885|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
789886|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
789887|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
789888|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
789889|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
789890|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789891|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789892|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
789893|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
789894|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
789895|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
789896|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789897|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790005|NCT02617199|Fentanyl|fentanyl|mesh-list
790006|NCT02617199|Analgesics|analgesics|mesh-list
790007|NCT02617199|Ropivacaine|ropivacaine|mesh-list
790008|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
790009|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
790010|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790011|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
790012|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
790013|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790014|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
790015|NCT02617199|Narcotics|narcotics|mesh-ancestor
790016|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
790017|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
790018|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
790104|NCT02616770|Perflubron|perflubron|mesh-list
790105|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
790143|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
790144|NCT02616302|Lansoprazole|lansoprazole|mesh-list
790145|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
790146|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
790147|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
790148|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790149|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790456|NCT02615262|Dexamethasone|dexamethasone|mesh-list
790457|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
790458|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
790459|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
790460|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789354|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243885|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243886|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2243887|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2243888|NCT00111163|Artesunate|artesunate|mesh-list
2243889|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
2243890|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
2243891|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2243892|NCT00111163|Amodiaquine|amodiaquine|mesh-list
2243893|NCT00111163|Dapsone|dapsone|mesh-list
2243894|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
2243895|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
2243896|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2243897|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2243898|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243899|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243900|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
2243901|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
789906|NCT02617758|Fentanyl|fentanyl|mesh-list
789907|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
789908|NCT02617758|Narcotics|narcotics|mesh-ancestor
789909|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789910|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789911|NCT02617758|Analgesics|analgesics|mesh-ancestor
789912|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
789913|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789914|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
789915|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
789916|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
789917|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
790351|NCT02615730|Paclitaxel|paclitaxel|mesh-list
790352|NCT02615730|GSK2636771|gsk2636771|mesh-list
790353|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
790354|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790355|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
790356|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
790357|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
790358|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790359|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
790360|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790481|NCT02615340|Melatonin|melatonin|mesh-list
790482|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
790483|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790484|NCT02615340|Protective Agents|protective agents|mesh-ancestor
790485|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790486|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243902|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2243903|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
2243904|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2243905|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243906|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243907|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2243908|NCT00111163|Renal Agents|renal agents|mesh-ancestor
2243909|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
2243910|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2243911|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2243912|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2243913|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2243914|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2243915|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791121|NCT02612207|Bilirubin|bilirubin|mesh-list
791122|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
791123|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791124|NCT02612207|Protective Agents|protective agents|mesh-ancestor
791125|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243916|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2243917|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2243918|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2243919|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
2243920|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243921|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243922|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
791687|NCT02609490|Olmesartan|olmesartan|mesh-list
791688|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
791689|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
791690|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
789419|NCT02619747|Antacids|antacids|mesh-ancestor
789420|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789421|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2243923|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2243924|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
2243925|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2243926|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
2243927|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2243928|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2243929|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243930|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
2243931|NCT00111215|Coagulants|coagulants|mesh-ancestor
2243932|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2243933|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
2243934|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243935|NCT00111267|Vitamins|vitamins|mesh-list
2243936|NCT00111267|Folic Acid|folic acid|mesh-list
2243937|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
789773|NCT02618096|Oxytocin|oxytocin|mesh-list
789774|NCT02618096|Dinoprostone|dinoprostone|mesh-list
789775|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
789776|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
789777|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789867|NCT02617810|Midazolam|midazolam|mesh-list
789868|NCT02617810|Warfarin|warfarin|mesh-list
789869|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
789870|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
789871|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789872|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789873|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
789874|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
789875|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
789876|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
789877|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
789878|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
789879|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
789880|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
789881|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789882|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789883|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
790057|NCT02616822|Resveratrol|resveratrol|mesh-list
790058|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
790059|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790060|NCT02616822|Protective Agents|protective agents|mesh-ancestor
790061|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790062|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790063|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
790445|NCT02615223|Bicalutamide|bicalutamide|mesh-list
790446|NCT02615223|Hormones|hormones|mesh-list
790447|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
790448|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
790449|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790450|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
790451|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
790452|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790532|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
790533|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
790534|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
790535|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
790536|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790537|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095724|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
2095725|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
2095726|NCT02295553|Analgesics|analgesics|mesh-ancestor
2095727|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
2095728|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095729|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2095730|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2095731|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2095732|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095733|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095734|NCT02295774|Methylene Blue|methylene blue|mesh-list
2243938|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
2243939|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
2243940|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
2243941|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243942|NCT00111267|Hematinics|hematinics|mesh-ancestor
2243943|NCT00111280|Etravirine|etravirine|mesh-list
789553|NCT02619201|Ondansetron|ondansetron|mesh-list
789554|NCT02619201|Metoclopramide|metoclopramide|mesh-list
789555|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
789556|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
789557|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789558|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789559|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
789560|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
789561|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
789562|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
789563|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
789564|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789565|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789566|NCT02619201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
789567|NCT02619201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
789568|NCT02619201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789569|NCT02619201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
789570|NCT02619201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
789571|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
789572|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
789573|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
789745|NCT02618356|Raltitrexed|raltitrexed|mesh-list
789746|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
789747|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
789748|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789749|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789750|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
789751|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243944|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2243945|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2243946|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243947|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243948|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
2243949|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243950|NCT00111306|Epratuzumab|epratuzumab|mesh-list
2243951|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2243952|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243953|NCT00111319|Bortezomib|bortezomib|mesh-list
2243954|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243955|NCT00111345|Daunorubicin|daunorubicin|mesh-list
2243956|NCT00111345|Idarubicin|idarubicin|mesh-list
2243957|NCT00111345|Cladribine|cladribine|mesh-list
2243958|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
790551|NCT02614612|Prednisone|prednisone|mesh-list
790552|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
790553|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
790554|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
790555|NCT02614612|Prednisolone|prednisolone|mesh-list
790556|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
790557|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
790558|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
790559|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
790560|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
790561|NCT02614612|Hormones|hormones|mesh-ancestor
790562|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
790563|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790564|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
790565|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790566|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
790567|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
790568|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790569|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
790570|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
790571|NCT02614612|Protective Agents|protective agents|mesh-ancestor
2754185|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2754186|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
2754187|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2754188|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2754189|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754190|NCT01835041|Antidotes|antidotes|mesh-ancestor
2754191|NCT01835041|Protective Agents|protective agents|mesh-ancestor
2754192|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
2754193|NCT01835041|Vitamins|vitamins|mesh-ancestor
2754194|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
2754195|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
2243959|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789551|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789552|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
789742|NCT02618564|Sennosides|sennosides|mesh-list
789743|NCT02618564|Laxatives|laxatives|mesh-ancestor
789744|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2095735|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095736|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095737|NCT02296099|Bupivacaine|bupivacaine|mesh-list
2095738|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
2095739|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
790294|NCT02616055|XL647|xl647|mesh-list
790295|NCT02616055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790296|NCT02616055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
790297|NCT02616055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790298|NCT02616055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790394|NCT02615574|Interferons|interferons|mesh-list
790395|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
790396|NCT02615574|Celecoxib|celecoxib|mesh-list
790397|NCT02615574|Vaccines|vaccines|mesh-list
790398|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
790399|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790400|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790401|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
790402|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
790403|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
790404|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
790405|NCT02615574|Analgesics|analgesics|mesh-ancestor
790406|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
790407|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790408|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
790409|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
790410|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
790411|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
790412|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790413|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243960|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2243961|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2243962|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2243963|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243964|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243965|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
2243966|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243967|NCT00111371|Levodopa|levodopa|mesh-list
2243968|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2243969|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2243970|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
2243971|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2243972|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2243973|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243974|NCT00111397|Interferons|interferons|mesh-list
2243975|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
2243976|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
791387|NCT02611466|Naproxen|naproxen|mesh-list
791388|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
791389|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
791390|NCT02611466|Analgesics|analgesics|mesh-ancestor
791391|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
791392|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791393|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791394|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
791395|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
791396|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
791397|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
791398|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791399|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791509|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
791510|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791633|NCT02609802|Sevoflurane|sevoflurane|mesh-list
791634|NCT02609802|Desflurane|desflurane|mesh-list
791635|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
791636|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
791637|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
791638|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
791639|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
791640|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791891|NCT02608606|Tacrolimus|tacrolimus|mesh-list
789646|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789647|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789648|NCT02619032|Analgesics|analgesics|mesh-ancestor
789649|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
789650|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789651|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
789652|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
789653|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
789654|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
789720|NCT02618603|Triamcinolone|triamcinolone|mesh-list
789721|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
789722|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
789723|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
789724|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
789725|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
789726|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
789727|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
789728|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
789729|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789730|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
789731|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
789732|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
789733|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
789734|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
789735|NCT02618603|Hormones|hormones|mesh-ancestor
789736|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
789737|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
789738|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
789739|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
789740|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
789741|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789830|NCT02617849|Paclitaxel|paclitaxel|mesh-list
789831|NCT02617849|Carboplatin|carboplatin|mesh-list
789832|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
789833|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
789834|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
789835|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
789836|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
789837|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
789838|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789839|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
789998|NCT02617407|Listerine|listerine|mesh-list
789999|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
790000|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
790001|NCT02617407|Protective Agents|protective agents|mesh-ancestor
790002|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790003|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
790004|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
790160|NCT02616497|Aspirin|aspirin|mesh-list
790161|NCT02616497|Triflusal|triflusal|mesh-list
790162|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
790163|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
790164|NCT02616497|Analgesics|analgesics|mesh-ancestor
790165|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
790166|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790167|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790168|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
790169|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
790170|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
790171|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
790172|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790173|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
790174|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
790175|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790176|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
790253|NCT02616003|Liraglutide|liraglutide|mesh-list
790254|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
790255|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790256|NCT02616003|Incretins|incretins|mesh-ancestor
790257|NCT02616003|Hormones|hormones|mesh-ancestor
790258|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2243977|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
2243978|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2243979|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2243980|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
789791|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
789792|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
789793|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
789794|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
789795|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
790080|NCT02616861|Praliciguat|praliciguat|mesh-list
790081|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
790082|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
790083|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790084|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
790311|NCT02616068|Loxoprofen|loxoprofen|mesh-list
790312|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
790313|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
790314|NCT02616068|Analgesics|analgesics|mesh-ancestor
790315|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
790316|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790317|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790318|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
790319|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
790382|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
790383|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
790384|NCT02615561|Vitamins|vitamins|mesh-ancestor
790385|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
790386|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243981|NCT00111436|Etanercept|etanercept|mesh-list
2243982|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2243983|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2243984|NCT00111436|Analgesics|analgesics|mesh-ancestor
2243985|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
2243986|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2243987|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2243988|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2243989|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243990|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2243991|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2243992|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
2243993|NCT00111449|Etanercept|etanercept|mesh-list
2243994|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2243995|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2095740|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2095741|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095742|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
2095743|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095744|NCT02296112|Trametinib|trametinib|mesh-list
2095745|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2243996|NCT00111449|Analgesics|analgesics|mesh-ancestor
2243997|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
2243998|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791804|NCT02608944|Adenosine|adenosine|mesh-list
791805|NCT02608944|Regadenoson|regadenoson|mesh-list
791806|NCT02608944|Analgesics|analgesics|mesh-ancestor
791807|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
791808|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791809|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791810|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
791811|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
791812|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
791813|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
791814|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
791815|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791816|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791817|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
791864|NCT02608710|Verinurad|verinurad|mesh-list
791865|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
791866|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2243999|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244000|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2244001|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
792503|NCT02606448|Bupivacaine|bupivacaine|mesh-list
792504|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
792505|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
792506|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
792507|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792508|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
792509|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
789821|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
789822|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244002|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2244003|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244004|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
2244005|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
2244006|NCT00111462|Hematinics|hematinics|mesh-ancestor
790764|NCT02613676|Bilirubin|bilirubin|mesh-list
790765|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
790766|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790767|NCT02613676|Protective Agents|protective agents|mesh-ancestor
790768|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244007|NCT00111540|Exenatide|exenatide|mesh-list
2244008|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2244009|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244010|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
792819|NCT02605356|Dexamethasone|dexamethasone|mesh-list
792820|NCT02605356|Bortezomib|bortezomib|mesh-list
792821|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
792822|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
792823|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
792824|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
792825|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
792826|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792827|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
792828|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
792829|NCT02605356|Hormones|hormones|mesh-ancestor
792830|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
792831|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
792832|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
793099|NCT02604537|Ketorolac|ketorolac|mesh-list
793100|NCT02604537|Betamethasone|betamethasone|mesh-list
793101|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
793102|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
793103|NCT02604537|Analgesics|analgesics|mesh-ancestor
793104|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
793105|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793106|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793107|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793108|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
793109|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
793110|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793111|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793112|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
793113|NCT02604537|Hormones|hormones|mesh-ancestor
793114|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
793115|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
793116|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
2244011|NCT00111540|Incretins|incretins|mesh-ancestor
2244012|NCT00111540|Hormones|hormones|mesh-ancestor
2244013|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2244014|NCT00111566|Eptifibatide|eptifibatide|mesh-list
2244015|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2244016|NCT00111618|Vadimezan|vadimezan|mesh-list
2244017|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244018|NCT00111631|Metformin|metformin|mesh-list
2244019|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2244020|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2244021|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244022|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
2244023|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794530|NCT02598726|Curcumin|curcumin|mesh-list
794531|NCT02598726|Piperine|piperine|mesh-list
794532|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
794533|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
794534|NCT02598726|Analgesics|analgesics|mesh-ancestor
794535|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
2244024|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244025|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
2244026|NCT00111644|Lactams|lactams|mesh-list
2244027|NCT00111644|beta-Lactams|beta-lactams|mesh-list
2244028|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2244029|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244030|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2244031|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
2244032|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790029|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
790030|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
790031|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
790032|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790033|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
790034|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
790035|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244033|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244034|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2244035|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244036|NCT00111709|Rizatriptan|rizatriptan|mesh-list
2244037|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244038|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244039|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244040|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
790368|NCT02615782|Tadalafil|tadalafil|mesh-list
790369|NCT02615782|Tamsulosin|tamsulosin|mesh-list
790370|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
790371|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
790372|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
790373|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790374|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790375|NCT02615782|Urological Agents|urological agents|mesh-ancestor
790376|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
790377|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
790378|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
790379|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
790380|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
790381|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790642|NCT02614352|Candesartan|candesartan|mesh-list
790643|NCT02614352|Atorvastatin|atorvastatin|mesh-list
790644|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
790645|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
790646|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
790647|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790648|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
790649|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
790650|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790651|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
790652|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
790653|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
790890|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
790891|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
790892|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
790893|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
790894|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
790895|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
790896|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790999|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
791000|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
791001|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
791002|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
791004|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791005|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
791006|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
791007|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791088|NCT02612298|Metoprolol|metoprolol|mesh-list
791089|NCT02612298|Arotinolol|arotinolol|mesh-list
791090|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
791091|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
791092|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
791093|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
791094|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791095|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790021|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
790022|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
790023|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
790024|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
790025|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
790026|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
790027|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790028|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244041|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
2244042|NCT00111722|Rizatriptan|rizatriptan|mesh-list
2244043|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244044|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244045|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244046|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2244047|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
2244048|NCT00111748|Thalidomide|thalidomide|mesh-list
2244049|NCT00111748|Dexamethasone|dexamethasone|mesh-list
790259|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
790260|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
790261|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
790262|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
790263|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
790264|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790265|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790266|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
790487|NCT02615106|Endostar protein|endostar protein|mesh-list
790488|NCT02615106|Endostatins|endostatins|mesh-list
790489|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
790490|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
790491|NCT02615106|Growth Substances|growth substances|mesh-ancestor
790492|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790493|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
790494|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790631|NCT02614534|Mitomycins|mitomycins|mesh-list
790632|NCT02614534|Mitomycin|mitomycin|mesh-list
790633|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
790634|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790635|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
790636|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790637|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
790638|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790875|NCT02613091|Clemastine|clemastine|mesh-list
790876|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
790877|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
790878|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
790879|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
790880|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
790881|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
790882|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790883|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790884|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
791707|NCT02609698|Aspirin|aspirin|mesh-list
791708|NCT02609698|Clopidogrel|clopidogrel|mesh-list
791709|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
791710|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
791711|NCT02609698|Analgesics|analgesics|mesh-ancestor
791712|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
791713|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791714|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791715|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
791716|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
791717|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
791718|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
791719|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791720|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
791721|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
791722|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791723|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
791724|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
791725|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
791726|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
791727|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
791728|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791944|NCT02608437|Ipilimumab|ipilimumab|mesh-list
2244050|NCT00111748|Bortezomib|bortezomib|mesh-list
790064|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
790065|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
790066|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790067|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
790068|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790746|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
790747|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
790748|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2244051|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2244052|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
2244053|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
791400|NCT02610920|Iron|iron|mesh-list
791401|NCT02610920|Trace Elements|trace elements|mesh-ancestor
791402|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
791403|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791544|NCT02610153|Vitamin K|vitamin k|mesh-list
791545|NCT02610153|Vitamins|vitamins|mesh-ancestor
791546|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
791547|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791548|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
791549|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
791550|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791551|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
791552|NCT02610153|Coagulants|coagulants|mesh-ancestor
2244054|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2244055|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244056|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2244057|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
2244058|NCT00111748|Hormones|hormones|mesh-ancestor
2244059|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
791950|NCT02608242|Amlodipine|amlodipine|mesh-list
791951|NCT02608242|Telmisartan|telmisartan|mesh-list
791952|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
791953|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
791954|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
791955|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
791956|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
791957|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791958|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
791959|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791960|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
791961|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
791962|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
791963|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
791964|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
791965|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
791966|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791967|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
791968|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
792046|NCT02607943|Insulin|insulin|mesh-list
792047|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
792048|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
792049|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
792050|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792890|NCT02605265|Capecitabine|capecitabine|mesh-list
792891|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
792892|NCT02605265|Irinotecan|irinotecan|mesh-list
792893|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
792894|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
792895|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792896|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792897|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
792898|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
792899|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244060|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2244061|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244062|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244063|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
2244064|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
790086|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
790087|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095746|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2095747|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095748|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095749|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2095750|NCT02296125|Gefitinib|gefitinib|mesh-list
2095751|NCT02296125|Osimertinib|osimertinib|mesh-list
2095752|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095753|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2095754|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095755|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095756|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
2095757|NCT02296138|Olodaterol|olodaterol|mesh-list
2095758|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2095759|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
2095760|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791318|NCT02611492|Cytarabine|cytarabine|mesh-list
791319|NCT02611492|Dexamethasone|dexamethasone|mesh-list
791320|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
791321|NCT02611492|Methotrexate|methotrexate|mesh-list
791322|NCT02611492|Vincristine|vincristine|mesh-list
791323|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
791324|NCT02611492|Sargramostim|sargramostim|mesh-list
791325|NCT02611492|Lenograstim|lenograstim|mesh-list
791326|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
791327|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
791328|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
791329|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791330|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791331|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
791332|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
791333|NCT02611492|Hormones|hormones|mesh-ancestor
791334|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
791335|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
791336|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
791337|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
791338|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
791339|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
791340|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
791341|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
791342|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791343|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
791344|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791345|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
791346|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
791347|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
791348|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
791349|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
791350|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
791351|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
791352|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
791353|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
791354|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
791355|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
791356|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
791574|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
791575|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
791576|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
791577|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791862|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
791863|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
792298|NCT02607332|Paclitaxel|paclitaxel|mesh-list
792299|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
792300|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792301|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
792302|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
792303|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
792304|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792510|NCT02606539|Leucovorin|leucovorin|mesh-list
792511|NCT02606539|Folic Acid|folic acid|mesh-list
792512|NCT02606539|Methotrexate|methotrexate|mesh-list
792513|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
792514|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
792515|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
792516|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
790097|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790098|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
790152|NCT02616367|Bupivacaine|bupivacaine|mesh-list
790153|NCT02616367|Ropivacaine|ropivacaine|mesh-list
790154|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
790155|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
790156|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
790157|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790158|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
790159|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2244065|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2244066|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244067|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2244068|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2244069|NCT00111748|Growth Substances|growth substances|mesh-ancestor
2244070|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
2244071|NCT00111774|Panitumumab|panitumumab|mesh-list
2244072|NCT00111774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
791255|NCT02611635|Warfarin|warfarin|mesh-list
791256|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
791257|NCT02611635|Dabigatran|dabigatran|mesh-list
791258|NCT02611635|Apixaban|apixaban|mesh-list
791259|NCT02611635|Edoxaban|edoxaban|mesh-list
791260|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
791261|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
791262|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
791263|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
791264|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
791265|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791266|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792318|NCT02607111|Dalteparin|dalteparin|mesh-list
792319|NCT02607111|Tinzaparin|tinzaparin|mesh-list
792320|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
792321|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
792322|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
792323|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
792324|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792569|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
792570|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
792571|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792630|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
792631|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
792632|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
792633|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792634|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
792635|NCT02606045|Coagulants|coagulants|mesh-ancestor
792781|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
792782|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
792783|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
792784|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
792785|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
792786|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
792986|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
792987|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
792988|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244073|NCT00111774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244074|NCT00111787|Paclitaxel|paclitaxel|mesh-list
2244075|NCT00111787|Lapatinib|lapatinib|mesh-list
2244076|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2244077|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244078|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
2095761|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095762|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2095763|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
2095764|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
2095765|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2095766|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
2095767|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095768|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095769|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
2095770|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
2244079|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
2244080|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
794392|NCT02599337|Sorafenib|sorafenib|mesh-list
794393|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794394|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
794395|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794396|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790127|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
790128|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790129|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
790130|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
790131|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
790132|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
790133|NCT02616640|Growth Substances|growth substances|mesh-ancestor
790134|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
2244081|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244082|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2244083|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244084|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
2244085|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2244086|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2244087|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244088|NCT00111891|Niacin|niacin|mesh-list
2244089|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2244090|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
2244091|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244092|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2244093|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
2244094|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
2244095|NCT00111891|Vitamins|vitamins|mesh-ancestor
2244096|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
2244097|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244098|NCT00111904|Paclitaxel|paclitaxel|mesh-list
2244099|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2244100|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244101|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
790959|NCT02612792|Atorvastatin|atorvastatin|mesh-list
790960|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
790961|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
790962|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
790963|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790964|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
790965|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
790966|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791025|NCT02612480|Aspirin|aspirin|mesh-list
791026|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
791027|NCT02612480|Clopidogrel|clopidogrel|mesh-list
791028|NCT02612480|Ticagrelor|ticagrelor|mesh-list
791029|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
791030|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
791031|NCT02612480|Analgesics|analgesics|mesh-ancestor
791032|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
791033|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791034|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791035|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
791036|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
791037|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
791038|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
791039|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791040|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
791041|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
791042|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791043|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
791044|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
791045|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
791046|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
791047|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
791048|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791107|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
791108|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
791109|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
791110|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791111|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
791112|NCT02612181|Analgesics|analgesics|mesh-ancestor
791113|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
791114|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791115|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
791116|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
791117|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
791118|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
790142|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244102|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
2244103|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
2244104|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244105|NCT00111943|Tenofovir|tenofovir|mesh-list
2244106|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
2244107|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244108|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2244109|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2244110|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244111|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244112|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2244113|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2244114|NCT00111956|Etanercept|etanercept|mesh-list
2244115|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2244116|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2244117|NCT00111956|Analgesics|analgesics|mesh-ancestor
2244118|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
2244119|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2244120|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244121|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
790749|NCT02613715|Ethanol|ethanol|mesh-list
790750|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
790751|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
790752|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
790753|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791304|NCT02611518|Metformin|metformin|mesh-list
791305|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
791306|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
791307|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791308|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
791309|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
791310|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
791311|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791312|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
791313|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
791314|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244122|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2244123|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2244124|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244125|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
2244126|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
2244127|NCT00111995|Hematinics|hematinics|mesh-ancestor
2244128|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
2244129|NCT00112008|Hematinics|hematinics|mesh-ancestor
2244130|NCT00112021|Pramlintide|pramlintide|mesh-list
2244131|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
2244132|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2244133|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244134|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
2244135|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2244136|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
2244137|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244138|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
2244139|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2244140|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2244141|NCT00112034|Prednisolone|prednisolone|mesh-list
2244142|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
2244143|NCT00112034|Methotrexate|methotrexate|mesh-list
2244144|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2244145|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
2244146|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
791878|NCT02608619|Choline|choline|mesh-list
791879|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
791880|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
791881|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
791882|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791883|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
791884|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
791885|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
2244147|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
2244148|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2244149|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244150|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244151|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
790192|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
790193|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790194|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
790195|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790196|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
790197|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
790198|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
790199|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
790200|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
790201|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
790202|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790203|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
790204|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
790205|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
790206|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
790207|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790414|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
790415|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
790416|NCT02615639|Entecavir|entecavir|mesh-list
790417|NCT02615639|Telbivudine|telbivudine|mesh-list
790418|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
790419|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
790420|NCT02615639|Vaccines|vaccines|mesh-list
790421|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
790422|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790423|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
790424|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
790425|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
790426|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790427|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790428|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790639|NCT02614339|Metformin|metformin|mesh-list
790640|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
790641|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244152|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244153|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244154|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
2244155|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244156|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2244157|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244158|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
2244159|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2244160|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2244161|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2244162|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
2244163|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
792673|NCT02605772|Metformin|metformin|mesh-list
792674|NCT02605772|Saxagliptin|saxagliptin|mesh-list
792675|NCT02605772|Acarbose|acarbose|mesh-list
792676|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
792677|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792678|NCT02605772|Incretins|incretins|mesh-ancestor
792679|NCT02605772|Hormones|hormones|mesh-ancestor
792680|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
792681|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
792682|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
792683|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792684|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792685|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
792727|NCT02605460|Plerixafor|plerixafor|mesh-list
792728|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
792729|NCT02605460|Busulfan|busulfan|mesh-list
792730|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
792731|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
792732|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792733|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
792734|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
792735|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
792736|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792737|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792738|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
792739|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
792740|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
792741|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
792742|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244164|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2244165|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2244166|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
2244167|NCT00112034|Hormones|hormones|mesh-ancestor
2244168|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2244169|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2244170|NCT00112034|Protective Agents|protective agents|mesh-ancestor
2244171|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2244172|NCT00112086|Paclitaxel|paclitaxel|mesh-list
2244173|NCT00112086|Carboplatin|carboplatin|mesh-list
2244174|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2244175|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244176|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
2244177|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
2244178|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
790320|NCT02615873|Levodopa|levodopa|mesh-list
790321|NCT02615873|Carbidopa|carbidopa|mesh-list
790322|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
790323|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
790324|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
790325|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
790326|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
790327|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790328|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790329|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
790330|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790331|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
790332|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
790333|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
2244179|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244180|NCT00112138|Gabapentin|gabapentin|mesh-list
2244181|NCT00112138|Analgesics|analgesics|mesh-ancestor
2244182|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
2244183|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791015|NCT02612701|Nicotine|nicotine|mesh-list
791016|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
791017|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
791018|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791019|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791020|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
791021|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
791022|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
791023|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791024|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791142|NCT02612233|Pregabalin|pregabalin|mesh-list
791143|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
791144|NCT02612233|Analgesics|analgesics|mesh-ancestor
791145|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
791146|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791147|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791148|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
791149|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
791150|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
791151|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791152|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
791153|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
791154|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
791155|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
791156|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
791157|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
791158|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
791159|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791160|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
791161|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
2244184|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244185|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
2244186|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2244187|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2244188|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2244189|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
792641|NCT02605811|Temozolomide|temozolomide|mesh-list
792642|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
792643|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
792644|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790442|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790443|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
790444|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
790612|NCT02614456|Interferons|interferons|mesh-list
790613|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
790614|NCT02614456|Nivolumab|nivolumab|mesh-list
790615|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
790616|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790617|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
790618|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790619|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
790620|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
790667|NCT02614118|Acetaminophen|acetaminophen|mesh-list
790668|NCT02614118|Ketorolac|ketorolac|mesh-list
790669|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
790670|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
790671|NCT02614118|Analgesics|analgesics|mesh-ancestor
790672|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
790673|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790674|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790675|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
790676|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
790677|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
790678|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
790679|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
790680|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
790681|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244190|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2244191|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2244192|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244193|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244194|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
790915|NCT02613052|Propofol|propofol|mesh-list
790916|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
790917|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
790918|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790919|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
790920|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
790921|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
791063|NCT02612272|Ketorolac|ketorolac|mesh-list
791064|NCT02612272|Betamethasone|betamethasone|mesh-list
791065|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
791066|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
791067|NCT02612272|Analgesics|analgesics|mesh-ancestor
791068|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
791069|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791070|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791071|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
791072|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
791073|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
791074|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791075|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791076|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
791077|NCT02612272|Hormones|hormones|mesh-ancestor
791078|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
791079|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
791080|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
2244195|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
791736|NCT02609477|Phentermine|phentermine|mesh-list
791737|NCT02609477|Istradefylline|istradefylline|mesh-list
791738|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
791739|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791740|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
791741|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
791742|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
791743|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
791744|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791745|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
791746|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791747|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791748|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
791749|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
791750|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
791751|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
790461|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790462|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
790463|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
790464|NCT02615262|Hormones|hormones|mesh-ancestor
790465|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
790466|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
790467|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244196|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244197|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244198|NCT00112346|Gemcitabine|gemcitabine|mesh-list
2244199|NCT00112346|Cetuximab|cetuximab|mesh-list
2244200|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244201|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
2244202|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244203|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790906|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
790907|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
790908|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791140|NCT02612220|Hemostatics|hemostatics|mesh-list
791141|NCT02612220|Coagulants|coagulants|mesh-ancestor
2244204|NCT00112346|Antiviral Agents|antiviral agents|mesh-ancestor
2244205|NCT00112346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244206|NCT00112346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244207|NCT00112346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244208|NCT00112346|Immunologic Factors|immunologic factors|mesh-ancestor
2244209|NCT00112346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244210|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2244211|NCT00112372|Sirolimus|sirolimus|mesh-list
2244212|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
791564|NCT02610127|Factor VIII|factor viii|mesh-list
791565|NCT02610127|Coagulants|coagulants|mesh-ancestor
791655|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
791656|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244213|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244214|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2244215|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244216|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
2244217|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244218|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
2244219|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754211|NCT01808820|Imiquimod|imiquimod|mesh-list
2754212|NCT01808820|Vaccines|vaccines|mesh-list
2754213|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
2754214|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754215|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2244226|NCT00112476|Sirolimus|sirolimus|mesh-list
2244227|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
2244228|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2244229|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244230|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2244231|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244232|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
2244233|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244234|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
2244235|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244236|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2244237|NCT00112515|Modafinil|modafinil|mesh-list
2244238|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2244239|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244240|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2754216|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
793277|NCT02603783|Capsaicin|capsaicin|mesh-list
793278|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
793279|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
793280|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
793281|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793282|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793653|NCT02602509|Rifampin|rifampin|mesh-list
793654|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
793655|NCT02602509|Celecoxib|celecoxib|mesh-list
793656|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
793657|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
793658|NCT02602509|Analgesics|analgesics|mesh-ancestor
793659|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
793660|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793661|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244241|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2244242|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2244243|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244244|NCT00112528|Gemcitabine|gemcitabine|mesh-list
2244245|NCT00112528|Bevacizumab|bevacizumab|mesh-list
2244246|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
2244247|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2244248|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244249|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
791232|NCT02611700|Paclitaxel|paclitaxel|mesh-list
791233|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
791234|NCT02611700|Cisplatin|cisplatin|mesh-list
791235|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
791236|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
791237|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
791238|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
791239|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
791240|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
791241|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791242|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
791473|NCT02610829|Vitamin E|vitamin e|mesh-list
791474|NCT02610829|Tocopherols|tocopherols|mesh-list
791475|NCT02610829|Tocotrienols|tocotrienols|mesh-list
791476|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
791477|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
791478|NCT02610829|Vitamins|vitamins|mesh-ancestor
791479|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
791480|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791481|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
791482|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791483|NCT02610829|Protective Agents|protective agents|mesh-ancestor
2095771|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095772|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2095773|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095774|NCT02296190|Etripamil|etripamil|mesh-list
2095775|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2095776|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2244250|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
791923|NCT02608697|Atorvastatin|atorvastatin|mesh-list
791924|NCT02608697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
791925|NCT02608697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
791926|NCT02608697|Antimetabolites|antimetabolites|mesh-ancestor
791927|NCT02608697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791928|NCT02608697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
791929|NCT02608697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
791930|NCT02608697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244251|NCT00112528|Growth Substances|growth substances|mesh-ancestor
2244252|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244253|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
2244254|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244255|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
2244256|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244257|NCT00112528|Antiviral Agents|antiviral agents|mesh-ancestor
2244258|NCT00112528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244259|NCT00112528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793143|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
793144|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
793145|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
793146|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793533|NCT02603276|Red yeast rice|red yeast rice|mesh-list
793534|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
793535|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
793536|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
793537|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
793538|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793539|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793540|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
793885|NCT02601586|Oxycodone|oxycodone|mesh-list
793886|NCT02601586|Levodopa|levodopa|mesh-list
793887|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
793888|NCT02601586|Narcotics|narcotics|mesh-ancestor
793889|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
793890|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793891|NCT02601586|Analgesics|analgesics|mesh-ancestor
793892|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
790709|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
790710|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790944|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
790945|NCT02613013|Pilocarpine|pilocarpine|mesh-list
790946|NCT02613013|Miotics|miotics|mesh-ancestor
790947|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
790948|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790949|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790950|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
790951|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
790952|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
790953|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
790954|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790955|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
790956|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
790957|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
790958|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
791103|NCT02612259|Tryptophan|tryptophan|mesh-list
791104|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
791105|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
791106|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2244260|NCT00112528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244261|NCT00112528|Immunologic Factors|immunologic factors|mesh-ancestor
2244262|NCT00112554|Cytarabine|cytarabine|mesh-list
2244263|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244264|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
2244265|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244266|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244267|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
2244268|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244269|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244270|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
2244271|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244272|NCT00112567|Fludarabine|fludarabine|mesh-list
2244273|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
792619|NCT02606032|Metronidazole|metronidazole|mesh-list
792620|NCT02606032|Doxycycline|doxycycline|mesh-list
792621|NCT02606032|Terbinafine|terbinafine|mesh-list
792622|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
792623|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
792624|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
792625|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
792626|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
792627|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
792628|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792629|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244274|NCT00112567|Thiotepa|thiotepa|mesh-list
2244275|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244276|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244277|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
2244278|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244279|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244280|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
2244281|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244282|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2244283|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
2244284|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2244285|NCT00112619|Topotecan|topotecan|mesh-list
2244286|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2244287|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2244288|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244289|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244290|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244291|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
2244292|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244293|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
793329|NCT02603770|Lovastatin|lovastatin|mesh-list
793330|NCT02603770|L 647318|l 647318|mesh-list
793331|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
793332|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
793333|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
793334|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
793335|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793336|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
793337|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
793338|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244294|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244295|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244296|NCT00112645|Cyclosporine|cyclosporine|mesh-list
2244297|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
2244298|NCT00112645|Methotrexate|methotrexate|mesh-list
2244299|NCT00112645|Melphalan|melphalan|mesh-list
2244300|NCT00112645|Busulfan|busulfan|mesh-list
2244301|NCT00112645|Cyclosporins|cyclosporins|mesh-list
2244302|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2244303|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2244304|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
2244305|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2244306|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244307|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244308|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
2244309|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244310|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790847|NCT02613130|Fluorides|fluorides|mesh-list
790848|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
790849|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
790850|NCT02613130|Protective Agents|protective agents|mesh-ancestor
790851|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791171|NCT02611973|Aspirin|aspirin|mesh-list
791172|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
791173|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
791174|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
791175|NCT02611973|Analgesics|analgesics|mesh-ancestor
791176|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
791177|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791178|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791179|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
791180|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
791181|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
791182|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
791183|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791184|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
791185|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
791186|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791187|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
791188|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
791189|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
791190|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
791602|NCT02609997|Dexamethasone|dexamethasone|mesh-list
791603|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
791604|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
791605|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
791606|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
791607|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791608|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791609|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
791610|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
791611|NCT02609997|Hormones|hormones|mesh-ancestor
791612|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
791613|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
791614|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
791615|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
791616|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
791617|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
791618|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
2244311|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
2244312|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244313|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2244314|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244315|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
2244316|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2244317|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2244318|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
2244319|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244320|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2244321|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2244322|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
2244323|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2244324|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2244325|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
2244326|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
2244327|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790774|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
790775|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
790776|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
790777|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
790778|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
790779|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790780|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790781|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
790782|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
790783|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
790784|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
790785|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
790786|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
790839|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2244328|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2244329|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
2244330|NCT00112645|Hormones|hormones|mesh-ancestor
2244331|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2244332|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
791524|NCT02610556|Cisplatin|cisplatin|mesh-list
791525|NCT02610556|Docetaxel|docetaxel|mesh-list
791526|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
791527|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
791528|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
791529|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
791530|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095777|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095778|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2095779|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095780|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2095781|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2095782|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
2095783|NCT02296346|Prednisolone|prednisolone|mesh-list
2095784|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
2095785|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2095786|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
2095787|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2095788|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
2095789|NCT02296346|Hormones|hormones|mesh-ancestor
2095790|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
791898|NCT02608788|Ketorolac|ketorolac|mesh-list
791899|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
791900|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
791901|NCT02608788|Analgesics|analgesics|mesh-ancestor
791902|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
791903|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791904|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791905|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
791906|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
791907|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
791908|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791909|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095791|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095792|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2095793|NCT02296346|Protective Agents|protective agents|mesh-ancestor
2095794|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2095795|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095796|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
2095797|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
2095798|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095799|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2095800|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2095801|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
2244333|NCT00112645|Protective Agents|protective agents|mesh-ancestor
792445|NCT02607423|Gemcitabine|gemcitabine|mesh-list
792446|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
792447|NCT02607423|Cisplatin|cisplatin|mesh-list
792448|NCT02607423|Docetaxel|docetaxel|mesh-list
792449|NCT02607423|Pemetrexed|pemetrexed|mesh-list
792450|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
792451|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792452|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
792453|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
792454|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792455|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
792456|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
790818|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
790922|NCT02612922|Nitazoxanide|nitazoxanide|mesh-list
790923|NCT02612922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
790924|NCT02612922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
791451|NCT02610881|Iron|iron|mesh-list
791452|NCT02610881|Trace Elements|trace elements|mesh-list
791453|NCT02610881|Folic Acid|folic acid|mesh-list
791454|NCT02610881|Micronutrients|micronutrients|mesh-list
791455|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791456|NCT02610881|Hematinics|hematinics|mesh-ancestor
791457|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
791458|NCT02610881|Vitamins|vitamins|mesh-ancestor
791534|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
791535|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
791536|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
791537|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791538|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
791539|NCT02610504|Protective Agents|protective agents|mesh-ancestor
791752|NCT02609230|TIC10 compound|tic10 compound|mesh-list
791753|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
791829|NCT02609048|Seladelpar|seladelpar|mesh-list
791830|NCT02609048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
791831|NCT02609048|Antimetabolites|antimetabolites|mesh-ancestor
791832|NCT02609048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791833|NCT02609048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2244334|NCT00112658|Leucovorin|leucovorin|mesh-list
2244335|NCT00112658|Gemcitabine|gemcitabine|mesh-list
2244336|NCT00112658|Fluorouracil|fluorouracil|mesh-list
2244337|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
2244338|NCT00112658|Irinotecan|irinotecan|mesh-list
2244339|NCT00112658|Calcium|calcium|mesh-list
2244340|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
2244341|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244342|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
2244343|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244344|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244345|NCT00112658|Antiviral Agents|antiviral agents|mesh-ancestor
2244346|NCT00112658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244347|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244348|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244349|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
2244350|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792293|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
792294|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
792295|NCT02607293|Hormones|hormones|mesh-ancestor
792296|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
792297|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792408|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
792409|NCT02606994|Lidocaine|lidocaine|mesh-list
792410|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
792411|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
792412|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
792413|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792414|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
792415|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
792416|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
792417|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
792418|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
792419|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
792420|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792421|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
792422|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
792423|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
792424|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
792425|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
792426|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
792427|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
792428|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
792429|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
792430|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
792774|NCT02605538|Vaccines|vaccines|mesh-list
792775|NCT02605538|Immunologic Factors|immunologic factors|mesh-ancestor
792776|NCT02605538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793261|NCT02603848|Ibuprofen|ibuprofen|mesh-list
793262|NCT02603848|Morphine|morphine|mesh-list
793263|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
793264|NCT02603848|Narcotics|narcotics|mesh-ancestor
793265|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2244351|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2244352|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2244353|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2244354|NCT00112658|Antidotes|antidotes|mesh-ancestor
2244355|NCT00112658|Protective Agents|protective agents|mesh-ancestor
2244356|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
2244357|NCT00112658|Vitamins|vitamins|mesh-ancestor
2244358|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
2244359|NCT00112684|Alvocidib|alvocidib|mesh-list
2244360|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244361|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
2244362|NCT00112684|Growth Substances|growth substances|mesh-ancestor
2244363|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244364|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2244365|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244366|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244367|NCT00112697|Docetaxel|docetaxel|mesh-list
2244368|NCT00112697|Fluorouracil|fluorouracil|mesh-list
2244369|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244370|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
2244371|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
2244372|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
2244373|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244374|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
2244375|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244376|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244377|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
2244378|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244379|NCT00112710|Gemcitabine|gemcitabine|mesh-list
791268|NCT02611804|Diclofenac|diclofenac|mesh-list
791269|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
791270|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
791271|NCT02611804|Analgesics|analgesics|mesh-ancestor
791272|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
791273|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791274|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791275|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
791276|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
791277|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
791278|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791279|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244380|NCT00112710|Carboplatin|carboplatin|mesh-list
2244381|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244382|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244383|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
2244384|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244385|NCT00112710|Antiviral Agents|antiviral agents|mesh-ancestor
2244386|NCT00112710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244387|NCT00112710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244388|NCT00112710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244389|NCT00112710|Immunologic Factors|immunologic factors|mesh-ancestor
2244390|NCT00112710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244391|NCT00112749|Infliximab|infliximab|mesh-list
2244392|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
792164|NCT02607657|Eplerenone|eplerenone|mesh-list
792165|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
792166|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
792167|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
792168|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792169|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
792170|NCT02607657|Diuretics|diuretics|mesh-ancestor
792171|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
792172|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
792467|NCT02606981|Vitamins|vitamins|mesh-list
792468|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
792469|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
792470|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792471|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
792472|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792473|NCT02606981|Protective Agents|protective agents|mesh-ancestor
792557|NCT02606383|Ketoconazole|ketoconazole|mesh-list
792558|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
792559|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
792560|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
792561|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2244393|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2244394|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
790901|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
790902|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
790903|NCT02613039|Hormones|hormones|mesh-ancestor
790904|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
790905|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
791162|NCT02612116|Ticagrelor|ticagrelor|mesh-list
791163|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
791164|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
791165|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
791166|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
791167|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
791168|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791169|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791170|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791495|NCT02610686|Chloroquine|chloroquine|mesh-list
791496|NCT02610686|Amebicides|amebicides|mesh-ancestor
791497|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
791498|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
791499|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
791500|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
791501|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
791694|NCT02609711|Candesartan|candesartan|mesh-list
791695|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
791696|NCT02609711|Atorvastatin|atorvastatin|mesh-list
791697|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
791698|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
791699|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
791700|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791701|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
791702|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
791703|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791704|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
791705|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
791706|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
791843|NCT02608931|Dronabinol|dronabinol|mesh-list
791844|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
791845|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791846|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
791847|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
791848|NCT02608931|Analgesics|analgesics|mesh-ancestor
791849|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
791850|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791851|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
791852|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
791853|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791854|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791855|NCT02608931|Hormones|hormones|mesh-ancestor
791856|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
792000|NCT02608112|Methotrexate|methotrexate|mesh-list
792001|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
792002|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
792003|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
792004|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792005|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
792006|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
792007|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792008|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792009|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
792010|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792011|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
792012|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
792013|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
792014|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
792015|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
792849|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
792850|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
792851|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244395|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
2244396|NCT00112775|Dasatinib|dasatinib|mesh-list
793486|NCT02602938|Aspirin|aspirin|mesh-list
793487|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
793488|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
793489|NCT02602938|Analgesics|analgesics|mesh-ancestor
793490|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
790936|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
790937|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
790938|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
790939|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
790940|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
790941|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
790942|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
790943|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
791049|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
791050|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
791051|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
791052|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791053|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
791054|NCT02612363|Analgesics|analgesics|mesh-ancestor
791055|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
791056|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791057|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
791058|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
791059|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
791060|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
791061|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791062|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791459|NCT02610712|Ketamine|ketamine|mesh-list
791460|NCT02610712|Analgesics|analgesics|mesh-ancestor
791461|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
791462|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791463|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791464|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
791465|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
791466|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
791467|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
791468|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
791469|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
791470|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
791471|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791472|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791867|NCT02608736|Valproic Acid|valproic acid|mesh-list
791868|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
791869|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791870|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791871|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
791872|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791873|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791874|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
791875|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
791876|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
791877|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2095802|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095803|NCT02296775|Rituximab|rituximab|mesh-list
2095804|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2095805|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095806|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
2095807|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095808|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2095809|NCT02296840|Acetaminophen|acetaminophen|mesh-list
2095810|NCT02296840|Ibuprofen|ibuprofen|mesh-list
792146|NCT02607748|Listerine|listerine|mesh-list
792147|NCT02607748|Fluorides|fluorides|mesh-list
792148|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
792149|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
792150|NCT02607748|Protective Agents|protective agents|mesh-ancestor
792151|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792152|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
792153|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
792307|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
792308|NCT02607371|Apixaban|apixaban|mesh-list
792309|NCT02607371|Edoxaban|edoxaban|mesh-list
792310|NCT02607371|Dabigatran|dabigatran|mesh-list
792311|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
792312|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
792313|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
792314|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
792315|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792316|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095811|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2095812|NCT02296840|Hydrocodone|hydrocodone|mesh-list
790998|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
791003|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
791008|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791009|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791010|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
791011|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
791012|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
791013|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791014|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791213|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
791555|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
791556|NCT02610088|Gliclazide|gliclazide|mesh-list
791557|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
791558|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791559|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
791560|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791818|NCT02609152|Esmolol|esmolol|mesh-list
791819|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
791820|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
791821|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
791822|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
791823|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791824|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791825|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095813|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2095814|NCT02296840|Analgesics|analgesics|mesh-ancestor
2095815|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
2095816|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095817|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095818|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
2095819|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2095820|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2095821|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2095822|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2095823|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095824|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095825|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
791972|NCT02608164|Vitamin D|vitamin d|mesh-list
791973|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
791974|NCT02608164|Vitamins|vitamins|mesh-ancestor
791975|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
791976|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791977|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
791978|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
792216|NCT02607410|Insulin|insulin|mesh-list
792217|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
792218|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
792219|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
792220|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
792221|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
792222|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
792223|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
792224|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
792225|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792226|NCT02607410|Incretins|incretins|mesh-ancestor
792227|NCT02607410|Hormones|hormones|mesh-ancestor
792228|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
792229|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
792230|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792231|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792355|NCT02607202|Gemcitabine|gemcitabine|mesh-list
792356|NCT02607202|Paclitaxel|paclitaxel|mesh-list
792357|NCT02607202|Carboplatin|carboplatin|mesh-list
792358|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
792359|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792360|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
792361|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
792362|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
792363|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792364|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
792365|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
792366|NCT02607202|Antiviral Agents|antiviral agents|mesh-ancestor
792367|NCT02607202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
792368|NCT02607202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792369|NCT02607202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
791096|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
791097|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
791098|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
791099|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
791100|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791101|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791102|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
791553|NCT02610010|Cisplatin|cisplatin|mesh-list
791554|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
791886|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
791887|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
791888|NCT02608658|Antibodies|antibodies|mesh-list
791889|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
791890|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095826|NCT02296840|Narcotics|narcotics|mesh-ancestor
2095827|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2095828|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
2095829|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
2095830|NCT02296892|Midazolam|midazolam|mesh-list
792305|NCT02607319|Bemiparin|bemiparin|mesh-list
792306|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
792518|NCT02606552|Aspirin|aspirin|mesh-list
792519|NCT02606552|Clopidogrel|clopidogrel|mesh-list
792520|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
792521|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
792522|NCT02606552|Analgesics|analgesics|mesh-ancestor
792523|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
792524|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
792525|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792526|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
792527|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
792528|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
792529|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
792530|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792531|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
792532|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
792533|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792534|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
792535|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
792536|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
792537|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
792538|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
792539|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244397|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244398|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2244399|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244400|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244401|NCT00112853|Etoposide|etoposide|mesh-list
2244402|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
2244403|NCT00112853|Tipifarnib|tipifarnib|mesh-list
2244404|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2244405|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244406|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2244407|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2244408|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244409|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244410|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
2244411|NCT00112879|Thalidomide|thalidomide|mesh-list
2244412|NCT00112879|Dexamethasone|dexamethasone|mesh-list
2244413|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
2244414|NCT00112879|Mitogens|mitogens|mesh-list
2244415|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2244416|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
2244417|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
2244418|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754217|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
793589|NCT02602860|Levetiracetam|levetiracetam|mesh-list
793590|NCT02602860|Brivaracetam|brivaracetam|mesh-list
793591|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
793592|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
793635|NCT02602444|Ticagrelor|ticagrelor|mesh-list
793636|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
793637|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
793638|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
793639|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
793640|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
2095831|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
791119|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
791120|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095832|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2095833|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2095834|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095835|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2244419|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791789|NCT02609087|Propofol|propofol|mesh-list
791790|NCT02609087|Sevoflurane|sevoflurane|mesh-list
791791|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
791792|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
791793|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791794|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
791795|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
791796|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
791797|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
791798|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
791799|NCT02608918|BMS-955176|bms-955176|mesh-list
791800|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
791801|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
791802|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
791803|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
791993|NCT02608216|Paclitaxel|paclitaxel|mesh-list
791994|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
791995|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
791996|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
791997|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
791998|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
791999|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792121|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
792122|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
792123|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792274|NCT02607488|Lidocaine|lidocaine|mesh-list
792275|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
792276|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
792277|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
792278|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792279|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
792280|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
792281|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
792282|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
792283|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
792284|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
792285|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792339|NCT02607072|Aspirin|aspirin|mesh-list
792340|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
792341|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
792342|NCT02607072|Analgesics|analgesics|mesh-ancestor
792343|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
792344|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
792345|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792346|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
792347|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
792348|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
792349|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
792350|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792351|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
792352|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
792353|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792354|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
792401|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
792402|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
792403|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792404|NCT02606773|Protective Agents|protective agents|mesh-ancestor
792405|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792406|NCT02606773|Vitamins|vitamins|mesh-ancestor
792407|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
2244420|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2244421|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
2244422|NCT00112879|Hormones|hormones|mesh-ancestor
2244423|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
792922|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
792923|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
792924|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
791357|NCT02611336|Tadalafil|tadalafil|mesh-list
791358|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
791359|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
791360|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
791361|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791362|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791363|NCT02611336|Urological Agents|urological agents|mesh-ancestor
2244424|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2244425|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244426|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
2244427|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792059|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
792060|NCT02608060|Hematinics|hematinics|mesh-ancestor
792325|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
792326|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
792327|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
792328|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792329|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
792330|NCT02607163|Analgesics|analgesics|mesh-ancestor
792331|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
792332|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
792333|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
792334|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
792335|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
792336|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
792337|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
792338|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244428|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
792860|NCT02604966|Artesunate|artesunate|mesh-list
792861|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
792862|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
792863|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
792864|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
792865|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792866|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
792867|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
792868|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
792869|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
793147|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
793148|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
793149|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
793150|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793151|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
793152|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793153|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793421|NCT02603679|Tamoxifen|tamoxifen|mesh-list
793422|NCT02603679|Paclitaxel|paclitaxel|mesh-list
793423|NCT02603679|Letrozole|letrozole|mesh-list
793424|NCT02603679|Palbociclib|palbociclib|mesh-list
793425|NCT02603679|Anastrozole|anastrozole|mesh-list
793426|NCT02603679|Exemestane|exemestane|mesh-list
793427|NCT02603679|Goserelin|goserelin|mesh-list
793428|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
793429|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
793430|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
793431|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
793432|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
793433|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
793434|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793435|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
793436|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793437|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
793438|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
793439|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
793440|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793441|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
793491|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2244429|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
2244430|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
792044|NCT02607904|Cannabidiol|cannabidiol|mesh-list
792045|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
792136|NCT02607696|Zolpidem|zolpidem|mesh-list
792137|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
792138|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
792139|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
792140|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792141|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
792142|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
792143|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
792144|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
792145|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792232|NCT02607436|Aspirin|aspirin|mesh-list
792233|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
792234|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
792235|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
792236|NCT02607436|Analgesics|analgesics|mesh-ancestor
792237|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
792238|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
792239|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792240|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
792241|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
792242|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
792243|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
792244|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792245|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
792246|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
792247|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792248|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
792249|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
792250|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
792251|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
792572|NCT02606266|Valganciclovir|valganciclovir|mesh-list
792573|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
792574|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244431|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2244432|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244433|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2244434|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2244435|NCT00112879|Growth Substances|growth substances|mesh-ancestor
2244436|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
2244437|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
2244438|NCT00112879|Protective Agents|protective agents|mesh-ancestor
2244439|NCT00112879|Vitamins|vitamins|mesh-ancestor
2244440|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
2244441|NCT00112892|Selenium|selenium|mesh-list
793377|NCT02603445|Idelalisib|idelalisib|mesh-list
793378|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
793379|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793380|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793479|NCT02603068|Treprostinil|treprostinil|mesh-list
793480|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
794522|NCT02599090|Temozolomide|temozolomide|mesh-list
794523|NCT02599090|Sorafenib|sorafenib|mesh-list
794524|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
794525|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
794526|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794527|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794528|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
794529|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794588|NCT02598466|Abatacept|abatacept|mesh-list
794589|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
794590|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794591|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794592|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
794593|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
794594|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794595|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
795179|NCT02596269|Nefopam|nefopam|mesh-list
795180|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
795181|NCT02596269|Analgesics|analgesics|mesh-ancestor
795182|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
795183|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795184|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244442|NCT00112892|Irinotecan|irinotecan|mesh-list
791367|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
791368|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
791369|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
791370|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791371|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791372|NCT02611258|Urological Agents|urological agents|mesh-ancestor
791410|NCT02610933|Vitamin K|vitamin k|mesh-list
791411|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
791412|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
791413|NCT02610933|Vitamins|vitamins|mesh-ancestor
791414|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
791415|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791416|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
791417|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
791418|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
791419|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
791420|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791421|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791422|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
791423|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
791424|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
791425|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
791426|NCT02610933|Coagulants|coagulants|mesh-ancestor
791531|NCT02610647|Anesthetics|anesthetics|mesh-list
791532|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
791533|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244443|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2244444|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2244445|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244446|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244447|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244448|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
2244449|NCT00112892|Protective Agents|protective agents|mesh-ancestor
2244450|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792088|NCT02607891|Cannabidiol|cannabidiol|mesh-list
792089|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
792200|NCT02607579|Ropivacaine|ropivacaine|mesh-list
792201|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
792202|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
792203|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
792204|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792205|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
792206|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2244451|NCT00112892|Trace Elements|trace elements|mesh-ancestor
2244452|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
2244453|NCT00112931|Rituximab|rituximab|mesh-list
2244454|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2244455|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244456|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
2244457|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244458|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2244459|NCT00112983|Eculizumab|eculizumab|mesh-list
2244460|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2244461|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244462|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
792753|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
792754|NCT02605421|Melphalan|melphalan|mesh-list
792755|NCT02605421|Thiotepa|thiotepa|mesh-list
792756|NCT02605421|Carboplatin|carboplatin|mesh-list
792757|NCT02605421|Etoposide|etoposide|mesh-list
792758|NCT02605421|Sargramostim|sargramostim|mesh-list
792759|NCT02605421|Lenograstim|lenograstim|mesh-list
792760|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
792761|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
792762|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792763|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
792764|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
792765|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
792766|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792767|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792768|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
792769|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
792770|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
792771|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
792772|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792773|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2095836|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2095837|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
791691|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
791692|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
791693|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791760|NCT02609386|Zinc|zinc|mesh-list
791761|NCT02609386|Indomethacin|indomethacin|mesh-list
791762|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
791763|NCT02609386|Omeprazole|omeprazole|mesh-list
791764|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
791765|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
791766|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
791767|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791768|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
791769|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
791770|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
791771|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791772|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
791773|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
791774|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
791775|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
791776|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
791777|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791778|NCT02609386|Trace Elements|trace elements|mesh-ancestor
791779|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
791780|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
791781|NCT02609386|Analgesics|analgesics|mesh-ancestor
791782|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
791783|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791784|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
791785|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
791786|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
791787|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
791788|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2244463|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244464|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
2244465|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
2244466|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244467|NCT00112996|Protective Agents|protective agents|mesh-ancestor
2244468|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792787|NCT02605434|Levodopa|levodopa|mesh-list
792788|NCT02605434|Carbidopa|carbidopa|mesh-list
792789|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
792790|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
792791|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
792792|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
792793|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
792794|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792795|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792796|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
792797|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792798|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
792799|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
792800|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
793117|NCT02604420|Eculizumab|eculizumab|mesh-list
793118|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
793119|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
793120|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
793121|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793181|NCT02604095|Melatonin|melatonin|mesh-list
793182|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
793183|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793184|NCT02604095|Protective Agents|protective agents|mesh-ancestor
793185|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793186|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
793286|NCT02603822|Indomethacin|indomethacin|mesh-list
793287|NCT02603822|Mannitol|mannitol|mesh-list
793288|NCT02603822|Lactulose|lactulose|mesh-list
793289|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
793290|NCT02603822|Diuretics|diuretics|mesh-ancestor
793291|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
793292|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793293|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
793294|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
793295|NCT02603822|Analgesics|analgesics|mesh-ancestor
793296|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
793297|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
791826|NCT02609061|Alendronate|alendronate|mesh-list
791827|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
791828|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792258|NCT02608320|Fentanyl|fentanyl|mesh-list
792259|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
792260|NCT02608320|Narcotics|narcotics|mesh-ancestor
792261|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
792262|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792263|NCT02608320|Analgesics|analgesics|mesh-ancestor
792264|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
792265|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
792266|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
792267|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
792268|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
792269|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
2244469|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
2244470|NCT00112996|Vitamins|vitamins|mesh-ancestor
2244471|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
2244472|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
2244473|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2244474|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244475|NCT00113074|Nicotine|nicotine|mesh-list
2244476|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2244477|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
2244478|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2244479|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244480|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2244481|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2244482|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
2244483|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244484|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244485|NCT00113100|Ethanol|ethanol|mesh-list
2244486|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2244487|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2244488|NCT00113100|Estradiol|estradiol|mesh-list
2244489|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2244490|NCT00113100|Estrogens|estrogens|mesh-ancestor
2244491|NCT00113100|Hormones|hormones|mesh-ancestor
2244492|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2244493|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244494|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2244495|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
2244496|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2244497|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2244498|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
793867|NCT02601508|Rocuronium|rocuronium|mesh-list
793868|NCT02601508|Atracurium|atracurium|mesh-list
793869|NCT02601508|Cisatracurium|cisatracurium|mesh-list
793870|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
793871|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
793872|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
793873|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793874|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793875|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
793876|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
793877|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
793878|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793879|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793997|NCT02600988|Vitamin D|vitamin d|mesh-list
793998|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
793999|NCT02600988|Vitamins|vitamins|mesh-list
794000|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
794001|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794002|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
794003|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2095838|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2095839|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
2095840|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
2095841|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
2095842|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
2244499|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244500|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2095843|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095844|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095845|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
2095846|NCT02296931|Analgesics|analgesics|mesh-ancestor
2244501|NCT00113113|Rubitecan|rubitecan|mesh-list
791892|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
791893|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
791894|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
791895|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
791896|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
791897|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244502|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244503|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2244504|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2244505|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244506|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244507|NCT00113165|Lamotrigine|lamotrigine|mesh-list
2244508|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
2244509|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2244510|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2244511|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244512|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2244513|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244514|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2244515|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2244516|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2244517|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2244518|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2244519|NCT00113256|Rubitecan|rubitecan|mesh-list
2244520|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244521|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2244522|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2244523|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244524|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244525|NCT00113282|Interleukin-2|interleukin-2|mesh-list
2244526|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244527|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2244528|NCT00113282|Analgesics|analgesics|mesh-ancestor
2244529|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
2244530|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2244531|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244532|NCT00113347|Docetaxel|docetaxel|mesh-list
2244533|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2244534|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244535|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
2244536|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
2244537|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
2244538|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244539|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2244540|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793325|NCT02603965|Copper|copper|mesh-list
793326|NCT02603965|Trace Elements|trace elements|mesh-ancestor
793327|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
793328|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793381|NCT02603497|Peficitinib|peficitinib|mesh-list
793382|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793383|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793384|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
793385|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
793386|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793880|NCT02601365|Molgramostim|molgramostim|mesh-list
793881|NCT02601365|Sargramostim|sargramostim|mesh-list
793882|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
793883|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793884|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244541|NCT00113438|Paclitaxel|paclitaxel|mesh-list
2244542|NCT00113438|Fosbretabulin|fosbretabulin|mesh-list
2244543|NCT00113438|Combretastatin|combretastatin|mesh-list
2244544|NCT00113438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2244545|NCT00113438|Carboplatin|carboplatin|mesh-list
2244546|NCT00113438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2244547|NCT00113438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244548|NCT00113438|Tubulin Modulators|tubulin modulators|mesh-ancestor
2244549|NCT00113438|Antimitotic Agents|antimitotic agents|mesh-ancestor
2244550|NCT00113438|Mitosis Modulators|mitosis modulators|mesh-ancestor
2244551|NCT00113438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244552|NCT00113503|Azathioprine|azathioprine|mesh-list
2244553|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
2244554|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
791945|NCT02608437|Guadecitabine|guadecitabine|mesh-list
791946|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
791947|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
791948|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
791949|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792051|NCT02607982|Paclitaxel|paclitaxel|mesh-list
792052|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
792053|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
792054|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792055|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
792056|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
792057|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
792058|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793137|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
793138|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
793139|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
793140|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
793141|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
793142|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244555|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244556|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244557|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244558|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
2244559|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244560|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2244561|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2244562|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
2244563|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
2244564|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244565|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244566|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2244567|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2244568|NCT00113542|Growth Substances|growth substances|mesh-ancestor
2244569|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244570|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
2244571|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244572|NCT00113594|Olanzapine|olanzapine|mesh-list
2244573|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
2244574|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
2244575|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2244576|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244577|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2244578|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2244579|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2244580|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2244581|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2244582|NCT00113594|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2244583|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2244584|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2244585|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793913|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
793914|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
793915|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
793916|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
793917|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793918|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2244586|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244587|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
2244588|NCT00113685|Dextrans|dextrans|mesh-list
2244589|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2244590|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
794182|NCT02600247|Acetaminophen|acetaminophen|mesh-list
794183|NCT02600247|Celecoxib|celecoxib|mesh-list
794184|NCT02600247|Pregabalin|pregabalin|mesh-list
794185|NCT02600247|Oxycodone|oxycodone|mesh-list
794186|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
794187|NCT02600247|Tramadol|tramadol|mesh-list
794188|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
794189|NCT02600247|Analgesics|analgesics|mesh-ancestor
794190|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
794191|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794192|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794193|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
794194|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
794195|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
794196|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2244591|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
2244592|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
2244593|NCT00113698|Enalapril|enalapril|mesh-list
2244594|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
792252|NCT02607592|Pemetrexed|pemetrexed|mesh-list
792253|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792254|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792255|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792256|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
792257|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
793046|NCT02604576|Bromopride|bromopride|mesh-list
793047|NCT02604576|Metoclopramide|metoclopramide|mesh-list
793048|NCT02604576|Simethicone|simethicone|mesh-list
793049|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
793050|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793051|NCT02604576|Emollients|emollients|mesh-ancestor
793052|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
793053|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
793054|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
793055|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793056|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793057|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
793058|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
793059|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
793060|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793061|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
793322|NCT02603991|Levetiracetam|levetiracetam|mesh-list
793323|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
793324|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
793593|NCT02602652|Vaccines|vaccines|mesh-list
793594|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
793595|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793751|NCT02602301|Oxytocin|oxytocin|mesh-list
793752|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
793753|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
793754|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793910|NCT02601040|Vaccines|vaccines|mesh-list
793911|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
793912|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244595|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
2244596|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244597|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244598|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2244599|NCT00113737|Fluoxetine|fluoxetine|mesh-list
795407|NCT02595268|Pitavastatin|pitavastatin|mesh-list
795408|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
795409|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
795410|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
795411|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
795412|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795413|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795414|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
795991|NCT02592772|Menthol|menthol|mesh-list
795992|NCT02592772|Nicotine|nicotine|mesh-list
795993|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
795994|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
795995|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795996|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795997|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
795998|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
795999|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
796000|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796001|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796002|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
796003|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
796145|NCT02592226|Anesthetics|anesthetics|mesh-list
796146|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
796147|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796364|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
796365|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
796948|NCT02588417|Dexamethasone|dexamethasone|mesh-list
796949|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
796950|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
796951|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
796952|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
796953|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796954|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796955|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
792070|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
792071|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
792072|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
792073|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792074|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
792075|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
792076|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
792077|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
792078|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
792079|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
792080|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
792081|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
792082|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
792083|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
792084|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
792085|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
792086|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792087|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
792207|NCT02607540|Cisplatin|cisplatin|mesh-list
792208|NCT02607540|Fluorouracil|fluorouracil|mesh-list
792209|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792210|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
792211|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792212|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
792213|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
792214|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
792215|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792286|NCT02607215|Vinorelbine|vinorelbine|mesh-list
792287|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
792288|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792289|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
792290|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
792291|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
792292|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792485|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
792486|NCT02606409|Propofol|propofol|mesh-list
792487|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
792488|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
792489|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792490|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
792491|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
792492|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
792493|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
792494|NCT02606409|Analgesics|analgesics|mesh-ancestor
792495|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
792496|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
792497|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
792498|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
792499|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
792500|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
792501|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
792502|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244600|NCT00113737|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2244601|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2244602|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2244603|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244604|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244605|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
2244606|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244607|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
794080|NCT02600806|Azithromycin|azithromycin|mesh-list
794081|NCT02600806|Levofloxacin|levofloxacin|mesh-list
794082|NCT02600806|Ofloxacin|ofloxacin|mesh-list
794083|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
794084|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794085|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
794086|NCT02600806|Renal Agents|renal agents|mesh-ancestor
2244608|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
2244609|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2244610|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2244611|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2244612|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244613|NCT00113776|Panitumumab|panitumumab|mesh-list
2244614|NCT00113776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2244615|NCT00113776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244616|NCT00113802|Epratuzumab|epratuzumab|mesh-list
792580|NCT02606084|Esketamine|esketamine|mesh-list
792581|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
792582|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
792616|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
792617|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
792618|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244617|NCT00113802|Antibodies|antibodies|mesh-list
2244618|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
2244619|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244620|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2244621|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244622|NCT00113815|Topiramate|topiramate|mesh-list
2244623|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
2244624|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2244625|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244626|NCT00113828|Cyclosporine|cyclosporine|mesh-list
2244627|NCT00113828|Cyclosporins|cyclosporins|mesh-list
793215|NCT02604004|Lamivudine|lamivudine|mesh-list
793216|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
793217|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
793218|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793219|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793220|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
793221|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
793222|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
793223|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
793254|NCT02603757|Vitamin D|vitamin d|mesh-list
793255|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
793256|NCT02603757|Vitamins|vitamins|mesh-ancestor
793257|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
793258|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793259|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
793260|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
794042|NCT02600793|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
794043|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
794044|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794599|NCT02598427|Trastuzumab|trastuzumab|mesh-list
794600|NCT02598427|Pertuzumab|pertuzumab|mesh-list
794601|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
794602|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095847|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
2095848|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095849|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795394|NCT02595476|Remifentanil|remifentanil|mesh-list
795395|NCT02595476|Propofol|propofol|mesh-list
795396|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
795397|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
795398|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795399|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
795400|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
795401|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
795402|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
795403|NCT02595476|Narcotics|narcotics|mesh-ancestor
795404|NCT02595476|Analgesics|analgesics|mesh-ancestor
795405|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
795406|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795705|NCT02593695|Fluoxetine|fluoxetine|mesh-list
795706|NCT02593695|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
795707|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
795708|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
795709|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795710|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
795711|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
795712|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795713|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
795714|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
792189|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792190|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
792191|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
792192|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
792193|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
792194|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
792195|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
792196|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
792197|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
792198|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
792199|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792694|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
792695|NCT02605915|Carboplatin|carboplatin|mesh-list
792696|NCT02605915|Docetaxel|docetaxel|mesh-list
792697|NCT02605915|Doxorubicin|doxorubicin|mesh-list
792698|NCT02605915|Trastuzumab|trastuzumab|mesh-list
792699|NCT02605915|Atezolizumab|atezolizumab|mesh-list
792700|NCT02605915|Pertuzumab|pertuzumab|mesh-list
792701|NCT02605915|Maytansine|maytansine|mesh-list
792702|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
792703|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
792704|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
792705|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792706|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
792707|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
792708|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
792709|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792710|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792711|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
792712|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
792713|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
792714|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
792715|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
792716|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
792717|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
792718|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792719|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
792720|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2244628|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244629|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244630|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244631|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
2244632|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244633|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
793446|NCT02603315|Mitogens|mitogens|mesh-list
793447|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
793448|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
793449|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793450|NCT02603315|Growth Substances|growth substances|mesh-ancestor
793451|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095850|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
2095851|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2095852|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2095853|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
794057|NCT02600650|Testosterone|testosterone|mesh-list
794058|NCT02600650|Androgens|androgens|mesh-ancestor
794059|NCT02600650|Hormones|hormones|mesh-ancestor
794060|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
794061|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794472|NCT02598960|Nivolumab|nivolumab|mesh-list
794473|NCT02598960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
794474|NCT02598960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794475|NCT02598960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
794476|NCT02598960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794834|NCT02597309|Canagliflozin|canagliflozin|mesh-list
794835|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
794836|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794837|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
794838|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244634|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244635|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
2244636|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2244637|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2244638|NCT00113854|Mannitol|mannitol|mesh-list
2244639|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2244640|NCT00113854|Diuretics|diuretics|mesh-ancestor
792370|NCT02607202|Immunologic Factors|immunologic factors|mesh-ancestor
792371|NCT02607202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792636|NCT02605746|Ceritinib|ceritinib|mesh-list
792637|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792638|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
792639|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792640|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792833|NCT02605213|Vancomycin|vancomycin|mesh-list
792834|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
792835|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
792950|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
792951|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
793736|NCT02601989|Tadalafil|tadalafil|mesh-list
793737|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
793738|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
793739|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
793740|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793741|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793742|NCT02601989|Urological Agents|urological agents|mesh-ancestor
793834|NCT02601703|Tacrolimus|tacrolimus|mesh-list
793835|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
793836|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
793837|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793838|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
793839|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793840|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794099|NCT02600585|Vaccines|vaccines|mesh-list
794100|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
794101|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244641|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
2244642|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244643|NCT00113906|Melatonin|melatonin|mesh-list
2244644|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
2244645|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244646|NCT00113906|Protective Agents|protective agents|mesh-ancestor
2244647|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244648|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2244649|NCT00113945|Cinacalcet|cinacalcet|mesh-list
794510|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
794511|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
794512|NCT02598778|Listerine|listerine|mesh-list
794513|NCT02598778|Fluorides|fluorides|mesh-list
794514|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
794515|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
794516|NCT02598778|Protective Agents|protective agents|mesh-ancestor
794517|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794518|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
794519|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794520|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
794521|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
794704|NCT02598011|Flucytosine|flucytosine|mesh-list
794705|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
794706|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794707|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
794708|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794766|NCT02597634|Ibuprofen|ibuprofen|mesh-list
794767|NCT02597634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
794768|NCT02597634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
794769|NCT02597634|Analgesics|analgesics|mesh-ancestor
794770|NCT02597634|Sensory System Agents|sensory system agents|mesh-ancestor
794771|NCT02597634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794772|NCT02597634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794773|NCT02597634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
794774|NCT02597634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
794775|NCT02597634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
794776|NCT02597634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794777|NCT02597634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795250|NCT02595918|Nivolumab|nivolumab|mesh-list
795251|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
795252|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795253|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
795254|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795418|NCT02595190|Gabapentin|gabapentin|mesh-list
795419|NCT02595190|Tramadol|tramadol|mesh-list
795420|NCT02595190|Analgesics|analgesics|mesh-ancestor
795421|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
2244650|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2244651|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244652|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2244653|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
792807|NCT02605694|Prednisone|prednisone|mesh-list
792808|NCT02605694|Rituximab|rituximab|mesh-list
792809|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
792810|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792811|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
792812|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792813|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
792814|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
792815|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
792816|NCT02605694|Hormones|hormones|mesh-ancestor
792817|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
792818|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
793811|NCT02601924|Anesthetics|anesthetics|mesh-list
793812|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
793813|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
793814|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793815|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
793816|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793925|NCT02601157|Aspirin|aspirin|mesh-list
793926|NCT02601157|Sirolimus|sirolimus|mesh-list
793927|NCT02601157|Clopidogrel|clopidogrel|mesh-list
793928|NCT02601157|Ticagrelor|ticagrelor|mesh-list
793929|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
793930|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
793931|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
793932|NCT02601157|Analgesics|analgesics|mesh-ancestor
793933|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
793934|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793935|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793936|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793937|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
793938|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
793939|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
793940|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793941|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
793942|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
793943|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793944|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
793945|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
793946|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
793947|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
793948|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
793949|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793950|NCT02601157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
793951|NCT02601157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
793952|NCT02601157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
793953|NCT02601157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
793954|NCT02601157|Antifungal Agents|antifungal agents|mesh-ancestor
793955|NCT02601157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
793956|NCT02601157|Immunologic Factors|immunologic factors|mesh-ancestor
794320|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
794321|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
794322|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244654|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2244655|NCT00113958|Cinacalcet|cinacalcet|mesh-list
2244656|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2244657|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244658|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2244659|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
2244660|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2244661|NCT00113971|Epratuzumab|epratuzumab|mesh-list
2244662|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2244663|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244664|NCT00113984|Metronidazole|metronidazole|mesh-list
2244665|NCT00113984|Ipilimumab|ipilimumab|mesh-list
2244666|NCT00113984|Sargramostim|sargramostim|mesh-list
2244667|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
2244668|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244669|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244670|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
792396|NCT02606864|Nifurtimox|nifurtimox|mesh-list
792397|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
792398|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
792399|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
792400|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
792474|NCT02606617|Mosapride|mosapride|mesh-list
792475|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
792476|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
792477|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
792478|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
792479|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792480|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792721|NCT02605720|Piperaquine|piperaquine|mesh-list
792722|NCT02605720|Artenimol|artenimol|mesh-list
792723|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
792724|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
792725|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
792726|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
792936|NCT02604992|Dronabinol|dronabinol|mesh-list
792937|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
792938|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792939|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
792940|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
792941|NCT02604992|Analgesics|analgesics|mesh-ancestor
792942|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
792943|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
792944|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
792945|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
792946|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
792947|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792948|NCT02604992|Hormones|hormones|mesh-ancestor
792949|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2244671|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2244672|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244673|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244674|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2244675|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2244676|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2244677|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2244678|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2244679|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
2244680|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244681|NCT00114010|Antacids|antacids|mesh-ancestor
2244682|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244683|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2244684|NCT00114023|Imiquimod|imiquimod|mesh-list
2244685|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
793554|NCT02603055|Vaccines|vaccines|mesh-list
793555|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
793556|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244686|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
2244687|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244688|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244689|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
2244690|NCT00114153|Carboplatin|carboplatin|mesh-list
794286|NCT02599701|Gabapentin|gabapentin|mesh-list
794287|NCT02599701|Analgesics|analgesics|mesh-ancestor
794288|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
794289|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794290|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794291|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
794292|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
794293|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
794294|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
794295|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
794296|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
794297|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
794298|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
794299|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794300|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
794497|NCT02598869|Triamcinolone|triamcinolone|mesh-list
794498|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
794499|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
794500|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
794501|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2244691|NCT00114153|Capecitabine|capecitabine|mesh-list
2244692|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244693|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244694|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
2244695|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244696|NCT00114179|Gemcitabine|gemcitabine|mesh-list
792852|NCT02605226|Bicalutamide|bicalutamide|mesh-list
792853|NCT02605226|Hormones|hormones|mesh-list
792854|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
792855|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
792856|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792857|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
792858|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
792859|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792952|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
792953|NCT02604719|Ethamsylate|ethamsylate|mesh-list
792954|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
792955|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
792956|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792957|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
792958|NCT02604719|Coagulants|coagulants|mesh-ancestor
2095854|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2095855|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2095856|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095857|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2095858|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
2095859|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2095860|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2095861|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2095862|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2095863|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095864|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095865|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2095866|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2244697|NCT00114179|Bevacizumab|bevacizumab|mesh-list
793481|NCT02603159|Capecitabine|capecitabine|mesh-list
793482|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
793483|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
793484|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793485|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
793725|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
793726|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
793727|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793786|NCT02601911|Acetaminophen|acetaminophen|mesh-list
793787|NCT02601911|Ketorolac|ketorolac|mesh-list
793788|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
793789|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
793790|NCT02601911|Analgesics|analgesics|mesh-ancestor
793791|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
793792|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793793|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793794|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
793795|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
793796|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793797|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
793798|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
793799|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793800|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794348|NCT02599493|Rifampin|rifampin|mesh-list
794349|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
794350|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
794351|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
794352|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794353|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
794354|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
794355|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794356|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794357|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
794358|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
794359|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
794360|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
794361|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
794362|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
795011|NCT02597036|Paclitaxel|paclitaxel|mesh-list
792457|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792458|NCT02607423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
792459|NCT02607423|Immunologic Factors|immunologic factors|mesh-ancestor
792460|NCT02607423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792461|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
792462|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
792463|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
792464|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
792465|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
792466|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2244698|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2244699|NCT00114179|Capecitabine|capecitabine|mesh-list
2244700|NCT00114179|Antibodies|antibodies|mesh-list
2244701|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
2244702|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2244703|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244704|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2244705|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
793156|NCT02604459|Fentanyl|fentanyl|mesh-list
793157|NCT02604459|Anesthetics|anesthetics|mesh-list
793158|NCT02604459|Propofol|propofol|mesh-list
793159|NCT02604459|Sevoflurane|sevoflurane|mesh-list
793160|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
793161|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793162|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
793163|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
793164|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
793165|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
793166|NCT02604459|Narcotics|narcotics|mesh-ancestor
793167|NCT02604459|Analgesics|analgesics|mesh-ancestor
793168|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
793169|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793170|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
793171|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
793172|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
793315|NCT02603861|Modafinil|modafinil|mesh-list
793316|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
793317|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793318|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
793319|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
793320|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
793321|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793374|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
793375|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
793376|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793557|NCT02603198|Epinephrine|epinephrine|mesh-list
793558|NCT02603198|Nordefrin|nordefrin|mesh-list
793559|NCT02603198|Anesthetics|anesthetics|mesh-list
793560|NCT02603198|Mepivacaine|mepivacaine|mesh-list
793561|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
793562|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793563|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
793564|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
793565|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
793566|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793567|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793568|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
793569|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
793570|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
793571|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793572|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
793573|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
793574|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
793575|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
793576|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
793577|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
793578|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
793697|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
793698|NCT02602483|Ibuprofen|ibuprofen|mesh-list
793699|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
793700|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
793701|NCT02602483|Analgesics|analgesics|mesh-ancestor
793702|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
793703|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793704|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793705|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793706|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
792517|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792540|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
792541|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
792542|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792543|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792544|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
792545|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792546|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
792547|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
792548|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
792549|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
792550|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
792551|NCT02606539|Antidotes|antidotes|mesh-ancestor
792552|NCT02606539|Protective Agents|protective agents|mesh-ancestor
792553|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
792554|NCT02606539|Vitamins|vitamins|mesh-ancestor
792555|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
792556|NCT02606539|Hematinics|hematinics|mesh-ancestor
2244706|NCT00114179|Growth Substances|growth substances|mesh-ancestor
2244707|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244708|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
2244709|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
792989|NCT02604784|Cisplatin|cisplatin|mesh-list
792990|NCT02604784|Doxorubicin|doxorubicin|mesh-list
792991|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
792992|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
792993|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
792994|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
792995|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
792996|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
792997|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792998|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244710|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244711|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
2244712|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244713|NCT00114179|Antiviral Agents|antiviral agents|mesh-ancestor
2244714|NCT00114179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244715|NCT00114179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244716|NCT00114179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244717|NCT00114192|Thalidomide|thalidomide|mesh-list
2244718|NCT00114192|Docetaxel|docetaxel|mesh-list
2244719|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244720|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
2244721|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
2244722|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
2244723|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244724|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2244725|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
2244726|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244727|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
2244728|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2244729|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244730|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2244731|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2244732|NCT00114192|Growth Substances|growth substances|mesh-ancestor
2244733|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
2244734|NCT00114205|Docetaxel|docetaxel|mesh-list
2244735|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244736|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
795335|NCT02595463|Lidocaine|lidocaine|mesh-list
795336|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
795337|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
795338|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
795339|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795340|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
795341|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795342|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
795343|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
795344|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
795345|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
795346|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795750|NCT02593669|Dexamethasone|dexamethasone|mesh-list
795751|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
795752|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
795753|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
795754|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
792562|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792563|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792564|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
792565|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
792566|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
792567|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792568|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
793801|NCT02602288|Nicotine|nicotine|mesh-list
793802|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
793803|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
793804|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793805|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793806|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
793807|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
793808|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
793809|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793810|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244737|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
2244738|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
2244739|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244740|NCT00114257|Decitabine|decitabine|mesh-list
2244741|NCT00114257|Romidepsin|romidepsin|mesh-list
2244742|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244743|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
2244744|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244745|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244746|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244747|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
795185|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
795186|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
795187|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795621|NCT02593968|Interferons|interferons|mesh-list
795622|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795623|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
795624|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
795911|NCT02593162|Ribavirin|ribavirin|mesh-list
795912|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
795913|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795914|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
795915|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796308|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
796309|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
796310|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796354|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
796355|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
796356|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796594|NCT02590055|Gemcitabine|gemcitabine|mesh-list
796595|NCT02590055|Docetaxel|docetaxel|mesh-list
796596|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
796597|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
796598|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796599|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796600|NCT02590055|Antiviral Agents|antiviral agents|mesh-ancestor
796601|NCT02590055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796602|NCT02590055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796603|NCT02590055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
796604|NCT02590055|Immunologic Factors|immunologic factors|mesh-ancestor
796605|NCT02590055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796606|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
796607|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
796608|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
796655|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
796656|NCT02589782|Linezolid|linezolid|mesh-list
796657|NCT02589782|Bedaquiline|bedaquiline|mesh-list
796658|NCT02589782|Clofazimine|clofazimine|mesh-list
796659|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
796660|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796661|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
796662|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
796663|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796664|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796665|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796666|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
796667|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
796668|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793010|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
793011|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
793012|NCT02604797|Sufentanil|sufentanil|mesh-list
793013|NCT02604797|Dsuvia|dsuvia|mesh-list
793014|NCT02604797|Nalbuphine|nalbuphine|mesh-list
793015|NCT02604797|Ramosetron|ramosetron|mesh-list
793016|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
793017|NCT02604797|Narcotics|narcotics|mesh-ancestor
793018|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
793019|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793020|NCT02604797|Analgesics|analgesics|mesh-ancestor
793021|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
793022|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793023|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
793024|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
793025|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
793026|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
793027|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
793028|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
793029|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793030|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
793031|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
793032|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793033|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793034|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
793035|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
793036|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
793037|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
793038|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
793039|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793173|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
793174|NCT02604134|Fluorides|fluorides|mesh-list
793175|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
793176|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
793177|NCT02604134|Protective Agents|protective agents|mesh-ancestor
793178|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793179|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
793180|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2095867|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095868|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
2095869|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
794344|NCT02599792|Ivacaftor|ivacaftor|mesh-list
794345|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
794346|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
794347|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794477|NCT02598830|Vitamin D|vitamin d|mesh-list
794478|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
794479|NCT02598830|Vitamins|vitamins|mesh-ancestor
794480|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
794481|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794482|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
794483|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
795308|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
795309|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
795310|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
795311|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
795312|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
795313|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795314|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795315|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
795454|NCT02595242|Prednisone|prednisone|mesh-list
795455|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
795456|NCT02595242|Vincristine|vincristine|mesh-list
795457|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
795458|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
795459|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795460|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
795461|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2244748|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
2244749|NCT00114270|Letrozole|letrozole|mesh-list
2244750|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244751|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2244752|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2244753|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244754|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244755|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2244756|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
2244757|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2244758|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244759|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2244760|NCT00114283|Lapatinib|lapatinib|mesh-list
2244761|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244762|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
792900|NCT02604914|Levodopa|levodopa|mesh-list
792901|NCT02604914|Carbidopa|carbidopa|mesh-list
792902|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
792903|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
792904|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
792905|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
792906|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
792907|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
792908|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792909|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
792910|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792911|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
792912|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
792913|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
2244763|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244764|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244765|NCT00114361|Ribavirin|ribavirin|mesh-list
2244766|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2244767|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
2244768|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244769|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
2244770|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244771|NCT00114374|Citalopram|citalopram|mesh-list
2244772|NCT00114374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
793714|NCT02602197|Acetaminophen|acetaminophen|mesh-list
793715|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
793716|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
793717|NCT02602197|Analgesics|analgesics|mesh-ancestor
793718|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
793719|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793720|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793721|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
793722|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
793723|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793724|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
793817|NCT02601963|Minocycline|minocycline|mesh-list
793818|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
793819|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244773|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2244774|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2244775|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244776|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244777|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
2244778|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244779|NCT00114374|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2244780|NCT00114374|Antidepressive Agents|antidepressive agents|mesh-ancestor
2244781|NCT00114374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2244782|NCT00114387|Tocopherols|tocopherols|mesh-list
2244783|NCT00114387|Vitamin E|vitamin e|mesh-list
2244784|NCT00114387|Tocotrienols|tocotrienols|mesh-list
2244785|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
2244786|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
2244787|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794502|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
792645|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095885|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
2095886|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2095887|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
2095888|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2095889|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2095890|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793364|NCT02603705|Oxycodone|oxycodone|mesh-list
793365|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
793366|NCT02603705|Narcotics|narcotics|mesh-ancestor
793367|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
793368|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793369|NCT02603705|Analgesics|analgesics|mesh-ancestor
793370|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
793371|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793527|NCT02603003|Pemetrexed|pemetrexed|mesh-list
793528|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
793529|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793530|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793531|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
793532|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
793596|NCT02602743|Ketamine|ketamine|mesh-list
793597|NCT02602743|Remifentanil|remifentanil|mesh-list
793598|NCT02602743|Propofol|propofol|mesh-list
793599|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
793600|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
793601|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793602|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
793603|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
793604|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
793605|NCT02602743|Analgesics|analgesics|mesh-ancestor
793606|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
793607|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793608|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
793609|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
793610|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
793611|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793612|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793613|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
793614|NCT02602743|Narcotics|narcotics|mesh-ancestor
793743|NCT02602028|Colchicine|colchicine|mesh-list
793744|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
793745|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
793746|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
793747|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
793748|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
793749|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793750|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
793820|NCT02601677|Fluoxetine|fluoxetine|mesh-list
793821|NCT02601677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
793822|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
793823|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
793824|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793825|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793826|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
793827|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793828|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
793829|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
793830|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
793831|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
793832|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
793833|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793856|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
793857|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
793858|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
793859|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
793860|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
793861|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793862|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
793863|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095891|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
2095892|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793007|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
793008|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
793009|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244788|NCT00114387|Protective Agents|protective agents|mesh-ancestor
2244789|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244790|NCT00114387|Vitamins|vitamins|mesh-ancestor
793372|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
793373|NCT02603406|Hematinics|hematinics|mesh-ancestor
794164|NCT02600468|Abatacept|abatacept|mesh-list
794165|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
794166|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794167|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794168|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
794169|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
794170|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794171|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
794277|NCT02600117|Tenofovir|tenofovir|mesh-list
794278|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
794279|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794280|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
794281|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
794282|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794283|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794284|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
794285|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2244791|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
2244792|NCT00114400|Vitamins|vitamins|mesh-list
2244793|NCT00114400|Folic Acid|folic acid|mesh-list
2244794|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
2244795|NCT00114400|Hydroxocobalamin|hydroxocobalamin|mesh-list
2244796|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
794853|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
794854|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
794855|NCT02597166|Ledipasvir|ledipasvir|mesh-list
794856|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
794857|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244797|NCT00114400|Pyridoxal|pyridoxal|mesh-list
2244798|NCT00114400|Pyridoxine|pyridoxine|mesh-list
2244799|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
2244800|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
2244801|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244802|NCT00114400|Hematinics|hematinics|mesh-ancestor
2244803|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
2244804|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
2244805|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2244806|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244807|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244808|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
2244809|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2244810|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2244811|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244812|NCT00114478|Epinephrine|epinephrine|mesh-list
2244813|NCT00114478|Albuterol|albuterol|mesh-list
2244814|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2244815|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2244816|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
2244817|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244818|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244819|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244820|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2244821|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2244822|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
2244823|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2244824|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2244825|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
2244826|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
2244827|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
2244828|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2244829|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
2244830|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2244831|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
792914|NCT02604849|Gentamicins|gentamicins|mesh-list
792915|NCT02604849|Neomycin|neomycin|mesh-list
792916|NCT02604849|Streptomycin|streptomycin|mesh-list
792917|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
792918|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
792919|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
792920|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
792921|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793040|NCT02604615|Capecitabine|capecitabine|mesh-list
793041|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
793042|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
793043|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
793044|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793045|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095893|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095894|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2095895|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
2095896|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
2095897|NCT02297503|Protective Agents|protective agents|mesh-ancestor
2095898|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
2095899|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2095900|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
793841|NCT02601651|Lidocaine|lidocaine|mesh-list
793842|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
793843|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
793844|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
793845|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793846|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
793847|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793848|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
793849|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
793850|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
793851|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
793852|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794062|NCT02600780|Allopurinol|allopurinol|mesh-list
794063|NCT02600780|Febuxostat|febuxostat|mesh-list
794064|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
794065|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794066|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794067|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
794068|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
794069|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
794070|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
794071|NCT02600780|Protective Agents|protective agents|mesh-ancestor
794072|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244832|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2244833|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2244834|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2244835|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
2244836|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244837|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2244838|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2244839|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244840|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
2244841|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2244842|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244843|NCT00114569|Lorazepam|lorazepam|mesh-list
2244844|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
2244845|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
794952|NCT02596880|Ribavirin|ribavirin|mesh-list
794953|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
794954|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
794955|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794956|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
794957|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
795451|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
795452|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
795453|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795625|NCT02594072|Goserelin|goserelin|mesh-list
795626|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
795627|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795808|NCT02593474|Naltrexone|naltrexone|mesh-list
795809|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
795810|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
795811|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095901|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2244846|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
792925|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
792926|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
792927|NCT02604940|Analgesics|analgesics|mesh-ancestor
792928|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
792929|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
792930|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
792931|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
792932|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
792933|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
792934|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
792935|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793621|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
793622|NCT02602704|Calcium|calcium|mesh-list
793623|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
793624|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793625|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
793626|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
793627|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
793628|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
793629|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
793728|NCT02602002|Remifentanil|remifentanil|mesh-list
793729|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
793730|NCT02602002|Narcotics|narcotics|mesh-ancestor
793731|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
793732|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793733|NCT02602002|Analgesics|analgesics|mesh-ancestor
793734|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
793735|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793770|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
793771|NCT02601898|Progesterone|progesterone|mesh-list
793772|NCT02601898|Progestins|progestins|mesh-ancestor
793773|NCT02601898|Hormones|hormones|mesh-ancestor
793774|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
793775|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793776|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
793777|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793778|NCT02601898|Protective Agents|protective agents|mesh-ancestor
793779|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
793780|NCT02601898|Vitamins|vitamins|mesh-ancestor
793781|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
794301|NCT02599857|Bisoprolol|bisoprolol|mesh-list
794302|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
794303|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
794304|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
794305|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794306|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794307|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
794308|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
794309|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
794310|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
794311|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
794312|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794436|NCT02599324|Paclitaxel|paclitaxel|mesh-list
794437|NCT02599324|Docetaxel|docetaxel|mesh-list
794438|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
794439|NCT02599324|Everolimus|everolimus|mesh-list
794440|NCT02599324|Cetuximab|cetuximab|mesh-list
794441|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
794442|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794443|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
794444|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
794445|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
794446|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794447|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
794448|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
794449|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
794450|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794596|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
794597|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
794598|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794745|NCT02597699|Lidocaine|lidocaine|mesh-list
794746|NCT02597699|Sufentanil|sufentanil|mesh-list
794747|NCT02597699|Remifentanil|remifentanil|mesh-list
794748|NCT02597699|Dsuvia|dsuvia|mesh-list
794749|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
794750|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
793266|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793267|NCT02603848|Analgesics|analgesics|mesh-ancestor
793268|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
793269|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793270|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
793271|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
793272|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793273|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
793274|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
793275|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793276|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793615|NCT02602600|Liraglutide|liraglutide|mesh-list
793616|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
793617|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793618|NCT02602600|Incretins|incretins|mesh-ancestor
793619|NCT02602600|Hormones|hormones|mesh-ancestor
793620|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2244847|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2244848|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244849|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2244850|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2244851|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
794172|NCT02600273|Nicotine|nicotine|mesh-list
794173|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
794174|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
794175|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794176|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794177|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
794178|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
794179|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
794180|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
794181|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794790|NCT02597660|Hormones|hormones|mesh-list
794791|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
794792|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794858|NCT02597257|Lidocaine|lidocaine|mesh-list
794859|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
794860|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
794861|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
794862|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794863|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
794864|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794865|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
794866|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
794867|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
794868|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
794869|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794997|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
794998|NCT02596776|Propranolol|propranolol|mesh-list
794999|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
795000|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
795001|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
795002|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
795003|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795004|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795005|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
795006|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
795007|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
795008|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795009|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
795010|NCT02596776|Protective Agents|protective agents|mesh-ancestor
795088|NCT02596503|Cefixime|cefixime|mesh-list
795089|NCT02596503|Irinotecan|irinotecan|mesh-list
795090|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
795091|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
795092|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795093|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795094|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795095|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
795096|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
795261|NCT02595892|Gemcitabine|gemcitabine|mesh-list
795262|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
795263|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
793298|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793299|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
793300|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
793301|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
793302|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
793303|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
793304|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793305|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793306|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
793387|NCT02603575|Caspofungin|caspofungin|mesh-list
793388|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
793389|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
793390|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
793391|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793392|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
793393|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
793394|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793395|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793396|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
793397|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
793398|NCT02603575|Hormones|hormones|mesh-ancestor
793399|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
793400|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
793401|NCT02603575|Protective Agents|protective agents|mesh-ancestor
793402|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
793403|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
793404|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793405|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793406|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
793502|NCT02603081|Ebselen|ebselen|mesh-list
793503|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
793504|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
793505|NCT02603081|Analgesics|analgesics|mesh-ancestor
793506|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
793507|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793508|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793509|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793510|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
793511|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
793512|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
793513|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
793514|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793515|NCT02603081|Protective Agents|protective agents|mesh-ancestor
793516|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
793517|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793518|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
794156|NCT02600455|Abatacept|abatacept|mesh-list
794157|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
794158|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794159|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794160|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
794161|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
794162|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794163|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
794544|NCT02598856|Naloxone|naloxone|mesh-list
794545|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
794546|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794547|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
794548|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794620|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
794621|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
794622|NCT02598414|Protective Agents|protective agents|mesh-ancestor
794623|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794819|NCT02597283|Sirolimus|sirolimus|mesh-list
794820|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
794821|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794822|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
794823|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794824|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
794825|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
794826|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
794827|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794839|NCT02597114|Insulin|insulin|mesh-list
794840|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
794841|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
794842|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244852|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2244853|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2244854|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2244855|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
793644|NCT02602353|Loxoprofen|loxoprofen|mesh-list
793645|NCT02602353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
793646|NCT02602353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
793647|NCT02602353|Analgesics|analgesics|mesh-ancestor
793648|NCT02602353|Sensory System Agents|sensory system agents|mesh-ancestor
793649|NCT02602353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793650|NCT02602353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793651|NCT02602353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793652|NCT02602353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
793761|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
793762|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
793763|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
793764|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793765|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793766|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
793767|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
793768|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
793769|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794266|NCT02600260|Enoxaparin|enoxaparin|mesh-list
794267|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
794268|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
794269|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
794270|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
794271|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095902|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2095903|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095904|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
2095905|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2095906|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095907|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2095908|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
2095909|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
2095910|NCT02297516|Protective Agents|protective agents|mesh-ancestor
2095911|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2095912|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2095913|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794568|NCT02598596|Azathioprine|azathioprine|mesh-list
794569|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
794570|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794571|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
794572|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794573|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
794574|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
794575|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794576|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2244856|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
2244857|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244858|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244859|NCT00114686|Valproic Acid|valproic acid|mesh-list
2244860|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2244861|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
2244862|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2244863|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2244864|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2244865|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2244866|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244867|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795059|NCT02596685|Nicotine|nicotine|mesh-list
795060|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
795061|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
795062|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795063|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795064|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
795065|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
795066|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
795067|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
795068|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795157|NCT02596100|Betrixaban|betrixaban|mesh-list
795158|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
795159|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
795160|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
793442|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
793443|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
793444|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
793445|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
793680|NCT02602470|Metronidazole|metronidazole|mesh-list
793681|NCT02602470|Azelaic acid|azelaic acid|mesh-list
793682|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
793683|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
793684|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
793685|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
793686|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
793687|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
793688|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
793689|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
793690|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
793691|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
793692|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793693|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793694|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793695|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
793696|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
794828|NCT02597231|Melatonin|melatonin|mesh-list
794829|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
794830|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794831|NCT02597231|Protective Agents|protective agents|mesh-ancestor
794832|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794833|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
795188|NCT02596256|Docetaxel|docetaxel|mesh-list
795189|NCT02596256|Apatinib|apatinib|mesh-list
795190|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795191|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
795192|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
795193|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
795194|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795195|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
795196|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795239|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
795240|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
795241|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795600|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
795601|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
795602|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796378|NCT02591199|Lidocaine|lidocaine|mesh-list
796379|NCT02591199|Heparin|heparin|mesh-list
796380|NCT02591199|Anesthetics, Local|anesthetics, local|mesh-ancestor
796381|NCT02591199|Anesthetics|anesthetics|mesh-ancestor
796382|NCT02591199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
796383|NCT02591199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796384|NCT02591199|Sensory System Agents|sensory system agents|mesh-ancestor
796385|NCT02591199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796386|NCT02591199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
796387|NCT02591199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
796388|NCT02591199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
796389|NCT02591199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
796390|NCT02591199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796391|NCT02591199|Anticoagulants|anticoagulants|mesh-ancestor
796392|NCT02591199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
796393|NCT02591199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2244868|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244869|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
2244870|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
2244871|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
2244872|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244873|NCT00114764|Lenograstim|lenograstim|mesh-list
2244874|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2244875|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
2244876|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244877|NCT00114803|Calcitonin|calcitonin|mesh-list
2244878|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
797116|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
797117|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
797118|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797431|NCT02586454|Morphine|morphine|mesh-list
797432|NCT02586454|Ropivacaine|ropivacaine|mesh-list
797433|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2244879|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
793492|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793493|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793494|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
793495|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
793496|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
793497|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793498|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
793499|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
793500|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793501|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
2244880|NCT00114803|Katacalcin|katacalcin|mesh-list
2244881|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2244882|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794004|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
794005|NCT02600949|Imiquimod|imiquimod|mesh-list
794006|NCT02600949|Vaccines|vaccines|mesh-list
794007|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
794008|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794009|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
794010|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
794011|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794012|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
2244883|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2244884|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
2244885|NCT00114816|Docetaxel|docetaxel|mesh-list
2244886|NCT00114816|Capecitabine|capecitabine|mesh-list
2244887|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244888|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
2244889|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
794331|NCT02599623|Anesthetics|anesthetics|mesh-list
794332|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
794333|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244890|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
2244891|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244892|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2244893|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
2244894|NCT00114868|Vitamins|vitamins|mesh-list
2244895|NCT00114868|Vitamin A|vitamin a|mesh-list
2244896|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
2244897|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
2244898|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244899|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
2244900|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244901|NCT00114868|Protective Agents|protective agents|mesh-ancestor
2244902|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2244903|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244904|NCT00114933|Ritonavir|ritonavir|mesh-list
2244905|NCT00114933|Lopinavir|lopinavir|mesh-list
2244906|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2244907|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
795560|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
795561|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
795562|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
795740|NCT02593708|Paclitaxel|paclitaxel|mesh-list
795741|NCT02593708|Trastuzumab|trastuzumab|mesh-list
795742|NCT02593708|Pertuzumab|pertuzumab|mesh-list
795743|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
795744|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795745|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
795746|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
795747|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
795748|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795749|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2244908|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
2244909|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244910|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244911|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2244912|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
796366|NCT02591836|Atorvastatin|atorvastatin|mesh-list
796367|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
796368|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
796369|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
796370|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796371|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2244913|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
2244914|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2095914|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
2095915|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2095916|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
2095917|NCT02298023|Coagulants|coagulants|mesh-ancestor
2095918|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2095919|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
2095920|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
793957|NCT02601235|Pyrilamine|pyrilamine|mesh-list
793958|NCT02601235|Phenylephrine|phenylephrine|mesh-list
793959|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
793960|NCT02601235|Naphazoline|naphazoline|mesh-list
793961|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793962|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
793963|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
793964|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
793965|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793966|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793967|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
793968|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
793969|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793970|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
793971|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
793972|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
793973|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
793974|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
793975|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
793976|NCT02601235|Protective Agents|protective agents|mesh-ancestor
793977|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
793978|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
793979|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
793980|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
793981|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
793982|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
793983|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
794216|NCT02600741|Droperidol|droperidol|mesh-list
794217|NCT02600741|Haloperidol|haloperidol|mesh-list
794218|NCT02600741|Pimozide|pimozide|mesh-list
794219|NCT02600741|Olanzapine|olanzapine|mesh-list
794220|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
794221|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
794222|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
794223|NCT02600741|Risperidone|risperidone|mesh-list
794224|NCT02600741|Aripiprazole|aripiprazole|mesh-list
794225|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
794226|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
794227|NCT02600741|Ziprasidone|ziprasidone|mesh-list
794228|NCT02600741|Clozapine|clozapine|mesh-list
794229|NCT02600741|Asenapine|asenapine|mesh-list
794230|NCT02600741|Loxapine|loxapine|mesh-list
794231|NCT02600741|Iloperidone|iloperidone|mesh-list
794232|NCT02600741|Perphenazine|perphenazine|mesh-list
794233|NCT02600741|Fluphenazine|fluphenazine|mesh-list
794234|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
794235|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
794236|NCT02600741|Thioridazine|thioridazine|mesh-list
794237|NCT02600741|Thiothixene|thiothixene|mesh-list
794238|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
794239|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
794240|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
794241|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794242|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794243|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
794244|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
794245|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
794246|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
794247|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
794248|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
794249|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
794250|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
794251|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794252|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
794253|NCT02600741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
794254|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
794255|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
794256|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
794257|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
794258|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
794259|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
794260|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
794503|NCT02598869|Hormones|hormones|mesh-ancestor
2095921|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
793641|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793642|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793643|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244915|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2244916|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2244917|NCT00114946|Bevacizumab|bevacizumab|mesh-list
2244918|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2244919|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244920|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2244921|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2244922|NCT00114946|Growth Substances|growth substances|mesh-ancestor
2244923|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244924|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
794457|NCT02599077|Dienogest|dienogest|mesh-list
794458|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
794459|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
794460|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
794461|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
794462|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794463|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
794464|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
794465|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
794466|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
794467|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
794468|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
794469|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
794470|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
794471|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794560|NCT02598687|Paclitaxel|paclitaxel|mesh-list
794561|NCT02598687|Carboplatin|carboplatin|mesh-list
794562|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
794563|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794564|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
794565|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
794566|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
794567|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794719|NCT02597868|Capecitabine|capecitabine|mesh-list
794720|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
794721|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
794722|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794723|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794778|NCT02597556|Albendazole|albendazole|mesh-list
794779|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
794780|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
794781|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794782|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
794783|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
794784|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
794785|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
794786|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
794787|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
794788|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794789|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795417|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
796241|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
796242|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
796243|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
796244|NCT02591953|Prednisolone|prednisolone|mesh-list
796245|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
796246|NCT02591953|Lidocaine|lidocaine|mesh-list
796247|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
796248|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
796249|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
796250|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
796251|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
796252|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796253|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
796254|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796255|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
796256|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
796257|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
796258|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
796259|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793662|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
793663|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
793664|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
793665|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
793666|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793667|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793668|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
793669|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
793670|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
793671|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
793672|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
793673|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
793674|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
793675|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
793676|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
793677|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
793678|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
793679|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2244925|NCT00115011|Citalopram|citalopram|mesh-list
2244926|NCT00115011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2244927|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2244928|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2244929|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244930|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244931|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
2244932|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244933|NCT00115011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2244934|NCT00115011|Antidepressive Agents|antidepressive agents|mesh-ancestor
2244935|NCT00115011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2244936|NCT00115024|Estradiol|estradiol|mesh-list
2244937|NCT00115024|Estrogens|estrogens|mesh-ancestor
2244938|NCT00115024|Hormones|hormones|mesh-ancestor
2244939|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2244940|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244941|NCT00115050|Darunavir|darunavir|mesh-list
2244942|NCT00115050|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2244943|NCT00115050|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2244944|NCT00115050|Protease Inhibitors|protease inhibitors|mesh-ancestor
2244945|NCT00115050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2244946|NCT00115050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244947|NCT00115050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2244948|NCT00115050|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2244949|NCT00115050|Antiviral Agents|antiviral agents|mesh-ancestor
2244950|NCT00115050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794682|NCT02598063|Lamivudine|lamivudine|mesh-list
794683|NCT02598063|Adefovir|adefovir|mesh-list
794684|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
794685|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
794686|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
794687|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
794688|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794689|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794690|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
794691|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794692|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
794693|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
794882|NCT02596997|Brincidofovir|brincidofovir|mesh-list
794883|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
794884|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2244951|NCT00115089|Beclomethasone|beclomethasone|mesh-list
2244952|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2244953|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
2244954|NCT00115089|Hormones|hormones|mesh-ancestor
2244955|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2244956|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244957|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2244958|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
2244959|NCT00115102|Fentanyl|fentanyl|mesh-list
2244960|NCT00115102|Ketamine|ketamine|mesh-list
2244961|NCT00115102|Esketamine|esketamine|mesh-list
2244962|NCT00115102|Analgesics|analgesics|mesh-ancestor
2244963|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
2244964|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2244965|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793707|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
793708|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
793709|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
793710|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
793711|NCT02602483|Protective Agents|protective agents|mesh-ancestor
793712|NCT02602483|Vitamins|vitamins|mesh-ancestor
793713|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
2244966|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2244967|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2244968|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
2244969|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
2244970|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2244971|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2095922|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095923|NCT02298179|Antacids|antacids|mesh-ancestor
2095924|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095925|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2095926|NCT02298192|Liraglutide|liraglutide|mesh-list
2095927|NCT02298192|Xultophy|xultophy|mesh-list
2095928|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
794487|NCT02598999|Lactoferrin|lactoferrin|mesh-list
794488|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
794489|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2095929|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095930|NCT02298192|Incretins|incretins|mesh-ancestor
2095931|NCT02298192|Hormones|hormones|mesh-ancestor
2095932|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2095933|NCT02298868|Baclofen|baclofen|mesh-list
2244972|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2244973|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244974|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244975|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2244976|NCT00115102|Narcotics|narcotics|mesh-ancestor
2244977|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2244978|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
2244979|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2244980|NCT00115115|Dopamine|dopamine|mesh-list
2244981|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2244982|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
2244983|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
2244984|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2244985|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244986|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
2244987|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2244988|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2244989|NCT00115115|Protective Agents|protective agents|mesh-ancestor
2244990|NCT00115128|Lenograstim|lenograstim|mesh-list
2244991|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2244992|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
2244993|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244994|NCT00115154|Imiquimod|imiquimod|mesh-list
2244995|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2244996|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
2244997|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2244998|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2244999|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
2245000|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
2245001|NCT00115167|Hematinics|hematinics|mesh-ancestor
795535|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
795536|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
795537|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
795900|NCT02593019|Adavosertib|adavosertib|mesh-list
795901|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795902|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796325|NCT02591849|Glucagon|glucagon|mesh-list
796326|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
796327|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
796328|NCT02591849|Hormones|hormones|mesh-ancestor
796329|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
796330|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796331|NCT02591849|Incretins|incretins|mesh-ancestor
2245002|NCT00115219|Etanercept|etanercept|mesh-list
793864|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
793865|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
793866|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245003|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2245004|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2245005|NCT00115219|Analgesics|analgesics|mesh-ancestor
2245006|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
2245007|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245008|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795097|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
795098|NCT02596373|Analgesics|analgesics|mesh-ancestor
795099|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
795100|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795101|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795102|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795103|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
795104|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
795105|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795106|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795229|NCT02595801|Anesthetics|anesthetics|mesh-list
795230|NCT02595801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
795231|NCT02595801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795255|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
795256|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
795257|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
795258|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795259|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
795260|NCT02595606|Protective Agents|protective agents|mesh-ancestor
795316|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
795317|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
795318|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
795319|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
795320|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
795321|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795322|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795323|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795563|NCT02594241|Prednisolone|prednisolone|mesh-list
795564|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
795565|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
795566|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
795567|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
795568|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
795569|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
795570|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
795571|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
795572|NCT02594241|Hormones|hormones|mesh-ancestor
795573|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
795574|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795575|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
795576|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795577|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
795578|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
795579|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795580|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
795581|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
795582|NCT02594241|Protective Agents|protective agents|mesh-ancestor
2245009|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2245010|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2245011|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2245012|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2245013|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
2245014|NCT00115245|Adefovir|adefovir|mesh-list
2245015|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2245016|NCT00115245|Telbivudine|telbivudine|mesh-list
2245017|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
2245018|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245019|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2245020|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
793893|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
793894|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
793895|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
793896|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
793897|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
793898|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245021|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245022|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245023|NCT00115310|Capsaicin|capsaicin|mesh-list
2245024|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
2245025|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
2245026|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
2245027|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245028|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245029|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2245030|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2245031|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2245032|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2095934|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2095935|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095936|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2095937|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2095938|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2095939|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
2095940|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
2095941|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245033|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245034|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245035|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796467|NCT02590653|Atorvastatin|atorvastatin|mesh-list
796468|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
796469|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
796470|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
796471|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796472|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
796473|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
796474|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797028|NCT02588131|Durvalumab|durvalumab|mesh-list
797029|NCT02588131|Tremelimumab|tremelimumab|mesh-list
797030|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
797031|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245036|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2245037|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
2245038|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2245039|NCT00115375|Clopidogrel|clopidogrel|mesh-list
2245040|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2245041|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2245042|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2245043|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
797631|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
797632|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
797633|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797634|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
797635|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797751|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
797752|NCT02585141|Clindamycin|clindamycin|mesh-list
797753|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
797754|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
797755|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
797756|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
797757|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797758|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245044|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
2245045|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245046|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245047|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245048|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
2245049|NCT00115414|Docetaxel|docetaxel|mesh-list
2245050|NCT00115414|Doxorubicin|doxorubicin|mesh-list
2245051|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2245052|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
2245053|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245054|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
794323|NCT02599532|Apixaban|apixaban|mesh-list
794324|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
794325|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
794326|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
794327|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
794328|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794329|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794330|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
794642|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
794643|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
794644|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794645|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
794646|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
794647|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794648|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794649|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794650|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
794651|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2245055|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2245056|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
2245057|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245058|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245059|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2245060|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
2245061|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
2245062|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
2245063|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2245064|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2245065|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2245066|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245067|NCT00115479|Benzocaine|benzocaine|mesh-list
2245068|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794932|NCT02596984|Caspofungin|caspofungin|mesh-list
794933|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
794934|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794935|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794936|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795140|NCT02596282|Anesthetics|anesthetics|mesh-list
795141|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
795142|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245069|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
2245070|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
2245071|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
797426|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
797427|NCT02586402|Hematinics|hematinics|mesh-ancestor
2245072|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
2245073|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245074|NCT00115492|Fluticasone|fluticasone|mesh-list
2245075|NCT00115492|Xhance|xhance|mesh-list
2245076|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
794087|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
794088|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
794089|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794090|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794091|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794092|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
794093|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2245077|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2245078|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2245079|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2095942|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095943|NCT02298933|Eculizumab|eculizumab|mesh-list
2095944|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2095945|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2095946|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
796494|NCT02590601|Bromocriptine|bromocriptine|mesh-list
796495|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
796496|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
796497|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
796498|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
796499|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796500|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
796501|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
796502|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796503|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796558|NCT02590224|Glycine|glycine|mesh-list
796559|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
796560|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796561|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796562|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245080|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
2245081|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245082|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245083|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2245084|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
2245085|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
2245086|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
796678|NCT02589457|Tenofovir|tenofovir|mesh-list
796679|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
796680|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796681|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
796682|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
796683|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796684|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796685|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
796686|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
796896|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
796897|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
796898|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797054|NCT02588118|Propofol|propofol|mesh-list
797055|NCT02588118|Cisatracurium|cisatracurium|mesh-list
797056|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
797057|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
797058|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797059|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
797060|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
797061|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
797062|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
797063|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
797064|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797643|NCT02585570|Phenylephrine|phenylephrine|mesh-list
797644|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
797645|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
797646|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
797647|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
797648|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797649|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797650|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
797651|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
797652|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
797653|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
797654|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
797655|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2245087|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
794334|NCT02599571|Nicotine|nicotine|mesh-list
794335|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
794336|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
794337|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794338|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794339|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
794340|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
794341|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
794342|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
794343|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794409|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
794410|NCT02599168|Propofol|propofol|mesh-list
794411|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
794412|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
794413|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794414|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
794415|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
794416|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
794417|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
794418|NCT02599168|Analgesics|analgesics|mesh-ancestor
794419|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
794420|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794421|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
794422|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
794423|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
794424|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
794425|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
794426|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794554|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
794555|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
794556|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794557|NCT02598635|Vitamins|vitamins|mesh-ancestor
794558|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
794559|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
794628|NCT02598310|Paclitaxel|paclitaxel|mesh-list
794629|NCT02598310|Trastuzumab|trastuzumab|mesh-list
794630|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
794631|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794632|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
794633|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
794634|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
794635|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794636|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
794652|NCT02597998|BI 409306|bi 409306|mesh-list
794653|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
794654|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794655|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794709|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
794710|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
794711|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
794712|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794713|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2245088|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2245089|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2245090|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
2245091|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245092|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245093|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
2245094|NCT00115492|Hormones|hormones|mesh-ancestor
2245095|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2245096|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
2245097|NCT00115518|Cetuximab|cetuximab|mesh-list
2245098|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2245099|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245100|NCT00115531|Vaccines|vaccines|mesh-list
2245101|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
2245102|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795858|NCT02593370|Lidocaine|lidocaine|mesh-list
795859|NCT02593370|Epinephrine|epinephrine|mesh-list
795860|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
795861|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
795862|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
795863|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
794197|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794198|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
794199|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
794200|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
794201|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
794202|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
794203|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
794204|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
794205|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
794206|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
794207|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
794208|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794209|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
794210|NCT02600247|Narcotics|narcotics|mesh-ancestor
794211|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
794212|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
794213|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
794214|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
794215|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
794427|NCT02599480|Mirabegron|mirabegron|mesh-list
794428|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
794429|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
794430|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
794431|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
794432|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
794433|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794434|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794435|NCT02599480|Urological Agents|urological agents|mesh-ancestor
794613|NCT02598791|Glucagon|glucagon|mesh-list
794614|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
794615|NCT02598791|Incretins|incretins|mesh-ancestor
794616|NCT02598791|Hormones|hormones|mesh-ancestor
794617|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
794618|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794619|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
794670|NCT02598102|Diclofenac|diclofenac|mesh-list
794671|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
794672|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
794673|NCT02598102|Analgesics|analgesics|mesh-ancestor
794674|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
794675|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794676|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794677|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
794678|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
794679|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
794680|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794681|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794803|NCT02597400|Metformin|metformin|mesh-list
794804|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
794805|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794843|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
794844|NCT02597153|Analgesics|analgesics|mesh-ancestor
794845|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
794846|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794847|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794848|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794849|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
794850|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
794851|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794852|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794978|NCT02596828|Sirolimus|sirolimus|mesh-list
794979|NCT02596828|Irinotecan|irinotecan|mesh-list
794980|NCT02596828|Temozolomide|temozolomide|mesh-list
794981|NCT02596828|Dasatinib|dasatinib|mesh-list
794982|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
794983|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
794984|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794985|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794986|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794987|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
794988|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
794989|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
794990|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
794991|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
794261|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
794262|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
794263|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
794264|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
794265|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
794313|NCT02599675|Vitamin D|vitamin d|mesh-list
794314|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
794315|NCT02599675|Vitamins|vitamins|mesh-ancestor
794316|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
794317|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794318|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
794319|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
794384|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
794385|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
794386|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
794387|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
794388|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
794389|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794390|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794391|NCT02599311|Urological Agents|urological agents|mesh-ancestor
2245103|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
2245104|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245105|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245106|NCT00115570|Insulin|insulin|mesh-list
2245107|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2245108|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
2245109|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
2245110|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
2245111|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
2245112|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
795529|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
795530|NCT02594462|Etonogestrel|etonogestrel|mesh-list
795531|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
795532|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795533|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
795534|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
796357|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
796358|NCT02591251|Povidone|povidone|mesh-list
796359|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
796360|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
796361|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
796362|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
796363|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796432|NCT02591017|Morphine|morphine|mesh-list
796433|NCT02591017|Ketamine|ketamine|mesh-list
796434|NCT02591017|Chitosan|chitosan|mesh-list
796435|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
796436|NCT02591017|Narcotics|narcotics|mesh-ancestor
796437|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
796438|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796439|NCT02591017|Analgesics|analgesics|mesh-ancestor
796440|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
796441|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796442|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
796443|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
796444|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
796445|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
796446|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
796447|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
796448|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796449|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796450|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
796451|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
796452|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
796453|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
796454|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
796455|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
796456|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
796457|NCT02591017|Coagulants|coagulants|mesh-ancestor
796563|NCT02590263|Temozolomide|temozolomide|mesh-list
796564|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
796565|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
796566|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796567|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796909|NCT02588443|Gemcitabine|gemcitabine|mesh-list
796910|NCT02588443|Paclitaxel|paclitaxel|mesh-list
796911|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2245113|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
794504|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
794505|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794506|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
794507|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
794508|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794509|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794937|NCT02597322|Axitinib|axitinib|mesh-list
794938|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794939|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
794940|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794941|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245114|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2245115|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245116|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
2245117|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2245118|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2245119|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245120|NCT00115609|Tenofovir|tenofovir|mesh-list
2245121|NCT00115609|Emtricitabine|emtricitabine|mesh-list
2245122|NCT00115609|Efavirenz|efavirenz|mesh-list
2245123|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
2245124|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245125|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2245126|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2245127|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245128|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245129|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2245130|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2245131|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2245132|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2245133|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2245134|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2245135|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2245136|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2245137|NCT00115622|Fluticasone|fluticasone|mesh-list
2245138|NCT00115622|Xhance|xhance|mesh-list
2245139|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2245140|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
795355|NCT02595541|Milrinone|milrinone|mesh-list
795356|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
795357|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
795358|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
795359|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
795360|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795361|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795362|NCT02595541|Urological Agents|urological agents|mesh-ancestor
795363|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
795364|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
795365|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
795366|NCT02595541|Protective Agents|protective agents|mesh-ancestor
795367|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795628|NCT02593747|Loratadine|loratadine|mesh-list
795629|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
795630|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
795631|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
795632|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
795633|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
795634|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
795635|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
795636|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
795637|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795638|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245141|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
2245142|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245143|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245144|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
795916|NCT02592941|Deflazacort|deflazacort|mesh-list
795917|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
795918|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
795919|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
795920|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796332|NCT02591667|Bevacizumab|bevacizumab|mesh-list
796333|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
794536|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794537|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794538|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
794539|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
794540|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794541|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794542|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794543|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
794624|NCT02598440|Alendronate|alendronate|mesh-list
794625|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
794626|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
794627|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245145|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
2245146|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
2245147|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2245148|NCT00115635|Gemcitabine|gemcitabine|mesh-list
2245149|NCT00115635|Docetaxel|docetaxel|mesh-list
2245150|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2245151|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
794885|NCT02597140|Lidocaine|lidocaine|mesh-list
794886|NCT02597140|Propofol|propofol|mesh-list
794887|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
794888|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
794889|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
794890|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794891|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
794892|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794893|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
794894|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
794895|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
794896|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
794897|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794898|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
794899|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
794900|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
794968|NCT02596763|Baclofen|baclofen|mesh-list
794969|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
794970|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794971|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
794972|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794973|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
794974|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
794975|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
794976|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
794977|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795178|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
795497|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
795498|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
795499|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
795500|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
795501|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795502|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
795503|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
795504|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245152|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245153|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245154|NCT00115635|Antiviral Agents|antiviral agents|mesh-ancestor
2245155|NCT00115635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245156|NCT00115635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245157|NCT00115635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2245158|NCT00115635|Immunologic Factors|immunologic factors|mesh-ancestor
2245159|NCT00115635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245160|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
2245161|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
2245162|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
2245163|NCT00115648|Zidovudine|zidovudine|mesh-list
2245164|NCT00115648|Nevirapine|nevirapine|mesh-list
2245165|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
2245166|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245167|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
795788|NCT02593500|Budesonide|budesonide|mesh-list
795789|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
795790|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2245168|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2754235|NCT01609790|Bevacizumab|bevacizumab|mesh-list
2754236|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2754237|NCT01609790|Trebananib|trebananib|mesh-list
2754238|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
2754239|NCT01609790|Antibodies|antibodies|mesh-list
2754240|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
2754241|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2754242|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
794806|NCT02597361|Irbesartan|irbesartan|mesh-list
794807|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
794808|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
794809|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
794810|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795165|NCT02596243|Vaccines|vaccines|mesh-list
795166|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
795167|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245169|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245170|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
2245171|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245172|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2245173|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2245174|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2245175|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
795505|NCT02594735|Abatacept|abatacept|mesh-list
795506|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
795507|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795508|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795509|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
795510|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
795511|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795512|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
795840|NCT02593383|Clindamycin|clindamycin|mesh-list
795841|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
795842|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
795843|NCT02593383|Adapalene|adapalene|mesh-list
795844|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
795845|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
795846|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
795847|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795848|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795849|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
795850|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
795851|NCT02593383|Analgesics|analgesics|mesh-ancestor
795852|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
795853|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795854|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795855|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
795856|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
795857|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
2245176|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
2245177|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2245178|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245179|NCT00115687|Nicotine|nicotine|mesh-list
797065|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
797066|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
797067|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
797068|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797069|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
797070|NCT02587845|Coagulants|coagulants|mesh-ancestor
797119|NCT02587533|Dopamine|dopamine|mesh-list
797120|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
797121|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
797122|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
797123|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797124|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797125|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
797126|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
797127|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797128|NCT02587533|Protective Agents|protective agents|mesh-ancestor
2245180|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2245181|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
2245182|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245183|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754243|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754244|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
794751|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
794752|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794753|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
794754|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794755|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
794756|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
794757|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
794758|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
794759|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
794760|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
794761|NCT02597699|Narcotics|narcotics|mesh-ancestor
794762|NCT02597699|Analgesics|analgesics|mesh-ancestor
794763|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
794764|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
794765|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
794793|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
794794|NCT02597387|Analgesics|analgesics|mesh-ancestor
794795|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
794796|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
794797|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794798|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
794799|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
794800|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
794801|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
794802|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095947|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095948|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
795513|NCT02594761|Trastuzumab|trastuzumab|mesh-list
795514|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
795515|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795598|NCT02594254|Anti-Infective Agents|anti-infective agents|mesh-list
795599|NCT02594254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
795668|NCT02593734|Olanzapine|olanzapine|mesh-list
795669|NCT02593734|Risperidone|risperidone|mesh-list
795670|NCT02593734|Fluoxetine|fluoxetine|mesh-list
795671|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
795672|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
795673|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
795674|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795675|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795676|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
795677|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
795678|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
795679|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
795680|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
795681|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
795682|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
795683|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
795684|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795685|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
795686|NCT02593734|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
795687|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
795688|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
795689|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
795690|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
795691|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
795692|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
795693|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795980|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
795981|NCT02593227|Vaccines|vaccines|mesh-list
795982|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
795983|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795984|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
795985|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
795986|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
795987|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
795988|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795989|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795990|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2095949|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2245184|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2245185|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2245186|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
2245187|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245188|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795538|NCT02594423|Bevacizumab|bevacizumab|mesh-list
795539|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
795540|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795541|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
795542|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
795543|NCT02594423|Growth Substances|growth substances|mesh-ancestor
795544|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795545|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
2095950|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
2095951|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095952|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2095953|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2095954|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
2095955|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095956|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795830|NCT02593448|Anesthetics|anesthetics|mesh-list
795831|NCT02593448|Propofol|propofol|mesh-list
795832|NCT02593448|Sevoflurane|sevoflurane|mesh-list
795833|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
795834|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795835|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
795836|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
795837|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
795838|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
795839|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
796004|NCT02593110|Telmisartan|telmisartan|mesh-list
796005|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
796006|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
796007|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
796008|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796169|NCT02592278|Listerine|listerine|mesh-list
796170|NCT02592278|Fluorides|fluorides|mesh-list
796171|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
796172|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
796173|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
796174|NCT02592278|Protective Agents|protective agents|mesh-ancestor
796175|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796176|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
796177|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796419|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
796420|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
796421|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
796422|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
796423|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796424|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796425|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796426|NCT02590874|Analgesics|analgesics|mesh-ancestor
796427|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
796428|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796429|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
796430|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
796431|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
796696|NCT02589678|Vaccines|vaccines|mesh-list
796697|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
796698|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797731|NCT02585388|Letrozole|letrozole|mesh-list
797732|NCT02585388|Vinorelbine|vinorelbine|mesh-list
797733|NCT02585388|Anastrozole|anastrozole|mesh-list
797734|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797735|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
797736|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
797737|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797738|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797739|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
797740|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
797741|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
797742|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797743|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
794992|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
794993|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
794994|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
794995|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
794996|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
795081|NCT02596555|Dabigatran|dabigatran|mesh-list
795082|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
795083|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
795084|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
795085|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795086|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795087|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
795731|NCT02593526|Bumetanide|bumetanide|mesh-list
795732|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
795733|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
795734|NCT02593526|Diuretics|diuretics|mesh-ancestor
795735|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
795736|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795737|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
795738|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
795739|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245189|NCT00115700|Prednisolone|prednisolone|mesh-list
2245190|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
2245191|NCT00115700|Rituximab|rituximab|mesh-list
2245192|NCT00115700|Vincristine|vincristine|mesh-list
2245193|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2245194|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
2245195|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245196|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2245197|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2245198|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
2245199|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245200|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245201|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2245202|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2245203|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2245204|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
796271|NCT02591914|Bevacizumab|bevacizumab|mesh-list
796272|NCT02591914|Ranibizumab|ranibizumab|mesh-list
796273|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
796274|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796275|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
796276|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
796277|NCT02591914|Growth Substances|growth substances|mesh-ancestor
796278|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796279|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
796311|NCT02591615|Paclitaxel|paclitaxel|mesh-list
796312|NCT02591615|Carboplatin|carboplatin|mesh-list
796313|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
796314|NCT02591615|Pemetrexed|pemetrexed|mesh-list
796315|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
796316|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796317|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
796318|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
796319|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
796320|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796321|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
796322|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796323|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
796324|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
796400|NCT02590900|Acetaminophen|acetaminophen|mesh-list
796401|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
796402|NCT02590900|Analgesics|analgesics|mesh-ancestor
796403|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
796404|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796405|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796406|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
796757|NCT02589288|Ropivacaine|ropivacaine|mesh-list
796758|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
796759|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
796760|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
796761|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796762|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
796763|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796787|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
796788|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
795012|NCT02597036|Ramucirumab|ramucirumab|mesh-list
795013|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
795014|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795015|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
795016|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
795017|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
795018|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795143|NCT02596334|Lamivudine|lamivudine|mesh-list
795144|NCT02596334|Abacavir|abacavir|mesh-list
795145|NCT02596334|Dolutegravir|dolutegravir|mesh-list
795146|NCT02596334|Triumeq|triumeq|mesh-list
795147|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
795148|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
795149|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795150|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795151|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
795152|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
795153|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
795154|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
795155|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
795156|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2245205|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
2245206|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
2245207|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2245208|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
2245209|NCT00115700|Hormones|hormones|mesh-ancestor
2245210|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2245211|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2245212|NCT00115726|Furosemide|furosemide|mesh-list
2245213|NCT00115726|Diuretics|diuretics|mesh-ancestor
2245214|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
2245215|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245216|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2245217|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2245218|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796283|NCT02591771|Epinephrine|epinephrine|mesh-list
796284|NCT02591771|Racepinephrine|racepinephrine|mesh-list
796285|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
796286|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
796287|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
796288|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
796289|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796290|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796291|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796292|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
796293|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
796294|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
796295|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796296|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
796297|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
796298|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
796299|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
796300|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
797461|NCT02586441|Bromides|bromides|mesh-list
797462|NCT02586441|Propofol|propofol|mesh-list
797463|NCT02586441|Rocuronium|rocuronium|mesh-list
797464|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
797465|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
797466|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797467|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
797468|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
797469|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
797470|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
797471|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
797472|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
797473|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
797474|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797857|NCT02584829|Interferons|interferons|mesh-list
797858|NCT02584829|Interferon-beta|interferon-beta|mesh-list
797859|NCT02584829|Avelumab|avelumab|mesh-list
797860|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
797861|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797862|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
797863|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
797864|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
797865|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
797906|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
2245219|NCT00115752|Valdecoxib|valdecoxib|mesh-list
2245220|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
2245221|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2245222|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245223|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245224|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2245225|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2245226|NCT00115752|Analgesics|analgesics|mesh-ancestor
2245227|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
2245228|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245229|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245230|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2245231|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2245232|NCT00115817|Atorvastatin|atorvastatin|mesh-list
2245233|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2245234|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2245235|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
2245236|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245237|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2245238|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2245239|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245240|NCT00115830|Atorvastatin|atorvastatin|mesh-list
2245241|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2095957|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2095958|NCT02299050|Bromocriptine|bromocriptine|mesh-list
2095959|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2095960|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2095961|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
2095962|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2095963|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095964|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
2095965|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
2095966|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796052|NCT02592720|Tenecteplase|tenecteplase|mesh-list
796053|NCT02592720|Tirofiban|tirofiban|mesh-list
796054|NCT02592720|Bivalirudin|bivalirudin|mesh-list
796055|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
796056|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
796057|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
796058|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796059|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796060|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
796061|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
796062|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
796063|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
796343|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
796344|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
796345|NCT02591628|Diuretics|diuretics|mesh-ancestor
796346|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
796347|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796348|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
796349|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
796350|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796407|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
796408|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
796409|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
796410|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
796411|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
796412|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
796413|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
796414|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
796415|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796416|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245242|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2245243|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2245244|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
2245245|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245246|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2245247|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2245248|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245249|NCT00115908|Ribavirin|ribavirin|mesh-list
2245250|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2245251|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
2754245|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
798198|NCT02583516|Vemurafenib|vemurafenib|mesh-list
795161|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
795162|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795163|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795164|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
795242|NCT02595840|Pemetrexed|pemetrexed|mesh-list
795243|NCT02595840|Afatinib|afatinib|mesh-list
795244|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795245|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795246|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795247|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
795248|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
795249|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
795347|NCT02595489|Vitamin D|vitamin d|mesh-list
795348|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
795349|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
795350|NCT02595489|Vitamins|vitamins|mesh-list
795351|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
795352|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795353|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
795354|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
795546|NCT02594410|Lercanidipine|lercanidipine|mesh-list
795547|NCT02594410|Clopidogrel|clopidogrel|mesh-list
795548|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
795549|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
795550|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
795551|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
795552|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
795553|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
795554|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795555|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795556|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
795557|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
795558|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
795559|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2245252|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245253|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
2245254|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245255|NCT00115921|Antimalarials|antimalarials|mesh-list
2245256|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
795799|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
795800|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
795801|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
795802|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795803|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795804|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
795805|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
795806|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
795807|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2245257|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2245258|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245259|NCT00115947|Terlipressin|terlipressin|mesh-list
796228|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
796229|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
796230|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
796231|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
796232|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796233|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
796234|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
796235|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
796236|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
796237|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796238|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796239|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796240|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
796340|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
796341|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
796342|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795264|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795265|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795266|NCT02595892|Antiviral Agents|antiviral agents|mesh-ancestor
795267|NCT02595892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
795268|NCT02595892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795269|NCT02595892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
795270|NCT02595892|Immunologic Factors|immunologic factors|mesh-ancestor
795271|NCT02595892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095967|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095968|NCT02299089|Octreotide|octreotide|mesh-list
2095969|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2095970|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2245260|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
795590|NCT02594371|Paclitaxel|paclitaxel|mesh-list
795591|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
795592|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
795593|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795594|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
795595|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
795596|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
795597|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795616|NCT02593786|Nivolumab|nivolumab|mesh-list
795617|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
795618|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795619|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
795620|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245261|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2245262|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
2245263|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2245264|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245265|NCT00116064|Lorazepam|lorazepam|mesh-list
2245266|NCT00116064|Paraldehyde|paraldehyde|mesh-list
2245267|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
2245268|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
796504|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
796505|NCT02590523|Vancomycin|vancomycin|mesh-list
796506|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
796507|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796508|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
796509|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
796510|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796511|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796512|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796583|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
796584|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
796585|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
796586|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
796587|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
796588|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796589|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
796590|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796591|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796592|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
796593|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245269|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
2245270|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245271|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245272|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2245273|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2245274|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
797225|NCT02587195|Teriflunomide|teriflunomide|mesh-list
797226|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
797227|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
797228|NCT02587195|Analgesics|analgesics|mesh-ancestor
797229|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
797230|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797231|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797232|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
797233|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
797234|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
797235|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
2245275|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2245276|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2245277|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
795294|NCT02595554|Paclitaxel|paclitaxel|mesh-list
795295|NCT02595554|Cisplatin|cisplatin|mesh-list
795296|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
795297|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795298|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
795299|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
795300|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
795301|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795519|NCT02594358|Caffeine|caffeine|mesh-list
795520|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
795521|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795522|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
795523|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795524|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795525|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
795526|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
795527|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
795528|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
795766|NCT02593643|Midazolam|midazolam|mesh-list
795767|NCT02593643|Ketamine|ketamine|mesh-list
795768|NCT02593643|Analgesics|analgesics|mesh-ancestor
795769|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
795770|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795771|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795772|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
795773|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
795774|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
795775|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
795776|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
795777|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
795778|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
795779|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
795780|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795781|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
795782|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
795783|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
795784|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
795785|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
795786|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
795787|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
796151|NCT02592395|Folfirinox|folfirinox|mesh-list
796152|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095971|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095972|NCT02299141|Nintedanib|nintedanib|mesh-list
2095973|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796925|NCT02588716|Terlipressin|terlipressin|mesh-list
796926|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
796927|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2095974|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2095975|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095976|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095977|NCT02299297|Tofacitinib|tofacitinib|mesh-list
2095978|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2095979|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2095980|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2095981|NCT02299336|Aflibercept|aflibercept|mesh-list
2095982|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2095983|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2095984|NCT02299336|Growth Substances|growth substances|mesh-ancestor
2095985|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2095986|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
2095987|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2095988|NCT02299349|Epinephrine|epinephrine|mesh-list
2095989|NCT02299349|Racepinephrine|racepinephrine|mesh-list
2095990|NCT02299349|Morphine|morphine|mesh-list
2095991|NCT02299349|Bupivacaine|bupivacaine|mesh-list
2095992|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
2095993|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
2095994|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
2095995|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2095996|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245278|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
2245279|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
2245280|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245281|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245282|NCT00116103|Tacrolimus|tacrolimus|mesh-list
2095997|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
2095998|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796417|NCT02591095|Navitoclax|navitoclax|mesh-list
796418|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796527|NCT02590510|Methotrexate|methotrexate|mesh-list
796528|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
796529|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
796530|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
796531|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796532|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
796533|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
796534|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796535|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796536|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
796537|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796538|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
796539|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
796540|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
796541|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
796542|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
796687|NCT02589353|Acarbose|acarbose|mesh-list
796688|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
796689|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796690|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796691|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
796692|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797019|NCT02588235|Atorvastatin|atorvastatin|mesh-list
797020|NCT02588235|Ezetimibe|ezetimibe|mesh-list
797021|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
797022|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
797023|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
797024|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797025|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
797026|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
797027|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797106|NCT02587871|Cytarabine|cytarabine|mesh-list
797107|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
797108|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797109|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
797110|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
797111|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797112|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797113|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
797114|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
797115|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
797211|NCT02587130|Ketamine|ketamine|mesh-list
797212|NCT02587130|Analgesics|analgesics|mesh-ancestor
797213|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
797214|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797215|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797216|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
797217|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
797218|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
797219|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
797220|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
797221|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
797222|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
797223|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
797224|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797415|NCT02586259|Budesonide|budesonide|mesh-list
797416|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
797417|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
797418|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
797419|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797420|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797421|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
797422|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
797423|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
797424|NCT02586259|Hormones|hormones|mesh-ancestor
797425|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
797510|NCT02586038|Thalidomide|thalidomide|mesh-list
797511|NCT02586038|Dexamethasone|dexamethasone|mesh-list
797512|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
797513|NCT02586038|Ixazomib|ixazomib|mesh-list
2095999|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2245283|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2245284|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
2245285|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245286|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
795480|NCT02595034|Clindamycin|clindamycin|mesh-list
795481|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
795482|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
795483|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
795484|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
795485|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
795486|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
795487|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795488|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795489|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
796064|NCT02592746|Capecitabine|capecitabine|mesh-list
796065|NCT02592746|Palbociclib|palbociclib|mesh-list
796066|NCT02592746|Leuprolide|leuprolide|mesh-list
796067|NCT02592746|Exemestane|exemestane|mesh-list
796068|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
796069|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
796070|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796071|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796072|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
796073|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796074|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
796075|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
796076|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
796077|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796078|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
796079|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
796080|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
796081|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
796082|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
796083|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2245287|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245288|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245289|NCT00116116|Lamivudine|lamivudine|mesh-list
2245290|NCT00116116|Efavirenz|efavirenz|mesh-list
2245291|NCT00116116|Stavudine|stavudine|mesh-list
796724|NCT02589340|Buspirone|buspirone|mesh-list
796725|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
796726|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
796727|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
796728|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796729|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
796730|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
796731|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
796732|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796733|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796780|NCT02589041|Ropivacaine|ropivacaine|mesh-list
796781|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
796782|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
796783|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
796784|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796785|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
796786|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796890|NCT02588742|Melatonin|melatonin|mesh-list
796891|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
796892|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796893|NCT02588742|Protective Agents|protective agents|mesh-ancestor
796894|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796895|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2245292|NCT00116116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2245293|NCT00116116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2245294|NCT00116116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245295|NCT00116116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245296|NCT00116116|Antiviral Agents|antiviral agents|mesh-ancestor
2245297|NCT00116116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245298|NCT00116116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2245299|NCT00116116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2245300|NCT00116116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2245301|NCT00116116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2245302|NCT00116116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2245303|NCT00116116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
795422|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795423|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795424|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
795425|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
795426|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
795427|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
795428|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
795429|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
795430|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
795431|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
795432|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795433|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
795434|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
795435|NCT02595190|Narcotics|narcotics|mesh-ancestor
795603|NCT02593942|Remifentanil|remifentanil|mesh-list
795604|NCT02593942|Propofol|propofol|mesh-list
795605|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
795606|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
795607|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795608|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
795609|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
795610|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
795611|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
795612|NCT02593942|Narcotics|narcotics|mesh-ancestor
795613|NCT02593942|Analgesics|analgesics|mesh-ancestor
795614|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
795615|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795822|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
795823|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
795824|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
795825|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
795826|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795827|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
795828|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
795829|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245304|NCT00116116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2245305|NCT00116116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2754246|NCT01609790|Growth Substances|growth substances|mesh-ancestor
2754247|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754248|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
2754249|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
2754250|NCT01572506|Biotin|biotin|mesh-list
2754251|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
2754252|NCT01572506|Vitamins|vitamins|mesh-ancestor
2754253|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
2754254|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754255|NCT01481272|Leucovorin|leucovorin|mesh-list
2754256|NCT01481272|Cytarabine|cytarabine|mesh-list
2754257|NCT01481272|Methotrexate|methotrexate|mesh-list
796280|NCT02591927|Insulin|insulin|mesh-list
796281|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
796282|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797277|NCT02587169|Doxorubicin|doxorubicin|mesh-list
797278|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
797279|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
797280|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797281|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
797282|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
797283|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797284|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797493|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
797494|NCT02586181|Vitamin D|vitamin d|mesh-list
797495|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
797496|NCT02586181|Vitamins|vitamins|mesh-list
797497|NCT02586181|Folic Acid|folic acid|mesh-list
797498|NCT02586181|Calcium|calcium|mesh-list
797499|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
797500|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797501|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
797502|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
797503|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
797504|NCT02586181|Hematinics|hematinics|mesh-ancestor
797873|NCT02584647|Sirolimus|sirolimus|mesh-list
2754258|NCT01481272|Etoposide|etoposide|mesh-list
2754259|NCT01481272|Ofatumumab|ofatumumab|mesh-list
795462|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
795463|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795464|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795465|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
795466|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
795467|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
795468|NCT02595242|Hormones|hormones|mesh-ancestor
795469|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
795470|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
795471|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
795472|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
795473|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
795474|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
795490|NCT02594579|Vitamin D|vitamin d|mesh-list
795491|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
795492|NCT02594579|Vitamins|vitamins|mesh-ancestor
795493|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
795494|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795495|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
795496|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2754260|NCT01481272|Lenograstim|lenograstim|mesh-list
2754261|NCT01481272|Sargramostim|sargramostim|mesh-list
2754262|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2754263|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
2754264|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2754265|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795719|NCT02593721|Ibuprofen|ibuprofen|mesh-list
795720|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
795721|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
795722|NCT02593721|Analgesics|analgesics|mesh-ancestor
795723|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
795724|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795725|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795726|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
795727|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
795728|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
795729|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795730|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096000|NCT02299349|Narcotics|narcotics|mesh-ancestor
2096001|NCT02299349|Analgesics|analgesics|mesh-ancestor
2096002|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2096003|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2096004|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
2096005|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096006|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096007|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2096008|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2096009|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
2096010|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2096011|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
2096012|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
2096013|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
2096014|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2096015|NCT02299375|Albuterol|albuterol|mesh-list
2096016|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2096017|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
2096018|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096019|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096020|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2096021|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
2096022|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
2096023|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2096024|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2096025|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2096026|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
796216|NCT02592356|Lenvatinib|lenvatinib|mesh-list
796217|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796218|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
796219|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796220|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796513|NCT02590627|Lumefantrine|lumefantrine|mesh-list
796514|NCT02590627|Artemether|artemether|mesh-list
796515|NCT02590627|Piperaquine|piperaquine|mesh-list
796516|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2096027|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
2245306|NCT00116116|Antimetabolites|antimetabolites|mesh-ancestor
2245307|NCT00116181|Etanercept|etanercept|mesh-list
795953|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
795954|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
795955|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
795956|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795957|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
795958|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
795959|NCT02592863|Protective Agents|protective agents|mesh-ancestor
795960|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795961|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
795962|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
795963|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
2245308|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2245309|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2245310|NCT00116181|Analgesics|analgesics|mesh-ancestor
2245311|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
2245312|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245313|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245314|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2245315|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2245316|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2245317|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2245318|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
2245327|NCT00116259|Aripiprazole|aripiprazole|mesh-list
2245328|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
2754266|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2754267|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
2754268|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754269|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754270|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
2754271|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754272|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2754273|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2754274|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
796764|NCT02589275|Cyclobenzaprine|cyclobenzaprine|mesh-list
796765|NCT02589275|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
796766|NCT02589275|Antidepressive Agents|antidepressive agents|mesh-ancestor
796767|NCT02589275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
796768|NCT02589275|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
796769|NCT02589275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796770|NCT02589275|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
796771|NCT02589275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796772|NCT02589275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
796773|NCT02589275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
797262|NCT02587741|Metformin|metformin|mesh-list
797263|NCT02587741|Acarbose|acarbose|mesh-list
797264|NCT02587741|Gliclazide|gliclazide|mesh-list
797265|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
797266|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
797267|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797268|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
797269|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797270|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245329|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2245330|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2245331|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2245332|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2245333|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245334|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
795715|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
795716|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
795717|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
795718|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096028|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096029|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096030|NCT02299388|Liraglutide|liraglutide|mesh-list
2096031|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2096032|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096033|NCT02299388|Incretins|incretins|mesh-ancestor
2096034|NCT02299388|Hormones|hormones|mesh-ancestor
2096035|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2096036|NCT02300077|Fentanyl|fentanyl|mesh-list
2096037|NCT02300077|Morphine|morphine|mesh-list
2096038|NCT02300077|Methadone|methadone|mesh-list
2096039|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2096040|NCT02300077|Narcotics|narcotics|mesh-ancestor
2096041|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2096042|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796084|NCT02592694|Tenecteplase|tenecteplase|mesh-list
796085|NCT02592694|Tirofiban|tirofiban|mesh-list
796086|NCT02592694|Bivalirudin|bivalirudin|mesh-list
796087|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
796088|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
796089|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
796090|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796091|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796092|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
796093|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
796094|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
796095|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
796195|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
796196|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
796197|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796458|NCT02591004|Nifedipine|nifedipine|mesh-list
796459|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
796460|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
796461|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796462|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
796463|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796464|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
796465|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
796466|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
796978|NCT02588287|Tenofovir|tenofovir|mesh-list
796979|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
796980|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796981|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
796982|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
796983|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796984|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796985|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
796986|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2245335|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
2245336|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245337|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245338|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2245339|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
797889|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
797890|NCT02584751|Omeprazole|omeprazole|mesh-list
797891|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
797892|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
797893|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
797894|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797895|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797896|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
797897|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
797898|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797899|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797900|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
797901|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
797902|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
797903|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
797904|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
797905|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2096043|NCT02300077|Analgesics|analgesics|mesh-ancestor
795755|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795756|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
795757|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
795758|NCT02593669|Hormones|hormones|mesh-ancestor
795759|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
795760|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
795761|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
795903|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
795904|NCT02593201|Cefazolin|cefazolin|mesh-list
795905|NCT02593201|Ceftazidime|ceftazidime|mesh-list
795906|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
795907|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
795908|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
796009|NCT02592915|Clonidine|clonidine|mesh-list
796010|NCT02592915|Anesthetics|anesthetics|mesh-list
796011|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
796012|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796013|NCT02592915|Analgesics|analgesics|mesh-ancestor
796014|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
796015|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796016|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
796017|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
796018|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
796019|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
796020|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
796021|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
796022|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
796023|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796024|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796178|NCT02592122|Bromides|bromides|mesh-list
796179|NCT02592122|Albuterol|albuterol|mesh-list
796180|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
796181|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
796182|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
796183|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796184|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796185|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
796186|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
796187|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
796188|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
796189|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
796190|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
796191|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
796192|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
796193|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796194|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245340|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
2245341|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2245342|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2245343|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2245344|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2245345|NCT00116298|Lamivudine|lamivudine|mesh-list
2245346|NCT00116298|Efavirenz|efavirenz|mesh-list
2245347|NCT00116298|Stavudine|stavudine|mesh-list
2754275|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2754276|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2754277|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2754278|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2754279|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2754280|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2754281|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
2754282|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2754283|NCT01481272|Antidotes|antidotes|mesh-ancestor
2754284|NCT01481272|Protective Agents|protective agents|mesh-ancestor
2754285|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
2754286|NCT01481272|Vitamins|vitamins|mesh-ancestor
797292|NCT02586961|Betamethasone|betamethasone|mesh-list
797293|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
797294|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
797295|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
797296|NCT02586961|Epinephrine|epinephrine|mesh-list
797297|NCT02586961|Racepinephrine|racepinephrine|mesh-list
797298|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
797299|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
797300|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
797301|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
2245348|NCT00116298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
795791|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
795792|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795793|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795794|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
795795|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
795796|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
795797|NCT02593500|Hormones|hormones|mesh-ancestor
795798|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
796198|NCT02592083|Tamoxifen|tamoxifen|mesh-list
796199|NCT02592083|Goserelin|goserelin|mesh-list
796200|NCT02592083|Palbociclib|palbociclib|mesh-list
796201|NCT02592083|Exemestane|exemestane|mesh-list
796202|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
796203|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
796204|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
796205|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
796206|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796207|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
796208|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796209|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
796210|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
796211|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
796212|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
796213|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796214|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796215|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
796693|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
796694|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
796695|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245349|NCT00116298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2245350|NCT00116298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245351|NCT00116298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245352|NCT00116298|Antiviral Agents|antiviral agents|mesh-ancestor
2245353|NCT00116298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245354|NCT00116298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2245355|NCT00116298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2245356|NCT00116298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2245357|NCT00116298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2245358|NCT00116298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2245359|NCT00116298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2245360|NCT00116298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2245361|NCT00116298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2245362|NCT00116298|Antimetabolites|antimetabolites|mesh-ancestor
2245363|NCT00116324|Montelukast|montelukast|mesh-list
797139|NCT02587416|Atorvastatin|atorvastatin|mesh-list
797140|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
797141|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
797142|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
797143|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797144|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
797145|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
797146|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245364|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2245365|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
2245366|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2245367|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
2245368|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
795812|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
795813|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245369|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245370|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2245371|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2245372|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245373|NCT00116350|Misoprostol|misoprostol|mesh-list
2245374|NCT00116350|Oxytocin|oxytocin|mesh-list
2245375|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
2245376|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
796875|NCT02588534|Etanercept|etanercept|mesh-list
796876|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
796877|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
796878|NCT02588534|Analgesics|analgesics|mesh-ancestor
796879|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
796880|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796881|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796882|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
796883|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
796884|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
796885|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
796886|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
2245377|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245378|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2245379|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
2245380|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2245381|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2245382|NCT00116389|Gemcitabine|gemcitabine|mesh-list
2245383|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
797748|NCT02585375|Latanoprost|latanoprost|mesh-list
797749|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
797750|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2245384|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
2245385|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245386|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245387|NCT00116389|Antiviral Agents|antiviral agents|mesh-ancestor
2245388|NCT00116389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245389|NCT00116389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245390|NCT00116389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2245391|NCT00116389|Immunologic Factors|immunologic factors|mesh-ancestor
2245392|NCT00116389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245393|NCT00116402|Fluticasone|fluticasone|mesh-list
2245394|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2245395|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2245396|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2245397|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
2245398|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245399|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245400|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2245401|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
2245402|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
2245403|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2245404|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2245405|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2245406|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2245407|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
2245408|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245409|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245410|NCT00116415|Lamivudine|lamivudine|mesh-list
2245411|NCT00116415|Efavirenz|efavirenz|mesh-list
2245412|NCT00116415|Didanosine|didanosine|mesh-list
2245413|NCT00116415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2245414|NCT00116415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2245415|NCT00116415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245416|NCT00116415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245417|NCT00116415|Antiviral Agents|antiviral agents|mesh-ancestor
2245418|NCT00116415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245419|NCT00116415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2245420|NCT00116415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2245421|NCT00116415|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2245422|NCT00116415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2245423|NCT00116415|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
800340|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
800341|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2754287|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
795864|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
795865|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
795866|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
795867|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
795868|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
795869|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
795870|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
795871|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
795872|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
795873|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
795874|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
795875|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
795876|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
795877|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
795878|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
795879|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
795880|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
795881|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
795882|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
795883|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
795884|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
795885|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
2245424|NCT00116415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2245425|NCT00116415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2245426|NCT00116415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2245427|NCT00116415|Antimetabolites|antimetabolites|mesh-ancestor
2245428|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
2245429|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245430|NCT00116467|Vaccines|vaccines|mesh-list
2245431|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
2245432|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245433|NCT00116480|Misoprostol|misoprostol|mesh-list
2245434|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2245435|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
2245436|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2245437|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245438|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2245439|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2245440|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
2245441|NCT00116493|Folic Acid|folic acid|mesh-list
2245442|NCT00116493|Mebendazole|mebendazole|mesh-list
2245443|NCT00116493|Piperazine|piperazine|mesh-list
2245444|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
2245445|NCT00116493|DMP 777|dmp 777|mesh-list
2245446|NCT00116493|Hematinics|hematinics|mesh-ancestor
797562|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
797563|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
797564|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
797565|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
797566|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
797567|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797568|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
797569|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
797570|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797571|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
797572|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797949|NCT02584426|Cefazolin|cefazolin|mesh-list
797950|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
797951|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245447|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
2245448|NCT00116493|Vitamins|vitamins|mesh-ancestor
2245449|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
2245450|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245451|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
2245452|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
2245453|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2245454|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245455|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
2245456|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
2245457|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
2245458|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245459|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245460|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245461|NCT00116506|Bevacizumab|bevacizumab|mesh-list
2245462|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2245463|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2245464|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245465|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2245466|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
795909|NCT02592980|Warfarin|warfarin|mesh-list
795910|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
796522|NCT02590614|Vitamin D|vitamin d|mesh-list
796523|NCT02590614|Vitamins|vitamins|mesh-ancestor
796524|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
796525|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796526|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
796568|NCT02590133|Fluorouracil|fluorouracil|mesh-list
796569|NCT02590133|Endostar protein|endostar protein|mesh-list
796570|NCT02590133|Endostatins|endostatins|mesh-list
796571|NCT02590133|Nedaplatin|nedaplatin|mesh-list
796572|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
796573|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796574|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
796575|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796576|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
796577|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
796578|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796579|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
796580|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
796581|NCT02590133|Growth Substances|growth substances|mesh-ancestor
796582|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
2245467|NCT00116506|Growth Substances|growth substances|mesh-ancestor
2245468|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245469|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
2245470|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
796899|NCT02588547|Granisetron|granisetron|mesh-list
796900|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
796901|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
796902|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796903|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796904|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
796905|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
796906|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
796907|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796908|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797168|NCT02587273|Fentanyl|fentanyl|mesh-list
797169|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
797170|NCT02587273|Narcotics|narcotics|mesh-ancestor
797171|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
797172|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797173|NCT02587273|Analgesics|analgesics|mesh-ancestor
797174|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
797175|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797176|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
797177|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
797178|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
797179|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
797271|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
797272|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
797273|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
797274|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
797275|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797276|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
797453|NCT02586311|Amlodipine|amlodipine|mesh-list
797454|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
797455|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
797456|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
797457|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797458|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
797459|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797460|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
2245471|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245472|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245473|NCT00116532|Citalopram|citalopram|mesh-list
2245474|NCT00116532|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2245475|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2245476|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2245477|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754288|NCT01434316|Veliparib|veliparib|mesh-list
2754289|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2754290|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793063|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796260|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
796261|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
796262|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
796263|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
796264|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
796265|NCT02591953|Hormones|hormones|mesh-ancestor
796266|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
796267|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
796268|NCT02591953|Protective Agents|protective agents|mesh-ancestor
796269|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
796270|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796613|NCT02590016|Insulin|insulin|mesh-list
796614|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
796615|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
796616|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796670|NCT02589717|Atezolizumab|atezolizumab|mesh-list
796671|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796790|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
796791|NCT02589158|Darunavir|darunavir|mesh-list
796792|NCT02589158|Cobicistat|cobicistat|mesh-list
796793|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
796794|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
796795|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
796796|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796797|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796798|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
796799|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
796800|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
796801|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796802|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
796803|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
797129|NCT02587312|Nicotine|nicotine|mesh-list
797130|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
797131|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
797132|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797133|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797134|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
797135|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
797136|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
797137|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
797138|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797552|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
797553|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
797554|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
797555|NCT02586051|Antibodies|antibodies|mesh-list
797556|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
797557|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
797558|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
797559|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797560|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
797561|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797724|NCT02585401|Aflibercept|aflibercept|mesh-list
797725|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
797726|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
797727|NCT02585401|Growth Substances|growth substances|mesh-ancestor
797728|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797729|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
797730|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245478|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245479|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
2245480|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245481|NCT00116532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2245482|NCT00116532|Antidepressive Agents|antidepressive agents|mesh-ancestor
2245483|NCT00116532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2245484|NCT00116545|Troglitazone|troglitazone|mesh-list
2245485|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2245486|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245487|NCT00116597|Vaccines|vaccines|mesh-list
2245488|NCT00116597|Immunologic Factors|immunologic factors|mesh-ancestor
2245489|NCT00116597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245490|NCT00116623|Indomethacin|indomethacin|mesh-list
2245491|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
2245492|NCT00116623|Analgesics|analgesics|mesh-ancestor
2245493|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
2245494|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245495|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245496|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
796301|NCT02591888|Bupivacaine|bupivacaine|mesh-list
796302|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
796303|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
796304|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
796305|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796306|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
796307|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796487|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
796488|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796489|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
796490|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
796491|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
796492|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796493|NCT02590536|Urological Agents|urological agents|mesh-ancestor
2245497|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2245498|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
797180|NCT02587390|Simvastatin|simvastatin|mesh-list
797181|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
797182|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
797183|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
797184|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797185|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
797186|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
797187|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797396|NCT02586610|Capecitabine|capecitabine|mesh-list
797397|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
797398|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
797399|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
797400|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797401|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797402|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2245499|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
2245500|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2245501|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2245502|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245503|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2245504|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
797780|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
797781|NCT02584881|Narcotics|narcotics|mesh-ancestor
797782|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
797783|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797784|NCT02584881|Analgesics|analgesics|mesh-ancestor
797785|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
797786|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245505|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2245506|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2245507|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2245508|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2245509|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2245510|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
2245511|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2245512|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245513|NCT00116636|Lopinavir|lopinavir|mesh-list
2245514|NCT00116636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
798275|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
798276|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
798277|NCT02583685|Ribavirin|ribavirin|mesh-list
798278|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
798279|NCT02583685|Simeprevir|simeprevir|mesh-list
798280|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
798281|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798282|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
798283|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798284|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
798285|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798286|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
798287|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798382|NCT02582892|Vitamin D|vitamin d|mesh-list
798383|NCT02582892|Vitamins|vitamins|mesh-ancestor
798384|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
798385|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798386|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
798634|NCT02582476|Bumetanide|bumetanide|mesh-list
798635|NCT02582476|Diuretics|diuretics|mesh-ancestor
798636|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
796334|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796335|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
796336|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
796337|NCT02591667|Growth Substances|growth substances|mesh-ancestor
796338|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796339|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
2245515|NCT00116636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2245516|NCT00116636|Protease Inhibitors|protease inhibitors|mesh-ancestor
2245517|NCT00116636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245518|NCT00116636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245519|NCT00116636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2245520|NCT00116636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
796475|NCT02590705|Lidocaine|lidocaine|mesh-list
796476|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
796477|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
796478|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
796479|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796480|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
796481|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
796482|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
796483|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
796484|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
796485|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
796486|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796712|NCT02589652|Interferons|interferons|mesh-list
796713|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
796714|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
796715|NCT02589652|Entecavir|entecavir|mesh-list
796716|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
796717|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796718|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
796719|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796720|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
796721|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796828|NCT02588937|Entecavir|entecavir|mesh-list
796829|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
796830|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796928|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
796929|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
796930|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796931|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
796932|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
796933|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
796934|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
796935|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796936|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
797159|NCT02587325|Sirolimus|sirolimus|mesh-list
797160|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
797161|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
797162|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
797163|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797164|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
797165|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
797166|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
797167|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797333|NCT02586987|Durvalumab|durvalumab|mesh-list
797334|NCT02586987|Tremelimumab|tremelimumab|mesh-list
797335|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
797336|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245521|NCT00116636|Antiviral Agents|antiviral agents|mesh-ancestor
2245522|NCT00116636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245523|NCT00116636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2245524|NCT00116636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2245525|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
2245526|NCT00116701|Hematinics|hematinics|mesh-ancestor
798021|NCT02584075|Metformin|metformin|mesh-list
798022|NCT02584075|Exenatide|exenatide|mesh-list
798023|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
798024|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798025|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
798026|NCT02584075|Incretins|incretins|mesh-ancestor
798027|NCT02584075|Hormones|hormones|mesh-ancestor
798028|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2245527|NCT00116727|Etanercept|etanercept|mesh-list
2245528|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2245529|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2096044|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
796804|NCT02588781|Pemetrexed|pemetrexed|mesh-list
796805|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796806|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796807|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796808|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
796809|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
798065|NCT02584309|Doxorubicin|doxorubicin|mesh-list
798066|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
798067|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
798068|NCT02584309|Razoxane|razoxane|mesh-list
798069|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
798070|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798071|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
798072|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
798073|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798074|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798075|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
798076|NCT02584309|Protective Agents|protective agents|mesh-ancestor
798077|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798078|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
798079|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
798331|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
798332|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
798333|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798614|NCT02582307|Acetaminophen|acetaminophen|mesh-list
798615|NCT02582307|Scopolamine|scopolamine|mesh-list
798616|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
798617|NCT02582307|Analgesics|analgesics|mesh-list
798618|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
798619|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
798620|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798621|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798622|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
798623|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
798624|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
798625|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
798626|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
798627|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
798628|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
798629|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
798630|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
798631|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798632|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
798633|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
798755|NCT02582008|Bupropion|bupropion|mesh-list
798756|NCT02582008|Nicotine|nicotine|mesh-list
798757|NCT02582008|Varenicline|varenicline|mesh-list
798758|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
798759|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
798760|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798761|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798762|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
798763|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
798764|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
798765|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
798766|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798767|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
798768|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
798769|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
798770|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
798771|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
798772|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
798773|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
798774|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
798775|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
798776|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798882|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
798883|NCT02581566|Bupivacaine|bupivacaine|mesh-list
798884|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
798885|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
798886|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
798887|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798888|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
798889|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798890|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
796372|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
796373|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796734|NCT02589444|Vitamin D|vitamin d|mesh-list
796735|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
796736|NCT02589444|Vitamins|vitamins|mesh-ancestor
796737|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
796738|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796739|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
796740|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2245530|NCT00116727|Analgesics|analgesics|mesh-ancestor
2245531|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
2245532|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245533|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245534|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2245535|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2245536|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2245537|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2245538|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
2245539|NCT00116870|Lovastatin|lovastatin|mesh-list
2245540|NCT00116870|L 647318|l 647318|mesh-list
2096045|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096046|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2096047|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2096048|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
2096049|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
2096050|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
2096051|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
2096052|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
2096053|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2096054|NCT02300103|Velpatasvir|velpatasvir|mesh-list
2096055|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
2096056|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096057|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
2096058|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2096059|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096060|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2096061|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2096062|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096063|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096064|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096065|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2096066|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2096067|NCT02300259|Itraconazole|itraconazole|mesh-list
2245541|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
2245542|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
797686|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
797687|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
797688|NCT02585479|Pirarubicin|pirarubicin|mesh-list
797689|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
797690|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797691|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
797692|NCT02585479|Coagulants|coagulants|mesh-ancestor
797713|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
797714|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
797715|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245543|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2245544|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
2245545|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245546|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2245547|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2245548|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798340|NCT02583217|Ketamine|ketamine|mesh-list
798341|NCT02583217|Remifentanil|remifentanil|mesh-list
798342|NCT02583217|Propofol|propofol|mesh-list
798343|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
798344|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
798345|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798346|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
798347|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
798348|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
798349|NCT02583217|Analgesics|analgesics|mesh-ancestor
798350|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
798351|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798352|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
798353|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
798354|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
798355|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796517|NCT02590627|Artenimol|artenimol|mesh-list
796518|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
796519|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
796520|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
796521|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096068|NCT02300259|Diltiazem|diltiazem|mesh-list
2096069|NCT02300259|Tadalafil|tadalafil|mesh-list
2096070|NCT02300259|Simvastatin|simvastatin|mesh-list
2096071|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
797236|NCT02587260|Clopidogrel|clopidogrel|mesh-list
797237|NCT02587260|Ticagrelor|ticagrelor|mesh-list
797238|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
797239|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
797240|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
797241|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
797242|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
797243|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
797244|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
797245|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797246|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797337|NCT02586753|Paclitaxel|paclitaxel|mesh-list
797338|NCT02586753|Cisplatin|cisplatin|mesh-list
797339|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
797340|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797341|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
797342|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
797343|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
797344|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797573|NCT02585947|Tenofovir|tenofovir|mesh-list
797574|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
797575|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
797576|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
797577|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
797578|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797579|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797580|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
797581|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
798059|NCT02584036|Vaccines|vaccines|mesh-list
798060|NCT02584036|Immunologic Factors|immunologic factors|mesh-ancestor
798061|NCT02584036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798146|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
798147|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
798148|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
798149|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798150|NCT02583672|Expectorants|expectorants|mesh-ancestor
798151|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
798152|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
798153|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
798154|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798155|NCT02583672|Protective Agents|protective agents|mesh-ancestor
798156|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798157|NCT02583672|Antidotes|antidotes|mesh-ancestor
798851|NCT02581748|Trastuzumab|trastuzumab|mesh-list
798852|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
798853|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798951|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
798952|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
798953|NCT02581371|Protective Agents|protective agents|mesh-ancestor
798954|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798955|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
799067|NCT02580773|Tinzaparin|tinzaparin|mesh-list
799068|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
799069|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
799070|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
799071|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799252|NCT02579642|Ketamine|ketamine|mesh-list
799253|NCT02579642|Analgesics|analgesics|mesh-ancestor
799254|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
799255|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
799256|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799257|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
799258|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
799259|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
799260|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
799261|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
799262|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2245549|NCT00116896|Cisplatin|cisplatin|mesh-list
2245550|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245551|NCT00116922|Metformin|metformin|mesh-list
2245552|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
2245553|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
796810|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
796811|NCT02588755|Tegafur|tegafur|mesh-list
796812|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
796813|NCT02588755|Estrogens|estrogens|mesh-ancestor
796814|NCT02588755|Hormones|hormones|mesh-ancestor
796815|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
796816|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796817|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
796818|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796819|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
796820|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
796821|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797032|NCT02588248|Peppermint oil|peppermint oil|mesh-list
797033|NCT02588248|Menthol|menthol|mesh-list
797034|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
797035|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
797036|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
797037|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
797038|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797039|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797040|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
797041|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
2096072|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2096073|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
797626|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
797627|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
797661|NCT02585531|Dexamethasone|dexamethasone|mesh-list
797662|NCT02585531|Epinephrine|epinephrine|mesh-list
797663|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
797664|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
797665|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
797666|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797667|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797668|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
797669|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
797670|NCT02585531|Hormones|hormones|mesh-ancestor
797671|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
797672|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
797673|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797674|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
797675|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
797676|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
797677|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
797678|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797679|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
797680|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
797681|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
797682|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
797683|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
797684|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
797685|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
797716|NCT02585258|Prednisolone|prednisolone|mesh-list
797717|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
797718|NCT02585258|Glucocorticoids|glucocorticoids|mesh-ancestor
797719|NCT02585258|Hormones|hormones|mesh-ancestor
797720|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
797721|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797722|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
797723|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798158|NCT02583633|Nifedipine|nifedipine|mesh-list
798159|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
798160|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
798161|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
798162|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798163|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2245554|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245555|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
2245556|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245557|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2245558|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245559|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245560|NCT00116948|Cimetidine|cimetidine|mesh-list
2245561|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2245562|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2245563|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2245564|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
2245565|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
2245566|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245567|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245568|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245569|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2245570|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2245571|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245572|NCT00116961|Dexamethasone|dexamethasone|mesh-list
2245573|NCT00116961|Bortezomib|bortezomib|mesh-list
2245574|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2245575|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
2245576|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
2245577|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245578|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245579|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2245580|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
2245581|NCT00116961|Hormones|hormones|mesh-ancestor
2245582|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2245583|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2245584|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245585|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
2245586|NCT00117000|Testosterone|testosterone|mesh-list
2245587|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
2245588|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
2245589|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2245590|NCT00117000|Androgens|androgens|mesh-ancestor
2245591|NCT00117000|Hormones|hormones|mesh-ancestor
2245592|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2245593|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245594|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2245595|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797204|NCT02587052|Tacrolimus|tacrolimus|mesh-list
797205|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
797206|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
797207|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797208|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
797209|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797210|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797708|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
797709|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
797710|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
797711|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
797712|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
797923|NCT02584465|Tamoxifen|tamoxifen|mesh-list
797924|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
797925|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
797926|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
797927|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797928|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
797929|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797930|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
797931|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
797932|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
796669|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
2245596|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
2245597|NCT00117013|Topotecan|topotecan|mesh-list
2245598|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2245599|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2245600|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245601|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796965|NCT02588677|Riluzole|riluzole|mesh-list
796966|NCT02588677|Anticonvulsants|anticonvulsants|mesh-ancestor
796967|NCT02588677|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
796968|NCT02588677|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
796969|NCT02588677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796970|NCT02588677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796971|NCT02588677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
796972|NCT02588677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
796973|NCT02588677|Protective Agents|protective agents|mesh-ancestor
797042|NCT02588027|Ibuprofen|ibuprofen|mesh-list
797043|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
797044|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
797045|NCT02588027|Analgesics|analgesics|mesh-ancestor
797046|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
797047|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797048|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797049|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
797050|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
797051|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
797052|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797053|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245602|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245603|NCT00117026|Benphothiamine|benphothiamine|mesh-list
2245604|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2245605|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
2245606|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245607|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
2245608|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
2245609|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797475|NCT02586363|Entecavir|entecavir|mesh-list
797476|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
797477|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798008|NCT02584335|Lidocaine|lidocaine|mesh-list
798009|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
798010|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
798011|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
798012|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
798013|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798014|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
798015|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798016|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
798017|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
798018|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
798019|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
798020|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096074|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096075|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2096076|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2096077|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096078|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
2096079|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096080|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2096081|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2096082|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2096083|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
798743|NCT02581969|Factor VIII|factor viii|mesh-list
798744|NCT02581969|Coagulants|coagulants|mesh-ancestor
799181|NCT02580305|Memantine|memantine|mesh-list
799182|NCT02580305|Donepezil|donepezil|mesh-list
799183|NCT02580305|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
799184|NCT02580305|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
799185|NCT02580305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799186|NCT02580305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799187|NCT02580305|Cholinergic Agents|cholinergic agents|mesh-ancestor
799188|NCT02580305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
796789|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
797403|NCT02586636|Metformin|metformin|mesh-list
797404|NCT02586636|Omeprazole|omeprazole|mesh-list
797405|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
797406|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797407|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
797408|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
797409|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
797410|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797411|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797759|NCT02585011|Epinephrine|epinephrine|mesh-list
797760|NCT02585011|Ropivacaine|ropivacaine|mesh-list
797761|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
797762|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
797763|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
797764|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797765|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
797766|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797767|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
797768|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
797769|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
797770|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
797771|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797772|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
797773|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
797774|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
797775|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
797776|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
797777|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
797778|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
797779|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
797811|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
797812|NCT02584738|Prednisolone|prednisolone|mesh-list
797813|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
797814|NCT02584738|Bromides|bromides|mesh-list
797815|NCT02584738|Albuterol|albuterol|mesh-list
797816|NCT02584738|Ipratropium|ipratropium|mesh-list
797817|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
797818|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
797819|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
797820|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797821|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797822|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
797823|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
797824|NCT02584738|Hormones|hormones|mesh-ancestor
797825|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
797826|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
797827|NCT02584738|Protective Agents|protective agents|mesh-ancestor
797828|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
797829|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797830|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
797831|NCT02584738|Analgesics|analgesics|mesh-ancestor
797832|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
797833|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
797834|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
797835|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
797836|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
797837|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
797838|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797839|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
797840|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
797841|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
797842|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
797843|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
797844|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
797845|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
797846|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
797847|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
797848|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
797849|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
797850|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
797851|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
798254|NCT02583451|Lemborexant|lemborexant|mesh-list
798267|NCT02583451|Zopiclone|zopiclone|mesh-list
798268|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
798269|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245610|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
796912|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796913|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
796914|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
796915|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
796916|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
796917|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
796918|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
796919|NCT02588443|Antiviral Agents|antiviral agents|mesh-ancestor
796920|NCT02588443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
796921|NCT02588443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
796922|NCT02588443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
796923|NCT02588443|Immunologic Factors|immunologic factors|mesh-ancestor
796924|NCT02588443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797002|NCT02588196|Dexamethasone|dexamethasone|mesh-list
797003|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
797004|NCT02588196|BB 1101|bb 1101|mesh-list
797005|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
797006|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
797007|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
797008|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797009|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797010|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
797011|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
797012|NCT02588196|Hormones|hormones|mesh-ancestor
797013|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
797014|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
797015|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797016|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
797017|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797018|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797483|NCT02586194|Peficitinib|peficitinib|mesh-list
797484|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797485|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797486|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
797487|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
797488|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797587|NCT02585882|Fluorides|fluorides|mesh-list
797588|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
797589|NCT02585882|Protective Agents|protective agents|mesh-ancestor
797590|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798989|NCT02581176|Apixaban|apixaban|mesh-list
798990|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
798991|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
798992|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
798993|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
798994|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798995|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798996|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
796956|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
796957|NCT02588417|Hormones|hormones|mesh-ancestor
796958|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
796959|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
796960|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
796961|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
796962|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
796963|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
796964|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
797188|NCT02587247|Antibodies|antibodies|mesh-list
797189|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
797190|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096084|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2096085|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096086|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2096087|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
2096088|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2096089|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2096090|NCT02300259|Urological Agents|urological agents|mesh-ancestor
2096091|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2096092|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2096093|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2096094|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
797582|NCT02585973|Cisplatin|cisplatin|mesh-list
797583|NCT02585973|Adavosertib|adavosertib|mesh-list
797584|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797585|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797586|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797628|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
797629|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
797630|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798334|NCT02583282|Doxycycline|doxycycline|mesh-list
798335|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
798336|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798337|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
798338|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
798339|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
798591|NCT02582372|Fentanyl|fentanyl|mesh-list
798592|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
798593|NCT02582372|Bupivacaine|bupivacaine|mesh-list
798594|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
798595|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
798596|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
798597|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798598|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
798599|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798600|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
798601|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
798602|NCT02582372|Analgesics|analgesics|mesh-ancestor
798603|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
798604|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
798605|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
798606|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
798607|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
798608|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798609|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
798610|NCT02582372|Narcotics|narcotics|mesh-ancestor
798611|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
798612|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
798613|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
798658|NCT02582099|Gentamicins|gentamicins|mesh-list
798659|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
798660|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798661|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
798662|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798663|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096095|NCT02300298|Docetaxel|docetaxel|mesh-list
2096096|NCT02300298|Nintedanib|nintedanib|mesh-list
2096097|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096098|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
2096099|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
2096100|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
2096101|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799155|NCT02580474|Asunaprevir|asunaprevir|mesh-list
799156|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
2245611|NCT00117039|Hematinics|hematinics|mesh-ancestor
2245612|NCT00117052|Cinacalcet|cinacalcet|mesh-list
2245613|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2245614|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245615|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2245616|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
2245617|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2245618|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
2245619|NCT00117065|Hematinics|hematinics|mesh-ancestor
797478|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
797479|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
797480|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
797481|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797482|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2245620|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
2245621|NCT00117078|Hematinics|hematinics|mesh-ancestor
2245622|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
798080|NCT02584010|Silicon|silicon|mesh-list
798081|NCT02584010|Trace Elements|trace elements|mesh-ancestor
798082|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
798083|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798203|NCT02583594|Loratadine|loratadine|mesh-list
798204|NCT02583594|Acyclovir|acyclovir|mesh-list
798205|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
798206|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
798207|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
798208|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
798209|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
798210|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
798211|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798212|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798213|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
798214|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
798215|NCT02583594|Hormones|hormones|mesh-ancestor
798216|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
798217|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
798218|NCT02583594|Protective Agents|protective agents|mesh-ancestor
798219|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798220|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
798221|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
798222|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798223|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
798224|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
798225|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
798226|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
798227|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
798228|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
798229|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
798230|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
798231|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798646|NCT02582190|Colchicine|colchicine|mesh-list
798647|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
798648|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
798649|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
798650|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
798651|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
798652|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798653|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798956|NCT02581631|Nivolumab|nivolumab|mesh-list
798957|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
798958|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
798959|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798960|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
798961|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799014|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
799015|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
799016|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
799017|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
799018|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799019|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
799020|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
799021|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799022|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
799023|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
799173|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
2245623|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
797302|NCT02586961|Hormones|hormones|mesh-ancestor
797303|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
797304|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797305|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
797306|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
797307|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
797308|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
797309|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
797310|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
797311|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797312|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
797313|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
797314|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
797315|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797316|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
797317|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
797318|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
797382|NCT02586649|Bromides|bromides|mesh-list
797383|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
797384|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
797385|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
797386|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
797387|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797388|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797389|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
797390|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
797391|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
797392|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
797393|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
797394|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797395|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
797541|NCT02586129|Metformin|metformin|mesh-list
797542|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
797543|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
797544|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797545|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
797546|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
797547|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
797548|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797549|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
797550|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
797551|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245624|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
2245625|NCT00117104|Hematinics|hematinics|mesh-ancestor
798170|NCT02583568|Bevacizumab|bevacizumab|mesh-list
798171|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
798172|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798173|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
798174|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
798175|NCT02583568|Growth Substances|growth substances|mesh-ancestor
798176|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798177|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
2245626|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
2245627|NCT00117117|Hematinics|hematinics|mesh-ancestor
2245628|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
2245629|NCT00117130|Hematinics|hematinics|mesh-ancestor
2245630|NCT00117182|Budesonide|budesonide|mesh-list
2245631|NCT00117182|Mannitol|mannitol|mesh-list
2245632|NCT00117182|Bromides|bromides|mesh-list
2245633|NCT00117182|Albuterol|albuterol|mesh-list
2245634|NCT00117182|Ipratropium|ipratropium|mesh-list
2245635|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2245636|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2245637|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
2245638|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245639|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245640|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2245641|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
2245642|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
2245643|NCT00117182|Hormones|hormones|mesh-ancestor
2245644|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2245645|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
2245646|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
2245647|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2245648|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2245649|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2754291|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754292|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797952|NCT02584400|Imidazole|imidazole|mesh-list
797953|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797954|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798062|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
798063|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
798064|NCT02584153|Coagulants|coagulants|mesh-ancestor
798508|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
798509|NCT02582736|Haloperidol|haloperidol|mesh-list
798510|NCT02582736|Pimozide|pimozide|mesh-list
798511|NCT02582736|Olanzapine|olanzapine|mesh-list
798512|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
798513|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
798514|NCT02582736|Risperidone|risperidone|mesh-list
798515|NCT02582736|Aripiprazole|aripiprazole|mesh-list
798516|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
798517|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
798518|NCT02582736|Ziprasidone|ziprasidone|mesh-list
798519|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
798520|NCT02582736|Clozapine|clozapine|mesh-list
798521|NCT02582736|Loxapine|loxapine|mesh-list
798522|NCT02582736|Perphenazine|perphenazine|mesh-list
798523|NCT02582736|Fluphenazine|fluphenazine|mesh-list
798524|NCT02582736|Thioridazine|thioridazine|mesh-list
798525|NCT02582736|Flupenthixol|flupenthixol|mesh-list
798526|NCT02582736|Clopenthixol|clopenthixol|mesh-list
798527|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
798528|NCT02582736|Fluspirilene|fluspirilene|mesh-list
798529|NCT02582736|Thiothixene|thiothixene|mesh-list
798530|NCT02582736|Mesoridazine|mesoridazine|mesh-list
798531|NCT02582736|Chlormezanone|chlormezanone|mesh-list
798532|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
798533|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
798534|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
798535|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
798536|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798537|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798538|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
798539|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
798540|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
798541|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
798542|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
798543|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
798544|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
798545|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798546|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
798547|NCT02582736|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
798548|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
798549|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
798550|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
798551|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
798552|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
798553|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
798554|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
798555|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
798556|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
798557|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
798558|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
798559|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
798560|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
798561|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
798562|NCT02582736|Analgesics|analgesics|mesh-ancestor
798563|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
798564|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
798565|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
798566|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2245650|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2245651|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
2245652|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245653|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245654|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2245655|NCT00117182|Diuretics|diuretics|mesh-ancestor
2245656|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
2245657|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2245658|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
2245659|NCT00117208|Mannitol|mannitol|mesh-list
2245660|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2245661|NCT00117208|Diuretics|diuretics|mesh-ancestor
797434|NCT02586454|Narcotics|narcotics|mesh-ancestor
797435|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
797436|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797437|NCT02586454|Analgesics|analgesics|mesh-ancestor
797438|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
797439|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797440|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
797441|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
797636|NCT02585765|Pioglitazone|pioglitazone|mesh-list
797637|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
797638|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797787|NCT02584920|Rituximab|rituximab|mesh-list
797788|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
797789|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797790|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
797791|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797792|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
798029|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
798030|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
798031|NCT02584231|Coagulants|coagulants|mesh-ancestor
798032|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
798033|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
798034|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798314|NCT02583243|Buprenorphine|buprenorphine|mesh-list
798315|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
798316|NCT02583243|Narcotics|narcotics|mesh-ancestor
798317|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
798318|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798319|NCT02583243|Analgesics|analgesics|mesh-ancestor
798320|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
798321|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798322|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
799124|NCT02580604|Calcium|calcium|mesh-list
799125|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
799126|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799170|NCT02580331|Metformin|metformin|mesh-list
799171|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
799172|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799497|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
799498|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
799780|NCT02578108|Lidocaine|lidocaine|mesh-list
799781|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
799782|NCT02578108|Anesthetics|anesthetics|mesh-list
799783|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
799784|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799785|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
799786|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
799787|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
799788|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
799789|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
799790|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
799791|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245662|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
2245663|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245664|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
2245665|NCT00117234|Hematinics|hematinics|mesh-ancestor
2245666|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
2245667|NCT00117247|Hematinics|hematinics|mesh-ancestor
2245668|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
2245669|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2245670|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2245671|NCT00117260|Estradiol|estradiol|mesh-list
800568|NCT02575768|Adenosine|adenosine|mesh-list
800569|NCT02575768|Analgesics|analgesics|mesh-ancestor
800570|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
800571|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800572|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800573|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
800574|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
800575|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
800576|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
800577|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
800578|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800579|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800741|NCT02575183|Varenicline|varenicline|mesh-list
800742|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2245672|NCT00117260|Estrogens|estrogens|mesh-ancestor
797514|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
797515|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
797516|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797517|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
797518|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
797519|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
797520|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797521|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797522|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
797523|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
797524|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
797525|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
797526|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
797527|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
797528|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
797529|NCT02586038|Hormones|hormones|mesh-ancestor
797530|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
797531|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
797532|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
797533|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
797534|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
797535|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
797536|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
797537|NCT02586038|Growth Substances|growth substances|mesh-ancestor
797538|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
797539|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
797540|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
797639|NCT02585791|Glycerol|glycerol|mesh-list
797640|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
797641|NCT02585791|Protective Agents|protective agents|mesh-ancestor
797642|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245673|NCT00117260|Hormones|hormones|mesh-ancestor
2245674|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
798359|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
798360|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
798361|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
798362|NCT02583022|Analgesics|analgesics|mesh-ancestor
798363|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
798364|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798365|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798366|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
798367|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
798368|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
798369|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
798370|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
798371|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
798372|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798373|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798934|NCT02581501|Gemcitabine|gemcitabine|mesh-list
798935|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
798936|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
798937|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
798938|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798939|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798940|NCT02581501|Antiviral Agents|antiviral agents|mesh-ancestor
798941|NCT02581501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798942|NCT02581501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798943|NCT02581501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
798944|NCT02581501|Immunologic Factors|immunologic factors|mesh-ancestor
798945|NCT02581501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798984|NCT02581124|Lapatinib|lapatinib|mesh-list
798985|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798986|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
798987|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798988|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245675|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799283|NCT02579902|Vitamin D|vitamin d|mesh-list
799284|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
799285|NCT02579902|Vitamins|vitamins|mesh-ancestor
799286|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
799287|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799288|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
799289|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
799518|NCT02578953|Dutasteride|dutasteride|mesh-list
2245676|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2245677|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
2245678|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
798288|NCT02582996|Acetaminophen|acetaminophen|mesh-list
798289|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
798290|NCT02582996|Metoclopramide|metoclopramide|mesh-list
798291|NCT02582996|Caffeine|caffeine|mesh-list
798292|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
798293|NCT02582996|Analgesics|analgesics|mesh-ancestor
798294|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
798295|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798296|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798297|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
798298|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
798299|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
798300|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798301|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798302|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
798303|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
798304|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
798305|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
798306|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
798307|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
798308|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
798309|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
798310|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
798311|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
798312|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
798313|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
2245679|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2245680|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2245681|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2245682|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2245683|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2245684|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
2245685|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2245686|NCT00117273|Estradiol|estradiol|mesh-list
2245687|NCT00117273|Estrogens|estrogens|mesh-ancestor
2245688|NCT00117273|Hormones|hormones|mesh-ancestor
2245689|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2245690|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798912|NCT02581527|Rifampin|rifampin|mesh-list
798913|NCT02581527|Isoniazid|isoniazid|mesh-list
798914|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
798915|NCT02581527|Ethambutol|ethambutol|mesh-list
798916|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
798917|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
798918|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
798919|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798920|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
798921|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
798922|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798923|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798924|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
798925|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
798926|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
798927|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
798928|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
798929|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
798930|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
798931|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
798932|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
798933|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2245691|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2245692|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
2245693|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2245694|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2245695|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2245696|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2245697|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2245698|NCT00117299|Vatalanib|vatalanib|mesh-list
2245699|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2245700|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245701|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799157|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245702|NCT00117351|Bortezomib|bortezomib|mesh-list
2245703|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245704|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
797798|NCT02584816|Vaccines|vaccines|mesh-list
797799|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
797800|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245705|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2245706|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2245707|NCT00117377|Analgesics|analgesics|mesh-ancestor
2245708|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
2245709|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245710|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245711|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2245712|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2245713|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
2245714|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2245715|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
2245716|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2245717|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245718|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245719|NCT00117403|Vitamins|vitamins|mesh-list
2245720|NCT00117403|Vitamin E|vitamin e|mesh-list
2245721|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
2245722|NCT00117403|Ubiquinone|ubiquinone|mesh-list
2245723|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
2245724|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245725|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
2245726|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245727|NCT00117403|Protective Agents|protective agents|mesh-ancestor
2245728|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
2245729|NCT00117442|Paclitaxel|paclitaxel|mesh-list
2245730|NCT00117442|Carboplatin|carboplatin|mesh-list
2245731|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2245732|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798584|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
798585|NCT02582437|Narcotics|narcotics|mesh-ancestor
798586|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
798587|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798588|NCT02582437|Analgesics|analgesics|mesh-ancestor
798589|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
798590|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798784|NCT02581826|Silodosin|silodosin|mesh-list
798785|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
798786|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
798787|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
798788|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
798789|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
798790|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798791|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798792|NCT02581826|Urological Agents|urological agents|mesh-ancestor
798962|NCT02581462|Trastuzumab|trastuzumab|mesh-list
798963|NCT02581462|Pertuzumab|pertuzumab|mesh-list
798964|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
798965|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245733|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
2245734|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
2245735|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
2245736|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245737|NCT00117455|Lenograstim|lenograstim|mesh-list
2245738|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2245739|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
2245740|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799649|NCT02578550|Tenofovir|tenofovir|mesh-list
799650|NCT02578550|Emtricitabine|emtricitabine|mesh-list
799651|NCT02578550|Darunavir|darunavir|mesh-list
799652|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
799653|NCT02578550|Cobicistat|cobicistat|mesh-list
799654|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
799655|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
799656|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
799657|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
799658|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
799659|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799660|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799661|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
799662|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
797656|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
797657|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
797658|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
797659|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
797660|NCT02585570|Protective Agents|protective agents|mesh-ancestor
797933|NCT02584582|Liraglutide|liraglutide|mesh-list
797934|NCT02584582|Exenatide|exenatide|mesh-list
797935|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
797936|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
797937|NCT02584582|Incretins|incretins|mesh-ancestor
797938|NCT02584582|Hormones|hormones|mesh-ancestor
797939|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
797940|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
798087|NCT02583854|Hemostatics|hemostatics|mesh-list
798088|NCT02583854|Coagulants|coagulants|mesh-ancestor
2245741|NCT00117468|Progesterone|progesterone|mesh-list
2245742|NCT00117468|Progestins|progestins|mesh-ancestor
2245743|NCT00117468|Hormones|hormones|mesh-ancestor
2245744|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2245745|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799326|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
799327|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
799328|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
799329|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
799330|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799331|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799332|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
799638|NCT02578602|Edetic Acid|edetic acid|mesh-list
799639|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
799640|NCT02578602|Antidotes|antidotes|mesh-ancestor
799641|NCT02578602|Protective Agents|protective agents|mesh-ancestor
799642|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799643|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
799644|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
799645|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799646|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
799647|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
799648|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
799919|NCT02577614|Coagulants|coagulants|mesh-list
799920|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
800100|NCT02576782|Dexamethasone|dexamethasone|mesh-list
800101|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
800102|NCT02576782|Bupivacaine|bupivacaine|mesh-list
800103|NCT02576782|BB 1101|bb 1101|mesh-list
800104|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
800105|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
800106|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
800107|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800108|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800109|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
800110|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
800111|NCT02576782|Hormones|hormones|mesh-ancestor
800112|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
800113|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
800114|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800115|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
800116|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800117|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800118|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
800119|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
800120|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
800121|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
800350|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
800351|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
800352|NCT02576314|Ledipasvir|ledipasvir|mesh-list
800353|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
2245746|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2245747|NCT00117494|Pravastatin|pravastatin|mesh-list
2245748|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2245749|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2245750|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
2245751|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245752|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2245753|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2245754|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245755|NCT00117520|Caffeine|caffeine|mesh-list
2245756|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2096102|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2096103|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096104|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
2096105|NCT02300311|Capsaicin|capsaicin|mesh-list
2096106|NCT02300311|Nonivamide|nonivamide|mesh-list
2096107|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
2096108|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096109|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096110|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
2096111|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
799538|NCT02578719|Bupivacaine|bupivacaine|mesh-list
799539|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
799540|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
799541|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
799542|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799543|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
799544|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
799770|NCT02578472|Zolpidem|zolpidem|mesh-list
799771|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
799772|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
799773|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
799774|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799775|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
799776|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
799777|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
799778|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
799779|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800090|NCT02577068|Propacetamol|propacetamol|mesh-list
800091|NCT02577068|Nefopam|nefopam|mesh-list
800092|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
800093|NCT02577068|Analgesics|analgesics|mesh-ancestor
800094|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
800095|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800096|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800097|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
800098|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
800099|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
800638|NCT02575677|Oxycodone|oxycodone|mesh-list
800639|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
800640|NCT02575677|Narcotics|narcotics|mesh-ancestor
800641|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
800642|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800643|NCT02575677|Analgesics|analgesics|mesh-ancestor
800644|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
800645|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801123|NCT02573935|Clarithromycin|clarithromycin|mesh-list
801124|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
801125|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801126|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
801127|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801128|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801129|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
801130|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
801497|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
801498|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
801499|NCT02572791|Mupirocin|mupirocin|mesh-list
801500|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2096112|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
2096113|NCT02300311|Vitamins|vitamins|mesh-ancestor
797744|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
797745|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
797746|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
797747|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
797920|NCT02584543|Vaccines|vaccines|mesh-list
797921|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
797922|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798122|NCT02583893|Cytarabine|cytarabine|mesh-list
798123|NCT02583893|Sirolimus|sirolimus|mesh-list
798124|NCT02583893|Etoposide|etoposide|mesh-list
798125|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
798126|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
798127|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
798128|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798129|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
798130|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
798131|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798132|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798133|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
798134|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
798135|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
798136|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798137|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
798138|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
798139|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798140|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
798141|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
798142|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
798143|NCT02583893|Analgesics|analgesics|mesh-ancestor
798144|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
798145|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798664|NCT02582177|Ketoconazole|ketoconazole|mesh-list
798665|NCT02582177|Clotrimazole|clotrimazole|mesh-list
798666|NCT02582177|Miconazole|miconazole|mesh-list
798667|NCT02582177|Dexamethasone|dexamethasone|mesh-list
798668|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
798669|NCT02582177|Betamethasone|betamethasone|mesh-list
798670|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
798671|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
798672|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
798673|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
798674|NCT02582177|BB 1101|bb 1101|mesh-list
798675|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
798676|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
798677|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
798678|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798679|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798680|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
798681|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
798682|NCT02582177|Hormones|hormones|mesh-ancestor
798683|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
798684|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
798685|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798686|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
798687|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798688|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798689|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
798690|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
798691|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
798692|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798693|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
798694|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
798695|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
798696|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
798697|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
798698|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
798699|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
798854|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
798855|NCT02581683|Ropivacaine|ropivacaine|mesh-list
798856|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
798857|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
798858|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
798859|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798860|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
798861|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
798862|NCT02581683|Analgesics|analgesics|mesh-ancestor
798863|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
797866|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798089|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
798090|NCT02583828|Letrozole|letrozole|mesh-list
798091|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
798092|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
798093|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798094|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
798095|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
798096|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
798097|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798098|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798099|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
798100|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
798101|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
798102|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798103|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
798104|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
798105|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
798188|NCT02583464|Tenofovir|tenofovir|mesh-list
798189|NCT02583464|Emtricitabine|emtricitabine|mesh-list
798190|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
798191|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798192|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
798193|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
798194|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798195|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798196|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
798197|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2245757|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245758|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2245759|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245760|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245761|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
799308|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
799309|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
799310|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
799311|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
799312|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799481|NCT02579161|Metronidazole|metronidazole|mesh-list
799482|NCT02579161|Clindamycin|clindamycin|mesh-list
799483|NCT02579161|Clindamycin palmitate|clindamycin palmitate|mesh-list
799484|NCT02579161|Clindamycin phosphate|clindamycin phosphate|mesh-list
799485|NCT02579161|Sulbactam|sulbactam|mesh-list
799486|NCT02579161|Cephalosporins|cephalosporins|mesh-list
799487|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
799488|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
799489|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
799490|NCT02579161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
799491|NCT02579161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
799492|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
799493|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799494|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799495|NCT02579161|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
799496|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2245762|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2245763|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
2245764|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245765|NCT00117533|Ribavirin|ribavirin|mesh-list
2245766|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
2245767|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
2245768|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245769|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
2245770|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245771|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245772|NCT00117546|Methyldopa|methyldopa|mesh-list
2245773|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2245774|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
800826|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
800827|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800828|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
800829|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800830|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800831|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
2096114|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
2245775|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
797874|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
797875|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
797876|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
797877|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
797878|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
797879|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
797880|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
797881|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798654|NCT02582203|Vancomycin|vancomycin|mesh-list
798655|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
798656|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
798657|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
799045|NCT02581046|Dexamethasone|dexamethasone|mesh-list
799046|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
799047|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
799048|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
799049|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
799050|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799051|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
799052|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
799053|NCT02581046|Hormones|hormones|mesh-ancestor
799054|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
799055|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
799056|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245776|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245777|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245778|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2245779|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2245780|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
799957|NCT02577406|Cytarabine|cytarabine|mesh-list
799958|NCT02577406|Azacitidine|azacitidine|mesh-list
799959|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
799960|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
799961|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799962|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799963|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
799964|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
799965|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
799966|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
799967|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799968|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800457|NCT02576327|Dexamethasone|dexamethasone|mesh-list
800458|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
800459|NCT02576327|Aprepitant|aprepitant|mesh-list
800460|NCT02576327|Tropisetron|tropisetron|mesh-list
800461|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
800462|NCT02576327|BB 1101|bb 1101|mesh-list
800463|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
800464|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
800465|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
800466|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800467|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800468|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
800469|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
800470|NCT02576327|Hormones|hormones|mesh-ancestor
800471|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
800472|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
800473|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800474|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
800475|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800476|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800477|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
800478|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800479|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
800480|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
800481|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
800539|NCT02575859|Cisplatin|cisplatin|mesh-list
800540|NCT02575859|Mitomycins|mitomycins|mesh-list
800541|NCT02575859|Mitomycin|mitomycin|mesh-list
800542|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800543|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
800544|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
800545|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800546|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
800547|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800664|NCT02575638|Camptothecin|camptothecin|mesh-list
2245781|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
2245782|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245783|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245784|NCT00117611|Omalizumab|omalizumab|mesh-list
2245785|NCT00117611|Antibodies|antibodies|mesh-list
2245786|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
2245787|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245788|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2245789|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2245790|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
2245791|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
2245792|NCT00117624|Hematinics|hematinics|mesh-ancestor
2245793|NCT00117650|Etoposide|etoposide|mesh-list
2245794|NCT00117650|Etoposide phosphate|etoposide phosphate|mesh-list
2245795|NCT00117650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2245796|NCT00117650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245797|NCT00117650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2245798|NCT00117650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
799138|NCT02580344|Ibuprofen|ibuprofen|mesh-list
799139|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
799140|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
799141|NCT02580344|Analgesics|analgesics|mesh-ancestor
799142|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
799143|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
799144|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799145|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
799146|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
799147|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
799148|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799149|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245799|NCT00117650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245800|NCT00117650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245801|NCT00117663|Hormones|hormones|mesh-list
800854|NCT02574975|Budesonide|budesonide|mesh-list
800855|NCT02574975|Adenosine|adenosine|mesh-list
800856|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
800857|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
800858|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
800859|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
800860|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
800861|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800862|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800863|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
800864|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
800865|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
800866|NCT02574975|Hormones|hormones|mesh-ancestor
800867|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
800868|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
800869|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
800870|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
800871|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
800872|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800873|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800874|NCT02574975|Analgesics|analgesics|mesh-ancestor
800875|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
800876|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
800877|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
800878|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
800879|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
800880|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
800881|NCT02574975|Miotics|miotics|mesh-ancestor
800882|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
800883|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
800884|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
800885|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
800886|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
801019|NCT02574377|Vaccines|vaccines|mesh-list
801020|NCT02574377|Immunologic Factors|immunologic factors|mesh-ancestor
801021|NCT02574377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245802|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2245803|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801625|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
797907|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
797908|NCT02584751|Protective Agents|protective agents|mesh-ancestor
799150|NCT02580448|Seviteronel|seviteronel|mesh-list
799151|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799152|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
799153|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799154|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799317|NCT02579733|Azathioprine|azathioprine|mesh-list
799318|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
799319|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799320|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
799321|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799322|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
799323|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
799324|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799325|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2096115|NCT02300610|Gemcitabine|gemcitabine|mesh-list
2096116|NCT02300610|Cisplatin|cisplatin|mesh-list
2096117|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096118|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2096119|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
2096120|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096121|NCT02300610|Antiviral Agents|antiviral agents|mesh-ancestor
2096122|NCT02300610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096123|NCT02300610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096124|NCT02300610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2096125|NCT02300610|Immunologic Factors|immunologic factors|mesh-ancestor
2096126|NCT02300610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096127|NCT02300727|Curcumin|curcumin|mesh-list
2096128|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2096129|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2096130|NCT02300727|Analgesics|analgesics|mesh-ancestor
2096131|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
2096132|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096133|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096134|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2096135|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2096136|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799983|NCT02577770|Caffeine|caffeine|mesh-list
799984|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
799985|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799986|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
799987|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799988|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799989|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
799990|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
799991|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
799992|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800658|NCT02575547|Docetaxel|docetaxel|mesh-list
800659|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800660|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
800661|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
800662|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
800663|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798084|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
798085|NCT02583958|Laxatives|laxatives|mesh-ancestor
798086|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
798745|NCT02581982|Paclitaxel|paclitaxel|mesh-list
798746|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
798747|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
798748|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
798749|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798750|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
798751|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
798752|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
798753|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798754|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
799036|NCT02581085|Tocotrienols|tocotrienols|mesh-list
799037|NCT02581085|Vitamin E|vitamin e|mesh-list
799038|NCT02581085|Tocopherols|tocopherols|mesh-list
799039|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
799040|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799041|NCT02581085|Protective Agents|protective agents|mesh-ancestor
799042|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799043|NCT02581085|Vitamins|vitamins|mesh-ancestor
799044|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
2245804|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
2245805|NCT00117689|Tacrolimus|tacrolimus|mesh-list
2245806|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
2245807|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2245808|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2245809|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
2245810|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245811|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2245812|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245813|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245814|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2245815|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245816|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2245817|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
2245818|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2245819|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245820|NCT00117702|Everolimus|everolimus|mesh-list
2245821|NCT00117702|Tacrolimus|tacrolimus|mesh-list
2245822|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2245823|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
801414|NCT02573220|Leucovorin|leucovorin|mesh-list
801415|NCT02573220|Fluorouracil|fluorouracil|mesh-list
801416|NCT02573220|Irinotecan|irinotecan|mesh-list
801417|NCT02573220|Cetuximab|cetuximab|mesh-list
801418|NCT02573220|Camptothecin|camptothecin|mesh-list
801419|NCT02573220|Calcium|calcium|mesh-list
801420|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
801421|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
801422|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801423|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
801424|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801425|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
801426|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
801427|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
801428|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
801429|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
801430|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
801431|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801432|NCT02573220|Antidotes|antidotes|mesh-ancestor
801433|NCT02573220|Protective Agents|protective agents|mesh-ancestor
801434|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
801435|NCT02573220|Vitamins|vitamins|mesh-ancestor
801436|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
801437|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
801438|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
802001|NCT02570490|Linezolid|linezolid|mesh-list
802002|NCT02570490|Fusidic Acid|fusidic acid|mesh-list
802003|NCT02570490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
802004|NCT02570490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802005|NCT02570490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2245824|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245825|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2245826|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245827|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245828|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245829|NCT00117728|Nevirapine|nevirapine|mesh-list
2245830|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2245831|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2245832|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245833|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245834|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
2245835|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245836|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2245837|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2245838|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2245839|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2245840|NCT00117754|Terbinafine|terbinafine|mesh-list
2245841|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
2096137|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096138|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096139|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
2096140|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2096141|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096142|NCT02301143|Gemcitabine|gemcitabine|mesh-list
2096143|NCT02301143|Paclitaxel|paclitaxel|mesh-list
2096144|NCT02301143|Capecitabine|capecitabine|mesh-list
2096145|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2096146|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096147|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
2096148|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
798899|NCT02581553|Allopurinol|allopurinol|mesh-list
798900|NCT02581553|Lesinurad|lesinurad|mesh-list
798901|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
798902|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798903|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798904|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
798905|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
798906|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
798907|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
798908|NCT02581553|Protective Agents|protective agents|mesh-ancestor
798909|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798910|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
798911|NCT02581553|Renal Agents|renal agents|mesh-ancestor
2245842|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245843|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245844|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245845|NCT00117767|Terbinafine|terbinafine|mesh-list
2245846|NCT00117767|Griseofulvin|griseofulvin|mesh-list
2245847|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
2245848|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2245849|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245850|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245851|NCT00117780|Insulin|insulin|mesh-list
2245852|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2245853|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
2245854|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
2245855|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2245856|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245857|NCT00117832|Azelastine|azelastine|mesh-list
799209|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
799210|NCT02580006|Hematinics|hematinics|mesh-ancestor
799313|NCT02579707|Ivosidenib|ivosidenib|mesh-list
799314|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799315|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799316|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799727|NCT02578368|Leucovorin|leucovorin|mesh-list
799728|NCT02578368|Docetaxel|docetaxel|mesh-list
799729|NCT02578368|Fluorouracil|fluorouracil|mesh-list
799730|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
799731|NCT02578368|Trastuzumab|trastuzumab|mesh-list
799732|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
799733|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799734|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
799735|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
799736|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
799737|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799738|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799739|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
798106|NCT02583698|Carvedilol|carvedilol|mesh-list
798107|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
798108|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
798109|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
798110|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
798111|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798112|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798113|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
798114|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
798115|NCT02583698|Protective Agents|protective agents|mesh-ancestor
798116|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
798117|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
798118|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
798119|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
798120|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
798121|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
798178|NCT02583438|Saxagliptin|saxagliptin|mesh-list
798179|NCT02583438|Incretins|incretins|mesh-ancestor
798180|NCT02583438|Hormones|hormones|mesh-ancestor
798181|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
798182|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798183|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
798184|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
798185|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798186|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798187|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
798323|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
798324|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
798325|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
798326|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
798327|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
798328|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798329|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798330|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
2245858|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2245859|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
2245860|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2245861|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245862|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2245863|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
2245864|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2245865|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245866|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245867|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2245868|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2245869|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2245870|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
2245871|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
2245872|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245873|NCT00117897|Lenograstim|lenograstim|mesh-list
2245874|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2245875|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
2245876|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245877|NCT00117936|Mitogens|mitogens|mesh-list
2245878|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
2245879|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245880|NCT00117975|Galiximab|galiximab|mesh-list
799712|NCT02578537|Clopidogrel|clopidogrel|mesh-list
799713|NCT02578537|Ticagrelor|ticagrelor|mesh-list
799714|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
799715|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
799716|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
799717|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
799718|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
799719|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
799720|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799721|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245881|NCT00117975|Rituximab|rituximab|mesh-list
2245882|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2245883|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245884|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
2245885|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245886|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
799993|NCT02577432|Fentanyl|fentanyl|mesh-list
798164|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798165|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
798166|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
798167|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
798244|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
798245|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
798246|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798871|NCT02581943|Paclitaxel|paclitaxel|mesh-list
798872|NCT02581943|Carboplatin|carboplatin|mesh-list
798873|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
798874|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
798875|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
798876|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798877|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
798878|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
798879|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
798880|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798881|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2245887|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2245888|NCT00118014|Sertraline|sertraline|mesh-list
2245889|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
799438|NCT02579356|Telmisartan|telmisartan|mesh-list
799439|NCT02579356|Atorvastatin|atorvastatin|mesh-list
799440|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
799441|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
799442|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
799443|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799444|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
799445|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
799446|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799447|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
799448|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
799449|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
799811|NCT02577965|Everolimus|everolimus|mesh-list
799812|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799813|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
799814|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
799815|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800280|NCT02576444|Olaparib|olaparib|mesh-list
800281|NCT02576444|Adavosertib|adavosertib|mesh-list
800282|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
800283|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800284|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800285|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245890|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2245891|NCT00118014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2245892|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2245893|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2245894|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245895|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2245896|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
2245897|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245898|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
2245899|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
2245900|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2245901|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
2245902|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2245903|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2245904|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802101|NCT02570035|Mirabegron|mirabegron|mesh-list
802102|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
802103|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
802104|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
802105|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
802106|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802107|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802108|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802109|NCT02570035|Urological Agents|urological agents|mesh-ancestor
2096149|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
2096150|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096151|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2096152|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
2096153|NCT02301143|Antiviral Agents|antiviral agents|mesh-ancestor
802507|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
798199|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798200|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
798201|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798202|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245905|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2245906|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245907|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245908|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2245909|NCT00118027|Renal Agents|renal agents|mesh-ancestor
2245910|NCT00118066|Calcitriol|calcitriol|mesh-list
2245911|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2245912|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245913|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2245914|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2245915|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245916|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2245917|NCT00118066|Vitamins|vitamins|mesh-ancestor
2245918|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
2245919|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2245920|NCT00118105|Bevacizumab|bevacizumab|mesh-list
2245921|NCT00118105|Capecitabine|capecitabine|mesh-list
2245922|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
2245923|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2245924|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245925|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2245926|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2245927|NCT00118105|Growth Substances|growth substances|mesh-ancestor
2245928|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245929|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
2245930|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2245931|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
2245932|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245933|NCT00118170|Sorafenib|sorafenib|mesh-list
2245934|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245935|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2245936|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245937|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799526|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
799527|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
799528|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
799529|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799530|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
799531|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
799532|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
799533|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
799534|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
799535|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799680|NCT02578511|Ixazomib|ixazomib|mesh-list
799681|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799682|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
799683|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799684|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799792|NCT02578043|Clindamycin|clindamycin|mesh-list
799793|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
799794|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
799795|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
799796|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
799797|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
799798|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
799799|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799800|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799801|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
2096154|NCT02301143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096155|NCT02301143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096156|NCT02301143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
800391|NCT02576275|Rituximab|rituximab|mesh-list
800392|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
800393|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
800394|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800395|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
800396|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800397|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
800743|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2245938|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2245939|NCT00118183|Cetuximab|cetuximab|mesh-list
2245940|NCT00118183|Docetaxel|docetaxel|mesh-list
2245941|NCT00118183|Bortezomib|bortezomib|mesh-list
798700|NCT02582047|Vaccines|vaccines|mesh-list
798701|NCT02582047|Immunologic Factors|immunologic factors|mesh-ancestor
798702|NCT02582047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798811|NCT02581761|Misoprostol|misoprostol|mesh-list
798816|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
798817|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
798818|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
798819|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798820|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
798821|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
798822|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
2245942|NCT00118183|Antibodies|antibodies|mesh-list
2245943|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
2245944|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2245945|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
2245946|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245947|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245948|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
2245949|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
2245950|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
2245951|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245952|NCT00118196|Azacitidine|azacitidine|mesh-list
2245953|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
2245954|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2245955|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
2245956|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245957|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245958|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245959|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2245960|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
2245961|NCT00118222|Ether|ether|mesh-list
2245962|NCT00118222|Trioxsalen|trioxsalen|mesh-list
2245963|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245964|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
2245965|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2245966|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2245967|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
800042|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
800043|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
800044|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
800045|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
800046|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
800047|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800048|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
800049|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800050|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800051|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
800052|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800243|NCT02576457|BMS-936559|bms-936559|mesh-list
800244|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
800245|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245968|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
2245969|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2245970|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245971|NCT00118235|Bevacizumab|bevacizumab|mesh-list
2245972|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2245973|NCT00118235|Irinotecan|irinotecan|mesh-list
800917|NCT02574403|Eculizumab|eculizumab|mesh-list
800918|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
800919|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
800920|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
800921|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801369|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
801776|NCT02571205|Testosterone|testosterone|mesh-list
801777|NCT02571205|Androgens|androgens|mesh-ancestor
801778|NCT02571205|Hormones|hormones|mesh-ancestor
801779|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
801780|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245974|NCT00118235|Antibodies|antibodies|mesh-list
2245975|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
802383|NCT02568800|Cefepime|cefepime|mesh-list
802384|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2245976|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2245977|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798270|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798271|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
798272|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
798273|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
798274|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245978|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2245979|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2245980|NCT00118235|Growth Substances|growth substances|mesh-ancestor
2245981|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2245982|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
2245983|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
2245984|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2245985|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2245986|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2245987|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2245988|NCT00118261|Leucovorin|leucovorin|mesh-list
2245989|NCT00118261|Bevacizumab|bevacizumab|mesh-list
2245990|NCT00118261|Fluorouracil|fluorouracil|mesh-list
2245991|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
2245992|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2245993|NCT00118261|Calcium|calcium|mesh-list
2245994|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
2245995|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2245996|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2245997|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2245998|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2245999|NCT00118261|Growth Substances|growth substances|mesh-ancestor
2246000|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246001|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
2246002|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2246003|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
2246004|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246005|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2246006|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2246007|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
2246008|NCT00118261|Antidotes|antidotes|mesh-ancestor
2246009|NCT00118261|Protective Agents|protective agents|mesh-ancestor
2246010|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
2246011|NCT00118261|Vitamins|vitamins|mesh-ancestor
2246012|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
2246013|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2246014|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246015|NCT00118300|Capecitabine|capecitabine|mesh-list
2246016|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2246017|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
2246018|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799536|NCT02578823|Antipyretics|antipyretics|mesh-list
799537|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246019|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246020|NCT00118313|Imiquimod|imiquimod|mesh-list
2246021|NCT00118313|Sargramostim|sargramostim|mesh-list
2246022|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
2246023|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2246024|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
2246025|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246026|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246027|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2246028|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
2246029|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2246030|NCT00118313|Protective Agents|protective agents|mesh-ancestor
2246031|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2246032|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
2246033|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800426|NCT02576223|Ropivacaine|ropivacaine|mesh-list
800427|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
800428|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
800429|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
800430|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800431|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
800432|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800714|NCT02575339|Sorafenib|sorafenib|mesh-list
800715|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800716|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
800717|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800744|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
2246034|NCT00118326|Lenograstim|lenograstim|mesh-list
798356|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798357|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
798358|NCT02583217|Narcotics|narcotics|mesh-ancestor
800494|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
800495|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800496|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
800497|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800498|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800646|NCT02575443|Rocuronium|rocuronium|mesh-list
800647|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
800648|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
800649|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
800650|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800651|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246035|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2246036|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
2246037|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246038|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
2246039|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2246040|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2246041|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246042|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2246043|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246044|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2246045|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
2246046|NCT00118638|Hematinics|hematinics|mesh-ancestor
2246047|NCT00118690|Fluticasone|fluticasone|mesh-list
2246048|NCT00118690|Xhance|xhance|mesh-list
2246049|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2246050|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2246051|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2246052|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
2246053|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246054|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246055|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2246056|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
2246057|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
2246058|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2246059|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2246060|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2246061|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2246062|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
801891|NCT02571166|Valacyclovir|valacyclovir|mesh-list
801892|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
801893|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801948|NCT02570841|Capsaicin|capsaicin|mesh-list
801949|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
801950|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
801951|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
801952|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801953|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246063|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2246064|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246065|NCT00118768|Interferons|interferons|mesh-list
2246066|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
2246067|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798567|NCT02582359|Cytarabine|cytarabine|mesh-list
798568|NCT02582359|Daunorubicin|daunorubicin|mesh-list
798569|NCT02582359|Ixazomib|ixazomib|mesh-list
798570|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
798571|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
798572|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798573|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798574|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
798575|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
798576|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
798577|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
798578|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798579|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
798580|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
798581|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
798582|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
798583|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
799127|NCT02580734|Melatonin|melatonin|mesh-list
799128|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
799129|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799130|NCT02580734|Protective Agents|protective agents|mesh-ancestor
799131|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799132|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
799876|NCT02577783|Dexamethasone|dexamethasone|mesh-list
799877|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
799878|NCT02577783|Doxorubicin|doxorubicin|mesh-list
799879|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
799880|NCT02577783|BB 1101|bb 1101|mesh-list
799881|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
799882|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
799883|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
799884|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
799885|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799886|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
799887|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
799888|NCT02577783|Hormones|hormones|mesh-ancestor
799889|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
799890|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
799891|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799892|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
799893|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799894|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799895|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
799896|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
799897|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
800652|NCT02575534|Procainamide|procainamide|mesh-list
800653|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
800654|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
800655|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
800656|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
800657|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800774|NCT02575222|Nivolumab|nivolumab|mesh-list
800775|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
800776|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800777|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
800778|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801830|NCT02571361|Acetaminophen|acetaminophen|mesh-list
801831|NCT02571361|Ibuprofen|ibuprofen|mesh-list
801833|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
801834|NCT02571361|Analgesics|analgesics|mesh-ancestor
801835|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
801836|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801837|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801838|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
801839|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
801840|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
801841|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
801842|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
801843|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801859|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2246068|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
2246069|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246070|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
2246071|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246072|NCT00118794|Lumefantrine|lumefantrine|mesh-list
2246073|NCT00118794|Artemether|artemether|mesh-list
2246074|NCT00118794|Dapsone|dapsone|mesh-list
799024|NCT02580968|Flunarizine|flunarizine|mesh-list
799025|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
799026|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
799027|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
799028|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799029|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
799030|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799031|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
799032|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
799033|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
799034|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
799035|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
799133|NCT02580708|Trametinib|trametinib|mesh-list
799134|NCT02580708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799135|NCT02580708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
799136|NCT02580708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799137|NCT02580708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799290|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
799291|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
799292|NCT02579590|Desogestrel|desogestrel|mesh-list
799293|NCT02579590|Etonogestrel|etonogestrel|mesh-list
799294|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
799295|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
799296|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
799297|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
799298|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
799299|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799300|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
799301|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
799302|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
799303|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
799304|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799305|NCT02579590|Progestins|progestins|mesh-ancestor
799306|NCT02579590|Hormones|hormones|mesh-ancestor
799307|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2246075|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
2246076|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2246077|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
2246078|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2246079|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2246080|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246081|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2246082|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246083|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246084|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
2246085|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2246086|NCT00118807|Artesunate|artesunate|mesh-list
2246087|NCT00118807|Chloroquine|chloroquine|mesh-list
2246088|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
2246089|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
2246090|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2246091|NCT00118807|Amodiaquine|amodiaquine|mesh-list
2246092|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
2246093|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2246094|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
799554|NCT02578771|Methylene Blue|methylene blue|mesh-list
799555|NCT02578771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799556|NCT02578771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799921|NCT02577458|Everolimus|everolimus|mesh-list
799922|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799923|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
799924|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
799925|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800061|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
800062|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
800063|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246095|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246096|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246097|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
798637|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798638|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
798639|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
798640|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798801|NCT02581696|Irsogladine|irsogladine|mesh-list
798802|NCT02581696|Lafutidine|lafutidine|mesh-list
798803|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798804|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
798805|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
798806|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
798807|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
798808|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
798809|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
798810|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
798812|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
798813|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
798814|NCT02581696|Protective Agents|protective agents|mesh-ancestor
798815|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
798946|NCT02581423|Capecitabine|capecitabine|mesh-list
798947|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
798948|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
798949|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798950|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799057|NCT02580994|Carboplatin|carboplatin|mesh-list
799058|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
799059|NCT02580994|Etoposide|etoposide|mesh-list
799060|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799061|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
799062|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
799063|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
799064|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
799065|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799066|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799375|NCT02579564|Gemcitabine|gemcitabine|mesh-list
799376|NCT02579564|Paclitaxel|paclitaxel|mesh-list
799377|NCT02579564|Vinorelbine|vinorelbine|mesh-list
799378|NCT02579564|Pemetrexed|pemetrexed|mesh-list
799379|NCT02579564|Endostar protein|endostar protein|mesh-list
799380|NCT02579564|Endostatins|endostatins|mesh-list
799381|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
799382|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799383|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
799384|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
799385|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
799386|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799387|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
799388|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
799389|NCT02579564|Antiviral Agents|antiviral agents|mesh-ancestor
799390|NCT02579564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
799391|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799392|NCT02579564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
799393|NCT02579564|Immunologic Factors|immunologic factors|mesh-ancestor
799394|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799395|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
799396|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
799397|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
799398|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
799399|NCT02579564|Growth Substances|growth substances|mesh-ancestor
799400|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
2246098|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
2246099|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2246100|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
2246101|NCT00118807|Amebicides|amebicides|mesh-ancestor
2246102|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2246103|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2246104|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246105|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246106|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2246107|NCT00118807|Renal Agents|renal agents|mesh-ancestor
2246108|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2246109|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246110|NCT00118937|Metformin|metformin|mesh-list
2246111|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2246112|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246113|NCT00118950|Metformin|metformin|mesh-list
2246114|NCT00118950|Repaglinide|repaglinide|mesh-list
2246115|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2246116|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246117|NCT00118963|Metformin|metformin|mesh-list
2246118|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
2246119|NCT00118963|Repaglinide|repaglinide|mesh-list
2246120|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2246121|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246122|NCT00118976|Lisinopril|lisinopril|mesh-list
2246123|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2246124|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
2246125|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246126|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246127|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2246128|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2246129|NCT00118976|Protective Agents|protective agents|mesh-ancestor
2246130|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246131|NCT00119002|Dexamethasone|dexamethasone|mesh-list
2246132|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2246133|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
2246134|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
2246135|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246136|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246137|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2246138|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
799344|NCT02579434|Midazolam|midazolam|mesh-list
799345|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
799346|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
799347|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
799348|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799349|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
799350|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
799351|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
799352|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
799353|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
799354|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
799355|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
799356|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
799357|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
799358|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246139|NCT00119002|Hormones|hormones|mesh-ancestor
2246140|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2246141|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2246142|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246143|NCT00119119|Tocopherols|tocopherols|mesh-list
2246144|NCT00119119|Vitamin E|vitamin e|mesh-list
2246145|NCT00119119|Tocotrienols|tocotrienols|mesh-list
2246146|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
2246147|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
2246148|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246149|NCT00119119|Protective Agents|protective agents|mesh-ancestor
799685|NCT02578277|BMS-955176|bms-955176|mesh-list
799686|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
799687|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
799688|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
799689|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096157|NCT02301143|Immunologic Factors|immunologic factors|mesh-ancestor
2096158|NCT02301143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096159|NCT02301390|Amiodarone|amiodarone|mesh-list
2096160|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2096161|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
2096162|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2096163|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2096164|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096165|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2246150|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246151|NCT00119119|Vitamins|vitamins|mesh-ancestor
2246152|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
2246153|NCT00119132|Artesunate|artesunate|mesh-list
2246154|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
2246155|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
2246156|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2096166|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2096167|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2096168|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246157|NCT00119132|Amodiaquine|amodiaquine|mesh-list
2246158|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
800342|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246159|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2246160|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2246161|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246162|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246163|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
799072|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
799073|NCT02581007|Melphalan|melphalan|mesh-list
799074|NCT02581007|Fludarabine|fludarabine|mesh-list
799075|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
799076|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
799077|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799078|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
799079|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
799080|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
799081|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799082|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799083|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
799211|NCT02580149|Clopidogrel|clopidogrel|mesh-list
799212|NCT02580149|Ticagrelor|ticagrelor|mesh-list
799213|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
799214|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
799215|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
799216|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
799217|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
799218|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
799219|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799220|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799668|NCT02578251|Acetaminophen|acetaminophen|mesh-list
799669|NCT02578251|Meperidine|meperidine|mesh-list
799670|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
799671|NCT02578251|Analgesics|analgesics|mesh-ancestor
799672|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
799673|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
799674|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799675|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
799676|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
799677|NCT02578251|Narcotics|narcotics|mesh-ancestor
799678|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
799679|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
799949|NCT02577341|Docetaxel|docetaxel|mesh-list
799950|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
799951|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799952|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
799953|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
799954|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
799955|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799956|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2246164|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
2246165|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2246166|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
2246167|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2246168|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246169|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246170|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2246171|NCT00119132|Renal Agents|renal agents|mesh-ancestor
2246172|NCT00119145|Artesunate|artesunate|mesh-list
2246173|NCT00119145|Amodiaquine|amodiaquine|mesh-list
2246174|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2246175|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
2246176|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2246177|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2246178|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246179|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246180|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
2246181|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
2246182|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2246183|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
2246184|NCT00119171|Capecitabine|capecitabine|mesh-list
2246185|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2246186|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
2246187|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246188|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246189|NCT00119184|Anesthetics|anesthetics|mesh-list
2246190|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2246191|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246192|NCT00119210|Bupropion|bupropion|mesh-list
798864|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
798865|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
798866|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
798867|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
798868|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
798869|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
798870|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2246193|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2246194|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
2246195|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
799159|NCT02580370|Botulinum Toxins|botulinum toxins|mesh-list
799160|NCT02580370|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
799161|NCT02580370|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
799162|NCT02580370|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
799163|NCT02580370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
799164|NCT02580370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799165|NCT02580370|Cholinergic Agents|cholinergic agents|mesh-ancestor
799166|NCT02580370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
799167|NCT02580370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799168|NCT02580370|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
799169|NCT02580370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800786|NCT02575092|Folic Acid|folic acid|mesh-list
800787|NCT02575092|Enalapril|enalapril|mesh-list
800788|NCT02575092|Enalaprilat|enalaprilat|mesh-list
800789|NCT02575092|Maleic acid|maleic acid|mesh-list
800790|NCT02575092|Hematinics|hematinics|mesh-ancestor
800791|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
800792|NCT02575092|Vitamins|vitamins|mesh-ancestor
800793|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
800794|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800795|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800796|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800797|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
800798|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
800799|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2246196|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2246197|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2246198|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
801508|NCT02572960|Vitamin D|vitamin d|mesh-list
801509|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
801510|NCT02572960|Valsartan|valsartan|mesh-list
801511|NCT02572960|Vitamins|vitamins|mesh-ancestor
801512|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
801513|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801514|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
801515|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
801516|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
801517|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
801518|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
801519|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801601|NCT02572323|Tesamorelin|tesamorelin|mesh-list
801602|NCT02572323|Growth Substances|growth substances|mesh-ancestor
801603|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801793|NCT02571426|Propofol|propofol|mesh-list
801794|NCT02571426|Sevoflurane|sevoflurane|mesh-list
801795|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
801796|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801797|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801798|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
801799|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
801800|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
801801|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
801802|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
802064|NCT02570243|Heparin|heparin|mesh-list
802065|NCT02570243|Calcium heparin|calcium heparin|mesh-list
802066|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
802067|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
802068|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
802069|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246199|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246200|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
2246201|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2246202|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246203|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
798891|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
798892|NCT02581566|Analgesics|analgesics|mesh-ancestor
798893|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
798894|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
798895|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
798896|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
798897|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
798898|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246204|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2246205|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246206|NCT00119236|Irinotecan|irinotecan|mesh-list
2246207|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2246208|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2246209|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246210|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246211|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246212|NCT00119249|Sorafenib|sorafenib|mesh-list
2246213|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246214|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2246215|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246216|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246217|NCT00119301|Leucovorin|leucovorin|mesh-list
2246218|NCT00119301|Trimetrexate|trimetrexate|mesh-list
2246219|NCT00119301|Methotrexate|methotrexate|mesh-list
2246220|NCT00119301|Calcium|calcium|mesh-list
2246221|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
2246222|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2246223|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246224|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2246225|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
2246226|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2246227|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2246228|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
2246229|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246230|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799898|NCT02577523|Levodopa|levodopa|mesh-list
799899|NCT02577523|Carbidopa|carbidopa|mesh-list
799900|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
799901|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
799902|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
799903|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
799904|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799905|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799906|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
799907|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799969|NCT02577250|Ketamine|ketamine|mesh-list
799970|NCT02577250|Analgesics|analgesics|mesh-ancestor
799971|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
799972|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
799973|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799974|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
799975|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
799976|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
799977|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
799978|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
799979|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
799980|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
799981|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
799982|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246231|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
2246232|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246233|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2246234|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2246235|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
800482|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
800483|NCT02576119|BMS-955176|bms-955176|mesh-list
800484|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
800485|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
800486|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
800487|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
800488|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800489|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800490|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800491|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2246236|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2246237|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
799198|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
799199|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
799200|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
799201|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799202|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
799203|NCT02580227|Coagulants|coagulants|mesh-ancestor
2246238|NCT00119301|Antidotes|antidotes|mesh-ancestor
2246239|NCT00119301|Protective Agents|protective agents|mesh-ancestor
2246240|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
2246241|NCT00119301|Vitamins|vitamins|mesh-ancestor
2246242|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
2246243|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
2246244|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246245|NCT00119314|Gemcitabine|gemcitabine|mesh-list
2246246|NCT00119314|Capecitabine|capecitabine|mesh-list
2246247|NCT00119314|Docetaxel|docetaxel|mesh-list
2246248|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2246249|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
2246250|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246251|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246252|NCT00119314|Antiviral Agents|antiviral agents|mesh-ancestor
2246253|NCT00119314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246254|NCT00119314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246255|NCT00119314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2246256|NCT00119314|Immunologic Factors|immunologic factors|mesh-ancestor
2246257|NCT00119314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246258|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
2246259|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
2246260|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
2246261|NCT00119340|Cyclosporine|cyclosporine|mesh-list
2246262|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
2246263|NCT00119340|Fludarabine|fludarabine|mesh-list
2246264|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
799844|NCT02577848|Liraglutide|liraglutide|mesh-list
799845|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
799846|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799847|NCT02577848|Incretins|incretins|mesh-ancestor
799848|NCT02577848|Hormones|hormones|mesh-ancestor
799849|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
799926|NCT02577497|Fluticasone|fluticasone|mesh-list
799927|NCT02577497|Beclomethasone|beclomethasone|mesh-list
799928|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
799929|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
799930|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
799931|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
799932|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799933|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
799934|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
799935|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
799936|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
799937|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
799938|NCT02577497|Hormones|hormones|mesh-ancestor
799939|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
800163|NCT02576717|Ozanimod|ozanimod|mesh-list
800164|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
800165|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800166|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
800167|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
800168|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801544|NCT02572583|Oseltamivir|oseltamivir|mesh-list
801545|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
801546|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801547|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801548|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246265|NCT00119340|Cyclosporins|cyclosporins|mesh-list
2246266|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246267|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2246268|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
2246269|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246270|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2246271|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
2246272|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246273|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246274|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
2246275|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
799158|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246276|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
2246277|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2246278|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2246279|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2246280|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2246281|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
2246282|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2246283|NCT00119366|Iodine|iodine|mesh-list
2246284|NCT00119366|Cyclosporine|cyclosporine|mesh-list
2246285|NCT00119366|Mycophenolic Acid|mycophenolic acid|mesh-list
2246286|NCT00119366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2246287|NCT00119366|Fludarabine|fludarabine|mesh-list
2246288|NCT00119366|Fludarabine phosphate|fludarabine phosphate|mesh-list
2246289|NCT00119366|Antibodies|antibodies|mesh-list
2246290|NCT00119366|Immunoglobulins|immunoglobulins|mesh-list
2246291|NCT00119366|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2246292|NCT00119366|Cyclosporins|cyclosporins|mesh-list
2246293|NCT00119366|Immunologic Factors|immunologic factors|mesh-ancestor
2246294|NCT00119366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246295|NCT00119366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246296|NCT00119366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
800328|NCT02576353|Fentanyl|fentanyl|mesh-list
800329|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
800330|NCT02576353|Narcotics|narcotics|mesh-ancestor
800331|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
800332|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800333|NCT02576353|Analgesics|analgesics|mesh-ancestor
800334|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
800335|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800336|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
800337|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
800338|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
800339|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
800810|NCT02575508|Fluorouracil|fluorouracil|mesh-list
800811|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
800812|NCT02575508|Irinotecan|irinotecan|mesh-list
800813|NCT02575508|Camptothecin|camptothecin|mesh-list
800814|NCT02575508|Infigratinib|infigratinib|mesh-list
800815|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
800816|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800817|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
800818|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800819|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
800820|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
800821|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800822|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
800823|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
800824|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800825|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
800887|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
800888|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
800889|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
800890|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800891|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801235|NCT02573727|Terlipressin|terlipressin|mesh-list
801236|NCT02573727|Epinephrine|epinephrine|mesh-list
801237|NCT02573727|Racepinephrine|racepinephrine|mesh-list
801238|NCT02573727|Norepinephrine|norepinephrine|mesh-list
801239|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
801240|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
801241|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
801242|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
801243|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
801244|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801245|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801246|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
801247|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
801248|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
801249|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801250|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
801251|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
801252|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
801253|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
801254|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2246297|NCT00119366|Antimetabolites|antimetabolites|mesh-ancestor
2246298|NCT00119366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799174|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
799175|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
799176|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799177|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
799178|NCT02580695|Protective Agents|protective agents|mesh-ancestor
2246299|NCT00119366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2246300|NCT00119366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246301|NCT00119366|Antifungal Agents|antifungal agents|mesh-ancestor
2246302|NCT00119366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246303|NCT00119366|Dermatologic Agents|dermatologic agents|mesh-ancestor
2246304|NCT00119366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2246305|NCT00119366|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2246306|NCT00119366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2246307|NCT00119366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2246308|NCT00119366|Antitubercular Agents|antitubercular agents|mesh-ancestor
2246309|NCT00119366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2246310|NCT00119366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2246311|NCT00119366|Trace Elements|trace elements|mesh-ancestor
2246312|NCT00119366|Micronutrients|micronutrients|mesh-ancestor
799568|NCT02578641|Gemcitabine|gemcitabine|mesh-list
799569|NCT02578641|Carboplatin|carboplatin|mesh-list
799570|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799571|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
799572|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
799573|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799574|NCT02578641|Antiviral Agents|antiviral agents|mesh-ancestor
799575|NCT02578641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
799576|NCT02578641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799577|NCT02578641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
799578|NCT02578641|Immunologic Factors|immunologic factors|mesh-ancestor
799579|NCT02578641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799940|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
799941|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
799942|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799943|NCT02577393|Protective Agents|protective agents|mesh-ancestor
799944|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799945|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
799946|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
799947|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799948|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
800066|NCT02577094|Fludarabine|fludarabine|mesh-list
800067|NCT02577094|Busulfan|busulfan|mesh-list
800068|NCT02577094|Epratuzumab|epratuzumab|mesh-list
800069|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
800070|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800071|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800072|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
800073|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
800074|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800075|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
800076|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
800077|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
800078|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
800222|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
800223|NCT02576626|Albuterol|albuterol|mesh-list
800224|NCT02576626|Ipratropium|ipratropium|mesh-list
800225|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
800226|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
800227|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800228|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800229|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
800230|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
800231|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
800232|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
800233|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
800234|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
800235|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
800236|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
800237|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800238|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800239|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
800240|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
800241|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
800242|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
800433|NCT02576366|Rifampin|rifampin|mesh-list
800434|NCT02576366|Voriconazole|voriconazole|mesh-list
799189|NCT02580305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799190|NCT02580305|Nootropic Agents|nootropic agents|mesh-ancestor
799191|NCT02580305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
799192|NCT02580305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
799193|NCT02580305|Dopamine Agents|dopamine agents|mesh-ancestor
799194|NCT02580305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
799195|NCT02580305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
799196|NCT02580305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
799197|NCT02580305|Serotonin Agents|serotonin agents|mesh-ancestor
799338|NCT02579473|Rotigotine|rotigotine|mesh-list
799339|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
799340|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
799341|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
799342|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799343|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799586|NCT02579187|Anesthetics|anesthetics|mesh-list
799587|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
799588|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246313|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
2246314|NCT00119483|Testosterone|testosterone|mesh-list
2246315|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
2246316|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
2246317|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2246318|NCT00119483|Androgens|androgens|mesh-ancestor
800805|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
800806|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
800807|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800808|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
800809|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801165|NCT02573987|Lidocaine|lidocaine|mesh-list
801166|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
801167|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
801168|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
801169|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801170|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801171|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
801172|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801173|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
801174|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
801175|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
801176|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
801177|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801178|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
801179|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
801180|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
801181|NCT02573987|Analgesics|analgesics|mesh-ancestor
801288|NCT02573519|Acetylcholine|acetylcholine|mesh-list
801289|NCT02573519|Donepezil|donepezil|mesh-list
801290|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
801291|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
801292|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801293|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801294|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
801295|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
801296|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801297|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
801298|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
801299|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
801549|NCT02572687|Durvalumab|durvalumab|mesh-list
801550|NCT02572687|Ramucirumab|ramucirumab|mesh-list
801551|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
801552|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
801846|NCT02571283|Epinephrine|epinephrine|mesh-list
801847|NCT02571283|Bupivacaine|bupivacaine|mesh-list
801848|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
801849|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
801850|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801851|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801852|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
801853|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801854|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801855|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
801856|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
801857|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
801858|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
2246319|NCT00119483|Hormones|hormones|mesh-ancestor
799263|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
799264|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
799265|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799507|NCT02579044|Everolimus|everolimus|mesh-list
799508|NCT02579044|Lonafarnib|lonafarnib|mesh-list
799509|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799510|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
799511|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
799512|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799513|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799514|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799816|NCT02578121|Dexamethasone|dexamethasone|mesh-list
799817|NCT02578121|Pomalidomide|pomalidomide|mesh-list
799818|NCT02578121|Ixazomib|ixazomib|mesh-list
799819|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
799820|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
799821|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
799822|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
799823|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799824|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
799825|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
799826|NCT02578121|Hormones|hormones|mesh-ancestor
799827|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
799828|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
799829|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
799830|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
799831|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
799832|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
799833|NCT02578121|Growth Substances|growth substances|mesh-ancestor
799834|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
799835|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
799836|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799837|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800122|NCT02576912|Dronabinol|dronabinol|mesh-list
800123|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
800124|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800125|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
800126|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
800127|NCT02576912|Analgesics|analgesics|mesh-ancestor
800128|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
800129|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800130|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
800131|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
800132|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800133|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800134|NCT02576912|Hormones|hormones|mesh-ancestor
800135|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2246320|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2246321|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246322|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2246323|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246324|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
2246325|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
2246326|NCT00119496|Beclomethasone|beclomethasone|mesh-list
2246327|NCT00119496|Theophylline|theophylline|mesh-list
2246328|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246329|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246330|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2246331|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246332|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2246333|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
2246334|NCT00119496|Hormones|hormones|mesh-ancestor
2246335|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
801188|NCT02573831|Oxycodone|oxycodone|mesh-list
801189|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
801190|NCT02573831|Narcotics|narcotics|mesh-ancestor
801191|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801192|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801193|NCT02573831|Analgesics|analgesics|mesh-ancestor
801194|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
801195|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801702|NCT02571959|Amoxicillin|amoxicillin|mesh-list
801703|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
801704|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
801705|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
800079|NCT02576808|Loratadine|loratadine|mesh-list
800080|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
800081|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
800082|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
800083|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
800084|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
800085|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
800086|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
800087|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800088|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800089|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800309|NCT02576340|Octylonium|octylonium|mesh-list
800310|NCT02576340|Bromides|bromides|mesh-list
800311|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
800312|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
800313|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
800314|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800315|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
800316|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800317|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
800318|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
800319|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
800320|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800321|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
800322|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
800323|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
800324|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800707|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
800708|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
800709|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
800710|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
801349|NCT02573337|Lidocaine|lidocaine|mesh-list
801350|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
801351|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
801352|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801353|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801354|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
801355|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801356|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
801357|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
801358|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
801359|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
801360|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246336|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2246337|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
2246338|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
801634|NCT02572089|Naloxone|naloxone|mesh-list
801635|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
801636|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801637|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
801638|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802070|NCT02570230|Ketamine|ketamine|mesh-list
802071|NCT02570230|Analgesics|analgesics|mesh-ancestor
802072|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
802073|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802074|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802075|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
802076|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
802077|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
802078|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
802079|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
802080|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
802081|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
802082|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802083|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246339|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
2246340|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246341|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2246342|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
802385|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
799519|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
799520|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
799521|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799522|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
799523|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
799524|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
799525|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799908|NCT02577575|Oxytocin|oxytocin|mesh-list
799909|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
799910|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
799911|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800210|NCT02576665|Flucytosine|flucytosine|mesh-list
800211|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
800212|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
800213|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
800214|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246343|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2246344|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2246345|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
2246346|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800800|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
800801|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
800802|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
800803|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
800804|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2246347|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
2246348|NCT00119587|Hematinics|hematinics|mesh-ancestor
2246349|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
2246350|NCT00119613|Hematinics|hematinics|mesh-ancestor
2246351|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
2246352|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
2246353|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246354|NCT00119626|Protective Agents|protective agents|mesh-ancestor
2246355|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246356|NCT00119639|Sorafenib|sorafenib|mesh-list
2246357|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246358|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2246359|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246360|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246361|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2246362|NCT00119652|Paroxetine|paroxetine|mesh-list
801755|NCT02571608|Metformin|metformin|mesh-list
801756|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
801757|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801832|NCT02571192|Volixibat|volixibat|mesh-list
801845|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
801926|NCT02570971|Mannitol|mannitol|mesh-list
801927|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
801928|NCT02570971|Diuretics|diuretics|mesh-ancestor
801929|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
801930|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802629|NCT02568033|Paclitaxel|paclitaxel|mesh-list
802630|NCT02568033|Docetaxel|docetaxel|mesh-list
802631|NCT02568033|Carboplatin|carboplatin|mesh-list
802632|NCT02568033|Pemetrexed|pemetrexed|mesh-list
802633|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
802634|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
802635|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
802636|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
802637|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
802638|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802639|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802640|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
802641|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
803097|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
803098|NCT02566252|Albuterol|albuterol|mesh-list
803099|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
803100|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
803101|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
803102|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803103|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803104|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
803105|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
803106|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
803107|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
803108|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2246363|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
2246364|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2246365|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2246366|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2246367|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2246368|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246369|NCT00119652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2246370|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2246371|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2246372|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246373|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2246374|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
2246375|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2246376|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2246377|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2246378|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246379|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
800029|NCT02577120|Decanoic acid|decanoic acid|mesh-list
800030|NCT02577120|Petrolatum|petrolatum|mesh-list
800031|NCT02577120|Emollients|emollients|mesh-ancestor
800032|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
800033|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
800034|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
800246|NCT02576600|Remifentanil|remifentanil|mesh-list
800247|NCT02576600|Propofol|propofol|mesh-list
800248|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
800249|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
800250|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800251|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
800252|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
800253|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
800254|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
800255|NCT02576600|Narcotics|narcotics|mesh-ancestor
800256|NCT02576600|Analgesics|analgesics|mesh-ancestor
800257|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
800258|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800376|NCT02576301|Cytarabine|cytarabine|mesh-list
800377|NCT02576301|Combretastatin|combretastatin|mesh-list
800378|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
800379|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
800380|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800381|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800382|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
800383|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
800384|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
800385|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
800386|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800387|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
800388|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
800389|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
800390|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
2096169|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2096170|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2096171|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2096172|NCT02301403|Nicotine|nicotine|mesh-list
2096173|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2096174|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
2096175|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096176|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096177|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2096178|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2096179|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
2096180|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096181|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096182|NCT02301416|Topiramate|topiramate|mesh-list
2096183|NCT02301416|Phentermine|phentermine|mesh-list
2096184|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
2096185|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2096186|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096187|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2096188|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
2096189|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2096190|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
2096191|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
2096192|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
799663|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
799664|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
799665|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
799666|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
799667|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2246380|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
2246381|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246382|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
2246383|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2246384|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2246385|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2246386|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2246387|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246388|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
2246389|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2246390|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246391|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2246392|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246393|NCT00119730|Rituximab|rituximab|mesh-list
2246394|NCT00119730|Fludarabine|fludarabine|mesh-list
2246395|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
2246396|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2246397|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246398|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
2246399|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246400|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
800711|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
800712|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
800713|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800782|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
800783|NCT02574962|Hormones|hormones|mesh-ancestor
800784|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
800785|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800892|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
800893|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
800894|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
800895|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
800896|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800897|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
800898|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
800899|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2246401|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246402|NCT00119730|Analgesics|analgesics|mesh-ancestor
2246403|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
2246404|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246405|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2246406|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2246407|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246408|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2246409|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2246410|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2246411|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2246412|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246413|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2246414|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2246415|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2246416|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
2246417|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2246418|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246419|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2246420|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2246421|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
2246422|NCT00119769|Hormones|hormones|mesh-list
2096193|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
2096194|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096195|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801939|NCT02571140|Teriparatide|teriparatide|mesh-list
801940|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
801941|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
801942|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801943|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
802116|NCT02569970|Fluoxetine|fluoxetine|mesh-list
802117|NCT02569970|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
799740|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
799741|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
799742|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
799743|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
799744|NCT02578368|Antidotes|antidotes|mesh-ancestor
799745|NCT02578368|Protective Agents|protective agents|mesh-ancestor
799746|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
799747|NCT02578368|Vitamins|vitamins|mesh-ancestor
799748|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
799850|NCT02577809|Indomethacin|indomethacin|mesh-list
799851|NCT02577809|Fentanyl|fentanyl|mesh-list
799852|NCT02577809|Morphine|morphine|mesh-list
799853|NCT02577809|Bupivacaine|bupivacaine|mesh-list
799854|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
799855|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
799856|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
799857|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799858|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
799859|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
799860|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
799861|NCT02577809|Narcotics|narcotics|mesh-ancestor
799862|NCT02577809|Analgesics|analgesics|mesh-ancestor
799863|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
799864|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
799865|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
799866|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
799867|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
799868|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
799869|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
799870|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
799871|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
799872|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
799873|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
799874|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
799875|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800053|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
800054|NCT02576964|Capecitabine|capecitabine|mesh-list
800055|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
800056|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
800057|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800058|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800059|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
800060|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
800613|NCT02575755|Azithromycin|azithromycin|mesh-list
800614|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
800615|NCT02575755|Piperaquine|piperaquine|mesh-list
800616|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
800617|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
800618|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
800619|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
800620|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
800621|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
800622|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
800623|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
800624|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800625|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800626|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
800627|NCT02575755|Renal Agents|renal agents|mesh-ancestor
800953|NCT02574741|Aripiprazole|aripiprazole|mesh-list
800954|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
800955|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
800956|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
800957|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
800958|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
800959|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800960|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
800961|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
800962|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800963|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800964|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
800965|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
800966|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
800967|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
800968|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
800969|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
800970|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
801102|NCT02574156|Insulin|insulin|mesh-list
799994|NCT02577432|Bupivacaine|bupivacaine|mesh-list
799995|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
799996|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
799997|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
799998|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
799999|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
800000|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800001|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
800002|NCT02577432|Narcotics|narcotics|mesh-ancestor
800003|NCT02577432|Analgesics|analgesics|mesh-ancestor
800004|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
800005|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
800006|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
2246423|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2246424|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246425|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
2246426|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2246427|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2246428|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246429|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
2246430|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2246431|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246432|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
2246433|NCT00119990|Icodextrin|icodextrin|mesh-list
2246434|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2246435|NCT00120003|Candesartan|candesartan|mesh-list
2246436|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
2246437|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2246438|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2246439|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2246440|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246441|NCT00120055|Atorvastatin|atorvastatin|mesh-list
2246442|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
800692|NCT02575664|Buprenorphine|buprenorphine|mesh-list
800693|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
800694|NCT02575664|Narcotics|narcotics|mesh-ancestor
800695|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
800696|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800697|NCT02575664|Analgesics|analgesics|mesh-ancestor
800698|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
800699|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800700|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2246443|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2246444|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
2246445|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246446|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2246447|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2246448|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246449|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2246450|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2246451|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
2246452|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246453|NCT00120081|Antacids|antacids|mesh-ancestor
2246454|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246455|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2246456|NCT00120120|Lenalidomide|lenalidomide|mesh-list
2246457|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
2246458|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246459|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2246460|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
801716|NCT02571881|Oxycodone|oxycodone|mesh-list
801717|NCT02571881|Naloxone|naloxone|mesh-list
801718|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
801719|NCT02571881|Narcotics|narcotics|mesh-ancestor
801720|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801721|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801722|NCT02571881|Analgesics|analgesics|mesh-ancestor
801723|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
801724|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801725|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
802438|NCT02568709|Oxytocin|oxytocin|mesh-list
802439|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
802440|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
802441|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246461|NCT00120120|Growth Substances|growth substances|mesh-ancestor
2246462|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
2246463|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246464|NCT00120133|Atorvastatin|atorvastatin|mesh-list
2246465|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2246466|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
800534|NCT02575924|Imidacloprid|imidacloprid|mesh-list
800535|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
800536|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800537|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800538|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800922|NCT02574754|Warfarin|warfarin|mesh-list
800923|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
801221|NCT02573714|Ketamine|ketamine|mesh-list
801222|NCT02573714|Analgesics|analgesics|mesh-ancestor
801223|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
801224|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801225|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801226|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
801227|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
801228|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
801229|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
801230|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801231|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
801232|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
801233|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
801234|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801397|NCT02573051|Isosorbide|isosorbide|mesh-list
801398|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
801399|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
801400|NCT02573051|Misoprostol|misoprostol|mesh-list
801401|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
801402|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
801403|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
801404|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801405|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
801406|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
801407|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
801408|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
801409|NCT02573051|Diuretics|diuretics|mesh-ancestor
801410|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
801411|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
801412|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
801413|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801639|NCT02572141|Leucovorin|leucovorin|mesh-list
801640|NCT02572141|Fluorouracil|fluorouracil|mesh-list
801641|NCT02572141|Capecitabine|capecitabine|mesh-list
801642|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
801643|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
801644|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
801645|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801646|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
801647|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
801648|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
801649|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
801650|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801651|NCT02572141|Antidotes|antidotes|mesh-ancestor
801652|NCT02572141|Protective Agents|protective agents|mesh-ancestor
801653|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
801654|NCT02572141|Vitamins|vitamins|mesh-ancestor
801655|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
801692|NCT02571712|Timolol|timolol|mesh-list
801693|NCT02571712|Bimatoprost|bimatoprost|mesh-list
801694|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
801695|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
801696|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
801697|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
801698|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801699|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801700|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
801701|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
802089|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
802090|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
802091|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802092|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
802093|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802094|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800064|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
800065|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801781|NCT02571543|Ibuprofen|ibuprofen|mesh-list
801782|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
801783|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
801784|NCT02571543|Analgesics|analgesics|mesh-ancestor
801785|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
801786|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801787|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801788|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
801789|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
801790|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
801791|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801792|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802714|NCT02567773|Itraconazole|itraconazole|mesh-list
802715|NCT02567773|GSK2881078|gsk2881078|mesh-list
802716|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
802717|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802718|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
802719|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
802720|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802721|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802722|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
802723|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
802724|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
802725|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802726|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
802727|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
802728|NCT02567773|Hormones|hormones|mesh-ancestor
803159|NCT02566187|Atorvastatin|atorvastatin|mesh-list
803160|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
803161|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
803162|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
803163|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803164|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
803165|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
803166|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803230|NCT02565680|Prednisone|prednisone|mesh-list
803231|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
803232|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
803233|NCT02565680|Hormones|hormones|mesh-ancestor
803234|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
803235|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803236|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
803237|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246467|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
2246468|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804053|NCT02562118|Letrozole|letrozole|mesh-list
804054|NCT02562118|Lenvatinib|lenvatinib|mesh-list
804055|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804056|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2096196|NCT02301624|Eculizumab|eculizumab|mesh-list
2096197|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2096198|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
800719|NCT02575248|Dienogest|dienogest|mesh-list
800720|NCT02575248|Clomiphene|clomiphene|mesh-list
800721|NCT02575248|Enclomiphene|enclomiphene|mesh-list
800722|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
800723|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
800724|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
800725|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
800726|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800727|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
800728|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
800729|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
800730|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
800731|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
800732|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
800733|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
800734|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
800735|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
800736|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
800737|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
800738|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
800739|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246469|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2246470|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2246471|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246472|NCT00120172|Bevacizumab|bevacizumab|mesh-list
2246473|NCT00120172|Capecitabine|capecitabine|mesh-list
2246474|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
2246475|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2246476|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246477|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2246478|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2246479|NCT00120172|Growth Substances|growth substances|mesh-ancestor
2246480|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246481|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
2246482|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2246483|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
2246484|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246485|NCT00120185|Interleukin-2|interleukin-2|mesh-list
2246486|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246487|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2246488|NCT00120185|Analgesics|analgesics|mesh-ancestor
2246489|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
2246490|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246491|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246492|NCT00120198|Rituximab|rituximab|mesh-list
2246493|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
802855|NCT02566967|Tofacitinib|tofacitinib|mesh-list
802856|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
802857|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802858|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803791|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
803792|NCT02563288|Esmolol|esmolol|mesh-list
803793|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
803794|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
803795|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
803796|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
803797|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
803798|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
803799|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803800|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
803801|NCT02563288|Analgesics|analgesics|mesh-ancestor
803802|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
803803|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803804|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
803805|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
803806|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803807|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
803808|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2246494|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246495|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
2246496|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800343|NCT02576288|Incretins|incretins|mesh-ancestor
800344|NCT02576288|Hormones|hormones|mesh-ancestor
800345|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
800346|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
800347|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
800348|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800349|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800499|NCT02576015|Lidocaine|lidocaine|mesh-list
800500|NCT02576015|Ropivacaine|ropivacaine|mesh-list
800501|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
800502|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
800503|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
800504|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800505|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
800506|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800507|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
800508|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
800509|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
800510|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
800511|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800605|NCT02575729|Betamethasone|betamethasone|mesh-list
800606|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
800607|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
800608|NCT02575729|Hormones|hormones|mesh-ancestor
800609|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
800610|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800611|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
800612|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
801131|NCT02573896|Lenalidomide|lenalidomide|mesh-list
801132|NCT02573896|Dinutuximab|dinutuximab|mesh-list
801133|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
801134|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801135|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
801136|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
801137|NCT02573896|Growth Substances|growth substances|mesh-ancestor
801138|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
801139|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
801563|NCT02572492|Dexamethasone|dexamethasone|mesh-list
801564|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
801565|NCT02572492|Melphalan|melphalan|mesh-list
801566|NCT02572492|BB 1101|bb 1101|mesh-list
801567|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
801568|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
801569|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
801570|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801571|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801572|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
801573|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
801574|NCT02572492|Hormones|hormones|mesh-ancestor
801575|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
801576|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
801577|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
801578|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
801579|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801580|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801581|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
801582|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
801583|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
801584|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
801585|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
802449|NCT02568488|Metformin|metformin|mesh-list
802450|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
802451|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802736|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
802737|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
802738|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
802739|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
802740|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802741|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
802742|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246497|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2246498|NCT00120237|Misoprostol|misoprostol|mesh-list
2246499|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2246500|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
2246501|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
800354|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801081|NCT02574338|Alprostadil|alprostadil|mesh-list
801082|NCT02574338|Misoprostol|misoprostol|mesh-list
801083|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
801084|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
801085|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
801086|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801087|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
801088|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
801089|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
801090|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
801091|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
801092|NCT02574338|Urological Agents|urological agents|mesh-ancestor
801361|NCT02573064|Vancomycin|vancomycin|mesh-list
801362|NCT02573064|Colistin|colistin|mesh-list
801363|NCT02573064|Tigecycline|tigecycline|mesh-list
801364|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
801365|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801366|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
801367|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801368|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246502|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246503|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2246504|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2246505|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
2246506|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
2246507|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2246508|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2246509|NCT00120302|Analgesics|analgesics|mesh-ancestor
2246510|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
2246511|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246512|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246513|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
802293|NCT02569346|Triumeq|triumeq|mesh-list
802294|NCT02569346|Lamivudine|lamivudine|mesh-list
802295|NCT02569346|Abacavir|abacavir|mesh-list
802296|NCT02569346|Dolutegravir|dolutegravir|mesh-list
802297|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
802298|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
802299|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
802300|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802301|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
802302|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
802303|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802304|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802305|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
802306|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2246514|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2246515|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
2246516|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
802824|NCT02567409|Gemcitabine|gemcitabine|mesh-list
802825|NCT02567409|Cisplatin|cisplatin|mesh-list
802826|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
802827|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
802828|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
802829|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802830|NCT02567409|Antiviral Agents|antiviral agents|mesh-ancestor
802831|NCT02567409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802832|NCT02567409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802833|NCT02567409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
802834|NCT02567409|Immunologic Factors|immunologic factors|mesh-ancestor
802835|NCT02567409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246517|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
2246518|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2246519|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803700|NCT02563704|Artesunate|artesunate|mesh-list
803701|NCT02563704|Quinine|quinine|mesh-list
803702|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
803703|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
803704|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
803705|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
803706|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803707|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
803708|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
803709|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
803710|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
803711|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
803712|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800398|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
800399|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
800400|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800512|NCT02575963|Cytarabine|cytarabine|mesh-list
800513|NCT02575963|Lintuzumab|lintuzumab|mesh-list
800514|NCT02575963|Furosemide|furosemide|mesh-list
800515|NCT02575963|Spironolactone|spironolactone|mesh-list
800516|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
800517|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
800518|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800519|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800520|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
800521|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
800522|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
800523|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
800524|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800525|NCT02575963|Diuretics|diuretics|mesh-ancestor
800526|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
800527|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
800528|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
800529|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
800530|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
800531|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
800532|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
800533|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2246520|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246521|NCT00120315|Esomeprazole|esomeprazole|mesh-list
2246522|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2246523|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2246524|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2246525|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246526|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246527|NCT00120341|Analgesics|analgesics|mesh-list
2246528|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
2246529|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246530|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246531|NCT00120354|Lamivudine|lamivudine|mesh-list
2246532|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2246533|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2246534|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246535|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246536|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
802475|NCT02568241|Interferons|interferons|mesh-list
802476|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
802477|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
802478|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
802479|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
802480|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802481|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
802482|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096199|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
2096200|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096201|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
2096202|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2096203|NCT02301936|Ledipasvir|ledipasvir|mesh-list
2096204|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
2096205|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096206|NCT02301975|Fluticasone|fluticasone|mesh-list
2096207|NCT02301975|Xhance|xhance|mesh-list
2096208|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2096209|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2096210|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2096211|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
2096212|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246537|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246538|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2246539|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2246540|NCT00120367|Tenofovir|tenofovir|mesh-list
2246541|NCT00120367|Emtricitabine|emtricitabine|mesh-list
2246542|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
2246543|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
2246544|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246545|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2246546|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2096213|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246547|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246548|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800580|NCT02575885|Nicotine|nicotine|mesh-list
800581|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
800582|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
800583|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800584|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800585|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
800586|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
800587|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
800588|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800589|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800671|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
800672|NCT02575521|Propofol|propofol|mesh-list
800673|NCT02575521|Sevoflurane|sevoflurane|mesh-list
800674|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
800675|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
800676|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800677|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
800678|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
800679|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
800680|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
800681|NCT02575521|Analgesics|analgesics|mesh-ancestor
800682|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
800683|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800684|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
800685|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
800686|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
800687|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
800688|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800689|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800690|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
800691|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
801068|NCT02574221|Fluorides|fluorides|mesh-list
801069|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
801070|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
801071|NCT02574221|Protective Agents|protective agents|mesh-ancestor
801072|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801370|NCT02573038|Aflibercept|aflibercept|mesh-list
801371|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
801372|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
801373|NCT02573038|Growth Substances|growth substances|mesh-ancestor
801374|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801375|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
801376|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096214|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2096215|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
2096216|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
801533|NCT02572505|Tenofovir|tenofovir|mesh-list
801534|NCT02572505|Emtricitabine|emtricitabine|mesh-list
801535|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
801536|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
801537|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801538|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
801539|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
801540|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801541|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801542|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
801543|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
801609|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
801610|NCT02572375|Codeine|codeine|mesh-list
801611|NCT02572375|Guaifenesin|guaifenesin|mesh-list
801612|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
801613|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
801614|NCT02572375|Narcotics|narcotics|mesh-ancestor
801615|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801616|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801617|NCT02572375|Analgesics|analgesics|mesh-ancestor
801618|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
801619|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801620|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
801621|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
801622|NCT02572375|Expectorants|expectorants|mesh-ancestor
801623|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
801624|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
800435|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
800436|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
800437|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
800438|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
800439|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
800440|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
800441|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800442|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800443|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
800444|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
800445|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
800446|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
800447|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
800448|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
800449|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
800450|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
800451|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
800452|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
800453|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
800454|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
800455|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800456|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
800779|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
800780|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
800781|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
800900|NCT02574468|Dexamethasone|dexamethasone|mesh-list
800901|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
800902|NCT02574468|BB 1101|bb 1101|mesh-list
800903|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
800904|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
800905|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
800906|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
800907|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800908|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
800909|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
800910|NCT02574468|Hormones|hormones|mesh-ancestor
800911|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
800912|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
800913|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800914|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
800915|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800916|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801115|NCT02573909|Oxycodone|oxycodone|mesh-list
801116|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
801117|NCT02573909|Narcotics|narcotics|mesh-ancestor
801118|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801119|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801120|NCT02573909|Analgesics|analgesics|mesh-ancestor
801121|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
801122|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801482|NCT02572947|Dolutegravir|dolutegravir|mesh-list
801483|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
801484|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
801485|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801486|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801487|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
801488|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
801489|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
801490|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801954|NCT02570789|Sunitinib|sunitinib|mesh-list
801955|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
801956|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
801957|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
801958|NCT02570789|Growth Substances|growth substances|mesh-ancestor
801959|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801960|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
801961|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
801962|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801963|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802008|NCT02570503|Ketorolac|ketorolac|mesh-list
802009|NCT02570503|Clonidine|clonidine|mesh-list
802010|NCT02570503|Epinephrine|epinephrine|mesh-list
802011|NCT02570503|Ropivacaine|ropivacaine|mesh-list
802012|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
800492|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
800493|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
2246549|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2246550|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2246551|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2246552|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2246553|NCT00120380|Iloprost|iloprost|mesh-list
2246554|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2246555|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
800740|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2246556|NCT00120393|Ritonavir|ritonavir|mesh-list
2246557|NCT00120393|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2246558|NCT00120393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2246559|NCT00120393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2246560|NCT00120393|Protease Inhibitors|protease inhibitors|mesh-ancestor
2246561|NCT00120393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246562|NCT00120393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246563|NCT00120393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2246564|NCT00120393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2246565|NCT00120393|Antiviral Agents|antiviral agents|mesh-ancestor
2246566|NCT00120393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246567|NCT00120393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2246568|NCT00120393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2246569|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
2246570|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2246571|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246572|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2246573|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
2246574|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2246575|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246576|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246577|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246578|NCT00120432|Phenylephrine|phenylephrine|mesh-list
2246579|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
2246580|NCT00120432|Tropicamide|tropicamide|mesh-list
801604|NCT02572336|Plasminogen|plasminogen|mesh-list
801605|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
801606|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
801607|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
801608|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802446|NCT02568566|Vaccines|vaccines|mesh-list
802447|NCT02568566|Immunologic Factors|immunologic factors|mesh-ancestor
802448|NCT02568566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802859|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
802860|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
802861|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802862|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
802863|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802864|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803632|NCT02564315|Nicotine|nicotine|mesh-list
803633|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
803634|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
803635|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803636|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803637|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
803638|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
803639|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
803640|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
803641|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096217|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2096218|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2096219|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
804312|NCT02560766|Gabapentin|gabapentin|mesh-list
804313|NCT02560766|Analgesics|analgesics|mesh-ancestor
804314|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
804315|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
804316|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804317|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
804318|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
804319|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
804320|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
804321|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
804322|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
804323|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2246581|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2246582|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
800665|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
800666|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800667|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
800668|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
800669|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800670|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800971|NCT02574663|Leucovorin|leucovorin|mesh-list
800972|NCT02574663|Folic Acid|folic acid|mesh-list
800973|NCT02574663|Gemcitabine|gemcitabine|mesh-list
800974|NCT02574663|Paclitaxel|paclitaxel|mesh-list
800975|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
800976|NCT02574663|Bevacizumab|bevacizumab|mesh-list
800977|NCT02574663|Fluorouracil|fluorouracil|mesh-list
800978|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
800979|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
800980|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
800981|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
800982|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
800983|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
800984|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
800985|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800986|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
800987|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
800988|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
800989|NCT02574663|Growth Substances|growth substances|mesh-ancestor
800990|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800991|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
800992|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
800993|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
800994|NCT02574663|Antiviral Agents|antiviral agents|mesh-ancestor
800995|NCT02574663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
800996|NCT02574663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
800997|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
800998|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
800999|NCT02574663|Antidotes|antidotes|mesh-ancestor
801000|NCT02574663|Protective Agents|protective agents|mesh-ancestor
801001|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
801002|NCT02574663|Vitamins|vitamins|mesh-ancestor
801003|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
801004|NCT02574663|Hematinics|hematinics|mesh-ancestor
801256|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
801257|NCT02573558|Propofol|propofol|mesh-list
801258|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
801259|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801260|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801261|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
801262|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
801263|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
801264|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
801265|NCT02573558|Analgesics|analgesics|mesh-ancestor
801266|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
801267|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801268|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
801269|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
801270|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
801271|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
801272|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
801273|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801662|NCT02571842|Prednisolone|prednisolone|mesh-list
801663|NCT02571842|Rituximab|rituximab|mesh-list
801664|NCT02571842|Enalapril|enalapril|mesh-list
801665|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
801666|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
801667|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
801668|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801669|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
801670|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
801671|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
801672|NCT02571842|Hormones|hormones|mesh-ancestor
801673|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
801674|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
801675|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
801676|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
801677|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801678|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801679|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
801894|NCT02571491|Morphine|morphine|mesh-list
800718|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801761|NCT02571556|Dexamethasone|dexamethasone|mesh-list
801762|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
801763|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
801764|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
801765|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
801766|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
801767|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801768|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801769|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
801770|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
801771|NCT02571556|Hormones|hormones|mesh-ancestor
801772|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
801773|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
801774|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
801775|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2246583|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
2246584|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246585|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246586|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
2246587|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2246588|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
2246589|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
2246590|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2246591|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2246592|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2246593|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
2246594|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2246595|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246596|NCT00120432|Protective Agents|protective agents|mesh-ancestor
803050|NCT02570581|Acetaminophen|acetaminophen|mesh-list
803051|NCT02570581|Ramipril|ramipril|mesh-list
803052|NCT02570581|Furosemide|furosemide|mesh-list
803053|NCT02570581|Memantine|memantine|mesh-list
803054|NCT02570581|Alprazolam|alprazolam|mesh-list
803055|NCT02570581|Zopiclone|zopiclone|mesh-list
803056|NCT02570581|Oxazepam|oxazepam|mesh-list
803057|NCT02570581|Donepezil|donepezil|mesh-list
803058|NCT02570581|Clopidogrel|clopidogrel|mesh-list
803059|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
803060|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
803061|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
803062|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
803063|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
803064|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
803065|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803066|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803067|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
803068|NCT02570581|Analgesics|analgesics|mesh-ancestor
803069|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
803070|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803071|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
803072|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
803073|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803074|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
803075|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
803076|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
803077|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
803078|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
803079|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
803080|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
803081|NCT02570581|Diuretics|diuretics|mesh-ancestor
803082|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
803083|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
803084|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
803085|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
803086|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
803087|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
803088|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
803089|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
803090|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
803091|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
803092|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
803093|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
803094|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
803156|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
800745|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
800746|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
800747|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801099|NCT02574130|Amikacin|amikacin|mesh-list
801100|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
801101|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801274|NCT02573597|Sufentanil|sufentanil|mesh-list
801275|NCT02573597|Bupivacaine|bupivacaine|mesh-list
801276|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
801277|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
801278|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801279|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801280|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
801281|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801282|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
801283|NCT02573597|Narcotics|narcotics|mesh-ancestor
801284|NCT02573597|Analgesics|analgesics|mesh-ancestor
801285|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
801286|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
801287|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
801710|NCT02571725|Olaparib|olaparib|mesh-list
801711|NCT02571725|Tremelimumab|tremelimumab|mesh-list
801712|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
801713|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801714|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801715|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246597|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2246598|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2246599|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
802746|NCT02567383|Docetaxel|docetaxel|mesh-list
802747|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
802748|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
802749|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
802750|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
802751|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802846|NCT02567149|Cidofovir|cidofovir|mesh-list
802847|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
802848|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802849|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802850|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803238|NCT02565862|Metformin|metformin|mesh-list
803239|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
803240|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096220|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2096221|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
2096222|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096223|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096224|NCT02301988|Paclitaxel|paclitaxel|mesh-list
2096225|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
803536|NCT02564237|Vaccines|vaccines|mesh-list
803537|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
803538|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803605|NCT02563951|Granisetron|granisetron|mesh-list
803606|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
803607|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
803608|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803609|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803610|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
803611|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
803612|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
803613|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
803614|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804470|NCT02559973|Buprenorphine|buprenorphine|mesh-list
804471|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
804472|NCT02559973|Naloxone|naloxone|mesh-list
804473|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
804474|NCT02559973|Narcotics|narcotics|mesh-ancestor
804475|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
804476|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804477|NCT02559973|Analgesics|analgesics|mesh-ancestor
804478|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
804479|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
804480|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2096226|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
801005|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
801006|NCT02574611|Neostigmine|neostigmine|mesh-list
801007|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
801008|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801009|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801010|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
801011|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
801012|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801013|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
801014|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
801015|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801016|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
801017|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
801018|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
801208|NCT02573610|Levofloxacin|levofloxacin|mesh-list
801209|NCT02573610|Ofloxacin|ofloxacin|mesh-list
801210|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
801211|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801212|NCT02573610|Renal Agents|renal agents|mesh-ancestor
801213|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
801214|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
801215|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
801216|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801217|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801218|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
801219|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
801220|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
801803|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
801804|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
801805|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
801806|NCT02571517|Prednisolone|prednisolone|mesh-list
801807|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
801808|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
801809|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
801810|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
801811|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
801812|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
801813|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
801814|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801815|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801816|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
801817|NCT02571517|Hormones|hormones|mesh-ancestor
801818|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
801819|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
801820|NCT02571517|Protective Agents|protective agents|mesh-ancestor
801821|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
801822|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096227|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
2096228|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
2096229|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
2246600|NCT00120471|Tenofovir|tenofovir|mesh-list
2246601|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
800832|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
800833|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
800834|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
801105|NCT02573922|Oxycodone|oxycodone|mesh-list
801106|NCT02573922|Naloxone|naloxone|mesh-list
801107|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
801108|NCT02573922|Narcotics|narcotics|mesh-ancestor
801109|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801110|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801111|NCT02573922|Analgesics|analgesics|mesh-ancestor
801112|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
801113|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801114|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
801196|NCT02573701|Risperidone|risperidone|mesh-list
801197|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
801198|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
801199|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
801200|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
801201|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801202|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801203|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
801204|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801205|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
801206|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
801207|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
801332|NCT02573363|Cytarabine|cytarabine|mesh-list
801333|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
801334|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
801335|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
801336|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801337|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
801338|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
801339|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801340|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
801341|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
801342|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801343|NCT02573363|Analgesics|analgesics|mesh-ancestor
801344|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
801345|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801346|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
801347|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
801348|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801439|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
801440|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
801441|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
801442|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
801443|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
801444|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801445|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
801446|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801447|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246602|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246603|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2246604|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2246605|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801998|NCT02570477|Vancomycin|vancomycin|mesh-list
801999|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
802000|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802061|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
802062|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
802063|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802398|NCT02569320|Dexamethasone|dexamethasone|mesh-list
802399|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
802400|NCT02569320|Pomalidomide|pomalidomide|mesh-list
802401|NCT02569320|Ichthammol|ichthammol|mesh-list
802402|NCT02569320|BB 1101|bb 1101|mesh-list
802403|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
802404|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
802405|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
802406|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
802407|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802408|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802409|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
802410|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
802411|NCT02569320|Hormones|hormones|mesh-ancestor
802412|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2096230|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096231|NCT02302092|Cefepime|cefepime|mesh-list
2096232|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2096233|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801553|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
801554|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
801555|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
801556|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801557|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
801558|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
801559|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
801560|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801561|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
801562|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
801879|NCT02571179|Fentanyl|fentanyl|mesh-list
801880|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
801881|NCT02571179|Narcotics|narcotics|mesh-ancestor
801882|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801883|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801884|NCT02571179|Analgesics|analgesics|mesh-ancestor
801885|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
801886|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801887|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
801888|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
801889|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
801890|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
802152|NCT02569814|Amlodipine|amlodipine|mesh-list
802153|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
802154|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
802155|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
802156|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
802157|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802158|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
802159|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802160|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
802161|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
802162|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
802163|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
802164|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
802165|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
802166|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802243|NCT02569554|Rabeprazole|rabeprazole|mesh-list
802244|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
802245|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
802246|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
802247|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802248|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802557|NCT02567955|Vaccines|vaccines|mesh-list
802558|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
802559|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754304|NCT01380028|Prednisone|prednisone|mesh-list
2754305|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2754306|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
2754307|NCT01380028|Hormones|hormones|mesh-ancestor
2754308|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2754309|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754310|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2754311|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754312|NCT01305460|Azacitidine|azacitidine|mesh-list
2754313|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2754314|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
2754315|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754316|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754317|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802785|NCT02567461|Aspirin|aspirin|mesh-list
802786|NCT02567461|Edoxaban|edoxaban|mesh-list
802787|NCT02567461|Clopidogrel|clopidogrel|mesh-list
802788|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
802789|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
802790|NCT02567461|Analgesics|analgesics|mesh-ancestor
802791|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
801103|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
801104|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096234|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
2096235|NCT02302339|Nivolumab|nivolumab|mesh-list
2096236|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
2096237|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2096238|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2096239|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246606|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246607|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2246608|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2246609|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
2246610|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
2246611|NCT00120484|Vitamins|vitamins|mesh-ancestor
2246612|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
2246613|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802095|NCT02569866|Cephalexin|cephalexin|mesh-list
802096|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
802097|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246614|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
2246615|NCT00120484|Hematinics|hematinics|mesh-ancestor
2246616|NCT00120497|Hormones|hormones|mesh-list
2246617|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2246618|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246619|NCT00120510|Lamivudine|lamivudine|mesh-list
2246620|NCT00120510|Zidovudine|zidovudine|mesh-list
2246621|NCT00120510|Efavirenz|efavirenz|mesh-list
2246622|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2246623|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2246624|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
803575|NCT02564068|Oxytocin|oxytocin|mesh-list
803576|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
803577|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
803578|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803666|NCT02563795|Fentanyl|fentanyl|mesh-list
803667|NCT02563795|Bupivacaine|bupivacaine|mesh-list
803668|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
803669|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
803670|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
803671|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803672|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
803673|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803674|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
803675|NCT02563795|Narcotics|narcotics|mesh-ancestor
803676|NCT02563795|Analgesics|analgesics|mesh-ancestor
803677|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
803678|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
803679|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
804449|NCT02560207|Cefotaxime|cefotaxime|mesh-list
804450|NCT02560207|Cefoxitin|cefoxitin|mesh-list
804451|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
804452|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096240|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2096241|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096242|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
2096243|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096244|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2096245|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096246|NCT02302807|Paclitaxel|paclitaxel|mesh-list
2096247|NCT02302807|Docetaxel|docetaxel|mesh-list
2096248|NCT02302807|Atezolizumab|atezolizumab|mesh-list
2246625|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246626|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246627|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
2246628|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
805097|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
805098|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
805099|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
805100|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
805101|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
805102|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805103|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
805104|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805105|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805106|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
805107|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805994|NCT02554253|Ketamine|ketamine|mesh-list
2246629|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
801255|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
801491|NCT02572986|Permethrin|permethrin|mesh-list
801492|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801493|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801872|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
801873|NCT02571400|Analgesics|analgesics|mesh-list
801874|NCT02571400|Narcotics|narcotics|mesh-ancestor
801875|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801876|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801877|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
801878|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246630|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2246631|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
2246632|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2246633|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2246634|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2246635|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2246636|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2246637|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2246638|NCT00120536|Vildagliptin|vildagliptin|mesh-list
2246639|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2246640|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246641|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2246642|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
2246643|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246644|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246645|NCT00120601|Naltrexone|naltrexone|mesh-list
2246646|NCT00120601|Acamprosate|acamprosate|mesh-list
2246647|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2246648|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2246649|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246650|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
2246651|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246652|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2246653|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2246654|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2246655|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
2246656|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2246657|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246658|NCT00120640|Progestins|progestins|mesh-ancestor
2246659|NCT00120640|Hormones|hormones|mesh-ancestor
2246660|NCT00120653|Metoclopramide|metoclopramide|mesh-list
2246661|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
802345|NCT02568995|Ketorolac|ketorolac|mesh-list
802346|NCT02568995|Epinephrine|epinephrine|mesh-list
802347|NCT02568995|Racepinephrine|racepinephrine|mesh-list
802348|NCT02568995|Ropivacaine|ropivacaine|mesh-list
802349|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
802350|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
802351|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
802352|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
802353|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802354|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
802355|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802356|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
802357|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
802358|NCT02568995|Analgesics|analgesics|mesh-ancestor
802359|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
802360|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
802361|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
802362|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802363|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802364|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
802365|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
802366|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
802367|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802368|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
802369|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
802370|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
802371|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
802372|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
802373|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
802374|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
802375|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2246662|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
2754318|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
2246663|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246664|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246665|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2246666|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2246667|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2246668|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
2246669|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2246670|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246671|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
2246672|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
2246673|NCT00120679|Hematinics|hematinics|mesh-ancestor
2246674|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
2246675|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
2246676|NCT00120692|Hematinics|hematinics|mesh-ancestor
2246677|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
2246678|NCT00120705|Hematinics|hematinics|mesh-ancestor
2246679|NCT00120718|Fasudil|fasudil|mesh-list
2246680|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2246681|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2246682|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246683|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2246684|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246685|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
2246686|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2246687|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246688|NCT00120731|Acetazolamide|acetazolamide|mesh-list
2246689|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
2246690|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246691|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
802226|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
802227|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
802228|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
802229|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
802230|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802231|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
802232|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
802233|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802752|NCT02567331|Capecitabine|capecitabine|mesh-list
802753|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
802754|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
802755|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802756|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
802851|NCT02567032|Oxytocin|oxytocin|mesh-list
802852|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
802853|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
802854|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246692|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2246693|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246694|NCT00120731|Diuretics|diuretics|mesh-ancestor
2246695|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
2246696|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246697|NCT00120731|Expectorants|expectorants|mesh-ancestor
2246698|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
2246699|NCT00120744|Ondansetron|ondansetron|mesh-list
2246700|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
2246701|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
2246702|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246703|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246704|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2246705|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
2246706|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
2246707|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2246708|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
2246709|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2246710|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246711|NCT00120744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2246712|NCT00120744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2246713|NCT00120744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2246714|NCT00120744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2246715|NCT00120744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2246716|NCT00120757|Alendronate|alendronate|mesh-list
2246717|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2246718|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803721|NCT02563847|Erythritol|erythritol|mesh-list
803722|NCT02563847|Tryptophan|tryptophan|mesh-list
2246719|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
801501|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801502|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
801503|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
801504|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
801505|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
801506|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801507|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801867|NCT02571296|Progesterone|progesterone|mesh-list
801868|NCT02571296|Progestins|progestins|mesh-ancestor
801869|NCT02571296|Hormones|hormones|mesh-ancestor
801870|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
801871|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801931|NCT02570893|Paclitaxel|paclitaxel|mesh-list
801932|NCT02570893|Carboplatin|carboplatin|mesh-list
801933|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
801934|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
801935|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
801936|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
801937|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
801938|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096249|NCT02302807|Antibodies|antibodies|mesh-list
2096250|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2096251|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096252|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
2096253|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
2096254|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
802905|NCT02567253|Cisplatin|cisplatin|mesh-list
802906|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803216|NCT02565888|Ritonavir|ritonavir|mesh-list
803217|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
803218|NCT02565888|Cobicistat|cobicistat|mesh-list
803219|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
803220|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
803221|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
803222|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803223|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803224|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
803225|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
803226|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
803227|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
803228|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
803229|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
803337|NCT02565602|Vitamin D|vitamin d|mesh-list
803338|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
803339|NCT02565602|Vitamins|vitamins|mesh-ancestor
803340|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
803341|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803342|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
803343|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
803958|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
803959|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
803960|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246720|NCT00120783|Ritonavir|ritonavir|mesh-list
2246721|NCT00120783|Indinavir|indinavir|mesh-list
2246722|NCT00120783|Lamivudine|lamivudine|mesh-list
2246723|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2246724|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2246725|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
804594|NCT02559778|Eflornithine|eflornithine|mesh-list
804595|NCT02559778|Sorafenib|sorafenib|mesh-list
804596|NCT02559778|Dasatinib|dasatinib|mesh-list
804597|NCT02559778|Vorinostat|vorinostat|mesh-list
804598|NCT02559778|Ceritinib|ceritinib|mesh-list
804599|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804600|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
804601|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804602|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804603|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
804604|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
804605|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
804606|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
804607|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804608|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2246726|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246727|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246728|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
805677|NCT02555748|Sunitinib|sunitinib|mesh-list
2246729|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
801626|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
801627|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801628|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
801629|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
801630|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
801631|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
801632|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
801633|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2246730|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
2246731|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246732|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2246733|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2246734|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2246735|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2246736|NCT00120796|Lamivudine|lamivudine|mesh-list
2246737|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2246738|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2246739|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246740|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246741|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
802206|NCT02569463|Aldesleukin|aldesleukin|mesh-list
802207|NCT02569463|Interleukin-2|interleukin-2|mesh-list
802208|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
802209|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
802210|NCT02569463|Analgesics|analgesics|mesh-ancestor
802211|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
802212|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802213|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802214|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
802215|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
802216|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
802217|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802332|NCT02569307|Minocycline|minocycline|mesh-list
802333|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
802334|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802424|NCT02568735|Etoricoxib|etoricoxib|mesh-list
802425|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
802426|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
802427|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
802428|NCT02568735|Analgesics|analgesics|mesh-ancestor
802429|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
802430|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802431|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802432|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
802433|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
802434|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
802435|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
802436|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802437|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802576|NCT02568423|Mirikizumab|mirikizumab|mesh-list
802577|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
802578|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
802579|NCT02568423|Analgesics|analgesics|mesh-ancestor
802580|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
802581|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802582|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802583|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
802584|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
802585|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
802586|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2246742|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246743|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2246744|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
803383|NCT02565316|Sertraline|sertraline|mesh-list
803384|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
803385|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
803386|NCT02565316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
803387|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
803388|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
803389|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803390|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
803391|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
803392|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096255|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801706|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
801707|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
801708|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
801709|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2246745|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
2246746|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
2246747|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2246748|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
2246749|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2246750|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2246751|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802084|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
802085|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
802086|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802130|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
802131|NCT02569905|Parecoxib|parecoxib|mesh-list
802132|NCT02569905|Analgesics|analgesics|mesh-ancestor
802133|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
802134|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802135|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802136|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
802137|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
802138|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
802139|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
802140|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
802141|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802142|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802143|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
802318|NCT02569073|Dronabinol|dronabinol|mesh-list
802319|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
802320|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802321|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
802322|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
802323|NCT02569073|Analgesics|analgesics|mesh-ancestor
802324|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
802325|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802326|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
802327|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
802328|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802329|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802330|NCT02569073|Hormones|hormones|mesh-ancestor
802331|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
802442|NCT02568618|Analgesics|analgesics|mesh-list
802443|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
802444|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802445|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802594|NCT02568111|Interferons|interferons|mesh-list
802595|NCT02568111|Interferon-beta|interferon-beta|mesh-list
802596|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
802597|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
802598|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
802599|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
802600|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802601|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
802604|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802605|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
802606|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
802607|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
802608|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
802609|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
802610|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802611|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802612|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2246752|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2246753|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246754|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246755|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2246756|NCT00120809|Renal Agents|renal agents|mesh-ancestor
2246757|NCT00120822|Folic Acid|folic acid|mesh-list
2246758|NCT00120822|Hematinics|hematinics|mesh-ancestor
2246759|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
2246760|NCT00120822|Vitamins|vitamins|mesh-ancestor
2246761|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
2246762|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246763|NCT00120835|Interferons|interferons|mesh-list
801844|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246764|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246765|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
2246766|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246767|NCT00120861|Interferons|interferons|mesh-list
2246768|NCT00120861|Ribavirin|ribavirin|mesh-list
2246769|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246770|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
2246771|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246772|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
802340|NCT02568943|Panobinostat|panobinostat|mesh-list
802341|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
802342|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
802343|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802344|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246773|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246774|NCT00120887|Atorvastatin|atorvastatin|mesh-list
2246775|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2246776|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2246777|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
2246778|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246779|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2246780|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2246781|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246782|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
2246783|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2096256|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
2096257|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803167|NCT02566096|Morphine|morphine|mesh-list
803168|NCT02566096|Bupivacaine|bupivacaine|mesh-list
803169|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
803170|NCT02566096|Anesthetics|anesthetics|mesh-list
803171|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
803172|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803173|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
803174|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803175|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
803176|NCT02566096|Narcotics|narcotics|mesh-ancestor
803177|NCT02566096|Analgesics|analgesics|mesh-ancestor
2096258|NCT02302846|Ixazomib|ixazomib|mesh-list
2246784|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2246785|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
2246786|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2246787|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246788|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
804235|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
804236|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
804256|NCT02561169|Oseltamivir|oseltamivir|mesh-list
804257|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
804258|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
804259|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804260|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804261|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804262|NCT02561169|Antacids|antacids|mesh-ancestor
804263|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
804306|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
804307|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
804308|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
804309|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804310|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
804311|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
2246789|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246790|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2246791|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
2246792|NCT00120952|Cobalt|cobalt|mesh-list
2246793|NCT00120952|Chromium|chromium|mesh-list
2246794|NCT00120952|Trace Elements|trace elements|mesh-ancestor
2246795|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
2246796|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804890|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
804891|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
804892|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
804893|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
804894|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804895|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
804899|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
2246797|NCT00120978|Fluticasone|fluticasone|mesh-list
2246798|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
801860|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
801861|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
801862|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
801863|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
801864|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
801865|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
801866|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2096259|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096260|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
2096261|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096262|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802098|NCT02569879|Vaccines|vaccines|mesh-list
802099|NCT02569879|Immunologic Factors|immunologic factors|mesh-ancestor
802100|NCT02569879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802603|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
802616|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
802618|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096263|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
2096264|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2096265|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2096266|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
2096267|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096268|NCT02303184|Aflibercept|aflibercept|mesh-list
2096269|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2096270|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2096271|NCT02303184|Growth Substances|growth substances|mesh-ancestor
2096272|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096273|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
2096274|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096275|NCT02303262|Gemcitabine|gemcitabine|mesh-list
2096276|NCT02303262|Mocetinostat|mocetinostat|mesh-list
2096277|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2096278|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
2096279|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096280|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096281|NCT02303262|Antiviral Agents|antiviral agents|mesh-ancestor
2096282|NCT02303262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096283|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096284|NCT02303262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2096285|NCT02303262|Immunologic Factors|immunologic factors|mesh-ancestor
2096286|NCT02303262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096287|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2096288|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2096289|NCT02303977|Gemcitabine|gemcitabine|mesh-list
2096290|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2096291|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2246799|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
803939|NCT02562417|Dexamethasone|dexamethasone|mesh-list
803940|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
803941|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
803942|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
803943|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803944|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803945|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
803946|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
803947|NCT02562417|Hormones|hormones|mesh-ancestor
803948|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
803949|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
803950|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246800|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246801|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246802|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2246803|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
2246804|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2246805|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
2246806|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2246807|NCT00121017|Ritonavir|ritonavir|mesh-list
2246808|NCT00121017|Lopinavir|lopinavir|mesh-list
2246809|NCT00121017|Tenofovir|tenofovir|mesh-list
2246810|NCT00121017|Emtricitabine|emtricitabine|mesh-list
2246811|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2246812|NCT00121017|Efavirenz|efavirenz|mesh-list
2246813|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
804278|NCT02561013|Monensin|monensin|mesh-list
804279|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
804280|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804281|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
801895|NCT02571491|Remifentanil|remifentanil|mesh-list
801896|NCT02571491|Ketamine|ketamine|mesh-list
801897|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
801898|NCT02571491|Narcotics|narcotics|mesh-ancestor
801899|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
801900|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
801901|NCT02571491|Analgesics|analgesics|mesh-ancestor
801902|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
801903|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
801904|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
801905|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
801906|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
801907|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
801908|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
801909|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
801910|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
801911|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802234|NCT02569489|Paclitaxel|paclitaxel|mesh-list
802235|NCT02569489|Trastuzumab|trastuzumab|mesh-list
802236|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
802237|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
802238|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
802239|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
802240|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
802241|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802242|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
802495|NCT02568280|Insulin|insulin|mesh-list
802496|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
802497|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
802498|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
802499|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
802500|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
802501|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802868|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
802869|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
802870|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
802871|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
802872|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802873|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802874|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
802875|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
802876|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
802877|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
802878|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
802879|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802880|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802881|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
802882|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
803539|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
803540|NCT02564094|Hematinics|hematinics|mesh-ancestor
804086|NCT02562287|Olanzapine|olanzapine|mesh-list
804087|NCT02562287|Risperidone|risperidone|mesh-list
804088|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
804089|NCT02562287|Clozapine|clozapine|mesh-list
804090|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
804091|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
804092|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
804093|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804094|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804095|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
804096|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
804097|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
804098|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
804099|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
804100|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
804101|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
804102|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
804103|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
804104|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
804105|NCT02562287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
804106|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
804107|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
804108|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
804109|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
804110|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
804441|NCT02560220|Mitomycins|mitomycins|mesh-list
804442|NCT02560220|Mitomycin|mitomycin|mesh-list
802202|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
802203|NCT02569515|Hematinics|hematinics|mesh-ancestor
2246814|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2246815|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
2246816|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246817|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246818|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2246819|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2246820|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
2246821|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246822|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2246823|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2246824|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2246825|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2246826|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
802997|NCT02566733|Remifentanil|remifentanil|mesh-list
802998|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
802999|NCT02566733|Narcotics|narcotics|mesh-ancestor
803000|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
803001|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803002|NCT02566733|Analgesics|analgesics|mesh-ancestor
803003|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
803004|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246827|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2246828|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2246829|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2246830|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2246831|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
2246832|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
2246833|NCT00121030|Hematinics|hematinics|mesh-ancestor
2246834|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2246835|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2246836|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2246837|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2246838|NCT00121069|Citalopram|citalopram|mesh-list
2246839|NCT00121069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2246840|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2246841|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2246842|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246843|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2246844|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
2246845|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246846|NCT00121069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2246847|NCT00121069|Antidepressive Agents|antidepressive agents|mesh-ancestor
2246848|NCT00121069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2246849|NCT00121095|Docetaxel|docetaxel|mesh-list
2246850|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
2246851|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246852|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
804019|NCT02562664|Metformin|metformin|mesh-list
802006|NCT02570490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802007|NCT02570490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246853|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
2246854|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
2246855|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246856|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2246857|NCT00121095|Analgesics|analgesics|mesh-ancestor
2246858|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
2246859|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246860|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246861|NCT00121147|Travoprost|travoprost|mesh-list
2246862|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2246863|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2246864|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2246865|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2246866|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2246867|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
2096292|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
2096293|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096294|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096295|NCT02303977|Antiviral Agents|antiviral agents|mesh-ancestor
2096296|NCT02303977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246868|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2246869|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246870|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246871|NCT00121264|Sorafenib|sorafenib|mesh-list
2246872|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246873|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2246874|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246875|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246876|NCT00121277|Capecitabine|capecitabine|mesh-list
2246877|NCT00121277|Vorinostat|vorinostat|mesh-list
2246878|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2246879|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
2246880|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246881|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246882|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2246883|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246884|NCT00121303|Cytarabine|cytarabine|mesh-list
2246885|NCT00121303|Daunorubicin|daunorubicin|mesh-list
2246886|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
2246887|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2246888|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
2246889|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246890|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246891|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
2246892|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246893|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2246894|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
2246895|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246896|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2246897|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2246898|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2246899|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246900|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2246901|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
2246902|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2246903|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2246904|NCT00121316|Analgesics|analgesics|mesh-ancestor
2246905|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
2246906|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246907|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246908|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2246909|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2246910|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
804083|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
804084|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
804085|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804140|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
804141|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
804142|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
804143|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
804144|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804282|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
802013|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
802014|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
802015|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802016|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
802017|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802018|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
802019|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
802020|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
802021|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802022|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802023|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
802024|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
802025|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
802026|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
802027|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
802028|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
802029|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
802030|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
802031|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
802032|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
802033|NCT02570503|Analgesics|analgesics|mesh-ancestor
802034|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
802035|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
802036|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
802037|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802038|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
802039|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
802040|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2246911|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2246912|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
2246913|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2246914|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246915|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246916|NCT00121329|Lidocaine|lidocaine|mesh-list
803303|NCT02565693|Aspirin|aspirin|mesh-list
803304|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
803305|NCT02565693|Dipyridamole|dipyridamole|mesh-list
803306|NCT02565693|Apixaban|apixaban|mesh-list
803307|NCT02565693|Clopidogrel|clopidogrel|mesh-list
803308|NCT02565693|Calcium|calcium|mesh-list
803309|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
803310|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803311|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
803312|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
803313|NCT02565693|Analgesics|analgesics|mesh-ancestor
803314|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
803315|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803316|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
803317|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
803318|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
803319|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
803320|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803321|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
803322|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
803323|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803324|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
803325|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
803326|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
803327|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
803328|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
803329|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
803330|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
803331|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
803332|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
803333|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
803334|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
803335|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
803336|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
803412|NCT02565173|Timolol|timolol|mesh-list
803413|NCT02565173|Adenosine|adenosine|mesh-list
803414|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
803415|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
803416|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
803417|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
803418|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246917|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
2246918|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
2246919|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2246920|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246921|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
2246922|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246923|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2246924|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2246925|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2246926|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2246927|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246928|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
2246929|NCT00121381|Tacrolimus|tacrolimus|mesh-list
2246930|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2246931|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2096297|NCT02303977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096298|NCT02303977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2096299|NCT02303977|Immunologic Factors|immunologic factors|mesh-ancestor
2096300|NCT02303977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096301|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
2096302|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2096303|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096304|NCT02304159|Ribavirin|ribavirin|mesh-list
2096305|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
2096306|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
2096307|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096308|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
2096309|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096310|NCT02304432|Cycloserine|cycloserine|mesh-list
2096311|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2096312|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096313|NCT02304432|Renal Agents|renal agents|mesh-ancestor
2096314|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2096315|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
2096316|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2096317|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
2096318|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096319|NCT02304484|Evolocumab|evolocumab|mesh-list
2096320|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2096321|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2096322|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
803248|NCT02565641|Gemcitabine|gemcitabine|mesh-list
803249|NCT02565641|Capecitabine|capecitabine|mesh-list
803250|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
803251|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
803252|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803253|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803254|NCT02565641|Antiviral Agents|antiviral agents|mesh-ancestor
803255|NCT02565641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
803256|NCT02565641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803257|NCT02565641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
803258|NCT02565641|Immunologic Factors|immunologic factors|mesh-ancestor
803259|NCT02565641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246932|NCT00121381|Analgesics|analgesics|mesh-ancestor
2246933|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
2246934|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246935|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246936|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2246937|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2246938|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
2246939|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2246940|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
2246941|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2246942|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2246943|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246944|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
2246945|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2246946|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246947|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
2246948|NCT00121407|Verteporfin|verteporfin|mesh-list
2246949|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2246950|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
2246951|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
2246952|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246953|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2246954|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
2246955|NCT00121446|Enoxaparin|enoxaparin|mesh-list
802118|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
802119|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
802120|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802121|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802122|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
802123|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802124|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
802125|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
802126|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
802127|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
802128|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
802129|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802520|NCT02568176|Midazolam|midazolam|mesh-list
802521|NCT02568176|Bupropion|bupropion|mesh-list
802522|NCT02568176|Esketamine|esketamine|mesh-list
802523|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
802524|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
802525|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
802526|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802527|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
802528|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
802529|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
802530|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
802531|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
802532|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
802533|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
802534|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
802535|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802536|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802537|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
802538|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
802539|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
802540|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
802541|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
802542|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
802543|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
802544|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
802545|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802619|NCT02567929|Propofol|propofol|mesh-list
802620|NCT02567929|Sevoflurane|sevoflurane|mesh-list
802621|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
802622|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
802623|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802624|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
802625|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
802626|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
802627|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
802628|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
802836|NCT02567175|Domperidone|domperidone|mesh-list
802837|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
802838|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
802839|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802840|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802841|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
802842|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
802843|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
802844|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802845|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803117|NCT02566304|Vidarabine|vidarabine|mesh-list
803118|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
803119|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
803120|NCT02566304|Fludarabine|fludarabine|mesh-list
803121|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
803122|NCT02566304|Tacrolimus|tacrolimus|mesh-list
803123|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
803124|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
803125|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803126|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
803127|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
803128|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
803129|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803130|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803131|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
803132|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
803133|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
2246956|NCT00121446|Tenecteplase|tenecteplase|mesh-list
802218|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
802219|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
802220|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
802221|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802222|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
802223|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
802224|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
802225|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2246957|NCT00121446|Clopidogrel|clopidogrel|mesh-list
2246958|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2246959|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2246960|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2246961|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2246962|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
2246963|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2246964|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246965|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246966|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
2246967|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2246968|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2246969|NCT00121459|Psyllium|psyllium|mesh-list
2246970|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
2246971|NCT00121459|Cathartics|cathartics|mesh-ancestor
2246972|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2246973|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
2246974|NCT00121498|Lidocaine|lidocaine|mesh-list
802951|NCT02566824|Methylphenidate|methylphenidate|mesh-list
802952|NCT02566824|Amphetamine|amphetamine|mesh-list
802953|NCT02566824|Adderall|adderall|mesh-list
802954|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
802955|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
802956|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802957|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
802958|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
802959|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
802960|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802961|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
802962|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802963|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
802964|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
802965|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802966|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
802967|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2246975|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
2246976|NCT00121498|Anesthetics|anesthetics|mesh-list
2246977|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2246978|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246979|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
2246980|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2246981|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2246982|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2246983|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2246984|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2246985|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246986|NCT00121511|Fluorouracil|fluorouracil|mesh-list
2246987|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
2246988|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2246989|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2246990|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2246991|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2246992|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
2246993|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2246994|NCT00121524|Atropine|atropine|mesh-list
2246995|NCT00121524|Amiodarone|amiodarone|mesh-list
2246996|NCT00121524|Epinephrine|epinephrine|mesh-list
2246997|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2246998|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2246999|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
2247000|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805083|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
805084|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
805085|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
805086|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805087|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2247001|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247002|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247003|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2247004|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2247005|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
2247006|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247007|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2247008|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
2247009|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
2247010|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
2247011|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2247012|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2247013|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2247014|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
802386|NCT02568839|Docetaxel|docetaxel|mesh-list
802387|NCT02568839|Trastuzumab|trastuzumab|mesh-list
802388|NCT02568839|Pertuzumab|pertuzumab|mesh-list
802389|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
802390|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
802391|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
802392|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
802393|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802394|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2096323|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096324|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2096325|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
2096326|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
2096327|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2096328|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2096329|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096330|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096331|NCT02304705|Urological Agents|urological agents|mesh-ancestor
2096332|NCT02304757|Alendronate|alendronate|mesh-list
2096333|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
2096334|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2096335|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096336|NCT02304926|Simvastatin|simvastatin|mesh-list
2096337|NCT02304926|Ezetimibe|ezetimibe|mesh-list
2247015|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
803036|NCT02566356|Oxytocin|oxytocin|mesh-list
803037|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
803038|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
803039|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247016|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2247017|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
2247018|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
2247019|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2247020|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2247021|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
804003|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
804004|NCT02562365|Carboplatin|carboplatin|mesh-list
804005|NCT02562365|Etoposide|etoposide|mesh-list
804006|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
804007|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
804008|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804009|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
804010|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
804011|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
804012|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804013|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804014|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
804015|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
804016|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
804017|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
804018|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804959|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
804960|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
804961|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804962|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
804963|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805327|NCT02556879|Liver Extracts|liver extracts|mesh-list
805328|NCT02556879|Antibodies|antibodies|mesh-list
805329|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
805330|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805331|NCT02556879|Hematinics|hematinics|mesh-ancestor
2096338|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
802335|NCT02569125|Everolimus|everolimus|mesh-list
802336|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
802337|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
802338|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
802339|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754319|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2754320|NCT01300143|Estrogens|estrogens|mesh-ancestor
2754321|NCT01300143|Hormones|hormones|mesh-ancestor
2754322|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2754323|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802560|NCT02567942|Propofol|propofol|mesh-list
802561|NCT02567942|Sevoflurane|sevoflurane|mesh-list
802562|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
802563|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
802564|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802565|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
802566|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
802567|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
802568|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
802569|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
802865|NCT02567279|Denosumab|denosumab|mesh-list
802866|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
802867|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803005|NCT02566707|Lamivudine|lamivudine|mesh-list
803006|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
803007|NCT02566707|Dolutegravir|dolutegravir|mesh-list
803008|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
803009|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
803010|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803011|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803012|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
803013|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
803014|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
803015|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
803016|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
803017|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
803018|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
803019|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
803020|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
803376|NCT02565303|Ropivacaine|ropivacaine|mesh-list
803377|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
803378|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
803379|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
803380|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803381|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
803382|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247022|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2247023|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2247024|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247025|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2247026|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2247027|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2247028|NCT00121550|Clarithromycin|clarithromycin|mesh-list
2247029|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2247030|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247031|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2247032|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247033|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247034|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2247035|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2247036|NCT00121563|Thalidomide|thalidomide|mesh-list
2247037|NCT00121563|Ibuprofen|ibuprofen|mesh-list
2247038|NCT00121563|Diazepam|diazepam|mesh-list
2247039|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2247040|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2247041|NCT00121563|Analgesics|analgesics|mesh-ancestor
2247042|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
2247043|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247044|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247045|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2247046|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
803831|NCT02563002|Bevacizumab|bevacizumab|mesh-list
803832|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
803833|NCT02563002|Cetuximab|cetuximab|mesh-list
2247047|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
802702|NCT02567838|Lidocaine|lidocaine|mesh-list
802703|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
802704|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
802705|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
802706|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802707|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
802708|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802709|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
802710|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
802711|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
802712|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
802713|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802984|NCT02566720|Amantadine|amantadine|mesh-list
802985|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
802986|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
802987|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
802988|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802989|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
802990|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802991|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802992|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802993|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
802994|NCT02566720|Analgesics|analgesics|mesh-ancestor
802995|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
802996|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803040|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
803041|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
803042|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
803043|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803044|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
803045|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
803046|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
803047|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803048|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803049|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
803769|NCT02563340|Rituximab|rituximab|mesh-list
803770|NCT02563340|Bortezomib|bortezomib|mesh-list
803771|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
803772|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803773|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
803774|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803775|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
803825|NCT02563041|Heparin|heparin|mesh-list
803826|NCT02563041|Calcium heparin|calcium heparin|mesh-list
803827|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
803828|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803829|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
803830|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
803899|NCT02562742|Ribavirin|ribavirin|mesh-list
803900|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
803901|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803902|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
803903|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247048|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247049|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247050|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2247051|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
2247052|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
2247053|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2247054|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247055|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2247056|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2247057|NCT00121563|Growth Substances|growth substances|mesh-ancestor
2247058|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
805585|NCT02556060|Lamotrigine|lamotrigine|mesh-list
805586|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
805587|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
805588|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
805589|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805590|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
805591|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805592|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
805593|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
802413|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
802414|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
802415|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
802416|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802417|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802418|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
802419|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
802420|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
802421|NCT02569320|Growth Substances|growth substances|mesh-ancestor
802422|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
802423|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
802757|NCT02567396|Talazoparib|talazoparib|mesh-list
802758|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
802759|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802760|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802761|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803556|NCT02564146|Gemcitabine|gemcitabine|mesh-list
803557|NCT02564146|Paclitaxel|paclitaxel|mesh-list
803558|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
803559|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
803560|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803561|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
803562|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
803563|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
803564|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803565|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
803566|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
803567|NCT02564146|Antiviral Agents|antiviral agents|mesh-ancestor
803568|NCT02564146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
803569|NCT02564146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803570|NCT02564146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
803571|NCT02564146|Immunologic Factors|immunologic factors|mesh-ancestor
803572|NCT02564146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247059|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247060|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2247061|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
2247062|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
2247063|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
2247064|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2247065|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2247066|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2247067|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2247068|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2247069|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2247070|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2247071|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2247072|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2247073|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
2247074|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
2247075|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
2247076|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
803896|NCT02562690|Thrombin|thrombin|mesh-list
803897|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
803898|NCT02562690|Coagulants|coagulants|mesh-ancestor
804196|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
804197|NCT02561767|Tacrolimus|tacrolimus|mesh-list
804198|NCT02561767|Basiliximab|basiliximab|mesh-list
804199|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
804200|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
804201|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804202|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
804203|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804204|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804205|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
804206|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804207|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
804208|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
804209|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
804210|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804701|NCT02559297|Sevoflurane|sevoflurane|mesh-list
804702|NCT02559297|Desflurane|desflurane|mesh-list
804703|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
804704|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
804705|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
804706|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
804707|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
804708|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247077|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247078|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
2247079|NCT00121602|Hematinics|hematinics|mesh-ancestor
2247080|NCT00121615|Etanercept|etanercept|mesh-list
2247081|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2247082|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2247083|NCT00121615|Analgesics|analgesics|mesh-ancestor
2247084|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
2247085|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802602|NCT02567981|Vitamin A|vitamin a|mesh-list
802613|NCT02567981|Micronutrients|micronutrients|mesh-list
802614|NCT02567981|Trace Elements|trace elements|mesh-list
802615|NCT02567981|Vitamins|vitamins|mesh-ancestor
802617|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803142|NCT02565979|Resveratrol|resveratrol|mesh-list
803143|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
803144|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803145|NCT02565979|Protective Agents|protective agents|mesh-ancestor
803146|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803147|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803148|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2096339|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2096340|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2096341|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
2096342|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096343|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2096344|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2096345|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096346|NCT02305017|Acetaminophen|acetaminophen|mesh-list
2096347|NCT02305017|Opicapone|opicapone|mesh-list
2096348|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2096349|NCT02305017|Analgesics|analgesics|mesh-ancestor
2247086|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247087|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2247088|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2247089|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2247090|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2247091|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
2247092|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
2247093|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2247094|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247095|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247096|NCT00121680|Lenvatinib|lenvatinib|mesh-list
2247097|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247098|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2247099|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247100|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247101|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
2247102|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
806159|NCT02553226|Oxytocin|oxytocin|mesh-list
806160|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
806161|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
806162|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806349|NCT02552537|Mannitol|mannitol|mesh-list
806350|NCT02552537|Omeprazole|omeprazole|mesh-list
806351|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
806352|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
806353|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
806354|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806355|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806356|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
806357|NCT02552537|Diuretics|diuretics|mesh-ancestor
806358|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
806359|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807273|NCT02548936|Simvastatin|simvastatin|mesh-list
807274|NCT02548936|Ezetimibe|ezetimibe|mesh-list
807275|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
807276|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
807277|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
807393|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
802508|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
802509|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
802510|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802511|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802512|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
802513|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
802514|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
802515|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
802516|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
802517|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
802518|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802519|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802587|NCT02567916|Propofol|propofol|mesh-list
802588|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
802589|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
802590|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802591|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
802592|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
802593|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
2247103|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247104|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2247105|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
2247106|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
803260|NCT02565732|Botulinum Toxins|botulinum toxins|mesh-list
803261|NCT02565732|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
803262|NCT02565732|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
803263|NCT02565732|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
803264|NCT02565732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
803265|NCT02565732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803266|NCT02565732|Cholinergic Agents|cholinergic agents|mesh-ancestor
803267|NCT02565732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
803268|NCT02565732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803269|NCT02565732|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
803270|NCT02565732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247107|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247108|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247109|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247110|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2247111|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247112|NCT00121875|Hormones|hormones|mesh-list
2247113|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2247114|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247115|NCT00121888|Paroxetine|paroxetine|mesh-list
2247116|NCT00121888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
803579|NCT02564003|Oxycodone|oxycodone|mesh-list
803580|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
803581|NCT02564003|Narcotics|narcotics|mesh-ancestor
803582|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
803583|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803584|NCT02564003|Analgesics|analgesics|mesh-ancestor
803585|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
803586|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803680|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
803681|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
803682|NCT02563769|Cocaine|cocaine|mesh-list
803683|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
803684|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
803685|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
803686|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803687|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
803688|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803689|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
803690|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
803691|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
803692|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
803693|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803694|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
803695|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
803696|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
803697|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
803698|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803699|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
804025|NCT02562443|ON 01910|on 01910|mesh-list
804026|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247117|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2247118|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2247119|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802762|NCT02567799|Paclitaxel|paclitaxel|mesh-list
802763|NCT02567799|Carboplatin|carboplatin|mesh-list
802764|NCT02567799|Genistein|genistein|mesh-list
802765|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
802766|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
802767|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
802768|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
802769|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
802770|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802771|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
802772|NCT02567799|Protective Agents|protective agents|mesh-ancestor
802773|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802774|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
802775|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802776|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
802777|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
802778|NCT02567799|Estrogens|estrogens|mesh-ancestor
802779|NCT02567799|Hormones|hormones|mesh-ancestor
802780|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
804363|NCT02560688|Clopidogrel|clopidogrel|mesh-list
804364|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
804365|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
804366|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
804367|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
804368|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
804369|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
804370|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804371|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247120|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247121|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
2247122|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247123|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2247124|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
2247125|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
805716|NCT02555644|Cetuximab|cetuximab|mesh-list
805717|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805718|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
805857|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
805858|NCT02554942|Hematinics|hematinics|mesh-ancestor
806060|NCT02554344|Curcumin|curcumin|mesh-list
806061|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
806062|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
806063|NCT02554344|Analgesics|analgesics|mesh-ancestor
806064|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
806065|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806066|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806067|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
806068|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
806069|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
806070|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806071|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806215|NCT02553083|Amoxicillin|amoxicillin|mesh-list
806216|NCT02553083|Doxycycline|doxycycline|mesh-list
806217|NCT02553083|Esomeprazole|esomeprazole|mesh-list
806218|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
806219|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
806220|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
806221|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
806222|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
806223|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
806224|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
806225|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
806226|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806227|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806605|NCT02551367|Letrozole|letrozole|mesh-list
806606|NCT02551367|Clomiphene|clomiphene|mesh-list
806607|NCT02551367|Enclomiphene|enclomiphene|mesh-list
806608|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
806609|NCT02551367|Hormones|hormones|mesh-list
806610|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806611|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
806766|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
802743|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
802744|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
802745|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
803271|NCT02565719|Interferons|interferons|mesh-list
803272|NCT02565719|Tenofovir|tenofovir|mesh-list
803273|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
803274|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
803275|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
803276|NCT02565719|REP 2139|rep 2139|mesh-list
803277|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803278|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
803279|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
803280|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
803281|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
803282|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803283|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803284|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
803285|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
803286|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
803287|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803350|NCT02565368|Metformin|metformin|mesh-list
803351|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
803352|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803487|NCT02564536|Decitabine|decitabine|mesh-list
803488|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
803489|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
803490|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803491|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803492|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803727|NCT02563821|Clonidine|clonidine|mesh-list
803728|NCT02563821|Sufentanil|sufentanil|mesh-list
803729|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
803730|NCT02563821|Analgesics|analgesics|mesh-ancestor
803731|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
803732|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803733|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803734|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
803735|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
803736|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
803737|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
803738|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
803739|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
803740|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
803741|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
803742|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803743|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
803744|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
803745|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
803746|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
803747|NCT02563821|Narcotics|narcotics|mesh-ancestor
803748|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
803749|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
803750|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
804264|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
804265|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
804266|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804791|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
804792|NCT02559102|Anesthetics|anesthetics|mesh-list
804793|NCT02559102|Sevoflurane|sevoflurane|mesh-list
804794|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
804795|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804796|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
804797|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
804798|NCT02559102|Analgesics|analgesics|mesh-ancestor
804799|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
804800|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
804801|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
804802|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
804803|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
804804|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
804805|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
804806|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804807|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
804808|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
804809|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
804897|NCT02558452|Tacrolimus|tacrolimus|mesh-list
804898|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
802792|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
802793|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
802794|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
802795|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
802796|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
802797|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
802798|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
802799|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
802800|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
802801|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802802|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
802803|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
802804|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
802805|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
802806|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
802807|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
802808|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
802809|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
802810|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
802811|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
802812|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
802972|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
802973|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
802974|NCT02566928|Bacitracin|bacitracin|mesh-list
802975|NCT02566928|Mupirocin|mupirocin|mesh-list
802976|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
802977|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
802978|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
802979|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
802980|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
802981|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
802982|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
802983|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247126|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2247127|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2247128|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247129|NCT00121914|Ethanol|ethanol|mesh-list
803881|NCT02562950|Midazolam|midazolam|mesh-list
803882|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
803883|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
803884|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
803885|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803886|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
803887|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
803888|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
803889|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
803890|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
803891|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
803892|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
803893|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
803894|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
803895|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804077|NCT02562183|Kallikreins|kallikreins|mesh-list
804078|NCT02562183|Coagulants|coagulants|mesh-ancestor
804079|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
804080|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
804081|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
804082|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804882|NCT02558517|Prednisone|prednisone|mesh-list
804883|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
804884|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
804885|NCT02558517|Hormones|hormones|mesh-ancestor
804886|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
804887|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804888|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
804889|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804909|NCT02558205|Liver Extracts|liver extracts|mesh-list
804910|NCT02558205|Hematinics|hematinics|mesh-ancestor
805025|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
805026|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
805027|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
805028|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
805029|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
805030|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805031|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
805088|NCT02557867|Analgesics|analgesics|mesh-ancestor
2247130|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2247131|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247132|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2247133|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247134|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
2247135|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2247136|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247137|NCT00121966|Insulin|insulin|mesh-list
2247138|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2247139|NCT00121966|Metformin|metformin|mesh-list
803178|NCT02566226|Morphine|morphine|mesh-list
803179|NCT02566226|Bupivacaine|bupivacaine|mesh-list
803180|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
803181|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
803182|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
803183|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803184|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
803185|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803186|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
803187|NCT02566226|Narcotics|narcotics|mesh-ancestor
803188|NCT02566226|Analgesics|analgesics|mesh-ancestor
803951|NCT02562599|Raltitrexed|raltitrexed|mesh-list
803952|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803953|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
803954|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
803955|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803956|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
803957|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804303|NCT02560909|Vaccines|vaccines|mesh-list
804304|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
804305|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804964|NCT02558153|Paclitaxel|paclitaxel|mesh-list
804965|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
804966|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804967|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
804968|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
804969|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
804970|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805375|NCT02556814|Dexamethasone|dexamethasone|mesh-list
805376|NCT02556814|Caffeic acid|caffeic acid|mesh-list
805377|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
805378|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
805379|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
805380|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805381|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805382|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
805383|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
805384|NCT02556814|Hormones|hormones|mesh-ancestor
805385|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
805386|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
805387|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805388|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
805389|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805390|NCT02556814|Protective Agents|protective agents|mesh-ancestor
805597|NCT02555813|Gemcitabine|gemcitabine|mesh-list
805598|NCT02555813|Paclitaxel|paclitaxel|mesh-list
805599|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
805600|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
805601|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805602|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
805603|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
805604|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
805605|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805606|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
805607|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
805608|NCT02555813|Antiviral Agents|antiviral agents|mesh-ancestor
805609|NCT02555813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
805610|NCT02555813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805611|NCT02555813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
805612|NCT02555813|Immunologic Factors|immunologic factors|mesh-ancestor
805613|NCT02555813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805805|NCT02555254|Methamphetamine|methamphetamine|mesh-list
805806|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
805807|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805808|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
805809|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
2247140|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
803109|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
803110|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
803111|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
803112|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
803113|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803114|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
803115|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
803116|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
803149|NCT02565953|Paclitaxel|paclitaxel|mesh-list
803150|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
803151|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803152|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
803153|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
803154|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
803155|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247141|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
2247142|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
2247143|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
2247144|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
2247145|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2247146|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247147|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2247148|NCT00121979|Racivir|racivir|mesh-list
2247149|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2247150|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247151|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247152|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
2247153|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
803601|NCT02563925|Durvalumab|durvalumab|mesh-list
803602|NCT02563925|Tremelimumab|tremelimumab|mesh-list
803603|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
803604|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804161|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
804162|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
804163|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
804164|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
804165|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
804166|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804167|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
804168|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
804169|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804170|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
804171|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
804172|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2247154|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
2247155|NCT00122018|Fenoldopam|fenoldopam|mesh-list
2247156|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2247157|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
2247158|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247159|NCT00122018|Expectorants|expectorants|mesh-ancestor
2247160|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
2247161|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2247162|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
2247163|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247164|NCT00122018|Protective Agents|protective agents|mesh-ancestor
2247165|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247166|NCT00122018|Antidotes|antidotes|mesh-ancestor
2247167|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2247168|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
2247169|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
2247170|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
2247171|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247172|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
2247173|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2247174|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2247175|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2247176|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2247177|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
2247178|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247179|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247180|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247181|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2247182|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247183|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2247184|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
803134|NCT02566304|Antiviral Agents|antiviral agents|mesh-ancestor
803135|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
803136|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
803137|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803138|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
803139|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
803140|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
803141|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
803244|NCT02565836|Thrombin|thrombin|mesh-list
803245|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
803246|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
803247|NCT02565836|Coagulants|coagulants|mesh-ancestor
803356|NCT02565212|Montelukast|montelukast|mesh-list
803357|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
803358|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
803359|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
803360|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
803361|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
803362|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803363|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
803364|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
803365|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247185|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2247186|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2247187|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2247188|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2247189|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247190|NCT00122096|Valdecoxib|valdecoxib|mesh-list
2247191|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2247192|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
803553|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
803554|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
803555|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803779|NCT02563353|Teriparatide|teriparatide|mesh-list
803780|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
803781|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803782|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
804148|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
804149|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
804150|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
804151|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
804152|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804153|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
804154|NCT02561923|Coagulants|coagulants|mesh-ancestor
804155|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
804156|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
804157|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
804158|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
804159|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804160|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
804251|NCT02561117|Metronidazole|metronidazole|mesh-list
804252|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804253|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
804254|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
804255|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2247193|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247194|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247195|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2247196|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
804618|NCT02559674|Gemcitabine|gemcitabine|mesh-list
804619|NCT02559674|Paclitaxel|paclitaxel|mesh-list
804620|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
804621|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804622|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
804623|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
804624|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
804625|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804626|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
804627|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
804628|NCT02559674|Antiviral Agents|antiviral agents|mesh-ancestor
804629|NCT02559674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804630|NCT02559674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804631|NCT02559674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
804632|NCT02559674|Immunologic Factors|immunologic factors|mesh-ancestor
804633|NCT02559674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803157|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
803158|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096350|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
2096351|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096352|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096353|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
2096354|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2096355|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096356|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096357|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2096358|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2096359|NCT02305238|Aflibercept|aflibercept|mesh-list
2096360|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2247197|NCT00122096|Analgesics|analgesics|mesh-ancestor
2247198|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
2247199|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247200|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247201|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2247202|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2247203|NCT00122226|Ritonavir|ritonavir|mesh-list
804372|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
804373|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
804374|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247204|NCT00122226|Lopinavir|lopinavir|mesh-list
2247205|NCT00122226|Lamivudine|lamivudine|mesh-list
2247206|NCT00122226|Zidovudine|zidovudine|mesh-list
2247207|NCT00122226|Nevirapine|nevirapine|mesh-list
2247208|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
804936|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
804937|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
804938|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
804939|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
804940|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804941|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
804942|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
804943|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
804944|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
804945|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
804946|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
804947|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
804948|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805868|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
805869|NCT02554955|Daclizumab|daclizumab|mesh-list
805870|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
805871|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805872|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
805873|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
805874|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
805875|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
805876|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805877|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805878|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
805879|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
805880|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806311|NCT02552641|Amoxicillin|amoxicillin|mesh-list
806312|NCT02552641|Clarithromycin|clarithromycin|mesh-list
806313|NCT02552641|Esomeprazole|esomeprazole|mesh-list
806314|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
806315|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247209|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2247210|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
2247211|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754324|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
803652|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
803653|NCT02563782|Tacrolimus|tacrolimus|mesh-list
803654|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
803655|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
803656|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803657|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
803658|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803659|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803660|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
803661|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803662|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
803663|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
803664|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
803665|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
803841|NCT02563327|Pyridoxine|pyridoxine|mesh-list
803842|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
803843|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
803844|NCT02563327|Rifampin|rifampin|mesh-list
803845|NCT02563327|Isoniazid|isoniazid|mesh-list
803846|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
803847|NCT02563327|Ethambutol|ethambutol|mesh-list
803848|NCT02563327|Rifapentine|rifapentine|mesh-list
803849|NCT02563327|Vitamins|vitamins|mesh-ancestor
803850|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
803851|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803852|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
803853|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
803854|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
803855|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
803856|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
803857|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803858|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803859|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
803860|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
803861|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
803862|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
803863|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
803864|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
803865|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
803866|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
803867|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
803868|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
803869|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
803870|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
803871|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
803872|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
803873|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2096361|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2096362|NCT02305238|Growth Substances|growth substances|mesh-ancestor
2096363|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096364|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
2096365|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096366|NCT02305277|Opicapone|opicapone|mesh-list
2096367|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2096368|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096369|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096370|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2096371|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2096372|NCT02305316|Opicapone|opicapone|mesh-list
2096373|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2096374|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096375|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096376|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2096377|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2096378|NCT02305329|Opicapone|opicapone|mesh-list
2096379|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2096380|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096381|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096382|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2096383|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
805522|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
803419|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803420|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
803421|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
803422|NCT02565173|Analgesics|analgesics|mesh-ancestor
803423|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
803424|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803425|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
803426|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
803427|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
803428|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
804022|NCT02562508|Vaccines|vaccines|mesh-list
804023|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
804024|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247212|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247213|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2247214|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2247215|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
2247216|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247217|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2247218|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
804237|NCT02561468|Nefopam|nefopam|mesh-list
804238|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
804239|NCT02561468|Analgesics|analgesics|mesh-ancestor
804240|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
804241|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
804242|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804911|NCT02558361|Apremilast|apremilast|mesh-list
804912|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
804913|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
804914|NCT02558361|Analgesics|analgesics|mesh-ancestor
804915|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
804916|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
804917|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804918|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
804919|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
804920|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
804921|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
804922|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804923|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805332|NCT02556866|Prednisone|prednisone|mesh-list
805333|NCT02556866|Rituximab|rituximab|mesh-list
805334|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
805335|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805336|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
805337|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805338|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
805339|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
805340|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
805341|NCT02556866|Hormones|hormones|mesh-ancestor
805342|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
805343|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
805575|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
805576|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
805577|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096384|NCT02305563|Cytarabine|cytarabine|mesh-list
2096385|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2096386|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
2096387|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805850|NCT02555007|Vinorelbine|vinorelbine|mesh-list
805851|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
805852|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805853|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
805854|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
805855|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
805856|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805914|NCT02554734|Levodopa|levodopa|mesh-list
805915|NCT02554734|Carbidopa|carbidopa|mesh-list
805916|NCT02554734|Entacapone|entacapone|mesh-list
805917|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
805918|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
805919|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
805920|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805921|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247219|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2247220|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2247221|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
804041|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
804042|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
804043|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247222|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2247223|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2247224|NCT00122291|Capecitabine|capecitabine|mesh-list
2247225|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2247226|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
2247227|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247228|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247229|NCT00122304|Eculizumab|eculizumab|mesh-list
804243|NCT02561442|Ceftriaxone|ceftriaxone|mesh-list
804244|NCT02561442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
804245|NCT02561442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804566|NCT02559791|Reslizumab|reslizumab|mesh-list
804567|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
804568|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
804715|NCT02559180|Aflibercept|aflibercept|mesh-list
804716|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
804717|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
804718|NCT02559180|Growth Substances|growth substances|mesh-ancestor
804719|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804720|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
804721|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804924|NCT02558283|Lidocaine|lidocaine|mesh-list
804925|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
804926|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
804927|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
804928|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804929|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
804930|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
804931|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
804932|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
804933|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
804934|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
804935|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805163|NCT02557503|Fluorouracil|fluorouracil|mesh-list
805166|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
2096388|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096389|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
2096390|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096391|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2096392|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
2096393|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096394|NCT02305758|Bevacizumab|bevacizumab|mesh-list
2096395|NCT02305758|Fluorouracil|fluorouracil|mesh-list
803816|NCT02563054|Fluorouracil|fluorouracil|mesh-list
803817|NCT02563054|Capecitabine|capecitabine|mesh-list
803818|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803819|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
803820|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803821|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
803822|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
803823|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
803824|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804111|NCT02562053|Fluoxetine|fluoxetine|mesh-list
804112|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
804113|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
804114|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
804115|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
804116|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804117|NCT02562053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
804118|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
804119|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
804120|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804121|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
804122|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
804123|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
804124|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
804125|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
804126|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
804127|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
804128|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804129|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2247230|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2247231|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2247232|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
2247233|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247234|NCT00122330|Eculizumab|eculizumab|mesh-list
2247235|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2247236|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2247237|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
2247238|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247239|NCT00122343|Sirolimus|sirolimus|mesh-list
805111|NCT02557581|Terbutaline|terbutaline|mesh-list
805112|NCT02557581|Clenbuterol|clenbuterol|mesh-list
805113|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
805114|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
805115|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805116|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805117|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
805118|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
805119|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
805120|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
805121|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
805122|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
805123|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
805124|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
805125|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
805126|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805127|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096396|NCT02305758|Veliparib|veliparib|mesh-list
803713|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
803714|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
803715|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
803716|NCT02563704|Analgesics|analgesics|mesh-ancestor
803717|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
804044|NCT02562300|Misoprostol|misoprostol|mesh-list
804045|NCT02562300|Oxytocin|oxytocin|mesh-list
804046|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
804047|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
804048|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804049|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
804050|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
804051|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
804052|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
804220|NCT02561936|Rilpivirine|rilpivirine|mesh-list
804221|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
804222|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
804223|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804224|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804225|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
804226|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804227|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
804228|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
804396|NCT02560376|Exenatide|exenatide|mesh-list
804397|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
804398|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804399|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
804400|NCT02560376|Incretins|incretins|mesh-ancestor
804401|NCT02560376|Hormones|hormones|mesh-ancestor
804402|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2247240|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2247241|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247242|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2247243|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247244|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
2247245|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2247246|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
2247247|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247248|NCT00122356|Alendronate|alendronate|mesh-list
2247249|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2247250|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247251|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
2247252|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2247253|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
2247254|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247255|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247256|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2247257|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
2247258|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
2247259|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2247260|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
2247261|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247262|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247263|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
2247264|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247265|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2247266|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247267|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247268|NCT00122486|Tenofovir|tenofovir|mesh-list
2247269|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
2247270|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247271|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2096397|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2096398|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096399|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2096400|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2096401|NCT02305758|Growth Substances|growth substances|mesh-ancestor
2096402|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096403|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
2096404|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
2096405|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096406|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2096407|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2096408|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
803723|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
803724|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
803725|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
803726|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
803753|NCT02563405|Doxazosin|doxazosin|mesh-list
803754|NCT02563405|Nifedipine|nifedipine|mesh-list
803755|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
803756|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
803757|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803758|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
803759|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803760|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
803761|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
803762|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
803763|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
803764|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
803765|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
803766|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
803767|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
803768|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247272|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2247273|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247274|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
803961|NCT02562651|Doxycycline|doxycycline|mesh-list
803962|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
803963|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
803964|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
803965|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
803966|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2247275|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2247276|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2247277|NCT00122499|Tadalafil|tadalafil|mesh-list
2247278|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
2247279|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2247280|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2247281|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804461|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
804462|NCT02560155|Mupirocin|mupirocin|mesh-list
804463|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
804464|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804465|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
804466|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
804467|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
804468|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804469|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804652|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
804653|NCT02559440|Phenylephrine|phenylephrine|mesh-list
804654|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
804655|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
804656|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
804657|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
804658|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
804659|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
804660|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
804661|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
804662|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804663|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804664|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
804665|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
804666|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
804667|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
804668|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
804669|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
804670|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
804671|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
804672|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
804673|NCT02559440|Protective Agents|protective agents|mesh-ancestor
804858|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
804859|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
804860|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
804861|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
804862|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
804863|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804864|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804865|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
805128|NCT02557958|Azithromycin|azithromycin|mesh-list
803834|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
803835|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
803836|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
803837|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
803838|NCT02563002|Growth Substances|growth substances|mesh-ancestor
803839|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
803840|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
2247282|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247283|NCT00122499|Urological Agents|urological agents|mesh-ancestor
2247284|NCT00122512|Tenofovir|tenofovir|mesh-list
2247285|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
2247286|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804866|NCT02558751|Vaccines|vaccines|mesh-list
804867|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
804868|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
804869|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247287|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2247288|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2247289|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247290|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247291|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2247292|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2247293|NCT00122538|Lamivudine|lamivudine|mesh-list
2247294|NCT00122538|Efavirenz|efavirenz|mesh-list
2247295|NCT00122538|Didanosine|didanosine|mesh-list
2247296|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2247297|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2247298|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247299|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247300|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
2247301|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247302|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2247303|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2247304|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2247305|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2247306|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2247307|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2247308|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2247309|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2247310|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
2247311|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2247312|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
2247313|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247314|NCT00122577|Ritonavir|ritonavir|mesh-list
2247315|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2247316|NCT00122577|Tenofovir|tenofovir|mesh-list
2247317|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2247318|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2247319|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
2247320|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806360|NCT02552459|Sufentanil|sufentanil|mesh-list
806361|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
806362|NCT02552459|Dsuvia|dsuvia|mesh-list
806363|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
806364|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
806365|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806366|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
806367|NCT02552459|Analgesics|analgesics|mesh-ancestor
806368|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
806369|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806370|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
806371|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
806372|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
806373|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
806374|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806375|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806376|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
806377|NCT02552459|Narcotics|narcotics|mesh-ancestor
806378|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
806379|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
806380|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
806381|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
2247321|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247322|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2247323|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2247324|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
2247325|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804291|NCT02560974|Capecitabine|capecitabine|mesh-list
804292|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
804293|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
804294|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
804295|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804296|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804497|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
804498|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
804499|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
804500|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804501|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
804502|NCT02559908|Protective Agents|protective agents|mesh-ancestor
2247326|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2247327|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2247328|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
804904|NCT02558387|Nintedanib|nintedanib|mesh-list
804905|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804906|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
804907|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804908|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805022|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
805023|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
805024|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
2247329|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2247330|NCT00122590|Ritonavir|ritonavir|mesh-list
2247331|NCT00122590|Lopinavir|lopinavir|mesh-list
2247332|NCT00122590|Nelfinavir|nelfinavir|mesh-list
2247333|NCT00122590|Indinavir|indinavir|mesh-list
2247334|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2247335|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2247336|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
2247337|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247338|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247339|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2247340|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2247341|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
2247342|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247343|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2247344|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2247345|NCT00122603|Saquinavir|saquinavir|mesh-list
2247346|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
2247347|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2247348|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2247349|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
2247350|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247351|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247352|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2247353|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2247354|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
2247355|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247356|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2247357|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2247358|NCT00122616|Ribavirin|ribavirin|mesh-list
2247359|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2247360|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2247361|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
2247362|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247363|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
2247364|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247365|NCT00122629|Interferons|interferons|mesh-list
2247366|NCT00122629|Ribavirin|ribavirin|mesh-list
2247367|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
806479|NCT02551523|Dolutegravir|dolutegravir|mesh-list
806480|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
806481|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
806482|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
806483|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806484|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806485|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
806486|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
806487|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
807392|NCT02548559|Cannabidiol|cannabidiol|mesh-list
804020|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
804021|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804065|NCT02562144|Lidocaine|lidocaine|mesh-list
804066|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
804067|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
804068|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
804069|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804070|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
804071|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
804072|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
804073|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
804074|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
804075|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
804076|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804229|NCT02561494|Nefopam|nefopam|mesh-list
804230|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
804231|NCT02561494|Analgesics|analgesics|mesh-ancestor
804232|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
804233|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
804234|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804297|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
804298|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804299|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
804300|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804301|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804302|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2247368|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
2247369|NCT00122629|Amantadine|amantadine|mesh-list
2247370|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2247371|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247372|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
2247373|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247374|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
2247375|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247376|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
2247377|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247378|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2247379|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2247380|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
2247381|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247382|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2247383|NCT00122629|Analgesics|analgesics|mesh-ancestor
2247384|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
2247385|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247386|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2247387|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2247388|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
2247389|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2247390|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805108|NCT02557789|Lefamulin|lefamulin|mesh-list
805109|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
805110|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247391|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247392|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
2247393|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247394|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2247395|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2247396|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2247397|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2247398|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2247399|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
2247400|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2247401|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247402|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247403|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
805614|NCT02555696|Paclitaxel|paclitaxel|mesh-list
805615|NCT02555696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
805616|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
805617|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805618|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
805619|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
805620|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
805621|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806289|NCT02552745|Parecoxib|parecoxib|mesh-list
804027|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
804028|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804029|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247404|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247405|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2247406|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
804526|NCT02559921|Vaccines|vaccines|mesh-list
804527|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
804528|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804634|NCT02559648|Denosumab|denosumab|mesh-list
804635|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
804636|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804709|NCT02559232|Anticoagulants|anticoagulants|mesh-list
804819|NCT02558972|Droxidopa|droxidopa|mesh-list
804820|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
804821|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
804870|NCT02558595|Niacinamide|niacinamide|mesh-list
804871|NCT02558595|Niacin|niacin|mesh-list
804872|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
804873|NCT02558595|Vitamins|vitamins|mesh-ancestor
804874|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
804875|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804876|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
804877|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
804878|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
804879|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804880|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
804881|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
804949|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
804950|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
804951|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
804952|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804953|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
804954|NCT02558218|Hormones|hormones|mesh-ancestor
804955|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
804956|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804957|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
804958|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
805139|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
805140|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
805141|NCT02557451|Growth Substances|growth substances|mesh-ancestor
805142|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805143|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
805144|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247407|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2247408|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
2247409|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
2247410|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247411|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
2247412|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247413|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247414|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
2247415|NCT00122720|Hematinics|hematinics|mesh-ancestor
2247416|NCT00122733|Loxapine|loxapine|mesh-list
2247417|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2247418|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2247419|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2247420|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247421|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2247422|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2247423|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
2247424|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247425|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247426|NCT00122746|Cisplatin|cisplatin|mesh-list
806150|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
806151|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
806152|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806793|NCT02550470|Sevoflurane|sevoflurane|mesh-list
806794|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
806795|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
806796|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
806797|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
806798|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
806799|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807042|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
807043|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2247427|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247428|NCT00122759|Ketamine|ketamine|mesh-list
2247429|NCT00122759|Analgesics|analgesics|mesh-ancestor
2247430|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
2247431|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247432|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247433|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
804757|NCT02559154|Thalidomide|thalidomide|mesh-list
804758|NCT02559154|Dexamethasone|dexamethasone|mesh-list
804759|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
804760|NCT02559154|Doxorubicin|doxorubicin|mesh-list
804761|NCT02559154|Bortezomib|bortezomib|mesh-list
804762|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
804763|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
804764|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804765|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
804766|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
804767|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
804768|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804769|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804770|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
804771|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
804772|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
804773|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
804774|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
804775|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
804776|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
804777|NCT02559154|Hormones|hormones|mesh-ancestor
804778|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
804779|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
804780|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
804781|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
804782|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
804783|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804784|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
804785|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
804786|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804787|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
804788|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
804789|NCT02559154|Growth Substances|growth substances|mesh-ancestor
804790|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
805251|NCT02556905|Dexamethasone|dexamethasone|mesh-list
805252|NCT02556905|Lenalidomide|lenalidomide|mesh-list
805253|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
805254|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
805255|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
805256|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805257|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805258|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
805259|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
805260|NCT02556905|Hormones|hormones|mesh-ancestor
805261|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
805262|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
805263|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805264|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
805265|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
805266|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
805267|NCT02556905|Growth Substances|growth substances|mesh-ancestor
805268|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
805896|NCT02554864|Lidocaine|lidocaine|mesh-list
805897|NCT02554864|Ropivacaine|ropivacaine|mesh-list
805898|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
805899|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
805900|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
805901|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805902|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
805903|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805904|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
805905|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
805906|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
805907|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
805908|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096409|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2096410|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096411|NCT02305797|Lorazepam|lorazepam|mesh-list
804057|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
804058|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804059|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804060|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
804061|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
804062|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
804063|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804064|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2247434|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2247435|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
2247436|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
2247437|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2247438|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2247439|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2247440|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247441|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247442|NCT00122772|Cisplatin|cisplatin|mesh-list
2247443|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247444|NCT00122785|Dexamethasone|dexamethasone|mesh-list
2247445|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2247446|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
2247447|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
2247448|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247449|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247450|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2247451|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
2247452|NCT00122785|Hormones|hormones|mesh-ancestor
2247453|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2247454|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2247455|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247456|NCT00122811|Perindopril|perindopril|mesh-list
2247457|NCT00122811|Indapamide|indapamide|mesh-list
2247458|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
804713|NCT02559167|Cannabidiol|cannabidiol|mesh-list
804714|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
805204|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
805205|NCT02557269|Azelastine|azelastine|mesh-list
805206|NCT02557269|Prednisolone|prednisolone|mesh-list
805207|NCT02557269|Xylometazoline|xylometazoline|mesh-list
805208|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
805209|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
805210|NCT02557269|Hormones|hormones|mesh-ancestor
805211|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
805212|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805213|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
805214|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805215|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
805216|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805217|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
805218|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
805219|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
805220|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
805221|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
805222|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
805223|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805224|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805225|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
805226|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
805227|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
805228|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
805229|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805230|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
805231|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2247459|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
2247460|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247461|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247462|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2247463|NCT00122811|Diuretics|diuretics|mesh-ancestor
2247464|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
2247465|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247466|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2247467|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2247468|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
805763|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
804145|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
804146|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
804147|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804375|NCT02560649|Tenofovir|tenofovir|mesh-list
804376|NCT02560649|Lamivudine|lamivudine|mesh-list
804377|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
804378|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
804379|NCT02560649|Entecavir|entecavir|mesh-list
804380|NCT02560649|Adefovir|adefovir|mesh-list
804381|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
804382|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
804383|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
804384|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
804385|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
804386|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804387|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804388|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
804389|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
804390|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
804391|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805131|NCT02557854|Doxorubicin|doxorubicin|mesh-list
805132|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
805133|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
805134|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805135|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
805136|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
805137|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805138|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247469|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2247470|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2247471|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2247472|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247473|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247474|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247475|NCT00122824|Analgesics|analgesics|mesh-ancestor
2247476|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
2247477|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247478|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
2247479|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2247480|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
2247481|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2247482|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2247483|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2247484|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2247485|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2247486|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247487|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247488|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247489|NCT00122837|Analgesics|analgesics|mesh-ancestor
2247490|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
2247491|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247492|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
2247493|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2247494|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
2247495|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2247496|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2247497|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2247498|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2247499|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2247500|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2754325|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807037|NCT02549690|Testosterone|testosterone|mesh-list
807038|NCT02549690|Androgens|androgens|mesh-ancestor
807039|NCT02549690|Hormones|hormones|mesh-ancestor
807040|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
807041|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807241|NCT02549118|Tenoxicam|tenoxicam|mesh-list
807242|NCT02549118|Meperidine|meperidine|mesh-list
807243|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
807244|NCT02549118|Narcotics|narcotics|mesh-ancestor
807245|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
807246|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807247|NCT02549118|Analgesics|analgesics|mesh-ancestor
804283|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
804284|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
804285|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
804286|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804287|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804288|NCT02561013|Ionophores|ionophores|mesh-ancestor
804289|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
804290|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
804392|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
804642|NCT02559388|Montelukast|montelukast|mesh-list
804643|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
804644|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
804645|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
804646|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
804647|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
804648|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804649|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
804650|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
804651|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247501|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247502|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247503|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247504|NCT00122850|Analgesics|analgesics|mesh-ancestor
2754326|NCT01295944|Bevacizumab|bevacizumab|mesh-list
805194|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
805195|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
805196|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
805197|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
805198|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805199|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
805200|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096412|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
2096413|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
2096414|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
2096415|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096416|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096417|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2096418|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2096419|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2096420|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2096421|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2096422|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2096423|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
2096424|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
2096425|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096426|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096427|NCT02305849|Methotrexate|methotrexate|mesh-list
2096428|NCT02305849|Peficitinib|peficitinib|mesh-list
2096429|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2096430|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
2096431|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2096432|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096433|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2096434|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
2096435|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096436|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096437|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
2096438|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096439|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2096440|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2096441|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
2096442|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2096443|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
806188|NCT02553161|Citalopram|citalopram|mesh-list
806189|NCT02553161|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
806190|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
806191|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
806192|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806193|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806194|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
806195|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806196|NCT02553161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
806197|NCT02553161|Antidepressive Agents|antidepressive agents|mesh-ancestor
804324|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
804325|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804326|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
2247505|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
2247506|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247507|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
2247508|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2247509|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
2247510|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2247511|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2247512|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2247513|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2247514|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2247515|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247516|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247517|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247518|NCT00122863|Analgesics|analgesics|mesh-ancestor
2247519|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
2247520|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247521|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
2247522|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2247523|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
2247524|NCT00122876|Talaporfin|talaporfin|mesh-list
2247525|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247526|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
804810|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
804811|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
804812|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804813|NCT02558933|Protective Agents|protective agents|mesh-ancestor
804814|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804815|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
804816|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
804817|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804818|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
805006|NCT02558023|Nicardipine|nicardipine|mesh-list
805007|NCT02558023|Urapidil|urapidil|mesh-list
805008|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
805009|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
805010|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
805011|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805012|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
805013|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805014|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
805015|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
805016|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
805017|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805018|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
805019|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
805020|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
805021|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
2247527|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
2247528|NCT00122889|Allicin|allicin|mesh-list
2247529|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
2247530|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
2247531|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247532|NCT00122889|Protective Agents|protective agents|mesh-ancestor
2247533|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247534|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2247535|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247536|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2247537|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247538|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247539|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2247540|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
2247541|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2247542|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2247543|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2247544|NCT00122941|Micronutrients|micronutrients|mesh-list
2247545|NCT00122941|Trace Elements|trace elements|mesh-list
2247546|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247547|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
2247548|NCT00123149|Hematinics|hematinics|mesh-ancestor
2247549|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2247550|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
2247551|NCT00123175|Progestins|progestins|mesh-list
2247552|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2247553|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2247554|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2247555|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
2247556|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
805066|NCT02557984|Naltrexone|naltrexone|mesh-list
805067|NCT02557984|Amisulpride|amisulpride|mesh-list
805068|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
805069|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
805070|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805071|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
805072|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805073|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
805074|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
805075|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
805076|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
805077|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
805078|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
805079|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805080|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805081|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
805082|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
805493|NCT02556463|Durvalumab|durvalumab|mesh-list
805494|NCT02556463|MEDI9197|medi9197|mesh-list
805495|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
805496|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805497|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
805498|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
805499|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805687|NCT02555839|Thalidomide|thalidomide|mesh-list
805688|NCT02555839|Dexamethasone|dexamethasone|mesh-list
805689|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
805690|NCT02555839|Bortezomib|bortezomib|mesh-list
805691|NCT02555839|Pomalidomide|pomalidomide|mesh-list
805692|NCT02555839|BB 1101|bb 1101|mesh-list
805693|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
805694|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
805695|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
805696|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805697|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805698|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
805699|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
805700|NCT02555839|Hormones|hormones|mesh-ancestor
805701|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
805702|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
805703|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805704|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
805705|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805706|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805707|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
805708|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
805709|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
805710|NCT02555839|Growth Substances|growth substances|mesh-ancestor
805711|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
805712|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
805713|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
805714|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
805715|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247557|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247558|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2247559|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2247560|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2247561|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2096444|NCT02306694|Factor VIII|factor viii|mesh-list
2096445|NCT02306694|Coagulants|coagulants|mesh-ancestor
2096446|NCT02306759|Ketamine|ketamine|mesh-list
2096447|NCT02306759|Analgesics|analgesics|mesh-ancestor
2096448|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
2096449|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096450|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096451|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2096452|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2247562|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247563|NCT00123175|Hormones|hormones|mesh-ancestor
2754327|NCT01295944|Carboplatin|carboplatin|mesh-list
2096453|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
804443|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
804444|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804445|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
804446|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804447|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
804448|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804722|NCT02559141|Dobutamine|dobutamine|mesh-list
804723|NCT02559141|Norepinephrine|norepinephrine|mesh-list
804724|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
804725|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
804726|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
804727|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
804728|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804729|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804730|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
804731|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
804732|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
804733|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
804734|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
804735|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
804736|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
804737|NCT02559141|Protective Agents|protective agents|mesh-ancestor
804831|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
804832|NCT02558868|Irinotecan|irinotecan|mesh-list
804833|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804834|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
804835|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
804836|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804837|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805184|NCT02557373|Vitamins|vitamins|mesh-list
805185|NCT02557373|Vitamin A|vitamin a|mesh-list
805186|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
805187|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
805188|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805189|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
805190|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805191|NCT02557373|Protective Agents|protective agents|mesh-ancestor
805192|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
805193|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805663|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
805664|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
805665|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
805666|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805667|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
805668|NCT02555605|Analgesics|analgesics|mesh-ancestor
805669|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
805670|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805671|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
805672|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
805673|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
805674|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
805675|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805676|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805753|NCT02555358|Docetaxel|docetaxel|mesh-list
805754|NCT02555358|Capecitabine|capecitabine|mesh-list
805755|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
805756|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805757|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
805758|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
805759|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
805760|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805761|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
805762|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
2247564|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2247565|NCT00123201|Dronabinol|dronabinol|mesh-list
2247566|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
2247567|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247568|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2247569|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2247570|NCT00123201|Analgesics|analgesics|mesh-ancestor
2247571|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
2247572|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247573|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2247574|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2247575|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096454|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
2096455|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
804843|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
804844|NCT02558816|Venetoclax|venetoclax|mesh-list
804845|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
804846|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805036|NCT02557932|Bismuth|bismuth|mesh-list
805037|NCT02557932|Antacids|antacids|mesh-ancestor
805038|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805039|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2247576|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247577|NCT00123201|Hormones|hormones|mesh-ancestor
2247578|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2247579|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
2247580|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2247581|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247582|NCT00123253|Tesamorelin|tesamorelin|mesh-list
2247583|NCT00123253|Growth Substances|growth substances|mesh-ancestor
2247584|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247585|NCT00123266|Plasminogen|plasminogen|mesh-list
2247586|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2247587|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
806153|NCT02553603|Hormones|hormones|mesh-list
806154|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
806155|NCT02553603|Tesamorelin|tesamorelin|mesh-list
806156|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
806157|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806158|NCT02553603|Growth Substances|growth substances|mesh-ancestor
806302|NCT02553044|Vitamin D|vitamin d|mesh-list
806303|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
806304|NCT02553044|Vitamins|vitamins|mesh-ancestor
806305|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
806306|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806307|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
806308|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
806426|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
806427|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
806428|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
806429|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
806430|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
806431|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
806432|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806433|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
806434|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806435|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806436|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
806437|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247588|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247589|NCT00123279|Plasminogen|plasminogen|mesh-list
2247590|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2247591|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2247592|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247593|NCT00123292|Plasminogen|plasminogen|mesh-list
2247594|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
2247595|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2247596|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
807570|NCT02547844|Tenofovir|tenofovir|mesh-list
807571|NCT02547844|Efavirenz|efavirenz|mesh-list
807572|NCT02547844|Emtricitabine|emtricitabine|mesh-list
807573|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
807574|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
807575|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
807576|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
807577|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807578|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807579|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
807580|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
807581|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
807582|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
807583|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
807584|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
807585|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
807586|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
807693|NCT02547402|CXA-10|cxa-10|mesh-list
807694|NCT02547402|Simvastatin|simvastatin|mesh-list
804822|NCT02558959|Capecitabine|capecitabine|mesh-list
804823|NCT02558959|Irinotecan|irinotecan|mesh-list
804824|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
804825|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
804826|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804827|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
804828|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
804829|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
804830|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804971|NCT02558114|Ribavirin|ribavirin|mesh-list
804972|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
804973|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804974|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
804975|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
805178|NCT02557542|Polidocanol|polidocanol|mesh-list
805181|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
805182|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
805183|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
805468|NCT02556229|Aflibercept|aflibercept|mesh-list
805469|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
805470|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
805471|NCT02556229|Growth Substances|growth substances|mesh-ancestor
805472|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805473|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
805474|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805839|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
805840|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
805841|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
805842|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
805843|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
805844|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805845|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805846|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
806038|NCT02554318|Rifampin|rifampin|mesh-list
806039|NCT02554318|Isoniazid|isoniazid|mesh-list
806040|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
806041|NCT02554318|Ethambutol|ethambutol|mesh-list
806042|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
806043|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
806044|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
806045|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
806046|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
806047|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
806048|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806049|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806050|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
806051|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
806052|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
806053|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
806054|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
806055|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
806056|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
806057|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
806058|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
806059|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
806324|NCT02552589|Fluorides|fluorides|mesh-list
806325|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
806326|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
806327|NCT02552589|Protective Agents|protective agents|mesh-ancestor
806328|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806638|NCT02550977|Gestodene|gestodene|mesh-list
806639|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
806640|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
806641|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
806642|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
806643|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
806644|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806645|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
806646|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
806647|NCT02550977|Progestins|progestins|mesh-ancestor
806648|NCT02550977|Hormones|hormones|mesh-ancestor
806649|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
806762|NCT02550665|Donepezil|donepezil|mesh-list
806763|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
806764|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806765|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
804896|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805040|NCT02557945|Gabapentin|gabapentin|mesh-list
805041|NCT02557945|Analgesics|analgesics|mesh-ancestor
805042|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
805043|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805044|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805045|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
805046|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
805047|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
805048|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
805049|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
805050|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
805051|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
805052|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805053|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805054|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
805145|NCT02557594|Tenofovir|tenofovir|mesh-list
805146|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
805147|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
805148|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
805149|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
805150|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805151|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805152|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
805153|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
805344|NCT02556723|Aflibercept|aflibercept|mesh-list
805345|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
805346|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
805347|NCT02556723|Growth Substances|growth substances|mesh-ancestor
805348|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805349|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
805350|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805488|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
805489|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
805490|NCT02556437|Antibodies|antibodies|mesh-list
805491|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
805492|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805644|NCT02555943|Ritonavir|ritonavir|mesh-list
805645|NCT02555943|Tenofovir|tenofovir|mesh-list
805646|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
805647|NCT02555943|Entecavir|entecavir|mesh-list
805648|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
805649|NCT02555943|Ledipasvir|ledipasvir|mesh-list
805650|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
805651|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
805652|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
805653|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805654|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805655|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
805656|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
805657|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
805658|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
805659|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
805660|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
805661|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
805662|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
805859|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
805860|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
805861|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805862|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
805863|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
805864|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
805865|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805866|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
805867|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806019|NCT02554357|Bupivacaine|bupivacaine|mesh-list
806020|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
806021|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
806022|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
806023|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806024|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
806025|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806082|NCT02554045|Tadalafil|tadalafil|mesh-list
806083|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
804900|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
804901|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
804902|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
804903|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805351|NCT02556970|Acetaminophen|acetaminophen|mesh-list
805352|NCT02556970|Diclofenac|diclofenac|mesh-list
805353|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
805354|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
805355|NCT02556970|Analgesics|analgesics|mesh-ancestor
805356|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
805357|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805358|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805359|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
805360|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
805361|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
805362|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
805363|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
805364|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805365|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805366|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
805367|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
805368|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
805516|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
805517|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805518|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
805519|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805520|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805521|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
805622|NCT02555800|Cidofovir|cidofovir|mesh-list
805623|NCT02555800|Bevacizumab|bevacizumab|mesh-list
805624|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
805625|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805626|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
805627|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
805628|NCT02555800|Growth Substances|growth substances|mesh-ancestor
805629|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805630|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
805631|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
805632|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
805633|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805634|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805794|NCT02555423|Anesthetics|anesthetics|mesh-list
805795|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
805796|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
805797|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
805798|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805799|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
805800|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805847|NCT02555046|Anesthetics|anesthetics|mesh-list
805848|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
805849|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247597|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247598|NCT00123305|Plasminogen|plasminogen|mesh-list
2247599|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
807350|NCT02548741|Metformin|metformin|mesh-list
807351|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
807352|NCT02548741|Calcium|calcium|mesh-list
807353|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
807354|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807355|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
807356|NCT02548741|Antacids|antacids|mesh-ancestor
807357|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807358|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2247600|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2247601|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2247602|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247603|NCT00123318|Cisplatin|cisplatin|mesh-list
2247604|NCT00123318|Fluorouracil|fluorouracil|mesh-list
2247605|NCT00123318|Epirubicin|epirubicin|mesh-list
2247606|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247607|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
2247608|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247609|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2247610|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2247611|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
2247612|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247613|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2247614|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2247615|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2247616|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247617|NCT00123331|Cyclosporine|cyclosporine|mesh-list
2247618|NCT00123331|Sirolimus|sirolimus|mesh-list
2247619|NCT00123331|Cyclosporins|cyclosporins|mesh-list
2247620|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247621|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247622|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2247623|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
2247624|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247625|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
2247626|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
806309|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
806310|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2247627|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
2247628|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2247629|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2247630|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2247631|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2247632|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247633|NCT00123370|Modafinil|modafinil|mesh-list
806656|NCT02551042|Factor VIII|factor viii|mesh-list
806657|NCT02551042|Coagulants|coagulants|mesh-ancestor
2096456|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2096457|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2096458|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096459|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096460|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
2096461|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2096462|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096463|NCT02307318|Hemostatics|hemostatics|mesh-list
2096464|NCT02307318|Coagulants|coagulants|mesh-ancestor
2247634|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
807442|NCT02548494|Insulin|insulin|mesh-list
807443|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
807444|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
807445|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807598|NCT02547896|Diclofenac|diclofenac|mesh-list
807599|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
807600|NCT02547896|Codeine|codeine|mesh-list
807601|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
807602|NCT02547896|Analgesics|analgesics|mesh-ancestor
807603|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
807604|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807605|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807606|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
807607|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
807608|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
807609|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807610|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807611|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
807612|NCT02547896|Narcotics|narcotics|mesh-ancestor
807613|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
807614|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
807615|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
808800|NCT02542930|Thymalfasin|thymalfasin|mesh-list
808801|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
808802|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
808803|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809070|NCT02541734|Exenatide|exenatide|mesh-list
809071|NCT02541734|Polygeline|polygeline|mesh-list
809072|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
809073|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809074|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
809075|NCT02541734|Incretins|incretins|mesh-ancestor
809076|NCT02541734|Hormones|hormones|mesh-ancestor
809077|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
809078|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
809079|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
809295|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
809296|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809297|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810173|NCT02537353|Epinephrine|epinephrine|mesh-list
805032|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805033|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805034|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
805035|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805269|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
805270|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
805271|NCT02556931|Fludarabine|fludarabine|mesh-list
805272|NCT02556931|Tacrolimus|tacrolimus|mesh-list
805273|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
805274|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
805275|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805276|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
805277|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
805278|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
805279|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805280|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805281|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
805282|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
805283|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805284|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
805285|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
805286|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
805287|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
805288|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
805408|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
805409|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805410|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
805411|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805412|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805467|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
805539|NCT02556008|Cannabidiol|cannabidiol|mesh-list
805540|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
805635|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
805636|NCT02555761|Alcaftadine|alcaftadine|mesh-list
805637|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
805638|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
805639|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
805640|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
805641|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805642|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805643|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806072|NCT02554123|Vitamin E|vitamin e|mesh-list
806073|NCT02554123|Petrolatum|petrolatum|mesh-list
806074|NCT02554123|Vitamins|vitamins|mesh-ancestor
806075|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
806076|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806077|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
806078|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806079|NCT02554123|Protective Agents|protective agents|mesh-ancestor
806080|NCT02554123|Emollients|emollients|mesh-ancestor
806081|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
806685|NCT02550912|Vitamin D|vitamin d|mesh-list
806686|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
806687|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
806688|NCT02550912|Vitamins|vitamins|mesh-list
806689|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
806690|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806691|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
806692|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
807012|NCT02549924|Resveratrol|resveratrol|mesh-list
807013|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
807014|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807015|NCT02549924|Protective Agents|protective agents|mesh-ancestor
807016|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807017|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807018|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
807400|NCT02548403|Simethicone|simethicone|mesh-list
807401|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
807402|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807403|NCT02548403|Emollients|emollients|mesh-ancestor
807404|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
807515|NCT02548052|Betamethasone|betamethasone|mesh-list
807516|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
807517|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
807518|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
807519|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
807520|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
805089|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
805090|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805091|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
805092|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
805093|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
805094|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
805095|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805096|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805157|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
805158|NCT02557490|Raltitrexed|raltitrexed|mesh-list
805159|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805160|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
805161|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
805162|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805164|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
805165|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247635|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247636|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2247637|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
806673|NCT02551133|Dexamethasone|dexamethasone|mesh-list
806674|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
806675|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
806676|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
806677|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806678|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806679|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
806680|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
806681|NCT02551133|Hormones|hormones|mesh-ancestor
806682|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
806683|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
806684|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807056|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
807057|NCT02549677|Docetaxel|docetaxel|mesh-list
807058|NCT02549677|Epirubicin|epirubicin|mesh-list
807059|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
807060|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
807061|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807062|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
807063|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
807064|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
807065|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807066|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807067|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
807068|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
807069|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
807070|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
807071|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
807072|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
807073|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
807074|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247638|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2247639|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247640|NCT00123383|Modafinil|modafinil|mesh-list
2247641|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2247642|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247643|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2247644|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
807567|NCT02547792|Vaccines|vaccines|mesh-list
807568|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
807569|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247645|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2247646|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247647|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2247648|NCT00123461|Vitamins|vitamins|mesh-ancestor
2247649|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
2247650|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247651|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
805129|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
805130|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
805201|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
805202|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
805203|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805372|NCT02556658|Anesthetics|anesthetics|mesh-list
805373|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
805374|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805454|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
805455|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
805456|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
805457|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
805458|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
805459|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805460|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
805461|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
805462|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
805463|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
805464|NCT02556411|Estrogens|estrogens|mesh-ancestor
805465|NCT02556411|Hormones|hormones|mesh-ancestor
805466|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
805893|NCT02554851|Mitogens|mitogens|mesh-list
805894|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
805895|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247652|NCT00123539|Estrogens|estrogens|mesh-list
2247653|NCT00123539|Hormones|hormones|mesh-ancestor
2247654|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2247655|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247656|NCT00123552|Artesunate|artesunate|mesh-list
2247657|NCT00123552|Lumefantrine|lumefantrine|mesh-list
2247658|NCT00123552|Artemether|artemether|mesh-list
2247659|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
806179|NCT02553265|Carbidopa|carbidopa|mesh-list
806180|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
806181|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
806182|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
806183|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806184|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806185|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806186|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
806187|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247660|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
2247661|NCT00123552|Amodiaquine|amodiaquine|mesh-list
2247662|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2247663|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
2247664|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
806894|NCT02550080|Dapsone|dapsone|mesh-list
806895|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
806896|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
806897|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
806898|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
806899|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
806900|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806901|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806902|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
806903|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2096465|NCT02307513|Apremilast|apremilast|mesh-list
2096466|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2096467|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2096468|NCT02307513|Analgesics|analgesics|mesh-ancestor
2096469|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
2096470|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096471|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096472|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2096473|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2247665|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
807808|NCT02546934|Gemcitabine|gemcitabine|mesh-list
807809|NCT02546934|Cisplatin|cisplatin|mesh-list
807810|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807811|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
807812|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
807813|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807814|NCT02546934|Antiviral Agents|antiviral agents|mesh-ancestor
807815|NCT02546934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
807816|NCT02546934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247666|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
805167|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
805168|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805169|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
805170|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805171|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
805172|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
805173|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805750|NCT02555488|Methylene Blue|methylene blue|mesh-list
805751|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805752|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805926|NCT02554695|Denosumab|denosumab|mesh-list
805927|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
805928|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096474|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2096475|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2096476|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096477|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096478|NCT02307526|Bromides|bromides|mesh-list
2096479|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2096480|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
2096481|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2096482|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096483|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096484|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
2096485|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096486|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807533|NCT02547597|Atenolol|atenolol|mesh-list
807534|NCT02547597|Carvedilol|carvedilol|mesh-list
807535|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
807536|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
807537|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
807538|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
807539|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807540|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807541|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
807542|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
807543|NCT02547597|Protective Agents|protective agents|mesh-ancestor
807544|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
807545|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
807546|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
807547|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
807548|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
807549|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
807550|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
807551|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
807552|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
807553|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807554|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
809003|NCT02542254|Albuterol|albuterol|mesh-list
809004|NCT02542254|Ipratropium|ipratropium|mesh-list
809005|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
809006|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
809007|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809008|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809009|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
809010|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
809011|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
809012|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
809013|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
809014|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
809015|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
809016|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
809017|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809018|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809019|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
809020|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
809150|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
809151|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
809152|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
809153|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809298|NCT02541032|Minocycline|minocycline|mesh-list
809299|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
809300|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809611|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
805232|NCT02557087|Scopolamine|scopolamine|mesh-list
805233|NCT02557087|Meperidine|meperidine|mesh-list
805234|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
805235|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
805236|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
805237|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805238|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805239|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
805240|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
805241|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
805242|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
805243|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805244|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805245|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
805246|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
805247|NCT02557087|Narcotics|narcotics|mesh-ancestor
805248|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
805249|NCT02557087|Analgesics|analgesics|mesh-ancestor
805250|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
805369|NCT02556840|Insulin|insulin|mesh-list
805370|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
805371|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805475|NCT02556424|Dexamethasone|dexamethasone|mesh-list
805476|NCT02556424|Triamcinolone|triamcinolone|mesh-list
805477|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
805478|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
805479|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
805480|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805481|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805482|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
805483|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
805484|NCT02556424|Hormones|hormones|mesh-ancestor
805485|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
805486|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
805487|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096487|NCT02307682|Aflibercept|aflibercept|mesh-list
2096488|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2096489|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2096490|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2096491|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2096492|NCT02307682|Growth Substances|growth substances|mesh-ancestor
2096493|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247667|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247668|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
2247669|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
2247670|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2247671|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
2247672|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2247673|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247674|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247675|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2247676|NCT00123552|Renal Agents|renal agents|mesh-ancestor
2247677|NCT00123578|Pentobarbital|pentobarbital|mesh-list
2247678|NCT00123578|Lorazepam|lorazepam|mesh-list
2247679|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
2247680|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
2247681|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
2247682|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247683|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247684|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2247685|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
807114|NCT02549391|Cinacalcet|cinacalcet|mesh-list
807115|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
807116|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807117|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
807118|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
807119|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
807484|NCT02548286|Amlodipine|amlodipine|mesh-list
807485|NCT02548286|Candesartan|candesartan|mesh-list
807486|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
807487|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
807488|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
807489|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807490|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
807491|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096494|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
805523|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
805524|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
805525|NCT02556268|Triumeq|triumeq|mesh-list
805526|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
805527|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
805528|NCT02556268|Riociguat|riociguat|mesh-list
805529|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
805530|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
805531|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
805532|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
805533|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805534|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
805535|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
805536|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805537|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
805538|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
806026|NCT02554175|Propofol|propofol|mesh-list
806027|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
806028|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
806029|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806030|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
806031|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
806032|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
806131|NCT02553642|Nivolumab|nivolumab|mesh-list
806132|NCT02553642|Ipilimumab|ipilimumab|mesh-list
806133|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
806134|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
806135|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
806136|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806525|NCT02551796|Levofloxacin|levofloxacin|mesh-list
806526|NCT02551796|Ofloxacin|ofloxacin|mesh-list
806527|NCT02551796|Tobramycin|tobramycin|mesh-list
806528|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
806529|NCT02551796|Dexamethasone|dexamethasone|mesh-list
806530|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
806531|NCT02551796|BB 1101|bb 1101|mesh-list
806532|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
806533|NCT02551796|Dipivefrin|dipivefrin|mesh-list
806534|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
806535|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
806536|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
806537|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806538|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806539|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
806540|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
806541|NCT02551796|Hormones|hormones|mesh-ancestor
806542|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
806543|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
806544|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
806545|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
806546|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806547|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806548|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
806549|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
806550|NCT02551796|Renal Agents|renal agents|mesh-ancestor
806551|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
806552|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
806553|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
806554|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
806555|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
806556|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
806557|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
806558|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
806559|NCT02551796|Protective Agents|protective agents|mesh-ancestor
806560|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
806561|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
806562|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806563|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
806564|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
806591|NCT02551237|Capecitabine|capecitabine|mesh-list
806592|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
806593|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
806594|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806595|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805594|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
805595|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
805596|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
806199|NCT02553018|Methotrexate|methotrexate|mesh-list
806200|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
806201|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
806202|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
806203|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806204|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
806205|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
806206|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806207|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
806208|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
806209|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806210|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
806211|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
806212|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
806213|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
806214|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2247686|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2247687|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2247688|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2247689|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2247690|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
807746|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
807747|NCT02547025|Amoxicillin|amoxicillin|mesh-list
807748|NCT02547025|Clarithromycin|clarithromycin|mesh-list
807749|NCT02547025|Levofloxacin|levofloxacin|mesh-list
807750|NCT02547025|Ofloxacin|ofloxacin|mesh-list
807751|NCT02547025|Tetracycline|tetracycline|mesh-list
807752|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
807753|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
807754|NCT02547025|Rabeprazole|rabeprazole|mesh-list
807755|NCT02547025|Bismuth|bismuth|mesh-list
807756|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
807757|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
807758|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
807759|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807760|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807761|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
807762|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
807763|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
807764|NCT02547025|Renal Agents|renal agents|mesh-ancestor
807765|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
807766|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
807767|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807768|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
807769|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
807770|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
807771|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
807772|NCT02547025|Antacids|antacids|mesh-ancestor
2247691|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
2247692|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247693|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247694|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2247695|NCT00123656|Fluticasone|fluticasone|mesh-list
809276|NCT02541019|Ondansetron|ondansetron|mesh-list
809277|NCT02541019|Palonosetron|palonosetron|mesh-list
809278|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
809279|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
809280|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809301|NCT02540876|Ilorasertib|ilorasertib|mesh-list
805678|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805679|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
805680|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
805681|NCT02555748|Growth Substances|growth substances|mesh-ancestor
805682|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805683|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
805684|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
805685|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805686|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805991|NCT02554812|Avelumab|avelumab|mesh-list
805992|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
805993|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247696|NCT00123656|Esomeprazole|esomeprazole|mesh-list
2247697|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2247698|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2247699|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
2247700|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247701|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247702|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2247703|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
2247704|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
2247705|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2247706|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2247707|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2247708|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2247709|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247710|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247711|NCT00123669|Progesterone|progesterone|mesh-list
2247712|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
807450|NCT02548468|Vidarabine|vidarabine|mesh-list
807451|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
807452|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
807453|NCT02548468|Fludarabine|fludarabine|mesh-list
807454|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
807455|NCT02548468|Tacrolimus|tacrolimus|mesh-list
807456|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
807457|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
807458|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807459|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
807460|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
807461|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
807462|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807463|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807464|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
807465|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
807466|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
807467|NCT02548468|Antiviral Agents|antiviral agents|mesh-ancestor
807468|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
807469|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
807470|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807471|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
807472|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
807473|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
807474|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2247713|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2247714|NCT00123669|Progestins|progestins|mesh-ancestor
2247715|NCT00123669|Hormones|hormones|mesh-ancestor
807965|NCT02546050|Metformin|metformin|mesh-list
807966|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
807967|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808063|NCT02545751|Thymalfasin|thymalfasin|mesh-list
808064|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
808065|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
808066|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273742|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809379|NCT02540785|Levofloxacin|levofloxacin|mesh-list
809380|NCT02540785|Ofloxacin|ofloxacin|mesh-list
809381|NCT02540785|Tobramycin|tobramycin|mesh-list
809382|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
809383|NCT02540785|Dexamethasone|dexamethasone|mesh-list
809384|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
809385|NCT02540785|BB 1101|bb 1101|mesh-list
809386|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
809387|NCT02540785|Dipivefrin|dipivefrin|mesh-list
809388|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
809389|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
809390|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
809452|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2247716|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2247717|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247718|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2247719|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
2247720|NCT00123825|Gemcitabine|gemcitabine|mesh-list
2247721|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
806163|NCT02553473|Doxycycline|doxycycline|mesh-list
806164|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
806165|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
806166|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
806167|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
806168|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
806476|NCT02551549|Rezafungin|rezafungin|mesh-list
806477|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
806478|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096495|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096496|NCT02307916|Mitogens|mitogens|mesh-list
2096497|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
2096498|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096499|NCT02308007|Metronidazole|metronidazole|mesh-list
2096500|NCT02308007|Terconazole|terconazole|mesh-list
2096501|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096502|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2096503|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2096504|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2096505|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
2096506|NCT02308033|Metronidazole|metronidazole|mesh-list
2096507|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096508|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2096509|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2096510|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2096511|NCT02308046|Terconazole|terconazole|mesh-list
2096512|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
2096513|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096514|NCT02308124|Midodrine|midodrine|mesh-list
2096515|NCT02308124|Bromides|bromides|mesh-list
2096516|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2096517|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
2096518|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
2096519|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
2247722|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2247723|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
2247724|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247725|NCT00123825|Antiviral Agents|antiviral agents|mesh-ancestor
2247726|NCT00123825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247727|NCT00123825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247728|NCT00123825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2247729|NCT00123825|Immunologic Factors|immunologic factors|mesh-ancestor
808195|NCT02545231|Pitavastatin|pitavastatin|mesh-list
808196|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
808197|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
808198|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
808199|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
808200|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808201|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808202|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
808331|NCT02544880|Tadalafil|tadalafil|mesh-list
808332|NCT02544880|Vaccines|vaccines|mesh-list
808333|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
808334|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808335|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
808336|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
808337|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
808338|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096520|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096521|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247730|NCT00123825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805764|NCT02555852|Esomeprazole|esomeprazole|mesh-list
805765|NCT02555852|Omeprazole|omeprazole|mesh-list
805766|NCT02555852|Rabeprazole|rabeprazole|mesh-list
805767|NCT02555852|Pantoprazole|pantoprazole|mesh-list
805768|NCT02555852|Lansoprazole|lansoprazole|mesh-list
805769|NCT02555852|Famotidine|famotidine|mesh-list
805770|NCT02555852|Ranitidine|ranitidine|mesh-list
805771|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
805772|NCT02555852|Cimetidine|cimetidine|mesh-list
805773|NCT02555852|Nizatidine|nizatidine|mesh-list
805774|NCT02555852|Lafutidine|lafutidine|mesh-list
805775|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
805776|NCT02555852|Bismuth|bismuth|mesh-list
805777|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
805778|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
805779|NCT02555852|Histamine|histamine|mesh-list
805780|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
805781|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805782|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
805783|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
805784|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805785|NCT02555852|Antacids|antacids|mesh-ancestor
805786|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
805787|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
805788|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805789|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805790|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
805791|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
805792|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
805793|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
805829|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
805830|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
805831|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
805832|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
805833|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
805834|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805835|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805836|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
805837|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
805838|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2247731|NCT00123851|Capecitabine|capecitabine|mesh-list
2247732|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
2247733|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2247734|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2247735|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
2247736|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247737|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247738|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2247739|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247740|NCT00123877|Esorubicin|esorubicin|mesh-list
2247741|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2247742|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247743|NCT00123890|Aplaviroc|aplaviroc|mesh-list
2247744|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
806857|NCT02550093|Oxytocin|oxytocin|mesh-list
806858|NCT02550093|Oxytocics|oxytocics|mesh-ancestor
806859|NCT02550093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
806860|NCT02550093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807022|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
807023|NCT02549963|Anticoagulants|anticoagulants|mesh-list
807024|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
807025|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
807026|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
807027|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
807028|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807029|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808616|NCT02543645|Atezolizumab|atezolizumab|mesh-list
2247745|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2273743|NCT00204243|Naltrexone|naltrexone|mesh-list
805810|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
805811|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
805812|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
805813|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805814|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
805815|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
805816|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
805817|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
805818|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
806137|NCT02553551|Vitamins|vitamins|mesh-list
806138|NCT02553551|Ascorbic Acid|ascorbic acid|mesh-list
806139|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
806140|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806141|NCT02553551|Antioxidants|antioxidants|mesh-ancestor
806142|NCT02553551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806143|NCT02553551|Protective Agents|protective agents|mesh-ancestor
806176|NCT02553343|Vaccines|vaccines|mesh-list
806177|NCT02553343|Immunologic Factors|immunologic factors|mesh-ancestor
806178|NCT02553343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807003|NCT02549846|Atorvastatin|atorvastatin|mesh-list
807004|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
807005|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
807006|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
807007|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
807008|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807009|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
807010|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
807011|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247746|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247747|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2247748|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2247749|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
2247750|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247751|NCT00123903|Metoprolol|metoprolol|mesh-list
2247752|NCT00123903|Carvedilol|carvedilol|mesh-list
2247753|NCT00123903|Lisinopril|lisinopril|mesh-list
2247754|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2247755|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2247756|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
2247757|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
2247758|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247759|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247760|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2247761|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2247762|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2247763|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
807394|NCT02548364|Vitamin D|vitamin d|mesh-list
807395|NCT02548364|Calcifediol|calcifediol|mesh-list
807396|NCT02548364|Vitamins|vitamins|mesh-ancestor
807397|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
807398|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807399|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2247764|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247765|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247766|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
2247767|NCT00123903|Protective Agents|protective agents|mesh-ancestor
2247768|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2247769|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2247770|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
807799|NCT02546791|Dasatinib|dasatinib|mesh-list
807800|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807801|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
807802|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807803|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808268|NCT02544815|Digoxin|digoxin|mesh-list
808269|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
808270|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
808271|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808272|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808273|NCT02544815|Protective Agents|protective agents|mesh-ancestor
808274|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247771|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
2247772|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2247773|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2273744|NCT00204243|Methadone|methadone|mesh-list
805922|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805923|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
805924|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
805925|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2247774|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2247775|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
2247776|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247777|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2247778|NCT00123916|Benzonidazole|benzonidazole|mesh-list
2247779|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2247780|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
2247781|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247782|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2247783|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2247784|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2247785|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247786|NCT00123929|Docetaxel|docetaxel|mesh-list
2247787|NCT00123929|Doxorubicin|doxorubicin|mesh-list
806693|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
806694|NCT02550782|Bupivacaine|bupivacaine|mesh-list
806695|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
806696|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
806697|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
806698|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806699|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
806700|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806701|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
806702|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
806703|NCT02550782|Analgesics|analgesics|mesh-ancestor
806704|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
806705|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
806706|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
806707|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
806708|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806709|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806748|NCT02550483|Beta Carotene|beta carotene|mesh-list
806749|NCT02550483|Lycopene|lycopene|mesh-list
806750|NCT02550483|Carotenoids|carotenoids|mesh-list
806751|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
806752|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
806753|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806754|NCT02550483|Protective Agents|protective agents|mesh-ancestor
806755|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806756|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
806757|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
806758|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
806759|NCT02550483|Provitamins|provitamins|mesh-ancestor
806760|NCT02550483|Vitamins|vitamins|mesh-ancestor
806761|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
806941|NCT02550327|Gemcitabine|gemcitabine|mesh-list
806942|NCT02550327|Paclitaxel|paclitaxel|mesh-list
806943|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
806944|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
806945|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
806946|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
806947|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
806948|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
806949|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806950|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
806951|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
806952|NCT02550327|Antiviral Agents|antiviral agents|mesh-ancestor
806953|NCT02550327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
806954|NCT02550327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806955|NCT02550327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
806956|NCT02550327|Immunologic Factors|immunologic factors|mesh-ancestor
806957|NCT02550327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806958|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
807170|NCT02549430|Letrozole|letrozole|mesh-list
807171|NCT02549430|Fulvestrant|fulvestrant|mesh-list
807172|NCT02549430|Palbociclib|palbociclib|mesh-list
807173|NCT02549430|Anastrozole|anastrozole|mesh-list
807174|NCT02549430|Exemestane|exemestane|mesh-list
807175|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807176|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
807177|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
807178|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807179|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
805995|NCT02554253|Propofol|propofol|mesh-list
805996|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
805997|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
805998|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
805999|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
806000|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
806001|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
806002|NCT02554253|Analgesics|analgesics|mesh-ancestor
806003|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
806004|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806005|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
806006|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
806007|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
806008|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806009|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806117|NCT02553824|Topiramate|topiramate|mesh-list
806118|NCT02553824|Phentermine|phentermine|mesh-list
806119|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
806120|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
806121|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806122|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
806123|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
806124|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
806125|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
806126|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
806127|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806128|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
806129|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806130|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096522|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2096523|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2096524|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2096525|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2096526|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
2096527|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247788|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247789|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
2247790|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
2247791|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
2247792|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247793|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2247794|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2247795|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2247796|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247797|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2247798|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
806925|NCT02550028|Levetiracetam|levetiracetam|mesh-list
806926|NCT02550028|Phenobarbital|phenobarbital|mesh-list
806927|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
806928|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
806929|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
806930|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
806931|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806932|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
806933|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
806934|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806935|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806936|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
806937|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
806938|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
806939|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
806940|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2247799|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2247800|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2247801|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2247802|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2247803|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247804|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
2247805|NCT00124098|Hematinics|hematinics|mesh-ancestor
807258|NCT02549001|Amorolfine|amorolfine|mesh-list
807259|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
807260|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247806|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
2247807|NCT00124111|Fluorouracil|fluorouracil|mesh-list
807492|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
806084|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
806085|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
806086|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806087|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806088|NCT02554045|Urological Agents|urological agents|mesh-ancestor
2247808|NCT00124111|Methotrexate|methotrexate|mesh-list
2247809|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2247810|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
2247811|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247812|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2247813|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2247814|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
2247815|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247816|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247817|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2247818|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
2247819|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2247820|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2247821|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
806710|NCT02550756|Capsaicin|capsaicin|mesh-list
806711|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
806712|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
806713|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
806714|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806715|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247822|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2247823|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
2247824|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247825|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2247826|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2247827|NCT00124137|Diuretics|diuretics|mesh-list
2247828|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
2247829|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247830|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
807329|NCT02548806|Clonidine|clonidine|mesh-list
807330|NCT02548806|Analgesics|analgesics|mesh-ancestor
807331|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
807332|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807333|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807334|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
807335|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
807336|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
807337|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
807338|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
807339|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
807340|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
807341|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
807342|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247831|NCT00124150|Analgesics|analgesics|mesh-ancestor
2247832|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
2247833|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807788|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
807789|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
807790|NCT02547103|Mupirocin|mupirocin|mesh-list
807791|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
807792|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
807793|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
807794|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
807795|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
807796|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
807797|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807798|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807876|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
807877|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
807878|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
807879|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
807880|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
807881|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807882|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
807883|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
807884|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807885|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
807886|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
807887|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
807888|NCT02546648|Coagulants|coagulants|mesh-ancestor
2247834|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247835|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
2247836|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2247837|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2247838|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
2247839|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2247840|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
806658|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
806659|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
806660|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
806661|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806662|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806663|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
806664|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
806665|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
806666|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
806667|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806668|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806669|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
806670|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
806671|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
806672|NCT02551107|Protective Agents|protective agents|mesh-ancestor
807030|NCT02550002|Aflibercept|aflibercept|mesh-list
807031|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
807032|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
807033|NCT02550002|Growth Substances|growth substances|mesh-ancestor
807034|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807035|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
807036|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807231|NCT02549066|Milrinone|milrinone|mesh-list
807232|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
807233|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
807234|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
807235|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
807236|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
807237|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807238|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807239|NCT02549066|Protective Agents|protective agents|mesh-ancestor
807240|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247841|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247842|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2247843|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
2247844|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2247845|NCT00124241|Lamivudine|lamivudine|mesh-list
2247846|NCT00124241|Telbivudine|telbivudine|mesh-list
2247847|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2247848|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2247849|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247850|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247851|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
2247852|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247853|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2247854|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2247855|NCT00124267|Quinine|quinine|mesh-list
2247856|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
2247857|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2247858|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2247859|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247860|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2247861|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247862|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2247863|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247864|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2247865|NCT00124267|Analgesics|analgesics|mesh-ancestor
2247866|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
2247867|NCT00124280|Everolimus|everolimus|mesh-list
2247868|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247869|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2247870|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
2247871|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247872|NCT00124306|Amitriptyline|amitriptyline|mesh-list
2247873|NCT00124306|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2247874|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2247875|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
2247876|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2247877|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
806448|NCT02551861|Ribavirin|ribavirin|mesh-list
806449|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
806450|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
806451|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806452|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
806453|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
806800|NCT02550444|Clonidine|clonidine|mesh-list
806801|NCT02550444|Analgesics|analgesics|mesh-ancestor
806802|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
806803|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806804|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806805|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
806806|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
806807|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
806808|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
806809|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
806810|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
806811|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
806812|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806813|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806959|NCT02550119|Dexamethasone|dexamethasone|mesh-list
806960|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
806961|NCT02550119|Aprepitant|aprepitant|mesh-list
806962|NCT02550119|Dolasetron|dolasetron|mesh-list
806963|NCT02550119|Ichthammol|ichthammol|mesh-list
806964|NCT02550119|BB 1101|bb 1101|mesh-list
806965|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
806966|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
806967|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
806968|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806969|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806970|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
806971|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
806972|NCT02550119|Hormones|hormones|mesh-ancestor
806973|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
806974|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
806975|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
806976|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
806977|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806978|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806979|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
806980|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806981|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
806982|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
806983|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
807075|NCT02549651|Durvalumab|durvalumab|mesh-list
807076|NCT02549651|Tremelimumab|tremelimumab|mesh-list
807077|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
807078|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247878|NCT00124306|Analgesics|analgesics|mesh-ancestor
2247879|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
2247880|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247881|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247882|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2247883|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2247884|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2247885|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247886|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
2247887|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247888|NCT00124306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2247889|NCT00124306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2247890|NCT00124306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2247891|NCT00124332|Rimonabant|rimonabant|mesh-list
2247892|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2247893|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2247894|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2247895|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2247896|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247897|NCT00124332|Hormones|hormones|mesh-ancestor
2247898|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2247899|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247900|NCT00124358|Buprenorphine|buprenorphine|mesh-list
2247901|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2247902|NCT00124358|Narcotics|narcotics|mesh-ancestor
806198|NCT02553161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2247903|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2247904|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247905|NCT00124358|Analgesics|analgesics|mesh-ancestor
806770|NCT02550717|Aspirin|aspirin|mesh-list
806771|NCT02550717|Anticoagulants|anticoagulants|mesh-list
806772|NCT02550717|Clopidogrel|clopidogrel|mesh-list
806773|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
806774|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
806775|NCT02550717|Analgesics|analgesics|mesh-ancestor
806776|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
806777|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806778|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806779|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
806780|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
806781|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
806782|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
806783|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806784|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
806785|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
806786|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806787|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
806788|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
806789|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
806790|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
806791|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
806792|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
807079|NCT02549898|Cilostazol|cilostazol|mesh-list
807080|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
807081|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
807082|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
807083|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807084|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807085|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
807086|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
807087|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
807088|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
807089|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807090|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
807091|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
807092|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
807093|NCT02549898|Protective Agents|protective agents|mesh-ancestor
807094|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
807095|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
807096|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807097|NCT02549898|Hematinics|hematinics|mesh-ancestor
807098|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
807099|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2247906|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
2247907|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247908|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
808102|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
808103|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
808104|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
808105|NCT02545959|Prednisolone|prednisolone|mesh-list
808106|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
808107|NCT02545959|Rituximab|rituximab|mesh-list
808108|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
808109|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
808110|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
808111|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
808112|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
808113|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808114|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
808115|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
808116|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
808117|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
808118|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808119|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
808120|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
808121|NCT02545959|Hormones|hormones|mesh-ancestor
808122|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
808123|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
808124|NCT02545959|Protective Agents|protective agents|mesh-ancestor
808125|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2096528|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096529|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2096530|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096531|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
2096532|NCT02308163|Etanercept|etanercept|mesh-list
2096533|NCT02308163|Peficitinib|peficitinib|mesh-list
2096534|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2096535|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2096536|NCT02308163|Analgesics|analgesics|mesh-ancestor
2096537|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
2096538|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096539|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096540|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2096541|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2096542|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2096543|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2096544|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
2096545|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096546|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096547|NCT02308228|Metformin|metformin|mesh-list
2096548|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2096549|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096550|NCT02308501|Alcaftadine|alcaftadine|mesh-list
2096551|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2096552|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
2096553|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
2096554|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096555|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096556|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096557|NCT02308540|Vaccines|vaccines|mesh-list
2096558|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2096559|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
2096560|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096561|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
2096562|NCT02308748|Lidocaine|lidocaine|mesh-list
2096563|NCT02308748|Mexiletine|mexiletine|mesh-list
2096564|NCT02308748|Dofetilide|dofetilide|mesh-list
2096565|NCT02308748|Diltiazem|diltiazem|mesh-list
2096566|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
2096567|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
2096568|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2096569|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096570|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
2096571|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096572|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2096573|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2096574|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2096575|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2096576|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096577|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2096578|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247909|NCT00124384|Modafinil|modafinil|mesh-list
2247910|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2247911|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247912|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2247913|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2247914|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2247915|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247916|NCT00124397|Atorvastatin|atorvastatin|mesh-list
2247917|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2247918|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2247919|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
2247920|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247921|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2247922|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2247923|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247924|NCT00124436|Alitretinoin|alitretinoin|mesh-list
2247925|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247926|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
2247927|NCT00124475|Alitretinoin|alitretinoin|mesh-list
808183|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
808184|NCT02545426|Calcium|calcium|mesh-list
808185|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
808186|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806290|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
806291|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
806292|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806293|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806294|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
806295|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
806296|NCT02552745|Analgesics|analgesics|mesh-ancestor
806297|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
806298|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806299|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806300|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
806301|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
806329|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
806330|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
806331|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
806332|NCT02552342|Prednisolone|prednisolone|mesh-list
806333|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
806334|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
806335|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
806336|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
806337|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
806338|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
806339|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806340|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806341|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
806342|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
806343|NCT02552342|Hormones|hormones|mesh-ancestor
806344|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
806345|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
806346|NCT02552342|Protective Agents|protective agents|mesh-ancestor
806347|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
806348|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247928|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247929|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
2247930|NCT00124527|Capecitabine|capecitabine|mesh-list
2247931|NCT00124527|Irofulven|irofulven|mesh-list
2247932|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2247933|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
2247934|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247935|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247936|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2247937|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
2247938|NCT00124540|Misoprostol|misoprostol|mesh-list
2247939|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2247940|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
2247941|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2247942|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247943|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2247944|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2247945|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
2247946|NCT00124566|Prednisone|prednisone|mesh-list
807213|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
807214|NCT02548923|Propofol|propofol|mesh-list
807215|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
807216|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
807217|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807218|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
807219|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
807220|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
807221|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
807222|NCT02548923|Analgesics|analgesics|mesh-ancestor
807223|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
807224|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807225|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
807226|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
807227|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
807228|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
807229|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
807230|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247947|NCT00124566|Capecitabine|capecitabine|mesh-list
2247948|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
2247949|NCT00124566|Irofulven|irofulven|mesh-list
2247950|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
807587|NCT02547870|Rilpivirine|rilpivirine|mesh-list
807588|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2247951|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
806316|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
806317|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
806318|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
806319|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806320|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806321|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
806322|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
806323|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
806576|NCT02551276|Albuterol|albuterol|mesh-list
806577|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
806578|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
806579|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806580|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806581|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
806582|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
806583|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
806584|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
806585|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
806586|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
806587|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
806588|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
806589|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806590|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806861|NCT02550418|Budesonide|budesonide|mesh-list
806862|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
806863|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
806864|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
806865|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806866|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806867|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
806868|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
806869|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
806870|NCT02550418|Hormones|hormones|mesh-ancestor
806871|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2247952|NCT00124566|Hormones|hormones|mesh-ancestor
2247953|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2247954|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247955|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2247956|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247957|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2247958|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
2247959|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247960|NCT00124566|Analgesics|analgesics|mesh-ancestor
2247961|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
2247962|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2247963|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2247964|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2247965|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2247966|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2247967|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
2247968|NCT00124605|Pamidronate|pamidronate|mesh-list
2247969|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
2247970|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247971|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2247972|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247973|NCT00124644|Cytarabine|cytarabine|mesh-list
2247974|NCT00124644|Etoposide|etoposide|mesh-list
2247975|NCT00124644|Daunorubicin|daunorubicin|mesh-list
2247976|NCT00124644|Tipifarnib|tipifarnib|mesh-list
2247977|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2247978|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2247979|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247980|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2247981|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2247982|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2247983|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2247984|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
2247985|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
2247986|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2247987|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2247988|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
2247989|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247990|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2247991|NCT00124683|Bupropion|bupropion|mesh-list
806507|NCT02551536|Fexofenadine|fexofenadine|mesh-list
806508|NCT02551536|Montelukast|montelukast|mesh-list
806509|NCT02551536|Levocetirizine|levocetirizine|mesh-list
806510|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
806511|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
806512|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
806513|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
806514|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
806515|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806516|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
806517|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
806518|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
806519|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
806520|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
806521|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
806522|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
806523|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
806524|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806650|NCT02551029|Capsaicin|capsaicin|mesh-list
806651|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
806652|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
806653|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
806654|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806655|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807187|NCT02549105|Lidocaine|lidocaine|mesh-list
807188|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
807189|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
807190|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
807191|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
807192|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807193|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
807194|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807195|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
807196|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
807197|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
807198|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
807199|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807200|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
807321|NCT02548832|Magnesium Oxide|magnesium oxide|mesh-list
807322|NCT02548832|Bezafibrate|bezafibrate|mesh-list
807323|NCT02548832|Antacids|antacids|mesh-ancestor
807324|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807325|NCT02548832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
807326|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
807327|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
807328|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
807475|NCT02548117|Finasteride|finasteride|mesh-list
807476|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
807477|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
807478|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807479|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807480|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
807481|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
807482|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807483|NCT02548117|Urological Agents|urological agents|mesh-ancestor
807687|NCT02547480|Irinotecan|irinotecan|mesh-list
807688|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
807689|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
807690|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807691|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807692|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247992|NCT00124683|Nicotine|nicotine|mesh-list
2096579|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2096580|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2096581|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096582|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096583|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2096584|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
806889|NCT02550249|Nivolumab|nivolumab|mesh-list
806890|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
806891|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
806892|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
806893|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807120|NCT02549469|Naproxen|naproxen|mesh-list
807121|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
807122|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
807123|NCT02549469|Analgesics|analgesics|mesh-ancestor
807124|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
807125|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807126|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807127|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
807128|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
807129|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
807130|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
807131|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807132|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807820|NCT02546843|Rocuronium|rocuronium|mesh-list
807821|NCT02546843|Atracurium|atracurium|mesh-list
807822|NCT02546843|Cisatracurium|cisatracurium|mesh-list
807823|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
807824|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
807825|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
807826|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807827|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807828|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
807829|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
807830|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
807831|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
807832|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807910|NCT02546531|Gemcitabine|gemcitabine|mesh-list
807911|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
807912|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
807913|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
807914|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807915|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807916|NCT02546531|Antiviral Agents|antiviral agents|mesh-ancestor
807917|NCT02546531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
807918|NCT02546531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807919|NCT02546531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
807920|NCT02546531|Immunologic Factors|immunologic factors|mesh-ancestor
807921|NCT02546531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807922|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
808029|NCT02546141|Caseins|caseins|mesh-list
808030|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
808031|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
808032|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808261|NCT02544906|Propofol|propofol|mesh-list
808262|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
808263|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
808264|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808265|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
808266|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
808267|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
808381|NCT02544724|Interleukin-12|interleukin-12|mesh-list
808382|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
808383|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
808384|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808385|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
808386|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
808387|NCT02544724|Growth Substances|growth substances|mesh-ancestor
808388|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
808389|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2247993|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2247994|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
2247995|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273745|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
808606|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806612|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806613|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
806614|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
806615|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
806616|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
806617|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
806618|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
806619|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
806620|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
806621|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
806622|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
806623|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
807019|NCT02549742|Bleomycin|bleomycin|mesh-list
807020|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
807021|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807142|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
807143|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
807144|NCT02549170|Antibodies|antibodies|mesh-list
807145|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
807146|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
807147|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
807148|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
807149|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807773|NCT02547116|Rifampin|rifampin|mesh-list
807774|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
807775|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
807776|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
807777|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
807778|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
807779|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
807780|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807781|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807782|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
807783|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
807784|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
807785|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
807786|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
807787|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
808126|NCT02545712|Ethanol|ethanol|mesh-list
808127|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
808128|NCT02545712|Sorbitol|sorbitol|mesh-list
808129|NCT02545712|Glycerol|glycerol|mesh-list
808130|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
808131|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
808132|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
808133|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808134|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
808135|NCT02545712|Protective Agents|protective agents|mesh-ancestor
808136|NCT02545712|Cathartics|cathartics|mesh-ancestor
808137|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
808138|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
808139|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
808140|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
808141|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808583|NCT02543697|Epinephrine|epinephrine|mesh-list
808584|NCT02543697|Racepinephrine|racepinephrine|mesh-list
808585|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
808586|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
808587|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
808588|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
808589|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
808590|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808591|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808592|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
808593|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
808594|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
808595|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808596|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
808597|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
808598|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
808599|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
808600|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
808753|NCT02543034|Petrolatum|petrolatum|mesh-list
808754|NCT02543034|Emollients|emollients|mesh-ancestor
808755|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
2247996|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2247997|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2247998|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2247999|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
2248000|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248001|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248002|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2248003|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
2248004|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2248005|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2248006|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2248007|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2248008|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
2248009|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
806908|NCT02550262|Fentanyl|fentanyl|mesh-list
806909|NCT02550262|Bupivacaine|bupivacaine|mesh-list
806910|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
806911|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
806912|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
806913|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806914|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
806915|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
806916|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
806917|NCT02550262|Narcotics|narcotics|mesh-ancestor
806918|NCT02550262|Analgesics|analgesics|mesh-ancestor
806919|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
806920|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
806921|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
807343|NCT02548780|Doxorubicin|doxorubicin|mesh-list
807344|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
807345|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807346|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
807347|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
807348|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807349|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808169|NCT02545530|Clonidine|clonidine|mesh-list
808170|NCT02545530|Analgesics|analgesics|mesh-ancestor
808171|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
808172|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808173|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808174|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
808175|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
808176|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
808177|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
808178|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
808179|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
808180|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
808181|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
808182|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808343|NCT02544776|Amlodipine|amlodipine|mesh-list
808344|NCT02544776|Clomiphene|clomiphene|mesh-list
808345|NCT02544776|Enclomiphene|enclomiphene|mesh-list
808346|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
808347|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808348|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
808349|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
808350|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
808351|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
808352|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808353|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
808354|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
808355|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
808356|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
808357|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
808358|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
808359|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
808360|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
808361|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2248010|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2248011|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248012|NCT00124696|Cocaethylene|cocaethylene|mesh-list
2248013|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2096585|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2096586|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
2096587|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2096588|NCT02309359|Methotrexate|methotrexate|mesh-list
806767|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
806768|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806769|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
806854|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
806855|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
806856|NCT02550314|Coagulants|coagulants|mesh-ancestor
806872|NCT02550067|Copper|copper|mesh-list
806873|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
806874|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
806875|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
806876|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
806877|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
806878|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
806879|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
806880|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
806881|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
806882|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
806883|NCT02550067|Trace Elements|trace elements|mesh-ancestor
806884|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
806885|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
806886|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
806887|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
806888|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807261|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
807262|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
807263|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
807264|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
807265|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
807266|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807267|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807268|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
807269|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
807270|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
807271|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
807272|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096589|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2096590|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
2096591|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2096592|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096593|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2096594|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
2096595|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096596|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096597|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
2096598|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096599|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2096600|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2248014|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2248015|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2248016|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248017|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
2248018|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248019|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248020|NCT00124722|Bromides|bromides|mesh-list
2248021|NCT00124722|Rocuronium|rocuronium|mesh-list
2248022|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
2248023|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2248024|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2248025|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2248026|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248027|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248028|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
2248029|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
2248030|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
2248031|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248032|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808095|NCT02545634|Sulfalene|sulfalene|mesh-list
808096|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
808097|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
808098|NCT02545634|Renal Agents|renal agents|mesh-ancestor
808099|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
808100|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
808101|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
808314|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
808315|NCT02544828|Hematinics|hematinics|mesh-ancestor
807044|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
807045|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807046|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
807047|NCT02549768|Analgesics|analgesics|mesh-ancestor
807048|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
807049|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807050|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
807051|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
807052|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
807053|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
807054|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
807055|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807107|NCT02549326|Vitamin D|vitamin d|mesh-list
807108|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
807109|NCT02549326|Vitamins|vitamins|mesh-ancestor
807110|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
807111|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807112|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
807113|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
807495|NCT02548195|Gemcitabine|gemcitabine|mesh-list
807496|NCT02548195|Capecitabine|capecitabine|mesh-list
807497|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
807498|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
807499|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
807500|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807501|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807502|NCT02548195|Antiviral Agents|antiviral agents|mesh-ancestor
807503|NCT02548195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
807504|NCT02548195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807505|NCT02548195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
807506|NCT02548195|Immunologic Factors|immunologic factors|mesh-ancestor
807507|NCT02548195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248033|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2248034|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2248035|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
2248036|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
2248037|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
808070|NCT02545972|Tacrolimus|tacrolimus|mesh-list
808071|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
808072|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
808073|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808074|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
808075|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808076|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808324|NCT02544854|Propofol|propofol|mesh-list
808325|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
808326|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
808327|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808328|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
808329|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
808330|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
808531|NCT02544243|Gemcitabine|gemcitabine|mesh-list
808532|NCT02544243|Vinorelbine|vinorelbine|mesh-list
808533|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
808534|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
808535|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
808536|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808537|NCT02544243|Antiviral Agents|antiviral agents|mesh-ancestor
808538|NCT02544243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
808539|NCT02544243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808540|NCT02544243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
808541|NCT02544243|Immunologic Factors|immunologic factors|mesh-ancestor
808542|NCT02544243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808543|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
808544|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
808545|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
808546|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
2248038|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248039|NCT00124813|Thalidomide|thalidomide|mesh-list
2248040|NCT00124813|Idarubicin|idarubicin|mesh-list
2248041|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2248042|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
2248043|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248044|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
2248045|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
807133|NCT02549261|Etoposide|etoposide|mesh-list
807134|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
807135|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807136|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
807137|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
807138|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
807139|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807140|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807141|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
807994|NCT02546297|Budesonide|budesonide|mesh-list
807995|NCT02546297|Bromides|bromides|mesh-list
807996|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
807997|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
807998|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
807999|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
808000|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
808001|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
808002|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808003|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808004|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
808005|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
808006|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
808007|NCT02546297|Hormones|hormones|mesh-ancestor
808008|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
808009|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
808010|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
808011|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
808012|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
808013|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
808014|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808015|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
808016|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
808017|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
808018|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
808203|NCT02545452|Anastrozole|anastrozole|mesh-list
808204|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
808205|NCT02545452|Nonoxynol|nonoxynol|mesh-list
808206|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
808207|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
808208|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
808209|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
808210|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808211|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808212|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
808213|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
808214|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
808215|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808216|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
808217|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
808218|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
808219|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
808220|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
808221|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
808222|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
808223|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
808224|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
808472|NCT02544308|Dexamethasone|dexamethasone|mesh-list
808496|NCT02544308|Lenalidomide|lenalidomide|mesh-list
808497|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
808498|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
808499|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
808500|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808501|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808502|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
808503|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
808504|NCT02544308|Hormones|hormones|mesh-ancestor
808505|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
808506|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
808507|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
808508|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
808509|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
808510|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
808511|NCT02544308|Growth Substances|growth substances|mesh-ancestor
808512|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
807180|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
807181|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
807182|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
807183|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807184|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
807185|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
807186|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2248046|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248047|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2248048|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2248049|NCT00124813|Growth Substances|growth substances|mesh-ancestor
2248050|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
2248051|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248052|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2248053|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2248054|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2248055|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248056|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248057|NCT00124826|Insulin|insulin|mesh-list
807928|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
807929|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
807930|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248058|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2248059|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248060|NCT00124839|Naltrexone|naltrexone|mesh-list
2248061|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2248062|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2248063|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248064|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
2248065|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248066|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2248067|NCT00124930|Olanzapine|olanzapine|mesh-list
2248068|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
809423|NCT02540720|Dexamethasone|dexamethasone|mesh-list
809424|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
809425|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
809426|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
809427|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
809428|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
809429|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
809430|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809431|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809432|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
809433|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
809434|NCT02540720|Hormones|hormones|mesh-ancestor
809435|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
809436|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
809437|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809438|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
2248069|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
2248070|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248071|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248072|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2248073|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2248074|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2248075|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2248076|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2248077|NCT00124930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2248078|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2248079|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2248080|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248081|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248082|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
2248083|NCT00124956|Doxorubicin|doxorubicin|mesh-list
807248|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
807249|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807250|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
807251|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
807252|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
807253|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
807254|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
807255|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
807256|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807257|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807405|NCT02548533|Lidocaine|lidocaine|mesh-list
807406|NCT02548533|Epinephrine|epinephrine|mesh-list
807407|NCT02548533|Prilocaine|prilocaine|mesh-list
807408|NCT02548533|Carticaine|carticaine|mesh-list
807409|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
807410|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
807411|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
807412|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
807413|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807414|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
807415|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807416|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
807417|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
807418|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
807419|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
807420|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807422|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
807423|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
807424|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
807425|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
807426|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
807427|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
807428|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
807429|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
807430|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
807431|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
807432|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
807433|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
807434|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
808067|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
808068|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
808069|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808275|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
808276|NCT02545153|Aprotinin|aprotinin|mesh-list
808277|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
808278|NCT02545153|Coagulants|coagulants|mesh-ancestor
808279|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
808280|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
808281|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
808282|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808283|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096601|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
2096602|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2096603|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2096604|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
2096605|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
809315|NCT02540824|Apatinib|apatinib|mesh-list
809316|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809317|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
809318|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809319|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248084|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2248085|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248086|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
810210|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
810211|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
810212|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810213|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810214|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
810215|NCT02537366|Analgesics|analgesics|mesh-ancestor
810216|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
810217|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810218|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
810219|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2096606|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
807278|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807279|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
807280|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
807281|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807382|NCT02548611|Clopidogrel|clopidogrel|mesh-list
807383|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
807384|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
807385|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
807386|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
807387|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
807388|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
807389|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
807390|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807391|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248087|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2248088|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807889|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
807890|NCT02546583|Furosemide|furosemide|mesh-list
807891|NCT02546583|Bumetanide|bumetanide|mesh-list
807892|NCT02546583|Diuretics|diuretics|mesh-list
807893|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
807894|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
807895|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807896|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
807897|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807898|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
807899|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
807923|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
807924|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
807925|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
807926|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
807927|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807955|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
807956|NCT02546154|Hematinics|hematinics|mesh-ancestor
808513|NCT02544165|Caffeine|caffeine|mesh-list
808514|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
808515|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808516|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
808517|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808518|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808519|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
808520|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
808521|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
808522|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248089|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248090|NCT00124969|Amlodipine|amlodipine|mesh-list
2248091|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2248092|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2248093|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2248094|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808894|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
808895|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
808896|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
808897|NCT02542592|Prednisolone|prednisolone|mesh-list
808898|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
808899|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
808900|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
808901|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
808902|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
808903|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
808904|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808905|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808906|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
808907|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
808908|NCT02542592|Hormones|hormones|mesh-ancestor
808909|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
808910|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
808911|NCT02542592|Protective Agents|protective agents|mesh-ancestor
808912|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
808913|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810224|NCT02537379|Ribavirin|ribavirin|mesh-list
810225|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
810294|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248095|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2248096|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248097|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
2248098|NCT00124995|Terbutaline|terbutaline|mesh-list
2248099|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2248100|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
2248101|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248102|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248103|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2248104|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
2248105|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
2248106|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
2248107|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2248108|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2248109|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2248110|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2248111|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
2248112|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
807804|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
807805|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
807806|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
807807|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
2096607|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2096608|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
2096609|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248113|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248114|NCT00125008|Vaccines|vaccines|mesh-list
2248115|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
2248116|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248117|NCT00125021|Capecitabine|capecitabine|mesh-list
2248118|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2248119|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2248120|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
2248121|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248122|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248123|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2248124|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248125|NCT00125047|Vaccines|vaccines|mesh-list
2248126|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
2248127|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248128|NCT00125060|Simvastatin|simvastatin|mesh-list
2248129|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
809108|NCT02541643|Elotuzumab|elotuzumab|mesh-list
809109|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809170|NCT02541383|Thalidomide|thalidomide|mesh-list
809171|NCT02541383|Dexamethasone|dexamethasone|mesh-list
809172|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
809173|NCT02541383|Bortezomib|bortezomib|mesh-list
809174|NCT02541383|Daratumumab|daratumumab|mesh-list
809175|NCT02541383|BB 1101|bb 1101|mesh-list
809176|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
809177|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
809178|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
809179|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
809180|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809181|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809182|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
809183|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
809184|NCT02541383|Hormones|hormones|mesh-ancestor
809185|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
809186|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
809187|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809188|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
809189|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809190|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809191|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
809192|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
809193|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
809194|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
809195|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809196|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
809197|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
809198|NCT02541383|Growth Substances|growth substances|mesh-ancestor
809199|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
2248130|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2248131|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
2273746|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
807493|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
807494|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
807684|NCT02547519|Insulin|insulin|mesh-list
807685|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
807686|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808257|NCT02544919|SMOFlipid|smoflipid|mesh-list
808258|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
808259|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
808260|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
808373|NCT02544737|Apatinib|apatinib|mesh-list
808374|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
808375|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
808376|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808377|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808556|NCT02544061|Interleukin-12|interleukin-12|mesh-list
808557|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
808558|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
808559|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808560|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
808561|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
808562|NCT02544061|Growth Substances|growth substances|mesh-ancestor
808563|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
808564|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809043|NCT02542111|Gemcitabine|gemcitabine|mesh-list
809044|NCT02542111|Dexamethasone|dexamethasone|mesh-list
809045|NCT02542111|Bortezomib|bortezomib|mesh-list
809046|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809047|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
809048|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
809049|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
809050|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809051|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809052|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
809053|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
809054|NCT02542111|Hormones|hormones|mesh-ancestor
809055|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
809056|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
809057|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
809058|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
809059|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809060|NCT02542111|Antiviral Agents|antiviral agents|mesh-ancestor
809061|NCT02542111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809062|NCT02542111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809063|NCT02542111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
809064|NCT02542111|Immunologic Factors|immunologic factors|mesh-ancestor
2248132|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248133|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
809640|NCT02539706|Rocuronium|rocuronium|mesh-list
809641|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
809642|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
809643|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
809644|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809645|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248134|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2248135|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248136|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
2248137|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
2248138|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2248139|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2248140|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
810102|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
810103|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
810104|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810105|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
810106|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248141|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2248142|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248143|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
2248144|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248145|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248146|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
807521|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
807522|NCT02548052|Hormones|hormones|mesh-ancestor
807523|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
807524|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807525|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
807526|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
807647|NCT02547662|Dexamethasone|dexamethasone|mesh-list
807648|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
807649|NCT02547662|Pomalidomide|pomalidomide|mesh-list
807650|NCT02547662|Ixazomib|ixazomib|mesh-list
807651|NCT02547662|Ichthammol|ichthammol|mesh-list
807652|NCT02547662|BB 1101|bb 1101|mesh-list
807653|NCT02547662|Glycine|glycine|mesh-list
807654|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
807655|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
807656|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
807657|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807658|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807659|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
807660|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
807661|NCT02547662|Hormones|hormones|mesh-ancestor
807662|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
807663|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
807664|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807665|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807666|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
807667|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807668|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
807669|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
807670|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
807671|NCT02547662|Growth Substances|growth substances|mesh-ancestor
807672|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
807673|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
807674|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
807675|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
807957|NCT02546232|Paclitaxel|paclitaxel|mesh-list
807958|NCT02546232|Carboplatin|carboplatin|mesh-list
807959|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
807960|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807961|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
807962|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
807963|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
807964|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808077|NCT02545777|Diclofenac|diclofenac|mesh-list
808078|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
808079|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
808080|NCT02545777|Analgesics|analgesics|mesh-ancestor
808081|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
808082|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808083|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808084|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
808085|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
808086|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
808087|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808088|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808166|NCT02545465|Riociguat|riociguat|mesh-list
808167|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
808168|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808235|NCT02545010|Paclitaxel|paclitaxel|mesh-list
808236|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
808237|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
808238|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
808239|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
808240|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
808241|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808368|NCT02544789|Clofarabine|clofarabine|mesh-list
808369|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
808370|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
808371|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808372|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
808601|NCT02543879|Azacitidine|azacitidine|mesh-list
808602|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
808603|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
808604|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808605|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807589|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
807590|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807591|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807592|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
807593|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
807594|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
807595|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
807676|NCT02547350|Pirarubicin|pirarubicin|mesh-list
807677|NCT02547350|Epirubicin|epirubicin|mesh-list
807678|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807679|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
807680|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
807681|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
807682|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807683|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248147|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248148|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2248149|NCT00125229|Mannitol|mannitol|mesh-list
2248150|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2248151|NCT00125229|Diuretics|diuretics|mesh-ancestor
2248152|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
2248153|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248154|NCT00125255|Lidocaine|lidocaine|mesh-list
2248155|NCT00125255|Tetracaine|tetracaine|mesh-list
2248156|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
2248157|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
2248158|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2248159|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248160|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
2248161|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248162|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2248163|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2248164|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
808609|NCT02543671|Vitamin D|vitamin d|mesh-list
808610|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
808611|NCT02543671|Vitamins|vitamins|mesh-ancestor
808612|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
808613|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808614|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
808615|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
808761|NCT02543060|Fluorides|fluorides|mesh-list
808762|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
808763|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
808764|NCT02543060|Protective Agents|protective agents|mesh-ancestor
808765|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808873|NCT02542787|3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide|3-(5-dimethylcarbamoylpent-1-enyl)-n-(2-hydroxy-1-methylethyl)benzamide|mesh-list
808874|NCT02542787|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
808875|NCT02542787|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
808876|NCT02542787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
808877|NCT02542787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808878|NCT02542787|Hormones|hormones|mesh-ancestor
808879|NCT02542787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
808880|NCT02542787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248165|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2248166|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248167|NCT00125294|Methadone|methadone|mesh-list
2248168|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2248169|NCT00125294|Narcotics|narcotics|mesh-ancestor
2248170|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2248171|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248172|NCT00125294|Analgesics|analgesics|mesh-ancestor
2248173|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
2248174|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248175|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
2248176|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
2248177|NCT00125307|Tacrolimus|tacrolimus|mesh-list
2248178|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2248179|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
2248180|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248181|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2248182|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248183|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248184|NCT00125346|Tobramycin|tobramycin|mesh-list
2248185|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
807695|NCT02547402|Ezetimibe|ezetimibe|mesh-list
807696|NCT02547402|Pravastatin|pravastatin|mesh-list
807697|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
807698|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
807699|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
807700|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
807701|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807702|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
807703|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
807704|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807705|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2754328|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2754329|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
808309|NCT02545114|Tolvaptan|tolvaptan|mesh-list
808310|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
808311|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808312|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
808313|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808406|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
808407|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
808408|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
808409|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
808410|NCT02544529|Laxatives|laxatives|mesh-ancestor
808411|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
808412|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
808413|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808414|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808415|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
808416|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
808417|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808418|NCT02544529|Miotics|miotics|mesh-ancestor
808419|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
808420|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808421|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
808618|NCT02543944|Clonidine|clonidine|mesh-list
808619|NCT02543944|Naltrexone|naltrexone|mesh-list
808620|NCT02543944|Buprenorphine|buprenorphine|mesh-list
808621|NCT02543944|Gabapentin|gabapentin|mesh-list
808622|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
808623|NCT02543944|Narcotics|narcotics|mesh-ancestor
808624|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
808625|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808626|NCT02543944|Analgesics|analgesics|mesh-ancestor
808627|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
808628|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808629|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
808630|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
808631|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
808632|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
808633|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
808634|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
808635|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
808636|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
808637|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
808638|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808639|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
808640|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
808641|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
808642|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
808643|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
808644|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
808645|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
808646|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
808939|NCT02542813|Oxytocin|oxytocin|mesh-list
808940|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
808941|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
808942|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248186|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248187|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2248188|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
2248189|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809448|NCT02540330|Fulvestrant|fulvestrant|mesh-list
809449|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
809450|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809451|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2248190|NCT00125398|Fospropofol|fospropofol|mesh-list
807723|NCT02547155|Anesthetics|anesthetics|mesh-list
807724|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
807725|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807968|NCT02546349|Fluticasone|fluticasone|mesh-list
807969|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
807970|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
807971|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
807972|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
807973|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
807974|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
807975|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
807976|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
807977|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
807978|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
807979|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
807980|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
807981|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
807982|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
807983|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
807984|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
807985|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
807986|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
807987|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
807988|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
807989|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
807990|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
807991|NCT02546349|Hormones|hormones|mesh-ancestor
807992|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
807993|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
808089|NCT02545738|Liraglutide|liraglutide|mesh-list
808090|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
808091|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808092|NCT02545738|Incretins|incretins|mesh-ancestor
808093|NCT02545738|Hormones|hormones|mesh-ancestor
808094|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
808523|NCT02544269|Bupivacaine|bupivacaine|mesh-list
808524|NCT02544269|Ropivacaine|ropivacaine|mesh-list
808525|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
808526|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
808527|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
808528|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808529|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
808530|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096610|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096611|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
2096612|NCT02309515|Lenalidomide|lenalidomide|mesh-list
2096613|NCT02309515|Vaccines|vaccines|mesh-list
2096614|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
2096615|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096616|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2096617|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2096618|NCT02309515|Growth Substances|growth substances|mesh-ancestor
2096619|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
2096620|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096621|NCT02310568|PF-06372865|pf-06372865|mesh-list
2096622|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
2096623|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
2096624|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096625|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096626|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096627|NCT02310581|Buprenorphine|buprenorphine|mesh-list
2248191|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2248192|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2248193|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809573|NCT02540070|Ketorolac|ketorolac|mesh-list
809574|NCT02540070|Epinephrine|epinephrine|mesh-list
809575|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
809576|NCT02540070|Morphine|morphine|mesh-list
809577|NCT02540070|Ropivacaine|ropivacaine|mesh-list
809578|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
809579|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
809580|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809581|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
809582|NCT02540070|Analgesics|analgesics|mesh-ancestor
809583|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
2096628|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2248194|NCT00125411|Docetaxel|docetaxel|mesh-list
2248195|NCT00125411|Satraplatin|satraplatin|mesh-list
2248196|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248197|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
2248198|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
2248199|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
2248200|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248201|NCT00125424|Midazolam|midazolam|mesh-list
2248202|NCT00125424|Fospropofol|fospropofol|mesh-list
807900|NCT02546661|Durvalumab|durvalumab|mesh-list
807901|NCT02546661|Olaparib|olaparib|mesh-list
807902|NCT02546661|Adavosertib|adavosertib|mesh-list
807903|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
807904|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
807905|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
807906|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
807907|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808459|NCT02544191|Goserelin|goserelin|mesh-list
808460|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
808461|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248203|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2248204|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2248205|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2248206|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248207|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2248208|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2248209|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2248210|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2248211|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
2248212|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
2248213|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
2248214|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
2248215|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248216|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248217|NCT00125437|Spironolactone|spironolactone|mesh-list
2248218|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2248219|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
2248220|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2248221|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248222|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2248223|NCT00125437|Diuretics|diuretics|mesh-ancestor
2248224|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
2248225|NCT00125463|Candesartan|candesartan|mesh-list
2248226|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
2248227|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2248228|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2248229|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2248230|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248231|NCT00125489|Chloroquine|chloroquine|mesh-list
2248232|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2248233|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
2248234|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
2248235|NCT00125489|Amebicides|amebicides|mesh-ancestor
2248236|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
808804|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
808805|NCT02543073|Hormones|hormones|mesh-ancestor
808806|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
808807|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809120|NCT02541552|Ropivacaine|ropivacaine|mesh-list
809121|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
809122|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
809123|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
809124|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809125|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
809126|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809259|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
809260|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
809261|NCT02541227|Protective Agents|protective agents|mesh-ancestor
809262|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809263|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
809960|NCT02538367|Prucalopride|prucalopride|mesh-list
809961|NCT02538367|YH12852|yh12852|mesh-list
809962|NCT02538367|Laxatives|laxatives|mesh-ancestor
809963|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
809964|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
809965|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
807817|NCT02546934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
807818|NCT02546934|Immunologic Factors|immunologic factors|mesh-ancestor
807819|NCT02546934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808341|NCT02544750|Cannabidiol|cannabidiol|mesh-list
808342|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
2248237|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2248238|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248239|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
2248240|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
808663|NCT02543411|Lidocaine|lidocaine|mesh-list
808664|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
808665|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
808666|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
808667|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808668|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
808669|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808670|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
808671|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
808672|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
808673|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
808674|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808808|NCT02543229|Ranibizumab|ranibizumab|mesh-list
808809|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
808810|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
808811|NCT02543229|Growth Substances|growth substances|mesh-ancestor
808812|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808813|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
808814|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809239|NCT02541071|Clonidine|clonidine|mesh-list
809240|NCT02541071|Yohimbine|yohimbine|mesh-list
809241|NCT02541071|Analgesics|analgesics|mesh-ancestor
809242|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
809243|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809244|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809245|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
809246|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
809247|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
809248|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
809249|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
809250|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
809251|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
809252|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809253|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809254|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
809255|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
809256|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
809257|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
809258|NCT02541071|Urological Agents|urological agents|mesh-ancestor
809320|NCT02540837|Bupivacaine|bupivacaine|mesh-list
809321|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
809322|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
809323|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
809324|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809325|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
809326|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248241|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2248242|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2248243|NCT00125489|Analgesics|analgesics|mesh-ancestor
810036|NCT02537860|Fentanyl|fentanyl|mesh-list
810037|NCT02537860|Bupivacaine|bupivacaine|mesh-list
810038|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
810039|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
810040|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810041|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810042|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
810043|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810044|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
810045|NCT02537860|Narcotics|narcotics|mesh-ancestor
810046|NCT02537860|Analgesics|analgesics|mesh-ancestor
810047|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
810048|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
810049|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
2248244|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
2248245|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248246|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248247|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2248248|NCT00125489|Filaricides|filaricides|mesh-ancestor
2248249|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
2248250|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
2248251|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2248252|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808027|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
808028|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
808191|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
808192|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
808193|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
808194|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
808284|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
808285|NCT02544893|Bupivacaine|bupivacaine|mesh-list
808286|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
808287|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
808288|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
808289|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808290|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
808291|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808292|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
808293|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
808294|NCT02544893|Analgesics|analgesics|mesh-ancestor
808295|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
808296|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
808297|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
808298|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
808299|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
808300|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808363|NCT02544659|Pamidronate|pamidronate|mesh-list
808364|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
808365|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808422|NCT02544425|Dexamethasone|dexamethasone|mesh-list
808423|NCT02544425|Etoposide|etoposide|mesh-list
808424|NCT02544425|Melphalan|melphalan|mesh-list
808425|NCT02544425|Busulfan|busulfan|mesh-list
808426|NCT02544425|Asparaginase|asparaginase|mesh-list
808427|NCT02544425|Ifosfamide|ifosfamide|mesh-list
808428|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
808429|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
808430|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
808431|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808432|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808433|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
808434|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
808435|NCT02544425|Hormones|hormones|mesh-ancestor
808436|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
808437|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
808438|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
808439|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
808440|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
808441|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
808442|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808443|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808444|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
808445|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
808446|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
808447|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
808448|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
808994|NCT02542137|Thymalfasin|thymalfasin|mesh-list
808995|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
808996|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
808997|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248253|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248254|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2248255|NCT00125489|Renal Agents|renal agents|mesh-ancestor
2248256|NCT00125554|Metyrapone|metyrapone|mesh-list
2248257|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
810938|NCT02534402|Prednisone|prednisone|mesh-list
810939|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
810940|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
810941|NCT02534402|Hormones|hormones|mesh-ancestor
810942|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
810943|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248258|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248259|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248260|NCT00125567|Levodopa|levodopa|mesh-list
2248261|NCT00125567|Carbidopa|carbidopa|mesh-list
2248262|NCT00125567|Entacapone|entacapone|mesh-list
2248263|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2248264|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2248265|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
2248266|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248267|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248268|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248269|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
808301|NCT02544932|Warfarin|warfarin|mesh-list
808302|NCT02544932|Dabigatran|dabigatran|mesh-list
808303|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
808304|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
808305|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
808306|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
808307|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808308|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808462|NCT02544282|Acetaminophen|acetaminophen|mesh-list
808463|NCT02544282|Sufentanil|sufentanil|mesh-list
808464|NCT02544282|Tramadol|tramadol|mesh-list
808465|NCT02544282|Pirinitramide|pirinitramide|mesh-list
808466|NCT02544282|Propofol|propofol|mesh-list
808467|NCT02544282|Sevoflurane|sevoflurane|mesh-list
808468|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
808469|NCT02544282|Atracurium|atracurium|mesh-list
808470|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
808471|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
808473|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808474|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
808475|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
808476|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
808477|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
808478|NCT02544282|Analgesics|analgesics|mesh-ancestor
808479|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
808480|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808481|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
808482|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
808483|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
808484|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
808485|NCT02544282|Narcotics|narcotics|mesh-ancestor
808486|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
808487|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
808488|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
808489|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
808490|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
808491|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
808492|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
808493|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
808494|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
808495|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808726|NCT02543606|Esomeprazole|esomeprazole|mesh-list
808727|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
808728|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
808729|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
808730|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808731|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809034|NCT02542007|Sirolimus|sirolimus|mesh-list
809035|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
809036|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809037|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
809038|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809039|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
809040|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
809041|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
809042|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809147|NCT02541500|Minocycline|minocycline|mesh-list
809148|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
809149|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809563|NCT02539940|Paclitaxel|paclitaxel|mesh-list
809564|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
809565|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809566|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
809567|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
809568|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
809678|NCT02539537|Vitamins|vitamins|mesh-ancestor
2248270|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248271|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2248272|NCT00125645|Irbesartan|irbesartan|mesh-list
2248273|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2248274|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2248275|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2248276|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248277|NCT00125671|Warfarin|warfarin|mesh-list
2248278|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
2248279|NCT00125684|Morphine|morphine|mesh-list
2248280|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2248281|NCT00125684|Narcotics|narcotics|mesh-ancestor
2248282|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2248283|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248284|NCT00125684|Analgesics|analgesics|mesh-ancestor
2248285|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
2248286|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248287|NCT00125736|Rabeprazole|rabeprazole|mesh-list
2248288|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
808746|NCT02543099|Policosanol|policosanol|mesh-list
808747|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
808748|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
808749|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
808750|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808751|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
808752|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
808815|NCT02542852|Ritonavir|ritonavir|mesh-list
808816|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
808817|NCT02542852|Dolutegravir|dolutegravir|mesh-list
808818|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
808819|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
808820|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
808821|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808822|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808823|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
808824|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
808825|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
808826|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
808827|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
808828|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
808829|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
808830|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
808943|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
809080|NCT02541786|Rabeprazole|rabeprazole|mesh-list
809081|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
809082|NCT02541786|Lansoprazole|lansoprazole|mesh-list
809083|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
809084|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
809085|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
809086|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809087|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809777|NCT02538718|Ritodrine|ritodrine|mesh-list
809778|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
809779|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
809780|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809781|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809782|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
809783|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
809784|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
809785|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
809786|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
809787|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
809788|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809789|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810253|NCT02537314|Benzocaine|benzocaine|mesh-list
810254|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
810255|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
810256|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810257|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810258|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
810259|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810322|NCT02536989|Omeprazole|omeprazole|mesh-list
810323|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
810324|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
810325|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2248289|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
808187|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
810315|NCT02537054|Aflibercept|aflibercept|mesh-list
810316|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
810317|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
810318|NCT02537054|Growth Substances|growth substances|mesh-ancestor
810319|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810320|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
810321|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810443|NCT02536209|Oxycodone|oxycodone|mesh-list
810444|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
810445|NCT02536209|Narcotics|narcotics|mesh-ancestor
810446|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810447|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810448|NCT02536209|Analgesics|analgesics|mesh-ancestor
810449|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
810450|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810524|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
810525|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
810526|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810527|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810528|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
810529|NCT02536014|Analgesics|analgesics|mesh-ancestor
810530|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
810531|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810532|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
810533|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
810534|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
810535|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
810536|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
810537|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810847|NCT02534376|Simvastatin|simvastatin|mesh-list
810848|NCT02534376|Ezetimibe|ezetimibe|mesh-list
810849|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
810850|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
810851|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
810852|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810853|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
810854|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
810855|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811178|NCT02533349|Pantoprazole|pantoprazole|mesh-list
811179|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
811180|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
811181|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
811182|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811183|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248290|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2248291|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248292|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248293|NCT00125749|Vaccines|vaccines|mesh-list
2248294|NCT00125749|Immunologic Factors|immunologic factors|mesh-ancestor
2248295|NCT00125749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248296|NCT00125801|Hydromorphone|hydromorphone|mesh-list
2248297|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2248298|NCT00125801|Narcotics|narcotics|mesh-ancestor
2248299|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2248300|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811472|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
811473|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
811474|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812089|NCT02530060|Tenofovir|tenofovir|mesh-list
812090|NCT02530060|Emtricitabine|emtricitabine|mesh-list
812091|NCT02530060|Rilpivirine|rilpivirine|mesh-list
812092|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
812093|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812094|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
812095|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
812096|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812097|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812098|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
812099|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2248301|NCT00125801|Analgesics|analgesics|mesh-ancestor
2248302|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
2248303|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248304|NCT00125814|Interferons|interferons|mesh-list
2248305|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
2248306|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
2248307|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248308|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
2248309|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248310|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
2248311|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248312|NCT00125827|Clofarabine|clofarabine|mesh-list
2248313|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2248314|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
2248315|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248316|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248317|NCT00125840|Clofarabine|clofarabine|mesh-list
2248318|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2248319|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
2248320|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248321|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248322|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2248323|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2248324|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2248325|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2248326|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248327|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248328|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248329|NCT00125892|Analgesics|analgesics|mesh-ancestor
2248330|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
2248331|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809441|NCT02540460|Delpazolid|delpazolid|mesh-list
809442|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
809443|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
809444|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809445|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
809446|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809447|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809719|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
809720|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
809721|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
809722|NCT02539394|Prednisolone|prednisolone|mesh-list
809723|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
809724|NCT02539394|Hemostatics|hemostatics|mesh-list
809725|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
809726|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
809727|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
809728|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
809729|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
809730|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809731|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809732|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
809733|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
809734|NCT02539394|Hormones|hormones|mesh-ancestor
809735|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
809736|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
809737|NCT02539394|Protective Agents|protective agents|mesh-ancestor
809738|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
809739|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809740|NCT02539394|Coagulants|coagulants|mesh-ancestor
809800|NCT02538744|Doxazosin|doxazosin|mesh-list
809801|NCT02538744|Cocaine|cocaine|mesh-list
809802|NCT02538744|Modafinil|modafinil|mesh-list
809803|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
809804|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809805|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
809806|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
809807|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
809808|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809809|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
809810|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
809811|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
809812|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
809813|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809814|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
809815|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
809816|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
809817|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
808339|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808340|NCT02544880|Urological Agents|urological agents|mesh-ancestor
809114|NCT02541708|Folic Acid|folic acid|mesh-list
809115|NCT02541708|Hematinics|hematinics|mesh-ancestor
809116|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
809117|NCT02541708|Vitamins|vitamins|mesh-ancestor
809118|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
809119|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809230|NCT02541084|Aflibercept|aflibercept|mesh-list
809231|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
809232|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
809233|NCT02541084|Growth Substances|growth substances|mesh-ancestor
809234|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809235|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
809236|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248332|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
2248333|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2248334|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
2248335|NCT00125905|Bupropion|bupropion|mesh-list
2248336|NCT00125905|Nicotine|nicotine|mesh-list
2248337|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2248338|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
2248339|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248340|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248341|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2248342|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2248343|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
2248344|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248345|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248346|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2248347|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
2248348|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2248349|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2248350|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2248351|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2248352|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
2248353|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
809931|NCT02538237|Ibuprofen|ibuprofen|mesh-list
809932|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
809933|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
809934|NCT02538237|Analgesics|analgesics|mesh-ancestor
809935|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
809936|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809937|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809938|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
809939|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
809940|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
809941|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809942|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809988|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
809989|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
809990|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
809991|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809992|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
809993|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
810145|NCT02537691|Theophylline|theophylline|mesh-list
810146|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
810147|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
810148|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810149|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810150|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
810151|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
810152|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
810153|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810154|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810155|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
810156|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
810157|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
810158|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
810159|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
810457|NCT02536430|Ketorolac|ketorolac|mesh-list
810458|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
810459|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
810460|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
810461|NCT02536430|Analgesics|analgesics|mesh-ancestor
2248354|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2248355|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248356|NCT00125918|Tadalafil|tadalafil|mesh-list
809110|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
809111|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
809112|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
809113|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
809608|NCT02539849|Adalimumab|adalimumab|mesh-list
809609|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
809610|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2248357|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
2248358|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2248359|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2248360|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248361|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248362|NCT00125918|Urological Agents|urological agents|mesh-ancestor
2248363|NCT00125970|Vaccines|vaccines|mesh-list
2248364|NCT00125970|Immunologic Factors|immunologic factors|mesh-ancestor
2248365|NCT00125970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248366|NCT00125983|Ritonavir|ritonavir|mesh-list
2248367|NCT00125983|Lopinavir|lopinavir|mesh-list
2248368|NCT00125983|Norinyl|norinyl|mesh-list
2248369|NCT00125983|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2248370|NCT00125983|Ortho Evra|ortho evra|mesh-list
809970|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
809971|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
809972|NCT02538146|Vitamins|vitamins|mesh-ancestor
809973|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
809974|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809975|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
810229|NCT02537392|Folic Acid|folic acid|mesh-list
810230|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
810231|NCT02537392|Vitamins|vitamins|mesh-ancestor
810232|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
810233|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810234|NCT02537392|Hematinics|hematinics|mesh-ancestor
810516|NCT02535910|Vitamin D|vitamin d|mesh-list
810517|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
810518|NCT02535910|Calcifediol|calcifediol|mesh-list
810519|NCT02535910|Vitamins|vitamins|mesh-ancestor
810520|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
810521|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810522|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
810523|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
810559|NCT02535689|Tofacitinib|tofacitinib|mesh-list
810560|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
810561|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810562|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810631|NCT02535351|Sunitinib|sunitinib|mesh-list
810632|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810633|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
810634|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
810635|NCT02535351|Growth Substances|growth substances|mesh-ancestor
810636|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810637|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
810638|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
810639|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810640|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811028|NCT02533648|Allopurinol|allopurinol|mesh-list
811029|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
811030|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811031|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811032|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
811033|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
811034|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
811035|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
811036|NCT02533648|Protective Agents|protective agents|mesh-ancestor
811037|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248371|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2248372|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2248373|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
2248374|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248375|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248376|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2248377|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2248378|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
2248379|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811475|NCT02532062|Vitamin D|vitamin d|mesh-list
808378|NCT02544698|Vaccines|vaccines|mesh-list
808379|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
808380|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096629|NCT02310581|Narcotics|narcotics|mesh-ancestor
2096630|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2096631|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096632|NCT02310581|Analgesics|analgesics|mesh-ancestor
2096633|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
2096634|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096635|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2096636|NCT02310672|Macitentan|macitentan|mesh-list
2096637|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2096638|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
810307|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
810308|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
810309|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
810310|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
810311|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
810312|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810313|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810314|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
810344|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
810345|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
810346|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
810347|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810348|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
810349|NCT02536807|Protective Agents|protective agents|mesh-ancestor
810437|NCT02536417|Melatonin|melatonin|mesh-list
810438|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
810439|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810440|NCT02536417|Protective Agents|protective agents|mesh-ancestor
810441|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810442|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810866|NCT02534363|Aripiprazole|aripiprazole|mesh-list
810867|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
810868|NCT02534363|Ziprasidone|ziprasidone|mesh-list
810869|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
810870|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
810871|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
810872|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
810873|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810874|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810875|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
810876|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
810877|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
810878|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810879|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
810880|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
810881|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
810882|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
810883|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
810884|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
810885|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2248380|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2248381|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2248382|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2248383|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2248384|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2248385|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
2248386|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2248387|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248388|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2248389|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2248390|NCT00125983|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2248391|NCT00125983|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2248392|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2248393|NCT00125996|Hematinics|hematinics|mesh-ancestor
2248394|NCT00126009|Amisulpride|amisulpride|mesh-list
2248395|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2248396|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2248397|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2248398|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248399|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
811905|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
2248400|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
808881|NCT02542748|Norepinephrine|norepinephrine|mesh-list
808882|NCT02542748|Ephedrine|ephedrine|mesh-list
808883|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
808884|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
808885|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
808886|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
808887|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808888|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808889|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
808890|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
808891|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808892|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
808893|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
808961|NCT02542293|Gemcitabine|gemcitabine|mesh-list
808962|NCT02542293|Paclitaxel|paclitaxel|mesh-list
808963|NCT02542293|Cisplatin|cisplatin|mesh-list
808964|NCT02542293|Carboplatin|carboplatin|mesh-list
808965|NCT02542293|Pemetrexed|pemetrexed|mesh-list
808966|NCT02542293|Durvalumab|durvalumab|mesh-list
808967|NCT02542293|Tremelimumab|tremelimumab|mesh-list
808968|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
808969|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
808970|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
808971|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
808972|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
808973|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808974|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
808975|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
808976|NCT02542293|Antiviral Agents|antiviral agents|mesh-ancestor
808977|NCT02542293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
808978|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
808979|NCT02542293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
808980|NCT02542293|Immunologic Factors|immunologic factors|mesh-ancestor
808981|NCT02542293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808982|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
808983|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
808984|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
809419|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
809420|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
809421|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
809422|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809473|NCT02540239|Simethicone|simethicone|mesh-list
809474|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
809475|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809476|NCT02540239|Emollients|emollients|mesh-ancestor
809477|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
809547|NCT02539966|Sirolimus|sirolimus|mesh-list
809548|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
809549|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809550|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
809551|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809552|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
809553|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
809554|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
809555|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809656|NCT02539537|Leucovorin|leucovorin|mesh-list
809657|NCT02539537|Folic Acid|folic acid|mesh-list
809658|NCT02539537|Gemcitabine|gemcitabine|mesh-list
809659|NCT02539537|Fluorouracil|fluorouracil|mesh-list
809660|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
809661|NCT02539537|Irinotecan|irinotecan|mesh-list
809662|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
809663|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
809664|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
809665|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809666|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809667|NCT02539537|Antiviral Agents|antiviral agents|mesh-ancestor
809668|NCT02539537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809669|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809670|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
809671|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
809672|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809673|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
809674|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
809675|NCT02539537|Antidotes|antidotes|mesh-ancestor
809676|NCT02539537|Protective Agents|protective agents|mesh-ancestor
809677|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
2248401|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
2248402|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248403|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248404|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2248405|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
2248406|NCT00126022|Tedisamil|tedisamil|mesh-list
2248407|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
808607|NCT02543710|Taxane|taxane|mesh-list
808608|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
808709|NCT02543385|Ketamine|ketamine|mesh-list
808710|NCT02543385|Esketamine|esketamine|mesh-list
808711|NCT02543385|Analgesics|analgesics|mesh-ancestor
808712|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
808713|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
808714|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808715|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
808716|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
808717|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
808718|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
808719|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
808720|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
808721|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
808722|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
808723|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808724|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
808725|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
808918|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
808919|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
808920|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
808921|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808922|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
808923|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
808924|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809024|NCT02542098|Hydrocodone|hydrocodone|mesh-list
809025|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
809026|NCT02542098|Narcotics|narcotics|mesh-ancestor
809027|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
809028|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809029|NCT02542098|Analgesics|analgesics|mesh-ancestor
809030|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
809031|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809032|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
809033|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
809456|NCT02540512|Acetaminophen|acetaminophen|mesh-list
809457|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
809458|NCT02540512|Hydrocodone|hydrocodone|mesh-list
809459|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
809460|NCT02540512|Analgesics|analgesics|mesh-ancestor
809461|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
809462|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809463|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809464|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
809465|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
809466|NCT02540512|Narcotics|narcotics|mesh-ancestor
809467|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
809468|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
809469|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
809470|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
809471|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
809472|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2248408|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2248409|NCT00126022|Protective Agents|protective agents|mesh-ancestor
2248410|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248411|NCT00126048|Atorvastatin|atorvastatin|mesh-list
2248412|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2248413|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2248414|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
2248415|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810287|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
810288|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
810289|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
810290|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
810291|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
810292|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810293|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808617|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
808756|NCT02543086|Piperaquine|piperaquine|mesh-list
808757|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
808758|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
808759|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
808760|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809540|NCT02539979|Acetaminophen|acetaminophen|mesh-list
809541|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
809542|NCT02539979|Analgesics|analgesics|mesh-ancestor
809543|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
809544|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809545|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809546|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
809634|NCT02539745|Vitamin D|vitamin d|mesh-list
809635|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
809636|NCT02539745|Vitamins|vitamins|mesh-ancestor
809637|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
809638|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809639|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2248416|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2248417|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2248418|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248419|NCT00126061|Tedisamil|tedisamil|mesh-list
810350|NCT02536937|Eliglustat|eliglustat|mesh-list
810351|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810352|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810429|NCT02536495|Docetaxel|docetaxel|mesh-list
810430|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810431|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
810432|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
810433|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
810434|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810653|NCT02535273|Lidocaine|lidocaine|mesh-list
810654|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
810655|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
810656|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
810657|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810658|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810659|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
810660|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810661|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
810662|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
810663|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
810664|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
810665|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810666|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
810667|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
810668|NCT02535273|Analgesics|analgesics|mesh-ancestor
810669|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
810670|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
810671|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
810672|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
810673|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248420|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2248421|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2248422|NCT00126061|Protective Agents|protective agents|mesh-ancestor
2248423|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248424|NCT00126074|Tedisamil|tedisamil|mesh-list
2248425|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2248426|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2248427|NCT00126074|Protective Agents|protective agents|mesh-ancestor
2248428|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248429|NCT00126087|Dopamine|dopamine|mesh-list
2248430|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2248431|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
2248432|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
2248433|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248434|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248435|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
2248436|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248437|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811398|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
811399|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
811400|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
811401|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
811402|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248438|NCT00126087|Protective Agents|protective agents|mesh-ancestor
2248439|NCT00126100|Sargramostim|sargramostim|mesh-list
2248440|NCT00126100|Lenograstim|lenograstim|mesh-list
2248441|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
2248442|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809264|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
809265|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
809266|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
809267|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809268|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809269|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
809270|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
809271|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
809272|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
809273|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
809274|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809275|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248443|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2248444|NCT00126139|Abciximab|abciximab|mesh-list
2248445|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
2248446|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2248447|NCT00126204|Doxycycline|doxycycline|mesh-list
2248448|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2248449|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248450|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
2248451|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
809873|NCT02538224|Doxycycline|doxycycline|mesh-list
809874|NCT02538224|Ketoprofen|ketoprofen|mesh-list
809875|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
809876|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809877|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
809878|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
809879|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
809880|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
809881|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
809882|NCT02538224|Analgesics|analgesics|mesh-ancestor
809883|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
809884|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809885|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809886|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
809887|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
809888|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
809889|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809890|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248452|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2248453|NCT00126230|Docetaxel|docetaxel|mesh-list
2248454|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248455|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
2248456|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
2248457|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
2248458|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248459|NCT00126243|Rituximab|rituximab|mesh-list
2248460|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2248461|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810196|NCT02537561|Gemcitabine|gemcitabine|mesh-list
810197|NCT02537561|Cisplatin|cisplatin|mesh-list
810198|NCT02537561|Talazoparib|talazoparib|mesh-list
810199|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810200|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
810201|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
810202|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810203|NCT02537561|Antiviral Agents|antiviral agents|mesh-ancestor
810204|NCT02537561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
810205|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810206|NCT02537561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
810207|NCT02537561|Immunologic Factors|immunologic factors|mesh-ancestor
810208|NCT02537561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810209|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2248462|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
2248463|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096639|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096640|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2096641|NCT02310750|PF-06700841|pf-06700841|mesh-list
2096642|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2096643|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248464|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
808791|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
808792|NCT02542969|Simvastatin|simvastatin|mesh-list
808793|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
808794|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
808795|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
808796|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
808797|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
808798|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
808799|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809366|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
809367|NCT02540707|Mirabegron|mirabegron|mesh-list
809368|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
809369|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
809370|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
809371|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809372|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809373|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809374|NCT02540707|Urological Agents|urological agents|mesh-ancestor
809375|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
809376|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
809377|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
809378|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
809707|NCT02539316|SMOFlipid|smoflipid|mesh-list
809708|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
809709|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
809710|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
810061|NCT02538926|Prednisone|prednisone|mesh-list
810062|NCT02538926|Cortisone|cortisone|mesh-list
810063|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
810064|NCT02538926|Rituximab|rituximab|mesh-list
810065|NCT02538926|Doxorubicin|doxorubicin|mesh-list
810066|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
810067|NCT02538926|Etoposide|etoposide|mesh-list
810068|NCT02538926|Vincristine|vincristine|mesh-list
810069|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
810070|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
810071|NCT02538926|Asparaginase|asparaginase|mesh-list
810072|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
810073|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
810074|NCT02538926|Antibodies|antibodies|mesh-list
810075|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
810076|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
810077|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
810078|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
810079|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810080|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
810081|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
810082|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
810083|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810084|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810085|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
810086|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
810087|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
810088|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
810089|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810090|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
810091|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
810092|NCT02538926|Hormones|hormones|mesh-ancestor
810093|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
810094|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
810095|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
810096|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
810097|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
810098|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
810099|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
810100|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
810101|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
810991|NCT02533973|Calcipotriene|calcipotriene|mesh-list
810992|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
811624|NCT02531581|Furosemide|furosemide|mesh-list
811625|NCT02531581|Diuretics|diuretics|mesh-list
811626|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
811627|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811646|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2096644|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096645|NCT02310789|Ivacaftor|ivacaftor|mesh-list
2096646|NCT02310789|Pilocarpine|pilocarpine|mesh-list
2096647|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
2096648|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2096649|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2096650|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096651|NCT02310789|Miotics|miotics|mesh-ancestor
2096652|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
2096653|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096654|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096655|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2096656|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2096657|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
2096658|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096659|NCT02311361|Durvalumab|durvalumab|mesh-list
2096660|NCT02311361|Tremelimumab|tremelimumab|mesh-list
2096661|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2096662|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096663|NCT02311478|Copper|copper|mesh-list
2096664|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
2096665|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2096666|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809237|NCT02541045|Metadoxine|metadoxine|mesh-list
809238|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
809478|NCT02540369|Aflibercept|aflibercept|mesh-list
809479|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
809480|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
809481|NCT02540369|Growth Substances|growth substances|mesh-ancestor
809482|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809483|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
809484|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248465|NCT00126256|Leucovorin|leucovorin|mesh-list
2248466|NCT00126256|Fluorouracil|fluorouracil|mesh-list
2248467|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
2248468|NCT00126256|Irinotecan|irinotecan|mesh-list
2248469|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
2248470|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248471|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2248472|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248473|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2248474|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
2248475|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248476|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2248477|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2248478|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248479|NCT00126256|Antidotes|antidotes|mesh-ancestor
2248480|NCT00126256|Protective Agents|protective agents|mesh-ancestor
810541|NCT02535767|Primaquine|primaquine|mesh-list
810542|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
810543|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
810544|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
810545|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248481|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
2248482|NCT00126256|Vitamins|vitamins|mesh-ancestor
2248483|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
2248484|NCT00126269|Gemcitabine|gemcitabine|mesh-list
2248485|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248486|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2248487|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
2248488|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248489|NCT00126269|Antiviral Agents|antiviral agents|mesh-ancestor
2248490|NCT00126269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248491|NCT00126269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248492|NCT00126269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2248493|NCT00126269|Immunologic Factors|immunologic factors|mesh-ancestor
2248494|NCT00126269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248495|NCT00126282|Cycloserine|cycloserine|mesh-list
2248496|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2248497|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248498|NCT00126282|Renal Agents|renal agents|mesh-ancestor
2248499|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2248500|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
2096667|NCT02311478|Trace Elements|trace elements|mesh-ancestor
2248501|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2248502|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
2248503|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248504|NCT00126308|Mannitol|mannitol|mesh-list
2248505|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2248506|NCT00126308|Diuretics|diuretics|mesh-ancestor
2248507|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
808985|NCT02542124|Interleukin-12|interleukin-12|mesh-list
808986|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
808987|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
808988|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
808989|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
808990|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
808991|NCT02542124|Growth Substances|growth substances|mesh-ancestor
808992|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
808993|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248508|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248509|NCT00126321|Cladribine|cladribine|mesh-list
2248510|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248511|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2248512|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
2248513|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248514|NCT00126347|Folic Acid|folic acid|mesh-list
2248515|NCT00126347|Betaine|betaine|mesh-list
2248516|NCT00126347|Hematinics|hematinics|mesh-ancestor
2248517|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
2248518|NCT00126347|Vitamins|vitamins|mesh-ancestor
2248519|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
2248520|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248521|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2248522|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
2248523|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2248524|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
2248525|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248526|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2248527|NCT00126360|Anastrozole|anastrozole|mesh-list
809200|NCT02541396|Ketamine|ketamine|mesh-list
809201|NCT02541396|Oxycodone|oxycodone|mesh-list
809202|NCT02541396|Analgesics|analgesics|mesh-ancestor
809203|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
809204|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809205|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809206|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
809207|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
809208|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
809209|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
809210|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
809211|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
809212|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
809213|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809214|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809215|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
809216|NCT02541396|Narcotics|narcotics|mesh-ancestor
2248528|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2248529|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248530|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2248531|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2248532|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248533|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248534|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
809859|NCT02538484|Letrozole|letrozole|mesh-list
809860|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809861|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
809862|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
809863|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809864|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809865|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
809866|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
809867|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
809868|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809957|NCT02538172|Valganciclovir|valganciclovir|mesh-list
809958|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
809959|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248535|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
2248536|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
811198|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
811199|NCT02533284|Analgesics|analgesics|mesh-ancestor
811200|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
811201|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811202|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809127|NCT02541526|Mirtazapine|mirtazapine|mesh-list
809128|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
809129|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
809130|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
809131|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
809132|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
809133|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809134|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809135|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809136|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
809137|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
809138|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
809139|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
809140|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
809141|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
809142|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
809143|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
809144|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
809145|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
809146|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2248537|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248538|NCT00126373|Bupropion|bupropion|mesh-list
2248539|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2248540|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
2248541|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2248542|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
809758|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
809759|NCT02538939|Antidotes|antidotes|mesh-ancestor
809760|NCT02538939|Protective Agents|protective agents|mesh-ancestor
809761|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809762|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
809763|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809764|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
809765|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
809766|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809767|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
809768|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
809994|NCT02538081|Risperidone|risperidone|mesh-list
809995|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
809996|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
809997|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809998|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809999|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810000|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
810001|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
810002|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810003|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
810004|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
810005|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
2248543|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2248544|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2248545|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248546|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
2248547|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248548|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248549|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2248550|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2248551|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248552|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
2248553|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2248554|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248555|NCT00126399|Doxycycline|doxycycline|mesh-list
2248556|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2248557|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811469|NCT02531984|Azithromycin|azithromycin|mesh-list
811470|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
811471|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811685|NCT02531737|Docetaxel|docetaxel|mesh-list
811686|NCT02531737|Nintedanib|nintedanib|mesh-list
811687|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811688|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
811689|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
811690|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
811691|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248558|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
2248559|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2248560|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2248561|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2248562|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248563|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248564|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248565|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2248566|NCT00126451|Vorinostat|vorinostat|mesh-list
2248567|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248568|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2248569|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248570|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248571|NCT00126464|Tamoxifen|tamoxifen|mesh-list
2248572|NCT00126464|Fulvestrant|fulvestrant|mesh-list
2248573|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
809848|NCT02538627|Trametinib|trametinib|mesh-list
809849|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809850|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
809851|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809852|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809869|NCT02538211|Vaccines|vaccines|mesh-list
809870|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
809871|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
809872|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248574|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
2248575|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2248576|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248577|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2248578|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248579|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2248580|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2248581|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2248582|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2248583|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
2248584|NCT00126516|Giapreza|giapreza|mesh-list
2248585|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2248586|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
2248587|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2248588|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2248589|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248590|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2248591|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2248592|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
2248593|NCT00126542|Bevacizumab|bevacizumab|mesh-list
2248594|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2248595|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2248596|NCT00126542|Antibodies|antibodies|mesh-list
2248597|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
2248598|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2248599|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248600|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2248601|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2248602|NCT00126542|Growth Substances|growth substances|mesh-ancestor
811025|NCT02533791|Vaccines|vaccines|mesh-list
811026|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
811027|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248603|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248604|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
2248605|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
2248606|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2248607|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248608|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096668|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
2096669|NCT02311881|Acetaminophen|acetaminophen|mesh-list
2096670|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
812479|NCT02528175|Capecitabine|capecitabine|mesh-list
812480|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
812481|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
812482|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812483|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812699|NCT02527707|Ritonavir|ritonavir|mesh-list
812700|NCT02527707|Lonafarnib|lonafarnib|mesh-list
812701|NCT02527707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2096671|NCT02311881|Analgesics|analgesics|mesh-ancestor
809281|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809282|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
809283|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
809284|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
809285|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
809286|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
809287|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809288|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809289|NCT02541019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
809290|NCT02541019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
809291|NCT02541019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
809292|NCT02541019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
809293|NCT02541019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
809294|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
809361|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
809362|NCT02540642|Vitamins|vitamins|mesh-ancestor
809363|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
809364|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809365|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
809711|NCT02539199|Misoprostol|misoprostol|mesh-list
809712|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
809713|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
809714|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
809715|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809716|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
809717|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
809718|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
2248609|NCT00126607|Trastuzumab|trastuzumab|mesh-list
2248610|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2248611|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248612|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2248613|NCT00126620|Sorafenib|sorafenib|mesh-list
2248614|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248615|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2248616|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248617|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248618|NCT00126633|Gemcitabine|gemcitabine|mesh-list
2248619|NCT00126633|Bevacizumab|bevacizumab|mesh-list
2248620|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2248621|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248622|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2248623|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2248624|NCT00126633|Growth Substances|growth substances|mesh-ancestor
2248625|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248626|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
2248627|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2248628|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
2248629|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248630|NCT00126633|Antiviral Agents|antiviral agents|mesh-ancestor
2248631|NCT00126633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248632|NCT00126633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248633|NCT00126633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2248634|NCT00126633|Immunologic Factors|immunologic factors|mesh-ancestor
809302|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809303|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
809304|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809305|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248635|NCT00126646|Antibodies|antibodies|mesh-list
2248636|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
2248637|NCT00126646|Immunotoxins|immunotoxins|mesh-list
2248638|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
2248639|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248640|NCT00126672|Sirolimus|sirolimus|mesh-list
2248641|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2248642|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248643|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2248644|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248645|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
2248646|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2248647|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
2248648|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248649|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
810239|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
810240|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
810241|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810242|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810243|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
810244|NCT02537249|Analgesics|analgesics|mesh-ancestor
810245|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
810246|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810247|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
810248|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
810249|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
810250|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
810251|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
810252|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810389|NCT02536690|Midazolam|midazolam|mesh-list
810390|NCT02536690|Remifentanil|remifentanil|mesh-list
810391|NCT02536690|Propofol|propofol|mesh-list
810392|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
810393|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810394|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810395|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
810396|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
810397|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
810398|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
810399|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
810400|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
810401|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
810402|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
810403|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
810404|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
810405|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810406|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
810407|NCT02536690|Narcotics|narcotics|mesh-ancestor
810408|NCT02536690|Analgesics|analgesics|mesh-ancestor
810409|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
810410|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810550|NCT02535832|Pioglitazone|pioglitazone|mesh-list
810551|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
810552|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810686|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
810687|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
810688|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810905|NCT02534610|Etoricoxib|etoricoxib|mesh-list
810906|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
810907|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
810908|NCT02534610|Analgesics|analgesics|mesh-ancestor
810909|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
810910|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810911|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810912|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
810913|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
810914|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
810915|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
810916|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810917|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811038|NCT02533440|Anesthetics|anesthetics|mesh-list
811039|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
2248650|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2248651|NCT00126698|Trimethoprim|trimethoprim|mesh-list
2248652|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
2248653|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2248654|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248655|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2248656|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2248657|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248658|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248659|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248660|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
809485|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
809486|NCT02540395|Prednisolone|prednisolone|mesh-list
809487|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
809488|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
809489|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
809490|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
809491|NCT02540395|Tacrolimus|tacrolimus|mesh-list
809492|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
809493|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
809494|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
809495|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
809496|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809497|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
809498|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809499|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809500|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
809501|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809502|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
809503|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
809504|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
809505|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809506|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
809507|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
809508|NCT02540395|Hormones|hormones|mesh-ancestor
809509|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
809510|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
809511|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
809512|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
809513|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809514|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
809515|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
809516|NCT02540395|Protective Agents|protective agents|mesh-ancestor
809891|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
809892|NCT02538302|Oxybutynin|oxybutynin|mesh-list
809893|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
809894|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
809895|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809896|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809897|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
809898|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
809899|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
809900|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809901|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809902|NCT02538302|Urological Agents|urological agents|mesh-ancestor
809903|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
809904|NCT02538302|Coagulants|coagulants|mesh-ancestor
809905|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
809906|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
809981|NCT02538003|Delpazolid|delpazolid|mesh-list
809982|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
809983|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
809984|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809985|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
809986|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809987|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810160|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
810161|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
810162|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
810163|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
810164|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
810165|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810166|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810167|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
810273|NCT02537210|Mesalamine|mesalamine|mesh-list
809391|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809392|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809393|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
809394|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
809395|NCT02540785|Hormones|hormones|mesh-ancestor
809396|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
809397|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
809398|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809399|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
809400|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809401|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809402|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
809403|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809404|NCT02540785|Renal Agents|renal agents|mesh-ancestor
809405|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
809406|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
809407|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
809408|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
809409|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
809410|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
809411|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
809412|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
809413|NCT02540785|Protective Agents|protective agents|mesh-ancestor
809414|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
809415|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
809416|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809417|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
809418|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
810268|NCT02537158|Sorafenib|sorafenib|mesh-list
810269|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810270|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
810271|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810272|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810815|NCT02534506|Nivolumab|nivolumab|mesh-list
810816|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
810817|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810818|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
810819|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811213|NCT02533232|Minocycline|minocycline|mesh-list
811214|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
811215|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811482|NCT02532322|Acetaminophen|acetaminophen|mesh-list
811483|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
811484|NCT02532322|Analgesics|analgesics|mesh-ancestor
811485|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
811486|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811487|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811488|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
811985|NCT02530424|Trastuzumab|trastuzumab|mesh-list
811986|NCT02530424|Pertuzumab|pertuzumab|mesh-list
811987|NCT02530424|Fulvestrant|fulvestrant|mesh-list
811988|NCT02530424|Palbociclib|palbociclib|mesh-list
811989|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
811990|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811991|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
811992|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
811993|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
811994|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
811995|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
811996|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811997|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
811998|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811999|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812484|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
812485|NCT02528461|Liver Extracts|liver extracts|mesh-list
812486|NCT02528461|Hematinics|hematinics|mesh-ancestor
812487|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
812488|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812614|NCT02527941|Metronidazole|metronidazole|mesh-list
812615|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812616|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
812617|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
812618|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2248661|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2248662|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
809453|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
809454|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
809455|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809556|NCT02540018|Paclitaxel|paclitaxel|mesh-list
809557|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
809558|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809559|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
809560|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
809561|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
809562|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809646|NCT02539628|Ropivacaine|ropivacaine|mesh-list
809647|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
809648|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
809649|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
809650|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809651|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
809652|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248663|NCT00126698|Renal Agents|renal agents|mesh-ancestor
2248664|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
2248665|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2248666|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2248667|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2248668|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2248669|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2248670|NCT00126763|Fentanyl|fentanyl|mesh-list
2248671|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2248672|NCT00126763|Narcotics|narcotics|mesh-ancestor
2248673|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2248674|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248675|NCT00126763|Analgesics|analgesics|mesh-ancestor
2248676|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
2248677|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248678|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2248679|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2248680|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
2248681|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
2248682|NCT00126789|Fentanyl|fentanyl|mesh-list
2248683|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
811321|NCT02532491|Risperidone|risperidone|mesh-list
811322|NCT02532491|Aripiprazole|aripiprazole|mesh-list
811323|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
811324|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
811325|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
811326|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811327|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811328|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
811329|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
811330|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
811331|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
811332|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
811333|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
811334|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
811335|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
811336|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
811337|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
811338|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
811339|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
811492|NCT02531854|Pemetrexed|pemetrexed|mesh-list
811493|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811494|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811495|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811496|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
811497|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
811622|NCT02531568|Warfarin|warfarin|mesh-list
811623|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
812059|NCT02530463|Nivolumab|nivolumab|mesh-list
812060|NCT02530463|Ipilimumab|ipilimumab|mesh-list
812061|NCT02530463|Azacitidine|azacitidine|mesh-list
812062|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
812063|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812064|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
812065|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812066|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2248684|NCT00126789|Narcotics|narcotics|mesh-ancestor
2248685|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
809569|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809653|NCT02539641|Hormones|hormones|mesh-list
809654|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
809655|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810609|NCT02535533|Selenium|selenium|mesh-list
810610|NCT02535533|Axitinib|axitinib|mesh-list
810611|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810612|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
810613|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810614|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810615|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
810616|NCT02535533|Protective Agents|protective agents|mesh-ancestor
810617|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810618|NCT02535533|Trace Elements|trace elements|mesh-ancestor
810619|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
810744|NCT02534870|Ritonavir|ritonavir|mesh-list
810745|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
810746|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
810747|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
810748|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810749|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810750|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
810751|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
810752|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
810753|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
810754|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
810755|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
811065|NCT02533492|Triclosan|triclosan|mesh-list
811066|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
811067|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811068|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
811069|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
811070|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
811071|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811072|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
811271|NCT02532790|Prednisone|prednisone|mesh-list
811272|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
811273|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
811274|NCT02532790|Hormones|hormones|mesh-ancestor
811275|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
811276|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811277|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
811278|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811340|NCT02532413|Entecavir|entecavir|mesh-list
811341|NCT02532413|Poly I-C|poly i-c|mesh-list
811342|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
811343|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811344|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
811345|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
811346|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811593|NCT02531906|Oxycodone|oxycodone|mesh-list
811594|NCT02531906|Methadone|methadone|mesh-list
811595|NCT02531906|Gabapentin|gabapentin|mesh-list
811596|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
811597|NCT02531906|Narcotics|narcotics|mesh-ancestor
811598|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
811599|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811600|NCT02531906|Analgesics|analgesics|mesh-ancestor
811601|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
811602|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811603|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
811604|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
811605|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
811606|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
811607|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
811608|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
811609|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
811610|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811611|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
811612|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
811613|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
812015|NCT02530489|Paclitaxel|paclitaxel|mesh-list
809584|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
809585|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
809586|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
809587|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
809588|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
809589|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809590|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809591|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
809592|NCT02540070|Narcotics|narcotics|mesh-ancestor
809593|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
809594|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
809595|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
809596|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
809597|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
809598|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
809599|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
809600|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
809601|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
809602|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
809603|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
809604|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
809605|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
809606|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
809607|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809918|NCT02538393|Sorafenib|sorafenib|mesh-list
809919|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809920|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
809921|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809922|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248686|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248687|NCT00126789|Analgesics|analgesics|mesh-ancestor
810741|NCT02535130|Amikacin|amikacin|mesh-list
810742|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
810743|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
810918|NCT02534636|Interferons|interferons|mesh-list
810919|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
810920|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
810921|NCT02534636|BMS-986165|bms-986165|mesh-list
810922|NCT02534636|Famotidine|famotidine|mesh-list
810923|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810924|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
810925|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
810926|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
810927|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810928|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
810929|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
810930|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
810931|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
810932|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
810933|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
810934|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810935|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
810936|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
810937|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810979|NCT02533908|Fentanyl|fentanyl|mesh-list
810980|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
810981|NCT02533908|Narcotics|narcotics|mesh-ancestor
810982|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810983|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810984|NCT02533908|Analgesics|analgesics|mesh-ancestor
810985|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
810986|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810987|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
810988|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
810989|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
810990|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
811936|NCT02530632|Propofol|propofol|mesh-list
811937|NCT02530632|Sevoflurane|sevoflurane|mesh-list
811938|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
811939|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
811940|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811941|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
811942|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
811943|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
811944|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
811945|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
811975|NCT02530359|Pirfenidone|pirfenidone|mesh-list
811976|NCT02530359|Analgesics|analgesics|mesh-ancestor
809679|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
809680|NCT02539537|Hematinics|hematinics|mesh-ancestor
809923|NCT02538198|Lenalidomide|lenalidomide|mesh-list
809924|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
809925|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
809926|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
809927|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
809928|NCT02538198|Growth Substances|growth substances|mesh-ancestor
809929|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
809930|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248688|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
2248689|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248690|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2248691|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2248692|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
2248693|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
2248694|NCT00126880|Lamivudine|lamivudine|mesh-list
2248695|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2248696|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2248697|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248698|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248699|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
2248700|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248701|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2248702|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2248703|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
2248704|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
2248705|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
810356|NCT02536911|Eliglustat|eliglustat|mesh-list
810357|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810358|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810538|NCT02535936|Anesthetics|anesthetics|mesh-list
810539|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810540|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810620|NCT02535650|Tipifarnib|tipifarnib|mesh-list
810621|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811106|NCT02533336|Abamectin|abamectin|mesh-list
811107|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
811108|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
811109|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811489|NCT02532140|Cefepime|cefepime|mesh-list
811490|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
811491|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811828|NCT02531165|Aspirin|aspirin|mesh-list
811829|NCT02531165|Heparin|heparin|mesh-list
811830|NCT02531165|Fentanyl|fentanyl|mesh-list
811831|NCT02531165|Morphine|morphine|mesh-list
811832|NCT02531165|Ticagrelor|ticagrelor|mesh-list
811833|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
811834|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
811835|NCT02531165|Analgesics|analgesics|mesh-ancestor
811836|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
811837|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811838|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811839|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
811840|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
811841|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
811842|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
811843|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811844|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
811845|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
811846|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811847|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
811848|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
811849|NCT02531165|Narcotics|narcotics|mesh-ancestor
811850|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
811851|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
811852|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
811853|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
811854|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
811855|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
811856|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
811857|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
811858|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
811859|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
811860|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
811891|NCT02530801|Bevacizumab|bevacizumab|mesh-list
811892|NCT02530801|Fluorouracil|fluorouracil|mesh-list
2248706|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
810139|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
810140|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
810141|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810142|NCT02537509|Vitamins|vitamins|mesh-ancestor
810143|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
810144|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
810266|NCT02537223|Cisplatin|cisplatin|mesh-list
810267|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248707|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2248708|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248709|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2248710|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810674|NCT02535156|Risperidone|risperidone|mesh-list
810675|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
810676|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
810677|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
810678|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810679|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810680|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
810681|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
810682|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810683|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
810684|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
810685|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
810946|NCT02534623|Fentanyl|fentanyl|mesh-list
810947|NCT02534623|Bupivacaine|bupivacaine|mesh-list
810948|NCT02534623|Anesthetics|anesthetics|mesh-list
810949|NCT02534623|Propofol|propofol|mesh-list
810950|NCT02534623|Sevoflurane|sevoflurane|mesh-list
810951|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
810952|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
810953|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810954|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
810955|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810956|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
810957|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
810958|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
810959|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
810960|NCT02534623|Narcotics|narcotics|mesh-ancestor
810961|NCT02534623|Analgesics|analgesics|mesh-ancestor
810962|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
810963|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
810964|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
811229|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
811230|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
811231|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
811232|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811233|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811498|NCT02532023|Curcumin|curcumin|mesh-list
811499|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
811500|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
811501|NCT02532023|Analgesics|analgesics|mesh-ancestor
811502|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
811503|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811504|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811505|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
811506|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
811507|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811508|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811509|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248711|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248712|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2248713|NCT00126906|Renal Agents|renal agents|mesh-ancestor
2248714|NCT00126971|Dapsone|dapsone|mesh-list
2248715|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
2248716|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248717|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
2248718|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
812144|NCT02529878|Paclitaxel|paclitaxel|mesh-list
812145|NCT02529878|Apatinib|apatinib|mesh-list
809818|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
809819|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809820|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
809821|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
809822|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
809823|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
809824|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
810353|NCT02536755|Eliglustat|eliglustat|mesh-list
810354|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810355|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248719|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2248720|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2248721|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248722|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096672|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
2096673|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096674|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096675|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
2096676|NCT02311907|Paclitaxel|paclitaxel|mesh-list
2096677|NCT02311907|Carboplatin|carboplatin|mesh-list
2096678|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2096679|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2096680|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248723|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
2248724|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2248725|NCT00126984|Vaccines|vaccines|mesh-list
2248726|NCT00126984|Immunologic Factors|immunologic factors|mesh-ancestor
2248727|NCT00126984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248728|NCT00127010|Vaccines|vaccines|mesh-list
2248729|NCT00127010|Immunoglobulins|immunoglobulins|mesh-list
2248730|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
2248731|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248732|NCT00127023|Vaccines|vaccines|mesh-list
2248733|NCT00127023|Immunoglobulins|immunoglobulins|mesh-list
811614|NCT02531672|Choline|choline|mesh-list
811615|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
811616|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
811617|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
811618|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811619|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
811620|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
811621|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
2248734|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
2248735|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248736|NCT00127049|Gemcitabine|gemcitabine|mesh-list
2248737|NCT00127049|Ifosfamide|ifosfamide|mesh-list
2248738|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248739|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
812165|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
812166|NCT02529839|Fludarabine|fludarabine|mesh-list
812167|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
812168|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
812169|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
812170|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812171|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
812172|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
812173|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
812174|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812175|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812176|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
812177|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
812639|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
812640|NCT02527824|Irinotecan|irinotecan|mesh-list
812641|NCT02527824|Tegafur|tegafur|mesh-list
812642|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812643|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
812644|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
812645|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812646|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812647|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
812648|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
2248740|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
2248741|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248742|NCT00127049|Antiviral Agents|antiviral agents|mesh-ancestor
2248743|NCT00127049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248744|NCT00127049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096681|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
809907|NCT02538432|Gemcitabine|gemcitabine|mesh-list
809908|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
809909|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
809910|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809911|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
809912|NCT02538432|Antiviral Agents|antiviral agents|mesh-ancestor
809913|NCT02538432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
809914|NCT02538432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
809915|NCT02538432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
809916|NCT02538432|Immunologic Factors|immunologic factors|mesh-ancestor
809917|NCT02538432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810282|NCT02537171|Apatinib|apatinib|mesh-list
810283|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810284|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
810285|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810286|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810451|NCT02536352|Vitamins|vitamins|mesh-list
810452|NCT02536352|Fluorides|fluorides|mesh-list
810453|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
810454|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810455|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
810456|NCT02536352|Protective Agents|protective agents|mesh-ancestor
2248745|NCT00127049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2248746|NCT00127049|Immunologic Factors|immunologic factors|mesh-ancestor
2248747|NCT00127049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248748|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2248749|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
2248750|NCT00127075|Estradiol|estradiol|mesh-list
2248751|NCT00127075|Estrogens|estrogens|mesh-ancestor
811741|NCT02531724|Simendan|simendan|mesh-list
811742|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
811743|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
811744|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
811745|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
811746|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811747|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811748|NCT02531724|Protective Agents|protective agents|mesh-ancestor
811749|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812121|NCT02529969|Curcumin|curcumin|mesh-list
812122|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
812123|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
812124|NCT02529969|Analgesics|analgesics|mesh-ancestor
812125|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
812126|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812127|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812128|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
812129|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
812130|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812131|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812132|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812459|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
812460|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
812461|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812756|NCT02527564|Suvorexant|suvorexant|mesh-list
812757|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
812758|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
812759|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
812760|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812761|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
812762|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
812763|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096682|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
2096683|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
813303|NCT02525276|Hormones|hormones|mesh-list
813304|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
813305|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813388|NCT02524821|Metformin|metformin|mesh-list
813389|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
813390|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813444|NCT02524405|Corticosterone|corticosterone|mesh-list
813445|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2248752|NCT00127075|Hormones|hormones|mesh-ancestor
2248753|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2248754|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813743|NCT02523131|Insulin|insulin|mesh-list
2248755|NCT00127088|Docetaxel|docetaxel|mesh-list
2248756|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248757|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
2248758|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
810107|NCT02537925|Celecoxib|celecoxib|mesh-list
810108|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
810109|NCT02537925|Nedaplatin|nedaplatin|mesh-list
810110|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
810111|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
810112|NCT02537925|Analgesics|analgesics|mesh-ancestor
810113|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
810114|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810115|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810116|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
810117|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
810118|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
810119|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810120|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810121|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810168|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
810169|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
810170|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810171|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
810172|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248759|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
2248760|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248761|NCT00127114|Amantadine|amantadine|mesh-list
2248762|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2248763|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2248764|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
2096684|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096685|NCT02311933|Tamoxifen|tamoxifen|mesh-list
2096686|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2096687|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
2096688|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
810733|NCT02534961|Cefazolin|cefazolin|mesh-list
810734|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
810735|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811694|NCT02531477|Propofol|propofol|mesh-list
811695|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
811696|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
811697|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811698|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
811699|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
811700|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
811970|NCT02530320|Palbociclib|palbociclib|mesh-list
811971|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811972|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
811973|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811974|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248765|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248766|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
2248767|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248768|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248769|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248770|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2248771|NCT00127114|Analgesics|analgesics|mesh-ancestor
2248772|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
2248773|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248774|NCT00127127|Vorinostat|vorinostat|mesh-list
2248775|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248776|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2248777|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248778|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248779|NCT00127140|Vorinostat|vorinostat|mesh-list
2248780|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248781|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2248782|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248783|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248784|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2248785|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
2248786|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248787|NCT00127179|Finasteride|finasteride|mesh-list
809966|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
809967|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
809968|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
809969|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810050|NCT02537847|Ertapenem|ertapenem|mesh-list
810051|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
810052|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
810053|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
810054|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
810055|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
810056|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810057|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810058|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
810059|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
810060|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810191|NCT02537600|Vemurafenib|vemurafenib|mesh-list
810192|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810193|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
810194|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810195|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810299|NCT02537080|Nimodipine|nimodipine|mesh-list
810300|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
810301|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
810302|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
810303|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810304|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
810305|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810306|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
2248788|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248789|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248790|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2248791|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2248792|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248793|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
2248794|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2248795|NCT00127179|Urological Agents|urological agents|mesh-ancestor
2248796|NCT00127257|Diazepam|diazepam|mesh-list
2248797|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2248798|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
811350|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
811351|NCT02532777|Prednisone|prednisone|mesh-list
811352|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
811353|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
811354|NCT02532777|Leflunomide|leflunomide|mesh-list
811355|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
811356|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
811357|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
811358|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
811359|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811360|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
811361|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
811362|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
811363|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811364|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811365|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
811366|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
811367|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
811368|NCT02532777|Hormones|hormones|mesh-ancestor
811369|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
811370|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
811371|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
811372|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
811373|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
811374|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
811375|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811376|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
811377|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
811378|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811379|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
811380|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
811381|NCT02532777|Protective Agents|protective agents|mesh-ancestor
811382|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
810174|NCT02537353|Racepinephrine|racepinephrine|mesh-list
810175|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
810176|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
810177|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
810178|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
810179|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
810180|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810181|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810182|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
810183|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
810184|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
810185|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810186|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
810187|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
810188|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
810189|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
810190|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
810260|NCT02537197|Naltrexone|naltrexone|mesh-list
810261|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
810262|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
810263|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810264|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
810265|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248799|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
2248800|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
2248801|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248802|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248803|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2248804|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2248805|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2248806|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2248807|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2248808|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2248809|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2248810|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2248811|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2248812|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
2248813|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
2248814|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
2248815|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
2248816|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248817|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248818|NCT00127270|Darifenacin|darifenacin|mesh-list
2248819|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2248820|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2248821|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
2248822|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248823|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248824|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248825|NCT00127270|Urological Agents|urological agents|mesh-ancestor
2248826|NCT00127335|Atorvastatin|atorvastatin|mesh-list
2248827|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2248828|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2248829|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
2248830|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248831|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2248832|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2248833|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248834|NCT00127387|Etanercept|etanercept|mesh-list
2248835|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2248836|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2248837|NCT00127387|Analgesics|analgesics|mesh-ancestor
2248838|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
810700|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
810701|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
810702|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810823|NCT02534571|Epinephrine|epinephrine|mesh-list
810824|NCT02534571|Hemostatics|hemostatics|mesh-list
810825|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
810826|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
810827|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
810828|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
810829|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810830|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810831|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
810220|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
810221|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
810222|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
810223|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810359|NCT02536742|Fulvestrant|fulvestrant|mesh-list
810360|NCT02536742|Palbociclib|palbociclib|mesh-list
810361|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
810362|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810363|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
810364|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
810365|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
810366|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
810367|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810368|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
810369|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810370|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810646|NCT02535299|Metformin|metformin|mesh-list
810647|NCT02535299|Liraglutide|liraglutide|mesh-list
810648|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
810649|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810650|NCT02535299|Incretins|incretins|mesh-ancestor
810651|NCT02535299|Hormones|hormones|mesh-ancestor
810652|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
811049|NCT02533544|Tenofovir|tenofovir|mesh-list
811050|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
811051|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811052|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
811053|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
811054|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811055|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811056|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
811057|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2096689|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096690|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2096691|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096692|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2096693|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2096694|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2096695|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2096696|NCT02312063|Glimepiride|glimepiride|mesh-list
2096697|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2096698|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096699|NCT02312063|Incretins|incretins|mesh-ancestor
2096700|NCT02312063|Hormones|hormones|mesh-ancestor
2096701|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2096702|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2096703|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
2096704|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096705|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096706|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
812684|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
812685|NCT02527746|Epirubicin|epirubicin|mesh-list
812686|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
812687|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
812688|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812689|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
812690|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
812691|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
812692|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812693|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812694|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
812695|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
812696|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
812697|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
812698|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812930|NCT02526953|Paclitaxel|paclitaxel|mesh-list
812931|NCT02526953|Capecitabine|capecitabine|mesh-list
812932|NCT02526953|Mitomycins|mitomycins|mesh-list
812933|NCT02526953|Mitomycin|mitomycin|mesh-list
812934|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
812935|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812936|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
812937|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
812938|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
810226|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810227|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
810228|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
810496|NCT02535988|Thymalfasin|thymalfasin|mesh-list
810497|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
810498|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
810499|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811216|NCT02533141|Simvastatin|simvastatin|mesh-list
811217|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
811218|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
811219|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
811220|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811221|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
811222|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
811223|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812971|NCT02526615|Metformin|metformin|mesh-list
812972|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
812973|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
812974|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812987|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
812988|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
812989|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
812990|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248839|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248840|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248841|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2248842|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2248843|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2248844|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2248845|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
2248846|NCT00127478|Atrasentan|atrasentan|mesh-list
2248847|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248848|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2248849|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2248850|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248851|NCT00127504|Azithromycin|azithromycin|mesh-list
2248852|NCT00127504|Rifampin|rifampin|mesh-list
2248853|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2248854|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248855|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2248856|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
2248857|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
2248858|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2248859|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248860|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248861|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2248862|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2248863|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2248864|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2248865|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2248866|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2248867|NCT00127569|Rituximab|rituximab|mesh-list
2248868|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2248869|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248870|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
813931|NCT02522234|Lenograstim|lenograstim|mesh-list
813932|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
813933|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
813934|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814048|NCT02521714|Lenalidomide|lenalidomide|mesh-list
814049|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
814050|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814051|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
814052|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
814053|NCT02521714|Growth Substances|growth substances|mesh-ancestor
814054|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
814055|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814171|NCT02521207|Ibuprofen|ibuprofen|mesh-list
810274|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
810275|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
810276|NCT02537210|Analgesics|analgesics|mesh-ancestor
810277|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
810278|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810279|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810280|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
810281|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
810758|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
810759|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
810760|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
810761|NCT02535039|Prednisolone|prednisolone|mesh-list
810762|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
810763|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
810764|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
810765|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
810766|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
810767|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
810768|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810769|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810770|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
810771|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
810772|NCT02535039|Hormones|hormones|mesh-ancestor
810773|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
810774|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
810775|NCT02535039|Protective Agents|protective agents|mesh-ancestor
810776|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
810777|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248871|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248872|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2248873|NCT00127595|Gemcitabine|gemcitabine|mesh-list
2248874|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
2248875|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2248876|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
2248877|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248878|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248879|NCT00127595|Antiviral Agents|antiviral agents|mesh-ancestor
2248880|NCT00127595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248881|NCT00127595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248882|NCT00127595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2248883|NCT00127595|Immunologic Factors|immunologic factors|mesh-ancestor
2248884|NCT00127595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248885|NCT00127634|Insulin|insulin|mesh-list
2248886|NCT00127634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2248887|NCT00127634|Insulin Glargine|insulin glargine|mesh-list
2248888|NCT00127634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2248889|NCT00127634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248890|NCT00127647|Montelukast|montelukast|mesh-list
2248891|NCT00127647|Pranlukast|pranlukast|mesh-list
2248892|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2248893|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
2248894|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2248895|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
2248896|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
811656|NCT02531451|Aspirin|aspirin|mesh-list
811657|NCT02531451|Ibuprofen|ibuprofen|mesh-list
811658|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
811659|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
811660|NCT02531451|Analgesics|analgesics|mesh-ancestor
811661|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
811662|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811663|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811664|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
811665|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
811666|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
811667|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811668|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811669|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
811670|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
811671|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
811672|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
812261|NCT02529579|Gemcitabine|gemcitabine|mesh-list
812262|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
812263|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
812264|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810326|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810327|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248897|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248898|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2248899|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2248900|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248901|NCT00127673|Sertraline|sertraline|mesh-list
2248902|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
2248903|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2248904|NCT00127673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2248905|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2248906|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2248907|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248908|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248909|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
2248910|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248911|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
2248912|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
2248913|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
2248914|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2248915|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2248916|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248917|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248918|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248919|NCT00127764|Dexamethasone|dexamethasone|mesh-list
2248920|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2248921|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
2248922|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
2248923|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812357|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
812358|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
812359|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813012|NCT02526394|Vaccines|vaccines|mesh-list
813013|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
813014|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813131|NCT02525822|Tazarotene|tazarotene|mesh-list
813132|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
813133|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
813220|NCT02525484|Pirfenidone|pirfenidone|mesh-list
813221|NCT02525484|Analgesics|analgesics|mesh-ancestor
813222|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
813223|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813224|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813225|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
813226|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
813227|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
813228|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
813229|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814226|NCT02521038|Ticagrelor|ticagrelor|mesh-list
814227|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
814228|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
814229|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
814230|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
814231|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
814232|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
814233|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814234|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248924|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248925|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2248926|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
2248927|NCT00127764|Hormones|hormones|mesh-ancestor
2248928|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2248929|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2248930|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248931|NCT00127777|Amantadine|amantadine|mesh-list
814924|NCT02518373|Omeprazole|omeprazole|mesh-list
814925|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
814926|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
814927|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
814928|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814929|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815162|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
815163|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2248932|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2248933|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2248934|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
2248935|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248936|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
2754330|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2754331|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2754332|NCT01295944|Growth Substances|growth substances|mesh-ancestor
2754333|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754334|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
811234|NCT02533076|Capsaicin|capsaicin|mesh-list
811235|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
811236|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
811237|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
811238|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811239|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811292|NCT02532634|Dexamethasone|dexamethasone|mesh-list
811293|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
811294|NCT02532634|Aprepitant|aprepitant|mesh-list
811295|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
811296|NCT02532634|Palonosetron|palonosetron|mesh-list
811297|NCT02532634|Ramosetron|ramosetron|mesh-list
811298|NCT02532634|BB 1101|bb 1101|mesh-list
811299|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
811300|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
811301|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
811302|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811303|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811304|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
811305|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
811306|NCT02532634|Hormones|hormones|mesh-ancestor
811307|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
811308|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
811309|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811310|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
811311|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811312|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811313|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
811314|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
811315|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
811316|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
811317|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
811962|NCT02530411|Fulvestrant|fulvestrant|mesh-list
811963|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
811964|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811965|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
811966|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
811967|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
811968|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
811969|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812178|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
812179|NCT02529787|Lansoprazole|lansoprazole|mesh-list
812180|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
812181|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
812182|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
812183|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812184|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812332|NCT02529059|Tenofovir|tenofovir|mesh-list
812333|NCT02529059|Emtricitabine|emtricitabine|mesh-list
812334|NCT02529059|Rilpivirine|rilpivirine|mesh-list
812335|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
812336|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812337|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
812338|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
812339|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812340|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812341|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
812342|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
812919|NCT02526875|Amlodipine|amlodipine|mesh-list
812920|NCT02526875|Telmisartan|telmisartan|mesh-list
812921|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
812922|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
812923|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
810339|NCT02536859|Insulin|insulin|mesh-list
810340|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
810341|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
810342|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
810343|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810800|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
810801|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
810802|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810803|NCT02534753|Protective Agents|protective agents|mesh-ancestor
810804|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810805|NCT02534753|Vitamins|vitamins|mesh-ancestor
810806|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
810966|NCT02534454|Nicotine|nicotine|mesh-list
810967|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
810968|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
810969|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810970|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810971|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
810972|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
810973|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
810974|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
810975|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811318|NCT02532569|Vaccines|vaccines|mesh-list
811319|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
811320|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096707|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2096708|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
2096709|NCT02312219|Folic Acid|folic acid|mesh-list
2096710|NCT02312219|Methotrexate|methotrexate|mesh-list
2096711|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2096712|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
2248937|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248938|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248939|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248940|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2248941|NCT00127777|Analgesics|analgesics|mesh-ancestor
2248942|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
2248943|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248944|NCT00127829|Gefitinib|gefitinib|mesh-list
2248945|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248946|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2248947|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2248948|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248949|NCT00127868|Selenium|selenium|mesh-list
2248950|NCT00127868|Ketoconazole|ketoconazole|mesh-list
2248951|NCT00127868|Ciclopirox|ciclopirox|mesh-list
2248952|NCT00127868|Griseofulvin|griseofulvin|mesh-list
2248953|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
2248954|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
2248955|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2248956|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2248957|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2248958|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812282|NCT02529540|Methamphetamine|methamphetamine|mesh-list
812283|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
812284|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812285|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
812286|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
812287|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812288|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
812289|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
812290|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812291|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
812292|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
812293|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
812294|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
812295|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
812539|NCT02528123|Tobramycin|tobramycin|mesh-list
812540|NCT02528123|Ofloxacin|ofloxacin|mesh-list
812541|NCT02528123|Dexamethasone|dexamethasone|mesh-list
812542|NCT02528123|Benoxinate|benoxinate|mesh-list
812543|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
812544|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
812545|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
812546|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
812547|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812548|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810371|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
810372|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2096713|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2096714|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096715|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2096716|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
2248959|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248960|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2248961|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
2248962|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2248963|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812033|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
812034|NCT02530502|Temozolomide|temozolomide|mesh-list
812035|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
812036|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812037|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
812038|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
812039|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812462|NCT02528201|Celecoxib|celecoxib|mesh-list
812463|NCT02528201|Diclofenac|diclofenac|mesh-list
812464|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
812465|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
812466|NCT02528201|Analgesics|analgesics|mesh-ancestor
812467|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
812468|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812469|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812470|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
812471|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
812472|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
812473|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
812474|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812475|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812649|NCT02527811|Urinastatin|urinastatin|mesh-list
812650|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
812651|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
812652|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
812653|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812654|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096717|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096718|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096719|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
2096720|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096721|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2096722|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2096723|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
2096724|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2096725|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2096726|NCT02312219|Hematinics|hematinics|mesh-ancestor
2096727|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
2096728|NCT02312219|Vitamins|vitamins|mesh-ancestor
2096729|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
813595|NCT02523846|Morphine|morphine|mesh-list
813596|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
813597|NCT02523846|Narcotics|narcotics|mesh-ancestor
813598|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813599|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813600|NCT02523846|Analgesics|analgesics|mesh-ancestor
813601|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
813602|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813877|NCT02522572|Plerixafor|plerixafor|mesh-list
813878|NCT02522572|Bortezomib|bortezomib|mesh-list
810462|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
810463|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810464|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810465|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
810466|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
810467|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
810468|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810469|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810513|NCT02535975|Metformin|metformin|mesh-list
810514|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
810515|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248964|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2248965|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
2248966|NCT00127868|Protective Agents|protective agents|mesh-ancestor
2248967|NCT00127868|Trace Elements|trace elements|mesh-ancestor
810736|NCT02535104|Ranpirnase|ranpirnase|mesh-list
810737|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810738|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
810739|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810740|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811529|NCT02532192|Cytarabine|cytarabine|mesh-list
811530|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
811531|NCT02532192|Fluconazole|fluconazole|mesh-list
811532|NCT02532192|Dexamethasone|dexamethasone|mesh-list
811533|NCT02532192|Cisplatin|cisplatin|mesh-list
811534|NCT02532192|Rituximab|rituximab|mesh-list
811535|NCT02532192|Belinostat|belinostat|mesh-list
811536|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811537|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
811538|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
811539|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
811540|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811541|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811542|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
811543|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
811544|NCT02532192|Hormones|hormones|mesh-ancestor
811545|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
811546|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
811547|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
811548|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
811549|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
811550|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
811551|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
811552|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811553|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
811554|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811555|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
811556|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
811557|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
811558|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
811559|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811560|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
811561|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
811562|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
811563|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
811564|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
811565|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
811566|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
811567|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
811568|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
811631|NCT02531490|Labetalol|labetalol|mesh-list
811632|NCT02531490|Methyldopa|methyldopa|mesh-list
811633|NCT02531490|Nifedipine|nifedipine|mesh-list
811634|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
811635|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
811636|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811637|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
811638|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811639|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
811640|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
811641|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
811642|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
811643|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
811644|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
811645|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
810856|NCT02534467|Montelukast|montelukast|mesh-list
810857|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
810858|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
810859|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
810860|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
810861|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
810862|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810863|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
810864|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
810865|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248968|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
2248969|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
2248970|NCT00127881|Zanolimumab|zanolimumab|mesh-list
2248971|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2248972|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248973|NCT00127907|Vasopressins|vasopressins|mesh-list
2248974|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
2248975|NCT00127907|Epinephrine|epinephrine|mesh-list
2248976|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2248977|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2248978|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
2096735|NCT02312622|Irinotecan|irinotecan|mesh-list
2096736|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
2096737|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2096738|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2096739|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096740|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096741|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248979|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2248980|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2248981|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2248982|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2248983|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2248984|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
2248985|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2248986|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2248987|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
2248988|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
2248989|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
2248990|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2248991|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
2248992|NCT00127907|Coagulants|coagulants|mesh-ancestor
2248993|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2248994|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
2248995|NCT00127920|Bevacizumab|bevacizumab|mesh-list
2248996|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2248997|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2248998|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2248999|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2249000|NCT00127920|Growth Substances|growth substances|mesh-ancestor
2249001|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249002|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
2249003|NCT00127959|Tenofovir|tenofovir|mesh-list
2249004|NCT00127959|Zidovudine|zidovudine|mesh-list
2249005|NCT00127959|Emtricitabine|emtricitabine|mesh-list
2249006|NCT00127959|Efavirenz|efavirenz|mesh-list
2249007|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
2249008|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249009|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2249010|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
814156|NCT02521246|Losartan|losartan|mesh-list
814157|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
814158|NCT02521246|Candesartan|candesartan|mesh-list
814159|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
814160|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
814161|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
814162|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
814163|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
814164|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
814165|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249011|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249012|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249013|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2249014|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2249015|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
810841|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
810842|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
810843|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
810844|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810845|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
810846|NCT02534415|Protective Agents|protective agents|mesh-ancestor
2249016|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2249017|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2249018|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
811165|NCT02533323|Gemcitabine|gemcitabine|mesh-list
811166|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
811167|NCT02533323|Pegaspargase|pegaspargase|mesh-list
811168|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
811169|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
811170|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811171|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811172|NCT02533323|Antiviral Agents|antiviral agents|mesh-ancestor
811173|NCT02533323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811174|NCT02533323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811175|NCT02533323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
811176|NCT02533323|Immunologic Factors|immunologic factors|mesh-ancestor
811177|NCT02533323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811224|NCT02533011|Heparin|heparin|mesh-list
811225|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
811226|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
811227|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
811228|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811825|NCT02531152|Latanoprost|latanoprost|mesh-list
811826|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
811827|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2249019|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2249020|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2249021|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2249022|NCT00127972|Lamivudine|lamivudine|mesh-list
2249023|NCT00127972|Efavirenz|efavirenz|mesh-list
2096742|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2096743|NCT02312739|Ketorolac|ketorolac|mesh-list
2096744|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2096745|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
2096746|NCT02312739|Analgesics|analgesics|mesh-list
2096747|NCT02312739|Lorazepam|lorazepam|mesh-list
2096748|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2096749|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2096750|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
2096751|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096752|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096753|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2096754|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2096755|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
812387|NCT02528682|Vaccines|vaccines|mesh-list
812388|NCT02528682|Immunologic Factors|immunologic factors|mesh-ancestor
812389|NCT02528682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249024|NCT00127972|Nevirapine|nevirapine|mesh-list
2249025|NCT00127972|Stavudine|stavudine|mesh-list
2249026|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2249027|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2249028|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249029|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249030|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
2249031|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249032|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2249033|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2249034|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2249035|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2249036|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2249037|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2249038|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2249039|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2249040|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
812660|NCT02527772|Leucovorin|leucovorin|mesh-list
812661|NCT02527772|Gemcitabine|gemcitabine|mesh-list
812662|NCT02527772|Fluorouracil|fluorouracil|mesh-list
812663|NCT02527772|Doxorubicin|doxorubicin|mesh-list
812664|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2096756|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249041|NCT00127985|Prednisolone|prednisolone|mesh-list
2249042|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2249043|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
2249044|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2249045|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
2249046|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2249047|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
811041|NCT02533765|Olaparib|olaparib|mesh-list
811042|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
811043|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811044|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811045|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811347|NCT02532400|Goserelin|goserelin|mesh-list
811348|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
811349|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811409|NCT02532114|Niclosamide|niclosamide|mesh-list
811410|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
811411|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
811412|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
811413|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
811414|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811415|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
2249048|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2249049|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
2249050|NCT00127985|Hormones|hormones|mesh-ancestor
2249051|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2249052|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814779|NCT02518945|Liraglutide|liraglutide|mesh-list
814780|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
814781|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
814782|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814783|NCT02518945|Incretins|incretins|mesh-ancestor
814784|NCT02518945|Hormones|hormones|mesh-ancestor
814785|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
814786|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
814787|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249053|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2249054|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249055|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
2249056|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
2249057|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249058|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2249059|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2249060|NCT00127985|Protective Agents|protective agents|mesh-ancestor
2249061|NCT00127998|Artesunate|artesunate|mesh-list
815216|NCT02517307|Heparin|heparin|mesh-list
815217|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
815218|NCT02517307|Glycerol|glycerol|mesh-list
815219|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
815220|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
815221|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
815222|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815223|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
815224|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
815225|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
815226|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
815227|NCT02517307|Protective Agents|protective agents|mesh-ancestor
815228|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815301|NCT02516904|Rezafungin|rezafungin|mesh-list
815302|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
815303|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249062|NCT00127998|Chloroquine|chloroquine|mesh-list
2249063|NCT00127998|Lumefantrine|lumefantrine|mesh-list
2249064|NCT00127998|Artemether|artemether|mesh-list
2249065|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
2096757|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096758|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2249066|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
2249067|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
810832|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
810833|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
810834|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
810835|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
810836|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
810837|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
810838|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
810839|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
810840|NCT02534571|Coagulants|coagulants|mesh-ancestor
810886|NCT02534337|Leucovorin|leucovorin|mesh-list
810887|NCT02534337|Gemcitabine|gemcitabine|mesh-list
810888|NCT02534337|Fluorouracil|fluorouracil|mesh-list
810889|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
810890|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
810891|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
810892|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
810893|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
810894|NCT02534337|Antiviral Agents|antiviral agents|mesh-ancestor
810895|NCT02534337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
810896|NCT02534337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810897|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
810898|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
810899|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
810900|NCT02534337|Antidotes|antidotes|mesh-ancestor
810901|NCT02534337|Protective Agents|protective agents|mesh-ancestor
810902|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
810903|NCT02534337|Vitamins|vitamins|mesh-ancestor
810904|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
2249068|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2249069|NCT00127998|Amodiaquine|amodiaquine|mesh-list
2249070|NCT00127998|Mefloquine|mefloquine|mesh-list
2249071|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
2249072|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2249073|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2249074|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249075|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249076|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
2249077|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
2249078|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2249079|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
2249080|NCT00127998|Amebicides|amebicides|mesh-ancestor
2249081|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2249082|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2249083|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249084|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249085|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2249086|NCT00127998|Renal Agents|renal agents|mesh-ancestor
2249087|NCT00128037|Mitomycins|mitomycins|mesh-list
2249088|NCT00128037|Mitomycin|mitomycin|mesh-list
2249089|NCT00128037|Vindesine|vindesine|mesh-list
2249090|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249091|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2249092|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
2249093|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811701|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
811702|NCT02531841|Dexamethasone|dexamethasone|mesh-list
811703|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
811704|NCT02531841|Etoposide|etoposide|mesh-list
811705|NCT02531841|Ifosfamide|ifosfamide|mesh-list
811706|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
811707|NCT02531841|Thiotepa|thiotepa|mesh-list
811708|NCT02531841|Carmustine|carmustine|mesh-list
811709|NCT02531841|Busulfan|busulfan|mesh-list
811710|NCT02531841|BB 1101|bb 1101|mesh-list
811711|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
811712|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
811713|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
811714|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811715|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811716|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
811717|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
811718|NCT02531841|Hormones|hormones|mesh-ancestor
811719|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
811720|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
811721|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811722|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
811723|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811724|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249094|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2249095|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
810944|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
810945|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811079|NCT02533557|Lidocaine|lidocaine|mesh-list
811080|NCT02533557|Epinephrine|epinephrine|mesh-list
811081|NCT02533557|Racepinephrine|racepinephrine|mesh-list
811082|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
811083|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
811084|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
811085|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
811086|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811087|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
811088|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811089|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
811090|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
811091|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
811092|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
811093|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811094|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
811095|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
811096|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
811097|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
811098|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
811099|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
811100|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
811101|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
811102|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
811103|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
811104|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
811105|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
811426|NCT02532270|Phenylephrine|phenylephrine|mesh-list
811427|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
811428|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
811429|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
811430|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
811431|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811432|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811433|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
811434|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
811435|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
811436|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
811437|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
811438|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
811439|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
811440|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
811441|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
811442|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811443|NCT02532270|Protective Agents|protective agents|mesh-ancestor
811783|NCT02531191|Peficitinib|peficitinib|mesh-list
811784|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811785|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811786|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
811787|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
811788|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811875|NCT02530918|Ranibizumab|ranibizumab|mesh-list
811876|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
811877|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
811878|NCT02530918|Growth Substances|growth substances|mesh-ancestor
811879|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811880|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
811881|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249096|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2249097|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
2249098|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
2249099|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
2249100|NCT00128154|Chromium|chromium|mesh-list
2249101|NCT00128154|Picolinic acid|picolinic acid|mesh-list
812133|NCT02530047|Interferons|interferons|mesh-list
812134|NCT02530047|Interferon-beta|interferon-beta|mesh-list
812135|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812136|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
812137|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812138|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
812139|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812272|NCT02529683|NuvaRing|nuvaring|mesh-list
812273|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
812274|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
2249102|NCT00128154|Trace Elements|trace elements|mesh-ancestor
811040|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
811046|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811047|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
811048|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811455|NCT02532153|Ketamine|ketamine|mesh-list
811456|NCT02532153|Analgesics|analgesics|mesh-ancestor
811457|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
811458|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811459|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811460|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
811461|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
811462|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
811463|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
811464|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
811465|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
811466|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
811467|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
811468|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249103|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
2249104|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249105|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2249106|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
2249107|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
2249108|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249109|NCT00128232|Octreotide|octreotide|mesh-list
2249110|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2249111|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2249112|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249113|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
2249114|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2249115|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2249116|NCT00128245|Analgesics|analgesics|mesh-ancestor
2249117|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
2249118|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249119|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249120|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2249121|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2249122|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
2249123|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2249124|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
2249125|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2249126|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249127|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249128|NCT00128271|Bavituximab|bavituximab|mesh-list
2249129|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2249130|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249131|NCT00128297|Pamidronate|pamidronate|mesh-list
812296|NCT02529670|Lidocaine|lidocaine|mesh-list
812297|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
812298|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
812299|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
812300|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812301|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
812302|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812303|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
812304|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
812305|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
812306|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
812307|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812728|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
812729|NCT02527993|Liraglutide|liraglutide|mesh-list
812730|NCT02527993|Acarbose|acarbose|mesh-list
812731|NCT02527993|Verapamil|verapamil|mesh-list
812732|NCT02527993|Pasireotide|pasireotide|mesh-list
812733|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
812734|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812735|NCT02527993|Incretins|incretins|mesh-ancestor
812736|NCT02527993|Hormones|hormones|mesh-ancestor
812737|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
812738|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
811203|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
811204|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
811205|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
811206|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
811207|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
811208|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
811209|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811210|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
811211|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
811212|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
811251|NCT02532660|Dexetimide|dexetimide|mesh-list
811252|NCT02532660|Citalopram|citalopram|mesh-list
811253|NCT02532660|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
811254|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
811255|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
811256|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811257|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
811258|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
811259|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811260|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
811261|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
811262|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
811263|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
811264|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
811265|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
811266|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
811267|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811268|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
811269|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
811270|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
811406|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
811407|NCT02532335|Cathartics|cathartics|mesh-ancestor
811408|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
811882|NCT02530788|Selenium|selenium|mesh-list
811883|NCT02530788|Selenious Acid|selenious acid|mesh-list
811884|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
811885|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
811886|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811887|NCT02530788|Protective Agents|protective agents|mesh-ancestor
811888|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811889|NCT02530788|Trace Elements|trace elements|mesh-ancestor
811890|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
812077|NCT02529982|Curcumin|curcumin|mesh-list
812078|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
812079|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
812080|NCT02529982|Analgesics|analgesics|mesh-ancestor
812081|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
812082|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812083|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812084|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
812085|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
812086|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812087|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812088|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812185|NCT02529774|Leucovorin|leucovorin|mesh-list
812186|NCT02529774|Dexamethasone|dexamethasone|mesh-list
812187|NCT02529774|Capecitabine|capecitabine|mesh-list
812188|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
812189|NCT02529774|Fluorouracil|fluorouracil|mesh-list
812190|NCT02529774|Floxuridine|floxuridine|mesh-list
812191|NCT02529774|Heparin|heparin|mesh-list
812192|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
812193|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
812194|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
812195|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
812196|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812197|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812198|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
812199|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
812200|NCT02529774|Hormones|hormones|mesh-ancestor
812201|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
812202|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
812203|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812204|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
812205|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
812206|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811403|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
811404|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
811405|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249132|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2249133|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249134|NCT00128310|Gemcitabine|gemcitabine|mesh-list
2249135|NCT00128310|Vinorelbine|vinorelbine|mesh-list
2249136|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2249137|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
2249138|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249139|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249140|NCT00128310|Antiviral Agents|antiviral agents|mesh-ancestor
2249141|NCT00128310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249142|NCT00128310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249143|NCT00128310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2249144|NCT00128310|Immunologic Factors|immunologic factors|mesh-ancestor
2249145|NCT00128310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249146|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
812343|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
812344|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
812345|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
812346|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812347|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
812348|NCT02529202|Analgesics|analgesics|mesh-ancestor
812349|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
812350|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812351|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
812352|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
812353|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
812354|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
812355|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
812356|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812748|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
812749|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
812750|NCT02527603|Analgesics|analgesics|mesh-ancestor
812751|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
812752|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812753|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812754|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
812755|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
812896|NCT02526979|Mirabegron|mirabegron|mesh-list
812897|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
812898|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
812899|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
812900|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
812901|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
812902|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812903|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812904|NCT02526979|Urological Agents|urological agents|mesh-ancestor
813015|NCT02525991|Loxapine|loxapine|mesh-list
813016|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
813017|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
813018|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813019|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813020|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
813021|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
813022|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
813023|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
813024|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249147|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
2249148|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
2249149|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
2249150|NCT00128323|Nystatin|nystatin|mesh-list
2249151|NCT00128323|Gentian Violet|gentian violet|mesh-list
813320|NCT02525081|Ramipril|ramipril|mesh-list
813321|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
813322|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
813323|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
813324|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813325|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
813558|NCT02523898|Metformin|metformin|mesh-list
813559|NCT02523898|Clomiphene|clomiphene|mesh-list
813560|NCT02523898|Enclomiphene|enclomiphene|mesh-list
813561|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
2249152|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
811673|NCT02531529|Fentanyl|fentanyl|mesh-list
811674|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
811675|NCT02531529|Narcotics|narcotics|mesh-ancestor
811676|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
811677|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811678|NCT02531529|Analgesics|analgesics|mesh-ancestor
811679|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
811680|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811681|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
811682|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
811683|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
811684|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
813256|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
813257|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
813258|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
813694|NCT02523547|Entecavir|entecavir|mesh-list
813695|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
813696|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
813811|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
813812|NCT02522975|Hematinics|hematinics|mesh-ancestor
2249153|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2249154|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249155|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
814409|NCT02520245|Cemiplimab|cemiplimab|mesh-list
814410|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
814411|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814673|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
814674|NCT02519335|Razoxane|razoxane|mesh-list
814675|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814676|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
814677|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
814678|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
814679|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814680|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814681|NCT02519335|Protective Agents|protective agents|mesh-ancestor
814682|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814683|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
814684|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
814774|NCT02518958|Nivolumab|nivolumab|mesh-list
814775|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
814776|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814777|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
814778|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814974|NCT02518516|Atorvastatin|atorvastatin|mesh-list
814975|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
814976|NCT02518516|Simvastatin|simvastatin|mesh-list
814977|NCT02518516|Pravastatin|pravastatin|mesh-list
814978|NCT02518516|Lovastatin|lovastatin|mesh-list
814979|NCT02518516|L 647318|l 647318|mesh-list
814980|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
814981|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
814982|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
814983|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
814984|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814985|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
814986|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
814987|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249156|NCT00128323|Ionophores|ionophores|mesh-ancestor
2249157|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2249158|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249159|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2249160|NCT00128414|Colchicine|colchicine|mesh-list
2249161|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
2249162|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2249163|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
2249164|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
2249165|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
2249166|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249167|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249168|NCT00128427|Colchicine|colchicine|mesh-list
815537|NCT02515682|Equol|equol|mesh-list
815538|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
815539|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2249169|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
2249170|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
811476|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
811477|NCT02532062|Vitamins|vitamins|mesh-ancestor
811478|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
811479|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811480|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
811481|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2249171|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
2249172|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
2249173|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
2249174|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249175|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249176|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
2249177|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2249178|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
2249179|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249180|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813059|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
813060|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
813061|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
813062|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
813063|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813064|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2249181|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2249182|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
2249183|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
2249184|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2249185|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
2249186|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2249187|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249188|NCT00128453|Colchicine|colchicine|mesh-list
2249189|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
2249190|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2249191|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
2249192|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
2249193|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
2249194|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249195|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249196|NCT00128466|Gentamicins|gentamicins|mesh-list
813969|NCT02522013|Aminophylline|aminophylline|mesh-list
813970|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
813971|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
813972|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813973|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813974|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
813975|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
813976|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
813977|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
813978|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
813979|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813980|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
813981|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
813982|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
813983|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
813984|NCT02522013|Protective Agents|protective agents|mesh-ancestor
2096759|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
2096760|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
2096761|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2096762|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
2096763|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
2096764|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
2096765|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2096766|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2096767|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2096768|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
814357|NCT02520947|Desflurane|desflurane|mesh-list
814358|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
814359|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
814360|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
814361|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
814362|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814766|NCT02518802|Pemetrexed|pemetrexed|mesh-list
814767|NCT02518802|Gefitinib|gefitinib|mesh-list
814768|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814769|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814770|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249197|NCT00128466|Streptomycin|streptomycin|mesh-list
811628|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
811629|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
811630|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811733|NCT02531412|Spironolactone|spironolactone|mesh-list
811734|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
811735|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
811736|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
811737|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811738|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
811739|NCT02531412|Diuretics|diuretics|mesh-ancestor
811740|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
2249198|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2249199|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249200|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2249201|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249202|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249203|NCT00128479|Mifepristone|mifepristone|mesh-list
2249204|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2249205|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
2249206|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2249207|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249208|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2249209|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2249210|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2249211|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
2249212|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2249213|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2249214|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
2249215|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2249216|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
2249217|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2249218|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2249219|NCT00128505|Mifepristone|mifepristone|mesh-list
2249220|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2249221|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
812803|NCT02527200|Liraglutide|liraglutide|mesh-list
812804|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
812805|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812806|NCT02527200|Incretins|incretins|mesh-ancestor
812807|NCT02527200|Hormones|hormones|mesh-ancestor
812808|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
812975|NCT02526745|Vaccines|vaccines|mesh-list
812976|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
812977|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249222|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
813514|NCT02523820|Fluticasone|fluticasone|mesh-list
813515|NCT02523820|Xhance|xhance|mesh-list
813516|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
813517|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
813518|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
813519|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813520|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813521|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
813522|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
813523|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
813524|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
813709|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
813710|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
813711|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
813712|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
813713|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813714|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813771|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
813772|NCT02523092|Hormones|hormones|mesh-ancestor
813773|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
813774|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813856|NCT02522754|Vaccines|vaccines|mesh-list
813857|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
813858|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814110|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
814111|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
814166|NCT02521246|Diuretics|diuretics|mesh-ancestor
811647|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
811648|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
811649|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811650|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
811651|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
811652|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
811653|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
811654|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
811655|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
811918|NCT02530697|Miltefosine|miltefosine|mesh-list
811919|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
811920|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
811921|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
811922|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811923|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811924|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
811925|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
811926|NCT02530697|Protective Agents|protective agents|mesh-ancestor
811927|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811928|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
811929|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
811930|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
811931|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
811932|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
811933|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811934|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
811935|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
812251|NCT02529514|Baclofen|baclofen|mesh-list
812252|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
812253|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812254|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
812255|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812256|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
812257|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
812258|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
812259|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
812260|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812476|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
812477|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
812478|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
812712|NCT02527668|Vitamin D|vitamin d|mesh-list
812713|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
812714|NCT02527668|Calcifediol|calcifediol|mesh-list
812715|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
812716|NCT02527668|Vitamins|vitamins|mesh-ancestor
812717|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
812718|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812719|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
812720|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
812855|NCT02527083|Ketamine|ketamine|mesh-list
812856|NCT02527083|Remifentanil|remifentanil|mesh-list
812857|NCT02527083|Propofol|propofol|mesh-list
812858|NCT02527083|Sevoflurane|sevoflurane|mesh-list
812859|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
812860|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
812861|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812862|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
812863|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
812864|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
812865|NCT02527083|Analgesics|analgesics|mesh-ancestor
812866|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
812867|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812868|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
812869|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
812870|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
812871|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
812872|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812873|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
812874|NCT02527083|Narcotics|narcotics|mesh-ancestor
812875|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
812876|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
812952|NCT02526758|Budesonide|budesonide|mesh-list
812953|NCT02526758|Beclomethasone|beclomethasone|mesh-list
812954|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
812955|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
812956|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
812957|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
811692|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
811693|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249223|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249224|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2249225|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2249226|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2249227|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
2249228|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2249229|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2249230|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
812454|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
812455|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
812456|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
812457|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
812458|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812569|NCT02528019|Glimepiride|glimepiride|mesh-list
812570|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
812571|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
812572|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
812573|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812574|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
812575|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
812576|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812626|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
812627|NCT02527785|Irinotecan|irinotecan|mesh-list
812628|NCT02527785|Tegafur|tegafur|mesh-list
812629|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812630|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
812631|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
812632|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812633|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812634|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
812635|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
812827|NCT02527109|Nifedipine|nifedipine|mesh-list
812828|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
812829|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
812830|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812831|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
812832|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812833|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
812834|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
812835|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2249231|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2249232|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
2249233|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2249234|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2249235|NCT00128518|Perindopril|perindopril|mesh-list
2249236|NCT00128518|Indapamide|indapamide|mesh-list
2249237|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2249238|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
813370|NCT02524964|Tanshinone|tanshinone|mesh-list
813371|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
813372|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
813373|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
813374|NCT02524964|Analgesics|analgesics|mesh-ancestor
813375|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
813376|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813377|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813378|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
813379|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
813380|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
813381|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
813382|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813383|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
813384|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
813495|NCT02524210|Omeprazole|omeprazole|mesh-list
813496|NCT02524210|Rabeprazole|rabeprazole|mesh-list
813497|NCT02524210|Dabigatran|dabigatran|mesh-list
813498|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
813499|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
813500|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
813501|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
813502|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813503|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
811725|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
811726|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
811727|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
811728|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
811729|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
811730|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
811731|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
811732|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
811909|NCT02530879|Esomeprazole|esomeprazole|mesh-list
811910|NCT02530879|Omeprazole|omeprazole|mesh-list
811911|NCT02530879|Lansoprazole|lansoprazole|mesh-list
811912|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
811913|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
811914|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
811915|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
811916|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
811917|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812006|NCT02530437|Paclitaxel|paclitaxel|mesh-list
812007|NCT02530437|Carboplatin|carboplatin|mesh-list
812008|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
812009|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
812010|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812011|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
812012|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
812013|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
812014|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249239|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249240|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249241|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2249242|NCT00128518|Diuretics|diuretics|mesh-ancestor
2249243|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
2249244|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249245|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2249246|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2249247|NCT00128531|Leuprolide|leuprolide|mesh-list
2249248|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2249249|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
2249250|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2249251|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815527|NCT02515773|Metformin|metformin|mesh-list
815528|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
815529|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815715|NCT02515175|Vaccines|vaccines|mesh-list
815716|NCT02515175|Immunologic Factors|immunologic factors|mesh-ancestor
815717|NCT02515175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815930|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
815931|NCT02514330|Vitamins|vitamins|mesh-ancestor
815932|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
815933|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815934|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
816579|NCT02512055|Atropine|atropine|mesh-list
816580|NCT02512055|Ketamine|ketamine|mesh-list
816581|NCT02512055|Analgesics|analgesics|mesh-ancestor
816582|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
816583|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816584|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816585|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
816586|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
816587|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
816588|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
816589|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
816590|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
816591|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
816592|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
816593|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816594|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
816595|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
816596|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
816597|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
816598|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
816599|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
816600|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
816601|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
816602|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
816603|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
816604|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
811893|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
811894|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811895|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
811896|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
811897|NCT02530801|Growth Substances|growth substances|mesh-ancestor
811898|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811899|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
811900|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
811901|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811902|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
811903|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
811904|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
2249252|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2249253|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249254|NCT00128544|Telbivudine|telbivudine|mesh-list
2249255|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
2249256|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812511|NCT02528513|Fentanyl|fentanyl|mesh-list
812512|NCT02528513|Midazolam|midazolam|mesh-list
812513|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
812514|NCT02528513|Propofol|propofol|mesh-list
812515|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
812516|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
812517|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812518|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
812519|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
812520|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
812521|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
812522|NCT02528513|Analgesics|analgesics|mesh-ancestor
812523|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
812524|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812525|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
812526|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
812527|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
812528|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
812529|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
812530|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812531|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
812532|NCT02528513|Narcotics|narcotics|mesh-ancestor
812533|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
812534|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
812535|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
812536|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
812537|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
812538|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
812905|NCT02527005|Azithromycin|azithromycin|mesh-list
812906|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
812907|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
812908|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
812909|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
812910|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812911|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
812912|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
812913|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
812914|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
812915|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812916|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812917|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
812918|NCT02527005|Renal Agents|renal agents|mesh-ancestor
2096769|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2096770|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
2096771|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
2096772|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096773|NCT02312882|Tofacitinib|tofacitinib|mesh-list
2096774|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2249257|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2249258|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249259|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249260|NCT00128557|Vitamin A|vitamin a|mesh-list
2249261|NCT00128557|Vitamins|vitamins|mesh-ancestor
2249262|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
2249263|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249264|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
2249265|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249266|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
813551|NCT02523859|Propofol|propofol|mesh-list
2096775|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249267|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811906|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
811907|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
811908|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
812308|NCT02529761|Sorafenib|sorafenib|mesh-list
812309|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812310|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
812311|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812312|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812367|NCT02529124|Caseins|caseins|mesh-list
812368|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
812369|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
812370|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812409|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
812410|NCT02528695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
812411|NCT02528695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
812412|NCT02528695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812413|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812790|NCT02527577|Ropivacaine|ropivacaine|mesh-list
812791|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
812792|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
812793|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
812794|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812795|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
812796|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249268|NCT00128635|Antibodies|antibodies|mesh-list
2249269|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2249270|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
2249271|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249272|NCT00128700|Temozolomide|temozolomide|mesh-list
813274|NCT02525172|Rituximab|rituximab|mesh-list
813275|NCT02525172|Methotrexate|methotrexate|mesh-list
813276|NCT02525172|Bortezomib|bortezomib|mesh-list
813277|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
813278|NCT02525172|Antibodies|antibodies|mesh-list
813279|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
813280|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
813281|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
813282|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
813283|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813284|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
813285|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813286|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
813287|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
813288|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
813289|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
813290|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
813291|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
813292|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813293|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
813294|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
813295|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
813296|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
813297|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
813715|NCT02523638|Interferons|interferons|mesh-list
813716|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
813717|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
813718|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813719|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
813720|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
813721|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
813722|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813735|NCT02523040|Lenalidomide|lenalidomide|mesh-list
813736|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
813737|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813738|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
813739|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
813740|NCT02523040|Growth Substances|growth substances|mesh-ancestor
813741|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
813742|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813798|NCT02522897|Ranibizumab|ranibizumab|mesh-list
813799|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
813800|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
813801|NCT02522897|Growth Substances|growth substances|mesh-ancestor
813802|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813803|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
813804|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
811977|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
811978|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
811979|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
811980|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
811981|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
811982|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
811983|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
811984|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812277|NCT02529631|Orlistat|orlistat|mesh-list
812278|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812279|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812280|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
812281|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
812437|NCT02528526|Inositol|inositol|mesh-list
812438|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
812439|NCT02528526|Vitamins|vitamins|mesh-ancestor
812440|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
812441|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812489|NCT02528136|Oxytocin|oxytocin|mesh-list
812490|NCT02528136|Carbetocin|carbetocin|mesh-list
812491|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
812492|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
812493|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812836|NCT02527096|Lamivudine|lamivudine|mesh-list
812837|NCT02527096|Dolutegravir|dolutegravir|mesh-list
812838|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
812839|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
812840|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812841|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812842|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
812843|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812844|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
812845|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
812846|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
812847|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
813029|NCT02526199|Dexamethasone|dexamethasone|mesh-list
813030|NCT02526199|Epinephrine|epinephrine|mesh-list
813031|NCT02526199|Bupivacaine|bupivacaine|mesh-list
813032|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
813033|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
813034|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
813035|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813036|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813037|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
813038|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
813039|NCT02526199|Hormones|hormones|mesh-ancestor
813040|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
813041|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
813042|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813043|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
813044|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
813045|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813046|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
813047|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
813048|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
813049|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
813050|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
813051|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813052|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
813053|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
813054|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
813055|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
813056|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
813057|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
813058|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
814013|NCT02522039|Timolol|timolol|mesh-list
814014|NCT02522039|Dorzolamide|dorzolamide|mesh-list
814015|NCT02522039|Latanoprost|latanoprost|mesh-list
814016|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
814017|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
814018|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
814019|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
814020|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812016|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
812017|NCT02530489|Atezolizumab|atezolizumab|mesh-list
812018|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
812019|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
812020|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812021|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
812022|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
812023|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
812024|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812025|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
812026|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812217|NCT02529852|Prednisone|prednisone|mesh-list
812218|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
812219|NCT02529852|Doxorubicin|doxorubicin|mesh-list
812220|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
812221|NCT02529852|Vincristine|vincristine|mesh-list
812222|NCT02529852|Lenalidomide|lenalidomide|mesh-list
812223|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
812224|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
812225|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
812226|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812227|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
812228|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
812229|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
812230|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812231|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812232|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
812233|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
812234|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
812235|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
812236|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812237|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
812238|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
812239|NCT02529852|Hormones|hormones|mesh-ancestor
812240|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
812241|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
812242|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
812243|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
812244|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
812245|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
812246|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
812247|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
812248|NCT02529852|Growth Substances|growth substances|mesh-ancestor
812249|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
812250|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2249273|NCT00128700|Vatalanib|vatalanib|mesh-list
2249274|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2249275|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
2249276|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249277|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813616|NCT02523976|Cytarabine|cytarabine|mesh-list
813617|NCT02523976|Dexamethasone|dexamethasone|mesh-list
813618|NCT02523976|Prednisone|prednisone|mesh-list
813619|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
813620|NCT02523976|Methotrexate|methotrexate|mesh-list
813621|NCT02523976|Etoposide|etoposide|mesh-list
813622|NCT02523976|Vincristine|vincristine|mesh-list
813623|NCT02523976|Daunorubicin|daunorubicin|mesh-list
813624|NCT02523976|Dasatinib|dasatinib|mesh-list
813625|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
813626|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
813627|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
813628|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
813629|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813630|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
813631|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
813632|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
813633|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813634|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813635|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
813636|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
813637|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
813638|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
813639|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813640|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
813641|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
813642|NCT02523976|Hormones|hormones|mesh-ancestor
812067|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
812068|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812442|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
812443|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
812444|NCT02528383|Estradiol|estradiol|mesh-list
812445|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
812446|NCT02528383|Estrogens|estrogens|mesh-ancestor
812447|NCT02528383|Hormones|hormones|mesh-ancestor
812448|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
812449|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812450|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
812451|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
812452|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
812453|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
812885|NCT02526914|Vasopressins|vasopressins|mesh-list
812886|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
812887|NCT02526914|Oxytocin|oxytocin|mesh-list
812888|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
812889|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
812890|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812891|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
812892|NCT02526914|Coagulants|coagulants|mesh-ancestor
812893|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
812894|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
812895|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
2096776|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096777|NCT02312934|Nicotine|nicotine|mesh-list
2096778|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2096779|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
2096780|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096781|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096782|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2096783|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2249278|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
813306|NCT02525302|Halofuginone|halofuginone|mesh-list
813307|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813308|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
813309|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
813310|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
813311|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
813312|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
813313|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
813314|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813315|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
813316|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
813317|NCT02525302|Growth Substances|growth substances|mesh-ancestor
813318|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813319|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
813525|NCT02523768|Basiliximab|basiliximab|mesh-list
813526|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
813527|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
813528|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813775|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
813776|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
813777|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
813778|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813779|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813780|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
813781|NCT02523144|Analgesics|analgesics|mesh-ancestor
813782|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
813783|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813784|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
813785|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
813786|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
813787|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
813788|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
813789|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249279|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249280|NCT00128739|Budesonide|budesonide|mesh-list
2249281|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2249282|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
814597|NCT02519608|Aspirin|aspirin|mesh-list
814598|NCT02519608|Clopidogrel|clopidogrel|mesh-list
814599|NCT02519608|Ticagrelor|ticagrelor|mesh-list
814600|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
814601|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
814602|NCT02519608|Analgesics|analgesics|mesh-ancestor
812146|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
812147|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812148|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
812149|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
812150|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
812151|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812152|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
812153|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812414|NCT02528877|Sirolimus|sirolimus|mesh-list
812415|NCT02528877|Fludarabine|fludarabine|mesh-list
812416|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
812417|NCT02528877|Melphalan|melphalan|mesh-list
812418|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
812419|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
812420|NCT02528877|Tacrolimus|tacrolimus|mesh-list
812421|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812422|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
812423|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
812424|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812425|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
812426|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
812427|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812428|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
812429|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812430|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
812431|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812432|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
812433|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
812434|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
812435|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
812436|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
812655|NCT02527863|Tolvaptan|tolvaptan|mesh-list
812656|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
812657|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812658|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
812659|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812769|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
812770|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
813266|NCT02525250|Lenalidomide|lenalidomide|mesh-list
813267|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
813268|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813269|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
813270|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
813271|NCT02525250|Growth Substances|growth substances|mesh-ancestor
813272|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
813273|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813441|NCT02524379|Glyburide|glyburide|mesh-list
813442|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
813443|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249283|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
2249284|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249285|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249286|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2249287|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
2249288|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
2249289|NCT00128739|Hormones|hormones|mesh-ancestor
2249290|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2249291|NCT00128752|Beta Carotene|beta carotene|mesh-list
2249292|NCT00128752|Carotenoids|carotenoids|mesh-list
2249293|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
2249294|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249295|NCT00128752|Protective Agents|protective agents|mesh-ancestor
2249296|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249297|NCT00128752|Provitamins|provitamins|mesh-ancestor
2249298|NCT00128752|Vitamins|vitamins|mesh-ancestor
2249299|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
2249300|NCT00128778|Doxorubicin|doxorubicin|mesh-list
2249301|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
814429|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
814430|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
814431|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
814432|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
814433|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
814434|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814603|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
2249302|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
812207|NCT02529774|Antidotes|antidotes|mesh-ancestor
812208|NCT02529774|Protective Agents|protective agents|mesh-ancestor
812209|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
812210|NCT02529774|Vitamins|vitamins|mesh-ancestor
812211|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
812212|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
812213|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
812214|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
812215|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
812216|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
812313|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
812314|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
812315|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812316|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
812317|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812390|NCT02528760|Erythromycin|erythromycin|mesh-list
812391|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
812392|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
812393|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
812394|NCT02528760|Metoclopramide|metoclopramide|mesh-list
812395|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
812396|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
812397|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812398|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812399|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
812400|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
812401|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
812402|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
812403|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
812404|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812405|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
812406|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812407|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
812408|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249303|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249304|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2249305|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2249306|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249307|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249308|NCT00128791|Nitroprusside|nitroprusside|mesh-list
2249309|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2249310|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
2249311|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2249312|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249313|NCT00128804|Beta Carotene|beta carotene|mesh-list
2249314|NCT00128804|Carotenoids|carotenoids|mesh-list
2249315|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
2249316|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249317|NCT00128804|Protective Agents|protective agents|mesh-ancestor
2249318|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249319|NCT00128804|Provitamins|provitamins|mesh-ancestor
2249320|NCT00128804|Vitamins|vitamins|mesh-ancestor
2249321|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
814198|NCT02521155|Fenbendazole|fenbendazole|mesh-list
814199|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
814200|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
814201|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
814202|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
814405|NCT02520362|Denosumab|denosumab|mesh-list
814406|NCT02520362|Diphosphonates|diphosphonates|mesh-list
814407|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
814408|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249322|NCT00128843|Anastrozole|anastrozole|mesh-list
2249323|NCT00128843|Exemestane|exemestane|mesh-list
2249324|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2249325|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249326|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2249327|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2249328|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249329|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249330|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2249331|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
2249332|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2249333|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249334|NCT00128856|Gemcitabine|gemcitabine|mesh-list
815164|NCT02517372|Pemirolast|pemirolast|mesh-list
815165|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
812265|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812266|NCT02529579|Antiviral Agents|antiviral agents|mesh-ancestor
812267|NCT02529579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812268|NCT02529579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812269|NCT02529579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
812270|NCT02529579|Immunologic Factors|immunologic factors|mesh-ancestor
812271|NCT02529579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812360|NCT02529241|Delpazolid|delpazolid|mesh-list
812361|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
812362|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
812363|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812364|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
812365|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812366|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812619|NCT02527733|Ranibizumab|ranibizumab|mesh-list
812620|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
812621|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
812622|NCT02527733|Growth Substances|growth substances|mesh-ancestor
812623|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812624|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
812625|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813025|NCT02526004|Tobramycin|tobramycin|mesh-list
813026|NCT02526004|Ceftazidime|ceftazidime|mesh-list
813027|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
813028|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249335|NCT00128856|Paclitaxel|paclitaxel|mesh-list
2249336|NCT00128856|Doxorubicin|doxorubicin|mesh-list
2249337|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2249338|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249339|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
2249340|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
2249341|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
813813|NCT02522858|Atropine|atropine|mesh-list
813814|NCT02522858|Ephedrine|ephedrine|mesh-list
813815|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
813816|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
813817|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813818|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813819|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
813820|NCT02522858|Analgesics|analgesics|mesh-ancestor
813821|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
813822|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813823|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
813824|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
813825|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
813826|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
813827|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
813828|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813829|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
813830|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
813831|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
813832|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
813833|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
813834|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
813835|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
813836|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
813837|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
813838|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
813839|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
813840|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
813841|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
813842|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
813961|NCT02522117|Atorvastatin|atorvastatin|mesh-list
813962|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
813963|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
813964|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
813965|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813966|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
813967|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
812275|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
812276|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812379|NCT02528825|Remifentanil|remifentanil|mesh-list
812380|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
812381|NCT02528825|Narcotics|narcotics|mesh-ancestor
812382|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
812383|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812384|NCT02528825|Analgesics|analgesics|mesh-ancestor
812385|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
812386|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249342|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249343|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2249344|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
2249345|NCT00128856|Antiviral Agents|antiviral agents|mesh-ancestor
2249346|NCT00128856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249347|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249348|NCT00128856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2249349|NCT00128856|Immunologic Factors|immunologic factors|mesh-ancestor
2249350|NCT00128856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249351|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2249352|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
814056|NCT02521753|Metformin|metformin|mesh-list
814057|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
814058|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814072|NCT02521441|Lenograstim|lenograstim|mesh-list
814073|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
814074|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
814075|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814570|NCT02520115|Dexamethasone|dexamethasone|mesh-list
814571|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
814572|NCT02520115|Valproic Acid|valproic acid|mesh-list
814573|NCT02520115|Ichthammol|ichthammol|mesh-list
814574|NCT02520115|BB 1101|bb 1101|mesh-list
814575|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
814576|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
814577|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
814578|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
814579|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814580|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
814581|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
814582|NCT02520115|Hormones|hormones|mesh-ancestor
814583|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
814584|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
814585|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814586|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
814587|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814588|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814589|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
814590|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
814591|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
814592|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
814593|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
814594|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
814595|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
814596|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
2249353|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2249354|NCT00128895|Azathioprine|azathioprine|mesh-list
2249355|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
2249356|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249357|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2249358|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249359|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2249360|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
2249361|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249362|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2249363|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2249364|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
815229|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
815230|NCT02517164|Calcifediol|calcifediol|mesh-list
815231|NCT02517164|Vitamins|vitamins|mesh-ancestor
815232|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
815233|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815234|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
815235|NCT02516774|Adalimumab|adalimumab|mesh-list
815236|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
815237|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
815351|NCT02516631|Misoprostol|misoprostol|mesh-list
812549|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
812550|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
812551|NCT02528123|Hormones|hormones|mesh-ancestor
812552|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
812553|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
812554|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812555|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
812556|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812557|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
812558|NCT02528123|Renal Agents|renal agents|mesh-ancestor
812559|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
812560|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
812561|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812562|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812563|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
812564|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
812565|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
812566|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
812567|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
812568|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
812779|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
812780|NCT02527213|Antidotes|antidotes|mesh-ancestor
812781|NCT02527213|Protective Agents|protective agents|mesh-ancestor
812782|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812783|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
812784|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812785|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
812786|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
812787|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812788|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
812789|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
2249365|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249366|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
2249367|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2249368|NCT00128934|Estradiol|estradiol|mesh-list
2249369|NCT00128934|Estrogens|estrogens|mesh-ancestor
2249370|NCT00128934|Hormones|hormones|mesh-ancestor
2249371|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2249372|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249373|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2249374|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
2249375|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2249376|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2249377|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2249378|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2249379|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2249380|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
2249381|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2249382|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249383|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2249384|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
2249385|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2249386|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249387|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249388|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249389|NCT00129038|Aspirin|aspirin|mesh-list
2249390|NCT00129038|Dipyridamole|dipyridamole|mesh-list
2249391|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2249392|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2249393|NCT00129038|Analgesics|analgesics|mesh-ancestor
2249394|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
813609|NCT02523755|Ropivacaine|ropivacaine|mesh-list
813610|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
813611|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
813612|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813613|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813614|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
2249395|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249396|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249397|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2249398|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2249399|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2249400|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2249401|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812812|NCT02527174|Cytarabine|cytarabine|mesh-list
812813|NCT02527174|Idarubicin|idarubicin|mesh-list
812814|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
812815|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
812816|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812817|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812818|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
812819|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812820|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
812821|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
812822|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812823|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
812824|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
812825|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
812826|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
813071|NCT02526030|Aripiprazole|aripiprazole|mesh-list
813072|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
813073|NCT02526030|Ziprasidone|ziprasidone|mesh-list
813074|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
813075|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
813076|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
813077|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
813078|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813079|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813080|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
813081|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
813082|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
813083|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813084|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
813085|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
813086|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
813087|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
813088|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
813089|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
813090|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
813259|NCT02525211|Ropivacaine|ropivacaine|mesh-list
813260|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
813261|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
813262|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813263|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813264|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
813265|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813346|NCT02525003|Vitamin D|vitamin d|mesh-list
813347|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
813348|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
813349|NCT02525003|Vitamins|vitamins|mesh-list
813350|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
813351|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813352|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
813353|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
813407|NCT02524652|Ropivacaine|ropivacaine|mesh-list
813408|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
813409|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
813410|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813411|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813412|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
813413|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813471|NCT02524301|Diprenorphine|diprenorphine|mesh-list
813472|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
813473|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813474|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
813475|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813723|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
813724|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
814062|NCT02521662|Nicotine|nicotine|mesh-list
814063|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
814064|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
814065|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812665|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
812666|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
812667|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
812668|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812669|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
812670|NCT02527772|Antiviral Agents|antiviral agents|mesh-ancestor
812671|NCT02527772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812672|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812673|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
812674|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
812675|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812676|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
812677|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
812678|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
812679|NCT02527772|Antidotes|antidotes|mesh-ancestor
812680|NCT02527772|Protective Agents|protective agents|mesh-ancestor
812681|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
812682|NCT02527772|Vitamins|vitamins|mesh-ancestor
812683|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
812994|NCT02526303|Nadroparin|nadroparin|mesh-list
812995|NCT02526303|Warfarin|warfarin|mesh-list
812996|NCT02526303|Calcium|calcium|mesh-list
812997|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
812998|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812999|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
813000|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
813001|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
813002|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813091|NCT02526017|Nivolumab|nivolumab|mesh-list
813092|NCT02526017|Sargramostim|sargramostim|mesh-list
813093|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
813094|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813095|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
813096|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813097|NCT02526017|Immunologic Factors|immunologic factors|mesh-ancestor
813098|NCT02526017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813572|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
813573|NCT02523911|Simethicone|simethicone|mesh-list
813574|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
813575|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
813576|NCT02523911|Analgesics|analgesics|mesh-ancestor
813577|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
813578|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813579|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813580|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
813581|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813582|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
813583|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
813584|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
813585|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
813586|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813587|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
813588|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
813589|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
813590|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
813591|NCT02523911|Emollients|emollients|mesh-ancestor
813592|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
813593|NCT02523911|Cathartics|cathartics|mesh-ancestor
813594|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
813805|NCT02522910|Docetaxel|docetaxel|mesh-list
813806|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813807|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
813808|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
813809|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
813810|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814219|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
814220|NCT02521077|Vitamins|vitamins|mesh-ancestor
814221|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
814222|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814223|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
814224|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814225|NCT02521077|Protective Agents|protective agents|mesh-ancestor
814312|NCT02520752|Midazolam|midazolam|mesh-list
814313|NCT02520752|Caffeine|caffeine|mesh-list
814314|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
814315|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
814316|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
812702|NCT02527707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
812703|NCT02527707|Protease Inhibitors|protease inhibitors|mesh-ancestor
812704|NCT02527707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812705|NCT02527707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812706|NCT02527707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
812707|NCT02527707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
812708|NCT02527707|Antiviral Agents|antiviral agents|mesh-ancestor
812709|NCT02527707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
812710|NCT02527707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
812711|NCT02527707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
812877|NCT02526888|Diltiazem|diltiazem|mesh-list
812878|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
812879|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
812880|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
812881|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812882|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
812883|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812884|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
813326|NCT02525016|Lidocaine|lidocaine|mesh-list
813327|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
813328|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
813329|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813330|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813331|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
813332|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813333|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
813334|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
813335|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
813336|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
813337|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813391|NCT02524743|Acetaminophen|acetaminophen|mesh-list
813392|NCT02524743|Lidocaine|lidocaine|mesh-list
813393|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
813394|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
813395|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813396|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813397|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
813398|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813399|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
813400|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
813401|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
813402|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
813403|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813404|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
813405|NCT02524743|Analgesics|analgesics|mesh-ancestor
813406|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
2249402|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2249403|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2249404|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249405|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
2249406|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2249407|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
2249408|NCT00129090|Rituximab|rituximab|mesh-list
2793064|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814038|NCT02521831|Bupivacaine|bupivacaine|mesh-list
814039|NCT02521831|Anesthetics|anesthetics|mesh-list
814040|NCT02521831|Isoflurane|isoflurane|mesh-list
814041|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
814042|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
814043|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814044|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
814045|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
814046|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
814047|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
2249409|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
812739|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
812740|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
812741|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812742|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
812743|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
812744|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
812745|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
812746|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
812747|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
812946|NCT02526810|Insulin|insulin|mesh-list
812947|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
812948|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
812949|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
812950|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
812951|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813341|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
813342|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
813343|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
813344|NCT02525458|Protective Agents|protective agents|mesh-ancestor
813345|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813419|NCT02524639|Sirolimus|sirolimus|mesh-list
813420|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
813421|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
813422|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
813423|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813424|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
813425|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
813426|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
813427|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813476|NCT02524249|Caffeine|caffeine|mesh-list
813477|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
813478|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813479|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
813480|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
813481|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813482|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
813483|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
813484|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
813485|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
815764|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
815765|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
815766|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815924|NCT02514278|Capecitabine|capecitabine|mesh-list
815925|NCT02514278|Folfirinox|folfirinox|mesh-list
815926|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
815927|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
815928|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815929|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816264|NCT02513290|Loratadine|loratadine|mesh-list
816265|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
816266|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
816267|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
816268|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
816269|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
816270|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
816271|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
816272|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
816273|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816274|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096784|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
2096785|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096786|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096787|NCT02313675|Acetaminophen|acetaminophen|mesh-list
2096788|NCT02313675|Ketorolac|ketorolac|mesh-list
2096789|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2096790|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2096791|NCT02313675|Analgesics|analgesics|mesh-ancestor
2096792|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
2096793|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096794|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816637|NCT02511847|Afatinib|afatinib|mesh-list
816638|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816639|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
816640|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817011|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249410|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249411|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
2096795|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
2096796|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2096797|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2096798|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2096799|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2096800|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096801|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096802|NCT02313909|Aspirin|aspirin|mesh-list
2096803|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
2096804|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2096805|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2096806|NCT02313909|Analgesics|analgesics|mesh-ancestor
2096807|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
2096808|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096809|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096810|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2096811|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2096812|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2249412|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249413|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2249414|NCT00129142|Toremifene|toremifene|mesh-list
2249415|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2249416|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249417|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2249418|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2249419|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
2249420|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2249421|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249422|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2249423|NCT00129155|Treosulfan|treosulfan|mesh-list
2249424|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2249425|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
2249426|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249427|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249428|NCT00129168|Cytarabine|cytarabine|mesh-list
2249429|NCT00129168|Daunorubicin|daunorubicin|mesh-list
2249430|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2249431|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
2249432|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249433|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249434|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
2249435|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249436|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2249437|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
2249438|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249439|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2249440|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2249441|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2249442|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249443|NCT00129181|Levodopa|levodopa|mesh-list
2249444|NCT00129181|Carbidopa|carbidopa|mesh-list
2249445|NCT00129181|Cabergoline|cabergoline|mesh-list
2249446|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2249447|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2249448|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2249449|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
2249450|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2249451|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814183|NCT02521233|Losartan|losartan|mesh-list
814184|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
814185|NCT02521233|Candesartan|candesartan|mesh-list
814186|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
814187|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
814188|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
814189|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
814190|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
814191|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
814192|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814193|NCT02521233|Diuretics|diuretics|mesh-ancestor
814194|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
814195|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096813|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
812924|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812925|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
812926|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812927|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
812928|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
812929|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
813544|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
813545|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
813546|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
813547|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
813548|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
813549|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813550|NCT02524184|Urological Agents|urological agents|mesh-ancestor
814076|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
814077|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
814268|NCT02520778|Osimertinib|osimertinib|mesh-list
814269|NCT02520778|Navitoclax|navitoclax|mesh-list
814270|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814271|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
814272|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814273|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249452|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249453|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2249454|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249455|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
2249456|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
814552|NCT02519582|Niclosamide|niclosamide|mesh-list
814553|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
814554|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
814555|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
814556|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
814557|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
814558|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
814988|NCT02518295|Sulfalene|sulfalene|mesh-list
814989|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
814990|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
814991|NCT02518295|Renal Agents|renal agents|mesh-ancestor
814992|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
814993|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
814994|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
815461|NCT02516059|Oxycodone|oxycodone|mesh-list
815462|NCT02516059|Naloxone|naloxone|mesh-list
815463|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
815464|NCT02516059|Narcotics|narcotics|mesh-ancestor
815465|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
815466|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815467|NCT02516059|Analgesics|analgesics|mesh-ancestor
815468|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
815469|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815470|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
815610|NCT02515526|Tolbutamide|tolbutamide|mesh-list
815611|NCT02515526|Ethanol|ethanol|mesh-list
815612|NCT02515526|Digoxin|digoxin|mesh-list
815613|NCT02515526|Midazolam|midazolam|mesh-list
815614|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
815615|NCT02515526|Caffeine|caffeine|mesh-list
815616|NCT02515526|Omeprazole|omeprazole|mesh-list
815617|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
815618|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
815619|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
815620|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815621|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
815622|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
815623|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
815624|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2249457|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
812939|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812940|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
812941|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
812942|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
812943|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
812944|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
812945|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
813428|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
813429|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
813430|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
813431|NCT02524444|Mefloquine|mefloquine|mesh-list
813432|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
813433|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
813434|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
813435|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
813436|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
813437|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
813438|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813439|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
813440|NCT02524444|Renal Agents|renal agents|mesh-ancestor
813843|NCT02522936|Muramidase|muramidase|mesh-list
813844|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
814354|NCT02520479|Pegaspargase|pegaspargase|mesh-list
814355|NCT02520479|Asparaginase|asparaginase|mesh-list
814356|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814412|NCT02520219|Endostar protein|endostar protein|mesh-list
814413|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
814414|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
814415|NCT02520219|Growth Substances|growth substances|mesh-ancestor
814416|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814417|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
814418|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814736|NCT02519010|Amlodipine|amlodipine|mesh-list
814737|NCT02519010|Valsartan|valsartan|mesh-list
814738|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
814739|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
814740|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
814741|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
814742|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814743|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
814744|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814745|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
814746|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
814747|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2249458|NCT00129207|Bortezomib|bortezomib|mesh-list
2249459|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249460|NCT00129233|Amlodipine|amlodipine|mesh-list
2249461|NCT00129233|Valsartan|valsartan|mesh-list
815869|NCT02514681|Gemcitabine|gemcitabine|mesh-list
815870|NCT02514681|Paclitaxel|paclitaxel|mesh-list
815871|NCT02514681|Vinorelbine|vinorelbine|mesh-list
815872|NCT02514681|Docetaxel|docetaxel|mesh-list
815873|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
815874|NCT02514681|Capecitabine|capecitabine|mesh-list
815875|NCT02514681|Trastuzumab|trastuzumab|mesh-list
815876|NCT02514681|Pertuzumab|pertuzumab|mesh-list
815877|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
815878|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815879|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
815880|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
815881|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
815882|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815883|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
815884|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
815885|NCT02514681|Antiviral Agents|antiviral agents|mesh-ancestor
815886|NCT02514681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815887|NCT02514681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815888|NCT02514681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
815889|NCT02514681|Immunologic Factors|immunologic factors|mesh-ancestor
815890|NCT02514681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815891|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2249462|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2249463|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2249464|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2249465|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249466|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
812958|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
812959|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
812960|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
812961|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
812962|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
812963|NCT02526758|Hormones|hormones|mesh-ancestor
812964|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
812965|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
812966|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
812967|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
812968|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
812969|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
812970|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
812991|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
812992|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
812993|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
813941|NCT02522078|Misoprostol|misoprostol|mesh-list
813942|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
813943|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
813944|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
813945|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813946|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
813947|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
813948|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
814424|NCT02520180|Everolimus|everolimus|mesh-list
814425|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814426|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
814427|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
814428|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249467|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249468|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
2249469|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2249470|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2249471|NCT00129298|Tiagabine|tiagabine|mesh-list
2249472|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
2249473|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
2249474|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2249475|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2249476|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249477|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
2249478|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2249479|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249480|NCT00129337|Bavituximab|bavituximab|mesh-list
2249481|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2249482|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249483|NCT00129363|Carvedilol|carvedilol|mesh-list
2249484|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2249485|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2249486|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
2249487|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2249488|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249489|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249490|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2249491|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
2249492|NCT00129363|Protective Agents|protective agents|mesh-ancestor
2249493|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2249494|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
815051|NCT02517814|Vitamin D|vitamin d|mesh-list
815052|NCT02517814|Vitamins|vitamins|mesh-ancestor
815053|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
815054|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815055|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2249495|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2249496|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
2249497|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2249498|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2249499|NCT00129506|Methotrexate|methotrexate|mesh-list
2249500|NCT00129506|Misoprostol|misoprostol|mesh-list
2249501|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2249502|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
2249503|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2249504|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249505|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2249506|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
813099|NCT02525848|Dexamethasone|dexamethasone|mesh-list
813100|NCT02525848|Gabapentin|gabapentin|mesh-list
813101|NCT02525848|Aprepitant|aprepitant|mesh-list
813102|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
813103|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
813104|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
813105|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813106|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813107|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
813108|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
813109|NCT02525848|Hormones|hormones|mesh-ancestor
813110|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
813111|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
813112|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813113|NCT02525848|Analgesics|analgesics|mesh-ancestor
813114|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
813115|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
813116|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
813117|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
813118|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813119|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
813120|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
813121|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
813122|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
813123|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813124|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
813125|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2096814|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096815|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2096816|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2096817|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096818|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
2096819|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2096820|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
2096821|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2096822|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
2096823|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
2096824|NCT02314104|Ropivacaine|ropivacaine|mesh-list
813298|NCT02525237|Apatinib|apatinib|mesh-list
813299|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813300|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
813301|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
813302|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813361|NCT02524899|Guanfacine|guanfacine|mesh-list
813362|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
813363|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
813364|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
813365|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
813366|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
813367|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
813368|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813369|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813753|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
813754|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
813755|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
813756|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
813757|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
813758|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813759|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813760|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
813761|NCT02523300|Hormones|hormones|mesh-ancestor
813762|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
813763|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
813764|NCT02523300|Protective Agents|protective agents|mesh-ancestor
813935|NCT02522221|Warfarin|warfarin|mesh-list
813936|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
814935|NCT02518594|Progesterone|progesterone|mesh-list
814936|NCT02518594|Progestins|progestins|mesh-ancestor
814937|NCT02518594|Hormones|hormones|mesh-ancestor
814938|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
814939|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815063|NCT02517736|Sorafenib|sorafenib|mesh-list
815064|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815065|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
815066|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249507|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813845|NCT02522650|Amiloride|amiloride|mesh-list
813846|NCT02522650|Triamterene|triamterene|mesh-list
813847|NCT02522650|Diuretics|diuretics|mesh-ancestor
813848|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
813849|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813850|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
813851|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
813852|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
813853|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813854|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
813855|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2249508|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249509|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
2249510|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249511|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2249512|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2249513|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
2249514|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2249515|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2249516|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2249517|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2249518|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
2249519|NCT00129519|Imiquimod|imiquimod|mesh-list
2249520|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2249521|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
2249522|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249523|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249524|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
815391|NCT02516436|Buprenorphine|buprenorphine|mesh-list
815392|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
815393|NCT02516436|Narcotics|narcotics|mesh-ancestor
815394|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
815395|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815396|NCT02516436|Analgesics|analgesics|mesh-ancestor
815397|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
815398|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815399|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2249525|NCT00129597|Ketamine|ketamine|mesh-list
2249526|NCT00129597|Analgesics|analgesics|mesh-ancestor
2249527|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
2249528|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249529|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249530|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2249531|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2249532|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
2249533|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
2249534|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2249535|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2249536|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2249537|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2249538|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249539|NCT00129688|Amikacin|amikacin|mesh-list
816179|NCT02513381|Vitamin D|vitamin d|mesh-list
816180|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
816181|NCT02513381|Vitamins|vitamins|mesh-ancestor
816182|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
816183|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816184|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
816185|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
816385|NCT02512887|Anesthetics|anesthetics|mesh-list
816386|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
816387|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816504|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
816505|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
816506|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816507|NCT02512523|Incretins|incretins|mesh-ancestor
816508|NCT02512523|Hormones|hormones|mesh-ancestor
816509|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
816510|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
816511|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
816512|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816513|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817136|NCT02509546|Adenosine|adenosine|mesh-list
817137|NCT02509546|Analgesics|analgesics|mesh-ancestor
813504|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
813505|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
813506|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
813529|NCT02523833|Albuterol|albuterol|mesh-list
813530|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
813531|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
813532|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813533|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813534|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
813535|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
813536|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
813537|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
813538|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
813539|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
813540|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
813541|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
813542|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
813543|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096825|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
2096826|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
2096827|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2096828|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096829|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
2096830|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096831|NCT02314117|Fluorouracil|fluorouracil|mesh-list
2096832|NCT02314117|Capecitabine|capecitabine|mesh-list
2096833|NCT02314117|Ramucirumab|ramucirumab|mesh-list
2096834|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096835|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
2096836|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096837|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2096838|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2096839|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
2096840|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096841|NCT02314143|Trametinib|trametinib|mesh-list
2096842|NCT02314143|Dabrafenib|dabrafenib|mesh-list
2096843|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096844|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2096845|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096846|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096847|NCT02314403|Rituximab|rituximab|mesh-list
2096848|NCT02314403|Abatacept|abatacept|mesh-list
2096849|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2096850|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096851|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
2096852|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096853|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2096854|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2096855|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249540|NCT00129688|Cloxacillin|cloxacillin|mesh-list
2249541|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
815489|NCT02515877|Carboplatin|carboplatin|mesh-list
815490|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249542|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249543|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
2249544|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2249545|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249546|NCT00129805|Aspirin|aspirin|mesh-list
2249547|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
2249548|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2249549|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2249550|NCT00129805|Analgesics|analgesics|mesh-ancestor
2249551|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
2249552|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249553|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249554|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2249555|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2249556|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2249557|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2249558|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249559|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2249560|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2249561|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249562|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
2249563|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
813552|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
813553|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813554|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813555|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
813556|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
813557|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
2096856|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2096857|NCT02314546|Lidocaine|lidocaine|mesh-list
2096858|NCT02314546|Midazolam|midazolam|mesh-list
2096859|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2096860|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2096861|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2096862|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096863|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2096864|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
814386|NCT02520505|Citric Acid|citric acid|mesh-list
814387|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
814388|NCT02520505|Clomiphene|clomiphene|mesh-list
814389|NCT02520505|Enclomiphene|enclomiphene|mesh-list
814390|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
814391|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
814392|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
814393|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
814394|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
814395|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814396|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
814397|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
814398|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
814399|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814400|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
814401|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
814402|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
814403|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
814404|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2249564|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
2249565|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2249566|NCT00129818|Famciclovir|famciclovir|mesh-list
2249567|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
2249568|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249569|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2249570|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249571|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249572|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
2249573|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249574|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2249575|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
2249576|NCT00129857|HU 211|hu 211|mesh-list
2249577|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2249578|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
2249579|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
2249580|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249581|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249582|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2249583|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2249584|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
815068|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
815069|NCT02517918|Sirolimus|sirolimus|mesh-list
815070|NCT02517918|Methotrexate|methotrexate|mesh-list
815071|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
815072|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
815073|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
815074|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815075|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
815076|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
815077|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815078|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815079|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
815080|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815081|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
815082|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
815083|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
815084|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
815085|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
815086|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
815087|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815088|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
813562|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
813563|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813564|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
813565|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
813566|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
813567|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
813568|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
813569|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
813570|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
813571|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2249585|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2249586|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249587|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2249588|NCT00129857|Protective Agents|protective agents|mesh-ancestor
2249589|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
2249590|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249591|NCT00129896|Docetaxel|docetaxel|mesh-list
813949|NCT02522208|Hydralazine|hydralazine|mesh-list
813950|NCT02522208|Isosorbide|isosorbide|mesh-list
813951|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
813952|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
813953|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
813954|NCT02522208|Diuretics|diuretics|mesh-ancestor
813955|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
813956|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813957|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
813958|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
813959|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813960|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
814130|NCT02521285|Aspirin|aspirin|mesh-list
814131|NCT02521285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
814132|NCT02521285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
814133|NCT02521285|Analgesics|analgesics|mesh-ancestor
814134|NCT02521285|Sensory System Agents|sensory system agents|mesh-ancestor
814135|NCT02521285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
814136|NCT02521285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814137|NCT02521285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
814138|NCT02521285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
814139|NCT02521285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
814140|NCT02521285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
814141|NCT02521285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814142|NCT02521285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
814143|NCT02521285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
814144|NCT02521285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814145|NCT02521285|Antipyretics|antipyretics|mesh-ancestor
814372|NCT02520453|Durvalumab|durvalumab|mesh-list
814373|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
814374|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814439|NCT02520102|Sargramostim|sargramostim|mesh-list
814440|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
814441|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814634|NCT02519660|Lidocaine|lidocaine|mesh-list
814635|NCT02519660|Tetracaine|tetracaine|mesh-list
814636|NCT02519660|Prilocaine|prilocaine|mesh-list
814637|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
814638|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
814639|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
814640|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
814641|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814642|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
814643|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
814644|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
814645|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
814646|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
814647|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
814648|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814649|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2249592|NCT00129896|Doxorubicin|doxorubicin|mesh-list
2249593|NCT00129896|Trastuzumab|trastuzumab|mesh-list
2249594|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249595|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
2249596|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
2249597|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
2249598|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249599|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
813615|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754365|NCT01269424|Temozolomide|temozolomide|mesh-list
2754366|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2754367|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
814375|NCT02520817|Vitamins|vitamins|mesh-list
814376|NCT02520817|Ascorbic Acid|ascorbic acid|mesh-list
814377|NCT02520817|Vitamin E|vitamin e|mesh-list
814378|NCT02520817|Vitamin A|vitamin a|mesh-list
814379|NCT02520817|Lactulose|lactulose|mesh-list
814380|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
814381|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814382|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
814383|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814384|NCT02520817|Protective Agents|protective agents|mesh-ancestor
814385|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
814930|NCT02518451|Valsartan|valsartan|mesh-list
814931|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
814932|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
814933|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
814934|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814995|NCT02518152|Alendronate|alendronate|mesh-list
814996|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
814997|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815091|NCT02517788|Interferons|interferons|mesh-list
815092|NCT02517788|Interferon-beta|interferon-beta|mesh-list
815093|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
815094|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815095|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
815096|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815097|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
815098|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815099|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2249600|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2249601|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2249602|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249603|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2249604|NCT00129922|Paclitaxel|paclitaxel|mesh-list
2249605|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
2249606|NCT00129922|Fluorouracil|fluorouracil|mesh-list
2249607|NCT00129922|Epirubicin|epirubicin|mesh-list
2249608|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2249609|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249610|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
2249611|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
2249612|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
2249613|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249614|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2249615|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
2249616|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249617|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
815480|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
815481|NCT02515929|Procyanidin|procyanidin|mesh-list
815482|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
815483|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815484|NCT02515929|Protective Agents|protective agents|mesh-ancestor
815485|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815486|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
815487|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
815488|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815691|NCT02515201|Taurolidine|taurolidine|mesh-list
815692|NCT02515201|Heparin|heparin|mesh-list
815693|NCT02515201|Calcium heparin|calcium heparin|mesh-list
815694|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
815695|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
815696|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
815697|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815698|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815699|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
815700|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815837|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
815838|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249618|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2249619|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
2249620|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2249621|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
813643|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
813644|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
813645|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
813646|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
813647|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
813648|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
813649|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
813650|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
813651|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
813652|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
813653|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
813654|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
813655|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
813656|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
813657|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
813658|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
813659|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
813660|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
813661|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
813662|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
813663|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
813664|NCT02523976|Analgesics|analgesics|mesh-ancestor
813665|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
813790|NCT02523053|Fluorouracil|fluorouracil|mesh-list
813791|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
813792|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813793|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
813794|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813795|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
813796|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
813797|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813937|NCT02522169|Infliximab|infliximab|mesh-list
813938|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
813939|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
813940|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
814748|NCT02519322|Nivolumab|nivolumab|mesh-list
814749|NCT02519322|Ipilimumab|ipilimumab|mesh-list
814750|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
814751|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
814752|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
814753|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814754|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
814755|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814756|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
814757|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814870|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
814871|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815107|NCT02517957|Loperamide|loperamide|mesh-list
815108|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
815109|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
815359|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
815360|NCT02516423|Dexamethasone|dexamethasone|mesh-list
815361|NCT02516423|Lenalidomide|lenalidomide|mesh-list
815362|NCT02516423|Ixazomib|ixazomib|mesh-list
815363|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
815364|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
815365|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
815366|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815367|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815368|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
815369|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
815370|NCT02516423|Hormones|hormones|mesh-ancestor
815371|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
815372|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
815373|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815374|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
815375|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
815376|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
815377|NCT02516423|Growth Substances|growth substances|mesh-ancestor
815378|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
815379|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
815380|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
815381|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815382|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754368|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
813744|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
813745|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813985|NCT02522130|Naproxen|naproxen|mesh-list
813986|NCT02522130|Lidocaine|lidocaine|mesh-list
813987|NCT02522130|Misoprostol|misoprostol|mesh-list
813988|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
813989|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
813990|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
813991|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
813992|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
813993|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
813994|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
813995|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
813996|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
813997|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
813998|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
813999|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
814000|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
814001|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
814002|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
814003|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
814004|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
814005|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
814006|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
814007|NCT02522130|Analgesics|analgesics|mesh-ancestor
814008|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
814009|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
814010|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
814011|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
814012|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814245|NCT02520921|Aspirin|aspirin|mesh-list
814246|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
814247|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
814248|NCT02520921|Analgesics|analgesics|mesh-ancestor
814249|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
814250|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
814251|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814252|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
814253|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
814254|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
814255|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
814256|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814257|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
814258|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
814259|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814260|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
814307|NCT02520635|Temozolomide|temozolomide|mesh-list
814308|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
814309|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
814310|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814311|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096865|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2096866|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2096867|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
2096868|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
2096869|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
2096870|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
2096871|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096872|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096873|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
2096874|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
2096875|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096876|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2096877|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
815056|NCT02517827|Paclitaxel|paclitaxel|mesh-list
815057|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
815058|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815059|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
815060|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
815061|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
815062|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815304|NCT02516696|Clarithromycin|clarithromycin|mesh-list
815305|NCT02516696|Dexamethasone|dexamethasone|mesh-list
815306|NCT02516696|Lenalidomide|lenalidomide|mesh-list
815307|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
813879|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
813880|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
813881|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
813882|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
813883|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
814261|NCT02521012|Vitamin D|vitamin d|mesh-list
814262|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
814263|NCT02521012|Vitamins|vitamins|mesh-list
814264|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
814265|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814266|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
814267|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2096878|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2096879|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2096880|NCT02314728|Misoprostol|misoprostol|mesh-list
2096881|NCT02314728|Oxytocin|oxytocin|mesh-list
2096882|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
2096883|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2096884|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096885|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2096886|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
2096887|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2096888|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2096889|NCT02315534|Temozolomide|temozolomide|mesh-list
2096890|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
814697|NCT02519400|Amitriptyline|amitriptyline|mesh-list
814698|NCT02519400|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
814699|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
814700|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
814701|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
814702|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
814703|NCT02519400|Analgesics|analgesics|mesh-ancestor
814704|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
814705|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
814706|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814707|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
814708|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
814709|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
814710|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814711|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
814712|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
814713|NCT02519400|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
814714|NCT02519400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
814715|NCT02519400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
815134|NCT02517684|Prednisolone|prednisolone|mesh-list
815135|NCT02517684|Azathioprine|azathioprine|mesh-list
815136|NCT02517684|Infliximab|infliximab|mesh-list
815137|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
815138|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
815139|NCT02517684|Hormones|hormones|mesh-ancestor
815140|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
815141|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815142|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
815143|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815144|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
815145|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
815146|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
815147|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
815148|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815149|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
815150|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
815151|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
815400|NCT02516670|Vitamins|vitamins|mesh-list
815401|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
815402|NCT02516670|Docetaxel|docetaxel|mesh-list
815403|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
815404|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815405|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815406|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
815407|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
815408|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
815409|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815410|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
815411|NCT02516670|Protective Agents|protective agents|mesh-ancestor
815599|NCT02515604|Misoprostol|misoprostol|mesh-list
815625|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
813968|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249622|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2249623|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2249624|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2249625|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2249626|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249627|NCT00129948|Troxacitabine|troxacitabine|mesh-list
2249628|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249629|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2249630|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2249631|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
2249632|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249633|NCT00130000|Eculizumab|eculizumab|mesh-list
2249634|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2249635|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2249636|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
2249637|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249638|NCT00130013|Amoxicillin|amoxicillin|mesh-list
2249639|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2249640|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249641|NCT00130026|Caffeine|caffeine|mesh-list
2249642|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2249643|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249644|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2249645|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249646|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249647|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2249648|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2249649|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
2249650|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2249651|NCT00130065|Folic Acid|folic acid|mesh-list
2249652|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
2249653|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
2249654|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2249655|NCT00130065|Hematinics|hematinics|mesh-ancestor
2249656|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
2249657|NCT00130065|Vitamins|vitamins|mesh-ancestor
2249658|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
2249659|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249660|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
2249661|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2249662|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2249663|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249664|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2249665|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249666|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249667|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2249668|NCT00130065|Renal Agents|renal agents|mesh-ancestor
2249669|NCT00130091|Clonidine|clonidine|mesh-list
2249670|NCT00130091|Analgesics|analgesics|mesh-ancestor
2249671|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
2249672|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815383|NCT02516813|Peposertib|peposertib|mesh-list
815384|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
815385|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815386|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816706|NCT02511483|Propranolol|propranolol|mesh-list
816707|NCT02511483|Morphine|morphine|mesh-list
816708|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
816709|NCT02511483|Narcotics|narcotics|mesh-ancestor
816710|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
816711|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816712|NCT02511483|Analgesics|analgesics|mesh-ancestor
816713|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
816714|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816715|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
816716|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
816717|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
816718|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
816719|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816720|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
816721|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
816722|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
816838|NCT02510599|Solithromycin|solithromycin|mesh-list
816839|NCT02510599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
816840|NCT02510599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
817026|NCT02509806|Apatinib|apatinib|mesh-list
814021|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814022|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
814023|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
814024|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
814025|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
814026|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
814027|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814078|NCT02521415|Acetaminophen|acetaminophen|mesh-list
814079|NCT02521415|Ibuprofen|ibuprofen|mesh-list
814080|NCT02521415|Fentanyl|fentanyl|mesh-list
814081|NCT02521415|Ketamine|ketamine|mesh-list
814082|NCT02521415|Analgesics|analgesics|mesh-list
814083|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
814084|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
814085|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814086|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
814087|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
814088|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
814089|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
814090|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
814091|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
814092|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
814093|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
814094|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814095|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
814096|NCT02521415|Narcotics|narcotics|mesh-ancestor
814097|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
814098|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
814099|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
814100|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
814101|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
814102|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
814103|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
814104|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814211|NCT02521064|Prednisone|prednisone|mesh-list
814212|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
814213|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
814214|NCT02521064|Hormones|hormones|mesh-ancestor
814215|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
814216|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814217|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
814218|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096891|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
2249673|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249674|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2249675|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
2249676|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
2249677|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2249678|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2249679|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2249680|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
2249681|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2249682|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249683|NCT00130143|Amifostine|amifostine|mesh-list
815341|NCT02516657|Liraglutide|liraglutide|mesh-list
815342|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
815343|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815344|NCT02516657|Incretins|incretins|mesh-ancestor
815345|NCT02516657|Hormones|hormones|mesh-ancestor
815346|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2249684|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2249685|NCT00130143|Protective Agents|protective agents|mesh-ancestor
2249686|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249687|NCT00130156|Doxazosin|doxazosin|mesh-list
2249688|NCT00130156|Bunazosin|bunazosin|mesh-list
2754369|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814105|NCT02521363|Taxane|taxane|mesh-list
814106|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814203|NCT02521051|Bevacizumab|bevacizumab|mesh-list
814204|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
814205|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814206|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
814207|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
814208|NCT02521051|Growth Substances|growth substances|mesh-ancestor
814209|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814210|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
814966|NCT02518438|Tramadol|tramadol|mesh-list
814967|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
814968|NCT02518438|Narcotics|narcotics|mesh-ancestor
814969|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
814970|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814971|NCT02518438|Analgesics|analgesics|mesh-ancestor
814972|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
814973|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249689|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2249690|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2249691|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2249692|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2249693|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
2249694|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
815238|NCT02516826|Olmesartan|olmesartan|mesh-list
815239|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
815240|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
815241|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
815242|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
815243|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
815244|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815245|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
815246|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
815247|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815248|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
815249|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
815250|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2249695|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249696|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249697|NCT00130195|Cytarabine|cytarabine|mesh-list
2249698|NCT00130195|Dexamethasone|dexamethasone|mesh-list
2249699|NCT00130195|Prednisolone|prednisolone|mesh-list
2249700|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
2249701|NCT00130195|Methotrexate|methotrexate|mesh-list
2249702|NCT00130195|Vincristine|vincristine|mesh-list
2249703|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
2249704|NCT00130195|Daunorubicin|daunorubicin|mesh-list
816478|NCT02512562|Simeprevir|simeprevir|mesh-list
816479|NCT02512562|Odalasvir|odalasvir|mesh-list
816480|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
816481|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
816482|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
816483|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816484|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249705|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2249706|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
2249707|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249708|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2249709|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2249710|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
2249711|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249712|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814066|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814067|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
814068|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
814069|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
814070|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
814071|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814334|NCT02520570|Urinastatin|urinastatin|mesh-list
814335|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
814336|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
814337|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
814338|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814339|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815892|NCT02514538|Acetaminophen|acetaminophen|mesh-list
815893|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
815894|NCT02514538|Analgesics|analgesics|mesh-ancestor
815895|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
815896|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815897|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815898|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
2249713|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2249714|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2249715|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
2249716|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
2249717|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249718|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2249719|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
2249720|NCT00130195|Hormones|hormones|mesh-ancestor
2249721|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2249722|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
816620|NCT02511613|Squalamine|squalamine|mesh-list
816621|NCT02511613|Ranibizumab|ranibizumab|mesh-list
816622|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
816623|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
816624|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
816625|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
816626|NCT02511613|Growth Substances|growth substances|mesh-ancestor
816627|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816628|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
816629|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816630|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
816631|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
816632|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
816633|NCT02511613|Protective Agents|protective agents|mesh-ancestor
816702|NCT02511366|Caseins|caseins|mesh-list
816703|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
816704|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
816705|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096892|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096893|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096894|NCT02315625|Everolimus|everolimus|mesh-list
2096895|NCT02315625|Sunitinib|sunitinib|mesh-list
2096896|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249723|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2249724|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
2249725|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2249726|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2249727|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
2249728|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
2249729|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249730|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2249731|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2249732|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
2249733|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249734|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
817336|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
817337|NCT02508753|Tazobactam|tazobactam|mesh-list
817338|NCT02508753|Ceftolozane|ceftolozane|mesh-list
817339|NCT02508753|Cephalosporins|cephalosporins|mesh-list
817340|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
817341|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
817342|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
817343|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
817344|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817345|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817346|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817347|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
814112|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
814113|NCT02521298|Prednisolone|prednisolone|mesh-list
814114|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
814115|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
814116|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
814117|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
814118|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
814119|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
814120|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
814121|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814122|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
814123|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
814124|NCT02521298|Hormones|hormones|mesh-ancestor
814125|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
814126|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
814127|NCT02521298|Protective Agents|protective agents|mesh-ancestor
814128|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
814129|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
814716|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
814717|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
814718|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
814719|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
814720|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814721|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814722|NCT02519153|Urological Agents|urological agents|mesh-ancestor
2249735|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
2249736|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
2249737|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
2249738|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2249739|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2249740|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2249741|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2249742|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
2249743|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2249744|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2249745|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249746|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
2249747|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
2249748|NCT00130234|Omalizumab|omalizumab|mesh-list
2249749|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2249750|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2249751|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
2249752|NCT00130312|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
2249753|NCT00130312|Anticoagulants|anticoagulants|mesh-ancestor
2249754|NCT00130312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2249755|NCT00130312|Antimetabolites|antimetabolites|mesh-ancestor
2249756|NCT00130312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249757|NCT00130312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
815607|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
815608|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
815609|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815845|NCT02514642|Clopidogrel|clopidogrel|mesh-list
815846|NCT02514642|Ticagrelor|ticagrelor|mesh-list
815847|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
815848|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
815849|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
815850|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
815851|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
815852|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
815853|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815854|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249758|NCT00130312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2249759|NCT00130312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2249760|NCT00130312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2249761|NCT00130312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096897|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2096898|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
2096899|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249762|NCT00130325|Isoniazid|isoniazid|mesh-list
817175|NCT02509195|Lamivudine|lamivudine|mesh-list
817176|NCT02509195|Abacavir|abacavir|mesh-list
817177|NCT02509195|Dolutegravir|dolutegravir|mesh-list
817178|NCT02509195|Triumeq|triumeq|mesh-list
817179|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
817180|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2249763|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
814167|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
814168|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814169|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
814170|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
814235|NCT02520934|Miglustat|miglustat|mesh-list
814236|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814237|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814238|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
814239|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
814240|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
814241|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
814242|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
814243|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
814244|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249764|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2249765|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249766|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2249767|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2249768|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
2249769|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249770|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2249771|NCT00130338|Rivastigmine|rivastigmine|mesh-list
2249772|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
814549|NCT02519543|Metformin|metformin|mesh-list
814550|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
814551|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249773|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249774|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249775|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
2249776|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2249777|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249778|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2249779|NCT00130338|Protective Agents|protective agents|mesh-ancestor
2249780|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
2249781|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2249782|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
2249783|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249784|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815581|NCT02515955|Minocycline|minocycline|mesh-list
815582|NCT02515955|Amphetamine|amphetamine|mesh-list
815583|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
815584|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
815585|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815586|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
815587|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815588|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
815589|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
815590|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815591|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
815592|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
815593|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815594|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
815595|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
815596|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
815597|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
815598|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
816237|NCT02513355|Cisplatin|cisplatin|mesh-list
816238|NCT02513355|Endostar protein|endostar protein|mesh-list
816239|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816240|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
816241|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
816242|NCT02513355|Growth Substances|growth substances|mesh-ancestor
816243|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816244|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
816388|NCT02513069|Nicotine|nicotine|mesh-list
816389|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
816390|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
816391|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
816392|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816393|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816394|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
816395|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
816396|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
816397|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2249785|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
814172|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
814173|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
814174|NCT02521207|Analgesics|analgesics|mesh-ancestor
814175|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
814176|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
814177|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814178|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
814179|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
814180|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
814181|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814182|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814436|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
814437|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
814438|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
814559|NCT02519699|Norepinephrine|norepinephrine|mesh-list
814560|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
814561|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
814562|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
814563|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
814564|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814565|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814566|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
814567|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
814568|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
814569|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2249786|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
2249787|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2249788|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2249789|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2249790|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
2249791|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2249792|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249793|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
2249794|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2249795|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2249796|NCT00130364|Analgesics|analgesics|mesh-ancestor
2249797|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
2249798|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249799|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249800|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2249801|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
815336|NCT02516527|Ipilimumab|ipilimumab|mesh-list
815337|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
815338|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815339|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
815340|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096900|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2096901|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2096902|NCT02315625|Growth Substances|growth substances|mesh-ancestor
2096903|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
2096904|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2096905|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096906|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096907|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2096908|NCT02315872|Hormones|hormones|mesh-ancestor
2096909|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2096910|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096911|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
2096912|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2096913|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096914|NCT02316171|Mitomycins|mitomycins|mesh-list
2096915|NCT02316171|Mitomycin|mitomycin|mesh-list
2096916|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2096917|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096918|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
2096919|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096920|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2096921|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096922|NCT02316353|Complement C1s|complement c1s|mesh-list
2096923|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2096924|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2096925|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
814196|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
814197|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
814442|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
814443|NCT02520141|Ramucirumab|ramucirumab|mesh-list
814444|NCT02520141|Antibodies|antibodies|mesh-list
814445|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
814446|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
814447|NCT02520141|Lexatumumab|lexatumumab|mesh-list
814448|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
814449|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814450|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249802|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
2249803|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2249804|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
2249805|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2249806|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249807|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249808|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
2249809|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2249810|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249811|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
2249812|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2249813|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
815418|NCT02516085|Metformin|metformin|mesh-list
815419|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
815420|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249814|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249815|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2249816|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249817|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2249818|NCT00130455|Citalopram|citalopram|mesh-list
2249819|NCT00130455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2249820|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2249821|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2249822|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249823|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2249824|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
2754370|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754371|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096926|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096927|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2096928|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2096929|NCT02316613|Rituximab|rituximab|mesh-list
2096930|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2096931|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096932|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
2096933|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096934|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2096935|NCT02316847|Diazepam|diazepam|mesh-list
2096936|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2096937|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
2096938|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
2096939|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
2096940|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096941|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096942|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2096943|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2096944|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2096945|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
817158|NCT02509312|Ketorolac|ketorolac|mesh-list
817159|NCT02509312|Morphine|morphine|mesh-list
817160|NCT02509312|Hydromorphone|hydromorphone|mesh-list
817161|NCT02509312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
817162|NCT02509312|Narcotics|narcotics|mesh-ancestor
817163|NCT02509312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
817164|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817165|NCT02509312|Analgesics|analgesics|mesh-ancestor
817166|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
817167|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817168|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
817181|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814317|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814318|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
814319|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
814320|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
814321|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
814322|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
814323|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
814324|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
814325|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
814326|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
814327|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814328|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
814329|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
814330|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814331|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
814332|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
814333|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
814652|NCT02519439|Ganaxolone|ganaxolone|mesh-list
814653|NCT02519439|Neurosteroids|neurosteroids|mesh-ancestor
814654|NCT02519439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
814655|NCT02519439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814656|NCT02519439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814657|NCT02519439|GABA Modulators|gaba modulators|mesh-ancestor
814658|NCT02519439|GABA Agents|gaba agents|mesh-ancestor
814940|NCT02518503|Atorvastatin|atorvastatin|mesh-list
814941|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
814942|NCT02518503|Simvastatin|simvastatin|mesh-list
814943|NCT02518503|Pravastatin|pravastatin|mesh-list
814944|NCT02518503|Lovastatin|lovastatin|mesh-list
814945|NCT02518503|L 647318|l 647318|mesh-list
814946|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
814947|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
814948|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
814949|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
814950|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814951|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
814952|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
814953|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249825|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249826|NCT00130455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2249827|NCT00130455|Antidepressive Agents|antidepressive agents|mesh-ancestor
2249828|NCT00130455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2249829|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
2249830|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2249831|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
2249832|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249833|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
2249834|NCT00130468|Protective Agents|protective agents|mesh-ancestor
2249835|NCT00130481|Atorvastatin|atorvastatin|mesh-list
2249836|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2249837|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
816668|NCT02511574|Progesterone|progesterone|mesh-list
816669|NCT02511574|Progestins|progestins|mesh-ancestor
816670|NCT02511574|Hormones|hormones|mesh-ancestor
816671|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
816672|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816752|NCT02511223|Olaparib|olaparib|mesh-list
816753|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
816754|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816755|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816756|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816914|NCT02510963|Tenofovir|tenofovir|mesh-list
816915|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
816916|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
816917|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
816918|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
816919|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816920|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816921|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
816922|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
817002|NCT02509845|Anti-Infective Agents|anti-infective agents|mesh-list
817003|NCT02509845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2096946|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2096947|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2096948|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2096949|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
814435|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814831|NCT02518789|Fentanyl|fentanyl|mesh-list
814832|NCT02518789|Midazolam|midazolam|mesh-list
814833|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
814834|NCT02518789|Remifentanil|remifentanil|mesh-list
814835|NCT02518789|Propofol|propofol|mesh-list
814836|NCT02518789|Etomidate|etomidate|mesh-list
814837|NCT02518789|Atracurium|atracurium|mesh-list
814838|NCT02518789|Rocuronium|rocuronium|mesh-list
814839|NCT02518789|Cisatracurium|cisatracurium|mesh-list
814840|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
814841|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
814842|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814843|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
814844|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
814845|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
814846|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
814847|NCT02518789|Analgesics|analgesics|mesh-ancestor
814848|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
814849|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
814850|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
814851|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
814852|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
814853|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
814854|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
814855|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814856|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
814857|NCT02518789|Narcotics|narcotics|mesh-ancestor
814858|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
814859|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
814860|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
814861|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
814862|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
814863|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
814864|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
814865|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
814866|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
814867|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
814868|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
814869|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
815387|NCT02516462|Hormones|hormones|mesh-list
815388|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
815389|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
815390|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815686|NCT02515435|Apatinib|apatinib|mesh-list
815687|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815688|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
815689|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815690|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249838|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
2249839|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249840|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2249841|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2249842|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249843|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
2249844|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2249845|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249846|NCT00130507|Capecitabine|capecitabine|mesh-list
2249847|NCT00130507|Trastuzumab|trastuzumab|mesh-list
2249848|NCT00130507|Vinorelbine|vinorelbine|mesh-list
2249849|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2249850|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
2249851|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249852|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249853|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2249854|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2249855|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
2249856|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
2249857|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
2249858|NCT00130546|Sirolimus|sirolimus|mesh-list
2249859|NCT00130546|Paclitaxel|paclitaxel|mesh-list
2249860|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2249861|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249862|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
2249863|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
2249864|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
814604|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
814605|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814606|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
814607|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
814608|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
814609|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
814610|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
814611|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
814612|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
814613|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
814614|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
814615|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
814616|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
814617|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
814618|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
814619|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
814758|NCT02518763|Vitamin D|vitamin d|mesh-list
814759|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
814760|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
814761|NCT02518763|Vitamins|vitamins|mesh-list
814762|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
814763|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
814764|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
814765|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
815001|NCT02518022|Insulin|insulin|mesh-list
815002|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
815003|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
815004|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
815005|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096950|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2096951|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
2096952|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
2096953|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
2096954|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
2096955|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096956|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096957|NCT02317016|Osimertinib|osimertinib|mesh-list
2096958|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2096959|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2096960|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2096961|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
2096962|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096963|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2096964|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2096965|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096966|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096967|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2096968|NCT02317510|Anesthetics|anesthetics|mesh-list
2249865|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249866|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2249867|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249868|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2249869|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
2249870|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2249871|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
816829|NCT02510976|Prucalopride|prucalopride|mesh-list
816830|NCT02510976|Laxatives|laxatives|mesh-ancestor
816831|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
816832|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
816833|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
816834|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
816835|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
816836|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816837|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817266|NCT02509104|Tamsulosin|tamsulosin|mesh-list
817267|NCT02509104|Dutasteride|dutasteride|mesh-list
817268|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
817269|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
817270|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
817271|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
817272|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817273|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817274|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817275|NCT02509104|Urological Agents|urological agents|mesh-ancestor
817324|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
814668|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
814669|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
814670|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
814671|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
814672|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815330|NCT02516618|Fasinumab|fasinumab|mesh-list
815331|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
815332|NCT02516618|Analgesics|analgesics|mesh-ancestor
815333|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
815334|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815335|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815471|NCT02515968|Propofol|propofol|mesh-list
815472|NCT02515968|Desflurane|desflurane|mesh-list
815473|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
815474|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
815475|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815476|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
815477|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
815478|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
815479|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
815660|NCT02515734|Leucovorin|leucovorin|mesh-list
815661|NCT02515734|Bevacizumab|bevacizumab|mesh-list
815662|NCT02515734|Cetuximab|cetuximab|mesh-list
815663|NCT02515734|Fluorouracil|fluorouracil|mesh-list
815664|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
815665|NCT02515734|Irinotecan|irinotecan|mesh-list
815666|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
815667|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815668|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
815669|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
815670|NCT02515734|Growth Substances|growth substances|mesh-ancestor
815671|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815672|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
815673|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
815674|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815675|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
815676|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
815677|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
815678|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
815679|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
815680|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815681|NCT02515734|Antidotes|antidotes|mesh-ancestor
815682|NCT02515734|Protective Agents|protective agents|mesh-ancestor
815683|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
815684|NCT02515734|Vitamins|vitamins|mesh-ancestor
815685|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
816009|NCT02513849|Tamoxifen|tamoxifen|mesh-list
816010|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
816011|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
816012|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
816013|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816014|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
816015|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816016|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
816017|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
816018|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
816099|NCT02513654|Lamotrigine|lamotrigine|mesh-list
816100|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
816101|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
816102|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
816103|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816104|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
816105|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816106|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
816107|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
816108|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
816109|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
816110|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
816213|NCT02513433|Bupivacaine|bupivacaine|mesh-list
816214|NCT02513433|Ropivacaine|ropivacaine|mesh-list
816215|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
816216|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
816217|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
816218|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
816219|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816220|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
814771|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
814772|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
814773|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
814963|NCT02518555|Vaccines|vaccines|mesh-list
814964|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
814965|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815018|NCT02518009|Estrogens|estrogens|mesh-list
815019|NCT02518009|Androgens|androgens|mesh-list
815020|NCT02518009|Hormones|hormones|mesh-ancestor
815021|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
815022|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249872|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249873|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
2249874|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2249875|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2249876|NCT00130572|Analgesics|analgesics|mesh-ancestor
2249877|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
2249878|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249879|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249880|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2249881|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2249882|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
2249883|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2249884|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
2249885|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2249886|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249887|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249888|NCT00130585|Folic Acid|folic acid|mesh-list
2249889|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
2249890|NCT00130585|Hematinics|hematinics|mesh-ancestor
2249891|NCT00130585|Vitamins|vitamins|mesh-ancestor
2249892|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
2249893|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249894|NCT00130676|Mifepristone|mifepristone|mesh-list
2249895|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2249896|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
2249897|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2249898|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249899|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
815767|NCT02514980|Ketamine|ketamine|mesh-list
815768|NCT02514980|Bupivacaine|bupivacaine|mesh-list
815769|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
815770|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
815771|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
815772|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815773|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
815774|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815775|NCT02514980|Analgesics|analgesics|mesh-ancestor
815776|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
815777|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
815778|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
815779|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
815780|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
815781|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
815782|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249900|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2249901|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2249902|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
2249903|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2249904|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2249905|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
2249906|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2249907|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
2249908|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2249909|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
816771|NCT02511132|Irinotecan|irinotecan|mesh-list
816772|NCT02511132|Temozolomide|temozolomide|mesh-list
816773|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
816774|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
816775|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816776|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816777|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816778|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
816779|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
817127|NCT02509234|Irinotecan|irinotecan|mesh-list
2249910|NCT00130702|Gefitinib|gefitinib|mesh-list
2249911|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249912|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2249913|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249914|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249915|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
2249916|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
2249917|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249918|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2249919|NCT00130767|Finasteride|finasteride|mesh-list
2249920|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2249921|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2249922|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249923|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249924|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
2249925|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2249926|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249927|NCT00130767|Urological Agents|urological agents|mesh-ancestor
2249928|NCT00130819|Buprenorphine|buprenorphine|mesh-list
2249929|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2249930|NCT00130819|Narcotics|narcotics|mesh-ancestor
2249931|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2249932|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249933|NCT00130819|Analgesics|analgesics|mesh-ancestor
2249934|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
815110|NCT02517619|Dexamethasone|dexamethasone|mesh-list
815111|NCT02517619|Prednisolone|prednisolone|mesh-list
815112|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
815113|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
815114|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
815115|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
815116|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
815117|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
815118|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
815119|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
815120|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
815121|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
815122|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
815123|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815124|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815125|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
815126|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
815127|NCT02517619|Hormones|hormones|mesh-ancestor
815128|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
815129|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
815130|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815131|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
815132|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
815133|NCT02517619|Protective Agents|protective agents|mesh-ancestor
815701|NCT02515565|Erythromycin|erythromycin|mesh-list
815702|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
815703|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
815704|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
815705|NCT02515565|Cephalosporins|cephalosporins|mesh-list
815706|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
815707|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815708|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
815709|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
815710|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815711|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815969|NCT02514200|Riboflavin|riboflavin|mesh-list
815970|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
815971|NCT02514200|Vitamins|vitamins|mesh-ancestor
815972|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
815973|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815974|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
815975|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
2249935|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2249936|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2249937|NCT00130845|Octreotide|octreotide|mesh-list
2249938|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2249939|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2249940|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249941|NCT00130858|Carboplatin|carboplatin|mesh-list
2249942|NCT00130858|Topotecan|topotecan|mesh-list
2249943|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815067|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815176|NCT02517424|Dronabinol|dronabinol|mesh-list
815177|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
815178|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815179|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
815180|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
815181|NCT02517424|Analgesics|analgesics|mesh-ancestor
815182|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
815183|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815184|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
815185|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
815186|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
815187|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815188|NCT02517424|Hormones|hormones|mesh-ancestor
815189|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
815347|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
815348|NCT02516475|Astringents|astringents|mesh-ancestor
815349|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815350|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
815712|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
815713|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
815714|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815819|NCT02514941|Acetaminophen|acetaminophen|mesh-list
815820|NCT02514941|Amoxicillin|amoxicillin|mesh-list
815821|NCT02514941|Talinolol|talinolol|mesh-list
815822|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
815823|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815824|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
815825|NCT02514941|Analgesics|analgesics|mesh-ancestor
815826|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
815827|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815828|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815829|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
815830|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
815831|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
815832|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
815833|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
815834|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815835|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
815836|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
816275|NCT02513303|Sirolimus|sirolimus|mesh-list
816276|NCT02513303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
816277|NCT02513303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
816278|NCT02513303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
816279|NCT02513303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816280|NCT02513303|Antifungal Agents|antifungal agents|mesh-ancestor
816281|NCT02513303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
816282|NCT02513303|Immunologic Factors|immunologic factors|mesh-ancestor
816283|NCT02513303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816605|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
816606|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
816607|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
816608|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816609|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249944|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2249945|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2249946|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249947|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249948|NCT00130871|Simendan|simendan|mesh-list
2249949|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2249950|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
2249951|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2249952|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2249953|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249954|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249955|NCT00130871|Protective Agents|protective agents|mesh-ancestor
2249956|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249957|NCT00130884|Simendan|simendan|mesh-list
2249958|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2249959|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
2249960|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
817189|NCT02509286|Leucovorin|leucovorin|mesh-list
817190|NCT02509286|Paclitaxel|paclitaxel|mesh-list
817191|NCT02509286|Docetaxel|docetaxel|mesh-list
2249961|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
815089|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
815090|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
815251|NCT02517099|Azithromycin|azithromycin|mesh-list
815252|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
815253|NCT02517099|Beclomethasone|beclomethasone|mesh-list
815254|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
815255|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815256|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
815257|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815258|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815259|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
815260|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
815261|NCT02517099|Hormones|hormones|mesh-ancestor
815262|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
815263|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815264|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
815265|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
815544|NCT02515695|Interferons|interferons|mesh-list
815545|NCT02515695|Interferon-beta|interferon-beta|mesh-list
815546|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
815547|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815548|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
815549|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815550|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
815551|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815552|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
815650|NCT02515448|Gentamicins|gentamicins|mesh-list
815651|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
815652|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815653|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
815654|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815655|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815721|NCT02515188|Acetaminophen|acetaminophen|mesh-list
815722|NCT02515188|Propacetamol|propacetamol|mesh-list
815723|NCT02515188|Analgesics|analgesics|mesh-ancestor
815724|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
815725|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815726|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815727|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
815728|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
815729|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
815730|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
815731|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
815935|NCT02514447|Topotecan|topotecan|mesh-list
815936|NCT02514447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
815937|NCT02514447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
815938|NCT02514447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815939|NCT02514447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815940|NCT02514447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249962|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249963|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249964|NCT00130884|Protective Agents|protective agents|mesh-ancestor
2249965|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249966|NCT00130897|Sunitinib|sunitinib|mesh-list
816485|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
816486|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
816658|NCT02511886|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
816659|NCT02511886|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
816660|NCT02511886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816661|NCT02511886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
816662|NCT02511886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816663|NCT02511886|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
816664|NCT02511886|GABA Agonists|gaba agonists|mesh-ancestor
816665|NCT02511886|GABA Agents|gaba agents|mesh-ancestor
816666|NCT02511886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
816667|NCT02511886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249967|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249968|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2249969|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2249970|NCT00130897|Growth Substances|growth substances|mesh-ancestor
2096969|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2096970|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096971|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
2096972|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
815166|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
815167|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
815168|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815169|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815506|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
815507|NCT02515864|Dotinurad|dotinurad|mesh-list
815508|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
815509|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
815510|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815511|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
815512|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
815513|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815514|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815515|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815516|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
815517|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
815518|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
815519|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815520|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
815521|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
815522|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
815523|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
815524|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
815525|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
815526|NCT02515864|Renal Agents|renal agents|mesh-ancestor
2096973|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2096974|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096975|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
2096976|NCT02317549|Coagulants|coagulants|mesh-ancestor
2096977|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
2096978|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2096979|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096980|NCT02317744|Naltrexone|naltrexone|mesh-list
2096981|NCT02317744|Bupropion|bupropion|mesh-list
2096982|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2249971|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2249972|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
2249973|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2249974|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249975|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249976|NCT00130910|Albendazole|albendazole|mesh-list
2249977|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
2249978|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
816749|NCT02511327|Vaccines|vaccines|mesh-list
816750|NCT02511327|Immunologic Factors|immunologic factors|mesh-ancestor
816751|NCT02511327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816874|NCT02510534|Menotropins|menotropins|mesh-list
816875|NCT02510534|Progesterone|progesterone|mesh-list
816876|NCT02510534|Progestins|progestins|mesh-ancestor
816877|NCT02510534|Hormones|hormones|mesh-ancestor
816878|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
816879|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816880|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
816881|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
816882|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2249979|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2249980|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
2249981|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2249982|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2249983|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
2249984|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
2249985|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
2249986|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249987|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2249988|NCT00130936|Carboplatin|carboplatin|mesh-list
2249989|NCT00130936|Capecitabine|capecitabine|mesh-list
2249990|NCT00130936|Epirubicin|epirubicin|mesh-list
2249991|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2096983|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2096984|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2096985|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
2096986|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2096987|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2096988|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
2249992|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2249993|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
2249994|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2249995|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2249996|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2249997|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2249998|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2249999|NCT00130975|Candesartan|candesartan|mesh-list
2250000|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2250001|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2250002|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2250003|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250004|NCT00131027|Cytarabine|cytarabine|mesh-list
2250005|NCT00131027|Dexamethasone|dexamethasone|mesh-list
2250006|NCT00131027|Prednisolone|prednisolone|mesh-list
2250007|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
2250008|NCT00131027|Doxorubicin|doxorubicin|mesh-list
2250009|NCT00131027|Methotrexate|methotrexate|mesh-list
2250010|NCT00131027|Etoposide|etoposide|mesh-list
815718|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
815719|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
815720|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816058|NCT02513862|Heparin|heparin|mesh-list
816059|NCT02513862|Protamines|protamines|mesh-list
816060|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
816061|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
816062|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
816063|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816064|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
816065|NCT02513862|Coagulants|coagulants|mesh-ancestor
816252|NCT02513342|Docetaxel|docetaxel|mesh-list
816253|NCT02513342|Endostar protein|endostar protein|mesh-list
816254|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816255|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
816256|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
816257|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
816258|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816259|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
816260|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
816261|NCT02513342|Growth Substances|growth substances|mesh-ancestor
816262|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816263|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
817253|NCT02508922|Vitamin D|vitamin d|mesh-list
817254|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
817255|NCT02508922|Vitamins|vitamins|mesh-ancestor
817256|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
817257|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817258|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
817259|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2096989|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2096990|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2096991|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2096992|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2096993|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2096994|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
2096995|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2096996|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2096997|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2096998|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2096999|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2097000|NCT02317809|Hormones|hormones|mesh-ancestor
2097001|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2097002|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097003|NCT02318095|Gemcitabine|gemcitabine|mesh-list
2097004|NCT02318095|Paclitaxel|paclitaxel|mesh-list
2097005|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2097006|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097007|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
2097008|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
2097009|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
2097010|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097011|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2097012|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
2097013|NCT02318095|Antiviral Agents|antiviral agents|mesh-ancestor
2097014|NCT02318095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097015|NCT02318095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250011|NCT00131027|Vincristine|vincristine|mesh-list
815308|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
815309|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
815310|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815311|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815312|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
815313|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
815314|NCT02516696|Hormones|hormones|mesh-ancestor
815315|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
815316|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
815317|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815318|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
815319|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
815320|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
815321|NCT02516696|Growth Substances|growth substances|mesh-ancestor
815322|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
815323|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
815324|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815325|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
815326|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815327|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815328|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
815329|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
816332|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
816333|NCT02512926|Etoposide|etoposide|mesh-list
816334|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
816335|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
816336|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816337|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
816338|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
816339|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
816340|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816341|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816342|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
816343|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
816344|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
816345|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
816346|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816791|NCT02511054|Chloroquine|chloroquine|mesh-list
816792|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
816793|NCT02511054|Amebicides|amebicides|mesh-ancestor
816794|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
816795|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
816796|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
816797|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
816798|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
816799|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
816800|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816801|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816931|NCT02510287|Lidocaine|lidocaine|mesh-list
816932|NCT02510287|Fentanyl|fentanyl|mesh-list
816933|NCT02510287|Bupivacaine|bupivacaine|mesh-list
816934|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
816935|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
816936|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
816937|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816938|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
816939|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816940|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
816941|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
816942|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
816943|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
816944|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816945|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
816946|NCT02510287|Narcotics|narcotics|mesh-ancestor
816947|NCT02510287|Analgesics|analgesics|mesh-ancestor
816948|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
816949|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
816950|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
817004|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
817005|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
817006|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
817007|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817008|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
817009|NCT02509949|Analgesics|analgesics|mesh-ancestor
817010|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
815352|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
815353|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
815354|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
815355|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815356|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
815357|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
815358|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
815738|NCT02515422|Ketamine|ketamine|mesh-list
815739|NCT02515422|Bupivacaine|bupivacaine|mesh-list
815740|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
815741|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
815742|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
815743|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815744|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
815745|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815746|NCT02515422|Analgesics|analgesics|mesh-ancestor
815747|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
815748|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
815749|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
815750|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
815751|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
815752|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
815753|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815816|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
815817|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
815818|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816111|NCT02513888|Vitamin D|vitamin d|mesh-list
816112|NCT02513888|Vitamins|vitamins|mesh-ancestor
816113|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
816114|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816115|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
816196|NCT02513394|Palbociclib|palbociclib|mesh-list
816197|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816198|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
816199|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816200|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816883|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
816884|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
816885|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
816886|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816887|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
816888|NCT02510612|Analgesics|analgesics|mesh-ancestor
816889|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
816890|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816891|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
816892|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
816893|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
816894|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
816895|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
816896|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816928|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
816929|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816930|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250012|NCT00131027|Daunorubicin|daunorubicin|mesh-list
2250013|NCT00131027|Asparaginase|asparaginase|mesh-list
2250014|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
2250015|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2250016|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
2097016|NCT02318095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2097017|NCT02318095|Immunologic Factors|immunologic factors|mesh-ancestor
2097018|NCT02318095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097022|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
2097023|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2097024|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2097025|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
2097026|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2097027|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2097028|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2097029|NCT02318303|Analgesics|analgesics|mesh-ancestor
2250017|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250018|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2250019|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2250020|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
2250021|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250022|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250023|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2250024|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2250025|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
2250026|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
2250027|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250028|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2250029|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
2250030|NCT00131027|Hormones|hormones|mesh-ancestor
2273747|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816347|NCT02513147|Lopinavir|lopinavir|mesh-list
816348|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
816349|NCT02513147|Darunavir|darunavir|mesh-list
816350|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
816351|NCT02513147|Dolutegravir|dolutegravir|mesh-list
816352|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
816353|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
816354|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
816355|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816356|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816357|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
816358|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
816359|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
816360|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
816361|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
816362|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
816363|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
816364|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
816497|NCT02512471|Ropivacaine|ropivacaine|mesh-list
816498|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
816499|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
816500|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
816501|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816502|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
816503|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816826|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
816827|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
816828|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
816958|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
816959|NCT02510222|Analgesics|analgesics|mesh-ancestor
816960|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
816961|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816962|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816963|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
816964|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
816965|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
816966|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
816967|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
816968|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
816969|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816970|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
816971|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
816972|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
817037|NCT02509728|Choline|choline|mesh-list
817038|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
817039|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
817040|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
817041|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817042|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
817043|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
817044|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
2097030|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
2097031|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097032|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097033|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2097034|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2097035|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2097036|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
2097037|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
2097038|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097039|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815540|NCT02515682|Estrogens|estrogens|mesh-ancestor
815541|NCT02515682|Hormones|hormones|mesh-ancestor
815542|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
815543|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250031|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2250032|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2250033|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2250034|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2250035|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2250036|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250037|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2250038|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
2250039|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2250040|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2250041|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
2250042|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
2250043|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2250044|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2250045|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2250046|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
2250047|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250048|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
2250049|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
816853|NCT02510781|Carboplatin|carboplatin|mesh-list
816854|NCT02510781|Docetaxel|docetaxel|mesh-list
816855|NCT02510781|Trastuzumab|trastuzumab|mesh-list
816856|NCT02510781|Epirubicin|epirubicin|mesh-list
816857|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816858|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
816859|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
816860|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
816861|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816862|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
816863|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
816864|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
816865|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
816866|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250050|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
2250051|NCT00131040|Aprotinin|aprotinin|mesh-list
2250052|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
2250053|NCT00131040|Coagulants|coagulants|mesh-ancestor
817250|NCT02509091|Amikacin|amikacin|mesh-list
817251|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
817252|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097043|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2097044|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097045|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2097046|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097047|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097048|NCT02318602|Cannabidiol|cannabidiol|mesh-list
2097049|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
2097050|NCT02318667|Golimumab|golimumab|mesh-list
2097051|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2097052|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2097053|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2097054|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
2097055|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097056|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2097057|NCT02318693|Glyburide|glyburide|mesh-list
2097058|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2097059|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097060|NCT02318693|Incretins|incretins|mesh-ancestor
2097061|NCT02318693|Hormones|hormones|mesh-ancestor
2097062|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2097063|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2097064|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
2097065|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097066|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097067|NCT02319031|Ribavirin|ribavirin|mesh-list
2097068|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
2097069|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
2097070|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815600|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
815601|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
815602|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
815603|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815604|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
815605|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
815606|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
816001|NCT02514018|Vaccines|vaccines|mesh-list
816002|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
816003|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816093|NCT02513784|Chlorhexidine|chlorhexidine|mesh-list
816094|NCT02513784|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
816095|NCT02513784|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
816096|NCT02513784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
816097|NCT02513784|Disinfectants|disinfectants|mesh-ancestor
816098|NCT02513784|Dermatologic Agents|dermatologic agents|mesh-ancestor
816154|NCT02513485|Levodopa|levodopa|mesh-list
816155|NCT02513485|Carbidopa|carbidopa|mesh-list
816156|NCT02513485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
816157|NCT02513485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
816158|NCT02513485|Dopamine Agents|dopamine agents|mesh-ancestor
816159|NCT02513485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
816160|NCT02513485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816161|NCT02513485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816162|NCT02513485|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
816163|NCT02513485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250054|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2250055|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2250056|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
2250057|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754380|NCT01199302|Brodalumab|brodalumab|mesh-list
2754381|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
2754382|NCT01192568|Oxybutynin|oxybutynin|mesh-list
2754383|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
2754384|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
2754385|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754386|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754387|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2754388|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2754389|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
816694|NCT02511405|Bevacizumab|bevacizumab|mesh-list
816695|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
816696|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816697|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
816698|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
816699|NCT02511405|Growth Substances|growth substances|mesh-ancestor
816700|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816701|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
817281|NCT02508805|Diclofenac|diclofenac|mesh-list
817282|NCT02508805|Tizanidine|tizanidine|mesh-list
817283|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
817284|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
817285|NCT02508805|Analgesics|analgesics|mesh-ancestor
817286|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
817287|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817288|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817289|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
817290|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
817291|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
817292|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817293|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817294|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
817295|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
817296|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
817297|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
817298|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
817299|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
817300|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
817301|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
817302|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
817303|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097071|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
2097072|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097073|NCT02319044|Durvalumab|durvalumab|mesh-list
2097074|NCT02319044|Tremelimumab|tremelimumab|mesh-list
2097075|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
815626|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
815627|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
815628|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
815629|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
815630|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815631|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
815632|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
815633|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
815634|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815635|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
815636|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
815637|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
815638|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
815639|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
815640|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
815641|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815642|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
815643|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
815644|NCT02515526|Protective Agents|protective agents|mesh-ancestor
815645|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
815646|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
815647|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
815648|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
815649|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
815855|NCT02514629|Metformin|metformin|mesh-list
815856|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
815857|NCT02514629|Testosterone|testosterone|mesh-list
815858|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
815859|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
815860|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
815861|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
815862|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815863|NCT02514629|Androgens|androgens|mesh-ancestor
815864|NCT02514629|Hormones|hormones|mesh-ancestor
815865|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
815866|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
815867|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815868|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
815907|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
815908|NCT02514343|Bupivacaine|bupivacaine|mesh-list
815909|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
815910|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
815911|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
815912|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
815913|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
815914|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
815915|NCT02514343|Analgesics|analgesics|mesh-ancestor
815916|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
815917|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
815918|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
815919|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
815920|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815921|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
815922|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
815923|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2097076|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2097077|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097078|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
2097079|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097080|NCT02319148|Itraconazole|itraconazole|mesh-list
2097081|NCT02319148|Verapamil|verapamil|mesh-list
2097082|NCT02319148|Diltiazem|diltiazem|mesh-list
2097083|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
2097084|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097085|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2097086|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2097087|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097088|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097089|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2097090|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
2097091|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2097092|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816135|NCT02513563|Paclitaxel|paclitaxel|mesh-list
816136|NCT02513563|Carboplatin|carboplatin|mesh-list
2250058|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250059|NCT00131053|Cytarabine|cytarabine|mesh-list
2250060|NCT00131053|Dexamethasone|dexamethasone|mesh-list
2250061|NCT00131053|Prednisolone|prednisolone|mesh-list
2250062|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
815941|NCT02514421|Gemcitabine|gemcitabine|mesh-list
815942|NCT02514421|Paclitaxel|paclitaxel|mesh-list
815943|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
815944|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
815945|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
815946|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
815947|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
815948|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
815949|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
815950|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
815951|NCT02514421|Antiviral Agents|antiviral agents|mesh-ancestor
815952|NCT02514421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
815953|NCT02514421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
815954|NCT02514421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
815955|NCT02514421|Immunologic Factors|immunologic factors|mesh-ancestor
815956|NCT02514421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816066|NCT02513927|Metoprolol|metoprolol|mesh-list
816067|NCT02513927|Nifedipine|nifedipine|mesh-list
816068|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
816069|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
816070|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
816071|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
816072|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816073|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816074|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
816075|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
816076|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
816077|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
816078|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
816079|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816080|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
816081|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
816082|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
816083|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
816084|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
816085|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2250063|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
2250064|NCT00131053|Methotrexate|methotrexate|mesh-list
2250065|NCT00131053|Vincristine|vincristine|mesh-list
2250066|NCT00131053|Asparaginase|asparaginase|mesh-list
2250067|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
2250068|NCT00131053|Pirarubicin|pirarubicin|mesh-list
2250069|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2250070|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
2250071|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816549|NCT02512315|Cisplatin|cisplatin|mesh-list
816550|NCT02512315|Docetaxel|docetaxel|mesh-list
816551|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816552|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
816553|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
816554|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
816555|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816739|NCT02511353|Ivermectin|ivermectin|mesh-list
816740|NCT02511353|Piperaquine|piperaquine|mesh-list
816741|NCT02511353|Artenimol|artenimol|mesh-list
816742|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
816743|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
816744|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
816745|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2250072|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2250073|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2250074|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
2250075|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250076|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250077|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2250078|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2097093|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2097094|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2097095|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2097096|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2097097|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2250079|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
2250080|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
2250081|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250082|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2250083|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
2250084|NCT00131053|Hormones|hormones|mesh-ancestor
2250085|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2250086|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
816004|NCT02513875|Vitamin D|vitamin d|mesh-list
816005|NCT02513875|Vitamins|vitamins|mesh-ancestor
816006|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
816007|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816008|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
816121|NCT02513693|Rocuronium|rocuronium|mesh-list
816122|NCT02513693|Neostigmine|neostigmine|mesh-list
816123|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
816124|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
816125|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
816126|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816127|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816128|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
816129|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816130|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816131|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
816132|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
816133|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
816134|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
816317|NCT02513004|Clopidogrel|clopidogrel|mesh-list
816318|NCT02513004|Ticagrelor|ticagrelor|mesh-list
816319|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
816320|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
816321|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
816322|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
816323|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
816324|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
816325|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816326|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250087|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2250088|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
2250089|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2250090|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2250091|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
2250092|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
2250093|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250094|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2250095|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2250096|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
2250097|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250098|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2097098|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
2097099|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2097100|NCT02319304|Leucovorin|leucovorin|mesh-list
2097101|NCT02319304|Fluorouracil|fluorouracil|mesh-list
2097102|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
2097103|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
2097104|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097105|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2097106|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097107|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2097108|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
2097109|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097110|NCT02319304|Antidotes|antidotes|mesh-ancestor
2097111|NCT02319304|Protective Agents|protective agents|mesh-ancestor
2097112|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
2097113|NCT02319304|Vitamins|vitamins|mesh-ancestor
2097114|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
2097115|NCT02319369|Azacitidine|azacitidine|mesh-list
2097116|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2097117|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
2097118|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097119|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097120|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097121|NCT02319486|Carboplatin|carboplatin|mesh-list
2097122|NCT02319486|Etoposide|etoposide|mesh-list
2097123|NCT02319486|Vincristine|vincristine|mesh-list
2097124|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097125|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
816137|NCT02513563|Adavosertib|adavosertib|mesh-list
816138|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
816139|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816140|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
816141|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
816142|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
816143|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816144|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816487|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
816488|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
816489|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
816490|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
816491|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816492|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
816493|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
816494|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
816495|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
816496|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816923|NCT02510469|Apatinib|apatinib|mesh-list
816924|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816925|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
816926|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816927|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816997|NCT02510053|Caspofungin|caspofungin|mesh-list
816998|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
816999|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
817000|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817001|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097126|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2097127|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2097128|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097129|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097130|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
2097131|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
2097132|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
2097133|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
2097134|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2097135|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
2097136|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097137|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2097138|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
2097139|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2097140|NCT02319668|Listerine|listerine|mesh-list
2097141|NCT02319668|Fluorides|fluorides|mesh-list
2097142|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
2097143|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
2097144|NCT02319668|Protective Agents|protective agents|mesh-ancestor
2097145|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097146|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2097147|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097148|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
2097149|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
2097150|NCT02319759|Ustekinumab|ustekinumab|mesh-list
2097151|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
2097152|NCT02320058|Nivolumab|nivolumab|mesh-list
2097153|NCT02320058|Ipilimumab|ipilimumab|mesh-list
2097154|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2097155|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097156|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2097157|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097158|NCT02320149|Sarecycline|sarecycline|mesh-list
2097159|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2097160|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097161|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
2097162|NCT02320396|Desloratadine|desloratadine|mesh-list
2097163|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2097164|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
2097165|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097166|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097167|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097168|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2097169|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2097170|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
2097171|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
2097172|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2097173|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
2250099|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
2250100|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
2250101|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
2250102|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
2250103|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2250104|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250105|NCT00131144|Octreotide|octreotide|mesh-list
2250106|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2250107|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2250108|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250109|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
2250110|NCT00131183|Androgens|androgens|mesh-ancestor
2250111|NCT00131183|Hormones|hormones|mesh-ancestor
2250112|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2250113|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250114|NCT00131235|Azithromycin|azithromycin|mesh-list
2250115|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
2250116|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
2250117|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2250118|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2250119|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250120|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
2250121|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2250122|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2250123|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2250124|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250125|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250126|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
816683|NCT02511418|Simvastatin|simvastatin|mesh-list
816684|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
816685|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
816686|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
816687|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816688|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
816689|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
816690|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816844|NCT02510950|Temozolomide|temozolomide|mesh-list
816845|NCT02510950|Poly ICLC|poly iclc|mesh-list
816846|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
816847|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
816848|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816849|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816850|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
816851|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
816852|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250127|NCT00131235|Renal Agents|renal agents|mesh-ancestor
2250128|NCT00131261|Dexamethasone|dexamethasone|mesh-list
2250129|NCT00131261|Belinostat|belinostat|mesh-list
2250130|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2250131|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
2250132|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
2250133|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250134|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250135|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2250136|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
2097174|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2097175|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
2097176|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097177|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097178|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2097179|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2097180|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
2097181|NCT02320695|Bacitracin|bacitracin|mesh-list
2097182|NCT02320695|Neomycin|neomycin|mesh-list
2097183|NCT02320695|Polymyxin B|polymyxin b|mesh-list
2097184|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2097185|NCT02320695|Ethanol|ethanol|mesh-list
2097186|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097187|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
2097188|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2097189|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2097190|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097191|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2097192|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250137|NCT00131261|Hormones|hormones|mesh-ancestor
2250138|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2250139|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2250140|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250141|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2250142|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250143|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816610|NCT02511795|Olaparib|olaparib|mesh-list
816611|NCT02511795|Adavosertib|adavosertib|mesh-list
816612|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
816613|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816614|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816615|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816841|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
816842|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
816843|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097193|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097194|NCT02320721|Insulin|insulin|mesh-list
2097195|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2097196|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
2097197|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2097198|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097199|NCT02321098|Amorolfine|amorolfine|mesh-list
2097200|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
2097201|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097202|NCT02321319|Hydromorphone|hydromorphone|mesh-list
2097203|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2097204|NCT02321319|Narcotics|narcotics|mesh-ancestor
2097205|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2097206|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097207|NCT02321319|Analgesics|analgesics|mesh-ancestor
2097208|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
2097209|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097210|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
2097211|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2097212|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2097213|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2097214|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2097215|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097216|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
2097217|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097218|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097219|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2097220|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097221|NCT02321748|Montelukast|montelukast|mesh-list
2097222|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2097223|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
2097224|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2097225|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
2097226|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2097227|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097228|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2097229|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2097230|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097231|NCT02321800|Imipenem|imipenem|mesh-list
2097232|NCT02321800|Cilastatin|cilastatin|mesh-list
2097233|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2097234|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097235|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
2097236|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097237|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097238|NCT02321930|Tofacitinib|tofacitinib|mesh-list
2097239|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2097240|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097241|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097242|NCT02322047|Prazosin|prazosin|mesh-list
2097243|NCT02322047|Naltrexone|naltrexone|mesh-list
2097244|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2097245|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2097246|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097247|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
2097248|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097249|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2250144|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
816221|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816474|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
816475|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
816476|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
816477|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2250145|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250146|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2250147|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250148|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250149|NCT00131300|Hylan|hylan|mesh-list
2250150|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
2250151|NCT00131300|Protective Agents|protective agents|mesh-ancestor
2250152|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250153|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
2250154|NCT00131313|Rituximab|rituximab|mesh-list
2097250|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2097251|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2097252|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2097253|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
2097254|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097255|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097256|NCT02322190|Methoxsalen|methoxsalen|mesh-list
817018|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
817019|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
817020|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
817021|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
817022|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817023|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
817024|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817025|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097257|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2097258|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
2097259|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2097260|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2097261|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2097262|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2097263|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2097264|NCT02322216|Analgesics|analgesics|mesh-ancestor
2097265|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
2097266|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097267|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097268|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2097269|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2097270|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2097271|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2097272|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2097273|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
2097274|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
2097275|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097276|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097277|NCT02322242|Dexamethasone|dexamethasone|mesh-list
2097278|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
2097279|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2097280|NCT02322242|BB 1101|bb 1101|mesh-list
2097281|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2097282|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
2097283|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
2097284|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097285|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097286|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2097287|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
2097288|NCT02322242|Hormones|hormones|mesh-ancestor
2097289|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2097290|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2097291|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097292|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
2097293|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097294|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097295|NCT02322281|Gemcitabine|gemcitabine|mesh-list
2097296|NCT02322281|Paclitaxel|paclitaxel|mesh-list
2097297|NCT02322281|Docetaxel|docetaxel|mesh-list
2097298|NCT02322281|Pemetrexed|pemetrexed|mesh-list
2097299|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2097300|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754390|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2754391|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754392|NCT01192568|Urological Agents|urological agents|mesh-ancestor
2250155|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2250156|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
2250157|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250158|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2250159|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2250160|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
2250161|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250162|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250163|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2250164|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2250165|NCT00131326|Hylan|hylan|mesh-list
2250166|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
2250167|NCT00131326|Protective Agents|protective agents|mesh-ancestor
2250168|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250169|NCT00131339|Cycloserine|cycloserine|mesh-list
2250170|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2250171|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
816867|NCT02510586|Sevoflurane|sevoflurane|mesh-list
816868|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
816869|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
816870|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
816871|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
816872|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
816873|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097301|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
2097302|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
2097303|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
2097304|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097305|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2097306|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
2097307|NCT02322281|Antiviral Agents|antiviral agents|mesh-ancestor
2097308|NCT02322281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097309|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097310|NCT02322281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2097311|NCT02322281|Immunologic Factors|immunologic factors|mesh-ancestor
2097312|NCT02322281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097313|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2097314|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2097315|NCT02322320|Lenalidomide|lenalidomide|mesh-list
2097316|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
2097317|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097318|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2097319|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2097320|NCT02322320|Growth Substances|growth substances|mesh-ancestor
2097321|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
2097322|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097323|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2097324|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2097325|NCT02322710|Petrolatum|petrolatum|mesh-list
2097326|NCT02322710|Emollients|emollients|mesh-ancestor
2097327|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
2097328|NCT02322775|Benralizumab|benralizumab|mesh-list
2097329|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2097330|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
2097331|NCT02322788|Terbutaline|terbutaline|mesh-list
2097332|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2097333|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
2097334|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097335|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097336|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2097337|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
2097338|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
2097339|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
2097340|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2097341|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2097342|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2097343|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2097344|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
2097345|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097346|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097347|NCT02322814|Paclitaxel|paclitaxel|mesh-list
2097348|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2097349|NCT02322814|Atezolizumab|atezolizumab|mesh-list
2097350|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2097351|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097352|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
2097353|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
2097354|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
2097355|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097356|NCT02322866|Sarecycline|sarecycline|mesh-list
2097357|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2097358|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097359|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
2097360|NCT02322892|Thiamine|thiamine|mesh-list
2097361|NCT02322892|Vitamins|vitamins|mesh-ancestor
2097362|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
2097363|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097364|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
2097365|NCT02323048|Methamphetamine|methamphetamine|mesh-list
2097366|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2097367|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097368|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
2097369|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
816463|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
816464|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
816465|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
816466|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
816467|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
816468|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816469|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
816470|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
816471|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816472|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
816473|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816673|NCT02511704|Nicotine|nicotine|mesh-list
816674|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
816675|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
816676|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816677|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816678|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
816679|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
816680|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
816681|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
816682|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816757|NCT02511210|Anesthetics|anesthetics|mesh-list
816758|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
816759|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816973|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
816974|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
816975|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
816976|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816977|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
816978|NCT02510235|Protective Agents|protective agents|mesh-ancestor
817156|NCT02509208|Hemostatics|hemostatics|mesh-list
817157|NCT02509208|Coagulants|coagulants|mesh-ancestor
817304|NCT02508857|Ketorolac|ketorolac|mesh-list
817305|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
817306|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
817307|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
817308|NCT02508857|Analgesics|analgesics|mesh-ancestor
817309|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
817310|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817311|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817312|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
817313|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
817314|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
817315|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817316|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817317|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
817318|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
817319|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
817320|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
817321|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
817322|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
817323|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2097370|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816398|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816399|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
816400|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
816521|NCT02512497|Vidarabine|vidarabine|mesh-list
816522|NCT02512497|Fludarabine|fludarabine|mesh-list
816523|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
816524|NCT02512497|Busulfan|busulfan|mesh-list
816525|NCT02512497|Romidepsin|romidepsin|mesh-list
816526|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
816527|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
816528|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816529|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
816530|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
816531|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816532|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
816533|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
816534|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816535|NCT02512497|Antiviral Agents|antiviral agents|mesh-ancestor
816536|NCT02512497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
816537|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
816538|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
816539|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
816540|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2250172|NCT00131339|Renal Agents|renal agents|mesh-ancestor
2250173|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2250174|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
817260|NCT02509052|Leflunomide|leflunomide|mesh-list
817261|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817262|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817263|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
817264|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
817265|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097371|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
2097372|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097373|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097374|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
2097375|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2097376|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2097377|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2097378|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2097379|NCT02323126|Nivolumab|nivolumab|mesh-list
2097380|NCT02323126|Nazartinib|nazartinib|mesh-list
2097381|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2097382|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097383|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2097384|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097385|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
2097386|NCT02323217|Idazoxan|idazoxan|mesh-list
2097387|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2097388|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2097389|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2097390|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
2097391|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097392|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097393|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097394|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
2097395|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2097396|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2097397|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097398|NCT02323334|Itraconazole|itraconazole|mesh-list
2097399|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
2097400|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097401|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2097402|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2097403|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097404|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097405|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2097406|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
2097407|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2097408|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097409|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2097410|NCT02324153|Riboflavin|riboflavin|mesh-list
2097411|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
2097412|NCT02324153|Vitamins|vitamins|mesh-ancestor
2250175|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2250176|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
2250177|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250178|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
2250179|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2250180|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2250181|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250182|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250183|NCT00131391|Hormones|hormones|mesh-ancestor
816642|NCT02511639|Everolimus|everolimus|mesh-list
816643|NCT02511639|Letrozole|letrozole|mesh-list
816644|NCT02511639|Anastrozole|anastrozole|mesh-list
816645|NCT02511639|Exemestane|exemestane|mesh-list
816646|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
816647|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816648|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
816649|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
816650|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816651|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
816652|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816653|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816654|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
816655|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
816656|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
816657|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
817079|NCT02509273|Clonidine|clonidine|mesh-list
817080|NCT02509273|Midazolam|midazolam|mesh-list
817081|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
817082|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
817083|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
817084|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817085|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
817086|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
817087|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
817088|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
817089|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
817090|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
817091|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
817092|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
817093|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817094|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817095|NCT02509273|Analgesics|analgesics|mesh-ancestor
817096|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
817097|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817098|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
817099|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
817100|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
817101|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
817102|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
817103|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
817104|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
2097413|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
2097414|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097415|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2097416|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
2097417|NCT02324270|Diclofenac|diclofenac|mesh-list
2097418|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
2097419|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2097420|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2097421|NCT02324270|Analgesics|analgesics|mesh-ancestor
2097422|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
2097423|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097424|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097425|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2097426|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2097427|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2097428|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097429|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097430|NCT02324543|Gemcitabine|gemcitabine|mesh-list
2097431|NCT02324543|Docetaxel|docetaxel|mesh-list
2097432|NCT02324543|Capecitabine|capecitabine|mesh-list
2097433|NCT02324543|Irinotecan|irinotecan|mesh-list
2097434|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097435|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2250184|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2250185|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250186|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
2250187|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2250188|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2250189|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250190|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250191|NCT00131404|Hormones|hormones|mesh-ancestor
2250192|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
816514|NCT02512380|Docetaxel|docetaxel|mesh-list
816515|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
816516|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
816517|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
816518|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
816519|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
816520|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816985|NCT02510157|Dexamethasone|dexamethasone|mesh-list
816986|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
816987|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
816988|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
816989|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
816990|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816991|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
816992|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
816993|NCT02510157|Hormones|hormones|mesh-ancestor
816994|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
816995|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
816996|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817326|NCT02509143|Ramosetron|ramosetron|mesh-list
817327|NCT02509143|Antiemetics|antiemetics|mesh-list
817328|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
817329|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817330|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817331|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
817332|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
817333|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
817334|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817335|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097436|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
2097437|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097438|NCT02324543|Antiviral Agents|antiviral agents|mesh-ancestor
2097439|NCT02324543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097440|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097441|NCT02324543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2097442|NCT02324543|Immunologic Factors|immunologic factors|mesh-ancestor
2097443|NCT02324543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097444|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
2097445|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
2097446|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
2097447|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2097448|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2097449|NCT02324673|Cannabidiol|cannabidiol|mesh-list
2097450|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
2097451|NCT02324699|Prednisone|prednisone|mesh-list
2097452|NCT02324699|Vedolizumab|vedolizumab|mesh-list
2097453|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2097454|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
2097455|NCT02324699|Hormones|hormones|mesh-ancestor
2097456|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2097457|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097458|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2097459|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097460|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2097461|NCT02324842|Liraglutide|liraglutide|mesh-list
2097462|NCT02324842|Canagliflozin|canagliflozin|mesh-list
2097463|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2097464|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097465|NCT02324842|Incretins|incretins|mesh-ancestor
2097466|NCT02324842|Hormones|hormones|mesh-ancestor
2097467|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2097468|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2097469|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816634|NCT02511665|Metformin|metformin|mesh-list
816635|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
816636|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816897|NCT02510911|Caffeine|caffeine|mesh-list
816898|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
816899|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816900|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
816901|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816902|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816903|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
816904|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
816905|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
816906|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817031|NCT02509923|Rabeprazole|rabeprazole|mesh-list
817032|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
817033|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
817034|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
817035|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817036|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817114|NCT02509429|Insulin|insulin|mesh-list
817115|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
817116|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
817117|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
817118|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
817119|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
817120|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
817121|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097470|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2097471|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
2097472|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097473|NCT02325401|Metformin|metformin|mesh-list
2097474|NCT02325401|Cisplatin|cisplatin|mesh-list
2097475|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097476|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2097477|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097478|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
2097479|NCT02325414|Diphosphonates|diphosphonates|mesh-list
2097480|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2097481|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097482|NCT02325518|Timolol|timolol|mesh-list
2097483|NCT02325518|Dorzolamide|dorzolamide|mesh-list
2097484|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2097485|NCT02325518|Maleic acid|maleic acid|mesh-list
2097486|NCT02325518|Brinzolamide|brinzolamide|mesh-list
2097487|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2097488|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2097489|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2097490|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
2097491|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097492|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097493|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097494|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2097495|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2097496|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097497|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2097498|NCT02325713|Praziquantel|praziquantel|mesh-list
2097499|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
2097500|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2097501|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097502|NCT02325739|Spartalizumab|spartalizumab|mesh-list
2097503|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2097504|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097505|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097506|NCT02326025|Doxorubicin|doxorubicin|mesh-list
2097507|NCT02326025|Olaratumab|olaratumab|mesh-list
2097508|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2097509|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097510|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2097511|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2097512|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097513|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097514|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
2097515|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2097516|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
2097517|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097518|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
816641|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816735|NCT02511340|HH-GV-678|hh-gv-678|mesh-list
816736|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
816737|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
816738|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
816764|NCT02511067|Ranibizumab|ranibizumab|mesh-list
816765|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
816766|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
816767|NCT02511067|Growth Substances|growth substances|mesh-ancestor
816768|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
816769|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
816770|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817148|NCT02509351|Misoprostol|misoprostol|mesh-list
817149|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
817150|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
817151|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
817152|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817153|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
817154|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
817155|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
2097519|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
2097520|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2097521|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
2097522|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097523|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2097524|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
2097525|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2097526|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2097527|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097528|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
2097529|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
2097530|NCT02326805|Metronidazole|metronidazole|mesh-list
2097531|NCT02326805|Vaccines|vaccines|mesh-list
2097532|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
2097533|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097534|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097535|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2097536|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2097537|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2097538|NCT02326844|Talazoparib|talazoparib|mesh-list
2097539|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2097540|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097541|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097542|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097543|NCT02326974|Pertuzumab|pertuzumab|mesh-list
2097544|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2097545|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097546|NCT02327013|Vortioxetine|vortioxetine|mesh-list
2097547|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
2097548|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2097549|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2097550|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2097551|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2097552|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097553|NCT02327013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2097554|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2097555|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2097556|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097557|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097558|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
2097559|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2097560|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2097561|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2097562|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2097563|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
2097564|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2097565|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2097566|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097567|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
2097568|NCT02327117|Coagulants|coagulants|mesh-ancestor
2097569|NCT02327169|Paclitaxel|paclitaxel|mesh-list
2097570|NCT02327169|Irinotecan|irinotecan|mesh-list
2097571|NCT02327169|Cetuximab|cetuximab|mesh-list
2097572|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2097573|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817012|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
817013|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
817014|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
817015|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
817016|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817017|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817228|NCT02509559|Propranolol|propranolol|mesh-list
817229|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
817230|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
817231|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
817232|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817233|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817234|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817235|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
817236|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
817237|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
2097574|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
2097575|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
2097576|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
2097577|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097578|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2097579|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2097580|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097581|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2097582|NCT02327741|Clopidogrel|clopidogrel|mesh-list
2097583|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2097584|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2097585|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2097586|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2097587|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
2097588|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097589|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097590|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097593|NCT02328040|Insulin|insulin|mesh-list
2097594|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2097595|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2097596|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
2097597|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2097598|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097599|NCT02328040|Incretins|incretins|mesh-ancestor
2097600|NCT02328040|Hormones|hormones|mesh-ancestor
2097601|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2097602|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2097603|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
2097604|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097605|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097606|NCT02328105|Paclitaxel|paclitaxel|mesh-list
2097607|NCT02328105|Carboplatin|carboplatin|mesh-list
2097608|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2097609|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2097610|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097611|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
2097612|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
2097613|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
2097614|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097615|NCT02328404|Vitamin D|vitamin d|mesh-list
2097616|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
2097617|NCT02328404|Vitamins|vitamins|mesh-ancestor
2097618|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
2097619|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097620|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2097621|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2097622|NCT02328755|Methotrexate|methotrexate|mesh-list
2097623|NCT02328755|Tacrolimus|tacrolimus|mesh-list
2097624|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2097625|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
2097626|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2097627|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097628|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2097629|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
2097630|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817027|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817028|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
817029|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817030|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817105|NCT02509468|Sirolimus|sirolimus|mesh-list
817106|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
817107|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
817108|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
817109|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817110|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
817111|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
817112|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
817113|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097631|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097632|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
2097633|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097634|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2097635|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2097636|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
2097637|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2097638|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2097639|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2097640|NCT02329223|Omalizumab|omalizumab|mesh-list
2097641|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2097642|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2097643|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
2097644|NCT02329600|Triamcinolone|triamcinolone|mesh-list
2097645|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2097646|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2097647|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2097648|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2097649|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
2097650|NCT02329600|Hormones|hormones|mesh-ancestor
2097651|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2097652|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097653|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2097654|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
2097655|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097656|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097657|NCT02329964|Neostigmine|neostigmine|mesh-list
2097658|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2097659|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2097660|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097661|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097662|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
2097663|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097664|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097665|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2097666|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
2097667|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097668|NCT02330094|Gabapentin|gabapentin|mesh-list
2097669|NCT02330094|Analgesics|analgesics|mesh-ancestor
2097670|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
2097671|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097672|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097673|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
2097674|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2097675|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2097676|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2097677|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2097678|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2097679|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2097680|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097681|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097682|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
2097683|NCT02330172|Neostigmine|neostigmine|mesh-list
2097684|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2097685|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097686|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097687|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
2097688|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097689|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097690|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2097691|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
817128|NCT02509234|Trabectedin|trabectedin|mesh-list
817129|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
817130|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
817131|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817132|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817133|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817134|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
817135|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
2097692|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097693|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
2097694|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2097695|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097696|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2097697|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2097698|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
2097699|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097700|NCT02331095|Warfarin|warfarin|mesh-list
2097701|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
2097702|NCT02331095|Atorvastatin|atorvastatin|mesh-list
2097703|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2097704|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2097705|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
2097706|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097707|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2097708|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2097709|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097710|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
2097711|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2097712|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
2097713|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2097714|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
2097715|NCT02331108|Anesthetics|anesthetics|mesh-list
2097716|NCT02331108|Propofol|propofol|mesh-list
2097717|NCT02331108|Sevoflurane|sevoflurane|mesh-list
2097718|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2097719|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097720|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2097721|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2097722|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
2097723|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2097724|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2097725|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
2097726|NCT02331368|Lenalidomide|lenalidomide|mesh-list
2097727|NCT02331368|Melphalan|melphalan|mesh-list
2097728|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2097729|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097730|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
2097731|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097732|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2097733|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2097734|NCT02331368|Growth Substances|growth substances|mesh-ancestor
2097735|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
2097736|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2097737|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
2097738|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097739|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2097740|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2097741|NCT02331680|Tolvaptan|tolvaptan|mesh-list
2097742|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2097743|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097744|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
2097745|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097746|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
2097747|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2097748|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
2097749|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097750|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097751|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2097752|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
2097753|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
2097754|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2097755|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
2097756|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097757|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097758|NCT02332291|Citalopram|citalopram|mesh-list
817138|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
817139|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817140|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817141|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
817142|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
817143|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
817144|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
817145|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
817146|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817147|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097759|NCT02332291|Bupropion|bupropion|mesh-list
2097760|NCT02332291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2097761|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2097762|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2097763|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097764|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097765|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
2097766|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097767|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2097768|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
2097769|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2097770|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2097771|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
2097772|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2097773|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2097774|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097778|NCT02332707|Ribavirin|ribavirin|mesh-list
2097779|NCT02332707|Grazoprevir|grazoprevir|mesh-list
2097780|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
2097781|NCT02332707|Ruzasvir|ruzasvir|mesh-list
2097782|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
2097783|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097784|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
2097785|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097786|NCT02332720|Ribavirin|ribavirin|mesh-list
2097787|NCT02332720|Grazoprevir|grazoprevir|mesh-list
2097788|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
2097789|NCT02332720|Ruzasvir|ruzasvir|mesh-list
2097790|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
2097791|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097792|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
2097793|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097794|NCT02332824|Candesartan|candesartan|mesh-list
2097795|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
2097796|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
2097797|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2097798|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2097799|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2097800|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097801|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097802|NCT02332889|Decitabine|decitabine|mesh-list
2097803|NCT02332889|Poly ICLC|poly iclc|mesh-list
2097804|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2097805|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
2097806|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097807|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097808|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097809|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
2097810|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
2097811|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097812|NCT02332902|Everolimus|everolimus|mesh-list
2097813|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097814|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2097815|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
2097816|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097817|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2097818|NCT02333045|Maraviroc|maraviroc|mesh-list
2097819|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2097820|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2097821|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097822|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817169|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
817170|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
817171|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
817172|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
817173|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817174|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097823|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
2097824|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097825|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2097826|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2097827|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2097828|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2097829|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2097830|NCT02333383|Adalimumab|adalimumab|mesh-list
2097831|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2097832|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2097833|NCT02334059|Ketamine|ketamine|mesh-list
2097834|NCT02334059|Analgesics|analgesics|mesh-ancestor
2097835|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
2097836|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097837|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097838|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2097839|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2097840|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
2097841|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
2097842|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2097843|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2097844|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2097845|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097846|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097847|NCT02334215|Methadone|methadone|mesh-list
2097848|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2097849|NCT02334215|Narcotics|narcotics|mesh-ancestor
2097850|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2097851|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097852|NCT02334215|Analgesics|analgesics|mesh-ancestor
2097853|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
2097854|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097855|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
2097856|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
2097857|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
2097858|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2097859|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
2097860|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2097861|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2097862|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2097863|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2097864|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097865|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
2097866|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097867|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097868|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2097869|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097870|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
2097871|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2097872|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2097873|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2097874|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2097875|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097876|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
2097877|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097878|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097879|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2097880|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097881|NCT02334527|Palbociclib|palbociclib|mesh-list
2097882|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097883|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2097884|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097885|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097886|NCT02334800|Palbociclib|palbociclib|mesh-list
2097887|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097888|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2097889|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097890|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817182|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817183|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
817184|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
817185|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
817186|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
817187|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
817188|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2097891|NCT02334813|Dexamethasone|dexamethasone|mesh-list
2097892|NCT02334813|Prednisone|prednisone|mesh-list
2097893|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2097894|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
2097895|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
2097896|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097897|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097898|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2097899|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
2097900|NCT02334813|Hormones|hormones|mesh-ancestor
2097901|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2097902|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2097903|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097904|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
2097905|NCT02335294|Morphine|morphine|mesh-list
2097906|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2097907|NCT02335294|Narcotics|narcotics|mesh-ancestor
2097908|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2097909|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097910|NCT02335294|Analgesics|analgesics|mesh-ancestor
2097911|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
2097912|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097913|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2097914|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2097915|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2097916|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2097917|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097918|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2097919|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097920|NCT02335346|Analgesics|analgesics|mesh-ancestor
2097921|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
2097922|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097923|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
2097924|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2097925|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
2097929|NCT02335905|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2097930|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2097931|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097932|NCT02335983|Dexamethasone|dexamethasone|mesh-list
2097933|NCT02335983|Lenalidomide|lenalidomide|mesh-list
2097934|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2097935|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
2097936|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
2097937|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2097938|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097939|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2097940|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
2097941|NCT02335983|Hormones|hormones|mesh-ancestor
2097942|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2097943|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2097944|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097945|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
2097946|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2097947|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2097948|NCT02335983|Growth Substances|growth substances|mesh-ancestor
2097949|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
2097950|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
2097951|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2097952|NCT02336074|Vorinostat|vorinostat|mesh-list
2097953|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097954|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2097955|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097956|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097957|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2097958|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
817192|NCT02509286|Carboplatin|carboplatin|mesh-list
817193|NCT02509286|Fluorouracil|fluorouracil|mesh-list
817194|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
817195|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
817196|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817197|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
817198|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
817199|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
817200|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817201|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
817202|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
817203|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
817204|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
817205|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817206|NCT02509286|Antidotes|antidotes|mesh-ancestor
817207|NCT02509286|Protective Agents|protective agents|mesh-ancestor
817208|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
817209|NCT02509286|Vitamins|vitamins|mesh-ancestor
817210|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
2097959|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2097960|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2097961|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2097962|NCT02336165|Bevacizumab|bevacizumab|mesh-list
2097963|NCT02336165|Durvalumab|durvalumab|mesh-list
2097964|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2097965|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097966|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2097967|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2097968|NCT02336165|Growth Substances|growth substances|mesh-ancestor
2097969|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097970|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
2097971|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
2097972|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097973|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
2097974|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097975|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097976|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2097977|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2097978|NCT02336438|Cathartics|cathartics|mesh-ancestor
2097979|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2097980|NCT02336451|Ceritinib|ceritinib|mesh-list
2097981|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2097982|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2097983|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2097984|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097985|NCT02336594|Verinurad|verinurad|mesh-list
2097986|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
2097987|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2097988|NCT02336607|Metoprolol|metoprolol|mesh-list
2097989|NCT02336607|Felodipine|felodipine|mesh-list
2097990|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2097991|NCT02336607|Lisinopril|lisinopril|mesh-list
2097992|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2097993|NCT02336607|Diuretics|diuretics|mesh-ancestor
2097994|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
2097995|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2097996|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2097997|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2097998|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2097999|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2098000|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
2098001|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
2098002|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098003|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2098004|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2098005|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2098006|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
2098007|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098008|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2098009|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
2098010|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098011|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2098012|NCT02336607|Protective Agents|protective agents|mesh-ancestor
2098013|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2098014|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2098015|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
2250193|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250194|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
2250195|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2250196|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2098016|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2098017|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2098018|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098019|NCT02336815|Dexamethasone|dexamethasone|mesh-list
2098020|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2098021|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
2098022|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
2098023|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098024|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098025|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2098026|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
2098027|NCT02336815|Hormones|hormones|mesh-ancestor
2098028|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2098029|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2098030|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098031|NCT02336958|Ropivacaine|ropivacaine|mesh-list
2098032|NCT02336958|Prilocaine|prilocaine|mesh-list
2098033|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
2098034|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
2098035|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2098036|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098037|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
2098038|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098039|NCT02337478|Vincristine|vincristine|mesh-list
2098040|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2098041|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098042|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
2098043|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
2098044|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
2098045|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098046|NCT02337491|Bevacizumab|bevacizumab|mesh-list
2098047|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
2098048|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2098049|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098050|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2098051|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2098052|NCT02337491|Growth Substances|growth substances|mesh-ancestor
2098053|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098054|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
2098055|NCT02337530|Carboplatin|carboplatin|mesh-list
2098056|NCT02337530|Pemetrexed|pemetrexed|mesh-list
2098057|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098058|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098059|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098060|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2098061|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2098064|NCT02337907|Donepezil|donepezil|mesh-list
2098065|NCT02337907|BI 409306|bi 409306|mesh-list
2098066|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2098067|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098068|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098069|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
2098070|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098071|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098072|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
2098073|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2098074|NCT02337933|Ursolic acid|ursolic acid|mesh-list
2098075|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098076|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098077|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2098078|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098079|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2098080|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098081|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2098082|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2098083|NCT02337933|Analgesics|analgesics|mesh-ancestor
817276|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
817277|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
817278|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817279|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
817280|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2098084|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
2098085|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098086|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098087|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2098088|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2098089|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
2098090|NCT02337946|Leucovorin|leucovorin|mesh-list
2098091|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
2098092|NCT02337946|Fluorouracil|fluorouracil|mesh-list
2098093|NCT02337946|Panitumumab|panitumumab|mesh-list
2098094|NCT02337946|Calcium|calcium|mesh-list
2098095|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
2098096|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2098097|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098098|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2098099|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098100|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
2098101|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098102|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2098103|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2098104|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
2098105|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2098106|NCT02337946|Antidotes|antidotes|mesh-ancestor
2098107|NCT02337946|Protective Agents|protective agents|mesh-ancestor
2098108|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
2098109|NCT02337946|Vitamins|vitamins|mesh-ancestor
2098110|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
2098111|NCT02338076|Petrolatum|petrolatum|mesh-list
2098112|NCT02338076|Emollients|emollients|mesh-ancestor
2098113|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
2098114|NCT02338193|Metformin|metformin|mesh-list
2098115|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
2098116|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2098117|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098118|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2098119|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098120|NCT02338362|Fluticasone|fluticasone|mesh-list
2098121|NCT02338362|Xhance|xhance|mesh-list
2098122|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2098123|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2098124|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
2098125|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098126|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098127|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2098128|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
2098129|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
2098130|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2098131|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
2098132|NCT02338713|Antacids|antacids|mesh-ancestor
2098133|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098134|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2098135|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
2098136|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2098137|NCT02338973|Interferons|interferons|mesh-list
2098138|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
2098139|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098140|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
2098141|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098142|NCT02338999|Pioglitazone|pioglitazone|mesh-list
2098143|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2098144|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098145|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
2098146|NCT02339038|Ledipasvir|ledipasvir|mesh-list
2098147|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
2098148|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098149|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
2098150|NCT02339155|Promethazine|promethazine|mesh-list
2098151|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2098152|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2098153|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2098154|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098155|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
2098156|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
817325|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
817353|NCT02508870|Azacitidine|azacitidine|mesh-list
817354|NCT02508870|Atezolizumab|atezolizumab|mesh-list
817355|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
817356|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
817357|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817358|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817359|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817360|NCT02508584|Antibodies|antibodies|mesh-list
817361|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
817362|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817363|NCT02508623|Rifaximin|rifaximin|mesh-list
817364|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
817365|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
817366|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2250197|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250198|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250199|NCT00131430|Hormones|hormones|mesh-ancestor
2250200|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2250201|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250202|NCT00131443|Topiramate|topiramate|mesh-list
2250203|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
2250204|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2250205|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250206|NCT00131482|Thrombin|thrombin|mesh-list
2250207|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
2250208|NCT00131482|Coagulants|coagulants|mesh-ancestor
2250209|NCT00131495|Testosterone|testosterone|mesh-list
2250210|NCT00131495|Androgens|androgens|mesh-ancestor
2250211|NCT00131495|Hormones|hormones|mesh-ancestor
2250212|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2250213|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250214|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
2250215|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
2250216|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250217|NCT00131521|Expectorants|expectorants|mesh-ancestor
817388|NCT02508402|Dexamethasone|dexamethasone|mesh-list
817389|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
817390|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
817391|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
817392|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817393|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817394|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
817395|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
817396|NCT02508402|Hormones|hormones|mesh-ancestor
817397|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
817398|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
817399|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250218|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
2250219|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2250220|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
2250221|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250222|NCT00131521|Protective Agents|protective agents|mesh-ancestor
2250223|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250224|NCT00131703|Chloroquine|chloroquine|mesh-list
2250225|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
2250226|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
2250227|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
817410|NCT02508311|Albuterol|albuterol|mesh-list
817411|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
817412|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
817413|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817414|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817415|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
817416|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
817417|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
817418|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
817419|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
817420|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
817421|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
817422|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
817423|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817424|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250228|NCT00131703|Amodiaquine|amodiaquine|mesh-list
2250229|NCT00131703|Amebicides|amebicides|mesh-ancestor
2250230|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2250231|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2250232|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250233|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
2250234|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
817426|NCT02508350|Daptomycin|daptomycin|mesh-list
817431|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
817432|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
817585|NCT02507440|Lidocaine|lidocaine|mesh-list
817586|NCT02507440|Propofol|propofol|mesh-list
817587|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
817588|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
817589|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
817590|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817591|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
817592|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817593|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
817594|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
817595|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
817596|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
817597|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817598|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
817599|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
817600|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
818029|NCT02505997|Midazolam|midazolam|mesh-list
818030|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
818031|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
818032|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
818033|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818034|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
818035|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
818036|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
818037|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
818038|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
818039|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
818040|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
818041|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
818042|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818043|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818085|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
818086|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
818340|NCT02504996|Acetaminophen|acetaminophen|mesh-list
818341|NCT02504996|Morphine|morphine|mesh-list
818342|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
818343|NCT02504996|Narcotics|narcotics|mesh-ancestor
818344|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
818345|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818346|NCT02504996|Analgesics|analgesics|mesh-ancestor
818347|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
818348|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818349|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
818350|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
818392|NCT02504801|Budesonide|budesonide|mesh-list
818393|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
818394|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
818395|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
818396|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818397|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818398|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
818399|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
818400|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
818401|NCT02504801|Hormones|hormones|mesh-ancestor
818402|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
818465|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
818466|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
818467|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818559|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
818560|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
818561|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
818562|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818563|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
818564|NCT02504125|Coagulants|coagulants|mesh-ancestor
2250235|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2250236|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250237|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250238|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2250239|NCT00131703|Renal Agents|renal agents|mesh-ancestor
2250240|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
818985|NCT02502253|Resveratrol|resveratrol|mesh-list
2250241|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
2250242|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2250243|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
2250244|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2250245|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2250246|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250247|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
817441|NCT02508142|Scopolamine|scopolamine|mesh-list
817442|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
817443|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
817444|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
817445|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
817446|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817447|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817448|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
817449|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
817450|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
817451|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
817452|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817453|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817454|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
817455|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
817456|NCT02508168|Metformin|metformin|mesh-list
817458|NCT02508168|Alogliptin|alogliptin|mesh-list
817459|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
817460|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817461|NCT02508168|Incretins|incretins|mesh-ancestor
817462|NCT02508168|Hormones|hormones|mesh-ancestor
817463|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
817464|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
817465|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
817466|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817467|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817457|NCT02508220|Oxytocin|oxytocin|mesh-list
817468|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
817469|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
817470|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250248|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250249|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250250|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2250251|NCT00131716|Renal Agents|renal agents|mesh-ancestor
817515|NCT02507648|Oseltamivir|oseltamivir|mesh-list
817516|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
817517|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
817518|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817519|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817523|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
817524|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817579|NCT02507609|Rocuronium|rocuronium|mesh-list
817580|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817581|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
817582|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
817583|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
817584|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250252|NCT00131742|Lamivudine|lamivudine|mesh-list
2250253|NCT00131742|Telbivudine|telbivudine|mesh-list
2250254|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2250255|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2250256|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250257|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250258|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
2250259|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250260|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2250261|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2250262|NCT00131755|Diazoxide|diazoxide|mesh-list
2250263|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
817702|NCT02507128|Liraglutide|liraglutide|mesh-list
817703|NCT02507128|Glucagon|glucagon|mesh-list
817704|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
817705|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
817706|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817707|NCT02507128|Incretins|incretins|mesh-ancestor
817708|NCT02507128|Hormones|hormones|mesh-ancestor
817709|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
817710|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2250264|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
2098157|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
2098158|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098159|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
817538|NCT02507479|Thiotepa|thiotepa|mesh-list
817539|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
817540|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
817541|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817542|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817543|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
817544|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
817545|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
817546|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817687|NCT02507167|Rifampin|rifampin|mesh-list
817688|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
817689|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
817690|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
817691|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
817692|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
817693|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
817694|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817695|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817696|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
817697|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
817698|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
817699|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
817700|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
817701|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2250265|NCT00131768|Hylan|hylan|mesh-list
2250266|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
2250267|NCT00131768|Protective Agents|protective agents|mesh-ancestor
2250268|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250269|NCT00131846|Diuretics|diuretics|mesh-list
2250270|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
2250271|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
2250272|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819089|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
819090|NCT02502708|Temozolomide|temozolomide|mesh-list
819091|NCT02502708|Etoposide|etoposide|mesh-list
819092|NCT02502708|Tryptophan|tryptophan|mesh-list
819093|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
819094|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
819095|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819096|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
819097|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
819098|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
819099|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819100|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819101|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
819102|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
819103|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
819104|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
819105|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819106|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
819107|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
819108|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
819258|NCT02501278|Cisplatin|cisplatin|mesh-list
819259|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250273|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2250274|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273748|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
2273749|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273750|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2273751|NCT00204243|Narcotics|narcotics|mesh-ancestor
2273752|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273753|NCT00204243|Analgesics|analgesics|mesh-ancestor
2273754|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
2273755|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
2273756|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2273757|NCT00204256|Hematinics|hematinics|mesh-ancestor
2273758|NCT00204269|Testosterone|testosterone|mesh-list
2273759|NCT00204269|Androgens|androgens|mesh-ancestor
2273760|NCT00204269|Hormones|hormones|mesh-ancestor
2098160|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
2098161|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2250275|NCT00131924|Estrogens|estrogens|mesh-list
2250276|NCT00131924|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
2250277|NCT00131924|Hormones|hormones|mesh-ancestor
2250278|NCT00131924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
817482|NCT02508064|Fostemsavir|fostemsavir|mesh-list
817483|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
817484|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
817485|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
817486|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
817487|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
817488|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
817489|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817490|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
817491|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
817492|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
817493|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817494|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
817495|NCT02507934|Protective Agents|protective agents|mesh-ancestor
817496|NCT02507843|Vitamin D|vitamin d|mesh-list
817497|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
817498|NCT02507843|Vitamins|vitamins|mesh-ancestor
817499|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
817500|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817501|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
817502|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
817536|NCT02507687|Bimatoprost|bimatoprost|mesh-list
817537|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
817605|NCT02507336|Thalidomide|thalidomide|mesh-list
817606|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
817607|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
817608|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817609|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
817610|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
817611|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
817612|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
817613|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
817614|NCT02507336|Growth Substances|growth substances|mesh-ancestor
817615|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
817616|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817654|NCT02507284|SRX246|srx246|mesh-list
817655|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
817656|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817657|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
817658|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817742|NCT02506933|Vaccines|vaccines|mesh-list
817743|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
817744|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817833|NCT02506829|Nicotine|nicotine|mesh-list
817834|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
817835|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
817836|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817837|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817838|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
817839|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
817840|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
817841|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817842|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817995|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
817996|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
817997|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817998|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817999|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
818000|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817503|NCT02508246|Cisplatin|cisplatin|mesh-list
817504|NCT02508246|Docetaxel|docetaxel|mesh-list
817505|NCT02508246|Adavosertib|adavosertib|mesh-list
817506|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817507|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
817508|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
817509|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
817510|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817511|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817601|NCT02507245|Hormones|hormones|mesh-list
817602|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
817603|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
817604|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817754|NCT02506803|Gemcitabine|gemcitabine|mesh-list
817755|NCT02506803|Paclitaxel|paclitaxel|mesh-list
817756|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
817757|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817758|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
817759|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
817760|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
817761|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817762|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
817763|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
817764|NCT02506803|Antiviral Agents|antiviral agents|mesh-ancestor
817765|NCT02506803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
817766|NCT02506803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817767|NCT02506803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
817768|NCT02506803|Immunologic Factors|immunologic factors|mesh-ancestor
817769|NCT02506803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818246|NCT02505581|Metronidazole|metronidazole|mesh-list
818247|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
818248|NCT02505581|Cefuroxime|cefuroxime|mesh-list
818249|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
818250|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818251|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
818252|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
818253|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
818254|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
818255|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
818256|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818257|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818258|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818259|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
818260|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2250279|NCT00131924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250280|NCT00131963|Paclitaxel|paclitaxel|mesh-list
2250281|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
2250282|NCT00131963|Doxorubicin|doxorubicin|mesh-list
2250283|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2250284|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250285|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
2250286|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
818731|NCT02504359|Cytarabine|cytarabine|mesh-list
818732|NCT02504359|Methotrexate|methotrexate|mesh-list
818733|NCT02504359|Etoposide|etoposide|mesh-list
818734|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
818735|NCT02504359|Melphalan|melphalan|mesh-list
818736|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
818737|NCT02504359|Carmustine|carmustine|mesh-list
818738|NCT02504359|Ixazomib|ixazomib|mesh-list
818739|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
818740|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
818741|NCT02504359|Tacrolimus|tacrolimus|mesh-list
818742|NCT02504359|Glycine|glycine|mesh-list
818743|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
818744|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
818745|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
818746|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818747|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
818748|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
818749|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818750|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818751|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
818752|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818753|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
818754|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
818755|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
818756|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
817512|NCT02507583|Insulin|insulin|mesh-list
817513|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
817514|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817525|NCT02507635|Levocetirizine|levocetirizine|mesh-list
817526|NCT02507635|Desloratadine|desloratadine|mesh-list
817527|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
817528|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
817529|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
817530|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
817531|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817532|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817533|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817534|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
817535|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
2250287|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
2250288|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250289|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2250290|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
2250291|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250292|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2250293|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2250294|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
2250295|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2250296|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2250297|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2250298|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2250299|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250300|NCT00131989|Sorafenib|sorafenib|mesh-list
2250301|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250302|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2250303|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250304|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250305|NCT00132054|Irinotecan|irinotecan|mesh-list
2250306|NCT00132054|Amrubicin|amrubicin|mesh-list
2250307|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2250308|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2250309|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250310|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250311|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250312|NCT00132067|Vorinostat|vorinostat|mesh-list
2250313|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250314|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2250315|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250316|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817617|NCT02507700|Bupivacaine|bupivacaine|mesh-list
817618|NCT02507700|Sevoflurane|sevoflurane|mesh-list
817619|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
817620|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
817621|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
817622|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817623|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
817624|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817625|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
817626|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
817627|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
817678|NCT02506998|Histamine|histamine|mesh-list
817679|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
817680|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
817681|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
817682|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
817683|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
817684|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817685|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817686|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817711|NCT02507076|Melphalan|melphalan|mesh-list
817712|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
817713|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
817714|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817715|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817716|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
817717|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
817718|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
817719|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817782|NCT02506647|Insulin|insulin|mesh-list
817628|NCT02507323|Ticagrelor|ticagrelor|mesh-list
817629|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
817630|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
817631|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
817632|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
817633|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
817634|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
817635|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817636|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817637|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817638|NCT02507362|Riboflavin|riboflavin|mesh-list
817639|NCT02507362|Dextrans|dextrans|mesh-list
817640|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
817641|NCT02507362|Vitamins|vitamins|mesh-ancestor
817642|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
817643|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817644|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
817645|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
817646|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
817647|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
817648|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
817649|NCT02507232|Temozolomide|temozolomide|mesh-list
817650|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
817651|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
817652|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817653|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250317|NCT00132093|Eplerenone|eplerenone|mesh-list
2250318|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2250319|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
2250320|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2250321|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250322|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2250323|NCT00132093|Diuretics|diuretics|mesh-ancestor
817720|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
817721|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
817722|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
817723|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817724|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817725|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250324|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
2250325|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2250326|NCT00132106|Phentolamine|phentolamine|mesh-list
2250327|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2250328|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2250329|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
2250330|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250331|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250332|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098162|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2098163|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
2098164|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
2098165|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098166|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098167|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2098168|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
2098169|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
2098170|NCT02339246|Tacrolimus|tacrolimus|mesh-list
2098171|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2098172|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
2098173|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098174|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2098175|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098176|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098177|NCT02339415|Edoxaban|edoxaban|mesh-list
2098178|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2098179|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
2098180|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2098181|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
2250333|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2250334|NCT00132119|Nalmefene|nalmefene|mesh-list
2250335|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2250336|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250337|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
817969|NCT02506192|Prednisone|prednisone|mesh-list
817970|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2250338|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250339|NCT00132158|Irinotecan|irinotecan|mesh-list
2250340|NCT00132158|Gefitinib|gefitinib|mesh-list
2250341|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2250342|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2250343|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250344|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250345|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250346|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2250347|NCT00132184|Vitamin D|vitamin d|mesh-list
2250348|NCT00132184|Vitamins|vitamins|mesh-ancestor
2250349|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
2250350|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250351|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
817770|NCT02507154|Cetuximab|cetuximab|mesh-list
817771|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
817772|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818229|NCT02505295|Selenium|selenium|mesh-list
818230|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
818231|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818232|NCT02505295|Protective Agents|protective agents|mesh-ancestor
818233|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818234|NCT02505295|Trace Elements|trace elements|mesh-ancestor
818235|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
2250352|NCT00132210|Interferons|interferons|mesh-list
2250353|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250354|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
2250355|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250356|NCT00132236|Nicotine|nicotine|mesh-list
2250357|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2250358|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
2250359|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250360|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250361|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2250362|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2250363|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
2250364|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250365|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250366|NCT00132275|Amoxicillin|amoxicillin|mesh-list
2250367|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
818433|NCT02504398|Methamphetamine|methamphetamine|mesh-list
818434|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
818435|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818436|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
818437|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
818438|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818439|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
818440|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818441|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818442|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
818443|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
818444|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
818445|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
818446|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
818507|NCT02504164|Midazolam|midazolam|mesh-list
818508|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
818509|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
818510|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
818511|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818512|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
818513|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
818514|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
818515|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
818516|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
818517|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
818518|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
818519|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
818520|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818521|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818694|NCT02503943|Metformin|metformin|mesh-list
818695|NCT02503943|Liraglutide|liraglutide|mesh-list
818696|NCT02503943|Mitiglinide|mitiglinide|mesh-list
818697|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
818698|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250368|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
2250369|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2250370|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250371|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2250372|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250373|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250374|NCT00132379|Docetaxel|docetaxel|mesh-list
817778|NCT02506699|Analgesics|analgesics|mesh-list
817779|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
817780|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817781|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817977|NCT02506231|Leucovorin|leucovorin|mesh-list
817978|NCT02506231|Folic Acid|folic acid|mesh-list
817979|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
817980|NCT02506231|Antidotes|antidotes|mesh-ancestor
817981|NCT02506231|Protective Agents|protective agents|mesh-ancestor
817982|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817983|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
817984|NCT02506231|Vitamins|vitamins|mesh-ancestor
817985|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
817986|NCT02506231|Hematinics|hematinics|mesh-ancestor
818165|NCT02505451|Dobutamine|dobutamine|mesh-list
818166|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
818167|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
818168|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
818169|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818170|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818171|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
818172|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
818173|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
818174|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
818175|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818176|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818177|NCT02505451|Protective Agents|protective agents|mesh-ancestor
818447|NCT02504489|Docetaxel|docetaxel|mesh-list
818448|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818449|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
818450|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
818451|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
818452|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818655|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
818656|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
818657|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818812|NCT02503358|Paclitaxel|paclitaxel|mesh-list
818813|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
818814|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
818815|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818816|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
818817|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
818818|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
818819|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818854|NCT02502968|Cytarabine|cytarabine|mesh-list
818855|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
818856|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
818857|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818858|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818859|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
818860|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818861|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
818862|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
818863|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818919|NCT02502669|Finasteride|finasteride|mesh-list
818920|NCT02502669|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
818921|NCT02502669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
818922|NCT02502669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817783|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
817784|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
817785|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
817786|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818197|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
818198|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
818199|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
818200|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818201|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
818202|NCT02505360|Protective Agents|protective agents|mesh-ancestor
818488|NCT02504307|Sirolimus|sirolimus|mesh-list
818489|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
818490|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818491|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
818492|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818493|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
818494|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
818495|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
818496|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818726|NCT02503722|Osimertinib|osimertinib|mesh-list
818727|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818728|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
818729|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818730|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250375|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250376|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
2250377|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
2250378|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
2250379|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250380|NCT00132418|Etanercept|etanercept|mesh-list
2250381|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2250382|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2250383|NCT00132418|Analgesics|analgesics|mesh-ancestor
2250384|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
2250385|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250386|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250387|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2250388|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2250389|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2250390|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2098182|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098183|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098184|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
2098185|NCT02339506|Cosyntropin|cosyntropin|mesh-list
2098186|NCT02339506|Hormones|hormones|mesh-ancestor
2098187|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2098188|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098189|NCT02339558|Nivolumab|nivolumab|mesh-list
2098190|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2098191|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098192|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
820296|NCT02497157|Leucovorin|leucovorin|mesh-list
820297|NCT02497157|Bevacizumab|bevacizumab|mesh-list
820298|NCT02497157|Fluorouracil|fluorouracil|mesh-list
820299|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
820300|NCT02497157|Irinotecan|irinotecan|mesh-list
820301|NCT02497157|Calcium|calcium|mesh-list
820302|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
820303|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
820304|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820305|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
820306|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
820307|NCT02497157|Growth Substances|growth substances|mesh-ancestor
820308|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820309|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
820310|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
820311|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
820312|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820313|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
820314|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
820315|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
820316|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
820317|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
820318|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820319|NCT02497157|Antidotes|antidotes|mesh-ancestor
820320|NCT02497157|Protective Agents|protective agents|mesh-ancestor
817787|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
817788|NCT02506894|Analgesics|analgesics|mesh-ancestor
817789|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
817790|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817791|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817792|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
817793|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
817794|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
817795|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
817796|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
817797|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
817798|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817799|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
817800|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
817801|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
818044|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
818045|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
818046|NCT02506023|Coagulants|coagulants|mesh-ancestor
818047|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
818048|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
818049|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818185|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
818186|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
818187|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
818188|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818189|NCT02505477|Expectorants|expectorants|mesh-ancestor
818190|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
818191|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
818192|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
818193|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818194|NCT02505477|Protective Agents|protective agents|mesh-ancestor
818195|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818196|NCT02505477|Antidotes|antidotes|mesh-ancestor
818351|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
818352|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
818353|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
818354|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818355|NCT02505087|Expectorants|expectorants|mesh-ancestor
818356|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
818357|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
818358|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
818359|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818360|NCT02505087|Protective Agents|protective agents|mesh-ancestor
818361|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818362|NCT02505087|Antidotes|antidotes|mesh-ancestor
818468|NCT02504476|Midazolam|midazolam|mesh-list
818469|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
818470|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
818471|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
818472|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818473|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
818474|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
818475|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
818476|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
818477|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
818478|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
818479|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
818480|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
818481|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818482|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818941|NCT02502877|Midazolam|midazolam|mesh-list
818942|NCT02502877|Propofol|propofol|mesh-list
818943|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
818944|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
818945|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818946|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
818947|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
818948|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
818949|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
818950|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
818951|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
818952|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
818953|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
818954|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
818955|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
817802|NCT02506686|Meropenem|meropenem|mesh-list
817803|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
817804|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818107|NCT02505971|Propranolol|propranolol|mesh-list
818108|NCT02505971|Nadolol|nadolol|mesh-list
818109|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
818110|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
818111|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
818112|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818113|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818114|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818115|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
818116|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
818117|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
818118|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
818119|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
818120|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818533|NCT02504333|Gemcitabine|gemcitabine|mesh-list
818534|NCT02504333|Paclitaxel|paclitaxel|mesh-list
818535|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
818536|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
818537|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818538|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
818539|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
818540|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
818541|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818542|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
818543|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
818544|NCT02504333|Antiviral Agents|antiviral agents|mesh-ancestor
818545|NCT02504333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818546|NCT02504333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818547|NCT02504333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
818548|NCT02504333|Immunologic Factors|immunologic factors|mesh-ancestor
818549|NCT02504333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250391|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
2250392|NCT00132431|Cinacalcet|cinacalcet|mesh-list
2250393|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2250394|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250395|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2250396|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
2250397|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2250398|NCT00132444|UC-781|uc-781|mesh-list
2250399|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2250400|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
2250401|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250402|NCT00132535|Chloroquine|chloroquine|mesh-list
2250403|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
2250404|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
2250405|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2250406|NCT00132535|Amebicides|amebicides|mesh-ancestor
2250407|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
818839|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
818840|NCT02502981|Spironolactone|spironolactone|mesh-list
818841|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
818842|NCT02502981|Diuretics|diuretics|mesh-list
818843|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
818844|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
818845|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
818846|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
818847|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818848|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
818849|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
818850|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
818851|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
818852|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818853|NCT02502981|Hormones|hormones|mesh-ancestor
819336|NCT02500940|Leucovorin|leucovorin|mesh-list
819337|NCT02500940|Fluorouracil|fluorouracil|mesh-list
819338|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819339|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819340|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
819341|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819342|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
819343|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
819344|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
2250408|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
817805|NCT02506517|Afatinib|afatinib|mesh-list
817806|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817807|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
817808|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817809|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818098|NCT02505893|Sirolimus|sirolimus|mesh-list
818099|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
818100|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818101|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
818102|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818103|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
818104|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
818105|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
818106|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250409|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250410|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
2250411|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2250412|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2250413|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250414|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818616|NCT02503826|Midazolam|midazolam|mesh-list
818617|NCT02503826|Sufentanil|sufentanil|mesh-list
818618|NCT02503826|Dsuvia|dsuvia|mesh-list
818619|NCT02503826|Propofol|propofol|mesh-list
818620|NCT02503826|Cisatracurium|cisatracurium|mesh-list
818621|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
818622|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
818623|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818624|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
818625|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
818626|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
818627|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
818628|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
818629|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
818630|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
818631|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
818632|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
818633|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818634|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818635|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
818636|NCT02503826|Narcotics|narcotics|mesh-ancestor
818637|NCT02503826|Analgesics|analgesics|mesh-ancestor
818638|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
818639|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818640|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
818641|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
818820|NCT02503137|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2098193|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098194|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2098195|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2250415|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2250416|NCT00132535|Renal Agents|renal agents|mesh-ancestor
2250417|NCT00132548|Artesunate|artesunate|mesh-list
2250418|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
2250419|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
2250420|NCT00132548|Amodiaquine|amodiaquine|mesh-list
2250421|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2250422|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
2250423|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
819504|NCT02500225|Sevoflurane|sevoflurane|mesh-list
819505|NCT02500225|Etomidate|etomidate|mesh-list
819506|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
819507|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
819508|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
819509|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
819510|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
819511|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819512|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
819513|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
820026|NCT02498392|JNJ-42165279|jnj-42165279|mesh-list
820027|NCT02498392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820028|NCT02498392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820257|NCT02497222|RNS60|rns60|mesh-list
820258|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
820259|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
820260|NCT02497222|Analgesics|analgesics|mesh-ancestor
820261|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
2250424|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
817811|NCT02506842|Leucovorin|leucovorin|mesh-list
817812|NCT02506842|Folic Acid|folic acid|mesh-list
817813|NCT02506842|Gemcitabine|gemcitabine|mesh-list
817814|NCT02506842|Fluorouracil|fluorouracil|mesh-list
817815|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
817816|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
817817|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817818|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817819|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
817820|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
817821|NCT02506842|Antiviral Agents|antiviral agents|mesh-ancestor
817822|NCT02506842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
817823|NCT02506842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817824|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
817825|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
817826|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817827|NCT02506842|Antidotes|antidotes|mesh-ancestor
817828|NCT02506842|Protective Agents|protective agents|mesh-ancestor
817829|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
817830|NCT02506842|Vitamins|vitamins|mesh-ancestor
817831|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
817832|NCT02506842|Hematinics|hematinics|mesh-ancestor
817810|NCT02506790|Toremifene|toremifene|mesh-list
817843|NCT02506790|Metformin|metformin|mesh-list
817844|NCT02506790|Melatonin|melatonin|mesh-list
817845|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
817846|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817847|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
817848|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817849|NCT02506790|Protective Agents|protective agents|mesh-ancestor
817850|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
817851|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
817852|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817853|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
817855|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
817856|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
817857|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
817858|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
817854|NCT02506855|Ropivacaine|ropivacaine|mesh-list
817859|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
817860|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
817861|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
817862|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817863|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
817864|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818063|NCT02505984|Oxytocin|oxytocin|mesh-list
818064|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
818065|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
818066|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250425|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250426|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250427|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
2250428|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
2250429|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
818132|NCT02505633|Lidocaine|lidocaine|mesh-list
818133|NCT02505633|Epinephrine|epinephrine|mesh-list
818134|NCT02505633|Racepinephrine|racepinephrine|mesh-list
818135|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
818136|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
818137|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
818138|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
818139|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818140|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
818141|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818142|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
818143|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
818144|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
818145|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
818146|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818147|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
818148|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
818149|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
818150|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818151|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
818152|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
818153|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
818154|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2250430|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
2250431|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2250432|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250433|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250434|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2250435|NCT00132548|Renal Agents|renal agents|mesh-ancestor
2250436|NCT00132561|Artesunate|artesunate|mesh-list
2250437|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
2250438|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
2250439|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
2250440|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2250441|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2250442|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250443|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250444|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
2098196|NCT02339584|Brinzolamide|brinzolamide|mesh-list
2098197|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2098198|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2098199|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2098200|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
818083|NCT02505776|Bimatoprost|bimatoprost|mesh-list
818084|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
818178|NCT02505516|Metformin|metformin|mesh-list
818179|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
818180|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098201|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2098202|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
2098203|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098204|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098205|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098206|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2098207|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098208|NCT02340000|Amoxicillin|amoxicillin|mesh-list
2098209|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
2098210|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
2098211|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2098212|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2098213|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098214|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2098215|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819392|NCT02500667|Rifampin|rifampin|mesh-list
819393|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
819394|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
819395|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
819396|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
819397|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
819398|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
819399|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819400|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819401|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
819402|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
819403|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
819404|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
819405|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
819406|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
819457|NCT02500446|Dolutegravir|dolutegravir|mesh-list
819458|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
819459|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
819460|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819461|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819462|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
819463|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
819464|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
819465|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250445|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
2250446|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2250447|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
2250448|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2250449|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250450|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250451|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2250452|NCT00132561|Renal Agents|renal agents|mesh-ancestor
2250453|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2250454|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
2250455|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2250456|NCT00132587|Protective Agents|protective agents|mesh-ancestor
2250457|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250458|NCT00132600|Bacitracin|bacitracin|mesh-list
2250459|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2250460|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250461|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2250462|NCT00132613|Bleomycin|bleomycin|mesh-list
2250463|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2250464|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250465|NCT00132639|Docetaxel|docetaxel|mesh-list
2250466|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250467|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
2250468|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
2250469|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
2250470|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250471|NCT00132652|Lamivudine|lamivudine|mesh-list
2250472|NCT00132652|Telbivudine|telbivudine|mesh-list
2250473|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2250474|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2250475|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250476|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250477|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
817900|NCT02506777|Metformin|metformin|mesh-list
817923|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
817924|NCT02506777|Doxorubicin|doxorubicin|mesh-list
817925|NCT02506777|Fluorouracil|fluorouracil|mesh-list
817926|NCT02506777|Melatonin|melatonin|mesh-list
817927|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
817928|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
817929|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817930|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
817931|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
817932|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
817933|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
817934|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
817935|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
817936|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
817937|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
817938|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
817939|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
817940|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817941|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
817942|NCT02506777|Protective Agents|protective agents|mesh-ancestor
817943|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
817944|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
817945|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
818073|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
818074|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
818075|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
818076|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
818077|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818078|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
818079|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818080|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818081|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
818082|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250478|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250479|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2250480|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2250481|NCT00132717|Atorvastatin|atorvastatin|mesh-list
2250482|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2250483|NCT00132717|Simvastatin|simvastatin|mesh-list
2250484|NCT00132717|Ezetimibe|ezetimibe|mesh-list
2250485|NCT00132717|Pravastatin|pravastatin|mesh-list
2250486|NCT00132717|Lovastatin|lovastatin|mesh-list
2250487|NCT00132717|L 647318|l 647318|mesh-list
818522|NCT02504580|Bupivacaine|bupivacaine|mesh-list
818523|NCT02504580|Anesthetics, Local|anesthetics, local|mesh-ancestor
818524|NCT02504580|Anesthetics|anesthetics|mesh-ancestor
818525|NCT02504580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
818526|NCT02504580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818527|NCT02504580|Sensory System Agents|sensory system agents|mesh-ancestor
818528|NCT02504580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250488|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
2250489|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2250490|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2250491|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
2250492|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250493|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2098216|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098217|NCT02340156|Temozolomide|temozolomide|mesh-list
2098218|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2098219|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
2098220|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818217|NCT02505282|Vitamin K|vitamin k|mesh-list
818218|NCT02505282|Vitamins|vitamins|mesh-ancestor
818219|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
818220|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818221|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
818222|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
818223|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818224|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
818225|NCT02505282|Coagulants|coagulants|mesh-ancestor
2250494|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2250495|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818891|NCT02502747|Sargramostim|sargramostim|mesh-list
818892|NCT02502747|Immunologic Factors|immunologic factors|mesh-ancestor
818893|NCT02502747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250496|NCT00132743|Cilostazol|cilostazol|mesh-list
2250497|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
819322|NCT02500849|Busulfan|busulfan|mesh-list
819323|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
819324|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819325|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
819326|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
819327|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819328|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
819329|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819330|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
819466|NCT02500524|Permethrin|permethrin|mesh-list
819467|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819468|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819579|NCT02500251|Rituximab|rituximab|mesh-list
819580|NCT02500251|Bortezomib|bortezomib|mesh-list
819581|NCT02500251|Belimumab|belimumab|mesh-list
819582|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
819583|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819584|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
819585|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819586|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
819587|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
819800|NCT02499341|Ketamine|ketamine|mesh-list
819801|NCT02499341|Tramadol|tramadol|mesh-list
819802|NCT02499341|Analgesics|analgesics|mesh-ancestor
819803|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
819804|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819805|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819806|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
819807|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
819808|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
819809|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
819810|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
819811|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
819812|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
819813|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
819814|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819815|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
819816|NCT02499341|Narcotics|narcotics|mesh-ancestor
819886|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
819887|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819888|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820071|NCT02498145|Nicotine|nicotine|mesh-list
820072|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
820073|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
820074|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820075|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820076|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
820077|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
820078|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
820079|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
820080|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250498|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
2250499|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250500|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817956|NCT02506348|Diclofenac|diclofenac|mesh-list
817957|NCT02506348|Nepafenac|nepafenac|mesh-list
817958|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
817959|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
817960|NCT02506348|Analgesics|analgesics|mesh-ancestor
817961|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
817962|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
817963|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817964|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
817965|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
817966|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
817967|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
817968|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818506|NCT02504177|Anticoagulants|anticoagulants|mesh-list
2250501|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2250502|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
2250503|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2250504|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2250505|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250506|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
818889|NCT02502643|Picibanil|picibanil|mesh-list
818890|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250507|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
2250508|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2250509|NCT00132743|Protective Agents|protective agents|mesh-ancestor
2250510|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2250511|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2250512|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250513|NCT00132756|Estramustine|estramustine|mesh-list
2250514|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
819757|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
819758|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
820041|NCT02498171|Fentanyl|fentanyl|mesh-list
820042|NCT02498171|Morphine|morphine|mesh-list
820043|NCT02498171|Bupivacaine|bupivacaine|mesh-list
820044|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
820045|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
820046|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
820047|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820048|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
820049|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820050|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
820051|NCT02498171|Narcotics|narcotics|mesh-ancestor
820052|NCT02498171|Analgesics|analgesics|mesh-ancestor
820053|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
820054|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
820055|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
2250515|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
2250516|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250517|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250518|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2250519|NCT00132821|Bupropion|bupropion|mesh-list
2250520|NCT00132821|Nicotine|nicotine|mesh-list
2250521|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2250522|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
2250523|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250524|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250525|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2250526|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2250527|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
2250528|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250529|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250530|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2250531|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
2250532|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2250533|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
817971|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
817972|NCT02506192|Hormones|hormones|mesh-ancestor
817973|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
817974|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817975|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
817976|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818121|NCT02505880|Anesthetics|anesthetics|mesh-list
818122|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
818123|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
818124|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818125|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
818126|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818226|NCT02505386|Ertapenem|ertapenem|mesh-list
818227|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
818228|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250534|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2250535|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2250536|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
2250537|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2250538|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
819003|NCT02502175|Methadone|methadone|mesh-list
819004|NCT02502175|Opium|opium|mesh-list
819005|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
819006|NCT02502175|Narcotics|narcotics|mesh-ancestor
819007|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
819008|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819009|NCT02502175|Analgesics|analgesics|mesh-ancestor
819010|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
819011|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819012|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
819013|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
819014|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
819015|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
819037|NCT02501837|Oxytocin|oxytocin|mesh-list
819038|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
819039|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
819040|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250539|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250540|NCT00132860|Azithromycin|azithromycin|mesh-list
2250541|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2250542|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250543|NCT00132886|Tolvaptan|tolvaptan|mesh-list
819498|NCT02500329|Acarbose|acarbose|mesh-list
819499|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
819500|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819501|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819502|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
819503|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250544|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2250545|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250546|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
2250547|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250548|NCT00132899|Methotrexate|methotrexate|mesh-list
2250549|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2250550|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
2250551|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2250552|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250553|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2250554|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
2250555|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250556|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250557|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
2250558|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820720|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
820721|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
820722|NCT02496052|Estradiol|estradiol|mesh-list
820723|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
820724|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
820725|NCT02496052|Estrogens|estrogens|mesh-ancestor
820726|NCT02496052|Hormones|hormones|mesh-ancestor
820727|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
820728|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820729|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
820730|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
817987|NCT02506439|Vitamin D|vitamin d|mesh-list
817988|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
817989|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
817990|NCT02506439|Vitamins|vitamins|mesh-list
817991|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
817992|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
817993|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
817994|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
818087|NCT02505841|Ropivacaine|ropivacaine|mesh-list
818088|NCT02505841|Succinylcholine|succinylcholine|mesh-list
818089|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
818090|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
818091|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
818092|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818093|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
818094|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818095|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
818096|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
818097|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
818907|NCT02502799|Methylphenidate|methylphenidate|mesh-list
818908|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
818909|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818910|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
818911|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
818912|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
818913|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818914|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
818915|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
819473|NCT02500511|Vaccines|vaccines|mesh-list
819474|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
819475|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250559|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2250560|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2250561|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
2098221|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250562|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
820136|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
820137|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
820138|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
820139|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
820140|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
820141|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820142|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820143|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
2250563|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2250564|NCT00132912|Vorapaxar|vorapaxar|mesh-list
2250565|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2250566|NCT00132925|Triamcinolone|triamcinolone|mesh-list
2250567|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2250568|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
820843|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
820844|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
820845|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820915|NCT02494687|Domperidone|domperidone|mesh-list
820916|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
820917|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
820918|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820919|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820920|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
820921|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
820922|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
820923|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
820924|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250569|NCT00132925|Hormones|hormones|mesh-ancestor
2250570|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2250571|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250572|NCT00132938|Telithromycin|telithromycin|mesh-list
2250573|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
821830|NCT02491268|Cilostazol|cilostazol|mesh-list
818006|NCT02506140|Aspirin|aspirin|mesh-list
818007|NCT02506140|Clopidogrel|clopidogrel|mesh-list
818008|NCT02506140|Ticagrelor|ticagrelor|mesh-list
818009|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
818010|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
818011|NCT02506140|Analgesics|analgesics|mesh-ancestor
818012|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
818013|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818014|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818015|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
818016|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
818017|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
818018|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
818019|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818020|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
818021|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
818022|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818023|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
818024|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
818025|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
818026|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
818027|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
818028|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818531|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
818532|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818664|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
818665|NCT02503904|Metronidazole|metronidazole|mesh-list
818666|NCT02503904|Lidocaine|lidocaine|mesh-list
818667|NCT02503904|Epinephrine|epinephrine|mesh-list
818668|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
818669|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
818670|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
818671|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818672|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
818673|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818674|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
818675|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
818676|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
818677|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
818678|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818679|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818680|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
818681|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
818682|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
818683|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818684|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
818685|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
818686|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
818687|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
818688|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
818689|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
818690|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
818691|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
818692|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
818693|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
819055|NCT02501798|Methylphenidate|methylphenidate|mesh-list
819056|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
819057|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819058|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
819059|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
819060|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
819061|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819062|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
819063|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2754408|NCT01164995|Carboplatin|carboplatin|mesh-list
2754409|NCT01164995|Adavosertib|adavosertib|mesh-list
2754410|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819563|NCT02500147|Metformin|metformin|mesh-list
819564|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
819565|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819604|NCT02499874|Tenofovir|tenofovir|mesh-list
2754411|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819041|NCT02501863|Fentanyl|fentanyl|mesh-list
819042|NCT02501863|Ropivacaine|ropivacaine|mesh-list
819043|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
819044|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
819045|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
819046|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819047|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
819048|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819049|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
819050|NCT02501863|Narcotics|narcotics|mesh-ancestor
819051|NCT02501863|Analgesics|analgesics|mesh-ancestor
819052|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
819053|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
819054|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
819211|NCT02501213|Furosemide|furosemide|mesh-list
819212|NCT02501213|Spironolactone|spironolactone|mesh-list
819213|NCT02501213|Diuretics|diuretics|mesh-ancestor
819214|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
819215|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819216|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
819217|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
819218|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819219|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
819220|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
819221|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
819222|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
819922|NCT02498860|Pemetrexed|pemetrexed|mesh-list
819923|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819924|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819925|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819926|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
819927|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
819959|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
819960|NCT02498496|Analgesics|analgesics|mesh-ancestor
819961|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
819962|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819963|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819964|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
819965|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
819966|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
819967|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
819968|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
819969|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
819970|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819971|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
819972|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
819973|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
820022|NCT02498301|Rifaximin|rifaximin|mesh-list
820023|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
820024|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
820025|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
820227|NCT02497326|Heparin|heparin|mesh-list
820228|NCT02497326|Tramadol|tramadol|mesh-list
820229|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
820230|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
820231|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
820232|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820233|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
820234|NCT02497326|Narcotics|narcotics|mesh-ancestor
820235|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
820236|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820237|NCT02497326|Analgesics|analgesics|mesh-ancestor
820238|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
820239|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820352|NCT02496962|Atorvastatin|atorvastatin|mesh-list
820353|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
820354|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
820355|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
820356|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820357|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
820358|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
818155|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
818156|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
818157|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
818158|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
818301|NCT02505113|Montelukast|montelukast|mesh-list
818302|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
818303|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
818304|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
818305|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
818306|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
818307|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818308|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
818309|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
818310|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250574|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250575|NCT00132951|Azithromycin|azithromycin|mesh-list
2250576|NCT00132951|Telithromycin|telithromycin|mesh-list
2250577|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2250578|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250579|NCT00133003|Abciximab|abciximab|mesh-list
2250580|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
2250581|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2250582|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2250583|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250584|NCT00133042|Omalizumab|omalizumab|mesh-list
2250585|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2250586|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2250587|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
2250588|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
2250589|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
2250590|NCT00133172|Prednisone|prednisone|mesh-list
2250591|NCT00133172|Tacrolimus|tacrolimus|mesh-list
818802|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
818803|NCT02503319|Oxytocin|oxytocin|mesh-list
818804|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
818805|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
818806|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818807|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
818808|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
818809|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818810|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
818811|NCT02503319|Coagulants|coagulants|mesh-ancestor
2754412|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098230|NCT02340520|Theophylline|theophylline|mesh-list
2098231|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2098232|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
2098233|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098234|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098235|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2098236|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
2098237|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2098238|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098239|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098240|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
2098241|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2098242|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2098243|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
2098244|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098245|NCT02340676|Interleukin-2|interleukin-2|mesh-list
2098246|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250592|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2250593|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
2250594|NCT00133172|Hormones|hormones|mesh-ancestor
2250595|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2250596|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250597|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
820108|NCT02497820|Aspirin|aspirin|mesh-list
820109|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
820110|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
820111|NCT02497820|Analgesics|analgesics|mesh-ancestor
820112|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
820113|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820114|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820115|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2250598|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250599|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2250600|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
2250601|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2250602|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250603|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818291|NCT02505009|Tenofovir|tenofovir|mesh-list
818292|NCT02505009|Entecavir|entecavir|mesh-list
818293|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
818294|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818295|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
818296|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
818297|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818298|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818299|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
818300|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
818774|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
818775|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
818776|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818777|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819229|NCT02501291|Thalidomide|thalidomide|mesh-list
819230|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
819231|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
819232|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819233|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
819234|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
819235|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
819236|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
819237|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
819238|NCT02501291|Growth Substances|growth substances|mesh-ancestor
819239|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
819240|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819569|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
819570|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
819571|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819572|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
819573|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
819574|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819704|NCT02499757|Nicotine|nicotine|mesh-list
819705|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
819706|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
819707|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819708|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819709|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
819710|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
819711|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
819712|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
819713|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820006|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
820007|NCT02498509|Levocabastine|levocabastine|mesh-list
820008|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
820009|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
820010|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
820011|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
820012|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
820013|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
820014|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
820015|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
820016|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820017|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250604|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2250605|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2250606|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
2250607|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2250608|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250609|NCT00133185|Losartan|losartan|mesh-list
2250610|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2250611|NCT00133185|Telmisartan|telmisartan|mesh-list
2250612|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2250613|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2250614|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2250615|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2250616|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250617|NCT00133185|Diuretics|diuretics|mesh-ancestor
818181|NCT02505568|Infliximab|infliximab|mesh-list
818182|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
818183|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
818184|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
818363|NCT02504983|Sorafenib|sorafenib|mesh-list
818364|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818365|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
818366|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818367|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818427|NCT02504463|Naltrexone|naltrexone|mesh-list
818428|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
818429|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
818430|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818431|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
818432|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250618|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
2250619|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250620|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2250621|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2250622|NCT00133198|Pramipexole|pramipexole|mesh-list
2250623|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
2250624|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819195|NCT02501434|Heparin|heparin|mesh-list
819196|NCT02501434|Calcium heparin|calcium heparin|mesh-list
819197|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
819198|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
819199|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
819200|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819304|NCT02500927|Naquotinib|naquotinib|mesh-list
819305|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819306|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
819307|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819308|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819476|NCT02500498|Abatacept|abatacept|mesh-list
819477|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
819478|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819479|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819480|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
819481|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
819482|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819483|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2250625|NCT00133198|Protective Agents|protective agents|mesh-ancestor
2250626|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250627|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2250628|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2250629|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
820499|NCT02496299|Dexamethasone|dexamethasone|mesh-list
820500|NCT02496299|Bupivacaine|bupivacaine|mesh-list
820501|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
820502|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
820503|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
820504|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820505|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820506|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
820507|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
820508|NCT02496299|Hormones|hormones|mesh-ancestor
820509|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
820510|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
820511|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820512|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
820513|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
820514|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
820515|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
821726|NCT02491749|Anesthetics|anesthetics|mesh-list
821727|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
821728|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821910|NCT02490904|Eplerenone|eplerenone|mesh-list
821911|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
821912|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
821913|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
821914|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821915|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
821916|NCT02490904|Diuretics|diuretics|mesh-ancestor
821917|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
821918|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
818236|NCT02505399|Clopidogrel|clopidogrel|mesh-list
818237|NCT02505399|Ticagrelor|ticagrelor|mesh-list
818238|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
818239|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
818240|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
818241|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
818242|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
818243|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818244|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818245|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819079|NCT02501850|Metformin|metformin|mesh-list
819080|NCT02501850|Liraglutide|liraglutide|mesh-list
819081|NCT02501850|Exenatide|exenatide|mesh-list
819082|NCT02501850|Lixisenatide|lixisenatide|mesh-list
819083|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
819084|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819085|NCT02501850|Incretins|incretins|mesh-ancestor
819086|NCT02501850|Hormones|hormones|mesh-ancestor
819087|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
819088|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2250630|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
2250631|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250632|NCT00133224|Prednisone|prednisone|mesh-list
2250633|NCT00133224|Docetaxel|docetaxel|mesh-list
2250634|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250635|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
2250636|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
2250637|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
820695|NCT02495818|Lidocaine|lidocaine|mesh-list
820696|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
820697|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
820698|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
820699|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820700|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
820701|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820702|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
820703|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
820704|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
820705|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
820706|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820769|NCT02495285|Polygeline|polygeline|mesh-list
820770|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
820771|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
820898|NCT02494856|Naproxen|naproxen|mesh-list
820899|NCT02494856|Esomeprazole|esomeprazole|mesh-list
820900|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
820901|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
820902|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
820903|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820904|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820905|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
820906|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
820907|NCT02494856|Analgesics|analgesics|mesh-ancestor
820908|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
820909|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820910|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820911|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
820912|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
820913|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
820914|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2250638|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250639|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2250640|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
2250641|NCT00133224|Hormones|hormones|mesh-ancestor
2250642|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2250643|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250644|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2250645|NCT00133237|Sirolimus|sirolimus|mesh-list
2250646|NCT00133237|Paclitaxel|paclitaxel|mesh-list
2250647|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2250648|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250649|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
2250650|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
2250651|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
2250652|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250653|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2250654|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250655|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2250656|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
2250657|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2250658|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
2250659|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250660|NCT00133250|Heparin|heparin|mesh-list
2250661|NCT00133250|Calcium heparin|calcium heparin|mesh-list
2250662|NCT00133250|Abciximab|abciximab|mesh-list
2250663|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
2250664|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2250665|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2250666|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250667|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2250668|NCT00133276|Citalopram|citalopram|mesh-list
2250669|NCT00133276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2250670|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2250671|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2250672|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250673|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250674|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
818785|NCT02503462|Ritonavir|ritonavir|mesh-list
818786|NCT02503462|Darunavir|darunavir|mesh-list
818787|NCT02503462|Cobicistat|cobicistat|mesh-list
818788|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
818789|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
818790|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
818791|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818792|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818793|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
818794|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
818795|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
818796|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818797|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
818798|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2250675|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250676|NCT00133276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2250677|NCT00133276|Antidepressive Agents|antidepressive agents|mesh-ancestor
2250678|NCT00133276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2250679|NCT00133315|Adalimumab|adalimumab|mesh-list
2250680|NCT00133315|Etanercept|etanercept|mesh-list
2250681|NCT00133315|Infliximab|infliximab|mesh-list
2250682|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2250683|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2250684|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2250685|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
819023|NCT02501941|Ketamine|ketamine|mesh-list
819024|NCT02501941|Analgesics|analgesics|mesh-ancestor
819025|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
819026|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819027|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819028|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
819029|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
819030|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
819031|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
819032|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
819033|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
819034|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
819035|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
819036|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819189|NCT02501616|Metformin|metformin|mesh-list
819190|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
819191|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
818281|NCT02505048|Rucaparib|rucaparib|mesh-list
818282|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
818283|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818284|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818285|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818550|NCT02504138|Anesthetics|anesthetics|mesh-list
818551|NCT02504138|Propofol|propofol|mesh-list
818552|NCT02504138|Desflurane|desflurane|mesh-list
818553|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
818554|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818555|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
818556|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
818557|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
818558|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
818642|NCT02503839|Etoricoxib|etoricoxib|mesh-list
818643|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
818644|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
818645|NCT02503839|Analgesics|analgesics|mesh-ancestor
818646|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
818647|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818648|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818649|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
818650|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
818651|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
818652|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
818653|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818654|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098247|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2098248|NCT02340676|Analgesics|analgesics|mesh-ancestor
2098249|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
2098250|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098251|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098252|NCT02340819|Teduglutide|teduglutide|mesh-list
2098253|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2250686|NCT00133315|Analgesics|analgesics|mesh-ancestor
2250687|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
2250688|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250689|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250690|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2250691|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2250692|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
2250693|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
820491|NCT02496455|Tramadol|tramadol|mesh-list
820492|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
820493|NCT02496455|Narcotics|narcotics|mesh-ancestor
820494|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
820495|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820496|NCT02496455|Analgesics|analgesics|mesh-ancestor
820497|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
820498|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250694|NCT00133328|Valsartan|valsartan|mesh-list
2250695|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2250696|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2250697|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2250698|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250699|NCT00133341|Parthenolide|parthenolide|mesh-list
2250700|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2250701|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2250702|NCT00133341|Analgesics|analgesics|mesh-ancestor
2250703|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
2250704|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250705|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250706|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2250707|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2250708|NCT00133354|Anastrozole|anastrozole|mesh-list
2250709|NCT00133354|Hormones|hormones|mesh-list
2250710|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2250711|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250712|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
820955|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
820956|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
820957|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
820958|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
818328|NCT02504944|Propranolol|propranolol|mesh-list
818329|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
818330|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
818331|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
818332|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
818333|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
818334|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818335|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818336|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818337|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
818338|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
818339|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
2250713|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250714|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2250715|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2250716|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250717|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250718|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2250719|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
2250720|NCT00133367|Sirolimus|sirolimus|mesh-list
2250721|NCT00133367|Fludarabine|fludarabine|mesh-list
818928|NCT02502500|Celecoxib|celecoxib|mesh-list
818929|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
818930|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
818931|NCT02502500|Analgesics|analgesics|mesh-ancestor
818932|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
818933|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818934|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818935|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
818936|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
818937|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
818938|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
818939|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818940|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250722|NCT00133367|Melphalan|melphalan|mesh-list
2250723|NCT00133367|Tacrolimus|tacrolimus|mesh-list
2250724|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
2250725|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2250726|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250727|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250728|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2250729|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
2250730|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250731|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2250732|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250733|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2250734|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250735|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2250736|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
2250737|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2250738|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
2250739|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2250740|NCT00133380|Atorvastatin|atorvastatin|mesh-list
2250741|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2250742|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
820989|NCT02495077|Acetaminophen|acetaminophen|mesh-list
820990|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
820991|NCT02495077|Promethazine|promethazine|mesh-list
820992|NCT02495077|Loratadine|loratadine|mesh-list
820993|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
820994|NCT02495077|Prednisone|prednisone|mesh-list
820995|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
820996|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
820997|NCT02495077|Infliximab|infliximab|mesh-list
820998|NCT02495077|Tacrolimus|tacrolimus|mesh-list
818403|NCT02504450|Haloperidol|haloperidol|mesh-list
818404|NCT02504450|Ziprasidone|ziprasidone|mesh-list
818405|NCT02504450|Loxapine|loxapine|mesh-list
818406|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
818407|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
818408|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818409|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818410|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
818411|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
818412|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
818413|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
818414|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
818415|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
818416|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
818417|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818418|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818419|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
818420|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
818421|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
818483|NCT02504346|Osimertinib|osimertinib|mesh-list
818484|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818485|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
818486|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818487|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250743|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
2250744|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250745|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
818894|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
818895|NCT02502825|Miotics|miotics|mesh-ancestor
818896|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
818897|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
818898|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818899|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
818900|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
818901|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
818902|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
818903|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
818904|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
818905|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
818906|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819000|NCT02502344|Metformin|metformin|mesh-list
819001|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
819002|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250746|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2250747|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250748|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
2250749|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2250750|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250751|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250752|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2250753|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2250754|NCT00133393|Protective Agents|protective agents|mesh-ancestor
2250755|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819648|NCT02499822|Ramipril|ramipril|mesh-list
819649|NCT02499822|Nifedipine|nifedipine|mesh-list
819650|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
819651|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
819652|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819653|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819654|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
819655|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
819656|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
819657|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
819658|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819659|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
819660|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
819661|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
819928|NCT02498756|Ipilimumab|ipilimumab|mesh-list
819929|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
819930|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819931|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
819932|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250756|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
2250757|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
818702|NCT02503761|Meropenem|meropenem|mesh-list
818703|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
818704|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818823|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
818824|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
819170|NCT02501564|Naproxen|naproxen|mesh-list
819171|NCT02501564|Codeine|codeine|mesh-list
819172|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
819173|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
819174|NCT02501564|Analgesics|analgesics|mesh-ancestor
819175|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
819176|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819177|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819178|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
819179|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
819180|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
819181|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
819182|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819183|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819184|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
819185|NCT02501564|Narcotics|narcotics|mesh-ancestor
819186|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
819187|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
819188|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
819223|NCT02501200|Ezetimibe|ezetimibe|mesh-list
819224|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
819225|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
819226|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
819227|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819228|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2250758|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
2250759|NCT00133406|Vitamin A|vitamin a|mesh-list
2250760|NCT00133406|Glycine|glycine|mesh-list
2250761|NCT00133406|Vitamins|vitamins|mesh-ancestor
2250762|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
2250763|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250764|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250765|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
2250766|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250767|NCT00133419|Vitamins|vitamins|mesh-list
2250768|NCT00133419|Vitamin A|vitamin a|mesh-list
819566|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
819567|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
819568|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819717|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
819718|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
819719|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
819720|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
819721|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819722|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819723|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
819817|NCT02499354|Iron|iron|mesh-list
819818|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
819819|NCT02499354|Trace Elements|trace elements|mesh-ancestor
819820|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
819821|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819822|NCT02499354|Hematinics|hematinics|mesh-ancestor
819823|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
819824|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2250769|NCT00133419|Zinc|zinc|mesh-list
2250770|NCT00133419|Trace Elements|trace elements|mesh-list
2250771|NCT00133419|Micronutrients|micronutrients|mesh-list
2250772|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
2250773|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250774|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
2250775|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250776|NCT00133419|Protective Agents|protective agents|mesh-ancestor
2250777|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2250778|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250779|NCT00133445|Vaccines|vaccines|mesh-list
820277|NCT02497118|Vinorelbine|vinorelbine|mesh-list
820278|NCT02497118|Endostatins|endostatins|mesh-list
820279|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820280|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2250780|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
2250781|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250782|NCT00133458|Albendazole|albendazole|mesh-list
2250783|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
2250784|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
819426|NCT02500680|Vaccines|vaccines|mesh-list
819427|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
819428|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819849|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
819850|NCT02499367|Doxorubicin|doxorubicin|mesh-list
819851|NCT02499367|Nivolumab|nivolumab|mesh-list
819852|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
819853|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
819854|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819855|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
819856|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
819857|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
819858|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819859|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819860|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
819861|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
819862|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
819863|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
819864|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819865|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
819866|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
820088|NCT02498015|Ribavirin|ribavirin|mesh-list
820089|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
820090|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820091|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
820092|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250785|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250786|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
2250787|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2250788|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2250789|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
2250790|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
2250791|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
2250792|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250793|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250794|NCT00133523|Vaccines|vaccines|mesh-list
2250795|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
2250796|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250797|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2250798|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
2250799|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250800|NCT00133562|Glycine|glycine|mesh-list
820576|NCT02496208|Nivolumab|nivolumab|mesh-list
820577|NCT02496208|Ipilimumab|ipilimumab|mesh-list
820578|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
820579|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820580|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
820581|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250801|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
2250802|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250803|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250804|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250805|NCT00133627|Ketotifen|ketotifen|mesh-list
2250806|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
2250807|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
2250808|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2250809|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
2250810|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
2250811|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250812|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250813|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821400|NCT02493231|Ketamine|ketamine|mesh-list
821401|NCT02493231|Nefopam|nefopam|mesh-list
821402|NCT02493231|Analgesics|analgesics|mesh-ancestor
821403|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
821404|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821405|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821406|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
821407|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
821408|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
821409|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
821410|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
821411|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2250814|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2250815|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
2250816|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2250817|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250818|NCT00133640|Vitamins|vitamins|mesh-ancestor
2250819|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
2250820|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2250821|NCT00133692|Atenolol|atenolol|mesh-list
2250822|NCT00133692|Verapamil|verapamil|mesh-list
2250823|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2250824|NCT00133692|Trandolapril|trandolapril|mesh-list
2250825|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2250826|NCT00133692|Diuretics|diuretics|mesh-ancestor
2250827|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
2250828|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250829|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2250830|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2250831|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250832|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2250833|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
2250834|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
819781|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
819782|NCT02499393|Analgesics|analgesics|mesh-ancestor
819783|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
819784|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819785|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819786|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
819787|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
819788|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
819789|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
819790|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
819791|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
819792|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819793|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
819794|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
819795|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2098254|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2098255|NCT02340819|Protective Agents|protective agents|mesh-ancestor
2098256|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820144|NCT02498002|Lidocaine|lidocaine|mesh-list
820145|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
820146|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
820147|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
820148|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820149|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
820150|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820151|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
820152|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
820153|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
820154|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
820155|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250835|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250836|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2250837|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2250838|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2250839|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
2250840|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250841|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2250842|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2250843|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
2250844|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2250845|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
2250846|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250847|NCT00133731|Heparin|heparin|mesh-list
2250848|NCT00133731|Calcium heparin|calcium heparin|mesh-list
2250849|NCT00133731|Otamixaban|otamixaban|mesh-list
2250850|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
2250851|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2250852|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2250853|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250854|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
820641|NCT02495688|Anesthetics|anesthetics|mesh-list
820642|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2250855|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
2250856|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
818878|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
818879|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
818880|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
818881|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818882|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
818883|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
818884|NCT02502565|Uric Acid|uric acid|mesh-list
818885|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
818886|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818887|NCT02502565|Protective Agents|protective agents|mesh-ancestor
818888|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819625|NCT02499965|Anesthetics|anesthetics|mesh-list
819626|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
819627|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
819628|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819629|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
819630|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
819631|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2250857|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
2250858|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250859|NCT00133744|Folic Acid|folic acid|mesh-list
2250860|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
2250861|NCT00133744|Vitamins|vitamins|mesh-ancestor
2250862|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
2250863|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250864|NCT00133744|Hematinics|hematinics|mesh-ancestor
2250865|NCT00133757|Bupropion|bupropion|mesh-list
2250866|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2250867|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
2250868|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2250869|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2250870|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2250871|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2250872|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250873|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
2250874|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250875|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250876|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
820000|NCT02498457|Calcium|calcium|mesh-list
820001|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
820002|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820207|NCT02497378|Dexamethasone|dexamethasone|mesh-list
820208|NCT02497378|Bortezomib|bortezomib|mesh-list
820209|NCT02497378|Daratumumab|daratumumab|mesh-list
820210|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
820211|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
820212|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
820213|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820214|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820215|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
820216|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
820217|NCT02497378|Hormones|hormones|mesh-ancestor
820218|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
820219|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
820220|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820387|NCT02496741|Metformin|metformin|mesh-list
820388|NCT02496741|Chloroquine|chloroquine|mesh-list
820389|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
820390|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820391|NCT02496741|Amebicides|amebicides|mesh-ancestor
820392|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
820393|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
820394|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
820395|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
820396|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
820484|NCT02496494|Tacrolimus|tacrolimus|mesh-list
820485|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
820486|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
820487|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820488|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
820489|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820490|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820572|NCT02496078|Asunaprevir|asunaprevir|mesh-list
820573|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
820574|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820731|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
818699|NCT02503943|Incretins|incretins|mesh-ancestor
818700|NCT02503943|Hormones|hormones|mesh-ancestor
818701|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
818821|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
818822|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2250877|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2250878|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250879|NCT00133770|Pantoprazole|pantoprazole|mesh-list
2250880|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2250881|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2250882|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2250883|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250884|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250885|NCT00133796|Trastuzumab|trastuzumab|mesh-list
2250886|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2250887|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250888|NCT00133822|Risperidone|risperidone|mesh-list
2250889|NCT00133822|Sertraline|sertraline|mesh-list
2250890|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
820896|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
820897|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821439|NCT02492945|Lidocaine|lidocaine|mesh-list
821440|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
821441|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
821442|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
821443|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
821444|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821445|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
821446|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821447|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
821448|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
821449|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
821450|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
821451|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821663|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
821664|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
821665|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
821666|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821667|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
821668|NCT02492087|Coagulants|coagulants|mesh-ancestor
821773|NCT02491723|Azithromycin|azithromycin|mesh-list
821774|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
821775|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
821827|NCT02491333|Metformin|metformin|mesh-list
821828|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
821829|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822376|NCT02489019|Fentanyl|fentanyl|mesh-list
822377|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
822378|NCT02489019|Narcotics|narcotics|mesh-ancestor
822379|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822380|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822381|NCT02489019|Analgesics|analgesics|mesh-ancestor
822382|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
822383|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822384|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
822385|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
822386|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
822387|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
822688|NCT02487797|Oxytocin|oxytocin|mesh-list
822689|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
822690|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
822691|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822764|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
822765|NCT02487329|Calcium|calcium|mesh-list
822766|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
822767|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822768|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
824215|NCT02482636|Vaccines|vaccines|mesh-list
824216|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
824217|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
824218|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250891|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
2250892|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250893|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250894|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825219|NCT02478710|Vancomycin|vancomycin|mesh-list
818757|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
818758|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
818759|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
818760|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
818761|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
818762|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
818763|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
818764|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
818765|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
818766|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
818767|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
818768|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
818769|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
818770|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
818771|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
818772|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
818773|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250895|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2250896|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2250897|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2250898|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2250899|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2250900|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
2250901|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
2250902|NCT00133822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2250903|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2250904|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2250905|NCT00133848|Retapamulin|retapamulin|mesh-list
819540|NCT02500212|Tacrolimus|tacrolimus|mesh-list
819541|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
819542|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
819543|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819544|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
819545|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819546|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250906|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2250907|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250908|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
2250909|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2250910|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2250911|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250912|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
2250913|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2250914|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250915|NCT00133874|Retapamulin|retapamulin|mesh-list
2250916|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
820093|NCT02497911|Bupivacaine|bupivacaine|mesh-list
820094|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
820095|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
820096|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
820097|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820098|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
820099|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820124|NCT02497638|Metformin|metformin|mesh-list
820125|NCT02497638|Biguanides|biguanides|mesh-list
820126|NCT02497638|Atorvastatin|atorvastatin|mesh-list
820127|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
820128|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820129|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
820130|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
820131|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
820132|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820133|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
820134|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
820135|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250917|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250918|NCT00133887|Sirolimus|sirolimus|mesh-list
2250919|NCT00133887|Cyclosporine|cyclosporine|mesh-list
2250920|NCT00133887|Tacrolimus|tacrolimus|mesh-list
2250921|NCT00133887|Cyclosporins|cyclosporins|mesh-list
820347|NCT02496988|Temozolomide|temozolomide|mesh-list
820348|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
820349|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
820350|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820351|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818825|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
818826|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2250922|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2250923|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
2250924|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250925|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2250926|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250927|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250928|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2250929|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250930|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2250931|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250932|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
2250933|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
2250934|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2250935|NCT00134030|Interferons|interferons|mesh-list
2250936|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
819547|NCT02500108|Domperidone|domperidone|mesh-list
819548|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
819549|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
819550|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819551|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819552|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
819553|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
819554|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
819555|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
819556|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098257|NCT02340949|Leucovorin|leucovorin|mesh-list
2098258|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
2098259|NCT02340949|Aflibercept|aflibercept|mesh-list
2098260|NCT02340949|Fluorouracil|fluorouracil|mesh-list
2250937|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
2250938|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2250939|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2250940|NCT00134030|Cisplatin|cisplatin|mesh-list
2250941|NCT00134030|Doxorubicin|doxorubicin|mesh-list
2250942|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2250943|NCT00134030|Methotrexate|methotrexate|mesh-list
2250944|NCT00134030|Etoposide|etoposide|mesh-list
2250945|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
2250946|NCT00134030|Ifosfamide|ifosfamide|mesh-list
2250947|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
2250948|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
2250949|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250950|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2250951|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2250952|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2250953|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250954|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250955|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2250956|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
2250957|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2250958|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250959|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2250960|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
2250961|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
2250962|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2250963|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2250964|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
2250965|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
821741|NCT02491970|Fluticasone|fluticasone|mesh-list
821742|NCT02491970|Xhance|xhance|mesh-list
821743|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
821744|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
821745|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
821746|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
821747|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
821748|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
821749|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821750|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821751|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
821752|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
821753|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
821754|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
821755|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2250966|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2250967|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2250968|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
2250969|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2250970|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2250971|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
2250972|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
2250973|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
2250974|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
2250975|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
2250976|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2250977|NCT00134069|Cetuximab|cetuximab|mesh-list
2250978|NCT00134069|Irinotecan|irinotecan|mesh-list
2250979|NCT00134069|Sorafenib|sorafenib|mesh-list
2250980|NCT00134069|Antibodies|antibodies|mesh-list
2250981|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
2250982|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
819016|NCT02502032|Cisatracurium|cisatracurium|mesh-list
819017|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
819018|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
819019|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819020|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250983|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
2250984|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2250985|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250986|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2250987|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2250988|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250989|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250990|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2250991|NCT00134095|Irinotecan|irinotecan|mesh-list
2250992|NCT00134095|Tegafur|tegafur|mesh-list
2250993|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2250994|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2250995|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2250996|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2250997|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2250998|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2250999|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
2251000|NCT00134147|Insulin|insulin|mesh-list
2251001|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2251002|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251003|NCT00134160|Amlodipine|amlodipine|mesh-list
2251004|NCT00134160|Olmesartan|olmesartan|mesh-list
2251005|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2251006|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
2251007|NCT00134160|Calcium|calcium|mesh-list
2251008|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2251009|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251010|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2251011|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2251012|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251013|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
2251014|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2251015|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2251016|NCT00134173|Atorvastatin|atorvastatin|mesh-list
2251017|NCT00134173|Torcetrapib|torcetrapib|mesh-list
2251018|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2251019|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2251020|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
820020|NCT02498444|Treprostinil|treprostinil|mesh-list
820021|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
820397|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
820398|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
820399|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820523|NCT02496286|Bevacizumab|bevacizumab|mesh-list
820524|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
820525|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820526|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
820527|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
820528|NCT02496286|Growth Substances|growth substances|mesh-ancestor
820529|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820530|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
820603|NCT02495922|Dexamethasone|dexamethasone|mesh-list
820604|NCT02495922|Lenalidomide|lenalidomide|mesh-list
820605|NCT02495922|Bortezomib|bortezomib|mesh-list
818923|NCT02502669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818924|NCT02502669|Hormone Antagonists|hormone antagonists|mesh-ancestor
818925|NCT02502669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
818926|NCT02502669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818927|NCT02502669|Urological Agents|urological agents|mesh-ancestor
819201|NCT02501603|Paclitaxel|paclitaxel|mesh-list
819202|NCT02501603|Afatinib|afatinib|mesh-list
819203|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
819204|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819205|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
819206|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
819207|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
819208|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819209|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
819210|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819267|NCT02501109|Aripiprazole|aripiprazole|mesh-list
819268|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
819269|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
819270|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
819271|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
819272|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
819273|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819274|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
819275|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
819276|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
819277|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819278|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
819279|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
819280|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
819281|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
819282|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
819283|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
819284|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
819309|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
819310|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
819311|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
819312|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819313|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819314|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
819315|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
819316|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
819317|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
819318|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
819319|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
819320|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
819321|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819469|NCT02500563|Caseins|caseins|mesh-list
819470|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
819471|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
819472|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819729|NCT02499666|Clopidogrel|clopidogrel|mesh-list
819730|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
819731|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
819732|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
819733|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
819734|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
819735|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
819736|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819737|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251021|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251022|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2251023|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2251024|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251025|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
820422|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
820423|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
820424|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
820425|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820426|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
820427|NCT02496650|Analgesics|analgesics|mesh-ancestor
820428|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
818956|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819514|NCT02500576|Aldesleukin|aldesleukin|mesh-list
819515|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
819516|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
819517|NCT02500576|Fludarabine|fludarabine|mesh-list
819518|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
819519|NCT02500576|Interleukin-2|interleukin-2|mesh-list
819520|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
819521|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
819522|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819523|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
819524|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
819525|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
819526|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819527|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819528|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
819529|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
819530|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
819531|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
819532|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
819533|NCT02500576|Analgesics|analgesics|mesh-ancestor
819534|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
819535|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819536|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
819537|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
819538|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
819539|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
819632|NCT02499978|Darunavir|darunavir|mesh-list
819633|NCT02499978|Dolutegravir|dolutegravir|mesh-list
819634|NCT02499978|Cobicistat|cobicistat|mesh-list
819635|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
819636|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
819637|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
819638|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819639|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819640|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
819641|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
819642|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
819643|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
819644|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
819645|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
819646|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
819647|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
819738|NCT02499562|Entecavir|entecavir|mesh-list
819739|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
819740|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
819796|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
819797|NCT02499237|Denosumab|denosumab|mesh-list
819798|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
819799|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819911|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
819912|NCT02498912|Fludarabine|fludarabine|mesh-list
819913|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
819914|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
819915|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819916|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
819917|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
819918|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
819919|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819920|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819921|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
819985|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
819986|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
819987|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
819988|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819989|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819990|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
819991|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
819992|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
819993|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
819994|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819995|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
819996|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
819997|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
819998|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
819999|NCT02498535|Protective Agents|protective agents|mesh-ancestor
818986|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
818987|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818988|NCT02502253|Protective Agents|protective agents|mesh-ancestor
818989|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
818990|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
818991|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2098261|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098262|NCT02340949|Antidotes|antidotes|mesh-ancestor
2098263|NCT02340949|Protective Agents|protective agents|mesh-ancestor
819575|NCT02500069|Caseins|caseins|mesh-list
819576|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
819577|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
819578|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820324|NCT02497079|Formaldehyde|formaldehyde|mesh-list
820325|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
820326|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
820732|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
820733|NCT02496052|Progestins|progestins|mesh-ancestor
820759|NCT02495415|Fenretinide|fenretinide|mesh-list
820760|NCT02495415|Retinamide|retinamide|mesh-list
820761|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820762|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
820763|NCT02495415|Protective Agents|protective agents|mesh-ancestor
820764|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820860|NCT02494830|Ketamine|ketamine|mesh-list
820861|NCT02494830|Analgesics|analgesics|mesh-ancestor
820862|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
820863|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820864|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820865|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
820866|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
820867|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
820868|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
820869|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
820870|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
820871|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
820872|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
820873|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251026|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251027|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2251028|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
2251029|NCT00134199|Sibutramine|sibutramine|mesh-list
2251030|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
2251031|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2251032|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
2251033|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2251034|NCT00134212|Epinephrine|epinephrine|mesh-list
2251035|NCT00134212|Norepinephrine|norepinephrine|mesh-list
2251036|NCT00134212|Dopexamine|dopexamine|mesh-list
821310|NCT02493504|Heparin|heparin|mesh-list
821311|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
821312|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
821313|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
821314|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821537|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
821538|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
821539|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
821540|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251037|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2251038|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2251039|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
821638|NCT02492282|Remifentanil|remifentanil|mesh-list
821639|NCT02492282|Propofol|propofol|mesh-list
821640|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
821641|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
821642|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821643|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
821644|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
821645|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
821646|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
821647|NCT02492282|Narcotics|narcotics|mesh-ancestor
821648|NCT02492282|Analgesics|analgesics|mesh-ancestor
821649|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
821650|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821669|NCT02492178|Artesunate|artesunate|mesh-list
821670|NCT02492178|Quinine|quinine|mesh-list
2251040|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251041|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819192|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819193|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
819194|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819701|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
819702|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
819703|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819759|NCT02499445|Sufentanil|sufentanil|mesh-list
819760|NCT02499445|Remifentanil|remifentanil|mesh-list
819761|NCT02499445|Propofol|propofol|mesh-list
819762|NCT02499445|Sevoflurane|sevoflurane|mesh-list
819763|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
819764|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
819765|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819766|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
819767|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
819768|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
819769|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
819770|NCT02499445|Narcotics|narcotics|mesh-ancestor
819771|NCT02499445|Analgesics|analgesics|mesh-ancestor
819772|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
819773|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
819774|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
819775|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
819776|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2251042|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251043|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2251044|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2251045|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
2251046|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251047|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2251048|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
820104|NCT02497833|Tretinoin|tretinoin|mesh-list
820105|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820106|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
820107|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
820156|NCT02497508|Nivolumab|nivolumab|mesh-list
820157|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
820158|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820159|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
820160|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820734|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2251049|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
2251050|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
2251051|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2251052|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
820846|NCT02494804|Temozolomide|temozolomide|mesh-list
820847|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
820848|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
820849|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820850|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820925|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
820926|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
820927|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
820928|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
821067|NCT02494466|Montelukast|montelukast|mesh-list
821068|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
821069|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
821070|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
821071|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
821072|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
821073|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821074|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
821075|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
821076|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251053|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
2251054|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
2251055|NCT00134238|Atorvastatin|atorvastatin|mesh-list
2251056|NCT00134238|Torcetrapib|torcetrapib|mesh-list
2251057|NCT00134238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2251058|NCT00134238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2251059|NCT00134238|Antimetabolites|antimetabolites|mesh-ancestor
2251060|NCT00134238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251061|NCT00134238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2251062|NCT00134238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
819345|NCT02500940|Antidotes|antidotes|mesh-ancestor
819346|NCT02500940|Protective Agents|protective agents|mesh-ancestor
819347|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
819348|NCT02500940|Vitamins|vitamins|mesh-ancestor
819349|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
819557|NCT02500017|Melatonin|melatonin|mesh-list
819558|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
819559|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819560|NCT02500017|Protective Agents|protective agents|mesh-ancestor
819561|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819562|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
820018|NCT02498288|Isotretinoin|isotretinoin|mesh-list
820019|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
820400|NCT02496780|Insulin|insulin|mesh-list
820401|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
820402|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
820403|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
820404|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
820405|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098264|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098265|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
2098266|NCT02340949|Vitamins|vitamins|mesh-ancestor
2098267|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
2098268|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2098269|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2098270|NCT02340949|Growth Substances|growth substances|mesh-ancestor
2098271|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
2098272|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
820959|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820960|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
820961|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
820962|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820963|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
821416|NCT02493049|Domperidone|domperidone|mesh-list
821417|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821418|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
821419|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
821420|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821421|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821422|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
821423|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
821424|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
821425|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
821558|NCT02492581|Nalmefene|nalmefene|mesh-list
821559|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
821560|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821561|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
821562|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251063|NCT00134238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251064|NCT00134264|Atorvastatin|atorvastatin|mesh-list
2251065|NCT00134264|Torcetrapib|torcetrapib|mesh-list
2251066|NCT00134264|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2251067|NCT00134264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2251068|NCT00134264|Antimetabolites|antimetabolites|mesh-ancestor
2251069|NCT00134264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251070|NCT00134264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2251071|NCT00134264|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2251072|NCT00134264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251073|NCT00134290|Metformin|metformin|mesh-list
2251074|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2251075|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251076|NCT00134303|Metformin|metformin|mesh-list
2251077|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2251078|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251079|NCT00134355|Vatalanib|vatalanib|mesh-list
2251080|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2251081|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251082|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251083|NCT00134368|Etanercept|etanercept|mesh-list
2251084|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2251085|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2251086|NCT00134368|Analgesics|analgesics|mesh-ancestor
821607|NCT02492490|Basiliximab|basiliximab|mesh-list
819588|NCT02499861|Decitabine|decitabine|mesh-list
819589|NCT02499861|Genistein|genistein|mesh-list
819590|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
819591|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
819592|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819593|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819594|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819595|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
819596|NCT02499861|Protective Agents|protective agents|mesh-ancestor
819597|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819598|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
819599|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
819600|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
819601|NCT02499861|Estrogens|estrogens|mesh-ancestor
819602|NCT02499861|Hormones|hormones|mesh-ancestor
819603|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
819724|NCT02499614|Crizotinib|crizotinib|mesh-list
819725|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819726|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
819727|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819728|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820675|NCT02495662|Prednisolone|prednisolone|mesh-list
820676|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
820677|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
820678|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
820679|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
820680|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
820681|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
820682|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
820683|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
820684|NCT02495662|Hormones|hormones|mesh-ancestor
820685|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
820686|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820687|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
820688|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820689|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
820690|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
820691|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820692|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
820693|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
820694|NCT02495662|Protective Agents|protective agents|mesh-ancestor
820999|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
821000|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
821001|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
821002|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
821003|NCT02495077|Hormones|hormones|mesh-ancestor
821004|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
821005|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821006|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
821007|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821008|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
821009|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
821010|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
821011|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821012|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821013|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
821014|NCT02495077|Analgesics|analgesics|mesh-ancestor
821015|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
821016|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821017|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
821018|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
821019|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
821020|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
821021|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
821022|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
821023|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
821024|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
821025|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
821026|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
821027|NCT02495077|Protective Agents|protective agents|mesh-ancestor
821028|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
821029|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
821030|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
821031|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
821176|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
819605|NCT02499874|Lamivudine|lamivudine|mesh-list
819606|NCT02499874|Zidovudine|zidovudine|mesh-list
819607|NCT02499874|Emtricitabine|emtricitabine|mesh-list
819608|NCT02499874|Efavirenz|efavirenz|mesh-list
819609|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
819610|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
819611|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
819612|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
819613|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
819614|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819615|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819616|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
819617|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
819618|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
819619|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
819620|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
819621|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
819622|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
819623|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
819624|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2251087|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
2251088|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251089|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251090|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
820656|NCT02495896|Gemcitabine|gemcitabine|mesh-list
820657|NCT02495896|Paclitaxel|paclitaxel|mesh-list
820658|NCT02495896|Docetaxel|docetaxel|mesh-list
820659|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
820660|NCT02495896|Cisplatin|cisplatin|mesh-list
820661|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
820662|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820663|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
820664|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
820665|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
820666|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820667|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
820668|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
820669|NCT02495896|Antiviral Agents|antiviral agents|mesh-ancestor
820670|NCT02495896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
820671|NCT02495896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820672|NCT02495896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
820673|NCT02495896|Immunologic Factors|immunologic factors|mesh-ancestor
820674|NCT02495896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821032|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
821033|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
821034|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
821035|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
821036|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
821037|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
821038|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
821039|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
821040|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
821041|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
821200|NCT02493725|Eculizumab|eculizumab|mesh-list
821201|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
821202|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
821203|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
821204|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821212|NCT02493738|Itraconazole|itraconazole|mesh-list
821213|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
821214|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
821215|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
821216|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
821217|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821218|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821219|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
821220|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
821221|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
821222|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821223|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
821426|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
821427|NCT02493322|Olmesartan|olmesartan|mesh-list
821428|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
821429|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
821430|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2251091|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2251092|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2251093|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2251094|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
2251095|NCT00134394|Etanercept|etanercept|mesh-list
2251096|NCT00134394|Tacrolimus|tacrolimus|mesh-list
2251097|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2251098|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
2251099|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251100|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2251101|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819889|NCT02498977|Cyclosporine|cyclosporine|mesh-list
819890|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
819891|NCT02498977|Azathioprine|azathioprine|mesh-list
819892|NCT02498977|Tacrolimus|tacrolimus|mesh-list
819893|NCT02498977|Cyclosporins|cyclosporins|mesh-list
819894|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
819895|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
819896|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
819897|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
819898|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819899|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819900|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
819901|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
819902|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
819903|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
819904|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
819905|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819906|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
819907|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
819908|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
819909|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
819910|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
820201|NCT02497313|Metformin|metformin|mesh-list
820202|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
820203|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
820204|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820205|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
820206|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
820290|NCT02497053|Pemetrexed|pemetrexed|mesh-list
820291|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820292|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820293|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820294|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
820295|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
820536|NCT02496182|Pirfenidone|pirfenidone|mesh-list
820537|NCT02496182|Analgesics|analgesics|mesh-ancestor
820538|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
820539|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820540|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820541|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
820542|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
820543|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
820544|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
820545|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820791|NCT02495324|Valsartan|valsartan|mesh-list
820792|NCT02495324|Olmesartan|olmesartan|mesh-list
820793|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
820794|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
820795|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
820796|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
820797|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821077|NCT02494284|Aspirin|aspirin|mesh-list
821078|NCT02494284|Clopidogrel|clopidogrel|mesh-list
821079|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
821080|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
821081|NCT02494284|Analgesics|analgesics|mesh-ancestor
821082|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
821083|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821084|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821085|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
821086|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
821087|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
821088|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
821089|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251102|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251103|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2251104|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
820161|NCT02497547|Oxytocin|oxytocin|mesh-list
820162|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
820163|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
820164|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251105|NCT00134394|Analgesics|analgesics|mesh-ancestor
2251106|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
2251107|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821090|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
821091|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
821092|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821093|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
821094|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
821095|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
821096|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
821097|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
821098|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
821139|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
821140|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
821141|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
821142|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
821143|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
821144|NCT02493933|Expectorants|expectorants|mesh-ancestor
821145|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
821146|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
821147|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
821148|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821149|NCT02493933|Protective Agents|protective agents|mesh-ancestor
821150|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821151|NCT02493933|Antidotes|antidotes|mesh-ancestor
821152|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
821153|NCT02493933|Estrogens|estrogens|mesh-ancestor
821154|NCT02493933|Hormones|hormones|mesh-ancestor
821155|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251108|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251109|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2251110|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2251111|NCT00134420|Clonidine|clonidine|mesh-list
2251112|NCT00134420|Mitogens|mitogens|mesh-list
2251113|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251114|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
2251115|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251116|NCT00134420|Analgesics|analgesics|mesh-ancestor
821380|NCT02493283|Dapsone|dapsone|mesh-list
821381|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
821382|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
821383|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
821384|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
821385|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
821386|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821387|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821388|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
821389|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
821541|NCT02492412|Cyclosporine|cyclosporine|mesh-list
821542|NCT02492412|Cyclosporins|cyclosporins|mesh-list
821543|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821544|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821545|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
821546|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
821547|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821548|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
821549|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
821550|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
821551|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
821552|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
821608|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
821609|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
821610|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251117|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
820116|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
820117|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
820118|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
820119|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820120|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
820121|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
820122|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820123|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
820360|NCT02496975|Cyclosporine|cyclosporine|mesh-list
820361|NCT02496975|Cyclosporins|cyclosporins|mesh-list
820362|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820363|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820364|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
820365|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
820366|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820367|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
820368|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
820369|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
820370|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
820371|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
820654|NCT02495636|Atezolizumab|atezolizumab|mesh-list
820655|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821177|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
821178|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821179|NCT02493959|Incretins|incretins|mesh-ancestor
821180|NCT02493959|Hormones|hormones|mesh-ancestor
821181|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
821182|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
821183|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
821184|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821185|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821611|NCT02492308|Basiliximab|basiliximab|mesh-list
821612|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
821613|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
821614|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821831|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
821832|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
821833|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821834|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821835|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
821836|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
821837|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
821838|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
821839|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821840|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
821841|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
821842|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
821843|NCT02491268|Protective Agents|protective agents|mesh-ancestor
821844|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
821845|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
821846|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251118|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251119|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2251120|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
2251121|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
2251122|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2251123|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2251124|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2251125|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
2251126|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251127|NCT00134485|Atorvastatin|atorvastatin|mesh-list
2251128|NCT00134485|Torcetrapib|torcetrapib|mesh-list
2251129|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2251130|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2251131|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
2251132|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251133|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2251134|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2251135|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821995|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
821996|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
821997|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
821998|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
821999|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
820240|NCT02497300|Amiloride|amiloride|mesh-list
820241|NCT02497300|Spironolactone|spironolactone|mesh-list
820242|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
820243|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
820244|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
820245|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820246|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
820247|NCT02497300|Diuretics|diuretics|mesh-ancestor
820248|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
820249|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
820250|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
820251|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
820252|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820253|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
820772|NCT02495363|Bupivacaine|bupivacaine|mesh-list
820773|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
820774|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
820775|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
820776|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820777|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
820778|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251136|NCT00134498|Atorvastatin|atorvastatin|mesh-list
2251137|NCT00134498|Torcetrapib|torcetrapib|mesh-list
2251138|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2251139|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2251140|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
2251141|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251142|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2251143|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2251144|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821355|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
821356|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
821357|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
821358|NCT02493179|Analgesics|analgesics|mesh-ancestor
821359|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
821360|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821361|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821362|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
821363|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
821364|NCT02493335|Budesonide|budesonide|mesh-list
821365|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
821366|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
821367|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
821368|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821369|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821370|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
821371|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
821372|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
821373|NCT02493335|Hormones|hormones|mesh-ancestor
821374|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
821615|NCT02492126|Citric Acid|citric acid|mesh-list
821616|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
821617|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
821618|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
821619|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
821620|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
821621|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821703|NCT02491983|Letrozole|letrozole|mesh-list
821704|NCT02491983|Fulvestrant|fulvestrant|mesh-list
821705|NCT02491983|Palbociclib|palbociclib|mesh-list
821706|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821707|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
821708|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2251145|NCT00134511|Atorvastatin|atorvastatin|mesh-list
820262|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820263|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820264|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
820265|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
820266|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
820406|NCT02496910|Amlodipine|amlodipine|mesh-list
820407|NCT02496910|Telmisartan|telmisartan|mesh-list
820408|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
820409|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
820410|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
820411|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
820412|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
820413|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820414|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
820415|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820416|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
820417|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
820418|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
820419|NCT02496910|Diuretics|diuretics|mesh-ancestor
820420|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
820421|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2251146|NCT00134511|Torcetrapib|torcetrapib|mesh-list
2251147|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2251148|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2251149|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
2251150|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821045|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
821046|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
821047|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821048|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
821049|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
821050|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
821051|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
821052|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821053|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251151|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2251152|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2251153|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251154|NCT00134550|Atorvastatin|atorvastatin|mesh-list
2251155|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2251156|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2251157|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
2251158|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251159|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2251160|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2251161|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251162|NCT00134641|Gemcitabine|gemcitabine|mesh-list
2251163|NCT00134641|Vinorelbine|vinorelbine|mesh-list
2251164|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
821315|NCT02493465|Everolimus|everolimus|mesh-list
821316|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821317|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
821318|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
821319|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251165|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
2251166|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251167|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821563|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
821564|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
821565|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820281|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
820282|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
820283|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
820284|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820285|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
820286|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
820287|NCT02497118|Growth Substances|growth substances|mesh-ancestor
820288|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820289|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
2251168|NCT00134641|Antiviral Agents|antiviral agents|mesh-ancestor
2251169|NCT00134641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251170|NCT00134641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251171|NCT00134641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2251172|NCT00134641|Immunologic Factors|immunologic factors|mesh-ancestor
2251173|NCT00134641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251174|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2251175|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
2251176|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
2251177|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
2251178|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2251179|NCT00134654|Estrogens|estrogens|mesh-ancestor
2251180|NCT00134654|Hormones|hormones|mesh-ancestor
2251181|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251182|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251183|NCT00134667|Verteporfin|verteporfin|mesh-list
2251184|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2251185|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
2098273|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098274|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2098275|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2098276|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
2098277|NCT02340962|Interferons|interferons|mesh-list
2098278|NCT02340962|Ribavirin|ribavirin|mesh-list
2098279|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
2098280|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
2098281|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251186|NCT00134680|Trastuzumab|trastuzumab|mesh-list
2251187|NCT00134680|Letrozole|letrozole|mesh-list
2251188|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2251189|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251190|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2251191|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2251192|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251193|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251194|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2251195|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
2251196|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251197|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251198|NCT00134693|Prednisolone|prednisolone|mesh-list
2251199|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
821529|NCT02492464|Red yeast rice|red yeast rice|mesh-list
821530|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
821531|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
821532|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
821533|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
821534|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821535|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821536|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
821660|NCT02492217|Adalimumab|adalimumab|mesh-list
821661|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
821662|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
821721|NCT02491697|Capecitabine|capecitabine|mesh-list
821722|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
821723|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
821724|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821725|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821847|NCT02491398|Rituximab|rituximab|mesh-list
821848|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
821849|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
821850|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821851|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
821852|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251200|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
820321|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
820322|NCT02497157|Vitamins|vitamins|mesh-ancestor
820323|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
820383|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
820384|NCT02496754|Hormones|hormones|mesh-ancestor
820385|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
820386|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821350|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
821351|NCT02493192|Narcotics|narcotics|mesh-ancestor
821352|NCT02493192|Analgesics|analgesics|mesh-ancestor
821353|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
821354|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2251201|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2251202|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
2251203|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2251204|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
2251205|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251206|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
2251207|NCT00134693|Hormones|hormones|mesh-ancestor
2251208|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251209|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251210|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2251211|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251212|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
2251213|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
2251214|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251215|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2251216|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2251217|NCT00134693|Protective Agents|protective agents|mesh-ancestor
2251218|NCT00134706|Carboplatin|carboplatin|mesh-list
2251219|NCT00134706|Docetaxel|docetaxel|mesh-list
2251220|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821805|NCT02491320|Letrozole|letrozole|mesh-list
821806|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821807|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
821808|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
821809|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821810|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821811|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
821812|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
821813|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
821814|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821853|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
821854|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
821855|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
821856|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821957|NCT02490657|Iloprost|iloprost|mesh-list
821958|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
821959|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
821974|NCT02490592|Fluorides|fluorides|mesh-list
821975|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
821976|NCT02490592|Protective Agents|protective agents|mesh-ancestor
821977|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821978|NCT02490865|RNS60|rns60|mesh-list
821979|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
821980|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
821981|NCT02490865|Analgesics|analgesics|mesh-ancestor
821982|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
821983|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821984|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821985|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
821986|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
821987|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
822000|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
822001|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
822002|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822003|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822004|NCT02490839|Antacids|antacids|mesh-ancestor
822005|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
822006|NCT02490527|Simvastatin|simvastatin|mesh-list
822007|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
822008|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
822009|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
822010|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822012|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
820359|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251221|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
2251222|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
2251223|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
2251224|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251225|NCT00134745|Estradiol|estradiol|mesh-list
2251226|NCT00134745|Estrogens|estrogens|mesh-ancestor
2251227|NCT00134745|Hormones|hormones|mesh-ancestor
2251228|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251229|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251230|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2251231|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2251232|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2251233|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
2251234|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
820707|NCT02495584|Vitamin D|vitamin d|mesh-list
820708|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
820709|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
820710|NCT02495584|Vitamins|vitamins|mesh-list
820711|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
820712|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820713|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
820714|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
820765|NCT02495272|Oxytocin|oxytocin|mesh-list
820766|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
820767|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
820768|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251235|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2251236|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2251237|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2251238|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251239|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
2251240|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251241|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821283|NCT02493582|Apatinib|apatinib|mesh-list
821284|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821285|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
821286|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821287|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251242|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2251243|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821671|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
821672|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
821673|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
821674|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
821675|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821676|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
821677|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
821678|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
821679|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
821680|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
821681|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821682|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
821683|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821684|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
821685|NCT02492178|Analgesics|analgesics|mesh-ancestor
821686|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
2251244|NCT00134875|Buprenorphine|buprenorphine|mesh-list
2251245|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2251246|NCT00134875|Naloxone|naloxone|mesh-list
821857|NCT02491606|Tafenoquine|tafenoquine|mesh-list
821858|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
821859|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
821860|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
821861|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
821893|NCT02490982|Teriflunomide|teriflunomide|mesh-list
821894|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
821895|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
821896|NCT02490982|Analgesics|analgesics|mesh-ancestor
821897|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
821898|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821899|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821900|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
821901|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
821902|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
821903|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
2251247|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2251248|NCT00134875|Narcotics|narcotics|mesh-ancestor
2251249|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2251250|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251251|NCT00134875|Analgesics|analgesics|mesh-ancestor
2251252|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
2251253|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821412|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
821413|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
821414|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821415|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2251254|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2251255|NCT00134888|Buprenorphine|buprenorphine|mesh-list
2251256|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2251257|NCT00134888|Naloxone|naloxone|mesh-list
2251258|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2251259|NCT00134888|Narcotics|narcotics|mesh-ancestor
2251260|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2251261|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251262|NCT00134888|Analgesics|analgesics|mesh-ancestor
2251263|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
2251264|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251265|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
821566|NCT02492373|Clobetasol|clobetasol|mesh-list
821567|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
821568|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
821569|NCT02492373|Hormones|hormones|mesh-ancestor
821570|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
821571|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821687|NCT02492074|Dronabinol|dronabinol|mesh-list
821688|NCT02492074|Cannabidiol|cannabidiol|mesh-list
821689|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
821690|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
821691|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821692|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
821693|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
821694|NCT02492074|Analgesics|analgesics|mesh-ancestor
821695|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
821696|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821697|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
821698|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
821699|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
821700|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821701|NCT02492074|Hormones|hormones|mesh-ancestor
821702|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
821709|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821710|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821711|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
821712|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
821713|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
821714|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821715|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
821716|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
821717|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
821862|NCT02491528|Insulin|insulin|mesh-list
821863|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
821864|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
821865|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
821866|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
821867|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
821868|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821883|NCT02491086|Nicotine|nicotine|mesh-list
821884|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
821885|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
821886|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821887|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821888|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
821889|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
821890|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
821891|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
821892|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251266|NCT00134914|Buprenorphine|buprenorphine|mesh-list
2251267|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2251268|NCT00134914|Narcotics|narcotics|mesh-ancestor
820429|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820430|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
820431|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
820432|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
820433|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
820434|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
820435|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820516|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
820517|NCT02496377|Glycine|glycine|mesh-list
820518|NCT02496377|Hematinics|hematinics|mesh-ancestor
820519|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
820520|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
820521|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820522|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251269|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2251270|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251271|NCT00134914|Analgesics|analgesics|mesh-ancestor
2251272|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
820742|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
820743|NCT02495220|Bupivacaine|bupivacaine|mesh-list
820744|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
820745|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
820746|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
820747|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820748|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
820749|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820750|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
820751|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
820752|NCT02495220|Analgesics|analgesics|mesh-ancestor
820753|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
820754|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
820755|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
820756|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
820757|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
820758|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251273|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251274|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2251275|NCT00134953|Rivastigmine|rivastigmine|mesh-list
2251276|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2251277|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251278|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251279|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
2251280|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251281|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251282|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2251283|NCT00134953|Protective Agents|protective agents|mesh-ancestor
2251284|NCT00134966|Levodopa|levodopa|mesh-list
2251285|NCT00134966|Carbidopa|carbidopa|mesh-list
821431|NCT02493322|Diuretics|diuretics|mesh-ancestor
821432|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
821433|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821434|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
821435|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
821436|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821437|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
821438|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2754425|NCT01123707|Aripiprazole|aripiprazole|mesh-list
2754426|NCT01123707|Citalopram|citalopram|mesh-list
2754427|NCT01123707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2754428|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2754429|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2754430|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754431|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2754432|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
821520|NCT02492503|Paclitaxel|paclitaxel|mesh-list
821521|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
821522|NCT02492503|Carboplatin|carboplatin|mesh-list
821523|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
821524|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821525|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
821526|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
821527|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
820443|NCT02496715|Fluticasone|fluticasone|mesh-list
820444|NCT02496715|Xhance|xhance|mesh-list
820445|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
820446|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
820447|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
820448|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
820449|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820450|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820451|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
820452|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
820453|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
820454|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
820455|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
820456|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
820457|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
820458|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
820459|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
820460|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820735|NCT02495181|Aflibercept|aflibercept|mesh-list
820736|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
820737|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
820738|NCT02495181|Growth Substances|growth substances|mesh-ancestor
820739|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820740|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
820741|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820827|NCT02494882|Dexamethasone|dexamethasone|mesh-list
820828|NCT02494882|Dasatinib|dasatinib|mesh-list
820829|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
820830|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
820831|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
820832|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820833|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820834|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
820835|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
820836|NCT02494882|Hormones|hormones|mesh-ancestor
820837|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
820838|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
820839|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820840|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
820841|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820842|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251286|NCT00134966|Entacapone|entacapone|mesh-list
2251287|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2251288|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2251289|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
2251290|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251291|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251292|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251293|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2251294|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251295|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2251296|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
2251297|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2251298|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
2251299|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251300|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251301|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2251302|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
2251303|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2251304|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2251305|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2251306|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
2251307|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251308|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251309|NCT00134992|Prednisolone|prednisolone|mesh-list
821487|NCT02492776|Omeprazole|omeprazole|mesh-list
821488|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
821489|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
821490|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
821491|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821492|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821553|NCT02492386|Everolimus|everolimus|mesh-list
821554|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821555|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2251310|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2251311|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
2251312|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2251313|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
2251314|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2251315|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
2251316|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251317|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
2251318|NCT00134992|Hormones|hormones|mesh-ancestor
2251319|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251320|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251321|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2251322|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251323|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
2251324|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
2251325|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821528|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821636|NCT02492360|Cisplatin|cisplatin|mesh-list
821637|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251326|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2251327|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2251328|NCT00134992|Protective Agents|protective agents|mesh-ancestor
821785|NCT02491879|Ketoprofen|ketoprofen|mesh-list
821786|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
821787|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
821788|NCT02491879|Analgesics|analgesics|mesh-ancestor
821789|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
821790|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821791|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821792|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
821793|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
821794|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
821795|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821796|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251329|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
2251330|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251331|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2251332|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251333|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251334|NCT00135018|Celecoxib|celecoxib|mesh-list
2251335|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2251336|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2251337|NCT00135018|Analgesics|analgesics|mesh-ancestor
2251338|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
2251339|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821919|NCT02491632|Dexamethasone|dexamethasone|mesh-list
821920|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
821921|NCT02491632|Ichthammol|ichthammol|mesh-list
821922|NCT02491632|BB 1101|bb 1101|mesh-list
821923|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
821924|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
821925|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
821926|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821927|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821928|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
821929|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
821930|NCT02491632|Hormones|hormones|mesh-ancestor
821931|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
821932|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
821933|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821934|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
821935|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821936|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821937|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
2251340|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251341|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251342|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2251343|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2251344|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
821988|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
821989|NCT02490839|Amoxicillin|amoxicillin|mesh-list
821990|NCT02490839|Metronidazole|metronidazole|mesh-list
821991|NCT02490839|Tetracycline|tetracycline|mesh-list
821992|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
821993|NCT02490839|Rabeprazole|rabeprazole|mesh-list
821994|NCT02490839|Bismuth|bismuth|mesh-list
820575|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251345|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251346|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251347|NCT00135057|Insulin|insulin|mesh-list
2251348|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2251349|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
2251350|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
2251351|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2251352|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251353|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
2251354|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2251355|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251356|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
2251357|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2098282|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
2098283|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098284|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
2098285|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098286|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
2098287|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098288|NCT02340975|Durvalumab|durvalumab|mesh-list
2098289|NCT02340975|Tremelimumab|tremelimumab|mesh-list
2098290|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2098291|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2098292|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098293|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
2098294|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098295|NCT02341144|Ropivacaine|ropivacaine|mesh-list
2098296|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
2098297|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
2098298|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2098299|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098300|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
2251358|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821556|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
821557|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821658|NCT02492230|Warfarin|warfarin|mesh-list
821659|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
821729|NCT02491736|Ketoprofen|ketoprofen|mesh-list
821730|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
821731|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
821732|NCT02491736|Analgesics|analgesics|mesh-ancestor
821733|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
821734|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821735|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821736|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
821737|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
821738|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
821739|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821740|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251359|NCT00135096|Insulin|insulin|mesh-list
2251360|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2251361|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
2251362|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
2251363|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2251364|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251365|NCT00135122|Prednisolone|prednisolone|mesh-list
2251366|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
821824|NCT02491515|Denosumab|denosumab|mesh-list
821825|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
821826|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821878|NCT02491099|Afatinib|afatinib|mesh-list
821879|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821880|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
821881|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
821882|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821905|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
821906|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821907|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
821908|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
821909|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251367|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
2251368|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2251369|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
2251370|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
820606|NCT02495922|Elotuzumab|elotuzumab|mesh-list
820607|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
820608|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
820609|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
820610|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820611|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820612|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
820613|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
820614|NCT02495922|Hormones|hormones|mesh-ancestor
820615|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
820616|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
820617|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820618|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
820619|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
820620|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
820621|NCT02495922|Growth Substances|growth substances|mesh-ancestor
820622|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
2098301|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098302|NCT02341417|Cinacalcet|cinacalcet|mesh-list
2098303|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2098304|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098305|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2098306|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
2098307|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2098308|NCT02341456|Paclitaxel|paclitaxel|mesh-list
2098309|NCT02341456|Carboplatin|carboplatin|mesh-list
2098310|NCT02341456|Adavosertib|adavosertib|mesh-list
2098311|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2098312|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098313|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
821054|NCT02494349|Tamsulosin|tamsulosin|mesh-list
821055|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
821056|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
821057|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
821058|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
821059|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
821060|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
821061|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821062|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821063|NCT02494349|Urological Agents|urological agents|mesh-ancestor
821064|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
821065|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
821066|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
821197|NCT02493894|Cefazolin|cefazolin|mesh-list
821198|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
821199|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
821572|NCT02492438|Vaccines|vaccines|mesh-list
821573|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
821574|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251371|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
2251372|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251373|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
2251374|NCT00135122|Hormones|hormones|mesh-ancestor
821756|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
821757|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
821758|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
821759|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
821760|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821761|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
821762|NCT02491970|Hormones|hormones|mesh-ancestor
821763|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
821764|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
821815|NCT02491242|Dolutegravir|dolutegravir|mesh-list
821816|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
821817|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
821818|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
821819|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821820|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
821821|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
821822|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
821823|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
821869|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
821870|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
821871|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
821904|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2251375|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
820643|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820715|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
820716|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
820717|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
820718|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820719|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820874|NCT02494895|Aspirin|aspirin|mesh-list
820875|NCT02494895|Ticagrelor|ticagrelor|mesh-list
820876|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
820877|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
820878|NCT02494895|Analgesics|analgesics|mesh-ancestor
820879|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
820880|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
820881|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
820882|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
820883|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
820884|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
820885|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
820886|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820887|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
820888|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
820889|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820890|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
820891|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
820892|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
820893|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
820894|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
820895|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
821042|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
821043|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
821044|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251376|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251377|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2251378|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251379|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
2251380|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
2251381|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251382|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2251383|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2251384|NCT00135122|Protective Agents|protective agents|mesh-ancestor
2251385|NCT00135135|Carboplatin|carboplatin|mesh-list
2251386|NCT00135135|Doxorubicin|doxorubicin|mesh-list
2251387|NCT00135135|Etoposide|etoposide|mesh-list
2251388|NCT00135135|Irinotecan|irinotecan|mesh-list
2251389|NCT00135135|Melphalan|melphalan|mesh-list
2251390|NCT00135135|Topotecan|topotecan|mesh-list
2251391|NCT00135135|Gefitinib|gefitinib|mesh-list
2251392|NCT00135135|Tretinoin|tretinoin|mesh-list
2251393|NCT00135135|Isotretinoin|isotretinoin|mesh-list
2251394|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251395|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2251396|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2251397|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2251398|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251399|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251400|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2251401|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2251402|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2251403|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
821333|NCT02493192|Meperidine|meperidine|mesh-list
821334|NCT02493192|Haloperidol|haloperidol|mesh-list
821335|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
821336|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
821337|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
821338|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
821339|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
821340|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
821341|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
821342|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
821343|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
821344|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
821345|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
821346|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
821347|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
821348|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
821349|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2251404|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2251405|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2251406|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
2251407|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251408|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2251409|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
2251410|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
2251411|NCT00135187|Dexamethasone|dexamethasone|mesh-list
2251412|NCT00135187|Bortezomib|bortezomib|mesh-list
2251413|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251414|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
2251415|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
2251416|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251417|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251418|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2251419|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
2251420|NCT00135187|Hormones|hormones|mesh-ancestor
2251421|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251422|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2251423|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
818992|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
818993|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
818994|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
818995|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
818996|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
818997|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
818998|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
818999|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819109|NCT02501954|Paclitaxel|paclitaxel|mesh-list
819110|NCT02501954|Carboplatin|carboplatin|mesh-list
819111|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
819112|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819113|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
819114|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
819115|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
819116|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251424|NCT00135304|Vitamin D|vitamin d|mesh-list
2251425|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2251426|NCT00135304|Cinacalcet|cinacalcet|mesh-list
2251427|NCT00135304|Vitamins|vitamins|mesh-ancestor
2251428|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
2251429|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251430|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2251431|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
819484|NCT02500459|Topotecan|topotecan|mesh-list
819485|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
819486|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
819487|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
819488|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
819489|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819662|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
819663|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
819664|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
819665|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
819666|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
819667|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
819668|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251432|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2251433|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
2251434|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251435|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
820267|NCT02497365|Cefazolin|cefazolin|mesh-list
820268|NCT02497365|Tobramycin|tobramycin|mesh-list
820269|NCT02497365|Besifloxacin|besifloxacin|mesh-list
820270|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
820271|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
820272|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
820273|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
820274|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
820275|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
820276|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251436|NCT00135317|Hematinics|hematinics|mesh-ancestor
2251437|NCT00135343|Ritonavir|ritonavir|mesh-list
2251438|NCT00135343|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2251439|NCT00135343|Efavirenz|efavirenz|mesh-list
2251440|NCT00135343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
822011|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
822014|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
822015|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822253|NCT02489448|Durvalumab|durvalumab|mesh-list
822254|NCT02489448|Tremelimumab|tremelimumab|mesh-list
822255|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
822256|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822905|NCT02487082|Melatonin|melatonin|mesh-list
822906|NCT02487082|Donepezil|donepezil|mesh-list
822907|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
822908|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822909|NCT02487082|Protective Agents|protective agents|mesh-ancestor
822910|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822911|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822912|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
822913|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822914|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
822915|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
822916|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
2251441|NCT00135343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2251442|NCT00135343|Protease Inhibitors|protease inhibitors|mesh-ancestor
2251443|NCT00135343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251444|NCT00135343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251445|NCT00135343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2251446|NCT00135343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2251447|NCT00135343|Antiviral Agents|antiviral agents|mesh-ancestor
2251448|NCT00135343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251449|NCT00135343|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2251450|NCT00135343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2251451|NCT00135343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2251452|NCT00135343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2251453|NCT00135343|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2251454|NCT00135343|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
823486|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
823487|NCT02485080|Simeprevir|simeprevir|mesh-list
823488|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
823489|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
823490|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
823491|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823492|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251455|NCT00135343|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2251456|NCT00135343|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2251457|NCT00135343|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2251458|NCT00135369|Lamivudine|lamivudine|mesh-list
2251459|NCT00135369|Efavirenz|efavirenz|mesh-list
2251460|NCT00135369|Stavudine|stavudine|mesh-list
2251461|NCT00135369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2251462|NCT00135369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2251463|NCT00135369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251464|NCT00135369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251465|NCT00135369|Antiviral Agents|antiviral agents|mesh-ancestor
2251466|NCT00135369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251467|NCT00135369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
824980|NCT02479529|Norepinephrine|norepinephrine|mesh-list
824981|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
824982|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
824983|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
824984|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
824985|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824986|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824987|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
824988|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
824989|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824990|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2251468|NCT00135369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2251469|NCT00135369|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2251470|NCT00135369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2251471|NCT00135369|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
825481|NCT02477501|Norepinephrine|norepinephrine|mesh-list
825488|NCT02477501|Ephedrine|ephedrine|mesh-list
825489|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
825490|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
825491|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
825492|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251472|NCT00135369|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2251473|NCT00135369|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2251474|NCT00135369|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
822117|NCT02490085|Insulin|insulin|mesh-list
822118|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
822119|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
822120|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822170|NCT02489695|Axitinib|axitinib|mesh-list
822171|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822172|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
822173|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822174|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822288|NCT02489487|Ritonavir|ritonavir|mesh-list
822289|NCT02489487|Darunavir|darunavir|mesh-list
822290|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
822291|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
822292|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
822293|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
822294|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822295|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822296|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
822297|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
822298|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
822299|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
822300|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
822301|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
822302|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
822303|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2251475|NCT00135369|Antimetabolites|antimetabolites|mesh-ancestor
2251476|NCT00135382|Efavirenz|efavirenz|mesh-list
2251477|NCT00135382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2251478|NCT00135382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2251479|NCT00135382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251480|NCT00135382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251481|NCT00135382|Antiviral Agents|antiviral agents|mesh-ancestor
2251482|NCT00135382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251483|NCT00135382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2251484|NCT00135382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2251485|NCT00135382|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2251486|NCT00135382|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2251487|NCT00135382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2251488|NCT00135382|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2251489|NCT00135395|Ritonavir|ritonavir|mesh-list
2251490|NCT00135395|Lopinavir|lopinavir|mesh-list
2251491|NCT00135395|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2251492|NCT00135395|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2251493|NCT00135395|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2251494|NCT00135395|Protease Inhibitors|protease inhibitors|mesh-ancestor
2251495|NCT00135395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822921|NCT02486822|Oxytocin|oxytocin|mesh-list
822922|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
822923|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
822924|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822980|NCT02486926|Remifentanil|remifentanil|mesh-list
822981|NCT02486926|Alfentanil|alfentanil|mesh-list
822982|NCT02486926|Thiopental|thiopental|mesh-list
822983|NCT02486926|Sevoflurane|sevoflurane|mesh-list
822984|NCT02486926|Rocuronium|rocuronium|mesh-list
822985|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
822986|NCT02486926|Narcotics|narcotics|mesh-ancestor
822987|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822988|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822989|NCT02486926|Analgesics|analgesics|mesh-ancestor
822990|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
822991|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822992|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
822993|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
822994|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
822995|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
822996|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
822997|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
822998|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
822999|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
823000|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
823001|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
823002|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
823003|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
822025|NCT02490436|Cetuximab|cetuximab|mesh-list
822026|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
822027|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822129|NCT02490176|Liraglutide|liraglutide|mesh-list
822130|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
822131|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822132|NCT02490176|Incretins|incretins|mesh-ancestor
822133|NCT02490176|Hormones|hormones|mesh-ancestor
822134|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251496|NCT00135395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251497|NCT00135395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2251498|NCT00135395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2251499|NCT00135395|Antiviral Agents|antiviral agents|mesh-ancestor
2251500|NCT00135395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251501|NCT00135395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2251502|NCT00135395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2251503|NCT00135408|Budesonide|budesonide|mesh-list
2251504|NCT00135408|Ipilimumab|ipilimumab|mesh-list
2251505|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2251506|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251507|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2251508|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251509|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251510|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2251511|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
2251512|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251513|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251514|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
822429|NCT02488512|Edotreotide|edotreotide|mesh-list
822430|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
822431|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822579|NCT02488291|Sufentanil|sufentanil|mesh-list
822580|NCT02488291|Dsuvia|dsuvia|mesh-list
822581|NCT02488291|Ropivacaine|ropivacaine|mesh-list
822582|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
822583|NCT02488291|Anesthetics|anesthetics|mesh-list
822584|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822585|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822586|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
822587|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822588|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
822589|NCT02488291|Narcotics|narcotics|mesh-ancestor
822590|NCT02488291|Analgesics|analgesics|mesh-ancestor
822591|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
822592|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
822593|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
822632|NCT02487953|Nicotine|nicotine|mesh-list
822633|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
822634|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
822635|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822636|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822637|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
822638|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
822639|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
822640|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
822641|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251515|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
2251516|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
2251517|NCT00135408|Hormones|hormones|mesh-ancestor
2251518|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251519|NCT00135421|Citalopram|citalopram|mesh-list
2251520|NCT00135421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2098314|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
2098315|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
2098316|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098317|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098318|NCT02341482|Itraconazole|itraconazole|mesh-list
2098319|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
2098320|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098321|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2098322|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2098323|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098324|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251521|NCT00135421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
823114|NCT02486341|Insulin|insulin|mesh-list
822028|NCT02490540|Sufentanil|sufentanil|mesh-list
822029|NCT02490540|Dsuvia|dsuvia|mesh-list
822030|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
822031|NCT02490540|Narcotics|narcotics|mesh-ancestor
822032|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822033|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822034|NCT02490540|Analgesics|analgesics|mesh-ancestor
822035|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
822036|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822037|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
822038|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
822039|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
822040|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
822304|NCT02489461|Efavirenz|efavirenz|mesh-list
822305|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
822306|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
822307|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
822308|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
822309|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822310|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822311|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
822312|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
822313|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
822314|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
822315|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
822316|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
822317|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
822318|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
822319|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
822365|NCT02488889|Ethanol|ethanol|mesh-list
822366|NCT02488889|Varenicline|varenicline|mesh-list
822367|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
822368|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
822369|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822370|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822371|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
822372|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
822373|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
822374|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
822375|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251522|NCT00135421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2251523|NCT00135421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251524|NCT00135421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251525|NCT00135421|Serotonin Agents|serotonin agents|mesh-ancestor
2251526|NCT00135421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251527|NCT00135421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2251528|NCT00135421|Antidepressive Agents|antidepressive agents|mesh-ancestor
2251529|NCT00135421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2251530|NCT00135434|Ritonavir|ritonavir|mesh-list
2251531|NCT00135434|Lopinavir|lopinavir|mesh-list
2251532|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2251533|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
822872|NCT02487095|Topotecan|topotecan|mesh-list
822873|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
822874|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
822875|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822876|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822877|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823088|NCT02486458|Listerine|listerine|mesh-list
823089|NCT02486458|Fluorides|fluorides|mesh-list
823090|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
823091|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
823092|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
823093|NCT02486458|Protective Agents|protective agents|mesh-ancestor
823094|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823095|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
823096|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251534|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2251535|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
2251536|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251537|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251538|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2251539|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2251540|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
2251541|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
822041|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
822042|NCT02490449|Lansoprazole|lansoprazole|mesh-list
822043|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
822044|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
822045|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
822046|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822047|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822167|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
822168|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
822169|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822392|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
822393|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
822394|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
822395|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
822396|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822397|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822398|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
822399|NCT02489097|Analgesics|analgesics|mesh-ancestor
822400|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
822401|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822476|NCT02488486|Remifentanil|remifentanil|mesh-list
822477|NCT02488486|Propofol|propofol|mesh-list
822478|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
822479|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822480|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822481|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
822482|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
822483|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
822484|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
822485|NCT02488486|Narcotics|narcotics|mesh-ancestor
822486|NCT02488486|Analgesics|analgesics|mesh-ancestor
822487|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
822488|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098325|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2098326|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
2098327|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2098328|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098329|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2098330|NCT02342015|Atorvastatin|atorvastatin|mesh-list
2098331|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2098332|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2098333|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
2098334|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251542|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2251543|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
822606|NCT02488135|Hemostatics|hemostatics|mesh-list
822607|NCT02488135|Coagulants|coagulants|mesh-ancestor
822666|NCT02487732|Ticagrelor|ticagrelor|mesh-list
822667|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
822668|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
822669|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
822670|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
822671|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
822672|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
822673|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
822674|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822675|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822821|NCT02487212|Clobetasol|clobetasol|mesh-list
822822|NCT02487212|Petrolatum|petrolatum|mesh-list
822823|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
822824|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
822825|NCT02487212|Hormones|hormones|mesh-ancestor
822826|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
822827|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822828|NCT02487212|Emollients|emollients|mesh-ancestor
822829|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
823050|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
823051|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
823052|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
823053|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
823054|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
823055|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823056|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823057|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
2251544|NCT00135473|Insulin|insulin|mesh-list
822048|NCT02490488|Gemcitabine|gemcitabine|mesh-list
822049|NCT02490488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
822050|NCT02490488|Antimetabolites|antimetabolites|mesh-ancestor
822051|NCT02490488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822052|NCT02490488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822053|NCT02490488|Antiviral Agents|antiviral agents|mesh-ancestor
822054|NCT02490488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
822055|NCT02490488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822056|NCT02490488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
822057|NCT02490488|Immunologic Factors|immunologic factors|mesh-ancestor
822058|NCT02490488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822099|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
822100|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
822101|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822102|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822103|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
822104|NCT02490072|Analgesics|analgesics|mesh-ancestor
822105|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
822106|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822107|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
822108|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
822109|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
822110|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
822111|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
822112|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822320|NCT02489409|Gemcitabine|gemcitabine|mesh-list
822321|NCT02489409|Vinorelbine|vinorelbine|mesh-list
822322|NCT02489409|Endostatins|endostatins|mesh-list
822323|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
822324|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
822325|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822326|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822327|NCT02489409|Antiviral Agents|antiviral agents|mesh-ancestor
822328|NCT02489409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
822329|NCT02489409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822330|NCT02489409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
822331|NCT02489409|Immunologic Factors|immunologic factors|mesh-ancestor
822332|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822333|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
822334|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
822335|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
822336|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
822337|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
822338|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
822339|NCT02489409|Growth Substances|growth substances|mesh-ancestor
822340|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
2098335|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2098336|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2098337|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098338|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2098339|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
2098340|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2251545|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2251546|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2251547|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2251548|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251549|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
2251550|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
2251551|NCT00135499|Prednisone|prednisone|mesh-list
2251552|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
2251553|NCT00135499|Rituximab|rituximab|mesh-list
2251554|NCT00135499|Doxorubicin|doxorubicin|mesh-list
2251555|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2251556|NCT00135499|Vincristine|vincristine|mesh-list
2251557|NCT00135499|Bleomycin|bleomycin|mesh-list
2251558|NCT00135499|Vindesine|vindesine|mesh-list
2251559|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2251560|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
823205|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
823206|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
823207|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
823208|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823361|NCT02485613|Dexamethasone|dexamethasone|mesh-list
823362|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
823363|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
823364|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
2251561|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251562|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2251563|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
822459|NCT02488564|Metformin|metformin|mesh-list
822460|NCT02488564|Docetaxel|docetaxel|mesh-list
822461|NCT02488564|Doxorubicin|doxorubicin|mesh-list
822462|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
822463|NCT02488564|Trastuzumab|trastuzumab|mesh-list
822464|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
822465|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822466|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822467|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
822468|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
822469|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
822470|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822471|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
822472|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
822473|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
822474|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822475|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
822648|NCT02487680|Chromium|chromium|mesh-list
822649|NCT02487680|Picolinic acid|picolinic acid|mesh-list
822650|NCT02487680|Trace Elements|trace elements|mesh-ancestor
822651|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
822652|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822653|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
822654|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
822655|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
822656|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251564|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
2251565|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251566|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251567|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2251568|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2251569|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2251570|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2251571|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
822961|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
822962|NCT02486744|Hormones|hormones|mesh-ancestor
822963|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
822964|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098341|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
2098342|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2098343|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098344|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2098345|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2251572|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823229|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
823230|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
823231|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251573|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251574|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
2251575|NCT00135499|Hormones|hormones|mesh-ancestor
2251576|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251577|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2251578|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2251579|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
2251580|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
2251581|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
2251582|NCT00135525|Paroxetine|paroxetine|mesh-list
2251583|NCT00135525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
823506|NCT02485106|Rifaximin|rifaximin|mesh-list
823507|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
823508|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
823509|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
823510|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
823511|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
823512|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823513|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823514|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
823515|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
823516|NCT02485106|Protective Agents|protective agents|mesh-ancestor
823517|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822062|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
822063|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
822064|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
822065|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
822066|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
2251584|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2251585|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2251586|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251587|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251588|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
2251589|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251590|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2251591|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
2251592|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2251593|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2251594|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2251595|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251596|NCT00135551|Benidipine|benidipine|mesh-list
2251597|NCT00135551|Diuretics|diuretics|mesh-list
2251598|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
2251599|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
822489|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
822490|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
822491|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822492|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822493|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
822494|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
822612|NCT02487914|Lidocaine|lidocaine|mesh-list
822613|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
822614|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
822615|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822616|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822617|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
822618|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822619|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
822620|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
822621|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
822622|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
822623|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823277|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
823278|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
823279|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
823280|NCT02485821|Estradiol|estradiol|mesh-list
823281|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
823282|NCT02485821|Estrogens|estrogens|mesh-ancestor
823283|NCT02485821|Hormones|hormones|mesh-ancestor
823284|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
823285|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823286|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
823287|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
823288|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
823289|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
823290|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
823291|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
823292|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
823293|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
823294|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
823295|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
823296|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
823498|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
823499|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
823500|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
823501|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
823502|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823503|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823504|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823505|NCT02485067|Urological Agents|urological agents|mesh-ancestor
823536|NCT02485184|Propranolol|propranolol|mesh-list
823537|NCT02485184|Warfarin|warfarin|mesh-list
823538|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
823539|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
823540|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
823541|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
823542|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251600|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2251601|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
2251602|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251603|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2251604|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251605|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2251606|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
2251607|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098346|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098347|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
2098348|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2098349|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
2098350|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098351|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
2098352|NCT02342223|Protective Agents|protective agents|mesh-ancestor
2098353|NCT02342327|Menthol|menthol|mesh-list
2098354|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
2098355|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
2098356|NCT02342379|Bevacizumab|bevacizumab|mesh-list
2098357|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2098358|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098359|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2098360|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2098361|NCT02342379|Growth Substances|growth substances|mesh-ancestor
2098362|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098363|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
2098364|NCT02342418|Tedizolid|tedizolid|mesh-list
2098365|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
2098366|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2098367|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098368|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
2098369|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2098370|NCT02342639|Rifaximin|rifaximin|mesh-list
2098371|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2098372|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098373|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
822513|NCT02488616|Insulin|insulin|mesh-list
822514|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
822515|NCT02488616|Hormones|hormones|mesh-list
822516|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
822517|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822518|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251608|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2251609|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2251610|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
2251611|NCT00135577|Alvimopan|alvimopan|mesh-list
2251612|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2251613|NCT00135603|Amoxicillin|amoxicillin|mesh-list
2251614|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
2251615|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
2251616|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2251617|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2251618|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251619|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2251620|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251621|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251622|NCT00135668|Nitroprusside|nitroprusside|mesh-list
2251623|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2251624|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
2251625|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2251626|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251627|NCT00135681|Nedocromil|nedocromil|mesh-list
2251628|NCT00135681|Budesonide|budesonide|mesh-list
2251629|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251630|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2251631|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
2251632|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251633|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251634|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2251635|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
2251636|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
822917|NCT02486848|Minoxidil|minoxidil|mesh-list
822918|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
822919|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
822920|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
2098374|NCT02342704|Natalizumab|natalizumab|mesh-list
2098375|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
822075|NCT02490345|Gabapentin|gabapentin|mesh-list
822076|NCT02490345|Analgesics|analgesics|mesh-ancestor
822077|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
822078|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822079|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822080|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
822081|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
822082|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
822083|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822084|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
822085|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
822086|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
822087|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
822088|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822089|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
822121|NCT02489942|Empagliflozin|empagliflozin|mesh-list
822122|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
822123|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822124|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
822125|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822519|NCT02488538|Fluoxetine|fluoxetine|mesh-list
822520|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
822521|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
822522|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
822523|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
822524|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822525|NCT02488538|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
822526|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
822527|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
822528|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822529|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
822530|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
822531|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
822532|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
822533|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
822534|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
822535|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
822536|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822537|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
822686|NCT02487719|Teferrol|teferrol|mesh-list
822687|NCT02487719|Hematinics|hematinics|mesh-ancestor
822780|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
822781|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
822782|NCT02487355|Bupivacaine|bupivacaine|mesh-list
822783|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
822784|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
822785|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822786|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822787|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
822788|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822789|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
822790|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
822791|NCT02487355|Analgesics|analgesics|mesh-ancestor
822792|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
822793|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
822794|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
822795|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
822796|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
822797|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822798|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
822799|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
822800|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
822801|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
822802|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
822803|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
822804|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2251637|NCT00135681|Hormones|hormones|mesh-ancestor
2251638|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251639|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
2251640|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
2251641|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2251642|NCT00135720|Etanercept|etanercept|mesh-list
823276|NCT02485821|Misoprostol|misoprostol|mesh-list
822090|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
822091|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
822092|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
822093|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822094|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822095|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
822096|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
822097|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822098|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098376|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
2098377|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251643|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
822495|NCT02488642|Isosorbide|isosorbide|mesh-list
822496|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
822497|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
822498|NCT02488642|Misoprostol|misoprostol|mesh-list
822499|NCT02488642|Oxytocin|oxytocin|mesh-list
822500|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
822501|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
822502|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822503|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
822504|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
822505|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
822506|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
822507|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
822508|NCT02488642|Diuretics|diuretics|mesh-ancestor
822509|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
822510|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
822511|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
822512|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822741|NCT02487849|Carboplatin|carboplatin|mesh-list
822742|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822878|NCT02487069|Cyclosporine|cyclosporine|mesh-list
822879|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
822880|NCT02487069|Methotrexate|methotrexate|mesh-list
822881|NCT02487069|Cyclosporins|cyclosporins|mesh-list
822882|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
822883|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
822884|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
822885|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
822886|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822887|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
822888|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
822889|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822890|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822891|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
822892|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822893|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
822894|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
822895|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
822896|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
822897|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
822898|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
822899|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
822900|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
822901|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
822902|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
822903|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
822904|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2251644|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2251645|NCT00135720|Analgesics|analgesics|mesh-ancestor
2251646|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
2251647|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251648|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251649|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251650|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2251651|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2251652|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2251653|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
2251654|NCT00135733|Alefacept|alefacept|mesh-list
2251655|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
2251656|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
2251657|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251658|NCT00135746|Nicotine|nicotine|mesh-list
2251659|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2251660|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
822113|NCT02489955|Tobramycin|tobramycin|mesh-list
822114|NCT02489955|Amikacin|amikacin|mesh-list
822115|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
822116|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
822264|NCT02489513|Ivosidenib|ivosidenib|mesh-list
822265|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822266|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822267|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822432|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
822433|NCT02488473|Ropivacaine|ropivacaine|mesh-list
822434|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
822435|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
822436|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822437|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
822438|NCT02488473|Analgesics|analgesics|mesh-ancestor
822439|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
822440|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822441|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
822442|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
822443|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
822444|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
822445|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
822446|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822447|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
822448|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
822608|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
822609|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
822610|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
822611|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2251661|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251662|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251663|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2251664|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2251665|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
2251666|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251667|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251668|NCT00135759|Naltrexone|naltrexone|mesh-list
2251669|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2251670|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2251671|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823027|NCT02486432|Levodopa|levodopa|mesh-list
823028|NCT02486432|Carbidopa|carbidopa|mesh-list
823029|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
823030|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
823031|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
823032|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
823033|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823034|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823035|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823036|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
823037|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823038|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
823039|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
823040|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
823209|NCT02486276|Cilostazol|cilostazol|mesh-list
823210|NCT02486276|Sumatriptan|sumatriptan|mesh-list
823211|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
823212|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
823213|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
823214|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
823215|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823216|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823217|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823218|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
823219|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
823220|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
823221|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
823222|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
823223|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
823224|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
823225|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
823226|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
823227|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
823228|NCT02486276|Protective Agents|protective agents|mesh-ancestor
2251672|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
2251673|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251674|NCT00135785|Bupropion|bupropion|mesh-list
2251675|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2251676|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
2251677|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2251678|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2251679|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2251680|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2251681|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251682|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
2251683|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251684|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251685|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2251686|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2251687|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251688|NCT00135811|Cyclosporine|cyclosporine|mesh-list
2251689|NCT00135811|Dexamethasone|dexamethasone|mesh-list
2251690|NCT00135811|Cyclosporins|cyclosporins|mesh-list
2251691|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251692|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
823412|NCT02485249|Dexamethasone|dexamethasone|mesh-list
823413|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
823414|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
823415|NCT02485249|BB 1101|bb 1101|mesh-list
823416|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
823417|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
823418|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
823419|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
823420|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823421|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
823422|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
823423|NCT02485249|Hormones|hormones|mesh-ancestor
823424|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
823425|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
823426|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823427|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
823428|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823429|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823430|NCT02485145|Diclofenac|diclofenac|mesh-list
823431|NCT02485145|Orphenadrine|orphenadrine|mesh-list
823432|NCT02485145|Bupivacaine|bupivacaine|mesh-list
823433|NCT02485145|Baclofen|baclofen|mesh-list
823434|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
823435|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
823436|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
823437|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823438|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
823439|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
823440|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
823441|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
823442|NCT02485145|Analgesics|analgesics|mesh-ancestor
823443|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
823444|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
823445|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
823446|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823447|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823448|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
823449|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
823450|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
823451|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
823452|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
823453|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823454|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
823455|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
823456|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
823457|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
823458|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
823459|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2251693|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
2251694|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251695|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251696|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2251697|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
2251698|NCT00135811|Hormones|hormones|mesh-ancestor
2251699|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251700|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2251701|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251702|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251703|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822573|NCT02488057|Liraglutide|liraglutide|mesh-list
822574|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
822575|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822576|NCT02488057|Incretins|incretins|mesh-ancestor
822577|NCT02488057|Hormones|hormones|mesh-ancestor
822578|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
822710|NCT02487407|Simendan|simendan|mesh-list
822711|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
822712|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
822713|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
822714|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
822715|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822716|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822717|NCT02487407|Protective Agents|protective agents|mesh-ancestor
822718|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823004|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823005|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823067|NCT02486484|Aflibercept|aflibercept|mesh-list
823068|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
823069|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
823070|NCT02486484|Growth Substances|growth substances|mesh-ancestor
823071|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823072|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
823073|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823244|NCT02485990|Olaparib|olaparib|mesh-list
823245|NCT02485990|Tremelimumab|tremelimumab|mesh-list
823246|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
823247|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823248|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823249|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823313|NCT02485691|Prednisone|prednisone|mesh-list
823314|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
823315|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
823316|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
823317|NCT02485691|Hormones|hormones|mesh-ancestor
823318|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
823319|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823320|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
823321|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823322|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
823323|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823324|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823325|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
823326|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
823365|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
823366|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823367|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
823368|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
823369|NCT02485613|Hormones|hormones|mesh-ancestor
823370|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
823371|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
823372|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823463|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
823464|NCT02485262|Simeprevir|simeprevir|mesh-list
823465|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
823466|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
823467|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
823468|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823469|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823521|NCT02484924|Clopidogrel|clopidogrel|mesh-list
823522|NCT02484924|Ticagrelor|ticagrelor|mesh-list
823523|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2251704|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2251705|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
2251706|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
2251707|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251708|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
2251709|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2251710|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2251711|NCT00135824|Povidone|povidone|mesh-list
2251712|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2251713|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2251714|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
2251715|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
2098378|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2098379|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098380|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2098381|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
2098382|NCT02342886|Rifampin|rifampin|mesh-list
2098383|NCT02342886|Isoniazid|isoniazid|mesh-list
2098384|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
2098385|NCT02342886|Ethambutol|ethambutol|mesh-list
2098386|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2098387|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098388|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2098389|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2098390|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098391|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098392|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098393|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2098394|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
2098395|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
2098396|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2098397|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2098398|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2098399|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2098400|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2098401|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2098402|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2098403|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2098404|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2098405|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
2098406|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2098407|NCT02343081|Temozolomide|temozolomide|mesh-list
2098408|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2098409|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
2098410|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098411|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098412|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
2098413|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
2098414|NCT02343406|Temozolomide|temozolomide|mesh-list
2098415|NCT02343406|Lomustine|lomustine|mesh-list
2098416|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2098417|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
2251716|NCT00135837|Verteporfin|verteporfin|mesh-list
2251717|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
823396|NCT02485340|Isosorbide|isosorbide|mesh-list
823397|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
823398|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
823399|NCT02485340|Sumatriptan|sumatriptan|mesh-list
823400|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
823401|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
823402|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
823403|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
823404|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823405|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823406|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823407|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
823408|NCT02485340|Diuretics|diuretics|mesh-ancestor
823409|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
823410|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
823411|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
823543|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823544|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823545|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
823546|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
823547|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
822159|NCT02490098|Insulin|insulin|mesh-list
822160|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
822161|NCT02490098|Glucagon|glucagon|mesh-list
822162|NCT02490098|Hormones|hormones|mesh-list
822163|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
822164|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822165|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
822166|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
822706|NCT02487433|Tofacitinib|tofacitinib|mesh-list
822707|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
822708|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822709|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823097|NCT02486549|Bupivacaine|bupivacaine|mesh-list
823098|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
823099|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
823100|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
823101|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823102|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
823103|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
823343|NCT02485548|Fluorouracil|fluorouracil|mesh-list
823344|NCT02485548|Raltitrexed|raltitrexed|mesh-list
823345|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823346|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
823347|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823348|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
823349|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
823350|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
823351|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823352|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
823353|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823460|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
823461|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
823462|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2251718|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
2251719|NCT00135863|Tinzaparin|tinzaparin|mesh-list
2251720|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2251721|NCT00135863|Dalteparin|dalteparin|mesh-list
2251722|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
2251723|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2251724|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2251725|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251726|NCT00135876|Dalteparin|dalteparin|mesh-list
2251727|NCT00135876|Tinzaparin|tinzaparin|mesh-list
2251728|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2251729|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
2251730|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2251731|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2251732|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251733|NCT00135902|Progesterone|progesterone|mesh-list
2251734|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2251735|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2251736|NCT00135902|Progestins|progestins|mesh-ancestor
2251737|NCT00135902|Hormones|hormones|mesh-ancestor
2251738|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251739|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251740|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2251741|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
823626|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
823627|NCT02484768|Hematinics|hematinics|mesh-ancestor
823629|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
823630|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251742|NCT00135928|Sargramostim|sargramostim|mesh-list
2251743|NCT00135928|Lenograstim|lenograstim|mesh-list
2251744|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
2251745|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251746|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2251747|NCT00135941|Insulin|insulin|mesh-list
823650|NCT02484573|Propranolol|propranolol|mesh-list
2251748|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2251749|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
2251750|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
822178|NCT02489929|Azacitidine|azacitidine|mesh-list
822179|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
822180|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
822181|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822182|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822183|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822414|NCT02488694|Pemetrexed|pemetrexed|mesh-list
822415|NCT02488694|Afatinib|afatinib|mesh-list
822416|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822417|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822418|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822419|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
822420|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
822421|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2251751|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2251752|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251753|NCT00135954|Prednisolone|prednisolone|mesh-list
2251754|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
2251755|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2251756|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
2251757|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251758|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2251759|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2251760|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
823104|NCT02486367|Clopidogrel|clopidogrel|mesh-list
823105|NCT02486367|Ticagrelor|ticagrelor|mesh-list
823106|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
823107|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
823108|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
823109|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
823110|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
823111|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823112|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823113|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823115|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
823116|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823165|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
823166|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
823167|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823168|NCT02486055|Vitamins|vitamins|mesh-ancestor
2251761|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251762|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251763|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2251764|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251765|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
2251766|NCT00135954|Hormones|hormones|mesh-ancestor
2251767|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251768|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2251769|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
2251770|NCT00135967|Prednisone|prednisone|mesh-list
2251771|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
2251772|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
823470|NCT02484885|Xenon|xenon|mesh-list
823471|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
823472|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
823473|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
823474|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
823475|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823476|NCT02484963|Zolpidem|zolpidem|mesh-list
823477|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
823478|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
823479|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
823480|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823481|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
823482|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
823483|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
823484|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823485|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251773|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2251774|NCT00135967|Prednisolone|prednisolone|mesh-list
2251775|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
2251776|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2251777|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
2251778|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251779|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
822184|NCT02489760|Adalimumab|adalimumab|mesh-list
822185|NCT02489760|Etanercept|etanercept|mesh-list
822186|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
822187|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
822188|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
822190|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
822191|NCT02489760|Analgesics|analgesics|mesh-ancestor
822192|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
822193|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822194|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822195|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
822196|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
822197|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
822268|NCT02489266|Aldesleukin|aldesleukin|mesh-list
822269|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
822270|NCT02489266|Fludarabine|fludarabine|mesh-list
822271|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
822272|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
822273|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822274|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
822275|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
822276|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
822277|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822278|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822279|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
822280|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
822281|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
822282|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
822283|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
822388|NCT02488993|Rifaximin|rifaximin|mesh-list
822389|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
822390|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
822391|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
822449|NCT02488603|Tamoxifen|tamoxifen|mesh-list
822450|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
822451|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
822452|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
822453|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822454|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
822455|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822456|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
822457|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
822458|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
823041|NCT02486510|Maraviroc|maraviroc|mesh-list
823042|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
823043|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
823044|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823045|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
823046|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
823047|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
823048|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
823049|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2251780|NCT00135967|Hormones|hormones|mesh-ancestor
2251781|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251782|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251783|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2251784|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251785|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2098418|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098419|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098420|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
823373|NCT02485444|Oxytocin|oxytocin|mesh-list
823374|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
823375|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
823376|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251786|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2251787|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
2251788|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2251789|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251790|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251791|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251792|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
2251793|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
2251794|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822189|NCT02489786|Digoxin|digoxin|mesh-list
822198|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
822199|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
822200|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822201|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822202|NCT02489786|Protective Agents|protective agents|mesh-ancestor
822203|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822743|NCT02487316|Crizotinib|crizotinib|mesh-list
822744|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822745|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
822746|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822747|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251795|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2251796|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2251797|NCT00135967|Protective Agents|protective agents|mesh-ancestor
2251798|NCT00135993|Rotigotine|rotigotine|mesh-list
2251799|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
2251800|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
2251801|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251802|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251803|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251804|NCT00136045|Rotigotine|rotigotine|mesh-list
2251805|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
2251806|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
2251807|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251808|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251809|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251810|NCT00136058|Alendronate|alendronate|mesh-list
2251811|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
2251812|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2251813|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251814|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2251815|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2251816|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251817|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2251818|NCT00136110|Valproic Acid|valproic acid|mesh-list
2251819|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
2251820|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251821|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251822|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
2251823|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251824|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251825|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
2251826|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2251827|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2251828|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2251829|NCT00136175|Gemcitabine|gemcitabine|mesh-list
2251830|NCT00136175|Paclitaxel|paclitaxel|mesh-list
2251831|NCT00136175|Carboplatin|carboplatin|mesh-list
2251832|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2251833|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251834|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
823518|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
823519|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
823520|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
2251835|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
2251836|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
2251837|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251838|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2251839|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
2251840|NCT00136175|Antiviral Agents|antiviral agents|mesh-ancestor
2251841|NCT00136175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251842|NCT00136175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251843|NCT00136175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2251844|NCT00136175|Immunologic Factors|immunologic factors|mesh-ancestor
2251845|NCT00136175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251846|NCT00136188|Folic Acid|folic acid|mesh-list
2251847|NCT00136188|Hematinics|hematinics|mesh-ancestor
2251848|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
2251849|NCT00136188|Vitamins|vitamins|mesh-ancestor
2251850|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
2251851|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251852|NCT00136201|Tigecycline|tigecycline|mesh-list
2251853|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2251854|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
823742|NCT02484170|Mannitol|mannitol|mesh-list
2251855|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2251856|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251857|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251858|NCT00136266|Vitamin D|vitamin d|mesh-list
2251859|NCT00136266|Vitamins|vitamins|mesh-list
2251860|NCT00136266|Vitamin A|vitamin a|mesh-list
2251861|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
822257|NCT02489240|Vitamin D|vitamin d|mesh-list
822258|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
822259|NCT02489240|Vitamins|vitamins|mesh-ancestor
822260|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
822261|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822262|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
822263|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
822360|NCT02489006|Olaparib|olaparib|mesh-list
822361|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
822362|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822363|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822364|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822657|NCT02487706|Dolutegravir|dolutegravir|mesh-list
822658|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
822659|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
822660|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
822661|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822662|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
822663|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
822664|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
822665|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
823058|NCT02486640|Interferons|interferons|mesh-list
823059|NCT02486640|Interferon-beta|interferon-beta|mesh-list
823060|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
823061|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823062|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
823063|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
823064|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
823065|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823066|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
823140|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
823141|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251862|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
2251863|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251864|NCT00136266|Trace Elements|trace elements|mesh-ancestor
2251865|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
823297|NCT02485873|Vitamin K|vitamin k|mesh-list
823298|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
823299|NCT02485873|Vitamins|vitamins|mesh-ancestor
823300|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
823301|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823302|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
823303|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
823304|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
823305|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
823306|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823307|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823308|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
823309|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
823310|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
823311|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
823312|NCT02485873|Coagulants|coagulants|mesh-ancestor
823377|NCT02485431|Deflazacort|deflazacort|mesh-list
823378|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
823379|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
823380|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
823381|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823524|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
823525|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
823526|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
823527|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
823528|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823529|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823530|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251866|NCT00136292|Daptomycin|daptomycin|mesh-list
2251867|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2251868|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251869|NCT00136344|Levofloxacin|levofloxacin|mesh-list
2251870|NCT00136344|Ofloxacin|ofloxacin|mesh-list
2251871|NCT00136344|Cefuroxime|cefuroxime|mesh-list
2251872|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
2251873|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2251874|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251875|NCT00136344|Renal Agents|renal agents|mesh-ancestor
2251876|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2251877|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2251878|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2251879|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251880|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251881|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251882|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2251883|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2251884|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
2251885|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2251886|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251887|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
2251888|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
823182|NCT02486133|Ritonavir|ritonavir|mesh-list
823183|NCT02486133|Darunavir|darunavir|mesh-list
823184|NCT02486133|Tenofovir|tenofovir|mesh-list
823185|NCT02486133|Lamivudine|lamivudine|mesh-list
823186|NCT02486133|Emtricitabine|emtricitabine|mesh-list
823187|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
823188|NCT02486133|Abacavir|abacavir|mesh-list
823189|NCT02486133|Dolutegravir|dolutegravir|mesh-list
823190|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
823191|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
823192|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
823193|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823194|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823195|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
823196|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
823197|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
823198|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
823199|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
823200|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
823201|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
823202|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
823203|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
823204|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
823392|NCT02485327|Insulin|insulin|mesh-list
823393|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
823394|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
823395|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823493|NCT02485041|Mirodenafil|mirodenafil|mesh-list
823494|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
823495|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
823496|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823497|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823531|NCT02485015|Apatinib|apatinib|mesh-list
823532|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823533|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
823534|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823535|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823573|NCT02485028|Mirodenafil|mirodenafil|mesh-list
823574|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
823575|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
823576|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823577|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251889|NCT00136383|Paroxetine|paroxetine|mesh-list
2251890|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2251891|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2251892|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2251893|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251894|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2251895|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251896|NCT00136383|Analgesics|analgesics|mesh-ancestor
2251897|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
2251898|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251899|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
823628|NCT02484833|Cetuximab|cetuximab|mesh-list
822013|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
822016|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
822017|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
822018|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822019|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
822020|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
822021|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
822175|NCT02489864|Terlipressin|terlipressin|mesh-list
822176|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
822177|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
822402|NCT02488902|Mefloquine|mefloquine|mesh-list
822403|NCT02488902|Tafenoquine|tafenoquine|mesh-list
822404|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
822405|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
822406|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
822407|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
822676|NCT02487823|Bicalutamide|bicalutamide|mesh-list
822677|NCT02487823|Buserelin|buserelin|mesh-list
822678|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
822679|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
822680|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
822681|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822682|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
822683|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
822684|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
822685|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
822748|NCT02487381|Dronabinol|dronabinol|mesh-list
822749|NCT02487381|Cannabidiol|cannabidiol|mesh-list
822750|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
822751|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
822752|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
822753|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
822754|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
822755|NCT02487381|Analgesics|analgesics|mesh-ancestor
822756|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
822757|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
822758|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
822759|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
822760|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
822761|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
822762|NCT02487381|Hormones|hormones|mesh-ancestor
822763|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
823074|NCT02486601|Paclitaxel|paclitaxel|mesh-list
823075|NCT02486601|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
823076|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
823077|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823078|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
823079|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
823080|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
823081|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251900|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2251901|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
2251902|NCT00136383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2251903|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
2251904|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2251905|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2251906|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
824197|NCT02482272|Lamivudine|lamivudine|mesh-list
824198|NCT02482272|Adefovir|adefovir|mesh-list
824199|NCT02482272|Entecavir|entecavir|mesh-list
824200|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
824201|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
824202|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824203|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824204|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
824205|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824206|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
824207|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2251907|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251908|NCT00136396|Rituximab|rituximab|mesh-list
2251909|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2251910|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251911|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
2251912|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251913|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2251914|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
823828|NCT02483845|Natalizumab|natalizumab|mesh-list
823829|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
823830|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251915|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251916|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
825521|NCT02477397|Fluticasone|fluticasone|mesh-list
825522|NCT02477397|Xhance|xhance|mesh-list
825523|NCT02477397|Budesonide|budesonide|mesh-list
825524|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
825525|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
825526|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
825527|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
825528|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
825529|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
825530|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
825531|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825532|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825533|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
825534|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
825535|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
825536|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
825537|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
825538|NCT02477397|Hormones|hormones|mesh-ancestor
825539|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
825540|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
825541|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
825542|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
825543|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
825544|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
825545|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825546|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
2098421|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
2098422|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2098423|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
2098424|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098425|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827048|NCT02472236|Digoxin|digoxin|mesh-list
827049|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
827050|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
827051|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827052|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827053|NCT02472236|Protective Agents|protective agents|mesh-ancestor
827054|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827198|NCT02471547|Mitomycins|mitomycins|mesh-list
827199|NCT02471547|Mitomycin|mitomycin|mesh-list
827200|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
827201|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827202|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
827203|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827204|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
827205|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827247|NCT02471209|Sevoflurane|sevoflurane|mesh-list
827248|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
827249|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
827250|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827251|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
827252|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
827253|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
827307|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
827308|NCT02470858|Asunaprevir|asunaprevir|mesh-list
827309|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
827310|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827311|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
827312|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827313|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827378|NCT02470442|Sevoflurane|sevoflurane|mesh-list
827379|NCT02470442|Desflurane|desflurane|mesh-list
2098426|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
823651|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
823652|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
823653|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
823654|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823655|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823656|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823657|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
823658|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
823659|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
823772|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
823773|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824208|NCT02482402|Iloprost|iloprost|mesh-list
824209|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
824211|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
2251917|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251918|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251919|NCT00136435|Leucovorin|leucovorin|mesh-list
2251920|NCT00136435|Cytarabine|cytarabine|mesh-list
2251921|NCT00136435|Dexamethasone|dexamethasone|mesh-list
2251922|NCT00136435|Prednisone|prednisone|mesh-list
2251923|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
824678|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
824679|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
824680|NCT02480387|Ledipasvir|ledipasvir|mesh-list
824681|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
824682|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
825449|NCT02477514|Tedizolid|tedizolid|mesh-list
825450|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
825451|NCT02477514|Midazolam|midazolam|mesh-list
825452|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
825453|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
825454|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
825455|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
825456|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825457|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
825458|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
825459|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
825460|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
825461|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
825462|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
825463|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
825464|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
825465|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
825466|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825467|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
825468|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
825469|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
825470|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
825471|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
825472|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825473|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
825474|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251924|NCT00136435|Doxorubicin|doxorubicin|mesh-list
2251925|NCT00136435|Methotrexate|methotrexate|mesh-list
2251926|NCT00136435|Vincristine|vincristine|mesh-list
2251927|NCT00136435|Asparaginase|asparaginase|mesh-list
2251928|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
2251929|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2251930|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
2251931|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
2251932|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251933|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251934|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2251935|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
2251936|NCT00136435|Hormones|hormones|mesh-ancestor
2251937|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251938|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2251939|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251940|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2251941|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2251942|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2251943|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251944|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251945|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2251946|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
2251947|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2251948|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
823660|NCT02484677|Docetaxel|docetaxel|mesh-list
823661|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823662|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
823663|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
823664|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
823665|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823736|NCT02484300|Melatonin|melatonin|mesh-list
823737|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
823738|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823739|NCT02484300|Protective Agents|protective agents|mesh-ancestor
823740|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823741|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
823875|NCT02483884|Bombesin|bombesin|mesh-list
823876|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823877|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823878|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824299|NCT02482324|Ibuprofen|ibuprofen|mesh-list
824300|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
824301|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
824302|NCT02482324|Analgesics|analgesics|mesh-ancestor
824303|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
824304|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824305|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824306|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
824307|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
824308|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
824309|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824310|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824404|NCT02481635|Gemcitabine|gemcitabine|mesh-list
824405|NCT02481635|Paclitaxel|paclitaxel|mesh-list
824406|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
824407|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824408|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
824409|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
824410|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
824411|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824412|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
824413|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
824414|NCT02481635|Antiviral Agents|antiviral agents|mesh-ancestor
824415|NCT02481635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824416|NCT02481635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824417|NCT02481635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
824418|NCT02481635|Immunologic Factors|immunologic factors|mesh-ancestor
824419|NCT02481635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824429|NCT02481323|Cilostazol|cilostazol|mesh-list
824430|NCT02481323|Isosorbide|isosorbide|mesh-list
824431|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
824432|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
824433|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
824434|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
824435|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824436|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824437|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
824438|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
824439|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
824440|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
824441|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824442|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
824443|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
824444|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
824445|NCT02481323|Protective Agents|protective agents|mesh-ancestor
824446|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
824447|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
824448|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824449|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
824450|NCT02481323|Diuretics|diuretics|mesh-ancestor
824451|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
824452|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
824724|NCT02479867|Cefadroxil|cefadroxil|mesh-list
824725|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
824726|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824876|NCT02479646|Lenograstim|lenograstim|mesh-list
824877|NCT02479646|Sargramostim|sargramostim|mesh-list
824878|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
824879|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
824880|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823666|NCT02484755|Gefitinib|gefitinib|mesh-list
823667|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823668|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
823669|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823670|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823762|NCT02484261|Bortezomib|bortezomib|mesh-list
823763|NCT02484261|Pravastatin|pravastatin|mesh-list
823764|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823765|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
823766|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
823767|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
823768|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823769|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
823770|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
823771|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823879|NCT02483689|Bupivacaine|bupivacaine|mesh-list
823880|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
823881|NCT02483689|Anesthetics|anesthetics|mesh-list
823882|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
823883|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823884|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
823885|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251949|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
2251950|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
2251951|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2251952|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2251953|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
2251954|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2251955|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2251956|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
2251957|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251958|NCT00136435|Antidotes|antidotes|mesh-ancestor
2754433|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754434|NCT01123707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2754435|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
2754436|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2754437|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2754438|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2754439|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2754440|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
2754441|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
2754442|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2754443|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2754444|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2754445|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2754446|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2754447|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2754448|NCT00999401|Roscovitine|roscovitine|mesh-list
2754449|NCT00999401|Sapacitabine|sapacitabine|mesh-list
2754450|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754451|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
2754452|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2754453|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2754454|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754455|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251959|NCT00136435|Protective Agents|protective agents|mesh-ancestor
2098427|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
2098428|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2098429|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2098430|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2098431|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
2098432|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098433|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098434|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2251960|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
823747|NCT02484209|Metformin|metformin|mesh-list
823748|NCT02484209|Glimepiride|glimepiride|mesh-list
823749|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
823750|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823751|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
823752|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
823753|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
823907|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
823908|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
823909|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
823910|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
823911|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823912|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
823913|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
823914|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824039|NCT02483026|Vitamin D|vitamin d|mesh-list
824040|NCT02483026|Vitamins|vitamins|mesh-list
824041|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
824042|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824043|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
824480|NCT02481193|Cisatracurium|cisatracurium|mesh-list
824481|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
824482|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
824483|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824484|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824959|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
824960|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
824961|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824962|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
824963|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825553|NCT02477267|Buprenorphine|buprenorphine|mesh-list
825554|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
825555|NCT02477267|Naloxone|naloxone|mesh-list
825556|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
825557|NCT02477267|Narcotics|narcotics|mesh-ancestor
825558|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
825559|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825560|NCT02477267|Analgesics|analgesics|mesh-ancestor
825561|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
825562|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825563|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2251961|NCT00136435|Vitamins|vitamins|mesh-ancestor
2251962|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
2251963|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2251964|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
2251965|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
2251966|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
2251967|NCT00136448|Cytarabine|cytarabine|mesh-list
2251968|NCT00136448|Interleukin-2|interleukin-2|mesh-list
2251969|NCT00136448|Daunorubicin|daunorubicin|mesh-list
2251970|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2251971|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
826329|NCT02474433|Misoprostol|misoprostol|mesh-list
826330|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
826331|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
2098435|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2098436|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2098437|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
2098438|NCT02343549|Bevacizumab|bevacizumab|mesh-list
2098439|NCT02343549|Temozolomide|temozolomide|mesh-list
2098440|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2098441|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098442|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2098443|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
824001|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
824002|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
824003|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824004|NCT02483143|Expectorants|expectorants|mesh-ancestor
824005|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
824006|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
824007|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
824008|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824009|NCT02483143|Protective Agents|protective agents|mesh-ancestor
824010|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824485|NCT02481180|T0001|t0001|mesh-list
824486|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
824487|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824488|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
824489|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
2251972|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2251973|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251974|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
825164|NCT02478879|Teriparatide|teriparatide|mesh-list
825165|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
825166|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825167|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
825168|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
825338|NCT02478255|Xenon|xenon|mesh-list
825339|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
825340|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
825341|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
825342|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
825343|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825368|NCT02477813|Temozolomide|temozolomide|mesh-list
825369|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
825370|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
825371|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825372|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251975|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2251976|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2251977|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
2251978|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251979|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2251980|NCT00136448|Analgesics|analgesics|mesh-ancestor
2251981|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
2251982|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2251983|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2251984|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2251985|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2251986|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2251987|NCT00136461|Tretinoin|tretinoin|mesh-list
2251988|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
2251989|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2251990|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
2251991|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
2251992|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2251993|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
2251994|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2251995|NCT00136474|Amifostine|amifostine|mesh-list
2251996|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2251997|NCT00136474|Protective Agents|protective agents|mesh-ancestor
2251998|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825758|NCT02476786|Tamoxifen|tamoxifen|mesh-list
825759|NCT02476786|Fulvestrant|fulvestrant|mesh-list
825760|NCT02476786|Anastrozole|anastrozole|mesh-list
825761|NCT02476786|Goserelin|goserelin|mesh-list
825762|NCT02476786|Exemestane|exemestane|mesh-list
825763|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
825764|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
825765|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2251999|NCT00136487|Celecoxib|celecoxib|mesh-list
2252000|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2098444|NCT02343549|Growth Substances|growth substances|mesh-ancestor
2098445|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098446|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
2098447|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2098448|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
824011|NCT02483156|Ribavirin|ribavirin|mesh-list
824012|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
824013|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
824014|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824015|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
824016|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824139|NCT02482857|Aspirin|aspirin|mesh-list
824140|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
824141|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
824142|NCT02482857|Analgesics|analgesics|mesh-ancestor
824143|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
824144|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824145|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824146|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
824147|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
824148|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
824149|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
824150|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824151|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
824152|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
824153|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824154|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
824354|NCT02481791|Remifentanil|remifentanil|mesh-list
824355|NCT02481791|Propofol|propofol|mesh-list
824356|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
824357|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
824358|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824359|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
824360|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
824361|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
824362|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
824363|NCT02481791|Narcotics|narcotics|mesh-ancestor
824364|NCT02481791|Analgesics|analgesics|mesh-ancestor
824365|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
824366|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824964|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
824965|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
824966|NCT02479347|Povidone|povidone|mesh-list
824967|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
824968|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824969|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
824970|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
824971|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
825316|NCT02478242|Nafamostat|nafamostat|mesh-list
825317|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
825318|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
825319|NCT02478242|Analgesics|analgesics|mesh-ancestor
825320|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
825321|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825322|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825323|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
825324|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
825325|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
825326|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
825327|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825328|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825329|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
825330|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
825331|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
825332|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
825333|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
825444|NCT02477631|Deferiprone|deferiprone|mesh-list
825445|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
825446|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
825447|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
825448|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825651|NCT02477098|Ropivacaine|ropivacaine|mesh-list
825652|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
825653|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
825654|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
825655|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825656|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
823701|NCT02484248|Ketotifen|ketotifen|mesh-list
823702|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
823703|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
823704|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
823705|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
823706|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
823707|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823708|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823709|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823710|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
824017|NCT02483260|Ribavirin|ribavirin|mesh-list
824018|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
824019|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824020|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
824021|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824155|NCT02482818|Pregabalin|pregabalin|mesh-list
824156|NCT02482818|Analgesics|analgesics|mesh-ancestor
824157|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
824158|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824159|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824160|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
824161|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
824162|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
824163|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824164|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
824165|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
824166|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
824167|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
824168|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2252001|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2252002|NCT00136487|Analgesics|analgesics|mesh-ancestor
2252003|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
2252004|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252005|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252006|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2252007|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252008|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2252009|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2252010|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252011|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252012|NCT00136526|Docetaxel|docetaxel|mesh-list
2252013|NCT00136526|Fosfestrol|fosfestrol|mesh-list
2252014|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
2252015|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252016|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
2252017|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
2252018|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
2252019|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252020|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2252021|NCT00136526|Estrogens|estrogens|mesh-ancestor
2252022|NCT00136526|Hormones|hormones|mesh-ancestor
2252023|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2252024|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252025|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2252026|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
2252027|NCT00136539|Doxorubicin|doxorubicin|mesh-list
2252028|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2252029|NCT00136539|Trastuzumab|trastuzumab|mesh-list
2252030|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2252031|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
2252032|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252033|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252034|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2252035|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
2252036|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825225|NCT02478281|Methylene Blue|methylene blue|mesh-list
825226|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825227|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252037|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252038|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2252039|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2252040|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2252041|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
826322|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
823992|NCT02483221|Morphine|morphine|mesh-list
823993|NCT02483221|Hydromorphone|hydromorphone|mesh-list
823994|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
823995|NCT02483221|Narcotics|narcotics|mesh-ancestor
823996|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
823997|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823998|NCT02483221|Analgesics|analgesics|mesh-ancestor
823999|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
824000|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824182|NCT02482649|Methylphenidate|methylphenidate|mesh-list
824183|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
824184|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
824185|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824186|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
824187|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
824188|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
824189|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824190|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
824191|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
824192|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
824193|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
824351|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
824352|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
824353|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252042|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252043|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2252044|NCT00136552|Rituximab|rituximab|mesh-list
2252045|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2252046|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252047|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
825112|NCT02479074|Prednisolone|prednisolone|mesh-list
825113|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
825114|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
825115|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
825116|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
825117|NCT02479074|Montelukast|montelukast|mesh-list
825118|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
825119|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
825120|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
825121|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
825122|NCT02479074|Hormones|hormones|mesh-ancestor
825123|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
825124|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825125|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
825126|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825127|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
825128|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
825129|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825130|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
825131|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
825132|NCT02479074|Protective Agents|protective agents|mesh-ancestor
825133|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
825134|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
823734|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
823735|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824420|NCT02481453|Sirolimus|sirolimus|mesh-list
824421|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
824422|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824423|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
824424|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824425|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
824426|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
824427|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
824428|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825435|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
825436|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
825437|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
825438|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
825439|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
825440|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825441|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
825442|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
825443|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098449|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098450|NCT02343575|Valproic Acid|valproic acid|mesh-list
2098451|NCT02343575|Haloperidol|haloperidol|mesh-list
2098452|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
2098453|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
2098454|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
2098455|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098456|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098457|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2098458|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
826167|NCT02475499|Metformin|metformin|mesh-list
826168|NCT02475499|Pioglitazone|pioglitazone|mesh-list
826169|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
826170|NCT02475499|Liraglutide|liraglutide|mesh-list
826171|NCT02475499|Exenatide|exenatide|mesh-list
826172|NCT02475499|Glimepiride|glimepiride|mesh-list
826173|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
826174|NCT02475499|Saxagliptin|saxagliptin|mesh-list
826175|NCT02475499|Vildagliptin|vildagliptin|mesh-list
826176|NCT02475499|Acarbose|acarbose|mesh-list
826177|NCT02475499|Repaglinide|repaglinide|mesh-list
826178|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
826179|NCT02475499|Gliclazide|gliclazide|mesh-list
826180|NCT02475499|Glipizide|glipizide|mesh-list
826181|NCT02475499|Biguanides|biguanides|mesh-list
826182|NCT02475499|Voglibose|voglibose|mesh-list
826183|NCT02475499|Tolbutamide|tolbutamide|mesh-list
826184|NCT02475499|Nateglinide|nateglinide|mesh-list
826185|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
826186|NCT02475499|Miglitol|miglitol|mesh-list
826187|NCT02475499|Troglitazone|troglitazone|mesh-list
826188|NCT02475499|Meglitinide|meglitinide|mesh-list
826189|NCT02475499|Acetohexamide|acetohexamide|mesh-list
826190|NCT02475499|Phenformin|phenformin|mesh-list
826191|NCT02475499|Buformin|buformin|mesh-list
826192|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
826193|NCT02475499|Glibornuride|glibornuride|mesh-list
826194|NCT02475499|Tolazamide|tolazamide|mesh-list
826195|NCT02475499|Carbutamide|carbutamide|mesh-list
826196|NCT02475499|Gliquidone|gliquidone|mesh-list
826197|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
826198|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
826199|NCT02475499|Incretins|incretins|mesh-list
826200|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826201|NCT02475499|Hormones|hormones|mesh-ancestor
826202|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
826203|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
826204|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826205|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826206|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
826207|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
826208|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
826209|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
826863|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
826864|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
826865|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
827901|NCT02467647|Thalidomide|thalidomide|mesh-list
827902|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
827903|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
827904|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827905|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
827906|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
823743|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
823744|NCT02484170|Diuretics|diuretics|mesh-ancestor
823745|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
823746|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252048|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252049|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252050|NCT00136565|Prednisone|prednisone|mesh-list
2252051|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
2252052|NCT00136565|Doxorubicin|doxorubicin|mesh-list
2252053|NCT00136565|Bortezomib|bortezomib|mesh-list
2252054|NCT00136565|Bleomycin|bleomycin|mesh-list
2252055|NCT00136565|Vindesine|vindesine|mesh-list
2252056|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2252057|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
2252058|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252059|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252060|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2252061|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
2252062|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252063|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252064|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2252065|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2252066|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2252067|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2252068|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252069|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
824839|NCT02479789|Lidocaine|lidocaine|mesh-list
824840|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
824841|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
824842|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
824843|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824844|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
824845|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824846|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
824847|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
824848|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
824849|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
824850|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825510|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
825511|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
825512|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825513|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825725|NCT02476981|Ephedrine|ephedrine|mesh-list
825726|NCT02476981|Midazolam|midazolam|mesh-list
825727|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
825728|NCT02476981|Remifentanil|remifentanil|mesh-list
825729|NCT02476981|Propofol|propofol|mesh-list
825730|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
825731|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
825732|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825733|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
825734|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
825735|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
825736|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
825737|NCT02476981|Analgesics|analgesics|mesh-ancestor
825738|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
825739|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825740|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
825741|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
825742|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
825743|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
825744|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
825745|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825746|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
825747|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
825748|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
825749|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
825750|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
825751|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
825752|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
825753|NCT02476981|Narcotics|narcotics|mesh-ancestor
825754|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
825755|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
825756|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
825757|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
825789|NCT02476552|Niraparib|niraparib|mesh-list
2252070|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
823754|NCT02484352|Oxycodone|oxycodone|mesh-list
823755|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
823756|NCT02484352|Narcotics|narcotics|mesh-ancestor
823757|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
823758|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823759|NCT02484352|Analgesics|analgesics|mesh-ancestor
823760|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
823761|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
823800|NCT02483793|Tamsulosin|tamsulosin|mesh-list
823801|NCT02483793|Oxybutynin|oxybutynin|mesh-list
823802|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
823803|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
823804|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
823805|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
823806|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823807|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823808|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823809|NCT02483793|Urological Agents|urological agents|mesh-ancestor
823810|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
823811|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
823812|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
823813|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
823814|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
823815|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
824121|NCT02482961|Colistin|colistin|mesh-list
824122|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
824123|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824311|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
824312|NCT02482090|Fludarabine|fludarabine|mesh-list
824313|NCT02482090|Interleukin-2|interleukin-2|mesh-list
824314|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
824315|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
824316|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824317|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
824318|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
824319|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
824320|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824321|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824322|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
824323|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
824324|NCT02482090|Analgesics|analgesics|mesh-ancestor
824325|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
824326|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824613|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
824614|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
824615|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824616|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
824617|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824618|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824619|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
824620|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
825223|NCT02478294|Warfarin|warfarin|mesh-list
825224|NCT02478294|Anticoagulants|anticoagulants|mesh-list
825355|NCT02477995|Vaccines|vaccines|mesh-list
825356|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
825357|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825428|NCT02477644|Olaparib|olaparib|mesh-list
825429|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
825430|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825431|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825432|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826235|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
826236|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
826374|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
826375|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
826376|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
826377|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826378|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826379|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
826380|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
826381|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
826382|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2252071|NCT00136565|Hormones|hormones|mesh-ancestor
2252072|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
823774|NCT02484053|Rituximab|rituximab|mesh-list
823775|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
823776|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823777|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
823778|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823779|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
823825|NCT02483767|Goserelin|goserelin|mesh-list
823826|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
823827|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823915|NCT02483598|Buspirone|buspirone|mesh-list
823916|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
823917|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
823918|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
823919|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823920|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
823921|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
823922|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
823923|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
823924|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252073|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2252074|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2252075|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
825038|NCT02479230|Gemcitabine|gemcitabine|mesh-list
825039|NCT02479230|Vaccines|vaccines|mesh-list
825040|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
825041|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825042|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
825043|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
825044|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825045|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825046|NCT02479230|Antiviral Agents|antiviral agents|mesh-ancestor
825047|NCT02479230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
825048|NCT02479230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825049|NCT02479230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2252076|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
2252077|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
2252078|NCT00136578|Carboplatin|carboplatin|mesh-list
2252079|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252080|NCT00136591|Bortezomib|bortezomib|mesh-list
2252081|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252082|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
2252083|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2252084|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
825673|NCT02476864|Macitentan|macitentan|mesh-list
825674|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
825675|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
825676|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825677|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2252085|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2252086|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252087|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2252088|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2252089|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2252090|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
2252091|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
2252092|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252093|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252094|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2252095|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2252096|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252097|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
2252098|NCT00136734|Methylphenidate|methylphenidate|mesh-list
825892|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
825893|NCT02476136|Fluoxetine|fluoxetine|mesh-list
825894|NCT02476136|Paroxetine|paroxetine|mesh-list
825895|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
825896|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
825897|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
825898|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
825899|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825900|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
825901|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825902|NCT02476136|Analgesics|analgesics|mesh-ancestor
2252099|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2252100|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252101|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2252102|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2252103|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2252104|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252105|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
2252106|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252107|NCT00136747|Memantine|memantine|mesh-list
2252108|NCT00136747|Bupropion|bupropion|mesh-list
2252109|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2252110|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
2252111|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2252112|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2252113|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2252114|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2252115|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252116|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
824727|NCT02479854|Montelukast|montelukast|mesh-list
824728|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
824729|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
824730|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
824731|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
824732|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
824733|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824734|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
824735|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
824736|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825250|NCT02478125|Docetaxel|docetaxel|mesh-list
825251|NCT02478125|Sargramostim|sargramostim|mesh-list
825252|NCT02478125|Lenograstim|lenograstim|mesh-list
825253|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825254|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
825255|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
825256|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
825257|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825258|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
825259|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825260|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2252117|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252118|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252119|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2252120|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2252121|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252122|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2252123|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2252124|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2252125|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2252126|NCT00136773|Amlodipine|amlodipine|mesh-list
2252127|NCT00136773|Benazepril|benazepril|mesh-list
2252128|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2252129|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2252130|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2252131|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252132|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
827098|NCT02471963|Empagliflozin|empagliflozin|mesh-list
827099|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
827100|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827101|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
827102|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827175|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
827176|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
827177|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
827178|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
827179|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827501|NCT02469831|Rocuronium|rocuronium|mesh-list
827502|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
827503|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
827504|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
827505|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827506|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827586|NCT02469519|Dexamethasone|dexamethasone|mesh-list
823792|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
823793|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
823794|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
823795|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
823796|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823797|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
823798|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
823799|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823925|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
823926|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
823927|NCT02483624|Protective Agents|protective agents|mesh-ancestor
823928|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823929|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823989|NCT02483182|Acyclovir|acyclovir|mesh-list
823990|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
823991|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824511|NCT02480894|Maraviroc|maraviroc|mesh-list
824512|NCT02480894|Fostemsavir|fostemsavir|mesh-list
824513|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
824514|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
824515|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824516|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
824517|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
824518|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
824519|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824520|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
824624|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
824625|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
824626|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824836|NCT02479815|Micronutrients|micronutrients|mesh-list
824837|NCT02479815|Trace Elements|trace elements|mesh-list
824838|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824907|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
824908|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252133|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252134|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
2252135|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2252136|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
2252137|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252138|NCT00136786|Memantine|memantine|mesh-list
825714|NCT02477072|Heparin|heparin|mesh-list
825715|NCT02477072|Calcium heparin|calcium heparin|mesh-list
825716|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
825717|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
825718|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
825719|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825914|NCT02476123|Nivolumab|nivolumab|mesh-list
825915|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
825916|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
825917|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825918|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
825919|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826282|NCT02475317|Volixibat|volixibat|mesh-list
826283|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
826337|NCT02474654|Ketorolac|ketorolac|mesh-list
826338|NCT02474654|Epinephrine|epinephrine|mesh-list
826339|NCT02474654|Racepinephrine|racepinephrine|mesh-list
826340|NCT02474654|Fentanyl|fentanyl|mesh-list
826341|NCT02474654|Bupivacaine|bupivacaine|mesh-list
826342|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
826343|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
826344|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
826345|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
826346|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826347|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
826348|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
826349|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
826350|NCT02474654|Narcotics|narcotics|mesh-ancestor
826351|NCT02474654|Analgesics|analgesics|mesh-ancestor
826352|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
826353|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
826354|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
826355|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
826356|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
826357|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
826358|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
826359|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823816|NCT02483897|Tetracaine|tetracaine|mesh-list
823817|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
823818|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
823819|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
823820|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
823821|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823822|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
823823|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
823824|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
824044|NCT02483169|Aspirin|aspirin|mesh-list
824045|NCT02483169|Cilostazol|cilostazol|mesh-list
824046|NCT02483169|Probucol|probucol|mesh-list
824047|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
824048|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
824049|NCT02483169|Analgesics|analgesics|mesh-ancestor
824050|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
824051|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824052|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824053|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
824054|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
824055|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
824056|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
824057|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824058|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
824059|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
824060|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824061|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
824062|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
824063|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
824064|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
824065|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
824066|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
824067|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
824068|NCT02483169|Protective Agents|protective agents|mesh-ancestor
824069|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
824070|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
824071|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
824072|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
824073|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
824074|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
824075|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
824194|NCT02482311|Adavosertib|adavosertib|mesh-list
824195|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824196|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824582|NCT02480803|Levodopa|levodopa|mesh-list
824583|NCT02480803|Carbidopa|carbidopa|mesh-list
824584|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
824585|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
824586|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
824587|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
824588|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
824589|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824590|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824591|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
824592|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824593|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
824594|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
824595|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
824637|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
824638|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
824639|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824640|NCT02480465|Incretins|incretins|mesh-ancestor
824641|NCT02480465|Hormones|hormones|mesh-ancestor
824642|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
824643|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
824644|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
824645|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824646|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825662|NCT02476825|Fluticasone|fluticasone|mesh-list
825663|NCT02476825|Xhance|xhance|mesh-list
825664|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
825665|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
825666|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
825667|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825668|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825669|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
823831|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
823832|NCT02483715|Amoxicillin|amoxicillin|mesh-list
823833|NCT02483715|Metronidazole|metronidazole|mesh-list
823834|NCT02483715|Tetracycline|tetracycline|mesh-list
823835|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
823836|NCT02483715|Rabeprazole|rabeprazole|mesh-list
823837|NCT02483715|Bismuth|bismuth|mesh-list
823838|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
823839|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
823840|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
823841|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
823842|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
823843|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
823844|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
823845|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
823846|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823847|NCT02483715|Antacids|antacids|mesh-ancestor
823848|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
824095|NCT02483247|Paclitaxel|paclitaxel|mesh-list
824096|NCT02483247|Doxorubicin|doxorubicin|mesh-list
824097|NCT02483247|Capecitabine|capecitabine|mesh-list
824098|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
824099|NCT02483247|Nivolumab|nivolumab|mesh-list
824100|NCT02483247|Sunitinib|sunitinib|mesh-list
824101|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
824102|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824103|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
824104|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
824105|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
824106|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824107|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
824108|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
824109|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
824110|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824111|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
824112|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
824113|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
824114|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
824115|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
824116|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
824117|NCT02483247|Growth Substances|growth substances|mesh-ancestor
824118|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824119|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
824120|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2252139|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2252140|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2252141|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
2252142|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252143|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252144|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252145|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2252146|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2252147|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
2252148|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2252149|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
2252150|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252151|NCT00136825|Expectorants|expectorants|mesh-ancestor
2252152|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
824596|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
824597|NCT02480647|Etonogestrel|etonogestrel|mesh-list
824598|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
824599|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
824600|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
824601|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824602|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
824603|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
824604|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
824658|NCT02480400|Dexetimide|dexetimide|mesh-list
824659|NCT02480400|Citalopram|citalopram|mesh-list
824660|NCT02480400|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
824661|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
824662|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
824663|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824664|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
824665|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
824666|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823849|NCT02483923|Ropivacaine|ropivacaine|mesh-list
823850|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
823851|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
823852|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
823853|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823854|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
823855|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252153|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2252154|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
2252155|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252156|NCT00136825|Protective Agents|protective agents|mesh-ancestor
2252157|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252158|NCT00136825|Antidotes|antidotes|mesh-ancestor
2252159|NCT00136851|Amlodipine|amlodipine|mesh-list
2252160|NCT00136851|Benazepril|benazepril|mesh-list
2252161|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2252162|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2252163|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2252164|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252165|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2252166|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252167|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
2252168|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2252169|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
2252170|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825196|NCT02478424|Cyclosporine|cyclosporine|mesh-list
825197|NCT02478424|Methotrexate|methotrexate|mesh-list
825198|NCT02478424|Cannabidiol|cannabidiol|mesh-list
825199|NCT02478424|Cyclosporins|cyclosporins|mesh-list
825200|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
825201|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
825202|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
825203|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825204|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
825205|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
825206|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825207|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825208|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
825209|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825210|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
825211|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
825212|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
825213|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
825214|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
825215|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
825216|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
825217|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
825218|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
825261|NCT02478047|Dexamethasone|dexamethasone|mesh-list
825262|NCT02478047|Ramosetron|ramosetron|mesh-list
825263|NCT02478047|Antiemetics|antiemetics|mesh-list
825264|NCT02478047|Tropisetron|tropisetron|mesh-list
825265|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
825266|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
825267|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825268|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825269|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
825270|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
825271|NCT02478047|Hormones|hormones|mesh-ancestor
825272|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
825273|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
825274|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825275|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
825276|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
825277|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
825278|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825279|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
825692|NCT02476799|Ketorolac|ketorolac|mesh-list
825693|NCT02476799|Fentanyl|fentanyl|mesh-list
825694|NCT02476799|Ropivacaine|ropivacaine|mesh-list
825695|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
823856|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
823857|NCT02483936|Olmesartan|olmesartan|mesh-list
823858|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
823859|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
823860|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
823861|NCT02483936|Diuretics|diuretics|mesh-ancestor
823862|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
823863|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823864|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
823865|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
823866|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823867|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
823868|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
824022|NCT02483195|Minoxidil|minoxidil|mesh-list
824023|NCT02483195|Spironolactone|spironolactone|mesh-list
824024|NCT02483195|Finasteride|finasteride|mesh-list
824025|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
824026|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
824027|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
824028|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824029|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
824030|NCT02483195|Diuretics|diuretics|mesh-ancestor
824031|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
824032|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
824033|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
824034|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824035|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824036|NCT02483195|Urological Agents|urological agents|mesh-ancestor
824037|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
824038|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
2252175|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
2252176|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2252177|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252178|NCT00136942|Atorvastatin|atorvastatin|mesh-list
2252179|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2252180|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2252181|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
2252182|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824367|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
824368|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
824369|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
824370|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824371|NCT02481609|Expectorants|expectorants|mesh-ancestor
824372|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
824373|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
824374|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
824375|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824376|NCT02481609|Protective Agents|protective agents|mesh-ancestor
824377|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824378|NCT02481609|Antidotes|antidotes|mesh-ancestor
824498|NCT02481076|Monensin|monensin|mesh-list
824499|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
824500|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824501|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
824502|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
824503|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
824504|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
824505|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
824506|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824507|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824508|NCT02481076|Ionophores|ionophores|mesh-ancestor
824509|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
824510|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
824621|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
824622|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
824623|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252183|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2252184|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2252185|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825050|NCT02479165|Oxycodone|oxycodone|mesh-list
825051|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
825052|NCT02479165|Narcotics|narcotics|mesh-ancestor
825053|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
825054|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825055|NCT02479165|Analgesics|analgesics|mesh-ancestor
823869|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
823870|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
823871|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
823872|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
823873|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
823874|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824270|NCT02482155|Ibuprofen|ibuprofen|mesh-list
824271|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
824272|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
824273|NCT02482155|Analgesics|analgesics|mesh-ancestor
824274|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
824275|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824276|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824277|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
824278|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
824279|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
824280|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824281|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824712|NCT02479971|Clindamycin|clindamycin|mesh-list
824713|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
824714|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
824715|NCT02479971|Gentamicins|gentamicins|mesh-list
824716|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
824717|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824718|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
824719|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824720|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824926|NCT02479451|Theophylline|theophylline|mesh-list
824927|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
824928|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
824929|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824930|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824931|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
824932|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
824933|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
824934|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824935|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824936|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
824937|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
824938|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
824939|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
824940|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
825092|NCT02479022|Insulin|insulin|mesh-list
825093|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
825094|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
825095|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
825096|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825191|NCT02478320|Ilorasertib|ilorasertib|mesh-list
825192|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825193|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
825194|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825195|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825344|NCT02478099|Atezolizumab|atezolizumab|mesh-list
825345|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825635|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
825636|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
825637|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
825638|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825639|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
825640|NCT02476903|Protective Agents|protective agents|mesh-ancestor
825820|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
825821|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
825822|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
825823|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825824|NCT02476773|Antacids|antacids|mesh-ancestor
825825|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825826|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
826299|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
826300|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
826301|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
826302|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826413|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
826414|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
826415|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252186|NCT00136968|Voriconazole|voriconazole|mesh-list
2252187|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
2252188|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252189|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2252190|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2252191|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252192|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252193|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2252194|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
2252195|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2252196|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252197|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2252198|NCT00136981|Atorvastatin|atorvastatin|mesh-list
2252199|NCT00136981|Torcetrapib|torcetrapib|mesh-list
2252200|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2252201|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2252202|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
2252203|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252204|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2252205|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2252206|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824540|NCT02480881|Fostemsavir|fostemsavir|mesh-list
824541|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
824542|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
824543|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
824544|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
824545|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824546|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
824547|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
824548|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
824549|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
824550|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824551|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
824552|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
824553|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824554|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
824555|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
824556|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
824557|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
824558|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2252207|NCT00136994|Ziprasidone|ziprasidone|mesh-list
2252208|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2252209|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
2252210|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252211|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252212|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252213|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2252214|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2252215|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
824920|NCT02479178|Docetaxel|docetaxel|mesh-list
824921|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824922|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
824923|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
824924|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
824925|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252216|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2252217|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2252218|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
2252219|NCT00137007|Azithromycin|azithromycin|mesh-list
2252220|NCT00137007|Ampicillin|ampicillin|mesh-list
2252221|NCT00137007|Sulbactam|sulbactam|mesh-list
2252222|NCT00137007|Sultamicillin|sultamicillin|mesh-list
826303|NCT02474563|Prednisone|prednisone|mesh-list
826304|NCT02474563|Bortezomib|bortezomib|mesh-list
826305|NCT02474563|Melphalan|melphalan|mesh-list
826306|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
826307|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
826308|NCT02474563|Hormones|hormones|mesh-ancestor
826309|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
826310|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826311|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
826312|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826323|NCT02474628|Calcium|calcium|mesh-list
2252223|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
823937|NCT02483325|Fludarabine|fludarabine|mesh-list
823938|NCT02483325|Busulfan|busulfan|mesh-list
823939|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
823940|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
823941|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823942|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
823943|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
823944|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823945|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
823946|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
823947|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
824169|NCT02482766|Poractant alfa|poractant alfa|mesh-list
824170|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
824171|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
824282|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
824283|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
824284|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
824285|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
824286|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824287|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
824288|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
824289|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824695|NCT02480335|Bosentan|bosentan|mesh-list
824696|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
824697|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
824698|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824909|NCT02479490|Prednisone|prednisone|mesh-list
824910|NCT02479490|Everolimus|everolimus|mesh-list
824911|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
824912|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
824913|NCT02479490|Hormones|hormones|mesh-ancestor
824914|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
824915|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824916|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
824917|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824918|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
824919|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
825020|NCT02479204|Atenolol|atenolol|mesh-list
825021|NCT02479204|Diltiazem|diltiazem|mesh-list
825022|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
825023|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
825024|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
825025|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
825026|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825027|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825028|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
825029|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
825030|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
825031|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
825032|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
825033|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825034|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
825035|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
825036|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
825037|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
825404|NCT02477826|Gemcitabine|gemcitabine|mesh-list
825405|NCT02477826|Paclitaxel|paclitaxel|mesh-list
825406|NCT02477826|Carboplatin|carboplatin|mesh-list
825407|NCT02477826|Nivolumab|nivolumab|mesh-list
825408|NCT02477826|Pemetrexed|pemetrexed|mesh-list
825409|NCT02477826|Ipilimumab|ipilimumab|mesh-list
825410|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
825411|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825412|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
825413|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
825414|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
825415|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825416|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
825417|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
825418|NCT02477826|Antiviral Agents|antiviral agents|mesh-ancestor
825419|NCT02477826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
825420|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825421|NCT02477826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
825422|NCT02477826|Immunologic Factors|immunologic factors|mesh-ancestor
825423|NCT02477826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825696|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
823948|NCT02483299|Metformin|metformin|mesh-list
823949|NCT02483299|Liraglutide|liraglutide|mesh-list
823950|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
823951|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823952|NCT02483299|Incretins|incretins|mesh-ancestor
823953|NCT02483299|Hormones|hormones|mesh-ancestor
823954|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2252224|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252225|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2252226|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252227|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252228|NCT00137020|Ziprasidone|ziprasidone|mesh-list
2252229|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2252230|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
2252231|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252232|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252233|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252234|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2252235|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2252236|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2252237|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2252238|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2252239|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
2252240|NCT00137033|Celecoxib|celecoxib|mesh-list
2252241|NCT00137033|Naproxen|naproxen|mesh-list
2252242|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2252243|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2252244|NCT00137033|Analgesics|analgesics|mesh-ancestor
2252245|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
2252246|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252247|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252248|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2252249|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252250|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2252251|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2252252|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252253|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252254|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
2252255|NCT00137059|Acetaminophen|acetaminophen|mesh-list
2252256|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2252257|NCT00137059|Analgesics|analgesics|mesh-ancestor
824524|NCT02480946|Methotrexate|methotrexate|mesh-list
824525|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
824526|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
824527|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
824528|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824529|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
824530|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
824531|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824532|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824533|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
824534|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824535|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
824536|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
824537|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
824538|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
824539|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
824881|NCT02479711|Methamphetamine|methamphetamine|mesh-list
824882|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
824883|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824884|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
824885|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
824886|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824887|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
824888|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
824889|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824890|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
824891|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
824892|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
824893|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
824894|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
824972|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
824973|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
824974|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
823977|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
823978|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
823979|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
823980|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
823981|NCT02483130|Expectorants|expectorants|mesh-ancestor
823982|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
823983|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
823984|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
823985|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
823986|NCT02483130|Protective Agents|protective agents|mesh-ancestor
823987|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
823988|NCT02483130|Antidotes|antidotes|mesh-ancestor
824460|NCT02481479|Saxagliptin|saxagliptin|mesh-list
824461|NCT02481479|Incretins|incretins|mesh-ancestor
824462|NCT02481479|Hormones|hormones|mesh-ancestor
824463|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
824464|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824465|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
824466|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
824467|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824468|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824469|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2252258|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
2252259|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252260|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825334|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
825335|NCT02478229|Ledipasvir|ledipasvir|mesh-list
825336|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
825337|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252261|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
2252262|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
2252263|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252264|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
2252265|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2252266|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
825777|NCT02476708|Curcumin|curcumin|mesh-list
825778|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
825779|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
825780|NCT02476708|Analgesics|analgesics|mesh-ancestor
825781|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
825782|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825783|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825784|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
825785|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
825786|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825787|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825788|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252267|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252268|NCT00137072|Urological Agents|urological agents|mesh-ancestor
2252269|NCT00137085|Ketamine|ketamine|mesh-list
2252270|NCT00137085|Analgesics|analgesics|mesh-ancestor
2252271|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
826319|NCT02474511|Anesthetics|anesthetics|mesh-list
826320|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
826321|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826716|NCT02473185|Methylphenidate|methylphenidate|mesh-list
826717|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
826718|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826719|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
826720|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
826721|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
826722|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826723|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
826724|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
826756|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
826757|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
826758|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
826759|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
826760|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826866|NCT02472613|Fluoxetine|fluoxetine|mesh-list
826867|NCT02472613|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
826868|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
826869|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
826870|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824076|NCT02483078|Leronlimab|leronlimab|mesh-list
824077|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
824078|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
824079|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824080|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
824081|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
824082|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
824083|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
824296|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
824297|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
824298|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098459|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2098460|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2098461|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2098462|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2098463|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
824627|NCT02480751|Beraprost|beraprost|mesh-list
824628|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
824629|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
824991|NCT02479217|Docetaxel|docetaxel|mesh-list
824992|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824993|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
824994|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
824995|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
824996|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825500|NCT02477488|Allopurinol|allopurinol|mesh-list
825501|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
825502|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825503|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825504|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
825505|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
825506|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
825507|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
825508|NCT02477488|Protective Agents|protective agents|mesh-ancestor
825509|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825591|NCT02477254|Vaccines|vaccines|mesh-list
825592|NCT02477254|Immunologic Factors|immunologic factors|mesh-ancestor
825593|NCT02477254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825617|NCT02476955|Paclitaxel|paclitaxel|mesh-list
825618|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
825619|NCT02476955|Carboplatin|carboplatin|mesh-list
825620|NCT02476955|Anastrozole|anastrozole|mesh-list
825621|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
825622|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825623|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
825624|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
825625|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
825626|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825627|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
825628|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
825629|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
825630|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825631|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
825632|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
825633|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
825634|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825987|NCT02475863|Warfarin|warfarin|mesh-list
825988|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
826159|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
826160|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
826161|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
826162|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
826163|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826164|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
826165|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
826166|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
827016|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
827017|NCT02472626|Cytarabine|cytarabine|mesh-list
827018|NCT02472626|Daunorubicin|daunorubicin|mesh-list
827019|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
827020|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
827021|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827022|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827023|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
827024|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827025|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
827026|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
824084|NCT02483104|Paclitaxel|paclitaxel|mesh-list
824085|NCT02483104|Carboplatin|carboplatin|mesh-list
824086|NCT02483104|Veliparib|veliparib|mesh-list
824087|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
824088|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824089|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
824090|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
824091|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
824092|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824093|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
824094|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824290|NCT02481960|Irinotecan|irinotecan|mesh-list
824291|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
824292|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
824293|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824294|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824295|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824683|NCT02480088|Palonosetron|palonosetron|mesh-list
824684|NCT02480088|Ramosetron|ramosetron|mesh-list
824685|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
824686|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
824687|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824688|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824689|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
824690|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
824691|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
824692|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
824693|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
824694|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252272|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252273|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252274|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2252275|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2252276|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
2252277|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
2252278|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2252279|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2252280|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2252281|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252282|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252283|NCT00137098|Caffeine|caffeine|mesh-list
2252284|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2252285|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252286|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2252287|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252288|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252289|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2252290|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2252291|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
2252292|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252293|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
2252294|NCT00137202|Promethazine|promethazine|mesh-list
2252295|NCT00137202|Ondansetron|ondansetron|mesh-list
2252296|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
2252297|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
2252298|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252299|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252300|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2252301|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
2252302|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
2252303|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2252304|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
2252305|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252306|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252307|NCT00137202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
826408|NCT02474446|Vitamin D|vitamin d|mesh-list
826409|NCT02474446|Vitamins|vitamins|mesh-ancestor
826410|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
826411|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826412|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
826769|NCT02472912|Adalimumab|adalimumab|mesh-list
826770|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
826771|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252308|NCT00137202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2252309|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
824124|NCT02482740|Tamoxifen|tamoxifen|mesh-list
824125|NCT02482740|Letrozole|letrozole|mesh-list
824126|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824127|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
824128|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
824129|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824130|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824131|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
824132|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
824133|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
824134|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824135|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
824136|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
824137|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
824138|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2252310|NCT00137202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2252311|NCT00137202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2252312|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2252313|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2252314|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
2252315|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
2252316|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
2252317|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2252318|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
2252319|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
2252320|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2252321|NCT00137254|Insulin|insulin|mesh-list
2252322|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2252323|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252324|NCT00137345|Sirolimus|sirolimus|mesh-list
2252325|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2252326|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252327|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2252328|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252329|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
2252330|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
824605|NCT02480543|Misoprostol|misoprostol|mesh-list
824606|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
824607|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
824608|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
824609|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824610|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
824611|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
824612|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
825358|NCT02477891|Daratumumab|daratumumab|mesh-list
825359|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826021|NCT02475772|Cisplatin|cisplatin|mesh-list
826022|NCT02475772|Doxorubicin|doxorubicin|mesh-list
826023|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
826024|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826025|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
826026|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
826027|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
826028|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826029|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826270|NCT02474953|Curcumin|curcumin|mesh-list
826271|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
826272|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
826273|NCT02474953|Analgesics|analgesics|mesh-ancestor
826274|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
826275|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
826276|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826277|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
826278|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
826279|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826280|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826281|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826296|NCT02474667|Mitogens|mitogens|mesh-list
826297|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
826298|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252331|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
2252332|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252333|NCT00137358|Amifostine|amifostine|mesh-list
2252334|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
824858|NCT02479620|Dexamethasone|dexamethasone|mesh-list
824859|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
824860|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
824861|NCT02479620|BB 1101|bb 1101|mesh-list
824862|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
824863|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
824864|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
824865|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824866|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824867|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
824868|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
824869|NCT02479620|Hormones|hormones|mesh-ancestor
824870|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
824871|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
824872|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824873|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
824874|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824875|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824997|NCT02479256|Tamoxifen|tamoxifen|mesh-list
824998|NCT02479256|Citric Acid|citric acid|mesh-list
824999|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
825000|NCT02479256|Clomiphene|clomiphene|mesh-list
825001|NCT02479256|Enclomiphene|enclomiphene|mesh-list
825002|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
825003|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
825004|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
825005|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
825006|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
825007|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825008|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
825009|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
825010|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
825011|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825012|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
825013|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825014|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
825015|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
825016|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
825017|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
825018|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
825019|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
825154|NCT02478645|Ramosetron|ramosetron|mesh-list
825155|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
825156|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
825157|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825158|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825159|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
825160|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
825161|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
825162|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
825163|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825244|NCT02478268|Xenon|xenon|mesh-list
825245|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
825246|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
825247|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
825248|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
825249|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825373|NCT02477969|Metformin|metformin|mesh-list
825374|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
825375|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252335|NCT00137358|Protective Agents|protective agents|mesh-ancestor
2252336|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252337|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2252338|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2252339|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2252340|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
2252341|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252342|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252343|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826030|NCT02475746|Itraconazole|itraconazole|mesh-list
826031|NCT02475746|PF-06372865|pf-06372865|mesh-list
826032|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
2252344|NCT00137397|Urological Agents|urological agents|mesh-ancestor
2252345|NCT00137410|Celecoxib|celecoxib|mesh-list
2252346|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2252347|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2252348|NCT00137410|Analgesics|analgesics|mesh-ancestor
824851|NCT02479828|Ropivacaine|ropivacaine|mesh-list
824852|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
824853|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
824854|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
824855|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824856|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
824857|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252349|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
2252350|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252351|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252352|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2252353|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252354|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2252355|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2252356|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252357|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252358|NCT00137462|Atorvastatin|atorvastatin|mesh-list
2252359|NCT00137462|Torcetrapib|torcetrapib|mesh-list
2252360|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2252361|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2252362|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
2252363|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825376|NCT02477852|Rifampin|rifampin|mesh-list
825377|NCT02477852|Isoniazid|isoniazid|mesh-list
825378|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
825379|NCT02477852|Ethambutol|ethambutol|mesh-list
825380|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
825381|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
825382|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
825383|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
825384|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
825385|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
825386|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825387|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825388|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
825389|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
825390|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
825391|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
825392|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
825393|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
825394|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
825395|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
825396|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
825397|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2252364|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2252365|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2252366|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252367|NCT00137501|Nifedipine|nifedipine|mesh-list
825808|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
825809|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
825810|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
825811|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
825812|NCT02476526|Expectorants|expectorants|mesh-ancestor
825813|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
825814|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
825815|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
825816|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825817|NCT02476526|Protective Agents|protective agents|mesh-ancestor
825818|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825819|NCT02476526|Antidotes|antidotes|mesh-ancestor
826447|NCT02474186|Paclitaxel|paclitaxel|mesh-list
826448|NCT02474186|Docetaxel|docetaxel|mesh-list
826449|NCT02474186|Capecitabine|capecitabine|mesh-list
826450|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
826451|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826452|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
826453|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
826454|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
826455|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252368|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2252369|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2252370|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824795|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
824796|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
824797|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
824798|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
824799|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
825058|NCT02479581|Floxacillin|floxacillin|mesh-list
825059|NCT02479581|Dexamethasone|dexamethasone|mesh-list
825060|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
825061|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
825062|NCT02479581|Scopolamine|scopolamine|mesh-list
825063|NCT02479581|Morphine|morphine|mesh-list
825064|NCT02479581|Anesthetics|anesthetics|mesh-list
825065|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
825066|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
825067|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
825068|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825069|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825070|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
825071|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
825072|NCT02479581|Hormones|hormones|mesh-ancestor
825073|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
825074|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
825075|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825076|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825077|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
825078|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
825079|NCT02479581|Narcotics|narcotics|mesh-ancestor
825080|NCT02479581|Analgesics|analgesics|mesh-ancestor
825081|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
825082|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
825083|NCT02479581|Protective Agents|protective agents|mesh-ancestor
825084|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
825085|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
825086|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
825087|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
825088|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
825089|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
825090|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
825091|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
825175|NCT02478515|Ranibizumab|ranibizumab|mesh-list
825176|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
825177|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
825178|NCT02478515|Growth Substances|growth substances|mesh-ancestor
825179|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825180|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
825181|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825827|NCT02476279|Indomethacin|indomethacin|mesh-list
825828|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
825829|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
825830|NCT02476279|Analgesics|analgesics|mesh-ancestor
825831|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
825832|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825833|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825834|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
825835|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
825836|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
825837|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
825838|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
825839|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
825840|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825841|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826288|NCT02475057|Hormones|hormones|mesh-list
826289|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
826290|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
826291|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252371|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2252372|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252373|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
2252374|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
2252375|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2252376|NCT00137514|Chloroquine|chloroquine|mesh-list
2252377|NCT00137514|Amodiaquine|amodiaquine|mesh-list
2252378|NCT00137514|Amebicides|amebicides|mesh-ancestor
2252379|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
824667|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
824668|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
824669|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
824670|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
824671|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
824672|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
824673|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
824674|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824675|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
824676|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
824677|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
824699|NCT02480049|Montelukast|montelukast|mesh-list
824700|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
824701|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
824702|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
824703|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
824704|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
824705|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824706|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
824707|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
824708|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825140|NCT02478788|Amphetamine|amphetamine|mesh-list
825141|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
825142|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825143|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
825144|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
825145|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825146|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
825147|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
825148|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825149|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
825150|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
825151|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
825152|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
825153|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
826121|NCT02475421|Glucagon|glucagon|mesh-list
826122|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
826123|NCT02475421|Hormones|hormones|mesh-ancestor
826124|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
826125|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826229|NCT02475161|Rabeprazole|rabeprazole|mesh-list
826230|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
826231|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
826232|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
826233|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826234|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826284|NCT02474914|Octreotide|octreotide|mesh-list
826285|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
826286|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
826287|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826636|NCT02473276|Morphine|morphine|mesh-list
826637|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
826638|NCT02473276|Narcotics|narcotics|mesh-ancestor
826639|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
826640|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826641|NCT02473276|Analgesics|analgesics|mesh-ancestor
826642|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
826643|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827005|NCT02472249|Norepinephrine|norepinephrine|mesh-list
827006|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
827007|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
827008|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
827009|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
827010|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827011|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827012|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
827013|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
827014|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827015|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
827142|NCT02471833|Telmisartan|telmisartan|mesh-list
827143|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
827144|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
827145|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
824941|NCT02479555|Dexamethasone|dexamethasone|mesh-list
824942|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
824943|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
824944|NCT02479555|BB 1101|bb 1101|mesh-list
824945|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
824946|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
824947|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
824948|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
824949|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
824950|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
824951|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
824952|NCT02479555|Hormones|hormones|mesh-ancestor
824953|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
824954|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
824955|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
824956|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
824957|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824958|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252380|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2252381|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252382|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
2252383|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252384|NCT00137527|Anesthetics|anesthetics|mesh-list
2252385|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2252386|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252387|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2252388|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
825583|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
825584|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
825585|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
825586|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
825587|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825588|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
825589|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
825590|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
825641|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
825642|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
825643|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
825644|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
825645|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
825646|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825647|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
825648|NCT02476929|Analgesics|analgesics|mesh-ancestor
825649|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
825650|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
826048|NCT02475824|Midazolam|midazolam|mesh-list
826049|NCT02475824|Meperidine|meperidine|mesh-list
826050|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
826051|NCT02475824|Propofol|propofol|mesh-list
826052|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
826053|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
826054|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826055|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
826056|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
826057|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
826058|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
826059|NCT02475824|Analgesics|analgesics|mesh-ancestor
826060|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
826061|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
826062|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
826063|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
826064|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
826065|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
826066|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252389|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
824975|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
824976|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
824977|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
824978|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
824979|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252390|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2252391|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
2252392|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2252393|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2252394|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252395|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2252396|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825360|NCT02477956|Vitamin D|vitamin d|mesh-list
825361|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
825362|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
825363|NCT02477956|Vitamins|vitamins|mesh-list
825364|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
825365|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825366|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
825367|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2252397|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252398|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2252399|NCT00137553|Renal Agents|renal agents|mesh-ancestor
2252400|NCT00137566|Acetaminophen|acetaminophen|mesh-list
2252401|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2252402|NCT00137566|Analgesics|analgesics|mesh-ancestor
2252403|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
826458|NCT02473887|Ondansetron|ondansetron|mesh-list
826459|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
826460|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
826461|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
826462|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826463|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
826464|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
826465|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
826466|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
826467|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
826468|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
826469|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826470|NCT02473887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
826471|NCT02473887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
826472|NCT02473887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
826473|NCT02473887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
826474|NCT02473887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2252404|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252405|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252406|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
2252407|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2252408|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
2252409|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252410|NCT00137657|Trimethoprim|trimethoprim|mesh-list
2252411|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2252412|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
2252413|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2252414|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252415|NCT00137657|Renal Agents|renal agents|mesh-ancestor
2252416|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
2252417|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2252418|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
826972|NCT02472054|Cyclosporine|cyclosporine|mesh-list
826973|NCT02472054|Prednisolone|prednisolone|mesh-list
826974|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
826975|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
826976|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
826977|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
826978|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
826979|NCT02472054|Cyclosporins|cyclosporins|mesh-list
826980|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
826981|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
826982|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826983|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826984|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
826985|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
826986|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252419|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2252420|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825056|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
825057|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825348|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
825349|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
825547|NCT02477306|Rabeprazole|rabeprazole|mesh-list
825548|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
825549|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
825550|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
825551|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825552|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825969|NCT02476045|Leucovorin|leucovorin|mesh-list
825970|NCT02476045|Fluorouracil|fluorouracil|mesh-list
825971|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
825972|NCT02476045|Panitumumab|panitumumab|mesh-list
825973|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
825974|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
825975|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825976|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
825977|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825978|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
825979|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
825980|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825981|NCT02476045|Antidotes|antidotes|mesh-ancestor
825982|NCT02476045|Protective Agents|protective agents|mesh-ancestor
825983|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
825984|NCT02476045|Vitamins|vitamins|mesh-ancestor
825985|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
825986|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
826416|NCT02474420|Amlodipine|amlodipine|mesh-list
826417|NCT02474420|Deferasirox|deferasirox|mesh-list
826418|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
826419|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
826420|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
826421|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826422|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
826423|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826424|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
826425|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
826426|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
826427|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
826522|NCT02473900|Oseltamivir|oseltamivir|mesh-list
826523|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
826524|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
826525|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826526|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826585|NCT02473627|Pioglitazone|pioglitazone|mesh-list
826586|NCT02473627|Tolbutamide|tolbutamide|mesh-list
826587|NCT02473627|Midazolam|midazolam|mesh-list
826588|NCT02473627|Omeprazole|omeprazole|mesh-list
826589|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
826590|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
826591|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
826592|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826593|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
826594|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
826595|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
826596|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
826597|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
826598|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
826599|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
826600|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
826601|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
826602|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826603|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
826604|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
826605|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
826606|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
826607|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826647|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
826648|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
826649|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
826650|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
826651|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826652|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
826653|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
826654|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
826655|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
826656|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
825135|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
825136|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
825137|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
825138|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
825139|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252421|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252422|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2252423|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2252424|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2252425|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2252426|NCT00137696|Vaccines|vaccines|mesh-list
2252427|NCT00137696|Immunologic Factors|immunologic factors|mesh-ancestor
2252428|NCT00137696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252429|NCT00137709|Lamotrigine|lamotrigine|mesh-list
2252430|NCT00137709|Valproic Acid|valproic acid|mesh-list
2252431|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
2252432|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2252433|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2252434|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252435|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2252436|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252437|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2252438|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2252439|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2252440|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2252441|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2252442|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252443|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
2252444|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252445|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
2252446|NCT00137735|Gabapentin|gabapentin|mesh-list
2252447|NCT00137735|Analgesics|analgesics|mesh-ancestor
2252448|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
2252449|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252450|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252451|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
2252452|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2252453|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2252454|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2252455|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2252456|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2252457|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
826644|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
826645|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
826646|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827397|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
827398|NCT02470663|Calcium|calcium|mesh-list
827399|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
827400|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827401|NCT02470663|Antacids|antacids|mesh-ancestor
827402|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827403|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
827480|NCT02470065|Afatinib|afatinib|mesh-list
827481|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827482|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
827483|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827484|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252458|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252459|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252460|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
2252461|NCT00137761|Docetaxel|docetaxel|mesh-list
2252462|NCT00137761|Gefitinib|gefitinib|mesh-list
827929|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
827930|NCT02467426|Analgesics|analgesics|mesh-ancestor
827931|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
827932|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827933|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827934|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827935|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
825220|NCT02478710|Tobramycin|tobramycin|mesh-list
825221|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
825222|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
825346|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
825347|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
825842|NCT02476760|Insulin|insulin|mesh-list
825843|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
825844|NCT02476760|Metformin|metformin|mesh-list
825845|NCT02476760|Pioglitazone|pioglitazone|mesh-list
825846|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
825847|NCT02476760|Liraglutide|liraglutide|mesh-list
825848|NCT02476760|Exenatide|exenatide|mesh-list
825849|NCT02476760|Glimepiride|glimepiride|mesh-list
825850|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
825851|NCT02476760|Saxagliptin|saxagliptin|mesh-list
825852|NCT02476760|Vildagliptin|vildagliptin|mesh-list
825853|NCT02476760|Acarbose|acarbose|mesh-list
825854|NCT02476760|Repaglinide|repaglinide|mesh-list
825855|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
825856|NCT02476760|Gliclazide|gliclazide|mesh-list
825857|NCT02476760|Glipizide|glipizide|mesh-list
825858|NCT02476760|Biguanides|biguanides|mesh-list
825859|NCT02476760|Voglibose|voglibose|mesh-list
825860|NCT02476760|Tolbutamide|tolbutamide|mesh-list
825861|NCT02476760|Nateglinide|nateglinide|mesh-list
825862|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
825863|NCT02476760|Miglitol|miglitol|mesh-list
825864|NCT02476760|Troglitazone|troglitazone|mesh-list
825865|NCT02476760|Meglitinide|meglitinide|mesh-list
825866|NCT02476760|Acetohexamide|acetohexamide|mesh-list
825867|NCT02476760|Phenformin|phenformin|mesh-list
825868|NCT02476760|Buformin|buformin|mesh-list
825869|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
825870|NCT02476760|Glibornuride|glibornuride|mesh-list
825871|NCT02476760|Tolazamide|tolazamide|mesh-list
825872|NCT02476760|Carbutamide|carbutamide|mesh-list
825873|NCT02476760|Gliquidone|gliquidone|mesh-list
825874|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
825875|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
825876|NCT02476760|Incretins|incretins|mesh-list
825877|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825878|NCT02476760|Hormones|hormones|mesh-ancestor
825879|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
825880|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
825881|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825882|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825883|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
825884|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
825885|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
825886|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
825949|NCT02475876|Clindamycin|clindamycin|mesh-list
825950|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
825951|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
825952|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
825953|NCT02475876|Trimethoprim|trimethoprim|mesh-list
825954|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
825955|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
825956|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
825957|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
825958|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825959|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825960|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
825961|NCT02475876|Renal Agents|renal agents|mesh-ancestor
825962|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
825963|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
825964|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
825965|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
825966|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
825967|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
825968|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
827037|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
827038|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
827039|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827040|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
827347|NCT02470702|Oritavancin|oritavancin|mesh-list
827348|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
827349|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827617|NCT02469155|Risperidone|risperidone|mesh-list
827618|NCT02469155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
827619|NCT02469155|Serotonin Agents|serotonin agents|mesh-ancestor
827620|NCT02469155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
827621|NCT02469155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827622|NCT02469155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825424|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
825425|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
825426|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
825427|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2252463|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252464|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
826222|NCT02475343|Riboflavin|riboflavin|mesh-list
826223|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
826224|NCT02475343|Vitamins|vitamins|mesh-ancestor
826225|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
826226|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826227|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
826228|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
826383|NCT02474290|Sorafenib|sorafenib|mesh-list
826384|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826385|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
826386|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826387|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252465|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
2252466|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
2252467|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252468|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2252469|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252470|NCT00137774|Bevacizumab|bevacizumab|mesh-list
2252471|NCT00137774|Temozolomide|temozolomide|mesh-list
2252472|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2252473|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252474|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2252475|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2252476|NCT00137774|Growth Substances|growth substances|mesh-ancestor
2252477|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827682|NCT02468999|Insulin|insulin|mesh-list
827683|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
827684|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
827685|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252478|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
2252479|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2252480|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
827965|NCT02467543|Ethanol|ethanol|mesh-list
827966|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
827967|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827968|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
827969|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828231|NCT02466568|Nivolumab|nivolumab|mesh-list
828232|NCT02466568|Vaccines|vaccines|mesh-list
828233|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
828234|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828235|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
828237|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
828238|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
828239|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828942|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
828943|NCT02463929|Promethazine|promethazine|mesh-list
828944|NCT02463929|Ketamine|ketamine|mesh-list
828945|NCT02463929|Bupivacaine|bupivacaine|mesh-list
828946|NCT02463929|Sevoflurane|sevoflurane|mesh-list
828947|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
828948|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
828949|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828950|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828951|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
828952|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828953|NCT02463929|Analgesics|analgesics|mesh-ancestor
828954|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
828955|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
828956|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
828957|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
828958|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
828959|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828960|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828961|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
828962|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
828963|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
828964|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
828965|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
825493|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825494|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825495|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
825496|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
825497|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825498|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
825499|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
825574|NCT02477280|Methylphenidate|methylphenidate|mesh-list
825575|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
825576|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825577|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
825578|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
825579|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
825580|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825581|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
825582|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
825678|NCT02477007|Acetaminophen|acetaminophen|mesh-list
825679|NCT02477007|Ibuprofen|ibuprofen|mesh-list
825680|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
825681|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
825682|NCT02477007|Analgesics|analgesics|mesh-ancestor
825683|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
825684|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825685|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825686|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
825687|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
825688|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
825689|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825690|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825691|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
2252481|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252482|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
2252483|NCT00137787|Cefepime|cefepime|mesh-list
2252484|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2252485|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252486|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2252487|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2252488|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252489|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827234|NCT02471430|Interferons|interferons|mesh-list
827235|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
827236|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
827237|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
827238|NCT02471430|Panobinostat|panobinostat|mesh-list
827239|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827240|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
827241|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827242|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
827243|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827244|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
827245|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827246|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827272|NCT02470832|Itraconazole|itraconazole|mesh-list
827273|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
827274|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827275|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
827276|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
827277|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827278|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827279|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
827280|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
827281|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
827282|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827283|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
827485|NCT02469987|Bevacizumab|bevacizumab|mesh-list
827486|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
827487|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827488|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
827489|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
827490|NCT02469987|Growth Substances|growth substances|mesh-ancestor
827491|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827492|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
825657|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
826138|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
826139|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
826140|NCT02475681|Chlorambucil|chlorambucil|mesh-list
826141|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
826142|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826143|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
826144|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
826145|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826398|NCT02474212|Enoxaparin|enoxaparin|mesh-list
826399|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
826400|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
826401|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
826402|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252490|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252491|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2252492|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2252493|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2252494|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252495|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2252496|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252497|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252498|NCT00137813|Bevacizumab|bevacizumab|mesh-list
2252499|NCT00137813|Docetaxel|docetaxel|mesh-list
2252500|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2252501|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252502|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2252503|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2252504|NCT00137813|Growth Substances|growth substances|mesh-ancestor
2252505|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252506|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
827103|NCT02471950|Isoflurane|isoflurane|mesh-list
827104|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
827105|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
827106|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
827107|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
827108|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827297|NCT02470767|Anticoagulants|anticoagulants|mesh-list
2252507|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
2252508|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
828138|NCT02466984|Metoclopramide|metoclopramide|mesh-list
828139|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
828140|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
828141|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828142|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828143|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
828144|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
828145|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
828146|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
828147|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828148|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828351|NCT02466334|Calcitonin|calcitonin|mesh-list
828352|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
828353|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
828354|NCT02466334|Katacalcin|katacalcin|mesh-list
828355|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
828356|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828357|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
828358|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
828435|NCT02466074|Acetazolamide|acetazolamide|mesh-list
828436|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
828437|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
828438|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
828439|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828440|NCT02466074|Diuretics|diuretics|mesh-ancestor
828441|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
828442|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828804|NCT02464631|Ribavirin|ribavirin|mesh-list
828805|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
828806|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
828807|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828808|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
828809|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829050|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
829051|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
825670|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
825671|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
825672|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
826000|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
826001|NCT02476058|Promethazine|promethazine|mesh-list
826002|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
826003|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
826004|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
826005|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826006|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
826007|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
826008|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
826009|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
826010|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
826011|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
826012|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
826013|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
826014|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
826015|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
826016|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
826017|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826018|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
826019|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
826020|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
827041|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
827042|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
827043|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
827044|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827045|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
827046|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
827047|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827601|NCT02469545|Citalopram|citalopram|mesh-list
827602|NCT02469545|Sertraline|sertraline|mesh-list
827603|NCT02469545|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
827604|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
827605|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
827606|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827607|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
827608|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
827609|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827610|NCT02469545|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
827611|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
827612|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
828377|NCT02466373|Clonidine|clonidine|mesh-list
828378|NCT02466373|Analgesics|analgesics|mesh-ancestor
828379|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
828380|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828381|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828382|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
828383|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
828384|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
828385|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
828386|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
828387|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
828388|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
828389|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828390|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828488|NCT02465606|Triamcinolone|triamcinolone|mesh-list
828489|NCT02465606|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
828490|NCT02465606|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
828491|NCT02465606|Hydrocortisone|hydrocortisone|mesh-list
828492|NCT02465606|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
828493|NCT02465606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
828494|NCT02465606|Glucocorticoids|glucocorticoids|mesh-ancestor
828495|NCT02465606|Hormones|hormones|mesh-ancestor
828496|NCT02465606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
828497|NCT02465606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828498|NCT02465606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
828499|NCT02465606|Immunologic Factors|immunologic factors|mesh-ancestor
828500|NCT02465606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
828501|NCT02465606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828651|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
828652|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
829365|NCT02462681|Ketamine|ketamine|mesh-list
829366|NCT02462681|Analgesics|analgesics|mesh-ancestor
825697|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
825698|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825699|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
825700|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825701|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
825702|NCT02476799|Narcotics|narcotics|mesh-ancestor
825703|NCT02476799|Analgesics|analgesics|mesh-ancestor
825704|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
825705|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
825706|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
825707|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
825708|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
825709|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
825710|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
825711|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
825712|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825713|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825887|NCT02476409|Tolvaptan|tolvaptan|mesh-list
825888|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
825889|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825890|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
825891|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826076|NCT02475915|Tenofovir|tenofovir|mesh-list
826077|NCT02475915|Emtricitabine|emtricitabine|mesh-list
826078|NCT02475915|Efavirenz|efavirenz|mesh-list
826079|NCT02475915|Maraviroc|maraviroc|mesh-list
826080|NCT02475915|Darunavir|darunavir|mesh-list
826081|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
826082|NCT02475915|Vorinostat|vorinostat|mesh-list
826083|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
826084|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
826085|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
826086|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
826087|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826088|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826089|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
826090|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
826091|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
826092|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
826093|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
826094|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
826095|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
826096|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
826097|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
826098|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
826099|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
826100|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
826101|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826102|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
826103|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
826104|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
826105|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
826106|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
826107|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
826108|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
2252509|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
2252510|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252511|NCT00137826|Bevacizumab|bevacizumab|mesh-list
826845|NCT02472691|Lenalidomide|lenalidomide|mesh-list
826846|NCT02472691|Azacitidine|azacitidine|mesh-list
826847|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
826848|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826849|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
826850|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
826851|NCT02472691|Growth Substances|growth substances|mesh-ancestor
826852|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
826853|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826854|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
826855|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
826856|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826857|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252512|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2252513|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2252514|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252515|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2252516|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2252517|NCT00137826|Growth Substances|growth substances|mesh-ancestor
2252518|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826151|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
826152|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
826153|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
826154|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
826155|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252519|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
2252520|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2252521|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252522|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252523|NCT00137852|Celecoxib|celecoxib|mesh-list
2252524|NCT00137852|Irinotecan|irinotecan|mesh-list
2252525|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252526|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2252527|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2252528|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252529|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252530|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2252531|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2252532|NCT00137852|Analgesics|analgesics|mesh-ancestor
2252533|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
2252534|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252535|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252536|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2252537|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252538|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2252539|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2252540|NCT00137995|Cytarabine|cytarabine|mesh-list
2252541|NCT00137995|Dexamethasone|dexamethasone|mesh-list
2252542|NCT00137995|Rituximab|rituximab|mesh-list
2252543|NCT00137995|Etoposide|etoposide|mesh-list
2252544|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
2252545|NCT00137995|Melphalan|melphalan|mesh-list
2252546|NCT00137995|Ifosfamide|ifosfamide|mesh-list
2252547|NCT00137995|Carboplatin|carboplatin|mesh-list
2252548|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2252549|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
2252550|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
2252551|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252552|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252553|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2252554|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
2252555|NCT00137995|Hormones|hormones|mesh-ancestor
2252556|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2252557|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2252558|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252559|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2252560|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
2252561|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252562|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2252563|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2252564|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2252565|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252566|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252567|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2252568|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
2252569|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
2252570|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252571|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2252572|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2252573|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
2252574|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2252575|NCT00138060|Fluorouracil|fluorouracil|mesh-list
2252576|NCT00138060|Irinotecan|irinotecan|mesh-list
2252577|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
2252578|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252579|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2252580|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
828733|NCT02464722|Epinephrine|epinephrine|mesh-list
828734|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
2252581|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2252582|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
2252583|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825766|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
825767|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
825768|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
825769|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
825770|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
825771|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
825772|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
825773|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
825774|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
825775|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825776|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252584|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2252585|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2252586|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252587|NCT00138099|Dalteparin|dalteparin|mesh-list
2252588|NCT00138099|Tinzaparin|tinzaparin|mesh-list
2252589|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2252590|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
2252591|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2252592|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2252593|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252594|NCT00138112|Vancomycin|vancomycin|mesh-list
2252595|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2252596|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252597|NCT00138138|Methylphenidate|methylphenidate|mesh-list
2252598|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2252599|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252600|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2252601|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2252602|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2252603|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252604|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
2252605|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252606|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
2252607|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252608|NCT00138177|Leucovorin|leucovorin|mesh-list
2252609|NCT00138177|Fluorouracil|fluorouracil|mesh-list
2252610|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
2252611|NCT00138177|Vorinostat|vorinostat|mesh-list
2252612|NCT00138177|Calcium|calcium|mesh-list
2252613|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
827530|NCT02469974|Busulfan|busulfan|mesh-list
827531|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
827532|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827533|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
827534|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827535|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
827536|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
827537|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827538|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2252614|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2252615|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252616|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
2252617|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252618|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2252619|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252620|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2252621|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
2252622|NCT00138177|Antidotes|antidotes|mesh-ancestor
2252623|NCT00138177|Protective Agents|protective agents|mesh-ancestor
2252624|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
2252625|NCT00138177|Vitamins|vitamins|mesh-ancestor
827771|NCT02468297|Ibuprofen|ibuprofen|mesh-list
827772|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
827773|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
827774|NCT02468297|Analgesics|analgesics|mesh-ancestor
827775|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
827776|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827777|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827778|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
827779|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
827780|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
827781|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827782|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825790|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
825791|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
825792|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
825793|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826246|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
826247|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
826248|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827109|NCT02471690|Oritavancin|oritavancin|mesh-list
827110|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
827111|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098464|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098465|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098466|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2098467|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
2098468|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098469|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
2098470|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
2098471|NCT02343939|Cytarabine|cytarabine|mesh-list
2098472|NCT02343939|Azacitidine|azacitidine|mesh-list
2252626|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
2252627|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2252628|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252629|NCT00138216|Irinotecan|irinotecan|mesh-list
2252630|NCT00138216|Vincristine|vincristine|mesh-list
827878|NCT02467907|Paclitaxel|paclitaxel|mesh-list
827879|NCT02467907|Bevacizumab|bevacizumab|mesh-list
827880|NCT02467907|Carboplatin|carboplatin|mesh-list
827881|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
827882|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827883|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
827884|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
827885|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
827886|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827887|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
827888|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
827889|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
827890|NCT02467907|Growth Substances|growth substances|mesh-ancestor
827891|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827892|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
828236|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
828240|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828241|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
828242|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
828243|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
828244|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
828245|NCT02466802|Urological Agents|urological agents|mesh-ancestor
828681|NCT02465255|Acetaminophen|acetaminophen|mesh-list
828682|NCT02465255|Ketorolac|ketorolac|mesh-list
828683|NCT02465255|Tramadol|tramadol|mesh-list
828684|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
828685|NCT02465255|Analgesics|analgesics|mesh-ancestor
828686|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
828687|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828688|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828689|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
828690|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
828691|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
828692|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
828693|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
828694|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
828695|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828696|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
828697|NCT02465255|Narcotics|narcotics|mesh-ancestor
828698|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828729|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
828730|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
828731|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2098473|NCT02343939|Decitabine|decitabine|mesh-list
2098474|NCT02343939|Daunorubicin|daunorubicin|mesh-list
2252631|NCT00138216|Temozolomide|temozolomide|mesh-list
825903|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
825904|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
825905|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
825906|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
825907|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
825908|NCT02476136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
825909|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
825910|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
825911|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
825912|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
825913|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826133|NCT02475382|Nivolumab|nivolumab|mesh-list
826134|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
826135|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826136|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
826137|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826292|NCT02474706|Imipenem|imipenem|mesh-list
826293|NCT02474706|Cefoxitin|cefoxitin|mesh-list
826294|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
826295|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252632|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2252633|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2252634|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252635|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252636|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252637|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2252638|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
2252639|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
2252640|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
2252641|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2252642|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
2252643|NCT00138229|Aldesleukin|aldesleukin|mesh-list
2252644|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
2252645|NCT00138229|Fludarabine|fludarabine|mesh-list
2252646|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
2252647|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2252648|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
2252649|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252650|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252651|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2252652|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
826621|NCT02473406|Thymalfasin|thymalfasin|mesh-list
826622|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
826623|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
826624|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098475|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2098476|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
2098477|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098478|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098479|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
2098480|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098481|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2098482|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
2098483|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098484|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098485|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2098486|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2098487|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2098488|NCT02344004|Amikacin|amikacin|mesh-list
2098489|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2098490|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098491|NCT02344225|Ibuprofen|ibuprofen|mesh-list
2098492|NCT02344225|Ketorolac|ketorolac|mesh-list
2098493|NCT02344225|Caffeine|caffeine|mesh-list
2098494|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
2098495|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098496|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2098497|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2098498|NCT02344225|Analgesics|analgesics|mesh-ancestor
2098499|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
2098500|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098501|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098502|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2098503|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2098504|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
826033|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
826034|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
826035|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
826036|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826037|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826038|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
826039|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
826040|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
826041|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826042|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
826043|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
826044|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
826045|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
826249|NCT02475135|Tenofovir|tenofovir|mesh-list
826250|NCT02475135|Emtricitabine|emtricitabine|mesh-list
826251|NCT02475135|Darunavir|darunavir|mesh-list
826252|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
826253|NCT02475135|Cobicistat|cobicistat|mesh-list
826254|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
826255|NCT02475135|Elvitegravir|elvitegravir|mesh-list
826256|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
826257|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
826258|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
826259|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
826260|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826261|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826262|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
826263|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
826264|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
826265|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
826266|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
826267|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
826268|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
826269|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
826445|NCT02474368|Cisplatin|cisplatin|mesh-list
826446|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826903|NCT02472600|Colistin|colistin|mesh-list
826904|NCT02472600|Polymyxins|polymyxins|mesh-list
826905|NCT02472600|Neomycin|neomycin|mesh-list
826906|NCT02472600|Omeprazole|omeprazole|mesh-list
826907|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
826908|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
826909|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
826910|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826911|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826912|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
826913|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
826914|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
826960|NCT02472080|Gemcitabine|gemcitabine|mesh-list
826961|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
826962|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
826963|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
826964|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826965|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826966|NCT02472080|Antiviral Agents|antiviral agents|mesh-ancestor
826967|NCT02472080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
826968|NCT02472080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826969|NCT02472080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
826970|NCT02472080|Immunologic Factors|immunologic factors|mesh-ancestor
826971|NCT02472080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827149|NCT02471911|Dexamethasone|dexamethasone|mesh-list
827150|NCT02471911|Rituximab|rituximab|mesh-list
827151|NCT02471911|Carboplatin|carboplatin|mesh-list
827152|NCT02471911|Etoposide|etoposide|mesh-list
827153|NCT02471911|Ifosfamide|ifosfamide|mesh-list
827154|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
827155|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
827156|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
827157|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827158|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827159|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
827160|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
827161|NCT02471911|Hormones|hormones|mesh-ancestor
827162|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
827163|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
827164|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826067|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826068|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
826069|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
826070|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
826071|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
826072|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
826073|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
826074|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
826075|NCT02475824|Narcotics|narcotics|mesh-ancestor
826570|NCT02473601|Mivacurium|mivacurium|mesh-list
826571|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
826572|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
826573|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
826574|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
826575|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252653|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252654|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252655|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2252656|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2252657|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
2252658|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2252659|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2252660|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
827896|NCT02467868|Lenograstim|lenograstim|mesh-list
827897|NCT02467868|Sargramostim|sargramostim|mesh-list
827898|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
827899|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
827900|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828297|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
828298|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
828299|NCT02466464|Coagulants|coagulants|mesh-ancestor
828427|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
828428|NCT02466204|Hormones|hormones|mesh-ancestor
828429|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
828430|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828475|NCT02465827|Ropivacaine|ropivacaine|mesh-list
828476|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
828477|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
828478|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828479|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828480|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
828481|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828780|NCT02464813|Pregabalin|pregabalin|mesh-list
828781|NCT02464813|Oxycodone|oxycodone|mesh-list
828782|NCT02464813|Analgesics|analgesics|mesh-ancestor
828783|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
828784|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828785|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828786|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
828787|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
828788|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
828789|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828790|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
828791|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
828792|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
828793|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828794|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
828795|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
828796|NCT02464813|Narcotics|narcotics|mesh-ancestor
828891|NCT02463994|Atezolizumab|atezolizumab|mesh-list
828892|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829020|NCT02463747|Vancomycin|vancomycin|mesh-list
829021|NCT02463747|Meropenem|meropenem|mesh-list
829022|NCT02463747|Tazobactam|tazobactam|mesh-list
829023|NCT02463747|Piperacillin|piperacillin|mesh-list
829024|NCT02463747|Ceftazidime|ceftazidime|mesh-list
829025|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
829026|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
829027|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829028|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
829029|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829030|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829282|NCT02462915|Lidocaine|lidocaine|mesh-list
829283|NCT02462915|Fentanyl|fentanyl|mesh-list
829284|NCT02462915|Propofol|propofol|mesh-list
829285|NCT02462915|Cisatracurium|cisatracurium|mesh-list
829286|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
2252661|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252662|NCT00138242|Carboplatin|carboplatin|mesh-list
2252663|NCT00138242|Docetaxel|docetaxel|mesh-list
2252664|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826725|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
826726|NCT02473198|Morphine|morphine|mesh-list
826727|NCT02473198|Bupivacaine|bupivacaine|mesh-list
826728|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
826729|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
826730|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
826731|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826732|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
826733|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
826734|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
826735|NCT02473198|Narcotics|narcotics|mesh-ancestor
826736|NCT02473198|Analgesics|analgesics|mesh-ancestor
826737|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
826738|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
826739|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
826740|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
826741|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
826742|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826743|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826747|NCT02472873|Ethanol|ethanol|mesh-list
826748|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
826749|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
826750|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
826751|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252665|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
2252666|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
2252667|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
2252668|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252669|NCT00138359|Niclosamide|niclosamide|mesh-list
2252670|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
2252671|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2252672|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
2252673|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2252674|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252675|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
2252676|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
2252677|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2252678|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252679|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2252680|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2252681|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252682|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827270|NCT02471105|Bimatoprost|bimatoprost|mesh-list
827271|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
827686|NCT02469012|Ribavirin|ribavirin|mesh-list
827687|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
827688|NCT02469012|Ledipasvir|ledipasvir|mesh-list
827689|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
827690|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827691|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
827692|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252683|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252684|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2252685|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2252686|NCT00138515|Vildagliptin|vildagliptin|mesh-list
2252687|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
826313|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
826314|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
826315|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826316|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
826317|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
826318|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
2252688|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252689|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2252690|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
827214|NCT02471391|Venetoclax|venetoclax|mesh-list
827215|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252691|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252692|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252693|NCT00138541|Vildagliptin|vildagliptin|mesh-list
2252694|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2252695|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252696|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2252697|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
2252698|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252699|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252700|NCT00138554|Pioglitazone|pioglitazone|mesh-list
2252701|NCT00138554|Vildagliptin|vildagliptin|mesh-list
2252702|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2252703|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252704|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2252705|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
2252706|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252707|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252708|NCT00138567|Vildagliptin|vildagliptin|mesh-list
828482|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
828483|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
828484|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
828485|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
828486|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828487|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2252709|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2252710|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252711|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2252712|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
2252713|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252714|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830011|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
830012|NCT02460393|Antibodies|antibodies|mesh-list
830013|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
830014|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
830015|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
830016|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830017|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830255|NCT02459574|Amiodarone|amiodarone|mesh-list
830256|NCT02459574|Sotalol|sotalol|mesh-list
830257|NCT02459574|Flecainide|flecainide|mesh-list
830258|NCT02459574|Propafenone|propafenone|mesh-list
830259|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
830260|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
830261|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
830262|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830263|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
830264|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
830265|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
830266|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
830267|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830268|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
830269|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
830270|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
830271|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
830272|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
830273|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
830274|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830275|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
830276|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
830277|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
830278|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
830279|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
826324|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
826325|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826326|NCT02474628|Antacids|antacids|mesh-ancestor
826327|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826328|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
826388|NCT02474225|Bevacizumab|bevacizumab|mesh-list
826389|NCT02474225|Ranibizumab|ranibizumab|mesh-list
826390|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
826391|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
826392|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826393|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
826394|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
826395|NCT02474225|Growth Substances|growth substances|mesh-ancestor
826396|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826397|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
826680|NCT02473302|Tocopherols|tocopherols|mesh-list
826681|NCT02473302|Vitamin E|vitamin e|mesh-list
826682|NCT02473302|Tocotrienols|tocotrienols|mesh-list
826683|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
826684|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
826685|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826686|NCT02473302|Protective Agents|protective agents|mesh-ancestor
826687|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826688|NCT02473302|Vitamins|vitamins|mesh-ancestor
826689|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
826786|NCT02472717|Liraglutide|liraglutide|mesh-list
826787|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
826788|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826789|NCT02472717|Incretins|incretins|mesh-ancestor
826790|NCT02472717|Hormones|hormones|mesh-ancestor
826791|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
827080|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
827081|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
827082|NCT02472275|Hormones|hormones|mesh-list
827083|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
827084|NCT02472275|Androgens|androgens|mesh-list
827085|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
827086|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
827087|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827088|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
827089|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827090|NCT02472275|Protective Agents|protective agents|mesh-ancestor
827091|NCT02472275|Vitamins|vitamins|mesh-ancestor
827092|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
827093|NCT02472275|Estrogens|estrogens|mesh-ancestor
827094|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
827095|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827096|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
827097|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
2252715|NCT00138580|Vildagliptin|vildagliptin|mesh-list
2252716|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2252717|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252718|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2252719|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
2252720|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252721|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252722|NCT00138593|Vildagliptin|vildagliptin|mesh-list
2252723|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2252724|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827864|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
827865|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
827866|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
827867|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
827868|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827869|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827871|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
828067|NCT02467595|Fentanyl|fentanyl|mesh-list
828068|NCT02467595|Bromides|bromides|mesh-list
828069|NCT02467595|Propofol|propofol|mesh-list
828070|NCT02467595|Sevoflurane|sevoflurane|mesh-list
828071|NCT02467595|Rocuronium|rocuronium|mesh-list
828072|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
828073|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828074|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828075|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
828076|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
826332|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
826333|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826334|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
826335|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
826336|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
826436|NCT02474134|Interferons|interferons|mesh-list
826437|NCT02474134|Interferon-beta|interferon-beta|mesh-list
826438|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
826439|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826440|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
826441|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
826442|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
826443|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826444|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
826555|NCT02473575|Caffeine|caffeine|mesh-list
826556|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
826557|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826558|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
826559|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826560|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826561|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
826562|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
826563|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
826564|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
826608|NCT02473328|Ritonavir|ritonavir|mesh-list
826609|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
826610|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
826611|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
826612|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
826613|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826614|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826615|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
826616|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
826617|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
826618|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
826619|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
826620|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
826744|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
826745|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
826746|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827112|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
827113|NCT02471677|Hormones|hormones|mesh-ancestor
827114|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
827115|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827386|NCT02470455|Atorvastatin|atorvastatin|mesh-list
827387|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
827388|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
827389|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
827390|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827391|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
827392|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
827393|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252725|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2252726|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
2252727|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252728|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252729|NCT00138606|Vildagliptin|vildagliptin|mesh-list
2252730|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2252731|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252732|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2252733|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
2252734|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829934|NCT02460588|Prednisolone|prednisolone|mesh-list
829935|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
829936|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
829937|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
829938|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829939|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
829940|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
829941|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
829942|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829943|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829944|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
826360|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
826361|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
826362|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
826363|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
826364|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
826365|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
826366|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
826367|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
826368|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
826369|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
826370|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
826371|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
826372|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
826373|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826752|NCT02472782|Teriparatide|teriparatide|mesh-list
826753|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
826754|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826755|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
827845|NCT02468063|Terlipressin|terlipressin|mesh-list
827846|NCT02468063|Norepinephrine|norepinephrine|mesh-list
827847|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
827848|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
827849|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
827850|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
827851|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
827852|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
827853|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827854|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827855|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
827856|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
827857|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828223|NCT02466542|Esmolol|esmolol|mesh-list
828224|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
828225|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
828226|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
828227|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
828228|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828229|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828230|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252735|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252736|NCT00138619|Vildagliptin|vildagliptin|mesh-list
2252737|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2252738|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252739|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2252740|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
2252741|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252742|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252743|NCT00138632|Vatalanib|vatalanib|mesh-list
2252744|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2252745|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252746|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252747|NCT00138710|Letrozole|letrozole|mesh-list
2252748|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252749|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2252750|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
830109|NCT02460042|Paclitaxel|paclitaxel|mesh-list
830110|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
830111|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830112|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
830113|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
830114|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
830115|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830571|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
830572|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
830573|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830574|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830575|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
830576|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
830577|NCT02458079|Protective Agents|protective agents|mesh-ancestor
830578|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830579|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
830580|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
830581|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
2252751|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826548|NCT02473562|Varenicline|varenicline|mesh-list
826549|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
826550|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
826551|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
826552|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
826553|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826554|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826625|NCT02473354|Remifentanil|remifentanil|mesh-list
826626|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
826627|NCT02473354|Narcotics|narcotics|mesh-ancestor
826628|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
826629|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826630|NCT02473354|Analgesics|analgesics|mesh-ancestor
826631|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
826632|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
826898|NCT02472574|Plasminogen|plasminogen|mesh-list
826899|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
826900|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
826901|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
826902|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827327|NCT02470637|Insulin|insulin|mesh-list
827328|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
827329|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
827330|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
827331|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827460|NCT02470117|Antacids|antacids|mesh-list
827461|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827462|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
827870|NCT02467920|Exenatide|exenatide|mesh-list
827872|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
827873|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827874|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
827875|NCT02467920|Incretins|incretins|mesh-ancestor
827876|NCT02467920|Hormones|hormones|mesh-ancestor
827877|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
828045|NCT02467608|Isoniazid|isoniazid|mesh-list
828046|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
828047|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
828048|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
828049|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
828050|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
828051|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
828052|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828053|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
828532|NCT02465385|Linaclotide|linaclotide|mesh-list
828533|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
828534|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
828535|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828536|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2252752|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252753|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2252754|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
2252755|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2252756|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252757|NCT00138736|Lectins|lectins|mesh-list
2252758|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
2252759|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
2252760|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252761|NCT00138736|Coagulants|coagulants|mesh-ancestor
2252762|NCT00138762|Atorvastatin|atorvastatin|mesh-list
2252763|NCT00138762|Torcetrapib|torcetrapib|mesh-list
2252764|NCT00138762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2252765|NCT00138762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2252766|NCT00138762|Antimetabolites|antimetabolites|mesh-ancestor
2252767|NCT00138762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252768|NCT00138762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2252769|NCT00138762|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2252770|NCT00138762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
826456|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
826457|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
826527|NCT02473809|Liraglutide|liraglutide|mesh-list
826528|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
826529|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826530|NCT02473809|Incretins|incretins|mesh-ancestor
826531|NCT02473809|Hormones|hormones|mesh-ancestor
826532|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
826659|NCT02473263|Tazobactam|tazobactam|mesh-list
826660|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
826661|NCT02473263|Piperacillin|piperacillin|mesh-list
826662|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
826663|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
826664|NCT02473263|Norepinephrine|norepinephrine|mesh-list
826665|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
826666|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
826667|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
826668|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
826669|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
826670|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826671|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826672|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
826673|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
826674|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
826675|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
826676|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
826677|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
826678|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
826679|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252771|NCT00138801|Doxycycline|doxycycline|mesh-list
2252772|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
2252773|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2252774|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252775|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
2252776|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2252777|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2252778|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
2252779|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2252780|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2252781|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252782|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2252783|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252784|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2252785|NCT00138944|Eplerenone|eplerenone|mesh-list
2252786|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2252787|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
2252788|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2252789|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252790|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2252791|NCT00138944|Diuretics|diuretics|mesh-ancestor
2252792|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
2252793|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2252794|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
2252795|NCT00138970|Cyclosporine|cyclosporine|mesh-list
2252796|NCT00138970|Prednisolone|prednisolone|mesh-list
2252797|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
827783|NCT02468531|Xenon|xenon|mesh-list
827784|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
827785|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
827786|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
827787|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
827788|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828300|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
828301|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
828302|NCT02466581|Prednisolone|prednisolone|mesh-list
828303|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
828304|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
828305|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
828306|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
828307|NCT02466581|Abatacept|abatacept|mesh-list
828308|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
828309|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
828310|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
828311|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
828312|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
2252798|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
2252799|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2252800|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
2252801|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2252802|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
2252803|NCT00138970|Daclizumab|daclizumab|mesh-list
2252804|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2252805|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
2252806|NCT00138970|Hormones|hormones|mesh-ancestor
827332|NCT02470559|Aldesleukin|aldesleukin|mesh-list
827333|NCT02470559|Interleukin-2|interleukin-2|mesh-list
827334|NCT02470559|Sargramostim|sargramostim|mesh-list
827335|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
827336|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827337|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
827338|NCT02470559|Analgesics|analgesics|mesh-ancestor
827339|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
827340|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827341|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827342|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
827343|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
827344|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
827345|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
827346|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827493|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
827494|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
827495|NCT02469753|Analgesics|analgesics|mesh-ancestor
827496|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
827497|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827498|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827499|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
827500|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
827693|NCT02468856|Modafinil|modafinil|mesh-list
827694|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
827695|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827696|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
827697|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
827698|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
827699|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828770|NCT02464865|Thiamine|thiamine|mesh-list
828771|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
828772|NCT02464865|Vitamins|vitamins|mesh-ancestor
828773|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
828774|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828884|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
828885|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
828886|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252807|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2252808|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252809|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2252810|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252811|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
2252812|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
2252813|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252814|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2252815|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2252816|NCT00138970|Protective Agents|protective agents|mesh-ancestor
2252817|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2252818|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2252819|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
2252820|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2252821|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252822|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252823|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252824|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
2252825|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
829491|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
829492|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
829493|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829494|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829495|NCT02462265|Analgesics|analgesics|mesh-ancestor
829496|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
826657|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
826658|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252826|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2252827|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
2252828|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252829|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2252830|NCT00138983|Vitamin D|vitamin d|mesh-list
2252831|NCT00138983|Alendronate|alendronate|mesh-list
2252832|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
2252833|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2252834|NCT00138983|Vitamins|vitamins|mesh-ancestor
2252835|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
827720|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
827721|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827722|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
827723|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827724|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827817|NCT02468206|Polidocanol|polidocanol|mesh-list
827818|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
827819|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2098505|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098506|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2098507|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2098508|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2098509|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2098510|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
2098511|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098512|NCT02344238|Riboflavin|riboflavin|mesh-list
2098513|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
2098514|NCT02344238|Vitamins|vitamins|mesh-ancestor
2098515|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
2098516|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252836|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252837|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2252838|NCT00139009|Cyclosporine|cyclosporine|mesh-list
2252839|NCT00139009|Cyclosporins|cyclosporins|mesh-list
2252840|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252841|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252842|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2252843|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
2252844|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252845|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
2252846|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252847|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
2252848|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252849|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2252850|NCT00139035|Cyclosporine|cyclosporine|mesh-list
2252851|NCT00139035|Cyclosporins|cyclosporins|mesh-list
2252852|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252853|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252854|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2252855|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
2252856|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252857|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
2252858|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
830208|NCT02459756|Ascorbic Acid|ascorbic acid|mesh-list
830209|NCT02459756|Citric Acid|citric acid|mesh-list
830210|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
830211|NCT02459756|Vitamins|vitamins|mesh-ancestor
830212|NCT02459756|Micronutrients|micronutrients|mesh-ancestor
830213|NCT02459756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830214|NCT02459756|Antioxidants|antioxidants|mesh-ancestor
830215|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830216|NCT02459756|Protective Agents|protective agents|mesh-ancestor
830217|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
830218|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
830219|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
830220|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
830383|NCT02458781|Metronidazole|metronidazole|mesh-list
830384|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
830385|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
830386|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
830387|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
830388|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
830389|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
830390|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
830391|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2252859|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
826761|NCT02473094|Metformin|metformin|mesh-list
826762|NCT02473094|Capecitabine|capecitabine|mesh-list
826763|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
826764|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826765|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
826766|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
826767|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826768|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252860|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2252861|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2252862|NCT00139061|Atorvastatin|atorvastatin|mesh-list
2252863|NCT00139061|Torcetrapib|torcetrapib|mesh-list
2252864|NCT00139061|Fenofibrate|fenofibrate|mesh-list
2252865|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2098517|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2098518|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
2098519|NCT02344316|Melatonin|melatonin|mesh-list
827789|NCT02468375|Mirabegron|mirabegron|mesh-list
827790|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
827791|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
827792|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
827793|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
827794|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
827795|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827796|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827797|NCT02468375|Urological Agents|urological agents|mesh-ancestor
828012|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
828013|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
828014|NCT02467673|Estradiol|estradiol|mesh-list
828015|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
828016|NCT02467673|Progesterone|progesterone|mesh-list
828017|NCT02467673|Estrogens|estrogens|mesh-ancestor
828018|NCT02467673|Hormones|hormones|mesh-ancestor
828019|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
828020|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828021|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
828022|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
828023|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
828024|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
828025|NCT02467673|Progestins|progestins|mesh-ancestor
828180|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
828181|NCT02466828|Hematinics|hematinics|mesh-ancestor
828182|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
828183|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
828246|NCT02466503|Fluticasone|fluticasone|mesh-list
828247|NCT02466503|Xhance|xhance|mesh-list
828248|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
828249|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
828250|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
828251|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
828252|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828253|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828254|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
828255|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
828256|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
828257|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
828258|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
828259|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
828260|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
828261|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
828262|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828263|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252866|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2252867|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
2252868|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252869|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2252870|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2252871|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252872|NCT00139074|Valproic Acid|valproic acid|mesh-list
2252873|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2252874|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
2252875|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
828775|NCT02464683|Vitamin D|vitamin d|mesh-list
828776|NCT02464683|Vitamins|vitamins|mesh-ancestor
828777|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
828778|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098520|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
2098521|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826932|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
826933|NCT02472392|Melphalan|melphalan|mesh-list
826934|NCT02472392|Busulfan|busulfan|mesh-list
826935|NCT02472392|Fludarabine|fludarabine|mesh-list
826936|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
826937|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
826938|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
826939|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
826940|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826941|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
826942|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
826943|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
826944|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
826945|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826946|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
827324|NCT02470611|Alendronate|alendronate|mesh-list
827325|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
827326|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252876|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2252877|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2252878|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2252879|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252880|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
2252881|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252882|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252883|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
2252884|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252885|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
2252886|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
2252887|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2098522|NCT02344316|Protective Agents|protective agents|mesh-ancestor
2098523|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828060|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
828061|NCT02467361|Nivolumab|nivolumab|mesh-list
828062|NCT02467361|Ipilimumab|ipilimumab|mesh-list
828063|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
828064|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
828065|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
828066|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828159|NCT02467010|Dexamethasone|dexamethasone|mesh-list
828160|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
828161|NCT02467010|Bortezomib|bortezomib|mesh-list
828162|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
828163|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
828164|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828165|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
828166|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
828167|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
828168|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828169|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
828170|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
828171|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
828172|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
828173|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
828174|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828175|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
828176|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
828177|NCT02467010|Hormones|hormones|mesh-ancestor
828178|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
828179|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
828431|NCT02466035|Caseins|caseins|mesh-list
828432|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
828433|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
828434|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828567|NCT02465801|Lenograstim|lenograstim|mesh-list
828568|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
828569|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
828570|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828999|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
829000|NCT02464124|Lactulose|lactulose|mesh-list
829001|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
829002|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
829003|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829247|NCT02463019|Tenofovir|tenofovir|mesh-list
829248|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
829249|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
826871|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
826872|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
826873|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
826874|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
826875|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
826876|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
826877|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
826878|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
826879|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827116|NCT02471820|Dexamethasone|dexamethasone|mesh-list
827117|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
827118|NCT02471820|Doxorubicin|doxorubicin|mesh-list
827119|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
827120|NCT02471820|Lenalidomide|lenalidomide|mesh-list
827121|NCT02471820|BB 1101|bb 1101|mesh-list
827122|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
827123|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
827124|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
827125|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827126|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827127|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
827128|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
827129|NCT02471820|Hormones|hormones|mesh-ancestor
827130|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
827131|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
827132|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827133|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
827134|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827135|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827136|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
827137|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
827138|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
827139|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
827140|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
827141|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
827147|NCT02471820|Growth Substances|growth substances|mesh-ancestor
827148|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
2252888|NCT00139152|Omalizumab|omalizumab|mesh-list
2252889|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2252890|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2252891|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
2252892|NCT00139165|Budesonide|budesonide|mesh-list
2252893|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2252894|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2252895|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
2252896|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252897|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252898|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2252899|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
2252900|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
2252901|NCT00139165|Hormones|hormones|mesh-ancestor
2252902|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2252903|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
2252904|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2252905|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252906|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
2252907|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2252908|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
2252909|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828537|NCT02465645|Carvedilol|carvedilol|mesh-list
828538|NCT02465645|Simvastatin|simvastatin|mesh-list
828539|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
828540|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
828541|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
828542|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828543|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
828544|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
828545|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
828546|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
828547|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
828548|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
828549|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828550|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828551|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
828552|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
2252910|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252911|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
827229|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
827230|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
827231|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827232|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
827233|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827350|NCT02470650|Ritonavir|ritonavir|mesh-list
827351|NCT02470650|Darunavir|darunavir|mesh-list
827352|NCT02470650|Tenofovir|tenofovir|mesh-list
827353|NCT02470650|Lamivudine|lamivudine|mesh-list
827354|NCT02470650|Emtricitabine|emtricitabine|mesh-list
827355|NCT02470650|Abacavir|abacavir|mesh-list
827356|NCT02470650|Cobicistat|cobicistat|mesh-list
827357|NCT02470650|Rilpivirine|rilpivirine|mesh-list
827358|NCT02470650|Elvitegravir|elvitegravir|mesh-list
827359|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
827360|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
827361|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
827362|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827363|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827364|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
827365|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
827366|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
827367|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827368|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
827369|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
827370|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
827371|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
827372|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
827404|NCT02470299|Ketorolac|ketorolac|mesh-list
827405|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
827406|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
827407|NCT02470299|Analgesics|analgesics|mesh-ancestor
827408|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
827409|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827410|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827411|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
827412|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
827413|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
827414|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827415|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827518|NCT02470026|Yohimbine|yohimbine|mesh-list
827519|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
827520|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
827521|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827522|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827523|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
827524|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
827525|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
827526|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
827527|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
827528|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827529|NCT02470026|Urological Agents|urological agents|mesh-ancestor
2252912|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
2252913|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2252914|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
2252915|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252916|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2252917|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2252918|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
2252919|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
2252920|NCT00139217|Protective Agents|protective agents|mesh-ancestor
2252921|NCT00139230|Leucovorin|leucovorin|mesh-list
2252922|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
2252923|NCT00139230|Fluorouracil|fluorouracil|mesh-list
2252924|NCT00139230|Docetaxel|docetaxel|mesh-list
2252925|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
828338|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
828339|NCT02466698|Metronidazole|metronidazole|mesh-list
828340|NCT02466698|Vancomycin|vancomycin|mesh-list
828341|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
828342|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
828343|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
828344|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
826987|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
826988|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
826989|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
826990|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
826991|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
826992|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
826993|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
826994|NCT02472054|Hormones|hormones|mesh-ancestor
826995|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
826996|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
826997|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
826998|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
826999|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
827000|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827001|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
827002|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
827003|NCT02472054|Protective Agents|protective agents|mesh-ancestor
827004|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
827206|NCT02471846|Atezolizumab|atezolizumab|mesh-list
827207|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827284|NCT02470923|Nicotine|nicotine|mesh-list
827285|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
827286|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
827287|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827288|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827289|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
827290|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
827291|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
827292|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
827293|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827394|NCT02470546|Metformin|metformin|mesh-list
827395|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
827396|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252926|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
2252927|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252928|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2252929|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2252930|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
2252931|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252932|NCT00139230|Antidotes|antidotes|mesh-ancestor
827982|NCT02467335|Fostemsavir|fostemsavir|mesh-list
827983|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
827984|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
827985|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
827986|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827987|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
827988|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
827989|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828119|NCT02467127|Vitamin D|vitamin d|mesh-list
828120|NCT02467127|Vitamins|vitamins|mesh-ancestor
828121|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
828122|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828123|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2252933|NCT00139230|Protective Agents|protective agents|mesh-ancestor
2252934|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
2252935|NCT00139230|Vitamins|vitamins|mesh-ancestor
2252936|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
2252937|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
2098524|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2098525|NCT02344342|Diuretics|diuretics|mesh-list
2098526|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
2098527|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098528|NCT02344628|Azithromycin|azithromycin|mesh-list
2098529|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2098530|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098531|NCT02345161|Budesonide|budesonide|mesh-list
2252938|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
2252939|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
2252940|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2252941|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252942|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2252943|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2252944|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2252945|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2252946|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2252947|NCT00139243|Leucovorin|leucovorin|mesh-list
2252948|NCT00139243|Fluorouracil|fluorouracil|mesh-list
827027|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827028|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
827029|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
827030|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
827031|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827032|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
827033|NCT02472626|Protective Agents|protective agents|mesh-ancestor
827034|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
827035|NCT02472626|Vitamins|vitamins|mesh-ancestor
827036|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
827463|NCT02470039|Insulin|insulin|mesh-list
827464|NCT02470039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
827465|NCT02470039|Insulin Glargine|insulin glargine|mesh-list
827466|NCT02470039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
827467|NCT02470039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827539|NCT02469740|Clopidogrel|clopidogrel|mesh-list
827540|NCT02469740|Ticagrelor|ticagrelor|mesh-list
827541|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
827542|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
827543|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
827544|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
827545|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
827546|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
827547|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827548|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252949|NCT00139243|Docetaxel|docetaxel|mesh-list
2252950|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252951|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
2252952|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252953|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2252954|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2252955|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
827861|NCT02468089|Sargramostim|sargramostim|mesh-list
827862|NCT02468089|Immunologic Factors|immunologic factors|mesh-ancestor
827863|NCT02468089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827990|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
827991|NCT02467517|Ketamine|ketamine|mesh-list
827992|NCT02467517|Analgesics|analgesics|mesh-ancestor
827993|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
827994|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827995|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827996|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
827997|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
827998|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
827999|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
828000|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828001|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
828002|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
828003|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828004|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828005|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
828006|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
828007|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
828008|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
828009|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
828010|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
828011|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
828571|NCT02465736|Cisplatin|cisplatin|mesh-list
828572|NCT02465736|Docetaxel|docetaxel|mesh-list
828573|NCT02465736|Vinorelbine|vinorelbine|mesh-list
828574|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
828575|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
828576|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
828577|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
828578|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828579|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2098532|NCT02345161|Albuterol|albuterol|mesh-list
2098533|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
2098534|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2098535|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2098536|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2098537|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
2098538|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098539|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828732|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
2252956|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252957|NCT00139243|Antidotes|antidotes|mesh-ancestor
2252958|NCT00139243|Protective Agents|protective agents|mesh-ancestor
2252959|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
2252960|NCT00139243|Vitamins|vitamins|mesh-ancestor
827373|NCT02470676|Progesterone|progesterone|mesh-list
827374|NCT02470676|Progestins|progestins|mesh-ancestor
827375|NCT02470676|Hormones|hormones|mesh-ancestor
827376|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
827377|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827837|NCT02468128|Nalbuphine|nalbuphine|mesh-list
827838|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
827839|NCT02468128|Narcotics|narcotics|mesh-ancestor
827840|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
827841|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827842|NCT02468128|Analgesics|analgesics|mesh-ancestor
827843|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
827844|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2252961|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
2252962|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
2252963|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
2252964|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
2252965|NCT00139256|Betamethasone|betamethasone|mesh-list
2252966|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
829387|NCT02462369|Glimepiride|glimepiride|mesh-list
829388|NCT02462369|Saxagliptin|saxagliptin|mesh-list
829389|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
829390|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
829391|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829392|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
829393|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
829394|NCT02462369|Incretins|incretins|mesh-ancestor
829395|NCT02462369|Hormones|hormones|mesh-ancestor
829396|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
829397|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
829398|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
829399|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829400|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829634|NCT02461927|Midazolam|midazolam|mesh-list
829635|NCT02461927|Naltrexone|naltrexone|mesh-list
829636|NCT02461927|Ketamine|ketamine|mesh-list
829637|NCT02461927|Analgesics|analgesics|mesh-ancestor
829638|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
829639|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829640|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829641|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
829642|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
829643|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
829644|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
829645|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
829646|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
829647|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
829648|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
829649|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829650|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
829651|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
829652|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
829653|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
829654|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
829655|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
829656|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
829657|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
829658|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2252967|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
2252968|NCT00139256|Hormones|hormones|mesh-ancestor
2252969|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2252970|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252971|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2098540|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2098541|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
2098542|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
2098543|NCT02345161|Hormones|hormones|mesh-ancestor
2098544|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2098545|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2098546|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2098547|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
827146|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827507|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
827508|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
827509|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
827510|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
827511|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
827512|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827513|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
827514|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
827515|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827516|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
827517|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827613|NCT02469259|Oxytocin|oxytocin|mesh-list
827614|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
827615|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
827616|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827706|NCT02468908|Molgramostim|molgramostim|mesh-list
827707|NCT02468908|Sargramostim|sargramostim|mesh-list
827708|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
827709|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827710|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
828149|NCT02466867|Naftifine|naftifine|mesh-list
828150|NCT02466867|Antifungal Agents|antifungal agents|mesh-ancestor
828151|NCT02466867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252972|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
2252973|NCT00139269|Docetaxel|docetaxel|mesh-list
2252974|NCT00139269|Fluorouracil|fluorouracil|mesh-list
2252975|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252976|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
2252977|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
2252978|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
2252979|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2252980|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
2252981|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
828877|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
828878|NCT02464410|Narcotics|narcotics|mesh-ancestor
828879|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828880|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828881|NCT02464410|Analgesics|analgesics|mesh-ancestor
828882|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
828883|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829044|NCT02463942|Doxycycline|doxycycline|mesh-list
829045|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
829046|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829047|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
829048|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
829049|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
829089|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
829090|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
829091|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
829343|NCT02462499|Eplerenone|eplerenone|mesh-list
829344|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
829345|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
829346|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
829347|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829348|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
829349|NCT02462499|Diuretics|diuretics|mesh-ancestor
829350|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
829351|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
829508|NCT02462252|Cyclosporine|cyclosporine|mesh-list
829509|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
829510|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
829511|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
829512|NCT02462252|Cyclosporins|cyclosporins|mesh-list
829513|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
829514|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829515|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829516|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
829517|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
829518|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829519|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
829520|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829521|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
829522|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
829523|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
829524|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
827165|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
827166|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
827167|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
827168|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
827169|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
827170|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
827171|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827172|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827173|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
827174|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
827216|NCT02471222|Amantadine|amantadine|mesh-list
827217|NCT02471222|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
827218|NCT02471222|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
827219|NCT02471222|Antiviral Agents|antiviral agents|mesh-ancestor
827220|NCT02471222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827221|NCT02471222|Dopamine Agents|dopamine agents|mesh-ancestor
827222|NCT02471222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
827223|NCT02471222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827224|NCT02471222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827225|NCT02471222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
827226|NCT02471222|Analgesics|analgesics|mesh-ancestor
827227|NCT02471222|Sensory System Agents|sensory system agents|mesh-ancestor
827228|NCT02471222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829040|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
829041|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
829042|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
829043|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2252982|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2252983|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
2252984|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252985|NCT00139282|Squalamine|squalamine|mesh-list
2252986|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2252987|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2252988|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2252989|NCT00139282|Protective Agents|protective agents|mesh-ancestor
2252990|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2252991|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252992|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2252993|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2252994|NCT00139282|Growth Substances|growth substances|mesh-ancestor
2252995|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
2252996|NCT00139360|Bevacizumab|bevacizumab|mesh-list
2252997|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2252998|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2252999|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2253000|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2253001|NCT00139360|Growth Substances|growth substances|mesh-ancestor
2253002|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253003|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
2253004|NCT00139373|Donepezil|donepezil|mesh-list
2253005|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2253006|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253007|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253008|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
2253009|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253010|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253011|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
2253012|NCT00139386|Candesartan|candesartan|mesh-list
2253013|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2253014|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2253015|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
829708|NCT02461667|Alendronate|alendronate|mesh-list
829709|NCT02461667|Metformin|metformin|mesh-list
829710|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
829711|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253016|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253017|NCT00139516|Nicotine|nicotine|mesh-list
2253018|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
827300|NCT02470780|Rifaximin|rifaximin|mesh-list
827301|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
827302|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827303|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2253019|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
2253020|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253021|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253022|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2253023|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2253024|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
2253025|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253026|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253027|NCT00139555|Amlodipine|amlodipine|mesh-list
2253028|NCT00139555|Benazepril|benazepril|mesh-list
828273|NCT02466919|Amoxicillin|amoxicillin|mesh-list
828274|NCT02466919|Metronidazole|metronidazole|mesh-list
828275|NCT02466919|Clarithromycin|clarithromycin|mesh-list
828276|NCT02466919|Levofloxacin|levofloxacin|mesh-list
828277|NCT02466919|Ofloxacin|ofloxacin|mesh-list
828278|NCT02466919|Pantoprazole|pantoprazole|mesh-list
828279|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
828280|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
828281|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
828282|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
828283|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
828284|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
828285|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828286|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
828287|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
828288|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
828289|NCT02466919|Renal Agents|renal agents|mesh-ancestor
828290|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
828291|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
828292|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
828293|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
828294|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
828295|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
828296|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
828502|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
828503|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
828504|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
828505|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828506|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
828507|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
828508|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
828509|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828510|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
828511|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
828586|NCT02465333|Lidocaine|lidocaine|mesh-list
828587|NCT02465333|Epinephrine|epinephrine|mesh-list
828588|NCT02465333|Anesthetics, Local|anesthetics, local|mesh-list
828589|NCT02465333|Anesthetics|anesthetics|mesh-list
828590|NCT02465333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828591|NCT02465333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828592|NCT02465333|Sensory System Agents|sensory system agents|mesh-ancestor
828593|NCT02465333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828594|NCT02465333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
828595|NCT02465333|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
828596|NCT02465333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
828597|NCT02465333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
828598|NCT02465333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828599|NCT02465333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
828600|NCT02465333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
828601|NCT02465333|Adrenergic Agents|adrenergic agents|mesh-ancestor
828602|NCT02465333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828603|NCT02465333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
828604|NCT02465333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
828605|NCT02465333|Autonomic Agents|autonomic agents|mesh-ancestor
828606|NCT02465333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
828607|NCT02465333|Respiratory System Agents|respiratory system agents|mesh-ancestor
828608|NCT02465333|Mydriatics|mydriatics|mesh-ancestor
828609|NCT02465333|Sympathomimetics|sympathomimetics|mesh-ancestor
828610|NCT02465333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
827380|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
827381|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
827382|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
827383|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
827384|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
827385|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827755|NCT02468518|Vitamin E|vitamin e|mesh-list
827756|NCT02468518|Vitamins|vitamins|mesh-ancestor
827757|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
827758|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827759|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
827760|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827761|NCT02468518|Protective Agents|protective agents|mesh-ancestor
827820|NCT02468232|Enalapril|enalapril|mesh-list
827821|NCT02468232|Enalaprilat|enalaprilat|mesh-list
827822|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
827823|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
827824|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
827825|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827826|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827827|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
827828|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
828216|NCT02467153|Vitamin D|vitamin d|mesh-list
828217|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
828218|NCT02467153|Vitamins|vitamins|mesh-ancestor
828219|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
828220|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828221|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
828222|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
828359|NCT02466347|Fluticasone|fluticasone|mesh-list
828360|NCT02466347|Xhance|xhance|mesh-list
828361|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
828362|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
828363|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
828364|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
828365|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828366|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828367|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
828368|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
828369|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
828370|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
828371|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
828372|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
828373|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
828374|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
828375|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828376|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828446|NCT02466022|Fentanyl|fentanyl|mesh-list
828447|NCT02466022|Midazolam|midazolam|mesh-list
828448|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
828449|NCT02466022|Bupivacaine|bupivacaine|mesh-list
828450|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
828451|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
828452|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828453|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828454|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
828455|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828456|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
828457|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
828458|NCT02466022|Analgesics|analgesics|mesh-ancestor
828459|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
828460|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
828461|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
828462|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
828463|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828464|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828465|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
828466|NCT02466022|Narcotics|narcotics|mesh-ancestor
828467|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
828468|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
828469|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
828470|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
828471|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
828472|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
828473|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
828474|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
827587|NCT02469519|Betamethasone|betamethasone|mesh-list
827588|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
827589|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
827590|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
827591|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827592|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827593|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
827594|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
827595|NCT02469519|Hormones|hormones|mesh-ancestor
827596|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
827597|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
827598|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827599|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
827600|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
2253029|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2253030|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2253031|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2253032|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253033|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2253034|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253035|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
2253036|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2253037|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
2253038|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827829|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
827830|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
827831|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
827832|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
827833|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
827834|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827835|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827836|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
827939|NCT02467478|Linagliptin|linagliptin|mesh-list
827940|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
827941|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827942|NCT02467478|Incretins|incretins|mesh-ancestor
827943|NCT02467478|Hormones|hormones|mesh-ancestor
827944|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
827945|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
827946|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
827947|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827948|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253039|NCT00139568|Tegaserod|tegaserod|mesh-list
2253040|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2253041|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
2253042|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
829536|NCT02462174|Ketamine|ketamine|mesh-list
829537|NCT02462174|Bupivacaine|bupivacaine|mesh-list
829538|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
829539|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
829540|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
829541|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829542|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
829543|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829544|NCT02462174|Analgesics|analgesics|mesh-ancestor
829545|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
829546|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
829547|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
829548|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
829549|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
829550|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
829551|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830240|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
830241|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
830242|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830243|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
827623|NCT02469155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
827624|NCT02469155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
827625|NCT02469155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
827626|NCT02469155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
827627|NCT02469155|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
827628|NCT02469155|Dopamine Agents|dopamine agents|mesh-ancestor
2253043|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253044|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253045|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
2253046|NCT00139581|Tacrolimus|tacrolimus|mesh-list
2253047|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2253048|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2253049|NCT00139581|Analgesics|analgesics|mesh-ancestor
2253050|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
2253051|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827798|NCT02468323|Ondansetron|ondansetron|mesh-list
827799|NCT02468323|Palonosetron|palonosetron|mesh-list
827800|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
827801|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
827802|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827803|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827804|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
827805|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
827806|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
827807|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
827808|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
827809|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
827810|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827811|NCT02468323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
827812|NCT02468323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
827813|NCT02468323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
827814|NCT02468323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
827815|NCT02468323|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
827816|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2253052|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253053|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
828767|NCT02464761|Verteporfin|verteporfin|mesh-list
828768|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
828769|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
829256|NCT02463006|Methamphetamine|methamphetamine|mesh-list
829257|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
829258|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829259|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
829260|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
829261|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829262|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
829263|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
829264|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829265|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
829266|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
829267|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
829268|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
829269|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
829325|NCT02462525|Dexamethasone|dexamethasone|mesh-list
829326|NCT02462525|Pomalidomide|pomalidomide|mesh-list
829327|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
829328|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
829329|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
829330|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829331|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829332|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
829333|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
829334|NCT02462525|Hormones|hormones|mesh-ancestor
829335|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
829336|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
829337|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829338|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
829339|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
829340|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
829341|NCT02462525|Growth Substances|growth substances|mesh-ancestor
829342|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
829552|NCT02462044|Iodine|iodine|mesh-list
829553|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
829554|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
829555|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827636|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
827637|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
827638|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
827639|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827640|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
827700|NCT02468791|Rituximab|rituximab|mesh-list
827701|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
827702|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
827703|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
827704|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827705|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
827893|NCT02468167|Polidocanol|polidocanol|mesh-list
827894|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
827895|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
827949|NCT02467556|Morphine|morphine|mesh-list
827950|NCT02467556|Memantine|memantine|mesh-list
827951|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
827952|NCT02467556|Narcotics|narcotics|mesh-ancestor
827953|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
827954|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
827955|NCT02467556|Analgesics|analgesics|mesh-ancestor
827956|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
827957|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
827958|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
827959|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
827960|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
827961|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
827962|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
827963|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
827964|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
828928|NCT02464020|Vancomycin|vancomycin|mesh-list
828929|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
828930|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829031|NCT02463682|Insulin|insulin|mesh-list
829032|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
829033|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829599|NCT02461706|Cannabidiol|cannabidiol|mesh-list
829600|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
829858|NCT02461121|Cyclosporine|cyclosporine|mesh-list
829859|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
829860|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
829861|NCT02461121|Fludarabine|fludarabine|mesh-list
829862|NCT02461121|Cyclosporins|cyclosporins|mesh-list
829863|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
829864|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
829865|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
829866|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829867|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
829868|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
829869|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
829870|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829871|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829872|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
829873|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829874|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
829875|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829876|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
829877|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
829878|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
829879|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
829880|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
829881|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
829882|NCT02460497|Minoxidil|minoxidil|mesh-list
829883|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
829884|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
829978|NCT02460419|Capecitabine|capecitabine|mesh-list
829979|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
829980|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
829981|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829982|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830159|NCT02460016|Ziresovir|ziresovir|mesh-list
830160|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
830161|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
830403|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
830404|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
830405|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
830406|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
830407|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
830455|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
827907|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
827908|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
827909|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
827910|NCT02467647|Growth Substances|growth substances|mesh-ancestor
827911|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
827912|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
828026|NCT02467400|Propranolol|propranolol|mesh-list
828027|NCT02467400|Atenolol|atenolol|mesh-list
828028|NCT02467400|Nebivolol|nebivolol|mesh-list
828029|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
828030|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
828031|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
828032|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828033|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828034|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828035|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
828036|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
828037|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
828038|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
828039|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
828040|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828041|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
828042|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
828043|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
828044|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
828400|NCT02466438|Tazobactam|tazobactam|mesh-list
828401|NCT02466438|Piperacillin|piperacillin|mesh-list
828402|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
828403|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
828404|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
828405|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
828406|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
828407|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253054|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253055|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
2253056|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2253057|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
829234|NCT02463110|Sertraline|sertraline|mesh-list
829235|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
829236|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
829237|NCT02463110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
829238|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
829239|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
829240|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829241|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
829242|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
829243|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829501|NCT02462161|Insulin|insulin|mesh-list
829502|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
829503|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
829504|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
829505|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
829506|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
829507|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829601|NCT02461836|Gemcitabine|gemcitabine|mesh-list
829602|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
829603|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
829604|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829605|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829606|NCT02461836|Antiviral Agents|antiviral agents|mesh-ancestor
829607|NCT02461836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829608|NCT02461836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829609|NCT02461836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
829610|NCT02461836|Immunologic Factors|immunologic factors|mesh-ancestor
829611|NCT02461836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830205|NCT02459613|Annexin A5|annexin a5|mesh-list
830206|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830207|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253058|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2253059|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253060|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253061|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2253062|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253063|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
827936|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
827937|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
827938|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098548|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
2253064|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829306|NCT02462837|Mirabegron|mirabegron|mesh-list
829307|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
829308|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
829309|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
829310|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
829311|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
829312|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829313|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829314|NCT02462837|Urological Agents|urological agents|mesh-ancestor
2253065|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253066|NCT00139633|Carboplatin|carboplatin|mesh-list
2253067|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253068|NCT00139646|Diclofenac|diclofenac|mesh-list
2253069|NCT00139646|Parecoxib|parecoxib|mesh-list
2253070|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
830091|NCT02460068|Nivolumab|nivolumab|mesh-list
830092|NCT02460068|Ipilimumab|ipilimumab|mesh-list
830093|NCT02460068|Fotemustine|fotemustine|mesh-list
830094|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
830095|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830096|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
830097|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830322|NCT02458963|Menotropins|menotropins|mesh-list
830323|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
830324|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
830325|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
830326|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830424|NCT02458625|Iron|iron|mesh-list
830425|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
830426|NCT02458625|Trace Elements|trace elements|mesh-ancestor
830427|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
830428|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830429|NCT02458625|Hematinics|hematinics|mesh-ancestor
830794|NCT02457130|Clopidogrel|clopidogrel|mesh-list
830795|NCT02457130|Ticagrelor|ticagrelor|mesh-list
830796|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
830797|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
830798|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
830799|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
830800|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
830801|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
830802|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830803|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831016|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
831017|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
831018|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
831019|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
831020|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
831021|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831022|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
831023|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
831024|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
831025|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831026|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
831027|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
831028|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
831278|NCT02455271|Eszopiclone|eszopiclone|mesh-list
831279|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
831280|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831281|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831482|NCT02455011|Volagidemab|volagidemab|mesh-list
831483|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
831484|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253071|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2253072|NCT00139646|Analgesics|analgesics|mesh-ancestor
2253073|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
2253074|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253075|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754497|NCT00885963|Sapacitabine|sapacitabine|mesh-list
832051|NCT02453009|Prednisone|prednisone|mesh-list
828077|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
828078|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
828079|NCT02467595|Narcotics|narcotics|mesh-ancestor
828080|NCT02467595|Analgesics|analgesics|mesh-ancestor
828081|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
828082|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828083|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
828084|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
828085|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
828086|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
828087|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
828088|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
828089|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
828184|NCT02467023|Lidocaine|lidocaine|mesh-list
828185|NCT02467023|Fentanyl|fentanyl|mesh-list
828186|NCT02467023|Midazolam|midazolam|mesh-list
828187|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
828188|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
828189|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828190|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828191|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
828192|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828193|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
828194|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
828195|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
828196|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
828197|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828198|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
828199|NCT02467023|Narcotics|narcotics|mesh-ancestor
828200|NCT02467023|Analgesics|analgesics|mesh-ancestor
828201|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
828202|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
828203|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
828204|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
828205|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
828206|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
828207|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
828208|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
828209|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
828210|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828264|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
828580|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
828581|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
828582|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
828583|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828584|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
828585|NCT02465853|Protective Agents|protective agents|mesh-ancestor
828661|NCT02465164|Oxytocin|oxytocin|mesh-list
828662|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
828663|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
828664|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253076|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2253077|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253078|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2253079|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253080|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253081|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2253082|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
829004|NCT02463552|Naproxen|naproxen|mesh-list
829005|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
829006|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
829007|NCT02463552|Analgesics|analgesics|mesh-ancestor
829008|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
829009|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829010|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829011|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
829012|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
829013|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
829014|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
829015|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829016|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253083|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
2253084|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
2253085|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2253086|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253087|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
828090|NCT02467686|Tamoxifen|tamoxifen|mesh-list
828091|NCT02467686|Exemestane|exemestane|mesh-list
828092|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
828093|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
828094|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
828095|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
828096|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828097|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
828098|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
828099|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
828100|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
828101|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
828102|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
828103|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
828104|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828152|NCT02466997|Tacrolimus|tacrolimus|mesh-list
828153|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
828154|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
828155|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828156|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
828157|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
828158|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828560|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
828561|NCT02465359|Antibodies|antibodies|mesh-list
828562|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
828563|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
828564|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
828565|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
828566|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829197|NCT02462811|Acetaminophen|acetaminophen|mesh-list
829198|NCT02462811|Promethazine|promethazine|mesh-list
829199|NCT02462811|Diphenhydramine|diphenhydramine|mesh-list
829200|NCT02462811|Hydrocodone|hydrocodone|mesh-list
829201|NCT02462811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
829202|NCT02462811|Analgesics|analgesics|mesh-ancestor
829203|NCT02462811|Sensory System Agents|sensory system agents|mesh-ancestor
829204|NCT02462811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829205|NCT02462811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829206|NCT02462811|Antipyretics|antipyretics|mesh-ancestor
829207|NCT02462811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
829208|NCT02462811|Narcotics|narcotics|mesh-ancestor
829209|NCT02462811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
829210|NCT02462811|Antitussive Agents|antitussive agents|mesh-ancestor
829211|NCT02462811|Respiratory System Agents|respiratory system agents|mesh-ancestor
829212|NCT02462811|Antipruritics|antipruritics|mesh-ancestor
829213|NCT02462811|Dermatologic Agents|dermatologic agents|mesh-ancestor
829214|NCT02462811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
829215|NCT02462811|Histamine Antagonists|histamine antagonists|mesh-ancestor
829216|NCT02462811|Histamine Agents|histamine agents|mesh-ancestor
829217|NCT02462811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
829218|NCT02462811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829219|NCT02462811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
829221|NCT02462811|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
829222|NCT02462811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
829223|NCT02462811|Anesthetics, Local|anesthetics, local|mesh-ancestor
829224|NCT02462811|Anesthetics|anesthetics|mesh-ancestor
829225|NCT02462811|Antiemetics|antiemetics|mesh-ancestor
829226|NCT02462811|Autonomic Agents|autonomic agents|mesh-ancestor
829227|NCT02462811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
829594|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
829595|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829596|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
829597|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829598|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830066|NCT02460133|Ritonavir|ritonavir|mesh-list
830068|NCT02460133|Ribavirin|ribavirin|mesh-list
830069|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
830070|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
830071|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
830072|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830073|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830074|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
830075|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
830076|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
830077|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
830078|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2253088|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2253089|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2253090|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2253091|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253092|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2253093|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2253094|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2253095|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2253096|NCT00139698|Olmesartan|olmesartan|mesh-list
2253097|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
828265|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
828266|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
828267|NCT02466490|Diuretics|diuretics|mesh-ancestor
828268|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
828269|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828270|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
828271|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
828272|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828620|NCT02465320|Lidocaine|lidocaine|mesh-list
828621|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
828622|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
828623|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828624|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828625|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
828626|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828627|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
828628|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
828629|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
828630|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
828631|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828653|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
828654|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
828655|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
828656|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828657|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828658|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
828659|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829826|NCT02460874|Glyburide|glyburide|mesh-list
829827|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
829828|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830034|NCT02460302|Progesterone|progesterone|mesh-list
830035|NCT02460302|Progestins|progestins|mesh-ancestor
830036|NCT02460302|Hormones|hormones|mesh-ancestor
830037|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
830038|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830566|NCT02458118|Secretin|secretin|mesh-list
830567|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
830568|NCT02458118|Hormones|hormones|mesh-ancestor
830569|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
830570|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830613|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
830614|NCT02457650|Fludarabine|fludarabine|mesh-list
830615|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
830616|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
830617|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830618|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
830619|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
830620|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
830621|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830622|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830623|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2253098|NCT00139698|Diuretics|diuretics|mesh-ancestor
2253099|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
2253100|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253101|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2253102|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2253103|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253104|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
831816|NCT02453607|Infliximab|infliximab|mesh-list
831817|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
831818|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
831819|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
832199|NCT02452281|Ipilimumab|ipilimumab|mesh-list
828313|NCT02466581|Hormones|hormones|mesh-ancestor
828314|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
828315|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828316|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
828317|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
828318|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
828319|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
828320|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828321|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
828322|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
828323|NCT02466581|Protective Agents|protective agents|mesh-ancestor
828324|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
828325|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
828326|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
828327|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
828328|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
828329|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828330|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
828331|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
828332|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
828333|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
828334|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
828335|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
828336|NCT02466581|Analgesics|analgesics|mesh-ancestor
828337|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
828632|NCT02465749|Vitamins|vitamins|mesh-list
828633|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
828634|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828869|NCT02464462|Vitamin D|vitamin d|mesh-list
828870|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
828871|NCT02464462|Calcium|calcium|mesh-list
828872|NCT02464462|Vitamins|vitamins|mesh-ancestor
828873|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
828874|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828875|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
828876|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
829270|NCT02462941|Adenosine|adenosine|mesh-list
829271|NCT02462941|Analgesics|analgesics|mesh-ancestor
829272|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
829273|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829274|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829275|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
829276|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
829277|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
829278|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
829279|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
829280|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
829281|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253105|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2253106|NCT00139711|Docetaxel|docetaxel|mesh-list
2253107|NCT00139711|Irinotecan|irinotecan|mesh-list
2253108|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253109|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
2253110|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
2253111|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
2253112|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253113|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2253114|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2253115|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253116|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2253117|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2253118|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2253119|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
2253120|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253121|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253122|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253123|NCT00139724|Urological Agents|urological agents|mesh-ancestor
2253124|NCT00139750|Varenicline|varenicline|mesh-list
2253125|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2253126|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2253127|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
2253128|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253129|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253130|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253131|NCT00139815|Enoxaparin|enoxaparin|mesh-list
2253132|NCT00139815|PENTA|penta|mesh-list
828345|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
828346|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
828347|NCT02466698|Laxatives|laxatives|mesh-ancestor
828348|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
828408|NCT02466191|Gabapentin|gabapentin|mesh-list
828409|NCT02466191|Memantine|memantine|mesh-list
828410|NCT02466191|Analgesics|analgesics|mesh-ancestor
828411|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
828412|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828413|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828414|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
828415|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
828416|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
828417|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828418|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
828419|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
828420|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
828421|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828422|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828423|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
828424|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
828425|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
828426|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
829885|NCT02460510|Mannitol|mannitol|mesh-list
829886|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
829887|NCT02460510|Diuretics|diuretics|mesh-ancestor
829888|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
829889|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830022|NCT02460367|Docetaxel|docetaxel|mesh-list
830023|NCT02460367|Tryptophan|tryptophan|mesh-list
830024|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830025|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
830026|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
830027|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
830028|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830029|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
830030|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
830031|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
830529|NCT02458209|Bococizumab|bococizumab|mesh-list
830530|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
830531|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
830532|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
830533|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830534|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2253133|NCT00139815|Fondaparinux|fondaparinux|mesh-list
2253134|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
830993|NCT02456454|Valproic Acid|valproic acid|mesh-list
830994|NCT02456454|Risperidone|risperidone|mesh-list
830995|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
830996|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
830997|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
830998|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830999|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831000|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
831001|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
831002|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831003|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
831004|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
831005|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
831006|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
831007|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831008|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
831009|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
831143|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
831144|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
831145|NCT02456116|Analgesics|analgesics|mesh-ancestor
831146|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
831147|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831148|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831149|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
831150|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
831274|NCT02455596|Interferons|interferons|mesh-list
831275|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831276|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
831277|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
831511|NCT02454764|Interferons|interferons|mesh-list
831512|NCT02454764|Tenofovir|tenofovir|mesh-list
831513|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
828553|NCT02465645|Protective Agents|protective agents|mesh-ancestor
828554|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
828555|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
828556|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
828557|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
828558|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
828559|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2253135|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2253136|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2253137|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253138|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2253139|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
2253140|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2253141|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
2253142|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253143|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2253144|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2253145|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
2253146|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253147|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253148|NCT00139854|Alprazolam|alprazolam|mesh-list
2253149|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2253150|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2253151|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253152|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2253153|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2253154|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2253155|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
2253156|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
2253157|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253158|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253159|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2253160|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2253161|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
2253162|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253163|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
829775|NCT02461043|Paclitaxel|paclitaxel|mesh-list
829776|NCT02461043|Cisplatin|cisplatin|mesh-list
829777|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
829778|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829779|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
829780|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
829781|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
829782|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830245|NCT02459288|Clopidogrel|clopidogrel|mesh-list
830246|NCT02459288|Ticagrelor|ticagrelor|mesh-list
830247|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
830248|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
830249|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
830250|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
830251|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
830252|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
830253|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830254|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830635|NCT02457806|Phenylephrine|phenylephrine|mesh-list
830636|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
830637|NCT02457806|Tetracaine|tetracaine|mesh-list
830638|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
830639|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
830640|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
830641|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830642|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
830643|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830644|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
830645|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
830646|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
830647|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
830648|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830649|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
830650|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
830651|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
830652|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
830653|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
830654|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
828660|NCT02465138|Ketorolac|ketorolac|mesh-list
828665|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
828666|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
828667|NCT02465138|Analgesics|analgesics|mesh-ancestor
828668|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
828669|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828670|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828671|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
828672|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
828673|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
828674|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
828675|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828810|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
828811|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
828812|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
828813|NCT02464696|Prednisolone|prednisolone|mesh-list
828814|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
828815|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
828816|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
828817|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
828818|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
828819|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
828820|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828821|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828822|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
828823|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
828824|NCT02464696|Hormones|hormones|mesh-ancestor
828825|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
828826|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
828827|NCT02464696|Protective Agents|protective agents|mesh-ancestor
828828|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
828829|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829034|NCT02463643|Rabeprazole|rabeprazole|mesh-list
829035|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
829036|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
829037|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
829038|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829039|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829424|NCT02462317|Baclofen|baclofen|mesh-list
829425|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
829426|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
829427|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
829428|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829429|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
829430|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829431|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
829432|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
829433|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
829434|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
829435|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829436|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
829437|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
829438|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
2253164|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2253165|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
2253166|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
2253167|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253168|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253169|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2253170|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2253171|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
2253172|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253173|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
830347|NCT02458911|Paclitaxel|paclitaxel|mesh-list
830348|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
830349|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830350|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
830351|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
830352|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
830353|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098549|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098550|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098551|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
2098552|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2098553|NCT02345226|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2098554|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2098555|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2098556|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2098557|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098558|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253174|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2253175|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
828931|NCT02463825|Pimozide|pimozide|mesh-list
828932|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
828933|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
828934|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828935|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828936|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
828937|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
828938|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
828939|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828940|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828941|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2253176|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
829475|NCT02462109|Lorazepam|lorazepam|mesh-list
829476|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
829477|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
829478|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
829479|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829480|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829481|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
829482|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
829483|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
829484|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
829485|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
829486|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
829487|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
829488|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
829489|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
829490|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829841|NCT02460887|Gemcitabine|gemcitabine|mesh-list
829842|NCT02460887|Cisplatin|cisplatin|mesh-list
829843|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829844|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
829845|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
829846|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829847|NCT02460887|Antiviral Agents|antiviral agents|mesh-ancestor
829848|NCT02460887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829849|NCT02460887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829850|NCT02460887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
829851|NCT02460887|Immunologic Factors|immunologic factors|mesh-ancestor
829852|NCT02460887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830354|NCT02458924|Niacin|niacin|mesh-list
830355|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
830356|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
830357|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830358|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
830359|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
830360|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
830361|NCT02458924|Vitamins|vitamins|mesh-ancestor
830362|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
830363|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830443|NCT02458482|Albuterol|albuterol|mesh-list
830444|NCT02458482|Ipratropium|ipratropium|mesh-list
830445|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
830446|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
830447|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830448|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830449|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
830450|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
830451|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
830452|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
830453|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
830454|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
828735|NCT02464722|Remifentanil|remifentanil|mesh-list
828736|NCT02464722|Propofol|propofol|mesh-list
828737|NCT02464722|Rocuronium|rocuronium|mesh-list
828738|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
828739|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
828740|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
828741|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
828742|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
828743|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
828744|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
828745|NCT02464722|Analgesics|analgesics|mesh-ancestor
828746|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
828747|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
828748|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
828749|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
828750|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
828751|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
828752|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
828753|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
828754|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
828755|NCT02464722|Narcotics|narcotics|mesh-ancestor
828756|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
828757|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
828758|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
828759|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
828760|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
828761|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
828762|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
828763|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
828764|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
828765|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
828766|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
828797|NCT02464501|Paclitaxel|paclitaxel|mesh-list
828798|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
828799|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
828800|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
828801|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
828802|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
828803|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253177|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253178|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253179|NCT00139893|Metoclopramide|metoclopramide|mesh-list
2253180|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
2253181|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
2253182|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253183|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253184|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2253185|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2253186|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2253187|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
2253188|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253189|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253190|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
2253191|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2253192|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
2253193|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253194|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253195|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2253196|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
2253197|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2253198|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2253199|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2253200|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
2253201|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253202|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253203|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
2253204|NCT00140010|Hematinics|hematinics|mesh-ancestor
2253205|NCT00140023|Azithromycin|azithromycin|mesh-list
2253206|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2253207|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2253208|NCT00140062|Latanoprost|latanoprost|mesh-list
2253209|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
829017|NCT02463591|Thrombin|thrombin|mesh-list
829018|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
829019|NCT02463591|Coagulants|coagulants|mesh-ancestor
829770|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
828779|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
829104|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
829105|NCT02463318|Melatonin|melatonin|mesh-list
829106|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
829107|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829108|NCT02463318|Protective Agents|protective agents|mesh-ancestor
829109|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829110|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
829111|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
829112|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829220|NCT02462889|Aflibercept|aflibercept|mesh-list
829228|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
829229|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
829230|NCT02462889|Growth Substances|growth substances|mesh-ancestor
829231|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829232|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
829233|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829379|NCT02462577|Morphine|morphine|mesh-list
829380|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
829381|NCT02462577|Narcotics|narcotics|mesh-ancestor
829382|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
829383|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829384|NCT02462577|Analgesics|analgesics|mesh-ancestor
829385|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
829386|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829612|NCT02461719|Cyclosporine|cyclosporine|mesh-list
829613|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
829614|NCT02461719|Cyclosporins|cyclosporins|mesh-list
829615|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829616|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829617|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
829618|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
829619|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829620|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
829621|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829622|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
829623|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
829624|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
829625|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
830050|NCT02460341|Ondansetron|ondansetron|mesh-list
830051|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
830052|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
830053|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830054|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830055|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
830056|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
830057|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
830058|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
830059|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
830060|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
830061|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830062|NCT02460341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
830063|NCT02460341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
830064|NCT02460341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
830065|NCT02460341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
830067|NCT02460341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
830535|NCT02458183|Vaccines|vaccines|mesh-list
830536|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
830537|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830988|NCT02456701|Vemurafenib|vemurafenib|mesh-list
830989|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830990|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
830991|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830992|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831114|NCT02456142|Morphine|morphine|mesh-list
831115|NCT02456142|Bupivacaine|bupivacaine|mesh-list
831116|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
831117|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
831118|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831119|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831120|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
831121|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831122|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
831123|NCT02456142|Narcotics|narcotics|mesh-ancestor
831124|NCT02456142|Analgesics|analgesics|mesh-ancestor
831199|NCT02455869|Alendronate|alendronate|mesh-list
831200|NCT02455869|Atorvastatin|atorvastatin|mesh-list
2253210|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2253211|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
2253212|NCT00140075|Epirubicin|epirubicin|mesh-list
2253213|NCT00140075|Taxane|taxane|mesh-list
2253214|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2253215|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
2253216|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253217|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253218|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2253219|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
2253220|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253221|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253222|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2253223|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2253224|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2253225|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
829092|NCT02463383|Ibuprofen|ibuprofen|mesh-list
829093|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
829094|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
829095|NCT02463383|Analgesics|analgesics|mesh-ancestor
829096|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
829097|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829098|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829099|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
829100|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
829101|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
829102|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829103|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829401|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
829402|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
829403|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829404|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
829405|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829406|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829407|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
830004|NCT02460211|Vitamin D|vitamin d|mesh-list
830005|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
830006|NCT02460211|Vitamins|vitamins|mesh-ancestor
830007|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
830008|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830009|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
830010|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
830098|NCT02459977|Basiliximab|basiliximab|mesh-list
830099|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
830100|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
830101|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253226|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253227|NCT00140101|Paclitaxel|paclitaxel|mesh-list
2253228|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2253229|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253230|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
2253231|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
2253232|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
2253233|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831053|NCT02456428|Insulin|insulin|mesh-list
831054|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
831055|NCT02456428|Metformin|metformin|mesh-list
831056|NCT02456428|Pioglitazone|pioglitazone|mesh-list
831057|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
831058|NCT02456428|Liraglutide|liraglutide|mesh-list
831059|NCT02456428|Exenatide|exenatide|mesh-list
831060|NCT02456428|Glimepiride|glimepiride|mesh-list
831061|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
831062|NCT02456428|Saxagliptin|saxagliptin|mesh-list
831063|NCT02456428|Vildagliptin|vildagliptin|mesh-list
831064|NCT02456428|Acarbose|acarbose|mesh-list
831065|NCT02456428|Repaglinide|repaglinide|mesh-list
831066|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
831067|NCT02456428|Gliclazide|gliclazide|mesh-list
831068|NCT02456428|Glipizide|glipizide|mesh-list
831069|NCT02456428|Biguanides|biguanides|mesh-list
831070|NCT02456428|Voglibose|voglibose|mesh-list
831071|NCT02456428|Tolbutamide|tolbutamide|mesh-list
831072|NCT02456428|Nateglinide|nateglinide|mesh-list
831073|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
831074|NCT02456428|Miglitol|miglitol|mesh-list
831075|NCT02456428|Troglitazone|troglitazone|mesh-list
831076|NCT02456428|Meglitinide|meglitinide|mesh-list
831077|NCT02456428|Acetohexamide|acetohexamide|mesh-list
831078|NCT02456428|Phenformin|phenformin|mesh-list
831079|NCT02456428|Buformin|buformin|mesh-list
828867|NCT02464228|Tipifarnib|tipifarnib|mesh-list
828868|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829113|NCT02463513|Vitamins|vitamins|mesh-list
829114|NCT02463513|Riboflavin|riboflavin|mesh-list
829115|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
829116|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
829117|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829118|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
829119|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
2253234|NCT00140114|Misoprostol|misoprostol|mesh-list
2253235|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2253236|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
2253237|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2253238|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253239|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
830001|NCT02460354|Metformin|metformin|mesh-list
830002|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
830003|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830965|NCT02456597|Lidocaine|lidocaine|mesh-list
830966|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
830967|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
830968|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
830969|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830970|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
830971|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830972|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
830973|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
830974|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
830975|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
830976|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253240|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2253241|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
2253242|NCT00140153|Testosterone|testosterone|mesh-list
2253243|NCT00140153|Androgens|androgens|mesh-ancestor
2253244|NCT00140153|Hormones|hormones|mesh-ancestor
2253245|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2253246|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253247|NCT00140166|Pyridoxine|pyridoxine|mesh-list
831612|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
831613|NCT02454556|Hormones|hormones|mesh-ancestor
831614|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
831615|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253248|NCT00140166|Niacinamide|niacinamide|mesh-list
2253249|NCT00140166|Niacin|niacin|mesh-list
2253250|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
2253251|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
2253252|NCT00140166|Vitamins|vitamins|mesh-ancestor
2253253|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
2253254|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253255|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2253256|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
2253257|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832236|NCT02452151|Infliximab|infliximab|mesh-list
832237|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
832238|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
832239|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2098559|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
2098560|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098561|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2098562|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2098563|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
2098564|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
2098565|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098566|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2098567|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2098568|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098569|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098570|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2253258|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2253259|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
2253260|NCT00140218|Pramipexole|pramipexole|mesh-list
2253261|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
2253262|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832906|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
832907|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2253263|NCT00140218|Protective Agents|protective agents|mesh-ancestor
828966|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
828967|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
828968|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
828969|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
828970|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
828971|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
828972|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
828973|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
2253264|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253265|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2253266|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2253267|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
2253268|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
2253269|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253270|NCT00140257|Citalopram|citalopram|mesh-list
829719|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
829720|NCT02461537|Analgesics|analgesics|mesh-ancestor
829721|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
829722|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829723|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829724|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829725|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
829726|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
829727|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829728|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829983|NCT02460432|Paclitaxel|paclitaxel|mesh-list
829984|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
829985|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829986|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
829987|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
829988|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
829989|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830430|NCT02458547|Bupivacaine|bupivacaine|mesh-list
830431|NCT02458547|Propofol|propofol|mesh-list
830432|NCT02458547|Desflurane|desflurane|mesh-list
830433|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
830434|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
830435|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
830436|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830437|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
830438|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830439|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
830440|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
830441|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
830442|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2253271|NCT00140257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2253272|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2253273|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2253274|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253275|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253276|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
2253277|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831125|NCT02456129|Itraconazole|itraconazole|mesh-list
831126|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
831127|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
831128|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
831129|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
831130|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831131|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831132|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
831133|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
831134|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
831135|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831136|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
831371|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
831372|NCT02455609|Ketamine|ketamine|mesh-list
831373|NCT02455609|Bupivacaine|bupivacaine|mesh-list
831374|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
831375|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
831376|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831377|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831378|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
831379|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831380|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
831381|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2098571|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2098572|NCT02345330|Interleukin-12|interleukin-12|mesh-list
2098573|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2098574|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
2098575|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098576|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2098577|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2098578|NCT02345330|Growth Substances|growth substances|mesh-ancestor
2098579|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
2098580|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098581|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
2098582|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2098583|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2098584|NCT02346240|Etanercept|etanercept|mesh-list
2098585|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
2098586|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2098587|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2098588|NCT02346240|Analgesics|analgesics|mesh-ancestor
2098589|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
2098590|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098591|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098592|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2098593|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2098594|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2098595|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2098596|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
2098597|NCT02346370|Docetaxel|docetaxel|mesh-list
2098598|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098599|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
2098600|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
2098601|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
2098602|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098603|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
2098604|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2098605|NCT02346721|Velpatasvir|velpatasvir|mesh-list
2098606|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
2098607|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2253278|NCT00140257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2253279|NCT00140257|Antidepressive Agents|antidepressive agents|mesh-ancestor
2253280|NCT00140257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2253281|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
833671|NCT02446860|Nivolumab|nivolumab|mesh-list
833672|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
833673|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833674|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
833675|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253282|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
834493|NCT02443623|Vaccines|vaccines|mesh-list
834494|NCT02443623|Immunologic Factors|immunologic factors|mesh-ancestor
834495|NCT02443623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098608|NCT02346903|Capsaicin|capsaicin|mesh-list
2098609|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
2098610|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
2098611|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
2098612|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098613|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098614|NCT02346916|Capsaicin|capsaicin|mesh-list
2098615|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
2098616|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
2098617|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
2098618|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098619|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098620|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
2098621|NCT02347072|Bromides|bromides|mesh-list
2098622|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
2098623|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
2098624|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2098625|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
2098626|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098627|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098628|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2098629|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
2098630|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2098631|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2098632|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2098633|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
2253283|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253284|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
2253285|NCT00140309|Rifampin|rifampin|mesh-list
2253286|NCT00140309|Isoniazid|isoniazid|mesh-list
2253287|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
2253288|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2253289|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2253290|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2253291|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2253292|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253293|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253294|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253295|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2253296|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
2253297|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
2253298|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2253299|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2253300|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2253301|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2253302|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
829184|NCT02462772|Cabotegravir|cabotegravir|mesh-list
829185|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
829186|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
829187|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
829188|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
829189|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
829190|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
829191|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829192|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829193|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
829194|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
829195|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
829196|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2253303|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2253304|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2253305|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2253306|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2253307|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
830664|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
830665|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
830666|NCT02457507|Vitamins|vitamins|mesh-ancestor
830667|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
830668|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830669|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
830670|NCT02457507|Hematinics|hematinics|mesh-ancestor
2253308|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2253309|NCT00140361|Artesunate|artesunate|mesh-list
2253310|NCT00140361|Lumefantrine|lumefantrine|mesh-list
2253311|NCT00140361|Artemether|artemether|mesh-list
2253312|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
2253313|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
2253314|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2253315|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
2253316|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2253317|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2253318|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2253319|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253320|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
2253321|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
2253322|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2253323|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
2253324|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2253325|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253326|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253327|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2253328|NCT00140361|Renal Agents|renal agents|mesh-ancestor
2098634|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098635|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098636|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
2098637|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2098638|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
2098639|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
2098640|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2098641|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2098642|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
2098643|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
2098644|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2253329|NCT00140452|Thalidomide|thalidomide|mesh-list
2253330|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
829408|NCT02462304|Bevacizumab|bevacizumab|mesh-list
829409|NCT02462304|Ranibizumab|ranibizumab|mesh-list
829410|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
829411|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829412|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
829413|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
829414|NCT02462304|Growth Substances|growth substances|mesh-ancestor
829415|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829416|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
829659|NCT02461914|Warfarin|warfarin|mesh-list
829660|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
829819|NCT02461030|Listerine|listerine|mesh-list
829820|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
829821|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
829822|NCT02461030|Protective Agents|protective agents|mesh-ancestor
829823|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829824|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
829825|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
830018|NCT02460224|Spartalizumab|spartalizumab|mesh-list
830019|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
830020|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830021|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830180|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
830181|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
830182|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
830183|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830184|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830185|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
830186|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
830187|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
830188|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
830189|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
830190|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253331|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
2253332|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253333|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
2253334|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2253335|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2253336|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2253337|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2253338|NCT00140452|Growth Substances|growth substances|mesh-ancestor
2253339|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
2253340|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253341|NCT00140465|Clopidogrel|clopidogrel|mesh-list
831175|NCT02456012|Esomeprazole|esomeprazole|mesh-list
831176|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
831177|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
831178|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
831179|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831180|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253342|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2253343|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2253344|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
832104|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
832105|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
832106|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832107|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
832108|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098645|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
2098646|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098647|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098648|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2098649|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
2098650|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2098651|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2098652|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
832744|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
832745|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
832746|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
832747|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
832748|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832749|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829250|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
829251|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
829252|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829253|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829254|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
829255|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
829783|NCT02461004|Ezetimibe|ezetimibe|mesh-list
829784|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
829785|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
829786|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
829787|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829788|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2253345|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2253346|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
2253347|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253348|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253349|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253350|NCT00140478|Mifepristone|mifepristone|mesh-list
2253351|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2253352|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
2253353|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2253354|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253355|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2253356|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2253357|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2253358|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
2253359|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2253360|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
830863|NCT02456961|Riboflavin|riboflavin|mesh-list
830864|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
830865|NCT02456961|Vitamins|vitamins|mesh-ancestor
830866|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
830867|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830868|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
830869|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
831181|NCT02455908|Aldesleukin|aldesleukin|mesh-list
831182|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831183|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
831184|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
831185|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
831186|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
831568|NCT02454491|Verapamil|verapamil|mesh-list
831569|NCT02454491|Heparin|heparin|mesh-list
831570|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
831571|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
831572|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
831573|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831574|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
831575|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
831576|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
831577|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
831578|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831579|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
831962|NCT02453425|Norepinephrine|norepinephrine|mesh-list
831963|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
831964|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
831965|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
831966|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
831967|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831968|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831969|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
831970|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
831971|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831972|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
832026|NCT02452983|Sertraline|sertraline|mesh-list
832027|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
832028|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
832029|NCT02452983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
832030|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
832031|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
832032|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832033|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
832034|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
2253361|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
829287|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
829288|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
829289|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829290|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
829291|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829292|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
829293|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
829294|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
829295|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
829296|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829297|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
829298|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
829299|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
829300|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
829301|NCT02462915|Narcotics|narcotics|mesh-ancestor
829302|NCT02462915|Analgesics|analgesics|mesh-ancestor
829303|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
829304|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
829305|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
829357|NCT02462447|Choline|choline|mesh-list
829358|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
829359|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
829360|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
829361|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829362|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
829363|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
829364|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
2253362|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2253363|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
2253364|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
829950|NCT02460692|Dronabinol|dronabinol|mesh-list
829951|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
829952|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829953|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
829954|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
829955|NCT02460692|Analgesics|analgesics|mesh-ancestor
829956|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
829957|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829958|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
829959|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
829960|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
829961|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829962|NCT02460692|Hormones|hormones|mesh-ancestor
829963|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2253365|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2253366|NCT00140517|Chloroquine|chloroquine|mesh-list
2253367|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
2253368|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
2253369|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
831230|NCT02455726|Pregabalin|pregabalin|mesh-list
831231|NCT02455726|Oxycodone|oxycodone|mesh-list
831232|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
831233|NCT02455726|Analgesics|analgesics|mesh-ancestor
831234|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
831235|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831236|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831237|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
831238|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
831239|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
831240|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831241|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
831242|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
831243|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
831244|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831245|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
831246|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
831247|NCT02455726|Narcotics|narcotics|mesh-ancestor
831248|NCT02455726|Antacids|antacids|mesh-ancestor
831249|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
831289|NCT02455232|Lidocaine|lidocaine|mesh-list
831290|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
831291|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
831292|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831293|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831294|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
829367|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
829368|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829369|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829370|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
829371|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
829372|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
829373|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
829374|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
829375|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
829376|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
829377|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
829378|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829661|NCT02461888|Dexamethasone|dexamethasone|mesh-list
829662|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
829663|NCT02461888|Ixazomib|ixazomib|mesh-list
829664|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
829665|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
829666|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829667|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
829668|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
829669|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
829670|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829671|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829672|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
829673|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
829674|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
829675|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
829676|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829677|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
829678|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
829679|NCT02461888|Hormones|hormones|mesh-ancestor
829680|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
829681|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
829682|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
829683|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829735|NCT02461368|Triamcinolone|triamcinolone|mesh-list
829736|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
829737|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
829738|NCT02461368|Lidocaine|lidocaine|mesh-list
829739|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
829740|NCT02461368|Anesthetics, Local|anesthetics, local|mesh-ancestor
829741|NCT02461368|Anesthetics|anesthetics|mesh-ancestor
829742|NCT02461368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
829743|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829744|NCT02461368|Sensory System Agents|sensory system agents|mesh-ancestor
829745|NCT02461368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829746|NCT02461368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
829747|NCT02461368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
829748|NCT02461368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
829749|NCT02461368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
829750|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829751|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
829752|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
829753|NCT02461368|Hormones|hormones|mesh-ancestor
829754|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
829755|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
829756|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
829757|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253370|NCT00140517|Amebicides|amebicides|mesh-ancestor
2253371|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2253372|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2253373|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2253374|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
830119|NCT02460055|Dexamethasone|dexamethasone|mesh-list
830120|NCT02460055|Fentanyl|fentanyl|mesh-list
830121|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
830122|NCT02460055|Ondansetron|ondansetron|mesh-list
830123|NCT02460055|Propofol|propofol|mesh-list
830124|NCT02460055|Sevoflurane|sevoflurane|mesh-list
830125|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
830126|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
830127|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
830128|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830129|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830130|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2253375|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253376|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
829795|NCT02461056|Ibuprofen|ibuprofen|mesh-list
829796|NCT02461056|Hydromorphone|hydromorphone|mesh-list
829797|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
829798|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
829799|NCT02461056|Analgesics|analgesics|mesh-ancestor
829800|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
829801|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829802|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829803|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
829804|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
829805|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
829806|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829807|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829808|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
829809|NCT02461056|Narcotics|narcotics|mesh-ancestor
829810|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
829964|NCT02460640|Morphine|morphine|mesh-list
829965|NCT02460640|Ropivacaine|ropivacaine|mesh-list
829966|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
829967|NCT02460640|Narcotics|narcotics|mesh-ancestor
829968|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
829969|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829970|NCT02460640|Analgesics|analgesics|mesh-ancestor
829971|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
829972|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829973|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
829974|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
2253377|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253378|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253379|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2253380|NCT00140517|Renal Agents|renal agents|mesh-ancestor
2253381|NCT00140530|Sirolimus|sirolimus|mesh-list
2253382|NCT00140530|Paclitaxel|paclitaxel|mesh-list
2253383|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2253384|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253385|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
2253386|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
2253387|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
2253388|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253389|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2253390|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2253391|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2253392|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
2253393|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2253394|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
2253395|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253396|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
2253397|NCT00140543|Sirolimus|sirolimus|mesh-list
2253398|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2253399|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253400|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
830940|NCT02456857|Bevacizumab|bevacizumab|mesh-list
830941|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
830942|NCT02456857|Doxorubicin|doxorubicin|mesh-list
830943|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
830944|NCT02456857|Everolimus|everolimus|mesh-list
830945|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
830946|NCT02456857|Antibodies|antibodies|mesh-list
830947|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
830948|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
830949|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
830950|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830951|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
830952|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
830953|NCT02456857|Growth Substances|growth substances|mesh-ancestor
830954|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830955|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
830956|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
830957|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
830958|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
830959|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
830960|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830961|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830962|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
831859|NCT02453516|Epinephrine|epinephrine|mesh-list
831860|NCT02453516|Ropivacaine|ropivacaine|mesh-list
2253401|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
829975|NCT02460289|Minoxidil|minoxidil|mesh-list
829976|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
829977|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
830191|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
830192|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
830193|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
830194|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830195|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
830196|NCT02459509|Analgesics|analgesics|mesh-ancestor
830197|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
830198|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830199|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
830200|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
830201|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
830202|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
830203|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
830204|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253402|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2253403|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2253404|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253405|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253406|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
830691|NCT02457286|Metformin|metformin|mesh-list
830692|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
830693|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831158|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
831159|NCT02456363|Adalimumab|adalimumab|mesh-list
831160|NCT02456363|Etanercept|etanercept|mesh-list
831161|NCT02456363|Golimumab|golimumab|mesh-list
831162|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
831163|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
831164|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
831165|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
831166|NCT02456363|Analgesics|analgesics|mesh-ancestor
831167|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
831168|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831169|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831170|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
831171|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
831172|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
831173|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
831174|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
831296|NCT02455401|Remifentanil|remifentanil|mesh-list
831297|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
831298|NCT02455401|Narcotics|narcotics|mesh-ancestor
831299|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831300|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831301|NCT02455401|Analgesics|analgesics|mesh-ancestor
831302|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
831303|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098653|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
2098654|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098655|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098656|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2098657|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2098658|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2098659|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
831742|NCT02453698|Methylphenidate|methylphenidate|mesh-list
831743|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
831744|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831745|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
831746|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
831747|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
831748|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831749|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
831750|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253407|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2253408|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
2253409|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253410|NCT00140569|Interferons|interferons|mesh-list
2253411|NCT00140569|Fludarabine|fludarabine|mesh-list
2253412|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253413|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
2253414|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829497|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829498|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
829499|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
829500|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
829626|NCT02461875|Cabergoline|cabergoline|mesh-list
829627|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
829628|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
829629|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
829630|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
829631|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
829632|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
829633|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830039|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
830040|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
830041|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
830042|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
830043|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
830044|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830045|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
830046|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
830047|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830048|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
830049|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830338|NCT02458755|Atorvastatin|atorvastatin|mesh-list
830339|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
830340|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
830341|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
830342|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
830343|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830344|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
830345|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
830346|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253415|NCT00140582|Rituximab|rituximab|mesh-list
2253416|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2253417|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253418|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
2253419|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831772|NCT02453529|Nafithromycin|nafithromycin|mesh-list
831773|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
831774|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
831775|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
831776|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831777|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832068|NCT02452775|Poly ICLC|poly iclc|mesh-list
832069|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
832070|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
832071|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832145|NCT02452515|Fulacimstat|fulacimstat|mesh-list
832146|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832147|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253420|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253421|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
2253422|NCT00140595|Rituximab|rituximab|mesh-list
2253423|NCT00140595|Doxorubicin|doxorubicin|mesh-list
2253424|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2253425|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
2253426|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253427|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253428|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2253429|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
2253430|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253431|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253432|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2253433|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2253434|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2253435|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2253436|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
832819|NCT02450084|Fentanyl|fentanyl|mesh-list
832820|NCT02450084|Ropivacaine|ropivacaine|mesh-list
832821|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
832822|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
832823|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
832824|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832825|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
829525|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
829526|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
829527|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829528|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
829529|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
829530|NCT02462252|Hormones|hormones|mesh-ancestor
829531|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
829532|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
829533|NCT02462252|Protective Agents|protective agents|mesh-ancestor
829534|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
829535|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829716|NCT02461329|Polygeline|polygeline|mesh-list
829717|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
829718|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
2253437|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253438|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
2253439|NCT00140647|Ramipril|ramipril|mesh-list
2253440|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2253441|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253442|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2253443|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
2253444|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253445|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253446|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2253447|NCT00140660|Rituximab|rituximab|mesh-list
2253448|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2253449|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253450|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
830225|NCT02459457|Paclitaxel|paclitaxel|mesh-list
830226|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
830227|NCT02459457|Carboplatin|carboplatin|mesh-list
830228|NCT02459457|Fluorouracil|fluorouracil|mesh-list
830229|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
830230|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830231|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
830232|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
830233|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
830234|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830235|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
830236|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
830237|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
830238|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
830239|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830485|NCT02458339|Methotrexate|methotrexate|mesh-list
830486|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
830487|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
830488|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
830489|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830490|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
830491|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
830492|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830493|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830494|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
830495|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830496|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
830497|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
830498|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
830499|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
830500|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
830914|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
830916|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
830917|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
830918|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830919|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
830920|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
830921|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
830922|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830923|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830924|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
831282|NCT02455362|Morphine|morphine|mesh-list
831283|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
831284|NCT02455362|Narcotics|narcotics|mesh-ancestor
831285|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831286|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831287|NCT02455362|Analgesics|analgesics|mesh-ancestor
829556|NCT02462044|Trace Elements|trace elements|mesh-ancestor
829557|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
829558|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829758|NCT02461186|Piperaquine|piperaquine|mesh-list
829759|NCT02461186|Artenimol|artenimol|mesh-list
829760|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
829761|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
829762|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
829763|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829811|NCT02460913|Morphine|morphine|mesh-list
829812|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
829813|NCT02460913|Narcotics|narcotics|mesh-ancestor
829814|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
829815|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829816|NCT02460913|Analgesics|analgesics|mesh-ancestor
829817|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
829818|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830032|NCT02460146|CXA-10|cxa-10|mesh-list
830033|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2754498|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754503|NCT00725127|Aspirin|aspirin|mesh-list
2754504|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
830676|NCT02457351|Itraconazole|itraconazole|mesh-list
830677|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
830678|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
830679|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
830680|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
830681|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830682|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830683|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
830684|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
830685|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
830686|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830687|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
831778|NCT02453659|Nicotine|nicotine|mesh-list
831779|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
831780|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
831781|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831782|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831783|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
831784|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
831785|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
831786|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
831787|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832257|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
832258|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
832259|NCT02452099|Protective Agents|protective agents|mesh-ancestor
832260|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832261|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
832262|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
832263|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832408|NCT02451865|Docetaxel|docetaxel|mesh-list
832409|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832410|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
832411|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
832412|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
832413|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832473|NCT02451527|Digoxin|digoxin|mesh-list
832474|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
832475|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
832476|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832477|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832478|NCT02451527|Protective Agents|protective agents|mesh-ancestor
832479|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832540|NCT02451293|Melatonin|melatonin|mesh-list
832541|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
832542|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832543|NCT02451293|Protective Agents|protective agents|mesh-ancestor
832544|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832545|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
832572|NCT02450981|Bevacizumab|bevacizumab|mesh-list
2754505|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
829712|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2253451|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253452|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253453|NCT00140712|Ropinirole|ropinirole|mesh-list
2253454|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2253455|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2253456|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
2253457|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
2253458|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253459|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253460|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253461|NCT00140725|Interferons|interferons|mesh-list
2253462|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
2253463|NCT00140725|Lamivudine|lamivudine|mesh-list
830804|NCT02456844|Leucovorin|leucovorin|mesh-list
830805|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
830806|NCT02456844|Methotrexate|methotrexate|mesh-list
830807|NCT02456844|Digoxin|digoxin|mesh-list
830808|NCT02456844|Midazolam|midazolam|mesh-list
830809|NCT02456844|Pravastatin|pravastatin|mesh-list
830810|NCT02456844|Montelukast|montelukast|mesh-list
830811|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
830812|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
830813|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
830814|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830815|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
830816|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
830817|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830818|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830819|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
830820|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830821|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
830822|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
830823|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
830824|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
830825|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
830826|NCT02456844|Antidotes|antidotes|mesh-ancestor
830827|NCT02456844|Protective Agents|protective agents|mesh-ancestor
830828|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
830829|NCT02456844|Vitamins|vitamins|mesh-ancestor
830830|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
830831|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
830832|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
830833|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
830834|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
830835|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
830836|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
830837|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
830838|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
830839|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
830840|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
830841|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
830842|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
830843|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
830844|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
830845|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
830846|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
830847|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
830848|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
830849|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
830850|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
830851|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
830852|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
830853|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
830854|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
830855|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
830856|NCT02456844|Analgesics|analgesics|mesh-ancestor
830857|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
830858|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830859|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
830860|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
830861|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
830862|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2253464|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
2253465|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253466|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
2253467|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
829771|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
829772|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
829773|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
829774|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829922|NCT02460627|Lidocaine|lidocaine|mesh-list
829923|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
829924|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
829925|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
829926|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829927|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
829928|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
829929|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
829930|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
829931|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
829932|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
829933|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830116|NCT02459782|Anesthetics|anesthetics|mesh-list
830117|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
830118|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830327|NCT02458742|Morphine|morphine|mesh-list
830328|NCT02458742|Bupivacaine|bupivacaine|mesh-list
830329|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
830330|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
830331|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
830332|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830333|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
830334|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830335|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
830336|NCT02458742|Narcotics|narcotics|mesh-ancestor
830337|NCT02458742|Analgesics|analgesics|mesh-ancestor
830766|NCT02457442|Remifentanil|remifentanil|mesh-list
830767|NCT02457442|Propofol|propofol|mesh-list
830768|NCT02457442|Sevoflurane|sevoflurane|mesh-list
830769|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
830770|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
830771|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830772|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
830773|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
830774|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
830775|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
830776|NCT02457442|Narcotics|narcotics|mesh-ancestor
830777|NCT02457442|Analgesics|analgesics|mesh-ancestor
830778|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
830779|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830780|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
830781|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2253468|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
2253469|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253470|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2253471|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2253472|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831679|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
831680|NCT02454088|Triamcinolone|triamcinolone|mesh-list
831681|NCT02454088|Calcium|calcium|mesh-list
831682|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
831683|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831684|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
831685|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
831686|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
831687|NCT02454088|Hormones|hormones|mesh-ancestor
831688|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
831788|NCT02453776|Infliximab|infliximab|mesh-list
831789|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
831790|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
831791|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253473|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253474|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2253475|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2253476|NCT00140751|Ritonavir|ritonavir|mesh-list
2253477|NCT00140751|Lopinavir|lopinavir|mesh-list
2253478|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2253479|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
832397|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
832398|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
832399|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832400|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098660|NCT02347098|Atorvastatin|atorvastatin|mesh-list
2098661|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2098662|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2098663|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2098664|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
2098665|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098666|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2098667|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098668|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
829990|NCT02460276|Rituximab|rituximab|mesh-list
829991|NCT02460276|Lenalidomide|lenalidomide|mesh-list
829992|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
829993|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
829994|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
829995|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
829996|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
829997|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
829998|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
829999|NCT02460276|Growth Substances|growth substances|mesh-ancestor
830000|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
830102|NCT02459938|Glucagon|glucagon|mesh-list
830103|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
830104|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
830105|NCT02459938|Hormones|hormones|mesh-ancestor
830106|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
830107|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830108|NCT02459938|Incretins|incretins|mesh-ancestor
830590|NCT02458157|Furosemide|furosemide|mesh-list
830591|NCT02458157|Diuretics|diuretics|mesh-ancestor
830592|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
830593|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830594|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
830595|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
830596|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253480|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
2253481|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253482|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253483|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
830704|NCT02457221|Prednisone|prednisone|mesh-list
830705|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
830706|NCT02457221|Tacrolimus|tacrolimus|mesh-list
830707|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
830708|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
830709|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830710|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
830711|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
830712|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
830713|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830714|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830715|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
830716|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
830717|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
830718|NCT02457221|Hormones|hormones|mesh-ancestor
830719|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
830720|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
830721|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
830722|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831408|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
831409|NCT02455141|Carboplatin|carboplatin|mesh-list
831410|NCT02455141|Epirubicin|epirubicin|mesh-list
831411|NCT02455141|Taxane|taxane|mesh-list
831412|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
831413|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
831414|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831415|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
831416|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
831417|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
831418|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831419|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831420|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
831421|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
831422|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
831423|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
831424|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832505|NCT02451475|Amitriptyline|amitriptyline|mesh-list
829945|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
829946|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
829947|NCT02460588|Hormones|hormones|mesh-ancestor
829948|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
829949|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2253484|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2253485|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
2253486|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
830364|NCT02459158|Arbekacin|arbekacin|mesh-list
830365|NCT02459158|Dibekacin|dibekacin|mesh-list
830366|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
830367|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
830368|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
830555|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
830556|NCT02458014|Blinatumomab|blinatumomab|mesh-list
830557|NCT02458014|Antibodies|antibodies|mesh-list
830558|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
830559|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
830560|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
830561|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
830562|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
830563|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830564|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830565|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
830963|NCT02456714|Folfirinox|folfirinox|mesh-list
830964|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831137|NCT02456207|Rituximab|rituximab|mesh-list
831138|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
831139|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831140|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
831141|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831142|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
831488|NCT02455115|Chromium|chromium|mesh-list
831489|NCT02455115|Norepinephrine|norepinephrine|mesh-list
831490|NCT02455115|Edetic Acid|edetic acid|mesh-list
831491|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
831492|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
831493|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
831494|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
831495|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
831496|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831497|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831498|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
831499|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
831500|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831501|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
831502|NCT02455115|Trace Elements|trace elements|mesh-ancestor
831503|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
831504|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
831505|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
831506|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
831507|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
831508|NCT02455115|Antidotes|antidotes|mesh-ancestor
831509|NCT02455115|Protective Agents|protective agents|mesh-ancestor
831510|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2253487|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2253488|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2253489|NCT00140764|Metronidazole|metronidazole|mesh-list
2253490|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2253491|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2253492|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2253493|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2253494|NCT00140790|Valsartan|valsartan|mesh-list
2253495|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2253496|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2253497|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2253498|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253499|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2253500|NCT00140803|Verteporfin|verteporfin|mesh-list
2253501|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2253502|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
2253503|NCT00140803|Hormones|hormones|mesh-ancestor
2253504|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2253505|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253506|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2253507|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
2253508|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2253509|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
830079|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
830080|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
2253510|NCT00140868|Phenobarbital|phenobarbital|mesh-list
2253511|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
831341|NCT02455440|Propofol|propofol|mesh-list
831342|NCT02455440|Sevoflurane|sevoflurane|mesh-list
831343|NCT02455440|Esmolol|esmolol|mesh-list
831344|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
831345|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831346|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831347|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
831348|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
831349|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
831350|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
831351|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
831352|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
831353|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
831354|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
831355|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
831356|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
831357|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831462|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
831463|NCT02454881|Oxycodone|oxycodone|mesh-list
831464|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
831465|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831466|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831467|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
831468|NCT02454881|Analgesics|analgesics|mesh-ancestor
831469|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
831470|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831471|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
831472|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
831473|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
831474|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
831475|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
831476|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831477|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
831478|NCT02454881|Narcotics|narcotics|mesh-ancestor
831580|NCT02454543|Androgens|androgens|mesh-list
831581|NCT02454543|Hormones|hormones|mesh-ancestor
831582|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
831583|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253512|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2253513|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2253514|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253515|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2253516|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2253517|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253518|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253519|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
2253520|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
830131|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
830132|NCT02460055|Hormones|hormones|mesh-ancestor
830133|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
830134|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
830135|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830136|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
830137|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
830138|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
830139|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
830140|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
830141|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
830142|NCT02460055|Narcotics|narcotics|mesh-ancestor
830143|NCT02460055|Analgesics|analgesics|mesh-ancestor
830144|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
830145|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
830146|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
830147|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
830148|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
830149|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
830150|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
830151|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
830152|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
830153|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830154|NCT02460055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
830155|NCT02460055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
830156|NCT02460055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
830157|NCT02460055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
830158|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
830369|NCT02458716|Leuprolide|leuprolide|mesh-list
830370|NCT02458716|Bicalutamide|bicalutamide|mesh-list
830371|NCT02458716|Androgens|androgens|mesh-list
830372|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
830373|NCT02458716|Hormones|hormones|mesh-ancestor
830374|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
830375|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830376|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
830377|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
830378|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
830379|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
830380|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830381|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
830382|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
830889|NCT02457026|Triamcinolone|triamcinolone|mesh-list
830890|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
830891|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
830892|NCT02457026|Aflibercept|aflibercept|mesh-list
830893|NCT02457026|Verteporfin|verteporfin|mesh-list
830894|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
830895|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
830896|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
830897|NCT02457026|Hormones|hormones|mesh-ancestor
830898|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
830899|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830900|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
830901|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
830902|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830903|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830904|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
830905|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
830906|NCT02457026|Growth Substances|growth substances|mesh-ancestor
830907|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
830908|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830909|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
830910|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
831010|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
831011|NCT02456558|Deferiprone|deferiprone|mesh-list
831012|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
831013|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
831014|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
831015|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831358|NCT02455245|Carboplatin|carboplatin|mesh-list
831359|NCT02455245|Vincristine|vincristine|mesh-list
831360|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831361|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
831362|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
831363|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
830244|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830538|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
830539|NCT02458196|Prednisone|prednisone|mesh-list
830540|NCT02458196|Prednisolone|prednisolone|mesh-list
830541|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
830542|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
830543|NCT02458196|Hormones|hormones|mesh-ancestor
830544|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
830545|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830546|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
830547|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830548|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
830549|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
830550|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
830551|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
830552|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
830553|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830554|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831098|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
831099|NCT02456194|Calcium|calcium|mesh-list
831100|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
831101|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831102|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
831187|NCT02455856|Itraconazole|itraconazole|mesh-list
831188|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
831189|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
831190|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
831191|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
831192|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831193|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831194|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
831195|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
831196|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
831197|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831198|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
831601|NCT02454712|Naltrexone|naltrexone|mesh-list
831602|NCT02454712|Oxycodone|oxycodone|mesh-list
831603|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
831604|NCT02454712|Narcotics|narcotics|mesh-ancestor
831605|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831606|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831607|NCT02454712|Analgesics|analgesics|mesh-ancestor
831608|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
831609|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831610|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
831611|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
831734|NCT02453932|Donepezil|donepezil|mesh-list
831735|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
831736|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831737|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831738|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
831739|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
831740|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831741|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
831902|NCT02453464|Leucovorin|leucovorin|mesh-list
831903|NCT02453464|Irinotecan|irinotecan|mesh-list
831904|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
831905|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
831906|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831907|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831908|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831909|NCT02453464|Antidotes|antidotes|mesh-ancestor
831910|NCT02453464|Protective Agents|protective agents|mesh-ancestor
831911|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831912|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
831913|NCT02453464|Vitamins|vitamins|mesh-ancestor
831914|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
2253521|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2253522|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
832666|NCT02450773|Furosemide|furosemide|mesh-list
832667|NCT02450773|Diuretics|diuretics|mesh-ancestor
832668|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
832669|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832670|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
830280|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830281|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
830609|NCT02457702|Glycerol|glycerol|mesh-list
830610|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
830611|NCT02457702|Protective Agents|protective agents|mesh-ancestor
830612|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830911|NCT02456948|Minocycline|minocycline|mesh-list
830912|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
830913|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
831103|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
831104|NCT02456350|Fludarabine|fludarabine|mesh-list
831105|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
831106|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
831107|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831108|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
831109|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
831110|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
831111|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831112|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831113|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2253523|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2253524|NCT00140881|Montelukast|montelukast|mesh-list
2253525|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2253526|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
2253527|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2253528|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
2253529|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2253530|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253531|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2253532|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2098669|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
2098670|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098671|NCT02347332|Methotrexate|methotrexate|mesh-list
2098672|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2098673|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
2098674|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2098675|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098676|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2098677|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
831976|NCT02453087|Rituximab|rituximab|mesh-list
831977|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
831978|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
831979|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831980|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
831981|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831982|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253533|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253534|NCT00140894|Rofecoxib|rofecoxib|mesh-list
2253535|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253536|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253537|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833493|NCT02447601|Simvastatin|simvastatin|mesh-list
833494|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
833495|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
833496|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
833497|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833498|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
833499|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
833500|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833604|NCT02447211|Doxepin|doxepin|mesh-list
833605|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
833606|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
833607|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
833608|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833609|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
833610|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
833611|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
833612|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
833613|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
833614|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
833615|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834053|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
830392|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830393|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830394|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830395|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
830396|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
830397|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
830582|NCT02457975|Ranibizumab|ranibizumab|mesh-list
830583|NCT02457975|Aflibercept|aflibercept|mesh-list
830584|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830585|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
830586|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
830587|NCT02457975|Growth Substances|growth substances|mesh-ancestor
830588|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830589|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
830733|NCT02457208|Rifampin|rifampin|mesh-list
830734|NCT02457208|Isoniazid|isoniazid|mesh-list
830735|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
830736|NCT02457208|Ethambutol|ethambutol|mesh-list
830737|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
830738|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
830739|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
830740|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
830741|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
830742|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
830743|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830744|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830745|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
830746|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
830747|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
830748|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
830749|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
830750|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
830751|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
830752|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
830753|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
830754|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
831880|NCT02453503|Triamcinolone|triamcinolone|mesh-list
831881|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
831882|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
831883|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
831884|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
831885|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
831886|NCT02453503|Hormones|hormones|mesh-ancestor
831887|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
831888|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831889|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
831890|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
831891|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831892|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832141|NCT02452385|Vorolanib|vorolanib|mesh-list
832142|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
832143|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832144|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832240|NCT02452177|Vitamin D|vitamin d|mesh-list
832241|NCT02452177|Vitamins|vitamins|mesh-ancestor
832242|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
832243|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832244|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2253538|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2253539|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2253540|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253541|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2253542|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2253543|NCT00140894|Analgesics|analgesics|mesh-ancestor
2253544|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
2253545|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2253546|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253547|NCT00140907|Losartan|losartan|mesh-list
2253548|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2253549|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2253550|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
834354|NCT02444559|Clonidine|clonidine|mesh-list
834355|NCT02444559|Ropivacaine|ropivacaine|mesh-list
834356|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
834357|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
830408|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830409|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
830410|NCT02458729|Coagulants|coagulants|mesh-ancestor
830411|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
830412|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
830413|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
830414|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
830415|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830416|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
830417|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
830418|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
830419|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
830420|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
830421|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
830422|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
830423|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253551|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2253552|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253553|NCT00140920|Diclofenac|diclofenac|mesh-list
2253554|NCT00140920|Rofecoxib|rofecoxib|mesh-list
2253555|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2253556|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
830629|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
830630|NCT02457585|Infliximab|infliximab|mesh-list
830631|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
830632|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
830633|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
830634|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
830723|NCT02457312|Letrozole|letrozole|mesh-list
830724|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830725|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
830726|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
830727|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830728|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830729|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
830730|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
830731|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
830732|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830788|NCT02456935|Esomeprazole|esomeprazole|mesh-list
830789|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
830790|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
830791|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
830792|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830793|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253557|NCT00140920|Analgesics|analgesics|mesh-ancestor
2253558|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
2253559|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253560|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253561|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2253562|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253563|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2253564|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253565|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253566|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2253567|NCT00140933|Diclofenac|diclofenac|mesh-list
2253568|NCT00140933|Rofecoxib|rofecoxib|mesh-list
2253569|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2253570|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2253571|NCT00140933|Analgesics|analgesics|mesh-ancestor
2253572|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
831452|NCT02455154|Letrozole|letrozole|mesh-list
831453|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831454|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
831455|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
831456|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831457|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831458|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
831459|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
831460|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
831461|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831664|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
831665|NCT02454322|Analgesics|analgesics|mesh-ancestor
831666|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
831667|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
830456|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
830457|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
830458|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830459|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
830460|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
2754506|NCT00725127|Analgesics|analgesics|mesh-ancestor
2754507|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
2754508|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754509|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831584|NCT02454426|Vortioxetine|vortioxetine|mesh-list
831585|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
831586|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
831587|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
831588|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
831589|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831590|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831591|NCT02454426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
831592|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
831593|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
831594|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831595|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
831596|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
831597|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
831598|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
831599|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
831600|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
831701|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
831702|NCT02454205|Levofloxacin|levofloxacin|mesh-list
831703|NCT02454205|Ofloxacin|ofloxacin|mesh-list
831704|NCT02454205|Isoniazid|isoniazid|mesh-list
831705|NCT02454205|Linezolid|linezolid|mesh-list
831706|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
831707|NCT02454205|Bedaquiline|bedaquiline|mesh-list
831708|NCT02454205|Kanamycin|kanamycin|mesh-list
831709|NCT02454205|Ethionamide|ethionamide|mesh-list
831710|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
831711|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
831712|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
831713|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
831714|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831715|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831716|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831717|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
831718|NCT02454205|Renal Agents|renal agents|mesh-ancestor
831719|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
831720|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
831721|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
831722|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
831723|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
831724|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
831725|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
831726|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
832109|NCT02452606|Levodopa|levodopa|mesh-list
832110|NCT02452606|Carbidopa|carbidopa|mesh-list
832111|NCT02452606|Entacapone|entacapone|mesh-list
832112|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
832113|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
832114|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
832115|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
832116|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832117|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832118|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
832119|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832120|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2098678|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098679|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098680|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
2098681|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832560|NCT02451072|Ketanserin|ketanserin|mesh-list
832561|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
832562|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
832563|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832564|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
832565|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
832566|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
2253573|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253574|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253575|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2253576|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253577|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2253578|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253579|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253580|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2253581|NCT00140946|Montelukast|montelukast|mesh-list
2253582|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253583|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253584|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
2253585|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2253586|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2253587|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
2253588|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2253589|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2253590|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2253591|NCT00140959|Losartan|losartan|mesh-list
2253592|NCT00140959|Atenolol|atenolol|mesh-list
2253593|NCT00140959|Amlodipine|amlodipine|mesh-list
2253594|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2253595|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2253596|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2253597|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253598|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2253599|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831927|NCT02453490|Fluorouracil|fluorouracil|mesh-list
831928|NCT02453490|Raltitrexed|raltitrexed|mesh-list
831929|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
831930|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831931|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
831932|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831933|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
831934|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
831935|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831936|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
831937|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832017|NCT02453022|Omeprazole|omeprazole|mesh-list
832018|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
832019|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
832020|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
832021|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832022|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832653|NCT02450877|Azacitidine|azacitidine|mesh-list
832654|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
832655|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
832656|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832657|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832658|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832801|NCT02450123|Sunitinib|sunitinib|mesh-list
832802|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832803|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
832804|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
832805|NCT02450123|Growth Substances|growth substances|mesh-ancestor
832806|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832807|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
832808|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
832809|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832810|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832860|NCT02449811|Amlodipine|amlodipine|mesh-list
832861|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
832862|NCT02449811|Olmesartan|olmesartan|mesh-list
832863|NCT02449811|Perindopril|perindopril|mesh-list
832864|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
832865|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
832866|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
832867|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832868|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
832869|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832870|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
832871|NCT02449811|Diuretics|diuretics|mesh-ancestor
832872|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
830655|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
830656|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
830657|NCT02457806|Protective Agents|protective agents|mesh-ancestor
830870|NCT02456974|Amoxicillin|amoxicillin|mesh-list
830871|NCT02456974|Vancomycin|vancomycin|mesh-list
830872|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
830873|NCT02456974|Meropenem|meropenem|mesh-list
830874|NCT02456974|Tazobactam|tazobactam|mesh-list
830875|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
830876|NCT02456974|Amikacin|amikacin|mesh-list
830877|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
830878|NCT02456974|Teicoplanin|teicoplanin|mesh-list
830879|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
830880|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
830881|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
830882|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
830883|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
830884|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
830885|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
830886|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
830887|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
830888|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
830977|NCT02456532|Zolpidem|zolpidem|mesh-list
830978|NCT02456532|Eszopiclone|eszopiclone|mesh-list
830979|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
830980|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
830981|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
830982|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
830983|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
830984|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
830985|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
830986|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
830987|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831402|NCT02454855|Melatonin|melatonin|mesh-list
831403|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
831404|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831405|NCT02454855|Protective Agents|protective agents|mesh-ancestor
831406|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831407|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2253600|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
2253601|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2253602|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2253603|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2253604|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
2253605|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253606|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
2253607|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253608|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
2253609|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2253610|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2253611|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2253612|NCT00140972|Diclofenac|diclofenac|mesh-list
2253613|NCT00140972|Etoricoxib|etoricoxib|mesh-list
2253614|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2253615|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2253616|NCT00140972|Analgesics|analgesics|mesh-ancestor
2253617|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
2253618|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253619|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253620|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
833336|NCT02448199|Meloxicam|meloxicam|mesh-list
833337|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
833338|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
833339|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
833340|NCT02448199|Analgesics|analgesics|mesh-ancestor
833341|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
833342|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833343|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833344|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
833345|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
833346|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
833347|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833348|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833726|NCT02446782|Clindamycin|clindamycin|mesh-list
833727|NCT02446782|Cefazolin|cefazolin|mesh-list
2253621|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253622|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2253623|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253624|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253625|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2253626|NCT00140985|Losartan|losartan|mesh-list
2253627|NCT00140985|Amlodipine|amlodipine|mesh-list
2253628|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
831662|NCT02453984|Atezolizumab|atezolizumab|mesh-list
831663|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831759|NCT02453893|Risperidone|risperidone|mesh-list
831760|NCT02453893|Iloperidone|iloperidone|mesh-list
831761|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
831762|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
831763|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
831764|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831765|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831766|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
831767|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
831768|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831769|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
831770|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
831771|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
831938|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
831939|NCT02453373|Plasminogen|plasminogen|mesh-list
831940|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
831941|NCT02453373|Propofol|propofol|mesh-list
831942|NCT02453373|Etomidate|etomidate|mesh-list
831943|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
831944|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831945|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831946|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
831947|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
831948|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
831949|NCT02453373|Analgesics|analgesics|mesh-ancestor
831950|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
831951|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831952|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
831953|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
831954|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
831955|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
831956|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831957|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
831958|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
831959|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
831960|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
831961|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
832006|NCT02452970|Gemcitabine|gemcitabine|mesh-list
832007|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832008|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
832009|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
832010|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832011|NCT02452970|Antiviral Agents|antiviral agents|mesh-ancestor
832012|NCT02452970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
832013|NCT02452970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832014|NCT02452970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
832015|NCT02452970|Immunologic Factors|immunologic factors|mesh-ancestor
832016|NCT02452970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098682|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2098683|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2098684|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
2253629|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2253630|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2253631|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253632|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2253633|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253634|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
2253635|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2253636|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2253637|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2253638|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2253639|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
831080|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
831081|NCT02456428|Glibornuride|glibornuride|mesh-list
831082|NCT02456428|Tolazamide|tolazamide|mesh-list
831083|NCT02456428|Carbutamide|carbutamide|mesh-list
831084|NCT02456428|Gliquidone|gliquidone|mesh-list
831085|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
831086|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
831087|NCT02456428|Incretins|incretins|mesh-list
831088|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831089|NCT02456428|Hormones|hormones|mesh-ancestor
831090|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
831091|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
831092|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831093|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831094|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
831095|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
831096|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
831097|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
831151|NCT02456025|Tacrolimus|tacrolimus|mesh-list
831152|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
831153|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
831154|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831155|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
831156|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831157|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831250|NCT02455687|Budesonide|budesonide|mesh-list
831251|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
831252|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
831253|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
831254|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
831255|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831256|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831257|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
831258|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
831259|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
831260|NCT02455687|Hormones|hormones|mesh-ancestor
831261|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
831262|NCT02455687|Analgesics|analgesics|mesh-ancestor
831263|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
831264|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
831265|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831266|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
831267|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
831268|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
831269|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
831270|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831271|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
831272|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
831273|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
831624|NCT02454348|Vasopressins|vasopressins|mesh-list
831625|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
831626|NCT02454348|Norepinephrine|norepinephrine|mesh-list
831627|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
831628|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
831629|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
831630|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
831631|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831632|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831633|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
831634|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
831635|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831636|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
831637|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
831638|NCT02454348|Coagulants|coagulants|mesh-ancestor
831639|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
831640|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
2253640|NCT00140998|Estradiol|estradiol|mesh-list
2253641|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2253642|NCT00140998|Estrogens|estrogens|mesh-ancestor
2253643|NCT00140998|Hormones|hormones|mesh-ancestor
2253644|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2253645|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253646|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2253647|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
2253648|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
832833|NCT02449941|Rabeprazole|rabeprazole|mesh-list
831201|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
831202|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
831203|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
831204|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831205|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
831206|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
831207|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831208|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
831209|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831437|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
831438|NCT02455180|Vitamins|vitamins|mesh-ancestor
831439|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
831440|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831441|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
831442|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831443|NCT02455180|Protective Agents|protective agents|mesh-ancestor
2253649|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2253650|NCT00141011|Ancrod|ancrod|mesh-list
2253651|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
2253652|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2253653|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2253654|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253655|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
2253656|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2253657|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253658|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2253659|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2253660|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
832533|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
832534|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
832535|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
832536|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
832537|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
832538|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
832539|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832922|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
832923|NCT02449603|Exenatide|exenatide|mesh-list
832924|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
832925|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
832926|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
832927|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832928|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
832929|NCT02449603|Incretins|incretins|mesh-ancestor
832930|NCT02449603|Hormones|hormones|mesh-ancestor
832931|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
833083|NCT02449278|Prednisone|prednisone|mesh-list
833084|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
833085|NCT02449278|Doxorubicin|doxorubicin|mesh-list
833086|NCT02449278|Vincristine|vincristine|mesh-list
833087|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
833088|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
833089|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833090|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
833091|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
833092|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
833093|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833094|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833095|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
833096|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
833097|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
833098|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
833099|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833100|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
833101|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
833102|NCT02449278|Hormones|hormones|mesh-ancestor
833103|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
833104|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
833105|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
833106|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
833107|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
833108|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
2253661|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253662|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
831210|NCT02455921|Atropine|atropine|mesh-list
831211|NCT02455921|Neostigmine|neostigmine|mesh-list
831212|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
831213|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
831214|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
831215|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
831216|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831217|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831218|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
831219|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
831220|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
831221|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
831222|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
831223|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
831224|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
831225|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
831226|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831227|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
831228|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831229|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
831526|NCT02454751|Fentanyl|fentanyl|mesh-list
831527|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
831528|NCT02454751|Narcotics|narcotics|mesh-ancestor
831529|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831530|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831531|NCT02454751|Analgesics|analgesics|mesh-ancestor
831532|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
831533|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831534|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
831535|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
831536|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
831537|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
2253663|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253664|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
2253665|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2253666|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253667|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2253668|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2253669|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
832659|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
832660|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
832661|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
832662|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832663|NCT02450838|Antacids|antacids|mesh-ancestor
832664|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832665|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
832691|NCT02450513|Adalimumab|adalimumab|mesh-list
832692|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
832693|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
833109|NCT02449369|Acetaminophen|acetaminophen|mesh-list
833110|NCT02449369|Oxycodone|oxycodone|mesh-list
833111|NCT02449369|Hydromorphone|hydromorphone|mesh-list
833112|NCT02449369|Orphenadrine|orphenadrine|mesh-list
833113|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
833114|NCT02449369|Analgesics|analgesics|mesh-ancestor
833115|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
833116|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833117|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833118|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
833119|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
833120|NCT02449369|Narcotics|narcotics|mesh-ancestor
833121|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
833122|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
833123|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
833124|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
833125|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
833126|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
833127|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
833128|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
833129|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
833130|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
833131|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
833132|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833133|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
833134|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
833135|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831288|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
831311|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831838|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
831839|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
831840|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
831841|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
831842|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
831843|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831844|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
831845|NCT02453802|Coagulants|coagulants|mesh-ancestor
831846|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
831847|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
831848|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
831849|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
831850|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831851|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
831852|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
831853|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
831854|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
831855|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
831856|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
831857|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831858|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832148|NCT02452450|Acetaminophen|acetaminophen|mesh-list
832149|NCT02452450|Ibuprofen|ibuprofen|mesh-list
832150|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
832151|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
832152|NCT02452450|Analgesics|analgesics|mesh-ancestor
832153|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
832154|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832155|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832156|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
832157|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
832158|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
832159|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832160|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832161|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
832214|NCT02452125|Nicotine|nicotine|mesh-list
832215|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
832216|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
832217|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832218|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832219|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
832220|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
832221|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
832222|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
832223|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832433|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
832434|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
832435|NCT02451748|Prednisone|prednisone|mesh-list
832436|NCT02451748|Triamcinolone|triamcinolone|mesh-list
832437|NCT02451748|Naproxen|naproxen|mesh-list
832438|NCT02451748|Methotrexate|methotrexate|mesh-list
832439|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
832440|NCT02451748|Leflunomide|leflunomide|mesh-list
832441|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
832442|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
832443|NCT02451748|Hormones|hormones|mesh-ancestor
832444|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
832445|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832446|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
832447|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832448|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
832449|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
832450|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
832451|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
832452|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
832453|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832454|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
832455|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832456|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
832457|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
832458|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
832459|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
832460|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
832461|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
832462|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2253670|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253671|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
2253672|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253673|NCT00141089|Tegaserod|tegaserod|mesh-list
2253674|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2253675|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
2253676|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253677|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253678|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253679|NCT00141141|Atorvastatin|atorvastatin|mesh-list
2253680|NCT00141141|Simvastatin|simvastatin|mesh-list
2253681|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2253682|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2253683|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
2253684|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253685|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2253686|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2253687|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831444|NCT02454868|Remifentanil|remifentanil|mesh-list
831445|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
831446|NCT02454868|Narcotics|narcotics|mesh-ancestor
831447|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831448|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831449|NCT02454868|Analgesics|analgesics|mesh-ancestor
831450|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
831451|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253688|NCT00141154|Celecoxib|celecoxib|mesh-list
2253689|NCT00141154|Loxoprofen|loxoprofen|mesh-list
2253690|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2253691|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2253692|NCT00141154|Analgesics|analgesics|mesh-ancestor
2253693|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
2253694|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253695|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253696|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2253697|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253698|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2253699|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2253700|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253701|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253702|NCT00141167|Varenicline|varenicline|mesh-list
2253703|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2253704|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2253705|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
832023|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
832024|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
832025|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
832245|NCT02452112|Lidocaine|lidocaine|mesh-list
832246|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
832247|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
832248|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
832249|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832250|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
832251|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832252|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
832253|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
832254|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
832255|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
832256|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832580|NCT02451111|Rituximab|rituximab|mesh-list
832581|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
832582|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832583|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
832584|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832585|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
832778|NCT02450253|Tadalafil|tadalafil|mesh-list
832779|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
832780|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
832781|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
832782|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832783|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832784|NCT02450253|Urological Agents|urological agents|mesh-ancestor
833317|NCT02448251|Abivertinib|abivertinib|mesh-list
833318|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
833319|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831364|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
831365|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253706|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253707|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253708|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253709|NCT00141193|Celecoxib|celecoxib|mesh-list
2253710|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2253711|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
832497|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
832498|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
832499|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253712|NCT00141193|Analgesics|analgesics|mesh-ancestor
2253713|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
2253714|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253715|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253716|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
833259|NCT02448264|Berotralstat|berotralstat|mesh-list
833260|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833261|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833801|NCT02446574|Paclitaxel|paclitaxel|mesh-list
833802|NCT02446574|Cisplatin|cisplatin|mesh-list
833803|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
833804|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833805|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
833806|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
833807|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
833808|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098685|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2098686|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2098687|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
2098688|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2098689|NCT02347345|Ledipasvir|ledipasvir|mesh-list
2098690|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
2098691|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098692|NCT02347605|Nicotine|nicotine|mesh-list
2098693|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2098694|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
2098695|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098696|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834329|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
834330|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834331|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
834332|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834520|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
834521|NCT02443831|Fludarabine|fludarabine|mesh-list
834522|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
834523|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
834524|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834525|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
834526|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
834527|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
834528|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834529|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834530|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
834722|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
834723|NCT02442752|Lansoprazole|lansoprazole|mesh-list
834724|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
834725|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
834726|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
834727|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834728|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834749|NCT02442362|Paclitaxel|paclitaxel|mesh-list
834750|NCT02442362|Fluorouracil|fluorouracil|mesh-list
834751|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
834752|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
834753|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834754|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
834755|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
834756|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
834757|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834758|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
834759|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
834760|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
834761|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
831382|NCT02455609|Analgesics|analgesics|mesh-ancestor
831383|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
831384|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
831385|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
831386|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
831387|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
831388|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831389|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
831390|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
831391|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
831392|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
831393|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
831425|NCT02454894|Lidocaine|lidocaine|mesh-list
831426|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
831427|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
831428|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831429|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831430|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
831431|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831432|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
831433|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
831434|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
831435|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
831436|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832036|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
832037|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
832038|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
832039|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
832040|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
832041|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832042|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832043|NCT02452879|Urological Agents|urological agents|mesh-ancestor
2253717|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253718|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2253719|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2253720|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253721|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253722|NCT00141206|Varenicline|varenicline|mesh-list
2253723|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2253724|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2253725|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
2253726|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2253727|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253728|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253729|NCT00141232|Atorvastatin|atorvastatin|mesh-list
2253730|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2253731|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2253732|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
2253733|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253734|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2253735|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2253736|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253737|NCT00141245|Pregabalin|pregabalin|mesh-list
2253738|NCT00141245|Analgesics|analgesics|mesh-ancestor
2253739|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
2253740|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253741|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253742|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
2253743|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2253744|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
832629|NCT02450786|Donepezil|donepezil|mesh-list
832630|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
832631|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832632|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832633|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
832634|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
832635|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832636|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
832790|NCT02450279|Edetic Acid|edetic acid|mesh-list
832791|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
832792|NCT02450279|Antidotes|antidotes|mesh-ancestor
832793|NCT02450279|Protective Agents|protective agents|mesh-ancestor
832794|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831514|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
831515|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
831516|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
831517|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
831518|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
831519|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
831520|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831521|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831522|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
831523|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
831524|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
831525|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831558|NCT02454504|Neostigmine|neostigmine|mesh-list
831559|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
831560|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831561|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831562|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
831563|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
831564|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831565|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
831566|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
831567|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253745|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253746|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2253747|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2253748|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2253749|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2253750|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2253751|NCT00141258|Pregabalin|pregabalin|mesh-list
2253752|NCT00141258|Analgesics|analgesics|mesh-ancestor
831820|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
831821|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
831822|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832003|NCT02452918|Oritavancin|oritavancin|mesh-list
832004|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
832005|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
832287|NCT02452307|Imiquimod|imiquimod|mesh-list
832288|NCT02452307|Molgramostim|molgramostim|mesh-list
832289|NCT02452307|Protamines|protamines|mesh-list
832290|NCT02452307|Sargramostim|sargramostim|mesh-list
832291|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
832292|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832293|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
832294|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832295|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
832296|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
832297|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832298|NCT02452307|Coagulants|coagulants|mesh-ancestor
832480|NCT02451605|Analgesics|analgesics|mesh-list
832481|NCT02451605|Ropivacaine|ropivacaine|mesh-list
832482|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
832483|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
832484|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832485|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
832486|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
832487|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832932|NCT02449733|Tenofovir|tenofovir|mesh-list
832933|NCT02449733|Emtricitabine|emtricitabine|mesh-list
832934|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
832935|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
832936|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
832937|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
832938|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
832939|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832940|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832941|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
832942|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
832988|NCT02449265|Prednisone|prednisone|mesh-list
832989|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
832990|NCT02449265|Doxorubicin|doxorubicin|mesh-list
832991|NCT02449265|Vincristine|vincristine|mesh-list
832992|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
832993|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
832994|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832995|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
831668|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831669|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
831670|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831671|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
831672|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
831673|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
831674|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
831675|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831676|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
831677|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
831678|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
831727|NCT02453867|Tacrolimus|tacrolimus|mesh-list
831728|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
831729|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
831730|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831731|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
831732|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
831733|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253753|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
2253754|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253755|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253756|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
2253757|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
832306|NCT02451956|Paclitaxel|paclitaxel|mesh-list
832307|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
832308|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832309|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
832310|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
832311|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
832312|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832390|NCT02451787|Vitamin D|vitamin d|mesh-list
832391|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
832392|NCT02451787|Vitamins|vitamins|mesh-ancestor
832393|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
832394|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832395|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
832396|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
832488|NCT02451579|Cetirizine|cetirizine|mesh-list
832489|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
832490|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
832491|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
832492|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
832493|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
832494|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
832495|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832496|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832785|NCT02450149|Sorafenib|sorafenib|mesh-list
832786|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832787|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
832788|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832789|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832943|NCT02449655|Paclitaxel|paclitaxel|mesh-list
832944|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
832945|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
832946|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832947|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
832948|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
832949|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
832950|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833152|NCT02448797|Vinorelbine|vinorelbine|mesh-list
833153|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
833154|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833155|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
833156|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
833157|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
833158|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833473|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
833474|NCT02448225|Fluorides|fluorides|mesh-list
833475|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
833476|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
833477|NCT02448225|Protective Agents|protective agents|mesh-ancestor
833478|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833479|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
833480|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831861|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
831862|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
831863|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
831864|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
831865|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
831866|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831867|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
831868|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
831869|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
831870|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
831871|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
831872|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
831873|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
831874|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
831875|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
831876|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
831877|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
831878|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
831879|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
832121|NCT02452684|Eszopiclone|eszopiclone|mesh-list
832122|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
832123|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
832124|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832268|NCT02452255|Propranolol|propranolol|mesh-list
832269|NCT02452255|Metoprolol|metoprolol|mesh-list
832270|NCT02452255|Fenofibrate|fenofibrate|mesh-list
832271|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
832272|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
832273|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
832274|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
832275|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832276|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832277|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
832278|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
832279|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
832280|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
832281|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
832282|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832283|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
832284|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
832285|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
832286|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
832384|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
832385|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
832386|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
832387|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
832388|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832389|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
832981|NCT02449486|Ropivacaine|ropivacaine|mesh-list
832982|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
832983|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
832984|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
832985|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832986|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
832987|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833029|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
833030|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
833031|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
833032|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
833033|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833034|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
833035|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
833036|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
833037|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833226|NCT02448550|Heparin|heparin|mesh-list
833227|NCT02448550|Calcium heparin|calcium heparin|mesh-list
833228|NCT02448550|Bivalirudin|bivalirudin|mesh-list
833229|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
833230|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
833231|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
833232|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833233|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
833234|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
833235|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
833236|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832035|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253758|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2253759|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253760|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2253761|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2253762|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2253763|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2253764|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2253765|NCT00141284|Lamivudine|lamivudine|mesh-list
2253766|NCT00141284|Zidovudine|zidovudine|mesh-list
2253767|NCT00141284|Nelfinavir|nelfinavir|mesh-list
832610|NCT02451033|Hormones|hormones|mesh-list
832611|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
832612|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253768|NCT00141284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2253769|NCT00141284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2253770|NCT00141284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253771|NCT00141284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253772|NCT00141284|Antiviral Agents|antiviral agents|mesh-ancestor
2253773|NCT00141284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2253774|NCT00141284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2253775|NCT00141284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2253776|NCT00141284|Antimetabolites|antimetabolites|mesh-ancestor
2253777|NCT00141284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2253778|NCT00141284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
833144|NCT02448901|Edoxaban|edoxaban|mesh-list
833145|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
833146|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
833147|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
833148|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
833149|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833150|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833151|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
833567|NCT02447289|Midazolam|midazolam|mesh-list
833568|NCT02447289|Ketamine|ketamine|mesh-list
833569|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
833570|NCT02447289|Analgesics|analgesics|mesh-ancestor
833571|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
833572|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833573|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833574|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
833575|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
833576|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
833577|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
833578|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
833579|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
833580|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
833581|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
833582|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833583|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
833584|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
833585|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
833586|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
833587|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
833588|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
833589|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
833793|NCT02446704|Temozolomide|temozolomide|mesh-list
833794|NCT02446704|Olaparib|olaparib|mesh-list
833795|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
833796|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
833797|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833798|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833799|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
833800|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834021|NCT02445872|Dexamethasone|dexamethasone|mesh-list
834022|NCT02445872|Aprepitant|aprepitant|mesh-list
834023|NCT02445872|Palonosetron|palonosetron|mesh-list
834024|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
834025|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
834026|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
2253779|NCT00141284|Protease Inhibitors|protease inhibitors|mesh-ancestor
832052|NCT02453009|Docetaxel|docetaxel|mesh-list
832053|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832054|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
832055|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
832056|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
832057|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832058|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
832059|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
832060|NCT02453009|Hormones|hormones|mesh-ancestor
832061|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
832062|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832063|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
832133|NCT02452502|Atorvastatin|atorvastatin|mesh-list
832134|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
832135|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
832136|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
832137|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832138|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
832139|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
832140|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832264|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
832265|NCT02452216|Hematinics|hematinics|mesh-ancestor
832266|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
832267|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
832375|NCT02451852|Osimertinib|osimertinib|mesh-list
832376|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832377|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
832378|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832379|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832500|NCT02451423|Atezolizumab|atezolizumab|mesh-list
832501|NCT02451423|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
832502|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832503|NCT02451423|Immunologic Factors|immunologic factors|mesh-ancestor
832504|NCT02451423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832586|NCT02450994|Dexamethasone|dexamethasone|mesh-list
832587|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
832588|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
832589|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
832590|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832591|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832592|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
832593|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
832594|NCT02450994|Hormones|hormones|mesh-ancestor
832595|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
832596|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
832597|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253780|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
2253781|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253782|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
2253783|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2253784|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
833051|NCT02449252|Prednisone|prednisone|mesh-list
833052|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
833053|NCT02449252|Doxorubicin|doxorubicin|mesh-list
833054|NCT02449252|Vincristine|vincristine|mesh-list
833055|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
833056|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
833057|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833058|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
833059|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
833060|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
833061|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833062|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833063|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
833064|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
833065|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
833066|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
833067|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833068|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
833069|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
833070|NCT02449252|Hormones|hormones|mesh-ancestor
833071|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
833072|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
833073|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2098697|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2098698|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2098699|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
2098700|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098701|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098702|NCT02347631|Dipivefrin|dipivefrin|mesh-list
2098703|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2098704|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
2098705|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098706|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098707|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098708|NCT02347657|Ivacaftor|ivacaftor|mesh-list
833077|NCT02449031|Tobramycin|tobramycin|mesh-list
833078|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
833079|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
833220|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
833221|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
833222|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
833223|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833224|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
833225|NCT02448407|Protective Agents|protective agents|mesh-ancestor
2098709|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2098710|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2098711|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098712|NCT02347813|Pioglitazone|pioglitazone|mesh-list
2098713|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2098714|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833770|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
833771|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
833772|NCT02446964|Fludarabine|fludarabine|mesh-list
833773|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
833774|NCT02446964|Tacrolimus|tacrolimus|mesh-list
833775|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
833776|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
833777|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833778|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
833779|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
833780|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
833781|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833782|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833783|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
833784|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
833785|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
833786|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
833787|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833788|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
833789|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
833790|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
833791|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
833792|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
834154|NCT02445339|Naltrexone|naltrexone|mesh-list
834155|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
834156|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
834157|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834158|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
834159|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834285|NCT02444611|Vaccines|vaccines|mesh-list
834286|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
834287|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
834288|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834289|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
834358|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
834359|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834360|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
834361|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834362|NCT02444559|Analgesics|analgesics|mesh-ancestor
834363|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
834364|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
834365|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
834366|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
834367|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
834368|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
834369|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
834370|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
834371|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098715|NCT02347917|Pemetrexed|pemetrexed|mesh-list
832200|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
832201|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832202|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
832203|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253785|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253786|NCT00141310|Urological Agents|urological agents|mesh-ancestor
2253787|NCT00141336|Pregabalin|pregabalin|mesh-list
2253788|NCT00141336|Analgesics|analgesics|mesh-ancestor
2253789|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
2253790|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253791|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253792|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
2253793|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2253794|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2253795|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253796|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2253797|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2253798|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2253799|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2253800|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2253801|NCT00141362|Pregabalin|pregabalin|mesh-list
2253802|NCT00141362|Analgesics|analgesics|mesh-ancestor
2253803|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
832811|NCT02450045|Bupivacaine|bupivacaine|mesh-list
832812|NCT02450045|Ropivacaine|ropivacaine|mesh-list
832813|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
832814|NCT02450045|Anesthetics|anesthetics|mesh-list
832815|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
832816|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832817|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
832818|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832951|NCT02449720|Ropivacaine|ropivacaine|mesh-list
832952|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
832953|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
832954|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
832955|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832956|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
832957|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833467|NCT02447666|Azacitidine|azacitidine|mesh-list
833468|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
833469|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
833470|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833471|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833472|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833616|NCT02447185|Triamcinolone|triamcinolone|mesh-list
833617|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
833618|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
833619|NCT02447185|Ranibizumab|ranibizumab|mesh-list
833620|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
833621|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
833622|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
833623|NCT02447185|Growth Substances|growth substances|mesh-ancestor
833624|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833625|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
833626|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833627|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
833628|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
833629|NCT02447185|Hormones|hormones|mesh-ancestor
833630|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
833631|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
833632|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
833633|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833634|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833939|NCT02446002|Lofexidine|lofexidine|mesh-list
833940|NCT02446002|Clonidine|clonidine|mesh-list
833941|NCT02446002|Naltrexone|naltrexone|mesh-list
833942|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
833943|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
833944|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833945|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
833946|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833947|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
833948|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
833949|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2253804|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253805|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833531|NCT02447224|Metronidazole|metronidazole|mesh-list
833532|NCT02447224|Ertapenem|ertapenem|mesh-list
833533|NCT02447224|Cefdinir|cefdinir|mesh-list
833534|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
833535|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
833536|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
833537|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
833763|NCT02446834|Metformin|metformin|mesh-list
833764|NCT02446834|Acarbose|acarbose|mesh-list
833765|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
833766|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833767|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
833768|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833769|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833820|NCT02446431|Sirolimus|sirolimus|mesh-list
833821|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
833822|NCT02446431|Bevacizumab|bevacizumab|mesh-list
833823|NCT02446431|Valproic Acid|valproic acid|mesh-list
833824|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
833825|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
833826|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833827|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
833828|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
833829|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
833830|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833831|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833832|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
833833|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
833834|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
833835|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
833836|NCT02446431|Growth Substances|growth substances|mesh-ancestor
833837|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
833838|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
833839|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
833840|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
833841|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
833842|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
833843|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833844|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
833845|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
833846|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
833847|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
833848|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
833849|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
833925|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
833926|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
833927|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
833928|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
833929|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
833930|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
833998|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
833999|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
834000|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
834001|NCT02445898|Prednisolone|prednisolone|mesh-list
834002|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
834003|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
834004|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
834005|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
834006|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
834007|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
834008|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834009|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834010|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
834011|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
834012|NCT02445898|Hormones|hormones|mesh-ancestor
834013|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
834014|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
834015|NCT02445898|Protective Agents|protective agents|mesh-ancestor
834016|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
834017|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834322|NCT02444481|Polymyxins|polymyxins|mesh-list
834323|NCT02444481|Nystatin|nystatin|mesh-list
834324|NCT02444481|Neomycin|neomycin|mesh-list
834325|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
834326|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
834327|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
834328|NCT02444481|Ionophores|ionophores|mesh-ancestor
2253806|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
2253807|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2253808|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2253809|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253810|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2253811|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2253812|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2253813|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
833243|NCT02448329|Paclitaxel|paclitaxel|mesh-list
833244|NCT02448329|Adavosertib|adavosertib|mesh-list
833245|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
833246|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833247|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
833248|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
833249|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
833250|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833251|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833641|NCT02447016|Tenofovir|tenofovir|mesh-list
833642|NCT02447016|Emtricitabine|emtricitabine|mesh-list
833643|NCT02447016|Efavirenz|efavirenz|mesh-list
833644|NCT02447016|Rilpivirine|rilpivirine|mesh-list
833645|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
833646|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
833647|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
833648|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
833649|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833650|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833651|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
833652|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
833653|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
833654|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
833655|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
833656|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
833657|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
833658|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
833753|NCT02446795|Sunitinib|sunitinib|mesh-list
833754|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833755|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
833756|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
833757|NCT02446795|Growth Substances|growth substances|mesh-ancestor
833758|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833759|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
833760|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
833761|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833762|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253814|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2253815|NCT00141375|Pregabalin|pregabalin|mesh-list
2253816|NCT00141375|Analgesics|analgesics|mesh-ancestor
2253817|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
2253818|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253819|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253820|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
2253821|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2253822|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2253823|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253824|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2253825|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2253826|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2253827|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2253828|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2253829|NCT00141388|Pregabalin|pregabalin|mesh-list
2253830|NCT00141388|Analgesics|analgesics|mesh-ancestor
2253831|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
2253832|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253833|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253834|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
2253835|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2253836|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
834151|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
834152|NCT02445300|Laxatives|laxatives|mesh-ancestor
834153|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
834290|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
834291|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
834292|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
2253837|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253838|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2253839|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2253840|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2253841|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2253842|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2253843|NCT00141401|Pregabalin|pregabalin|mesh-list
2253844|NCT00141401|Analgesics|analgesics|mesh-ancestor
2253845|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
2253846|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253847|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253848|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
2253849|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2253850|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
832958|NCT02450058|Paclitaxel|paclitaxel|mesh-list
832959|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
832960|NCT02450058|Fluorouracil|fluorouracil|mesh-list
832961|NCT02450058|Epirubicin|epirubicin|mesh-list
832962|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
832963|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832964|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
832965|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
832966|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
832967|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832968|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
832969|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
832970|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832971|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
832972|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
832973|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
832974|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
832975|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
832976|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
832977|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
832978|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
832979|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
832980|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833136|NCT02448784|Donepezil|donepezil|mesh-list
833137|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
833138|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833139|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833140|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
833141|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
833142|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833143|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
833358|NCT02447965|Bupivacaine|bupivacaine|mesh-list
833359|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
833360|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
833361|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
833362|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833363|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
833364|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833484|NCT02447679|Tegafur|tegafur|mesh-list
833485|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
833486|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
833487|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833488|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833525|NCT02447380|Docetaxel|docetaxel|mesh-list
833526|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833527|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
833528|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
833529|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
833530|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253851|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253852|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2253853|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2253854|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2253855|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2253856|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
834372|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
834373|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
834374|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834375|NCT02444364|Incretins|incretins|mesh-ancestor
834376|NCT02444364|Hormones|hormones|mesh-ancestor
832401|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
832402|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
832403|NCT02451774|Protective Agents|protective agents|mesh-ancestor
832404|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832405|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
832406|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
832407|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
2754510|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2754511|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2754512|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2754513|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2754514|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754515|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2754516|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2754517|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832598|NCT02450968|Dexamethasone|dexamethasone|mesh-list
832599|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
832600|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
832601|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
832602|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832603|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832604|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
832605|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
832606|NCT02450968|Hormones|hormones|mesh-ancestor
832607|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
832608|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
832609|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832673|NCT02450682|Warfarin|warfarin|mesh-list
832674|NCT02450682|Apixaban|apixaban|mesh-list
832675|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
832676|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
832677|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
832678|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
832679|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
832680|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832681|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833014|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
833015|NCT02449187|Metformin|metformin|mesh-list
833016|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
833017|NCT02449187|Calcium|calcium|mesh-list
833018|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
833019|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833020|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
833021|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
833022|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
833023|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
833024|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
833025|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833026|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
833027|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
833028|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253857|NCT00141414|Pregabalin|pregabalin|mesh-list
2253858|NCT00141414|Analgesics|analgesics|mesh-ancestor
2253859|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
2253860|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253861|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253862|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
2253863|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2754518|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
2754519|NCT00690066|Remestemcel-l|remestemcel-l|mesh-list
2754520|NCT00690066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2754521|NCT00690066|Antiviral Agents|antiviral agents|mesh-ancestor
2754522|NCT00690066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2754523|NCT00683722|Remestemcel-l|remestemcel-l|mesh-list
2754524|NCT00683722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2754525|NCT00683722|Antiviral Agents|antiviral agents|mesh-ancestor
2754526|NCT00683722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
834377|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
834378|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
834379|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
834380|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834381|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834875|NCT02442128|Fentanyl|fentanyl|mesh-list
832463|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
832464|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
832465|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
832466|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
832467|NCT02451748|Analgesics|analgesics|mesh-ancestor
832468|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
832469|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832470|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
832471|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
832472|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2253864|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2253865|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253866|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
832682|NCT02450656|Docetaxel|docetaxel|mesh-list
832683|NCT02450656|Afatinib|afatinib|mesh-list
832684|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832685|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
832686|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
832687|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
832688|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832689|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
832690|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833038|NCT02449070|Nicorandil|nicorandil|mesh-list
833039|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
833040|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
833041|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
833042|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
833043|NCT02449070|Vitamins|vitamins|mesh-ancestor
833044|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
833045|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253867|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2253868|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2253869|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2253870|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2253871|NCT00141427|Pregabalin|pregabalin|mesh-list
2253872|NCT00141427|Analgesics|analgesics|mesh-ancestor
2253873|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
2253874|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253875|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253876|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
833507|NCT02447393|Cetirizine|cetirizine|mesh-list
833508|NCT02447393|Levocetirizine|levocetirizine|mesh-list
833509|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
833510|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
833511|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
833512|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
833513|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
833514|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
833515|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833516|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835051|NCT02441673|Ephedrine|ephedrine|mesh-list
835052|NCT02441673|Meperidine|meperidine|mesh-list
835053|NCT02441673|Tramadol|tramadol|mesh-list
835054|NCT02441673|Nefopam|nefopam|mesh-list
835055|NCT02441673|Metoclopramide|metoclopramide|mesh-list
835056|NCT02441673|Ranitidine|ranitidine|mesh-list
835057|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
835058|NCT02441673|Oxytocin|oxytocin|mesh-list
835059|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
835060|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
832506|NCT02451475|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
832507|NCT02451475|Paroxetine|paroxetine|mesh-list
832508|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
832509|NCT02451475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
832510|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
832511|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
832512|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832513|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
832514|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
832515|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832516|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
832517|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
832518|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
832519|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
832520|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
832521|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832522|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
832523|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
832524|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
832525|NCT02451475|Analgesics|analgesics|mesh-ancestor
832526|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
832527|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832528|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
832529|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
832530|NCT02451475|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
832531|NCT02451475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
832532|NCT02451475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
832637|NCT02451098|Atorvastatin|atorvastatin|mesh-list
832638|NCT02451098|Ezetimibe|ezetimibe|mesh-list
832639|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
832640|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
832641|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
832642|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832643|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
832644|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
832645|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832751|NCT02450175|Everolimus|everolimus|mesh-list
832752|NCT02450175|Letrozole|letrozole|mesh-list
832753|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832754|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
832755|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
832756|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832757|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
832758|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
832759|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832760|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832761|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
832762|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
832763|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2253877|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2253878|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2253879|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253880|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2253881|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2253882|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2253883|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2253884|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2253885|NCT00141492|Testosterone|testosterone|mesh-list
2253886|NCT00141492|Androgens|androgens|mesh-ancestor
2253887|NCT00141492|Hormones|hormones|mesh-ancestor
833429|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
833430|NCT02447796|Propofol|propofol|mesh-list
832567|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
832568|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832569|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
832570|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
832571|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
833501|NCT02447406|Docetaxel|docetaxel|mesh-list
833502|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833503|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
833504|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
833505|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
833506|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253888|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2253889|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253890|NCT00141531|Apaziquone|apaziquone|mesh-list
2253891|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253892|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
2253893|NCT00141544|Estrogens|estrogens|mesh-list
2253894|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
2253895|NCT00141544|Estrone|estrone|mesh-list
2253896|NCT00141544|Testosterone|testosterone|mesh-list
2253897|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
2253898|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
2253899|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
834351|NCT02444546|Sargramostim|sargramostim|mesh-list
834352|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
834353|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834422|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
834423|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
834424|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
834425|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834426|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
834427|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
834428|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
834429|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834430|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834431|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
834450|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
834451|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834452|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
834453|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
834454|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
834455|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
834456|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
834457|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
834458|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
834459|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
834460|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
834461|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834462|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
834463|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
834464|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834465|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
834466|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
834467|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
834468|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2098716|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098717|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098718|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253900|NCT00141544|Hormones|hormones|mesh-ancestor
2253901|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2253902|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253903|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2253904|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253905|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
2253906|NCT00141544|Androgens|androgens|mesh-ancestor
2253907|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
2253908|NCT00141557|Estrogens|estrogens|mesh-list
834763|NCT02442531|Docetaxel|docetaxel|mesh-list
834764|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834765|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
834766|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
834767|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
834768|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253909|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
832573|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
832574|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832575|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
832576|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
832577|NCT02450981|Growth Substances|growth substances|mesh-ancestor
832578|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832579|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
2098719|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2098720|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2253910|NCT00141557|Estrone|estrone|mesh-list
2253911|NCT00141557|Testosterone|testosterone|mesh-list
2253912|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
2253913|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
2253914|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2253915|NCT00141557|Hormones|hormones|mesh-ancestor
2253916|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2253917|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253918|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2253919|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253920|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
2253921|NCT00141557|Androgens|androgens|mesh-ancestor
2253922|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
2253923|NCT00141570|Estrogens|estrogens|mesh-list
2253924|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
2253925|NCT00141570|Testosterone|testosterone|mesh-list
2253926|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
2253927|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
2253928|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2253929|NCT00141570|Hormones|hormones|mesh-ancestor
2253930|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2253931|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833277|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
833278|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
833279|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
833280|NCT02448316|Prednisolone|prednisolone|mesh-list
833281|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
833282|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
833283|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
833284|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
833285|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
833286|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
833287|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833288|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833289|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
833290|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
833291|NCT02448316|Hormones|hormones|mesh-ancestor
833292|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
833293|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
833294|NCT02448316|Protective Agents|protective agents|mesh-ancestor
833295|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
833296|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833377|NCT02447757|Remifentanil|remifentanil|mesh-list
833378|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
833379|NCT02447757|Narcotics|narcotics|mesh-ancestor
833380|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
833381|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833382|NCT02447757|Analgesics|analgesics|mesh-ancestor
833383|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
833384|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833522|NCT02447510|Mitogens|mitogens|mesh-list
833523|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
833524|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833699|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
833700|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
833701|NCT02447055|Melphalan|melphalan|mesh-list
833702|NCT02447055|Fludarabine|fludarabine|mesh-list
833703|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
833704|NCT02447055|Tacrolimus|tacrolimus|mesh-list
833705|NCT02447055|Lenograstim|lenograstim|mesh-list
833706|NCT02447055|Sargramostim|sargramostim|mesh-list
833707|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
833708|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
833709|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833710|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
833711|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
833712|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
2253932|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
832671|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
832672|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832764|NCT02450214|Ketamine|ketamine|mesh-list
832765|NCT02450214|Analgesics|analgesics|mesh-ancestor
832766|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
832767|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832768|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832769|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
832770|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
832771|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
832772|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
832773|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
832774|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
832775|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
832776|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
832777|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253933|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253934|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
2253935|NCT00141570|Androgens|androgens|mesh-ancestor
2253936|NCT00141583|Candesartan|candesartan|mesh-list
2253937|NCT00141583|Enalapril|enalapril|mesh-list
2253938|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2253939|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2253940|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2253941|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253942|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2253943|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
2253944|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253945|NCT00141596|Amiloride|amiloride|mesh-list
2253946|NCT00141596|Furosemide|furosemide|mesh-list
2253947|NCT00141596|Diuretics|diuretics|mesh-ancestor
2253948|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
2253949|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253950|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2253951|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2253952|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253953|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2253954|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
833814|NCT02446548|Losartan|losartan|mesh-list
833815|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
833816|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
833817|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
833818|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
833819|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833850|NCT02446236|Rituximab|rituximab|mesh-list
833851|NCT02446236|Lenalidomide|lenalidomide|mesh-list
833852|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
833853|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833854|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
833855|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833856|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
833857|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
833858|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
833859|NCT02446236|Growth Substances|growth substances|mesh-ancestor
833860|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
834220|NCT02445053|Ivacaftor|ivacaftor|mesh-list
834221|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
834222|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
834223|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834558|NCT02443246|Vitamin D|vitamin d|mesh-list
834559|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
834560|NCT02443246|Vitamins|vitamins|mesh-ancestor
834561|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
834562|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834563|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
834564|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
834637|NCT02443142|Acetaminophen|acetaminophen|mesh-list
834638|NCT02443142|Ibuprofen|ibuprofen|mesh-list
834639|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
834640|NCT02443142|Analgesics|analgesics|mesh-ancestor
834641|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
834642|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834643|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834644|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
832750|NCT02450188|Urological Agents|urological agents|mesh-ancestor
832842|NCT02449954|Ketorolac|ketorolac|mesh-list
832843|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
832844|NCT02449954|Morphine|morphine|mesh-list
832845|NCT02449954|Tramadol|tramadol|mesh-list
832846|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
832847|NCT02449954|Narcotics|narcotics|mesh-ancestor
832848|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
832849|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832850|NCT02449954|Analgesics|analgesics|mesh-ancestor
832851|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
832852|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832853|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
832854|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
832855|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
832856|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
832857|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
832858|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832859|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832913|NCT02449564|Sirolimus|sirolimus|mesh-list
832914|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
832915|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
832916|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
832917|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832918|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
832919|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
832920|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
832921|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833262|NCT02448420|Trastuzumab|trastuzumab|mesh-list
833263|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
833264|NCT02448420|Palbociclib|palbociclib|mesh-list
833265|NCT02448420|Antibodies|antibodies|mesh-list
833266|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
833267|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
833268|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833269|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
833270|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833271|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
833272|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833273|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833274|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
833275|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
833276|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
2253955|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2253956|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2253957|NCT00141648|Prednisolone|prednisolone|mesh-list
2253958|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
2253959|NCT00141648|Doxorubicin|doxorubicin|mesh-list
2253960|NCT00141648|Vincristine|vincristine|mesh-list
2253961|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2253962|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
2253963|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253964|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253965|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2253966|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
834333|NCT02444507|Esomeprazole|esomeprazole|mesh-list
834334|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
834335|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
834336|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
834337|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834338|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834553|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
834554|NCT02443285|Cefotaxime|cefotaxime|mesh-list
834555|NCT02443285|Cefoxitin|cefoxitin|mesh-list
834556|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
834557|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
834593|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
834594|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
834595|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
834596|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
834597|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834598|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
834599|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834600|NCT02443194|Analgesics|analgesics|mesh-ancestor
834601|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
834602|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832795|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
832796|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
832797|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832798|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
832799|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
832800|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
832901|NCT02449538|Everolimus|everolimus|mesh-list
832902|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
832903|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
832904|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
832905|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833080|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
833081|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
833082|NCT02449005|Coagulants|coagulants|mesh-ancestor
833659|NCT02446977|Riboflavin|riboflavin|mesh-list
833660|NCT02446977|Vitamins|vitamins|mesh-ancestor
833661|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
833662|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833663|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
833664|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
833665|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
833864|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
833865|NCT02446353|Megestrol|megestrol|mesh-list
833866|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
833867|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833868|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
833869|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
833870|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833871|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
833872|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
833873|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
833874|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
833875|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
833876|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
833877|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
834172|NCT02445404|Dexamethasone|dexamethasone|mesh-list
834173|NCT02445404|Prednisone|prednisone|mesh-list
834174|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
834175|NCT02445404|Ifosfamide|ifosfamide|mesh-list
834176|NCT02445404|Carboplatin|carboplatin|mesh-list
834177|NCT02445404|Etoposide|etoposide|mesh-list
834178|NCT02445404|Vincristine|vincristine|mesh-list
834179|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
834180|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
834181|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834182|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
834183|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
834184|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
834185|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834186|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834187|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
834188|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
834189|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
834190|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
834191|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834192|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
834193|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
834194|NCT02445404|Hormones|hormones|mesh-ancestor
834195|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
834196|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
834197|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834198|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
834199|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
834200|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
834201|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
834202|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
834203|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
834382|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
834383|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
834384|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
834385|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834386|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
834387|NCT02444169|Protective Agents|protective agents|mesh-ancestor
834603|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
834604|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
834605|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
834628|NCT02443012|Nepafenac|nepafenac|mesh-list
834629|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
832826|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
832827|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
832828|NCT02450084|Narcotics|narcotics|mesh-ancestor
832829|NCT02450084|Analgesics|analgesics|mesh-ancestor
832830|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
832831|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
832832|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
2253967|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2253968|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253969|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2253970|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2253971|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2253972|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2253973|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253974|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2253975|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
2253976|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
2253977|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
2253978|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2253979|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
2253980|NCT00141648|Hormones|hormones|mesh-ancestor
2253981|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2253982|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2253983|NCT00141700|Rituximab|rituximab|mesh-list
2253984|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
834630|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
834631|NCT02443012|Analgesics|analgesics|mesh-ancestor
834632|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
834633|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834634|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834635|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
834636|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
834735|NCT02442739|Ketamine|ketamine|mesh-list
834736|NCT02442739|Analgesics|analgesics|mesh-ancestor
834737|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
834738|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834739|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834740|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
834741|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
834742|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
834743|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
834744|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
834745|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
834746|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
834747|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
834748|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834802|NCT02442466|BQ 788|bq 788|mesh-list
834803|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
834804|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
834805|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
834806|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835118|NCT02441803|Cytarabine|cytarabine|mesh-list
835119|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
835120|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
835121|NCT02441803|Busulfan|busulfan|mesh-list
835122|NCT02441803|Fludarabine|fludarabine|mesh-list
835123|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
835124|NCT02441803|Decitabine|decitabine|mesh-list
835125|NCT02441803|Idarubicin|idarubicin|mesh-list
835126|NCT02441803|Clofarabine|clofarabine|mesh-list
835127|NCT02441803|Tacrolimus|tacrolimus|mesh-list
835128|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
835129|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
835130|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
835131|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
835132|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835133|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
835134|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
835135|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
835136|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835137|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835138|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
835139|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
835140|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
835141|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
835142|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
832834|NCT02449941|Pantoprazole|pantoprazole|mesh-list
832835|NCT02449941|Lansoprazole|lansoprazole|mesh-list
832836|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
832837|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
832838|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
832839|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
832840|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
832841|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833413|NCT02447835|Olanzapine|olanzapine|mesh-list
833414|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
833415|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
833416|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833417|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833418|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
833419|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
833420|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
833421|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
833422|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
833423|NCT02447835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
833424|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
833425|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
833426|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833427|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
833428|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
833742|NCT02446652|Paclitaxel|paclitaxel|mesh-list
833743|NCT02446652|Carboplatin|carboplatin|mesh-list
833744|NCT02446652|Hydralazine|hydralazine|mesh-list
833745|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
833746|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833747|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
833748|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
833749|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
833750|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833751|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
833752|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
833887|NCT02446457|Rituximab|rituximab|mesh-list
833888|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
833889|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
833890|NCT02446457|Lenalidomide|lenalidomide|mesh-list
833891|NCT02446457|Antibodies|antibodies|mesh-list
833892|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
833893|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
833894|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
833895|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833896|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833897|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
833898|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
833899|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
833900|NCT02446457|Growth Substances|growth substances|mesh-ancestor
833901|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
2253985|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2253986|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
2253987|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834247|NCT02444767|Bimatoprost|bimatoprost|mesh-list
834248|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
834480|NCT02443818|Sirolimus|sirolimus|mesh-list
834481|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
834482|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
834483|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
834484|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834485|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
834486|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
834487|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
834488|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834546|NCT02443545|Deferiprone|deferiprone|mesh-list
834547|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
834548|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
834549|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
834550|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834645|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
834646|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
834647|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
834648|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
834649|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834650|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834681|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
834682|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
832873|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
832874|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
832875|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
832876|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
832877|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
832878|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2253988|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253989|NCT00141713|Etanercept|etanercept|mesh-list
2253990|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2253991|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2253992|NCT00141713|Analgesics|analgesics|mesh-ancestor
2253993|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
2253994|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2253995|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2253996|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2253997|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2253998|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2253999|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2254000|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
2254001|NCT00141791|Etanercept|etanercept|mesh-list
2254002|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2254003|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2254004|NCT00141791|Analgesics|analgesics|mesh-ancestor
2254005|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
2254006|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254007|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254008|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
833861|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
833862|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
833863|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834050|NCT02446093|Valacyclovir|valacyclovir|mesh-list
834051|NCT02446093|Antiviral Agents|antiviral agents|mesh-ancestor
834052|NCT02446093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
834056|NCT02445547|Hormones|hormones|mesh-list
834057|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
834058|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834339|NCT02445391|Cisplatin|cisplatin|mesh-list
834340|NCT02445391|Carboplatin|carboplatin|mesh-list
834341|NCT02445391|Capecitabine|capecitabine|mesh-list
834342|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834343|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
834344|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
834345|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834683|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
834684|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
834685|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834686|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
834687|NCT02442713|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
834688|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
834689|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
834690|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834691|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
834692|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
834693|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
834694|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
834695|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
834696|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
834697|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834698|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
835143|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
835144|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835145|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
835146|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
835147|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
835148|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
835149|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
835150|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
835166|NCT02441088|Octreotide|octreotide|mesh-list
835167|NCT02441088|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
835168|NCT02441088|Edotreotide|edotreotide|mesh-list
835552|NCT02439190|Aspirin|aspirin|mesh-list
2254009|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2254010|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
832908|NCT02449746|Antibodies|antibodies|mesh-list
832909|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
832910|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
832911|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
832912|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254011|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2254012|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
2254013|NCT00141804|Sirolimus|sirolimus|mesh-list
2254014|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2254015|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254016|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2254017|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254018|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
2254019|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2254020|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
833373|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
833374|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
833375|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833376|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
833931|NCT02446301|Nalbuphine|nalbuphine|mesh-list
833932|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
833933|NCT02446301|Narcotics|narcotics|mesh-ancestor
833934|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
833935|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833936|NCT02446301|Analgesics|analgesics|mesh-ancestor
833937|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
833938|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834489|NCT02443727|Oxytocin|oxytocin|mesh-list
834490|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
834491|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
834492|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834709|NCT02442674|Tolvaptan|tolvaptan|mesh-list
834710|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
834711|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834712|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
834713|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098721|NCT02348008|Bevacizumab|bevacizumab|mesh-list
2098722|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
2098723|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2098724|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098725|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2254021|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254022|NCT00141830|Methotrexate|methotrexate|mesh-list
2254023|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2254024|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
2254025|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2254026|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254027|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2254028|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
2254029|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254030|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254031|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
2254032|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254033|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2254034|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
835116|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
835117|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
835151|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
835152|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
835153|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
835154|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835155|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
835156|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
835157|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
835158|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835159|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835160|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2254035|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
2254036|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2254037|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
835290|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
835291|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
835313|NCT02440230|Anastrozole|anastrozole|mesh-list
835314|NCT02440230|Exemestane|exemestane|mesh-list
835315|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2254038|NCT00141843|Factor VIII|factor viii|mesh-list
832996|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
832997|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
832998|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
832999|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833000|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
833001|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
833002|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
833003|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
833004|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833005|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
833006|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
833007|NCT02449265|Hormones|hormones|mesh-ancestor
833008|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
833009|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
833010|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
833011|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
833012|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
833013|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
833237|NCT02448290|Docetaxel|docetaxel|mesh-list
833238|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833239|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
833240|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
833241|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
833242|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833326|NCT02448069|Argatroban|argatroban|mesh-list
833327|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
833328|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
833329|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
833330|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833331|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833332|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
833333|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2254039|NCT00141843|Coagulants|coagulants|mesh-ancestor
2254040|NCT00141882|Memantine|memantine|mesh-list
2254041|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2254042|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2254043|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
2254044|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
833957|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
833958|NCT02445989|NuvaRing|nuvaring|mesh-list
833959|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
833960|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833961|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
834233|NCT02444949|Cisplatin|cisplatin|mesh-list
834234|NCT02444949|Endostar protein|endostar protein|mesh-list
834235|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834236|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
834237|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
834238|NCT02444949|Growth Substances|growth substances|mesh-ancestor
834239|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834240|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
834531|NCT02443922|Metformin|metformin|mesh-list
834532|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
834533|NCT02443922|Glimepiride|glimepiride|mesh-list
834534|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
834535|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834536|NCT02443922|Incretins|incretins|mesh-ancestor
834537|NCT02443922|Hormones|hormones|mesh-ancestor
834538|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
834539|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
834540|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
834541|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834542|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834543|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
834544|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
834545|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
2254045|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254046|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254047|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
834729|NCT02442648|Rituximab|rituximab|mesh-list
834730|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
834731|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834732|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
834733|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834807|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
833074|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
833075|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
833076|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
833407|NCT02447705|Telbivudine|telbivudine|mesh-list
833408|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
833409|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
833410|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
833411|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833412|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834108|NCT02445599|Dipyrone|dipyrone|mesh-list
834109|NCT02445599|Diclofenac|diclofenac|mesh-list
834110|NCT02445599|Atropine|atropine|mesh-list
834111|NCT02445599|Fentanyl|fentanyl|mesh-list
834112|NCT02445599|Midazolam|midazolam|mesh-list
834113|NCT02445599|Tramadol|tramadol|mesh-list
834114|NCT02445599|Nalbuphine|nalbuphine|mesh-list
834115|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
834116|NCT02445599|Narcotics|narcotics|mesh-ancestor
834117|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
834118|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834119|NCT02445599|Analgesics|analgesics|mesh-ancestor
834120|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
834121|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834122|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
834123|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
834124|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
834125|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
834126|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
834127|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
834128|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
834129|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
834130|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
834131|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
834132|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
834133|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834134|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
834135|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
834136|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
834137|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
834138|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
834139|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834140|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
834141|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
834142|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
834143|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
834144|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
834145|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
834146|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
834147|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
834148|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
834149|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
834150|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
834249|NCT02444897|Fentanyl|fentanyl|mesh-list
834250|NCT02444897|Nefopam|nefopam|mesh-list
834251|NCT02444897|Ramosetron|ramosetron|mesh-list
834252|NCT02444897|Ropivacaine|ropivacaine|mesh-list
834253|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
834254|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
834255|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
834256|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834257|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
834258|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834259|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
834260|NCT02444897|Narcotics|narcotics|mesh-ancestor
834261|NCT02444897|Analgesics|analgesics|mesh-ancestor
834262|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
834263|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
834264|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
834265|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
834266|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
834267|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
834268|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
834269|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
834270|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
834271|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834272|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
834446|NCT02444260|Lidocaine|lidocaine|mesh-list
834447|NCT02444260|Midazolam|midazolam|mesh-list
834448|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
834449|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2254048|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2254049|NCT00141895|Misoprostol|misoprostol|mesh-list
2254050|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2254051|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
2254052|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2254053|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254054|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2254055|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2254056|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
2254057|NCT00141908|Castor Oil|castor oil|mesh-list
833367|NCT02447939|Trametinib|trametinib|mesh-list
833368|NCT02447939|Dabrafenib|dabrafenib|mesh-list
833369|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833370|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
833371|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833372|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254058|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2254059|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2254060|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2254061|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
2254062|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2254063|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254064|NCT00141908|Progestins|progestins|mesh-ancestor
2254065|NCT00141908|Hormones|hormones|mesh-ancestor
2254066|NCT00141908|Cathartics|cathartics|mesh-ancestor
2254067|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2254068|NCT00141947|Bexarotene|bexarotene|mesh-list
2254069|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254070|NCT00141960|Famotidine|famotidine|mesh-list
2254071|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2254072|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
834565|NCT02443311|Betamethasone|betamethasone|mesh-list
834566|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
834567|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
834568|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
834569|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
834570|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
834571|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
834572|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
834573|NCT02443311|Hormones|hormones|mesh-ancestor
834574|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
834575|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834576|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
834577|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
834578|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
834579|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
834580|NCT02443311|Analgesics|analgesics|mesh-ancestor
834581|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
834582|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834583|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
834584|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
834585|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
834586|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
834587|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
834588|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834589|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834734|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2254073|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2254074|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
2254075|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
2254076|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254077|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254078|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254079|NCT00141986|Vitamin D|vitamin d|mesh-list
2254080|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
2254081|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
2254082|NCT00141986|Vitamins|vitamins|mesh-list
2254083|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
2254084|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254085|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2254086|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
835086|NCT02441465|Vemurafenib|vemurafenib|mesh-list
835087|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835088|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
835089|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254087|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
2254088|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
833320|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833385|NCT02447809|Aspirin|aspirin|mesh-list
833386|NCT02447809|Clopidogrel|clopidogrel|mesh-list
833387|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
833388|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
833389|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
833390|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
833391|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
833392|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
833393|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833394|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833395|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
833396|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
833397|NCT02447809|Analgesics|analgesics|mesh-ancestor
833398|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
833399|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833400|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
833401|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
833402|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
833403|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
833404|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
833405|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833406|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
2254089|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2254090|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2254091|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
833967|NCT02446028|Insulin Lispro|insulin lispro|mesh-list
833968|NCT02446028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
833969|NCT02446028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834059|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
834060|NCT02445716|Testosterone|testosterone|mesh-list
834061|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
834062|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
834063|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
834064|NCT02445716|Androgens|androgens|mesh-ancestor
834065|NCT02445716|Hormones|hormones|mesh-ancestor
834066|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
834067|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834068|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
834069|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834070|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
834282|NCT02444585|Denosumab|denosumab|mesh-list
834283|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
834284|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834762|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834867|NCT02442427|Palivizumab|palivizumab|mesh-list
834868|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
834869|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
835161|NCT02441075|Ethanol|ethanol|mesh-list
835162|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
835163|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
835164|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
835165|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835228|NCT02440880|Dexamethasone|dexamethasone|mesh-list
835229|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
835230|NCT02440880|BB 1101|bb 1101|mesh-list
835231|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
835232|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
835233|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
835234|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835235|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835236|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
835237|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
835238|NCT02440880|Hormones|hormones|mesh-ancestor
835239|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
835240|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
835241|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835242|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
835243|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835244|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835280|NCT02440581|Alendronate|alendronate|mesh-list
835281|NCT02440581|Teriparatide|teriparatide|mesh-list
835282|NCT02440581|Cinacalcet|cinacalcet|mesh-list
835283|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2254092|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833590|NCT02447315|Pilocarpine|pilocarpine|mesh-list
833591|NCT02447315|Miotics|miotics|mesh-ancestor
833592|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
833593|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833594|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833595|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
833596|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
833597|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
833598|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
833599|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834213|NCT02445066|Vitamin D|vitamin d|mesh-list
834214|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
834215|NCT02445066|Vitamins|vitamins|mesh-ancestor
834216|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
834217|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834218|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
834219|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2254093|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2254094|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
834779|NCT02442440|Anisodamine|anisodamine|mesh-list
834780|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
834781|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
834782|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
834783|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
834784|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834785|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834786|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
834787|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
834788|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
834789|NCT02442440|Analgesics|analgesics|mesh-ancestor
834790|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
834791|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834792|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
834793|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
834794|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
834795|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
834796|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
834797|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
834798|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
834799|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
834800|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
834801|NCT02442440|Protective Agents|protective agents|mesh-ancestor
2254095|NCT00142038|Docetaxel|docetaxel|mesh-list
2254096|NCT00142038|Capecitabine|capecitabine|mesh-list
2254097|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254098|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
2254099|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
835169|NCT02441088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
835170|NCT02441088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
835171|NCT02441088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835172|NCT02441088|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
835173|NCT02441088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835174|NCT02441088|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
835175|NCT02441088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2254100|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
2254101|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254102|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2254103|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
2254104|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
2254105|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2254106|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
2254107|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254108|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254109|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2254110|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
2254111|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2254112|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
2254113|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254114|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254115|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2254116|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
2254117|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
2254118|NCT00142051|Protective Agents|protective agents|mesh-ancestor
2254119|NCT00142129|Bortezomib|bortezomib|mesh-list
833431|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
833432|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
833433|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
833434|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
833435|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
833436|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
833437|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
833438|NCT02447796|Analgesics|analgesics|mesh-ancestor
833439|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
833440|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833441|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
833442|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
833443|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
833444|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
833445|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
833446|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833517|NCT02447419|Gefitinib|gefitinib|mesh-list
833518|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833519|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
833520|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833521|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834092|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
834093|NCT02445508|Sevelamer|sevelamer|mesh-list
834094|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
834095|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
834096|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834097|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
834098|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
834273|NCT02444637|Rivastigmine|rivastigmine|mesh-list
834274|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
834275|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834276|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834277|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
834278|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
834279|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834280|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
834281|NCT02444637|Protective Agents|protective agents|mesh-ancestor
834388|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
834389|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
834390|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
834391|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
834392|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
834393|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834394|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
834395|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
834396|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834397|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
834398|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834610|NCT02443064|Vancomycin|vancomycin|mesh-list
834611|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
834612|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
834668|NCT02442791|Exenatide|exenatide|mesh-list
834669|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
834670|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834671|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
834672|NCT02442791|Incretins|incretins|mesh-ancestor
834673|NCT02442791|Hormones|hormones|mesh-ancestor
834674|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
834808|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
834809|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
834810|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
834811|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834812|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834813|NCT02442492|Urological Agents|urological agents|mesh-ancestor
834859|NCT02442063|Paclitaxel|paclitaxel|mesh-list
834860|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
834861|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
834862|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834863|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
834864|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
834865|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
834866|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834910|NCT02441907|Aflibercept|aflibercept|mesh-list
834911|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2254120|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254121|NCT00142155|Rituximab|rituximab|mesh-list
2254122|NCT00142155|Antibodies|antibodies|mesh-list
2254123|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2254124|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
833733|NCT02446730|Clopidogrel|clopidogrel|mesh-list
833734|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
833735|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
833736|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
833737|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
833738|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
833739|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
833740|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833741|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254125|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254126|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2254127|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254128|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2254129|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
2254130|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
834476|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
834477|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
834478|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
834479|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098726|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2098727|NCT02348008|Growth Substances|growth substances|mesh-ancestor
2254131|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254132|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
2254133|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
2254134|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2254135|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
2254136|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2254137|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2254138|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254139|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2254140|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254141|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254142|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2254143|NCT00142207|Renal Agents|renal agents|mesh-ancestor
2254144|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
2254145|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2254146|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2254147|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254148|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254149|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254150|NCT00142246|Amodiaquine|amodiaquine|mesh-list
2254151|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
835310|NCT02440347|Anesthetics|anesthetics|mesh-list
835311|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
835312|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835340|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
835341|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
835342|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
835343|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
835344|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
835345|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
835346|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835347|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098728|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098729|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
2098730|NCT02348203|Aspirin|aspirin|mesh-list
2098731|NCT02348203|Zileuton|zileuton|mesh-list
2098732|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2098733|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2098734|NCT02348203|Analgesics|analgesics|mesh-ancestor
2098735|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
2254152|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
833481|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
833482|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
833483|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254153|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2254154|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254155|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
2254156|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2254157|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254158|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2254159|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2254160|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254161|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254162|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254163|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2254164|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2254165|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
2254166|NCT00142285|Astringents|astringents|mesh-ancestor
2254167|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254168|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
2254169|NCT00142324|Donepezil|donepezil|mesh-list
2254170|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2254171|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254172|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254173|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
2254174|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254175|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254176|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
2254177|NCT00142337|Zidovudine|zidovudine|mesh-list
2254178|NCT00142337|Didanosine|didanosine|mesh-list
2254179|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
2254180|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254181|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
834876|NCT02442128|Propofol|propofol|mesh-list
834877|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
834878|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
834879|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834880|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
834881|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
834882|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
834883|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
834884|NCT02442128|Narcotics|narcotics|mesh-ancestor
834885|NCT02442128|Analgesics|analgesics|mesh-ancestor
834886|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
834887|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834888|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
834889|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
834890|NCT02442180|Prednisolone|prednisolone|mesh-list
834891|NCT02442180|Lenograstim|lenograstim|mesh-list
834892|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
834893|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
834894|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834895|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
834896|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
834897|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
834898|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834899|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
834900|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
834901|NCT02442180|Hormones|hormones|mesh-ancestor
834902|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
834903|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
834904|NCT02442180|Protective Agents|protective agents|mesh-ancestor
834905|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
834906|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834995|NCT02441660|Capsaicin|capsaicin|mesh-list
834996|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
834997|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
834998|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
834999|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835000|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835034|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
835035|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
835036|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
835037|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835038|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
835039|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
835040|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
833553|NCT02447276|Fasinumab|fasinumab|mesh-list
833554|NCT02447276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
833555|NCT02447276|Analgesics|analgesics|mesh-ancestor
833556|NCT02447276|Sensory System Agents|sensory system agents|mesh-ancestor
833557|NCT02447276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
833558|NCT02447276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834496|NCT02443844|Tamsulosin|tamsulosin|mesh-list
834497|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
834498|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
834499|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
834500|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
834501|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
834502|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834503|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834504|NCT02443844|Urological Agents|urological agents|mesh-ancestor
834907|NCT02441933|Carboplatin|carboplatin|mesh-list
834908|NCT02441933|Taxane|taxane|mesh-list
834909|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834950|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
834951|NCT02441894|Promethazine|promethazine|mesh-list
834952|NCT02441894|Dexamethasone|dexamethasone|mesh-list
834953|NCT02441894|Prednisolone|prednisolone|mesh-list
834954|NCT02441894|Ondansetron|ondansetron|mesh-list
834955|NCT02441894|Metoclopramide|metoclopramide|mesh-list
834956|NCT02441894|Granisetron|granisetron|mesh-list
834957|NCT02441894|Ranitidine|ranitidine|mesh-list
834958|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
834959|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
834960|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
834961|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
834962|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834963|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834964|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
834965|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
834966|NCT02441894|Hormones|hormones|mesh-ancestor
834967|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
834968|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
834969|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834970|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
834971|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
834972|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
834973|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
834974|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
834975|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834976|NCT02441894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
834977|NCT02441894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
834978|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
834979|NCT02441894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
834980|NCT02441894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
834981|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
834982|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
834983|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
834984|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
834985|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
834986|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
834987|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
834988|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
834989|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
834990|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
834991|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
834992|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
834993|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
834994|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
835091|NCT02441439|Iron|iron|mesh-list
835092|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
835093|NCT02441439|Trace Elements|trace elements|mesh-ancestor
835094|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
835095|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835096|NCT02441439|Hematinics|hematinics|mesh-ancestor
835214|NCT02440750|Dienogest|dienogest|mesh-list
835215|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
835216|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
835217|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
835218|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
835219|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835220|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
835221|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
835222|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
833713|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833714|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833715|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
833716|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
833717|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
833718|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
833719|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
833720|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833721|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
833722|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
833723|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
833724|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
833725|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098736|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098737|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098738|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2098739|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2098740|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2098741|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2098742|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098743|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2098744|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2098745|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098746|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
2098747|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2098748|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2098749|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
2098750|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2098751|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
2098752|NCT02348216|Fludarabine|fludarabine|mesh-list
2098753|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2098754|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
2098755|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098756|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2098757|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2098758|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
2098759|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098760|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098761|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2254182|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2254183|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834912|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
834913|NCT02441907|Growth Substances|growth substances|mesh-ancestor
834914|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834915|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
834916|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835097|NCT02441530|Vitamin D|vitamin d|mesh-list
835098|NCT02441530|Vitamins|vitamins|mesh-list
835099|NCT02441530|Vitamin E|vitamin e|mesh-list
835100|NCT02441530|Ibuprofen|ibuprofen|mesh-list
835101|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
835102|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835103|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
835104|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
835105|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
835106|NCT02441530|Analgesics|analgesics|mesh-ancestor
835107|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
835108|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835109|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
835110|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
835111|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
835112|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835113|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835114|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
835115|NCT02441530|Protective Agents|protective agents|mesh-ancestor
2254184|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
2254185|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254186|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2254187|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2254188|NCT00142350|Fluorouracil|fluorouracil|mesh-list
2254189|NCT00142350|Irinotecan|irinotecan|mesh-list
2254190|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254191|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
2254192|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833728|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
833729|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
833730|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
833731|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833732|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254193|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2254194|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2254195|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
834083|NCT02445703|Vaccines|vaccines|mesh-list
834084|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
834085|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254196|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254197|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2254198|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2254199|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254200|NCT00142402|Modafinil|modafinil|mesh-list
2254201|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2254202|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254203|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2254204|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2254205|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2254206|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254207|NCT00142428|Cetuximab|cetuximab|mesh-list
2254208|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2254209|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254210|NCT00142467|Gemcitabine|gemcitabine|mesh-list
2254211|NCT00142467|Bevacizumab|bevacizumab|mesh-list
2254212|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
2254213|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2254214|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835223|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
835224|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
835225|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
835226|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
835227|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835316|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835317|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
835318|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
835319|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835320|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835321|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
835322|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
835323|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
835324|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835348|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
835349|NCT02440256|Narcotics|narcotics|mesh-ancestor
835350|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
835351|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835352|NCT02440256|Analgesics|analgesics|mesh-ancestor
835353|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
835354|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254215|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2254216|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2254217|NCT00142467|Growth Substances|growth substances|mesh-ancestor
2254218|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254219|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
2254220|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2254221|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
2254222|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254223|NCT00142467|Antiviral Agents|antiviral agents|mesh-ancestor
2254224|NCT00142467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
835430|NCT02440100|Midazolam|midazolam|mesh-list
835431|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
835432|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
835433|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
835434|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835435|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
835436|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
835437|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
833950|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
833951|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
833952|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
833953|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833954|NCT02446002|Analgesics|analgesics|mesh-ancestor
833955|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
833956|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
2254225|NCT00142467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254226|NCT00142467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2254227|NCT00142467|Immunologic Factors|immunologic factors|mesh-ancestor
2254228|NCT00142480|Bevacizumab|bevacizumab|mesh-list
2254229|NCT00142480|Capecitabine|capecitabine|mesh-list
2254230|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
2254231|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
834515|NCT02443714|Insulin|insulin|mesh-list
834516|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
834517|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
834518|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
834519|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834660|NCT02442921|Colchicine|colchicine|mesh-list
834661|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
834662|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
834663|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
834664|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
834665|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
834666|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834667|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834917|NCT02441842|Atenolol|atenolol|mesh-list
834918|NCT02441842|Lisinopril|lisinopril|mesh-list
834919|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
834920|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
834921|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834922|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834923|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
834924|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
834925|NCT02441842|Protective Agents|protective agents|mesh-ancestor
834926|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834927|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
834928|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
834929|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
834930|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834931|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
834932|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
834933|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
834934|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
834935|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
835041|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835042|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835043|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2254232|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254233|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2254234|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2254235|NCT00142480|Growth Substances|growth substances|mesh-ancestor
2254236|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254237|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
2254238|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2254239|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
2254240|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835245|NCT02440958|Folfirinox|folfirinox|mesh-list
835246|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835247|NCT02440841|Itraconazole|itraconazole|mesh-list
835248|NCT02440841|Rifampin|rifampin|mesh-list
835249|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
835250|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
835251|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
835252|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
835253|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835254|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835255|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
835256|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
835257|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
835258|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835259|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
835260|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
835261|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
834027|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834028|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834029|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
834030|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
834031|NCT02445872|Hormones|hormones|mesh-ancestor
834032|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
834033|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
834034|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834035|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
834036|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
834037|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834038|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
834039|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
834040|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
2254241|NCT00142493|Midazolam|midazolam|mesh-list
2254242|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
2254243|NCT00142493|Thiopental|thiopental|mesh-list
2254244|NCT00142493|Propofol|propofol|mesh-list
2254245|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2254246|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2254247|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254248|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2254249|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
834346|NCT02444572|Enoxaparin|enoxaparin|mesh-list
834347|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
834348|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
834349|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
834350|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254250|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
2254251|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2254252|NCT00142493|Analgesics|analgesics|mesh-ancestor
2254253|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
2254254|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254255|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2254256|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
834774|NCT02442453|Turmeric extract|turmeric extract|mesh-list
834775|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
834776|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834777|NCT02442453|Protective Agents|protective agents|mesh-ancestor
834778|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835015|NCT02441686|Dexamethasone|dexamethasone|mesh-list
835016|NCT02441686|Lenalidomide|lenalidomide|mesh-list
835017|NCT02441686|Bortezomib|bortezomib|mesh-list
835018|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
835019|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
835020|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
835021|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835022|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835023|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
835024|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
835025|NCT02441686|Hormones|hormones|mesh-ancestor
835026|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
835027|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
835028|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835029|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
835030|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
835031|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
835032|NCT02441686|Growth Substances|growth substances|mesh-ancestor
835033|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
835061|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835062|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
835063|NCT02441673|Narcotics|narcotics|mesh-ancestor
835064|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
835065|NCT02441673|Analgesics|analgesics|mesh-ancestor
835066|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
835067|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835068|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
835069|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
835070|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
835071|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
835072|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
835073|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
835074|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
835075|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835289|NCT02440828|Tobramycin|tobramycin|mesh-list
834054|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
834055|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
834699|NCT02442817|Linagliptin|linagliptin|mesh-list
834700|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
834701|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834702|NCT02442817|Incretins|incretins|mesh-ancestor
834703|NCT02442817|Hormones|hormones|mesh-ancestor
834704|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
834705|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
834706|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
834707|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834708|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835076|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
835077|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
835078|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
835079|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
835080|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
835081|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
835082|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
835083|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
835084|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
835085|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
835262|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
835263|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
835264|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
835265|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
835266|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
835267|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
835268|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
835269|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
835270|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
835325|NCT02440243|Vaccines|vaccines|mesh-list
835326|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
835327|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098762|NCT02348359|Bevacizumab|bevacizumab|mesh-list
2098763|NCT02348359|Ranibizumab|ranibizumab|mesh-list
2098764|NCT02348359|Aflibercept|aflibercept|mesh-list
2254257|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2254258|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
2254259|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254260|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254261|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2254262|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2254263|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2254264|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2254265|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
2254266|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
2254267|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
2254268|NCT00142545|Apomorphine|apomorphine|mesh-list
2254269|NCT00142545|Emetics|emetics|mesh-ancestor
835398|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
835399|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
835400|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
835401|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835402|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
835403|NCT02439905|Analgesics|analgesics|mesh-ancestor
835404|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
835405|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835406|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
835407|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
835408|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
835409|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
835410|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
835411|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835412|NCT02439944|Nicotine|nicotine|mesh-list
835413|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
835414|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
835415|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835416|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835417|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
835418|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
835419|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
835420|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
835421|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835601|NCT02439385|Curcumin|curcumin|mesh-list
834293|NCT02444728|Azathioprine|azathioprine|mesh-list
834294|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
834295|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
834296|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834297|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
834298|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
834299|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
834300|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834301|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
834302|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
834303|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
834304|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
834305|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
834306|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
834307|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
834308|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
834309|NCT02444728|Hormones|hormones|mesh-ancestor
834310|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
834311|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
834312|NCT02444728|Protective Agents|protective agents|mesh-ancestor
834313|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
834314|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
834315|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
834316|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
834317|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
834318|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
834319|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
834505|NCT02444013|Folic Acid|folic acid|mesh-list
834506|NCT02444013|Uric Acid|uric acid|mesh-list
834507|NCT02444013|Hematinics|hematinics|mesh-ancestor
834508|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
834509|NCT02444013|Vitamins|vitamins|mesh-ancestor
834510|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
834511|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
834512|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
834513|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834514|NCT02444013|Protective Agents|protective agents|mesh-ancestor
2254270|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254271|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
2254272|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254273|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2254274|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
2254275|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
2254276|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254277|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254278|NCT00142558|Indomethacin|indomethacin|mesh-list
2254279|NCT00142558|Etoricoxib|etoricoxib|mesh-list
2254280|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254281|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254282|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254283|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
835044|NCT02441816|Aflibercept|aflibercept|mesh-list
835045|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
835046|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
835047|NCT02441816|Growth Substances|growth substances|mesh-ancestor
835048|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835049|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
835050|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835090|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835284|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835285|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
835286|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
835287|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
835288|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
835328|NCT02440399|Acetaminophen|acetaminophen|mesh-list
835329|NCT02440399|Diclofenac|diclofenac|mesh-list
835330|NCT02440399|Morphine|morphine|mesh-list
835331|NCT02440399|Oxycodone|oxycodone|mesh-list
835332|NCT02440399|Tramadol|tramadol|mesh-list
835333|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
835334|NCT02440399|Narcotics|narcotics|mesh-ancestor
835335|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
835336|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835337|NCT02440399|Analgesics|analgesics|mesh-ancestor
835338|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
835339|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831295|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
831312|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
831313|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
831314|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
831315|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
831316|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254284|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2254285|NCT00142558|Analgesics|analgesics|mesh-ancestor
2254286|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
2254287|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2254288|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2254289|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
2254290|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
2254291|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2254292|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2254293|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254294|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2254295|NCT00142571|Gemcitabine|gemcitabine|mesh-list
2254296|NCT00142571|Docetaxel|docetaxel|mesh-list
2254297|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
832125|NCT02452437|Oxycodone|oxycodone|mesh-list
832126|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
832127|NCT02452437|Narcotics|narcotics|mesh-ancestor
832128|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
832129|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
832130|NCT02452437|Analgesics|analgesics|mesh-ancestor
832131|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
832132|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254298|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
2254299|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254300|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833334|NCT02448082|Ichthammol|ichthammol|mesh-list
833335|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
833666|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
833667|NCT02447094|Plasminogen|plasminogen|mesh-list
833668|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
833669|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
833670|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
833962|NCT02445976|Seviteronel|seviteronel|mesh-list
833963|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
833964|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
833965|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
833966|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834224|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
834225|NCT02445352|Ezetimibe|ezetimibe|mesh-list
834226|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
834227|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
834228|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
834229|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
834230|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
834231|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
834232|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835521|NCT02439658|Sotalol|sotalol|mesh-list
835522|NCT02439658|Dofetilide|dofetilide|mesh-list
835523|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
835524|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
835525|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
835526|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
835527|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835528|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835529|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
835530|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
835531|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
835532|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835533|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
835534|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
835619|NCT02439034|Acetaminophen|acetaminophen|mesh-list
835620|NCT02439034|Ketoprofen|ketoprofen|mesh-list
835621|NCT02439034|Codeine|codeine|mesh-list
835622|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
835623|NCT02439034|Analgesics|analgesics|mesh-ancestor
835624|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
2254301|NCT00142571|Antiviral Agents|antiviral agents|mesh-ancestor
835438|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
835439|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
835440|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
835441|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
835442|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
835443|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
835444|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836070|NCT02437032|Menotropins|menotropins|mesh-list
836071|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
836072|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
836073|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
836074|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836502|NCT02435563|Ritonavir|ritonavir|mesh-list
836503|NCT02435563|Ticagrelor|ticagrelor|mesh-list
836504|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
836505|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
836506|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
836507|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836508|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836509|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
836510|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
836511|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
836512|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
836513|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
836514|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
836515|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
836516|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
836517|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
836518|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
836519|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
836520|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836521|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254302|NCT00142571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254303|NCT00142571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254304|NCT00142571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
836875|NCT02433652|Vaccines|vaccines|mesh-list
836876|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
836877|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836975|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
836976|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
836977|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
836978|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
836979|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836980|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836981|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836982|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
836983|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
836984|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2254305|NCT00142571|Immunologic Factors|immunologic factors|mesh-ancestor
2254306|NCT00142571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254307|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
2254308|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
2254309|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
2254310|NCT00142584|Metoprolol|metoprolol|mesh-list
837156|NCT02432612|Nabiximols|nabiximols|mesh-list
837157|NCT02432612|Analgesics|analgesics|mesh-ancestor
837158|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
837159|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
837160|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254311|NCT00142584|Nebivolol|nebivolol|mesh-list
2254312|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2254313|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2254314|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
2254315|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
2254316|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254317|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837659|NCT02431208|Dexamethasone|dexamethasone|mesh-list
837660|NCT02431208|Lenalidomide|lenalidomide|mesh-list
837661|NCT02431208|Atezolizumab|atezolizumab|mesh-list
837662|NCT02431208|Pomalidomide|pomalidomide|mesh-list
837663|NCT02431208|Daratumumab|daratumumab|mesh-list
837664|NCT02431208|Antibodies|antibodies|mesh-list
837665|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
837666|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
837667|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837668|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2254318|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2254319|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2254320|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2254321|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
2098765|NCT02348359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2098766|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098767|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
835826|NCT02438007|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
835827|NCT02438007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835828|NCT02438007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836297|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
836298|NCT02436395|Povidone|povidone|mesh-list
836299|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
836300|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
836301|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
836302|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254322|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254323|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254324|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
2254325|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2254326|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2254327|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2254328|NCT00142610|Vitamins|vitamins|mesh-list
2254329|NCT00142610|Vitamin E|vitamin e|mesh-list
2254330|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
2254331|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254332|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
2254333|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254334|NCT00142610|Protective Agents|protective agents|mesh-ancestor
2254335|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
2254336|NCT00142727|Methadone|methadone|mesh-list
2254337|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
2254338|NCT00142727|Narcotics|narcotics|mesh-ancestor
2254339|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2254340|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254341|NCT00142727|Analgesics|analgesics|mesh-ancestor
2254342|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
2254343|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254344|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
2254345|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
2254346|NCT00142779|Fluoxetine|fluoxetine|mesh-list
2254347|NCT00142779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2098768|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2098769|NCT02348359|Growth Substances|growth substances|mesh-ancestor
2098770|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098771|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
2254348|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
837723|NCT02430545|Rifampin|rifampin|mesh-list
837724|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
837725|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
837726|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
837727|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837728|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
837729|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
837730|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837731|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837732|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
837733|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
837734|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
837735|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
837736|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
837737|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
837759|NCT02430298|Melatonin|melatonin|mesh-list
837760|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
837761|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837762|NCT02430298|Protective Agents|protective agents|mesh-ancestor
837763|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837764|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
837831|NCT02429973|Gemcitabine|gemcitabine|mesh-list
837832|NCT02429973|Sirolimus|sirolimus|mesh-list
837833|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
837834|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
837939|NCT02429817|Edetic Acid|edetic acid|mesh-list
835453|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
835454|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
835455|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
835456|NCT02439866|Prednisolone|prednisolone|mesh-list
835457|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
835458|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
835459|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
835460|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
835461|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
835462|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
835463|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835464|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835465|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
835466|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
835467|NCT02439866|Hormones|hormones|mesh-ancestor
835468|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
835469|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
835470|NCT02439866|Protective Agents|protective agents|mesh-ancestor
835471|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
835472|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254349|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2254350|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254351|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254352|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
2254353|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254354|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2254355|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
2254356|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2254357|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2254358|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2254359|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254360|NCT00142844|Naltrexone|naltrexone|mesh-list
2254361|NCT00142844|Disulfiram|disulfiram|mesh-list
2254362|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2254363|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2254364|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836212|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
836213|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
836214|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
836215|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
836216|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
836217|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836218|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836219|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836694|NCT02434744|Metformin|metformin|mesh-list
836695|NCT02434744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
836696|NCT02434744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836804|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836805|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836806|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2254365|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
2254366|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254367|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2254368|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254369|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254370|NCT00142870|Bupropion|bupropion|mesh-list
836911|NCT02433535|Simvastatin|simvastatin|mesh-list
835473|NCT02440009|Itraconazole|itraconazole|mesh-list
835474|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
835475|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
835476|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
835477|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
835478|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
835479|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835480|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835481|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
835482|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
835483|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
835484|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835485|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
835486|NCT02440009|Hormones|hormones|mesh-ancestor
835639|NCT02439125|Eltoprazine|eltoprazine|mesh-list
835640|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
835641|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
835642|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
835643|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835644|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835780|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
835781|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
835782|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
835783|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
835784|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
835785|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835786|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835787|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
2098772|NCT02348385|Amphetamine|amphetamine|mesh-list
2098773|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
2098774|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2098775|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098776|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
2098777|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
2098778|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098779|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
2098780|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098781|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098782|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
2098783|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2098784|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2098785|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2098786|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2098787|NCT02348489|Guadecitabine|guadecitabine|mesh-list
2098788|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098789|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2098790|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2254371|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
835898|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
835899|NCT02437955|Trace Elements|trace elements|mesh-ancestor
835900|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
835901|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836038|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
836039|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
836040|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254372|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
2254373|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2254374|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2254375|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2254376|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2254377|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254378|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
2254379|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254380|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254381|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2254382|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2254383|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254384|NCT00142883|Pregabalin|pregabalin|mesh-list
836800|NCT02433925|Resveratrol|resveratrol|mesh-list
836801|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
836802|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836803|NCT02433925|Protective Agents|protective agents|mesh-ancestor
836902|NCT02433704|Cefazolin|cefazolin|mesh-list
835487|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
835488|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
835489|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
835490|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
835491|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835884|NCT02438020|Metformin|metformin|mesh-list
835885|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
835886|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835887|NCT02437812|Metformin|metformin|mesh-list
835888|NCT02437812|Paclitaxel|paclitaxel|mesh-list
835889|NCT02437812|Carboplatin|carboplatin|mesh-list
835890|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
835891|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835892|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
835893|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
835894|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
835895|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835896|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
835897|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836078|NCT02436993|Paclitaxel|paclitaxel|mesh-list
836079|NCT02436993|Bevacizumab|bevacizumab|mesh-list
836080|NCT02436993|Carboplatin|carboplatin|mesh-list
836081|NCT02436993|Trastuzumab|trastuzumab|mesh-list
836082|NCT02436993|Pertuzumab|pertuzumab|mesh-list
836083|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
836084|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836085|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
836086|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
836087|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
836088|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836089|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
836090|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
836091|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
836092|NCT02436993|Growth Substances|growth substances|mesh-ancestor
836093|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836094|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
2098791|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2098792|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098793|NCT02348723|Warfarin|warfarin|mesh-list
2098794|NCT02348723|Dabigatran|dabigatran|mesh-list
2098795|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
2098796|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
2098797|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2098798|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
2098799|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098800|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098801|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
2098802|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2098803|NCT02348775|Glycine|glycine|mesh-list
2098804|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
2098805|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098806|NCT02348775|Expectorants|expectorants|mesh-ancestor
2098807|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
2098808|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2098809|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
2098810|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098811|NCT02348775|Protective Agents|protective agents|mesh-ancestor
2098812|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098813|NCT02348775|Antidotes|antidotes|mesh-ancestor
2098814|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
2098815|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098816|NCT02348918|Bevacizumab|bevacizumab|mesh-list
2098817|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2098818|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098819|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2098820|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2098821|NCT02348918|Growth Substances|growth substances|mesh-ancestor
2098822|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836323|NCT02436096|Cyclobenzaprine|cyclobenzaprine|mesh-list
836324|NCT02436096|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
836325|NCT02436096|Antidepressive Agents|antidepressive agents|mesh-ancestor
836326|NCT02436096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
836327|NCT02436096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
836328|NCT02436096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836329|NCT02436096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
836330|NCT02436096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098823|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
835492|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
835493|NCT02439788|Fludarabine|fludarabine|mesh-list
835494|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
835495|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
835496|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835497|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
835498|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
835499|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
835500|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835501|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835502|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
835822|NCT02437825|Octreotide|octreotide|mesh-list
835823|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
835824|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
835825|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835957|NCT02437721|Folic Acid|folic acid|mesh-list
835958|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
835959|NCT02437721|Hematinics|hematinics|mesh-ancestor
835960|NCT02437721|Vitamins|vitamins|mesh-ancestor
835961|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
835962|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254385|NCT00142883|Analgesics|analgesics|mesh-ancestor
2254386|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
2254387|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254388|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254389|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
2254390|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2098824|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
2098825|NCT02349048|Simeprevir|simeprevir|mesh-list
2098826|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
2098827|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098828|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
2098829|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098830|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098831|NCT02349061|Ustekinumab|ustekinumab|mesh-list
2098832|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
2098833|NCT02349152|Fentanyl|fentanyl|mesh-list
2098834|NCT02349152|Remifentanil|remifentanil|mesh-list
2098835|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2098836|NCT02349152|Narcotics|narcotics|mesh-ancestor
2098837|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2098838|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098839|NCT02349152|Analgesics|analgesics|mesh-ancestor
2098840|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
2098841|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098842|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2254391|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2254392|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098843|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2098844|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
2098845|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
2098846|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
2098847|NCT02349178|Etoposide|etoposide|mesh-list
2254393|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2254394|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2254395|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2254396|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
836704|NCT02434614|Cisplatin|cisplatin|mesh-list
836705|NCT02434614|Docetaxel|docetaxel|mesh-list
836706|NCT02434614|Fluorouracil|fluorouracil|mesh-list
836707|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836708|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
836709|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
836710|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
836711|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836712|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
836713|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
836714|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
836715|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
836716|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836812|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
836813|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
836814|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
836815|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836816|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836817|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
836818|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
2098848|NCT02349178|Clofarabine|clofarabine|mesh-list
835503|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
835504|NCT02439697|Hematinics|hematinics|mesh-ancestor
2254397|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2254398|NCT00142896|Morphine|morphine|mesh-list
2254399|NCT00142896|Tramadol|tramadol|mesh-list
2254400|NCT00142896|Naloxone|naloxone|mesh-list
2254401|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2254402|NCT00142896|Narcotics|narcotics|mesh-ancestor
2254403|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2254404|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254405|NCT00142896|Analgesics|analgesics|mesh-ancestor
2254406|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
2254407|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254408|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2254409|NCT00142948|Naltrexone|naltrexone|mesh-list
2254410|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2254411|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2254412|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254413|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
2254414|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254415|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2254416|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2254417|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2254418|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2254419|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254420|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
2254421|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254422|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254423|NCT00142974|Tegaserod|tegaserod|mesh-list
2254424|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2254425|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
2254426|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254427|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254428|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254429|NCT00142987|Tegaserod|tegaserod|mesh-list
2254430|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2254431|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
2254432|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254433|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254434|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254435|NCT00143000|Ribavirin|ribavirin|mesh-list
2254436|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2254437|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
2254438|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254439|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
2254440|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
836759|NCT02433860|Nicotine|nicotine|mesh-list
836760|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
836761|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
836762|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836763|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836764|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
836765|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
836766|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
836767|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836768|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836819|NCT02433899|Hormones|hormones|mesh-ancestor
836820|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
836821|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
836822|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836823|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
836824|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
836825|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
836826|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
836827|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
836828|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
836829|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
836830|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836831|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836832|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
836833|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
836834|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
836835|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
836836|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
836837|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
835505|NCT02439632|Levofloxacin|levofloxacin|mesh-list
835506|NCT02439632|Ofloxacin|ofloxacin|mesh-list
835507|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
835508|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
835509|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
835510|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
835511|NCT02439632|Renal Agents|renal agents|mesh-ancestor
835512|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
835513|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
835514|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
835515|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835516|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835517|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835518|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
835519|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
835520|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
835933|NCT02437461|Triamcinolone|triamcinolone|mesh-list
835934|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
835935|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
835936|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
835937|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
835938|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
835939|NCT02437461|Hormones|hormones|mesh-ancestor
835940|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
835941|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835942|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
835943|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
835944|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835945|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836065|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
836066|NCT02436980|Narcotics|narcotics|mesh-ancestor
836067|NCT02436980|Analgesics|analgesics|mesh-ancestor
836068|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
836069|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836158|NCT02436694|Dexamethasone|dexamethasone|mesh-list
836159|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
836160|NCT02436694|Ropivacaine|ropivacaine|mesh-list
836161|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
836162|NCT02436694|Anesthetics|anesthetics|mesh-list
836163|NCT02436694|BB 1101|bb 1101|mesh-list
836164|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
836165|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
836166|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
836167|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836168|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836169|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
836170|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
836171|NCT02436694|Hormones|hormones|mesh-ancestor
836172|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
836173|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
836174|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836175|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
836176|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836177|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836178|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
836179|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
836486|NCT02435654|Olanzapine|olanzapine|mesh-list
836487|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
836488|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
836489|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836490|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836491|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
836492|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
836493|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
836494|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
836495|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
836496|NCT02435654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
836497|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
836498|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
836499|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836500|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836501|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
836616|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
836617|NCT02434861|Digoxin|digoxin|mesh-list
836618|NCT02434861|Rolapitant|rolapitant|mesh-list
836619|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
835535|NCT02439489|Carboplatin|carboplatin|mesh-list
835536|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835752|NCT02438345|Leronlimab|leronlimab|mesh-list
835753|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
835754|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
835755|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835756|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
835757|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
835758|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
835759|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254441|NCT00143026|Levodopa|levodopa|mesh-list
2254442|NCT00143026|Carbidopa|carbidopa|mesh-list
2254443|NCT00143026|Entacapone|entacapone|mesh-list
836370|NCT02436044|Leucovorin|leucovorin|mesh-list
836371|NCT02436044|Fluorouracil|fluorouracil|mesh-list
836372|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
836373|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
836374|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
836375|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836376|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
836377|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836378|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
836379|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
836380|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836381|NCT02436044|Antidotes|antidotes|mesh-ancestor
836382|NCT02436044|Protective Agents|protective agents|mesh-ancestor
836383|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
836384|NCT02436044|Vitamins|vitamins|mesh-ancestor
836385|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
836522|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
836523|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
836524|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836525|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
836526|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
836527|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
836528|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
836529|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836530|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254444|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2254445|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2254446|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
836838|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
836839|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
836840|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
836841|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
836842|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
836919|NCT02433418|Diclofenac|diclofenac|mesh-list
836920|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
836921|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
836922|NCT02433418|Analgesics|analgesics|mesh-ancestor
836923|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
836924|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836925|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836926|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
836927|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
836928|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
836929|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836930|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254447|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254448|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254449|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254450|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2254451|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254452|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2254453|NCT00143065|Rituximab|rituximab|mesh-list
2254454|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
2254455|NCT00143065|Fludarabine|fludarabine|mesh-list
2254456|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2254457|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254458|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
2254459|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254460|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2254461|NCT00143091|Sertraline|sertraline|mesh-list
2254462|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
2254463|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2254464|NCT00143091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
835537|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
835538|NCT02439450|Nivolumab|nivolumab|mesh-list
835539|NCT02439450|Pemetrexed|pemetrexed|mesh-list
835540|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
835541|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835542|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
835543|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835544|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835545|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
835546|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2254465|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2254466|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2254467|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254468|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254469|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
835952|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
835953|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
835954|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
835955|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
835956|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
836095|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
836096|NCT02437136|Entinostat|entinostat|mesh-list
836097|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
836098|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836099|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
836100|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836101|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836126|NCT02436902|Sorafenib|sorafenib|mesh-list
836127|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
836128|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836129|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
836130|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836131|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836132|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
836133|NCT02436902|Estrogens|estrogens|mesh-ancestor
836134|NCT02436902|Hormones|hormones|mesh-ancestor
836135|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
836136|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836137|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
836186|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
836187|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
836188|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
836189|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
836190|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
836191|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836192|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
836193|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836194|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836195|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
836196|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254470|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254471|NCT00143104|Insulin|insulin|mesh-list
2254472|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2254473|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254474|NCT00143130|Pregabalin|pregabalin|mesh-list
2254475|NCT00143130|Analgesics|analgesics|mesh-ancestor
2254476|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
2254477|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254478|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836596|NCT02435186|Paclitaxel|paclitaxel|mesh-list
836597|NCT02435186|Cisplatin|cisplatin|mesh-list
836598|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
836599|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836600|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
836601|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
836602|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
836603|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836700|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
836701|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
836702|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836703|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
836769|NCT02433808|Neostigmine|neostigmine|mesh-list
836770|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
836771|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837140|NCT02432599|Choline|choline|mesh-list
835547|NCT02439411|Trametinib|trametinib|mesh-list
835548|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835549|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
835550|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835551|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835829|NCT02438072|Fexofenadine|fexofenadine|mesh-list
835830|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
835831|NCT02438072|Midazolam|midazolam|mesh-list
835832|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
835833|NCT02438072|Caffeine|caffeine|mesh-list
835834|NCT02438072|Bupropion|bupropion|mesh-list
835835|NCT02438072|Omeprazole|omeprazole|mesh-list
835836|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
835837|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
835838|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
835839|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835840|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
835841|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
835842|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
835843|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
835844|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
835845|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
835846|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
835847|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
835848|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
835849|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835850|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
835851|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
835852|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
835853|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835854|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
835855|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
835856|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
835857|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
835858|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
835859|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
835860|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
835861|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
835862|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
835863|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
835864|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
835865|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
835866|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
835867|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
835868|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
835869|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
835870|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
835871|NCT02438072|Analgesics|analgesics|mesh-ancestor
835872|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
835873|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835874|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
835875|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
835876|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
835877|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
835878|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
835879|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
835880|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
835881|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
835882|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
835883|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
836049|NCT02436980|Midazolam|midazolam|mesh-list
836050|NCT02436980|Tramadol|tramadol|mesh-list
836051|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
836052|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
836053|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
836054|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836055|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
836056|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
836057|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
836058|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
836059|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
836060|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
836061|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
836062|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
836063|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836064|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835553|NCT02439190|Clopidogrel|clopidogrel|mesh-list
835554|NCT02439190|BMS-986120|bms-986120|mesh-list
835555|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
835556|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
835557|NCT02439190|Analgesics|analgesics|mesh-ancestor
835558|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
835559|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835560|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835561|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
835562|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
835563|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
835564|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
835565|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835566|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
835567|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
835568|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835569|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
835570|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
835571|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
835572|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
835573|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
835574|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
835726|NCT02438865|Epirubicin|epirubicin|mesh-list
835727|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
835728|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835729|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
835730|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
835731|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835732|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835946|NCT02437656|Metformin|metformin|mesh-list
835947|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
835948|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836123|NCT02436928|Vaccines|vaccines|mesh-list
836124|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
836125|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836138|NCT02436538|Hormones|hormones|mesh-list
836139|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
836140|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836197|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
836198|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
836199|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
836200|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836201|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836202|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
836203|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
836204|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
836205|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
836206|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836207|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836208|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
836209|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
836210|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
836211|NCT02436512|Protective Agents|protective agents|mesh-ancestor
2254479|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
2254480|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2254481|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2254482|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254483|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2254484|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2254485|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2254486|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2254487|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2254488|NCT00143143|Pregabalin|pregabalin|mesh-list
2254489|NCT00143143|Analgesics|analgesics|mesh-ancestor
2254490|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
2254491|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254492|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254493|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
2254494|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2254495|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2254496|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254497|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
836843|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
835575|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
835576|NCT02439307|Rifaximin|rifaximin|mesh-list
835577|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
835578|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
835736|NCT02438852|Ropivacaine|ropivacaine|mesh-list
835737|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
835738|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
835739|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
835740|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835741|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
835742|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098849|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2098850|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
2098851|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098852|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2098853|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2098854|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
2098855|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098856|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836331|NCT02436096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
836332|NCT02436096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
836350|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
836351|NCT02436083|Cefuroxime|cefuroxime|mesh-list
836352|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
836353|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254498|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2254499|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2254500|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2254501|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2254502|NCT00143156|Pregabalin|pregabalin|mesh-list
2254503|NCT00143156|Analgesics|analgesics|mesh-ancestor
2254504|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
2254505|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254506|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254507|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
2254508|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2254509|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2254510|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254511|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2254512|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2254513|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2254514|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2254515|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
836428|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
836429|NCT02435771|Vitamin D|vitamin d|mesh-list
836430|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
836431|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836432|NCT02435771|Vitamins|vitamins|mesh-ancestor
836433|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
836434|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
836609|NCT02434952|Piperaquine|piperaquine|mesh-list
836610|NCT02434952|Primaquine|primaquine|mesh-list
836611|NCT02434952|Artenimol|artenimol|mesh-list
836612|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
836613|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
836614|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
836615|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254516|NCT00143169|Parecoxib|parecoxib|mesh-list
2254517|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2254518|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
836844|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
836845|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
836846|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
836847|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836848|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
836849|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
836850|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
836851|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
836852|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836853|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836854|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
836855|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
836856|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
2254519|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254520|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837111|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
2254521|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2254522|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2254523|NCT00143169|Analgesics|analgesics|mesh-ancestor
2254524|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
835788|NCT02438397|Insulin|insulin|mesh-list
835789|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
835790|NCT02438397|Metformin|metformin|mesh-list
835791|NCT02438397|Acarbose|acarbose|mesh-list
835792|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
835793|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835794|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
835795|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835796|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254525|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254526|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254527|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2254528|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2254529|NCT00143182|Olanzapine|olanzapine|mesh-list
2254530|NCT00143182|Asenapine|asenapine|mesh-list
2254531|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
2254532|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
836386|NCT02435927|Leucovorin|leucovorin|mesh-list
836387|NCT02435927|Fluorouracil|fluorouracil|mesh-list
836388|NCT02435927|Capecitabine|capecitabine|mesh-list
836389|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
836390|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
836391|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836392|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
836393|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836394|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
836395|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
836396|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836397|NCT02435927|Antidotes|antidotes|mesh-ancestor
836398|NCT02435927|Protective Agents|protective agents|mesh-ancestor
836399|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
836400|NCT02435927|Vitamins|vitamins|mesh-ancestor
836401|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
836531|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
836532|NCT02435537|Morphine|morphine|mesh-list
836533|NCT02435537|Bupivacaine|bupivacaine|mesh-list
836534|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
836535|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
836536|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
836537|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836538|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
836539|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836540|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
836541|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
836542|NCT02435537|Analgesics|analgesics|mesh-ancestor
836543|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
836544|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
836545|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
836546|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
836547|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836548|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836549|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
836550|NCT02435537|Narcotics|narcotics|mesh-ancestor
836571|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
836572|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
836573|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
836574|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
836575|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836576|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836577|NCT02435303|Urological Agents|urological agents|mesh-ancestor
2254533|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254534|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254535|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2254536|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2254537|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2254538|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2254539|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2254540|NCT00143182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2254541|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
836807|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
836808|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
836809|NCT02433899|Dexamethasone|dexamethasone|mesh-list
836810|NCT02433899|Epinephrine|epinephrine|mesh-list
836811|NCT02433899|Mepivacaine|mepivacaine|mesh-list
835602|NCT02439385|Bevacizumab|bevacizumab|mesh-list
835603|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
835604|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835605|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
835606|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
835607|NCT02439385|Growth Substances|growth substances|mesh-ancestor
835608|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835609|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
835610|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
835611|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
835612|NCT02439385|Analgesics|analgesics|mesh-ancestor
835613|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
835614|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835615|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
835616|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
835617|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835618|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835693|NCT02438761|Gedatolisib|gedatolisib|mesh-list
835694|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
835695|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835696|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254542|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2254543|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254544|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254545|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
2254546|NCT00143195|Amlodipine|amlodipine|mesh-list
2254547|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2254548|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2254549|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
836141|NCT02436798|Ondansetron|ondansetron|mesh-list
836142|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
836143|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
836144|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836145|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836146|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
836147|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
836148|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
836149|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
836150|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
836151|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836152|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836153|NCT02436798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
836154|NCT02436798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
836155|NCT02436798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
836156|NCT02436798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
836157|NCT02436798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
836586|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836587|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2254550|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254551|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2254552|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254553|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
2254554|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
2254555|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
2254556|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2254557|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2254558|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254559|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254560|NCT00143221|Urological Agents|urological agents|mesh-ancestor
2254561|NCT00143234|Amlodipine|amlodipine|mesh-list
836957|NCT02433457|Omeprazole|omeprazole|mesh-list
836958|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
836959|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
836960|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
836961|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836962|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836985|NCT02433912|Acetaminophen|acetaminophen|mesh-list
836986|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
836987|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
836988|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
836989|NCT02433912|Analgesics|analgesics|mesh-ancestor
836990|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
836991|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836992|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835625|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835626|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835627|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
835628|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
835629|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
835630|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
835631|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
835632|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835633|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835634|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
835635|NCT02439034|Narcotics|narcotics|mesh-ancestor
835636|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
835637|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
835638|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
835680|NCT02438709|Etoricoxib|etoricoxib|mesh-list
835681|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
835682|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
835683|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
835684|NCT02438709|Analgesics|analgesics|mesh-ancestor
835685|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
835686|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835687|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835688|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
835689|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
835690|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
835691|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835692|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836032|NCT02437279|Nivolumab|nivolumab|mesh-list
836033|NCT02437279|Ipilimumab|ipilimumab|mesh-list
836034|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
836035|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836036|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
836037|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098857|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2098858|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2098859|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2098860|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2098861|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098862|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2098863|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
2098864|NCT02349295|Ixekizumab|ixekizumab|mesh-list
2098865|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
2098866|NCT02349451|Adalimumab|adalimumab|mesh-list
2098867|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2098868|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2098869|NCT02349477|Gabapentin|gabapentin|mesh-list
2098870|NCT02349477|Analgesics|analgesics|mesh-ancestor
2098871|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
2098872|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098873|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098874|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
2098875|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2098876|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
836620|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
836621|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836622|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836623|NCT02434861|Protective Agents|protective agents|mesh-ancestor
836624|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836625|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
836626|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
836627|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
836628|NCT02434861|Analgesics|analgesics|mesh-ancestor
836629|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
836630|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836631|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
836632|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
836633|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
836634|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
836635|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836752|NCT02433847|Mosapride|mosapride|mesh-list
836753|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
836754|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
836755|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
836756|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254562|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
2254563|NCT00143234|Atorvastatin|atorvastatin|mesh-list
2254564|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2254565|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2254566|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
2254567|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254568|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2254569|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2254570|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254571|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2254572|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2254573|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2254574|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2254575|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254576|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
2254577|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
2254578|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254579|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
2254580|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2098877|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2098878|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2098879|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2098880|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2098881|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098882|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098883|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
2098884|NCT02349542|Bupivacaine|bupivacaine|mesh-list
2098885|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
2098886|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
2098887|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2098888|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098889|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
2098890|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098891|NCT02349633|Palbociclib|palbociclib|mesh-list
2098892|NCT02349633|Avelumab|avelumab|mesh-list
2098893|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098894|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2098895|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098896|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098897|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2098898|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
836303|NCT02436226|Citric Acid|citric acid|mesh-list
836304|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
836305|NCT02436226|Clomiphene|clomiphene|mesh-list
836306|NCT02436226|Enclomiphene|enclomiphene|mesh-list
836307|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
836308|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
836309|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
836310|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
836311|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
836312|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
836313|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836314|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
836315|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
836316|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
836317|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836318|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
836319|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
836320|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
836321|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
836322|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
836473|NCT02435732|Heparin|heparin|mesh-list
836474|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
836475|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
836476|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
836477|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836551|NCT02435459|Calcium|calcium|mesh-list
836552|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
836553|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836583|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
836584|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
836585|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
836878|NCT02433626|Cisplatin|cisplatin|mesh-list
835669|NCT02438982|Rituximab|rituximab|mesh-list
835670|NCT02438982|Tacrolimus|tacrolimus|mesh-list
835671|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
835672|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
835673|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
835674|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
835675|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835676|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
835677|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
835678|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835679|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836588|NCT02435108|Crizotinib|crizotinib|mesh-list
836589|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836590|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
836591|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836592|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254581|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2254582|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254583|NCT00143260|Urological Agents|urological agents|mesh-ancestor
2254584|NCT00143286|Varenicline|varenicline|mesh-list
2254585|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2254586|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2254587|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
2254588|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254589|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254590|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254591|NCT00143299|Varenicline|varenicline|mesh-list
2254592|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2254593|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2254594|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
2254595|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254596|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254597|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254598|NCT00143325|Varenicline|varenicline|mesh-list
836655|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
836656|NCT02434757|Hormones|hormones|mesh-ancestor
836657|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
836658|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836789|NCT02434029|Budesonide|budesonide|mesh-list
836790|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
836791|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
836792|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
836793|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836794|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836795|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
836796|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
836797|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
836798|NCT02434029|Hormones|hormones|mesh-ancestor
836799|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
836879|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836905|NCT02433522|Rituximab|rituximab|mesh-list
836906|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
836907|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836908|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
836909|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836910|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
836963|NCT02433314|Brexanolone|brexanolone|mesh-list
836964|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
836965|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836966|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836967|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836968|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
836969|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
836998|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
836999|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
837000|NCT02433184|Etanercept|etanercept|mesh-list
837001|NCT02433184|Methotrexate|methotrexate|mesh-list
837002|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
837003|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
837004|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
837005|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837006|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
837007|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
837053|NCT02433041|Ketamine|ketamine|mesh-list
2254599|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2254600|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
835697|NCT02438683|BI 409306|bi 409306|mesh-list
835698|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
835699|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
835700|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254601|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
2254602|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254603|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254604|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254605|NCT00143338|Insulin|insulin|mesh-list
2254606|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2254607|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254608|NCT00143351|Ziprasidone|ziprasidone|mesh-list
2254609|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2254610|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
2254611|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254612|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254613|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254614|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2254615|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2254616|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2254617|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2254618|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2254619|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
2254620|NCT00143364|Varenicline|varenicline|mesh-list
2254621|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2254622|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2254623|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
2254624|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254625|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254626|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254627|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2254628|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2254629|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2254630|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
2254631|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254632|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254633|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254634|NCT00143377|Urological Agents|urological agents|mesh-ancestor
2254635|NCT00143429|Latanoprost|latanoprost|mesh-list
2254636|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
836880|NCT02433587|Aspirin|aspirin|mesh-list
836881|NCT02433587|Clopidogrel|clopidogrel|mesh-list
836882|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
836883|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
836884|NCT02433587|Analgesics|analgesics|mesh-ancestor
836885|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
836886|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836887|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836888|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
836889|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
836890|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
836891|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
836892|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836893|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
836894|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
836895|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836896|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
836897|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
836898|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
836899|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
836900|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
836901|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836993|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
836994|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
836995|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
836996|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
836997|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
837028|NCT02432885|Enalapril|enalapril|mesh-list
837029|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
837030|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
837031|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837032|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837033|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
837084|NCT02432833|Tacrolimus|tacrolimus|mesh-list
2254637|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2254638|NCT00143442|Reboxetine|reboxetine|mesh-list
2254639|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
835949|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
835950|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
835951|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
836004|NCT02437045|Meropenem|meropenem|mesh-list
836005|NCT02437045|Tazobactam|tazobactam|mesh-list
836006|NCT02437045|Piperacillin|piperacillin|mesh-list
836007|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
836008|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
836009|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
836010|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
836011|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836012|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836180|NCT02436733|Pemetrexed|pemetrexed|mesh-list
836181|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836182|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836183|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836184|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
836185|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2254640|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2254641|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2254642|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2254643|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2254644|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254645|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
2254646|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254647|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254648|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2254649|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2254650|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2254651|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
2254652|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254653|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254654|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254655|NCT00143481|Urological Agents|urological agents|mesh-ancestor
2254656|NCT00143520|Pioglitazone|pioglitazone|mesh-list
836683|NCT02434822|Vaccines|vaccines|mesh-list
836684|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
836685|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254657|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2254658|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254659|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
2254660|NCT00143533|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
2254661|NCT00143533|Irinotecan|irinotecan|mesh-list
2254662|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2254663|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2254664|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254665|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254666|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254667|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2254668|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254669|NCT00143546|Defibrotide|defibrotide|mesh-list
2254670|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2254671|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2254672|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836903|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
836904|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
836970|NCT02433730|Testosterone|testosterone|mesh-list
836971|NCT02433730|Androgens|androgens|mesh-ancestor
836972|NCT02433730|Hormones|hormones|mesh-ancestor
836973|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
836974|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837008|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837009|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837010|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
837011|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837012|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
837013|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
837014|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
837015|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
837016|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
837017|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
835743|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
835744|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
835745|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
835746|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835747|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
835748|NCT02438566|Coagulants|coagulants|mesh-ancestor
2254673|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2254674|NCT00143559|Antibodies|antibodies|mesh-list
2254675|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
2254676|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254677|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
2254678|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254679|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
2254680|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
836757|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836758|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836912|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
836913|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
836914|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
836915|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836916|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
836917|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
836918|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837018|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
837019|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
837020|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837021|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
837022|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
837023|NCT02433184|Analgesics|analgesics|mesh-ancestor
837024|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
837025|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
837026|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
837027|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
837034|NCT02432911|Cytarabine|cytarabine|mesh-list
837035|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
837036|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
837037|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
837038|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837039|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837040|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
837041|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837042|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
837043|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
837044|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837045|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
837046|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
837078|NCT02432807|Vancomycin|vancomycin|mesh-list
837079|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
837080|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837085|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
837086|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
837087|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837088|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
837089|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837090|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837101|NCT02432976|Insulin|insulin|mesh-list
837102|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
837103|NCT02432976|Exenatide|exenatide|mesh-list
837104|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
837105|NCT02432976|Incretins|incretins|mesh-list
837106|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
837107|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837108|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
837109|NCT02432976|Hormones|hormones|mesh-ancestor
837110|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
837121|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837122|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837123|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
837124|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837125|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
837126|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
837127|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837128|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
837129|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2254681|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254682|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2254683|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
2254684|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2254685|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254686|NCT00143676|Atorvastatin|atorvastatin|mesh-list
2254687|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2254688|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2254689|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
2254690|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254691|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2254692|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
836772|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836773|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
836774|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836775|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836776|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
836777|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
836778|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
836779|NCT02433795|Rituximab|rituximab|mesh-list
836780|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
836781|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
836782|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
836783|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
836784|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836785|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
836786|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
836787|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
836788|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254693|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254694|NCT00143689|Ritonavir|ritonavir|mesh-list
837054|NCT02433041|Haloperidol|haloperidol|mesh-list
837055|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
837056|NCT02433041|Analgesics|analgesics|mesh-ancestor
837057|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
837058|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
837059|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837060|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
837061|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
837062|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
837063|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
837064|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
837065|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
837066|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
837067|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837068|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837069|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
837070|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
837071|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
837072|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
837073|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
837074|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
837075|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
837076|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
837077|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
837091|NCT02432846|Sunitinib|sunitinib|mesh-list
837092|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837093|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
837094|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
837095|NCT02432846|Growth Substances|growth substances|mesh-ancestor
837096|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837097|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
837098|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
837099|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837100|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837112|NCT02432963|Vaccines|vaccines|mesh-list
837113|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
837114|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837115|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
837116|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837117|NCT02432872|Cytarabine|cytarabine|mesh-list
837118|NCT02432872|Daunorubicin|daunorubicin|mesh-list
837119|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
837120|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
2254695|NCT00143689|Lopinavir|lopinavir|mesh-list
2254696|NCT00143689|Lamivudine|lamivudine|mesh-list
2254697|NCT00143689|Zidovudine|zidovudine|mesh-list
2254698|NCT00143689|Nevirapine|nevirapine|mesh-list
2254699|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2254700|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2254701|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
2254702|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254703|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254704|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2254705|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2254706|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
2254707|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254708|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2254709|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2254710|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2254711|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2254712|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
2254713|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
835701|NCT02438657|Lidocaine|lidocaine|mesh-list
835702|NCT02438657|Epinephrine|epinephrine|mesh-list
835703|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
835704|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
835705|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
835706|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
835707|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
835708|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
835709|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
835710|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
835711|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
835712|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
835713|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
835714|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
835715|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
835716|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
835717|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
835718|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
835719|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
835720|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
835721|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
835722|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
835723|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
835724|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
835725|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
836420|NCT02435797|Nicorandil|nicorandil|mesh-list
836421|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
836422|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
836423|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
836424|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
836425|NCT02435797|Vitamins|vitamins|mesh-ancestor
836426|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
836427|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
836659|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
836660|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
836661|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
836662|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
836663|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
836664|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
836665|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098899|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2098900|NCT02350309|Lemborexant|lemborexant|mesh-list
2098901|NCT02350309|Flurazepam|flurazepam|mesh-list
2098902|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2098903|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837081|NCT02432781|Insulin|insulin|mesh-list
837082|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
837083|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837288|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
837289|NCT02432261|ST 1435|st 1435|mesh-list
837290|NCT02432261|Testosterone|testosterone|mesh-list
837291|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
837292|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
837293|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
837294|NCT02432261|Androgens|androgens|mesh-ancestor
837295|NCT02432261|Hormones|hormones|mesh-ancestor
837296|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2254714|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
837130|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
837131|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838054|NCT02429466|Guadecitabine|guadecitabine|mesh-list
838055|NCT02429466|Azacitidine|azacitidine|mesh-list
838056|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838057|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
838058|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
838059|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838060|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838333|NCT02428439|Lamotrigine|lamotrigine|mesh-list
838334|NCT02428439|Bupropion|bupropion|mesh-list
838335|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
838336|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
838337|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
838338|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
838339|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
838340|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
838341|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838342|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
838343|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
838344|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838345|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
838346|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
838347|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838348|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
838349|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
838350|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
838351|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
838352|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
838353|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
838354|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
839754|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
839755|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839994|NCT02422706|Metronidazole|metronidazole|mesh-list
839995|NCT02422706|Clarithromycin|clarithromycin|mesh-list
839996|NCT02422706|Levofloxacin|levofloxacin|mesh-list
839997|NCT02422706|Ofloxacin|ofloxacin|mesh-list
839998|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
839999|NCT02422706|Doxycycline|doxycycline|mesh-list
840000|NCT02422706|Omeprazole|omeprazole|mesh-list
840001|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
840002|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
840003|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
840004|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
840005|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
840006|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
840007|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
840008|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840009|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254715|NCT00143702|Riboflavin|riboflavin|mesh-list
2254716|NCT00143702|Thiamine|thiamine|mesh-list
2254717|NCT00143702|Abacavir|abacavir|mesh-list
2254718|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2254719|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2254720|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254721|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254722|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
2254723|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254724|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2254725|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2254726|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
2254727|NCT00143702|Vitamins|vitamins|mesh-ancestor
2254728|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
2254729|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254730|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2254731|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
2254732|NCT00143715|Vitamin K|vitamin k|mesh-list
2254733|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
2254734|NCT00143715|Vitamins|vitamins|mesh-ancestor
2254735|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
2254736|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254737|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2254738|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2254739|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254740|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
2254741|NCT00143715|Coagulants|coagulants|mesh-ancestor
2254742|NCT00143728|Lamivudine|lamivudine|mesh-list
2254743|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2254744|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
837998|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
837999|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
838000|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
838001|NCT02429570|Analgesics|analgesics|mesh-ancestor
838002|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
838003|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838004|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838005|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
838006|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
838007|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
838008|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838009|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838081|NCT02429219|Ethanol|ethanol|mesh-list
838082|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
838083|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
838084|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
838085|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098904|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098905|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2098906|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
838379|NCT02428283|Remifentanil|remifentanil|mesh-list
838380|NCT02428283|Ropivacaine|ropivacaine|mesh-list
838381|NCT02428283|Sevoflurane|sevoflurane|mesh-list
838382|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
838383|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
838384|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
838385|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838386|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
838387|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838388|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
838389|NCT02428283|Narcotics|narcotics|mesh-ancestor
838390|NCT02428283|Analgesics|analgesics|mesh-ancestor
838391|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
838392|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
838393|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
2254745|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254746|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254747|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
2254748|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254749|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2254750|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2254751|NCT00143741|Atorvastatin|atorvastatin|mesh-list
838862|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
838863|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838864|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2254752|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2254753|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2254754|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
2254755|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254756|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2254757|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2254758|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837508|NCT02431429|Miltefosine|miltefosine|mesh-list
837509|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
837510|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837511|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837512|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
837513|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2254759|NCT00143780|Vaccines|vaccines|mesh-list
2254760|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
2254761|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254762|NCT00143806|Cyclosporine|cyclosporine|mesh-list
2254763|NCT00143806|Alefacept|alefacept|mesh-list
2254764|NCT00143806|Cyclosporins|cyclosporins|mesh-list
2254765|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254766|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254767|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2254768|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
2254769|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254770|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
2254771|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254772|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
2254773|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2254774|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2254775|NCT00143871|Rituximab|rituximab|mesh-list
2254776|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2254777|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098907|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2098908|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098909|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2098910|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2098911|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2098912|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
2098913|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
2098914|NCT02350478|Linagliptin|linagliptin|mesh-list
2098915|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2098916|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098917|NCT02350478|Incretins|incretins|mesh-ancestor
2098918|NCT02350478|Hormones|hormones|mesh-ancestor
838968|NCT02427620|Cytarabine|cytarabine|mesh-list
838969|NCT02427620|Dexamethasone|dexamethasone|mesh-list
838970|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
838971|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
838972|NCT02427620|Rituximab|rituximab|mesh-list
838973|NCT02427620|Doxorubicin|doxorubicin|mesh-list
838974|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
838975|NCT02427620|Methotrexate|methotrexate|mesh-list
838976|NCT02427620|Vincristine|vincristine|mesh-list
838977|NCT02427620|Daunorubicin|daunorubicin|mesh-list
838978|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
838979|NCT02427620|Antibodies|antibodies|mesh-list
838980|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
838981|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
838982|NCT02427620|BB 1101|bb 1101|mesh-list
838983|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
838984|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
838985|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838986|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
838987|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
838988|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
838989|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838990|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838991|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
838992|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
838993|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
838994|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
838995|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838996|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
838997|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
838998|NCT02427620|Hormones|hormones|mesh-ancestor
838999|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
839000|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
839001|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
839002|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098919|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
837141|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
837142|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
837143|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
837144|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837145|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
837146|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
837147|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
837312|NCT02432365|Paclitaxel|paclitaxel|mesh-list
837313|NCT02432365|Cisplatin|cisplatin|mesh-list
837314|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
837315|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837316|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
837317|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
837318|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
837319|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837445|NCT02431728|Melatonin|melatonin|mesh-list
837446|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
837447|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837448|NCT02431728|Protective Agents|protective agents|mesh-ancestor
837449|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837450|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2254778|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
2254779|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838010|NCT02429622|Paclitaxel|paclitaxel|mesh-list
838011|NCT02429622|Nedaplatin|nedaplatin|mesh-list
838012|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
838013|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838014|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
838015|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
838016|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
838017|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254780|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2254781|NCT00143949|Losartan|losartan|mesh-list
2254782|NCT00143949|Enalapril|enalapril|mesh-list
2254783|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2254784|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2254785|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
838648|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
838649|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
838650|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
838651|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838652|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
838653|NCT02427412|Coagulants|coagulants|mesh-ancestor
838712|NCT02426866|Efavirenz|efavirenz|mesh-list
838713|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
838714|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
838715|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838716|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838717|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
838718|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
838719|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
838720|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
838721|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
838722|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
838723|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
838724|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
839378|NCT02424695|Gabapentin|gabapentin|mesh-list
839379|NCT02424695|Analgesics|analgesics|mesh-ancestor
839380|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
839381|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839382|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839383|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
839384|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
839385|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
839386|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
839387|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
839388|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
839389|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
839390|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839391|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839392|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
839534|NCT02424045|Dexamethasone|dexamethasone|mesh-list
839535|NCT02424045|Carboplatin|carboplatin|mesh-list
839536|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
837148|NCT02432534|Atorvastatin|atorvastatin|mesh-list
837149|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
837150|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
837151|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
837152|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837153|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
837154|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
837155|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837220|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
837221|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
837222|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837223|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
837224|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
837225|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
837226|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837227|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837228|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837320|NCT02432027|Betamethasone|betamethasone|mesh-list
837321|NCT02432027|Calcipotriene|calcipotriene|mesh-list
837322|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
837323|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
837324|NCT02432027|Hormones|hormones|mesh-ancestor
837325|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
837326|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837327|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
837328|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
837329|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
837652|NCT02431065|Ropivacaine|ropivacaine|mesh-list
837653|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
837654|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
837655|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837656|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
837657|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
837658|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
837687|NCT02430714|Lenvatinib|lenvatinib|mesh-list
837688|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837689|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
837690|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837691|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838018|NCT02429804|Listerine|listerine|mesh-list
838019|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
838020|NCT02429804|Fluorides|fluorides|mesh-list
838021|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
838022|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
838023|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
838024|NCT02429804|Protective Agents|protective agents|mesh-ancestor
838025|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838026|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
838027|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838028|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
838029|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
838030|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
838031|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
838211|NCT02428751|Prednisone|prednisone|mesh-list
838212|NCT02428751|Rituximab|rituximab|mesh-list
838213|NCT02428751|Doxorubicin|doxorubicin|mesh-list
838214|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
838215|NCT02428751|Vincristine|vincristine|mesh-list
838216|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
838217|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838218|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
838219|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838220|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
838221|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
838222|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
838223|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
838224|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838225|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838226|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
838227|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
838228|NCT02428751|Hormones|hormones|mesh-ancestor
838229|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838230|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
838231|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
838232|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
837161|NCT02432547|Aflibercept|aflibercept|mesh-list
837162|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
837163|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
837164|NCT02432547|Growth Substances|growth substances|mesh-ancestor
837165|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837166|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
837167|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837378|NCT02431715|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
837379|NCT02431715|Dopamine Agents|dopamine agents|mesh-ancestor
837380|NCT02431715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837381|NCT02431715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837382|NCT02431715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837572|NCT02431286|Dexamethasone|dexamethasone|mesh-list
837573|NCT02431286|Aprepitant|aprepitant|mesh-list
837574|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
837575|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
837576|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
837577|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
837578|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837579|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
837580|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
837581|NCT02431286|Hormones|hormones|mesh-ancestor
837582|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
837583|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
837584|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837585|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
837586|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837587|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837751|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
837752|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
837753|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
837754|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
837755|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
837756|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837757|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837758|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254786|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2254787|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254788|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
838270|NCT02429037|Cisplatin|cisplatin|mesh-list
838271|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838676|NCT02427165|Albuterol|albuterol|mesh-list
838677|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
838678|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
838679|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838680|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838681|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
838682|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
838683|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
838684|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
838685|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
838686|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
838687|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
838688|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
838689|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
838690|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838725|NCT02426723|Dexamethasone|dexamethasone|mesh-list
838726|NCT02426723|Lenalidomide|lenalidomide|mesh-list
838727|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
838728|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
838729|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
838730|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838731|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838732|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
838733|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
838734|NCT02426723|Hormones|hormones|mesh-ancestor
838735|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838736|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
838737|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838738|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
838739|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
838740|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
838741|NCT02426723|Growth Substances|growth substances|mesh-ancestor
837168|NCT02432651|Xanthohumol|xanthohumol|mesh-list
837169|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837170|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
837171|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
837172|NCT02432651|Growth Substances|growth substances|mesh-ancestor
837173|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837174|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
837417|NCT02431663|Ketamine|ketamine|mesh-list
837418|NCT02431663|Analgesics|analgesics|mesh-ancestor
837419|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
837420|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
837421|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837422|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
837423|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
837424|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
837425|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
837426|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
837427|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
837428|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
837429|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837430|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837514|NCT02431416|Hormones|hormones|mesh-list
837515|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
837516|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837806|NCT02430181|Interferons|interferons|mesh-list
837807|NCT02430181|Ritonavir|ritonavir|mesh-list
837808|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
837809|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
837810|NCT02430181|Lonafarnib|lonafarnib|mesh-list
837811|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837812|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
837813|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837814|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
837815|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
837816|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
837817|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837818|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837819|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
837820|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
837821|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
837822|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
837823|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
837824|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838099|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
838100|NCT02429388|Spironolactone|spironolactone|mesh-list
838101|NCT02429388|Diuretics|diuretics|mesh-list
838102|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
838103|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
838104|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
838105|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838106|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838107|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
838108|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
838109|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838255|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
838256|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
838257|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
838258|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838259|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838260|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
838261|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
838262|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838263|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
838264|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254789|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
2254790|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254791|NCT00143975|Cytarabine|cytarabine|mesh-list
2254792|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
2254793|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
2254794|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2254795|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
2254796|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254797|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254798|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
837175|NCT02432677|Remifentanil|remifentanil|mesh-list
837176|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
837177|NCT02432677|Narcotics|narcotics|mesh-ancestor
837178|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
837179|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837180|NCT02432677|Analgesics|analgesics|mesh-ancestor
837181|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
837182|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254799|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254800|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2254801|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
2254802|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254803|NCT00143975|Analgesics|analgesics|mesh-ancestor
2254804|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
2254805|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254806|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2254807|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2254808|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838117|NCT02429518|Miltefosine|miltefosine|mesh-list
838118|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
838119|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
838120|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838121|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
838122|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
838314|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
838315|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
838316|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
838317|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838318|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
838319|NCT02428868|Coagulants|coagulants|mesh-ancestor
838770|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
838771|NCT02426619|Fluorides|fluorides|mesh-list
838772|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
838773|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
838774|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
838775|NCT02426619|Protective Agents|protective agents|mesh-ancestor
838776|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839190|NCT02425865|Golimumab|golimumab|mesh-list
839191|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
839192|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
839193|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
839194|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
839195|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254809|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2254810|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2254811|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2254812|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
839623|NCT02423811|Fursultiamin|fursultiamin|mesh-list
839624|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
839625|NCT02423811|Vitamins|vitamins|mesh-ancestor
839626|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
839627|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839790|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
839791|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
839792|NCT02422836|Protective Agents|protective agents|mesh-ancestor
839793|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839794|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
840217|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
840218|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
840219|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
840220|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
840221|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840222|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840223|NCT02422277|Urological Agents|urological agents|mesh-ancestor
840690|NCT02419729|Estrogens|estrogens|mesh-list
840691|NCT02419729|Hormones|hormones|mesh-ancestor
840692|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
840693|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254813|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
2254814|NCT00144053|Paclitaxel|paclitaxel|mesh-list
2254815|NCT00144053|Vindesine|vindesine|mesh-list
2254816|NCT00144053|Carboplatin|carboplatin|mesh-list
2254817|NCT00144053|Irinotecan|irinotecan|mesh-list
2254818|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2254819|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254820|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
2254821|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
2254822|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
838355|NCT02428270|Trametinib|trametinib|mesh-list
838356|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838357|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
838358|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838359|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254823|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254824|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2254825|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2254826|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254827|NCT00144066|Gefitinib|gefitinib|mesh-list
2254828|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254829|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2254830|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254831|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254832|NCT00144118|Sevoflurane|sevoflurane|mesh-list
2254833|NCT00144118|Isoflurane|isoflurane|mesh-list
2254834|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2254835|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2254836|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
2254837|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
2254838|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2254839|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254840|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
2254841|NCT00144131|Hematinics|hematinics|mesh-ancestor
2254842|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
2254843|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
2254844|NCT00144144|Giapreza|giapreza|mesh-list
2254845|NCT00144144|Calcium|calcium|mesh-list
2254846|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
2254847|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2254848|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2254849|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254850|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2254851|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2254852|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
2254853|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254854|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254855|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2254856|NCT00144157|Zidovudine|zidovudine|mesh-list
2254857|NCT00144157|Nevirapine|nevirapine|mesh-list
2254858|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
2254859|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254860|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2254861|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2254862|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254863|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
2254864|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254865|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
839472|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
839473|NCT02424201|Misoprostol|misoprostol|mesh-list
839474|NCT02424201|Vitamins|vitamins|mesh-ancestor
839475|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
839476|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839477|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
839478|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
839479|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
839480|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
839481|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
839482|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
839483|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
839484|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839485|NCT02424201|Protective Agents|protective agents|mesh-ancestor
2098920|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2098921|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
2254866|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
840053|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837198|NCT02432417|Chloroquine|chloroquine|mesh-list
837199|NCT02432417|Amebicides|amebicides|mesh-ancestor
837200|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
837201|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
837202|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837203|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
837204|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2254867|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2254868|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2254869|NCT00144183|Zidovudine|zidovudine|mesh-list
2254870|NCT00144183|Nevirapine|nevirapine|mesh-list
2254871|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
838698|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
838699|NCT02426840|Vitamin D|vitamin d|mesh-list
838700|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
838701|NCT02426840|Vitamins|vitamins|mesh-list
838702|NCT02426840|Calcium|calcium|mesh-list
838703|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
838704|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838705|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
838706|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2254872|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254873|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2254874|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2254875|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254876|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
2254877|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254878|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2254879|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
840533|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
840534|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
840535|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840536|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
841045|NCT02419287|Crizotinib|crizotinib|mesh-list
841046|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841047|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
841048|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841049|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841440|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
841441|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
841442|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
841443|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841444|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841445|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
841446|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
841447|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841448|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
841449|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
841764|NCT02416128|Prednisolone|prednisolone|mesh-list
841765|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
841766|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
841767|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
841768|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
841769|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
841770|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
841771|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
841772|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
841773|NCT02416128|Hormones|hormones|mesh-ancestor
841774|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841775|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841776|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
841777|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841778|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
841779|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
841780|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841781|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
841782|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
841783|NCT02416128|Protective Agents|protective agents|mesh-ancestor
842619|NCT02413021|Cytarabine|cytarabine|mesh-list
842620|NCT02413021|Deferasirox|deferasirox|mesh-list
842621|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
842622|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
842623|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842624|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842625|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
842626|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837205|NCT02432664|Midazolam|midazolam|mesh-list
837206|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
837207|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
837208|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
837209|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837210|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
837211|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
837212|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
837213|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
837214|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
837215|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
837216|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
837217|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
837218|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837219|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254880|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2254881|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2254882|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
2254883|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2254884|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
2254885|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254886|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254887|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2254888|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
2254889|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
2254890|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2254891|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
2254892|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837626|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
837627|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
838123|NCT02429453|Thrombin|thrombin|mesh-list
838124|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
838125|NCT02429453|Coagulants|coagulants|mesh-ancestor
838467|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
838468|NCT02427880|Furosemide|furosemide|mesh-list
838469|NCT02427880|Acetazolamide|acetazolamide|mesh-list
838470|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
838471|NCT02427880|Diuretics|diuretics|mesh-ancestor
838472|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
838473|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838474|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
838475|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
838476|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838477|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
838478|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
838479|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
838480|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254893|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254894|NCT00144209|Levodopa|levodopa|mesh-list
2254895|NCT00144209|Pramipexole|pramipexole|mesh-list
2254896|NCT00144209|Benserazide|benserazide|mesh-list
2254897|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2254898|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2254899|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
2254900|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2254901|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254902|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254903|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
838849|NCT02426463|Oxycodone|oxycodone|mesh-list
838850|NCT02426463|Propofol|propofol|mesh-list
838851|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
838852|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
838853|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838854|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
838855|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
838856|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
838857|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
838858|NCT02426463|Narcotics|narcotics|mesh-ancestor
838859|NCT02426463|Analgesics|analgesics|mesh-ancestor
838860|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
838861|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839185|NCT02425605|Sorafenib|sorafenib|mesh-list
839186|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839187|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
837229|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
837230|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
837231|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
837232|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837330|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
837331|NCT02431988|Fludarabine|fludarabine|mesh-list
837332|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
837333|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
837334|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837335|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
837336|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
837337|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
837338|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837339|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837340|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
837532|NCT02431221|Perhexiline|perhexiline|mesh-list
837533|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
837534|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
837535|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837536|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
837537|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837538|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
837628|NCT02431013|Cilostazol|cilostazol|mesh-list
837629|NCT02431013|Simvastatin|simvastatin|mesh-list
837630|NCT02431013|Pravastatin|pravastatin|mesh-list
837631|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
837632|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
837633|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
837634|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837635|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
837636|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
837637|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837638|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
837639|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
837640|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
837641|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837642|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
837643|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
837644|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
837645|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
837646|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
837647|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
837648|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
837649|NCT02431013|Protective Agents|protective agents|mesh-ancestor
837650|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
837651|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
837780|NCT02430350|Edaravone|edaravone|mesh-list
837781|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
837782|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
837783|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837784|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
837785|NCT02430350|Protective Agents|protective agents|mesh-ancestor
837786|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254904|NCT00144209|Protective Agents|protective agents|mesh-ancestor
2254905|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
2254906|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254907|NCT00144222|Telmisartan|telmisartan|mesh-list
2254908|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2254909|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2254910|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2254911|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839603|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
839604|NCT02423863|Nivolumab|nivolumab|mesh-list
839605|NCT02423863|Durvalumab|durvalumab|mesh-list
839606|NCT02423863|Cemiplimab|cemiplimab|mesh-list
839607|NCT02423863|Atezolizumab|atezolizumab|mesh-list
839608|NCT02423863|Poly ICLC|poly iclc|mesh-list
839609|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
839610|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839611|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
839612|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839613|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
839614|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
839615|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254912|NCT00144248|Nevirapine|nevirapine|mesh-list
2254913|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2254914|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2254915|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254916|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254917|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
2254918|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254919|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2254920|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2254921|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2254922|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2254923|NCT00144261|Nevirapine|nevirapine|mesh-list
2254924|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2254925|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2254926|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254927|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254928|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
2254929|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254930|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2254931|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2254932|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2254933|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2254934|NCT00144274|Ambroxol|ambroxol|mesh-list
2254935|NCT00144274|Expectorants|expectorants|mesh-ancestor
2254936|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
2254937|NCT00144287|Ritonavir|ritonavir|mesh-list
2254938|NCT00144287|Tipranavir|tipranavir|mesh-list
2254939|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2254940|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2254941|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
2254942|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098922|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098923|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098924|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
2098925|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2098926|NCT02350569|Ledipasvir|ledipasvir|mesh-list
2098927|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
2098928|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2098929|NCT02351037|Azacitidine|azacitidine|mesh-list
2098930|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
837522|NCT02431325|Teduglutide|teduglutide|mesh-list
837523|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
837524|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
837525|NCT02431325|Protective Agents|protective agents|mesh-ancestor
837526|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837797|NCT02430233|Progesterone|progesterone|mesh-list
837798|NCT02430233|Progestins|progestins|mesh-ancestor
837799|NCT02430233|Hormones|hormones|mesh-ancestor
837800|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
837801|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837874|NCT02429921|Selenium|selenium|mesh-list
837875|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
837876|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837877|NCT02429921|Protective Agents|protective agents|mesh-ancestor
837878|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837879|NCT02429921|Trace Elements|trace elements|mesh-ancestor
837880|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
838075|NCT02429505|Miltefosine|miltefosine|mesh-list
838076|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
838077|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
838078|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838079|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
838080|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
838607|NCT02427295|Octreotide|octreotide|mesh-list
838608|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
838609|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
838610|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838871|NCT02426229|Dabigatran|dabigatran|mesh-list
838872|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
838873|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
838874|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
838875|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838876|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838877|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
839072|NCT02425904|Clofarabine|clofarabine|mesh-list
839073|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
839074|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
2098931|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
2254943|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254944|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2254945|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
838086|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
838087|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
838088|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838185|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
838186|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
838805|NCT02426502|Cyclosporine|cyclosporine|mesh-list
838806|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
838807|NCT02426502|Prednisone|prednisone|mesh-list
838808|NCT02426502|Azathioprine|azathioprine|mesh-list
838809|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
838810|NCT02426502|Cyclosporins|cyclosporins|mesh-list
838811|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
838812|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
838813|NCT02426502|Hormones|hormones|mesh-ancestor
838814|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838815|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838816|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
838817|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838818|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838819|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838820|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
838821|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
838822|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
838823|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
838824|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
838825|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
838826|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
838827|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
838828|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
838829|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
838830|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
838831|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
838832|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2254946|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
2254947|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254948|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2254949|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2254950|NCT00144326|Bromides|bromides|mesh-list
2254951|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
2254952|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
839341|NCT02424552|Vitamin D|vitamin d|mesh-list
839342|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
839343|NCT02424552|Vitamins|vitamins|mesh-ancestor
839344|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
839345|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839346|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
839347|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2254953|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
2254954|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2254955|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2254956|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2254957|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
2254958|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
2254959|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2254960|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
2254961|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837281|NCT02432053|Tacrolimus|tacrolimus|mesh-list
837282|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
837283|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
837284|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837285|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
837286|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837287|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254962|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254963|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
2254964|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
2254965|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
2254966|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2254967|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
2254968|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2254969|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2254970|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254971|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2254972|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254973|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254974|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2254975|NCT00144352|Renal Agents|renal agents|mesh-ancestor
2254976|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2254977|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
2254978|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254979|NCT00144378|Irinotecan|irinotecan|mesh-list
2254980|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2254981|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2254982|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254983|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254984|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254985|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
2254986|NCT00144417|Rifampin|rifampin|mesh-list
2254987|NCT00144417|Isoniazid|isoniazid|mesh-list
2254988|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
2254989|NCT00144417|Ethambutol|ethambutol|mesh-list
2254990|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
838089|NCT02429271|Clopidogrel|clopidogrel|mesh-list
838090|NCT02429271|Ticagrelor|ticagrelor|mesh-list
838091|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
838092|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
838093|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
838094|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
838095|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
838096|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
838097|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838098|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838161|NCT02428933|Bromocriptine|bromocriptine|mesh-list
838162|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
838163|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
838164|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
838165|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838166|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838167|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
838168|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
838169|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
838170|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254991|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2254992|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2254993|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2254994|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2254995|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2254996|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2254997|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2254998|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
2254999|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
839070|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
839071|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839182|NCT02425488|Coal Tar|coal tar|mesh-list
839183|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
839184|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
839439|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
839440|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2255000|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2255001|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2255002|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
837297|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837298|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
837299|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837300|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
837301|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
837302|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
837303|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
837304|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
837403|NCT02431845|Fluoxetine|fluoxetine|mesh-list
837404|NCT02431845|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
837405|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
837406|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
837407|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837408|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837409|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
837410|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837411|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
837412|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
837413|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
837414|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
837415|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
837416|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837984|NCT02429687|Paclitaxel|paclitaxel|mesh-list
837985|NCT02429687|Etoposide|etoposide|mesh-list
837986|NCT02429687|Carboplatin|carboplatin|mesh-list
837987|NCT02429687|Bleomycin|bleomycin|mesh-list
837988|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
837989|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837990|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
837991|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
837992|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
837993|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837994|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
837995|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
837996|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837997|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
838171|NCT02428764|Gemcitabine|gemcitabine|mesh-list
838172|NCT02428764|Carboplatin|carboplatin|mesh-list
838173|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
838174|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838175|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
838176|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
838177|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838178|NCT02428764|Antiviral Agents|antiviral agents|mesh-ancestor
838179|NCT02428764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
838180|NCT02428764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838181|NCT02428764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
838182|NCT02428764|Immunologic Factors|immunologic factors|mesh-ancestor
838183|NCT02428764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838184|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2098932|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098933|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098934|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098935|NCT02351115|Alprazolam|alprazolam|mesh-list
2098936|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2098937|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2098938|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098939|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2098940|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2098941|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2098942|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
2098943|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
2098944|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098945|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838954|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
838955|NCT02426099|Spironolactone|spironolactone|mesh-list
838956|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
838957|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
838958|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838959|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838960|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
838961|NCT02426099|Diuretics|diuretics|mesh-ancestor
838962|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
839245|NCT02425137|Gemcitabine|gemcitabine|mesh-list
837305|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
837306|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
837307|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
837308|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
837309|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837310|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837311|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255003|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2255004|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2255005|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2255006|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2255007|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
837917|NCT02429882|Brodalumab|brodalumab|mesh-list
837918|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
838187|NCT02428777|Diclofenac|diclofenac|mesh-list
838188|NCT02428777|Tramadol|tramadol|mesh-list
838189|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
838190|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
838191|NCT02428777|Analgesics|analgesics|mesh-ancestor
838192|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
838193|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838194|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838195|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
838196|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
838197|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
838198|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838199|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838200|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
838201|NCT02428777|Narcotics|narcotics|mesh-ancestor
838202|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2255008|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2255009|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
2255010|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2255011|NCT00144430|Pentostatin|pentostatin|mesh-list
2255012|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255013|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2255014|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255015|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255016|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
2255017|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2255018|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
2255019|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
838463|NCT02427919|Lenograstim|lenograstim|mesh-list
838464|NCT02427919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
838465|NCT02427919|Immunologic Factors|immunologic factors|mesh-ancestor
838466|NCT02427919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838526|NCT02427581|Poly I-C|poly i-c|mesh-list
838527|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
838528|NCT02427581|Poly ICLC|poly iclc|mesh-list
838529|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
838530|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
838531|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838532|NCT02427581|Laxatives|laxatives|mesh-ancestor
838533|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
838534|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
838535|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
838963|NCT02426060|Warfarin|warfarin|mesh-list
838964|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
2255020|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255021|NCT00144456|Vitamins|vitamins|mesh-ancestor
2255022|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
839698|NCT02423915|Vidarabine|vidarabine|mesh-list
839699|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
839700|NCT02423915|Sirolimus|sirolimus|mesh-list
839701|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
839702|NCT02423915|Rituximab|rituximab|mesh-list
839703|NCT02423915|Fludarabine|fludarabine|mesh-list
839704|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
839705|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
839706|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
839707|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839708|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
839709|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
839710|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
839711|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839712|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839713|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2255023|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2255024|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
2255025|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255026|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
2255027|NCT00144482|Hematinics|hematinics|mesh-ancestor
2255028|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
2255029|NCT00144495|Hematinics|hematinics|mesh-ancestor
2255030|NCT00144677|Sirolimus|sirolimus|mesh-list
2255031|NCT00144677|Tacrolimus|tacrolimus|mesh-list
2255032|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2255033|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
2255034|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255035|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2255036|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255037|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838493|NCT02428062|Phenylephrine|phenylephrine|mesh-list
838494|NCT02428062|Dopamine|dopamine|mesh-list
838495|NCT02428062|Epinephrine|epinephrine|mesh-list
838496|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
838497|NCT02428062|Norepinephrine|norepinephrine|mesh-list
838498|NCT02428062|Ephedrine|ephedrine|mesh-list
838499|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
838500|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838501|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
838502|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
838503|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
838504|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
838505|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838506|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
838507|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
838508|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
838509|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838510|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
838511|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
838512|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
838513|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
838514|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
838515|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
838516|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
838517|NCT02428062|Protective Agents|protective agents|mesh-ancestor
838518|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
838519|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2255038|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2255039|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255040|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2255041|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255042|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
839209|NCT02426112|Azithromycin|azithromycin|mesh-list
839210|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
839211|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
839279|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
839280|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
839281|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
839282|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
839283|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
839284|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
839285|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839286|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
839287|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839288|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839289|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
839290|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255043|NCT00144703|Sirolimus|sirolimus|mesh-list
2255044|NCT00144703|Tacrolimus|tacrolimus|mesh-list
2255045|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2255046|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
2255047|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255048|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2255049|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255050|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255051|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
839742|NCT02423525|Afatinib|afatinib|mesh-list
839743|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839744|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
839745|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839746|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255052|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837352|NCT02431975|Ritonavir|ritonavir|mesh-list
837353|NCT02431975|Lopinavir|lopinavir|mesh-list
837354|NCT02431975|Lamivudine|lamivudine|mesh-list
837355|NCT02431975|Zidovudine|zidovudine|mesh-list
837356|NCT02431975|Nevirapine|nevirapine|mesh-list
837357|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
837358|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
837359|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
837360|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837361|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837362|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
837363|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
837364|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
837365|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837366|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
837367|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
837368|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
837369|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
837370|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
837371|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
837372|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2255053|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2255054|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255055|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
2255056|NCT00144716|Insect Repellents|insect repellents|mesh-list
2255057|NCT00144716|Protective Agents|protective agents|mesh-ancestor
2255058|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255059|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
2255060|NCT00144755|Hematinics|hematinics|mesh-ancestor
2255061|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
2255062|NCT00144807|Rituximab|rituximab|mesh-list
2255063|NCT00144807|Doxorubicin|doxorubicin|mesh-list
2255064|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2255065|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
2255066|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255067|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2255068|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2255069|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
2255070|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255071|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255072|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2255073|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2255074|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2255075|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2255076|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2255077|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255078|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
2255079|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2255080|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
2255081|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255082|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
2255083|NCT00144820|Protective Agents|protective agents|mesh-ancestor
2255084|NCT00144833|Ritonavir|ritonavir|mesh-list
2255085|NCT00144833|Lopinavir|lopinavir|mesh-list
837846|NCT02430194|Interferons|interferons|mesh-list
837847|NCT02430194|Ritonavir|ritonavir|mesh-list
837848|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
837849|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
837850|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
837851|NCT02430194|Lonafarnib|lonafarnib|mesh-list
837852|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837853|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
837854|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837855|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
837856|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
837857|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
837858|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837859|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837860|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
837861|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
837862|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
837863|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
837864|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
837865|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838403|NCT02428257|Ephedrine|ephedrine|mesh-list
838404|NCT02428257|Bupivacaine|bupivacaine|mesh-list
838405|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
2255086|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
2255087|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2255088|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2255089|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
2255090|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255091|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255092|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2255093|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2255094|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
837591|NCT02431143|Miltefosine|miltefosine|mesh-list
837592|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
837593|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837594|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837595|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
837596|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
837682|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
837683|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
837684|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
837685|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837686|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
837802|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
837803|NCT02430363|Dactolisib|dactolisib|mesh-list
837804|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
837805|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837921|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
837922|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
837923|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
837924|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
837925|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837926|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
837927|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
837928|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
837929|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
837930|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
837931|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
837932|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837933|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838061|NCT02429193|Prednisone|prednisone|mesh-list
838062|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
838063|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
838064|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
838065|NCT02429193|Hormones|hormones|mesh-ancestor
838066|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838067|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838068|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
838069|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838070|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
838071|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838072|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838073|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
838074|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
838372|NCT02428322|Vitamin D|vitamin d|mesh-list
838373|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
838374|NCT02428322|Vitamins|vitamins|mesh-ancestor
838375|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
838376|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838377|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
838378|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
838965|NCT02426008|Mitogens|mitogens|mesh-list
838966|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
838967|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839509|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
839510|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
839511|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
839512|NCT02424136|Antibodies|antibodies|mesh-list
839513|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
839514|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839515|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
839516|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
839517|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839518|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
839519|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
839520|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
839521|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
839522|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255095|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255096|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2255097|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2255098|NCT00144846|Albuterol|albuterol|mesh-list
2255099|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2255100|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
2255101|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255102|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255103|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2255104|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
2255105|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
2255106|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2255107|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2255108|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2255109|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
837765|NCT02430259|Isoniazid|isoniazid|mesh-list
837766|NCT02430259|Rifapentine|rifapentine|mesh-list
837767|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
837768|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
837769|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837770|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
837771|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
837772|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
837773|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837774|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
837775|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
837776|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
837866|NCT02429960|Remifentanil|remifentanil|mesh-list
837867|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
837868|NCT02429960|Narcotics|narcotics|mesh-ancestor
837869|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
837870|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837871|NCT02429960|Analgesics|analgesics|mesh-ancestor
837872|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
837873|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
837964|NCT02429596|Lamotrigine|lamotrigine|mesh-list
837965|NCT02429596|Carbamazepine|carbamazepine|mesh-list
837966|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
837967|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837968|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
837969|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
837970|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837971|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
837972|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
837973|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
837974|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
837975|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
837976|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
837977|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
837978|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
837979|NCT02429596|Analgesics|analgesics|mesh-ancestor
837980|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
837981|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
837982|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
837983|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2098946|NCT02351167|Nicotine|nicotine|mesh-list
2098947|NCT02351167|Varenicline|varenicline|mesh-list
2098948|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2098949|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
2098950|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098951|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098952|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2098953|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2098954|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
2098955|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098956|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098957|NCT02351700|Ibuprofen|ibuprofen|mesh-list
2098958|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2098959|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2098960|NCT02351700|Analgesics|analgesics|mesh-ancestor
2098961|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
2098962|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098963|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098964|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2098965|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2098966|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
837397|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
837398|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
837399|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837400|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
837401|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837402|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837692|NCT02430896|Methylphenidate|methylphenidate|mesh-list
837693|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
837694|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
837695|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837696|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
837697|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
837698|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
837699|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837700|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
837701|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837702|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
837703|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
2255110|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
2255111|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2255112|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255113|NCT00144872|Lamotrigine|lamotrigine|mesh-list
2255114|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
2255115|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2098967|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098968|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098969|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
2098970|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
2098971|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
839486|NCT02424214|Ionophores|ionophores|mesh-list
839487|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
839488|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839680|NCT02423590|Gemcitabine|gemcitabine|mesh-list
839681|NCT02423590|Carboplatin|carboplatin|mesh-list
839682|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839683|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
839684|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
839685|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839686|NCT02423590|Antiviral Agents|antiviral agents|mesh-ancestor
839687|NCT02423590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
839688|NCT02423590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839689|NCT02423590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
839690|NCT02423590|Immunologic Factors|immunologic factors|mesh-ancestor
839691|NCT02423590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839920|NCT02422563|Paclitaxel|paclitaxel|mesh-list
839921|NCT02422563|Carboplatin|carboplatin|mesh-list
839922|NCT02422563|Ifosfamide|ifosfamide|mesh-list
839923|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
839924|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839925|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
839926|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
839927|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
839928|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839929|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
839930|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
2255116|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2255117|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255118|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2255119|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255120|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2255121|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2255122|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2255123|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
840434|NCT02420509|Leucovorin|leucovorin|mesh-list
840435|NCT02420509|Capecitabine|capecitabine|mesh-list
840436|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840437|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840438|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
840439|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
840440|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840441|NCT02420509|Antidotes|antidotes|mesh-ancestor
840442|NCT02420509|Protective Agents|protective agents|mesh-ancestor
2098972|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2098973|NCT02351934|Celecoxib|celecoxib|mesh-list
2098974|NCT02351934|Furosemide|furosemide|mesh-list
2098975|NCT02351934|Gabapentin|gabapentin|mesh-list
2098976|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2098977|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2098978|NCT02351934|Analgesics|analgesics|mesh-ancestor
2098979|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
2098980|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2098981|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2098982|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2098983|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2098984|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2098985|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2098986|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2098987|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098988|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
2098989|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2098990|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
838235|NCT02428972|Propofol|propofol|mesh-list
838236|NCT02428972|Sevoflurane|sevoflurane|mesh-list
838237|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
838238|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
838239|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838240|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
838241|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
838242|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
838243|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
838244|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
838418|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
838419|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
838420|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
838421|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
838422|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838488|NCT02427893|Vemurafenib|vemurafenib|mesh-list
838489|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838490|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
838491|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838492|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838694|NCT02426905|Trientine|trientine|mesh-list
838695|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
838696|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
838697|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839212|NCT02425501|Aflibercept|aflibercept|mesh-list
839213|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
839214|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
839215|NCT02425501|Growth Substances|growth substances|mesh-ancestor
839216|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839217|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
839218|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839256|NCT02425202|Ketamine|ketamine|mesh-list
839257|NCT02425202|Analgesics|analgesics|mesh-ancestor
839258|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
839259|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839260|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839261|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
839262|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
839263|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
839264|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
839265|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
839266|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
839267|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
839268|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839269|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839747|NCT02423265|Ranolazine|ranolazine|mesh-list
839748|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
839749|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
839750|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840046|NCT02422199|Capecitabine|capecitabine|mesh-list
840047|NCT02422199|Lapatinib|lapatinib|mesh-list
840048|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
840049|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
840050|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840051|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840052|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
837436|NCT02431936|Prazosin|prazosin|mesh-list
837437|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
837438|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
837439|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
837440|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
837441|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
837442|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837443|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837444|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837517|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
837518|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837519|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
837520|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837521|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838126|NCT02429232|Pioglitazone|pioglitazone|mesh-list
838127|NCT02429232|Linagliptin|linagliptin|mesh-list
838128|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
838129|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838130|NCT02429232|Incretins|incretins|mesh-ancestor
838131|NCT02429232|Hormones|hormones|mesh-ancestor
838132|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838133|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
838134|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
838135|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838136|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838643|NCT02427386|Estradiol|estradiol|mesh-list
838644|NCT02427386|Estrogens|estrogens|mesh-list
838645|NCT02427386|Hormones|hormones|mesh-ancestor
838646|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838647|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838900|NCT02426177|Labetalol|labetalol|mesh-list
838901|NCT02426177|Nifedipine|nifedipine|mesh-list
838902|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
838903|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
838904|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838905|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
838906|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838907|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
838908|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
838909|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
838910|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
838911|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
838912|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
838913|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
838914|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
838915|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
838916|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
838917|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838918|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
838919|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
839091|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
839092|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
839093|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
839094|NCT02425813|Prednisolone|prednisolone|mesh-list
839095|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
839096|NCT02425813|Budesonide|budesonide|mesh-list
839097|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
839098|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
839099|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
839100|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
839101|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
839102|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839103|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839104|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
839105|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
839106|NCT02425813|Hormones|hormones|mesh-ancestor
839107|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
839108|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
839109|NCT02425813|Protective Agents|protective agents|mesh-ancestor
2255124|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2255125|NCT00144911|Fluticasone|fluticasone|mesh-list
2255126|NCT00144911|Xhance|xhance|mesh-list
837919|NCT02429726|Cisplatin|cisplatin|mesh-list
837920|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838047|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
838048|NCT02429375|Mocetinostat|mocetinostat|mesh-list
838049|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
838050|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838051|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
838052|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838053|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2098991|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2098992|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2098993|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2255127|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2255128|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2255129|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2255130|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
2255131|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255132|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255133|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2255134|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
839636|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
839637|NCT02423759|Gentamicins|gentamicins|mesh-list
839638|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
839639|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
839640|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
839641|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
839642|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839643|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839644|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839645|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
839646|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
839647|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
839802|NCT02422966|Acetaminophen|acetaminophen|mesh-list
839803|NCT02422966|Ibuprofen|ibuprofen|mesh-list
839804|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
839805|NCT02422966|Analgesics|analgesics|mesh-ancestor
839806|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
839807|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839808|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839809|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
839810|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
839811|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
839812|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
839813|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
839814|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839815|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839971|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
839972|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
839973|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
839974|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
839975|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
839976|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839977|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839978|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
2255135|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
2255136|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2255137|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2255138|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2255139|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2255140|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
2255141|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2255142|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255143|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2255144|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255145|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2255146|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255147|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255148|NCT00144989|Cisplatin|cisplatin|mesh-list
2255149|NCT00144989|Etoposide|etoposide|mesh-list
2255150|NCT00144989|Irinotecan|irinotecan|mesh-list
2255151|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255152|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2255153|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2255154|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2255155|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255156|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255157|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2255158|NCT00145002|Lenograstim|lenograstim|mesh-list
2255159|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
838272|NCT02429076|Propofol|propofol|mesh-list
838273|NCT02429076|Sevoflurane|sevoflurane|mesh-list
838274|NCT02429076|Methylphenidate|methylphenidate|mesh-list
838275|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
838276|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
838277|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838278|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
838279|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
838280|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
838281|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
838282|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
838283|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
838284|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
838285|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
838286|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
838287|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838288|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
838289|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
838783|NCT02426736|Dexamethasone|dexamethasone|mesh-list
838784|NCT02426736|Bupivacaine|bupivacaine|mesh-list
838785|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
838786|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
838787|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
838788|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838789|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838790|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
838791|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
838792|NCT02426736|Hormones|hormones|mesh-ancestor
838793|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838794|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
838795|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838796|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
838797|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
838798|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
838799|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
839489|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
839490|NCT02424461|Ofloxacin|ofloxacin|mesh-list
839491|NCT02424461|Levofloxacin|levofloxacin|mesh-list
839492|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
839493|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
839494|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
839495|NCT02424461|Renal Agents|renal agents|mesh-ancestor
839496|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
839497|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
839498|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839499|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839500|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839501|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
839502|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
839872|NCT02422823|Epinephrine|epinephrine|mesh-list
839873|NCT02422823|Carticaine|carticaine|mesh-list
839874|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
839875|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
839876|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
839877|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839878|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839879|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839880|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
839881|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
839882|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
839883|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839884|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
839885|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
839886|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
839887|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
839888|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
839889|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
839890|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
837669|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
837670|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
837671|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
837672|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
837673|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
837674|NCT02431208|Hormones|hormones|mesh-ancestor
837675|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
837676|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
837677|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837678|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
837679|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
837680|NCT02431208|Growth Substances|growth substances|mesh-ancestor
837681|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
2255160|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
2255161|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255162|NCT00145028|Carboplatin|carboplatin|mesh-list
2255163|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255164|NCT00145093|Chromium|chromium|mesh-list
2255165|NCT00145093|Trace Elements|trace elements|mesh-ancestor
2255166|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
2255167|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838203|NCT02429050|Morphine|morphine|mesh-list
838204|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
838205|NCT02429050|Narcotics|narcotics|mesh-ancestor
838206|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
838207|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838208|NCT02429050|Analgesics|analgesics|mesh-ancestor
838209|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
838210|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838320|NCT02428543|Cytarabine|cytarabine|mesh-list
838321|NCT02428543|Ponatinib|ponatinib|mesh-list
838322|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
838323|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
838324|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838325|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838326|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
838327|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
838328|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
838329|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
838330|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838331|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
838332|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255168|NCT00145106|Minocycline|minocycline|mesh-list
2255169|NCT00145106|Tazarotene|tazarotene|mesh-list
2255170|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2255171|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255172|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
2255173|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
838893|NCT02426294|Pioglitazone|pioglitazone|mesh-list
838894|NCT02426294|Glimepiride|glimepiride|mesh-list
838895|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
838896|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838897|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
838898|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
838899|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
839051|NCT02425852|Prednisolone|prednisolone|mesh-list
839052|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
839053|NCT02425852|Azathioprine|azathioprine|mesh-list
839054|NCT02425852|Infliximab|infliximab|mesh-list
839055|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
839056|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
839057|NCT02425852|Hormones|hormones|mesh-ancestor
839058|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
839059|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839060|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
839061|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839062|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
839063|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
839064|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
839065|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
839066|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839067|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
839068|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
839069|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
839692|NCT02423824|Liraglutide|liraglutide|mesh-list
839693|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
840054|NCT02422108|Denosumab|denosumab|mesh-list
2255174|NCT00145171|Apomorphine|apomorphine|mesh-list
2255175|NCT00145171|Emetics|emetics|mesh-ancestor
837825|NCT02430103|Goserelin|goserelin|mesh-list
837826|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
837827|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837950|NCT02429700|Paclitaxel|paclitaxel|mesh-list
837951|NCT02429700|Etoposide|etoposide|mesh-list
837952|NCT02429700|Carboplatin|carboplatin|mesh-list
837953|NCT02429700|Bleomycin|bleomycin|mesh-list
837954|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
837955|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837956|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
837957|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
837958|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
837959|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837960|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
837961|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
837962|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837963|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
838617|NCT02427334|Dienogest|dienogest|mesh-list
838618|NCT02427334|Fluoxetine|fluoxetine|mesh-list
838619|NCT02427334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
838620|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
838621|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
838622|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838623|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
838624|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
838625|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838626|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
838627|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
838628|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
838629|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
838630|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
838631|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838632|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
838633|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
838634|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
838635|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
838636|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
838637|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
838638|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
838639|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
838640|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838641|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
838642|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838762|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
838763|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
838764|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
838765|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
838766|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
838767|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
838768|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838769|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255176|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255177|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
2255178|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255179|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2255180|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
2255181|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
2255182|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2255183|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255184|NCT00145184|Vitamins|vitamins|mesh-list
2255185|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
2255186|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
2255187|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255188|NCT00145210|Atenolol|atenolol|mesh-list
2255189|NCT00145210|Nebivolol|nebivolol|mesh-list
839795|NCT02422901|Ascorbic Acid|ascorbic acid|mesh-list
839796|NCT02422901|Vitamins|vitamins|mesh-ancestor
839797|NCT02422901|Micronutrients|micronutrients|mesh-ancestor
839798|NCT02422901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839799|NCT02422901|Antioxidants|antioxidants|mesh-ancestor
2255190|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
837835|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837836|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
837837|NCT02429973|Antiviral Agents|antiviral agents|mesh-ancestor
837838|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
837839|NCT02429973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
837840|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
837841|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
837842|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837843|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
837844|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
837845|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
837904|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
837905|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
837906|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
837907|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
837908|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
837909|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837910|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837911|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
837912|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
837913|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
837914|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
837915|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
837916|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
838137|NCT02429440|Molgramostim|molgramostim|mesh-list
838138|NCT02429440|Sargramostim|sargramostim|mesh-list
838139|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
838140|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838141|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255191|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2255192|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
2255193|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
2255194|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255195|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838565|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
838566|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
838567|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839270|NCT02425254|Acetaminophen|acetaminophen|mesh-list
839271|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
839272|NCT02425254|Analgesics|analgesics|mesh-ancestor
839273|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
839274|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839275|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839276|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
2255196|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2255197|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2255198|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2255199|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
2255200|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2255201|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255202|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
2255203|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2255204|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2255205|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2255206|NCT00145236|Nebivolol|nebivolol|mesh-list
2255207|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2255208|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
2255209|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
840732|NCT02419560|Venetoclax|venetoclax|mesh-list
840733|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255210|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2255211|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2255212|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
2255213|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2255214|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255215|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255216|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
2255217|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2255218|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255219|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
2255220|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2255221|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2255222|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255223|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837940|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
837941|NCT02429817|Antidotes|antidotes|mesh-ancestor
837942|NCT02429817|Protective Agents|protective agents|mesh-ancestor
837943|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
837944|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
837945|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
837946|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
837947|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
837948|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
837949|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
838110|NCT02429323|Sevoflurane|sevoflurane|mesh-list
838111|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
838112|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
838113|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
838114|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
838115|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
838116|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838312|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
838313|NCT02428686|Hematinics|hematinics|mesh-ancestor
839046|NCT02425943|Mannitol|mannitol|mesh-list
839047|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
839048|NCT02425943|Diuretics|diuretics|mesh-ancestor
839049|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
839050|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839167|NCT02425566|Trimethaphan|trimethaphan|mesh-list
839168|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
839169|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
839170|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
839171|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
839172|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
839173|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
839174|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
839175|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839176|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839177|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
839178|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
839179|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
839180|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839181|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255224|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2255225|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2255226|NCT00145301|Analgesics|analgesics|mesh-ancestor
2255227|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
2255228|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255229|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255230|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2255231|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2255232|NCT00145314|Leucovorin|leucovorin|mesh-list
2255233|NCT00145314|Folic Acid|folic acid|mesh-list
2255234|NCT00145314|Fluorouracil|fluorouracil|mesh-list
2255235|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
2098994|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2098995|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2098996|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
2098997|NCT02351934|Diuretics|diuretics|mesh-ancestor
2098998|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
2098999|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2099000|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2255236|NCT00145314|Cetuximab|cetuximab|mesh-list
2255237|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
2255238|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
2255239|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840420|NCT02420795|TIC10 compound|tic10 compound|mesh-list
840421|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840727|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
840728|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
840729|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
840730|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
840731|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255240|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2255241|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255242|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2255243|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
2255244|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255245|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2255246|NCT00145314|Antidotes|antidotes|mesh-ancestor
2255247|NCT00145314|Protective Agents|protective agents|mesh-ancestor
2255248|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
2255249|NCT00145314|Vitamins|vitamins|mesh-ancestor
2255250|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
2255251|NCT00145314|Hematinics|hematinics|mesh-ancestor
2255252|NCT00145340|Pioglitazone|pioglitazone|mesh-list
2255253|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2255254|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255255|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
2255256|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
838428|NCT02428374|Clopidogrel|clopidogrel|mesh-list
838429|NCT02428374|Ticagrelor|ticagrelor|mesh-list
838430|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
838431|NCT02428374|Simvastatin|simvastatin|mesh-list
838432|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
838433|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
838434|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
838435|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
838436|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
838437|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
838438|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838439|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838440|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
838441|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
838442|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
838443|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
838444|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
838445|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255257|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255258|NCT00145379|Metformin|metformin|mesh-list
2255259|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2255260|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255261|NCT00145405|Octreotide|octreotide|mesh-list
2255262|NCT00145405|Lanreotide|lanreotide|mesh-list
2255263|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2255264|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2255265|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255266|NCT00145431|Atorvastatin|atorvastatin|mesh-list
2255267|NCT00145431|Torcetrapib|torcetrapib|mesh-list
2255268|NCT00145431|Fenofibrate|fenofibrate|mesh-list
2255269|NCT00145431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2255270|NCT00145431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2255271|NCT00145431|Antimetabolites|antimetabolites|mesh-ancestor
2255272|NCT00145431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255273|NCT00145431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2255274|NCT00145431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2255275|NCT00145431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255276|NCT00145444|Olanzapine|olanzapine|mesh-list
2255277|NCT00145444|Ziprasidone|ziprasidone|mesh-list
2255278|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
2255279|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
2255280|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838920|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
838921|NCT02426164|Epinephrine|epinephrine|mesh-list
838922|NCT02426164|Morphine|morphine|mesh-list
838923|NCT02426164|Bupivacaine|bupivacaine|mesh-list
838924|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
838925|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
838926|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
838927|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838928|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
838929|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838930|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
838931|NCT02426164|Narcotics|narcotics|mesh-ancestor
838932|NCT02426164|Analgesics|analgesics|mesh-ancestor
838933|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
838934|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
838935|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
838936|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
838937|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
838938|NCT02426164|Hormones|hormones|mesh-ancestor
838939|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838940|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
838941|NCT02426164|Protective Agents|protective agents|mesh-ancestor
838942|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
838943|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
838944|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
838945|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099001|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
2255281|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255282|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
838233|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
838234|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
838691|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
838692|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
838693|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838743|NCT02426697|Fentanyl|fentanyl|mesh-list
838744|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
838745|NCT02426697|Narcotics|narcotics|mesh-ancestor
838746|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
838747|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838748|NCT02426697|Analgesics|analgesics|mesh-ancestor
838749|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
838750|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838751|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
838752|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
838753|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
838754|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
838878|NCT02426450|Leucovorin|leucovorin|mesh-list
838879|NCT02426450|Fluorouracil|fluorouracil|mesh-list
838880|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
838881|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
838882|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838883|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
838884|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838885|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
838886|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
838887|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838888|NCT02426450|Antidotes|antidotes|mesh-ancestor
838889|NCT02426450|Protective Agents|protective agents|mesh-ancestor
838890|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
838891|NCT02426450|Vitamins|vitamins|mesh-ancestor
838892|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
839040|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
839041|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
839042|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
839043|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
839044|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839045|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
839219|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
839220|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
839221|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839222|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
839223|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839224|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255283|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2255284|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2255285|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2255286|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
839897|NCT02423018|Pregabalin|pregabalin|mesh-list
839898|NCT02423018|Analgesics|analgesics|mesh-ancestor
839899|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
839900|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839901|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839902|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
839903|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
839904|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
839905|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839906|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
839907|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
839908|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
839909|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
839910|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2255287|NCT00145444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2255288|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2255289|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2099002|NCT02351960|Lansoprazole|lansoprazole|mesh-list
2099003|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2099004|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2099005|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2099006|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099007|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099008|NCT02352090|Dienogest|dienogest|mesh-list
2099009|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2099010|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2099011|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2099012|NCT02352090|Estradiol|estradiol|mesh-list
838245|NCT02428946|Bromocriptine|bromocriptine|mesh-list
838246|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
838247|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
838248|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
838249|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838250|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838251|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
838252|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
838253|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
838254|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838446|NCT02428205|Propranolol|propranolol|mesh-list
838447|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
838448|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
838449|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
838450|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
838451|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838452|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838453|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
838454|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
838455|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
2255290|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255291|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2255292|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
2255293|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2255294|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2255295|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
2255296|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
2255297|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
2255298|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2255299|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2255300|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255301|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255302|NCT00145483|Urological Agents|urological agents|mesh-ancestor
2255303|NCT00145522|Tibolone|tibolone|mesh-list
2255304|NCT00145522|Estradiol|estradiol|mesh-list
2255305|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
2255306|NCT00145522|Estrogens|estrogens|mesh-ancestor
2255307|NCT00145522|Hormones|hormones|mesh-ancestor
2255308|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2255309|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255310|NCT00145522|Progestins|progestins|mesh-ancestor
2255311|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
839423|NCT02424318|Topiramate|topiramate|mesh-list
839424|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
839425|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
839426|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839725|NCT02423395|Orphenadrine|orphenadrine|mesh-list
839726|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839727|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
839728|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
839729|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
839730|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
839731|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839732|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
839733|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
839734|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
839735|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
839736|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
839737|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839738|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839739|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
839740|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
839741|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839846|NCT02423096|Haloperidol|haloperidol|mesh-list
839847|NCT02423096|Olanzapine|olanzapine|mesh-list
839848|NCT02423096|Risperidone|risperidone|mesh-list
839849|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
839850|NCT02423096|Sulpiride|sulpiride|mesh-list
839851|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
839852|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
839853|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839854|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839855|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839856|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
839857|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2255312|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
838406|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
838407|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
838408|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838409|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
838410|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
838411|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
838412|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
838413|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
838414|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
838415|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
838416|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
838417|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838481|NCT02427932|Gentamicins|gentamicins|mesh-list
838482|NCT02427932|Ampicillin|ampicillin|mesh-list
838483|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
838484|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
838485|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
838486|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838487|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838611|NCT02427308|Miltefosine|miltefosine|mesh-list
838612|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
838613|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
838614|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838615|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
838616|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
839115|NCT02425709|Diclofenac|diclofenac|mesh-list
839116|NCT02425709|Tramadol|tramadol|mesh-list
839117|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
839118|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
839119|NCT02425709|Analgesics|analgesics|mesh-ancestor
839120|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
839121|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839122|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839123|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
839124|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
839125|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
839126|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839127|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839128|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
839129|NCT02425709|Narcotics|narcotics|mesh-ancestor
839130|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
840304|NCT02421263|Psilocybin|psilocybin|mesh-list
840305|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
840306|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840307|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
840364|NCT02420860|Lenalidomide|lenalidomide|mesh-list
840365|NCT02420860|Elotuzumab|elotuzumab|mesh-list
840366|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
840367|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840368|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
840369|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
840370|NCT02420860|Growth Substances|growth substances|mesh-ancestor
840371|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
840372|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255313|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2255314|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2255315|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255316|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2255317|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
2255318|NCT00145561|Ritonavir|ritonavir|mesh-list
2255319|NCT00145561|Saquinavir|saquinavir|mesh-list
2255320|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2255321|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2255322|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
841422|NCT02417467|Nicotine|nicotine|mesh-list
841423|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
841424|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
841425|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841426|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841427|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
841428|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
841429|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
841430|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
841431|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841784|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
841785|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2255323|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255324|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255325|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
838833|NCT02426281|Gemcitabine|gemcitabine|mesh-list
838834|NCT02426281|Paclitaxel|paclitaxel|mesh-list
838835|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
838836|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
838837|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
838838|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
838839|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
838840|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838841|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
838842|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
838843|NCT02426281|Antiviral Agents|antiviral agents|mesh-ancestor
838844|NCT02426281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
838845|NCT02426281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838846|NCT02426281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
838847|NCT02426281|Immunologic Factors|immunologic factors|mesh-ancestor
838848|NCT02426281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839077|NCT02425722|Linaclotide|linaclotide|mesh-list
839078|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
839079|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
839080|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839081|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2255326|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2255327|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
2255328|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255329|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2255330|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2099013|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2099014|NCT02352090|Nandrolone|nandrolone|mesh-list
2099015|NCT02352090|Estrogens|estrogens|mesh-ancestor
2099016|NCT02352090|Hormones|hormones|mesh-ancestor
2099017|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2099018|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099019|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2099020|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
2099021|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2099022|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2099023|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2099024|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2099025|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2099026|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
2255331|NCT00145613|Antibodies|antibodies|mesh-list
841148|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
841149|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
841150|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
841151|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
841152|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841153|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
841154|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
841155|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255332|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
2255333|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255334|NCT00145639|Carboplatin|carboplatin|mesh-list
2255335|NCT00145639|Doxorubicin|doxorubicin|mesh-list
2255336|NCT00145639|Ifosfamide|ifosfamide|mesh-list
2255337|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255338|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
841705|NCT02416388|Cytarabine|cytarabine|mesh-list
841706|NCT02416388|Cyclosporine|cyclosporine|mesh-list
841707|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
841708|NCT02416388|Dexamethasone|dexamethasone|mesh-list
841709|NCT02416388|Methotrexate|methotrexate|mesh-list
841710|NCT02416388|Daunorubicin|daunorubicin|mesh-list
841711|NCT02416388|Venetoclax|venetoclax|mesh-list
841712|NCT02416388|Idarubicin|idarubicin|mesh-list
841713|NCT02416388|Cyclosporins|cyclosporins|mesh-list
841714|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
841715|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
841716|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
841717|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841718|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841719|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
841720|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
841721|NCT02416388|Hormones|hormones|mesh-ancestor
2255339|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
838742|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
839037|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
839038|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
839039|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840501|NCT02420782|Itraconazole|itraconazole|mesh-list
840502|NCT02420782|Midazolam|midazolam|mesh-list
840503|NCT02420782|Pilocarpine|pilocarpine|mesh-list
840504|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
840505|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
840506|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
840507|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840508|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
840509|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
840510|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
840511|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
840512|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
840513|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
840514|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
840515|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
840516|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
840517|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840518|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
840519|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
840520|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
840521|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
840522|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840523|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
840524|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
840525|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
840526|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
840527|NCT02420782|Miotics|miotics|mesh-ancestor
840528|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
840529|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
840530|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
840531|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
840532|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
840956|NCT02419820|Aspirin|aspirin|mesh-list
840957|NCT02419820|Clopidogrel|clopidogrel|mesh-list
840958|NCT02419820|APD791|apd791|mesh-list
840959|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
840960|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
840961|NCT02419820|Analgesics|analgesics|mesh-ancestor
840962|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
840963|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
840964|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840965|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
840966|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
840967|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
840968|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
840969|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840970|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
840971|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
840972|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840973|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
840974|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
840975|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
840976|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
840977|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
840978|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
840979|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
840980|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
840981|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
841116|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
841117|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
841118|NCT02418988|Estrogens|estrogens|mesh-ancestor
841119|NCT02418988|Hormones|hormones|mesh-ancestor
841120|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841121|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841122|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
841123|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841142|NCT02418624|Carboplatin|carboplatin|mesh-list
841143|NCT02418624|Olaparib|olaparib|mesh-list
841144|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841145|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
841146|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838865|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
838866|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838867|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
838868|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
838869|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
838870|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2255340|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2255341|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255342|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255343|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2255344|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
2255345|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2255346|NCT00145652|Hematinics|hematinics|mesh-ancestor
2255347|NCT00145665|Telbivudine|telbivudine|mesh-list
2255348|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
2255349|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255350|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2255351|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255352|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255353|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
2255354|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
2255355|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2255356|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2255357|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2255358|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255359|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
839583|NCT02423954|Sirolimus|sirolimus|mesh-list
839584|NCT02423954|Capecitabine|capecitabine|mesh-list
839585|NCT02423954|Nivolumab|nivolumab|mesh-list
839586|NCT02423954|Irinotecan|irinotecan|mesh-list
839587|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
839588|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
839589|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839590|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839591|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
839592|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
839593|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
839594|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
839595|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839596|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
839597|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
839598|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
839599|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
839600|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
839601|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
839602|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255360|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2255361|NCT00145730|Ibuprofen|ibuprofen|mesh-list
2255362|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2255363|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2255364|NCT00145730|Analgesics|analgesics|mesh-ancestor
840540|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
840541|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
838946|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
838947|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
838948|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
838949|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
838950|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
838951|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
838952|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
838953|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
839082|NCT02425774|Prucalopride|prucalopride|mesh-list
839083|NCT02425774|Laxatives|laxatives|mesh-ancestor
839084|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
839085|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
839086|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
839087|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
839088|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839089|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839090|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839196|NCT02425462|Dienogest|dienogest|mesh-list
839197|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
839198|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
839199|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
839200|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839201|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
839202|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
839203|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
839204|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
839205|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
839206|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
839207|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
839208|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255365|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
2255366|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255367|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255368|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2255369|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2255370|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2255371|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255372|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255373|NCT00145847|Naltrexone|naltrexone|mesh-list
2255374|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2255375|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2255376|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255377|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
2255378|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255379|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2255380|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
2255381|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255382|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
2255383|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255384|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2255385|NCT00145925|Gliclazide|gliclazide|mesh-list
2255386|NCT00145925|Perindopril|perindopril|mesh-list
2255387|NCT00145925|Indapamide|indapamide|mesh-list
2255388|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
2255389|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2255390|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
2255391|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255392|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842359|NCT02414399|Azithromycin|azithromycin|mesh-list
842360|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
842361|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
842435|NCT02413827|Ipilimumab|ipilimumab|mesh-list
842436|NCT02413827|Poly ICLC|poly iclc|mesh-list
842437|NCT02413827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
842438|NCT02413827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
842439|NCT02413827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842440|NCT02413827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
839003|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
839004|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
839005|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
839006|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
839007|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
839008|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
839009|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
839010|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
839011|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
839012|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
839013|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
839014|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
839015|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
839016|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
839017|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
839018|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
839019|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
839375|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
839376|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
839377|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255393|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2255394|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2255395|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255396|NCT00145925|Diuretics|diuretics|mesh-ancestor
2255397|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
2255398|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2255399|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2255400|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
839564|NCT02423837|Rituximab|rituximab|mesh-list
839565|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
839566|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
839567|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839568|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
839569|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839570|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
839571|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
839572|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
839573|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839756|NCT02423239|Gemcitabine|gemcitabine|mesh-list
839757|NCT02423239|Paclitaxel|paclitaxel|mesh-list
839758|NCT02423239|Sorafenib|sorafenib|mesh-list
839759|NCT02423239|HU 211|hu 211|mesh-list
839760|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
839761|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839762|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
839763|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
839764|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
839765|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839766|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
839767|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
839768|NCT02423239|Antiviral Agents|antiviral agents|mesh-ancestor
839769|NCT02423239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
839770|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839771|NCT02423239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
839772|NCT02423239|Immunologic Factors|immunologic factors|mesh-ancestor
839773|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839774|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
839775|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
839776|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
839777|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
839778|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839779|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
839780|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
839781|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
839782|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839783|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
839784|NCT02423239|Protective Agents|protective agents|mesh-ancestor
840028|NCT02422654|Eliglustat|eliglustat|mesh-list
840029|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840030|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255401|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
2255402|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2255403|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2255404|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841350|NCT02418065|Testosterone|testosterone|mesh-list
839075|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839076|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255405|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255406|NCT00145938|Urological Agents|urological agents|mesh-ancestor
2255407|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
2255408|NCT00145990|Miotics|miotics|mesh-ancestor
2255409|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
2255410|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255411|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255412|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2255413|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2255414|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
2255415|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2255416|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2255417|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
2255418|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2255419|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255420|NCT00146016|Amantadine|amantadine|mesh-list
2255421|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2255422|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2255423|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
2255424|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255425|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
839834|NCT02422953|Micronutrients|micronutrients|mesh-list
839835|NCT02422953|Trace Elements|trace elements|mesh-list
839836|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840314|NCT02421042|Lenvatinib|lenvatinib|mesh-list
840315|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840316|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
840317|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840318|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840982|NCT02420717|Leucovorin|leucovorin|mesh-list
840983|NCT02420717|Cytarabine|cytarabine|mesh-list
840984|NCT02420717|Dexamethasone|dexamethasone|mesh-list
840985|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
840986|NCT02420717|Prednisone|prednisone|mesh-list
840987|NCT02420717|Cortisone|cortisone|mesh-list
840988|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
840989|NCT02420717|Rituximab|rituximab|mesh-list
840990|NCT02420717|Doxorubicin|doxorubicin|mesh-list
840991|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
840992|NCT02420717|Methotrexate|methotrexate|mesh-list
840993|NCT02420717|Vincristine|vincristine|mesh-list
840994|NCT02420717|Daunorubicin|daunorubicin|mesh-list
840995|NCT02420717|Dasatinib|dasatinib|mesh-list
840996|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
840997|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
840998|NCT02420717|Antibodies|antibodies|mesh-list
840999|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
841000|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
841001|NCT02420717|BB 1101|bb 1101|mesh-list
841002|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
841003|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
841004|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841005|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
841006|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
841007|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
841008|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841009|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841010|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
841011|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
841012|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
841013|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
841014|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841015|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
841016|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
841017|NCT02420717|Hormones|hormones|mesh-ancestor
841018|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841019|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
841020|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
841021|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841022|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
841023|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
841024|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
841025|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
841026|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
841027|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2255426|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839110|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
839111|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839112|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
839113|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
839114|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
2255427|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255428|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255429|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2255430|NCT00146016|Analgesics|analgesics|mesh-ancestor
2255431|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
2255432|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839992|NCT02422498|Cisplatin|cisplatin|mesh-list
839993|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255433|NCT00146042|Erythromycin|erythromycin|mesh-list
2255434|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
2255435|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2255436|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
840778|NCT02419417|Nivolumab|nivolumab|mesh-list
840779|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
840780|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840781|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
840782|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841050|NCT02419118|Dexamethasone|dexamethasone|mesh-list
841051|NCT02419118|Lenalidomide|lenalidomide|mesh-list
841052|NCT02419118|Daratumumab|daratumumab|mesh-list
841053|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
841054|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
841055|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
841056|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841057|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841058|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
841059|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
841060|NCT02419118|Hormones|hormones|mesh-ancestor
841061|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841062|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
841063|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841064|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
841065|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
841066|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
841067|NCT02419118|Growth Substances|growth substances|mesh-ancestor
841068|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
2255437|NCT00146042|Docetaxel|docetaxel|mesh-list
2255438|NCT00146042|Trastuzumab|trastuzumab|mesh-list
2255439|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255440|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
2255441|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
2255442|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
2255443|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255444|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2255445|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2255446|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255447|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2255448|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
841384|NCT02417493|Epinephrine|epinephrine|mesh-list
841385|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
841392|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
841393|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
841394|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
841395|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841396|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841397|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
841398|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
841399|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
841400|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841401|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
841402|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
841403|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
841404|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
841405|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
841450|NCT02417298|Ketamine|ketamine|mesh-list
841451|NCT02417298|Analgesics|analgesics|mesh-ancestor
841452|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
841453|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841454|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841455|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2099027|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2099028|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099029|NCT02352090|Androgens|androgens|mesh-ancestor
2099030|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
2099031|NCT02352259|Bleomycin|bleomycin|mesh-list
2099032|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2099033|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099034|NCT02352363|Levodopa|levodopa|mesh-list
2099035|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2099036|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
839837|NCT02423083|Guanabenz|guanabenz|mesh-list
839838|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
839839|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
839840|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
839841|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
839842|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
839843|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839844|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839845|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840037|NCT02422017|Timolol|timolol|mesh-list
840038|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
840039|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
840040|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
840041|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
840042|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840043|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840044|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
840045|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2255449|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255450|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
2255451|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2255452|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
2255453|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255454|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255455|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
2255456|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255457|NCT00146120|Etoposide|etoposide|mesh-list
2255458|NCT00146120|Idarubicin|idarubicin|mesh-list
2255459|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2255460|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255461|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2255462|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2255463|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255464|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255465|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2255466|NCT00146146|Letrozole|letrozole|mesh-list
2255467|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
2255468|NCT00146146|Dutasteride|dutasteride|mesh-list
2255469|NCT00146146|Testosterone|testosterone|mesh-list
840873|NCT02419352|Atropine|atropine|mesh-list
840874|NCT02419352|Neostigmine|neostigmine|mesh-list
840875|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
840876|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
840877|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
840878|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
840879|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
840880|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840881|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
840882|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
840883|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
840884|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
840885|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
840886|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
840887|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
840888|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
840889|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840890|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
840891|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840892|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
841323|NCT02418078|Anesthetics|anesthetics|mesh-list
841324|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
841325|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255470|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
2255471|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
2099037|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
2255472|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2255473|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839188|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839189|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839303|NCT02425241|Vaccines|vaccines|mesh-list
839304|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
839305|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839528|NCT02424071|Melatonin|melatonin|mesh-list
839529|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
839530|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839531|NCT02424071|Protective Agents|protective agents|mesh-ancestor
839532|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839533|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
839648|NCT02423694|Dexetimide|dexetimide|mesh-list
839649|NCT02423694|Citalopram|citalopram|mesh-list
839650|NCT02423694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
839651|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
839652|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
839653|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839654|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839655|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
839656|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839657|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
839658|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
839659|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
839660|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
839661|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
839662|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
839663|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
839664|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839665|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
839666|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
839667|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
839824|NCT02422888|Ticagrelor|ticagrelor|mesh-list
839825|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
839826|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
839827|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
839828|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
839829|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
839830|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
839831|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839832|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839833|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840205|NCT02422121|RNS60|rns60|mesh-list
840206|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
840207|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
840208|NCT02422121|Analgesics|analgesics|mesh-ancestor
840209|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
840210|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
840211|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840212|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
840213|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
840214|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2255474|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2255475|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2255476|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255477|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255478|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2255479|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
839246|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
839247|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
839248|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839249|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839250|NCT02425137|Antiviral Agents|antiviral agents|mesh-ancestor
839251|NCT02425137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
839252|NCT02425137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839253|NCT02425137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
839254|NCT02425137|Immunologic Factors|immunologic factors|mesh-ancestor
839255|NCT02425137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839934|NCT02422589|Ceritinib|ceritinib|mesh-list
839935|NCT02422589|Midazolam|midazolam|mesh-list
839936|NCT02422589|Warfarin|warfarin|mesh-list
839937|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
839938|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
839939|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
839940|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839941|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
839942|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
839943|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
839944|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
839945|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
839946|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
839947|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
839948|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
839949|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839950|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839951|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
839952|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839953|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
839954|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840108|NCT02422030|Atorvastatin|atorvastatin|mesh-list
840109|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
840110|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
840111|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
840112|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
840113|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840114|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
840115|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
840116|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840215|NCT02421640|Cisplatin|cisplatin|mesh-list
840216|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840483|NCT02420652|Aspirin|aspirin|mesh-list
840484|NCT02420652|Metformin|metformin|mesh-list
840485|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
840486|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840487|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
840488|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
840489|NCT02420652|Analgesics|analgesics|mesh-ancestor
840490|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
840491|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
840492|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
840493|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
840494|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
840495|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
840496|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840497|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
840498|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
840499|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840500|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
840559|NCT02420080|Brincidofovir|brincidofovir|mesh-list
840560|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
840561|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
840640|NCT02419742|Paclitaxel|paclitaxel|mesh-list
840641|NCT02419742|Docetaxel|docetaxel|mesh-list
840642|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
840643|NCT02419742|Carboplatin|carboplatin|mesh-list
840644|NCT02419742|Doxorubicin|doxorubicin|mesh-list
840645|NCT02419742|Trastuzumab|trastuzumab|mesh-list
840646|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
840647|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840648|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
840649|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
840650|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
840651|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840652|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
840653|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
839441|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
839442|NCT02424435|Prednisolone|prednisolone|mesh-list
839443|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
839444|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
839445|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
839446|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
839447|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
839448|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
839449|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839450|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839451|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
839452|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
839453|NCT02424435|Hormones|hormones|mesh-ancestor
839454|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
839455|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
839456|NCT02424435|Protective Agents|protective agents|mesh-ancestor
839457|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
839458|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839551|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
839552|NCT02423928|Ipilimumab|ipilimumab|mesh-list
839553|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
839554|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
839555|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839556|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
839557|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
839558|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
839559|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839560|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839561|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
839562|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
839563|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
839668|NCT02423642|Heparin|heparin|mesh-list
839669|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
839670|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839671|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
839672|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2255480|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2255481|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255482|NCT00146146|Androgens|androgens|mesh-ancestor
840382|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
840383|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
840384|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
840385|NCT02420834|Laxatives|laxatives|mesh-ancestor
840386|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
841096|NCT02419105|Vitamin D|vitamin d|mesh-list
841097|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
841098|NCT02419105|Testosterone|testosterone|mesh-list
841099|NCT02419105|Vitamins|vitamins|mesh-ancestor
841100|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
841101|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841102|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
841103|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
841104|NCT02419105|Androgens|androgens|mesh-ancestor
841105|NCT02419105|Hormones|hormones|mesh-ancestor
841106|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2255483|NCT00146146|Hormones|hormones|mesh-ancestor
2255484|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2255485|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
842100|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
842101|NCT02414945|Fludarabine|fludarabine|mesh-list
842102|NCT02414945|Interleukin-2|interleukin-2|mesh-list
842103|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
842104|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
842105|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842106|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
842107|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
842108|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
842109|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842110|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842111|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
842112|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
842113|NCT02414945|Analgesics|analgesics|mesh-ancestor
842114|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
842115|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
842247|NCT02414568|Prednisone|prednisone|mesh-list
842248|NCT02414568|Doxorubicin|doxorubicin|mesh-list
2255486|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2255487|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
2255488|NCT00146159|Analgesics|analgesics|mesh-ancestor
2255489|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
839673|NCT02423603|Paclitaxel|paclitaxel|mesh-list
839674|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
839675|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839676|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
839677|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
839678|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
839679|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840552|NCT02420132|Ranibizumab|ranibizumab|mesh-list
840553|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
840554|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
840555|NCT02420132|Growth Substances|growth substances|mesh-ancestor
840556|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840557|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
840558|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840734|NCT02419443|Gabapentin|gabapentin|mesh-list
840735|NCT02419443|Analgesics|analgesics|mesh-ancestor
840736|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
840737|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
840738|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840739|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
840740|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
840741|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
840742|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
840743|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
840744|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
840745|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
840746|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
840747|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840748|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
840893|NCT02419261|Analgesics|analgesics|mesh-list
840894|NCT02419261|Ropivacaine|ropivacaine|mesh-list
840895|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
840896|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
840897|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
840898|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840899|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
840900|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841074|NCT02419040|Lidocaine|lidocaine|mesh-list
841075|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
841076|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
841077|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
841078|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841079|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
841080|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841081|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
841082|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
841083|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
841084|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
841085|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255490|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255491|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255492|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255493|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2255494|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2255495|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255496|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255497|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2255498|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2255499|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2255500|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
2255501|NCT00146224|Hematinics|hematinics|mesh-ancestor
2255502|NCT00146237|Phenytoin|phenytoin|mesh-list
2255503|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
2255504|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2255505|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2255506|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2255507|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255508|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2255509|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2255510|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
839523|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
839524|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
839525|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
839526|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
839527|NCT02424136|Protective Agents|protective agents|mesh-ancestor
839816|NCT02422784|Vitamin D|vitamin d|mesh-list
839817|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
839818|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
839819|NCT02422784|Vitamins|vitamins|mesh-list
839820|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
839821|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839822|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
839823|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
840256|NCT02421289|Efavirenz|efavirenz|mesh-list
840257|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
840258|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
840259|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840260|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840261|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
840262|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
840263|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
840264|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
840265|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
840266|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
840267|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
840268|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2099038|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099039|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099040|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099041|NCT02352831|Capecitabine|capecitabine|mesh-list
2099042|NCT02352831|Tosedostat|tosedostat|mesh-list
2099043|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2099044|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
2099045|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099046|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099047|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099048|NCT02352844|Everolimus|everolimus|mesh-list
2099049|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099050|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2099051|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
2099052|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255511|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
841470|NCT02417207|Entecavir|entecavir|mesh-list
841471|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
841472|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
841593|NCT02416804|Buprenorphine|buprenorphine|mesh-list
841594|NCT02416804|Tramadol|tramadol|mesh-list
841595|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
841596|NCT02416804|Narcotics|narcotics|mesh-ancestor
841597|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
841598|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841599|NCT02416804|Analgesics|analgesics|mesh-ancestor
841600|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
841601|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841602|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2255512|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
2255513|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
2255514|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2255515|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255516|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2255517|NCT00146250|Analgesics|analgesics|mesh-ancestor
2255518|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
842036|NCT02415270|Menthol|menthol|mesh-list
842037|NCT02415270|Nicotine|nicotine|mesh-list
842038|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
842039|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
842040|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
842041|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842042|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
842043|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
842044|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
842045|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
842046|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842047|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
842048|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
839537|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
839538|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
839539|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
839540|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839541|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839542|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
839543|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
839544|NCT02424045|Hormones|hormones|mesh-ancestor
839545|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
839546|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
839547|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839548|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
839549|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
839550|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255519|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255520|NCT00146276|Gemcitabine|gemcitabine|mesh-list
2255521|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2255522|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
2255523|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255524|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255525|NCT00146276|Antiviral Agents|antiviral agents|mesh-ancestor
2255526|NCT00146276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255527|NCT00146276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255528|NCT00146276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2255529|NCT00146276|Immunologic Factors|immunologic factors|mesh-ancestor
2255530|NCT00146276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255531|NCT00146289|Telmisartan|telmisartan|mesh-list
2255532|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2255533|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2255534|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2255535|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255536|NCT00146341|Telmisartan|telmisartan|mesh-list
2255537|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
840449|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
840450|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
840451|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840452|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
840453|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841170|NCT02418533|Menotropins|menotropins|mesh-list
841171|NCT02418533|Hormones|hormones|mesh-list
841172|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
841173|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841174|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841175|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
841176|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
841177|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
841587|NCT02416687|Etonogestrel|etonogestrel|mesh-list
841588|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
841589|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
841590|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
841591|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841592|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
841748|NCT02416167|Dotinurad|dotinurad|mesh-list
841749|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
841750|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
841751|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
841752|NCT02416167|Renal Agents|renal agents|mesh-ancestor
841879|NCT02415803|Clopidogrel|clopidogrel|mesh-list
841880|NCT02415803|Ticagrelor|ticagrelor|mesh-list
841881|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
841882|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
841883|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
841884|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
841885|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
841886|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
841887|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841888|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842049|NCT02415114|Resveratrol|resveratrol|mesh-list
842050|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
842051|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842052|NCT02415114|Protective Agents|protective agents|mesh-ancestor
842053|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839694|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839695|NCT02423824|Incretins|incretins|mesh-ancestor
839696|NCT02423824|Hormones|hormones|mesh-ancestor
839697|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2255538|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2255539|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2255540|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255541|NCT00146380|Lamivudine|lamivudine|mesh-list
2255542|NCT00146380|Zidovudine|zidovudine|mesh-list
2255543|NCT00146380|Nevirapine|nevirapine|mesh-list
2255544|NCT00146380|Nelfinavir|nelfinavir|mesh-list
2255545|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2255546|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2255547|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255548|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255549|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
2255550|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255551|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2255552|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2255553|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
2255554|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2255555|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
840308|NCT02420938|Rituximab|rituximab|mesh-list
840309|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
840310|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840311|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
840312|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840313|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2255556|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2255557|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2255558|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
2255559|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2255560|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2255561|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255562|NCT00146471|Levetiracetam|levetiracetam|mesh-list
2255563|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
2255564|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
2255565|NCT00146484|Insulin|insulin|mesh-list
2255566|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2255567|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255568|NCT00146497|Budesonide|budesonide|mesh-list
2255569|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2255570|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2255571|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
839714|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
839715|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
839716|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
839717|NCT02423915|Antiviral Agents|antiviral agents|mesh-ancestor
839718|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
839719|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
839720|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
839721|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
839722|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
839723|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839724|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
839979|NCT02422381|Gemcitabine|gemcitabine|mesh-list
839980|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
839981|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
839982|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
839983|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839984|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
839985|NCT02422381|Antiviral Agents|antiviral agents|mesh-ancestor
839986|NCT02422381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
839987|NCT02422381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
839988|NCT02422381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
839989|NCT02422381|Immunologic Factors|immunologic factors|mesh-ancestor
839990|NCT02422381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839991|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
840031|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
840032|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
840033|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
840034|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840035|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
840036|NCT02422056|Coagulants|coagulants|mesh-ancestor
840165|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
840166|NCT02421926|Dasatinib|dasatinib|mesh-list
840167|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840168|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
840169|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840170|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255572|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
2255573|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255574|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255575|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2255576|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
2255577|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
2255578|NCT00146497|Hormones|hormones|mesh-ancestor
2255579|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2255580|NCT00146523|Mifepristone|mifepristone|mesh-list
2255581|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2255582|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
2255583|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2255584|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255585|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2255586|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2255587|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2255588|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
2255589|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2255590|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2255591|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
2255592|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2255593|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
2255594|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2255595|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2255596|NCT00146549|Paclitaxel|paclitaxel|mesh-list
2255597|NCT00146549|Vinorelbine|vinorelbine|mesh-list
2255598|NCT00146549|Docetaxel|docetaxel|mesh-list
2255599|NCT00146549|Trastuzumab|trastuzumab|mesh-list
2255600|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2255601|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255602|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
840197|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
840198|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
840199|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
840200|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
840201|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
840202|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840203|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840204|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
840446|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
840447|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
840448|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2255603|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
2255604|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
2255605|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255606|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2255607|NCT00146562|Paclitaxel|paclitaxel|mesh-list
2255608|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
2255609|NCT00146562|Doxorubicin|doxorubicin|mesh-list
2255610|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
2255611|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2255612|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255613|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
2255614|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
2255615|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
2255616|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255617|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2255618|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
2255619|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840674|NCT02419651|Diclofenac|diclofenac|mesh-list
840675|NCT02419651|Tramadol|tramadol|mesh-list
840676|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
840677|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
840678|NCT02419651|Analgesics|analgesics|mesh-ancestor
840679|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
840680|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
840681|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840682|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
840683|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
840684|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
840685|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840686|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840687|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
840688|NCT02419651|Narcotics|narcotics|mesh-ancestor
840689|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2255620|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2255621|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2255622|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
2255623|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2255624|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2255625|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2255626|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2255627|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255628|NCT00146562|Hematinics|hematinics|mesh-ancestor
841485|NCT02416999|Bevacizumab|bevacizumab|mesh-list
841486|NCT02416999|Temozolomide|temozolomide|mesh-list
841487|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
841488|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841489|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
841490|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
841491|NCT02416999|Growth Substances|growth substances|mesh-ancestor
841492|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841493|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
841494|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
841495|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
841496|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841806|NCT02416115|Morphine|morphine|mesh-list
841807|NCT02416115|Ramosetron|ramosetron|mesh-list
841808|NCT02416115|Naloxone|naloxone|mesh-list
841809|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
841810|NCT02416115|Narcotics|narcotics|mesh-ancestor
2255629|NCT00146575|Sirolimus|sirolimus|mesh-list
2255630|NCT00146575|Paclitaxel|paclitaxel|mesh-list
839800|NCT02422901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
839801|NCT02422901|Protective Agents|protective agents|mesh-ancestor
840422|NCT02420665|Acetic Acid|acetic acid|mesh-list
840423|NCT02420665|Proflavine|proflavine|mesh-list
840424|NCT02420665|Retinol acetate|retinol acetate|mesh-list
840425|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
840426|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
840427|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
840428|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
840429|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840430|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
840431|NCT02420665|Protective Agents|protective agents|mesh-ancestor
840432|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840433|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2255631|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2255632|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255633|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
2255634|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
2255635|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
2255636|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255637|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2255638|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255639|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2255640|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
2255641|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2255642|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
2255643|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841696|NCT02416271|Vitamin D|vitamin d|mesh-list
841697|NCT02416271|Alendronate|alendronate|mesh-list
841698|NCT02416271|Teriparatide|teriparatide|mesh-list
841699|NCT02416271|Calcium|calcium|mesh-list
841700|NCT02416271|Vitamins|vitamins|mesh-ancestor
841701|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
841702|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841703|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
841704|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
841949|NCT02415192|Amlodipine|amlodipine|mesh-list
841950|NCT02415192|Valsartan|valsartan|mesh-list
841951|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
841952|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
841953|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
841954|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841955|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
841956|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841957|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
841958|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
841959|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
842077|NCT02414984|Golimumab|golimumab|mesh-list
842078|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
842079|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
842080|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
842081|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
842082|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842521|NCT02413541|Polymyxins|polymyxins|mesh-list
842522|NCT02413541|Polymyxin B|polymyxin b|mesh-list
842523|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
842524|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255644|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
2255645|NCT00146588|Capecitabine|capecitabine|mesh-list
2255646|NCT00146588|Epirubicin|epirubicin|mesh-list
2255647|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2255648|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
2255649|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255650|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2255651|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2255652|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
2255653|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255654|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255655|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2255656|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2255657|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
2255658|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2255659|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2255660|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2255661|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255662|NCT00146601|Fulvestrant|fulvestrant|mesh-list
839858|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
839859|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
839860|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
839861|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
839862|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
839863|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
839864|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839865|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
839866|NCT02423096|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
839867|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
839868|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
839869|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
839870|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
839871|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
839911|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
839912|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
839913|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
839914|NCT02422485|Analgesics|analgesics|mesh-ancestor
839915|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
839916|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839917|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
839918|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
839919|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
840094|NCT02421913|Ketamine|ketamine|mesh-list
840095|NCT02421913|Analgesics|analgesics|mesh-ancestor
840096|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
840097|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
840098|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840099|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
840100|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
840101|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
840102|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
840103|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
840104|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
840105|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
840106|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
840107|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840155|NCT02421679|Cyclobenzaprine|cyclobenzaprine|mesh-list
840156|NCT02421679|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
840157|NCT02421679|Antidepressive Agents|antidepressive agents|mesh-ancestor
840158|NCT02421679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
840159|NCT02421679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
840160|NCT02421679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840161|NCT02421679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
840162|NCT02421679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
840163|NCT02421679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
840164|NCT02421679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099053|NCT02352922|Bupivacaine|bupivacaine|mesh-list
2099054|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
2099055|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
841870|NCT02415881|Panitumumab|panitumumab|mesh-list
841871|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
841872|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842194|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
842195|NCT02414802|Heparin|heparin|mesh-list
842196|NCT02414802|Calcium heparin|calcium heparin|mesh-list
842197|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
842198|NCT02414802|Tinzaparin|tinzaparin|mesh-list
842199|NCT02414802|Dalteparin|dalteparin|mesh-list
842200|NCT02414802|Calcium|calcium|mesh-list
842201|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
842202|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842203|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
842204|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
842205|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
842206|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
842207|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099056|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099057|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099058|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
2099059|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
839891|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
839892|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
841315|NCT02417896|Spironolactone|spironolactone|mesh-list
841316|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
841317|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
841318|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841319|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841320|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
841321|NCT02417896|Diuretics|diuretics|mesh-ancestor
841322|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
841541|NCT02416817|Thrombin|thrombin|mesh-list
841542|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
841543|NCT02416817|Coagulants|coagulants|mesh-ancestor
2255663|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2255664|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255665|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2255666|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2255667|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
2255668|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2255669|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255670|NCT00146614|Sirolimus|sirolimus|mesh-list
2255671|NCT00146614|Methotrexate|methotrexate|mesh-list
2255672|NCT00146614|Tacrolimus|tacrolimus|mesh-list
2255673|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2255674|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
2255675|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2255676|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255677|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2255678|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
2255679|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255680|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255681|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
2255682|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255683|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2255684|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2255685|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
2255686|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2255687|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2255688|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2255689|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2255690|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
842637|NCT02412917|Valacyclovir|valacyclovir|mesh-list
842638|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
842639|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
842797|NCT02412345|Alprostadil|alprostadil|mesh-list
842798|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
842799|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
842800|NCT02412345|Urological Agents|urological agents|mesh-ancestor
842876|NCT02412085|Golimumab|golimumab|mesh-list
842894|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
842895|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
842896|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
842897|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
842898|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843138|NCT02411318|Ethanol|ethanol|mesh-list
843139|NCT02411318|Caffeine|caffeine|mesh-list
843140|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
843141|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843142|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
843143|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843144|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843145|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
843146|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
843147|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
843148|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843149|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
843150|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
843151|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2255691|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2255692|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
2255693|NCT00146627|Eflornithine|eflornithine|mesh-list
2255694|NCT00146627|Nifurtimox|nifurtimox|mesh-list
2255695|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255696|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
843263|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
840010|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
840011|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
840012|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
840013|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
840014|NCT02422706|Renal Agents|renal agents|mesh-ancestor
840015|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
840016|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
840017|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840018|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
840019|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
2255697|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2255698|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2255699|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255700|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2255701|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840664|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
840665|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
840666|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
840667|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
840668|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
840669|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840670|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
840671|NCT02420002|Analgesics|analgesics|mesh-ancestor
840672|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
840673|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099082|NCT02352974|Vitamin D|vitamin d|mesh-list
2099083|NCT02352974|Vitamins|vitamins|mesh-ancestor
2099084|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
2099085|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099086|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2099087|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
2099088|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2099089|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099090|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099091|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2099092|NCT02353169|Analgesics|analgesics|mesh-ancestor
2099093|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
2099094|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099095|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2099096|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2099097|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2099098|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
2099099|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099100|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099101|NCT02353299|Zolpidem|zolpidem|mesh-list
2099102|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2099103|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2099104|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099105|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099106|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2099107|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
2099108|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
2099109|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099110|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099111|NCT02353754|Morphine|morphine|mesh-list
2099112|NCT02353754|Bupivacaine|bupivacaine|mesh-list
2099113|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
2099114|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
2099115|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099116|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099117|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
840319|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
840320|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
840321|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
840322|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
840323|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840324|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
840325|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
840326|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841156|NCT02418702|Ketamine|ketamine|mesh-list
841157|NCT02418702|Analgesics|analgesics|mesh-ancestor
841158|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
841159|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841160|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841161|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
841162|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
841163|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
841164|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
841165|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
841166|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
841167|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
841168|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
841169|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841219|NCT02418273|Denosumab|denosumab|mesh-list
841220|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
841221|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255702|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255703|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
2255704|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
2255705|NCT00146718|Amodiaquine|amodiaquine|mesh-list
2255706|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
2255707|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2255708|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2255709|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255710|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2255711|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255712|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255713|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
842232|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
842233|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
842234|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
842235|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
842236|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
842237|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
842238|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842239|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
842374|NCT02414373|Bupivacaine|bupivacaine|mesh-list
842375|NCT02414373|Ropivacaine|ropivacaine|mesh-list
842376|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
842377|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
842378|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
842379|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842380|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
842381|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255714|NCT00146718|Renal Agents|renal agents|mesh-ancestor
2255715|NCT00146731|Artesunate|artesunate|mesh-list
2255716|NCT00146731|Amodiaquine|amodiaquine|mesh-list
2255717|NCT00146731|Dapsone|dapsone|mesh-list
842663|NCT02412566|SMOFlipid|smoflipid|mesh-list
842664|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
842665|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
842666|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
844001|NCT02407782|Ivermectin|ivermectin|mesh-list
844002|NCT02407782|Permethrin|permethrin|mesh-list
844003|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
844004|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844005|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844006|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844166|NCT02407080|Interferons|interferons|mesh-list
844167|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
844168|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
2099118|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
840055|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
840056|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840337|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
840338|NCT02421029|Edetic Acid|edetic acid|mesh-list
840339|NCT02421029|Calcium|calcium|mesh-list
840340|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
840341|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
840342|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840343|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
840344|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
840345|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
840346|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
840347|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
840348|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840349|NCT02421029|Antidotes|antidotes|mesh-ancestor
840350|NCT02421029|Protective Agents|protective agents|mesh-ancestor
840351|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
841512|NCT02417337|Acetaminophen|acetaminophen|mesh-list
841513|NCT02417337|Ibuprofen|ibuprofen|mesh-list
841514|NCT02417337|Diclofenac|diclofenac|mesh-list
841515|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
841516|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
841517|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
841518|NCT02417337|Analgesics|analgesics|mesh-ancestor
841519|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
841520|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841521|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841522|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
841523|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
841524|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
841525|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841526|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841527|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
841576|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
841577|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
841578|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255718|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
2255719|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
2255720|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2255721|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2255722|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
842445|NCT02413658|Phenytoin|phenytoin|mesh-list
842446|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
842447|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
842448|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
842449|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
842450|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842451|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
842452|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2255723|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255724|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
2255725|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
2255726|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2255727|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
2255728|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2255729|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255730|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255731|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
2255732|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2255733|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
2255734|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
2255735|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2255736|NCT00146783|Amodiaquine|amodiaquine|mesh-list
2255737|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
2255738|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2255739|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2255740|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255741|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2255742|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255743|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255744|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2255745|NCT00146783|Renal Agents|renal agents|mesh-ancestor
843320|NCT02410460|Lidocaine|lidocaine|mesh-list
843321|NCT02410460|Clonidine|clonidine|mesh-list
843322|NCT02410460|Midazolam|midazolam|mesh-list
843323|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
2255746|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2099119|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2099120|NCT02353754|Narcotics|narcotics|mesh-ancestor
2099121|NCT02353754|Analgesics|analgesics|mesh-ancestor
2099122|NCT02353780|Etanercept|etanercept|mesh-list
2099123|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
2099124|NCT02353780|Abatacept|abatacept|mesh-list
2099125|NCT02353780|Infliximab|infliximab|mesh-list
2099126|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
2099127|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2099128|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2099129|NCT02353780|Analgesics|analgesics|mesh-ancestor
2099130|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
2099131|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099132|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255747|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
2255748|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255749|NCT00146900|Citalopram|citalopram|mesh-list
2255750|NCT00146900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2255751|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2255752|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2255753|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255754|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2255755|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
2255756|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255757|NCT00146900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2255758|NCT00146900|Antidepressive Agents|antidepressive agents|mesh-ancestor
2255759|NCT00146900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2255760|NCT00146913|Interferons|interferons|mesh-list
2255761|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
2255762|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255763|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
2255764|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255765|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2255766|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255767|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255768|NCT00146926|Lidocaine|lidocaine|mesh-list
2255769|NCT00146926|Ephedrine|ephedrine|mesh-list
2255770|NCT00146926|Ketamine|ketamine|mesh-list
2255771|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
2255772|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
2255773|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2255774|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255775|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
2255776|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255777|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2255778|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2255779|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2255780|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2255781|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255782|NCT00146926|Analgesics|analgesics|mesh-ancestor
2255783|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2255784|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2255785|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
2255786|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2255787|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2255788|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2255789|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2255790|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
2255791|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
2255792|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
841688|NCT02416570|Clarithromycin|clarithromycin|mesh-list
841689|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
841690|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
841691|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
841692|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841693|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841694|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
841695|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2099133|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2255793|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
2255794|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
2255795|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2255796|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2255797|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2255798|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2255799|NCT00147121|Rituximab|rituximab|mesh-list
2255800|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
840470|NCT02420613|Sirolimus|sirolimus|mesh-list
840471|NCT02420613|Vorinostat|vorinostat|mesh-list
840472|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
840473|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
840474|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
840475|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840476|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
840477|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
840478|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
840479|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840480|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
840481|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840482|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841615|NCT02416583|Oxytocin|oxytocin|mesh-list
841616|NCT02416583|Dinoprostone|dinoprostone|mesh-list
841617|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
841618|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
841619|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841824|NCT02416258|Betamethasone|betamethasone|mesh-list
841825|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
841826|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
841827|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
841828|NCT02416258|Calcipotriene|calcipotriene|mesh-list
841829|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
841830|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
841831|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
841832|NCT02416258|Hormones|hormones|mesh-ancestor
841833|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841834|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841835|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
841836|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
841837|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
842092|NCT02415062|Donepezil|donepezil|mesh-list
842093|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
842094|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
842095|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842096|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
842097|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
842098|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842099|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
842308|NCT02414555|Phenylephrine|phenylephrine|mesh-list
842309|NCT02414555|Norepinephrine|norepinephrine|mesh-list
842310|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
842311|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
842312|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
842313|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
842314|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
842315|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842316|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
842317|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
842318|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
842319|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
842320|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
842321|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
842322|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
842323|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
842324|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842325|NCT02414555|Protective Agents|protective agents|mesh-ancestor
842389|NCT02414165|Flucytosine|flucytosine|mesh-list
842390|NCT02414165|Bevacizumab|bevacizumab|mesh-list
842391|NCT02414165|Temozolomide|temozolomide|mesh-list
842392|NCT02414165|Lomustine|lomustine|mesh-list
842393|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2255801|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255802|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
2255803|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255804|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2255805|NCT00147160|Temozolomide|temozolomide|mesh-list
2255806|NCT00147160|Cisplatin|cisplatin|mesh-list
2255807|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2255808|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
2255809|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255810|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255811|NCT00147186|Hylan|hylan|mesh-list
2255812|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
2255813|NCT00147186|Protective Agents|protective agents|mesh-ancestor
2255814|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255815|NCT00147264|Telmisartan|telmisartan|mesh-list
2255816|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2255817|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2255818|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2255819|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255820|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
2255821|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2255822|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2255823|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255824|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2255825|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2255826|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
841432|NCT02417389|Alendronate|alendronate|mesh-list
841433|NCT02417389|Cinacalcet|cinacalcet|mesh-list
841434|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
841435|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841436|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
841437|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
841438|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
841439|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841497|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
841498|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
841499|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
841500|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
841501|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
841502|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841503|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
841504|NCT02417116|Protective Agents|protective agents|mesh-ancestor
2255827|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2255828|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255829|NCT00147355|Acetaminophen|acetaminophen|mesh-list
2255830|NCT00147355|Ibuprofen|ibuprofen|mesh-list
2255831|NCT00147355|Codeine|codeine|mesh-list
2255832|NCT00147355|Ondansetron|ondansetron|mesh-list
2255833|NCT00147355|Metoclopramide|metoclopramide|mesh-list
2255834|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2255835|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2255836|NCT00147355|Analgesics|analgesics|mesh-ancestor
2255837|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
2255838|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2255839|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255840|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2255841|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2255842|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2255843|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255844|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255845|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
2255846|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
2255847|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
2255848|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2255849|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
2255850|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
2255851|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2255852|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
2255853|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2255854|NCT00147355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
843978|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
843979|NCT02407834|Eusol|eusol|mesh-list
843980|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
843981|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844369|NCT02406183|Ipilimumab|ipilimumab|mesh-list
844370|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
844371|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
840443|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
840444|NCT02420509|Vitamins|vitamins|mesh-ancestor
840445|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
840537|NCT02420171|Insulin|insulin|mesh-list
840538|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
840539|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841069|NCT02419235|Ethanol|ethanol|mesh-list
841070|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
841071|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
841072|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
841073|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841864|NCT02415829|Capecitabine|capecitabine|mesh-list
841865|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
841866|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
841867|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
841868|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841869|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841912|NCT02415569|Bisacodyl|bisacodyl|mesh-list
841913|NCT02415569|Cathartics|cathartics|mesh-ancestor
841914|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
841915|NCT02415569|Laxatives|laxatives|mesh-ancestor
842116|NCT02415036|Melphalan|melphalan|mesh-list
842117|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
842118|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
842119|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842120|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842121|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
842122|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
842123|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
842124|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255855|NCT00147355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2255856|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2255857|NCT00147355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2255858|NCT00147355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2255859|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2255860|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2255861|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
2255862|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2255863|NCT00147355|Narcotics|narcotics|mesh-ancestor
2255864|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
2255865|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
2255866|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
2255867|NCT00147381|Tacrolimus|tacrolimus|mesh-list
2255868|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2255869|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
2255870|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255871|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2255872|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255873|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255874|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2255875|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255876|NCT00147394|Risperidone|risperidone|mesh-list
2255877|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2255878|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
2255879|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2255880|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255881|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255882|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2255883|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2255884|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843246|NCT02410590|Atropine|atropine|mesh-list
843247|NCT02410590|Rocuronium|rocuronium|mesh-list
843248|NCT02410590|Cisatracurium|cisatracurium|mesh-list
843249|NCT02410590|Succinylcholine|succinylcholine|mesh-list
843250|NCT02410590|Neostigmine|neostigmine|mesh-list
843251|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
843252|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
843253|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
843254|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843255|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843256|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
843257|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
843258|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
843259|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
843260|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
843261|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
843262|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
840542|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
840543|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
840544|NCT02420418|Expectorants|expectorants|mesh-ancestor
840545|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
840546|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
840547|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
840548|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840549|NCT02420418|Protective Agents|protective agents|mesh-ancestor
840550|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840551|NCT02420418|Antidotes|antidotes|mesh-ancestor
840749|NCT02419859|Insulin|insulin|mesh-list
840750|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
840751|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
840752|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841308|NCT02417883|Furosemide|furosemide|mesh-list
841309|NCT02417883|Diuretics|diuretics|mesh-ancestor
841310|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
841311|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841312|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
841313|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
841314|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255885|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2255886|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2255887|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
2255888|NCT00147511|Linezolid|linezolid|mesh-list
2255889|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2255890|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255891|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
842012|NCT02415179|Fluticasone|fluticasone|mesh-list
842013|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
842014|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
842015|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
842016|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
842017|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
842018|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
842019|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
842020|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
842021|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842022|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
842023|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
842024|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
842025|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
842026|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
842027|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
842028|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
842029|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
842030|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
842031|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842032|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
842033|NCT02415179|Hormones|hormones|mesh-ancestor
842034|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
842035|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
842494|NCT02413554|Rivastigmine|rivastigmine|mesh-list
842495|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
842496|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
842497|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842498|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
842499|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
842500|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842501|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
842502|NCT02413554|Protective Agents|protective agents|mesh-ancestor
843528|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
843529|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
843586|NCT02409433|Lacosamide|lacosamide|mesh-list
843587|NCT02409433|Phenytoin|phenytoin|mesh-list
843588|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
843589|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
843590|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
843591|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
843592|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843593|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
843594|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
843956|NCT02407821|Citalopram|citalopram|mesh-list
843957|NCT02407821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
843992|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
2255892|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255893|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255894|NCT00147524|Quinapril|quinapril|mesh-list
2255895|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2255896|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
2255897|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255898|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255899|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2255900|NCT00147563|Eplerenone|eplerenone|mesh-list
2255901|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
840637|NCT02419664|Edotreotide|edotreotide|mesh-list
840638|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
840639|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841637|NCT02416765|Glucagon|glucagon|mesh-list
841638|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841639|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
841640|NCT02416765|Hormones|hormones|mesh-ancestor
841641|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841650|NCT02416232|Trametinib|trametinib|mesh-list
841651|NCT02416232|Dabrafenib|dabrafenib|mesh-list
841652|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841653|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
841654|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841655|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841923|NCT02415699|Leucovorin|leucovorin|mesh-list
841924|NCT02415699|Fluorouracil|fluorouracil|mesh-list
841925|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
841926|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
841927|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841928|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
841929|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841930|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
841931|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
841932|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841933|NCT02415699|Antidotes|antidotes|mesh-ancestor
841934|NCT02415699|Protective Agents|protective agents|mesh-ancestor
841935|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
841936|NCT02415699|Vitamins|vitamins|mesh-ancestor
841937|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
841982|NCT02415257|Gentamicins|gentamicins|mesh-list
841983|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
841984|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
841985|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
841986|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841987|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842125|NCT02414880|Rocuronium|rocuronium|mesh-list
842126|NCT02414880|Neostigmine|neostigmine|mesh-list
842127|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
842128|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
842129|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
842130|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
842131|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842132|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
842133|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
842134|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842135|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
842136|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
842137|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
842138|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
842278|NCT02414529|Vitamin D|vitamin d|mesh-list
842279|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
842280|NCT02414529|Vitamins|vitamins|mesh-list
842281|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
842282|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842283|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
842284|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2255902|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
2255903|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2255904|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255905|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2255906|NCT00147563|Diuretics|diuretics|mesh-ancestor
2255907|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
2255908|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2255909|NCT00147589|Eplerenone|eplerenone|mesh-list
2255910|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
840654|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840655|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
840656|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
840657|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
840658|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
840659|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
840660|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
840661|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
840662|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
840663|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
840719|NCT02419534|Diltiazem|diltiazem|mesh-list
840720|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
840721|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
840722|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
840723|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
840724|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
840725|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
840726|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
841479|NCT02417103|Liraglutide|liraglutide|mesh-list
841480|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
841481|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841482|NCT02417103|Incretins|incretins|mesh-ancestor
841483|NCT02417103|Hormones|hormones|mesh-ancestor
841484|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841842|NCT02415985|Lopinavir|lopinavir|mesh-list
841843|NCT02415985|Rifabutin|rifabutin|mesh-list
841844|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
841845|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
841846|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
841847|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841848|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841849|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
841850|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
841851|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
841852|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
841853|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
841854|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
841855|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
841856|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
841857|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
2255911|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
2255912|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2255913|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255914|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
842240|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
842241|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
842242|NCT02414490|Antibodies|antibodies|mesh-list
842243|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
842244|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
842245|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
842246|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255915|NCT00147589|Diuretics|diuretics|mesh-ancestor
2255916|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
2255917|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2255918|NCT00147602|Atorvastatin|atorvastatin|mesh-list
2255919|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2255920|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2255921|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
2255922|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255923|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2255924|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2255925|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255926|NCT00147615|Eplerenone|eplerenone|mesh-list
2255927|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2255928|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
2255929|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2255930|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255931|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2255932|NCT00147615|Diuretics|diuretics|mesh-ancestor
2255933|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
2255934|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2255935|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
2255936|NCT00147628|Citric Acid|citric acid|mesh-list
2255937|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
2255938|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
2255939|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2255940|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
2255941|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
2255942|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255943|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
2255944|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2255945|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
841086|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
841087|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
841088|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
841089|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841090|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
841091|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
841092|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
841093|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841094|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841095|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
841418|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
841419|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
841420|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
841421|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255946|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255947|NCT00147628|Urological Agents|urological agents|mesh-ancestor
2255948|NCT00147654|Tamsulosin|tamsulosin|mesh-list
2255949|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2255950|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2255951|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2255952|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2255953|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
2255954|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2255955|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255956|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255957|NCT00147654|Urological Agents|urological agents|mesh-ancestor
2255958|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2255959|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2255960|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
843165|NCT02410759|Carbetocin|carbetocin|mesh-list
843166|NCT02410759|Ergonovine|ergonovine|mesh-list
843167|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
843168|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
843169|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843387|NCT02410226|Anesthetics|anesthetics|mesh-list
843388|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843389|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255961|NCT00147667|Erythromycin|erythromycin|mesh-list
2255962|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
2255963|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2255964|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
2255965|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2255966|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2255967|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2255968|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2255969|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2255970|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255971|NCT00147680|Paclitaxel|paclitaxel|mesh-list
2255972|NCT00147680|Carboplatin|carboplatin|mesh-list
844061|NCT02407392|Acetic Acid|acetic acid|mesh-list
844062|NCT02407392|Retinol acetate|retinol acetate|mesh-list
844063|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
844064|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844065|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
844066|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
844067|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844068|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
844069|NCT02407392|Protective Agents|protective agents|mesh-ancestor
844070|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844478|NCT02405988|Remifentanil|remifentanil|mesh-list
844479|NCT02405988|Naloxone|naloxone|mesh-list
844480|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
844481|NCT02405988|Narcotics|narcotics|mesh-ancestor
2255973|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2255974|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255975|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
2255976|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
2255977|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
2255978|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255979|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2255980|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2255981|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2255982|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
2255983|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255984|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2255985|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2255986|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2255987|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2255988|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
841680|NCT02416141|Tramadol|tramadol|mesh-list
841681|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
841682|NCT02416141|Narcotics|narcotics|mesh-ancestor
841683|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
841684|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841685|NCT02416141|Analgesics|analgesics|mesh-ancestor
841686|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
841687|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841838|NCT02415920|Oxytocin|oxytocin|mesh-list
841839|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
841840|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
841841|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841943|NCT02415309|Melatonin|melatonin|mesh-list
841944|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
841945|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841946|NCT02415309|Protective Agents|protective agents|mesh-ancestor
841947|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841948|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
842083|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
842084|NCT02414919|Etonogestrel|etonogestrel|mesh-list
842085|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
842086|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
842087|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
842088|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842089|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
842090|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
842091|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
842326|NCT02414724|Gemcitabine|gemcitabine|mesh-list
842327|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
842328|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
842329|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842330|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842331|NCT02414724|Antiviral Agents|antiviral agents|mesh-ancestor
842332|NCT02414724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
842333|NCT02414724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
842334|NCT02414724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
842335|NCT02414724|Immunologic Factors|immunologic factors|mesh-ancestor
842336|NCT02414724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842730|NCT02412449|Glycine|glycine|mesh-list
842731|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
842732|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
842733|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842734|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843758|NCT02408744|Pirfenidone|pirfenidone|mesh-list
843759|NCT02408744|Analgesics|analgesics|mesh-ancestor
843760|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
843761|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843762|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843763|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
843764|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
843765|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
843766|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
843767|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099134|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2099135|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
846231|NCT02399657|Dexamethasone|dexamethasone|mesh-list
846232|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
846233|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
846234|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
2255989|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2255990|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2255991|NCT00147771|Imiquimod|imiquimod|mesh-list
2255992|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2255993|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
2255994|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2255995|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2255996|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
2255997|NCT00147784|Interferons|interferons|mesh-list
2255998|NCT00147784|Ribavirin|ribavirin|mesh-list
2255999|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256000|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
2256001|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256002|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
2256003|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256004|NCT00147836|Insulin|insulin|mesh-list
2256005|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2256006|NCT00147836|Metformin|metformin|mesh-list
2256007|NCT00147836|Gliclazide|gliclazide|mesh-list
2256008|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
2256009|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
2256010|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
2256011|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2256012|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256013|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
2256014|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2256015|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2256016|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256017|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
2256018|NCT00147862|Coagulants|coagulants|mesh-ancestor
2256019|NCT00147875|Gemcitabine|gemcitabine|mesh-list
2256020|NCT00147875|Prednisone|prednisone|mesh-list
2256021|NCT00147875|Doxorubicin|doxorubicin|mesh-list
2256022|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2256023|NCT00147875|Vinblastine|vinblastine|mesh-list
2256024|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2256025|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
2256026|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256027|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256028|NCT00147875|Antiviral Agents|antiviral agents|mesh-ancestor
2256029|NCT00147875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256030|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256031|NCT00147875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
841386|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
841387|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
841388|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
841389|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841390|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
841391|NCT02417610|Protective Agents|protective agents|mesh-ancestor
2099136|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2099137|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
2099138|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
841579|NCT02416752|Remifentanil|remifentanil|mesh-list
841580|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
841581|NCT02416752|Narcotics|narcotics|mesh-ancestor
841582|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
841583|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841584|NCT02416752|Analgesics|analgesics|mesh-ancestor
841585|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
841586|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
842285|NCT02414685|Paclitaxel|paclitaxel|mesh-list
842286|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
842287|NCT02414685|Cisplatin|cisplatin|mesh-list
842288|NCT02414685|Ifosfamide|ifosfamide|mesh-list
842289|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
842290|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
842291|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842292|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
842293|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
842294|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
842295|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842296|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
842297|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
2256032|NCT00147875|Immunologic Factors|immunologic factors|mesh-ancestor
2256033|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256034|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2256035|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2256036|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
841028|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
841029|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
841030|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
841031|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
841032|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
841033|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
841034|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
841035|NCT02420717|Antidotes|antidotes|mesh-ancestor
841036|NCT02420717|Protective Agents|protective agents|mesh-ancestor
841037|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
841038|NCT02420717|Vitamins|vitamins|mesh-ancestor
841039|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
841040|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
841041|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
841042|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
841043|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
841044|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2256037|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2256038|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
2256039|NCT00147875|Hormones|hormones|mesh-ancestor
2256040|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256041|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2256042|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2256043|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
2256044|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
2256045|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
2256046|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
2256047|NCT00147901|Fludarabine|fludarabine|mesh-list
2256048|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
2256049|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2256050|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
2256051|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256052|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2256053|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2256054|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
2256055|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256056|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256057|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2256058|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2256059|NCT00147914|Amoxicillin|amoxicillin|mesh-list
2256060|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
2256061|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
2256062|NCT00147914|Cefdinir|cefdinir|mesh-list
2256063|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2256064|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2256065|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256066|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2256067|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256068|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256069|NCT00147953|Rituximab|rituximab|mesh-list
2256070|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2256071|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842348|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
842349|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
842350|NCT02414464|Calcium|calcium|mesh-list
842351|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
842352|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842353|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
842354|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
842355|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
842942|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
842943|NCT02411955|Tazarotene|tazarotene|mesh-list
842944|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
842945|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
842946|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
842947|NCT02411955|Vitamins|vitamins|mesh-ancestor
842948|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
842949|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843031|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
843032|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
843033|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843034|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843035|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843036|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
843037|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
2256072|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
843738|NCT02409290|Renal Agents|renal agents|mesh-ancestor
2256073|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841137|NCT02418572|Testosterone|testosterone|mesh-list
841138|NCT02418572|Androgens|androgens|mesh-ancestor
841139|NCT02418572|Hormones|hormones|mesh-ancestor
841140|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841141|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099139|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099140|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099141|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
2099142|NCT02353806|Amlodipine|amlodipine|mesh-list
2099143|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2099144|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2099145|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2099146|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099147|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2099148|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099149|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
2099150|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
2099151|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2099152|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
841464|NCT02417090|Metformin|metformin|mesh-list
841465|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
841466|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256074|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2256075|NCT00147979|Heparin|heparin|mesh-list
2256076|NCT00147979|Calcium heparin|calcium heparin|mesh-list
2256077|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
2256078|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2256079|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2256080|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842483|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
842484|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
2099153|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2099154|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2099155|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099156|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
2099157|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256081|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
842645|NCT02412813|Cobalt|cobalt|mesh-list
842646|NCT02412813|Trace Elements|trace elements|mesh-ancestor
842647|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
842648|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843005|NCT02411877|Clotrimazole|clotrimazole|mesh-list
843006|NCT02411877|Miconazole|miconazole|mesh-list
843007|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
843008|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
843009|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
843010|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
843011|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
843012|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843013|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843014|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
843015|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
843016|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
843017|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843018|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
843019|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2256082|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
2256083|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256084|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256085|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256086|NCT00148018|Dexamethasone|dexamethasone|mesh-list
2256087|NCT00148018|Bortezomib|bortezomib|mesh-list
843422|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
843423|NCT02410096|Miotics|miotics|mesh-ancestor
843424|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
843425|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843426|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843427|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
843428|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
843429|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
843430|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
843431|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
843432|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
841147|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256088|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2256089|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
2256090|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
2256091|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256092|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256093|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2256094|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
2256095|NCT00148018|Hormones|hormones|mesh-ancestor
2256096|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256097|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2256098|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841236|NCT02418130|Inositol|inositol|mesh-list
841237|NCT02418130|Thiamine|thiamine|mesh-list
841238|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
841239|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
841240|NCT02418130|Vitamins|vitamins|mesh-ancestor
841241|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
841242|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841243|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
841244|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2256099|NCT00148031|Interferons|interferons|mesh-list
2256100|NCT00148031|Ribavirin|ribavirin|mesh-list
2256101|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256102|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
2256103|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256104|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
2256105|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256106|NCT00148070|Erythromycin|erythromycin|mesh-list
2256107|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
2256108|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2256109|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
2256110|NCT00148070|Docetaxel|docetaxel|mesh-list
2256111|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256112|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
2256113|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
2256114|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
2256115|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256116|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2256117|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256118|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2256119|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2256120|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256121|NCT00148083|Risperidone|risperidone|mesh-list
2256122|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2256123|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
2256124|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256125|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256126|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256127|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
841873|NCT02415712|Fomepizole|fomepizole|mesh-list
841874|NCT02415712|Antidotes|antidotes|mesh-ancestor
841875|NCT02415712|Protective Agents|protective agents|mesh-ancestor
841876|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841877|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841878|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842269|NCT02414581|Ethanol|ethanol|mesh-list
842270|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
842271|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
842272|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
842273|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
842274|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
842275|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842276|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
842277|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
842577|NCT02413138|Hormones|hormones|mesh-list
842578|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
842579|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843020|NCT02411786|Molgramostim|molgramostim|mesh-list
843021|NCT02411786|Sargramostim|sargramostim|mesh-list
843022|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
843023|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843024|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
843126|NCT02411526|Risperidone|risperidone|mesh-list
843127|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
843128|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
2256128|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2256129|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2256130|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2256131|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2256132|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
2256133|NCT00148135|Gemcitabine|gemcitabine|mesh-list
841674|NCT02416531|Clobetasol|clobetasol|mesh-list
841675|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
841676|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
841677|NCT02416531|Hormones|hormones|mesh-ancestor
841678|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841679|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841964|NCT02415335|Dexamethasone|dexamethasone|mesh-list
841965|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
841966|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
841967|NCT02415335|BB 1101|bb 1101|mesh-list
841968|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
841969|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
841970|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
841971|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841972|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841973|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
841974|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
841975|NCT02415335|Hormones|hormones|mesh-ancestor
841976|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841977|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
841978|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841979|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
841980|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841981|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842485|NCT02413515|Nifedipine|nifedipine|mesh-list
842486|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
842487|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
842488|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842489|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
842490|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842491|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
842492|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
842493|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
843116|NCT02411331|Ethanol|ethanol|mesh-list
843117|NCT02411331|Enoxaparin|enoxaparin|mesh-list
843118|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
843119|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
843120|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
843121|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843122|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
843123|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
843124|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843125|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843634|NCT02408991|Lenograstim|lenograstim|mesh-list
843635|NCT02408991|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
843636|NCT02408991|Immunologic Factors|immunologic factors|mesh-ancestor
843637|NCT02408991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843858|NCT02408328|Caffeine|caffeine|mesh-list
843859|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
843860|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843861|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
843862|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843863|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
843864|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843865|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
843866|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
843867|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
843868|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844152|NCT02407119|Amoxicillin|amoxicillin|mesh-list
844153|NCT02407119|Clarithromycin|clarithromycin|mesh-list
844154|NCT02407119|Omeprazole|omeprazole|mesh-list
844155|NCT02407119|Rabeprazole|rabeprazole|mesh-list
844156|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
844157|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
844158|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844159|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
844160|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
844161|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844162|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844163|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2099158|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256134|NCT00148135|Carboplatin|carboplatin|mesh-list
2256135|NCT00148135|Capecitabine|capecitabine|mesh-list
2256136|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256137|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2256138|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
2256139|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256140|NCT00148135|Antiviral Agents|antiviral agents|mesh-ancestor
2256141|NCT00148135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256142|NCT00148135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256143|NCT00148135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2256144|NCT00148135|Immunologic Factors|immunologic factors|mesh-ancestor
2256145|NCT00148135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256146|NCT00148148|Amphotericin B|amphotericin b|mesh-list
2256147|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2256148|NCT00148148|Caspofungin|caspofungin|mesh-list
842298|NCT02414451|Propranolol|propranolol|mesh-list
842299|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
842300|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
842301|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
842302|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
842303|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842304|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842305|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
842306|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
842307|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
2256149|NCT00148148|Amebicides|amebicides|mesh-ancestor
2256150|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2256151|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2256152|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256153|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
842899|NCT02412033|Misoprostol|misoprostol|mesh-list
842900|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
842901|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
842902|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
842903|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842904|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
842905|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
842906|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
843662|NCT02408978|Naproxen|naproxen|mesh-list
843663|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
843664|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
843665|NCT02408978|Analgesics|analgesics|mesh-ancestor
843666|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
843667|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843668|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843669|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
843670|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
843671|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
843672|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
843673|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843674|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843783|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
843784|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
843785|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
843786|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
843787|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843788|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
844175|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
844176|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
844177|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256154|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
2256155|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256156|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256157|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
2256158|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2256159|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256160|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2256161|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
2256162|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
844584|NCT02405793|Meloxicam|meloxicam|mesh-list
844585|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
844586|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
844587|NCT02405793|Analgesics|analgesics|mesh-ancestor
2256163|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
841351|NCT02418065|Androgens|androgens|mesh-ancestor
841352|NCT02418065|Hormones|hormones|mesh-ancestor
841353|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841354|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841406|NCT02417506|Ibuprofen|ibuprofen|mesh-list
841407|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
841408|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
841409|NCT02417506|Analgesics|analgesics|mesh-ancestor
841410|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
841411|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841412|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841413|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
841414|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
841415|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
841416|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841417|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841642|NCT02416427|Atorvastatin|atorvastatin|mesh-list
841643|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
841644|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
841645|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
841646|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841647|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
841648|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
841649|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256164|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256165|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256166|NCT00148265|Triamcinolone|triamcinolone|mesh-list
2256167|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2256168|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
2256169|NCT00148265|Hormones|hormones|mesh-ancestor
2256170|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256171|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256172|NCT00148278|Dobutamine|dobutamine|mesh-list
2256173|NCT00148278|Epinephrine|epinephrine|mesh-list
2256174|NCT00148278|Norepinephrine|norepinephrine|mesh-list
2256175|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2256176|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2256177|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
2256178|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256179|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256180|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256181|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2256182|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2256183|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
2256184|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256185|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2256186|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
842962|NCT02411903|Clopidogrel|clopidogrel|mesh-list
842963|NCT02411903|Atorvastatin|atorvastatin|mesh-list
842964|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
842965|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
842966|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
842967|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
842968|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842969|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
842970|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
842971|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
842972|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
842973|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
842974|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
842975|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
842976|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
842977|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
842978|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256187|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
2256188|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
843967|NCT02408003|Simendan|simendan|mesh-list
843968|NCT02408003|Milrinone|milrinone|mesh-list
843969|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
843970|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
843971|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
843972|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
843973|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843991|NCT02407899|Vitamins|vitamins|mesh-ancestor
841456|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
841457|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
841458|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
841459|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
841460|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
841461|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
841462|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
841463|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841620|NCT02416869|Dexamethasone|dexamethasone|mesh-list
841621|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
841622|NCT02416869|BB 1101|bb 1101|mesh-list
841623|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
841624|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
841625|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
841626|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841627|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841628|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
841629|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
841630|NCT02416869|Hormones|hormones|mesh-ancestor
841631|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841632|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
841633|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841634|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
841635|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841636|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841671|NCT02416245|Micronutrients|micronutrients|mesh-list
841672|NCT02416245|Trace Elements|trace elements|mesh-list
841673|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256189|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2256190|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2256191|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
842208|NCT02414750|Vemurafenib|vemurafenib|mesh-list
842209|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842210|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
842211|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
842212|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842356|NCT02414256|Anesthetics|anesthetics|mesh-list
842357|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
842358|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256192|NCT00148278|Protective Agents|protective agents|mesh-ancestor
2256193|NCT00148291|Docetaxel|docetaxel|mesh-list
2256194|NCT00148291|Vinorelbine|vinorelbine|mesh-list
2256195|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256196|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
2256197|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
2256198|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
2256199|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256200|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2256201|NCT00148330|Triamcinolone|triamcinolone|mesh-list
2256202|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2256203|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
2256204|NCT00148330|Hormones|hormones|mesh-ancestor
2256205|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256206|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256207|NCT00148356|Paclitaxel|paclitaxel|mesh-list
2256208|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2256209|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
843152|NCT02411344|Pertuzumab|pertuzumab|mesh-list
843153|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
843154|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256210|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
2256211|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
2256212|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
2256213|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256214|NCT00148382|Cetilistat|cetilistat|mesh-list
2256215|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754557|NCT00543374|Remestemcel-l|remestemcel-l|mesh-list
841603|NCT02416739|Niacinamide|niacinamide|mesh-list
841604|NCT02416739|Niacin|niacin|mesh-list
841605|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
841606|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
841607|NCT02416739|Vitamins|vitamins|mesh-ancestor
841608|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
841609|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841610|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
841611|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
841612|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841613|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
841614|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
841889|NCT02415777|Riboflavin|riboflavin|mesh-list
841890|NCT02415777|Thiamine|thiamine|mesh-list
841891|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
841892|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
841893|NCT02415777|Vitamins|vitamins|mesh-ancestor
841894|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
841895|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841896|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
841897|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
841898|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
841899|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
841988|NCT02415413|Dexamethasone|dexamethasone|mesh-list
841989|NCT02415413|Lenalidomide|lenalidomide|mesh-list
841990|NCT02415413|Melphalan|melphalan|mesh-list
841991|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
841992|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
841993|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
841994|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841995|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841996|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
841997|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
841998|NCT02415413|Hormones|hormones|mesh-ancestor
841999|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
842000|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
842001|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842002|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
842003|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
842004|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
842005|NCT02415413|Growth Substances|growth substances|mesh-ancestor
842006|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
842007|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
842008|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
842009|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842010|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
842011|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
842228|NCT02414503|Oxytocin|oxytocin|mesh-list
842229|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
842230|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
842231|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842337|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
842338|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
842339|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
842340|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
842341|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
842342|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842343|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
842344|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
842345|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842346|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
842347|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256216|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256217|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2256218|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2256219|NCT00148395|Gemcitabine|gemcitabine|mesh-list
842649|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
842650|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842801|NCT02412475|Cytarabine|cytarabine|mesh-list
842802|NCT02412475|Fludarabine|fludarabine|mesh-list
842803|NCT02412475|Sorafenib|sorafenib|mesh-list
842804|NCT02412475|Decitabine|decitabine|mesh-list
842805|NCT02412475|Vorinostat|vorinostat|mesh-list
842806|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842807|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
842808|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
842809|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842810|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
841722|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
841723|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
841724|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
841725|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
841726|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
841727|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
841728|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
841729|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
841730|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
841731|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
841732|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
841733|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
841734|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
841735|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
841736|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
841737|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
841738|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
841739|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
841740|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
841741|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
841742|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
841743|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
841744|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
841745|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
841746|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
841747|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
842406|NCT02414009|Leucovorin|leucovorin|mesh-list
842407|NCT02414009|Fluorouracil|fluorouracil|mesh-list
842408|NCT02414009|Capecitabine|capecitabine|mesh-list
842409|NCT02414009|Irinotecan|irinotecan|mesh-list
842410|NCT02414009|Temozolomide|temozolomide|mesh-list
842411|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
842412|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842413|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
842414|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842415|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
842416|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
842417|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842418|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
842419|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
842420|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
842421|NCT02414009|Antidotes|antidotes|mesh-ancestor
842422|NCT02414009|Protective Agents|protective agents|mesh-ancestor
842423|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
842424|NCT02414009|Vitamins|vitamins|mesh-ancestor
842425|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
842426|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
842427|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
2256220|NCT00148395|Carboplatin|carboplatin|mesh-list
2256221|NCT00148395|Ifosfamide|ifosfamide|mesh-list
2256222|NCT00148395|Mitomycins|mitomycins|mesh-list
2256223|NCT00148395|Mitomycin|mitomycin|mesh-list
2256224|NCT00148395|Vinorelbine|vinorelbine|mesh-list
2256225|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256226|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2256227|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
2256228|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256229|NCT00148395|Antiviral Agents|antiviral agents|mesh-ancestor
2256230|NCT00148395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256231|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256232|NCT00148395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2256233|NCT00148395|Immunologic Factors|immunologic factors|mesh-ancestor
2256234|NCT00148395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256235|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2256236|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
2256237|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2256238|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2256239|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2256240|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
2256241|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
2256242|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
2256243|NCT00148408|Montelukast|montelukast|mesh-list
2256244|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
843276|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
843277|NCT02410720|Cathartics|cathartics|mesh-ancestor
2256245|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
841786|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
841787|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841788|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
841789|NCT02416063|Analgesics|analgesics|mesh-ancestor
841790|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
841791|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841792|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
841793|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
841794|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
841795|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
841796|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
841797|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842069|NCT02415023|Paclitaxel|paclitaxel|mesh-list
842070|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
842071|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
842072|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842073|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
842074|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
842075|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
842076|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256246|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2256247|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
842984|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
842985|NCT02412150|Remifentanil|remifentanil|mesh-list
842986|NCT02412150|Desflurane|desflurane|mesh-list
842987|NCT02412150|Anesthetics|anesthetics|mesh-list
842988|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
842989|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
842990|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
842991|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842992|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
842993|NCT02412150|Analgesics|analgesics|mesh-ancestor
842994|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
842995|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
842996|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
842997|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
842998|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
842999|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
843000|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843001|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843002|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
843003|NCT02412150|Narcotics|narcotics|mesh-ancestor
843004|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
843040|NCT02411604|Tacrolimus|tacrolimus|mesh-list
843041|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
843042|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
843043|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843044|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
843045|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843046|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256248|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256249|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256250|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2256251|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
843196|NCT02410746|Ibuprofen|ibuprofen|mesh-list
843197|NCT02410746|Morphine|morphine|mesh-list
843198|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
843199|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
843200|NCT02410746|Narcotics|narcotics|mesh-ancestor
843201|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843202|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843203|NCT02410746|Analgesics|analgesics|mesh-ancestor
843204|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
843205|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843206|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
843207|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
843208|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
843209|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
843210|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
843211|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843212|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843213|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
843214|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
843710|NCT02409186|Paclitaxel|paclitaxel|mesh-list
841811|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
841812|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
841813|NCT02416115|Analgesics|analgesics|mesh-ancestor
841814|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
841815|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
841816|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
841817|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
841818|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
841819|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
841820|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
841821|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
841822|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
841823|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842720|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
842721|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
842722|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
842723|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842724|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
842725|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
842726|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
842727|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842728|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842729|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
842825|NCT02412267|Carboplatin|carboplatin|mesh-list
842826|NCT02412267|Etoposide|etoposide|mesh-list
842827|NCT02412267|Ifosfamide|ifosfamide|mesh-list
842828|NCT02412267|Ofatumumab|ofatumumab|mesh-list
842829|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842830|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
842831|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
842832|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
842833|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
842834|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842835|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
842836|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
843028|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
843029|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
843030|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
843084|NCT02411149|Epinephrine|epinephrine|mesh-list
843085|NCT02411149|Racepinephrine|racepinephrine|mesh-list
843086|NCT02411149|Morphine|morphine|mesh-list
843087|NCT02411149|Ropivacaine|ropivacaine|mesh-list
843088|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
843089|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
843090|NCT02411149|Narcotics|narcotics|mesh-ancestor
843091|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843092|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843093|NCT02411149|Analgesics|analgesics|mesh-ancestor
843094|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
843095|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843096|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
843097|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
843098|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
843099|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
843100|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
843101|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843102|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843103|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
843104|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
843105|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
843106|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
843107|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
843108|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
843109|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
843110|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
843159|NCT02410863|Trametinib|trametinib|mesh-list
843160|NCT02410863|Dabrafenib|dabrafenib|mesh-list
843161|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
843162|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
843163|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843164|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256252|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256253|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
2256254|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
2256255|NCT00148421|Hematinics|hematinics|mesh-ancestor
2256256|NCT00148447|Citalopram|citalopram|mesh-list
2256257|NCT00148447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
842459|NCT02413853|Leucovorin|leucovorin|mesh-list
842460|NCT02413853|Bevacizumab|bevacizumab|mesh-list
842461|NCT02413853|Fluorouracil|fluorouracil|mesh-list
842462|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
842463|NCT02413853|Calcium|calcium|mesh-list
842464|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
842465|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
842466|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842467|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
842468|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
842469|NCT02413853|Growth Substances|growth substances|mesh-ancestor
842470|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842471|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
842472|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
842473|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
842474|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842475|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
842476|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
842477|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
842478|NCT02413853|Antidotes|antidotes|mesh-ancestor
842479|NCT02413853|Protective Agents|protective agents|mesh-ancestor
842480|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
842481|NCT02413853|Vitamins|vitamins|mesh-ancestor
842482|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
842507|NCT02413281|Buprenorphine|buprenorphine|mesh-list
842508|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
842509|NCT02413281|Narcotics|narcotics|mesh-ancestor
842510|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
842511|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842512|NCT02413281|Analgesics|analgesics|mesh-ancestor
842513|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
842514|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
842515|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
843804|NCT02408393|Ropivacaine|ropivacaine|mesh-list
843805|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
843806|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
843807|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843808|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843809|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
843810|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256258|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2256259|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2256260|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256261|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256262|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
2256263|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256264|NCT00148447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2256265|NCT00148447|Antidepressive Agents|antidepressive agents|mesh-ancestor
2256266|NCT00148447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2256267|NCT00148460|Tenecteplase|tenecteplase|mesh-list
2256268|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2256269|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2256270|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256271|NCT00148473|Misoprostol|misoprostol|mesh-list
2256272|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2256273|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
2256274|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2256275|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256276|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2256277|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2256278|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
2256279|NCT00148499|Benzocaine|benzocaine|mesh-list
844879|NCT02404259|Ritonavir|ritonavir|mesh-list
844880|NCT02404259|Lopinavir|lopinavir|mesh-list
844881|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
844882|NCT02404259|Tenofovir|tenofovir|mesh-list
844883|NCT02404259|Efavirenz|efavirenz|mesh-list
844884|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
844885|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
844886|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
844887|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844888|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842054|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
842055|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
842667|NCT02412618|Misoprostol|misoprostol|mesh-list
842668|NCT02412618|Mifepristone|mifepristone|mesh-list
842669|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
842670|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
842671|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
842672|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842673|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
842674|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
842675|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
842676|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
842677|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
842678|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
842679|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
842680|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
842681|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
842682|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
842683|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
842684|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
842685|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
842686|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
842687|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
843170|NCT02410694|Thalidomide|thalidomide|mesh-list
843171|NCT02410694|Dexamethasone|dexamethasone|mesh-list
843172|NCT02410694|Ixazomib|ixazomib|mesh-list
843173|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
843174|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
843175|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
843176|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843177|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843178|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
843179|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
843180|NCT02410694|Hormones|hormones|mesh-ancestor
843181|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
843182|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
843183|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
843184|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
843185|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
843186|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
843187|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
843188|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
843189|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
843190|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
843191|NCT02410694|Growth Substances|growth substances|mesh-ancestor
843192|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
843193|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
843194|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843195|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256280|NCT00148499|Ambroxol|ambroxol|mesh-list
2256281|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
2256282|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
2256283|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2256284|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256285|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
2256286|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256287|NCT00148499|Expectorants|expectorants|mesh-ancestor
2256288|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
2256289|NCT00148551|Triamcinolone|triamcinolone|mesh-list
2256290|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2256291|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
843707|NCT02409238|Metformin|metformin|mesh-list
843708|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
843709|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843855|NCT02408185|Colistin|colistin|mesh-list
843856|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
843857|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
843982|NCT02407899|Vitamin D|vitamin d|mesh-list
843983|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
843984|NCT02407899|Insulin|insulin|mesh-list
843985|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
843986|NCT02407899|Metformin|metformin|mesh-list
843987|NCT02407899|Saxagliptin|saxagliptin|mesh-list
843988|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
843989|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
843990|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256292|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2256293|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2256294|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
2256295|NCT00148551|Hormones|hormones|mesh-ancestor
2256296|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256297|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256298|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2256299|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
2256300|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256301|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256302|NCT00148564|Olanzapine|olanzapine|mesh-list
2256303|NCT00148564|Ziprasidone|ziprasidone|mesh-list
2256304|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
2256305|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
2256306|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256307|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256308|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2256309|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2256310|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2256311|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2256312|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2256313|NCT00148564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2256314|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
843631|NCT02409017|Insulin|insulin|mesh-list
843632|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
843633|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256315|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2256316|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256317|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256318|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
2256319|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2256320|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2256321|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
2256322|NCT00148590|Memantine|memantine|mesh-list
2256323|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2256324|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2256325|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
2256326|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844091|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
844092|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
844093|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844094|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
844236|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
844237|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
844238|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
844239|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844240|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
844241|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
844242|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844243|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
844244|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
844245|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
844246|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844247|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
844385|NCT02406209|Prednisolone|prednisolone|mesh-list
844396|NCT02406209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
844397|NCT02406209|Methylprednisolone|methylprednisolone|mesh-list
844398|NCT02406209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
844399|NCT02406209|Prednisolone acetate|prednisolone acetate|mesh-list
844400|NCT02406209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
844401|NCT02406209|Prednisolone phosphate|prednisolone phosphate|mesh-list
844402|NCT02406209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
844403|NCT02406209|Glucocorticoids|glucocorticoids|mesh-ancestor
844404|NCT02406209|Hormones|hormones|mesh-ancestor
844405|NCT02406209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
844406|NCT02406209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844407|NCT02406209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
844408|NCT02406209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844409|NCT02406209|Antiemetics|antiemetics|mesh-ancestor
844410|NCT02406209|Autonomic Agents|autonomic agents|mesh-ancestor
844411|NCT02406209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844412|NCT02406209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
844413|NCT02406209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
844414|NCT02406209|Protective Agents|protective agents|mesh-ancestor
844809|NCT02404688|Ethanol|ethanol|mesh-list
844810|NCT02404688|Dronabinol|dronabinol|mesh-list
2754558|NCT00543374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
842249|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
842250|NCT02414568|Vinblastine|vinblastine|mesh-list
842251|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
842252|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842253|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
842254|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
842255|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
842256|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842257|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
842258|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
842259|NCT02414568|Hormones|hormones|mesh-ancestor
842260|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
842261|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842262|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
842263|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
842264|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
842265|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
842266|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
842267|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
842268|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
2256327|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256328|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256329|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2256330|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2256331|NCT00148603|Montelukast|montelukast|mesh-list
2256332|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2256333|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
2256334|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2256335|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
2256336|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256337|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843273|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
843274|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
843275|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843487|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
843488|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
843489|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843490|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843491|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
843492|NCT02409810|Analgesics|analgesics|mesh-ancestor
843493|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
843494|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843495|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
843496|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
843497|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
843498|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
843499|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843500|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843875|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
843876|NCT02408289|Procyanidin|procyanidin|mesh-list
843877|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
843878|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843879|NCT02408289|Protective Agents|protective agents|mesh-ancestor
843880|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843881|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
843882|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
843883|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256338|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2256339|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2256340|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256341|NCT00148616|Memantine|memantine|mesh-list
2256342|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2256343|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2256344|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
2256345|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256346|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256347|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754559|NCT00543374|Antiviral Agents|antiviral agents|mesh-ancestor
2099159|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2099160|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099161|NCT02354092|Anesthetics|anesthetics|mesh-list
2099162|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
2099163|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099164|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099165|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
2099166|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099167|NCT02354222|Canagliflozin|canagliflozin|mesh-list
842640|NCT02412904|Menotropins|menotropins|mesh-list
842641|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
842642|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
842643|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
842644|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842837|NCT02412059|Prednisolone|prednisolone|mesh-list
842838|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
842839|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
842840|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
842841|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
842842|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
842843|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
842844|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
842845|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
842846|NCT02412059|Hormones|hormones|mesh-ancestor
842847|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
842848|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842849|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
842850|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842851|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
842852|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
842853|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
842854|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
842855|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
842856|NCT02412059|Protective Agents|protective agents|mesh-ancestor
842932|NCT02411942|Adapalene|adapalene|mesh-list
842933|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
842934|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
842935|NCT02411942|Analgesics|analgesics|mesh-ancestor
842936|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
842937|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
842938|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842939|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
842940|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
842941|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
2256348|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2256349|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2256350|NCT00148629|Mebendazole|mebendazole|mesh-list
2256351|NCT00148629|Piperazine|piperazine|mesh-list
2256352|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
2256353|NCT00148629|DMP 777|dmp 777|mesh-list
2256354|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
2256355|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
2256356|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2256357|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256358|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
2256359|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
2256360|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
2256361|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256362|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256363|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256364|NCT00148681|Paclitaxel|paclitaxel|mesh-list
2256365|NCT00148681|Vinorelbine|vinorelbine|mesh-list
2256366|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
2256367|NCT00148681|Doxorubicin|doxorubicin|mesh-list
2256368|NCT00148681|Trastuzumab|trastuzumab|mesh-list
2256369|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2099168|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2099169|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099170|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2099171|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099172|NCT02354235|Canagliflozin|canagliflozin|mesh-list
2099173|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2099174|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099175|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2099176|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099177|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
2099178|NCT02354339|Antacids|antacids|mesh-ancestor
2099179|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099180|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2256370|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842394|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842395|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
842396|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
842397|NCT02414165|Growth Substances|growth substances|mesh-ancestor
842398|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842399|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
842400|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
842401|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
842402|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842403|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
842404|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
842405|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
843408|NCT02410317|Morphine|morphine|mesh-list
843409|NCT02410317|Ropivacaine|ropivacaine|mesh-list
843410|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
843411|NCT02410317|Narcotics|narcotics|mesh-ancestor
843412|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843413|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843414|NCT02410317|Analgesics|analgesics|mesh-ancestor
843415|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
843416|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843417|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
843418|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
843557|NCT02409498|Bupivacaine|bupivacaine|mesh-list
843558|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
843559|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
843560|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843561|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843562|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
843563|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843753|NCT02408679|Vitamin D|vitamin d|mesh-list
843754|NCT02408679|Vitamins|vitamins|mesh-ancestor
843755|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
843756|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843757|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2256371|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
2256372|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
2256373|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
2256374|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256375|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2256376|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
2256377|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256378|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2256379|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2256380|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
2256381|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2256382|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2256383|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2256384|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2256385|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844178|NCT02407314|Aspirin|aspirin|mesh-list
844179|NCT02407314|Ticagrelor|ticagrelor|mesh-list
844180|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
844181|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
844182|NCT02407314|Analgesics|analgesics|mesh-ancestor
844183|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
844184|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844185|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844186|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
844187|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
844188|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
844189|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
844190|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844191|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
844192|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
844193|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844194|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
844195|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
844196|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
844197|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
844198|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
844199|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844262|NCT02406690|Leuprolide|leuprolide|mesh-list
844263|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
844264|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
842441|NCT02413827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842442|NCT02413827|Interferon Inducers|interferon inducers|mesh-ancestor
842443|NCT02413827|Immunologic Factors|immunologic factors|mesh-ancestor
842444|NCT02413827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842598|NCT02413086|Chitosan|chitosan|mesh-list
842599|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
842600|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
842601|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
842602|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842603|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
842604|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
842605|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
842606|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
842607|NCT02413086|Coagulants|coagulants|mesh-ancestor
843155|NCT02410980|Tretinoin|tretinoin|mesh-list
843156|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
843157|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
843158|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
843242|NCT02410655|Oxytocin|oxytocin|mesh-list
843243|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
843244|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
843245|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844536|NCT02406092|Prednisone|prednisone|mesh-list
844537|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
844538|NCT02406092|Rituximab|rituximab|mesh-list
844539|NCT02406092|Doxorubicin|doxorubicin|mesh-list
844540|NCT02406092|Fludarabine|fludarabine|mesh-list
844541|NCT02406092|Vincristine|vincristine|mesh-list
844542|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
844543|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
844544|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844545|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
844546|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
844547|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
844548|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844549|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844550|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
844551|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
844552|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
844553|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
844554|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
844555|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844556|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
844557|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
844558|NCT02406092|Hormones|hormones|mesh-ancestor
844559|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
844560|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
844561|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
844562|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
844563|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
844564|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
844619|NCT02405520|Vaccines|vaccines|mesh-list
844620|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
844621|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844728|NCT02405156|Letrozole|letrozole|mesh-list
844729|NCT02405156|Misoprostol|misoprostol|mesh-list
844730|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844731|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
844732|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
844733|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844734|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844735|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
844736|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
844737|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
844738|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844739|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
844740|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
844741|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
844742|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
844743|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
844744|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
2256386|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2256387|NCT00148694|Cisplatin|cisplatin|mesh-list
2256388|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256389|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2256390|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099181|NCT02354352|Eplerenone|eplerenone|mesh-list
2256391|NCT00148720|Capecitabine|capecitabine|mesh-list
842608|NCT02412930|Tramadol|tramadol|mesh-list
842609|NCT02412930|Bupivacaine|bupivacaine|mesh-list
842610|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
842611|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
842612|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
842613|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842614|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
842615|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
842616|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
842617|NCT02412930|Narcotics|narcotics|mesh-ancestor
842618|NCT02412930|Analgesics|analgesics|mesh-ancestor
2256392|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2256393|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
2256394|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256395|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256396|NCT00148746|Cyclosporine|cyclosporine|mesh-list
2256397|NCT00148746|Prednisolone|prednisolone|mesh-list
2256398|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
2256399|NCT00148746|Prednicarbate|prednicarbate|mesh-list
2256400|NCT00148746|Tacrolimus|tacrolimus|mesh-list
2256401|NCT00148746|Cyclosporins|cyclosporins|mesh-list
2256402|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2256403|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
2256404|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843111|NCT02411175|Ethanol|ethanol|mesh-list
843112|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
843113|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
843114|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843115|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099182|NCT02354352|Spironolactone|spironolactone|mesh-list
2099183|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2099184|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
843771|NCT02408705|Acetaminophen|acetaminophen|mesh-list
843772|NCT02408705|Liraglutide|liraglutide|mesh-list
843773|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
843774|NCT02408705|Analgesics|analgesics|mesh-ancestor
843775|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
843776|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843777|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843778|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
843779|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
843780|NCT02408705|Incretins|incretins|mesh-ancestor
843781|NCT02408705|Hormones|hormones|mesh-ancestor
843782|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256405|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2256406|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256407|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256408|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
2256409|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256410|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
2256411|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2256412|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
844415|NCT02406144|Dexamethasone|dexamethasone|mesh-list
844416|NCT02406144|Lenalidomide|lenalidomide|mesh-list
844417|NCT02406144|Ixazomib|ixazomib|mesh-list
844418|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
844419|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
844420|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
844421|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844422|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844423|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
844424|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
844425|NCT02406144|Hormones|hormones|mesh-ancestor
844426|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
844427|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
844428|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844429|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
844430|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
844431|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
844432|NCT02406144|Growth Substances|growth substances|mesh-ancestor
844433|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
844434|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
844435|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844436|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844998|NCT02404051|Everolimus|everolimus|mesh-list
2256413|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
2256414|NCT00148746|Hormones|hormones|mesh-ancestor
842627|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
842628|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
842629|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842630|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
842631|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
842632|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
2256415|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256416|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2256417|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256418|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256419|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
842859|NCT02412189|Norepinephrine|norepinephrine|mesh-list
842860|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
842861|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
842862|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
842863|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
842864|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
842865|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842866|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
842867|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
842868|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
842869|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
843390|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
843391|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
843392|NCT02410031|Cyproterone|cyproterone|mesh-list
843393|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
843394|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
843395|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
843396|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
843397|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
843398|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
843399|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843400|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
843401|NCT02410031|Estrogens|estrogens|mesh-ancestor
843402|NCT02410031|Hormones|hormones|mesh-ancestor
843403|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
843404|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
843405|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
843406|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
843407|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
843546|NCT02409563|Budesonide|budesonide|mesh-list
843547|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
843548|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
843549|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
843550|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843551|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843552|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
843553|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
843554|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
843555|NCT02409563|Hormones|hormones|mesh-ancestor
843556|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
843675|NCT02409147|Aspirin|aspirin|mesh-list
843676|NCT02409147|Nystatin|nystatin|mesh-list
843677|NCT02409147|Prednisone|prednisone|mesh-list
843678|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
843679|NCT02409147|Basiliximab|basiliximab|mesh-list
843680|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
843681|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
843682|NCT02409147|Hormones|hormones|mesh-ancestor
843683|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
843684|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843685|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
843686|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
843687|NCT02409147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
843688|NCT02409147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
843689|NCT02409147|Analgesics|analgesics|mesh-ancestor
843690|NCT02409147|Sensory System Agents|sensory system agents|mesh-ancestor
843691|NCT02409147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843692|NCT02409147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
843693|NCT02409147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
843694|NCT02409147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
843695|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843696|NCT02409147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2256420|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2256421|NCT00148746|Analgesics|analgesics|mesh-ancestor
2256422|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
2256423|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
842907|NCT02411994|Artesunate|artesunate|mesh-list
842908|NCT02411994|Lumefantrine|lumefantrine|mesh-list
842909|NCT02411994|Artemether|artemether|mesh-list
842910|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
842911|NCT02411994|Pyronaridine|pyronaridine|mesh-list
842912|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
842913|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
842914|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
842915|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
842916|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
842917|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
842918|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
842919|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
842920|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
843510|NCT02409862|Oxytocin|oxytocin|mesh-list
843511|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
843512|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
843513|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843653|NCT02409199|Docetaxel|docetaxel|mesh-list
843654|NCT02409199|Apatinib|apatinib|mesh-list
843655|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
843656|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
843657|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
843658|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
843659|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843660|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
843661|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256424|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256425|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2256426|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256427|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256428|NCT00148785|Ritonavir|ritonavir|mesh-list
2256429|NCT00148785|Indinavir|indinavir|mesh-list
2256430|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
2256431|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2256432|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2256433|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
2256434|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256435|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256436|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2256437|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2256438|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
2256439|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256440|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2256441|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2256442|NCT00148824|Vaccines|vaccines|mesh-list
2256443|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
844381|NCT02406300|Bupivacaine|bupivacaine|mesh-list
844382|NCT02406300|Ropivacaine|ropivacaine|mesh-list
844383|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
844384|NCT02406300|Sevoflurane|sevoflurane|mesh-list
844386|NCT02406300|Desflurane|desflurane|mesh-list
844387|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
844388|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
844389|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
844390|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844391|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
844392|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844393|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
844394|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
844395|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
2256444|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
2256445|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256446|NCT00148837|Interferons|interferons|mesh-list
845337|NCT02403063|Neostigmine|neostigmine|mesh-list
845338|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
845339|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845340|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845341|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
845342|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
845343|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845344|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
845345|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
845346|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
842811|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
842812|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
842813|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
842814|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
842815|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
842816|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
842817|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
843025|NCT02411825|Metformin|metformin|mesh-list
843026|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
843027|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843235|NCT02410512|Atezolizumab|atezolizumab|mesh-list
843236|NCT02410512|Antibodies|antibodies|mesh-list
843237|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
843238|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
843239|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
843240|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843241|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
843460|NCT02410083|Aspirin|aspirin|mesh-list
843461|NCT02410083|Clopidogrel|clopidogrel|mesh-list
843462|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
843463|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
843464|NCT02410083|Analgesics|analgesics|mesh-ancestor
843465|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
843466|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843467|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843468|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
843469|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
843470|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
843471|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
843472|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843473|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
843474|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
843475|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843476|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
843477|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
843478|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
843479|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
843480|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
843481|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843564|NCT02409407|Alprostadil|alprostadil|mesh-list
843565|NCT02409407|Misoprostol|misoprostol|mesh-list
843566|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
843567|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
843568|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
843569|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843570|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
843571|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
843572|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
843573|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
843574|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
843575|NCT02409407|Urological Agents|urological agents|mesh-ancestor
843846|NCT02408419|Bupivacaine|bupivacaine|mesh-list
843847|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
843848|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
843849|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843850|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843851|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
843852|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844707|NCT02405130|Epinephrine|epinephrine|mesh-list
844708|NCT02405130|Racepinephrine|racepinephrine|mesh-list
844709|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
844710|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
844711|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
844712|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
844713|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844714|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844715|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844716|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
844717|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
844718|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
844719|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844720|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
844721|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
844722|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
844723|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
844724|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2256447|NCT00148837|Ribavirin|ribavirin|mesh-list
2256448|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
2256449|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
2256450|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2256451|NCT00148837|Prazosin|prazosin|mesh-list
2256452|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
843070|NCT02411630|Tenofovir|tenofovir|mesh-list
843071|NCT02411630|Emtricitabine|emtricitabine|mesh-list
843072|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
843073|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
843074|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
843075|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
843076|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843077|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843078|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
843079|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
843501|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
843502|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
843503|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843504|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843505|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
843579|NCT02409537|Resveratrol|resveratrol|mesh-list
843580|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
843581|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843582|NCT02409537|Protective Agents|protective agents|mesh-ancestor
843583|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843584|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843585|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
844565|NCT02405598|Albuterol|albuterol|mesh-list
844566|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
844567|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
844568|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844569|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844570|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
844571|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
844572|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
844573|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
844574|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
844575|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
844576|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
844577|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
844578|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844579|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844725|NCT02405338|Vaccines|vaccines|mesh-list
844726|NCT02405338|Immunologic Factors|immunologic factors|mesh-ancestor
844727|NCT02405338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845605|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
845606|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
845693|NCT02401477|Amoxicillin|amoxicillin|mesh-list
845694|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
845695|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256453|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
2256454|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256455|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
2256456|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256457|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
2256458|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256459|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2256460|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2256461|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2256462|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2256463|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
2256464|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256465|NCT00148850|Pioglitazone|pioglitazone|mesh-list
2256466|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2256467|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256468|NCT00148863|Interferons|interferons|mesh-list
2256469|NCT00148863|Ribavirin|ribavirin|mesh-list
2256470|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
2256471|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
2256472|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
2256473|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2256474|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256475|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
2256476|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256477|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
2256478|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256479|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
2256480|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256481|NCT00148876|Capecitabine|capecitabine|mesh-list
843506|NCT02409849|Octreotide|octreotide|mesh-list
843507|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
843508|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
843509|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099185|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2099186|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099187|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2099188|NCT02354352|Diuretics|diuretics|mesh-ancestor
2099189|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
2099190|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
843830|NCT02408172|Metoprolol|metoprolol|mesh-list
843831|NCT02408172|Amlodipine|amlodipine|mesh-list
843832|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
843833|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
843834|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
843835|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843836|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
843837|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843838|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
843839|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
843840|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
843841|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
843842|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843843|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
843844|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
843845|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
843853|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
843854|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844209|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
844210|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
844211|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844212|NCT02406950|Incretins|incretins|mesh-ancestor
844213|NCT02406950|Hormones|hormones|mesh-ancestor
844214|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
844215|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
844216|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
844217|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844218|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844931|NCT02404142|Atracurium|atracurium|mesh-list
844932|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
844933|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
844934|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
844935|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844936|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844937|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
844938|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
844939|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
844940|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844941|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256482|NCT00148876|Trastuzumab|trastuzumab|mesh-list
2256483|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2256484|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
2256485|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256486|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256487|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2256488|NCT00148902|Docetaxel|docetaxel|mesh-list
2256489|NCT00148902|Lapatinib|lapatinib|mesh-list
2256490|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256491|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
2256492|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
2256493|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
2256494|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256495|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2256496|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256497|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
846506|NCT02398474|Ropivacaine|ropivacaine|mesh-list
846507|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
846508|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
846509|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2256498|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
843129|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843130|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843131|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843132|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
843133|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
843134|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843135|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
843136|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
843137|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
843444|NCT02410005|Calcitriol|calcitriol|mesh-list
843445|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
843446|NCT02410005|Losartan|losartan|mesh-list
843447|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
843448|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
843449|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
843450|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
843451|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843452|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
843453|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843454|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
843455|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
843456|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
843457|NCT02410005|Vitamins|vitamins|mesh-ancestor
843458|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
843459|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
844845|NCT02404363|Clopidogrel|clopidogrel|mesh-list
844846|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
844847|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
844848|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
844849|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
844850|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
844851|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844852|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844853|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844958|NCT02404064|Metronidazole|metronidazole|mesh-list
844959|NCT02404064|Cefotaxime|cefotaxime|mesh-list
844960|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844961|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
844962|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
844963|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2256499|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256500|NCT00149019|Antibodies|antibodies|mesh-list
2256501|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2256502|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
2256503|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256504|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
2256505|NCT00149058|Hematinics|hematinics|mesh-ancestor
2256506|NCT00149084|Amoxicillin|amoxicillin|mesh-list
2256507|NCT00149084|Clarithromycin|clarithromycin|mesh-list
2256508|NCT00149084|Lansoprazole|lansoprazole|mesh-list
2256509|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
2256510|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2256511|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256512|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2256513|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256514|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256515|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2256516|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
845159|NCT02403531|Docetaxel|docetaxel|mesh-list
845167|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845168|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
845169|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
845170|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
845171|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845781|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
845782|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
845783|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845889|NCT02400879|Sufentanil|sufentanil|mesh-list
845890|NCT02400879|Remifentanil|remifentanil|mesh-list
845891|NCT02400879|Sevoflurane|sevoflurane|mesh-list
845892|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
845893|NCT02400879|Narcotics|narcotics|mesh-ancestor
845894|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
845895|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845896|NCT02400879|Analgesics|analgesics|mesh-ancestor
2256517|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2256518|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2256519|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2256520|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2256521|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2256522|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2256523|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2256524|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256525|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256526|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256527|NCT00149110|Analgesics|analgesics|mesh-ancestor
2256528|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
2256529|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843638|NCT02409004|Rifampin|rifampin|mesh-list
843639|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
843640|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
843641|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
843642|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
843643|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
843644|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
843645|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843646|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843647|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
843648|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
843649|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
843650|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
843651|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
843652|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
843798|NCT02408562|Becaplermin|becaplermin|mesh-list
843799|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
843800|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
843801|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
843802|NCT02408562|Growth Substances|growth substances|mesh-ancestor
843803|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844200|NCT02406911|Ticagrelor|ticagrelor|mesh-list
844201|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
844202|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
844203|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
844204|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
844205|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
844206|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844207|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844208|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844374|NCT02406170|Paclitaxel|paclitaxel|mesh-list
844375|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
844376|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844377|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
844378|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
844379|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
844380|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844488|NCT02405910|Gemcitabine|gemcitabine|mesh-list
844489|NCT02405910|Paclitaxel|paclitaxel|mesh-list
844490|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
844491|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844492|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
844493|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
844494|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
844495|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844496|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
844497|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
844498|NCT02405910|Antiviral Agents|antiviral agents|mesh-ancestor
844499|NCT02405910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844500|NCT02405910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844501|NCT02405910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
844502|NCT02405910|Immunologic Factors|immunologic factors|mesh-ancestor
844503|NCT02405910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845372|NCT02402842|Docetaxel|docetaxel|mesh-list
845373|NCT02402842|Fluorouracil|fluorouracil|mesh-list
845374|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845375|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
845376|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
845377|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
845378|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843264|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
843265|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
843266|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
843267|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843268|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843269|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
843270|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843271|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
843272|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2256530|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
2256531|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2256532|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
2256533|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
2256534|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2099191|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
2099192|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2099193|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099194|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099195|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2099196|NCT02354378|Analgesics|analgesics|mesh-ancestor
844107|NCT02407366|Carboplatin|carboplatin|mesh-list
844108|NCT02407366|Pemetrexed|pemetrexed|mesh-list
844109|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844110|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844111|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844112|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
844113|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
845198|NCT02403687|Topiramate|topiramate|mesh-list
845199|NCT02403687|Diclofenac|diclofenac|mesh-list
845200|NCT02403687|Meloxicam|meloxicam|mesh-list
845201|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
845202|NCT02403687|Lidocaine|lidocaine|mesh-list
845203|NCT02403687|Clonidine|clonidine|mesh-list
845204|NCT02403687|Sumatriptan|sumatriptan|mesh-list
845205|NCT02403687|Ketamine|ketamine|mesh-list
845206|NCT02403687|Gabapentin|gabapentin|mesh-list
845207|NCT02403687|Amitriptyline|amitriptyline|mesh-list
845208|NCT02403687|Tizanidine|tizanidine|mesh-list
845209|NCT02403687|Bupivacaine|bupivacaine|mesh-list
845210|NCT02403687|Prilocaine|prilocaine|mesh-list
845211|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
845212|NCT02403687|Baclofen|baclofen|mesh-list
845213|NCT02403687|Capsaicin|capsaicin|mesh-list
845214|NCT02403687|Menthol|menthol|mesh-list
845215|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
845216|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
845217|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
845218|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845219|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
845220|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845221|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
845222|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
845223|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
845224|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
845225|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845226|NCT02403687|Analgesics|analgesics|mesh-ancestor
845227|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
845228|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
845229|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
845230|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
845231|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
845232|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
845233|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
845234|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
845235|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
845236|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
845237|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
845238|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
845239|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
845240|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
845241|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
845242|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
845243|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845244|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
845245|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
845246|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
845247|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
845248|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2099197|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
843278|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
843435|NCT02410135|Mirabegron|mirabegron|mesh-list
843436|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
843437|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
843438|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
843439|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
843440|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843441|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843442|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843443|NCT02410135|Urological Agents|urological agents|mesh-ancestor
2099198|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099199|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2099200|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2099201|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2099202|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
2099203|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099204|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099205|NCT02354508|Pasireotide|pasireotide|mesh-list
2099206|NCT02354508|Hormones|hormones|mesh-ancestor
2099207|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2099208|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099209|NCT02354534|Artesunate|artesunate|mesh-list
2099210|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
2099211|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2099212|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2099213|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099214|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844102|NCT02407509|Everolimus|everolimus|mesh-list
844103|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844104|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
844105|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
844106|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844281|NCT02406703|Mepivacaine|mepivacaine|mesh-list
844282|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
844283|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
844284|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
844285|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
844286|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844287|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
844288|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844316|NCT02406222|Dexamethasone|dexamethasone|mesh-list
844317|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
844318|NCT02406222|Pomalidomide|pomalidomide|mesh-list
844319|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
844320|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
844321|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844322|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
844323|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
844324|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
844325|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844326|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844327|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
844328|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
844329|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
844330|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
844331|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844332|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
844333|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
844334|NCT02406222|Hormones|hormones|mesh-ancestor
844335|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
844336|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
844337|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
844338|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
844339|NCT02406222|Growth Substances|growth substances|mesh-ancestor
844340|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
845384|NCT02402868|Ketamine|ketamine|mesh-list
845385|NCT02402868|Analgesics|analgesics|mesh-ancestor
845386|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
845387|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845388|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845389|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
845390|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
845391|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
845392|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
845393|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2256535|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
2256536|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256537|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2256538|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256539|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256540|NCT00149149|Polaprezinc|polaprezinc|mesh-list
2256541|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2256542|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2256543|NCT00149162|Aldesleukin|aldesleukin|mesh-list
2256544|NCT00149162|Interleukin-2|interleukin-2|mesh-list
2256545|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256546|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2256547|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2256548|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
2256549|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256550|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2256551|NCT00149162|Analgesics|analgesics|mesh-ancestor
2256552|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
2256553|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256554|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844760|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
844761|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
844762|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
844763|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844764|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
844765|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
844766|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256555|NCT00149188|Lanreotide|lanreotide|mesh-list
2256556|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256557|NCT00149201|Fluorouracil|fluorouracil|mesh-list
2256558|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
2256559|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256560|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2256561|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256562|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2256563|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
2256564|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256565|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
2256566|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2256567|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2256568|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2256569|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2256570|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256571|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
2256572|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256573|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256574|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2256575|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256576|NCT00149253|Etoricoxib|etoricoxib|mesh-list
2256577|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256578|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2256579|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2256580|NCT00149253|Analgesics|analgesics|mesh-ancestor
2256581|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
845554|NCT02402920|Cisplatin|cisplatin|mesh-list
845555|NCT02402920|Carboplatin|carboplatin|mesh-list
845556|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
845557|NCT02402920|Etoposide|etoposide|mesh-list
845558|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
845559|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
845560|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845561|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
845562|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
845563|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
845564|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
845565|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845566|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845567|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
845568|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
845569|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
845570|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
845571|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
845855|NCT02401139|Ketamine|ketamine|mesh-list
845856|NCT02401139|Analgesics|analgesics|mesh-ancestor
845857|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
846405|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
2256582|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256583|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2256584|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2256585|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2256586|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2256587|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256588|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256589|NCT00149292|Olanzapine|olanzapine|mesh-list
2256590|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
2256591|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
2256592|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256593|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256594|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2256595|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2256596|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2256597|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2256598|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2256599|NCT00149292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2256600|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2256601|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2256602|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256603|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256604|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
2256605|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
843795|NCT02408926|Vaccines|vaccines|mesh-list
843796|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
843797|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844007|NCT02408042|Rituximab|rituximab|mesh-list
844008|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
844009|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
844010|NCT02408042|Carboplatin|carboplatin|mesh-list
844011|NCT02408042|Etoposide|etoposide|mesh-list
844012|NCT02408042|Ifosfamide|ifosfamide|mesh-list
844013|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
844014|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844015|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
844016|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844017|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
844018|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
844019|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
844020|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
844021|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844022|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844023|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
844024|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
844145|NCT02407210|Olmesartan|olmesartan|mesh-list
844146|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
844147|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
844148|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
844149|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
844150|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
844151|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844221|NCT02406872|Propofol|propofol|mesh-list
844222|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
844223|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
844224|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844225|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
844226|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
844227|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
2256606|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2256607|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256608|NCT00149539|Buprenorphine|buprenorphine|mesh-list
2256609|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2256610|NCT00149539|Naloxone|naloxone|mesh-list
2256611|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2256612|NCT00149539|Narcotics|narcotics|mesh-ancestor
2256613|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2256614|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256615|NCT00149539|Analgesics|analgesics|mesh-ancestor
2256616|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
2256617|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256618|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2256619|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
2256620|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256621|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
2256622|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256623|NCT00149578|Leucovorin|leucovorin|mesh-list
843324|NCT02410460|Scopolamine|scopolamine|mesh-list
843325|NCT02410460|Ketamine|ketamine|mesh-list
843326|NCT02410460|Ondansetron|ondansetron|mesh-list
843327|NCT02410460|Metoclopramide|metoclopramide|mesh-list
843328|NCT02410460|Bupivacaine|bupivacaine|mesh-list
843329|NCT02410460|Propofol|propofol|mesh-list
843330|NCT02410460|Sevoflurane|sevoflurane|mesh-list
843331|NCT02410460|Desflurane|desflurane|mesh-list
843332|NCT02410460|Famotidine|famotidine|mesh-list
843333|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
843334|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
843335|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
843336|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843337|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843338|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
843339|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843340|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
843341|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
843342|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
843343|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
843344|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843345|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
843346|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
843347|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
843348|NCT02410460|Analgesics|analgesics|mesh-ancestor
843349|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
843350|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
843351|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
843352|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843353|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
843354|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
843355|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
843356|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
843357|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
843358|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
843359|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
843360|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
843361|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
843362|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
843363|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
843364|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
843365|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
843366|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
843367|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
843368|NCT02410460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
843369|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
843370|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
843371|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
843372|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
843373|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
843374|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
843375|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
843376|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
843377|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
843378|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
843379|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
843380|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
843381|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
843382|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
843383|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
843384|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
843385|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
843386|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
843721|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
843722|NCT02409290|Levofloxacin|levofloxacin|mesh-list
843723|NCT02409290|Isoniazid|isoniazid|mesh-list
843724|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
843725|NCT02409290|Ethambutol|ethambutol|mesh-list
843726|NCT02409290|Bedaquiline|bedaquiline|mesh-list
843727|NCT02409290|Clofazimine|clofazimine|mesh-list
843728|NCT02409290|Kanamycin|kanamycin|mesh-list
843729|NCT02409290|Prothionamide|prothionamide|mesh-list
843730|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
843731|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
843732|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
843733|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
843734|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843735|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843736|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
843737|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
843433|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843434|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843954|NCT02407912|Cisplatin|cisplatin|mesh-list
843955|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844071|NCT02407626|Propofol|propofol|mesh-list
844072|NCT02407626|Sevoflurane|sevoflurane|mesh-list
844073|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
844074|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
844075|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844076|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
844077|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
844078|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
844079|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
844080|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2256624|NCT00149578|Gemcitabine|gemcitabine|mesh-list
2256625|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
2256626|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2256627|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
845515|NCT02402413|Androgens|androgens|mesh-list
845516|NCT02402413|Hormones|hormones|mesh-ancestor
845517|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845518|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845709|NCT02401347|Talazoparib|talazoparib|mesh-list
845710|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
845711|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845712|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845713|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845849|NCT02401035|Pantoprazole|pantoprazole|mesh-list
845850|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
845851|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
845852|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
845853|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845854|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845982|NCT02400645|Ketorolac|ketorolac|mesh-list
845983|NCT02400645|Bupivacaine|bupivacaine|mesh-list
845984|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
845985|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
845986|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
845987|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845988|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
845989|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845990|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
845991|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
845992|NCT02400645|Analgesics|analgesics|mesh-ancestor
845993|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
845994|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
845995|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
845996|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845997|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846024|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
846025|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
846026|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
846027|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
846159|NCT02399943|Panitumumab|panitumumab|mesh-list
846160|NCT02399943|Trametinib|trametinib|mesh-list
846161|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
846162|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846163|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
846164|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846165|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846978|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
846979|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
846980|NCT02396329|Povidone|povidone|mesh-list
846981|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
846982|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
846983|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
846984|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
846985|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
847275|NCT02395068|Irinotecan|irinotecan|mesh-list
847276|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
2256628|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256629|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256630|NCT00149578|Antiviral Agents|antiviral agents|mesh-ancestor
2256631|NCT00149578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256632|NCT00149578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256633|NCT00149578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2256634|NCT00149578|Immunologic Factors|immunologic factors|mesh-ancestor
2256635|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843768|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
843769|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
843770|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
843811|NCT02408354|Glycerol|glycerol|mesh-list
843812|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
843813|NCT02408354|Protective Agents|protective agents|mesh-ancestor
843814|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256636|NCT00149578|Antidotes|antidotes|mesh-ancestor
2256637|NCT00149578|Protective Agents|protective agents|mesh-ancestor
2256638|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
2256639|NCT00149578|Vitamins|vitamins|mesh-ancestor
2256640|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
2256641|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2256642|NCT00149604|Estrogens|estrogens|mesh-list
2256643|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
844250|NCT02406508|Sorafenib|sorafenib|mesh-list
844251|NCT02406508|Melphalan|melphalan|mesh-list
844252|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844253|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
844254|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844255|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844256|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
844257|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
844258|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
844259|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
844260|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
844261|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845277|NCT02403349|Atenolol|atenolol|mesh-list
845278|NCT02403349|Valsartan|valsartan|mesh-list
845279|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
845280|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
845281|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
845282|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845283|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
845284|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
845285|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
845286|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845287|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845288|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
845289|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
845290|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
845291|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
845292|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
845354|NCT02403037|Dexamethasone|dexamethasone|mesh-list
845355|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
845356|NCT02403037|Antiemetics|antiemetics|mesh-list
845357|NCT02403037|Emetics|emetics|mesh-list
845358|NCT02403037|BB 1101|bb 1101|mesh-list
845359|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
845360|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
845361|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845362|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845363|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
845364|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
845365|NCT02403037|Hormones|hormones|mesh-ancestor
845366|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845367|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
845368|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845369|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
845370|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845371|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845412|NCT02402725|Dexamethasone|dexamethasone|mesh-list
845413|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
845414|NCT02402725|BB 1101|bb 1101|mesh-list
845415|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
845416|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
845417|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
845418|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845678|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
2256644|NCT00149604|Hormones|hormones|mesh-ancestor
2256645|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256646|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256647|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
843904|NCT02408146|Celecoxib|celecoxib|mesh-list
843905|NCT02408146|Parecoxib|parecoxib|mesh-list
843906|NCT02408146|Fentanyl|fentanyl|mesh-list
843907|NCT02408146|Ondansetron|ondansetron|mesh-list
843908|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
843909|NCT02408146|Narcotics|narcotics|mesh-ancestor
843910|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843911|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843912|NCT02408146|Analgesics|analgesics|mesh-ancestor
843913|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
843914|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
843915|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
843916|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
843917|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
843918|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
843919|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843920|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
843921|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
843922|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
843923|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
843924|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
843925|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
843926|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843927|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
843928|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
843929|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
843930|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
843931|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
843932|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
843933|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
843934|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843935|NCT02408146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
843936|NCT02408146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
843937|NCT02408146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
843938|NCT02408146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2256648|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
2256649|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2256650|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2256651|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2256652|NCT00149617|Buspirone|buspirone|mesh-list
2256653|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2256654|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2256655|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2256656|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256657|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2256658|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2256659|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
2256660|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256661|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256662|NCT00149656|Selenium|selenium|mesh-list
2256663|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
2256664|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256665|NCT00149656|Protective Agents|protective agents|mesh-ancestor
2256666|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256667|NCT00149656|Trace Elements|trace elements|mesh-ancestor
2256668|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
2256669|NCT00149708|Hormones|hormones|mesh-list
2256670|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256671|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256672|NCT00149851|Tegaserod|tegaserod|mesh-list
2256673|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2256674|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
2256675|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844745|NCT02405260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
844746|NCT02405260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
844747|NCT02405260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844748|NCT02405260|Incretins|incretins|mesh-ancestor
844749|NCT02405260|Hormones|hormones|mesh-ancestor
844750|NCT02405260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
844751|NCT02405260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
844752|NCT02405260|Protease Inhibitors|protease inhibitors|mesh-ancestor
844753|NCT02405260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843697|NCT02409147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
843698|NCT02409147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
843699|NCT02409147|Antipyretics|antipyretics|mesh-ancestor
843700|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
843701|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
843702|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
843703|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
843704|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
843705|NCT02409147|Ionophores|ionophores|mesh-ancestor
843706|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
843815|NCT02408302|Midazolam|midazolam|mesh-list
843816|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
843817|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
843818|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
843819|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843820|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
843821|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
843822|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
843823|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
843824|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
843825|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
843826|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
843827|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
843828|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843829|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844095|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
844096|NCT02407340|Oxytocin|oxytocin|mesh-list
844097|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
844098|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
844099|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844100|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
844101|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256676|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256677|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256678|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
2256679|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2256680|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256681|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2256682|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
2256683|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2256684|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256685|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844854|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
844855|NCT02404519|Vitamin K|vitamin k|mesh-list
844856|NCT02404519|Vitamin MK 7|vitamin mk 7|mesh-list
844857|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
844858|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
844859|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844860|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
844861|NCT02404519|Coagulants|coagulants|mesh-ancestor
844862|NCT02404519|Vitamins|vitamins|mesh-ancestor
844863|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
844864|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844968|NCT02404038|NuvaRing|nuvaring|mesh-list
844969|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
844970|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
844971|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
844972|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
844973|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844974|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
844975|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
844976|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
844977|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
844978|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
844979|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
844980|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
844981|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
845463|NCT02402660|Vitamin A|vitamin a|mesh-list
845464|NCT02402660|Retinol acetate|retinol acetate|mesh-list
845465|NCT02402660|Vitamins|vitamins|mesh-ancestor
845466|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
843711|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
843712|NCT02409186|Cisplatin|cisplatin|mesh-list
843713|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
843714|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
843715|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
843716|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
843717|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
843718|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
843719|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843720|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
844522|NCT02406066|Oxazepam|oxazepam|mesh-list
844523|NCT02406066|Metyrapone|metyrapone|mesh-list
844524|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
844525|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844526|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844527|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
844528|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
844529|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844530|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
844531|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
844532|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
844533|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
844534|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
844535|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844622|NCT02405585|Leucovorin|leucovorin|mesh-list
844623|NCT02405585|Gemcitabine|gemcitabine|mesh-list
844624|NCT02405585|Fluorouracil|fluorouracil|mesh-list
844625|NCT02405585|Oxaliplatin|oxaliplatin|mesh-list
844626|NCT02405585|Irinotecan|irinotecan|mesh-list
844627|NCT02405585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
844628|NCT02405585|Antimetabolites|antimetabolites|mesh-ancestor
844629|NCT02405585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844630|NCT02405585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844631|NCT02405585|Antiviral Agents|antiviral agents|mesh-ancestor
844632|NCT02405585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844633|NCT02405585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844634|NCT02405585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
844635|NCT02405585|Immunologic Factors|immunologic factors|mesh-ancestor
844636|NCT02405585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844637|NCT02405585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
844638|NCT02405585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
844639|NCT02405585|Antidotes|antidotes|mesh-ancestor
844640|NCT02405585|Protective Agents|protective agents|mesh-ancestor
844641|NCT02405585|Vitamin B Complex|vitamin b complex|mesh-ancestor
844642|NCT02405585|Vitamins|vitamins|mesh-ancestor
844643|NCT02405585|Micronutrients|micronutrients|mesh-ancestor
844755|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
844756|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
844757|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844758|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
844759|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845014|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
845015|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
845016|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
845017|NCT02403856|Prednisolone|prednisolone|mesh-list
845018|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
845019|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
845020|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
845021|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
845022|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
845023|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
845024|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845025|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845026|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
845027|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
845028|NCT02403856|Hormones|hormones|mesh-ancestor
845029|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845030|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
845031|NCT02403856|Protective Agents|protective agents|mesh-ancestor
845032|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
845033|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845671|NCT02401828|Dolutegravir|dolutegravir|mesh-list
845672|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
845673|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
845674|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845675|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845676|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
845677|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
843739|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
843740|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
843741|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
843742|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
843743|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
843744|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
843745|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
843746|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
843747|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
843748|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
844644|NCT02405676|Cytarabine|cytarabine|mesh-list
844645|NCT02405676|Prednisone|prednisone|mesh-list
844646|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
844647|NCT02405676|Ifosfamide|ifosfamide|mesh-list
844648|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
844649|NCT02405676|Rituximab|rituximab|mesh-list
844650|NCT02405676|Methotrexate|methotrexate|mesh-list
844651|NCT02405676|Etoposide|etoposide|mesh-list
844652|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
844653|NCT02405676|Vincristine|vincristine|mesh-list
844654|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
844655|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
844656|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844657|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
844658|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
844659|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
844660|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844661|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844662|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
844663|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
844664|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
844665|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
844666|NCT02405676|Hormones|hormones|mesh-ancestor
844667|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
844668|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
844669|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
844670|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
844671|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
844672|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
844673|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
844674|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
844675|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844676|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
844677|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
844678|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
844679|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
844680|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
844681|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
844682|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844683|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
844684|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
844685|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
2256686|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256687|NCT00149877|Tegaserod|tegaserod|mesh-list
2256688|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2256689|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
2256690|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256691|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256692|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256693|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
2256694|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
846735|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
846736|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
846737|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847377|NCT02394496|Lapatinib|lapatinib|mesh-list
847378|NCT02394496|Fulvestrant|fulvestrant|mesh-list
847379|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
847380|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847381|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
847382|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847383|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847384|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
847385|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
847386|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
847387|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
843958|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
843959|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
843960|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843961|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
843962|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
843963|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843964|NCT02407821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
843965|NCT02407821|Antidepressive Agents|antidepressive agents|mesh-ancestor
843966|NCT02407821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
844081|NCT02407600|Aprepitant|aprepitant|mesh-list
844082|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
844083|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
844084|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
844085|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844086|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844087|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
844088|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
844089|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844090|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844305|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
844306|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
844466|NCT02406014|Diclofenac|diclofenac|mesh-list
844467|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
844468|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
844469|NCT02406014|Analgesics|analgesics|mesh-ancestor
844470|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
844471|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844472|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844473|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
844474|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
844475|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
844476|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844477|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844580|NCT02405715|Oxytocin|oxytocin|mesh-list
844581|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
844582|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
844583|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844686|NCT02405364|Dexamethasone|dexamethasone|mesh-list
844687|NCT02405364|Lenalidomide|lenalidomide|mesh-list
844688|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
844689|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
844690|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
844691|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844692|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844693|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
844694|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
844695|NCT02405364|Hormones|hormones|mesh-ancestor
844696|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
844697|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
844698|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844699|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
844700|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
844701|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
844702|NCT02405364|Growth Substances|growth substances|mesh-ancestor
844703|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
2256695|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256696|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2256697|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
2256698|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2256699|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256700|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256701|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256702|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
2256703|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2256704|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256705|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2256706|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
2256707|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2256708|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256709|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256710|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256711|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
2256712|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
845330|NCT02403128|Aflibercept|aflibercept|mesh-list
843974|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
843975|NCT02408003|Protective Agents|protective agents|mesh-ancestor
843976|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
843977|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
844114|NCT02407548|Vitamin E|vitamin e|mesh-list
844115|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
844116|NCT02407548|Ubiquinone|ubiquinone|mesh-list
844117|NCT02407548|Vitamins|vitamins|mesh-ancestor
844118|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
844119|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844120|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
844121|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844122|NCT02407548|Protective Agents|protective agents|mesh-ancestor
844289|NCT02406521|Sorafenib|sorafenib|mesh-list
844290|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
844291|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844292|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
844293|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844294|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099215|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
2099216|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
2099217|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2099218|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
2256713|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256714|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2256715|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
2256716|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2256717|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256718|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256719|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256720|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
846483|NCT02398500|Ranibizumab|ranibizumab|mesh-list
846484|NCT02398500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
846485|NCT02398500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
846486|NCT02398500|Growth Substances|growth substances|mesh-ancestor
846487|NCT02398500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846488|NCT02398500|Growth Inhibitors|growth inhibitors|mesh-ancestor
846489|NCT02398500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847816|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
847817|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
847818|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
848350|NCT02390882|Tamsulosin|tamsulosin|mesh-list
848351|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
848352|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
848353|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
848354|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
848355|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
848356|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848357|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848358|NCT02390882|Urological Agents|urological agents|mesh-ancestor
848393|NCT02390544|Melphalan|melphalan|mesh-list
848394|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
848395|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
848396|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848397|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848398|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
848399|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
848400|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
848401|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848786|NCT02389543|Dexamethasone|dexamethasone|mesh-list
848787|NCT02389543|Lenalidomide|lenalidomide|mesh-list
848788|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
848789|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
848790|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
848791|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
848792|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848793|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
848794|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
848795|NCT02389543|Hormones|hormones|mesh-ancestor
848796|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
848797|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
848798|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848799|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
848800|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
848801|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
843993|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
843994|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
843995|NCT02407899|Incretins|incretins|mesh-ancestor
843996|NCT02407899|Hormones|hormones|mesh-ancestor
843997|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
843998|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
843999|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844000|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844504|NCT02406053|Antioxidants|antioxidants|mesh-list
844505|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844506|NCT02406053|Protective Agents|protective agents|mesh-ancestor
844507|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844865|NCT02404376|Exenatide|exenatide|mesh-list
844866|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
844867|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844868|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
844869|NCT02404376|Incretins|incretins|mesh-ancestor
844870|NCT02404376|Hormones|hormones|mesh-ancestor
844871|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845116|NCT02403713|Fluticasone|fluticasone|mesh-list
845117|NCT02403713|Xhance|xhance|mesh-list
845118|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
845119|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
845120|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
845121|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
845122|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845123|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845124|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
845125|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
845126|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
845127|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
845128|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
845129|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
845130|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
845131|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
845132|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
845133|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845551|NCT02402348|Metformin|metformin|mesh-list
845552|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
845553|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845631|NCT02401971|Thalidomide|thalidomide|mesh-list
845632|NCT02401971|Irinotecan|irinotecan|mesh-list
845633|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
845634|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
845635|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845636|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845637|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845638|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
845639|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
845640|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845641|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
845642|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
845643|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
845644|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
845645|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
845646|NCT02401971|Growth Substances|growth substances|mesh-ancestor
845647|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
846190|NCT02399800|Triamcinolone|triamcinolone|mesh-list
846191|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
846192|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
846193|NCT02399800|Bupivacaine|bupivacaine|mesh-list
846194|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
846195|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
846196|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
846197|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
846198|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846199|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
846200|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846201|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
846202|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
846203|NCT02399800|Hormones|hormones|mesh-ancestor
846204|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
846205|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
846206|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
846207|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844164|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
844165|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
844508|NCT02405858|Prednisolone|prednisolone|mesh-list
844509|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
844510|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
844511|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
844512|NCT02405858|Hormones|hormones|mesh-ancestor
844513|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
844514|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844515|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
844516|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844517|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
844518|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844519|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844520|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
844521|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
845610|NCT02402179|Tryptophan|tryptophan|mesh-list
845611|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
845612|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
845613|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
845680|NCT02401815|Sunitinib|sunitinib|mesh-list
845681|NCT02401815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845682|NCT02401815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
845683|NCT02401815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
845684|NCT02401815|Growth Substances|growth substances|mesh-ancestor
845685|NCT02401815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845686|NCT02401815|Growth Inhibitors|growth inhibitors|mesh-ancestor
845687|NCT02401815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
845688|NCT02401815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845689|NCT02401815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845696|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
845697|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
846049|NCT02400385|Nivolumab|nivolumab|mesh-list
846050|NCT02400385|Sunitinib|sunitinib|mesh-list
846051|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
846052|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846053|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
846054|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846055|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
846056|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
846057|NCT02400385|Growth Substances|growth substances|mesh-ancestor
846058|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846059|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
846060|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
846061|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846215|NCT02399566|Pemetrexed|pemetrexed|mesh-list
846216|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
846217|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846218|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846219|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846220|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
846221|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
846222|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
846311|NCT02399397|Fentanyl|fentanyl|mesh-list
846312|NCT02399397|Midazolam|midazolam|mesh-list
846313|NCT02399397|Anesthetics|anesthetics|mesh-list
846314|NCT02399397|Propofol|propofol|mesh-list
846315|NCT02399397|Rocuronium|rocuronium|mesh-list
846316|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
846317|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846318|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
846319|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
846320|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
846321|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
846322|NCT02399397|Narcotics|narcotics|mesh-ancestor
846323|NCT02399397|Analgesics|analgesics|mesh-ancestor
846324|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
846325|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846326|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
846327|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
846328|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
846329|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
846330|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
846331|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
846332|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844169|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
844170|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844171|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
844172|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844173|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
844174|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844780|NCT02404779|Cisatracurium|cisatracurium|mesh-list
844781|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
844782|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
844783|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844784|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099219|NCT02354586|Niraparib|niraparib|mesh-list
2099220|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2099221|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099222|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099223|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099224|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2256721|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
845398|NCT02402972|Leucovorin|leucovorin|mesh-list
845399|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
845400|NCT02402972|Floxuridine|floxuridine|mesh-list
845401|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
845402|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845403|NCT02402972|Antidotes|antidotes|mesh-ancestor
845404|NCT02402972|Protective Agents|protective agents|mesh-ancestor
845405|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845406|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
845407|NCT02402972|Vitamins|vitamins|mesh-ancestor
845408|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
845409|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
845410|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
845411|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845730|NCT02401425|Letrozole|letrozole|mesh-list
845731|NCT02401425|Misoprostol|misoprostol|mesh-list
845732|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845733|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
845734|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
845735|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845736|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845737|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
845738|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
845739|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845740|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845741|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
845742|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
845743|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
845744|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
845745|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
845746|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
2256722|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256723|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2256724|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
846565|NCT02397863|Cannabidiol|cannabidiol|mesh-list
846566|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
846818|NCT02397330|Morphine|morphine|mesh-list
846819|NCT02397330|Bupivacaine|bupivacaine|mesh-list
846820|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
846821|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
846822|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
846823|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846824|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
846825|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846826|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
846827|NCT02397330|Narcotics|narcotics|mesh-ancestor
846828|NCT02397330|Analgesics|analgesics|mesh-ancestor
846876|NCT02396888|Insulin|insulin|mesh-list
846877|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
846878|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846962|NCT02396225|Voriconazole|voriconazole|mesh-list
846963|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
846964|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
846965|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
844265|NCT02406690|Estradiol|estradiol|mesh-list
844266|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
844267|NCT02406690|Progesterone|progesterone|mesh-list
844268|NCT02406690|Estrogens|estrogens|mesh-ancestor
844269|NCT02406690|Hormones|hormones|mesh-ancestor
844270|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
844271|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844272|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
844273|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
844274|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
844275|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
844276|NCT02406690|Progestins|progestins|mesh-ancestor
844277|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
844278|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
844279|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
844280|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256725|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2256726|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256727|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256728|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846473|NCT02398487|Nicotine|nicotine|mesh-list
846474|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
846475|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
846476|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846477|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846478|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
846479|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
846480|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
846481|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
846482|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256729|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
2256730|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2256731|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256732|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2256733|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
2256734|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2256735|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256736|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256737|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256738|NCT00149981|Everolimus|everolimus|mesh-list
2256739|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256740|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2256741|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
2256742|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256743|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
2256744|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2256745|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256746|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2256747|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
2256748|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
848259|NCT02391805|Tenofovir|tenofovir|mesh-list
848260|NCT02391805|Entecavir|entecavir|mesh-list
848261|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
848262|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
848263|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
848264|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
848265|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848266|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848267|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
848268|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
848321|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
848322|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
848323|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
848324|NCT02391077|Povidone|povidone|mesh-list
848325|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844372|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
844373|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844790|NCT02405013|Ribavirin|ribavirin|mesh-list
844791|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
844792|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
844793|NCT02405013|Ledipasvir|ledipasvir|mesh-list
844794|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
844795|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844796|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
844797|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844827|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
844828|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
844829|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
844830|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844831|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
844832|NCT02404454|Protective Agents|protective agents|mesh-ancestor
844942|NCT02404233|Darunavir|darunavir|mesh-list
844943|NCT02404233|Cobicistat|cobicistat|mesh-list
844944|NCT02404233|Rilpivirine|rilpivirine|mesh-list
844945|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
844946|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
844947|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
844948|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844949|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844950|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
844951|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
844952|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
844953|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844954|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
844955|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
844956|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
844957|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2256749|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256750|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256751|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256752|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
2256753|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
845539|NCT02402283|Metronidazole|metronidazole|mesh-list
845540|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
845541|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
845542|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
845543|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
845698|NCT02401594|Enoxaparin|enoxaparin|mesh-list
845699|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
845700|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
845701|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
845702|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
845703|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
845704|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845705|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845706|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
845707|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
845708|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
845925|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
845926|NCT02400567|Letrozole|letrozole|mesh-list
845927|NCT02400567|Epirubicin|epirubicin|mesh-list
845928|NCT02400567|Palbociclib|palbociclib|mesh-list
845929|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
845930|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
845931|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845932|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
845933|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
845934|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
845935|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845936|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845937|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
845938|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
845939|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
845940|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845941|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
845942|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
845943|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845944|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
845945|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
845946|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
845971|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
2256754|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256755|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2256756|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
2256757|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2256758|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256759|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256760|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844597|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
844598|NCT02405689|Remifentanil|remifentanil|mesh-list
844599|NCT02405689|Sevoflurane|sevoflurane|mesh-list
844600|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
844601|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
844602|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844603|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
844604|NCT02405689|Analgesics|analgesics|mesh-ancestor
844605|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
844606|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844607|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
844608|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
844609|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
844610|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
844611|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844612|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844613|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
844614|NCT02405689|Narcotics|narcotics|mesh-ancestor
844615|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
844616|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
844617|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
844618|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
845097|NCT02403804|Betaine|betaine|mesh-list
845098|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
845099|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
845100|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
845101|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
845102|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845103|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
845110|NCT02403544|Capecitabine|capecitabine|mesh-list
845111|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
845112|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
845113|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
845114|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845115|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845324|NCT02403284|Liraglutide|liraglutide|mesh-list
845325|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
845326|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845327|NCT02403284|Incretins|incretins|mesh-ancestor
845328|NCT02403284|Hormones|hormones|mesh-ancestor
845329|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845494|NCT02402491|Aspirin|aspirin|mesh-list
845495|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
845496|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
845497|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
845498|NCT02402491|Analgesics|analgesics|mesh-ancestor
845499|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
845500|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845501|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845502|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
845503|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
845504|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
845505|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
845506|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845507|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
845508|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
845509|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845510|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
845511|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
845512|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
845513|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
845514|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256761|NCT00150046|Everolimus|everolimus|mesh-list
2256762|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256763|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2099225|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
2099226|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099227|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
844482|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
844483|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844484|NCT02405988|Analgesics|analgesics|mesh-ancestor
844485|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
844486|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844487|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2099228|NCT02354690|Fludarabine|fludarabine|mesh-list
2099229|NCT02354690|Interleukin-2|interleukin-2|mesh-list
2099230|NCT02354690|Vemurafenib|vemurafenib|mesh-list
2099231|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2099232|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
2099233|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099234|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2099235|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2099236|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
2099237|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099238|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099239|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2099240|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2099241|NCT02354690|Analgesics|analgesics|mesh-ancestor
2099242|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
2256764|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
2256765|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256766|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
2256767|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2256768|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2256769|NCT00150059|Analgesics|analgesics|mesh-ancestor
2256770|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
845451|NCT02402621|Fentanyl|fentanyl|mesh-list
845452|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
845453|NCT02402621|Narcotics|narcotics|mesh-ancestor
845454|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
845455|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845456|NCT02402621|Analgesics|analgesics|mesh-ancestor
845457|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
845458|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845459|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
845460|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
845461|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
845462|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
845948|NCT02400788|Sorafenib|sorafenib|mesh-list
845949|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845950|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
845951|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845952|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846396|NCT02398929|Bisoprolol|bisoprolol|mesh-list
846397|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
846398|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
846399|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
846400|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846401|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846402|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
846403|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
846404|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
844588|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
844589|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844590|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844591|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
844592|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
844593|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
844594|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
844595|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
844596|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844770|NCT02404844|Tamoxifen|tamoxifen|mesh-list
844771|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
844772|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
844773|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
844774|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844775|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
844776|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
844777|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
844778|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
844779|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
844840|NCT02404623|Vitamin D|vitamin d|mesh-list
844841|NCT02404623|Vitamins|vitamins|mesh-ancestor
844842|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
844843|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844844|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
845172|NCT02403648|Glucagon|glucagon|mesh-list
845173|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
845174|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
845175|NCT02403648|Hormones|hormones|mesh-ancestor
845176|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845177|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845178|NCT02403648|Incretins|incretins|mesh-ancestor
845297|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
845298|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
845299|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
845300|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
845301|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
845302|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
845303|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845304|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
845305|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
845306|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845307|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
845308|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845473|NCT02402595|Itraconazole|itraconazole|mesh-list
845474|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
845475|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
845476|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
845477|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
845478|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845479|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845480|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
845481|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
845482|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845483|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845484|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
845624|NCT02401945|Aflibercept|aflibercept|mesh-list
845625|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
845626|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
845627|NCT02401945|Growth Substances|growth substances|mesh-ancestor
845628|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845629|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
845630|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845714|NCT02401269|Aspirin|aspirin|mesh-list
845715|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
845716|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
845717|NCT02401269|Analgesics|analgesics|mesh-ancestor
845718|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
845719|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845720|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845721|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
845722|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
845723|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
844754|NCT02405260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844917|NCT02404077|Clonidine|clonidine|mesh-list
844918|NCT02404077|Analgesics|analgesics|mesh-ancestor
844919|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
844920|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844921|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844922|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
844923|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
844924|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
844925|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
844926|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
844927|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
844928|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
844929|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844930|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256771|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256772|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256773|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2256774|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2256775|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
2256776|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2256777|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
2256778|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2256779|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256780|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256781|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
845436|NCT02402712|Docetaxel|docetaxel|mesh-list
845437|NCT02402712|Trastuzumab|trastuzumab|mesh-list
845438|NCT02402712|Pertuzumab|pertuzumab|mesh-list
845439|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845440|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
845441|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
845442|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
845443|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845444|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
845953|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
845954|NCT02400801|Dienogest|dienogest|mesh-list
845955|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
845956|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
845957|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
845958|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
845959|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
845960|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845961|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
845962|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
845963|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845964|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
845965|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
845966|NCT02400801|Estrogens|estrogens|mesh-ancestor
845967|NCT02400801|Hormones|hormones|mesh-ancestor
845968|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845969|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
845970|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
846074|NCT02400255|Crenolanib|crenolanib|mesh-list
846075|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846337|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
846338|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
846339|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846618|NCT02398058|Olaparib|olaparib|mesh-list
846619|NCT02398058|Trabectedin|trabectedin|mesh-list
846620|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
846621|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846622|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846623|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846624|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
846625|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
2256782|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256783|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2256784|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256785|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256786|NCT00150085|Cyclosporine|cyclosporine|mesh-list
2256787|NCT00150085|Cyclosporins|cyclosporins|mesh-list
2256788|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754560|NCT00543374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
847524|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
844811|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
844812|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844813|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
844814|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
844815|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
844816|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
844817|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
844818|NCT02404688|Analgesics|analgesics|mesh-ancestor
844819|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
844820|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
844821|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
844822|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
844823|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
844824|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844825|NCT02404688|Hormones|hormones|mesh-ancestor
844826|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
844833|NCT02404337|Betaine|betaine|mesh-list
844834|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
844835|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
844836|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
844837|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
844838|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
844839|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2256789|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256790|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2256791|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
2256792|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256793|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
2256794|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256795|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
2256796|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
845485|NCT02402400|Ticagrelor|ticagrelor|mesh-list
845486|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
845487|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
845488|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
845489|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
845490|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
845491|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
845492|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845493|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256797|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2256798|NCT00150111|Rituximab|rituximab|mesh-list
2256799|NCT00150111|Vaccines|vaccines|mesh-list
2256800|NCT00150111|Methimazole|methimazole|mesh-list
2256801|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2256802|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256803|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
2256804|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256805|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2256806|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
2256807|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
2256808|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256809|NCT00150124|Methimazole|methimazole|mesh-list
2256810|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
2256811|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
2256812|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256813|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256814|NCT00150137|Methimazole|methimazole|mesh-list
2256815|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
2256816|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
846499|NCT02398630|Hormones|hormones|mesh-list
846500|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
846501|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256817|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256818|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256819|NCT00150215|Olanzapine|olanzapine|mesh-list
2256820|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
2256821|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
2256822|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256823|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256824|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
846834|NCT02396979|Methadone|methadone|mesh-list
846835|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
844889|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
844890|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
844891|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
844892|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
844893|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
844894|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
844895|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
844896|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
844897|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
844898|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
844899|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
844900|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
844901|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
845572|NCT02402543|Acetaminophen|acetaminophen|mesh-list
845573|NCT02402543|Dexamethasone|dexamethasone|mesh-list
845574|NCT02402543|Ketamine|ketamine|mesh-list
845575|NCT02402543|Gabapentin|gabapentin|mesh-list
845576|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
845577|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
845578|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
845579|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845580|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845581|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
845582|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
845583|NCT02402543|Hormones|hormones|mesh-ancestor
845584|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845585|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
845586|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845587|NCT02402543|Analgesics|analgesics|mesh-ancestor
845588|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
845589|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
845590|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
845591|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
845592|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
845593|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
845594|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
845595|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
845596|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
845597|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845598|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
845599|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
845600|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
845601|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
845602|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
845603|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
845604|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
845883|NCT02400931|Rocuronium|rocuronium|mesh-list
845884|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
845885|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
845886|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
845887|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845888|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846099|NCT02400476|Budesonide|budesonide|mesh-list
846100|NCT02400476|Loperamide|loperamide|mesh-list
846101|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
846102|NCT02400476|Colestipol|colestipol|mesh-list
846103|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
846104|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
846105|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
846106|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846107|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846108|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
846109|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
846110|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
846111|NCT02400476|Hormones|hormones|mesh-ancestor
846112|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
846113|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
846114|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
846115|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
846116|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846117|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
846118|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
846429|NCT02398656|Tenecteplase|tenecteplase|mesh-list
846430|NCT02398656|Clopidogrel|clopidogrel|mesh-list
846431|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2256825|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2256826|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2256827|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2256828|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
845269|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
845270|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
845271|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
845272|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
845273|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845274|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
845275|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
845276|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2256829|NCT00150215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2256830|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2256831|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2256832|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846243|NCT02399709|Simvastatin|simvastatin|mesh-list
846244|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
846245|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
846246|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
846247|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846248|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
846249|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
846250|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846558|NCT02398123|Bupivacaine|bupivacaine|mesh-list
846559|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
846560|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
846561|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
846562|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846563|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
846564|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846743|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
846744|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
846745|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
846746|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846747|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846748|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
846749|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
846750|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
846751|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
846752|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
846753|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
846754|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
846755|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846904|NCT02396563|Ropivacaine|ropivacaine|mesh-list
846905|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
846906|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
846907|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
846908|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846909|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
846910|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847102|NCT02395926|Choline|choline|mesh-list
847103|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
847104|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
847105|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
847106|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847107|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
847108|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
847109|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
847526|NCT02394093|Aspirin|aspirin|mesh-list
847527|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
847528|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
847529|NCT02394093|Analgesics|analgesics|mesh-ancestor
847530|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
847531|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847532|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847533|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
847534|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
847535|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
847536|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
847537|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847538|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
847539|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
844999|NCT02404051|Fulvestrant|fulvestrant|mesh-list
845000|NCT02404051|Exemestane|exemestane|mesh-list
845001|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845002|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
845003|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
845004|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845005|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
845006|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
845007|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
845008|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
845009|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845010|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
845011|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
845012|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845013|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845544|NCT02402231|Omalizumab|omalizumab|mesh-list
845545|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
845546|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
845547|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
2256833|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256834|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
2256835|NCT00150228|Varenicline|varenicline|mesh-list
2256836|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2256837|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2256838|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
2256839|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256840|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256841|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256842|NCT00150241|Varenicline|varenicline|mesh-list
2256843|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2256844|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2256845|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
2256846|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256847|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256848|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256849|NCT00150254|Varenicline|varenicline|mesh-list
2256850|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2256851|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2256852|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
2256853|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256854|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256855|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256856|NCT00150280|Ibuprofen|ibuprofen|mesh-list
2256857|NCT00150280|Celecoxib|celecoxib|mesh-list
2256858|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2256859|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2256860|NCT00150280|Analgesics|analgesics|mesh-ancestor
2256861|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
2256862|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256863|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256864|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2256865|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2256866|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2256867|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256868|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256869|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2256870|NCT00150293|Pregabalin|pregabalin|mesh-list
2256871|NCT00150293|Analgesics|analgesics|mesh-ancestor
2256872|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
2256873|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256874|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256875|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
2256876|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
847353|NCT02394652|Metformin|metformin|mesh-list
847354|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
847355|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
847356|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847357|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
847358|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847519|NCT02394002|Propofol|propofol|mesh-list
847520|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
847521|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
847522|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847523|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2256877|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2256878|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256879|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2256880|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2256881|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2256882|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2256883|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
845104|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
845105|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
845106|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
845107|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845108|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
845109|NCT02403596|Coagulants|coagulants|mesh-ancestor
2256884|NCT00150306|Sertraline|sertraline|mesh-list
2256885|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
2256886|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
845921|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
845922|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
845923|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
845924|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846446|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
846447|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
846448|NCT02398682|Protective Agents|protective agents|mesh-ancestor
846449|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846540|NCT02398201|Bezafibrate|bezafibrate|mesh-list
846541|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
846542|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
846543|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846544|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
846960|NCT02396862|Factor VIII|factor viii|mesh-list
846961|NCT02396862|Coagulants|coagulants|mesh-ancestor
847031|NCT02396043|Cytarabine|cytarabine|mesh-list
847032|NCT02396043|Dexamethasone|dexamethasone|mesh-list
847033|NCT02396043|Prednisone|prednisone|mesh-list
847034|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
847035|NCT02396043|Methotrexate|methotrexate|mesh-list
847036|NCT02396043|Vincristine|vincristine|mesh-list
847037|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
847038|NCT02396043|Pegaspargase|pegaspargase|mesh-list
847039|NCT02396043|Asparaginase|asparaginase|mesh-list
847040|NCT02396043|Pirarubicin|pirarubicin|mesh-list
847041|NCT02396043|Doxorubicin|doxorubicin|mesh-list
847042|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
847043|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
847044|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847045|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
847046|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
847047|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
847048|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847049|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847050|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
847051|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
847052|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
847053|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
847054|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847055|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
847056|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
847057|NCT02396043|Hormones|hormones|mesh-ancestor
847058|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
847059|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
847060|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847061|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
847062|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
847063|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
847064|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
847065|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
847066|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
847067|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
847068|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
847069|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
847070|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
847071|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
847072|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
2256887|NCT00150306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
845249|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
845250|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
845251|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
845252|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
845253|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
845254|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
845255|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
845256|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
845257|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
845258|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
845259|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
845260|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
845261|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
845262|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
845263|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
845264|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
845265|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
845266|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
845267|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
845268|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
845690|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
845691|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
845692|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
845755|NCT02401295|Itraconazole|itraconazole|mesh-list
845756|NCT02401295|Celecoxib|celecoxib|mesh-list
845757|NCT02401295|Tretinoin|tretinoin|mesh-list
845758|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
845759|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
845760|NCT02401295|Analgesics|analgesics|mesh-ancestor
845761|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
845762|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845763|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845764|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
845765|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
845766|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
845767|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
845768|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845769|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845770|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
845771|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
845772|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
845773|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
845774|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
845775|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
845776|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845777|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
845778|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845779|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
845780|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
2256888|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2256889|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2256890|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256891|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256892|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
2256893|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847081|NCT02395705|Paclitaxel|paclitaxel|mesh-list
847082|NCT02395705|Cisplatin|cisplatin|mesh-list
847083|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
847084|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847085|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
847086|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
847087|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
847088|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099243|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099244|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2099245|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847494|NCT02394106|Ofatumumab|ofatumumab|mesh-list
847495|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099246|NCT02354833|Phenylephrine|phenylephrine|mesh-list
2099247|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
2099248|NCT02354833|Norepinephrine|norepinephrine|mesh-list
2099249|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2099250|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
2099251|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
2099252|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845331|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
845332|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
845333|NCT02403128|Growth Substances|growth substances|mesh-ancestor
845334|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845335|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
845336|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846463|NCT02398552|Sunitinib|sunitinib|mesh-list
846464|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846465|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
846466|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
846467|NCT02398552|Growth Substances|growth substances|mesh-ancestor
846468|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846469|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
846470|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
846471|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846472|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846724|NCT02397395|Simeprevir|simeprevir|mesh-list
846725|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
846726|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
846727|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
846728|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846729|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846974|NCT02396303|Carbetocin|carbetocin|mesh-list
846975|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
846976|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
846977|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847496|NCT02394015|Doxorubicin|doxorubicin|mesh-list
847497|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
847498|NCT02394015|Trabectedin|trabectedin|mesh-list
847499|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
847500|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847501|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
847502|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
847503|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847504|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847505|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
847506|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
2256894|NCT00150332|Linezolid|linezolid|mesh-list
2256895|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2256896|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2256897|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2256898|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256899|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256900|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
2256901|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256902|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
2256903|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2256904|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2256905|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256906|NCT00150358|Urological Agents|urological agents|mesh-ancestor
2256907|NCT00150371|Atorvastatin|atorvastatin|mesh-list
2256908|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2256909|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2256910|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
847894|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
847895|NCT02393066|Propofol|propofol|mesh-list
847896|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
847897|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
847898|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847899|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
847900|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
847901|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
847902|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
847903|NCT02393066|Analgesics|analgesics|mesh-ancestor
847904|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
847905|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847906|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
847907|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
847908|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
847909|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
847910|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
847911|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847965|NCT02392468|BI 409306|bi 409306|mesh-list
847966|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
847967|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845379|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
845380|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
845381|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
845382|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
845383|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845519|NCT02402465|Fluticasone|fluticasone|mesh-list
845520|NCT02402465|Xhance|xhance|mesh-list
845521|NCT02402465|Azelastine|azelastine|mesh-list
845522|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
845523|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
845524|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
845525|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845526|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845527|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
845528|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
845529|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
845530|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
845531|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
845532|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845533|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845534|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
845535|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
845536|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
845537|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
845538|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
846069|NCT02400151|Vitamin D|vitamin d|mesh-list
846070|NCT02400151|Vitamins|vitamins|mesh-ancestor
846071|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
846072|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846073|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2256911|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256912|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2256913|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2256914|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256915|NCT00150384|Amlodipine|amlodipine|mesh-list
2256916|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
2099253|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099254|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
2099255|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2099256|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
2099257|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
2099258|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2099259|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2099260|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2099261|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
2099262|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099263|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099264|NCT02354833|Protective Agents|protective agents|mesh-ancestor
2099265|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
2099266|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2099267|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099268|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099269|NCT02354976|Fenofibrate|fenofibrate|mesh-list
2256917|NCT00150384|Atorvastatin|atorvastatin|mesh-list
846589|NCT02397928|Carboplatin|carboplatin|mesh-list
846590|NCT02397928|Pemetrexed|pemetrexed|mesh-list
846591|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846592|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846593|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846594|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
846595|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2256918|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2256919|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2256920|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
2256921|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256922|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2256923|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
847089|NCT02395744|Paclitaxel|paclitaxel|mesh-list
847090|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
847091|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847092|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
847093|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
847094|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
847095|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845394|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
845395|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
845396|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
845397|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845747|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
845748|NCT02401503|Venetoclax|venetoclax|mesh-list
845749|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
845750|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
845751|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
845752|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845753|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845754|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
845905|NCT02400866|Olanzapine|olanzapine|mesh-list
845906|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
845907|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
845908|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845909|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845910|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
845911|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
845912|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
845913|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
845914|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
845915|NCT02400866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
845916|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
845917|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
845918|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845919|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
845920|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
2256924|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256925|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2256926|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2256927|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2099270|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2099271|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
846986|NCT02396108|Paclitaxel|paclitaxel|mesh-list
846987|NCT02396108|Carboplatin|carboplatin|mesh-list
846988|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
846989|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846990|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
846991|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
846992|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
846993|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256928|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2256929|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256930|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
2256931|NCT00150410|Insulin|insulin|mesh-list
2256932|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2256933|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256934|NCT00150423|Pregabalin|pregabalin|mesh-list
2256935|NCT00150423|Analgesics|analgesics|mesh-ancestor
847478|NCT02394119|Rituximab|rituximab|mesh-list
847479|NCT02394119|Ofatumumab|ofatumumab|mesh-list
847480|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
847481|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847482|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
847483|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847484|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2099272|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099273|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2099274|NCT02355028|Ranibizumab|ranibizumab|mesh-list
2099275|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2099276|NCT02355028|Acrizanib|acrizanib|mesh-list
2099277|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2099278|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2099279|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2099280|NCT02355028|Growth Substances|growth substances|mesh-ancestor
2256936|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
2256937|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256938|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256939|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
2256940|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2256941|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2256942|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256943|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
845419|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845420|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
845421|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
845422|NCT02402725|Hormones|hormones|mesh-ancestor
845423|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845424|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
845425|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845426|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
845427|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845428|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845648|NCT02401750|Naltrexone|naltrexone|mesh-list
845649|NCT02401750|Oxycodone|oxycodone|mesh-list
845650|NCT02401750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
845651|NCT02401750|Narcotics|narcotics|mesh-ancestor
845652|NCT02401750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
845653|NCT02401750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845654|NCT02401750|Analgesics|analgesics|mesh-ancestor
845655|NCT02401750|Sensory System Agents|sensory system agents|mesh-ancestor
845656|NCT02401750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845657|NCT02401750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
845658|NCT02401750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
846263|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
846264|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
846265|NCT02399449|Hematinics|hematinics|mesh-ancestor
846290|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
846291|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
847180|NCT02395510|Vortioxetine|vortioxetine|mesh-list
847181|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
847182|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
847183|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
847184|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
847185|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
847186|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847187|NCT02395510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
847188|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
847189|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
847190|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847191|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
847192|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
847193|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
847194|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
847195|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
847196|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2256944|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2256945|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2256946|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2256947|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2256948|NCT00150436|Pregabalin|pregabalin|mesh-list
2256949|NCT00150436|Analgesics|analgesics|mesh-ancestor
2256950|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
2256951|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256952|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256953|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
2256954|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2256955|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2256956|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849109|NCT02387918|Dexamethasone|dexamethasone|mesh-list
849110|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
849111|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
849112|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
849113|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849114|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849115|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
849116|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
849117|NCT02387918|Hormones|hormones|mesh-ancestor
849118|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
849119|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
849120|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849435|NCT02386566|Natalizumab|natalizumab|mesh-list
849436|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
849437|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849652|NCT02385617|Octreotide|octreotide|mesh-list
849653|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
849654|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
850008|NCT02384343|Analgesics|analgesics|mesh-ancestor
845467|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845468|NCT02402660|Protective Agents|protective agents|mesh-ancestor
845469|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
845470|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845471|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
845472|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
845607|NCT02402270|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
845608|NCT02402270|Laxatives|laxatives|mesh-ancestor
845609|NCT02402270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
845659|NCT02401880|Empagliflozin|empagliflozin|mesh-list
845660|NCT02401880|Linagliptin|linagliptin|mesh-list
845661|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
845662|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845663|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
845664|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845665|NCT02401880|Incretins|incretins|mesh-ancestor
845666|NCT02401880|Hormones|hormones|mesh-ancestor
845667|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
845668|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
845669|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
845670|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846166|NCT02400047|Dexamethasone|dexamethasone|mesh-list
846167|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
846168|NCT02400047|Ketoprofen|ketoprofen|mesh-list
846169|NCT02400047|BB 1101|bb 1101|mesh-list
846170|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
846171|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
846172|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
846173|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846174|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846175|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
846176|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
846177|NCT02400047|Hormones|hormones|mesh-ancestor
846178|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
846179|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
846180|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846181|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
846182|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846183|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846184|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
846185|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
846186|NCT02400047|Analgesics|analgesics|mesh-ancestor
846187|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
846188|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
846189|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
846490|NCT02398357|Nadroparin|nadroparin|mesh-list
846491|NCT02398357|Warfarin|warfarin|mesh-list
846492|NCT02398357|Calcium|calcium|mesh-list
846493|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
846494|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846495|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
846496|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
846497|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
846498|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256957|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2256958|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2256959|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2256960|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2256961|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2256962|NCT00150449|Pregabalin|pregabalin|mesh-list
2256963|NCT00150449|Analgesics|analgesics|mesh-ancestor
2256964|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
2256965|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256966|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256967|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
2256968|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2256969|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2256970|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256971|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2256972|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
847440|NCT02394158|Metformin|metformin|mesh-list
847441|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
847442|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847507|NCT02393846|Ketoprofen|ketoprofen|mesh-list
847508|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2256973|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2256974|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2256975|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2256976|NCT00150527|Dexamethasone|dexamethasone|mesh-list
2256977|NCT00150527|Citalopram|citalopram|mesh-list
2256978|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2256979|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
2256980|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
2256981|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2256982|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2256983|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2256984|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
2256985|NCT00150527|Hormones|hormones|mesh-ancestor
846596|NCT02397772|Albendazole|albendazole|mesh-list
846597|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
846598|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
846599|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
846600|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
846601|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
846602|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
846603|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
846604|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
846605|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
846606|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846607|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846756|NCT02397538|Amlodipine|amlodipine|mesh-list
846757|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
846758|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
846759|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
846760|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
846761|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846762|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
846763|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846764|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
846765|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
846766|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
846767|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
846768|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
846769|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
846770|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2256986|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2256987|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2256988|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2256989|NCT00150527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2256990|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2256991|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2256992|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2256993|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2256994|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
2256995|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2256996|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
2256997|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2256998|NCT00150553|Carbamazepine|carbamazepine|mesh-list
2256999|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
847359|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
847360|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847361|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
847362|NCT02394470|Protective Agents|protective agents|mesh-ancestor
847363|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847976|NCT02392572|Cytarabine|cytarabine|mesh-list
847977|NCT02392572|TIC10 compound|tic10 compound|mesh-list
847978|NCT02392572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
847979|NCT02392572|Antimetabolites|antimetabolites|mesh-ancestor
847980|NCT02392572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847981|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847982|NCT02392572|Antiviral Agents|antiviral agents|mesh-ancestor
847983|NCT02392572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
847984|NCT02392572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
847985|NCT02392572|Immunologic Factors|immunologic factors|mesh-ancestor
847986|NCT02392572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848137|NCT02392156|Factor VIII|factor viii|mesh-list
848138|NCT02392156|Coagulants|coagulants|mesh-ancestor
848181|NCT02391688|Fexofenadine|fexofenadine|mesh-list
848182|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
848183|NCT02391688|Midazolam|midazolam|mesh-list
2257000|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
845679|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257001|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2257002|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2257003|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257004|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2257005|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2257006|NCT00150553|Analgesics|analgesics|mesh-ancestor
2257007|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
2257008|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257009|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2257010|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257011|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257012|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2257013|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
846076|NCT02400112|Vancomycin|vancomycin|mesh-list
846077|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
846078|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
846408|NCT02398838|Misoprostol|misoprostol|mesh-list
846409|NCT02398838|Mifepristone|mifepristone|mesh-list
846410|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
846411|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
846412|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
846413|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846414|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
846415|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
846416|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
846417|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
846418|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
846419|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
846420|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
846421|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
846422|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
846423|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
846424|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
846425|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
846426|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
846427|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
846428|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
846852|NCT02397213|Cyclosporine|cyclosporine|mesh-list
846853|NCT02397213|Cyclosporins|cyclosporins|mesh-list
846854|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846855|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846856|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
846857|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
846858|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846859|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
846860|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
846861|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
846862|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
846863|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2257014|NCT00150579|Amphetamine|amphetamine|mesh-list
2257015|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
2257016|NCT00150579|Adderall|adderall|mesh-list
2257017|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2257018|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257019|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
2257020|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
2257021|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847843|NCT02392871|Trametinib|trametinib|mesh-list
847844|NCT02392871|Dabrafenib|dabrafenib|mesh-list
847845|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847846|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
847847|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847848|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257022|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
2257023|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257024|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257025|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
2257026|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2257027|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2257028|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257029|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2257030|NCT00150605|Carbamazepine|carbamazepine|mesh-list
2257031|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
845724|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
845725|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845726|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
845727|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
845728|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
845729|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
846154|NCT02400021|Progesterone|progesterone|mesh-list
846155|NCT02400021|Progestins|progestins|mesh-ancestor
846156|NCT02400021|Hormones|hormones|mesh-ancestor
846157|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
846158|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099281|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099282|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
2099283|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099284|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2099285|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846567|NCT02398136|Midazolam|midazolam|mesh-list
846568|NCT02398136|Ketamine|ketamine|mesh-list
846569|NCT02398136|Analgesics|analgesics|mesh-ancestor
846570|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
846571|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846572|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846573|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
846574|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
846575|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
846576|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
846577|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
846578|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
846579|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
846580|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
846581|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846582|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
846583|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
846584|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
846585|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
846586|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
846587|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
846588|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
846799|NCT02397590|Atorvastatin|atorvastatin|mesh-list
846800|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
846801|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
846802|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
846803|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846804|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
846805|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
846806|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099286|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099287|NCT02355158|Clonidine|clonidine|mesh-list
2099288|NCT02355158|Analgesics|analgesics|mesh-ancestor
2099289|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
2099290|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099291|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099292|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2099293|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
2099294|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
2099295|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2257032|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
847416|NCT02394483|Olorofim|olorofim|mesh-list
847417|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
847418|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
847803|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
847804|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
847805|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
847806|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847807|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
847808|NCT02393300|Coagulants|coagulants|mesh-ancestor
847849|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
847850|NCT02392910|Hematinics|hematinics|mesh-ancestor
2257033|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2257034|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2257035|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257036|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2257037|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2257038|NCT00150605|Analgesics|analgesics|mesh-ancestor
2257039|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
2257040|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257041|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2257042|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257043|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257044|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2257045|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2257046|NCT00150631|Candesartan|candesartan|mesh-list
2257047|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2257048|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2257049|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2257050|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257051|NCT00150657|Gemcitabine|gemcitabine|mesh-list
2257052|NCT00150657|Bevacizumab|bevacizumab|mesh-list
2257053|NCT00150657|Carboplatin|carboplatin|mesh-list
2257054|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2257055|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257056|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2257057|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2257058|NCT00150657|Growth Substances|growth substances|mesh-ancestor
2257059|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257060|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
2257061|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2257062|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
2257063|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257064|NCT00150657|Antiviral Agents|antiviral agents|mesh-ancestor
2257065|NCT00150657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257066|NCT00150657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257067|NCT00150657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2257068|NCT00150657|Immunologic Factors|immunologic factors|mesh-ancestor
2257069|NCT00150670|Cisplatin|cisplatin|mesh-list
2257070|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257071|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
2257072|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2257073|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257074|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257075|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
847283|NCT02394821|Metronidazole|metronidazole|mesh-list
847284|NCT02394821|Polihexanide|polihexanide|mesh-list
847285|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
847286|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
847287|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
847288|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
847289|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
847557|NCT02393937|Metronidazole|metronidazole|mesh-list
847558|NCT02393937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
847559|NCT02393937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
847560|NCT02393937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
847561|NCT02393937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
848160|NCT02391662|Gemcitabine|gemcitabine|mesh-list
848161|NCT02391662|Paclitaxel|paclitaxel|mesh-list
848162|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
848163|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
848164|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848165|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
848166|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
848167|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
848168|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848169|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
848170|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
848171|NCT02391662|Antiviral Agents|antiviral agents|mesh-ancestor
848172|NCT02391662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
848173|NCT02391662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848174|NCT02391662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
848175|NCT02391662|Immunologic Factors|immunologic factors|mesh-ancestor
848176|NCT02391662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848461|NCT02390440|Bupivacaine|bupivacaine|mesh-list
848462|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
848463|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
848464|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
848465|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848466|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
848467|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849202|NCT02387242|Rifampin|rifampin|mesh-list
849203|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2257076|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257077|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2257078|NCT00150709|Levetiracetam|levetiracetam|mesh-list
2257079|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
2257080|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
2257081|NCT00150722|Atorvastatin|atorvastatin|mesh-list
2257082|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2257083|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2257084|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
2257085|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257086|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2257087|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2257088|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257089|NCT00150735|Levetiracetam|levetiracetam|mesh-list
2257090|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
2257091|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
2257092|NCT00150748|Levetiracetam|levetiracetam|mesh-list
2257093|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
846223|NCT02399592|Bevacizumab|bevacizumab|mesh-list
846224|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
846225|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846226|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
846227|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
846228|NCT02399592|Growth Substances|growth substances|mesh-ancestor
846229|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846230|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
846785|NCT02397486|Vitamin E|vitamin e|mesh-list
846786|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
846787|NCT02397486|Vitamins|vitamins|mesh-ancestor
846788|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
846789|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846790|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
846791|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846792|NCT02397486|Protective Agents|protective agents|mesh-ancestor
846793|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
846794|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846795|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
846796|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
846797|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
846798|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
847078|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
847079|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
847080|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099296|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2099297|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2099298|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
2099299|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099300|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099301|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
2099302|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099303|NCT02355665|Nicotine|nicotine|mesh-list
2099304|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2099305|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
2099306|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099307|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099308|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2099309|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2099310|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
2099311|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099312|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099313|NCT02355821|Bisoprolol|bisoprolol|mesh-list
2099314|NCT02355821|Moxonidine|moxonidine|mesh-list
2099315|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2099316|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
2099317|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
2099318|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099319|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099320|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2099321|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2257094|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
847700|NCT02393456|Oxytocin|oxytocin|mesh-list
847701|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
847702|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
847703|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257095|NCT00150761|Levocetirizine|levocetirizine|mesh-list
2257096|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2257097|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
845858|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845859|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845860|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
845861|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
845862|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
845863|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
845864|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
845865|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
845866|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
845867|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
845868|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846281|NCT02399410|Bevacizumab|bevacizumab|mesh-list
846282|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
846283|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
846284|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846285|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
846286|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
846287|NCT02399410|Growth Substances|growth substances|mesh-ancestor
846288|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846289|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
846531|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
846532|NCT02398539|Triamcinolone|triamcinolone|mesh-list
846533|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
846534|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
846535|NCT02398539|Hormones|hormones|mesh-ancestor
846536|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
846537|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846538|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
846539|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
846674|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
846675|NCT02397603|Bupivacaine|bupivacaine|mesh-list
846676|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
846677|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
846678|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
846679|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846680|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
846681|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846682|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
846683|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
846684|NCT02397603|Analgesics|analgesics|mesh-ancestor
846685|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
846686|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
846687|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
846688|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
846689|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
846690|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257098|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
2257099|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
2257100|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257101|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257102|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257103|NCT00150774|Levetiracetam|levetiracetam|mesh-list
2257104|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
2257105|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
2257106|NCT00150787|Levetiracetam|levetiracetam|mesh-list
2257107|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
2257108|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
2257109|NCT00150826|Quinapril|quinapril|mesh-list
2257110|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2257111|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
847689|NCT02393573|Metformin|metformin|mesh-list
847690|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
847691|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847932|NCT02392793|Irinotecan|irinotecan|mesh-list
847933|NCT02392793|Temozolomide|temozolomide|mesh-list
847934|NCT02392793|Talazoparib|talazoparib|mesh-list
847935|NCT02392793|Lenograstim|lenograstim|mesh-list
847936|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
847937|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
847938|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847939|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847940|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
845897|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
845898|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
845899|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
845900|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
845901|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
845902|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
845903|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
845904|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
846119|NCT02400281|Cytarabine|cytarabine|mesh-list
846120|NCT02400281|Fludarabine|fludarabine|mesh-list
846121|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
846122|NCT02400281|Etoposide|etoposide|mesh-list
846123|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
846124|NCT02400281|Azacitidine|azacitidine|mesh-list
846125|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
846126|NCT02400281|Idarubicin|idarubicin|mesh-list
846127|NCT02400281|Crenolanib|crenolanib|mesh-list
846128|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846129|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
846130|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
846131|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846132|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
846133|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
846134|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846135|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
846136|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
846137|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
846138|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
846139|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
846140|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846141|NCT02400281|Analgesics|analgesics|mesh-ancestor
846142|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
846143|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846144|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
846292|NCT02399189|Methotrexate|methotrexate|mesh-list
846293|NCT02399189|Temozolomide|temozolomide|mesh-list
846294|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846295|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
846296|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846297|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
846298|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
846299|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
846300|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
846301|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
846302|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
846303|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846304|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
846305|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846306|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
846307|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
846308|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
846309|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
846310|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
2257112|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257113|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257114|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2257115|NCT00150839|Mirtazapine|mirtazapine|mesh-list
2257116|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2257117|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2257118|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2257119|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257120|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257121|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257122|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257123|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2257124|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
2257125|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2257126|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2257127|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
2257128|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
2257129|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2257130|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2257131|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2257132|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
845947|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
846361|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
846362|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
846363|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
846364|NCT02398994|Antibodies|antibodies|mesh-list
846365|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
846366|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
846367|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
846368|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
846369|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
846370|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846371|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846372|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
846373|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
846374|NCT02398994|Hormones|hormones|mesh-ancestor
846375|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
846376|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
846377|NCT02398994|Protective Agents|protective agents|mesh-ancestor
846378|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
846450|NCT02398448|Allopurinol|allopurinol|mesh-list
846451|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
846452|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846453|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846454|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
846455|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
846456|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
846457|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
846458|NCT02398448|Protective Agents|protective agents|mesh-ancestor
846459|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257133|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2257134|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2257135|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
2257136|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2257137|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2257138|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
2257139|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2257140|NCT00150852|Vancomycin|vancomycin|mesh-list
2257141|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2257142|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257143|NCT00150865|Ropivacaine|ropivacaine|mesh-list
2257144|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
2257145|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
846730|NCT02397512|Lactulose|lactulose|mesh-list
846731|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
846999|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
847000|NCT02396030|Analgesics|analgesics|mesh-ancestor
847001|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
847002|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847003|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847004|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
847005|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
847006|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
847007|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
847008|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
847009|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
847010|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847011|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
847012|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
847013|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2257146|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2257147|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847647|NCT02394028|Etrolizumab|etrolizumab|mesh-list
847648|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
847649|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
847650|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848297|NCT02391480|Venetoclax|venetoclax|mesh-list
848298|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257148|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
2257149|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257150|NCT00150891|Cyclosporine|cyclosporine|mesh-list
2257151|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
2257152|NCT00150891|Azathioprine|azathioprine|mesh-list
2257153|NCT00150891|Tacrolimus|tacrolimus|mesh-list
2257154|NCT00150891|Cyclosporins|cyclosporins|mesh-list
2257155|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2257156|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
2257157|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845972|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
845973|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
845974|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
845975|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
845976|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
845977|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
845978|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
845979|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
845980|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
845981|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846356|NCT02399215|Nintedanib|nintedanib|mesh-list
846357|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846358|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
846359|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846360|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847468|NCT02394145|Clopidogrel|clopidogrel|mesh-list
847469|NCT02394145|Ticagrelor|ticagrelor|mesh-list
847470|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
847471|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
847472|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
847473|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
847474|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
847475|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
847476|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847477|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847912|NCT02393157|Carboplatin|carboplatin|mesh-list
847913|NCT02393157|Etoposide|etoposide|mesh-list
847914|NCT02393157|Ifosfamide|ifosfamide|mesh-list
847915|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
847916|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847917|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
847918|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
847919|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
847920|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847921|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847922|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
847923|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
847924|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
848472|NCT02390310|Lidocaine|lidocaine|mesh-list
848473|NCT02390310|Prilocaine|prilocaine|mesh-list
848474|NCT02390310|Anesthetics|anesthetics|mesh-list
848475|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
848476|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
848477|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848478|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
848479|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
848480|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
848481|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
848482|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
848483|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
848484|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849078|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
846208|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846251|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
846252|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
846253|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
846254|NCT02399462|Hormones|hormones|mesh-ancestor
846255|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
846256|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846257|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
846258|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846738|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
846739|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
846740|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846741|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
846742|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846829|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
846830|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
846831|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
846832|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
846833|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
2257158|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2257159|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257160|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257161|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
2257162|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257163|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
2257164|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2257165|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2257166|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257167|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2257168|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
2257169|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2257170|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
2257171|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2257172|NCT00150982|Alefacept|alefacept|mesh-list
2257173|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
2257174|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
2257175|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847110|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
847111|NCT02395952|Laxatives|laxatives|mesh-ancestor
847112|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2257176|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2257177|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
2257178|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
2257179|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847692|NCT02393625|Nivolumab|nivolumab|mesh-list
847693|NCT02393625|Ceritinib|ceritinib|mesh-list
847694|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
847695|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847696|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
847697|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847698|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
847699|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847969|NCT02392364|Aflibercept|aflibercept|mesh-list
847970|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
847971|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
847972|NCT02392364|Growth Substances|growth substances|mesh-ancestor
847973|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847974|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
847975|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848086|NCT02392169|Methylphenidate|methylphenidate|mesh-list
848087|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
848088|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848089|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
848090|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
848091|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
848092|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848093|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
848094|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
848139|NCT02391883|Clopidogrel|clopidogrel|mesh-list
848140|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
848141|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
848142|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
846235|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846236|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846237|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
846238|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
846239|NCT02399657|Hormones|hormones|mesh-ancestor
846240|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
846241|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
846242|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846340|NCT02399137|Gemcitabine|gemcitabine|mesh-list
846341|NCT02399137|Paclitaxel|paclitaxel|mesh-list
846342|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
846343|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846344|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
846345|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
846346|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
846347|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846348|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
846349|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
846350|NCT02399137|Antiviral Agents|antiviral agents|mesh-ancestor
846351|NCT02399137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
846352|NCT02399137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846353|NCT02399137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
846354|NCT02399137|Immunologic Factors|immunologic factors|mesh-ancestor
846355|NCT02399137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846994|NCT02396433|Carboplatin|carboplatin|mesh-list
846995|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
846996|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846997|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846998|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257180|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257181|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2257182|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2257183|NCT00150995|Growth Substances|growth substances|mesh-ancestor
2257184|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257185|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
2257186|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848414|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
848415|NCT02390843|Topotecan|topotecan|mesh-list
848416|NCT02390843|Simvastatin|simvastatin|mesh-list
848417|NCT02390843|Sargramostim|sargramostim|mesh-list
848418|NCT02390843|Lenograstim|lenograstim|mesh-list
848419|NCT02390843|Mitogens|mitogens|mesh-list
848420|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
848421|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
848422|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848423|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
848424|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
848425|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
848426|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848427|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848428|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
848429|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
848430|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
848431|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
848432|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
848433|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
848434|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848435|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
848436|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
848437|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
848438|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
848700|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
848701|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
848702|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
848703|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848704|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
848705|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
848706|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
848707|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848708|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848709|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
848759|NCT02389400|Methotrexate|methotrexate|mesh-list
848760|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
848761|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
848782|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
846333|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846334|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
846335|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
846336|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
846504|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
846505|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846633|NCT02397720|Nivolumab|nivolumab|mesh-list
846634|NCT02397720|Ipilimumab|ipilimumab|mesh-list
846635|NCT02397720|Azacitidine|azacitidine|mesh-list
846636|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
846637|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846638|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
846639|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846640|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
846641|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
846642|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846771|NCT02397356|Ketamine|ketamine|mesh-list
846772|NCT02397356|Analgesics|analgesics|mesh-ancestor
846773|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
846774|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846775|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846776|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
846777|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
846778|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
846779|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
846780|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
846781|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
846782|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
846783|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
846784|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257187|NCT00151008|Bexarotene|bexarotene|mesh-list
2257188|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257189|NCT00151034|Gemcitabine|gemcitabine|mesh-list
2257190|NCT00151034|Paclitaxel|paclitaxel|mesh-list
2257191|NCT00151034|Carboplatin|carboplatin|mesh-list
2257192|NCT00151034|Trastuzumab|trastuzumab|mesh-list
2257193|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2257194|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847562|NCT02394054|Vasopressins|vasopressins|mesh-list
847563|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
847564|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
847565|NCT02394054|Coagulants|coagulants|mesh-ancestor
847566|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
847567|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
847568|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
847569|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847869|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
847870|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
847871|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
847872|NCT02392780|Prednisolone|prednisolone|mesh-list
847873|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
847874|NCT02392780|Cannabidiol|cannabidiol|mesh-list
847875|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
847876|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
847877|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
847878|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
847879|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
847880|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
847881|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847882|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847883|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
847884|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
847885|NCT02392780|Hormones|hormones|mesh-ancestor
847886|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
847887|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
847888|NCT02392780|Protective Agents|protective agents|mesh-ancestor
847889|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
847890|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847891|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
847892|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847893|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848447|NCT02390505|Ascorbic Acid|ascorbic acid|mesh-list
848448|NCT02390505|Vitamins|vitamins|mesh-ancestor
848449|NCT02390505|Micronutrients|micronutrients|mesh-ancestor
848450|NCT02390505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848451|NCT02390505|Antioxidants|antioxidants|mesh-ancestor
2257195|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
846406|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
846407|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099322|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2099323|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
2099324|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
846732|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
846733|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
846734|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847197|NCT02395458|Amoxicillin|amoxicillin|mesh-list
847198|NCT02395458|Metronidazole|metronidazole|mesh-list
847199|NCT02395458|Clarithromycin|clarithromycin|mesh-list
847200|NCT02395458|Omeprazole|omeprazole|mesh-list
847201|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
847202|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
847203|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
847204|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
847205|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
847206|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
847207|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
847208|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847209|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847210|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
847211|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
847212|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
847801|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
847802|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
847987|NCT02392702|Ivacaftor|ivacaftor|mesh-list
847988|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
847989|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
847990|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848095|NCT02392130|Clobetasol|clobetasol|mesh-list
848096|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
848097|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
848098|NCT02392130|Hormones|hormones|mesh-ancestor
848099|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
848100|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848377|NCT02390739|Aldesleukin|aldesleukin|mesh-list
848378|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
848379|NCT02390739|Fludarabine|fludarabine|mesh-list
848380|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
848381|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
848382|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848383|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
848384|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
848385|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
848386|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848387|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848388|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
848389|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
848390|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
848391|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
848392|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
848570|NCT02389972|Dasatinib|dasatinib|mesh-list
848571|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848572|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
848573|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848574|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849438|NCT02386358|Benzonidazole|benzonidazole|mesh-list
849439|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
849440|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
849441|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849442|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
849443|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
849444|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
849445|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
850063|NCT02383901|Methotrexate|methotrexate|mesh-list
850064|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
850065|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
850066|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
850067|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850068|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
850069|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
850070|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850071|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850072|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
846432|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
846433|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
846434|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
846435|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
846436|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
846437|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846438|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846439|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
846440|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
846691|NCT02397382|Midazolam|midazolam|mesh-list
846692|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
846693|NCT02397382|Caffeine|caffeine|mesh-list
846694|NCT02397382|Omeprazole|omeprazole|mesh-list
846695|NCT02397382|Warfarin|warfarin|mesh-list
846696|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
846697|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
846698|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
846699|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846700|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
846701|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
846702|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
846703|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
846704|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
846705|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
846706|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
846707|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
846708|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
846709|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846710|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
846711|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
846712|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
846713|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
846714|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846715|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
846716|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
846717|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
846718|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
846719|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
846720|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
846721|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
846722|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
846723|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
847136|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
847137|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847138|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099325|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099326|NCT02355886|Gabapentin|gabapentin|mesh-list
2099327|NCT02355886|Analgesics|analgesics|mesh-ancestor
2099328|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
2099329|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099330|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099331|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
2099332|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2099333|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2099334|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099335|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2099336|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2099337|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2099338|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099339|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099340|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
2099341|NCT02355977|Minocycline|minocycline|mesh-list
2099342|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2099343|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099344|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
2099345|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2099346|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
2099347|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2099348|NCT02356198|Hydromorphone|hydromorphone|mesh-list
2099349|NCT02356198|Bupivacaine|bupivacaine|mesh-list
847819|NCT02393144|Meperidine|meperidine|mesh-list
847820|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
847821|NCT02393144|Analgesics|analgesics|mesh-list
846510|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846511|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
846512|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257196|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
2257197|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
2257198|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257199|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2257200|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
2257201|NCT00151034|Antiviral Agents|antiviral agents|mesh-ancestor
2257202|NCT00151034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
846864|NCT02397083|Everolimus|everolimus|mesh-list
846865|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
846866|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
846867|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
846868|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
846869|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846870|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
846871|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
846872|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
846873|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
846874|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
846875|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2257203|NCT00151034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257204|NCT00151034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2257205|NCT00151034|Immunologic Factors|immunologic factors|mesh-ancestor
2257206|NCT00151034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257207|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2257208|NCT00151047|Docetaxel|docetaxel|mesh-list
2257209|NCT00151047|Capecitabine|capecitabine|mesh-list
2257210|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257211|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
2257212|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
2257213|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
2257214|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257215|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2257216|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
2257217|NCT00151060|Paclitaxel|paclitaxel|mesh-list
2257218|NCT00151060|Etoposide|etoposide|mesh-list
2257219|NCT00151060|Estramustine|estramustine|mesh-list
2257220|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2257221|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257222|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
2257223|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
2257224|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
2257225|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847096|NCT02395783|Melatonin|melatonin|mesh-list
847097|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
847098|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847099|NCT02395783|Protective Agents|protective agents|mesh-ancestor
847100|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847101|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
847213|NCT02395497|Antibodies|antibodies|mesh-list
847214|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
847215|NCT02395497|Tacrolimus|tacrolimus|mesh-list
847216|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
847217|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847218|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
847219|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
847220|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847221|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847992|NCT02392676|Olaparib|olaparib|mesh-list
847993|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
847994|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847995|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847996|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848111|NCT02392039|Loratadine|loratadine|mesh-list
848112|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
848113|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
848114|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
848115|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
848116|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
848117|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
848118|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
848119|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
848120|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846836|NCT02396979|Narcotics|narcotics|mesh-ancestor
846837|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
846838|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846839|NCT02396979|Analgesics|analgesics|mesh-ancestor
846840|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
846841|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
846842|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
846843|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
2257226|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2257227|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2257228|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257229|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2257230|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
847222|NCT02395237|Glimepiride|glimepiride|mesh-list
847223|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
847224|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
847225|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847226|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
847227|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
847366|NCT02394535|Paclitaxel|paclitaxel|mesh-list
847367|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
847368|NCT02394535|Capecitabine|capecitabine|mesh-list
847369|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
847370|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847371|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
847372|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
847373|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
847374|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847375|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
847376|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
847754|NCT02393443|Oxytocin|oxytocin|mesh-list
847755|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
847756|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
847757|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257231|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2257232|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
2257233|NCT00151073|Docetaxel|docetaxel|mesh-list
2257234|NCT00151073|Estramustine|estramustine|mesh-list
2257235|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257236|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
2257237|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
2257238|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
2257239|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257240|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2257241|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257242|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2257243|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
2257244|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
848813|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
848814|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
848815|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
848816|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257245|NCT00151086|Vinorelbine|vinorelbine|mesh-list
2257246|NCT00151086|Estramustine|estramustine|mesh-list
2257247|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2257248|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257249|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
2257250|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
2257251|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
849383|NCT02387021|Ropivacaine|ropivacaine|mesh-list
849384|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
849385|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
849386|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
849387|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849388|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
849389|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849978|NCT02384512|Rasagiline|rasagiline|mesh-list
849979|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
849980|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849981|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849982|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
849983|NCT02384512|Protective Agents|protective agents|mesh-ancestor
849984|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850328|NCT02382679|Vitamins|vitamins|mesh-list
850329|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
850330|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099350|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
847350|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
847351|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
847352|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257252|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257253|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2257254|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
2257255|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2257256|NCT00151112|Anesthetics|anesthetics|mesh-list
2257257|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2257258|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257259|NCT00151125|Oprelvekin|oprelvekin|mesh-list
2257260|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257261|NCT00151138|Atenolol|atenolol|mesh-list
2257262|NCT00151138|Lisinopril|lisinopril|mesh-list
2257263|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2257264|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
2257265|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257266|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257267|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2257268|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2257269|NCT00151138|Protective Agents|protective agents|mesh-ancestor
2257270|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257271|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2257272|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
2257273|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
847832|NCT02392845|Docetaxel|docetaxel|mesh-list
847833|NCT02392845|Epirubicin|epirubicin|mesh-list
847834|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847835|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
847836|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
847837|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
847838|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847839|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
847840|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
847841|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
847842|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848557|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
848558|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
848559|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849135|NCT02387931|Vitamin D|vitamin d|mesh-list
849136|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
849137|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
849138|NCT02387931|Vitamins|vitamins|mesh-list
849139|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
849140|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849141|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
849142|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
849408|NCT02386774|Benoxinate|benoxinate|mesh-list
849409|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
849410|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
849411|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
849412|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
849413|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
849414|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849415|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
849416|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849842|NCT02385227|Nicotine|nicotine|mesh-list
849843|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
849844|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
849845|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849846|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849847|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
849848|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
849849|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
849850|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
849851|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850406|NCT02382445|Anesthetics|anesthetics|mesh-list
850407|NCT02382445|Propofol|propofol|mesh-list
850408|NCT02382445|Sevoflurane|sevoflurane|mesh-list
850409|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850410|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850411|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
850412|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
850413|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
846966|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
846967|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
846968|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
846969|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
846970|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
846971|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
846972|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
846973|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2257274|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257275|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2257276|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2257277|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2257278|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
2257279|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257280|NCT00151203|Clarithromycin|clarithromycin|mesh-list
2257281|NCT00151203|Dexamethasone|dexamethasone|mesh-list
2257282|NCT00151203|Lenalidomide|lenalidomide|mesh-list
2257283|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2257284|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
2257285|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
2257286|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257287|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257288|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2257289|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
847542|NCT02393898|Paclitaxel|paclitaxel|mesh-list
847543|NCT02393898|Bevacizumab|bevacizumab|mesh-list
847544|NCT02393898|Carboplatin|carboplatin|mesh-list
847545|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
847546|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847547|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
847548|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
847549|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
847550|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847551|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
847552|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
847553|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
847554|NCT02393898|Growth Substances|growth substances|mesh-ancestor
847555|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847556|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
2257290|NCT00151203|Hormones|hormones|mesh-ancestor
2257291|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2257292|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2257293|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257294|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
2257295|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2257296|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2257297|NCT00151203|Growth Substances|growth substances|mesh-ancestor
2257298|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
2257299|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2257300|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257301|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2257302|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257303|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257304|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2257305|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2257306|NCT00151242|Cytarabine|cytarabine|mesh-list
2257307|NCT00151242|Etoposide|etoposide|mesh-list
2257308|NCT00151242|Idarubicin|idarubicin|mesh-list
2257309|NCT00151242|Tretinoin|tretinoin|mesh-list
2257310|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2257311|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257312|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2257313|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2257314|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257315|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257316|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2257317|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
2257318|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
2257319|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257320|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2257321|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
2257322|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257323|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
847073|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
847074|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
847075|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
847076|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
847077|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
847262|NCT02395016|Gemcitabine|gemcitabine|mesh-list
847263|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
847264|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
847265|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
847266|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847267|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847268|NCT02395016|Antiviral Agents|antiviral agents|mesh-ancestor
847269|NCT02395016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
847270|NCT02395016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847271|NCT02395016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
847272|NCT02395016|Immunologic Factors|immunologic factors|mesh-ancestor
847273|NCT02395016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847274|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
847419|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
847420|NCT02394418|Propofol|propofol|mesh-list
847421|NCT02394418|Sevoflurane|sevoflurane|mesh-list
847422|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
847423|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
847424|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847425|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
847426|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
847427|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
847428|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
847429|NCT02394418|Analgesics|analgesics|mesh-ancestor
847430|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
847431|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847432|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
847433|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
847434|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
847435|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
847436|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
847437|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847438|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
847439|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
848057|NCT02392429|Cytarabine|cytarabine|mesh-list
848058|NCT02392429|Alovudine|alovudine|mesh-list
848059|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
848060|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
848061|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848062|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848063|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
848064|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
848065|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
848066|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
848067|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848269|NCT02391571|Naltrexone|naltrexone|mesh-list
848270|NCT02391571|Oxycodone|oxycodone|mesh-list
848271|NCT02391571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
848272|NCT02391571|Narcotics|narcotics|mesh-ancestor
848273|NCT02391571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
848274|NCT02391571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848275|NCT02391571|Analgesics|analgesics|mesh-ancestor
848276|NCT02391571|Sensory System Agents|sensory system agents|mesh-ancestor
848277|NCT02391571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
848278|NCT02391571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
848279|NCT02391571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
848299|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
848300|NCT02391181|Hematinics|hematinics|mesh-ancestor
848775|NCT02389439|Artesunate|artesunate|mesh-list
848776|NCT02389439|Pyronaridine|pyronaridine|mesh-list
848777|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
848778|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
848779|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
848780|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
848781|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257324|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
2257325|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
2257326|NCT00151255|Cytarabine|cytarabine|mesh-list
2257327|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
2257328|NCT00151255|Idarubicin|idarubicin|mesh-list
2257329|NCT00151255|Tretinoin|tretinoin|mesh-list
2257330|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
847228|NCT02394847|Propofol|propofol|mesh-list
847229|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
847230|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
847231|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847232|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
847233|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
847234|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
847570|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
847571|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
847572|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
847573|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847574|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
847575|NCT02393963|Coagulants|coagulants|mesh-ancestor
847711|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
847712|NCT02393482|Leuprolide|leuprolide|mesh-list
847713|NCT02393482|Tibolone|tibolone|mesh-list
847714|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
847715|NCT02393482|Hormones|hormones|mesh-list
847716|NCT02393482|Estradiol|estradiol|mesh-list
847717|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
847718|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847719|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
847720|NCT02393482|Estrogens|estrogens|mesh-ancestor
847721|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
847722|NCT02393482|Antacids|antacids|mesh-ancestor
847723|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847724|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
847725|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
847726|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
847727|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
847728|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847729|NCT02393482|Vitamins|vitamins|mesh-ancestor
847730|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
847731|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
847732|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
847733|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
847734|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
847735|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
847736|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
848103|NCT02392026|Metronidazole|metronidazole|mesh-list
848104|NCT02392026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
848105|NCT02392026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
848106|NCT02392026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
848107|NCT02392026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
848626|NCT02390089|Capsaicin|capsaicin|mesh-list
848627|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
848628|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
848629|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
848630|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
848631|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257331|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
2257332|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257333|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257334|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
2257335|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257336|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2257337|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
2257338|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257339|NCT00151255|Analgesics|analgesics|mesh-ancestor
2257340|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
2257341|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257342|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2257343|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2257344|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847462|NCT02394132|Imiquimod|imiquimod|mesh-list
847463|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
847464|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
847465|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847466|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847467|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
2257345|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2257346|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
2257347|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
2257348|NCT00151294|Dexetimide|dexetimide|mesh-list
2257349|NCT00151294|Citalopram|citalopram|mesh-list
2257350|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
2257351|NCT00151294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2257352|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
847958|NCT02392520|Cetrorelix|cetrorelix|mesh-list
847959|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
847960|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
847961|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
847962|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847963|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
847964|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
849102|NCT02387892|Vitamin D|vitamin d|mesh-list
849103|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
849104|NCT02387892|Vitamins|vitamins|mesh-ancestor
849105|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
849106|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849107|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
849108|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
849198|NCT02387307|Interferons|interferons|mesh-list
849199|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849200|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
849201|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
849709|NCT02385396|Folic Acid|folic acid|mesh-list
849710|NCT02385396|Inositol|inositol|mesh-list
849711|NCT02385396|Hematinics|hematinics|mesh-ancestor
849712|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
849713|NCT02385396|Vitamins|vitamins|mesh-ancestor
849714|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
849715|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849852|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
849853|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
849854|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
850316|NCT02382653|Piroxicam|piroxicam|mesh-list
850317|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
850318|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
850319|NCT02382653|Analgesics|analgesics|mesh-ancestor
850320|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
850321|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850322|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850323|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
850324|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
850325|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
850326|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850327|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257353|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257354|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257355|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257356|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
2257357|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850744|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
850745|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
850746|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257358|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
847277|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
847278|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
847279|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847280|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847281|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
847282|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
847443|NCT02394197|Chloroquine|chloroquine|mesh-list
847444|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
847445|NCT02394197|Primaquine|primaquine|mesh-list
847446|NCT02394197|Amebicides|amebicides|mesh-ancestor
847447|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
847448|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
847449|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
847450|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
847451|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
847452|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
847453|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
847454|NCT02394197|Analgesics|analgesics|mesh-ancestor
847455|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
847456|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847457|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847458|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
847459|NCT02394197|Filaricides|filaricides|mesh-ancestor
847460|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
847461|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
847737|NCT02393430|Rebamipide|rebamipide|mesh-list
847738|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
847739|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
847740|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
847741|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847742|NCT02393430|Protective Agents|protective agents|mesh-ancestor
847743|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847744|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257359|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2257360|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2257361|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2257362|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
848892|NCT02389309|Sirolimus|sirolimus|mesh-list
848893|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
848894|NCT02389309|Dasatinib|dasatinib|mesh-list
848895|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
848896|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
848897|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848898|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
848899|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
848900|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
848901|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848902|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848903|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
848904|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
848905|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
848906|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
848907|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
848908|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
848909|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848944|NCT02388750|Palonosetron|palonosetron|mesh-list
848945|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
848946|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
848947|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
848948|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848949|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
848950|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
848951|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
848952|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
848953|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
848954|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849009|NCT02388516|Vitamin D|vitamin d|mesh-list
849010|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
849011|NCT02388516|Vitamins|vitamins|mesh-ancestor
849012|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
849013|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849014|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
849015|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
849705|NCT02385474|Fluorides|fluorides|mesh-list
849706|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
849707|NCT02385474|Protective Agents|protective agents|mesh-ancestor
2257363|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
847388|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
847389|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847390|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
847781|NCT02393586|Amoxicillin|amoxicillin|mesh-list
847782|NCT02393586|Rifampin|rifampin|mesh-list
847783|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
847784|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
847785|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
847786|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
847787|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
847788|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
847789|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
847790|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
847791|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
847792|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847793|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847794|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
847795|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
847796|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
847797|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
847798|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
847799|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
847800|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2257364|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257365|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2257366|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2257367|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
848511|NCT02390258|S66913|s66913|mesh-list
848512|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
848513|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
848514|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257368|NCT00151346|Fentanyl|fentanyl|mesh-list
2257369|NCT00151346|Bupivacaine|bupivacaine|mesh-list
2257370|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
2257371|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
2257372|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
848854|NCT02389426|Bosentan|bosentan|mesh-list
848855|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
848856|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
848857|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257373|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257374|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
2257375|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257376|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2257377|NCT00151346|Narcotics|narcotics|mesh-ancestor
2257378|NCT00151346|Analgesics|analgesics|mesh-ancestor
2257379|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2257380|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2257381|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
2257382|NCT00151398|Donepezil|donepezil|mesh-list
2257383|NCT00151398|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2257384|NCT00151398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257385|NCT00151398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257386|NCT00151398|Cholinergic Agents|cholinergic agents|mesh-ancestor
2257387|NCT00151398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257388|NCT00151398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257389|NCT00151398|Nootropic Agents|nootropic agents|mesh-ancestor
2257390|NCT00151424|Olanzapine|olanzapine|mesh-list
2257391|NCT00151424|Asenapine|asenapine|mesh-list
2257392|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
850684|NCT02380898|Ketorolac|ketorolac|mesh-list
850685|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
850686|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
850687|NCT02380898|Analgesics|analgesics|mesh-ancestor
850688|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
850689|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850690|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850691|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
850692|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
850693|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
850694|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850695|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257393|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
2257394|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847509|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
847510|NCT02393846|Analgesics|analgesics|mesh-ancestor
847511|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
847512|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847513|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847514|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
847515|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
847516|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
847517|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847518|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847593|NCT02393664|Bupivacaine|bupivacaine|mesh-list
847594|NCT02393664|Propofol|propofol|mesh-list
847595|NCT02393664|Sevoflurane|sevoflurane|mesh-list
847596|NCT02393664|Rocuronium|rocuronium|mesh-list
847597|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
847598|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
847599|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
847600|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847601|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
847602|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847603|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
847604|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
847605|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
847606|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
847607|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
847608|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
847609|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
847610|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2257395|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257396|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2257397|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2257398|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2257399|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2257400|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2257401|NCT00151424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2257402|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
848749|NCT02389582|Enoxaparin|enoxaparin|mesh-list
848750|NCT02389582|Dabigatran|dabigatran|mesh-list
848751|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
848752|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
848753|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
848754|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848755|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
848756|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
848757|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
848758|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848858|NCT02389231|Interleukin-2|interleukin-2|mesh-list
848859|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848860|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
848861|NCT02389231|Analgesics|analgesics|mesh-ancestor
848862|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
848863|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
848864|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849020|NCT02388373|Fluticasone|fluticasone|mesh-list
849021|NCT02388373|Xhance|xhance|mesh-list
849022|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
849023|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
849024|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
849025|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
849026|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
849027|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849028|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849029|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
849030|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
849031|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
849032|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
849033|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
849034|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
849035|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
849036|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
849037|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
849038|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257403|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257404|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257405|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
847525|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
847745|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
847746|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
847747|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
847748|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847749|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
847750|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
847751|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
847752|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
847753|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848068|NCT02392637|Gemcitabine|gemcitabine|mesh-list
848069|NCT02392637|Paclitaxel|paclitaxel|mesh-list
848070|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
848071|NCT02392637|Cisplatin|cisplatin|mesh-list
848072|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
848073|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848074|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
848075|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
848076|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
848077|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848078|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
848079|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
848080|NCT02392637|Antiviral Agents|antiviral agents|mesh-ancestor
848081|NCT02392637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
848082|NCT02392637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848083|NCT02392637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
848084|NCT02392637|Immunologic Factors|immunologic factors|mesh-ancestor
848085|NCT02392637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848454|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
848455|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
848456|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
848457|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848458|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
848459|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
848460|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
848538|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
848539|NCT02390102|Hematinics|hematinics|mesh-ancestor
2099351|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
2099352|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099353|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099354|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
2099355|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099356|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2099357|NCT02356198|Narcotics|narcotics|mesh-ancestor
2099358|NCT02356198|Analgesics|analgesics|mesh-ancestor
2099359|NCT02356562|Ritonavir|ritonavir|mesh-list
2099360|NCT02356562|Ribavirin|ribavirin|mesh-list
2099361|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
2099362|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2099363|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2099364|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
2099365|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099366|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099367|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2099368|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2099369|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
2099370|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099371|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2099372|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2099373|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
2099374|NCT02356588|Sufentanil|sufentanil|mesh-list
2099375|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2099376|NCT02356588|Narcotics|narcotics|mesh-ancestor
2257406|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
2257407|NCT00151450|Pregabalin|pregabalin|mesh-list
2257408|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2257409|NCT00151450|Analgesics|analgesics|mesh-ancestor
2257410|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
2257411|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849585|NCT02386072|Mirabegron|mirabegron|mesh-list
849586|NCT02386072|Oxybutynin|oxybutynin|mesh-list
849587|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
849588|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
849589|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
849590|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
849591|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
849592|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257412|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257413|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
847540|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
847541|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
847675|NCT02393599|Cocaine|cocaine|mesh-list
847676|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
847677|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
847678|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
847679|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847680|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
847681|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847682|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
847683|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
847684|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
847685|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
847686|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
847687|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
847688|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
847991|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
848054|NCT02392117|Insulin|insulin|mesh-list
848055|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
848056|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848339|NCT02390869|Rituximab|rituximab|mesh-list
848340|NCT02390869|Lenalidomide|lenalidomide|mesh-list
848341|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
848342|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848343|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
848344|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848345|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
848346|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
848347|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
848348|NCT02390869|Growth Substances|growth substances|mesh-ancestor
848349|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
2257414|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2257415|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257416|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257417|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2257418|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2257419|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2257420|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2257421|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2257422|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2257423|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
849400|NCT02386735|Prednisone|prednisone|mesh-list
849401|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
849402|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
849403|NCT02386735|Hormones|hormones|mesh-ancestor
849404|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
849405|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849406|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
849407|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257424|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257425|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2257426|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
2257427|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
849877|NCT02384837|Sirolimus|sirolimus|mesh-list
849878|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
849879|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
849880|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
849881|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849882|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
849883|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
849884|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
849885|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850017|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
850018|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
850019|NCT02384499|Coagulants|coagulants|mesh-ancestor
850463|NCT02382432|Meperidine|meperidine|mesh-list
850464|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
850465|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
850466|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850467|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850468|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
850469|NCT02382432|Analgesics|analgesics|mesh-ancestor
850470|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
850471|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099377|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099378|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099379|NCT02356588|Analgesics|analgesics|mesh-ancestor
2099380|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
2099381|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099382|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2099383|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2099384|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
2099385|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
2099386|NCT02356705|Lidocaine|lidocaine|mesh-list
2099387|NCT02356705|Midazolam|midazolam|mesh-list
2099388|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2099389|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2099390|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099391|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099392|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2099393|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2099394|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2099395|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2099396|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
2099397|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
2099398|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
2099399|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
2099400|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099401|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099402|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
2099403|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
2099404|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099405|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2099406|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2099407|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2099408|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2099409|NCT02357147|Pemetrexed|pemetrexed|mesh-list
2099410|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099411|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257428|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257429|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
2257430|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2257431|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2257432|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257433|NCT00151463|Urological Agents|urological agents|mesh-ancestor
849892|NCT02384876|Ephedrine|ephedrine|mesh-list
849893|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
849894|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
849895|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
849896|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849897|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
849898|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
849899|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849900|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
849901|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
849902|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
849903|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849904|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
849905|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
849906|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
849907|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
2257434|NCT00151489|Pregabalin|pregabalin|mesh-list
2257435|NCT00151489|Analgesics|analgesics|mesh-ancestor
2257436|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
2257437|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257438|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850423|NCT02382510|Tiotropium Bromide|tiotropium bromide|mesh-list
850424|NCT02382510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
850425|NCT02382510|Autonomic Agents|autonomic agents|mesh-ancestor
850426|NCT02382510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850427|NCT02382510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850428|NCT02382510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
850429|NCT02382510|Respiratory System Agents|respiratory system agents|mesh-ancestor
850430|NCT02382510|Parasympatholytics|parasympatholytics|mesh-ancestor
850431|NCT02382510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
850432|NCT02382510|Cholinergic Agents|cholinergic agents|mesh-ancestor
850433|NCT02382510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
850472|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2257439|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
847822|NCT02393144|Oxytocin|oxytocin|mesh-list
847823|NCT02393144|Dinoprostone|dinoprostone|mesh-list
847824|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
847825|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
847826|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847827|NCT02393144|Narcotics|narcotics|mesh-ancestor
847828|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
847829|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
847830|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
847831|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
848359|NCT02390700|Golimumab|golimumab|mesh-list
848360|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
848361|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
848362|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
848363|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
848364|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848485|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
848486|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
848487|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
848488|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
848489|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848490|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
848491|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
848492|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257440|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2257441|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257442|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257443|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2257444|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2257445|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2257446|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2257447|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2257448|NCT00151502|Atorvastatin|atorvastatin|mesh-list
2257449|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2257450|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2257451|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
2257452|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257453|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2257454|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2257455|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257456|NCT00151515|Minoxidil|minoxidil|mesh-list
849084|NCT02388178|Fluorides|fluorides|mesh-list
849085|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
849086|NCT02388178|Protective Agents|protective agents|mesh-ancestor
849087|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257457|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2257458|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
2257459|NCT00151528|Pregabalin|pregabalin|mesh-list
2257460|NCT00151528|Analgesics|analgesics|mesh-ancestor
2257461|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
2257462|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257463|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257464|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
2257465|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2257466|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257467|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257468|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2257469|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2257470|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2257471|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2257472|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
849499|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
849500|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
849501|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
849502|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
849503|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
849504|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
2257473|NCT00151541|Dapsone|dapsone|mesh-list
2257474|NCT00151541|Adapalene|adapalene|mesh-list
2257475|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2257476|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
2257477|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2257478|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2257479|NCT00151541|Analgesics|analgesics|mesh-ancestor
2257480|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
2099412|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099413|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2099414|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2099415|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
2099416|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2099417|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
2099418|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099419|NCT02357290|Expectorants|expectorants|mesh-ancestor
2099420|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
2099421|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2099422|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
847955|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
847956|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
847957|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
2257481|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257482|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257483|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2257484|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2257485|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257486|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
2257487|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2257488|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2257489|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
849911|NCT02384850|Leucovorin|leucovorin|mesh-list
849912|NCT02384850|Folic Acid|folic acid|mesh-list
849913|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
849914|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
849915|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849916|NCT02384850|Antidotes|antidotes|mesh-ancestor
849917|NCT02384850|Protective Agents|protective agents|mesh-ancestor
849918|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849919|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
849920|NCT02384850|Vitamins|vitamins|mesh-ancestor
849921|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
849922|NCT02384850|Hematinics|hematinics|mesh-ancestor
850115|NCT02383888|BI 425809|bi 425809|mesh-list
850116|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
850236|NCT02383121|Midodrine|midodrine|mesh-list
850237|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
850238|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
850239|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850240|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850241|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
850242|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
850243|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
850244|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
850245|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
850246|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
850247|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850651|NCT02381470|Amoxicillin|amoxicillin|mesh-list
850652|NCT02381470|Rifampin|rifampin|mesh-list
850653|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
850654|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
850655|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
850656|NCT02381470|Cefadroxil|cefadroxil|mesh-list
850657|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
850658|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
850659|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
850660|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
850661|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
850662|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
850663|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850664|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850665|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
850666|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
850667|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
850668|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
850669|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
850670|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
850671|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2257490|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257491|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257492|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
2257493|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2257494|NCT00151567|Tamsulosin|tamsulosin|mesh-list
2257495|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
847941|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
847942|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
847943|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
847944|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
847945|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
847946|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2257496|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2257497|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2257498|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
2257499|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257500|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257501|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257502|NCT00151567|Urological Agents|urological agents|mesh-ancestor
2257503|NCT00151580|Ribavirin|ribavirin|mesh-list
2257504|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
2257505|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257506|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
2257507|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257508|NCT00151619|Amlodipine|amlodipine|mesh-list
2257509|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2257510|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2257511|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257512|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257513|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2257514|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257515|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
2257516|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
2257517|NCT00151632|Tacrolimus|tacrolimus|mesh-list
848330|NCT02390960|Sildenafil Citrate|sildenafil citrate|mesh-list
848331|NCT02390960|Vasodilator Agents|vasodilator agents|mesh-ancestor
848332|NCT02390960|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
848333|NCT02390960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
848334|NCT02390960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848335|NCT02390960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848336|NCT02390960|Urological Agents|urological agents|mesh-ancestor
848955|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
848956|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
848957|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
848958|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848959|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
848960|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
848961|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
848962|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848963|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848964|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
849039|NCT02388477|Doxycycline|doxycycline|mesh-list
849040|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
849041|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
849042|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
849043|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
849044|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
849239|NCT02387567|Lidocaine|lidocaine|mesh-list
849246|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
849247|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
849248|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
849249|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849250|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
849251|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849252|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
849253|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
849254|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
849255|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
849256|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849669|NCT02385500|Fesoterodine|fesoterodine|mesh-list
849670|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
849671|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
849672|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
849673|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
849674|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849675|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849676|NCT02385500|Urological Agents|urological agents|mesh-ancestor
849932|NCT02384759|Aflibercept|aflibercept|mesh-list
849933|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
847968|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848236|NCT02391636|Oxytocin|oxytocin|mesh-list
848237|NCT02391636|Carbetocin|carbetocin|mesh-list
848238|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
848239|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
848240|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848337|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
848338|NCT02390921|Hematinics|hematinics|mesh-ancestor
849088|NCT02388035|Cefotaxime|cefotaxime|mesh-list
849089|NCT02388035|Cefoxitin|cefoxitin|mesh-list
849090|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
849091|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
849536|NCT02386150|Vaccines|vaccines|mesh-list
849537|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
849538|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849734|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
849735|NCT02385435|Bupivacaine|bupivacaine|mesh-list
849736|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
849737|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
849738|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
849739|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849740|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
849741|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849742|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
849743|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
849744|NCT02385435|Analgesics|analgesics|mesh-ancestor
849745|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
849746|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
849747|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
849748|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
849749|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
849750|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850038|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
850039|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
850040|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
850041|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850042|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
850043|NCT02384135|Coagulants|coagulants|mesh-ancestor
850633|NCT02381249|Octreotide|octreotide|mesh-list
850634|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
850635|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
850636|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851649|NCT02376049|Betamethasone|betamethasone|mesh-list
851650|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
851651|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
851652|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
851653|NCT02376049|Clobetasol|clobetasol|mesh-list
851654|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
851655|NCT02376049|Emollients|emollients|mesh-list
851656|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
851657|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
851658|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
851659|NCT02376049|Hormones|hormones|mesh-ancestor
851660|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
851661|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851662|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
851663|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
851664|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
851665|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
851666|NCT02376049|Analgesics|analgesics|mesh-ancestor
851667|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
851668|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851669|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
851670|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
851671|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
851672|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
851673|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
851674|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851675|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851919|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
851920|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
851921|NCT02374736|Antibodies|antibodies|mesh-list
851922|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
851923|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
851924|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851959|NCT02374489|Ceritinib|ceritinib|mesh-list
851960|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257518|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2257519|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
848148|NCT02391844|Oxycodone|oxycodone|mesh-list
848149|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
848150|NCT02391844|Narcotics|narcotics|mesh-ancestor
848151|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
848152|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848153|NCT02391844|Analgesics|analgesics|mesh-ancestor
848154|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
848155|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257520|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257521|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2257522|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257523|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257524|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2257525|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257526|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2099423|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099424|NCT02357290|Protective Agents|protective agents|mesh-ancestor
2099425|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099426|NCT02357290|Antidotes|antidotes|mesh-ancestor
2099427|NCT02357342|Sirolimus|sirolimus|mesh-list
2099428|NCT02357342|Aflibercept|aflibercept|mesh-list
2099429|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099430|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2257527|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
2257528|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2257529|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257530|NCT00151684|Diazoxide|diazoxide|mesh-list
2257531|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2257532|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
2257533|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
2257534|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2257535|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2257536|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257537|NCT00151710|Pioglitazone|pioglitazone|mesh-list
2257538|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2257539|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257540|NCT00151736|Etodolac|etodolac|mesh-list
2257541|NCT00151736|Chlorambucil|chlorambucil|mesh-list
2257542|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2257543|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
2257544|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257545|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257546|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
849347|NCT02387060|Fentanyl|fentanyl|mesh-list
849348|NCT02387060|Bupivacaine|bupivacaine|mesh-list
849349|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
849350|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
849351|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
849352|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849353|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
849354|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849355|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
849356|NCT02387060|Narcotics|narcotics|mesh-ancestor
849357|NCT02387060|Analgesics|analgesics|mesh-ancestor
849358|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
849359|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
849360|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
849557|NCT02386059|Dexamethasone|dexamethasone|mesh-list
849558|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
849559|NCT02386059|Ondansetron|ondansetron|mesh-list
849560|NCT02386059|BB 1101|bb 1101|mesh-list
849561|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
849562|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
849563|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
849564|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849565|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849566|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
849567|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
849568|NCT02386059|Hormones|hormones|mesh-ancestor
849569|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
849570|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
849571|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849572|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
849573|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257547|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2257548|NCT00151736|Analgesics|analgesics|mesh-ancestor
2257549|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
2257550|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257551|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848365|NCT02390674|Cyclosporine|cyclosporine|mesh-list
848366|NCT02390674|Cyclosporins|cyclosporins|mesh-list
848367|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848368|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848369|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
848370|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
848371|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848372|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
848373|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
848374|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
848375|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
848376|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2257552|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2257553|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2257554|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2257555|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2257556|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257557|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2257558|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2257559|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2257560|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
2257561|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257562|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
849604|NCT02385656|Modafinil|modafinil|mesh-list
849605|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
849606|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849607|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
849608|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
849609|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
849610|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849923|NCT02384889|Eflornithine|eflornithine|mesh-list
849924|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849925|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
849926|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
849927|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
849928|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
849929|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
849930|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849931|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850110|NCT02383823|Estradiol|estradiol|mesh-list
850111|NCT02383823|Estrogens|estrogens|mesh-list
850112|NCT02383823|Hormones|hormones|mesh-ancestor
850113|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850114|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850889|NCT02379767|Harmine|harmine|mesh-list
850890|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
850891|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850892|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
850893|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
850894|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850895|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851232|NCT02378532|Chloroquine|chloroquine|mesh-list
851233|NCT02378532|Temozolomide|temozolomide|mesh-list
851234|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
851235|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
851236|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851237|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851238|NCT02378532|Amebicides|amebicides|mesh-ancestor
851239|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
851240|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
851241|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
851242|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
851243|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
851338|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
851351|NCT02377492|Vasopressins|vasopressins|mesh-list
851352|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
851353|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
851354|NCT02377492|Coagulants|coagulants|mesh-ancestor
851355|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
851356|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
848121|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848575|NCT02389842|Palbociclib|palbociclib|mesh-list
848576|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848577|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
848578|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848579|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848910|NCT02389179|Vitamin D|vitamin d|mesh-list
848911|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
848912|NCT02389179|Vitamins|vitamins|mesh-ancestor
848913|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
848914|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848915|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
848916|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2257563|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2257564|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2257565|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2257566|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
2257567|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257568|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2257569|NCT00151801|Interferons|interferons|mesh-list
2257570|NCT00151801|Interferon-beta|interferon-beta|mesh-list
2257571|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
2257572|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257573|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
2257574|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257575|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
2257576|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257577|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2257578|NCT00151827|Losartan|losartan|mesh-list
2257579|NCT00151827|Olmesartan|olmesartan|mesh-list
2257580|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2257581|NCT00151827|Furosemide|furosemide|mesh-list
2257582|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
849340|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
849341|NCT02387138|Irinotecan|irinotecan|mesh-list
849342|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849343|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
849344|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
849345|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849346|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849470|NCT02386397|Gemcitabine|gemcitabine|mesh-list
849471|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
849472|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
849473|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
849474|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849475|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849476|NCT02386397|Antiviral Agents|antiviral agents|mesh-ancestor
849477|NCT02386397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
849478|NCT02386397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849479|NCT02386397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
849480|NCT02386397|Immunologic Factors|immunologic factors|mesh-ancestor
849481|NCT02386397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257583|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2257584|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2257585|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2257586|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257587|NCT00151827|Diuretics|diuretics|mesh-ancestor
849772|NCT02385058|Mebendazole|mebendazole|mesh-list
849773|NCT02385058|Piperazine|piperazine|mesh-list
849774|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
849775|NCT02385058|DMP 777|dmp 777|mesh-list
849776|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
849777|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
849778|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
849779|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
849780|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
849781|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
849782|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
849783|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849784|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849785|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850003|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
850004|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
850005|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850006|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850007|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2257588|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
2257589|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257590|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2257591|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
848308|NCT02391142|Lidocaine|lidocaine|mesh-list
848309|NCT02391142|Ropivacaine|ropivacaine|mesh-list
848310|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
848311|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
848312|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
848313|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848314|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
848315|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
848316|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
848317|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
848318|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
848319|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
848320|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099431|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2099432|NCT02357342|Growth Substances|growth substances|mesh-ancestor
2099433|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099434|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
2099435|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2099436|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099437|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2099438|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
2099439|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2099440|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
2099441|NCT02357368|Copper|copper|mesh-list
2099442|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
848710|NCT02389751|Paclitaxel|paclitaxel|mesh-list
848711|NCT02389751|Carboplatin|carboplatin|mesh-list
848712|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
848713|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
848714|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848715|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
848716|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
848717|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
848718|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848804|NCT02389348|Artefenomel|artefenomel|mesh-list
848805|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
848806|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
848807|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
848808|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
848917|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
848918|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
848919|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
848920|NCT02389036|Tobramycin|tobramycin|mesh-list
848921|NCT02389036|Colistin|colistin|mesh-list
848922|NCT02389036|Nystatin|nystatin|mesh-list
848923|NCT02389036|Cefotaxime|cefotaxime|mesh-list
848924|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
848925|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
848926|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
848927|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848928|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848929|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848930|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
848931|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
848932|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
848933|NCT02389036|Ionophores|ionophores|mesh-ancestor
848934|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
848965|NCT02388581|Amoxicillin|amoxicillin|mesh-list
848966|NCT02388581|Metronidazole|metronidazole|mesh-list
848967|NCT02388581|Clarithromycin|clarithromycin|mesh-list
848968|NCT02388581|Lansoprazole|lansoprazole|mesh-list
848969|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
848970|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
848971|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
848972|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
848973|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
848974|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
848975|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848976|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848977|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
848978|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
848979|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
848980|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
848143|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
848144|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
848145|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
848146|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848147|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257592|NCT00151944|Mesalamine|mesalamine|mesh-list
2257593|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2257594|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2257595|NCT00151944|Analgesics|analgesics|mesh-ancestor
2257596|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
2257597|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257598|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257599|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2257600|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2257601|NCT00151957|Methylphenidate|methylphenidate|mesh-list
848941|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
848942|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
848943|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257602|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2257603|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257604|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2257605|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2257606|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257607|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257608|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
2257609|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257610|NCT00151970|Methylphenidate|methylphenidate|mesh-list
2257611|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
849482|NCT02386488|Vortioxetine|vortioxetine|mesh-list
849483|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
849484|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
849485|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
849486|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
849487|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
849488|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849489|NCT02386488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
849490|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
849491|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
849492|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849493|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
849494|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
849495|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
849496|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
849497|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
849498|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
849860|NCT02384967|Darunavir|darunavir|mesh-list
849861|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
849862|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
849863|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
849864|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849865|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849866|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
849867|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
849868|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
849869|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
850086|NCT02384083|Dexamethasone|dexamethasone|mesh-list
850087|NCT02384083|Pomalidomide|pomalidomide|mesh-list
850088|NCT02384083|Filanesib|filanesib|mesh-list
850089|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
850090|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
850091|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
850092|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850093|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850094|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
850095|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
850096|NCT02384083|Hormones|hormones|mesh-ancestor
850097|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850098|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
850099|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850100|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
850101|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
850102|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
850103|NCT02384083|Growth Substances|growth substances|mesh-ancestor
848184|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
848185|NCT02391688|Caffeine|caffeine|mesh-list
848186|NCT02391688|Bupropion|bupropion|mesh-list
848187|NCT02391688|Omeprazole|omeprazole|mesh-list
848188|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
848189|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
848190|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
848191|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848192|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
848193|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
848194|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
848195|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
848196|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
848197|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
848198|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
848199|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
848200|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
848201|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848202|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
848203|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
848204|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
848205|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848206|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
848207|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
848208|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
848209|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
848210|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
848211|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
848212|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
848213|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
848214|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
848215|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
848216|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
848217|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
848218|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
848219|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
848220|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
848221|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
848222|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
848223|NCT02391688|Analgesics|analgesics|mesh-ancestor
848224|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
848225|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
848226|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
848227|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
848228|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
848229|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
848230|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
848231|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
848232|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
848233|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
848234|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
848235|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
2257612|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257613|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2257614|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2257615|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257616|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257617|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
2257618|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257619|NCT00151983|Methylphenidate|methylphenidate|mesh-list
2257620|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2257621|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257622|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2257623|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2257624|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257625|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257626|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
848404|NCT02390817|Neostigmine|neostigmine|mesh-list
848405|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
848406|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848407|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848408|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
2257627|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257628|NCT00152022|Amphetamine|amphetamine|mesh-list
2257629|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
2257630|NCT00152022|Adderall|adderall|mesh-list
2257631|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2257632|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257633|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
2257634|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
2257635|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257636|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
2257637|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257638|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257639|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
848402|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
848403|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
849232|NCT02387203|Amoxicillin|amoxicillin|mesh-list
849233|NCT02387203|Clarithromycin|clarithromycin|mesh-list
849234|NCT02387203|Lansoprazole|lansoprazole|mesh-list
849235|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
849236|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
849237|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
849238|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849240|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849241|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
849242|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
849243|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
849244|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
849245|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
849549|NCT02386033|Atorvastatin|atorvastatin|mesh-list
849550|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
849551|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
849552|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
849553|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849554|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
849555|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
849556|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849886|NCT02384954|Rituximab|rituximab|mesh-list
849887|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
849888|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849889|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
849890|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849891|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
850609|NCT02381314|Ipilimumab|ipilimumab|mesh-list
850610|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
850611|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850612|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
850613|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257640|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2257641|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2257642|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257643|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2257644|NCT00152035|Amphetamine|amphetamine|mesh-list
2257645|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
2257646|NCT00152035|Adderall|adderall|mesh-list
2257647|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2257648|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257649|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
2257650|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
2257651|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257652|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
2257653|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257654|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257655|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
2257656|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2257657|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
851424|NCT02377180|Anesthetics|anesthetics|mesh-list
851425|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
851426|NCT02377180|Capsaicin|capsaicin|mesh-list
851427|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
851428|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851429|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
848326|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
848327|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
848328|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
848329|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
848580|NCT02389985|Paclitaxel|paclitaxel|mesh-list
848581|NCT02389985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
848582|NCT02389985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848583|NCT02389985|Tubulin Modulators|tubulin modulators|mesh-ancestor
848584|NCT02389985|Antimitotic Agents|antimitotic agents|mesh-ancestor
848585|NCT02389985|Mitosis Modulators|mitosis modulators|mesh-ancestor
848586|NCT02389985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257658|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257659|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2257660|NCT00152048|Eflornithine|eflornithine|mesh-list
2257661|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257662|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2257663|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2257664|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
849465|NCT02386293|Irbesartan|irbesartan|mesh-list
849466|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
849467|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
849468|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
849469|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849649|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
849650|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
849651|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257665|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257666|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2257667|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257668|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257669|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
2257670|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2257671|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257672|NCT00152126|Melphalan|melphalan|mesh-list
2257673|NCT00152126|Busulfan|busulfan|mesh-list
2257674|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2257675|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
2257676|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257677|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257678|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2257679|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2257680|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
2257681|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257682|NCT00152139|Antibodies|antibodies|mesh-list
2257683|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
2257684|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257685|NCT00152178|Tamoxifen|tamoxifen|mesh-list
2257686|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
2257687|NCT00152178|Fluorouracil|fluorouracil|mesh-list
2257688|NCT00152178|Methotrexate|methotrexate|mesh-list
2257689|NCT00152178|Tegafur|tegafur|mesh-list
2257690|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2257691|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
2257692|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257693|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
850758|NCT02380508|Vaccines|vaccines|mesh-list
850759|NCT02380508|Immunologic Factors|immunologic factors|mesh-ancestor
850760|NCT02380508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850878|NCT02379754|Gentamicins|gentamicins|mesh-list
850879|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
850880|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
850881|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
850882|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850883|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257694|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2257695|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
2257696|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257697|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851455|NCT02376985|Everolimus|everolimus|mesh-list
851456|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851457|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
851458|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
851459|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851740|NCT02375880|Gemcitabine|gemcitabine|mesh-list
851741|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848409|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
848410|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848411|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
848412|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
848413|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099443|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
2099444|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
2099445|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
2099446|NCT02357368|Etonogestrel|etonogestrel|mesh-list
2099447|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2099448|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099449|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2099450|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2099451|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2099452|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2099453|NCT02357368|Trace Elements|trace elements|mesh-ancestor
2099454|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
2099455|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2099456|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2099457|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2099458|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099459|NCT02357459|Triamcinolone|triamcinolone|mesh-list
2099460|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2099461|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2099462|NCT02357459|FX006|fx006|mesh-list
2099463|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2099464|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2257698|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2257699|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
2257700|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2257701|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2257702|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
2257703|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2257704|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
2257705|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257706|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2257707|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2257708|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2257709|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
2257710|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2257711|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2257712|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2257713|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2257714|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2257715|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
2257716|NCT00152191|Fluorouracil|fluorouracil|mesh-list
2257717|NCT00152191|Methotrexate|methotrexate|mesh-list
2257718|NCT00152191|Tegafur|tegafur|mesh-list
2257719|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2257720|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
2257721|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257722|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2257723|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2257724|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
848989|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
848990|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
848991|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849372|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
849373|NCT02386943|Saxagliptin|saxagliptin|mesh-list
849374|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
849375|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849376|NCT02386943|Incretins|incretins|mesh-ancestor
849377|NCT02386943|Hormones|hormones|mesh-ancestor
849378|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
849379|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
849380|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
849381|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849382|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257725|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257726|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257727|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2257728|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
2257729|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2257730|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
848452|NCT02390505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848453|NCT02390505|Protective Agents|protective agents|mesh-ancestor
848560|NCT02389868|Lovastatin|lovastatin|mesh-list
848561|NCT02389868|L 647318|l 647318|mesh-list
848562|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
848563|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
848564|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
848565|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
848566|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848567|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
848568|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
848569|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257731|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
2257732|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2257733|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
2257734|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257735|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2257736|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2257737|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
2257738|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
2257739|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2257740|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
2257741|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2257742|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2257743|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257744|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2257745|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257746|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257747|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2257748|NCT00152204|Renal Agents|renal agents|mesh-ancestor
2257749|NCT00152230|Tegafur|tegafur|mesh-list
2257750|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2257751|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
2257752|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849511|NCT02386475|Dexetimide|dexetimide|mesh-list
849512|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
849513|NCT02386475|Citalopram|citalopram|mesh-list
849514|NCT02386475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
849515|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
849516|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
849517|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849518|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
849519|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
849520|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849521|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
849522|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
849523|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
849524|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
849525|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
849526|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
849527|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
849528|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849529|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
849530|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
849531|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
849532|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
849533|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
849534|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
849535|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
849972|NCT02385071|Simeprevir|simeprevir|mesh-list
849973|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
849974|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
849975|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
849976|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849977|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850108|NCT02383927|Tipifarnib|tipifarnib|mesh-list
850109|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850340|NCT02382666|Rolapitant|rolapitant|mesh-list
850341|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
850342|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
850343|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850344|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850518|NCT02382068|Dexamethasone|dexamethasone|mesh-list
850519|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257753|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257754|NCT00152243|Tegafur|tegafur|mesh-list
2257755|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2257756|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
2257757|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257758|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257759|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2257760|NCT00152282|Estrogens|estrogens|mesh-ancestor
2257761|NCT00152282|Hormones|hormones|mesh-ancestor
2257762|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2257763|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257764|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2257765|NCT00152295|Estrogens|estrogens|mesh-ancestor
2257766|NCT00152295|Hormones|hormones|mesh-ancestor
2257767|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2257768|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257769|NCT00152308|Sirolimus|sirolimus|mesh-list
2257770|NCT00152308|Ethanol|ethanol|mesh-list
2257771|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2257772|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257773|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2257774|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849361|NCT02386826|Bevacizumab|bevacizumab|mesh-list
849362|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
849363|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849364|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
849365|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
849366|NCT02386826|Growth Substances|growth substances|mesh-ancestor
849367|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849368|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
849539|NCT02386111|Sunitinib|sunitinib|mesh-list
849540|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849541|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
849542|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
849543|NCT02386111|Growth Substances|growth substances|mesh-ancestor
849544|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849545|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
849546|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
849547|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849548|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849646|NCT02385734|Mitogens|mitogens|mesh-list
849647|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
849648|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099465|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
2099466|NCT02357459|Hormones|hormones|mesh-ancestor
2099467|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2099468|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099469|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2099470|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
2099471|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099472|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099473|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2099474|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2099475|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2099476|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2099477|NCT02357706|Acetaminophen|acetaminophen|mesh-list
2099478|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2099479|NCT02357706|Analgesics|analgesics|mesh-ancestor
2099480|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
2099481|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257775|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
2257776|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2257777|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
2257778|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257779|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2257780|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850261|NCT02383251|Paclitaxel|paclitaxel|mesh-list
850262|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
850263|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850264|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
850265|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
850266|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
850267|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850565|NCT02381717|Morphine|morphine|mesh-list
850566|NCT02381717|Bupivacaine|bupivacaine|mesh-list
2257781|NCT00152360|Orlistat|orlistat|mesh-list
2257782|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257783|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257784|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2257785|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2257786|NCT00152373|Levetiracetam|levetiracetam|mesh-list
2257787|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
2257788|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
2257789|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
2257790|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2257791|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
2257792|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257793|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2257794|NCT00152399|Somatostatin|somatostatin|mesh-list
2257795|NCT00152399|Hormones|hormones|mesh-ancestor
2257796|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2257797|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257798|NCT00152412|Levocetirizine|levocetirizine|mesh-list
2257799|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2257800|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2257801|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
2257802|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
850755|NCT02380586|Anesthetics|anesthetics|mesh-list
850756|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850757|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257803|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257804|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257805|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257806|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
2257807|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2257808|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
2257809|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257810|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2257811|NCT00152438|Progesterone|progesterone|mesh-list
2257812|NCT00152438|Progestins|progestins|mesh-ancestor
2257813|NCT00152438|Hormones|hormones|mesh-ancestor
2257814|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2257815|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257816|NCT00152477|Paclitaxel|paclitaxel|mesh-list
2257817|NCT00152477|Carboplatin|carboplatin|mesh-list
2257818|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
851215|NCT02378441|Metformin|metformin|mesh-list
851216|NCT02378441|Atorvastatin|atorvastatin|mesh-list
851217|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
851218|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851219|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
851220|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
851221|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
851222|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851223|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
851224|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
851225|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851388|NCT02377401|Zanamivir|zanamivir|mesh-list
851389|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
851390|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
851391|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851392|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851720|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
851721|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
851722|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
851723|NCT02375867|Prednisolone|prednisolone|mesh-list
851724|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
851725|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
851726|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
851727|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
851728|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
848762|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
848763|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848764|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
848765|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
848766|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848767|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
848768|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
848769|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
848770|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
848771|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
848772|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
848773|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
848774|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
848876|NCT02389218|Sotalol|sotalol|mesh-list
848877|NCT02389218|Flecainide|flecainide|mesh-list
848878|NCT02389218|Propafenone|propafenone|mesh-list
848879|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
848880|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
848881|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
848882|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
848883|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
848884|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848885|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
848886|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
848887|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
848888|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
848889|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
848890|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
848891|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2257819|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257820|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
2257821|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
2257822|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
2257823|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257824|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
2257825|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2257826|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
2257827|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257828|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2257829|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
2257830|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2257831|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
2257832|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849390|NCT02387099|Everolimus|everolimus|mesh-list
849391|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849392|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
849393|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
849394|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849751|NCT02385305|Anesthetics|anesthetics|mesh-list
849752|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
849753|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851175|NCT02378805|Ramipril|ramipril|mesh-list
851176|NCT02378805|Spironolactone|spironolactone|mesh-list
851177|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
851178|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
851179|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
851180|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
851181|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851182|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
851183|NCT02378805|Diuretics|diuretics|mesh-ancestor
851184|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
851185|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
851186|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851187|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851188|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
851686|NCT02376075|Linagliptin|linagliptin|mesh-list
851687|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
851688|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851689|NCT02376075|Incretins|incretins|mesh-ancestor
851690|NCT02376075|Hormones|hormones|mesh-ancestor
851691|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
851692|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
851693|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
2257833|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
848783|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
848784|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
848785|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
849306|NCT02387086|Aspirin|aspirin|mesh-list
849307|NCT02387086|Thalidomide|thalidomide|mesh-list
849308|NCT02387086|Gefitinib|gefitinib|mesh-list
849309|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
849310|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
849311|NCT02387086|Analgesics|analgesics|mesh-ancestor
849312|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
849313|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849314|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849315|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
849316|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
849317|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
849318|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
849319|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849320|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
849321|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
849322|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849323|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
849324|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
849325|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
849326|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
849327|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
849328|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
849329|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
849330|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
849331|NCT02387086|Growth Substances|growth substances|mesh-ancestor
849332|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
849333|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849334|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2099482|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099483|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
2099484|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
849417|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
849418|NCT02386462|Propofol|propofol|mesh-list
849419|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
849420|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
849421|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849422|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
849423|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
849424|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
849425|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
849426|NCT02386462|Analgesics|analgesics|mesh-ancestor
849427|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
849428|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849429|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
849430|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
849431|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
849432|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
849433|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
849434|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257834|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2257835|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
2257836|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2257837|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
2257838|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257839|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257840|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2257841|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
2257842|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
2257843|NCT00152542|Protective Agents|protective agents|mesh-ancestor
2257844|NCT00152581|Interferons|interferons|mesh-list
2257845|NCT00152581|Ribavirin|ribavirin|mesh-list
2257846|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
2257847|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
2257848|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2257849|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257850|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
2257851|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257852|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
2257853|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257854|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
2257855|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257856|NCT00152594|Voriconazole|voriconazole|mesh-list
848802|NCT02389543|Growth Substances|growth substances|mesh-ancestor
848803|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
2257857|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
2257858|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257859|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2257860|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2257861|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257862|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849217|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
849218|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
849219|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
849220|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
849221|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849222|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849223|NCT02387450|Urological Agents|urological agents|mesh-ancestor
2099485|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099486|NCT02357810|Topotecan|topotecan|mesh-list
2099487|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2099488|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2099489|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099490|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099491|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099492|NCT02357836|Itraconazole|itraconazole|mesh-list
2099493|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
849947|NCT02384746|Fulvestrant|fulvestrant|mesh-list
849948|NCT02384746|Ixazomib|ixazomib|mesh-list
849949|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
849950|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849951|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
849952|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
849953|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
849954|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
849955|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849956|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
849957|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849958|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850044|NCT02384122|Octreotide|octreotide|mesh-list
850045|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
850046|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
850047|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257863|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2257864|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
851339|NCT02377609|Tacrolimus|tacrolimus|mesh-list
851340|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
851341|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
851342|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851343|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
851344|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851345|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851714|NCT02376335|Rituximab|rituximab|mesh-list
851715|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
851716|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851717|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
851718|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851719|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
851767|NCT02375503|Vitamin D|vitamin d|mesh-list
851768|NCT02375503|Calcium|calcium|mesh-list
851769|NCT02375503|Vitamins|vitamins|mesh-ancestor
851770|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
851771|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851772|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
851773|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
852477|NCT02373163|Amlodipine|amlodipine|mesh-list
852478|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
852479|NCT02373163|Telmisartan|telmisartan|mesh-list
852480|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
852481|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
852482|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
852483|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852484|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
852485|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852486|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
2099494|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2257865|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2257866|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257867|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2257868|NCT00152620|Dexamethasone|dexamethasone|mesh-list
2257869|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
849045|NCT02388048|Ofatumumab|ofatumumab|mesh-list
849046|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099495|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2099496|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2099497|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099498|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849697|NCT02385461|Heparin|heparin|mesh-list
849698|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
849699|NCT02385461|Tinzaparin|tinzaparin|mesh-list
849700|NCT02385461|Dalteparin|dalteparin|mesh-list
849701|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
849702|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
849703|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
849704|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849786|NCT02385110|Dexamethasone|dexamethasone|mesh-list
849787|NCT02385110|Methotrexate|methotrexate|mesh-list
849788|NCT02385110|Etoposide|etoposide|mesh-list
849789|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
849790|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
849791|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
849792|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
849793|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849794|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849795|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
849796|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
849797|NCT02385110|Hormones|hormones|mesh-ancestor
849798|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
849799|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
849800|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849801|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
849802|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
849803|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
849804|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
849805|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
849806|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849807|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
849808|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849809|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
849810|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
849811|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
849812|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
849813|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
849814|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
849815|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
849816|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
849817|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
850117|NCT02384187|Gabapentin|gabapentin|mesh-list
850118|NCT02384187|Analgesics|analgesics|mesh-ancestor
850119|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
850120|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850121|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850122|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
850123|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
850124|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
850125|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850126|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
850127|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
850128|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
850129|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
850130|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850131|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
850256|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
850257|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
850258|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850259|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
850260|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850862|NCT02380053|Celiprolol|celiprolol|mesh-list
850863|NCT02380053|Bisoprolol|bisoprolol|mesh-list
850864|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
848981|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
849169|NCT02387619|Amlodipine|amlodipine|mesh-list
849170|NCT02387619|Telmisartan|telmisartan|mesh-list
849171|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
849172|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
849173|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
849174|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
849175|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
849176|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849177|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
849178|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849179|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
849180|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
849181|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
849182|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
849183|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
849184|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
849185|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849186|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
849187|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
849656|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
849657|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
849658|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
849659|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
849660|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849661|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
849662|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849870|NCT02384668|Vitamin D|vitamin d|mesh-list
849871|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
849872|NCT02384668|Vitamins|vitamins|mesh-ancestor
849873|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
849874|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849875|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
849876|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
850358|NCT02382575|Rituximab|rituximab|mesh-list
850359|NCT02382575|Tacrolimus|tacrolimus|mesh-list
850360|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
850361|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
850362|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850363|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
850364|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850365|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
850366|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
850367|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850368|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851072|NCT02379156|Midodrine|midodrine|mesh-list
851073|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
851074|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
851075|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851076|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851077|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
851078|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
851079|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
851080|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
851081|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
851082|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
851083|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851846|NCT02375191|Fentanyl|fentanyl|mesh-list
851847|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
851848|NCT02375191|Ropivacaine|ropivacaine|mesh-list
851849|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
851850|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
851851|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851852|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
851853|NCT02375191|Analgesics|analgesics|mesh-ancestor
851854|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
851855|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851856|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
851857|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
851858|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
851859|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
851860|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
851861|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851862|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
849079|NCT02388061|Plasminogen|plasminogen|mesh-list
849080|NCT02388061|Tenecteplase|tenecteplase|mesh-list
849081|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
849082|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
849083|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257870|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2257871|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2257872|NCT00152620|Prednisolone|prednisolone|mesh-list
2257873|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
2257874|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2257875|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
2257876|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
849446|NCT02386449|Mannitol|mannitol|mesh-list
849447|NCT02386449|Bisacodyl|bisacodyl|mesh-list
849448|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
849449|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
849450|NCT02386449|Citric Acid|citric acid|mesh-list
849451|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
849452|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
849453|NCT02386449|Diuretics|diuretics|mesh-ancestor
849454|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
849455|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849456|NCT02386449|Cathartics|cathartics|mesh-ancestor
849457|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
849458|NCT02386449|Laxatives|laxatives|mesh-ancestor
849459|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
849460|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
849461|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
849462|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
849463|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849464|NCT02386449|Antacids|antacids|mesh-ancestor
849716|NCT02385422|Propranolol|propranolol|mesh-list
849717|NCT02385422|Carvedilol|carvedilol|mesh-list
849718|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
849719|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
849720|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
849721|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
849722|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849723|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849724|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
849725|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
849726|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
849727|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
849728|NCT02385422|Protective Agents|protective agents|mesh-ancestor
849729|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
849730|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
849731|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
849732|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
849733|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
850268|NCT02383212|Paclitaxel|paclitaxel|mesh-list
850269|NCT02383212|Docetaxel|docetaxel|mesh-list
850270|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
850271|NCT02383212|Carboplatin|carboplatin|mesh-list
850272|NCT02383212|Pemetrexed|pemetrexed|mesh-list
850273|NCT02383212|Cemiplimab|cemiplimab|mesh-list
850274|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
850275|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850276|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
850277|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
850278|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
850279|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850280|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
850281|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
850282|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850283|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
850284|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
850285|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
850286|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
850287|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850288|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
850289|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
850290|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2257877|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
2257878|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
2257879|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257880|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257881|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2257882|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
2257883|NCT00152620|Hormones|hormones|mesh-ancestor
2257884|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2257885|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2257886|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2257887|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2257888|NCT00152620|Protective Agents|protective agents|mesh-ancestor
2257889|NCT00152633|Losartan|losartan|mesh-list
2257890|NCT00152633|Metoprolol|metoprolol|mesh-list
2257891|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2257892|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2257893|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2257894|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
849224|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
849225|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
849226|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
849227|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
849228|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
849229|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849230|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849231|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
849677|NCT02385448|Dienogest|dienogest|mesh-list
849678|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
849679|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
849680|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
849681|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
849682|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
849683|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849684|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
849685|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
849686|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
849687|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
849688|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
849689|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
849690|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
849691|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849692|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
849693|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
849694|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
849695|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
849696|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2257895|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257896|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
2257897|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
2257898|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257899|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257900|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2257901|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2257902|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2257903|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
2257904|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257905|NCT00152646|Clopidogrel|clopidogrel|mesh-list
2257906|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2257907|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2257908|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2257909|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2257910|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
2257911|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257912|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257913|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257914|NCT00152698|Irbesartan|irbesartan|mesh-list
2257915|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2257916|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2257917|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2257918|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257919|NCT00152724|Aspirin|aspirin|mesh-list
2257920|NCT00152724|Celecoxib|celecoxib|mesh-list
2257921|NCT00152724|Indomethacin|indomethacin|mesh-list
2257922|NCT00152724|Nitroprusside|nitroprusside|mesh-list
2257923|NCT00152724|Acetylcholine|acetylcholine|mesh-list
2257924|NCT00152724|Capsaicin|capsaicin|mesh-list
2257925|NCT00152724|Clopidogrel|clopidogrel|mesh-list
2257926|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
849204|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
849205|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
849206|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
849207|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
849208|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
849209|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
849210|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849211|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
849212|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
849213|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
849214|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
849215|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
849216|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
849601|NCT02385825|Vaccines|vaccines|mesh-list
849602|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
849603|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849754|NCT02385266|Cycloserine|cycloserine|mesh-list
849755|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
849756|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
849757|NCT02385266|Renal Agents|renal agents|mesh-ancestor
849758|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
849759|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
849760|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
849761|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
849762|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849939|NCT02384915|Prilocaine|prilocaine|mesh-list
849940|NCT02384915|Mepivacaine|mepivacaine|mesh-list
849941|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
849942|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
849943|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849944|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
849945|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
849946|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099499|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2099500|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
2099501|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2099502|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099503|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2099504|NCT02357901|Buprenorphine|buprenorphine|mesh-list
2099505|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2099506|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2099507|NCT02357901|Narcotics|narcotics|mesh-ancestor
2099508|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099509|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257927|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2257928|NCT00152724|Analgesics|analgesics|mesh-ancestor
2257929|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
850800|NCT02380131|Capecitabine|capecitabine|mesh-list
850801|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
850802|NCT02380131|Trastuzumab|trastuzumab|mesh-list
850803|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
850804|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
850805|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850806|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850807|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
850884|NCT02379806|Enoxaparin|enoxaparin|mesh-list
850885|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
850886|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
850887|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
850888|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851026|NCT02379000|Triamcinolone|triamcinolone|mesh-list
851027|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
851028|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
851029|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
851030|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
851031|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
851032|NCT02379000|Hormones|hormones|mesh-ancestor
851033|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
851034|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851035|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
851036|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
851037|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851038|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849574|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849575|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
849576|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
849577|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
849578|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
849579|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
849580|NCT02386059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
849581|NCT02386059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
849582|NCT02386059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
849583|NCT02386059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
849584|NCT02386059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
849855|NCT02385136|Temozolomide|temozolomide|mesh-list
849856|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
849857|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
849858|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849859|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849908|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
849909|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
849910|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850436|NCT02382354|Remifentanil|remifentanil|mesh-list
850437|NCT02382354|Propofol|propofol|mesh-list
850438|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
850439|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850440|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850441|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
850442|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
850443|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
850444|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
850445|NCT02382354|Narcotics|narcotics|mesh-ancestor
850446|NCT02382354|Analgesics|analgesics|mesh-ancestor
850447|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
850448|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850548|NCT02381899|Rituximab|rituximab|mesh-list
850549|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
850550|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
850551|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850552|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
850553|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850554|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
850555|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
850556|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
850557|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851393|NCT02377479|Letrozole|letrozole|mesh-list
851394|NCT02377479|Clomiphene|clomiphene|mesh-list
851395|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851396|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
851397|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
851398|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851399|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851400|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
851401|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
851402|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
851403|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851404|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
851405|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
851406|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
851407|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
851408|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
851576|NCT02376309|Nandrolone|nandrolone|mesh-list
851577|NCT02376309|Androgens|androgens|mesh-ancestor
851578|NCT02376309|Hormones|hormones|mesh-ancestor
851579|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
851580|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851581|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
2257930|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257931|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257932|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2257933|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2257934|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2257935|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2257936|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257937|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
851945|NCT02374931|Estradiol|estradiol|mesh-list
851946|NCT02374931|Estrogens|estrogens|mesh-ancestor
851947|NCT02374931|Hormones|hormones|mesh-ancestor
849593|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849594|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849595|NCT02386072|Urological Agents|urological agents|mesh-ancestor
849596|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
849597|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
849598|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
849599|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
849600|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850189|NCT02383563|Metformin|metformin|mesh-list
850190|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
850191|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850486|NCT02382146|Dexamethasone|dexamethasone|mesh-list
850487|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
850488|NCT02382146|Ondansetron|ondansetron|mesh-list
850489|NCT02382146|BB 1101|bb 1101|mesh-list
850490|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
850491|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
850492|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
850493|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850494|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850495|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
850496|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
850497|NCT02382146|Hormones|hormones|mesh-ancestor
850498|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850499|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
850500|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850501|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
850502|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850503|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850504|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
850505|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
850506|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
850507|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
850508|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
850509|NCT02382146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
850510|NCT02382146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
850511|NCT02382146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850512|NCT02382146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
850513|NCT02382146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
850614|NCT02381353|Bupivacaine|bupivacaine|mesh-list
850615|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
850616|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
850617|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850618|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850619|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
850620|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850761|NCT02380625|Azithromycin|azithromycin|mesh-list
850762|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
850763|NCT02380625|Sunitinib|sunitinib|mesh-list
850764|NCT02380625|Irbesartan|irbesartan|mesh-list
850765|NCT02380625|Atorvastatin|atorvastatin|mesh-list
850766|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
850767|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
850768|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
850769|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850770|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
850771|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
850772|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850773|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850774|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
850775|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
850776|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
850777|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
850778|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
850779|NCT02380625|Growth Substances|growth substances|mesh-ancestor
850780|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850781|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
850782|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
850783|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
850784|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2257938|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2257939|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257940|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
2257941|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2257942|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2257943|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2257944|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
2257945|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257946|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2257947|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
2257948|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
850192|NCT02383771|Aspirin|aspirin|mesh-list
850193|NCT02383771|Ticagrelor|ticagrelor|mesh-list
850194|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
850195|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
850196|NCT02383771|Analgesics|analgesics|mesh-ancestor
850197|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
850198|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850199|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850200|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
850201|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
850202|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
850203|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
850204|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850205|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
850206|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
850207|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850208|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
850209|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
850210|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
850211|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
850212|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
850213|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
850354|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
850355|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
850356|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
850357|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850398|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
850399|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
850400|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
850401|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
850402|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
850403|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
850404|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850405|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850816|NCT02380118|Midazolam|midazolam|mesh-list
850817|NCT02380118|Haloperidol|haloperidol|mesh-list
850818|NCT02380118|Olanzapine|olanzapine|mesh-list
850819|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
850820|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
850821|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
850822|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850823|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850824|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
850825|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
850826|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
850827|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
850828|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
850829|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
850830|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
850831|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
850832|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
850833|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850834|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
850835|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
850836|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850837|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
850838|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
850839|NCT02380118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
850840|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
850841|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
850842|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
850843|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
850844|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
850845|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
850936|NCT02379546|Desflurane|desflurane|mesh-list
850937|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
850938|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
2257949|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
2257950|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
2754565|NCT00476554|Sapacitabine|sapacitabine|mesh-list
849655|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849818|NCT02385188|Acetaminophen|acetaminophen|mesh-list
849819|NCT02385188|Imiquimod|imiquimod|mesh-list
849820|NCT02385188|Lidocaine|lidocaine|mesh-list
849821|NCT02385188|Petrolatum|petrolatum|mesh-list
849822|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
849823|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
849824|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
849825|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849826|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
849827|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
849828|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
849829|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
849830|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
849831|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
849832|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
849833|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
849834|NCT02385188|Analgesics|analgesics|mesh-ancestor
849835|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
849836|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
849837|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
849838|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
849839|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
849840|NCT02385188|Emollients|emollients|mesh-ancestor
849841|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
850530|NCT02382094|Bicalutamide|bicalutamide|mesh-list
850531|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
850532|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
850533|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850534|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850535|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850621|NCT02381184|Clomiphene|clomiphene|mesh-list
850622|NCT02381184|Enclomiphene|enclomiphene|mesh-list
850623|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
850624|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
850625|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
850626|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850627|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850628|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
850629|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
850630|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
850631|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
850632|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
851448|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
851449|NCT02377076|Calcium|calcium|mesh-list
851450|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
851451|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851452|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
852219|NCT02373241|Losartan|losartan|mesh-list
852220|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
852221|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
852222|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
852223|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
852224|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257951|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2257952|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2257953|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
2257954|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2257955|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2257956|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
2257957|NCT00152750|Clonidine|clonidine|mesh-list
2257958|NCT00152750|Analgesics|analgesics|mesh-ancestor
2257959|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
2257960|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257961|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853033|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
853034|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
853035|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
853036|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853037|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853089|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
853090|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853091|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
853482|NCT02368743|Mesalamine|mesalamine|mesh-list
853483|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
849708|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849998|NCT02384239|Palbociclib|palbociclib|mesh-list
849999|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850000|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
850001|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850002|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257962|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2257963|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
2257964|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
2257965|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2257966|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2257967|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2257968|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
2257969|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2257970|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257971|NCT00152802|Vaccines|vaccines|mesh-list
2257972|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
2257973|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257974|NCT00152815|Vitamin E|vitamin e|mesh-list
2257975|NCT00152815|Antioxidants|antioxidants|mesh-list
850415|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
850416|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
850417|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850418|NCT02382328|Protective Agents|protective agents|mesh-ancestor
850419|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850420|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
850421|NCT02382328|Vitamins|vitamins|mesh-ancestor
850422|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
850514|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
850515|NCT02381964|Vitamins|vitamins|mesh-ancestor
850516|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
850517|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850677|NCT02381145|Resveratrol|resveratrol|mesh-list
850678|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
850679|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850680|NCT02381145|Protective Agents|protective agents|mesh-ancestor
850681|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850682|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850683|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
850859|NCT02379793|Mineral Oil|mineral oil|mesh-list
850860|NCT02379793|Emollients|emollients|mesh-ancestor
850861|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
850942|NCT02379676|Clopidogrel|clopidogrel|mesh-list
850943|NCT02379676|Ticagrelor|ticagrelor|mesh-list
850944|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
850945|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
850946|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
850947|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
850948|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
850949|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
850950|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850951|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851453|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
851454|NCT02376881|Hematinics|hematinics|mesh-ancestor
851469|NCT02376595|Bromides|bromides|mesh-list
851470|NCT02376595|Rocuronium|rocuronium|mesh-list
851471|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
851472|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
851473|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
851474|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
851475|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851476|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851596|NCT02376296|Docetaxel|docetaxel|mesh-list
851597|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851598|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
851599|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
851600|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
851601|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852255|NCT02374567|Topiramate|topiramate|mesh-list
852256|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
852257|NCT02374567|Promethazine|promethazine|mesh-list
852258|NCT02374567|Pregabalin|pregabalin|mesh-list
852259|NCT02374567|Lamotrigine|lamotrigine|mesh-list
852260|NCT02374567|Lacosamide|lacosamide|mesh-list
852261|NCT02374567|Carbamazepine|carbamazepine|mesh-list
852262|NCT02374567|Phenytoin|phenytoin|mesh-list
852263|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
852264|NCT02374567|Nicergoline|nicergoline|mesh-list
852265|NCT02374567|Midazolam|midazolam|mesh-list
2257976|NCT00152815|Vitamins|vitamins|mesh-ancestor
849934|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
849935|NCT02384759|Growth Substances|growth substances|mesh-ancestor
849936|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
849937|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
849938|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850175|NCT02383680|Vaccines|vaccines|mesh-list
850176|NCT02383680|Immunologic Factors|immunologic factors|mesh-ancestor
850177|NCT02383680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850248|NCT02383030|Fulvestrant|fulvestrant|mesh-list
850249|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
850250|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850251|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
850252|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
850253|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
850254|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850255|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850449|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
850450|NCT02382523|Hormones|hormones|mesh-ancestor
850451|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850452|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850732|NCT02380755|Clomiphene|clomiphene|mesh-list
850733|NCT02380755|Enclomiphene|enclomiphene|mesh-list
850734|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
850735|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
850736|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
850737|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850738|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850739|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
850740|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
850741|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
850742|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
850743|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
850808|NCT02380313|Prednisone|prednisone|mesh-list
850809|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
850810|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
850811|NCT02380313|Hormones|hormones|mesh-ancestor
850812|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850813|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850814|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
850815|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851226|NCT02378389|Docetaxel|docetaxel|mesh-list
851227|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851228|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
851229|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
851230|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
851231|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852655|NCT02372604|Cetirizine|cetirizine|mesh-list
852656|NCT02372604|Levocetirizine|levocetirizine|mesh-list
852657|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
852658|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
852659|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
852660|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
852661|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
852662|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852663|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852664|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
852777|NCT02372318|Nalmefene|nalmefene|mesh-list
852778|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
852779|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852780|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
852781|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257977|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
2257978|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257979|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257980|NCT00152815|Protective Agents|protective agents|mesh-ancestor
2257981|NCT00152828|Celecoxib|celecoxib|mesh-list
2257982|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2257983|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2257984|NCT00152828|Analgesics|analgesics|mesh-ancestor
2257985|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
2257986|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2257987|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257988|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
850009|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
850010|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850011|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
850012|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
850013|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
850014|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
850015|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
850016|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257989|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2257990|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2257991|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2257992|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2257993|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2257994|NCT00152841|Vitamin E|vitamin e|mesh-list
2257995|NCT00152841|Vitamins|vitamins|mesh-ancestor
2257996|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
2257997|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2257998|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
2257999|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258000|NCT00152841|Protective Agents|protective agents|mesh-ancestor
2258001|NCT00152854|Acetaminophen|acetaminophen|mesh-list
2258002|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2258003|NCT00152854|Analgesics|analgesics|mesh-ancestor
2258004|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
2258005|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258006|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258007|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
2258008|NCT00152867|Dexamethasone|dexamethasone|mesh-list
2258009|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2258010|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
2258011|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
2258012|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258013|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258014|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2258015|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
2258016|NCT00152867|Hormones|hormones|mesh-ancestor
2258017|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2258018|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2258019|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258020|NCT00152893|Chromium|chromium|mesh-list
2258021|NCT00152893|Niacin|niacin|mesh-list
2258022|NCT00152893|Trace Elements|trace elements|mesh-ancestor
2258023|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
2258024|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850381|NCT02382263|Gemcitabine|gemcitabine|mesh-list
850382|NCT02382263|Paclitaxel|paclitaxel|mesh-list
850383|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
850384|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
850385|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850386|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
850387|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
850388|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
850389|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850390|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
850391|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
850392|NCT02382263|Antiviral Agents|antiviral agents|mesh-ancestor
850393|NCT02382263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
850394|NCT02382263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850395|NCT02382263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
850396|NCT02382263|Immunologic Factors|immunologic factors|mesh-ancestor
850397|NCT02382263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850643|NCT02381158|Beclomethasone|beclomethasone|mesh-list
850644|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
850645|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
850646|NCT02381158|Hormones|hormones|mesh-ancestor
850647|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850648|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850649|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
850650|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
2258025|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2258026|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
2258027|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258028|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2258029|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
2258030|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
2258031|NCT00152893|Vitamins|vitamins|mesh-ancestor
850073|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850074|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
850075|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
850076|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
850077|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
850078|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
850312|NCT02382757|Insulin|insulin|mesh-list
850313|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
850314|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
850315|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850375|NCT02382549|Trametinib|trametinib|mesh-list
850376|NCT02382549|Dabrafenib|dabrafenib|mesh-list
850377|NCT02382549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850378|NCT02382549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
850379|NCT02382549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850380|NCT02382549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850672|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
850673|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
850674|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
850788|NCT02380417|Ropivacaine|ropivacaine|mesh-list
850789|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
850790|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
850791|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850792|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850793|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
850794|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851514|NCT02376452|Leucovorin|leucovorin|mesh-list
851515|NCT02376452|Fluorouracil|fluorouracil|mesh-list
851516|NCT02376452|Raltitrexed|raltitrexed|mesh-list
851517|NCT02376452|Irinotecan|irinotecan|mesh-list
851518|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
851519|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851520|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
851521|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851522|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
851523|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
851524|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851525|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
851526|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
851527|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851528|NCT02376452|Antidotes|antidotes|mesh-ancestor
851529|NCT02376452|Protective Agents|protective agents|mesh-ancestor
851530|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
851531|NCT02376452|Vitamins|vitamins|mesh-ancestor
851532|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
851533|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2099510|NCT02357901|Analgesics|analgesics|mesh-ancestor
2099511|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
2099512|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099513|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2099514|NCT02357979|Fluorides|fluorides|mesh-list
2099515|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
2099516|NCT02357979|Protective Agents|protective agents|mesh-ancestor
2099517|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099518|NCT02358031|Carboplatin|carboplatin|mesh-list
2099519|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
2099520|NCT02358031|Cetuximab|cetuximab|mesh-list
2099521|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099522|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2099523|NCT02358044|Ribavirin|ribavirin|mesh-list
2099524|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
2099525|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2099526|NCT02358044|Grazoprevir|grazoprevir|mesh-list
2099527|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
2099528|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099529|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
2258032|NCT00152919|Meloxicam|meloxicam|mesh-list
2258033|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2258034|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2258035|NCT00152919|Analgesics|analgesics|mesh-ancestor
2258036|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
2258037|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258038|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258039|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
853218|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
853219|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
853220|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2099530|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099531|NCT02358343|Sertraline|sertraline|mesh-list
850104|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
850105|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
850106|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
850107|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850453|NCT02382406|Paclitaxel|paclitaxel|mesh-list
850454|NCT02382406|Carboplatin|carboplatin|mesh-list
850455|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
850456|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
850457|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850458|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
850459|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
850460|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
850461|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850462|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2099532|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
2099533|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
850785|NCT02380573|Methylene Blue|methylene blue|mesh-list
850786|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850787|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850910|NCT02379663|Enoxaparin|enoxaparin|mesh-list
850911|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
850912|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
850913|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
850914|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
850915|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
850916|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850917|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850918|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
850919|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
850920|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2258040|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2258041|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2258042|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2258043|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258044|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258045|NCT00152932|Dorzolamide|dorzolamide|mesh-list
2258046|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2258047|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2258048|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258049|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258050|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2258051|NCT00152945|Glycerol|glycerol|mesh-list
2258052|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2258053|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2258054|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2258055|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2258056|NCT00152945|Protective Agents|protective agents|mesh-ancestor
2258057|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258058|NCT00152958|Pramipexole|pramipexole|mesh-list
2258059|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
2258060|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258061|NCT00152958|Protective Agents|protective agents|mesh-ancestor
2258062|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258063|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2258064|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2258065|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
2258066|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
2258067|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258068|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
2258069|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2258070|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
2258071|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258072|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258073|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
852225|NCT02373254|Acetaminophen|acetaminophen|mesh-list
852226|NCT02373254|Ibuprofen|ibuprofen|mesh-list
852227|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
852228|NCT02373254|Hydrocodone|hydrocodone|mesh-list
852229|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
852230|NCT02373254|Analgesics|analgesics|mesh-ancestor
852231|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
852232|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852233|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852234|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
852235|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2258074|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
2258075|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
2258076|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2258077|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
2258078|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258079|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258080|NCT00152997|Pramipexole|pramipexole|mesh-list
850536|NCT02382029|Clonazepam|clonazepam|mesh-list
850537|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
850538|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
850539|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
850540|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
850541|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850542|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850698|NCT02381080|Voriconazole|voriconazole|mesh-list
850699|NCT02381080|Erythromycin|erythromycin|mesh-list
850700|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
850701|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
850702|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
850703|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
850704|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
850705|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
850706|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
850707|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850708|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850709|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
850710|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
850711|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850712|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850713|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
850714|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
850715|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
850716|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2258081|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
2258082|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258083|NCT00152997|Protective Agents|protective agents|mesh-ancestor
2258084|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258085|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2258086|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2258087|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
2258088|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
2258089|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258090|NCT00153023|Valsartan|valsartan|mesh-list
2258091|NCT00153023|Telmisartan|telmisartan|mesh-list
2258092|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2258093|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2258094|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2258095|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258096|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2258097|NCT00153049|Telmisartan|telmisartan|mesh-list
2258098|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
2258099|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2258100|NCT00153049|Diuretics|diuretics|mesh-ancestor
2258101|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
2258102|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258103|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2258104|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2258105|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851346|NCT02377648|Everolimus|everolimus|mesh-list
851347|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851348|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
851349|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
851350|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851897|NCT02375100|Acetaminophen|acetaminophen|mesh-list
851898|NCT02375100|Tramadol|tramadol|mesh-list
851899|NCT02375100|Analgesics|analgesics|mesh-list
851900|NCT02375100|Bupivacaine|bupivacaine|mesh-list
851901|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
851902|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
851903|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
851904|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851905|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
851906|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851907|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2258106|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2258107|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
850543|NCT02381600|Vitamin D|vitamin d|mesh-list
850544|NCT02381600|Vitamins|vitamins|mesh-ancestor
850545|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
850546|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850547|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
850675|NCT02381028|Emollients|emollients|mesh-list
850676|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
850846|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
850847|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
850848|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
850849|NCT02380001|Analgesics|analgesics|mesh-ancestor
850850|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
850851|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850852|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850853|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
850854|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2258108|NCT00153075|Fenoterol|fenoterol|mesh-list
2258109|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
852676|NCT02372760|Lidocaine|lidocaine|mesh-list
852677|NCT02372760|Anesthetics|anesthetics|mesh-list
852678|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
852679|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
852680|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852681|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
852682|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852683|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
852684|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
852685|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
852686|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
852687|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258110|NCT00153075|Ipratropium|ipratropium|mesh-list
2258111|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2258112|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
2258113|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258114|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258115|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2258116|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
2258117|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
2258118|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
2258119|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2258120|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2258121|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2258122|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
853983|NCT02366819|Leucovorin|leucovorin|mesh-list
853984|NCT02366819|Fluorouracil|fluorouracil|mesh-list
853985|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
853986|NCT02366819|Irinotecan|irinotecan|mesh-list
853987|NCT02366819|Calcium|calcium|mesh-list
853988|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
853989|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
853990|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853991|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
853992|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853993|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
853994|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853995|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
853996|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
853997|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
853998|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
853999|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854000|NCT02366819|Antidotes|antidotes|mesh-ancestor
854001|NCT02366819|Protective Agents|protective agents|mesh-ancestor
854002|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
854003|NCT02366819|Vitamins|vitamins|mesh-ancestor
854004|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
854035|NCT02366481|Vitamins|vitamins|mesh-list
854036|NCT02366481|Vitamin K|vitamin k|mesh-list
854037|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
854038|NCT02366481|Vitamin MK 7|vitamin mk 7|mesh-list
854039|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
854040|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854041|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
854042|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
854043|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854044|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
850414|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
850435|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
850558|NCT02381730|Aflibercept|aflibercept|mesh-list
850559|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
850560|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
850561|NCT02381730|Growth Substances|growth substances|mesh-ancestor
850562|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850563|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
850564|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850795|NCT02380352|Amoxicillin|amoxicillin|mesh-list
850796|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
850797|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
851039|NCT02379026|Vitamin D|vitamin d|mesh-list
851040|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
851041|NCT02379026|Vitamins|vitamins|mesh-ancestor
851042|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
851043|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851044|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
851045|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2258123|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
2258124|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258125|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258126|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2258127|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
2258128|NCT00153088|Telmisartan|telmisartan|mesh-list
2258129|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
851869|NCT02375178|Biguanides|biguanides|mesh-list
851870|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
851871|NCT02375178|Polihexanide|polihexanide|mesh-list
851872|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
851873|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
851874|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
851875|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
851876|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852140|NCT02373449|Ketamine|ketamine|mesh-list
852141|NCT02373449|Analgesics|analgesics|mesh-ancestor
852142|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
852143|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852144|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852145|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
852146|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
852147|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
852148|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
852149|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
852150|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
852151|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
852152|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
852153|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852510|NCT02373280|Amoxicillin|amoxicillin|mesh-list
852511|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
852512|NCT02373280|Metronidazole|metronidazole|mesh-list
852513|NCT02373280|Clarithromycin|clarithromycin|mesh-list
852514|NCT02373280|Esomeprazole|esomeprazole|mesh-list
852515|NCT02373280|Bismuth|bismuth|mesh-list
852516|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
852517|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
852518|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
852519|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
852520|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
852521|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852522|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852523|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850473|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
850474|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
850475|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
850476|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
850477|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850478|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
850479|NCT02382432|Narcotics|narcotics|mesh-ancestor
850480|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
850637|NCT02381548|Belinostat|belinostat|mesh-list
850638|NCT02381548|Adavosertib|adavosertib|mesh-list
850639|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850640|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850641|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
850642|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
851299|NCT02377856|Interferons|interferons|mesh-list
851300|NCT02377856|Ribavirin|ribavirin|mesh-list
851301|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
851302|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
851303|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
851304|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851305|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
851306|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
851307|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
851308|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851309|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
851310|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851359|NCT02377635|Selenious Acid|selenious acid|mesh-list
851360|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
851361|NCT02377635|Trace Elements|trace elements|mesh-ancestor
851362|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
851363|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851593|NCT02376374|Vaccines|vaccines|mesh-list
851594|NCT02376374|Immunologic Factors|immunologic factors|mesh-ancestor
851595|NCT02376374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851829|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
851830|NCT02375217|Neostigmine|neostigmine|mesh-list
851831|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
851832|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851833|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851834|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
851835|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
851836|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851837|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
851838|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
851839|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851840|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
851841|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
851842|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
851863|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
851864|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
851865|NCT02375191|Narcotics|narcotics|mesh-ancestor
851866|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
851867|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
851868|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
2258130|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2258131|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2258132|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258133|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2258134|NCT00153114|Laxatives|laxatives|mesh-ancestor
852003|NCT02374008|Dexamethasone|dexamethasone|mesh-list
852004|NCT02374008|Ketorolac|ketorolac|mesh-list
852005|NCT02374008|Ropivacaine|ropivacaine|mesh-list
852006|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
852007|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
852008|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
852009|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852010|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852011|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
852012|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
852013|NCT02374008|Hormones|hormones|mesh-ancestor
852014|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
852015|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
852016|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
852017|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852018|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852019|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
852020|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
850520|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
850521|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
850522|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
850523|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850524|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850525|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
850526|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
850527|NCT02382068|Hormones|hormones|mesh-ancestor
850528|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850529|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
850600|NCT02381275|Tenofovir|tenofovir|mesh-list
850601|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
850602|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
850603|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
850604|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
850605|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850606|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850607|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
850608|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
850748|NCT02380521|Exenatide|exenatide|mesh-list
850749|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
850750|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850751|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
850752|NCT02380521|Incretins|incretins|mesh-ancestor
850753|NCT02380521|Hormones|hormones|mesh-ancestor
850754|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850995|NCT02379377|Fluorides|fluorides|mesh-list
850996|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
850997|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
850998|NCT02379377|Protective Agents|protective agents|mesh-ancestor
850999|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851000|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
851001|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851168|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
851169|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
851170|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
851171|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
851172|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851173|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851174|NCT02378649|Urological Agents|urological agents|mesh-ancestor
851262|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
851263|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
851264|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
851265|NCT02378298|Prednisolone|prednisolone|mesh-list
851266|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
851267|NCT02378298|Rituximab|rituximab|mesh-list
851268|NCT02378298|Methotrexate|methotrexate|mesh-list
851269|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
851270|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
851271|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
851272|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851273|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
851274|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851275|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
851276|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
851277|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
851278|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
851279|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
851280|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
851281|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851282|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
851283|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851284|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
851285|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
851286|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
851287|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
851288|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
851289|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
851290|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851291|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
851292|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
851293|NCT02378298|Hormones|hormones|mesh-ancestor
851294|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
851295|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
851296|NCT02378298|Protective Agents|protective agents|mesh-ancestor
850567|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
850568|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
850569|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850570|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850571|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
850572|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850573|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
850574|NCT02381717|Narcotics|narcotics|mesh-ancestor
850575|NCT02381717|Analgesics|analgesics|mesh-ancestor
850898|NCT02379715|Remifentanil|remifentanil|mesh-list
850899|NCT02379715|Desflurane|desflurane|mesh-list
850900|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
850901|NCT02379715|Narcotics|narcotics|mesh-ancestor
850902|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850903|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850904|NCT02379715|Analgesics|analgesics|mesh-ancestor
850905|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
850906|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850907|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
850908|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
850909|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
850978|NCT02379299|Hormones|hormones|mesh-list
850979|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
850980|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851298|NCT02377895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
851908|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
851909|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
851910|NCT02375100|Narcotics|narcotics|mesh-ancestor
851954|NCT02374645|Gefitinib|gefitinib|mesh-list
851955|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851956|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
851957|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851958|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852497|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
852498|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
852499|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
852500|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852501|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852502|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
852630|NCT02372461|Amoxicillin|amoxicillin|mesh-list
852631|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
852632|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
852671|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
852672|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852673|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
852674|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
852675|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852750|NCT02372292|Furosemide|furosemide|mesh-list
852751|NCT02372292|Diuretics|diuretics|mesh-ancestor
852752|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
852753|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852754|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
852755|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
852756|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258135|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2258136|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2258137|NCT00153127|Laxatives|laxatives|mesh-ancestor
2258138|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
852911|NCT02371603|Trimethoprim|trimethoprim|mesh-list
852912|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
852913|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
852914|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
852915|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
852916|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852917|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
852918|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
852919|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852920|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
852921|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852922|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
852923|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
852924|NCT02371603|Renal Agents|renal agents|mesh-ancestor
852925|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
852926|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
852927|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
852928|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2258139|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2258140|NCT00153140|Laxatives|laxatives|mesh-ancestor
2258141|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2258142|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2258143|NCT00153153|Laxatives|laxatives|mesh-ancestor
2258144|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2258145|NCT00153192|Dronabinol|dronabinol|mesh-list
2258146|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
2258147|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851413|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
851414|NCT02377388|Saxagliptin|saxagliptin|mesh-list
851415|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
851416|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851417|NCT02377388|Incretins|incretins|mesh-ancestor
851418|NCT02377388|Hormones|hormones|mesh-ancestor
851419|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
851420|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
851421|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
851422|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851423|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851462|NCT02376972|Rifaximin|rifaximin|mesh-list
851463|NCT02376972|Metronidazole|metronidazole|mesh-list
851464|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
851465|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
851466|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
851467|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
851468|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
851619|NCT02376088|Methimazole|methimazole|mesh-list
851620|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
851621|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
851622|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
851623|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851942|NCT02374853|Vancomycin|vancomycin|mesh-list
851943|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
851944|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
851948|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
851949|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851964|NCT02374320|Bupivacaine|bupivacaine|mesh-list
851965|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
851966|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
851967|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
851968|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851969|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
851970|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852185|NCT02373579|Methotrexate|methotrexate|mesh-list
852186|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
852187|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
852188|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
852189|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852190|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
852191|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
852192|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852193|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
852194|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
852195|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852196|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
852197|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
852198|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
852199|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
852200|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
852447|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
852448|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
852492|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
852493|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
852494|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852495|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
852496|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852665|NCT02372656|Metformin|metformin|mesh-list
852666|NCT02372656|Simvastatin|simvastatin|mesh-list
852667|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
852668|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852669|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
852670|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2258148|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2258149|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
850747|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
851141|NCT02378623|Apixaban|apixaban|mesh-list
851142|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
851143|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
851144|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
851145|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
851146|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851147|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851148|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
2258150|NCT00153192|Analgesics|analgesics|mesh-ancestor
2258151|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
2258152|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258153|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2258154|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2258155|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
851409|NCT02377271|Bosentan|bosentan|mesh-list
851410|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
851411|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
851412|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258156|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258157|NCT00153192|Hormones|hormones|mesh-ancestor
2258158|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
851795|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
851796|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
851797|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
851798|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851799|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
851800|NCT02375243|Analgesics|analgesics|mesh-ancestor
851801|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
851802|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851803|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
851804|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
851805|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
851806|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
851807|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
851808|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851961|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
851962|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851963|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851971|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
851972|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
851973|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258159|NCT00153244|Lamotrigine|lamotrigine|mesh-list
2258160|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
2258161|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2258162|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2258163|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258164|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2258165|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258166|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2258167|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2258168|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2258169|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2258170|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2258171|NCT00153270|Valproic Acid|valproic acid|mesh-list
2258172|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
2258173|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258174|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258175|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
2258176|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258177|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258178|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
2258179|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2258180|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2258181|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2258182|NCT00153283|Gabapentin|gabapentin|mesh-list
2258183|NCT00153283|Analgesics|analgesics|mesh-ancestor
2258184|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
2258185|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852441|NCT02373033|Folic Acid|folic acid|mesh-list
852442|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
852443|NCT02373033|Hematinics|hematinics|mesh-ancestor
852444|NCT02373033|Vitamins|vitamins|mesh-ancestor
852445|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
850865|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
850866|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
850867|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
850868|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850869|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
850870|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
850871|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
850872|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
850873|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
850874|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850875|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
850876|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
850877|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
2258186|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258187|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
2258188|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2258189|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2258190|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2258191|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2258192|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2258193|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2258194|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258195|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258196|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
2258197|NCT00153296|Carbamazepine|carbamazepine|mesh-list
2258198|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
2258199|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
2258200|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2258201|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2258202|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258203|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2258204|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2258205|NCT00153296|Analgesics|analgesics|mesh-ancestor
2258206|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
2258207|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258208|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
851624|NCT02376192|Phenylephrine|phenylephrine|mesh-list
851625|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
851626|NCT02376192|Ephedrine|ephedrine|mesh-list
851627|NCT02376192|Bupivacaine|bupivacaine|mesh-list
851628|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
851629|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
851630|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
851631|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851632|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
851633|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851634|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
851635|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
851636|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
851637|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
851638|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
851639|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
851640|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
851641|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
851642|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
851643|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
851644|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
851645|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
851646|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851647|NCT02376192|Protective Agents|protective agents|mesh-ancestor
851648|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
852021|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
852022|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
852023|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
852024|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
852025|NCT02374008|Analgesics|analgesics|mesh-ancestor
852026|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
852027|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
852154|NCT02373514|Acetaminophen|acetaminophen|mesh-list
852155|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
852156|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
852157|NCT02373514|Analgesics|analgesics|mesh-ancestor
852158|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
852159|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852160|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
850921|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
850922|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
850923|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
850924|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
850925|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
850926|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
850927|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
850928|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
851196|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
851197|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851198|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851199|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851200|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
851311|NCT02378129|Methamphetamine|methamphetamine|mesh-list
851312|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
851313|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851314|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
851315|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
851316|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851317|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
851318|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
851319|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851320|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
851321|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
851322|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
851323|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
851324|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
851433|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
851434|NCT02377193|Tacrolimus|tacrolimus|mesh-list
851435|NCT02377193|Basiliximab|basiliximab|mesh-list
851436|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
851437|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
851438|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851439|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
851440|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851441|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851442|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
851443|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851444|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
851445|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
851446|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
851447|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258209|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2258210|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258211|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2258212|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2258213|NCT00153491|Lumefantrine|lumefantrine|mesh-list
2258214|NCT00153491|Artemether|artemether|mesh-list
2258215|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2258216|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
2258217|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2258218|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2258219|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258220|NCT00153517|Metronidazole|metronidazole|mesh-list
2258221|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258222|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2258223|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2258224|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2258225|NCT00153530|Methotrexate|methotrexate|mesh-list
2258226|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2258227|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
2258228|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2258229|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258230|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2258231|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
2258232|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258233|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
852161|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
852162|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
852163|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
852164|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
852165|NCT02373384|Allopurinol|allopurinol|mesh-list
852166|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
2258234|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
850939|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
850940|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
850941|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754566|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754567|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
2754568|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2754569|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754570|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2754571|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754572|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754573|NCT00454753|Dasatinib|dasatinib|mesh-list
2754574|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754575|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2754576|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754577|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754578|NCT00372073|Roscovitine|roscovitine|mesh-list
2754579|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754580|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
2754581|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2754582|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2754583|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754584|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258235|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258236|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2258237|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2258238|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
2258239|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2258240|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2258241|NCT00153543|Vaccines|vaccines|mesh-list
2258242|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2258243|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
2258244|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258245|NCT00153556|Vaccines|vaccines|mesh-list
2258246|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
2258247|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258248|NCT00153634|Azithromycin|azithromycin|mesh-list
2258249|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
2258250|NCT00153634|Meropenem|meropenem|mesh-list
2258251|NCT00153634|Tazobactam|tazobactam|mesh-list
2258252|NCT00153634|Piperacillin|piperacillin|mesh-list
2258253|NCT00153634|Tobramycin|tobramycin|mesh-list
2258254|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
852167|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852168|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
852169|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852170|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
852171|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
852172|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
852173|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
852174|NCT02373384|Protective Agents|protective agents|mesh-ancestor
852175|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852176|NCT02373384|Diuretics|diuretics|mesh-ancestor
852177|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
852178|NCT02373384|Expectorants|expectorants|mesh-ancestor
852179|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
852503|NCT02372916|Ranibizumab|ranibizumab|mesh-list
852504|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
852505|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
852506|NCT02372916|Growth Substances|growth substances|mesh-ancestor
852507|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852508|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
852509|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
852613|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
852614|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852615|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
852616|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
852617|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
852618|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852619|NCT02372487|Urological Agents|urological agents|mesh-ancestor
852701|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852738|NCT02372240|Dexamethasone|dexamethasone|mesh-list
852739|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
852740|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
852741|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
852742|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258255|NCT00153634|Amikacin|amikacin|mesh-list
2258256|NCT00153634|Ceftazidime|ceftazidime|mesh-list
2258257|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2258258|NCT00153634|Ticarcillin|ticarcillin|mesh-list
2258259|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
2258260|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2258261|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258262|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2258263|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2258264|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258265|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258266|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258267|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
851751|NCT02375646|Heparin|heparin|mesh-list
851752|NCT02375646|Enoxaparin|enoxaparin|mesh-list
851753|NCT02375646|Warfarin|warfarin|mesh-list
851754|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
851755|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
851756|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
851757|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852211|NCT02373215|Nalbuphine|nalbuphine|mesh-list
852212|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
852213|NCT02373215|Narcotics|narcotics|mesh-ancestor
852214|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
852215|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852216|NCT02373215|Analgesics|analgesics|mesh-ancestor
852217|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
852218|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852472|NCT02372942|Progesterone|progesterone|mesh-list
852473|NCT02372942|Progestins|progestins|mesh-ancestor
852474|NCT02372942|Hormones|hormones|mesh-ancestor
852475|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
852476|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852743|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852744|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
852745|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
852746|NCT02372240|Hormones|hormones|mesh-ancestor
852747|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
852748|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
852749|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
852813|NCT02372409|Doxorubicin|doxorubicin|mesh-list
852814|NCT02372409|Etoposide|etoposide|mesh-list
852815|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
852816|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
852817|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
852818|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
852819|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
852820|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852821|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852822|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
852858|NCT02371993|Choline|choline|mesh-list
852859|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
852860|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
852861|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
852862|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852863|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
852864|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
852865|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
2258268|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2258269|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2258270|NCT00153660|Celecoxib|celecoxib|mesh-list
2258271|NCT00153660|Naproxen|naproxen|mesh-list
2258272|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2258273|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2258274|NCT00153660|Analgesics|analgesics|mesh-ancestor
2258275|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
2258276|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258277|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258278|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2258279|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2258280|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2258281|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2258282|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258283|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852929|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
852930|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2258284|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
2258285|NCT00153673|Celecoxib|celecoxib|mesh-list
2258286|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2258287|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2258288|NCT00153673|Analgesics|analgesics|mesh-ancestor
2258289|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
2258290|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258291|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258292|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2258293|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2258294|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2258295|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2258296|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258297|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258298|NCT00153699|Topiramate|topiramate|mesh-list
2258299|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
2258300|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2258301|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258302|NCT00153725|Aspirin|aspirin|mesh-list
2258303|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
852106|NCT02373735|Mannitol|mannitol|mesh-list
852107|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
852108|NCT02373735|Diuretics|diuretics|mesh-ancestor
852109|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
852110|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852204|NCT02373410|Bupivacaine|bupivacaine|mesh-list
852205|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
852206|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
852207|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
852208|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852209|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
852210|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852236|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
852237|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
852238|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
852239|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852240|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852241|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
852242|NCT02373254|Narcotics|narcotics|mesh-ancestor
852243|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
852244|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
852245|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
852455|NCT02372903|Palmidrol|palmidrol|mesh-list
852456|NCT02372903|Analgesics|analgesics|mesh-ancestor
852457|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
852458|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852459|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852460|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
852461|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
852462|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
852463|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
852464|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
852465|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
852466|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
852467|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
852468|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
852469|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852470|NCT02372903|Hormones|hormones|mesh-ancestor
852471|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
852782|NCT02372357|Posaconazole|posaconazole|mesh-list
852783|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
852784|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
852785|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
852786|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
852787|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
852788|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
852789|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
852790|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852791|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852792|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
852793|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
852794|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
852795|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754585|NCT00364637|Anesthetics|anesthetics|mesh-list
2258304|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
851364|NCT02377661|Amlodipine|amlodipine|mesh-list
851365|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
851366|NCT02377661|Olmesartan|olmesartan|mesh-list
851367|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
851368|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
851369|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
851370|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
851371|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851372|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
851373|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851374|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
851375|NCT02377661|Diuretics|diuretics|mesh-ancestor
851376|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
851377|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
851378|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
851379|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
851460|NCT02376803|Warfarin|warfarin|mesh-list
851461|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
2258305|NCT00153725|Analgesics|analgesics|mesh-ancestor
2258306|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
2258307|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852266|NCT02374567|Diazepam|diazepam|mesh-list
852267|NCT02374567|Triazolam|triazolam|mesh-list
852268|NCT02374567|Acamprosate|acamprosate|mesh-list
852269|NCT02374567|Gabapentin|gabapentin|mesh-list
852270|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
852271|NCT02374567|Amitriptyline|amitriptyline|mesh-list
852272|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
852273|NCT02374567|Levetiracetam|levetiracetam|mesh-list
852274|NCT02374567|Valproic Acid|valproic acid|mesh-list
852275|NCT02374567|Lorazepam|lorazepam|mesh-list
852276|NCT02374567|Clonazepam|clonazepam|mesh-list
852277|NCT02374567|Phenobarbital|phenobarbital|mesh-list
852278|NCT02374567|Clobazam|clobazam|mesh-list
852279|NCT02374567|Zaleplon|zaleplon|mesh-list
852280|NCT02374567|Nitrazepam|nitrazepam|mesh-list
852281|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
852282|NCT02374567|Memantine|memantine|mesh-list
852283|NCT02374567|Biperiden|biperiden|mesh-list
852284|NCT02374567|Haloperidol|haloperidol|mesh-list
852285|NCT02374567|Pimozide|pimozide|mesh-list
852286|NCT02374567|Olanzapine|olanzapine|mesh-list
852287|NCT02374567|Zolpidem|zolpidem|mesh-list
852288|NCT02374567|Alprazolam|alprazolam|mesh-list
852289|NCT02374567|Zopiclone|zopiclone|mesh-list
852290|NCT02374567|S 20098|s 20098|mesh-list
852291|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
852292|NCT02374567|Doxepin|doxepin|mesh-list
852293|NCT02374567|Oxazepam|oxazepam|mesh-list
852294|NCT02374567|Temazepam|temazepam|mesh-list
852295|NCT02374567|Brotizolam|brotizolam|mesh-list
852296|NCT02374567|Lormetazepam|lormetazepam|mesh-list
852297|NCT02374567|Flurazepam|flurazepam|mesh-list
852298|NCT02374567|Mirtazapine|mirtazapine|mesh-list
852299|NCT02374567|Buspirone|buspirone|mesh-list
852300|NCT02374567|Trazodone|trazodone|mesh-list
852301|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
852302|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
852303|NCT02374567|Bromazepam|bromazepam|mesh-list
852304|NCT02374567|Risperidone|risperidone|mesh-list
852305|NCT02374567|Melatonin|melatonin|mesh-list
852306|NCT02374567|Aripiprazole|aripiprazole|mesh-list
852307|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
852308|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
852309|NCT02374567|Ziprasidone|ziprasidone|mesh-list
852310|NCT02374567|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
852311|NCT02374567|Clozapine|clozapine|mesh-list
852312|NCT02374567|Amisulpride|amisulpride|mesh-list
852313|NCT02374567|Flupenthixol|flupenthixol|mesh-list
852314|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
852315|NCT02374567|Perphenazine|perphenazine|mesh-list
852316|NCT02374567|Sertindole|sertindole|mesh-list
852317|NCT02374567|Fluphenazine|fluphenazine|mesh-list
852318|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
852319|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
852320|NCT02374567|Sulpiride|sulpiride|mesh-list
852321|NCT02374567|Thioridazine|thioridazine|mesh-list
852322|NCT02374567|Clopenthixol|clopenthixol|mesh-list
852323|NCT02374567|Pipamperone|pipamperone|mesh-list
852324|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
852325|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
852326|NCT02374567|Fluspirilene|fluspirilene|mesh-list
852327|NCT02374567|Perazine|perazine|mesh-list
852328|NCT02374567|Bromperidol|bromperidol|mesh-list
852329|NCT02374567|Benperidol|benperidol|mesh-list
852330|NCT02374567|Rivastigmine|rivastigmine|mesh-list
852331|NCT02374567|Piracetam|piracetam|mesh-list
852332|NCT02374567|Donepezil|donepezil|mesh-list
852333|NCT02374567|Galantamine|galantamine|mesh-list
2754586|NCT00364637|Sevoflurane|sevoflurane|mesh-list
851149|NCT02378740|Ketamine|ketamine|mesh-list
851150|NCT02378740|Analgesics|analgesics|mesh-ancestor
851151|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
851152|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851153|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851154|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
851155|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
851156|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
851157|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
851158|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
851159|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
851160|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
851161|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
851162|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851201|NCT02378415|Ketamine|ketamine|mesh-list
851202|NCT02378415|Analgesics|analgesics|mesh-ancestor
851203|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
851204|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851205|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851206|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
851207|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
851208|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
851209|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
851210|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
851211|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
851212|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
851213|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
851214|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851511|NCT02376413|Trastuzumab|trastuzumab|mesh-list
851512|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
851513|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851758|NCT02375464|Octreotide|octreotide|mesh-list
851759|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
851760|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
851761|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
852334|NCT02374567|Citalopram|citalopram|mesh-list
852335|NCT02374567|Bupropion|bupropion|mesh-list
852336|NCT02374567|Sertraline|sertraline|mesh-list
852337|NCT02374567|Fluoxetine|fluoxetine|mesh-list
852338|NCT02374567|Paroxetine|paroxetine|mesh-list
852339|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
852340|NCT02374567|Nortriptyline|nortriptyline|mesh-list
852341|NCT02374567|Reboxetine|reboxetine|mesh-list
852342|NCT02374567|Imipramine|imipramine|mesh-list
852343|NCT02374567|Clomipramine|clomipramine|mesh-list
852344|NCT02374567|Mianserin|mianserin|mesh-list
852345|NCT02374567|Moclobemide|moclobemide|mesh-list
852346|NCT02374567|Opipramol|opipramol|mesh-list
852347|NCT02374567|Maprotiline|maprotiline|mesh-list
852348|NCT02374567|Trimipramine|trimipramine|mesh-list
852349|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
852350|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
852351|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
852352|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
852353|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852354|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
852355|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
852356|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
852357|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
852358|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
852359|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
852360|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
852361|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
852362|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
852363|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852364|NCT02374567|Analgesics|analgesics|mesh-ancestor
852365|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
852366|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852367|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
852368|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
852369|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
852370|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
852371|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
852372|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
852373|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
852374|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
852375|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
852376|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
853065|NCT02370680|Aspirin|aspirin|mesh-list
2258308|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258309|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2258310|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2258311|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2258312|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2258313|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258314|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2258315|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2258316|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258317|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
2258318|NCT00153764|Vitamins|vitamins|mesh-list
2258319|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
2754587|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2754588|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754589|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2754590|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2754591|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
2754592|NCT00310180|Tamoxifen|tamoxifen|mesh-list
2754593|NCT00310180|Letrozole|letrozole|mesh-list
2754594|NCT00310180|Anastrozole|anastrozole|mesh-list
2754595|NCT00310180|Exemestane|exemestane|mesh-list
2754596|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754597|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754598|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2754599|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2754600|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754601|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2754602|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
2754603|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2754604|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851911|NCT02375022|Endostar protein|endostar protein|mesh-list
851912|NCT02375022|Endostatins|endostatins|mesh-list
851913|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
851914|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
851915|NCT02375022|Growth Substances|growth substances|mesh-ancestor
851916|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851917|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
851918|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
852028|NCT02373943|Carotenoids|carotenoids|mesh-list
852029|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
852030|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852031|NCT02373943|Protective Agents|protective agents|mesh-ancestor
852032|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852246|NCT02373722|Petrolatum|petrolatum|mesh-list
852247|NCT02373722|Mineral Oil|mineral oil|mesh-list
852248|NCT02373722|Emollients|emollients|mesh-ancestor
852249|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
852377|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
852378|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
852379|NCT02374567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
852380|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
852381|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
852382|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
852383|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
852384|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
852385|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
852386|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
852387|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
852388|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
852389|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
852390|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
852391|NCT02374567|Protective Agents|protective agents|mesh-ancestor
852392|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
852393|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
852394|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
852395|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
852396|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
852397|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852398|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
852399|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
852400|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
852401|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
852402|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
852403|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
852404|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
851297|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
851843|NCT02375139|Metformin|metformin|mesh-list
851844|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
851845|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852180|NCT02373462|Olmesartan|olmesartan|mesh-list
852181|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
852182|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
852183|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
852184|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852405|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
852406|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
852407|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
852408|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
852409|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
852410|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
852411|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
852412|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
852413|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
852414|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
852415|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
852416|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
852417|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
852418|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
852419|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
852420|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
852421|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
852422|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
852423|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
852424|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
852425|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
852426|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
852427|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
852428|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
852429|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
852430|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
852431|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
852432|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
852433|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
852434|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
852435|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
852436|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
852437|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
852438|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
852439|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
852440|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
2258320|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258321|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
2258322|NCT00153868|Hematinics|hematinics|mesh-ancestor
2258323|NCT00153881|Carboplatin|carboplatin|mesh-list
2258324|NCT00153881|Docetaxel|docetaxel|mesh-list
2258325|NCT00153881|Capecitabine|capecitabine|mesh-list
2258326|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258327|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
2258328|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
2258329|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
2258330|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258331|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2258332|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
2258333|NCT00153907|Capecitabine|capecitabine|mesh-list
2258334|NCT00153907|Vinorelbine|vinorelbine|mesh-list
2258335|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2258336|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
2258337|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258338|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258339|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2258340|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
2258341|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
2258342|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
2258343|NCT00153933|Lenalidomide|lenalidomide|mesh-list
2258344|NCT00153933|Bortezomib|bortezomib|mesh-list
2258345|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
2258346|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258347|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2258348|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2258349|NCT00153933|Growth Substances|growth substances|mesh-ancestor
851357|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
851358|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851477|NCT02376478|Folic Acid|folic acid|mesh-list
851478|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
851479|NCT02376478|Adalimumab|adalimumab|mesh-list
851480|NCT02376478|Etanercept|etanercept|mesh-list
851481|NCT02376478|Methotrexate|methotrexate|mesh-list
851482|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
851483|NCT02376478|Infliximab|infliximab|mesh-list
851484|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
851485|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
851486|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
851487|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
851488|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851489|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
851490|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
851491|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851492|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851493|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
851494|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851495|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
851496|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
851497|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
851498|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
851499|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
851500|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
851501|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
851502|NCT02376478|Analgesics|analgesics|mesh-ancestor
851503|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
851504|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851505|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
851506|NCT02376478|Hematinics|hematinics|mesh-ancestor
851507|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
851508|NCT02376478|Vitamins|vitamins|mesh-ancestor
851509|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
851510|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258350|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
2258351|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258352|NCT00153946|Edaravone|edaravone|mesh-list
2258353|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2258354|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
2258355|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258356|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2258357|NCT00153946|Protective Agents|protective agents|mesh-ancestor
2258358|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258359|NCT00153972|Levodopa|levodopa|mesh-list
2258360|NCT00153972|Cabergoline|cabergoline|mesh-list
2258361|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2258362|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2258363|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
2258364|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258365|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258366|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852446|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852620|NCT02372669|Chitosan|chitosan|mesh-list
852621|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
852622|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
852623|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
852624|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852625|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
852626|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
852627|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
852628|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
852629|NCT02372669|Coagulants|coagulants|mesh-ancestor
2258367|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
2258368|NCT00153998|Leucovorin|leucovorin|mesh-list
2258369|NCT00153998|Folic Acid|folic acid|mesh-list
2258370|NCT00153998|Fluorouracil|fluorouracil|mesh-list
2258371|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
2258372|NCT00153998|Irinotecan|irinotecan|mesh-list
2258373|NCT00153998|Cetuximab|cetuximab|mesh-list
2258374|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
2258375|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
2258376|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258377|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2258378|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258379|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2258380|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
2258381|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851430|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851431|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
851432|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
851602|NCT02376205|Bupivacaine|bupivacaine|mesh-list
851603|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
851604|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
851605|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
851606|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
851607|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851608|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
851609|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851696|NCT02375828|Glyburide|glyburide|mesh-list
851697|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
851698|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851950|NCT02374632|Octreotide|octreotide|mesh-list
851951|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
851952|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
851953|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851974|NCT02374242|Nivolumab|nivolumab|mesh-list
851975|NCT02374242|Ipilimumab|ipilimumab|mesh-list
851976|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
851977|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851978|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
851979|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258382|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2258383|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2258384|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258385|NCT00153998|Antidotes|antidotes|mesh-ancestor
2258386|NCT00153998|Protective Agents|protective agents|mesh-ancestor
2258387|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
852758|NCT02372630|Linagliptin|linagliptin|mesh-list
852768|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
852769|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852770|NCT02372630|Incretins|incretins|mesh-ancestor
852771|NCT02372630|Hormones|hormones|mesh-ancestor
852772|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
852773|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
852774|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
852775|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852776|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258388|NCT00153998|Vitamins|vitamins|mesh-ancestor
2258389|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
2258390|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2258391|NCT00153998|Hematinics|hematinics|mesh-ancestor
2258392|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
2258393|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2258394|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258395|NCT00154024|Irbesartan|irbesartan|mesh-list
2258396|NCT00154024|Atorvastatin|atorvastatin|mesh-list
2258397|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2258398|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2258399|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
2258400|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258401|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2258402|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2258403|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258404|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2258405|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2258406|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
852931|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
852932|NCT02371590|Lenalidomide|lenalidomide|mesh-list
852933|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
852934|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
852935|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852936|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
852937|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
852938|NCT02371590|Growth Substances|growth substances|mesh-ancestor
852939|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
852940|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
852941|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
852952|NCT02371473|Acetazolamide|acetazolamide|mesh-list
852953|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
852954|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2258407|NCT00154037|Pioglitazone|pioglitazone|mesh-list
2258408|NCT00154037|Candesartan|candesartan|mesh-list
2258409|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
851694|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851695|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852033|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
852034|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
852035|NCT02374021|Adalimumab|adalimumab|mesh-list
852036|NCT02374021|Etanercept|etanercept|mesh-list
852037|NCT02374021|Methotrexate|methotrexate|mesh-list
852038|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
852039|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
852040|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
852041|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852042|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
852043|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
852044|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852045|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
852046|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
852047|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852048|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
852049|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
852050|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
852051|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
852052|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
852053|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
852054|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
852055|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
852056|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
852057|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
852058|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
852059|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
852060|NCT02374021|Analgesics|analgesics|mesh-ancestor
852061|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
852062|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852063|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2258410|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258411|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
852487|NCT02373163|Diuretics|diuretics|mesh-ancestor
852488|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
852489|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
852490|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
852491|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
852643|NCT02372812|Dexamethasone|dexamethasone|mesh-list
852644|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
852645|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
852646|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
852647|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852648|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852649|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
852650|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
852651|NCT02372812|Hormones|hormones|mesh-ancestor
852652|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
852653|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
852654|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
852702|NCT02372526|Orlistat|orlistat|mesh-list
852703|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852704|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852705|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
852706|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
852796|NCT02372188|Caffeine|caffeine|mesh-list
852797|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
852798|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852799|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
852800|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852801|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852802|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
852803|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
852804|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
852805|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
852851|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
852852|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
852853|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
852854|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852855|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
852856|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
852910|NCT02371603|Pioglitazone|pioglitazone|mesh-list
2258412|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2258413|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2258414|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258415|NCT00154050|Candesartan|candesartan|mesh-list
2258416|NCT00154050|Quinapril|quinapril|mesh-list
852524|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
852525|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
852526|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
852527|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852528|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
852529|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
852530|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
852531|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
852532|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
852533|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
852534|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
852535|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
852536|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
852537|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
852538|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
852539|NCT02373280|Antacids|antacids|mesh-ancestor
852707|NCT02372578|Pregabalin|pregabalin|mesh-list
852708|NCT02372578|Analgesics|analgesics|mesh-ancestor
852709|NCT02372578|Sensory System Agents|sensory system agents|mesh-ancestor
852710|NCT02372578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852711|NCT02372578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852712|NCT02372578|Anticonvulsants|anticonvulsants|mesh-ancestor
852713|NCT02372578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
852714|NCT02372578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
852715|NCT02372578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852716|NCT02372578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
852717|NCT02372578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
852718|NCT02372578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
852719|NCT02372578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
852720|NCT02372578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
852806|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
852807|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
852808|NCT02372149|Antibodies|antibodies|mesh-list
852809|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
852810|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
852811|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
852812|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852857|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
852903|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
852904|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852905|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
852906|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
852907|NCT02371577|Growth Substances|growth substances|mesh-ancestor
852908|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
852909|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
852942|NCT02371421|Allopurinol|allopurinol|mesh-list
852943|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
852944|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852945|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852946|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
852947|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
852948|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
852949|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
852950|NCT02371421|Protective Agents|protective agents|mesh-ancestor
852951|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852955|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852956|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852957|NCT02371473|Diuretics|diuretics|mesh-ancestor
852958|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
852959|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258417|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2258418|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2258419|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2258420|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258421|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2258422|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
2258423|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258424|NCT00154076|Topiramate|topiramate|mesh-list
852996|NCT02371226|Insulin|insulin|mesh-list
851729|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
851730|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
851731|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851732|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
851733|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
851734|NCT02375867|Hormones|hormones|mesh-ancestor
851735|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
851736|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
851737|NCT02375867|Protective Agents|protective agents|mesh-ancestor
851738|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
851739|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
852098|NCT02374047|Atorvastatin|atorvastatin|mesh-list
852099|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
852100|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
852101|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
852102|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852103|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
852104|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
852105|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258425|NCT00154076|Zonisamide|zonisamide|mesh-list
2258426|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
2258427|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2258428|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258429|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2258430|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2258431|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258432|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2258433|NCT00154089|Masoprocol|masoprocol|mesh-list
2258434|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
2258435|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258436|NCT00154089|Protective Agents|protective agents|mesh-ancestor
2258437|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258438|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2258439|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258440|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2258441|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2258442|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2258443|NCT00154089|Analgesics|analgesics|mesh-ancestor
2258444|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
2258445|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258446|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2258447|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2258448|NCT00154115|Simendan|simendan|mesh-list
2258449|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2258450|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
2258451|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2258452|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2258453|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258454|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258455|NCT00154115|Protective Agents|protective agents|mesh-ancestor
2258456|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258457|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
2258458|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258459|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
2258460|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
2258461|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
2258462|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
852757|NCT02372110|Caffeine|caffeine|mesh-list
852759|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
852760|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852761|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
852762|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
852763|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852764|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
852765|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
852766|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
852767|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258463|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
2258464|NCT00154141|Coagulants|coagulants|mesh-ancestor
2258465|NCT00154167|Phentolamine|phentolamine|mesh-list
2258466|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2258467|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2258468|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
2258469|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
851742|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
851743|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
851744|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851745|NCT02375880|Antiviral Agents|antiviral agents|mesh-ancestor
851746|NCT02375880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
851747|NCT02375880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851748|NCT02375880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
851749|NCT02375880|Immunologic Factors|immunologic factors|mesh-ancestor
851750|NCT02375880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851774|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
851775|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
851776|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
851777|NCT02375295|Trimethoprim|trimethoprim|mesh-list
851778|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
851779|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
851780|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
851781|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
851782|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
851783|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
851784|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
851785|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
851786|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
851787|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
851788|NCT02375295|Renal Agents|renal agents|mesh-ancestor
851789|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
851790|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
851791|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
851792|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
851793|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
851794|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2258470|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258471|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258472|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2258473|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2258474|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2258475|NCT00154180|Estradiol|estradiol|mesh-list
2258476|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2258477|NCT00154180|Estrogens|estrogens|mesh-list
2258478|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2258479|NCT00154180|Progesterone|progesterone|mesh-list
2258480|NCT00154180|Hormones|hormones|mesh-ancestor
2258481|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2258482|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258483|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
852250|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
852251|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
852252|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
852253|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
852254|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852633|NCT02372591|Buprenorphine|buprenorphine|mesh-list
852634|NCT02372591|Hydromorphone|hydromorphone|mesh-list
852635|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
852636|NCT02372591|Narcotics|narcotics|mesh-ancestor
852637|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
852638|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852639|NCT02372591|Analgesics|analgesics|mesh-ancestor
852640|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
852641|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852642|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
852688|NCT02372786|Lidocaine|lidocaine|mesh-list
852689|NCT02372786|Tetracaine|tetracaine|mesh-list
852690|NCT02372786|Prilocaine|prilocaine|mesh-list
852691|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
852692|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
852693|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
852694|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
852695|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
852696|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
852697|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
852698|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
852699|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
852700|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
852902|NCT02371577|Lenalidomide|lenalidomide|mesh-list
850434|NCT02382510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754605|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2754606|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2754607|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2754608|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2754609|NCT00280761|Fluorouracil|fluorouracil|mesh-list
2754610|NCT00280761|Capecitabine|capecitabine|mesh-list
2754611|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
851325|NCT02377778|Thiopental|thiopental|mesh-list
851326|NCT02377778|Propofol|propofol|mesh-list
851327|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
851328|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
851329|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
851330|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
851331|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
851332|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
851333|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
851334|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
851335|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
851336|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
851337|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258484|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
2258485|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2258486|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2258487|NCT00154180|Progestins|progestins|mesh-ancestor
2258488|NCT00154193|Cyclosporine|cyclosporine|mesh-list
2258489|NCT00154193|Cyclosporins|cyclosporins|mesh-list
2258490|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258491|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258492|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2258493|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
2258494|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258495|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
2258496|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258497|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
2258498|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2258499|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2258500|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
2258501|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2258502|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258503|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2258504|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
2258505|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2258506|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258507|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258508|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258509|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
2258510|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2258511|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2258512|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258513|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258514|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2258515|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2258516|NCT00154219|Analgesics|analgesics|mesh-ancestor
2258517|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
2258518|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258519|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258520|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
853384|NCT02369133|Acetaminophen|acetaminophen|mesh-list
853385|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
853386|NCT02369133|Analgesics|analgesics|mesh-ancestor
853387|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
853388|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853389|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853390|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
854020|NCT02366585|Cyclosporine|cyclosporine|mesh-list
854021|NCT02366585|Cyclosporins|cyclosporins|mesh-list
854022|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854023|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854024|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
854025|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
854026|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854027|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
2258521|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2258522|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
2258523|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
853316|NCT02369523|Bupivacaine|bupivacaine|mesh-list
853317|NCT02369523|Ropivacaine|ropivacaine|mesh-list
853318|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
853319|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
853320|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
853321|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853322|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
853323|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258524|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258525|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2258526|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
2258527|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2258528|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258529|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099534|NCT02358343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2099535|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2099536|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2099537|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099538|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258530|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854162|NCT02366208|Adefovir|adefovir|mesh-list
854163|NCT02366208|Thymalfasin|thymalfasin|mesh-list
854164|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
854165|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854166|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
854167|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
854168|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854169|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854170|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
854171|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
854172|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854424|NCT02365402|Entecavir|entecavir|mesh-list
854425|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
854426|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258531|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
2258532|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2258533|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258534|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2258535|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
2258536|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2258537|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258538|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258539|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258540|NCT00154258|Clozapine|clozapine|mesh-list
2258541|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2258542|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
2258543|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258544|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258545|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258546|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2258547|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2258548|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2258549|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2258550|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
2258551|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
2258552|NCT00154271|Valsartan|valsartan|mesh-list
2258553|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2258554|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2258555|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2258556|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258557|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
2258558|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
2258559|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2258560|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
855735|NCT02359266|Vitamin D|vitamin d|mesh-list
855736|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
855737|NCT02359266|Vitamins|vitamins|mesh-ancestor
855738|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
855739|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855740|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
855741|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
852997|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
852998|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
852999|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853644|NCT02368379|Metyrapone|metyrapone|mesh-list
853645|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
853646|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853647|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853735|NCT02367807|Tenofovir|tenofovir|mesh-list
853736|NCT02367807|Emtricitabine|emtricitabine|mesh-list
853737|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
853738|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
853739|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
853740|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
853741|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853742|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853743|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
853744|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
853909|NCT02366975|Testosterone|testosterone|mesh-list
853910|NCT02366975|Androgens|androgens|mesh-ancestor
853911|NCT02366975|Hormones|hormones|mesh-ancestor
853912|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
853913|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854173|NCT02366377|Metformin|metformin|mesh-list
854174|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
854175|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854801|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
854802|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854803|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
854804|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854805|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854964|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
854965|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854966|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
854967|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
854968|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
854969|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854970|NCT02362399|Urological Agents|urological agents|mesh-ancestor
855201|NCT02361502|Mirabegron|mirabegron|mesh-list
855202|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
855203|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
855204|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
855205|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
855206|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
855207|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855208|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855209|NCT02361502|Urological Agents|urological agents|mesh-ancestor
2258561|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2258562|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258563|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2258564|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2258565|NCT00154336|Methotrexate|methotrexate|mesh-list
2258566|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
2258567|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2258568|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
2258569|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2258570|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258571|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2258572|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
2258573|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258574|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258575|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
2258576|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258577|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2258578|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2258579|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
2258580|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
856365|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
856366|NCT02357407|Ofloxacin|ofloxacin|mesh-list
856367|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
856368|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
856369|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
856370|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
856371|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856372|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853000|NCT02371304|Capecitabine|capecitabine|mesh-list
853001|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
853002|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
853003|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853004|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258581|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2258582|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2258583|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
2258584|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258585|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2258586|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258587|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258588|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
2258589|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
2258590|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2258591|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2258592|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2258593|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258594|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
854617|NCT02364206|Temozolomide|temozolomide|mesh-list
854618|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
854619|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
854620|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854621|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258595|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2258596|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
2258597|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854943|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
854944|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
854945|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855152|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
855153|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
855154|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
855155|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
855156|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855157|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
855241|NCT02361528|Sargramostim|sargramostim|mesh-list
855242|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
855243|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855534|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
855535|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
855623|NCT02359643|Aspirin|aspirin|mesh-list
855624|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
855625|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
855626|NCT02359643|Analgesics|analgesics|mesh-ancestor
855627|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
855628|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855629|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855630|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
855631|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
855632|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
855633|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
855634|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855635|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
855636|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
855637|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
855638|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
856276|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2258598|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2258599|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258600|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258601|NCT00154401|Liraglutide|liraglutide|mesh-list
2258602|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2258603|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258604|NCT00154401|Incretins|incretins|mesh-ancestor
2258605|NCT00154401|Hormones|hormones|mesh-ancestor
853043|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
853044|NCT02370862|Neostigmine|neostigmine|mesh-list
853045|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
853046|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853047|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853048|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
853049|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
853050|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853051|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
853052|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
853053|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853054|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
853055|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
853056|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
853335|NCT02369406|Lamivudine|lamivudine|mesh-list
853336|NCT02369406|Zidovudine|zidovudine|mesh-list
853337|NCT02369406|Nevirapine|nevirapine|mesh-list
853338|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
853339|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
853340|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853341|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853342|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
853343|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
853344|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
853345|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
853346|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
853347|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
853348|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2258606|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2258607|NCT00154414|Liraglutide|liraglutide|mesh-list
2258608|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2258609|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258610|NCT00154414|Incretins|incretins|mesh-ancestor
2258611|NCT00154414|Hormones|hormones|mesh-ancestor
2258612|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2258613|NCT00154440|Amoxicillin|amoxicillin|mesh-list
2258614|NCT00154440|Metronidazole|metronidazole|mesh-list
2258615|NCT00154440|Clarithromycin|clarithromycin|mesh-list
2258616|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2258617|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2258618|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258619|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2258620|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2258621|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2258622|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258623|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258624|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2258625|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2258626|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
2258627|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2258628|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258629|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258630|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2258631|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2258632|NCT00154661|Protective Agents|protective agents|mesh-ancestor
2258633|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258634|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
2258635|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2258636|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
2258637|NCT00154687|Paclitaxel|paclitaxel|mesh-list
2258638|NCT00154687|Fluorouracil|fluorouracil|mesh-list
2258639|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
854604|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
854605|NCT02364609|Afatinib|afatinib|mesh-list
854606|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
854607|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854608|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
854609|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854610|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855183|NCT02361879|Leuprolide|leuprolide|mesh-list
855184|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
855185|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
855186|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
853010|NCT02371408|Ribavirin|ribavirin|mesh-list
853011|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
853012|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
853013|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853014|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
853015|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
853221|NCT02369978|Benzonidazole|benzonidazole|mesh-list
853222|NCT02369978|Nifurtimox|nifurtimox|mesh-list
853223|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
853224|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
853225|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853226|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
853227|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
853228|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
853229|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258640|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258641|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
2258642|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
2258643|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
2258644|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258645|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
2258646|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2258647|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2258648|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
2258649|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258650|NCT00154700|Folic Acid|folic acid|mesh-list
2258651|NCT00154700|Paclitaxel|paclitaxel|mesh-list
2258652|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2258653|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258654|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
2258655|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
2258656|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
2258657|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258658|NCT00154700|Hematinics|hematinics|mesh-ancestor
2258659|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
2258660|NCT00154700|Vitamins|vitamins|mesh-ancestor
855711|NCT02359292|Charcoal|charcoal|mesh-list
855712|NCT02359292|Antidotes|antidotes|mesh-ancestor
855713|NCT02359292|Protective Agents|protective agents|mesh-ancestor
855714|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258661|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
2258662|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258663|NCT00154726|Paclitaxel|paclitaxel|mesh-list
2258664|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2258665|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258666|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
2258667|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
2258668|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
2258669|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258670|NCT00154739|Gemcitabine|gemcitabine|mesh-list
2258671|NCT00154739|Epirubicin|epirubicin|mesh-list
2258672|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258673|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2258674|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
2258675|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258676|NCT00154739|Antiviral Agents|antiviral agents|mesh-ancestor
2258677|NCT00154739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
856859|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
856860|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
856861|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
856862|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856863|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
856864|NCT02354885|Coagulants|coagulants|mesh-ancestor
2258678|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258679|NCT00154739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2258680|NCT00154739|Immunologic Factors|immunologic factors|mesh-ancestor
2258681|NCT00154739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258682|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2258683|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2258684|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2258685|NCT00154778|Leucovorin|leucovorin|mesh-list
2258686|NCT00154778|Antidotes|antidotes|mesh-ancestor
2258687|NCT00154778|Protective Agents|protective agents|mesh-ancestor
857157|NCT02353936|Afatinib|afatinib|mesh-list
857158|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
857159|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
857160|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857161|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853016|NCT02371096|Rituximab|rituximab|mesh-list
853017|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
853018|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853019|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
853020|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853021|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
853444|NCT02369081|Bisoprolol|bisoprolol|mesh-list
853445|NCT02369081|Doxazosin|doxazosin|mesh-list
853446|NCT02369081|Spironolactone|spironolactone|mesh-list
853447|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
853448|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
853449|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
853450|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853451|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
853452|NCT02369081|Diuretics|diuretics|mesh-ancestor
853453|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
853454|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
853455|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
853456|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
853457|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853458|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
853459|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
853460|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
853461|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
853462|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
853463|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853464|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
853465|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
853501|NCT02368717|Mesalamine|mesalamine|mesh-list
853502|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
853503|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
853504|NCT02368717|Analgesics|analgesics|mesh-ancestor
853505|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
853506|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853507|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853508|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
853509|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2258688|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258689|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
2258690|NCT00154778|Vitamins|vitamins|mesh-ancestor
2258691|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
2258692|NCT00154791|Gemcitabine|gemcitabine|mesh-list
2258693|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
2258694|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2258695|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
2258696|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258697|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258698|NCT00154791|Antiviral Agents|antiviral agents|mesh-ancestor
854046|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
854047|NCT02366546|Fludarabine|fludarabine|mesh-list
854048|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
854049|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
854050|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854051|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
854052|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
854053|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
854054|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854055|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854056|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2258699|NCT00154791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258700|NCT00154791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258701|NCT00154791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2258702|NCT00154791|Immunologic Factors|immunologic factors|mesh-ancestor
2258703|NCT00154791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258704|NCT00154804|Paclitaxel|paclitaxel|mesh-list
2258705|NCT00154804|Cisplatin|cisplatin|mesh-list
853022|NCT02371148|Rituximab|rituximab|mesh-list
853023|NCT02371148|Bortezomib|bortezomib|mesh-list
853024|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
853025|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
853026|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853027|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
853028|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853029|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
853030|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
853031|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
853032|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258706|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2258707|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258708|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
2258709|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
2258710|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
2258711|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258712|NCT00154843|Lycopene|lycopene|mesh-list
853510|NCT02368795|Indomethacin|indomethacin|mesh-list
853511|NCT02368795|Isosorbide|isosorbide|mesh-list
853512|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
853513|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
853514|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
853515|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
853516|NCT02368795|Analgesics|analgesics|mesh-ancestor
853517|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
853518|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853519|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853520|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
853521|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
853522|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
853523|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
853524|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
853525|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
853526|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853527|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853528|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
853529|NCT02368795|Diuretics|diuretics|mesh-ancestor
853530|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
853531|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
853532|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
853927|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
853928|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
853929|NCT02366884|Clotrimazole|clotrimazole|mesh-list
853930|NCT02366884|Miconazole|miconazole|mesh-list
853931|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
853932|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
853933|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
853934|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
853935|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
853936|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853937|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853938|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
853939|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
853940|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
853941|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853942|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
853943|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
853944|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2258713|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2258714|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
2258715|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258716|NCT00154843|Protective Agents|protective agents|mesh-ancestor
2258717|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258718|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2258719|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2258720|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258721|NCT00154869|Ribavirin|ribavirin|mesh-list
2258722|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2258723|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
2258724|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854657|NCT02364258|Atorvastatin|atorvastatin|mesh-list
854658|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
854659|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2258725|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
2258726|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258727|NCT00154882|Paclitaxel|paclitaxel|mesh-list
2258728|NCT00154882|Cisplatin|cisplatin|mesh-list
2258729|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2258730|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258731|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
2258732|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
2258733|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
2258734|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258735|NCT00154895|Minocycline|minocycline|mesh-list
2258736|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2258737|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258738|NCT00155064|Losartan|losartan|mesh-list
2258739|NCT00155064|Captopril|captopril|mesh-list
2258740|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2258741|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2258742|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2258743|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2258744|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258745|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2258746|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
2258747|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853745|NCT02367755|Lorazepam|lorazepam|mesh-list
853746|NCT02367755|Propofol|propofol|mesh-list
853747|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
853748|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
853749|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853750|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
853751|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
853752|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
853753|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
853754|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
853755|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
853756|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853757|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
853758|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
853759|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
853760|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
853761|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
853762|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
853763|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
853764|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853890|NCT02367053|Glucagon|glucagon|mesh-list
853891|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
853892|NCT02367053|Hormones|hormones|mesh-ancestor
853893|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
853894|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854123|NCT02366247|Adefovir|adefovir|mesh-list
854124|NCT02366247|Thymalfasin|thymalfasin|mesh-list
854125|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
854126|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854127|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
854128|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
854129|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854130|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854131|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
854132|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
854133|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854247|NCT02365935|Paclitaxel|paclitaxel|mesh-list
854248|NCT02365935|Cisplatin|cisplatin|mesh-list
854249|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
854250|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854251|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
854252|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
854253|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
854254|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258748|NCT00155233|Morphine|morphine|mesh-list
2258749|NCT00155233|Nalbuphine|nalbuphine|mesh-list
2258750|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2258751|NCT00155233|Narcotics|narcotics|mesh-ancestor
2258752|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2258753|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258754|NCT00155233|Analgesics|analgesics|mesh-ancestor
2258755|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
2258756|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258757|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
2258758|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2258759|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258760|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258761|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2258762|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2258763|NCT00155246|Protective Agents|protective agents|mesh-ancestor
2258764|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258765|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
853296|NCT02369549|Curcumin|curcumin|mesh-list
853297|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
853298|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
853299|NCT02369549|Analgesics|analgesics|mesh-ancestor
853300|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
853301|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853302|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853303|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
853304|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
853305|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853306|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853307|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853395|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
853396|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
853397|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
853398|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
853399|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853400|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
853401|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
853402|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853466|NCT02368860|Capecitabine|capecitabine|mesh-list
853467|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
853468|NCT02368860|Irinotecan|irinotecan|mesh-list
853469|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
853470|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
853471|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853472|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853473|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
853474|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
853475|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853558|NCT02368665|Amlodipine|amlodipine|mesh-list
853559|NCT02368665|Candesartan|candesartan|mesh-list
853560|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
853561|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
853562|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
853563|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
853564|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853565|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
853566|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853567|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
853568|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
853569|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2258766|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2258767|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
2258768|NCT00155259|Docetaxel|docetaxel|mesh-list
2258769|NCT00155259|Capecitabine|capecitabine|mesh-list
2258770|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258771|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
2258772|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
2258773|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
2258774|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258775|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2258776|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
2258777|NCT00155272|Thalidomide|thalidomide|mesh-list
2258778|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2258779|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
2258780|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854277|NCT02365675|Petrolatum|petrolatum|mesh-list
854278|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
854279|NCT02365675|Laxatives|laxatives|mesh-ancestor
854280|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
854281|NCT02365675|Emollients|emollients|mesh-ancestor
854282|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
854442|NCT02365415|Sirolimus|sirolimus|mesh-list
854443|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
854444|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854445|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
853066|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
853067|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
853068|NCT02370680|Analgesics|analgesics|mesh-ancestor
853069|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
853070|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853071|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853072|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
853073|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
853074|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
853075|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
853076|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853077|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
853078|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
853079|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853080|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
2258781|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
2258782|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2258783|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258784|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2258785|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2258786|NCT00155272|Growth Substances|growth substances|mesh-ancestor
2258787|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
2258788|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258789|NCT00155350|Pioglitazone|pioglitazone|mesh-list
2258790|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2258791|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258792|NCT00155376|Morphine|morphine|mesh-list
2258793|NCT00155376|Glucagon|glucagon|mesh-list
2258794|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2258795|NCT00155376|Narcotics|narcotics|mesh-ancestor
854014|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
854015|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
854016|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
854017|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854018|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
854019|NCT02366676|Protective Agents|protective agents|mesh-ancestor
854404|NCT02365766|Gemcitabine|gemcitabine|mesh-list
854405|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
854406|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854407|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
854408|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
854409|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854410|NCT02365766|Antiviral Agents|antiviral agents|mesh-ancestor
854411|NCT02365766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854412|NCT02365766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854413|NCT02365766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
854414|NCT02365766|Immunologic Factors|immunologic factors|mesh-ancestor
854415|NCT02365766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854416|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
854487|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
854488|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
854489|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
854490|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
854491|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854492|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854493|NCT02364882|Urological Agents|urological agents|mesh-ancestor
854939|NCT02362945|Oxytocin|oxytocin|mesh-list
854940|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
854941|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
854942|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258796|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2258797|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258798|NCT00155376|Analgesics|analgesics|mesh-ancestor
2258799|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
2258800|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258801|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2258802|NCT00155376|Hormones|hormones|mesh-ancestor
2258803|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
855509|NCT02360592|Interferons|interferons|mesh-list
855510|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
855511|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
855512|NCT02360592|Entecavir|entecavir|mesh-list
855513|NCT02360592|Interleukin-2|interleukin-2|mesh-list
855514|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855515|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
2258804|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2258805|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
853081|NCT02370758|Valganciclovir|valganciclovir|mesh-list
853082|NCT02370758|Ganciclovir|ganciclovir|mesh-list
853083|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
853084|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
853085|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
853086|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
853087|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853088|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853262|NCT02369939|Fluorouracil|fluorouracil|mesh-list
853263|NCT02369939|Mitomycins|mitomycins|mesh-list
853264|NCT02369939|Mitomycin|mitomycin|mesh-list
853265|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
853266|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853267|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
853268|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853269|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
853270|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
853271|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853272|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
853273|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
853274|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
853275|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258806|NCT00155402|Coagulants|coagulants|mesh-ancestor
2258807|NCT00155558|Leucovorin|leucovorin|mesh-list
2258808|NCT00155558|Fluorouracil|fluorouracil|mesh-list
2258809|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
2258810|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258811|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2258812|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258813|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2099539|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
2099540|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099541|NCT02358369|Timolol|timolol|mesh-list
2099542|NCT02358369|Bimatoprost|bimatoprost|mesh-list
2099543|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2099544|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2099545|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2099546|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2099547|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
2099548|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099549|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099550|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099551|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2099552|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2099553|NCT02358473|Docetaxel|docetaxel|mesh-list
2099554|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
2099555|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099556|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
2099557|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
2099558|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
2099559|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854286|NCT02365727|Clonidine|clonidine|mesh-list
854293|NCT02365727|Epinephrine|epinephrine|mesh-list
854294|NCT02365727|Bupivacaine|bupivacaine|mesh-list
854295|NCT02365727|Ropivacaine|ropivacaine|mesh-list
854296|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
854297|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
854298|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
854299|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854300|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
854301|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
854302|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
854303|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
854304|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
854305|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
854306|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854307|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
854308|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
854309|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
854310|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
854311|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
854312|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
854313|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
854314|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
854315|NCT02365727|Analgesics|analgesics|mesh-ancestor
854316|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2258814|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
853092|NCT02370550|Cyclosporine|cyclosporine|mesh-list
853093|NCT02370550|Prednisone|prednisone|mesh-list
853094|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
853095|NCT02370550|Calcium|calcium|mesh-list
853096|NCT02370550|Cyclosporins|cyclosporins|mesh-list
853097|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
853098|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853099|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
853100|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
853101|NCT02370550|Hormones|hormones|mesh-ancestor
853102|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
853103|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
853104|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853105|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853106|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853107|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
853108|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
853109|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
853110|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
853111|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
853112|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
853113|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
853114|NCT02370550|Antacids|antacids|mesh-ancestor
853115|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
853727|NCT02368249|Terlipressin|terlipressin|mesh-list
853728|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
853729|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2258815|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258816|NCT00155558|Antidotes|antidotes|mesh-ancestor
2258817|NCT00155558|Protective Agents|protective agents|mesh-ancestor
2258818|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
2258819|NCT00155558|Vitamins|vitamins|mesh-ancestor
2258820|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
2258821|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
854513|NCT02364934|Propofol|propofol|mesh-list
854514|NCT02364934|Sevoflurane|sevoflurane|mesh-list
854515|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
854516|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
854517|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854518|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
854519|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
854520|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
854521|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
854522|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
854581|NCT02364583|Primaquine|primaquine|mesh-list
854582|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
854583|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
854584|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
854585|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258822|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
2258823|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
2258824|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2258825|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258826|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258827|NCT00155714|Urological Agents|urological agents|mesh-ancestor
2258828|NCT00155883|Leucovorin|leucovorin|mesh-list
2258829|NCT00155883|Fluorouracil|fluorouracil|mesh-list
2258830|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
2258831|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855715|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
855716|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
855717|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
855718|NCT02359526|Hormones|hormones|mesh-ancestor
855719|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
855720|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855974|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
855975|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
855976|NCT02358694|Antibodies|antibodies|mesh-list
855977|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
855978|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856063|NCT02358304|Calcitonin|calcitonin|mesh-list
856064|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
856065|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
856066|NCT02358304|Katacalcin|katacalcin|mesh-list
856067|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
856068|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856069|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
853124|NCT02370745|Insulin|insulin|mesh-list
853125|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
853126|NCT02370745|Incretins|incretins|mesh-list
853127|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
853128|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853129|NCT02370745|Hormones|hormones|mesh-ancestor
853130|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2258832|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2258833|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258834|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2258835|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
2258836|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258837|NCT00155883|Antidotes|antidotes|mesh-ancestor
2258838|NCT00155883|Protective Agents|protective agents|mesh-ancestor
2258839|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
2258840|NCT00155883|Vitamins|vitamins|mesh-ancestor
2258841|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
2258842|NCT00156078|Pregabalin|pregabalin|mesh-list
2258843|NCT00156078|Analgesics|analgesics|mesh-ancestor
2258844|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
2258845|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853801|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
853802|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
853803|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
853804|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
853858|NCT02367248|Deferoxamine|deferoxamine|mesh-list
853859|NCT02367248|Siderophores|siderophores|mesh-ancestor
853860|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
853861|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
853862|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
853863|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854204|NCT02365909|Bupivacaine|bupivacaine|mesh-list
854205|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
854206|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
854207|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
854208|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854209|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
854210|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258846|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258847|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
2258848|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2258849|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2258850|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258851|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2258852|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2258853|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
855346|NCT02361177|Oxytocin|oxytocin|mesh-list
855347|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
855348|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
855349|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855473|NCT02360423|Sirolimus|sirolimus|mesh-list
855474|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
855475|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
855476|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
855477|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855478|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
855479|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
855480|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
855481|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258854|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2258855|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2258856|NCT00156091|Olanzapine|olanzapine|mesh-list
2258857|NCT00156091|Asenapine|asenapine|mesh-list
855639|NCT02359617|Insulin|insulin|mesh-list
855640|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
855641|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855861|NCT02358824|Amlodipine|amlodipine|mesh-list
855862|NCT02358824|Telmisartan|telmisartan|mesh-list
855863|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
855864|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
855865|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
855866|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855867|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
855868|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855869|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
855870|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2258858|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
2258859|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
2258860|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258861|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258862|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2258863|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2258864|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2258865|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2258866|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2258867|NCT00156091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2258868|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2258869|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2258870|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258871|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258872|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
2258873|NCT00156104|Haloperidol|haloperidol|mesh-list
2258874|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
2258875|NCT00156104|Asenapine|asenapine|mesh-list
2258876|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
853587|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
853588|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
853589|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
853590|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853591|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853592|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
853593|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
853597|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258877|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
2258878|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258879|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258880|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2258881|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2258882|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2258883|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2258884|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2258885|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2258886|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
2258887|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258888|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258889|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2258890|NCT00156117|Olanzapine|olanzapine|mesh-list
2258891|NCT00156117|Asenapine|asenapine|mesh-list
2258892|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
2258893|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
2258894|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258895|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258896|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2258897|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2258898|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2258899|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2258900|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2258901|NCT00156117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2258902|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2258903|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2258904|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258905|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258906|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
2258907|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
2258908|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854592|NCT02364479|Etanercept|etanercept|mesh-list
854593|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
854594|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
854595|NCT02364479|Analgesics|analgesics|mesh-ancestor
854596|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
854597|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
854598|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854599|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
854600|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
854601|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
854602|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
854603|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
854971|NCT02362581|Factor VIII|factor viii|mesh-list
854972|NCT02362581|Coagulants|coagulants|mesh-ancestor
855150|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
855151|NCT02361931|Hematinics|hematinics|mesh-ancestor
855767|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
855768|NCT02359149|Growth Substances|growth substances|mesh-ancestor
853141|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
853142|NCT02370433|Neostigmine|neostigmine|mesh-list
853143|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
853144|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853145|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853146|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
853147|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
853148|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853149|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
853150|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
853151|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853152|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
853153|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
853154|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2258909|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2258910|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258911|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258912|NCT00156299|Dexamethasone|dexamethasone|mesh-list
2258913|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
2258914|NCT00156299|Choline|choline|mesh-list
2258915|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2258916|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
2258917|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
854346|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
854347|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
854348|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
854349|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854350|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
854586|NCT02364752|Diuretics|diuretics|mesh-list
854587|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
854588|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
854589|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854590|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
854591|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854781|NCT02363452|Lamivudine|lamivudine|mesh-list
854782|NCT02363452|Zidovudine|zidovudine|mesh-list
854783|NCT02363452|Abacavir|abacavir|mesh-list
854784|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
854785|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
854786|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854787|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854788|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
854789|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854790|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
854791|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
854792|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
854879|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
854880|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
854881|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854882|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
854883|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
854884|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
854885|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854886|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
854887|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258918|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2258919|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258920|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2258921|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
2258922|NCT00156299|Hormones|hormones|mesh-ancestor
2258923|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2258924|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2258925|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258926|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
2258927|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2258928|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
2258929|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258930|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2258931|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
2258932|NCT00156299|Analgesics|analgesics|mesh-ancestor
2258933|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
2258934|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2258935|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2258936|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2258937|NCT00156312|Docetaxel|docetaxel|mesh-list
2258938|NCT00156312|Capecitabine|capecitabine|mesh-list
2258939|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258940|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
2258941|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
2258942|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
2258943|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258944|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2258945|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
2258946|NCT00156325|Citalopram|citalopram|mesh-list
2258947|NCT00156325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2258948|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2258949|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2258950|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258951|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2258952|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
2258953|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258954|NCT00156325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2258955|NCT00156325|Antidepressive Agents|antidepressive agents|mesh-ancestor
2258956|NCT00156325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2258957|NCT00156377|Mupirocin|mupirocin|mesh-list
2258958|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2258959|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258960|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2258961|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2258962|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258963|NCT00156403|Amlodipine|amlodipine|mesh-list
2258964|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2258965|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
853491|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
853492|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
853493|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
853494|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
853495|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
853496|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
853497|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853498|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
853499|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
853500|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853614|NCT02368288|Entecavir|entecavir|mesh-list
853615|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
853616|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854861|NCT02363374|Leucovorin|leucovorin|mesh-list
854862|NCT02363374|Folic Acid|folic acid|mesh-list
854863|NCT02363374|Fluorouracil|fluorouracil|mesh-list
854864|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
854865|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
854866|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
854867|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854868|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
854869|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854870|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
854871|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
854872|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854873|NCT02363374|Antidotes|antidotes|mesh-ancestor
854874|NCT02363374|Protective Agents|protective agents|mesh-ancestor
854875|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
854876|NCT02363374|Vitamins|vitamins|mesh-ancestor
854877|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
854878|NCT02363374|Hematinics|hematinics|mesh-ancestor
855054|NCT02362256|Clonidine|clonidine|mesh-list
855055|NCT02362256|Naltrexone|naltrexone|mesh-list
855056|NCT02362256|Lorazepam|lorazepam|mesh-list
855057|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
855058|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
855059|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855060|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
855061|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855062|NCT02362256|Analgesics|analgesics|mesh-ancestor
855063|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
855064|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
855065|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
855066|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
855067|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
855068|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
855069|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
855070|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099560|NCT02358668|PAZ320|paz320|mesh-list
2099561|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2099562|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099563|NCT02358863|Leucovorin|leucovorin|mesh-list
854137|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
854138|NCT02366299|Propofol|propofol|mesh-list
854139|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
854140|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
854141|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854142|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
854143|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
854144|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
854145|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
854146|NCT02366299|Analgesics|analgesics|mesh-ancestor
854147|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
854148|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
854149|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
854150|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
854151|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
854152|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
854153|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
854154|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854211|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
854212|NCT02365857|Bupivacaine|bupivacaine|mesh-list
854213|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
854214|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
854215|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
854216|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854217|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
854218|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
854219|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
854220|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
854221|NCT02365857|Analgesics|analgesics|mesh-ancestor
854222|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
854223|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
854224|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
854225|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
854226|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
854227|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099564|NCT02358863|Cisplatin|cisplatin|mesh-list
2099565|NCT02358863|Docetaxel|docetaxel|mesh-list
2099566|NCT02358863|Capecitabine|capecitabine|mesh-list
2099567|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
2099568|NCT02358863|Irinotecan|irinotecan|mesh-list
2099569|NCT02358863|Epirubicin|epirubicin|mesh-list
2099570|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099571|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
2099572|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
2099573|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
2099574|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099575|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2099576|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
2099577|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2099578|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2099579|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099580|NCT02358863|Antidotes|antidotes|mesh-ancestor
854834|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
854835|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
854836|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
855599|NCT02359942|Citric Acid|citric acid|mesh-list
855600|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
855601|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
855602|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
855603|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
855604|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
855605|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099581|NCT02358863|Protective Agents|protective agents|mesh-ancestor
2099582|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099583|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
2099584|NCT02358863|Vitamins|vitamins|mesh-ancestor
2099585|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
2099586|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2099587|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2099588|NCT02358889|Ranibizumab|ranibizumab|mesh-list
2099589|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
2099590|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2099591|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2099592|NCT02358889|Growth Substances|growth substances|mesh-ancestor
2099593|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853205|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
853206|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
853207|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258966|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2258967|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258968|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2258969|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258970|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
853329|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
853330|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
853331|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
853332|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853333|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
853334|NCT02369380|Protective Agents|protective agents|mesh-ancestor
2258971|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
2258972|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2258973|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2258974|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2258975|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
2258976|NCT00156520|Coagulants|coagulants|mesh-ancestor
2258977|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2258978|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2258979|NCT00156611|Abciximab|abciximab|mesh-list
2258980|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
2258981|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2258982|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2258983|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
2258984|NCT00156650|Testosterone|testosterone|mesh-list
2258985|NCT00156650|Acyline|acyline|mesh-list
2258986|NCT00156650|Androgens|androgens|mesh-ancestor
2258987|NCT00156650|Hormones|hormones|mesh-ancestor
2258988|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2258989|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2258990|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2258991|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2258992|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2258993|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2258994|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2258995|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
2258996|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2258997|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2258998|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2258999|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2259000|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
2259001|NCT00156689|Levetiracetam|levetiracetam|mesh-list
2259002|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
2259003|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
2259004|NCT00156858|Busulfan|busulfan|mesh-list
2259005|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
2259006|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259007|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2259008|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
2259009|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259010|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2259011|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259012|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
855194|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
855195|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
855196|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
855197|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855198|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
855199|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
855200|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259013|NCT00156884|Cisplatin|cisplatin|mesh-list
2259014|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259015|NCT00156897|Orlistat|orlistat|mesh-list
2259016|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259017|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259018|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2259019|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2259020|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
2259021|NCT00156949|Hematinics|hematinics|mesh-ancestor
2259022|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
855709|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259023|NCT00156962|Hematinics|hematinics|mesh-ancestor
853230|NCT02369822|Ascorbic Acid|ascorbic acid|mesh-list
853231|NCT02369822|Vitamins|vitamins|mesh-ancestor
853232|NCT02369822|Micronutrients|micronutrients|mesh-ancestor
853233|NCT02369822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853234|NCT02369822|Antioxidants|antioxidants|mesh-ancestor
853235|NCT02369822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853236|NCT02369822|Protective Agents|protective agents|mesh-ancestor
853391|NCT02369146|UB-421|ub-421|mesh-list
853392|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
853393|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
853394|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
853648|NCT02368197|Paclitaxel|paclitaxel|mesh-list
853649|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
853650|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853651|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
853652|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
853653|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
853654|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259024|NCT00156975|Capecitabine|capecitabine|mesh-list
2259025|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
2259026|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2259027|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
2259028|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259029|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259030|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
2259031|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2259032|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
2259033|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2259034|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259035|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2259036|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2259037|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
2259038|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
856554|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
856555|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
856556|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
856557|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
856558|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856559|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
856560|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099594|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
2099595|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099596|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
2099597|NCT02359006|Minocycline|minocycline|mesh-list
2099598|NCT02359006|Tetracycline|tetracycline|mesh-list
2099599|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
856690|NCT02355678|Acetaminophen|acetaminophen|mesh-list
856691|NCT02355678|Dexamethasone|dexamethasone|mesh-list
856692|NCT02355678|Propacetamol|propacetamol|mesh-list
856693|NCT02355678|Tramadol|tramadol|mesh-list
856694|NCT02355678|Anesthetics|anesthetics|mesh-list
856695|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
856696|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
856697|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
856698|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
856699|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
856700|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856701|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
856702|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
856703|NCT02355678|Hormones|hormones|mesh-ancestor
856704|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
856705|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
856706|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856707|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
856708|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
856709|NCT02355678|Analgesics|analgesics|mesh-ancestor
856710|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
856711|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
856712|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
856713|NCT02355678|Narcotics|narcotics|mesh-ancestor
856714|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
856715|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
856939|NCT02354950|Cabotegravir|cabotegravir|mesh-list
856940|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
856941|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
856942|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856943|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856944|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2099600|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
853237|NCT02369965|Ritonavir|ritonavir|mesh-list
853238|NCT02369965|Lopinavir|lopinavir|mesh-list
853239|NCT02369965|Tenofovir|tenofovir|mesh-list
853240|NCT02369965|Lamivudine|lamivudine|mesh-list
853241|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
853242|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
853243|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
853244|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853245|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853246|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
853247|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
853248|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
853249|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
853250|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
853251|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
853252|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
853253|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2259039|NCT00157040|Factor VIII|factor viii|mesh-list
2259040|NCT00157040|Coagulants|coagulants|mesh-ancestor
2259041|NCT00157053|Factor VIII|factor viii|mesh-list
2259042|NCT00157053|Coagulants|coagulants|mesh-ancestor
2259043|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
854451|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
854452|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854453|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
854454|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854455|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855116|NCT02362022|Morphine|morphine|mesh-list
855117|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
855118|NCT02362022|Narcotics|narcotics|mesh-ancestor
855119|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
855120|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855121|NCT02362022|Analgesics|analgesics|mesh-ancestor
855122|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
855123|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855221|NCT02361645|Ketorolac|ketorolac|mesh-list
855222|NCT02361645|Indomethacin|indomethacin|mesh-list
855223|NCT02361645|Nepafenac|nepafenac|mesh-list
855224|NCT02361645|Bromfenac|bromfenac|mesh-list
855225|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
855226|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
855227|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
855228|NCT02361645|Analgesics|analgesics|mesh-ancestor
855229|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
855230|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855231|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855232|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
855233|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
855234|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
855235|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
855236|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855237|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
855238|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
855239|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
855240|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
855578|NCT02359994|Hemostatics|hemostatics|mesh-list
855579|NCT02359994|Coagulants|coagulants|mesh-ancestor
855642|NCT02359721|Clarithromycin|clarithromycin|mesh-list
855643|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
855644|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
855645|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
855646|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
855647|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855648|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
855649|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
855742|NCT02359331|Amoxicillin|amoxicillin|mesh-list
855743|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
855744|NCT02359331|Metronidazole|metronidazole|mesh-list
855745|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
855746|NCT02359331|Tetracycline|tetracycline|mesh-list
855747|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
855748|NCT02359331|Bismuth|bismuth|mesh-list
855749|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
855750|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
855751|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
855752|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
855753|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259044|NCT00157066|Vitamin D|vitamin d|mesh-list
2099601|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2099602|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099603|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099604|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
2099605|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2099606|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099607|NCT02359058|Capecitabine|capecitabine|mesh-list
2099608|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
2099609|NCT02359058|Ramucirumab|ramucirumab|mesh-list
2099610|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099611|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2099612|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
2099613|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099614|NCT02359110|Gabapentin|gabapentin|mesh-list
2099615|NCT02359110|Analgesics|analgesics|mesh-ancestor
2099616|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
2099617|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099618|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099619|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
2099620|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2099621|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2099622|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099623|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2099624|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2099625|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2259045|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
853773|NCT02367664|Vaccines|vaccines|mesh-list
853774|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
853775|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259046|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259047|NCT00157066|Vitamins|vitamins|mesh-ancestor
2259048|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
2259049|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2259050|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
2259051|NCT00157079|Antibodies|antibodies|mesh-list
2259052|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
855087|NCT02362152|Diclofenac|diclofenac|mesh-list
855088|NCT02362152|Fluorouracil|fluorouracil|mesh-list
855089|NCT02362152|Imiquimod|imiquimod|mesh-list
855090|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
855091|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855092|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
855093|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855094|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
855095|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
855096|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855097|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
855098|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
855099|NCT02362152|Analgesics|analgesics|mesh-ancestor
855100|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
855101|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855102|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
855103|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
855104|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
855105|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
855106|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
855107|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
2259053|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2259054|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2259055|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
855770|NCT02359500|Octreotide|octreotide|mesh-list
855771|NCT02359500|Edotreotide|edotreotide|mesh-list
855772|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
855773|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
855774|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855775|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
855776|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856188|NCT02357797|Vortioxetine|vortioxetine|mesh-list
856189|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
856190|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
856191|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
856192|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
856193|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
856194|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856195|NCT02357797|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
856196|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2099626|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099627|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099628|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
2099629|NCT02359305|Acetaminophen|acetaminophen|mesh-list
2099630|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2099631|NCT02359305|Analgesics|analgesics|mesh-ancestor
2099632|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
2099633|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259056|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259057|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2259058|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
854155|NCT02366065|Acetaminophen|acetaminophen|mesh-list
854156|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
854157|NCT02366065|Analgesics|analgesics|mesh-ancestor
854158|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
854159|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
854160|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854161|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
854357|NCT02365805|Paclitaxel|paclitaxel|mesh-list
854358|NCT02365805|Docetaxel|docetaxel|mesh-list
854359|NCT02365805|Fluorouracil|fluorouracil|mesh-list
854360|NCT02365805|Epirubicin|epirubicin|mesh-list
854361|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
854362|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
854363|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854364|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
854365|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
854366|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
854367|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854368|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
854369|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
854370|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
854371|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
854372|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854373|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
854374|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
854375|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
854376|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854377|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
854378|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
854379|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
854380|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
854432|NCT02365272|Amikacin|amikacin|mesh-list
854433|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
854434|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854532|NCT02365012|Midodrine|midodrine|mesh-list
854533|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
854534|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
854535|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
854536|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854537|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
854538|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
854539|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
854540|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
854541|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
854542|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
854543|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854572|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
854573|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854574|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
854575|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854576|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854577|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
854578|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
854579|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854580|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2259059|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2259060|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2259061|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
855251|NCT02361619|Clarithromycin|clarithromycin|mesh-list
855252|NCT02361619|Diclofenac|diclofenac|mesh-list
855253|NCT02361619|Metoprolol|metoprolol|mesh-list
855254|NCT02361619|Midazolam|midazolam|mesh-list
855255|NCT02361619|Caffeine|caffeine|mesh-list
855256|NCT02361619|Esomeprazole|esomeprazole|mesh-list
855257|NCT02361619|Dabigatran|dabigatran|mesh-list
2259062|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259063|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259064|NCT00157105|Factor VIII|factor viii|mesh-list
2259065|NCT00157105|Coagulants|coagulants|mesh-ancestor
853546|NCT02368652|Amlodipine|amlodipine|mesh-list
853547|NCT02368652|Candesartan|candesartan|mesh-list
853548|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
853549|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
853550|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
853551|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
853552|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853553|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
853554|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853555|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
853556|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
853557|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
853914|NCT02367118|Prednisone|prednisone|mesh-list
853915|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
853916|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
853917|NCT02367118|Hormones|hormones|mesh-ancestor
853918|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
853919|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853920|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
853921|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854288|NCT02365740|Insulin|insulin|mesh-list
854330|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
854331|NCT02365740|Hormones|hormones|mesh-list
854332|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
854333|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854334|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2259066|NCT00157118|Protein C|protein c|mesh-list
2259067|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
2259068|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2259069|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2259070|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259071|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2259072|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
2259073|NCT00157131|Coagulants|coagulants|mesh-ancestor
2259074|NCT00157235|Bromides|bromides|mesh-list
2259075|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
2259076|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2259077|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
2259078|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259079|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259080|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2259081|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
2259082|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
2259083|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2259084|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
2259085|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
855979|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
855980|NCT02359097|Hematinics|hematinics|mesh-ancestor
855981|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
855982|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
856160|NCT02358200|Paclitaxel|paclitaxel|mesh-list
856161|NCT02358200|Carboplatin|carboplatin|mesh-list
856162|NCT02358200|Talazoparib|talazoparib|mesh-list
856163|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
856164|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856165|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
856166|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
856167|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
856168|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856169|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
856170|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856228|NCT02357693|Aprepitant|aprepitant|mesh-list
856229|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
856230|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
856231|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
856232|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856233|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
856234|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
856235|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
856236|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856645|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
2259086|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259087|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
2259088|NCT00157261|Tenecteplase|tenecteplase|mesh-list
2259089|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2259090|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2259091|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259092|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
2259093|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2259094|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259095|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
2259096|NCT00157300|Hematinics|hematinics|mesh-ancestor
2259097|NCT00157326|Tadalafil|tadalafil|mesh-list
2259098|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
2259099|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2259100|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
853655|NCT02368054|Epinephrine|epinephrine|mesh-list
853656|NCT02368054|Racepinephrine|racepinephrine|mesh-list
853657|NCT02368054|Bupivacaine|bupivacaine|mesh-list
853658|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
853659|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
853660|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
853661|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
853662|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853663|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
853664|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853665|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
853666|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
853667|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
853668|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
853669|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853670|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
853671|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
853672|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
853673|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
853674|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
853675|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
853676|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
853677|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
854398|NCT02365649|Upadacitinib|upadacitinib|mesh-list
854399|NCT02365649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
854400|NCT02365649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
854401|NCT02365649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854402|NCT02365649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854403|NCT02365649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
854946|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
854947|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
854948|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
854949|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
854950|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
854951|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854952|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
854953|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
854954|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
854955|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
854956|NCT02362711|Estrogens|estrogens|mesh-ancestor
854957|NCT02362711|Hormones|hormones|mesh-ancestor
854958|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
855413|NCT02360709|Sirolimus|sirolimus|mesh-list
855414|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
855415|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
855416|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
855417|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855418|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
855419|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
855420|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
855421|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855705|NCT02359448|Melatonin|melatonin|mesh-list
855706|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
855707|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855708|NCT02359448|Protective Agents|protective agents|mesh-ancestor
2259101|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853476|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
853477|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
853478|NCT02368730|Coagulants|coagulants|mesh-ancestor
853479|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
853480|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
853481|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853539|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
853540|NCT02368561|Hylan|hylan|mesh-list
853541|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
853542|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
853543|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853544|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
853545|NCT02368561|Protective Agents|protective agents|mesh-ancestor
853624|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
853625|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
853626|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
853627|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
853628|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853629|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853630|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
853631|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
853632|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
853633|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
853634|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853635|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
853636|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
853637|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
853638|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
853639|NCT02368171|Protective Agents|protective agents|mesh-ancestor
853640|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
853692|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
853693|NCT02367937|Midazolam|midazolam|mesh-list
853694|NCT02367937|Omeprazole|omeprazole|mesh-list
853695|NCT02367937|Simvastatin|simvastatin|mesh-list
853696|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
853697|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
853698|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
853699|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853700|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
853701|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
853702|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
853703|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
853704|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
853705|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
853706|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
853707|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
853708|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
853709|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853710|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
853711|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
853712|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
853713|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
853714|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
853715|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853716|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
853717|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
853718|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
853719|NCT02367937|Analgesics|analgesics|mesh-ancestor
853720|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
853721|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853722|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
853723|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
853724|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
853725|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
853726|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2259102|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259103|NCT00157326|Urological Agents|urological agents|mesh-ancestor
2259104|NCT00157339|Insulin|insulin|mesh-list
2259105|NCT00157339|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2259106|NCT00157339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2259107|NCT00157339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259108|NCT00157378|Haloperidol|haloperidol|mesh-list
2259109|NCT00157378|Risperidone|risperidone|mesh-list
2259110|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
2259111|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2259112|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
2259113|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
853484|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
853485|NCT02368743|Analgesics|analgesics|mesh-ancestor
853486|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
853487|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853488|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853489|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
853490|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
853765|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
853766|NCT02367846|NuvaRing|nuvaring|mesh-list
853767|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
853768|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
853769|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
853770|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853771|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
853772|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
853864|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
853865|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
853866|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
853867|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
853868|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853869|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
853870|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853871|NCT02367404|Analgesics|analgesics|mesh-ancestor
853872|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
853873|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853874|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
853875|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
853876|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
853956|NCT02366949|Paclitaxel|paclitaxel|mesh-list
853957|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
853958|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853959|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
853960|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
853961|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
853962|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854287|NCT02365571|Itraconazole|itraconazole|mesh-list
854319|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
854320|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854321|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
854322|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
854323|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854324|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854325|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
854326|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
854327|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
854328|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854329|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2259114|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259115|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259116|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2259117|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
854934|NCT02363127|Progesterone|progesterone|mesh-list
854935|NCT02363127|Progestins|progestins|mesh-ancestor
854936|NCT02363127|Hormones|hormones|mesh-ancestor
854937|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
854938|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854959|NCT02362516|BI 425809|bi 425809|mesh-list
854960|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
855244|NCT02361775|Ropivacaine|ropivacaine|mesh-list
855245|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
855246|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
855247|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
855248|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855249|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
855250|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855532|NCT02360254|Insulin|insulin|mesh-list
855533|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
855536|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855921|NCT02359162|Gemcitabine|gemcitabine|mesh-list
855922|NCT02359162|Prednisone|prednisone|mesh-list
855923|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
855924|NCT02359162|Doxorubicin|doxorubicin|mesh-list
855925|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
855926|NCT02359162|Etoposide|etoposide|mesh-list
2259118|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2259119|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2259120|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2259121|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
2259122|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
2259123|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
2259124|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259125|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2259126|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2259127|NCT00157482|Simvastatin|simvastatin|mesh-list
2259128|NCT00157482|Ezetimibe|ezetimibe|mesh-list
2259129|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2259130|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2259131|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
2259132|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259133|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2259134|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2259135|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259136|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
2259137|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2259138|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2259139|NCT00157508|Analgesics|analgesics|mesh-ancestor
2259140|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
2259141|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259142|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259143|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2259144|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2259145|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2259146|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
854435|NCT02365493|Cefazolin|cefazolin|mesh-list
854436|NCT02365493|Lactams|lactams|mesh-list
854437|NCT02365493|beta-Lactams|beta-lactams|mesh-list
854438|NCT02365493|Floxacillin|floxacillin|mesh-list
854439|NCT02365493|Cloxacillin|cloxacillin|mesh-list
854440|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
854441|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854696|NCT02363985|Vitamin A|vitamin a|mesh-list
854697|NCT02363985|Vitamins|vitamins|mesh-ancestor
854698|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
854699|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854721|NCT02363699|Lidocaine|lidocaine|mesh-list
854722|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
854723|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
854724|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
854725|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854726|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
854727|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
854728|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
854729|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
854730|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
854731|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
854732|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854961|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
854962|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
854963|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259147|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259148|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2259149|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2259150|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
2259151|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259152|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
2259153|NCT00157547|Citalopram|citalopram|mesh-list
2259154|NCT00157547|Fluoxetine|fluoxetine|mesh-list
2259155|NCT00157547|Paroxetine|paroxetine|mesh-list
2259156|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2259157|NCT00157547|Sertraline|sertraline|mesh-list
2259158|NCT00157547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2259159|NCT00157547|Serotonin|serotonin|mesh-list
855526|NCT02360202|Clobetasol|clobetasol|mesh-list
855527|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
855528|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
855529|NCT02360202|Hormones|hormones|mesh-ancestor
855530|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
855531|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855777|NCT02359474|Trabectedin|trabectedin|mesh-list
855778|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
855779|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
853641|NCT02368015|Cefazolin|cefazolin|mesh-list
853642|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
853643|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259160|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2259161|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2259162|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259163|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259164|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
2259165|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259166|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2259167|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
853852|NCT02367196|Rituximab|rituximab|mesh-list
853853|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
853854|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853855|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
853856|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853857|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
854285|NCT02365623|Bedaquiline|bedaquiline|mesh-list
854289|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
854290|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
854291|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
854292|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854611|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
854612|NCT02364453|Growth Substances|growth substances|mesh-ancestor
854613|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854614|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
854615|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
854616|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259168|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2259169|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2259170|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2259171|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259172|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2259173|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
855388|NCT02360982|Fentanyl|fentanyl|mesh-list
855389|NCT02360982|Propofol|propofol|mesh-list
855390|NCT02360982|Bupivacaine|bupivacaine|mesh-list
855391|NCT02360982|Rocuronium|rocuronium|mesh-list
855392|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
855393|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
855394|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855395|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
855396|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
855397|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
855398|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
855399|NCT02360982|Narcotics|narcotics|mesh-ancestor
855400|NCT02360982|Analgesics|analgesics|mesh-ancestor
855401|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
855402|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855403|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
855404|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
855405|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
855406|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
855407|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
855482|NCT02360384|Linaclotide|linaclotide|mesh-list
855483|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
855484|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
855485|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855486|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
855537|NCT02360007|Buprenorphine|buprenorphine|mesh-list
855538|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
855539|NCT02360007|Narcotics|narcotics|mesh-ancestor
855540|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
855541|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855542|NCT02360007|Analgesics|analgesics|mesh-ancestor
855543|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
855544|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855545|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
855650|NCT02359604|Esomeprazole|esomeprazole|mesh-list
855651|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
855652|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
855653|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
855654|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
855655|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853730|NCT02367924|Trabectedin|trabectedin|mesh-list
853731|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
853732|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
853733|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853734|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853776|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
853777|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
853778|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
853779|NCT02367560|Prednisolone|prednisolone|mesh-list
853780|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
853781|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
853782|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
853783|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
853784|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
853785|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
853786|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
853787|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
853788|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
853789|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
853790|NCT02367560|Hormones|hormones|mesh-ancestor
853791|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
853792|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
853793|NCT02367560|Protective Agents|protective agents|mesh-ancestor
853794|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
853795|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
853895|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
853896|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
853897|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
853898|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
853899|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
853900|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
853901|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
853902|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
2259174|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2259175|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2259176|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2259177|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2259178|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2259179|NCT00157586|Manidipine|manidipine|mesh-list
2259180|NCT00157586|Delapril|delapril|mesh-list
2259181|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2259182|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2259183|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2259184|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259185|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2259186|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259187|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2259188|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
2259189|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259190|NCT00157651|Warfarin|warfarin|mesh-list
2259191|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
854819|NCT02363400|Cisplatin|cisplatin|mesh-list
854820|NCT02363400|Epirubicin|epirubicin|mesh-list
854821|NCT02363400|Mitomycins|mitomycins|mesh-list
854822|NCT02363400|Mitomycin|mitomycin|mesh-list
854823|NCT02363400|Tegafur|tegafur|mesh-list
854824|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854825|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
854826|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
854827|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
854828|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854829|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854830|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
854831|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
854832|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
854833|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
854976|NCT02362529|Minocycline|minocycline|mesh-list
854977|NCT02362529|Celecoxib|celecoxib|mesh-list
854978|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
854979|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
854980|NCT02362529|Analgesics|analgesics|mesh-ancestor
854981|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
854982|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
854983|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854984|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
854985|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
854078|NCT02366494|Docetaxel|docetaxel|mesh-list
854079|NCT02366494|Leuprolide|leuprolide|mesh-list
854080|NCT02366494|Goserelin|goserelin|mesh-list
854081|NCT02366494|Bicalutamide|bicalutamide|mesh-list
854082|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
854083|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854084|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
854085|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
854086|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
854087|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854088|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
854089|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
854090|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
854091|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854092|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
854093|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
854094|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
854095|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
854096|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
854097|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
854098|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
854099|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
854427|NCT02365155|Vitamin D|vitamin d|mesh-list
854428|NCT02365155|Vitamins|vitamins|mesh-list
854429|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
854430|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854431|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
854703|NCT02363829|Nelfinavir|nelfinavir|mesh-list
854704|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
854705|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
854706|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
854707|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854708|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854709|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
854710|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
854711|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
854712|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854816|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
854817|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
854818|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
854922|NCT02362906|Azithromycin|azithromycin|mesh-list
854923|NCT02362906|Erythromycin|erythromycin|mesh-list
854924|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
854925|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
854926|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
854927|NCT02362906|Cephalosporins|cephalosporins|mesh-list
854928|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
854929|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854930|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
854931|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
854932|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854933|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855124|NCT02362165|Dexamethasone|dexamethasone|mesh-list
855125|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
855126|NCT02362165|Doxorubicin|doxorubicin|mesh-list
855127|NCT02362165|Bortezomib|bortezomib|mesh-list
855128|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
855129|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
855130|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855131|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
855132|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
855133|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
855134|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855135|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855136|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
855137|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
855138|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
855139|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
854028|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854029|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
854030|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
854031|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
854564|NCT02364765|Remifentanil|remifentanil|mesh-list
854565|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
854566|NCT02364765|Narcotics|narcotics|mesh-ancestor
854567|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
854568|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854569|NCT02364765|Analgesics|analgesics|mesh-ancestor
854570|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
854571|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
854672|NCT02364089|Epinephrine|epinephrine|mesh-list
854673|NCT02364089|Racepinephrine|racepinephrine|mesh-list
854674|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
854675|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
854676|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
854677|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
854678|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
854679|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854680|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854681|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
854682|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
854683|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
854684|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
854685|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
854686|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
854687|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
854688|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
854689|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
855955|NCT02358707|Ibuprofen|ibuprofen|mesh-list
855956|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
855957|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
855958|NCT02358707|Analgesics|analgesics|mesh-ancestor
855959|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
855960|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855961|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855962|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
855963|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
855964|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
855965|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
855966|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259192|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
2259193|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2259194|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2259195|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259196|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
2259197|NCT00157677|Coagulants|coagulants|mesh-ancestor
2259198|NCT00157690|Alendronate|alendronate|mesh-list
2259199|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2259200|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259201|NCT00157716|Pyridoxal|pyridoxal|mesh-list
2259202|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
2259203|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
856378|NCT02357277|Budesonide|budesonide|mesh-list
856379|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
856380|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
856381|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
856382|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
856383|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856384|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
856385|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
856386|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
856387|NCT02357277|Hormones|hormones|mesh-ancestor
856388|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2259204|NCT00157716|Vitamins|vitamins|mesh-ancestor
2259205|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
2259206|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259207|NCT00157729|Pyridoxal|pyridoxal|mesh-list
2259208|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
2259209|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2259210|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
2259211|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259212|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259213|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
2259214|NCT00157729|Vitamins|vitamins|mesh-ancestor
854045|NCT02366481|Coagulants|coagulants|mesh-ancestor
2099634|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099635|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
2099636|NCT02359435|Amoxicillin|amoxicillin|mesh-list
2259215|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
2259216|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854713|NCT02363751|Bevacizumab|bevacizumab|mesh-list
854714|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
854715|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854716|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
854717|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
854718|NCT02363751|Growth Substances|growth substances|mesh-ancestor
854719|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854720|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
854806|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
854807|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
854808|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854809|NCT02363335|Incretins|incretins|mesh-ancestor
854810|NCT02363335|Hormones|hormones|mesh-ancestor
854811|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
854812|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
854813|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
854814|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854815|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259217|NCT00157859|Chloroquine|chloroquine|mesh-list
2259218|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
2259219|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
2099637|NCT02359435|Metronidazole|metronidazole|mesh-list
2099638|NCT02359435|Clarithromycin|clarithromycin|mesh-list
2099639|NCT02359435|Pantoprazole|pantoprazole|mesh-list
856237|NCT02357849|Aripiprazole|aripiprazole|mesh-list
856238|NCT02357849|Fluoxetine|fluoxetine|mesh-list
856239|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
856240|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
856241|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
856242|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
856243|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
856244|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856245|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
856246|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
856247|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
856248|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856249|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
856250|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
856251|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
856252|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
856253|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
856254|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
856255|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
856256|NCT02357849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
856257|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
856258|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
856259|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
856260|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
856261|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
856262|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856622|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
856623|NCT02356419|Hematinics|hematinics|mesh-ancestor
2259220|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2259221|NCT00157859|Amebicides|amebicides|mesh-ancestor
2259222|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2259223|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2259224|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259225|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
2259226|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2259227|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2259228|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259229|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259230|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2259231|NCT00157859|Renal Agents|renal agents|mesh-ancestor
2259232|NCT00157872|Naproxen|naproxen|mesh-list
2259233|NCT00157872|Rofecoxib|rofecoxib|mesh-list
2099640|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2099641|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099642|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2099643|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2259234|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2259235|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2259236|NCT00157872|Analgesics|analgesics|mesh-ancestor
2259237|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
2259238|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259239|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259240|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2259241|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2259242|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
2259243|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2259244|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259245|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259246|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2259247|NCT00157885|Artesunate|artesunate|mesh-list
2259248|NCT00157885|Amodiaquine|amodiaquine|mesh-list
854417|NCT02365532|Dofetilide|dofetilide|mesh-list
854418|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
854419|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
854420|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
854421|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854456|NCT02365181|Ropivacaine|ropivacaine|mesh-list
854457|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
854458|NCT02365181|Anesthetics|anesthetics|mesh-list
854459|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
854460|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854461|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
854462|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
854523|NCT02364804|Aprepitant|aprepitant|mesh-list
854524|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
854525|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
854526|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
854527|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854528|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
854529|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
854530|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
854531|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259249|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
2259250|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2259251|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2259252|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259253|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259254|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
2259255|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
2259256|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2259257|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
2259258|NCT00157898|Metronidazole|metronidazole|mesh-list
2259259|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
2259260|NCT00157898|Ertapenem|ertapenem|mesh-list
2259261|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259262|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2259263|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2259264|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2259265|NCT00157911|Simvastatin|simvastatin|mesh-list
2259266|NCT00157911|Ezetimibe|ezetimibe|mesh-list
2259267|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
855158|NCT02361801|Dobutamine|dobutamine|mesh-list
855159|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
855160|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
855161|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
855162|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855163|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855164|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
855165|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
855166|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
855167|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
855168|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
855169|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855170|NCT02361801|Protective Agents|protective agents|mesh-ancestor
855368|NCT02361060|Atropine|atropine|mesh-list
855369|NCT02361060|Neostigmine|neostigmine|mesh-list
855370|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
855371|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
855372|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
855373|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
855374|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259268|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2259269|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
854317|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
854318|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2259270|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259271|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2259272|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
854992|NCT02362308|Eplerenone|eplerenone|mesh-list
854993|NCT02362308|Spironolactone|spironolactone|mesh-list
854994|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
854995|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
854996|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
854997|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
854998|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854999|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
855000|NCT02362308|Diuretics|diuretics|mesh-ancestor
855001|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
855002|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
855003|NCT02362308|Hormones|hormones|mesh-ancestor
855108|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
855109|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
855110|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
855111|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855171|NCT02361567|Acetaminophen|acetaminophen|mesh-list
855172|NCT02361567|Oxycodone|oxycodone|mesh-list
855173|NCT02361567|Tramadol|tramadol|mesh-list
855174|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
855175|NCT02361567|Narcotics|narcotics|mesh-ancestor
855176|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
855177|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855178|NCT02361567|Analgesics|analgesics|mesh-ancestor
855179|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
855180|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855181|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
855182|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
855453|NCT02360501|Docetaxel|docetaxel|mesh-list
855454|NCT02360501|Capecitabine|capecitabine|mesh-list
855455|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855456|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
855457|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
855458|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
855459|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855460|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
855461|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
2259273|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259274|NCT00157924|Atorvastatin|atorvastatin|mesh-list
2259275|NCT00157924|Simvastatin|simvastatin|mesh-list
2259276|NCT00157924|Ezetimibe|ezetimibe|mesh-list
856035|NCT02358499|Posaconazole|posaconazole|mesh-list
856036|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
856037|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
856038|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
856039|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
856040|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
856041|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
856042|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
856043|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856044|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856045|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
856046|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
856047|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
856048|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259277|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2259278|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
854666|NCT02364362|Docetaxel|docetaxel|mesh-list
854667|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854668|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
854669|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
854670|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
854671|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856120|NCT02358187|Poly ICLC|poly iclc|mesh-list
856121|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
856122|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
856123|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259279|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
2259280|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259281|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2259282|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2259283|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259284|NCT00157937|Theophylline|theophylline|mesh-list
2259285|NCT00157937|Montelukast|montelukast|mesh-list
2259286|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259287|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259288|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259289|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
2259290|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259291|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
2259292|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2259293|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2259294|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
2259295|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2259296|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2259297|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2259298|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2259299|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2259300|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259301|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
858732|NCT02347891|Belimumab|belimumab|mesh-list
858733|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
858734|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
858735|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858968|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
858969|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
858970|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860304|NCT02341963|Ketamine|ketamine|mesh-list
860305|NCT02341963|Analgesics|analgesics|mesh-ancestor
860306|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
860307|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
860308|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860309|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
860310|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
860311|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
860312|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
860313|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
860314|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
860315|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
860316|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
860317|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860756|NCT02339753|Carboplatin|carboplatin|mesh-list
860757|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259302|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2259303|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2259304|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
2259305|NCT00157963|Losartan|losartan|mesh-list
2259306|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2259307|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2259308|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
854446|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854447|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
854448|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
854449|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
854450|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854478|NCT02364986|Interferons|interferons|mesh-list
854479|NCT02364986|Interferon-beta|interferon-beta|mesh-list
854480|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
854481|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854482|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
854483|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854484|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
854485|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854486|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
854622|NCT02364713|Gemcitabine|gemcitabine|mesh-list
854623|NCT02364713|Paclitaxel|paclitaxel|mesh-list
854624|NCT02364713|Bevacizumab|bevacizumab|mesh-list
854625|NCT02364713|Doxorubicin|doxorubicin|mesh-list
854626|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
854627|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
854628|NCT02364713|Topotecan|topotecan|mesh-list
854629|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
854630|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
854631|NCT02364713|Antibodies|antibodies|mesh-list
854632|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
854633|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
854634|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
854635|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
854636|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854637|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
854638|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
854639|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
854640|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854641|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
854642|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
854643|NCT02364713|Growth Substances|growth substances|mesh-ancestor
854644|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854645|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
854646|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
854647|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
854648|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
854649|NCT02364713|Antiviral Agents|antiviral agents|mesh-ancestor
854650|NCT02364713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
854651|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854652|NCT02364713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
854653|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
854654|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
854655|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
854656|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2259309|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2259310|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2259311|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259312|NCT00157963|Diuretics|diuretics|mesh-ancestor
2259313|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
2259314|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259315|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2259316|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2259317|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
2259318|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2259319|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
2259320|NCT00158002|Topiramate|topiramate|mesh-list
2259321|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
2259322|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2259323|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259324|NCT00158028|Risperidone|risperidone|mesh-list
2259325|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2259326|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
2259327|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259328|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855422|NCT02360644|Vitamin D|vitamin d|mesh-list
855423|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
855424|NCT02360644|Vitamins|vitamins|mesh-ancestor
855425|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
855426|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855427|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
855428|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2259329|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259330|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2259331|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2259332|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2259333|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2259334|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2259335|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
2259336|NCT00158041|Amifostine|amifostine|mesh-list
2259337|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2259338|NCT00158041|Protective Agents|protective agents|mesh-ancestor
2259339|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259340|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
2259341|NCT00158093|Atenolol|atenolol|mesh-list
854765|NCT02363556|Misoprostol|misoprostol|mesh-list
854766|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
854767|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
854768|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
854769|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
854770|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
854771|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
854772|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
2259342|NCT00158093|Nebivolol|nebivolol|mesh-list
2259343|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2259344|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259345|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2259346|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2259347|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259348|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259349|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855350|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
855351|NCT02360800|Hemostatics|hemostatics|mesh-list
855352|NCT02360800|Coagulants|coagulants|mesh-ancestor
855462|NCT02360618|Metformin|metformin|mesh-list
855463|NCT02360618|Simvastatin|simvastatin|mesh-list
855464|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
855465|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855466|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
855467|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
855468|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
855469|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855470|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
855471|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
855472|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856030|NCT02358395|Sorafenib|sorafenib|mesh-list
856031|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856032|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
856033|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856034|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856273|NCT02357524|Oritavancin|oritavancin|mesh-list
856274|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
856275|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259350|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259351|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2259352|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2259353|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
2259354|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
2259355|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259356|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2259357|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2259358|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2259359|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
2259360|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259361|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
2259362|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2259363|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2259364|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2259365|NCT00158132|Amantadine|amantadine|mesh-list
2259366|NCT00158132|Propranolol|propranolol|mesh-list
2259367|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2259368|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2259369|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
2259370|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259371|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854660|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
854661|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
854662|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854663|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
854664|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
854665|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854909|NCT02362958|Capecitabine|capecitabine|mesh-list
854910|NCT02362958|Vinorelbine|vinorelbine|mesh-list
854911|NCT02362958|Lapatinib|lapatinib|mesh-list
854912|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
854913|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
854914|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854915|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
854916|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
854917|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
854918|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
854919|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
854920|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
854921|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
855353|NCT02360956|Olmesartan|olmesartan|mesh-list
855354|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
855355|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
855356|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
855357|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
855358|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855679|NCT02359370|Lidocaine|lidocaine|mesh-list
855680|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
855681|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
855682|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
855683|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
855684|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855685|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
855686|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855687|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
855688|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
855689|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
855690|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
855691|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855692|NCT02359370|Analgesics|analgesics|mesh-ancestor
855693|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
855694|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
855695|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
855696|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
855697|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2259372|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259373|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2259374|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2259375|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
2259376|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2259377|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2259378|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
856071|NCT02358356|Capecitabine|capecitabine|mesh-list
856072|NCT02358356|Temozolomide|temozolomide|mesh-list
856073|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
856074|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
856075|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856076|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856077|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
856078|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
2259379|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259380|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
856499|NCT02356965|Ketamine|ketamine|mesh-list
856500|NCT02356965|Analgesics|analgesics|mesh-ancestor
856501|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
856502|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
856503|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856504|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
856505|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
856506|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
856507|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
856508|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
856509|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
856510|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
856511|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
854986|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
854987|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
854988|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
854989|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
854990|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
854991|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
855329|NCT02361112|Capecitabine|capecitabine|mesh-list
855330|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
855331|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
855332|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855333|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259381|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2259382|NCT00158132|Analgesics|analgesics|mesh-ancestor
2259383|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
2259384|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855620|NCT02359695|Hormones|hormones|mesh-list
855621|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
855622|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856049|NCT02358538|Ganaxolone|ganaxolone|mesh-list
856050|NCT02358538|Neurosteroids|neurosteroids|mesh-ancestor
856051|NCT02358538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
856052|NCT02358538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856053|NCT02358538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856054|NCT02358538|GABA Modulators|gaba modulators|mesh-ancestor
856055|NCT02358538|GABA Agents|gaba agents|mesh-ancestor
2259385|NCT00158158|Nicotine|nicotine|mesh-list
2259386|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2259387|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
2259388|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259389|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259390|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2259391|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2259392|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
856620|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
856621|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
856948|NCT02354612|Bevacizumab|bevacizumab|mesh-list
856949|NCT02354612|Capecitabine|capecitabine|mesh-list
856950|NCT02354612|Axitinib|axitinib|mesh-list
856951|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
856952|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856953|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
856954|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
856955|NCT02354612|Growth Substances|growth substances|mesh-ancestor
856956|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856957|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
856958|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
856959|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
856960|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856961|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
856962|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857016|NCT02354313|Lenalidomide|lenalidomide|mesh-list
857017|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
857018|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857019|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
857020|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
857021|NCT02354313|Growth Substances|growth substances|mesh-ancestor
857022|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
857023|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858613|NCT02348450|Irinotecan|irinotecan|mesh-list
858614|NCT02348450|Etoposide|etoposide|mesh-list
858615|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858616|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
858617|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
858618|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858619|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858620|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
858621|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
858692|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
858693|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858888|NCT02347033|Sertraline|sertraline|mesh-list
858889|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
858890|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
858891|NCT02347033|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
858892|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
858893|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
855071|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855072|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
855073|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
855074|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
855075|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
855076|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
855077|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
855078|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
855079|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
855080|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
855081|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
855210|NCT02361905|Leuprolide|leuprolide|mesh-list
855211|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
855212|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
855213|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
855214|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
855215|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855216|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
855217|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855218|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
855219|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
855220|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
855334|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
855335|NCT02361190|Testosterone|testosterone|mesh-list
855336|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
855337|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
855338|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
855339|NCT02361190|Androgens|androgens|mesh-ancestor
855340|NCT02361190|Hormones|hormones|mesh-ancestor
855341|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
855342|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855343|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
855344|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855345|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
2099644|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2099645|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099646|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099647|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2099648|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2099649|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2099650|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2099651|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2099652|NCT02359552|Rasagiline|rasagiline|mesh-list
2099653|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2099654|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099655|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259393|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259394|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855852|NCT02358967|Vitamin E|vitamin e|mesh-list
855853|NCT02358967|Tocopherols|tocopherols|mesh-list
855854|NCT02358967|Tocotrienols|tocotrienols|mesh-list
855855|NCT02358967|Vitamins|vitamins|mesh-ancestor
855856|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
855857|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855858|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
855859|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855860|NCT02358967|Protective Agents|protective agents|mesh-ancestor
856021|NCT02358642|Lisinopril|lisinopril|mesh-list
856022|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
856023|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
856024|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
856025|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856026|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
856027|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
856028|NCT02358642|Protective Agents|protective agents|mesh-ancestor
856029|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856547|NCT02356458|Bortezomib|bortezomib|mesh-list
856548|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259395|NCT00158171|Folic Acid|folic acid|mesh-list
2259396|NCT00158171|Nicotine|nicotine|mesh-list
2259397|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2259398|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
2259399|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259400|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259401|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2259402|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
855140|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855141|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
855142|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
855143|NCT02362165|Hormones|hormones|mesh-ancestor
855144|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
855145|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
855146|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
855147|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
855148|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
855149|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259403|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
2259404|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259405|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259406|NCT00158171|Hematinics|hematinics|mesh-ancestor
2259407|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
2259408|NCT00158171|Vitamins|vitamins|mesh-ancestor
2259409|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
2259410|NCT00158210|Rivastigmine|rivastigmine|mesh-list
2259411|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
856513|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
856514|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
856515|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
856516|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
856517|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856518|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
856519|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
856520|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
856521|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
856522|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856523|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
856524|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
856525|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
856526|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
856527|NCT02356835|Protective Agents|protective agents|mesh-ancestor
856528|NCT02356445|Methotrexate|methotrexate|mesh-list
856529|NCT02356445|Azathioprine|azathioprine|mesh-list
856530|NCT02356445|Infliximab|infliximab|mesh-list
856531|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
856532|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
856533|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
856534|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856535|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
856536|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
856537|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856538|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856539|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
856540|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856541|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
856542|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
856543|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
856544|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
856545|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
856546|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
856870|NCT02354898|Sorafenib|sorafenib|mesh-list
856871|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856872|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
856873|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856874|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857024|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
857025|NCT02354547|Topotecan|topotecan|mesh-list
857026|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
857027|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
855187|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
855188|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855189|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
855190|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855191|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
855192|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
855193|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2259412|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259413|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259414|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
2259415|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259416|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856171|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
856172|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857133|NCT02353949|Flutemetamol|flutemetamol|mesh-list
857134|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
857135|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857383|NCT02353026|Artesunate|artesunate|mesh-list
857384|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
857385|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
857386|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
857387|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857388|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
857389|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
857390|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
857391|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
857392|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
857652|NCT02351882|Nabilone|nabilone|mesh-list
857653|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
857654|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
857655|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857656|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857657|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
857658|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
857659|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
857660|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
857661|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2099656|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2099657|NCT02359552|Protective Agents|protective agents|mesh-ancestor
2099658|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099659|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
2099660|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2099661|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099662|NCT02359877|Interferons|interferons|mesh-list
2099663|NCT02359877|Interferon-beta|interferon-beta|mesh-list
2099664|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
2099665|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099666|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
2099667|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857892|NCT02351310|Betamethasone|betamethasone|mesh-list
857893|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
857894|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
857895|NCT02351310|Hormones|hormones|mesh-ancestor
857896|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857897|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857898|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
857899|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
858072|NCT02350673|Atezolizumab|atezolizumab|mesh-list
858073|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858303|NCT02349581|Bupivacaine|bupivacaine|mesh-list
858304|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
858305|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
858306|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
858307|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858308|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
858309|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858492|NCT02348788|Chloroquine|chloroquine|mesh-list
858493|NCT02348788|Lumefantrine|lumefantrine|mesh-list
858494|NCT02348788|Artemether|artemether|mesh-list
858495|NCT02348788|Primaquine|primaquine|mesh-list
858496|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
858497|NCT02348788|Amebicides|amebicides|mesh-ancestor
858498|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
858499|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
858500|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
858501|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
2099668|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
855258|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
855259|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
855260|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
855261|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855262|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
855263|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
855264|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
855265|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
855266|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
855267|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
855268|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
855269|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
855270|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
855271|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855272|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
855273|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
855274|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
855275|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
855276|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
855277|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
855278|NCT02361619|Analgesics|analgesics|mesh-ancestor
855279|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
855280|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855281|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
855282|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
855283|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
855284|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
855285|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
855286|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
855287|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
855288|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
855289|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
855290|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
855291|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
855292|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
855293|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
855294|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
855295|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
855296|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
855297|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
855298|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
855299|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
855300|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
855301|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
855302|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
855303|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
855304|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
855305|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
855359|NCT02360826|Simvastatin|simvastatin|mesh-list
855360|NCT02360826|Pravastatin|pravastatin|mesh-list
855361|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
855362|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
855363|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
855364|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855365|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
855366|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
855367|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259417|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2259418|NCT00158210|Protective Agents|protective agents|mesh-ancestor
2259419|NCT00158236|Buprenorphine|buprenorphine|mesh-list
2259420|NCT00158236|Hydromorphone|hydromorphone|mesh-list
2259421|NCT00158236|Naloxone|naloxone|mesh-list
2259422|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2259423|NCT00158236|Narcotics|narcotics|mesh-ancestor
2259424|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2259425|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856344|NCT02357225|Bromides|bromides|mesh-list
856345|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
856346|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
856347|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
856348|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856349|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856350|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
856351|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259426|NCT00158236|Analgesics|analgesics|mesh-ancestor
855375|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855376|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
855377|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
855378|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
855379|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
855380|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
855381|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
855382|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
855383|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
855384|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855385|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
855386|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
855387|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2259427|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
2259428|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259429|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2259430|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
2259431|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2259432|NCT00158301|Fluoxetine|fluoxetine|mesh-list
2259433|NCT00158301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2259434|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2259435|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2259436|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259437|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259438|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
2259439|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259440|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2259441|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
2259442|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2259443|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2259444|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2259445|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259446|NCT00158405|Ritonavir|ritonavir|mesh-list
2259447|NCT00158405|Indinavir|indinavir|mesh-list
2259448|NCT00158405|Lamivudine|lamivudine|mesh-list
2259449|NCT00158405|Zidovudine|zidovudine|mesh-list
2259450|NCT00158405|Efavirenz|efavirenz|mesh-list
2259451|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2259452|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2259453|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
2259454|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259455|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259456|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2259457|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2259458|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
2259459|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259460|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2259461|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2259462|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2259463|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2259464|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
2259465|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
856549|NCT02356679|Ethanol|ethanol|mesh-list
856550|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
856551|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
856552|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
856553|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856901|NCT02354937|Cabotegravir|cabotegravir|mesh-list
856902|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
856903|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
856904|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856905|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856906|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
856907|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
856908|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
856909|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259466|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2259467|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2259468|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2259469|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2259470|NCT00158457|Tenofovir|tenofovir|mesh-list
2259471|NCT00158457|Emtricitabine|emtricitabine|mesh-list
2259472|NCT00158457|Efavirenz|efavirenz|mesh-list
2259473|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
2259474|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259475|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2259476|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2259477|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259478|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259479|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2259480|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2259481|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
855815|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
855816|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
855817|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
855818|NCT02358993|Methenamine|methenamine|mesh-list
855819|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
855820|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
855821|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
855822|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
855823|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
855824|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855825|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855826|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
855827|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
855828|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
855829|NCT02358993|Renal Agents|renal agents|mesh-ancestor
2259482|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2259483|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2259484|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2259485|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2259486|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
856611|NCT02356146|Tacrolimus|tacrolimus|mesh-list
856612|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
856613|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
856614|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856615|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
856616|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856617|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259487|NCT00158470|Lamivudine|lamivudine|mesh-list
2259488|NCT00158470|Efavirenz|efavirenz|mesh-list
2259489|NCT00158470|Didanosine|didanosine|mesh-list
856795|NCT02355236|Celecoxib|celecoxib|mesh-list
856796|NCT02355236|Naproxen|naproxen|mesh-list
856797|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
856798|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
856799|NCT02355236|Analgesics|analgesics|mesh-ancestor
856800|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
856801|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
856802|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856803|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
856804|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
856805|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
856806|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
856807|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856808|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856809|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
857136|NCT02354027|Metformin|metformin|mesh-list
857137|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
857138|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857619|NCT02351895|Copper|copper|mesh-list
857620|NCT02351895|Trace Elements|trace elements|mesh-ancestor
857621|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
857622|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259490|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2259491|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
858283|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
858284|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
858285|NCT02349399|Cyproterone|cyproterone|mesh-list
858286|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
855516|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
855517|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
855518|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855519|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
855520|NCT02360592|Analgesics|analgesics|mesh-ancestor
855521|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
855522|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855698|NCT02359214|Vitamin D|vitamin d|mesh-list
855699|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
855700|NCT02359214|Vitamins|vitamins|mesh-ancestor
855701|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
855702|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855703|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
855704|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2259492|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259493|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259494|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
2259495|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259496|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2259497|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2259498|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2259499|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2259500|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2259501|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2259502|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2259503|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2259504|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
2259505|NCT00158483|Acyclovir|acyclovir|mesh-list
2259506|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
2259507|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857267|NCT02353494|Piperaquine|piperaquine|mesh-list
857268|NCT02353494|Artenimol|artenimol|mesh-list
857269|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
857270|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
857271|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
857272|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857343|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
857344|NCT02353182|Remifentanil|remifentanil|mesh-list
857345|NCT02353182|Bupivacaine|bupivacaine|mesh-list
857346|NCT02353182|Ropivacaine|ropivacaine|mesh-list
857347|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
857348|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
857349|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
857350|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857351|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
857352|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857353|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
857354|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
857355|NCT02353182|Analgesics|analgesics|mesh-ancestor
857356|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
857357|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
857358|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
857359|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
857360|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
857361|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857362|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
857363|NCT02353182|Narcotics|narcotics|mesh-ancestor
857476|NCT02352545|Montelukast|montelukast|mesh-list
857477|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
857478|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
857479|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
857480|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
857481|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857482|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857483|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
857484|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
857485|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857553|NCT02352402|Ticagrelor|ticagrelor|mesh-list
857554|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
857555|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
857556|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
857557|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
857558|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
857559|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
857588|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259508|NCT00158496|Interferons|interferons|mesh-list
2259509|NCT00158496|Ribavirin|ribavirin|mesh-list
2259510|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
2259511|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
2259512|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2259513|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259514|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
2259515|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259516|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
2259517|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259518|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
2259519|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259520|NCT00158509|Valacyclovir|valacyclovir|mesh-list
2259521|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
2259522|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259523|NCT00158522|Interferons|interferons|mesh-list
2259524|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
2259525|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
2259526|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2259527|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259528|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
2259529|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259530|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
2259531|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259532|NCT00158548|Artesunate|artesunate|mesh-list
2259533|NCT00158548|Chloroquine|chloroquine|mesh-list
2259534|NCT00158548|Primaquine|primaquine|mesh-list
2259535|NCT00158548|Amodiaquine|amodiaquine|mesh-list
2259536|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
2259537|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2259538|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2259539|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259540|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259541|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
2259542|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
2259543|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2259544|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
2259545|NCT00158548|Amebicides|amebicides|mesh-ancestor
2259546|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2259547|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
2259548|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
2259549|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2259550|NCT00158561|Dapsone|dapsone|mesh-list
2259551|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
2259552|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
2259553|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2259554|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2259555|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259556|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2259557|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857530|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
857531|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
857532|NCT02352597|Clomiphene|clomiphene|mesh-list
857533|NCT02352597|Enclomiphene|enclomiphene|mesh-list
857534|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
857535|NCT02352597|Estradiol|estradiol|mesh-list
857536|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
857537|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
857538|NCT02352597|Estrogens|estrogens|mesh-ancestor
857539|NCT02352597|Hormones|hormones|mesh-ancestor
857540|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857541|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857542|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
857543|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
857544|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
857545|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
857546|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
857547|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
857548|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
857549|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
857550|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
857551|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
857552|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
857584|NCT02352168|Budesonide|budesonide|mesh-list
857585|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
857586|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
857587|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
2259558|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259559|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2259560|NCT00158561|Renal Agents|renal agents|mesh-ancestor
2259561|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
2259562|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2259563|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
2259564|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
2259565|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
855830|NCT02359136|Epinephrine|epinephrine|mesh-list
855831|NCT02359136|Analgesics|analgesics|mesh-list
855832|NCT02359136|Anesthetics|anesthetics|mesh-list
855833|NCT02359136|Ropivacaine|ropivacaine|mesh-list
855834|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
855835|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855836|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
855837|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
855838|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855839|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
855840|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
855841|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
855842|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
855843|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855844|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
855845|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
855846|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
855847|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
855848|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
855849|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
855850|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
855851|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
856117|NCT02358018|Edotreotide|edotreotide|mesh-list
856118|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
856119|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856716|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
856717|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856718|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
856719|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856720|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099669|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099670|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2099671|NCT02359903|Infliximab|infliximab|mesh-list
2099672|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
2099673|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2099674|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2099675|NCT02360098|Anesthetics|anesthetics|mesh-list
2099676|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099677|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099678|NCT02360124|Fluorides|fluorides|mesh-list
2099679|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
2099680|NCT02360124|Protective Agents|protective agents|mesh-ancestor
2099681|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099682|NCT02360215|Memantine|memantine|mesh-list
2099683|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2099684|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2099685|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
2259566|NCT00158574|Dapsone|dapsone|mesh-list
2259567|NCT00158574|Mefloquine|mefloquine|mesh-list
2259568|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
2259569|NCT00158574|Proguanil|proguanil|mesh-list
2259570|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
2259571|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2259572|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2259573|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259574|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2259575|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259576|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259577|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2259578|NCT00158574|Renal Agents|renal agents|mesh-ancestor
2259579|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
2259580|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
857913|NCT02351180|Beclomethasone|beclomethasone|mesh-list
857914|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
857915|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
857916|NCT02351180|Hormones|hormones|mesh-ancestor
857917|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857918|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857919|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
857920|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
2099686|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259581|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
2259582|NCT00158587|Primaquine|primaquine|mesh-list
2259583|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
855710|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2259584|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2259585|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2259586|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259587|NCT00158652|Carboplatin|carboplatin|mesh-list
2259588|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259589|NCT00158678|Cisplatin|cisplatin|mesh-list
2259590|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259591|NCT00158691|Amifostine|amifostine|mesh-list
2259592|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2259593|NCT00158691|Protective Agents|protective agents|mesh-ancestor
2259594|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259595|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2259596|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
2259597|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259598|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2259599|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2259600|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259601|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259602|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2259603|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
2259604|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259605|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2259606|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2259607|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259608|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259609|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2259610|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
2259611|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259612|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2259613|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2259614|NCT00158782|Lapatinib|lapatinib|mesh-list
2259615|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259616|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2259617|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259618|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259619|NCT00158821|Tenofovir|tenofovir|mesh-list
2259620|NCT00158821|Lamivudine|lamivudine|mesh-list
2259621|NCT00158821|Efavirenz|efavirenz|mesh-list
2259622|NCT00158821|Stavudine|stavudine|mesh-list
2259623|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
2259624|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259625|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2259626|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2259627|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259628|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259629|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2259630|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2259631|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2259632|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2259633|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
857853|NCT02351622|Dexamethasone|dexamethasone|mesh-list
857854|NCT02351622|Caffeic acid|caffeic acid|mesh-list
857855|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
857856|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
857857|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
857858|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857859|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857860|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
857861|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
857862|NCT02351622|Hormones|hormones|mesh-ancestor
857863|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857864|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
857865|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
857866|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
857867|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857868|NCT02351622|Protective Agents|protective agents|mesh-ancestor
858115|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
858116|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
858117|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259634|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2259635|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2259636|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2259637|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
2259638|NCT00158834|Fluticasone|fluticasone|mesh-list
2099687|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099688|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099689|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
856328|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
856329|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
856330|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
856331|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856991|NCT02354560|Erythromycin|erythromycin|mesh-list
856992|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
856993|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
856994|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
856995|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
856996|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
856997|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
856998|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
856999|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857000|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857251|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
857252|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
857253|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
857254|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857255|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857256|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
857257|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857258|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857259|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
857517|NCT02352701|Amoxicillin|amoxicillin|mesh-list
857518|NCT02352701|Levofloxacin|levofloxacin|mesh-list
857519|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
857520|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857521|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
857522|NCT02352701|Renal Agents|renal agents|mesh-ancestor
857523|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
857524|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
857525|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857526|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857527|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
857528|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
857529|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
857623|NCT02352155|Epinephrine|epinephrine|mesh-list
857624|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
857625|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
857626|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
857627|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
857628|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857629|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857630|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
857631|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
857632|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
857633|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857634|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
857635|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
857636|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
857637|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
857638|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
857804|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
857805|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
857806|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
857807|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
857808|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857809|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857810|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857811|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
858342|NCT02349282|Vitamin D|vitamin d|mesh-list
858343|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
858344|NCT02349282|Calcifediol|calcifediol|mesh-list
858345|NCT02349282|Vitamins|vitamins|mesh-ancestor
858346|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
858347|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858348|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
858349|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2259639|NCT00158834|Xhance|xhance|mesh-list
2259640|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2259641|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
855754|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855755|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
855756|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
855757|NCT02359331|Antacids|antacids|mesh-ancestor
855758|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
855759|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
856308|NCT02357602|Tenofovir|tenofovir|mesh-list
856309|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
856310|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
856311|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
856312|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
856313|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856314|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856315|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
856316|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
856353|NCT02357212|Adenosine|adenosine|mesh-list
856354|NCT02357212|Analgesics|analgesics|mesh-ancestor
856355|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
856356|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
856357|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856358|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
856359|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
856360|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
856361|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
856362|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
856363|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
856364|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856457|NCT02357004|Carvedilol|carvedilol|mesh-list
856458|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
856459|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
856460|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
856461|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
856462|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
856463|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856464|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856465|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
856466|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
856467|NCT02357004|Protective Agents|protective agents|mesh-ancestor
856468|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
856469|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
856470|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
856471|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
856472|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
856473|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
856474|NCT02357004|Diuretics|diuretics|mesh-ancestor
856475|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
856476|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
856733|NCT02355639|Betamethasone|betamethasone|mesh-list
856734|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
856735|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
856736|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
856737|NCT02355639|Clobetasol|clobetasol|mesh-list
856738|NCT02355639|Petrolatum|petrolatum|mesh-list
856739|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
856740|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
856741|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
856742|NCT02355639|Hormones|hormones|mesh-ancestor
856743|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
856744|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856745|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
856746|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
856747|NCT02355639|Emollients|emollients|mesh-ancestor
856748|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
856818|NCT02355093|Ropivacaine|ropivacaine|mesh-list
856819|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
856820|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
856821|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
856822|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856823|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
856824|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259642|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2259643|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
2259644|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259645|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259646|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2259647|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
2259648|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
2259649|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2259650|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2259651|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2259652|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2259653|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
855872|NCT02358850|Acetaminophen|acetaminophen|mesh-list
855873|NCT02358850|Oxycodone|oxycodone|mesh-list
855874|NCT02358850|Hydromorphone|hydromorphone|mesh-list
855875|NCT02358850|Hydrocodone|hydrocodone|mesh-list
855876|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
855877|NCT02358850|Analgesics|analgesics|mesh-ancestor
855878|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
855879|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
855880|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855881|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
855882|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
855883|NCT02358850|Narcotics|narcotics|mesh-ancestor
855884|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
855885|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
855886|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
857093|NCT02354170|Mifepristone|mifepristone|mesh-list
857094|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
857095|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
857096|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
857097|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857098|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
857099|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
857100|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
857101|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
857102|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
857103|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
857104|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
857105|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857106|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
857107|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
857108|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2259654|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259655|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259656|NCT00158847|Fluticasone|fluticasone|mesh-list
2259657|NCT00158847|Xhance|xhance|mesh-list
2259658|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2259659|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2259660|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2259661|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
857486|NCT02352883|Hormones|hormones|mesh-list
857487|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857488|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858410|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
858411|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
858661|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
858662|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
858663|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2259662|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259663|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259664|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2259665|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
2259666|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
2259667|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2259668|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2259669|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2259670|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2259671|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
2259672|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
855769|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259673|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259674|NCT00158873|Fentanyl|fentanyl|mesh-list
2259675|NCT00158873|Midazolam|midazolam|mesh-list
2259676|NCT00158873|Morphine|morphine|mesh-list
2259677|NCT00158873|Remifentanil|remifentanil|mesh-list
2259678|NCT00158873|Lorazepam|lorazepam|mesh-list
2259679|NCT00158873|Propofol|propofol|mesh-list
2259680|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2259681|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2259682|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259683|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2259684|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
2259685|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
2259686|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2259687|NCT00158873|Narcotics|narcotics|mesh-ancestor
2259688|NCT00158873|Analgesics|analgesics|mesh-ancestor
2259689|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
2259690|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259691|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2259692|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2259693|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2259694|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2259695|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
2259696|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
2259697|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259698|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259699|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
2259700|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
2259701|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
2259702|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2259703|NCT00158886|Topotecan|topotecan|mesh-list
2259704|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2259705|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2259706|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259707|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259708|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259709|NCT00158990|Sertraline|sertraline|mesh-list
856297|NCT02357563|Leuprolide|leuprolide|mesh-list
856298|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
856299|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
856300|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
856301|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
856302|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856303|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
856304|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856305|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
856306|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
856307|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
856763|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
856764|NCT02355197|Vitamins|vitamins|mesh-ancestor
856765|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
856766|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856767|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
856768|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856769|NCT02355197|Protective Agents|protective agents|mesh-ancestor
857001|NCT02354872|Nicotine|nicotine|mesh-list
857002|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
857003|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
857004|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857005|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857006|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
857007|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
857008|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
857009|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
857010|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857276|NCT02353260|Docetaxel|docetaxel|mesh-list
857277|NCT02353260|Fluorouracil|fluorouracil|mesh-list
857278|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
857279|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
857280|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
857281|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
857282|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857283|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
857284|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
857285|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
857286|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
857287|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855780|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855781|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856124|NCT02358161|Gemcitabine|gemcitabine|mesh-list
856125|NCT02358161|Paclitaxel|paclitaxel|mesh-list
856126|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
856127|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856128|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
856129|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
856130|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
856131|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856132|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
856133|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
856134|NCT02358161|Antiviral Agents|antiviral agents|mesh-ancestor
856135|NCT02358161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
856136|NCT02358161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856137|NCT02358161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
856138|NCT02358161|Immunologic Factors|immunologic factors|mesh-ancestor
856139|NCT02358161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856286|NCT02357732|Nivolumab|nivolumab|mesh-list
856287|NCT02357732|Trametinib|trametinib|mesh-list
856288|NCT02357732|Dabrafenib|dabrafenib|mesh-list
856289|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
856290|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856291|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
856292|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856293|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
856294|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856618|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
856619|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
856749|NCT02355184|Leronlimab|leronlimab|mesh-list
856750|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
856751|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
856752|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856753|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
856754|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
856755|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
856756|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857201|NCT02353702|Ropivacaine|ropivacaine|mesh-list
857202|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
857203|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
857204|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
857205|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857206|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
857207|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857900|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
857901|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
857902|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
857903|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
857904|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857905|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
857906|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857907|NCT02351440|Analgesics|analgesics|mesh-ancestor
857908|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
857909|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857910|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
857911|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
857912|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
858084|NCT02350543|Aspirin|aspirin|mesh-list
858085|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
858086|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
858087|NCT02350543|Analgesics|analgesics|mesh-ancestor
858088|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
858089|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858090|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858091|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
858092|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
858093|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
858094|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
858095|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858096|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
858097|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
858098|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858099|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
858207|NCT02349802|Exenatide|exenatide|mesh-list
855871|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
856094|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
856095|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
856096|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
856097|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
856098|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
856099|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
856100|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
856101|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
856102|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856103|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856104|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
856105|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
856106|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
856721|NCT02355522|Lidocaine|lidocaine|mesh-list
856722|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
856723|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
856724|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
856725|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856726|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
856727|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
856728|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
856729|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
856730|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
856731|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
856732|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856865|NCT02354768|Lanreotide|lanreotide|mesh-list
856866|NCT02354768|Loperamide|loperamide|mesh-list
856867|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
856868|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856869|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
857152|NCT02354053|Triumeq|triumeq|mesh-list
857153|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
857154|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
857155|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
857156|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259710|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
2259711|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2259712|NCT00158990|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2259713|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2259714|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2259715|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858019|NCT02350439|Adenosine|adenosine|mesh-list
858020|NCT02350439|Analgesics|analgesics|mesh-ancestor
858021|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
858022|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858023|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858024|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
858025|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
858026|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
858027|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
858028|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
858029|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858030|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858074|NCT02350335|Nicotine|nicotine|mesh-list
858075|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
858076|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
858077|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858078|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858079|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
858080|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
858081|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
858082|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858083|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099690|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2099691|NCT02360280|Midazolam|midazolam|mesh-list
2099692|NCT02360280|Ketamine|ketamine|mesh-list
2099693|NCT02360280|Analgesics|analgesics|mesh-ancestor
2099694|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
2099695|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099696|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099697|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
858317|NCT02349516|Squalamine|squalamine|mesh-list
858318|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
858319|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2259716|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259717|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
2259718|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259719|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
2259720|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259721|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2259722|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259723|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259724|NCT00159081|Haloperidol|haloperidol|mesh-list
2259725|NCT00159081|Risperidone|risperidone|mesh-list
2259726|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
2259727|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2259728|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
2259729|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
856477|NCT02357069|Etanercept|etanercept|mesh-list
856478|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
856479|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
856480|NCT02357069|Analgesics|analgesics|mesh-ancestor
856481|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
856482|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
856483|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856484|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
856485|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
856486|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
856487|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
856488|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
2259730|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259731|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259732|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2259733|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2259734|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2259735|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2259736|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2259737|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
2259738|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
2259739|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
2259740|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259741|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2259742|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2259743|NCT00159094|Vinorelbine|vinorelbine|mesh-list
2259744|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2259745|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259746|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
2259747|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
2259748|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
2259749|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259750|NCT00159107|Acamprosate|acamprosate|mesh-list
2259751|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2259752|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
2259753|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2259754|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2259755|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259756|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2259757|NCT00159133|Lorazepam|lorazepam|mesh-list
2259758|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
2259759|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
2259760|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
2259761|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
2259762|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259763|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259764|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2259765|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2259766|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2259767|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2259768|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2259769|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2259770|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
2259771|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
2259772|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259773|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259774|NCT00159146|Pindolol|pindolol|mesh-list
2259775|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2259776|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2259777|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
2259778|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858354|NCT02349607|Ibuprofen|ibuprofen|mesh-list
855927|NCT02359162|Vincristine|vincristine|mesh-list
855928|NCT02359162|Pegaspargase|pegaspargase|mesh-list
855929|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
855930|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
855931|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
855932|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
855933|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
855934|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
855935|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
855936|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
855937|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
855938|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
855939|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
855940|NCT02359162|Antiviral Agents|antiviral agents|mesh-ancestor
855941|NCT02359162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
855942|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
855943|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
855944|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
855945|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
855946|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
855947|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
855948|NCT02359162|Hormones|hormones|mesh-ancestor
855949|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
855950|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
855951|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
855952|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
855953|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
855954|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
856177|NCT02358083|Vaccines|vaccines|mesh-list
856178|NCT02358083|Immunologic Factors|immunologic factors|mesh-ancestor
856179|NCT02358083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856277|NCT02357615|Nifedipine|nifedipine|mesh-list
856278|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
856279|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
856280|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856281|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
856282|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856283|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
856284|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
856285|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2259779|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259780|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259781|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2259782|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2259783|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
2259784|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
2259785|NCT00159159|Cyclosporine|cyclosporine|mesh-list
2259786|NCT00159159|Cyclosporins|cyclosporins|mesh-list
2259787|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259788|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259789|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2259790|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
2259791|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259792|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
2259793|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
856810|NCT02355054|Choline|choline|mesh-list
856811|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
856812|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
856813|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
856814|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856815|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
856816|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
856817|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
2259794|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
2259795|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2259796|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2259797|NCT00159211|Pioglitazone|pioglitazone|mesh-list
857260|NCT02353676|Bupivacaine|bupivacaine|mesh-list
857261|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
857262|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
857263|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
857264|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857265|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
857266|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857562|NCT02352285|Tolvaptan|tolvaptan|mesh-list
856070|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
856140|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
856141|NCT02358057|Alfentanil|alfentanil|mesh-list
856142|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
856143|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
856144|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856145|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
856146|NCT02358057|Analgesics|analgesics|mesh-ancestor
856147|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
856148|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
856149|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
856150|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
856151|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
856152|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
856153|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
856154|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856155|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
856156|NCT02358057|Narcotics|narcotics|mesh-ancestor
856157|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
856158|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
856159|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
2099698|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2099699|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
2099700|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
2099701|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099702|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2259798|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2259799|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259800|NCT00159224|Ritonavir|ritonavir|mesh-list
2259801|NCT00159224|Lopinavir|lopinavir|mesh-list
2259802|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2259803|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2259804|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
2259805|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259806|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259807|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2259808|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2259809|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
2259810|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259811|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2259812|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2259813|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
2259814|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2259815|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
2259816|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259817|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259818|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2259819|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
2259820|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2259821|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
2259822|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259823|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259824|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2259825|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
2259826|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
2259827|NCT00159302|Protective Agents|protective agents|mesh-ancestor
2259828|NCT00159380|Pimagedine|pimagedine|mesh-list
2259829|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259830|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858301|NCT02349490|Hemostatics|hemostatics|mesh-list
858302|NCT02349490|Coagulants|coagulants|mesh-ancestor
2259831|NCT00159445|Gemcitabine|gemcitabine|mesh-list
2259832|NCT00159445|Capecitabine|capecitabine|mesh-list
2259833|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2259834|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
2259835|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858590|NCT02348333|Dotinurad|dotinurad|mesh-list
858591|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
858592|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
858593|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
858594|NCT02348333|Renal Agents|renal agents|mesh-ancestor
2099703|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2099704|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099705|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099706|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
856197|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
856198|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856199|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
856200|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
856201|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
856202|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
856203|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
856204|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
856389|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
856390|NCT02357303|Simethicone|simethicone|mesh-list
856391|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
856392|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
856393|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
856394|NCT02357303|Expectorants|expectorants|mesh-ancestor
856395|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
856396|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
856397|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
856398|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856399|NCT02357303|Protective Agents|protective agents|mesh-ancestor
856400|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856401|NCT02357303|Antidotes|antidotes|mesh-ancestor
856402|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
856403|NCT02357303|Emollients|emollients|mesh-ancestor
856404|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
856489|NCT02356913|Nicotine|nicotine|mesh-list
856490|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
856491|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
856492|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
856493|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856494|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
856495|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
856496|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
856497|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
856498|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857334|NCT02353429|Toremifene|toremifene|mesh-list
857335|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
857336|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
857337|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
857338|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
857339|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
857340|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857341|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857342|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2259836|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259837|NCT00159445|Antiviral Agents|antiviral agents|mesh-ancestor
2259838|NCT00159445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259839|NCT00159445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259840|NCT00159445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2259841|NCT00159445|Immunologic Factors|immunologic factors|mesh-ancestor
2259842|NCT00159445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259843|NCT00159458|Gemcitabine|gemcitabine|mesh-list
2259844|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
2259845|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2259846|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
2259847|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259848|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259849|NCT00159458|Antiviral Agents|antiviral agents|mesh-ancestor
2259850|NCT00159458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259851|NCT00159458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259852|NCT00159458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
858041|NCT02350686|Capecitabine|capecitabine|mesh-list
858042|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
858043|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
858044|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
858045|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858046|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858182|NCT02349919|Procaterol|procaterol|mesh-list
858183|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
858184|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
858185|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858186|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858187|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
858188|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
858189|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
2259853|NCT00159458|Immunologic Factors|immunologic factors|mesh-ancestor
2259854|NCT00159458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259855|NCT00159471|Gemcitabine|gemcitabine|mesh-list
2259856|NCT00159471|Capecitabine|capecitabine|mesh-list
2259857|NCT00159471|Docetaxel|docetaxel|mesh-list
2259858|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
856757|NCT02355509|Acarbose|acarbose|mesh-list
856758|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
856759|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856760|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856761|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
856762|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857170|NCT02353988|Bicalutamide|bicalutamide|mesh-list
857171|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
857172|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
857173|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857174|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857175|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
857374|NCT02353130|Memantine|memantine|mesh-list
857375|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
857376|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
857377|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
857378|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
857379|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857380|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857381|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
857382|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2259859|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
2259860|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259861|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259862|NCT00159471|Antiviral Agents|antiviral agents|mesh-ancestor
2259863|NCT00159471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259864|NCT00159471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259865|NCT00159471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2259866|NCT00159471|Immunologic Factors|immunologic factors|mesh-ancestor
2259867|NCT00159471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259868|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
2259869|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
2259870|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
2259871|NCT00159484|Celecoxib|celecoxib|mesh-list
2259872|NCT00159484|Epothilone B|epothilone b|mesh-list
2259873|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2259874|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2259875|NCT00159484|Analgesics|analgesics|mesh-ancestor
2259876|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
2259877|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259878|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259879|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2259880|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2259881|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
857890|NCT02351427|Bortezomib|bortezomib|mesh-list
857891|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858375|NCT02349243|Entacapone|entacapone|mesh-list
858376|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
858377|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
858378|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
858379|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858380|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858813|NCT02347111|Sotalol|sotalol|mesh-list
858814|NCT02347111|Flecainide|flecainide|mesh-list
858815|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
858816|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
858817|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
858818|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858819|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858820|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858821|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
858822|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
858823|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
858824|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858825|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
858826|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
858827|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
858954|NCT02346682|Clonazepam|clonazepam|mesh-list
858955|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
859107|NCT02345837|Clomiphene|clomiphene|mesh-list
856352|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259882|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2259883|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259884|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259885|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2259886|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
2259887|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
2259888|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
2259889|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
2259890|NCT00159510|Methylene Blue|methylene blue|mesh-list
2259891|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2259892|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
2259893|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259894|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259895|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2259896|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
2259897|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2259898|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
2259899|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259900|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259901|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2259902|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
2259903|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
2259904|NCT00159510|Protective Agents|protective agents|mesh-ancestor
856784|NCT02355119|Gemcitabine|gemcitabine|mesh-list
856785|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
856786|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
856787|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856788|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856789|NCT02355119|Antiviral Agents|antiviral agents|mesh-ancestor
856790|NCT02355119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
856791|NCT02355119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856792|NCT02355119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
856793|NCT02355119|Immunologic Factors|immunologic factors|mesh-ancestor
856794|NCT02355119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259905|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259906|NCT00159536|Metformin|metformin|mesh-list
2259907|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2259908|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259909|NCT00159575|Metformin|metformin|mesh-list
2259910|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2259911|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259912|NCT00159614|Rolofylline|rolofylline|mesh-list
2259913|NCT00159614|Diuretics|diuretics|mesh-ancestor
2259914|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
2259915|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259916|NCT00159627|Rolofylline|rolofylline|mesh-list
2259917|NCT00159627|Diuretics|diuretics|mesh-ancestor
2259918|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
2259919|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259920|NCT00159653|Timolol|timolol|mesh-list
2259921|NCT00159653|Latanoprost|latanoprost|mesh-list
2259922|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2259923|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2259924|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
2259925|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2259926|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259927|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857698|NCT02352311|Tadalafil|tadalafil|mesh-list
857699|NCT02352311|Dutasteride|dutasteride|mesh-list
857700|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
857701|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
857702|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
857703|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857704|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857705|NCT02352311|Urological Agents|urological agents|mesh-ancestor
857706|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
857707|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
857708|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
857709|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857710|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857972|NCT02350959|Atorvastatin|atorvastatin|mesh-list
857973|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
857974|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
857975|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
2259928|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
856373|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856374|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
856375|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
856376|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
856377|NCT02357407|Renal Agents|renal agents|mesh-ancestor
856892|NCT02354807|Mirabegron|mirabegron|mesh-list
856893|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
856894|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
856895|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
856896|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
856897|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
856898|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856899|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856900|NCT02354807|Urological Agents|urological agents|mesh-ancestor
857288|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
857289|NCT02353325|Fesoterodine|fesoterodine|mesh-list
857290|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
857291|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857292|NCT02353325|Protective Agents|protective agents|mesh-ancestor
857293|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857294|NCT02353325|Vitamins|vitamins|mesh-ancestor
857295|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
857296|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
857297|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
857298|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
857299|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
857300|NCT02353325|Urological Agents|urological agents|mesh-ancestor
857832|NCT02351804|Dexamethasone|dexamethasone|mesh-list
857833|NCT02351804|Ropivacaine|ropivacaine|mesh-list
857834|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
857835|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
857836|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
857837|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857838|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857839|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
857840|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
857841|NCT02351804|Hormones|hormones|mesh-ancestor
857842|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857843|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
857844|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
857845|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
857846|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
857847|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
857848|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
857880|NCT02351297|Caseins|caseins|mesh-list
857881|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
857882|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
857883|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259929|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2259930|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2259931|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2259932|NCT00159666|Pregabalin|pregabalin|mesh-list
2259933|NCT00159666|Analgesics|analgesics|mesh-ancestor
2259934|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
2259935|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259936|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259937|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
2259938|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
858828|NCT02347046|Dotinurad|dotinurad|mesh-list
858829|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
858830|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
858831|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
858832|NCT02347046|Renal Agents|renal agents|mesh-ancestor
859493|NCT02344511|Vancomycin|vancomycin|mesh-list
859494|NCT02344511|Cefazolin|cefazolin|mesh-list
859495|NCT02344511|Dalbavancin|dalbavancin|mesh-list
859496|NCT02344511|Oxacillin|oxacillin|mesh-list
859497|NCT02344511|Nafcillin|nafcillin|mesh-list
859498|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
859499|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
859669|NCT02344095|Paclitaxel|paclitaxel|mesh-list
859670|NCT02344095|Cisplatin|cisplatin|mesh-list
859671|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
859672|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859673|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
859674|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
859675|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
859676|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259939|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2259940|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259941|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2259942|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2259943|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2259944|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2259945|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2259946|NCT00159679|Pregabalin|pregabalin|mesh-list
2259947|NCT00159679|Analgesics|analgesics|mesh-ancestor
2259948|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
2259949|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259950|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259951|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
856668|NCT02355938|Vancomycin|vancomycin|mesh-list
856669|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
856670|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
856671|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2259952|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2259953|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2259954|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259955|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2259956|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2259957|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2259958|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2259959|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2259960|NCT00159692|Amlodipine|amlodipine|mesh-list
2259961|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2259962|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2259963|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2259964|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259965|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
856929|NCT02354638|Nicotine|nicotine|mesh-list
856930|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
856931|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
856932|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
856933|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856934|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
856935|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
856936|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
856937|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
856938|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259966|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259967|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
2259968|NCT00159705|Pregabalin|pregabalin|mesh-list
2259969|NCT00159705|Analgesics|analgesics|mesh-ancestor
2259970|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
2259971|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754612|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754613|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2754614|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754615|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2754616|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
2754617|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754618|NCT00248287|Carboplatin|carboplatin|mesh-list
2754619|NCT00248287|Irinotecan|irinotecan|mesh-list
2754620|NCT00248287|Cetuximab|cetuximab|mesh-list
2754621|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754622|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2754623|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
857869|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
857870|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
857871|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
857872|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
857873|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
857874|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857875|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
857876|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
857877|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857878|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
857879|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2259972|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259973|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
2259974|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
856512|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259975|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2259976|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259977|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2259978|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
856647|NCT02355704|Atorvastatin|atorvastatin|mesh-list
856648|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
856649|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
856650|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
856651|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856652|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
856653|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
856654|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
856825|NCT02355379|Capecitabine|capecitabine|mesh-list
856826|NCT02355379|Fluorouracil|fluorouracil|mesh-list
856827|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
856828|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
856829|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
856830|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
856831|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
856832|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
856833|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857567|NCT02352558|Dexamethasone|dexamethasone|mesh-list
857568|NCT02352558|Bortezomib|bortezomib|mesh-list
857569|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
857570|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
857571|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
857572|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
857573|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857574|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857575|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
857576|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
857577|NCT02352558|Hormones|hormones|mesh-ancestor
857578|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857579|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
857580|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
857581|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
857582|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857583|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857672|NCT02351908|Tenofovir|tenofovir|mesh-list
857673|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
857674|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
857675|NCT02351908|Dolutegravir|dolutegravir|mesh-list
857676|NCT02351908|Cobicistat|cobicistat|mesh-list
857677|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
857678|NCT02351908|Elvitegravir|elvitegravir|mesh-list
857679|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
857680|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857681|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
857682|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
857683|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857684|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857685|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
857686|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
857687|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
857688|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
857689|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
857690|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
857884|NCT02351232|Liraglutide|liraglutide|mesh-list
857885|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
857886|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857887|NCT02351232|Incretins|incretins|mesh-ancestor
857888|NCT02351232|Hormones|hormones|mesh-ancestor
857889|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857991|NCT02350985|Propranolol|propranolol|mesh-list
857992|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
857993|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
857994|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
857995|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
857996|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
857997|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857998|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259979|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2259980|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2259981|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2259982|NCT00159718|Amlodipine|amlodipine|mesh-list
2259983|NCT00159718|Atorvastatin|atorvastatin|mesh-list
2259984|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2259985|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2259986|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
2259987|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2259988|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2259989|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2259990|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2259991|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2259992|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2259993|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2259994|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2259995|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2259996|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
2259997|NCT00159731|Pregabalin|pregabalin|mesh-list
2259998|NCT00159731|Analgesics|analgesics|mesh-ancestor
2259999|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
857639|NCT02351973|Amiloride|amiloride|mesh-list
857640|NCT02351973|Diuretics|diuretics|mesh-ancestor
857641|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
857642|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857643|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
857644|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
857645|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
857646|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857647|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
857648|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
857790|NCT02351765|Cisplatin|cisplatin|mesh-list
857791|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858167|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
858168|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
858169|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
858170|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858171|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
858172|NCT02350179|Coagulants|coagulants|mesh-ancestor
858222|NCT02349763|Dexamethasone|dexamethasone|mesh-list
858223|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
858224|NCT02349763|BB 1101|bb 1101|mesh-list
858225|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
858226|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
858227|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
858228|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858229|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858230|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
858231|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
858232|NCT02349763|Hormones|hormones|mesh-ancestor
858233|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
858234|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
858235|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858236|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
858237|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858238|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260000|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2260001|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260002|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
858971|NCT02346539|Nicotine|nicotine|mesh-list
858972|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
858973|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
858974|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858975|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858976|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
858977|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
858978|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
858979|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858980|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859279|NCT02345590|Eplerenone|eplerenone|mesh-list
859280|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
859281|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
859282|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859283|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
856646|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
2099707|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2099708|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2260003|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2260004|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2260005|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260006|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2260007|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2260008|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2260009|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2260010|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2260011|NCT00159744|Olanzapine|olanzapine|mesh-list
2260012|NCT00159744|Asenapine|asenapine|mesh-list
2260013|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
2260014|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
2260015|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2260016|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260017|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260018|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2260019|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2260020|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
857038|NCT02354261|Itraconazole|itraconazole|mesh-list
857039|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
857040|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857041|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
857042|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
857043|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857044|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857045|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
857046|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
857047|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857048|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857049|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
857144|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
857145|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
857146|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
857147|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857148|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857149|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
857150|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
857151|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
858100|NCT02350517|Paclitaxel|paclitaxel|mesh-list
858101|NCT02350517|Endostar protein|endostar protein|mesh-list
858102|NCT02350517|Endostatins|endostatins|mesh-list
858103|NCT02350517|Nedaplatin|nedaplatin|mesh-list
858104|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
858105|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858106|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
858107|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
858108|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
858109|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858110|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
858111|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
858112|NCT02350517|Growth Substances|growth substances|mesh-ancestor
858113|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858114|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
859009|NCT02346357|Ropivacaine|ropivacaine|mesh-list
859010|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
859011|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
859012|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
859013|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859014|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
859015|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
859137|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
859138|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
859139|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
859140|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
859141|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859142|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859143|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2099709|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2099710|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2260021|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2260022|NCT00159744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2260023|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2260024|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2260025|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260026|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
857162|NCT02353858|Fluorouracil|fluorouracil|mesh-list
857163|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
857164|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857165|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
857166|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
857167|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
857168|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
857169|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857273|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
857274|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
857275|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857433|NCT02352714|Lidocaine|lidocaine|mesh-list
857434|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
857435|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
857436|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
857437|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857438|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
857439|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857440|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
857441|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
857442|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
857443|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
857444|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858137|NCT02350400|Irinotecan|irinotecan|mesh-list
858138|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
858139|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
858140|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858141|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858142|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858239|NCT02349906|Treosulfan|treosulfan|mesh-list
858240|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
858241|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
858242|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858243|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260027|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
2260028|NCT00159757|Ziprasidone|ziprasidone|mesh-list
2260029|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2260030|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
2260031|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260032|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260033|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260034|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2260035|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2260036|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2260037|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2260038|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2260039|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
2260040|NCT00159770|Olanzapine|olanzapine|mesh-list
2260041|NCT00159770|Risperidone|risperidone|mesh-list
859159|NCT02345746|Leucovorin|leucovorin|mesh-list
859160|NCT02345746|Folic Acid|folic acid|mesh-list
859161|NCT02345746|Fluorouracil|fluorouracil|mesh-list
859162|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
859163|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
859164|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
859165|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859166|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
859167|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859168|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
859169|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
859170|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859171|NCT02345746|Antidotes|antidotes|mesh-ancestor
859172|NCT02345746|Protective Agents|protective agents|mesh-ancestor
859173|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
859174|NCT02345746|Vitamins|vitamins|mesh-ancestor
859175|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
859176|NCT02345746|Hematinics|hematinics|mesh-ancestor
859353|NCT02345213|Donepezil|donepezil|mesh-list
2260042|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2260043|NCT00159770|Ziprasidone|ziprasidone|mesh-list
856945|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
856946|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
856947|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260044|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2260045|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
2260046|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260047|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260048|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260049|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2260050|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2260051|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2260052|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2260053|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2260054|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
2260055|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
2260056|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
2260057|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857331|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
857332|NCT02353507|Laxatives|laxatives|mesh-ancestor
857333|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260058|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260059|NCT00159770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2260060|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2260061|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2260062|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
858031|NCT02350712|Carboplatin|carboplatin|mesh-list
858032|NCT02350712|Cetuximab|cetuximab|mesh-list
858033|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858034|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2260063|NCT00159796|Olanzapine|olanzapine|mesh-list
2260064|NCT00159796|Asenapine|asenapine|mesh-list
2260065|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
2260066|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
2260067|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2260068|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260069|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260070|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2260071|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2260072|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2260073|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2260074|NCT00159796|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2260075|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2260076|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2260077|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260078|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260079|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
2260080|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
2260081|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260082|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
2754624|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858981|NCT02346578|Flutamide|flutamide|mesh-list
858982|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
858983|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
858984|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
858985|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858986|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
858987|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859523|NCT02344550|Everolimus|everolimus|mesh-list
859524|NCT02344550|Letrozole|letrozole|mesh-list
859525|NCT02344550|Leuprolide|leuprolide|mesh-list
859526|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859527|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
859528|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
859529|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859530|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
859531|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
859532|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859533|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859534|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
859535|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
859536|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859537|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
859538|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
859539|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
859540|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2260083|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2260084|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2099711|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
2099712|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
2099713|NCT02360319|Aripiprazole|aripiprazole|mesh-list
2099714|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
2099715|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
857248|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
857249|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
857250|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857364|NCT02353247|Norethindrone|norethindrone|mesh-list
857365|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
857366|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
857367|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
857368|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
857369|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
857370|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
857371|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857372|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
857373|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2260085|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260086|NCT00159809|Urological Agents|urological agents|mesh-ancestor
2260087|NCT00159835|Atorvastatin|atorvastatin|mesh-list
2260088|NCT00159835|Simvastatin|simvastatin|mesh-list
2260089|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
857665|NCT02352025|Equol|equol|mesh-list
857666|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
857667|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
857668|NCT02352025|Estrogens|estrogens|mesh-ancestor
857669|NCT02352025|Hormones|hormones|mesh-ancestor
857670|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857671|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858381|NCT02349204|Zaleplon|zaleplon|mesh-list
858382|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
858383|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
858384|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
858385|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858386|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
858387|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
858388|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858389|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260090|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2260091|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
2260092|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260093|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2260094|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2260095|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260096|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
2260097|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099716|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2099717|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2099718|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099719|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099720|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
2099721|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
2099722|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099723|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099724|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2099725|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2099726|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
859431|NCT02344862|Dotinurad|dotinurad|mesh-list
859432|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
859433|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
859434|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
859435|NCT02344862|Renal Agents|renal agents|mesh-ancestor
2260098|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
2260099|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2260100|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2260101|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260102|NCT00159887|Urological Agents|urological agents|mesh-ancestor
2260103|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
2260104|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260105|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
2260106|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2260107|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
857028|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857029|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
857030|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
857031|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
857032|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857033|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
857034|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
857035|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
857036|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
857037|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857404|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
857405|NCT02352987|Salicylates|salicylates|mesh-list
857406|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857407|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
857408|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
857409|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
857410|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
857411|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
857412|NCT02352987|Analgesics|analgesics|mesh-ancestor
857413|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
857414|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857415|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857416|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
857417|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
857418|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
857419|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857420|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857511|NCT02352519|Anesthetics|anesthetics|mesh-list
857512|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
857513|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
857514|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857515|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
857516|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857951|NCT02350751|MEDI8852|medi8852|mesh-list
857952|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
857953|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
858196|NCT02350023|Betamethasone|betamethasone|mesh-list
858197|NCT02350023|Latanoprost|latanoprost|mesh-list
858198|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
858199|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
858200|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
858201|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
858202|NCT02350023|Hormones|hormones|mesh-ancestor
858203|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
858204|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858205|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
858206|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
858759|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
858760|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
858761|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858762|NCT02347501|Incretins|incretins|mesh-ancestor
858763|NCT02347501|Hormones|hormones|mesh-ancestor
858764|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
858765|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
858766|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
858767|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858768|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260108|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260109|NCT00159900|Urological Agents|urological agents|mesh-ancestor
2260110|NCT00159952|Insulin|insulin|mesh-list
2260111|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2260112|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260113|NCT00159978|Alovudine|alovudine|mesh-list
859696|NCT02343861|Emollients|emollients|mesh-list
859697|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
2099727|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2099728|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2099729|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2099730|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2099731|NCT02360397|Ranolazine|ranolazine|mesh-list
2099732|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2099733|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2099734|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099735|NCT02360475|Vaccines|vaccines|mesh-list
2260114|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
2260115|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857607|NCT02352051|Methylphenidate|methylphenidate|mesh-list
857608|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
857609|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
857610|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857611|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
857612|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
857613|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
857614|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857615|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
857616|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
857617|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
857618|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
2260116|NCT00160030|Cisplatin|cisplatin|mesh-list
2260117|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260118|NCT00160043|Vatalanib|vatalanib|mesh-list
2260119|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2260120|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260121|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260122|NCT00160069|Sagopilone|sagopilone|mesh-list
2260123|NCT00160069|Epothilones|epothilones|mesh-list
2260124|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260125|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
2260126|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
2099736|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
2099737|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099738|NCT02360631|Varenicline|varenicline|mesh-list
2099739|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2099740|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2099741|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
2099742|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099743|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099744|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099745|NCT02360774|Canagliflozin|canagliflozin|mesh-list
2099746|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2099747|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099748|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2099749|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260127|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
858503|NCT02348528|Dexamethasone|dexamethasone|mesh-list
858504|NCT02348528|Lenalidomide|lenalidomide|mesh-list
858505|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
858506|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
858507|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
858508|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858509|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858510|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
858511|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
858512|NCT02348528|Hormones|hormones|mesh-ancestor
858513|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
858514|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
858515|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858516|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
858517|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
858518|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
858519|NCT02348528|Growth Substances|growth substances|mesh-ancestor
858520|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
858754|NCT02347839|Gefitinib|gefitinib|mesh-list
858755|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858756|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
858757|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858758|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260128|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260129|NCT00160160|Eprosartan|eprosartan|mesh-list
2260130|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2260131|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
2260132|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2260133|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260134|NCT00160173|Estradiol|estradiol|mesh-list
2260135|NCT00160173|Estrogens|estrogens|mesh-ancestor
2260136|NCT00160173|Hormones|hormones|mesh-ancestor
2260137|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2260138|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260139|NCT00160186|Pancreatin|pancreatin|mesh-list
857396|NCT02353078|Sucralfate|sucralfate|mesh-list
857397|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
857398|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
857921|NCT02351128|Lanreotide|lanreotide|mesh-list
857922|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858065|NCT02350361|Endostatins|endostatins|mesh-list
858066|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
858067|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
858068|NCT02350361|Growth Substances|growth substances|mesh-ancestor
858069|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858070|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
858071|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260140|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260141|NCT00160238|Betahistine|betahistine|mesh-list
2260142|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
2260143|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
2260144|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
2260145|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260146|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260147|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260148|NCT00160264|Vitamin D|vitamin d|mesh-list
2260149|NCT00160264|Lactulose|lactulose|mesh-list
2260150|NCT00160264|Calcium|calcium|mesh-list
2260151|NCT00160264|Vitamins|vitamins|mesh-ancestor
2260152|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
2260153|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260154|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2260155|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2260156|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260157|NCT00160277|Moxonidine|moxonidine|mesh-list
858622|NCT02348398|Topotecan|topotecan|mesh-list
858623|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
858624|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
858625|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858626|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858627|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858802|NCT02347358|Plasminogen|plasminogen|mesh-list
858803|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
858804|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
858805|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
858806|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260158|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2260159|NCT00160290|Lactulose|lactulose|mesh-list
2260160|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260161|NCT00160316|Estradiol|estradiol|mesh-list
2260162|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
2260163|NCT00160316|Estrogens|estrogens|mesh-ancestor
2260164|NCT00160316|Hormones|hormones|mesh-ancestor
2260165|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2260166|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260167|NCT00160316|Progestins|progestins|mesh-ancestor
2260168|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2260169|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2260170|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2260171|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
2260172|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260173|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260174|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2260175|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2260176|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
2260177|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260178|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
2260179|NCT00160342|Estrogens|estrogens|mesh-list
859475|NCT02344810|Leucovorin|leucovorin|mesh-list
859476|NCT02344810|Fluorouracil|fluorouracil|mesh-list
859477|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
859478|NCT02344810|Calcium|calcium|mesh-list
859479|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
859480|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
859481|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859482|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
859483|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859484|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2260180|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
2260181|NCT00160342|Estrone|estrone|mesh-list
2260182|NCT00160342|Testosterone|testosterone|mesh-list
2260183|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
2260184|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
2260185|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2260186|NCT00160342|Hormones|hormones|mesh-ancestor
2099750|NCT02360995|Triclosan|triclosan|mesh-list
2099751|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
2099752|NCT02360995|Fluorides|fluorides|mesh-list
2099753|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
2099754|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
2099755|NCT02360995|Protective Agents|protective agents|mesh-ancestor
2099756|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099757|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2099758|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099759|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2099760|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2099761|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
2099762|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099763|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2099764|NCT02361476|Clonidine|clonidine|mesh-list
2099765|NCT02361476|Analgesics|analgesics|mesh-ancestor
2099766|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
2099767|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099768|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099769|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2099770|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
2099771|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
858052|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
858053|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
858054|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
858055|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
858056|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858057|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858058|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858059|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
858060|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
858061|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858062|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
858063|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
858064|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
2260187|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2260188|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858807|NCT02347423|Vaccines|vaccines|mesh-list
858808|NCT02347423|Immunologic Factors|immunologic factors|mesh-ancestor
858809|NCT02347423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859252|NCT02345681|Furosemide|furosemide|mesh-list
859253|NCT02345681|Diuretics|diuretics|mesh-ancestor
859254|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
859255|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859256|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
859257|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
859258|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260189|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2260190|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260191|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
2260192|NCT00160342|Androgens|androgens|mesh-ancestor
2260193|NCT00160355|Fludarabine|fludarabine|mesh-list
2260194|NCT00160355|Melphalan|melphalan|mesh-list
2260195|NCT00160355|Thiotepa|thiotepa|mesh-list
2260196|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260197|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260198|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
859845|NCT02343536|Prednisone|prednisone|mesh-list
859846|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
859847|NCT02343536|Rituximab|rituximab|mesh-list
859848|NCT02343536|Vincristine|vincristine|mesh-list
859849|NCT02343536|Azacitidine|azacitidine|mesh-list
859850|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
859851|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
859852|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859853|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
859854|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
859855|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
2260199|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
2260200|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260201|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2754625|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857746|NCT02351869|Midazolam|midazolam|mesh-list
857747|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
857748|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
857749|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
857750|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
857751|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857752|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
857753|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
857754|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
857755|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
857756|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
857757|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
857758|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
857759|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
857760|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
857761|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857762|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
857763|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
857764|NCT02351869|Analgesics|analgesics|mesh-ancestor
857765|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
857766|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857987|NCT02350946|Oxytocin|oxytocin|mesh-list
857988|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
857989|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
857990|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858439|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
858440|NCT02348905|Hormones|hormones|mesh-ancestor
858441|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
858442|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859119|NCT02345993|Beclomethasone|beclomethasone|mesh-list
859120|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
859121|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
859122|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
859123|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
859124|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859125|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
859126|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
859127|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
859128|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
859129|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
859130|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
859131|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
859132|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859133|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
859134|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
859135|NCT02345993|Hormones|hormones|mesh-ancestor
859136|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859966|NCT02343250|Valsartan|valsartan|mesh-list
859967|NCT02343250|Cilnidipine|cilnidipine|mesh-list
859968|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
859969|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
859970|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
859971|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859972|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
859973|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
859974|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
859975|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860013|NCT02342717|Itraconazole|itraconazole|mesh-list
860014|NCT02342717|BI 425809|bi 425809|mesh-list
860015|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
860016|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860017|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
860018|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
860019|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860020|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860021|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
860022|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
860023|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
860024|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860025|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
860026|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
857560|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857561|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099772|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2099773|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2099774|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2099775|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
2099776|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858271|NCT02349828|Acyclovir|acyclovir|mesh-list
858272|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
858273|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
858477|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
858478|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
858479|NCT02348762|Glycine|glycine|mesh-list
858480|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
858481|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
858482|NCT02348762|Expectorants|expectorants|mesh-ancestor
858483|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
858484|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
858485|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
858486|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858487|NCT02348762|Protective Agents|protective agents|mesh-ancestor
858488|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858489|NCT02348762|Antidotes|antidotes|mesh-ancestor
858490|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
858491|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
859018|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
859019|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
859020|NCT02346188|Trace Elements|trace elements|mesh-ancestor
859021|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
859022|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859023|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
859024|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
859025|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
859026|NCT02346188|Protective Agents|protective agents|mesh-ancestor
859935|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
859936|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
859937|NCT02343211|Antibodies|antibodies|mesh-list
859938|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
859939|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860107|NCT02342509|Sevoflurane|sevoflurane|mesh-list
860108|NCT02342509|Desflurane|desflurane|mesh-list
860109|NCT02342509|Isoflurane|isoflurane|mesh-list
860110|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
860111|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
860112|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
860113|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
860114|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
860115|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860193|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
860194|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
860195|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860616|NCT02340455|Pregabalin|pregabalin|mesh-list
860617|NCT02340455|Analgesics|analgesics|mesh-ancestor
860618|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
860619|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
860620|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860621|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
860622|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
860623|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
860624|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860625|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
860626|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
860627|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
860628|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
860629|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2260202|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
2260203|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2260204|NCT00160394|Adapalene|adapalene|mesh-list
2260205|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2260206|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2099777|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099778|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
2099779|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
2099780|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2099781|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099782|NCT02362269|Vitamin D|vitamin d|mesh-list
2099783|NCT02362269|Vitamins|vitamins|mesh-ancestor
857563|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
857564|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857565|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
857566|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857662|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
857663|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
857664|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857812|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
857813|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
857814|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
857815|NCT02351687|Albendazole|albendazole|mesh-list
857816|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
857817|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
857818|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
857819|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857820|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
857821|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857822|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857823|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
857824|NCT02351687|Renal Agents|renal agents|mesh-ancestor
857825|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
857826|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
857827|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
857828|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
857829|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
857830|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
857831|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260207|NCT00160394|Analgesics|analgesics|mesh-ancestor
2260208|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
2260209|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2260210|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260211|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2260212|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
858178|NCT02350218|Alprostadil|alprostadil|mesh-list
858179|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
858180|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
858181|NCT02350218|Urological Agents|urological agents|mesh-ancestor
2260213|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
2260214|NCT00160407|Orlistat|orlistat|mesh-list
2260215|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260216|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260217|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2260218|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2260219|NCT00160485|Glyburide|glyburide|mesh-list
2260220|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2260221|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260222|NCT00160498|Lercanidipine|lercanidipine|mesh-list
2260223|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
859762|NCT02343614|Celecoxib|celecoxib|mesh-list
859763|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
859764|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
859765|NCT02343614|Analgesics|analgesics|mesh-ancestor
859766|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
859767|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
859768|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859769|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
859770|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
859771|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
859772|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
859773|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859774|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862921|NCT02330926|Ibuprofen|ibuprofen|mesh-list
862922|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
862923|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
862924|NCT02330926|Analgesics|analgesics|mesh-ancestor
862925|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
862926|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862927|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862928|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
862929|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
862930|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2260224|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
857589|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857590|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
857591|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
857592|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
857593|NCT02352168|Hormones|hormones|mesh-ancestor
857594|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
857923|NCT02351102|Valacyclovir|valacyclovir|mesh-list
857924|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
857925|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
857980|NCT02350725|Furosemide|furosemide|mesh-list
857981|NCT02350725|Diuretics|diuretics|mesh-ancestor
857982|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
857983|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857984|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
857985|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
857986|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260225|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2260226|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260227|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2260228|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260229|NCT00160511|Levetiracetam|levetiracetam|mesh-list
2260230|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
2260231|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
2260232|NCT00160537|Levocetirizine|levocetirizine|mesh-list
2260233|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2260234|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
858723|NCT02347878|Aprepitant|aprepitant|mesh-list
858724|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
858725|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
858726|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858727|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858728|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
858729|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
858730|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858731|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099784|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
2099785|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859091|NCT02345902|Haloperidol|haloperidol|mesh-list
859092|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
859093|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
859094|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
859095|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
859096|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859097|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
859098|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
859099|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
859100|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
859101|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
859102|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
859103|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
859104|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
859105|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859106|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
859565|NCT02344589|Lidocaine|lidocaine|mesh-list
859566|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
859567|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
859568|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
859569|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859570|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
859571|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
859572|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
859573|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
859574|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
859575|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2099786|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2099787|NCT02362321|Dexamethasone|dexamethasone|mesh-list
2099788|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2099789|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
2099790|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
2099791|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099792|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099793|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2099794|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
2099795|NCT02362321|Hormones|hormones|mesh-ancestor
857959|NCT02351024|Naproxen|naproxen|mesh-list
857960|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
857961|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
857962|NCT02351024|Analgesics|analgesics|mesh-ancestor
857963|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
857964|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
857965|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
857966|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
857967|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
857968|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
857969|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
857970|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
857971|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858274|NCT02349841|Amoxicillin|amoxicillin|mesh-list
858275|NCT02349841|Meropenem|meropenem|mesh-list
858276|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
858277|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
858278|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
858279|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
858280|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858281|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858282|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
858443|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
858444|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
858445|NCT02349113|Estrogens|estrogens|mesh-list
858446|NCT02349113|Estradiol|estradiol|mesh-list
858447|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
858448|NCT02349113|Hormones|hormones|mesh-ancestor
858449|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
858450|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858451|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
858452|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
858453|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
858454|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
858694|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
858695|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
858696|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858697|NCT02348125|Protective Agents|protective agents|mesh-ancestor
858698|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858699|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
858700|NCT02348125|Vitamins|vitamins|mesh-ancestor
858701|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
2260235|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
2260236|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
2260237|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260238|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260239|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260240|NCT00160550|Levetiracetam|levetiracetam|mesh-list
2260241|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
2260242|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
2260243|NCT00160576|Levetiracetam|levetiracetam|mesh-list
2260244|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
858810|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
858811|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
858812|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858998|NCT02346526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
858999|NCT02346526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260245|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
2260246|NCT00160589|Levocetirizine|levocetirizine|mesh-list
2260247|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2260248|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2260249|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
2260250|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
2260251|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260252|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260253|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260254|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
2260255|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2099796|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2099797|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2099798|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099799|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
2099800|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2099801|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
2099802|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
857976|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
857977|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
857978|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
857979|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858118|NCT02350530|Bevacizumab|bevacizumab|mesh-list
858119|NCT02350530|Fluorouracil|fluorouracil|mesh-list
858120|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
858121|NCT02350530|Irinotecan|irinotecan|mesh-list
858122|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
858123|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858124|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
858125|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
858126|NCT02350530|Growth Substances|growth substances|mesh-ancestor
858127|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858128|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
858129|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
858130|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858131|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
858132|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
858133|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
858134|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
858135|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
858136|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858244|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
858245|NCT02349945|Hormones|hormones|mesh-ancestor
858246|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
858247|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260256|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
2260257|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260258|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2260259|NCT00160628|Levetiracetam|levetiracetam|mesh-list
2260260|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
2260261|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
2260262|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2260263|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2260264|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
859382|NCT02345187|Micronutrients|micronutrients|mesh-list
859383|NCT02345187|Trace Elements|trace elements|mesh-list
859384|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859512|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
859513|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
859514|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
859515|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099803|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099804|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2099805|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2099806|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2099807|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2099808|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
2099809|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2099810|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
859960|NCT02342977|Lacosamide|lacosamide|mesh-list
859961|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
859962|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
859963|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
859964|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
859965|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860116|NCT02342392|Ranibizumab|ranibizumab|mesh-list
860117|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
860118|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
860119|NCT02342392|Growth Substances|growth substances|mesh-ancestor
860120|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860121|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
860122|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860237|NCT02342145|Cyclosporine|cyclosporine|mesh-list
860238|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
860239|NCT02342145|Methotrexate|methotrexate|mesh-list
860240|NCT02342145|Cyclosporins|cyclosporins|mesh-list
860241|NCT02342145|Basiliximab|basiliximab|mesh-list
860242|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
860243|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
860244|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
860245|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860246|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
860247|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
2260265|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
857999|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
858000|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
858001|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
858002|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
858003|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
858004|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
858005|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
858006|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
858007|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
858263|NCT02349958|Doxorubicin|doxorubicin|mesh-list
858264|NCT02349958|Cisplatin|cisplatin|mesh-list
858265|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
858266|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858267|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
858268|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
858269|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858270|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858330|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
858331|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
858332|NCT02349386|Estradiol|estradiol|mesh-list
858333|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
858334|NCT02349386|Estrogens|estrogens|mesh-ancestor
858335|NCT02349386|Hormones|hormones|mesh-ancestor
858336|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
858337|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858338|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
858339|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
858340|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
858341|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
858595|NCT02348307|Dotinurad|dotinurad|mesh-list
858596|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
858597|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
858598|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
858599|NCT02348307|Renal Agents|renal agents|mesh-ancestor
859151|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
859152|NCT02345733|Amoxicillin|amoxicillin|mesh-list
859153|NCT02345733|Metronidazole|metronidazole|mesh-list
859154|NCT02345733|Doxycycline|doxycycline|mesh-list
859155|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
859156|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
859157|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
859158|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
859468|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
859469|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
859470|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
859471|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
859472|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859473|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859474|NCT02344823|Urological Agents|urological agents|mesh-ancestor
859577|NCT02344498|Tenofovir|tenofovir|mesh-list
859578|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
859579|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
859580|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
859581|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
859582|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859583|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859584|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
859585|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
859757|NCT02343484|Ethanol|ethanol|mesh-list
859758|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
859759|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
859760|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
859761|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859998|NCT02342769|Abacavir|abacavir|mesh-list
859999|NCT02342769|Dolutegravir|dolutegravir|mesh-list
860000|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
860001|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
860002|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860003|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860004|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
860005|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860006|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
860007|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
860008|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
860009|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2260266|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260267|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2260268|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2260269|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260270|NCT00160849|Lopinavir|lopinavir|mesh-list
2260271|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2260272|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2260273|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
2260274|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260275|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260276|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2260277|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2260278|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
2260279|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260280|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2260281|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2260282|NCT00160875|Irinotecan|irinotecan|mesh-list
2260283|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260284|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2260285|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2260286|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260287|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260288|NCT00160888|Nitroprusside|nitroprusside|mesh-list
2260289|NCT00160888|Acetylcholine|acetylcholine|mesh-list
2260290|NCT00160888|Bradykinin|bradykinin|mesh-list
2260291|NCT00160888|Kininogens|kininogens|mesh-list
2260292|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2260293|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
2260294|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2260295|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260296|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2260297|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
2260298|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260299|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260300|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2260301|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
2260302|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260303|NCT00160927|Nitroprusside|nitroprusside|mesh-list
2260304|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2260305|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
2260306|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2260307|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260308|NCT00160966|Cyclosporine|cyclosporine|mesh-list
2260309|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
2260310|NCT00160966|Everolimus|everolimus|mesh-list
859385|NCT02344940|Tamoxifen|tamoxifen|mesh-list
859386|NCT02344940|Toremifene|toremifene|mesh-list
859387|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
859388|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
859389|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859390|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859391|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
859392|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859393|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
859394|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
859395|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
859516|NCT02344641|Exenatide|exenatide|mesh-list
859517|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
859518|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859519|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
859520|NCT02344641|Incretins|incretins|mesh-ancestor
859521|NCT02344641|Hormones|hormones|mesh-ancestor
859522|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2260311|NCT00160966|Tacrolimus|tacrolimus|mesh-list
2260312|NCT00160966|Cyclosporins|cyclosporins|mesh-list
2260313|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
859809|NCT02343393|Hydralazine|hydralazine|mesh-list
859810|NCT02343393|Isosorbide|isosorbide|mesh-list
859811|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
859812|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
859813|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
859814|NCT02343393|Diuretics|diuretics|mesh-ancestor
859815|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
859816|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859817|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
2260314|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
858173|NCT02350231|Progesterone|progesterone|mesh-list
858174|NCT02350231|Progestins|progestins|mesh-ancestor
858175|NCT02350231|Hormones|hormones|mesh-ancestor
858176|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
858177|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858350|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
858351|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
858352|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
858353|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
858609|NCT02348268|Analgesics|analgesics|mesh-list
858610|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
858611|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858612|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260315|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260316|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2260317|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260318|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260319|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
2260320|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
859296|NCT02345239|Pantoprazole|pantoprazole|mesh-list
859297|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
859298|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
859299|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
859300|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859301|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859500|NCT02344784|Methylphenidate|methylphenidate|mesh-list
859501|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
859502|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859503|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
859504|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
859505|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
859506|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859507|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
859508|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
859872|NCT02343666|Plerixafor|plerixafor|mesh-list
859873|NCT02343666|Carmustine|carmustine|mesh-list
859874|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
859875|NCT02343666|Lenograstim|lenograstim|mesh-list
859876|NCT02343666|Sargramostim|sargramostim|mesh-list
859877|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
859878|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
859879|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859880|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
859881|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
859882|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859883|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859884|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
859885|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
859886|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
859887|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
859888|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860644|NCT02340611|Olaparib|olaparib|mesh-list
860645|NCT02340611|Cediranib|cediranib|mesh-list
860646|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
860647|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860648|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860649|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860650|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2260321|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
2260322|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2260323|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260324|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2260325|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2260326|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
2260327|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2260328|NCT00161018|Risperidone|risperidone|mesh-list
2260329|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2260330|NCT00161018|Fluphenazine|fluphenazine|mesh-list
2260331|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
2260332|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
2260333|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2260334|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
858190|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
858191|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
858192|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
858193|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
858194|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858195|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858600|NCT02348424|Solithromycin|solithromycin|mesh-list
858601|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
858602|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
858933|NCT02346890|Sevelamer|sevelamer|mesh-list
858934|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
858935|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
858936|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260335|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260336|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260337|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260338|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2260339|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2260340|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2260341|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2260342|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2260343|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
2260344|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
2260345|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2260346|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2260347|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
859698|NCT02344472|Paclitaxel|paclitaxel|mesh-list
859699|NCT02344472|Vinorelbine|vinorelbine|mesh-list
859700|NCT02344472|Docetaxel|docetaxel|mesh-list
859701|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
859702|NCT02344472|Capecitabine|capecitabine|mesh-list
859703|NCT02344472|Trastuzumab|trastuzumab|mesh-list
859704|NCT02344472|Letrozole|letrozole|mesh-list
859705|NCT02344472|Fulvestrant|fulvestrant|mesh-list
859706|NCT02344472|Anastrozole|anastrozole|mesh-list
859707|NCT02344472|Exemestane|exemestane|mesh-list
859708|NCT02344472|Goserelin|goserelin|mesh-list
859709|NCT02344472|Pertuzumab|pertuzumab|mesh-list
859710|NCT02344472|Leuprolide|leuprolide|mesh-list
859711|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
859712|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859713|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
859714|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
859715|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
859716|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859717|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
859718|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
859719|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
859720|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
859721|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
859722|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859723|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
859724|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
859725|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859726|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859727|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
859728|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
859729|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
859730|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
859731|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2260348|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2260349|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260350|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
2260351|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260352|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260353|NCT00161044|Galantamine|galantamine|mesh-list
2260354|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2260355|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260356|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260357|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
2260358|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260359|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260360|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2260361|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
2260362|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858208|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
858209|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858210|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
858211|NCT02349802|Incretins|incretins|mesh-ancestor
858212|NCT02349802|Hormones|hormones|mesh-ancestor
858213|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
858432|NCT02349165|Riboflavin|riboflavin|mesh-list
858433|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
858434|NCT02349165|Vitamins|vitamins|mesh-ancestor
858435|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
858436|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858437|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
858438|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
2260363|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
2260364|NCT00161070|Aspirin|aspirin|mesh-list
859000|NCT02346201|Methylphenidate|methylphenidate|mesh-list
859001|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
859002|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859003|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
859004|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
859005|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
859006|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859007|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
859008|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
859324|NCT02345304|Digoxin|digoxin|mesh-list
859325|NCT02345304|Midazolam|midazolam|mesh-list
859326|NCT02345304|Omeprazole|omeprazole|mesh-list
859327|NCT02345304|Warfarin|warfarin|mesh-list
859328|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
859329|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
859330|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
859331|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859332|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
859333|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
859334|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
859335|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
859336|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
859337|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
859338|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
859339|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
859340|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
859341|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859342|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
859343|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
859344|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
859345|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
859346|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859347|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
859348|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
859349|NCT02345304|Protective Agents|protective agents|mesh-ancestor
859677|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
859678|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
859679|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
860196|NCT02342574|Olorofim|olorofim|mesh-list
860197|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
2260365|NCT00161070|Dipyridamole|dipyridamole|mesh-list
858287|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
858288|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
858289|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
858290|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
858291|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
858292|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858293|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
858294|NCT02349399|Estrogens|estrogens|mesh-ancestor
858295|NCT02349399|Hormones|hormones|mesh-ancestor
858296|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
858297|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
858298|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
858299|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858300|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
858628|NCT02348372|Glycine|glycine|mesh-list
858629|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
858630|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858631|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858632|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260366|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2260367|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2260368|NCT00161070|Analgesics|analgesics|mesh-ancestor
2260369|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
2260370|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2260371|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260372|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2260373|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2260374|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2260375|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2260376|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260377|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2260378|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2260379|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260380|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
2260381|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2260382|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
2260383|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2260384|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2260385|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260386|NCT00161096|Pantoprazole|pantoprazole|mesh-list
2260387|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2260388|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260389|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2260390|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260391|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260392|NCT00161122|Vaccines|vaccines|mesh-list
2260393|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2260394|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
2260395|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260396|NCT00161200|Pantoprazole|pantoprazole|mesh-list
2260397|NCT00161200|Ranitidine|ranitidine|mesh-list
2260398|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2260399|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2260400|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260401|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2260402|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260403|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260404|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2260405|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
2260406|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
2260407|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260408|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260409|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
2260410|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2260411|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
2260412|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2260413|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260414|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2260415|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2260416|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2260417|NCT00161239|Prednisone|prednisone|mesh-list
2260418|NCT00161239|Methotrexate|methotrexate|mesh-list
2260419|NCT00161239|Asparaginase|asparaginase|mesh-list
2260420|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2260421|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
858320|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
858321|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
858322|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
858323|NCT02349516|Protective Agents|protective agents|mesh-ancestor
858324|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858325|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858326|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
858327|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
858328|NCT02349516|Growth Substances|growth substances|mesh-ancestor
858329|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
2260422|NCT00161239|Hormones|hormones|mesh-ancestor
2260423|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2260424|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260425|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2260426|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260427|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2260428|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
2260429|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
858736|NCT02347865|Denosumab|denosumab|mesh-list
858737|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
858738|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858792|NCT02347319|Allyl sulfide|allyl sulfide|mesh-list
858793|NCT02347319|Silymarin|silymarin|mesh-list
858794|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
858795|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858796|NCT02347319|Protective Agents|protective agents|mesh-ancestor
858797|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858798|NCT02347319|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
858799|NCT02347319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858800|NCT02347319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
858801|NCT02347319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859074|NCT02346253|Leuprolide|leuprolide|mesh-list
859075|NCT02346253|Goserelin|goserelin|mesh-list
859076|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
859077|NCT02346253|Bicalutamide|bicalutamide|mesh-list
859078|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
859079|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
859080|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
859081|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859082|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
859083|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859084|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
859085|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
859086|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859087|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
859088|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
859089|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
859090|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
859212|NCT02345707|Cabotegravir|cabotegravir|mesh-list
859213|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
859214|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
859215|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859216|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859217|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
859218|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
859219|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
859220|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
859370|NCT02345044|Eplerenone|eplerenone|mesh-list
859371|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
859372|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
859373|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859374|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859375|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
859376|NCT02345044|Diuretics|diuretics|mesh-ancestor
859377|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
859378|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
859750|NCT02343692|Pancrelipase|pancrelipase|mesh-list
859751|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260430|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2260431|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
2260432|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260433|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
2260434|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260435|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
858355|NCT02349607|Pregabalin|pregabalin|mesh-list
858356|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
858357|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
858358|NCT02349607|Analgesics|analgesics|mesh-ancestor
858359|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
858360|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
858361|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858362|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
858363|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
858364|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
858365|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858366|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858367|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
858368|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
858369|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
858370|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
858371|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
858372|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
858373|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
858374|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
858556|NCT02348463|Clindamycin|clindamycin|mesh-list
858557|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
858558|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
858559|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
858560|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
858561|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
858562|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858563|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858578|NCT02348255|Bevacizumab|bevacizumab|mesh-list
858579|NCT02348255|Carmustine|carmustine|mesh-list
858580|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
858581|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
858582|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
858583|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
858584|NCT02348255|Growth Substances|growth substances|mesh-ancestor
858585|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858586|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
858587|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
858588|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
858589|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858679|NCT02348177|Ritonavir|ritonavir|mesh-list
858680|NCT02348177|Lopinavir|lopinavir|mesh-list
858681|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
858682|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
858683|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
858684|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
858685|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858686|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
858687|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
858688|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
858689|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
858690|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
858691|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2260436|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2260437|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
2260438|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2260439|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2260440|NCT00161278|Paclitaxel|paclitaxel|mesh-list
2260441|NCT00161278|Carboplatin|carboplatin|mesh-list
2260442|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2260443|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260444|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
859027|NCT02346110|Dexamethasone|dexamethasone|mesh-list
859028|NCT02346110|Epinephrine|epinephrine|mesh-list
859029|NCT02346110|Racepinephrine|racepinephrine|mesh-list
859030|NCT02346110|Bupivacaine|bupivacaine|mesh-list
859031|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
859032|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
859033|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
859034|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
859035|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
859036|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859037|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
859038|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
859039|NCT02346110|Hormones|hormones|mesh-ancestor
2260445|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
2260446|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
2260447|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260448|NCT00161291|Bevacizumab|bevacizumab|mesh-list
2260449|NCT00161291|Letrozole|letrozole|mesh-list
2260450|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2260451|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260452|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2260453|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2260454|NCT00161291|Growth Substances|growth substances|mesh-ancestor
2260455|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858664|NCT02348190|Heparin|heparin|mesh-list
858665|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
858666|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
858667|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
858668|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260456|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
2260457|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2260458|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2260459|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260460|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260461|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2260462|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
2260463|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2260464|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
2260465|NCT00161304|Testosterone|testosterone|mesh-list
2260466|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
2260467|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
2260468|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2260469|NCT00161304|Androgens|androgens|mesh-ancestor
859350|NCT02345148|Esketamine|esketamine|mesh-list
859351|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
859352|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
859426|NCT02344875|Dotinurad|dotinurad|mesh-list
859427|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
859428|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
859429|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
859430|NCT02344875|Renal Agents|renal agents|mesh-ancestor
860545|NCT02341014|Lenalidomide|lenalidomide|mesh-list
860546|NCT02341014|Romidepsin|romidepsin|mesh-list
860547|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
860548|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860549|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
860550|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
860551|NCT02341014|Growth Substances|growth substances|mesh-ancestor
860552|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
860553|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860554|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
860790|NCT02339662|Gabapentin|gabapentin|mesh-list
860791|NCT02339662|Amitriptyline|amitriptyline|mesh-list
860792|NCT02339662|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
860793|NCT02339662|Analgesics|analgesics|mesh-ancestor
860794|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
860795|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
860796|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860797|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
860798|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
860799|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
860800|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
860801|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
860802|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
860803|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
860804|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
860805|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860806|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
860807|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2260470|NCT00161304|Hormones|hormones|mesh-ancestor
858502|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
858571|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
858572|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
858573|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
858574|NCT02348346|Protective Agents|protective agents|mesh-ancestor
858575|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858576|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
858577|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
858872|NCT02347059|Dopamine|dopamine|mesh-list
858873|NCT02347059|Levodopa|levodopa|mesh-list
858874|NCT02347059|Pramipexole|pramipexole|mesh-list
858875|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
858876|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
858877|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
858878|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
858879|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858880|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858881|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858882|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
858883|NCT02347059|Protective Agents|protective agents|mesh-ancestor
858884|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
858885|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
858886|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
858887|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
859144|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
859145|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
859146|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
859147|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
859148|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859149|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859150|NCT02345980|Urological Agents|urological agents|mesh-ancestor
859268|NCT02345343|Apixaban|apixaban|mesh-list
859269|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
859270|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
859271|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
859272|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
859273|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859274|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859275|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
859775|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
859776|NCT02343419|Miotics|miotics|mesh-ancestor
859777|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
859778|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
859779|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859780|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
859781|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
859782|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
859783|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
859784|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
859785|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
859786|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
859787|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860318|NCT02341872|Calcium|calcium|mesh-list
860319|NCT02341872|Fluorides|fluorides|mesh-list
860320|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
860321|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860322|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
860323|NCT02341872|Protective Agents|protective agents|mesh-ancestor
860377|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
860378|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
860379|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
860380|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
860381|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
860382|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260471|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2260472|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260473|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2260474|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260475|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
2260476|NCT00161330|Amoxicillin|amoxicillin|mesh-list
2260477|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
2260478|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
2260479|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
2260480|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2260481|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260482|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260483|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260484|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2260485|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2260486|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
2260487|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260488|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2260489|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2260490|NCT00161421|Leuprolide|leuprolide|mesh-list
2260491|NCT00161421|Testosterone|testosterone|mesh-list
2260492|NCT00161421|Dutasteride|dutasteride|mesh-list
2260493|NCT00161421|Androgens|androgens|mesh-ancestor
2260494|NCT00161421|Hormones|hormones|mesh-ancestor
858603|NCT02348281|Bicalutamide|bicalutamide|mesh-list
858604|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
858605|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
858606|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
858607|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858608|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859541|NCT02344732|Polymyxins|polymyxins|mesh-list
859542|NCT02344732|Neomycin|neomycin|mesh-list
859543|NCT02344732|Polymyxin B|polymyxin b|mesh-list
859544|NCT02344732|Dexamethasone|dexamethasone|mesh-list
859545|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
859546|NCT02344732|Homatropine|homatropine|mesh-list
859547|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
859548|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
859549|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
859550|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
859551|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859552|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
859553|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
859554|NCT02344732|Hormones|hormones|mesh-ancestor
859555|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859556|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
859557|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859558|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
859559|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
859560|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
859561|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
859562|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859563|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859564|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
859752|NCT02343679|Ceritinib|ceritinib|mesh-list
859753|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859754|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
859755|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859756|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860178|NCT02342275|Propranolol|propranolol|mesh-list
860179|NCT02342275|Atenolol|atenolol|mesh-list
860180|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
860181|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
860182|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
860183|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
860184|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860185|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860186|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
860187|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
860188|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
860189|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
860190|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
860191|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
860192|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2099811|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2099812|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099813|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099814|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
2099815|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
860555|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
860556|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
860557|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
860558|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099816|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
2099817|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099818|NCT02362425|Expectorants|expectorants|mesh-ancestor
2099819|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
2099820|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
858894|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858895|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858896|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
858897|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859059|NCT02346084|Maraviroc|maraviroc|mesh-list
859060|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
859061|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
859062|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859063|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
859064|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
859065|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
859066|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
859067|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2260495|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2260496|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260497|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2260498|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260499|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2260500|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
2260501|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2260502|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2260503|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2260504|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260505|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260506|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
2260507|NCT00161434|Valacyclovir|valacyclovir|mesh-list
2260508|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
2260509|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260510|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2260511|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
2260512|NCT00161447|Testosterone|testosterone|mesh-list
2260513|NCT00161447|Acyline|acyline|mesh-list
2260514|NCT00161447|Androgens|androgens|mesh-ancestor
2260515|NCT00161447|Hormones|hormones|mesh-ancestor
2260516|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2260517|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260518|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2260519|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860102|NCT02342587|Lapatinib|lapatinib|mesh-list
860103|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860104|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
860105|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860106|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860222|NCT02342249|Oseltamivir|oseltamivir|mesh-list
860223|NCT02342249|Antiviral Agents|antiviral agents|mesh-ancestor
860224|NCT02342249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860225|NCT02342249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860226|NCT02342249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860638|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
860639|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
860640|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
860641|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
860642|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860643|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260520|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2260521|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2260522|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2260523|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
2260524|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2260525|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2260526|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2260527|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2260528|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
2099821|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
2099822|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099823|NCT02362425|Protective Agents|protective agents|mesh-ancestor
2099824|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099825|NCT02362425|Antidotes|antidotes|mesh-ancestor
2099826|NCT02362503|Fostemsavir|fostemsavir|mesh-list
2099827|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2099828|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2099829|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
2099830|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260529|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
2260530|NCT00161486|Testosterone|testosterone|mesh-list
2260531|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
2260532|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
2260533|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2260534|NCT00161486|Acyline|acyline|mesh-list
2260535|NCT00161486|Androgens|androgens|mesh-ancestor
2260536|NCT00161486|Hormones|hormones|mesh-ancestor
2260537|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859379|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
859380|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
859381|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260538|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260539|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2260540|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260541|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
2260542|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
2260543|NCT00161564|Rituximab|rituximab|mesh-list
2260544|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2260545|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260546|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
2260547|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860066|NCT02342600|Trametinib|trametinib|mesh-list
860067|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860068|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
860069|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860070|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860133|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
860134|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860135|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
860136|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860137|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860214|NCT02342093|Drospirenone|drospirenone|mesh-list
860215|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
860216|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
860217|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
860218|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860219|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
860220|NCT02342093|Diuretics|diuretics|mesh-ancestor
860221|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
860297|NCT02341833|Sevoflurane|sevoflurane|mesh-list
860298|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
860299|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
860300|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
860301|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
860302|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
860303|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860387|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
860388|NCT02341547|Hematinics|hematinics|mesh-ancestor
860761|NCT02339844|Aripiprazole|aripiprazole|mesh-list
860762|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
860763|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
860764|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
860765|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
860766|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
860767|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860768|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
860769|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
860770|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
860771|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860772|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
860773|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
860774|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
860775|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
860776|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
860777|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
860778|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
860910|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
860911|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
860912|NCT02339441|Methotrexate|methotrexate|mesh-list
860913|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
860914|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
860915|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860916|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
860917|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
858956|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
858957|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
858958|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
858959|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
858960|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
858961|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
858962|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
858963|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
858964|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
858965|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
858966|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
858967|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
859016|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
859017|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260548|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2260549|NCT00161577|Ketorolac|ketorolac|mesh-list
2260550|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2260551|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2260552|NCT00161577|Analgesics|analgesics|mesh-ancestor
2260553|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
2260554|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2260555|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260556|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2260557|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2260558|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
860160|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
860161|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
860162|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
860163|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
860164|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
860165|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
860166|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860484|NCT02341105|Amiodarone|amiodarone|mesh-list
860485|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
860486|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
860487|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
860488|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
860489|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860490|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
860491|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
860492|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
860493|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860494|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
860495|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
860496|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
861464|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
861465|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
861466|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
861467|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861468|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
861469|NCT02337166|Protective Agents|protective agents|mesh-ancestor
861752|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
861753|NCT02336139|Velpatasvir|velpatasvir|mesh-list
861754|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
861755|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260559|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260560|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260561|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
862540|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
862541|NCT02332980|Idelalisib|idelalisib|mesh-list
862542|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
862543|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862544|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862545|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260562|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2260563|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260564|NCT00161655|Etanercept|etanercept|mesh-list
2260565|NCT00161655|Methotrexate|methotrexate|mesh-list
2260566|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2260567|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
2260568|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2260569|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260570|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2260571|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
859040|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859041|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
859042|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859043|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
859044|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
859045|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
859046|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
859047|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
859048|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
859049|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
859050|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
859051|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859052|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
859053|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
859054|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
859055|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
859056|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
859057|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
859058|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
859237|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
859238|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
859239|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
859240|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
859241|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859242|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
859243|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
859244|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
859245|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
859246|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859247|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
859248|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
859249|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
859250|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
859251|NCT02345616|Protective Agents|protective agents|mesh-ancestor
2099831|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2099832|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2099833|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099834|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
2099835|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2099836|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099837|NCT02363270|Ketamine|ketamine|mesh-list
2260572|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859688|NCT02343926|Metformin|metformin|mesh-list
859689|NCT02343926|Vildagliptin|vildagliptin|mesh-list
859690|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
859691|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859692|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
859693|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
859694|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859695|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260573|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260574|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
2260575|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260576|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2260577|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2260578|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
2260579|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2260580|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2260581|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2260582|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2260583|NCT00161655|Analgesics|analgesics|mesh-ancestor
2260584|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
2260585|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2260586|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2260587|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260588|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
2260589|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2260590|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260591|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
2260592|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2260593|NCT00161681|Estradiol|estradiol|mesh-list
860010|NCT02342925|Metformin|metformin|mesh-list
860011|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
860012|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859108|NCT02345837|Enclomiphene|enclomiphene|mesh-list
859109|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
859110|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
859111|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
859112|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859113|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859114|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
859115|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
859116|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
859117|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
859118|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
859396|NCT02344888|Folic Acid|folic acid|mesh-list
859397|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
859398|NCT02344888|Prednisolone|prednisolone|mesh-list
859399|NCT02344888|Citric Acid|citric acid|mesh-list
859400|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
859401|NCT02344888|Clomiphene|clomiphene|mesh-list
859402|NCT02344888|Enclomiphene|enclomiphene|mesh-list
859403|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
859404|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
859405|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
859406|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
859407|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
859408|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859409|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
859410|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
859411|NCT02344888|Hormones|hormones|mesh-ancestor
859412|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859413|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859414|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
859415|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859416|NCT02344888|Hematinics|hematinics|mesh-ancestor
859417|NCT02344888|Vitamins|vitamins|mesh-ancestor
859418|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
859419|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
859420|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
859421|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
859422|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
859423|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
859424|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
859425|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
859509|NCT02344602|Febuxostat|febuxostat|mesh-list
859510|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
859511|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
859604|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
859605|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
859606|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
859607|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
859608|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
859609|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859610|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859611|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859735|NCT02343718|Sirolimus|sirolimus|mesh-list
859736|NCT02343718|Vinblastine|vinblastine|mesh-list
859737|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
859738|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
859739|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
859740|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859741|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
859742|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
859743|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
859744|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859745|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
859746|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
859747|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
859748|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
859749|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860227|NCT02342067|Pioglitazone|pioglitazone|mesh-list
860228|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
860229|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
860230|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860231|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
860232|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860233|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
860234|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
860235|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
860236|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
859284|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
859285|NCT02345590|Diuretics|diuretics|mesh-ancestor
859286|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
859287|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2260594|NCT00161681|Estrogens|estrogens|mesh-ancestor
2260595|NCT00161681|Hormones|hormones|mesh-ancestor
2260596|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859680|NCT02344017|Prednisone|prednisone|mesh-list
859681|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
859682|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
859683|NCT02344017|Hormones|hormones|mesh-ancestor
859684|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859685|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859686|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
859687|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260597|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260598|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2260599|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
2260600|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2260601|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2260602|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2260603|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
861526|NCT02336633|Resveratrol|resveratrol|mesh-list
861527|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
861528|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861529|NCT02336633|Protective Agents|protective agents|mesh-ancestor
861530|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861531|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861532|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
862007|NCT02334865|Lenalidomide|lenalidomide|mesh-list
862008|NCT02334865|Sargramostim|sargramostim|mesh-list
862009|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
862010|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
862011|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862012|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
862013|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
862014|NCT02334865|Growth Substances|growth substances|mesh-ancestor
862015|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
862016|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862017|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
862274|NCT02333799|Linezolid|linezolid|mesh-list
862275|NCT02333799|Bedaquiline|bedaquiline|mesh-list
862276|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
862277|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
862278|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
862279|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862280|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862281|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
862397|NCT02333292|Ritonavir|ritonavir|mesh-list
862398|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
862399|NCT02333292|Grazoprevir|grazoprevir|mesh-list
862400|NCT02333292|Ledipasvir|ledipasvir|mesh-list
862401|NCT02333292|Velpatasvir|velpatasvir|mesh-list
862402|NCT02333292|Simeprevir|simeprevir|mesh-list
862403|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
862404|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
862405|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
862406|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862407|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862408|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
862409|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
862410|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
862411|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099838|NCT02363270|Analgesics|analgesics|mesh-ancestor
2099839|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
2099840|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099841|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099842|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2099843|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2099844|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
2099845|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
2099846|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099847|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2099848|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
859354|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
859355|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859356|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859357|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
859358|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
859359|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859360|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
859597|NCT02344264|Ropivacaine|ropivacaine|mesh-list
859598|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
859599|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
859600|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
859601|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859602|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
859603|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2260604|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2260605|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
859949|NCT02343289|Clarithromycin|clarithromycin|mesh-list
859950|NCT02343289|Esketamine|esketamine|mesh-list
859951|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
859952|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
859953|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
859954|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859955|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859956|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
859957|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
859958|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
859959|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
860075|NCT02342782|Cytarabine|cytarabine|mesh-list
860076|NCT02342782|Etoposide|etoposide|mesh-list
860077|NCT02342782|Melphalan|melphalan|mesh-list
860078|NCT02342782|Carmustine|carmustine|mesh-list
860079|NCT02342782|Basiliximab|basiliximab|mesh-list
860080|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
860081|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860082|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
860083|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
860084|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860085|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860086|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
860087|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
860088|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
860089|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860090|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
860091|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
860092|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860093|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
860094|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
860095|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
860684|NCT02340169|Desoximetasone|desoximetasone|mesh-list
860685|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
860686|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
860687|NCT02340169|Hormones|hormones|mesh-ancestor
860688|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
860689|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860873|NCT02339324|Interferons|interferons|mesh-list
860874|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
860875|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
860876|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
860877|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
860878|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860879|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
860880|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860881|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
860882|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861041|NCT02339116|Bevacizumab|bevacizumab|mesh-list
861042|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
861043|NCT02339116|Irinotecan|irinotecan|mesh-list
861044|NCT02339116|Fluorouracil|fluorouracil|mesh-list
861045|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
861046|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861047|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
861048|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
861049|NCT02339116|Growth Substances|growth substances|mesh-ancestor
861050|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861051|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
861307|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
859485|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859486|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
859487|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
859488|NCT02344810|Antidotes|antidotes|mesh-ancestor
859489|NCT02344810|Protective Agents|protective agents|mesh-ancestor
859490|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
859491|NCT02344810|Vitamins|vitamins|mesh-ancestor
859492|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
859821|NCT02343432|Triamcinolone|triamcinolone|mesh-list
859822|NCT02343432|Bupivacaine|bupivacaine|mesh-list
859823|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
859824|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
859825|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
859826|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859827|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
859828|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
859829|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
859830|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
859831|NCT02343432|Hormones|hormones|mesh-ancestor
859832|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859930|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
859931|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859932|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
859933|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
859934|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860383|NCT02341586|Iron|iron|mesh-list
860384|NCT02341586|Trace Elements|trace elements|mesh-ancestor
860385|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
860386|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860535|NCT02340988|Oritavancin|oritavancin|mesh-list
860536|NCT02340988|Warfarin|warfarin|mesh-list
860537|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
860538|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
860539|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860704|NCT02340117|Gemcitabine|gemcitabine|mesh-list
860705|NCT02340117|Paclitaxel|paclitaxel|mesh-list
860706|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
860707|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
860708|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860709|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
860710|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
860711|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
860712|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860713|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
860714|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
860715|NCT02340117|Antiviral Agents|antiviral agents|mesh-ancestor
860716|NCT02340117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860717|NCT02340117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860718|NCT02340117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
860719|NCT02340117|Immunologic Factors|immunologic factors|mesh-ancestor
860720|NCT02340117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861255|NCT02338011|Gefitinib|gefitinib|mesh-list
861256|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861257|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
861258|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861259|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861687|NCT02336152|Anesthetics|anesthetics|mesh-list
861688|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
861689|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861813|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
861814|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
861815|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
861816|NCT02335593|Hematinics|hematinics|mesh-ancestor
861817|NCT02335593|Astringents|astringents|mesh-ancestor
861818|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861819|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
861879|NCT02335281|Mesalamine|mesalamine|mesh-list
861880|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
861881|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
861882|NCT02335281|Analgesics|analgesics|mesh-ancestor
861883|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
861884|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
861885|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861886|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
861887|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2754626|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2754627|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
2754628|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
859576|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859629|NCT02344186|Liraglutide|liraglutide|mesh-list
859630|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
859631|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
859632|NCT02344186|Incretins|incretins|mesh-ancestor
859633|NCT02344186|Hormones|hormones|mesh-ancestor
859634|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2260606|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
2260607|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2260608|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2260609|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
2260610|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260611|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260612|NCT00161720|Protein C|protein c|mesh-list
2260613|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
2260614|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2260615|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2260616|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260617|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2260618|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
2260619|NCT00161733|Coagulants|coagulants|mesh-ancestor
2260620|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2260621|NCT00161759|Thrombin|thrombin|mesh-list
2260622|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
2260623|NCT00161759|Coagulants|coagulants|mesh-ancestor
2260624|NCT00161811|Vaccines|vaccines|mesh-list
2260625|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
2260626|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260627|NCT00161837|Vaccines|vaccines|mesh-list
2260628|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
861434|NCT02337283|BI 425809|bi 425809|mesh-list
861435|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
861950|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
861951|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
861952|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
861953|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
861954|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
861955|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
861956|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
861957|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861958|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
861959|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
861960|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
861961|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
861962|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862370|NCT02333188|Leucovorin|leucovorin|mesh-list
862371|NCT02333188|Paclitaxel|paclitaxel|mesh-list
862372|NCT02333188|Fluorouracil|fluorouracil|mesh-list
862373|NCT02333188|Irinotecan|irinotecan|mesh-list
862374|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
862375|NCT02333188|Calcium|calcium|mesh-list
862376|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
862377|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
862378|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862379|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
862380|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
862381|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
862382|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862383|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
862384|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862385|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
862386|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
862387|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
862388|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
862389|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
862390|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
862391|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862392|NCT02333188|Antidotes|antidotes|mesh-ancestor
862393|NCT02333188|Protective Agents|protective agents|mesh-ancestor
862394|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
862395|NCT02333188|Vitamins|vitamins|mesh-ancestor
862396|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
2260629|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260630|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2260631|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
2260632|NCT00161902|Coagulants|coagulants|mesh-ancestor
2260633|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2260634|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
2260635|NCT00161915|Coagulants|coagulants|mesh-ancestor
2260636|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2260637|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
2260638|NCT00161980|Coagulants|coagulants|mesh-ancestor
2260639|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
2260640|NCT00161993|Antibodies|antibodies|mesh-list
2260641|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
860497|NCT02341638|Aspirin|aspirin|mesh-list
860498|NCT02341638|Itraconazole|itraconazole|mesh-list
860499|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
860500|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
860501|NCT02341638|Analgesics|analgesics|mesh-ancestor
860502|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
860503|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
860504|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860505|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
860506|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
860507|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
860508|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
860509|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860510|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
860511|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
860512|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860513|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
860514|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
860515|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860516|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
860517|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
860518|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
860519|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
860520|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
860521|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
860630|NCT02340481|Simethicone|simethicone|mesh-list
860631|NCT02340481|Loperamide|loperamide|mesh-list
860632|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
860633|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
860634|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
860635|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860636|NCT02340481|Emollients|emollients|mesh-ancestor
860637|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
861178|NCT02338622|Olaparib|olaparib|mesh-list
861179|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
861180|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861181|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861182|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260642|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2260643|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2260644|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
2260645|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260646|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
2260647|NCT00162006|Antibodies|antibodies|mesh-list
861432|NCT02337231|Borage oil|borage oil|mesh-list
861433|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
861493|NCT02337036|Tacrolimus|tacrolimus|mesh-list
861494|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
861495|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
861496|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861497|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
861498|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861499|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861523|NCT02336698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
861524|NCT02336698|Immunologic Factors|immunologic factors|mesh-ancestor
2260648|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
2260649|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2260650|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2260651|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
2260652|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260653|NCT00162019|Factor VIII|factor viii|mesh-list
2260654|NCT00162019|Coagulants|coagulants|mesh-ancestor
2260655|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2260656|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2260657|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260658|NCT00162110|Cetuximab|cetuximab|mesh-list
2260659|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2099849|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099850|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099851|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
2099852|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
860264|NCT02341911|Gemcitabine|gemcitabine|mesh-list
860265|NCT02341911|Carboplatin|carboplatin|mesh-list
860266|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860267|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
860268|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
860269|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860270|NCT02341911|Antiviral Agents|antiviral agents|mesh-ancestor
860271|NCT02341911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860272|NCT02341911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860273|NCT02341911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
860274|NCT02341911|Immunologic Factors|immunologic factors|mesh-ancestor
860275|NCT02341911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860359|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
860360|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
860361|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
860362|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
860363|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860449|NCT02341300|Iron|iron|mesh-list
860450|NCT02341300|Trace Elements|trace elements|mesh-ancestor
860451|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
860452|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860522|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
860523|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
860524|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
860525|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
860526|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
860527|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860528|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860529|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
860530|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
860531|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
860532|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
860533|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
860534|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
860690|NCT02340182|Metronidazole|metronidazole|mesh-list
860691|NCT02340182|Vancomycin|vancomycin|mesh-list
860692|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
860693|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860694|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
860695|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
860696|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
860697|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
860698|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
860699|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860700|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860701|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860702|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
860703|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
860758|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
860759|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
860760|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861175|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
861176|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
861177|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
861213|NCT02338310|Letrozole|letrozole|mesh-list
861214|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
861215|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861216|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
861217|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099853|NCT02363283|Immunotoxins|immunotoxins|mesh-list
2099854|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
859818|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
859819|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859820|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
860411|NCT02341352|Fluorides|fluorides|mesh-list
860412|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
860413|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
860414|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
860415|NCT02341352|Antibodies|antibodies|mesh-list
860416|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
860417|NCT02341352|Protective Agents|protective agents|mesh-ancestor
860418|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860419|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
861088|NCT02338830|Progesterone|progesterone|mesh-list
861089|NCT02338830|Progestins|progestins|mesh-ancestor
861090|NCT02338830|Hormones|hormones|mesh-ancestor
861091|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
861092|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861183|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
861184|NCT02338518|Etoposide|etoposide|mesh-list
861185|NCT02338518|Epirubicin|epirubicin|mesh-list
861186|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861187|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
861188|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
861189|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
861190|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861191|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861192|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
861470|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
861471|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
861472|NCT02337192|Curcumin|curcumin|mesh-list
861473|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
861474|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
861475|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
861476|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
861477|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
861478|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
861479|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
861480|NCT02337192|Analgesics|analgesics|mesh-ancestor
861481|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
861482|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
861483|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861484|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
861485|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
861486|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861487|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861488|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861489|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
2260660|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260661|NCT00162149|Ritonavir|ritonavir|mesh-list
2260662|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
861726|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
861727|NCT02336048|Chlorambucil|chlorambucil|mesh-list
861728|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
861729|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861730|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
861731|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
861732|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861904|NCT02335190|Lidocaine|lidocaine|mesh-list
861905|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
861906|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
861907|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
861908|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861909|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
861910|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
861911|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
861912|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
861913|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
861914|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
861915|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862069|NCT02334670|Fluconazole|fluconazole|mesh-list
862070|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
862071|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
862072|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
862073|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2260663|NCT00162149|Nevirapine|nevirapine|mesh-list
2099855|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
2099856|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860096|NCT02342444|Enoxaparin|enoxaparin|mesh-list
860097|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
860098|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
860099|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
860100|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
860101|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860276|NCT02342002|Misoprostol|misoprostol|mesh-list
860277|NCT02342002|Mifepristone|mifepristone|mesh-list
860278|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
860279|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
860280|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
860281|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860282|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
860283|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
860284|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
860285|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
860286|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
860287|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
860288|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
860289|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
860290|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
860291|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
860292|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
860293|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
860294|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
860295|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
860296|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
860945|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
860946|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
860947|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
861015|NCT02338934|Vitamin D|vitamin d|mesh-list
861016|NCT02338934|Cinacalcet|cinacalcet|mesh-list
861017|NCT02338934|Vitamins|vitamins|mesh-ancestor
861018|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
861019|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861020|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
861021|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
861022|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
861023|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
861024|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2754629|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
2754630|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754631|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
2754632|NCT00225095|Protective Agents|protective agents|mesh-ancestor
2099857|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
861573|NCT02336568|Oxytocin|oxytocin|mesh-list
861574|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
861575|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
861576|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861876|NCT02335255|Naftifine|naftifine|mesh-list
861877|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
861878|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
862304|NCT02333643|Digoxin|digoxin|mesh-list
862305|NCT02333643|Furosemide|furosemide|mesh-list
862306|NCT02333643|Diuretics|diuretics|mesh-ancestor
862307|NCT02333643|Natriuretic Agents|natriuretic agents|mesh-ancestor
862308|NCT02333643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862309|NCT02333643|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
862310|NCT02333643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
862311|NCT02333643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862312|NCT02333643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
862313|NCT02333643|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
862314|NCT02333643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862315|NCT02333643|Protective Agents|protective agents|mesh-ancestor
862579|NCT02332603|Protective Agents|protective agents|mesh-ancestor
859856|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
859857|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
859858|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
859859|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
859860|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
859861|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
859862|NCT02343536|Hormones|hormones|mesh-ancestor
859863|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
859864|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
859865|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
859866|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
859867|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
859868|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
859869|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
859870|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
859871|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099858|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099859|NCT02363478|Buspirone|buspirone|mesh-list
2099860|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2099861|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2099862|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099863|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099864|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2099865|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2099866|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
2099867|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099868|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099869|NCT02363621|Ranibizumab|ranibizumab|mesh-list
2099870|NCT02363621|Aflibercept|aflibercept|mesh-list
2099871|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2099872|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2099873|NCT02363621|Growth Substances|growth substances|mesh-ancestor
2099874|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099875|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
2099876|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099877|NCT02363738|Infliximab|infliximab|mesh-list
2099878|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
2099879|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2099880|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2099881|NCT02363803|Lidocaine|lidocaine|mesh-list
2099882|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
2099883|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
2099884|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099885|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099886|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
2099887|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099888|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2260664|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2260665|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2260666|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
2260667|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260668|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260669|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2260670|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2260671|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
2260672|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260673|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2260674|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2260675|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
860726|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
860727|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
860728|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
860729|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
860730|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
860731|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
860732|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
860733|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860734|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
860735|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
860736|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
860737|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
860738|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861305|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
861306|NCT02337972|Povidone|povidone|mesh-list
2260676|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2260677|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
860364|NCT02341703|Metformin|metformin|mesh-list
860365|NCT02341703|Pioglitazone|pioglitazone|mesh-list
860366|NCT02341703|Letrozole|letrozole|mesh-list
860367|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
860368|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860369|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860370|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
860371|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
860372|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860373|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860374|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
860375|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
860376|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
861244|NCT02338245|Capecitabine|capecitabine|mesh-list
861245|NCT02338245|Lapatinib|lapatinib|mesh-list
861246|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
861247|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
861248|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861249|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861250|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
861251|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861501|NCT02336984|Trastuzumab|trastuzumab|mesh-list
861502|NCT02336984|Pertuzumab|pertuzumab|mesh-list
861503|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
861504|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862246|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
862247|NCT02334124|Floxacillin|floxacillin|mesh-list
862248|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
862249|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
862554|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
862555|NCT02332473|Molgramostim|molgramostim|mesh-list
862556|NCT02332473|Sargramostim|sargramostim|mesh-list
862557|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
862558|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862559|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
862560|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
862561|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260678|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2260679|NCT00162188|Efavirenz|efavirenz|mesh-list
2260680|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2260681|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2260682|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260683|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260684|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
2260685|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260686|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2260687|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2260688|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2260689|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2260690|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
863623|NCT02327676|Emtricitabine|emtricitabine|mesh-list
863624|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
863625|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863626|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
863627|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
863628|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863629|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863630|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
863631|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2260691|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2260692|NCT00162201|Abatacept|abatacept|mesh-list
2260693|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2260694|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260695|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260696|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2260697|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
2260698|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260699|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2260700|NCT00162214|Ketoconazole|ketoconazole|mesh-list
2260701|NCT00162214|Dasatinib|dasatinib|mesh-list
2260702|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260703|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2260704|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260705|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260706|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
2260707|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260708|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2260709|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2260710|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2260711|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
2260712|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2260713|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260714|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2260715|NCT00162227|Efavirenz|efavirenz|mesh-list
2260716|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2260717|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2260718|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260719|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260720|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
2260721|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260722|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2260723|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2260724|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2260725|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2260726|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2260727|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2260728|NCT00162279|Abatacept|abatacept|mesh-list
2260729|NCT00162279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2260730|NCT00162279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260731|NCT00162279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260732|NCT00162279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2260733|NCT00162279|Immunologic Factors|immunologic factors|mesh-ancestor
2260734|NCT00162279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260735|NCT00162279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2260736|NCT00162292|Methotrexate|methotrexate|mesh-list
2260737|NCT00162292|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2260738|NCT00162292|Abortifacient Agents|abortifacient agents|mesh-ancestor
2260739|NCT00162292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2260740|NCT00162292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260741|NCT00162292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2260742|NCT00162292|Antimetabolites|antimetabolites|mesh-ancestor
2260743|NCT00162292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861226|NCT02338323|Febuxostat|febuxostat|mesh-list
861227|NCT02338323|Benzbromarone|benzbromarone|mesh-list
861228|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
861229|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
861230|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
861231|NCT02338323|Renal Agents|renal agents|mesh-ancestor
2260744|NCT00162292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260745|NCT00162292|Dermatologic Agents|dermatologic agents|mesh-ancestor
2260746|NCT00162292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260747|NCT00162292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2260748|NCT00162292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2260749|NCT00162292|Immunologic Factors|immunologic factors|mesh-ancestor
2260750|NCT00162292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2260751|NCT00162292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2260752|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
2260753|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2260754|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260755|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2260756|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260757|NCT00162318|Cetuximab|cetuximab|mesh-list
2260758|NCT00162318|Gefitinib|gefitinib|mesh-list
2260759|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2260760|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260761|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2260762|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260763|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260764|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2260765|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2260766|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260767|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2260768|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2260769|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260770|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2260771|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2260772|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260773|NCT00162383|Dapsone|dapsone|mesh-list
860443|NCT02341209|Doxycycline|doxycycline|mesh-list
860444|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
860445|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860446|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
860447|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
860448|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2260774|NCT00162383|Debrisoquin|debrisoquin|mesh-list
2260775|NCT00162383|Mephenytoin|mephenytoin|mesh-list
2260776|NCT00162383|Caffeine|caffeine|mesh-list
2260777|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2260778|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099889|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2099890|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2099891|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2099892|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099893|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
2099894|NCT02363946|Promethazine|promethazine|mesh-list
2099895|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2099896|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
863004|NCT02331251|Gemcitabine|gemcitabine|mesh-list
863005|NCT02331251|Paclitaxel|paclitaxel|mesh-list
863006|NCT02331251|Vinorelbine|vinorelbine|mesh-list
863007|NCT02331251|Docetaxel|docetaxel|mesh-list
863008|NCT02331251|Doxorubicin|doxorubicin|mesh-list
863009|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
863010|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
863011|NCT02331251|Irinotecan|irinotecan|mesh-list
863012|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
863013|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863014|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
863015|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
863016|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
863017|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863018|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
863019|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
863020|NCT02331251|Antiviral Agents|antiviral agents|mesh-ancestor
863021|NCT02331251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863022|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863023|NCT02331251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
863024|NCT02331251|Immunologic Factors|immunologic factors|mesh-ancestor
863025|NCT02331251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863026|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
863027|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
863028|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
863029|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
863030|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
863159|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
863160|NCT02330120|Propofol|propofol|mesh-list
863161|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
863162|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
863163|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863164|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
863165|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
863166|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
863167|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
863168|NCT02330120|Analgesics|analgesics|mesh-ancestor
863169|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
863170|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863171|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
863172|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
863173|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2260779|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2260780|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260781|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260782|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2260783|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2260784|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
2260785|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260786|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260787|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
2260788|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2260789|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2260790|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2260791|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
2260792|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2260793|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2260794|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
2260795|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
2260796|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2260797|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
2260798|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
2260799|NCT00162396|Albuterol|albuterol|mesh-list
2260800|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2260801|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
860350|NCT02341729|Ticagrelor|ticagrelor|mesh-list
860351|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
860352|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
860353|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
860354|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
860355|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
860356|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
860357|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860358|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860389|NCT02341365|Vitamin D|vitamin d|mesh-list
860390|NCT02341365|Vitamins|vitamins|mesh-ancestor
860391|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
860392|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860393|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2260802|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2260803|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260804|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2260805|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
2260806|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
2260807|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2260808|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2099897|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2099898|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099899|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
2099900|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
2099901|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
2099902|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099903|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
2099904|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
2260809|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2260810|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2260811|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
2260812|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260813|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260814|NCT00162409|Folic Acid|folic acid|mesh-list
861838|NCT02335372|Acetic Acid|acetic acid|mesh-list
861839|NCT02335372|Proflavine|proflavine|mesh-list
861840|NCT02335372|Retinol acetate|retinol acetate|mesh-list
861841|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
861842|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
861843|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
861844|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
861845|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861846|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
861847|NCT02335372|Protective Agents|protective agents|mesh-ancestor
861848|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861849|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
862023|NCT02334501|Lansoprazole|lansoprazole|mesh-list
862024|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
862025|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
862026|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2099905|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260815|NCT00162409|Hematinics|hematinics|mesh-ancestor
860198|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860996|NCT02339129|Ibuprofen|ibuprofen|mesh-list
860997|NCT02339129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
860998|NCT02339129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
860999|NCT02339129|Analgesics|analgesics|mesh-ancestor
861000|NCT02339129|Sensory System Agents|sensory system agents|mesh-ancestor
861001|NCT02339129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
861002|NCT02339129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861003|NCT02339129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
861004|NCT02339129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
861005|NCT02339129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
861006|NCT02339129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861007|NCT02339129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861157|NCT02338687|Calcium|calcium|mesh-list
861158|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
861159|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861223|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
861224|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
861225|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
861490|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
861491|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
861492|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861546|NCT02336750|Aprepitant|aprepitant|mesh-list
861547|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
861548|NCT02336750|Mirtazapine|mirtazapine|mesh-list
861549|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
861550|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
861551|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
861552|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861553|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
861554|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
861555|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
861556|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861557|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
861558|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
861559|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
861560|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
861561|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
861562|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
861563|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
861564|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
861565|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
861566|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
861567|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
861568|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
861569|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
861570|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
861571|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
861572|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
861700|NCT02336347|Quinidine|quinidine|mesh-list
861701|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
861702|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
861703|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
861704|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
861705|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
861706|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
861707|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861708|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861709|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
861710|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
861711|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
861712|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
861713|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
861714|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
861715|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
861716|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
861717|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861718|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
861719|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
861720|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
861721|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
861722|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
861723|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
862074|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260816|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
2260817|NCT00162409|Vitamins|vitamins|mesh-ancestor
2260818|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
2260819|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260820|NCT00162422|Albuterol|albuterol|mesh-list
2260821|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2260822|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
2260823|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2260824|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860893|NCT02339428|Diclofenac|diclofenac|mesh-list
860894|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
860895|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
860896|NCT02339428|Analgesics|analgesics|mesh-ancestor
860897|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
860898|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
860899|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860900|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
860901|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
860902|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
860903|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860904|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860966|NCT02339064|Apomorphine|apomorphine|mesh-list
860967|NCT02339064|Emetics|emetics|mesh-ancestor
860968|NCT02339064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860969|NCT02339064|Autonomic Agents|autonomic agents|mesh-ancestor
860970|NCT02339064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
860971|NCT02339064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
860972|NCT02339064|Dopamine Agonists|dopamine agonists|mesh-ancestor
860973|NCT02339064|Dopamine Agents|dopamine agents|mesh-ancestor
860974|NCT02339064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
860975|NCT02339064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861170|NCT02338570|Everolimus|everolimus|mesh-list
861171|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861172|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
861173|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
861174|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861237|NCT02338206|Hormones|hormones|mesh-list
861238|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
861239|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861425|NCT02337257|Vitamin D|vitamin d|mesh-list
861426|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
861427|NCT02337257|Vitamins|vitamins|mesh-ancestor
861428|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
861429|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861430|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
861431|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
861500|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
862092|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
862093|NCT02334488|Everolimus|everolimus|mesh-list
862094|NCT02334488|Tacrolimus|tacrolimus|mesh-list
862095|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
862096|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
862097|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862098|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
862099|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862100|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862101|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862102|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
862103|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
862104|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
862105|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
862106|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
862257|NCT02333838|Vidarabine|vidarabine|mesh-list
862258|NCT02333838|Fludarabine|fludarabine|mesh-list
862259|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
862260|NCT02333838|Busulfan|busulfan|mesh-list
862261|NCT02333838|Thiotepa|thiotepa|mesh-list
862262|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862263|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
862264|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
862265|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862266|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
862267|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
2260825|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
860248|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860249|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860250|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
860251|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860252|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
860253|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
860254|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
860255|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
860256|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
860257|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
860258|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860259|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
860260|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
860261|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
860262|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
860263|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
860453|NCT02341274|Tacrolimus|tacrolimus|mesh-list
860454|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
860455|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
860456|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860457|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
860458|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860459|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860883|NCT02339532|Carboplatin|carboplatin|mesh-list
860884|NCT02339532|Docetaxel|docetaxel|mesh-list
860885|NCT02339532|Trastuzumab|trastuzumab|mesh-list
860886|NCT02339532|Pertuzumab|pertuzumab|mesh-list
860887|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860888|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
860889|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
860890|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
860891|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860892|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2260826|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
2260827|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
2260828|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2260829|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2260830|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2260831|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2260832|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
2260833|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260834|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260835|NCT00162435|Warfarin|warfarin|mesh-list
2260836|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
862243|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
862244|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
862245|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862327|NCT02333513|Vincristine|vincristine|mesh-list
862328|NCT02333513|Lomustine|lomustine|mesh-list
862329|NCT02333513|Procarbazine|procarbazine|mesh-list
862330|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
862331|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862332|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
862333|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
862334|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
862335|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862336|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
862337|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
862761|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
862762|NCT02331823|Isoniazid|isoniazid|mesh-list
862763|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
862764|NCT02331823|Ethambutol|ethambutol|mesh-list
862765|NCT02331823|Rifabutin|rifabutin|mesh-list
862766|NCT02331823|Streptomycin|streptomycin|mesh-list
862767|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
862768|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
862769|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
862770|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
862771|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862772|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862773|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862774|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
862775|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
862776|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
862777|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
862778|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
2099906|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2099907|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
2099908|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
2099909|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099910|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099911|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2099912|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
2260837|NCT00162461|Phenytoin|phenytoin|mesh-list
2260838|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
2260839|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2260840|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2260841|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2260842|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260843|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2260844|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2260845|NCT00162474|Phenytoin|phenytoin|mesh-list
2260846|NCT00162474|Warfarin|warfarin|mesh-list
2260847|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
2260848|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
2260849|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2260850|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
861240|NCT02338089|Oxytocin|oxytocin|mesh-list
861241|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
861242|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
861243|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861347|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
861348|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
861349|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
861350|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861351|NCT02337855|Antacids|antacids|mesh-ancestor
861352|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861353|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
861389|NCT02337426|Temozolomide|temozolomide|mesh-list
861390|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
861391|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
861392|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
861393|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861394|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861395|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
861396|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
861397|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
861398|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861513|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
861514|NCT02336906|Laxatives|laxatives|mesh-ancestor
861515|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260851|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2260852|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260853|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2260854|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2260855|NCT00162487|Albuterol|albuterol|mesh-list
2260856|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2260857|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
2260858|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2260859|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260860|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2260861|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
2260862|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
2260863|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2260864|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2260865|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
862215|NCT02334046|Remifentanil|remifentanil|mesh-list
862216|NCT02334046|Sevoflurane|sevoflurane|mesh-list
862217|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
862218|NCT02334046|Narcotics|narcotics|mesh-ancestor
862219|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
862220|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862221|NCT02334046|Analgesics|analgesics|mesh-ancestor
862222|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
862223|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862224|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
862225|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
862226|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
862227|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
862982|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
2099913|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
860342|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
860343|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
860344|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
860345|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
860346|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860347|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
860348|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
860349|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860570|NCT02340936|Lenalidomide|lenalidomide|mesh-list
860571|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
860572|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860573|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
860574|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
860575|NCT02340936|Growth Substances|growth substances|mesh-ancestor
860576|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
860577|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861267|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
861268|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861794|NCT02335918|Nivolumab|nivolumab|mesh-list
861795|NCT02335918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
861796|NCT02335918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861797|NCT02335918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
861798|NCT02335918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861857|NCT02335151|Desflurane|desflurane|mesh-list
861858|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
861859|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
861860|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
861861|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
861862|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099914|NCT02363998|Lofexidine|lofexidine|mesh-list
2099915|NCT02363998|Clonidine|clonidine|mesh-list
2099916|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
862669|NCT02332057|Diclofenac|diclofenac|mesh-list
862670|NCT02332057|Lidocaine|lidocaine|mesh-list
862671|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
862672|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
862673|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
862674|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862675|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
862676|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862677|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
862678|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
862679|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
862680|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
862681|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862682|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
862683|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
862684|NCT02332057|Analgesics|analgesics|mesh-ancestor
862685|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
862686|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
862687|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
862688|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863263|NCT02329561|Tramadol|tramadol|mesh-list
863264|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
863265|NCT02329561|Narcotics|narcotics|mesh-ancestor
863266|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
863267|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863268|NCT02329561|Analgesics|analgesics|mesh-ancestor
863269|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
863270|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863331|NCT02329171|Imiquimod|imiquimod|mesh-list
863332|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
863333|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
863334|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863335|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863336|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
863409|NCT02328716|Cisplatin|cisplatin|mesh-list
863410|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260866|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2260867|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
2260868|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260869|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260870|NCT00162526|Tocopherols|tocopherols|mesh-list
2260871|NCT00162526|Vitamin E|vitamin e|mesh-list
2260872|NCT00162526|Tocotrienols|tocotrienols|mesh-list
863858|NCT02327247|Felodipine|felodipine|mesh-list
2260873|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
2260874|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
2260875|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260876|NCT00162526|Protective Agents|protective agents|mesh-ancestor
2260877|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260878|NCT00162526|Vitamins|vitamins|mesh-ancestor
2260879|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
2260880|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
2260881|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2260882|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260883|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260884|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2260885|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2754678|NCT00038727|Metformin|metformin|mesh-list
2754679|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2754680|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861399|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
861400|NCT02337413|Laxatives|laxatives|mesh-ancestor
861401|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
861536|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
861537|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
861538|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861539|NCT02336659|Incretins|incretins|mesh-ancestor
861540|NCT02336659|Hormones|hormones|mesh-ancestor
861541|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
861542|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
861543|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
861544|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861545|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861850|NCT02335411|Capecitabine|capecitabine|mesh-list
861851|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
861852|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861853|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
861854|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
861855|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861856|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
862601|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
862602|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2260886|NCT00162552|Protective Agents|protective agents|mesh-ancestor
860477|NCT02341079|Bupivacaine|bupivacaine|mesh-list
860478|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
860479|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
860480|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
860481|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860482|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
860483|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099917|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2099918|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099919|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
2099920|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099921|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2099922|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2099923|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2099924|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
860857|NCT02339350|Methotrexate|methotrexate|mesh-list
860858|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
860859|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
860860|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
860861|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860862|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
860863|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
860864|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860865|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860866|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
860867|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860868|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
860869|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
860870|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
860871|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
860872|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
860976|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
860977|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
860978|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
860979|NCT02339142|Prednisolone|prednisolone|mesh-list
860980|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
860981|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
860982|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
860983|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
860984|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
860985|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
860986|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
860987|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860988|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
860989|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
860990|NCT02339142|Hormones|hormones|mesh-ancestor
860991|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
860992|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
860993|NCT02339142|Protective Agents|protective agents|mesh-ancestor
860994|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
860995|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260887|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260888|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
2260889|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2260890|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
2260891|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2260892|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2260893|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
863328|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
863329|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
863330|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863471|NCT02328495|Misoprostol|misoprostol|mesh-list
863472|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
863473|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
863474|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2099925|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099926|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099927|NCT02363998|Analgesics|analgesics|mesh-ancestor
2099928|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
2099929|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
2099930|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
2099931|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2099932|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099933|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
2260894|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2260895|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260896|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260897|NCT00162591|Remifentanil|remifentanil|mesh-list
2260898|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
860666|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
860667|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
860668|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
860669|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
860670|NCT02340247|Cathartics|cathartics|mesh-ancestor
2260899|NCT00162591|Narcotics|narcotics|mesh-ancestor
2260900|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2260901|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260902|NCT00162591|Analgesics|analgesics|mesh-ancestor
2260903|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
861232|NCT02338232|Telmisartan|telmisartan|mesh-list
861233|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
861234|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
861235|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
861236|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861311|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
861312|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
861313|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
861314|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
861315|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861316|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861317|NCT02337881|Urological Agents|urological agents|mesh-ancestor
2260904|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2260905|NCT00162604|Cefuroxime|cefuroxime|mesh-list
2260906|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
2260907|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2260908|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260909|NCT00162643|Ritonavir|ritonavir|mesh-list
2260910|NCT00162643|Lopinavir|lopinavir|mesh-list
861586|NCT02336529|Bupivacaine|bupivacaine|mesh-list
861587|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
861588|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
861589|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
861590|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861591|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
861592|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
861888|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
861889|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
861890|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
861891|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861892|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
861893|NCT02335359|Coagulants|coagulants|mesh-ancestor
861985|NCT02334904|Risperidone|risperidone|mesh-list
861986|NCT02334904|Aripiprazole|aripiprazole|mesh-list
861987|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
861988|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
861989|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
861990|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861991|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861992|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
861993|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
861994|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
861995|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
861996|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
861997|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
861998|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
861999|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
862000|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
862001|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
862002|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
862003|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
862130|NCT02334254|Warfarin|warfarin|mesh-list
862131|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
862132|NCT02334254|Clopidogrel|clopidogrel|mesh-list
862133|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
862134|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
862135|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
862136|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
862137|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
2260911|NCT00162643|Lamivudine|lamivudine|mesh-list
2260912|NCT00162643|Zidovudine|zidovudine|mesh-list
860559|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
860560|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
860561|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
860562|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2260913|NCT00162643|Efavirenz|efavirenz|mesh-list
2260914|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2260915|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2260916|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
2260917|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260918|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260919|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2260920|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2260921|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
2260922|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260923|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2260924|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2260925|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2260926|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
861160|NCT02338674|Tenofovir|tenofovir|mesh-list
861161|NCT02338674|Telbivudine|telbivudine|mesh-list
861162|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
861163|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
861164|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
861165|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
861166|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861167|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861168|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
861169|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
861275|NCT02337985|Prednisone|prednisone|mesh-list
861276|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
861277|NCT02337985|Rituximab|rituximab|mesh-list
861278|NCT02337985|Doxorubicin|doxorubicin|mesh-list
861279|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
861280|NCT02337985|Etoposide|etoposide|mesh-list
861281|NCT02337985|Vincristine|vincristine|mesh-list
861282|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
861283|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
861284|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861285|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
861286|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
861287|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
861288|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861289|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861290|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
861291|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
861292|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
861293|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
861294|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
861295|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861296|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
861297|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
861298|NCT02337985|Hormones|hormones|mesh-ancestor
861299|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
861300|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
861301|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
861302|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
861303|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
861304|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
861436|NCT02337322|Ritonavir|ritonavir|mesh-list
861437|NCT02337322|Darunavir|darunavir|mesh-list
861438|NCT02337322|Dolutegravir|dolutegravir|mesh-list
861439|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
861440|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
861441|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
861442|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861443|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861444|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
861445|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
861446|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
861447|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
861448|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
861449|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
861450|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
861451|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
861583|NCT02336516|Azithromycin|azithromycin|mesh-list
2260927|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
2260928|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2260929|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2260930|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
860671|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
860672|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
860673|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
860674|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
860675|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
860676|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860677|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
860678|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
860679|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
860680|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
860681|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
860682|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
860683|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
2099934|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2099935|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099936|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2099937|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
2099938|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2099939|NCT02364947|Nalmefene|nalmefene|mesh-list
2099940|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2099941|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099942|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
2099943|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099944|NCT02364999|Paclitaxel|paclitaxel|mesh-list
2099945|NCT02364999|Bevacizumab|bevacizumab|mesh-list
2099946|NCT02364999|Carboplatin|carboplatin|mesh-list
2099947|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2099948|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260931|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2260932|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2260933|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
2260934|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2260935|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
2260936|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260937|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2260938|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2260939|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
2260940|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861318|NCT02337712|Etoposide|etoposide|mesh-list
861319|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861320|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
861321|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
861322|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
861323|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861324|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260941|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260942|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2260943|NCT00162669|Bevacizumab|bevacizumab|mesh-list
2260944|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2260945|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260946|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2260947|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
861642|NCT02336308|Ketamine|ketamine|mesh-list
861643|NCT02336308|Analgesics|analgesics|mesh-ancestor
861644|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
861645|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
861646|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861647|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
861648|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
861649|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
861650|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
861651|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
861652|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
861653|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
861654|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
861655|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861733|NCT02336087|Metformin|metformin|mesh-list
861734|NCT02336087|Gemcitabine|gemcitabine|mesh-list
861735|NCT02336087|Paclitaxel|paclitaxel|mesh-list
861736|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2260948|NCT00162669|Growth Substances|growth substances|mesh-ancestor
2260949|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260950|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
2260951|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2260952|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
2260953|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
860779|NCT02339714|Loratadine|loratadine|mesh-list
860780|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
860781|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
860782|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
860783|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
860784|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
860785|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
860786|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
860787|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
860788|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860789|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260954|NCT00162695|Etoposide|etoposide|mesh-list
2260955|NCT00162695|Vincristine|vincristine|mesh-list
2260956|NCT00162695|Epirubicin|epirubicin|mesh-list
2260957|NCT00162695|Ifosfamide|ifosfamide|mesh-list
2260958|NCT00162695|Carboplatin|carboplatin|mesh-list
2260959|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2260960|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260961|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
861081|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
861082|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
861083|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
861084|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
861085|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861086|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861087|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
861141|NCT02338544|Adapalene|adapalene|mesh-list
861142|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
861143|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
861144|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
861145|NCT02338544|Analgesics|analgesics|mesh-ancestor
861146|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
861147|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
861148|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861149|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
861150|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
861151|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
2260962|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2260963|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2260964|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260965|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2260966|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
2260967|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
2260968|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
2260969|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
2260970|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2260971|NCT00162721|Doxorubicin|doxorubicin|mesh-list
2260972|NCT00162721|Ifosfamide|ifosfamide|mesh-list
2260973|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260974|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2260975|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2260976|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2260977|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860808|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
860809|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
860810|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
860811|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
860812|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
860813|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
860814|NCT02339662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
861008|NCT02339090|Hormones|hormones|mesh-list
861009|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
861010|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861452|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
861453|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861454|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260978|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260979|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2260980|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
2260981|NCT00162734|Interferons|interferons|mesh-list
2260982|NCT00162734|Ribavirin|ribavirin|mesh-list
2260983|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
2260984|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2260985|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
2260986|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
862112|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
862113|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
862114|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
862115|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862116|NCT02334462|Antacids|antacids|mesh-ancestor
862117|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862118|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2260987|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
2260988|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2260989|NCT00162760|Thalidomide|thalidomide|mesh-list
2260990|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2260991|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
2260992|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2260993|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
2260994|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2260995|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2260996|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2260997|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2260998|NCT00162760|Growth Substances|growth substances|mesh-ancestor
2260999|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
2261000|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862414|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
862644|NCT02332135|Vitamin D|vitamin d|mesh-list
862645|NCT02332135|Vitamins|vitamins|mesh-ancestor
862646|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
862647|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862648|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
862720|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
862721|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
862722|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
862723|NCT02331862|Prednisolone|prednisolone|mesh-list
862724|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
862725|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
862726|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
862727|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
862728|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
862729|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
862730|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862731|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862732|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
862733|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
862734|NCT02331862|Hormones|hormones|mesh-ancestor
862735|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
862736|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
862737|NCT02331862|Protective Agents|protective agents|mesh-ancestor
862738|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
862739|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863354|NCT02329080|Cytarabine|cytarabine|mesh-list
863355|NCT02329080|Rituximab|rituximab|mesh-list
863356|NCT02329080|Methotrexate|methotrexate|mesh-list
863357|NCT02329080|Etoposide|etoposide|mesh-list
863358|NCT02329080|Ifosfamide|ifosfamide|mesh-list
863359|NCT02329080|Thiotepa|thiotepa|mesh-list
863360|NCT02329080|Carmustine|carmustine|mesh-list
863499|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
860918|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
860919|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
860920|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
860921|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
860922|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
860923|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
860924|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
860925|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
860926|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
860927|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
860928|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
860929|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
860930|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
860931|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
860932|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
860933|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
860934|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
860935|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261001|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
2261002|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
2261003|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
2261004|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
861260|NCT02338115|Paclitaxel|paclitaxel|mesh-list
861261|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
861262|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861263|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
861264|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
861265|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
861266|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861661|NCT02336386|Dexamethasone|dexamethasone|mesh-list
861662|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
861663|NCT02336386|Doxorubicin|doxorubicin|mesh-list
861664|NCT02336386|Bortezomib|bortezomib|mesh-list
861665|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
861666|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
861667|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861668|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
861669|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
861670|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
861671|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861672|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861673|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
861674|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
861675|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
861676|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
861677|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
861678|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
861679|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
861680|NCT02336386|Hormones|hormones|mesh-ancestor
861681|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
861682|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
861683|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861684|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
861685|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
861686|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2261005|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
2261006|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
2261007|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261008|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261009|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261010|NCT00162799|Triflusal|triflusal|mesh-list
2261011|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2261012|NCT00162812|Epirubicin|epirubicin|mesh-list
2261013|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2261014|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261015|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2261016|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2261017|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862443|NCT02332941|Rituximab|rituximab|mesh-list
862444|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
862445|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862446|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
862447|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862448|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
861052|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
861053|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
861054|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861055|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861056|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
861057|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
861058|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
861059|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
861193|NCT02338466|Tenecteplase|tenecteplase|mesh-list
861194|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
861195|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
861196|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861374|NCT02337634|Silymarin|silymarin|mesh-list
861375|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
861376|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861377|NCT02337634|Protective Agents|protective agents|mesh-ancestor
861378|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861516|NCT02336854|Tacrolimus|tacrolimus|mesh-list
861517|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
861518|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
861519|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861520|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
861521|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861522|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861577|NCT02336477|Mexiletine|mexiletine|mesh-list
861578|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
861579|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
861580|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
861581|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
861582|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261018|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261019|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
2261020|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2261021|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261022|NCT00162864|Montelukast|montelukast|mesh-list
2261023|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2261024|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
2261025|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2261026|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
2261027|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261028|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261029|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2261030|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2261031|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261032|NCT00162877|Esomeprazole|esomeprazole|mesh-list
2261033|NCT00162877|Rabeprazole|rabeprazole|mesh-list
2261034|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2261035|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2261036|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
862740|NCT02331771|Donepezil|donepezil|mesh-list
862741|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
862742|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862743|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862744|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
862745|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
862746|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862747|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
862872|NCT02331511|Aspirin|aspirin|mesh-list
862873|NCT02331511|Clopidogrel|clopidogrel|mesh-list
862874|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
862875|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
862876|NCT02331511|Analgesics|analgesics|mesh-ancestor
862877|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
862878|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862879|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862880|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
862881|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
862882|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
862883|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
862884|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862885|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
862886|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
861218|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861219|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
861220|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
861221|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
861222|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261037|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261038|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261039|NCT00162916|Citalopram|citalopram|mesh-list
2261040|NCT00162916|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2261041|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2261042|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2261043|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261044|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261045|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
2261046|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261047|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2261048|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
2261049|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2261050|NCT00162955|Valsartan|valsartan|mesh-list
2261051|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2261052|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
862689|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
862690|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
862748|NCT02331745|Sargramostim|sargramostim|mesh-list
862749|NCT02331745|Lenograstim|lenograstim|mesh-list
862750|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
862751|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862752|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
863255|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
863256|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
863257|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
864146|NCT02326194|Vaccines|vaccines|mesh-list
864147|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
864148|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789041|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789042|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2789043|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2789044|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
2789045|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
2789046|NCT04305457|Protective Agents|protective agents|mesh-ancestor
2789047|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
2789048|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2789049|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
2789050|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
2789051|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789052|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789053|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2789054|NCT04305158|Analgesics|analgesics|mesh-ancestor
2099949|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
2099950|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
2099951|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
2099952|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099953|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2099954|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2099955|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2099956|NCT02364999|Growth Substances|growth substances|mesh-ancestor
2099957|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099958|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
2099959|NCT02365285|Heparin|heparin|mesh-list
2099960|NCT02365285|Galantamine|galantamine|mesh-list
2099961|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2099962|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
2099963|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2099964|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2099965|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861308|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
861309|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
861310|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261053|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2261054|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261055|NCT00162968|Citalopram|citalopram|mesh-list
861790|NCT02335580|Somatostatin|somatostatin|mesh-list
861791|NCT02335580|Hormones|hormones|mesh-ancestor
861792|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
861793|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862172|NCT02334150|Sufentanil|sufentanil|mesh-list
862173|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
862174|NCT02334150|Narcotics|narcotics|mesh-ancestor
862175|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
862176|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862177|NCT02334150|Analgesics|analgesics|mesh-ancestor
862178|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
862179|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862180|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
862181|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
862182|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
862183|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
862808|NCT02331576|Fentanyl|fentanyl|mesh-list
862809|NCT02331576|Ropivacaine|ropivacaine|mesh-list
862810|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
862811|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
862813|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
862814|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862815|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
862816|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862817|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
862818|NCT02331576|Narcotics|narcotics|mesh-ancestor
862819|NCT02331576|Analgesics|analgesics|mesh-ancestor
862820|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
862821|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
862822|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
2261056|NCT00162968|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2261057|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2261058|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2261059|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261060|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261061|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
2261062|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261063|NCT00162968|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2261064|NCT00162968|Antidepressive Agents|antidepressive agents|mesh-ancestor
2261065|NCT00162968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2261066|NCT00163046|Gabapentin|gabapentin|mesh-list
2261067|NCT00163046|Analgesics|analgesics|mesh-ancestor
2261068|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
2261069|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261070|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754695|NCT05174507|Empagliflozin|empagliflozin|mesh-list
2754696|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2754697|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2754698|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754699|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2261071|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
2261072|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2261073|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2261074|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2261075|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2261076|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2261077|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2261078|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261079|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261080|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
2261081|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
2261082|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2261083|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261084|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
2261085|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2261086|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261087|NCT00163111|Amphotericin B|amphotericin b|mesh-list
2261088|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2261089|NCT00163111|Fluconazole|fluconazole|mesh-list
2261090|NCT00163111|Amebicides|amebicides|mesh-ancestor
2261091|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2261092|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2261093|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261094|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
861455|NCT02337127|Lamivudine|lamivudine|mesh-list
861456|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
861457|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
861458|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861459|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861460|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
861461|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
861462|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
861463|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
862195|NCT02334163|Metronidazole|metronidazole|mesh-list
862196|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
862197|NCT02334163|Lactulose|lactulose|mesh-list
862198|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
862199|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
862200|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
862201|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
862202|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
862316|NCT02333565|Everolimus|everolimus|mesh-list
862317|NCT02333565|Octreotide|octreotide|mesh-list
862318|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862319|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
862320|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
862321|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862322|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
862323|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
862338|NCT02333253|Cetrorelix|cetrorelix|mesh-list
862339|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
862340|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
862341|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
862342|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862343|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
862344|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
862449|NCT02333058|Treosulfan|treosulfan|mesh-list
862450|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
862451|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
862452|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862453|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862584|NCT02332447|Naloxone|naloxone|mesh-list
862585|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
862586|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862587|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
862588|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261095|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
2261096|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2261097|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2261098|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261099|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261100|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2261101|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
2261102|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261103|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261104|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
863533|NCT02328209|Ranibizumab|ranibizumab|mesh-list
863534|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
863535|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
863536|NCT02328209|Growth Substances|growth substances|mesh-ancestor
863537|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863538|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
863539|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261105|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2261106|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2261107|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2261108|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
2261109|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261110|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261111|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2261112|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2261113|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2261114|NCT00163150|Atorvastatin|atorvastatin|mesh-list
2261115|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2261116|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2261117|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
2261118|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261119|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
861533|NCT02336685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
861534|NCT02336685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861535|NCT02336685|Immunologic Factors|immunologic factors|mesh-ancestor
2099966|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2099967|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2099968|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
861894|NCT02335398|Methadone|methadone|mesh-list
861895|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
861896|NCT02335398|Narcotics|narcotics|mesh-ancestor
861897|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
861898|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861899|NCT02335398|Analgesics|analgesics|mesh-ancestor
861900|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
861901|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
861902|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
861903|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
862082|NCT02334631|Simethicone|simethicone|mesh-list
862083|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
862084|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862085|NCT02334631|Emollients|emollients|mesh-ancestor
862086|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
862663|NCT02332174|Rufinamide|rufinamide|mesh-list
862664|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
862665|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
862666|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
862667|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
862668|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862983|NCT02330796|Bucillamine|bucillamine|mesh-list
862987|NCT02330796|Colchicine|colchicine|mesh-list
862988|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
862989|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
862990|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
862991|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
862992|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
862993|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862994|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862995|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
862996|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
862997|NCT02330796|Analgesics|analgesics|mesh-ancestor
862998|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
862999|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863000|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863001|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
863002|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
863003|NCT02330796|Protective Agents|protective agents|mesh-ancestor
863079|NCT02330367|Abivertinib|abivertinib|mesh-list
863080|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
863081|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863082|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099969|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2099970|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2099971|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
864099|NCT02326285|Docetaxel|docetaxel|mesh-list
864100|NCT02326285|Gefitinib|gefitinib|mesh-list
864101|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099972|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099973|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099974|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2099975|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
2099976|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2099977|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
2099978|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2099979|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2099980|NCT02365558|Omeprazole|omeprazole|mesh-list
2099981|NCT02365558|Evacetrapib|evacetrapib|mesh-list
2099982|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2099983|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2099984|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2099985|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861525|NCT02336698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861963|NCT02335099|Ticagrelor|ticagrelor|mesh-list
861964|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
861965|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
861966|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
861967|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
861968|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
861969|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
861970|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861971|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862018|NCT02334735|Vaccines|vaccines|mesh-list
862019|NCT02334735|Poly ICLC|poly iclc|mesh-list
862020|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
862021|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862022|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
2261120|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2261121|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261122|NCT00163202|Atorvastatin|atorvastatin|mesh-list
2261123|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2261124|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
862649|NCT02332356|Adalimumab|adalimumab|mesh-list
862650|NCT02332356|Azathioprine|azathioprine|mesh-list
862651|NCT02332356|Infliximab|infliximab|mesh-list
862652|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
862653|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
862654|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
862655|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
862656|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
862657|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862658|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
862659|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862660|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
862661|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
862662|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862713|NCT02331927|Aflibercept|aflibercept|mesh-list
862714|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
862715|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
862716|NCT02331927|Growth Substances|growth substances|mesh-ancestor
862717|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862718|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
862719|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862907|NCT02331173|Dorzolamide|dorzolamide|mesh-list
862908|NCT02331173|Brinzolamide|brinzolamide|mesh-list
862909|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
862910|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862911|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862912|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
862980|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
862981|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
862984|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261125|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
2261126|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261127|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2261128|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2261129|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261130|NCT00163241|Celecoxib|celecoxib|mesh-list
2261131|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2261132|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2261133|NCT00163241|Analgesics|analgesics|mesh-ancestor
2261134|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
2261135|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261136|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754700|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754701|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2754702|NCT05174455|Niraparib|niraparib|mesh-list
2754703|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2754704|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754705|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754706|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754707|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2754708|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2754709|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
2754710|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
861584|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
861585|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
861690|NCT02336230|Remestemcel-l|remestemcel-l|mesh-list
861691|NCT02336230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
861692|NCT02336230|Antiviral Agents|antiviral agents|mesh-ancestor
861693|NCT02336230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
862043|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
862044|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
862045|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
862046|NCT02334475|Prednisolone|prednisolone|mesh-list
862047|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
862048|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
862049|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
862050|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
862051|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
862052|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
862053|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862054|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862055|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
862056|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
862057|NCT02334475|Hormones|hormones|mesh-ancestor
862058|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
862059|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
862060|NCT02334475|Protective Agents|protective agents|mesh-ancestor
862061|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
862062|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099986|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099987|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2099988|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2754711|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
864033|NCT02326441|KX2-361|kx2-361|mesh-list
864034|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
864035|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
864036|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
864037|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
864038|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
864039|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
864040|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754712|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754713|NCT05174312|Diuretics|diuretics|mesh-list
2754714|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
2754715|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754716|NCT05174195|Desogestrel|desogestrel|mesh-list
2754717|NCT05174195|Etonogestrel|etonogestrel|mesh-list
2754718|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2754719|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2754720|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2754721|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
2754722|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2754723|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754724|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2754725|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2754726|NCT05174195|Progestins|progestins|mesh-ancestor
2754727|NCT05174195|Hormones|hormones|mesh-ancestor
2754728|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2754729|NCT05174156|Paclitaxel|paclitaxel|mesh-list
2754730|NCT05174156|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2754731|NCT05174156|Cisplatin|cisplatin|mesh-list
2754732|NCT05174156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2754733|NCT05174156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754734|NCT05174156|Tubulin Modulators|tubulin modulators|mesh-ancestor
2754735|NCT05174156|Antimitotic Agents|antimitotic agents|mesh-ancestor
2754736|NCT05174156|Mitosis Modulators|mitosis modulators|mesh-ancestor
2754737|NCT05174156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754738|NCT05174065|Apremilast|apremilast|mesh-list
2754739|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2754740|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2754741|NCT05174065|Analgesics|analgesics|mesh-ancestor
2261137|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2261138|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2261139|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2261140|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2261141|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261142|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261143|NCT00163254|Abciximab|abciximab|mesh-list
2261144|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
2261145|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2261146|NCT00163267|Clopidogrel|clopidogrel|mesh-list
2261147|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
861799|NCT02335684|Methamphetamine|methamphetamine|mesh-list
861800|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
861801|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861802|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
861803|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
861804|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
861805|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
861806|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
861807|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861808|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
861809|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
861810|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
861811|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
861812|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
862147|NCT02334176|Lidocaine|lidocaine|mesh-list
862148|NCT02334176|Epinephrine|epinephrine|mesh-list
862149|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
862150|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
862151|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
862152|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862153|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
862154|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862155|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
862156|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
862157|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
862158|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
862159|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862160|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
862161|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
862162|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
862163|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
862164|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
862165|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
862166|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
862167|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
862168|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
862169|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
862170|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
862171|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
862235|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
862236|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
862237|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
862238|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
862239|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
862240|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862241|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862242|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
862562|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
862563|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
862564|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
862565|NCT02332603|Prednisolone|prednisolone|mesh-list
862566|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
862567|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
862568|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
862569|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
862570|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
862571|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
862572|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862573|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862574|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
862575|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
862576|NCT02332603|Hormones|hormones|mesh-ancestor
862577|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
862578|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2261148|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2261149|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2261150|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2261151|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
2261152|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261153|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261154|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261155|NCT00163306|Pantoprazole|pantoprazole|mesh-list
2261156|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2261157|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2261158|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2261159|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261160|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261161|NCT00163319|Ciclesonide|ciclesonide|mesh-list
2261162|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
2261163|NCT00163319|Hormones|hormones|mesh-ancestor
2261164|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261165|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261166|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2261167|NCT00163332|Ciclesonide|ciclesonide|mesh-list
2261168|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
2261169|NCT00163332|Hormones|hormones|mesh-ancestor
2261170|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261171|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261172|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2261173|NCT00163345|Ciclesonide|ciclesonide|mesh-list
2261174|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
2261175|NCT00163345|Hormones|hormones|mesh-ancestor
2261176|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261177|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261178|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2261179|NCT00163358|Ciclesonide|ciclesonide|mesh-list
2261180|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
2261181|NCT00163358|Hormones|hormones|mesh-ancestor
2261182|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261183|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261184|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2261185|NCT00163371|Ciclesonide|ciclesonide|mesh-list
2261186|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
2261187|NCT00163371|Hormones|hormones|mesh-ancestor
2261188|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261189|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261190|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
862493|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
862494|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862495|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862582|NCT02332655|Cannabidiol|cannabidiol|mesh-list
862583|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
863061|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
863062|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
863063|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
863064|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863065|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
863066|NCT02330822|Protective Agents|protective agents|mesh-ancestor
863236|NCT02329795|Temozolomide|temozolomide|mesh-list
863237|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
863238|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
863239|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863240|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863483|NCT02328079|Acyclovir|acyclovir|mesh-list
863484|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
863485|NCT02328079|Prednisolone|prednisolone|mesh-list
863486|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
863487|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
863488|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
863489|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
863490|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
863491|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
863492|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
863493|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
863494|NCT02328079|Hormones|hormones|mesh-ancestor
863495|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
863496|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863497|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
863498|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861724|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
861725|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
861981|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
861982|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
861983|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
861984|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862063|NCT02334605|Capsaicin|capsaicin|mesh-list
862064|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
862065|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
862066|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
862067|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862068|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862250|NCT02334007|Dalteparin|dalteparin|mesh-list
862251|NCT02334007|Tinzaparin|tinzaparin|mesh-list
862252|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
862253|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
862254|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
862255|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
862256|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862476|NCT02332954|Vortioxetine|vortioxetine|mesh-list
862477|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
862478|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
862479|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
862480|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
862481|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
862482|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862483|NCT02332954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
862484|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
862485|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
862486|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862487|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
862488|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
862489|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
862490|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
862491|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
862492|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2261191|NCT00163384|Ciclesonide|ciclesonide|mesh-list
2261192|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
2261193|NCT00163384|Hormones|hormones|mesh-ancestor
2261194|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261195|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261196|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2261197|NCT00163397|Ciclesonide|ciclesonide|mesh-list
2261198|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
2261199|NCT00163397|Hormones|hormones|mesh-ancestor
2261200|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261201|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261202|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2261203|NCT00163410|Ciclesonide|ciclesonide|mesh-list
2261204|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
2261205|NCT00163410|Hormones|hormones|mesh-ancestor
2261206|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261207|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862812|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
862823|NCT02331602|Dabigatran|dabigatran|mesh-list
862824|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
862825|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
862826|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
862827|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
862828|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862829|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862830|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
863106|NCT02330302|Ropivacaine|ropivacaine|mesh-list
863107|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
863108|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
863109|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
863110|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863111|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
863112|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863305|NCT02329288|Triamcinolone|triamcinolone|mesh-list
863306|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
863307|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
863308|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
863309|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2261208|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
861737|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
861738|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
861739|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
861740|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
861741|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
861742|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
861743|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
861744|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
861745|NCT02336087|Antiviral Agents|antiviral agents|mesh-ancestor
861746|NCT02336087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
861747|NCT02336087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
861748|NCT02336087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
861749|NCT02336087|Immunologic Factors|immunologic factors|mesh-ancestor
861750|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861751|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
861782|NCT02335736|Cetrorelix|cetrorelix|mesh-list
861783|NCT02335736|Hormones|hormones|mesh-list
861784|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
861785|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
861786|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
861787|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
861788|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
861789|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2261209|NCT00163423|Ciclesonide|ciclesonide|mesh-list
2261210|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
2261211|NCT00163423|Hormones|hormones|mesh-ancestor
2261212|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261213|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261214|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2261215|NCT00163436|Ciclesonide|ciclesonide|mesh-list
2261216|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
2261217|NCT00163436|Hormones|hormones|mesh-ancestor
2261218|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261219|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862228|NCT02333890|Chloroquine|chloroquine|mesh-list
862229|NCT02333890|Amebicides|amebicides|mesh-ancestor
862230|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
862231|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
862232|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
862233|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
862234|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
862831|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
862832|NCT02331563|Bupivacaine|bupivacaine|mesh-list
862833|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
862834|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
862835|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
862836|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862837|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
862838|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862839|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
862840|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
862841|NCT02331563|Analgesics|analgesics|mesh-ancestor
862842|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
862843|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
862844|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
862845|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
862846|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
862847|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862937|NCT02331030|Ropivacaine|ropivacaine|mesh-list
862938|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
862939|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
862940|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
862941|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862942|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
862943|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261220|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2261221|NCT00163449|Ciclesonide|ciclesonide|mesh-list
2261222|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
2261223|NCT00163449|Hormones|hormones|mesh-ancestor
2261224|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261225|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261226|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
863389|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
863390|NCT02328963|Everolimus|everolimus|mesh-list
863391|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261227|NCT00163462|Ciclesonide|ciclesonide|mesh-list
2261228|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
2261229|NCT00163462|Hormones|hormones|mesh-ancestor
2261230|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261231|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261232|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
862282|NCT02333682|Vitamin D|vitamin d|mesh-list
862283|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
862284|NCT02333682|Calcifediol|calcifediol|mesh-list
862285|NCT02333682|Vitamins|vitamins|mesh-ancestor
862286|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
862287|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862288|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
862289|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
862959|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
862960|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
862961|NCT02330757|Clomiphene|clomiphene|mesh-list
862962|NCT02330757|Enclomiphene|enclomiphene|mesh-list
862963|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
862964|NCT02330757|Estradiol|estradiol|mesh-list
862965|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
862966|NCT02330757|Estrogens|estrogens|mesh-ancestor
862967|NCT02330757|Hormones|hormones|mesh-ancestor
862968|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
862969|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862970|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
862971|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
862972|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
862973|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
862974|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
862975|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
862976|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
862977|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
862978|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
862979|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
863113|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
863114|NCT02330406|Anagliptin|anagliptin|mesh-list
863115|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
863116|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863117|NCT02330406|Incretins|incretins|mesh-ancestor
863118|NCT02330406|Hormones|hormones|mesh-ancestor
863119|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
863120|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
863121|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
863122|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863123|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863670|NCT02327936|Fesoterodine|fesoterodine|mesh-list
863671|NCT02327936|Oxybutynin|oxybutynin|mesh-list
863672|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
863673|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
863674|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
863675|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863676|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863677|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863678|NCT02327936|Urological Agents|urological agents|mesh-ancestor
863679|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
863680|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
863681|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863759|NCT02327338|Ibuprofen|ibuprofen|mesh-list
863760|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
863761|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
863762|NCT02327338|Analgesics|analgesics|mesh-ancestor
863763|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
863764|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863765|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863766|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
863767|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
863768|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
863769|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863770|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862027|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
862028|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862029|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862460|NCT02333123|Aspirin|aspirin|mesh-list
862461|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
862462|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
862463|NCT02333123|Analgesics|analgesics|mesh-ancestor
862464|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
862465|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862466|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862467|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
862468|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
862469|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
862470|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
862471|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862472|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
862473|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
862474|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862475|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
2261233|NCT00163488|Ciclesonide|ciclesonide|mesh-list
2261234|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
2261235|NCT00163488|Hormones|hormones|mesh-ancestor
863092|NCT02330419|Naltrexone|naltrexone|mesh-list
863093|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
863094|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
863095|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863096|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
863097|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261236|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261237|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261238|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2261239|NCT00163501|Ciclesonide|ciclesonide|mesh-list
2261240|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
2261241|NCT00163501|Hormones|hormones|mesh-ancestor
2261242|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261243|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754742|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
863682|NCT02327624|Clopidogrel|clopidogrel|mesh-list
863683|NCT02327624|Ticagrelor|ticagrelor|mesh-list
863684|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
863685|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
863686|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
863687|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
863688|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
863689|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863690|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863691|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754743|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754744|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754745|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2754746|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2754747|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2754748|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2754749|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754750|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754751|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
2754752|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2754753|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754754|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2754755|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754756|NCT05174039|Miglustat|miglustat|mesh-list
2754757|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754758|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754759|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2754760|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2754761|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
2754762|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2754763|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2754764|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2754765|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754766|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
2754767|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2754768|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
862075|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862076|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
862077|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
862078|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
862079|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862080|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
862081|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2261244|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2261245|NCT00163514|Ciclesonide|ciclesonide|mesh-list
2261246|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
2261247|NCT00163514|Hormones|hormones|mesh-ancestor
2261248|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261249|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261250|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2261251|NCT00163540|Formaldehyde|formaldehyde|mesh-list
2261252|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
2261253|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261254|NCT00163553|Meperidine|meperidine|mesh-list
2261255|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2261256|NCT00163553|Narcotics|narcotics|mesh-ancestor
2261257|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2261258|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261259|NCT00163553|Analgesics|analgesics|mesh-ancestor
862913|NCT02330952|Prednisone|prednisone|mesh-list
862914|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
862915|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
862916|NCT02330952|Hormones|hormones|mesh-ancestor
862917|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
862918|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862919|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
862920|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863177|NCT02330068|Citalopram|citalopram|mesh-list
863178|NCT02330068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
863179|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
863180|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
863181|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863182|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863183|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
863184|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863185|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
863186|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
863187|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2261260|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
2261261|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261262|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2261263|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
2261264|NCT00163566|Androgens|androgens|mesh-ancestor
2261265|NCT00163566|Hormones|hormones|mesh-ancestor
2261266|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261267|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261268|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2261269|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
2261270|NCT00163592|Coagulants|coagulants|mesh-ancestor
2261271|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2261272|NCT00163605|Thrombin|thrombin|mesh-list
863787|NCT02327923|Ketorolac|ketorolac|mesh-list
863788|NCT02327923|Lidocaine|lidocaine|mesh-list
863789|NCT02327923|Atropine|atropine|mesh-list
863790|NCT02327923|Ephedrine|ephedrine|mesh-list
863791|NCT02327923|Fentanyl|fentanyl|mesh-list
863792|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
863793|NCT02327923|Morphine|morphine|mesh-list
863794|NCT02327923|Tramadol|tramadol|mesh-list
863795|NCT02327923|Ondansetron|ondansetron|mesh-list
863796|NCT02327923|Bupivacaine|bupivacaine|mesh-list
863797|NCT02327923|Propofol|propofol|mesh-list
863798|NCT02327923|Neostigmine|neostigmine|mesh-list
863799|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
863800|NCT02327923|Esmolol|esmolol|mesh-list
863801|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
863802|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
863803|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
863804|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863805|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
863806|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261273|NCT00163605|Calcium|calcium|mesh-list
2261274|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
862138|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
862139|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862140|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862141|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
862142|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
862143|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
862144|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
862145|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
862146|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862363|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
862364|NCT02333305|Vitamins|vitamins|mesh-ancestor
862365|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
862366|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099989|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
2099990|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2099991|NCT02365584|Lanreotide|lanreotide|mesh-list
2099992|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2099993|NCT02365870|Rotigotine|rotigotine|mesh-list
2099994|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
862933|NCT02331134|Lenograstim|lenograstim|mesh-list
862934|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
862935|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
862936|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863321|NCT02329132|Ranibizumab|ranibizumab|mesh-list
863322|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
863323|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
863324|NCT02329132|Growth Substances|growth substances|mesh-ancestor
863325|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863326|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
863327|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863894|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
863895|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
863896|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
863897|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863898|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
863899|NCT02327156|Analgesics|analgesics|mesh-ancestor
863900|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
863901|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863902|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
863903|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
863904|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
863905|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
863906|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863907|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261275|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261276|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
2261277|NCT00163605|Coagulants|coagulants|mesh-ancestor
2754769|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754770|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
2754771|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
2754772|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2754773|NCT05173987|Paclitaxel|paclitaxel|mesh-list
2754774|NCT05173987|Docetaxel|docetaxel|mesh-list
2754775|NCT05173987|Carboplatin|carboplatin|mesh-list
2754776|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
2754777|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2754778|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754779|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
2754780|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
2754781|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
2754782|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754783|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2754784|NCT05173896|Tadalafil|tadalafil|mesh-list
2754785|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
2754786|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2754787|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2754788|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754789|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754790|NCT05173896|Urological Agents|urological agents|mesh-ancestor
2099995|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
2099996|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2099997|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2099998|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2099999|NCT02365961|Clonidine|clonidine|mesh-list
2100000|NCT02365961|Epinephrine|epinephrine|mesh-list
2100001|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
862268|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862269|NCT02333838|Antiviral Agents|antiviral agents|mesh-ancestor
862270|NCT02333838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
862271|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
862272|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
862273|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
862324|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
862325|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
862326|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862753|NCT02332005|Choline|choline|mesh-list
862754|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
862755|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
862756|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
862757|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862758|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
862759|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
862760|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
863277|NCT02329405|Rifampin|rifampin|mesh-list
863278|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
863279|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
863280|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
863281|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863282|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
863283|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
863284|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863285|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863286|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
863287|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
863288|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
863289|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
863290|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
863291|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
864046|NCT02326623|Anesthetics|anesthetics|mesh-list
864047|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
864048|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
864049|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
864050|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
864051|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261278|NCT00163618|Formaldehyde|formaldehyde|mesh-list
2261279|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
2261280|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261281|NCT00163748|Gemcitabine|gemcitabine|mesh-list
2754798|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2754799|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
2754800|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754801|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2754802|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
2754803|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2754804|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754805|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2754806|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2754807|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2754808|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
2754809|NCT05173688|Propofol|propofol|mesh-list
2754810|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2754811|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2754812|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754813|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2754814|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
2754815|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
2100002|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2100003|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
2100004|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261282|NCT00163748|Vinorelbine|vinorelbine|mesh-list
2261283|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2754820|NCT05173584|Albuterol|albuterol|mesh-list
2754821|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2754822|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
2754823|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754824|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754825|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2754826|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
2754827|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
2754828|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2754829|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2754830|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2754831|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
862806|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
862807|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863083|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
863084|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
863085|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
863086|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
863087|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863088|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863089|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863090|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
863091|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
863506|NCT02328053|Voriconazole|voriconazole|mesh-list
863507|NCT02328053|Natamycin|natamycin|mesh-list
863508|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
863509|NCT02328053|Clotrimazole|clotrimazole|mesh-list
863510|NCT02328053|Miconazole|miconazole|mesh-list
863511|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863512|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
863513|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
863514|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863515|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863516|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
863517|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
863518|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
863519|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863520|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
863521|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
863522|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
863523|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
863746|NCT02327455|Dobutamine|dobutamine|mesh-list
863747|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
863748|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
863749|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
863750|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863751|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863752|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
863753|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
863754|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
863755|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
863756|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863757|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863758|NCT02327455|Protective Agents|protective agents|mesh-ancestor
2261284|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
2261285|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261286|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754832|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
862412|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
862413|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
862536|NCT02332811|Sevelamer|sevelamer|mesh-list
862537|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
862538|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
862539|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862549|NCT02332512|Apatinib|apatinib|mesh-list
862550|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862551|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
862552|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862553|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862691|NCT02332031|Sorafenib|sorafenib|mesh-list
862692|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862693|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
862694|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862695|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100005|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100006|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100007|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2100008|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2100009|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
2100010|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100011|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2100012|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
863738|NCT02327299|Fesoterodine|fesoterodine|mesh-list
863739|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
863740|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
863741|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
863742|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863743|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863744|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863745|NCT02327299|Urological Agents|urological agents|mesh-ancestor
863976|NCT02327078|Nivolumab|nivolumab|mesh-list
863977|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
863978|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863979|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
863980|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261287|NCT00163748|Antiviral Agents|antiviral agents|mesh-ancestor
2261288|NCT00163748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261289|NCT00163748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261290|NCT00163748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2261291|NCT00163748|Immunologic Factors|immunologic factors|mesh-ancestor
2754833|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2754834|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754835|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
2754836|NCT05173545|Analgesics|analgesics|mesh-ancestor
2754837|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
2754838|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754839|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754840|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754841|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2754842|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2754843|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754844|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754845|NCT05173493|Amoxicillin|amoxicillin|mesh-list
2754846|NCT05173493|Levofloxacin|levofloxacin|mesh-list
2754847|NCT05173493|Ofloxacin|ofloxacin|mesh-list
2754848|NCT05173493|Tetracycline|tetracycline|mesh-list
2754849|NCT05173493|Furazolidone|furazolidone|mesh-list
2754850|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2754851|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2754852|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2754853|NCT05173493|Renal Agents|renal agents|mesh-ancestor
2754854|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2754855|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2754856|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754857|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754858|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261292|NCT00163748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261293|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2261294|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
2261295|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
2261296|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
862621|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
862622|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
862623|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
862624|NCT02332616|Prednisolone|prednisolone|mesh-list
862625|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
862626|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
862627|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
862628|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
862629|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
862630|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
862631|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862632|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862633|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
862634|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
862635|NCT02332616|Hormones|hormones|mesh-ancestor
862636|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
862637|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
862638|NCT02332616|Protective Agents|protective agents|mesh-ancestor
862639|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
862640|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863031|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
863032|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
863033|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
863034|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
863035|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
863036|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
863037|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863038|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
863039|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
863040|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863402|NCT02328794|Varenicline|varenicline|mesh-list
863403|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
863404|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
863405|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
863406|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863407|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863408|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863442|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
863443|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
863553|NCT02328144|Metronidazole|metronidazole|mesh-list
863554|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863555|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
863556|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
863557|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
863703|NCT02327715|Emtricitabine|emtricitabine|mesh-list
863704|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
863705|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863706|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
863707|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
863708|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863709|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863710|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
863711|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
863922|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
863923|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
863924|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863925|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
863926|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
864080|NCT02326584|Cytarabine|cytarabine|mesh-list
864081|NCT02326584|Daunorubicin|daunorubicin|mesh-list
2100013|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
2100014|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
2100015|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2100016|NCT02365961|Analgesics|analgesics|mesh-ancestor
863041|NCT02330640|Clopidogrel|clopidogrel|mesh-list
863042|NCT02330640|Ticagrelor|ticagrelor|mesh-list
863043|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
863044|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
863045|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
863046|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
863047|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
863048|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863049|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863050|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261297|NCT00163761|Gemcitabine|gemcitabine|mesh-list
2261298|NCT00163761|Vinorelbine|vinorelbine|mesh-list
2261299|NCT00163761|Ifosfamide|ifosfamide|mesh-list
2261300|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2261301|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
2261302|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261303|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261304|NCT00163761|Antiviral Agents|antiviral agents|mesh-ancestor
2261305|NCT00163761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261306|NCT00163761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261307|NCT00163761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
863434|NCT02328521|Nicorandil|nicorandil|mesh-list
863435|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
863436|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
863437|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
863438|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
863439|NCT02328521|Vitamins|vitamins|mesh-ancestor
863440|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
863441|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863879|NCT02327195|Methylphenidate|methylphenidate|mesh-list
863880|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
863881|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863882|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
863883|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
863884|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
863885|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863886|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
863887|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100017|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
2100018|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2100019|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
2100020|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2100021|NCT02366091|Methotrexate|methotrexate|mesh-list
2100022|NCT02366091|Colchicine|colchicine|mesh-list
2100023|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2100024|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
864058|NCT02326350|Aspirin|aspirin|mesh-list
864059|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
864060|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
864061|NCT02326350|Analgesics|analgesics|mesh-ancestor
864062|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
864063|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
864064|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
864065|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
864066|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
864067|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
864068|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
864069|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
864070|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
864071|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
864072|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
864073|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
864183|NCT02326051|Enoxaparin|enoxaparin|mesh-list
864184|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
864185|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
864186|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
864187|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
864188|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754859|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2100025|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2261308|NCT00163761|Immunologic Factors|immunologic factors|mesh-ancestor
862580|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
862581|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862781|NCT02331706|Interferons|interferons|mesh-list
862782|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
862783|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
862784|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
862785|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
862786|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
862787|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
862788|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261309|NCT00163761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261310|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2261311|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
2261312|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
2261313|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
2261314|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2261315|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
2261316|NCT00163969|Ketamine|ketamine|mesh-list
2261317|NCT00163969|Analgesics|analgesics|mesh-ancestor
2261318|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
2261319|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261320|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261321|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2261322|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2261323|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
2261324|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
864044|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
864045|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2754860|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2754861|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2754862|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2754863|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2754864|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2754865|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2754866|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2754872|NCT05173337|Nefopam|nefopam|mesh-list
2754873|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2754874|NCT05173337|Analgesics|analgesics|mesh-ancestor
2754875|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
2754876|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754877|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261325|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2261326|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2261327|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2261328|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261329|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261330|NCT00163982|Norfloxacin|norfloxacin|mesh-list
2261331|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2261332|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261333|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2261334|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2754890|NCT05173246|Paclitaxel|paclitaxel|mesh-list
2754891|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2754892|NCT05173246|Cisplatin|cisplatin|mesh-list
2754893|NCT05173246|Carboplatin|carboplatin|mesh-list
2754894|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2754895|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754896|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
2754897|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
862603|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
862604|NCT02332629|Prednisolone|prednisolone|mesh-list
862605|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
862606|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
862607|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
862608|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
862609|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
862610|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
862611|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
862612|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
862613|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
862614|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
862615|NCT02332629|Hormones|hormones|mesh-ancestor
862616|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
862617|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
862618|NCT02332629|Protective Agents|protective agents|mesh-ancestor
862619|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
862620|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863241|NCT02330029|Pinaverium|pinaverium|mesh-list
863242|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
863243|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
863244|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863245|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
863246|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863247|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
863248|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
863249|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863411|NCT02328729|Epinephrine|epinephrine|mesh-list
863412|NCT02328729|Racepinephrine|racepinephrine|mesh-list
863413|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
863414|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
863415|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
863416|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
863417|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863418|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863419|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863420|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
863421|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
863422|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
863423|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863424|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
863425|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
863426|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
863427|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
863428|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
863558|NCT02328443|Itraconazole|itraconazole|mesh-list
863559|NCT02328443|Rifampin|rifampin|mesh-list
863560|NCT02328443|Midazolam|midazolam|mesh-list
863561|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
863562|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
863563|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
863564|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863565|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
863566|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
863567|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
863568|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
863569|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
863570|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
863571|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
863572|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
863573|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863574|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863575|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
863576|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863577|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
863578|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
863579|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863580|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
863581|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
863582|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
863583|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
863584|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
863585|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
863586|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
863587|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
862779|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
862780|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
863203|NCT02329834|Furosemide|furosemide|mesh-list
863204|NCT02329834|Diuretics|diuretics|mesh-ancestor
863205|NCT02329834|Natriuretic Agents|natriuretic agents|mesh-ancestor
863206|NCT02329834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863207|NCT02329834|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
863208|NCT02329834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
863209|NCT02329834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863258|NCT02329535|Progesterone|progesterone|mesh-list
863259|NCT02329535|Progestins|progestins|mesh-ancestor
863260|NCT02329535|Hormones|hormones|mesh-ancestor
863261|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
863262|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261335|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261336|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261337|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261338|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2261339|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2261340|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
2261341|NCT00164008|Pamidronate|pamidronate|mesh-list
2261342|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2261343|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261344|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
2261345|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2261346|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
2261347|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
2261348|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2261349|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261350|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2261351|NCT00164047|Analgesics|analgesics|mesh-ancestor
2261352|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
863641|NCT02327754|FYX-051|fyx-051|mesh-list
863642|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863643|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863771|NCT02327416|Entecavir|entecavir|mesh-list
863772|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
863773|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
863774|NCT02327416|Adefovir|adefovir|mesh-list
863775|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
863776|NCT02327416|Molgramostim|molgramostim|mesh-list
863777|NCT02327416|Sargramostim|sargramostim|mesh-list
863778|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
863779|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863780|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
863781|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863782|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
863783|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
863784|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863785|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863786|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863914|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
863915|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
863916|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
863917|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
863918|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863919|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
863920|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
863921|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2261353|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261354|NCT00164086|Atorvastatin|atorvastatin|mesh-list
2261355|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2261356|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2261357|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
2754898|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
2754899|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754900|NCT05173090|Ropivacaine|ropivacaine|mesh-list
2754901|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
2754902|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
2754903|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2754904|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754905|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
2754906|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261358|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261359|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2261360|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2261361|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261362|NCT00164112|Azithromycin|azithromycin|mesh-list
2261363|NCT00164112|Levofloxacin|levofloxacin|mesh-list
2261364|NCT00164112|Ofloxacin|ofloxacin|mesh-list
2261365|NCT00164112|Telithromycin|telithromycin|mesh-list
2261366|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2261367|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261368|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2261369|NCT00164112|Renal Agents|renal agents|mesh-ancestor
2261370|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2261371|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2261372|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261373|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261374|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261375|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
863429|NCT02328651|Ribavirin|ribavirin|mesh-list
863430|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
863431|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863432|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
863433|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2754915|NCT05172934|Tenecteplase|tenecteplase|mesh-list
2754916|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2754917|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2754918|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754931|NCT05172817|Adalimumab|adalimumab|mesh-list
2754932|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2754933|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2754934|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2754935|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261376|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2261377|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2261378|NCT00164125|Laxatives|laxatives|mesh-ancestor
2261379|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2261380|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2261381|NCT00164164|Laxatives|laxatives|mesh-ancestor
2261382|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2261383|NCT00164216|Artesunate|artesunate|mesh-list
2261384|NCT00164216|Mefloquine|mefloquine|mesh-list
2261385|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
2261386|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2261387|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2261388|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261389|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261390|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
2261391|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
2261392|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2261393|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
2261394|NCT00164242|Galantamine|galantamine|mesh-list
2261395|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2754936|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
2754937|NCT05172739|Anesthetics|anesthetics|mesh-list
2754938|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2754939|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754940|NCT05172739|Narcotics|narcotics|mesh-ancestor
2754941|NCT05172739|Analgesics|analgesics|mesh-ancestor
2261396|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261397|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261398|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
2261399|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261400|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261401|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2261402|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
2100026|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100027|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2100028|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
2100029|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100030|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863337|NCT02328950|Cytarabine|cytarabine|mesh-list
863338|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
863339|NCT02328950|Busulfan|busulfan|mesh-list
863340|NCT02328950|Fludarabine|fludarabine|mesh-list
863341|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
863342|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
863343|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863344|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
863345|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
863346|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
863347|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863348|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863349|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
863350|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
863351|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
863352|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
863353|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863479|NCT02328183|Polymyxins|polymyxins|mesh-list
863480|NCT02328183|Polymyxin B|polymyxin b|mesh-list
863481|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
863482|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261403|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261404|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
2261405|NCT00164255|Artesunate|artesunate|mesh-list
2261406|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
2261407|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
2261408|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
2261409|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2261410|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2261411|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261412|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261413|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
2261414|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
2261415|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2261416|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
2261417|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2261418|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261419|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261420|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2754942|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
2754943|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754944|NCT05172570|Gabapentin|gabapentin|mesh-list
2754945|NCT05172570|Analgesics|analgesics|mesh-ancestor
2754946|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
2754947|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754948|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754949|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
2754950|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2754951|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2754952|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2754953|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2754954|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2754955|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2754956|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2754957|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754958|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
2754959|NCT05172531|Cisatracurium|cisatracurium|mesh-list
2754960|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2100031|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
2100032|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100033|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2100034|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2100035|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
2100036|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2100037|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
862887|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862888|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
862889|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
862890|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
862891|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
862892|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
862893|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
862902|NCT02330991|Temozolomide|temozolomide|mesh-list
862903|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
862904|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
862905|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
862906|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863067|NCT02330783|Bevacizumab|bevacizumab|mesh-list
863068|NCT02330783|Sorafenib|sorafenib|mesh-list
863069|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
863070|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863071|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
863072|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
863073|NCT02330783|Growth Substances|growth substances|mesh-ancestor
863074|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863075|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
863076|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
863077|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863078|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863908|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
863909|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
863910|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
863911|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863912|NCT02327091|Vitamins|vitamins|mesh-ancestor
863913|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
2754961|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2754962|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2754963|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754964|NCT05172518|Capecitabine|capecitabine|mesh-list
2754965|NCT05172518|Taxane|taxane|mesh-list
2754966|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2754967|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
2754968|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754969|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2754970|NCT05172440|Axitinib|axitinib|mesh-list
2754971|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261421|NCT00164255|Renal Agents|renal agents|mesh-ancestor
2261422|NCT00164281|Isoniazid|isoniazid|mesh-list
2261423|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
2261424|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2261425|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261426|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2261427|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2261428|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
2261429|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261430|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2261431|NCT00164359|Artesunate|artesunate|mesh-list
2261432|NCT00164359|Amodiaquine|amodiaquine|mesh-list
2261433|NCT00164359|Dapsone|dapsone|mesh-list
2261434|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
2261435|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
2261436|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2261437|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2261438|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261439|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261440|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
2261441|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
2754972|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2754973|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754974|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261442|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2261443|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
2261444|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2754975|NCT05172401|Triamcinolone|triamcinolone|mesh-list
2754976|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2754977|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2754978|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2754979|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2754980|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
2754981|NCT05172401|Hormones|hormones|mesh-ancestor
2261445|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754982|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
862931|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
862932|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863124|NCT02330380|Adalimumab|adalimumab|mesh-list
863125|NCT02330380|Etanercept|etanercept|mesh-list
863126|NCT02330380|Methotrexate|methotrexate|mesh-list
863127|NCT02330380|Ustekinumab|ustekinumab|mesh-list
863128|NCT02330380|Acitretin|acitretin|mesh-list
863129|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
863130|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
863131|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
863132|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863133|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
863134|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
863135|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863136|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863137|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
863138|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863139|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
863140|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
863141|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
863142|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
863143|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
863144|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
863145|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
863146|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
863147|NCT02330380|Analgesics|analgesics|mesh-ancestor
863148|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
863149|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863150|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
863151|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
863188|NCT02329860|Apatinib|apatinib|mesh-list
863189|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863190|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
863191|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863192|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863692|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
863693|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
863694|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
863695|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
863696|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
863697|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863698|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
863699|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863700|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863701|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
863702|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863992|NCT02326727|Fentanyl|fentanyl|mesh-list
863993|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
863994|NCT02326727|Propofol|propofol|mesh-list
863995|NCT02326727|Ropivacaine|ropivacaine|mesh-list
863996|NCT02326727|Isoflurane|isoflurane|mesh-list
863997|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
863998|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
863999|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
864000|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
864001|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
864002|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
864003|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
864004|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
864005|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
864006|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
864007|NCT02326727|Narcotics|narcotics|mesh-ancestor
864008|NCT02326727|Analgesics|analgesics|mesh-ancestor
864009|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
864010|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
864011|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
864179|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
864180|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
864181|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
864182|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261446|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261447|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
2261448|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2261449|NCT00164411|Vaccines|vaccines|mesh-list
2754983|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754984|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
862985|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
862986|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863655|NCT02327793|Labetalol|labetalol|mesh-list
863656|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
863657|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
863658|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
863659|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
863660|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
863661|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863662|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863663|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863664|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
863665|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
863666|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
863667|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863668|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
863669|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2754985|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
2754986|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2754987|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754988|NCT05172310|FAPI-46|fapi-46|mesh-list
2754989|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2754990|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2754996|NCT05172167|Antibodies|antibodies|mesh-list
2754997|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
2754998|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2754999|NCT05172115|Heparin|heparin|mesh-list
2755000|NCT05172115|Enoxaparin|enoxaparin|mesh-list
2755001|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2755002|NCT05172115|Tinzaparin|tinzaparin|mesh-list
2755003|NCT05172115|Dalteparin|dalteparin|mesh-list
2755004|NCT05172115|Plasminogen|plasminogen|mesh-list
2755005|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2755006|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
2755007|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2755008|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2755009|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261450|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2261451|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
2261452|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261453|NCT00164424|Acyclovir|acyclovir|mesh-list
2261454|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
2261455|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261456|NCT00164450|Isoniazid|isoniazid|mesh-list
2261457|NCT00164450|Rifapentine|rifapentine|mesh-list
2261458|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
2261459|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2261460|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261461|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2261462|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2261463|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
2261464|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261465|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2261466|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2261467|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
2261468|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
2261469|NCT00164463|Isoniazid|isoniazid|mesh-list
2261470|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2261471|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261472|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2261473|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2261474|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261475|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261476|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863174|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
863175|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863176|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863271|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
863272|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
863273|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
863274|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863275|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
863276|NCT02329756|Coagulants|coagulants|mesh-ancestor
863730|NCT02327403|Abatacept|abatacept|mesh-list
863731|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
863732|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863733|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863734|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
863735|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
863736|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863737|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2261477|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
2261478|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2261479|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2261480|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
2261481|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2261482|NCT00164710|Artesunate|artesunate|mesh-list
2755018|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
2755019|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2755020|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2755021|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755022|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2755023|NCT05171985|Analgesics|analgesics|mesh-ancestor
2755024|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
2755025|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2755026|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2755027|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2755028|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2755029|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
2755030|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2755031|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755034|NCT05171946|Vaccines|vaccines|mesh-list
2755035|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
2755036|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261483|NCT00164710|Lumefantrine|lumefantrine|mesh-list
2261484|NCT00164710|Artemether|artemether|mesh-list
2261485|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
2261486|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
2100038|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
2100039|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
2100040|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
2100041|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
2100042|NCT02366130|Denosumab|denosumab|mesh-list
2100043|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2100044|NCT02366130|Hormones|hormones|mesh-list
2100045|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2100046|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100047|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2100048|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100049|NCT02366143|Paclitaxel|paclitaxel|mesh-list
2100050|NCT02366143|Bevacizumab|bevacizumab|mesh-list
2100051|NCT02366143|Carboplatin|carboplatin|mesh-list
2100052|NCT02366143|Atezolizumab|atezolizumab|mesh-list
2261487|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
863310|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
863311|NCT02329288|Hormones|hormones|mesh-ancestor
863312|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
863313|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863314|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
863315|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
863316|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863317|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863318|NCT02329054|Favipiravir|favipiravir|mesh-list
863319|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
863320|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863941|NCT02326779|Aspirin|aspirin|mesh-list
863942|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
863943|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
863944|NCT02326779|Analgesics|analgesics|mesh-ancestor
863945|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
863946|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863947|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863948|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
863949|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
863950|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
863951|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
863952|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863953|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
863954|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
863955|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863956|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
864121|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
864122|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
864123|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
864124|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
864125|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
864126|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
864127|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
864128|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
864129|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
864130|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2755050|NCT05171751|Octreotide|octreotide|mesh-list
2755051|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2755052|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2755053|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261488|NCT00164710|Amodiaquine|amodiaquine|mesh-list
2261489|NCT00164710|Dapsone|dapsone|mesh-list
2261490|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
2261491|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
2261492|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2261493|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2261494|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261495|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261496|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
2261497|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
2261498|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2261499|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
2261500|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
863361|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
863362|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863363|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
863364|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863365|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
863366|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
863367|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
863368|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
863369|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
863370|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
863371|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863372|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
863373|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863374|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
863375|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
863376|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
863377|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
863378|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
863379|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
863380|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
863381|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863382|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
863383|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
863384|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
863462|NCT02328469|Doxycycline|doxycycline|mesh-list
863463|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
863464|NCT02328469|Acyclovir|acyclovir|mesh-list
863465|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
863466|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863467|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
863468|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
863469|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
863470|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
863644|NCT02327689|Emtricitabine|emtricitabine|mesh-list
863645|NCT02327689|Adefovir|adefovir|mesh-list
863646|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
863647|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
863648|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863649|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
863650|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
863651|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863652|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863653|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
863654|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
863927|NCT02327000|Pregabalin|pregabalin|mesh-list
863928|NCT02327000|Analgesics|analgesics|mesh-ancestor
863929|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
863930|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863931|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863932|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
863933|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
863934|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
863935|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863936|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
863937|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
863938|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
863939|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
863940|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2755080|NCT05171660|Capecitabine|capecitabine|mesh-list
2755081|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
2755082|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755083|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2755084|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
2755085|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863392|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
863393|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
863394|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863395|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
863396|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
863397|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
863398|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
863399|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863400|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863401|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863595|NCT02328118|Triamcinolone|triamcinolone|mesh-list
863596|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
863597|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
863598|NCT02328118|Ranibizumab|ranibizumab|mesh-list
863599|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
863600|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
863601|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
863602|NCT02328118|Growth Substances|growth substances|mesh-ancestor
863603|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863604|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
863605|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
863606|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
863607|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
863608|NCT02328118|Hormones|hormones|mesh-ancestor
863609|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
863610|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
863611|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
863612|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863613|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863632|NCT02327663|Emtricitabine|emtricitabine|mesh-list
863633|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
863634|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863635|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
863636|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
863637|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863638|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863639|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
863640|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
864149|NCT02326038|Methylphenidate|methylphenidate|mesh-list
864150|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
864151|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
864152|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
864153|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
864154|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
864155|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
864156|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
864157|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2755101|NCT05171530|Lenvatinib|lenvatinib|mesh-list
2755102|NCT05171530|Taxane|taxane|mesh-list
2755103|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755104|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2755105|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261501|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261502|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261503|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2261504|NCT00164710|Renal Agents|renal agents|mesh-ancestor
2100053|NCT02366143|Antibodies|antibodies|mesh-list
2100054|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2100055|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2100056|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100057|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
2100058|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
2100059|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
863475|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863476|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
863477|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
863478|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
863867|NCT02327234|Ibuprofen|ibuprofen|mesh-list
863868|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
863869|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
863870|NCT02327234|Analgesics|analgesics|mesh-ancestor
863871|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
863872|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863873|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863874|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
863875|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
863876|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
863877|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863878|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
864095|NCT02326454|Talaporfin|talaporfin|mesh-list
864096|NCT02326454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
864097|NCT02326454|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
864098|NCT02326454|Dermatologic Agents|dermatologic agents|mesh-ancestor
2755106|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755114|NCT05164653|Valsartan|valsartan|mesh-list
2755115|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
2755116|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2755117|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2755118|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2755119|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2755120|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2755121|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755122|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2755123|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
2755124|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2755125|NCT05155293|Aflibercept|aflibercept|mesh-list
2755126|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2755127|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2755128|NCT05155293|Growth Substances|growth substances|mesh-ancestor
2755129|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755130|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
2755131|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755140|NCT05151848|Adalimumab|adalimumab|mesh-list
2755141|NCT05151848|Tofacitinib|tofacitinib|mesh-list
2755142|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2755143|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2755144|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2755145|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2755146|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755147|NCT05151588|Docetaxel|docetaxel|mesh-list
2755148|NCT05151588|Fluorouracil|fluorouracil|mesh-list
2755149|NCT05151588|Cisplatin|cisplatin|mesh-list
2755150|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755151|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
2755152|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
2755153|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
2755154|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755155|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
2755156|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2755157|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2755158|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
2755159|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755160|NCT05151263|Aspirin|aspirin|mesh-list
2755161|NCT05151263|Salicylates|salicylates|mesh-list
863500|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
863501|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863502|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
863503|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
863504|NCT02328079|Protective Agents|protective agents|mesh-ancestor
863505|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261505|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
2261506|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2261507|NCT00164736|Ritonavir|ritonavir|mesh-list
2261508|NCT00164736|Lopinavir|lopinavir|mesh-list
2261509|NCT00164736|Lamivudine|lamivudine|mesh-list
864074|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
864075|NCT02326311|Dasatinib|dasatinib|mesh-list
864076|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
864077|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
864078|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
864079|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261510|NCT00164736|Zidovudine|zidovudine|mesh-list
2261511|NCT00164736|Nevirapine|nevirapine|mesh-list
2261512|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2261513|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2261514|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
2261515|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261516|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261517|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2755162|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2755163|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2755164|NCT05151263|Analgesics|analgesics|mesh-ancestor
2755165|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
2755166|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2755167|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755168|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2755169|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2755170|NCT05151263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2755171|NCT05151263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2261518|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2261519|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
2261520|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261521|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2261522|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2261523|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2261524|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2755172|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755173|NCT05151263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2755174|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2755175|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2755176|NCT05151263|Antipyretics|antipyretics|mesh-ancestor
2100060|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100061|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2100062|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2100063|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2100064|NCT02366143|Growth Substances|growth substances|mesh-ancestor
2100065|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100066|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
2100067|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
2100068|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2100069|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2100070|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100071|NCT02366468|Ranibizumab|ranibizumab|mesh-list
2100072|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2100073|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2100074|NCT02366468|Growth Substances|growth substances|mesh-ancestor
2100075|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100076|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
2100077|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100078|NCT02366663|Cytarabine|cytarabine|mesh-list
2100079|NCT02366663|Rituximab|rituximab|mesh-list
2100080|NCT02366663|Etoposide|etoposide|mesh-list
863588|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
863589|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
863590|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
863591|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
863592|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
863593|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
863594|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
863712|NCT02327702|Emtricitabine|emtricitabine|mesh-list
863713|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
863714|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
863715|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
863716|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
863717|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863718|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863719|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
863720|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
864041|NCT02326610|Hormones|hormones|mesh-list
864042|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
864043|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261525|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
2261526|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2261527|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2261528|NCT00164749|Curcumin|curcumin|mesh-list
2261529|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2261530|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2261531|NCT00164749|Analgesics|analgesics|mesh-ancestor
2261532|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
2261533|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261534|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261535|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2261536|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2261537|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755193|NCT05145348|Vaccines|vaccines|mesh-list
2755194|NCT05145348|Immunologic Factors|immunologic factors|mesh-ancestor
2755195|NCT05145348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261538|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261539|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755196|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
2755197|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2755198|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2755199|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
2100081|NCT02366663|Melphalan|melphalan|mesh-list
2100082|NCT02366663|Carmustine|carmustine|mesh-list
2100083|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2100084|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100085|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
2100086|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100087|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2100088|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2100089|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2100090|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2100091|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100092|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100093|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2100094|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
2100095|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
2100096|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100097|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2100098|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2100099|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
2100100|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2100101|NCT02366689|Triclosan|triclosan|mesh-list
2100102|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
2100103|NCT02366689|Fluorides|fluorides|mesh-list
2100104|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
2261540|NCT00164775|Imipramine|imipramine|mesh-list
864138|NCT02325986|Fluorouracil|fluorouracil|mesh-list
864139|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
864140|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
864141|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
864142|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
864143|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
864144|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
864145|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755200|NCT05142267|Oxycodone|oxycodone|mesh-list
2755201|NCT05142267|Naloxone|naloxone|mesh-list
2755202|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2755203|NCT05142267|Narcotics|narcotics|mesh-ancestor
2755204|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2755205|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755206|NCT05142267|Analgesics|analgesics|mesh-ancestor
2755207|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
2755208|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2755209|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2755210|NCT05137938|Ketamine|ketamine|mesh-list
2755211|NCT05137938|Analgesics|analgesics|mesh-ancestor
2755212|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
2755213|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2755214|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755215|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2755216|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2755217|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
2755218|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
2755219|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2755220|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2755221|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2755222|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2755223|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261541|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2261542|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
2261543|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2755232|NCT05133804|Methylphenidate|methylphenidate|mesh-list
2755233|NCT05133804|Reboxetine|reboxetine|mesh-list
2100105|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
2100106|NCT02366689|Protective Agents|protective agents|mesh-ancestor
2100107|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100108|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2100109|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100110|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2100111|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2100112|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
2100113|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100114|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2100115|NCT02366767|Insulin|insulin|mesh-list
2100116|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2100117|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100118|NCT02366871|Enoxaparin|enoxaparin|mesh-list
2100119|NCT02366871|Apixaban|apixaban|mesh-list
2100120|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
2100121|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2100122|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2100123|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100124|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2100125|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
2100126|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2100127|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
2100128|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100134|NCT02367131|Empagliflozin|empagliflozin|mesh-list
863807|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
863808|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
863809|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
863810|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
863811|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863812|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
863813|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
863814|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
863815|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
863816|NCT02327923|Narcotics|narcotics|mesh-ancestor
863817|NCT02327923|Analgesics|analgesics|mesh-ancestor
863818|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
863819|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
863820|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
863821|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
863822|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
863823|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
863824|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
863825|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
863826|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
863827|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
863828|NCT02327923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
863829|NCT02327923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
863830|NCT02327923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
863831|NCT02327923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
863832|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
863833|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
863834|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
863835|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
863836|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
863837|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
863838|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
863839|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
863840|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
863841|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
863842|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
863843|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
863844|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
863845|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
863846|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
863847|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
863848|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
863849|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
863850|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
863851|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
863852|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
863853|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
863854|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
863855|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
863856|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
863857|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2261544|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2261545|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2261546|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2261547|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755234|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2755235|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755236|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2755237|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2755238|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2755239|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755240|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
2755241|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2755242|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
2755243|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2755244|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2755245|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
2755251|NCT05117307|Bupivacaine|bupivacaine|mesh-list
2755252|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
863859|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
863860|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
863861|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
863862|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
863863|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863864|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
863865|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863866|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
2755253|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
2755254|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2755255|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755256|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
2755257|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2755258|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2755259|NCT05105633|Tenecteplase|tenecteplase|mesh-list
2755260|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2755261|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2755262|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261548|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
2261549|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261550|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261551|NCT00164788|Esomeprazole|esomeprazole|mesh-list
2261552|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2261553|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2261554|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2261555|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261556|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261557|NCT00164801|Diltiazem|diltiazem|mesh-list
2261558|NCT00164801|Baclofen|baclofen|mesh-list
2261559|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2261560|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261561|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2261562|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261563|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2261564|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
2100135|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2100136|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100137|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2100138|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100139|NCT02367352|Paclitaxel|paclitaxel|mesh-list
2100140|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2100141|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100142|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
2100143|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
2100144|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
2100145|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100152|NCT02367599|Vitamin D|vitamin d|mesh-list
2100153|NCT02367599|Vitamins|vitamins|mesh-ancestor
2100154|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
2261565|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
2261566|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261567|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261568|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2261569|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
864029|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
864030|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
864031|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
864032|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755288|NCT05085496|Atezolizumab|atezolizumab|mesh-list
2755289|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2755290|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755291|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
2755292|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755293|NCT05085054|Osimertinib|osimertinib|mesh-list
2755294|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755295|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2755296|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2755297|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755298|NCT05084508|Vaccines|vaccines|mesh-list
2755299|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2755300|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
2755301|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755334|NCT05077332|Celecoxib|celecoxib|mesh-list
2755335|NCT05077332|Famotidine|famotidine|mesh-list
2755336|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2755337|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2755338|NCT05077332|Analgesics|analgesics|mesh-ancestor
2755339|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
2755340|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261570|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2261571|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2261572|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
2261573|NCT00164840|Esomeprazole|esomeprazole|mesh-list
2261574|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2755341|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863957|NCT02326987|Pregabalin|pregabalin|mesh-list
863958|NCT02326987|Analgesics|analgesics|mesh-ancestor
863959|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
863960|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
863961|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
863962|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
863963|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
863964|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
863965|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
863966|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
863967|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
863968|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
863969|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
863970|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
864131|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
864132|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2261575|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2261576|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2261577|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261578|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261579|NCT00164866|Omeprazole|omeprazole|mesh-list
2261580|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2261581|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2261582|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2261583|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261584|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100155|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100156|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2100157|NCT02367781|Paclitaxel|paclitaxel|mesh-list
2100158|NCT02367781|Carboplatin|carboplatin|mesh-list
2100159|NCT02367781|Pemetrexed|pemetrexed|mesh-list
2100160|NCT02367781|Atezolizumab|atezolizumab|mesh-list
2100161|NCT02367781|Antibodies|antibodies|mesh-list
2100162|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2100163|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2100164|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100165|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
2100166|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
2100167|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
2100168|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100169|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
2100170|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100171|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100172|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2100173|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2100174|NCT02367794|Paclitaxel|paclitaxel|mesh-list
2100175|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2100176|NCT02367794|Carboplatin|carboplatin|mesh-list
2100177|NCT02367794|Atezolizumab|atezolizumab|mesh-list
2100178|NCT02367794|Antibodies|antibodies|mesh-list
2100179|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2100180|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100181|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
2100182|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
2100183|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
2100184|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100185|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
2100186|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100187|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
2100188|NCT02367833|NuvaRing|nuvaring|mesh-list
2100189|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
2100190|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2100191|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2100192|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100193|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2100194|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2100195|NCT02367859|Trametinib|trametinib|mesh-list
2100196|NCT02367859|Dabrafenib|dabrafenib|mesh-list
2100197|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100198|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2100199|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100200|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100201|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
2100202|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261585|NCT00164892|Rofecoxib|rofecoxib|mesh-list
2261586|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2261587|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2261588|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261589|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261590|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2261591|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2261592|NCT00164892|Analgesics|analgesics|mesh-ancestor
2261593|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
2261594|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261595|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261596|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2261597|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2261598|NCT00164931|Omeprazole|omeprazole|mesh-list
2261599|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2755342|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2755343|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2755344|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2755345|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2755346|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2755347|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755348|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2755349|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2755350|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2755351|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
2755352|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
2755353|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261600|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2261601|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2261602|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261603|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261604|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
2755369|NCT05054374|Fulvestrant|fulvestrant|mesh-list
2755370|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2755371|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755372|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2100203|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100204|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
2100205|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
2100206|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
2100207|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2100208|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2100209|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100210|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100211|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100212|NCT02368314|Enoxaparin|enoxaparin|mesh-list
2100213|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
2100214|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
2100215|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2100216|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2100217|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100218|NCT02368431|Zonisamide|zonisamide|mesh-list
2100219|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
2100220|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2100221|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2100222|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100223|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2100224|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100225|NCT02368457|Tocopherols|tocopherols|mesh-list
2755373|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2755374|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
864082|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
864083|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
864084|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
864085|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
864086|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
864087|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
864088|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
864089|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
864090|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
864091|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
864092|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
864093|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
864094|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261605|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
2261606|NCT00164970|Vitamins|vitamins|mesh-ancestor
2261607|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
2261608|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261609|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
2755375|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2755376|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755377|NCT05054179|Ropivacaine|ropivacaine|mesh-list
2755378|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
2755379|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
2755380|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2755381|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755382|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
2755383|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2755405|NCT05030272|Nicotine|nicotine|mesh-list
2755406|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2755407|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
2755408|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2755409|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755410|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2755411|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2755412|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
2755413|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2755414|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261610|NCT00164970|Hematinics|hematinics|mesh-ancestor
2261611|NCT00164996|Anesthetics|anesthetics|mesh-list
2261612|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2261613|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261614|NCT00165035|Paclitaxel|paclitaxel|mesh-list
2261615|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2261616|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2261617|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261618|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
2261619|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
2261620|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
2261621|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261622|NCT00165048|Rofecoxib|rofecoxib|mesh-list
2261623|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2261624|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
864102|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
864103|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
864104|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
864105|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
864106|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
864107|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2755436|NCT05027425|Durvalumab|durvalumab|mesh-list
2755437|NCT05027425|Tremelimumab|tremelimumab|mesh-list
2755438|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2755439|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261625|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261626|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261627|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2261628|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2261629|NCT00165048|Analgesics|analgesics|mesh-ancestor
2261630|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
2755440|NCT05024513|Fluorouracil|fluorouracil|mesh-list
2755441|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
2755442|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
2755443|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755444|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2755445|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755446|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2755447|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
2755448|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100226|NCT02368457|Vitamin E|vitamin e|mesh-list
2100227|NCT02368457|Tocotrienols|tocotrienols|mesh-list
2100228|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
2100229|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
2100230|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2100231|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100232|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100233|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2100234|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2100235|NCT02368457|Protective Agents|protective agents|mesh-ancestor
2100236|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261631|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261632|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261633|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2261634|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2261635|NCT00165074|Calfactant|calfactant|mesh-list
2261636|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2261637|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
2261638|NCT00165087|Doxorubicin|doxorubicin|mesh-list
2261639|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
2261640|NCT00165087|Asparaginase|asparaginase|mesh-list
2755475|NCT04995003|Cyclophosphamide|cyclophosphamide|mesh-list
2755476|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
2755477|NCT04995003|Nivolumab|nivolumab|mesh-list
2755478|NCT04995003|Fludarabine|fludarabine|mesh-list
2755479|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2755480|NCT04995003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2755481|NCT04995003|Immunologic Factors|immunologic factors|mesh-ancestor
2755482|NCT04995003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755483|NCT04995003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2755484|NCT04995003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2755485|NCT04995003|Alkylating Agents|alkylating agents|mesh-ancestor
2755486|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755487|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755488|NCT04995003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2755489|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2755490|NCT04994561|Niacinamide|niacinamide|mesh-list
2755491|NCT04994561|Metformin|metformin|mesh-list
2755492|NCT04994561|Dasatinib|dasatinib|mesh-list
2755493|NCT04994561|Resveratrol|resveratrol|mesh-list
2755494|NCT04994561|Quercetin|quercetin|mesh-list
2755495|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2755496|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755497|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755498|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2755499|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2755500|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755501|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
2755502|NCT04994561|Protective Agents|protective agents|mesh-ancestor
2755503|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2755504|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
2755505|NCT04994561|Vitamins|vitamins|mesh-ancestor
2755506|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
2100237|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
2100238|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2100239|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
2100240|NCT02368457|Vitamins|vitamins|mesh-ancestor
2100241|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
2100248|NCT02369068|Triamcinolone|triamcinolone|mesh-list
2100249|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2755513|NCT04991662|Phenylephrine|phenylephrine|mesh-list
2755514|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
2755515|NCT04991662|Norepinephrine|norepinephrine|mesh-list
2100250|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2100251|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2100252|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2100253|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
2100254|NCT02369068|Hormones|hormones|mesh-ancestor
2100255|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2100256|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261641|NCT00165087|Razoxane|razoxane|mesh-list
2755516|NCT04991662|Metaraminol|metaraminol|mesh-list
2755517|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2755518|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
2755519|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
2755520|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2755521|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755522|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
2755523|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2755524|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
2755525|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
2755526|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2755527|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2261642|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2261643|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261644|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2261645|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2261646|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261647|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261648|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2261649|NCT00165087|Protective Agents|protective agents|mesh-ancestor
2261650|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261651|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
2261652|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
2261653|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
2261654|NCT00165139|Melphalan|melphalan|mesh-list
2261655|NCT00165139|Ifosfamide|ifosfamide|mesh-list
2261656|NCT00165139|Carboplatin|carboplatin|mesh-list
2261657|NCT00165139|Etoposide|etoposide|mesh-list
2261658|NCT00165139|Vincristine|vincristine|mesh-list
2261659|NCT00165139|Doxorubicin|doxorubicin|mesh-list
2261660|NCT00165139|Sargramostim|sargramostim|mesh-list
2755528|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2755529|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
2755530|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2755531|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755532|NCT04991662|Protective Agents|protective agents|mesh-ancestor
2755533|NCT04969120|Metoclopramide|metoclopramide|mesh-list
2755534|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
2755535|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
2755536|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2755537|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261661|NCT00165139|Lenograstim|lenograstim|mesh-list
2261662|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2261663|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
2261664|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261665|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2261666|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2261667|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
2261668|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261669|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261670|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2261671|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2261672|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2261673|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2261674|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261675|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
2261676|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
2261677|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
2261678|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2261679|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2261680|NCT00165178|Leucovorin|leucovorin|mesh-list
2261681|NCT00165178|Cytarabine|cytarabine|mesh-list
2261682|NCT00165178|Dexamethasone|dexamethasone|mesh-list
2261683|NCT00165178|Prednisone|prednisone|mesh-list
2261684|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
2261685|NCT00165178|Doxorubicin|doxorubicin|mesh-list
2100257|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2100258|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
2100259|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100260|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2100261|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100262|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2100263|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2100264|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
2100265|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100266|NCT02369159|Oseltamivir|oseltamivir|mesh-list
2100267|NCT02369159|Peramivir|peramivir|mesh-list
2100268|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
2100269|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2755538|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2755539|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2755540|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2755541|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
2755542|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2755543|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755559|NCT04947072|Anesthetics|anesthetics|mesh-list
2755560|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2755561|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755565|NCT04942158|Eugenol|eugenol|mesh-list
2755566|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
2755567|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
2755568|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
2755569|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2261686|NCT00165178|Methotrexate|methotrexate|mesh-list
2261687|NCT00165178|Vincristine|vincristine|mesh-list
2261688|NCT00165178|Asparaginase|asparaginase|mesh-list
2261689|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
2261690|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2261691|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
2755570|NCT04942158|Protective Agents|protective agents|mesh-ancestor
2755571|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755572|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100270|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100271|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100272|NCT02369172|Bupropion|bupropion|mesh-list
2100273|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2100274|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
2100275|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2100276|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2100277|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2100278|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2100279|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100280|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
2100281|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100282|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100283|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2100284|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2100285|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100286|NCT02369211|Acetaminophen|acetaminophen|mesh-list
2100287|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2100288|NCT02369211|Analgesics|analgesics|mesh-ancestor
2100289|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
2100290|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100291|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100292|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
2100293|NCT02369341|Vaccines|vaccines|mesh-list
2261692|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
2755598|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
2755599|NCT04941703|Cathartics|cathartics|mesh-ancestor
2755600|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2100294|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
2100295|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100296|NCT02369484|Afatinib|afatinib|mesh-list
2100297|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100298|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2100299|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100300|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100301|NCT02369510|Epinephrine|epinephrine|mesh-list
2100302|NCT02369510|Racepinephrine|racepinephrine|mesh-list
2261693|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261694|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261695|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2261696|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
2261697|NCT00165178|Hormones|hormones|mesh-ancestor
2261698|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261699|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2261700|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261701|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2261702|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2261703|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2261704|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261705|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261706|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2261707|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
2261708|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2261709|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2261710|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
2100303|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
2100304|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2100305|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2100306|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
2100307|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100308|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100309|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100310|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2100311|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2100312|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
2100313|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100314|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2100315|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
2100316|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
2100317|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
2100318|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2100319|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2100320|NCT02369835|Eusol|eusol|mesh-list
2100321|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2100322|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
2100323|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100324|NCT02369874|Durvalumab|durvalumab|mesh-list
2100325|NCT02369874|Tremelimumab|tremelimumab|mesh-list
2100326|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2100327|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2100328|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100329|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
2100330|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261711|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
2261712|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2100331|NCT02369900|Esmolol|esmolol|mesh-list
2100332|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2100333|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2100334|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
2100335|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100336|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100337|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100338|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2100339|NCT02370095|Treprostinil|treprostinil|mesh-list
2100340|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2100341|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2100342|NCT02370238|Paclitaxel|paclitaxel|mesh-list
2100343|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2100344|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100345|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
2100346|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
2100347|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
2100348|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100349|NCT02370498|Paclitaxel|paclitaxel|mesh-list
2100350|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2100351|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100352|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
2100353|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
2100354|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
2100355|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100356|NCT02370615|Itraconazole|itraconazole|mesh-list
2100357|NCT02370615|Digoxin|digoxin|mesh-list
2100358|NCT02370615|Midazolam|midazolam|mesh-list
2100359|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
2100360|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2100361|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2100362|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2100363|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100364|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2100365|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2100366|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2100367|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2100368|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
2100369|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
2100370|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
2100371|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
2100372|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261713|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2261714|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
2261715|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2261716|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2261717|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
2261718|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261719|NCT00165178|Antidotes|antidotes|mesh-ancestor
2100373|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100374|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
2100375|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100376|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2100377|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2100378|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100379|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2100380|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
2100381|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2100382|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2100383|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2100384|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2100385|NCT02370615|Protective Agents|protective agents|mesh-ancestor
2100386|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
2100387|NCT02370693|Bortezomib|bortezomib|mesh-list
2100388|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2100389|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100390|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2100391|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
2100392|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2100393|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100394|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100395|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100396|NCT02370784|Atorvastatin|atorvastatin|mesh-list
2100397|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2100398|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2100399|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
2100400|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100401|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2100402|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2100403|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100404|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
2100405|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2100406|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100407|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2100408|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100409|NCT02371252|Alendronate|alendronate|mesh-list
2100410|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2100411|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100412|NCT02371616|Listerine|listerine|mesh-list
2100413|NCT02371616|Calcium|calcium|mesh-list
2100414|NCT02371616|Fluorides|fluorides|mesh-list
2100415|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
2100416|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
2100417|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2100418|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100419|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
2100420|NCT02371616|Protective Agents|protective agents|mesh-ancestor
2100421|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2100422|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261720|NCT00165178|Protective Agents|protective agents|mesh-ancestor
2755682|NCT04911166|Atezolizumab|atezolizumab|mesh-list
2755683|NCT04911166|Interleukin-12|interleukin-12|mesh-list
2755684|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755685|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2755686|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
2261721|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
2261722|NCT00165178|Vitamins|vitamins|mesh-ancestor
2261723|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
2261724|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2261725|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
2261726|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
2261727|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
2100423|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
2100424|NCT02371629|Bromides|bromides|mesh-list
2100425|NCT02371629|Albuterol|albuterol|mesh-list
2100426|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
2100427|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2100428|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
2100429|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100430|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100431|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2100432|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
2100433|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
2100434|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2100435|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2100436|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2100437|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2100438|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
2100439|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100440|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100441|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2100442|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2100443|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2100444|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
2100445|NCT02371746|Travoprost|travoprost|mesh-list
2100446|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2100447|NCT02371759|Anesthetics|anesthetics|mesh-list
2100448|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2100449|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100450|NCT02371850|Nicotine|nicotine|mesh-list
2100451|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2100452|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
2100453|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100454|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100455|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2100456|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2100457|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
2100458|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261728|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2755687|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755688|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2100459|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100464|NCT02371980|Vortioxetine|vortioxetine|mesh-list
2100465|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
2100466|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2100467|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2100468|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2100469|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2100470|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100471|NCT02371980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2100472|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2100473|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2100474|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100475|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100476|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
2100477|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2100478|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2100479|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2100480|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2100481|NCT02372006|Afatinib|afatinib|mesh-list
2100482|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100483|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2100484|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100485|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100486|NCT02372253|Verapamil|verapamil|mesh-list
2100487|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2100488|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2100489|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2100490|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100491|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2100492|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100493|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
2100494|NCT02372383|Azithromycin|azithromycin|mesh-list
2100495|NCT02372383|Rifampin|rifampin|mesh-list
2100496|NCT02372383|Ethambutol|ethambutol|mesh-list
2100497|NCT02372383|Pancrelipase|pancrelipase|mesh-list
2100498|NCT02372383|Pancreatin|pancreatin|mesh-list
2100499|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2100500|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100501|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2100502|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
2100503|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
2100504|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2100505|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100506|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100507|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2100508|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2100509|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2100510|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2100511|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2100512|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2100513|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2100514|NCT02372799|Fluoxetine|fluoxetine|mesh-list
2100515|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2100516|NCT02372799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2100517|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2100518|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2100519|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100520|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100521|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
2100522|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100523|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2100524|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
2100525|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2100526|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2100527|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2755689|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2755690|NCT04911166|Growth Substances|growth substances|mesh-ancestor
2755691|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
2755692|NCT04906213|Dapagliflozin|dapagliflozin|mesh-list
2755693|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2755694|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755695|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2755696|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100528|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100529|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2100530|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2100531|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2100532|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2100533|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100534|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2100535|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
2100536|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100537|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
2100538|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2100539|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2100540|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100541|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100542|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100543|NCT02373137|Ofloxacin|ofloxacin|mesh-list
2100544|NCT02373137|Prednisolone|prednisolone|mesh-list
2100545|NCT02373137|Phenylephrine|phenylephrine|mesh-list
2100546|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
2100547|NCT02373137|Tropicamide|tropicamide|mesh-list
2100548|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2100549|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
2100550|NCT02373137|Hormones|hormones|mesh-ancestor
2100551|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2100552|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100553|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2100554|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100555|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
2100556|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100557|NCT02373137|Protective Agents|protective agents|mesh-ancestor
2100558|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2100559|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
2100560|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
2100561|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2100562|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
2100563|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
2100564|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2100565|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2100566|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2100567|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
2100568|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100569|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100570|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2100571|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2100572|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
2100573|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2100574|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100575|NCT02373137|Renal Agents|renal agents|mesh-ancestor
2100576|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2261729|NCT00165191|Doxorubicin|doxorubicin|mesh-list
2261730|NCT00165191|Fluorouracil|fluorouracil|mesh-list
2100577|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2100578|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2100579|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100580|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2100581|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2100582|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
2100583|NCT02373202|Mizoribine|mizoribine|mesh-list
2100584|NCT02373202|Bucillamine|bucillamine|mesh-list
2100585|NCT02373202|Tacrolimus|tacrolimus|mesh-list
2100586|NCT02373202|Leflunomide|leflunomide|mesh-list
2100587|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2100588|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
2100589|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100590|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2100591|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100592|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100593|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100594|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2100595|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2100596|NCT02373202|Analgesics|analgesics|mesh-ancestor
2100597|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
2100598|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100599|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2100600|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2100601|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2100602|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
2100603|NCT02373202|Protective Agents|protective agents|mesh-ancestor
2100604|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2100605|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2100606|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100607|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
2100608|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2100609|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2100610|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2100611|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2100612|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
2100613|NCT02373813|Folic Acid|folic acid|mesh-list
2100614|NCT02373813|Etanercept|etanercept|mesh-list
2100615|NCT02373813|Methotrexate|methotrexate|mesh-list
2100616|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2100617|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
2100618|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2100619|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100620|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2100621|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
2100622|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100623|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100624|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
2100625|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100626|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2100627|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2100628|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
2100629|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2100630|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2100631|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2100632|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2100633|NCT02373813|Analgesics|analgesics|mesh-ancestor
2100634|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
2100635|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100636|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2100637|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2100638|NCT02373813|Hematinics|hematinics|mesh-ancestor
2100639|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
2100640|NCT02373813|Vitamins|vitamins|mesh-ancestor
2100641|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
2100642|NCT02374060|Dexamethasone|dexamethasone|mesh-list
2100643|NCT02374060|Triamcinolone|triamcinolone|mesh-list
2100644|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2261731|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261732|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2261733|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2261734|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2261735|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261736|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261737|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
2261738|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2261739|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2261740|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
2261741|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261742|NCT00165204|Tibolone|tibolone|mesh-list
2100645|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2100646|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2100647|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2100648|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
2100649|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
2100650|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100651|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100652|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2100653|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
2100654|NCT02374060|Hormones|hormones|mesh-ancestor
2100655|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2100656|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2100657|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100658|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2100659|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
2100660|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100661|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100662|NCT02374099|Azacitidine|azacitidine|mesh-list
2100663|NCT02374099|Fulvestrant|fulvestrant|mesh-list
2100664|NCT02374099|Cc-486|cc-486|mesh-list
2100665|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2100666|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
2100667|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100668|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100669|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100670|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2100671|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2100672|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2100673|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
2100674|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2100675|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100676|NCT02374164|Febuxostat|febuxostat|mesh-list
2100677|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
2100678|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2100679|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
2261743|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
2261744|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
2755747|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
2755748|NCT04827836|Povidone|povidone|mesh-list
2755749|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2755750|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2755751|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
2755752|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
2755753|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2100680|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2100681|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2100682|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100683|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
2100684|NCT02374398|Coagulants|coagulants|mesh-ancestor
2100685|NCT02374957|Cilostazol|cilostazol|mesh-list
2100686|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2100687|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
2100688|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100689|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100690|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2100691|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
2100692|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2100693|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2100694|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100695|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2100696|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
2100697|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2100698|NCT02374957|Protective Agents|protective agents|mesh-ancestor
2100699|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2100700|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2100701|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100702|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
2100703|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2100704|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100705|NCT02375724|Bromides|bromides|mesh-list
2100706|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
2100707|NCT02375971|Ranibizumab|ranibizumab|mesh-list
2100708|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2100709|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2100710|NCT02375971|Growth Substances|growth substances|mesh-ancestor
2100711|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100712|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
2100713|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100714|NCT02376010|Warfarin|warfarin|mesh-list
2100715|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
2100716|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
2100717|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2100718|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
2100719|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2100720|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
2100721|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100722|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100723|NCT02376166|Metformin|metformin|mesh-list
2100724|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2100725|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100726|NCT02376257|Cycloserine|cycloserine|mesh-list
2100727|NCT02376257|Modafinil|modafinil|mesh-list
2100728|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2100729|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100730|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2100731|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2100732|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2100733|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100734|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2100735|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100736|NCT02376257|Renal Agents|renal agents|mesh-ancestor
2100737|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2100738|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
2100739|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2100740|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
2100741|NCT02376283|Clopidogrel|clopidogrel|mesh-list
2100742|NCT02376283|Ticagrelor|ticagrelor|mesh-list
2100743|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2100744|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2100745|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2100746|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2261745|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261746|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261747|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2261748|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2261749|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261750|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2261751|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
2261752|NCT00165204|Hormones|hormones|mesh-ancestor
2261753|NCT00165217|Thalidomide|thalidomide|mesh-list
2755754|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2755755|NCT04810208|Docetaxel|docetaxel|mesh-list
2755756|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755757|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
2755758|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
2755759|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
2100747|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2100748|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
2100749|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100750|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100751|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100752|NCT02376790|Etanercept|etanercept|mesh-list
2100753|NCT02376790|Methotrexate|methotrexate|mesh-list
2100754|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2100755|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
2100756|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2100757|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100758|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2100759|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
2100760|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100761|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100762|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
2100763|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100764|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2100765|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2100766|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
2100767|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2100768|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2100769|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2100770|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2100771|NCT02376790|Analgesics|analgesics|mesh-ancestor
2100772|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
2100773|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100774|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2100775|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2100776|NCT02377752|Doxorubicin|doxorubicin|mesh-list
2100777|NCT02377752|Olaratumab|olaratumab|mesh-list
2100778|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2100779|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100780|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2100781|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2100782|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100783|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100784|NCT02378480|Linezolid|linezolid|mesh-list
2100785|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2100786|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100787|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2100788|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100789|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100790|NCT02378506|Etanercept|etanercept|mesh-list
2100791|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2100792|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2100793|NCT02378506|Analgesics|analgesics|mesh-ancestor
2100794|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
2100795|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100796|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100797|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2100798|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2100799|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2100800|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2100801|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
2100802|NCT02378714|Varenicline|varenicline|mesh-list
2100803|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2100804|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2100805|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
2789055|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
2755760|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755761|NCT04804540|Vedolizumab|vedolizumab|mesh-list
2755762|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2755763|NCT04802161|Cytarabine|cytarabine|mesh-list
2755764|NCT04802161|Daunorubicin|daunorubicin|mesh-list
2755765|NCT04802161|Pomalidomide|pomalidomide|mesh-list
2261754|NCT00165217|Capecitabine|capecitabine|mesh-list
2261755|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2261756|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
2261757|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261758|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755766|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2100806|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100807|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100808|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100809|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
2100810|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2100811|NCT02378935|Velpatasvir|velpatasvir|mesh-list
2100812|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
2100813|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100814|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
2100815|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2100816|NCT02378961|Velpatasvir|velpatasvir|mesh-list
2100817|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
2100818|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100819|NCT02379091|Leucovorin|leucovorin|mesh-list
2100820|NCT02379091|Folic Acid|folic acid|mesh-list
2100821|NCT02379091|Methotrexate|methotrexate|mesh-list
2100822|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
2100823|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2100824|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
2100825|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2100826|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100827|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2100828|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
2100829|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100830|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100831|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
2100832|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100833|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2100834|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2100835|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
2100836|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2100837|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2100838|NCT02379091|Antidotes|antidotes|mesh-ancestor
2100839|NCT02379091|Protective Agents|protective agents|mesh-ancestor
2100840|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
2100841|NCT02379091|Vitamins|vitamins|mesh-ancestor
2100842|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
2100843|NCT02379091|Hematinics|hematinics|mesh-ancestor
2100844|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2100845|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
2100846|NCT02379195|Fludarabine|fludarabine|mesh-list
2100847|NCT02379195|Interleukin-2|interleukin-2|mesh-list
2100848|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2100849|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
2100850|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100851|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2100852|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2100853|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
2100854|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100855|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100856|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2100857|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2100858|NCT02379195|Analgesics|analgesics|mesh-ancestor
2100859|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
2100860|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100861|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
2100862|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100863|NCT02379221|Lidocaine|lidocaine|mesh-list
2100864|NCT02379221|Epinephrine|epinephrine|mesh-list
2100865|NCT02379221|Benzocaine|benzocaine|mesh-list
2100866|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
2100867|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
2100868|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2100869|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100870|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
2100871|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2755767|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
2755768|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755769|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755770|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
2755771|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2755772|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2755773|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
2755774|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100872|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2100873|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2100874|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2100875|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2100876|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100877|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2100878|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2100879|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
2100880|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100881|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2100882|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2100883|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
2100884|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2100885|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
2100886|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
2100887|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
2100888|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2100889|NCT02379247|Paclitaxel|paclitaxel|mesh-list
2100890|NCT02379247|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2100891|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2100892|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2100893|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
2100894|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
2100895|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
2100896|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100897|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
2100898|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2100899|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
2100900|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100901|NCT02379637|Expectorants|expectorants|mesh-ancestor
2100902|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
2100903|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2100904|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
2100905|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100906|NCT02379637|Protective Agents|protective agents|mesh-ancestor
2100907|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100908|NCT02379637|Antidotes|antidotes|mesh-ancestor
2100909|NCT02379858|Alvimopan|alvimopan|mesh-list
2100910|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2100911|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2100912|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2100913|NCT02380287|Antibodies|antibodies|mesh-list
2100914|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2100915|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
2100916|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100917|NCT02380742|Lidocaine|lidocaine|mesh-list
2100918|NCT02380742|Prilocaine|prilocaine|mesh-list
2100919|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2100920|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
2100921|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
2100922|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2100923|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100924|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
2100925|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100926|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2100927|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2100928|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2100929|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2100930|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100931|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2100932|NCT02381652|Triamcinolone|triamcinolone|mesh-list
2100933|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2100934|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2100935|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
2100936|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2100937|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2100938|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
2755775|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2261759|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2261760|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
2261761|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261762|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
2261763|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2261764|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100939|NCT02381652|Hormones|hormones|mesh-ancestor
2100940|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2100941|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100942|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2100943|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
2100944|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2100945|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100946|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2100947|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
2100948|NCT02381652|Protective Agents|protective agents|mesh-ancestor
2100949|NCT02382016|Macitentan|macitentan|mesh-list
2100950|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2100951|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2100952|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100953|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2100954|NCT02382276|Nalmefene|nalmefene|mesh-list
2100955|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2100956|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100957|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
2100958|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100959|NCT02382640|Febuxostat|febuxostat|mesh-list
2100960|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
2100961|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2100962|NCT02382848|Prazosin|prazosin|mesh-list
2100963|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2100964|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2100965|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2100966|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2100967|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
2100968|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100969|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100970|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100971|NCT02383043|Cocaine|cocaine|mesh-list
2100972|NCT02383043|Amphetamine|amphetamine|mesh-list
2100973|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
2100974|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2100975|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2100976|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
2100977|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
2100978|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2100979|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
2100980|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2100981|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2100982|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
2100983|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2100984|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2100985|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2100986|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2100987|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
2100988|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
2100989|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2100990|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
2100991|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2100992|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
2100993|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2100994|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2100995|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
2100996|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2100997|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2100998|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2100999|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101000|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101001|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
2101002|NCT02383589|Rituximab|rituximab|mesh-list
2101003|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101004|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101005|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
2755776|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2755777|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2755778|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2755779|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2755780|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2755781|NCT04802161|Growth Substances|growth substances|mesh-ancestor
2755782|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
2755788|NCT04787835|Anesthetics|anesthetics|mesh-list
2755789|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
2101006|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101007|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2101008|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2101009|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2101010|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
2101011|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2101012|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101013|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101014|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101015|NCT02383758|Bisacodyl|bisacodyl|mesh-list
2101016|NCT02383758|Glycerol|glycerol|mesh-list
2101017|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2101018|NCT02383758|Protective Agents|protective agents|mesh-ancestor
2101019|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101020|NCT02383758|Cathartics|cathartics|mesh-ancestor
2101021|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2101022|NCT02383758|Laxatives|laxatives|mesh-ancestor
2101023|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2101024|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2101025|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101026|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2101027|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101028|NCT02383966|Carboplatin|carboplatin|mesh-list
2101029|NCT02383966|Fluorouracil|fluorouracil|mesh-list
2101030|NCT02383966|Cetuximab|cetuximab|mesh-list
2101031|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101032|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
2101033|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101034|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2101035|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2101036|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
2101037|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101038|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101039|NCT02384044|Listerine|listerine|mesh-list
2101040|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
2101041|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
2101042|NCT02384044|Protective Agents|protective agents|mesh-ancestor
2101043|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101044|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2101045|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101046|NCT02384070|Aspirin|aspirin|mesh-list
2101047|NCT02384070|Bivalirudin|bivalirudin|mesh-list
2101048|NCT02384070|Clopidogrel|clopidogrel|mesh-list
2101049|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2101050|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2101051|NCT02384070|Analgesics|analgesics|mesh-ancestor
2101052|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
2101053|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101054|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101055|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2101056|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2101057|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2101058|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2101059|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101060|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2101061|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2101062|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101063|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
2101064|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2755790|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2261765|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2261766|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2261767|NCT00165217|Growth Substances|growth substances|mesh-ancestor
2261768|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
2261769|NCT00165230|Thalidomide|thalidomide|mesh-list
2261770|NCT00165230|Temozolomide|temozolomide|mesh-list
2755791|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755792|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
2755793|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2755794|NCT04774380|Carboplatin|carboplatin|mesh-list
2755795|NCT04774380|Etoposide|etoposide|mesh-list
2755796|NCT04774380|Durvalumab|durvalumab|mesh-list
2101065|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2101066|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2101067|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
2101068|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101069|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
2101070|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2101071|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
2101072|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
2101073|NCT02384200|Vancomycin|vancomycin|mesh-list
2101074|NCT02384200|Gentamicins|gentamicins|mesh-list
2101075|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
2101076|NCT02384200|Ampicillin|ampicillin|mesh-list
2101077|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
2101078|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2101079|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101080|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2101081|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101082|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101083|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2101084|NCT02384200|Renal Agents|renal agents|mesh-ancestor
2101085|NCT02384395|Lamivudine|lamivudine|mesh-list
2101086|NCT02384395|Abacavir|abacavir|mesh-list
2101087|NCT02384395|Dolutegravir|dolutegravir|mesh-list
2101088|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2101089|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2101090|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101091|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101092|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
2101093|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101094|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2101095|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2101096|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2101097|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2101098|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2101099|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2101100|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101101|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2101102|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101103|NCT02385097|Ropivacaine|ropivacaine|mesh-list
2101104|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
2101105|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
2101106|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
2101107|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101108|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101109|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
2101110|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101111|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2101112|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2101113|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2101114|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2101115|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2101116|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
2101117|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101118|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101119|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101120|NCT02385669|Ipilimumab|ipilimumab|mesh-list
2101121|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101122|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101123|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2101124|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101125|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
2261771|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2755797|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755798|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2755799|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2755800|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2101126|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2101127|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2101128|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101129|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
2101130|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
2101131|NCT02385799|Sertraline|sertraline|mesh-list
2101132|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
2101133|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2101134|NCT02385799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2101135|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2101136|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2101137|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101138|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101139|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
2101140|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101141|NCT02386098|Ritonavir|ritonavir|mesh-list
2101142|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2101143|NCT02386098|Tenofovir|tenofovir|mesh-list
2101144|NCT02386098|Dolutegravir|dolutegravir|mesh-list
2101145|NCT02386098|BMS-955176|bms-955176|mesh-list
2101146|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2101147|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2101148|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
2101149|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101150|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101151|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2101152|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2101153|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
2101154|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101155|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2101156|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2101157|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2101158|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2101159|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2101160|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2101161|NCT02386319|Melatonin|melatonin|mesh-list
2101162|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
2101163|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101164|NCT02386319|Protective Agents|protective agents|mesh-ancestor
2101165|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101166|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101167|NCT02387164|Vitamin D|vitamin d|mesh-list
2101168|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
2101169|NCT02387164|Vitamins|vitamins|mesh-ancestor
2101170|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
2101171|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101172|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2101173|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2101174|NCT02387216|Docetaxel|docetaxel|mesh-list
2101175|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101176|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
2101177|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
2101178|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
2101179|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101180|NCT02387294|Vaccines|vaccines|mesh-list
2101181|NCT02387294|Immunologic Factors|immunologic factors|mesh-ancestor
2101182|NCT02387294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101183|NCT02387359|Plecanatide|plecanatide|mesh-list
2101184|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2101185|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
2101186|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101187|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2101188|NCT02387372|Tazobactam|tazobactam|mesh-list
2101189|NCT02387372|Ceftolozane|ceftolozane|mesh-list
2101190|NCT02387372|Cephalosporins|cephalosporins|mesh-list
2101191|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2101192|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
2101193|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2101194|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101195|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2101196|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101197|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261772|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
2261773|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261774|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
2261775|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2261776|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261777|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2261778|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2261779|NCT00165230|Growth Substances|growth substances|mesh-ancestor
2261780|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
2261781|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261782|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2261783|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
2261784|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755801|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2755802|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755803|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2755804|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
2755805|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2755806|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755813|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2755814|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
2755815|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755816|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
2755817|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2755818|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755819|NCT04741997|Nivolumab|nivolumab|mesh-list
2755820|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2755821|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755822|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2755823|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755839|NCT04729608|Paclitaxel|paclitaxel|mesh-list
2755840|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2755841|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755842|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
2755843|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
2755844|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
2755845|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755854|NCT04710030|Valacyclovir|valacyclovir|mesh-list
2755855|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
2755856|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2755857|NCT04708054|Fludarabine|fludarabine|mesh-list
2755858|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
2755859|NCT04708054|Busulfan|busulfan|mesh-list
2755860|NCT04708054|Venetoclax|venetoclax|mesh-list
2755861|NCT04708054|Thiotepa|thiotepa|mesh-list
2755862|NCT04708054|Cladribine|cladribine|mesh-list
2755863|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
2755864|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755865|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2755866|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
2755867|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755868|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2755869|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
2755870|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261785|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
2261786|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261787|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
2261788|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2261789|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2261790|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261791|NCT00165295|Urological Agents|urological agents|mesh-ancestor
2261792|NCT00165308|Tamoxifen|tamoxifen|mesh-list
2261793|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2261794|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
2261795|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261796|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261797|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2261798|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261799|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2261800|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2755871|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
2755872|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2755873|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2755874|NCT04703621|Daratumumab|daratumumab|mesh-list
2755875|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755890|NCT04691804|Prednisone|prednisone|mesh-list
2755891|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
2755892|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2755893|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
2261801|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2261802|NCT00165334|Cetuximab|cetuximab|mesh-list
2261803|NCT00165334|Vinorelbine|vinorelbine|mesh-list
2261804|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2261805|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261806|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2261807|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
2261808|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
2261809|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
2261810|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261811|NCT00165347|Vatalanib|vatalanib|mesh-list
2261812|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2261813|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261814|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261815|NCT00165360|Temozolomide|temozolomide|mesh-list
2261816|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2261817|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
2755894|NCT04691804|Hormones|hormones|mesh-ancestor
2755895|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2755896|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755897|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2755898|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755899|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2755900|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2755901|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755902|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
2755903|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2261818|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261819|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261820|NCT00165373|Endostatins|endostatins|mesh-list
2261821|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261822|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2261823|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2261824|NCT00165373|Growth Substances|growth substances|mesh-ancestor
2261825|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261826|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
2755909|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
2755910|NCT04671030|Neostigmine|neostigmine|mesh-list
2261827|NCT00165399|Docetaxel|docetaxel|mesh-list
2261828|NCT00165399|Goserelin|goserelin|mesh-list
2261829|NCT00165399|Bicalutamide|bicalutamide|mesh-list
2261830|NCT00165399|Estramustine|estramustine|mesh-list
2261831|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261832|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
2261833|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
2261834|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
2755911|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2755912|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2755913|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755914|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
2755915|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2755916|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755917|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2755918|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
2755919|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2755920|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2755921|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2755922|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2755923|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
2755924|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2755925|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2755926|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2755927|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2755928|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2755929|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2755930|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755931|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755932|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2755933|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
2755934|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2755935|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755936|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2755937|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2755938|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2755939|NCT04652206|Gemcitabine|gemcitabine|mesh-list
2755940|NCT04652206|Paclitaxel|paclitaxel|mesh-list
2755941|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2755942|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2755943|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
2755944|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
2755945|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
2755946|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755947|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2755948|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
2755949|NCT04652206|Antiviral Agents|antiviral agents|mesh-ancestor
2755950|NCT04652206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2755951|NCT04652206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2755952|NCT04652206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2755953|NCT04652206|Immunologic Factors|immunologic factors|mesh-ancestor
2755954|NCT04652206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755955|NCT04647903|Amphetamine|amphetamine|mesh-list
2755956|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
2755957|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2755958|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2755959|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
2755960|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
2755961|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2755962|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
2755963|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261835|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261836|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2261837|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
2755964|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2755965|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
2755966|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2755967|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2755968|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2755969|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2755970|NCT04642378|Insulin|insulin|mesh-list
2261838|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
2261839|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261840|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261841|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2261842|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
2261843|NCT00165451|Thalidomide|thalidomide|mesh-list
2261844|NCT00165451|Celecoxib|celecoxib|mesh-list
2261845|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
2261846|NCT00165451|Etoposide|etoposide|mesh-list
2261847|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2261848|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
2261849|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261850|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2261851|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2261852|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
2261853|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261854|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261855|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2261856|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2755971|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2755972|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2755973|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261857|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2261858|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2261859|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756001|NCT04632264|Oxytocin|oxytocin|mesh-list
2756002|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
2756003|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2756004|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756005|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2756006|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2756007|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756008|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2756009|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
2756010|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756011|NCT04616560|Trastuzumab|trastuzumab|mesh-list
2756012|NCT04616560|Camptothecin|camptothecin|mesh-list
2756013|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
2756014|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2756015|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756016|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2756017|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2756018|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2756019|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756020|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756021|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
2756022|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756023|NCT04616248|Poly I-C|poly i-c|mesh-list
2756024|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2756025|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2756026|NCT04616248|Antibodies|antibodies|mesh-list
2756027|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
2756028|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2756029|NCT04616248|Poly ICLC|poly iclc|mesh-list
2756030|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
2756031|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
2261860|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2261861|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2261862|NCT00165451|Analgesics|analgesics|mesh-ancestor
2261863|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
2261864|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2261865|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2261866|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2261867|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2261868|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
2261869|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2261870|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261871|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2261872|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2756032|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756033|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756034|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
2756035|NCT04616248|Laxatives|laxatives|mesh-ancestor
2756036|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2756037|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
2756038|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2756039|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2756040|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2756041|NCT04616248|Protective Agents|protective agents|mesh-ancestor
2261873|NCT00165451|Growth Substances|growth substances|mesh-ancestor
2261874|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
2261875|NCT00165464|Irinotecan|irinotecan|mesh-list
2756051|NCT04607928|Pirfenidone|pirfenidone|mesh-list
2756052|NCT04607928|Analgesics|analgesics|mesh-ancestor
2756053|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
2756054|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2756055|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756056|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2756057|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2756058|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2756059|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2756060|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756110|NCT04564846|Insulin|insulin|mesh-list
2756111|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2756112|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756113|NCT04552223|Nivolumab|nivolumab|mesh-list
2756114|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2756115|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756116|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2756117|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756133|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
2756134|NCT04539366|Fludarabine|fludarabine|mesh-list
2756135|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
2756136|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
2756137|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756138|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2756139|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2756140|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2756141|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
2756142|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756143|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756144|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2756145|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2261876|NCT00165464|Docetaxel|docetaxel|mesh-list
2261877|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261878|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2756146|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
2756147|NCT04537026|Dexamethasone|dexamethasone|mesh-list
2756148|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
2756149|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2756150|NCT04537026|BB 1101|bb 1101|mesh-list
2756151|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2756152|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
2261879|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2261880|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261881|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261882|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
2261883|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
2261884|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
2261885|NCT00165477|Lenalidomide|lenalidomide|mesh-list
2261886|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
2261887|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261888|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2261889|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2261890|NCT00165477|Growth Substances|growth substances|mesh-ancestor
2261891|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
2261892|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261893|NCT00165490|Irinotecan|irinotecan|mesh-list
2261894|NCT00165490|Cetuximab|cetuximab|mesh-list
2261895|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261896|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2261897|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2261898|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261899|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261900|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2261901|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
2261902|NCT00165516|Antidotes|antidotes|mesh-ancestor
2261903|NCT00165516|Protective Agents|protective agents|mesh-ancestor
2261904|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261905|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
2261906|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261907|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
2261908|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2261909|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261910|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
2261911|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
2261912|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
2261913|NCT00165555|Antidotes|antidotes|mesh-ancestor
2756153|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
2756154|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2756155|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756156|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2756157|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
2756158|NCT04537026|Hormones|hormones|mesh-ancestor
2756159|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2756160|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2756161|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756162|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
2756163|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756164|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756165|NCT04533750|Peposertib|peposertib|mesh-list
2756166|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2756167|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756168|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756169|NCT04526730|Nivolumab|nivolumab|mesh-list
2756170|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2756171|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756172|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2756173|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756174|NCT04506086|Blinatumomab|blinatumomab|mesh-list
2756175|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261914|NCT00165555|Protective Agents|protective agents|mesh-ancestor
2261915|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261916|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
2261917|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261918|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
2756182|NCT04498780|Valsartan|valsartan|mesh-list
2756183|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2756184|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2756185|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2756186|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2756187|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756198|NCT04448717|Antibodies|antibodies|mesh-list
2756199|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
2756200|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261919|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2261920|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2261921|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
2756213|NCT04436965|Cisplatin|cisplatin|mesh-list
2756214|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756215|NCT04424641|Antibodies|antibodies|mesh-list
2756216|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2756217|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
2756218|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756219|NCT04420741|Iloprost|iloprost|mesh-list
2756220|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2756221|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
2756222|NCT04409041|Naltrexone|naltrexone|mesh-list
2756223|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2756224|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2756225|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756226|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
2756227|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2756228|NCT04407286|Vitamin D|vitamin d|mesh-list
2756229|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
2756230|NCT04407286|Vitamins|vitamins|mesh-ancestor
2756231|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
2756232|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756233|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2756234|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2756249|NCT04388839|Dactinomycin|dactinomycin|mesh-list
2756250|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
2261922|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
2756251|NCT04388839|Vincristine|vincristine|mesh-list
2756252|NCT04388839|Vinorelbine|vinorelbine|mesh-list
2756253|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2756254|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
2756255|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756256|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2756257|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2756258|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
2756259|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101198|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2101199|NCT02387372|Renal Agents|renal agents|mesh-ancestor
2101200|NCT02387554|Losartan|losartan|mesh-list
2101201|NCT02387554|Amlodipine|amlodipine|mesh-list
2101202|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
2101203|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2101204|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2101205|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2101206|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101207|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2756260|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756261|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2756262|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2756263|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
2756264|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
2756265|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
2756266|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2756267|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2756268|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2756269|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2756270|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756271|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2756272|NCT04382885|Cariprazine|cariprazine|mesh-list
2756273|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2756274|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2756275|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2756276|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756277|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2756278|NCT04373369|Atezolizumab|atezolizumab|mesh-list
2756279|NCT04373369|Vorolanib|vorolanib|mesh-list
2756280|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756281|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2756282|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756283|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756298|NCT04366713|Capecitabine|capecitabine|mesh-list
2756299|NCT04366713|Loperamide|loperamide|mesh-list
2756300|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
2756301|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2756302|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
2756303|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756304|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756305|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2756306|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2756307|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2756308|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756346|NCT04317404|Triamcinolone|triamcinolone|mesh-list
2756347|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2756348|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2756349|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2756350|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2756351|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
2756352|NCT04317404|Hormones|hormones|mesh-ancestor
2756353|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2756354|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756355|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2756356|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
2756357|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756358|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756389|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
2756390|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2756391|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261923|NCT00165568|Bevacizumab|bevacizumab|mesh-list
2261924|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2261925|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261926|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2261927|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2261928|NCT00165568|Growth Substances|growth substances|mesh-ancestor
2261929|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261930|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
2261931|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
2261932|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261933|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2261934|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261935|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261936|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
2261937|NCT00165633|Menatetrenone|menatetrenone|mesh-list
2261938|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
2261939|NCT00165633|Coagulants|coagulants|mesh-ancestor
2261940|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2261941|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2261942|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261943|NCT00165633|Vitamins|vitamins|mesh-ancestor
2261944|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
2261945|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261946|NCT00165659|Donepezil|donepezil|mesh-list
2261947|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2261948|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261949|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261950|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
2101208|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101209|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
2101210|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2101211|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2756407|NCT04282239|Lidocaine|lidocaine|mesh-list
2756408|NCT04282239|Epinephrine|epinephrine|mesh-list
2756409|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
2756410|NCT04282239|Ropivacaine|ropivacaine|mesh-list
2756411|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
2756412|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
2756413|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2756414|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756415|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
2101212|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2101213|NCT02387554|Diuretics|diuretics|mesh-ancestor
2101214|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
2756416|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2756417|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2756418|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2756419|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2756420|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2756421|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101215|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2101216|NCT02387580|Artefenomel|artefenomel|mesh-list
2101217|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
2101218|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2101219|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2101220|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101221|NCT02387710|Tiagabine|tiagabine|mesh-list
2101222|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
2101223|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
2101224|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2756422|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2756423|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2756424|NCT04282239|Analgesics|analgesics|mesh-ancestor
2756425|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2756426|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2756427|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2756428|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
2756429|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2756430|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2756431|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2756432|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
2756433|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2756434|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
2756435|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
2756436|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
2756437|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2101225|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2101226|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101227|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
2101228|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261951|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2756449|NCT04242238|Avelumab|avelumab|mesh-list
2756450|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2756451|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261952|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261953|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
2261954|NCT00165685|Sibutramine|sibutramine|mesh-list
2261955|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
2261956|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2261957|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
2261958|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2756491|NCT04232072|Ibuprofen|ibuprofen|mesh-list
2756492|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2756493|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2756494|NCT04232072|Analgesics|analgesics|mesh-ancestor
2756495|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
2756496|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2756497|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756498|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2756499|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2756500|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2756501|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756502|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756507|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
2756508|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2756509|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756574|NCT04201197|Dronabinol|dronabinol|mesh-list
2756575|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
2756576|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756577|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2756578|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2756579|NCT04201197|Analgesics|analgesics|mesh-ancestor
2756580|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
2756581|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2756582|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2756583|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2756584|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2756585|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756586|NCT04201197|Hormones|hormones|mesh-ancestor
2756587|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2261967|NCT00165737|Donepezil|donepezil|mesh-list
2261968|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2261969|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261970|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261971|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
2261972|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261973|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261974|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
2261975|NCT00165750|Donepezil|donepezil|mesh-list
2261976|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2261977|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261978|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261979|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
2261980|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261981|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261982|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
2261983|NCT00165763|Donepezil|donepezil|mesh-list
2261984|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2261985|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261986|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261987|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
2261988|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261989|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261990|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
2261991|NCT00165815|Donepezil|donepezil|mesh-list
2261992|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2756614|NCT04182633|Vancomycin|vancomycin|mesh-list
2756615|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2756616|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2756617|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2756618|NCT04182633|Laxatives|laxatives|mesh-ancestor
2756619|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2756638|NCT04179864|Prednisone|prednisone|mesh-list
2756639|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2756640|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
2756641|NCT04179864|Hormones|hormones|mesh-ancestor
2756642|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2756643|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756644|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2756645|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2261993|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2261994|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2261995|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
2756676|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2756677|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2261996|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2261997|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2261998|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
2261999|NCT00165828|Zonisamide|zonisamide|mesh-list
2756694|NCT04143477|Peficitinib|peficitinib|mesh-list
2756695|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756696|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756697|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2756698|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
2756699|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756700|NCT04132427|Vancomycin|vancomycin|mesh-list
2756701|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
2756702|NCT04132427|Citric Acid|citric acid|mesh-list
2756703|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
2756704|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
2756705|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2262000|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
2262001|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2262002|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2262003|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262004|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2262005|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262006|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
2262007|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262008|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2262009|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262010|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262011|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
2262012|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262013|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2262014|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262015|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262016|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
2262017|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262018|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2262019|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262020|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262021|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2262022|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
2262023|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262024|NCT00166127|Simendan|simendan|mesh-list
2756706|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
2756707|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
2756708|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756709|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2756710|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2756711|NCT04132427|Cathartics|cathartics|mesh-ancestor
2756712|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2756713|NCT04122755|Buprenorphine|buprenorphine|mesh-list
2756714|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2756715|NCT04122755|Narcotics|narcotics|mesh-ancestor
2756716|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2756717|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756718|NCT04122755|Analgesics|analgesics|mesh-ancestor
2756719|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
2756720|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2756721|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2756722|NCT04099836|Bevacizumab|bevacizumab|mesh-list
2756723|NCT04099836|Atezolizumab|atezolizumab|mesh-list
2756724|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2756725|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756726|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2756727|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2756728|NCT04099836|Growth Substances|growth substances|mesh-ancestor
2756729|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756730|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
2756731|NCT04097470|Decitabine|decitabine|mesh-list
2756732|NCT04097470|Midostaurin|midostaurin|mesh-list
2756733|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2756734|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
2756735|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756736|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756737|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756738|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2756785|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
2756786|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2756787|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2756788|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
2756789|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
2756790|NCT04054999|Methylene Blue|methylene blue|mesh-list
2756791|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756792|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756793|NCT04054999|Hematinics|hematinics|mesh-ancestor
2756794|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
2756795|NCT04054999|Vitamins|vitamins|mesh-ancestor
2756796|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
2756797|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262025|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2262026|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
2262027|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2262028|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2262029|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262030|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262031|NCT00166127|Protective Agents|protective agents|mesh-ancestor
2262032|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262033|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
2262034|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2262035|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262036|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2262037|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
2262038|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2262039|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262040|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262041|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262042|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
2262043|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2262044|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262045|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2262046|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
2262047|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2262048|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262049|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262050|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262051|NCT00166400|Metoprolol|metoprolol|mesh-list
2262052|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2262053|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2262054|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
2262055|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
2262056|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262057|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262058|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2262059|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2262060|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2262061|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
2262062|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262063|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262064|NCT00166413|Thalidomide|thalidomide|mesh-list
2262065|NCT00166413|Lenalidomide|lenalidomide|mesh-list
2262066|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262067|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
2756801|NCT04041232|Glycerol|glycerol|mesh-list
2756802|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2756803|NCT04041232|Protective Agents|protective agents|mesh-ancestor
2756804|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756825|NCT03947385|Crizotinib|crizotinib|mesh-list
2756826|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756827|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2756828|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756829|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756833|NCT03918278|Gemcitabine|gemcitabine|mesh-list
2756834|NCT03918278|Paclitaxel|paclitaxel|mesh-list
2756835|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2756836|NCT03918278|Carboplatin|carboplatin|mesh-list
2756837|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
2756838|NCT03918278|Pemetrexed|pemetrexed|mesh-list
2756839|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2756840|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756841|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
2756842|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
2756843|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
2756844|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756845|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2756846|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
2756847|NCT03918278|Antiviral Agents|antiviral agents|mesh-ancestor
2756848|NCT03918278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2756849|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756850|NCT03918278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2756851|NCT03918278|Immunologic Factors|immunologic factors|mesh-ancestor
2756852|NCT03918278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756853|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2756854|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2756855|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2756856|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2756857|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262068|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262069|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
2262070|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2262071|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262072|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2756867|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2756868|NCT03857542|Pilocarpine|pilocarpine|mesh-list
2756869|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2756870|NCT03857542|Miotics|miotics|mesh-ancestor
2756871|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
2756872|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2756873|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756874|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2756875|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2756876|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
2756877|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2756878|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756879|NCT03848832|Cannabidiol|cannabidiol|mesh-list
2756880|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
2756881|NCT03835013|Exenatide|exenatide|mesh-list
2756882|NCT03835013|Glucagon|glucagon|mesh-list
2756883|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2756884|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2756885|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756886|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2756887|NCT03835013|Incretins|incretins|mesh-ancestor
2756888|NCT03835013|Hormones|hormones|mesh-ancestor
2756889|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2756890|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2262073|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2262074|NCT00166413|Growth Substances|growth substances|mesh-ancestor
2262075|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
2262076|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262077|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
2262078|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262079|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2262080|NCT00166426|Protective Agents|protective agents|mesh-ancestor
2262081|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262082|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2262083|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262084|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262085|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2262086|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2262087|NCT00166426|Analgesics|analgesics|mesh-ancestor
2262088|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
2262089|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262090|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2262091|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262092|NCT00166465|Leucovorin|leucovorin|mesh-list
2262093|NCT00166465|Fluorouracil|fluorouracil|mesh-list
2262094|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
2262095|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
2262096|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262097|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2756923|NCT03810807|Osimertinib|osimertinib|mesh-list
2756924|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756925|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2756926|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2756927|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262098|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262099|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262100|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
2262101|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262102|NCT00166465|Antidotes|antidotes|mesh-ancestor
2262103|NCT00166465|Protective Agents|protective agents|mesh-ancestor
2756928|NCT03807765|Nivolumab|nivolumab|mesh-list
2756929|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2756930|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2756931|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2756932|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756933|NCT03794388|Pregabalin|pregabalin|mesh-list
2756934|NCT03794388|Capsaicin|capsaicin|mesh-list
2756935|NCT03794388|Analgesics|analgesics|mesh-ancestor
2756936|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
2262104|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
2262105|NCT00166465|Vitamins|vitamins|mesh-ancestor
2262106|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
2262107|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
2262108|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262109|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2262110|NCT00166478|Protective Agents|protective agents|mesh-ancestor
2262111|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262112|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2756937|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2756938|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2756939|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
2756940|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2756941|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2756942|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2756943|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2756944|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2756945|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2756946|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2756947|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2756948|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
2756949|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
2262113|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262114|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262115|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2262116|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2262117|NCT00166478|Analgesics|analgesics|mesh-ancestor
2262118|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
2262119|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262120|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2262121|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262122|NCT00166491|Insulin|insulin|mesh-list
2262123|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2262124|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262125|NCT00166530|Atorvastatin|atorvastatin|mesh-list
2262126|NCT00166530|Simvastatin|simvastatin|mesh-list
2262127|NCT00166530|Ezetimibe|ezetimibe|mesh-list
2262128|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2101229|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101230|NCT02387762|Methotrexate|methotrexate|mesh-list
2101231|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
2101232|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2101233|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
2101234|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2262129|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2262130|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
2262131|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262132|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2262133|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2262134|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262135|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
2262136|NCT00166556|Tacrolimus|tacrolimus|mesh-list
2262137|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262138|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
2262139|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262140|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2262141|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262142|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262143|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2262144|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262145|NCT00166595|Risperidone|risperidone|mesh-list
2262146|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2262147|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
2262148|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262149|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262150|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262151|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2101235|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101236|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2101237|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
2101238|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101239|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101240|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
2101241|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101242|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2101243|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262152|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2262153|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2262154|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2262155|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2757015|NCT03712943|Nivolumab|nivolumab|mesh-list
2757016|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757017|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757018|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2757019|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262156|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
2262157|NCT00166621|Buspirone|buspirone|mesh-list
2262158|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2757026|NCT03700541|Morphine|morphine|mesh-list
2757027|NCT03700541|Pirinitramide|pirinitramide|mesh-list
2262159|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2262160|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2262161|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262162|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2262163|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2262164|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
2101244|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
2101245|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2101246|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2101247|NCT02387801|Ixekizumab|ixekizumab|mesh-list
2101248|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
2101249|NCT02387957|Bevacizumab|bevacizumab|mesh-list
2101250|NCT02387957|Ranibizumab|ranibizumab|mesh-list
2101251|NCT02387957|Aflibercept|aflibercept|mesh-list
2101252|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101253|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757028|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2757029|NCT03700541|Narcotics|narcotics|mesh-ancestor
2757030|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2757031|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757032|NCT03700541|Analgesics|analgesics|mesh-ancestor
2757033|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
2757034|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2757035|NCT03700411|Morphine|morphine|mesh-list
2757036|NCT03700411|Pirinitramide|pirinitramide|mesh-list
2757037|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2757038|NCT03700411|Narcotics|narcotics|mesh-ancestor
2757039|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101254|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2101255|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2101256|NCT02387957|Growth Substances|growth substances|mesh-ancestor
2101257|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101258|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
2101259|NCT02387983|Posaconazole|posaconazole|mesh-list
2101260|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
2101261|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101262|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2101263|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2101264|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2101265|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2101266|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2101267|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101268|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101269|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2101270|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
2102961|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262165|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262166|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262167|NCT00166686|Clonidine|clonidine|mesh-list
2262168|NCT00166686|Analgesics|analgesics|mesh-ancestor
2262169|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
2262170|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262171|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262172|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2757040|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757041|NCT03700411|Analgesics|analgesics|mesh-ancestor
2757042|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
2757043|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2757047|NCT03691051|Capecitabine|capecitabine|mesh-list
2757048|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2757049|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
2757050|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757051|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757052|NCT03688802|Varenicline|varenicline|mesh-list
2757053|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2757054|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2757055|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
2757056|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2757057|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757058|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757059|NCT03686488|Ramucirumab|ramucirumab|mesh-list
2757060|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757076|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
2757077|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2757078|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2757084|NCT03630666|Hormones|hormones|mesh-list
2757085|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2757086|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2757087|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757088|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
2757089|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2757090|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757091|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757092|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2757093|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2757094|NCT03625648|Protective Agents|protective agents|mesh-ancestor
2757095|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757096|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
2757097|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2757098|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
2757099|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
2757100|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2757114|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
2757115|NCT03602612|Fludarabine|fludarabine|mesh-list
2757116|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2757117|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
2757118|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757119|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2757120|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2757121|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
2757122|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757123|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757124|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2757145|NCT03595917|Prednisone|prednisone|mesh-list
2757146|NCT03595917|Dasatinib|dasatinib|mesh-list
2757147|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2757148|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
2757149|NCT03595917|Hormones|hormones|mesh-ancestor
2757150|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2757151|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757152|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2757153|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757154|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2757155|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757156|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757157|NCT03562195|Albuterol|albuterol|mesh-list
2757158|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2757159|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
2757160|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2757161|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757162|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2757163|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
2757164|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
2757165|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2262173|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
2262174|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
2262175|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2262176|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2262177|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2262178|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
2262179|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262180|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262181|NCT00166725|Octreotide|octreotide|mesh-list
2262182|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2262183|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2262184|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262185|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
2262186|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2262187|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262188|NCT00166816|Cyclosporine|cyclosporine|mesh-list
2262189|NCT00166816|Sirolimus|sirolimus|mesh-list
2262190|NCT00166816|Tacrolimus|tacrolimus|mesh-list
2262191|NCT00166816|Cyclosporins|cyclosporins|mesh-list
2262192|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262193|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
2262194|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262195|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2262196|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262197|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262198|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
2262199|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262200|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
2262201|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262202|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2757166|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2757167|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2757168|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2757169|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
2757170|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2757171|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757172|NCT03541083|Blinatumomab|blinatumomab|mesh-list
2757173|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757174|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
2757175|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2757176|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2262203|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2757203|NCT03465111|Hormones|hormones|mesh-list
2757204|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2757205|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2757206|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
2757207|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2757208|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757209|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2757210|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757221|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
2757222|NCT03448393|Fludarabine|fludarabine|mesh-list
2757223|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2757224|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
2757225|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757226|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2757227|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2757228|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
2757229|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757230|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757231|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2757232|NCT03446612|Nitroprusside|nitroprusside|mesh-list
2757233|NCT03446612|Acetylcholine|acetylcholine|mesh-list
2757234|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
2757235|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2757236|NCT03446612|Hematinics|hematinics|mesh-ancestor
2757237|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2757238|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
2757239|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2757240|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757241|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2757242|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
2757243|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2757244|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757245|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262204|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262205|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
2262206|NCT00166829|Sirolimus|sirolimus|mesh-list
2262207|NCT00166829|Tacrolimus|tacrolimus|mesh-list
2757256|NCT03436433|Lacosamide|lacosamide|mesh-list
2757257|NCT03436433|Levetiracetam|levetiracetam|mesh-list
2757258|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
2262208|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262209|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
2262210|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262211|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2262212|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262213|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262214|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2262215|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262216|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2262217|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
2757259|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
2757260|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2757261|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2262218|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2262219|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262220|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
2262221|NCT00166842|Cyclosporine|cyclosporine|mesh-list
2262222|NCT00166842|Sirolimus|sirolimus|mesh-list
2262223|NCT00166842|Tacrolimus|tacrolimus|mesh-list
2757262|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2757263|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757264|NCT03434379|Bevacizumab|bevacizumab|mesh-list
2757265|NCT03434379|Sorafenib|sorafenib|mesh-list
2757266|NCT03434379|Atezolizumab|atezolizumab|mesh-list
2757267|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757268|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757269|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2757270|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2757271|NCT03434379|Growth Substances|growth substances|mesh-ancestor
2757272|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757273|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
2757274|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2757275|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757276|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757277|NCT03408886|Vancomycin|vancomycin|mesh-list
2262224|NCT00166842|Cyclosporins|cyclosporins|mesh-list
2262225|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262226|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
2262227|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262228|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2262229|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262230|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262231|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
2262232|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262233|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
2262234|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262235|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2262236|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2262237|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262238|NCT00166868|Neomycin|neomycin|mesh-list
2262239|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2262240|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262241|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2262242|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262243|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262244|NCT00166881|Docetaxel|docetaxel|mesh-list
2262245|NCT00166881|Irinotecan|irinotecan|mesh-list
2262246|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262247|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
2262248|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
2262249|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
2262250|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262251|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2757278|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2757279|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2757280|NCT03407144|Prednisone|prednisone|mesh-list
2757281|NCT03407144|Prednisolone|prednisolone|mesh-list
2262252|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2262253|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757282|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
2757283|NCT03407144|Dacarbazine|dacarbazine|mesh-list
2757284|NCT03407144|Doxorubicin|doxorubicin|mesh-list
2757285|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
2757286|NCT03407144|Etoposide|etoposide|mesh-list
2757287|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
2757288|NCT03407144|Vincristine|vincristine|mesh-list
2757289|NCT03407144|Bleomycin|bleomycin|mesh-list
2757290|NCT03407144|Vinblastine|vinblastine|mesh-list
2757291|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2757292|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
2757293|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757294|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2757295|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2757296|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
2757297|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757298|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757299|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2757300|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2757301|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2757302|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2757303|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757304|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2757305|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
2757306|NCT03407144|Hormones|hormones|mesh-ancestor
2757307|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2757308|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2757309|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757310|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2757311|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
2757312|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
2757313|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
2757314|NCT03399539|Dexamethasone|dexamethasone|mesh-list
2757315|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
2757316|NCT03399539|Venetoclax|venetoclax|mesh-list
2757317|NCT03399539|Ixazomib|ixazomib|mesh-list
2757318|NCT03399539|Ichthammol|ichthammol|mesh-list
2757319|NCT03399539|BB 1101|bb 1101|mesh-list
2757320|NCT03399539|Glycine|glycine|mesh-list
2757321|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2757322|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
2757323|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
2757324|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2757325|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757326|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2757327|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
2757328|NCT03399539|Hormones|hormones|mesh-ancestor
2757329|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2757330|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2757331|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757332|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757333|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
2757334|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757335|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
2757336|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
2757337|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2757338|NCT03387774|Urinastatin|urinastatin|mesh-list
2757339|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2757340|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2757341|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
2757342|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757343|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757344|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2757345|NCT03387579|SMOFlipid|smoflipid|mesh-list
2757346|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
2757347|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2757348|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2757349|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
2757350|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757351|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262254|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
2262255|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
2262256|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2262257|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757352|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
2757353|NCT03290079|Lenvatinib|lenvatinib|mesh-list
2757354|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757355|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757356|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2757357|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757358|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262258|NCT00167154|Risperidone|risperidone|mesh-list
2262259|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2262260|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
2262261|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262262|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262263|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262264|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2262265|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2262266|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2262267|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2262268|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2262269|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
2262270|NCT00167232|Naltrexone|naltrexone|mesh-list
2262271|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2101271|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2101272|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101273|NCT02387996|Nivolumab|nivolumab|mesh-list
2101274|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101275|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101276|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2101277|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101278|NCT02388165|Vaccines|vaccines|mesh-list
2101279|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
2101280|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101281|NCT02388191|Naproxen|naproxen|mesh-list
2101282|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2101283|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2101284|NCT02388191|Analgesics|analgesics|mesh-ancestor
2262272|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2262273|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262274|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
2262275|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262276|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2262277|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2757395|NCT03260504|Aldesleukin|aldesleukin|mesh-list
2757396|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
2757397|NCT03260504|Interleukin-2|interleukin-2|mesh-list
2757398|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757399|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757400|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2757401|NCT03260504|Analgesics|analgesics|mesh-ancestor
2757402|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
2757403|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2757404|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757405|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2757406|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2757407|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
2757408|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2757412|NCT03255512|Isosorbide|isosorbide|mesh-list
2757413|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2757414|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2757415|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2757416|NCT03255512|Diuretics|diuretics|mesh-ancestor
2757417|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
2757418|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757419|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
2757420|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2757421|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757435|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
2757436|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2757437|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757438|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757439|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757440|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757441|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
2757442|NCT03233724|Decitabine|decitabine|mesh-list
2757443|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
2757444|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757445|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757446|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2757447|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
2757448|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757449|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757450|NCT03230266|Insulin|insulin|mesh-list
2757451|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2757452|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757460|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
2757461|NCT03193216|Antacids|antacids|mesh-ancestor
2757462|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757463|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2757464|NCT03112590|Interferons|interferons|mesh-list
2757465|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
2757466|NCT03112590|Paclitaxel|paclitaxel|mesh-list
2757467|NCT03112590|Trastuzumab|trastuzumab|mesh-list
2757468|NCT03112590|Pertuzumab|pertuzumab|mesh-list
2757469|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2757470|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757471|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
2757472|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
2262278|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2262279|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2262280|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262281|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
2262282|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262283|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262284|NCT00167375|Eszopiclone|eszopiclone|mesh-list
2262285|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2262286|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2262287|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262288|NCT00167401|Docetaxel|docetaxel|mesh-list
2262289|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757473|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
2757474|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757475|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757476|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
2757477|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2757478|NCT03111212|Iloprost|iloprost|mesh-list
2757479|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2757480|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
2757481|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
2757482|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2757483|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2757484|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2757499|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
2757500|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2757501|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
2757502|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2757503|NCT03063021|Expectorants|expectorants|mesh-ancestor
2757504|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
2757505|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2757506|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
2757507|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757508|NCT03063021|Protective Agents|protective agents|mesh-ancestor
2757509|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757510|NCT03063021|Antidotes|antidotes|mesh-ancestor
2757511|NCT02997358|Doxorubicin|doxorubicin|mesh-list
2757512|NCT02997358|Trabectedin|trabectedin|mesh-list
2757513|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2757514|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757515|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2757516|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2757517|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757518|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757519|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2757520|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
2757530|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
2757531|NCT02963610|Lenalidomide|lenalidomide|mesh-list
2757532|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757533|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757534|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
2757535|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757536|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2757537|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2757538|NCT02963610|Growth Substances|growth substances|mesh-ancestor
2757539|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
2757540|NCT02945800|Gemcitabine|gemcitabine|mesh-list
2757541|NCT02945800|Paclitaxel|paclitaxel|mesh-list
2757542|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2757543|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757544|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
2757545|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
2757546|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
2757547|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757548|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2757549|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
2757550|NCT02945800|Antiviral Agents|antiviral agents|mesh-ancestor
2757551|NCT02945800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2757552|NCT02945800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262290|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
2262291|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
2262292|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
2757553|NCT02945800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2757554|NCT02945800|Immunologic Factors|immunologic factors|mesh-ancestor
2757555|NCT02945800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757556|NCT02903160|Prednisone|prednisone|mesh-list
2757557|NCT02903160|Carboplatin|carboplatin|mesh-list
2757558|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
2757559|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2757560|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757561|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2757562|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
2757563|NCT02903160|Hormones|hormones|mesh-ancestor
2757564|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2757565|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757566|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2757567|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2757568|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757569|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757570|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
2757571|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2757572|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
2757573|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757574|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757575|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262293|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262294|NCT00167479|Risperidone|risperidone|mesh-list
2262295|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2262296|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
2262297|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262298|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262299|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262300|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2262301|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2262302|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2262303|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2262304|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2262305|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
2262306|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
2262307|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2262308|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262309|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2101285|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
2101286|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101287|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262310|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
2262311|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2262312|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262313|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757592|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
2757593|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2757594|NCT02836925|Ledipasvir|ledipasvir|mesh-list
2757595|NCT02836925|Velpatasvir|velpatasvir|mesh-list
2757596|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
2757597|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2757626|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
2757627|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
2757628|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757629|NCT02814695|Protective Agents|protective agents|mesh-ancestor
2757630|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757631|NCT02814695|Vitamins|vitamins|mesh-ancestor
2757632|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
2757633|NCT02798536|Paclitaxel|paclitaxel|mesh-list
2757634|NCT02798536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2757635|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2757636|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757637|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
2757638|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
2757639|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
2757640|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757641|NCT02771249|Pyridoxine|pyridoxine|mesh-list
2757642|NCT02771249|Darunavir|darunavir|mesh-list
2757643|NCT02771249|Cobicistat|cobicistat|mesh-list
2101288|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2101289|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2101290|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
2101291|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2101292|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101293|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101294|NCT02388321|Fentanyl|fentanyl|mesh-list
2101295|NCT02388321|Ketamine|ketamine|mesh-list
2101296|NCT02388321|Analgesics|analgesics|mesh-ancestor
2101297|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
2101298|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101299|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101300|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2262314|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262315|NCT00167518|Triamcinolone|triamcinolone|mesh-list
2262316|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2262317|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
2262318|NCT00167518|Hormones|hormones|mesh-ancestor
2262319|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2262320|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262321|NCT00167557|Interferons|interferons|mesh-list
2262322|NCT00167557|Ribavirin|ribavirin|mesh-list
2262323|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262324|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
2262325|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262326|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
2262327|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757644|NCT02771249|Isoniazid|isoniazid|mesh-list
2757645|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2757646|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2757647|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
2757648|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757649|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757650|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2757651|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2262328|NCT00167583|Interferons|interferons|mesh-list
2262329|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
2262330|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
2262331|NCT00167583|Cyclosporine|cyclosporine|mesh-list
2262332|NCT00167583|Cyclosporins|cyclosporins|mesh-list
2262333|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262334|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
2262335|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262336|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262337|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757652|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
2757653|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2757654|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
2757655|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2757656|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2757657|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2757658|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
2757659|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2757660|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2757661|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2757662|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
2757663|NCT02771249|Vitamins|vitamins|mesh-ancestor
2757664|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
2757665|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757666|NCT02766335|Docetaxel|docetaxel|mesh-list
2757667|NCT02766335|Durvalumab|durvalumab|mesh-list
2757668|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
2757669|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2757670|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
2757671|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757672|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
2757673|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
2757674|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
2757675|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757676|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757677|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
2757678|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757679|NCT02740699|Atorvastatin|atorvastatin|mesh-list
2757680|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2757681|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2757682|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2757683|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
2757684|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757685|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2757686|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2757687|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757688|NCT02736422|Xenon|xenon|mesh-list
2757689|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2757690|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
2757691|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
2757692|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2757693|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757694|NCT02710643|Ofatumumab|ofatumumab|mesh-list
2757695|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757696|NCT02675439|Ipilimumab|ipilimumab|mesh-list
2757697|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757698|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757699|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2757700|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757714|NCT02651740|Rifaximin|rifaximin|mesh-list
2757715|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2757716|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2757717|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2262338|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262339|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
2262340|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757730|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
2757731|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
2757732|NCT02606136|Mitogens|mitogens|mesh-list
2757733|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
2757734|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757735|NCT02576574|Gemcitabine|gemcitabine|mesh-list
2757736|NCT02576574|Paclitaxel|paclitaxel|mesh-list
2757737|NCT02576574|Carboplatin|carboplatin|mesh-list
2757738|NCT02576574|Pemetrexed|pemetrexed|mesh-list
2757739|NCT02576574|Avelumab|avelumab|mesh-list
2757740|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2757741|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2757742|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757743|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
2757744|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
2757745|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
2757746|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757747|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2757748|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
2757749|NCT02576574|Antiviral Agents|antiviral agents|mesh-ancestor
2757750|NCT02576574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2757751|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757752|NCT02576574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2757753|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
2757754|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757755|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2757756|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2757757|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757774|NCT02535078|Durvalumab|durvalumab|mesh-list
2757775|NCT02535078|Tremelimumab|tremelimumab|mesh-list
2757776|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2757777|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262341|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
2262342|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
2262343|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262344|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2262345|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2262346|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2262347|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
2262348|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262349|NCT00167648|Leuprolide|leuprolide|mesh-list
2262350|NCT00167648|Goserelin|goserelin|mesh-list
2262351|NCT00167648|Estradiol|estradiol|mesh-list
2262352|NCT00167648|Estrogens|estrogens|mesh-ancestor
2262353|NCT00167648|Hormones|hormones|mesh-ancestor
2262354|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2262355|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262356|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2262357|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2262358|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
2262359|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2262360|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262361|NCT00167674|Zidovudine|zidovudine|mesh-list
2262362|NCT00167674|Nevirapine|nevirapine|mesh-list
2262363|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
2262364|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262365|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2262366|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2262367|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262368|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
2262369|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262370|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2262371|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2262372|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2262373|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2262374|NCT00167687|Prazosin|prazosin|mesh-list
2262375|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2262376|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2262377|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2262378|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2262379|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
2262380|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262381|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262382|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262383|NCT00167713|Ibuprofen|ibuprofen|mesh-list
2262384|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2757803|NCT02496585|Prednisone|prednisone|mesh-list
2757804|NCT02496585|Nintedanib|nintedanib|mesh-list
2757805|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2757806|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
2757807|NCT02496585|Hormones|hormones|mesh-ancestor
2757808|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2757809|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757810|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2757811|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757812|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2757813|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757814|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757815|NCT02494141|Curcumin|curcumin|mesh-list
2757816|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2757817|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2757818|NCT02494141|Analgesics|analgesics|mesh-ancestor
2757819|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
2757820|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2757821|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757822|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2757823|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2757824|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757825|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757826|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757827|NCT02493426|Oxytocin|oxytocin|mesh-list
2757828|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
2757829|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2757830|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757831|NCT02484404|Durvalumab|durvalumab|mesh-list
2757832|NCT02484404|Olaparib|olaparib|mesh-list
2757833|NCT02484404|Cediranib|cediranib|mesh-list
2757834|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101301|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2101302|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
2101303|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
2757835|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757836|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2757837|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757838|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757839|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2262385|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2262386|NCT00167713|Analgesics|analgesics|mesh-ancestor
2262387|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
2262388|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262389|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262390|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2262391|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262392|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2262393|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262394|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262395|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
2262396|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
2262397|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2757877|NCT02432378|Celecoxib|celecoxib|mesh-list
2757878|NCT02432378|Cisplatin|cisplatin|mesh-list
2262398|NCT00167739|Quinine|quinine|mesh-list
2262399|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
2262400|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2262401|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2262402|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262403|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2262404|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262405|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262406|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2262407|NCT00167739|Renal Agents|renal agents|mesh-ancestor
2262408|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2262409|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262410|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2262411|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262412|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2262413|NCT00167739|Analgesics|analgesics|mesh-ancestor
2262414|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
2262415|NCT00167765|Abciximab|abciximab|mesh-list
2262416|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
2262417|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2262418|NCT00167791|Rituximab|rituximab|mesh-list
2262419|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2262420|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262421|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
2262422|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262423|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262424|NCT00167817|Aripiprazole|aripiprazole|mesh-list
2262425|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
2262426|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2262427|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2757879|NCT02432378|Vaccines|vaccines|mesh-list
2757880|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
2757881|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757882|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757883|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2757884|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2757885|NCT02432378|Analgesics|analgesics|mesh-ancestor
2757886|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
2757887|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2757888|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2757889|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2757890|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2757891|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2757892|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2757893|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757908|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2757909|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2757910|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262428|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2262429|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2262430|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262431|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
2262432|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
2262433|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2757921|NCT02211755|Bortezomib|bortezomib|mesh-list
2757922|NCT02211755|Clofarabine|clofarabine|mesh-list
2757923|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2757924|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2757925|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
2757926|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757958|NCT02090998|Lidocaine|lidocaine|mesh-list
2757959|NCT02090998|Amitriptyline|amitriptyline|mesh-list
2757960|NCT02090998|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2757961|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
2757962|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
2757963|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2757964|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757965|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
2757966|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2757967|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2757968|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2757969|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2757970|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2757971|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2757972|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2757973|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
2757974|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2757975|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2757976|NCT02090998|Analgesics|analgesics|mesh-ancestor
2757977|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2757978|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2757979|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
2757980|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2757981|NCT02090998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2757982|NCT02090998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2101304|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101305|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2101306|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2101307|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101308|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101309|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2101310|NCT02388321|Narcotics|narcotics|mesh-ancestor
2101311|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2101312|NCT02388724|Lansoprazole|lansoprazole|mesh-list
2101313|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
2101314|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2101315|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2101316|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2757989|NCT02063685|Prednisone|prednisone|mesh-list
2757990|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
2757991|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2757992|NCT02063685|Rituximab|rituximab|mesh-list
2757993|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2757994|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2757995|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
2757996|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2757997|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2757998|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2757999|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
2758000|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758001|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758002|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2758003|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2758004|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2758005|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
2758006|NCT02063685|Hormones|hormones|mesh-ancestor
2758007|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2758008|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2758009|NCT02051309|Guanfacine|guanfacine|mesh-list
2758010|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2758011|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2758012|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2758013|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2758014|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
2758015|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2758016|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758017|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758023|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
2758024|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2758025|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758026|NCT01900002|Sorafenib|sorafenib|mesh-list
2758027|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758028|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2758029|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758030|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262434|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262435|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2262436|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2758059|NCT01595061|Gemcitabine|gemcitabine|mesh-list
2758060|NCT01595061|Cisplatin|cisplatin|mesh-list
2758061|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758062|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2758063|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
2758064|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758065|NCT01595061|Antiviral Agents|antiviral agents|mesh-ancestor
2758066|NCT01595061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758067|NCT01595061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758068|NCT01595061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2758069|NCT01595061|Immunologic Factors|immunologic factors|mesh-ancestor
2758070|NCT01595061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758071|NCT01587352|Vorinostat|vorinostat|mesh-list
2758072|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758073|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2758074|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758075|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758076|NCT01572480|Dexamethasone|dexamethasone|mesh-list
2262437|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
2262438|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2262439|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2262440|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2262441|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2262442|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
2262443|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
2262444|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2262445|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
2262446|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2262447|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2262448|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262449|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2262450|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262451|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262452|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2262453|NCT00167843|Renal Agents|renal agents|mesh-ancestor
2262454|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2262455|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2262456|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2262457|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2758077|NCT01572480|Lenalidomide|lenalidomide|mesh-list
2758078|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2758079|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
2758080|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
2758081|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2758082|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758083|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2758084|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
2758085|NCT01572480|Hormones|hormones|mesh-ancestor
2758086|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2758087|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2758088|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758089|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
2758090|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2758091|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2758092|NCT01572480|Growth Substances|growth substances|mesh-ancestor
2758093|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
2262458|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262459|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262460|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262461|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2262462|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
2262463|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2262464|NCT00167882|Mesalamine|mesalamine|mesh-list
2262465|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2262466|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2262467|NCT00167882|Analgesics|analgesics|mesh-ancestor
2262468|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
2262469|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262470|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262471|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2262472|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262473|NCT00167908|Amifostine|amifostine|mesh-list
2262474|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2262475|NCT00167908|Protective Agents|protective agents|mesh-ancestor
2262476|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262477|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2262478|NCT00167921|Estrogens|estrogens|mesh-ancestor
2262479|NCT00167921|Hormones|hormones|mesh-ancestor
2262480|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2262481|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262482|NCT00167947|Cyclosporine|cyclosporine|mesh-list
2262483|NCT00167947|Sirolimus|sirolimus|mesh-list
2262484|NCT00167947|Cyclosporins|cyclosporins|mesh-list
2262485|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262486|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262487|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262488|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
2262489|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262490|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
2262491|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262492|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
2262493|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262494|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2262495|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2262496|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2262497|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262498|NCT00167960|Tazobactam|tazobactam|mesh-list
2262499|NCT00167960|Piperacillin|piperacillin|mesh-list
2262500|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2262501|NCT00167960|Lactams|lactams|mesh-list
2262502|NCT00167960|beta-Lactams|beta-lactams|mesh-list
2262503|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2262504|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262505|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2262506|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262507|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262508|NCT00167986|Vancomycin|vancomycin|mesh-list
2262509|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2262510|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262511|NCT00167999|Tazobactam|tazobactam|mesh-list
2262512|NCT00167999|Piperacillin|piperacillin|mesh-list
2262513|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2262514|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2262515|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262516|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2262517|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262518|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262519|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
2758176|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
2758177|NCT00902044|Fludarabine|fludarabine|mesh-list
2758178|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2758179|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
2262520|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2262521|NCT00168012|Antibodies|antibodies|mesh-list
2262522|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
2262523|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758180|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758181|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2758182|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2758183|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
2758184|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758185|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758186|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2758189|NCT00165724|Donepezil|donepezil|mesh-list
2758190|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2758191|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758192|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758193|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
2758194|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2758195|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758196|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
2758197|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
2758198|NCT00097474|Melatonin|melatonin|mesh-list
2758199|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2758200|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
2758201|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758202|NCT00097474|Protective Agents|protective agents|mesh-ancestor
2758203|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758204|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2262524|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
2262525|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2262526|NCT00168025|Antibodies|antibodies|mesh-list
2262527|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
2262528|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262529|NCT00168051|Factor VIII|factor viii|mesh-list
2262530|NCT00168051|Coagulants|coagulants|mesh-ancestor
2262531|NCT00168077|Thrombin|thrombin|mesh-list
2262532|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
2262533|NCT00168077|Coagulants|coagulants|mesh-ancestor
2262534|NCT00168090|Factor VIII|factor viii|mesh-list
2262535|NCT00168090|Coagulants|coagulants|mesh-ancestor
2262536|NCT00168168|Lenograstim|lenograstim|mesh-list
2262537|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2262538|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
2262539|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262540|NCT00168181|Pilocarpine|pilocarpine|mesh-list
2262541|NCT00168181|Miotics|miotics|mesh-ancestor
2262542|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
2262543|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262544|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262545|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2262546|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2262547|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
2262548|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262549|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262550|NCT00168350|Memantine|memantine|mesh-list
2101317|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102962|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
2262551|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2789056|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789057|NCT04305028|Aspirin|aspirin|mesh-list
2789058|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
2789059|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2789060|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2789061|NCT04305028|Analgesics|analgesics|mesh-ancestor
2789062|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
2789063|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789064|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789065|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2789066|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2789067|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2789068|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2789069|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789070|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2789071|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2262552|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2262553|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
2262554|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262555|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262556|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262557|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2262558|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2262559|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2758288|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
2758289|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2758290|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
2758291|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2758292|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
2758293|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758294|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758295|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
2758296|NCT04527133|Aprotinin|aprotinin|mesh-list
2758297|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
2758298|NCT04527133|Coagulants|coagulants|mesh-ancestor
2758299|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2758300|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2758301|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
2758302|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758303|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758304|NCT04526795|Cytarabine|cytarabine|mesh-list
2758305|NCT04526795|Fludarabine|fludarabine|mesh-list
2758306|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758307|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2758308|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
2758309|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758310|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2758311|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
2758312|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758313|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
2262560|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2262561|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2262562|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2262563|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2262564|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
2262565|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262566|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262567|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262568|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
2262569|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2262570|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2262571|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2262572|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2262573|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262574|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
2262575|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262576|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262577|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2758314|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758315|NCT04527055|Metronidazole|metronidazole|mesh-list
2758316|NCT04527055|Tetracycline|tetracycline|mesh-list
2758317|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
2758318|NCT04527055|Esomeprazole|esomeprazole|mesh-list
2758319|NCT04527055|Bismuth|bismuth|mesh-list
2758320|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758321|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2758322|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2758323|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2758324|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2758325|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2262578|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262579|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
2262580|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2262581|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2758326|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2758327|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758328|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758329|NCT04527055|Antacids|antacids|mesh-ancestor
2758330|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2758331|NCT04526951|Aspirin|aspirin|mesh-list
2758332|NCT04526951|Tenecteplase|tenecteplase|mesh-list
2789072|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758333|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2758334|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2758335|NCT04526951|Analgesics|analgesics|mesh-ancestor
2758336|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
2758337|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2758338|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758339|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2758340|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2758341|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2758342|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2758343|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758344|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2758345|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2758346|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758347|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
2758348|NCT04527068|Bevacizumab|bevacizumab|mesh-list
2758349|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2758350|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758351|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2758352|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2758353|NCT04527068|Growth Substances|growth substances|mesh-ancestor
2758354|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758355|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
2262582|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2262583|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2262584|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262585|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
2262586|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262587|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262588|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2758356|NCT04526782|Docetaxel|docetaxel|mesh-list
2758357|NCT04526782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758358|NCT04526782|Tubulin Modulators|tubulin modulators|mesh-ancestor
2758359|NCT04526782|Antimitotic Agents|antimitotic agents|mesh-ancestor
2758360|NCT04526782|Mitosis Modulators|mitosis modulators|mesh-ancestor
2758361|NCT04526782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758362|NCT04526470|Paclitaxel|paclitaxel|mesh-list
2758363|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2758364|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758365|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
2758366|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
2758367|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
2262589|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262590|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
2758368|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758369|NCT04526353|Oxybutynin|oxybutynin|mesh-list
2758370|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
2758371|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
2758372|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2758373|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758374|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2758375|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2758376|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
2758377|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2758378|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262591|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2262592|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2262593|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2262594|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2262595|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262596|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
2262597|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262598|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262599|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2262600|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262601|NCT00168467|Ramipril|ramipril|mesh-list
2262602|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2262603|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
2262604|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758379|NCT04526353|Urological Agents|urological agents|mesh-ancestor
2758380|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2758381|NCT04526210|Choline|choline|mesh-list
2758382|NCT04526210|Bupropion|bupropion|mesh-list
2789073|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
2262605|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262606|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2262607|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
2262608|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2262609|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2262610|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2262611|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2758383|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2758384|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
2758385|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2758386|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2758387|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2758388|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2758389|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758390|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
2758391|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262612|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262613|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
2262614|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262615|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262616|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2262617|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262618|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
2262619|NCT00168493|Serotonin|serotonin|mesh-list
2262620|NCT00168493|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2262621|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2262622|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2262623|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
2262624|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262625|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262626|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758392|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758393|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2758394|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2758395|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758396|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
2758397|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2758398|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
2758399|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2758400|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2758401|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
2758402|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
2758403|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
2758404|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2758405|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2758406|NCT04526210|Growth Substances|growth substances|mesh-ancestor
2758407|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
2758408|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758409|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
2758410|NCT04526509|Fludarabine|fludarabine|mesh-list
2758411|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2758412|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
2758413|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758414|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2758415|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2758416|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
2758417|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758418|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758419|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2758420|NCT04526028|Fulvestrant|fulvestrant|mesh-list
2758421|NCT04526028|Palbociclib|palbociclib|mesh-list
2758422|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2758423|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758424|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2758425|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2758426|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
2758427|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2758428|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758429|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2758430|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758431|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758432|NCT04526119|Z 338|z 338|mesh-list
2262627|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2262628|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2262629|NCT00168519|Nitroprusside|nitroprusside|mesh-list
2262630|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2262631|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
2262632|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2262633|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262634|NCT00168532|Trimethoprim|trimethoprim|mesh-list
2262635|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2262636|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
2262637|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2262638|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758433|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2758434|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758435|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758436|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
2262639|NCT00168532|Renal Agents|renal agents|mesh-ancestor
2262640|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
2262641|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2262642|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2262643|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2262644|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262645|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262646|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2262647|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2262648|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2262649|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2262650|NCT00168584|Vitamin A|vitamin a|mesh-list
2262651|NCT00168584|Vitamins|vitamins|mesh-ancestor
2262652|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
2262653|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262654|NCT00168597|Vitamin A|vitamin a|mesh-list
2262655|NCT00168597|Vitamins|vitamins|mesh-ancestor
2262656|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
2262657|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262658|NCT00168610|Vitamin A|vitamin a|mesh-list
2262659|NCT00168610|Vitamins|vitamins|mesh-ancestor
2262660|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
2758437|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2758438|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101318|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101319|NCT02388737|Lansoprazole|lansoprazole|mesh-list
2101320|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
2101321|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2101322|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2101323|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2758439|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2758440|NCT04526236|Methadone|methadone|mesh-list
2758441|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2758442|NCT04526236|Narcotics|narcotics|mesh-ancestor
2758443|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2758444|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262661|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758445|NCT04526236|Analgesics|analgesics|mesh-ancestor
2758446|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
2758447|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2758448|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
2758449|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
2758450|NCT04526288|Cytarabine|cytarabine|mesh-list
2758451|NCT04526288|Daunorubicin|daunorubicin|mesh-list
2101324|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101325|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101326|NCT02388906|Nivolumab|nivolumab|mesh-list
2101327|NCT02388906|Ipilimumab|ipilimumab|mesh-list
2101328|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101329|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101330|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2101331|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101332|NCT02388997|Omalizumab|omalizumab|mesh-list
2101333|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2101334|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2101335|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
2101336|NCT02389088|Letrozole|letrozole|mesh-list
2101337|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101338|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2101339|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2262662|NCT00168623|Vitamin A|vitamin a|mesh-list
2758452|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2758453|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
2758454|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758455|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758456|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
2758457|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758458|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2758459|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
2758460|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758461|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2758462|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2758463|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2758464|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758474|NCT04525820|Vitamin D|vitamin d|mesh-list
2758475|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
2758476|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
2758477|NCT04525820|Vitamins|vitamins|mesh-list
2758478|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2758479|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
2758480|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758481|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2758482|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2758483|NCT04525664|Amoxicillin|amoxicillin|mesh-list
2758484|NCT04525664|Clarithromycin|clarithromycin|mesh-list
2758485|NCT04525664|Omeprazole|omeprazole|mesh-list
2758486|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2758487|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758488|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2758489|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2758490|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2758491|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758492|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758493|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2758494|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2758495|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2758496|NCT04525729|Rituximab|rituximab|mesh-list
2758497|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2758498|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758499|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
2758500|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262663|NCT00168623|Vitamins|vitamins|mesh-ancestor
2262664|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
2262665|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262666|NCT00168636|Vitamin A|vitamin a|mesh-list
2262667|NCT00168636|Vitamins|vitamins|mesh-ancestor
2262668|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
2758501|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2758502|NCT04525755|Nicotine|nicotine|mesh-list
2758503|NCT04525755|Varenicline|varenicline|mesh-list
2758504|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2758505|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
2758506|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2758507|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262669|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262670|NCT00168649|Vitamin A|vitamin a|mesh-list
2262671|NCT00168649|Vitamins|vitamins|mesh-ancestor
2262672|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
2262673|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262674|NCT00168688|Micronutrients|micronutrients|mesh-list
2262675|NCT00168688|Trace Elements|trace elements|mesh-list
2262676|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758508|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2758509|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2758510|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
2758511|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2789074|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2262677|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2262678|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
2758512|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758513|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
2758514|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2758515|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758516|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
2758517|NCT04525495|Dopamine|dopamine|mesh-list
2758518|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2758519|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
2758520|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
2758521|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2758522|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758523|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
2758524|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2758525|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758526|NCT04525495|Protective Agents|protective agents|mesh-ancestor
2758527|NCT04525638|Nivolumab|nivolumab|mesh-list
2758528|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2758529|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2758530|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758531|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2758532|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758533|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2789075|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
2789076|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2789077|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
2789078|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
2789079|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2789080|NCT04304807|Melatonin|melatonin|mesh-list
2789081|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789082|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
2789083|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789084|NCT04304807|Protective Agents|protective agents|mesh-ancestor
2789085|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789086|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789087|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
2789088|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
2789089|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2789090|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789091|NCT04305106|Bevacizumab|bevacizumab|mesh-list
2789092|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2789093|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789094|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2789095|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2789096|NCT04305106|Growth Substances|growth substances|mesh-ancestor
2789097|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262679|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262680|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
2262681|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262682|NCT00168714|Interferons|interferons|mesh-list
2262683|NCT00168714|Interferon-beta|interferon-beta|mesh-list
2262684|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
2262685|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262686|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
2262687|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262688|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
2262689|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262690|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2262691|NCT00168740|Rituximab|rituximab|mesh-list
2789098|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
2789099|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
2789100|NCT04305015|Narcotics|narcotics|mesh-ancestor
2789101|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789102|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789103|NCT04305015|Analgesics|analgesics|mesh-ancestor
2262692|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2262693|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262694|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
2262695|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262696|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262697|NCT00168753|Alefacept|alefacept|mesh-list
2262698|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
2789104|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
2789105|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789106|NCT04304716|Anesthetics|anesthetics|mesh-list
2262699|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
2262700|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262701|NCT00168766|Interferons|interferons|mesh-list
2262702|NCT00168766|Interferon-beta|interferon-beta|mesh-list
2262703|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
2262704|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
2262705|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262706|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
2262707|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262708|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2262709|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
2101340|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101341|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101342|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2101343|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
2101344|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2101345|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101346|NCT02389361|Acetaminophen|acetaminophen|mesh-list
2101347|NCT02389361|Tramadol|tramadol|mesh-list
2101348|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2101349|NCT02389361|Analgesics|analgesics|mesh-ancestor
2101350|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
2101351|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101352|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101353|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
2101354|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2101355|NCT02389361|Narcotics|narcotics|mesh-ancestor
2101356|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101357|NCT02389374|Chloroquine|chloroquine|mesh-list
2101358|NCT02389374|Lumefantrine|lumefantrine|mesh-list
2101359|NCT02389374|Artemether|artemether|mesh-list
2101360|NCT02389374|Primaquine|primaquine|mesh-list
2101361|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2101362|NCT02389374|Amebicides|amebicides|mesh-ancestor
2101363|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2101364|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2101365|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101366|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
2101367|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2101368|NCT02389452|Hylan|hylan|mesh-list
2101369|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
2758534|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
2758535|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2758536|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
2758537|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758538|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
2758539|NCT04525066|Protective Agents|protective agents|mesh-ancestor
2758540|NCT04525391|Durvalumab|durvalumab|mesh-list
2758541|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2758542|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758543|NCT04525235|Tolbutamide|tolbutamide|mesh-list
2758544|NCT04525235|Rifampin|rifampin|mesh-list
2758545|NCT04525235|Digoxin|digoxin|mesh-list
2758546|NCT04525235|Midazolam|midazolam|mesh-list
2758547|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
2758548|NCT04525235|Caffeine|caffeine|mesh-list
2758549|NCT04525235|Omeprazole|omeprazole|mesh-list
2758550|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2758551|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2758552|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2758553|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758554|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2758555|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2758556|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2758557|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2758558|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
2758559|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
2758560|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
2758561|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
2758562|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2758563|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758564|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2758565|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2758566|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2758567|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758568|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2758569|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2758570|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2262710|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
2262711|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2758571|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2758572|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
2758573|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2758574|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
2758575|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2758576|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758577|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
2758578|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2758579|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2758580|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2758581|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2758582|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2758583|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2758584|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2758585|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2758586|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2758587|NCT04525235|Protective Agents|protective agents|mesh-ancestor
2758588|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
2758589|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
2758590|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2758591|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2758592|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2758593|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
2758594|NCT04525274|Ketamine|ketamine|mesh-list
2758595|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2758596|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101370|NCT02389452|Protective Agents|protective agents|mesh-ancestor
2101371|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101372|NCT02389738|Temozolomide|temozolomide|mesh-list
2101373|NCT02389738|Regadenoson|regadenoson|mesh-list
2101374|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2101375|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
2101376|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101377|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101378|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2101379|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2758597|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758598|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2758599|NCT04525274|Analgesics|analgesics|mesh-ancestor
2758600|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
2758601|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2758602|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2758603|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2758604|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2758605|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
2758606|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2758607|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758608|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2758609|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2758610|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
2758611|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
2758612|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2758613|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2758614|NCT04525326|Bevacizumab|bevacizumab|mesh-list
2758615|NCT04525326|Cetuximab|cetuximab|mesh-list
2758616|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2758617|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758618|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2758619|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2758620|NCT04525326|Growth Substances|growth substances|mesh-ancestor
2758621|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758622|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
2758623|NCT04525300|Liraglutide|liraglutide|mesh-list
2758624|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2758625|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758626|NCT04525300|Incretins|incretins|mesh-ancestor
2758627|NCT04525300|Hormones|hormones|mesh-ancestor
2758628|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2758629|NCT04524702|Gemcitabine|gemcitabine|mesh-list
2758630|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
2758631|NCT04524702|Paclitaxel|paclitaxel|mesh-list
2758632|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2758633|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2758634|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758635|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
2758636|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
2758637|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
2758638|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262712|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262713|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2262714|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
2262715|NCT00168766|Hormones|hormones|mesh-ancestor
2262716|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2262717|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2262718|NCT00168766|Protective Agents|protective agents|mesh-ancestor
2262719|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
2262720|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2758639|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2758640|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
2758641|NCT04524702|Antiviral Agents|antiviral agents|mesh-ancestor
2758642|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758643|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758644|NCT04524702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2758645|NCT04524702|Immunologic Factors|immunologic factors|mesh-ancestor
2758646|NCT04524702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758647|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
2758648|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2758649|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2758650|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2758651|NCT04524728|Letrozole|letrozole|mesh-list
2758652|NCT04524728|Fulvestrant|fulvestrant|mesh-list
2758653|NCT04524728|Palbociclib|palbociclib|mesh-list
2758654|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758655|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2758656|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2758657|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758658|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262721|NCT00168779|Valsartan|valsartan|mesh-list
2262722|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2262723|NCT00168779|Telmisartan|telmisartan|mesh-list
2262724|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2262725|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2262726|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2262727|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262728|NCT00168779|Diuretics|diuretics|mesh-ancestor
2262729|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
2262730|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262731|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2262732|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2262733|NCT00168792|Tenecteplase|tenecteplase|mesh-list
2262734|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2262735|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2262736|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758659|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2758660|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
2758661|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2758662|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758663|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2758664|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2262737|NCT00168857|Losartan|losartan|mesh-list
2262738|NCT00168857|Telmisartan|telmisartan|mesh-list
2262739|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2262740|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2262741|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2262742|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2262743|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758665|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2758666|NCT04524897|Triamcinolone|triamcinolone|mesh-list
2758667|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2758668|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2758669|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2758670|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2758671|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
2262744|NCT00168870|Gemcitabine|gemcitabine|mesh-list
2262745|NCT00168870|Treosulfan|treosulfan|mesh-list
2262746|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2262747|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
2262748|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262749|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758672|NCT04524897|Hormones|hormones|mesh-ancestor
2758673|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2758674|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758675|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2758676|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
2758677|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758678|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758679|NCT04524663|Camostat|camostat|mesh-list
2758680|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
2758681|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758682|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758683|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2758684|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2758685|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2758686|NCT04524169|Thymalfasin|thymalfasin|mesh-list
2758687|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2758688|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
2758689|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758706|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
2758707|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2758708|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758709|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2758710|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2758711|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758712|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758713|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758714|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2758715|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2758716|NCT04524026|Letrozole|letrozole|mesh-list
2758717|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2758718|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758719|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2758720|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758721|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758722|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2758723|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
2758724|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2758725|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758726|NCT04524130|Lidocaine|lidocaine|mesh-list
2758727|NCT04524130|Ketamine|ketamine|mesh-list
2758728|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
2758729|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
2758730|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2758731|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758732|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
2758733|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262750|NCT00168870|Antiviral Agents|antiviral agents|mesh-ancestor
2262751|NCT00168870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262752|NCT00168870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262753|NCT00168870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262754|NCT00168870|Immunologic Factors|immunologic factors|mesh-ancestor
2262755|NCT00168870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262756|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2262757|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
2262758|NCT00168883|Paclitaxel|paclitaxel|mesh-list
2262759|NCT00168883|Vinorelbine|vinorelbine|mesh-list
2262760|NCT00168883|Carboplatin|carboplatin|mesh-list
2262761|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2758734|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2758735|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2758736|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2758737|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2758738|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758739|NCT04524130|Analgesics|analgesics|mesh-ancestor
2758740|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2262762|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262763|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
2262764|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
2262765|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
2262766|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262767|NCT00168896|Carboplatin|carboplatin|mesh-list
2262768|NCT00168896|Etoposide|etoposide|mesh-list
2262769|NCT00168896|Irinotecan|irinotecan|mesh-list
2262770|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262771|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2262772|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2262773|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2262774|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758741|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2758742|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
2758743|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2758744|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2758745|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2758746|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2758747|NCT04523844|Brinzolamide|brinzolamide|mesh-list
2758748|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2758749|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2758750|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2758751|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2758752|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
2758753|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2758754|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758755|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758756|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2758757|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758758|NCT04523818|Fluorouracil|fluorouracil|mesh-list
2758759|NCT04523818|Capecitabine|capecitabine|mesh-list
2758760|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
2758761|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758762|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2758763|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758764|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2758765|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
2758766|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758767|NCT04523792|Buprenorphine|buprenorphine|mesh-list
2758768|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2758769|NCT04523792|Narcotics|narcotics|mesh-ancestor
2758770|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101380|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
2101381|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
2101382|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101383|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101384|NCT02389764|Nintedanib|nintedanib|mesh-list
2101385|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101386|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2101387|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101388|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101389|NCT02389816|Vortioxetine|vortioxetine|mesh-list
2262775|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262776|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2262777|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
2758771|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758772|NCT04523792|Analgesics|analgesics|mesh-ancestor
2758773|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
2758774|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2758775|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2758776|NCT04523740|Acetaminophen|acetaminophen|mesh-list
2758777|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2758778|NCT04523740|Analgesics|analgesics|mesh-ancestor
2758779|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
2758780|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2758781|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262778|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2758782|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
2758783|NCT04523623|Ibuprofen|ibuprofen|mesh-list
2758784|NCT04523623|Oxycodone|oxycodone|mesh-list
2758785|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2262779|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2262780|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262781|NCT00168909|Vitamins|vitamins|mesh-ancestor
2262782|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
2262783|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2262784|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2262785|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
2262786|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262787|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262788|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
2262789|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
2262790|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2262791|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2262792|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262793|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2262794|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758786|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2758787|NCT04523623|Analgesics|analgesics|mesh-ancestor
2758788|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
2758789|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2758790|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758791|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2758792|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2758793|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2758794|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758795|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758796|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2758797|NCT04523623|Narcotics|narcotics|mesh-ancestor
2758798|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2758799|NCT04523662|Apatinib|apatinib|mesh-list
2758800|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758801|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2758802|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758803|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758804|NCT04523493|Lenvatinib|lenvatinib|mesh-list
2758805|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758806|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2758807|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758808|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758809|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
2758810|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2758811|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
2758812|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758813|NCT04523675|Expectorants|expectorants|mesh-ancestor
2758814|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
2758815|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2758816|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
2758817|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758818|NCT04523675|Protective Agents|protective agents|mesh-ancestor
2758819|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758820|NCT04523675|Antidotes|antidotes|mesh-ancestor
2758821|NCT04523701|SMOFlipid|smoflipid|mesh-list
2758822|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2758823|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2758824|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2758825|NCT04524000|Fulvestrant|fulvestrant|mesh-list
2758826|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2758827|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758828|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2758829|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2758830|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
2758831|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2758832|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758833|NCT04523688|Temozolomide|temozolomide|mesh-list
2758834|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2758835|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
2758836|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758837|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758838|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
2758839|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
2758840|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2758841|NCT04523467|Growth Substances|growth substances|mesh-ancestor
2758842|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758843|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
2758844|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758845|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2758846|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
2758847|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2758848|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2758849|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758850|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
2758851|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2758852|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789107|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789108|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789112|NCT04305002|Exenatide|exenatide|mesh-list
2789113|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2789114|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789115|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2789116|NCT04305002|Incretins|incretins|mesh-ancestor
2789117|NCT04305002|Hormones|hormones|mesh-ancestor
2789118|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2789119|NCT04304573|Calcium|calcium|mesh-list
2789120|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2789121|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789122|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
2789123|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2789124|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789125|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2789126|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789127|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
2789128|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2789129|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2789130|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789131|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
2789132|NCT04304625|Coagulants|coagulants|mesh-ancestor
2789133|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
2789134|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2789135|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2789136|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789137|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2789138|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789139|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
2789140|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789141|NCT04304209|Capecitabine|capecitabine|mesh-list
2789142|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
2789143|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2789144|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
2789145|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789146|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789147|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
2789148|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2789149|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789150|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789151|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2789152|NCT04304157|Analgesics|analgesics|mesh-ancestor
2789153|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
2789154|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789155|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2789156|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2789157|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2789158|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
2789159|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2789160|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789161|NCT04304274|Morphine|morphine|mesh-list
2789162|NCT04304274|Ropivacaine|ropivacaine|mesh-list
2789163|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2789164|NCT04304274|Narcotics|narcotics|mesh-ancestor
2789165|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2758853|NCT04523363|Metformin|metformin|mesh-list
2758854|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2758855|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758856|NCT04523233|Vitamins|vitamins|mesh-list
2758857|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
2758858|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758859|NCT04523428|Venetoclax|venetoclax|mesh-list
2758860|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
2758861|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758862|NCT04523272|Sunitinib|sunitinib|mesh-list
2758863|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758864|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2758865|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2758866|NCT04523272|Growth Substances|growth substances|mesh-ancestor
2758867|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758868|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
2758869|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2758870|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758871|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758874|NCT04523077|Antibodies|antibodies|mesh-list
2758875|NCT04523077|Hormones|hormones|mesh-list
2758876|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
2758877|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758878|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2758879|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2758880|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2758881|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
2758882|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2758883|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758884|NCT04522882|Insulin|insulin|mesh-list
2758885|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2758886|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758891|NCT04523064|Empagliflozin|empagliflozin|mesh-list
2758892|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2758893|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758894|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2758895|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758901|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2758902|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758903|NCT04522739|Spironolactone|spironolactone|mesh-list
2758904|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2758905|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
2758906|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2758907|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758908|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2758909|NCT04522739|Diuretics|diuretics|mesh-ancestor
2758910|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
2758911|NCT04522622|Teriparatide|teriparatide|mesh-list
2758912|NCT04522622|Listerine|listerine|mesh-list
2758913|NCT04522622|Fluorides|fluorides|mesh-list
2758914|NCT04522622|Sodium Fluoride|sodium fluoride|mesh-list
2262795|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262796|NCT00169000|Docetaxel|docetaxel|mesh-list
2262797|NCT00169000|Capecitabine|capecitabine|mesh-list
2262798|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262799|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
2262800|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
2262801|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
2262802|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262803|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2262804|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
2262805|NCT00169013|Gabapentin|gabapentin|mesh-list
2262806|NCT00169013|Analgesics|analgesics|mesh-ancestor
2758915|NCT04522622|Cariostatic Agents|cariostatic agents|mesh-ancestor
2758916|NCT04522622|Protective Agents|protective agents|mesh-ancestor
2758917|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758918|NCT04522622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2758919|NCT04522622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758920|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2758921|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2758922|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
2758923|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758924|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
2758925|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758926|NCT04522544|Durvalumab|durvalumab|mesh-list
2758927|NCT04522544|Tremelimumab|tremelimumab|mesh-list
2262807|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
2262808|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262809|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262810|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
2262811|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2262812|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2262813|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2262814|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2262815|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2262816|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2262817|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262818|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262819|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
2262820|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
2262821|NCT00169026|Clozapine|clozapine|mesh-list
2758928|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2758929|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758930|NCT04522336|Docetaxel|docetaxel|mesh-list
2758931|NCT04522336|Fluorouracil|fluorouracil|mesh-list
2758932|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
2758933|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
2758934|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758935|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
2758936|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
2758937|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
2758938|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758939|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
2758940|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2758941|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2758942|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
2758943|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758944|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2758945|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
2758946|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
2758947|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2758948|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2758949|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2758950|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2758951|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758952|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2758953|NCT04522297|Octreotide|octreotide|mesh-list
2758954|NCT04522297|Epinephrine|epinephrine|mesh-list
2758955|NCT04522297|Midodrine|midodrine|mesh-list
2758956|NCT04522297|Norepinephrine|norepinephrine|mesh-list
2758957|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2758958|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2758959|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
2758960|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2758961|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2758962|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758963|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2262822|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2262823|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2262824|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262825|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2262826|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2262827|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
2262828|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262829|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262830|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
2262831|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
2262832|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
2262833|NCT00169039|Clozapine|clozapine|mesh-list
2758964|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2262834|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2758965|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
2758966|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2758967|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2758968|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
2758969|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
2758970|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
2758971|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2758972|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2758973|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2758974|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758975|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2758976|NCT04522167|Aflibercept|aflibercept|mesh-list
2758977|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2758978|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2758979|NCT04522167|Growth Substances|growth substances|mesh-ancestor
2758980|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758981|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
2758982|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2758983|NCT04522206|Oxycodone|oxycodone|mesh-list
2758984|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2758985|NCT04522206|Narcotics|narcotics|mesh-ancestor
2758986|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2758987|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2758988|NCT04522206|Analgesics|analgesics|mesh-ancestor
2758989|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
2758990|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2758996|NCT04521868|Sulforaphane|sulforaphane|mesh-list
2758997|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2758998|NCT04521868|Protective Agents|protective agents|mesh-ancestor
2758999|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759000|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759001|NCT04522050|Gemcitabine|gemcitabine|mesh-list
2262835|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
2262836|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262837|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262838|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262839|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2262840|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2262841|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2262842|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2262843|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
2262844|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
2262845|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
2262846|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
2262847|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262848|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2759002|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759003|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2759004|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
2759005|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759006|NCT04522050|Antiviral Agents|antiviral agents|mesh-ancestor
2759007|NCT04522050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759008|NCT04522050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759009|NCT04522050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2759010|NCT04522050|Immunologic Factors|immunologic factors|mesh-ancestor
2759011|NCT04522050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759012|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
2759013|NCT04521946|Fludarabine|fludarabine|mesh-list
2759014|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
2262849|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2262850|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
2262851|NCT00169065|Olanzapine|olanzapine|mesh-list
2262852|NCT00169065|Clozapine|clozapine|mesh-list
2759015|NCT04521946|Etoposide|etoposide|mesh-list
2759016|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
2759017|NCT04521946|Melphalan|melphalan|mesh-list
2262853|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
2262854|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
2759018|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
2759019|NCT04521946|Thiotepa|thiotepa|mesh-list
2759020|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
2759021|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2759022|NCT04521946|Tacrolimus|tacrolimus|mesh-list
2759023|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
2759024|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2759025|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
2759026|NCT04521946|Antibodies|antibodies|mesh-list
2759027|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
2759028|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2759029|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2759030|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759031|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2759032|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
2759033|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759034|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2759035|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
2759036|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759037|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2759038|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2759039|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2759040|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759041|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2759042|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2759043|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2759044|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
2759045|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2759046|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759047|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2759048|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
2101390|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
2101391|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2101392|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2101393|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2101394|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101395|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101396|NCT02389816|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2102963|NCT02415959|Pancrelipase|pancrelipase|mesh-list
2759049|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2759050|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
2759051|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
2759052|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
2759053|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
2759054|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
2789166|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789167|NCT04304274|Analgesics|analgesics|mesh-ancestor
2789168|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
2789169|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789170|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
2789171|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
2789172|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
2789173|NCT04304352|Capecitabine|capecitabine|mesh-list
2789174|NCT04304352|Vinorelbine|vinorelbine|mesh-list
2789175|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2789176|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
2789177|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789178|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2789179|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2789180|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
2789181|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789182|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789183|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2789184|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2789185|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
2789186|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2789187|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
2789188|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
2789189|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
2789190|NCT04304261|Metformin|metformin|mesh-list
2789191|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
2789192|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2789193|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789194|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2789195|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789196|NCT04304248|Paclitaxel|paclitaxel|mesh-list
2789197|NCT04304248|Carboplatin|carboplatin|mesh-list
2789198|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2789199|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2789200|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789201|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
2262855|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759055|NCT04522037|Morphine|morphine|mesh-list
2759056|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2759057|NCT04522037|Narcotics|narcotics|mesh-ancestor
2759058|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2759059|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759060|NCT04522037|Analgesics|analgesics|mesh-ancestor
2759061|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
2759062|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759063|NCT04521400|Interferons|interferons|mesh-list
2759064|NCT04521400|Ritonavir|ritonavir|mesh-list
2759065|NCT04521400|Lopinavir|lopinavir|mesh-list
2759066|NCT04521400|Interferon-beta|interferon-beta|mesh-list
2759067|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
2759068|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759069|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
2759070|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759071|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2759072|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2759073|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
2759074|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759075|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759076|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2759077|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2759078|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2759079|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2759080|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
2759081|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759082|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2759083|NCT04521569|Regadenoson|regadenoson|mesh-list
2759084|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2759085|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2759086|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
2759087|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
2759088|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2759089|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759090|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759091|NCT04521556|Morphine|morphine|mesh-list
2759092|NCT04521556|Tramadol|tramadol|mesh-list
2759093|NCT04521556|Anesthetics|anesthetics|mesh-list
2759094|NCT04521556|Ropivacaine|ropivacaine|mesh-list
2262856|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262857|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2262858|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2262859|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2262860|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2262861|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2262862|NCT00169065|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2262863|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2262864|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2262865|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262866|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262867|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
2262868|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2262869|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
2262870|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
2262871|NCT00169078|Chloroquine|chloroquine|mesh-list
2262872|NCT00169078|Amebicides|amebicides|mesh-ancestor
2262873|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2262874|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2262875|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262876|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
2759095|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2759096|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759097|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2759098|NCT04521556|Narcotics|narcotics|mesh-ancestor
2759099|NCT04521556|Analgesics|analgesics|mesh-ancestor
2759100|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
2759101|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759102|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
2759103|NCT04521582|Amlodipine|amlodipine|mesh-list
2759104|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2759105|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2759106|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2759107|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262877|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2759108|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2262878|NCT00169091|Haloperidol|haloperidol|mesh-list
2262879|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
2759109|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759110|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
2759111|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
2759112|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2759113|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759114|NCT04521647|Nicotine|nicotine|mesh-list
2759115|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2759116|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
2759117|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759118|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759119|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2759120|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2759121|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
2759122|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2759123|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759124|NCT04521751|Acarbose|acarbose|mesh-list
2759125|NCT04521751|Orlistat|orlistat|mesh-list
2759126|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2759127|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759128|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759129|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2759130|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759131|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2759132|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2759133|NCT04521517|Imidacloprid|imidacloprid|mesh-list
2759134|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
2759135|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2759136|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759137|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759138|NCT04521491|Leucovorin|leucovorin|mesh-list
2759139|NCT04521491|Fluorouracil|fluorouracil|mesh-list
2759140|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
2759141|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
2759142|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759143|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2759144|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759145|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2759146|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
2759147|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759148|NCT04521491|Antidotes|antidotes|mesh-ancestor
2759149|NCT04521491|Protective Agents|protective agents|mesh-ancestor
2759150|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
2759151|NCT04521491|Vitamins|vitamins|mesh-ancestor
2759152|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
2759153|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
2759154|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2759155|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
2759156|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759157|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
2759158|NCT04521387|Protective Agents|protective agents|mesh-ancestor
2262880|NCT00169091|Clozapine|clozapine|mesh-list
2262881|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
2262882|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
2262883|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262884|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262885|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2262886|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2262887|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2262888|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2262889|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2262890|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2262891|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
2262892|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2262893|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262894|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2262895|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2262896|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
2262897|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
2262898|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
2262899|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
2262900|NCT00169130|Doxorubicin|doxorubicin|mesh-list
2262901|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262902|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
2262903|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262904|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2759167|NCT04521075|Nivolumab|nivolumab|mesh-list
2759168|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2759169|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759170|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2759171|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759172|NCT04521335|Copper|copper|mesh-list
2759173|NCT04521335|Disulfiram|disulfiram|mesh-list
2759174|NCT04521335|Trace Elements|trace elements|mesh-ancestor
2759175|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
2759176|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759177|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2759178|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2759179|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759180|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759181|NCT04521140|Dexamethasone|dexamethasone|mesh-list
2759182|NCT04521140|Prednisolone|prednisolone|mesh-list
2759183|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2759184|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
2759185|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2759186|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
2759187|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2759188|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
2759189|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2759190|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
2759191|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
2759192|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759193|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759194|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2759195|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
2759196|NCT04521140|Hormones|hormones|mesh-ancestor
2759197|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2759198|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2759199|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759200|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2759201|NCT04521140|Protective Agents|protective agents|mesh-ancestor
2759202|NCT04521348|Antibodies|antibodies|mesh-list
2759203|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
2759204|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
2759205|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759206|NCT04521309|Antibodies|antibodies|mesh-list
2759207|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
2759208|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759209|NCT04521153|Apatinib|apatinib|mesh-list
2759210|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759211|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2759212|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759213|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759214|NCT04521049|Saxagliptin|saxagliptin|mesh-list
2759215|NCT04521049|Incretins|incretins|mesh-ancestor
2759216|NCT04521049|Hormones|hormones|mesh-ancestor
2759217|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2759218|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759219|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2759220|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
2759221|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759222|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759223|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2759224|NCT04520646|Empagliflozin|empagliflozin|mesh-list
2759225|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2759226|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759227|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2759228|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759229|NCT04520620|Enoxaparin|enoxaparin|mesh-list
2759230|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
2759231|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2759232|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2759233|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759236|NCT04520880|Antibodies|antibodies|mesh-list
2759237|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
2759238|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
2759239|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
2759240|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759243|NCT04520919|Anesthetics|anesthetics|mesh-list
2759244|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2262905|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2262906|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
2262907|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262908|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262909|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2262910|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2262911|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2262912|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2262913|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262914|NCT00169143|Rituximab|rituximab|mesh-list
2759245|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759246|NCT04520503|Propofol|propofol|mesh-list
2759247|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2759248|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2759249|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262915|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2262916|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262917|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
2262918|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262919|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262920|NCT00169156|Prednisone|prednisone|mesh-list
2262921|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
2262922|NCT00169156|Rituximab|rituximab|mesh-list
2262923|NCT00169156|Doxorubicin|doxorubicin|mesh-list
2262924|NCT00169156|Vincristine|vincristine|mesh-list
2262925|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262926|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
2262927|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262928|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262929|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2262930|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
2262931|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262932|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262933|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2262934|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2262935|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2262936|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2262937|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2262938|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262939|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2262940|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
2262941|NCT00169156|Hormones|hormones|mesh-ancestor
2262942|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2759250|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2759251|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
2759252|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
2759253|NCT04520230|Budesonide|budesonide|mesh-list
2759254|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
2759255|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
2759256|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2759257|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2759258|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2759259|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
2759260|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759261|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759262|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2759263|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
2759264|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
2759265|NCT04520230|Hormones|hormones|mesh-ancestor
2759266|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2759267|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2759268|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2759269|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2759270|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
2262943|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2759271|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2759272|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759273|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
2262944|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2262945|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
2262946|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
2262947|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
2262948|NCT00169169|Rituximab|rituximab|mesh-list
2262949|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2262950|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262951|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
2262952|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262953|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2759274|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2759275|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
2759287|NCT04520490|Exenatide|exenatide|mesh-list
2759288|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2759289|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759290|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2759291|NCT04520490|Incretins|incretins|mesh-ancestor
2759292|NCT04520490|Hormones|hormones|mesh-ancestor
2759293|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2759294|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
2759295|NCT04520074|Carboplatin|carboplatin|mesh-list
2759296|NCT04520074|Etoposide|etoposide|mesh-list
2759297|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2759298|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
2759299|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759300|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2759301|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2759302|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
2759303|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759304|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759305|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2759306|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2759307|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2759308|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2759309|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759310|NCT04520451|Prednisone|prednisone|mesh-list
2759311|NCT04520451|Prednisolone|prednisolone|mesh-list
2759312|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
2759313|NCT04520451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2759314|NCT04520451|Hormones|hormones|mesh-ancestor
2759315|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2759316|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759317|NCT04520451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2759318|NCT04520451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789202|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
2789203|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
2789204|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789205|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
2789206|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789207|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
2789208|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2789209|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2789210|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789211|NCT04304313|Urological Agents|urological agents|mesh-ancestor
2789212|NCT04304196|TEMPO|tempo|mesh-list
2789213|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
2789214|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789215|NCT04304196|Protective Agents|protective agents|mesh-ancestor
2789216|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793065|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2759319|NCT04520048|Acetylcholine|acetylcholine|mesh-list
2759320|NCT04520048|Vasodilator Agents|vasodilator agents|mesh-ancestor
2759321|NCT04520048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2759322|NCT04520048|Cholinergic Agents|cholinergic agents|mesh-ancestor
2759323|NCT04520048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2759324|NCT04520048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759325|NCT04520048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759326|NCT04520178|Carbidopa|carbidopa|mesh-list
2759327|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
2262954|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
2262955|NCT00169182|Niacin|niacin|mesh-list
2262956|NCT00169182|Docetaxel|docetaxel|mesh-list
2262957|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262958|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
2262959|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
2262960|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
2262961|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262962|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
2262963|NCT00169182|Vitamins|vitamins|mesh-ancestor
2262964|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
2262965|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262966|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2262967|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
2262968|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2262969|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
2262970|NCT00169195|Gemcitabine|gemcitabine|mesh-list
2262971|NCT00169195|Rituximab|rituximab|mesh-list
2262972|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
2262973|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2262974|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759328|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2759329|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2759330|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
2759331|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2759332|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759333|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262975|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
2262976|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262977|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262978|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2262979|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
2262980|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262981|NCT00169195|Antiviral Agents|antiviral agents|mesh-ancestor
2262982|NCT00169195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2262983|NCT00169195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2262984|NCT00169195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2262985|NCT00169208|Rituximab|rituximab|mesh-list
2262986|NCT00169208|Fludarabine|fludarabine|mesh-list
2262987|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
2262988|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2262989|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2262990|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
2262991|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2262992|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2262993|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2262994|NCT00169208|Analgesics|analgesics|mesh-ancestor
2262995|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
2262996|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2262997|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2262998|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2262999|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263000|NCT00169221|Gefitinib|gefitinib|mesh-list
2263001|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263002|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2263003|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759334|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2759335|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759336|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2759337|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
2759338|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2759339|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
2759340|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759341|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
2759342|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759343|NCT04520126|Protective Agents|protective agents|mesh-ancestor
2759344|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759345|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2759346|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
2759347|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2759348|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
2759349|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759350|NCT04520139|Expectorants|expectorants|mesh-ancestor
2759351|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
2759352|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2759353|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
2759354|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759355|NCT04520139|Protective Agents|protective agents|mesh-ancestor
2759356|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759357|NCT04520139|Antidotes|antidotes|mesh-ancestor
2759358|NCT04519983|Osimertinib|osimertinib|mesh-list
2759359|NCT04519983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759360|NCT04519983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2759361|NCT04519983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759362|NCT04519983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759363|NCT04520035|Paclitaxel|paclitaxel|mesh-list
2759364|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2759365|NCT04520035|Cisplatin|cisplatin|mesh-list
2759366|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2759367|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759368|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
2759369|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
2759370|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
2263004|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263005|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2263006|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
2263007|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263008|NCT00169247|Cetuximab|cetuximab|mesh-list
2263009|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263010|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2263011|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2263012|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
2263013|NCT00169299|Estrogens|estrogens|mesh-list
2263014|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2263015|NCT00169299|Hormones|hormones|mesh-ancestor
2759371|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759372|NCT04519944|Edoxaban|edoxaban|mesh-list
2759373|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2759374|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
2759375|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2759376|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
2759377|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759378|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759379|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
2759380|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
2759381|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2759382|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2759383|NCT04519476|Prednisolone|prednisolone|mesh-list
2759384|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
2759385|NCT04519476|Lenalidomide|lenalidomide|mesh-list
2759386|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2759387|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
2759388|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
2759389|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759390|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2759391|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2759392|NCT04519476|Growth Substances|growth substances|mesh-ancestor
2759393|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
2759394|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759395|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2759396|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
2759397|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
2759398|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759399|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2759400|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
2759401|NCT04519476|Hormones|hormones|mesh-ancestor
2759402|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2759403|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2759404|NCT04519476|Protective Agents|protective agents|mesh-ancestor
2759405|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2759406|NCT04519463|Lidocaine|lidocaine|mesh-list
2759407|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
2759408|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
2789217|NCT04303741|Apatinib|apatinib|mesh-list
2759409|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2759410|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759411|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
2759412|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759413|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2759414|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2759415|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2759416|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2759417|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759418|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2759419|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759420|NCT04519710|Rituximab|rituximab|mesh-list
2759421|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
2759422|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2759423|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759424|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
2759425|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759426|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2759427|NCT04519164|Eplerenone|eplerenone|mesh-list
2759428|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
2759429|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2759430|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
2759431|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2759432|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759433|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2759434|NCT04519164|Diuretics|diuretics|mesh-ancestor
2759435|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
2759436|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2759437|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2759438|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2759439|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759440|NCT04519125|Tenofovir|tenofovir|mesh-list
2759441|NCT04519125|Emtricitabine|emtricitabine|mesh-list
2759442|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
2759443|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759444|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2759445|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2759446|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759447|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759448|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2759449|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2263016|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2263017|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263018|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2263019|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2263020|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2263021|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
2263022|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2263023|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2263024|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2263025|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2263026|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2263027|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263028|NCT00169416|Valacyclovir|valacyclovir|mesh-list
2263029|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
2263030|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2263031|NCT00169468|Rituximab|rituximab|mesh-list
2263032|NCT00169468|Bortezomib|bortezomib|mesh-list
2263033|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2263034|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263035|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
2263036|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263037|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2263038|NCT00169520|Docetaxel|docetaxel|mesh-list
2263039|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263040|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
2263041|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
2263042|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
2263043|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263044|NCT00169533|Lapatinib|lapatinib|mesh-list
2263045|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263046|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2263047|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759450|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
2759451|NCT04519151|Lenvatinib|lenvatinib|mesh-list
2759452|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2759453|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263048|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263049|NCT00169546|Fluticasone|fluticasone|mesh-list
2263050|NCT00169546|Xhance|xhance|mesh-list
2263051|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2263052|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263053|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2263054|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
2263055|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263056|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263057|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2263058|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
2263059|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
2759454|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2759455|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759456|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759457|NCT04519281|Ascorbic Acid|ascorbic acid|mesh-list
2759458|NCT04519281|Vitamins|vitamins|mesh-ancestor
2759459|NCT04519281|Micronutrients|micronutrients|mesh-ancestor
2759460|NCT04519281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759461|NCT04519281|Antioxidants|antioxidants|mesh-ancestor
2759462|NCT04519281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759463|NCT04519281|Protective Agents|protective agents|mesh-ancestor
2759464|NCT04519385|Dexamethasone|dexamethasone|mesh-list
2759465|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2759466|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
2759467|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
2759468|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759469|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759470|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2759471|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
2759472|NCT04519385|Hormones|hormones|mesh-ancestor
2759473|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2759474|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2759475|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759476|NCT04518852|Sorafenib|sorafenib|mesh-list
2759477|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759478|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2759479|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759480|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759481|NCT04518735|Anticoagulants|anticoagulants|mesh-list
2759482|NCT04518618|Fentanyl|fentanyl|mesh-list
2759483|NCT04518618|Naloxone|naloxone|mesh-list
2759484|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2759485|NCT04518618|Narcotics|narcotics|mesh-ancestor
2759486|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2759487|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759488|NCT04518618|Analgesics|analgesics|mesh-ancestor
2759489|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
2759490|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759491|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2759492|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2759493|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
2759494|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
2759495|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2759496|NCT04518982|Lenalidomide|lenalidomide|mesh-list
2759497|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
2759498|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759499|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2759500|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2759501|NCT04518982|Growth Substances|growth substances|mesh-ancestor
2759502|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
2759503|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759504|NCT04518280|Capecitabine|capecitabine|mesh-list
2759505|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
2759506|NCT04518280|Antibodies|antibodies|mesh-list
2759507|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
2759508|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759509|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2759510|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
2759511|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759512|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759513|NCT04518319|Olanzapine|olanzapine|mesh-list
2759514|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
2759515|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
2759516|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759517|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759518|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2759519|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2759520|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2759521|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2759522|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2759523|NCT04518319|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2759524|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2759525|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2759526|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759527|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2759528|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
2789218|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789219|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2789220|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789221|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789222|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2789223|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2789224|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2789225|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
2789226|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789227|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2789228|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2789229|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789230|NCT04304040|Antibodies|antibodies|mesh-list
2789231|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2789232|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
2263060|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2263061|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2263062|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2263063|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2263064|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
2263065|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2789233|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789234|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
2789235|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2789236|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789237|NCT04303845|Erenumab|erenumab|mesh-list
2789238|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2789239|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789240|NCT04303845|Analgesics|analgesics|mesh-ancestor
2101397|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2101398|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2789241|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
2789242|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789243|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789244|NCT04303988|Bevacizumab|bevacizumab|mesh-list
2789245|NCT04303988|Carboplatin|carboplatin|mesh-list
2789246|NCT04303988|Temozolomide|temozolomide|mesh-list
2789247|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2789248|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789249|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2789250|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2789251|NCT04303988|Growth Substances|growth substances|mesh-ancestor
2789252|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789253|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
2789254|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2789255|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
2789256|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789257|NCT04303819|Exenatide|exenatide|mesh-list
2789258|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2789259|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789260|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2789261|NCT04303819|Incretins|incretins|mesh-ancestor
2789262|NCT04303819|Hormones|hormones|mesh-ancestor
2101399|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101400|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101401|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
2101402|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2101403|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2101404|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2263066|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263067|NCT00169559|Fenofibrate|fenofibrate|mesh-list
2263068|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2759537|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
2759538|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759539|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
2759540|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
2759541|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759542|NCT04518540|Protective Agents|protective agents|mesh-ancestor
2759543|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759544|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
2759545|NCT04518540|Vitamins|vitamins|mesh-ancestor
2759546|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
2759547|NCT04518475|Rituximab|rituximab|mesh-list
2759548|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2759549|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759550|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
2759551|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759552|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2759553|NCT04518462|Bupivacaine|bupivacaine|mesh-list
2759554|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
2759555|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
2759556|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2759557|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759558|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
2759559|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759560|NCT04518202|Lidocaine|lidocaine|mesh-list
2759561|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
2759562|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
2759563|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2759564|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759565|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
2759566|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759567|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2759568|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2759569|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2759570|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2759571|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759572|NCT04518189|Lidocaine|lidocaine|mesh-list
2759573|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
2759574|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
2759575|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2759576|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759577|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
2759578|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759579|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2759580|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2759581|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2759582|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2759583|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759584|NCT04517799|Cannabidiol|cannabidiol|mesh-list
2759585|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
2759586|NCT04517890|Lidocaine|lidocaine|mesh-list
2759587|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
2759588|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
2759589|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2759590|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759591|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
2759592|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759593|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2759594|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2759595|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2759596|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2759597|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759598|NCT04518176|Oxytocin|oxytocin|mesh-list
2263069|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
2759599|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
2759600|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2759601|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759602|NCT04517851|Elotuzumab|elotuzumab|mesh-list
2759603|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759610|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
2759611|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2759612|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2759613|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759614|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
2759615|NCT04518163|Coagulants|coagulants|mesh-ancestor
2759616|NCT04517747|Ramucirumab|ramucirumab|mesh-list
2759617|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759618|NCT04517526|Bevacizumab|bevacizumab|mesh-list
2263070|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263071|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2263072|NCT00169572|Dexamethasone|dexamethasone|mesh-list
2263073|NCT00169572|Ondansetron|ondansetron|mesh-list
2263074|NCT00169572|Aprepitant|aprepitant|mesh-list
2263075|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
2263076|NCT00169572|Casopitant|casopitant|mesh-list
2263077|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263078|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
2263079|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
2263080|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263081|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263082|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2263083|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
2263084|NCT00169572|Hormones|hormones|mesh-ancestor
2263085|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2263086|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2263087|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263088|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
2263089|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
2759619|NCT04517526|Durvalumab|durvalumab|mesh-list
2759620|NCT04517526|Carboplatin|carboplatin|mesh-list
2759621|NCT04517526|Pemetrexed|pemetrexed|mesh-list
2759622|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2759623|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759624|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2759625|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2759626|NCT04517526|Growth Substances|growth substances|mesh-ancestor
2759627|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759628|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
2759629|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759630|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759631|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2759632|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2759633|NCT04517396|Fenofibrate|fenofibrate|mesh-list
2759634|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
2759635|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2759636|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
2759637|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759638|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2759639|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2759640|NCT04517435|Prednisone|prednisone|mesh-list
2759641|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
2263090|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2263091|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
2263092|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263093|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263094|NCT00169572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2263095|NCT00169572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2263096|NCT00169572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2263097|NCT00169572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2263098|NCT00169572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2263099|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2263100|NCT00169585|Levofloxacin|levofloxacin|mesh-list
2263101|NCT00169585|Ofloxacin|ofloxacin|mesh-list
2759642|NCT04517435|Rituximab|rituximab|mesh-list
2759643|NCT04517435|Doxorubicin|doxorubicin|mesh-list
2759644|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2759645|NCT04517435|Vincristine|vincristine|mesh-list
2759646|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2759647|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
2759648|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759649|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2759650|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2759651|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
2759652|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759653|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759654|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2759655|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2759656|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2759657|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2101405|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2101406|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
2101407|NCT02389829|Promethazine|promethazine|mesh-list
2101408|NCT02389829|Hydromorphone|hydromorphone|mesh-list
2101409|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
2101410|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2101411|NCT02389829|Narcotics|narcotics|mesh-ancestor
2759658|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2759659|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759660|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2759661|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
2759662|NCT04517435|Hormones|hormones|mesh-ancestor
2759663|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2759664|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2759665|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2759666|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
2759667|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
2263102|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2759668|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
2759669|NCT04517292|Gemcitabine|gemcitabine|mesh-list
2759670|NCT04517292|Cisplatin|cisplatin|mesh-list
2759671|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759672|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2759673|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
2759674|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759675|NCT04517292|Antiviral Agents|antiviral agents|mesh-ancestor
2759676|NCT04517292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759677|NCT04517292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759678|NCT04517292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2759679|NCT04517292|Immunologic Factors|immunologic factors|mesh-ancestor
2759680|NCT04517292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759681|NCT04517227|Durvalumab|durvalumab|mesh-list
2759682|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2759683|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759684|NCT04517214|Gemcitabine|gemcitabine|mesh-list
2759685|NCT04517214|Capecitabine|capecitabine|mesh-list
2759686|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759687|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2759688|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
2759689|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759690|NCT04517214|Antiviral Agents|antiviral agents|mesh-ancestor
2759691|NCT04517214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759692|NCT04517214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759693|NCT04517214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2759694|NCT04517214|Immunologic Factors|immunologic factors|mesh-ancestor
2759695|NCT04517214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759696|NCT04517201|Insulin|insulin|mesh-list
2759697|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2759698|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2759699|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759700|NCT04517110|Pregabalin|pregabalin|mesh-list
2759701|NCT04517110|Analgesics|analgesics|mesh-ancestor
2759702|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
2759703|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759704|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759705|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
2759706|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2759707|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2759708|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759709|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2759710|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2101412|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2263103|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2263104|NCT00169585|Renal Agents|renal agents|mesh-ancestor
2263105|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2263106|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2263107|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2263108|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263109|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263110|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263111|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2263112|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2263113|NCT00169611|Methylphenidate|methylphenidate|mesh-list
2263114|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2263115|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263116|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2263117|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2263118|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263119|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263120|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
2263121|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263122|NCT00169624|Metformin|metformin|mesh-list
2263123|NCT00169624|Gliclazide|gliclazide|mesh-list
2263124|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2263125|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263126|NCT00169728|Vaccines|vaccines|mesh-list
2263127|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2263128|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
2263129|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263130|NCT00169819|Abciximab|abciximab|mesh-list
2263131|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
2263132|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2263133|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
2263134|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2263135|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263136|NCT00169845|Tocopherols|tocopherols|mesh-list
2263137|NCT00169845|Vitamin E|vitamin e|mesh-list
2263138|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
2263139|NCT00169845|Beta Carotene|beta carotene|mesh-list
2263140|NCT00169845|Carotenoids|carotenoids|mesh-list
2263141|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
2263142|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263143|NCT00169845|Protective Agents|protective agents|mesh-ancestor
2263144|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263145|NCT00169845|Vitamins|vitamins|mesh-ancestor
2263146|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
2263147|NCT00169845|Provitamins|provitamins|mesh-ancestor
2263148|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
2263149|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2263150|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263151|NCT00169949|Aripiprazole|aripiprazole|mesh-list
2263152|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
2263153|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2263154|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2263155|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2263156|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2263157|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263158|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
2263159|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
2263160|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263161|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263162|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2263163|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2263164|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
2263165|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2263166|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2263167|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2263168|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2263169|NCT00169988|Risperidone|risperidone|mesh-list
2263170|NCT00169988|Sertraline|sertraline|mesh-list
2263171|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2263172|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
2263173|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263174|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263175|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263176|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2263177|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2759711|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2759712|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2759713|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2759714|NCT04517188|Iodine|iodine|mesh-list
2759715|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
2759716|NCT04517188|Povidone|povidone|mesh-list
2759717|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2759718|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759719|NCT04517188|Trace Elements|trace elements|mesh-ancestor
2759720|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
2759721|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759722|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
2759723|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
2759724|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2759725|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
2759726|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
2759727|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759728|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2759729|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
2759730|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2759731|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759732|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2263178|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2263179|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2263180|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2263181|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
2263182|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
2263183|NCT00169988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2759733|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2759734|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2759735|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
2263184|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2263185|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263186|NCT00170001|Esomeprazole|esomeprazole|mesh-list
2263187|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2263188|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2759736|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2759737|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2789263|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2789264|NCT04303767|Calcium|calcium|mesh-list
2789265|NCT04303767|Caseins|caseins|mesh-list
2789266|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2789267|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789268|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
2789269|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
2789270|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789271|NCT04304014|Sulfalene|sulfalene|mesh-list
2789272|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789273|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2789274|NCT04304014|Renal Agents|renal agents|mesh-ancestor
2789275|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
2789276|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2789277|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2789278|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
2789279|NCT04303520|Fludarabine|fludarabine|mesh-list
2789280|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2263189|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2263190|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263191|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263192|NCT00170053|Sirolimus|sirolimus|mesh-list
2263193|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2263194|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2263195|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2263196|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263197|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
2263198|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2263199|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
2263200|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789281|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
2789282|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789283|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2789284|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2789285|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
2789286|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263201|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2789287|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759738|NCT04516941|Colchicine|colchicine|mesh-list
2759739|NCT04516941|Edoxaban|edoxaban|mesh-list
2759740|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
2759741|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2759742|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
2759743|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
2759744|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
2759745|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759746|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759747|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2759748|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
2759749|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2759750|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
2759751|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759752|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
2759753|NCT04516915|Oseltamivir|oseltamivir|mesh-list
2759754|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
2759755|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759756|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759757|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759758|NCT04517162|Povidone|povidone|mesh-list
2263202|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
2263203|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263204|NCT00170196|Prednisone|prednisone|mesh-list
2263205|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263206|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
2263207|NCT00170196|Hormones|hormones|mesh-ancestor
2263208|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2263209|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263210|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2263211|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263212|NCT00170209|Rifampin|rifampin|mesh-list
2263213|NCT00170209|Isoniazid|isoniazid|mesh-list
2263214|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2263215|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
2263216|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2263217|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2263218|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
2263219|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2263220|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263221|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263222|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2263223|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2263224|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2263225|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2263226|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2263227|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2263228|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2263229|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2263230|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
2263231|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2263232|NCT00170222|Doxycycline|doxycycline|mesh-list
2263233|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2263234|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2263235|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
2263236|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2263237|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2263238|NCT00170378|Enoxaparin|enoxaparin|mesh-list
2263239|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
2759759|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
2759760|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
2759761|NCT04516616|Paclitaxel|paclitaxel|mesh-list
2759762|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2759763|NCT04516616|Cisplatin|cisplatin|mesh-list
2759764|NCT04516616|Antibodies|antibodies|mesh-list
2759765|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2759766|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2759767|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759768|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
2759769|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
2759770|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
2759771|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263240|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2263241|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2759772|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
2759773|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759774|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
2759775|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759776|NCT04516681|Vitamins|vitamins|mesh-ancestor
2759777|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
2759778|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
2759779|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759780|NCT04516681|Protective Agents|protective agents|mesh-ancestor
2759781|NCT04516655|Rituximab|rituximab|mesh-list
2759782|NCT04516655|Methotrexate|methotrexate|mesh-list
2759783|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2759784|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759785|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
2759786|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759787|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2759788|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2759789|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
2759790|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2759791|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2759792|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
2759793|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759794|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
2759795|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759796|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2759797|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2759798|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2759799|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
2759800|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2759801|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2759802|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759803|NCT04516304|Equol|equol|mesh-list
2759804|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
2759805|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2759806|NCT04516304|Estrogens|estrogens|mesh-ancestor
2759807|NCT04516304|Hormones|hormones|mesh-ancestor
2759808|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2759809|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759810|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
2759811|NCT04516174|Ropivacaine|ropivacaine|mesh-list
2759812|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2759813|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2759814|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759815|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2759816|NCT04516174|Analgesics|analgesics|mesh-ancestor
2759817|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
2759818|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759819|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2759820|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2759821|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2759822|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
2759823|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2759824|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759825|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
2759826|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
2759827|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2759828|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759829|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2759830|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2759831|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759832|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
2759833|NCT04516148|Clindamycin|clindamycin|mesh-list
2759834|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
2759835|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
2263242|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263243|NCT00170404|Vitamins|vitamins|mesh-list
2263244|NCT00170404|Folic Acid|folic acid|mesh-list
2759836|NCT04516148|Cefazolin|cefazolin|mesh-list
2759837|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2759838|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759839|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2759840|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759841|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759842|NCT04516317|Artesunate|artesunate|mesh-list
2759843|NCT04516317|Quinine|quinine|mesh-list
2759844|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
2759845|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2759846|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2759847|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759848|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759849|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
2263245|NCT00170404|Vitamin A|vitamin a|mesh-list
2263246|NCT00170404|Thiamine|thiamine|mesh-list
2263247|NCT00170404|Selenium|selenium|mesh-list
2263248|NCT00170404|Micronutrients|micronutrients|mesh-list
2263249|NCT00170404|Trace Elements|trace elements|mesh-list
2263250|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759850|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
2759851|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2759852|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
2759853|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2759854|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759855|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2759856|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759857|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2759858|NCT04516317|Analgesics|analgesics|mesh-ancestor
2759859|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
2759860|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
2759861|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2759862|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2759863|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759864|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
2759865|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
2759866|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
2759867|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2759868|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2759869|NCT04515966|Prednisolone|prednisolone|mesh-list
2759870|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
2759871|NCT04515966|Lidocaine|lidocaine|mesh-list
2759872|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2759873|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
2759874|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
2759875|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
2759876|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2759877|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759878|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
2759879|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759880|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2759881|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2759882|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2759883|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2759884|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759885|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2759886|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
2759887|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
2759888|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2263251|NCT00170404|Hematinics|hematinics|mesh-ancestor
2263252|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
2263253|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
2263254|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263255|NCT00170404|Protective Agents|protective agents|mesh-ancestor
2263256|NCT00170430|Fluconazole|fluconazole|mesh-list
2263257|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
2263258|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2263259|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2263260|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2263261|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263262|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263263|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2263264|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
2263265|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2263266|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263267|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2263268|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2263269|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2263270|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2263271|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
2263272|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759889|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
2759890|NCT04515966|Hormones|hormones|mesh-ancestor
2759891|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2759892|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2759893|NCT04515966|Protective Agents|protective agents|mesh-ancestor
2759894|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2759895|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263273|NCT00170456|Antacids|antacids|mesh-ancestor
2263274|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263275|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2263276|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2263277|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2263278|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
2263279|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263280|NCT00170469|Antacids|antacids|mesh-ancestor
2263281|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263282|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2759906|NCT04515719|Belimumab|belimumab|mesh-list
2759907|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2759908|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
2759909|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759910|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
2759911|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2759912|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759913|NCT04515836|Olaparib|olaparib|mesh-list
2759914|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2759915|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759916|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759917|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759918|NCT04515368|Vaccines|vaccines|mesh-list
2759919|NCT04515368|Immunologic Factors|immunologic factors|mesh-ancestor
2759920|NCT04515368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759921|NCT04515732|Apremilast|apremilast|mesh-list
2759922|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2759923|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2759924|NCT04515732|Analgesics|analgesics|mesh-ancestor
2759925|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
2759926|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759927|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759928|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2759929|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2759930|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2759931|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2759932|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759933|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759934|NCT04515420|Norepinephrine|norepinephrine|mesh-list
2759935|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2759936|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2759937|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
2759938|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2759939|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759940|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759941|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
2759942|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
2759943|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759944|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2759945|NCT04515641|Islatravir|islatravir|mesh-list
2759946|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
2759947|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2759948|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759949|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759950|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2759951|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2759952|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2759953|NCT04515576|Dulaglutide|dulaglutide|mesh-list
2759954|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2759955|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759956|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2759957|NCT04515628|Branebrutinib|branebrutinib|mesh-list
2759958|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2263283|NCT00170547|Vaccines|vaccines|mesh-list
2759959|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2759960|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
2759961|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759962|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2759963|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2759964|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759965|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2759966|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
2759967|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789288|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2789289|NCT04303390|Cefazolin|cefazolin|mesh-list
2789290|NCT04303390|Cefuroxime|cefuroxime|mesh-list
2789291|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
2789292|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2789293|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789294|NCT04303377|Evolocumab|evolocumab|mesh-list
2789295|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2789296|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2789297|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
2789298|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789299|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2789300|NCT04303312|Benzydamine|benzydamine|mesh-list
2789301|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2789302|NCT04303494|Vaccines|vaccines|mesh-list
2789303|NCT04303494|Immunologic Factors|immunologic factors|mesh-ancestor
2789304|NCT04303494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789305|NCT04303403|Trametinib|trametinib|mesh-list
2789306|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789307|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2789308|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789309|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263284|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
2263285|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263286|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2263287|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2263288|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263289|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2263290|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
2263291|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263292|NCT00170664|Paclitaxel|paclitaxel|mesh-list
2263293|NCT00170664|Carboplatin|carboplatin|mesh-list
2263294|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2789320|NCT04303429|Capecitabine|capecitabine|mesh-list
2789321|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2789322|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
2789323|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789324|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789325|NCT04303598|Tenofovir|tenofovir|mesh-list
2789326|NCT04303598|Lamivudine|lamivudine|mesh-list
2789327|NCT04303598|Efavirenz|efavirenz|mesh-list
2789328|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
2789329|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789330|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2789331|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2789332|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789333|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789334|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2789335|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2789336|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2789337|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2789338|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2789339|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2759971|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2759972|NCT04515238|Venetoclax|venetoclax|mesh-list
2759973|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
2759974|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
2759975|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2759976|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
2759977|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759978|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759979|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2759980|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2263295|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263296|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
2263297|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
2759981|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2759982|NCT04514835|Capecitabine|capecitabine|mesh-list
2759983|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2759984|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2759985|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
2759986|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2759987|NCT04514770|Misoprostol|misoprostol|mesh-list
2759988|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2759989|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
2759990|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2759991|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2759992|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2759993|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2759994|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
2759995|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
2759996|NCT04514731|Analgesics|analgesics|mesh-ancestor
2759997|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
2759998|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2759999|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760000|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
2760001|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760002|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2760003|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
2760004|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2760005|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2760006|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760007|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2760008|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
2760009|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2760010|NCT04514796|Adalimumab|adalimumab|mesh-list
2760011|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2760012|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2760013|NCT04514692|Lenograstim|lenograstim|mesh-list
2760014|NCT04514692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2760015|NCT04514692|Immunologic Factors|immunologic factors|mesh-ancestor
2760016|NCT04514692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760017|NCT04514419|Docetaxel|docetaxel|mesh-list
2760018|NCT04514419|Trastuzumab|trastuzumab|mesh-list
2760019|NCT04514419|Pertuzumab|pertuzumab|mesh-list
2760020|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760021|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
2760022|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
2760023|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
2263298|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
2263299|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263300|NCT00170677|Topotecan|topotecan|mesh-list
2263301|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2263302|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2263303|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263304|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263305|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263306|NCT00170690|Treosulfan|treosulfan|mesh-list
2263307|NCT00170690|Busulfan|busulfan|mesh-list
2263308|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2263309|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
2263310|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263311|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263312|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2263313|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
2263314|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263315|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2760024|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101413|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101414|NCT02389829|Analgesics|analgesics|mesh-ancestor
2101415|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
2101416|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101417|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2101418|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2101419|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
2101420|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
2101421|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
2101422|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
2263316|NCT00170729|Prednisolone|prednisolone|mesh-list
2263317|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2263318|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
2263319|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2263320|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
2263321|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2263322|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
2263323|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263324|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
2263325|NCT00170729|Hormones|hormones|mesh-ancestor
2760025|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2760026|NCT04514588|Caffeine|caffeine|mesh-list
2760027|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2760028|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760029|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2760030|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760031|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760032|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2760033|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2760034|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
2760035|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2760036|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2760037|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2760038|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760039|NCT04514094|Fluorides|fluorides|mesh-list
2760040|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
2760041|NCT04514094|Protective Agents|protective agents|mesh-ancestor
2760042|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760043|NCT04514211|Propofol|propofol|mesh-list
2760044|NCT04514211|Sevoflurane|sevoflurane|mesh-list
2760045|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2760046|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760047|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760048|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2760049|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
2760050|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
2760051|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2760052|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2760053|NCT04514393|Methotrexate|methotrexate|mesh-list
2760054|NCT04514393|Temozolomide|temozolomide|mesh-list
2760055|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2760056|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
2760057|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2760058|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760059|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2760060|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
2760061|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760062|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760063|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
2760064|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760065|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2760066|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2760067|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
2760068|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2760069|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2760070|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2760071|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
2760072|NCT04514029|Dexamethasone|dexamethasone|mesh-list
2760073|NCT04514029|Simvastatin|simvastatin|mesh-list
2760074|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2760075|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
2760076|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
2760077|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263326|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793066|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
2101423|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2760078|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760079|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2760080|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
2760081|NCT04514029|Hormones|hormones|mesh-ancestor
2760082|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2760083|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2760084|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760085|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2760086|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2760087|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
2760088|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760089|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2760090|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2760091|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760092|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2760093|NCT04514081|Decitabine|decitabine|mesh-list
2760094|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2760095|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
2760096|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760097|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760098|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760101|NCT04513821|Ethanol|ethanol|mesh-list
2760102|NCT04513821|Minocycline|minocycline|mesh-list
2760103|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2760104|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2760105|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760106|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760107|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2760108|NCT04513808|Anesthetics|anesthetics|mesh-list
2760109|NCT04513808|Propofol|propofol|mesh-list
2760110|NCT04513808|Sevoflurane|sevoflurane|mesh-list
2760111|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760112|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760113|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2760114|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2760115|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
2760116|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2760117|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2760118|NCT04513652|Carticaine|carticaine|mesh-list
2760119|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
2760120|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
2760121|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760122|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760123|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
2760124|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760125|NCT04513639|Dexamethasone|dexamethasone|mesh-list
2760126|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
2760127|NCT04513639|Daratumumab|daratumumab|mesh-list
2760128|NCT04513639|BB 1101|bb 1101|mesh-list
2760129|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2760130|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2760131|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
2760132|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
2760133|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760134|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760135|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2760136|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
2760137|NCT04513639|Hormones|hormones|mesh-ancestor
2760138|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2760139|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2760140|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760141|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
2760142|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760143|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760144|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
2760145|NCT04513509|Propranolol|propranolol|mesh-list
2760146|NCT04513509|Metoprolol|metoprolol|mesh-list
2760147|NCT04513509|Digoxin|digoxin|mesh-list
2760148|NCT04513509|Atenolol|atenolol|mesh-list
2760149|NCT04513509|Verapamil|verapamil|mesh-list
2760150|NCT04513509|Nebivolol|nebivolol|mesh-list
2760151|NCT04513509|Diltiazem|diltiazem|mesh-list
2760152|NCT04513509|Bisoprolol|bisoprolol|mesh-list
2760153|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2760154|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2760155|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
2263327|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263328|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2263329|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263330|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
2263331|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
2263332|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263333|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2263334|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2263335|NCT00170729|Protective Agents|protective agents|mesh-ancestor
2263336|NCT00170742|Octreotide|octreotide|mesh-list
2263337|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2263338|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2263339|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263340|NCT00170755|Darifenacin|darifenacin|mesh-list
2263341|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2263342|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2263343|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
2263344|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2760156|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2760157|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760158|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760159|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2760160|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2760161|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
2760162|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
2263345|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263346|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263347|NCT00170755|Urological Agents|urological agents|mesh-ancestor
2263348|NCT00170768|Oxybutynin|oxybutynin|mesh-list
2263349|NCT00170768|Darifenacin|darifenacin|mesh-list
2263350|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
2263351|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
2263352|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760163|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
2760164|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760165|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2760166|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2760167|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760168|NCT04513509|Protective Agents|protective agents|mesh-ancestor
2760169|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2760170|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2760171|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2263353|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263354|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2263355|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2263356|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
2263357|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263358|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263359|NCT00170768|Urological Agents|urological agents|mesh-ancestor
2263360|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
2263361|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2263362|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2263363|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263364|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263365|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2263366|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2263367|NCT00170781|Analgesics|analgesics|mesh-ancestor
2263368|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
2263369|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263370|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263371|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263372|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2263373|NCT00170794|Everolimus|everolimus|mesh-list
2263374|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263375|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2263376|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
2263377|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263378|NCT00170820|Everolimus|everolimus|mesh-list
2263379|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760172|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2760173|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263380|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2263381|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
2263382|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263383|NCT00170833|Everolimus|everolimus|mesh-list
2760174|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2760175|NCT04513717|Prednisone|prednisone|mesh-list
2760176|NCT04513717|Cortisone|cortisone|mesh-list
2760177|NCT04513717|Leuprolide|leuprolide|mesh-list
2760178|NCT04513717|Goserelin|goserelin|mesh-list
2760179|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2760180|NCT04513717|Flutamide|flutamide|mesh-list
2760181|NCT04513717|Abiraterone Acetate|abiraterone acetate|mesh-list
2760182|NCT04513717|Bicalutamide|bicalutamide|mesh-list
2760183|NCT04513717|Tryptophan|tryptophan|mesh-list
2760184|NCT04513717|Buserelin|buserelin|mesh-list
2760185|NCT04513717|Hormones|hormones|mesh-list
2760186|NCT04513717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2760187|NCT04513717|Glucocorticoids|glucocorticoids|mesh-ancestor
2760188|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2760189|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760190|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2760191|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760192|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2760193|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
2760194|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2760195|NCT04513717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2760196|NCT04513717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760197|NCT04513717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760198|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
2760199|NCT04513717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2760200|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
2760201|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
2760202|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2760203|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
2760204|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2760205|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2760206|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
2760207|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2760208|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
2760209|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2263384|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263385|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2263386|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
2263387|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263388|NCT00170859|Everolimus|everolimus|mesh-list
2263389|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263390|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2263391|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
2760210|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2760211|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
2760212|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2760213|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2760214|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2760215|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760216|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760217|NCT04513457|Liver Extracts|liver extracts|mesh-list
2760218|NCT04513457|Hematinics|hematinics|mesh-ancestor
2760219|NCT04513340|Levodopa|levodopa|mesh-list
2760220|NCT04513340|Carbidopa|carbidopa|mesh-list
2760221|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2760222|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2760223|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
2760224|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2760225|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760226|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760227|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2760228|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789340|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2789341|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2789342|NCT04302870|Memantine|memantine|mesh-list
2789343|NCT04302870|Trazodone|trazodone|mesh-list
2789344|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2789345|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2789346|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2789347|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
2789348|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2789349|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789350|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793067|NCT04273282|Hormones|hormones|mesh-ancestor
2263392|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263393|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
2760229|NCT04513522|Nivolumab|nivolumab|mesh-list
2760230|NCT04513522|Ipilimumab|ipilimumab|mesh-list
2760231|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2760232|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760233|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2760234|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760235|NCT04513379|Efavirenz|efavirenz|mesh-list
2760236|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2760237|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2760238|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760239|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760240|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
2760241|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2760242|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2760243|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2760244|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2760245|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2760246|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2760247|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2760248|NCT04513015|Antioxidants|antioxidants|mesh-list
2760249|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760250|NCT04513015|Protective Agents|protective agents|mesh-ancestor
2760251|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760252|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
2760253|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2760254|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760255|NCT04513184|Dexamethasone|dexamethasone|mesh-list
2760256|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
2760257|NCT04513184|BB 1101|bb 1101|mesh-list
2760258|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2760259|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
2263394|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2263395|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2263396|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263397|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263398|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2263399|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2263400|NCT00170872|Analgesics|analgesics|mesh-ancestor
2263401|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
2263402|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263403|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263404|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263405|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2263406|NCT00170885|Everolimus|everolimus|mesh-list
2263407|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263408|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2263409|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
2263410|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263411|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
2263412|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2263413|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2263414|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263415|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263416|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2760260|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
2760261|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760262|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760263|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2760264|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
2760265|NCT04513184|Hormones|hormones|mesh-ancestor
2760266|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2760267|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2760268|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760269|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
2760270|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760271|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760272|NCT04513145|Ropivacaine|ropivacaine|mesh-list
2760273|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
2760274|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
2760275|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760276|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263417|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2760277|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
2760278|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760279|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2760280|NCT04512872|Denosumab|denosumab|mesh-list
2760281|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2760282|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760283|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2760284|NCT04512638|Amoxicillin|amoxicillin|mesh-list
2760285|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
2760286|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2760287|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2760288|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2760289|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
2760290|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
2760291|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2760292|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2760293|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2760294|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
2760295|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760296|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760297|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2760298|NCT04512313|Rocuronium|rocuronium|mesh-list
2760299|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2760300|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2760301|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2760302|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263418|NCT00170898|Analgesics|analgesics|mesh-ancestor
2263419|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
2263420|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263421|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263422|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263423|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2760303|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760312|NCT04512105|Venetoclax|venetoclax|mesh-list
2760313|NCT04512105|Pitavastatin|pitavastatin|mesh-list
2760314|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760315|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2760316|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2760317|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2760318|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
2760319|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760320|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263424|NCT00170924|Valsartan|valsartan|mesh-list
2263425|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263426|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263427|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263428|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263429|NCT00170937|Valsartan|valsartan|mesh-list
2263430|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2263431|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2760321|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2760322|NCT04512365|Dronabinol|dronabinol|mesh-list
2760323|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
2760324|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760325|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2760326|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2760327|NCT04512365|Analgesics|analgesics|mesh-ancestor
2760328|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
2760329|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760330|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2760331|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2760332|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2760333|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760334|NCT04512365|Hormones|hormones|mesh-ancestor
2760335|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2760347|NCT04511975|Azacitidine|azacitidine|mesh-list
2760348|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2760349|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
2760350|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760351|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760352|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760353|NCT04511702|Methotrexate|methotrexate|mesh-list
2760354|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2760355|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
2760356|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2760357|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760358|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2760359|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
2760360|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760361|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760362|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
2760363|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263432|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263433|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263434|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263435|NCT00170937|Diuretics|diuretics|mesh-ancestor
2263436|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
2263437|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760364|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2760365|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2760366|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
2760367|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2760368|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2760369|NCT04511832|Diclofenac|diclofenac|mesh-list
2760370|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2760371|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2760372|NCT04511832|Analgesics|analgesics|mesh-ancestor
2760373|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
2760374|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760375|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760376|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2760377|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2760378|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2760379|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760380|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760381|NCT04511715|Bevacizumab|bevacizumab|mesh-list
2760382|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2760383|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760384|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2760385|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2760386|NCT04511715|Growth Substances|growth substances|mesh-ancestor
2760387|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760388|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
2760389|NCT04511897|Expectorants|expectorants|mesh-list
2760390|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
2789351|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2789352|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2789353|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2789354|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2789355|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789356|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2789357|NCT04302870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2789358|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2789359|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2789360|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
2789361|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2101424|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2101425|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
2263438|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2263439|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263440|NCT00170963|Amlodipine|amlodipine|mesh-list
2263441|NCT00170963|Valsartan|valsartan|mesh-list
2263442|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263443|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2263444|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263445|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263446|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2263447|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263448|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
2263449|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263450|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263451|NCT00170976|Amlodipine|amlodipine|mesh-list
2263452|NCT00170976|Valsartan|valsartan|mesh-list
2263453|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263454|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2263455|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263456|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263457|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2263458|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263459|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
2263460|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263461|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263462|NCT00170989|Valsartan|valsartan|mesh-list
2263463|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2263464|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263465|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263466|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263467|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263468|NCT00170989|Diuretics|diuretics|mesh-ancestor
2263469|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
2263470|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263471|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2263472|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263473|NCT00171002|Amlodipine|amlodipine|mesh-list
2263474|NCT00171002|Valsartan|valsartan|mesh-list
2263475|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263476|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2263477|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263478|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263479|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2263480|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263481|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
2263482|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2760391|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2760392|NCT04511728|Propofol|propofol|mesh-list
2263483|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263484|NCT00171015|Valsartan|valsartan|mesh-list
2263485|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2263486|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263487|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263488|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263489|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263490|NCT00171015|Diuretics|diuretics|mesh-ancestor
2263491|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
2263492|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263493|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2263494|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263495|NCT00171028|Valsartan|valsartan|mesh-list
2263496|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263497|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2760393|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2760394|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760395|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760396|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2263498|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263499|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263500|NCT00171041|Valsartan|valsartan|mesh-list
2263501|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2760397|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
2760398|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
2760399|NCT04511923|Heparin|heparin|mesh-list
2760400|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
2760401|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2760402|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2760403|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760404|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
2760405|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2760406|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
2760407|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2760408|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
2760409|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760410|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760411|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
2760412|NCT04511468|Ascorbic Acid|ascorbic acid|mesh-list
2760413|NCT04511468|Copper|copper|mesh-list
2760414|NCT04511468|Chromium|chromium|mesh-list
2263502|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263503|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263504|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263505|NCT00171067|Valsartan|valsartan|mesh-list
2263506|NCT00171067|Lisinopril|lisinopril|mesh-list
2263507|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263508|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263509|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263510|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263511|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2263512|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
2263513|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263514|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2263515|NCT00171067|Protective Agents|protective agents|mesh-ancestor
2263516|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760415|NCT04511468|Vitamins|vitamins|mesh-ancestor
2760416|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
2760417|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760418|NCT04511468|Antioxidants|antioxidants|mesh-ancestor
2760419|NCT04511468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760420|NCT04511468|Protective Agents|protective agents|mesh-ancestor
2760421|NCT04511468|Trace Elements|trace elements|mesh-ancestor
2760422|NCT04511416|Metformin|metformin|mesh-list
2760423|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2760424|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760425|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
2760426|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2760427|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
2760428|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2760429|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
2760430|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263517|NCT00171080|Valsartan|valsartan|mesh-list
2263518|NCT00171080|Irbesartan|irbesartan|mesh-list
2263519|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263520|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263521|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263522|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263523|NCT00171093|Valsartan|valsartan|mesh-list
2263524|NCT00171093|Simvastatin|simvastatin|mesh-list
2263525|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2263526|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2263527|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
2263528|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263529|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2760431|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760432|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
2263530|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2263531|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263532|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263533|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2760442|NCT04511299|SMOFlipid|smoflipid|mesh-list
2760443|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2760444|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2760445|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2760455|NCT04511000|Atorvastatin|atorvastatin|mesh-list
2760456|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2760457|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2760458|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
2760459|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760460|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2760461|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2760462|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760463|NCT04510935|Anesthetics|anesthetics|mesh-list
2760464|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760465|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760466|NCT04510844|Evolocumab|evolocumab|mesh-list
2263534|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263535|NCT00171106|Valsartan|valsartan|mesh-list
2263536|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263537|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263538|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263539|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263540|NCT00171119|Valsartan|valsartan|mesh-list
2263541|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2760467|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2760468|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2760469|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
2760470|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760471|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2760472|NCT04511039|Trifluridine|trifluridine|mesh-list
2760473|NCT04511039|Talazoparib|talazoparib|mesh-list
2760474|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2760475|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760476|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760477|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760478|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
2760479|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
2760480|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2760481|NCT04511195|Diclofenac|diclofenac|mesh-list
2760482|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2760483|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2760484|NCT04511195|Analgesics|analgesics|mesh-ancestor
2760485|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
2760486|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760487|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760488|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2760489|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2760490|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2760491|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760492|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760493|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
2760494|NCT04510870|Hematinics|hematinics|mesh-ancestor
2760495|NCT04510922|Droxidopa|droxidopa|mesh-list
2760496|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2760497|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2760498|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2760499|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
2760500|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760501|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760502|NCT04510649|Rifampin|rifampin|mesh-list
2760503|NCT04510649|Rabeprazole|rabeprazole|mesh-list
2760504|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2760505|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2760506|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2760507|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760508|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760509|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2760510|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
2760511|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2760512|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2760513|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
2760514|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2760515|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2760516|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2760517|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2760518|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2760519|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2760520|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2760521|NCT04510818|Capecitabine|capecitabine|mesh-list
2760522|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2760523|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
2760524|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760525|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760533|NCT04510610|Decitabine|decitabine|mesh-list
2760534|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2760535|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
2760536|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760537|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760538|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760539|NCT04510662|Telmisartan|telmisartan|mesh-list
2760540|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2760541|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2760542|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2760543|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760544|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
2760545|NCT04510285|Trastuzumab|trastuzumab|mesh-list
2760546|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2760547|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760548|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
2263542|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263543|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263544|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263545|NCT00171132|Atenolol|atenolol|mesh-list
2263546|NCT00171132|Valsartan|valsartan|mesh-list
2263547|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2263548|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263549|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263550|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263551|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263552|NCT00171132|Diuretics|diuretics|mesh-ancestor
2263553|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
2263554|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263555|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2263556|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263557|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2263558|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
2263559|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
2263560|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263561|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2263562|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2263563|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2263564|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
2263565|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263566|NCT00171145|Darifenacin|darifenacin|mesh-list
2263567|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2263568|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2263569|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
2760549|NCT04510428|Antibodies|antibodies|mesh-list
2760550|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
2760551|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2101426|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
2101427|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102964|NCT02415959|Pancreatin|pancreatin|mesh-list
2760552|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2760553|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
2760554|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760555|NCT04510207|Vaccines|vaccines|mesh-list
2760556|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
2760557|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760558|NCT04510220|Ofatumumab|ofatumumab|mesh-list
2760559|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760560|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
2760561|NCT04510337|Rocuronium|rocuronium|mesh-list
2760562|NCT04510337|Analgesics|analgesics|mesh-ancestor
2760563|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
2760564|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760565|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760566|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
2760567|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760568|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2760569|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
2760570|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2760571|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2760572|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760573|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2760574|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
2760575|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2760576|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2760577|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2760578|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2760579|NCT04510233|Ivermectin|ivermectin|mesh-list
2760580|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2760581|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2760582|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
2760583|NCT04510051|Fludarabine|fludarabine|mesh-list
2760584|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2760585|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
2760586|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760587|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2760588|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2760589|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
2760590|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760591|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760592|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2760593|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
2760594|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2760595|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2760596|NCT04509973|Dexamethasone|dexamethasone|mesh-list
2760597|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2760598|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
2760599|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
2760600|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760601|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760602|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2760603|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
2760604|NCT04509973|Hormones|hormones|mesh-ancestor
2760605|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2760606|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2760607|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789362|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
2789363|NCT04302766|Remdesivir|remdesivir|mesh-list
2789364|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
2789365|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789366|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
2789367|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2263570|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263571|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263572|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263573|NCT00171145|Urological Agents|urological agents|mesh-ancestor
2263574|NCT00171171|Deferasirox|deferasirox|mesh-list
2263575|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2263576|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
2263577|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
2789368|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
2789369|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2263578|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263579|NCT00171184|Darifenacin|darifenacin|mesh-list
2760608|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
2760609|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
2760610|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760611|NCT04510038|Colchicine|colchicine|mesh-list
2760612|NCT04510038|Gout Suppressants|gout suppressants|mesh-ancestor
2760613|NCT04510038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2760614|NCT04510038|Tubulin Modulators|tubulin modulators|mesh-ancestor
2760615|NCT04510038|Antimitotic Agents|antimitotic agents|mesh-ancestor
2760616|NCT04510038|Mitosis Modulators|mitosis modulators|mesh-ancestor
2760617|NCT04510038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760618|NCT04510038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760619|NCT04509999|Bicalutamide|bicalutamide|mesh-list
2760620|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
2760621|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
2760622|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2760623|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760624|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760632|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
2760633|NCT04509466|Pegaspargase|pegaspargase|mesh-list
2760634|NCT04509466|Asparaginase|asparaginase|mesh-list
2760635|NCT04509466|Analgesics|analgesics|mesh-ancestor
2760636|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
2760637|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760638|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760639|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263580|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2263581|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2263582|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
2263583|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263584|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263585|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263586|NCT00171184|Urological Agents|urological agents|mesh-ancestor
2263587|NCT00171288|Ezetimibe|ezetimibe|mesh-list
2263588|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2263589|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2263590|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
2263591|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263592|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2263593|NCT00171327|Valsartan|valsartan|mesh-list
2263594|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263595|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2760640|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2760641|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2760642|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760643|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760644|NCT04509583|Vitamin E|vitamin e|mesh-list
2760645|NCT04509583|Vitamins|vitamins|mesh-ancestor
2760646|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
2760647|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760648|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
2760649|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760650|NCT04509583|Protective Agents|protective agents|mesh-ancestor
2760651|NCT04509622|Cytarabine|cytarabine|mesh-list
2760652|NCT04509622|Venetoclax|venetoclax|mesh-list
2760653|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2760654|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
2760655|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760656|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760657|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
2760658|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2760659|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2760660|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
2760661|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760662|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
2760663|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
2760664|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760665|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263596|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263597|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263598|NCT00171353|Valsartan|valsartan|mesh-list
2263599|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263600|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263601|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263602|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263603|NCT00171366|Amlodipine|amlodipine|mesh-list
2263604|NCT00171366|Benazepril|benazepril|mesh-list
2263605|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263606|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2263607|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263608|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263609|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2263610|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263611|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
2263612|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2760666|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2760667|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
2760668|NCT04509596|Capecitabine|capecitabine|mesh-list
2760669|NCT04509596|Trastuzumab|trastuzumab|mesh-list
2760670|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2760671|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
2760672|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760673|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760674|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2760675|NCT04509635|Cetuximab|cetuximab|mesh-list
2760676|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2760677|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263613|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
2263614|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760678|NCT04509440|Triamcinolone|triamcinolone|mesh-list
2760679|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2760680|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2263615|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
2263616|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2263617|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760681|NCT04509440|Anesthetics|anesthetics|mesh-list
2760682|NCT04509440|Mepivacaine|mepivacaine|mesh-list
2760683|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
2760684|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2760685|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760686|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760687|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2760688|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
2760689|NCT04509440|Hormones|hormones|mesh-ancestor
2760690|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2760691|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2263618|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2263619|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
2263620|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2263621|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2263622|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263623|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263624|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
2263625|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2263626|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263627|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2263628|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
2263629|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2263630|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2263631|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263632|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263633|NCT00171418|Tegaserod|tegaserod|mesh-list
2263634|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2263635|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
2263636|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263637|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263638|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263639|NCT00171431|Tegaserod|tegaserod|mesh-list
2263640|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2263641|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
2263642|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2760692|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
2760693|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760694|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760695|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
2760696|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760697|NCT04509414|Midazolam|midazolam|mesh-list
2760698|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
2760699|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2760700|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760701|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760702|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2760703|NCT04509414|Analgesics|analgesics|mesh-ancestor
2760704|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
2760705|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760706|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2760707|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2760708|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2760709|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
2760710|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2760711|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760712|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2760713|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2263643|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263644|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263645|NCT00171457|Tegaserod|tegaserod|mesh-list
2263646|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2263647|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
2263648|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263649|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263650|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263651|NCT00171470|Tegaserod|tegaserod|mesh-list
2263652|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2263653|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
2760714|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2760715|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2760716|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2760717|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
2760718|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
2760719|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
2760720|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
2760721|NCT04509336|Orphenadrine|orphenadrine|mesh-list
2760722|NCT04509336|Baclofen|baclofen|mesh-list
2760723|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2760724|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760725|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2760726|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760727|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2760728|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
2760729|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
2760730|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2760731|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760732|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2760733|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2263654|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263655|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263656|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263657|NCT00171483|Tegaserod|tegaserod|mesh-list
2263658|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2263659|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
2263660|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263661|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263662|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760734|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
2760735|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
2760736|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2760737|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2760738|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
2263663|NCT00171496|Cyclosporine|cyclosporine|mesh-list
2263664|NCT00171496|Tacrolimus|tacrolimus|mesh-list
2263665|NCT00171496|Cyclosporins|cyclosporins|mesh-list
2263666|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2263667|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
2263668|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263669|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2263670|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263671|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760739|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
2760740|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2760741|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760742|NCT04509401|Vitamins|vitamins|mesh-list
2760743|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
2760744|NCT04509401|Pyridoxal|pyridoxal|mesh-list
2760745|NCT04509401|Pyridoxine|pyridoxine|mesh-list
2760746|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
2760747|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
2760748|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760749|NCT04509102|Adderall|adderall|mesh-list
2760750|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2760751|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760752|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
2760753|NCT04509115|Narcotics|narcotics|mesh-ancestor
2760754|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760755|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760756|NCT04509115|Analgesics|analgesics|mesh-ancestor
2760757|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
2760758|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760759|NCT04509323|Huperzine A|huperzine a|mesh-list
2263672|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
2263673|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2263674|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
2263675|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2263676|NCT00171509|Cyclosporine|cyclosporine|mesh-list
2263677|NCT00171509|Cyclosporins|cyclosporins|mesh-list
2263678|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263679|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263680|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2263681|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
2263682|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263683|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
2263684|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2263685|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
2263686|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2760760|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2760761|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760762|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760763|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
2760764|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2760765|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760766|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2760767|NCT04509323|Protective Agents|protective agents|mesh-ancestor
2760768|NCT04508946|Ascorbic Acid|ascorbic acid|mesh-list
2760769|NCT04508946|Thiamine|thiamine|mesh-list
2760770|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
2760771|NCT04508946|Vitamins|vitamins|mesh-ancestor
2760772|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
2760773|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760774|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2760775|NCT04508946|Antioxidants|antioxidants|mesh-ancestor
2760776|NCT04508946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760777|NCT04508946|Protective Agents|protective agents|mesh-ancestor
2760778|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
2760779|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
2760780|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2760781|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2760782|NCT04509219|Prednisolone|prednisolone|mesh-list
2760783|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
2760784|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2760785|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
2760786|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2760787|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
2760788|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
2760789|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760790|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760791|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2760792|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
2760793|NCT04509219|Hormones|hormones|mesh-ancestor
2760794|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2760795|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2760796|NCT04509219|Protective Agents|protective agents|mesh-ancestor
2760797|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2760798|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760799|NCT04509232|Fluorides|fluorides|mesh-list
2760800|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
2760801|NCT04509232|Protective Agents|protective agents|mesh-ancestor
2760802|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760803|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
2760804|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
2760805|NCT04509258|Ondansetron|ondansetron|mesh-list
2263687|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2263688|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2263689|NCT00171522|Tegaserod|tegaserod|mesh-list
2263690|NCT00171522|Laxatives|laxatives|mesh-ancestor
2263691|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2263692|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2263693|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
2263694|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263695|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263696|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760806|NCT04509258|Mineral Oil|mineral oil|mesh-list
2760807|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2760808|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
2760809|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
2760810|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760811|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760812|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2760813|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
2760814|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
2760815|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2760816|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
2760817|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2760818|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760819|NCT04509258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2760820|NCT04509258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2760821|NCT04509258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760822|NCT04509258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2760823|NCT04509258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2760824|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
2760825|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2760826|NCT04509258|Expectorants|expectorants|mesh-ancestor
2760827|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
2760828|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2760829|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
2760830|NCT04509258|Protective Agents|protective agents|mesh-ancestor
2760831|NCT04509258|Antidotes|antidotes|mesh-ancestor
2760832|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
2760833|NCT04509258|Vitamins|vitamins|mesh-ancestor
2760834|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
2760835|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
2760836|NCT04509258|Emollients|emollients|mesh-ancestor
2760837|NCT04509193|Warfarin|warfarin|mesh-list
2760838|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
2760839|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
2760840|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2760841|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
2760842|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2760843|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
2760844|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760845|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760846|NCT04508803|Trastuzumab|trastuzumab|mesh-list
2760847|NCT04508803|Niraparib|niraparib|mesh-list
2760848|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2760849|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760850|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2760851|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760852|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760853|NCT04508829|Cetuximab|cetuximab|mesh-list
2760854|NCT04508829|Antibodies|antibodies|mesh-list
2760855|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2760856|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
2760857|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760858|NCT04508829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2760859|NCT04508829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760860|NCT04508816|Cetuximab|cetuximab|mesh-list
2760861|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
2760862|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2263697|NCT00171535|Amlodipine|amlodipine|mesh-list
2760863|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760864|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
2760865|NCT04508894|Ketamine|ketamine|mesh-list
2760866|NCT04508894|Bupivacaine|bupivacaine|mesh-list
2760867|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
2760868|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
2760869|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760870|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760871|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
2760872|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760873|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2760874|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2760875|NCT04508894|Analgesics|analgesics|mesh-ancestor
2263698|NCT00171535|Valsartan|valsartan|mesh-list
2263699|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263700|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2263701|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2760876|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2760877|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2760878|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2760879|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
2760880|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2760881|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760882|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2760883|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2760884|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
2760885|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2760886|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2760890|NCT04508686|Capecitabine|capecitabine|mesh-list
2760891|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2760892|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
2760893|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760894|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263702|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789370|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789371|NCT04303130|Endostar protein|endostar protein|mesh-list
2789372|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2789373|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2789374|NCT04303130|Growth Substances|growth substances|mesh-ancestor
2789375|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789376|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
2789377|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789378|NCT04303065|Dexamethasone|dexamethasone|mesh-list
2789379|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2789380|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
2789381|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
2789382|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789383|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789384|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2789385|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
2789386|NCT04303065|Hormones|hormones|mesh-ancestor
2760922|NCT04508439|Heparin|heparin|mesh-list
2760923|NCT04508439|Enoxaparin|enoxaparin|mesh-list
2760924|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2760925|NCT04508439|Tinzaparin|tinzaparin|mesh-list
2760926|NCT04508439|Dalteparin|dalteparin|mesh-list
2760927|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
2760928|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2760929|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2760930|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760931|NCT04508400|Dexamethasone|dexamethasone|mesh-list
2760932|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
2760933|NCT04508400|Ondansetron|ondansetron|mesh-list
2760934|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
2263703|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2263704|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263705|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
2263706|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263707|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263708|NCT00171561|Valsartan|valsartan|mesh-list
2263709|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2263710|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263711|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263712|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2760935|NCT04508400|Aprepitant|aprepitant|mesh-list
2760936|NCT04508400|BB 1101|bb 1101|mesh-list
2760937|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2760938|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
2760939|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
2760940|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760941|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760942|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2760943|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
2760944|NCT04508400|Hormones|hormones|mesh-ancestor
2760945|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2760946|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2760947|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760948|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
2760949|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760950|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760951|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
2760952|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
2760953|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2760954|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
2760955|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2760956|NCT04508400|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2760957|NCT04508400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2760958|NCT04508400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760959|NCT04508400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2760960|NCT04508400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2760961|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2760962|NCT04508452|Bevacizumab|bevacizumab|mesh-list
2760963|NCT04508452|Capecitabine|capecitabine|mesh-list
2760964|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
2760965|NCT04508452|Irinotecan|irinotecan|mesh-list
2760966|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2760967|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2760968|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2760969|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2760970|NCT04508452|Growth Substances|growth substances|mesh-ancestor
2760971|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760972|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
2760973|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2760974|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
2760975|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760976|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2760977|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2760978|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760979|NCT04508504|Ropivacaine|ropivacaine|mesh-list
2760980|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
2760981|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
2760982|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760983|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760984|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
2760985|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2760986|NCT04508855|Heparin|heparin|mesh-list
2760987|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2760988|NCT04508855|Tinzaparin|tinzaparin|mesh-list
2263713|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263714|NCT00171561|Diuretics|diuretics|mesh-ancestor
2263715|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
2263716|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263717|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2263718|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263719|NCT00171574|Valsartan|valsartan|mesh-list
2263720|NCT00171574|Lisinopril|lisinopril|mesh-list
2263721|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263722|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263723|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263724|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263725|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2263726|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
2263727|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263728|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2263729|NCT00171574|Protective Agents|protective agents|mesh-ancestor
2263730|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263731|NCT00171587|Vatalanib|vatalanib|mesh-list
2263732|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2263733|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2760989|NCT04508855|Dalteparin|dalteparin|mesh-list
2760990|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
2760991|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2760992|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2760993|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2760994|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
2760995|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
2760996|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2760997|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2760998|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2760999|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2761000|NCT04508166|Analgesics|analgesics|mesh-ancestor
2761001|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
2761002|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761003|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2761004|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2761005|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2761006|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
2761007|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2761008|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761009|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2761010|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2761011|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
2761012|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
2761013|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
2761014|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2761015|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761016|NCT04508244|Propranolol|propranolol|mesh-list
2761017|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2761018|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2761019|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
2761020|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2761021|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761022|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761023|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2761024|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2761025|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
2761026|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
2761027|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2761028|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2761029|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761030|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
2761031|NCT04508036|Coagulants|coagulants|mesh-ancestor
2761032|NCT04507906|Nivolumab|nivolumab|mesh-list
2761033|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2761034|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761035|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2761036|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761037|NCT04508231|Hormones|hormones|mesh-list
2761038|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2761039|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761040|NCT04507919|Dabrafenib|dabrafenib|mesh-list
2761041|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761042|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2761043|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761044|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761045|NCT04507607|Tenofovir|tenofovir|mesh-list
2761046|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
2761047|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761048|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2761049|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2761050|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761051|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761052|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2761053|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2761054|NCT04507477|Rituximab|rituximab|mesh-list
2761055|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2761056|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761057|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
2761058|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761059|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2761060|NCT04507750|Apatinib|apatinib|mesh-list
2761061|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761062|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2761063|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761064|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761065|NCT04507503|Futibatinib|futibatinib|mesh-list
2761066|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761067|NCT04507412|Dexamethasone|dexamethasone|mesh-list
2761068|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263734|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263735|NCT00171600|Valsartan|valsartan|mesh-list
2263736|NCT00171600|Lisinopril|lisinopril|mesh-list
2263737|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263738|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263739|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263740|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761069|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
2761070|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
2761071|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761072|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761073|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2761074|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
2761075|NCT04507412|Hormones|hormones|mesh-ancestor
2761076|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2761077|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2761078|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761087|NCT04507217|Carboplatin|carboplatin|mesh-list
2761088|NCT04507217|Pemetrexed|pemetrexed|mesh-list
2761089|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761090|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761091|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761092|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2761093|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2761094|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
2761095|NCT04507165|Anesthetics|anesthetics|mesh-list
2761096|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2761097|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761098|NCT04507165|Narcotics|narcotics|mesh-ancestor
2761099|NCT04507165|Analgesics|analgesics|mesh-ancestor
2761100|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
2761101|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761102|NCT04507178|Nadroparin|nadroparin|mesh-list
2761103|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
2761104|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2761105|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2761106|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761107|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
2761108|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2761109|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
2761110|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761111|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
2761112|NCT04506827|Protective Agents|protective agents|mesh-ancestor
2789387|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2789388|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2789389|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789400|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
2789401|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2789402|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
2789403|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789404|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2789405|NCT04302532|Ubiquinone|ubiquinone|mesh-list
2263741|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2263742|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
2263743|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263744|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2263745|NCT00171600|Protective Agents|protective agents|mesh-ancestor
2263746|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263747|NCT00171613|Octreotide|octreotide|mesh-list
2263748|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2263749|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2263750|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263751|NCT00171626|Diclofenac|diclofenac|mesh-list
2263752|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2789406|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
2789407|NCT04302532|Clomiphene|clomiphene|mesh-list
2789408|NCT04302532|Enclomiphene|enclomiphene|mesh-list
2789409|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
2789410|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2789411|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
2789412|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2789413|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789414|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2789415|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
2789416|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2789417|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2789418|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2789419|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
2789420|NCT04302532|Vitamins|vitamins|mesh-ancestor
2789421|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
2789422|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2789423|NCT04302402|Rifaximin|rifaximin|mesh-list
2789424|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2789425|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789426|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2789427|NCT04302441|Capecitabine|capecitabine|mesh-list
2789428|NCT04302441|Vinorelbine|vinorelbine|mesh-list
2789429|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2789430|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
2789431|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789432|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789433|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2789434|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
2789435|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
2263753|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2263754|NCT00171626|Analgesics|analgesics|mesh-ancestor
2263755|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
2263756|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263757|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263758|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263759|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2263760|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2263761|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789436|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
2263762|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761113|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2761114|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2761115|NCT04507022|Estradiol|estradiol|mesh-list
2761116|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2761117|NCT04507022|Progesterone|progesterone|mesh-list
2761118|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2761119|NCT04507022|Estrogens|estrogens|mesh-ancestor
2761120|NCT04507022|Hormones|hormones|mesh-ancestor
2761121|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2761122|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761123|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2761124|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
2761125|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2761126|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2761127|NCT04507022|Progestins|progestins|mesh-ancestor
2761128|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2761129|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761130|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761131|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2761132|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
2761135|NCT04506554|Nivolumab|nivolumab|mesh-list
2263763|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
2263764|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2263765|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263766|NCT00171652|Diclofenac|diclofenac|mesh-list
2263767|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2263768|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2263769|NCT00171652|Analgesics|analgesics|mesh-ancestor
2263770|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
2263771|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263772|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263773|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263774|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2761136|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2761137|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761138|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2761139|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761140|NCT04507711|Palonosetron|palonosetron|mesh-list
2761141|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
2761142|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
2761143|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761144|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761145|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2761146|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2761147|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2761148|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
2761149|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2761150|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761151|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2761152|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2761153|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761154|NCT04506450|Anesthetics|anesthetics|mesh-list
2761155|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2761156|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263775|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2263776|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263777|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263778|NCT00171665|Diclofenac|diclofenac|mesh-list
2263779|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2263780|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2263781|NCT00171665|Analgesics|analgesics|mesh-ancestor
2263782|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
2263783|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263784|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263785|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263786|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2263787|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2263788|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263789|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263790|NCT00171678|Diclofenac|diclofenac|mesh-list
2761157|NCT04506034|Lidocaine|lidocaine|mesh-list
2761158|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
2761159|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
2761160|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2761161|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761162|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
2761163|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761164|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2761165|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2761166|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2761167|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2761168|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761173|NCT04506242|Apatinib|apatinib|mesh-list
2761174|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761175|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2761176|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761177|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761178|NCT04505930|Vaccines|vaccines|mesh-list
2761179|NCT04505930|Immunologic Factors|immunologic factors|mesh-ancestor
2761180|NCT04505930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761181|NCT04505904|Oxytocin|oxytocin|mesh-list
2761182|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
2761183|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2761184|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761185|NCT04505943|Isoniazid|isoniazid|mesh-list
2761186|NCT04505943|Misoprostol|misoprostol|mesh-list
2761187|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2761188|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
2761189|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2761190|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761191|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2761192|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2761193|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
2761194|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
2761195|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2761196|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761197|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2263791|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2263792|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2263793|NCT00171678|Analgesics|analgesics|mesh-ancestor
2263794|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
2263795|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263796|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263797|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263798|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2263799|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2263800|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263801|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263802|NCT00171691|Diclofenac|diclofenac|mesh-list
2263803|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2263804|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2263805|NCT00171691|Analgesics|analgesics|mesh-ancestor
2263806|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
2263807|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263808|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263809|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263810|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2263811|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2263812|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263813|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263814|NCT00171717|Cyclosporine|cyclosporine|mesh-list
2263815|NCT00171717|Cyclosporins|cyclosporins|mesh-list
2263816|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263817|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263818|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2263819|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
2263820|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263821|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
2263822|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761198|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2761199|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
2761200|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761201|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2761202|NCT04505566|Ketorolac|ketorolac|mesh-list
2761203|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2761204|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
2761205|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2761206|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2761207|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2761208|NCT04505566|Analgesics|analgesics|mesh-ancestor
2761209|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
2761210|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761211|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761212|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2761213|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2761214|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2761215|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761216|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761217|NCT04505995|Azacitidine|azacitidine|mesh-list
2761218|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
2761219|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2761220|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
2761221|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761222|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761223|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761224|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2761225|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2761226|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2761227|NCT04505514|Hematinics|hematinics|mesh-ancestor
2761228|NCT04505644|Lidocaine|lidocaine|mesh-list
2761229|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
2761230|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
2761231|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2761232|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761233|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
2761234|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761235|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2761236|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2761237|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2761238|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263823|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
2263824|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2263825|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2263826|NCT00171743|Cyclosporine|cyclosporine|mesh-list
2263827|NCT00171743|Cyclosporins|cyclosporins|mesh-list
2263828|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761239|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761240|NCT04505475|Hemostatics|hemostatics|mesh-list
2761241|NCT04505475|Coagulants|coagulants|mesh-ancestor
2761242|NCT04505800|Tryptophan|tryptophan|mesh-list
2761243|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2761244|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
2761245|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2761246|NCT04505917|Misoprostol|misoprostol|mesh-list
2761247|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2761248|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
2761249|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2761250|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761251|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2761252|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2761253|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
2101428|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101429|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2101430|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
2101431|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
2101432|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2101433|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2101434|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2101435|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2101436|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
2101437|NCT02389946|Sirolimus|sirolimus|mesh-list
2101438|NCT02389946|Everolimus|everolimus|mesh-list
2263829|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263830|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2761256|NCT04505592|Tenecteplase|tenecteplase|mesh-list
2761257|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2761258|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2761259|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761260|NCT04505683|Ertapenem|ertapenem|mesh-list
2761261|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2761262|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761263|NCT04505657|Celecoxib|celecoxib|mesh-list
2761264|NCT04505657|Lidocaine|lidocaine|mesh-list
2761265|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
2761266|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
2761267|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2761268|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761269|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
2761270|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761271|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2761272|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2761273|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2761274|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2761275|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761276|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2761277|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2761278|NCT04505657|Analgesics|analgesics|mesh-ancestor
2761279|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2761280|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2761281|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2761282|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2761283|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761284|NCT04505189|Psilocybin|psilocybin|mesh-list
2761285|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
2761286|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761287|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2761288|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
2761289|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2761290|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2761291|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761292|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
2761293|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
2761297|NCT04505410|Tofacitinib|tofacitinib|mesh-list
2761298|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2761299|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761300|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789437|NCT04302454|Leuprolide|leuprolide|mesh-list
2789438|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2789439|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
2789440|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2789441|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789442|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2789443|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789444|NCT04302675|Vaccines|vaccines|mesh-list
2789445|NCT04302675|Immunologic Factors|immunologic factors|mesh-ancestor
2789446|NCT04302675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789447|NCT04302584|Vasopressins|vasopressins|mesh-list
2789448|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
2789449|NCT04302584|Norepinephrine|norepinephrine|mesh-list
2789450|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2789451|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2789452|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
2789453|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2789454|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789455|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789456|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
2789457|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
2789458|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789459|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2789460|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
2789461|NCT04302584|Coagulants|coagulants|mesh-ancestor
2789462|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2789463|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
2789464|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
2789465|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2789466|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
2761312|NCT04505228|Atropine|atropine|mesh-list
2761313|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2761314|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2761315|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2761316|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
2761317|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761318|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263831|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
2263832|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263833|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
2263834|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101439|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101440|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2101441|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
2101442|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101443|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2101444|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101445|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2761319|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2761320|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
2761321|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
2761322|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
2761323|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2761324|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2761325|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
2761326|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2761327|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761328|NCT04505280|Lidocaine|lidocaine|mesh-list
2761329|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
2761330|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
2761331|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2761332|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761333|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
2761334|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761335|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2761336|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2761337|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2761338|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2761339|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761340|NCT04504877|Cannabidiol|cannabidiol|mesh-list
2761341|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
2761342|NCT04504864|Aspirin|aspirin|mesh-list
2761343|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2101446|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
2101447|NCT02389959|Bevacizumab|bevacizumab|mesh-list
2101448|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101449|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101450|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2101451|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2101452|NCT02389959|Growth Substances|growth substances|mesh-ancestor
2101453|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101454|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
2101455|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
2101456|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2101457|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2101458|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2101459|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
2101460|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101461|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101462|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2101463|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
2101464|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
2101465|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
2263835|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
2263836|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2263837|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2263838|NCT00171756|Atenolol|atenolol|mesh-list
2263839|NCT00171756|Valsartan|valsartan|mesh-list
2263840|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263841|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263842|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263843|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263844|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2263845|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
2263846|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
2101466|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2101467|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2101468|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
2101469|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101470|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101471|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
2101472|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2101473|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101474|NCT02390219|Ivacaftor|ivacaftor|mesh-list
2101475|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2101476|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2101477|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761344|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2761345|NCT04504864|Analgesics|analgesics|mesh-ancestor
2761346|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
2761347|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101478|NCT02391337|Digoxin|digoxin|mesh-list
2101479|NCT02391337|Bisoprolol|bisoprolol|mesh-list
2101480|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2101481|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2101482|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101483|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101484|NCT02391337|Protective Agents|protective agents|mesh-ancestor
2101485|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101486|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2761348|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761349|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2761350|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2761351|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2761352|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2761353|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761354|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2761355|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2761356|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761357|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
2761358|NCT04504851|Rifampin|rifampin|mesh-list
2761359|NCT04504851|Isoniazid|isoniazid|mesh-list
2761360|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
2761361|NCT04504851|Ethambutol|ethambutol|mesh-list
2761362|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2761363|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2761364|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2263847|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2263848|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263849|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2263850|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2263851|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2263852|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
2761365|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
2761366|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761367|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2761368|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2761369|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761370|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2761371|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
2761372|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2761373|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761374|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
2761375|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2761376|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2761377|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2263853|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263854|NCT00171769|Certoparin|certoparin|mesh-list
2263855|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
2263856|NCT00171782|Valsartan|valsartan|mesh-list
2761378|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2761379|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2761380|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2761381|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2761382|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2761383|NCT04504552|Avelumab|avelumab|mesh-list
2761384|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2761385|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761386|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2263857|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2263858|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2263859|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2263860|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263861|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263862|NCT00171782|Diuretics|diuretics|mesh-ancestor
2263863|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
2263864|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263865|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2263866|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2263867|NCT00171795|Rivastigmine|rivastigmine|mesh-list
2263868|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2263869|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263870|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263871|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
2263872|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2263873|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263874|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2263875|NCT00171795|Protective Agents|protective agents|mesh-ancestor
2761387|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2761388|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761389|NCT04504318|Enoxaparin|enoxaparin|mesh-list
2761390|NCT04504318|Apixaban|apixaban|mesh-list
2761391|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
2761392|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2761393|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2761394|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761395|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2761396|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
2761397|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2761398|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
2761399|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761400|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2761401|NCT04504123|Doxycycline|doxycycline|mesh-list
2761402|NCT04504123|Tetracycline|tetracycline|mesh-list
2761403|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761404|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
2761405|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2761406|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2761407|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2263876|NCT00171808|Letrozole|letrozole|mesh-list
2263877|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263878|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2263879|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2263880|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263881|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263882|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2263883|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
2263884|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2263885|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263886|NCT00171821|Deferasirox|deferasirox|mesh-list
2263887|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2761408|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761409|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761410|NCT04504045|Metformin|metformin|mesh-list
2761411|NCT04504045|Efavirenz|efavirenz|mesh-list
2761412|NCT04504045|Losartan|losartan|mesh-list
2761413|NCT04504045|Metoprolol|metoprolol|mesh-list
2761414|NCT04504045|Midazolam|midazolam|mesh-list
2761415|NCT04504045|Caffeine|caffeine|mesh-list
2761416|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2761417|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263888|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
2761418|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2263889|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
2263890|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263891|NCT00171847|Trastuzumab|trastuzumab|mesh-list
2263892|NCT00171847|Letrozole|letrozole|mesh-list
2263893|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2263894|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263895|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2263896|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2263897|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263898|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263899|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2263900|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
2263901|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2263902|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263903|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
2263904|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263905|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2761419|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2761420|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2761421|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2761422|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2761423|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2761424|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2761425|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
2761426|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
2761427|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
2761428|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
2761429|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2761430|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761431|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2761432|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2761433|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2761434|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2263906|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263907|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263908|NCT00171886|Octreotide|octreotide|mesh-list
2263909|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2263910|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2263911|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263912|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
2263913|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263914|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2263915|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263916|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263917|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
2263918|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263919|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2263920|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263921|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263922|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
2263923|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263924|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2263925|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263926|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263927|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
2263928|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2263929|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263930|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
2263931|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263932|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2263933|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263934|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263935|NCT00171990|Famciclovir|famciclovir|mesh-list
2263936|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
2263937|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2263938|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2761435|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2761436|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2761437|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761438|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2761439|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2761440|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
2761441|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2761442|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2263939|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2263940|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761443|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
2761444|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761445|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2263941|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
2263942|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2263943|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263944|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
2263945|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2263946|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263947|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
2761446|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2761447|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2761448|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2761449|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2761450|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2761451|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
2761452|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
2761453|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761454|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2761455|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2761456|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2761457|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
2761458|NCT04503915|Estrogens|estrogens|mesh-list
2761459|NCT04503915|Hormones|hormones|mesh-ancestor
2263948|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2263949|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263950|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
2761460|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2761461|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761462|NCT04504331|Tamoxifen|tamoxifen|mesh-list
2761463|NCT04504331|Infigratinib|infigratinib|mesh-list
2761464|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2761465|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
2761466|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2761467|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761468|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2761469|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761470|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2761471|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2761472|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2263951|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2263952|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263953|NCT00172068|Vitamin D|vitamin d|mesh-list
2761473|NCT04503967|Nivolumab|nivolumab|mesh-list
2761474|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2761475|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761476|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2761477|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761478|NCT04503850|Mirabegron|mirabegron|mesh-list
2761479|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
2761480|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2761481|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2761482|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2761483|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
2761484|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2761485|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761486|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761487|NCT04503850|Urological Agents|urological agents|mesh-ancestor
2761488|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2761489|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
2761490|NCT04503616|Abatacept|abatacept|mesh-list
2761491|NCT04503616|Tacrolimus|tacrolimus|mesh-list
2761492|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2761493|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
2761494|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761495|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2761496|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2761497|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
2761498|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761499|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761500|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2761501|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2761502|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761503|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2263954|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
2263955|NCT00172068|Calcium|calcium|mesh-list
2263956|NCT00172068|Vitamins|vitamins|mesh-ancestor
2263957|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
2263958|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263959|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2263960|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2263961|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
2263962|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2263963|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263964|NCT00172172|Calcium|calcium|mesh-list
2263965|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
2263966|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2263967|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263968|NCT00172302|Ascorbic Acid|ascorbic acid|mesh-list
2263969|NCT00172302|Vitamins|vitamins|mesh-ancestor
2263970|NCT00172302|Micronutrients|micronutrients|mesh-ancestor
2263971|NCT00172302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263972|NCT00172302|Antioxidants|antioxidants|mesh-ancestor
2263973|NCT00172302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263974|NCT00172302|Protective Agents|protective agents|mesh-ancestor
2263975|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
2263976|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263977|NCT00172367|Lycopene|lycopene|mesh-list
2263978|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2263979|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
2263980|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263981|NCT00172367|Protective Agents|protective agents|mesh-ancestor
2263982|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2263983|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2263984|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2101487|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
2101488|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
2101489|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101490|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2101491|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2101492|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2101493|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
2101494|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101495|NCT02391545|Rituximab|rituximab|mesh-list
2101496|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
2263985|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263986|NCT00172380|Docetaxel|docetaxel|mesh-list
2263987|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2263988|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
2761537|NCT04503993|Antibodies|antibodies|mesh-list
2761538|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
2761539|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
2761540|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761541|NCT04503694|Nivolumab|nivolumab|mesh-list
2761542|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2761543|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761544|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2761545|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789467|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
2789468|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789469|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789470|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2789471|NCT04302350|Analgesics|analgesics|mesh-ancestor
2789472|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
2789473|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792706|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792707|NCT04275960|Selitrectinib|selitrectinib|mesh-list
2263989|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
2263990|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
2263991|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263992|NCT00172419|Atorvastatin|atorvastatin|mesh-list
2263993|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2263994|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2263995|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
2263996|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2263997|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2263998|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2263999|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264000|NCT00172809|Interferons|interferons|mesh-list
2264001|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
2264002|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
2792708|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792709|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792710|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
2792711|NCT04275661|Ketamine|ketamine|mesh-list
2792712|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
2792713|NCT04275661|Analgesics|analgesics|mesh-ancestor
2792714|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
2792715|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792716|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792717|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2792718|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2792719|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
2792720|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
2792721|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264003|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2264004|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792722|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2792723|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2792724|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792725|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792726|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2264005|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
2264006|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264007|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
2264008|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264009|NCT00173667|Nifedipine|nifedipine|mesh-list
2264010|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2264011|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2264012|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264013|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2264014|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264015|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
2264016|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
2264017|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2264018|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
2264019|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2264020|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2264021|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2264022|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2264023|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264024|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
2264025|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2761546|NCT04503629|Rabeprazole|rabeprazole|mesh-list
2761547|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2761548|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2761549|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2761550|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761551|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761552|NCT04503460|Fluticasone|fluticasone|mesh-list
2761553|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2761554|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2761555|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2761556|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2761557|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
2761558|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761559|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761560|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2761561|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
2761562|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
2761563|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2761564|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2761565|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2761566|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2761567|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
2761568|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2761569|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761570|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
2761571|NCT04503460|Hormones|hormones|mesh-ancestor
2761572|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2761573|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
2761582|NCT04503252|Cefazolin|cefazolin|mesh-list
2761583|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2761584|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761585|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2761586|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2761587|NCT04503161|Estradiol|estradiol|mesh-list
2264026|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264027|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2264028|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264029|NCT00173862|Gemcitabine|gemcitabine|mesh-list
2264030|NCT00173862|Ifosfamide|ifosfamide|mesh-list
2264031|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2264032|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
2264033|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264034|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264035|NCT00173862|Antiviral Agents|antiviral agents|mesh-ancestor
2264036|NCT00173862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264037|NCT00173862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264038|NCT00173862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2264039|NCT00173862|Immunologic Factors|immunologic factors|mesh-ancestor
2264040|NCT00173862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264041|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2264042|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
2264043|NCT00173875|Gefitinib|gefitinib|mesh-list
2264044|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264045|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2264046|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761588|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2761589|NCT04503161|Estrogens|estrogens|mesh-ancestor
2761590|NCT04503161|Hormones|hormones|mesh-ancestor
2761591|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2761592|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761593|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2761594|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
2761595|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2761596|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2761597|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
2761598|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2761599|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761600|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
2761601|NCT04502771|Clotrimazole|clotrimazole|mesh-list
2761602|NCT04502771|Miconazole|miconazole|mesh-list
2761603|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761604|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2761605|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2761606|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2761607|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761608|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761609|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2761610|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
2761611|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2761612|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761613|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2761614|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2761615|NCT04502849|Vitamin E|vitamin e|mesh-list
2761616|NCT04502849|Tocopherols|tocopherols|mesh-list
2761617|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
2761618|NCT04502849|Vitamins|vitamins|mesh-ancestor
2761619|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
2761620|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761621|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
2761622|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761623|NCT04502849|Protective Agents|protective agents|mesh-ancestor
2761624|NCT04502667|Vitamin D|vitamin d|mesh-list
2761625|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
2761626|NCT04502667|Vitamins|vitamins|mesh-ancestor
2761627|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
2761628|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761629|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2761630|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2761631|NCT04502641|Docetaxel|docetaxel|mesh-list
2761632|NCT04502641|Fluorouracil|fluorouracil|mesh-list
2761633|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761634|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
2761635|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
2761636|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
2761637|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761638|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
2761639|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2761640|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2761641|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
2761642|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761643|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
2761644|NCT04502537|Hematinics|hematinics|mesh-ancestor
2761645|NCT04502589|Disulfiram|disulfiram|mesh-list
2761646|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2761647|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2761648|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761649|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761650|NCT04502602|Niraparib|niraparib|mesh-list
2761651|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2761652|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761653|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761654|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761655|NCT04502433|Poractant alfa|poractant alfa|mesh-list
2761656|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2761657|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
2761658|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
2761659|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2761660|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2761661|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2761662|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2761663|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761664|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
2761665|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2761666|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761667|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2264047|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264048|NCT00173888|Gemcitabine|gemcitabine|mesh-list
2264049|NCT00173888|Cisplatin|cisplatin|mesh-list
2264050|NCT00173888|Docetaxel|docetaxel|mesh-list
2264051|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264052|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2761668|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761678|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2761679|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2761680|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761683|NCT04502277|Fluconazole|fluconazole|mesh-list
2761684|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
2761685|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761686|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2761687|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2761688|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761689|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761690|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2761691|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
2761692|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2761693|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761694|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2761695|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2761696|NCT04502251|Naltrexone|naltrexone|mesh-list
2761697|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2761698|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2264053|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
2264054|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264055|NCT00173888|Antiviral Agents|antiviral agents|mesh-ancestor
2264056|NCT00173888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264057|NCT00173888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264058|NCT00173888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2264059|NCT00173888|Immunologic Factors|immunologic factors|mesh-ancestor
2264060|NCT00173888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264061|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
2264062|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
2761699|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761700|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
2761701|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761702|NCT04502017|Clopidogrel|clopidogrel|mesh-list
2761703|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2761704|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2761705|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2761706|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2761707|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
2761708|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2761709|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761710|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761711|NCT04501965|Azithromycin|azithromycin|mesh-list
2761712|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
2761713|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2761714|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761715|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
2761716|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2761717|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2761718|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761719|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761720|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2789474|NCT04302116|Prednisolone|prednisolone|mesh-list
2789475|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2264063|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
2761721|NCT04502095|Levofloxacin|levofloxacin|mesh-list
2761722|NCT04502095|Ofloxacin|ofloxacin|mesh-list
2761723|NCT04502095|Trimethoprim|trimethoprim|mesh-list
2761724|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2761725|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
2761726|NCT04502095|Clindamycin|clindamycin|mesh-list
2761727|NCT04502095|Ertapenem|ertapenem|mesh-list
2761728|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
2761729|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2761730|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761731|NCT04502095|Renal Agents|renal agents|mesh-ancestor
2761732|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2761733|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2761734|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2761735|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761736|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761737|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761738|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2761739|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2761740|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2761741|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
2761742|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2761743|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2761744|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2761745|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2761746|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2761747|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2761748|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761749|NCT04501900|Clopidogrel|clopidogrel|mesh-list
2761750|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2761751|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2761752|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2761753|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2761754|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
2761755|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2761756|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761757|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761758|NCT04501809|Misoprostol|misoprostol|mesh-list
2761759|NCT04501809|Oxytocin|oxytocin|mesh-list
2761760|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
2761761|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2761762|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761763|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2761764|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
2761765|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2761766|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2761767|NCT04501783|Favipiravir|favipiravir|mesh-list
2761768|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
2761769|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761770|NCT04501718|Etoposide|etoposide|mesh-list
2761771|NCT04501718|Temozolomide|temozolomide|mesh-list
2761772|NCT04501718|Apatinib|apatinib|mesh-list
2761773|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2761774|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761775|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2761776|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2761777|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761778|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761779|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2761780|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
2761781|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2761782|NCT04501523|Capecitabine|capecitabine|mesh-list
2761783|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2761784|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
2761785|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761786|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761787|NCT04501705|Apatinib|apatinib|mesh-list
2761788|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761789|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2761790|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761791|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761805|NCT04501224|Tenofovir|tenofovir|mesh-list
2761806|NCT04501224|Entecavir|entecavir|mesh-list
2761807|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
2761808|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761809|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2761810|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2761811|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761812|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761813|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2761814|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2761815|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
2761816|NCT04501289|Analgesics|analgesics|mesh-ancestor
2761817|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
2761818|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761819|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761820|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
2761821|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2761822|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2761823|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
2761824|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2761825|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2264064|NCT00173901|Ceftazidime|ceftazidime|mesh-list
2264065|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2264066|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264067|NCT00174174|Modafinil|modafinil|mesh-list
2264068|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2264069|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264070|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2264071|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2264072|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2264073|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264074|NCT00174200|Risperidone|risperidone|mesh-list
2264075|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2264076|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
2264077|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264078|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264079|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264080|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2264081|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2761826|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761827|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2761828|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
2761829|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2761830|NCT04501211|Granisetron|granisetron|mesh-list
2761831|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
2761832|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
2761833|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761834|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761835|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2761836|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2761837|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
2761838|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2761839|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761840|NCT04501380|Rifamycins|rifamycins|mesh-list
2761841|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
2761842|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2761843|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761844|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2761845|NCT04501367|Dexamethasone|dexamethasone|mesh-list
2761846|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
2761847|NCT04501367|Prednisone|prednisone|mesh-list
2761848|NCT04501367|BB 1101|bb 1101|mesh-list
2761849|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2101497|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101498|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101499|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
2761850|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
2761851|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
2101500|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101501|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2101502|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
2101503|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
2101504|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
2101505|NCT02391714|Povidone|povidone|mesh-list
2101506|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2101507|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101508|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
2101509|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
2761852|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761853|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761854|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2761855|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
2761856|NCT04501367|Hormones|hormones|mesh-ancestor
2761857|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2761858|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2761859|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761860|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
2761861|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761862|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761863|NCT04501107|Insulin|insulin|mesh-list
2761864|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2761865|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
2761866|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2761867|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761868|NCT04501250|Insulin|insulin|mesh-list
2761869|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2761870|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2761871|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761872|NCT04500899|Phenylephrine|phenylephrine|mesh-list
2761873|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2761874|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
2761875|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
2761876|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2761877|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761878|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
2761879|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2761880|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
2761881|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
2761882|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2761883|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2761884|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2761885|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
2761886|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2761887|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761888|NCT04500899|Protective Agents|protective agents|mesh-ancestor
2761889|NCT04500860|Tadalafil|tadalafil|mesh-list
2761890|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
2761891|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2761892|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2761893|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761894|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761895|NCT04500860|Urological Agents|urological agents|mesh-ancestor
2761896|NCT04501406|Pioglitazone|pioglitazone|mesh-list
2761897|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2761898|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761899|NCT04500808|Macitentan|macitentan|mesh-list
2761900|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2761901|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2761902|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761903|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2761904|NCT04500574|Latanoprost|latanoprost|mesh-list
2761905|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2761906|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2761907|NCT04500717|Carboplatin|carboplatin|mesh-list
2761908|NCT04500717|Pemetrexed|pemetrexed|mesh-list
2761909|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761910|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761911|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101510|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
2101511|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2761912|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2761913|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2264082|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264083|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2264084|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2264085|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
2264086|NCT00174226|Buspirone|buspirone|mesh-list
2264087|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2264088|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2264089|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2264090|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2264091|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264092|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
2264093|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264094|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264095|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2264096|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2264097|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264098|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2264099|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2264100|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
2761914|NCT04500496|Isoniazid|isoniazid|mesh-list
2761915|NCT04500496|Dinoprostone|dinoprostone|mesh-list
2761916|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
2761917|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2761918|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761919|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
2761920|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2761921|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761922|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2761923|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2761924|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
2761925|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761926|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2761927|NCT04500704|Carboplatin|carboplatin|mesh-list
2761928|NCT04500704|Pemetrexed|pemetrexed|mesh-list
2761929|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761930|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761931|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761932|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2761933|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2761934|NCT04500743|Leuprolide|leuprolide|mesh-list
2761935|NCT04500743|Dienogest|dienogest|mesh-list
2761936|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2761937|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
2761938|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2761939|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761940|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2761941|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761942|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2761943|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
2761944|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2761945|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2761946|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2761947|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2761948|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
2761949|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2761950|NCT04500522|Isoniazid|isoniazid|mesh-list
2761951|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
2761952|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2761953|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761954|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2761955|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2761956|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
2761957|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761958|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2264101|NCT00174239|Levodopa|levodopa|mesh-list
2264102|NCT00174239|Carbidopa|carbidopa|mesh-list
2264103|NCT00174239|Cabergoline|cabergoline|mesh-list
2264104|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2264105|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2264106|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
2264107|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264108|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264109|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264110|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2264111|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264112|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
2264113|NCT00174304|Amlodipine|amlodipine|mesh-list
2264114|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
2264115|NCT00174304|Atorvastatin|atorvastatin|mesh-list
2264116|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2264117|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2264118|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
2264119|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264120|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2264121|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2264122|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264123|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2264124|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2264125|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2264126|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2264127|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264128|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
2761974|NCT04500561|Gemcitabine|gemcitabine|mesh-list
2761975|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
2761976|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2761977|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
2761978|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2761979|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2761980|NCT04500561|Antiviral Agents|antiviral agents|mesh-ancestor
2761981|NCT04500561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761982|NCT04500561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2761983|NCT04500561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2264129|NCT00174317|Celecoxib|celecoxib|mesh-list
2264130|NCT00174317|Diclofenac|diclofenac|mesh-list
2264131|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2264132|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2264133|NCT00174317|Analgesics|analgesics|mesh-ancestor
2264134|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
2264135|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264136|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264137|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2264138|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2264139|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2761984|NCT04500561|Immunologic Factors|immunologic factors|mesh-ancestor
2761985|NCT04500561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761986|NCT04500236|Anesthetics|anesthetics|mesh-list
2761987|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2761988|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2761989|NCT04500275|Vancomycin|vancomycin|mesh-list
2761990|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2761991|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761992|NCT04500756|Metformin|metformin|mesh-list
2761993|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2761994|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789476|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
2789477|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2789478|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
2789479|NCT04302116|Vigabatrin|vigabatrin|mesh-list
2789480|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2789481|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
2789482|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2789483|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
2789484|NCT04302116|Hormones|hormones|mesh-ancestor
2789485|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2792727|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
2761995|NCT04499989|Isoniazid|isoniazid|mesh-list
2761996|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
2761997|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2761998|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2761999|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2762000|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2264140|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2264141|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264142|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762001|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
2762002|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762003|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2762004|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
2762005|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
2762006|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264143|NCT00174330|Amlodipine|amlodipine|mesh-list
2264144|NCT00174330|Atorvastatin|atorvastatin|mesh-list
2264145|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2264146|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2264147|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
2264148|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264149|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2264150|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2264151|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264152|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2264153|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2264154|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2264155|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2762019|NCT04500613|Dexamethasone|dexamethasone|mesh-list
2762020|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
2762021|NCT04500613|Bupivacaine|bupivacaine|mesh-list
2762022|NCT04500613|BB 1101|bb 1101|mesh-list
2762023|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2101512|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
2101513|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
2762024|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
2762025|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
2762026|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762027|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762028|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2762029|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
2762030|NCT04500613|Hormones|hormones|mesh-ancestor
2762031|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2762032|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2762033|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762034|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
2762035|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762036|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762037|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
2762038|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
2762039|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762040|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
2762041|NCT04500678|Metformin|metformin|mesh-list
2762042|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2762043|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762044|NCT04500002|Isoniazid|isoniazid|mesh-list
2762045|NCT04500002|Misoprostol|misoprostol|mesh-list
2762046|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2762047|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
2762048|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2762049|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762050|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2762051|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2101514|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101515|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101516|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2101517|NCT02391714|Analgesics|analgesics|mesh-ancestor
2101518|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
2101519|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101520|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
2101521|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2101522|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2762052|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
2762053|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
2762054|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2762055|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762056|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2762057|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2762058|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
2762059|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762060|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2762061|NCT04500158|Lidocaine|lidocaine|mesh-list
2762062|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
2762063|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
2762064|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762065|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762066|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
2762067|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762068|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2762069|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2762070|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2762071|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2762072|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762073|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
2762074|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2264156|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264157|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
2264158|NCT00174343|Exemestane|exemestane|mesh-list
2264159|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264160|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2762075|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762076|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2762077|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2762078|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
2762079|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762080|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2762081|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2762082|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762083|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
2762084|NCT04499950|Naltrexone|naltrexone|mesh-list
2762085|NCT04499950|Bupropion|bupropion|mesh-list
2762086|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2762087|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2762088|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762089|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
2762090|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762091|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2762092|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
2762093|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2762094|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2762095|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2762096|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2762097|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762098|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
2762099|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762100|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2762101|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2762102|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762103|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2762104|NCT04499898|Carvedilol|carvedilol|mesh-list
2762105|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2762106|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2762107|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
2762108|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762109|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762110|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762111|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2762112|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
2762113|NCT04499898|Protective Agents|protective agents|mesh-ancestor
2762114|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2762115|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2762116|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2762117|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
2264161|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2264162|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264163|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264164|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2264165|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
2264166|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2264167|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264168|NCT00174356|Paclitaxel|paclitaxel|mesh-list
2264169|NCT00174356|Carboplatin|carboplatin|mesh-list
2762118|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2762119|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2762120|NCT04499885|Mineral Oil|mineral oil|mesh-list
2762121|NCT04499885|Emollients|emollients|mesh-ancestor
2762122|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
2762123|NCT04499586|Irinotecan|irinotecan|mesh-list
2762124|NCT04499586|Raltitrexed|raltitrexed|mesh-list
2762125|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2762126|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2762127|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762128|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762129|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762130|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2762131|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
2762132|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2762133|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2762134|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2762135|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2762136|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
2762137|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264170|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2264171|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264172|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
2264173|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
2264174|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
2264175|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264176|NCT00174395|Eletriptan|eletriptan|mesh-list
2264177|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2264178|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
2264179|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264180|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264181|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762138|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2762139|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2762140|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762141|NCT04499573|Cytarabine|cytarabine|mesh-list
2762142|NCT04499573|Dexamethasone|dexamethasone|mesh-list
2762143|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
2762144|NCT04499573|Fludarabine|fludarabine|mesh-list
2762145|NCT04499573|Etoposide|etoposide|mesh-list
2762146|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2762147|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
2762148|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762149|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2762150|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2762151|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
2762152|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762153|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762154|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2762155|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2762156|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
2762157|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
2762158|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762159|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2762160|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
2264182|NCT00174434|Paclitaxel|paclitaxel|mesh-list
2762161|NCT04499573|Hormones|hormones|mesh-ancestor
2789486|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762162|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2762163|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2762164|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762165|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2762166|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
2762167|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2762168|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2762169|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2762170|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
2762171|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762172|NCT04499976|Misoprostol|misoprostol|mesh-list
2762173|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2762174|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
2762175|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2762176|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762177|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2762178|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2762179|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
2762180|NCT04499053|Durvalumab|durvalumab|mesh-list
2762181|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2762182|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762183|NCT04499118|Paclitaxel|paclitaxel|mesh-list
2762184|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2762185|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2762186|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762187|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
2762188|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
2762189|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
2762190|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762191|NCT04499313|Dexamethasone|dexamethasone|mesh-list
2762192|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
2762193|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2762194|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2762195|NCT04499313|Prednisolone|prednisolone|mesh-list
2762196|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
2762197|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2762198|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
2762199|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2762200|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
2762201|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
2762202|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762203|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762204|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2762205|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
2762206|NCT04499313|Hormones|hormones|mesh-ancestor
2762207|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2762208|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2762209|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762210|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2762211|NCT04499313|Protective Agents|protective agents|mesh-ancestor
2762212|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
2762213|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2264183|NCT00174434|Sunitinib|sunitinib|mesh-list
2264184|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2264185|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264186|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
2264187|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
2264188|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
2264189|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264190|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2264191|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2264192|NCT00174434|Growth Substances|growth substances|mesh-ancestor
2264193|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264194|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
2264195|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2264196|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264197|NCT00174473|Voriconazole|voriconazole|mesh-list
2264198|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
2264199|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264200|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2264201|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2264202|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264203|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762214|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
2264204|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2264205|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
2264206|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2264207|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762215|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2762216|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
2762217|NCT04499196|Hormones|hormones|mesh-ancestor
2762218|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2762219|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762220|NCT04499274|Ondansetron|ondansetron|mesh-list
2762221|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
2762222|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
2762223|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762224|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762225|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2762226|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
2762227|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
2762228|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2762229|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
2762230|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762231|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264208|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2264209|NCT00174486|Tadalafil|tadalafil|mesh-list
2264210|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
2264211|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2762232|NCT04499274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2762233|NCT04499274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2762234|NCT04499274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762235|NCT04499274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2762236|NCT04499274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2762242|NCT04499209|Naproxen|naproxen|mesh-list
2762243|NCT04499209|Pregabalin|pregabalin|mesh-list
2762244|NCT04499209|Analgesics|analgesics|mesh-ancestor
2762245|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
2762246|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762247|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762248|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
2762249|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2762250|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2762251|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762252|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2762253|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2762254|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2762255|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762256|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2762257|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2762258|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2762259|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2762260|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2762261|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
2762262|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2762263|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762264|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
2762265|NCT04498936|Ledipasvir|ledipasvir|mesh-list
2762266|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2762267|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
2762268|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
2762269|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762270|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2762271|NCT04498832|Vaccines|vaccines|mesh-list
2762272|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
2762273|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762274|NCT04498923|Dexamethasone|dexamethasone|mesh-list
2762275|NCT04498923|Epinephrine|epinephrine|mesh-list
2762276|NCT04498923|Bupivacaine|bupivacaine|mesh-list
2762277|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2762278|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
2762279|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
2762280|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762281|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762282|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2264212|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2264213|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264214|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264215|NCT00174486|Urological Agents|urological agents|mesh-ancestor
2264216|NCT00174499|Nicotine|nicotine|mesh-list
2264217|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2264218|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
2264219|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264220|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264221|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2762283|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
2762284|NCT04498923|Hormones|hormones|mesh-ancestor
2762285|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2762286|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2762287|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762288|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
2762289|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
2762290|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762291|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
2762292|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2762293|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2762294|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
2762295|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762296|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762297|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2762298|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2762299|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2762300|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
2762301|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
2762302|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
2762303|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2762304|NCT04498897|Acamprosate|acamprosate|mesh-list
2762305|NCT04498897|Vortioxetine|vortioxetine|mesh-list
2762306|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
2762307|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2762308|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2101523|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101524|NCT02392104|Warfarin|warfarin|mesh-list
2101525|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
2101526|NCT02392208|Telavancin|telavancin|mesh-list
2101527|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2101528|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101529|NCT02392234|Ivacaftor|ivacaftor|mesh-list
2101530|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2101531|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2101532|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101533|NCT02392286|Prednisone|prednisone|mesh-list
2101534|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
2101535|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2101536|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
2101537|NCT02392286|Hormones|hormones|mesh-ancestor
2101538|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2101539|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101540|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2101541|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762309|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2762310|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762311|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762312|NCT04498897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2762313|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2762314|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2762315|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762316|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762317|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
2762318|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2762319|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2762320|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2762321|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2762322|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2264222|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2264223|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
2264224|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264225|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264226|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
2264227|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2264228|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264229|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2264230|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2264231|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789487|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2789488|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789489|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
2789490|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
2789491|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789492|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2789493|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2789494|NCT04302116|Protective Agents|protective agents|mesh-ancestor
2789495|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
2789496|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264232|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264233|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264234|NCT00174538|Codeine|codeine|mesh-list
2264235|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2264236|NCT00174538|Narcotics|narcotics|mesh-ancestor
2264237|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264238|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264239|NCT00174538|Analgesics|analgesics|mesh-ancestor
2264240|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
2264241|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264242|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
2264243|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
2264244|NCT00174551|Prazosin|prazosin|mesh-list
2264245|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2264246|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2264247|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2264248|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2264249|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
2264250|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264251|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264252|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264253|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
2264254|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264255|NCT00174577|Risperidone|risperidone|mesh-list
2264256|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2264257|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
2264258|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264259|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264260|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264261|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2264262|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2264263|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264264|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2264265|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2264266|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
2264267|NCT00174590|Risperidone|risperidone|mesh-list
2264268|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2264269|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
2264270|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264271|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264272|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264273|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2789497|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789498|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
2789499|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264274|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2264275|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264276|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2264277|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2264278|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
2264279|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2264280|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
2264281|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2264282|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2264283|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2264284|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264285|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264286|NCT00174616|Capecitabine|capecitabine|mesh-list
2264287|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
2264288|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2264289|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
2762335|NCT04498689|Gemcitabine|gemcitabine|mesh-list
2762336|NCT04498689|Paclitaxel|paclitaxel|mesh-list
2762337|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2762338|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762339|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
2762340|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
2762341|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
2762342|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762343|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2762344|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
2762345|NCT04498689|Antiviral Agents|antiviral agents|mesh-ancestor
2762346|NCT04498689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762347|NCT04498689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762348|NCT04498689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2762349|NCT04498689|Immunologic Factors|immunologic factors|mesh-ancestor
2762350|NCT04498689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762354|NCT04498793|Paclitaxel|paclitaxel|mesh-list
2762355|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
2762356|NCT04498793|Doxorubicin|doxorubicin|mesh-list
2762357|NCT04498793|Epirubicin|epirubicin|mesh-list
2762358|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2762359|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762360|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
2762361|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
2264290|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264291|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264292|NCT00174629|Gemcitabine|gemcitabine|mesh-list
2264293|NCT00174629|Docetaxel|docetaxel|mesh-list
2264294|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2264295|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
2264296|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264297|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264298|NCT00174629|Antiviral Agents|antiviral agents|mesh-ancestor
2264299|NCT00174629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264300|NCT00174629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264301|NCT00174629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2264302|NCT00174629|Immunologic Factors|immunologic factors|mesh-ancestor
2264303|NCT00174629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264304|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
2264305|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
2264306|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
2264307|NCT00174642|Insulin|insulin|mesh-list
2264308|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2264309|NCT00174642|Metformin|metformin|mesh-list
2264310|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
2264311|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
2264312|NCT00174642|Secretagogues|secretagogues|mesh-list
2264313|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2264314|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264315|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
2264316|NCT00174655|Docetaxel|docetaxel|mesh-list
2264317|NCT00174655|Doxorubicin|doxorubicin|mesh-list
2264318|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2264319|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2264320|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
2264321|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264322|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2264323|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2264324|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
2762362|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
2762363|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762364|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2762365|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
2762366|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762367|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2762368|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2762369|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
2762370|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2762371|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2762372|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2762373|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2762374|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762375|NCT04498884|Insulin|insulin|mesh-list
2762376|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2762377|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2762378|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762379|NCT04498325|Antibodies|antibodies|mesh-list
2762380|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
2762381|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762382|NCT04498286|Antibodies|antibodies|mesh-list
2264325|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264326|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264327|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2264328|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
2264329|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
2762383|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
2762384|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762385|NCT04498520|Fulvestrant|fulvestrant|mesh-list
2762386|NCT04498520|Palbociclib|palbociclib|mesh-list
2762387|NCT04498520|Abexinostat|abexinostat|mesh-list
2762388|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2762389|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762390|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2762391|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2762392|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
2762393|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2762394|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762395|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2762396|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762397|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762398|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2762399|NCT04498234|Bupivacaine|bupivacaine|mesh-list
2762400|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
2762401|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
2762402|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762403|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762404|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
2762405|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762406|NCT04498260|Triamcinolone|triamcinolone|mesh-list
2762407|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2762408|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2762409|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2762410|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2762411|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
2762412|NCT04498260|Hormones|hormones|mesh-ancestor
2762413|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2762414|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762415|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2762416|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
2762417|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762418|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762419|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
2762420|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
2762421|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2762422|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762423|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762424|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2762425|NCT04498351|Analgesics|analgesics|mesh-ancestor
2762426|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
2762427|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762428|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2762429|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2762430|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2762431|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
2101542|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
2101543|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
2101544|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264330|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
2264331|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2762432|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762433|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762434|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
2762435|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2762436|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
2762437|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2762438|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2762439|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2762440|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
2762441|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2762451|NCT04497831|Morphine|morphine|mesh-list
2762452|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2762453|NCT04497831|Narcotics|narcotics|mesh-ancestor
2762454|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762455|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762456|NCT04497831|Analgesics|analgesics|mesh-ancestor
2762457|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
2762458|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762459|NCT04497883|Maribavir|maribavir|mesh-list
2762460|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
2762461|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762462|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
2762463|NCT04497766|Analgesics|analgesics|mesh-ancestor
2762464|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
2762465|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762466|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762467|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
2762468|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762469|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2762470|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
2762471|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2762472|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2762473|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762474|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2762475|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
2762476|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2762477|NCT04497792|Metformin|metformin|mesh-list
2762478|NCT04497792|Empagliflozin|empagliflozin|mesh-list
2762479|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2762480|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762481|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2762482|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762483|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
2762484|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
2762485|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762486|NCT04497298|Vaccines|vaccines|mesh-list
2762487|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
2762488|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762489|NCT04497012|Iron|iron|mesh-list
2762490|NCT04497012|Trace Elements|trace elements|mesh-ancestor
2762491|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
2762492|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762498|NCT04497142|Levetiracetam|levetiracetam|mesh-list
2101545|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2101546|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2101547|NCT02392286|Protective Agents|protective agents|mesh-ancestor
2101548|NCT02392507|Paclitaxel|paclitaxel|mesh-list
2101549|NCT02392507|Carboplatin|carboplatin|mesh-list
2762499|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
2762500|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
2762501|NCT04497168|Citalopram|citalopram|mesh-list
2762502|NCT04497168|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2762503|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2762504|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2762505|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762506|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762507|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
2762508|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762509|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2762510|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
2762511|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2264332|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2264333|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2789506|NCT04301908|Interferons|interferons|mesh-list
2789507|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789508|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
2789509|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789510|NCT04302168|Choline|choline|mesh-list
2789511|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
2789512|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2789513|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
2789514|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789515|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2264334|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264335|NCT00174668|Insulin|insulin|mesh-list
2264336|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2264337|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
2264338|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
2264339|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2789516|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2789517|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
2789518|NCT04302181|Ropivacaine|ropivacaine|mesh-list
2789519|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
2789520|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
2789521|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789522|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789523|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
2789524|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789525|NCT04301895|Remifentanil|remifentanil|mesh-list
2789526|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2789527|NCT04301895|Narcotics|narcotics|mesh-ancestor
2789528|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789529|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789530|NCT04301895|Analgesics|analgesics|mesh-ancestor
2789531|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
2789532|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789533|NCT04301882|Interferons|interferons|mesh-list
2264340|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264341|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
2264342|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2264343|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264344|NCT00174694|Telithromycin|telithromycin|mesh-list
2264345|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2264346|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264347|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
2264348|NCT00174707|Docetaxel|docetaxel|mesh-list
2264349|NCT00174707|Methotrexate|methotrexate|mesh-list
2264350|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2264351|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
2264352|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789534|NCT04301882|Ribavirin|ribavirin|mesh-list
2789535|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
2789536|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789537|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789538|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
2789539|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264353|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2264354|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2264355|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
2789540|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2789541|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762512|NCT04497155|Norepinephrine|norepinephrine|mesh-list
2762513|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2762514|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2762515|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
2762516|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762517|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762518|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762519|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
2762520|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
2762521|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762522|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2762523|NCT04496921|Vitamins|vitamins|mesh-list
2264356|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264357|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264358|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2762524|NCT04496921|Vitamin K|vitamin k|mesh-list
2762525|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
2762526|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762527|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2762528|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2762529|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762530|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
2762531|NCT04496921|Coagulants|coagulants|mesh-ancestor
2762532|NCT04496882|Tenofovir|tenofovir|mesh-list
2762533|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
2762534|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762535|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2762536|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2762537|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762538|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762539|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2762540|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2762541|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
2762542|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2762543|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
2762544|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762545|NCT04496401|Tacrolimus|tacrolimus|mesh-list
2762546|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2762547|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
2762548|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762549|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2762550|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264359|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
2264360|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
2264361|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
2762551|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762557|NCT04496453|Vaccines|vaccines|mesh-list
2762558|NCT04496453|Immunologic Factors|immunologic factors|mesh-ancestor
2762559|NCT04496453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762560|NCT04496492|Tocotrienols|tocotrienols|mesh-list
2762561|NCT04496492|Vitamin E|vitamin e|mesh-list
2762562|NCT04496492|Tocopherols|tocopherols|mesh-list
2762563|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
2762564|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101550|NCT02392507|Necitumumab|necitumumab|mesh-list
2101551|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2101552|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101553|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
2101554|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
2101555|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
2101556|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101557|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101558|NCT02392559|Evolocumab|evolocumab|mesh-list
2101559|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2101560|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2762565|NCT04496492|Protective Agents|protective agents|mesh-ancestor
2762566|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762567|NCT04496492|Vitamins|vitamins|mesh-ancestor
2762568|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
2762569|NCT04496141|Antibodies|antibodies|mesh-list
2762570|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
2264362|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2264363|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
2264364|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2762571|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762572|NCT04496037|Rituximab|rituximab|mesh-list
2762573|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2762574|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762575|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
2762576|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762577|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2762578|NCT04496050|Alprostadil|alprostadil|mesh-list
2762579|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2762580|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
2762581|NCT04496050|Urological Agents|urological agents|mesh-ancestor
2762582|NCT04495894|Ketorolac|ketorolac|mesh-list
2762583|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2762584|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2762585|NCT04495894|Analgesics|analgesics|mesh-ancestor
2762586|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
2762587|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762588|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762589|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2762590|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2762591|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2762592|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762593|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762594|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2762595|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2762596|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762597|NCT04495881|Incretins|incretins|mesh-ancestor
2762598|NCT04495881|Hormones|hormones|mesh-ancestor
2762599|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2762600|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2762601|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
2762602|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762603|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762604|NCT04496063|Ustekinumab|ustekinumab|mesh-list
2762605|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
2762606|NCT04495933|Vaccines|vaccines|mesh-list
2762607|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
2762608|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
2762609|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762610|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2762611|NCT04495608|Fluconazole|fluconazole|mesh-list
2762612|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
2762613|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762614|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2762615|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2762616|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762617|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762618|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2762619|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
2762620|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2762621|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762622|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2762623|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2762624|NCT04496024|Ofloxacin|ofloxacin|mesh-list
2762625|NCT04496024|Levofloxacin|levofloxacin|mesh-list
2762626|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2762627|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762628|NCT04496024|Renal Agents|renal agents|mesh-ancestor
2762629|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2762630|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2762631|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2762632|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762633|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762634|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762635|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2762636|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2762637|NCT04495569|Antibodies|antibodies|mesh-list
2762638|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2762639|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
2762640|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762641|NCT04495478|Ramucirumab|ramucirumab|mesh-list
2762642|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2762643|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762644|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
2762645|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762646|NCT04495504|Ropivacaine|ropivacaine|mesh-list
2762647|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
2762648|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
2762649|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762650|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762651|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
2762652|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762653|NCT04495868|Lidocaine|lidocaine|mesh-list
2264365|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2264366|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
2264367|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
2264368|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264369|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2264370|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2264371|NCT00174720|Ciclesonide|ciclesonide|mesh-list
2264372|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
2264373|NCT00174720|Hormones|hormones|mesh-ancestor
2762654|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
2762655|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
2762656|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762657|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762658|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
2762659|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762660|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2762661|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2762662|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2762663|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2762664|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762665|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
2762666|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2762667|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762668|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762669|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2762670|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2789551|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
2789552|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2789553|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2789554|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2789555|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2789556|NCT04301492|Vortioxetine|vortioxetine|mesh-list
2789557|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
2789558|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2789559|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2789560|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2789561|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789562|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789563|NCT04301492|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2789564|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2789565|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2789566|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789567|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2789568|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
2789569|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2789570|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2789571|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2789572|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2101561|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
2264374|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2762671|NCT04495621|Cetuximab|cetuximab|mesh-list
2762672|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2762673|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762674|NCT04494958|Palbociclib|palbociclib|mesh-list
2762675|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762676|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2762677|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762678|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762679|NCT04495010|Nivolumab|nivolumab|mesh-list
2762680|NCT04495010|Ipilimumab|ipilimumab|mesh-list
2762681|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2264375|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264376|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2264377|NCT00174733|Ciclesonide|ciclesonide|mesh-list
2264378|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
2264379|NCT00174733|Hormones|hormones|mesh-ancestor
2264380|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2264381|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264382|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2264383|NCT00174759|Clopidogrel|clopidogrel|mesh-list
2264384|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2264385|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2264386|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2264387|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2264388|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
2264389|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264390|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264391|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762682|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762683|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2762684|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762685|NCT04494880|Bupivacaine|bupivacaine|mesh-list
2762686|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
2762687|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
2762688|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762689|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762690|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
2762691|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762692|NCT04494659|Rifampin|rifampin|mesh-list
2762693|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2762694|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
2762695|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2762696|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762697|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
2762698|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2264392|NCT00174772|Cisplatin|cisplatin|mesh-list
2264393|NCT00174772|Docetaxel|docetaxel|mesh-list
2264394|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762699|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762700|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762701|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2762702|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2762703|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2762704|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2762705|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2762706|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2762707|NCT04494763|Propranolol|propranolol|mesh-list
2762708|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2762709|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2762710|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
2762711|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762712|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762713|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762714|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2264395|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
2264396|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
2264397|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
2264398|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264399|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2264400|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2264401|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2264402|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
2264403|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762715|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2762716|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
2762717|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
2762718|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2762719|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762720|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762721|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2762722|NCT04494828|Analgesics|analgesics|mesh-ancestor
2762723|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
2762724|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762725|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2762726|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2762727|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2762728|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
2762729|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762730|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762731|NCT04494529|Betamethasone|betamethasone|mesh-list
2762732|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
2762733|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2762734|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
2762735|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2762736|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2762737|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
2762738|NCT04494529|Hormones|hormones|mesh-ancestor
2762739|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2762740|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762741|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2762742|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
2762743|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
2762744|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2762745|NCT04494503|Rituximab|rituximab|mesh-list
2762746|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2762747|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762748|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
2762749|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762750|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2762751|NCT04494321|Budesonide|budesonide|mesh-list
2762752|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
2762753|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2762754|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2762755|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
2762756|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762757|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762758|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2762759|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
2762760|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
2762761|NCT04494321|Hormones|hormones|mesh-ancestor
2762762|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2762763|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2762764|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2762765|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2762766|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
2762767|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762768|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762769|NCT04494100|Lidocaine|lidocaine|mesh-list
2762770|NCT04494100|Epinephrine|epinephrine|mesh-list
2762771|NCT04494100|Ropivacaine|ropivacaine|mesh-list
2762772|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
2762773|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
2762774|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762775|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762776|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
2762777|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762778|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2762779|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2762780|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2264404|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264405|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762781|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2762782|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762783|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2762784|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2762785|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
2762786|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762787|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2762788|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2762789|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
2762790|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2762791|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
2762792|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
2762793|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
2762794|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2762795|NCT04494438|Rituximab|rituximab|mesh-list
2762796|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2762797|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762798|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
2762799|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762800|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2762801|NCT04494243|Rabeprazole|rabeprazole|mesh-list
2762802|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2762803|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2762804|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2762805|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762806|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762807|NCT04494399|Interferons|interferons|mesh-list
2762808|NCT04494399|Ribavirin|ribavirin|mesh-list
2762809|NCT04494399|Interferon-beta|interferon-beta|mesh-list
2762810|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
2762811|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762812|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
2762813|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762814|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
2762815|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762816|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
2101562|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101563|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2101564|NCT02392611|Fulvestrant|fulvestrant|mesh-list
2101565|NCT02392611|Exemestane|exemestane|mesh-list
2101566|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2101567|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101568|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2101569|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2101570|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
2101571|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2101572|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101573|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2101574|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2101575|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101576|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101577|NCT02392624|Omalizumab|omalizumab|mesh-list
2101578|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2101579|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2101580|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
2264406|NCT00174798|Urological Agents|urological agents|mesh-ancestor
2264407|NCT00174811|Telithromycin|telithromycin|mesh-list
2762817|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762818|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2264408|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2264409|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264410|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
2264411|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2762824|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
2762825|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2762826|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2762827|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762828|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
2762829|NCT04494126|Coagulants|coagulants|mesh-ancestor
2762830|NCT04493931|Rifampin|rifampin|mesh-list
2762831|NCT04493931|Digoxin|digoxin|mesh-list
2264412|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264413|NCT00174837|Tirapazamine|tirapazamine|mesh-list
2264414|NCT00174837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762832|NCT04493931|Midazolam|midazolam|mesh-list
2762833|NCT04493931|Cimetidine|cimetidine|mesh-list
2762834|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2762835|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2762836|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762837|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762838|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2762839|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2762840|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2762841|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2762842|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
2762843|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
2762844|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
2762845|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
2762846|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762847|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762848|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2762849|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
2762850|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2762851|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762852|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
2762853|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2762854|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762855|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2762856|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2762857|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2762858|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2762859|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2264415|NCT00174863|SR 31747|sr 31747|mesh-list
2264416|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264417|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264418|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2264419|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
2762860|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2762861|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2762862|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2762863|NCT04493931|Protective Agents|protective agents|mesh-ancestor
2762864|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2762865|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2762866|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2762867|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
2762868|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
2762869|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2762870|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2762871|NCT04493619|Carboplatin|carboplatin|mesh-list
2762872|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762873|NCT04493554|Vasopressins|vasopressins|mesh-list
2762874|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
2762875|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
2762876|NCT04493554|Coagulants|coagulants|mesh-ancestor
2762877|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2762878|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2762879|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
2762880|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762881|NCT04493515|Oxytocin|oxytocin|mesh-list
2762882|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
2762883|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2762884|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789578|NCT04301661|Tenofovir|tenofovir|mesh-list
2789579|NCT04301661|Lamivudine|lamivudine|mesh-list
2789580|NCT04301661|Emtricitabine|emtricitabine|mesh-list
2789581|NCT04301661|Abacavir|abacavir|mesh-list
2789582|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
2789583|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789584|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2789585|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2789586|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789587|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789588|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2789589|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2789590|NCT04301739|Paclitaxel|paclitaxel|mesh-list
2789591|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
2789592|NCT04301739|Carboplatin|carboplatin|mesh-list
2789593|NCT04301739|Doxorubicin|doxorubicin|mesh-list
2789594|NCT04301739|Epirubicin|epirubicin|mesh-list
2789595|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2789596|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264420|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762885|NCT04493489|Propranolol|propranolol|mesh-list
2762886|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2762887|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2762888|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
2762889|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762890|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762891|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762892|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2762893|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2762894|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
2762895|NCT04493528|Lidocaine|lidocaine|mesh-list
2762896|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
2762897|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
2762898|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762899|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762900|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
2762901|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2762902|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2762903|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2762904|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2762905|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2762906|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762907|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
2264421|NCT00174876|Aripiprazole|aripiprazole|mesh-list
2264422|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
2264423|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2264424|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2264425|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2264426|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264427|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264428|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
2264429|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
2264430|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762908|NCT04493333|Psyllium|psyllium|mesh-list
2762909|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2762910|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2762911|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
2762912|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762913|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
2762914|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2762915|NCT04493333|Cathartics|cathartics|mesh-ancestor
2762916|NCT04493320|Levodopa|levodopa|mesh-list
2762917|NCT04493320|Carbidopa|carbidopa|mesh-list
2762918|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2762919|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2762920|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2762921|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
2762922|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762923|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762924|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762925|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2762926|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762927|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2762928|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
2762929|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
2762930|NCT04493229|Oxytocin|oxytocin|mesh-list
2762931|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
2762932|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2762933|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762934|NCT04493203|Nivolumab|nivolumab|mesh-list
2762935|NCT04493203|Axitinib|axitinib|mesh-list
2762936|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2762937|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762938|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2762939|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762940|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2762941|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762942|NCT04493125|Mosapride|mosapride|mesh-list
2762943|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762944|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2762945|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2762946|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
2762947|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2762948|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762949|NCT04493151|Imipenem|imipenem|mesh-list
2762950|NCT04493151|Relebactam|relebactam|mesh-list
2762951|NCT04493151|Cilastatin|cilastatin|mesh-list
2762952|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2762953|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2762954|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
2762955|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2762956|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762957|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2762958|NCT04493398|Erythritol|erythritol|mesh-list
2762959|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
2762960|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
2762961|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2762962|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2762963|NCT04493463|Prednisolone|prednisolone|mesh-list
2762964|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
2762965|NCT04493463|Ropivacaine|ropivacaine|mesh-list
2762966|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2762967|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
2762968|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
2762969|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
2762970|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2762971|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762972|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
2762973|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264431|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264432|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2264433|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2264434|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
2264435|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2264436|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2762974|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2762975|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
2762976|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
2762977|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2762978|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
2762979|NCT04493463|Hormones|hormones|mesh-ancestor
2762980|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2762981|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2762982|NCT04493463|Protective Agents|protective agents|mesh-ancestor
2762983|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2762984|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762985|NCT04493281|Edaravone|edaravone|mesh-list
2762986|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2762987|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
2762988|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762989|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2762990|NCT04493281|Protective Agents|protective agents|mesh-ancestor
2762991|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2762992|NCT04493099|Decitabine|decitabine|mesh-list
2762993|NCT04493099|Venetoclax|venetoclax|mesh-list
2762994|NCT04493099|Alvocidib|alvocidib|mesh-list
2762995|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2762996|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
2762997|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2762998|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2762999|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763000|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
2763001|NCT04493099|Growth Substances|growth substances|mesh-ancestor
2763002|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763003|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2763004|NCT04493164|Cytarabine|cytarabine|mesh-list
2763005|NCT04493164|Daunorubicin|daunorubicin|mesh-list
2763006|NCT04493164|Ivosidenib|ivosidenib|mesh-list
2264437|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2264438|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2264439|NCT00174902|Aspirin|aspirin|mesh-list
2264440|NCT00174902|Propranolol|propranolol|mesh-list
2763007|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2763008|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
2763009|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763010|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763011|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
2763012|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763013|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2763014|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
2763015|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763016|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2763017|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2763018|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2763019|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763020|NCT04493073|Mitomycins|mitomycins|mesh-list
2763021|NCT04493073|Mitomycin|mitomycin|mesh-list
2763022|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2763023|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763024|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
2763025|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763026|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2763027|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763028|NCT04493060|Niraparib|niraparib|mesh-list
2763029|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
2763030|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
2763031|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
2763032|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763033|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2763034|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763035|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763036|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763037|NCT04492774|Dexamethasone|dexamethasone|mesh-list
2763038|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2763039|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
2763040|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
2763041|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763042|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763043|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2763044|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
2763045|NCT04492774|Hormones|hormones|mesh-ancestor
2763046|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2763047|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2763048|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763049|NCT04492813|Remifentanil|remifentanil|mesh-list
2763050|NCT04492813|Propofol|propofol|mesh-list
2763051|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2763052|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763053|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763054|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2763055|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
2763056|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
2763057|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2264441|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2264442|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2264443|NCT00174902|Analgesics|analgesics|mesh-ancestor
2264444|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
2264445|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264446|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264447|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2763058|NCT04492813|Narcotics|narcotics|mesh-ancestor
2763059|NCT04492813|Analgesics|analgesics|mesh-ancestor
2763060|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
2763061|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763062|NCT04492709|Midazolam|midazolam|mesh-list
2763063|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2763064|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2763065|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763066|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763067|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2763068|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2763069|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2763070|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2763071|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
2763072|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
2763073|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
2763074|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
2763075|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264448|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2264449|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2264450|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2264451|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264452|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2264453|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2264454|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264455|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
2264456|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2763076|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763077|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
2763078|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2763079|NCT04492319|Neostigmine|neostigmine|mesh-list
2264457|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2264458|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
2763080|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2763081|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763082|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763083|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
2763084|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763085|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763086|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2763087|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
2763088|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763089|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
2763090|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
2763091|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2763092|NCT04492254|Enoxaparin|enoxaparin|mesh-list
2264459|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264460|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2264461|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2264462|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
2264463|NCT00174928|Lansoprazole|lansoprazole|mesh-list
2264464|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
2264465|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2763093|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
2763094|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2763095|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2763096|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763097|NCT04492566|Pancrelipase|pancrelipase|mesh-list
2763098|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2763099|NCT04492553|Testosterone|testosterone|mesh-list
2763100|NCT04492553|Androgens|androgens|mesh-ancestor
2763101|NCT04492553|Hormones|hormones|mesh-ancestor
2763102|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2763103|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763104|NCT04492358|Prednisone|prednisone|mesh-list
2763105|NCT04492358|Colchicine|colchicine|mesh-list
2763106|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2763107|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
2763108|NCT04492358|Hormones|hormones|mesh-ancestor
2763109|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2763110|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763111|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2763112|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763113|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
2763114|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2763115|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
2763116|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
2763117|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
2763118|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763119|NCT04492501|Remdesivir|remdesivir|mesh-list
2763120|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
2763121|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763122|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
2763123|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763124|NCT04492072|Misoprostol|misoprostol|mesh-list
2763125|NCT04492072|Oxytocin|oxytocin|mesh-list
2763126|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
2763127|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2763128|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763129|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2763130|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
2763131|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2763132|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2763133|NCT04492033|Paclitaxel|paclitaxel|mesh-list
2763134|NCT04492033|Irinotecan|irinotecan|mesh-list
2763135|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2763136|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763137|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
2763138|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
2763139|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
2763140|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763141|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2763142|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2763143|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763151|NCT04491773|Tadalafil|tadalafil|mesh-list
2763152|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
2763153|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2763154|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2763155|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763156|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763157|NCT04491773|Urological Agents|urological agents|mesh-ancestor
2763158|NCT04491786|Gabapentin|gabapentin|mesh-list
2763159|NCT04491786|Nefopam|nefopam|mesh-list
2763160|NCT04491786|Analgesics|analgesics|mesh-ancestor
2763161|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
2763162|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763163|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763164|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
2763165|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2763166|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2763167|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763168|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2763169|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2763170|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2763171|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763172|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763173|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
2763174|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2763175|NCT04491695|Tirofiban|tirofiban|mesh-list
2763176|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2763177|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2763178|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763179|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2763180|NCT04491682|Megestrol|megestrol|mesh-list
2763181|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
2763182|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2763183|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2763184|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2763185|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
2763186|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763187|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2763188|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2763189|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264466|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2264467|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2264468|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264469|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264470|NCT00174993|Pioglitazone|pioglitazone|mesh-list
2264471|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2264472|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264473|NCT00175032|Aspirin|aspirin|mesh-list
2264474|NCT00175032|Celecoxib|celecoxib|mesh-list
2264475|NCT00175032|Naproxen|naproxen|mesh-list
2264476|NCT00175032|Lansoprazole|lansoprazole|mesh-list
2264477|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
2101581|NCT02393209|Docetaxel|docetaxel|mesh-list
2101582|NCT02393209|Serabelisib|serabelisib|mesh-list
2101583|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101584|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
2101585|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
2101586|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
2101587|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101588|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101589|NCT02393339|Acetaminophen|acetaminophen|mesh-list
2763190|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2763191|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2763192|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2763193|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
2763194|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2763195|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763196|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2101590|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2101591|NCT02393339|Analgesics|analgesics|mesh-ancestor
2763197|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2763198|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2763199|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763200|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
2763201|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2763202|NCT04491474|Lidocaine|lidocaine|mesh-list
2763203|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
2763204|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
2763205|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763206|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763207|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
2763208|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763209|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2763210|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2763211|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2763212|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2763213|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763214|NCT04491968|Methadone|methadone|mesh-list
2763215|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2763216|NCT04491968|Narcotics|narcotics|mesh-ancestor
2763217|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763218|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763219|NCT04491968|Analgesics|analgesics|mesh-ancestor
2763220|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
2763221|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763222|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
2763223|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
2763224|NCT04491383|Tocovid|tocovid|mesh-list
2763225|NCT04491383|Vitamins|vitamins|mesh-ancestor
2763226|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
2763227|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763228|NCT04491643|Megestrol|megestrol|mesh-list
2763229|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
2763230|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2763231|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2763232|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2763233|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
2763234|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763235|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2763236|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2763237|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264478|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2264479|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2264480|NCT00175032|Analgesics|analgesics|mesh-ancestor
2264481|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
2264482|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264483|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264484|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2264485|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2264486|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2264487|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2264488|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264489|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2264490|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2763238|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2763239|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2763240|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2763241|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
2763242|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2763243|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763244|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2763245|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2763246|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2763247|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763248|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
2763249|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2763250|NCT04491084|Antibodies|antibodies|mesh-list
2763251|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
2763252|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
2763253|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763254|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2763255|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2763256|NCT04491084|Protective Agents|protective agents|mesh-ancestor
2264491|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264492|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
2264493|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2264494|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
2264495|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2264496|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2264497|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2264498|NCT00175045|Lansoprazole|lansoprazole|mesh-list
2264499|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
2264500|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2264501|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2264502|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2264503|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264504|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264505|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2264506|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2264507|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2264508|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264509|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763257|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
2763258|NCT04491357|Calcium|calcium|mesh-list
2763259|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2763260|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763261|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2763262|NCT04491032|Anesthetics|anesthetics|mesh-list
2763263|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763264|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763265|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
2763266|NCT04490967|Salicylates|salicylates|mesh-list
2763267|NCT04490967|Silybin|silybin|mesh-list
2763268|NCT04490967|Silymarin|silymarin|mesh-list
2763269|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
2763270|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763271|NCT04490967|Protective Agents|protective agents|mesh-ancestor
2763272|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763273|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763274|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
2763275|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
2763276|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
2763277|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2763278|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2763279|NCT04490967|Analgesics|analgesics|mesh-ancestor
2763280|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
2763281|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763282|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2763283|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2264510|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2264511|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2264512|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264513|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
2763284|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2763285|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763286|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2763287|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763288|NCT04490837|Antibodies|antibodies|mesh-list
2763289|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
2763290|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763291|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
2763292|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2763293|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763294|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2763295|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763296|NCT04490980|Butorphanol|butorphanol|mesh-list
2763297|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2763298|NCT04490980|Narcotics|narcotics|mesh-ancestor
2763299|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763300|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763301|NCT04490980|Analgesics|analgesics|mesh-ancestor
2763302|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
2264514|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264515|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2264516|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
2264517|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2264518|NCT00175162|Protective Agents|protective agents|mesh-ancestor
2763303|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763304|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
2763305|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
2763306|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2763307|NCT04490993|Epirubicin|epirubicin|mesh-list
2763308|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2763309|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763310|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2763311|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2763312|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763313|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763314|NCT04490707|Lenalidomide|lenalidomide|mesh-list
2763315|NCT04490707|Azacitidine|azacitidine|mesh-list
2763316|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
2763317|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763318|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2763319|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2264519|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264520|NCT00175227|Furosemide|furosemide|mesh-list
2264521|NCT00175227|Mannitol|mannitol|mesh-list
2264522|NCT00175227|Diuretics|diuretics|mesh-ancestor
2264523|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
2264524|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264525|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2264526|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2264527|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264528|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2264529|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
2264530|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2264531|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264532|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
2264533|NCT00175266|Infliximab|infliximab|mesh-list
2264534|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
2264535|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2763320|NCT04490707|Growth Substances|growth substances|mesh-ancestor
2763321|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
2763322|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763323|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2763324|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
2763325|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763326|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763327|NCT04490694|Lenvatinib|lenvatinib|mesh-list
2763328|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763329|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2763330|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763331|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763332|NCT04490590|Etoposide|etoposide|mesh-list
2763333|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2763334|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763335|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2763336|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2763337|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763338|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763339|NCT04490434|Celecoxib|celecoxib|mesh-list
2763340|NCT04490434|Naproxen|naproxen|mesh-list
2763341|NCT04490434|Meloxicam|meloxicam|mesh-list
2763342|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2763343|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2763344|NCT04490434|Analgesics|analgesics|mesh-ancestor
2763345|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
2763346|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763347|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763348|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2763349|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2763350|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2763351|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2763352|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763353|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763354|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
2101592|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
2101593|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101594|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101595|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
2264536|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2789597|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
2789598|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
2789599|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
2789600|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789601|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2789602|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
2789603|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789604|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2789605|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2789606|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
2789607|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2789608|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2789609|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2789610|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2789611|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789612|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
2789613|NCT04301583|Procyanidin|procyanidin|mesh-list
2789614|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
2789615|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789616|NCT04301583|Protective Agents|protective agents|mesh-ancestor
2789617|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789618|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2789619|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2789620|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789621|NCT04301557|Capecitabine|capecitabine|mesh-list
2789622|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
2789623|NCT04301557|Antibodies|antibodies|mesh-list
2789624|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
2789625|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789626|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2789627|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
2789628|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789629|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789630|NCT04301778|Durvalumab|durvalumab|mesh-list
2789631|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2789632|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789633|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
2789634|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2789635|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2789636|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2789637|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789638|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
2789639|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2789640|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789641|NCT04301349|Misoprostol|misoprostol|mesh-list
2789642|NCT04301349|Dinoprostone|dinoprostone|mesh-list
2789643|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2789644|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
2789645|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2789646|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789647|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2789648|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2264537|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2264538|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264539|NCT00175305|Octreotide|octreotide|mesh-list
2264540|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2264541|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2264542|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789649|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
2789650|NCT04301336|Zinc|zinc|mesh-list
2789651|NCT04301336|Folic Acid|folic acid|mesh-list
2789652|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
2789653|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
2789654|NCT04301336|Morphine|morphine|mesh-list
2789655|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
2789656|NCT04301336|Simvastatin|simvastatin|mesh-list
2789657|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2789658|NCT04301336|Narcotics|narcotics|mesh-ancestor
2789659|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789660|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789661|NCT04301336|Analgesics|analgesics|mesh-ancestor
2789662|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
2789663|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789664|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2789665|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2789666|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
2763358|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2763359|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763360|NCT04490421|Etoposide|etoposide|mesh-list
2763361|NCT04490421|Apatinib|apatinib|mesh-list
2763362|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763363|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2763364|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2763365|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2763366|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763367|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763368|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2763369|NCT04490031|Ketamine|ketamine|mesh-list
2763370|NCT04490031|Analgesics|analgesics|mesh-ancestor
2763371|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
2763372|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763373|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763374|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2763375|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2763376|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
2763377|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
2763378|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763379|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2763380|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2763381|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763382|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763383|NCT04490057|Bupropion|bupropion|mesh-list
2763384|NCT04490057|Nicotine|nicotine|mesh-list
2763385|NCT04490057|Varenicline|varenicline|mesh-list
2763386|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2763387|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
2763388|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763389|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763390|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2763391|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2763392|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
2763393|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763394|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763395|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2763396|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
2763397|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2763398|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2763399|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2763400|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2763401|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
2763402|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2763403|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2763404|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763405|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2763406|NCT04490213|Laxatives|laxatives|mesh-ancestor
2763407|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2763408|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
2763409|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763410|NCT04489589|Midodrine|midodrine|mesh-list
2763411|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
2763412|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
2763413|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763414|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763415|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2763416|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2763417|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2763418|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2763419|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
2763420|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763421|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763422|NCT04489745|Androgens|androgens|mesh-list
2763423|NCT04489745|Hormones|hormones|mesh-ancestor
2763424|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2763425|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264543|NCT00175357|Methadone|methadone|mesh-list
2264544|NCT00175357|Heroin|heroin|mesh-list
2264545|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2264546|NCT00175357|Narcotics|narcotics|mesh-ancestor
2264547|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264548|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264549|NCT00175357|Analgesics|analgesics|mesh-ancestor
2763426|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
2763427|NCT04489797|Rabeprazole|rabeprazole|mesh-list
2763428|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2763429|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2763430|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2763431|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763432|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763433|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763434|NCT04489849|Apixaban|apixaban|mesh-list
2763435|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2763436|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
2763437|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2763438|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
2763439|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763440|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763441|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
2763442|NCT04489628|Vitamin D|vitamin d|mesh-list
2763443|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
2763444|NCT04489628|Vitamins|vitamins|mesh-ancestor
2763445|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
2763446|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763447|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2763448|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2763449|NCT04489459|Meropenem|meropenem|mesh-list
2763450|NCT04489459|Colistin|colistin|mesh-list
2763451|NCT04489459|Tigecycline|tigecycline|mesh-list
2763452|NCT04489459|Polymyxins|polymyxins|mesh-list
2763453|NCT04489459|Polymyxin B|polymyxin b|mesh-list
2763454|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2763455|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763456|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2763457|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264550|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
2264551|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264552|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
2264553|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
2264554|NCT00175370|Vancomycin|vancomycin|mesh-list
2264555|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2264556|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264557|NCT00175383|Hormones|hormones|mesh-list
2763458|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763459|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
2763460|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
2763461|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2763462|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2763463|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763464|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763465|NCT04489446|Urological Agents|urological agents|mesh-ancestor
2763472|NCT04489147|Metformin|metformin|mesh-list
2763473|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2763474|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763475|NCT04489121|Omalizumab|omalizumab|mesh-list
2763476|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2763477|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2763478|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
2763479|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
2763480|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2763481|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763482|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2763483|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2763484|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2763485|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
2763486|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763487|NCT04489173|Trifluridine|trifluridine|mesh-list
2763488|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
2763489|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763490|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
2763491|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763492|NCT04488978|Amlodipine|amlodipine|mesh-list
2763493|NCT04488978|Irbesartan|irbesartan|mesh-list
2763494|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2763495|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2264558|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2264559|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2264560|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264561|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
2264562|NCT00175396|Leuprolide|leuprolide|mesh-list
2763496|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2763497|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763498|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2763499|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763500|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
2763501|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2763502|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2763503|NCT04488705|Albuterol|albuterol|mesh-list
2763504|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2763505|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
2763506|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763507|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763508|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2763509|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
2763510|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
2763511|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2763512|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2763513|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2763514|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2763515|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
2763516|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763517|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763518|NCT04488744|Nicotine|nicotine|mesh-list
2763519|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2763520|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
2763521|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763522|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763523|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2763524|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2763525|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
2763526|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763527|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763528|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
2763529|NCT04488614|Estrogens|estrogens|mesh-list
2763530|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2763531|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763532|NCT04488614|Hormones|hormones|mesh-ancestor
2763533|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2763534|NCT04488926|Palmidrol|palmidrol|mesh-list
2763535|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2763536|NCT04488926|Analgesics|analgesics|mesh-ancestor
2763537|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
2763538|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763539|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763540|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2763541|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2763542|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2763543|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
2763544|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763545|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2763546|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2763547|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763548|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763549|NCT04488926|Hormones|hormones|mesh-ancestor
2763550|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2763551|NCT04488952|Anesthetics|anesthetics|mesh-list
2763552|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763553|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789667|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789668|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2789669|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2789670|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789671|NCT04301336|Trace Elements|trace elements|mesh-ancestor
2789672|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
2789673|NCT04301336|Hematinics|hematinics|mesh-ancestor
2789674|NCT04301336|Vitamins|vitamins|mesh-ancestor
2264563|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
2264564|NCT00175396|Flutamide|flutamide|mesh-list
2264565|NCT00175396|Bicalutamide|bicalutamide|mesh-list
2264566|NCT00175396|Nilutamide|nilutamide|mesh-list
2264567|NCT00175396|Buserelin|buserelin|mesh-list
2264568|NCT00175396|Androgens|androgens|mesh-list
2264569|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2264570|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2264571|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
2264572|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2264573|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264574|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2264575|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264576|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
2264577|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
2264578|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2264579|NCT00175396|Hormones|hormones|mesh-ancestor
2264580|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
2264581|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264582|NCT00175396|Protective Agents|protective agents|mesh-ancestor
2264583|NCT00175396|Vitamins|vitamins|mesh-ancestor
2264584|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
2264585|NCT00175396|Estrogens|estrogens|mesh-ancestor
2264586|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
2264587|NCT00175435|Vaccines|vaccines|mesh-list
2264588|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
2264589|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264590|NCT00175513|Valacyclovir|valacyclovir|mesh-list
2264591|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
2264592|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264593|NCT00175565|Fluticasone|fluticasone|mesh-list
2264594|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2264595|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2264596|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
2264597|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264598|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264599|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2264600|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
2264601|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
2264602|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2264603|NCT00175591|Bupivacaine|bupivacaine|mesh-list
2264604|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
2763554|NCT04488874|Mannitol|mannitol|mesh-list
2763555|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2763556|NCT04488874|Diuretics|diuretics|mesh-ancestor
2763557|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
2763558|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763559|NCT04488601|Sirolimus|sirolimus|mesh-list
2763560|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2763561|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763562|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2264605|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
2264606|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264607|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264608|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
2264609|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264610|NCT00175617|Minoxidil|minoxidil|mesh-list
2763563|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763564|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
2763565|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2763566|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
2763567|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763568|NCT04488315|Dexamethasone|dexamethasone|mesh-list
2763569|NCT04488315|Dexamethasone acetate|dexamethasone acetate|mesh-list
2763570|NCT04488315|Ropivacaine|ropivacaine|mesh-list
2264611|NCT00175617|Spironolactone|spironolactone|mesh-list
2264612|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2264613|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
2264614|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2264615|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264616|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2264617|NCT00175617|Diuretics|diuretics|mesh-ancestor
2264618|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
2264619|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2264620|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
2264621|NCT00175630|Bupivacaine|bupivacaine|mesh-list
2264622|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
2264623|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
2763571|NCT04488315|BB 1101|bb 1101|mesh-list
2763572|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2763573|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
2763574|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
2763575|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763576|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763577|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2763578|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
2763579|NCT04488315|Hormones|hormones|mesh-ancestor
2763580|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2763581|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2763582|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763583|NCT04488315|Protease Inhibitors|protease inhibitors|mesh-ancestor
2763584|NCT04488315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763585|NCT04488315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763586|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
2763587|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
2763588|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763589|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
2763590|NCT04488159|Leucovorin|leucovorin|mesh-list
2763591|NCT04488159|Fluorouracil|fluorouracil|mesh-list
2763592|NCT04488159|Capecitabine|capecitabine|mesh-list
2763593|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
2763594|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
2763595|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763596|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2763597|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763598|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2763599|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
2763600|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763601|NCT04488159|Antidotes|antidotes|mesh-ancestor
2763602|NCT04488159|Protective Agents|protective agents|mesh-ancestor
2763603|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
2763604|NCT04488159|Vitamins|vitamins|mesh-ancestor
2763605|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
2763606|NCT04488107|Letrozole|letrozole|mesh-list
2763607|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763608|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2763609|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2763610|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763611|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763612|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2763613|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
2763614|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2763615|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763616|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
2763617|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2264624|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264625|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264626|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
2264627|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264628|NCT00175643|Imiquimod|imiquimod|mesh-list
2264629|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2264630|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
2264631|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264632|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264633|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
2264634|NCT00175682|Prazosin|prazosin|mesh-list
2264635|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2264636|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2264637|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2264638|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2264639|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
2264640|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264641|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763618|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2763619|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763620|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
2763621|NCT04488367|Coagulants|coagulants|mesh-ancestor
2763622|NCT04488081|Cyclosporine|cyclosporine|mesh-list
2763623|NCT04488081|Remdesivir|remdesivir|mesh-list
2763624|NCT04488081|Celecoxib|celecoxib|mesh-list
2763625|NCT04488081|Famotidine|famotidine|mesh-list
2763626|NCT04488081|Cyclosporins|cyclosporins|mesh-list
2763627|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763628|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763629|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2763630|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
2789675|NCT04301336|Astringents|astringents|mesh-ancestor
2264642|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264643|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
2264644|NCT00175695|Protein C|protein c|mesh-list
2264645|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
2264646|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2264647|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2264648|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264649|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264650|NCT00175747|Budesonide|budesonide|mesh-list
2264651|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2264652|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2264653|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
2264654|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763631|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763632|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
2763633|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763634|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
2763635|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2763636|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2763637|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2763638|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2763639|NCT04488081|Analgesics|analgesics|mesh-ancestor
2763640|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
2763641|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763642|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2763643|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2763644|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2763645|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2763646|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2763647|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2763648|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
2763649|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
2763650|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763651|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
2763652|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
2763653|NCT04488172|Vitamins|vitamins|mesh-list
2763654|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
2763655|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763656|NCT04487990|Heparin|heparin|mesh-list
2763657|NCT04487990|Calcium heparin|calcium heparin|mesh-list
2763658|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
2763659|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2763660|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2763661|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763662|NCT04487951|Vitamin D|vitamin d|mesh-list
2763663|NCT04487951|Vitamins|vitamins|mesh-ancestor
2763664|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
2763665|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763666|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2763667|NCT04487743|Liraglutide|liraglutide|mesh-list
2763668|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2763669|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763670|NCT04487743|Incretins|incretins|mesh-ancestor
2763671|NCT04487743|Hormones|hormones|mesh-ancestor
2763672|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2763673|NCT04487834|Simethicone|simethicone|mesh-list
2763674|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
2763675|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763676|NCT04487834|Emollients|emollients|mesh-ancestor
2763677|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
2763678|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
2763679|NCT04487652|Vitamins|vitamins|mesh-ancestor
2763680|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
2763681|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763682|NCT04487756|Carboplatin|carboplatin|mesh-list
2763683|NCT04487756|Atezolizumab|atezolizumab|mesh-list
2763684|NCT04487756|Vaccines|vaccines|mesh-list
2763685|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
2763686|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763687|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763688|NCT04487587|Olaparib|olaparib|mesh-list
2763689|NCT04487587|Cediranib|cediranib|mesh-list
2763690|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2763691|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763692|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763693|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763694|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2763695|NCT04487236|Capecitabine|capecitabine|mesh-list
2763696|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2763697|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
2763698|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264655|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264656|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2264657|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
2264658|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
2264659|NCT00175747|Hormones|hormones|mesh-ancestor
2264660|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2264661|NCT00175812|Tretinoin|tretinoin|mesh-list
2264662|NCT00175812|Theophylline|theophylline|mesh-list
2264663|NCT00175812|Valproic Acid|valproic acid|mesh-list
2264664|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264665|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
2264666|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
2264667|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
2264668|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264669|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264670|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
2264671|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264672|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264673|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
2264674|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2264675|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264676|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2264677|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2264678|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
2264679|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264680|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2264681|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
2763699|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763700|NCT04487444|Thymalfasin|thymalfasin|mesh-list
2763701|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2763702|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
2763703|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763704|NCT04487392|Estrogens|estrogens|mesh-list
2763705|NCT04487392|Hormones|hormones|mesh-ancestor
2763706|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2763707|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763708|NCT04487106|Azacitidine|azacitidine|mesh-list
2763709|NCT04487106|Venetoclax|venetoclax|mesh-list
2763710|NCT04487106|Trametinib|trametinib|mesh-list
2763711|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2763712|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
2763713|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763714|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763715|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763716|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2789676|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
2789677|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789678|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
2789679|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2789680|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
2789681|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2789682|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
2789683|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
2789684|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789685|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789686|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2789687|NCT04301024|Analgesics|analgesics|mesh-ancestor
2789688|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
2789689|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789690|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
2789691|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2789692|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789693|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2264682|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2264683|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
2264684|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2264685|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2264686|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
2264687|NCT00175838|Aspirin|aspirin|mesh-list
2264688|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
2789694|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2789695|NCT04301310|Rifampin|rifampin|mesh-list
2789696|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2763717|NCT04487093|Vaccines|vaccines|mesh-list
2763718|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
2763719|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763720|NCT04486911|Letrozole|letrozole|mesh-list
2763721|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763722|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2763723|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2763724|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763725|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763726|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2763727|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
2763728|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2763729|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763730|NCT04487145|Piperaquine|piperaquine|mesh-list
2763731|NCT04487145|Artenimol|artenimol|mesh-list
2763732|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
2763733|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2763734|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2763735|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763736|NCT04486690|Ketamine|ketamine|mesh-list
2763737|NCT04486690|Propofol|propofol|mesh-list
2763738|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2763739|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763740|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763741|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2763742|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
2763743|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
2763744|NCT04486690|Analgesics|analgesics|mesh-ancestor
2763745|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
2763746|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763747|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2763748|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2763749|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2763750|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763751|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763752|NCT04486651|Irinotecan|irinotecan|mesh-list
2763753|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2763754|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2763755|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763756|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763757|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763758|NCT04486508|Heparin|heparin|mesh-list
2763759|NCT04486508|Calcium heparin|calcium heparin|mesh-list
2763760|NCT04486508|Enoxaparin|enoxaparin|mesh-list
2763761|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
2763762|NCT04486508|Atorvastatin|atorvastatin|mesh-list
2763763|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2763764|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2763765|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2763766|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
2763767|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763768|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2763769|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763770|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
2763771|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2763772|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2763773|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
2264689|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2264690|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2264691|NCT00175838|Analgesics|analgesics|mesh-ancestor
2264692|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
2264693|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763774|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101596|NCT02393378|Folic Acid|folic acid|mesh-list
2101597|NCT02393378|Adalimumab|adalimumab|mesh-list
2101598|NCT02393378|Methotrexate|methotrexate|mesh-list
2101599|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2101600|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
2101601|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2101602|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101603|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2101604|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
2101605|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101606|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763775|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763776|NCT04486612|Anesthetics|anesthetics|mesh-list
2763777|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763778|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763779|NCT04486430|Salicylates|salicylates|mesh-list
2763780|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2763781|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2763782|NCT04486430|Analgesics|analgesics|mesh-ancestor
2763783|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
2763784|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264694|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264695|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2264696|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2264697|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2264698|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2763785|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763786|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2763787|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2763788|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2763789|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763790|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763791|NCT04486521|Siltuximab|siltuximab|mesh-list
2763792|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763793|NCT04486313|Nitazoxanide|nitazoxanide|mesh-list
2763794|NCT04486313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2763795|NCT04486313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763796|NCT04486092|Valproic Acid|valproic acid|mesh-list
2763797|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
2763798|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763799|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763800|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
2763801|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763802|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763803|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
2763804|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2763805|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763806|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2763807|NCT04485845|Metformin|metformin|mesh-list
2763808|NCT04485845|Vildagliptin|vildagliptin|mesh-list
2763809|NCT04485845|Captopril|captopril|mesh-list
2763810|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2763811|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763812|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2763813|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
2763814|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763815|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763816|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2763817|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2763818|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2763819|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2763820|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
2763821|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763822|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763823|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763824|NCT04485949|Temozolomide|temozolomide|mesh-list
2763825|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2763826|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
2763827|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763828|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763829|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
2763830|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2763831|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2763832|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2763833|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2763834|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763835|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
2763836|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763837|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763838|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2763839|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763840|NCT04485702|Midazolam|midazolam|mesh-list
2763841|NCT04485702|Ketamine|ketamine|mesh-list
2763842|NCT04485702|Analgesics|analgesics|mesh-ancestor
2763843|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
2763844|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763845|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763846|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2763847|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2763848|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
2763849|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
2763850|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763851|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2763852|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2763853|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763854|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763855|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2763856|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2264699|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264700|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2264701|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2264702|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264703|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
2264704|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264705|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
2264706|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2264707|NCT00175890|Levetiracetam|levetiracetam|mesh-list
2264708|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
2763857|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2763858|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2763859|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2763860|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
2763861|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
2763862|NCT04485585|Tamsulosin|tamsulosin|mesh-list
2763863|NCT04485585|Mirabegron|mirabegron|mesh-list
2763864|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2763865|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2763866|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2763867|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
2763868|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2763869|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763870|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763871|NCT04485585|Urological Agents|urological agents|mesh-ancestor
2763872|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2763873|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2763874|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2763875|NCT04485689|Capsaicin|capsaicin|mesh-list
2763876|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
2763877|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
2763878|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
2763879|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763880|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763883|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
2763884|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2763885|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763886|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
2763887|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
2763888|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2763889|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2763890|NCT04485429|Prednisolone|prednisolone|mesh-list
2763891|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
2763892|NCT04485429|Heparin|heparin|mesh-list
2763893|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2763894|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
2763895|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2763896|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
2763897|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
2763898|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763899|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763900|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2763901|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
2763902|NCT04485429|Hormones|hormones|mesh-ancestor
2763903|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2763904|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2763905|NCT04485429|Protective Agents|protective agents|mesh-ancestor
2763906|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2763907|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2763908|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
2763909|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2763910|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2789697|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
2763911|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763912|NCT04485130|Disulfiram|disulfiram|mesh-list
2763913|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2763914|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2763915|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763916|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763917|NCT04485273|Anesthetics|anesthetics|mesh-list
2763918|NCT04485273|Sevoflurane|sevoflurane|mesh-list
2763919|NCT04485273|Bupivacaine|bupivacaine|mesh-list
2763920|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
2763921|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2763922|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264709|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
2264710|NCT00175903|Carbamazepine|carbamazepine|mesh-list
2264711|NCT00175903|Levetiracetam|levetiracetam|mesh-list
2264712|NCT00175903|Valproic Acid|valproic acid|mesh-list
2264713|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
2264714|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
2264715|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264716|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264717|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
2264718|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264719|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264720|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
2264721|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2264722|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264723|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2264724|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2264725|NCT00175903|Analgesics|analgesics|mesh-ancestor
2264726|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
2264727|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264728|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2264729|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2264730|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2264731|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2264732|NCT00175929|Brivaracetam|brivaracetam|mesh-list
2264733|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
2264734|NCT00175955|Levetiracetam|levetiracetam|mesh-list
2264735|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
2264736|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
2264737|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
2264738|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
2264739|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
2264740|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2763923|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763924|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2763925|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2763926|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
2763927|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
2763928|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763929|NCT04485299|Listerine|listerine|mesh-list
2763930|NCT04485299|Fluorides|fluorides|mesh-list
2763931|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
2763932|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
2763933|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
2763934|NCT04485299|Protective Agents|protective agents|mesh-ancestor
2763935|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763936|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2264741|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2264742|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763937|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789698|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2789699|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789700|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
2789701|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2789702|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789703|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789704|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2789705|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2789706|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2789707|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2789708|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2789709|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2789710|NCT04300959|Gemcitabine|gemcitabine|mesh-list
2264743|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789711|NCT04300959|Cisplatin|cisplatin|mesh-list
2264744|NCT00175981|Urological Agents|urological agents|mesh-ancestor
2264745|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2264746|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2264747|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264748|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763938|NCT04485403|Ibuprofen|ibuprofen|mesh-list
2763939|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2763940|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2763941|NCT04485403|Analgesics|analgesics|mesh-ancestor
2763942|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
2763943|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763944|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763945|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2763946|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2763947|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2763948|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763949|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763950|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
2763951|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2763952|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763953|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
2763956|NCT04485195|Procainamide|procainamide|mesh-list
2763957|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2763958|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2763959|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2763960|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2763961|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763962|NCT04485325|Etanercept|etanercept|mesh-list
2763963|NCT04485325|Tofacitinib|tofacitinib|mesh-list
2763964|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2763965|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2763966|NCT04485325|Analgesics|analgesics|mesh-ancestor
2763967|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
2763968|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2763969|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763970|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2763971|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2763972|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2763973|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2763974|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
2763975|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2763976|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763977|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2763978|NCT04485117|Anesthetics|anesthetics|mesh-list
2763979|NCT04485117|Propofol|propofol|mesh-list
2763980|NCT04485117|Sevoflurane|sevoflurane|mesh-list
2763981|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2763982|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2763983|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2763984|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2763985|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
2763986|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2763987|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2763988|NCT04485156|Rifampin|rifampin|mesh-list
2763989|NCT04485156|Isoniazid|isoniazid|mesh-list
2763990|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
2763991|NCT04485156|Ethambutol|ethambutol|mesh-list
2763992|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2763993|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
2763994|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2763995|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2763996|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
2763997|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2763998|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2763999|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764000|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2764001|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2764002|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2764003|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2764004|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2764005|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2264749|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2264750|NCT00175981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2764006|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2764007|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2764008|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
2764009|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2764010|NCT04485065|Azacitidine|azacitidine|mesh-list
2764011|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2764012|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
2764013|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764014|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764015|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764016|NCT04485052|Azacitidine|azacitidine|mesh-list
2764017|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2264751|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2264752|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2264753|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264754|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
2264755|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2264756|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
2264757|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2264758|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2264759|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2264760|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
2264761|NCT00176020|Niacin|niacin|mesh-list
2764018|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
2764019|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764020|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764021|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764022|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2764023|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2764024|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764025|NCT04484688|Bisoprolol|bisoprolol|mesh-list
2764026|NCT04484688|Perindopril|perindopril|mesh-list
2764027|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2764028|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
2264762|NCT00176020|Niacinamide|niacinamide|mesh-list
2264763|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
2264764|NCT00176020|Vitamins|vitamins|mesh-ancestor
2264765|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
2264766|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264767|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2264768|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
2264769|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264770|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2264771|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
2264772|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
2264773|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264774|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2264775|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2264776|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
2264777|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264778|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
2264779|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2264780|NCT00176059|Antibodies|antibodies|mesh-list
2264781|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
2264782|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2264783|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
2264784|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264785|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2764029|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
2764030|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764031|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764032|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2764033|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2764034|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2764035|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
2764036|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2764037|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764038|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2764039|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
2764040|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764041|NCT04484779|Insulin|insulin|mesh-list
2764042|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
2764043|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
2764044|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2764045|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764046|NCT04484844|Listerine|listerine|mesh-list
2764047|NCT04484844|Fluorides|fluorides|mesh-list
2764048|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
2764049|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
2764050|NCT04484844|Protective Agents|protective agents|mesh-ancestor
2764051|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764052|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2764053|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764054|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
2764055|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2764056|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2764057|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764058|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2764059|NCT04484922|Analgesics|analgesics|mesh-ancestor
2764060|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
2764061|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764062|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2764063|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2764064|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2764065|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
2764066|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2764067|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764068|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
2764069|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2764070|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
2764071|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2764072|NCT04484506|Prednisone|prednisone|mesh-list
2764073|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
2764074|NCT04484506|Etoposide|etoposide|mesh-list
2764075|NCT04484506|Vincristine|vincristine|mesh-list
2764076|NCT04484506|Pegaspargase|pegaspargase|mesh-list
2764077|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764078|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
2764079|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764080|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2764081|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2764082|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
2764083|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764084|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764085|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2101607|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
2101608|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101609|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2101610|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2101611|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
2101612|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2101613|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2264786|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2764086|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2764087|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
2764088|NCT04484506|Hormones|hormones|mesh-ancestor
2764089|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2764090|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2764091|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2764092|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2764093|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2764094|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764095|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
2764096|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
2764097|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
2764098|NCT04484532|Vaccines|vaccines|mesh-list
2764099|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
2764100|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764101|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
2764102|NCT04484610|Narcotics|narcotics|mesh-ancestor
2764103|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2764104|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764105|NCT04484610|Analgesics|analgesics|mesh-ancestor
2764106|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
2764107|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764108|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2764109|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2764110|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2764111|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764112|NCT04484337|Cabotegravir|cabotegravir|mesh-list
2764113|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2764114|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2764115|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764116|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764117|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2764118|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2764119|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
2764120|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764121|NCT04484467|Menthol|menthol|mesh-list
2764122|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
2764123|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
2764124|NCT04484623|Dexamethasone|dexamethasone|mesh-list
2764125|NCT04484623|Bortezomib|bortezomib|mesh-list
2764126|NCT04484623|Pomalidomide|pomalidomide|mesh-list
2764127|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2764128|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
2764129|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
2764130|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764131|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764132|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2764133|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
2764134|NCT04484623|Hormones|hormones|mesh-ancestor
2764135|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2764136|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2764137|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764138|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
2764139|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2764140|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2764141|NCT04484623|Growth Substances|growth substances|mesh-ancestor
2764142|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
2764143|NCT04484428|Menthol|menthol|mesh-list
2764144|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
2764145|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
2764146|NCT04484350|Enalapril|enalapril|mesh-list
2764147|NCT04484350|Hydralazine|hydralazine|mesh-list
2764148|NCT04484350|Labetalol|labetalol|mesh-list
2764149|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2764150|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
2764151|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764152|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764153|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2764154|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
2764155|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2764156|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2764157|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
2764158|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2764159|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764160|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
2764161|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
2764162|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764163|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2764164|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2764165|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
2764166|NCT04484272|Narcotics|narcotics|mesh-ancestor
2764167|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2764168|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764169|NCT04484272|Analgesics|analgesics|mesh-ancestor
2764170|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
2764171|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764172|NCT04484259|Aspirin|aspirin|mesh-list
2764173|NCT04484259|Clopidogrel|clopidogrel|mesh-list
2764174|NCT04484259|Ticagrelor|ticagrelor|mesh-list
2764175|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2764176|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2764177|NCT04484259|Analgesics|analgesics|mesh-ancestor
2764178|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
2764179|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764180|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764181|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2764182|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2764183|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2764184|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2764185|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764186|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2764187|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2264787|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264788|NCT00176241|Gemcitabine|gemcitabine|mesh-list
2764188|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764189|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
2264789|NCT00176241|Paclitaxel|paclitaxel|mesh-list
2264790|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2264791|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264792|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
2264793|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
2264794|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
2264795|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264796|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2264797|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
2264798|NCT00176241|Antiviral Agents|antiviral agents|mesh-ancestor
2264799|NCT00176241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264800|NCT00176241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264801|NCT00176241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2264802|NCT00176241|Immunologic Factors|immunologic factors|mesh-ancestor
2264803|NCT00176241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264804|NCT00176267|Paclitaxel|paclitaxel|mesh-list
2264805|NCT00176267|Carboplatin|carboplatin|mesh-list
2764190|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2764191|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2764192|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2764193|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
2764194|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2764195|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
2764196|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
2764197|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2764198|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
2764199|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764200|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2764201|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2764202|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2764203|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2764204|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764205|NCT04483960|Nafamostat|nafamostat|mesh-list
2764206|NCT04483960|Enoxaparin|enoxaparin|mesh-list
2764207|NCT04483960|Dalteparin|dalteparin|mesh-list
2764208|NCT04483960|Tinzaparin|tinzaparin|mesh-list
2764209|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2764210|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
2764211|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2764212|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2764213|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764214|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2764215|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2764216|NCT04483960|Analgesics|analgesics|mesh-ancestor
2764217|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
2764218|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264806|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2264807|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264808|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
2264809|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
2264810|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
2264811|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264812|NCT00176280|Dexamethasone|dexamethasone|mesh-list
2764219|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764220|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2764221|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2764222|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
2764223|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764224|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2764225|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2764226|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2764227|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764228|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
2764229|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
2764230|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764231|NCT04483765|Anesthetics|anesthetics|mesh-list
2764232|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2764233|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764234|NCT04483596|Melatonin|melatonin|mesh-list
2764235|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
2764236|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764237|NCT04483596|Protective Agents|protective agents|mesh-ancestor
2764238|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764239|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264813|NCT00176280|Sargramostim|sargramostim|mesh-list
2264814|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2264815|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
2264816|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
2764240|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2764241|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2764242|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764243|NCT04483427|Ketorolac|ketorolac|mesh-list
2764244|NCT04483427|Nalbuphine|nalbuphine|mesh-list
2764245|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2764246|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2764247|NCT04483427|Analgesics|analgesics|mesh-ancestor
2764248|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
2764249|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764250|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764251|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2764252|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2764253|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2764254|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764255|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764256|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2764257|NCT04483427|Narcotics|narcotics|mesh-ancestor
2764258|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101614|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2101615|NCT02393378|Hematinics|hematinics|mesh-ancestor
2101616|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
2101617|NCT02393378|Vitamins|vitamins|mesh-ancestor
2101618|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
2764269|NCT04483635|Vitamin D|vitamin d|mesh-list
2764270|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
2764271|NCT04483635|Vitamins|vitamins|mesh-ancestor
2764272|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
2764273|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764274|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2764275|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2764276|NCT04483466|Methotrexate|methotrexate|mesh-list
2764277|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2764278|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
2764279|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2764280|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764281|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2764282|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
2764283|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764284|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764285|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
2764286|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764287|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2764288|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764289|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
2764290|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2764291|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2764292|NCT04483739|Dexamethasone|dexamethasone|mesh-list
2764293|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
2764294|NCT04483739|Lenalidomide|lenalidomide|mesh-list
2764295|NCT04483739|BB 1101|bb 1101|mesh-list
2764296|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2764297|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
2764298|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
2764299|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764300|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764301|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2764302|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
2764303|NCT04483739|Hormones|hormones|mesh-ancestor
2764304|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2764305|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2101619|NCT02393547|Varenicline|varenicline|mesh-list
2764306|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764307|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
2764308|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764309|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764310|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
2764311|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2764312|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2764313|NCT04483739|Growth Substances|growth substances|mesh-ancestor
2264817|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264818|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264819|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2264820|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
2264821|NCT00176280|Hormones|hormones|mesh-ancestor
2264822|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2264823|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2264824|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264825|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
2264826|NCT00176293|Dexamethasone|dexamethasone|mesh-list
2264827|NCT00176293|Doxorubicin|doxorubicin|mesh-list
2264828|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2764314|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
2764315|NCT04483674|Tenofovir|tenofovir|mesh-list
2764316|NCT04483674|Emtricitabine|emtricitabine|mesh-list
2764317|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
2764318|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764319|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2264829|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
2264830|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
2264831|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264832|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264833|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2264834|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
2264835|NCT00176293|Hormones|hormones|mesh-ancestor
2264836|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2264837|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2264838|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264839|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2264840|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2264841|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2264842|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264843|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264844|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2264845|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2264846|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2264847|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
2264848|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264849|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2264850|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2764320|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2764321|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264851|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264852|NCT00176449|Bupropion|bupropion|mesh-list
2264853|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2264854|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
2264855|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2264856|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2264857|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2264858|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2764322|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264859|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264860|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
2264861|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264862|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264863|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2264864|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2264865|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264866|NCT00176475|Rituximab|rituximab|mesh-list
2264867|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2264868|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264869|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
2264870|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264871|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2264872|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
2264873|NCT00176527|Interferons|interferons|mesh-list
2764323|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2764324|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2764325|NCT04483492|Caffeine|caffeine|mesh-list
2764326|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
2764327|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764328|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2764329|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764330|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2764331|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764332|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2764333|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2764334|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
2764335|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2764336|NCT04483505|Fulvestrant|fulvestrant|mesh-list
2764337|NCT04483505|Palbociclib|palbociclib|mesh-list
2764338|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2764339|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764340|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2764341|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2764342|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
2764343|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2764344|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764345|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2764346|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764347|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764348|NCT04483102|Liver Extracts|liver extracts|mesh-list
2764349|NCT04483102|Hematinics|hematinics|mesh-ancestor
2764350|NCT04483258|Sevoflurane|sevoflurane|mesh-list
2764351|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2764352|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2764353|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
2764354|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
2764355|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2764356|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764357|NCT04483206|Melphalan|melphalan|mesh-list
2764358|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2764359|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
2764360|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764361|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764362|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2764363|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764364|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
2764365|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764366|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
2764367|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2764368|NCT04483284|Estrogens|estrogens|mesh-ancestor
2764369|NCT04483284|Hormones|hormones|mesh-ancestor
2764370|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2764371|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764372|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2764373|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764374|NCT04483219|Antibodies|antibodies|mesh-list
2764375|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
2764376|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764377|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
2764378|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2764379|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2764380|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764381|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
2764382|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
2764383|NCT04482907|Hormones|hormones|mesh-list
2764384|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2764385|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764386|NCT04482842|Warfarin|warfarin|mesh-list
2764387|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
2764388|NCT04482959|Carbetocin|carbetocin|mesh-list
2764389|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
2764390|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2764391|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764392|NCT04482881|Isosorbide|isosorbide|mesh-list
2764393|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2764394|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2764395|NCT04482881|Misoprostol|misoprostol|mesh-list
2101620|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2101621|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2764396|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2764397|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
2764398|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2764399|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764400|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2764401|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2764402|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
2764403|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2764404|NCT04482881|Diuretics|diuretics|mesh-ancestor
2764405|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
2764406|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
2764407|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2764408|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764409|NCT04482985|Meclizine|meclizine|mesh-list
2764410|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
2764411|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
2764412|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764413|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764414|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2764415|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2764416|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
2764417|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
2764418|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2764419|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764420|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2764421|NCT04482504|Vitamin D|vitamin d|mesh-list
2764422|NCT04482504|Vitamins|vitamins|mesh-ancestor
2764423|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
2764424|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764425|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2764434|NCT04482621|Decitabine|decitabine|mesh-list
2764435|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2764436|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
2764437|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764438|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764439|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764440|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2764441|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2764442|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
2764443|NCT04482803|Hormones|hormones|mesh-ancestor
2764444|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2764445|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764446|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2764447|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264874|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
2264875|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
2264876|NCT00176527|Docetaxel|docetaxel|mesh-list
2264877|NCT00176527|Estramustine|estramustine|mesh-list
2264878|NCT00176527|Isotretinoin|isotretinoin|mesh-list
2264879|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764448|NCT04482712|Sirolimus|sirolimus|mesh-list
2764449|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2764450|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764451|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2764452|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764453|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
2764454|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764455|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
2764456|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764457|NCT04482764|Valproic Acid|valproic acid|mesh-list
2764458|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
2764459|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764460|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764461|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
2764462|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264880|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
2764463|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764464|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
2764465|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2764466|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2764467|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2764468|NCT04482543|Methotrexate|methotrexate|mesh-list
2764469|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2764470|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
2764471|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2764472|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764473|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2764474|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
2764475|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764476|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764477|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
2764478|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764479|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2764480|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764481|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
2764482|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2764483|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2764484|NCT04482413|Donepezil|donepezil|mesh-list
2764485|NCT04482413|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2764486|NCT04482413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764487|NCT04482413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764488|NCT04482413|Cholinergic Agents|cholinergic agents|mesh-ancestor
2764489|NCT04482413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2764490|NCT04482413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764491|NCT04482413|Nootropic Agents|nootropic agents|mesh-ancestor
2764494|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
2764495|NCT04482296|Astringents|astringents|mesh-ancestor
2764496|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764497|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
2789712|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789713|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2789714|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
2789715|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789716|NCT04300959|Antiviral Agents|antiviral agents|mesh-ancestor
2789717|NCT04300959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789718|NCT04300959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789719|NCT04300959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2789720|NCT04300959|Immunologic Factors|immunologic factors|mesh-ancestor
2789721|NCT04300959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789722|NCT04301271|Simvastatin|simvastatin|mesh-list
2789723|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2789724|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2789725|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
2789726|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789727|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2789728|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2789729|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789730|NCT04301375|Paclitaxel|paclitaxel|mesh-list
2789731|NCT04301375|Trastuzumab|trastuzumab|mesh-list
2789732|NCT04301375|Pertuzumab|pertuzumab|mesh-list
2789733|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2789734|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789735|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
2789736|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
2789737|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
2789738|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789739|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2264881|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
2264882|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
2789752|NCT04300686|Adalimumab|adalimumab|mesh-list
2789753|NCT04300686|Antibodies|antibodies|mesh-list
2764498|NCT04482257|Irinotecan|irinotecan|mesh-list
2764499|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2264883|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264884|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
2264885|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264886|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
2264887|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764500|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2764501|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764502|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764503|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764504|NCT04481802|Acemannan|acemannan|mesh-list
2764505|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2764506|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
2764507|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764508|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764509|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
2764510|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764511|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2764512|NCT04481815|Rituximab|rituximab|mesh-list
2764513|NCT04481815|Methotrexate|methotrexate|mesh-list
2764514|NCT04481815|Lenalidomide|lenalidomide|mesh-list
2764515|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2764516|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764517|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
2264888|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
2264889|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2264890|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
2264891|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2264892|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
2264893|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
2264894|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
2264895|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2264896|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2264897|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264898|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264899|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264900|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
2264901|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
2764518|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764519|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2764520|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2764521|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
2264902|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
2264903|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2264904|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2264905|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264906|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264907|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264908|NCT00176618|Curcumin|curcumin|mesh-list
2264909|NCT00176618|Sulindac|sulindac|mesh-list
2264910|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2264911|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2264912|NCT00176618|Analgesics|analgesics|mesh-ancestor
2764522|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2764523|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2764524|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
2764525|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764526|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
2264913|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
2264914|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264915|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264916|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2264917|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2264918|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264919|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264920|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264921|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2264922|NCT00176670|Midazolam|midazolam|mesh-list
2764527|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764528|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2764529|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764530|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2764531|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2764532|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2764533|NCT04481815|Growth Substances|growth substances|mesh-ancestor
2764534|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
2764535|NCT04481841|Vitamins|vitamins|mesh-list
2764536|NCT04481841|Vitamin E|vitamin e|mesh-list
2764537|NCT04481841|Riboflavin|riboflavin|mesh-list
2764538|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
2764539|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764540|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
2764541|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
2764542|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764543|NCT04481841|Protective Agents|protective agents|mesh-ancestor
2764544|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2764545|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
2764546|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
2764547|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2764548|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2764549|NCT04481724|Analgesics|analgesics|mesh-ancestor
2764550|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
2764551|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764552|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764553|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2764554|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2764555|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2764556|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
2764557|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764558|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2764559|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
2764560|NCT04481971|Prednisolone|prednisolone|mesh-list
2764561|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2764562|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
2764563|NCT04481971|Hormones|hormones|mesh-ancestor
2764564|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2764565|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764566|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2764567|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764568|NCT04481555|Azithromycin|azithromycin|mesh-list
2764569|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2764570|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764571|NCT04481750|Edaravone|edaravone|mesh-list
2764572|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2764573|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
2764574|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764575|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2764576|NCT04481750|Protective Agents|protective agents|mesh-ancestor
2764577|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764578|NCT04481789|Furosemide|furosemide|mesh-list
2764579|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
2101622|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
2101623|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101624|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101625|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101626|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
2764580|NCT04481789|Edaravone|edaravone|mesh-list
2764581|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2764582|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2764583|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2764584|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
2764585|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764586|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2764587|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2764588|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764589|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
2764590|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2764591|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2764592|NCT04481789|Urological Agents|urological agents|mesh-ancestor
2764593|NCT04481789|Diuretics|diuretics|mesh-ancestor
2764594|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
2764595|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764596|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2764597|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2764598|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2764599|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
2764600|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2764601|NCT04481789|Protective Agents|protective agents|mesh-ancestor
2764602|NCT04481932|Trastuzumab|trastuzumab|mesh-list
2764603|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2764604|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764605|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2764606|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
2764607|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764608|NCT04481282|Terbutaline|terbutaline|mesh-list
2764609|NCT04481282|Danazol|danazol|mesh-list
2764610|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2764611|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
2764612|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764613|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764614|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2764615|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
2764616|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
2764617|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
2764618|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2764619|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2764620|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2764621|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2764622|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
2764623|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2764624|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764625|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2764626|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
2764627|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2764628|NCT04481204|Leucovorin|leucovorin|mesh-list
2764629|NCT04481204|Gemcitabine|gemcitabine|mesh-list
2764630|NCT04481204|Paclitaxel|paclitaxel|mesh-list
2764631|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2764632|NCT04481204|Cisplatin|cisplatin|mesh-list
2764633|NCT04481204|Fluorouracil|fluorouracil|mesh-list
2764634|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
2764635|NCT04481204|Irinotecan|irinotecan|mesh-list
2764636|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2264923|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2264924|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2264925|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264926|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264927|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2264928|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2264929|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2264930|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2264931|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
2264932|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
2264933|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
2264934|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
2764637|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764638|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
2764639|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
2764640|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
2764641|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764642|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2764643|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
2764644|NCT04481204|Antiviral Agents|antiviral agents|mesh-ancestor
2764645|NCT04481204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764646|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764647|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764648|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
2764649|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264935|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2264936|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264937|NCT00176696|Anesthetics|anesthetics|mesh-list
2264938|NCT00176696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2264939|NCT00176696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264940|NCT00176735|Capecitabine|capecitabine|mesh-list
2264941|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2264942|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
2264943|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264944|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264945|NCT00176761|Interleukin-2|interleukin-2|mesh-list
2264946|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264947|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2264948|NCT00176761|Analgesics|analgesics|mesh-ancestor
2264949|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
2764650|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2764651|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2764652|NCT04481204|Antidotes|antidotes|mesh-ancestor
2764653|NCT04481204|Protective Agents|protective agents|mesh-ancestor
2764654|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
2764655|NCT04481204|Vitamins|vitamins|mesh-ancestor
2764656|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
2764657|NCT04481308|Fentanyl|fentanyl|mesh-list
2764658|NCT04481308|Propofol|propofol|mesh-list
2764659|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2764660|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2764661|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764662|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2764663|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
2764664|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
2764665|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2764666|NCT04481308|Narcotics|narcotics|mesh-ancestor
2764667|NCT04481308|Analgesics|analgesics|mesh-ancestor
2764668|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
2764669|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764670|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2764671|NCT04481412|Cetirizine|cetirizine|mesh-list
2764672|NCT04481412|Ethanol|ethanol|mesh-list
2764673|NCT04481412|Minoxidil|minoxidil|mesh-list
2764674|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2764675|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764676|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2764677|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764678|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2764679|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2764680|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2764681|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
2764682|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
2764683|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2764684|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764685|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2764686|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
2764687|NCT04481451|Ropivacaine|ropivacaine|mesh-list
2764688|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
2764689|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
2764690|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2764691|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764692|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
2764693|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764694|NCT04481256|Paclitaxel|paclitaxel|mesh-list
2764695|NCT04481256|Carboplatin|carboplatin|mesh-list
2764696|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2764697|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764698|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
2764699|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
2764700|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
2764701|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764702|NCT04481100|Itraconazole|itraconazole|mesh-list
2764703|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
2764704|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764705|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2764706|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2101627|NCT02393677|Ropivacaine|ropivacaine|mesh-list
2101628|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2101629|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101630|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101631|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2101632|NCT02393677|Analgesics|analgesics|mesh-ancestor
2101633|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
2101634|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101635|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2101636|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2764707|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764708|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764709|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2764710|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
2764711|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2764712|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764713|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2764714|NCT04480918|Ketamine|ketamine|mesh-list
2764715|NCT04480918|Esketamine|esketamine|mesh-list
2101637|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2101638|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
2101639|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101640|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264950|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264951|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264952|NCT00176774|Leucovorin|leucovorin|mesh-list
2264953|NCT00176774|Fluorouracil|fluorouracil|mesh-list
2264954|NCT00176774|Irinotecan|irinotecan|mesh-list
2264955|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2264956|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
2264957|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101641|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
2101642|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
2101643|NCT02393690|Iodine|iodine|mesh-list
2101644|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
2101645|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2101646|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101647|NCT02393690|Trace Elements|trace elements|mesh-ancestor
2101648|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
2101649|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101650|NCT02393755|Capecitabine|capecitabine|mesh-list
2101651|NCT02393755|Nintedanib|nintedanib|mesh-list
2101652|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2101653|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
2101654|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101655|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101656|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2101657|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101658|NCT02393859|Dexamethasone|dexamethasone|mesh-list
2264958|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2264959|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264960|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764716|NCT04480918|Analgesics|analgesics|mesh-ancestor
2764717|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
2764718|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764719|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764720|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2764721|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2764722|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
2764723|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
2764724|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2764725|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2764726|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2764727|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2764728|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764729|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
2764730|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2764731|NCT04480827|Cholic Acids|cholic acids|mesh-list
2764732|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2764733|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
2764734|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2764735|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
2764736|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764737|NCT04481048|Expectorants|expectorants|mesh-ancestor
2764738|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
2764739|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2764740|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
2764741|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764742|NCT04481048|Protective Agents|protective agents|mesh-ancestor
2764743|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764744|NCT04481048|Antidotes|antidotes|mesh-ancestor
2764745|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
2764746|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2764747|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2764748|NCT04480775|Prednisolone|prednisolone|mesh-list
2764749|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
2764750|NCT04480775|Triamcinolone|triamcinolone|mesh-list
2764751|NCT04480775|Bupivacaine|bupivacaine|mesh-list
2764752|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2764753|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
2764754|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
2764755|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
2764756|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101659|NCT02393859|Methotrexate|methotrexate|mesh-list
2264961|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
2764757|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764758|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
2764759|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764760|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2764761|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
2764762|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
2764763|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2764764|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
2764765|NCT04480775|Hormones|hormones|mesh-ancestor
2764766|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2764767|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2764768|NCT04480775|Protective Agents|protective agents|mesh-ancestor
2764769|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2764770|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764771|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2764772|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2764773|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764774|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764775|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
2764776|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764777|NCT04480593|Propolis|propolis|mesh-list
2764778|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764779|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
2764780|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2764781|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
2764782|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764783|NCT04481035|Expectorants|expectorants|mesh-ancestor
2764784|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
2764785|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2764786|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
2764787|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764788|NCT04481035|Protective Agents|protective agents|mesh-ancestor
2764789|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264962|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264963|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2264964|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2764790|NCT04481035|Antidotes|antidotes|mesh-ancestor
2764807|NCT04480502|Ipilimumab|ipilimumab|mesh-list
2764808|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2764809|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764810|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2764811|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764812|NCT04480450|Rituximab|rituximab|mesh-list
2764813|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2764814|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764815|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
2764816|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764817|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2764818|NCT04480190|Gemcitabine|gemcitabine|mesh-list
2764819|NCT04480190|Fluorouracil|fluorouracil|mesh-list
2764820|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764821|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2764822|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
2764823|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764824|NCT04480190|Antiviral Agents|antiviral agents|mesh-ancestor
2764825|NCT04480190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764826|NCT04480190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764827|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764828|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
2764829|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789754|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
2764830|NCT04480086|Navitoclax|navitoclax|mesh-list
2764831|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764832|NCT04480281|Lidocaine|lidocaine|mesh-list
2764833|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
2764834|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
2764835|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2764836|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764837|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
2764838|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764839|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2764840|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2764841|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2764842|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2764843|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764844|NCT04480268|Gemcitabine|gemcitabine|mesh-list
2764845|NCT04480268|Paclitaxel|paclitaxel|mesh-list
2764846|NCT04480268|Capecitabine|capecitabine|mesh-list
2764847|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2764848|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764849|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
2764850|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
2764851|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
2764852|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764853|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2764854|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
2764855|NCT04480268|Antiviral Agents|antiviral agents|mesh-ancestor
2764856|NCT04480268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764857|NCT04480268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764858|NCT04480268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764859|NCT04480268|Immunologic Factors|immunologic factors|mesh-ancestor
2764860|NCT04480268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764861|NCT04480463|Aflibercept|aflibercept|mesh-list
2764862|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2764863|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2764864|NCT04480463|Growth Substances|growth substances|mesh-ancestor
2764865|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764866|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
2764867|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764868|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
2764869|NCT04480333|Remdesivir|remdesivir|mesh-list
2764870|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
2764871|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764872|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
2764873|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764874|NCT04480333|Protective Agents|protective agents|mesh-ancestor
2764875|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764876|NCT04480372|Gemcitabine|gemcitabine|mesh-list
2764877|NCT04480372|Atezolizumab|atezolizumab|mesh-list
2764878|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2764879|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
2764880|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764881|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764882|NCT04480372|Antiviral Agents|antiviral agents|mesh-ancestor
2764883|NCT04480372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264965|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264966|NCT00176774|Antidotes|antidotes|mesh-ancestor
2264967|NCT00176774|Protective Agents|protective agents|mesh-ancestor
2264968|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
2264969|NCT00176774|Vitamins|vitamins|mesh-ancestor
2264970|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
2264971|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
2264972|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
2264973|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2264974|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2264975|NCT00176774|Growth Substances|growth substances|mesh-ancestor
2264976|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
2264977|NCT00176787|Capecitabine|capecitabine|mesh-list
2264978|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2264979|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
2264980|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264981|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264982|NCT00176813|Gemcitabine|gemcitabine|mesh-list
2264983|NCT00176813|Celecoxib|celecoxib|mesh-list
2264984|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2264985|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2264986|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
2764884|NCT04480372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764885|NCT04480372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764886|NCT04480372|Immunologic Factors|immunologic factors|mesh-ancestor
2764887|NCT04480372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764888|NCT04480125|Azacitidine|azacitidine|mesh-list
2764889|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2764890|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
2764891|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764892|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764893|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764894|NCT04480138|Interferons|interferons|mesh-list
2764895|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764896|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
2764897|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764898|NCT04480359|Meloxicam|meloxicam|mesh-list
2764899|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2764900|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2764901|NCT04480359|Analgesics|analgesics|mesh-ancestor
2764902|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
2764903|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264987|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2264988|NCT00176813|Antiviral Agents|antiviral agents|mesh-ancestor
2264989|NCT00176813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2264990|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264991|NCT00176813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2764904|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764905|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2764906|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2764907|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2764908|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2764909|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764910|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764911|NCT04479748|Dexamethasone|dexamethasone|mesh-list
2764912|NCT04479748|Prednisolone|prednisolone|mesh-list
2764913|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2764914|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
2764915|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2101660|NCT02393859|Daunorubicin|daunorubicin|mesh-list
2101661|NCT02393859|Asparaginase|asparaginase|mesh-list
2101662|NCT02393859|Ifosfamide|ifosfamide|mesh-list
2764916|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
2764917|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2764918|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
2764919|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2764920|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
2764921|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
2764922|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2764923|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764924|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2764925|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
2764926|NCT04479748|Hormones|hormones|mesh-ancestor
2764927|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2764928|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2764929|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764930|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2764931|NCT04479748|Protective Agents|protective agents|mesh-ancestor
2764932|NCT04479657|Cefuroxime|cefuroxime|mesh-list
2764933|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
2764934|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2764935|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764936|NCT04479865|Donepezil|donepezil|mesh-list
2764937|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2764938|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764939|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764940|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
2101663|NCT02393859|Blinatumomab|blinatumomab|mesh-list
2101664|NCT02393859|Pegaspargase|pegaspargase|mesh-list
2101665|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2101666|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
2101667|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
2101668|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101669|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101670|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2101671|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
2101672|NCT02393859|Hormones|hormones|mesh-ancestor
2101673|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2101674|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2764941|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2764942|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764943|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
2764944|NCT04479891|Itraconazole|itraconazole|mesh-list
2764945|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
2764946|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2764947|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2764948|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2764949|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2264992|NCT00176813|Immunologic Factors|immunologic factors|mesh-ancestor
2264993|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2264994|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2264995|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2264996|NCT00176813|Analgesics|analgesics|mesh-ancestor
2264997|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
2764950|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764951|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2764952|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
2264998|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2264999|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2265000|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2265001|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2265002|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2265003|NCT00176943|Imiquimod|imiquimod|mesh-list
2265004|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2764953|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2764954|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764955|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2764956|NCT04479813|Moxonidine|moxonidine|mesh-list
2764957|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2764958|NCT04479527|Apatinib|apatinib|mesh-list
2764959|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764960|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2764961|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764962|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2764963|NCT04479202|Bentonite|bentonite|mesh-list
2764964|NCT04479202|Antidotes|antidotes|mesh-ancestor
2764965|NCT04479202|Protective Agents|protective agents|mesh-ancestor
2764966|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2764967|NCT04479306|Osimertinib|osimertinib|mesh-list
2764968|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2764969|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2764970|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2764971|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265005|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
2265006|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265007|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265008|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
2265009|NCT00176969|Capsaicin|capsaicin|mesh-list
2265010|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
2265011|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
2265012|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
2265013|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265014|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265015|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
2265016|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
2265017|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2265018|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2265019|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265020|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265021|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265022|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2265023|NCT00176995|Eflornithine|eflornithine|mesh-list
2265024|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265025|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2265026|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2265027|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2265028|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265029|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2265030|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265031|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265032|NCT00177008|Aripiprazole|aripiprazole|mesh-list
2265033|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
2265034|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265035|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2265036|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2265037|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765015|NCT04479371|Bupivacaine|bupivacaine|mesh-list
2765016|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
2765017|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
2765018|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765019|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765020|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
2765021|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765022|NCT04479449|Otaplimastat|otaplimastat|mesh-list
2765023|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2765024|NCT04479449|Protective Agents|protective agents|mesh-ancestor
2765025|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765026|NCT04479072|Aspirin|aspirin|mesh-list
2765027|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2765028|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2765029|NCT04479072|Analgesics|analgesics|mesh-ancestor
2765030|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
2765031|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765032|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765033|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2765034|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2765035|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2765036|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2765037|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765038|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2765039|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2765040|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765041|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
2765042|NCT04478838|Olanzapine|olanzapine|mesh-list
2765043|NCT04478838|Risperidone|risperidone|mesh-list
2765044|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2765045|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
2765046|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2765047|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765048|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765049|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2765050|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2765051|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765052|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2765053|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2765054|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
2765055|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
2765056|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
2765057|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765058|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2765059|NCT04478838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2765060|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2765061|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2765062|NCT04478617|Metronidazole|metronidazole|mesh-list
2765063|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765064|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2765065|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2765066|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2789755|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
2789756|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789757|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2789758|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2792728|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2792729|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2792730|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2792731|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
2792732|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2792733|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
2792734|NCT04275713|Metformin|metformin|mesh-list
2792735|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2792736|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792737|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
2792738|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
2792739|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2792740|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2792741|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792742|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792743|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792744|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2792745|NCT04275414|Bevacizumab|bevacizumab|mesh-list
2792746|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2792747|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792748|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2792749|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2792750|NCT04275414|Growth Substances|growth substances|mesh-ancestor
2792751|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792752|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
2792753|NCT04275518|Cytarabine|cytarabine|mesh-list
2792754|NCT04275518|Azacitidine|azacitidine|mesh-list
2792755|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2792756|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
2792757|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792758|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792759|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
2792760|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792761|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2792762|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
2792763|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792764|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792765|NCT04275375|Anesthetics|anesthetics|mesh-list
2792766|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792767|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792768|NCT04275232|Plasminogen|plasminogen|mesh-list
2792769|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2792770|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2792771|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792772|NCT04275388|Interferons|interferons|mesh-list
2792773|NCT04275388|Ritonavir|ritonavir|mesh-list
2792774|NCT04275388|Lopinavir|lopinavir|mesh-list
2792775|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
2792776|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2792777|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792778|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
2792779|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765067|NCT04478448|Favipiravir|favipiravir|mesh-list
2765068|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
2765069|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765070|NCT04478461|Antibodies|antibodies|mesh-list
2765071|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2265038|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265039|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
2265040|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
2265041|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265042|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265043|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2265044|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2765072|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
2765073|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765074|NCT04478526|Norepinephrine|norepinephrine|mesh-list
2265045|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
2265046|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2265047|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2765075|NCT04478526|Serotonin|serotonin|mesh-list
2765076|NCT04478526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2765077|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
2765078|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2765079|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2765080|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
2765081|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2765082|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265048|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2265049|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2265050|NCT00177021|Imiquimod|imiquimod|mesh-list
2265051|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2265052|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
2265053|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101675|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101676|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2101677|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
2101678|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2101679|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2101680|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
2101681|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101682|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
2101683|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101684|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2101685|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2101686|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
2101687|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2101688|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2765083|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765084|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
2765085|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
2765086|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765087|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2765088|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2765089|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
2765090|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2765091|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2765092|NCT04478357|Fesoterodine|fesoterodine|mesh-list
2765093|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2765094|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2765095|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
2765096|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2765097|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765098|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765099|NCT04478357|Urological Agents|urological agents|mesh-ancestor
2765100|NCT04478474|Ganciclovir|ganciclovir|mesh-list
2765101|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2765102|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
2765103|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765104|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2765105|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765106|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765107|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
2765108|NCT04478292|Cisplatin|cisplatin|mesh-list
2765109|NCT04478292|Carboplatin|carboplatin|mesh-list
2765110|NCT04478292|Doxorubicin|doxorubicin|mesh-list
2765111|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2765112|NCT04478292|Fluorouracil|fluorouracil|mesh-list
2765113|NCT04478292|Irinotecan|irinotecan|mesh-list
2765114|NCT04478292|Vincristine|vincristine|mesh-list
2765115|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765116|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2765117|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2765118|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2765119|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765120|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765121|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
2765122|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2101689|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2101690|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2101691|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2101692|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2101693|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
2101694|NCT02394340|Luliconazole|luliconazole|mesh-list
2101695|NCT02394340|Omeprazole|omeprazole|mesh-list
2101696|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2101697|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2101698|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2101699|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101700|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101701|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
2101702|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101703|NCT02394457|Cosyntropin|cosyntropin|mesh-list
2101704|NCT02394457|Hormones|hormones|mesh-ancestor
2101705|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2101706|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101707|NCT02394730|Vorapaxar|vorapaxar|mesh-list
2101708|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2101709|NCT02394769|Aspirin|aspirin|mesh-list
2101710|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2101711|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2101712|NCT02394769|Analgesics|analgesics|mesh-ancestor
2101713|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
2101714|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101715|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101716|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2101717|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2101718|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2101719|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2101720|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101721|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2101722|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2101723|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101724|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
2101725|NCT02394951|Pregabalin|pregabalin|mesh-list
2101726|NCT02394951|Analgesics|analgesics|mesh-ancestor
2101727|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
2101728|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101729|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101730|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
2101731|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2101732|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2101733|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101734|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2101735|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2101736|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2101737|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765123|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2765124|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
2765125|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765126|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2765127|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2765128|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
2765129|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
2765130|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
2765131|NCT04478292|Antidotes|antidotes|mesh-ancestor
2765132|NCT04478292|Protective Agents|protective agents|mesh-ancestor
2765133|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
2765134|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
2765135|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2765136|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265054|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265055|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
2265056|NCT00177060|Hydromorphone|hydromorphone|mesh-list
2265057|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2265058|NCT00177060|Narcotics|narcotics|mesh-ancestor
2265059|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2265060|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265061|NCT00177060|Analgesics|analgesics|mesh-ancestor
2265062|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
2265063|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265064|NCT00177086|Alfuzosin|alfuzosin|mesh-list
2265065|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2265066|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2265067|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2265068|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
2265069|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265070|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265071|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265072|NCT00177086|Urological Agents|urological agents|mesh-ancestor
2765137|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
2765138|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
2765139|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
2765140|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2765141|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2765142|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765143|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765144|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2765145|NCT04478513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2765146|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2765147|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2765148|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765149|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2765150|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
2765151|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2765152|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
2765153|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2765154|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2765155|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765156|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2765157|NCT04478500|Minocycline|minocycline|mesh-list
2765158|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2765159|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765160|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2765161|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2765162|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765163|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765175|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
2765176|NCT04478019|Povidone|povidone|mesh-list
2765177|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
2765178|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
2765179|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2765180|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765181|NCT04477850|Luspatercept|luspatercept|mesh-list
2765182|NCT04477850|Hematinics|hematinics|mesh-ancestor
2765183|NCT04477772|Antibodies|antibodies|mesh-list
2765184|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2765185|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
2765186|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765187|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
2765188|NCT04477629|Abatacept|abatacept|mesh-list
2765189|NCT04477629|Tacrolimus|tacrolimus|mesh-list
2765190|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2765191|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
2765192|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765193|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2265073|NCT00177099|Tacrolimus|tacrolimus|mesh-list
2765194|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765195|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765196|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2765197|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765198|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2765199|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
2765200|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2765201|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765202|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2765203|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2765204|NCT04477642|Abatacept|abatacept|mesh-list
2765205|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2765206|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765207|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765208|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2765209|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
2765210|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765211|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2765212|NCT04477811|Vitamins|vitamins|mesh-list
2765213|NCT04477811|Vitamin K|vitamin k|mesh-list
2765214|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
2765215|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
2765216|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
2765217|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765218|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2765219|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2765220|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765221|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
2765222|NCT04477811|Coagulants|coagulants|mesh-ancestor
2765223|NCT04477590|Metformin|metformin|mesh-list
2765224|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2765225|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765226|NCT04477525|Bupivacaine|bupivacaine|mesh-list
2765227|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
2765228|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
2765229|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765230|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265074|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265075|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
2265076|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265077|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2265078|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265079|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265080|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
2265081|NCT00177138|Tacrolimus|tacrolimus|mesh-list
2265082|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265083|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
2265084|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765231|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
2765232|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765233|NCT04477317|Epinephrine|epinephrine|mesh-list
2765234|NCT04477317|Racepinephrine|racepinephrine|mesh-list
2765235|NCT04477317|Nordefrin|nordefrin|mesh-list
2765236|NCT04477317|Mepivacaine|mepivacaine|mesh-list
2765237|NCT04477317|Carticaine|carticaine|mesh-list
2765238|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
2765239|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2765240|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2765241|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
2765242|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2765243|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765244|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765245|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2765246|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2765247|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
2765248|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765249|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2765250|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
2765251|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
2765252|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
2765253|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2765254|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
2265085|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2765255|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
2765256|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765257|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
2765258|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
2765259|NCT04477304|Narcotics|narcotics|mesh-ancestor
2765260|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765261|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765262|NCT04477304|Analgesics|analgesics|mesh-ancestor
2765263|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
2765264|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765265|NCT04477096|Emtricitabine|emtricitabine|mesh-list
2765266|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
2765267|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765268|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2765269|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2765270|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765271|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765272|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2765273|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2765274|NCT04476979|Dexamethasone|dexamethasone|mesh-list
2765275|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2765276|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
2765277|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
2265086|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265087|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265088|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2265089|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265090|NCT00177242|Gefitinib|gefitinib|mesh-list
2265091|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265092|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2265093|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765278|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765279|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765280|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2765281|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
2765282|NCT04476979|Hormones|hormones|mesh-ancestor
2765283|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2765284|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2765285|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765294|NCT04476966|Mirabegron|mirabegron|mesh-list
2765295|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2765296|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2765297|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2765298|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
2765299|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2765300|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765301|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765302|NCT04476966|Urological Agents|urological agents|mesh-ancestor
2265094|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265095|NCT00177281|Belotecan|belotecan|mesh-list
2265096|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2265097|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2265098|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265099|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265100|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265101|NCT00177333|Doxycycline|doxycycline|mesh-list
2265102|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2265103|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265104|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
2265105|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2265106|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2265107|NCT00177372|Misoprostol|misoprostol|mesh-list
2265108|NCT00177372|Mifepristone|mifepristone|mesh-list
2265109|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2265110|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
2265111|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2265112|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265113|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2765303|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
2765304|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
2265114|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2765305|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2765306|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2765307|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765308|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765309|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765310|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2765311|NCT04477018|Ascorbic Acid|ascorbic acid|mesh-list
2265115|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
2265116|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2265117|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2265118|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2765312|NCT04477018|Iron|iron|mesh-list
2765313|NCT04477018|Chelating Agents|chelating agents|mesh-list
2765314|NCT04477018|Vitamins|vitamins|mesh-ancestor
2765315|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
2765316|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765317|NCT04477018|Trace Elements|trace elements|mesh-ancestor
2765318|NCT04477018|Antioxidants|antioxidants|mesh-ancestor
2765319|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765320|NCT04477018|Protective Agents|protective agents|mesh-ancestor
2765321|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
2765322|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
2765323|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2265119|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2265120|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
2265121|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2265122|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2265123|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
2265124|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2265125|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
2265126|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2265127|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2265128|NCT00177398|Insulin|insulin|mesh-list
2265129|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2265130|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
2265131|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2265132|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265133|NCT00177411|Hormones|hormones|mesh-list
2265134|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
2265135|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
2265136|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2265137|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265138|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2265139|NCT00177424|Sertraline|sertraline|mesh-list
2265140|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
2265141|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265142|NCT00177424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2265143|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265144|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2265145|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265146|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265147|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
2265148|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265149|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2265150|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2265151|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265152|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2265153|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265154|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265155|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765324|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
2765325|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765326|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765327|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2765328|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
2765329|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2765330|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
2765331|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765332|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2765333|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2765334|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
2765335|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
2765336|NCT04476992|Protective Agents|protective agents|mesh-ancestor
2789759|NCT04300881|Eplerenone|eplerenone|mesh-list
2789760|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2789761|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
2789762|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2789763|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789764|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2789765|NCT04300881|Diuretics|diuretics|mesh-ancestor
2789766|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
2789767|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2789768|NCT04300452|Carbetocin|carbetocin|mesh-list
2789769|NCT04300452|Ergonovine|ergonovine|mesh-list
2789770|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
2789771|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2789772|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789773|NCT04300374|Anesthetics|anesthetics|mesh-list
2789774|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789775|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789776|NCT04300790|Metformin|metformin|mesh-list
2789777|NCT04300790|Fulvestrant|fulvestrant|mesh-list
2789778|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2789779|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789780|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2789781|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789782|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2789783|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2789784|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
2789785|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2265156|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2265157|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
2265158|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265159|NCT00177567|Lamotrigine|lamotrigine|mesh-list
2265160|NCT00177567|Valproic Acid|valproic acid|mesh-list
2265161|NCT00177567|Olanzapine|olanzapine|mesh-list
2265162|NCT00177567|Risperidone|risperidone|mesh-list
2265163|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
2265164|NCT00177567|Mirtazapine|mirtazapine|mesh-list
2265165|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
2265166|NCT00177567|Bupropion|bupropion|mesh-list
2265167|NCT00177567|Paroxetine|paroxetine|mesh-list
2265168|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2265169|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2101738|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2101739|NCT02395055|Adalimumab|adalimumab|mesh-list
2101740|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2101741|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2101742|NCT02395081|Vitamin D|vitamin d|mesh-list
2265170|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
2265171|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2789786|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
2789787|NCT04300751|Narcotics|narcotics|mesh-ancestor
2789788|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789789|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789790|NCT04300751|Analgesics|analgesics|mesh-ancestor
2789791|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
2789792|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789793|NCT04300322|Progesterone|progesterone|mesh-list
2789794|NCT04300322|Progestins|progestins|mesh-ancestor
2789795|NCT04300322|Hormones|hormones|mesh-ancestor
2789796|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2789797|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789798|NCT04300192|Vaccines|vaccines|mesh-list
2789799|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
2789800|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789801|NCT04300231|Hydromorphone|hydromorphone|mesh-list
2789802|NCT04300231|Bupivacaine|bupivacaine|mesh-list
2789803|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
2789804|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
2789805|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789806|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789807|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
2789808|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789809|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2101743|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
2101744|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
2101745|NCT02395081|Vitamins|vitamins|mesh-list
2101746|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
2789810|NCT04300231|Narcotics|narcotics|mesh-ancestor
2789811|NCT04300231|Analgesics|analgesics|mesh-ancestor
2765346|NCT04476628|Budesonide|budesonide|mesh-list
2765347|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2765348|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2765349|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
2765350|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765351|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765352|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2765353|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
2765354|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
2765355|NCT04476628|Hormones|hormones|mesh-ancestor
2765356|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2765357|NCT04476550|Lenograstim|lenograstim|mesh-list
2765358|NCT04476550|Sargramostim|sargramostim|mesh-list
2765359|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2765360|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
2265172|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265173|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265174|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2265175|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2265176|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2265177|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265178|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2265179|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
2265180|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
2265181|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
2265182|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265183|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2265184|NCT00177567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2265185|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265186|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2265187|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2265188|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
2765361|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765362|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
2765363|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2765364|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765365|NCT04476511|Vitamins|vitamins|mesh-ancestor
2765366|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
2765367|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2765368|NCT04476680|Vitamin D|vitamin d|mesh-list
2765369|NCT04476680|Vitamins|vitamins|mesh-ancestor
2765370|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
2765371|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765372|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2765373|NCT04476745|Vitamin D|vitamin d|mesh-list
2265189|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2265190|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2265191|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2265192|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265193|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
2265194|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2265195|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
2265196|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2265197|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2265198|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2765374|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
2765375|NCT04476745|Vitamins|vitamins|mesh-ancestor
2765376|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
2765377|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765378|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2765379|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2765380|NCT04476459|Apatinib|apatinib|mesh-list
2765381|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765382|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2765383|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265199|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
2265200|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2265201|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
2265202|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
2265203|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2265204|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2265205|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2265206|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2265207|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
2265208|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2265209|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2265210|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2265211|NCT00177580|Pravastatin|pravastatin|mesh-list
2265212|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2265213|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2265214|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
2265215|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265216|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2265217|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2265218|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265219|NCT00177619|Alendronate|alendronate|mesh-list
2265220|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2265221|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265222|NCT00177684|Amphotericin B|amphotericin b|mesh-list
2265223|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2265224|NCT00177684|Amebicides|amebicides|mesh-ancestor
2265225|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2265226|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2265227|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265228|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2765384|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765385|NCT04476121|Aspirin|aspirin|mesh-list
2765386|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2765387|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2765388|NCT04476121|Analgesics|analgesics|mesh-ancestor
2765389|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
2765390|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765391|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765392|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2765393|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2765394|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2765395|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2765396|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765397|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2765398|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2765399|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765400|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
2765401|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2765402|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765403|NCT04476173|Morphine|morphine|mesh-list
2765404|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
2765405|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2765406|NCT04476173|Narcotics|narcotics|mesh-ancestor
2765407|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765408|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765409|NCT04476173|Analgesics|analgesics|mesh-ancestor
2765410|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
2765411|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765412|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2265229|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
2265230|NCT00177710|Amphotericin B|amphotericin b|mesh-list
2265231|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2265232|NCT00177710|Amebicides|amebicides|mesh-ancestor
2265233|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2265234|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2265235|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265236|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2265237|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
2265238|NCT00177749|Posaconazole|posaconazole|mesh-list
2265239|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
2265240|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265241|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2265242|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2765413|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
2765414|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
2765415|NCT04476186|Acyclovir|acyclovir|mesh-list
2765416|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
2765417|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765418|NCT04476069|Ibuprofen|ibuprofen|mesh-list
2765419|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2765420|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2765421|NCT04476069|Analgesics|analgesics|mesh-ancestor
2765422|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
2765423|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765424|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765425|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2765426|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2765427|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2765428|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765429|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765430|NCT04476199|Decitabine|decitabine|mesh-list
2765431|NCT04476199|Venetoclax|venetoclax|mesh-list
2765432|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2765433|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
2765434|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765435|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765436|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765437|NCT04475705|Propofol|propofol|mesh-list
2765438|NCT04475705|Sevoflurane|sevoflurane|mesh-list
2765439|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2765440|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765441|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765442|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2765443|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
2765444|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
2765445|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2765446|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2765447|NCT04475887|Iron|iron|mesh-list
2765448|NCT04475887|Trace Elements|trace elements|mesh-ancestor
2765449|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
2765450|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765456|NCT04475835|Heparin|heparin|mesh-list
2765457|NCT04475835|Bivalirudin|bivalirudin|mesh-list
2765458|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
2765459|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2765460|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2765461|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765462|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
2765463|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2765464|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
2765465|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765466|NCT04475991|Maraviroc|maraviroc|mesh-list
2765467|NCT04475991|Favipiravir|favipiravir|mesh-list
2765468|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2765469|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2765470|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765471|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2765472|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2765473|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
2765474|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265243|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2265244|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2265245|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2265246|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265247|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265248|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2265249|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
2265250|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2265251|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265252|NCT00177853|Celecoxib|celecoxib|mesh-list
2265253|NCT00177853|Irinotecan|irinotecan|mesh-list
2265254|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2265255|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2765475|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2765476|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
2765477|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
2765478|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265256|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265257|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265258|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265259|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2265260|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2265261|NCT00177853|Analgesics|analgesics|mesh-ancestor
2265262|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
2265263|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265264|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265265|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2265266|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2265267|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2265268|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2265269|NCT00177996|Sertraline|sertraline|mesh-list
2265270|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
2265271|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2765479|NCT04475276|Protective Agents|protective agents|mesh-ancestor
2765480|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765481|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
2765482|NCT04475276|Vitamins|vitamins|mesh-ancestor
2765483|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
2765484|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
2765485|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2765486|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
2765487|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765488|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
2765489|NCT04475614|Vitamins|vitamins|mesh-ancestor
2765490|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
2765491|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789812|NCT04300049|Glucagon|glucagon|mesh-list
2789813|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2789814|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2789815|NCT04300049|Hormones|hormones|mesh-ancestor
2789816|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2789817|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789818|NCT04300049|Incretins|incretins|mesh-ancestor
2789819|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2265272|NCT00177996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2265273|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265274|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2789820|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
2789821|NCT04299971|Methotrexate|methotrexate|mesh-list
2789822|NCT04299971|Tofacitinib|tofacitinib|mesh-list
2265275|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265276|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265277|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
2265278|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265279|NCT00178035|Paroxetine|paroxetine|mesh-list
2265280|NCT00178035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2265281|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265282|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2265283|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265284|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265285|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
2265286|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789823|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2789824|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
2789825|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2789826|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789827|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2789828|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
2789829|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789830|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789831|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
2789832|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789833|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2789834|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2789835|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
2789836|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2789837|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2265287|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2265288|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
2789838|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2789839|NCT04300127|Pioglitazone|pioglitazone|mesh-list
2765492|NCT04475224|Mitogens|mitogens|mesh-list
2765493|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
2765494|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765495|NCT04475016|Paclitaxel|paclitaxel|mesh-list
2765496|NCT04475016|Ifosfamide|ifosfamide|mesh-list
2765497|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2765498|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
2765499|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2765500|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765501|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
2765502|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
2765503|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
2765504|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765505|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2765506|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
2765507|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2765508|NCT04475107|Artesunate|artesunate|mesh-list
2765509|NCT04475107|Pyronaridine|pyronaridine|mesh-list
2765510|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
2765511|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2765512|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2765513|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765514|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765515|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
2765516|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
2765517|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2765518|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
2765519|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
2765520|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2765521|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765522|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2765523|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765524|NCT04475120|Lactoferrin|lactoferrin|mesh-list
2765525|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765526|NCT04474899|Amlodipine|amlodipine|mesh-list
2765527|NCT04474899|Moxonidine|moxonidine|mesh-list
2765528|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2265289|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265290|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2265291|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2765529|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2765530|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2765531|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765532|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2765533|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765534|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
2765535|NCT04475029|Morphine|morphine|mesh-list
2765536|NCT04475029|Methadone|methadone|mesh-list
2765537|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2765538|NCT04475029|Narcotics|narcotics|mesh-ancestor
2765539|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101747|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101748|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2101749|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2101750|NCT02395172|Docetaxel|docetaxel|mesh-list
2101751|NCT02395172|Avelumab|avelumab|mesh-list
2101752|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101753|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
2101754|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
2101755|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
2101756|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101757|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101758|NCT02395627|Tamoxifen|tamoxifen|mesh-list
2101759|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
2765540|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765541|NCT04475029|Analgesics|analgesics|mesh-ancestor
2765542|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
2765543|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765544|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
2765545|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
2765546|NCT04474938|Dexamethasone|dexamethasone|mesh-list
2765547|NCT04474938|Bortezomib|bortezomib|mesh-list
2765548|NCT04474938|Daratumumab|daratumumab|mesh-list
2765549|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2765550|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
2765551|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
2765552|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265292|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265293|NCT00178048|Paroxetine|paroxetine|mesh-list
2265294|NCT00178048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2265295|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265296|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2265297|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265298|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265299|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
2265300|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265301|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2265302|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
2265303|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265304|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2265305|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2265306|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765553|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765554|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2765555|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
2765556|NCT04474938|Hormones|hormones|mesh-ancestor
2765557|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2765558|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2765559|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765568|NCT04474600|Propofol|propofol|mesh-list
2765569|NCT04474600|Desflurane|desflurane|mesh-list
2765570|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2765571|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765572|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765573|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2765574|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
2765575|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
2765576|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2765577|NCT04474457|Favipiravir|favipiravir|mesh-list
2765578|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
2765579|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765580|NCT04474483|Melatonin|melatonin|mesh-list
2765581|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
2765582|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765583|NCT04474483|Protective Agents|protective agents|mesh-ancestor
2765584|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765585|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765586|NCT04474327|Montelukast|montelukast|mesh-list
2765587|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2265307|NCT00178100|Paroxetine|paroxetine|mesh-list
2265308|NCT00178100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2265309|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265310|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2765588|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
2765589|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2765590|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
2765591|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2765592|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765593|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2765594|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2765595|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765596|NCT04474366|Ropivacaine|ropivacaine|mesh-list
2265311|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265312|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265313|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
2265314|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265315|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2265316|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
2265317|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265318|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2265319|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2765597|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
2765598|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
2765599|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765600|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765601|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
2765602|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765603|NCT04474262|Midodrine|midodrine|mesh-list
2765604|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
2765605|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
2765606|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765607|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765608|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2765609|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2765610|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2765611|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2765612|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
2765613|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2765614|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765615|NCT04474288|Antibodies|antibodies|mesh-list
2765616|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
2765617|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265320|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265321|NCT00178113|Lycopene|lycopene|mesh-list
2265322|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2265323|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
2265324|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265325|NCT00178113|Protective Agents|protective agents|mesh-ancestor
2265326|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265327|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2265328|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2265329|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265330|NCT00178269|Docetaxel|docetaxel|mesh-list
2265331|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265332|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
2265333|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
2265334|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
2265335|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265336|NCT00178373|Modafinil|modafinil|mesh-list
2265337|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2265338|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265339|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2265340|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2265341|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2265342|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265343|NCT00178451|Abciximab|abciximab|mesh-list
2265344|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
2265345|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2265346|NCT00178620|Reteplase|reteplase|mesh-list
2265347|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2765630|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
2765631|NCT04474093|Methamphetamine|methamphetamine|mesh-list
2765632|NCT04474093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2765633|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765634|NCT04474093|Sympathomimetics|sympathomimetics|mesh-ancestor
2765635|NCT04474093|Autonomic Agents|autonomic agents|mesh-ancestor
2765636|NCT04474093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765637|NCT04474093|Dopamine Agents|dopamine agents|mesh-ancestor
2765638|NCT04474093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2765639|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265348|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2265349|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265350|NCT00178698|Gemcitabine|gemcitabine|mesh-list
2765640|NCT04474093|Adrenergic Agents|adrenergic agents|mesh-ancestor
2765641|NCT04474093|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2765642|NCT04474093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2765643|NCT04474093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2765644|NCT04474093|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2765645|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
2765646|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2765647|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765648|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
2765649|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2765650|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765651|NCT04473989|Teriparatide|teriparatide|mesh-list
2765652|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2765653|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765654|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2765666|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
2765667|NCT04473911|Sirolimus|sirolimus|mesh-list
2765668|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
2765669|NCT04473911|Melphalan|melphalan|mesh-list
2765670|NCT04473911|Fludarabine|fludarabine|mesh-list
2765671|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2765672|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
2765673|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765674|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2765675|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2765676|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
2765677|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765678|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765679|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2765680|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2765681|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2765682|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
2765683|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2765684|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765685|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765686|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
2765687|NCT04473950|Naloxone|naloxone|mesh-list
2765688|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2765689|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765690|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
2765691|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765692|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
2765693|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2765694|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765695|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2765696|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
2765697|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2765698|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765699|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765700|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765701|NCT04473508|Ropivacaine|ropivacaine|mesh-list
2765702|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
2765703|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
2765704|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765705|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765706|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
2265351|NCT00178698|Interferons|interferons|mesh-list
2265352|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265353|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2265354|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
2765707|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765708|NCT04473820|Lidocaine|lidocaine|mesh-list
2765709|NCT04473820|Prilocaine|prilocaine|mesh-list
2765710|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2765711|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
2765712|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
2765713|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765714|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765715|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
2765716|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765717|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2765718|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2765719|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2765720|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2765721|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765722|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2765723|NCT04473482|Ethanol|ethanol|mesh-list
2765724|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2765725|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765726|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765727|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765728|NCT04473846|Anesthetics|anesthetics|mesh-list
2765729|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765730|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789840|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2789841|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789842|NCT04299633|Calcium|calcium|mesh-list
2789843|NCT04299633|Sevelamer|sevelamer|mesh-list
2789844|NCT04299633|Calcium acetate|calcium acetate|mesh-list
2789845|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2789846|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789847|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
2789848|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
2265355|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265356|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
2789849|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789855|NCT04299854|Dinoprostone|dinoprostone|mesh-list
2789856|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
2789857|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2789858|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789859|NCT04299438|Propranolol|propranolol|mesh-list
2789860|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2789861|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2789862|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
2789863|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2789864|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789865|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789866|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2789867|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2789868|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
2792780|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2792781|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2792782|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
2792783|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792784|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792785|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2792786|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2792787|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2792788|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2792789|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
2792790|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792791|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2792792|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
2792793|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792794|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
2792795|NCT04275258|Narcotics|narcotics|mesh-ancestor
2792796|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792797|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792798|NCT04275258|Analgesics|analgesics|mesh-ancestor
2792799|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
2792800|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792801|NCT04275492|Pramipexole|pramipexole|mesh-list
2765731|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
2765732|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2765733|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765734|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2765735|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765736|NCT04473274|Pioglitazone|pioglitazone|mesh-list
2765737|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2765738|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765739|NCT04473261|Iodine|iodine|mesh-list
2765740|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
2765741|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2765742|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765743|NCT04473261|Trace Elements|trace elements|mesh-ancestor
2765744|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
2765745|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765746|NCT04473053|Nafamostat|nafamostat|mesh-list
2765747|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2265357|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265358|NCT00178698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265359|NCT00178698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265360|NCT00178698|Immunologic Factors|immunologic factors|mesh-ancestor
2265361|NCT00178698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265362|NCT00178763|Gemcitabine|gemcitabine|mesh-list
2265363|NCT00178763|Interferons|interferons|mesh-list
2265364|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
2265365|NCT00178763|Cisplatin|cisplatin|mesh-list
2265366|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265367|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2265368|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
2765748|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2765749|NCT04473053|Analgesics|analgesics|mesh-ancestor
2765750|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
2765751|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765752|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765753|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2765754|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2765755|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
2765756|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
2765757|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765758|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765759|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2765760|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2765761|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2765762|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2765763|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
2765764|NCT04473144|Urinastatin|urinastatin|mesh-list
2765765|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2765766|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2765767|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
2765768|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765769|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765770|NCT04472910|Folfirinox|folfirinox|mesh-list
2765771|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765772|NCT04472949|Carboplatin|carboplatin|mesh-list
2765773|NCT04472949|Etoposide|etoposide|mesh-list
2765774|NCT04472949|Durvalumab|durvalumab|mesh-list
2765775|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765776|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2765777|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2765778|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2765779|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765780|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765781|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2765782|NCT04472585|Ivermectin|ivermectin|mesh-list
2765783|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2765784|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765785|NCT04472806|Endostar protein|endostar protein|mesh-list
2765786|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2765787|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2765788|NCT04472806|Growth Substances|growth substances|mesh-ancestor
2765789|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765790|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
2765791|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765792|NCT04472767|Nivolumab|nivolumab|mesh-list
2765793|NCT04472767|Ipilimumab|ipilimumab|mesh-list
2765794|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2765795|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765796|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2765797|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765798|NCT04472637|Atorvastatin|atorvastatin|mesh-list
2765799|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2265369|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265370|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
2265371|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265372|NCT00178763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265373|NCT00178763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265374|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
2265375|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265376|NCT00178802|Interferons|interferons|mesh-list
2265377|NCT00178802|Doxorubicin|doxorubicin|mesh-list
2265378|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2265379|NCT00178802|Fluorouracil|fluorouracil|mesh-list
2765800|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2765801|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
2765802|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765803|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2765804|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2765805|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265380|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2265381|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265382|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2265383|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2265384|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265385|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265386|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
2265387|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2265388|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265389|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
2265390|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265391|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
2265392|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265393|NCT00178828|Bupropion|bupropion|mesh-list
2265394|NCT00178828|Sertraline|sertraline|mesh-list
2265395|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2265396|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
2265397|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265398|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2265399|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265400|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2265401|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265402|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
2265403|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265404|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265405|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2265406|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2265407|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765814|NCT04472689|Lidocaine|lidocaine|mesh-list
2765815|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
2765816|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
2765817|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765818|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765819|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
2765820|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765821|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2765822|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2765823|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2765824|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2765825|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765826|NCT04472611|Colchicine|colchicine|mesh-list
2765827|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2765828|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2265408|NCT00178828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2265409|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
2265410|NCT00178854|Risperidone|risperidone|mesh-list
2265411|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2265412|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
2265413|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265414|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265415|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265416|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2265417|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2265418|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2265419|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265420|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2265421|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
2265422|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
2265423|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2265424|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2265425|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2265426|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2265427|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265428|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
2265429|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265430|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265431|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2265432|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265433|NCT00178971|Buspirone|buspirone|mesh-list
2265434|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2265435|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2265436|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765829|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2765830|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
2765831|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765832|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2765833|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2765834|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765835|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
2765836|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2765837|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
2765838|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
2765839|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
2765840|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765841|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
2765842|NCT04472481|Vitamin D|vitamin d|mesh-list
2765843|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2765844|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765845|NCT04472481|Vitamins|vitamins|mesh-ancestor
2765846|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
2765847|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2765848|NCT04472416|Analgesics|analgesics|mesh-list
2765849|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
2765850|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765851|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765859|NCT04472299|Ropivacaine|ropivacaine|mesh-list
2765860|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
2765861|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
2765862|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765863|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265437|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265438|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265439|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2765864|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
2765865|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765866|NCT04471922|Rabeprazole|rabeprazole|mesh-list
2765867|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2765868|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2765869|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2765870|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765871|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765872|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
2789869|NCT04298983|Androgens|androgens|mesh-list
2765873|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2765874|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765875|NCT04472143|Granisetron|granisetron|mesh-list
2765876|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
2765877|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
2765878|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765879|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265440|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
2265441|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265442|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265443|NCT00179023|Trimethaphan|trimethaphan|mesh-list
2265444|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
2265445|NCT00179023|Ephedrine|ephedrine|mesh-list
2765880|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2765881|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2765882|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
2765883|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2765884|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765885|NCT04471818|Ketamine|ketamine|mesh-list
2765886|NCT04471818|Analgesics|analgesics|mesh-ancestor
2765887|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
2765888|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765889|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765890|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2765891|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2765892|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
2765893|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
2765894|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765895|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2765896|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2765897|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2765898|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765899|NCT04472000|Ascorbic Acid|ascorbic acid|mesh-list
2765900|NCT04472000|Vitamins|vitamins|mesh-ancestor
2765901|NCT04472000|Micronutrients|micronutrients|mesh-ancestor
2765902|NCT04472000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765903|NCT04472000|Antioxidants|antioxidants|mesh-ancestor
2765904|NCT04472000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765905|NCT04472000|Protective Agents|protective agents|mesh-ancestor
2789870|NCT04298983|Hormones|hormones|mesh-ancestor
2789871|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2789872|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265446|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
2265447|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2265448|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
2265449|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265450|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265451|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2265452|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
2789883|NCT04298853|Morphine|morphine|mesh-list
2789884|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2789885|NCT04298853|Narcotics|narcotics|mesh-ancestor
2789886|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789887|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789888|NCT04298853|Analgesics|analgesics|mesh-ancestor
2789889|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
2789890|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789891|NCT04298775|Morphine|morphine|mesh-list
2789892|NCT04298775|Anesthetics|anesthetics|mesh-list
2789893|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789894|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789895|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2789896|NCT04298775|Narcotics|narcotics|mesh-ancestor
2789897|NCT04298775|Analgesics|analgesics|mesh-ancestor
2789898|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
2265453|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
2265454|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2265455|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2265456|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
2265457|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
2265458|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265459|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265460|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2265461|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2265462|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2265463|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2265464|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2265465|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
2265466|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
2265467|NCT00179062|Olanzapine|olanzapine|mesh-list
2265468|NCT00179062|Risperidone|risperidone|mesh-list
2265469|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2265470|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
2265471|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265472|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265473|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265474|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2265475|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2265476|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2265477|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265478|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2265479|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
2265480|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
2265481|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
2265482|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265483|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2265484|NCT00179062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2265485|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265486|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2765906|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2765907|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765908|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765915|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
2765916|NCT04471441|Everolimus|everolimus|mesh-list
2765917|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765918|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2765919|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
2765920|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765921|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2765922|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2765923|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
2765924|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2765925|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765926|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765927|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765935|NCT04471714|Baclofen|baclofen|mesh-list
2765936|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2765937|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765938|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2765939|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765940|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2765941|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
2765942|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
2765943|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2765944|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765945|NCT04471415|Atezolizumab|atezolizumab|mesh-list
2265487|NCT00179114|Baclofen|baclofen|mesh-list
2265488|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
2265489|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2265490|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2265491|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2265492|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2265493|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765946|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765947|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
2765948|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2765949|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2765950|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765951|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2765952|NCT04471402|Analgesics|analgesics|mesh-ancestor
2765953|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
2765954|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2765955|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2765956|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2765957|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2765958|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
2765959|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2765960|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765961|NCT04470908|Rifabutin|rifabutin|mesh-list
2765962|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
2765963|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2765964|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765965|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2765966|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
2765967|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2765968|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2765969|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765970|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2765971|NCT04471246|Cephalexin|cephalexin|mesh-list
2765972|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2265494|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
2265495|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265496|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265497|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2265498|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265499|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2265500|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2265501|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
2265502|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
2265503|NCT00179231|Olanzapine|olanzapine|mesh-list
2265504|NCT00179231|Clozapine|clozapine|mesh-list
2265505|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
2265506|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
2265507|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265508|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265509|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2265510|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2265511|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2265512|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2265513|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265514|NCT00179231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2265515|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265516|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2265517|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265518|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265519|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
2265520|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2265521|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
2265522|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
2265523|NCT00179244|Bupropion|bupropion|mesh-list
2265524|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2765973|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765974|NCT04470973|Amikacin|amikacin|mesh-list
2765975|NCT04470973|Cefuroxime|cefuroxime|mesh-list
2765976|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
2765977|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2765978|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2765979|NCT04470843|Acetazolamide|acetazolamide|mesh-list
2765980|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
2765981|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2765982|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2765983|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101760|NCT02395627|Vorinostat|vorinostat|mesh-list
2101761|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101762|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101763|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2765984|NCT04470843|Diuretics|diuretics|mesh-ancestor
2765985|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
2765986|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2765996|NCT04470479|Pilocarpine|pilocarpine|mesh-list
2765997|NCT04470479|Miotics|miotics|mesh-ancestor
2765998|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
2765999|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766000|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766001|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2766002|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2766003|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
2766004|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766005|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766006|NCT04470752|Capsaicin|capsaicin|mesh-list
2766007|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2766008|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
2766009|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
2766010|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
2766011|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766012|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766013|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2766014|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2766015|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766016|NCT04470531|Renal Agents|renal agents|mesh-ancestor
2766017|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2766018|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
2766019|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2766020|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2766021|NCT04470674|Carboplatin|carboplatin|mesh-list
2766022|NCT04470674|Pemetrexed|pemetrexed|mesh-list
2766023|NCT04470674|Durvalumab|durvalumab|mesh-list
2265525|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
2265526|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265527|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2766024|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766025|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766026|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766027|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2766028|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2766029|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2766030|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
2766031|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2766032|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2792802|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
2101764|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
2101765|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2101766|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101767|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2101768|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2101769|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2101770|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2101771|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2101772|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101773|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101774|NCT02395653|Fentanyl|fentanyl|mesh-list
2101775|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2101776|NCT02395653|Narcotics|narcotics|mesh-ancestor
2101777|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101778|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101779|NCT02395653|Analgesics|analgesics|mesh-ancestor
2101780|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
2766033|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766034|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
2766035|NCT04470557|Coagulants|coagulants|mesh-ancestor
2766036|NCT04470414|Antibodies|antibodies|mesh-list
2766037|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
2766038|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
2766039|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766040|NCT04470544|Camostat|camostat|mesh-list
2766041|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
2766042|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766043|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766044|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2766045|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2766046|NCT04470791|Antivenins|antivenins|mesh-list
2766047|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
2766048|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766049|NCT04470804|Cyclosporine|cyclosporine|mesh-list
2766050|NCT04470804|Sirolimus|sirolimus|mesh-list
2766051|NCT04470804|Cyclosporins|cyclosporins|mesh-list
2766052|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766053|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766054|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2766055|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
2766056|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766057|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
2766058|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766059|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
2766060|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2766061|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2766062|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2766063|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2766064|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766065|NCT04470609|Vaccines|vaccines|mesh-list
2766066|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
2766067|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766068|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2766069|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2766070|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2766071|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2766072|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766073|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
2766074|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766075|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766076|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2766077|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766078|NCT04470076|Gemcitabine|gemcitabine|mesh-list
2766079|NCT04470076|Carboplatin|carboplatin|mesh-list
2766080|NCT04470076|Pemetrexed|pemetrexed|mesh-list
2766081|NCT04470076|Afatinib|afatinib|mesh-list
2766082|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766083|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2766084|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
2766085|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766086|NCT04470076|Antiviral Agents|antiviral agents|mesh-ancestor
2766087|NCT04470076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766088|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766089|NCT04470076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2766090|NCT04470076|Immunologic Factors|immunologic factors|mesh-ancestor
2766091|NCT04470076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766092|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2766093|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2766094|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2766095|NCT04470310|Pioglitazone|pioglitazone|mesh-list
2766096|NCT04470310|Glimepiride|glimepiride|mesh-list
2766097|NCT04470310|Alogliptin|alogliptin|mesh-list
2766098|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2766099|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766100|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2766101|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2766102|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
2766103|NCT04470310|Incretins|incretins|mesh-ancestor
2766104|NCT04470310|Hormones|hormones|mesh-ancestor
2766105|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2766106|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2766107|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
2766108|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766109|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789899|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789900|NCT04298528|Dronabinol|dronabinol|mesh-list
2789901|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
2789902|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789903|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2789904|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2789905|NCT04298528|Analgesics|analgesics|mesh-ancestor
2789906|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
2789907|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789908|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2789909|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2789910|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2789911|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789912|NCT04298528|Hormones|hormones|mesh-ancestor
2789913|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2265528|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265529|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2265530|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265531|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
2265532|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265533|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265534|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2265535|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2265536|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265537|NCT00179257|Sertraline|sertraline|mesh-list
2265538|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
2265539|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2789914|NCT04298684|Metformin|metformin|mesh-list
2789915|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2789916|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2789917|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789918|NCT04298684|Incretins|incretins|mesh-ancestor
2789919|NCT04298684|Hormones|hormones|mesh-ancestor
2789920|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2789921|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2789922|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
2789923|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265540|NCT00179257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2265541|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265542|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2265543|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265544|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265545|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
2265546|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265547|NCT00179283|Sertraline|sertraline|mesh-list
2265548|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2265549|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
2265550|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265551|NCT00179283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2265552|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265553|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2789924|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789925|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
2789926|NCT04298229|Diuretics|diuretics|mesh-list
2789927|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2789928|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789929|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2789930|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789931|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
2789932|NCT04298372|Lenalidomide|lenalidomide|mesh-list
2789933|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
2789934|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789935|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2789936|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2789937|NCT04298372|Growth Substances|growth substances|mesh-ancestor
2789938|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
2789939|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789940|NCT04298463|Vancomycin|vancomycin|mesh-list
2789941|NCT04298463|Daptomycin|daptomycin|mesh-list
2789942|NCT04298463|Teicoplanin|teicoplanin|mesh-list
2789943|NCT04298463|Dalbavancin|dalbavancin|mesh-list
2789944|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2766110|NCT04470115|Anesthetics|anesthetics|mesh-list
2766111|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766112|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766113|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
2766114|NCT04469868|Narcotics|narcotics|mesh-ancestor
2766115|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766116|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766117|NCT04469868|Analgesics|analgesics|mesh-ancestor
2766118|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
2766119|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766120|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
2766121|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2766122|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766123|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766124|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2766125|NCT04470050|Analgesics|analgesics|mesh-ancestor
2766126|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
2766127|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766128|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2766129|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2766130|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2766131|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
2766132|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766133|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766134|NCT04470128|Fentanyl|fentanyl|mesh-list
2766135|NCT04470128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2766136|NCT04470128|Narcotics|narcotics|mesh-ancestor
2766137|NCT04470128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766138|NCT04470128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766139|NCT04470128|Analgesics|analgesics|mesh-ancestor
2766140|NCT04470128|Sensory System Agents|sensory system agents|mesh-ancestor
2766141|NCT04470128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766142|NCT04470128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2766143|NCT04470128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2766144|NCT04470128|Anesthetics, General|anesthetics, general|mesh-ancestor
2766145|NCT04470128|Anesthetics|anesthetics|mesh-ancestor
2766146|NCT04469959|Levodopa|levodopa|mesh-list
2766147|NCT04469959|Carbidopa|carbidopa|mesh-list
2766148|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2766149|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2766150|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2766151|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
2766152|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766153|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766154|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766155|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2766156|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766157|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2265554|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265555|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265556|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
2265557|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265558|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2265559|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2265560|NCT00179400|Pioglitazone|pioglitazone|mesh-list
2265561|NCT00179400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2265562|NCT00179400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766158|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
2766159|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
2766160|NCT04469829|Methotrexate|methotrexate|mesh-list
2766161|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2766162|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
2766163|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2766164|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766165|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2766166|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
2766167|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766168|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766169|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
2766170|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766171|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2766172|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2766173|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
2265563|NCT00179465|Tiagabine|tiagabine|mesh-list
2265564|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
2265565|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2265566|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2265567|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265568|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265569|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
2265570|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
2265571|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265572|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2265573|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265574|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
2265575|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265576|NCT00179608|Lenalidomide|lenalidomide|mesh-list
2265577|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
2265578|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265579|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2265580|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2265581|NCT00179608|Growth Substances|growth substances|mesh-ancestor
2265582|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
2265583|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265584|NCT00179686|Lenalidomide|lenalidomide|mesh-list
2265585|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
2265586|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265587|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2265588|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2766174|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2766175|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2766176|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
2766177|NCT04469842|Prednisone|prednisone|mesh-list
2766178|NCT04469842|Azathioprine|azathioprine|mesh-list
2766179|NCT04469842|Tacrolimus|tacrolimus|mesh-list
2766180|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2766181|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
2766182|NCT04469842|Hormones|hormones|mesh-ancestor
2766183|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2766184|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766185|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2766186|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766187|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2766188|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
2766189|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2766190|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766191|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766192|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2766193|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2766194|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
2766195|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2766196|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766197|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
2766198|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2766199|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2766200|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
2766201|NCT04469777|Hematinics|hematinics|mesh-ancestor
2766202|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2766203|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2766204|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
2766210|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
2766211|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2766212|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2766213|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2766214|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2265589|NCT00179686|Growth Substances|growth substances|mesh-ancestor
2265590|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
2265591|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265592|NCT00179699|Pemetrexed|pemetrexed|mesh-list
2265593|NCT00179699|Lenalidomide|lenalidomide|mesh-list
2265594|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265595|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265596|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265597|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2265598|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2766227|NCT04469530|Sirolimus|sirolimus|mesh-list
2766228|NCT04469530|Celecoxib|celecoxib|mesh-list
2766229|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
2766230|NCT04469530|Etoposide|etoposide|mesh-list
2766231|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2766232|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
2766233|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766234|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2766235|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2766236|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
2766237|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766238|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766239|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2766240|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2766241|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2766242|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2766243|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766244|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2766245|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766246|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2766247|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
2766248|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2766249|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2766250|NCT04469530|Analgesics|analgesics|mesh-ancestor
2766251|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
2766252|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766253|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2766254|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2766255|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2766256|NCT04469556|Leucovorin|leucovorin|mesh-list
2766257|NCT04469556|Gemcitabine|gemcitabine|mesh-list
2766258|NCT04469556|Paclitaxel|paclitaxel|mesh-list
2766259|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
2766260|NCT04469556|Irinotecan|irinotecan|mesh-list
2766261|NCT04469556|Folfirinox|folfirinox|mesh-list
2766262|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2766263|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766264|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
2766265|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
2265599|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
2265600|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265601|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2766266|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
2766267|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766268|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2766269|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
2766270|NCT04469556|Antiviral Agents|antiviral agents|mesh-ancestor
2766271|NCT04469556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101781|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101782|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2101783|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2101784|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
2101785|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
2101795|NCT02395692|Temozolomide|temozolomide|mesh-list
2766272|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766273|NCT04469556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2766274|NCT04469556|Immunologic Factors|immunologic factors|mesh-ancestor
2766275|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766276|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2766277|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2766278|NCT04469556|Antidotes|antidotes|mesh-ancestor
2766279|NCT04469556|Protective Agents|protective agents|mesh-ancestor
2766280|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
2766281|NCT04469556|Vitamins|vitamins|mesh-ancestor
2766282|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
2766283|NCT04469413|Acetaminophen|acetaminophen|mesh-list
2766284|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2766285|NCT04469413|Analgesics|analgesics|mesh-ancestor
2766286|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
2766287|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766288|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766289|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
2766290|NCT04469283|Caffeine|caffeine|mesh-list
2766291|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2766292|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766293|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2265602|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2265603|NCT00179699|Growth Substances|growth substances|mesh-ancestor
2265604|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
2265605|NCT00179712|Topotecan|topotecan|mesh-list
2265606|NCT00179712|Lenalidomide|lenalidomide|mesh-list
2265607|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2265608|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2265609|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766294|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766295|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766296|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2766297|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2766298|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
2766299|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766300|NCT04469010|Ascorbic Acid|ascorbic acid|mesh-list
2766301|NCT04469010|Iron|iron|mesh-list
2265610|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265611|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265612|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
2265613|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265614|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2265615|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2265616|NCT00179712|Growth Substances|growth substances|mesh-ancestor
2766302|NCT04469010|Chelating Agents|chelating agents|mesh-list
2766303|NCT04469010|Vitamins|vitamins|mesh-ancestor
2766304|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
2766305|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766306|NCT04469010|Trace Elements|trace elements|mesh-ancestor
2766307|NCT04469010|Antioxidants|antioxidants|mesh-ancestor
2766308|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766309|NCT04469010|Protective Agents|protective agents|mesh-ancestor
2766310|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
2766311|NCT04469114|Tofacitinib|tofacitinib|mesh-list
2766312|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2766313|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766314|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766315|NCT04469062|Mirikizumab|mirikizumab|mesh-list
2766316|NCT04469062|Vedolizumab|vedolizumab|mesh-list
2766317|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2766318|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2766319|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2766320|NCT04469062|Analgesics|analgesics|mesh-ancestor
2766321|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
2766322|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766323|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766324|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2766325|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2766326|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2766327|NCT04468815|Esomeprazole|esomeprazole|mesh-list
2766328|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2766329|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2766330|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2766331|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766332|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766333|NCT04468568|Terbutaline|terbutaline|mesh-list
2766334|NCT04468568|Atosiban|atosiban|mesh-list
2766335|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2766336|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
2265617|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
2265618|NCT00179725|Doxorubicin|doxorubicin|mesh-list
2766337|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766338|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766339|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2766340|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
2766341|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
2766342|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
2766343|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2766344|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2766345|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2766346|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2766347|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
2766348|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766349|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766350|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
2766351|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2766352|NCT04468711|Vitamin D|vitamin d|mesh-list
2766353|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
2766354|NCT04468711|Vitamins|vitamins|mesh-ancestor
2766355|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
2766356|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766357|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2766358|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2766359|NCT04468685|Ondansetron|ondansetron|mesh-list
2766360|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
2766361|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
2766362|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766363|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766364|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2766365|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
2766366|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
2766367|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2766368|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
2766369|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766370|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766371|NCT04468685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2766372|NCT04468685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2766373|NCT04468685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766374|NCT04468685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2766375|NCT04468685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2766376|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
2766377|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766378|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
2766379|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
2766380|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
2766381|NCT04468139|Ascorbic Acid|ascorbic acid|mesh-list
2766382|NCT04468139|Quercetin|quercetin|mesh-list
2766383|NCT04468139|Vitamins|vitamins|mesh-ancestor
2766384|NCT04468139|Micronutrients|micronutrients|mesh-ancestor
2766385|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766386|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
2766387|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766388|NCT04468139|Protective Agents|protective agents|mesh-ancestor
2789945|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2789946|NCT04298541|Edotreotide|edotreotide|mesh-list
2789947|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2265619|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2265620|NCT00179725|Lenalidomide|lenalidomide|mesh-list
2265621|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2789948|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789949|NCT04298099|Ropivacaine|ropivacaine|mesh-list
2789950|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
2789951|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
2789952|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2789953|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789954|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
2789955|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789956|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2789957|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2789958|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2789959|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265622|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766389|NCT04468542|Triamcinolone|triamcinolone|mesh-list
2766390|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2766391|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2766392|NCT04468542|Bupivacaine|bupivacaine|mesh-list
2766393|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2766394|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
2766395|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
2766396|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766397|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766398|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
2766399|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766400|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2766401|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
2265623|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2265624|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2265625|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265626|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265627|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
2265628|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265629|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2265630|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2265631|NCT00179725|Growth Substances|growth substances|mesh-ancestor
2265632|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
2265633|NCT00179738|Lenalidomide|lenalidomide|mesh-list
2265634|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
2265635|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265636|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2265637|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2766402|NCT04468542|Hormones|hormones|mesh-ancestor
2766403|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2766404|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2766405|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
2766406|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766407|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766408|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2766409|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
2766410|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2766411|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
2766412|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766413|NCT04468438|Estrogens|estrogens|mesh-list
2265638|NCT00179738|Growth Substances|growth substances|mesh-ancestor
2265639|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
2265640|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265641|NCT00179751|Gemcitabine|gemcitabine|mesh-list
2265642|NCT00179751|Lenalidomide|lenalidomide|mesh-list
2265643|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2265644|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
2265645|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265646|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766414|NCT04468438|Hormones|hormones|mesh-ancestor
2766415|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2766416|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766417|NCT04468282|Vigabatrin|vigabatrin|mesh-list
2766418|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
2766419|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766420|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766421|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
2766422|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766423|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766427|NCT04467957|Xenon|xenon|mesh-list
2766428|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2766429|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
2766430|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
2766431|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766432|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766433|NCT04467918|Cannabidiol|cannabidiol|mesh-list
2766434|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
2265647|NCT00179751|Antiviral Agents|antiviral agents|mesh-ancestor
2101796|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2101797|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
2101798|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101799|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101800|NCT02396147|Relugolix|relugolix|mesh-list
2101801|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
2101802|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
2101803|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2101804|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101805|NCT02396316|Aflibercept|aflibercept|mesh-list
2101806|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2101807|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2101808|NCT02396316|Growth Substances|growth substances|mesh-ancestor
2101809|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101810|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
2101811|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101812|NCT02396511|Bevacizumab|bevacizumab|mesh-list
2766446|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
2766447|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2766448|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2766449|NCT04467892|Prednisolone|prednisolone|mesh-list
2766450|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
2766451|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2766452|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
2766453|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2766454|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
2766455|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
2766456|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766457|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766458|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2766459|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
2766460|NCT04467892|Hormones|hormones|mesh-ancestor
2766461|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2766462|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2766463|NCT04467892|Protective Agents|protective agents|mesh-ancestor
2766464|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2766465|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766466|NCT04467931|Losartan|losartan|mesh-list
2766467|NCT04467931|Timolol|timolol|mesh-list
2766468|NCT04467931|Propranolol|propranolol|mesh-list
2766469|NCT04467931|Metoprolol|metoprolol|mesh-list
2766470|NCT04467931|Atenolol|atenolol|mesh-list
2766471|NCT04467931|Verapamil|verapamil|mesh-list
2766472|NCT04467931|Felodipine|felodipine|mesh-list
2766473|NCT04467931|Nadolol|nadolol|mesh-list
2766474|NCT04467931|Acebutolol|acebutolol|mesh-list
2766475|NCT04467931|Amlodipine|amlodipine|mesh-list
2766476|NCT04467931|Valsartan|valsartan|mesh-list
2766477|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2766478|NCT04467931|Telmisartan|telmisartan|mesh-list
2766479|NCT04467931|Clonidine|clonidine|mesh-list
2766480|NCT04467931|Carvedilol|carvedilol|mesh-list
2766481|NCT04467931|Candesartan|candesartan|mesh-list
2766482|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
2766483|NCT04467931|Ramipril|ramipril|mesh-list
2766484|NCT04467931|Olmesartan|olmesartan|mesh-list
2766485|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2766486|NCT04467931|Enalapril|enalapril|mesh-list
2766487|NCT04467931|Enalaprilat|enalaprilat|mesh-list
2766488|NCT04467931|Lisinopril|lisinopril|mesh-list
2766489|NCT04467931|Irbesartan|irbesartan|mesh-list
2766490|NCT04467931|Eplerenone|eplerenone|mesh-list
2766491|NCT04467931|Nebivolol|nebivolol|mesh-list
2766492|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
2766493|NCT04467931|Diltiazem|diltiazem|mesh-list
2766494|NCT04467931|Bisoprolol|bisoprolol|mesh-list
2766495|NCT04467931|Perindopril|perindopril|mesh-list
2766496|NCT04467931|Guanfacine|guanfacine|mesh-list
2766497|NCT04467931|Prazosin|prazosin|mesh-list
2766498|NCT04467931|Minoxidil|minoxidil|mesh-list
2766499|NCT04467931|Doxazosin|doxazosin|mesh-list
2766500|NCT04467931|Benazepril|benazepril|mesh-list
2766501|NCT04467931|Hydralazine|hydralazine|mesh-list
2766502|NCT04467931|Captopril|captopril|mesh-list
2766503|NCT04467931|Labetalol|labetalol|mesh-list
2766504|NCT04467931|Indapamide|indapamide|mesh-list
2766505|NCT04467931|Nicardipine|nicardipine|mesh-list
2766506|NCT04467931|Quinapril|quinapril|mesh-list
2766507|NCT04467931|Trandolapril|trandolapril|mesh-list
2766508|NCT04467931|Torsemide|torsemide|mesh-list
2766509|NCT04467931|Metolazone|metolazone|mesh-list
2766510|NCT04467931|Methyldopa|methyldopa|mesh-list
2766511|NCT04467931|Fosinopril|fosinopril|mesh-list
2766512|NCT04467931|Isradipine|isradipine|mesh-list
2766513|NCT04467931|Eprosartan|eprosartan|mesh-list
2766514|NCT04467931|Pindolol|pindolol|mesh-list
2766515|NCT04467931|Moexipril|moexipril|mesh-list
2766516|NCT04467931|Betaxolol|betaxolol|mesh-list
2766517|NCT04467931|Reserpine|reserpine|mesh-list
2766518|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
2766519|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
2766520|NCT04467931|Guanabenz|guanabenz|mesh-list
2766521|NCT04467931|Nisoldipine|nisoldipine|mesh-list
2766522|NCT04467931|Penbutolol|penbutolol|mesh-list
2766523|NCT04467931|Nifedipine|nifedipine|mesh-list
2766524|NCT04467931|Amiloride|amiloride|mesh-list
2766525|NCT04467931|Triamterene|triamterene|mesh-list
2766526|NCT04467931|Furosemide|furosemide|mesh-list
2766527|NCT04467931|Spironolactone|spironolactone|mesh-list
2766528|NCT04467931|Bumetanide|bumetanide|mesh-list
2766529|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
2766530|NCT04467931|Terazosin|terazosin|mesh-list
2766531|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2766532|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2766533|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2766534|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2766535|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2766536|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766537|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2766538|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766539|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
2766540|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2766541|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2766542|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2766543|NCT04467931|Diuretics|diuretics|mesh-ancestor
2766544|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
2766545|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2766546|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2766547|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2766548|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
2265648|NCT00179751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265649|NCT00179751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265650|NCT00179751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265651|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
2265652|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766549|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766550|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
2766551|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
2766552|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766553|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2766554|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2766555|NCT04467931|Analgesics|analgesics|mesh-ancestor
2766556|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
2766557|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2766558|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2766559|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2766560|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2265653|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2265654|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2265655|NCT00179751|Growth Substances|growth substances|mesh-ancestor
2265656|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
2265657|NCT00179764|Busulfan|busulfan|mesh-list
2265658|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
2265659|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265660|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265661|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
2265662|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265663|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2766561|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
2766562|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2766563|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2766564|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
2766565|NCT04467931|Protective Agents|protective agents|mesh-ancestor
2265664|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766566|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2766567|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2766568|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
2766569|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265665|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2265666|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
2265667|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265668|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
2766570|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
2766571|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2766572|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2766573|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2766574|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2766575|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2766576|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2766577|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2766578|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
2766579|NCT04467931|Urological Agents|urological agents|mesh-ancestor
2766580|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
2766581|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2766582|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
2766583|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2766584|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2766585|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766586|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2766587|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2766588|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2265669|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265670|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2265671|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2766589|NCT04467983|Denosumab|denosumab|mesh-list
2766590|NCT04467983|Abaloparatide|abaloparatide|mesh-list
2766591|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2766592|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766593|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
2766594|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
2766595|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
2766596|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766597|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265672|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
2265673|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265674|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265675|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2766598|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
2766599|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766600|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2766601|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
2766602|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2766603|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2766604|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2766605|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2766606|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766607|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
2766608|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766609|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766610|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2766611|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766612|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2265676|NCT00179881|Thalidomide|thalidomide|mesh-list
2265677|NCT00179881|Carboplatin|carboplatin|mesh-list
2265678|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265679|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2766613|NCT04467281|Daratumumab|daratumumab|mesh-list
2766614|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766615|NCT04467346|Temozolomide|temozolomide|mesh-list
2766616|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2265680|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
2265681|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265682|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
2265683|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2265684|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265685|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2265686|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2265687|NCT00179881|Growth Substances|growth substances|mesh-ancestor
2265688|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
2265689|NCT00179920|Carboplatin|carboplatin|mesh-list
2265690|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265691|NCT00180011|Omalizumab|omalizumab|mesh-list
2265692|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2265693|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2265694|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
2265695|NCT00180024|Irbesartan|irbesartan|mesh-list
2265696|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2265697|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2265698|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2265699|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265700|NCT00180037|Ubiquinone|ubiquinone|mesh-list
2265701|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
2265702|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
2265703|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265704|NCT00180037|Vitamins|vitamins|mesh-ancestor
2265705|NCT00180050|Budesonide|budesonide|mesh-list
2265706|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2265707|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2766617|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
2766618|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766619|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766620|NCT04467125|Lidocaine|lidocaine|mesh-list
2766621|NCT04467125|Prilocaine|prilocaine|mesh-list
2766622|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2766623|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
2766624|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
2766625|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766626|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766627|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
2766628|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766629|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2766630|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2766631|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2766632|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2766633|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766634|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2766635|NCT04467086|Propranolol|propranolol|mesh-list
2766636|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2766637|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2766638|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
2766639|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766640|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766641|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766642|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2766643|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2766644|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
2766645|NCT04466904|Dulaglutide|dulaglutide|mesh-list
2766646|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2766647|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265708|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
2265709|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265710|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766648|NCT04466917|Paclitaxel|paclitaxel|mesh-list
2766649|NCT04466917|Bevacizumab|bevacizumab|mesh-list
2766650|NCT04466917|Carboplatin|carboplatin|mesh-list
2766651|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2766652|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766653|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
2766654|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
2766655|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
2265711|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2265712|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
2265713|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
2265714|NCT00180050|Hormones|hormones|mesh-ancestor
2265715|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2265716|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2265717|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265718|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265719|NCT00180076|Budesonide|budesonide|mesh-list
2265720|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2265721|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2766656|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766657|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2766658|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2766659|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2766660|NCT04466917|Growth Substances|growth substances|mesh-ancestor
2265722|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
2766661|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766662|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
2766663|NCT04466943|Rocuronium|rocuronium|mesh-list
2766664|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766665|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2766666|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2766667|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2766668|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766669|NCT04466670|Aspirin|aspirin|mesh-list
2766670|NCT04466670|Heparin|heparin|mesh-list
2766671|NCT04466670|Calcium heparin|calcium heparin|mesh-list
2766672|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2766673|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2766674|NCT04466670|Analgesics|analgesics|mesh-ancestor
2766675|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
2766676|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766677|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766678|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2766679|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2766680|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2766681|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2766682|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766683|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2766684|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2766685|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766686|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
2766687|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
2789960|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789961|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
2789962|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265723|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265724|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265725|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2101813|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2101814|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101815|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2101816|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2101817|NCT02396511|Growth Substances|growth substances|mesh-ancestor
2101818|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101819|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
2101820|NCT02396537|Lidocaine|lidocaine|mesh-list
2101821|NCT02396537|Midazolam|midazolam|mesh-list
2101822|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
2101823|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
2101824|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101825|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101826|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
2101827|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101828|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2101829|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2101830|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2101831|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2101832|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101833|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2101834|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2789963|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2789964|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2789965|NCT04298021|Durvalumab|durvalumab|mesh-list
2789966|NCT04298021|Olaparib|olaparib|mesh-list
2789967|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2789968|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789969|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2789970|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2789971|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789972|NCT04298008|Durvalumab|durvalumab|mesh-list
2789973|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2789974|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789975|NCT04297839|Heparin|heparin|mesh-list
2789976|NCT04297839|Calcium heparin|calcium heparin|mesh-list
2789977|NCT04297839|Citric Acid|citric acid|mesh-list
2789978|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
2789979|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
2789980|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2789981|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
2789982|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
2766688|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
2766689|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
2766690|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2766691|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2766692|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766693|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766694|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766695|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2766696|NCT04466618|Heparin|heparin|mesh-list
2265726|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
2265727|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
2265728|NCT00180076|Hormones|hormones|mesh-ancestor
2265729|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2265730|NCT00180089|Budesonide|budesonide|mesh-list
2265731|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2265732|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2265733|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
2265734|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265735|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265736|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2766697|NCT04466618|Calcium heparin|calcium heparin|mesh-list
2766698|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2766699|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
2766700|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2766701|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2766702|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766703|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2766704|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2766705|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2766706|NCT04466436|Tryptophan|tryptophan|mesh-list
2766707|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2766708|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
2766709|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2766710|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
2766711|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766712|NCT04466046|Midazolam|midazolam|mesh-list
2766713|NCT04466046|Palonosetron|palonosetron|mesh-list
2766714|NCT04466046|Ramosetron|ramosetron|mesh-list
2766715|NCT04466046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2766716|NCT04466046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2766717|NCT04466046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766718|NCT04466046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766719|NCT04466046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2766720|NCT04466046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2766721|NCT04466046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2766722|NCT04466046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2766723|NCT04466046|Anesthetics, General|anesthetics, general|mesh-ancestor
2766724|NCT04466046|Anesthetics|anesthetics|mesh-ancestor
2766725|NCT04466046|GABA Modulators|gaba modulators|mesh-ancestor
2766726|NCT04466046|GABA Agents|gaba agents|mesh-ancestor
2766727|NCT04466046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766728|NCT04466046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766729|NCT04466046|Antiemetics|antiemetics|mesh-ancestor
2766730|NCT04466046|Autonomic Agents|autonomic agents|mesh-ancestor
2766731|NCT04466046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766732|NCT04466046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2766733|NCT04466046|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2766734|NCT04466046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2766735|NCT04466046|Serotonin Agents|serotonin agents|mesh-ancestor
2766736|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
2766737|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
2766738|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766739|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
2766740|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
2766741|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2766742|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2766743|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766744|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766745|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766746|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2766747|NCT04466254|Cetuximab|cetuximab|mesh-list
2766748|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2766749|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766750|NCT04466176|Fluticasone|fluticasone|mesh-list
2766751|NCT04466176|Xhance|xhance|mesh-list
2766752|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2766753|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2766754|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2766755|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2766756|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
2766757|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766758|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766759|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2766760|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
2766761|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
2766762|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2766763|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2766764|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2766765|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2766766|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
2766767|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766768|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766769|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
2766770|NCT04466176|Hormones|hormones|mesh-ancestor
2766771|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2766772|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
2766773|NCT04466241|Ritonavir|ritonavir|mesh-list
2766774|NCT04466241|Lopinavir|lopinavir|mesh-list
2766775|NCT04466241|Telmisartan|telmisartan|mesh-list
2766776|NCT04466241|Atorvastatin|atorvastatin|mesh-list
2766777|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2766778|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2766779|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
2766780|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766781|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2766782|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2766783|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766784|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2766785|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2766786|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
2766787|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2766788|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2766789|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
2766790|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766791|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2766792|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2766793|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2766794|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2766795|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2766796|NCT04465968|Durvalumab|durvalumab|mesh-list
2766797|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2766798|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766799|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2766800|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
2766801|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766802|NCT04466085|Vaccines|vaccines|mesh-list
2766803|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
2766804|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766805|NCT04465916|Tenofovir|tenofovir|mesh-list
2766806|NCT04465916|Entecavir|entecavir|mesh-list
2766807|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
2766808|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766809|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2766810|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2766811|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766812|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766813|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2766814|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2766815|NCT04465942|Paclitaxel|paclitaxel|mesh-list
2766816|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
2766817|NCT04465942|Nivolumab|nivolumab|mesh-list
2766818|NCT04465942|Pemetrexed|pemetrexed|mesh-list
2766819|NCT04465942|Atezolizumab|atezolizumab|mesh-list
2766820|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2766821|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265737|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
2265738|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
2265739|NCT00180089|Hormones|hormones|mesh-ancestor
2265740|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2265741|NCT00180102|Cytarabine|cytarabine|mesh-list
2265742|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
2265743|NCT00180102|Amsacrine|amsacrine|mesh-list
2265744|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2265745|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
2766822|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
2766823|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
2766824|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
2766825|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766826|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2766827|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2766828|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766829|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2766830|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2766831|NCT04465864|Dexamethasone|dexamethasone|mesh-list
2766832|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2766833|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
2766834|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
2766835|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766836|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766837|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2766838|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
2766839|NCT04465864|Hormones|hormones|mesh-ancestor
2766840|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2766841|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2766842|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766843|NCT04465734|Sorafenib|sorafenib|mesh-list
2766844|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265746|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265747|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265748|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
2265749|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265750|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265751|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
2265752|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265753|NCT00180102|Analgesics|analgesics|mesh-ancestor
2265754|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
2265755|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265756|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2265757|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2265758|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265759|NCT00180115|Cytarabine|cytarabine|mesh-list
2265760|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2265761|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
2265762|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265763|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265764|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
2265765|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2265766|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265767|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
2766845|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2766846|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766847|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265768|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265769|NCT00180128|Cytarabine|cytarabine|mesh-list
2265770|NCT00180128|Daunorubicin|daunorubicin|mesh-list
2766848|NCT04465760|Antibodies|antibodies|mesh-list
2766849|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
2766850|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
2766851|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766852|NCT04465773|Remifentanil|remifentanil|mesh-list
2766853|NCT04465773|Propofol|propofol|mesh-list
2766854|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
2766855|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766856|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766857|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2766858|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2766859|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
2766860|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2766861|NCT04465773|Narcotics|narcotics|mesh-ancestor
2766862|NCT04465773|Analgesics|analgesics|mesh-ancestor
2766863|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
2766864|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766865|NCT04465643|Nivolumab|nivolumab|mesh-list
2766866|NCT04465643|Ipilimumab|ipilimumab|mesh-list
2766867|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2766868|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766869|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2766870|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766871|NCT04465500|Androgens|androgens|mesh-list
2766872|NCT04465500|Hormones|hormones|mesh-ancestor
2766873|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2766874|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766875|NCT04465695|Interferons|interferons|mesh-list
2766876|NCT04465695|Interferon-beta|interferon-beta|mesh-list
2766877|NCT04465695|Clofazimine|clofazimine|mesh-list
2766878|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
2766879|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766880|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
2766881|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766882|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
2766883|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766884|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2766885|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2766886|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
2766887|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2766888|NCT04465851|Curcumin|curcumin|mesh-list
2766889|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2766890|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2766891|NCT04465851|Analgesics|analgesics|mesh-ancestor
2766892|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
2766893|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766894|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766895|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2766896|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2766897|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766898|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766899|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766900|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
2766901|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2766902|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2766903|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
2766904|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
2766910|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2766911|NCT04465123|Spironolactone|spironolactone|mesh-list
2766912|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2766913|NCT04465123|Diuretics|diuretics|mesh-ancestor
2766914|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
2766915|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766916|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2766917|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2766918|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766919|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2766920|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
2766921|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2766922|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2766923|NCT04465357|Erenumab|erenumab|mesh-list
2766924|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2766925|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766926|NCT04465357|Analgesics|analgesics|mesh-ancestor
2766927|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
2766928|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766929|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766930|NCT04465318|Nicotine|nicotine|mesh-list
2766931|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2766932|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
2766933|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2766934|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766935|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2766936|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2766937|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
2766938|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2766939|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766940|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
2766941|NCT04465175|Analgesics|analgesics|mesh-ancestor
2265771|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
2265772|NCT00180128|Idarubicin|idarubicin|mesh-list
2265773|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2265774|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
2766942|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
2766943|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265775|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265776|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265777|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
2265778|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766944|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766945|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
2766946|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766947|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2766948|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
2766949|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2766950|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2766951|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766952|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2766953|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
2766954|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2766955|NCT04465396|Teduglutide|teduglutide|mesh-list
2766956|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2766957|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2766958|NCT04465396|Protective Agents|protective agents|mesh-ancestor
2766959|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766960|NCT04465383|Propofol|propofol|mesh-list
2766961|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2766962|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2766963|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766964|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2766965|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
2766966|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
2766967|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2766968|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
2766969|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2766970|NCT04464967|Trastuzumab|trastuzumab|mesh-list
2766971|NCT04464967|Cetuximab|cetuximab|mesh-list
2766972|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2766973|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789983|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789984|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2789985|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2265779|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265780|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
2265781|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265782|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2265783|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2265784|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2265785|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265786|NCT00180128|Analgesics|analgesics|mesh-ancestor
2265787|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
2789999|NCT04297618|Lifitegrast|lifitegrast|mesh-list
2790000|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2790001|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2790002|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
2790003|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2790004|NCT04297215|Chitosan|chitosan|mesh-list
2790005|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2790006|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2790007|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
2790008|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790009|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2790010|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
2790011|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
2790012|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
2766974|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
2766975|NCT04464759|Nivolumab|nivolumab|mesh-list
2766976|NCT04464759|Ipilimumab|ipilimumab|mesh-list
2766977|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2766978|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766979|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2766980|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2766981|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
2766982|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2766983|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2766984|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2766985|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2766986|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2766987|NCT04464694|Ranibizumab|ranibizumab|mesh-list
2766988|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2766989|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2766990|NCT04464694|Growth Substances|growth substances|mesh-ancestor
2766991|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766992|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
2265788|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265789|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
2265790|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2265791|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2265792|NCT00180141|Analgesics|analgesics|mesh-ancestor
2265793|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
2265794|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265795|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265796|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2265797|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2766993|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2766994|NCT04464811|Furosemide|furosemide|mesh-list
2766995|NCT04464811|Diuretics|diuretics|mesh-ancestor
2766996|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
2766997|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2766998|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2766999|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2767000|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767001|NCT04465097|Exemestane|exemestane|mesh-list
2767002|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767003|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2767004|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2767005|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767006|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767007|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2767008|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
2767009|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767010|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767011|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
2767012|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2767013|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767014|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
2767015|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767016|NCT04465110|Protective Agents|protective agents|mesh-ancestor
2767017|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767018|NCT04464850|Iron|iron|mesh-list
2767019|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
2767020|NCT04464850|Folic Acid|folic acid|mesh-list
2767021|NCT04464850|Trace Elements|trace elements|mesh-ancestor
2767022|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
2767023|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767024|NCT04464850|Hematinics|hematinics|mesh-ancestor
2767025|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
2767026|NCT04464850|Vitamins|vitamins|mesh-ancestor
2767027|NCT04464863|Metronidazole|metronidazole|mesh-list
2767028|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767029|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2767030|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2767031|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2767032|NCT04464629|Prednisolone|prednisolone|mesh-list
2767033|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2767034|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
2767035|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2767036|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
2767037|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2767038|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
2767039|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2265798|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
2265799|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265800|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
2265801|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2265802|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767040|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
2767041|NCT04464629|Hormones|hormones|mesh-ancestor
2767042|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767043|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767044|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2767045|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767046|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
2767047|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
2767048|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767049|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2767050|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2767051|NCT04464629|Protective Agents|protective agents|mesh-ancestor
2767052|NCT04464577|Itraconazole|itraconazole|mesh-list
2767053|NCT04464577|Fluconazole|fluconazole|mesh-list
2767054|NCT04464577|Bupropion|bupropion|mesh-list
2767055|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2767056|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
2265803|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265804|NCT00180310|Paclitaxel|paclitaxel|mesh-list
2265805|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2265806|NCT00180310|Everolimus|everolimus|mesh-list
2767057|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2767058|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2767059|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2767060|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2767061|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767062|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
2767063|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265807|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2265808|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265809|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
2265810|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
2265811|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
2265812|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265813|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265814|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
2265815|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265816|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
2265817|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
2265818|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2265819|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
2265820|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265821|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767064|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767065|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2767066|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2767067|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767068|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
2767069|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767070|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2767071|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2767072|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
2767073|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767074|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2767075|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2767076|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2767077|NCT04464512|Sufentanil|sufentanil|mesh-list
2767078|NCT04464512|Buprenorphine|buprenorphine|mesh-list
2767079|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2767080|NCT04464512|Narcotics|narcotics|mesh-ancestor
2767081|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2767082|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767083|NCT04464512|Analgesics|analgesics|mesh-ancestor
2767084|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
2767085|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767086|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2767087|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2767088|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2767089|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
2767090|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
2265822|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2265823|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
2767091|NCT04464642|Methotrexate|methotrexate|mesh-list
2767092|NCT04464642|Tofacitinib|tofacitinib|mesh-list
2767093|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2767094|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
2767095|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2767096|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767097|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2767098|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
2767099|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767100|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767101|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
2767102|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767103|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2767104|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2767105|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
2767106|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2767107|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2767108|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2767109|NCT04464616|Anesthetics|anesthetics|mesh-list
2767110|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2767111|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767112|NCT04464265|Propofol|propofol|mesh-list
2767113|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2767114|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2767115|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767116|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2767117|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
2767118|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
2767119|NCT04464135|Acetic Acid|acetic acid|mesh-list
2767120|NCT04464135|Retinol acetate|retinol acetate|mesh-list
2767121|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2767122|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767123|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2767124|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
2767125|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767126|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2767127|NCT04464135|Protective Agents|protective agents|mesh-ancestor
2767128|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767129|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
2767130|NCT04464005|Analgesics|analgesics|mesh-ancestor
2767131|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
2767132|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767133|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767134|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
2767135|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2767136|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2767137|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
2767138|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2767139|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2767140|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767141|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2767142|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
2767143|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2767144|NCT04464174|Gemcitabine|gemcitabine|mesh-list
2767145|NCT04464174|Carboplatin|carboplatin|mesh-list
2767146|NCT04464174|Capecitabine|capecitabine|mesh-list
2767147|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767148|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2101835|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2101836|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2101837|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2101838|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2101839|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
2101840|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
2101841|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
2101842|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101843|NCT02396732|Aspirin|aspirin|mesh-list
2101844|NCT02396732|Enoxaparin|enoxaparin|mesh-list
2101845|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2101846|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2101847|NCT02396732|Analgesics|analgesics|mesh-ancestor
2101848|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
2101849|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767149|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
2767150|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767151|NCT04464174|Antiviral Agents|antiviral agents|mesh-ancestor
2767152|NCT04464174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767153|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767154|NCT04464174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2767155|NCT04464174|Immunologic Factors|immunologic factors|mesh-ancestor
2767156|NCT04464174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767157|NCT04464122|Somatostatin|somatostatin|mesh-list
2767158|NCT04464122|Hormones|hormones|mesh-ancestor
2767159|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767160|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767161|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
2767162|NCT04463875|Riboflavin|riboflavin|mesh-list
2767163|NCT04463875|Ubiquinone|ubiquinone|mesh-list
2767164|NCT04463875|Andrographolide|andrographolide|mesh-list
2767165|NCT04463875|Vitamins|vitamins|mesh-ancestor
2767166|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
2767167|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767168|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
2767169|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2767170|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
2767171|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2767172|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2767173|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2767174|NCT04463875|Analgesics|analgesics|mesh-ancestor
2767175|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
2767176|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767177|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2265824|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2265825|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
2265826|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265827|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265828|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2767178|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2767179|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2767180|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767181|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
2767182|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2767183|NCT04463784|Efavirenz|efavirenz|mesh-list
2767184|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2767185|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2767186|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767187|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767188|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
2767189|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767190|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2767191|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2767192|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2767193|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2767194|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2767195|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2767196|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
2767197|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2767198|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2767199|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767200|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
2767201|NCT04463966|Coagulants|coagulants|mesh-ancestor
2767226|NCT04463953|Dexamethasone|dexamethasone|mesh-list
2767227|NCT04463953|Ixazomib|ixazomib|mesh-list
2767228|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
2767229|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2767230|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
2767231|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
2767232|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767233|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767234|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2767235|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
2767236|NCT04463953|Hormones|hormones|mesh-ancestor
2767237|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767238|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2767239|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767240|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
2767241|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767242|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767243|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2767244|NCT04463901|Mitomycins|mitomycins|mesh-list
2767245|NCT04463901|Mitomycin|mitomycin|mesh-list
2767246|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2767247|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767248|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
2767249|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767250|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2767251|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767252|NCT04463368|Nivolumab|nivolumab|mesh-list
2265829|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
2265830|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
2265831|NCT00180622|Protective Agents|protective agents|mesh-ancestor
2265832|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
2265833|NCT00180635|Pimagedine|pimagedine|mesh-list
2265834|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265835|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265836|NCT00180791|Carboplatin|carboplatin|mesh-list
2265837|NCT00180791|Etoposide|etoposide|mesh-list
2265838|NCT00180791|Melphalan|melphalan|mesh-list
2265839|NCT00180791|Thiotepa|thiotepa|mesh-list
2265840|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265841|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2265842|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2265843|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2265844|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265845|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265846|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2265847|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
2265848|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2265849|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265850|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
2265851|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767253|NCT04463368|Ipilimumab|ipilimumab|mesh-list
2767254|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2767255|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767256|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2767257|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767258|NCT04463615|Leflunomide|leflunomide|mesh-list
2767259|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767260|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767261|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2767262|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
2767263|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767264|NCT04463459|Vitamins|vitamins|mesh-list
2767265|NCT04463459|Ascorbic Acid|ascorbic acid|mesh-list
2767266|NCT04463459|Vitamin E|vitamin e|mesh-list
2767267|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
2767268|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767269|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
2767270|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767271|NCT04463459|Protective Agents|protective agents|mesh-ancestor
2767272|NCT04463394|Vasopressins|vasopressins|mesh-list
2767273|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
2265852|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
2265853|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265854|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2265855|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265856|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767274|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
2767275|NCT04463394|Coagulants|coagulants|mesh-ancestor
2767276|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2767277|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2767278|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
2767279|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767280|NCT04463342|Methamphetamine|methamphetamine|mesh-list
2767281|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2767282|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767283|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
2767284|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
2767285|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767286|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
2767287|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2767288|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767289|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
2767290|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2767291|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2767292|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2767293|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2767294|NCT04463030|Vitamins|vitamins|mesh-list
2767295|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
2767296|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
2767297|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767298|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
2767299|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767300|NCT04463030|Protective Agents|protective agents|mesh-ancestor
2767301|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
2767302|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2767303|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767304|NCT04463056|Eculizumab|eculizumab|mesh-list
2767305|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2767306|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2767307|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
2767308|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767309|NCT04462939|Micronutrients|micronutrients|mesh-list
2767310|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767316|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2767317|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2767318|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
2767319|NCT04462796|Cathartics|cathartics|mesh-ancestor
2767320|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2767321|NCT04462588|Metronidazole|metronidazole|mesh-list
2767322|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767323|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2767324|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2767325|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2767326|NCT04462614|Heparin|heparin|mesh-list
2767327|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
2767328|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2767329|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2767330|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767331|NCT04462822|Fluticasone|fluticasone|mesh-list
2767332|NCT04462822|Xhance|xhance|mesh-list
2767333|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2767334|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2767335|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2767336|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2767337|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
2767338|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767339|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767340|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2767341|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
2767342|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
2767343|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2767344|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2767345|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2767346|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2767347|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
2767348|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2767349|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767350|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
2767351|NCT04462822|Hormones|hormones|mesh-ancestor
2767352|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767353|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
2767354|NCT04462809|Talazoparib|talazoparib|mesh-list
2767355|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2767356|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767357|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767358|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767359|NCT04462666|Etoricoxib|etoricoxib|mesh-list
2767360|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2767361|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2767362|NCT04462666|Analgesics|analgesics|mesh-ancestor
2767363|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
2767364|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767365|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767366|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2767367|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2767368|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2767369|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2767370|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767371|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767372|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
2767373|NCT04462250|Narcotics|narcotics|mesh-ancestor
2767374|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2767375|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767376|NCT04462250|Analgesics|analgesics|mesh-ancestor
2767377|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
2265857|NCT00180843|Bromides|bromides|mesh-list
2265858|NCT00180843|Albuterol|albuterol|mesh-list
2265859|NCT00180843|Ipratropium|ipratropium|mesh-list
2265860|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
2265861|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2265862|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
2767378|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767379|NCT04462627|Antibodies|antibodies|mesh-list
2767380|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
2767381|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767382|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
2767383|NCT04462406|Nivolumab|nivolumab|mesh-list
2767384|NCT04462406|Ipilimumab|ipilimumab|mesh-list
2767385|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2767386|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767387|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2265863|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265864|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265865|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2265866|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
2265867|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
2265868|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2265869|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2265870|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2265871|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2767388|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767389|NCT04462315|Cobalt|cobalt|mesh-list
2767390|NCT04462315|Chromium|chromium|mesh-list
2767391|NCT04462315|Everolimus|everolimus|mesh-list
2767392|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767393|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2767394|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
2767395|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767396|NCT04462315|Trace Elements|trace elements|mesh-ancestor
2767397|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
2767398|NCT04462276|Atezolizumab|atezolizumab|mesh-list
2767399|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767400|NCT04462328|Durvalumab|durvalumab|mesh-list
2767401|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
2767402|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2265872|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
2265873|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2767403|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767404|NCT04462523|Prednisolone|prednisolone|mesh-list
2767405|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2767406|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
2767407|NCT04462523|Hormones|hormones|mesh-ancestor
2767408|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767409|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767410|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2767411|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767412|NCT04462094|Ketamine|ketamine|mesh-list
2767413|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
2767414|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2767415|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767416|NCT04462094|Analgesics|analgesics|mesh-ancestor
2767417|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
2767418|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767419|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2767420|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2767421|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
2767422|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2767423|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2767424|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2767425|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767426|NCT04462003|Enoxaparin|enoxaparin|mesh-list
2767427|NCT04462003|Apixaban|apixaban|mesh-list
2767428|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
2101850|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101851|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2101852|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2101853|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2101854|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2101855|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101856|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2101857|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2101858|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101859|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
2101860|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
2101861|NCT02396758|Plasminogen|plasminogen|mesh-list
2101862|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2101863|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2101864|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2101865|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101866|NCT02396953|Lanreotide|lanreotide|mesh-list
2101867|NCT02396953|Somatostatin|somatostatin|mesh-list
2101868|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265874|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265875|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2265876|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
2767429|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2767430|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2767431|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767432|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2767433|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
2767434|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2767435|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
2767436|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767437|NCT04461587|Pirfenidone|pirfenidone|mesh-list
2767438|NCT04461587|Analgesics|analgesics|mesh-ancestor
2767439|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
2767440|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767441|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767442|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2767443|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2767444|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2767445|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2767446|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790013|NCT04297215|Coagulants|coagulants|mesh-ancestor
2790014|NCT04297202|Apatinib|apatinib|mesh-list
2790015|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790016|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2790017|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790018|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792803|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792804|NCT04275492|Protective Agents|protective agents|mesh-ancestor
2767447|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2767448|NCT04461925|Azithromycin|azithromycin|mesh-list
2767449|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
2767450|NCT04461925|Dexamethasone|dexamethasone|mesh-list
2767451|NCT04461925|Enoxaparin|enoxaparin|mesh-list
2767452|NCT04461925|Anticoagulants|anticoagulants|mesh-list
2767453|NCT04461925|Hormones|hormones|mesh-list
2767454|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2767455|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
2767456|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
2767457|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767458|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767459|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2767460|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
2767461|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767462|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2767463|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767464|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767465|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767466|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2767467|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2767468|NCT04461795|Erenumab|erenumab|mesh-list
2767469|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2767470|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
2767471|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767472|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2767473|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767474|NCT04461795|Analgesics|analgesics|mesh-ancestor
2767475|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
2767476|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767477|NCT04461665|Vitamin D|vitamin d|mesh-list
2767478|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
2767479|NCT04461665|Vitamins|vitamins|mesh-list
2767480|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
2767481|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767482|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2767483|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2767484|NCT04461535|Hormones|hormones|mesh-list
2767485|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2767486|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2767487|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
2767488|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767489|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767490|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2767491|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767492|NCT04461249|Travoprost|travoprost|mesh-list
2767493|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2767494|NCT04461249|Latanoprost|latanoprost|mesh-list
2767495|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2767496|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2767497|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
2767498|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
2767499|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2767500|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2767501|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767502|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767503|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767504|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2767505|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
2767506|NCT04461418|Hormones|hormones|mesh-ancestor
2767507|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767508|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767509|NCT04461379|Vaccines|vaccines|mesh-list
2767510|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
2767511|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
2767512|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767513|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2767514|NCT04461288|Nicotine|nicotine|mesh-list
2767515|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2767516|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
2767517|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767518|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767519|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2767520|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2767521|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
2767522|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265877|NCT00180882|Rituximab|rituximab|mesh-list
2265878|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2265879|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265880|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
2265881|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265882|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2265883|NCT00180895|Rituximab|rituximab|mesh-list
2265884|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2265885|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265886|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
2265887|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767523|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767524|NCT04461340|Sirolimus|sirolimus|mesh-list
2767525|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2767526|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767527|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2767528|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767529|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
2767530|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2767531|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
2767532|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767533|NCT04461041|Empagliflozin|empagliflozin|mesh-list
2767534|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2767535|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767536|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2767537|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767538|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
2767539|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2767540|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2767541|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
2767542|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767543|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767544|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2767545|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
2767546|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2767547|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
2767548|NCT04460963|Protective Agents|protective agents|mesh-ancestor
2767549|NCT04460781|Vaccines|vaccines|mesh-list
2767550|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
2767551|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767552|NCT04460820|Doxorubicin|doxorubicin|mesh-list
2767553|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2767554|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2767555|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767556|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2767557|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2767558|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767559|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767560|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
2767561|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767562|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767563|NCT04460807|Exemestane|exemestane|mesh-list
2767564|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767565|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2767566|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2767567|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767568|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767569|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2767570|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
2767571|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767572|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767573|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2767574|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2767575|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2767580|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
2265888|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2265889|NCT00180908|Doxorubicin|doxorubicin|mesh-list
2265890|NCT00180908|Etoposide|etoposide|mesh-list
2265891|NCT00180908|Methotrexate|methotrexate|mesh-list
2265892|NCT00180908|Ifosfamide|ifosfamide|mesh-list
2265893|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2767581|NCT04460872|Testosterone|testosterone|mesh-list
2767582|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
2767583|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
2767584|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2767585|NCT04460872|Androgens|androgens|mesh-ancestor
2767586|NCT04460872|Hormones|hormones|mesh-ancestor
2767587|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767588|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767589|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2767590|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767591|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
2767599|NCT04460352|Leucovorin|leucovorin|mesh-list
2767600|NCT04460352|Paclitaxel|paclitaxel|mesh-list
2767601|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2767602|NCT04460352|Carboplatin|carboplatin|mesh-list
2767603|NCT04460352|Fluorouracil|fluorouracil|mesh-list
2767604|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
2767605|NCT04460352|Calcium|calcium|mesh-list
2767606|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
2767607|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2767608|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767609|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
2767610|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
2767611|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
2767612|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767613|NCT04460352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2767614|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767615|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
2767616|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2767617|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2767618|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
2767619|NCT04460352|Antidotes|antidotes|mesh-ancestor
2767620|NCT04460352|Protective Agents|protective agents|mesh-ancestor
2767621|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
2767622|NCT04460352|Vitamins|vitamins|mesh-ancestor
2767623|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
2767624|NCT04460547|Interferons|interferons|mesh-list
2767625|NCT04460547|Interferon-beta|interferon-beta|mesh-list
2767626|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
2767627|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
2767628|NCT04460547|Ivermectin|ivermectin|mesh-list
2767629|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767630|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
2767631|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767632|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
2767633|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2767634|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2767635|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767636|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767637|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2767638|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
2767639|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767640|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2767656|NCT04460248|Rituximab|rituximab|mesh-list
2767657|NCT04460248|Lenalidomide|lenalidomide|mesh-list
2767658|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
2767659|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2767660|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767661|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
2767662|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767663|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2767664|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2767665|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2767666|NCT04460248|Growth Substances|growth substances|mesh-ancestor
2767667|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
2767668|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2767669|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767670|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767671|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
2767672|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
2767673|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790019|NCT04297176|Vancomycin|vancomycin|mesh-list
2790020|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2790021|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790022|NCT04297254|Lenvatinib|lenvatinib|mesh-list
2265894|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265895|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2265896|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2265897|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265898|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790023|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790024|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2790025|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790026|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790027|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2790028|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
2790029|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790030|NCT04297462|Oseltamivir|oseltamivir|mesh-list
2790031|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
2790032|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790033|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790034|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790035|NCT04297267|Gemcitabine|gemcitabine|mesh-list
2790036|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790037|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2790038|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
2790039|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790040|NCT04297267|Antiviral Agents|antiviral agents|mesh-ancestor
2790041|NCT04297267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790042|NCT04297267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790043|NCT04297267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2790044|NCT04297267|Immunologic Factors|immunologic factors|mesh-ancestor
2790045|NCT04297267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790046|NCT04297332|Nicotine|nicotine|mesh-list
2790047|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2790048|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
2790049|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790050|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790051|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2790052|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2790053|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
2790054|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790055|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790067|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
2790068|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2790069|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
2790070|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2790071|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
2790072|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790073|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790074|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
2790075|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2767674|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
2767675|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2767676|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
2767677|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767678|NCT04460521|Expectorants|expectorants|mesh-ancestor
2767679|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
2767680|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2767681|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
2767682|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767683|NCT04460521|Protective Agents|protective agents|mesh-ancestor
2767684|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767685|NCT04460521|Antidotes|antidotes|mesh-ancestor
2767686|NCT04460001|Triamcinolone|triamcinolone|mesh-list
2767687|NCT04460001|Ranibizumab|ranibizumab|mesh-list
2767688|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2767689|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2767690|NCT04460001|Growth Substances|growth substances|mesh-ancestor
2767691|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767692|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
2767693|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767694|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2767695|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
2767696|NCT04460001|Hormones|hormones|mesh-ancestor
2767697|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767698|NCT04460066|Paclitaxel|paclitaxel|mesh-list
2767699|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2767700|NCT04460066|Antibodies|antibodies|mesh-list
2767701|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2767702|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767703|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
2767704|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
2767705|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
2767706|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767707|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
2767708|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767709|NCT04460092|Insulin|insulin|mesh-list
2767710|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2767711|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2767712|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767713|NCT04460079|Lenograstim|lenograstim|mesh-list
2767714|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2767715|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
2767716|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767717|NCT04459598|Efavirenz|efavirenz|mesh-list
2767718|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2767719|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2767720|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767721|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767722|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
2767723|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767724|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2767725|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2767726|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2767727|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2767728|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2767729|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2767730|NCT04459663|Axitinib|axitinib|mesh-list
2767731|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265899|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2265900|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
2265901|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2265902|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265903|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2265904|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
2265905|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
2265906|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2265907|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265908|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
2767732|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2767733|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767734|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767735|NCT04459702|Ritonavir|ritonavir|mesh-list
2767736|NCT04459702|Lopinavir|lopinavir|mesh-list
2767737|NCT04459702|Azithromycin|azithromycin|mesh-list
2767738|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
2767739|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2767740|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2767741|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
2767742|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767743|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767744|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2767745|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2767746|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
2767747|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767748|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2767749|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2767750|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2767751|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
2767752|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2767753|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2767754|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2767755|NCT04459676|Mitogens|mitogens|mesh-list
2767756|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
2767757|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767758|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
2767759|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
2767760|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767761|NCT04459312|Antibodies|antibodies|mesh-list
2767762|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
2767763|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767764|NCT04459117|Acetaminophen|acetaminophen|mesh-list
2767765|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2767766|NCT04459117|Analgesics|analgesics|mesh-ancestor
2767767|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
2767768|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767769|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767770|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
2767771|NCT04459078|Apatinib|apatinib|mesh-list
2767772|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2767773|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767774|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2767775|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767776|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767777|NCT04458948|Azithromycin|azithromycin|mesh-list
2767778|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
2767779|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2767780|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767781|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
2767782|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2767783|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2767784|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767785|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767786|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2767787|NCT04459377|Ketamine|ketamine|mesh-list
2767788|NCT04459377|Esketamine|esketamine|mesh-list
2767789|NCT04459377|Analgesics|analgesics|mesh-ancestor
2767790|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
2767791|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767792|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767793|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2767794|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2767795|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
2767796|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
2767797|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2767798|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2767799|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2767800|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2767801|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767802|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
2767803|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2767804|NCT04459273|FAPI-46|fapi-46|mesh-list
2767805|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2767806|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767807|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
2767808|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2767809|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767810|NCT04459026|Ropivacaine|ropivacaine|mesh-list
2767811|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
2767812|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
2767813|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2767814|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767815|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
2767816|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767817|NCT04459234|Ketamine|ketamine|mesh-list
2767818|NCT04459234|Analgesics|analgesics|mesh-ancestor
2767819|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
2767820|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767821|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265909|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2265910|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2265911|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2265912|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2265913|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
2265914|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
2265915|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265916|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2265917|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265918|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265919|NCT00180947|Vinorelbine|vinorelbine|mesh-list
2265920|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2265921|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265922|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
2265923|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
2265924|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
2265925|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265926|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
2767822|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2767823|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2767824|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
2767825|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
2767826|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2767827|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2767828|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2767829|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2767830|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767831|NCT04458454|Methocarbamol|methocarbamol|mesh-list
2767832|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2767833|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767834|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2767835|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767836|NCT04458558|Mifepristone|mifepristone|mesh-list
2767837|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2767838|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
2767839|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2767840|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767841|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2767842|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2767843|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2767844|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
2767845|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2767846|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2767847|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
2767848|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767849|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
2767850|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2767851|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2767852|NCT04458610|Rituximab|rituximab|mesh-list
2767853|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2767854|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
2767855|NCT04458610|Antibodies|antibodies|mesh-list
2767856|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
2767857|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2767858|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
2767859|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767860|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767861|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2767862|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2767863|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767864|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767865|NCT04458545|Heroin|heroin|mesh-list
2767866|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2767867|NCT04458545|Narcotics|narcotics|mesh-ancestor
2265927|NCT00180960|Irinotecan|irinotecan|mesh-list
2265928|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265929|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2265930|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2767868|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2767869|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767870|NCT04458545|Analgesics|analgesics|mesh-ancestor
2767871|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
2767872|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767873|NCT04458636|Prednisolone|prednisolone|mesh-list
2767874|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2767875|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
2767876|NCT04458636|Hormones|hormones|mesh-ancestor
2767877|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767878|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767879|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2265931|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265932|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265933|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
2265934|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265935|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
2265936|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265937|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265938|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2265939|NCT00181012|Lidocaine|lidocaine|mesh-list
2265940|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
2265941|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
2265942|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2265943|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265944|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
2265945|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265946|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2265947|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2265948|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2265949|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2265950|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265951|NCT00181025|Melphalan|melphalan|mesh-list
2265952|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2265953|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
2265954|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265955|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2265956|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2265957|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265958|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
2265959|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265960|NCT00181116|Levetiracetam|levetiracetam|mesh-list
2265961|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
2265962|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
2767880|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767881|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
2767882|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
2767883|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790076|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2790077|NCT04297033|Lovastatin|lovastatin|mesh-list
2790078|NCT04297033|L 647318|l 647318|mesh-list
2790079|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
2790080|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2790081|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2790082|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
2265963|NCT00181142|Daclizumab|daclizumab|mesh-list
2265964|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2265965|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
2265966|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265967|NCT00181181|Atorvastatin|atorvastatin|mesh-list
2265968|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2265969|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2265970|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
2790083|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790084|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2790085|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2790086|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790087|NCT04296851|Niclosamide|niclosamide|mesh-list
2790088|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
2790089|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2790090|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
2790091|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2790092|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790093|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
2790094|NCT04296890|Maytansine|maytansine|mesh-list
2767884|NCT04458324|Buspirone|buspirone|mesh-list
2767885|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2767886|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2767887|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2767888|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767889|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2767890|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2767891|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
2767892|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2767893|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767894|NCT04458285|Valsartan|valsartan|mesh-list
2767895|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2767896|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2767897|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2767898|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2767899|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767900|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
2767901|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767902|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2767903|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767904|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767905|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
2767906|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2767907|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767908|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2767909|NCT04458116|Curcumin|curcumin|mesh-list
2767910|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2767911|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2767912|NCT04458116|Analgesics|analgesics|mesh-ancestor
2767913|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
2767914|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767915|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767916|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2265971|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265972|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2265973|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2265974|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265975|NCT00181220|Valproic Acid|valproic acid|mesh-list
2265976|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
2265977|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2265978|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2265979|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
2265980|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2265981|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265982|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
2265983|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2265984|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2265985|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2265986|NCT00181246|Fentanyl|fentanyl|mesh-list
2265987|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2265988|NCT00181246|Narcotics|narcotics|mesh-ancestor
2265989|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2767917|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2767918|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767919|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767920|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767921|NCT04457557|Ropivacaine|ropivacaine|mesh-list
2265990|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2265991|NCT00181246|Analgesics|analgesics|mesh-ancestor
2767922|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
2767923|NCT04457557|Anesthetics|anesthetics|mesh-list
2767924|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2767925|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767926|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
2767927|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2767928|NCT04457609|Azithromycin|azithromycin|mesh-list
2767929|NCT04457609|Oseltamivir|oseltamivir|mesh-list
2767930|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2767931|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767932|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
2767933|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767934|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767935|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2767936|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2767937|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
2767938|NCT04457765|Povidone|povidone|mesh-list
2767939|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
2767940|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
2767941|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2767942|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767943|NCT04457466|Mitogens|mitogens|mesh-list
2767944|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
2265992|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
2265993|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2265994|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2265995|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2265996|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
2265997|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
2265998|NCT00181272|Azithromycin|azithromycin|mesh-list
2265999|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2266000|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2266001|NCT00181298|Memantine|memantine|mesh-list
2266002|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2266003|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2266004|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
2266005|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266006|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767945|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767951|NCT04457258|FAPI-46|fapi-46|mesh-list
2767952|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2767953|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767954|NCT04457050|Ribavirin|ribavirin|mesh-list
2767955|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
2767956|NCT04457050|Ledipasvir|ledipasvir|mesh-list
2767957|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
2767958|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767959|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
2767960|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2767961|NCT04457180|Repaglinide|repaglinide|mesh-list
2767962|NCT04457180|Apatinib|apatinib|mesh-list
2767963|NCT04457180|Bupropion|bupropion|mesh-list
2767964|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767965|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2767966|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2767967|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767968|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2767969|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
2767970|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2767971|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2767972|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266007|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266008|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2266009|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2266010|NCT00181532|Celecoxib|celecoxib|mesh-list
2266011|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2266012|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2266013|NCT00181532|Analgesics|analgesics|mesh-ancestor
2266014|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
2266015|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266016|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266017|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2266018|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2266019|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2266020|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2266021|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266022|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266023|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
2266024|NCT00181558|Atrasentan|atrasentan|mesh-list
2266025|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2266026|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266027|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266028|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2767973|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2767974|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
2767975|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2767976|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767977|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2767978|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2767979|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2767980|NCT04457232|FAPI-46|fapi-46|mesh-list
2767981|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2767982|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767983|NCT04457245|Fluorides|fluorides|mesh-list
2767984|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
2767985|NCT04457245|Protective Agents|protective agents|mesh-ancestor
2767986|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2767987|NCT04457219|Hemostatics|hemostatics|mesh-list
2767988|NCT04457219|Coagulants|coagulants|mesh-ancestor
2767989|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2767990|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2767991|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2767992|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2767993|NCT04457089|Simvastatin|simvastatin|mesh-list
2767994|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2767995|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2767996|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
2767997|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2767998|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2767999|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2768000|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768001|NCT04457284|Nivolumab|nivolumab|mesh-list
2768002|NCT04457284|Temozolomide|temozolomide|mesh-list
2768003|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768004|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2768005|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2768006|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768007|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2768008|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
2768009|NCT04456985|Folic Acid|folic acid|mesh-list
2768010|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
2768011|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
2768012|NCT04456985|Vitamins|vitamins|mesh-ancestor
2768013|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
2768014|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768015|NCT04456985|Hematinics|hematinics|mesh-ancestor
2768016|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
2768017|NCT04456803|Sevelamer|sevelamer|mesh-list
2768018|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
2768019|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
2768020|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790095|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2790096|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790097|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
2790098|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
2790099|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
2790100|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790101|NCT04296422|Ibuprofen|ibuprofen|mesh-list
2790102|NCT04296422|Diclofenac|diclofenac|mesh-list
2790103|NCT04296422|Naproxen|naproxen|mesh-list
2790104|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2790105|NCT04296422|Piroxicam|piroxicam|mesh-list
2790106|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
2790107|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
2790108|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2790109|NCT04296422|Analgesics|analgesics|mesh-ancestor
2790110|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
2790111|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790112|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790113|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2790114|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2790115|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2790116|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790117|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790118|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
2790119|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2790120|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2790121|NCT04296578|Selenious Acid|selenious acid|mesh-list
2790122|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
2101869|NCT02396953|Hormones|hormones|mesh-ancestor
2101870|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2266029|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2266030|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266031|NCT00181571|Methylphenidate|methylphenidate|mesh-list
2266032|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2266033|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266034|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2266035|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266036|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266037|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266038|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
2266039|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2768021|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
2768022|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768023|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
2768024|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
2768025|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
2768026|NCT04456829|Resveratrol|resveratrol|mesh-list
2768027|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
2768028|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768029|NCT04456829|Protective Agents|protective agents|mesh-ancestor
2768030|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768031|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768032|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2768033|NCT04456777|Vortioxetine|vortioxetine|mesh-list
2768034|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
2768035|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2768036|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2768037|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2768038|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2768039|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768040|NCT04456777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2768041|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2768042|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2768043|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768044|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2768045|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
2768046|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2768047|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2768048|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2768049|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2768050|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
2768051|NCT04456712|Levofloxacin|levofloxacin|mesh-list
2768052|NCT04456712|Ofloxacin|ofloxacin|mesh-list
2768053|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2768054|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768055|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2768056|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2768057|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768058|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768059|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768060|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2768061|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2768062|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2768063|NCT04456712|Renal Agents|renal agents|mesh-ancestor
2768064|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
2101871|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101872|NCT02397096|Ritonavir|ritonavir|mesh-list
2101873|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2101874|NCT02397096|Tenofovir|tenofovir|mesh-list
2101875|NCT02397096|Lamivudine|lamivudine|mesh-list
2101876|NCT02397096|Cobicistat|cobicistat|mesh-list
2101877|NCT02397096|Elvitegravir|elvitegravir|mesh-list
2101878|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2101879|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
2101880|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2101881|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2101882|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101883|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2101884|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2101885|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
2101886|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768065|NCT04456439|Promethazine|promethazine|mesh-list
2768066|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
2768067|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
2768068|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2768069|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2768070|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2768071|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2768072|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768073|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
2768074|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
2768075|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
2768076|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768077|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
2768078|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
2768079|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2768080|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2768081|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
2768082|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
2768083|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2768084|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768085|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2768086|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
2768087|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
2768088|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
2768089|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768090|NCT04456608|Aspirin|aspirin|mesh-list
2768091|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2768092|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2768093|NCT04456608|Analgesics|analgesics|mesh-ancestor
2768094|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
2768095|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768096|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768097|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2768098|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2768099|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2768100|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2768101|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768102|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2768103|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2768104|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768105|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
2768106|NCT04456387|Factor VIII|factor viii|mesh-list
2768107|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2768108|NCT04456387|Coagulants|coagulants|mesh-ancestor
2768109|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
2768110|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768111|NCT04455932|Liver Extracts|liver extracts|mesh-list
2768112|NCT04455932|Hematinics|hematinics|mesh-ancestor
2768113|NCT04455802|Morphine|morphine|mesh-list
2768114|NCT04455802|Buprenorphine|buprenorphine|mesh-list
2768115|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2768116|NCT04455802|Narcotics|narcotics|mesh-ancestor
2768117|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2768118|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768119|NCT04455802|Analgesics|analgesics|mesh-ancestor
2768120|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
2768121|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768122|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2768123|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
2768124|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2768125|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
2768126|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768127|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768128|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2768129|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
2768130|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2768131|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
2768132|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768133|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2768134|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2768135|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
2768136|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
2768137|NCT04456088|Protective Agents|protective agents|mesh-ancestor
2768138|NCT04455711|Lidocaine|lidocaine|mesh-list
2768139|NCT04455711|Remifentanil|remifentanil|mesh-list
2768140|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
2768141|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
2790123|NCT04296578|Prednisone|prednisone|mesh-list
2768142|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2768143|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768144|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
2768145|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768146|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2768147|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2768148|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2768149|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2768150|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768151|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2768152|NCT04455711|Narcotics|narcotics|mesh-ancestor
2768153|NCT04455711|Analgesics|analgesics|mesh-ancestor
2768154|NCT04455555|Rotigotine|rotigotine|mesh-list
2768155|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
2768156|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
2768157|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2768158|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768159|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768160|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2768161|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
2768162|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768163|NCT04455594|Carboplatin|carboplatin|mesh-list
2768164|NCT04455594|Pemetrexed|pemetrexed|mesh-list
2768165|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2768166|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768167|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768168|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768169|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2768170|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2266040|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
2266041|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2266042|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266043|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
2266044|NCT00181597|Trilostane|trilostane|mesh-list
2266045|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2266046|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2266047|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
2266048|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2266049|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266050|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266051|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266052|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266053|NCT00181636|Galantamine|galantamine|mesh-list
2266054|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2266055|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266056|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266057|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
2266058|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266059|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266060|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2266061|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
2266062|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768171|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2768172|NCT04455958|Ritonavir|ritonavir|mesh-list
2768173|NCT04455958|Lopinavir|lopinavir|mesh-list
2768174|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2768175|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2768176|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
2768177|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768178|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768179|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2768180|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2768181|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
2768182|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768183|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2768184|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2768185|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2768186|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2790124|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
2790125|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2790126|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
2790127|NCT04296578|Hormones|hormones|mesh-ancestor
2790128|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2768187|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
2768188|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2768189|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
2768190|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768191|NCT04455243|Expectorants|expectorants|mesh-ancestor
2768192|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
2768193|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2768194|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
2768195|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768196|NCT04455243|Protective Agents|protective agents|mesh-ancestor
2768197|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768198|NCT04455243|Antidotes|antidotes|mesh-ancestor
2768199|NCT04454775|Protein C|protein c|mesh-list
2768200|NCT04454775|Antithrombins|antithrombins|mesh-list
2768201|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
2768202|NCT04454775|Protein S|protein s|mesh-list
2768203|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2768204|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
2768205|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768206|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768207|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
2768208|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2768209|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2768221|NCT04454840|Riluzole|riluzole|mesh-list
2768222|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
2768223|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2768224|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2768225|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2768226|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768227|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768228|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2768229|NCT04454840|Protective Agents|protective agents|mesh-ancestor
2768230|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2768231|NCT04454788|Tenecteplase|tenecteplase|mesh-list
2768232|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2768233|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2768234|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768235|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
2768236|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2768237|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768238|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
2768239|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2768240|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2768241|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768242|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2768243|NCT04454515|Analgesics|analgesics|mesh-ancestor
2768244|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
2768245|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768246|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2768247|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2768248|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2768249|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
2768250|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2768251|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768252|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2768253|NCT04454580|Azacitidine|azacitidine|mesh-list
2768254|NCT04454580|Decitabine|decitabine|mesh-list
2768255|NCT04454580|Venetoclax|venetoclax|mesh-list
2768256|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2768257|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
2768258|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768259|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768260|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768261|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2768262|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2768263|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768264|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768265|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
2768266|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768267|NCT04454411|Naltrexone|naltrexone|mesh-list
2768268|NCT04454411|Buprenorphine|buprenorphine|mesh-list
2768269|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2768270|NCT04454411|Narcotics|narcotics|mesh-ancestor
2768271|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2768272|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768273|NCT04454411|Analgesics|analgesics|mesh-ancestor
2768274|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
2768275|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768276|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2768277|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2768278|NCT04454307|Tramadol|tramadol|mesh-list
2768279|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2768280|NCT04454307|Narcotics|narcotics|mesh-ancestor
2768281|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2768282|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768283|NCT04454307|Analgesics|analgesics|mesh-ancestor
2768284|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
2768285|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768286|NCT04454151|Azithromycin|azithromycin|mesh-list
2768287|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2768288|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2266063|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
2266064|NCT00181662|Curcumin|curcumin|mesh-list
2266065|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2266066|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2266067|NCT00181662|Analgesics|analgesics|mesh-ancestor
2266068|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
2266069|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266070|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266071|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2266072|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2266073|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266074|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768289|NCT04454203|Anesthetics|anesthetics|mesh-list
2768290|NCT04454203|Mepivacaine|mepivacaine|mesh-list
2768291|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
2768292|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2768293|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768294|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
2768295|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768296|NCT04454281|Naloxone|naloxone|mesh-list
2768297|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2768298|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768299|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
2768300|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768301|NCT04454229|Penicillins|penicillins|mesh-list
2768302|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2768303|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768304|NCT04453930|Irinotecan|irinotecan|mesh-list
2768305|NCT04453930|Apatinib|apatinib|mesh-list
2768306|NCT04453930|Antibodies|antibodies|mesh-list
2768307|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
2768308|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768309|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2768310|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2768311|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768312|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768313|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768314|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2768315|NCT04453852|Vaccines|vaccines|mesh-list
2768316|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
2768317|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768318|NCT04453735|Atorvastatin|atorvastatin|mesh-list
2768319|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2768320|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2768321|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
2768322|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768323|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2768324|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2768325|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768326|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
2768327|NCT04453761|Vitamins|vitamins|mesh-ancestor
2768328|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
2768329|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768330|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
2768331|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2768332|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790129|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790130|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2790131|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790132|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2790133|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790134|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790135|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
2790136|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2790137|NCT04296578|Trace Elements|trace elements|mesh-ancestor
2790138|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
2790139|NCT04296396|Oxycodone|oxycodone|mesh-list
2790140|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2790141|NCT04296396|Narcotics|narcotics|mesh-ancestor
2790142|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790143|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790144|NCT04296396|Analgesics|analgesics|mesh-ancestor
2790145|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
2790146|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790147|NCT04296695|Tenofovir|tenofovir|mesh-list
2790148|NCT04296695|Efavirenz|efavirenz|mesh-list
2790149|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
2790150|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790151|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2790152|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2790153|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790154|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790155|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2790156|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2790157|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2790158|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2790159|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2790160|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2790161|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2790162|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2790163|NCT04296214|Azacitidine|azacitidine|mesh-list
2790164|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2790165|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
2790166|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790167|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790168|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790169|NCT04296240|Capecitabine|capecitabine|mesh-list
2790170|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
2790171|NCT04296240|Antiemetics|antiemetics|mesh-list
2790172|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2790173|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
2790174|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790175|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790176|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
2790177|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790178|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790179|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2790180|NCT04296370|Apatinib|apatinib|mesh-list
2790181|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790182|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2790183|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790184|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790185|NCT04296383|Azithromycin|azithromycin|mesh-list
2790186|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2790187|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790188|NCT04296006|Amphetamine|amphetamine|mesh-list
2790189|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
2790190|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2790191|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790192|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
2790193|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
2790194|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790195|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
2790196|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266075|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266076|NCT00181675|Galantamine|galantamine|mesh-list
2768333|NCT04453280|Antibodies|antibodies|mesh-list
2768334|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
2768335|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768336|NCT04453423|Carboplatin|carboplatin|mesh-list
2768337|NCT04453423|Pemetrexed|pemetrexed|mesh-list
2768338|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768339|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768340|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768341|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2768342|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2768343|NCT04453306|Topiramate|topiramate|mesh-list
2768344|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
2768345|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2768346|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768347|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2768348|NCT04453371|Plasminogen|plasminogen|mesh-list
2768349|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2768350|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2768351|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768352|NCT04453345|Thalidomide|thalidomide|mesh-list
2768353|NCT04453345|Prednisone|prednisone|mesh-list
2768354|NCT04453345|Methotrexate|methotrexate|mesh-list
2768355|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2768356|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
2768357|NCT04453345|Hormones|hormones|mesh-ancestor
2768358|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2768359|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768360|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2768361|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768362|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2768363|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
2266077|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2266078|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266079|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266080|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
2266081|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266082|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266083|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2266084|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
2266085|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266086|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
2266087|NCT00181688|Anastrozole|anastrozole|mesh-list
2266088|NCT00181688|Gefitinib|gefitinib|mesh-list
2266089|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2266090|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768364|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2768365|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2768366|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
2768367|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768368|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
2768369|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768370|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2768371|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2768372|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
2768373|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2768374|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2768375|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
2768376|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2768377|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768378|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2768379|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2768380|NCT04453345|Growth Substances|growth substances|mesh-ancestor
2768381|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
2768382|NCT04453436|Tenofovir|tenofovir|mesh-list
2768383|NCT04453436|Lamivudine|lamivudine|mesh-list
2768384|NCT04453436|Dolutegravir|dolutegravir|mesh-list
2768385|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
2768386|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768387|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2768388|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2768389|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768390|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768391|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2768392|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2768393|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2768394|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2266091|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2266092|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2266093|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266094|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266095|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2768395|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2768396|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2768397|NCT04453332|Hormones|hormones|mesh-list
2768398|NCT04453332|Estradiol|estradiol|mesh-list
2768399|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2768400|NCT04453332|Progesterone|progesterone|mesh-list
2768401|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2768402|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768403|NCT04453332|Estrogens|estrogens|mesh-ancestor
2768404|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2768405|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
2768406|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2101887|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2101888|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2101889|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2101890|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2101891|NCT02397265|Insulin|insulin|mesh-list
2768407|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2768408|NCT04453332|Progestins|progestins|mesh-ancestor
2768409|NCT04453449|Midazolam|midazolam|mesh-list
2768410|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2768411|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2768412|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2768413|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768414|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2768415|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2768416|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2768417|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2768418|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
2768419|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
2768420|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
2768421|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
2768422|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2768423|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768424|NCT04453189|Lansoprazole|lansoprazole|mesh-list
2768425|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
2768426|NCT04453189|Famotidine|famotidine|mesh-list
2768427|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2768428|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2768429|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2768430|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768431|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768432|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2768433|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
2768434|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
2768435|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2768436|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768437|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2768438|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768439|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
2768440|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2768441|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
2768442|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768443|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
2768444|NCT04453111|Protective Agents|protective agents|mesh-ancestor
2768445|NCT04452838|Fesoterodine|fesoterodine|mesh-list
2101892|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2101893|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101894|NCT02397291|Inositol|inositol|mesh-list
2101895|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
2101896|NCT02397291|Vitamins|vitamins|mesh-ancestor
2101897|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
2101898|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101899|NCT02397408|Choline|choline|mesh-list
2768446|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2768447|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2768448|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
2768449|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101900|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
2266096|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
2266097|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2266098|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266099|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2266100|NCT00181701|Paclitaxel|paclitaxel|mesh-list
2266101|NCT00181701|Carboplatin|carboplatin|mesh-list
2768450|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768451|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768452|NCT04452838|Urological Agents|urological agents|mesh-ancestor
2768453|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
2768454|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2768455|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768456|NCT04452929|Calcitonin|calcitonin|mesh-list
2768457|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
2768458|NCT04452929|Cilostazol|cilostazol|mesh-list
2768459|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2768460|NCT04452929|Erenumab|erenumab|mesh-list
2768461|NCT04452929|Katacalcin|katacalcin|mesh-list
2768462|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2768463|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
2768464|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768465|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768466|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2768467|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
2768468|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2768469|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2768470|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768471|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2768472|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
2768473|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2768474|NCT04452929|Protective Agents|protective agents|mesh-ancestor
2768475|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2768476|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2768477|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768478|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2768479|NCT04452929|Analgesics|analgesics|mesh-ancestor
2768480|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
2768481|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2768482|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2768483|NCT04452669|Epoprostenol|epoprostenol|mesh-list
2768484|NCT04452669|Tezosentan|tezosentan|mesh-list
2768485|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2768486|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2768487|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
2768488|NCT04452370|Etoposide|etoposide|mesh-list
2768489|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2768490|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768491|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2768492|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2768493|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768494|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768495|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2768496|NCT04452565|Dexamethasone|dexamethasone|mesh-list
2768497|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
2768498|NCT04452565|BB 1101|bb 1101|mesh-list
2768499|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2768500|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
2768501|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
2768502|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768503|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768504|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2768505|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
2768506|NCT04452565|Hormones|hormones|mesh-ancestor
2768507|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2768508|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2768509|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768510|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
2768511|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768512|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768513|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2768514|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2768515|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2768516|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2768517|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
2768518|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101901|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2101902|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
2101903|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101904|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2101905|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2101906|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
2101907|NCT02397694|Dolutegravir|dolutegravir|mesh-list
2101908|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2101909|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2768523|NCT04452461|Leucovorin|leucovorin|mesh-list
2266102|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2266103|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266104|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
2266105|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
2266106|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
2266107|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266108|NCT00181727|Valproic Acid|valproic acid|mesh-list
2266109|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
2266110|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266111|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266112|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
2266113|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266114|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266115|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
2266116|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2266117|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266118|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266119|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2266120|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2266121|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266122|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2768524|NCT04452461|Gemcitabine|gemcitabine|mesh-list
2768525|NCT04452461|Paclitaxel|paclitaxel|mesh-list
2768526|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
2768527|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2768528|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768529|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
2768530|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
2768531|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
2768532|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768533|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2768534|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
2768535|NCT04452461|Antiviral Agents|antiviral agents|mesh-ancestor
2768536|NCT04452461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2266123|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266124|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
2266125|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266126|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266127|NCT00181779|Aripiprazole|aripiprazole|mesh-list
2266128|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
2266129|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266130|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2266131|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2266132|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266133|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266134|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
2266135|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
2266136|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2768537|NCT04452461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768538|NCT04452461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2768539|NCT04452461|Immunologic Factors|immunologic factors|mesh-ancestor
2768540|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768541|NCT04452461|Antidotes|antidotes|mesh-ancestor
2768542|NCT04452461|Protective Agents|protective agents|mesh-ancestor
2768543|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
2768544|NCT04452461|Vitamins|vitamins|mesh-ancestor
2768545|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
2768546|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
2768547|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2768548|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101910|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768549|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
2768550|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
2768551|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2768552|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2768553|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768554|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2790197|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790198|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
2790199|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2790200|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2790201|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2790202|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2790203|NCT04296175|Paclitaxel|paclitaxel|mesh-list
2790204|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2790205|NCT04296175|Carboplatin|carboplatin|mesh-list
2790206|NCT04296175|Epirubicin|epirubicin|mesh-list
2790207|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2790208|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790209|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
2790210|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
2790211|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
2790212|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790213|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2790214|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2790215|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2790216|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790217|NCT04296162|Capecitabine|capecitabine|mesh-list
2266137|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266138|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2266139|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2266140|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
2266141|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2266142|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2266143|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2266144|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2266145|NCT00181818|Bupropion|bupropion|mesh-list
2266146|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2790218|NCT04296162|Trastuzumab|trastuzumab|mesh-list
2790219|NCT04296162|Vinorelbine|vinorelbine|mesh-list
2790220|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2790221|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
2790222|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790223|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790224|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2790225|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2790226|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
2790227|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
2790228|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
2790229|NCT04295993|Norepinephrine|norepinephrine|mesh-list
2790230|NCT04295993|Methylene Blue|methylene blue|mesh-list
2790231|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2790232|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2790233|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
2790234|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790235|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790236|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790237|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
2790238|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
2266147|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
2266148|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266149|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2266150|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266151|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2790239|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790240|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2790241|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790242|NCT04295850|Aspirin|aspirin|mesh-list
2790243|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2790244|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2790245|NCT04295850|Analgesics|analgesics|mesh-ancestor
2790246|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
2790247|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266152|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266153|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
2768555|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
2768556|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2768557|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768558|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2768559|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768560|NCT04451655|Insulin|insulin|mesh-list
2768561|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2768562|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768563|NCT04451395|Micronutrients|micronutrients|mesh-list
2768564|NCT04451395|Trace Elements|trace elements|mesh-list
2768565|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768566|NCT04451447|SMOFlipid|smoflipid|mesh-list
2768567|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2768568|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2768569|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2768570|NCT04451200|Busulfan|busulfan|mesh-list
2768571|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
2768572|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768573|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2768574|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
2266154|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266155|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266156|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2266157|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2266158|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266159|NCT00181870|Carbamazepine|carbamazepine|mesh-list
2266160|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
2266161|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
2768575|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768576|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2768577|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768578|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2768579|NCT04451239|Cyclosporine|cyclosporine|mesh-list
2768580|NCT04451239|Cyclosporins|cyclosporins|mesh-list
2768581|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768582|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768583|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2768584|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
2768585|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768586|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
2768587|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768588|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
2768589|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2768590|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2768591|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2768592|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2768593|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2768594|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768595|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768596|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2768597|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2768598|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768599|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
2768600|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2768601|NCT04451330|Doxycycline|doxycycline|mesh-list
2768602|NCT04451330|Trifarotene|trifarotene|mesh-list
2768603|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2768604|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768605|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
2768606|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2768607|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2768608|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
2768609|NCT04451174|Prednisone|prednisone|mesh-list
2768610|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2768611|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
2768612|NCT04451174|Hormones|hormones|mesh-ancestor
2768613|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2768614|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768615|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2768616|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768617|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
2768618|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2768619|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768620|NCT04451083|Camostat|camostat|mesh-list
2768621|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
2768622|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768623|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768624|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2768625|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2768626|NCT04450836|Trifluridine|trifluridine|mesh-list
2768627|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
2768628|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768629|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
2768630|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768631|NCT04450680|Lactams|lactams|mesh-list
2768632|NCT04450680|beta-Lactams|beta-lactams|mesh-list
2768633|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2768634|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768638|NCT04450446|Heparin|heparin|mesh-list
2768639|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2768640|NCT04450446|Tinzaparin|tinzaparin|mesh-list
2768641|NCT04450446|Dalteparin|dalteparin|mesh-list
2768642|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
2768643|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2768644|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2768645|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768646|NCT04450160|Temozolomide|temozolomide|mesh-list
2768647|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2768648|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
2768649|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768650|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768651|NCT04450173|Venetoclax|venetoclax|mesh-list
2768652|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
2768653|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768654|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2768655|NCT04450134|Fexofenadine|fexofenadine|mesh-list
2768656|NCT04450134|Famotidine|famotidine|mesh-list
2768657|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2768658|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2768659|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2768660|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
2768661|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
2768662|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2768663|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266162|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2266163|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266164|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266165|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266166|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2266167|NCT00181870|Analgesics|analgesics|mesh-ancestor
2768664|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768665|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2768666|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2768667|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2768668|NCT04450212|Vitamin K|vitamin k|mesh-list
2768669|NCT04450212|Vitamins|vitamins|mesh-ancestor
2768670|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
2768671|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768672|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2768673|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2768674|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768675|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
2768676|NCT04450212|Coagulants|coagulants|mesh-ancestor
2790248|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790249|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2790250|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2790251|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2790252|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2790253|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790254|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2790255|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2790256|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790257|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
2790258|NCT04295967|Formaldehyde|formaldehyde|mesh-list
2790259|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
2790260|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790261|NCT04296149|Octreotide|octreotide|mesh-list
2790262|NCT04296149|Edotreotide|edotreotide|mesh-list
2790263|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2790264|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2768677|NCT04450095|Ambrisentan|ambrisentan|mesh-list
2768678|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2768679|NCT04450329|Aflibercept|aflibercept|mesh-list
2768680|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2768681|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2768682|NCT04450329|Growth Substances|growth substances|mesh-ancestor
2768683|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768684|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
2768685|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768686|NCT04450316|Naltrexone|naltrexone|mesh-list
2768687|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2768688|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2768689|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768690|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
2768691|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768692|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
2768693|NCT04449965|Povidone|povidone|mesh-list
2768694|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
2768695|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
2768696|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2768697|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768698|NCT04449952|Listerine|listerine|mesh-list
2768699|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
2768700|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
2266168|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
2266169|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266170|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2266171|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266172|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266173|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2266174|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2266175|NCT00181896|Bupropion|bupropion|mesh-list
2266176|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2266177|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
2266178|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266179|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2266180|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266181|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266182|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266183|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
2768701|NCT04449952|Protective Agents|protective agents|mesh-ancestor
2768702|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768703|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2768704|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768705|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2768706|NCT04449718|Vitamin D|vitamin d|mesh-list
2768707|NCT04449718|Vitamins|vitamins|mesh-ancestor
2768708|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
2768709|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768710|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2768711|NCT04449874|Bevacizumab|bevacizumab|mesh-list
2768712|NCT04449874|Cetuximab|cetuximab|mesh-list
2768713|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2768714|NCT04449874|Atezolizumab|atezolizumab|mesh-list
2768715|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2768716|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768717|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2768718|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2768719|NCT04449874|Growth Substances|growth substances|mesh-ancestor
2768720|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768721|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
2768722|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2768723|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768724|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768725|NCT04450199|Vitamin D|vitamin d|mesh-list
2768726|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
2768727|NCT04450199|Vitamins|vitamins|mesh-list
2768728|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
2768729|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768730|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2768731|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2768732|NCT04450355|Nefopam|nefopam|mesh-list
2768733|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2768734|NCT04450355|Analgesics|analgesics|mesh-ancestor
2768735|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
2768736|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768737|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768738|NCT04449536|Mesna|mesna|mesh-list
2768739|NCT04449536|Protective Agents|protective agents|mesh-ancestor
2768740|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768750|NCT04449198|Resveratrol|resveratrol|mesh-list
2768751|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
2768752|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768753|NCT04449198|Protective Agents|protective agents|mesh-ancestor
2768754|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768755|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768756|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2768757|NCT04449224|Etanercept|etanercept|mesh-list
2768758|NCT04449224|Abatacept|abatacept|mesh-list
2768759|NCT04449224|Tofacitinib|tofacitinib|mesh-list
2768760|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2768761|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2768762|NCT04449224|Analgesics|analgesics|mesh-ancestor
2768763|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
2768764|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768765|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768766|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2768767|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2768768|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2768769|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2768770|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
2768771|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2768772|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768773|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768774|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2768775|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768776|NCT04449289|Lidocaine|lidocaine|mesh-list
2768777|NCT04449289|Ropivacaine|ropivacaine|mesh-list
2768778|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
2768779|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
2768780|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2768781|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768782|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
2768783|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768784|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2768785|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2768786|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2768787|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2768788|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768789|NCT04449471|Naproxen|naproxen|mesh-list
2768790|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2768791|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2768792|NCT04449471|Analgesics|analgesics|mesh-ancestor
2768793|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
2768794|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768795|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768796|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2768797|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2768798|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
2768799|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2768800|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768801|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768802|NCT04449185|Amoxicillin|amoxicillin|mesh-list
2768803|NCT04449185|Clarithromycin|clarithromycin|mesh-list
2768804|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2768805|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768806|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2768807|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768808|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768809|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2768810|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2768811|NCT04449380|Interferons|interferons|mesh-list
2768812|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768813|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
2768814|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768818|NCT04448873|Sirolimus|sirolimus|mesh-list
2768819|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2768820|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768821|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2768822|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768823|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
2768824|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2768825|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
2768826|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768827|NCT04448821|Metformin|metformin|mesh-list
2768828|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2768829|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768830|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
2768831|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
2768832|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768833|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2768834|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2768835|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768836|NCT04448587|Incretins|incretins|mesh-ancestor
2768837|NCT04448587|Hormones|hormones|mesh-ancestor
2768838|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2768839|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2768840|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
2768841|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768842|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768843|NCT04448496|Dexamethasone|dexamethasone|mesh-list
2768844|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2768845|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
2768846|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
2768847|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768848|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768849|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2768850|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
2768851|NCT04448496|Hormones|hormones|mesh-ancestor
2768852|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2768853|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2768854|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790265|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790266|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2790267|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792805|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792806|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2792807|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2792808|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
2792809|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
2792810|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792811|NCT04275362|Cimetidine|cimetidine|mesh-list
2792812|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2792813|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2792814|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2792815|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
2792816|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
2792817|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792818|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792819|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101911|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101912|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2101913|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2101914|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
2101915|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2266184|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266185|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266186|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2266187|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2266188|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792820|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2768855|NCT04448457|Sufentanil|sufentanil|mesh-list
2768856|NCT04448457|Oxycodone|oxycodone|mesh-list
2768857|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2768858|NCT04448457|Narcotics|narcotics|mesh-ancestor
2768859|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2768860|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768861|NCT04448457|Analgesics|analgesics|mesh-ancestor
2768862|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
2768863|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768864|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2768865|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2768866|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
2768867|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
2768868|NCT04448379|Afatinib|afatinib|mesh-list
2768869|NCT04448379|Osimertinib|osimertinib|mesh-list
2768870|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101916|NCT02397837|Pramipexole|pramipexole|mesh-list
2101917|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
2101918|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101919|NCT02397837|Protective Agents|protective agents|mesh-ancestor
2101920|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101921|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2101922|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2101923|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
2101924|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
2101925|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101926|NCT02397889|Midazolam|midazolam|mesh-list
2768871|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2768872|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266189|NCT00181922|Ziprasidone|ziprasidone|mesh-list
2266190|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2266191|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
2266192|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266193|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266194|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768873|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768874|NCT04448392|Valacyclovir|valacyclovir|mesh-list
2768875|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
2768876|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768877|NCT04448223|Latanoprost|latanoprost|mesh-list
2768878|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2768879|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2768880|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
2768881|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2768882|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2768883|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768884|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
2768885|NCT04448184|Coagulants|coagulants|mesh-ancestor
2768886|NCT04448119|Favipiravir|favipiravir|mesh-list
2768887|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
2768888|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768889|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
2768890|NCT04448015|Narcotics|narcotics|mesh-ancestor
2768891|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2768892|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768893|NCT04448015|Analgesics|analgesics|mesh-ancestor
2768894|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
2768895|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768896|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
2768897|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
2768898|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2768899|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2768900|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768901|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768902|NCT04447989|Urological Agents|urological agents|mesh-ancestor
2768903|NCT04447781|Citric Acid|citric acid|mesh-list
2768904|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
2768905|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
2768906|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2768907|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
2768908|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
2768909|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768910|NCT04447716|Rituximab|rituximab|mesh-list
2768911|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2101927|NCT02397889|Ketamine|ketamine|mesh-list
2768912|NCT04447716|Lenalidomide|lenalidomide|mesh-list
2768913|NCT04447716|Venetoclax|venetoclax|mesh-list
2768914|NCT04447716|Piperidine|piperidine|mesh-list
2768915|NCT04447716|Antibodies|antibodies|mesh-list
2768916|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
2768917|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2768918|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
2768919|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768920|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266195|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2266196|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2266197|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266198|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266199|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2266200|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
2266201|NCT00181935|Olanzapine|olanzapine|mesh-list
2266202|NCT00181935|Risperidone|risperidone|mesh-list
2266203|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2266204|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
2266205|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266206|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266207|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266208|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2266209|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2266210|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266211|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2768921|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2768922|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2768923|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2768924|NCT04447716|Growth Substances|growth substances|mesh-ancestor
2768925|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
2768926|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768927|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2768928|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2768929|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2768930|NCT04448028|Esomeprazole|esomeprazole|mesh-list
2768931|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2768932|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2768933|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2768934|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768935|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768936|NCT04447911|Empagliflozin|empagliflozin|mesh-list
2768937|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2768938|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768939|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2768940|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768941|NCT04447612|Gemcitabine|gemcitabine|mesh-list
2768942|NCT04447612|Durvalumab|durvalumab|mesh-list
2768943|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768944|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2768945|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
2768946|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768947|NCT04447612|Antiviral Agents|antiviral agents|mesh-ancestor
2768948|NCT04447612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2266212|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2266213|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
2266214|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
2266215|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
2266216|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266217|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2266218|NCT00181935|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2266219|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266220|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266221|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2266222|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2266223|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266224|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266225|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266226|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
2266227|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266228|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266229|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2768949|NCT04447612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2768950|NCT04447612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2768951|NCT04447612|Immunologic Factors|immunologic factors|mesh-ancestor
2768952|NCT04447612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266230|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
2266231|NCT00181974|Coagulants|coagulants|mesh-ancestor
2768953|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2768954|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
2768955|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2768956|NCT04447352|Leucovorin|leucovorin|mesh-list
2768957|NCT04447352|Docetaxel|docetaxel|mesh-list
2768958|NCT04447352|Fluorouracil|fluorouracil|mesh-list
2768959|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
2768960|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2768961|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
2768962|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
2768963|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
2768964|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768965|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
2768966|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2768967|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2768968|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
2768969|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768970|NCT04447352|Antidotes|antidotes|mesh-ancestor
2768971|NCT04447352|Protective Agents|protective agents|mesh-ancestor
2768972|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
2768973|NCT04447352|Vitamins|vitamins|mesh-ancestor
2768974|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
2768975|NCT04447534|Chloroquine|chloroquine|mesh-list
2768976|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2768977|NCT04447534|Amebicides|amebicides|mesh-ancestor
2768978|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2768979|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2768980|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2768981|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
2768982|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2768983|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2768984|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2768985|NCT04447534|Analgesics|analgesics|mesh-ancestor
2768986|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
2266232|NCT00181987|Methylphenidate|methylphenidate|mesh-list
2266233|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2266234|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266235|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2266236|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266237|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266238|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266239|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
2266240|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266241|NCT00182013|Olanzapine|olanzapine|mesh-list
2768987|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2768988|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2768989|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2768990|NCT04447534|Filaricides|filaricides|mesh-ancestor
2768991|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
2768992|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
2768993|NCT04447326|Endostar protein|endostar protein|mesh-list
2768994|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2768995|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2768996|NCT04447326|Growth Substances|growth substances|mesh-ancestor
2768997|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266242|NCT00182013|Risperidone|risperidone|mesh-list
2266243|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2266244|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2266245|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
2266246|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266247|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2768998|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
2768999|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769000|NCT04447274|Apatinib|apatinib|mesh-list
2769001|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769002|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2769003|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769004|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769005|NCT04447443|Loperamide|loperamide|mesh-list
2769006|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
2769007|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2769008|NCT04447235|Ivermectin|ivermectin|mesh-list
2769009|NCT04447235|Losartan|losartan|mesh-list
2769010|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2769011|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2769012|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2769013|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2769014|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769015|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2769016|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769017|NCT04447560|Bupivacaine|bupivacaine|mesh-list
2769018|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
2769019|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
2769020|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769021|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769022|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
2769023|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769035|NCT04447092|Leucovorin|leucovorin|mesh-list
2769036|NCT04447092|Gemcitabine|gemcitabine|mesh-list
2769037|NCT04447092|Paclitaxel|paclitaxel|mesh-list
2266248|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266249|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2266250|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2266251|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266252|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266253|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2266254|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
2266255|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
2266256|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
2266257|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266258|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2769038|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
2769039|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
2769040|NCT04447092|Irinotecan|irinotecan|mesh-list
2769041|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2769042|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769043|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
2769044|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
2769045|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
2769046|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769047|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2769048|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
2769049|NCT04447092|Antiviral Agents|antiviral agents|mesh-ancestor
2769050|NCT04447092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769051|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769052|NCT04447092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2769053|NCT04447092|Immunologic Factors|immunologic factors|mesh-ancestor
2769054|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769055|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2769056|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2769057|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2769058|NCT04447092|Antidotes|antidotes|mesh-ancestor
2769059|NCT04447092|Protective Agents|protective agents|mesh-ancestor
2769060|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
2769061|NCT04447092|Vitamins|vitamins|mesh-ancestor
2769062|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
2769063|NCT04447378|PENTA|penta|mesh-list
2769064|NCT04447378|Fondaparinux|fondaparinux|mesh-list
2769065|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2769066|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
2769067|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2769068|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
2769069|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769070|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769071|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
2769072|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2769073|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2769074|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2769075|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2769076|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769077|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
2769078|NCT04447105|Anesthetics|anesthetics|mesh-list
2769079|NCT04447105|Propofol|propofol|mesh-list
2769080|NCT04447105|Desflurane|desflurane|mesh-list
2769081|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769082|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769083|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2769084|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2769085|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
2769086|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2769091|NCT04446923|Propranolol|propranolol|mesh-list
2769092|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2769093|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2769094|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
2769095|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2769096|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769097|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769098|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2769099|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2769100|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
2769101|NCT04447040|Acetaminophen|acetaminophen|mesh-list
2769102|NCT04447040|Naproxen|naproxen|mesh-list
2266259|NCT00182013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2266260|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266261|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266262|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
2266263|NCT00182039|Metoprolol|metoprolol|mesh-list
2266264|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2769103|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2769104|NCT04447040|Analgesics|analgesics|mesh-ancestor
2769105|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
2769106|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769107|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769108|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
2769109|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2769110|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2769111|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2769112|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
2769113|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2769114|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769115|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769116|NCT04446962|Lenalidomide|lenalidomide|mesh-list
2769117|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
2769118|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769119|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2769120|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2769121|NCT04446962|Growth Substances|growth substances|mesh-ancestor
2769122|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
2769123|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769124|NCT04446871|Methylene Blue|methylene blue|mesh-list
2769125|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769126|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790273|NCT04295408|Ropivacaine|ropivacaine|mesh-list
2790274|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
2790275|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
2790276|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790277|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266265|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2266266|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
2266267|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
2266268|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266269|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266270|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2266271|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2790278|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
2790279|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790280|NCT04295486|Aspirin|aspirin|mesh-list
2790281|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2790282|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2790283|NCT04295486|Analgesics|analgesics|mesh-ancestor
2769127|NCT04446663|Paclitaxel|paclitaxel|mesh-list
2769128|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2769129|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2769130|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769131|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
2769132|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
2769133|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
2266272|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2266273|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
2266274|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2769134|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769135|NCT04446715|Sufentanil|sufentanil|mesh-list
2769136|NCT04446715|Meperidine|meperidine|mesh-list
2769137|NCT04446715|Bupivacaine|bupivacaine|mesh-list
2769138|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
2769139|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
2769140|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769141|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769142|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
2769143|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769144|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2769145|NCT04446715|Narcotics|narcotics|mesh-ancestor
2769146|NCT04446715|Analgesics|analgesics|mesh-ancestor
2769147|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2769148|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2769149|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
2769150|NCT04446598|Tadalafil|tadalafil|mesh-list
2769151|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
2769152|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2769153|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2769154|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769155|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769156|NCT04446598|Urological Agents|urological agents|mesh-ancestor
2769157|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
2769158|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2769159|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2769160|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
2769161|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2769162|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769163|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
2769164|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
2769165|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2769166|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
2769167|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769168|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
2769169|NCT04446533|Protective Agents|protective agents|mesh-ancestor
2769170|NCT04446637|Albuterol|albuterol|mesh-list
2769171|NCT04446637|Ipratropium|ipratropium|mesh-list
2769172|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2769173|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
2769174|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769175|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769176|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2769177|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
2769178|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
2769179|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2769180|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2769181|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2769182|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2769183|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
2769184|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2769185|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769186|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2769187|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
2769188|NCT04446416|Bevacizumab|bevacizumab|mesh-list
2769189|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2769190|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769191|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2769192|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2769193|NCT04446416|Growth Substances|growth substances|mesh-ancestor
2769194|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769195|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
2769196|NCT04446403|Anesthetics|anesthetics|mesh-list
2769197|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769198|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769199|NCT04446338|Antibodies|antibodies|mesh-list
2769200|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
2769201|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266275|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266276|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
2266277|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2266278|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266279|NCT00182104|Warfarin|warfarin|mesh-list
2266280|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
2266281|NCT00182143|Heparin|heparin|mesh-list
2266282|NCT00182143|Calcium heparin|calcium heparin|mesh-list
2266283|NCT00182143|Dalteparin|dalteparin|mesh-list
2266284|NCT00182143|Tinzaparin|tinzaparin|mesh-list
2266285|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2266286|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
2769202|NCT04446390|Listerine|listerine|mesh-list
2769203|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
2769204|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
2769205|NCT04446390|Protective Agents|protective agents|mesh-ancestor
2769206|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769207|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2769208|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769209|NCT04446364|Disinfectants|disinfectants|mesh-list
2769210|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769211|NCT04445922|Anastrozole|anastrozole|mesh-list
2769212|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2769213|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769214|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2769215|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2769216|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769217|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769218|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2769219|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
2769220|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2769221|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769222|NCT04446234|Risperidone|risperidone|mesh-list
2769223|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2769224|NCT04446234|Aripiprazole|aripiprazole|mesh-list
2769225|NCT04446234|Ziprasidone|ziprasidone|mesh-list
2769226|NCT04446234|Amisulpride|amisulpride|mesh-list
2769227|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2769228|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
2769229|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2769230|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769231|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769232|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2769233|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2769234|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769235|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2769236|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2769237|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
2769238|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
2266287|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2266288|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2266289|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769239|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
2769240|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2769241|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2769242|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2769243|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2769244|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2769245|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2769246|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
2769247|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769248|NCT04446065|Protective Agents|protective agents|mesh-ancestor
2769249|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769250|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2769251|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2769252|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769253|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2769254|NCT04445948|Amoxicillin|amoxicillin|mesh-list
2769255|NCT04445948|Metronidazole|metronidazole|mesh-list
2769256|NCT04445948|Clarithromycin|clarithromycin|mesh-list
2769257|NCT04445948|Lactoferrin|lactoferrin|mesh-list
2769258|NCT04445948|Esomeprazole|esomeprazole|mesh-list
2769259|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2769260|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2266290|NCT00182169|Hormones|hormones|mesh-list
2769261|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2266291|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2266292|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266293|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
2769262|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2769263|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2769264|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2769265|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2769266|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769267|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769268|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2769269|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2769270|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2769271|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2769272|NCT04446039|Vortioxetine|vortioxetine|mesh-list
2769273|NCT04446039|Mirtazapine|mirtazapine|mesh-list
2769274|NCT04446039|Citalopram|citalopram|mesh-list
2769275|NCT04446039|Bupropion|bupropion|mesh-list
2769276|NCT04446039|Fluoxetine|fluoxetine|mesh-list
2769277|NCT04446039|Paroxetine|paroxetine|mesh-list
2769278|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2769279|NCT04446039|Sertraline|sertraline|mesh-list
2769280|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2769281|NCT04446039|Tianeptine|tianeptine|mesh-list
2769282|NCT04446039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2769283|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2769284|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2769285|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769286|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2769287|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
2769288|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769289|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2769290|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
2769291|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2769292|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769293|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2769294|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
2769295|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2769296|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2769297|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769298|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2769299|NCT04446039|Analgesics|analgesics|mesh-ancestor
2769300|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
2769301|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2769302|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2769303|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769304|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2769305|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2769306|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2769307|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2769308|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2769309|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
2769310|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
2769311|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2769312|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2769313|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2769314|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
2769315|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2769316|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2769317|NCT04446091|Irinotecan|irinotecan|mesh-list
2769318|NCT04446091|Apatinib|apatinib|mesh-list
2769319|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
2769320|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2769321|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2769322|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769323|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769324|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266294|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2266295|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2266296|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266297|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
2266298|NCT00182221|Coagulants|coagulants|mesh-ancestor
2266299|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2266300|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266301|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266302|NCT00182312|Caffeine|caffeine|mesh-list
2769325|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2769326|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2769327|NCT04446091|Growth Substances|growth substances|mesh-ancestor
2769328|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769329|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
2769330|NCT04446104|Ascorbic Acid|ascorbic acid|mesh-list
2769331|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
2769332|NCT04446104|Ivermectin|ivermectin|mesh-list
2769333|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
2769334|NCT04446104|Povidone|povidone|mesh-list
2769335|NCT04446104|Vitamins|vitamins|mesh-ancestor
2769336|NCT04446104|Micronutrients|micronutrients|mesh-ancestor
2769337|NCT04446104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769338|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
2769339|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2769340|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2769341|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769342|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769343|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769344|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2769345|NCT04446104|Antioxidants|antioxidants|mesh-ancestor
2769346|NCT04446104|Protective Agents|protective agents|mesh-ancestor
2769347|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
2769348|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
2769349|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2769350|NCT04445935|Bivalirudin|bivalirudin|mesh-list
2769351|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
2769352|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2769353|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
2769354|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769355|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769356|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
2769357|NCT04446130|Decitabine|decitabine|mesh-list
2769358|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2769359|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
2769360|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769361|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769362|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769363|NCT04445857|Calcitonin|calcitonin|mesh-list
2769364|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
2769365|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2769366|NCT04445857|Katacalcin|katacalcin|mesh-list
2769367|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2769368|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769369|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2769370|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
2769371|NCT04445727|Ascorbic Acid|ascorbic acid|mesh-list
2769372|NCT04445727|Vitamins|vitamins|mesh-ancestor
2769373|NCT04445727|Micronutrients|micronutrients|mesh-ancestor
2769374|NCT04445727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769375|NCT04445727|Antioxidants|antioxidants|mesh-ancestor
2769376|NCT04445727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769377|NCT04445727|Protective Agents|protective agents|mesh-ancestor
2769378|NCT04445779|Ubiquinone|ubiquinone|mesh-list
2769379|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
2769380|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
2769381|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769382|NCT04445779|Vitamins|vitamins|mesh-ancestor
2769383|NCT04445519|Latanoprost|latanoprost|mesh-list
2769384|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2769385|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2769386|NCT04445467|Favipiravir|favipiravir|mesh-list
2769387|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
2769388|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769389|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2266303|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
2266304|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266305|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2769390|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
2769391|NCT04445688|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2769392|NCT04445688|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2769393|NCT04445688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2769394|NCT04445688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2769395|NCT04445688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769396|NCT04445688|Adrenergic Agents|adrenergic agents|mesh-ancestor
2769397|NCT04445688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2769398|NCT04445688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769399|NCT04445662|Varenicline|varenicline|mesh-list
2769400|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2769401|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2769402|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
2769403|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2769404|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769405|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769406|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
2266306|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266307|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2266308|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266309|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2266310|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2266311|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
2266312|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266313|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
2266314|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2266315|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2266316|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266317|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
2266318|NCT00182351|Coagulants|coagulants|mesh-ancestor
2266319|NCT00182364|Heparin|heparin|mesh-list
2266320|NCT00182364|Calcium heparin|calcium heparin|mesh-list
2266321|NCT00182364|Dalteparin|dalteparin|mesh-list
2266322|NCT00182364|Tinzaparin|tinzaparin|mesh-list
2266323|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2266324|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
2266325|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2266326|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2266327|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266328|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2266329|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
2266330|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
2266331|NCT00182429|Metronidazole|metronidazole|mesh-list
2266332|NCT00182429|Rifampin|rifampin|mesh-list
2266333|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769407|NCT04445636|Morphine|morphine|mesh-list
2769408|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2769409|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769410|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769411|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2769412|NCT04445636|Analgesics|analgesics|mesh-ancestor
2769413|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
2769414|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769415|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2769416|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2769417|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2769418|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
2769419|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2769420|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769421|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2769422|NCT04445636|Narcotics|narcotics|mesh-ancestor
2769423|NCT04445506|Dexamethasone|dexamethasone|mesh-list
2769424|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2769425|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
2266334|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2266335|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2266336|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2266337|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2266338|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
2266339|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
2266340|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2266341|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266342|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266343|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2266344|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2266345|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2266346|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2266347|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2266348|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2266349|NCT00182442|Olanzapine|olanzapine|mesh-list
2266350|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2769426|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
2266351|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
2769427|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769428|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769429|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2769430|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
2769431|NCT04445506|Hormones|hormones|mesh-ancestor
2769432|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2769433|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2769434|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769435|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2769436|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2769437|NCT04445311|Ivermectin|ivermectin|mesh-list
2769438|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2769439|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790284|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
2790285|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790286|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790287|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2790288|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2790289|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2790290|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2790291|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790292|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2790293|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2790294|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790295|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
2790296|NCT04295317|Capecitabine|capecitabine|mesh-list
2790297|NCT04295317|Antibodies|antibodies|mesh-list
2790298|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
2790299|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
2790300|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790301|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2790302|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
2790303|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790304|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790305|NCT04295551|Ritonavir|ritonavir|mesh-list
2790306|NCT04295551|Lopinavir|lopinavir|mesh-list
2790307|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2790308|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2790309|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
2790310|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790311|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790312|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2790313|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2790314|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
2790315|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790316|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2790317|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2790318|NCT04295330|Lidocaine|lidocaine|mesh-list
2790319|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
2790320|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
2790321|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790322|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790323|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
2790324|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790325|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2790326|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2790327|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2790328|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2790329|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790330|NCT04295629|Anesthetics|anesthetics|mesh-list
2790331|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790332|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790333|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
2790334|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266352|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
2266353|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266354|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266355|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2266356|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2266357|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2266358|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266359|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266360|NCT00182442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2769440|NCT04445194|Vaccines|vaccines|mesh-list
2769441|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
2769442|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769443|NCT04445246|Iloprost|iloprost|mesh-list
2769444|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2769445|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
2769446|NCT04445025|Leuprolide|leuprolide|mesh-list
2769447|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2769448|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
2769449|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2769450|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769451|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2769452|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769453|NCT04444986|Favipiravir|favipiravir|mesh-list
2769454|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
2769455|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769456|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
2769457|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2769458|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769459|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2769460|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
2769461|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2769462|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769463|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769464|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769465|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
2769466|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
2769467|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2769468|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
2769469|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2769470|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
2769471|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769472|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769473|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
2769474|NCT04444635|Fentanyl|fentanyl|mesh-list
2769475|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2769476|NCT04444635|Narcotics|narcotics|mesh-ancestor
2769477|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769478|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769479|NCT04444635|Analgesics|analgesics|mesh-ancestor
2769480|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
2769481|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769482|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2769483|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2266361|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2769484|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
2769485|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
2769486|NCT04444726|Betamethasone|betamethasone|mesh-list
2769487|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
2769488|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2769489|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
2769490|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2769491|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2769492|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
2769493|NCT04444726|Hormones|hormones|mesh-ancestor
2769494|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2769495|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769496|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2769497|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
2769498|NCT04444830|Ketorolac|ketorolac|mesh-list
2769499|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2769500|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2769501|NCT04444830|Analgesics|analgesics|mesh-ancestor
2769502|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
2769503|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769504|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769505|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2769506|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2769507|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2769508|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769509|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769510|NCT04444817|Tacrolimus|tacrolimus|mesh-list
2769511|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2769512|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
2769513|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769514|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2769515|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769516|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769517|NCT04444167|Lenvatinib|lenvatinib|mesh-list
2769518|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769519|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2769520|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769521|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769522|NCT04444349|Ubiquinone|ubiquinone|mesh-list
2769523|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
2769524|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
2769525|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769526|NCT04444349|Vitamins|vitamins|mesh-ancestor
2769527|NCT04444284|Vaccines|vaccines|mesh-list
2769528|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
2769529|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769530|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
2769531|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2769532|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769533|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2769534|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2769535|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769536|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769537|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769538|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2769539|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2769540|NCT04444193|Durvalumab|durvalumab|mesh-list
2266362|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266363|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266364|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266365|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
2266366|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
2266367|NCT00182455|Topiramate|topiramate|mesh-list
2266368|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
2769541|NCT04444193|Lenvatinib|lenvatinib|mesh-list
2769542|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2769543|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2769544|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769545|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
2769546|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769547|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2769548|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769549|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769550|NCT04444492|Ranibizumab|ranibizumab|mesh-list
2769551|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2769552|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2769553|NCT04444492|Growth Substances|growth substances|mesh-ancestor
2769554|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769555|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
2266369|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2266370|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266371|NCT00182494|Metformin|metformin|mesh-list
2266372|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2266373|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266374|NCT00182507|Olanzapine|olanzapine|mesh-list
2266375|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
2266376|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
2266377|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266378|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266379|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2266380|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2266381|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2266382|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266383|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266384|NCT00182507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2266385|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266386|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266387|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266388|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266389|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
2266390|NCT00182520|Topiramate|topiramate|mesh-list
2266391|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
2266392|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2769556|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769557|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
2266393|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769558|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2769559|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2769560|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769561|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
2769562|NCT04443920|Coagulants|coagulants|mesh-ancestor
2769563|NCT04443946|Sufentanil|sufentanil|mesh-list
2769564|NCT04443946|Propofol|propofol|mesh-list
2769565|NCT04443946|Sevoflurane|sevoflurane|mesh-list
2769566|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2769567|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769568|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769569|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2769570|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
2769571|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
2769572|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2769573|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2769574|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2769575|NCT04443946|Narcotics|narcotics|mesh-ancestor
2769576|NCT04443946|Analgesics|analgesics|mesh-ancestor
2769577|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
2769578|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769579|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2769580|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
2769581|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
2769582|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
2769583|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2769584|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2769585|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769586|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769587|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769588|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2769589|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
2769590|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
2769591|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2769592|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
2769593|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769594|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769595|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2769596|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
2769597|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2769598|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
2769599|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769600|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2769601|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2769602|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
2769603|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
2769604|NCT04443868|Protective Agents|protective agents|mesh-ancestor
2769605|NCT04443556|Tramadol|tramadol|mesh-list
2769606|NCT04443556|Anesthetics|anesthetics|mesh-list
2769607|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
2769608|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769609|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769610|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2769611|NCT04443556|Narcotics|narcotics|mesh-ancestor
2769612|NCT04443556|Analgesics|analgesics|mesh-ancestor
2769613|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
2769614|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769615|NCT04443634|Bupivacaine|bupivacaine|mesh-list
2769616|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
2769617|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
2769618|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769619|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769620|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
2769621|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769622|NCT04443673|Glycine|glycine|mesh-list
2769623|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
2769624|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2769625|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769626|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769627|NCT04443517|Propofol|propofol|mesh-list
2769628|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
2769629|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769630|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769631|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2769632|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2769633|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
2769634|NCT04444011|Amoxicillin|amoxicillin|mesh-list
2769635|NCT04444011|Clarithromycin|clarithromycin|mesh-list
2769636|NCT04444011|Bismuth|bismuth|mesh-list
2769637|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2769638|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769639|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2769640|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769641|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769642|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2769643|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2266394|NCT00182533|Sertraline|sertraline|mesh-list
2266395|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
2266396|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266397|NCT00182533|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2266398|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266399|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266400|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266401|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266402|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
2266403|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266404|NCT00182559|Cyclosporine|cyclosporine|mesh-list
2266405|NCT00182559|Tacrolimus|tacrolimus|mesh-list
2266406|NCT00182559|Cyclosporins|cyclosporins|mesh-list
2266407|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2266408|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
2266409|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266410|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2266411|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266412|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266413|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
2769644|NCT04444011|Antacids|antacids|mesh-ancestor
2769645|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2790335|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2790336|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790337|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790338|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
2790339|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2790340|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790341|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2790342|NCT04294784|Paclitaxel|paclitaxel|mesh-list
2790343|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2790344|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2790345|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2790346|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790347|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
2790348|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
2790349|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
2790350|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790351|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2790352|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790353|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790354|NCT04294823|Esomeprazole|esomeprazole|mesh-list
2790355|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2790356|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2790357|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2790358|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790359|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790360|NCT04294836|Curcumin|curcumin|mesh-list
2790361|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2790362|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2790363|NCT04294836|Analgesics|analgesics|mesh-ancestor
2790364|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
2790365|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790366|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790367|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2790368|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2790369|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790370|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790371|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790372|NCT04294966|Dronabinol|dronabinol|mesh-list
2790373|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
2790374|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790375|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2790376|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2790377|NCT04294966|Analgesics|analgesics|mesh-ancestor
2769646|NCT04443647|Oxytocin|oxytocin|mesh-list
2769647|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
2769648|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2769649|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769650|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2769651|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2266414|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2266415|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
2266416|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2266417|NCT00182572|Naltrexone|naltrexone|mesh-list
2266418|NCT00182572|Buprenorphine|buprenorphine|mesh-list
2266419|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2266420|NCT00182572|Narcotics|narcotics|mesh-ancestor
2266421|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266422|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266423|NCT00182572|Analgesics|analgesics|mesh-ancestor
2266424|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
2266425|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266426|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2266427|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2266428|NCT00182611|Tegafur|tegafur|mesh-list
2266429|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266430|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2266431|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
2769678|NCT04443387|Vitamin D|vitamin d|mesh-list
2769679|NCT04443387|Vitamins|vitamins|mesh-ancestor
2769680|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
2769681|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769682|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2769683|NCT04443543|Fluorouracil|fluorouracil|mesh-list
2769684|NCT04443543|Capecitabine|capecitabine|mesh-list
2769685|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
2769686|NCT04443543|Irinotecan|irinotecan|mesh-list
2769687|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
2769688|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769689|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2769690|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769691|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2769692|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
2769693|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769694|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2769695|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2769696|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769697|NCT04443270|Chloroquine|chloroquine|mesh-list
2769698|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2769699|NCT04443270|Amebicides|amebicides|mesh-ancestor
2769700|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2266432|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266433|NCT00182650|Aldesleukin|aldesleukin|mesh-list
2769701|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2769702|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769703|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
2769704|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2769705|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2769706|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2769707|NCT04443270|Analgesics|analgesics|mesh-ancestor
2769708|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
2769709|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769710|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769711|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2769712|NCT04443270|Filaricides|filaricides|mesh-ancestor
2769713|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
2769714|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
2769715|NCT04443322|Durvalumab|durvalumab|mesh-list
2769716|NCT04443322|Lenvatinib|lenvatinib|mesh-list
2769717|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2769718|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2769719|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769720|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
2769721|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769722|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2769723|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769724|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769725|NCT04443010|Temozolomide|temozolomide|mesh-list
2769726|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2769727|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
2769728|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769729|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769730|NCT04443036|Paclitaxel|paclitaxel|mesh-list
2769731|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2769732|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2769733|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769734|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
2769735|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
2769736|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
2769737|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769738|NCT04443049|Mebendazole|mebendazole|mesh-list
2769739|NCT04443049|Piperazine|piperazine|mesh-list
2769740|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
2769741|NCT04443049|Lenvatinib|lenvatinib|mesh-list
2769742|NCT04443049|DMP 777|dmp 777|mesh-list
2769743|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769744|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2769745|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769746|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769747|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
2769748|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
2769749|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2769750|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769751|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
2769752|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
2769753|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
2769754|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
2769755|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2769756|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
2769757|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769758|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
2769759|NCT04443166|Protective Agents|protective agents|mesh-ancestor
2769760|NCT04442919|Morphine|morphine|mesh-list
2769761|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
2769762|NCT04442919|Ticagrelor|ticagrelor|mesh-list
2769763|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2769764|NCT04442919|Narcotics|narcotics|mesh-ancestor
2769765|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769766|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769767|NCT04442919|Analgesics|analgesics|mesh-ancestor
2769768|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
2769769|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769770|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2769771|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2769772|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2769773|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2769774|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
2769775|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2769776|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769777|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2769778|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
2769779|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
2769780|NCT04442750|Bupivacaine|bupivacaine|mesh-list
2769781|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
2769782|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
2769783|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769784|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769785|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
2769786|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769787|NCT04442984|Leucovorin|leucovorin|mesh-list
2769788|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
2769789|NCT04442984|Irinotecan|irinotecan|mesh-list
2769790|NCT04442984|Fluorouracil|fluorouracil|mesh-list
2769791|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769792|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2769793|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2769794|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769795|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769796|NCT04442984|Antidotes|antidotes|mesh-ancestor
2769797|NCT04442984|Protective Agents|protective agents|mesh-ancestor
2769798|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769799|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
2769800|NCT04442984|Vitamins|vitamins|mesh-ancestor
2769801|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
2769802|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
2769803|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2769804|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2769805|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
2769806|NCT04442906|Fentanyl|fentanyl|mesh-list
2769807|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
2769808|NCT04442906|Bupivacaine|bupivacaine|mesh-list
2769809|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
2769810|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
2769811|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2769812|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769813|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
2769814|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769815|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2769816|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2769817|NCT04442906|Analgesics|analgesics|mesh-ancestor
2769818|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2769819|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2769820|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2769821|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
2769822|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2769823|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769824|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2769825|NCT04442906|Narcotics|narcotics|mesh-ancestor
2769826|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2769827|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2769828|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
2769829|NCT04443309|Lenvatinib|lenvatinib|mesh-list
2769830|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769831|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2769832|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769833|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769834|NCT04442412|Vitamin D|vitamin d|mesh-list
2769835|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
2769836|NCT04442412|Vitamins|vitamins|mesh-ancestor
2769837|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
2769838|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769839|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2769840|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2769841|NCT04442633|Miconazole|miconazole|mesh-list
2769842|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
2769843|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769844|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2769845|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2769846|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769847|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769848|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2769849|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
2769850|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2769851|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769852|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2769853|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2266434|NCT00182650|Rituximab|rituximab|mesh-list
2266435|NCT00182650|Fludarabine|fludarabine|mesh-list
2266436|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
2769878|NCT04441918|Antibodies|antibodies|mesh-list
2769879|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2769880|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
2769881|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769882|NCT04441762|Ketorolac|ketorolac|mesh-list
2769883|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2769884|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2769885|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2769886|NCT04441762|Analgesics|analgesics|mesh-ancestor
2769887|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
2769888|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769889|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769890|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2769891|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2769892|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2769893|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769894|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790378|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
2790379|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790380|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2790381|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2790382|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790383|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790384|NCT04294966|Hormones|hormones|mesh-ancestor
2790385|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2790386|NCT04294732|Bupivacaine|bupivacaine|mesh-list
2790387|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
2790388|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
2790389|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790390|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790391|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
2790392|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790405|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2790406|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2790407|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2790408|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2769895|NCT04441385|Maraviroc|maraviroc|mesh-list
2769896|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2769897|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2769898|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769899|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2769900|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2769901|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
2769902|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769903|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2769904|NCT04441424|Azithromycin|azithromycin|mesh-list
2769905|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
2769906|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2769907|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769908|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
2769909|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2769910|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2769911|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769912|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769913|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2769914|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
2769915|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2769916|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769917|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
2769918|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2769919|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
2769920|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769921|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
2769922|NCT04441528|Protective Agents|protective agents|mesh-ancestor
2769923|NCT04441112|Triamcinolone|triamcinolone|mesh-list
2769924|NCT04441112|Ketorolac|ketorolac|mesh-list
2769925|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2769926|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
2769927|NCT04441112|Hormones|hormones|mesh-ancestor
2266437|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2266438|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266439|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
2266440|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769928|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2769929|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769930|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769931|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769932|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2769933|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2769934|NCT04441112|Analgesics|analgesics|mesh-ancestor
2769935|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
2769936|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2769937|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2769938|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2266441|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2266442|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2266443|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
2266444|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769939|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
2769940|NCT04441034|Convulsants|convulsants|mesh-list
2769941|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
2769942|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2769943|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2769944|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769945|NCT04440917|Apatinib|apatinib|mesh-list
2769946|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2769947|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769948|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2769949|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769950|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769951|NCT04441138|Durvalumab|durvalumab|mesh-list
2769952|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2769953|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769954|NCT04441021|Penicillins|penicillins|mesh-list
2769955|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2769956|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2769969|NCT04440735|Atezolizumab|atezolizumab|mesh-list
2769970|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2769971|NCT04440371|Betamethasone|betamethasone|mesh-list
2769972|NCT04440371|Calcipotriene|calcipotriene|mesh-list
2769973|NCT04440371|Tacrolimus|tacrolimus|mesh-list
2769974|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2769975|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
2769976|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2769977|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2769978|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769979|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769980|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2769981|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
2769982|NCT04440371|Hormones|hormones|mesh-ancestor
2769983|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2769984|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2266445|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2266446|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2266447|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2266448|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
2266449|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2266450|NCT00182663|Thalidomide|thalidomide|mesh-list
2266451|NCT00182663|Clarithromycin|clarithromycin|mesh-list
2266452|NCT00182663|Dexamethasone|dexamethasone|mesh-list
2769985|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
2769986|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
2769987|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
2769988|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2769989|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2769990|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769991|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2769992|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2769993|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
2769994|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
2769995|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
2769996|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2769997|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
2769998|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2769999|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2770000|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2770001|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
2770002|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770003|NCT04440280|Expectorants|expectorants|mesh-ancestor
2770004|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
2770005|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2770006|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
2770007|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770008|NCT04440280|Protective Agents|protective agents|mesh-ancestor
2770009|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770010|NCT04440280|Antidotes|antidotes|mesh-ancestor
2770011|NCT04440267|Dexamethasone|dexamethasone|mesh-list
2770012|NCT04440267|Prednisone|prednisone|mesh-list
2770013|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
2770014|NCT04440267|Methotrexate|methotrexate|mesh-list
2770015|NCT04440267|Vincristine|vincristine|mesh-list
2770016|NCT04440267|Daunorubicin|daunorubicin|mesh-list
2770017|NCT04440267|Asparaginase|asparaginase|mesh-list
2770018|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
2770019|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2770020|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
2770021|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770022|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770023|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2770024|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
2770025|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770026|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770027|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2266453|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2266454|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
2770028|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2770029|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
2266455|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
2266456|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266457|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266458|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2266459|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
2266460|NCT00182663|Hormones|hormones|mesh-ancestor
2266461|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2266462|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2266463|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266464|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2266465|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
2266466|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
2266467|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2266468|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2266469|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2266470|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2266471|NCT00182663|Growth Substances|growth substances|mesh-ancestor
2266472|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
2266473|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2266474|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266475|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266476|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2266477|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2266478|NCT00182702|Epothilones|epothilones|mesh-list
2266479|NCT00182702|Epothilone B|epothilone b|mesh-list
2266480|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
2266481|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
2266482|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
2266483|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266484|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266485|NCT00182715|Leucovorin|leucovorin|mesh-list
2266486|NCT00182715|Fluorouracil|fluorouracil|mesh-list
2266487|NCT00182715|Capecitabine|capecitabine|mesh-list
2266488|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
2266489|NCT00182715|Cetuximab|cetuximab|mesh-list
2266490|NCT00182715|Calcium|calcium|mesh-list
2266491|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
2266492|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2266493|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266494|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
2266495|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266496|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2266497|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266498|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2266499|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
2266500|NCT00182715|Antidotes|antidotes|mesh-ancestor
2770030|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
2770031|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770032|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2770033|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
2770034|NCT04440267|Hormones|hormones|mesh-ancestor
2770035|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2770036|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2770037|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2770038|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
2770039|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2770040|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2770041|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
2770042|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
2770043|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770044|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2770045|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2770046|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2770047|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
2770048|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
2266501|NCT00182715|Protective Agents|protective agents|mesh-ancestor
2266502|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
2266503|NCT00182715|Vitamins|vitamins|mesh-ancestor
2266504|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
2266505|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2266506|NCT00182741|Calcitriol|calcitriol|mesh-list
2266507|NCT00182741|Prednisone|prednisone|mesh-list
2266508|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
2266509|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2266510|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
2770049|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
2770050|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2770051|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2770052|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2770053|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
2770054|NCT04440436|Fludarabine|fludarabine|mesh-list
2770055|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2770056|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
2770057|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770058|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770059|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2770060|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
2770061|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770062|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770063|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2770064|NCT04440085|Midodrine|midodrine|mesh-list
2770065|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
2770066|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
2770067|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770068|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770069|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2770070|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2770071|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2770072|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2770073|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
2770074|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2770075|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790409|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790410|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790411|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790412|NCT04294953|Analgesics|analgesics|mesh-ancestor
2790413|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
2790414|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790415|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
2790416|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2790417|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
2790418|NCT04294992|Ondansetron|ondansetron|mesh-list
2790419|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
2790420|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
2790421|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790422|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790423|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2790424|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
2790425|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
2790426|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2790427|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
2790428|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790429|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790430|NCT04294992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2790431|NCT04294992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2790432|NCT04294992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790433|NCT04294992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2790434|NCT04294992|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2790435|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2790436|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2790437|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790438|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790439|NCT04294576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2790440|NCT04294576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790441|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790442|NCT04294537|Anesthetics|anesthetics|mesh-list
2790443|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266511|NCT00182741|Hormones|hormones|mesh-ancestor
2266512|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2266513|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266514|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2266515|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266516|NCT00182741|Analgesics|analgesics|mesh-ancestor
2266517|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
2266518|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266519|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2266520|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2266521|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770076|NCT04439929|Adalimumab|adalimumab|mesh-list
2770077|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2770078|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770079|NCT04439890|Carboplatin|carboplatin|mesh-list
2770080|NCT04439890|Pemetrexed|pemetrexed|mesh-list
2770081|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770082|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266522|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266523|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2266524|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2266525|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266526|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2266527|NCT00182741|Vitamins|vitamins|mesh-ancestor
2266528|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
2266529|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2266530|NCT00182806|Gemcitabine|gemcitabine|mesh-list
2266531|NCT00182806|Irinotecan|irinotecan|mesh-list
2266532|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2266533|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
2266534|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266535|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266536|NCT00182806|Antiviral Agents|antiviral agents|mesh-ancestor
2266537|NCT00182806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2266538|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266539|NCT00182806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2266540|NCT00182806|Immunologic Factors|immunologic factors|mesh-ancestor
2266541|NCT00182806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266542|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2770083|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770084|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2770085|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2770086|NCT04439786|Lidocaine|lidocaine|mesh-list
2770087|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
2770088|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
2770089|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266543|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2266544|NCT00182819|Temozolomide|temozolomide|mesh-list
2266545|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2266546|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
2266547|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266548|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266549|NCT00182845|Donepezil|donepezil|mesh-list
2266550|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2266551|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266552|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266553|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
2266554|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2770090|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770091|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
2770092|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770093|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2770094|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2770095|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2770096|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2770097|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770098|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
2770099|NCT04439799|Testosterone|testosterone|mesh-list
2770100|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
2770101|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
2770102|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2770103|NCT04439799|Androgens|androgens|mesh-ancestor
2770104|NCT04439799|Hormones|hormones|mesh-ancestor
2770105|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2770106|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770107|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2770108|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770109|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
2770110|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
2770111|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2770112|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2770113|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770114|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
2770115|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2770116|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770119|NCT04439773|Lidocaine|lidocaine|mesh-list
2770120|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
2770121|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
2770122|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770123|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770124|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
2770125|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770126|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2770127|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2770128|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2770129|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2770130|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770131|NCT04439318|Trametinib|trametinib|mesh-list
2770132|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2770133|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770134|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2770135|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770136|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770137|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2770138|NCT04439318|Protective Agents|protective agents|mesh-ancestor
2770139|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770140|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2770141|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
2770142|NCT04439474|Vitamin D|vitamin d|mesh-list
2770143|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
2770144|NCT04439474|Vitamins|vitamins|mesh-ancestor
2770145|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
2266555|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266556|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
2266557|NCT00182871|Testosterone|testosterone|mesh-list
2266558|NCT00182871|Androgens|androgens|mesh-ancestor
2266559|NCT00182871|Hormones|hormones|mesh-ancestor
2266560|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2266561|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266562|NCT00182884|Donepezil|donepezil|mesh-list
2266563|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2266564|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266565|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266566|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
2266567|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2770146|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770147|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2770148|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2770154|NCT04439292|Trametinib|trametinib|mesh-list
2770155|NCT04439292|Dabrafenib|dabrafenib|mesh-list
2770156|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2770157|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770158|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2770159|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770160|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770161|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2770162|NCT04439292|Protective Agents|protective agents|mesh-ancestor
2770163|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770164|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2770165|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
2266568|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266569|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
2266570|NCT00183001|Vitamin K|vitamin k|mesh-list
2266571|NCT00183001|Vitamins|vitamins|mesh-ancestor
2266572|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
2266573|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266574|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2266575|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2266576|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266577|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
2266578|NCT00183001|Coagulants|coagulants|mesh-ancestor
2770166|NCT04439305|Dasatinib|dasatinib|mesh-list
2266579|NCT00183040|Hormones|hormones|mesh-list
2770167|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770168|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2770169|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770170|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770171|NCT04439487|Anesthetics|anesthetics|mesh-list
2770172|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770173|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770174|NCT04439227|Adavosertib|adavosertib|mesh-list
2770175|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770176|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266580|NCT00183040|Testosterone|testosterone|mesh-list
2266581|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2266582|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266583|NCT00183040|Androgens|androgens|mesh-ancestor
2770177|NCT04439396|Ketorolac|ketorolac|mesh-list
2770178|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2770179|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2770180|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2770181|NCT04439396|Analgesics|analgesics|mesh-ancestor
2770182|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
2770183|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770184|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770185|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2770186|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770187|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2770188|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770189|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770190|NCT04439357|Trametinib|trametinib|mesh-list
2770191|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2770192|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770193|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2770194|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770195|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770196|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2770197|NCT04439357|Protective Agents|protective agents|mesh-ancestor
2770198|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770199|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2770200|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
2770201|NCT04439136|Afatinib|afatinib|mesh-list
2770202|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770203|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2770204|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770205|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770211|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
2266584|NCT00183222|Naltrexone|naltrexone|mesh-list
2266585|NCT00183222|Ondansetron|ondansetron|mesh-list
2266586|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2266587|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2266588|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266589|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
2266590|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266591|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
2266592|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
2266593|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2266594|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
2770212|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2770213|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2770214|NCT04438980|Prednisolone|prednisolone|mesh-list
2770215|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
2770216|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2770217|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
2770218|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2770219|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
2770220|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
2770221|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770222|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770223|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2266595|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
2770224|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
2770225|NCT04438980|Hormones|hormones|mesh-ancestor
2266596|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2266597|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
2266598|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266599|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266600|NCT00183222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2266601|NCT00183222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2266602|NCT00183222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266603|NCT00183222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266604|NCT00183222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2266605|NCT00183235|Aripiprazole|aripiprazole|mesh-list
2266606|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
2770226|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2770227|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2770228|NCT04438980|Protective Agents|protective agents|mesh-ancestor
2770229|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2770230|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770231|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2770232|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770233|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
2770234|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
2770235|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2770236|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2770237|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770238|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770239|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770240|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770241|NCT04438902|Osimertinib|osimertinib|mesh-list
2770242|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770243|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2770244|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770245|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770246|NCT04438733|Anastrozole|anastrozole|mesh-list
2770247|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2770248|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770249|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2770250|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2770251|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770252|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770253|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2770254|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
2266607|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266608|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2266609|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2266610|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266611|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266612|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
2266613|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
2266614|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266615|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266616|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2266617|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2266618|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
2266619|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2266620|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2770255|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2770256|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770257|NCT04438811|Anesthetics|anesthetics|mesh-list
2770258|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770259|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770260|NCT04438850|Ivermectin|ivermectin|mesh-list
2770261|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2770262|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2266621|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2266622|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2266623|NCT00183404|Olanzapine|olanzapine|mesh-list
2266624|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
2266625|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
2266626|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770263|NCT04438928|Micronutrients|micronutrients|mesh-list
2770264|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770265|NCT04438720|Nifedipine|nifedipine|mesh-list
2266627|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266628|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2266629|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2266630|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2266631|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266632|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266633|NCT00183404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2266634|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266635|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266636|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266637|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266638|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
2770266|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2770267|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2770268|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770269|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2770270|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770271|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
2770272|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
2770273|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2770274|NCT04438772|Anesthetics|anesthetics|mesh-list
2770275|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770276|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770277|NCT04438330|Nickel|nickel|mesh-list
2770278|NCT04438330|Trace Elements|trace elements|mesh-ancestor
2770279|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
2770280|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770281|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
2770282|NCT04438213|Metolazone|metolazone|mesh-list
2770283|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2770284|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770285|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2770286|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770287|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2770288|NCT04438213|Diuretics|diuretics|mesh-ancestor
2770289|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
2770290|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2770291|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2770292|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
2770293|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
2770294|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
2770295|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770296|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770297|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
2770298|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790444|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790457|NCT04294329|Bupivacaine|bupivacaine|mesh-list
2790458|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
2790459|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
2790460|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790461|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790462|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
2790463|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790464|NCT04294056|Propofol|propofol|mesh-list
2790465|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2790466|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790467|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790468|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2790469|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
2790470|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
2792821|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2792822|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792823|NCT04275115|Midazolam|midazolam|mesh-list
2792824|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2770299|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
2770300|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2266639|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
2266640|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266641|NCT00183612|Olanzapine|olanzapine|mesh-list
2266642|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
2266643|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
2266644|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266645|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266646|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2266647|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2770301|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2770302|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
2770303|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2770304|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770305|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
2770306|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
2770307|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2770308|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
2770309|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770310|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
2770311|NCT04438421|Protective Agents|protective agents|mesh-ancestor
2770312|NCT04438577|Lidocaine|lidocaine|mesh-list
2770313|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
2770314|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
2770315|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770316|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266648|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2266649|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266650|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266651|NCT00183612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2266652|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266653|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266654|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266655|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266656|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
2266657|NCT00183742|Docetaxel|docetaxel|mesh-list
2266658|NCT00183742|Doxorubicin|doxorubicin|mesh-list
2266659|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2266660|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266661|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
2770317|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
2770318|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770319|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2770320|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2770321|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2770322|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2770323|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770324|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
2770325|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2770326|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
2770327|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2770328|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2770329|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
2770330|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2770331|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770332|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
2770333|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
2770334|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2770335|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
2770336|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770337|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
2770338|NCT04438434|Protective Agents|protective agents|mesh-ancestor
2770339|NCT04437836|Rifampin|rifampin|mesh-list
2770340|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2770341|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
2770342|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2770343|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770344|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
2770345|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2770346|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770347|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770348|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2770349|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2770350|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2266662|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
2770351|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2770352|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2770353|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2770354|NCT04437758|Ascorbic Acid|ascorbic acid|mesh-list
2770355|NCT04437758|Vitamins|vitamins|mesh-ancestor
2770356|NCT04437758|Micronutrients|micronutrients|mesh-ancestor
2770357|NCT04437758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770358|NCT04437758|Antioxidants|antioxidants|mesh-ancestor
2770359|NCT04437758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770360|NCT04437758|Protective Agents|protective agents|mesh-ancestor
2770361|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
2770362|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
2770363|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2770364|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2266663|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
2266664|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266665|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2266666|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2266667|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2266668|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266669|NCT00183807|Celecoxib|celecoxib|mesh-list
2266670|NCT00183807|Irinotecan|irinotecan|mesh-list
2266671|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266672|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2770365|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770366|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770367|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770368|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770395|NCT04437654|Apixaban|apixaban|mesh-list
2770396|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2770397|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
2770398|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2770399|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
2770400|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770401|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770402|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
2770403|NCT04437329|Cisplatin|cisplatin|mesh-list
2770404|NCT04437329|Docetaxel|docetaxel|mesh-list
2770405|NCT04437329|Fluorouracil|fluorouracil|mesh-list
2770406|NCT04437329|Nedaplatin|nedaplatin|mesh-list
2770407|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770408|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
2770409|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
2770410|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
2770411|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770412|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
2770413|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2770414|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2770415|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
2770416|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770425|NCT04437004|Fenfluramine|fenfluramine|mesh-list
2770426|NCT04437004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2770427|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2770428|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2770429|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770430|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2770431|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
2770432|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770433|NCT04437225|Glycolic acid|glycolic acid|mesh-list
2770434|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
2770435|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
2770436|NCT04437017|Dexamethasone|dexamethasone|mesh-list
2770437|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
2770438|NCT04437017|Olanzapine|olanzapine|mesh-list
2770439|NCT04437017|Serotonin|serotonin|mesh-list
2770440|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2770441|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
2770442|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
2770443|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770444|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770445|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2770446|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
2770447|NCT04437017|Hormones|hormones|mesh-ancestor
2770448|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2770449|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2266673|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2266674|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266675|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266676|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2266677|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2266678|NCT00183807|Analgesics|analgesics|mesh-ancestor
2266679|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
2266680|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266681|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266682|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2266683|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2266684|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2266685|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2266686|NCT00183820|Gemcitabine|gemcitabine|mesh-list
2266687|NCT00183820|Paclitaxel|paclitaxel|mesh-list
2266688|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
2266689|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2266690|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266691|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
2266692|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
2266693|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
2266694|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266695|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2266696|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
2266697|NCT00183820|Antiviral Agents|antiviral agents|mesh-ancestor
2266698|NCT00183820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2266699|NCT00183820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770450|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770451|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2770452|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2770453|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770454|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2770455|NCT04437017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2770456|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2770457|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2770458|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770459|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2770460|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
2770461|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2770462|NCT04437303|Anticoagulants|anticoagulants|mesh-list
2266700|NCT00183820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2770463|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
2770464|NCT04437160|Epirubicin|epirubicin|mesh-list
2770465|NCT04437160|Pirarubicin|pirarubicin|mesh-list
2770466|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2770467|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
2770468|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770469|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770470|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2770471|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
2770472|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770473|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770474|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2770475|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2770476|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2770477|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2770478|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770479|NCT04436796|Pancrelipase|pancrelipase|mesh-list
2770480|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2770481|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
2770482|NCT04436926|Narcotics|narcotics|mesh-ancestor
2770483|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770484|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770485|NCT04436926|Analgesics|analgesics|mesh-ancestor
2770486|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
2770487|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770488|NCT04436601|Lactulose|lactulose|mesh-list
2770489|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2790471|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
2790472|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2790473|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
2790474|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790475|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790476|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790477|NCT04294264|Trifluridine|trifluridine|mesh-list
2790478|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
2790479|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790480|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
2790481|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790482|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
2266701|NCT00183820|Immunologic Factors|immunologic factors|mesh-ancestor
2266702|NCT00183820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266703|NCT00183833|Capecitabine|capecitabine|mesh-list
2266704|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
2266705|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2266706|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
2266707|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266708|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790483|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790484|NCT04294225|Letrozole|letrozole|mesh-list
2790485|NCT04294225|Anastrozole|anastrozole|mesh-list
2790486|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790487|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2790488|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2790489|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790490|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790491|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2790492|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
2790493|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2790494|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790495|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2790496|NCT04294147|Erenumab|erenumab|mesh-list
2790497|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2790498|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790499|NCT04294147|Analgesics|analgesics|mesh-ancestor
2790500|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
2790501|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790502|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790503|NCT04293809|Bupivacaine|bupivacaine|mesh-list
2790504|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
2790505|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
2790506|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790507|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790508|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
2790509|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266709|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2770490|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
2770491|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
2770492|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770493|NCT04436419|Protective Agents|protective agents|mesh-ancestor
2770494|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770495|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
2770496|NCT04436419|Vitamins|vitamins|mesh-ancestor
2266710|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266711|NCT00183846|Irinotecan|irinotecan|mesh-list
2266712|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2266713|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2266714|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266715|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266716|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266717|NCT00183859|Irinotecan|irinotecan|mesh-list
2266718|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2770497|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
2770498|NCT04436731|Phentolamine|phentolamine|mesh-list
2770499|NCT04436731|Phenylephrine|phenylephrine|mesh-list
2770500|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
2770501|NCT04436731|Norepinephrine|norepinephrine|mesh-list
2770502|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
2770503|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2770504|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770505|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770506|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2770507|NCT04436731|Analgesics|analgesics|mesh-ancestor
2770508|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
2770509|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770510|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2770511|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2770512|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2770513|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
2770514|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266719|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2266720|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266721|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266722|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266723|NCT00183885|Mitomycins|mitomycins|mesh-list
2266724|NCT00183885|Mitomycin|mitomycin|mesh-list
2266725|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266726|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2266727|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
2266728|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770515|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770516|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2770517|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
2770518|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
2770519|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
2770520|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2770521|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
2770522|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
2770523|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2770524|NCT04436731|Protective Agents|protective agents|mesh-ancestor
2770525|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2770526|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2770527|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2770528|NCT04436458|Niclosamide|niclosamide|mesh-list
2770529|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
2770530|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2770531|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
2770532|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2770533|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770534|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
2770535|NCT04436536|Methamphetamine|methamphetamine|mesh-list
2770536|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2770537|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770538|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
2770539|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
2770540|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770541|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
2770542|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2770543|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770544|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
2770545|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2770546|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2770547|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2770548|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2770549|NCT04436172|Anesthetics|anesthetics|mesh-list
2770550|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770551|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770552|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
2770553|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2770554|NCT04436250|Ketamine|ketamine|mesh-list
2770555|NCT04436250|Esketamine|esketamine|mesh-list
2770556|NCT04436250|Analgesics|analgesics|mesh-ancestor
2770557|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
2770558|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770559|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770560|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2770561|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2770562|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
2770563|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
2770564|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770565|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2770566|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2770567|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2770568|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770569|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
2770570|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2770571|NCT04436107|Lenalidomide|lenalidomide|mesh-list
2770572|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
2770573|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
2770574|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770575|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2770576|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2770577|NCT04436107|Growth Substances|growth substances|mesh-ancestor
2770578|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
2770579|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770580|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2770581|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770582|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770583|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
2266729|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2266730|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266731|NCT00183898|Capecitabine|capecitabine|mesh-list
2770584|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2770585|NCT04435925|Fentanyl|fentanyl|mesh-list
2770586|NCT04435925|Remifentanil|remifentanil|mesh-list
2770587|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2770588|NCT04435925|Narcotics|narcotics|mesh-ancestor
2770589|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770590|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770591|NCT04435925|Analgesics|analgesics|mesh-ancestor
2770592|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
2770593|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770594|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2770595|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2770596|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
2770597|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
2770615|NCT04435795|Ciclesonide|ciclesonide|mesh-list
2266732|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
2266733|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2266734|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
2770616|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
2770617|NCT04435795|Hormones|hormones|mesh-ancestor
2770618|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2770619|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266735|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266736|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266737|NCT00183911|Leucovorin|leucovorin|mesh-list
2770620|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2770621|NCT04435743|Lenalidomide|lenalidomide|mesh-list
2770622|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
2770623|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770624|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2770625|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2770626|NCT04435743|Growth Substances|growth substances|mesh-ancestor
2770627|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
2770628|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770629|NCT04435704|Oxytocin|oxytocin|mesh-list
2770630|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
2770631|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2770632|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770633|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2770634|NCT04435587|Ritonavir|ritonavir|mesh-list
2770635|NCT04435587|Darunavir|darunavir|mesh-list
2770636|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
2770637|NCT04435587|Ivermectin|ivermectin|mesh-list
2770638|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2770639|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2770640|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
2770641|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770642|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770643|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2770644|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2770645|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
2770646|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770647|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2770648|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2770649|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
2770650|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2770651|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2770652|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770653|NCT04435652|Paclitaxel|paclitaxel|mesh-list
2770654|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2770655|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2770656|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770657|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
2770658|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
2770659|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
2770660|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770661|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
2770662|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770663|NCT04435522|Maraviroc|maraviroc|mesh-list
2770664|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2770665|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2770666|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770667|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2770668|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2770669|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
2770670|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770671|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2770672|NCT04435574|Lactoferrin|lactoferrin|mesh-list
2770673|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770674|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
2770675|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2770676|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770677|NCT04435418|Apixaban|apixaban|mesh-list
2770678|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2266738|NCT00183911|Fluorouracil|fluorouracil|mesh-list
2266739|NCT00183911|Floxuridine|floxuridine|mesh-list
2266740|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
2266741|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266742|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2266743|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266744|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2266745|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
2266746|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266747|NCT00183911|Antidotes|antidotes|mesh-ancestor
2266748|NCT00183911|Protective Agents|protective agents|mesh-ancestor
2770679|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
2770680|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2770681|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
2770682|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770683|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101928|NCT02397889|Analgesics|analgesics|mesh-ancestor
2101929|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
2101930|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101931|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101932|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2101933|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2101934|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
2101935|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
2101936|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2101937|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2101938|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2101939|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101940|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101941|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2101942|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2101943|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2101944|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2101945|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2101946|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
2770684|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
2770685|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
2770686|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2770687|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770688|NCT04435015|Camostat|camostat|mesh-list
2770689|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
2770690|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770691|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770692|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2770693|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2770694|NCT04435028|Ketotifen|ketotifen|mesh-list
2266749|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
2266750|NCT00183911|Vitamins|vitamins|mesh-ancestor
2266751|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
2266752|NCT00183924|Carboplatin|carboplatin|mesh-list
2266753|NCT00183924|Docetaxel|docetaxel|mesh-list
2266754|NCT00183924|Estramustine|estramustine|mesh-list
2266755|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266756|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
2266757|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
2266758|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
2266759|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266760|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2266761|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
2266762|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2266763|NCT00183937|Docetaxel|docetaxel|mesh-list
2266764|NCT00183937|Bortezomib|bortezomib|mesh-list
2266765|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266766|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
2770695|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
2770696|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
2770697|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2770698|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
2770699|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
2770700|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2770701|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770702|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770703|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2790510|NCT04293822|Cetirizine|cetirizine|mesh-list
2790511|NCT04293822|Minoxidil|minoxidil|mesh-list
2790512|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2790513|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2790514|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2790515|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
2790516|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
2790517|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790518|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790519|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790520|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2790521|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
2790522|NCT04293887|Interferons|interferons|mesh-list
2266767|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
2266768|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
2790523|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790524|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
2770704|NCT04435210|Hydralazine|hydralazine|mesh-list
2770705|NCT04435210|Nifedipine|nifedipine|mesh-list
2770706|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2770707|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2770708|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770709|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2770710|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770711|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
2770712|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
2770713|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2770714|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2770715|NCT04434482|Temozolomide|temozolomide|mesh-list
2770716|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2770717|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
2770718|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770719|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770720|NCT04434560|Nivolumab|nivolumab|mesh-list
2770721|NCT04434560|Ipilimumab|ipilimumab|mesh-list
2770722|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2770723|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770724|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2266769|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266770|NCT00183950|Noscapine|noscapine|mesh-list
2266771|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
2266772|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
2266773|NCT00183976|Rituximab|rituximab|mesh-list
2266774|NCT00183976|Doxorubicin|doxorubicin|mesh-list
2770725|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770726|NCT04434378|Tamsulosin|tamsulosin|mesh-list
2770727|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2770728|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2770729|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2770730|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
2770731|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2770732|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770733|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770734|NCT04434378|Urological Agents|urological agents|mesh-ancestor
2770735|NCT04434664|Metoprolol|metoprolol|mesh-list
2770736|NCT04434664|Amlodipine|amlodipine|mesh-list
2770737|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2770738|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2770739|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2770740|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770741|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2770742|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770743|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
2770744|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2770745|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
2770746|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
2770747|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770748|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2770749|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2770750|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2770751|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
2770752|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2770753|NCT04434404|Silymarin|silymarin|mesh-list
2770754|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
2770755|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770756|NCT04434404|Protective Agents|protective agents|mesh-ancestor
2770757|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770758|NCT04434430|Gabapentin|gabapentin|mesh-list
2770759|NCT04434430|Analgesics|analgesics|mesh-ancestor
2770760|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
2770761|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770762|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770763|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
2770764|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2770765|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2770766|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770767|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2770768|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2770769|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2770770|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2770771|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770772|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
2770776|NCT04434365|Aspirin|aspirin|mesh-list
2770777|NCT04434365|Clopidogrel|clopidogrel|mesh-list
2770778|NCT04434365|Atorvastatin|atorvastatin|mesh-list
2770779|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2770780|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2770781|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2770782|NCT04434365|Analgesics|analgesics|mesh-ancestor
2770783|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
2770784|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770785|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770786|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2770787|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770788|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2770789|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2266775|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2266776|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2266777|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266778|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
2266779|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266780|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770790|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770791|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2770792|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2266781|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2266782|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2266783|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2266784|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266785|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266786|NCT00183989|Rituximab|rituximab|mesh-list
2266787|NCT00183989|Fludarabine|fludarabine|mesh-list
2266788|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
2266789|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2266790|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266791|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
2266792|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770793|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770794|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
2770795|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2770796|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2770797|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
2770798|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2770799|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2770800|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2770801|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2770802|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2770803|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
2770804|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2770805|NCT04434248|Ritonavir|ritonavir|mesh-list
2770806|NCT04434248|Lopinavir|lopinavir|mesh-list
2770807|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
2770808|NCT04434248|Chloroquine|chloroquine|mesh-list
2770809|NCT04434248|Favipiravir|favipiravir|mesh-list
2770810|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2770811|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2770812|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
2770813|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770814|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770815|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2770816|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2770817|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
2770818|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770819|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2770820|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2770821|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
2770822|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2770823|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2770824|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770825|NCT04434248|Amebicides|amebicides|mesh-ancestor
2770826|NCT04434105|Triamcinolone|triamcinolone|mesh-list
2770827|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2266793|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770828|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2770829|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2770830|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2770831|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
2770832|NCT04434105|Hormones|hormones|mesh-ancestor
2770833|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2770834|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770835|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2770836|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
2770837|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770838|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770850|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
2770851|NCT04434144|Azithromycin|azithromycin|mesh-list
2770852|NCT04434144|Doxycycline|doxycycline|mesh-list
2770853|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
2770854|NCT04434144|Ivermectin|ivermectin|mesh-list
2770855|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2770856|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770857|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
2770858|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2770859|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2770860|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266794|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266795|NCT00183989|Analgesics|analgesics|mesh-ancestor
2266796|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
2266797|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266798|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2266799|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2266800|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266801|NCT00184015|Bevacizumab|bevacizumab|mesh-list
2770861|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770862|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770863|NCT04434170|Valsartan|valsartan|mesh-list
2770864|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2770865|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2770866|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2770867|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2770868|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770869|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2770870|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2770871|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2770872|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
2770873|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770874|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2770875|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2770876|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770877|NCT04433780|Tenofovir|tenofovir|mesh-list
2770878|NCT04433780|Lamivudine|lamivudine|mesh-list
2770879|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
2770880|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770881|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2770882|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2770883|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770884|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770885|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2770886|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2770887|NCT04433611|Lidocaine|lidocaine|mesh-list
2770888|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
2770889|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
2770890|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2770891|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770892|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
2266802|NCT00184015|Bortezomib|bortezomib|mesh-list
2770893|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2770894|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2770895|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2770896|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2770897|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2770898|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770899|NCT04433481|Dabigatran|dabigatran|mesh-list
2770900|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
2770901|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2770902|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
2770903|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770904|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770905|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
2770906|NCT04433494|Tamoxifen|tamoxifen|mesh-list
2770907|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2770908|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
2770909|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2770910|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770911|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2770912|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770913|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2770914|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2770915|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2770916|NCT04433741|Oxytocin|oxytocin|mesh-list
2770917|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
2770918|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2770919|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770930|NCT04433572|Sirolimus|sirolimus|mesh-list
2266803|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2266804|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770931|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2770932|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770933|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2770934|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770935|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
2770936|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2770937|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
2770938|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770939|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
2770940|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
2770941|NCT04433559|Tadalafil|tadalafil|mesh-list
2770942|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
2770943|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2770944|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2770945|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770946|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770947|NCT04433559|Urological Agents|urological agents|mesh-ancestor
2770948|NCT04433390|Naloxegol|naloxegol|mesh-list
2770949|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2770950|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770951|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
2770952|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790525|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790526|NCT04294069|Azithromycin|azithromycin|mesh-list
2790527|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2790528|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790529|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2790530|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2266805|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2266806|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2266807|NCT00184015|Growth Substances|growth substances|mesh-ancestor
2266808|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266809|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
2790531|NCT04293549|Mitogens|mitogens|mesh-list
2770953|NCT04433169|Tretinoin|tretinoin|mesh-list
2770954|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770955|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
2770956|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
2770957|NCT04433156|Prednisone|prednisone|mesh-list
2770958|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
2770959|NCT04433156|Rituximab|rituximab|mesh-list
2770960|NCT04433156|Bortezomib|bortezomib|mesh-list
2770961|NCT04433156|Epirubicin|epirubicin|mesh-list
2266810|NCT00184041|Cytarabine|cytarabine|mesh-list
2266811|NCT00184041|Prednisone|prednisone|mesh-list
2266812|NCT00184041|Methotrexate|methotrexate|mesh-list
2266813|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
2266814|NCT00184041|Vincristine|vincristine|mesh-list
2266815|NCT00184041|Daunorubicin|daunorubicin|mesh-list
2266816|NCT00184041|Asparaginase|asparaginase|mesh-list
2266817|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
2266818|NCT00184041|Thioguanine|thioguanine|mesh-list
2266819|NCT00184041|Pegaspargase|pegaspargase|mesh-list
2266820|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2770962|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2770963|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
2770964|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2770965|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2770966|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2770967|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
2770968|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2770969|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2770970|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2770971|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2770972|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2266821|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
2266822|NCT00184041|Hormones|hormones|mesh-ancestor
2266823|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2266824|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266825|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2266826|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2266827|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2266828|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
2266829|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2266830|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2266831|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
2770973|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
2770974|NCT04433156|Hormones|hormones|mesh-ancestor
2770975|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2770976|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2770977|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2770978|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2770979|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2770980|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2770981|NCT04433143|Minocycline|minocycline|mesh-list
2770982|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2770983|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770984|NCT04433078|Doxycycline|doxycycline|mesh-list
2770985|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2770986|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2770987|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
2770988|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2770989|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2770990|NCT04432714|Prednisone|prednisone|mesh-list
2770991|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
2770992|NCT04432714|Rituximab|rituximab|mesh-list
2770993|NCT04432714|Doxorubicin|doxorubicin|mesh-list
2266832|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266833|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
2266834|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266835|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2266836|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2266837|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
2266838|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2266839|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2266840|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2266841|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
2266842|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2266843|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2266844|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
2770994|NCT04432714|Etoposide|etoposide|mesh-list
2770995|NCT04432714|Vincristine|vincristine|mesh-list
2770996|NCT04432714|Lenalidomide|lenalidomide|mesh-list
2770997|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2770998|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
2770999|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771000|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2771001|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2771002|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
2771003|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771004|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771005|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2771006|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2771007|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2771008|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2771009|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2771010|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771011|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771012|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
2771013|NCT04432714|Hormones|hormones|mesh-ancestor
2771014|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2771015|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2771016|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2771017|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
2771018|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
2771019|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
2771020|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2771021|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2771022|NCT04432714|Growth Substances|growth substances|mesh-ancestor
2771023|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
2771024|NCT04432974|Anesthetics|anesthetics|mesh-list
2771025|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771026|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771027|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2771028|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2771029|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2771030|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771031|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266845|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
2266846|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
2266847|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
2266848|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2266849|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2266850|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2266851|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2771032|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2771033|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2771034|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2771035|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2771036|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
2771037|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2771038|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771039|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2771040|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2771041|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
2771042|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2771043|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2771044|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
2771045|NCT04432935|Lactoferrin|lactoferrin|mesh-list
2771046|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771047|NCT04432662|Epoetin Alfa|epoetin alfa|mesh-list
2771048|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
2771049|NCT04432662|Hematinics|hematinics|mesh-ancestor
2771050|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
2771051|NCT04432506|Fludarabine|fludarabine|mesh-list
2771052|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2266852|NCT00184106|Paroxetine|paroxetine|mesh-list
2266853|NCT00184106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2266854|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2266855|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266856|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266857|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266858|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
2266859|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266860|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2266861|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
2771053|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2771054|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
2771055|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771056|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2771057|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2771058|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
2771059|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771060|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771061|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2771062|NCT04432376|Miconazole|miconazole|mesh-list
2771063|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
2771064|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771065|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2771066|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2771067|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771068|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771069|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2771070|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
2771071|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2771072|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771073|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2771074|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2771075|NCT04432610|Nebivolol|nebivolol|mesh-list
2771076|NCT04432610|Bisoprolol|bisoprolol|mesh-list
2771077|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2771078|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
2771079|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2771080|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2101947|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
2101948|NCT02397954|Ranibizumab|ranibizumab|mesh-list
2101949|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2101950|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2101951|NCT02397954|Growth Substances|growth substances|mesh-ancestor
2101952|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101953|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
2101954|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101955|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2101956|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2771081|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2771082|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
2771083|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2771084|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771085|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771086|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
2771087|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
2771088|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771089|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2771090|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2771091|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2771092|NCT04432415|Fluorides|fluorides|mesh-list
2771093|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
2771094|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
2771095|NCT04432415|Protective Agents|protective agents|mesh-ancestor
2771096|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771097|NCT04432623|Benserazide|benserazide|mesh-list
2771098|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2771099|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2771100|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771101|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771102|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
2771103|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2771104|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771105|NCT04432558|Acetaminophen|acetaminophen|mesh-list
2771106|NCT04432558|Diclofenac|diclofenac|mesh-list
2771107|NCT04432558|Tramadol|tramadol|mesh-list
2771108|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2771109|NCT04432558|Analgesics|analgesics|mesh-ancestor
2771110|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
2771111|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771112|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771113|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
2771114|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2771115|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771116|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2771117|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2771118|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771119|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771120|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2771121|NCT04432558|Narcotics|narcotics|mesh-ancestor
2771122|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771123|NCT04432402|Gemcitabine|gemcitabine|mesh-list
2771124|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
2771125|NCT04432402|Lenalidomide|lenalidomide|mesh-list
2771126|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771127|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
2771128|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771129|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2771130|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
2771131|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771132|NCT04432402|Antiviral Agents|antiviral agents|mesh-ancestor
2771133|NCT04432402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771134|NCT04432402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771135|NCT04432402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2771136|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2771137|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2771138|NCT04432402|Growth Substances|growth substances|mesh-ancestor
2771139|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
2771140|NCT04432428|Sufentanil|sufentanil|mesh-list
2771141|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2771142|NCT04432428|Narcotics|narcotics|mesh-ancestor
2771143|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771144|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771145|NCT04432428|Analgesics|analgesics|mesh-ancestor
2771146|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
2771147|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771148|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2771149|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2771150|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
2771151|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
2771152|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
2771153|NCT04432324|Antibodies|antibodies|mesh-list
2771154|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
2771155|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2771156|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2771157|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
2771158|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771159|NCT04432220|Apixaban|apixaban|mesh-list
2771160|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2771161|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
2771162|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2771163|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
2771164|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771165|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771166|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
2771167|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
2771168|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2771169|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2771170|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771171|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
2771172|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2771173|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771174|NCT04432259|Dexamethasone|dexamethasone|mesh-list
2771175|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771176|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
2771177|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
2771178|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771179|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771180|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2771181|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
2771182|NCT04432259|Hormones|hormones|mesh-ancestor
2771183|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2771184|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2771185|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771186|NCT04432233|Metronidazole|metronidazole|mesh-list
2771187|NCT04432233|Levofloxacin|levofloxacin|mesh-list
2771188|NCT04432233|Ofloxacin|ofloxacin|mesh-list
2771189|NCT04432233|Esomeprazole|esomeprazole|mesh-list
2771190|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771191|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2771192|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2771193|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2771194|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2771195|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2771196|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2771197|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771198|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771199|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2771200|NCT04432233|Renal Agents|renal agents|mesh-ancestor
2771201|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2771202|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2771203|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771204|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2771205|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2771206|NCT04432155|Xenon|xenon|mesh-list
2771207|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2771208|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
2771209|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
2771210|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771211|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771212|NCT04432012|Dexamethasone|dexamethasone|mesh-list
2771213|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
2771214|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2771215|NCT04432012|BB 1101|bb 1101|mesh-list
2771216|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771217|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
2771218|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
2771219|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771220|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771221|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2771222|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
2771223|NCT04432012|Hormones|hormones|mesh-ancestor
2771224|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2771225|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2771226|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771227|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
2771228|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771229|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266862|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2266863|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2266864|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2266865|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266866|NCT00184171|Budesonide|budesonide|mesh-list
2266867|NCT00184171|Bismuth|bismuth|mesh-list
2266868|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2266869|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2266870|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
2266871|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266872|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266873|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2266874|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
2266875|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
2771230|NCT04431895|Tofacitinib|tofacitinib|mesh-list
2771231|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2771232|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771233|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771234|NCT04431713|Exenatide|exenatide|mesh-list
2771235|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2771236|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771237|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2771238|NCT04431713|Incretins|incretins|mesh-ancestor
2771239|NCT04431713|Hormones|hormones|mesh-ancestor
2771240|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2790532|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
2790533|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790534|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2790535|NCT04293419|Durvalumab|durvalumab|mesh-list
2790536|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2790537|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790538|NCT04293081|Maleic acid|maleic acid|mesh-list
2790539|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790540|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790541|NCT04292873|Vitamin D|vitamin d|mesh-list
2790542|NCT04292873|Vitamins|vitamins|mesh-ancestor
2790543|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
2266876|NCT00184171|Hormones|hormones|mesh-ancestor
2771252|NCT04431349|Clopidogrel|clopidogrel|mesh-list
2771253|NCT04431349|Ticagrelor|ticagrelor|mesh-list
2771254|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2771255|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2771256|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2771257|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2266877|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2266878|NCT00184171|Antacids|antacids|mesh-ancestor
2266879|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266880|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2266881|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
2266882|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2771258|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
2771259|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2771260|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771261|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771262|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
2771263|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
2771264|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
2771265|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771266|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771267|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
2771268|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771269|NCT04431193|Oxytocin|oxytocin|mesh-list
2771270|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
2771271|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2771272|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771273|NCT04431245|Entecavir|entecavir|mesh-list
2771274|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
2771275|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771276|NCT04431258|Folfirinox|folfirinox|mesh-list
2771277|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771278|NCT04431206|Oxytocin|oxytocin|mesh-list
2771279|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
2771280|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2771281|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771282|NCT04430790|Doxapram|doxapram|mesh-list
2771283|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2771284|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771285|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
2771286|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
2771287|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2771288|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2771289|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771290|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
2771291|NCT04430777|Coagulants|coagulants|mesh-ancestor
2266883|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2266884|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266885|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
2266886|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266887|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266888|NCT00184496|Methadone|methadone|mesh-list
2266889|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2266890|NCT00184496|Narcotics|narcotics|mesh-ancestor
2266891|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2266892|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266893|NCT00184496|Analgesics|analgesics|mesh-ancestor
2266894|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
2266895|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266896|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
2266897|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
2266898|NCT00184522|Esomeprazole|esomeprazole|mesh-list
2266899|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2266900|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2266901|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2771292|NCT04430894|Dexamethasone|dexamethasone|mesh-list
2771293|NCT04430894|Lenalidomide|lenalidomide|mesh-list
2771294|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771295|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
2771296|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
2771297|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771298|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771299|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2771300|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
2771301|NCT04430894|Hormones|hormones|mesh-ancestor
2771302|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2771303|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2771304|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771305|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
2771306|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2101957|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
2101958|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2101959|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101960|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2101961|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
2101962|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2266902|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771307|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2771308|NCT04430894|Growth Substances|growth substances|mesh-ancestor
2771309|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
2771310|NCT04430933|Paclitaxel|paclitaxel|mesh-list
2771311|NCT04430933|Docetaxel|docetaxel|mesh-list
2771312|NCT04430933|Carboplatin|carboplatin|mesh-list
2771313|NCT04430933|Pemetrexed|pemetrexed|mesh-list
2771314|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2771315|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771316|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
2771317|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
2266903|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266904|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
2266905|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
2266906|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2266907|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266908|NCT00184574|Metformin|metformin|mesh-list
2266909|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
2266910|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
2266911|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2266912|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771318|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
2771319|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771320|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771321|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2771322|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2771323|NCT04430855|Upadacitinib|upadacitinib|mesh-list
2771324|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2771325|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2771326|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771327|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771328|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2771329|NCT04430959|Candesartan|candesartan|mesh-list
2771330|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2771331|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2771332|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2771333|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771334|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
2771335|NCT04430998|Polaprezinc|polaprezinc|mesh-list
2771336|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2771337|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771338|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
2771339|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2771340|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2771341|NCT04430699|Cisplatin|cisplatin|mesh-list
2771342|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
2771343|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771344|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2771345|NCT04430621|Hormones|hormones|mesh-list
2771346|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2771347|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2771348|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771349|NCT04430556|Sertraline|sertraline|mesh-list
2771350|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
2266913|NCT00184587|Candesartan|candesartan|mesh-list
2771351|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2771352|NCT04430556|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2771353|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2771354|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2771355|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771356|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2771357|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
2771358|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771359|NCT04430426|Glycolic acid|glycolic acid|mesh-list
2771360|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
2771361|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
2771362|NCT04430361|Dexamethasone|dexamethasone|mesh-list
2771363|NCT04430361|Megestrol|megestrol|mesh-list
2771364|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
2771365|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771366|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
2771367|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
2771368|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771369|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771370|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2771371|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
2771372|NCT04430361|Hormones|hormones|mesh-ancestor
2771373|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2266914|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
2266915|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
2266916|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2266917|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2266918|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2266919|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266920|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2266921|NCT00184613|Insulin|insulin|mesh-list
2266922|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2266923|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
2266924|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
2266925|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2771374|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2771375|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771376|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2771377|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2771378|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2771379|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
2771380|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2771381|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2771382|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2771383|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
2771384|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2771385|NCT04430166|Antibodies|antibodies|mesh-list
2771386|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2771387|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
2771388|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790544|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790545|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2790546|NCT04293172|Ticagrelor|ticagrelor|mesh-list
2790547|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2790548|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2790549|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2790550|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2790551|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
2790552|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790553|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790554|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790555|NCT04292990|Fentanyl|fentanyl|mesh-list
2790556|NCT04292990|Morphine|morphine|mesh-list
2790557|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2790558|NCT04292990|Narcotics|narcotics|mesh-ancestor
2790559|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790560|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790561|NCT04292990|Analgesics|analgesics|mesh-ancestor
2790562|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
2790563|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790564|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2790565|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2790566|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
2790567|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
2790568|NCT04292886|Tamoxifen|tamoxifen|mesh-list
2266926|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266927|NCT00184626|Insulin|insulin|mesh-list
2266928|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2266929|NCT00184626|Metformin|metformin|mesh-list
2266930|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
2266931|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
2266932|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
2266933|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2266934|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266935|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
2266936|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2266937|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266938|NCT00184665|Insulin|insulin|mesh-list
2266939|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2266940|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
2266941|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
2266942|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
2266943|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
2266944|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
2771389|NCT04430062|Anesthetics|anesthetics|mesh-list
2771390|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771391|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771392|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
2771393|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
2771394|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2771395|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2771396|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771397|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771398|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771399|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2771400|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
2771401|NCT04429893|Bupivacaine|bupivacaine|mesh-list
2771402|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
2266945|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2266946|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266947|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2266948|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2266949|NCT00184795|Norethindrone|norethindrone|mesh-list
2266950|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
2266951|NCT00184795|Estradiol|estradiol|mesh-list
2266952|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2266953|NCT00184795|Estrogens|estrogens|mesh-ancestor
2266954|NCT00184795|Hormones|hormones|mesh-ancestor
2266955|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2266956|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266957|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2266958|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
2266959|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2266960|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2266961|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2266962|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2266963|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2266964|NCT00184821|Glyburide|glyburide|mesh-list
2266965|NCT00184821|Adenosine|adenosine|mesh-list
2266966|NCT00184821|Diazoxide|diazoxide|mesh-list
2266967|NCT00184821|Annexin A5|annexin a5|mesh-list
2266968|NCT00184821|Analgesics|analgesics|mesh-ancestor
2266969|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
2771403|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
2771404|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771405|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771406|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
2771407|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771408|NCT04429893|Analgesics|analgesics|mesh-ancestor
2771409|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2771410|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
2771411|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2771412|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2771413|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771414|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2771415|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
2771416|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2771417|NCT04430192|177Lu-PSMA-617|177lu-psma-617|mesh-list
2771418|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2771419|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771420|NCT04429880|Oxytocin|oxytocin|mesh-list
2266970|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266971|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771421|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
2771422|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2771423|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771424|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2771425|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
2771426|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266972|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2266973|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
2266974|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2266975|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
2771427|NCT04429711|Ivermectin|ivermectin|mesh-list
2771428|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2771429|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771430|NCT04429633|Candesartan|candesartan|mesh-list
2771431|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2771432|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2771433|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2771434|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771449|NCT04429516|Morphine|morphine|mesh-list
2771450|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2771451|NCT04429516|Narcotics|narcotics|mesh-ancestor
2771452|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771453|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771454|NCT04429516|Analgesics|analgesics|mesh-ancestor
2771455|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
2771456|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771457|NCT04429503|Aflibercept|aflibercept|mesh-list
2771458|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2771459|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2771460|NCT04429503|Growth Substances|growth substances|mesh-ancestor
2771461|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771462|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
2771463|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771464|NCT04429425|Anesthetics|anesthetics|mesh-list
2771465|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771466|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771467|NCT04429282|Ibuprofen|ibuprofen|mesh-list
2771468|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2771469|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2771470|NCT04429282|Analgesics|analgesics|mesh-ancestor
2771471|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
2771472|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771473|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771474|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771475|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2771476|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2771477|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771478|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771479|NCT04429555|Ibudilast|ibudilast|mesh-list
2771480|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2771481|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
2771482|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771483|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771484|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2771485|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
2771486|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2771487|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771488|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771489|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2771490|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
2771491|NCT04429295|Vaccines|vaccines|mesh-list
2771492|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
2771493|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771494|NCT04429321|Nivolumab|nivolumab|mesh-list
2771495|NCT04429321|Ipilimumab|ipilimumab|mesh-list
2771496|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2771497|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771498|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2771499|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771500|NCT04429347|Gabapentin|gabapentin|mesh-list
2771501|NCT04429347|Tizanidine|tizanidine|mesh-list
2771502|NCT04429347|Analgesics|analgesics|mesh-ancestor
2771503|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
2771504|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771505|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771506|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
2771507|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2771508|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2771509|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771510|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2771511|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2771512|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2771513|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2771514|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771515|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
2771516|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2771517|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2771518|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
2771519|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
2771520|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2771521|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2771522|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2771523|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
2771524|NCT04429334|Nangibotide|nangibotide|mesh-list
2771525|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771526|NCT04429191|Antibodies|antibodies|mesh-list
2771527|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2771528|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
2771529|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771530|NCT04429152|Tenofovir|tenofovir|mesh-list
2771531|NCT04429152|Lamivudine|lamivudine|mesh-list
2771532|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
2771533|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771534|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2771535|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2771536|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266976|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
2266977|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266978|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2266979|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2266980|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2266981|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266982|NCT00184847|Adenosine|adenosine|mesh-list
2266983|NCT00184847|Acetylcholine|acetylcholine|mesh-list
2266984|NCT00184847|Caffeine|caffeine|mesh-list
2266985|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2266986|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2266987|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2266988|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2266989|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771537|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771538|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2771539|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2771540|NCT04429035|Vitamin K|vitamin k|mesh-list
2771541|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
2771542|NCT04429035|Vitamins|vitamins|mesh-ancestor
2771543|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
2771544|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771545|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2771546|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2771547|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771548|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
2771549|NCT04429035|Coagulants|coagulants|mesh-ancestor
2771550|NCT04429022|Acetaminophen|acetaminophen|mesh-list
2771551|NCT04429022|Celecoxib|celecoxib|mesh-list
2771552|NCT04429022|Ketorolac|ketorolac|mesh-list
2771553|NCT04429022|Oxycodone|oxycodone|mesh-list
2771554|NCT04429022|Gabapentin|gabapentin|mesh-list
2771555|NCT04429022|Hydromorphone|hydromorphone|mesh-list
2771556|NCT04429022|Ropivacaine|ropivacaine|mesh-list
2771557|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
2771558|NCT04429022|Anesthetics|anesthetics|mesh-list
2771559|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771560|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771561|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
2771562|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771563|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2771564|NCT04429022|Analgesics|analgesics|mesh-ancestor
2771565|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
2771566|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2771567|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771568|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2771569|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2771570|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2771571|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771572|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771573|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2771574|NCT04429022|Narcotics|narcotics|mesh-ancestor
2771575|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
2771576|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2771577|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2771578|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2771579|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2266990|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2266991|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2266992|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
2266993|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2266994|NCT00184847|Analgesics|analgesics|mesh-ancestor
2266995|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
2771580|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2771581|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2771582|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
2771583|NCT04428879|Topotecan|topotecan|mesh-list
2771584|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2771585|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2771586|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771587|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771588|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771589|NCT04428814|Ustekinumab|ustekinumab|mesh-list
2771590|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
2771591|NCT04428437|Lenvatinib|lenvatinib|mesh-list
2771592|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771593|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2771594|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771595|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771596|NCT04428671|Cemiplimab|cemiplimab|mesh-list
2771597|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2266996|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2266997|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2771598|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771599|NCT04428684|Goserelin|goserelin|mesh-list
2771600|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2771601|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771602|NCT04428372|Mannitol|mannitol|mesh-list
2771603|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2771604|NCT04428372|Diuretics|diuretics|mesh-ancestor
2771605|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
2771606|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790569|NCT04292886|Ascorbic Acid|ascorbic acid|mesh-list
2790570|NCT04292886|Vitamins|vitamins|mesh-ancestor
2790571|NCT04292886|Micronutrients|micronutrients|mesh-ancestor
2790572|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790573|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2790574|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
2790575|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2266998|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
2266999|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2267000|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
2267001|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2267002|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
2267003|NCT00184886|Methotrexate|methotrexate|mesh-list
2267004|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2267005|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
2790576|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2771607|NCT04428268|Chloroquine|chloroquine|mesh-list
2771608|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2771609|NCT04428268|Losartan|losartan|mesh-list
2771610|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2771611|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2771612|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2771613|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2771614|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771615|NCT04428268|Amebicides|amebicides|mesh-ancestor
2267006|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2267007|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267008|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2267009|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
2267010|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267011|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267012|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
2267013|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771616|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2771617|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2771618|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771619|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
2771620|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2771621|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2771622|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2771623|NCT04428268|Analgesics|analgesics|mesh-ancestor
2771624|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
2771625|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771626|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771627|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771628|NCT04428268|Filaricides|filaricides|mesh-ancestor
2771629|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
2771630|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
2771631|NCT04428086|Metformin|metformin|mesh-list
2771632|NCT04428086|Apatinib|apatinib|mesh-list
2771633|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2771634|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2771635|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771636|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2771637|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2771638|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
2771639|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771640|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2771641|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2771642|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771643|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267014|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2267015|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267016|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
2267017|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267018|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2771644|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2771645|NCT04428333|Fluorouracil|fluorouracil|mesh-list
2771646|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
2771647|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
2771648|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771649|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2771650|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771651|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2771652|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
2771653|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771654|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2771655|NCT04428632|Berotralstat|berotralstat|mesh-list
2771656|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771657|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771658|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2771659|NCT04428866|Glucagon|glucagon|mesh-list
2771660|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2771661|NCT04428866|Hormones|hormones|mesh-ancestor
2771662|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2771663|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771664|NCT04427709|Oxytocin|oxytocin|mesh-list
2771665|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
2771666|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2771667|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771668|NCT04427826|Morphine|morphine|mesh-list
2267019|NCT00184899|Heparin|heparin|mesh-list
2267020|NCT00184899|Calcium heparin|calcium heparin|mesh-list
2267021|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2267022|NCT00184899|Glycerol|glycerol|mesh-list
2267023|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
2267024|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2267025|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2267026|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267027|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2267028|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2267029|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2267030|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2267031|NCT00184899|Protective Agents|protective agents|mesh-ancestor
2771669|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2771670|NCT04427826|Narcotics|narcotics|mesh-ancestor
2771671|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771672|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771673|NCT04427826|Analgesics|analgesics|mesh-ancestor
2771674|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
2771675|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771676|NCT04427865|Lactoferrin|lactoferrin|mesh-list
2771677|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771678|NCT04428008|Thymalfasin|thymalfasin|mesh-list
2771679|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2771680|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
2771681|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771682|NCT04427787|Lanreotide|lanreotide|mesh-list
2771683|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771684|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
2771685|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2771686|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2771687|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771688|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
2771689|NCT04427618|Coagulants|coagulants|mesh-ancestor
2771690|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
2267032|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267033|NCT00184912|Caffeine|caffeine|mesh-list
2267034|NCT00184912|Annexin A5|annexin a5|mesh-list
2267035|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2267036|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267037|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2267038|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267039|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771691|NCT04427293|Lenvatinib|lenvatinib|mesh-list
2771692|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2771693|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771694|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2771695|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771696|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771697|NCT04427241|Amantadine|amantadine|mesh-list
2771698|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
2771699|NCT04427241|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2771700|NCT04427241|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2771701|NCT04427241|Antiviral Agents|antiviral agents|mesh-ancestor
2771702|NCT04427241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771703|NCT04427241|Dopamine Agents|dopamine agents|mesh-ancestor
2771704|NCT04427241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2771705|NCT04427241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771706|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771707|NCT04427241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2771708|NCT04427241|Analgesics|analgesics|mesh-ancestor
2771709|NCT04427241|Sensory System Agents|sensory system agents|mesh-ancestor
2771710|NCT04427241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771711|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2771712|NCT04427241|Protective Agents|protective agents|mesh-ancestor
2771713|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
2771714|NCT04427540|Oxytocin|oxytocin|mesh-list
2771715|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
2771716|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2771717|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771718|NCT04426890|Omalizumab|omalizumab|mesh-list
2771719|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2771720|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2771721|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2771722|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
2771723|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
2771724|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267040|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2267041|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2267042|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
2267043|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2267044|NCT00184938|Morphine|morphine|mesh-list
2267045|NCT00184938|Naloxone|naloxone|mesh-list
2267046|NCT00184938|Annexin A5|annexin a5|mesh-list
2771725|NCT04427020|Caseins|caseins|mesh-list
2771726|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
2771727|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
2771728|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771729|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2771730|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771731|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790577|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790578|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2790579|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2790580|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2790581|NCT04292886|Antioxidants|antioxidants|mesh-ancestor
2790582|NCT04292886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790583|NCT04292886|Protective Agents|protective agents|mesh-ancestor
2790584|NCT04292756|Triamcinolone|triamcinolone|mesh-list
2790585|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2790586|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2790587|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2790588|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2790589|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
2790590|NCT04292756|Hormones|hormones|mesh-ancestor
2790591|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2790592|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790593|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2790594|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
2790595|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790596|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790597|NCT04292743|Leucovorin|leucovorin|mesh-list
2790598|NCT04292743|Fluorouracil|fluorouracil|mesh-list
2790599|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
2790600|NCT04292743|Irinotecan|irinotecan|mesh-list
2790601|NCT04292743|Folfirinox|folfirinox|mesh-list
2790602|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
2790603|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790604|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2790605|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790606|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2790607|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
2790608|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790609|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2790610|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2790611|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790612|NCT04292743|Antidotes|antidotes|mesh-ancestor
2790613|NCT04292743|Protective Agents|protective agents|mesh-ancestor
2790614|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
2790615|NCT04292743|Vitamins|vitamins|mesh-ancestor
2790616|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
2790617|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
2790618|NCT04292418|Tacrolimus|tacrolimus|mesh-list
2267047|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2267048|NCT00184938|Narcotics|narcotics|mesh-ancestor
2267049|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2267050|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267051|NCT00184938|Analgesics|analgesics|mesh-ancestor
2267052|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
2267053|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267054|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2267055|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267056|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267057|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2267058|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2267059|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2790619|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2790620|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
2790621|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790622|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2790623|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790624|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267060|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
2267061|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267062|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2267063|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2267064|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267065|NCT00184977|Fluticasone|fluticasone|mesh-list
2267066|NCT00184977|Xhance|xhance|mesh-list
2771732|NCT04427098|Enoxaparin|enoxaparin|mesh-list
2771733|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
2771734|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
2771735|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2771736|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2771737|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771738|NCT04426734|Dexamethasone|dexamethasone|mesh-list
2771739|NCT04426734|Prednisolone|prednisolone|mesh-list
2771740|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2771741|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
2771742|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2771743|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
2771744|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2771745|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
2771746|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771747|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
2771748|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
2771749|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771750|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771751|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2771752|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
2771753|NCT04426734|Hormones|hormones|mesh-ancestor
2771754|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2771755|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2771756|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267067|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
2771757|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2771758|NCT04426734|Protective Agents|protective agents|mesh-ancestor
2771759|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
2771760|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2771761|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
2771762|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771763|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
2771764|NCT04426721|Protective Agents|protective agents|mesh-ancestor
2771765|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
2771766|NCT04426552|Sevoflurane|sevoflurane|mesh-list
2771767|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2771768|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771769|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771770|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2771771|NCT04426552|Analgesics|analgesics|mesh-ancestor
2771772|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
2771773|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771774|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2771775|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2771776|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2771777|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
2771778|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2771779|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771780|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2771781|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2771782|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
2771783|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
2771784|NCT04426578|Perhexiline|perhexiline|mesh-list
2101963|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2101964|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2101965|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
2771785|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2771786|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2771787|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771788|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2771789|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771790|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
2101966|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2101967|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101968|NCT02399085|Lenalidomide|lenalidomide|mesh-list
2101969|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
2101970|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101971|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2771791|NCT04426669|Aldesleukin|aldesleukin|mesh-list
2771792|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
2771793|NCT04426669|Fludarabine|fludarabine|mesh-list
2771794|NCT04426669|Interleukin-2|interleukin-2|mesh-list
2771795|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2771796|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
2771797|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771798|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2771799|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2771800|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
2771801|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771802|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771803|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2771804|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2771805|NCT04426669|Analgesics|analgesics|mesh-ancestor
2771806|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
2771807|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771808|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2771809|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2771810|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
2771811|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771812|NCT04426422|Metformin|metformin|mesh-list
2771813|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2771814|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771815|NCT04426500|Bupivacaine|bupivacaine|mesh-list
2771816|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
2771817|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
2771818|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771819|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771820|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
2771821|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771822|NCT04426409|Ofloxacin|ofloxacin|mesh-list
2771823|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2771824|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771825|NCT04426409|Renal Agents|renal agents|mesh-ancestor
2771826|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2771827|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2771828|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2771829|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771830|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771831|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771832|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2771833|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2771834|NCT04426487|Progesterone|progesterone|mesh-list
2771835|NCT04426487|Progestins|progestins|mesh-ancestor
2771836|NCT04426487|Hormones|hormones|mesh-ancestor
2771837|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2771838|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771839|NCT04426097|Iodine|iodine|mesh-list
2771840|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2771841|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771842|NCT04426097|Trace Elements|trace elements|mesh-ancestor
2771843|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
2771844|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771845|NCT04425993|Indomethacin|indomethacin|mesh-list
2771846|NCT04425993|Isosorbide|isosorbide|mesh-list
2771847|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2771848|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2771849|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2771850|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2771851|NCT04425993|Analgesics|analgesics|mesh-ancestor
2771852|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
2771853|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771854|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771855|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771856|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2771857|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
2771858|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
2771859|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2771860|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2771861|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771862|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771863|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2771864|NCT04425993|Diuretics|diuretics|mesh-ancestor
2771865|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
2771866|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
2771867|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2771868|NCT04426955|Paclitaxel|paclitaxel|mesh-list
2771869|NCT04426955|Cisplatin|cisplatin|mesh-list
2771870|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2771871|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771872|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
2771873|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
2771874|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
2771875|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771876|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
2771877|NCT04425902|Metoprolol|metoprolol|mesh-list
2771878|NCT04425902|Digoxin|digoxin|mesh-list
2771879|NCT04425902|Midazolam|midazolam|mesh-list
2771880|NCT04425902|Caffeine|caffeine|mesh-list
2771881|NCT04425902|Omeprazole|omeprazole|mesh-list
2771882|NCT04425902|Pravastatin|pravastatin|mesh-list
2771883|NCT04425902|Montelukast|montelukast|mesh-list
2771884|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2771885|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2771886|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2771887|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771888|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2771889|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2771890|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2771891|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2771892|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
2771893|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
2771894|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
2771895|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
2771896|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2771897|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771898|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2771899|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2771900|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2771901|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771902|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2267068|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2267069|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2267070|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2267071|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
2267072|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267073|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771903|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2771904|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2771905|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2771906|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
2771907|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2771908|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
2771909|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2771910|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
2771911|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2771912|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2771913|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2771914|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2771915|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2771916|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
2771917|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
2771918|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771919|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2771920|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2771921|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2771922|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
2771923|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2771924|NCT04425902|Protective Agents|protective agents|mesh-ancestor
2771925|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2771926|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2771927|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
2771928|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2771929|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2771930|NCT04425902|Analgesics|analgesics|mesh-ancestor
2771931|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
2771932|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2771933|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2771934|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771935|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267074|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2267075|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
2267076|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
2267077|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2267078|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
2267079|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267080|NCT00184977|Expectorants|expectorants|mesh-ancestor
2267081|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2267082|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
2267083|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771936|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2771937|NCT04426240|Cyclosporine|cyclosporine|mesh-list
2771938|NCT04426240|Cyclosporins|cyclosporins|mesh-list
2771939|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771940|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771941|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2771942|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
2771943|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771944|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
2771945|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771946|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
2771947|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2771948|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2771949|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
2771950|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2771951|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2771952|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2771953|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2771954|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771955|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
2771956|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2267084|NCT00184977|Protective Agents|protective agents|mesh-ancestor
2267085|NCT00184977|Antidotes|antidotes|mesh-ancestor
2267086|NCT00184990|Pimagedine|pimagedine|mesh-list
2267087|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267088|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267089|NCT00185003|Tolbutamide|tolbutamide|mesh-list
2267090|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
2267091|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267092|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2267093|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267094|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2267095|NCT00185055|Valsartan|valsartan|mesh-list
2267096|NCT00185055|Olmesartan|olmesartan|mesh-list
2267097|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2267098|NCT00185055|Irbesartan|irbesartan|mesh-list
2267099|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2771957|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771958|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2771959|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771960|NCT04425564|Capecitabine|capecitabine|mesh-list
2771961|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
2771962|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2771963|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
2771964|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771965|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771966|NCT04425590|Aspirin|aspirin|mesh-list
2771967|NCT04425590|Atorvastatin|atorvastatin|mesh-list
2771968|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2771969|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2771970|NCT04425590|Analgesics|analgesics|mesh-ancestor
2771971|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
2771972|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2771973|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771974|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2771975|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2771976|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2267100|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2267101|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2267102|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267103|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2267104|NCT00185068|Olmesartan|olmesartan|mesh-list
2267105|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2267106|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2267107|NCT00185068|Diuretics|diuretics|mesh-ancestor
2267108|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
2771977|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2771978|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2771979|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2771980|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2771981|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2771982|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
2771983|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2771984|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2771985|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
2771986|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2771987|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2771988|NCT04425655|Fludarabine|fludarabine|mesh-list
2771989|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2771990|NCT04425460|Favipiravir|favipiravir|mesh-list
2771991|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
2771992|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2771993|NCT04425642|Methamphetamine|methamphetamine|mesh-list
2771994|NCT04425642|SMOFlipid|smoflipid|mesh-list
2771995|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2771996|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2771997|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
2771998|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
2771999|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772000|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
2772001|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772002|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772003|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
2772004|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2772005|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2772006|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2772007|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2772008|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2772009|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2772010|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2772011|NCT04425681|Bevacizumab|bevacizumab|mesh-list
2772012|NCT04425681|Osimertinib|osimertinib|mesh-list
2772013|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2772014|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772015|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2772016|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2772017|NCT04425681|Growth Substances|growth substances|mesh-ancestor
2772018|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772019|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
2772020|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2772021|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772022|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772023|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
2772024|NCT04425707|Ivermectin|ivermectin|mesh-list
2772025|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
2772026|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2772027|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2772028|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772029|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772030|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772031|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772032|NCT04425824|Rituximab|rituximab|mesh-list
2772033|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2772034|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772035|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
2772036|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772037|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772038|NCT04425187|Bevacizumab|bevacizumab|mesh-list
2772039|NCT04425187|Gefitinib|gefitinib|mesh-list
2772040|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2772041|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772042|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2772043|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2772044|NCT04425187|Growth Substances|growth substances|mesh-ancestor
2772045|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772046|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
2772047|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2772048|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772049|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772050|NCT04425473|Esketamine|esketamine|mesh-list
2772051|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
2772052|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2772053|NCT04425382|Ritonavir|ritonavir|mesh-list
2772054|NCT04425382|Lopinavir|lopinavir|mesh-list
2772055|NCT04425382|Darunavir|darunavir|mesh-list
2772056|NCT04425382|Cobicistat|cobicistat|mesh-list
2772057|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2772058|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2772059|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
2772060|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772061|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772062|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2772063|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2772064|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
2772065|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772066|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2772067|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2772068|NCT04425291|Vaccines|vaccines|mesh-list
2267109|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267110|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2267111|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2267112|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267113|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2267114|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2267115|NCT00185094|Losartan|losartan|mesh-list
2267116|NCT00185094|Atenolol|atenolol|mesh-list
2267117|NCT00185094|Olmesartan|olmesartan|mesh-list
2772069|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
2772070|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772071|NCT04425135|Carboplatin|carboplatin|mesh-list
2772072|NCT04425135|Apatinib|apatinib|mesh-list
2772073|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772074|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2772075|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772076|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772077|NCT04424966|Infigratinib|infigratinib|mesh-list
2772078|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772079|NCT04425239|Leucovorin|leucovorin|mesh-list
2772080|NCT04425239|Folic Acid|folic acid|mesh-list
2267118|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2267119|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2267120|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2772081|NCT04425239|Fluorouracil|fluorouracil|mesh-list
2772082|NCT04425239|Irinotecan|irinotecan|mesh-list
2772083|NCT04425239|Panitumumab|panitumumab|mesh-list
2772084|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
2772085|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
2772086|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772087|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2772088|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772089|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2772090|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
2772091|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267121|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2267122|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2267123|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267124|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
2772092|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2772093|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2772094|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772095|NCT04425239|Antidotes|antidotes|mesh-ancestor
2772096|NCT04425239|Protective Agents|protective agents|mesh-ancestor
2772097|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
2772098|NCT04425239|Vitamins|vitamins|mesh-ancestor
2772099|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
2772100|NCT04425239|Hematinics|hematinics|mesh-ancestor
2772101|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2790625|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2790626|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790627|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2790628|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
2790629|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2790630|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790631|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
2790632|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2790633|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
2790634|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790635|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790636|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2267125|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
2267126|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267127|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267128|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2267129|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2267130|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2267131|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
2772102|NCT04425252|Brequinar|brequinar|mesh-list
2772103|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772104|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772105|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772106|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2772107|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
2772108|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772109|NCT04425070|Gemcitabine|gemcitabine|mesh-list
2772110|NCT04425070|Carboplatin|carboplatin|mesh-list
2772111|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
2772112|NCT04425070|Etoposide|etoposide|mesh-list
2772113|NCT04425070|Ifosfamide|ifosfamide|mesh-list
2772114|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772115|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2772116|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
2772117|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772118|NCT04425070|Antiviral Agents|antiviral agents|mesh-ancestor
2772119|NCT04425070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772120|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772121|NCT04425070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2772122|NCT04425070|Immunologic Factors|immunologic factors|mesh-ancestor
2772123|NCT04425070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772124|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2772125|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2772126|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2772127|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2772128|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
2267132|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2267133|NCT00185107|Simvastatin|simvastatin|mesh-list
2267134|NCT00185107|Ezetimibe|ezetimibe|mesh-list
2267135|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2267136|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2267137|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2267138|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
2267139|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267140|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2267141|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2267142|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267143|NCT00185120|Amlodipine|amlodipine|mesh-list
2267144|NCT00185120|Olmesartan|olmesartan|mesh-list
2267145|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2267146|NCT00185120|Benazepril|benazepril|mesh-list
2267147|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2267148|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2267149|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2267150|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267151|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2267152|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267153|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
2267154|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2267155|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2267156|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2267157|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
2267158|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267159|NCT00185133|Amlodipine|amlodipine|mesh-list
2772129|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
2772130|NCT04425226|Lenvatinib|lenvatinib|mesh-list
2772131|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2772132|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772133|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2772134|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772135|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772136|NCT04424901|Dipyridamole|dipyridamole|mesh-list
2772137|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2772138|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772139|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772140|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2772141|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
2772142|NCT04424862|Cyclosporine|cyclosporine|mesh-list
2772143|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
2772144|NCT04424862|Prednisone|prednisone|mesh-list
2772145|NCT04424862|Cyclosporins|cyclosporins|mesh-list
2772146|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2772147|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
2772148|NCT04424862|Hormones|hormones|mesh-ancestor
2772149|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2772150|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101972|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2101973|NCT02399085|Growth Substances|growth substances|mesh-ancestor
2101974|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
2101975|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2101976|NCT02399163|Fluorides|fluorides|mesh-list
2101977|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
2101978|NCT02399163|Protective Agents|protective agents|mesh-ancestor
2101979|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101980|NCT02399345|Ritonavir|ritonavir|mesh-list
2101981|NCT02399345|Ribavirin|ribavirin|mesh-list
2101982|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
2101983|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2101984|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2101985|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
2772151|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2772152|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772153|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772154|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772155|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2772156|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
2772157|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
2772158|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772159|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
2772160|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772161|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2772162|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2772163|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2772164|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
2772165|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2772166|NCT04424875|Melatonin|melatonin|mesh-list
2772167|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
2772168|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772169|NCT04424875|Protective Agents|protective agents|mesh-ancestor
2772170|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772171|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2772172|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
2772173|NCT04424602|Dimethoate|dimethoate|mesh-list
2772174|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772175|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772176|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772177|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2772178|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
2772179|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772180|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772181|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2772182|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
2772183|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772184|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2772185|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
2772186|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2772187|NCT04424420|Acetaminophen|acetaminophen|mesh-list
2772188|NCT04424420|Ibuprofen|ibuprofen|mesh-list
2772189|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2772190|NCT04424420|Analgesics|analgesics|mesh-ancestor
2772191|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
2772192|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772193|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772194|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
2772195|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2772196|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2772197|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772198|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2772199|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772200|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101986|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772201|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
2772202|NCT04424654|Testosterone|testosterone|mesh-list
2772203|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
2772204|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
2772205|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2772206|NCT04424654|Androgens|androgens|mesh-ancestor
2772207|NCT04424654|Hormones|hormones|mesh-ancestor
2772208|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2772209|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772210|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2772211|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772212|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
2772213|NCT04424511|Azithromycin|azithromycin|mesh-list
2772214|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2772215|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772216|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
2772217|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2772218|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2772219|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772220|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
2772221|NCT04424563|Coagulants|coagulants|mesh-ancestor
2772222|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
2772223|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2772224|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772225|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
2772226|NCT04424459|Narcotics|narcotics|mesh-ancestor
2267160|NCT00185133|Olmesartan|olmesartan|mesh-list
2267161|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2267162|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2267163|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2267164|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2267165|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267166|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2267167|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267168|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
2267169|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2267170|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2267171|NCT00185159|Olmesartan|olmesartan|mesh-list
2267172|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2267173|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2267174|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2267175|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2267176|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267177|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2267178|NCT00185172|Olmesartan|olmesartan|mesh-list
2267179|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2267180|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2267181|NCT00185172|Diuretics|diuretics|mesh-ancestor
2267182|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
2267183|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267184|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2267185|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2772227|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2772228|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772229|NCT04424459|Analgesics|analgesics|mesh-ancestor
2772230|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
2772231|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772232|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
2772233|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2772234|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
2772235|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2772236|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
2772237|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772238|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772239|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
2772240|NCT04424264|Tenofovir|tenofovir|mesh-list
2772241|NCT04424264|Lamivudine|lamivudine|mesh-list
2772242|NCT04424264|Emtricitabine|emtricitabine|mesh-list
2267186|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267187|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2267188|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2267189|NCT00185185|Atenolol|atenolol|mesh-list
2267190|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2267191|NCT00185185|Olmesartan|olmesartan|mesh-list
2267192|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2772243|NCT04424264|Efavirenz|efavirenz|mesh-list
2790637|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
2772244|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2772245|NCT04424264|Rifampin|rifampin|mesh-list
2772246|NCT04424264|Isoniazid|isoniazid|mesh-list
2772247|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
2772248|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772249|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2772250|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2772251|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772252|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772253|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2772254|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2772255|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2772256|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2772257|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2772258|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2772259|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2772260|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2772261|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2772262|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
2772263|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2772264|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
2772265|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2772266|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2772267|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2772268|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2772269|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2772270|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
2772271|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2772272|NCT04424303|Tofacitinib|tofacitinib|mesh-list
2772273|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2772274|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772275|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772276|NCT04423926|Prednisolone|prednisolone|mesh-list
2772277|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
2772278|NCT04423926|Doxorubicin|doxorubicin|mesh-list
2772279|NCT04423926|Vincristine|vincristine|mesh-list
2772280|NCT04423926|Lenalidomide|lenalidomide|mesh-list
2772281|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2772282|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
2772283|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772284|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772285|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2772286|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
2772287|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772288|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772289|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2772290|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2772291|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2772292|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2772293|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772294|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2772295|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
2772296|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
2772297|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
2772298|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2772299|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2772300|NCT04423926|Growth Substances|growth substances|mesh-ancestor
2772301|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
2772302|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2772303|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
2772304|NCT04423926|Hormones|hormones|mesh-ancestor
2267193|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2267194|NCT00185185|Diuretics|diuretics|mesh-ancestor
2267195|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
2267196|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267197|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2772305|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2772306|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2772307|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2772308|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772309|NCT04424017|Antibodies|antibodies|mesh-list
2267198|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2772310|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
2772311|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772312|NCT04424134|Spironolactone|spironolactone|mesh-list
2772313|NCT04424134|Bromhexine|bromhexine|mesh-list
2772314|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2772315|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
2772316|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2772317|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772318|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2772319|NCT04424134|Diuretics|diuretics|mesh-ancestor
2772320|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
2772321|NCT04424134|Expectorants|expectorants|mesh-ancestor
2772322|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
2772330|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2772331|NCT04423627|Clonidine|clonidine|mesh-list
2772332|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2772333|NCT04423627|Diuretics|diuretics|mesh-ancestor
2772334|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
2772335|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772336|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2772337|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2267199|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267200|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2267201|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2267202|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2267203|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
2267204|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
2267205|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267206|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2267207|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2267208|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2267209|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
2267210|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2267211|NCT00185198|Testosterone|testosterone|mesh-list
2267212|NCT00185198|Androgens|androgens|mesh-ancestor
2267213|NCT00185198|Hormones|hormones|mesh-ancestor
2267214|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2267215|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267216|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2267217|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2267218|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2267219|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2267220|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
2267221|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2267222|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267223|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2267224|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2267225|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2267226|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2267227|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2267228|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2267229|NCT00185237|Estradiol|estradiol|mesh-list
2267230|NCT00185237|Estrogens|estrogens|mesh-ancestor
2267231|NCT00185237|Hormones|hormones|mesh-ancestor
2267232|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2267233|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267234|NCT00185250|Interferons|interferons|mesh-list
2267235|NCT00185250|Interferon-beta|interferon-beta|mesh-list
2267236|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
2267237|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267238|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
2267239|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267240|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
2267241|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267242|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2772338|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772339|NCT04423627|Analgesics|analgesics|mesh-ancestor
2772340|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
2772341|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772342|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
2772343|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
2267243|NCT00185302|Entinostat|entinostat|mesh-list
2267244|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2267245|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267246|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267247|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267248|NCT00185315|Iloprost|iloprost|mesh-list
2267249|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2267250|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
2267251|NCT00185328|Estradiol|estradiol|mesh-list
2267252|NCT00185328|Estrogens|estrogens|mesh-ancestor
2101987|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2101988|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2101989|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2101990|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
2101991|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2101992|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2101993|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2101994|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
2101995|NCT02399475|Hormones|hormones|mesh-list
2101996|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
2101997|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2101998|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2101999|NCT02399917|Azacitidine|azacitidine|mesh-list
2102000|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2102001|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
2102002|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102003|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102004|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102005|NCT02400333|Ticagrelor|ticagrelor|mesh-list
2267253|NCT00185328|Hormones|hormones|mesh-ancestor
2772344|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2772345|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2772346|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2772347|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
2772348|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772349|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
2772350|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2772351|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772352|NCT04423731|Leucovorin|leucovorin|mesh-list
2772353|NCT04423731|Gemcitabine|gemcitabine|mesh-list
2772354|NCT04423731|Paclitaxel|paclitaxel|mesh-list
2772355|NCT04423731|Fluorouracil|fluorouracil|mesh-list
2772356|NCT04423731|Folfirinox|folfirinox|mesh-list
2772357|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2772358|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772359|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
2772360|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
2772361|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
2772362|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772363|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2772364|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
2772365|NCT04423731|Antiviral Agents|antiviral agents|mesh-ancestor
2267254|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2267255|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267256|NCT00185419|Desogestrel|desogestrel|mesh-list
2267257|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2267258|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267259|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2267260|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2267261|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2267262|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
2267263|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2267264|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2267265|NCT00185419|Progestins|progestins|mesh-ancestor
2267266|NCT00185419|Hormones|hormones|mesh-ancestor
2267267|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2267268|NCT00185445|Fludarabine|fludarabine|mesh-list
2772366|NCT04423731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772367|NCT04423731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772368|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2772369|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
2267269|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
2267270|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267271|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2267272|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
2267273|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267274|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267275|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
2267276|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267277|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
2267278|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2267279|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2267280|NCT00185510|Prednisolone|prednisolone|mesh-list
2267281|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
2267282|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
2267283|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2267284|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
2267285|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2267286|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
2267287|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
2772370|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772371|NCT04423731|Antidotes|antidotes|mesh-ancestor
2772372|NCT04423731|Protective Agents|protective agents|mesh-ancestor
2772373|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
2772374|NCT04423731|Vitamins|vitamins|mesh-ancestor
2772375|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
2772384|NCT04423510|Phenol|phenol|mesh-list
2772385|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2772386|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772387|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
2772388|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2772389|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2790638|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2790639|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
2790640|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790641|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790642|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2267288|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267289|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267290|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2267291|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
2790643|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
2790644|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
2790645|NCT04292483|Protective Agents|protective agents|mesh-ancestor
2790646|NCT04292457|Propofol|propofol|mesh-list
2790647|NCT04292457|Sevoflurane|sevoflurane|mesh-list
2790648|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2790649|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790650|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790651|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2790652|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
2790653|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
2790654|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2790655|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2790656|NCT04292444|Oxytocin|oxytocin|mesh-list
2790657|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
2790658|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2790659|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792825|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2792826|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792827|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792828|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2792829|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2792830|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2792831|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2792832|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
2792833|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
2792834|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
2267292|NCT00185510|Hormones|hormones|mesh-ancestor
2792835|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
2772390|NCT04423107|Acetaminophen|acetaminophen|mesh-list
2772391|NCT04423107|Ibuprofen|ibuprofen|mesh-list
2772392|NCT04423107|Oxycodone|oxycodone|mesh-list
2772393|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2772394|NCT04423107|Analgesics|analgesics|mesh-ancestor
2772395|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
2772396|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772397|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772398|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
2772399|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2772400|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2772401|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772402|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2772403|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267293|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2267294|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2267295|NCT00185510|Protective Agents|protective agents|mesh-ancestor
2772404|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772405|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2772406|NCT04423107|Narcotics|narcotics|mesh-ancestor
2772407|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2772413|NCT04423276|Donepezil|donepezil|mesh-list
2772414|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2772415|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772416|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772417|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
2772418|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772419|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772420|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
2772421|NCT04423185|Atezolizumab|atezolizumab|mesh-list
2772422|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
2772423|NCT04423185|Palbociclib|palbociclib|mesh-list
2772424|NCT04423185|Niraparib|niraparib|mesh-list
2772425|NCT04423185|Vemurafenib|vemurafenib|mesh-list
2267296|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2267297|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267298|NCT00185562|Adalimumab|adalimumab|mesh-list
2267299|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2267300|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267301|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2267302|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2267303|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2772426|NCT04423185|Crizotinib|crizotinib|mesh-list
2772427|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772428|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2772429|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772430|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772431|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2772432|NCT04423367|Dexamethasone|dexamethasone|mesh-list
2772433|NCT04423367|Bortezomib|bortezomib|mesh-list
2772434|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2772435|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
2772436|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
2772437|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772438|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772439|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2772440|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
2772441|NCT04423367|Hormones|hormones|mesh-ancestor
2772442|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2772443|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2772444|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772445|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
2772446|NCT04423055|Etonogestrel|etonogestrel|mesh-list
2772447|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2772448|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772449|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2772450|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2772454|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
2772455|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772456|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2772457|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772458|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772459|NCT04422652|Bupropion|bupropion|mesh-list
2772460|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2772461|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
2772462|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2772463|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2772464|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2772465|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2772466|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772467|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
2772468|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772469|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772470|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2772471|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2772472|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772473|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
2772474|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
2772475|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
2772476|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2772477|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772478|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
2772479|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772480|NCT04422275|Budesonide|budesonide|mesh-list
2772481|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2772482|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2267304|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2267305|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267306|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2267307|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267308|NCT00185575|Analgesics|analgesics|mesh-ancestor
2267309|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
2267310|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267311|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
2267312|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2267313|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
2267314|NCT00185705|Telmisartan|telmisartan|mesh-list
2267315|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2267316|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2267317|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2267318|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267319|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
2267320|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2267321|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2267322|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
2267323|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267324|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267325|NCT00185835|Gefitinib|gefitinib|mesh-list
2267326|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267327|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2267328|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267329|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267330|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
2267331|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267332|NCT00185887|Terbutaline|terbutaline|mesh-list
2267333|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2267334|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
2267335|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267336|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267337|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2267338|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
2267339|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
2267340|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
2267341|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2267342|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2267343|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2267344|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2267345|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
2267346|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2267347|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772483|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
2772484|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772485|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772486|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2772487|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
2772488|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
2772489|NCT04422275|Hormones|hormones|mesh-ancestor
2772490|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2772491|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2772492|NCT04422431|Choline|choline|mesh-list
2772493|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
2772494|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2772495|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
2772496|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772497|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2772498|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2772499|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
2267348|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2267349|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2267350|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267351|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2267352|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772500|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
2772501|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
2772502|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772503|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2772504|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2772505|NCT04422431|Growth Substances|growth substances|mesh-ancestor
2772506|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267353|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267354|NCT00185952|Nifedipine|nifedipine|mesh-list
2267355|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2267356|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2267357|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267358|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2267359|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267360|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
2267361|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
2267362|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2267363|NCT00185991|Gentamicins|gentamicins|mesh-list
2267364|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2267365|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267366|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2267367|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267368|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267369|NCT00186082|Cefoxitin|cefoxitin|mesh-list
2267370|NCT00186082|Cefotetan|cefotetan|mesh-list
2267371|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2267372|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267373|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
2772507|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
2772508|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772509|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2772510|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2772511|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2772512|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772513|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772514|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2772515|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2772516|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772517|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
2772518|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772519|NCT04422392|Paclitaxel|paclitaxel|mesh-list
2772520|NCT04422392|Carboplatin|carboplatin|mesh-list
2772521|NCT04422392|Pemetrexed|pemetrexed|mesh-list
2772522|NCT04422392|Antibodies|antibodies|mesh-list
2772523|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2772524|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772525|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
2772526|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
2772527|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
2772528|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772529|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
2772530|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772531|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772532|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2772533|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2772534|NCT04422028|Desogestrel|desogestrel|mesh-list
2772535|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2772536|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2772537|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2772538|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
2772539|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2772540|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772541|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2772542|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2772543|NCT04422028|Progestins|progestins|mesh-ancestor
2772544|NCT04422028|Hormones|hormones|mesh-ancestor
2772545|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2772546|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
2772547|NCT04422184|Diuretics|diuretics|mesh-ancestor
2772548|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
2772549|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772550|NCT04422184|Expectorants|expectorants|mesh-ancestor
2772551|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
2772552|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
2772553|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
2772554|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2772555|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2772556|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772557|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772558|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772559|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772560|NCT04421560|Rituximab|rituximab|mesh-list
2772561|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
2772562|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2772563|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772564|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
2772565|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772566|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772567|NCT04421872|Anesthetics|anesthetics|mesh-list
2772568|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2772569|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772570|NCT04421716|Ursolic acid|ursolic acid|mesh-list
2772571|NCT04421716|Curcumin|curcumin|mesh-list
2772572|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2772573|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2772574|NCT04421716|Analgesics|analgesics|mesh-ancestor
2772575|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
2772576|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772577|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772578|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2772579|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772580|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772581|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772582|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772583|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772584|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2772585|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2772586|NCT04421911|Diclofenac|diclofenac|mesh-list
2267374|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2267375|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2267376|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2267377|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2267378|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2267379|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267380|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772587|NCT04421911|Ketoprofen|ketoprofen|mesh-list
2772588|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2772589|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2772590|NCT04421911|Analgesics|analgesics|mesh-ancestor
2772591|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
2772592|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772593|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772594|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2772595|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772596|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2772597|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772598|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790660|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
2790661|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2790662|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
2267381|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267382|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2267383|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
2790663|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
2790664|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790665|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790666|NCT04292691|Ropivacaine|ropivacaine|mesh-list
2790667|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
2790668|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
2790669|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790670|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790671|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
2790672|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790673|NCT04292769|Decitabine|decitabine|mesh-list
2790674|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2790675|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
2790676|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790677|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790678|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790679|NCT04292704|Clotrimazole|clotrimazole|mesh-list
2790680|NCT04292704|Miconazole|miconazole|mesh-list
2790681|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2790682|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790683|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
2790684|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2790685|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2790686|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267384|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2267385|NCT00186277|Docetaxel|docetaxel|mesh-list
2267386|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
2267387|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267388|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
2267389|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
2790687|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790688|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2790689|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
2790690|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2790691|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790692|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2790693|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2790694|NCT04292119|Crizotinib|crizotinib|mesh-list
2790695|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790696|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2790697|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790698|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790699|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
2790700|NCT04292184|Antidotes|antidotes|mesh-ancestor
2790701|NCT04292184|Protective Agents|protective agents|mesh-ancestor
2790702|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790703|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
2790704|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790705|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
2790706|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2790707|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790708|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
2790709|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
2790710|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
2790711|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
2790712|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2790713|NCT04292236|Protective Agents|protective agents|mesh-ancestor
2790714|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790715|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790716|NCT04292054|Cefazolin|cefazolin|mesh-list
2790717|NCT04292054|Tazobactam|tazobactam|mesh-list
2790718|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2790719|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790720|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2790721|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790722|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267390|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
2772599|NCT04421742|Beclomethasone|beclomethasone|mesh-list
2772600|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
2772601|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2772602|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
2772603|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772604|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772605|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2772606|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
2772607|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2772608|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2772609|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2267391|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267392|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2267393|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
2267394|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772610|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
2772611|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772612|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772613|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2772614|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
2772615|NCT04421742|Hormones|hormones|mesh-ancestor
2267395|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2267396|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
2267397|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267398|NCT00186420|Docetaxel|docetaxel|mesh-list
2267399|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267400|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
2772616|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2772617|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2772618|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772619|NCT04421547|Letrozole|letrozole|mesh-list
2772620|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772621|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2772622|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2772623|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772624|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772625|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2772626|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
2772627|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2772628|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772629|NCT04421339|Melatonin|melatonin|mesh-list
2772630|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
2772631|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772632|NCT04421339|Protective Agents|protective agents|mesh-ancestor
2772633|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772634|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2772635|NCT04421534|Lactoferrin|lactoferrin|mesh-list
2772636|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772637|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2772638|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
2772639|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2772640|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2772641|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
2772642|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772643|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
2772644|NCT04421300|Protective Agents|protective agents|mesh-ancestor
2772645|NCT04421209|Propranolol|propranolol|mesh-list
2772646|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2772647|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2772648|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
2772649|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772650|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772651|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772652|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2772653|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2772654|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
2772655|NCT04421079|Resveratrol|resveratrol|mesh-list
2772656|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
2772657|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772658|NCT04421079|Protective Agents|protective agents|mesh-ancestor
2772659|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772660|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772661|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2772662|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
2772663|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
2772664|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772665|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2772666|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2772667|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
2772668|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772669|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772670|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2772671|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
2772672|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2772673|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772674|NCT04420975|Nivolumab|nivolumab|mesh-list
2267401|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
2267402|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
2267403|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267404|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2267405|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
2267406|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772675|NCT04420975|Immunologic Factors|immunologic factors|mesh-list
2772676|NCT04420975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
2772677|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2772678|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772679|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2772680|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772681|NCT04420975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772682|NCT04420598|Trastuzumab|trastuzumab|mesh-list
2772683|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2772684|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772685|NCT04420936|Benzocaine|benzocaine|mesh-list
2772686|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
2772687|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
2772688|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2772689|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772690|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
2772691|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772692|NCT04420871|Capecitabine|capecitabine|mesh-list
2267407|NCT00186706|Selenium|selenium|mesh-list
2267408|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
2267409|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267410|NCT00186706|Protective Agents|protective agents|mesh-ancestor
2267411|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267412|NCT00186706|Trace Elements|trace elements|mesh-ancestor
2267413|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
2267414|NCT00186745|Tinzaparin|tinzaparin|mesh-list
2267415|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2267416|NCT00186745|Dalteparin|dalteparin|mesh-list
2772693|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2772694|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
2772695|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772696|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772697|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2772698|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
2772699|NCT04420585|Coagulants|coagulants|mesh-ancestor
2772700|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2772701|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
2772702|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772703|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
2772704|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
2772705|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772715|NCT04420533|Mirabegron|mirabegron|mesh-list
2772716|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2772717|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2772718|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2772719|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
2772720|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772721|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267417|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
2267418|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2267419|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2267420|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267421|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
2267422|NCT00186797|Fludarabine|fludarabine|mesh-list
2267423|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267424|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
2267425|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267426|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267427|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2267428|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
2267429|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267430|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267431|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2267432|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
2267433|NCT00186810|Busulfan|busulfan|mesh-list
2267434|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267435|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
2267436|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267437|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267438|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2267439|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
2267440|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267441|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772722|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772723|NCT04420533|Urological Agents|urological agents|mesh-ancestor
2772724|NCT04419948|Ibuprofen|ibuprofen|mesh-list
2772725|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2772726|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2772727|NCT04419948|Analgesics|analgesics|mesh-ancestor
2772728|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
2267442|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2267443|NCT00186823|Antibodies|antibodies|mesh-list
2267444|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
2267445|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267446|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
2267447|NCT00186849|Ifosfamide|ifosfamide|mesh-list
2267448|NCT00186849|Carboplatin|carboplatin|mesh-list
2267449|NCT00186849|Doxorubicin|doxorubicin|mesh-list
2267450|NCT00186849|Etoposide|etoposide|mesh-list
2267451|NCT00186849|Topotecan|topotecan|mesh-list
2267452|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267453|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
2267454|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267455|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267456|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2267457|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
2267458|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772729|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772730|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772731|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2772732|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772733|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2772734|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772735|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772736|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2772737|NCT04420299|Bemiparin|bemiparin|mesh-list
2772738|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
2772739|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2772740|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2772741|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772742|NCT04420195|Tacrolimus|tacrolimus|mesh-list
2772743|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2772744|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
2772745|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772746|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2772747|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772748|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772749|NCT04420351|Aspirin|aspirin|mesh-list
2772750|NCT04420351|Clopidogrel|clopidogrel|mesh-list
2772751|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2772752|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2267459|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267460|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2267461|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2267462|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2267463|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2267464|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267465|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2267466|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2267467|NCT00186862|Interleukin-2|interleukin-2|mesh-list
2267468|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267469|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2267470|NCT00186862|Analgesics|analgesics|mesh-ancestor
2267471|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
2267472|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772753|NCT04420351|Analgesics|analgesics|mesh-ancestor
2772754|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
2772755|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772756|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772757|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2772758|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772759|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2772760|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2772761|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772762|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2772763|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2772764|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772765|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
2772766|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2772767|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2772768|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2772769|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
2772770|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790723|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
2790724|NCT04292314|Deferoxamine|deferoxamine|mesh-list
2790725|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790726|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
2790727|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790728|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790729|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2790730|NCT04292314|Siderophores|siderophores|mesh-ancestor
2790731|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2267473|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267474|NCT00186940|Rasburicase|rasburicase|mesh-list
2267475|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
2267476|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267477|NCT00186966|Cytarabine|cytarabine|mesh-list
2267478|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
2267479|NCT00186966|Melphalan|melphalan|mesh-list
2267480|NCT00186966|Busulfan|busulfan|mesh-list
2267481|NCT00186966|Fludarabine|fludarabine|mesh-list
2267482|NCT00186966|Etoposide|etoposide|mesh-list
2267483|NCT00186966|Daunorubicin|daunorubicin|mesh-list
2267484|NCT00186966|Thioguanine|thioguanine|mesh-list
2267485|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267486|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
2267487|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267488|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267489|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2267490|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
2267491|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790732|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
2790733|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
2790734|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2790735|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
2790736|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2790737|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
2790738|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790739|NCT04291794|Propofol|propofol|mesh-list
2790740|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2790741|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790742|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790743|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2790744|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
2790745|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
2790746|NCT04291729|Interferons|interferons|mesh-list
2790747|NCT04291729|Ritonavir|ritonavir|mesh-list
2267492|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267493|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2267494|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2772771|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
2772772|NCT04420247|Chloroquine|chloroquine|mesh-list
2772773|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
2772774|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2772775|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2772776|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772777|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772778|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772779|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772780|NCT04420247|Amebicides|amebicides|mesh-ancestor
2772781|NCT04419662|Phenylephrine|phenylephrine|mesh-list
2772782|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
2772783|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2772784|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
2772785|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
2772786|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772787|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772788|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
2772789|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2772790|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
2772791|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
2772792|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2772793|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2772794|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2267495|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
2267496|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2267497|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2267498|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2267499|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267500|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
2772795|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
2772796|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772797|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772798|NCT04419662|Protective Agents|protective agents|mesh-ancestor
2772799|NCT04419493|Heparin|heparin|mesh-list
2772800|NCT04419493|Calcium heparin|calcium heparin|mesh-list
2772801|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2772802|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
2772803|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2772804|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2772805|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772806|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2772807|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772808|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772809|NCT04419181|Carboplatin|carboplatin|mesh-list
2772810|NCT04419181|Docetaxel|docetaxel|mesh-list
2772811|NCT04419181|Trastuzumab|trastuzumab|mesh-list
2772812|NCT04419181|Pertuzumab|pertuzumab|mesh-list
2772813|NCT04419181|Maytansine|maytansine|mesh-list
2772814|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2772815|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772816|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
2267501|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267502|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2267503|NCT00186979|Cefixime|cefixime|mesh-list
2772817|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
2772818|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
2772819|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772820|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2772821|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2772822|NCT04419259|Erenumab|erenumab|mesh-list
2772823|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2772824|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772825|NCT04419259|Analgesics|analgesics|mesh-ancestor
2772826|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
2267504|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
2267505|NCT00186979|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
2267506|NCT00186979|Irinotecan|irinotecan|mesh-list
2267507|NCT00186979|Vincristine|vincristine|mesh-list
2267508|NCT00186979|Gefitinib|gefitinib|mesh-list
2267509|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2267510|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2267511|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772827|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772828|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267512|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772829|NCT04419389|Rituximab|rituximab|mesh-list
2772830|NCT04419389|Venetoclax|venetoclax|mesh-list
2772831|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
2772832|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2772833|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772834|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
2772835|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772836|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772837|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
2772838|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2772839|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2267513|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267514|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2267515|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
2267516|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
2267517|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
2267518|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2267519|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2772840|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772841|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
2772842|NCT04419246|Coagulants|coagulants|mesh-ancestor
2267520|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267521|NCT00187005|Cytarabine|cytarabine|mesh-list
2267522|NCT00187005|Dexamethasone|dexamethasone|mesh-list
2267523|NCT00187005|Prednisone|prednisone|mesh-list
2267524|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
2267525|NCT00187005|Methotrexate|methotrexate|mesh-list
2267526|NCT00187005|Etoposide|etoposide|mesh-list
2267527|NCT00187005|Vincristine|vincristine|mesh-list
2267528|NCT00187005|Daunorubicin|daunorubicin|mesh-list
2267529|NCT00187005|Asparaginase|asparaginase|mesh-list
2267530|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
2267531|NCT00187005|Idarubicin|idarubicin|mesh-list
2267532|NCT00187005|Pegaspargase|pegaspargase|mesh-list
2267533|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267534|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
2267535|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267536|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267537|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2267538|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
2267539|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267540|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267541|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2267542|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2267543|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
2267544|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
2267545|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267546|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2267547|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
2267548|NCT00187005|Hormones|hormones|mesh-ancestor
2267549|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2267550|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2267551|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2267552|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
2267553|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2267554|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2267555|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
2267556|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
2267557|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267558|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2267559|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2267560|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2267561|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2267562|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2267563|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
2267564|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267565|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
2267566|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
2772849|NCT04419272|Methylphenidate|methylphenidate|mesh-list
2267567|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
2267568|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2267569|NCT00187031|Topotecan|topotecan|mesh-list
2772850|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2772851|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772852|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2772853|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2772854|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2772855|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772856|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
2772857|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772858|NCT04419038|Mitomycins|mitomycins|mesh-list
2772859|NCT04419038|Mitomycin|mitomycin|mesh-list
2772860|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2772861|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772862|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
2267570|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2267571|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2267572|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772863|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772864|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2772865|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772866|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2772867|NCT04418999|Dexamethasone|dexamethasone|mesh-list
2772868|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2772869|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
2772870|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
2772871|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772872|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772873|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2772874|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
2772875|NCT04418999|Hormones|hormones|mesh-ancestor
2772876|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2772877|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2772878|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772879|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2772880|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
2772881|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2772882|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
2772883|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2772884|NCT04419025|Expectorants|expectorants|mesh-ancestor
2772885|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
2772886|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2772887|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
2772888|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772889|NCT04419025|Protective Agents|protective agents|mesh-ancestor
2772890|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772891|NCT04419025|Antidotes|antidotes|mesh-ancestor
2772892|NCT04418908|Cetrorelix|cetrorelix|mesh-list
2772893|NCT04418908|Estradiol|estradiol|mesh-list
2267573|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267574|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267575|NCT00187057|Cytarabine|cytarabine|mesh-list
2267576|NCT00187057|Dexamethasone|dexamethasone|mesh-list
2267577|NCT00187057|Prednisone|prednisone|mesh-list
2267578|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
2772894|NCT04418908|Estrogens|estrogens|mesh-ancestor
2772895|NCT04418908|Hormones|hormones|mesh-ancestor
2772896|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2772897|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772898|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2772899|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2772900|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
2772901|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
2772905|NCT04418856|Methamphetamine|methamphetamine|mesh-list
2772906|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2772907|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772908|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
2772909|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
2772910|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772911|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
2772912|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772913|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772914|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
2772915|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2772916|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2772917|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2772918|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2772919|NCT04418557|Antibodies|antibodies|mesh-list
2772920|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
2267579|NCT00187057|Doxorubicin|doxorubicin|mesh-list
2267580|NCT00187057|Methotrexate|methotrexate|mesh-list
2267581|NCT00187057|Etoposide|etoposide|mesh-list
2267582|NCT00187057|Vincristine|vincristine|mesh-list
2267583|NCT00187057|Daunorubicin|daunorubicin|mesh-list
2267584|NCT00187057|Asparaginase|asparaginase|mesh-list
2267585|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
2267586|NCT00187057|Vinblastine|vinblastine|mesh-list
2267587|NCT00187057|Procarbazine|procarbazine|mesh-list
2267588|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267589|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
2267590|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267591|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267592|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2267593|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
2267594|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267595|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267596|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2267597|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2267598|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
2267599|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
2267600|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267601|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2267602|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
2267603|NCT00187057|Hormones|hormones|mesh-ancestor
2267604|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2267605|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2267606|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2267607|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2267608|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2267609|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267610|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2267611|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
2267612|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2267613|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2267614|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
2267615|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
2267616|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2267617|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2267618|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2772921|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772922|NCT04418674|Fentanyl|fentanyl|mesh-list
2772923|NCT04418674|Ketamine|ketamine|mesh-list
2772924|NCT04418674|Analgesics|analgesics|mesh-ancestor
2772925|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
2772926|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2772927|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772928|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2772929|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2772930|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
2772931|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
2772932|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2772933|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2102006|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2102007|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2102008|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2772934|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2772935|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772936|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772937|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2772938|NCT04418674|Narcotics|narcotics|mesh-ancestor
2102009|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2102010|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
2102011|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102012|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102013|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102014|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
2102015|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
2102016|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102965|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2772939|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2772940|NCT04418531|Antibodies|antibodies|mesh-list
2772941|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
2772942|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2772943|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
2772944|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772945|NCT04418466|Risperidone|risperidone|mesh-list
2772946|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2772947|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
2772948|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2772949|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772950|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772951|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2772952|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2772953|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2772954|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2772955|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2772956|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
2790748|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790749|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
2790750|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790751|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2790752|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2790753|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
2790754|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790755|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790756|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2790757|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2790758|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2790759|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2790760|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2790761|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2790762|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790763|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
2790764|NCT04291820|Anesthetics|anesthetics|mesh-list
2790765|NCT04291820|Sevoflurane|sevoflurane|mesh-list
2790766|NCT04291820|Desflurane|desflurane|mesh-list
2790767|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790768|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790769|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2790770|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2790771|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
2790775|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
2267619|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
2267620|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267621|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
2267622|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
2267623|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
2267624|NCT00187070|Cytarabine|cytarabine|mesh-list
2267625|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2790776|NCT04291755|Nivolumab|nivolumab|mesh-list
2790777|NCT04291755|Ipilimumab|ipilimumab|mesh-list
2790778|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2790779|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790780|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2790781|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790782|NCT04291664|Prednisone|prednisone|mesh-list
2790783|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
2790784|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2790785|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
2790786|NCT04291664|Hormones|hormones|mesh-ancestor
2790787|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2790788|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790789|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2790790|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790791|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2790792|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790793|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790794|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
2790795|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2790796|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
2790797|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2772957|NCT04418154|Paclitaxel|paclitaxel|mesh-list
2772958|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
2772959|NCT04418154|Epirubicin|epirubicin|mesh-list
2772960|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2772961|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2772962|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772963|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
2772964|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
2772965|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
2772966|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772967|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2772968|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
2772969|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772970|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772971|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2772972|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
2772973|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2772974|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2772975|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2772976|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2772977|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2772978|NCT04418180|Fenofibrate|fenofibrate|mesh-list
2772979|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2772980|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
2772981|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772982|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2772983|NCT04418219|Interferons|interferons|mesh-list
2772984|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
2772985|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
2772986|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
2772987|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
2772988|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2772989|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
2772990|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2772991|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2772992|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2772993|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
2772994|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2772995|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2772996|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2772997|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2772998|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
2772999|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102017|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102018|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267626|NCT00187070|Dexamethasone|dexamethasone|mesh-list
2267627|NCT00187070|Prednisone|prednisone|mesh-list
2267628|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
2773007|NCT04418128|Nafamostat|nafamostat|mesh-list
2773008|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2773009|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2773010|NCT04418128|Analgesics|analgesics|mesh-ancestor
2773011|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
2773012|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773013|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773014|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2773015|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2773016|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
2773017|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
2773018|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773019|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773020|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2773021|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2773022|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2773023|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2773024|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
2773025|NCT04417920|Mitomycins|mitomycins|mesh-list
2773026|NCT04417920|Mitomycin|mitomycin|mesh-list
2773027|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2773028|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773029|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
2773030|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773031|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2773032|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773033|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2773034|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2773035|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773036|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
2773037|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773038|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773039|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
2773040|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773041|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2773042|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2773043|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773044|NCT04418089|Simvastatin|simvastatin|mesh-list
2773045|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2773046|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2773047|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
2773048|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773049|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2773050|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2773051|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773052|NCT04417582|Liraglutide|liraglutide|mesh-list
2773053|NCT04417582|Orlistat|orlistat|mesh-list
2773054|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2773055|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773056|NCT04417582|Incretins|incretins|mesh-ancestor
2773057|NCT04417582|Hormones|hormones|mesh-ancestor
2773058|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773059|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773060|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773061|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2773062|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2773063|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
2773064|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773065|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773066|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773067|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
2773068|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2773069|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
2773070|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773071|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2773072|NCT04417569|Estradiol|estradiol|mesh-list
2773073|NCT04417569|Progesterone|progesterone|mesh-list
2773074|NCT04417569|Hormones|hormones|mesh-ancestor
2773075|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773076|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773077|NCT04417569|Estrogens|estrogens|mesh-ancestor
2773078|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2773079|NCT04417569|Progestins|progestins|mesh-ancestor
2773080|NCT04417361|Erenumab|erenumab|mesh-list
2267629|NCT00187070|Ifosfamide|ifosfamide|mesh-list
2267630|NCT00187070|Carboplatin|carboplatin|mesh-list
2267631|NCT00187070|Doxorubicin|doxorubicin|mesh-list
2267632|NCT00187070|Methotrexate|methotrexate|mesh-list
2267633|NCT00187070|Etoposide|etoposide|mesh-list
2267634|NCT00187070|Vincristine|vincristine|mesh-list
2267635|NCT00187070|Vinblastine|vinblastine|mesh-list
2267636|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267637|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
2267638|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267639|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267640|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2267641|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
2267642|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267643|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267644|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2267645|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2267646|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
2267647|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
2267648|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267649|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2267650|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
2267651|NCT00187070|Hormones|hormones|mesh-ancestor
2773081|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2773082|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773083|NCT04417361|Analgesics|analgesics|mesh-ancestor
2773084|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
2773085|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773086|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773087|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
2773088|NCT04417192|Olaparib|olaparib|mesh-list
2773089|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2773090|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773091|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2773092|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773093|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267652|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2267653|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2267654|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2773094|NCT04417179|Bupivacaine|bupivacaine|mesh-list
2773095|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
2773096|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
2773097|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2773098|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773099|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
2773100|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267655|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2267656|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2267657|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267658|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2267659|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
2773101|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2773102|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2773103|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2773104|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
2773105|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773106|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2773107|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2773108|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773109|NCT04417517|Azacitidine|azacitidine|mesh-list
2773110|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2773111|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
2773112|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773113|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267660|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2267661|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2267662|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
2267663|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
2267664|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2267665|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2773114|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773115|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
2773116|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2773117|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773118|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773119|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2773120|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2773121|NCT04417049|Protective Agents|protective agents|mesh-ancestor
2773122|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773123|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
2773124|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2773125|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
2773126|NCT04417348|Tretinoin|tretinoin|mesh-list
2773127|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773128|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
2773129|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
2773130|NCT04417543|Memantine|memantine|mesh-list
2773131|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2773132|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2773133|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
2773134|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773135|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773136|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773137|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2773138|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2267666|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2267667|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
2267668|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267669|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
2267670|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
2267671|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
2267672|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2267673|NCT00187070|Renal Agents|renal agents|mesh-ancestor
2267674|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2267675|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
2267676|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2267677|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2267678|NCT00187083|Dexamethasone|dexamethasone|mesh-list
2267679|NCT00187083|Methotrexate|methotrexate|mesh-list
2267680|NCT00187083|Fludarabine|fludarabine|mesh-list
2267681|NCT00187083|Etoposide|etoposide|mesh-list
2267682|NCT00187083|Vincristine|vincristine|mesh-list
2267683|NCT00187083|Topotecan|topotecan|mesh-list
2267684|NCT00187083|Asparaginase|asparaginase|mesh-list
2773144|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
2773145|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773146|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2773147|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773148|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790798|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790799|NCT04291313|Vitamin D|vitamin d|mesh-list
2790800|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
2790801|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
2790802|NCT04291313|Vitamins|vitamins|mesh-list
2790803|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
2790804|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790805|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2790806|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2790807|NCT04291521|Ketamine|ketamine|mesh-list
2790808|NCT04291521|Propofol|propofol|mesh-list
2790809|NCT04291521|Etomidate|etomidate|mesh-list
2790810|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2790811|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790812|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790813|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2790814|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
2790815|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
2790816|NCT04291521|Analgesics|analgesics|mesh-ancestor
2790817|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
2790818|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790819|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2790820|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2790821|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2790822|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790823|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790841|NCT04291456|Minocycline|minocycline|mesh-list
2790842|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2790843|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267685|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
2267686|NCT00187083|Idarubicin|idarubicin|mesh-list
2267687|NCT00187083|Pegaspargase|pegaspargase|mesh-list
2267688|NCT00187083|Teniposide|teniposide|mesh-list
2773149|NCT04416568|Nivolumab|nivolumab|mesh-list
2773150|NCT04416568|Ipilimumab|ipilimumab|mesh-list
2773151|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2773152|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773153|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2773154|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773155|NCT04416334|Acetaminophen|acetaminophen|mesh-list
2773156|NCT04416334|Colchicine|colchicine|mesh-list
2773157|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2773158|NCT04416334|Analgesics|analgesics|mesh-ancestor
2773159|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
2773160|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773161|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773162|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
2773163|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
2773164|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2773165|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
2773166|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
2773167|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
2773168|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773169|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773170|NCT04416399|Budesonide|budesonide|mesh-list
2773171|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2773172|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2773173|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
2773174|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267689|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2267690|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
2267691|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
2267692|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267693|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267694|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2267695|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
2267696|NCT00187083|Hormones|hormones|mesh-ancestor
2773175|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773176|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2773177|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
2773178|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
2773179|NCT04416399|Hormones|hormones|mesh-ancestor
2773180|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773188|NCT04416607|Menotropins|menotropins|mesh-list
2773189|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2773190|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
2773191|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2773192|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773201|NCT04416269|Insulin|insulin|mesh-list
2773202|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2773203|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2773204|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773205|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2773206|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2773207|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773208|NCT04415944|Carboplatin|carboplatin|mesh-list
2773209|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773210|NCT04415840|Acetic Acid|acetic acid|mesh-list
2773211|NCT04415840|Retinol acetate|retinol acetate|mesh-list
2773212|NCT04415840|Lugol's solution|lugol's solution|mesh-list
2773213|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2773214|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773215|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2773216|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
2773217|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790844|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
2773218|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2773219|NCT04415840|Protective Agents|protective agents|mesh-ancestor
2773220|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773221|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
2773222|NCT04415840|Coagulants|coagulants|mesh-ancestor
2773223|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
2773224|NCT04415892|Capsaicin|capsaicin|mesh-list
2773225|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
2267697|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773226|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
2773227|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
2773228|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773229|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773230|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2773231|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773232|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2773233|NCT04415892|Protective Agents|protective agents|mesh-ancestor
2773234|NCT04415905|Propofol|propofol|mesh-list
2773235|NCT04415905|Sevoflurane|sevoflurane|mesh-list
2773236|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2773237|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2773238|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773239|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2773240|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
2773241|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
2773242|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2773243|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2773244|NCT04416035|Paclitaxel|paclitaxel|mesh-list
2773245|NCT04416035|Bevacizumab|bevacizumab|mesh-list
2773246|NCT04416035|Carboplatin|carboplatin|mesh-list
2773247|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2773248|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773249|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
2773250|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
2773251|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
2773252|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773253|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2773254|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2773255|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2773256|NCT04416035|Growth Substances|growth substances|mesh-ancestor
2773257|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773258|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
2773259|NCT04415983|Metronidazole|metronidazole|mesh-list
2773260|NCT04415983|Clarithromycin|clarithromycin|mesh-list
2773261|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
2773262|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2773263|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773264|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2773265|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2773266|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2773267|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2773268|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773269|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773270|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2773271|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2773272|NCT04415853|Irinotecan|irinotecan|mesh-list
2773273|NCT04415853|Tegafur|tegafur|mesh-list
2773274|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2773275|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2773276|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773277|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773278|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773279|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2773280|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
2773281|NCT04415567|Lenvatinib|lenvatinib|mesh-list
2773282|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773283|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2773284|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773285|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773286|NCT04415320|Ensartinib|ensartinib|mesh-list
2773287|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773288|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2773289|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773290|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773291|NCT04415333|Butyric Acid|butyric acid|mesh-list
2773292|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
2773293|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
2773294|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773295|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773296|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773297|NCT04415385|Apatinib|apatinib|mesh-list
2773298|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773299|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2773300|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773301|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773302|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
2267698|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2267699|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773303|NCT04415476|Sirolimus|sirolimus|mesh-list
2773304|NCT04415476|Prednisone|prednisone|mesh-list
2773305|NCT04415476|Tacrolimus|tacrolimus|mesh-list
2773306|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2773307|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
2773308|NCT04415476|Hormones|hormones|mesh-ancestor
2773309|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773310|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773311|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2773312|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773313|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2773314|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
2773315|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2773316|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773317|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773318|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2773319|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2773320|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
2773321|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2773322|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773323|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
2773324|NCT04414748|Cetrorelix|cetrorelix|mesh-list
2773325|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
2773326|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2773327|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
2773328|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2267700|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2267701|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
2267702|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2267703|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2267704|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
2267705|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267706|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
2773329|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773330|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
2773331|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773332|NCT04414748|Progestins|progestins|mesh-ancestor
2773333|NCT04414748|Hormones|hormones|mesh-ancestor
2790845|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2790846|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
2790847|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790848|NCT04291209|Expectorants|expectorants|mesh-ancestor
2790849|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
2790850|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2790851|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
2790852|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790853|NCT04291209|Protective Agents|protective agents|mesh-ancestor
2790854|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790855|NCT04291209|Antidotes|antidotes|mesh-ancestor
2792836|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792837|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792838|NCT04275180|Argatroban|argatroban|mesh-list
2792839|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
2792840|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2792841|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
2792842|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792843|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792844|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
2792845|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2792846|NCT04274933|Capecitabine|capecitabine|mesh-list
2792847|NCT04274933|Venetoclax|venetoclax|mesh-list
2792848|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2792849|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
2773334|NCT04414995|Acetaminophen|acetaminophen|mesh-list
2773335|NCT04414995|Ibuprofen|ibuprofen|mesh-list
2773336|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2773337|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2773338|NCT04414995|Analgesics|analgesics|mesh-ancestor
2773339|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
2773340|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773341|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773342|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2773343|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2773344|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2267707|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267708|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2267709|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267710|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
2267711|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267712|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2267713|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2267714|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2267715|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2267716|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
2267717|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
2267718|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
2267719|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2267720|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2267721|NCT00187122|Cytarabine|cytarabine|mesh-list
2267722|NCT00187122|Dexamethasone|dexamethasone|mesh-list
2267723|NCT00187122|Prednisone|prednisone|mesh-list
2267724|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
2267725|NCT00187122|Methotrexate|methotrexate|mesh-list
2267726|NCT00187122|Etoposide|etoposide|mesh-list
2267727|NCT00187122|Vincristine|vincristine|mesh-list
2267728|NCT00187122|Asparaginase|asparaginase|mesh-list
2267729|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
2267730|NCT00187122|Daunorubicin|daunorubicin|mesh-list
2267731|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2773345|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773346|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773347|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
2773348|NCT04414852|Apatinib|apatinib|mesh-list
2773349|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773350|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2773351|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773352|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773353|NCT04415008|Cytarabine|cytarabine|mesh-list
2773354|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2773355|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
2773356|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773357|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773358|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
2773359|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773360|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2773361|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
2773362|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773372|NCT04414969|Asparaginase|asparaginase|mesh-list
2773373|NCT04414969|Pegaspargase|pegaspargase|mesh-list
2773374|NCT04414969|Antibodies|antibodies|mesh-list
2773375|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
2773376|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
2773377|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773378|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773379|NCT04415060|Sevoflurane|sevoflurane|mesh-list
2773380|NCT04415060|Isoflurane|isoflurane|mesh-list
2773381|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2773382|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2773383|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
2773384|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
2267732|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
2267733|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773385|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2773386|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773387|NCT04414956|Vitamin K|vitamin k|mesh-list
2773388|NCT04414956|Agglutinins|agglutinins|mesh-list
2773389|NCT04414956|Vitamins|vitamins|mesh-ancestor
2773390|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
2773391|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267734|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267735|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2267736|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
2267737|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267738|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267739|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2267740|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2267741|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
2267742|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
2267743|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773392|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2773393|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2773394|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773395|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
2773396|NCT04414956|Coagulants|coagulants|mesh-ancestor
2773397|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
2773398|NCT04414800|Fentanyl|fentanyl|mesh-list
2773399|NCT04414800|Ketamine|ketamine|mesh-list
2773400|NCT04414800|Analgesics|analgesics|mesh-ancestor
2773401|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
2773402|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773403|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773404|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2773405|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2773406|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
2773407|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
2773408|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2773409|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2773410|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2773411|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773412|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773413|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2773414|NCT04414800|Narcotics|narcotics|mesh-ancestor
2773415|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2773416|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2773417|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
2773418|NCT04414761|Cetrorelix|cetrorelix|mesh-list
2773419|NCT04414761|Progesterone|progesterone|mesh-list
2773420|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
2773421|NCT04414761|Ganirelix|ganirelix|mesh-list
2773422|NCT04414761|Progestins|progestins|mesh-ancestor
2773423|NCT04414761|Hormones|hormones|mesh-ancestor
2773424|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773425|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773426|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2773427|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2773428|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2773429|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
2773430|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2773431|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2773432|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2773433|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2773434|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2773435|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773436|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
2773437|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2773438|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
2773439|NCT04414943|Ketamine|ketamine|mesh-list
2773440|NCT04414943|Esketamine|esketamine|mesh-list
2773441|NCT04414943|Analgesics|analgesics|mesh-ancestor
2773442|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
2773443|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773444|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773445|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2773446|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2773447|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
2773448|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
2773449|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2773450|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2773451|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2773452|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773453|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773454|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
2773455|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2773456|NCT04414540|Metformin|metformin|mesh-list
2773457|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
2773458|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2773459|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773460|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2773461|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773462|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2773463|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
2773464|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773465|NCT04414566|Gemcitabine|gemcitabine|mesh-list
2773466|NCT04414566|Cisplatin|cisplatin|mesh-list
2773467|NCT04414566|Docetaxel|docetaxel|mesh-list
2773468|NCT04414566|Fluorouracil|fluorouracil|mesh-list
2773469|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773470|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2773471|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
2773472|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773473|NCT04414566|Antiviral Agents|antiviral agents|mesh-ancestor
2773474|NCT04414566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773475|NCT04414566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773476|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2773477|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
2773478|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267744|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2267745|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
2267746|NCT00187122|Hormones|hormones|mesh-ancestor
2267747|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2267748|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2773479|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
2773480|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
2773481|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
2773482|NCT04414579|Insulin|insulin|mesh-list
2773483|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2773484|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
2773485|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
2773486|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2773487|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2773488|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773489|NCT04414228|Anesthetics|anesthetics|mesh-list
2773490|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2773491|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773492|NCT04414254|Cefprozil|cefprozil|mesh-list
2773493|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2773494|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773495|NCT04414267|Vaccines|vaccines|mesh-list
2773496|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
2773497|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
2773498|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773499|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2773500|NCT04413734|Gemcitabine|gemcitabine|mesh-list
2773501|NCT04413734|Cisplatin|cisplatin|mesh-list
2773502|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102019|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
2102020|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
2102021|NCT02400437|Dexamethasone|dexamethasone|mesh-list
2773503|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2773504|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
2773505|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773506|NCT04413734|Antiviral Agents|antiviral agents|mesh-ancestor
2773507|NCT04413734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773508|NCT04413734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773509|NCT04413734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2773510|NCT04413734|Immunologic Factors|immunologic factors|mesh-ancestor
2773511|NCT04413734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773512|NCT04413799|Lidocaine|lidocaine|mesh-list
2773513|NCT04413799|Ketamine|ketamine|mesh-list
2773514|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
2102022|NCT02400437|Rituximab|rituximab|mesh-list
2102023|NCT02400437|Ixazomib|ixazomib|mesh-list
2102024|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102025|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
2102026|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
2102027|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773515|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
2773516|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2773517|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773518|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
2773519|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773520|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2773521|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2773522|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2773523|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2773524|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773525|NCT04413799|Analgesics|analgesics|mesh-ancestor
2773526|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2773527|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2773528|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
2773529|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2773530|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2773531|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773532|NCT04413838|Nivolumab|nivolumab|mesh-list
2773533|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2773534|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773535|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2773536|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773537|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
2773538|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2773539|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2773540|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773541|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2773542|NCT04413864|Analgesics|analgesics|mesh-ancestor
2773543|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
2773544|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773545|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2773546|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2773547|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2773548|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
2773549|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773550|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773551|NCT04414020|Progesterone|progesterone|mesh-list
2773552|NCT04414020|Progestins|progestins|mesh-ancestor
2773553|NCT04414020|Hormones|hormones|mesh-ancestor
2773554|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773555|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773556|NCT04414137|Daptomycin|daptomycin|mesh-list
2773557|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2773558|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773559|NCT04413786|Oxytocin|oxytocin|mesh-list
2267749|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2267750|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
2267751|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2267752|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2267753|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
2267754|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
2267755|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267756|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2267757|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2267758|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2773560|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
2773561|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2773562|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773563|NCT04413890|Dinoprostone|dinoprostone|mesh-list
2267759|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2267760|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2267761|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
2267762|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267763|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
2267764|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
2267765|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
2773564|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
2773565|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2773566|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773567|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2773568|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773569|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2773570|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2267766|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2267767|NCT00187161|Cytarabine|cytarabine|mesh-list
2267768|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
2267769|NCT00187161|Doxorubicin|doxorubicin|mesh-list
2267770|NCT00187161|Methotrexate|methotrexate|mesh-list
2267771|NCT00187161|Etoposide|etoposide|mesh-list
2267772|NCT00187161|Vincristine|vincristine|mesh-list
2267773|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267774|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
2267775|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267776|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267777|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2267778|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
2267779|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267780|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267781|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2267782|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2267783|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2267784|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2267785|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267786|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2267787|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
2267788|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2267789|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2267790|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
2267791|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
2267792|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2267793|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2267794|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2267795|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
2267796|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267797|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
2267798|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
2267799|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
2267800|NCT00187174|Everolimus|everolimus|mesh-list
2267801|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267802|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267803|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
2267804|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267805|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
2773571|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773572|NCT04413253|Dexamethasone|dexamethasone|mesh-list
2773573|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2773574|NCT04413253|Lifitegrast|lifitegrast|mesh-list
2773575|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2773576|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2773577|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
2773578|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
2102028|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102029|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2102030|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
2773579|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773580|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773581|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2773582|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
2773583|NCT04413253|Hormones|hormones|mesh-ancestor
2773584|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773585|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2773586|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267806|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2267807|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
2267808|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267809|NCT00187330|Expectorants|expectorants|mesh-ancestor
2102031|NCT02400437|Hormones|hormones|mesh-ancestor
2102032|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102033|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102034|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102035|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2102036|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
2102037|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2102038|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
2102039|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102040|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102041|NCT02400580|Acetaminophen|acetaminophen|mesh-list
2102042|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2102043|NCT02400580|Analgesics|analgesics|mesh-ancestor
2267810|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
2267811|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2267812|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
2267813|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267814|NCT00187330|Protective Agents|protective agents|mesh-ancestor
2267815|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267816|NCT00187330|Antidotes|antidotes|mesh-ancestor
2267817|NCT00187408|Heparin|heparin|mesh-list
2267818|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2267819|NCT00187408|Tinzaparin|tinzaparin|mesh-list
2773587|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
2773588|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2773589|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
2773590|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773591|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773592|NCT04413227|Docetaxel|docetaxel|mesh-list
2773593|NCT04413227|Endostatins|endostatins|mesh-list
2773594|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773595|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
2773596|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
2773597|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
2773598|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773599|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2773600|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2773601|NCT04413227|Growth Substances|growth substances|mesh-ancestor
2773602|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773603|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
2267820|NCT00187408|Dalteparin|dalteparin|mesh-list
2267821|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
2267822|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2267823|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2267824|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267825|NCT00187447|Indomethacin|indomethacin|mesh-list
2267826|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2267827|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2267828|NCT00187447|Analgesics|analgesics|mesh-ancestor
2267829|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
2267830|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267831|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267832|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2267833|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2773604|NCT04413279|Dexamethasone|dexamethasone|mesh-list
2773605|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2773606|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
2773607|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
2773608|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773609|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773610|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2773611|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
2773612|NCT04413279|Hormones|hormones|mesh-ancestor
2773613|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773614|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2773615|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773616|NCT04413344|Bromocriptine|bromocriptine|mesh-list
2773617|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2773618|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2773619|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
2773620|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773621|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773622|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
2773623|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
2773624|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773625|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790856|NCT04290819|Caffeine|caffeine|mesh-list
2773659|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2773660|NCT04412876|Imipramine|imipramine|mesh-list
2773661|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2773662|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2773663|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2773664|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773665|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773666|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773667|NCT04412876|Analgesics|analgesics|mesh-ancestor
2773668|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
2773669|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773670|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
2773671|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2773672|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
2773673|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2773674|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2773675|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
2773676|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
2773677|NCT04412850|Analgesics|analgesics|mesh-ancestor
2773678|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
2773679|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773680|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773681|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
2773682|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2773683|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2773684|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
2773685|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2773686|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2773687|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773688|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2773689|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
2773690|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2773691|NCT04412538|Vaccines|vaccines|mesh-list
2773692|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
2773693|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773694|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
2267834|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
2267835|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
2267836|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2267837|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2267838|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267839|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267840|NCT00187499|Fluticasone|fluticasone|mesh-list
2267841|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2267842|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2267843|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
2267844|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267845|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267846|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2267847|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
2773695|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2773696|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
2773697|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
2773698|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2773699|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773700|NCT04412694|Dexamethasone|dexamethasone|mesh-list
2773701|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
2773702|NCT04412694|BB 1101|bb 1101|mesh-list
2267848|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
2267849|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2267850|NCT00187525|Memantine|memantine|mesh-list
2267851|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2773703|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2773704|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
2773705|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
2773706|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773707|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773708|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2773709|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
2773710|NCT04412694|Hormones|hormones|mesh-ancestor
2773711|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773712|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2773713|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773714|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
2773715|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773716|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773717|NCT04412421|Vitamins|vitamins|mesh-list
2773718|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
2773719|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773720|NCT04412304|Dalteparin|dalteparin|mesh-list
2773721|NCT04412304|Tinzaparin|tinzaparin|mesh-list
2773722|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2773723|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
2773724|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2773725|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2773726|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773727|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2773728|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2773729|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773730|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2773731|NCT04412148|Triamcinolone|triamcinolone|mesh-list
2773732|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2773733|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2773734|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2773735|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2773736|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
2773737|NCT04412148|Hormones|hormones|mesh-ancestor
2773738|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773739|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773740|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2773741|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
2773742|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773743|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773744|NCT04411953|Haloperidol|haloperidol|mesh-list
2773745|NCT04411953|Benztropine|benztropine|mesh-list
2773746|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
2773747|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
2773748|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
2773749|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773750|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773751|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2773752|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2773753|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2102044|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
2102045|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102046|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102047|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
2102048|NCT02400749|Apremilast|apremilast|mesh-list
2102049|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2102050|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2102051|NCT02400749|Analgesics|analgesics|mesh-ancestor
2102052|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
2102053|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102054|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773754|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2773755|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2773756|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2773757|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
2267852|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2267853|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
2267854|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2267855|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267856|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267857|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2267858|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2773758|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773759|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773760|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2773761|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2773762|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
2773763|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2773764|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2773765|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
2773766|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2773767|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2773768|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2773769|NCT04412096|Timolol|timolol|mesh-list
2773770|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2773771|NCT04412096|Latanoprost|latanoprost|mesh-list
2773772|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2773773|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2773774|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2773775|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
2773776|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773777|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773778|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773779|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2773780|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2773781|NCT04411940|Haloperidol|haloperidol|mesh-list
2267859|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
2267860|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2267861|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2267862|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267863|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2267864|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2267865|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
2267866|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267867|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
2267868|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
2267869|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267870|NCT00187564|Protective Agents|protective agents|mesh-ancestor
2267871|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267872|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
2267873|NCT00187564|Vitamins|vitamins|mesh-ancestor
2267874|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
2267875|NCT00187577|Bimatoprost|bimatoprost|mesh-list
2267876|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2267877|NCT00187577|Latanoprost|latanoprost|mesh-list
2267878|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2267879|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2267880|NCT00187707|Gabapentin|gabapentin|mesh-list
2267881|NCT00187707|Analgesics|analgesics|mesh-ancestor
2267882|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
2267883|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267884|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773782|NCT04411940|Benztropine|benztropine|mesh-list
2773783|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
2773784|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
2773785|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
2773786|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773787|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773788|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2773789|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2773790|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2773791|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2773792|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2267885|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
2267886|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2773793|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2773794|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
2773795|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773796|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267887|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2773797|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2773798|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2773799|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
2773800|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2773801|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2773802|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
2773803|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2773804|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2773805|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2773806|NCT04412252|Tofacitinib|tofacitinib|mesh-list
2773807|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2773808|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773809|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773810|NCT04411875|Amlodipine|amlodipine|mesh-list
2773811|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2773812|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2773813|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2773814|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773815|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2773816|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773817|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
2773818|NCT04411836|Primaquine|primaquine|mesh-list
2267888|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2267889|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2267890|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2773819|NCT04411836|Tafenoquine|tafenoquine|mesh-list
2773820|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
2773821|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2773822|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2773823|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773824|NCT04411680|Sargramostim|sargramostim|mesh-list
2773825|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
2773826|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773827|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
2773828|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
2773829|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2773830|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773831|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773832|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773833|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2773834|NCT04411654|Sirolimus|sirolimus|mesh-list
2773835|NCT04411654|Prednisone|prednisone|mesh-list
2773836|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
2267891|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2267892|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2267893|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267894|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
2773837|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2773838|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2773839|NCT04411654|Prednisolone|prednisolone|mesh-list
2773840|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
2773841|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2773842|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
2773843|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2773844|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
2773845|NCT04411654|Hormones|hormones|mesh-ancestor
2773846|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773847|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773848|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2773849|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773850|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2773851|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773852|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2773853|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
2773854|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2773855|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
2773856|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
2773857|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
2773858|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773859|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2773860|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2773861|NCT04411654|Protective Agents|protective agents|mesh-ancestor
2773862|NCT04411693|Dexamethasone|dexamethasone|mesh-list
2773863|NCT04411693|Aflibercept|aflibercept|mesh-list
2267895|NCT00187746|Adefovir|adefovir|mesh-list
2267896|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2267897|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
2267898|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267899|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2267900|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2267901|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267902|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267903|NCT00187759|Cephalexin|cephalexin|mesh-list
2267904|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2267905|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267906|NCT00187798|Metformin|metformin|mesh-list
2267907|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2267908|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267909|NCT00187915|Cyclosporine|cyclosporine|mesh-list
2267910|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
2267911|NCT00187915|Tacrolimus|tacrolimus|mesh-list
2267912|NCT00187915|Cyclosporins|cyclosporins|mesh-list
2773864|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2773865|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
2773866|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
2773867|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773868|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773869|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2773870|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
2773871|NCT04411693|Hormones|hormones|mesh-ancestor
2773872|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773873|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2773874|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773875|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2773876|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2773877|NCT04411693|Growth Substances|growth substances|mesh-ancestor
2773878|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
2790857|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2790858|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790859|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2790860|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790861|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790862|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2790863|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2790864|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
2790865|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790866|NCT04290936|Tenofovir|tenofovir|mesh-list
2790867|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
2790868|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790869|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2790870|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2790871|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790872|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790873|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2790874|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2790875|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
2790876|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2790877|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
2790878|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790879|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790880|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2790881|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
2790882|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2790883|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
2790884|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790885|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790886|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2790887|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
2790888|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
2790889|NCT04290871|Protective Agents|protective agents|mesh-ancestor
2790890|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
2790891|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2790892|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790893|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
2790894|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790895|NCT04291066|Expectorants|expectorants|mesh-ancestor
2790896|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
2790897|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2790898|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
2790899|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267913|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2773879|NCT04411706|Capecitabine|capecitabine|mesh-list
2773880|NCT04411706|Apatinib|apatinib|mesh-list
2773881|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2773882|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
2773883|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773884|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773885|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2773886|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773887|NCT04411524|Capecitabine|capecitabine|mesh-list
2773888|NCT04411524|Irinotecan|irinotecan|mesh-list
2773889|NCT04411524|Antibodies|antibodies|mesh-list
2773890|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
2773891|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773892|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2773893|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
2773894|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773895|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773896|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2773897|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2773898|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773899|NCT04411550|Pertuzumab|pertuzumab|mesh-list
2267914|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
2267915|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267916|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2267917|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267918|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267919|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
2267920|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2267921|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
2267922|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267923|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2267924|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267925|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2267926|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
2267927|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2267928|NCT00187928|Topiramate|topiramate|mesh-list
2267929|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
2773900|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2773901|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773902|NCT04411862|Choline|choline|mesh-list
2773903|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
2773904|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2773905|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
2773906|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773907|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2773908|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2773909|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
2773910|NCT04411758|Propolis|propolis|mesh-list
2773911|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773912|NCT04411537|Capecitabine|capecitabine|mesh-list
2773913|NCT04411537|Irinotecan|irinotecan|mesh-list
2773914|NCT04411537|Antibodies|antibodies|mesh-list
2773915|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
2773916|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773917|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2773918|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
2773919|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773920|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773921|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2773922|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2773923|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773924|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
2773925|NCT04411901|Vitamin D|vitamin d|mesh-list
2267930|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2267931|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267932|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
2267933|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2267934|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267935|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2267936|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
2267937|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2267938|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773926|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2773927|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773928|NCT04411901|Vitamins|vitamins|mesh-ancestor
2773929|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
2773930|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2773931|NCT04411433|Azithromycin|azithromycin|mesh-list
2773932|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
2773933|NCT04411433|Favipiravir|favipiravir|mesh-list
2102055|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102056|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2102057|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2102058|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2102059|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102060|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102061|NCT02401048|Durvalumab|durvalumab|mesh-list
2102062|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2102063|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102064|NCT02401230|Tenofovir|tenofovir|mesh-list
2102065|NCT02401230|Emtricitabine|emtricitabine|mesh-list
2102066|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2102067|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
2102068|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102069|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2267939|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267940|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267941|NCT00187993|Hormones|hormones|mesh-list
2267942|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2267943|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267944|NCT00188006|Heparin|heparin|mesh-list
2267945|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
2267946|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2267947|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2267948|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267949|NCT00188045|Propranolol|propranolol|mesh-list
2267950|NCT00188045|Spironolactone|spironolactone|mesh-list
2267951|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2267952|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2267953|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
2267954|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2267955|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773934|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2773935|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2773936|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
2773937|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2773938|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2773939|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2773940|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773941|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2773942|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
2773943|NCT04411446|Vitamin D|vitamin d|mesh-list
2773944|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
2773945|NCT04411446|Vitamins|vitamins|mesh-ancestor
2773946|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
2773947|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773948|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2773949|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2773950|NCT04411329|Dexamethasone|dexamethasone|mesh-list
2773951|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
2773952|NCT04411329|Bupivacaine|bupivacaine|mesh-list
2773953|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2773954|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
2773955|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
2773956|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773957|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773958|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2773959|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
2773960|NCT04411329|Hormones|hormones|mesh-ancestor
2773961|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2773962|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2773963|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2773964|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
2773965|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
2773966|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2773967|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
2773968|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2773969|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2773970|NCT04411329|Analgesics|analgesics|mesh-ancestor
2773971|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2773972|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2773973|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2773974|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
2773975|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773976|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773977|NCT04411225|Cannabidiol|cannabidiol|mesh-list
2773978|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
2773979|NCT04411160|Ascorbic Acid|ascorbic acid|mesh-list
2773980|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
2773981|NCT04411160|Vitamins|vitamins|mesh-ancestor
2773982|NCT04411160|Micronutrients|micronutrients|mesh-ancestor
2773983|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2773984|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
2773985|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2773986|NCT04411160|Protective Agents|protective agents|mesh-ancestor
2773987|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2773988|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
2773989|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2773990|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2773991|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
2773992|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2773993|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2773994|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2773995|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
2267956|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267957|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2267958|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2267959|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
2773996|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
2773997|NCT04411212|Sargramostim|sargramostim|mesh-list
2773998|NCT04411212|Lenograstim|lenograstim|mesh-list
2773999|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
2774000|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774001|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2774002|NCT04411069|Droperidol|droperidol|mesh-list
2774003|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2774004|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
2774005|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
2774006|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774007|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774008|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2774009|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2774010|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2774011|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2774012|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2774013|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2774014|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2774015|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
2774016|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774017|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774022|NCT04410874|Vaccines|vaccines|mesh-list
2774023|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
2774024|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267960|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2267961|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
2267962|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2267963|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2267964|NCT00188045|Diuretics|diuretics|mesh-ancestor
2267965|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
2267966|NCT00188071|Acetaminophen|acetaminophen|mesh-list
2267967|NCT00188071|Ketoprofen|ketoprofen|mesh-list
2774025|NCT04410887|Olaparib|olaparib|mesh-list
2774026|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2774027|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774028|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774029|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774030|NCT04410965|Teriflunomide|teriflunomide|mesh-list
2774031|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2774032|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2774033|NCT04410965|Analgesics|analgesics|mesh-ancestor
2774034|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
2774035|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774036|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774037|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2774038|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2774039|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2774040|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
2774041|NCT04411030|Itraconazole|itraconazole|mesh-list
2774042|NCT04411030|Midazolam|midazolam|mesh-list
2774043|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2774044|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2774045|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2774046|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774047|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2774048|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2774049|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2774050|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2774051|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
2774052|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
2774053|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
2774054|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
2774055|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774056|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774057|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
2774058|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774059|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2774060|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2774061|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774062|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2774063|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
2774064|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2774065|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2774066|NCT04410588|Fentanyl|fentanyl|mesh-list
2774067|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
2774068|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2774069|NCT04410588|Narcotics|narcotics|mesh-ancestor
2774070|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2774071|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774072|NCT04410588|Analgesics|analgesics|mesh-ancestor
2774073|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
2774074|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774075|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2774076|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2774077|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
2774078|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
2774079|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
2774080|NCT04410354|Remdesivir|remdesivir|mesh-list
2774081|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
2774082|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774083|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
2774084|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774085|NCT04410328|Aspirin|aspirin|mesh-list
2774086|NCT04410328|Dipyridamole|dipyridamole|mesh-list
2774087|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2774088|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2774089|NCT04410328|Analgesics|analgesics|mesh-ancestor
2774090|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
2774091|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774092|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774093|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2774094|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2774095|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2774096|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2774097|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774098|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2774099|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2774100|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774101|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
2774102|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2774103|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
2774104|NCT04410406|Ivermectin|ivermectin|mesh-list
2774105|NCT04410406|Albendazole|albendazole|mesh-list
2774106|NCT04410406|Moxidectin|moxidectin|mesh-list
2774107|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
2774108|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774109|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2774110|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774111|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
2774112|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
2774113|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2774114|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2774115|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
2774116|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
2774117|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
2774118|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774119|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
2774120|NCT04410406|Filaricides|filaricides|mesh-ancestor
2774121|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2774122|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790900|NCT04291066|Protective Agents|protective agents|mesh-ancestor
2790901|NCT04291066|Antidotes|antidotes|mesh-ancestor
2790902|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
2790903|NCT04291001|Etonogestrel|etonogestrel|mesh-list
2790904|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2790905|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
2790906|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2790907|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790908|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2790909|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
2790910|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2790911|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2790912|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790913|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
2790914|NCT04290884|Coagulants|coagulants|mesh-ancestor
2790915|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
2790916|NCT04290793|Trastuzumab|trastuzumab|mesh-list
2790917|NCT04290793|Epirubicin|epirubicin|mesh-list
2790918|NCT04290793|Taxane|taxane|mesh-list
2790919|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2790920|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
2790921|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790922|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2790923|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2790924|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
2790925|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790926|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790927|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2790928|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2790929|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2790930|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2790931|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2102070|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2102071|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102072|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102073|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2102074|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2102075|NCT02401256|Efavirenz|efavirenz|mesh-list
2102076|NCT02401256|Bupropion|bupropion|mesh-list
2102077|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2102078|NCT02401256|Montelukast|montelukast|mesh-list
2102079|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2102080|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2790932|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2790933|NCT04291079|Antibodies|antibodies|mesh-list
2774147|NCT04409964|Lidocaine|lidocaine|mesh-list
2774148|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
2774149|NCT04409964|Remifentanil|remifentanil|mesh-list
2774150|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
2774151|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
2774152|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2774153|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774154|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
2774155|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774156|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2774157|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2774158|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2774159|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2774160|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774161|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2774162|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2774163|NCT04409964|Analgesics|analgesics|mesh-ancestor
2774164|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2774165|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2774166|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2774167|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
2774168|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774169|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2774170|NCT04409964|Narcotics|narcotics|mesh-ancestor
2774171|NCT04409860|Paclitaxel|paclitaxel|mesh-list
2774172|NCT04409860|Cisplatin|cisplatin|mesh-list
2774173|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2267968|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2267969|NCT00188071|Analgesics|analgesics|mesh-ancestor
2774174|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774175|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
2774176|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
2774177|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
2774178|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774179|NCT04409912|Sirolimus|sirolimus|mesh-list
2774180|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2774181|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774182|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2774183|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774184|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
2774185|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2774186|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
2774187|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774188|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2774189|NCT04409873|Listerine|listerine|mesh-list
2774190|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
2774191|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
2774192|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2774193|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774194|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
2774195|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
2774196|NCT04410081|Lazertinib|lazertinib|mesh-list
2774197|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2774198|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774199|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267970|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
2267971|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2267972|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267973|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
2267974|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2267975|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2267976|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2267977|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2267978|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2267979|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267980|NCT00188136|Fludarabine|fludarabine|mesh-list
2267981|NCT00188136|Melphalan|melphalan|mesh-list
2267982|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2267983|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2267984|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2267985|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
2774200|NCT04410094|Itraconazole|itraconazole|mesh-list
2774201|NCT04410094|Rifampin|rifampin|mesh-list
2774202|NCT04410094|Lazertinib|lazertinib|mesh-list
2774203|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
2774204|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774205|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2774206|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2774207|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774208|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774209|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2774210|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
2774211|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2774212|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774213|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2774214|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2774215|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
2774216|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2774217|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
2774218|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2774219|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2774220|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2774221|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2774222|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2774223|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2774224|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2774225|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2774226|NCT04410211|Midazolam|midazolam|mesh-list
2774227|NCT04410211|Sevoflurane|sevoflurane|mesh-list
2774228|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2267986|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267987|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2267988|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
2267989|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2267990|NCT00188227|Midazolam|midazolam|mesh-list
2267991|NCT00188227|Pirinitramide|pirinitramide|mesh-list
2267992|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2267993|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2267994|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2267995|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2267996|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2267997|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2267998|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2267999|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2268000|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
2268001|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
2268002|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
2268003|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
2268004|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268005|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268006|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2268007|NCT00188227|Narcotics|narcotics|mesh-ancestor
2268008|NCT00188227|Analgesics|analgesics|mesh-ancestor
2268009|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
2268010|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268011|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2268012|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
2268013|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268014|NCT00188266|Fluorouracil|fluorouracil|mesh-list
2268015|NCT00188266|Cisplatin|cisplatin|mesh-list
2774229|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2774230|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2774231|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774232|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2774233|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2774234|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2774235|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2774236|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
2774237|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
2774238|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
2774239|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
2774240|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774241|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774242|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2774243|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2774244|NCT04409522|Melatonin|melatonin|mesh-list
2774245|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
2774246|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774247|NCT04409522|Protective Agents|protective agents|mesh-ancestor
2268016|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
2268017|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774248|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268018|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2268019|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268020|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268021|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
2268022|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268023|NCT00188383|Amantadine|amantadine|mesh-list
2774249|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2774250|NCT04409431|Epinephrine|epinephrine|mesh-list
2774251|NCT04409431|Racepinephrine|racepinephrine|mesh-list
2774252|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
2774253|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2774254|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2774255|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
2774256|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774257|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774258|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774259|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2774260|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2774261|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
2774262|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774263|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2774264|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
2774265|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
2774266|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
2774267|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2774268|NCT04409691|Sirolimus|sirolimus|mesh-list
2774269|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2774270|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774271|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2774272|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774273|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
2774274|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2774275|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
2774276|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774277|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
2774278|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2774279|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2774280|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774281|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
2774282|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774283|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268024|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2268025|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2268026|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
2268027|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268028|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
2268029|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268030|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268031|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268032|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2268033|NCT00188383|Analgesics|analgesics|mesh-ancestor
2268034|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
2268035|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774299|NCT04409769|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2774300|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
2774301|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2774302|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2774303|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268036|NCT00188396|Citalopram|citalopram|mesh-list
2774318|NCT04409223|Sunitinib|sunitinib|mesh-list
2774319|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774320|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2774321|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2774322|NCT04409223|Growth Substances|growth substances|mesh-ancestor
2774323|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774324|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
2774325|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2774326|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774327|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774328|NCT04409483|Ritonavir|ritonavir|mesh-list
2774329|NCT04409483|Lopinavir|lopinavir|mesh-list
2774330|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2774331|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2774332|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
2774333|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774334|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774335|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2774336|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2774337|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
2774338|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774339|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2774340|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2268037|NCT00188396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2268038|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268039|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268040|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268041|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268042|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
2268043|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774341|NCT04409262|Remdesivir|remdesivir|mesh-list
2774342|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
2774343|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774344|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
2774345|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774346|NCT04409327|Dactolisib|dactolisib|mesh-list
2774347|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774348|NCT04408586|Topiramate|topiramate|mesh-list
2774349|NCT04408586|Phentermine|phentermine|mesh-list
2774350|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
2774351|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2268044|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2268045|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
2268046|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268047|NCT00188539|Anesthetics|anesthetics|mesh-list
2268048|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2268049|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268050|NCT00188552|Tocopherols|tocopherols|mesh-list
2268051|NCT00188552|Vitamin E|vitamin e|mesh-list
2268052|NCT00188552|Tocotrienols|tocotrienols|mesh-list
2268053|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
2268054|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
2774352|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774353|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2774354|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
2774355|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2774356|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
2774357|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
2774358|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774359|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
2774360|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774361|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774362|NCT04408560|Acetaminophen|acetaminophen|mesh-list
2774363|NCT04408560|Analgesics|analgesics|mesh-list
2774364|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2774365|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
2774366|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774367|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774368|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
2774369|NCT04408989|Bevacizumab|bevacizumab|mesh-list
2774370|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2774371|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774372|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2774373|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2774374|NCT04408989|Growth Substances|growth substances|mesh-ancestor
2774375|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774376|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
2774377|NCT04408911|Midazolam|midazolam|mesh-list
2774378|NCT04408911|Lormetazepam|lormetazepam|mesh-list
2774379|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2774380|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2774381|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2774382|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774383|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2774384|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2774385|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2774386|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2774387|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
2774388|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
2774389|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
2774390|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
2774391|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774392|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774393|NCT04408508|Amoxicillin|amoxicillin|mesh-list
2774394|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2774395|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774396|NCT04408625|Sirolimus|sirolimus|mesh-list
2774397|NCT04408625|Prednisone|prednisone|mesh-list
2774398|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
2774399|NCT04408625|Rituximab|rituximab|mesh-list
2774400|NCT04408625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2774401|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774402|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
2774403|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774404|NCT04408625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2774405|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2774406|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
2774407|NCT04408625|Hormones|hormones|mesh-ancestor
2774408|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2774409|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2774410|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2102081|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
2102082|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102083|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2102084|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2268055|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2268056|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268057|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268058|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2268059|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2774411|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774412|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2774413|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
2774414|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2774415|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
2774416|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
2774417|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774418|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2774419|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2774420|NCT04408625|Protective Agents|protective agents|mesh-ancestor
2790934|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
2790935|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790939|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
2790940|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2790941|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
2774421|NCT04408313|Naltrexone|naltrexone|mesh-list
2774422|NCT04408313|Buprenorphine|buprenorphine|mesh-list
2774423|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2774424|NCT04408313|Narcotics|narcotics|mesh-ancestor
2774425|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2774426|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268060|NCT00188552|Protective Agents|protective agents|mesh-ancestor
2268061|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268062|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
2268063|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2268064|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
2268065|NCT00188552|Vitamins|vitamins|mesh-ancestor
2268066|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
2268067|NCT00188565|Celecoxib|celecoxib|mesh-list
2268068|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2268069|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2774427|NCT04408313|Analgesics|analgesics|mesh-ancestor
2774428|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
2774429|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774430|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2774431|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2774432|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2774433|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
2774434|NCT04408326|Giapreza|giapreza|mesh-list
2774435|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
2774436|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2774437|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2774438|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2774439|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
2774440|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774441|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774442|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
2774443|NCT04408144|Progestins|progestins|mesh-ancestor
2774444|NCT04408144|Hormones|hormones|mesh-ancestor
2774445|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2774446|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774447|NCT04408443|Vitamin D|vitamin d|mesh-list
2774448|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
2774449|NCT04408443|Vitamins|vitamins|mesh-ancestor
2774450|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
2774451|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774452|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2774453|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2774454|NCT04408235|Enoxaparin|enoxaparin|mesh-list
2774455|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
2774456|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2774457|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2774458|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774459|NCT04407975|Betamethasone|betamethasone|mesh-list
2774460|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2774461|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
2774462|NCT04407975|Hormones|hormones|mesh-ancestor
2774463|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2774464|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774465|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2774466|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
2774467|NCT04407754|Inositol|inositol|mesh-list
2774468|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
2774469|NCT04407754|Vitamins|vitamins|mesh-ancestor
2774470|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
2774471|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774472|NCT04407650|Metformin|metformin|mesh-list
2774473|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2774474|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2774475|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774476|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2774477|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2774478|NCT04408118|Paclitaxel|paclitaxel|mesh-list
2774479|NCT04408118|Bevacizumab|bevacizumab|mesh-list
2774480|NCT04408118|Atezolizumab|atezolizumab|mesh-list
2774481|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2774482|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774483|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
2774484|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
2774485|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
2774486|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268070|NCT00188565|Analgesics|analgesics|mesh-ancestor
2774487|NCT04408118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2774488|NCT04408118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2774489|NCT04408118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2774490|NCT04408118|Growth Substances|growth substances|mesh-ancestor
2774491|NCT04408118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774492|NCT04408118|Growth Inhibitors|growth inhibitors|mesh-ancestor
2774493|NCT04407715|Anesthetics|anesthetics|mesh-list
2774494|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2774495|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774496|NCT04407442|Dexamethasone|dexamethasone|mesh-list
2774497|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
2774498|NCT04407442|Azacitidine|azacitidine|mesh-list
2774499|NCT04407442|Daratumumab|daratumumab|mesh-list
2774500|NCT04407442|Ichthammol|ichthammol|mesh-list
2774501|NCT04407442|BB 1101|bb 1101|mesh-list
2774502|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2774503|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
2774504|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
2774505|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774506|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774507|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2774508|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
2774509|NCT04407442|Hormones|hormones|mesh-ancestor
2774510|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2774511|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2774512|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774513|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
2774514|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774515|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774516|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2774517|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
2774518|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
2774519|NCT04407312|Aspirin|aspirin|mesh-list
2774520|NCT04407312|Cilostazol|cilostazol|mesh-list
2774521|NCT04407312|Clopidogrel|clopidogrel|mesh-list
2774522|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2774523|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2774524|NCT04407312|Analgesics|analgesics|mesh-ancestor
2774525|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
2268071|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
2268072|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268073|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268074|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2268075|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2268076|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2268077|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2268078|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268079|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268080|NCT00188604|Selenious Acid|selenious acid|mesh-list
2268081|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
2268082|NCT00188604|Trace Elements|trace elements|mesh-ancestor
2268083|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
2268084|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268085|NCT00188617|Gefitinib|gefitinib|mesh-list
2268086|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268087|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2268088|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268089|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268090|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
2774526|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774527|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774528|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2774529|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2774530|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2774531|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2774532|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774533|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2774534|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2774535|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774536|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
2774537|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2774538|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2774539|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2774540|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
2774541|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774542|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2774543|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
2268091|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2268092|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
2268093|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268094|NCT00188630|Expectorants|expectorants|mesh-ancestor
2268095|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
2268096|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2774544|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2774545|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
2774546|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
2774547|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2774548|NCT04407312|Protective Agents|protective agents|mesh-ancestor
2774549|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2774550|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2774551|NCT04407247|Infliximab|infliximab|mesh-list
2268097|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
2268098|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268099|NCT00188630|Protective Agents|protective agents|mesh-ancestor
2268100|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268101|NCT00188630|Antidotes|antidotes|mesh-ancestor
2268102|NCT00188643|Lamotrigine|lamotrigine|mesh-list
2268103|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2268104|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2268105|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268106|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268107|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268108|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268109|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268110|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2268111|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
2268112|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268113|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
2268114|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2268115|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2268116|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2268117|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2268118|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2774552|NCT04407247|Vedolizumab|vedolizumab|mesh-list
2774553|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
2774554|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
2774555|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
2774556|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774557|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
2774558|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2774559|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2774560|NCT04407234|Acetaminophen|acetaminophen|mesh-list
2774561|NCT04407234|Tirzepatide|tirzepatide|mesh-list
2774562|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2774563|NCT04407234|Analgesics|analgesics|mesh-ancestor
2774564|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
2774565|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774566|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774567|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
2774568|NCT04407234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2774569|NCT04407234|Incretins|incretins|mesh-ancestor
2774570|NCT04407234|Hormones|hormones|mesh-ancestor
2774571|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2774572|NCT04407130|Doxycycline|doxycycline|mesh-list
2774573|NCT04407130|Ivermectin|ivermectin|mesh-list
2774574|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2774575|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774576|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
2774577|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2774578|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2774579|NCT04407078|Neostigmine|neostigmine|mesh-list
2774580|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2774581|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774582|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774583|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
2774584|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774585|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774586|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2774587|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
2774588|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268119|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2268120|NCT00188669|Tocopherols|tocopherols|mesh-list
2268121|NCT00188669|Vitamin E|vitamin e|mesh-list
2268122|NCT00188669|Tocotrienols|tocotrienols|mesh-list
2268123|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
2268124|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
2774600|NCT04407390|Niacinamide|niacinamide|mesh-list
2774601|NCT04407390|Niacin|niacin|mesh-list
2774602|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
2774603|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
2774604|NCT04407390|Vitamins|vitamins|mesh-ancestor
2774605|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
2774606|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774607|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2774608|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
2774609|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774610|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2774611|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
2774612|NCT04406779|Hormones|hormones|mesh-list
2774613|NCT04406779|Autoantibodies|autoantibodies|mesh-list
2774614|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2774615|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774616|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
2774617|NCT04406857|Capecitabine|capecitabine|mesh-list
2774618|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
2774619|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2774620|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
2774621|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774622|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774623|NCT04406870|Sirolimus|sirolimus|mesh-list
2774624|NCT04406870|Propranolol|propranolol|mesh-list
2774625|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2774626|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774627|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2774628|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774629|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
2774630|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2774631|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
2774632|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774633|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2774634|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2774635|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
2774636|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774637|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774638|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2774639|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2774640|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
2774641|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2774642|NCT04406727|UB-421|ub-421|mesh-list
2774643|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
2774644|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2790942|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790943|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790944|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2790945|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
2790946|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2790947|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
2790948|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790949|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790950|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2790951|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
2790952|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
2790953|NCT04290858|Protective Agents|protective agents|mesh-ancestor
2790954|NCT04291118|Budesonide|budesonide|mesh-list
2790955|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2790956|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2790957|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
2268125|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2790958|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774645|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2774646|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
2774647|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774648|NCT04407000|Favipiravir|favipiravir|mesh-list
2774649|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
2774650|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774651|NCT04406883|Simvastatin|simvastatin|mesh-list
2774652|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2774653|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2774654|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
2774655|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774656|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2774657|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2774658|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774659|NCT04406272|Bevacizumab|bevacizumab|mesh-list
2774660|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2268126|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268127|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268128|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2268129|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2268130|NCT00188669|Protective Agents|protective agents|mesh-ancestor
2268131|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268132|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
2268133|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2268134|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
2268135|NCT00188669|Vitamins|vitamins|mesh-ancestor
2774661|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774662|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2774663|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2774664|NCT04406272|Growth Substances|growth substances|mesh-ancestor
2774665|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774666|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
2774667|NCT04406389|Heparin|heparin|mesh-list
2774668|NCT04406389|Calcium heparin|calcium heparin|mesh-list
2268136|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
2268137|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
2268138|NCT00188773|Heparin|heparin|mesh-list
2268139|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2268140|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2774669|NCT04406389|Enoxaparin|enoxaparin|mesh-list
2774670|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
2774671|NCT04406389|Argatroban|argatroban|mesh-list
2774672|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
2774673|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2774674|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2774675|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774676|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
2774677|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2774678|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
2774679|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774680|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2774681|NCT04406376|Prednisone|prednisone|mesh-list
2774682|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2774683|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
2774684|NCT04406376|Hormones|hormones|mesh-ancestor
2774685|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2774686|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774687|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2774688|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774689|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
2774690|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2774691|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774692|NCT04406506|Erythromycin|erythromycin|mesh-list
2774693|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
2774694|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2774695|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
2774696|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2774697|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774698|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2774699|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2774700|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774701|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774702|NCT04406259|Verapamil|verapamil|mesh-list
2774703|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2774704|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2268141|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
2774705|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2774706|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774707|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2774708|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774709|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
2774710|NCT04405999|Bromhexine|bromhexine|mesh-list
2774711|NCT04405999|Expectorants|expectorants|mesh-ancestor
2774712|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
2774713|NCT04406025|Anesthetics|anesthetics|mesh-list
2774714|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2774715|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774716|NCT04406051|Norepinephrine|norepinephrine|mesh-list
2774717|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2268142|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2268143|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2268144|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774718|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2774719|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
2774720|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774721|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774722|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774723|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
2774724|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
2774725|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774726|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2774727|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
2774728|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2774729|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2774730|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774731|NCT04405960|Vitamins|vitamins|mesh-ancestor
2774732|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
2774733|NCT04405843|Ivermectin|ivermectin|mesh-list
2774734|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2774735|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774736|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2774737|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
2102085|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102086|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2102087|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
2102088|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2102089|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2102090|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2102091|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2102092|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
2774738|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
2774739|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2774740|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
2774741|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774742|NCT04405908|Antacids|antacids|mesh-ancestor
2774743|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774744|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2774745|NCT04405921|Azithromycin|azithromycin|mesh-list
2774746|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
2774747|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2774748|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774749|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
2774750|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2774751|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2774752|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774753|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774754|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2774755|NCT04405596|Ambroxol|ambroxol|mesh-list
2774756|NCT04405596|Expectorants|expectorants|mesh-ancestor
2774757|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
2774758|NCT04405622|Gemcitabine|gemcitabine|mesh-list
2774759|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2774760|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
2774761|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774762|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774763|NCT04405622|Antiviral Agents|antiviral agents|mesh-ancestor
2774764|NCT04405622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774765|NCT04405622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774766|NCT04405622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2774767|NCT04405622|Immunologic Factors|immunologic factors|mesh-ancestor
2774768|NCT04405622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774769|NCT04405505|Paclitaxel|paclitaxel|mesh-list
2774770|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2774771|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774772|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
2774773|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
2774774|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
2268145|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
2268146|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268147|NCT00188773|Expectorants|expectorants|mesh-ancestor
2268148|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
2774775|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774776|NCT04405375|Dexamethasone|dexamethasone|mesh-list
2774777|NCT04405375|Etoposide|etoposide|mesh-list
2774778|NCT04405375|Pegaspargase|pegaspargase|mesh-list
2774779|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2774780|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
2774781|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
2774782|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774783|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774784|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2774785|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
2774786|NCT04405375|Hormones|hormones|mesh-ancestor
2774787|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2774788|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2774789|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774790|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2774791|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2774792|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2774793|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774794|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774795|NCT04405206|Capecitabine|capecitabine|mesh-list
2774796|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
2774797|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2774798|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
2774799|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774800|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790959|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790960|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2790961|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
2790962|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
2790963|NCT04291118|Hormones|hormones|mesh-ancestor
2790964|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2790965|NCT04290546|Ipilimumab|ipilimumab|mesh-list
2790966|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2790967|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2790968|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2790969|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790970|NCT04290442|Ropivacaine|ropivacaine|mesh-list
2790971|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
2790972|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
2790973|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2790974|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790975|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
2102093|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102094|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102095|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2102096|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2102097|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2102098|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
2102099|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2102100|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
2102101|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102102|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2102103|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2102104|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2102105|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2102106|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
2790976|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790977|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
2790978|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2790979|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2790980|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2790981|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2102107|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102108|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2102109|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2102110|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2774801|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
2774802|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2774803|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
2774804|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774805|NCT04405193|Expectorants|expectorants|mesh-ancestor
2774806|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
2774807|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2268149|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2268150|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
2268151|NCT00188773|Protective Agents|protective agents|mesh-ancestor
2268152|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268153|NCT00188773|Antidotes|antidotes|mesh-ancestor
2268154|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2268155|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2268156|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2268157|NCT00188812|Donepezil|donepezil|mesh-list
2268158|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2268159|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774808|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
2774809|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774810|NCT04405193|Protective Agents|protective agents|mesh-ancestor
2774811|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774812|NCT04405193|Antidotes|antidotes|mesh-ancestor
2774813|NCT04405271|Tenofovir|tenofovir|mesh-list
2774814|NCT04405271|Emtricitabine|emtricitabine|mesh-list
2774815|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2774816|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
2774817|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774818|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2774819|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2774820|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774821|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774822|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2774823|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2774824|NCT04405154|Cisplatin|cisplatin|mesh-list
2774825|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774826|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2774827|NCT04405245|Latanoprost|latanoprost|mesh-list
2774828|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2774829|NCT04405037|Alvimopan|alvimopan|mesh-list
2774830|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2774839|NCT04405011|Entecavir|entecavir|mesh-list
2774840|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
2774841|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774842|NCT04405323|Itraconazole|itraconazole|mesh-list
2774843|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
2774844|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774845|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2774846|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2774847|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774848|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774849|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2268160|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268161|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
2268162|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268163|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268164|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
2268165|NCT00188825|Basiliximab|basiliximab|mesh-list
2774850|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
2774851|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102111|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2102112|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2102113|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2774852|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774853|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2774854|NCT04404946|Phenylephrine|phenylephrine|mesh-list
2774855|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
2774856|NCT04404946|Norepinephrine|norepinephrine|mesh-list
2774857|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2774858|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
2774859|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
2774860|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774861|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774862|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
2774863|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2774864|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
2774865|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
2774866|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2774867|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2774868|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2774869|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
2774870|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774871|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774872|NCT04404946|Protective Agents|protective agents|mesh-ancestor
2774873|NCT04404881|Bevacizumab|bevacizumab|mesh-list
2774874|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2774875|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774876|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2774877|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2774878|NCT04404881|Growth Substances|growth substances|mesh-ancestor
2774879|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774880|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
2774881|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2774882|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774883|NCT04404959|Ropivacaine|ropivacaine|mesh-list
2268166|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268167|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
2268168|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268169|NCT00188864|Dexamethasone|dexamethasone|mesh-list
2268170|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2268171|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
2268172|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
2268173|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268174|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268175|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2774884|NCT04404959|Anesthetics|anesthetics|mesh-list
2774885|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
2774886|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2774887|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774888|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
2774889|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774890|NCT04404751|Folic Acid|folic acid|mesh-list
2774891|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
2774892|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
2774893|NCT04404751|Iron|iron|mesh-list
2774894|NCT04404751|Vitamins|vitamins|mesh-ancestor
2774895|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
2774896|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268176|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
2268177|NCT00188864|Hormones|hormones|mesh-ancestor
2268178|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2268179|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2268180|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268181|NCT00188877|Fluorouracil|fluorouracil|mesh-list
2268182|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
2268183|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268184|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2268185|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268186|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268187|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
2774897|NCT04404751|Trace Elements|trace elements|mesh-ancestor
2774898|NCT04404751|Hematinics|hematinics|mesh-ancestor
2774899|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
2774900|NCT04404686|Indomethacin|indomethacin|mesh-list
2774901|NCT04404686|Nifedipine|nifedipine|mesh-list
2774902|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2774903|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2774904|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774905|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2774906|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774907|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
2774908|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
2268188|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268189|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
2268190|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
2268191|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268192|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
2268193|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268194|NCT00188942|Olanzapine|olanzapine|mesh-list
2268195|NCT00188942|Fluoxetine|fluoxetine|mesh-list
2268196|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
2268197|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
2268198|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268199|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268200|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2268201|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2268202|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2268203|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2268204|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268205|NCT00188942|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2268206|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268207|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268208|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268209|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268210|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
2268211|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2774909|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2774910|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2774911|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2774912|NCT04404686|Analgesics|analgesics|mesh-ancestor
2774913|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
2774914|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2774915|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2774916|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2774917|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
2774918|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2774919|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774920|NCT04404517|Adalimumab|adalimumab|mesh-list
2774921|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2774922|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2774923|NCT04404491|Capecitabine|capecitabine|mesh-list
2774924|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2774925|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
2774926|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774927|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774928|NCT04404439|Topiramate|topiramate|mesh-list
2774929|NCT04404439|Verapamil|verapamil|mesh-list
2774930|NCT04404439|Paroxetine|paroxetine|mesh-list
2774931|NCT04404439|Nortriptyline|nortriptyline|mesh-list
2774932|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
2774933|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2774934|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774935|NCT04404439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2774936|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2774937|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2774938|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774939|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2774940|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
2774941|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2774942|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
2774943|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2774944|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2774945|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2774946|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102114|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2102115|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102116|NCT02401529|Acetaminophen|acetaminophen|mesh-list
2102117|NCT02401529|Dexamethasone|dexamethasone|mesh-list
2102118|NCT02401529|Prednisolone|prednisolone|mesh-list
2102119|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102120|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
2102121|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
2102122|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102123|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774947|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2774948|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2774949|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2774950|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
2774951|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2774952|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2774953|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
2774954|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2774955|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2774956|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774957|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774958|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
2774959|NCT04404387|Vitamins|vitamins|mesh-ancestor
2774960|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
2774961|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774962|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
2774963|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774964|NCT04404387|Protective Agents|protective agents|mesh-ancestor
2774965|NCT04404062|Antibodies|antibodies|mesh-list
2774966|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
2774967|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
2774968|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774969|NCT04404049|UB-421|ub-421|mesh-list
2774970|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2774971|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
2774972|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2774973|NCT04404127|Basiliximab|basiliximab|mesh-list
2774974|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2774975|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
2774976|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774977|NCT04404088|Rituximab|rituximab|mesh-list
2774978|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2774979|NCT04404088|Lenalidomide|lenalidomide|mesh-list
2774980|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
2774981|NCT04404088|Antibodies|antibodies|mesh-list
2774982|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
2774983|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2774984|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
2774985|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2774986|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2774987|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2774988|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2774989|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2774990|NCT04404088|Growth Substances|growth substances|mesh-ancestor
2774991|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
2774992|NCT04403776|Tofacitinib|tofacitinib|mesh-list
2774993|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2774994|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2774995|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2774996|NCT04403503|Thrombin|thrombin|mesh-list
2774997|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
2774998|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
2774999|NCT04403503|Coagulants|coagulants|mesh-ancestor
2775000|NCT04403724|Fentanyl|fentanyl|mesh-list
2775001|NCT04403724|Morphine|morphine|mesh-list
2775002|NCT04403724|Bupivacaine|bupivacaine|mesh-list
2775003|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
2775004|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
2775005|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775006|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775007|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
2775008|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775009|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2775010|NCT04403724|Narcotics|narcotics|mesh-ancestor
2775011|NCT04403724|Analgesics|analgesics|mesh-ancestor
2775012|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2775013|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2775014|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
2790982|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2790983|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
2790984|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2790985|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102124|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2102125|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
2102126|NCT02401529|Hormones|hormones|mesh-ancestor
2790986|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2790987|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2790988|NCT04290455|Castor Oil|castor oil|mesh-list
2790989|NCT04290455|Cathartics|cathartics|mesh-ancestor
2775015|NCT04403516|Dexamethasone|dexamethasone|mesh-list
2775016|NCT04403516|Prednisolone|prednisolone|mesh-list
2775017|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2775018|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
2775019|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2775020|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
2775021|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2775022|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
2775023|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2268212|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
2268213|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2268214|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2268215|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268216|NCT00188955|Sirolimus|sirolimus|mesh-list
2268217|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2268218|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268219|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2775024|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
2775025|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
2775026|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775027|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775028|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2775029|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
2775030|NCT04403516|Hormones|hormones|mesh-ancestor
2775031|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2775032|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2775033|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775034|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2775035|NCT04403516|Protective Agents|protective agents|mesh-ancestor
2775036|NCT04403698|Alendronate|alendronate|mesh-list
2775037|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2775038|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775039|NCT04403568|Ursolic acid|ursolic acid|mesh-list
2775040|NCT04403568|Curcumin|curcumin|mesh-list
2268220|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268221|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
2775041|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2775042|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2775043|NCT04403568|Analgesics|analgesics|mesh-ancestor
2775044|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
2775045|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775046|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775047|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2775048|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2775049|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775050|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775051|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775052|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775053|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2775054|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2775055|NCT04403555|Ivermectin|ivermectin|mesh-list
2775056|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2775057|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775058|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
2775059|NCT04403711|Anesthetics|anesthetics|mesh-list
2775060|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
2775061|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2775062|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775063|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775064|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2775065|NCT04403711|Analgesics|analgesics|mesh-ancestor
2775066|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
2775067|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775068|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2775069|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2775070|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2775071|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
2775072|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775073|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775074|NCT04403347|Losartan|losartan|mesh-list
2775075|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
2775076|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2775077|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2775078|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2790990|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2775079|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775080|NCT04403087|Trimebutine|trimebutine|mesh-list
2775081|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2775082|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
2775083|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
2775084|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775085|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775086|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
2775087|NCT04403334|Levofloxacin|levofloxacin|mesh-list
2775088|NCT04403334|Ofloxacin|ofloxacin|mesh-list
2775089|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2268222|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268223|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
2268224|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268225|NCT00188994|Insulin|insulin|mesh-list
2268226|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2268227|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268228|NCT00189007|Allopurinol|allopurinol|mesh-list
2268229|NCT00189007|Mannitol|mannitol|mesh-list
2775090|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775091|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2775092|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2775093|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775094|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775095|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775096|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2775097|NCT04403334|Renal Agents|renal agents|mesh-ancestor
2775098|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2775099|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2775100|NCT04403100|Ritonavir|ritonavir|mesh-list
2775101|NCT04403100|Lopinavir|lopinavir|mesh-list
2775102|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
2775103|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2775104|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2775105|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
2775106|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775107|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775108|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2775109|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2775110|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
2775111|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775112|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2775113|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2775114|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
2775115|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2775116|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2775117|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2775118|NCT04403243|Colchicine|colchicine|mesh-list
2775119|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
2775120|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2775121|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
2775122|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
2775123|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
2268230|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
2268231|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268232|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268233|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
2268234|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2268235|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2268236|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
2268237|NCT00189007|Protective Agents|protective agents|mesh-ancestor
2268238|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268239|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2268240|NCT00189007|Diuretics|diuretics|mesh-ancestor
2268241|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
2268242|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2268243|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
2268244|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775124|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775125|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775126|NCT04403165|Norepinephrine|norepinephrine|mesh-list
2268245|NCT00189033|Psyllium|psyllium|mesh-list
2268246|NCT00189033|Cathartics|cathartics|mesh-ancestor
2268247|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2268248|NCT00189059|Amitriptyline|amitriptyline|mesh-list
2268249|NCT00189059|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2268250|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2775127|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2775128|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2775129|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
2775130|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775131|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775132|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775133|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
2775134|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
2775135|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775136|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2775137|NCT04403282|Eflornithine|eflornithine|mesh-list
2775138|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775139|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2775140|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2775141|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2775142|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775143|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2775144|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775145|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775146|NCT04403191|Ondansetron|ondansetron|mesh-list
2775147|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
2775148|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
2775149|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775150|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775151|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2775152|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
2775153|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
2775154|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2775155|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
2102127|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102128|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102129|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102130|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2102131|NCT02401529|Analgesics|analgesics|mesh-ancestor
2102132|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
2775156|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775157|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775158|NCT04403191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2775159|NCT04403191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2775160|NCT04403191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2268251|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
2268252|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268253|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2268254|NCT00189059|Analgesics|analgesics|mesh-ancestor
2268255|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
2775161|NCT04403191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2775162|NCT04403191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2775163|NCT04403321|Cyclosporine|cyclosporine|mesh-list
2775164|NCT04403321|Tacrolimus|tacrolimus|mesh-list
2775165|NCT04403321|Cyclosporins|cyclosporins|mesh-list
2775166|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2775167|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
2775168|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775169|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2775170|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775171|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775172|NCT04403321|Antifungal Agents|antifungal agents|mesh-ancestor
2775173|NCT04403321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775174|NCT04403321|Dermatologic Agents|dermatologic agents|mesh-ancestor
2775175|NCT04403321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2775176|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
2775177|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
2775178|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2775179|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775180|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775181|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
2775182|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2775183|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775184|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775185|NCT04402762|Enoxaparin|enoxaparin|mesh-list
2268256|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775186|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
2775187|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
2775188|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2102133|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
2102134|NCT02401542|Docetaxel|docetaxel|mesh-list
2268257|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268258|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2268259|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268260|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268261|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268262|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
2268263|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268264|NCT00189059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2268265|NCT00189059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2268266|NCT00189059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2268267|NCT00189072|Gabapentin|gabapentin|mesh-list
2268268|NCT00189072|Analgesics|analgesics|mesh-ancestor
2268269|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
2268270|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268271|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268272|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
2268273|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2268274|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2268275|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2102135|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102136|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
2102137|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
2102138|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
2102139|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102140|NCT02402062|Sunitinib|sunitinib|mesh-list
2102141|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102142|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2775189|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2775190|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268276|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2775191|NCT04402658|Albuterol|albuterol|mesh-list
2775192|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2775193|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
2775194|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775195|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775196|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2775197|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
2775198|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
2775199|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2775200|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2775201|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2775202|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2775203|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
2775204|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775205|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775206|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
2775207|NCT04402580|Rituximab|rituximab|mesh-list
2775208|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2775209|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775210|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
2775211|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775212|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2775213|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2775214|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2775215|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
2775216|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2775217|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775218|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775219|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775220|NCT04402671|Glutaral|glutaral|mesh-list
2775221|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
2775222|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775223|NCT04402723|Cytarabine|cytarabine|mesh-list
2775224|NCT04402723|Daunorubicin|daunorubicin|mesh-list
2775225|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2775226|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
2775227|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775228|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775229|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
2775230|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775231|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2775232|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
2775233|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102143|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2775234|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2775235|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2775236|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2775237|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775238|NCT04402320|Midazolam|midazolam|mesh-list
2775239|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2775240|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2775241|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775242|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775243|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2775244|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2775245|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2775246|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2775247|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
2775248|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
2775249|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
2775250|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
2775251|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775252|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775253|NCT04402359|Meropenem|meropenem|mesh-list
2775254|NCT04402359|Ceftazidime|ceftazidime|mesh-list
2775255|NCT04402359|Avibactam|avibactam|mesh-list
2775256|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2775257|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775258|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2775259|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775260|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775261|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
2775262|NCT04402411|Narcotics|narcotics|mesh-ancestor
2775263|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775264|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775265|NCT04402411|Analgesics|analgesics|mesh-ancestor
2775266|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
2775267|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775268|NCT04402346|Pancrelipase|pancrelipase|mesh-list
2775269|NCT04402346|Pancreatin|pancreatin|mesh-list
2775270|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2775271|NCT04402203|Favipiravir|favipiravir|mesh-list
2775272|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
2775273|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775274|NCT04402047|Diclofenac|diclofenac|mesh-list
2102144|NCT02402062|Growth Substances|growth substances|mesh-ancestor
2102145|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102146|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
2268277|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2268278|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2268279|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268280|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268281|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
2268282|NCT00189085|Simvastatin|simvastatin|mesh-list
2268283|NCT00189085|Ezetimibe|ezetimibe|mesh-list
2268284|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2268285|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2775275|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2775276|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2775277|NCT04402047|Analgesics|analgesics|mesh-ancestor
2775278|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
2775279|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775280|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775281|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2775282|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2775283|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2775284|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775285|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775286|NCT04402112|Pitavastatin|pitavastatin|mesh-list
2775287|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2775288|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2775289|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2775290|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
2790991|NCT04290429|Teduglutide|teduglutide|mesh-list
2102147|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2102148|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102149|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102150|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
2102151|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2102152|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2775291|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775292|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775293|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2775294|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
2775295|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268286|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2268287|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
2268288|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268289|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2268290|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2268291|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268292|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2268293|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2268294|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
2268295|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268296|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
2268297|NCT00189150|Valganciclovir|valganciclovir|mesh-list
2268298|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2268299|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268300|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2268301|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
2775296|NCT04401878|Lidocaine|lidocaine|mesh-list
2775297|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
2775298|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
2775299|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775300|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775301|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
2775302|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775303|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2775304|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2775305|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2775306|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2775307|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775308|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2775309|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2775310|NCT04402073|Vincristine|vincristine|mesh-list
2775311|NCT04402073|Lomustine|lomustine|mesh-list
2775312|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775313|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2775314|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
2775315|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
2775316|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
2775317|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775318|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2775319|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
2775320|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
2775321|NCT04401852|Analgesics|analgesics|mesh-ancestor
2775322|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
2775323|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775324|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775325|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
2775326|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775327|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2775328|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
2775329|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2775330|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2775331|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775332|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2775333|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
2775334|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2775342|NCT04401839|Oxytocin|oxytocin|mesh-list
2775343|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
2775344|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2775345|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775346|NCT04401709|Gemcitabine|gemcitabine|mesh-list
2775347|NCT04401709|Capecitabine|capecitabine|mesh-list
2775348|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2775349|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
2775350|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775351|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775352|NCT04401709|Antiviral Agents|antiviral agents|mesh-ancestor
2775353|NCT04401709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775354|NCT04401709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775355|NCT04401709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2775356|NCT04401709|Immunologic Factors|immunologic factors|mesh-ancestor
2775357|NCT04401709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790992|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2790993|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2790994|NCT04290429|Protective Agents|protective agents|mesh-ancestor
2790995|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2790996|NCT04290572|Isotretinoin|isotretinoin|mesh-list
2790997|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
2790998|NCT04290390|Itraconazole|itraconazole|mesh-list
2790999|NCT04290390|Rifampin|rifampin|mesh-list
2791000|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2791001|NCT04290390|Estradiol|estradiol|mesh-list
2791002|NCT04290390|Estrogens|estrogens|mesh-ancestor
2791003|NCT04290390|Hormones|hormones|mesh-ancestor
2791004|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2791005|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791006|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2791007|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
2791008|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2791009|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2791010|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
2791011|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268302|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2268303|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268304|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268305|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268306|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
2268307|NCT00189163|Pioglitazone|pioglitazone|mesh-list
2268308|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2268309|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268310|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2791012|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2791013|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2791014|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791015|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791016|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2791017|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
2791018|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2791019|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2791020|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
2791021|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2791022|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
2791023|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2268311|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
2268312|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
2268313|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268314|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268315|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2268316|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2268317|NCT00189176|Growth Substances|growth substances|mesh-ancestor
2268318|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791024|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2791025|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2791026|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2791027|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2791028|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2791029|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2791030|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2791031|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2791032|NCT04290195|Aflibercept|aflibercept|mesh-list
2791033|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2791034|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2791035|NCT04290195|Growth Substances|growth substances|mesh-ancestor
2791036|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791037|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
2791038|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791039|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
2775358|NCT04401774|Nivolumab|nivolumab|mesh-list
2775359|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2775360|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775361|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2775362|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775363|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2775364|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
2775365|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775366|NCT04401657|Adenosine|adenosine|mesh-list
2775367|NCT04401657|Analgesics|analgesics|mesh-ancestor
2775368|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
2775369|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775370|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775371|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2775372|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
2775373|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2775374|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
2775375|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
2775376|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268319|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
2268320|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268321|NCT00189241|Imiquimod|imiquimod|mesh-list
2268322|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2268323|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
2268324|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268325|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268326|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
2268327|NCT00189254|Imiquimod|imiquimod|mesh-list
2268328|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2268329|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
2268330|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268331|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268332|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
2268333|NCT00189267|Imiquimod|imiquimod|mesh-list
2268334|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2268335|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
2775377|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775378|NCT04401137|Topiramate|topiramate|mesh-list
2775379|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
2775380|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2775381|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775382|NCT04401176|Lidocaine|lidocaine|mesh-list
2775383|NCT04401176|Heparin|heparin|mesh-list
2775384|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
2775385|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
2775386|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775387|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775388|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
2775389|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775390|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2775391|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2775392|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2775393|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2775394|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775395|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
2775396|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2775397|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2775399|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
2775400|NCT04401345|Bromides|bromides|mesh-list
2268336|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268337|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268338|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
2268339|NCT00189280|Imiquimod|imiquimod|mesh-list
2268340|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2268341|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
2268342|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268343|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268344|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
2268345|NCT00189293|Imiquimod|imiquimod|mesh-list
2268346|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2268347|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
2268348|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268349|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268350|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
2268351|NCT00189319|Flecainide|flecainide|mesh-list
2268352|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2775401|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
2775402|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2775403|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2268353|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2268354|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2268355|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268356|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268357|NCT00189345|Catumaxomab|catumaxomab|mesh-list
2268358|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
2268359|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
2268360|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268361|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268362|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2268363|NCT00189358|Tamoxifen|tamoxifen|mesh-list
2268364|NCT00189358|Gefitinib|gefitinib|mesh-list
2775404|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2775405|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
2775406|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775407|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775408|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775409|NCT04401085|Antibodies|antibodies|mesh-list
2775410|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
2775411|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775412|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2775413|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2775414|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
2775422|NCT04401059|Gefitinib|gefitinib|mesh-list
2775423|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775424|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2775425|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775426|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268365|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2268366|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
2268367|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2268368|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268369|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2268370|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268371|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2268372|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2268373|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2268374|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2268375|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268376|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268377|NCT00189371|Paclitaxel|paclitaxel|mesh-list
2268378|NCT00189371|Carboplatin|carboplatin|mesh-list
2268379|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
2268380|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2268381|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268382|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
2268383|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
2268384|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
2268385|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268386|NCT00189371|Hematinics|hematinics|mesh-ancestor
2268387|NCT00189384|Gentamicins|gentamicins|mesh-list
2268388|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
2268389|NCT00189384|Penicillins|penicillins|mesh-list
2268390|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2268391|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
2268392|NCT00189384|Penicillin G|penicillin g|mesh-list
2268393|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2268394|NCT00189384|Procaine|procaine|mesh-list
2268395|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2268396|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268397|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2268398|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268399|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268400|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2775427|NCT04401007|Lidocaine|lidocaine|mesh-list
2775428|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
2775429|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
2775430|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775431|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775432|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
2775433|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775434|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2775435|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2775436|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2775437|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2775438|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775439|NCT04400747|Vitamin D|vitamin d|mesh-list
2775440|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
2775441|NCT04400747|Vitamins|vitamins|mesh-ancestor
2775442|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
2775443|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775444|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2775445|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2775446|NCT04400721|Ropivacaine|ropivacaine|mesh-list
2775447|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
2775448|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
2775449|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775450|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775451|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
2775452|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775453|NCT04400994|Rituximab|rituximab|mesh-list
2268401|NCT00189384|Renal Agents|renal agents|mesh-ancestor
2268402|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
2268403|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2268404|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2268405|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
2268406|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
2268407|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775454|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2775455|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775456|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
2775457|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775458|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2775459|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
2775460|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2775461|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2775462|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775463|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
2775464|NCT04400916|Coagulants|coagulants|mesh-ancestor
2775465|NCT04400929|Molgramostim|molgramostim|mesh-list
2775466|NCT04400929|Sargramostim|sargramostim|mesh-list
2775467|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
2775468|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775469|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775470|NCT04400890|Vitamin D|vitamin d|mesh-list
2775471|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
2775472|NCT04400890|Resveratrol|resveratrol|mesh-list
2775473|NCT04400890|Vitamins|vitamins|mesh-ancestor
2775474|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
2775475|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775476|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2775477|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2775478|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
2775479|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775480|NCT04400890|Protective Agents|protective agents|mesh-ancestor
2775481|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775482|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2775483|NCT04400474|Atezolizumab|atezolizumab|mesh-list
2775484|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775485|NCT04400539|Nivolumab|nivolumab|mesh-list
2775486|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2775487|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775488|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2775489|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775490|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2775491|NCT04400383|Antibodies|antibodies|mesh-list
2268408|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268409|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
2268410|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268411|NCT00189397|Azathioprine|azathioprine|mesh-list
2268412|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
2268413|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268414|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2268415|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268416|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268417|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
2268418|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268419|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2775492|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
2775493|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2775494|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
2775495|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775496|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775497|NCT04400201|Propofol|propofol|mesh-list
2775498|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2775499|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775500|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775501|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2775502|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
2775503|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
2775504|NCT04400175|Silicon|silicon|mesh-list
2775505|NCT04400175|Trace Elements|trace elements|mesh-ancestor
2775506|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
2775507|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775508|NCT04400188|Temozolomide|temozolomide|mesh-list
2775509|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2775510|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
2775511|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775512|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775513|NCT04400045|Treosulfan|treosulfan|mesh-list
2775514|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2775515|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
2775516|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775517|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775518|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
2775519|NCT04399746|Azithromycin|azithromycin|mesh-list
2775520|NCT04399746|Ivermectin|ivermectin|mesh-list
2775521|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2775522|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775523|NCT04399746|Vitamins|vitamins|mesh-ancestor
2775524|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
2775525|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2775526|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2775527|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775528|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2775529|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
2775530|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
2775531|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2775532|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2775533|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775534|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268420|NCT00189410|Carboplatin|carboplatin|mesh-list
2268421|NCT00189410|Doxorubicin|doxorubicin|mesh-list
2268422|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2268423|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268424|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2268425|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2268426|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2268427|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775535|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775536|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2791040|NCT04290013|Norethindrone|norethindrone|mesh-list
2791041|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
2791042|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2791043|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2791044|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791045|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
2791046|NCT04290013|Coagulants|coagulants|mesh-ancestor
2791047|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2791048|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2791049|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2791050|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
2791051|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2268428|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791052|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791053|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2268429|NCT00189501|Cinacalcet|cinacalcet|mesh-list
2268430|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2268431|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268432|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2268433|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
2268434|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2268435|NCT00189514|Pramlintide|pramlintide|mesh-list
2268436|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2268437|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268438|NCT00189553|Paclitaxel|paclitaxel|mesh-list
2268439|NCT00189553|Carboplatin|carboplatin|mesh-list
2268440|NCT00189553|Doxorubicin|doxorubicin|mesh-list
2268441|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2268442|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2268443|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268444|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
2268445|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
2268446|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
2268447|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268448|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2268449|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2268450|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2268451|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268452|NCT00189566|Paclitaxel|paclitaxel|mesh-list
2268453|NCT00189566|Carboplatin|carboplatin|mesh-list
2268454|NCT00189566|Topotecan|topotecan|mesh-list
2268455|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2268456|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268457|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
2268458|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
2775537|NCT04400136|Lansoprazole|lansoprazole|mesh-list
2775538|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
2775539|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2775540|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2775541|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2775542|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268459|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
2268460|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268461|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2268462|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2268463|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268464|NCT00189579|Trastuzumab|trastuzumab|mesh-list
2268465|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2268466|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268467|NCT00189618|Aspirin|aspirin|mesh-list
2268468|NCT00189618|Clopidogrel|clopidogrel|mesh-list
2268469|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2268470|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2268471|NCT00189618|Analgesics|analgesics|mesh-ancestor
2268472|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
2268473|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268474|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268475|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2268476|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2268477|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2268478|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2268479|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268480|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2268481|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2268482|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268483|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
2268484|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2268485|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2268486|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2268487|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
2268488|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268489|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
2268490|NCT00189644|Fluorouracil|fluorouracil|mesh-list
2268491|NCT00189644|Epirubicin|epirubicin|mesh-list
2268492|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268493|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
2268494|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775543|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775544|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2775545|NCT04399187|Eusol|eusol|mesh-list
2775546|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
2102153|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102154|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
2775547|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775548|NCT04399213|Histamine|histamine|mesh-list
2775549|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
2775550|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
2775551|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
2775552|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775553|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775554|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775555|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
2775556|NCT04399226|Ketamine|ketamine|mesh-list
2775557|NCT04399226|Propofol|propofol|mesh-list
2775558|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2775559|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775560|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775561|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2775562|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
2775563|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
2775564|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2775565|NCT04399226|Analgesics|analgesics|mesh-ancestor
2775566|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
2775567|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268495|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2268496|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2268497|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
2268498|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268499|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775568|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2775569|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2775570|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2775571|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
2775572|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775573|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775574|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2775575|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2775576|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2775577|NCT04399395|Naltrexone|naltrexone|mesh-list
2775578|NCT04399395|Bupropion|bupropion|mesh-list
2775579|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2775580|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2775581|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775582|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
2775583|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775584|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2775585|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
2775586|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2775587|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2775588|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2775589|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2775590|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775591|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
2775592|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775593|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2775594|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2775595|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775596|NCT04399434|Insulin|insulin|mesh-list
2775597|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2775598|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775599|NCT04399525|Cetirizine|cetirizine|mesh-list
2102155|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
2102156|NCT02402933|Glucagon|glucagon|mesh-list
2102157|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2102158|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2102159|NCT02402933|Hormones|hormones|mesh-ancestor
2102160|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102161|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102162|NCT02402933|Incretins|incretins|mesh-ancestor
2102163|NCT02403271|Durvalumab|durvalumab|mesh-list
2102164|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2102165|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102166|NCT02403635|Midazolam|midazolam|mesh-list
2775600|NCT04399525|Loratadine|loratadine|mesh-list
2775601|NCT04399525|Levocetirizine|levocetirizine|mesh-list
2102167|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2775602|NCT04399525|Desloratadine|desloratadine|mesh-list
2775603|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2775604|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2775605|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
2775606|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
2775607|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775608|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775609|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775610|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2775611|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2775612|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
2775613|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
2775614|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
2775615|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
2775616|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2775617|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775618|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775619|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2775620|NCT04399343|Analgesics|analgesics|mesh-ancestor
2775621|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
2775622|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775623|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2775624|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2775625|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2775626|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
2775627|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775628|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775629|NCT04399148|Ketotifen|ketotifen|mesh-list
2775630|NCT04399148|Aprepitant|aprepitant|mesh-list
2775631|NCT04399148|Desloratadine|desloratadine|mesh-list
2775632|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
2775633|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
2775634|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775635|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775636|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2775637|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2775638|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775639|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775640|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2775641|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
2775642|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2775643|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2775644|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
2775645|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
2775646|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
2775647|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
2775648|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2268500|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2268501|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
2268502|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2268503|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2268504|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2268505|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2268506|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268507|NCT00189657|Irinotecan|irinotecan|mesh-list
2102168|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2102169|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2102170|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102171|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2102172|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2102173|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2102174|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2102175|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
2102176|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
2102177|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
2102178|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
2102179|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102180|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102181|NCT02403674|Tenofovir|tenofovir|mesh-list
2102182|NCT02403674|Lamivudine|lamivudine|mesh-list
2268508|NCT00189657|Fluorouracil|fluorouracil|mesh-list
2268509|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2268510|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2268511|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268512|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775649|NCT04398823|Polidocanol|polidocanol|mesh-list
2775650|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2775651|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2775652|NCT04399070|Ketamine|ketamine|mesh-list
2775653|NCT04399070|Esketamine|esketamine|mesh-list
2775654|NCT04399070|Analgesics|analgesics|mesh-ancestor
2775655|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
2775656|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775657|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775658|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2775659|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2775660|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
2775661|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
2775662|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775663|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2775664|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2775665|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775666|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775667|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
2775668|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2775669|NCT04398914|Paclitaxel|paclitaxel|mesh-list
2775670|NCT04398914|Trastuzumab|trastuzumab|mesh-list
2775671|NCT04398914|Pertuzumab|pertuzumab|mesh-list
2775672|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2775673|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775674|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
2775675|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
2775676|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
2775677|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775678|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2775679|NCT04398927|Folfirinox|folfirinox|mesh-list
2775680|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775681|NCT04399083|Caffeine|caffeine|mesh-list
2775682|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2775683|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775684|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2268513|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268514|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
2268515|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2268516|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268517|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
2268518|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268519|NCT00189683|Capecitabine|capecitabine|mesh-list
2268520|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2268521|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
2268522|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268523|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775685|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775686|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775687|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2775688|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2775689|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
2775690|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775691|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2775692|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2775693|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
2775694|NCT04398537|Hormones|hormones|mesh-ancestor
2775695|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2775696|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775697|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775698|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775699|NCT04398719|Capsaicin|capsaicin|mesh-list
2775700|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
2775701|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
2775702|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
2775703|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775704|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775705|NCT04398771|Valsartan|valsartan|mesh-list
2775706|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2775707|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2775708|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2775709|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
2775710|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775711|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2775712|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2775713|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775714|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2775715|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2775716|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2775717|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
2775718|NCT04398589|Ropivacaine|ropivacaine|mesh-list
2775719|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2775720|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775721|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775722|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2775723|NCT04398589|Analgesics|analgesics|mesh-ancestor
2775724|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
2775725|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775726|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2775727|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2775728|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2775729|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
2775730|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775731|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775732|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
2775733|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
2775737|NCT04398251|Febuxostat|febuxostat|mesh-list
2775738|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
2775739|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2775740|NCT04398108|Margetuximab|margetuximab|mesh-list
2775741|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775742|NCT04398329|Bupivacaine|bupivacaine|mesh-list
2775743|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
2775744|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
2775745|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775746|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775747|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
2775748|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775749|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
2775750|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2775751|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
2775752|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775753|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775754|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2775755|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
2775756|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2775757|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
2775758|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775759|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775760|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2775761|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
2775762|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
2775763|NCT04398290|Protective Agents|protective agents|mesh-ancestor
2791054|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2791055|NCT04290208|Acetaminophen|acetaminophen|mesh-list
2791056|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2268524|NCT00189709|Fluconazole|fluconazole|mesh-list
2268525|NCT00189709|Micafungin|micafungin|mesh-list
2268526|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
2268527|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268528|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2268529|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2268530|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268531|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268532|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2268533|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
2268534|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2268535|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268536|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2268537|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2791057|NCT04290208|Analgesics|analgesics|mesh-ancestor
2791058|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
2791059|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791060|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791061|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
2775764|NCT04398316|Lidocaine|lidocaine|mesh-list
2775765|NCT04398316|Hydromorphone|hydromorphone|mesh-list
2775766|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
2775767|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
2775768|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775769|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775770|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
2268538|NCT00189722|Tacrolimus|tacrolimus|mesh-list
2268539|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268540|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
2268541|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268542|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2268543|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268544|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268545|NCT00189748|Tacrolimus|tacrolimus|mesh-list
2268546|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268547|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
2268548|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268549|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2268550|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775771|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775772|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2775773|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2775774|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2775775|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2775776|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775777|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2775778|NCT04398316|Narcotics|narcotics|mesh-ancestor
2775779|NCT04398316|Analgesics|analgesics|mesh-ancestor
2775780|NCT04398004|Clarithromycin|clarithromycin|mesh-list
2775781|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2775782|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775783|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2775784|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775785|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775786|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2775787|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2775788|NCT04397770|Temozolomide|temozolomide|mesh-list
2775789|NCT04397770|Apatinib|apatinib|mesh-list
2775790|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2268551|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268552|NCT00189761|Tacrolimus|tacrolimus|mesh-list
2268553|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268554|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
2268555|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268556|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2268557|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775791|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
2775792|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775793|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775794|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2775795|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775796|NCT04397601|Bevacizumab|bevacizumab|mesh-list
2775797|NCT04397601|Aflibercept|aflibercept|mesh-list
2775798|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2775799|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775800|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2775801|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2775802|NCT04397601|Growth Substances|growth substances|mesh-ancestor
2775803|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775804|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
2775805|NCT04397991|Furosemide|furosemide|mesh-list
2775806|NCT04397991|Diuretics|diuretics|mesh-ancestor
2775807|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
2775808|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775809|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2775810|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2775811|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775812|NCT04397653|Ezetimibe|ezetimibe|mesh-list
2775813|NCT04397653|Evolocumab|evolocumab|mesh-list
2775814|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2775815|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2775816|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
2775817|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775818|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2775819|NCT04397679|Chloroquine|chloroquine|mesh-list
2775820|NCT04397679|Temozolomide|temozolomide|mesh-list
2775821|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2775822|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
2775823|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775824|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775825|NCT04397679|Amebicides|amebicides|mesh-ancestor
2775826|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2775827|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2775828|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775829|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
2775830|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2775831|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
2775832|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2775833|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
2775834|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775835|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775836|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2775837|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
2775838|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2775839|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
2775840|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775841|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775842|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2775843|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
2775844|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
2775845|NCT04397692|Protective Agents|protective agents|mesh-ancestor
2775846|NCT04397913|Acetaminophen|acetaminophen|mesh-list
2775847|NCT04397913|Ibuprofen|ibuprofen|mesh-list
2775848|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2268558|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268559|NCT00189774|Nateglinide|nateglinide|mesh-list
2268560|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2268561|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268562|NCT00189787|Tacrolimus|tacrolimus|mesh-list
2268563|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268564|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
2268565|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268566|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2268567|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268568|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268569|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
2268570|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2775849|NCT04397913|Analgesics|analgesics|mesh-ancestor
2775850|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
2775851|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775852|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775853|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
2775854|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2775855|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2775856|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2775857|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2775858|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775859|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775860|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
2775861|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2775862|NCT04397341|Docetaxel|docetaxel|mesh-list
2775863|NCT04397341|Fluorouracil|fluorouracil|mesh-list
2775864|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775865|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
2775866|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
2775867|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
2775868|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775869|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
2775870|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2775871|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2775872|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
2775873|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775874|NCT04397458|Dexamethasone|dexamethasone|mesh-list
2775875|NCT04397458|Bupivacaine|bupivacaine|mesh-list
2775876|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2775877|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
2775878|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
2775879|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775880|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775881|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2775882|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
2775883|NCT04397458|Hormones|hormones|mesh-ancestor
2775884|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2775885|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2775886|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2775887|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
2775888|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
2268571|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2268572|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
2268573|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268574|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268575|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268576|NCT00189800|Urological Agents|urological agents|mesh-ancestor
2268577|NCT00189826|Tacrolimus|tacrolimus|mesh-list
2268578|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268579|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
2268580|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268581|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2268582|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268583|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268584|NCT00189839|Tacrolimus|tacrolimus|mesh-list
2775889|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775890|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
2775891|NCT04397510|Heparin|heparin|mesh-list
2268585|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268586|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
2268587|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268588|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2268589|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268590|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268591|NCT00189878|Methotrexate|methotrexate|mesh-list
2268592|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2268593|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
2268594|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2268595|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268596|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2268597|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
2268598|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268599|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268600|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
2268601|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268602|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2268603|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268604|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
2268605|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2268606|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2268607|NCT00189982|Factor VIII|factor viii|mesh-list
2268608|NCT00189982|Coagulants|coagulants|mesh-ancestor
2268609|NCT00189995|Haloperidol|haloperidol|mesh-list
2268610|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
2268611|NCT00189995|Clozapine|clozapine|mesh-list
2268612|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
2268613|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
2268614|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268615|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268616|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2775892|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
2775893|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2775894|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2775895|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102183|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2102184|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
2102185|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102186|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2102187|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2102188|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102189|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102190|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2102966|NCT02416102|Losartan|losartan|mesh-list
2268617|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2268618|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2268619|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2268620|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268621|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2268622|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
2268623|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268624|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102191|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2102192|NCT02403778|Ipilimumab|ipilimumab|mesh-list
2102193|NCT02403778|Tretinoin|tretinoin|mesh-list
2102194|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2102195|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102196|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2102197|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102198|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
2102199|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
2102200|NCT02403830|Morphine|morphine|mesh-list
2102201|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
2102202|NCT02403830|Ticagrelor|ticagrelor|mesh-list
2102203|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2102204|NCT02403830|Narcotics|narcotics|mesh-ancestor
2102205|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2102206|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102207|NCT02403830|Analgesics|analgesics|mesh-ancestor
2775913|NCT04397393|Midazolam|midazolam|mesh-list
2775914|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2775915|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2775916|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775917|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775918|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2775919|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2268625|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2268626|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2268627|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
2268628|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
2775920|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2775921|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2775922|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
2775923|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
2775924|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
2775925|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
2775926|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775927|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775928|NCT04397289|Heparin|heparin|mesh-list
2775929|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
2775930|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
2775931|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2775932|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2775933|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775934|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2775935|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
2775936|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2775937|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
2775938|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775939|NCT04397549|Morphine|morphine|mesh-list
2775940|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2775941|NCT04397549|Narcotics|narcotics|mesh-ancestor
2775942|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775943|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775944|NCT04397549|Analgesics|analgesics|mesh-ancestor
2775945|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
2102208|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
2102209|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268629|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
2775946|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775947|NCT04397484|Lidocaine|lidocaine|mesh-list
2775948|NCT04397484|Epinephrine|epinephrine|mesh-list
2775949|NCT04397484|Racepinephrine|racepinephrine|mesh-list
2775950|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
2775951|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
2775952|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
2268630|NCT00190008|Piracetam|piracetam|mesh-list
2268631|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2268632|NCT00190008|Protective Agents|protective agents|mesh-ancestor
2775953|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
2775954|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775955|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775956|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
2775957|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775958|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2775959|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2775960|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2775961|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2775962|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775963|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2775964|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2268633|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268634|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
2268635|NCT00190021|Donepezil|donepezil|mesh-list
2268636|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2268637|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268638|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268639|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
2268640|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268641|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268642|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
2268643|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
2268644|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2268645|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
2268646|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268647|NCT00190034|Expectorants|expectorants|mesh-ancestor
2268648|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
2268649|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2268650|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
2775965|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
2775966|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268651|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268652|NCT00190034|Protective Agents|protective agents|mesh-ancestor
2268653|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268654|NCT00190034|Antidotes|antidotes|mesh-ancestor
2268655|NCT00190060|Testosterone|testosterone|mesh-list
2268656|NCT00190060|Androgens|androgens|mesh-ancestor
2268657|NCT00190060|Hormones|hormones|mesh-ancestor
2775967|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2775968|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2775969|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
2775970|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2775971|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
2775972|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
2775973|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
2775974|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2775975|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
2775976|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
2775977|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2775978|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2775979|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2775980|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2775981|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775982|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2775983|NCT04397406|Fentanyl|fentanyl|mesh-list
2775984|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
2775985|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
2775986|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2775987|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2775988|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2775989|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2775990|NCT04397406|Analgesics|analgesics|mesh-ancestor
2775991|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
2775992|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2775993|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2775994|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2775995|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2775996|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
2775997|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2775998|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2775999|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2776000|NCT04397406|Narcotics|narcotics|mesh-ancestor
2776001|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2776002|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2776003|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
2776004|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
2776005|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
2776006|NCT04396990|Prednisolone|prednisolone|mesh-list
2776007|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2776008|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
2776009|NCT04396990|Hormones|hormones|mesh-ancestor
2776010|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2776011|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776012|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2776013|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776014|NCT04397003|Durvalumab|durvalumab|mesh-list
2776015|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2776016|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776017|NCT04396938|Lamotrigine|lamotrigine|mesh-list
2776018|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
2776019|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2776020|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2776021|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776022|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2776023|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776024|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2776025|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2776026|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2776027|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2776028|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2776029|NCT04396730|Cannabidiol|cannabidiol|mesh-list
2776030|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
2776031|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
2776032|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2776033|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2776034|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776035|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
2776036|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2776037|NCT04396743|Clotrimazole|clotrimazole|mesh-list
2776038|NCT04396743|Miconazole|miconazole|mesh-list
2776039|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2776040|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776041|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
2776042|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2776043|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2776044|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776045|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776046|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2776047|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
2776048|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2776049|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776050|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2776051|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2102210|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2102211|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2102212|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2102213|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2102214|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
2102215|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102216|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102217|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2102218|NCT02403895|Paclitaxel|paclitaxel|mesh-list
2102219|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2102220|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102221|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
2102222|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
2776052|NCT04396977|Histamine|histamine|mesh-list
2776053|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
2776054|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
2776055|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2776056|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268658|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2268659|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268660|NCT00190099|Dexamethasone|dexamethasone|mesh-list
2268661|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2268662|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
2268663|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
2268664|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268665|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268666|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2268667|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
2268668|NCT00190099|Hormones|hormones|mesh-ancestor
2268669|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2268670|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2268671|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268672|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
2776057|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776058|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
2776059|NCT04396457|Pemetrexed|pemetrexed|mesh-list
2776060|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2776061|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776062|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776063|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776064|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2776065|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2776066|NCT04396496|Daratumumab|daratumumab|mesh-list
2776067|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791062|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
2791063|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2791064|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2791065|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2791066|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2791067|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791068|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
2791069|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791070|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268673|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2268674|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268675|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2791071|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2791072|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791073|NCT04290104|Ampicillin|ampicillin|mesh-list
2791074|NCT04290104|Sulbactam|sulbactam|mesh-list
2791075|NCT04290104|Sultamicillin|sultamicillin|mesh-list
2791076|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2791077|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2791078|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2791079|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791080|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268676|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2268677|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268678|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268679|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791081|NCT04290026|Metoclopramide|metoclopramide|mesh-list
2791082|NCT04290026|Granisetron|granisetron|mesh-list
2791083|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
2791084|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
2791085|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791086|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791087|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2791088|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2791089|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2791090|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
2791091|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791092|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791093|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2791094|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
2791095|NCT04289805|Letrozole|letrozole|mesh-list
2791096|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791097|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2791098|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2791099|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268680|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2268681|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2268682|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
2268683|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268684|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
2268685|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268686|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2268687|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2268688|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
2268689|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268690|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268691|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2776068|NCT04396548|Midodrine|midodrine|mesh-list
2776069|NCT04396548|Anesthetics|anesthetics|mesh-list
2776070|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2776071|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776072|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
2776073|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
2776074|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776075|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2776076|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2776077|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2776078|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2776079|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
2776080|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2776081|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776082|NCT04396223|Methotrexate|methotrexate|mesh-list
2776083|NCT04396223|Avelumab|avelumab|mesh-list
2776084|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2776085|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
2776086|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2776087|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776088|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2776089|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
2776090|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776091|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776092|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
2776093|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776094|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2776095|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2776096|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
2776097|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2268692|NCT00190268|Amifampridine|amifampridine|mesh-list
2268693|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2268694|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268695|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268696|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2268697|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268698|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268699|NCT00190294|Misoprostol|misoprostol|mesh-list
2268700|NCT00190294|Mifepristone|mifepristone|mesh-list
2776098|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2776099|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2776100|NCT04396067|Tretinoin|tretinoin|mesh-list
2776101|NCT04396067|Isotretinoin|isotretinoin|mesh-list
2776102|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776103|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
2776104|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
2776105|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2776106|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2776107|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
2776108|NCT04395768|Vitamin D|vitamin d|mesh-list
2776109|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
2776110|NCT04395768|Vitamins|vitamins|mesh-list
2776111|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
2776112|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
2776113|NCT04395768|Hydroxocobalamin|hydroxocobalamin|mesh-list
2776114|NCT04395768|Azithromycin|azithromycin|mesh-list
2776115|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
2776116|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
2776117|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776118|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2776119|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776120|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2776121|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2776122|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776123|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
2776124|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2776125|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2776126|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776127|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2776128|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
2776129|NCT04395768|Protective Agents|protective agents|mesh-ancestor
2776130|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
2776131|NCT04395768|Hematinics|hematinics|mesh-ancestor
2776132|NCT04395989|Paclitaxel|paclitaxel|mesh-list
2776133|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2776134|NCT04395989|Capecitabine|capecitabine|mesh-list
2776135|NCT04395989|Everolimus|everolimus|mesh-list
2776136|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2776137|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776138|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
2776139|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
2776140|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
2776141|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776142|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2776143|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
2776144|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2776145|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
2776146|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776150|NCT04395612|Niraparib|niraparib|mesh-list
2776151|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2776152|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776153|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776154|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776155|NCT04395638|Vitamin D|vitamin d|mesh-list
2776156|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
2776157|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
2776158|NCT04395638|Vitamins|vitamins|mesh-list
2776159|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
2776160|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268701|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2268702|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
2268703|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2268704|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268705|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2268706|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2268707|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
2268708|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2268709|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2268710|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2268711|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2268712|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
2268713|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2268714|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2268715|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
2268716|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2268717|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
2268718|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2268719|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2268720|NCT00190307|Aspirin|aspirin|mesh-list
2268721|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2268722|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2268723|NCT00190307|Analgesics|analgesics|mesh-ancestor
2268724|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
2268725|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268726|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268727|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2268728|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2268729|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2268730|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2776161|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2776162|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2776163|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
2776164|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2776165|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
2776166|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776167|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
2776168|NCT04395417|Protective Agents|protective agents|mesh-ancestor
2776169|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2776170|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2776171|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776172|NCT04395365|Renal Agents|renal agents|mesh-ancestor
2776173|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2776174|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
2776175|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2776176|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2776177|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
2776178|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2776179|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
2776180|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2776181|NCT04395105|Dexamethasone|dexamethasone|mesh-list
2776182|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2776183|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
2776184|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
2776185|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776186|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776187|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2776188|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
2776189|NCT04395105|Hormones|hormones|mesh-ancestor
2776190|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2776191|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2776192|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776193|NCT04395248|Anesthetics|anesthetics|mesh-list
2776194|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2776195|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776196|NCT04395196|Choline|choline|mesh-list
2776197|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
2776198|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2776199|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
2776200|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776201|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2776202|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2776203|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
2776204|NCT04394975|Sunitinib|sunitinib|mesh-list
2776205|NCT04394975|Axitinib|axitinib|mesh-list
2776206|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776207|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2776208|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2776209|NCT04394975|Growth Substances|growth substances|mesh-ancestor
2776210|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776211|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
2776212|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2776213|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776214|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776215|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
2776216|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2776217|NCT04395170|Antibodies|antibodies|mesh-list
2776218|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
2776219|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776220|NCT04395079|Durvalumab|durvalumab|mesh-list
2776221|NCT04395079|Ipilimumab|ipilimumab|mesh-list
2776222|NCT04395079|Tremelimumab|tremelimumab|mesh-list
2776223|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
2776224|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2776225|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
2776226|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2776227|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776228|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
2776229|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776230|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2776231|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776232|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2776233|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2776234|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2776235|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2776236|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776237|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2776238|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776239|NCT04395001|Analgesics|analgesics|mesh-ancestor
2776240|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
2776241|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776242|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
2776243|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2776244|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
2776245|NCT04394897|Remifentanil|remifentanil|mesh-list
2776246|NCT04394897|Propofol|propofol|mesh-list
2268731|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268732|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2268733|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2268734|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268735|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
2268736|NCT00190333|Citalopram|citalopram|mesh-list
2776247|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2776248|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2776249|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776250|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2776251|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
2776252|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
2776253|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2776254|NCT04394897|Narcotics|narcotics|mesh-ancestor
2776255|NCT04394897|Analgesics|analgesics|mesh-ancestor
2776256|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
2776257|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776258|NCT04394728|Trabectedin|trabectedin|mesh-list
2776259|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2776260|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
2776261|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776262|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776263|NCT04394598|Capecitabine|capecitabine|mesh-list
2776264|NCT04394598|Irinotecan|irinotecan|mesh-list
2776265|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2776266|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
2776267|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776268|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776269|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2776270|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2776271|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776272|NCT04394663|Omeprazole|omeprazole|mesh-list
2776273|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2776274|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2776275|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2776276|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776277|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791100|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791101|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2791102|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
2791103|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2791104|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791105|NCT04289675|Interferons|interferons|mesh-list
2791106|NCT04289675|Interferon-beta|interferon-beta|mesh-list
2791107|NCT04289675|Teriflunomide|teriflunomide|mesh-list
2791108|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2791109|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791110|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
2791111|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2791112|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
2791113|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791114|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
2791115|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2791116|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2791117|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2791118|NCT04289675|Analgesics|analgesics|mesh-ancestor
2791119|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
2791120|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791121|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2791122|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2791123|NCT04289974|Fulvestrant|fulvestrant|mesh-list
2791124|NCT04289974|Palbociclib|palbociclib|mesh-list
2102223|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
2102224|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102225|NCT02403986|Lidocaine|lidocaine|mesh-list
2102226|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
2102227|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
2102228|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2102229|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102230|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
2776278|NCT04394533|Bupivacaine|bupivacaine|mesh-list
2776279|NCT04394533|Prilocaine|prilocaine|mesh-list
2776280|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
2776281|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
2776282|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2268737|NCT00190333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2268738|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268739|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268740|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268741|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268742|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
2268743|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268744|NCT00190333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2268745|NCT00190333|Antidepressive Agents|antidepressive agents|mesh-ancestor
2268746|NCT00190333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268747|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2268748|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2268749|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268750|NCT00190411|Celiprolol|celiprolol|mesh-list
2268751|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2268752|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2268753|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
2268754|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
2268755|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268756|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268757|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
2776283|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776284|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
2776285|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268758|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2268759|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2268760|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2268761|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
2268762|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268763|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268764|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
2268765|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2268766|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
2268767|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268768|NCT00190437|Amoxicillin|amoxicillin|mesh-list
2268769|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2268770|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268771|NCT00190463|Amphotericin B|amphotericin b|mesh-list
2268772|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2268773|NCT00190463|Amebicides|amebicides|mesh-ancestor
2268774|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2776313|NCT04394234|Warfarin|warfarin|mesh-list
2776314|NCT04394234|Anticoagulants|anticoagulants|mesh-list
2102231|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102232|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2102233|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2102234|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2102235|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2776315|NCT04394182|Ritonavir|ritonavir|mesh-list
2776316|NCT04394182|Lopinavir|lopinavir|mesh-list
2776317|NCT04394182|Azithromycin|azithromycin|mesh-list
2776318|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
2776319|NCT04394182|Tazobactam|tazobactam|mesh-list
2776320|NCT04394182|Piperacillin|piperacillin|mesh-list
2776321|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2776322|NCT04394182|Heparin|heparin|mesh-list
2776323|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2776324|NCT04394182|Tinzaparin|tinzaparin|mesh-list
2776325|NCT04394182|Dalteparin|dalteparin|mesh-list
2776326|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2776327|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2776328|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
2776329|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776330|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776331|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2776332|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2776333|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
2776334|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776335|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2776336|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2776337|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
2776338|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2776339|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2776340|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2776341|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
2776342|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2776343|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2776344|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2776345|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2776346|NCT04394130|Ropivacaine|ropivacaine|mesh-list
2776347|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
2776348|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
2776349|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2776350|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776351|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
2776352|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776353|NCT04394208|Silymarin|silymarin|mesh-list
2776354|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
2776355|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776356|NCT04394208|Protective Agents|protective agents|mesh-ancestor
2776357|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776358|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
2776359|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
2776360|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2776361|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2776362|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776363|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776364|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776365|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2776366|NCT04394390|Vitamin D|vitamin d|mesh-list
2776367|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
2776368|NCT04394390|Vitamins|vitamins|mesh-list
2776369|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
2776370|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776371|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2776372|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2776373|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
2776374|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776375|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2776376|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776377|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776378|NCT04394377|Heparin|heparin|mesh-list
2776379|NCT04394377|Enoxaparin|enoxaparin|mesh-list
2776380|NCT04394377|Calcium heparin|calcium heparin|mesh-list
2776381|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
2776382|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
2776383|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
2776384|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2776385|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2776386|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776387|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2268775|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2268776|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268777|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2268778|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
2268779|NCT00190476|Docetaxel|docetaxel|mesh-list
2268780|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268781|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
2268782|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
2268783|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
2268784|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268785|NCT00190489|Docetaxel|docetaxel|mesh-list
2268786|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268787|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
2268788|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
2776388|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
2776389|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2776390|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
2776391|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776392|NCT04394143|Mannitol|mannitol|mesh-list
2776393|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2776394|NCT04394143|Diuretics|diuretics|mesh-ancestor
2776395|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
2776396|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776397|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
2776398|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2776399|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776400|NCT04393805|Heparin|heparin|mesh-list
2776401|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2776402|NCT04393805|Tinzaparin|tinzaparin|mesh-list
2268789|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
2268790|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268791|NCT00190502|Antibodies|antibodies|mesh-list
2268792|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
2268793|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268794|NCT00190515|Leucovorin|leucovorin|mesh-list
2268795|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
2268796|NCT00190515|Antidotes|antidotes|mesh-ancestor
2268797|NCT00190515|Protective Agents|protective agents|mesh-ancestor
2776403|NCT04393805|Dalteparin|dalteparin|mesh-list
2776404|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
2776405|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2776406|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2776407|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268798|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268799|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
2268800|NCT00190515|Vitamins|vitamins|mesh-ancestor
2268801|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
2268802|NCT00190554|Cisplatin|cisplatin|mesh-list
2268803|NCT00190554|Fluorouracil|fluorouracil|mesh-list
2268804|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268805|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
2268806|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268807|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2776408|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
2776409|NCT04393792|Povidone|povidone|mesh-list
2776410|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
2776411|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
2776412|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2776413|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776414|NCT04393610|Lidocaine|lidocaine|mesh-list
2776415|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
2776416|NCT04393610|Fentanyl|fentanyl|mesh-list
2776417|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
2776418|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
2776419|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2776420|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776421|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
2776422|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776423|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2268808|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268809|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
2268810|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268811|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2268812|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2268813|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268814|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2776424|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2776425|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2268815|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268816|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268817|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268818|NCT00190567|Analgesics|analgesics|mesh-ancestor
2268819|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
2268820|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268821|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
2776426|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2776427|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776428|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2776429|NCT04393610|Narcotics|narcotics|mesh-ancestor
2776430|NCT04393610|Analgesics|analgesics|mesh-ancestor
2776431|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2776432|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2776433|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
2776434|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
2776435|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2776436|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2776437|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
2776438|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2776446|NCT04393389|Paclitaxel|paclitaxel|mesh-list
2776447|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2776448|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776449|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
2776450|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
2776451|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
2776452|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776453|NCT04393506|Apatinib|apatinib|mesh-list
2776454|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2776455|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776456|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2776457|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776458|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776459|NCT04393454|Sirolimus|sirolimus|mesh-list
2776460|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2776461|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776462|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2776463|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776464|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
2776465|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2776466|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
2776467|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776468|NCT04393584|Leucovorin|leucovorin|mesh-list
2776469|NCT04393584|Docetaxel|docetaxel|mesh-list
2776470|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
2776471|NCT04393584|Irinotecan|irinotecan|mesh-list
2776472|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776473|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
2776474|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
2776475|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
2776476|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776477|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2776478|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2776479|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776480|NCT04393584|Antidotes|antidotes|mesh-ancestor
2776481|NCT04393584|Protective Agents|protective agents|mesh-ancestor
2776482|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776483|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
2776484|NCT04393584|Vitamins|vitamins|mesh-ancestor
2776485|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
2776486|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
2776487|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2776488|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2776489|NCT04393220|Bevacizumab|bevacizumab|mesh-list
2776490|NCT04393220|Nivolumab|nivolumab|mesh-list
2776491|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2776492|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776493|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2776494|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2776495|NCT04393220|Growth Substances|growth substances|mesh-ancestor
2776496|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776497|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
2776498|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2776499|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776500|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
2776501|NCT04393246|Ambrisentan|ambrisentan|mesh-list
2776502|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2776503|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776504|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2776505|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776506|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2776507|NCT04393207|Bupivacaine|bupivacaine|mesh-list
2776508|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
2776509|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
2776510|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2776511|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776512|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
2776513|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776514|NCT04392921|Amiodarone|amiodarone|mesh-list
2776515|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2776516|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
2776517|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2776518|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2776519|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776520|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2776521|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2776522|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2776523|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776524|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2776525|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2776526|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2791125|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2791126|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791127|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2791128|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2791129|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
2791130|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2791131|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791132|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2791133|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791134|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791135|NCT04289883|Calcium|calcium|mesh-list
2791136|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2791137|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791138|NCT04289792|Gemcitabine|gemcitabine|mesh-list
2791139|NCT04289792|Paclitaxel|paclitaxel|mesh-list
2791140|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2791141|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791142|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
2791143|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
2791144|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
2791145|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791146|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2791147|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
2791148|NCT04289792|Antiviral Agents|antiviral agents|mesh-ancestor
2791149|NCT04289792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2791150|NCT04289792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791151|NCT04289792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2791152|NCT04289792|Immunologic Factors|immunologic factors|mesh-ancestor
2791153|NCT04289792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792850|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792851|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792852|NCT04274920|Calcium|calcium|mesh-list
2792853|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2792854|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792855|NCT04275024|Calcipotriene|calcipotriene|mesh-list
2792856|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
2792857|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
2792858|NCT04274907|Venetoclax|venetoclax|mesh-list
2792859|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2792860|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776527|NCT04393025|Aspirin|aspirin|mesh-list
2776528|NCT04393025|Clopidogrel|clopidogrel|mesh-list
2776529|NCT04393025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2776530|NCT04393025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2776531|NCT04393025|Analgesics|analgesics|mesh-ancestor
2776532|NCT04393025|Sensory System Agents|sensory system agents|mesh-ancestor
2776533|NCT04393025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776534|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776535|NCT04393025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2776536|NCT04393025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2776537|NCT04393025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2776538|NCT04393025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2776539|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776540|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2776541|NCT04393025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2776542|NCT04393025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776543|NCT04393025|Antipyretics|antipyretics|mesh-ancestor
2776544|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2776545|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2776546|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2776547|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
2776548|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2776549|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
2776550|NCT04392973|Favipiravir|favipiravir|mesh-list
2776551|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
2776552|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2776553|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2776554|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776555|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776556|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776557|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2776558|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
2776559|NCT04392427|Ribavirin|ribavirin|mesh-list
2776560|NCT04392427|Ivermectin|ivermectin|mesh-list
2776561|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
2776562|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
2776563|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268822|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268823|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
2268824|NCT00190580|Valsartan|valsartan|mesh-list
2268825|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
2268826|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2268827|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2268828|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268829|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2268830|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2268831|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
2268832|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2776564|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
2776565|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776566|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2776567|NCT04392622|Cisplatin|cisplatin|mesh-list
2776568|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776569|NCT04392700|Tenofovir|tenofovir|mesh-list
2776570|NCT04392700|Entecavir|entecavir|mesh-list
2776571|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
2776572|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776573|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2776574|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2776575|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776576|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776577|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2776578|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2776579|NCT04392648|Dexamethasone|dexamethasone|mesh-list
2776580|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
2776581|NCT04392648|Bortezomib|bortezomib|mesh-list
2776582|NCT04392648|Pomalidomide|pomalidomide|mesh-list
2776583|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2776584|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
2776585|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776586|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2776587|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2776588|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
2776589|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776590|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776591|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2268833|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268834|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2268835|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2776592|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2776593|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
2776594|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
2776595|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776596|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2776597|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
2776598|NCT04392648|Hormones|hormones|mesh-ancestor
2776599|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2776600|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2776601|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2776602|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2776603|NCT04392648|Growth Substances|growth substances|mesh-ancestor
2776604|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
2776605|NCT04392479|Aflibercept|aflibercept|mesh-list
2776606|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2776607|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2776608|NCT04392479|Growth Substances|growth substances|mesh-ancestor
2776609|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268836|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2268837|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2268838|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2268839|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268840|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2776610|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
2776611|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776612|NCT04392557|Metformin|metformin|mesh-list
2776613|NCT04392557|Pioglitazone|pioglitazone|mesh-list
2776614|NCT04392557|Alogliptin|alogliptin|mesh-list
2268841|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776615|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2776616|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776617|NCT04392557|Incretins|incretins|mesh-ancestor
2776618|NCT04392557|Hormones|hormones|mesh-ancestor
2776619|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2776620|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2776621|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
2776622|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776623|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776624|NCT04392713|Ivermectin|ivermectin|mesh-list
2776625|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2776626|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776627|NCT04392375|Nifedipine|nifedipine|mesh-list
2776628|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2776629|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2776630|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776631|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2776632|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776633|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
2776634|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
2776635|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2776636|NCT04392531|Cyclosporine|cyclosporine|mesh-list
2776637|NCT04392531|Cyclosporins|cyclosporins|mesh-list
2776638|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776639|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776640|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2776641|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
2776642|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776643|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
2776644|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776645|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
2776646|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2776647|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2776648|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
2776649|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
2776650|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776651|NCT04392102|Niraparib|niraparib|mesh-list
2776652|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2776653|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776654|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776655|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776656|NCT04392063|Melatonin|melatonin|mesh-list
2776657|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
2776658|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776659|NCT04392063|Protective Agents|protective agents|mesh-ancestor
2776660|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776661|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2776662|NCT04392128|Azithromycin|azithromycin|mesh-list
2776663|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
2776664|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2776665|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776666|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
2776667|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2776668|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2776669|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776670|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776671|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2776672|NCT04392297|Antibodies|antibodies|mesh-list
2776673|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
2776674|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
2776675|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776676|NCT04392037|Dexamethasone|dexamethasone|mesh-list
2776677|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
2776678|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2776679|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
2776680|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776681|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2776682|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2776683|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
2776684|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776685|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102236|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102237|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
2102238|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
2102239|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102240|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2102241|NCT02404103|Flunisolide|flunisolide|mesh-list
2776686|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2776687|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2776688|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
2776689|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
2776690|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776691|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2776692|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
2776693|NCT04392037|Hormones|hormones|mesh-ancestor
2776694|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2776695|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2776696|NCT04392011|Midazolam|midazolam|mesh-list
2776697|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
2776698|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2776699|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2776700|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2776701|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776702|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2776703|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2268842|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268843|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268844|NCT00190606|Analgesics|analgesics|mesh-ancestor
2268845|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
2776704|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2776705|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2776706|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
2776707|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
2776708|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
2776709|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
2776710|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2776711|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776712|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
2776713|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
2776714|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2776715|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2776716|NCT04391998|Metronidazole|metronidazole|mesh-list
2776717|NCT04391998|Albendazole|albendazole|mesh-list
2776718|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102242|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102243|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2102244|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
2102245|NCT02404168|Lamotrigine|lamotrigine|mesh-list
2268846|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268847|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
2268848|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268849|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
2268850|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2268851|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2268852|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268853|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268854|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268855|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2776719|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2776720|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2776721|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2776722|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
2776723|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
2776724|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2776725|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
2776726|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
2776727|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
2776728|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776729|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776730|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
2776731|NCT04391868|Citric Acid|citric acid|mesh-list
2776732|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
2776733|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
2776734|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2776735|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
2776736|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
2776737|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776738|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
2776739|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2776740|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2776741|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776742|NCT04391868|Urological Agents|urological agents|mesh-ancestor
2776743|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
2268856|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268857|NCT00190619|Analgesics|analgesics|mesh-ancestor
2268858|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
2268859|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268860|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
2268861|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268862|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
2776744|NCT04391855|Tramadol|tramadol|mesh-list
2776745|NCT04391855|Ropivacaine|ropivacaine|mesh-list
2776746|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2776747|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2776748|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776749|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2776750|NCT04391855|Analgesics|analgesics|mesh-ancestor
2776751|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
2776752|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776753|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2776754|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2776755|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2776756|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
2776757|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2776758|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776759|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
2776760|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
2776761|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2776762|NCT04391855|Narcotics|narcotics|mesh-ancestor
2776763|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
2776764|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2776765|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2776766|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776767|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2776768|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2776769|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
2776770|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2776771|NCT04391621|Triamcinolone|triamcinolone|mesh-list
2776772|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2776773|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2776774|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2776775|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2776776|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
2776777|NCT04391621|Hormones|hormones|mesh-ancestor
2776778|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2776779|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776780|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2776781|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
2776782|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776783|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776784|NCT04391660|Ethanol|ethanol|mesh-list
2776785|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2776786|NCT04391660|Eusol|eusol|mesh-list
2776787|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2776788|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2776789|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776790|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2776791|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776792|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
2776793|NCT04391608|Tenofovir|tenofovir|mesh-list
2776794|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
2776795|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776796|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2776797|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2776798|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776799|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776800|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2776801|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2791154|NCT04289103|Inolimomab|inolimomab|mesh-list
2791155|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2791156|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
2791157|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791158|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
2791159|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2791160|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791161|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791162|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2791163|NCT04289142|Analgesics|analgesics|mesh-ancestor
2791164|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
2791165|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791166|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2791167|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2791168|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2791169|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
2791170|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791171|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791172|NCT04289467|Fenfluramine|fenfluramine|mesh-list
2791173|NCT04289467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2791174|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2791175|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2791176|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791177|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791178|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
2791179|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791180|NCT04289090|Propofol|propofol|mesh-list
2791181|NCT04289090|Sevoflurane|sevoflurane|mesh-list
2791182|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2791183|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791184|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791185|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2791186|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
2791187|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
2791188|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2791189|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2791190|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2791191|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2791192|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2791193|NCT04289207|Danazol|danazol|mesh-list
2791194|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2791195|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
2791196|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2791197|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791198|NCT04288999|Capecitabine|capecitabine|mesh-list
2791199|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2791200|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
2791201|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791202|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776802|NCT04391764|Naltrexone|naltrexone|mesh-list
2776803|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2776804|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2776805|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776806|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
2776807|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776808|NCT04391569|Ganaxolone|ganaxolone|mesh-list
2776809|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
2776810|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2776811|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776812|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776813|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
2776814|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
2776815|NCT04391478|Milrinone|milrinone|mesh-list
2776816|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
2776817|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
2776818|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2776819|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2776820|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776821|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776822|NCT04391478|Urological Agents|urological agents|mesh-ancestor
2776823|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2776824|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2776825|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2776826|NCT04391478|Protective Agents|protective agents|mesh-ancestor
2776827|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776828|NCT04391361|Atropine|atropine|mesh-list
2776829|NCT04391361|Scopolamine|scopolamine|mesh-list
2776830|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
2776831|NCT04391361|Edaravone|edaravone|mesh-list
2776832|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2776833|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2776834|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2776835|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776836|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2776837|NCT04391361|Analgesics|analgesics|mesh-ancestor
2776838|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
2776839|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776840|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2776841|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2776842|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2776843|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
2776844|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2776845|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776846|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2776847|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2776848|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2776849|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
2776850|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2776851|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
2776852|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
2776853|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
2776854|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2776855|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2776856|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
2776857|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
2776858|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2776859|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2776860|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
2776861|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2776862|NCT04391361|Protective Agents|protective agents|mesh-ancestor
2776863|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2776864|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2776865|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776866|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
2776867|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2776868|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776869|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776870|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2776871|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2776872|NCT04391231|Protective Agents|protective agents|mesh-ancestor
2776873|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776874|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
2776875|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2776876|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
2776877|NCT04391309|Remdesivir|remdesivir|mesh-list
2776878|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
2776879|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776880|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
2776881|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776882|NCT04391283|Osimertinib|osimertinib|mesh-list
2776883|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776884|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2776885|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776886|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776887|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
2776888|NCT04391127|Ivermectin|ivermectin|mesh-list
2776889|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
2776890|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2776891|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2776892|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2776893|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776894|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776895|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2776896|NCT04390789|Calcium|calcium|mesh-list
2776897|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2776898|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776899|NCT04391179|Dipyridamole|dipyridamole|mesh-list
2776900|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2776901|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776902|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776903|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2776904|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
2776905|NCT04390984|Apatinib|apatinib|mesh-list
2776906|NCT04390984|Gefitinib|gefitinib|mesh-list
2776907|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776908|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2776909|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776910|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776911|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
2776912|NCT04390698|Anesthetics|anesthetics|mesh-list
2776913|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2776914|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776915|NCT04390698|Narcotics|narcotics|mesh-ancestor
2776916|NCT04390698|Analgesics|analgesics|mesh-ancestor
2776917|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
2776918|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776919|NCT04390854|Clotrimazole|clotrimazole|mesh-list
2776920|NCT04390854|Miconazole|miconazole|mesh-list
2776921|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2776922|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268863|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2268864|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2268865|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268866|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268867|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268868|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268869|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268870|NCT00190632|Analgesics|analgesics|mesh-ancestor
2268871|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
2268872|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268873|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
2268874|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268875|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
2268876|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2268877|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2268878|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268879|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268880|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268881|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268882|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268883|NCT00190645|Analgesics|analgesics|mesh-ancestor
2268884|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
2268885|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268886|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
2268887|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268888|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
2268889|NCT00190710|Gemcitabine|gemcitabine|mesh-list
2268890|NCT00190710|Carboplatin|carboplatin|mesh-list
2776923|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
2268891|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268892|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2268893|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
2268894|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268895|NCT00190710|Antiviral Agents|antiviral agents|mesh-ancestor
2268896|NCT00190710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268897|NCT00190710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268898|NCT00190710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2268899|NCT00190710|Immunologic Factors|immunologic factors|mesh-ancestor
2268900|NCT00190710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268901|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2268902|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2268903|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268904|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268905|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268906|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
2268907|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268908|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268909|NCT00190762|Pemetrexed|pemetrexed|mesh-list
2268910|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776924|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2776925|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2776926|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776927|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776928|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2776929|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
2776930|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2776931|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776932|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2776933|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2268911|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268912|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268913|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2268914|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2268915|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
2268916|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2268917|NCT00190801|Pemetrexed|pemetrexed|mesh-list
2268918|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268919|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268920|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268921|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2268922|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2776934|NCT04390945|Capecitabine|capecitabine|mesh-list
2776935|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2776936|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
2776937|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776938|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268923|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2268924|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2776939|NCT04390815|Insulin|insulin|mesh-list
2776940|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2776941|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2776942|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776943|NCT04390958|Paclitaxel|paclitaxel|mesh-list
2776944|NCT04390958|Capecitabine|capecitabine|mesh-list
2776945|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2776946|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2776947|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
2776948|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
2776949|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
2776950|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776951|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2776952|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
2776953|NCT04390464|Ravulizumab|ravulizumab|mesh-list
2776954|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2776955|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2776956|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
2776957|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776958|NCT04390581|Lidocaine|lidocaine|mesh-list
2776959|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
2776960|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
2791203|NCT04288765|Dexamethasone|dexamethasone|mesh-list
2776961|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2268925|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268926|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268927|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268928|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268929|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268930|NCT00190814|Analgesics|analgesics|mesh-ancestor
2268931|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
2268932|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268933|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
2268934|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268935|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
2268936|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2268937|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2268938|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268939|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2776962|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776963|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
2776964|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776965|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2776966|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2776967|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2776968|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2776969|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776970|NCT04390685|Tacrolimus|tacrolimus|mesh-list
2776971|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2776972|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
2776973|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776974|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2268940|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268941|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268942|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268943|NCT00190827|Analgesics|analgesics|mesh-ancestor
2268944|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
2268945|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268946|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
2268947|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268948|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
2268949|NCT00190840|Pemetrexed|pemetrexed|mesh-list
2268950|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2268951|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2268952|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268953|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2268954|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2268955|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2268956|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2268957|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2776975|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2776976|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2776977|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2776978|NCT04390646|Hormones|hormones|mesh-ancestor
2268958|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268959|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268960|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2776979|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2776980|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776981|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
2776982|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2776983|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2776984|NCT04391439|Prednisolone|prednisolone|mesh-list
2776985|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
2776986|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2776987|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
2776988|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2776989|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
2776990|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
2776991|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2776992|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2776993|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2776994|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
2268961|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268962|NCT00190853|Analgesics|analgesics|mesh-ancestor
2268963|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
2268964|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268965|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
2268966|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268967|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
2268968|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2268969|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2268970|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268971|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2268972|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268973|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268974|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268975|NCT00190866|Analgesics|analgesics|mesh-ancestor
2268976|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
2268977|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268978|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
2776995|NCT04391439|Hormones|hormones|mesh-ancestor
2776996|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2776997|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2776998|NCT04391439|Protective Agents|protective agents|mesh-ancestor
2776999|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2777000|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777001|NCT04390334|Efavirenz|efavirenz|mesh-list
2777002|NCT04390334|Famotidine|famotidine|mesh-list
2777003|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2777004|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2777005|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777006|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777007|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
2777008|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777009|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2777010|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2777011|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2777012|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2777013|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2777014|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2777015|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2777016|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2777017|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2777018|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
2777019|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
2777020|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777021|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777022|NCT04390594|Nafamostat|nafamostat|mesh-list
2777023|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2777024|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2777025|NCT04390594|Analgesics|analgesics|mesh-ancestor
2777026|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
2777027|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777028|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777029|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2777030|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2777031|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
2777032|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
2777033|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777034|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777035|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2777036|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2777037|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2777038|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2777039|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
2777040|NCT04390295|Metformin|metformin|mesh-list
2777041|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2777042|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777043|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
2777044|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777045|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
2777046|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2777047|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2777048|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777049|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
2777050|NCT04390217|Coagulants|coagulants|mesh-ancestor
2777051|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
2777052|NCT04390061|Tofacitinib|tofacitinib|mesh-list
2777053|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
2777054|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2777055|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2777056|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777057|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777058|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777059|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2777060|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2777061|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
2268979|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2268980|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
2268981|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2268982|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2268983|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2268984|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2777062|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2777063|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
2777064|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777065|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
2777066|NCT04389866|Protective Agents|protective agents|mesh-ancestor
2777067|NCT04390152|Ritonavir|ritonavir|mesh-list
2777068|NCT04390152|Lopinavir|lopinavir|mesh-list
2777069|NCT04390152|Azithromycin|azithromycin|mesh-list
2777070|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
2777071|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2777072|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2777073|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
2777074|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777075|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777076|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2777077|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2268985|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2268986|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
2268987|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2268988|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268989|NCT00190892|Carbamazepine|carbamazepine|mesh-list
2777078|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
2777079|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777080|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2777081|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2777082|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2777083|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
2777084|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2777085|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2777086|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2791204|NCT04288765|Lenalidomide|lenalidomide|mesh-list
2791205|NCT04288765|Daratumumab|daratumumab|mesh-list
2791206|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2791207|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
2791208|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
2791209|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791210|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791211|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2791212|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
2791213|NCT04288765|Hormones|hormones|mesh-ancestor
2791214|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2791215|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102246|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
2102247|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2102248|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2102249|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102250|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2102251|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102252|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2102253|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2102254|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2102255|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2102256|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2268990|NCT00190892|Olanzapine|olanzapine|mesh-list
2268991|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
2268992|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
2791216|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791217|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
2777087|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
2777088|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
2268993|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2268994|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2268995|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2268996|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2268997|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2268998|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2268999|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269000|NCT00190892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2269001|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269002|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269003|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269004|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269005|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
2777089|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2777090|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
2777091|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777092|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
2777093|NCT04390100|Protective Agents|protective agents|mesh-ancestor
2777094|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
2777095|NCT04390100|Coagulants|coagulants|mesh-ancestor
2777096|NCT04389840|Heparin|heparin|mesh-list
2777097|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
2777098|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2777099|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2777100|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777101|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
2777102|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2777103|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2777104|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777105|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
2777106|NCT04389554|Coagulants|coagulants|mesh-ancestor
2777107|NCT04389567|Famotidine|famotidine|mesh-list
2777108|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2777109|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2777110|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2777111|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
2777112|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
2777113|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777114|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777115|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777116|NCT04389801|Deferoxamine|deferoxamine|mesh-list
2777117|NCT04389801|Siderophores|siderophores|mesh-ancestor
2777118|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2777119|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
2777120|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
2777121|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777122|NCT04389580|Tamoxifen|tamoxifen|mesh-list
2777123|NCT04389580|Isotretinoin|isotretinoin|mesh-list
2777124|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2777125|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
2777126|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2777127|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777128|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2777129|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777130|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2777131|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2777132|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2777133|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
2777134|NCT04389424|Tamoxifen|tamoxifen|mesh-list
2777135|NCT04389424|Anastrozole|anastrozole|mesh-list
2777136|NCT04389424|Exemestane|exemestane|mesh-list
2777137|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2777138|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
2777139|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2777140|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777141|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2777142|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777143|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2777144|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2777145|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2777146|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2777147|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2269006|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
2269007|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
2269008|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2269009|NCT00190892|Analgesics|analgesics|mesh-ancestor
2269010|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
2269011|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2269012|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2777148|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777149|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777150|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
2777151|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
2777152|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2777153|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2777154|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777155|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777156|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777157|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2777158|NCT04389411|Montelukast|montelukast|mesh-list
2777159|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2777160|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
2777161|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2777162|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
2777163|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2777164|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777165|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2777166|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2777167|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777168|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
2777169|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
2777170|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2777171|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2777172|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777173|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777174|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777175|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2777176|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
2777177|NCT04389073|Bevacizumab|bevacizumab|mesh-list
2777178|NCT04389073|Capecitabine|capecitabine|mesh-list
2777179|NCT04389073|Vinorelbine|vinorelbine|mesh-list
2777180|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2777181|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
2777182|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777183|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2777184|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2777185|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
2777186|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777187|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777188|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2777189|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2777190|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2777191|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2777192|NCT04389073|Growth Substances|growth substances|mesh-ancestor
2777193|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
2777194|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2777195|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
2777196|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2777197|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
2777198|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
2777199|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
2777200|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
2777201|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2777202|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777203|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
2777204|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777205|NCT04389060|Protective Agents|protective agents|mesh-ancestor
2777206|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777207|NCT04389229|Aldesleukin|aldesleukin|mesh-list
2777208|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
2777209|NCT04389229|Fludarabine|fludarabine|mesh-list
2777210|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2777211|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
2777212|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777213|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2777214|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2777215|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
2777216|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777217|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777218|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2777219|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2777220|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2777221|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
2777222|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777223|NCT04389177|Paclitaxel|paclitaxel|mesh-list
2777224|NCT04389177|Cisplatin|cisplatin|mesh-list
2777225|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
2777226|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2777227|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777228|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
2777229|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
2777230|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
2777231|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777232|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2777233|NCT04388774|Ketamine|ketamine|mesh-list
2777234|NCT04388774|Analgesics|analgesics|mesh-ancestor
2777235|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
2777236|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777237|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777238|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2777239|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2777240|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
2777241|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
2777242|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2777243|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2777244|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2777245|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777246|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777252|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
2777253|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2777254|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
2777255|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777256|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777257|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2777258|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
2777259|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2777260|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
2777261|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777262|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777263|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2777264|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
2777265|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
2777266|NCT04388683|Protective Agents|protective agents|mesh-ancestor
2777267|NCT04388709|Interferons|interferons|mesh-list
2777268|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777269|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
2777270|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777271|NCT04388176|Compound 21|compound 21|mesh-list
2777272|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2777273|NCT04388904|Tenofovir|tenofovir|mesh-list
2777274|NCT04388904|Emtricitabine|emtricitabine|mesh-list
2269013|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2269014|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2269015|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2269016|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269017|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269018|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269019|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269020|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269021|NCT00190905|Analgesics|analgesics|mesh-ancestor
2269022|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
2269023|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269024|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
2269025|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269026|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
2269027|NCT00190918|Pemetrexed|pemetrexed|mesh-list
2269028|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777275|NCT04388904|Darunavir|darunavir|mesh-list
2777276|NCT04388904|Cobicistat|cobicistat|mesh-list
2777277|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2777278|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
2777279|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777280|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2777281|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2777282|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777283|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777284|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2777285|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2777286|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2777287|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2777288|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
2777289|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2777290|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2777291|NCT04388202|Citalopram|citalopram|mesh-list
2777292|NCT04388202|Sertraline|sertraline|mesh-list
2777293|NCT04388202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2777294|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269029|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269030|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269031|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2269032|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2269033|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2269034|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2269035|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269036|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269037|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269038|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269039|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269040|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269041|NCT00190944|Teriparatide|teriparatide|mesh-list
2269042|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2269043|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777295|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2777296|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777297|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777298|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
2777299|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777300|NCT04388202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2777301|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
2777302|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2777303|NCT04388124|Bosentan|bosentan|mesh-list
2777304|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2777305|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2777306|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791218|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2791219|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2791220|NCT04288765|Growth Substances|growth substances|mesh-ancestor
2791221|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
2791222|NCT04288895|Vortioxetine|vortioxetine|mesh-list
2791223|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
2791224|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2791225|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2791226|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2791227|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2269044|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2269045|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2269046|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2269047|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269048|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269049|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269050|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269051|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269052|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269053|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
2269054|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269055|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777307|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2777308|NCT04388189|Bupropion|bupropion|mesh-list
2777309|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2777310|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
2777311|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2777312|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2777313|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2777314|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2777315|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777316|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
2777317|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777318|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777319|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2777320|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2777321|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777322|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2777323|NCT04388189|Analgesics|analgesics|mesh-ancestor
2777324|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
2777325|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777326|NCT04388111|Morphine|morphine|mesh-list
2777327|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2777328|NCT04388111|Narcotics|narcotics|mesh-ancestor
2777329|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2777330|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777331|NCT04388111|Analgesics|analgesics|mesh-ancestor
2777332|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
2777333|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777334|NCT04388319|Zonisamide|zonisamide|mesh-list
2777335|NCT04388319|Bupropion|bupropion|mesh-list
2777336|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2777337|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
2777338|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2777339|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2777340|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2777341|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2777342|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777343|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
2777344|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777345|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777346|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2777347|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2777348|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777349|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
2777350|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2792861|NCT04274894|Testosterone|testosterone|mesh-list
2269056|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2269057|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2269058|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2102257|NCT02404220|Dexamethasone|dexamethasone|mesh-list
2102258|NCT02404220|Vincristine|vincristine|mesh-list
2102259|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102260|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
2102261|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
2102262|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102263|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102264|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2102265|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
2102266|NCT02404220|Hormones|hormones|mesh-ancestor
2102267|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102268|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102269|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102270|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2102271|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
2102272|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
2102273|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
2102274|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102275|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
2102276|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2102277|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
2102278|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269059|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269060|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777351|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2777352|NCT04387786|Albuterol|albuterol|mesh-list
2777353|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2777354|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
2777355|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777356|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777357|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2777358|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
2777359|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
2777360|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2777361|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2777362|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2777363|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2777364|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
2777365|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777366|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777367|NCT04387929|Antibodies|antibodies|mesh-list
2777368|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
2777369|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777370|NCT04387695|Sorafenib|sorafenib|mesh-list
2777371|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777372|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2777373|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777374|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777375|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
2777376|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
2777377|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777378|NCT04388033|Temozolomide|temozolomide|mesh-list
2777379|NCT04388033|Interleukin-12|interleukin-12|mesh-list
2777380|NCT04388033|Vaccines|vaccines|mesh-list
2777381|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
2777382|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777383|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2777384|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
2777385|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777386|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777387|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2777388|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2269061|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269062|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269063|NCT00190996|Analgesics|analgesics|mesh-ancestor
2269064|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
2269065|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777389|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2777390|NCT04388033|Growth Substances|growth substances|mesh-ancestor
2777391|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
2777392|NCT04387617|Cannabidiol|cannabidiol|mesh-list
2777393|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
2777394|NCT04387604|Ranibizumab|ranibizumab|mesh-list
2777395|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2777396|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2777397|NCT04387604|Growth Substances|growth substances|mesh-ancestor
2777398|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777399|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
2777400|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777401|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
2777402|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2777403|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2777404|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777405|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
2777406|NCT04387305|Coagulants|coagulants|mesh-ancestor
2777407|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
2777408|NCT04387539|Simeprevir|simeprevir|mesh-list
2777409|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
2777410|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777411|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
2777412|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777413|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777414|NCT04387565|Vanadium|vanadium|mesh-list
2777415|NCT04387565|Trace Elements|trace elements|mesh-ancestor
2777416|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
2777417|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777418|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
2777419|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
2777420|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777421|NCT04387500|Axitinib|axitinib|mesh-list
2777422|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269066|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
2269067|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269068|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
2269069|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2269070|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2269071|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269072|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269073|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269074|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269075|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269076|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269077|NCT00191022|Paroxetine|paroxetine|mesh-list
2269078|NCT00191022|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2269079|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2777423|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2777424|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777425|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777426|NCT04387630|Metformin|metformin|mesh-list
2777427|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2777428|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777429|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
2777430|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
2777431|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777432|NCT04387240|Artesunate|artesunate|mesh-list
2777433|NCT04387240|Artemisinins|artemisinins|mesh-list
2777434|NCT04387240|Artemisinin|artemisinin|mesh-list
2777435|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
2777436|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2777437|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2777438|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777439|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777440|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
2777441|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
2269080|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269081|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269082|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269083|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
2269084|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269085|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2269086|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
2269087|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269088|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2269089|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2269090|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269091|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2269092|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2269093|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269094|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2777442|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2777443|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
2777444|NCT04387227|Carboplatin|carboplatin|mesh-list
2777445|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
2777446|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777447|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2777448|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
2777449|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
2777450|NCT04387201|Dulaglutide|dulaglutide|mesh-list
2777451|NCT04387201|Vitamins|vitamins|mesh-ancestor
2777452|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
2777453|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777454|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
2777455|NCT04387201|Hematinics|hematinics|mesh-ancestor
2777456|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2777457|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
2777458|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2777459|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777460|NCT04387136|Sufentanil|sufentanil|mesh-list
2777461|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2777462|NCT04387136|Narcotics|narcotics|mesh-ancestor
2777463|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2777464|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777465|NCT04387136|Analgesics|analgesics|mesh-ancestor
2777466|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
2777467|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777468|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2777469|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2269095|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269096|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269097|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269098|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269099|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2269100|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2777470|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
2777471|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
2777472|NCT04386876|Ritonavir|ritonavir|mesh-list
2777473|NCT04386876|Lopinavir|lopinavir|mesh-list
2777474|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2777475|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2777476|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
2777477|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777478|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777479|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2777480|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2777481|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
2269101|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269102|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269103|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269104|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269105|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269106|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269107|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2269108|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2777482|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777483|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2777484|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2777485|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
2777486|NCT04387084|Nivolumab|nivolumab|mesh-list
2777487|NCT04387084|Durvalumab|durvalumab|mesh-list
2777488|NCT04387084|Avelumab|avelumab|mesh-list
2777489|NCT04387084|Cemiplimab|cemiplimab|mesh-list
2777490|NCT04387084|Atezolizumab|atezolizumab|mesh-list
2777491|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
2777492|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2777493|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
2777494|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2777495|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777496|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2777497|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777498|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
2777499|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777500|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2777501|NCT04386850|Calcifediol|calcifediol|mesh-list
2777502|NCT04386850|Vitamins|vitamins|mesh-ancestor
2777503|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
2777504|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777505|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2777516|NCT04386746|Gemcitabine|gemcitabine|mesh-list
2777517|NCT04386746|Docetaxel|docetaxel|mesh-list
2777518|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2777519|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
2777520|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777521|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777522|NCT04386746|Antiviral Agents|antiviral agents|mesh-ancestor
2777523|NCT04386746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777524|NCT04386746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777525|NCT04386746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2777526|NCT04386746|Immunologic Factors|immunologic factors|mesh-ancestor
2777527|NCT04386746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777528|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
2777529|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
2777530|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
2269109|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269110|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269111|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269112|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269113|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269114|NCT00191061|Analgesics|analgesics|mesh-ancestor
2777531|NCT04387097|Remifentanil|remifentanil|mesh-list
2777532|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2777533|NCT04387097|Narcotics|narcotics|mesh-ancestor
2777534|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2777535|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777536|NCT04387097|Analgesics|analgesics|mesh-ancestor
2269115|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
2777537|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
2777538|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791228|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791229|NCT04288895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2791230|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2791231|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2791232|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791233|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791234|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
2791235|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2791236|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2791237|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2791238|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2791239|NCT04288687|Niraparib|niraparib|mesh-list
2791240|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2791241|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791242|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791243|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791244|NCT04288700|Timolol|timolol|mesh-list
2791245|NCT04288700|Propranolol|propranolol|mesh-list
2791246|NCT04288700|Captopril|captopril|mesh-list
2791247|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2791248|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2791249|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2791250|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2791251|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
2791252|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791253|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791254|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791255|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2791256|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2791257|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791258|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
2791259|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2791260|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
2791261|NCT04288427|Finasteride|finasteride|mesh-list
2791262|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2791263|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2791264|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791265|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791266|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
2791267|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2791268|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791269|NCT04288427|Urological Agents|urological agents|mesh-ancestor
2791270|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
2791271|NCT04288323|Edetic Acid|edetic acid|mesh-list
2791272|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
2791273|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2791274|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791275|NCT04288323|Antidotes|antidotes|mesh-ancestor
2791276|NCT04288323|Protective Agents|protective agents|mesh-ancestor
2791277|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791278|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
2791279|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
2791280|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2791281|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
2791282|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2791283|NCT04288349|Epinephrine|epinephrine|mesh-list
2791284|NCT04288349|Racepinephrine|racepinephrine|mesh-list
2791285|NCT04288349|Ropivacaine|ropivacaine|mesh-list
2791286|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
2777539|NCT04386499|Folic Acid|folic acid|mesh-list
2777540|NCT04386499|Resveratrol|resveratrol|mesh-list
2777541|NCT04386499|Hematinics|hematinics|mesh-ancestor
2777542|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
2777543|NCT04386499|Vitamins|vitamins|mesh-ancestor
2777544|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
2777545|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777546|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
2777547|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777548|NCT04386499|Protective Agents|protective agents|mesh-ancestor
2777549|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269116|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269117|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
2269118|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269119|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
2269120|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2269121|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2269122|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269123|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269124|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269125|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269126|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269127|NCT00191087|Analgesics|analgesics|mesh-ancestor
2269128|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
2269129|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269130|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
2777550|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2777551|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
2777552|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2777553|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2777554|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777555|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
2777556|NCT04386642|Coagulants|coagulants|mesh-ancestor
2777557|NCT04386577|Vitamin D|vitamin d|mesh-list
2777558|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
2777559|NCT04386577|Vitamins|vitamins|mesh-ancestor
2777560|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
2777561|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777562|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2777563|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2777572|NCT04386122|Loxoprofen|loxoprofen|mesh-list
2777573|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2777574|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2777575|NCT04386122|Analgesics|analgesics|mesh-ancestor
2777576|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
2777577|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777578|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777579|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2777580|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2777581|NCT04386447|Oxytocin|oxytocin|mesh-list
2777582|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
2777583|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2777584|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777585|NCT04385940|Vitamin D|vitamin d|mesh-list
2777586|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
2777587|NCT04385940|Vitamins|vitamins|mesh-ancestor
2777588|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
2777589|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777590|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2777591|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2777592|NCT04385719|Remdesivir|remdesivir|mesh-list
2777593|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
2777594|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777595|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
2777596|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777597|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2777598|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2777599|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777600|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
2777601|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2777602|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
2777603|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2777604|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777605|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2777606|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2777607|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2777608|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
2777609|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
2777610|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
2777611|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2777612|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777613|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
2777614|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777615|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
2777616|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2777617|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2777618|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777619|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2777620|NCT04385602|Analgesics|analgesics|mesh-ancestor
2777621|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
2777622|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777623|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2777624|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2777625|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2777626|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
2777627|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777628|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777629|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
2777630|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2777631|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2777632|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777633|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
2777634|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
2777635|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
2777636|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2777637|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2777638|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777639|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777640|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2777641|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
2777642|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2777643|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2777644|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
2777645|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777646|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777647|NCT04385654|Axitinib|axitinib|mesh-list
2777648|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777649|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2777650|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777651|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777652|NCT04385563|Docetaxel|docetaxel|mesh-list
2777653|NCT04385563|Trastuzumab|trastuzumab|mesh-list
2777654|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777655|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
2777656|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
2777657|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
2777658|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777659|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2777660|NCT04385550|Paclitaxel|paclitaxel|mesh-list
2777661|NCT04385550|Docetaxel|docetaxel|mesh-list
2777662|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2777663|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777664|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
2777665|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
2777666|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
2777667|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777668|NCT04385303|Lorecivivint|lorecivivint|mesh-list
2777669|NCT04385303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2777670|NCT04385290|Cytarabine|cytarabine|mesh-list
2777671|NCT04385290|Daunorubicin|daunorubicin|mesh-list
2777672|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
2777673|NCT04385290|Midostaurin|midostaurin|mesh-list
2777674|NCT04385290|Staurosporine|staurosporine|mesh-list
2102279|NCT02404441|Spartalizumab|spartalizumab|mesh-list
2777675|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2777676|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
2777677|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777678|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777679|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
2777680|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777681|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2777682|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
2777683|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777684|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2777685|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2777686|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2777687|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777688|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2777689|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2777690|NCT04385173|Temozolomide|temozolomide|mesh-list
2777691|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2777692|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
2269131|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269132|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
2269133|NCT00191126|Gemcitabine|gemcitabine|mesh-list
2269134|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269135|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269136|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
2777693|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777694|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777695|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
2777696|NCT04385264|Mannitol|mannitol|mesh-list
2777697|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
2777698|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2777699|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2777700|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777701|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777702|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777703|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2777704|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2777705|NCT04385264|Diuretics|diuretics|mesh-ancestor
2777706|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
2777707|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777708|NCT04385407|Ribavirin|ribavirin|mesh-list
2777709|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
2777710|NCT04385407|Simeprevir|simeprevir|mesh-list
2777711|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
2777712|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777713|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
2777714|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777715|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
2777716|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791287|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
2102280|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2102281|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102282|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102283|NCT02404493|Decanoic acid|decanoic acid|mesh-list
2102284|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
2102285|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102286|NCT02404610|Propofol|propofol|mesh-list
2102287|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2102288|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2102289|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102290|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2102291|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
2102292|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
2102293|NCT02404805|Dolutegravir|dolutegravir|mesh-list
2102294|NCT02404805|Simeprevir|simeprevir|mesh-list
2102295|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2102296|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2102297|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102298|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102299|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2791288|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
2791289|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791290|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791291|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
2791292|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791293|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2791294|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2791295|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
2791296|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791297|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269137|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269138|NCT00191126|Antiviral Agents|antiviral agents|mesh-ancestor
2269139|NCT00191126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269140|NCT00191126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269141|NCT00191126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269142|NCT00191126|Immunologic Factors|immunologic factors|mesh-ancestor
2269143|NCT00191126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269144|NCT00191178|Insulin|insulin|mesh-list
2269145|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2269146|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
2269147|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
2269148|NCT00191178|Protamines|protamines|mesh-list
2791298|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2791299|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2791300|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
2791301|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2791302|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
2791303|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
2791304|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
2791305|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2791306|NCT04288232|Aflibercept|aflibercept|mesh-list
2791307|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2791308|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2791309|NCT04288232|Growth Substances|growth substances|mesh-ancestor
2791310|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791311|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
2791312|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791313|NCT04288219|Nifedipine|nifedipine|mesh-list
2269149|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2269150|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269151|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
2269152|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269153|NCT00191178|Coagulants|coagulants|mesh-ancestor
2269154|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2269155|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2269156|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269157|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269158|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269159|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269160|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791314|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2791315|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2791316|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269161|NCT00191204|Analgesics|analgesics|mesh-ancestor
2269162|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
2269163|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269164|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
2269165|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269166|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
2269167|NCT00191230|Gemcitabine|gemcitabine|mesh-list
2269168|NCT00191230|Carboplatin|carboplatin|mesh-list
2269169|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269170|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269171|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
2269172|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269173|NCT00191230|Antiviral Agents|antiviral agents|mesh-ancestor
2791317|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2791318|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791319|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
2791320|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
2791321|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2791322|NCT04288206|Cefazolin|cefazolin|mesh-list
2777725|NCT04384744|Hormones|hormones|mesh-list
2777726|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2777727|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777728|NCT04384783|Hormones|hormones|mesh-list
2777729|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2777730|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777731|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2777732|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2777733|NCT04384666|Rotigotine|rotigotine|mesh-list
2777734|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
2777735|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
2777736|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777737|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777738|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777739|NCT04384562|Methylphenidate|methylphenidate|mesh-list
2777740|NCT04384562|Reboxetine|reboxetine|mesh-list
2777741|NCT04384562|Nicotine|nicotine|mesh-list
2777742|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2777743|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
2777744|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777745|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777746|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2777747|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2777748|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
2777749|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777750|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777751|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2269174|NCT00191230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269175|NCT00191230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269176|NCT00191230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2102300|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2102301|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
2102302|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102303|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
2102304|NCT02405780|Adalimumab|adalimumab|mesh-list
2102305|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102306|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2102307|NCT02406248|Ticagrelor|ticagrelor|mesh-list
2102308|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2102309|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2102310|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2102311|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2102312|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
2102313|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777752|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2777753|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2777754|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2777755|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
2269177|NCT00191230|Immunologic Factors|immunologic factors|mesh-ancestor
2269178|NCT00191230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269179|NCT00191243|Gemcitabine|gemcitabine|mesh-list
2269180|NCT00191243|Docetaxel|docetaxel|mesh-list
2269181|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269182|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
2269183|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269184|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269185|NCT00191243|Antiviral Agents|antiviral agents|mesh-ancestor
2269186|NCT00191243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269187|NCT00191243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269188|NCT00191243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269189|NCT00191243|Immunologic Factors|immunologic factors|mesh-ancestor
2269190|NCT00191243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269191|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
2269192|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
2269193|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
2269194|NCT00191256|Gemcitabine|gemcitabine|mesh-list
2269195|NCT00191256|Paclitaxel|paclitaxel|mesh-list
2269196|NCT00191256|Carboplatin|carboplatin|mesh-list
2269197|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2269198|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269199|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
2269200|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
2269201|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
2269202|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269203|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269204|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
2269205|NCT00191256|Antiviral Agents|antiviral agents|mesh-ancestor
2269206|NCT00191256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269207|NCT00191256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269208|NCT00191256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269209|NCT00191256|Immunologic Factors|immunologic factors|mesh-ancestor
2269210|NCT00191256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269211|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2269212|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2269213|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2777756|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
2777757|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2777758|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2777759|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
2777760|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
2777761|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
2777762|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2777763|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2777764|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777765|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777766|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777767|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2777768|NCT04384653|Furosemide|furosemide|mesh-list
2777769|NCT04384653|Diuretics|diuretics|mesh-ancestor
2777770|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
2777771|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777772|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2777773|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2777774|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777775|NCT04384367|Naproxen|naproxen|mesh-list
2777776|NCT04384367|Rizatriptan|rizatriptan|mesh-list
2777777|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2777778|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2777779|NCT04384367|Analgesics|analgesics|mesh-ancestor
2777780|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
2269214|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269215|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269216|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269217|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269218|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269219|NCT00191321|Teriparatide|teriparatide|mesh-list
2269220|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2269221|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269222|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2269223|NCT00191347|Gemcitabine|gemcitabine|mesh-list
2269224|NCT00191347|Pemetrexed|pemetrexed|mesh-list
2269225|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269226|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
2269227|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269228|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269229|NCT00191347|Antiviral Agents|antiviral agents|mesh-ancestor
2269230|NCT00191347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269231|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777781|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777782|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777783|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2777784|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2777785|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
2777786|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2777787|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777788|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777789|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2777790|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
2777791|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777792|NCT04384731|Poractant alfa|poractant alfa|mesh-list
2777793|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2777794|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
2777795|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
2777796|NCT04384458|Ivermectin|ivermectin|mesh-list
2777797|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
2777798|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2777799|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2777800|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269232|NCT00191347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2777801|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777802|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777803|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2269233|NCT00191347|Immunologic Factors|immunologic factors|mesh-ancestor
2269234|NCT00191347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269235|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2269236|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2269237|NCT00191373|Gemcitabine|gemcitabine|mesh-list
2269238|NCT00191373|Trastuzumab|trastuzumab|mesh-list
2269239|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269240|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
2269241|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269242|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269243|NCT00191373|Antiviral Agents|antiviral agents|mesh-ancestor
2269244|NCT00191373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269245|NCT00191373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269246|NCT00191373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269247|NCT00191373|Immunologic Factors|immunologic factors|mesh-ancestor
2269248|NCT00191373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269249|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2269250|NCT00191399|Olanzapine|olanzapine|mesh-list
2269251|NCT00191399|Fluoxetine|fluoxetine|mesh-list
2269252|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
2269253|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
2269254|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269255|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269256|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2269257|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2269258|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2269259|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2269260|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269261|NCT00191399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2269262|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269263|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269264|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269265|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269266|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
2269267|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2269268|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
2269269|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2269270|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2269271|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269272|NCT00191412|Pemetrexed|pemetrexed|mesh-list
2269273|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269274|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269275|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269276|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2269277|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2269278|NCT00191425|Teriparatide|teriparatide|mesh-list
2269279|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2269280|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2269281|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269282|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2269283|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2269284|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
2269285|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2269286|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2269287|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2269288|NCT00191438|Gemcitabine|gemcitabine|mesh-list
2269289|NCT00191438|Capecitabine|capecitabine|mesh-list
2269290|NCT00191438|Docetaxel|docetaxel|mesh-list
2777807|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
2777808|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2777809|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
2777810|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777811|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777812|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2777813|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
2777814|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2777815|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
2777816|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269291|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269292|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
2269293|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269294|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269295|NCT00191438|Antiviral Agents|antiviral agents|mesh-ancestor
2777817|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777818|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2777819|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
2777820|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
2777821|NCT04384133|Protective Agents|protective agents|mesh-ancestor
2777822|NCT04383990|Insulin|insulin|mesh-list
2777823|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2777824|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777825|NCT04383977|Etoposide|etoposide|mesh-list
2777826|NCT04383977|Apatinib|apatinib|mesh-list
2777827|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2777828|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777829|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2777830|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2777831|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777832|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777833|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2777834|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
2777835|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
2777836|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2777837|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777838|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2777839|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2777840|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2777841|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2777842|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777843|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2777844|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2777845|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2777846|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2777847|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
2777848|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777849|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777850|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2777851|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2777852|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
2777853|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2777854|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2777855|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
2777856|NCT04383639|Locust bean gum|locust bean gum|mesh-list
2777857|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
2777858|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2777859|NCT04383717|Azithromycin|azithromycin|mesh-list
2777860|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
2777861|NCT04383717|Levamisole|levamisole|mesh-list
2777862|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
2777863|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2777864|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777865|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
2777866|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2777867|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2777868|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777869|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777870|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2777871|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2777872|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
2777873|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777874|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
2777875|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
2777876|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
2777877|NCT04383574|Vaccines|vaccines|mesh-list
2777878|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
2777879|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777880|NCT04383743|Cisplatin|cisplatin|mesh-list
2777881|NCT04383743|Doxorubicin|doxorubicin|mesh-list
2777882|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2777883|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
2777884|NCT04383743|Methotrexate|methotrexate|mesh-list
2777885|NCT04383743|Daunorubicin|daunorubicin|mesh-list
2777886|NCT04383743|Vinblastine|vinblastine|mesh-list
2777887|NCT04383743|Lenograstim|lenograstim|mesh-list
2777888|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777889|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2777890|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2777891|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2777892|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777893|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777894|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2777895|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2777896|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
2777897|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2777898|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777899|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2777900|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
2777901|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
2777902|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2777903|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2777904|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
2777905|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2777906|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2777907|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2777908|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2777909|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
2777910|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
2777911|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
2777912|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
2777913|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2777914|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2777915|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777916|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2777917|NCT04383418|Analgesics|analgesics|mesh-ancestor
2777918|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
2777919|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777920|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2777921|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2777922|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2777923|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269296|NCT00191438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269297|NCT00191438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269298|NCT00191438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269299|NCT00191438|Immunologic Factors|immunologic factors|mesh-ancestor
2269300|NCT00191438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777924|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777925|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777926|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
2777927|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2777928|NCT04383548|Antibodies|antibodies|mesh-list
2777929|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
2777930|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791323|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2791324|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792862|NCT04274894|Androgens|androgens|mesh-ancestor
2792863|NCT04274894|Hormones|hormones|mesh-ancestor
2792864|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2792865|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792866|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
2792867|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2792868|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2792869|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2792870|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2792871|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792872|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
2792873|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792874|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792875|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2792876|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792877|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2792878|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
2792879|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777931|NCT04383093|Tadalafil|tadalafil|mesh-list
2777932|NCT04383093|Tamsulosin|tamsulosin|mesh-list
2777933|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
2777934|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2777935|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2777936|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777937|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777938|NCT04383093|Urological Agents|urological agents|mesh-ancestor
2777939|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2777940|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2777941|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2777942|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
2777943|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777944|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777951|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2777952|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
2777953|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777954|NCT04382768|Ibuprofen|ibuprofen|mesh-list
2777955|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2777956|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2777957|NCT04382768|Analgesics|analgesics|mesh-ancestor
2777958|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
2777959|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777960|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777961|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2777962|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2777963|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2777964|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2777965|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777966|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
2777967|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2777968|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
2777969|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2777970|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777971|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2777972|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
2777973|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2777974|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
2777975|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777976|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2777977|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2777978|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
2777979|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
2777980|NCT04383002|Protective Agents|protective agents|mesh-ancestor
2777981|NCT04383275|Capecitabine|capecitabine|mesh-list
2777982|NCT04383275|Trastuzumab|trastuzumab|mesh-list
2777983|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2777984|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
2777985|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2777986|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777987|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2777988|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
2777989|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2777990|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2777991|NCT04383067|Aldesleukin|aldesleukin|mesh-list
2777992|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2777993|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2777994|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2269301|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
2269302|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
2269303|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
2269304|NCT00191464|Insulin|insulin|mesh-list
2269305|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2269306|NCT00191464|Metformin|metformin|mesh-list
2269307|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
2269308|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
2269309|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2269310|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2777995|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
2777996|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269311|NCT00191490|Gemcitabine|gemcitabine|mesh-list
2269312|NCT00191490|Docetaxel|docetaxel|mesh-list
2269313|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269314|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269315|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
2269316|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269317|NCT00191490|Antiviral Agents|antiviral agents|mesh-ancestor
2269318|NCT00191490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269319|NCT00191490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269320|NCT00191490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269321|NCT00191490|Immunologic Factors|immunologic factors|mesh-ancestor
2269322|NCT00191490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269323|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
2269324|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
2269325|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
2269326|NCT00191503|Gemcitabine|gemcitabine|mesh-list
2269327|NCT00191503|Pemetrexed|pemetrexed|mesh-list
2269328|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269329|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
2777997|NCT04382950|Tretinoin|tretinoin|mesh-list
2777998|NCT04382950|Isotretinoin|isotretinoin|mesh-list
2777999|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778000|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
2778001|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
2778002|NCT04382859|Bupivacaine|bupivacaine|mesh-list
2778003|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
2778004|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
2778005|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2269330|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269331|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269332|NCT00191503|Antiviral Agents|antiviral agents|mesh-ancestor
2269333|NCT00191503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269334|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269335|NCT00191503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269336|NCT00191503|Immunologic Factors|immunologic factors|mesh-ancestor
2269337|NCT00191503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269338|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2269339|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2269340|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2269341|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2269342|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269343|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269344|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269345|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269346|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269347|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269348|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2269349|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2269350|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269351|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269352|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269353|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269354|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269355|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269356|NCT00191555|Haloperidol|haloperidol|mesh-list
2269357|NCT00191555|Olanzapine|olanzapine|mesh-list
2778006|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778007|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
2778008|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778009|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
2778010|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2778011|NCT04382404|Velpatasvir|velpatasvir|mesh-list
2778012|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
2778013|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778014|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
2778015|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
2778016|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2778017|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2778018|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778019|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778020|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778021|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778022|NCT04382443|Colchicine|colchicine|mesh-list
2778023|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
2778024|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778025|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
2778026|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
2778027|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
2778028|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778029|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778030|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
2778031|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2778032|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2778033|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778034|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2778035|NCT04382170|Analgesics|analgesics|mesh-ancestor
2778036|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
2778037|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778038|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2778039|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2778040|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2778041|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
2778042|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2778043|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778044|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
2778045|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778046|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2778047|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778048|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778049|NCT04382079|Propolis|propolis|mesh-list
2778050|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778051|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2778052|NCT04382352|Trastuzumab|trastuzumab|mesh-list
2778053|NCT04382352|Antibodies|antibodies|mesh-list
2778054|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
2778055|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2778056|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
2778057|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778058|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778059|NCT04382209|Meperidine|meperidine|mesh-list
2778060|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2778061|NCT04382209|Narcotics|narcotics|mesh-ancestor
2778062|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2778063|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778064|NCT04382209|Analgesics|analgesics|mesh-ancestor
2778065|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
2778066|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778067|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2778068|NCT04382300|Thalidomide|thalidomide|mesh-list
2778069|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2778070|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
2778071|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778072|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
2778073|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2778074|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778075|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2778076|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2778077|NCT04382300|Growth Substances|growth substances|mesh-ancestor
2778078|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
2778079|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778080|NCT04382027|Vitamins|vitamins|mesh-list
2778081|NCT04382027|Vitamin K|vitamin k|mesh-list
2778082|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
2778083|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
2778084|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778085|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2778086|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2778087|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778088|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
2778089|NCT04382027|Coagulants|coagulants|mesh-ancestor
2778090|NCT04381884|Ivermectin|ivermectin|mesh-list
2778091|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2778092|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778093|NCT04381962|Azithromycin|azithromycin|mesh-list
2778094|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2778095|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778096|NCT04381910|Irinotecan|irinotecan|mesh-list
2778097|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2778098|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2778099|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778100|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778101|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778102|NCT04381741|Antibodies|antibodies|mesh-list
2778103|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2778104|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
2778105|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778106|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
2778107|NCT04381845|Vaccines|vaccines|mesh-list
2778108|NCT04381845|Immunologic Factors|immunologic factors|mesh-ancestor
2778109|NCT04381845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778110|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
2778111|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2778112|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778113|NCT04382144|Bupivacaine|bupivacaine|mesh-list
2778114|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
2778115|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
2778116|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2778117|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778118|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
2778119|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102314|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102315|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102316|NCT02406261|Midazolam|midazolam|mesh-list
2102317|NCT02406261|Donepezil|donepezil|mesh-list
2102318|NCT02406261|Simvastatin|simvastatin|mesh-list
2791325|NCT04287894|Pemetrexed|pemetrexed|mesh-list
2791326|NCT04287894|Durvalumab|durvalumab|mesh-list
2791327|NCT04287894|Tremelimumab|tremelimumab|mesh-list
2791328|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791329|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791330|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791331|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2791332|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2791333|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2791334|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
2269358|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
2269359|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
2269360|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
2269361|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269362|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269363|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2269364|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2269365|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2269366|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2269367|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269368|NCT00191555|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2269369|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269370|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269371|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269372|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791335|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2791336|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
2791337|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
2791338|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791339|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791340|NCT04287790|Naltrexone|naltrexone|mesh-list
2791341|NCT04287790|Disulfiram|disulfiram|mesh-list
2791342|NCT04287790|Acamprosate|acamprosate|mesh-list
2791343|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2791344|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2791345|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791346|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
2791347|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791348|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2791349|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791350|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791351|NCT04287777|Mupirocin|mupirocin|mesh-list
2269373|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
2269374|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2269375|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
2791352|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2791353|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2791354|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2791355|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791356|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791357|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
2791358|NCT04287829|Lenvatinib|lenvatinib|mesh-list
2102319|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2778120|NCT04382014|Curcumin|curcumin|mesh-list
2778121|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2778122|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2778123|NCT04382014|Analgesics|analgesics|mesh-ancestor
2778124|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
2778125|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778126|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778127|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2778128|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778129|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778130|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778131|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269376|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2269377|NCT00191568|Gemcitabine|gemcitabine|mesh-list
2269378|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
2269379|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269380|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
2778132|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
2778133|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2778134|NCT04381858|Antibodies|antibodies|mesh-list
2778135|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
2778136|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778137|NCT04381364|Ciclesonide|ciclesonide|mesh-list
2778138|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
2778139|NCT04381364|Hormones|hormones|mesh-ancestor
2778140|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2778141|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778142|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2778143|NCT04381377|Bromides|bromides|mesh-list
2778144|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
2778145|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
2778146|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
2778147|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2778148|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2778149|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778150|NCT04381234|Citric Acid|citric acid|mesh-list
2778151|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
2778152|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
2778153|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
2778154|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2778155|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
2778156|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
2778157|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778158|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2778159|NCT04380974|Bevacizumab|bevacizumab|mesh-list
2778160|NCT04380974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2778161|NCT04380974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778162|NCT04380974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2778163|NCT04380974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2778164|NCT04380974|Growth Substances|growth substances|mesh-ancestor
2778165|NCT04380974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778166|NCT04380974|Growth Inhibitors|growth inhibitors|mesh-ancestor
2778167|NCT04381104|Acetaminophen|acetaminophen|mesh-list
2778168|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2778169|NCT04381104|Analgesics|analgesics|mesh-ancestor
2778170|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
2778171|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778172|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778173|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
2778174|NCT04380597|Betamethasone|betamethasone|mesh-list
2778175|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
2269381|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269382|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269383|NCT00191568|Antiviral Agents|antiviral agents|mesh-ancestor
2269384|NCT00191568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778176|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2778177|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
2778178|NCT04380597|Calcipotriene|calcipotriene|mesh-list
2778179|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2778180|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2778181|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
2778182|NCT04380597|Hormones|hormones|mesh-ancestor
2778183|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2778184|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778185|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2778186|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
2269385|NCT00191568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269386|NCT00191568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269387|NCT00191568|Immunologic Factors|immunologic factors|mesh-ancestor
2269388|NCT00191568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269389|NCT00191581|Insulin|insulin|mesh-list
2269390|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
2269391|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2269392|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
2269393|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2269394|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269395|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2269396|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2269397|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269398|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269399|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269400|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269401|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269402|NCT00191594|Analgesics|analgesics|mesh-ancestor
2269403|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
2269404|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269405|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
2269406|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269407|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
2269408|NCT00191607|Gemcitabine|gemcitabine|mesh-list
2269409|NCT00191607|Doxorubicin|doxorubicin|mesh-list
2269410|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2269411|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269412|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
2269413|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269414|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269415|NCT00191607|Antiviral Agents|antiviral agents|mesh-ancestor
2269416|NCT00191607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269417|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778187|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
2778188|NCT04380818|Ritonavir|ritonavir|mesh-list
2778189|NCT04380818|Lopinavir|lopinavir|mesh-list
2778190|NCT04380818|Azithromycin|azithromycin|mesh-list
2778191|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
2778192|NCT04380818|Heparin|heparin|mesh-list
2778193|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2778194|NCT04380818|Tinzaparin|tinzaparin|mesh-list
2778195|NCT04380818|Dalteparin|dalteparin|mesh-list
2778196|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2778197|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2778198|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
2778199|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778200|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778201|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2778202|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2778203|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
2778204|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778205|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2778206|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2778207|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
2778208|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2778209|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2778210|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2778211|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
2778212|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2778213|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2778214|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778215|NCT04380857|Dexamethasone|dexamethasone|mesh-list
2778216|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2778217|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
2778218|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
2778219|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778220|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778221|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2778222|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
2778223|NCT04380857|Hormones|hormones|mesh-ancestor
2102320|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2102321|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2102322|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102323|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2778224|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2778225|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2778226|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778227|NCT04380402|Atorvastatin|atorvastatin|mesh-list
2778228|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2778229|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2778230|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
2778231|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778232|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2778233|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2269418|NCT00191607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269419|NCT00191607|Immunologic Factors|immunologic factors|mesh-ancestor
2269420|NCT00191607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269421|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2269422|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2269423|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2269424|NCT00191620|Gemcitabine|gemcitabine|mesh-list
2269425|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269426|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269427|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
2778234|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778235|NCT04380467|Vitamin D|vitamin d|mesh-list
2778236|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
2778237|NCT04380467|Vitamins|vitamins|mesh-ancestor
2778238|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
2778239|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778240|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2778241|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2778242|NCT04380220|Protein C|protein c|mesh-list
2778243|NCT04380220|Antithrombins|antithrombins|mesh-list
2778244|NCT04380220|Protein S|protein s|mesh-list
2778245|NCT04380220|Factor VIII|factor viii|mesh-list
2778246|NCT04380220|Complement C3|complement c3|mesh-list
2778247|NCT04380220|Coagulants|coagulants|mesh-ancestor
2778248|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2778249|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
2778250|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778251|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778252|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
2778253|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2778254|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2778255|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
2778256|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778257|NCT04380376|Melphalan|melphalan|mesh-list
2778258|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2778259|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
2778260|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778261|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778262|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2778263|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2778264|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
2778265|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778266|NCT04380181|Milrinone|milrinone|mesh-list
2778267|NCT04380181|Epinephrine|epinephrine|mesh-list
2778268|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2778269|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2778270|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
2778271|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2778272|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778273|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778274|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2778275|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2778276|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
2778277|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778278|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2778279|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
2778280|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
2778281|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
2778282|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2778283|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2778284|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2778285|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
2778286|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2778287|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2778288|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778289|NCT04380181|Protective Agents|protective agents|mesh-ancestor
2778290|NCT04380311|Tacrolimus|tacrolimus|mesh-list
2778291|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2778292|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
2269428|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269429|NCT00191620|Antiviral Agents|antiviral agents|mesh-ancestor
2269430|NCT00191620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269431|NCT00191620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269432|NCT00191620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269433|NCT00191620|Immunologic Factors|immunologic factors|mesh-ancestor
2269434|NCT00191620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269435|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2269436|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2778293|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778294|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2778295|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778296|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102324|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2102325|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2102326|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2102327|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
2102328|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
2102329|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
2102330|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
2102331|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102332|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102333|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2102334|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2102335|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
2102336|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2102337|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2102338|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102339|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2102340|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
2102341|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
2102342|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2102343|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2102344|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102345|NCT02406443|Incretins|incretins|mesh-ancestor
2102346|NCT02406443|Hormones|hormones|mesh-ancestor
2102347|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102348|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2102349|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
2102350|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269437|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2778297|NCT04380298|Ketorolac|ketorolac|mesh-list
2778298|NCT04380298|Epinephrine|epinephrine|mesh-list
2778299|NCT04380298|Ropivacaine|ropivacaine|mesh-list
2778300|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
2778301|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
2778302|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2778303|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778304|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
2778305|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778306|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2778307|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2778308|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
2778309|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2778310|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778311|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2778312|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2778313|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
2778314|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2778315|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
2778316|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
2778317|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
2778318|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2778319|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2778320|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2778321|NCT04380298|Analgesics|analgesics|mesh-ancestor
2778322|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2778323|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778324|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2778325|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778326|NCT04380103|Bevacizumab|bevacizumab|mesh-list
2778327|NCT04380103|Capecitabine|capecitabine|mesh-list
2778328|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
2778329|NCT04380103|Irinotecan|irinotecan|mesh-list
2778330|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2778331|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778332|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2778333|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2778334|NCT04380103|Growth Substances|growth substances|mesh-ancestor
2778335|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778336|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
2269438|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269439|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269440|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269441|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269442|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269443|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2269444|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2269445|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269446|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269447|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269448|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269449|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269450|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269451|NCT00191672|Gemcitabine|gemcitabine|mesh-list
2269452|NCT00191672|Paclitaxel|paclitaxel|mesh-list
2269453|NCT00191672|Docetaxel|docetaxel|mesh-list
2269454|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2778337|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2778338|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
2778339|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778340|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2778341|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2778342|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778343|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
2778344|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778348|NCT04380012|Trastuzumab|trastuzumab|mesh-list
2778349|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2778350|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778351|NCT04379999|Aspirin|aspirin|mesh-list
2778352|NCT04379999|Atorvastatin|atorvastatin|mesh-list
2778353|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2778354|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2778355|NCT04379999|Analgesics|analgesics|mesh-ancestor
2778356|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
2778357|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269455|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269456|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
2269457|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
2269458|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
2269459|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269460|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269461|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
2778358|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778359|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2778360|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778361|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2778362|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2778363|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778364|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2778365|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2778366|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778367|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
2778368|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2778369|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2778370|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
2778371|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2778372|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2791359|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2791360|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791361|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2791362|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791363|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791364|NCT04287842|Sevoflurane|sevoflurane|mesh-list
2791365|NCT04287842|Desflurane|desflurane|mesh-list
2791366|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2778373|NCT04380025|Pycnogenols|pycnogenols|mesh-list
2778374|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2269462|NCT00191672|Antiviral Agents|antiviral agents|mesh-ancestor
2269463|NCT00191672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269464|NCT00191672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269465|NCT00191672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269466|NCT00191672|Immunologic Factors|immunologic factors|mesh-ancestor
2269467|NCT00191672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269468|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2269469|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2269470|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269471|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269472|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269473|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269474|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269475|NCT00191685|Analgesics|analgesics|mesh-ancestor
2269476|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
2269477|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269478|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
2269479|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269480|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
2269481|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2269482|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2269483|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269484|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2778375|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
2778376|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778377|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
2778378|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778379|NCT04380025|Protective Agents|protective agents|mesh-ancestor
2778380|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2778381|NCT04379739|Apatinib|apatinib|mesh-list
2778382|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778383|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2778384|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778385|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778386|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
2778387|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
2778388|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2778389|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2778390|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778391|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778392|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778393|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778394|NCT04379180|Bosentan|bosentan|mesh-list
2778395|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
2778396|NCT04379180|Tadalafil|tadalafil|mesh-list
2778397|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
2778398|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2778399|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2778400|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778401|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778402|NCT04379180|Urological Agents|urological agents|mesh-ancestor
2778403|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2778404|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2778405|NCT04379271|Calcium|calcium|mesh-list
2778406|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2778407|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778408|NCT04379219|Methotrexate|methotrexate|mesh-list
2778409|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2778410|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
2778411|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2778412|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778413|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2778414|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
2778415|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778416|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778417|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
2778418|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778419|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2778420|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2778421|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
2778422|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778423|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2778424|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
2778425|NCT04379310|Calcium|calcium|mesh-list
2778426|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2778427|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2778428|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778429|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
2778430|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778431|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778432|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2778433|NCT04378959|Lidocaine|lidocaine|mesh-list
2778434|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
2778435|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
2778436|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2778437|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778438|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
2778439|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778440|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2778441|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2778442|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2778443|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2778444|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778445|NCT04378972|Vitamin D|vitamin d|mesh-list
2778446|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
2778447|NCT04378972|Curcumin|curcumin|mesh-list
2778448|NCT04378972|Tramiprosate|tramiprosate|mesh-list
2778449|NCT04378972|Vitamins|vitamins|mesh-ancestor
2778450|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
2778451|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778452|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2778453|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2778454|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2778455|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2778456|NCT04378972|Analgesics|analgesics|mesh-ancestor
2778457|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
2778458|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778459|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2778460|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778461|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778462|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778463|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778464|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
2778465|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
2778466|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
2778467|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2778482|NCT04379011|Brivaracetam|brivaracetam|mesh-list
2778483|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
2778484|NCT04379102|Anesthetics|anesthetics|mesh-list
2778485|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
2778486|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2778487|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778488|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
2778489|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778490|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2778491|NCT04378868|Metronidazole|metronidazole|mesh-list
2778492|NCT04378868|Cefuroxime|cefuroxime|mesh-list
2778493|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
2778494|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2778495|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778496|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
2778497|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2778498|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2778499|NCT04378608|Ribavirin|ribavirin|mesh-list
2778500|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
2778501|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778502|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
2778503|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778504|NCT04378621|Adalimumab|adalimumab|mesh-list
2778505|NCT04378621|Etanercept|etanercept|mesh-list
2778506|NCT04378621|Golimumab|golimumab|mesh-list
2778507|NCT04378621|Infliximab|infliximab|mesh-list
2778508|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
2778509|NCT04378621|Tofacitinib|tofacitinib|mesh-list
2778510|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2778511|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2778512|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778513|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2778514|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2778515|NCT04378621|Analgesics|analgesics|mesh-ancestor
2778516|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
2778517|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778518|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778519|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2778520|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2778521|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
2778522|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
2778523|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2778524|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778525|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778526|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2778527|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2778528|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2778529|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2778530|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778531|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
2778532|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778533|NCT04378231|Amoxicillin|amoxicillin|mesh-list
2269485|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269486|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269487|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269488|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269489|NCT00191711|Gemcitabine|gemcitabine|mesh-list
2269490|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269491|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
2269492|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269493|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269494|NCT00191711|Antiviral Agents|antiviral agents|mesh-ancestor
2269495|NCT00191711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269496|NCT00191711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269497|NCT00191711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269498|NCT00191711|Immunologic Factors|immunologic factors|mesh-ancestor
2778534|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
2778535|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
2778536|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2778537|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2778538|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778539|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2778540|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778541|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778542|NCT04378114|Acetaminophen|acetaminophen|mesh-list
2778543|NCT04378114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2778544|NCT04378114|Analgesics|analgesics|mesh-ancestor
2778545|NCT04378114|Sensory System Agents|sensory system agents|mesh-ancestor
2778546|NCT04378114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778547|NCT04378114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778548|NCT04378114|Antipyretics|antipyretics|mesh-ancestor
2778549|NCT04378283|Lidocaine|lidocaine|mesh-list
2778550|NCT04378283|Epinephrine|epinephrine|mesh-list
2778551|NCT04378283|Tetracaine|tetracaine|mesh-list
2269499|NCT00191711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269500|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2269501|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2269502|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269503|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2778552|NCT04378283|Anesthetics|anesthetics|mesh-list
2778553|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
2778554|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2778555|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778556|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
2778557|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778558|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2778559|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2778560|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2778561|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2778562|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778563|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2778564|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2778565|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
2778566|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2778567|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2778568|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2778569|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
2778570|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2778571|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
2778572|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
2778573|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
2778574|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2791367|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2791368|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
2791369|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
2791370|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791371|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791372|NCT04287426|Remifentanil|remifentanil|mesh-list
2791373|NCT04287426|Rocuronium|rocuronium|mesh-list
2791374|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2791375|NCT04287426|Narcotics|narcotics|mesh-ancestor
2791376|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791377|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791378|NCT04287426|Analgesics|analgesics|mesh-ancestor
2791379|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
2791380|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791381|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2791382|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2791383|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2791384|NCT04287543|Melatonin|melatonin|mesh-list
2791385|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
2791386|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791387|NCT04287543|Protective Agents|protective agents|mesh-ancestor
2791388|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791389|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791390|NCT04287361|Clonazepam|clonazepam|mesh-list
2791391|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
2791392|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
2791393|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
2791394|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791395|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791396|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791397|NCT04287387|Pioglitazone|pioglitazone|mesh-list
2269504|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269505|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269506|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269507|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269508|NCT00191750|Pemetrexed|pemetrexed|mesh-list
2102351|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102352|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2102353|NCT02406586|Carvedilol|carvedilol|mesh-list
2102354|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2102355|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2102356|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2102357|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
2102358|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102359|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791398|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2791399|NCT04287387|Metformin|metformin|mesh-list
2791400|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
2791401|NCT04287387|Glimepiride|glimepiride|mesh-list
2791402|NCT04287387|Acarbose|acarbose|mesh-list
2791403|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2791404|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791405|NCT04287387|Incretins|incretins|mesh-ancestor
2791406|NCT04287387|Hormones|hormones|mesh-ancestor
2778575|NCT04377867|Abatacept|abatacept|mesh-list
2778576|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2778577|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778578|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778579|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2778580|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
2778581|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778582|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778583|NCT04377997|Heparin|heparin|mesh-list
2778584|NCT04377997|Calcium heparin|calcium heparin|mesh-list
2778585|NCT04377997|Enoxaparin|enoxaparin|mesh-list
2269509|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269510|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269511|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269512|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2269513|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2269514|NCT00191763|Gemcitabine|gemcitabine|mesh-list
2269515|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269516|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269517|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
2269518|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269519|NCT00191763|Antiviral Agents|antiviral agents|mesh-ancestor
2269520|NCT00191763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102360|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102361|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2102362|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
2102363|NCT02406586|Protective Agents|protective agents|mesh-ancestor
2102364|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2102365|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2102366|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2102367|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
2269521|NCT00191763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269522|NCT00191763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269523|NCT00191763|Immunologic Factors|immunologic factors|mesh-ancestor
2778586|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2778587|NCT04377997|Tinzaparin|tinzaparin|mesh-list
2778588|NCT04377997|Dalteparin|dalteparin|mesh-list
2778589|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
2778590|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2778591|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2778592|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778593|NCT04377789|Quercetin|quercetin|mesh-list
2778594|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
2778595|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778596|NCT04377789|Protective Agents|protective agents|mesh-ancestor
2778597|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778604|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
2778605|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2778606|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2778607|NCT04377503|Prednisolone|prednisolone|mesh-list
2778608|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
2778609|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2778610|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
2778611|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2778612|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
2778613|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
2778614|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778615|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778616|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2778617|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
2778618|NCT04377503|Hormones|hormones|mesh-ancestor
2778619|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2778620|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2778621|NCT04377503|Protective Agents|protective agents|mesh-ancestor
2778622|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2778623|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778624|NCT04377646|Zinc|zinc|mesh-list
2778625|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
2778626|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
2778627|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2269524|NCT00191763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269525|NCT00191802|Teriparatide|teriparatide|mesh-list
2269526|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2269527|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269528|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2269529|NCT00191828|Olanzapine|olanzapine|mesh-list
2102368|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2102369|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2102370|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2778628|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2778629|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778630|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778631|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778632|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778633|NCT04377646|Trace Elements|trace elements|mesh-ancestor
2778634|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
2778635|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778640|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
2778641|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
2778642|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778643|NCT04377386|Vitamin D|vitamin d|mesh-list
2778644|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
2778645|NCT04377386|Vitamins|vitamins|mesh-list
2269530|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
2269531|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
2269532|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269533|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269534|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2269535|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2269536|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2269537|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2269538|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269539|NCT00191828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2269540|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269541|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269542|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269543|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269544|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
2269545|NCT00191841|Gemcitabine|gemcitabine|mesh-list
2269546|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269547|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269548|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
2269549|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269550|NCT00191841|Antiviral Agents|antiviral agents|mesh-ancestor
2269551|NCT00191841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269552|NCT00191841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269553|NCT00191841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269554|NCT00191841|Immunologic Factors|immunologic factors|mesh-ancestor
2269555|NCT00191841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269556|NCT00191867|Teriparatide|teriparatide|mesh-list
2269557|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2269558|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269559|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2269560|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2269561|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2269562|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269563|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2778646|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
2102371|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2102372|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2102373|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2102374|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2102375|NCT02406586|Analgesics|analgesics|mesh-ancestor
2102376|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
2102377|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102378|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102379|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2102380|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
2102381|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2269564|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778647|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778648|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2778649|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2778650|NCT04377399|Vitamin D|vitamin d|mesh-list
2778651|NCT04377399|Vitamins|vitamins|mesh-ancestor
2778652|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
2778653|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778654|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2778655|NCT04377321|Colchicine|colchicine|mesh-list
2778656|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
2778657|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778658|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
2778659|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
2778660|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
2778661|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778662|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778663|NCT04377087|Olaparib|olaparib|mesh-list
2778664|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2778665|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778666|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778667|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778668|NCT04377204|Lidocaine|lidocaine|mesh-list
2778669|NCT04377204|Bupivacaine|bupivacaine|mesh-list
2778670|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
2778671|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
2778672|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2778673|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778674|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
2269565|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
2269566|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269567|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269568|NCT00191893|Teriparatide|teriparatide|mesh-list
2269569|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2269570|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269571|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2269572|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2269573|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2269574|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269575|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269576|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269577|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269578|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269579|NCT00191919|Analgesics|analgesics|mesh-ancestor
2269580|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
2269581|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269582|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
2269583|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269584|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
2269585|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2269586|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2269587|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2778675|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778676|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2778677|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2778678|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2778679|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2778680|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778681|NCT04377308|Fluoxetine|fluoxetine|mesh-list
2778682|NCT04377308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2778683|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2778684|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2778685|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778686|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2778687|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
2778688|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778689|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2778690|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
2778691|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2778692|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2778693|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2778694|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778695|NCT04376970|Fluorometholone|fluorometholone|mesh-list
2778696|NCT04376970|Cyclosporine|cyclosporine|mesh-list
2778697|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2778698|NCT04376970|Cyclosporins|cyclosporins|mesh-list
2778699|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778700|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778701|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2778702|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
2778703|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778704|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
2778705|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778706|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
2778707|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778708|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2778709|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2778710|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2778711|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
2778712|NCT04376970|Hormones|hormones|mesh-ancestor
2778713|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2778714|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2778715|NCT04377048|Gemcitabine|gemcitabine|mesh-list
2778716|NCT04377048|Tegafur|tegafur|mesh-list
2778717|NCT04377048|Nivolumab|nivolumab|mesh-list
2778718|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2778719|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
2778720|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778721|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778722|NCT04377048|Antiviral Agents|antiviral agents|mesh-ancestor
2778723|NCT04377048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778724|NCT04377048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778725|NCT04377048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2778726|NCT04377048|Immunologic Factors|immunologic factors|mesh-ancestor
2778727|NCT04377048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778728|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2778729|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2778730|NCT04376788|Methylene Blue|methylene blue|mesh-list
2778731|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778732|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778733|NCT04376528|Cyclosporine|cyclosporine|mesh-list
2778734|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
2778735|NCT04376528|Cyclosporins|cyclosporins|mesh-list
2778736|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778737|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778738|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2778739|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
2778740|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778741|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
2778742|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778743|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
2778744|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778745|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2778746|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2778747|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778748|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2778749|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
2778750|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2778751|NCT04376814|Ritonavir|ritonavir|mesh-list
2778752|NCT04376814|Lopinavir|lopinavir|mesh-list
2778753|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
2778754|NCT04376814|Favipiravir|favipiravir|mesh-list
2778755|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2778756|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2778757|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
2778758|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778759|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778760|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2778761|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2778762|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
2778763|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778764|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2778765|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2778766|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
2778767|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2778768|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2778769|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778770|NCT04376554|Amoxicillin|amoxicillin|mesh-list
2778771|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
2778772|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
2778773|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2778774|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2778775|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778776|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2778777|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778778|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791407|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2791408|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2791409|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
2791410|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791411|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791412|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2791413|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2791414|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2791415|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
2791416|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2791417|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
2791418|NCT04287205|Progestins|progestins|mesh-ancestor
2791419|NCT04287205|Hormones|hormones|mesh-ancestor
2791420|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2791421|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791422|NCT04287062|Suvorexant|suvorexant|mesh-list
2791423|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2791424|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2791425|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791426|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791427|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2791428|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791429|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791438|NCT04286711|Paclitaxel|paclitaxel|mesh-list
2791439|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2791440|NCT04286711|Apatinib|apatinib|mesh-list
2791441|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2791442|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791443|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
2791444|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
2791445|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
2791446|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791447|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2791448|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791449|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2791450|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
2791451|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2791452|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2791453|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2791454|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2791455|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
2791456|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791457|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791458|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791459|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2269588|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269589|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269590|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269591|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269592|NCT00191932|Analgesics|analgesics|mesh-ancestor
2269593|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
2269594|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269595|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
2269596|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269597|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
2269598|NCT00191971|Gemcitabine|gemcitabine|mesh-list
2269599|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269600|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
2269601|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269602|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269603|NCT00191971|Antiviral Agents|antiviral agents|mesh-ancestor
2269604|NCT00191971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269605|NCT00191971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778779|NCT04376541|Fentanyl|fentanyl|mesh-list
2778780|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2778781|NCT04376541|Narcotics|narcotics|mesh-ancestor
2778782|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2778783|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778784|NCT04376541|Analgesics|analgesics|mesh-ancestor
2778785|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
2778786|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778787|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2778788|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2778789|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
2778790|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
2778791|NCT04376307|Anesthetics|anesthetics|mesh-list
2778792|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2778793|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778794|NCT04376073|Niraparib|niraparib|mesh-list
2778795|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2778796|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778797|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778798|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778799|NCT04376086|Anesthetics|anesthetics|mesh-list
2778800|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2778801|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778802|NCT04376216|Prednisone|prednisone|mesh-list
2269606|NCT00191971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269607|NCT00191971|Immunologic Factors|immunologic factors|mesh-ancestor
2269608|NCT00191971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269609|NCT00191997|Olanzapine|olanzapine|mesh-list
2269610|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
2269611|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
2269612|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269613|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269614|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2269615|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2269616|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2269617|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2269618|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2269619|NCT00191997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2269620|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2269621|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2269622|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269623|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2269624|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
2269625|NCT00192049|Gemcitabine|gemcitabine|mesh-list
2269626|NCT00192049|Mitomycins|mitomycins|mesh-list
2269627|NCT00192049|Mitomycin|mitomycin|mesh-list
2269628|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269629|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
2269630|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269631|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269632|NCT00192049|Antiviral Agents|antiviral agents|mesh-ancestor
2269633|NCT00192049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269634|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269635|NCT00192049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269636|NCT00192049|Immunologic Factors|immunologic factors|mesh-ancestor
2269637|NCT00192049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269638|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2269639|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
2269640|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2269641|NCT00192062|Gemcitabine|gemcitabine|mesh-list
2269642|NCT00192062|Vinorelbine|vinorelbine|mesh-list
2269643|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269644|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
2269645|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778803|NCT04376216|Prednisolone|prednisolone|mesh-list
2778804|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2778805|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
2778806|NCT04376216|Hormones|hormones|mesh-ancestor
2778807|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2778808|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778809|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2778810|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778811|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
2778812|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2778813|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
2778814|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778815|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778816|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2778817|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
2778818|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2778819|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
2778820|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778821|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2778822|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2778823|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
2778824|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
2778825|NCT04375995|Protective Agents|protective agents|mesh-ancestor
2778826|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2778827|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2778828|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778829|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778830|NCT04375852|Autoantibodies|autoantibodies|mesh-list
2778831|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
2778832|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778833|NCT04375787|Atorvastatin|atorvastatin|mesh-list
2778834|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2778835|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2778836|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
2778837|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778838|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2778839|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2778840|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778841|NCT04375683|HH-GV-678|hh-gv-678|mesh-list
2778842|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2102382|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102383|NCT02406885|Apixaban|apixaban|mesh-list
2102384|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2102385|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
2102386|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2102387|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
2102388|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102389|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102390|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
2102391|NCT02407223|Ustekinumab|ustekinumab|mesh-list
2778843|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778844|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778845|NCT04375384|Cetuximab|cetuximab|mesh-list
2778846|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2778847|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778848|NCT04375527|Nivolumab|nivolumab|mesh-list
2778849|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2269646|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269647|NCT00192062|Antiviral Agents|antiviral agents|mesh-ancestor
2269648|NCT00192062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269649|NCT00192062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269650|NCT00192062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269651|NCT00192062|Immunologic Factors|immunologic factors|mesh-ancestor
2269652|NCT00192062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269653|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2269654|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
2269655|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
2269656|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
2269657|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
2269658|NCT00192088|Pemetrexed|pemetrexed|mesh-list
2269659|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102392|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
2102393|NCT02407236|Ustekinumab|ustekinumab|mesh-list
2102394|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
2102395|NCT02407704|Lorazepam|lorazepam|mesh-list
2102396|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2102397|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2778850|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778851|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2778852|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778853|NCT04375605|Leucovorin|leucovorin|mesh-list
2778854|NCT04375605|Docetaxel|docetaxel|mesh-list
2778855|NCT04375605|Fluorouracil|fluorouracil|mesh-list
2778856|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
2778857|NCT04375605|Calcium|calcium|mesh-list
2778858|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
2778859|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778860|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
2778861|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
2778862|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
2778863|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778864|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2778865|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778866|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
2778867|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2778868|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2778869|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
2778870|NCT04375605|Antidotes|antidotes|mesh-ancestor
2778871|NCT04375605|Protective Agents|protective agents|mesh-ancestor
2778872|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
2778873|NCT04375605|Vitamins|vitamins|mesh-ancestor
2778874|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
2778875|NCT04374981|Celecoxib|celecoxib|mesh-list
2778876|NCT04374981|Montelukast|montelukast|mesh-list
2778877|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2778878|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2778879|NCT04374981|Analgesics|analgesics|mesh-ancestor
2778880|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
2778881|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269660|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269661|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269662|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2269663|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2269664|NCT00192101|Gemcitabine|gemcitabine|mesh-list
2269665|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269666|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269667|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
2269668|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269669|NCT00192101|Antiviral Agents|antiviral agents|mesh-ancestor
2778882|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778883|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2778884|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778885|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2778886|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2778887|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778888|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778889|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2778890|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
2778891|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2778892|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
2778893|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2778894|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2778895|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2778896|NCT04375228|Rituximab|rituximab|mesh-list
2778897|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2778898|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778899|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
2778900|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778901|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778902|NCT04375267|Olaparib|olaparib|mesh-list
2778903|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2778904|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2778905|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778906|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778907|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2778908|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2778909|NCT04375202|Colchicine|colchicine|mesh-list
2778910|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
2778911|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2778912|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
2778913|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
2778914|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
2778915|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778916|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269670|NCT00192101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269671|NCT00192101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269672|NCT00192101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269673|NCT00192101|Immunologic Factors|immunologic factors|mesh-ancestor
2269674|NCT00192101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269675|NCT00192413|Vaccines|vaccines|mesh-list
2778927|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2778928|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
2778929|NCT04374929|Hormones|hormones|mesh-ancestor
2778930|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2778931|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269676|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
2269677|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269678|NCT00192569|Interferons|interferons|mesh-list
2269679|NCT00192569|Ribavirin|ribavirin|mesh-list
2269680|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
2269681|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
2778932|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
2778933|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
2778934|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2778935|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2778936|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778937|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2778938|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778939|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2791460|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
2791461|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791462|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2269682|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2269683|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269684|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
2269685|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269686|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
2269687|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269688|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
2269689|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269690|NCT00192595|Tenofovir|tenofovir|mesh-list
2269691|NCT00192595|Lamivudine|lamivudine|mesh-list
2269692|NCT00192595|Zidovudine|zidovudine|mesh-list
2269693|NCT00192595|Efavirenz|efavirenz|mesh-list
2269694|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
2269695|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269696|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2791473|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
2791474|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
2791475|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269697|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2269698|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269699|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791476|NCT04286178|Vitamins|vitamins|mesh-ancestor
2269700|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2269701|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2269702|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
2791477|NCT04286503|Ritonavir|ritonavir|mesh-list
2791478|NCT04286503|Lopinavir|lopinavir|mesh-list
2791479|NCT04286503|Chloroquine|chloroquine|mesh-list
2778940|NCT04374604|Mitogens|mitogens|mesh-list
2778941|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
2778942|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778943|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
2778944|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2778945|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2778946|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778947|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2778948|NCT04374318|Analgesics|analgesics|mesh-ancestor
2269703|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2269704|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2269705|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2269706|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2269707|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2269708|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2269709|NCT00192608|Saquinavir|saquinavir|mesh-list
2269710|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2269711|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2269712|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
2778949|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
2778950|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778951|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2778952|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2778953|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2778954|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
2778955|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2778956|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778957|NCT04374474|Budesonide|budesonide|mesh-list
2778958|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2778959|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2778960|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
2778961|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778962|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778963|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2778964|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
2778965|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
2778966|NCT04374474|Hormones|hormones|mesh-ancestor
2778967|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2778968|NCT04374578|Dulaglutide|dulaglutide|mesh-list
2778969|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2778970|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778971|NCT04374773|Dronabinol|dronabinol|mesh-list
2269713|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269714|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269715|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2269716|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2269717|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
2269718|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269719|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2269720|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2269721|NCT00192621|Lamivudine|lamivudine|mesh-list
2269722|NCT00192621|Zidovudine|zidovudine|mesh-list
2269723|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2778972|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
2778973|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778974|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2778975|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2778976|NCT04374773|Analgesics|analgesics|mesh-ancestor
2778977|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
2778978|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2778979|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2778980|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2269724|NCT00192621|Lopinavir|lopinavir|mesh-list
2269725|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2778981|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2778982|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778983|NCT04374773|Hormones|hormones|mesh-ancestor
2778984|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2778985|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
2778986|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2778987|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
2778988|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2778989|NCT04374461|Expectorants|expectorants|mesh-ancestor
2792887|NCT04274816|Tremelimumab|tremelimumab|mesh-list
2778990|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
2778991|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2778992|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
2778993|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2778994|NCT04374461|Protective Agents|protective agents|mesh-ancestor
2778995|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2778996|NCT04374461|Antidotes|antidotes|mesh-ancestor
2778997|NCT04374799|Heparin|heparin|mesh-list
2778998|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
2778999|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2779000|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2779001|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779002|NCT04374279|Bicalutamide|bicalutamide|mesh-list
2779003|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
2779004|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
2779005|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2779006|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779007|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779008|NCT04374552|Azithromycin|azithromycin|mesh-list
2779009|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
2779010|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2779011|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779012|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
2779013|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2779014|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2779015|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779016|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779017|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779018|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
2779019|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2779020|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2779021|NCT04374071|Prednisolone|prednisolone|mesh-list
2779022|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
2779023|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2779024|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
2779025|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2779026|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
2779027|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
2779028|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779029|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779030|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2779031|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
2779032|NCT04374071|Hormones|hormones|mesh-ancestor
2779033|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2779034|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2779035|NCT04374071|Protective Agents|protective agents|mesh-ancestor
2779036|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2779037|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779038|NCT04373824|Ivermectin|ivermectin|mesh-list
2779039|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2269726|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2269727|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269728|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269729|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
2269730|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779040|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779041|NCT04374006|Propolis|propolis|mesh-list
2779042|NCT04374006|Dienogest|dienogest|mesh-list
2779043|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2779044|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
2779045|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2779046|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779047|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2779048|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2779049|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2779050|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2779051|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
2779052|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2779053|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2779054|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779055|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779073|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
2779074|NCT04374188|Levofloxacin|levofloxacin|mesh-list
2779075|NCT04374188|Ofloxacin|ofloxacin|mesh-list
2779076|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2779077|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779078|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2102398|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2102399|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2102400|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102401|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102402|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102403|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2102404|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
2102405|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2102406|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
2102407|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
2102408|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
2779079|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2779080|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779081|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779082|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779083|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2779084|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2779085|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2779086|NCT04374188|Renal Agents|renal agents|mesh-ancestor
2779087|NCT04373785|Temozolomide|temozolomide|mesh-list
2779088|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2779089|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
2779090|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779091|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779092|NCT04373967|Metformin|metformin|mesh-list
2779093|NCT04373967|Liraglutide|liraglutide|mesh-list
2779094|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2779095|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779096|NCT04373967|Incretins|incretins|mesh-ancestor
2779097|NCT04373967|Hormones|hormones|mesh-ancestor
2779098|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2779099|NCT04373941|Lenograstim|lenograstim|mesh-list
2779100|NCT04373941|Sargramostim|sargramostim|mesh-list
2779101|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2779102|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
2779103|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779108|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2779109|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2779110|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779111|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
2779112|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2779113|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779114|NCT04373356|Listerine|listerine|mesh-list
2779115|NCT04373356|Fluorides|fluorides|mesh-list
2779116|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
2779117|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
2779118|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
2779119|NCT04373356|Protective Agents|protective agents|mesh-ancestor
2779120|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779121|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2779122|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779123|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
2779124|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2779125|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791480|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2791481|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2791482|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2791483|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
2791484|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791485|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791486|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2791487|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2791488|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
2791489|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2791490|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2791491|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2791492|NCT04286503|Amebicides|amebicides|mesh-ancestor
2791493|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2269731|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2269732|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2791494|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2791495|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
2791496|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2791497|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2791498|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2791499|NCT04286503|Analgesics|analgesics|mesh-ancestor
2791500|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
2791501|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791502|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791503|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2791504|NCT04286503|Filaricides|filaricides|mesh-ancestor
2791505|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
2791506|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
2792888|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792889|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2792890|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2792891|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2792892|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2792893|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
2792894|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2792895|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2792896|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792897|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
2792898|NCT04274335|Coagulants|coagulants|mesh-ancestor
2792899|NCT04274270|Endostar protein|endostar protein|mesh-list
2792900|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2792901|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2792902|NCT04274270|Growth Substances|growth substances|mesh-ancestor
2792903|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792904|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
2792905|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792906|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2792907|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
2792908|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792909|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
2792910|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792911|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792912|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792913|NCT04274257|Rituximab|rituximab|mesh-list
2792914|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2792915|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792916|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
2792917|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792918|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2792919|NCT04274179|Lamotrigine|lamotrigine|mesh-list
2792920|NCT04274179|Valproic Acid|valproic acid|mesh-list
2792921|NCT04274179|Ethosuximide|ethosuximide|mesh-list
2792922|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
2792923|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2792924|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2792925|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792926|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2792927|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792928|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2792929|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2269733|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
2779126|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
2779127|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2779128|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779129|NCT04373083|Cemiplimab|cemiplimab|mesh-list
2779130|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2779131|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779132|NCT04372849|Insulin|insulin|mesh-list
2779133|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2779134|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779135|NCT04372836|Vasopressins|vasopressins|mesh-list
2779136|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
2779137|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
2779138|NCT04372836|Coagulants|coagulants|mesh-ancestor
2779139|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2779140|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2779141|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
2779142|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779143|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
2779144|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
2779145|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2779146|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2779147|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779148|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779149|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779150|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779151|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
2779152|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2779153|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2779154|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2779155|NCT04373018|Eusol|eusol|mesh-list
2779156|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2779157|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779158|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
2779159|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
2779160|NCT04372732|Autoantibodies|autoantibodies|mesh-list
2779161|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
2779162|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779163|NCT04372589|Heparin|heparin|mesh-list
2779164|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
2779165|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2779166|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2779167|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779168|NCT04372342|Remifentanil|remifentanil|mesh-list
2779169|NCT04372342|Nalbuphine|nalbuphine|mesh-list
2779170|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2269734|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2269735|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2269736|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
2269737|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2269738|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2269739|NCT00192634|Tenofovir|tenofovir|mesh-list
2269740|NCT00192634|Lamivudine|lamivudine|mesh-list
2269741|NCT00192634|Emtricitabine|emtricitabine|mesh-list
2269742|NCT00192634|Abacavir|abacavir|mesh-list
2269743|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
2269744|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269745|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2269746|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2269747|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269748|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269749|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2269750|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2269751|NCT00192660|Ritonavir|ritonavir|mesh-list
2269752|NCT00192660|Nelfinavir|nelfinavir|mesh-list
2779171|NCT04372342|Narcotics|narcotics|mesh-ancestor
2779172|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2779173|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779174|NCT04372342|Analgesics|analgesics|mesh-ancestor
2779175|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
2779176|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779177|NCT04372264|Acetaminophen|acetaminophen|mesh-list
2779178|NCT04372264|Ibuprofen|ibuprofen|mesh-list
2779179|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2269753|NCT00192660|Indinavir|indinavir|mesh-list
2779180|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2779181|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2779182|NCT04372264|Analgesics|analgesics|mesh-ancestor
2779183|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
2779184|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791507|NCT04285866|Durvalumab|durvalumab|mesh-list
2269754|NCT00192660|Saquinavir|saquinavir|mesh-list
2269755|NCT00192660|Amprenavir|amprenavir|mesh-list
2269756|NCT00192660|Tenofovir|tenofovir|mesh-list
2269757|NCT00192660|Lamivudine|lamivudine|mesh-list
2269758|NCT00192660|Zidovudine|zidovudine|mesh-list
2269759|NCT00192660|Nevirapine|nevirapine|mesh-list
2269760|NCT00192660|Abacavir|abacavir|mesh-list
2269761|NCT00192660|Stavudine|stavudine|mesh-list
2269762|NCT00192660|Didanosine|didanosine|mesh-list
2269763|NCT00192660|Tipranavir|tipranavir|mesh-list
2269764|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
2269765|NCT00192660|Efavirenz|efavirenz|mesh-list
2269766|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2269767|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2269768|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
2779185|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779186|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2779187|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779188|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2779189|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779190|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779191|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
2779192|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
2779193|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
2779194|NCT04372316|Vitamins|vitamins|mesh-ancestor
2779195|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
2779196|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779197|NCT04372407|Itraconazole|itraconazole|mesh-list
2779198|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
2779199|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779200|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2779201|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2779202|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779203|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779204|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2779205|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
2779206|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2779207|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779208|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2779209|NCT04371952|Doxycycline|doxycycline|mesh-list
2779210|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2779211|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779212|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
2779213|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2779214|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2779215|NCT04371874|Aspirin|aspirin|mesh-list
2779216|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2779217|NCT04371874|Captopril|captopril|mesh-list
2779218|NCT04371874|Nitrendipine|nitrendipine|mesh-list
2779219|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2779220|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2779221|NCT04371874|Analgesics|analgesics|mesh-ancestor
2779222|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
2779223|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779224|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779225|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2779226|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779227|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2779228|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2779229|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779230|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2779231|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2779232|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779233|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
2779234|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2102409|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102410|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2102411|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2102412|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2102413|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2102414|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2102415|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
2102416|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
2102417|NCT02408016|Aldesleukin|aldesleukin|mesh-list
2269769|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269770|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269771|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2269772|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2779235|NCT04371874|Diuretics|diuretics|mesh-ancestor
2269773|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
2779236|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
2779237|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2779238|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2779239|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2779240|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
2779241|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2779242|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2779243|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
2779244|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
2779245|NCT04371965|Povidone|povidone|mesh-list
2779246|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
2779247|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
2779248|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2779249|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779250|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
2779251|NCT04372082|Niclosamide|niclosamide|mesh-list
2779252|NCT04372082|Diltiazem|diltiazem|mesh-list
2779253|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
2779254|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2779255|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2779256|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779257|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779258|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779259|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779260|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2779261|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2779262|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2779263|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2779264|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779265|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
2269774|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269775|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2269776|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2269777|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2269778|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2269779|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
2269780|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2269781|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2269782|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2269783|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2269784|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2269785|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2269786|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2269787|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2269788|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
2269789|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2269790|NCT00192673|Asparaginase|asparaginase|mesh-list
2779266|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
2779267|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2779268|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
2779269|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
2779270|NCT04371978|Linagliptin|linagliptin|mesh-list
2779271|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2779272|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779273|NCT04371978|Incretins|incretins|mesh-ancestor
2779274|NCT04371978|Hormones|hormones|mesh-ancestor
2779275|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2779276|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2779277|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
2779278|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779279|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779280|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
2779281|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
2779282|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2779283|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2779284|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779285|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779286|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779287|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779288|NCT04371757|Doxazosin|doxazosin|mesh-list
2779289|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
2779290|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2779291|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2269791|NCT00192673|Pegaspargase|pegaspargase|mesh-list
2269792|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269793|NCT00192712|Gemcitabine|gemcitabine|mesh-list
2269794|NCT00192712|Irinotecan|irinotecan|mesh-list
2269795|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269796|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
2269797|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269798|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779292|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2779293|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2779294|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2779295|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779296|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779297|NCT04371601|Oseltamivir|oseltamivir|mesh-list
2779298|NCT04371601|Hormones|hormones|mesh-list
2779299|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2779300|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779301|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
2779302|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779303|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779304|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779305|NCT04371445|Dexamethasone|dexamethasone|mesh-list
2779306|NCT04371445|Prednisolone|prednisolone|mesh-list
2779307|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2779308|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
2779309|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2779310|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
2779311|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2779312|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
2779313|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2779314|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
2779315|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
2779316|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779317|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779318|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2779319|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
2779320|NCT04371445|Hormones|hormones|mesh-ancestor
2779321|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2779322|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2779323|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779324|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2779325|NCT04371445|Protective Agents|protective agents|mesh-ancestor
2779326|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
2779327|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
2779328|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2779329|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2779330|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779331|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779332|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779333|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779334|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
2779335|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
2779336|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2779337|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
2779338|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779339|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779340|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
2779341|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2779342|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
2779343|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779344|NCT04371224|Leucovorin|leucovorin|mesh-list
2779345|NCT04371224|Fluorouracil|fluorouracil|mesh-list
2779346|NCT04371224|Capecitabine|capecitabine|mesh-list
2779347|NCT04371224|Irinotecan|irinotecan|mesh-list
2779348|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
2779349|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779350|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2779351|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779352|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2779353|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
2779354|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269799|NCT00192712|Antiviral Agents|antiviral agents|mesh-ancestor
2269800|NCT00192712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779355|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2779356|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2779357|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102418|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
2102419|NCT02408016|Interleukin-2|interleukin-2|mesh-list
2102420|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2102421|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
2102422|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102423|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2102424|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2102425|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
2102426|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102427|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102428|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2102429|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2102430|NCT02408016|Analgesics|analgesics|mesh-ancestor
2102431|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
2102432|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779358|NCT04371224|Antidotes|antidotes|mesh-ancestor
2779359|NCT04371224|Protective Agents|protective agents|mesh-ancestor
2779360|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
2779361|NCT04371224|Vitamins|vitamins|mesh-ancestor
2779362|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
2779363|NCT04371575|Carbamazepine|carbamazepine|mesh-list
2779364|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
2779365|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
2779366|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
2779367|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2779368|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2779369|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779370|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2779371|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2779372|NCT04371575|Analgesics|analgesics|mesh-ancestor
2779373|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
2779374|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779375|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2779376|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2779377|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779378|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2779379|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2779380|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2779381|NCT04371341|Bupivacaine|bupivacaine|mesh-list
2779382|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
2779383|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
2779384|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2779385|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779386|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
2779387|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269801|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269802|NCT00192712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269803|NCT00192712|Immunologic Factors|immunologic factors|mesh-ancestor
2269804|NCT00192712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269805|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2269806|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2269807|NCT00192725|Tryptophan|tryptophan|mesh-list
2269808|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2269809|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
2269810|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2791508|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2791509|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791510|NCT04286035|Bupivacaine|bupivacaine|mesh-list
2791511|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
2791512|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
2791513|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791514|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791515|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
2791516|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791517|NCT04286087|Anesthetics|anesthetics|mesh-list
2791518|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791519|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791520|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2791521|NCT04285671|Trastuzumab|trastuzumab|mesh-list
2791522|NCT04285671|Necitumumab|necitumumab|mesh-list
2791523|NCT04285671|Cetuximab|cetuximab|mesh-list
2791524|NCT04285671|Osimertinib|osimertinib|mesh-list
2791525|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2791526|NCT04285671|Antibodies|antibodies|mesh-list
2791527|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
2791528|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2269811|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
2269812|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269813|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
2269814|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269815|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2269816|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2269817|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
2269818|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269819|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269820|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2779388|NCT04371367|Avdoralimab|avdoralimab|mesh-list
2779389|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2779390|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
2779391|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779392|NCT04371406|Azithromycin|azithromycin|mesh-list
2779393|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
2779394|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2779395|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779396|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
2779397|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2779398|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2779399|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779400|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779401|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779402|NCT04371185|Ustekinumab|ustekinumab|mesh-list
2779403|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
2779404|NCT04371146|Methylphenidate|methylphenidate|mesh-list
2779405|NCT04371146|Reboxetine|reboxetine|mesh-list
2779406|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2779407|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779408|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2779409|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2779410|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2779411|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779412|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
2779413|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2779414|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
2779415|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2779416|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2779417|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
2779418|NCT04370977|Artesunate|artesunate|mesh-list
2779419|NCT04370977|Lumefantrine|lumefantrine|mesh-list
2779420|NCT04370977|Artemether|artemether|mesh-list
2779421|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2779422|NCT04370977|Amodiaquine|amodiaquine|mesh-list
2779423|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
2779424|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2779425|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2779426|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779427|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779428|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
2779429|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
2779430|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2779431|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
2779457|NCT04370782|Azithromycin|azithromycin|mesh-list
2779458|NCT04370782|Doxycycline|doxycycline|mesh-list
2779459|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
2779460|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
2779461|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2779462|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269821|NCT00192777|Capecitabine|capecitabine|mesh-list
2269822|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269823|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
2269824|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269825|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269826|NCT00192803|Candesartan|candesartan|mesh-list
2269827|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2269828|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2269829|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2269830|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779463|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
2779464|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2779465|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2779466|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779467|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779468|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779469|NCT04370782|Astringents|astringents|mesh-ancestor
2779470|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779471|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
2779472|NCT04371107|Azithromycin|azithromycin|mesh-list
2779473|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2779474|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779475|NCT04370483|Leflunomide|leflunomide|mesh-list
2779476|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779477|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779478|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2779479|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
2779480|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779481|NCT04370418|Fluorouracil|fluorouracil|mesh-list
2779482|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
2102433|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2102434|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2102435|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
2102436|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102437|NCT02408068|Dexamethasone|dexamethasone|mesh-list
2269831|NCT00192842|Gemcitabine|gemcitabine|mesh-list
2269832|NCT00192842|Curcumin|curcumin|mesh-list
2269833|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269834|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
2269835|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269836|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269837|NCT00192842|Antiviral Agents|antiviral agents|mesh-ancestor
2269838|NCT00192842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269839|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269840|NCT00192842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269841|NCT00192842|Immunologic Factors|immunologic factors|mesh-ancestor
2269842|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269843|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2269844|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2269845|NCT00192842|Analgesics|analgesics|mesh-ancestor
2269846|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
2269847|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269848|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2269849|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2269850|NCT00192855|Entacapone|entacapone|mesh-list
2779483|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779484|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2779485|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779486|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2779487|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
2779488|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779489|NCT04370431|Edaravone|edaravone|mesh-list
2779490|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2779491|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
2779492|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779493|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2779494|NCT04370431|Protective Agents|protective agents|mesh-ancestor
2779495|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102438|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
2779496|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
2779497|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2779498|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779499|NCT04370262|Famotidine|famotidine|mesh-list
2779500|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2779501|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2269851|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2269852|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2269853|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2269854|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269855|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269856|NCT00192959|Propofol|propofol|mesh-list
2269857|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2779502|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2779503|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
2779504|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
2779505|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2779506|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779507|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779508|NCT04370093|Pioglitazone|pioglitazone|mesh-list
2779509|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2779510|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779511|NCT04370145|Meropenem|meropenem|mesh-list
2779512|NCT04370145|Tinidazole|tinidazole|mesh-list
2779513|NCT04370145|Teicoplanin|teicoplanin|mesh-list
2779514|NCT04370145|Sulperazone|sulperazone|mesh-list
2779515|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2779516|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779517|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
2779518|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779519|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2779520|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2779521|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2779522|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2779523|NCT04370145|Renal Agents|renal agents|mesh-ancestor
2779524|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
2779525|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
2779526|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2779527|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2779528|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779529|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779530|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779531|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779532|NCT04370288|Ascorbic Acid|ascorbic acid|mesh-list
2779533|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
2779534|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2779535|NCT04370288|Methylene Blue|methylene blue|mesh-list
2779536|NCT04370288|Vitamins|vitamins|mesh-ancestor
2779537|NCT04370288|Micronutrients|micronutrients|mesh-ancestor
2779538|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779539|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
2779540|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779541|NCT04370288|Protective Agents|protective agents|mesh-ancestor
2779542|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
2779543|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779544|NCT04370288|Expectorants|expectorants|mesh-ancestor
2779545|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
2779546|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2779547|NCT04370288|Antidotes|antidotes|mesh-ancestor
2779548|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779549|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
2779550|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2779551|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
2779552|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779553|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
2779554|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779555|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2779556|NCT04369950|Lidocaine|lidocaine|mesh-list
2779557|NCT04369950|Epinephrine|epinephrine|mesh-list
2779558|NCT04369950|Morphine|morphine|mesh-list
2779559|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
2779560|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
2779561|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
2779562|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2779563|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779564|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
2779565|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779566|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2779567|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2779568|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2779569|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2779570|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779571|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2779572|NCT04369950|Narcotics|narcotics|mesh-ancestor
2779573|NCT04369950|Analgesics|analgesics|mesh-ancestor
2779574|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2269858|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2269859|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269860|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2269861|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
2269862|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
2269863|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
2779575|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2779576|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
2779577|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2779578|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2779579|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2779580|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
2779581|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2779582|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
2779583|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
2779584|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
2779585|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2779586|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
2779587|NCT04369742|Calcium|calcium|mesh-list
2779588|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2779589|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779590|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779591|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
2779592|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2779593|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2779594|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779595|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779596|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779597|NCT04369534|Clopidogrel|clopidogrel|mesh-list
2779598|NCT04369534|Ticagrelor|ticagrelor|mesh-list
2269864|NCT00193011|Docetaxel|docetaxel|mesh-list
2269865|NCT00193011|Fluorouracil|fluorouracil|mesh-list
2269866|NCT00193011|Methotrexate|methotrexate|mesh-list
2269867|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269868|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
2269869|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269870|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2269871|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2269872|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
2269873|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269874|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269875|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2269876|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
2269877|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
2269878|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
2269879|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
2779599|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2779600|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2779601|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2779602|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2779603|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
2779604|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2779605|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779606|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791529|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
2791530|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269880|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269881|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2269882|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
2269883|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2269884|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
2269885|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269886|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2269887|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2269888|NCT00193024|Docetaxel|docetaxel|mesh-list
2269889|NCT00193024|Epirubicin|epirubicin|mesh-list
2269890|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269891|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
2779617|NCT04369469|Ravulizumab|ravulizumab|mesh-list
2779618|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2779619|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2779620|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
2779621|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779626|NCT04370080|Fluorides|fluorides|mesh-list
2779627|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
2779628|NCT04370080|Protective Agents|protective agents|mesh-ancestor
2779629|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779630|NCT04370392|Anesthetics|anesthetics|mesh-list
2779631|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
2779632|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2779633|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779634|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
2779635|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779636|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
2779637|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2779638|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779639|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2779640|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2779641|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779642|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779643|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779644|NCT04369365|Azithromycin|azithromycin|mesh-list
2779645|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2779646|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779655|NCT04369222|Acetaminophen|acetaminophen|mesh-list
2779656|NCT04369222|Aspirin|aspirin|mesh-list
2779657|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
2779658|NCT04369222|Salicylates|salicylates|mesh-list
2779659|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2779660|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2779661|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2779662|NCT04369222|Analgesics|analgesics|mesh-ancestor
2779663|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
2779664|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2269892|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
2269893|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
2269894|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779665|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779666|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
2779667|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779668|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
2779669|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
2779670|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
2779671|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779672|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2779673|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779674|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779675|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2779676|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2779677|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2779692|NCT04368819|Allopurinol|allopurinol|mesh-list
2779693|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
2779694|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779695|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779696|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
2779697|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779698|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2779699|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
2779700|NCT04368819|Protective Agents|protective agents|mesh-ancestor
2779701|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779702|NCT04368585|Simethicone|simethicone|mesh-list
2779703|NCT04368585|Omeprazole|omeprazole|mesh-list
2779704|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2779705|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
2779706|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
2779707|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
2779708|NCT04368585|TEMPO|tempo|mesh-list
2779709|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2779710|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2779711|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2779712|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779713|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779714|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
2779715|NCT04368585|Emollients|emollients|mesh-ancestor
2779716|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
2779717|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2779718|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
2779719|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779720|NCT04368585|Antacids|antacids|mesh-ancestor
2779721|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
2779722|NCT04368585|Protective Agents|protective agents|mesh-ancestor
2779723|NCT04368546|Sunitinib|sunitinib|mesh-list
2779724|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779725|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2779726|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2779727|NCT04368546|Growth Substances|growth substances|mesh-ancestor
2779728|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779729|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
2779730|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2779731|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779732|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779733|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
2779734|NCT04368598|Dexamethasone|dexamethasone|mesh-list
2779735|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
2269895|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2269896|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2269897|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2269898|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269899|NCT00193076|Gemcitabine|gemcitabine|mesh-list
2269900|NCT00193076|Carboplatin|carboplatin|mesh-list
2269901|NCT00193076|Trastuzumab|trastuzumab|mesh-list
2269902|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269903|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269904|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
2269905|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269906|NCT00193076|Antiviral Agents|antiviral agents|mesh-ancestor
2269907|NCT00193076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269908|NCT00193076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269909|NCT00193076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269910|NCT00193076|Immunologic Factors|immunologic factors|mesh-ancestor
2269911|NCT00193076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269912|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2269913|NCT00193089|Docetaxel|docetaxel|mesh-list
2269914|NCT00193089|Trastuzumab|trastuzumab|mesh-list
2779736|NCT04368598|BB 1101|bb 1101|mesh-list
2779737|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2779738|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2779739|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
2779740|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
2779741|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779742|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779743|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2779744|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
2779745|NCT04368598|Hormones|hormones|mesh-ancestor
2779746|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2779747|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2779748|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779749|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
2779750|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779751|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779752|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
2779753|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779754|NCT04368598|Expectorants|expectorants|mesh-ancestor
2779755|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
2779756|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2779757|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
2779758|NCT04368598|Protective Agents|protective agents|mesh-ancestor
2779759|NCT04368598|Antidotes|antidotes|mesh-ancestor
2779760|NCT04368520|Vitamin D|vitamin d|mesh-list
2779761|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
2779762|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
2779763|NCT04368520|Vitamins|vitamins|mesh-list
2779764|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
2779765|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779766|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2779767|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2779768|NCT04368533|Fluorides|fluorides|mesh-list
2779769|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
2779770|NCT04368533|Protective Agents|protective agents|mesh-ancestor
2779771|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779772|NCT04368377|Aspirin|aspirin|mesh-list
2779773|NCT04368377|PENTA|penta|mesh-list
2779774|NCT04368377|Tirofiban|tirofiban|mesh-list
2779775|NCT04368377|Fondaparinux|fondaparinux|mesh-list
2779776|NCT04368377|Clopidogrel|clopidogrel|mesh-list
2779777|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2779778|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2779779|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2779780|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2779781|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
2779782|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2779783|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779784|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779785|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2779786|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2779787|NCT04368377|Analgesics|analgesics|mesh-ancestor
2779788|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
2779789|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779790|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2779791|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779792|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2779793|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2779794|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2779795|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779796|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
2779797|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2779798|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
2779799|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2779800|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
2779801|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
2779802|NCT04368403|Brodalumab|brodalumab|mesh-list
2779803|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
2779804|NCT04368273|Antibodies|antibodies|mesh-list
2779805|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
2779806|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779807|NCT04368078|Lenvatinib|lenvatinib|mesh-list
2779808|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779809|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2779810|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779811|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779812|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2779813|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2779814|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779815|NCT04368091|Sirolimus|sirolimus|mesh-list
2779816|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2779817|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779818|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2779819|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779820|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
2779821|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2779822|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
2779823|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791531|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791532|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791533|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2791534|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791535|NCT04285853|Oxycodone|oxycodone|mesh-list
2791536|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2791537|NCT04285853|Narcotics|narcotics|mesh-ancestor
2791538|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791539|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791540|NCT04285853|Analgesics|analgesics|mesh-ancestor
2791541|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
2791542|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791543|NCT04286152|Mirabegron|mirabegron|mesh-list
2791544|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2791545|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2791546|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2791547|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
2791548|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791549|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791550|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791551|NCT04286152|Urological Agents|urological agents|mesh-ancestor
2791552|NCT04285580|Bimatoprost|bimatoprost|mesh-list
2791553|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2791554|NCT04285528|Lidocaine|lidocaine|mesh-list
2791555|NCT04285528|Fentanyl|fentanyl|mesh-list
2791556|NCT04285528|Ketamine|ketamine|mesh-list
2791557|NCT04285528|Propofol|propofol|mesh-list
2791558|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
2791559|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
2791560|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791561|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269915|NCT00193089|Vinorelbine|vinorelbine|mesh-list
2269916|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269917|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
2269918|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
2269919|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
2269920|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269921|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2269922|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2269923|NCT00193102|Thalidomide|thalidomide|mesh-list
2269924|NCT00193102|Capecitabine|capecitabine|mesh-list
2269925|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2269926|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
2791562|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
2791563|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791564|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2791565|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2791566|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2791567|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2791568|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791569|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2791570|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2791571|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
2791572|NCT04285528|Analgesics|analgesics|mesh-ancestor
2791573|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2791574|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2791575|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2791576|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791577|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2791578|NCT04285528|Narcotics|narcotics|mesh-ancestor
2791579|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2791580|NCT04285450|Vitamin K|vitamin k|mesh-list
2791581|NCT04285450|Vitamins|vitamins|mesh-ancestor
2791582|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
2791583|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791584|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2791585|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2779824|NCT04368351|Azithromycin|azithromycin|mesh-list
2779825|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
2779826|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2779827|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779828|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
2779829|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2779830|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2779831|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779832|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779833|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779834|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
2779835|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2779836|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779837|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779838|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2779839|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2779840|NCT04367935|Protective Agents|protective agents|mesh-ancestor
2779841|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779842|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
2779843|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2779844|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
2779845|NCT04368364|Morphine|morphine|mesh-list
2779846|NCT04368364|Bupivacaine|bupivacaine|mesh-list
2779847|NCT04368364|Ropivacaine|ropivacaine|mesh-list
2779848|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
2779849|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
2779850|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2779851|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779852|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
2779853|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779854|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2779855|NCT04368364|Narcotics|narcotics|mesh-ancestor
2779856|NCT04368364|Analgesics|analgesics|mesh-ancestor
2779861|NCT04367883|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2779862|NCT04367883|Protease Inhibitors|protease inhibitors|mesh-ancestor
2779863|NCT04367883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2779864|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779865|NCT04367831|Heparin|heparin|mesh-list
2779866|NCT04367831|Calcium heparin|calcium heparin|mesh-list
2779867|NCT04367831|Enoxaparin|enoxaparin|mesh-list
2779868|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
2779869|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
2779870|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2779871|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2779872|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779873|NCT04367818|Anesthetics|anesthetics|mesh-list
2779874|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
2779875|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2779876|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779877|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
2779878|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779879|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
2779880|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2779881|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2779882|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779883|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
2779884|NCT04367155|Coagulants|coagulants|mesh-ancestor
2779885|NCT04367103|Phenylephrine|phenylephrine|mesh-list
2779886|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
2779887|NCT04367103|Norepinephrine|norepinephrine|mesh-list
2779888|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2779889|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
2779890|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
2779891|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779892|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779893|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
2779894|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2779895|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
2779896|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
2779897|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2779898|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2779899|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2779900|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
2779901|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2779902|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779903|NCT04367103|Protective Agents|protective agents|mesh-ancestor
2779904|NCT04367051|Spironolactone|spironolactone|mesh-list
2779905|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2779906|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
2779907|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2779908|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779909|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2779910|NCT04367051|Diuretics|diuretics|mesh-ancestor
2779911|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
2779920|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
2779921|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779922|NCT04367168|Colchicine|colchicine|mesh-list
2779923|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
2269927|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269928|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269929|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269930|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
2269931|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269932|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
2269933|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2269934|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269935|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2779924|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779925|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
2779926|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
2779927|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
2779928|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779929|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779930|NCT04366609|Methylphenidate|methylphenidate|mesh-list
2779931|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2779932|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779933|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2779934|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2779935|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2779936|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779937|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
2779938|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2779939|NCT04366622|Riociguat|riociguat|mesh-list
2779940|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
2779941|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779942|NCT04366596|Paclitaxel|paclitaxel|mesh-list
2779943|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2779944|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779945|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
2779946|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
2779947|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
2269936|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2269937|NCT00193102|Growth Substances|growth substances|mesh-ancestor
2269938|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
2269939|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
2269940|NCT00193115|Docetaxel|docetaxel|mesh-list
2269941|NCT00193115|Doxorubicin|doxorubicin|mesh-list
2269942|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269943|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
2779948|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779949|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
2779950|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
2779951|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
2269944|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269945|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2269946|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2269947|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
2269948|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269949|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269950|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2779952|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779953|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779954|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2779955|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2779956|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2779957|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2269951|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
2269952|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
2269953|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
2779958|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2779959|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2779960|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
2779961|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2779962|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779963|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
2779964|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2779965|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
2779966|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
2779967|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
2779968|NCT04366726|Abaloparatide|abaloparatide|mesh-list
2779969|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2779970|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779971|NCT04366960|Enoxaparin|enoxaparin|mesh-list
2779972|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
2779973|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2779974|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2779975|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2779976|NCT04366908|Calcifediol|calcifediol|mesh-list
2779977|NCT04366908|Vitamins|vitamins|mesh-ancestor
2779978|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
2779979|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779980|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2791586|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791587|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
2791588|NCT04285450|Coagulants|coagulants|mesh-ancestor
2791589|NCT04285229|Ixekizumab|ixekizumab|mesh-list
2791590|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
2791591|NCT04285281|Gabapentin|gabapentin|mesh-list
2791592|NCT04285281|Analgesics|analgesics|mesh-ancestor
2791593|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
2791594|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791595|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791596|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
2791597|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2791598|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2791599|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791600|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2791601|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2791602|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2791603|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791604|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791605|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
2791606|NCT04285073|Paclitaxel|paclitaxel|mesh-list
2791607|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2791608|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791609|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
2791610|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
2791611|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
2791612|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791613|NCT04285268|Rituximab|rituximab|mesh-list
2791614|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2791615|NCT04285268|Bortezomib|bortezomib|mesh-list
2791616|NCT04285268|Venetoclax|venetoclax|mesh-list
2791617|NCT04285268|Antibodies|antibodies|mesh-list
2791618|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
2791619|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2791620|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
2791621|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791622|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791623|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2791624|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2791625|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2791626|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2791627|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
2791628|NCT04285346|Ganaxolone|ganaxolone|mesh-list
2791629|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
2791630|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2779981|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2779982|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2779983|NCT04366115|Dexamethasone|dexamethasone|mesh-list
2779984|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
2779985|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2779986|NCT04366115|BB 1101|bb 1101|mesh-list
2779987|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2779988|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
2779989|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
2779990|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2779991|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2779992|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2779993|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
2779994|NCT04366115|Hormones|hormones|mesh-ancestor
2779995|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2779996|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2779997|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2779998|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
2779999|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780000|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780001|NCT04366089|Azithromycin|azithromycin|mesh-list
2780002|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
2780003|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2780004|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780005|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
2780006|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2780007|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780008|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780009|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780010|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780011|NCT04366050|Ramipril|ramipril|mesh-list
2780012|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2780013|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
2780014|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780015|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780016|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2780034|NCT04365933|Interferons|interferons|mesh-list
2780035|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
2780036|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
2780037|NCT04365933|Entecavir|entecavir|mesh-list
2780038|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2780039|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780040|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
2780041|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780042|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
2780043|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780044|NCT04365686|Propofol|propofol|mesh-list
2780045|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2780046|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2780047|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780048|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2780049|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
2780050|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
2780051|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2780052|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2780053|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780054|NCT04365517|Incretins|incretins|mesh-ancestor
2780055|NCT04365517|Hormones|hormones|mesh-ancestor
2780056|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2780057|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2780058|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
2780059|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780060|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780061|NCT04365582|Ritonavir|ritonavir|mesh-list
2780062|NCT04365582|Lopinavir|lopinavir|mesh-list
2780063|NCT04365582|Azithromycin|azithromycin|mesh-list
2780064|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
2780065|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2780066|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2780067|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
2780068|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780069|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780070|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2780071|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2780072|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
2780073|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780074|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2780075|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2780076|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2780077|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
2780078|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2780079|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780080|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780081|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
2780082|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2780083|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
2780084|NCT04365270|Chitosan|chitosan|mesh-list
2780085|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2780086|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780087|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
2780088|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
2780089|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2780090|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2780091|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
2780092|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780093|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2780094|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
2780095|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
2780096|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
2780097|NCT04365270|Coagulants|coagulants|mesh-ancestor
2780098|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
2780099|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2780100|NCT04365270|Protective Agents|protective agents|mesh-ancestor
2780101|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780102|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2780103|NCT04365127|Progesterone|progesterone|mesh-list
2780104|NCT04365127|Progestins|progestins|mesh-ancestor
2780105|NCT04365127|Hormones|hormones|mesh-ancestor
2780106|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2780107|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780108|NCT04365309|Aspirin|aspirin|mesh-list
2780109|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2780110|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2780111|NCT04365309|Analgesics|analgesics|mesh-ancestor
2780112|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
2780113|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780114|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780115|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2780116|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780117|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2780118|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2780119|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780120|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2780121|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2780122|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780123|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
2780124|NCT04365231|Azithromycin|azithromycin|mesh-list
2780125|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
2780126|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2780127|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780128|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
2780129|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2269954|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2269955|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2780130|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780131|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780132|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780133|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780134|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
2780135|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
2780136|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2780137|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780138|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2780139|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2102439|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2102440|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2102441|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2102442|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102443|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
2102444|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
2102445|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102446|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780140|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2780141|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2780142|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780143|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
2780144|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2780145|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2780146|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780147|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
2780148|NCT04364906|Anesthetics|anesthetics|mesh-list
2780149|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2780150|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780151|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
2780152|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
2780153|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2780154|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780155|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780156|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780157|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780158|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780159|NCT04365049|Gemcitabine|gemcitabine|mesh-list
2780160|NCT04365049|Apatinib|apatinib|mesh-list
2780161|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780162|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2780163|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
2780164|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780165|NCT04365049|Antiviral Agents|antiviral agents|mesh-ancestor
2780166|NCT04365049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780167|NCT04365049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780168|NCT04365049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2780169|NCT04365049|Immunologic Factors|immunologic factors|mesh-ancestor
2780170|NCT04365049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780171|NCT04365049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2780172|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
2780173|NCT04364945|Remifentanil|remifentanil|mesh-list
2780174|NCT04364945|Sevoflurane|sevoflurane|mesh-list
2780175|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2780176|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2780177|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780178|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2780179|NCT04364945|Analgesics|analgesics|mesh-ancestor
2780180|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
2780181|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780182|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2780183|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2780184|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2780185|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
2780186|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2780187|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780188|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2780189|NCT04364945|Narcotics|narcotics|mesh-ancestor
2780190|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2780191|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2780192|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
2780193|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
2780194|NCT04364802|Iodine|iodine|mesh-list
2780195|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
2780196|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
2780197|NCT04364802|Povidone|povidone|mesh-list
2780198|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2780199|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780200|NCT04364802|Trace Elements|trace elements|mesh-ancestor
2780201|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
2780202|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780203|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
2780204|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
2780205|NCT04364620|Docetaxel|docetaxel|mesh-list
2780206|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780207|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
2780208|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
2780209|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
2780210|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791631|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791632|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791633|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
2791634|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
2791654|NCT04284839|Warfarin|warfarin|mesh-list
2791655|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
2791656|NCT04284839|Dabigatran|dabigatran|mesh-list
2791657|NCT04284839|Apixaban|apixaban|mesh-list
2791658|NCT04284839|Edoxaban|edoxaban|mesh-list
2791659|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
2791660|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2269956|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2269957|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269958|NCT00193141|Paclitaxel|paclitaxel|mesh-list
2269959|NCT00193141|Carboplatin|carboplatin|mesh-list
2269960|NCT00193141|Fluorouracil|fluorouracil|mesh-list
2269961|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2269962|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791661|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
2791662|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2791663|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
2791664|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791665|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791666|NCT04284826|Mitomycins|mitomycins|mesh-list
2791667|NCT04284826|Mitomycin|mitomycin|mesh-list
2791668|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2791669|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791670|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
2791671|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791672|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2791673|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791674|NCT04284644|Propofol|propofol|mesh-list
2791675|NCT04284644|Sevoflurane|sevoflurane|mesh-list
2791676|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2791677|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791678|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791679|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2791680|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
2791681|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
2791682|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2791683|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2791684|NCT04284722|Metformin|metformin|mesh-list
2791685|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2791686|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791687|NCT04284761|Bicalutamide|bicalutamide|mesh-list
2791688|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
2780211|NCT04365036|Gemcitabine|gemcitabine|mesh-list
2780212|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
2780213|NCT04365036|Pegaspargase|pegaspargase|mesh-list
2780214|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2780215|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
2780216|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780217|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780218|NCT04365036|Antiviral Agents|antiviral agents|mesh-ancestor
2780219|NCT04365036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780220|NCT04365036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780221|NCT04365036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2780222|NCT04365036|Immunologic Factors|immunologic factors|mesh-ancestor
2780223|NCT04365036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780224|NCT04364516|Vitamin K|vitamin k|mesh-list
2780225|NCT04364516|Anticoagulants|anticoagulants|mesh-list
2780226|NCT04364516|Vitamins|vitamins|mesh-ancestor
2780227|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
2780228|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780229|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2780230|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2780231|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780232|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
2780233|NCT04364516|Coagulants|coagulants|mesh-ancestor
2780234|NCT04364607|Neostigmine|neostigmine|mesh-list
2780235|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2780236|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780237|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780238|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
2780239|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2780240|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780241|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2780242|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
2780243|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780244|NCT04364399|Vaccines|vaccines|mesh-list
2780245|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
2780246|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780247|NCT04364477|Anesthetics|anesthetics|mesh-list
2780248|NCT04364477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2780249|NCT04364477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780250|NCT04364360|Sulforaphane|sulforaphane|mesh-list
2780251|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2780252|NCT04364360|Protective Agents|protective agents|mesh-ancestor
2102447|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2102448|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
2102449|NCT02408068|Hormones|hormones|mesh-ancestor
2102450|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102451|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102452|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102453|NCT02408120|Insulin|insulin|mesh-list
2102454|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2102455|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
2102456|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
2102457|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
2102458|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2102459|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2102460|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102461|NCT02408315|Misoprostol|misoprostol|mesh-list
2102462|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2102463|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
2102464|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2780253|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780254|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780255|NCT04364555|Clobetasol|clobetasol|mesh-list
2780256|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2780257|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
2780258|NCT04364555|Hormones|hormones|mesh-ancestor
2780259|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2780260|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780261|NCT04364451|Asparaginase|asparaginase|mesh-list
2780262|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780263|NCT04364464|Riociguat|riociguat|mesh-list
2780264|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
2780265|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780266|NCT04364425|Triamcinolone|triamcinolone|mesh-list
2780267|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2780268|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2780269|NCT04364425|Lidocaine|lidocaine|mesh-list
2780270|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2780271|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
2780272|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
2780273|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2780274|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780275|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
2780276|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780277|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2780278|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2780279|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2780280|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2780281|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780282|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2780283|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
2780284|NCT04364425|Hormones|hormones|mesh-ancestor
2780285|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2780286|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2780287|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
2780288|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780289|NCT04364230|Poly ICLC|poly iclc|mesh-list
2780290|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
2780291|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780292|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
2780293|NCT04364321|Diazepam|diazepam|mesh-list
2780294|NCT04364321|Clonazepam|clonazepam|mesh-list
2780295|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2780296|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
2780297|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
2780298|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
2780299|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780300|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780301|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2780302|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2780303|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2780304|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2780305|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2780306|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2780307|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2780308|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2780309|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2780310|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
2780311|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
2780312|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
2780313|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
2780314|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2780315|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780316|NCT04364139|Metoprolol|metoprolol|mesh-list
2780317|NCT04364139|Amlodipine|amlodipine|mesh-list
2780318|NCT04364139|Ramipril|ramipril|mesh-list
2780319|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2780320|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2780321|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2780322|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780323|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2780324|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780325|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
2780326|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2780327|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
2780328|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
2780329|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780330|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2780331|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2780332|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2780333|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
2780334|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2780335|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2780336|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
2780337|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780338|NCT04364581|Letrozole|letrozole|mesh-list
2780339|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780340|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2780341|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2780342|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780343|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780344|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2780345|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
2780346|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2780347|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780348|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2780349|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780350|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
2780351|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
2780352|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2780353|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780354|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780355|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780356|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780357|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780358|NCT04364113|Benzocaine|benzocaine|mesh-list
2780359|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
2780360|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
2780361|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2780362|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780363|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
2780364|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780365|NCT04364022|Ritonavir|ritonavir|mesh-list
2780366|NCT04364022|Lopinavir|lopinavir|mesh-list
2780367|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2780368|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2780369|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
2780370|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780371|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780372|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2780373|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2780374|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
2780375|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780376|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2780377|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2780378|NCT04364035|Vesatolimod|vesatolimod|mesh-list
2780379|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
2780380|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2269963|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
2269964|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
2269965|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
2269966|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269967|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
2269968|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2780398|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
2780399|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
2780400|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2780401|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780402|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780403|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780404|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780405|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780406|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
2780407|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780408|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
2780409|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
2780410|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
2780411|NCT04363801|Capecitabine|capecitabine|mesh-list
2780412|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
2780413|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2780414|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
2780415|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780416|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780417|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
2780418|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
2780419|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2780420|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780421|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780422|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780423|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780424|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780425|NCT04363437|Colchicine|colchicine|mesh-list
2780426|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
2780427|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780428|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
2780429|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
2780430|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
2780431|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780432|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780433|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
2780434|NCT04363164|Testosterone|testosterone|mesh-list
2780435|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
2780436|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
2780437|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2780438|NCT04363164|Androgens|androgens|mesh-ancestor
2780439|NCT04363164|Hormones|hormones|mesh-ancestor
2780440|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2780441|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780442|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2780443|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780444|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
2780445|NCT04363203|Azithromycin|azithromycin|mesh-list
2780446|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
2780447|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2780448|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780449|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
2780450|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2780451|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780452|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780453|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780454|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2791689|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
2791690|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2791691|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791692|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791693|NCT04284852|Niraparib|niraparib|mesh-list
2791694|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2791695|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791696|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791697|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791698|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2791699|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2791700|NCT04284215|Paclitaxel|paclitaxel|mesh-list
2791701|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2791702|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2791703|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791704|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
2791705|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
2791706|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
2791707|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791708|NCT04284202|Dasatinib|dasatinib|mesh-list
2791709|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791710|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2791711|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791712|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792930|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2269969|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2269970|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
2269971|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269972|NCT00193154|Bevacizumab|bevacizumab|mesh-list
2269973|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2269974|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2269975|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269976|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2792931|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2780455|NCT04363255|Cisplatin|cisplatin|mesh-list
2780456|NCT04363255|Carboplatin|carboplatin|mesh-list
2780457|NCT04363255|Etoposide|etoposide|mesh-list
2780458|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
2780459|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780460|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2780461|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2780462|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2780463|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780464|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780465|NCT04363359|Vaccines|vaccines|mesh-list
2780466|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
2780467|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780468|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
2780469|NCT04363216|Vitamins|vitamins|mesh-ancestor
2780470|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
2780471|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780472|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
2780473|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780474|NCT04363216|Protective Agents|protective agents|mesh-ancestor
2780475|NCT04363060|Amoxicillin|amoxicillin|mesh-list
2780476|NCT04363060|Azithromycin|azithromycin|mesh-list
2780477|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
2780478|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
2780479|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2780480|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2780481|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780482|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2780483|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780484|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780485|NCT04362839|Nivolumab|nivolumab|mesh-list
2780486|NCT04362839|Ipilimumab|ipilimumab|mesh-list
2780487|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2780488|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780489|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2780490|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780491|NCT04362761|Ivacaftor|ivacaftor|mesh-list
2780492|NCT04362761|Elexacaftor|elexacaftor|mesh-list
2780493|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2780494|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2780495|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780496|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2780497|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780498|NCT04362735|Vedolizumab|vedolizumab|mesh-list
2780499|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2780500|NCT04362527|Milrinone|milrinone|mesh-list
2780501|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2780502|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2780503|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2780504|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
2780505|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2780506|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2269977|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2269978|NCT00193154|Growth Substances|growth substances|mesh-ancestor
2269979|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2269980|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
2269981|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2269982|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269983|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269984|NCT00193167|Topotecan|topotecan|mesh-list
2269985|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2269986|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2269987|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2269988|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2269989|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269990|NCT00193193|Paclitaxel|paclitaxel|mesh-list
2269991|NCT00193193|Carboplatin|carboplatin|mesh-list
2269992|NCT00193193|Estramustine|estramustine|mesh-list
2780507|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780508|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780509|NCT04362527|Protective Agents|protective agents|mesh-ancestor
2780510|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780511|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2780512|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
2780513|NCT04362384|Vitamin E|vitamin e|mesh-list
2780514|NCT04362384|Prednisolone|prednisolone|mesh-list
2780515|NCT04362384|Vitamins|vitamins|mesh-ancestor
2780516|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
2780517|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780518|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2780519|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
2780520|NCT04362384|Hormones|hormones|mesh-ancestor
2780521|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2780522|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2780523|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780524|NCT04362384|Protective Agents|protective agents|mesh-ancestor
2780525|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
2780526|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780527|NCT04362241|Prednisolone|prednisolone|mesh-list
2780528|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2780529|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
2780530|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2780531|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
2780532|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2780533|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
2780534|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2780535|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
2780536|NCT04362241|Hormones|hormones|mesh-ancestor
2780537|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2780538|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780539|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2780540|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780541|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
2780542|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
2780543|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780544|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2780545|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2780546|NCT04362241|Protective Agents|protective agents|mesh-ancestor
2780547|NCT04362293|Sirolimus|sirolimus|mesh-list
2780548|NCT04362293|Plerixafor|plerixafor|mesh-list
2780549|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
2780550|NCT04362293|Thiotepa|thiotepa|mesh-list
2780551|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
2780552|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
2780553|NCT04362293|Azathioprine|azathioprine|mesh-list
2780554|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2780555|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
2780556|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780557|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780558|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2780559|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
2780560|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780561|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780562|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2780563|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2780564|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780565|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2780566|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
2780567|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2780568|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
2780569|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780570|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2780571|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
2780572|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2780573|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2780574|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2780575|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
2780576|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2780577|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780578|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
2780579|NCT04362332|Chloroquine|chloroquine|mesh-list
2780580|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2269993|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2269994|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2269995|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
2269996|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
2269997|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
2269998|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780581|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
2780582|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2780583|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780584|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780585|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780586|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780587|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780588|NCT04362332|Amebicides|amebicides|mesh-ancestor
2780589|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2780590|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2780591|NCT04362332|Analgesics|analgesics|mesh-ancestor
2780592|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
2780593|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780594|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780595|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2780596|NCT04362332|Filaricides|filaricides|mesh-ancestor
2780597|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
2780598|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
2780599|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
2780600|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2780601|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
2780602|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780603|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2780604|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
2780605|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780606|NCT04361825|Durvalumab|durvalumab|mesh-list
2269999|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2270000|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
2270001|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2270002|NCT00193232|Docetaxel|docetaxel|mesh-list
2270003|NCT00193232|Bortezomib|bortezomib|mesh-list
2270004|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270005|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270006|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270007|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270008|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270009|NCT00193245|Docetaxel|docetaxel|mesh-list
2270010|NCT00193245|Topotecan|topotecan|mesh-list
2270011|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270012|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270013|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270014|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270015|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270016|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2270017|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2270018|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270019|NCT00193271|Docetaxel|docetaxel|mesh-list
2270020|NCT00193271|Estramustine|estramustine|mesh-list
2270021|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270022|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270023|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270024|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270025|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270026|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2270027|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
2270028|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2270029|NCT00193284|Carboplatin|carboplatin|mesh-list
2270030|NCT00193284|Docetaxel|docetaxel|mesh-list
2270031|NCT00193284|Fluorouracil|fluorouracil|mesh-list
2270032|NCT00193284|Gefitinib|gefitinib|mesh-list
2270033|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270034|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270035|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270036|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270037|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270038|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
2270039|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2270040|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270041|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
2270042|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270043|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2270044|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270045|NCT00193297|Paclitaxel|paclitaxel|mesh-list
2270046|NCT00193297|Carboplatin|carboplatin|mesh-list
2270047|NCT00193297|Topotecan|topotecan|mesh-list
2270048|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2270049|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270050|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270051|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270052|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
2780607|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2780608|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780609|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
2780610|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
2780611|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
2780612|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2780613|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780614|NCT04361708|Leucovorin|leucovorin|mesh-list
2780615|NCT04361708|Docetaxel|docetaxel|mesh-list
2780616|NCT04361708|Fluorouracil|fluorouracil|mesh-list
2780617|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
2780618|NCT04361708|Irinotecan|irinotecan|mesh-list
2780619|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780620|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
2780621|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
2780622|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
2780623|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780624|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
2780625|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2780626|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2780627|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
2780628|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780629|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2780630|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2780631|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780632|NCT04361708|Antidotes|antidotes|mesh-ancestor
2780633|NCT04361708|Protective Agents|protective agents|mesh-ancestor
2780634|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
2780635|NCT04361708|Vitamins|vitamins|mesh-ancestor
2780636|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
2780637|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
2780638|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
2780639|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
2780640|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780641|NCT04361721|Erenumab|erenumab|mesh-list
2780642|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2780643|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780644|NCT04361721|Analgesics|analgesics|mesh-ancestor
2780645|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
2780646|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780647|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780648|NCT04361812|Omalizumab|omalizumab|mesh-list
2780649|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2780650|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2780651|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2780652|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
2780653|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
2780654|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780655|NCT04361656|Lubiprostone|lubiprostone|mesh-list
2780656|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2780657|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2780658|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780659|NCT04361643|Lenalidomide|lenalidomide|mesh-list
2780660|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
2780661|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780662|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2780663|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2780664|NCT04361643|Growth Substances|growth substances|mesh-ancestor
2780665|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
2780666|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780667|NCT04361513|Triamcinolone|triamcinolone|mesh-list
2780668|NCT04361513|Bupivacaine|bupivacaine|mesh-list
2780669|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
2780670|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
2780671|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2780672|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780673|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
2780674|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780675|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2780676|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
2780677|NCT04361513|Hormones|hormones|mesh-ancestor
2270053|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270054|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2270055|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2270056|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780678|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2791713|NCT04284397|Aspirin|aspirin|mesh-list
2780679|NCT04361175|Letrozole|letrozole|mesh-list
2780680|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780681|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780682|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2780683|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2780684|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780685|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2780686|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
2780687|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2780688|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780689|NCT04361461|Azithromycin|azithromycin|mesh-list
2780690|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
2780691|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2780692|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780693|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
2780694|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2780695|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780696|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780697|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780698|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780699|NCT04361279|Rituximab|rituximab|mesh-list
2780700|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2780701|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780702|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
2780703|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780704|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780705|NCT04361188|Anesthetics|anesthetics|mesh-list
2780706|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2780707|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780708|NCT04361422|Isotretinoin|isotretinoin|mesh-list
2780709|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
2270057|NCT00193310|Paclitaxel|paclitaxel|mesh-list
2270058|NCT00193310|Carboplatin|carboplatin|mesh-list
2270059|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2780710|NCT04361331|Lenvatinib|lenvatinib|mesh-list
2780711|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780712|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2780713|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780714|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780715|NCT04361214|Leflunomide|leflunomide|mesh-list
2780716|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780717|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780718|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2780719|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
2780720|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780721|NCT04361305|Tadalafil|tadalafil|mesh-list
2780722|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
2780723|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2780724|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2780725|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780726|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780727|NCT04361305|Urological Agents|urological agents|mesh-ancestor
2780728|NCT04361370|Bevacizumab|bevacizumab|mesh-list
2780729|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
2780730|NCT04361370|Olaparib|olaparib|mesh-list
2780731|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2780732|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780733|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2780734|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2780735|NCT04361370|Growth Substances|growth substances|mesh-ancestor
2780736|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780737|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
2780738|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2780739|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780740|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780741|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
2270060|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270061|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270062|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270063|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270064|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270065|NCT00193323|Gemcitabine|gemcitabine|mesh-list
2270066|NCT00193323|Docetaxel|docetaxel|mesh-list
2780742|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
2780743|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
2780744|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2780745|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780746|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780747|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780748|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780749|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780750|NCT04361149|Capsaicin|capsaicin|mesh-list
2780751|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
2780752|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
2780753|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
2780754|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780755|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780756|NCT04361474|Budesonide|budesonide|mesh-list
2780757|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2780758|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2780759|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
2780760|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780761|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780762|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2780763|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
2780764|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
2780765|NCT04361474|Hormones|hormones|mesh-ancestor
2780766|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2780767|NCT04361058|Nivolumab|nivolumab|mesh-list
2780768|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2780769|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780770|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2780771|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780772|NCT04360681|Lofexidine|lofexidine|mesh-list
2780773|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2780774|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2270067|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2270068|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
2270069|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270070|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270071|NCT00193323|Antiviral Agents|antiviral agents|mesh-ancestor
2270072|NCT00193323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270073|NCT00193323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780775|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780776|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
2780777|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780778|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2270074|NCT00193323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270075|NCT00193323|Immunologic Factors|immunologic factors|mesh-ancestor
2270076|NCT00193323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270077|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270078|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270079|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270080|NCT00193336|Gefitinib|gefitinib|mesh-list
2270081|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270082|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2780779|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2780780|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2780781|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
2780782|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2780783|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270083|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270084|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270085|NCT00193349|Carboplatin|carboplatin|mesh-list
2270086|NCT00193349|Irinotecan|irinotecan|mesh-list
2270087|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
2270088|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270089|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2270090|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2270091|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270092|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270093|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2780784|NCT04361409|Gemcitabine|gemcitabine|mesh-list
2780785|NCT04361409|Rituximab|rituximab|mesh-list
2780786|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780787|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2780788|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
2780789|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270094|NCT00193362|Gemcitabine|gemcitabine|mesh-list
2270095|NCT00193362|Paclitaxel|paclitaxel|mesh-list
2780790|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780791|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2780792|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
2780793|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780794|NCT04361409|Antiviral Agents|antiviral agents|mesh-ancestor
2780795|NCT04361409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780796|NCT04361409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780797|NCT04361409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2780798|NCT04361162|Nivolumab|nivolumab|mesh-list
2780799|NCT04361162|Ipilimumab|ipilimumab|mesh-list
2780800|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2780801|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780802|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2780803|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780804|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
2780805|NCT04360759|Chloroquine|chloroquine|mesh-list
2780806|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
2780807|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2780808|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780809|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780810|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780811|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780812|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780813|NCT04360759|Amebicides|amebicides|mesh-ancestor
2780814|NCT04361032|Deferoxamine|deferoxamine|mesh-list
2780815|NCT04361032|Siderophores|siderophores|mesh-ancestor
2780816|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2780817|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
2780818|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
2780819|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780820|NCT04360941|Palbociclib|palbociclib|mesh-list
2780821|NCT04360941|Avelumab|avelumab|mesh-list
2780822|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780823|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2780824|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270096|NCT00193362|Vinorelbine|vinorelbine|mesh-list
2270097|NCT00193362|Carboplatin|carboplatin|mesh-list
2270098|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2270099|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270100|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270101|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270102|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270103|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270104|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2270105|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
2270106|NCT00193362|Antiviral Agents|antiviral agents|mesh-ancestor
2270107|NCT00193362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780825|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780826|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2780835|NCT04360824|Enoxaparin|enoxaparin|mesh-list
2780836|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
2780837|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2780838|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2780839|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780840|NCT04360889|Tocopherols|tocopherols|mesh-list
2780841|NCT04360889|Vitamin E|vitamin e|mesh-list
2780842|NCT04360889|Tocotrienols|tocotrienols|mesh-list
2780843|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
2780844|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
2780845|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780846|NCT04360889|Protective Agents|protective agents|mesh-ancestor
2780847|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780848|NCT04360889|Vitamins|vitamins|mesh-ancestor
2780849|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
2780850|NCT04360785|Methotrexate|methotrexate|mesh-list
2780851|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2780852|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
2780853|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2780854|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780855|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2780856|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
2780857|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780858|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780859|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2780860|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780861|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2780862|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2780863|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
2780864|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780865|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2780866|NCT04360655|Antibodies|antibodies|mesh-list
2780867|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2780868|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
2780869|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780870|NCT04360317|Docetaxel|docetaxel|mesh-list
2270108|NCT00193362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270109|NCT00193362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270110|NCT00193362|Immunologic Factors|immunologic factors|mesh-ancestor
2270111|NCT00193362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270112|NCT00193388|Topotecan|topotecan|mesh-list
2270113|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2270114|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2270115|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270116|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270117|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270118|NCT00193401|Topotecan|topotecan|mesh-list
2270119|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2270120|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2270121|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270122|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270123|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780871|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780872|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
2780873|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
2780874|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
2780875|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780876|NCT04360551|Telmisartan|telmisartan|mesh-list
2780877|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2780878|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2780879|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2780880|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780881|NCT04360421|Bupivacaine|bupivacaine|mesh-list
2780882|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
2270124|NCT00193440|Rituximab|rituximab|mesh-list
2270125|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2270126|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270127|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
2270128|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270129|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270130|NCT00193466|Rituximab|rituximab|mesh-list
2270131|NCT00193466|Fludarabine|fludarabine|mesh-list
2780883|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
2780884|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2780885|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780886|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
2780887|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780888|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
2780889|NCT04360473|Ketamine|ketamine|mesh-list
2780890|NCT04360473|Anesthetics|anesthetics|mesh-list
2780891|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2780892|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780893|NCT04360473|Analgesics|analgesics|mesh-ancestor
2780894|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
2780895|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780896|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2780897|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2780898|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
2780899|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2780900|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2780901|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2780902|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780903|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2780904|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
2780905|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2270132|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2270133|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270134|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
2270135|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270136|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270137|NCT00193505|Rituximab|rituximab|mesh-list
2270138|NCT00193505|Carboplatin|carboplatin|mesh-list
2270139|NCT00193505|Etoposide|etoposide|mesh-list
2270140|NCT00193505|Ifosfamide|ifosfamide|mesh-list
2270141|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2270142|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270143|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
2270144|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270145|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270146|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2270147|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2270148|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2270149|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780906|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2780907|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2780908|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
2780909|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2780910|NCT04359979|Tamsulosin|tamsulosin|mesh-list
2780911|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2780912|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2270150|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270151|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2270152|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
2270153|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
2270154|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270155|NCT00193531|Paclitaxel|paclitaxel|mesh-list
2270156|NCT00193531|Etoposide|etoposide|mesh-list
2270157|NCT00193531|Carboplatin|carboplatin|mesh-list
2270158|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2270159|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270160|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270161|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270162|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270163|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270164|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2270165|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2270166|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270167|NCT00193544|Thalidomide|thalidomide|mesh-list
2270168|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
2270169|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2780913|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2780914|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
2780915|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2780916|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780917|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780918|NCT04359979|Urological Agents|urological agents|mesh-ancestor
2780919|NCT04360070|Ketamine|ketamine|mesh-list
2780920|NCT04360070|Analgesics|analgesics|mesh-ancestor
2780921|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
2780922|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2780923|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780924|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2780925|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2780926|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
2780927|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
2780928|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2780929|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2780930|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2780931|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2780932|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780933|NCT04359953|Azithromycin|azithromycin|mesh-list
2780934|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
2780935|NCT04359953|Telmisartan|telmisartan|mesh-list
2780936|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2780937|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780938|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
2780939|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2270170|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
2780940|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780941|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780942|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780943|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2780944|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2780945|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2780946|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2780947|NCT04359966|Amoxicillin|amoxicillin|mesh-list
2780948|NCT04359966|Metronidazole|metronidazole|mesh-list
2780949|NCT04359966|Clarithromycin|clarithromycin|mesh-list
2780950|NCT04359966|Levofloxacin|levofloxacin|mesh-list
2780951|NCT04359966|Ofloxacin|ofloxacin|mesh-list
2780952|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
2270171|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270172|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
2270173|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2270174|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270175|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2270176|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2270177|NCT00193544|Growth Substances|growth substances|mesh-ancestor
2270178|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
2270179|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270180|NCT00193557|Bortezomib|bortezomib|mesh-list
2270181|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270182|NCT00193570|Docetaxel|docetaxel|mesh-list
2270183|NCT00193570|Topotecan|topotecan|mesh-list
2270184|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270185|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270186|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270187|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270188|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780953|NCT04359966|Esomeprazole|esomeprazole|mesh-list
2780954|NCT04359966|Bismuth|bismuth|mesh-list
2780955|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2780956|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780957|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2780958|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2780959|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2780960|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2780961|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2780962|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780963|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780964|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2780965|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2780966|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2780967|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2780968|NCT04359966|Renal Agents|renal agents|mesh-ancestor
2780969|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2780970|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2780971|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780972|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2780973|NCT04359966|Antacids|antacids|mesh-ancestor
2791714|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2791715|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2791716|NCT04284397|Analgesics|analgesics|mesh-ancestor
2791717|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
2791718|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791719|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791720|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2791721|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2791722|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2791723|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2791724|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791725|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2791726|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2791727|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791728|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
2791729|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
2791730|NCT04284098|Bupivacaine|bupivacaine|mesh-list
2791731|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
2791732|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
2791733|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791734|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791735|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
2791736|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270189|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2270190|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2780974|NCT04359862|Propofol|propofol|mesh-list
2270191|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270192|NCT00193583|Carboplatin|carboplatin|mesh-list
2270193|NCT00193583|Topotecan|topotecan|mesh-list
2270194|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270195|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2270196|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2270197|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780975|NCT04359862|Sevoflurane|sevoflurane|mesh-list
2780976|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2780977|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2780978|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780979|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2780980|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
2780981|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
2780982|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2780983|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2780984|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
2780985|NCT04360031|Tacrolimus|tacrolimus|mesh-list
2780986|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2780987|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
2780988|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2780989|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2780990|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2780991|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2780992|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2780993|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2780994|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2780995|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
2780996|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2780997|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2780998|NCT04360122|Levamisole|levamisole|mesh-list
2780999|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
2781000|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2781001|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
2781002|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781003|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
2781004|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
2781005|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2781006|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781007|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781008|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
2781009|NCT04360044|Dronabinol|dronabinol|mesh-list
2781010|NCT04360044|Cannabidiol|cannabidiol|mesh-list
2781011|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
2781012|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
2781013|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781014|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2781015|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2781016|NCT04360044|Analgesics|analgesics|mesh-ancestor
2102465|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102466|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2102467|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2102468|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
2102469|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
2102470|NCT02408445|Testosterone|testosterone|mesh-list
2102471|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
2781017|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
2781018|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781019|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2781020|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2781021|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2781022|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781023|NCT04360044|Hormones|hormones|mesh-ancestor
2781024|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2781025|NCT04360135|Acetaminophen|acetaminophen|mesh-list
2781026|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2781027|NCT04360135|Analgesics|analgesics|mesh-ancestor
2781028|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
2781029|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781030|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781031|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
2781032|NCT04360356|Ivermectin|ivermectin|mesh-list
2781033|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
2781034|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2102472|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
2781035|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781036|NCT04360876|Dexamethasone|dexamethasone|mesh-list
2781037|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
2781038|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2781039|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
2781040|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
2781041|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781042|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781043|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2781044|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
2781045|NCT04360876|Hormones|hormones|mesh-ancestor
2781046|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2781047|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2781048|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781049|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
2781050|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2781051|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781052|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
2781053|NCT04359615|Favipiravir|favipiravir|mesh-list
2781054|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
2781055|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2781056|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2781057|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781058|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781059|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781060|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781061|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
2781062|NCT04359823|Lovastatin|lovastatin|mesh-list
2781063|NCT04359823|L 647318|l 647318|mesh-list
2781064|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
2781065|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2781066|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2781067|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
2102473|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2102474|NCT02408445|Androgens|androgens|mesh-ancestor
2102475|NCT02408445|Hormones|hormones|mesh-ancestor
2102476|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102477|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781068|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781069|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2781070|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2781071|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781072|NCT04359576|Hemostatics|hemostatics|mesh-list
2781073|NCT04359576|Coagulants|coagulants|mesh-ancestor
2781074|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
2781075|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
2781076|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2781077|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2781078|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781079|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781080|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781081|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781082|NCT04359485|Glycolic acid|glycolic acid|mesh-list
2781083|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
2781084|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
2781085|NCT04359511|Prednisone|prednisone|mesh-list
2781086|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
2781087|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2781088|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
2781089|NCT04359511|Hormones|hormones|mesh-ancestor
2781090|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2781091|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781092|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2781093|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781094|NCT04359550|Antibodies|antibodies|mesh-list
2781095|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2781096|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
2781097|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781098|NCT04359524|Vitamin D|vitamin d|mesh-list
2781099|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
2781100|NCT04359524|Vitamins|vitamins|mesh-ancestor
2781101|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
2781102|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781103|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2781104|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2781105|NCT04359199|Cisplatin|cisplatin|mesh-list
2781106|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
2781107|NCT04359199|Nivolumab|nivolumab|mesh-list
2781108|NCT04359199|Cetuximab|cetuximab|mesh-list
2781109|NCT04359199|Durvalumab|durvalumab|mesh-list
2781110|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781111|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2781112|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2781113|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781114|NCT04359095|Tenofovir|tenofovir|mesh-list
2781115|NCT04359095|Emtricitabine|emtricitabine|mesh-list
2270198|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270199|NCT00193622|Bevacizumab|bevacizumab|mesh-list
2270200|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2270201|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2270202|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270203|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2270204|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2270205|NCT00193622|Growth Substances|growth substances|mesh-ancestor
2270206|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270207|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
2270208|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2270209|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270210|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270211|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
2270212|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2270213|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270214|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2781116|NCT04359095|Colchicine|colchicine|mesh-list
2781117|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2781118|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
2781119|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781120|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2781121|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2781122|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781123|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781124|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2781125|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2781126|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2781127|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2781128|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
2781129|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2781130|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2781131|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
2781132|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781133|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
2781134|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
2781135|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
2781136|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781137|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
2781138|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2781139|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2781140|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2781141|NCT04359147|Yohimbine|yohimbine|mesh-list
2781142|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2781143|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
2781144|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
2781145|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781146|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781147|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2781148|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2781149|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2781150|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
2781151|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2781152|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781153|NCT04359147|Urological Agents|urological agents|mesh-ancestor
2781154|NCT04359212|Heparin|heparin|mesh-list
2781155|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2781156|NCT04359212|Tinzaparin|tinzaparin|mesh-list
2781157|NCT04359212|Dalteparin|dalteparin|mesh-list
2781158|NCT04359212|PENTA|penta|mesh-list
2781159|NCT04359212|Fondaparinux|fondaparinux|mesh-list
2781160|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
2781161|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2781162|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2781163|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781164|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2781165|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
2781166|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2781167|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
2781168|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270215|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
2270216|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2270217|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270218|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270219|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270220|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
2270221|NCT00193648|Adalimumab|adalimumab|mesh-list
2270222|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2270223|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270224|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2270225|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270226|NCT00193661|Testosterone|testosterone|mesh-list
2270227|NCT00193661|Androgens|androgens|mesh-ancestor
2270228|NCT00193661|Hormones|hormones|mesh-ancestor
2270229|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270230|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270231|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
2270232|NCT00193674|Progestins|progestins|mesh-ancestor
2270233|NCT00193674|Hormones|hormones|mesh-ancestor
2270234|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270235|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270236|NCT00193700|Testosterone|testosterone|mesh-list
2270237|NCT00193700|Androgens|androgens|mesh-ancestor
2270238|NCT00193700|Hormones|hormones|mesh-ancestor
2270239|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270240|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270241|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2270242|NCT00193726|Estradiol|estradiol|mesh-list
2270243|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2270244|NCT00193726|Estrogens|estrogens|mesh-ancestor
2270245|NCT00193726|Hormones|hormones|mesh-ancestor
2270246|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270247|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270248|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2781169|NCT04359316|Azithromycin|azithromycin|mesh-list
2781170|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
2781171|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2781172|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781173|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
2781174|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2781175|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2781176|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781177|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781178|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781179|NCT04358965|Misoprostol|misoprostol|mesh-list
2781180|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
2781181|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2781182|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2781183|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781184|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
2781185|NCT04358965|Coagulants|coagulants|mesh-ancestor
2781186|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2781187|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
2781188|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2781189|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781190|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2781191|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2781192|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
2781193|NCT04358614|Ritonavir|ritonavir|mesh-list
2781194|NCT04358614|Lopinavir|lopinavir|mesh-list
2781195|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2781196|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2781197|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
2781198|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781199|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781200|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2781201|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2781202|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
2781203|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781204|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2781205|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2781206|NCT04358796|Perflubron|perflubron|mesh-list
2781207|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2781208|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
2781209|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2270249|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
2270250|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2781210|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2781211|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781212|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2781213|NCT04358627|Analgesics|analgesics|mesh-ancestor
2781214|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
2781215|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781216|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2781217|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2781218|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2781219|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
2781220|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2781221|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781222|NCT04358718|Anesthetics|anesthetics|mesh-list
2781223|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2781224|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781225|NCT04358770|Clocortolone|clocortolone|mesh-list
2781226|NCT04358770|Fluocortolone|fluocortolone|mesh-list
2781227|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
2781228|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2781229|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
2781230|NCT04358770|Hormones|hormones|mesh-ancestor
2781231|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2781232|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270251|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2270252|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2270253|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2270254|NCT00193739|Paclitaxel|paclitaxel|mesh-list
2270255|NCT00193739|Carboplatin|carboplatin|mesh-list
2270256|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2270257|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270258|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270259|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270260|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270261|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270262|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
2270263|NCT00193856|Leuprolide|leuprolide|mesh-list
2270264|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2270265|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270266|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2781233|NCT04358562|Gefitinib|gefitinib|mesh-list
2781234|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781235|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2781236|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781237|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781238|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
2781239|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2781240|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781241|NCT04358146|Locust bean gum|locust bean gum|mesh-list
2781242|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
2781243|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2781244|NCT04358549|Favipiravir|favipiravir|mesh-list
2781245|NCT04358549|Antiviral Agents|antiviral agents|mesh-ancestor
2781246|NCT04358549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2791737|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2791738|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2791739|NCT04284098|Analgesics|analgesics|mesh-ancestor
2791740|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2791741|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2791742|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2791743|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
2791744|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791745|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791746|NCT04284150|Midazolam|midazolam|mesh-list
2791747|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
2791748|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2791749|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791750|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791751|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2791752|NCT04284150|Analgesics|analgesics|mesh-ancestor
2791753|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
2791754|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791755|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2270267|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
2270268|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2781247|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
2781248|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2781249|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2781250|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781251|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2781252|NCT04358367|Analgesics|analgesics|mesh-ancestor
2781253|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
2781254|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781255|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2781256|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2781257|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2781258|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
2270269|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2270270|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270271|NCT00193869|Dexamethasone|dexamethasone|mesh-list
2270272|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2270273|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
2270274|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
2270275|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270276|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270277|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2781259|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2781260|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781269|NCT04358341|Doxorubicin|doxorubicin|mesh-list
2781270|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2270278|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
2270279|NCT00193869|Hormones|hormones|mesh-ancestor
2270280|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2781271|NCT04358341|Fluorouracil|fluorouracil|mesh-list
2781272|NCT04358341|Irinotecan|irinotecan|mesh-list
2781273|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2781274|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781275|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2781276|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2781277|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781278|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781279|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
2781280|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2781281|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2781282|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
2781283|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781284|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2781285|NCT04358432|Ezetimibe|ezetimibe|mesh-list
2781286|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2781287|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2781288|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
2781289|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781290|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2781291|NCT04358354|Fluorouracil|fluorouracil|mesh-list
2781292|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
2781293|NCT04358354|Irinotecan|irinotecan|mesh-list
2781294|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
2781295|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781296|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2781297|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781298|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2781299|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
2781300|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781301|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2270281|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2270282|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270283|NCT00193882|Cisplatin|cisplatin|mesh-list
2270284|NCT00193882|Fluorouracil|fluorouracil|mesh-list
2270285|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270286|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
2781302|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2781303|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781304|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
2781305|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
2781306|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781307|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
2781308|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2781309|NCT04358003|Coal Tar|coal tar|mesh-list
2781310|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
2781311|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
2781312|NCT04358497|Ibuprofen|ibuprofen|mesh-list
2781313|NCT04358497|Polidocanol|polidocanol|mesh-list
2781314|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2781315|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2781316|NCT04358497|Analgesics|analgesics|mesh-ancestor
2781317|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
2781318|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781319|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781320|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2781321|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781322|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2781323|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781324|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781325|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2781326|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2781327|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
2781328|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2781329|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
2102478|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102479|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102480|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
2102481|NCT02408523|Lacosamide|lacosamide|mesh-list
2102482|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2102483|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
2102484|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2102485|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2102486|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2102487|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781330|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781331|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
2781332|NCT04358120|Protective Agents|protective agents|mesh-ancestor
2781333|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
2781334|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2781335|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
2781336|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781337|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
2781338|NCT04358055|Protective Agents|protective agents|mesh-ancestor
2781339|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
2781340|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781341|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
2781342|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2781343|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2781344|NCT04358016|Terlipressin|terlipressin|mesh-list
2781345|NCT04358016|Somatostatin|somatostatin|mesh-list
2781346|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2781347|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2781348|NCT04358016|Hormones|hormones|mesh-ancestor
2781349|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2781350|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781351|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
2781352|NCT04357873|Vorinostat|vorinostat|mesh-list
2781353|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2781354|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781355|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2781356|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781357|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270287|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270288|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2270289|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270290|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
2270291|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270292|NCT00193895|Carboplatin|carboplatin|mesh-list
2781362|NCT04357522|Vaccines|vaccines|mesh-list
2781363|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2781364|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
2781365|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781366|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
2781367|NCT04357782|Vitamins|vitamins|mesh-ancestor
2781368|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
2781369|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781370|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
2781371|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781372|NCT04357782|Protective Agents|protective agents|mesh-ancestor
2781373|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
2781374|NCT04357535|Giapreza|giapreza|mesh-list
2781375|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2781376|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
2781377|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2781378|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2781379|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781380|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2781381|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2781382|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
2781383|NCT04357483|Thrombin|thrombin|mesh-list
2781384|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
2781385|NCT04357483|Coagulants|coagulants|mesh-ancestor
2781386|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2781387|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781388|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2781389|NCT04357392|Prednisone|prednisone|mesh-list
2270293|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270294|NCT00193921|Gemcitabine|gemcitabine|mesh-list
2270295|NCT00193921|Cisplatin|cisplatin|mesh-list
2270296|NCT00193921|Vinorelbine|vinorelbine|mesh-list
2270297|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781390|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781391|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2781392|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
2781393|NCT04357392|Hormones|hormones|mesh-ancestor
2781394|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2781395|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2781396|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781397|NCT04357093|Listerine|listerine|mesh-list
2781398|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
2781399|NCT04357093|Fluorides|fluorides|mesh-list
2781400|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
2781401|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
2781402|NCT04357093|Protective Agents|protective agents|mesh-ancestor
2781403|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781404|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2781405|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781406|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2781407|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781408|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
2781409|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781410|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
2781411|NCT04357002|Dinoprostone|dinoprostone|mesh-list
2781412|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2781413|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2781414|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781415|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
2781416|NCT04357002|Coagulants|coagulants|mesh-ancestor
2781417|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
2781418|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2781419|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781420|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2781421|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
2781422|NCT04357015|Carbetocin|carbetocin|mesh-list
2781423|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2781424|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2781425|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781426|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
2781427|NCT04357015|Coagulants|coagulants|mesh-ancestor
2781428|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
2270298|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2781429|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2781430|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781431|NCT04356872|Doxorubicin|doxorubicin|mesh-list
2781432|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2781433|NCT04356872|Ifosfamide|ifosfamide|mesh-list
2781434|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2781435|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781436|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2781437|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2781438|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781439|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781440|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2781441|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
2781442|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
2781443|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
2781444|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2781445|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2781446|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781447|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781448|NCT04356716|Urological Agents|urological agents|mesh-ancestor
2781449|NCT04356729|Bevacizumab|bevacizumab|mesh-list
2781450|NCT04356729|Atezolizumab|atezolizumab|mesh-list
2781451|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2781452|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781453|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2781454|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2781455|NCT04356729|Growth Substances|growth substances|mesh-ancestor
2781456|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781457|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
2781458|NCT04356638|Midazolam|midazolam|mesh-list
2781459|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
2781460|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2781461|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2781462|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781463|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2781464|NCT04356638|Analgesics|analgesics|mesh-ancestor
2781465|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
2781466|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781467|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2781468|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2781469|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2781470|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
2781471|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2781472|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781473|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2781474|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2781475|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2781476|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2781477|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2781478|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
2102488|NCT02408965|Methylergonovine|methylergonovine|mesh-list
2102489|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
2102490|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2102491|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102492|NCT02409342|Gemcitabine|gemcitabine|mesh-list
2102493|NCT02409342|Carboplatin|carboplatin|mesh-list
2781479|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
2781480|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
2781481|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
2781482|NCT04356742|Metformin|metformin|mesh-list
2781483|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
2781484|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2781485|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781486|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2781487|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781488|NCT04356508|Nivolumab|nivolumab|mesh-list
2781489|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2781490|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781491|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2781492|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791756|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2791757|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2791758|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
2791759|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791760|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791761|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2791762|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2791763|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2791764|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2791765|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2791766|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
2102494|NCT02409342|Pemetrexed|pemetrexed|mesh-list
2270299|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
2781493|NCT04356677|Ribavirin|ribavirin|mesh-list
2781494|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
2781495|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781496|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
2781497|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781498|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2781499|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
2781500|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2781501|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
2781502|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2781503|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781504|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2781505|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2781506|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781507|NCT04356833|Plasminogen|plasminogen|mesh-list
2781508|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2781509|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2781510|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2781511|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781512|NCT04356495|Ciclesonide|ciclesonide|mesh-list
2270300|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270301|NCT00193921|Antiviral Agents|antiviral agents|mesh-ancestor
2270302|NCT00193921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781513|NCT04356495|Interferons|interferons|mesh-list
2781514|NCT04356495|Interferon-beta|interferon-beta|mesh-list
2781515|NCT04356495|Telmisartan|telmisartan|mesh-list
2781516|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
2781517|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781518|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781519|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
2781520|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781521|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2781522|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2781523|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2781524|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781525|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
2781526|NCT04356495|Hormones|hormones|mesh-ancestor
2781527|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2781528|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2781529|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
2781530|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2270303|NCT00193921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270304|NCT00193921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270305|NCT00193921|Immunologic Factors|immunologic factors|mesh-ancestor
2270306|NCT00193921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270307|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2270308|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270309|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270310|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270311|NCT00193973|Methotrexate|methotrexate|mesh-list
2270312|NCT00193973|Idarubicin|idarubicin|mesh-list
2270313|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2270314|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
2270315|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2270316|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270317|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2270318|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
2270319|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270320|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270321|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
2270322|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270323|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2270324|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270325|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
2270326|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270327|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2270328|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2270329|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2781538|NCT04356326|Aspirin|aspirin|mesh-list
2781539|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2781540|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2781541|NCT04356326|Analgesics|analgesics|mesh-ancestor
2781542|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
2781543|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781544|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781545|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2781546|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781547|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2781548|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2781549|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781550|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2781551|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2781552|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781553|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
2781554|NCT04356352|Lidocaine|lidocaine|mesh-list
2781555|NCT04356352|Esmolol|esmolol|mesh-list
2781556|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
2781557|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
2781558|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2781559|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781560|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
2781561|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781562|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2781563|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2781564|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2781565|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2781566|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781567|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2781568|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2781569|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2781570|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
2781571|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102495|NCT02409342|Atezolizumab|atezolizumab|mesh-list
2102496|NCT02409342|Antibodies|antibodies|mesh-list
2102497|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2102498|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
2102499|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102500|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102501|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2102502|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
2102503|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102504|NCT02409342|Antiviral Agents|antiviral agents|mesh-ancestor
2102505|NCT02409342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102506|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102507|NCT02409342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2102508|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2102509|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2102515|NCT02409680|Aspirin|aspirin|mesh-list
2102516|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2102517|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2102518|NCT02409680|Analgesics|analgesics|mesh-ancestor
2102519|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
2270330|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2270331|NCT00194038|Aripiprazole|aripiprazole|mesh-list
2270332|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
2270333|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2270334|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2270335|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2270336|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2781587|NCT04356417|Antimalarials|antimalarials|mesh-list
2781588|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2781589|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2781590|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270337|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270338|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
2270339|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
2270340|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270341|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270342|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2270343|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2270344|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
2781591|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2781592|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2781593|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781594|NCT04356222|Methotrexate|methotrexate|mesh-list
2781595|NCT04356222|Durvalumab|durvalumab|mesh-list
2781596|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2781597|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
2781598|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2781599|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781600|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2781601|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
2781602|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781603|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781604|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
2781605|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781606|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2781607|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2781608|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
2781609|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781610|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2781611|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2781612|NCT04356144|Thrombin|thrombin|mesh-list
2781613|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
2781614|NCT04356144|Coagulants|coagulants|mesh-ancestor
2781623|NCT04356118|Methotrexate|methotrexate|mesh-list
2781624|NCT04356118|Endostatins|endostatins|mesh-list
2781625|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2781626|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
2781627|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2781628|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781629|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2781630|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
2781631|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781632|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781633|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
2781634|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781635|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2781636|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2781637|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
2781638|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781639|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2270345|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2270346|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2270347|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2270348|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2270349|NCT00194064|Olanzapine|olanzapine|mesh-list
2270350|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
2270351|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
2781640|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2781641|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2270352|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270353|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270354|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2270355|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2270356|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2270357|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2270358|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2270359|NCT00194064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2270360|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2270361|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2270362|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270363|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270364|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
2781642|NCT04356118|Growth Substances|growth substances|mesh-ancestor
2781643|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
2781644|NCT04356170|Docetaxel|docetaxel|mesh-list
2781645|NCT04356170|Fluorouracil|fluorouracil|mesh-list
2781646|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781647|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
2781648|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
2781649|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
2781650|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781651|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
2781652|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2781653|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2781654|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
2781655|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781656|NCT04355832|Glucagon|glucagon|mesh-list
2781657|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2781658|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2781659|NCT04355832|Hormones|hormones|mesh-ancestor
2781660|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2781661|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781662|NCT04355832|Incretins|incretins|mesh-ancestor
2781663|NCT04355845|Sumatriptan|sumatriptan|mesh-list
2781664|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2781665|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2781666|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2781667|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
2781668|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2781669|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781670|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781671|NCT04355962|Sevoflurane|sevoflurane|mesh-list
2781672|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2781673|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2781674|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
2781675|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
2781676|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2781677|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781678|NCT04355949|Vitamin D|vitamin d|mesh-list
2781679|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
2781680|NCT04355949|Vitamins|vitamins|mesh-list
2781681|NCT04355949|Folic Acid|folic acid|mesh-list
2781682|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
2781683|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
2781684|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
2781685|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
2781686|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781687|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2781688|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2781689|NCT04355949|Hematinics|hematinics|mesh-ancestor
2781690|NCT04355936|Telmisartan|telmisartan|mesh-list
2270365|NCT00194090|Celecoxib|celecoxib|mesh-list
2270366|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2270367|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2270368|NCT00194090|Analgesics|analgesics|mesh-ancestor
2270369|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
2270370|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270371|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781691|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2781692|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2781693|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2781694|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781695|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2270372|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2270373|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270374|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2270375|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2270376|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270377|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270378|NCT00194272|Methotrexate|methotrexate|mesh-list
2270379|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2270380|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
2270381|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2270382|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270383|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2781696|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2781697|NCT04355806|Vaccines|vaccines|mesh-list
2781698|NCT04355806|Antibodies|antibodies|mesh-list
2781699|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
2781700|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2781701|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
2781702|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781703|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781704|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781705|NCT04355585|Colchicine|colchicine|mesh-list
2781706|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
2781707|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781708|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
2781709|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
2781710|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
2781711|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781712|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781713|NCT04355572|Vitamin D|vitamin d|mesh-list
2781714|NCT04355572|Vitamins|vitamins|mesh-ancestor
2781715|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
2781716|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781717|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2781718|NCT04355598|Lidocaine|lidocaine|mesh-list
2781719|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
2781720|NCT04355598|Prilocaine|prilocaine|mesh-list
2781721|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2781722|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
2781723|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
2781724|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2781725|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781726|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
2781727|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781728|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2781729|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2781730|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2781731|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2781732|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781733|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
2781734|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2781735|NCT04355637|Budesonide|budesonide|mesh-list
2781736|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2781737|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2781738|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
2781739|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781740|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781741|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2781742|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
2781743|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
2781744|NCT04355637|Hormones|hormones|mesh-ancestor
2781745|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2781746|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
2781747|NCT04355468|Anesthetics|anesthetics|mesh-list
2781748|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2781749|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781750|NCT04355468|Narcotics|narcotics|mesh-ancestor
2781751|NCT04355468|Analgesics|analgesics|mesh-ancestor
2781752|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
2781753|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781754|NCT04355416|Curcumin|curcumin|mesh-list
2270384|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
2270385|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270386|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270387|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
2270388|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270389|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2270390|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270391|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
2270392|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270393|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2270394|NCT00194324|Miconazole|miconazole|mesh-list
2270395|NCT00194324|Clotrimazole|clotrimazole|mesh-list
2270396|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
2270397|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270398|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2270399|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2270400|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270401|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270402|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2270403|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
2270404|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270405|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270406|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2270407|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2270408|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2270409|NCT00194402|Niacin|niacin|mesh-list
2270410|NCT00194402|Niacinamide|niacinamide|mesh-list
2270411|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
2270412|NCT00194402|Atorvastatin|atorvastatin|mesh-list
2270413|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2270414|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2270415|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
2270416|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270417|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2270418|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2270419|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270420|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
2270421|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
2270422|NCT00194402|Vitamins|vitamins|mesh-ancestor
2270423|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
2270424|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270425|NCT00194467|Valganciclovir|valganciclovir|mesh-list
2270426|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
2270427|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270428|NCT00194480|Interferons|interferons|mesh-list
2270429|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270430|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
2270431|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270432|NCT00194519|Acyclovir|acyclovir|mesh-list
2270433|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
2270434|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270435|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
2270436|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270437|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
2781755|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2781756|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2781757|NCT04355416|Analgesics|analgesics|mesh-ancestor
2781758|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
2781759|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781760|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781761|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2781762|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781763|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781764|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781765|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781766|NCT04355494|Eculizumab|eculizumab|mesh-list
2781767|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2781768|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2781769|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
2781770|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781771|NCT04355520|Fulvestrant|fulvestrant|mesh-list
2781772|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2781773|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781774|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2781775|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2781776|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
2781777|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270438|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2781778|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781779|NCT04355273|Heparin|heparin|mesh-list
2102520|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102521|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102522|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102523|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2102524|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2102525|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2102526|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102527|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2102528|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2102529|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102530|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
2102531|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2102532|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2102533|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
2102534|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2102535|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
2102536|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2102537|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
2102538|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102539|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2102540|NCT02410278|Montelukast|montelukast|mesh-list
2102541|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2102542|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
2102543|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2102544|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
2270439|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2781780|NCT04355273|Calcium heparin|calcium heparin|mesh-list
2781781|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
2781782|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2781783|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2781784|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781785|NCT04355429|Captopril|captopril|mesh-list
2781786|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2781787|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
2781788|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781789|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781790|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2270440|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270441|NCT00194597|Urological Agents|urological agents|mesh-ancestor
2270442|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
2270443|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2270444|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2270445|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2270446|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2270447|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270448|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
2270449|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2781791|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
2781792|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2781793|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2781794|NCT04355247|Prednisolone|prednisolone|mesh-list
2781795|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
2781796|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2781797|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
2781798|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2781799|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
2781800|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
2781801|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781802|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781803|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2781804|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
2781805|NCT04355247|Hormones|hormones|mesh-ancestor
2781806|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2781807|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2781808|NCT04355247|Protective Agents|protective agents|mesh-ancestor
2781809|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2781810|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781811|NCT04355455|Citalopram|citalopram|mesh-list
2781812|NCT04355455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2781813|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2781814|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2270450|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270451|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2781815|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781816|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2781817|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
2781818|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781819|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2781820|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
2781821|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2781822|NCT04355143|Colchicine|colchicine|mesh-list
2781823|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
2781824|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781825|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
2781826|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
2781827|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
2781828|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781829|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791767|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
2791768|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
2791769|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
2270452|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270453|NCT00194649|Miglustat|miglustat|mesh-list
2270454|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270455|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270456|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2270457|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2270458|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
2270459|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270460|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2270461|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2270462|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270463|NCT00194714|Vaccines|vaccines|mesh-list
2791770|NCT04284059|Vitamin D|vitamin d|mesh-list
2791771|NCT04284059|Vitamins|vitamins|mesh-list
2791772|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
2791773|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791774|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2791775|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
2791776|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2791777|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2791778|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791779|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
2791780|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791781|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791782|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
2791783|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2791784|NCT04283747|Antibodies|antibodies|mesh-list
2791785|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
2791786|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791787|NCT04284007|Dexamethasone|dexamethasone|mesh-list
2791788|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
2791789|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
2791790|NCT04284007|BB 1101|bb 1101|mesh-list
2791791|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2791792|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
2791793|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
2791794|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791795|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791796|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2791797|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
2791798|NCT04284007|Hormones|hormones|mesh-ancestor
2791799|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2791800|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2791801|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791802|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
2791803|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791804|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791805|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
2791806|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
2791807|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791808|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
2791809|NCT04283890|Nivolumab|nivolumab|mesh-list
2791810|NCT04283890|Ipilimumab|ipilimumab|mesh-list
2791811|NCT04283890|Melphalan|melphalan|mesh-list
2791812|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2791813|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270464|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
2791814|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2781830|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
2781831|NCT04355026|Bromhexine|bromhexine|mesh-list
2781832|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
2781833|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2781834|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2781835|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781836|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781837|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781838|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781839|NCT04355026|Expectorants|expectorants|mesh-ancestor
2781840|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
2781841|NCT04355052|Azithromycin|azithromycin|mesh-list
2781842|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
2781843|NCT04355052|Camostat|camostat|mesh-list
2781844|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2781845|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781846|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
2781847|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2781848|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2781849|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781850|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781851|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781852|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
2781853|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2781854|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2781855|NCT04354961|Paclitaxel|paclitaxel|mesh-list
2781856|NCT04354961|Carboplatin|carboplatin|mesh-list
2781857|NCT04354961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2781858|NCT04354961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781859|NCT04354961|Tubulin Modulators|tubulin modulators|mesh-ancestor
2781860|NCT04354961|Antimitotic Agents|antimitotic agents|mesh-ancestor
2781861|NCT04354961|Mitosis Modulators|mitosis modulators|mesh-ancestor
2781862|NCT04354961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781863|NCT04355039|Dexamethasone|dexamethasone|mesh-list
2781864|NCT04355039|Pomalidomide|pomalidomide|mesh-list
2781865|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2781866|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
2781867|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
2781868|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781869|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781870|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2781871|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
2781872|NCT04355039|Hormones|hormones|mesh-ancestor
2781873|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2781874|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2781875|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781876|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
2781877|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2781878|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2781879|NCT04355039|Growth Substances|growth substances|mesh-ancestor
2781880|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
2270465|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270466|NCT00194727|Capecitabine|capecitabine|mesh-list
2270467|NCT00194727|Vinorelbine|vinorelbine|mesh-list
2270468|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2270469|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
2270470|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781881|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
2781882|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
2781883|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
2781884|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2781885|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781886|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2781887|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2781888|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2781889|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2781890|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2781891|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2781892|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
2781893|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2781894|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781895|NCT04355156|Axitinib|axitinib|mesh-list
2781896|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270471|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270472|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2781897|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2781898|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270473|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270474|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270475|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270476|NCT00194740|Docetaxel|docetaxel|mesh-list
2270477|NCT00194740|Vinorelbine|vinorelbine|mesh-list
2270478|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270479|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270480|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
2781899|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781900|NCT04354662|Leucovorin|leucovorin|mesh-list
2781901|NCT04354662|Docetaxel|docetaxel|mesh-list
2781902|NCT04354662|Fluorouracil|fluorouracil|mesh-list
2781903|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
2781904|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2781905|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
2781906|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
2781907|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
2781908|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781909|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
2781910|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2781911|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270481|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270482|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270483|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2270484|NCT00194753|Paclitaxel|paclitaxel|mesh-list
2270485|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
2102545|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102546|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102547|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2102548|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2102549|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270486|NCT00194753|Doxorubicin|doxorubicin|mesh-list
2270487|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2781912|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
2781913|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781914|NCT04354662|Antidotes|antidotes|mesh-ancestor
2781915|NCT04354662|Protective Agents|protective agents|mesh-ancestor
2781916|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
2781917|NCT04354662|Vitamins|vitamins|mesh-ancestor
2781918|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
2781919|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
2781920|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
2781921|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2781922|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2781923|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781924|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781925|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781926|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781927|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2781928|NCT04354545|Lifitegrast|lifitegrast|mesh-list
2781929|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2781930|NCT04354350|Telmisartan|telmisartan|mesh-list
2781931|NCT04354350|Ramipril|ramipril|mesh-list
2781932|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2781933|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2781934|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2781935|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781936|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2781937|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
2781938|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781939|NCT04354428|Folic Acid|folic acid|mesh-list
2781940|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
2781941|NCT04354428|Ritonavir|ritonavir|mesh-list
2781942|NCT04354428|Lopinavir|lopinavir|mesh-list
2781943|NCT04354428|Azithromycin|azithromycin|mesh-list
2781944|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
2781945|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2781946|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2781947|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
2781948|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2781949|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270488|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270489|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270490|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270491|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
2781950|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2781951|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2781952|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
2781953|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2781954|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2781955|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2781956|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2781957|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
2781958|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2781959|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2781960|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2781961|NCT04354428|Hematinics|hematinics|mesh-ancestor
2781962|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
2781963|NCT04354428|Vitamins|vitamins|mesh-ancestor
2781964|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
2781965|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781966|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
2781967|NCT04354428|Protective Agents|protective agents|mesh-ancestor
2102550|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
2102551|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2102552|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
2270492|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270493|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270494|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
2270495|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270496|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270497|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2270498|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
2270499|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2270500|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2270501|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2270502|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2270503|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270504|NCT00194766|Temozolomide|temozolomide|mesh-list
2270505|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2270506|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
2270507|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270508|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270509|NCT00194818|Mesalamine|mesalamine|mesh-list
2270510|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2270511|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2270512|NCT00194818|Analgesics|analgesics|mesh-ancestor
2781968|NCT04354376|Telmisartan|telmisartan|mesh-list
2781969|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
2781970|NCT04354376|Diuretics|diuretics|mesh-list
2781971|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
2781972|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
2781973|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2781974|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2781975|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2781976|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2781977|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
2781978|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2781979|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2781980|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2781981|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2781998|NCT04354155|Enoxaparin|enoxaparin|mesh-list
2781999|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
2782000|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2782001|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2782002|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782003|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
2782004|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
2782005|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782006|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
2782007|NCT04353986|Ledipasvir|ledipasvir|mesh-list
2782008|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2782009|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
2782010|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782011|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2782012|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2782013|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782014|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782015|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
2270513|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
2270514|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270515|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270516|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2270517|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270518|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
2270519|NCT00194857|Hematinics|hematinics|mesh-ancestor
2270520|NCT00194883|Hormones|hormones|mesh-list
2782016|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2782017|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782018|NCT04353817|Ivacaftor|ivacaftor|mesh-list
2782019|NCT04353817|Elexacaftor|elexacaftor|mesh-list
2782020|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2782021|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2782022|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782023|NCT04353505|Dexamethasone|dexamethasone|mesh-list
2782024|NCT04353505|Ketorolac|ketorolac|mesh-list
2782025|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2782026|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
2782027|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
2782028|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782029|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782030|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2782031|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
2782032|NCT04353505|Hormones|hormones|mesh-ancestor
2782033|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2782034|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2782035|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782036|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2782037|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2782038|NCT04353505|Analgesics|analgesics|mesh-ancestor
2782039|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
2782040|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782041|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2782042|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782043|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782044|NCT04353479|Decitabine|decitabine|mesh-list
2782045|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2782046|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2782047|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
2782048|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782049|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782050|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782051|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2782052|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2782053|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
2782054|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782055|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782056|NCT04353362|Amoxicillin|amoxicillin|mesh-list
2782057|NCT04353362|Metronidazole|metronidazole|mesh-list
2782058|NCT04353362|Ofloxacin|ofloxacin|mesh-list
2782059|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2782060|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782061|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782062|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782063|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2782064|NCT04353362|Renal Agents|renal agents|mesh-ancestor
2782065|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2782066|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2782067|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782068|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782069|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782070|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2782071|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2782072|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2782073|NCT04353713|Laxatives|laxatives|mesh-ancestor
2782074|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2782075|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782076|NCT04353336|Chloroquine|chloroquine|mesh-list
2782077|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2782078|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
2782079|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782080|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782081|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782082|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782083|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782084|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782085|NCT04353336|Amebicides|amebicides|mesh-ancestor
2782086|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2782087|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2782088|NCT04353336|Analgesics|analgesics|mesh-ancestor
2782089|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
2782090|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782091|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782092|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2782093|NCT04353336|Filaricides|filaricides|mesh-ancestor
2782094|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
2782095|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
2782096|NCT04353414|Bupivacaine|bupivacaine|mesh-list
2782097|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
2782098|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
2782099|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2782100|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782101|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
2782102|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791815|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791816|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2791817|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
2791818|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2791819|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2791820|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
2791821|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791822|NCT04283877|Methylphenidate|methylphenidate|mesh-list
2791823|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2791824|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791825|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2791826|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2791827|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2791828|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791829|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
2791830|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270521|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270522|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270523|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
2270524|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
2270525|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2270526|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2270527|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270528|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270529|NCT00194909|Urological Agents|urological agents|mesh-ancestor
2270530|NCT00194935|Topotecan|topotecan|mesh-list
2270531|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2270532|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2791831|NCT04283630|Ascorbic Acid|ascorbic acid|mesh-list
2791832|NCT04283630|Vitamins|vitamins|mesh-ancestor
2791833|NCT04283630|Micronutrients|micronutrients|mesh-ancestor
2791834|NCT04283630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270533|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270534|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270535|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270536|NCT00194948|Citalopram|citalopram|mesh-list
2270537|NCT00194948|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2270538|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2270539|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2270540|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270541|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270542|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
2270543|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270544|NCT00194948|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2270545|NCT00194948|Antidepressive Agents|antidepressive agents|mesh-ancestor
2270546|NCT00194948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2270547|NCT00194961|Hormones|hormones|mesh-list
2270548|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270549|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270550|NCT00194974|Clonidine|clonidine|mesh-list
2270551|NCT00194974|Labetalol|labetalol|mesh-list
2782103|NCT04353284|Gabexate|gabexate|mesh-list
2782104|NCT04353284|Camostat|camostat|mesh-list
2782105|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
2782106|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782107|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782108|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2782109|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2782110|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
2270552|NCT00194974|Methyldopa|methyldopa|mesh-list
2270553|NCT00194974|Nifedipine|nifedipine|mesh-list
2270554|NCT00194974|Analgesics|analgesics|mesh-ancestor
2270555|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
2270556|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270557|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270558|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2270559|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
2270560|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
2270561|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2270562|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2270563|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2270564|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
2270565|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270566|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270567|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2270568|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2270569|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2270570|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
2270571|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
2270572|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2782119|NCT04352959|Betadex|betadex|mesh-list
2782120|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
2782121|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782122|NCT04353180|Tretinoin|tretinoin|mesh-list
2782123|NCT04353180|Isotretinoin|isotretinoin|mesh-list
2782124|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782125|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
2782126|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
2782127|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
2270573|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2270574|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2270575|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
2270576|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2270577|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2270578|NCT00195000|Cytarabine|cytarabine|mesh-list
2782128|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
2782129|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782130|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2782131|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2782132|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
2782133|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270579|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
2782134|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791835|NCT04283630|Antioxidants|antioxidants|mesh-ancestor
2782135|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2782136|NCT04353193|Octreotide|octreotide|mesh-list
2782137|NCT04353193|Terlipressin|terlipressin|mesh-list
2270580|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2270581|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
2270582|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270583|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270584|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
2270585|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270586|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270587|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
2270588|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270589|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2270590|NCT00195078|Gefitinib|gefitinib|mesh-list
2270591|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270592|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2270593|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782138|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2782139|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2782140|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782141|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2782142|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2782143|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782144|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
2782145|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782146|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782147|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782148|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782149|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782150|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782151|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782152|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
2782153|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782154|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782155|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782156|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782157|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782158|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782159|NCT04352855|Tazobactam|tazobactam|mesh-list
2782160|NCT04352855|Ceftolozane|ceftolozane|mesh-list
2782161|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2782162|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2782163|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782164|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2782165|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782166|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782167|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2782168|NCT04352855|Renal Agents|renal agents|mesh-ancestor
2782169|NCT04352777|Fulvestrant|fulvestrant|mesh-list
2782170|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2782171|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2782172|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782173|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2782174|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2782175|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
2782176|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2782177|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782178|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2782179|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782180|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782181|NCT04352686|Buspirone|buspirone|mesh-list
2782182|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2782183|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2782184|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2782185|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782186|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2782187|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2782188|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
2782189|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2782190|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782191|NCT04352621|Ketamine|ketamine|mesh-list
2782192|NCT04352621|Analgesics|analgesics|mesh-ancestor
2782193|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
2782194|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782195|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782196|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2782197|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2782198|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
2782199|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
2782200|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2782201|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2782202|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2782203|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2782204|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782205|NCT04352439|Aspirin|aspirin|mesh-list
2782206|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2782207|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2782208|NCT04352439|Analgesics|analgesics|mesh-ancestor
2782209|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
2782210|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782211|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782212|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2782213|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782214|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2782215|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2782216|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782217|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2782218|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2782219|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782220|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
2782221|NCT04352400|Nafamostat|nafamostat|mesh-list
2782222|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2782223|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2782224|NCT04352400|Analgesics|analgesics|mesh-ancestor
2782225|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
2782226|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782227|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782228|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2270594|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270595|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2270596|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
2270597|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
2270598|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270599|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270600|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2270601|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2270602|NCT00195091|Growth Substances|growth substances|mesh-ancestor
2270603|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270604|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
2270605|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270606|NCT00195104|Cytarabine|cytarabine|mesh-list
2270607|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
2270608|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2270609|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
2270610|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270611|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782229|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782230|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
2782231|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
2782232|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782233|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782234|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2782235|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2782236|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2782237|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2782238|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
2782239|NCT04352608|Vaccines|vaccines|mesh-list
2782240|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
2782241|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782242|NCT04352153|Febuxostat|febuxostat|mesh-list
2782243|NCT04352153|Citric Acid|citric acid|mesh-list
2782244|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
2782245|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2782246|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
2782247|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
2782248|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782249|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
2782250|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782251|NCT04352205|Thalidomide|thalidomide|mesh-list
2782252|NCT04352205|Dexamethasone|dexamethasone|mesh-list
2782253|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
2782254|NCT04352205|Lenalidomide|lenalidomide|mesh-list
2782255|NCT04352205|Bortezomib|bortezomib|mesh-list
2782256|NCT04352205|Daratumumab|daratumumab|mesh-list
2782257|NCT04352205|Ichthammol|ichthammol|mesh-list
2782258|NCT04352205|BB 1101|bb 1101|mesh-list
2270612|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
2270613|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270614|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270615|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
2270616|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270617|NCT00195156|Valproic Acid|valproic acid|mesh-list
2270618|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
2270619|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782259|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2782260|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
2782261|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
2782262|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782263|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782264|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2782265|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
2782266|NCT04352205|Hormones|hormones|mesh-ancestor
2782267|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2782268|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2782269|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782270|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
2782271|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782272|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782273|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
2782274|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2782275|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2782276|NCT04352205|Growth Substances|growth substances|mesh-ancestor
2782277|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
2782278|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2782279|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
2782280|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2782281|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782282|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
2782283|NCT04352166|Buprenorphine|buprenorphine|mesh-list
2782284|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2782285|NCT04352166|Narcotics|narcotics|mesh-ancestor
2782286|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2782287|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782288|NCT04352166|Analgesics|analgesics|mesh-ancestor
2782289|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
2782290|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782291|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2782292|NCT04352465|Methotrexate|methotrexate|mesh-list
2782293|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2782294|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
2782295|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2782296|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782297|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2782298|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
2782299|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782300|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782301|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
2782302|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782303|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2782304|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270620|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270621|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
2270622|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270623|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270624|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
2270625|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2270626|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2270627|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2270628|NCT00195195|Sirolimus|sirolimus|mesh-list
2270629|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2270630|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270631|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2270632|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782305|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
2782306|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782307|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2782325|NCT04351724|Ritonavir|ritonavir|mesh-list
2782326|NCT04351724|Lopinavir|lopinavir|mesh-list
2782327|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
2270633|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
2270634|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270635|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
2270636|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270637|NCT00195208|Pantoprazole|pantoprazole|mesh-list
2270638|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2270639|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2270640|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2270641|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782328|NCT04351724|Chloroquine|chloroquine|mesh-list
2782329|NCT04351724|Remdesivir|remdesivir|mesh-list
2782330|NCT04351724|Candesartan|candesartan|mesh-list
2782331|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
2782332|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
2782333|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2782334|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2782335|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
2782336|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782337|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782338|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2782339|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2782340|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
2782341|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782342|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2782343|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2782344|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
2782345|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782346|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782347|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782348|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2782349|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
2782350|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2782351|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
2782352|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2782353|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2782354|NCT04351724|Amebicides|amebicides|mesh-ancestor
2782355|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
2782356|NCT04351763|Amiodarone|amiodarone|mesh-list
2782357|NCT04351763|Verapamil|verapamil|mesh-list
2782358|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2782359|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
2782360|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2782361|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2782362|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782363|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2782364|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2782365|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2782366|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782367|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2782368|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2782369|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2782370|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2782371|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2782372|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782373|NCT04352062|Amoxicillin|amoxicillin|mesh-list
2782374|NCT04352062|Levofloxacin|levofloxacin|mesh-list
2782375|NCT04352062|Ofloxacin|ofloxacin|mesh-list
2782376|NCT04352062|Melatonin|melatonin|mesh-list
2782377|NCT04352062|Pantoprazole|pantoprazole|mesh-list
2782378|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2782379|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782380|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
2782381|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782382|NCT04352062|Protective Agents|protective agents|mesh-ancestor
2270642|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270643|NCT00195286|Tazobactam|tazobactam|mesh-list
2782383|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782384|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2782385|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2782386|NCT04352062|Renal Agents|renal agents|mesh-ancestor
2782387|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2782388|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2782389|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782390|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782391|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2782392|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2782393|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2782394|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2782395|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2782396|NCT04351919|Azithromycin|azithromycin|mesh-list
2782397|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782398|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2782399|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782400|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
2782401|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782402|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782403|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782404|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782405|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2791836|NCT04283630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791837|NCT04283630|Protective Agents|protective agents|mesh-ancestor
2791843|NCT04283604|Methylphenidate|methylphenidate|mesh-list
2791844|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2270644|NCT00195286|Piperacillin|piperacillin|mesh-list
2270645|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2270646|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2270647|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270648|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2270649|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270650|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270651|NCT00195299|Sirolimus|sirolimus|mesh-list
2791845|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791846|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2791847|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2791848|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2791849|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791850|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
2791851|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791852|NCT04283487|Levan|levan|mesh-list
2791853|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791854|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
2791855|NCT04283331|Propoxycaine|propoxycaine|mesh-list
2791856|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
2791857|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
2791858|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791859|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791860|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
2791861|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791862|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
2791863|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2791864|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2791865|NCT04283435|Estradiol|estradiol|mesh-list
2791866|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2791867|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782406|NCT04351867|Docetaxel|docetaxel|mesh-list
2782407|NCT04351867|Capecitabine|capecitabine|mesh-list
2782408|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
2782409|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782410|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
2782411|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
2782412|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
2782413|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782414|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2782415|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
2782416|NCT04351737|Dexamethasone|dexamethasone|mesh-list
2782417|NCT04351737|Prednisolone|prednisolone|mesh-list
2782418|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2782419|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
2782420|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2782421|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
2782422|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2782423|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
2782424|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2782425|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
2782426|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
2782427|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782428|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782429|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2782430|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
2782431|NCT04351737|Hormones|hormones|mesh-ancestor
2782432|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2782433|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2782434|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782435|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2782436|NCT04351737|Protective Agents|protective agents|mesh-ancestor
2270652|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2270653|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270654|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2270655|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270656|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
2270657|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270658|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
2270659|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270660|NCT00195312|Bupivacaine|bupivacaine|mesh-list
2270661|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
2270662|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
2270663|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2782447|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782448|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
2782449|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782450|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782451|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782452|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782453|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270664|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270665|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
2270666|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270667|NCT00195364|Etanercept|etanercept|mesh-list
2270668|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2270669|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2270670|NCT00195364|Analgesics|analgesics|mesh-ancestor
2270671|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
2270672|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270673|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270674|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2270675|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270676|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2270677|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270678|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
2782454|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782455|NCT04351412|Fluorides|fluorides|mesh-list
2782456|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
2782457|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
2782458|NCT04351412|Protective Agents|protective agents|mesh-ancestor
2782459|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782460|NCT04351594|Menthol|menthol|mesh-list
2782461|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
2782462|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
2782463|NCT04351347|Ivermectin|ivermectin|mesh-list
2782464|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782465|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782466|NCT04351308|Apatinib|apatinib|mesh-list
2782467|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782468|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2782469|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782470|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782471|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782472|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
2782473|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782474|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782475|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782476|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782477|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782478|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782479|NCT04351256|Durvalumab|durvalumab|mesh-list
2782480|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2782481|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782482|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
2782483|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2782484|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782485|NCT04351490|Vitamins|vitamins|mesh-ancestor
2782486|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
2782487|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2782488|NCT04351230|Trastuzumab|trastuzumab|mesh-list
2782489|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2782490|NCT04351230|Maytansine|maytansine|mesh-list
2782491|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
2782492|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2782493|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782494|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2782495|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
2782496|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
2782497|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
2782498|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782499|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
2782500|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782501|NCT04351438|Heparin|heparin|mesh-list
2782502|NCT04351438|Citric Acid|citric acid|mesh-list
2782503|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
2782504|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
2782505|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2782506|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
2782507|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
2782508|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782509|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2782510|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2782511|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
2270679|NCT00195377|Etanercept|etanercept|mesh-list
2270680|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2270681|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2270682|NCT00195377|Analgesics|analgesics|mesh-ancestor
2270683|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
2270684|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270685|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782512|NCT04351191|Chloroquine|chloroquine|mesh-list
2782513|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
2782514|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782515|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782516|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782517|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782518|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782519|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782520|NCT04351191|Amebicides|amebicides|mesh-ancestor
2782521|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2782522|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
2782523|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270686|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2270687|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270688|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2270689|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270690|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
2270691|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2270692|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
2270693|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782524|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782525|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
2782526|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2782527|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
2782528|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782529|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
2782530|NCT04351126|Bromocriptine|bromocriptine|mesh-list
2782531|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2782532|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2782533|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
2782534|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2782535|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782536|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
2782537|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
2782538|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2782539|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782540|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2782541|NCT04351100|Diacetylrhein|diacetylrhein|mesh-list
2782542|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2782543|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
2782544|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2782545|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2782546|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782547|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
2782548|NCT04350645|Coagulants|coagulants|mesh-ancestor
2782549|NCT04350320|Colchicine|colchicine|mesh-list
2782550|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
2782551|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782552|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
2782553|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
2782554|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
2782555|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782556|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782564|NCT04350528|Pentobarbital|pentobarbital|mesh-list
2782565|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
2782566|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
2782567|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
2782568|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782569|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270694|NCT00195416|Etanercept|etanercept|mesh-list
2270695|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2270696|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2270697|NCT00195416|Analgesics|analgesics|mesh-ancestor
2270698|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
2270699|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270700|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782570|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2782571|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2782572|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2782573|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2782574|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2782575|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2782576|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
2782577|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2782578|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782579|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2782580|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2782581|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
2782582|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
2782583|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
2782584|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2782585|NCT04350580|Antibodies|antibodies|mesh-list
2782586|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
2782587|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782588|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
2782589|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2782590|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782591|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2782592|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782593|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2782594|NCT04350502|Amoxicillin|amoxicillin|mesh-list
2782595|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
2782596|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
2782597|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2782598|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782599|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782600|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782601|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2782602|NCT04350684|Interferons|interferons|mesh-list
2782603|NCT04350684|Ritonavir|ritonavir|mesh-list
2782604|NCT04350684|Lopinavir|lopinavir|mesh-list
2782605|NCT04350684|Interferon-beta|interferon-beta|mesh-list
2782606|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
2782607|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782608|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782609|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
2782610|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782611|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2782612|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2782613|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
2782614|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782615|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782616|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2782617|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2782618|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2782619|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2782620|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
2782621|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782622|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782623|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782624|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
2782625|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782626|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2782627|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782628|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
2782629|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782630|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782631|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782632|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782633|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782634|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782635|NCT04350671|Interferons|interferons|mesh-list
2782636|NCT04350671|Ritonavir|ritonavir|mesh-list
2782637|NCT04350671|Lopinavir|lopinavir|mesh-list
2782638|NCT04350671|Interferon-beta|interferon-beta|mesh-list
2782639|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
2782640|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782641|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782642|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
2782643|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782644|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2782645|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2782646|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
2782647|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782648|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782649|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2782650|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2782651|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2782652|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2782653|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
2270701|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2270702|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270703|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2270704|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270705|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
2270706|NCT00195455|Estradiol|estradiol|mesh-list
2270707|NCT00195455|Estrogens|estrogens|mesh-ancestor
2782654|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782655|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782656|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782657|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
2782658|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782659|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2791868|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791869|NCT04283435|Estrogens|estrogens|mesh-ancestor
2791870|NCT04283435|Hormones|hormones|mesh-ancestor
2791871|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2791872|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2791873|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
2791874|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2791875|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2791876|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
2791877|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2791878|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2791879|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791880|NCT04283435|Urological Agents|urological agents|mesh-ancestor
2791881|NCT04283292|Capsaicin|capsaicin|mesh-list
2791882|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
2791883|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
2791884|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
2791885|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791886|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791887|NCT04283578|Oxytocin|oxytocin|mesh-list
2791888|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
2791889|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2791890|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791891|NCT04283526|Decitabine|decitabine|mesh-list
2791892|NCT04283526|Spartalizumab|spartalizumab|mesh-list
2791893|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2791894|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
2791895|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791896|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791897|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791898|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2791910|NCT04283513|Ribavirin|ribavirin|mesh-list
2791911|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
2791912|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791913|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
2791914|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2791915|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
2791916|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
2791917|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2791918|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2791919|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791920|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791921|NCT04283240|Urological Agents|urological agents|mesh-ancestor
2791922|NCT04282902|Pirfenidone|pirfenidone|mesh-list
2791923|NCT04282902|Analgesics|analgesics|mesh-ancestor
2791924|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
2791925|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791926|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791927|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2791928|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2791929|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2791930|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2791931|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2791932|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
2791933|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
2791934|NCT04283162|Calcium|calcium|mesh-list
2791935|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2791936|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270708|NCT00195455|Hormones|hormones|mesh-ancestor
2270709|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270710|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270711|NCT00195468|Cyclosporine|cyclosporine|mesh-list
2270712|NCT00195468|Cyclosporins|cyclosporins|mesh-list
2270713|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782660|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
2782661|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2782662|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2782663|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782664|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2782665|NCT04350086|Analgesics|analgesics|mesh-ancestor
2782666|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
2782667|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782668|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2782669|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2782670|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2782671|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
2782672|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2782673|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782674|NCT04350190|Apatinib|apatinib|mesh-list
2782675|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782676|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2782677|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782678|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782679|NCT04350281|Interferons|interferons|mesh-list
2782680|NCT04350281|Interferon-beta|interferon-beta|mesh-list
2782681|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782682|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
2782683|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782684|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
2782685|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782686|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
2782687|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782688|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782689|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782690|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782691|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782692|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
2782693|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782694|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2782695|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
2782696|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2782697|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2782698|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782699|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
2782700|NCT04349982|Coagulants|coagulants|mesh-ancestor
2782701|NCT04349930|Cannabidiol|cannabidiol|mesh-list
2782702|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
2782703|NCT04349722|Scopolamine|scopolamine|mesh-list
2782704|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2782705|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2782706|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
2782707|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
2782708|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782709|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782710|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2782711|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
2782712|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2782713|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
2782714|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2782715|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782716|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2782717|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
2782718|NCT04349592|Azithromycin|azithromycin|mesh-list
2782719|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782720|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2782721|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782722|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
2782723|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782724|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782725|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782726|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782727|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782728|NCT04349696|Mitiglinide|mitiglinide|mesh-list
2782729|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2782730|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782738|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782739|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
2782740|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782741|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782742|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782743|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782744|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782745|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782746|NCT04349306|Rasburicase|rasburicase|mesh-list
2782747|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
2782748|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782749|NCT04349410|Interferons|interferons|mesh-list
2782750|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
2782751|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
2782752|NCT04349410|Remdesivir|remdesivir|mesh-list
2782753|NCT04349410|Azithromycin|azithromycin|mesh-list
2782754|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782755|NCT04349410|Doxycycline|doxycycline|mesh-list
2782756|NCT04349410|Clindamycin|clindamycin|mesh-list
2782757|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
2782758|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
2782759|NCT04349410|Primaquine|primaquine|mesh-list
2782760|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
2782761|NCT04349410|Losartan|losartan|mesh-list
2782762|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782763|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
2782764|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782765|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2782766|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
2782767|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
2782768|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782769|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782770|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2782771|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
2782772|NCT04349410|Hormones|hormones|mesh-ancestor
2782773|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2782774|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2782775|NCT04349410|Protective Agents|protective agents|mesh-ancestor
2782776|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
2782777|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2782778|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
2782779|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782780|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782781|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782782|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782783|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782784|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2782785|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2270714|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270715|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270716|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
2270717|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270718|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
2270719|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270720|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
2270721|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270722|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2270723|NCT00195481|Sirolimus|sirolimus|mesh-list
2782786|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2782787|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2782788|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2782789|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
2782790|NCT04349241|Favipiravir|favipiravir|mesh-list
2782791|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
2782792|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782793|NCT04349826|Azithromycin|azithromycin|mesh-list
2782794|NCT04349826|Cefixime|cefixime|mesh-list
2782795|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2782796|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782797|NCT04348786|Amoxicillin|amoxicillin|mesh-list
2782798|NCT04348786|Doxycycline|doxycycline|mesh-list
2782799|NCT04348786|Levofloxacin|levofloxacin|mesh-list
2782800|NCT04348786|Ofloxacin|ofloxacin|mesh-list
2782801|NCT04348786|Esomeprazole|esomeprazole|mesh-list
2782802|NCT04348786|Bismuth|bismuth|mesh-list
2782803|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2782804|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2782805|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782806|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2782807|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2782808|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2782809|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782810|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782811|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
2782812|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782813|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782814|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2270724|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2270725|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270726|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2270727|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270728|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
2270729|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270730|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
2270731|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270732|NCT00195533|Tazobactam|tazobactam|mesh-list
2270733|NCT00195533|Piperacillin|piperacillin|mesh-list
2270734|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2270735|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2270736|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270737|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2270738|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270739|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270740|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
2270741|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2270742|NCT00195559|Estradiol|estradiol|mesh-list
2782815|NCT04348786|Renal Agents|renal agents|mesh-ancestor
2782816|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2782817|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2782818|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782819|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2782820|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2782821|NCT04348786|Antacids|antacids|mesh-ancestor
2782822|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
2782823|NCT04348695|Simvastatin|simvastatin|mesh-list
2782824|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2782825|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2782826|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
2782827|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782828|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2782829|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2782830|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782831|NCT04348877|Antibodies|antibodies|mesh-list
2782832|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
2782833|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782834|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
2782835|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2782836|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782837|NCT04348292|Sirolimus|sirolimus|mesh-list
2782838|NCT04348292|Durvalumab|durvalumab|mesh-list
2782839|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
2782840|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2782841|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
2782842|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2270743|NCT00195559|Estrogens|estrogens|mesh-ancestor
2270744|NCT00195559|Hormones|hormones|mesh-ancestor
2270745|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270746|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270747|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2270748|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
2270749|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2270750|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2270751|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2270752|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2270753|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2270754|NCT00195572|Leucovorin|leucovorin|mesh-list
2270755|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
2270756|NCT00195572|Antidotes|antidotes|mesh-ancestor
2782843|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782844|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2270757|NCT00195572|Protective Agents|protective agents|mesh-ancestor
2270758|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270759|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
2270760|NCT00195572|Vitamins|vitamins|mesh-ancestor
2270761|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
2270762|NCT00195585|Leucovorin|leucovorin|mesh-list
2270763|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
2270764|NCT00195585|Antidotes|antidotes|mesh-ancestor
2270765|NCT00195585|Protective Agents|protective agents|mesh-ancestor
2270766|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270767|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
2782845|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782846|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
2782847|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2782848|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
2782849|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782850|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2782851|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
2782852|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2782853|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2791937|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2791938|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
2791939|NCT04283162|Coagulants|coagulants|mesh-ancestor
2791940|NCT04282824|Edetic Acid|edetic acid|mesh-list
2791941|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2791942|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
2791943|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
2791944|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791945|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
2791946|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2791947|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2791948|NCT04283058|Ketamine|ketamine|mesh-list
2791949|NCT04283058|Anesthetics|anesthetics|mesh-list
2791950|NCT04283058|Analgesics|analgesics|mesh-ancestor
2791951|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
2791952|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791953|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791954|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2791955|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2791956|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
2791957|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791958|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2791959|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2791960|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791961|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791962|NCT04282954|Esomeprazole|esomeprazole|mesh-list
2791963|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2791964|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2791965|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2270768|NCT00195585|Vitamins|vitamins|mesh-ancestor
2270769|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
2270770|NCT00195598|Paroxetine|paroxetine|mesh-list
2791966|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791967|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792932|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2792933|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792934|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
2792935|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792936|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
2792937|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
2792938|NCT04273880|Methylphenidate|methylphenidate|mesh-list
2792939|NCT04273880|Vitamins|vitamins|mesh-ancestor
2792940|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
2792941|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792942|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2792943|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2792944|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2792945|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2792946|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792947|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
2792948|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792949|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
2792950|NCT04273880|Protective Agents|protective agents|mesh-ancestor
2792951|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
2792952|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
2792953|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2270771|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2270772|NCT00195598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2782854|NCT04348370|Vaccines|vaccines|mesh-list
2782855|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
2782856|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
2782857|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782858|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2782859|NCT04348383|Defibrotide|defibrotide|mesh-list
2782860|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2782861|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2782862|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782863|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2782864|NCT04348474|Azithromycin|azithromycin|mesh-list
2782865|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782866|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2782867|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782868|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
2782869|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782870|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782871|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782872|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782873|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782874|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
2782875|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782876|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782877|NCT04347915|Clevudine|clevudine|mesh-list
2782878|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
2782879|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782880|NCT04348006|Dexamethasone|dexamethasone|mesh-list
2782881|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
2782882|NCT04348006|Lenalidomide|lenalidomide|mesh-list
2782883|NCT04348006|Bortezomib|bortezomib|mesh-list
2782884|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2782885|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
2782886|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782887|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782888|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2782889|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
2782890|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782891|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782892|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2782893|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2782894|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
2782895|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
2782896|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782897|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2782898|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
2782899|NCT04348006|Hormones|hormones|mesh-ancestor
2782900|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2782901|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2782902|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2782903|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2782904|NCT04348006|Growth Substances|growth substances|mesh-ancestor
2782905|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
2782906|NCT04347733|Triamcinolone|triamcinolone|mesh-list
2782907|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2782908|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2782909|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2782910|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2782911|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
2782912|NCT04347733|Hormones|hormones|mesh-ancestor
2782913|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2782914|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782915|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2782916|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
2782917|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782918|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782919|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
2782920|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2782921|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2782922|NCT04348045|Durvalumab|durvalumab|mesh-list
2782923|NCT04348045|Olaparib|olaparib|mesh-list
2782924|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2782925|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782926|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2782927|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782928|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782929|NCT04347889|Ascorbic Acid|ascorbic acid|mesh-list
2782930|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782931|NCT04347889|Vitamins|vitamins|mesh-ancestor
2782932|NCT04347889|Micronutrients|micronutrients|mesh-ancestor
2782933|NCT04347889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782934|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
2782935|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782936|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782937|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782938|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782939|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782940|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782941|NCT04347889|Antioxidants|antioxidants|mesh-ancestor
2782942|NCT04347889|Protective Agents|protective agents|mesh-ancestor
2782943|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782944|NCT04347980|Dexamethasone|dexamethasone|mesh-list
2782945|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2782946|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
2782947|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
2782948|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782949|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782950|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2270773|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2782951|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
2782952|NCT04347980|Hormones|hormones|mesh-ancestor
2782953|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2782954|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2782955|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782956|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
2782957|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782958|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782959|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782960|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782961|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782962|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782963|NCT04348032|Apatinib|apatinib|mesh-list
2782964|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2782965|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2782966|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782967|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782968|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
2782969|NCT04347798|Chloroquine|chloroquine|mesh-list
2782970|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
2782971|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2782972|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2782973|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2782974|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782975|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782976|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782977|NCT04347798|Amebicides|amebicides|mesh-ancestor
2782978|NCT04347720|Acetaminophen|acetaminophen|mesh-list
2782979|NCT04347720|Ibuprofen|ibuprofen|mesh-list
2782980|NCT04347720|Indomethacin|indomethacin|mesh-list
2782981|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2102556|NCT02410382|Dexamethasone|dexamethasone|mesh-list
2102557|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102558|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
2102559|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
2102560|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102561|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102562|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2782982|NCT04347720|Analgesics|analgesics|mesh-ancestor
2102563|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
2102564|NCT02410382|Hormones|hormones|mesh-ancestor
2102565|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102566|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102567|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102568|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
2102569|NCT02410707|Propofol|propofol|mesh-list
2102570|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2102571|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2102572|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102573|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2102574|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
2102575|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
2102576|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2102577|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2102578|NCT02410707|Analgesics|analgesics|mesh-ancestor
2782983|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
2782984|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2782985|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2782986|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
2782987|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2782988|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2782989|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2782990|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2782991|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2782992|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2782993|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
2782994|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
2782995|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2782996|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2782997|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2782998|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2782999|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2783000|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783001|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2783002|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783003|NCT04347577|Analgesics|analgesics|mesh-ancestor
2783004|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
2783005|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783006|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
2783007|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2783008|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
2783009|NCT04347512|Azithromycin|azithromycin|mesh-list
2783010|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
2783011|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2783012|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783013|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
2783014|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783015|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783016|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783017|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783018|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783019|NCT04347486|Atropine|atropine|mesh-list
2783020|NCT04347486|Neostigmine|neostigmine|mesh-list
2783021|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2783022|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2783023|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2783024|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
2783025|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783026|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783027|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2783028|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
2783029|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
2783030|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
2783031|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2783032|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2783033|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
2783034|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2783035|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783036|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2783037|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783038|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2783039|NCT04347434|Atorvastatin|atorvastatin|mesh-list
2783040|NCT04347434|Ezetimibe|ezetimibe|mesh-list
2783041|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2783042|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2783043|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
2783044|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783045|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2783046|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2783047|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783048|NCT04347252|Glucagon|glucagon|mesh-list
2783049|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2783050|NCT04347252|Hormones|hormones|mesh-ancestor
2783051|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2783052|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783061|NCT04346914|Carboplatin|carboplatin|mesh-list
2783062|NCT04346914|Etoposide|etoposide|mesh-list
2783063|NCT04346914|Antibodies|antibodies|mesh-list
2783064|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2783065|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
2783066|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783067|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783068|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2783069|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2783070|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2783071|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783072|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783073|NCT04346901|Methimazole|methimazole|mesh-list
2783074|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
2783075|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
2783076|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2783077|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783078|NCT04347031|Azithromycin|azithromycin|mesh-list
2783079|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
2783080|NCT04347031|Mefloquine|mefloquine|mesh-list
2783081|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2783082|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270774|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2270775|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270776|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270777|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
2270778|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270779|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2270780|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
2270781|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2270782|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2270783|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2270784|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270785|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2270786|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2270787|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
2270788|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270789|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
2270790|NCT00195637|Antibodies|antibodies|mesh-list
2783083|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
2783084|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783085|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783086|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783087|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783088|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783089|NCT04347005|Allopurinol|allopurinol|mesh-list
2783090|NCT04347005|Febuxostat|febuxostat|mesh-list
2783091|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
2783092|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783093|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783094|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
2783095|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783096|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2270791|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
2270792|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2270793|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2270794|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
2270795|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270796|NCT00195689|Adalimumab|adalimumab|mesh-list
2270797|NCT00195689|Antibodies|antibodies|mesh-list
2270798|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2270799|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
2270800|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270801|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2270802|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270803|NCT00195728|Acetaminophen|acetaminophen|mesh-list
2270804|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2270805|NCT00195728|Hydrocodone|hydrocodone|mesh-list
2270806|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2270807|NCT00195728|Analgesics|analgesics|mesh-ancestor
2783097|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
2783098|NCT04347005|Protective Agents|protective agents|mesh-ancestor
2783099|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783100|NCT04347200|Anticoagulants|anticoagulants|mesh-list
2783101|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2783102|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
2783103|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
2783104|NCT04346862|Vitamins|vitamins|mesh-ancestor
2783105|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
2783106|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783107|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
2783108|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
2783109|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2783110|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2783111|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783112|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
2783113|NCT04347122|Coagulants|coagulants|mesh-ancestor
2791968|NCT04282941|Ibuprofen|ibuprofen|mesh-list
2791969|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2791970|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2791971|NCT04282941|Analgesics|analgesics|mesh-ancestor
2791972|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
2791973|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2791974|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791975|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2791976|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2791977|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2791978|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791979|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791980|NCT04283110|Midazolam|midazolam|mesh-list
2791981|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2791982|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2791983|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2791984|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2791985|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2791986|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2791987|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2791988|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2791989|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
2270808|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
2270809|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270810|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270811|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
2270812|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2270813|NCT00195728|Narcotics|narcotics|mesh-ancestor
2270814|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2270815|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
2270816|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
2270817|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2270818|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2270819|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2270820|NCT00195741|Valproic Acid|valproic acid|mesh-list
2270821|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
2270822|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270823|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270824|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
2270825|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270826|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270827|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
2270828|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2270829|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2270830|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2270831|NCT00195754|Valproic Acid|valproic acid|mesh-list
2270832|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
2270833|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270834|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270835|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
2270836|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270837|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270838|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
2270839|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2270840|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2270841|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2270842|NCT00195767|Valproic Acid|valproic acid|mesh-list
2270843|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
2270844|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2791990|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
2791991|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
2791992|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
2783114|NCT04346823|Sevoflurane|sevoflurane|mesh-list
2783115|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2783116|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2783117|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
2783118|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
2783119|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2783120|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783121|NCT04347187|Anticoagulants|anticoagulants|mesh-list
2783122|NCT04346797|Eculizumab|eculizumab|mesh-list
2783123|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2783124|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2783125|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
2783126|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783127|NCT04346628|Favipiravir|favipiravir|mesh-list
2783128|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
2783129|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783130|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
2783131|NCT04346667|Chloroquine|chloroquine|mesh-list
2783132|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
2783133|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783134|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783135|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783136|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783137|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783138|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783139|NCT04346667|Amebicides|amebicides|mesh-ancestor
2783140|NCT04346407|Dronabinol|dronabinol|mesh-list
2783141|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
2783142|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783143|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2783144|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2783145|NCT04346407|Analgesics|analgesics|mesh-ancestor
2783146|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
2783147|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783148|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2783149|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2783150|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2783151|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783152|NCT04346407|Hormones|hormones|mesh-ancestor
2783153|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2783166|NCT04346589|Antibodies|antibodies|mesh-list
2783167|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
2783168|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2783169|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
2783170|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783171|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2783172|NCT04346004|Hematinics|hematinics|mesh-ancestor
2783173|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
2783174|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
2783175|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783176|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783177|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783178|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783179|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783180|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783181|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
2783182|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2783183|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2783184|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783185|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2783186|NCT04346290|Analgesics|analgesics|mesh-ancestor
2783187|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
2783188|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783189|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2783190|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2783191|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2783192|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
2783193|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2783194|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783195|NCT04346277|Antibodies|antibodies|mesh-list
2783196|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2783197|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
2783198|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783199|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
2783200|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
2783201|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
2783202|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783203|NCT04345926|Propofol|propofol|mesh-list
2783204|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2783205|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2783206|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783207|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2783208|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
2783209|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
2783210|NCT04346030|Triamcinolone|triamcinolone|mesh-list
2783211|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2783212|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2783213|NCT04346030|Lidocaine|lidocaine|mesh-list
2783214|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2783215|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
2783216|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
2783217|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2783218|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783219|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
2783220|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783221|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2783222|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2783223|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2783224|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2783225|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783226|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2783227|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
2783228|NCT04346030|Hormones|hormones|mesh-ancestor
2783229|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270845|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270846|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
2270847|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270848|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270849|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
2270850|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2783230|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2783231|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
2783232|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783233|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
2783234|NCT04346108|Antibodies|antibodies|mesh-list
2783235|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
2783236|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2783237|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2783238|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
2783239|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
2783240|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783241|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2783242|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2783243|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783244|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
2783245|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
2783246|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783247|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
2783248|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783249|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2270851|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2270852|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2270853|NCT00195780|Valproic Acid|valproic acid|mesh-list
2270854|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
2270855|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270856|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270857|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
2270858|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270859|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783250|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783251|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783252|NCT04345848|Heparin|heparin|mesh-list
2783253|NCT04345848|Enoxaparin|enoxaparin|mesh-list
2783254|NCT04345848|Calcium heparin|calcium heparin|mesh-list
2783255|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
2783256|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2783257|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2783258|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783259|NCT04345796|Empagliflozin|empagliflozin|mesh-list
2783260|NCT04345796|Carvedilol|carvedilol|mesh-list
2783261|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2783262|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783263|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2783264|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783265|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2783266|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2783267|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
2783268|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2783269|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2783270|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
2783271|NCT04345796|Protective Agents|protective agents|mesh-ancestor
2783272|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2783273|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2783274|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2783275|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
2783276|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2783277|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2783278|NCT04345783|Apatinib|apatinib|mesh-list
2783279|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783280|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2783281|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783282|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783283|NCT04345432|Gabapentin|gabapentin|mesh-list
2783284|NCT04345432|Analgesics|analgesics|mesh-ancestor
2783285|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
2783286|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783287|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783288|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
2783289|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2783290|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2783291|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2783292|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2783293|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2783294|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2783295|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2783296|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783297|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
2783298|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
2783299|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
2783300|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783301|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783302|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783303|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783304|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783305|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783306|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
2783307|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2783308|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2783309|NCT04345445|Prednisolone|prednisolone|mesh-list
2783310|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
2783311|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2783312|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
2783313|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2783314|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
2783315|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
2783316|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783317|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783318|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2783319|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
2783320|NCT04345445|Hormones|hormones|mesh-ancestor
2783321|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2783322|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2783323|NCT04345445|Protective Agents|protective agents|mesh-ancestor
2783324|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2783325|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783326|NCT04345588|Dexamethasone|dexamethasone|mesh-list
2783327|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
2783328|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2783329|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
2783330|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
2783331|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783332|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783333|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2783334|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
2783335|NCT04345588|Hormones|hormones|mesh-ancestor
2783336|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2783337|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2783338|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783339|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
2783340|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2783341|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2783342|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783343|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
2783344|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
2783345|NCT04345458|Etanercept|etanercept|mesh-list
2783346|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2783347|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2783348|NCT04345458|Analgesics|analgesics|mesh-ancestor
2783349|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
2783350|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783351|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783352|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2783353|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783354|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2783355|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2783356|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
2783357|NCT04345419|Remdesivir|remdesivir|mesh-list
2783358|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
2783359|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783360|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
2783361|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783362|NCT04345406|Chloroquine|chloroquine|mesh-list
2783363|NCT04345406|Enalapril|enalapril|mesh-list
2783364|NCT04345406|Captopril|captopril|mesh-list
2783365|NCT04345406|Amebicides|amebicides|mesh-ancestor
2783366|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783367|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783368|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783369|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
2783370|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783371|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2783372|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
2783373|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783374|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783375|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2783376|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2783377|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2783378|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2783379|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2783380|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783381|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2783382|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783383|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
2783384|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2783385|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
2783386|NCT04345666|Testosterone|testosterone|mesh-list
2783387|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
2783388|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
2783389|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2783390|NCT04345666|Androgens|androgens|mesh-ancestor
2783391|NCT04345666|Hormones|hormones|mesh-ancestor
2783392|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2783393|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783394|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2783395|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270860|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
2270861|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2270862|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2270863|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2783396|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
2783397|NCT04345718|Buprenorphine|buprenorphine|mesh-list
2783398|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
2783399|NCT04345718|Narcotics|narcotics|mesh-ancestor
2783400|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2783401|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783402|NCT04345718|Analgesics|analgesics|mesh-ancestor
2783403|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
2783404|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783405|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2791993|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2791994|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2791995|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2791996|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2791999|NCT04282746|Ketamine|ketamine|mesh-list
2792000|NCT04282746|Analgesics|analgesics|mesh-ancestor
2792001|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
2792002|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792003|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792004|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2792005|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2792006|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
2792007|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
2792008|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792009|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2792010|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2792011|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792012|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792013|NCT04282668|Tretinoin|tretinoin|mesh-list
2792014|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792015|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
2792016|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
2792017|NCT04282291|Morphine|morphine|mesh-list
2792018|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2792019|NCT04282291|Narcotics|narcotics|mesh-ancestor
2792020|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792021|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792022|NCT04282291|Analgesics|analgesics|mesh-ancestor
2792023|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
2792024|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792025|NCT04282200|Ketorolac|ketorolac|mesh-list
2792026|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2792027|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2792028|NCT04282200|Analgesics|analgesics|mesh-ancestor
2792029|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
2792030|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792031|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792032|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2270864|NCT00195793|Atorvastatin|atorvastatin|mesh-list
2270865|NCT00195793|Ezetimibe|ezetimibe|mesh-list
2270866|NCT00195793|Fenofibrate|fenofibrate|mesh-list
2270867|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2270868|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2270869|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
2270870|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270871|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2270872|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2270873|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270874|NCT00195806|Valproic Acid|valproic acid|mesh-list
2270875|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
2270876|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792033|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2792034|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2792035|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792036|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792037|NCT04282187|Azacitidine|azacitidine|mesh-list
2792038|NCT04282187|Decitabine|decitabine|mesh-list
2792039|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2792040|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2792041|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
2270877|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783410|NCT04344951|Chloroquine|chloroquine|mesh-list
2783411|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2783412|NCT04344951|Amebicides|amebicides|mesh-ancestor
2783413|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783414|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783415|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783416|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
2783417|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783418|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2783419|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2783420|NCT04344951|Analgesics|analgesics|mesh-ancestor
2783421|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
2783422|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783423|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783424|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2783425|NCT04344951|Filaricides|filaricides|mesh-ancestor
2783426|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
2783427|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
2783428|NCT04345094|Hydroquinone|hydroquinone|mesh-list
2783429|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
2783430|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783431|NCT04345094|Protective Agents|protective agents|mesh-ancestor
2783432|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783433|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2783434|NCT04345146|Bevacizumab|bevacizumab|mesh-list
2783435|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2783436|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783437|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2783438|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2783439|NCT04345146|Growth Substances|growth substances|mesh-ancestor
2783440|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783441|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
2783442|NCT04345276|Ritonavir|ritonavir|mesh-list
2783443|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2783444|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2783445|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
2270878|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
2270879|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270880|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270881|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
2270882|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2270883|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2270884|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2270885|NCT00195845|Galantamine|galantamine|mesh-list
2270886|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2270887|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270888|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270889|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
2270890|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2270891|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270892|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2270893|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
2270894|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270895|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
2270896|NCT00195871|Cytarabine|cytarabine|mesh-list
2270897|NCT00195871|Prednisone|prednisone|mesh-list
2270898|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
2270899|NCT00195871|Methotrexate|methotrexate|mesh-list
2270900|NCT00195871|Etoposide|etoposide|mesh-list
2270901|NCT00195871|Vincristine|vincristine|mesh-list
2270902|NCT00195871|Daunorubicin|daunorubicin|mesh-list
2270903|NCT00195871|Asparaginase|asparaginase|mesh-list
2270904|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270905|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
2270906|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783446|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783447|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783448|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2783449|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2783450|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
2783451|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783452|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2783453|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2783454|NCT04345198|Epinephrine|epinephrine|mesh-list
2783455|NCT04345198|Racepinephrine|racepinephrine|mesh-list
2270907|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783456|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
2783457|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2783458|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2783459|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
2783460|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2783461|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783462|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783463|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2783464|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2783465|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
2783466|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783467|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2783468|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
2783469|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
2783470|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
2783471|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2783480|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
2783481|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2270908|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2270909|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
2270910|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270911|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270912|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2270913|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2270914|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
2270915|NCT00195871|Hormones|hormones|mesh-ancestor
2270916|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270917|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2270918|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2270919|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
2270920|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2270921|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2270922|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
2270923|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
2270924|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270925|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2270926|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2270927|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2270928|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2270929|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2270930|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
2270931|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
2270932|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
2270933|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
2270934|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783482|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2783483|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783484|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
2783485|NCT04344860|Coagulants|coagulants|mesh-ancestor
2783486|NCT04344821|Calcium|calcium|mesh-list
2783487|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2783488|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783489|NCT04344483|Lidocaine|lidocaine|mesh-list
2783490|NCT04344483|Epinephrine|epinephrine|mesh-list
2783491|NCT04344483|Racepinephrine|racepinephrine|mesh-list
2783492|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
2783493|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
2783494|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
2783495|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2783496|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783497|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
2783498|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783499|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2783500|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2783501|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2783502|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2783503|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783504|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2783505|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2783506|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
2783507|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2783508|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2783509|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2783510|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
2783511|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2783512|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
2783513|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
2783514|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
2783515|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2783516|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
2783517|NCT04344457|Azithromycin|azithromycin|mesh-list
2783518|NCT04344457|Indomethacin|indomethacin|mesh-list
2783519|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
2270935|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2270936|NCT00195910|Morphine|morphine|mesh-list
2270937|NCT00195910|Hydromorphone|hydromorphone|mesh-list
2270938|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2270939|NCT00195910|Narcotics|narcotics|mesh-ancestor
2270940|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2270941|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270942|NCT00195910|Analgesics|analgesics|mesh-ancestor
2270943|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
2270944|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270945|NCT00195923|Clindamycin|clindamycin|mesh-list
2270946|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
2270947|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
2270948|NCT00195923|Gentamicins|gentamicins|mesh-list
2270949|NCT00195923|Ceftazidime|ceftazidime|mesh-list
2270950|NCT00195923|Ampicillin|ampicillin|mesh-list
2270951|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2270952|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270953|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2270954|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270955|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270956|NCT00195936|Cinacalcet|cinacalcet|mesh-list
2270957|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2270958|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270959|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2270960|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
2783520|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783521|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783522|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270961|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270962|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
2270963|NCT00195988|Tacrolimus|tacrolimus|mesh-list
2270964|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2270965|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
2270966|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270967|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2270968|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2270969|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2270970|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2783523|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783524|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783525|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783526|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2783527|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2783528|NCT04344457|Analgesics|analgesics|mesh-ancestor
2783529|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
2783530|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783531|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783532|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2783533|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
2783534|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
2783535|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2783536|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2783537|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2783538|NCT04344717|Apixaban|apixaban|mesh-list
2783539|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2270971|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270972|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2270973|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
2270974|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2783540|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
2270975|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2270976|NCT00196131|Morphine|morphine|mesh-list
2270977|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2270978|NCT00196131|Narcotics|narcotics|mesh-ancestor
2270979|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2270980|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270981|NCT00196131|Analgesics|analgesics|mesh-ancestor
2270982|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
2270983|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2270984|NCT00196339|Cyproterone Acetate|cyproterone acetate|mesh-list
2783541|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2783542|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
2783543|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783544|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783545|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
2783546|NCT04344756|Heparin|heparin|mesh-list
2783547|NCT04344756|Calcium heparin|calcium heparin|mesh-list
2783548|NCT04344756|Tinzaparin|tinzaparin|mesh-list
2783549|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2783550|NCT04344756|Dalteparin|dalteparin|mesh-list
2783551|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
2783552|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2783553|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2783554|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783555|NCT04344782|Bevacizumab|bevacizumab|mesh-list
2783556|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2783557|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783558|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2783559|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2783560|NCT04344782|Growth Substances|growth substances|mesh-ancestor
2783561|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783562|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
2783570|NCT04344730|Dexamethasone|dexamethasone|mesh-list
2783571|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
2783572|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2783573|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
2783574|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
2783575|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783576|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270985|NCT00196339|Cyproterone|cyproterone|mesh-list
2270986|NCT00196339|Androgen Antagonists|androgen antagonists|mesh-ancestor
2270987|NCT00196339|Hormone Antagonists|hormone antagonists|mesh-ancestor
2270988|NCT00196339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2270989|NCT00196339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270990|NCT00196339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2270991|NCT00196339|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2270992|NCT00196339|Contraceptive Agents|contraceptive agents|mesh-ancestor
2270993|NCT00196339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2270994|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
2270995|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2270996|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
2270997|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2270998|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2270999|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2271000|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2271001|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2271002|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
2271003|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2271004|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
2271005|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2271006|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271007|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2271008|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2271009|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2271010|NCT00196378|Estrogens|estrogens|mesh-list
2271011|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2271012|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
2271013|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
2783577|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2783578|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
2783579|NCT04344730|Hormones|hormones|mesh-ancestor
2783580|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2783581|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2783582|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783583|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
2783584|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
2783585|NCT04344236|Povidone|povidone|mesh-list
2783586|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2783587|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783588|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
2783589|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
2783590|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
2783591|NCT04344288|Prednisone|prednisone|mesh-list
2783592|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2271014|NCT00196378|Hormones|hormones|mesh-ancestor
2271015|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2271016|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271017|NCT00196391|Progesterone|progesterone|mesh-list
2271018|NCT00196391|Progestins|progestins|mesh-ancestor
2271019|NCT00196391|Hormones|hormones|mesh-ancestor
2783593|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
2783594|NCT04344288|Hormones|hormones|mesh-ancestor
2783595|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2783596|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783597|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2783598|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783599|NCT04344262|Atracurium|atracurium|mesh-list
2783600|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2783601|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2783602|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2783603|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783604|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783605|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2783606|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2783607|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
2783608|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2271020|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2271021|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271022|NCT00196417|Heparin|heparin|mesh-list
2271023|NCT00196417|Certoparin|certoparin|mesh-list
2783609|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271024|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
2271025|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2271026|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2271027|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271028|NCT00196469|Heparin|heparin|mesh-list
2271029|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
2271030|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2271031|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2271032|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271033|NCT00196534|Thrombin|thrombin|mesh-list
2271034|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
2271035|NCT00196534|Coagulants|coagulants|mesh-ancestor
2271036|NCT00196547|Montelukast|montelukast|mesh-list
2271037|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2271038|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
2783620|NCT04344405|Vitamin D|vitamin d|mesh-list
2783621|NCT04344405|Vitamins|vitamins|mesh-ancestor
2271039|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2271040|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
2271041|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2271042|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271043|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2271044|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2271045|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271046|NCT00196586|Interferons|interferons|mesh-list
2783622|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
2783623|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783624|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2783625|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
2783626|NCT04344184|Vitamins|vitamins|mesh-ancestor
2783627|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
2783628|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271047|NCT00196586|Ribavirin|ribavirin|mesh-list
2271048|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
2271049|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
2271050|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2271051|NCT00196586|Interleukin-2|interleukin-2|mesh-list
2271052|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271053|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
2271054|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271055|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
2271056|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271057|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
2271058|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271059|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2271060|NCT00196586|Analgesics|analgesics|mesh-ancestor
2271061|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
2271062|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271063|NCT00196599|Emtricitabine|emtricitabine|mesh-list
2271064|NCT00196599|Efavirenz|efavirenz|mesh-list
2271065|NCT00196599|Didanosine|didanosine|mesh-list
2271066|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
2271067|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102579|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
2102580|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102581|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
2102582|NCT02410772|Rifapentine|rifapentine|mesh-list
2102583|NCT02410772|Rifampin|rifampin|mesh-list
2102584|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2102585|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102586|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2102587|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2102588|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102589|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102590|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783629|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
2783630|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783631|NCT04344184|Protective Agents|protective agents|mesh-ancestor
2783632|NCT04344379|Azithromycin|azithromycin|mesh-list
2783633|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
2783634|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2783635|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783636|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
2783637|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783638|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783639|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783640|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783641|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783642|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
2783643|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2783644|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783645|NCT04344041|Vitamins|vitamins|mesh-ancestor
2783646|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
2783647|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2783648|NCT04343976|Interferons|interferons|mesh-list
2271068|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2271069|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2271070|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271071|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271072|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2271073|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2271074|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2271075|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2271076|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2271077|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2271078|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2271079|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2271080|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
2783649|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783650|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
2783651|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783652|NCT04343885|Docetaxel|docetaxel|mesh-list
2783653|NCT04343885|177Lu-PSMA-617|177lu-psma-617|mesh-list
2783654|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783655|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
2783656|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
2783657|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
2783658|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783659|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2783660|NCT04344158|Sorafenib|sorafenib|mesh-list
2783661|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271081|NCT00196612|Emtricitabine|emtricitabine|mesh-list
2271082|NCT00196612|Efavirenz|efavirenz|mesh-list
2271083|NCT00196612|Didanosine|didanosine|mesh-list
2271084|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
2271085|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271086|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2271087|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2271088|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271089|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271090|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2271091|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2271092|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2271093|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2271094|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2271095|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2271096|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2271097|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2271098|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
2271099|NCT00196625|Ritonavir|ritonavir|mesh-list
2271100|NCT00196625|Amprenavir|amprenavir|mesh-list
2271101|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2271102|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2271103|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
2271104|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271105|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271106|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2271107|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2271108|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
2271109|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271110|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2271111|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2271112|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2271113|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
2271114|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2271115|NCT00196638|Interferons|interferons|mesh-list
2271116|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
2271117|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2271118|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271119|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
2271120|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271121|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
2271122|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271123|NCT00196664|Paroxetine|paroxetine|mesh-list
2783662|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2783663|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783664|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783665|NCT04343872|Metformin|metformin|mesh-list
2783666|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2783667|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783668|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
2783669|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
2783670|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
2783671|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792042|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792043|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792044|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792045|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2792046|NCT04282629|Milrinone|milrinone|mesh-list
2792047|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2792048|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2792049|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
2792050|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2792051|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2792052|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783672|NCT04343768|Interferons|interferons|mesh-list
2783673|NCT04343768|Ritonavir|ritonavir|mesh-list
2783674|NCT04343768|Lopinavir|lopinavir|mesh-list
2783675|NCT04343768|Interferon-beta|interferon-beta|mesh-list
2783676|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
2783677|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
2783678|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
2783679|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783680|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
2783681|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783682|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2783683|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2783684|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
2783685|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783686|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783687|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2783688|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2783689|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2783690|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2783691|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
2783692|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783693|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783694|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783695|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
2783696|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783697|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2783698|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
2783699|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2783700|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2783701|NCT04343729|Prednisolone|prednisolone|mesh-list
2783702|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
2783703|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2783704|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
2783705|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2783706|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
2783707|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
2783708|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783709|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783710|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2783711|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
2783712|NCT04343729|Hormones|hormones|mesh-ancestor
2783713|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2783714|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2783715|NCT04343729|Protective Agents|protective agents|mesh-ancestor
2783716|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2783717|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783718|NCT04343963|Bromides|bromides|mesh-list
2783719|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2783720|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
2783721|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2783722|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783723|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783724|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
2783725|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2783726|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783727|NCT04343651|Leronlimab|leronlimab|mesh-list
2783728|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2783729|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2783730|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783731|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2783732|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2783733|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
2271124|NCT00196664|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2271125|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2271126|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2271127|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783734|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783735|NCT04343326|Menthol|menthol|mesh-list
2783736|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
2783737|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
2783738|NCT04343170|Folic Acid|folic acid|mesh-list
2783739|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
2783740|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
2783741|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
2783742|NCT04343170|Vitamins|vitamins|mesh-ancestor
2783743|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
2783744|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783745|NCT04343170|Hematinics|hematinics|mesh-ancestor
2783746|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
2783747|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
2783748|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783749|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783750|NCT04343001|Aspirin|aspirin|mesh-list
2783751|NCT04343001|Losartan|losartan|mesh-list
2783752|NCT04343001|Simvastatin|simvastatin|mesh-list
2783753|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2783754|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2783755|NCT04343001|Analgesics|analgesics|mesh-ancestor
2783756|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
2783757|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783758|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783759|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2783760|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783761|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2783762|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2783763|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783764|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2783765|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2783766|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783767|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
2783768|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2783769|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2783770|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
2783771|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2783772|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2783773|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2783774|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2783775|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2783776|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2783777|NCT04343235|Labetalol|labetalol|mesh-list
2783778|NCT04343235|Furosemide|furosemide|mesh-list
2271128|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2271129|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
2271130|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271131|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2271132|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
2271133|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2271134|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2271135|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2271136|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783779|NCT04343235|Diuretics|diuretics|mesh-ancestor
2783780|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
2783781|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783782|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2783783|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2783784|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783785|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2783786|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2783787|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
2783788|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2783789|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2783790|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
2783791|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
2783792|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783793|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2783794|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2783795|NCT04343144|Nivolumab|nivolumab|mesh-list
2783796|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2783797|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271137|NCT00196677|Vitamins|vitamins|mesh-list
2271138|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
2271139|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271140|NCT00196690|Donepezil|donepezil|mesh-list
2271141|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2271142|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271143|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271144|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
2271145|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2271146|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271147|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
2783798|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2783799|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271148|NCT00196703|Memantine|memantine|mesh-list
2271149|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2271150|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2271151|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
2271152|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2271153|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271154|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271155|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2271156|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2271157|NCT00196755|Calcium|calcium|mesh-list
2271158|NCT00196755|Sevelamer|sevelamer|mesh-list
2271159|NCT00196755|Calcium acetate|calcium acetate|mesh-list
2271160|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2271161|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271162|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
2271163|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
2271164|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271165|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
2271166|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271167|NCT00196820|Capecitabine|capecitabine|mesh-list
2271168|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2271169|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
2271170|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271171|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271172|NCT00196846|Goserelin|goserelin|mesh-list
2271173|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2271174|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271175|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
2783809|NCT04342910|Paclitaxel|paclitaxel|mesh-list
2783810|NCT04342910|Irinotecan|irinotecan|mesh-list
2783811|NCT04342910|Apatinib|apatinib|mesh-list
2783812|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2271176|NCT00196859|Capecitabine|capecitabine|mesh-list
2271177|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2783813|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783814|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
2783815|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
2783816|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
2783817|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783818|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2783819|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2783820|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783821|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2783822|NCT04342676|Panitumumab|panitumumab|mesh-list
2783823|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2783824|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783825|NCT04342598|Vitamin D|vitamin d|mesh-list
2783826|NCT04342598|Vitamins|vitamins|mesh-ancestor
2783827|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
2783828|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783829|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2783830|NCT04342585|Progesterone|progesterone|mesh-list
2783831|NCT04342585|Progestins|progestins|mesh-ancestor
2783832|NCT04342585|Hormones|hormones|mesh-ancestor
2783833|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2783834|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783835|NCT04342858|Listerine|listerine|mesh-list
2783836|NCT04342858|Fluorides|fluorides|mesh-list
2783837|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
2783838|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
2783839|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271178|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
2271179|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271180|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271181|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2271182|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271183|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
2783840|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
2783841|NCT04342858|Protective Agents|protective agents|mesh-ancestor
2783842|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2783843|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783844|NCT04342728|Vitamins|vitamins|mesh-list
2783845|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
2783846|NCT04342728|Zinc|zinc|mesh-list
2783847|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
2783848|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783849|NCT04342728|Trace Elements|trace elements|mesh-ancestor
2783850|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
2271184|NCT00196872|Epirubicin|epirubicin|mesh-list
2271185|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2271186|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
2271187|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271188|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2271189|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2271190|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
2271191|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271192|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783851|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783852|NCT04342728|Protective Agents|protective agents|mesh-ancestor
2783853|NCT04342975|Niacinamide|niacinamide|mesh-list
2783854|NCT04342975|Niacin|niacin|mesh-list
2783855|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
2783856|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
2783857|NCT04342975|Vitamins|vitamins|mesh-ancestor
2783858|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
2783859|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783860|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2783861|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
2783862|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783863|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2783864|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
2783865|NCT04342650|Chloroquine|chloroquine|mesh-list
2783866|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2783867|NCT04342650|Amebicides|amebicides|mesh-ancestor
2783868|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783869|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783870|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783871|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
2783872|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783873|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2783874|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2783875|NCT04342650|Analgesics|analgesics|mesh-ancestor
2783876|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
2783877|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783878|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783879|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2783880|NCT04342650|Filaricides|filaricides|mesh-ancestor
2783881|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
2783882|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
2783883|NCT04342819|Empagliflozin|empagliflozin|mesh-list
2783884|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2783885|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783886|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2783887|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783888|NCT04342065|Celecoxib|celecoxib|mesh-list
2783889|NCT04342065|Pregabalin|pregabalin|mesh-list
2783890|NCT04342065|Analgesics|analgesics|mesh-ancestor
2271193|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2271194|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2271195|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2271196|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2271197|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271198|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
2271199|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2271200|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
2271201|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271202|NCT00196885|Expectorants|expectorants|mesh-ancestor
2271203|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
2271204|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2271205|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
2271206|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271207|NCT00196885|Protective Agents|protective agents|mesh-ancestor
2271208|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271209|NCT00196885|Antidotes|antidotes|mesh-ancestor
2271210|NCT00196989|Pioglitazone|pioglitazone|mesh-list
2783891|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
2792954|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271211|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2271212|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271213|NCT00197080|Ropinirole|ropinirole|mesh-list
2271214|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2783892|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2783893|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783894|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
2783895|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2783896|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2783897|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783898|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2783899|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2783900|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2783901|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2783902|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2783903|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2783904|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2783905|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2783906|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783907|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2783908|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2783909|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783910|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
2783911|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
2783912|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783913|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783914|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783915|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783916|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783917|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783918|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
2783919|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
2783920|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783921|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783922|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783923|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271215|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2783924|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783925|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783926|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
2783927|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2783928|NCT04342247|Testosterone|testosterone|mesh-list
2783929|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
2783930|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
2783931|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2783932|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783933|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
2783934|NCT04342247|Hormones|hormones|mesh-ancestor
2783935|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2783936|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783937|NCT04342247|Androgens|androgens|mesh-ancestor
2783938|NCT04342351|Valsartan|valsartan|mesh-list
2783939|NCT04342351|Perindopril|perindopril|mesh-list
2783940|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2783941|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2783942|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2783943|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783944|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2783945|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
2783946|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783947|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
2783948|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
2102591|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2102592|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
2102593|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
2102594|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2102595|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2102596|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2102597|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2102598|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2102599|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2102600|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2102967|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2271216|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
2271217|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
2271218|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2783949|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783950|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783951|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783952|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783953|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783954|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783955|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
2783956|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2783957|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783958|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2783959|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2783960|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783961|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783962|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783963|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
2783964|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783965|NCT04341870|Azithromycin|azithromycin|mesh-list
2783966|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
2783967|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2783968|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783969|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
2783970|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2783971|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2783972|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271219|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271220|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271221|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
2271222|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2271223|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271224|NCT00197197|Aplaviroc|aplaviroc|mesh-list
2271225|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2271226|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2271227|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271228|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2271229|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2271230|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
2271231|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783973|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783974|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2783975|NCT04341935|Linagliptin|linagliptin|mesh-list
2783976|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2783977|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783978|NCT04341935|Incretins|incretins|mesh-ancestor
2271232|NCT00197249|Vaccines|vaccines|mesh-list
2271233|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
2271234|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2783979|NCT04341935|Hormones|hormones|mesh-ancestor
2783980|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2783981|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2783982|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
2783983|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783984|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783985|NCT04341831|Teicoplanin|teicoplanin|mesh-list
2783986|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2783987|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2783988|NCT04341844|Methylene Blue|methylene blue|mesh-list
2783989|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2783990|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2783991|NCT04341857|Antibodies|antibodies|mesh-list
2783992|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2271235|NCT00197301|Vaccines|vaccines|mesh-list
2271236|NCT00197301|Immunologic Factors|immunologic factors|mesh-ancestor
2271237|NCT00197301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271238|NCT00197327|Bupivacaine|bupivacaine|mesh-list
2271239|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
2271240|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
2271241|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2271242|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271243|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
2271244|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271245|NCT00197340|Ropivacaine|ropivacaine|mesh-list
2271246|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
2271247|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
2783993|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
2783994|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792053|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792054|NCT04282629|Protective Agents|protective agents|mesh-ancestor
2792055|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792056|NCT04282096|Caseins|caseins|mesh-list
2792057|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
2792058|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
2792059|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792060|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
2792061|NCT04282174|Melphalan|melphalan|mesh-list
2792062|NCT04282174|Busulfan|busulfan|mesh-list
2792063|NCT04282174|Thiotepa|thiotepa|mesh-list
2792064|NCT04282174|Fludarabine|fludarabine|mesh-list
2792065|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2792066|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
2792067|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792068|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2792069|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2792070|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
2792071|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792072|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792073|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2792074|NCT04281862|Prednisolone|prednisolone|mesh-list
2792075|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2792076|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
2792077|NCT04281862|Hormones|hormones|mesh-ancestor
2792078|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2792079|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792080|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2792081|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271248|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2271249|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271250|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
2271251|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271252|NCT00197353|Bupivacaine|bupivacaine|mesh-list
2271253|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
2271254|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
2271255|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792082|NCT04282031|Letrozole|letrozole|mesh-list
2792083|NCT04282031|Fulvestrant|fulvestrant|mesh-list
2792084|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792085|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2792086|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2792087|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792088|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792089|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2792090|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
2792091|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2792092|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792093|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2792094|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2792095|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
2792096|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2792097|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2792098|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2792099|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2792100|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792101|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
2792102|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792103|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792104|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2792105|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792106|NCT04281576|Capecitabine|capecitabine|mesh-list
2792107|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
2792108|NCT04281576|Trastuzumab|trastuzumab|mesh-list
2792109|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2792110|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
2792111|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792112|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792113|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2792114|NCT04281706|Propofol|propofol|mesh-list
2792115|NCT04281706|Etomidate|etomidate|mesh-list
2792116|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2783995|NCT04341883|Paclitaxel|paclitaxel|mesh-list
2783996|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2783997|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2783998|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2783999|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
2784000|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
2784001|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
2784002|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784003|NCT04341779|Tenofovir|tenofovir|mesh-list
2271256|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271257|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
2271258|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271259|NCT00197379|Roxithromycin|roxithromycin|mesh-list
2271260|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2271261|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271262|NCT00197418|Amoxicillin|amoxicillin|mesh-list
2271263|NCT00197418|Metronidazole|metronidazole|mesh-list
2271264|NCT00197418|Clarithromycin|clarithromycin|mesh-list
2271265|NCT00197418|Rabeprazole|rabeprazole|mesh-list
2271266|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2271267|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271268|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2271269|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2271270|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2271271|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271272|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271273|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2271274|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2271275|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2271276|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2271277|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2271278|NCT00197444|Nedaplatin|nedaplatin|mesh-list
2271279|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271280|NCT00197483|Pergolide|pergolide|mesh-list
2271281|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
2271282|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
2271283|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2271284|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271285|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271286|NCT00197548|Folic Acid|folic acid|mesh-list
2784004|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
2784005|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784006|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2784007|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2784008|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784009|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271287|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
2271288|NCT00197548|Vitamins|vitamins|mesh-ancestor
2271289|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
2271290|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271291|NCT00197548|Hematinics|hematinics|mesh-ancestor
2271292|NCT00197561|Selenium|selenium|mesh-list
2271293|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
2271294|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784010|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2784011|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2784012|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
2784013|NCT04341402|Clotrimazole|clotrimazole|mesh-list
2784014|NCT04341402|Miconazole|miconazole|mesh-list
2784015|NCT04341402|Diclofenac|diclofenac|mesh-list
2784016|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2784017|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2784018|NCT04341402|Analgesics|analgesics|mesh-ancestor
2784019|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
2784020|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784021|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784022|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2784023|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784024|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2784025|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784026|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784027|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784028|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2784029|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2784030|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2271295|NCT00197561|Protective Agents|protective agents|mesh-ancestor
2784031|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2784032|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
2784033|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2784034|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2784035|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2784036|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2271296|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271297|NCT00197561|Trace Elements|trace elements|mesh-ancestor
2271298|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
2271299|NCT00197587|Nevirapine|nevirapine|mesh-list
2271300|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2271301|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2271302|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271303|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271304|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
2271305|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271306|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2271307|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2271308|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2271309|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2271310|NCT00197613|Lamivudine|lamivudine|mesh-list
2271311|NCT00197613|Zidovudine|zidovudine|mesh-list
2784037|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784038|NCT04341428|Lansoprazole|lansoprazole|mesh-list
2784039|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
2784040|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2784041|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2784042|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2784043|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784044|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784045|NCT04341571|Metformin|metformin|mesh-list
2784046|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2784047|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784048|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
2784049|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
2784050|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
2784051|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2271312|NCT00197613|Efavirenz|efavirenz|mesh-list
2271313|NCT00197613|Nevirapine|nevirapine|mesh-list
2271314|NCT00197613|Stavudine|stavudine|mesh-list
2271315|NCT00197613|Didanosine|didanosine|mesh-list
2271316|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2784052|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784053|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784054|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784055|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784056|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784057|NCT04341675|Sirolimus|sirolimus|mesh-list
2784058|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2784059|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784060|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2784061|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784062|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
2784063|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2784064|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
2784065|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784066|NCT04341818|Vitamin D|vitamin d|mesh-list
2784067|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
2784068|NCT04341818|Vitamins|vitamins|mesh-list
2784069|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
2784070|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784071|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2784072|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2784073|NCT04341727|Azithromycin|azithromycin|mesh-list
2784074|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
2784075|NCT04341727|Chloroquine|chloroquine|mesh-list
2784076|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2784077|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2784078|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784079|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
2784080|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784081|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784082|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792117|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2271317|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2271318|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271319|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271320|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
2271321|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271322|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2271323|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2271324|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
2271325|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2271326|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2784083|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784084|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784085|NCT04341727|Amebicides|amebicides|mesh-ancestor
2784086|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2784087|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2784088|NCT04341727|Analgesics|analgesics|mesh-ancestor
2784089|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
2784090|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784091|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784092|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2784093|NCT04341727|Filaricides|filaricides|mesh-ancestor
2784094|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
2784095|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
2784096|NCT04341545|Letrozole|letrozole|mesh-list
2784097|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784098|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2784099|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2784100|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784101|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784102|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2784103|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
2784104|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2784105|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784106|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
2784107|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
2784108|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784109|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784110|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784111|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784112|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784113|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784114|NCT04341350|Analgesics|analgesics|mesh-list
2784115|NCT04341350|Propofol|propofol|mesh-list
2784116|NCT04341350|Isoflurane|isoflurane|mesh-list
2784117|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2784118|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2784119|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784120|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2784121|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
2784122|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
2784123|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
2784124|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784125|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2784126|NCT04341207|Azithromycin|azithromycin|mesh-list
2784127|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
2784128|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2784129|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784130|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
2784131|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784132|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784133|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784134|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784135|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784136|NCT04341311|Panobinostat|panobinostat|mesh-list
2784137|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784138|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2784139|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784140|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784141|NCT04341181|Trastuzumab|trastuzumab|mesh-list
2784142|NCT04341181|Avelumab|avelumab|mesh-list
2784143|NCT04341181|Pertuzumab|pertuzumab|mesh-list
2784144|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2784145|NCT04341181|Atezolizumab|atezolizumab|mesh-list
2784146|NCT04341181|Axitinib|axitinib|mesh-list
2784147|NCT04341181|Niraparib|niraparib|mesh-list
2784148|NCT04341181|Vemurafenib|vemurafenib|mesh-list
2784149|NCT04341181|Maytansine|maytansine|mesh-list
2784150|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2784151|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784152|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2271327|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2271328|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2271329|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2271330|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2271331|NCT00197639|Ritonavir|ritonavir|mesh-list
2271332|NCT00197639|Indinavir|indinavir|mesh-list
2271333|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2271334|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2784153|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784154|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784155|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2784156|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2784157|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
2784158|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
2784159|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
2784160|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
2784161|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2784162|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2784163|NCT04341038|Prednisolone|prednisolone|mesh-list
2784164|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
2784165|NCT04341038|Tacrolimus|tacrolimus|mesh-list
2784166|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2784167|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
2784168|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2784169|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
2784170|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784171|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2784172|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784173|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784174|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2784175|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
2784176|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
2784177|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784178|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2784179|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
2784180|NCT04341038|Hormones|hormones|mesh-ancestor
2784181|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2784182|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2784183|NCT04341038|Protective Agents|protective agents|mesh-ancestor
2784184|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2784185|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784186|NCT04341155|Dexamethasone|dexamethasone|mesh-list
2784187|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
2784188|NCT04341155|BB 1101|bb 1101|mesh-list
2784189|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2784190|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
2784191|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
2784192|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784193|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784194|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2784195|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
2784196|NCT04341155|Hormones|hormones|mesh-ancestor
2784197|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2784198|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2784199|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784200|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
2784201|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784202|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784203|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
2784204|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
2784205|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784206|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784207|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784208|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792118|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271335|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
2271336|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271337|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271338|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2271339|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2271340|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
2271341|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271342|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2271343|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2271344|NCT00197730|Folic Acid|folic acid|mesh-list
2271345|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
2271346|NCT00197730|Vitamins|vitamins|mesh-ancestor
2271347|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
2271348|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271349|NCT00197730|Hematinics|hematinics|mesh-ancestor
2271350|NCT00197743|Vitamin A|vitamin a|mesh-list
2271351|NCT00197743|Beta Carotene|beta carotene|mesh-list
2271352|NCT00197743|Carotenoids|carotenoids|mesh-list
2271353|NCT00197743|Vitamins|vitamins|mesh-ancestor
2271354|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
2271355|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271356|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
2271357|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271358|NCT00197743|Protective Agents|protective agents|mesh-ancestor
2271359|NCT00197743|Provitamins|provitamins|mesh-ancestor
2271360|NCT00197756|Vitamins|vitamins|mesh-list
2271361|NCT00197756|Vitamin A|vitamin a|mesh-list
2271362|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
2271363|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
2271364|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271365|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
2271366|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271367|NCT00197756|Protective Agents|protective agents|mesh-ancestor
2271368|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2271369|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271370|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2271371|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
2271372|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271373|NCT00197834|Valproic Acid|valproic acid|mesh-list
2271374|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
2271375|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271376|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271377|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
2271378|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2271379|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271380|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
2271381|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2271382|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2271383|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2271384|NCT00197886|Norepinephrine|norepinephrine|mesh-list
2271385|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2271386|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2271387|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
2271388|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2271389|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271390|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271391|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
2271392|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
2271393|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271394|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2271395|NCT00197912|Celecoxib|celecoxib|mesh-list
2271396|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
2271397|NCT00197912|Interleukin-2|interleukin-2|mesh-list
2271398|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
2271399|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271400|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2271401|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784209|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784210|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784211|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2784212|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
2784213|NCT04340882|Docetaxel|docetaxel|mesh-list
2784214|NCT04340882|Ramucirumab|ramucirumab|mesh-list
2784215|NCT04340882|Antibodies|antibodies|mesh-list
2784216|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
2784217|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2784218|NCT04340882|Lexatumumab|lexatumumab|mesh-list
2784219|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
2784220|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784221|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784222|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
2784223|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
2784224|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
2784225|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784226|NCT04340869|Theobromine|theobromine|mesh-list
2784227|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2784228|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
2784229|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271402|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2271403|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
2784230|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784231|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2784232|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
2784233|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
2784234|NCT04340856|Bisacodyl|bisacodyl|mesh-list
2784235|NCT04340856|Laxatives|laxatives|mesh-list
2784236|NCT04340856|Cathartics|cathartics|mesh-ancestor
2784237|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2784238|NCT04340778|Lidocaine|lidocaine|mesh-list
2784239|NCT04340778|Prilocaine|prilocaine|mesh-list
2784240|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2784241|NCT04340778|Dinoprostone|dinoprostone|mesh-list
2784242|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
2784243|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
2784244|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2784245|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784246|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
2784247|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271404|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271405|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271406|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2271407|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2271408|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2102601|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2102602|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
2102603|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
2102604|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102605|NCT02411292|Enoxaparin|enoxaparin|mesh-list
2271409|NCT00197912|Analgesics|analgesics|mesh-ancestor
2271410|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
2271411|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784248|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2784249|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2784250|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2784251|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2784252|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784253|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
2784254|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2784255|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2784256|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2784257|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2784258|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
2784259|NCT04340505|Hormones|hormones|mesh-ancestor
2784260|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2271412|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2271413|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2271414|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2271415|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271416|NCT00198055|Aripiprazole|aripiprazole|mesh-list
2271417|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
2271418|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2271419|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2271420|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2271421|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2271422|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271423|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
2271424|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
2271425|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2271426|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271427|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2271428|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2271429|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
2271430|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2102606|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
2102607|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2102608|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2102609|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102610|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2102611|NCT02411448|Gefitinib|gefitinib|mesh-list
2102612|NCT02411448|Osimertinib|osimertinib|mesh-list
2102613|NCT02411448|Ramucirumab|ramucirumab|mesh-list
2271431|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2271432|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2271433|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2271434|NCT00198094|Alprazolam|alprazolam|mesh-list
2271435|NCT00198094|Sertraline|sertraline|mesh-list
2271436|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
2271437|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2271438|NCT00198094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2271439|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2271440|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2271441|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271442|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2271443|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
2271444|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271445|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2271446|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2271447|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2271448|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2271449|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
2271450|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
2271451|NCT00198120|Cycloserine|cycloserine|mesh-list
2271452|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2271453|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271454|NCT00198120|Renal Agents|renal agents|mesh-ancestor
2271455|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2784261|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784262|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
2784263|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2784264|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784265|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2784266|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784267|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
2784268|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2784269|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784270|NCT04340401|Capecitabine|capecitabine|mesh-list
2784271|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
2784272|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2784273|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
2784274|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784275|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784276|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
2784277|NCT04340349|Bromhexine|bromhexine|mesh-list
2784278|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
2784279|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784280|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784281|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271456|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
2271457|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2271458|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
2271459|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271460|NCT00198146|Daclizumab|daclizumab|mesh-list
2271461|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2271462|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
2271463|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271464|NCT00198159|Gefitinib|gefitinib|mesh-list
2271465|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784282|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784283|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784284|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784285|NCT04340349|Expectorants|expectorants|mesh-ancestor
2784286|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
2784287|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2784288|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784289|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784290|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792119|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2792120|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
2271466|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2271467|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271468|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271469|NCT00198172|Epirubicin|epirubicin|mesh-list
2271470|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271471|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2271472|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2271473|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2792121|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
2271474|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271475|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271476|NCT00198198|Aripiprazole|aripiprazole|mesh-list
2784291|NCT04340388|Tenofovir|tenofovir|mesh-list
2784292|NCT04340388|Lamivudine|lamivudine|mesh-list
2784293|NCT04340388|Zidovudine|zidovudine|mesh-list
2784294|NCT04340388|Darunavir|darunavir|mesh-list
2784295|NCT04340388|Abacavir|abacavir|mesh-list
2784296|NCT04340388|Dolutegravir|dolutegravir|mesh-list
2784297|NCT04340388|Cobicistat|cobicistat|mesh-list
2784298|NCT04340388|Rilpivirine|rilpivirine|mesh-list
2784299|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2784300|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
2784301|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784302|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2784303|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2784304|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784305|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784306|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2784307|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
2784308|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2784309|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2784310|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
2784311|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2784312|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2784313|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2784314|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2784315|NCT04340141|Leucovorin|leucovorin|mesh-list
2784316|NCT04340141|Fluorouracil|fluorouracil|mesh-list
2784317|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
2784318|NCT04340141|Irinotecan|irinotecan|mesh-list
2784319|NCT04340141|Calcium|calcium|mesh-list
2784320|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
2784321|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2784322|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784323|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
2784324|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784325|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2784326|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784327|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2784328|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
2784329|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2784330|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2784331|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784332|NCT04340141|Antidotes|antidotes|mesh-ancestor
2784333|NCT04340141|Protective Agents|protective agents|mesh-ancestor
2784334|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
2784335|NCT04340141|Vitamins|vitamins|mesh-ancestor
2784336|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
2784337|NCT04339816|Azithromycin|azithromycin|mesh-list
2784338|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
2784339|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2784340|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784341|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
2784342|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784343|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784344|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784345|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784346|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784347|NCT04339868|Terlipressin|terlipressin|mesh-list
2784348|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2784349|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2784350|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2784351|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784352|NCT04339426|Azithromycin|azithromycin|mesh-list
2784353|NCT04339426|Atovaquone|atovaquone|mesh-list
2784354|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2784355|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784356|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
2784357|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784358|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784359|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784360|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784361|NCT04339101|Sirolimus|sirolimus|mesh-list
2784362|NCT04339101|Fludarabine|fludarabine|mesh-list
2784363|NCT04339101|Melphalan|melphalan|mesh-list
2784364|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
2784365|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2784366|NCT04339101|Tacrolimus|tacrolimus|mesh-list
2784367|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784368|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784369|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2784370|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
2784371|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784372|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2784373|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784374|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2784375|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784376|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2784377|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
2271477|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
2271478|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2271479|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2271480|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2271481|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2271482|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271483|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
2271484|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
2271485|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2271486|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271487|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2271488|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2271489|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
2271490|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2271491|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2271492|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2784378|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2784379|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
2784380|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2784381|NCT04339361|Lidocaine|lidocaine|mesh-list
2784382|NCT04339361|Dinoprostone|dinoprostone|mesh-list
2784383|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
2784384|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
2784385|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2784386|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784387|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
2784388|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784389|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2784390|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2784391|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2784392|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2784393|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271493|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2271494|NCT00198237|Docetaxel|docetaxel|mesh-list
2271495|NCT00198237|Capecitabine|capecitabine|mesh-list
2271496|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271497|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
2271498|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
2271499|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
2784394|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
2784395|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2784396|NCT04339062|Sirolimus|sirolimus|mesh-list
2784397|NCT04339062|Prednisone|prednisone|mesh-list
2784398|NCT04339062|Everolimus|everolimus|mesh-list
2784399|NCT04339062|Cemiplimab|cemiplimab|mesh-list
2784400|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2784401|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
2784402|NCT04339062|Hormones|hormones|mesh-ancestor
2784403|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2784404|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784405|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2784406|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784407|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2784408|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
2784409|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2784410|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784411|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2784412|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
2784413|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2784414|NCT04339348|Lidocaine|lidocaine|mesh-list
2784415|NCT04339348|Prilocaine|prilocaine|mesh-list
2784416|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2784417|NCT04339348|Misoprostol|misoprostol|mesh-list
2784418|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
2784419|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
2792122|NCT04281628|Ketamine|ketamine|mesh-list
2784420|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2784421|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784422|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
2784423|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784424|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2784425|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2784426|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2784427|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2784428|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784429|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2784430|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
2784431|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2784432|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2271500|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271501|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2271502|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
2271503|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2271504|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2271505|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2271506|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2271507|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271508|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2271509|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271510|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2271511|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
2271512|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2271513|NCT00198263|Bleomycin|bleomycin|mesh-list
2271514|NCT00198263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2271515|NCT00198263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271516|NCT00198276|Bleomycin|bleomycin|mesh-list
2271517|NCT00198276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2271518|NCT00198276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271519|NCT00198315|Bleomycin|bleomycin|mesh-list
2271520|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2271521|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271522|NCT00198328|Bleomycin|bleomycin|mesh-list
2784433|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2784434|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
2784435|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2784436|NCT04338984|Fentanyl|fentanyl|mesh-list
2784437|NCT04338984|Anesthetics|anesthetics|mesh-list
2784438|NCT04338984|Ropivacaine|ropivacaine|mesh-list
2784439|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
2784440|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2784441|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784442|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
2784443|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
2784444|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784445|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2784446|NCT04338984|Narcotics|narcotics|mesh-ancestor
2784447|NCT04338984|Analgesics|analgesics|mesh-ancestor
2784448|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2784449|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2784458|NCT04338698|Azithromycin|azithromycin|mesh-list
2784459|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
2784460|NCT04338698|Oseltamivir|oseltamivir|mesh-list
2784461|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2784462|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784463|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
2784464|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784465|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784466|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784467|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784468|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784469|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
2784470|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
2784471|NCT04338633|Calcium|calcium|mesh-list
2784472|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2784473|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784474|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2784475|NCT04338711|Tofacitinib|tofacitinib|mesh-list
2784476|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2784477|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784478|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784494|NCT04338763|Gemcitabine|gemcitabine|mesh-list
2784495|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2784496|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
2784497|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784498|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784499|NCT04338763|Antiviral Agents|antiviral agents|mesh-ancestor
2784500|NCT04338763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784501|NCT04338763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784502|NCT04338763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2784503|NCT04338763|Immunologic Factors|immunologic factors|mesh-ancestor
2784504|NCT04338763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784505|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
2784506|NCT04338906|Camostat|camostat|mesh-list
2784507|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
2271523|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2271524|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271525|NCT00198354|Gemcitabine|gemcitabine|mesh-list
2271526|NCT00198354|Paclitaxel|paclitaxel|mesh-list
2271527|NCT00198354|Carboplatin|carboplatin|mesh-list
2271528|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2271529|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271530|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
2271531|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
2271532|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
2271533|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271534|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2271535|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
2271536|NCT00198354|Antiviral Agents|antiviral agents|mesh-ancestor
2271537|NCT00198354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271538|NCT00198354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271539|NCT00198354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2271540|NCT00198354|Immunologic Factors|immunologic factors|mesh-ancestor
2271541|NCT00198354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271542|NCT00198367|Cisplatin|cisplatin|mesh-list
2271543|NCT00198367|Carboplatin|carboplatin|mesh-list
2784508|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784509|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784510|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784511|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784512|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784513|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784514|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
2784515|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2784516|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2784517|NCT04338802|Nintedanib|nintedanib|mesh-list
2784518|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784519|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2784520|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784521|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784522|NCT04338919|Aspirin|aspirin|mesh-list
2784523|NCT04338919|Ticagrelor|ticagrelor|mesh-list
2784524|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2784525|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2271544|NCT00198367|Vinorelbine|vinorelbine|mesh-list
2784526|NCT04338919|Analgesics|analgesics|mesh-ancestor
2784527|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
2784528|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784529|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784530|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2784531|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784532|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2784533|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2784534|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784535|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2784536|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2784537|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784538|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
2784539|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2784540|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2784541|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2784542|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
2784543|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792123|NCT04281628|Analgesics|analgesics|mesh-ancestor
2792124|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
2792125|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792126|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792127|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2792128|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2792129|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
2792130|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
2792131|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792132|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2792133|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2792134|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792135|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792136|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2792137|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792138|NCT04281680|Octreotide|octreotide|mesh-list
2792139|NCT04281680|Pasireotide|pasireotide|mesh-list
2792140|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2792141|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2792142|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792143|NCT04281680|Hormones|hormones|mesh-ancestor
2792144|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2792145|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792146|NCT04281290|Bleomycin|bleomycin|mesh-list
2792147|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2792148|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792149|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
2792150|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2792151|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792152|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2792153|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2792154|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792155|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792156|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792157|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2792158|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2792159|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2792955|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792956|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
2792957|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2792958|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792959|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792960|NCT04273997|Metronidazole|metronidazole|mesh-list
2792961|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792962|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2792963|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2792964|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2792965|NCT04273984|Misoprostol|misoprostol|mesh-list
2792966|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2792967|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
2792968|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2792969|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792970|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2792971|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2792972|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
2792973|NCT04273776|Zolpidem|zolpidem|mesh-list
2271545|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271546|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271547|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2271548|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
2271549|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
2271550|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
2271551|NCT00198380|Gefitinib|gefitinib|mesh-list
2271552|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271553|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2271554|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271555|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271556|NCT00198393|Gemcitabine|gemcitabine|mesh-list
2271557|NCT00198393|Docetaxel|docetaxel|mesh-list
2271558|NCT00198393|Gefitinib|gefitinib|mesh-list
2271559|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2271560|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
2784544|NCT04338620|Paclitaxel|paclitaxel|mesh-list
2784545|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2784546|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2784547|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784548|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
2784549|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
2784550|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
2784551|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784552|NCT04338373|Atropine|atropine|mesh-list
2784553|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2784554|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2784555|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2784556|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
2784557|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784558|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784559|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2784560|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
2784561|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
2784562|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
2784563|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2784564|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2784565|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
2784566|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2784567|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271561|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271562|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271563|NCT00198393|Antiviral Agents|antiviral agents|mesh-ancestor
2271564|NCT00198393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271565|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271566|NCT00198393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2271567|NCT00198393|Immunologic Factors|immunologic factors|mesh-ancestor
2784568|NCT04338191|Leucovorin|leucovorin|mesh-list
2784569|NCT04338191|Fluorouracil|fluorouracil|mesh-list
2784570|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
2784571|NCT04338191|Irinotecan|irinotecan|mesh-list
2784572|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
2784573|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
2784574|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784575|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2784576|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784577|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2784578|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
2784579|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784580|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2784581|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2271568|NCT00198393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271569|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
2271570|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
2271571|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
2271572|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2271573|NCT00198432|Paclitaxel|paclitaxel|mesh-list
2784582|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784583|NCT04338191|Antidotes|antidotes|mesh-ancestor
2784584|NCT04338191|Protective Agents|protective agents|mesh-ancestor
2784585|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
2784586|NCT04338191|Vitamins|vitamins|mesh-ancestor
2784587|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
2784588|NCT04338438|Apatinib|apatinib|mesh-list
2784589|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271574|NCT00198432|Vinorelbine|vinorelbine|mesh-list
2784590|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2271575|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2271576|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271577|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
2271578|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
2271579|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
2271580|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271581|NCT00198445|Bromfenac|bromfenac|mesh-list
2271582|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2271583|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2271584|NCT00198445|Analgesics|analgesics|mesh-ancestor
2271585|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
2271586|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271587|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271588|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2271589|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2271590|NCT00198523|Tobramycin|tobramycin|mesh-list
2271591|NCT00198523|Prednisolone|prednisolone|mesh-list
2271592|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2271593|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
2271594|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2271595|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
2271596|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2271597|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
2271598|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2271599|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
2271600|NCT00198523|Hormones|hormones|mesh-ancestor
2271601|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2784591|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784592|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784593|NCT04338165|Evolocumab|evolocumab|mesh-list
2784594|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2784595|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2784596|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
2784597|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784598|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2271602|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271603|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2271604|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271605|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
2271606|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
2271607|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271608|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2271609|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2271610|NCT00198523|Protective Agents|protective agents|mesh-ancestor
2271611|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2271612|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271613|NCT00198536|Ecabet|ecabet|mesh-list
2271614|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271615|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2271616|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2271617|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
2271618|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271619|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271620|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2271621|NCT00198536|Protective Agents|protective agents|mesh-ancestor
2271622|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271623|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271624|NCT00198562|Losartan|losartan|mesh-list
2784599|NCT04337970|Axitinib|axitinib|mesh-list
2784600|NCT04337970|Talazoparib|talazoparib|mesh-list
2784601|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784602|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2784603|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784604|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784605|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2784606|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
2784607|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2784608|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2784609|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784610|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
2784611|NCT04338126|Coagulants|coagulants|mesh-ancestor
2784612|NCT04337827|Rituximab|rituximab|mesh-list
2784613|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
2784614|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2784615|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784616|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
2784617|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784618|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784619|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
2784620|NCT04337879|Irinotecan|irinotecan|mesh-list
2784621|NCT04337879|Calcium|calcium|mesh-list
2784622|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2784623|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784624|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784625|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2784626|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2784627|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784628|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784629|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
2784630|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2784631|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2784632|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
2784633|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784634|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784635|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2784636|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
2784637|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2784638|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
2784639|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784640|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2784641|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2784642|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
2784643|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
2784644|NCT04337918|Protective Agents|protective agents|mesh-ancestor
2784645|NCT04337814|Ibuprofen|ibuprofen|mesh-list
2784646|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2784647|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2784648|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2784649|NCT04337814|Analgesics|analgesics|mesh-ancestor
2784650|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
2784651|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784652|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784653|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2784654|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784655|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2784656|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784657|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784658|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
2784659|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
2784660|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2271625|NCT00198562|Amlodipine|amlodipine|mesh-list
2271626|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
2271627|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2271628|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2271629|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271630|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2271631|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271632|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
2271633|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2271634|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2271635|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2271636|NCT00198588|Argatroban|argatroban|mesh-list
2271637|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
2271638|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2271639|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
2271640|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271641|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271642|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
2271643|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2271644|NCT00198601|Gentamicins|gentamicins|mesh-list
2271645|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2271646|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271647|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2271648|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271649|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271650|NCT00198614|Metoprolol|metoprolol|mesh-list
2271651|NCT00198614|Carvedilol|carvedilol|mesh-list
2271652|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2784661|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2784662|NCT04337593|Pegaspargase|pegaspargase|mesh-list
2784663|NCT04337593|Basiliximab|basiliximab|mesh-list
2784664|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784665|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2784666|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
2784667|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784668|NCT04337632|Paclitaxel|paclitaxel|mesh-list
2784669|NCT04337632|Carboplatin|carboplatin|mesh-list
2271653|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2271654|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
2784670|NCT04337632|Doxorubicin|doxorubicin|mesh-list
2784671|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2784672|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2784673|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784674|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
2784675|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
2784676|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
2784677|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784678|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2784679|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2784680|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2784681|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784682|NCT04337658|Capecitabine|capecitabine|mesh-list
2784683|NCT04337658|Trastuzumab|trastuzumab|mesh-list
2784684|NCT04337658|Fulvestrant|fulvestrant|mesh-list
2784685|NCT04337658|Pertuzumab|pertuzumab|mesh-list
2784686|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2784687|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
2784688|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784689|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784690|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2784691|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2784692|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2784693|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2784694|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
2784695|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2784696|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784697|NCT04337450|Lamivudine|lamivudine|mesh-list
2784698|NCT04337450|Dolutegravir|dolutegravir|mesh-list
2784699|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2784700|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2784701|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784702|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784703|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
2784704|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784705|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2784706|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2784707|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2784708|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2784709|NCT04337580|Omeprazole|omeprazole|mesh-list
2784710|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2784711|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2784712|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2784713|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784714|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784715|NCT04337606|Decitabine|decitabine|mesh-list
2784716|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2784717|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
2784718|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784719|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784720|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784721|NCT04337268|Glucagon|glucagon|mesh-list
2102614|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102615|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2102616|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784722|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2784723|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2784724|NCT04337268|Hormones|hormones|mesh-ancestor
2784725|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2784726|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102617|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102618|NCT02411578|Glucagon|glucagon|mesh-list
2102619|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2102620|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2102621|NCT02411578|Hormones|hormones|mesh-ancestor
2784727|NCT04337268|Incretins|incretins|mesh-ancestor
2784728|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
2784729|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2784730|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2784731|NCT04336891|Estradiol|estradiol|mesh-list
2784732|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2784733|NCT04336891|Testosterone|testosterone|mesh-list
2784734|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
2784735|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
2784736|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2784737|NCT04336891|Estrogens|estrogens|mesh-ancestor
2784738|NCT04336891|Hormones|hormones|mesh-ancestor
2102622|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102623|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102624|NCT02411578|Incretins|incretins|mesh-ancestor
2102625|NCT02411591|Necitumumab|necitumumab|mesh-list
2102626|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2102627|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102628|NCT02411916|Misoprostol|misoprostol|mesh-list
2102629|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2102630|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
2102631|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2102632|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102633|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2102634|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2102635|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
2102636|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
2102637|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2102638|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102639|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2102640|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102641|NCT02412111|Ivacaftor|ivacaftor|mesh-list
2102642|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2102643|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2102644|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102645|NCT02412228|Dexamethasone|dexamethasone|mesh-list
2784739|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2784740|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784741|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2784742|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
2784743|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2784744|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2784745|NCT04336891|Androgens|androgens|mesh-ancestor
2784746|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2784747|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784748|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
2784761|NCT04336904|Favipiravir|favipiravir|mesh-list
2784762|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
2784763|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784764|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
2784765|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
2784766|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784767|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784768|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784769|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784770|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784771|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784772|NCT04337073|Propofol|propofol|mesh-list
2784773|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2784774|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2784775|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784776|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2784777|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
2784778|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
2792160|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2792161|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792162|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2792163|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
2792164|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2792165|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2792166|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2792167|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792168|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792169|NCT04281017|Anesthetics|anesthetics|mesh-list
2792170|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792171|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792172|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
2792173|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2792174|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2792175|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2792176|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2792177|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792178|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
2792179|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792180|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792181|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2792182|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792183|NCT04280874|Dinoprostone|dinoprostone|mesh-list
2792184|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
2271655|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
2271656|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271657|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271658|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2271659|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2271660|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2271661|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
2271662|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2271663|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271664|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
2271665|NCT00198614|Protective Agents|protective agents|mesh-ancestor
2271666|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2271667|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2271668|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2271669|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
2792185|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2792186|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792187|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2792188|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2792189|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792190|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2792191|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
2792192|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792193|NCT04280939|Anesthetics|anesthetics|mesh-list
2792194|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792195|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792196|NCT04280601|Vitamin D|vitamin d|mesh-list
2792197|NCT04280601|Vitamins|vitamins|mesh-ancestor
2792198|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
2792199|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271670|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2271671|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2271672|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2271673|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2271674|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271675|NCT00198627|Renal Agents|renal agents|mesh-ancestor
2271676|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2271677|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
2271678|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2271679|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2271680|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2271681|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271682|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
2271683|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2271684|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271685|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
2271686|NCT00198718|Vitamin A|vitamin a|mesh-list
2271687|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
2271688|NCT00198718|Vitamins|vitamins|mesh-ancestor
2271689|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
2271690|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271691|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
2271692|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271693|NCT00198718|Protective Agents|protective agents|mesh-ancestor
2271694|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2271695|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271696|NCT00198848|Folic Acid|folic acid|mesh-list
2271697|NCT00198848|Hematinics|hematinics|mesh-ancestor
2271698|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
2271699|NCT00198848|Vitamins|vitamins|mesh-ancestor
2271700|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
2271701|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271702|NCT00198978|Cytarabine|cytarabine|mesh-list
2271703|NCT00198978|Dexamethasone|dexamethasone|mesh-list
2271704|NCT00198978|Prednisolone|prednisolone|mesh-list
2271705|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
2271706|NCT00198978|Rituximab|rituximab|mesh-list
2271707|NCT00198978|Methotrexate|methotrexate|mesh-list
2271708|NCT00198978|Vincristine|vincristine|mesh-list
2271709|NCT00198978|Asparaginase|asparaginase|mesh-list
2271710|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
2271711|NCT00198978|Idarubicin|idarubicin|mesh-list
2784779|NCT04336917|Lidocaine|lidocaine|mesh-list
2784780|NCT04336917|Bupivacaine|bupivacaine|mesh-list
2784781|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
2784782|NCT04336917|Anesthetics|anesthetics|mesh-list
2784783|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2784784|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784785|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
2784786|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784787|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2784788|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2784789|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2784790|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2784791|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784792|NCT04337099|Tempol|tempol|mesh-list
2784793|NCT04337099|TEMPO|tempo|mesh-list
2784794|NCT04337099|TEMPOL-H|tempol-h|mesh-list
2271712|NCT00198978|Sargramostim|sargramostim|mesh-list
2271713|NCT00198978|Lenograstim|lenograstim|mesh-list
2271714|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2271715|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
2271716|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271717|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2271718|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2271719|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
2271720|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271721|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271722|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2271723|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2271724|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
2271725|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
2271726|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271727|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2271728|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
2271729|NCT00198978|Hormones|hormones|mesh-ancestor
2271730|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2271731|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2271732|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2271733|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2271734|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
2271735|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2271736|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2271737|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
2271738|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
2271739|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271740|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2271741|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2271742|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
2271743|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271744|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2271745|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
2271746|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
2271747|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
2271748|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2271749|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2784795|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
2271750|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2784796|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784797|NCT04337099|Protective Agents|protective agents|mesh-ancestor
2784798|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784799|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2784800|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784801|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2784802|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2784803|NCT04336566|Melatonin|melatonin|mesh-list
2784804|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
2784805|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784806|NCT04336566|Protective Agents|protective agents|mesh-ancestor
2784807|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784808|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2784809|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
2784810|NCT04336189|Piperaquine|piperaquine|mesh-list
2784811|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
2784812|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2784813|NCT04336189|Artenimol|artenimol|mesh-list
2784814|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
2784815|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784816|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784817|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784818|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2784819|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784820|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784821|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2784822|NCT04336189|Renal Agents|renal agents|mesh-ancestor
2784823|NCT04336332|Azithromycin|azithromycin|mesh-list
2784824|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
2784825|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2784826|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784827|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
2784828|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784829|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784830|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784831|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784832|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784833|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2784834|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
2784835|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2784836|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
2784837|NCT04336488|Hormones|hormones|mesh-ancestor
2784838|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2784839|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784840|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2784841|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
2784842|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784843|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784844|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
2784845|NCT04336605|Analgesics|analgesics|mesh-list
2784846|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
2784847|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784848|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784849|NCT04336228|Dexetimide|dexetimide|mesh-list
2784850|NCT04336228|Citalopram|citalopram|mesh-list
2784851|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784852|NCT04336228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2784853|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2784854|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2784855|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784856|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2784857|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
2784858|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2271751|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2271752|NCT00198991|Cytarabine|cytarabine|mesh-list
2271753|NCT00198991|Dexamethasone|dexamethasone|mesh-list
2271754|NCT00198991|Prednisolone|prednisolone|mesh-list
2271755|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
2271756|NCT00198991|Methotrexate|methotrexate|mesh-list
2271757|NCT00198991|Fludarabine|fludarabine|mesh-list
2271758|NCT00198991|Vincristine|vincristine|mesh-list
2271759|NCT00198991|Doxorubicin|doxorubicin|mesh-list
2271760|NCT00198991|Daunorubicin|daunorubicin|mesh-list
2271761|NCT00198991|Asparaginase|asparaginase|mesh-list
2271762|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
2271763|NCT00198991|Idarubicin|idarubicin|mesh-list
2271764|NCT00198991|Thioguanine|thioguanine|mesh-list
2271765|NCT00198991|Cladribine|cladribine|mesh-list
2271766|NCT00198991|Vindesine|vindesine|mesh-list
2784859|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
2784860|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2784861|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2784862|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2784863|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
2784864|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
2784865|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784866|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2784867|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2784868|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
2784869|NCT04336046|Bupivacaine|bupivacaine|mesh-list
2784870|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
2784871|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
2784872|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2784873|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784874|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
2784875|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2784876|NCT04336241|Nivolumab|nivolumab|mesh-list
2784877|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2784878|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784879|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2784880|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784881|NCT04335968|Melatonin|melatonin|mesh-list
2784882|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
2271767|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2271768|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
2271769|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271770|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2271771|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2271772|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
2271773|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271774|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271775|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2271776|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2271777|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
2271778|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
2271779|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271780|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2271781|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
2271782|NCT00198991|Hormones|hormones|mesh-ancestor
2784883|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784884|NCT04335968|Protective Agents|protective agents|mesh-ancestor
2784885|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784886|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2784887|NCT04335786|Valsartan|valsartan|mesh-list
2784888|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2784889|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2784890|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2784891|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784892|NCT04335890|Vaccines|vaccines|mesh-list
2784893|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
2784894|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784895|NCT04335461|Anesthetics|anesthetics|mesh-list
2784896|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
2784897|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2784898|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784899|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
2784900|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271783|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2271784|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2271785|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2271786|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
2271787|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2271788|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2271789|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
2271790|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
2271791|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271792|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2271793|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2271794|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
2271795|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271796|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2271797|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
2271798|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
2271799|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
2271800|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2271801|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2271802|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2784927|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
2784928|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2784929|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2784930|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
2784931|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784932|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2784933|NCT04335292|Pemetrexed|pemetrexed|mesh-list
2784934|NCT04335292|Osimertinib|osimertinib|mesh-list
2784935|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784936|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784937|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784938|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2784939|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2784940|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2784941|NCT04335383|Antibodies|antibodies|mesh-list
2784942|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
2784943|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784944|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
2784945|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2784946|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784947|NCT04335123|Losartan|losartan|mesh-list
2784948|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2784949|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2784950|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2784951|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2784952|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784953|NCT04335513|Insulin|insulin|mesh-list
2784954|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2784955|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784956|NCT04335006|Paclitaxel|paclitaxel|mesh-list
2784957|NCT04335006|Apatinib|apatinib|mesh-list
2784958|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2784959|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271803|NCT00199004|Cytarabine|cytarabine|mesh-list
2271804|NCT00199004|Dexamethasone|dexamethasone|mesh-list
2271805|NCT00199004|Prednisolone|prednisolone|mesh-list
2271806|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
2271807|NCT00199004|Rituximab|rituximab|mesh-list
2271808|NCT00199004|Methotrexate|methotrexate|mesh-list
2271809|NCT00199004|Vincristine|vincristine|mesh-list
2271810|NCT00199004|Doxorubicin|doxorubicin|mesh-list
2271811|NCT00199004|Daunorubicin|daunorubicin|mesh-list
2271812|NCT00199004|Asparaginase|asparaginase|mesh-list
2271813|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
2271814|NCT00199004|Thioguanine|thioguanine|mesh-list
2784960|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
2784961|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
2784962|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
2784963|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784964|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2784965|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792200|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2792201|NCT04280562|Acetaminophen|acetaminophen|mesh-list
2792202|NCT04280562|Analgesics|analgesics|mesh-list
2792203|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2792204|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
2792205|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792206|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792207|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
2792208|NCT04280536|Trifluridine|trifluridine|mesh-list
2792209|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
2792210|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792211|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
2792212|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792213|NCT04280406|Azithromycin|azithromycin|mesh-list
2271815|NCT00199004|Vindesine|vindesine|mesh-list
2271816|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2271817|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
2271818|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271819|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2271820|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2271821|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
2271822|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271823|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271824|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2271825|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2271826|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
2271827|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
2271828|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792214|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2792215|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792216|NCT04280289|Cannabidiol|cannabidiol|mesh-list
2792217|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
2792218|NCT04279938|Rituximab|rituximab|mesh-list
2792219|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
2792220|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2792221|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271829|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2271830|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
2271831|NCT00199004|Hormones|hormones|mesh-ancestor
2271832|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2271833|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2271834|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2271835|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2271836|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
2792222|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
2792223|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792224|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2792225|NCT04280263|Caffeine|caffeine|mesh-list
2792226|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2792227|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792228|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2792229|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792230|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792231|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2792232|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2792233|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
2792234|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792235|NCT04280055|Psilocybin|psilocybin|mesh-list
2792236|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
2792237|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792238|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2792239|NCT04279561|Edetic Acid|edetic acid|mesh-list
2792240|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2792241|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
2792242|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
2792243|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792244|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
2792245|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2792246|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2792974|NCT04273776|Suvorexant|suvorexant|mesh-list
2784966|NCT04334993|Blinatumomab|blinatumomab|mesh-list
2784967|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2784968|NCT04335201|Defibrotide|defibrotide|mesh-list
2784969|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2784970|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2784971|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784972|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2271837|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2271838|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2271839|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
2271840|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
2271841|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271842|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2271843|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2784973|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2784974|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2784975|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2784976|NCT04334824|Diuretics|diuretics|mesh-ancestor
2784977|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
2784978|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784979|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2784980|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2271844|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
2271845|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271846|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2784981|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784982|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
2784983|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784984|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
2784985|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
2784986|NCT04334967|Vitamins|vitamins|mesh-ancestor
2784987|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
2784988|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2784989|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
2784990|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2784991|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2784992|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2784993|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2784994|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2784995|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2784996|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
2271847|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
2271848|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
2271849|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
2271850|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2271851|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2271852|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2271853|NCT00199017|Cytarabine|cytarabine|mesh-list
2271854|NCT00199017|Dexamethasone|dexamethasone|mesh-list
2784997|NCT04334967|Protective Agents|protective agents|mesh-ancestor
2784998|NCT04334928|Tenofovir|tenofovir|mesh-list
2784999|NCT04334928|Emtricitabine|emtricitabine|mesh-list
2785000|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2785001|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
2785002|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
2271855|NCT00199017|Prednisolone|prednisolone|mesh-list
2271856|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
2271857|NCT00199017|Methotrexate|methotrexate|mesh-list
2271858|NCT00199017|Vincristine|vincristine|mesh-list
2271859|NCT00199017|Doxorubicin|doxorubicin|mesh-list
2271860|NCT00199017|Daunorubicin|daunorubicin|mesh-list
2271861|NCT00199017|Asparaginase|asparaginase|mesh-list
2271862|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
2271863|NCT00199017|Thioguanine|thioguanine|mesh-list
2271864|NCT00199017|Cladribine|cladribine|mesh-list
2271865|NCT00199017|Vindesine|vindesine|mesh-list
2271866|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2271867|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
2271868|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271869|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2271870|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2785003|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785004|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2785005|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2785006|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271871|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
2271872|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785007|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785008|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2785009|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2785010|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
2785011|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785012|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2785013|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785014|NCT04334863|Tyrphostins|tyrphostins|mesh-list
2785015|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785016|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785017|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785018|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
2785019|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2785020|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785021|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2785022|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2785023|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
2785024|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785025|NCT04334629|Ibuprofen|ibuprofen|mesh-list
2785026|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2785027|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2785028|NCT04334629|Analgesics|analgesics|mesh-ancestor
2785029|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
2785030|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785031|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785032|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2785033|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785034|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2785035|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785036|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785037|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2785038|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785039|NCT04334512|Vitamin D|vitamin d|mesh-list
2785040|NCT04334512|Vitamins|vitamins|mesh-list
2785041|NCT04334512|Ascorbic Acid|ascorbic acid|mesh-list
2785042|NCT04334512|Azithromycin|azithromycin|mesh-list
2785043|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
2785044|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
2271873|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271874|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2271875|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2271876|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
2271877|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
2271878|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271879|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2271880|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
2271881|NCT00199017|Hormones|hormones|mesh-ancestor
2271882|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2271883|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2271884|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2271885|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
2785045|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785046|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2785047|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2785048|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785049|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
2785050|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785051|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2785052|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785053|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785054|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785055|NCT04334512|Antioxidants|antioxidants|mesh-ancestor
2785056|NCT04334512|Protective Agents|protective agents|mesh-ancestor
2785057|NCT04334330|Trastuzumab|trastuzumab|mesh-list
2785058|NCT04334330|Lapatinib|lapatinib|mesh-list
2785059|NCT04334330|Fulvestrant|fulvestrant|mesh-list
2785060|NCT04334330|Palbociclib|palbociclib|mesh-list
2785061|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2271886|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2271887|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2271888|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
2271889|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
2271890|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271891|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2271892|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2785062|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785063|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2785064|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785065|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785066|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2785067|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2785068|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2785069|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
2785070|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2785071|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785072|NCT04334382|Azithromycin|azithromycin|mesh-list
2785073|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
2785074|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2785075|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785076|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
2785077|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785078|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2785079|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785080|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785081|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785082|NCT04334005|Vitamin D|vitamin d|mesh-list
2785083|NCT04334005|Vitamins|vitamins|mesh-ancestor
2785084|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
2785085|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785086|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2785087|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
2785088|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2785089|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785090|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2785091|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785092|NCT04333992|Remifentanil|remifentanil|mesh-list
2785093|NCT04333992|Propofol|propofol|mesh-list
2785094|NCT04333992|Sevoflurane|sevoflurane|mesh-list
2785095|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2785096|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2785097|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785098|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2785099|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
2785100|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
2785101|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2785102|NCT04333992|Narcotics|narcotics|mesh-ancestor
2785103|NCT04333992|Analgesics|analgesics|mesh-ancestor
2785104|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
2785105|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785106|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2785107|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2785108|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
2785109|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
2785110|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785111|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2785112|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785113|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785114|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785115|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2271893|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
2271894|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271895|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2271896|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
2271897|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
2271898|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
2271899|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2271900|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2271901|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2271902|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
2271903|NCT00199030|Cladribine|cladribine|mesh-list
2271904|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2271905|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271906|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2271907|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
2271908|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271909|NCT00199043|Allopurinol|allopurinol|mesh-list
2271910|NCT00199043|Rasburicase|rasburicase|mesh-list
2271911|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
2271912|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271913|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785116|NCT04333628|Chloroquine|chloroquine|mesh-list
2785117|NCT04333628|Amebicides|amebicides|mesh-ancestor
2785118|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785119|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2785120|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785121|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
2271914|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
2785122|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785123|NCT04333550|Deferoxamine|deferoxamine|mesh-list
2785124|NCT04333550|Siderophores|siderophores|mesh-ancestor
2785125|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2785126|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
2785127|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
2785128|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792247|NCT04279054|Morphine|morphine|mesh-list
2792248|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2792249|NCT04279054|Narcotics|narcotics|mesh-ancestor
2271915|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2271916|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2271917|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
2271918|NCT00199043|Protective Agents|protective agents|mesh-ancestor
2271919|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271920|NCT00199056|Cytarabine|cytarabine|mesh-list
2271921|NCT00199056|Dexamethasone|dexamethasone|mesh-list
2271922|NCT00199056|Prednisolone|prednisolone|mesh-list
2271923|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
2271924|NCT00199056|Ifosfamide|ifosfamide|mesh-list
2271925|NCT00199056|Methotrexate|methotrexate|mesh-list
2271926|NCT00199056|Fludarabine|fludarabine|mesh-list
2271927|NCT00199056|Vincristine|vincristine|mesh-list
2271928|NCT00199056|Doxorubicin|doxorubicin|mesh-list
2792250|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792251|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792252|NCT04279054|Analgesics|analgesics|mesh-ancestor
2792253|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
2792254|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792255|NCT04279379|Decitabine|decitabine|mesh-list
2792256|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2792257|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
2792258|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792259|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792260|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792261|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
2792262|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2792263|NCT04279106|Listerine|listerine|mesh-list
2792264|NCT04279106|Fluorides|fluorides|mesh-list
2792265|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
2792266|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
2792267|NCT04279106|Protective Agents|protective agents|mesh-ancestor
2792268|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792269|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2792270|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792271|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
2792272|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
2271929|NCT00199056|Daunorubicin|daunorubicin|mesh-list
2271930|NCT00199056|Asparaginase|asparaginase|mesh-list
2271931|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
2271932|NCT00199056|Idarubicin|idarubicin|mesh-list
2271933|NCT00199056|Thioguanine|thioguanine|mesh-list
2271934|NCT00199056|Vindesine|vindesine|mesh-list
2271935|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2271936|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
2271937|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271938|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2271939|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2271940|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
2792280|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
2792281|NCT04278950|Povidone|povidone|mesh-list
2792282|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
2792283|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
2792284|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2792285|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271941|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271942|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792286|NCT04278729|Apixaban|apixaban|mesh-list
2792287|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2792288|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
2271943|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2271944|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2271945|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
2271946|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
2271947|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2271948|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2785129|NCT04333589|Favipiravir|favipiravir|mesh-list
2785130|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
2785131|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785132|NCT04333459|Vaccines|vaccines|mesh-list
2785133|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
2785134|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785135|NCT04333407|Aspirin|aspirin|mesh-list
2785136|NCT04333407|Omeprazole|omeprazole|mesh-list
2785137|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
2785138|NCT04333407|Clopidogrel|clopidogrel|mesh-list
2785139|NCT04333407|Atorvastatin|atorvastatin|mesh-list
2785140|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2785141|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2785142|NCT04333407|Analgesics|analgesics|mesh-ancestor
2785143|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
2785144|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785145|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785146|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2785147|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785148|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2785149|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2785150|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785151|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2785152|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2785153|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785154|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
2785155|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2785156|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2785157|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
2785158|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2785159|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2785160|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2785161|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2785162|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2785163|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
2785164|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2785165|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2785166|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
2785167|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2785168|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
2785169|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
2785170|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2785171|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2785172|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2785173|NCT04332978|Fluticasone|fluticasone|mesh-list
2785174|NCT04332978|Xhance|xhance|mesh-list
2785175|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2785176|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2785177|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
2785178|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785179|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785180|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2785181|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
2785182|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
2785183|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2785184|NCT04332874|Dactinomycin|dactinomycin|mesh-list
2785185|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
2785186|NCT04332874|Melphalan|melphalan|mesh-list
2271949|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
2271950|NCT00199056|Hormones|hormones|mesh-ancestor
2271951|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2271952|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2271953|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2271954|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
2271955|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2271956|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2271957|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
2271958|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
2271959|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785187|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2785188|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2271960|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2271961|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2271962|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
2271963|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2271964|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2271965|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
2271966|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
2271967|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
2271968|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2271969|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2271970|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2271971|NCT00199069|Cytarabine|cytarabine|mesh-list
2271972|NCT00199069|Dexamethasone|dexamethasone|mesh-list
2271973|NCT00199069|Prednisolone|prednisolone|mesh-list
2271974|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
2271975|NCT00199069|Ifosfamide|ifosfamide|mesh-list
2271976|NCT00199069|Methotrexate|methotrexate|mesh-list
2271977|NCT00199069|Vincristine|vincristine|mesh-list
2271978|NCT00199069|Doxorubicin|doxorubicin|mesh-list
2271979|NCT00199069|Daunorubicin|daunorubicin|mesh-list
2271980|NCT00199069|Asparaginase|asparaginase|mesh-list
2271981|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
2271982|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
2271983|NCT00199069|Thioguanine|thioguanine|mesh-list
2271984|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2271985|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
2271986|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271987|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2271988|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2271989|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
2271990|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2271991|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785189|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2785190|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
2785191|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785192|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2785193|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2785194|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
2785195|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2271992|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2271993|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2271994|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
2271995|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
2271996|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785196|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2785197|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785198|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2785199|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2785200|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2271997|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2271998|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
2271999|NCT00199069|Hormones|hormones|mesh-ancestor
2272000|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2785201|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2785202|NCT04333095|Bupivacaine|bupivacaine|mesh-list
2785203|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
2785204|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
2785205|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2785206|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785207|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
2785208|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785209|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
2785210|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2102646|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
2102647|NCT02412228|Ixazomib|ixazomib|mesh-list
2102648|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2102649|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
2102650|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102651|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785211|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785212|NCT04333160|Hylan|hylan|mesh-list
2785213|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
2785214|NCT04333160|Protective Agents|protective agents|mesh-ancestor
2102652|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2102653|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
2102654|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102655|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102656|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2272001|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2272002|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2272003|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
2272004|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2785215|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785216|NCT04332744|Talazoparib|talazoparib|mesh-list
2785217|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2785218|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785219|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785220|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785221|NCT04332627|Neostigmine|neostigmine|mesh-list
2785222|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2785223|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785224|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785225|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
2785226|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2785227|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785228|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2785229|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
2785230|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785231|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
2785232|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2785233|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785234|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2785235|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2785236|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
2785237|NCT04332536|Codeine|codeine|mesh-list
2785238|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2785239|NCT04332536|Narcotics|narcotics|mesh-ancestor
2785240|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2785241|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785242|NCT04332536|Analgesics|analgesics|mesh-ancestor
2785243|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
2785244|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785245|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
2785246|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
2102657|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102658|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
2102659|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
2102660|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102661|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2102662|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
2102663|NCT02412228|Hormones|hormones|mesh-ancestor
2102664|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102665|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102666|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
2102667|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102668|NCT02412306|Blinatumomab|blinatumomab|mesh-list
2102669|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102670|NCT02412371|Paclitaxel|paclitaxel|mesh-list
2102671|NCT02412371|Carboplatin|carboplatin|mesh-list
2102672|NCT02412371|Veliparib|veliparib|mesh-list
2102673|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2102674|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102675|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
2102676|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
2102677|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
2102678|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102679|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2102680|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785247|NCT04332809|Gentamicins|gentamicins|mesh-list
2785248|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2785249|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785250|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2785251|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785252|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785253|NCT04332367|Paclitaxel|paclitaxel|mesh-list
2785254|NCT04332367|Carboplatin|carboplatin|mesh-list
2785255|NCT04332367|Ramucirumab|ramucirumab|mesh-list
2785256|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2785257|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785258|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
2785259|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
2785260|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
2272005|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2272006|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
2272007|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
2785261|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785262|NCT04332276|Dopamine|dopamine|mesh-list
2785263|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2785264|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
2785265|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
2785266|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785267|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785268|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
2785269|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272008|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272009|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2272010|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2272011|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
2272012|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272013|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2272014|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
2272015|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
2272016|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
2272017|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2272018|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2272019|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2785270|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785271|NCT04332276|Protective Agents|protective agents|mesh-ancestor
2785272|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
2785273|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785274|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2785275|NCT04332289|Protective Agents|protective agents|mesh-ancestor
2785276|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785277|NCT04332497|Ibuprofen|ibuprofen|mesh-list
2785278|NCT04332497|Fentanyl|fentanyl|mesh-list
2785279|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2785280|NCT04332497|Narcotics|narcotics|mesh-ancestor
2272020|NCT00199069|Analgesics|analgesics|mesh-ancestor
2272021|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
2272022|NCT00199082|Cytarabine|cytarabine|mesh-list
2272023|NCT00199082|Dexamethasone|dexamethasone|mesh-list
2272024|NCT00199082|Prednisolone|prednisolone|mesh-list
2272025|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
2272026|NCT00199082|Ifosfamide|ifosfamide|mesh-list
2272027|NCT00199082|Rituximab|rituximab|mesh-list
2272028|NCT00199082|Methotrexate|methotrexate|mesh-list
2272029|NCT00199082|Vincristine|vincristine|mesh-list
2272030|NCT00199082|Doxorubicin|doxorubicin|mesh-list
2785281|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2785282|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785283|NCT04332497|Analgesics|analgesics|mesh-ancestor
2785284|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
2785285|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272031|NCT00199082|Vindesine|vindesine|mesh-list
2272032|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2272033|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
2272034|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272035|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2272036|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2272037|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
2272038|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272039|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272040|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2272041|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2785286|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2785287|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2785288|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
2785289|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
2785290|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2785291|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2785292|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2785293|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785294|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2785295|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785296|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785297|NCT04332341|Niacinamide|niacinamide|mesh-list
2785298|NCT04332341|Niacin|niacin|mesh-list
2272042|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
2272043|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
2272044|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272045|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2272046|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
2272047|NCT00199082|Hormones|hormones|mesh-ancestor
2272048|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2272049|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102681|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2102682|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
2102683|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2102684|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2102685|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2272050|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2272051|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2272052|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
2272053|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2272054|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2785299|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
2785300|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
2785301|NCT04332341|Vitamins|vitamins|mesh-ancestor
2785302|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
2785303|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785304|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2785305|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
2785306|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785307|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2785308|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
2785309|NCT04332042|Tofacitinib|tofacitinib|mesh-list
2785310|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2785311|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785312|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272055|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
2272056|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
2272057|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272058|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2272059|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2272060|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
2785328|NCT04332393|Metformin|metformin|mesh-list
2785329|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2785330|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785331|NCT04331938|Anesthetics|anesthetics|mesh-list
2785332|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2785333|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785334|NCT04332094|Azithromycin|azithromycin|mesh-list
2785335|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
2785336|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2785337|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785338|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
2785339|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785340|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2785341|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785342|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785343|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2102686|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
2102687|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2102688|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102689|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2785350|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
2785351|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
2785352|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785353|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2785354|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785355|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785356|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785357|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785358|NCT04331652|Anesthetics|anesthetics|mesh-list
2785359|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2785360|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785361|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
2785362|NCT04331743|Analgesics|analgesics|mesh-ancestor
2785363|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
2785364|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785365|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785366|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785367|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2785368|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2785369|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785370|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792289|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2792290|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
2792291|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792292|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792293|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
2792294|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2792295|NCT04278651|Hematinics|hematinics|mesh-ancestor
2792296|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2792297|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2792298|NCT04278859|Antibodies|antibodies|mesh-list
2792299|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2792300|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
2792301|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792302|NCT04278703|Oxycodone|oxycodone|mesh-list
2792303|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2272061|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272062|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2272063|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
2272064|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
2272065|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
2272066|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2272067|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2272068|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2272069|NCT00199095|Cytarabine|cytarabine|mesh-list
2272070|NCT00199095|Dexamethasone|dexamethasone|mesh-list
2272071|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
2272072|NCT00199095|Ifosfamide|ifosfamide|mesh-list
2792304|NCT04278703|Narcotics|narcotics|mesh-ancestor
2792305|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792306|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792307|NCT04278703|Analgesics|analgesics|mesh-ancestor
2792308|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
2792309|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792310|NCT04278807|Anesthetics|anesthetics|mesh-list
2792311|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2272073|NCT00199095|Methotrexate|methotrexate|mesh-list
2272074|NCT00199095|Vincristine|vincristine|mesh-list
2272075|NCT00199095|Doxorubicin|doxorubicin|mesh-list
2272076|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
2272077|NCT00199095|Idarubicin|idarubicin|mesh-list
2272078|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2272079|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
2272080|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272081|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2272082|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2272083|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
2272084|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272085|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272086|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2272087|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2792312|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792313|NCT04278677|Melatonin|melatonin|mesh-list
2792314|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
2792975|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2272088|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
2785371|NCT04331730|Aflibercept|aflibercept|mesh-list
2785372|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2785373|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2785374|NCT04331730|Growth Substances|growth substances|mesh-ancestor
2785375|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785376|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
2785377|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785378|NCT04331626|Gemcitabine|gemcitabine|mesh-list
2785379|NCT04331626|Nivolumab|nivolumab|mesh-list
2785380|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2785381|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
2785382|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785383|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785384|NCT04331626|Antiviral Agents|antiviral agents|mesh-ancestor
2785385|NCT04331626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785386|NCT04331626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785387|NCT04331626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2785388|NCT04331626|Immunologic Factors|immunologic factors|mesh-ancestor
2785389|NCT04331626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785390|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2785391|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2785392|NCT04331691|Amiloride|amiloride|mesh-list
2785393|NCT04331691|Spironolactone|spironolactone|mesh-list
2785394|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2785395|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
2785396|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2785397|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785398|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2272089|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
2272090|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272091|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2785399|NCT04331691|Diuretics|diuretics|mesh-ancestor
2785400|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
2785401|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2785402|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2785403|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2785404|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785405|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2785406|NCT04331600|Chloroquine|chloroquine|mesh-list
2785407|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2785408|NCT04331600|Amebicides|amebicides|mesh-ancestor
2785409|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785410|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2785411|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785412|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
2785413|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785414|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2785415|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2785416|NCT04331600|Analgesics|analgesics|mesh-ancestor
2785417|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
2785418|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785419|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785420|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2785421|NCT04331600|Filaricides|filaricides|mesh-ancestor
2785422|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
2785423|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
2785424|NCT04331639|Vitamin D|vitamin d|mesh-list
2785425|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
2785426|NCT04331639|Vitamins|vitamins|mesh-ancestor
2785427|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
2785428|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785429|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2785430|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2785441|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
2785442|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2785443|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2785444|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785445|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2785446|NCT04331418|Analgesics|analgesics|mesh-ancestor
2785447|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
2785448|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785449|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2785450|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2785451|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2785452|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
2785453|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2785454|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272092|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
2272093|NCT00199095|Hormones|hormones|mesh-ancestor
2272094|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2272095|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2272096|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2272097|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
2272098|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2272099|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2272100|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
2272101|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
2272102|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272103|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2272104|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2272105|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
2272106|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785456|NCT04331470|Ritonavir|ritonavir|mesh-list
2785457|NCT04331470|Lopinavir|lopinavir|mesh-list
2785458|NCT04331470|Chloroquine|chloroquine|mesh-list
2785459|NCT04331470|Levamisole|levamisole|mesh-list
2785460|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
2785461|NCT04331470|Budesonide|budesonide|mesh-list
2785462|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
2785463|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2785464|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2785465|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
2272107|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2272108|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
2272109|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
2272110|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
2272111|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2272112|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2272113|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2272114|NCT00199108|Dexamethasone|dexamethasone|mesh-list
2272115|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2272116|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
2272117|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
2272118|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272119|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272120|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2272121|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
2272122|NCT00199108|Hormones|hormones|mesh-ancestor
2785466|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785467|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785468|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2785469|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2785470|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
2785471|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785472|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2785473|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2785474|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2785475|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2785476|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
2785477|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785478|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785479|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2785480|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
2785481|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
2785482|NCT04331470|Hormones|hormones|mesh-ancestor
2785483|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2785484|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2272123|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2785485|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2785486|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2785487|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
2785488|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2785489|NCT04331470|Amebicides|amebicides|mesh-ancestor
2785490|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785491|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2785492|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
2785493|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785494|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
2785495|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
2785496|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2785497|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
2785498|NCT04331327|Mitogens|mitogens|mesh-list
2785499|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
2272124|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2272125|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272126|NCT00199121|Zidovudine|zidovudine|mesh-list
2272127|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
2272128|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272129|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2272130|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2272131|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272132|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
2272133|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272134|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2272135|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2272136|NCT00199134|Letrozole|letrozole|mesh-list
2272137|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785500|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785506|NCT04331197|Letrozole|letrozole|mesh-list
2785507|NCT04331197|Clomiphene|clomiphene|mesh-list
2785508|NCT04331197|Enclomiphene|enclomiphene|mesh-list
2785509|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
2785510|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785511|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272138|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2272139|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2272140|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272141|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272142|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2272143|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
2272144|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2272145|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272146|NCT00199147|Cytarabine|cytarabine|mesh-list
2272147|NCT00199147|Fludarabine|fludarabine|mesh-list
2272148|NCT00199147|Etoposide|etoposide|mesh-list
2272149|NCT00199147|Idarubicin|idarubicin|mesh-list
2272150|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272151|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2272152|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
2272153|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272154|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2272155|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
2785512|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2785513|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2785514|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785515|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2785516|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
2785517|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2785518|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785519|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2785520|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
2785521|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2785522|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2785523|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2785524|NCT04331210|Diclofenac|diclofenac|mesh-list
2785525|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2785526|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2785527|NCT04331210|Analgesics|analgesics|mesh-ancestor
2785528|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
2272156|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272157|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2272158|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2272159|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2272160|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272161|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
2272162|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272163|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2272164|NCT00199160|Sorafenib|sorafenib|mesh-list
2272165|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272166|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2272167|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272168|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272169|NCT00199186|Cytarabine|cytarabine|mesh-list
2272170|NCT00199186|Dexamethasone|dexamethasone|mesh-list
2272171|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
2272172|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
2272173|NCT00199186|Methotrexate|methotrexate|mesh-list
2272174|NCT00199186|Vincristine|vincristine|mesh-list
2272175|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
2272176|NCT00199186|Idarubicin|idarubicin|mesh-list
2272177|NCT00199186|BB 1101|bb 1101|mesh-list
2272178|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2272179|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
2272180|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272181|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2272182|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2785529|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785530|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785531|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2785532|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785533|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2785534|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785535|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785536|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2785537|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2785538|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
2785539|NCT04331145|Ticagrelor|ticagrelor|mesh-list
2785540|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2785541|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2785542|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2785543|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2785544|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
2785545|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2785546|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785547|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785548|NCT04331132|Tolvaptan|tolvaptan|mesh-list
2272183|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
2272184|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272185|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272186|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2272187|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2272188|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
2272189|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
2272190|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272191|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2272192|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
2272193|NCT00199186|Hormones|hormones|mesh-ancestor
2272194|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2272195|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2272196|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
2272197|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272198|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2272199|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
2272200|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2272201|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2272202|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
2272203|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
2272204|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2272205|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2272206|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2272207|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
2272208|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
2272209|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
2785549|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2785550|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785551|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
2785552|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785553|NCT04330872|Aspirin|aspirin|mesh-list
2785554|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2785555|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2785556|NCT04330872|Analgesics|analgesics|mesh-ancestor
2785557|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
2785558|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785559|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785560|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2785561|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785562|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2785563|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2785564|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785565|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2785566|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2785567|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785568|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
2785569|NCT04330820|Venetoclax|venetoclax|mesh-list
2785570|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785571|NCT04331093|Apatinib|apatinib|mesh-list
2785572|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785573|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2785574|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785575|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785576|NCT04330729|Aspirin|aspirin|mesh-list
2785577|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2785578|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2785579|NCT04330729|Analgesics|analgesics|mesh-ancestor
2785580|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
2785581|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785582|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785583|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2785584|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785585|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2785586|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2785587|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785588|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2785589|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2785590|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272210|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
2272211|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272212|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2272213|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2272214|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2272215|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2272216|NCT00199212|Trastuzumab|trastuzumab|mesh-list
2785591|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
2785592|NCT04330690|Interferons|interferons|mesh-list
2785593|NCT04330690|Interferon-beta|interferon-beta|mesh-list
2785594|NCT04330690|Interferon beta-1a|interferon beta-1a|mesh-list
2785595|NCT04330690|Remdesivir|remdesivir|mesh-list
2785596|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785597|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
2785598|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785599|NCT04330690|Immunologic Factors|immunologic factors|mesh-ancestor
2785600|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785601|NCT04330690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2785602|NCT04330690|Antimetabolites|antimetabolites|mesh-ancestor
2785603|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785604|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
2785605|NCT04330755|Simendan|simendan|mesh-list
2785606|NCT04330755|Analgesics|analgesics|mesh-ancestor
2785607|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
2785608|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785609|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785610|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
2785611|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2785612|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2785613|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
2785614|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2785615|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2792976|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2272217|NCT00199212|Bortezomib|bortezomib|mesh-list
2272218|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2272219|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272220|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
2272221|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2272222|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272223|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2272224|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2272225|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272226|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272227|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272228|NCT00199238|Histamine|histamine|mesh-list
2272229|NCT00199238|Histamine Antagonists|histamine antagonists|mesh-list
2272230|NCT00199238|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2272231|NCT00199238|Histamine Agonists|histamine agonists|mesh-ancestor
2272232|NCT00199238|Histamine Agents|histamine agents|mesh-ancestor
2272233|NCT00199238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272234|NCT00199238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272235|NCT00199238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272236|NCT00199264|Albaconazole|albaconazole|mesh-list
2272237|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
2272238|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272239|NCT00199277|Iron|iron|mesh-list
2272240|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2272241|NCT00199277|Trace Elements|trace elements|mesh-ancestor
2272242|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
2272243|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272244|NCT00199277|Hematinics|hematinics|mesh-ancestor
2272245|NCT00199316|Morphine|morphine|mesh-list
2272246|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2272247|NCT00199316|Narcotics|narcotics|mesh-ancestor
2785616|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785617|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2785618|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
2785619|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2785620|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2785621|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
2785622|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2785623|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2785624|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785625|NCT04330755|Protective Agents|protective agents|mesh-ancestor
2785626|NCT04330300|Losartan|losartan|mesh-list
2785627|NCT04330300|Verapamil|verapamil|mesh-list
2785628|NCT04330300|Felodipine|felodipine|mesh-list
2785629|NCT04330300|Amlodipine|amlodipine|mesh-list
2785630|NCT04330300|Valsartan|valsartan|mesh-list
2785631|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2785632|NCT04330300|Telmisartan|telmisartan|mesh-list
2785633|NCT04330300|Candesartan|candesartan|mesh-list
2785634|NCT04330300|Ramipril|ramipril|mesh-list
2785635|NCT04330300|Olmesartan|olmesartan|mesh-list
2785636|NCT04330300|Enalapril|enalapril|mesh-list
2785637|NCT04330300|Lisinopril|lisinopril|mesh-list
2785638|NCT04330300|Irbesartan|irbesartan|mesh-list
2785639|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
2785640|NCT04330300|Diltiazem|diltiazem|mesh-list
2785641|NCT04330300|Perindopril|perindopril|mesh-list
2785642|NCT04330300|Benazepril|benazepril|mesh-list
2785643|NCT04330300|Captopril|captopril|mesh-list
2785644|NCT04330300|Indapamide|indapamide|mesh-list
2785645|NCT04330300|Nicardipine|nicardipine|mesh-list
2785646|NCT04330300|Nimodipine|nimodipine|mesh-list
2785647|NCT04330300|Quinapril|quinapril|mesh-list
2785648|NCT04330300|Trandolapril|trandolapril|mesh-list
2785649|NCT04330300|Metolazone|metolazone|mesh-list
2272248|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2272249|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272250|NCT00199316|Analgesics|analgesics|mesh-ancestor
2272251|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
2272252|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272253|NCT00199329|Ondansetron|ondansetron|mesh-list
2272254|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
2272255|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
2272256|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272257|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272258|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2785650|NCT04330300|Fosinopril|fosinopril|mesh-list
2785651|NCT04330300|Eprosartan|eprosartan|mesh-list
2785652|NCT04330300|Nitrendipine|nitrendipine|mesh-list
2785653|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
2785654|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
2785655|NCT04330300|Nifedipine|nifedipine|mesh-list
2785656|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
2785657|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2272259|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
2272260|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
2272261|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2272262|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
2272263|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272264|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272265|NCT00199329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2272266|NCT00199329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2272267|NCT00199329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2272268|NCT00199329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2272269|NCT00199329|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2272270|NCT00199342|Ecromeximab|ecromeximab|mesh-list
2272271|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2272272|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272273|NCT00199355|Istradefylline|istradefylline|mesh-list
2272274|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2272275|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2272276|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2272277|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
2272278|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272279|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272280|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785658|NCT04330300|Diuretics|diuretics|mesh-list
2785659|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2785660|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2785661|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785662|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2785663|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2785664|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785665|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
2272281|NCT00199368|Istradefylline|istradefylline|mesh-list
2272282|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2272283|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2272284|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2272285|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
2272286|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272287|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272288|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272289|NCT00199394|Istradefylline|istradefylline|mesh-list
2272290|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2272291|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2272292|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2272293|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
2785666|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2785667|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2785668|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
2785669|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2785670|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
2785671|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785672|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
2785673|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2785674|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2785675|NCT04330300|Protective Agents|protective agents|mesh-ancestor
2785676|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
2785677|NCT04330547|Analgesics|analgesics|mesh-list
2785678|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
2785679|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785680|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785681|NCT04330586|Ciclesonide|ciclesonide|mesh-list
2785682|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
2785683|NCT04330586|Hormones|hormones|mesh-ancestor
2785684|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2785685|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785686|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2785687|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2785688|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
2785689|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
2785690|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
2785691|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785692|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2785693|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785694|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785695|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785696|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785697|NCT04330430|Nivolumab|nivolumab|mesh-list
2785698|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2785699|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785700|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2785701|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785702|NCT04330677|Oxytocin|oxytocin|mesh-list
2785703|NCT04330677|Estrogens|estrogens|mesh-list
2785704|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
2785705|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2785706|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785707|NCT04330677|Hormones|hormones|mesh-ancestor
2785708|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2785709|NCT04330248|Rifampin|rifampin|mesh-list
2785710|NCT04330248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2785711|NCT04330248|Antitubercular Agents|antitubercular agents|mesh-ancestor
2785712|NCT04330248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2785713|NCT04330248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785714|NCT04330248|Leprostatic Agents|leprostatic agents|mesh-ancestor
2785715|NCT04330248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2785716|NCT04330248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785717|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785718|NCT04330248|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2785719|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2785720|NCT04330248|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2785721|NCT04330248|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2272294|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272295|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272296|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272297|NCT00199407|Istradefylline|istradefylline|mesh-list
2272298|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2272299|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2272300|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2272301|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
2272302|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2785722|NCT04330248|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2785723|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2785724|NCT04330027|Mitogens|mitogens|mesh-list
2785725|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
2785726|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792315|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792316|NCT04278677|Protective Agents|protective agents|mesh-ancestor
2792317|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792318|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792319|NCT04278625|Acetaminophen|acetaminophen|mesh-list
2792320|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2792321|NCT04278625|Analgesics|analgesics|mesh-ancestor
2792322|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
2272303|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272304|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272305|NCT00199420|Istradefylline|istradefylline|mesh-list
2272306|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2272307|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2272308|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2272309|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
2272310|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792323|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792324|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792325|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
2792326|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
2792327|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2792328|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
2792329|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792330|NCT04278898|Expectorants|expectorants|mesh-ancestor
2272311|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792331|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
2792332|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2792333|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
2792334|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792335|NCT04278898|Protective Agents|protective agents|mesh-ancestor
2785727|NCT04330638|Siltuximab|siltuximab|mesh-list
2785728|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2785729|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785730|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785731|NCT04330326|Sorbitol|sorbitol|mesh-list
2785732|NCT04330326|Cathartics|cathartics|mesh-ancestor
2785733|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2785734|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
2785735|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2785736|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785737|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2785738|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785739|NCT04329624|Simendan|simendan|mesh-list
2785740|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2785741|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
2785742|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2785743|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2785744|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785745|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785746|NCT04329624|Protective Agents|protective agents|mesh-ancestor
2785747|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785748|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
2785749|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
2785750|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785751|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2785752|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785753|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785754|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785755|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785756|NCT04329650|Methylprednisolone|methylprednisolone|mesh-list
2785757|NCT04329650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2272312|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272313|NCT00199433|Istradefylline|istradefylline|mesh-list
2272314|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2272315|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2272316|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2272317|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
2272318|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2785758|NCT04329650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2785759|NCT04329650|Prednisolone|prednisolone|mesh-list
2785760|NCT04329650|Prednisolone acetate|prednisolone acetate|mesh-list
2785761|NCT04329650|Siltuximab|siltuximab|mesh-list
2785762|NCT04329650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2785763|NCT04329650|Prednisolone phosphate|prednisolone phosphate|mesh-list
2785764|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2785765|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
2785766|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
2785767|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785768|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785769|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2785770|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
2785771|NCT04329650|Hormones|hormones|mesh-ancestor
2785772|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2785773|NCT04329650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2785774|NCT04329650|Protective Agents|protective agents|mesh-ancestor
2785775|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2785776|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785777|NCT04329832|Azithromycin|azithromycin|mesh-list
2785778|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
2785779|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2785780|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785781|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
2785782|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785783|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2785784|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785785|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785786|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785787|NCT04329949|Paclitaxel|paclitaxel|mesh-list
2785788|NCT04329949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2785789|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2785790|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272319|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272320|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272321|NCT00199446|Istradefylline|istradefylline|mesh-list
2785791|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
2785792|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
2785793|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
2785794|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785795|NCT04329858|Methamphetamine|methamphetamine|mesh-list
2785796|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2785797|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785798|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
2785799|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
2785800|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785801|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
2785802|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2785803|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785804|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
2785805|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2785806|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2785807|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2785808|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2785809|NCT04329806|Amlodipine|amlodipine|mesh-list
2785810|NCT04329806|Moxonidine|moxonidine|mesh-list
2785811|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2785812|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2785813|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2785814|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785815|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2785816|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785817|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
2785818|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
2785819|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
2785820|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785821|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2272322|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2272323|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2272324|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2272325|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
2272326|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272327|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272328|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272329|NCT00199472|Diuretics|diuretics|mesh-list
2272330|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
2272331|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785822|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785823|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785824|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785825|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785826|NCT04329585|Flumazenil|flumazenil|mesh-list
2785827|NCT04329585|Antidotes|antidotes|mesh-ancestor
2785828|NCT04329585|Protective Agents|protective agents|mesh-ancestor
2785829|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785830|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
2785831|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
2785832|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2785833|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785834|NCT04329572|Azithromycin|azithromycin|mesh-list
2785835|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
2785836|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2785837|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785838|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
2785839|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785840|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2272332|NCT00199511|Mannitol|mannitol|mesh-list
2272333|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2272334|NCT00199511|Diuretics|diuretics|mesh-ancestor
2272335|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
2785841|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785842|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785843|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785844|NCT04329494|Leucovorin|leucovorin|mesh-list
2785845|NCT04329494|Cisplatin|cisplatin|mesh-list
2785846|NCT04329494|Doxorubicin|doxorubicin|mesh-list
2785847|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2785848|NCT04329494|Fluorouracil|fluorouracil|mesh-list
2785849|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
2785850|NCT04329494|Daunorubicin|daunorubicin|mesh-list
2785851|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785852|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2785853|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2785854|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2785855|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785856|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785857|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
2785858|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2785859|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2785860|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
2785861|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785862|NCT04329494|Antidotes|antidotes|mesh-ancestor
2785863|NCT04329494|Protective Agents|protective agents|mesh-ancestor
2785864|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
2785865|NCT04329494|Vitamins|vitamins|mesh-ancestor
2272336|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272337|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
2272338|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
2272339|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2272340|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2272341|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272342|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785866|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
2785867|NCT04329403|Adapalene|adapalene|mesh-list
2785868|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2272343|NCT00199563|Urological Agents|urological agents|mesh-ancestor
2272344|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
2272345|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2272346|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2272347|NCT00199576|Prednisolone|prednisolone|mesh-list
2272348|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
2272349|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2272350|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
2272351|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2272352|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
2272353|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
2272354|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272355|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272356|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2272357|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
2272358|NCT00199576|Hormones|hormones|mesh-ancestor
2272359|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2272360|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2272361|NCT00199576|Protective Agents|protective agents|mesh-ancestor
2272362|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2272363|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272364|NCT00199602|Heparin|heparin|mesh-list
2272365|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
2272366|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2785869|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2785870|NCT04329403|Analgesics|analgesics|mesh-ancestor
2785871|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
2785872|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785873|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785874|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2785875|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2272367|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2272368|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272369|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
2785876|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
2785877|NCT04329390|Anticoagulants|anticoagulants|mesh-list
2785878|NCT04329442|Tenofovir|tenofovir|mesh-list
2785879|NCT04329442|Emtricitabine|emtricitabine|mesh-list
2785880|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
2785881|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785882|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2272370|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2272371|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272372|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2272373|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
2785883|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2785884|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785885|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785886|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2785887|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2785888|NCT04329039|Somatostatin|somatostatin|mesh-list
2785889|NCT04329039|Hormones|hormones|mesh-ancestor
2785890|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2785891|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785892|NCT04329130|Lenalidomide|lenalidomide|mesh-list
2785893|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
2785894|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785895|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2785896|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2785897|NCT04329130|Growth Substances|growth substances|mesh-ancestor
2785898|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
2785899|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785900|NCT04329429|Trastuzumab|trastuzumab|mesh-list
2785901|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2785902|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2785903|NCT04329221|Calcitriol|calcitriol|mesh-list
2785904|NCT04329221|Fluorouracil|fluorouracil|mesh-list
2785905|NCT04329221|Calcipotriene|calcipotriene|mesh-list
2785906|NCT04329221|Petrolatum|petrolatum|mesh-list
2785907|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
2785908|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785909|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2785910|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272374|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2272375|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272376|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272377|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272378|NCT00199719|Ribavirin|ribavirin|mesh-list
2272379|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
2272380|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272381|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
2272382|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272383|NCT00199745|Atorvastatin|atorvastatin|mesh-list
2272384|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2272385|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2272386|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
2272387|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272388|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2272389|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2272390|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272391|NCT00199758|Gemcitabine|gemcitabine|mesh-list
2272392|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272393|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2785911|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2785912|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
2785913|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785914|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
2785915|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2785916|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2272394|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
2272395|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272396|NCT00199758|Antiviral Agents|antiviral agents|mesh-ancestor
2272397|NCT00199758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272398|NCT00199758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272399|NCT00199758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2272400|NCT00199758|Immunologic Factors|immunologic factors|mesh-ancestor
2272401|NCT00199758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272402|NCT00199771|Dextrans|dextrans|mesh-list
2272403|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
2272404|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
2272405|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
2272406|NCT00199784|Phenylephrine|phenylephrine|mesh-list
2785917|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2785918|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2785919|NCT04329221|Vitamins|vitamins|mesh-ancestor
2785920|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
2785921|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2785922|NCT04329221|Emollients|emollients|mesh-ancestor
2785923|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
2785924|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2785925|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2785926|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785927|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2785928|NCT04329091|Analgesics|analgesics|mesh-ancestor
2785929|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
2785930|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272407|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
2785931|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2785932|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2272408|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2272409|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
2785933|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2785934|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
2785935|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2785936|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785937|NCT04328870|Oxytocin|oxytocin|mesh-list
2785938|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785939|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
2785940|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2785941|NCT04328805|Ibuprofen|ibuprofen|mesh-list
2785942|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2785943|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2785944|NCT04328805|Analgesics|analgesics|mesh-ancestor
2785945|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
2785946|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785947|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785948|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2272410|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
2272411|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272412|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272413|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
2272414|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2272415|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
2272416|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
2785949|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785950|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2785951|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785952|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272417|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2272418|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2272419|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2272420|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
2272421|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272422|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272423|NCT00199784|Protective Agents|protective agents|mesh-ancestor
2272424|NCT00199862|Antibodies|antibodies|mesh-list
2272425|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
2272426|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272427|NCT00199940|Ziprasidone|ziprasidone|mesh-list
2272428|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2272429|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
2272430|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272431|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272432|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272433|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2272434|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2272435|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2272436|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2272437|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2272438|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
2785953|NCT04329000|Esomeprazole|esomeprazole|mesh-list
2785954|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2785955|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2785956|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2785957|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785958|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785959|NCT04328883|Aspirin|aspirin|mesh-list
2785960|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2785961|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2785962|NCT04328883|Analgesics|analgesics|mesh-ancestor
2785963|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
2785964|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785965|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785966|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2785967|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2785968|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2785969|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2785970|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785971|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2272439|NCT00199953|Rabeprazole|rabeprazole|mesh-list
2272440|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2272441|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2272442|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2785972|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2785973|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2785974|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
2785975|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
2785976|NCT04328636|Analgesics|analgesics|mesh-ancestor
2785977|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
2785978|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2785979|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2785980|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
2785981|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2272443|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272444|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272445|NCT00199966|Valproic Acid|valproic acid|mesh-list
2272446|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
2272447|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272448|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272449|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
2102690|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2102691|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2102692|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102693|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102694|NCT02412631|Varenicline|varenicline|mesh-list
2102695|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2102696|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2102697|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
2785982|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2785983|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
2785984|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2785985|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2785986|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2785987|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2785988|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
2785989|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2785990|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
2785991|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2272450|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272451|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272452|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
2785992|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2785993|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
2785994|NCT04328493|Chloroquine|chloroquine|mesh-list
2785995|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2785996|NCT04328493|Amebicides|amebicides|mesh-ancestor
2785997|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2785998|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2785999|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786000|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
2786001|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786002|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2786003|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2786004|NCT04328493|Analgesics|analgesics|mesh-ancestor
2786005|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
2786006|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786007|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786008|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786009|NCT04328493|Filaricides|filaricides|mesh-ancestor
2786010|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
2786011|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
2792336|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272453|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2272454|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2272455|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2272456|NCT00199979|Nevirapine|nevirapine|mesh-list
2272457|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2272458|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2272459|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272460|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272461|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
2272462|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272463|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2272464|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2792337|NCT04278898|Antidotes|antidotes|mesh-ancestor
2792338|NCT04278833|Dexamethasone|dexamethasone|mesh-list
2792339|NCT04278833|Triamcinolone|triamcinolone|mesh-list
2792340|NCT04278833|Betamethasone|betamethasone|mesh-list
2792341|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2792342|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
2786012|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
2786013|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2786014|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
2786015|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786016|NCT04328285|Ritonavir|ritonavir|mesh-list
2786017|NCT04328285|Lopinavir|lopinavir|mesh-list
2786018|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
2786019|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2786020|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2786021|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
2786022|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786023|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786024|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2272465|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2272466|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2272467|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2272468|NCT00200174|Exemestane|exemestane|mesh-list
2272469|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272470|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2272471|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2272472|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272473|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272474|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2272475|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
2272476|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2272477|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272478|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2272479|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2272480|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2272481|NCT00200187|Anesthetics|anesthetics|mesh-list
2272482|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2272483|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272484|NCT00200200|Bevacizumab|bevacizumab|mesh-list
2786025|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2786026|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
2786027|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786028|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2786029|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2786030|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
2786031|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2786032|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2786033|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786034|NCT04328480|Colchicine|colchicine|mesh-list
2786035|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
2786036|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786037|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
2786038|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
2786039|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
2786040|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786041|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786042|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2786043|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2786044|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2786045|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2786046|NCT04328272|Azithromycin|azithromycin|mesh-list
2786047|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
2786048|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2786049|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786050|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
2786051|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2786052|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2786053|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786054|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786055|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786056|NCT04328194|Thrombin|thrombin|mesh-list
2786057|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
2786058|NCT04328194|Coagulants|coagulants|mesh-ancestor
2786059|NCT04328012|Losartan|losartan|mesh-list
2786060|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2786061|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2786062|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2786063|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2786064|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786065|NCT04327791|Baloxavir|baloxavir|mesh-list
2786066|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
2786067|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786068|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786069|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786070|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
2786071|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2786072|NCT04327934|Testosterone|testosterone|mesh-list
2786073|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
2786074|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
2786075|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2786076|NCT04327934|Hormones|hormones|mesh-ancestor
2786077|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786078|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786079|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2786080|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786081|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
2786082|NCT04327934|Androgens|androgens|mesh-ancestor
2786083|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
2786084|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2786085|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
2786086|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786087|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
2786088|NCT04327947|Protective Agents|protective agents|mesh-ancestor
2786089|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
2786090|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2786091|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2786092|NCT04328064|Calcium|calcium|mesh-list
2786093|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2786094|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786095|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2786096|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2786097|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
2786098|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786099|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2786100|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2786101|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786105|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
2786106|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2786107|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2786108|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786109|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2786110|NCT04327726|Analgesics|analgesics|mesh-ancestor
2786111|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
2786112|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786113|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2786114|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2786115|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2786116|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
2786117|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2786118|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786119|NCT04327245|Tagatose|tagatose|mesh-list
2786120|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2786121|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
2786122|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
2786123|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786124|NCT04327401|Dexamethasone|dexamethasone|mesh-list
2786125|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786126|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
2272485|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2272486|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272487|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2272488|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2272489|NCT00200200|Growth Substances|growth substances|mesh-ancestor
2272490|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272491|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
2272492|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
2272493|NCT00200226|Pyridoxal|pyridoxal|mesh-list
2272494|NCT00200226|Pyridoxine|pyridoxine|mesh-list
2272495|NCT00200226|Misoprostol|misoprostol|mesh-list
2272496|NCT00200226|Vitamins|vitamins|mesh-ancestor
2786127|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
2786128|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792343|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
2272497|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
2272498|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272499|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2272500|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
2272501|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2272502|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2272503|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2786129|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786130|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2786131|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
2786132|NCT04327401|Hormones|hormones|mesh-ancestor
2786133|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786134|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2786135|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786136|NCT04327427|Aspirin|aspirin|mesh-list
2786137|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2786138|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2786139|NCT04327427|Analgesics|analgesics|mesh-ancestor
2786140|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
2786141|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786142|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786143|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786144|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786145|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2786146|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2786147|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786148|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2786149|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2786150|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786151|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
2786152|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2786153|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2786154|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786155|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
2786156|NCT04327232|Spironolactone|spironolactone|mesh-list
2786157|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2786158|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
2786159|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786160|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786161|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2786162|NCT04327232|Diuretics|diuretics|mesh-ancestor
2786163|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
2786164|NCT04326920|Sargramostim|sargramostim|mesh-list
2786165|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
2786166|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786167|NCT04327063|Ropivacaine|ropivacaine|mesh-list
2786168|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
2786169|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
2786170|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2786171|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786172|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
2786173|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786174|NCT04327011|Flucytosine|flucytosine|mesh-list
2786175|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
2102698|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102699|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102700|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102701|NCT02412644|Apremilast|apremilast|mesh-list
2786176|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786177|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
2786178|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786179|NCT04326959|Triamcinolone|triamcinolone|mesh-list
2786180|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2786181|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2786182|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2786183|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786184|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
2786185|NCT04326959|Hormones|hormones|mesh-ancestor
2786186|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786187|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786188|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2102702|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2102703|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2102704|NCT02412644|Analgesics|analgesics|mesh-ancestor
2786189|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
2786190|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786191|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786192|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
2786193|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786194|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2786195|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786196|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786197|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
2786198|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2786199|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
2786200|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786201|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
2786202|NCT04326985|Protective Agents|protective agents|mesh-ancestor
2786203|NCT04326894|Methotrexate|methotrexate|mesh-list
2786204|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2786205|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
2786206|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2786207|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786208|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2786209|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
2786210|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786211|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786212|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
2786213|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786214|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2786215|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2786216|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
2786217|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786218|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2786219|NCT04326868|Albendazole|albendazole|mesh-list
2786220|NCT04326868|Mebendazole|mebendazole|mesh-list
2786221|NCT04326868|Benzimidazole|benzimidazole|mesh-list
2786222|NCT04326868|Pyrantel|pyrantel|mesh-list
2786223|NCT04326868|Anthelmintics|anthelmintics|mesh-list
2786224|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2786225|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786226|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
2786227|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2786228|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2786229|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
2786230|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
2786231|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
2786232|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786233|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786234|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
2786235|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2786236|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2786237|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2786238|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786239|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792344|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792345|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792346|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2792347|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
2792348|NCT04278833|Hormones|hormones|mesh-ancestor
2792349|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2792350|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2792351|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792352|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2792353|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
2792354|NCT04278768|Azacitidine|azacitidine|mesh-list
2792355|NCT04278768|Venetoclax|venetoclax|mesh-list
2792356|NCT04278768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2792357|NCT04278768|Antimetabolites|antimetabolites|mesh-ancestor
2792358|NCT04278768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792359|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792360|NCT04278768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792361|NCT04278846|Bupivacaine|bupivacaine|mesh-list
2792362|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
2792363|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
2792364|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792365|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792366|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
2786240|NCT04326764|Panobinostat|panobinostat|mesh-list
2786241|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786242|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2786243|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786244|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786245|NCT04326790|Colchicine|colchicine|mesh-list
2786246|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
2786247|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786248|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
2786249|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
2786250|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
2786251|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786252|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272504|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
2272505|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
2272506|NCT00200252|Oxytocin|oxytocin|mesh-list
2272507|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
2272508|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2272509|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272510|NCT00200382|Bortezomib|bortezomib|mesh-list
2272511|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272512|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2272513|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272514|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2272515|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272516|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272517|NCT00200421|Atenolol|atenolol|mesh-list
2272518|NCT00200421|Nebivolol|nebivolol|mesh-list
2272519|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2272520|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2272521|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
2272522|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
2272523|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272524|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272525|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2272526|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2272527|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2272528|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
2272529|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272530|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272531|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
2272532|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2272533|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2786253|NCT04326803|Vaccines|vaccines|mesh-list
2786254|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
2786255|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786256|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
2786257|NCT04326673|Testosterone|testosterone|mesh-list
2786258|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
2786259|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
2272534|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2786260|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2786261|NCT04326673|Androgens|androgens|mesh-ancestor
2786262|NCT04326673|Hormones|hormones|mesh-ancestor
2786263|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786264|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786265|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102705|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
2102706|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102707|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102708|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102709|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2102710|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2102711|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2102712|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102713|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102714|NCT02412657|Dexamethasone|dexamethasone|mesh-list
2102715|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102716|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
2102717|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
2102718|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102719|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102720|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2102721|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
2102722|NCT02412657|Hormones|hormones|mesh-ancestor
2272535|NCT00200434|Nebivolol|nebivolol|mesh-list
2272536|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2272537|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
2272538|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2272539|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2272540|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2272541|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
2272542|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272543|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272544|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272545|NCT00200447|Carbidopa|carbidopa|mesh-list
2272546|NCT00200447|Levodopa|levodopa|mesh-list
2272547|NCT00200447|Entacapone|entacapone|mesh-list
2786266|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786267|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
2786268|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
2786269|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
2786270|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2786271|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2786272|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786273|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272548|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
2272549|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2272550|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2272551|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
2272552|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272553|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272554|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272555|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2272556|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272557|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2272558|NCT00200460|Nebivolol|nebivolol|mesh-list
2272559|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2272560|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
2272561|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2272562|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2272563|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2272564|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
2272565|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272566|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272567|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272568|NCT00200473|Nebivolol|nebivolol|mesh-list
2786274|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786275|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786276|NCT04326738|Midazolam|midazolam|mesh-list
2786277|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2786278|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2786279|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2786280|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786281|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2786282|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2786283|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2786284|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2786285|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
2786286|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
2272569|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2272570|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
2272571|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2272572|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2272573|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2272574|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
2272575|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272576|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272577|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272578|NCT00200499|Nebivolol|nebivolol|mesh-list
2786287|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
2786288|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
2786289|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272579|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2272580|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
2272581|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2786290|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786291|NCT04326296|Lenalidomide|lenalidomide|mesh-list
2786292|NCT04326296|Antibodies|antibodies|mesh-list
2786293|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2786294|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
2786295|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786296|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2786297|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2786298|NCT04326296|Growth Substances|growth substances|mesh-ancestor
2786299|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
2786300|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786301|NCT04326439|Cytarabine|cytarabine|mesh-list
2786302|NCT04326439|Etoposide|etoposide|mesh-list
2786303|NCT04326439|Daunorubicin|daunorubicin|mesh-list
2786304|NCT04326439|Sorafenib|sorafenib|mesh-list
2786305|NCT04326439|Asparaginase|asparaginase|mesh-list
2786306|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
2786307|NCT04326439|Calicheamicins|calicheamicins|mesh-list
2786308|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2786309|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786310|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2786311|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2786312|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786313|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786314|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2786315|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
2786316|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
2786317|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272582|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2272583|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2272584|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
2272585|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272586|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272587|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272588|NCT00200512|Apomorphine|apomorphine|mesh-list
2272589|NCT00200512|Emetics|emetics|mesh-ancestor
2272590|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272591|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
2272592|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272593|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2786318|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2786319|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
2786320|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786321|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2786322|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2786323|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2786324|NCT04326257|Nivolumab|nivolumab|mesh-list
2786325|NCT04326257|Ipilimumab|ipilimumab|mesh-list
2786326|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2786327|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786328|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2786329|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786330|NCT04326478|Azithromycin|azithromycin|mesh-list
2272594|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
2272595|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
2272596|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272597|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272598|NCT00200525|Apomorphine|apomorphine|mesh-list
2272599|NCT00200525|Emetics|emetics|mesh-ancestor
2272600|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272601|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
2272602|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272603|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2272604|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
2272605|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
2272606|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272607|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102723|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102724|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102725|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272608|NCT00200538|Memantine|memantine|mesh-list
2272609|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2786331|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2786332|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786333|NCT04326166|Metformin|metformin|mesh-list
2786334|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2786335|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786336|NCT04325984|Dexamethasone|dexamethasone|mesh-list
2786337|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786338|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
2786339|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
2786340|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786341|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786342|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2786343|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
2786344|NCT04325984|Hormones|hormones|mesh-ancestor
2786345|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786346|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2786347|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786348|NCT04325932|Kallikreins|kallikreins|mesh-list
2786349|NCT04325932|Coagulants|coagulants|mesh-ancestor
2786350|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
2786351|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
2786352|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2786353|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786354|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
2786355|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
2786356|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2786357|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2786358|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786359|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786360|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786361|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786362|NCT04325802|Naltrexone|naltrexone|mesh-list
2786363|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2786364|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2786365|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786366|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
2786367|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272610|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2272611|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
2272612|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272613|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272614|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272615|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2272616|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2272617|NCT00200551|Cyclosporine|cyclosporine|mesh-list
2272618|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
2272619|NCT00200551|Cyclosporins|cyclosporins|mesh-list
2272620|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2786368|NCT04325633|Naproxen|naproxen|mesh-list
2786369|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2786370|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2786371|NCT04325633|Analgesics|analgesics|mesh-ancestor
2786372|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
2786373|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786374|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786375|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786376|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786377|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
2786378|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2786379|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786380|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786381|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2786382|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786383|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
2786384|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
2786385|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786386|NCT04325503|Levodopa|levodopa|mesh-list
2786387|NCT04325503|Carbidopa|carbidopa|mesh-list
2786388|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2786389|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2786390|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
2786391|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2786392|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786393|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786394|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2786395|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786396|NCT04325698|Paclitaxel|paclitaxel|mesh-list
2786397|NCT04325698|Bevacizumab|bevacizumab|mesh-list
2786398|NCT04325698|Carboplatin|carboplatin|mesh-list
2786399|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2786400|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786401|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
2786402|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
2786403|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
2786404|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786405|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2786406|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2786407|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2786408|NCT04325698|Growth Substances|growth substances|mesh-ancestor
2786409|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786410|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
2786411|NCT04325581|Liraglutide|liraglutide|mesh-list
2786412|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2786413|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786414|NCT04325581|Incretins|incretins|mesh-ancestor
2786415|NCT04325581|Hormones|hormones|mesh-ancestor
2786416|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786417|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
2786418|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2786419|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786420|NCT04325425|Carboplatin|carboplatin|mesh-list
2786421|NCT04325425|Etoposide|etoposide|mesh-list
2786422|NCT04325425|Folfirinox|folfirinox|mesh-list
2786423|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786424|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2786425|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2786426|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2786427|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786428|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786429|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
2786430|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
2786431|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
2786432|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2786433|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786434|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
2786435|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792367|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792368|NCT04278599|Zinc|zinc|mesh-list
2792369|NCT04278599|Trace Elements|trace elements|mesh-ancestor
2792370|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
2792371|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792372|NCT04278937|Azithromycin|azithromycin|mesh-list
2792373|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2792374|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792375|NCT04278378|Folic Acid|folic acid|mesh-list
2792376|NCT04278378|Riboflavin|riboflavin|mesh-list
2792377|NCT04278378|Hematinics|hematinics|mesh-ancestor
2792378|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
2792379|NCT04278378|Vitamins|vitamins|mesh-ancestor
2272621|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272622|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272623|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2272624|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
2272625|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272626|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
2272627|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272628|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
2272629|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2272630|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2272631|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2272632|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272633|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2272634|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
2272635|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2272636|NCT00200564|Ketamine|ketamine|mesh-list
2272637|NCT00200564|Analgesics|analgesics|mesh-ancestor
2272638|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
2272639|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272640|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272641|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2272642|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2272643|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
2792380|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
2786436|NCT04325191|Melatonin|melatonin|mesh-list
2786437|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
2786438|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786439|NCT04325191|Protective Agents|protective agents|mesh-ancestor
2786440|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786441|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2786442|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
2786443|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
2786444|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2786445|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2786446|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786447|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786448|NCT04325243|Urological Agents|urological agents|mesh-ancestor
2786449|NCT04325061|Dexamethasone|dexamethasone|mesh-list
2786450|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
2786451|NCT04325061|BB 1101|bb 1101|mesh-list
2786452|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786453|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
2272644|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
2272645|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2272646|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2272647|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2272648|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2786454|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
2786455|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786456|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786457|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2786458|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
2786459|NCT04325061|Hormones|hormones|mesh-ancestor
2786460|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786461|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2786462|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786463|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
2786464|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786465|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786466|NCT04325009|Atorvastatin|atorvastatin|mesh-list
2786467|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2786468|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2786469|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
2786470|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786471|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2786472|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2786473|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786474|NCT04324840|Temozolomide|temozolomide|mesh-list
2786475|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2786476|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
2786477|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786478|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786479|NCT04324411|Sirolimus|sirolimus|mesh-list
2786480|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2786481|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786482|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2786483|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786484|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
2786485|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2786486|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
2786487|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786521|NCT04324346|Paclitaxel|paclitaxel|mesh-list
2786522|NCT04324346|Docetaxel|docetaxel|mesh-list
2786523|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2786524|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786525|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
2786526|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
2786527|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
2786528|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786538|NCT04324229|Liraglutide|liraglutide|mesh-list
2786539|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2786540|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786541|NCT04324229|Incretins|incretins|mesh-ancestor
2786542|NCT04324229|Hormones|hormones|mesh-ancestor
2786543|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786544|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2786545|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786546|NCT04324307|Gemcitabine|gemcitabine|mesh-list
2786547|NCT04324307|Paclitaxel|paclitaxel|mesh-list
2786548|NCT04324307|Fluorouracil|fluorouracil|mesh-list
2786549|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
2786550|NCT04324307|Irinotecan|irinotecan|mesh-list
2786551|NCT04324307|Folfirinox|folfirinox|mesh-list
2786552|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2786553|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786554|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
2786555|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
2786556|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
2786557|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786558|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2786559|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
2786560|NCT04324307|Antiviral Agents|antiviral agents|mesh-ancestor
2786561|NCT04324307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272649|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272650|NCT00200590|Acetaminophen|acetaminophen|mesh-list
2272651|NCT00200590|Morphine|morphine|mesh-list
2272652|NCT00200590|Nalbuphine|nalbuphine|mesh-list
2272653|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2272654|NCT00200590|Narcotics|narcotics|mesh-ancestor
2272655|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2272656|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272657|NCT00200590|Analgesics|analgesics|mesh-ancestor
2272658|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
2272659|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272660|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2272661|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
2786562|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786563|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2786564|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
2272662|NCT00200603|Calcium|calcium|mesh-list
2786565|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786566|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2786567|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2786568|NCT04324476|Bevacizumab|bevacizumab|mesh-list
2786569|NCT04324476|Capecitabine|capecitabine|mesh-list
2786570|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
2272663|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2272664|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272665|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
2272666|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2272667|NCT00200629|Adenosine|adenosine|mesh-list
2272668|NCT00200629|Analgesics|analgesics|mesh-ancestor
2272669|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
2272670|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272671|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272672|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2272673|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
2272674|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2272675|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
2272676|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
2272677|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272678|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272679|NCT00200655|Pravastatin|pravastatin|mesh-list
2272680|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2272681|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2272682|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
2272683|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272684|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2272685|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2272686|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786571|NCT04324476|Irinotecan|irinotecan|mesh-list
2786572|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2786573|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786574|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2786575|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2786576|NCT04324476|Growth Substances|growth substances|mesh-ancestor
2786577|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786578|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
2786579|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2786580|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
2786581|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786582|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2786583|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2786584|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786585|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
2786586|NCT04324086|Calcium|calcium|mesh-list
2786587|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2786588|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786589|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2786590|NCT04324060|Danazol|danazol|mesh-list
2786591|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2786592|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
2786593|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786594|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786595|NCT04324294|Pancrelipase|pancrelipase|mesh-list
2786596|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2786597|NCT04323748|Rituximab|rituximab|mesh-list
2786598|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2786599|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786600|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
2786601|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786602|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786603|NCT04323956|Prednisone|prednisone|mesh-list
2786604|NCT04323956|Cortisone|cortisone|mesh-list
2786605|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
2786606|NCT04323956|Rituximab|rituximab|mesh-list
2786607|NCT04323956|Doxorubicin|doxorubicin|mesh-list
2786608|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2786609|NCT04323956|Vincristine|vincristine|mesh-list
2786610|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2786611|NCT04323956|Antibodies|antibodies|mesh-list
2786612|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
2786613|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2786614|NCT04323956|Lenograstim|lenograstim|mesh-list
2786615|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2786616|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
2272687|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2272688|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2272689|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272690|NCT00200681|Bortezomib|bortezomib|mesh-list
2272691|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272692|NCT00200694|Valsartan|valsartan|mesh-list
2272693|NCT00200694|Ramipril|ramipril|mesh-list
2272694|NCT00200694|Furosemide|furosemide|mesh-list
2272695|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2272696|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2786617|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786618|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786619|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2786620|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
2786621|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786622|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786623|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2786624|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2786625|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2786626|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2786627|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786628|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786629|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
2786630|NCT04323956|Hormones|hormones|mesh-ancestor
2786631|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786632|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2786633|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2786634|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2786635|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
2786636|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
2786637|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
2786638|NCT04323566|Rituximab|rituximab|mesh-list
2786639|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2786640|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786641|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
2786642|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786643|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2792381|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792382|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2792383|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
2792384|NCT04278755|Drospirenone|drospirenone|mesh-list
2792385|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2792386|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2792387|NCT04278755|Estradiol|estradiol|mesh-list
2792388|NCT04278755|Estrogens|estrogens|mesh-ancestor
2792389|NCT04278755|Hormones|hormones|mesh-ancestor
2792390|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2792391|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792392|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2792393|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
2792394|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2792395|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2792396|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2792397|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2792398|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2792399|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
2792400|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2792401|NCT04278755|Diuretics|diuretics|mesh-ancestor
2272697|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2272698|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272699|NCT00200694|Diuretics|diuretics|mesh-ancestor
2272700|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
2272701|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272702|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2272703|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2272704|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2272705|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
2272706|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272707|NCT00200941|Topiramate|topiramate|mesh-list
2272708|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
2272709|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2272710|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272711|NCT00201305|Leucovorin|leucovorin|mesh-list
2272712|NCT00201305|Gemcitabine|gemcitabine|mesh-list
2786644|NCT04323761|Remdesivir|remdesivir|mesh-list
2786645|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
2786646|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786647|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
2786648|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786649|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
2786650|NCT04323657|Fludarabine|fludarabine|mesh-list
2786651|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2786652|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
2272713|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2272714|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
2272715|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272716|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272717|NCT00201305|Antiviral Agents|antiviral agents|mesh-ancestor
2272718|NCT00201305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272719|NCT00201305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786653|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786654|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786655|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2786656|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
2786657|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786658|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786659|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2786660|NCT04323527|Chloroquine|chloroquine|mesh-list
2786661|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2786662|NCT04323527|Amebicides|amebicides|mesh-ancestor
2786663|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2272720|NCT00201305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2272721|NCT00201305|Immunologic Factors|immunologic factors|mesh-ancestor
2272722|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272723|NCT00201305|Antidotes|antidotes|mesh-ancestor
2272724|NCT00201305|Protective Agents|protective agents|mesh-ancestor
2272725|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
2272726|NCT00201305|Vitamins|vitamins|mesh-ancestor
2272727|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
2272728|NCT00201318|Lamivudine|lamivudine|mesh-list
2272729|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
2272730|NCT00201318|Doxorubicin|doxorubicin|mesh-list
2786664|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2786665|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786666|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
2786667|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786668|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2786669|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2786670|NCT04323527|Analgesics|analgesics|mesh-ancestor
2786671|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
2786672|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786673|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786674|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786675|NCT04323527|Filaricides|filaricides|mesh-ancestor
2786676|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
2786677|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
2786678|NCT04323514|Ascorbic Acid|ascorbic acid|mesh-list
2786679|NCT04323514|Vitamins|vitamins|mesh-ancestor
2786680|NCT04323514|Micronutrients|micronutrients|mesh-ancestor
2786681|NCT04323514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786682|NCT04323514|Antioxidants|antioxidants|mesh-ancestor
2786683|NCT04323514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786684|NCT04323514|Protective Agents|protective agents|mesh-ancestor
2786685|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
2786686|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
2786687|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2786688|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2786689|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786690|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786691|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786692|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786693|NCT04322955|Nivolumab|nivolumab|mesh-list
2786694|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2786695|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786696|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2786697|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786698|NCT04323280|Dexamethasone|dexamethasone|mesh-list
2786699|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786700|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
2272731|NCT00201318|Vincristine|vincristine|mesh-list
2786701|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
2786702|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786703|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786704|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2786705|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
2786706|NCT04323280|Hormones|hormones|mesh-ancestor
2786707|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786708|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2786709|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786720|NCT04323228|Antioxidants|antioxidants|mesh-list
2272732|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2272733|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
2272734|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272735|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2272736|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2786721|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786722|NCT04323228|Protective Agents|protective agents|mesh-ancestor
2786723|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786724|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
2786725|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2786726|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786727|NCT04322760|Lidocaine|lidocaine|mesh-list
2786728|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
2786729|NCT04322760|Bupivacaine|bupivacaine|mesh-list
2786730|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
2786731|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
2786732|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2786733|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786734|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
2786735|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786736|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2786737|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2786738|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2786739|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2786740|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786741|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2786742|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2786743|NCT04322760|Analgesics|analgesics|mesh-ancestor
2786744|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2272737|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
2272738|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786745|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2786746|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2786747|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
2786748|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2786749|NCT04322565|Colchicine|colchicine|mesh-list
2786750|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
2786751|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786752|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
2786753|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
2786754|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
2786755|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786756|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786757|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
2786758|NCT04322643|Nivolumab|nivolumab|mesh-list
2786759|NCT04322643|Durvalumab|durvalumab|mesh-list
2786760|NCT04322643|Avelumab|avelumab|mesh-list
2786761|NCT04322643|Atezolizumab|atezolizumab|mesh-list
2786762|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2786763|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786764|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2786765|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786766|NCT04322669|Pidotimod|pidotimod|mesh-list
2786767|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2786768|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
2786769|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786770|NCT04322552|Apatinib|apatinib|mesh-list
2786771|NCT04322552|Digoxin|digoxin|mesh-list
2786772|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786773|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2786774|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786775|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786776|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2786777|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2786778|NCT04322552|Protective Agents|protective agents|mesh-ancestor
2786779|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786780|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2786781|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
2786782|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786783|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786784|NCT04322422|Montelukast|montelukast|mesh-list
2786785|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2786786|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
2786787|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2786788|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
2786789|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786790|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786791|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2786792|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2786793|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272739|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272740|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2272741|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2272742|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2272743|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2272744|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272745|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2272746|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
2272747|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
2272748|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
2272749|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2272750|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2272751|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
2272752|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272753|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2272754|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2272755|NCT00201331|Leucovorin|leucovorin|mesh-list
2786794|NCT04322175|Meloxicam|meloxicam|mesh-list
2786795|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2786796|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2786797|NCT04322175|Analgesics|analgesics|mesh-ancestor
2786798|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
2786799|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786800|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786801|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786802|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786803|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2786804|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2786805|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786806|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272756|NCT00201331|Antidotes|antidotes|mesh-ancestor
2272757|NCT00201331|Protective Agents|protective agents|mesh-ancestor
2272758|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272759|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
2272760|NCT00201331|Vitamins|vitamins|mesh-ancestor
2272761|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
2272762|NCT00201344|Leucovorin|leucovorin|mesh-list
2272763|NCT00201344|Antidotes|antidotes|mesh-ancestor
2786807|NCT04322214|Cobicistat|cobicistat|mesh-list
2786808|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2786809|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2786810|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
2786811|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786812|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2786813|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2786814|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786815|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786816|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
2786817|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
2786818|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786819|NCT04322240|Protective Agents|protective agents|mesh-ancestor
2272764|NCT00201344|Protective Agents|protective agents|mesh-ancestor
2272765|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272766|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
2272767|NCT00201344|Vitamins|vitamins|mesh-ancestor
2272768|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
2272769|NCT00201357|Thalidomide|thalidomide|mesh-list
2272770|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2272771|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
2272772|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272773|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
2272774|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2272775|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272776|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2272777|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2272778|NCT00201357|Growth Substances|growth substances|mesh-ancestor
2786820|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786821|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
2786822|NCT04322240|Vitamins|vitamins|mesh-ancestor
2786823|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
2786824|NCT04322357|Prednisone|prednisone|mesh-list
2786825|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
2786826|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786827|NCT04322357|Hormones|hormones|mesh-ancestor
2786828|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786829|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272779|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
2272780|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272781|NCT00201383|Cisplatin|cisplatin|mesh-list
2786830|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2786831|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786832|NCT04322123|Azithromycin|azithromycin|mesh-list
2786833|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
2786834|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2786835|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786836|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
2786837|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2786838|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2786839|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786840|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786841|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786842|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
2786843|NCT04322318|Ifosfamide|ifosfamide|mesh-list
2786844|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
2786845|NCT04322318|Carboplatin|carboplatin|mesh-list
2786846|NCT04322318|Doxorubicin|doxorubicin|mesh-list
2786847|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2786848|NCT04322318|Irinotecan|irinotecan|mesh-list
2786849|NCT04322318|Etoposide|etoposide|mesh-list
2786850|NCT04322318|Vincristine|vincristine|mesh-list
2786851|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
2786852|NCT04322318|Daunorubicin|daunorubicin|mesh-list
2786853|NCT04322318|Topotecan|topotecan|mesh-list
2786854|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
2272782|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272783|NCT00201396|Leucovorin|leucovorin|mesh-list
2272784|NCT00201396|Fluorouracil|fluorouracil|mesh-list
2786855|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2786856|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
2272785|NCT00201396|Epirubicin|epirubicin|mesh-list
2272786|NCT00201396|Mitomycins|mitomycins|mesh-list
2786857|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786858|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786859|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2786860|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
2786861|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786862|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786863|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2786864|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2786865|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2786866|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2786867|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786868|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2786869|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2786870|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
2786871|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
2786872|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
2786873|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
2786874|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
2792402|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
2792403|NCT04278287|Paclitaxel|paclitaxel|mesh-list
2792404|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2792405|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2792406|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792407|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
2792408|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
2792409|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
2792410|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792411|NCT04278508|Progesterone|progesterone|mesh-list
2792412|NCT04278508|Progestins|progestins|mesh-ancestor
2792413|NCT04278508|Hormones|hormones|mesh-ancestor
2792414|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2792415|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792416|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2792417|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
2792418|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792419|NCT04278495|Losartan|losartan|mesh-list
2792420|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2792421|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2792422|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2792423|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2792424|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792425|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
2792426|NCT04278547|Valganciclovir|valganciclovir|mesh-list
2792427|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
2792428|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792429|NCT04278092|Paclitaxel|paclitaxel|mesh-list
2792430|NCT04278092|Cetuximab|cetuximab|mesh-list
2792431|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2792432|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792433|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
2792434|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
2792435|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
2792436|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792437|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2792438|NCT04278053|Inositol|inositol|mesh-list
2792439|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
2792440|NCT04278053|Vitamins|vitamins|mesh-ancestor
2792441|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
2792442|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792443|NCT04278040|Melphalan|melphalan|mesh-list
2792444|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2792445|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
2792446|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792447|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792448|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2792449|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2792450|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
2792451|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792452|NCT04277884|Firibastat|firibastat|mesh-list
2792453|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2272787|NCT00201396|Mitomycin|mitomycin|mesh-list
2272788|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272789|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
2792454|NCT04277845|Dexamethasone|dexamethasone|mesh-list
2792455|NCT04277845|Bortezomib|bortezomib|mesh-list
2792456|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2792457|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
2792458|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
2792459|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272790|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786875|NCT04322305|Pregabalin|pregabalin|mesh-list
2786876|NCT04322305|Analgesics|analgesics|mesh-ancestor
2786877|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
2786878|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786879|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786880|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
2786881|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2786882|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2786883|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786884|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2786885|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2786886|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2786887|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2786888|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2786889|NCT04321954|Lenvatinib|lenvatinib|mesh-list
2786890|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786891|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2786892|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786893|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786894|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2786895|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2786896|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786897|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786898|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
2786899|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
2786900|NCT04321785|Caffeine|caffeine|mesh-list
2786901|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2786902|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786903|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2786904|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786905|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786906|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2786907|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2786908|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
2786909|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2786910|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
2786911|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786912|NCT04321655|Ibuprofen|ibuprofen|mesh-list
2786913|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2786914|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2786915|NCT04321655|Analgesics|analgesics|mesh-ancestor
2786916|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
2786917|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786918|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272791|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2272792|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2272793|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
2786919|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2786920|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786921|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2786922|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786923|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786924|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
2786925|NCT04321642|Entonox|entonox|mesh-list
2786926|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2786927|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
2786928|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2786929|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786930|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2272794|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272795|NCT00201396|Antidotes|antidotes|mesh-ancestor
2272796|NCT00201396|Protective Agents|protective agents|mesh-ancestor
2272797|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
2272798|NCT00201396|Vitamins|vitamins|mesh-ancestor
2786931|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
2786932|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2786933|NCT04321642|Analgesics|analgesics|mesh-ancestor
2786934|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
2786935|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786936|NCT04321850|Zinc|zinc|mesh-list
2786937|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
2786938|NCT04321850|Trace Elements|trace elements|mesh-ancestor
2786939|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
2786940|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786941|NCT04321850|Astringents|astringents|mesh-ancestor
2786942|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
2786943|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
2786944|NCT04321616|Remdesivir|remdesivir|mesh-list
2786945|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
2786946|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2786947|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2786948|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2786949|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2786950|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786951|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2786952|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
2272799|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
2272800|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2272801|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2272802|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2272803|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272804|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
2272805|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2272806|NCT00201422|Amoxicillin|amoxicillin|mesh-list
2272807|NCT00201422|Clarithromycin|clarithromycin|mesh-list
2272808|NCT00201422|Omeprazole|omeprazole|mesh-list
2272809|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2272810|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272811|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2272812|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2272813|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2272814|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272815|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272816|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2272817|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2272818|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2272819|NCT00201435|Paclitaxel|paclitaxel|mesh-list
2272820|NCT00201435|Docetaxel|docetaxel|mesh-list
2272821|NCT00201435|Capecitabine|capecitabine|mesh-list
2272822|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2272823|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272824|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
2272825|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
2272826|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
2272827|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786953|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
2786954|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
2786955|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
2786956|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2786957|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2786958|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2786959|NCT04321837|Vitamin D|vitamin d|mesh-list
2786960|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
2786961|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
2786962|NCT04321837|Vitamins|vitamins|mesh-ancestor
2786963|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
2786964|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786965|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2786966|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2786967|NCT04321668|Hylan|hylan|mesh-list
2786968|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
2786969|NCT04321668|Protective Agents|protective agents|mesh-ancestor
2786970|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786971|NCT04321551|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2786972|NCT04321551|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2786973|NCT04321551|Hormones|hormones|mesh-list
2786974|NCT04321551|Estradiol|estradiol|mesh-list
2786975|NCT04321551|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2786976|NCT04321551|Progesterone|progesterone|mesh-list
2786977|NCT04321551|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2786978|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2786979|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786980|NCT04321551|Estrogens|estrogens|mesh-ancestor
2786981|NCT04321551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2786982|NCT04321551|Contraceptive Agents|contraceptive agents|mesh-ancestor
2786983|NCT04321551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2786984|NCT04321551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2786985|NCT04321551|Progestins|progestins|mesh-ancestor
2786986|NCT04321746|Ketamine|ketamine|mesh-list
2786987|NCT04321746|Analgesics|analgesics|mesh-ancestor
2786988|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
2786989|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2786990|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2786991|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2786992|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2786993|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
2786994|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
2786995|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2786996|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2786997|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2786998|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2786999|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787000|NCT04321408|Ziconotide|ziconotide|mesh-list
2787001|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2787002|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2787003|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787004|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2787005|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787006|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2787007|NCT04321408|Protective Agents|protective agents|mesh-ancestor
2787008|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2787009|NCT04321408|Analgesics|analgesics|mesh-ancestor
2787010|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
2787011|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787012|NCT04321395|Vigabatrin|vigabatrin|mesh-list
2787013|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
2787014|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787015|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787016|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
2787017|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787018|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787019|NCT04321278|Azithromycin|azithromycin|mesh-list
2787020|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
2787021|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2787022|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787023|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
2787024|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2787025|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2787026|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787027|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787028|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2272828|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2272829|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
2272830|NCT00201539|Morphine|morphine|mesh-list
2272831|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2272832|NCT00201539|Narcotics|narcotics|mesh-ancestor
2272833|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2272834|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272835|NCT00201539|Analgesics|analgesics|mesh-ancestor
2272836|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
2272837|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272838|NCT00201630|Alfuzosin|alfuzosin|mesh-list
2272839|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2272840|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2272841|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2272842|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
2272843|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272844|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272845|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272846|NCT00201630|Urological Agents|urological agents|mesh-ancestor
2272847|NCT00201669|Clofarabine|clofarabine|mesh-list
2272848|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2272849|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
2272850|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272851|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272852|NCT00201682|Etanercept|etanercept|mesh-list
2272853|NCT00201682|Rituximab|rituximab|mesh-list
2272854|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2272855|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272856|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
2272857|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787043|NCT04321070|Clindamycin|clindamycin|mesh-list
2787044|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
2787045|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
2787046|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2787047|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787048|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2787049|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787050|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787051|NCT04321096|Camostat|camostat|mesh-list
2272858|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2272859|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2272860|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2272861|NCT00201682|Analgesics|analgesics|mesh-ancestor
2272862|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
2272863|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272864|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2272865|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2272866|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2272867|NCT00201695|Dexamethasone|dexamethasone|mesh-list
2272868|NCT00201695|Doxorubicin|doxorubicin|mesh-list
2272869|NCT00201695|Vincristine|vincristine|mesh-list
2272870|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
2272871|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2272872|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
2272873|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
2272874|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272875|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272876|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2272877|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
2787052|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
2787053|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787054|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787055|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2787056|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2787057|NCT04320914|Ibuprofen|ibuprofen|mesh-list
2787058|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2787059|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2787060|NCT04320914|Analgesics|analgesics|mesh-ancestor
2787061|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
2787062|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787063|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787064|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787065|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787066|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2787067|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102757|NCT02412722|Paclitaxel|paclitaxel|mesh-list
2102758|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2102759|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102760|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
2102761|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
2102762|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
2787068|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787069|NCT04320706|Oxytocin|oxytocin|mesh-list
2787070|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
2787071|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2787072|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787073|NCT04320745|Testosterone|testosterone|mesh-list
2787074|NCT04320745|Androgens|androgens|mesh-ancestor
2787075|NCT04320745|Hormones|hormones|mesh-ancestor
2787076|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2272878|NCT00201695|Hormones|hormones|mesh-ancestor
2102763|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102764|NCT02412761|Amlodipine|amlodipine|mesh-list
2102765|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2102766|NCT02412761|Lisinopril|lisinopril|mesh-list
2102767|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
2787077|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787078|NCT04320602|Eculizumab|eculizumab|mesh-list
2787079|NCT04320602|Ravulizumab|ravulizumab|mesh-list
2787080|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2787081|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2787082|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
2787083|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792460|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792461|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2792462|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
2792463|NCT04277845|Hormones|hormones|mesh-ancestor
2792464|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2792465|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2792466|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792467|NCT04277858|Cisplatin|cisplatin|mesh-list
2792468|NCT04277858|Docetaxel|docetaxel|mesh-list
2792469|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792470|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
2792471|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
2792472|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
2792473|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792977|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792978|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792979|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2792980|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
2792981|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
2792982|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792983|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792984|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2792985|NCT04273763|Interferons|interferons|mesh-list
2792986|NCT04273763|Bromhexine|bromhexine|mesh-list
2792987|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792988|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
2792989|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792990|NCT04273763|Expectorants|expectorants|mesh-ancestor
2792991|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
2792992|NCT04273581|Thalidomide|thalidomide|mesh-list
2792993|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2792994|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
2792995|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792996|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
2792997|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2792998|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792999|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2793000|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2793001|NCT04273581|Growth Substances|growth substances|mesh-ancestor
2793002|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
2793003|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793004|NCT04273607|Heparin|heparin|mesh-list
2793005|NCT04273607|Calcium heparin|calcium heparin|mesh-list
2793006|NCT04273607|Enoxaparin|enoxaparin|mesh-list
2793007|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
2793008|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2793009|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2793010|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793011|NCT04273529|Thalidomide|thalidomide|mesh-list
2793012|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2793013|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
2793014|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793015|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
2793016|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2793017|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793018|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2793019|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2793020|NCT04273529|Growth Substances|growth substances|mesh-ancestor
2793021|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
2793022|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793023|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
2793024|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2793025|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
2793026|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2793027|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
2793028|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793029|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793030|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
2793031|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
2793032|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2272879|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2272880|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2272881|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272882|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2787084|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
2787085|NCT04320589|Anesthetics|anesthetics|mesh-list
2787086|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
2787087|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2787088|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787089|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787090|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2787091|NCT04320589|Analgesics|analgesics|mesh-ancestor
2787092|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
2787093|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787094|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2787095|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2787096|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2787097|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
2787098|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787099|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787100|NCT04320238|Interferons|interferons|mesh-list
2787101|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
2787102|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2787103|NCT04320238|Thymalfasin|thymalfasin|mesh-list
2787104|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787105|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
2787106|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787107|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
2787108|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787109|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2787112|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
2272883|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2272884|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2272885|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272886|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272887|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2272888|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
2272889|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
2272890|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
2272891|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
2272892|NCT00201708|Docetaxel|docetaxel|mesh-list
2272893|NCT00201708|Doxorubicin|doxorubicin|mesh-list
2272894|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2272895|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
2272896|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272897|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2272898|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2272899|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
2272900|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272901|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272902|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2272903|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
2272904|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
2272905|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
2272906|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2272907|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2272908|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2272909|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272910|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
2272911|NCT00201721|Rituximab|rituximab|mesh-list
2272912|NCT00201721|Pentostatin|pentostatin|mesh-list
2272913|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2787113|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787114|NCT04320277|Ritonavir|ritonavir|mesh-list
2787115|NCT04320277|Lopinavir|lopinavir|mesh-list
2272914|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
2272915|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272916|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2272917|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2272918|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
2272919|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787116|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2787117|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2787118|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
2272920|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272921|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2272922|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2272923|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2272924|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272925|NCT00201747|Mitomycins|mitomycins|mesh-list
2272926|NCT00201747|Mitomycin|mitomycin|mesh-list
2272927|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2272928|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787119|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787120|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787121|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2787122|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2787123|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
2787124|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2272929|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
2272930|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102768|NCT02412761|Diuretics|diuretics|mesh-list
2102769|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
2102770|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2102771|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2102772|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2102773|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102774|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2272931|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2272932|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272933|NCT00201786|Pentostatin|pentostatin|mesh-list
2272934|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272935|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2272936|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2272937|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272938|NCT00201799|Infliximab|infliximab|mesh-list
2272939|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
2272940|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2272941|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2272942|NCT00201812|Dexamethasone|dexamethasone|mesh-list
2272943|NCT00201812|Etanercept|etanercept|mesh-list
2272944|NCT00201812|Docetaxel|docetaxel|mesh-list
2272945|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
2272946|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2272947|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
2272948|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
2272949|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2272950|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272951|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2272952|NCT00201812|Hormones|hormones|mesh-ancestor
2272953|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2272954|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2272955|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2272956|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
2272957|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
2272958|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
2272959|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272960|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2272961|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2272962|NCT00201812|Analgesics|analgesics|mesh-ancestor
2787125|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2787126|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2787127|NCT04320225|Dexamethasone|dexamethasone|mesh-list
2787128|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787129|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
2787130|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
2787131|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787132|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787133|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2787134|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
2787135|NCT04320225|Hormones|hormones|mesh-ancestor
2787136|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2787137|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2787138|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787139|NCT04319978|Dexamethasone|dexamethasone|mesh-list
2787140|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
2787141|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787142|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
2787143|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
2787144|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787145|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787146|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2787147|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
2787148|NCT04319978|Hormones|hormones|mesh-ancestor
2787149|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2787150|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2787151|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787152|NCT04320173|Lidocaine|lidocaine|mesh-list
2787153|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
2787154|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
2787155|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787156|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787157|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
2787158|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787159|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2787160|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2787161|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2787162|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2787163|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787164|NCT04319926|Lidocaine|lidocaine|mesh-list
2272963|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
2272964|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2272965|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2272966|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
2272967|NCT00201955|Rebamipide|rebamipide|mesh-list
2272968|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2272969|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2272970|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
2787165|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
2787166|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
2787167|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787168|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787169|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
2272971|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272972|NCT00201955|Protective Agents|protective agents|mesh-ancestor
2272973|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272974|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787170|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787171|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2787172|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2787173|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2787174|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2787175|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787176|NCT04319900|Chloroquine|chloroquine|mesh-list
2787177|NCT04319900|Favipiravir|favipiravir|mesh-list
2272975|NCT00201981|Rebamipide|rebamipide|mesh-list
2272976|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2272977|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2272978|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
2272979|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272980|NCT00201981|Protective Agents|protective agents|mesh-ancestor
2272981|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272982|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787178|NCT04319900|Amebicides|amebicides|mesh-ancestor
2272983|NCT00201994|Tolvaptan|tolvaptan|mesh-list
2272984|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2272985|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272986|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
2272987|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272988|NCT00202007|Risperidone|risperidone|mesh-list
2272989|NCT00202007|Aripiprazole|aripiprazole|mesh-list
2272990|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2272991|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
2272992|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2272993|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2272994|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2272995|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2272996|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2272997|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2272998|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2272999|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2273000|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
2787179|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2787180|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2787181|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787182|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
2787183|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787184|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
2787185|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
2787186|NCT04319757|Fludarabine|fludarabine|mesh-list
2787187|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2787188|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
2787189|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787190|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787191|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2787192|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
2787193|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787194|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787195|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2787196|NCT04319471|Capecitabine|capecitabine|mesh-list
2787197|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2787198|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
2787199|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787200|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787201|NCT04319588|Anesthetics|anesthetics|mesh-list
2787202|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
2787203|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787204|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787205|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
2787206|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787207|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
2787208|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2787209|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
2787210|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787211|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
2787212|NCT04319770|Protective Agents|protective agents|mesh-ancestor
2787213|NCT04319484|Lenvatinib|lenvatinib|mesh-list
2787214|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787215|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2787216|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787217|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787218|NCT04319601|Rituximab|rituximab|mesh-list
2787219|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2787220|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787221|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
2787222|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787223|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787224|NCT04319692|Acetic Acid|acetic acid|mesh-list
2787225|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2787226|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787227|NCT04319705|Azithromycin|azithromycin|mesh-list
2787228|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2787229|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273001|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
2273002|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
2273003|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2273004|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2273005|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2273006|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2273007|NCT00202020|Aspirin|aspirin|mesh-list
2273008|NCT00202020|Cilostazol|cilostazol|mesh-list
2273009|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2273010|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2273011|NCT00202020|Analgesics|analgesics|mesh-ancestor
2273012|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
2273013|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273014|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273015|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2273016|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273017|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2273018|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2787241|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
2787242|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2787243|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2787244|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787245|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
2273019|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273020|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2273021|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2787246|NCT04319614|Coagulants|coagulants|mesh-ancestor
2787247|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
2787248|NCT04319328|Cefazolin|cefazolin|mesh-list
2787249|NCT04319328|Ceftazidime|ceftazidime|mesh-list
2787250|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2787251|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787252|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2787253|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2787254|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787255|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787256|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787257|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2787258|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2787259|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2787260|NCT04319549|Eusol|eusol|mesh-list
2787261|NCT04319549|Ketorolac|ketorolac|mesh-list
2787262|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2787263|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2787264|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2787265|NCT04319549|Analgesics|analgesics|mesh-ancestor
2787266|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
2787267|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787268|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787269|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787270|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787271|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2787272|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787273|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787274|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
2787275|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787276|NCT04319289|Vitamin D|vitamin d|mesh-list
2787277|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
2787278|NCT04319289|Vitamins|vitamins|mesh-list
2787279|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
2787280|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787281|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2787282|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2787283|NCT04319224|Nivolumab|nivolumab|mesh-list
2787284|NCT04319224|Ipilimumab|ipilimumab|mesh-list
2787285|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2787286|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787287|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2787288|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787289|NCT04319419|Micronutrients|micronutrients|mesh-list
2787290|NCT04319419|Trace Elements|trace elements|mesh-list
2787291|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787292|NCT04318847|Ondansetron|ondansetron|mesh-list
2787293|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
2787294|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
2273022|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273023|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
2273024|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2273025|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
2273026|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2273027|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
2273028|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
2273029|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2273030|NCT00202020|Protective Agents|protective agents|mesh-ancestor
2787295|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787296|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787297|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2787298|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
2787299|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
2787300|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2787301|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
2787302|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787303|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787304|NCT04318847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2787305|NCT04318847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2787306|NCT04318847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787307|NCT04318847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2787308|NCT04318847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2792474|NCT04277702|Montelukast|montelukast|mesh-list
2792475|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2792476|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
2792477|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2792478|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
2792479|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2792480|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792481|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2792482|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2792483|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792484|NCT04277663|Interferons|interferons|mesh-list
2102775|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2102776|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102777|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
2102778|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
2102779|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
2102780|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2102781|NCT02412761|Protective Agents|protective agents|mesh-ancestor
2102782|NCT02412878|Dexamethasone|dexamethasone|mesh-list
2102783|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102784|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
2102785|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
2102786|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102787|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273031|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2273032|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2273033|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
2273034|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2273035|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792485|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792486|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
2792487|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792488|NCT04277923|SMOFlipid|smoflipid|mesh-list
2792489|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2792490|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2273036|NCT00202124|Tryptophan|tryptophan|mesh-list
2273037|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2273038|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
2273039|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2273040|NCT00202163|Testosterone|testosterone|mesh-list
2273041|NCT00202163|Androgens|androgens|mesh-ancestor
2273042|NCT00202163|Hormones|hormones|mesh-ancestor
2273043|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2273044|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273045|NCT00202176|Bromides|bromides|mesh-list
2792491|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2792492|NCT04277442|Nivolumab|nivolumab|mesh-list
2792493|NCT04277442|Decitabine|decitabine|mesh-list
2792494|NCT04277442|Venetoclax|venetoclax|mesh-list
2792495|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2792496|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792497|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2792498|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792499|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2792500|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
2792501|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792502|NCT04277533|Calcium|calcium|mesh-list
2792503|NCT04277533|Bilirubin|bilirubin|mesh-list
2792504|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2792505|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792506|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
2792507|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792508|NCT04277533|Protective Agents|protective agents|mesh-ancestor
2792509|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
2792510|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2792511|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2787309|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
2787310|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
2787311|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2787312|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2787313|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787314|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787315|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787316|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787320|NCT04318730|Apatinib|apatinib|mesh-list
2787321|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787322|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2787323|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787324|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787325|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
2787326|NCT04318678|Rituximab|rituximab|mesh-list
2787327|NCT04318678|Fludarabine|fludarabine|mesh-list
2787328|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2787329|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
2787330|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787331|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787332|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2787333|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
2787334|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787335|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787336|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2787337|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2787338|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
2787339|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2787340|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2787341|NCT04318652|Prednisolone|prednisolone|mesh-list
2787342|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
2787343|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2787344|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2787345|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
2787346|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787347|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
2787348|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
2787349|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787350|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787351|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2787352|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
2787353|NCT04318652|Hormones|hormones|mesh-ancestor
2787354|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2787355|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2787356|NCT04318652|Protective Agents|protective agents|mesh-ancestor
2787357|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2787358|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787359|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2787360|NCT04318158|Fentanyl|fentanyl|mesh-list
2787361|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
2787362|NCT04318158|Bupivacaine|bupivacaine|mesh-list
2787363|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
2787364|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
2787365|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787366|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787367|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
2787368|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787369|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2787370|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2273046|NCT00202176|Ipratropium|ipratropium|mesh-list
2273047|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
2273048|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2273049|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
2273050|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273051|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787371|NCT04318158|Analgesics|analgesics|mesh-ancestor
2787372|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2787373|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2273052|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2273053|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
2273054|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2787374|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2787375|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
2787376|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787377|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787378|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2787379|NCT04318158|Narcotics|narcotics|mesh-ancestor
2787380|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2787381|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2273055|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
2273056|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273057|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273058|NCT00202189|Budesonide|budesonide|mesh-list
2273059|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2273060|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2273061|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
2273062|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273063|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273064|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2273065|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
2273066|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
2273067|NCT00202189|Hormones|hormones|mesh-ancestor
2273068|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2273069|NCT00202228|Riboflavin|riboflavin|mesh-list
2273070|NCT00202228|Thiamine|thiamine|mesh-list
2273071|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
2273072|NCT00202228|Vitamins|vitamins|mesh-ancestor
2787382|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
2787383|NCT04318210|Tenofovir|tenofovir|mesh-list
2787384|NCT04318210|Emtricitabine|emtricitabine|mesh-list
2273073|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
2273074|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273075|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2273076|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
2273077|NCT00202241|Testosterone|testosterone|mesh-list
2273078|NCT00202241|Androgens|androgens|mesh-ancestor
2273079|NCT00202241|Hormones|hormones|mesh-ancestor
2273080|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2273081|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273082|NCT00202280|Folic Acid|folic acid|mesh-list
2273083|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
2273084|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
2273085|NCT00202280|Vitamins|vitamins|mesh-ancestor
2273086|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
2273087|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273088|NCT00202280|Hematinics|hematinics|mesh-ancestor
2273089|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
2273090|NCT00202293|Olanzapine|olanzapine|mesh-list
2273091|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
2787385|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
2787386|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787387|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2787388|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2787389|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787390|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787391|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2787392|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2787393|NCT04318223|Palbociclib|palbociclib|mesh-list
2787394|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787395|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2787396|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787397|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787398|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2787399|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787400|NCT04318067|Melatonin|melatonin|mesh-list
2787401|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
2787402|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787403|NCT04318067|Protective Agents|protective agents|mesh-ancestor
2787404|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787405|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273092|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
2273093|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
2273094|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273095|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273096|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2273097|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2787414|NCT04317872|Dexamethasone|dexamethasone|mesh-list
2787415|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
2787416|NCT04317872|BB 1101|bb 1101|mesh-list
2787417|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787418|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
2787419|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
2787420|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787421|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787422|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2787423|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
2787424|NCT04317872|Hormones|hormones|mesh-ancestor
2787425|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102788|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2102789|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
2102790|NCT02412878|Hormones|hormones|mesh-ancestor
2102791|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102792|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102793|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102794|NCT02412982|Enoxaparin|enoxaparin|mesh-list
2102795|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
2102796|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
2102797|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2102798|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2102799|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102800|NCT02413034|Vancomycin|vancomycin|mesh-list
2102801|NCT02413034|Cefazolin|cefazolin|mesh-list
2102802|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2102803|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102804|NCT02413203|Celecoxib|celecoxib|mesh-list
2102805|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2102806|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2102807|NCT02413203|Analgesics|analgesics|mesh-ancestor
2102808|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
2102809|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102810|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102811|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102812|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2102813|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2102814|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2102815|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102816|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102817|NCT02413320|Paclitaxel|paclitaxel|mesh-list
2102818|NCT02413320|Docetaxel|docetaxel|mesh-list
2102819|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
2102820|NCT02413320|Carboplatin|carboplatin|mesh-list
2102821|NCT02413320|Doxorubicin|doxorubicin|mesh-list
2102822|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2102823|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102824|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
2102825|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
2787426|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2787427|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787428|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
2787429|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787430|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787431|NCT04317703|Metformin|metformin|mesh-list
2787432|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2787433|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787434|NCT04317300|Varenicline|varenicline|mesh-list
2787435|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2787436|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2787437|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
2787438|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787439|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787440|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273098|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2273099|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273100|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2273101|NCT00202293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2273102|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2273103|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2787441|NCT04317508|Benzocaine|benzocaine|mesh-list
2787442|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
2787443|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
2787444|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787445|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787446|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
2787447|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787448|NCT04317430|Niclosamide|niclosamide|mesh-list
2787449|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
2787450|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2787451|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
2787452|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2787453|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787454|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
2787455|NCT04317235|Ropivacaine|ropivacaine|mesh-list
2787456|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
2787457|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
2787458|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787459|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787460|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
2787461|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787462|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
2273104|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273105|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273106|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
2787463|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2787464|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
2787465|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787466|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787467|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2787468|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
2787469|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787470|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787471|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2787472|NCT04316936|Dexamethasone|dexamethasone|mesh-list
2273107|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2273108|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
2273109|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
2273110|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
2273111|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2273112|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273113|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273114|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
2273115|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2273116|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273117|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273118|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2273119|NCT00202345|Hematinics|hematinics|mesh-ancestor
2273120|NCT00202358|Atenolol|atenolol|mesh-list
2273121|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2273122|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2273123|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
2273124|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
2273125|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273126|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273127|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2273128|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2787473|NCT04316936|Prednisolone|prednisolone|mesh-list
2787474|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2787475|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
2787476|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2787477|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
2787478|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2787479|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
2787480|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787481|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
2787482|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
2787483|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787484|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787485|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2787486|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
2787487|NCT04316936|Hormones|hormones|mesh-ancestor
2787488|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2787489|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2787490|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787491|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2102826|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
2102827|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102828|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2102829|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
2102830|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102831|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2102832|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2102833|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
2102834|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2273129|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2787492|NCT04316936|Protective Agents|protective agents|mesh-ancestor
2792512|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2792513|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2792514|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792515|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
2792516|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792517|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792518|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2792519|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792520|NCT04277143|Daptomycin|daptomycin|mesh-list
2792521|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2792522|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792523|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
2792524|NCT04276792|Narcotics|narcotics|mesh-ancestor
2792525|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792526|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792527|NCT04276792|Analgesics|analgesics|mesh-ancestor
2792528|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
2792529|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792530|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
2792531|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2792532|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792533|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792534|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2792535|NCT04276883|Analgesics|analgesics|mesh-ancestor
2792536|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
2792537|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792538|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2273130|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
2273131|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273132|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273133|NCT00202397|Riluzole|riluzole|mesh-list
2273134|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
2273135|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2273136|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2273137|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792539|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2792540|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2792541|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
2792542|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792543|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792544|NCT04276857|Leucovorin|leucovorin|mesh-list
2792545|NCT04276857|Gemcitabine|gemcitabine|mesh-list
2792546|NCT04276857|Paclitaxel|paclitaxel|mesh-list
2792547|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
2792548|NCT04276857|Irinotecan|irinotecan|mesh-list
2792549|NCT04276857|Folfirinox|folfirinox|mesh-list
2792550|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2792551|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792552|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
2792553|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
2792554|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
2792555|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792556|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2792557|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
2792558|NCT04276857|Antiviral Agents|antiviral agents|mesh-ancestor
2792559|NCT04276857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792560|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792561|NCT04276857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2792562|NCT04276857|Immunologic Factors|immunologic factors|mesh-ancestor
2792563|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792564|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2792565|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2792566|NCT04276857|Antidotes|antidotes|mesh-ancestor
2792567|NCT04276857|Protective Agents|protective agents|mesh-ancestor
2787493|NCT04317157|Caffeine|caffeine|mesh-list
2787494|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2787495|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787496|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2787497|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787498|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787499|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2787500|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2787501|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
2787502|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787503|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
2787504|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787505|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
2787506|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787507|NCT04317079|Protective Agents|protective agents|mesh-ancestor
2787508|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787509|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2787510|NCT04317183|Miconazole|miconazole|mesh-list
2787511|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
2787512|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787513|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2787514|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2787515|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787516|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787517|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2787518|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
2787519|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2787520|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787521|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2787522|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2787523|NCT04317001|Modafinil|modafinil|mesh-list
2787524|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2787525|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787526|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2787527|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2787528|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2787529|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787530|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2787531|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2787532|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787533|NCT04316806|Rifaximin|rifaximin|mesh-list
2787534|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2787535|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273138|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273139|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273140|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2273141|NCT00202397|Protective Agents|protective agents|mesh-ancestor
2273142|NCT00202423|Nabiximols|nabiximols|mesh-list
2273143|NCT00202423|Analgesics|analgesics|mesh-ancestor
2273144|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
2273145|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273146|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273147|NCT00202462|Testosterone|testosterone|mesh-list
2273148|NCT00202462|Androgens|androgens|mesh-ancestor
2273149|NCT00202462|Hormones|hormones|mesh-ancestor
2273150|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2273151|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273152|NCT00202514|Valproic Acid|valproic acid|mesh-list
2273153|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
2273154|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273155|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273156|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
2787536|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2787537|NCT04316390|Vitamins|vitamins|mesh-list
2787538|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
2787539|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
2787540|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787541|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
2787542|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787543|NCT04316390|Protective Agents|protective agents|mesh-ancestor
2787544|NCT04316676|Regadenoson|regadenoson|mesh-list
2792568|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
2787545|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2787546|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2787547|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
2787548|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
2787549|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787550|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787551|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787552|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
2787553|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
2787554|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2787555|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2787556|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787557|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787558|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787559|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787560|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2787561|NCT04316702|Analgesics|analgesics|mesh-ancestor
2273157|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273158|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273159|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
2273160|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2273161|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273162|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2273163|NCT00202553|Perindopril|perindopril|mesh-list
2273164|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2787562|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
2787563|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787564|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787565|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2787566|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787567|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2787568|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2787569|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2787570|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787571|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
2787572|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
2787573|NCT04316351|Pemetrexed|pemetrexed|mesh-list
2787574|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787575|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787576|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787577|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2787578|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2787579|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
2787580|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
2787581|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2787582|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2787583|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787584|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787585|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787586|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787587|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
2787588|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
2787589|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787590|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
2787591|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2787592|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
2787593|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2787594|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
2787595|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787596|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787597|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
2787598|NCT04316013|Lidocaine|lidocaine|mesh-list
2787599|NCT04316013|Propofol|propofol|mesh-list
2787600|NCT04316013|Sevoflurane|sevoflurane|mesh-list
2787601|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
2787602|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
2787603|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787604|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787605|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
2787606|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787607|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2787608|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2787609|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2792569|NCT04276857|Vitamins|vitamins|mesh-ancestor
2787610|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2787611|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787612|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2787613|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2787614|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
2787615|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2787616|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2787617|NCT04316039|Temozolomide|temozolomide|mesh-list
2787618|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2787619|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
2787620|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787621|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787622|NCT04315935|Fentanyl|fentanyl|mesh-list
2787623|NCT04315935|Butorphanol|butorphanol|mesh-list
2787624|NCT04315935|Propofol|propofol|mesh-list
2787625|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2787626|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787627|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787628|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2787629|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
2787630|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
2787631|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2787632|NCT04315935|Narcotics|narcotics|mesh-ancestor
2787633|NCT04315935|Analgesics|analgesics|mesh-ancestor
2787634|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
2787635|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787636|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2787637|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
2787638|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
2787639|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2787640|NCT04315909|Vitamin E|vitamin e|mesh-list
2787641|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2787642|NCT04315909|Vitamins|vitamins|mesh-ancestor
2273165|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
2273166|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273167|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273168|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2273169|NCT00202592|Perindopril|perindopril|mesh-list
2273170|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2273171|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
2273172|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273173|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273174|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2273175|NCT00202605|Amphetamine|amphetamine|mesh-list
2273176|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
2273177|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2273178|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273179|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
2273180|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
2273181|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273182|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
2273183|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787643|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
2787644|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787645|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
2787646|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787647|NCT04315909|Protective Agents|protective agents|mesh-ancestor
2787648|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
2787649|NCT04315909|Coagulants|coagulants|mesh-ancestor
2787650|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
2787651|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2787652|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
2787653|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2787654|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787655|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787656|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
2787657|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
2787658|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787659|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
2787660|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787661|NCT04315831|Buprenorphine|buprenorphine|mesh-list
2787662|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2787663|NCT04315831|Narcotics|narcotics|mesh-ancestor
2787664|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787665|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787666|NCT04315831|Analgesics|analgesics|mesh-ancestor
2787667|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
2787668|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787669|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2787670|NCT04315558|Bromides|bromides|mesh-list
2787671|NCT04315558|Ipratropium|ipratropium|mesh-list
2787672|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
2787673|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2787674|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
2787675|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787676|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787677|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2787678|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
2787679|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2787680|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
2787681|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787682|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787693|NCT04315688|Insulin|insulin|mesh-list
2787694|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2787695|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273184|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273185|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
2273186|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2273187|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2273188|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2273189|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2273190|NCT00202618|Amlodipine|amlodipine|mesh-list
2273191|NCT00202618|Valsartan|valsartan|mesh-list
2273192|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2787696|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
2787697|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
2787698|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
2787699|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787700|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787701|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
2787702|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787703|NCT04315493|Maleic acid|maleic acid|mesh-list
2787704|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787705|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792570|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
2792571|NCT04276688|Interferons|interferons|mesh-list
2792572|NCT04276688|Ritonavir|ritonavir|mesh-list
2792573|NCT04276688|Ribavirin|ribavirin|mesh-list
2792574|NCT04276688|Lopinavir|lopinavir|mesh-list
2792575|NCT04276688|Interferon-beta|interferon-beta|mesh-list
2792576|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
2792577|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792578|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
2792579|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792580|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2792581|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2792582|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
2792583|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792584|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792585|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2792586|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2792587|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2792588|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2792589|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
2792590|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
2792591|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792592|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2792593|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
2792594|NCT04276649|Antacids|antacids|mesh-ancestor
2792595|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792596|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2792597|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
2792598|NCT04276636|Antacids|antacids|mesh-ancestor
2787706|NCT04315194|Clarithromycin|clarithromycin|mesh-list
2787707|NCT04315194|Oseltamivir|oseltamivir|mesh-list
2787708|NCT04315194|Naproxen|naproxen|mesh-list
2787709|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2787710|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787711|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2787712|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787713|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787714|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2787715|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2787716|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2787717|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2787718|NCT04315194|Analgesics|analgesics|mesh-ancestor
2787719|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
2787720|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787721|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787722|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787723|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787724|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
2787725|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2787726|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
2787730|NCT04315350|Prednisolone|prednisolone|mesh-list
2787731|NCT04315350|Curcumin|curcumin|mesh-list
2787732|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787733|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
2787734|NCT04315350|Hormones|hormones|mesh-ancestor
2787735|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2273193|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2273194|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2273195|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273196|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2787736|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787737|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2787738|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787739|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787740|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2787741|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2787742|NCT04315350|Analgesics|analgesics|mesh-ancestor
2787743|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
2787744|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787745|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787746|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787747|NCT04315155|Nivolumab|nivolumab|mesh-list
2787748|NCT04315155|Ipilimumab|ipilimumab|mesh-list
2787749|NCT04315155|Belinostat|belinostat|mesh-list
2787750|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2787751|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787752|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2787753|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787754|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2787755|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787756|NCT04315116|Loperamide|loperamide|mesh-list
2787757|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
2787758|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2787759|NCT04314713|Scopolamine|scopolamine|mesh-list
2787760|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2787761|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2787762|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
2787763|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
2787764|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787765|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787766|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2787767|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
2787768|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2787769|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
2787770|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787771|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787772|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2787773|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
2787774|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
2787775|NCT04314843|Fludarabine|fludarabine|mesh-list
2787776|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2787777|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
2787778|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787779|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787780|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2787781|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
2787782|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787783|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787784|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2787788|NCT04314739|Resveratrol|resveratrol|mesh-list
2787789|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
2787790|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787791|NCT04314739|Protective Agents|protective agents|mesh-ancestor
2787792|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787793|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787794|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2787795|NCT04314570|Ropivacaine|ropivacaine|mesh-list
2787796|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
2273197|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273198|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
2273199|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2273200|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2273201|NCT00202696|Nalmefene|nalmefene|mesh-list
2273202|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2787797|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
2787798|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787799|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787800|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
2787801|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787802|NCT04314310|Tenoxicam|tenoxicam|mesh-list
2787803|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2787804|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2787805|NCT04314310|Analgesics|analgesics|mesh-ancestor
2787806|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
2787807|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787808|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787809|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787810|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787811|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2787812|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787813|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787814|NCT04314375|Budesonide|budesonide|mesh-list
2787815|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787816|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2787817|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
2787818|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787819|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787820|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2787821|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
2273203|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273204|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
2273205|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102835|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2102836|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2102837|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2102838|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102839|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
2102840|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2102841|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
2102842|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102843|NCT02413346|Sarecycline|sarecycline|mesh-list
2102844|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2102845|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102846|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
2102847|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
2102848|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2102849|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273206|NCT00202774|Fluorouracil|fluorouracil|mesh-list
2273207|NCT00202774|Capecitabine|capecitabine|mesh-list
2273208|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
2273209|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
2787822|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
2787823|NCT04314375|Hormones|hormones|mesh-ancestor
2787824|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2787825|NCT04314297|Durvalumab|durvalumab|mesh-list
2787826|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2787827|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787828|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
2787829|NCT04314219|Methotrexate|methotrexate|mesh-list
2787830|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2787831|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
2787832|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787833|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787834|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2787835|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
2787836|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787837|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787838|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2787839|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2787840|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
2787841|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2787842|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2787843|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
2787844|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
2787845|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787846|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2787847|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2787848|NCT04314674|Mannitol|mannitol|mesh-list
2102850|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2102851|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102852|NCT02413489|Daratumumab|daratumumab|mesh-list
2102853|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102854|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
2102855|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2102856|NCT02413593|Ledipasvir|ledipasvir|mesh-list
2102857|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
2102858|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102859|NCT02413918|Iloperidone|iloperidone|mesh-list
2102860|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2102861|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2102862|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2102863|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102864|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2102865|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
2102866|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
2102867|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2102868|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2102869|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102870|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787849|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2787850|NCT04314674|Diuretics|diuretics|mesh-ancestor
2787851|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
2787852|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787853|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
2787854|NCT04314505|Narcotics|narcotics|mesh-ancestor
2787855|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787856|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787857|NCT04314505|Analgesics|analgesics|mesh-ancestor
2787858|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
2787859|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787860|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
2787861|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102871|NCT02414204|Urological Agents|urological agents|mesh-ancestor
2102872|NCT02414854|Albuterol|albuterol|mesh-list
2102873|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2102874|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
2102875|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102876|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787862|NCT04313959|Dexamethasone|dexamethasone|mesh-list
2787863|NCT04313959|Ropivacaine|ropivacaine|mesh-list
2787864|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787865|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
2787866|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
2787867|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787868|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787869|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2787870|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
2787871|NCT04313959|Hormones|hormones|mesh-ancestor
2787872|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2787873|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2102877|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2102878|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
2102879|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
2102880|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2102881|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2102882|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2102883|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2102884|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
2102885|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102886|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102887|NCT02414932|Midazolam|midazolam|mesh-list
2102888|NCT02414932|Ketamine|ketamine|mesh-list
2102889|NCT02414932|Analgesics|analgesics|mesh-ancestor
2102890|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
2102891|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102892|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102893|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2102894|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2102895|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
2102896|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
2102897|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273210|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273211|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2273212|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273213|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273214|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
2273215|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273216|NCT00202787|Leucovorin|leucovorin|mesh-list
2273217|NCT00202787|Cetuximab|cetuximab|mesh-list
2273218|NCT00202787|Fluorouracil|fluorouracil|mesh-list
2273219|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
2273220|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2273221|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273222|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
2273223|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273224|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2273225|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273226|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
2273227|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273228|NCT00202787|Antidotes|antidotes|mesh-ancestor
2273229|NCT00202787|Protective Agents|protective agents|mesh-ancestor
2273230|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
2273231|NCT00202787|Vitamins|vitamins|mesh-ancestor
2273232|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
2273233|NCT00202800|Gemcitabine|gemcitabine|mesh-list
2273234|NCT00202800|Etoposide|etoposide|mesh-list
2273235|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2273236|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
2273237|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273238|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273239|NCT00202800|Antiviral Agents|antiviral agents|mesh-ancestor
2273240|NCT00202800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273241|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273242|NCT00202800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273243|NCT00202800|Immunologic Factors|immunologic factors|mesh-ancestor
2273244|NCT00202800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102898|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2102899|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2273245|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2787874|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787875|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
2787876|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
2787877|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787878|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
2273246|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2787879|NCT04314193|Prednisolone|prednisolone|mesh-list
2787880|NCT04314193|Methotrexate|methotrexate|mesh-list
2787881|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2787882|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
2787883|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2787884|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787885|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2787886|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
2787887|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787888|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787889|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
2787890|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787891|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2787892|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273247|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2273248|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
2273249|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2273250|NCT00202852|Infliximab|infliximab|mesh-list
2273251|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
2273252|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2273253|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273254|NCT00202865|Infliximab|infliximab|mesh-list
2273255|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
2273256|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2273257|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273258|NCT00202891|Sisomicin|sisomicin|mesh-list
2273259|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2273260|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273261|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2273262|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273263|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273264|NCT00202904|Ezetimibe|ezetimibe|mesh-list
2273265|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2273266|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2273267|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
2273268|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273269|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2273270|NCT00202917|Fludarabine|fludarabine|mesh-list
2273271|NCT00202917|Melphalan|melphalan|mesh-list
2273272|NCT00202917|Thiotepa|thiotepa|mesh-list
2273273|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273274|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273275|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273276|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
2273277|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273278|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2273279|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
2273280|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2273281|NCT00202969|Cisplatin|cisplatin|mesh-list
2273282|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273283|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
2273284|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
2273285|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2273286|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
2273287|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787893|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
2787894|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787895|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2273288|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273289|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273290|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
2273291|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
2273292|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
2273293|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2273294|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
2787896|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787897|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
2787898|NCT04314193|Hormones|hormones|mesh-ancestor
2787899|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2787900|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2787901|NCT04313972|Naltrexone|naltrexone|mesh-list
2787902|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2787903|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2787904|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787905|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
2787906|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787907|NCT04313907|Clonazepam|clonazepam|mesh-list
2787908|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
2787909|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
2787910|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
2787911|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787912|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273295|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273296|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273297|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273298|NCT00203034|Rasagiline|rasagiline|mesh-list
2273299|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2273300|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273301|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273302|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2273303|NCT00203034|Protective Agents|protective agents|mesh-ancestor
2273304|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273305|NCT00203060|Rasagiline|rasagiline|mesh-list
2273306|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2273307|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787913|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787914|NCT04313790|Heparin|heparin|mesh-list
2787915|NCT04313790|Calcium heparin|calcium heparin|mesh-list
2787916|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
2787917|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2787918|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2787919|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792599|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792600|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2792601|NCT04276389|Paclitaxel|paclitaxel|mesh-list
2792602|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2792603|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2792604|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792605|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
2792606|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
2792607|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
2792608|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792609|NCT04276376|Atezolizumab|atezolizumab|mesh-list
2792610|NCT04276376|Rucaparib|rucaparib|mesh-list
2792611|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792612|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2792613|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792614|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792615|NCT04276298|Metronidazole|metronidazole|mesh-list
2792616|NCT04276298|Lidocaine|lidocaine|mesh-list
2792617|NCT04276298|Diltiazem|diltiazem|mesh-list
2792618|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
2792619|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
2792620|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792621|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792622|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
2792623|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792624|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2792625|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2792626|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2273308|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273309|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2273310|NCT00203060|Protective Agents|protective agents|mesh-ancestor
2273311|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273312|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
2273313|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
2273314|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
2792627|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2792628|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792629|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792630|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2792631|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2792632|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2792633|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2792634|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2792635|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2792636|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
2792637|NCT04276480|Tazobactam|tazobactam|mesh-list
2792638|NCT04276480|Piperacillin|piperacillin|mesh-list
2792639|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2792640|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2792641|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2792642|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2792643|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2792644|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792645|NCT04276428|Insulin|insulin|mesh-list
2792646|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2792647|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792648|NCT04276597|Edotreotide|edotreotide|mesh-list
2792649|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2273315|NCT00203073|Analgesics|analgesics|mesh-ancestor
2273316|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
2273317|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273318|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102900|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2102901|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102902|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2102903|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2102904|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2102905|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2102906|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2102907|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
2102908|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
2102909|NCT02414958|Empagliflozin|empagliflozin|mesh-list
2102910|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2102911|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102912|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2102913|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102914|NCT02415127|Interferons|interferons|mesh-list
2102915|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
2102916|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102917|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
2102918|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2102919|NCT02415400|Aspirin|aspirin|mesh-list
2102920|NCT02415400|Vitamin K|vitamin k|mesh-list
2102921|NCT02415400|Apixaban|apixaban|mesh-list
2102922|NCT02415400|Vitamins|vitamins|mesh-ancestor
2102923|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
2102924|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787920|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2787921|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
2787922|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2787923|NCT04313764|Bupivacaine|bupivacaine|mesh-list
2787924|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
2787925|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
2787926|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2787927|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787928|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
2787929|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787930|NCT04313504|Niraparib|niraparib|mesh-list
2787931|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2787932|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787933|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787934|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787935|NCT04313452|Insulin|insulin|mesh-list
2787936|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2787937|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787938|NCT04313634|Dasatinib|dasatinib|mesh-list
2787939|NCT04313634|Quercetin|quercetin|mesh-list
2787940|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2787941|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2787942|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787943|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787944|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
2787945|NCT04313634|Protective Agents|protective agents|mesh-ancestor
2787946|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787947|NCT04313270|Evolocumab|evolocumab|mesh-list
2787948|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2787949|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2787950|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
2787951|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787952|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2787953|NCT04313218|Misoprostol|misoprostol|mesh-list
2787954|NCT04313218|Carbetocin|carbetocin|mesh-list
2787955|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2787956|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
2787957|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2787958|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787959|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2787960|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2787961|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
2787962|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2787963|NCT04313374|Morphine|morphine|mesh-list
2787964|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2787965|NCT04313374|Narcotics|narcotics|mesh-ancestor
2787966|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273319|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273320|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2273321|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2273322|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2787967|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787968|NCT04313374|Analgesics|analgesics|mesh-ancestor
2787969|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
2787970|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787971|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2787972|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2787973|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2787974|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2787975|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2787976|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2787977|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2787978|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2787979|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2787980|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2787981|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2787982|NCT04313335|Analgesics|analgesics|mesh-ancestor
2787983|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
2787984|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2787985|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
2787986|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2787987|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
2787990|NCT04313166|Copper|copper|mesh-list
2787991|NCT04313166|Trace Elements|trace elements|mesh-ancestor
2787992|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
2787993|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788002|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
2788003|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
2788004|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
2788005|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
2788006|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
2788007|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2788008|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2788009|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788010|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
2788011|NCT04312880|Coagulants|coagulants|mesh-ancestor
2788012|NCT04313036|Defibrotide|defibrotide|mesh-list
2788013|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2788014|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2788015|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788016|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2788017|NCT04312841|Acetic Acid|acetic acid|mesh-list
2788018|NCT04312841|Letermovir|letermovir|mesh-list
2788019|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2788020|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788021|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788022|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788023|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788024|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2788025|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
2788026|NCT04312750|Lidocaine|lidocaine|mesh-list
2788027|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
2788028|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
2788029|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2788030|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788031|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
2273323|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273324|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2273325|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
2273326|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273327|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273328|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
2273329|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
2273330|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2788032|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788033|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2788034|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2788035|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2788036|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2788037|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788038|NCT04313088|Eluxadoline|eluxadoline|mesh-list
2788039|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2788040|NCT04312503|Olanzapine|olanzapine|mesh-list
2788041|NCT04312503|Risperidone|risperidone|mesh-list
2788042|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2788043|NCT04312503|Aripiprazole|aripiprazole|mesh-list
2788044|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2788045|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2788046|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
2788047|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2788048|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788049|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788050|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2788051|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2788052|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2788053|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2788054|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2788055|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
2788056|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
2788057|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
2788058|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788059|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2788060|NCT04312503|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2788061|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2788062|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2788063|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
2788064|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
2788065|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2788066|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2788067|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2788068|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2788069|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2788070|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2788071|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2788072|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
2788073|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
2788074|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
2788075|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
2788076|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788077|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2788078|NCT04312347|Tamoxifen|tamoxifen|mesh-list
2788079|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2788080|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
2788081|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2788082|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788083|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2788084|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788085|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2788086|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2788087|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2788088|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
2273331|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
2273332|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
2273333|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273334|NCT00203099|Expectorants|expectorants|mesh-ancestor
2273335|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
2273336|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2273337|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
2273338|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273339|NCT00203099|Protective Agents|protective agents|mesh-ancestor
2273340|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273341|NCT00203099|Antidotes|antidotes|mesh-ancestor
2273342|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2273343|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
2273344|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2788089|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2788090|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
2788091|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788092|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788093|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2788094|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
2788095|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2788096|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
2788097|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788098|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2788099|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2788100|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
2788101|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
2788102|NCT04312243|Protective Agents|protective agents|mesh-ancestor
2788103|NCT04312438|Caseins|caseins|mesh-list
2788104|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
2788105|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
2788106|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788107|NCT04312360|Metronidazole|metronidazole|mesh-list
2788108|NCT04312360|Fosfomycin|fosfomycin|mesh-list
2788109|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788110|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2788111|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2788112|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2788113|NCT04312204|Gemcitabine|gemcitabine|mesh-list
2788114|NCT04312204|Carboplatin|carboplatin|mesh-list
2788115|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788116|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2788117|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
2788118|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788119|NCT04312204|Antiviral Agents|antiviral agents|mesh-ancestor
2788120|NCT04312204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788121|NCT04312204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273345|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273346|NCT00203112|Minocycline|minocycline|mesh-list
2273347|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
2788122|NCT04312204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2788123|NCT04312204|Immunologic Factors|immunologic factors|mesh-ancestor
2788124|NCT04312204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788125|NCT04312282|Itraconazole|itraconazole|mesh-list
2788126|NCT04312282|Rifampin|rifampin|mesh-list
2788127|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
2788128|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788129|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2788130|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2788131|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788132|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273348|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
2273349|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2273350|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273351|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2273352|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
2273353|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273354|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273355|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273356|NCT00203125|Rasagiline|rasagiline|mesh-list
2273357|NCT00203125|Tyramine|tyramine|mesh-list
2273358|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2273359|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273360|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273361|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2273362|NCT00203125|Protective Agents|protective agents|mesh-ancestor
2273363|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788133|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2788134|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
2788135|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2788136|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788137|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2788138|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2788139|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
2788140|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2788141|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
2788142|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2273364|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
2273365|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
2788143|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2788144|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2788145|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2788146|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2788147|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2788148|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2788149|NCT04312152|Vitamins|vitamins|mesh-list
2788150|NCT04312152|Vitamin E|vitamin e|mesh-list
2788151|NCT04312152|Tocopherols|tocopherols|mesh-list
2273366|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273367|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2273368|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2273369|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2273370|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
2273371|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273372|NCT00203138|Rasagiline|rasagiline|mesh-list
2273373|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2273374|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273375|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273376|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2273377|NCT00203138|Protective Agents|protective agents|mesh-ancestor
2273378|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273379|NCT00203164|Rasagiline|rasagiline|mesh-list
2273380|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2273381|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273382|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273383|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2273384|NCT00203164|Protective Agents|protective agents|mesh-ancestor
2273385|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273386|NCT00203177|Rasagiline|rasagiline|mesh-list
2273387|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2273388|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273389|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273390|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2273391|NCT00203177|Protective Agents|protective agents|mesh-ancestor
2273392|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273393|NCT00203190|Topiramate|topiramate|mesh-list
2273394|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
2273395|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2788152|NCT04312152|Folic Acid|folic acid|mesh-list
2788153|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
2788154|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
2788155|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788156|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
2788157|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788158|NCT04312152|Protective Agents|protective agents|mesh-ancestor
2788159|NCT04312152|Hematinics|hematinics|mesh-ancestor
2792650|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793033|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2793034|NCT04273321|Prednisolone|prednisolone|mesh-list
2793035|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
2793036|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2793037|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
2793038|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793039|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
2793040|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
2793041|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793042|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793043|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2793044|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
2793045|NCT04273321|Hormones|hormones|mesh-ancestor
2793046|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793047|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2102925|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2102926|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2793048|NCT04273321|Protective Agents|protective agents|mesh-ancestor
2793049|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2793050|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793051|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
2793052|NCT04273282|Dexamethasone|dexamethasone|mesh-list
2793053|NCT04273282|Prednisolone|prednisolone|mesh-list
2793054|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2793055|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
2793056|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2793057|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
2788160|NCT04311762|Cisplatin|cisplatin|mesh-list
2788161|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788162|NCT04312009|Losartan|losartan|mesh-list
2788163|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2788164|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2788165|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2788166|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2788167|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788168|NCT04312139|Lincomycin|lincomycin|mesh-list
2788169|NCT04312139|Calcium|calcium|mesh-list
2788170|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2788171|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788172|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2788173|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788174|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2788175|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102927|NCT02415400|Analgesics|analgesics|mesh-ancestor
2102928|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
2102929|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102930|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2102931|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2102932|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2102933|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2102934|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102935|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2102936|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2102937|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2102938|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
2102939|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2102940|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
2102941|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2102942|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
2273396|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273397|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
2273398|NCT00203281|Tacrolimus|tacrolimus|mesh-list
2273399|NCT00203281|Daclizumab|daclizumab|mesh-list
2273400|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
2273401|NCT00203281|Antibodies|antibodies|mesh-list
2273402|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
2273403|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2273404|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2273405|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273406|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
2273407|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273408|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2273409|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273410|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273411|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2273412|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273413|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2273414|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
2788176|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788177|NCT04312048|Isosorbide|isosorbide|mesh-list
2788178|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2273415|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2273416|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273417|NCT00203320|Etanercept|etanercept|mesh-list
2788179|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2788180|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2788181|NCT04312048|Diuretics|diuretics|mesh-ancestor
2788182|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
2788183|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788184|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
2788185|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2788186|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788187|NCT04312061|Tramadol|tramadol|mesh-list
2788188|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2788189|NCT04312061|Narcotics|narcotics|mesh-ancestor
2788190|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273418|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2273419|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2273420|NCT00203320|Analgesics|analgesics|mesh-ancestor
2273421|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
2273422|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273423|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788191|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273424|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2273425|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273426|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2273427|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273428|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
2788192|NCT04312061|Analgesics|analgesics|mesh-ancestor
2788193|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
2788194|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273429|NCT00203359|Etanercept|etanercept|mesh-list
2273430|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2273431|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2273432|NCT00203359|Analgesics|analgesics|mesh-ancestor
2273433|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
2273434|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273435|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273436|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2273437|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273438|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2273439|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273440|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
2273441|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
2273442|NCT00203372|Bevacizumab|bevacizumab|mesh-list
2273443|NCT00203372|Docetaxel|docetaxel|mesh-list
2273444|NCT00203372|Doxorubicin|doxorubicin|mesh-list
2273445|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273446|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
2273447|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788209|NCT04311489|Ularitide|ularitide|mesh-list
2788210|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2788211|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
2788212|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788213|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788214|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2788215|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
2788216|NCT04311489|Diuretics|diuretics|mesh-ancestor
2788217|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
2788218|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2788219|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2273448|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273449|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2273450|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
2273451|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273452|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273453|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2273454|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2788220|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788221|NCT04311567|Methotrexate|methotrexate|mesh-list
2788222|NCT04311567|Tofacitinib|tofacitinib|mesh-list
2788223|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2788224|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
2788225|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2788226|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273455|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2273456|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2273457|NCT00203372|Growth Substances|growth substances|mesh-ancestor
2273458|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
2273459|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
2273460|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
2273461|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
2273462|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2273463|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2788227|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2788228|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
2788229|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788230|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788231|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
2788232|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788233|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2788234|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2788235|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
2788236|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2788237|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2788238|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2788239|NCT04311671|Ivermectin|ivermectin|mesh-list
2788240|NCT04311671|Moxidectin|moxidectin|mesh-list
2788241|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2788242|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788243|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
2788244|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
2788245|NCT04311697|Phentolamine|phentolamine|mesh-list
2788246|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
2788247|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2788248|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2788249|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
2788250|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2788251|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788252|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788253|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2788254|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2788255|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
2788256|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2788257|NCT04311697|Protective Agents|protective agents|mesh-ancestor
2788258|NCT04311580|Mitomycins|mitomycins|mesh-list
2788259|NCT04311580|Mitomycin|mitomycin|mesh-list
2788260|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2788261|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788262|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
2788263|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788264|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2788265|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788266|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
2788267|NCT04311632|Tacrolimus|tacrolimus|mesh-list
2788268|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2788269|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
2788270|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788271|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2788272|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788273|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273464|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2273465|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273466|NCT00203385|Valproic Acid|valproic acid|mesh-list
2273467|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
2273468|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273469|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273470|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
2273471|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273472|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273473|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
2273474|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2273475|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273476|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2273477|NCT00203450|Zonisamide|zonisamide|mesh-list
2273478|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
2273479|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2273480|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2273481|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273482|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2788274|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2788275|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788276|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2788277|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
2788278|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2788279|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788280|NCT04311424|Tirzepatide|tirzepatide|mesh-list
2788281|NCT04311424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2788282|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788283|NCT04311424|Incretins|incretins|mesh-ancestor
2788284|NCT04311424|Hormones|hormones|mesh-ancestor
2788285|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2788286|NCT04311658|Isosorbide|isosorbide|mesh-list
2788287|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2788288|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2788289|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2788290|NCT04311658|Diuretics|diuretics|mesh-ancestor
2788291|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
2788292|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788293|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
2788294|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2788295|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788296|NCT04311645|Charcoal|charcoal|mesh-list
2788297|NCT04311645|Antidotes|antidotes|mesh-ancestor
2788298|NCT04311645|Protective Agents|protective agents|mesh-ancestor
2788299|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788300|NCT04311606|Aflibercept|aflibercept|mesh-list
2788301|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2788302|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2788303|NCT04311606|Growth Substances|growth substances|mesh-ancestor
2788304|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788305|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
2788306|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788307|NCT04311255|Anesthetics|anesthetics|mesh-list
2788308|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2788309|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788310|NCT04310995|Nicorandil|nicorandil|mesh-list
2788311|NCT04310995|Diltiazem|diltiazem|mesh-list
2788312|NCT04310995|Isosorbide|isosorbide|mesh-list
2788313|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2788314|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2788315|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2788316|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2788317|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2788318|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788319|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2788320|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788321|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
2788322|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2788323|NCT04310995|Diuretics|diuretics|mesh-ancestor
2788324|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
2788325|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2788326|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2788327|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
2788328|NCT04310995|Vitamins|vitamins|mesh-ancestor
2788329|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
2788330|NCT04310930|Azithromycin|azithromycin|mesh-list
2788331|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
2788332|NCT04310930|Clarithromycin|clarithromycin|mesh-list
2788333|NCT04310930|Doxycycline|doxycycline|mesh-list
2788334|NCT04310930|Linezolid|linezolid|mesh-list
2788335|NCT04310930|Imipenem|imipenem|mesh-list
2788336|NCT04310930|Amikacin|amikacin|mesh-list
2788337|NCT04310930|Ethambutol|ethambutol|mesh-list
2788338|NCT04310930|Rifabutin|rifabutin|mesh-list
2788339|NCT04310930|Tigecycline|tigecycline|mesh-list
2788340|NCT04310930|Bedaquiline|bedaquiline|mesh-list
2788341|NCT04310930|Clofazimine|clofazimine|mesh-list
2788342|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2788343|NCT04310930|Cefoxitin|cefoxitin|mesh-list
2788344|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2788345|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788346|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2788347|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2788348|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788349|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788350|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788351|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2788352|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2788353|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2788354|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
2079444|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079445|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079446|NCT02058368|Urological Agents|urological agents|mesh-ancestor
2079447|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2788355|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2788356|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2788357|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
2788358|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2788359|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2788360|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
2788361|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2788362|NCT04310930|Renal Agents|renal agents|mesh-ancestor
2788363|NCT04310943|Paclitaxel|paclitaxel|mesh-list
2788364|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2788365|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788366|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
2788367|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
2788368|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
2788369|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788370|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
2788371|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2788372|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2788373|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788374|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
2788375|NCT04311073|Coagulants|coagulants|mesh-ancestor
2788376|NCT04311099|Ropivacaine|ropivacaine|mesh-list
2788377|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
2788378|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
2788379|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2788380|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788381|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
2788382|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788383|NCT04311177|Losartan|losartan|mesh-list
2788384|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2788385|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2273483|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273484|NCT00203463|Topiramate|topiramate|mesh-list
2273485|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
2273486|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2273487|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273488|NCT00203528|Valproic Acid|valproic acid|mesh-list
2273489|NCT00203528|Risperidone|risperidone|mesh-list
2273490|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2273491|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
2273492|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273493|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273494|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273495|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2273496|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2273497|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273498|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2273499|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2273500|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
2273501|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
2273502|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273503|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
2273504|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
2273505|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2273506|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
2273507|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2273508|NCT00203554|Protective Agents|protective agents|mesh-ancestor
2273509|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788386|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2788387|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2788388|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788389|NCT04310683|Hormones|hormones|mesh-list
2788390|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2788391|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788392|NCT04310579|Midazolam|midazolam|mesh-list
2788393|NCT04310579|Oxycodone|oxycodone|mesh-list
2788394|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2788395|NCT04310579|Paroxetine|paroxetine|mesh-list
2788396|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2788397|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2788398|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2788399|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788400|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2788401|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2788402|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2788403|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2273510|NCT00203567|Carbamazepine|carbamazepine|mesh-list
2788404|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
2788405|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
2273511|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
2273512|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
2273513|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2273514|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273515|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273516|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2273517|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2273518|NCT00203567|Analgesics|analgesics|mesh-ancestor
2273519|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
2273520|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273521|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2273522|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2273523|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273524|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2788406|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
2788407|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
2788408|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2788409|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788410|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2788411|NCT04310579|Narcotics|narcotics|mesh-ancestor
2788412|NCT04310579|Analgesics|analgesics|mesh-ancestor
2788413|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
2788414|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788415|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
2788416|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2788417|NCT04310579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2788418|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2788419|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2788420|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
2788421|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2788422|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2788423|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2788424|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788425|NCT04310709|Nivolumab|nivolumab|mesh-list
2788426|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2788427|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788428|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2788429|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792651|NCT04276363|Nicotine|nicotine|mesh-list
2792652|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2792653|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
2792654|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2792655|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792656|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2792657|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2792658|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
2792659|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792660|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273525|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2273526|NCT00203580|Tinzaparin|tinzaparin|mesh-list
2273527|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2273528|NCT00203580|Dalteparin|dalteparin|mesh-list
2273529|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
2273530|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2273531|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2273532|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273533|NCT00203606|Interferons|interferons|mesh-list
2273534|NCT00203606|Ribavirin|ribavirin|mesh-list
2273535|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
2273536|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
2273537|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2273538|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273539|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
2273540|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273541|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
2273542|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273543|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
2273544|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273545|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
2273546|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2273547|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273548|NCT00203658|Tinzaparin|tinzaparin|mesh-list
2273549|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2788430|NCT04310774|Tegafur|tegafur|mesh-list
2788431|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2788432|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
2788433|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788434|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788435|NCT04310254|Edetic Acid|edetic acid|mesh-list
2788436|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2788437|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
2788438|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
2788439|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2788440|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
2788441|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
2788442|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788443|NCT04310254|Antidotes|antidotes|mesh-ancestor
2788444|NCT04310254|Protective Agents|protective agents|mesh-ancestor
2788445|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788446|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2788447|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
2788448|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2788449|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788450|NCT04310228|Favipiravir|favipiravir|mesh-list
2788451|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
2788452|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788453|NCT04310176|Bevacizumab|bevacizumab|mesh-list
2788454|NCT04310176|Fluorouracil|fluorouracil|mesh-list
2788455|NCT04310176|Capecitabine|capecitabine|mesh-list
2788456|NCT04310176|Valproic Acid|valproic acid|mesh-list
2788457|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2788458|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788459|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2788460|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2788461|NCT04310176|Growth Substances|growth substances|mesh-ancestor
2788462|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788463|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
2788464|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
2788465|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788466|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2788467|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2788468|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
2788469|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
2788470|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788471|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
2788472|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2788473|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
2788474|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2788475|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2788476|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2788477|NCT04310397|Trametinib|trametinib|mesh-list
2788478|NCT04310397|Dabrafenib|dabrafenib|mesh-list
2788479|NCT04310397|Spartalizumab|spartalizumab|mesh-list
2788480|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788481|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2788482|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788483|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788484|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2788485|NCT04309838|Treprostinil|treprostinil|mesh-list
2788486|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2788487|NCT04310150|Hemostatics|hemostatics|mesh-list
2079448|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2079449|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079450|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
2079451|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2079452|NCT02058511|Anesthetics|anesthetics|mesh-list
2079453|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079454|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079455|NCT02058628|Clindamycin|clindamycin|mesh-list
2079456|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
2079457|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
2079458|NCT02058628|Azelaic acid|azelaic acid|mesh-list
2079459|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2079460|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2079461|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2079462|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079463|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788488|NCT04310150|Coagulants|coagulants|mesh-ancestor
2788489|NCT04310059|Folic Acid|folic acid|mesh-list
2788490|NCT04310059|Hematinics|hematinics|mesh-ancestor
2788491|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
2788492|NCT04310059|Vitamins|vitamins|mesh-ancestor
2788493|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
2788494|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788495|NCT04310293|Hormones|hormones|mesh-list
2788496|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2788497|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788498|NCT04309929|Analgesics|analgesics|mesh-list
2788499|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
2788500|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788501|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788510|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
2788511|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2788512|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
2788513|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
2788514|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2788515|NCT04309643|Estradiol|estradiol|mesh-list
2788516|NCT04309643|Estrogens|estrogens|mesh-ancestor
2788517|NCT04309643|Hormones|hormones|mesh-ancestor
2788518|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2273550|NCT00203658|Dalteparin|dalteparin|mesh-list
2273551|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
2273552|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2273553|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2273554|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273555|NCT00203684|Flunisolide|flunisolide|mesh-list
2273556|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2273557|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2273558|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
2273559|NCT00203697|Minocycline|minocycline|mesh-list
2273560|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2273561|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273562|NCT00203723|Risperidone|risperidone|mesh-list
2273563|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2788519|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788520|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2788521|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2788522|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2788523|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2788524|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2788525|NCT04309708|Nimodipine|nimodipine|mesh-list
2273564|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
2273565|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273566|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273567|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788526|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2788527|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2788528|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2788529|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788530|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2788531|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788532|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
2788533|NCT04309578|Capecitabine|capecitabine|mesh-list
2788534|NCT04309578|Trastuzumab|trastuzumab|mesh-list
2788535|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788536|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2788537|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
2788538|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788539|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2788540|NCT04309552|Alovudine|alovudine|mesh-list
2788541|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
2788542|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788543|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2788544|NCT04309357|Plasminogen|plasminogen|mesh-list
2788545|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2788546|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2788547|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788548|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
2788549|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2788550|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
2788551|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2788552|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
2788553|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788554|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788555|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
2788556|NCT04308954|Flumazenil|flumazenil|mesh-list
2788557|NCT04308954|Antidotes|antidotes|mesh-ancestor
2788558|NCT04308954|Protective Agents|protective agents|mesh-ancestor
2788559|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788560|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
2273568|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2273569|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2273570|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273571|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2788561|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
2788562|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2788563|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788564|NCT04309058|Vitamin D|vitamin d|mesh-list
2788565|NCT04309058|Vitamins|vitamins|mesh-ancestor
2788566|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
2788567|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788568|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2792672|NCT04276545|Midazolam|midazolam|mesh-list
2792673|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2792674|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2792675|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2792676|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792677|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2792678|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2792679|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2792680|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2792681|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
2792682|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
2792683|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
2792684|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
2273572|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2273573|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
2273574|NCT00203736|Artesunate|artesunate|mesh-list
2273575|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
2273576|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
2273577|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2273578|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
2792685|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2792686|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792687|NCT04276090|Dexamethasone|dexamethasone|mesh-list
2792688|NCT04276090|Floxuridine|floxuridine|mesh-list
2792689|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2792690|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
2792691|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
2273579|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2273580|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2273581|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273582|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273583|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
2273584|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
2273585|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2273586|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
2273587|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2273588|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273589|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273590|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2273591|NCT00203736|Renal Agents|renal agents|mesh-ancestor
2273592|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2273593|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
2273594|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273595|NCT00203775|Risperidone|risperidone|mesh-list
2273596|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2273597|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
2788569|NCT04308863|Chitosan|chitosan|mesh-list
2788570|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788571|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2788572|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2788573|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
2788574|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2788575|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
2788576|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
2788577|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
2788578|NCT04308863|Coagulants|coagulants|mesh-ancestor
2273598|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273599|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273600|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788579|NCT04308551|Aspirin|aspirin|mesh-list
2788580|NCT04308551|Indobufen|indobufen|mesh-list
2788581|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2788582|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2788583|NCT04308551|Analgesics|analgesics|mesh-ancestor
2788584|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
2788585|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788586|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788587|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2788588|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2788589|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2788590|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2788591|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788592|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2788593|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2788594|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788595|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
2788596|NCT04308850|Vitamin D|vitamin d|mesh-list
2788597|NCT04308850|Vitamins|vitamins|mesh-ancestor
2788598|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
2788599|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788600|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2788601|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
2788602|NCT04308525|Narcotics|narcotics|mesh-ancestor
2788603|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2788604|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788605|NCT04308525|Analgesics|analgesics|mesh-ancestor
2788606|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
2788607|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788608|NCT04308317|Tetrandrine|tetrandrine|mesh-list
2273601|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2273602|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2273603|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273604|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2273605|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2273606|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
2273607|NCT00203788|Risperidone|risperidone|mesh-list
2273608|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2273609|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
2273610|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273611|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273612|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273613|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2273614|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2273615|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273616|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2273617|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2273618|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
2788609|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
2788610|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2788611|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2788612|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788613|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2788614|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788615|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
2788616|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2788617|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2788618|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788619|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2788620|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273619|NCT00203801|Artesunate|artesunate|mesh-list
2788621|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2788622|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
2788623|NCT04308343|Methotrexate|methotrexate|mesh-list
2788624|NCT04308343|Letrozole|letrozole|mesh-list
2788625|NCT04308343|Cetrorelix|cetrorelix|mesh-list
2788626|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2788627|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
2788628|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2788629|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788630|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2788631|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
2788632|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788633|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788634|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
2788635|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788636|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2788637|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2788638|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
2788639|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2788640|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2788641|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2788642|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2788643|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2788644|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
2788645|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2788646|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2788647|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
2788648|NCT04308174|Durvalumab|durvalumab|mesh-list
2788649|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2788650|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788651|NCT04308161|Vitamin D|vitamin d|mesh-list
2788652|NCT04308161|Miconazole|miconazole|mesh-list
2788653|NCT04308161|Vitamins|vitamins|mesh-ancestor
2788654|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
2788655|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788656|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2273620|NCT00203801|Lumefantrine|lumefantrine|mesh-list
2273621|NCT00203801|Artemether|artemether|mesh-list
2273622|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
2273623|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
2273624|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2788657|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
2788658|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788659|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2788660|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2788661|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788662|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788663|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2788664|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
2788665|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2788666|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2788667|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2788668|NCT04308031|Digoxin|digoxin|mesh-list
2788669|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2788670|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2788671|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788672|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788673|NCT04308031|Protective Agents|protective agents|mesh-ancestor
2788674|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788675|NCT04308070|Hemostatics|hemostatics|mesh-list
2788676|NCT04308070|Coagulants|coagulants|mesh-ancestor
2788677|NCT04307693|Ritonavir|ritonavir|mesh-list
2788678|NCT04307693|Lopinavir|lopinavir|mesh-list
2788679|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
2788680|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2079464|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2079465|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
2079466|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
2079467|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2079468|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2788681|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2788682|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
2788683|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788684|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788685|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2788686|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2788687|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
2788688|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788689|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2788690|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2788691|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
2788692|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2788693|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2788694|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2788695|NCT04307953|Saracatinib|saracatinib|mesh-list
2788696|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788697|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788698|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788740|NCT04307550|Ethanol|ethanol|mesh-list
2788741|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2788742|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788743|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2788744|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788745|NCT04307329|Trastuzumab|trastuzumab|mesh-list
2788746|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2788747|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788748|NCT04307511|Aspirin|aspirin|mesh-list
2788749|NCT04307511|Ticagrelor|ticagrelor|mesh-list
2788750|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2788751|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2788752|NCT04307511|Analgesics|analgesics|mesh-ancestor
2788753|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
2788754|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788755|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788756|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2788757|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2788758|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2788759|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2788760|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788761|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2788762|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2788763|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788764|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
2273625|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2273626|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
2273627|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2273628|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2273629|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273630|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273631|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
2273632|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
2273633|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2273634|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
2273635|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2273636|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273637|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273638|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2273639|NCT00203801|Renal Agents|renal agents|mesh-ancestor
2273640|NCT00203814|Artesunate|artesunate|mesh-list
2273641|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
2273642|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
2273643|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2788765|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2788766|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2788767|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2788768|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
2788769|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2788770|NCT04307485|Ticagrelor|ticagrelor|mesh-list
2788771|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2788772|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2788773|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2788774|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2788775|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
2788776|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2788777|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788778|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788779|NCT04307238|Anesthetics|anesthetics|mesh-list
2788780|NCT04307238|Propofol|propofol|mesh-list
2788781|NCT04307238|Sevoflurane|sevoflurane|mesh-list
2788782|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2788783|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788784|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2273644|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
2273645|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2273646|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2788785|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2788786|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
2788787|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2788788|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2792692|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273647|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273648|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273649|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
2273650|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
2273651|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2273652|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
2273653|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2273654|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273655|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273656|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2273657|NCT00203814|Renal Agents|renal agents|mesh-ancestor
2273658|NCT00203905|Bevacizumab|bevacizumab|mesh-list
2273659|NCT00203905|Fluorouracil|fluorouracil|mesh-list
2273660|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
2273661|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2273662|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273663|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2273664|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2273665|NCT00203905|Growth Substances|growth substances|mesh-ancestor
2273666|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792693|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792694|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2792695|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
2792696|NCT04276090|Hormones|hormones|mesh-ancestor
2792697|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2792698|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2273667|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
2273668|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
2788789|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
2788790|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2788791|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2788792|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788793|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2788794|NCT04307290|Analgesics|analgesics|mesh-ancestor
2788795|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
2788796|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788797|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2788798|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2788799|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2788800|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
2788801|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2788802|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788803|NCT04307147|Capecitabine|capecitabine|mesh-list
2788804|NCT04307147|Vinorelbine|vinorelbine|mesh-list
2788805|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2788806|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
2788807|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788808|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788809|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2788810|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
2788811|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
2788812|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
2788813|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
2788814|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
2788815|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788816|NCT04307069|Oxytocin|oxytocin|mesh-list
2788817|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
2788818|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2788819|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788820|NCT04306965|Apremilast|apremilast|mesh-list
2788821|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2788822|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2788823|NCT04306965|Analgesics|analgesics|mesh-ancestor
2273669|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273670|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2273671|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273672|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
2273673|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
2273674|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273675|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2273676|NCT00203957|Istradefylline|istradefylline|mesh-list
2273677|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2273678|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2273679|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2273680|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
2273681|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273682|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273683|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273684|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
2273685|NCT00204022|Azathioprine|azathioprine|mesh-list
2273686|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2273687|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273688|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2273689|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
2273690|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2273691|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273692|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273693|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273694|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
2273695|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2273696|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2788824|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
2788825|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788826|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788827|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2788828|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2788829|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2788830|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2788831|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788832|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788833|NCT04306900|Gemcitabine|gemcitabine|mesh-list
2788834|NCT04306900|Paclitaxel|paclitaxel|mesh-list
2788835|NCT04306900|Docetaxel|docetaxel|mesh-list
2788836|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2788837|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
2788838|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2788839|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788840|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
2788841|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
2788842|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
2788843|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788844|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2788845|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
2788846|NCT04306900|Antiviral Agents|antiviral agents|mesh-ancestor
2788847|NCT04306900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788848|NCT04306900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788849|NCT04306900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2788850|NCT04306900|Immunologic Factors|immunologic factors|mesh-ancestor
2788851|NCT04306900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788852|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2788853|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
2788854|NCT04306913|Esmolol|esmolol|mesh-list
2788855|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2788856|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2788857|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2788858|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
2788859|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2788860|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788861|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788862|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2788863|NCT04306666|Anesthetics|anesthetics|mesh-list
2788864|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273697|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
2273698|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273699|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273700|NCT00204061|Amisulpride|amisulpride|mesh-list
2273701|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2273702|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2273703|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273704|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273705|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2273706|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2273707|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
2273708|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273709|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273710|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2273711|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
2273712|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2273713|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2273714|NCT00204074|Estradiol|estradiol|mesh-list
2788865|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788866|NCT04306653|Betamethasone|betamethasone|mesh-list
2788867|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2788868|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
2788869|NCT04306653|Hormones|hormones|mesh-ancestor
2788870|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2788871|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788872|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2788873|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
2788874|NCT04306731|Trimethoprim|trimethoprim|mesh-list
2788875|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2788876|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2788877|NCT04306731|Renal Agents|renal agents|mesh-ancestor
2788878|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
2788879|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2788880|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2788881|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2788882|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788883|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788884|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2788885|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2788886|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2788887|NCT04306692|Inositol|inositol|mesh-list
2788888|NCT04306692|Clomiphene|clomiphene|mesh-list
2788889|NCT04306692|Enclomiphene|enclomiphene|mesh-list
2788890|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
2079469|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2079470|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079471|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
2079472|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079473|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079474|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2079475|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079476|NCT02058940|Exenatide|exenatide|mesh-list
2079477|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2273715|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2788891|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2788892|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
2788893|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2788894|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788895|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2788896|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
2788897|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2788898|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2788899|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2788900|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
2788901|NCT04306692|Vitamins|vitamins|mesh-ancestor
2788902|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
2788903|NCT04306627|Amlodipine|amlodipine|mesh-list
2788904|NCT04306627|Perindopril|perindopril|mesh-list
2788905|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
2788906|NCT04306627|Atorvastatin|atorvastatin|mesh-list
2788907|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2788908|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2788909|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
2788910|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788911|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2788912|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2788913|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788914|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2788915|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2788916|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2788917|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2788918|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788919|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
2788920|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2788921|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
2273716|NCT00204074|Estrogens|estrogens|mesh-ancestor
2273717|NCT00204074|Hormones|hormones|mesh-ancestor
2273718|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2273719|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788922|NCT04306354|Oxytocin|oxytocin|mesh-list
2788923|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
2788924|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2788925|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788926|NCT04306276|Dienogest|dienogest|mesh-list
2788927|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2788928|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
2788929|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2788930|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788931|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2788932|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2788933|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2788934|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2788935|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
2273720|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2273721|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
2273722|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2788936|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2788937|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2788938|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788939|NCT04306471|Evolocumab|evolocumab|mesh-list
2788940|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2788941|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2788942|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
2788943|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788944|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2788945|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
2788946|NCT04306367|Olaparib|olaparib|mesh-list
2788947|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2788948|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788949|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2788950|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788951|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788952|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
2788953|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2788954|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
2788955|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788956|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788957|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2788958|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
2788959|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2788960|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
2788961|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079478|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079479|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2079480|NCT02058940|Incretins|incretins|mesh-ancestor
2079481|NCT02058940|Hormones|hormones|mesh-ancestor
2273723|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2273724|NCT00204152|Vaccines|vaccines|mesh-list
2273725|NCT00204152|Immunologic Factors|immunologic factors|mesh-ancestor
2273726|NCT00204152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273727|NCT00204191|Tacrolimus|tacrolimus|mesh-list
2273728|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273729|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
2273730|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273731|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2273732|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273733|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273734|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
2788962|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2788963|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2788964|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
2788965|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
2788966|NCT04306393|Protective Agents|protective agents|mesh-ancestor
2788967|NCT04306159|Anesthetics|anesthetics|mesh-list
2788968|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2788969|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788970|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2788971|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2788972|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2788973|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2788974|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788975|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2788976|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2788977|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788978|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
2788979|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2788980|NCT04305964|Silicon|silicon|mesh-list
2788981|NCT04305964|Trace Elements|trace elements|mesh-ancestor
2788982|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
2788983|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2788984|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
2788985|NCT04306042|Nivolumab|nivolumab|mesh-list
2788986|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2788987|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788988|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2788989|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788990|NCT04305691|Ixazomib|ixazomib|mesh-list
2788991|NCT04305691|Glycine|glycine|mesh-list
2788992|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2788993|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2788994|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
2788995|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2788996|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
2788997|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2788998|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2792699|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2792700|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2792701|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
2792702|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2792703|NCT04276155|Anticoagulants|anticoagulants|mesh-list
2792704|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2079482|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2079483|NCT02058966|Entacapone|entacapone|mesh-list
2079484|NCT02058966|Methamphetamine|methamphetamine|mesh-list
2079485|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2079486|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2079487|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2079488|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079489|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079490|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2079491|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079492|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
2079493|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
2079494|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079495|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
2079496|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2079497|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
2079498|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2079499|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2079500|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2079501|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2079502|NCT02059070|Bupivacaine|bupivacaine|mesh-list
2079503|NCT02059070|Ropivacaine|ropivacaine|mesh-list
2079504|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
2079505|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
2079506|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2079507|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2079508|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
2079509|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2079510|NCT02059135|Antithrombins|antithrombins|mesh-list
2079511|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
2079512|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2079513|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
2079514|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2079515|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2079516|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
2788999|NCT04306081|Evolocumab|evolocumab|mesh-list
2789000|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2789001|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2789002|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
2789003|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789004|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2789005|NCT04305587|Clopidogrel|clopidogrel|mesh-list
2789006|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2789007|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2789008|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2789009|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2789010|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
2789011|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2789012|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2789013|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789014|NCT04305236|Fulvestrant|fulvestrant|mesh-list
2789015|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2789016|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789017|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2789018|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2789019|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
2789020|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2789021|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789022|NCT04305444|Everolimus|everolimus|mesh-list
2789023|NCT04305444|Pomalidomide|pomalidomide|mesh-list
2789024|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2789025|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2789026|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
2789027|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2789028|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2789029|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2789030|NCT04305444|Growth Substances|growth substances|mesh-ancestor
2789031|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
2789032|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
2789033|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2789034|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
2789035|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2789036|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273761|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2273762|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273763|NCT00204308|Tenofovir|tenofovir|mesh-list
2273764|NCT00204308|Emtricitabine|emtricitabine|mesh-list
2273765|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
2273766|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273767|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2273768|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2273769|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793068|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793069|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2793070|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793071|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2793072|NCT04273282|Protective Agents|protective agents|mesh-ancestor
2793073|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2793074|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793075|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2793076|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2793077|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793078|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793079|NCT04273165|Etravirine|etravirine|mesh-list
2793080|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2793081|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2793082|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793083|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793084|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
2793085|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793086|NCT04273256|Inositol|inositol|mesh-list
2793087|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
2793088|NCT04273256|Vitamins|vitamins|mesh-ancestor
2793089|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
2793090|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273770|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273771|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2273772|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2273773|NCT00204321|Sirolimus|sirolimus|mesh-list
2273774|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2273775|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793091|NCT04273191|Brexanolone|brexanolone|mesh-list
2793092|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
2793093|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793094|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793095|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793096|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
2793097|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
2793098|NCT04273100|Lenvatinib|lenvatinib|mesh-list
2793099|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793100|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2793101|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793102|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793103|NCT04273035|Midazolam|midazolam|mesh-list
2793104|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2793105|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2793106|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793107|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793108|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2793109|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2793110|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2793111|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2793112|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
2793113|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
2793114|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
2793115|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
2793116|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793117|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793118|NCT04273061|Atezolizumab|atezolizumab|mesh-list
2793119|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793120|NCT04272801|Tamoxifen|tamoxifen|mesh-list
2793121|NCT04272801|Letrozole|letrozole|mesh-list
2793122|NCT04272801|Anastrozole|anastrozole|mesh-list
2793123|NCT04272801|Exemestane|exemestane|mesh-list
2793124|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793125|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2793126|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2793127|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273776|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2273777|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273778|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
2273779|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273780|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
2273781|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273782|NCT00204347|Risperidone|risperidone|mesh-list
2273783|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2793128|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793129|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2793130|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
2793131|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793132|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793133|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2273784|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
2273785|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273786|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273787|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273788|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2273789|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2372120|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
2102969|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2102970|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2102971|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102972|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2102973|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2102974|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
2102975|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2102976|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102977|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2793134|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2793135|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2793136|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2793137|NCT04272788|Infliximab|infliximab|mesh-list
2793138|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
2793139|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2793140|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2793141|NCT04272645|Atezolizumab|atezolizumab|mesh-list
2793142|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793149|NCT04272567|Norepinephrine|norepinephrine|mesh-list
2793150|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2793151|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2793152|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
2793153|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273790|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273791|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2273792|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2273793|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
2273794|NCT00204386|Topiramate|topiramate|mesh-list
2793154|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793155|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793156|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
2793157|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
2793158|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793159|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2793160|NCT04272476|Fluoxetine|fluoxetine|mesh-list
2793161|NCT04272476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2793162|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2793163|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2793164|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793165|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793166|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
2793167|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793168|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2793169|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
2793170|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2793171|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2793172|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2793173|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793174|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2793175|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793176|NCT04272333|Nivolumab|nivolumab|mesh-list
2793177|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2793178|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793179|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2793180|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793181|NCT04272372|Ketoprofen|ketoprofen|mesh-list
2793182|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2793183|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2793184|NCT04272372|Analgesics|analgesics|mesh-ancestor
2793185|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
2793186|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793187|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273795|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
2273796|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2273797|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273798|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2793188|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793189|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2793190|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2793191|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273799|NCT00204438|Desogestrel|desogestrel|mesh-list
2273800|NCT00204438|Estradiol|estradiol|mesh-list
2273801|NCT00204438|Estrogens|estrogens|mesh-ancestor
2273802|NCT00204438|Hormones|hormones|mesh-ancestor
2273803|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793192|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793193|NCT04272255|Scopolamine|scopolamine|mesh-list
2793194|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2273804|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273805|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2273806|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
2273807|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2273808|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2273809|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2102978|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
2102979|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
2102980|NCT02416180|Hormones|hormones|mesh-ancestor
2102981|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2102982|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
2102983|NCT02416193|Vitamin D|vitamin d|mesh-list
2102984|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
2102985|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
2102986|NCT02416193|Vitamins|vitamins|mesh-list
2102987|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
2102988|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2102989|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2102990|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2102991|NCT02416908|Cytarabine|cytarabine|mesh-list
2102992|NCT02416908|Plerixafor|plerixafor|mesh-list
2793195|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2793196|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
2793197|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
2793198|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793199|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793200|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2793201|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
2793202|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2793203|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
2793204|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793205|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793206|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2793207|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
2793208|NCT04272086|Bupivacaine|bupivacaine|mesh-list
2793209|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
2793210|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
2793211|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793212|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793213|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
2793214|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793215|NCT04272320|Bupivacaine|bupivacaine|mesh-list
2793216|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
2793217|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
2793218|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793219|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793220|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
2793221|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793222|NCT04271917|Acetaminophen|acetaminophen|mesh-list
2793223|NCT04271917|Ibuprofen|ibuprofen|mesh-list
2793224|NCT04271917|Cannabidiol|cannabidiol|mesh-list
2793225|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2793226|NCT04271917|Analgesics|analgesics|mesh-ancestor
2793227|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
2793228|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793229|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793230|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
2793231|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2793232|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793233|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2793234|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2793235|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793236|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793237|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
2793238|NCT04271839|Fluticasone|fluticasone|mesh-list
2793239|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
2793240|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793241|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2793242|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
2793243|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793244|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793245|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2793246|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
2793247|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
2793248|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2793249|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2793250|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2793251|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2793252|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
2793253|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793254|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102993|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
2793255|NCT04272021|Methylphenidate|methylphenidate|mesh-list
2793256|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2793257|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793258|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2793259|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2793260|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2793261|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793262|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
2793263|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793264|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
2793265|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793266|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2793267|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793268|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273810|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2273811|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2273812|NCT00204438|Progestins|progestins|mesh-ancestor
2273813|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
2273814|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2273815|NCT00204451|Estradiol|estradiol|mesh-list
2273816|NCT00204451|Estrogens|estrogens|mesh-ancestor
2273817|NCT00204451|Hormones|hormones|mesh-ancestor
2273818|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2273819|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273820|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2273821|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
2273822|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2793269|NCT04271904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2793270|NCT04271332|Baclofen|baclofen|mesh-list
2793271|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2793272|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793273|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2793274|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793275|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2793276|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
2793277|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
2793278|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793279|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793280|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
2793281|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793282|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
2793283|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2793284|NCT04270994|Misoprostol|misoprostol|mesh-list
2793285|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2793286|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
2793287|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2793288|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793289|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2793290|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2793291|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
2793292|NCT04271189|Metformin|metformin|mesh-list
2793293|NCT04271189|Pioglitazone|pioglitazone|mesh-list
2793294|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2793295|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2793296|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793297|NCT04271189|Incretins|incretins|mesh-ancestor
2793298|NCT04271189|Hormones|hormones|mesh-ancestor
2793299|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2273823|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2273824|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2273825|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2273826|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2273827|NCT00204503|Valproic Acid|valproic acid|mesh-list
2273828|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
2273829|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273830|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273831|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
2273832|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273833|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273834|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
2273835|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2273836|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2273837|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2273838|NCT00204529|Interferons|interferons|mesh-list
2793300|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2793301|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
2273839|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
2273840|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
2273841|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2273842|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273843|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
2273844|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2273845|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
2273846|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273847|NCT00204542|Diclofenac|diclofenac|mesh-list
2273848|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2273849|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2273850|NCT00204542|Analgesics|analgesics|mesh-ancestor
2273851|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
2273852|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273853|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273854|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2273855|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273856|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2273857|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273858|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102994|NCT02416908|Cladribine|cladribine|mesh-list
2102995|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2102996|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
2102997|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2102998|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2102999|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
2793302|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793303|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793304|NCT04271384|Nivolumab|nivolumab|mesh-list
2793305|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2793306|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793307|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2793308|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793309|NCT04271202|Erenumab|erenumab|mesh-list
2793310|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2793311|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793312|NCT04271202|Analgesics|analgesics|mesh-ancestor
2793313|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
2793314|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793315|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793316|NCT04270864|Nivolumab|nivolumab|mesh-list
2793317|NCT04270864|Ipilimumab|ipilimumab|mesh-list
2793318|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2793319|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793320|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2793321|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793322|NCT04270877|Naltrexone|naltrexone|mesh-list
2793323|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2793324|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2793325|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793326|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
2793327|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793328|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2793329|NCT04270929|Folfirinox|folfirinox|mesh-list
2793330|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793331|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2793332|NCT04270682|Cathartics|cathartics|mesh-ancestor
2793333|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2793334|NCT04270656|Insulin|insulin|mesh-list
2793335|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2793336|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793337|NCT04270643|Vitamin D|vitamin d|mesh-list
2793338|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
2793339|NCT04270643|Vitamins|vitamins|mesh-ancestor
2793340|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
2793341|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793342|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2793343|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2793344|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
2793345|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2793346|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793347|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793348|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2793349|NCT04270708|Analgesics|analgesics|mesh-ancestor
2793350|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
2793351|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793352|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2793353|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2793354|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2793355|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
2793356|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793357|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793358|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
2793359|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2793360|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
2793361|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793362|NCT04270487|Octylonium|octylonium|mesh-list
2793363|NCT04270487|Bromides|bromides|mesh-list
2793364|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
2793365|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2793366|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2793367|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793368|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2793369|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273859|NCT00204555|Imiquimod|imiquimod|mesh-list
2273860|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2273861|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
2793370|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2793371|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
2793372|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
2793373|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793374|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2793375|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2793376|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
2793377|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793378|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2793379|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
2793380|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793381|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793382|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793383|NCT04270370|Atorvastatin|atorvastatin|mesh-list
2273862|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273863|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273864|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
2273865|NCT00204568|Doxorubicin|doxorubicin|mesh-list
2273866|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2273867|NCT00204568|Trofosfamide|trofosfamide|mesh-list
2273868|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2273869|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793384|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2793385|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2793386|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
2793387|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793388|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2793389|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2793390|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793391|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
2793392|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
2793393|NCT04270344|Valsartan|valsartan|mesh-list
2793394|NCT04270344|Pitavastatin|pitavastatin|mesh-list
2793395|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2793396|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2793397|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2793398|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793399|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2793400|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2793401|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2793402|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
2793403|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793404|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2793405|NCT04270175|Dexamethasone|dexamethasone|mesh-list
2793406|NCT04270175|Daratumumab|daratumumab|mesh-list
2793407|NCT04270175|Pomalidomide|pomalidomide|mesh-list
2793408|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793409|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
2793410|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
2793411|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793412|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793413|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2793414|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
2793415|NCT04270175|Hormones|hormones|mesh-ancestor
2793416|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793417|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2793418|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793419|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
2793420|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2793421|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2793422|NCT04270175|Growth Substances|growth substances|mesh-ancestor
2793423|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
2793424|NCT04269954|Heparin|heparin|mesh-list
2793425|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2793426|NCT04269954|Tinzaparin|tinzaparin|mesh-list
2793427|NCT04269954|Dalteparin|dalteparin|mesh-list
2793428|NCT04269954|Batroxobin|batroxobin|mesh-list
2793429|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
2793430|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2793431|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2793432|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793433|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
2793434|NCT04269954|Coagulants|coagulants|mesh-ancestor
2793435|NCT04270318|Pemetrexed|pemetrexed|mesh-list
2793436|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793437|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793438|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793439|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2793440|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2793441|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
2793442|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
2793443|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2793444|NCT04270019|Laxatives|laxatives|mesh-ancestor
2793445|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2793446|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2793447|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2793448|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2273870|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2273871|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2273872|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273873|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273874|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273875|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
2273876|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273877|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2273878|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
2273879|NCT00204581|Aldesleukin|aldesleukin|mesh-list
2273880|NCT00204581|Interleukin-2|interleukin-2|mesh-list
2273881|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273882|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2273883|NCT00204581|Analgesics|analgesics|mesh-ancestor
2793449|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793450|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
2793451|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793452|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103000|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103001|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2103002|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
2103003|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273884|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
2273885|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273886|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273887|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2103004|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2103005|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2103006|NCT02416934|Dexamethasone|dexamethasone|mesh-list
2103007|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2103008|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
2103009|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
2103010|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2273888|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2273889|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
2273890|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793453|NCT04269863|Aspirin|aspirin|mesh-list
2793454|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2793455|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2793456|NCT04269863|Analgesics|analgesics|mesh-ancestor
2793457|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
2793458|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793459|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793460|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793461|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2793462|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2793463|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2793464|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793465|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2793466|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2103011|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103012|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2103013|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
2103014|NCT02416934|Hormones|hormones|mesh-ancestor
2103015|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2103016|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2103017|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103018|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2103019|NCT02417064|Citalopram|citalopram|mesh-list
2103020|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2103021|NCT02417064|Sertraline|sertraline|mesh-list
2103022|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
2103023|NCT02417064|Esketamine|esketamine|mesh-list
2793467|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793468|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
2793469|NCT04269928|Epinephrine|epinephrine|mesh-list
2793470|NCT04269928|Racepinephrine|racepinephrine|mesh-list
2793471|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
2793472|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2793473|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2793474|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
2793475|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793476|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793477|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793478|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2793479|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2793480|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
2793481|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793482|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2793483|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
2793484|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
2793485|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
2793486|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2793487|NCT04269369|Fluorouracil|fluorouracil|mesh-list
2793488|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
2793489|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793490|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2793491|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793492|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2793493|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
2793494|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273891|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2273892|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2103024|NCT02417064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2103025|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2103026|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2103027|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103028|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103029|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
2103030|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103031|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2273893|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
2273894|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273895|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273896|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
2273897|NCT00204633|Hematinics|hematinics|mesh-ancestor
2273898|NCT00204646|Carboplatin|carboplatin|mesh-list
2273899|NCT00204646|Etoposide|etoposide|mesh-list
2273900|NCT00204646|Doxorubicin|doxorubicin|mesh-list
2273901|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2273902|NCT00204646|Ifosfamide|ifosfamide|mesh-list
2273903|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273904|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2273905|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2273906|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2273907|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273908|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273909|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2273910|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2273911|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
2273912|NCT00204659|Rituximab|rituximab|mesh-list
2273913|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2273914|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273915|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
2273916|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793511|NCT04269460|Bupivacaine|bupivacaine|mesh-list
2793512|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
2793513|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
2793514|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793515|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793516|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
2793517|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793523|NCT04269408|Nicardipine|nicardipine|mesh-list
2793524|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2793525|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2793526|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2793527|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793528|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2793529|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793530|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
2793531|NCT04269187|Theophylline|theophylline|mesh-list
2273917|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273918|NCT00204698|Rabeprazole|rabeprazole|mesh-list
2273919|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2273920|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2273921|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2273922|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273923|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273924|NCT00204737|Prednisone|prednisone|mesh-list
2793532|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2793533|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
2793534|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793535|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793536|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2793537|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
2793538|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2793539|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793540|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793541|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
2273925|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2273926|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
2273927|NCT00204737|Hormones|hormones|mesh-ancestor
2793542|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2793543|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2793544|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
2793545|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793546|NCT04268966|Brincidofovir|brincidofovir|mesh-list
2793547|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
2793548|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793549|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
2793550|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2793551|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793552|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273928|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2273929|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273930|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2273931|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273932|NCT00204776|Capecitabine|capecitabine|mesh-list
2273933|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
2273934|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2273935|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
2273936|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273937|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103032|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2103033|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103034|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2103035|NCT02417064|Analgesics|analgesics|mesh-ancestor
2103036|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
2103037|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
2103038|NCT02417129|Rituximab|rituximab|mesh-list
2103039|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2103040|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103041|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
2103042|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103043|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2793553|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2793554|NCT04269278|Analgesics|analgesics|mesh-ancestor
2793555|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
2793556|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793557|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2793558|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2793559|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2793560|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
2793561|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793562|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793563|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
2793564|NCT04269109|Narcotics|narcotics|mesh-ancestor
2793565|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793566|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793567|NCT04269109|Analgesics|analgesics|mesh-ancestor
2793568|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
2793569|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793570|NCT04268888|Nivolumab|nivolumab|mesh-list
2793571|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
2793572|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2793573|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793574|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2793575|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793576|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2793577|NCT04268888|Estrogens|estrogens|mesh-ancestor
2793578|NCT04268888|Hormones|hormones|mesh-ancestor
2793579|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793580|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793581|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2793582|NCT04268927|Letrozole|letrozole|mesh-list
2793583|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
2793584|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2793585|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793586|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2793587|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2793588|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793589|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793590|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2793591|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
2793592|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793593|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793594|NCT04268927|Hormones|hormones|mesh-ancestor
2793595|NCT04268849|Ascorbic Acid|ascorbic acid|mesh-list
2793596|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2793597|NCT04268849|Vitamins|vitamins|mesh-ancestor
2793598|NCT04268849|Micronutrients|micronutrients|mesh-ancestor
2793599|NCT04268849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793600|NCT04268849|Antioxidants|antioxidants|mesh-ancestor
2793601|NCT04268849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793602|NCT04268849|Protective Agents|protective agents|mesh-ancestor
2793603|NCT04268849|Hematinics|hematinics|mesh-ancestor
2793604|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2793605|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2793606|NCT04268771|Rituximab|rituximab|mesh-list
2793607|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2793608|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793609|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
2793610|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273938|NCT00204789|Eflornithine|eflornithine|mesh-list
2273939|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2273940|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2273941|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2273942|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2273943|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793611|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2793612|NCT04268706|Fludarabine|fludarabine|mesh-list
2793613|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2793614|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793615|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793616|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2793617|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
2793618|NCT04268602|Anesthetics|anesthetics|mesh-list
2793619|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
2793620|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793621|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793622|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
2793623|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793624|NCT04268407|Amoxicillin|amoxicillin|mesh-list
2793625|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
2793626|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
2793627|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2793628|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2793629|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793630|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2793631|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793632|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793633|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
2793634|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2793635|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793636|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793637|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2793638|NCT04268303|Analgesics|analgesics|mesh-ancestor
2793639|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
2793640|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793641|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2793642|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2793643|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2793644|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
2793645|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103051|NCT02417246|Metoprolol|metoprolol|mesh-list
2103052|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2103053|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2103054|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
2103055|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
2273944|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2273945|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793646|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793647|NCT04268524|Miltefosine|miltefosine|mesh-list
2793648|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
2793649|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793650|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793651|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2793652|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2793653|NCT04268563|Metformin|metformin|mesh-list
2273946|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273947|NCT00204893|Calcium|calcium|mesh-list
2273948|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2273949|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273950|NCT00204906|Vitamin D|vitamin d|mesh-list
2273951|NCT00204906|Vitamins|vitamins|mesh-ancestor
2273952|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
2793654|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2793655|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2793656|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793657|NCT04268563|Incretins|incretins|mesh-ancestor
2793658|NCT04268563|Hormones|hormones|mesh-ancestor
2793659|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793660|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2793661|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
2793662|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793663|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793664|NCT04268472|Darunavir|darunavir|mesh-list
2793665|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2793666|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2793667|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
2793668|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793669|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793670|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2793671|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2793672|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
2793673|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793674|NCT04268537|Antibodies|antibodies|mesh-list
2793675|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
2793676|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
2793677|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793678|NCT04268394|Metformin|metformin|mesh-list
2793679|NCT04268394|Itraconazole|itraconazole|mesh-list
2793680|NCT04268394|Rifampin|rifampin|mesh-list
2793681|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
2793682|NCT04268394|Methotrexate|methotrexate|mesh-list
2793683|NCT04268394|Digoxin|digoxin|mesh-list
2793684|NCT04268394|Midazolam|midazolam|mesh-list
2793685|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2793686|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2793687|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793688|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2793689|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
2793690|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2793691|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2793692|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
2793693|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793694|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793695|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
2793696|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793697|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2793698|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2793699|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
2793700|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2793701|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2793702|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2793703|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2793704|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793705|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2793706|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2793707|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2793708|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2793709|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
2793710|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
2793711|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
2793712|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
2793713|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793714|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2793715|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2793716|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2793717|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2793718|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
2793719|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793720|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2793721|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2793722|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2793723|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
2793724|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793725|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2793726|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2793727|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
2793728|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2273953|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273954|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2273955|NCT00204919|Vitamin D|vitamin d|mesh-list
2273956|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
2273957|NCT00204919|Vitamins|vitamins|mesh-ancestor
2273958|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
2273959|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273960|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2793729|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
2793730|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2793731|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2793732|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2793733|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2273961|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2273962|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2273963|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
2273964|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273965|NCT00204984|Hydralazine|hydralazine|mesh-list
2793734|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2793735|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2793736|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2793737|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2793738|NCT04268394|Protective Agents|protective agents|mesh-ancestor
2793739|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2793740|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2793741|NCT04268394|Analgesics|analgesics|mesh-ancestor
2793742|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
2793743|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793744|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793745|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2273966|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2273967|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
2273968|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273969|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2273970|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
2273971|NCT00205166|Caffeine|caffeine|mesh-list
2273972|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2273973|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273974|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2273975|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273976|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273977|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2273978|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2273979|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
2793746|NCT04268199|Bortezomib|bortezomib|mesh-list
2793747|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793748|NCT04267978|Irinotecan|irinotecan|mesh-list
2793749|NCT04267978|Temozolomide|temozolomide|mesh-list
2793750|NCT04267978|Endostatins|endostatins|mesh-list
2793751|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2793752|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2793753|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793754|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793755|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793756|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2793757|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
2793758|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2793759|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2793760|NCT04267978|Growth Substances|growth substances|mesh-ancestor
2793761|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793762|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
2793763|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
2273980|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2273981|NCT00205231|Etanercept|etanercept|mesh-list
2273982|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2273983|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2793764|NCT04267887|Prednisone|prednisone|mesh-list
2793765|NCT04267887|Cortisone|cortisone|mesh-list
2793766|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
2793767|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
2793768|NCT04267887|Hormones|hormones|mesh-list
2793769|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2793770|NCT04267887|Androgens|androgens|mesh-list
2793771|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
2793772|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793773|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
2793774|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793775|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793776|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2793777|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793778|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2273984|NCT00205231|Analgesics|analgesics|mesh-ancestor
2273985|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
2273986|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793779|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793780|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793781|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
2793782|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2793783|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
2793784|NCT04267887|Protective Agents|protective agents|mesh-ancestor
2793785|NCT04267887|Vitamins|vitamins|mesh-ancestor
2793786|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
2793787|NCT04267887|Estrogens|estrogens|mesh-ancestor
2793788|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
2793789|NCT04267991|Tacrolimus|tacrolimus|mesh-list
2793790|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2793791|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
2793792|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793793|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2793794|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793795|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793796|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2793797|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2793798|NCT04267653|Lactoferrin|lactoferrin|mesh-list
2793799|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793800|NCT04267679|Cannabidiol|cannabidiol|mesh-list
2793801|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
2793802|NCT04267913|Dexamethasone|dexamethasone|mesh-list
2793803|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
2793804|NCT04267913|Docetaxel|docetaxel|mesh-list
2793805|NCT04267913|Ramucirumab|ramucirumab|mesh-list
2793806|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2793807|NCT04267913|Antibodies|antibodies|mesh-list
2793808|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
2793809|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2793810|NCT04267913|BB 1101|bb 1101|mesh-list
2793811|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
2793812|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793813|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793814|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
2273987|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2273988|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2273989|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2273990|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2273991|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2273992|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
2273993|NCT00205283|Nelfinavir|nelfinavir|mesh-list
2273994|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2273995|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2273996|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
2273997|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2273998|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2273999|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2274000|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2274001|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
2274002|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274003|NCT00205322|Leucovorin|leucovorin|mesh-list
2274004|NCT00205322|Capecitabine|capecitabine|mesh-list
2274005|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
2274006|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2274007|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
2274008|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274009|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274010|NCT00205322|Antidotes|antidotes|mesh-ancestor
2274011|NCT00205322|Protective Agents|protective agents|mesh-ancestor
2793815|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
2793816|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793817|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2793818|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
2793819|NCT04267913|Hormones|hormones|mesh-ancestor
2793820|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793821|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2793822|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793823|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
2793824|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793825|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793826|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
2793827|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
2793828|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
2793829|NCT04267614|Etanercept|etanercept|mesh-list
2793830|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2793831|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2793832|NCT04267614|Analgesics|analgesics|mesh-ancestor
2793833|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
2793834|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793835|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793836|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793837|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2793838|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2793839|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2793840|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
2793841|NCT04267809|Metformin|metformin|mesh-list
2793842|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2793843|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793844|NCT04267497|Amphotericin B|amphotericin b|mesh-list
2793845|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2793846|NCT04267497|Amebicides|amebicides|mesh-ancestor
2793847|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2793848|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2793849|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793850|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2793851|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
2793852|NCT04267549|Paclitaxel|paclitaxel|mesh-list
2793853|NCT04267549|Apatinib|apatinib|mesh-list
2793854|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2793855|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793856|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
2793857|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
2793858|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
2793859|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793860|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2793861|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793862|NCT04267926|Ubiquinone|ubiquinone|mesh-list
2793863|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
2793864|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274012|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274013|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
2274014|NCT00205322|Vitamins|vitamins|mesh-ancestor
2274015|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
2274016|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2793865|NCT04267237|Atezolizumab|atezolizumab|mesh-list
2793866|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793867|NCT04267224|Ticagrelor|ticagrelor|mesh-list
2793868|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2793869|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2793870|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2793871|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2793872|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
2793873|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793874|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793875|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274017|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
2274018|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274019|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2274020|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2274021|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2793876|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
2793877|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2793878|NCT04267250|Estradiol|estradiol|mesh-list
2793879|NCT04267250|PF-06700841|pf-06700841|mesh-list
2793880|NCT04267250|Estrogens|estrogens|mesh-ancestor
2793881|NCT04267250|Hormones|hormones|mesh-ancestor
2793882|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793883|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793884|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2793885|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
2793886|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2793887|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2793888|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2793889|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2793890|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2793891|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2793892|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793893|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793894|NCT04267042|Budesonide|budesonide|mesh-list
2793895|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793896|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2793897|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
2793898|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793899|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793900|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2274022|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2274023|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274024|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274025|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274026|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2274027|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
2274028|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274029|NCT00205634|Clarithromycin|clarithromycin|mesh-list
2103056|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103057|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103058|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2103059|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2103060|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2103061|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
2103062|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103063|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103064|NCT02417831|Tamsulosin|tamsulosin|mesh-list
2103065|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2103066|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2103067|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2103068|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
2103069|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103070|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103071|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103072|NCT02417831|Urological Agents|urological agents|mesh-ancestor
2103073|NCT02417844|Tamsulosin|tamsulosin|mesh-list
2103074|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2793901|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
2793902|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
2793903|NCT04267042|Hormones|hormones|mesh-ancestor
2793904|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793905|NCT04267081|Venetoclax|venetoclax|mesh-list
2793906|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793907|NCT04267146|Nivolumab|nivolumab|mesh-list
2793908|NCT04267146|Temozolomide|temozolomide|mesh-list
2793909|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2793910|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793911|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2793912|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793913|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2793914|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
2793915|NCT04266977|Dexamethasone|dexamethasone|mesh-list
2793916|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793917|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
2793918|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
2793919|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793920|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793921|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2793922|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
2793923|NCT04266977|Hormones|hormones|mesh-ancestor
2793924|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2793925|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2793926|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793927|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2793928|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
2793929|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793930|NCT04266756|Selexipag|selexipag|mesh-list
2793931|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2274030|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2274031|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274032|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2274033|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274034|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274035|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2103075|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2103076|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2103077|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
2103078|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103079|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103080|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103081|NCT02417844|Urological Agents|urological agents|mesh-ancestor
2103082|NCT02417935|Pregabalin|pregabalin|mesh-list
2103083|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2103084|NCT02417935|Analgesics|analgesics|mesh-ancestor
2103085|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
2103086|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103087|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793932|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
2793933|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2793934|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793935|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793936|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2793937|NCT04266665|Analgesics|analgesics|mesh-ancestor
2793938|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
2793939|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793940|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2793941|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2793942|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2793943|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
2793944|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2793945|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793946|NCT04266353|Resveratrol|resveratrol|mesh-list
2793947|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
2793948|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793949|NCT04266353|Protective Agents|protective agents|mesh-ancestor
2793950|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793951|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793952|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2793953|NCT04266275|Curcumin|curcumin|mesh-list
2793954|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2793955|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2793956|NCT04266275|Analgesics|analgesics|mesh-ancestor
2793957|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
2793958|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793959|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793960|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2793961|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2793962|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2793963|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793964|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793965|NCT04266509|Rifampin|rifampin|mesh-list
2793966|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2793967|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
2793968|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2793969|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2793970|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
2793971|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2793972|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2793973|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2793974|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2793975|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2793976|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2793977|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2793978|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2793979|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2793980|NCT04266236|Ropivacaine|ropivacaine|mesh-list
2793981|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
2793982|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793983|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274036|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2274037|NCT00205725|Olanzapine|olanzapine|mesh-list
2274038|NCT00205725|Ziprasidone|ziprasidone|mesh-list
2274039|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
2274040|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
2274041|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274042|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274043|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274044|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274045|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2793984|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
2793985|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
2793986|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793987|NCT04266288|Ketamine|ketamine|mesh-list
2793988|NCT04266288|Analgesics|analgesics|mesh-ancestor
2793989|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
2793990|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2793991|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2793992|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2793993|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2274046|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793994|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
2793995|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
2793996|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2793997|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2793998|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2793999|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794000|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274047|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274048|NCT00205725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2274049|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2274050|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2274051|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274052|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274053|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
2274054|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2274055|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2274056|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
2274057|NCT00205738|Olanzapine|olanzapine|mesh-list
2274058|NCT00205738|Risperidone|risperidone|mesh-list
2274059|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2274060|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
2274061|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274062|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794001|NCT04266340|Midazolam|midazolam|mesh-list
2794002|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
2794003|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2794004|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794005|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794006|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2794007|NCT04266340|Analgesics|analgesics|mesh-ancestor
2794008|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
2794009|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794010|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2794011|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2794012|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2794013|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
2794014|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794015|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794016|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2794017|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2794018|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2794019|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2794020|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2794021|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
2794022|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
2794023|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
2794024|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
2794025|NCT04266132|Bupivacaine|bupivacaine|mesh-list
2794026|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
2794027|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
2794028|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794029|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794030|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
2794031|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794032|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2794033|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
2794034|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2794035|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2794036|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794037|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794038|NCT04266197|Urological Agents|urological agents|mesh-ancestor
2794039|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
2794040|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2794041|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794042|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794043|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2794044|NCT04266145|Analgesics|analgesics|mesh-ancestor
2274063|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274064|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274065|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274066|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274067|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274068|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2274069|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
2274070|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
2794045|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
2794046|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794047|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2794048|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2794049|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2794050|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
2794051|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794052|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794053|NCT04265833|Calcium|calcium|mesh-list
2794054|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2794055|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794056|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2794057|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
2794058|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2794059|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
2794060|NCT04265872|Bortezomib|bortezomib|mesh-list
2794061|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794062|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2794063|NCT04265456|Acetaminophen|acetaminophen|mesh-list
2794064|NCT04265456|Pregabalin|pregabalin|mesh-list
2794065|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2794066|NCT04265456|Analgesics|analgesics|mesh-ancestor
2794067|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
2794068|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794069|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794070|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
2794071|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
2794072|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2794073|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2794074|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794075|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2794076|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2794077|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2794078|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794079|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2794080|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2794081|NCT04265612|Laxatives|laxatives|mesh-ancestor
2794082|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2794083|NCT04265508|Hemostatics|hemostatics|mesh-list
2794084|NCT04265508|Coagulants|coagulants|mesh-ancestor
2794085|NCT04265274|Copper|copper|mesh-list
2794086|NCT04265274|Disulfiram|disulfiram|mesh-list
2103088|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
2103089|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2103090|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2794087|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794088|NCT04265274|Trace Elements|trace elements|mesh-ancestor
2794089|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
2794090|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794091|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2794092|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2794093|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794094|NCT04265105|Fluticasone|fluticasone|mesh-list
2794095|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2794096|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2794097|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
2794098|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794099|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794100|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2794101|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
2794102|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
2794103|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2794104|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
2794105|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2794106|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
2794107|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794108|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
2794109|NCT04265001|Protective Agents|protective agents|mesh-ancestor
2794110|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
2794111|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2794112|NCT04264858|Antibodies|antibodies|mesh-list
2794113|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
2794114|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
2794115|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794116|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
2794117|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
2794118|NCT04264988|Protective Agents|protective agents|mesh-ancestor
2794119|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794120|NCT04265027|Opicapone|opicapone|mesh-list
2794121|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2794122|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794123|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794124|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2794125|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2794126|NCT04265053|Ketorolac|ketorolac|mesh-list
2794127|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2794128|NCT04265053|Estradiol|estradiol|mesh-list
2794129|NCT04265053|Testosterone|testosterone|mesh-list
2794130|NCT04265053|Ganirelix|ganirelix|mesh-list
2794131|NCT04265053|Estrogens|estrogens|mesh-ancestor
2794132|NCT04265053|Hormones|hormones|mesh-ancestor
2794133|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2794134|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794135|NCT04265053|Androgens|androgens|mesh-ancestor
2794136|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2794137|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2794138|NCT04265053|Analgesics|analgesics|mesh-ancestor
2794139|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
2794140|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794141|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2794142|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2794143|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2794144|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794145|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794146|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
2794147|NCT04264806|Azacitidine|azacitidine|mesh-list
2794148|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2794149|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
2794150|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794151|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794152|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794153|NCT04264676|Metronidazole|metronidazole|mesh-list
2103091|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103092|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2103093|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2274071|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
2274072|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274073|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274074|NCT00205738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2274075|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2274076|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2274077|NCT00205751|Thalidomide|thalidomide|mesh-list
2274078|NCT00205751|Dexamethasone|dexamethasone|mesh-list
2274079|NCT00205751|Prednisone|prednisone|mesh-list
2274080|NCT00205751|Melphalan|melphalan|mesh-list
2274081|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2274082|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
2274083|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
2274084|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274085|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794154|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2794155|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2794156|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2794157|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2794158|NCT04264481|Lidocaine|lidocaine|mesh-list
2794159|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
2274086|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274087|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
2274088|NCT00205751|Hormones|hormones|mesh-ancestor
2794160|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
2794161|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794162|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794163|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
2794164|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794165|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2794166|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2103094|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2103095|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274089|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2794167|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2794168|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2794169|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794170|NCT04264624|Erythritol|erythritol|mesh-list
2794171|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
2794172|NCT04264637|Azelastine|azelastine|mesh-list
2794173|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2794174|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
2794175|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794176|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794177|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2794178|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
2794179|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2794180|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103096|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2103097|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2103098|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2103099|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103100|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
2103101|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
2103102|NCT02417961|Benralizumab|benralizumab|mesh-list
2103103|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2794181|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794182|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2794183|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2794184|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2794185|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
2794186|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
2794187|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794188|NCT04264078|Fludarabine|fludarabine|mesh-list
2794189|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
2794190|NCT04264078|Melphalan|melphalan|mesh-list
2794191|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794192|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794193|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794194|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
2794195|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794196|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2794197|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2794198|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
2794199|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2794200|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2274090|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2274091|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274092|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2274093|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
2274094|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274095|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2274096|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2274097|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
2274098|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
2794201|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
2794202|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794203|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2794204|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
2103104|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
2103105|NCT02418182|Acetaminophen|acetaminophen|mesh-list
2103106|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2103107|NCT02418182|Analgesics|analgesics|mesh-ancestor
2103108|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
2103109|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103110|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103111|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
2103112|NCT02418312|Famotidine|famotidine|mesh-list
2103113|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
2103114|NCT02418312|Histamine|histamine|mesh-list
2103115|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2103116|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2103117|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
2103118|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
2103119|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103120|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103121|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274099|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2794205|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794206|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794207|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2794208|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2794209|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2794210|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
2794211|NCT04264039|Fludarabine|fludarabine|mesh-list
2794212|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
2794213|NCT04264039|Melphalan|melphalan|mesh-list
2794214|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274100|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274101|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2274102|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2794215|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794216|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794217|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
2794218|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794219|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2794220|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2794221|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
2794222|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2794223|NCT04264260|Colchicine|colchicine|mesh-list
2794224|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
2794225|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2794226|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
2794227|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
2794228|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
2794229|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794230|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794231|NCT04264130|Artesunate|artesunate|mesh-list
2794232|NCT04264130|Lumefantrine|lumefantrine|mesh-list
2794233|NCT04264130|Artemether|artemether|mesh-list
2794234|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2274103|NCT00205751|Growth Substances|growth substances|mesh-ancestor
2274104|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
2794235|NCT04264130|Pyronaridine|pyronaridine|mesh-list
2794236|NCT04264130|Artefenomel|artefenomel|mesh-list
2794237|NCT04264130|Ferroquine|ferroquine|mesh-list
2794238|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
2794239|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2794240|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2794241|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2794242|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794243|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
2794244|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
2794245|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2794246|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
2794247|NCT04264286|Esmolol|esmolol|mesh-list
2794248|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2794249|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2794250|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2103122|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
2103123|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2103124|NCT02418585|Citalopram|citalopram|mesh-list
2103125|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2103126|NCT02418585|Sertraline|sertraline|mesh-list
2103127|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
2103128|NCT02418585|Esketamine|esketamine|mesh-list
2103129|NCT02418585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2103130|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2103131|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2103132|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103133|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103134|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
2103135|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103136|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2103137|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2103138|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103139|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2103140|NCT02418585|Analgesics|analgesics|mesh-ancestor
2103141|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
2103142|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
2103143|NCT02418676|Insulin|insulin|mesh-list
2103144|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2103145|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103146|NCT02418754|Aflibercept|aflibercept|mesh-list
2103147|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2794251|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
2794252|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794253|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794254|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794267|NCT04263870|Capecitabine|capecitabine|mesh-list
2794268|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
2794269|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2794270|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
2794271|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794272|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794273|NCT04263922|Valsartan|valsartan|mesh-list
2794274|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2794275|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2794276|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2794277|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794278|NCT04263844|Midazolam|midazolam|mesh-list
2794279|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
2794280|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2794281|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794282|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794283|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2794284|NCT04263844|Analgesics|analgesics|mesh-ancestor
2794285|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
2794286|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794287|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2794288|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2794289|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2794290|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
2794291|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794292|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794293|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2794294|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2794295|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2794296|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2794297|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2794298|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
2794299|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
2794300|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
2794301|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
2794314|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2794315|NCT04264208|Bombesin|bombesin|mesh-list
2794316|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2794317|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794318|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794319|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794320|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2794321|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
2794322|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794323|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
2794324|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794325|NCT04263519|Tacrolimus|tacrolimus|mesh-list
2794326|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794327|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
2794328|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794329|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2794330|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794331|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794332|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
2794333|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2794334|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2794335|NCT04263402|Prednisolone|prednisolone|mesh-list
2794336|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
2794337|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2794338|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
2794339|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2794340|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
2794341|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
2794342|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794343|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794344|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2794345|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
2794346|NCT04263402|Hormones|hormones|mesh-ancestor
2794347|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2794348|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2794349|NCT04263402|Protective Agents|protective agents|mesh-ancestor
2794350|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2794351|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274105|NCT00205764|Melphalan|melphalan|mesh-list
2483660|NCT01129375|Omeprazole|omeprazole|mesh-list
2274106|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2274107|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
2274108|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274109|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274110|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2274111|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2274112|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
2274113|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274114|NCT00205816|Tigecycline|tigecycline|mesh-list
2274115|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2274116|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274117|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2274118|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274119|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274120|NCT00205842|Alvimopan|alvimopan|mesh-list
2274121|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274122|NCT00205946|Bupropion|bupropion|mesh-list
2274123|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2274124|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
2274125|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2483661|NCT01129375|Clopidogrel|clopidogrel|mesh-list
2794352|NCT04263051|Nivolumab|nivolumab|mesh-list
2794353|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2794354|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794355|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2794356|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794357|NCT04263298|Capecitabine|capecitabine|mesh-list
2794358|NCT04263298|Fulvestrant|fulvestrant|mesh-list
2794359|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2794360|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
2794361|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794362|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794363|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2794364|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2794365|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2794366|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
2794367|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2794368|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794369|NCT04263090|Nivolumab|nivolumab|mesh-list
2794370|NCT04263090|ON 01910|on 01910|mesh-list
2794371|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2794372|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794373|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2794374|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794375|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2794376|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794377|NCT04263064|Clonidine|clonidine|mesh-list
2794378|NCT04263064|Analgesics|analgesics|mesh-ancestor
2794379|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
2794380|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794381|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794382|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2794383|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
2794384|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
2794385|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2794386|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2794387|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2794388|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
2794389|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794390|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794399|NCT04262999|Levetiracetam|levetiracetam|mesh-list
2794400|NCT04262999|Valproic Acid|valproic acid|mesh-list
2794401|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
2794402|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
2794403|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794404|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274126|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2274127|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2274128|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2274129|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274130|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
2274131|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274132|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274133|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2794405|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
2794406|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794407|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794408|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
2794409|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2794410|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794411|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2794412|NCT04262934|Vitamin D|vitamin d|mesh-list
2794413|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
2794414|NCT04262934|Vitamins|vitamins|mesh-ancestor
2794415|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
2794416|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794417|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2794418|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2794419|NCT04262635|Capecitabine|capecitabine|mesh-list
2794420|NCT04262635|Cetuximab|cetuximab|mesh-list
2794421|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2794422|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
2794423|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794424|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794425|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2794426|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
2794427|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2794428|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794429|NCT04262817|Nicotine|nicotine|mesh-list
2794430|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2794431|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
2794432|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794433|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794434|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2794435|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2794436|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
2794437|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794438|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794439|NCT04262843|Vidarabine|vidarabine|mesh-list
2794440|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
2794441|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
2794442|NCT04262843|Fludarabine|fludarabine|mesh-list
2794443|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
2794444|NCT04262843|Tacrolimus|tacrolimus|mesh-list
2794445|NCT04262843|Lenograstim|lenograstim|mesh-list
2794446|NCT04262843|Sargramostim|sargramostim|mesh-list
2274134|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2274135|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274136|NCT00206024|Esomeprazole|esomeprazole|mesh-list
2274137|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2274138|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274139|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2274140|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274141|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274142|NCT00206050|Esomeprazole|esomeprazole|mesh-list
2274143|NCT00206050|Pantoprazole|pantoprazole|mesh-list
2274144|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2794447|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794448|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
2794449|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794450|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2794451|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2794452|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
2794453|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794454|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794455|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2103148|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2103149|NCT02418754|Growth Substances|growth substances|mesh-ancestor
2103150|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103151|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
2103152|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794456|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2794457|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
2794458|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
2794459|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2794460|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2794461|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794462|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2794463|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2794464|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
2794465|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2794466|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2794467|NCT04262765|Amlodipine|amlodipine|mesh-list
2794468|NCT04262765|Ramipril|ramipril|mesh-list
2794469|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
2794470|NCT04262765|Atorvastatin|atorvastatin|mesh-list
2794471|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2794472|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2794473|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
2794474|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794475|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2794476|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2794477|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794478|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2794479|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2794480|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2794481|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2794482|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794483|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
2794484|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2794485|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
2794486|NCT04262804|Gemcitabine|gemcitabine|mesh-list
2794487|NCT04262804|Capecitabine|capecitabine|mesh-list
2794488|NCT04262804|Trastuzumab|trastuzumab|mesh-list
2794489|NCT04262804|Vinorelbine|vinorelbine|mesh-list
2274145|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274146|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2274147|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274148|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274149|NCT00206063|Ximelagatran|ximelagatran|mesh-list
2274150|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
2274151|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2274152|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
2274153|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274154|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274155|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
2274156|NCT00206089|Ximelagatran|ximelagatran|mesh-list
2274157|NCT00206089|Melagatran|melagatran|mesh-list
2274158|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
2274159|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2274160|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
2794490|NCT04262804|Margetuximab|margetuximab|mesh-list
2794491|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2794492|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
2794493|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794494|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794495|NCT04262804|Antiviral Agents|antiviral agents|mesh-ancestor
2274161|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274162|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274163|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
2274164|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2274165|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
2274166|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274167|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274168|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274169|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274170|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103153|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
2103154|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
2103155|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
2103156|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2103157|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2103158|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
2103159|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
2103160|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103161|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274171|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2274172|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
2274173|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274174|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274175|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274176|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274177|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274178|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2274179|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
2274180|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274181|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274182|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274183|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274184|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274185|NCT00206154|Budesonide|budesonide|mesh-list
2274186|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
2274187|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2274188|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2274189|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
2274190|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274191|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274192|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2274193|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
2274194|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
2274195|NCT00206154|Hormones|hormones|mesh-ancestor
2274196|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2274197|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2274198|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2274199|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2274200|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
2274201|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274202|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274203|NCT00206167|Budesonide|budesonide|mesh-list
2274204|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
2274205|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2274206|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2274207|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
2274208|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274209|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274210|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2274211|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
2274212|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
2274213|NCT00206167|Hormones|hormones|mesh-ancestor
2274214|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2274215|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2274216|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2274217|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2274218|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
2274219|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274220|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794496|NCT04262804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2794497|NCT04262804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794498|NCT04262804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794499|NCT04262804|Immunologic Factors|immunologic factors|mesh-ancestor
2794500|NCT04262804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794501|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2794502|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2794503|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
2794504|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
2274221|NCT00206180|Esomeprazole|esomeprazole|mesh-list
2274222|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2274223|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274224|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2274225|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274226|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274227|NCT00206193|Misoprostol|misoprostol|mesh-list
2274228|NCT00206193|Sulprostone|sulprostone|mesh-list
2274229|NCT00206193|Mifepristone|mifepristone|mesh-list
2794505|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
2794506|NCT04262687|Bevacizumab|bevacizumab|mesh-list
2103162|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103163|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2103164|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
2103165|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2103166|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2794507|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
2794508|NCT04262687|Capecitabine|capecitabine|mesh-list
2794509|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
2794510|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2794511|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794512|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2794513|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2794514|NCT04262687|Growth Substances|growth substances|mesh-ancestor
2794515|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794516|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
2794517|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2794518|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
2794519|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794520|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
2794521|NCT04262492|Apixaban|apixaban|mesh-list
2794522|NCT04262492|Edoxaban|edoxaban|mesh-list
2794523|NCT04262492|Dabigatran|dabigatran|mesh-list
2274230|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2274231|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
2274232|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2274233|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274234|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2274235|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274236|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
2274237|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2274238|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2274239|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2274240|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2274241|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
2274242|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2274243|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2274244|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
2274245|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2274246|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
2274247|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2274248|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2274249|NCT00206219|Methotrexate|methotrexate|mesh-list
2274250|NCT00206219|Gefitinib|gefitinib|mesh-list
2274251|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2274252|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
2274253|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2794524|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2794525|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
2794526|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2794527|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
2794528|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794529|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794530|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
2794531|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
2794532|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
2794533|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794534|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
2794535|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794536|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2794537|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2274254|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274255|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2274256|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
2274257|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274258|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274259|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
2274260|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794538|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
2794539|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794540|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794541|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2794542|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2794543|NCT04262388|Durvalumab|durvalumab|mesh-list
2794544|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2794545|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794546|NCT04262375|Durvalumab|durvalumab|mesh-list
2794547|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2794548|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103167|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2794549|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
2794550|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
2794551|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2794552|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
2794553|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794554|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
2794555|NCT04262336|Protective Agents|protective agents|mesh-ancestor
2794556|NCT04262336|Antidotes|antidotes|mesh-ancestor
2794557|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
2794558|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794559|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
2794560|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2794561|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2794562|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
2794563|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
2794564|NCT04262193|Suvorexant|suvorexant|mesh-list
2794565|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2794566|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2794567|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794568|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794569|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2794570|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794571|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794572|NCT04262206|Atorvastatin|atorvastatin|mesh-list
2794573|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2794574|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2794575|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
2794576|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794577|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2794578|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2794579|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794580|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
2794581|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2794582|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794591|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
2794592|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
2794593|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794594|NCT04261907|Ritonavir|ritonavir|mesh-list
2794595|NCT04261907|Lopinavir|lopinavir|mesh-list
2794596|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2794597|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2794598|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
2794599|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794600|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794601|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2794602|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2103168|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103169|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103170|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2103171|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2103172|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103173|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
2103174|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103175|NCT02419469|Cytarabine|cytarabine|mesh-list
2103176|NCT02419469|Dexamethasone|dexamethasone|mesh-list
2103177|NCT02419469|Prednisone|prednisone|mesh-list
2103178|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
2103179|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
2103180|NCT02419469|Rituximab|rituximab|mesh-list
2103181|NCT02419469|Doxorubicin|doxorubicin|mesh-list
2103182|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2103183|NCT02419469|Methotrexate|methotrexate|mesh-list
2103184|NCT02419469|Vincristine|vincristine|mesh-list
2103185|NCT02419469|Daunorubicin|daunorubicin|mesh-list
2103186|NCT02419469|Asparaginase|asparaginase|mesh-list
2103187|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
2103188|NCT02419469|Ofatumumab|ofatumumab|mesh-list
2103189|NCT02419469|Pegaspargase|pegaspargase|mesh-list
2103190|NCT02419469|Thioguanine|thioguanine|mesh-list
2103191|NCT02419469|BB 1101|bb 1101|mesh-list
2103192|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794603|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
2794604|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2794605|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2794606|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2794607|NCT04261855|Avelumab|avelumab|mesh-list
2794608|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2794609|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2794610|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794611|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2794612|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794613|NCT04261634|Mitogens|mitogens|mesh-list
2794614|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
2794615|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274261|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2274262|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2274263|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
2274264|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2274265|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2274266|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2274267|NCT00206232|Spironolactone|spironolactone|mesh-list
2274268|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2274269|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
2274270|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2274271|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274272|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2274273|NCT00206232|Diuretics|diuretics|mesh-ancestor
2274274|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
2274275|NCT00206258|Pramlintide|pramlintide|mesh-list
2274276|NCT00206258|Glucagon|glucagon|mesh-list
2274277|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274278|NCT00206258|Hormones|hormones|mesh-ancestor
2274279|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2274280|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274281|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2103193|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
2103194|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103195|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2103196|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2103197|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
2103198|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103199|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794616|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
2794617|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2794618|NCT04261426|Antibodies|antibodies|mesh-list
2794619|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
2794620|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2794621|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
2794622|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794623|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2794624|NCT04261465|Paclitaxel|paclitaxel|mesh-list
2794625|NCT04261465|Carboplatin|carboplatin|mesh-list
2794626|NCT04261465|Olaparib|olaparib|mesh-list
2794627|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2794628|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794629|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
2794630|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
2794631|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
2794632|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794633|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2794634|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794635|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
2794636|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
2103200|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2103201|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2103202|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
2103203|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
2103204|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103205|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2103206|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
2103207|NCT02419469|Hormones|hormones|mesh-ancestor
2103208|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2103209|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2103210|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2103211|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2103212|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2103213|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2794637|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2794638|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2794639|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2794640|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794641|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794642|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2794650|NCT04261270|Ritonavir|ritonavir|mesh-list
2794651|NCT04261270|Oseltamivir|oseltamivir|mesh-list
2794652|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2794653|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2794654|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
2794655|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794656|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794657|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2794658|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2794659|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
2794660|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2794661|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2794662|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2103214|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103215|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2103216|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
2103217|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2103218|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2103219|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
2103220|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
2103221|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2103222|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2103223|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
2103224|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103225|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2103226|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
2103227|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
2274282|NCT00206297|Pramlintide|pramlintide|mesh-list
2274283|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2794663|NCT04261023|Abatacept|abatacept|mesh-list
2794664|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2794665|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794666|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274284|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274285|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2274286|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2274287|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2794667|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794668|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
2794669|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274288|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
2274289|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274290|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2274291|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2274292|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274293|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
2274294|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2274295|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
2274296|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274297|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2274298|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2274299|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
2794670|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2274300|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274301|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274302|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2274303|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
2274304|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2274305|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274306|NCT00206414|Gefitinib|gefitinib|mesh-list
2274307|NCT00206414|Fulvestrant|fulvestrant|mesh-list
2274308|NCT00206414|Anastrozole|anastrozole|mesh-list
2274309|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274310|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2274311|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274312|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274313|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2274314|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2274315|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2274316|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
2274317|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2274318|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274319|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2274320|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2274321|NCT00206453|Docetaxel|docetaxel|mesh-list
2274322|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103228|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
2103229|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
2103230|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2103231|NCT02419508|Bimatoprost|bimatoprost|mesh-list
2103232|NCT02419508|Travoprost|travoprost|mesh-list
2103233|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2103234|NCT02419508|Latanoprost|latanoprost|mesh-list
2103235|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2103236|NCT02419508|Brinzolamide|brinzolamide|mesh-list
2103237|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2103238|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2103239|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2103240|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2103241|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
2103242|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103243|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103244|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103245|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2103246|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103247|NCT02419547|Fentanyl|fentanyl|mesh-list
2103248|NCT02419547|Midazolam|midazolam|mesh-list
2103249|NCT02419547|Propofol|propofol|mesh-list
2103250|NCT02419547|Sevoflurane|sevoflurane|mesh-list
2103251|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2103252|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2103253|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794671|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
2794672|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
2794673|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794674|NCT04261036|Protective Agents|protective agents|mesh-ancestor
2794675|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794676|NCT04261036|Vitamins|vitamins|mesh-ancestor
2794677|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
2794678|NCT04261049|Triamcinolone|triamcinolone|mesh-list
2794679|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2794680|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2794681|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2794682|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2794683|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
2794684|NCT04261049|Hormones|hormones|mesh-ancestor
2794685|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2794686|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794687|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794688|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
2794689|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794690|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794691|NCT04260828|Aspirin|aspirin|mesh-list
2794692|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2794693|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2794694|NCT04260828|Analgesics|analgesics|mesh-ancestor
2794695|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
2274323|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
2274324|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
2274325|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
2274326|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274327|NCT00206466|Docetaxel|docetaxel|mesh-list
2274328|NCT00206466|Doxorubicin|doxorubicin|mesh-list
2274329|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
2274330|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2274331|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274332|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
2274333|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
2274334|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
2274335|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274336|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2274337|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2274338|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2274339|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274340|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794696|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794697|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794698|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2794699|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2794700|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2794701|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2794702|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794703|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2794704|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2794705|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794706|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
2794707|NCT04260711|Interferons|interferons|mesh-list
2794708|NCT04260711|Teriflunomide|teriflunomide|mesh-list
2794709|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
2794710|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2794711|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
2794712|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794713|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
2794714|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2794715|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2794716|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
2103254|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2103255|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
2103256|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
2103257|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2103258|NCT02419547|Narcotics|narcotics|mesh-ancestor
2103259|NCT02419547|Analgesics|analgesics|mesh-ancestor
2103260|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
2103261|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103262|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2274341|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
2794717|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794718|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794719|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2794720|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2794721|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2794722|NCT04260711|Analgesics|analgesics|mesh-ancestor
2794723|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
2794724|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794725|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2794726|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
2794727|NCT04260607|Ketamine|ketamine|mesh-list
2794728|NCT04260607|Analgesics|analgesics|mesh-ancestor
2794729|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
2794730|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794731|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794732|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2794733|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2794734|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
2794735|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
2794736|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794737|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2794738|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2794739|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794740|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794741|NCT04260659|Lidocaine|lidocaine|mesh-list
2794742|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
2794743|NCT04260659|Fentanyl|fentanyl|mesh-list
2794744|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
2274342|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274343|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2274344|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2274345|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
2274346|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2274347|NCT00206492|Tamoxifen|tamoxifen|mesh-list
2274348|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2274349|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
2274350|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2794745|NCT04260659|Ketamine|ketamine|mesh-list
2794746|NCT04260659|Remifentanil|remifentanil|mesh-list
2794747|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
2794748|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
2794749|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794750|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794751|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
2794752|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274351|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274352|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2274353|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274354|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2794753|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2794754|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2794755|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2794756|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2794757|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794758|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2794759|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2794760|NCT04260659|Analgesics|analgesics|mesh-ancestor
2794761|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2103263|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2103264|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2103265|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2103266|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
2103267|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
2103268|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103269|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103270|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2103271|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2103272|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
2103273|NCT02419612|Glimepiride|glimepiride|mesh-list
2103274|NCT02419612|Saxagliptin|saxagliptin|mesh-list
2103275|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2103276|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103277|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2103278|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103279|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2103280|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794762|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2794763|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2794764|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
2794765|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794766|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2794767|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2794768|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
2794769|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2794770|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2794771|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2794772|NCT04260659|Narcotics|narcotics|mesh-ancestor
2794773|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2794774|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
2794775|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2794776|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2794777|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
2794778|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2794779|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
2794780|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2794781|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
2794782|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2794783|NCT04260516|Expectorants|expectorants|mesh-ancestor
2794784|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
2794785|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2794786|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
2794787|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794788|NCT04260516|Protective Agents|protective agents|mesh-ancestor
2794789|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794790|NCT04260516|Antidotes|antidotes|mesh-ancestor
2794791|NCT04260581|Amantadine|amantadine|mesh-list
2794792|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2794793|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2794794|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
2794795|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2794796|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
2794797|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794798|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794799|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794800|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2794801|NCT04260581|Analgesics|analgesics|mesh-ancestor
2794802|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
2794803|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794804|NCT04260412|Psyllium|psyllium|mesh-list
2794805|NCT04260412|Cathartics|cathartics|mesh-ancestor
2794806|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2794807|NCT04260685|Lidocaine|lidocaine|mesh-list
2794808|NCT04260685|Esmolol|esmolol|mesh-list
2794809|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
2794810|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
2794811|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794812|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794813|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
2794814|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794815|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2103281|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
2103282|NCT02419612|Incretins|incretins|mesh-ancestor
2103283|NCT02419612|Hormones|hormones|mesh-ancestor
2103284|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2103285|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2103286|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
2103287|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103288|NCT02419755|Cytarabine|cytarabine|mesh-list
2103289|NCT02419755|Dexamethasone|dexamethasone|mesh-list
2103290|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
2103291|NCT02419755|Doxorubicin|doxorubicin|mesh-list
2103292|NCT02419755|Methotrexate|methotrexate|mesh-list
2103293|NCT02419755|Bortezomib|bortezomib|mesh-list
2103294|NCT02419755|Asparaginase|asparaginase|mesh-list
2103295|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
2103296|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
2103297|NCT02419755|Vorinostat|vorinostat|mesh-list
2103298|NCT02419755|Pegaspargase|pegaspargase|mesh-list
2103299|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2103300|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
2103301|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
2103302|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103303|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794816|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2794817|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2794818|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2794819|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794820|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2794821|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2794822|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2794823|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
2794824|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794825|NCT04260464|PF-06700841|pf-06700841|mesh-list
2794826|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2794827|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794828|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794829|NCT04260360|Docetaxel|docetaxel|mesh-list
2794830|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794831|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
2794832|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
2794833|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
2794834|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794835|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
2103304|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2103305|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
2103306|NCT02419755|Hormones|hormones|mesh-ancestor
2103307|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2103308|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2103309|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103310|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2103311|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2103312|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2103313|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274355|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2274356|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2274357|NCT00206505|Docetaxel|docetaxel|mesh-list
2274358|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274359|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
2103314|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103315|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2103316|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
2103317|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2103318|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2103319|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
2103320|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
2103321|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2103322|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2103323|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
2103324|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2103325|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2103326|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
2103327|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103328|NCT02419755|Analgesics|analgesics|mesh-ancestor
2103329|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
2103330|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2103331|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2103332|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2103333|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2103334|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103335|NCT02420015|Bupropion|bupropion|mesh-list
2103336|NCT02420015|Nicotine|nicotine|mesh-list
2103337|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2103338|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
2103339|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103340|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103341|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2103342|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2103343|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
2103344|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103345|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103346|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2103347|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
2103348|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2103349|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2103350|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2103351|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2103352|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
2794836|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2794837|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
2794838|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2794839|NCT04260035|Protective Agents|protective agents|mesh-ancestor
2794840|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274360|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
2274361|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
2274362|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274363|NCT00206544|Tamoxifen|tamoxifen|mesh-list
2274364|NCT00206544|Progesterone|progesterone|mesh-list
2274365|NCT00206544|Progestins|progestins|mesh-ancestor
2274366|NCT00206544|Hormones|hormones|mesh-ancestor
2274367|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2274368|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274369|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2274370|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
2274371|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2274372|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274373|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2274374|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2274375|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2274376|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2103353|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2103354|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2103355|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103356|NCT02420041|Triamcinolone|triamcinolone|mesh-list
2103357|NCT02420041|Lidocaine|lidocaine|mesh-list
2103358|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
2103359|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
2103360|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2103361|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103362|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
2103363|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103364|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2103365|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2103366|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2103367|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2103368|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103369|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2103370|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
2103371|NCT02420041|Hormones|hormones|mesh-ancestor
2103372|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2103373|NCT02420210|Dexamethasone|dexamethasone|mesh-list
2103374|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2103375|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
2103376|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2103377|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
2103378|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
2103379|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103380|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103381|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2794841|NCT04260269|Trifluridine|trifluridine|mesh-list
2794842|NCT04260269|Fluorouracil|fluorouracil|mesh-list
2274377|NCT00206557|Estradiol|estradiol|mesh-list
2274378|NCT00206557|Estrogens|estrogens|mesh-ancestor
2274379|NCT00206557|Hormones|hormones|mesh-ancestor
2274380|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2274381|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274382|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2274383|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
2274384|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2274385|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2274386|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2274387|NCT00206570|Estradiol|estradiol|mesh-list
2274388|NCT00206570|Estrogens|estrogens|mesh-ancestor
2103382|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
2103383|NCT02420210|Hormones|hormones|mesh-ancestor
2103384|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2103385|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2103386|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103387|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2103388|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
2103389|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103390|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2103391|NCT02420223|Propranolol|propranolol|mesh-list
2103392|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2103393|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2103394|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
2103395|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103396|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103397|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103398|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2103399|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2103400|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
2103401|NCT02420262|Insulin|insulin|mesh-list
2103402|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2103403|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
2103404|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
2103405|NCT02420262|Liraglutide|liraglutide|mesh-list
2103406|NCT02420262|Xultophy|xultophy|mesh-list
2103407|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2103408|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103409|NCT02420262|Incretins|incretins|mesh-ancestor
2103410|NCT02420262|Hormones|hormones|mesh-ancestor
2103411|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2103412|NCT02420327|Galantamine|galantamine|mesh-list
2103413|NCT02420327|Nicotine|nicotine|mesh-list
2103414|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2103415|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
2103416|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103417|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103418|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2103419|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2103420|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
2103421|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103422|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103423|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2103424|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103425|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2103426|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
2103443|NCT02420873|Maytansine|maytansine|mesh-list
2794843|NCT04260269|Capecitabine|capecitabine|mesh-list
2794844|NCT04260269|Tegafur|tegafur|mesh-list
2794845|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
2794846|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794847|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2794848|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794849|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2794850|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
2794851|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794852|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
2794853|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2794854|NCT04260113|Apatinib|apatinib|mesh-list
2794855|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794856|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2794857|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794858|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794859|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
2794860|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2794861|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
2794862|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794863|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794864|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2794865|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
2794866|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2794867|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
2794868|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794869|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794870|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2794871|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
2794872|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
2794873|NCT04259684|Protective Agents|protective agents|mesh-ancestor
2794874|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
2794875|NCT04259606|Antacids|antacids|mesh-ancestor
2794876|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794877|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2794878|NCT04259775|Insulin|insulin|mesh-list
2794879|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2794880|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794881|NCT04259398|Propofol|propofol|mesh-list
2794882|NCT04259398|Sevoflurane|sevoflurane|mesh-list
2103444|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
2103445|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2103446|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103447|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
2103448|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
2103449|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
2103450|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103451|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2103452|NCT02420951|Bupivacaine|bupivacaine|mesh-list
2103453|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
2103454|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
2103455|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2103456|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103457|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
2103458|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103459|NCT02421120|Tazobactam|tazobactam|mesh-list
2103460|NCT02421120|Ceftolozane|ceftolozane|mesh-list
2103461|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2103462|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2103463|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103464|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2103465|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103466|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103467|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2103468|NCT02421120|Renal Agents|renal agents|mesh-ancestor
2103469|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
2103470|NCT02421211|Ledipasvir|ledipasvir|mesh-list
2103471|NCT02421211|Simeprevir|simeprevir|mesh-list
2103472|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
2103473|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103474|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
2103475|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103476|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794883|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2794884|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794885|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274389|NCT00206570|Hormones|hormones|mesh-ancestor
2274390|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2274391|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274392|NCT00206596|Sargramostim|sargramostim|mesh-list
2274393|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
2274394|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274395|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2274396|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2274397|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
2274398|NCT00206622|Estradiol|estradiol|mesh-list
2274399|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2274400|NCT00206622|Estrogens|estrogens|mesh-ancestor
2274401|NCT00206622|Hormones|hormones|mesh-ancestor
2274402|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2794886|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2794887|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
2794888|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
2794889|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2794890|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2794891|NCT04259749|Menthol|menthol|mesh-list
2794892|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
2794893|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
2794894|NCT04259476|Ketamine|ketamine|mesh-list
2794895|NCT04259476|Analgesics|analgesics|mesh-ancestor
2794896|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
2794897|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794898|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794899|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2794900|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2794901|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
2794902|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
2794903|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794904|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2794905|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2794906|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103477|NCT02421354|Nivolumab|nivolumab|mesh-list
2103478|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2103479|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103480|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2103481|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103482|NCT02421419|Dexamethasone|dexamethasone|mesh-list
2103483|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
2103484|NCT02421419|Lidocaine|lidocaine|mesh-list
2103485|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2103486|NCT02421419|BB 1101|bb 1101|mesh-list
2103487|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2103488|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
2103489|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
2103490|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103491|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103492|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2103493|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
2103494|NCT02421419|Hormones|hormones|mesh-ancestor
2103495|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2103496|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2103497|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103498|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
2103499|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
2103500|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2103501|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
2103502|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2103503|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2103504|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2103505|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2103506|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103507|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
2103508|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103509|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2103510|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2103511|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103512|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2274403|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274404|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2794907|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794908|NCT04259346|Ixekizumab|ixekizumab|mesh-list
2794909|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
2794910|NCT04259645|Bupivacaine|bupivacaine|mesh-list
2794911|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
2794912|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
2794913|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794914|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794915|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
2794916|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794917|NCT04259333|Acetaminophen|acetaminophen|mesh-list
2794918|NCT04259333|Celecoxib|celecoxib|mesh-list
2794919|NCT04259333|Codeine|codeine|mesh-list
2794920|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2794921|NCT04259333|Analgesics|analgesics|mesh-ancestor
2794922|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
2794923|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2794924|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794925|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
2794926|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2794927|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2794928|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2794929|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2794930|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2274405|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
2274406|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2274407|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2274408|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2274409|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2274410|NCT00206635|Interferons|interferons|mesh-list
2103513|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103514|NCT02421588|Doxorubicin|doxorubicin|mesh-list
2103515|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2103516|NCT02421588|Topotecan|topotecan|mesh-list
2103517|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2103518|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103519|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2103520|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2103521|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103522|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103523|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2103524|NCT02421887|Antioxidants|antioxidants|mesh-list
2103525|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103526|NCT02421887|Protective Agents|protective agents|mesh-ancestor
2103527|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103528|NCT02421939|Cytarabine|cytarabine|mesh-list
2103529|NCT02421939|Fludarabine|fludarabine|mesh-list
2103530|NCT02421939|Etoposide|etoposide|mesh-list
2103531|NCT02421939|Azacitidine|azacitidine|mesh-list
2103532|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
2103533|NCT02421939|Idarubicin|idarubicin|mesh-list
2103534|NCT02421939|Sargramostim|sargramostim|mesh-list
2103535|NCT02421939|Lenograstim|lenograstim|mesh-list
2103536|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103537|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2103538|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
2103539|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103540|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2103541|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
2103542|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103543|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2103544|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2103545|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2103546|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103547|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
2103548|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103549|NCT02421939|Analgesics|analgesics|mesh-ancestor
2103550|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
2103551|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103552|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2103553|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2103554|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2103555|NCT02422186|Citalopram|citalopram|mesh-list
2103556|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2103557|NCT02422186|Sertraline|sertraline|mesh-list
2103558|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
2103559|NCT02422186|Esketamine|esketamine|mesh-list
2274411|NCT00206635|Interferon-beta|interferon-beta|mesh-list
2794931|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794932|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794933|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2794934|NCT04259333|Narcotics|narcotics|mesh-ancestor
2794935|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794936|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
2794937|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
2794938|NCT04259658|Calcium|calcium|mesh-list
2794939|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2794940|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794941|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
2794942|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
2794943|NCT04259060|Hematinics|hematinics|mesh-ancestor
2274412|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
2274413|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274414|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
2274415|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274416|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
2274417|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274418|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2274419|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
2274420|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2274421|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
2274422|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274423|NCT00206661|Molgramostim|molgramostim|mesh-list
2274424|NCT00206661|Sargramostim|sargramostim|mesh-list
2274425|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
2274426|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274427|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103560|NCT02422186|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2103561|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2103562|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2103563|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103564|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103565|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
2103566|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103567|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2103568|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2103569|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103570|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2103571|NCT02422186|Analgesics|analgesics|mesh-ancestor
2103572|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
2103573|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
2103574|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2103575|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
2103576|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103577|NCT02422290|Ketamine|ketamine|mesh-list
2103578|NCT02422290|Analgesics|analgesics|mesh-ancestor
2103579|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
2103580|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103581|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103582|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2103583|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2103584|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
2103585|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
2103586|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2103587|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2103588|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2103589|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103590|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103591|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2103592|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2103593|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2794944|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
2794945|NCT04259060|Vitamins|vitamins|mesh-ancestor
2794946|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
2794947|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794948|NCT04259073|Pregabalin|pregabalin|mesh-list
2794949|NCT04259073|Analgesics|analgesics|mesh-ancestor
2794950|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
2794951|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274428|NCT00206674|Sargramostim|sargramostim|mesh-list
2274429|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
2794952|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274430|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274431|NCT00206700|Sargramostim|sargramostim|mesh-list
2274432|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
2274433|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794953|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
2794954|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2794955|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2794956|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794957|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2794958|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2794959|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2794960|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2794961|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2794962|NCT04258956|Avelumab|avelumab|mesh-list
2794963|NCT04258956|Axitinib|axitinib|mesh-list
2794964|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2794965|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794966|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2794967|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2794968|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794969|NCT04259086|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2794970|NCT04259086|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2794971|NCT04259086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2794972|NCT04259086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103602|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
2103603|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2103604|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2103605|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103606|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2103607|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2103608|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103609|NCT02423343|Nivolumab|nivolumab|mesh-list
2103610|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2103611|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103612|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2103613|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103614|NCT02423980|Glucagon|glucagon|mesh-list
2103615|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2103616|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2103617|NCT02423980|Hormones|hormones|mesh-ancestor
2103618|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2103619|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103620|NCT02423980|Incretins|incretins|mesh-ancestor
2103621|NCT02424097|Listerine|listerine|mesh-list
2103622|NCT02424097|Fluorides|fluorides|mesh-list
2103623|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
2103624|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
2103625|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
2103626|NCT02424097|Protective Agents|protective agents|mesh-ancestor
2103627|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103628|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2103629|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103630|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
2103631|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2103632|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
2103633|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103634|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103635|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2103636|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
2103637|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2103638|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2103639|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2103640|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
2103641|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103642|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103643|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
2103644|NCT02424357|Povidone|povidone|mesh-list
2103645|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2103646|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2103647|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
2103648|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
2103649|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2103650|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103651|NCT02424578|Diclofenac|diclofenac|mesh-list
2274434|NCT00206713|Sargramostim|sargramostim|mesh-list
2274435|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
2274436|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274437|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
2274438|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
2274439|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
2274440|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2103652|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2103653|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2103654|NCT02424578|Analgesics|analgesics|mesh-ancestor
2103655|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
2103656|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103657|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103658|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2103659|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2103660|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2103661|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103662|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103663|NCT02424591|Ketamine|ketamine|mesh-list
2103664|NCT02424591|Analgesics|analgesics|mesh-ancestor
2103665|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
2103666|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103667|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103668|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2103669|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2103670|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
2103671|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
2103672|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2103673|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2103674|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2103675|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103676|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103677|NCT02424630|Ropivacaine|ropivacaine|mesh-list
2103678|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
2103679|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
2103680|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2103681|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103682|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
2103683|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103684|NCT02424734|Ampicillin|ampicillin|mesh-list
2103685|NCT02424734|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2103686|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2103687|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103688|NCT02424799|GSK2646264|gsk2646264|mesh-list
2103689|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2103690|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103691|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103692|NCT02424968|Cyclosporine|cyclosporine|mesh-list
2103693|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
2103694|NCT02424968|Cyclosporins|cyclosporins|mesh-list
2103695|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
2103696|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2103697|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103698|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103699|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2103700|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
2103701|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103702|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
2103703|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103704|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
2103705|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2103706|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2103707|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2103708|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103709|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2103710|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
2103711|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2103712|NCT02425098|Vaccines|vaccines|mesh-list
2103713|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
2103714|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103715|NCT02425111|Vedolizumab|vedolizumab|mesh-list
2103716|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2103717|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
2103718|NCT02425306|Poly ICLC|poly iclc|mesh-list
2103719|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
2103720|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274441|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2794973|NCT04259086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794974|NCT04259086|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2794975|NCT04259086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2794976|NCT04259086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2794977|NCT04259086|Cholinergic Agents|cholinergic agents|mesh-ancestor
2794978|NCT04259086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2794979|NCT04259008|Manganese|manganese|mesh-list
2794980|NCT04259008|Trace Elements|trace elements|mesh-ancestor
2794981|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
2794982|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794983|NCT04258930|Calcium|calcium|mesh-list
2794984|NCT04258930|Calcium acetate|calcium acetate|mesh-list
2794985|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
2794986|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2794987|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2794988|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
2794989|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
2794990|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103721|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2103722|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2103723|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2103724|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
2103725|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103726|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103727|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2103728|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
2103729|NCT02425449|Succinylcholine|succinylcholine|mesh-list
2103730|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2103731|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2103732|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2103733|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103734|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103749|NCT02425826|Thalidomide|thalidomide|mesh-list
2103750|NCT02425826|Apremilast|apremilast|mesh-list
2103751|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2103752|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2103753|NCT02425826|Analgesics|analgesics|mesh-ancestor
2103754|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
2103755|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103756|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103757|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2103758|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2103759|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2103760|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2103761|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103762|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103763|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2103764|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
2103765|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
2103766|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2103767|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103768|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2103769|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2103770|NCT02425826|Growth Substances|growth substances|mesh-ancestor
2103771|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
2103772|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103773|NCT02425891|Paclitaxel|paclitaxel|mesh-list
2103774|NCT02425891|Atezolizumab|atezolizumab|mesh-list
2103775|NCT02425891|Antibodies|antibodies|mesh-list
2103776|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2274442|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274443|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2274444|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274445|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274446|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2274447|NCT00206739|Renal Agents|renal agents|mesh-ancestor
2274448|NCT00206765|Risperidone|risperidone|mesh-list
2274449|NCT00206765|Paroxetine|paroxetine|mesh-list
2794991|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2794992|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
2794993|NCT04258657|Paclitaxel|paclitaxel|mesh-list
2794994|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2794995|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2794996|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
2794997|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
2794998|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
2103777|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2103778|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103779|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
2103780|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
2103781|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
2103782|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103783|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
2103784|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103785|NCT02426086|Niacinamide|niacinamide|mesh-list
2103786|NCT02426086|Imetelstat|imetelstat|mesh-list
2103787|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
2103788|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103789|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103790|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2103791|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
2103792|NCT02426086|Vitamins|vitamins|mesh-ancestor
2103793|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
2103794|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274450|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2274451|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
2274452|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274453|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274454|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274455|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274456|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274457|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274458|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274459|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2274460|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
2274461|NCT00206765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2274462|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2274463|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2274464|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2274465|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
2274466|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2274467|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2274468|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274469|NCT00206778|Lamotrigine|lamotrigine|mesh-list
2274470|NCT00206778|Valproic Acid|valproic acid|mesh-list
2274471|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
2274472|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2274473|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2794999|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795000|NCT04258852|Nicotine|nicotine|mesh-list
2795001|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2795002|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
2795003|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795004|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795005|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2795006|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2795007|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
2795008|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2795009|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795010|NCT04258553|Antioxidants|antioxidants|mesh-list
2795011|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795012|NCT04258553|Protective Agents|protective agents|mesh-ancestor
2795013|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795014|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
2795015|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
2795016|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2795017|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795018|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795019|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
2795020|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
2795021|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
2795022|NCT04258475|Calcium|calcium|mesh-list
2795023|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2274474|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274475|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2274476|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795024|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795025|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2795026|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2795027|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
2795028|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795029|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2795030|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2795031|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274477|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274478|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274479|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274480|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274481|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2274482|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274483|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
2274484|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274485|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
2274486|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2274487|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
2274488|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274489|NCT00206934|Dexetimide|dexetimide|mesh-list
2274490|NCT00206934|Citalopram|citalopram|mesh-list
2274491|NCT00206934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2274492|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2274493|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2274494|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274495|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274496|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
2795032|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795033|NCT04258644|Paclitaxel|paclitaxel|mesh-list
2795034|NCT04258644|Apatinib|apatinib|mesh-list
2795035|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2795036|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795037|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
2795038|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
2795039|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
2795040|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795041|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2795042|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795043|NCT04258397|Pirfenidone|pirfenidone|mesh-list
2795044|NCT04258397|Analgesics|analgesics|mesh-ancestor
2795045|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
2795046|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795047|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795048|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2795049|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2795050|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2795051|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2795052|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795053|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
2795054|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2795055|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795056|NCT04258631|Hydromorphone|hydromorphone|mesh-list
2795057|NCT04258631|Bupivacaine|bupivacaine|mesh-list
2795058|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
2795059|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
2795060|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795061|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274497|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274498|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2274499|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
2795062|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
2795063|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795064|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2795065|NCT04258631|Narcotics|narcotics|mesh-ancestor
2795066|NCT04258631|Analgesics|analgesics|mesh-ancestor
2795067|NCT04258163|Gemcitabine|gemcitabine|mesh-list
2795068|NCT04258163|Capecitabine|capecitabine|mesh-list
2795069|NCT04258163|Doxorubicin|doxorubicin|mesh-list
2795070|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2795071|NCT04258163|Letrozole|letrozole|mesh-list
2795072|NCT04258163|Fulvestrant|fulvestrant|mesh-list
2795073|NCT04258163|Anastrozole|anastrozole|mesh-list
2795074|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2795075|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
2795076|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795077|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795078|NCT04258163|Antiviral Agents|antiviral agents|mesh-ancestor
2795079|NCT04258163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795080|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795081|NCT04258163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2795082|NCT04258163|Immunologic Factors|immunologic factors|mesh-ancestor
2795083|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795084|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2795085|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2795086|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2795087|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2795088|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2795089|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2795090|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
2795091|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2274500|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274501|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2274502|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2795092|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2795093|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2274503|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
2274504|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
2274505|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274506|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2274507|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2274508|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
2274509|NCT00206947|Ziprasidone|ziprasidone|mesh-list
2274510|NCT00206947|Donepezil|donepezil|mesh-list
2274511|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2795094|NCT04258241|Bupivacaine|bupivacaine|mesh-list
2795095|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
2795096|NCT04258241|Anesthetics|anesthetics|mesh-list
2795097|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2795098|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795099|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795100|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
2795101|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795102|NCT04258423|Everolimus|everolimus|mesh-list
2795103|NCT04258423|Tacrolimus|tacrolimus|mesh-list
2795104|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2795105|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
2795106|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795107|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2795108|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795109|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274512|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274513|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274514|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
2274515|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274516|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274517|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
2274518|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2274519|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
2274520|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274521|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274522|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274523|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274524|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2274525|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
2274526|NCT00206960|Risperidone|risperidone|mesh-list
2274527|NCT00206960|Clopenthixol|clopenthixol|mesh-list
2274528|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2274529|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
2274530|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274531|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274532|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274533|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274534|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274535|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274536|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274537|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2274538|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
2274539|NCT00206973|Mannitol|mannitol|mesh-list
2274540|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2274541|NCT00206973|Diuretics|diuretics|mesh-ancestor
2274542|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
2274543|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274544|NCT00206986|Clonidine|clonidine|mesh-list
2274545|NCT00206986|Analgesics|analgesics|mesh-ancestor
2274546|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
2274547|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274548|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274549|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2274550|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
2274551|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
2274552|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2274553|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2274554|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2274555|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
2274556|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274557|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274558|NCT00206999|Imipramine|imipramine|mesh-list
2274559|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2274560|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
2274561|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274562|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2274563|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2274564|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2274565|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274566|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
2274567|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274568|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795110|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795111|NCT04258306|Resveratrol|resveratrol|mesh-list
2795112|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
2103802|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
2103803|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2103804|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103805|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2103806|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103807|NCT02426658|Pemetrexed|pemetrexed|mesh-list
2103808|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103809|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274569|NCT00207051|Cetuximab|cetuximab|mesh-list
2274570|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2274571|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274572|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2274573|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
2795113|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795114|NCT04258306|Protective Agents|protective agents|mesh-ancestor
2795115|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795116|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795117|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2795118|NCT04258150|Nivolumab|nivolumab|mesh-list
2795119|NCT04258150|Ipilimumab|ipilimumab|mesh-list
2795120|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2795121|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795122|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2795123|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795124|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
2795125|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2795126|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795127|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2795128|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274574|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274575|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274576|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274577|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795129|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2795130|NCT04258098|Metronidazole|metronidazole|mesh-list
2795131|NCT04258098|Streptomycin|streptomycin|mesh-list
2795132|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795133|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2795134|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2795135|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2795136|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795137|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795138|NCT04258111|Antibodies|antibodies|mesh-list
2795139|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
2795140|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
2795141|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795142|NCT04258046|Trametinib|trametinib|mesh-list
2795143|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795144|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2795145|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795146|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795147|NCT04258007|Neostigmine|neostigmine|mesh-list
2795148|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2795149|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795150|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795151|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
2795152|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274578|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274579|NCT00207077|Cetuximab|cetuximab|mesh-list
2274580|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2274581|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2274582|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274583|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2274584|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274585|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274586|NCT00207116|Cetuximab|cetuximab|mesh-list
2274587|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2274588|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274589|NCT00207129|Capecitabine|capecitabine|mesh-list
2795153|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795154|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2795155|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
2795156|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795157|NCT04257838|Meropenem|meropenem|mesh-list
2795158|NCT04257838|Tazobactam|tazobactam|mesh-list
2795159|NCT04257838|Piperacillin|piperacillin|mesh-list
2795160|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2795161|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2795162|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795163|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2795164|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795165|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795166|NCT04257851|Sumatriptan|sumatriptan|mesh-list
2795167|NCT04257851|Theophylline|theophylline|mesh-list
2795168|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2795169|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2795170|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2795171|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
2795172|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2795173|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795174|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795175|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2795176|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
2795177|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795178|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2795179|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
2795180|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2795181|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795182|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
2795183|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2795184|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2795185|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
2795186|NCT04257812|Tazobactam|tazobactam|mesh-list
2795187|NCT04257812|Ceftolozane|ceftolozane|mesh-list
2795188|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2795189|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2795190|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795191|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2795192|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795193|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795194|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2795195|NCT04257812|Renal Agents|renal agents|mesh-ancestor
2795196|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
2795197|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2795198|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795199|NCT04257461|Capecitabine|capecitabine|mesh-list
2795200|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
2795201|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2795202|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
2274590|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2274591|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
2274592|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274593|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274594|NCT00207155|Cetuximab|cetuximab|mesh-list
2274595|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2274596|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274597|NCT00207311|Interferons|interferons|mesh-list
2274598|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
2274599|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
2274600|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2274601|NCT00207311|Orlistat|orlistat|mesh-list
2274602|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274603|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
2274604|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274605|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
2274606|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274607|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274608|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274609|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2795203|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795204|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795205|NCT04257682|Bupivacaine|bupivacaine|mesh-list
2795206|NCT04257682|Ropivacaine|ropivacaine|mesh-list
2795207|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
2274610|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2274611|NCT00207363|Interferons|interferons|mesh-list
2274612|NCT00207363|Ribavirin|ribavirin|mesh-list
2274613|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
2274614|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
2274615|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2274616|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274617|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
2274618|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274619|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
2274620|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795208|NCT04257682|Mepivacaine|mepivacaine|mesh-list
2795209|NCT04257682|Anesthetics|anesthetics|mesh-list
2795210|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795211|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795212|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
2795213|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795214|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
2274621|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
2274622|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274623|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
2274624|NCT00207402|Interferons|interferons|mesh-list
2274625|NCT00207402|Ribavirin|ribavirin|mesh-list
2274626|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
2274627|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274628|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
2274629|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274630|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
2795215|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795216|NCT04257448|Gemcitabine|gemcitabine|mesh-list
2795217|NCT04257448|Paclitaxel|paclitaxel|mesh-list
2795218|NCT04257448|Lenalidomide|lenalidomide|mesh-list
2795219|NCT04257448|Azacitidine|azacitidine|mesh-list
2795220|NCT04257448|Durvalumab|durvalumab|mesh-list
2795221|NCT04257448|Romidepsin|romidepsin|mesh-list
2274631|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274632|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2274633|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274634|NCT00207428|Carbamazepine|carbamazepine|mesh-list
2274635|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
2274636|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
2274637|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2795222|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2795223|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795224|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
2795225|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
2795226|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
2795227|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795228|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2795229|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
2795230|NCT04257448|Antiviral Agents|antiviral agents|mesh-ancestor
2274638|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274639|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274640|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274641|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2274642|NCT00207428|Analgesics|analgesics|mesh-ancestor
2274643|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
2274644|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274645|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2795231|NCT04257448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795232|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795233|NCT04257448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2795234|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
2795235|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795236|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2795237|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2795238|NCT04257448|Growth Substances|growth substances|mesh-ancestor
2274646|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2274647|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274648|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2103810|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103811|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2103812|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2103813|NCT02426918|Vancomycin|vancomycin|mesh-list
2103814|NCT02426918|Linezolid|linezolid|mesh-list
2103815|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2103816|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103817|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2103818|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114041|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
2795239|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
2795240|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2795241|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2795242|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2795243|NCT04257500|Etonogestrel|etonogestrel|mesh-list
2795244|NCT04257500|NuvaRing|nuvaring|mesh-list
2795245|NCT04257500|Estradiol|estradiol|mesh-list
2795246|NCT04257500|Estrogens|estrogens|mesh-ancestor
2795247|NCT04257500|Hormones|hormones|mesh-ancestor
2795248|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2795249|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795250|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2795251|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
2795252|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2795253|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2795254|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2795255|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2274649|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2274650|NCT00207532|Folic Acid|folic acid|mesh-list
2274651|NCT00207532|Hematinics|hematinics|mesh-ancestor
2274652|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
2274653|NCT00207532|Vitamins|vitamins|mesh-ancestor
2274654|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
2274655|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274656|NCT00207558|Folic Acid|folic acid|mesh-list
2274657|NCT00207558|Hematinics|hematinics|mesh-ancestor
2274658|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
2274659|NCT00207558|Vitamins|vitamins|mesh-ancestor
2274660|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
2795256|NCT04257656|Remdesivir|remdesivir|mesh-list
2795257|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
2795258|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795259|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
2795260|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795261|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
2795262|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
2795263|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2795264|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
2795265|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795266|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2795267|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2795268|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2795269|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2795270|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795271|NCT04257188|Anesthetics|anesthetics|mesh-list
2795272|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795273|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795274|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2795275|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795276|NCT04256824|Triclosan|triclosan|mesh-list
2795277|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2795278|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795279|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2795280|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2795281|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
2795282|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795283|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2795284|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
2795285|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2795286|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795287|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
2274661|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795288|NCT04257032|Dabigatran|dabigatran|mesh-list
2795289|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2795290|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2795291|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2795292|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
2795293|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795294|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2795295|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2795296|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795297|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
2795298|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2795299|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
2795300|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
2795301|NCT04256642|Morphine|morphine|mesh-list
2795302|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2795303|NCT04256642|Narcotics|narcotics|mesh-ancestor
2795304|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795305|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795306|NCT04256642|Analgesics|analgesics|mesh-ancestor
2795307|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
2795308|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795309|NCT04256733|Capsaicin|capsaicin|mesh-list
2795310|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
2795311|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
2795312|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
2795313|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795314|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795315|NCT04256707|Docetaxel|docetaxel|mesh-list
2795316|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
2795317|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795318|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
2795319|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
2795320|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
2795321|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795322|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2795334|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2795335|NCT04256473|Saruplase|saruplase|mesh-list
2795336|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2795337|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2795338|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795339|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
2795340|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795341|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2795342|NCT04256343|Protective Agents|protective agents|mesh-ancestor
2795343|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795344|NCT04256252|Rituximab|rituximab|mesh-list
2795345|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2795346|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795347|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
2795348|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795349|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2795350|NCT04256525|Aspirin|aspirin|mesh-list
2795351|NCT04256525|Heparin|heparin|mesh-list
2795352|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
2795353|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2795354|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2795355|NCT04256525|Analgesics|analgesics|mesh-ancestor
2795356|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
2795357|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795358|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795359|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2795360|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2795361|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2795362|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2795363|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795364|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2795365|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2795366|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795367|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
2795368|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
2795369|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2795370|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
2795371|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2795372|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
2795373|NCT04256200|Dienogest|dienogest|mesh-list
2795374|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
2795375|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
2795376|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2795377|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2795378|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795379|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2795380|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2795381|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2795382|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2795383|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
2795384|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2795385|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2103819|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274662|NCT00207584|Doxycycline|doxycycline|mesh-list
2274663|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2274664|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274665|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
2274666|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2795386|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795387|NCT04256317|Azacitidine|azacitidine|mesh-list
2795388|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2795389|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
2795390|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795391|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795392|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795393|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
2795394|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274667|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2274668|NCT00207662|Infliximab|infliximab|mesh-list
2274669|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
2274670|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274671|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2795395|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
2795396|NCT04256057|Analgesics|analgesics|mesh-ancestor
2795397|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
2795398|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795399|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795400|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
2795401|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795402|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2795403|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
2795404|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2795405|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2795406|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795407|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2795408|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
2795409|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2795410|NCT04256213|Nivolumab|nivolumab|mesh-list
2795411|NCT04256213|Ipilimumab|ipilimumab|mesh-list
2795412|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2795413|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795414|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2795415|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795416|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
2795417|NCT04255992|Vitamin D|vitamin d|mesh-list
2795418|NCT04255992|Calcium|calcium|mesh-list
2795419|NCT04255992|Vitamins|vitamins|mesh-ancestor
2795420|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
2795421|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795422|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2795423|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2795424|NCT04255836|Durvalumab|durvalumab|mesh-list
2795425|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2274672|NCT00207675|Infliximab|infliximab|mesh-list
2274673|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
2274674|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274675|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2274676|NCT00207688|Infliximab|infliximab|mesh-list
2274677|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
2795426|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795427|NCT04255771|Gemcitabine|gemcitabine|mesh-list
2795428|NCT04255771|Cisplatin|cisplatin|mesh-list
2795429|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795430|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2795431|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
2795432|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795433|NCT04255771|Antiviral Agents|antiviral agents|mesh-ancestor
2795434|NCT04255771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795435|NCT04255771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795436|NCT04255771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2795437|NCT04255771|Immunologic Factors|immunologic factors|mesh-ancestor
2795438|NCT04255771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795439|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2795440|NCT04255602|Ticagrelor|ticagrelor|mesh-list
2795441|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2795442|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2274678|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274679|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2274680|NCT00207701|Infliximab|infliximab|mesh-list
2274681|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
2274682|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274683|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2274684|NCT00207753|Ivermectin|ivermectin|mesh-list
2274685|NCT00207753|Albendazole|albendazole|mesh-list
2795443|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2795444|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2795445|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
2795446|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2795447|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795448|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795449|NCT04255589|Ethanol|ethanol|mesh-list
2795450|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2795451|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795452|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795453|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795456|NCT04255576|Vitamin D|vitamin d|mesh-list
2795457|NCT04255576|Calcium|calcium|mesh-list
2795458|NCT04255576|Vitamins|vitamins|mesh-ancestor
2795459|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
2274686|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2274687|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274688|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
2274689|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
2274690|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2795460|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795461|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2795462|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2795463|NCT04255498|Etanercept|etanercept|mesh-list
2795464|NCT04255498|Mifepristone|mifepristone|mesh-list
2795465|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2795466|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2795467|NCT04255498|Analgesics|analgesics|mesh-ancestor
2795468|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
2795469|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795470|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795471|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2795472|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2795473|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2795474|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2795475|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
2795476|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2795477|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
2795478|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2795479|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2274691|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2274692|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
2274693|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
2795480|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2795481|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2795482|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
2795483|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2795484|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2795485|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
2795486|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2795487|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
2795488|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2795489|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2795490|NCT04255368|Choline|choline|mesh-list
2795491|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
2795492|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2795493|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
2795494|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795495|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2795496|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2795497|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
2795498|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
2795499|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2795500|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795501|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2795502|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795503|NCT04255251|Fluorides|fluorides|mesh-list
2795504|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
2274694|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
2274695|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274696|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274697|NCT00207766|Infliximab|infliximab|mesh-list
2274698|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
2274699|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274700|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2274701|NCT00207779|Heparin|heparin|mesh-list
2274702|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
2274703|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2274704|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2274705|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274706|NCT00207792|Lenograstim|lenograstim|mesh-list
2274707|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2274708|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
2274709|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795505|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
2795506|NCT04255251|Protective Agents|protective agents|mesh-ancestor
2795507|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795508|NCT04255160|Estradiol|estradiol|mesh-list
2795509|NCT04255160|Estrogens|estrogens|mesh-ancestor
2795510|NCT04255160|Hormones|hormones|mesh-ancestor
2795511|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2795512|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795513|NCT04255134|Adalimumab|adalimumab|mesh-list
2795514|NCT04255134|Abatacept|abatacept|mesh-list
2795515|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2795516|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2795517|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2795518|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795519|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795520|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2795521|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
2795522|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795523|NCT04255017|Ritonavir|ritonavir|mesh-list
2795524|NCT04255017|Lopinavir|lopinavir|mesh-list
2795525|NCT04255017|Oseltamivir|oseltamivir|mesh-list
2795526|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2795527|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2795528|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
2795529|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795530|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795531|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2795532|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2795533|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
2274710|NCT00207831|Tegafur|tegafur|mesh-list
2274711|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2274712|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
2274713|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274714|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274715|NCT00207844|Selenium|selenium|mesh-list
2795534|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795535|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2795536|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2795537|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
2795538|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2795539|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795540|NCT04255121|Lidocaine|lidocaine|mesh-list
2795541|NCT04255121|Epinephrine|epinephrine|mesh-list
2795542|NCT04255121|Racepinephrine|racepinephrine|mesh-list
2795543|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
2795544|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
2795545|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
2795546|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795547|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795548|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
2795549|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795550|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2274716|NCT00207844|Selenious Acid|selenious acid|mesh-list
2795551|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2795552|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2795553|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2795554|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795555|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2795556|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2795557|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
2795558|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2795559|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2795560|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2795561|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
2795562|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2795563|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
2795564|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
2795565|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
2795566|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2795567|NCT04254822|Carvedilol|carvedilol|mesh-list
2795568|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2795569|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2795570|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
2795571|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2795572|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795573|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795574|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2795575|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
2795576|NCT04254822|Protective Agents|protective agents|mesh-ancestor
2795577|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2795578|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2795579|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2795580|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
2795581|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2795582|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2795583|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
2795584|NCT04255056|Epirubicin|epirubicin|mesh-list
2795585|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2795586|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
2274717|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
2274718|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
2274719|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274720|NCT00207844|Protective Agents|protective agents|mesh-ancestor
2274721|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274722|NCT00207844|Trace Elements|trace elements|mesh-ancestor
2274723|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
2274724|NCT00207948|Ritonavir|ritonavir|mesh-list
2274725|NCT00207948|Lopinavir|lopinavir|mesh-list
2274726|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2795587|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795588|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2795589|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2795590|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
2795591|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795592|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795593|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2795594|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2795595|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2795596|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2795597|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795598|NCT04254913|Edaravone|edaravone|mesh-list
2795599|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2795600|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
2795601|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795602|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2795603|NCT04254913|Protective Agents|protective agents|mesh-ancestor
2795604|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795605|NCT04254874|Interferons|interferons|mesh-list
2795606|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795607|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
2795608|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795609|NCT04254744|Sevoflurane|sevoflurane|mesh-list
2795610|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2795611|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2795612|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
2795613|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
2795614|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274727|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2795615|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795616|NCT04254523|Morphine|morphine|mesh-list
2795617|NCT04254523|Bupivacaine|bupivacaine|mesh-list
2795618|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
2795619|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
2795620|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795621|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795622|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
2795623|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795624|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2795625|NCT04254523|Narcotics|narcotics|mesh-ancestor
2795626|NCT04254523|Analgesics|analgesics|mesh-ancestor
2795627|NCT04254601|Erythromycin|erythromycin|mesh-list
2274728|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
2274729|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274730|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274731|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2274732|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2795628|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
2795629|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2795630|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
2795631|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2795632|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795633|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2795634|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2795635|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274733|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
2274734|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274735|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2274736|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2274737|NCT00208039|Calfactant|calfactant|mesh-list
2274738|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2274739|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
2274740|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
2274741|NCT00208065|Ephedrine|ephedrine|mesh-list
2795636|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795637|NCT04254692|Bupivacaine|bupivacaine|mesh-list
2795638|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
2795639|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
2795640|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795641|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795642|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
2795643|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795644|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
2795645|NCT04254679|Analgesics|analgesics|mesh-list
2795646|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
2795647|NCT04254679|Narcotics|narcotics|mesh-ancestor
2795648|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795649|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274742|NCT00208065|Almotriptan|almotriptan|mesh-list
2274743|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2274744|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
2274745|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274746|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274747|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2274748|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
2274749|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
2274750|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2274751|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2274752|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
2274753|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
2274754|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274755|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274756|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2274757|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
2274758|NCT00208117|Sertraline|sertraline|mesh-list
2274759|NCT00208117|Simvastatin|simvastatin|mesh-list
2274760|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2274761|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2274762|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
2274763|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274764|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2795650|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
2795651|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795652|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
2795653|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2795654|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795655|NCT04254471|Carboplatin|carboplatin|mesh-list
2795656|NCT04254471|Etoposide|etoposide|mesh-list
2795657|NCT04254471|Rabeprazole|rabeprazole|mesh-list
2795658|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795659|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2795660|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2795661|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2795662|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795663|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795664|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2795665|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2795666|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2795667|NCT04254640|Cytarabine|cytarabine|mesh-list
2795668|NCT04254640|Cladribine|cladribine|mesh-list
2795669|NCT04254640|Aclarubicin|aclarubicin|mesh-list
2795670|NCT04254640|Sargramostim|sargramostim|mesh-list
2795671|NCT04254640|Lenograstim|lenograstim|mesh-list
2795672|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2795673|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
2795674|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795675|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795676|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
2795677|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795678|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2274765|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2274766|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274767|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
2274768|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274769|NCT00208117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2274770|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2274771|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2274772|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2795679|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
2795680|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795681|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2795682|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2795683|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2795684|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2795685|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795686|NCT04254042|Perindopril|perindopril|mesh-list
2795687|NCT04254042|Zofenopril|zofenopril|mesh-list
2795688|NCT04254042|Captopril|captopril|mesh-list
2795689|NCT04254042|Calcium|calcium|mesh-list
2274773|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
2274774|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274775|NCT00208130|Topiramate|topiramate|mesh-list
2795690|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2795691|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795692|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2795693|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
2795694|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795695|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795696|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2795697|NCT04254081|Lidocaine|lidocaine|mesh-list
2795698|NCT04254081|Buprenorphine|buprenorphine|mesh-list
2795699|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
2795700|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
2795701|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795702|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795703|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
2795704|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274776|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
2274777|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2274778|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795705|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2795706|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2795707|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2795708|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2795709|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795710|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2795711|NCT04254081|Narcotics|narcotics|mesh-ancestor
2795712|NCT04254081|Analgesics|analgesics|mesh-ancestor
2274779|NCT00208143|Risperidone|risperidone|mesh-list
2274780|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2274781|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2274782|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
2274783|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274784|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274785|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274786|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274787|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274788|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274789|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274790|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2274791|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
2274792|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
2274793|NCT00208156|Mifepristone|mifepristone|mesh-list
2274794|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2274795|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
2274796|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2274797|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274798|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2274799|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2274800|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2274801|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
2274802|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2274803|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2274804|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
2274805|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2274806|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
2274807|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2274808|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2274809|NCT00208169|Aripiprazole|aripiprazole|mesh-list
2274810|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
2274811|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274812|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274813|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274814|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795713|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2795714|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
2795715|NCT04253912|Povidone|povidone|mesh-list
2795716|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
2795717|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
2795718|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2795719|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795720|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2795721|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2795722|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795723|NCT04253678|Vortioxetine|vortioxetine|mesh-list
2795724|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
2795725|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2795726|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2795727|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2795728|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795729|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795730|NCT04253678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2795731|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2795732|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2795733|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795734|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2795735|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
2795736|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2795737|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2795738|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2795739|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2274815|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795740|NCT04253561|Trastuzumab|trastuzumab|mesh-list
2795741|NCT04253561|Pertuzumab|pertuzumab|mesh-list
2795742|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2795743|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795744|NCT04253873|Temozolomide|temozolomide|mesh-list
2795745|NCT04253873|Apatinib|apatinib|mesh-list
2795746|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2795747|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
2795748|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795749|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795750|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2795751|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795752|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
2795753|NCT04253132|Analgesics|analgesics|mesh-ancestor
2795754|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
2795755|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795756|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795757|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2795758|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2274816|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
2274817|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
2274818|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274819|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274820|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2274821|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2274822|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
2274823|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2274824|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2274825|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2274826|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2274827|NCT00208182|Risperidone|risperidone|mesh-list
2274828|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2274829|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
2274830|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274831|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274832|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274833|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274834|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274835|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274836|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274837|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2274838|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
2274839|NCT00208195|Valproic Acid|valproic acid|mesh-list
2274840|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
2274841|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2274842|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274843|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
2274844|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274845|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274846|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
2274847|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274848|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274849|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274850|NCT00208208|Ziprasidone|ziprasidone|mesh-list
2274851|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2274852|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
2274853|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274854|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274855|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274856|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274857|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274858|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274859|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2795759|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2795760|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2795761|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2795762|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2795763|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795764|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2795765|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
2274860|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2274861|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
2274862|NCT00208221|Telmisartan|telmisartan|mesh-list
2274863|NCT00208221|Ramipril|ramipril|mesh-list
2274864|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2274865|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2274866|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2274867|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274868|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2274869|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
2274870|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795766|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
2795767|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2795768|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2795769|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
2795770|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2795771|NCT04253145|Atezolizumab|atezolizumab|mesh-list
2795772|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795773|NCT04253457|Triamcinolone|triamcinolone|mesh-list
2795774|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2795775|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
2795776|NCT04253457|Hormones|hormones|mesh-ancestor
2795777|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2795778|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795779|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2795780|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2795781|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2795782|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
2795783|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795784|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2795785|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2795786|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795787|NCT04253223|Volagidemab|volagidemab|mesh-list
2795788|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2795789|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795790|NCT04252963|Streptokinase|streptokinase|mesh-list
2795791|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2795792|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2795793|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795794|NCT04252664|Remdesivir|remdesivir|mesh-list
2795795|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
2795796|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795797|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
2795798|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795799|NCT04252768|Paclitaxel|paclitaxel|mesh-list
2795800|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2795801|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795802|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
2795803|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
2795804|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
2795805|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795806|NCT04252612|Pramlintide|pramlintide|mesh-list
2795807|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2795808|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795809|NCT04252885|Ritonavir|ritonavir|mesh-list
2795810|NCT04252885|Lopinavir|lopinavir|mesh-list
2795811|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2795812|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2795813|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
2795814|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795815|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795816|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2795817|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2795818|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
2795819|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795820|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2795821|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2795822|NCT04252586|Cannabidiol|cannabidiol|mesh-list
2274871|NCT00208234|Omalizumab|omalizumab|mesh-list
2274872|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2274873|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2274874|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2274875|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
2795823|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
2795824|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
2795825|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2795826|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795827|NCT04252456|Leucovorin|leucovorin|mesh-list
2795828|NCT04252456|Folic Acid|folic acid|mesh-list
2795829|NCT04252456|Fluorouracil|fluorouracil|mesh-list
2795830|NCT04252456|Aflibercept|aflibercept|mesh-list
2795831|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
2795832|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
2795833|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795834|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2795835|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795836|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2795837|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
2795838|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795839|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2795840|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2795841|NCT04252456|Growth Substances|growth substances|mesh-ancestor
2795842|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
2795843|NCT04252456|Antidotes|antidotes|mesh-ancestor
2795844|NCT04252456|Protective Agents|protective agents|mesh-ancestor
2795845|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
2795846|NCT04252456|Vitamins|vitamins|mesh-ancestor
2795847|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
2795848|NCT04252456|Hematinics|hematinics|mesh-ancestor
2795849|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
2795850|NCT04252443|Analgesics|analgesics|mesh-list
2795851|NCT04252443|Narcotics|narcotics|mesh-ancestor
2795852|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795853|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795854|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
2795855|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795856|NCT04252248|Decitabine|decitabine|mesh-list
2795857|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2795858|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
2795859|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795860|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795861|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795862|NCT04252274|Darunavir|darunavir|mesh-list
2795863|NCT04252274|Cobicistat|cobicistat|mesh-list
2795864|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2795865|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2795866|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
2795867|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795868|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795869|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2795870|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2795871|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
2795872|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2795873|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2795874|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2795875|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2795876|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2795877|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2795878|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
2795879|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795880|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2795881|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2795882|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795883|NCT04252261|Sulforaphane|sulforaphane|mesh-list
2795884|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2795885|NCT04252261|Protective Agents|protective agents|mesh-ancestor
2795886|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795887|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795888|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2795889|NCT04252521|Ketoprofen|ketoprofen|mesh-list
2795890|NCT04252521|Metoclopramide|metoclopramide|mesh-list
2795891|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
2795892|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
2795893|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795894|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795895|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2795896|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2795897|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2795898|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
2795899|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2795900|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795901|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2795902|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2795903|NCT04252521|Analgesics|analgesics|mesh-ancestor
2795904|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
2795905|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2795906|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2795907|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2795908|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795909|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
2795910|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2795911|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795912|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795913|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2795914|NCT04251910|Analgesics|analgesics|mesh-ancestor
2795915|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
2795916|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795917|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2795918|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2795919|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2795920|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
2795921|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2795922|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795923|NCT04252105|Antioxidants|antioxidants|mesh-list
2795924|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795925|NCT04252105|Protective Agents|protective agents|mesh-ancestor
2795926|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795927|NCT04251962|Fentanyl|fentanyl|mesh-list
2795928|NCT04251962|Bupivacaine|bupivacaine|mesh-list
2795929|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
2795930|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
2795931|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2795932|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795933|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
2795934|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795935|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2795936|NCT04251962|Narcotics|narcotics|mesh-ancestor
2795937|NCT04251962|Analgesics|analgesics|mesh-ancestor
2795938|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2795939|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2795940|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
2795941|NCT04251871|Interferons|interferons|mesh-list
2795942|NCT04251871|Ritonavir|ritonavir|mesh-list
2795943|NCT04251871|Lopinavir|lopinavir|mesh-list
2795944|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
2795945|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2795946|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795947|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
2274876|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
2274877|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795948|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274878|NCT00208260|Leucovorin|leucovorin|mesh-list
2274879|NCT00208260|Fluorouracil|fluorouracil|mesh-list
2274880|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
2274881|NCT00208260|Folfirinox|folfirinox|mesh-list
2274882|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
2274883|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274884|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2274885|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2795949|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2795950|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2795951|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
2795952|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2795953|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2795954|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2795955|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2795956|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2795957|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2795958|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
2795959|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274886|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2274887|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
2795994|NCT04251819|Baclofen|baclofen|mesh-list
2795995|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2795996|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2795997|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2795998|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2795999|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2796000|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
2796001|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
2796002|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796003|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796004|NCT04251741|Adalimumab|adalimumab|mesh-list
2796005|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2796006|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2274888|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274889|NCT00208260|Antidotes|antidotes|mesh-ancestor
2274890|NCT00208260|Protective Agents|protective agents|mesh-ancestor
2274891|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
2274892|NCT00208260|Vitamins|vitamins|mesh-ancestor
2274893|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
2274894|NCT00208273|Letrozole|letrozole|mesh-list
2274895|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796012|NCT04251845|Melatonin|melatonin|mesh-list
2796013|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
2796014|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796015|NCT04251845|Protective Agents|protective agents|mesh-ancestor
2796016|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796017|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796018|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
2274896|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2274897|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2274898|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796019|NCT04251832|Antidotes|antidotes|mesh-ancestor
2796020|NCT04251832|Protective Agents|protective agents|mesh-ancestor
2796021|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796022|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
2796023|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796024|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
2796025|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2796026|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796027|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
2796028|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
2796029|NCT04251585|Insulin|insulin|mesh-list
2796030|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2796031|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796032|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
2796033|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2796034|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2796035|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796036|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
2796037|NCT04251247|Coagulants|coagulants|mesh-ancestor
2796038|NCT04251169|Paclitaxel|paclitaxel|mesh-list
2796039|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
2796040|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2274899|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274900|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2274901|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
2274902|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2274903|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274904|NCT00208299|Adenosine|adenosine|mesh-list
2274905|NCT00208299|Regadenoson|regadenoson|mesh-list
2274906|NCT00208299|Analgesics|analgesics|mesh-ancestor
2274907|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
2274908|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274909|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274910|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2796041|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796042|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
2796043|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
2796044|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
2796045|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796046|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2796047|NCT04251364|Acetazolamide|acetazolamide|mesh-list
2796048|NCT04251364|Atorvastatin|atorvastatin|mesh-list
2796049|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2796050|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2796051|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
2796052|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796053|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2796054|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2796055|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796056|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
2796057|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2796058|NCT04251364|Diuretics|diuretics|mesh-ancestor
2796059|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
2796060|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274911|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
2274912|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2274913|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
2274914|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
2274915|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274916|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274917|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2274918|NCT00208312|Adenosine|adenosine|mesh-list
2274919|NCT00208312|Regadenoson|regadenoson|mesh-list
2274920|NCT00208312|Analgesics|analgesics|mesh-ancestor
2274921|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
2274922|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274923|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274924|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2274925|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
2274926|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2274927|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
2274928|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
2274929|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274930|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274931|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2274932|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2274933|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
2274934|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2274935|NCT00208403|Protective Agents|protective agents|mesh-ancestor
2274936|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274937|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
2274938|NCT00208442|Diuretics|diuretics|mesh-ancestor
2274939|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
2274940|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274941|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2274942|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2274943|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274944|NCT00208520|Lamotrigine|lamotrigine|mesh-list
2274945|NCT00208520|Carbamazepine|carbamazepine|mesh-list
2274946|NCT00208520|Levetiracetam|levetiracetam|mesh-list
2796068|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
2796069|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2796070|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103831|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2103832|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2103833|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
2103834|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2103835|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2103836|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103837|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103838|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2103839|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2103840|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103841|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
2103842|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103843|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2103844|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2103845|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103846|NCT02427802|Gentamicins|gentamicins|mesh-list
2103847|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2103848|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103849|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2103850|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103851|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274947|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
2274948|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
2796071|NCT04250805|Lidocaine|lidocaine|mesh-list
2796072|NCT04250805|Ropivacaine|ropivacaine|mesh-list
2796073|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
2796074|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
2796075|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796076|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796077|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
2796078|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796079|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2796080|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2274949|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2274950|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796081|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2796082|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796083|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796084|NCT04250948|Capecitabine|capecitabine|mesh-list
2796085|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
2796086|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2796087|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
2796088|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796089|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796090|NCT04250792|Naltrexone|naltrexone|mesh-list
2796091|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2796092|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2796093|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796094|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
2796095|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796096|NCT04250831|Chromium|chromium|mesh-list
2796097|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2796098|NCT04250831|Trace Elements|trace elements|mesh-ancestor
2796099|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
2796100|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796101|NCT04250831|Cathartics|cathartics|mesh-ancestor
2796102|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2796103|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2796104|NCT04250636|Antibodies|antibodies|mesh-list
2796105|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
2796106|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2796107|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
2796108|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796109|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796110|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
2796111|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2796112|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796113|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2796114|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2796115|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796116|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796117|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103852|NCT02427841|Gemcitabine|gemcitabine|mesh-list
2103853|NCT02427841|Paclitaxel|paclitaxel|mesh-list
2103854|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2103855|NCT02427841|Fluorouracil|fluorouracil|mesh-list
2103856|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2103857|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796118|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2796119|NCT04250519|Eusol|eusol|mesh-list
2796120|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
2796121|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796122|NCT04250493|Insulin|insulin|mesh-list
2796123|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2796124|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796125|NCT04250246|Nivolumab|nivolumab|mesh-list
2796126|NCT04250246|Ipilimumab|ipilimumab|mesh-list
2796127|NCT04250246|Guadecitabine|guadecitabine|mesh-list
2796128|NCT04250246|Azacitidine|azacitidine|mesh-list
2796129|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2796130|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796131|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2796132|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796133|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2796134|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
2796135|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796136|NCT04250142|Methamphetamine|methamphetamine|mesh-list
2796137|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2796138|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796139|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
2796140|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
2796141|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796142|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
2796143|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796144|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796145|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
2796146|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2796147|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2796148|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796149|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2796150|NCT04250116|Apixaban|apixaban|mesh-list
2796151|NCT04250116|Clopidogrel|clopidogrel|mesh-list
2796152|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2796153|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2796154|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2796155|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2796156|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
2796157|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796158|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796159|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796160|NCT04250116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2796161|NCT04250116|Antithrombins|antithrombins|mesh-ancestor
2796162|NCT04250116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2796163|NCT04250116|Protease Inhibitors|protease inhibitors|mesh-ancestor
2796164|NCT04250116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796165|NCT04250116|Anticoagulants|anticoagulants|mesh-ancestor
2796166|NCT04250064|Bevacizumab|bevacizumab|mesh-list
2796167|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2796168|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796169|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2796170|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2796171|NCT04250064|Growth Substances|growth substances|mesh-ancestor
2796172|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796173|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
2796174|NCT04250051|Vidarabine|vidarabine|mesh-list
2796175|NCT04250051|Cytarabine|cytarabine|mesh-list
2796176|NCT04250051|Fludarabine|fludarabine|mesh-list
2796177|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
2796178|NCT04250051|Ivosidenib|ivosidenib|mesh-list
2796179|NCT04250051|Lenograstim|lenograstim|mesh-list
2796180|NCT04250051|Sargramostim|sargramostim|mesh-list
2796181|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796182|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2796183|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
2796184|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796185|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2796186|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
2796187|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796188|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
2796189|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2274951|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274952|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2274953|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274954|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274955|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274956|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274957|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274958|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2274959|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
2274960|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2274961|NCT00208520|Analgesics|analgesics|mesh-ancestor
2796190|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2796191|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796192|NCT04249713|Brodalumab|brodalumab|mesh-list
2796193|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
2796194|NCT04249908|Maleic acid|maleic acid|mesh-list
2796195|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796196|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796197|NCT04249687|Botulinum Toxins|botulinum toxins|mesh-list
2796198|NCT04249687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2796199|NCT04249687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796200|NCT04249687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796201|NCT04249687|Cholinergic Agents|cholinergic agents|mesh-ancestor
2796202|NCT04249687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796203|NCT04249687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796204|NCT04249882|Naltrexone|naltrexone|mesh-list
2796205|NCT04249882|Varenicline|varenicline|mesh-list
2796206|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2796207|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2796208|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796209|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
2796210|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796211|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2796212|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2796213|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
2796214|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796215|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796216|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
2796217|NCT04249570|Povidone|povidone|mesh-list
2796218|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
2796219|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
2796220|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2796221|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796222|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
2796223|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2796224|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796225|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2796226|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796227|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
2796228|NCT04249804|Analgesics|analgesics|mesh-ancestor
2796229|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
2796230|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796231|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796232|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
2796233|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796234|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2796235|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
2796236|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2796237|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796238|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796239|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2796240|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
2796241|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2796242|NCT04249544|Pramipexole|pramipexole|mesh-list
2796243|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
2796244|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796245|NCT04249544|Protective Agents|protective agents|mesh-ancestor
2274962|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
2274963|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2274964|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2274965|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2274966|NCT00208533|Aripiprazole|aripiprazole|mesh-list
2274967|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
2796246|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796247|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2796248|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2796249|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
2796250|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
2796251|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796252|NCT04249531|Amikacin|amikacin|mesh-list
2796253|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2796254|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796255|NCT04249427|Erenumab|erenumab|mesh-list
2274968|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2274969|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2274970|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2274971|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2274972|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796256|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2796257|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796258|NCT04249427|Analgesics|analgesics|mesh-ancestor
2796259|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
2796260|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796261|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796262|NCT04249622|Rifaximin|rifaximin|mesh-list
2796263|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2796264|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796265|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2274973|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
2274974|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
2274975|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2274976|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274977|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2274978|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2274979|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
2274980|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2274981|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2274982|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2274983|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2274984|NCT00208546|Bevacizumab|bevacizumab|mesh-list
2796288|NCT04249232|Abaloparatide|abaloparatide|mesh-list
2796289|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2796290|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796291|NCT04249154|Leuprolide|leuprolide|mesh-list
2796292|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2796293|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
2796294|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2796295|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796296|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2796297|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796310|NCT04249583|Botulinum Toxins|botulinum toxins|mesh-list
2796311|NCT04249583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2796312|NCT04249583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796313|NCT04249583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796314|NCT04249583|Cholinergic Agents|cholinergic agents|mesh-ancestor
2796315|NCT04249583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796316|NCT04249583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796317|NCT04249284|BMS-986165|bms-986165|mesh-list
2796318|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
2796319|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2796320|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796321|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796322|NCT04248998|Metformin|metformin|mesh-list
2796323|NCT04248998|Paclitaxel|paclitaxel|mesh-list
2796324|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
2796325|NCT04248998|Doxorubicin|doxorubicin|mesh-list
2796326|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2274985|NCT00208546|Cetuximab|cetuximab|mesh-list
2274986|NCT00208546|Capecitabine|capecitabine|mesh-list
2274987|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
2274988|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2274989|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2274990|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2274991|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2274992|NCT00208546|Growth Substances|growth substances|mesh-ancestor
2274993|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2274994|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
2274995|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2274996|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
2274997|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2274998|NCT00208559|Ziprasidone|ziprasidone|mesh-list
2274999|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2796327|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796328|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
2796329|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
2796330|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
2796331|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796332|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2796333|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
2796334|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796335|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2796336|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2796337|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
2796338|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2796339|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2796340|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2796341|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2796342|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2796343|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796344|NCT04249063|Lidocaine|lidocaine|mesh-list
2796345|NCT04249063|Anesthetics|anesthetics|mesh-list
2796346|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
2796347|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796348|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275000|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
2796349|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
2796350|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796351|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2796352|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2796353|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2796354|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796355|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796356|NCT04248712|Loratadine|loratadine|mesh-list
2796357|NCT04248712|Famotidine|famotidine|mesh-list
2796358|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2796359|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2796360|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2796361|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
2796362|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
2275001|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796363|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796364|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796365|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796366|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
2796367|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
2796368|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2796369|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2796370|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2796371|NCT04249037|Tenofovir|tenofovir|mesh-list
2796372|NCT04249037|Emtricitabine|emtricitabine|mesh-list
2796373|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2796374|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2796375|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
2796376|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796377|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2796378|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2796379|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796380|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796381|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2275002|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275003|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275004|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2275005|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2796382|NCT04248569|Nivolumab|nivolumab|mesh-list
2796383|NCT04248569|Ipilimumab|ipilimumab|mesh-list
2796384|NCT04248569|Poly ICLC|poly iclc|mesh-list
2796385|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2796386|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796387|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2796388|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796389|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
2796390|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
2796391|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796392|NCT04248621|Goserelin|goserelin|mesh-list
2796393|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2796394|NCT04248621|Leuprolide|leuprolide|mesh-list
2796395|NCT04248621|Flutamide|flutamide|mesh-list
2796396|NCT04248621|Bicalutamide|bicalutamide|mesh-list
2796397|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
2796398|NCT04248621|Androgens|androgens|mesh-list
2796399|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2796400|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796401|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
2796402|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2796403|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796404|NCT04248621|Hormones|hormones|mesh-ancestor
2796405|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
2796406|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2796407|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
2796408|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2796409|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2275006|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275007|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2275008|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2796410|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2796411|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
2796412|NCT04248608|Morphine|morphine|mesh-list
2275009|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
2275010|NCT00208572|Citalopram|citalopram|mesh-list
2275011|NCT00208572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2275012|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2275013|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2275014|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275015|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275016|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
2275017|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796413|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2796414|NCT04248608|Narcotics|narcotics|mesh-ancestor
2796415|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796416|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796417|NCT04248608|Analgesics|analgesics|mesh-ancestor
2796418|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
2796419|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796420|NCT04248595|Azacitidine|azacitidine|mesh-list
2796421|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
2796422|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2796423|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
2796424|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796425|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796426|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796427|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2796428|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2796429|NCT04248348|Heparin|heparin|mesh-list
2796430|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2796431|NCT04248348|Tinzaparin|tinzaparin|mesh-list
2796432|NCT04248348|Dalteparin|dalteparin|mesh-list
2796433|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
2796434|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2796435|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2796436|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796437|NCT04248335|Midazolam|midazolam|mesh-list
2796438|NCT04248335|Pantoprazole|pantoprazole|mesh-list
2796439|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2796440|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2796441|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796442|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796443|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2796444|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2796445|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2796446|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2103858|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
2103859|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
2103860|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
2103861|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103862|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2103863|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
2103864|NCT02427841|Antiviral Agents|antiviral agents|mesh-ancestor
2103865|NCT02427841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103866|NCT02427841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103867|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2103868|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
2103869|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103870|NCT02427958|Leuprolide|leuprolide|mesh-list
2103871|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2275018|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2275019|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
2275020|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2275021|NCT00208585|Sertraline|sertraline|mesh-list
2275022|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
2275023|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2275024|NCT00208585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2275025|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2275026|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2275027|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275028|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275029|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
2275030|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275031|NCT00208611|Vitamins|vitamins|mesh-list
2275032|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
2275033|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
2275034|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
2275035|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
2275036|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275037|NCT00208611|Hematinics|hematinics|mesh-ancestor
2275038|NCT00208702|Sertraline|sertraline|mesh-list
2275039|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
2275040|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2796447|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
2796448|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
2796449|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
2796450|NCT04248335|GABA Agents|gaba agents|mesh-ancestor
2796451|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796452|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796453|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2796454|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2796455|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2796456|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796457|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
2796458|NCT04248452|Leucovorin|leucovorin|mesh-list
2796459|NCT04248452|Folic Acid|folic acid|mesh-list
2796460|NCT04248452|Fluorouracil|fluorouracil|mesh-list
2796461|NCT04248452|Capecitabine|capecitabine|mesh-list
2796462|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
2796463|NCT04248452|Calcium|calcium|mesh-list
2796464|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
2796465|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2796466|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796467|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2796468|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
2796469|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796470|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2796471|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796472|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2796473|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
2796474|NCT04248452|Antidotes|antidotes|mesh-ancestor
2275041|NCT00208702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2275042|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2275043|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2275044|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275045|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275046|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
2275047|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275048|NCT00208715|Modafinil|modafinil|mesh-list
2275049|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2275050|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796475|NCT04248452|Protective Agents|protective agents|mesh-ancestor
2796476|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
2796477|NCT04248452|Vitamins|vitamins|mesh-ancestor
2796478|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
2796479|NCT04248452|Hematinics|hematinics|mesh-ancestor
2796480|NCT04248309|Progesterone|progesterone|mesh-list
2796481|NCT04248309|Progestins|progestins|mesh-ancestor
2796482|NCT04248309|Hormones|hormones|mesh-ancestor
2796483|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2796484|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796485|NCT04247867|Psyllium|psyllium|mesh-list
2796486|NCT04247867|Cathartics|cathartics|mesh-ancestor
2796487|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2796488|NCT04248205|Ketamine|ketamine|mesh-list
2796489|NCT04248205|Analgesics|analgesics|mesh-ancestor
2796490|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
2796491|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796492|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796493|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2796494|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2796495|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
2796496|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
2796497|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796498|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2275051|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2275052|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2275053|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2275054|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275055|NCT00208741|Tiagabine|tiagabine|mesh-list
2275056|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
2275057|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
2275058|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2275059|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2275060|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275061|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
2275062|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275063|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275064|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
2275065|NCT00208793|Vitamin D|vitamin d|mesh-list
2275066|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
2275067|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
2275068|NCT00208793|Vitamins|vitamins|mesh-list
2275069|NCT00208793|Calcium|calcium|mesh-list
2275070|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
2275071|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275072|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2275073|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2796499|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2796500|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796501|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796502|NCT04247984|Bevacizumab|bevacizumab|mesh-list
2796503|NCT04247984|Fluorouracil|fluorouracil|mesh-list
2796504|NCT04247984|Capecitabine|capecitabine|mesh-list
2796505|NCT04247984|Irinotecan|irinotecan|mesh-list
2796506|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2796507|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796508|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2796509|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2796510|NCT04247984|Growth Substances|growth substances|mesh-ancestor
2275074|NCT00208819|Valproic Acid|valproic acid|mesh-list
2275075|NCT00208819|Olanzapine|olanzapine|mesh-list
2275076|NCT00208819|Risperidone|risperidone|mesh-list
2275077|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2275078|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2275079|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
2275080|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275081|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275082|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275083|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2275084|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2275085|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275086|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2275087|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2275088|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
2275089|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
2275090|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
2275091|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796511|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796512|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
2796513|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
2796514|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796515|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2796516|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2796517|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
2796518|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2796519|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2796520|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796521|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
2796522|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2796523|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796524|NCT04248179|Sufentanil|sufentanil|mesh-list
2796525|NCT04248179|Ropivacaine|ropivacaine|mesh-list
2796526|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
2796527|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
2796528|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796529|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796530|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
2275092|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2275093|NCT00208819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2275094|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2275095|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2275096|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
2275097|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
2275098|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796531|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796532|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2796533|NCT04248179|Narcotics|narcotics|mesh-ancestor
2796534|NCT04248179|Analgesics|analgesics|mesh-ancestor
2796535|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2796536|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2796537|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
2796538|NCT04247633|Palbociclib|palbociclib|mesh-list
2796539|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796540|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2796541|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796542|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796543|NCT04247646|Melatonin|melatonin|mesh-list
2796544|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
2796545|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796546|NCT04247646|Protective Agents|protective agents|mesh-ancestor
2796547|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796548|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796549|NCT04247815|Methotrexate|methotrexate|mesh-list
2796550|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2275099|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
2275100|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
2275101|NCT00208858|Topiramate|topiramate|mesh-list
2275102|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
2275103|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2275104|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275105|NCT00208897|Fluoxetine|fluoxetine|mesh-list
2275106|NCT00208897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2275107|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2275108|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2275109|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275110|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275111|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
2275112|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275113|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2275114|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
2275115|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2796551|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
2796552|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2796553|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796554|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2796555|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
2796556|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796557|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796558|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
2796559|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796560|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2796561|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2796562|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
2796563|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2275116|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2275117|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2275118|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275119|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
2275120|NCT00208923|Busulfan|busulfan|mesh-list
2275121|NCT00208923|Fludarabine|fludarabine|mesh-list
2275122|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275123|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
2796564|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2796565|NCT04247373|Ropivacaine|ropivacaine|mesh-list
2796566|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
2796567|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
2796568|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275124|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275125|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2275126|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2275127|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
2275128|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275129|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275130|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2275131|NCT00208936|Fluorouracil|fluorouracil|mesh-list
2275132|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275133|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
2275134|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275135|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2275136|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275137|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
2275138|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275139|NCT00209014|Thalidomide|thalidomide|mesh-list
2275140|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2796569|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796570|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
2796571|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796572|NCT04247230|Tetracaine|tetracaine|mesh-list
2796573|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
2796574|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
2796575|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796576|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796577|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
2796578|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796579|NCT04247126|Fulvestrant|fulvestrant|mesh-list
2796580|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2275141|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
2275142|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275143|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
2796581|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796582|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2796583|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2796584|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
2796585|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2796586|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275144|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2275145|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275146|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2275147|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2275148|NCT00209014|Growth Substances|growth substances|mesh-ancestor
2275149|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
2796587|NCT04247087|Vitamin K|vitamin k|mesh-list
2796588|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
2796589|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2796590|NCT04247087|Vitamins|vitamins|mesh-ancestor
2796591|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
2796592|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796593|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2796594|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2796595|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796596|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
2796597|NCT04247087|Coagulants|coagulants|mesh-ancestor
2796598|NCT04247074|Botulinum Toxins|botulinum toxins|mesh-list
2796599|NCT04247074|Neurotransmitter Agents|neurotransmitter agents|mesh-list
2796600|NCT04247074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2796601|NCT04247074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796602|NCT04247074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796603|NCT04247074|Cholinergic Agents|cholinergic agents|mesh-ancestor
2796604|NCT04247074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796605|NCT04247165|Gemcitabine|gemcitabine|mesh-list
2796606|NCT04247165|Paclitaxel|paclitaxel|mesh-list
2796607|NCT04247165|Nivolumab|nivolumab|mesh-list
2796608|NCT04247165|Ipilimumab|ipilimumab|mesh-list
2796609|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2796610|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796611|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
2796612|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
2796613|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
2796614|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796615|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2796616|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
2796617|NCT04247165|Antiviral Agents|antiviral agents|mesh-ancestor
2796618|NCT04247165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796619|NCT04247165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796620|NCT04247165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2796621|NCT04247165|Immunologic Factors|immunologic factors|mesh-ancestor
2796622|NCT04247165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796623|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2796624|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2796625|NCT04246996|Gentamicins|gentamicins|mesh-list
2796626|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2796627|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796628|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2796629|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796630|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796631|NCT04246905|Sulforaphane|sulforaphane|mesh-list
2796632|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2796633|NCT04246905|Protective Agents|protective agents|mesh-ancestor
2796634|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796635|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796636|NCT04246619|Pregabalin|pregabalin|mesh-list
2796637|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2796638|NCT04246619|Analgesics|analgesics|mesh-ancestor
2796639|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
2275150|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275151|NCT00209079|Docetaxel|docetaxel|mesh-list
2275152|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
2275153|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275154|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
2275155|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
2275156|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
2275157|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275158|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2275159|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275160|NCT00209118|Paroxetine|paroxetine|mesh-list
2275161|NCT00209118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2275162|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2275163|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796640|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796641|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796642|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
2796643|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2796644|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796645|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796646|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2275164|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796647|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2796648|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2796649|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796650|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2796651|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2796652|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2796653|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796654|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
2796655|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
2796656|NCT04246723|Ritonavir|ritonavir|mesh-list
2796657|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
2796658|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2796659|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2796660|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
2796661|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796662|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796663|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2796664|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2796665|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
2796666|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796667|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2796668|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2796669|NCT04246684|Leucovorin|leucovorin|mesh-list
2796670|NCT04246684|Folic Acid|folic acid|mesh-list
2796671|NCT04246684|Capecitabine|capecitabine|mesh-list
2796672|NCT04246684|Fluorouracil|fluorouracil|mesh-list
2796673|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
2796674|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
2796675|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2796676|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
2796677|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796678|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796679|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2796680|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
2796681|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796682|NCT04246684|Antidotes|antidotes|mesh-ancestor
2796683|NCT04246684|Protective Agents|protective agents|mesh-ancestor
2796684|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
2796685|NCT04246684|Vitamins|vitamins|mesh-ancestor
2796686|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
2796687|NCT04246684|Hematinics|hematinics|mesh-ancestor
2796688|NCT04246567|Fentanyl|fentanyl|mesh-list
2796689|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2796690|NCT04246567|Narcotics|narcotics|mesh-ancestor
2796691|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796692|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796693|NCT04246567|Analgesics|analgesics|mesh-ancestor
2796694|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
2796695|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796696|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2796697|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2796698|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
2796699|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
2796700|NCT04246697|Acetaminophen|acetaminophen|mesh-list
2796701|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2796702|NCT04246697|Morphine|morphine|mesh-list
2796703|NCT04246697|Oxycodone|oxycodone|mesh-list
2796704|NCT04246697|Gabapentin|gabapentin|mesh-list
2796705|NCT04246697|Bupivacaine|bupivacaine|mesh-list
2796706|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
2796707|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
2796708|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796709|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796710|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
2796711|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796712|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2796713|NCT04246697|Narcotics|narcotics|mesh-ancestor
2796714|NCT04246697|Analgesics|analgesics|mesh-ancestor
2796715|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
2796716|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2796717|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2796718|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2796719|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2796720|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2796721|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796722|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796723|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
2796724|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2796725|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
2796726|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2796727|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2796728|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2796729|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2796730|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796731|NCT04246502|Capecitabine|capecitabine|mesh-list
2796732|NCT04246502|Trastuzumab|trastuzumab|mesh-list
2796733|NCT04246502|Pertuzumab|pertuzumab|mesh-list
2796734|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2796735|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
2796736|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796737|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796738|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2796739|NCT04246437|Carbidopa|carbidopa|mesh-list
2796740|NCT04246437|Entacapone|entacapone|mesh-list
2796741|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2796742|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2796743|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
2796744|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796745|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796746|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796747|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2796748|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796749|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2796750|NCT04246151|Vancomycin|vancomycin|mesh-list
2796751|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2796752|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796753|NCT04246255|Lidocaine|lidocaine|mesh-list
2796754|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
2796755|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
2796756|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796757|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275165|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275166|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
2275167|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275168|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2275169|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
2796758|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
2796759|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796760|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2796761|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2796762|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2796763|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796764|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796765|NCT04246229|Bilirubin|bilirubin|mesh-list
2796766|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
2796767|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796768|NCT04246229|Protective Agents|protective agents|mesh-ancestor
2796769|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796770|NCT04246359|Interferons|interferons|mesh-list
2796771|NCT04246359|Rituximab|rituximab|mesh-list
2796772|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2796773|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796774|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
2796775|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796776|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2796777|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
2796778|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796793|NCT04245787|Fluorides|fluorides|mesh-list
2796794|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
2796795|NCT04245787|Protective Agents|protective agents|mesh-ancestor
2796796|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796797|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2796798|NCT04245748|Citalopram|citalopram|mesh-list
2796799|NCT04245748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2796800|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2796801|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796802|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796803|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796804|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
2796805|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796806|NCT04245748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2275170|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2275171|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2275172|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2275173|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275174|NCT00209144|Insulin|insulin|mesh-list
2275175|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2275176|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796807|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
2796808|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2796809|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796810|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2796811|NCT04245748|Analgesics|analgesics|mesh-ancestor
2796812|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
2796813|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
2796814|NCT04245774|Bupivacaine|bupivacaine|mesh-list
2796815|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
2796816|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
2796817|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
2796818|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796819|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796820|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
2275177|NCT00209209|Interferons|interferons|mesh-list
2275178|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
2275179|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
2275180|NCT00209209|Prednisone|prednisone|mesh-list
2275181|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
2275182|NCT00209209|Rituximab|rituximab|mesh-list
2275183|NCT00209209|Doxorubicin|doxorubicin|mesh-list
2275184|NCT00209209|Fludarabine|fludarabine|mesh-list
2275185|NCT00209209|Vincristine|vincristine|mesh-list
2275186|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275187|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
2275188|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275189|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2275190|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2796821|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796829|NCT04245371|Lidocaine|lidocaine|mesh-list
2796830|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
2796831|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
2796832|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796833|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796834|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
2796835|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796836|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2796837|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2796838|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2796839|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796840|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796841|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
2796842|NCT04245722|Rituximab|rituximab|mesh-list
2796843|NCT04245722|Fludarabine|fludarabine|mesh-list
2796844|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
2796845|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2796846|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
2796847|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796848|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2275191|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
2372121|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796849|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2796850|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
2796851|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796852|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796853|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2796854|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2275192|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275193|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275194|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2275195|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2275196|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2275197|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2275198|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2275199|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275200|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2275201|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
2275202|NCT00209209|Hormones|hormones|mesh-ancestor
2796855|NCT04245618|Gemcitabine|gemcitabine|mesh-list
2796856|NCT04245618|Cisplatin|cisplatin|mesh-list
2796857|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796858|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2796859|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
2796860|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796861|NCT04245618|Antiviral Agents|antiviral agents|mesh-ancestor
2796862|NCT04245618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796863|NCT04245618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796864|NCT04245618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2796865|NCT04245618|Immunologic Factors|immunologic factors|mesh-ancestor
2796866|NCT04245618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796867|NCT04245709|Clenbuterol|clenbuterol|mesh-list
2796868|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2796869|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2796870|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
2796871|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796872|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796873|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796874|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2796875|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
2796876|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796877|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2796878|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
2796879|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
2796880|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2796881|NCT04245436|Citalopram|citalopram|mesh-list
2796882|NCT04245436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2796883|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2796884|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796885|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796886|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2796887|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
2796888|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796889|NCT04245436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2796890|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
2796891|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2796892|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796893|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2796894|NCT04245436|Analgesics|analgesics|mesh-ancestor
2796895|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
2796896|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
2796897|NCT04245644|Aspirin|aspirin|mesh-list
2275203|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2796898|NCT04245644|Metformin|metformin|mesh-list
2796899|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2796900|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2796901|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796902|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2796903|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2796904|NCT04245644|Analgesics|analgesics|mesh-ancestor
2796905|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
2796906|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796907|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2796908|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2796909|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2796910|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2796911|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796912|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2796913|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2796914|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796915|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
2796916|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
2796917|NCT04245046|Amlodipine|amlodipine|mesh-list
2796918|NCT04245046|Candesartan|candesartan|mesh-list
2796919|NCT04245046|Atorvastatin|atorvastatin|mesh-list
2796920|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2796921|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2796922|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
2796923|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796924|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2796925|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2796926|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2796927|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2796928|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2796929|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2796930|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2796931|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796932|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
2796933|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2796934|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2796935|NCT04245215|Ustekinumab|ustekinumab|mesh-list
2796936|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
2275204|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2275205|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
2275206|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275207|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2275208|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
2275209|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
2796957|NCT04245319|Acitretin|acitretin|mesh-list
2796958|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
2796959|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
2796960|NCT04244981|Thrombin|thrombin|mesh-list
2796961|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
2796962|NCT04244981|Coagulants|coagulants|mesh-ancestor
2796963|NCT04245280|Ropivacaine|ropivacaine|mesh-list
2796964|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2796965|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
2796966|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
2796967|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2796968|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796969|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
2796970|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796971|NCT04245033|Piperaquine|piperaquine|mesh-list
2796972|NCT04245033|Artenimol|artenimol|mesh-list
2796973|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
2796974|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2796975|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2796976|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2796977|NCT04244695|Dexamethasone|dexamethasone|mesh-list
2796978|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2796979|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
2796980|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
2796981|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2796982|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2796983|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2796984|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
2796985|NCT04244695|Hormones|hormones|mesh-ancestor
2796986|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2796987|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2796988|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2796989|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
2796990|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2796991|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2796992|NCT04244591|Prednisolone|prednisolone|mesh-list
2796993|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
2796994|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2796995|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
2796996|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2796997|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
2796998|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
2275210|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
2275211|NCT00209222|Cytarabine|cytarabine|mesh-list
2275212|NCT00209222|Dexamethasone|dexamethasone|mesh-list
2275213|NCT00209222|Prednisone|prednisone|mesh-list
2275214|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
2275215|NCT00209222|Melphalan|melphalan|mesh-list
2275216|NCT00209222|Rituximab|rituximab|mesh-list
2275217|NCT00209222|Doxorubicin|doxorubicin|mesh-list
2275218|NCT00209222|Etoposide|etoposide|mesh-list
2275219|NCT00209222|Vincristine|vincristine|mesh-list
2275220|NCT00209222|Cisplatin|cisplatin|mesh-list
2275221|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275222|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
2275223|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275224|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2275225|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2275226|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
2275227|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2796999|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797000|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797001|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2797002|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
2797003|NCT04244591|Hormones|hormones|mesh-ancestor
2797004|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2797005|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2797006|NCT04244591|Protective Agents|protective agents|mesh-ancestor
2797007|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2797008|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797009|NCT04244708|Temozolomide|temozolomide|mesh-list
2797010|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2797011|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
2797012|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797013|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797014|NCT04244448|Emtricitabine|emtricitabine|mesh-list
2797015|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
2797016|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797017|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2797018|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2797019|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797020|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797021|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2797022|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2797023|NCT04244630|Antioxidants|antioxidants|mesh-list
2797024|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797025|NCT04244630|Protective Agents|protective agents|mesh-ancestor
2797026|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797027|NCT04243954|Morphine|morphine|mesh-list
2797028|NCT04243954|Hydromorphone|hydromorphone|mesh-list
2797029|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2797030|NCT04243954|Narcotics|narcotics|mesh-ancestor
2797031|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797032|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797033|NCT04243954|Analgesics|analgesics|mesh-ancestor
2797034|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
2797035|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797036|NCT04244058|Amantadine|amantadine|mesh-list
2797037|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2797038|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2797039|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
2797040|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797041|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
2797042|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797043|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797044|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797045|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2797046|NCT04244058|Analgesics|analgesics|mesh-ancestor
2797047|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
2275228|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275229|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2275230|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2275231|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
2275232|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
2275233|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275234|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2275235|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
2275236|NCT00209222|Hormones|hormones|mesh-ancestor
2275237|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2275238|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2275239|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2275240|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2275241|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2275242|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2275243|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275244|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2275245|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
2275246|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
2275247|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
2797048|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797049|NCT04244097|Bupivacaine|bupivacaine|mesh-list
2797050|NCT04244097|Neostigmine|neostigmine|mesh-list
2797051|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
2797052|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
2797053|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797054|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797055|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
2797056|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797057|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2797058|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797059|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797060|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
2797061|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797062|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2797063|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
2797064|NCT04243993|Calcium|calcium|mesh-list
2797065|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2797066|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275248|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2275249|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
2275250|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
2275251|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275252|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2275253|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
2275254|NCT00209261|Coagulants|coagulants|mesh-ancestor
2275255|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2275256|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
2275257|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275258|NCT00209300|Mesalamine|mesalamine|mesh-list
2275259|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2275260|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2275261|NCT00209300|Analgesics|analgesics|mesh-ancestor
2275262|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
2275263|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275264|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275265|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2275266|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2275267|NCT00209313|Acyclovir|acyclovir|mesh-list
2275268|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
2275269|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275270|NCT00209352|Acyclovir|acyclovir|mesh-list
2275271|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
2275272|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275273|NCT00209469|Alendronate|alendronate|mesh-list
2275274|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2275275|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275276|NCT00209482|Metformin|metformin|mesh-list
2275277|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2275278|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275279|NCT00209495|Dexamethasone|dexamethasone|mesh-list
2275280|NCT00209495|Pregabalin|pregabalin|mesh-list
2275281|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2275282|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
2275283|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
2275284|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275285|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275286|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2275287|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
2275288|NCT00209495|Hormones|hormones|mesh-ancestor
2275289|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2275290|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2275291|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275292|NCT00209495|Analgesics|analgesics|mesh-ancestor
2275293|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
2797067|NCT04243616|Paclitaxel|paclitaxel|mesh-list
2797068|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
2797069|NCT04243616|Carboplatin|carboplatin|mesh-list
2797070|NCT04243616|Doxorubicin|doxorubicin|mesh-list
2797071|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2797072|NCT04243616|Cemiplimab|cemiplimab|mesh-list
2797073|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2797074|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797075|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
2797076|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
2797077|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
2797078|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797079|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2797080|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
2797081|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797082|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2797083|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2797084|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
2797085|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2797086|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2797087|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2797088|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2797089|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797090|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2797091|NCT04243850|Empagliflozin|empagliflozin|mesh-list
2797092|NCT04243850|Caffeine|caffeine|mesh-list
2797093|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2797094|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797095|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2797096|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797097|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797098|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2797099|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2275294|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
2275295|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2275296|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2275297|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275298|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2275299|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2275300|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2275301|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275302|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2275303|NCT00209521|Propofol|propofol|mesh-list
2797100|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
2797101|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797102|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2797103|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2797104|NCT04243733|Pemetrexed|pemetrexed|mesh-list
2797105|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797106|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797107|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275304|NCT00209521|Fospropofol|fospropofol|mesh-list
2275305|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2275306|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275307|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275308|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2275309|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
2275310|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
2275311|NCT00209534|Fospropofol|fospropofol|mesh-list
2275312|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2275313|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275314|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275315|NCT00209547|Fospropofol|fospropofol|mesh-list
2275316|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2797108|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2797109|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2797110|NCT04243811|Anesthetics|anesthetics|mesh-list
2797111|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797112|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797113|NCT04243434|Prednisone|prednisone|mesh-list
2797114|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
2797115|NCT04243434|Doxorubicin|doxorubicin|mesh-list
2797116|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2797117|NCT04243434|Vincristine|vincristine|mesh-list
2797118|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2797119|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
2797120|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797121|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2797122|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2275317|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275318|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275319|NCT00209573|Fospropofol|fospropofol|mesh-list
2275320|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2275321|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275322|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797123|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
2797124|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797125|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797126|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2797127|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2797128|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2797129|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2797130|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797131|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2797132|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
2797133|NCT04243434|Hormones|hormones|mesh-ancestor
2797134|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2797135|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2797136|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2797137|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
2797138|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
2275323|NCT00209586|Fospropofol|fospropofol|mesh-list
2275324|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2275325|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275326|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275327|NCT00209599|Fospropofol|fospropofol|mesh-list
2275328|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2275329|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275330|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275331|NCT00209612|Paclitaxel|paclitaxel|mesh-list
2275332|NCT00209612|Irinotecan|irinotecan|mesh-list
2797139|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
2797140|NCT04243109|Dexamethasone|dexamethasone|mesh-list
2797141|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
2797142|NCT04243109|Pomalidomide|pomalidomide|mesh-list
2797143|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275333|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2275334|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275335|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
2275336|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
2275337|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
2275338|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275339|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2797144|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
2797145|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797146|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2797147|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2797148|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
2797149|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797150|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797151|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2797152|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2797153|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
2797154|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
2797155|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797156|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2797157|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
2797158|NCT04243109|Hormones|hormones|mesh-ancestor
2797159|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2797160|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2797161|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2797162|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2797163|NCT04243109|Growth Substances|growth substances|mesh-ancestor
2797164|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
2797165|NCT04243278|Aspirin|aspirin|mesh-list
2797166|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2797167|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2797168|NCT04243278|Analgesics|analgesics|mesh-ancestor
2797169|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
2797170|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797171|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797172|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2797173|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2797174|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2797175|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2797176|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797177|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2797178|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2797179|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797180|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
2797181|NCT04242914|Midazolam|midazolam|mesh-list
2797182|NCT04242914|Ketamine|ketamine|mesh-list
2797183|NCT04242914|Analgesics|analgesics|mesh-ancestor
2797184|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
2797185|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797186|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797187|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2797188|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2797189|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
2797190|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
2797191|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797192|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2797193|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2797194|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797195|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797196|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2797197|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2797198|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2797199|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2797200|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2797201|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
2797202|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
2797203|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
2797204|NCT04242927|Niacin|niacin|mesh-list
2797205|NCT04242927|Niacinamide|niacinamide|mesh-list
2797206|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
2797207|NCT04242927|Vitamins|vitamins|mesh-ancestor
2797208|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
2797209|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797210|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2797211|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
2797212|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797213|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2797214|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
2797215|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
2797216|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797217|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
2797218|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2797219|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2797220|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797221|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2797222|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797223|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2797224|NCT04242758|Diuretics|diuretics|mesh-ancestor
2797225|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
2797226|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2797227|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2797228|NCT04242212|Misoprostol|misoprostol|mesh-list
2797229|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2797230|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
2797231|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2797232|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797233|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2797234|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2797235|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
2275340|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2275341|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275342|NCT00209625|Leucovorin|leucovorin|mesh-list
2275343|NCT00209625|Fluorouracil|fluorouracil|mesh-list
2275344|NCT00209625|Irinotecan|irinotecan|mesh-list
2275345|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
2275346|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275347|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2275348|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275349|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275350|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
2275351|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275352|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2275353|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2275354|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275355|NCT00209625|Antidotes|antidotes|mesh-ancestor
2797236|NCT04242368|Fluticasone|fluticasone|mesh-list
2797237|NCT04242368|Xhance|xhance|mesh-list
2797238|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2797239|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2797240|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
2797241|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275356|NCT00209625|Protective Agents|protective agents|mesh-ancestor
2275357|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
2275358|NCT00209625|Vitamins|vitamins|mesh-ancestor
2275359|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
2275360|NCT00209638|Irinotecan|irinotecan|mesh-list
2797242|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797243|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2797244|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
2797245|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
2797246|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2797247|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2797248|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
2797249|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2797250|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
2797251|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2797252|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797253|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2797254|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2797255|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797256|NCT04241705|Lumefantrine|lumefantrine|mesh-list
2797257|NCT04241705|Artemether|artemether|mesh-list
2797258|NCT04241705|Primaquine|primaquine|mesh-list
2797259|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2797260|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
2797261|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2797262|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2797263|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797264|NCT04241640|Nefopam|nefopam|mesh-list
2797265|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2797266|NCT04241640|Analgesics|analgesics|mesh-ancestor
2797267|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
2797268|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797269|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797270|NCT04241653|Sevoflurane|sevoflurane|mesh-list
2275361|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2275362|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2275363|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275364|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275365|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275366|NCT00209651|Irinotecan|irinotecan|mesh-list
2275367|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2275368|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2275369|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275370|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275371|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275372|NCT00209664|Irinotecan|irinotecan|mesh-list
2275373|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2275374|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2275375|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275376|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275377|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275378|NCT00209677|Gemcitabine|gemcitabine|mesh-list
2797271|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
2797272|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797273|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797274|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2797275|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2797276|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
2797283|NCT04241731|Cetuximab|cetuximab|mesh-list
2797284|NCT04241731|Raltitrexed|raltitrexed|mesh-list
2797285|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2797286|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797287|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2797288|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
2797289|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797290|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2797291|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797292|NCT04241744|Vancomycin|vancomycin|mesh-list
2797293|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2797294|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797295|NCT04241887|Anesthetics|anesthetics|mesh-list
2797296|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797297|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797298|NCT04241601|Aldesleukin|aldesleukin|mesh-list
2797299|NCT04241601|Interleukin-2|interleukin-2|mesh-list
2797300|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797301|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2797302|NCT04241601|Analgesics|analgesics|mesh-ancestor
2797303|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
2797304|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797305|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797306|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2797307|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2797308|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
2797309|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797310|NCT04241562|Mitogens|mitogens|mesh-list
2797311|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
2797312|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797313|NCT04241523|Lenvatinib|lenvatinib|mesh-list
2797314|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797315|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2797316|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797317|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797318|NCT04241380|Heparin|heparin|mesh-list
2797319|NCT04241380|Anticoagulants|anticoagulants|mesh-list
2797320|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2797321|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2797322|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2797323|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797324|NCT04241211|Denosumab|denosumab|mesh-list
2797325|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2797326|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797327|NCT04241458|Midazolam|midazolam|mesh-list
2797328|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2797329|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2797330|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797331|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797332|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2797333|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2797334|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2797335|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2797336|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
2797337|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
2797338|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
2797339|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
2797340|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797341|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797342|NCT04241276|Gemcitabine|gemcitabine|mesh-list
2797343|NCT04241276|Paclitaxel|paclitaxel|mesh-list
2797344|NCT04241276|Tretinoin|tretinoin|mesh-list
2797345|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2797346|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797347|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
2797348|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
2797349|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
2797350|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797351|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2797352|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
2797353|NCT04241276|Antiviral Agents|antiviral agents|mesh-ancestor
2797354|NCT04241276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797355|NCT04241276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797356|NCT04241276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2797357|NCT04241276|Immunologic Factors|immunologic factors|mesh-ancestor
2797358|NCT04241276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797359|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
2797360|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
2797361|NCT04240821|Theophylline|theophylline|mesh-list
2797362|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2797363|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
2797364|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797365|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275379|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2275380|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
2275381|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275382|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275383|NCT00209677|Antiviral Agents|antiviral agents|mesh-ancestor
2275384|NCT00209677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275385|NCT00209677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275386|NCT00209677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275387|NCT00209677|Immunologic Factors|immunologic factors|mesh-ancestor
2275388|NCT00209677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275389|NCT00209690|Cisplatin|cisplatin|mesh-list
2275390|NCT00209690|Docetaxel|docetaxel|mesh-list
2275391|NCT00209690|Fluorouracil|fluorouracil|mesh-list
2275392|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275393|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
2275394|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
2275395|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
2275396|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275397|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
2275398|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2275399|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275400|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
2275401|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275402|NCT00209703|Leucovorin|leucovorin|mesh-list
2797366|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2797367|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
2797368|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2797369|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797370|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275403|NCT00209703|Fluorouracil|fluorouracil|mesh-list
2275404|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
2275405|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
2275406|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
2797371|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
2797372|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2797373|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2797374|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
2797375|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275407|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275408|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2275409|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275410|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275411|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
2275412|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275413|NCT00209703|Antidotes|antidotes|mesh-ancestor
2275414|NCT00209703|Protective Agents|protective agents|mesh-ancestor
2275415|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
2275416|NCT00209703|Vitamins|vitamins|mesh-ancestor
2275417|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
2275418|NCT00209716|Cisplatin|cisplatin|mesh-list
2275419|NCT00209716|Docetaxel|docetaxel|mesh-list
2275420|NCT00209716|Fluorouracil|fluorouracil|mesh-list
2797376|NCT04240756|Amphetamine|amphetamine|mesh-list
2797377|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2797378|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797379|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
2797380|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
2797381|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797382|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
2797383|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797384|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797385|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
2797386|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2797387|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2797388|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2797389|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2797390|NCT04240834|Aspirin|aspirin|mesh-list
2275421|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275422|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
2275423|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
2275424|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
2275425|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275426|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
2275427|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2275428|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275429|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
2275430|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275431|NCT00209729|Docetaxel|docetaxel|mesh-list
2275432|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275433|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
2275434|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
2275435|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
2275436|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275437|NCT00209742|Leucovorin|leucovorin|mesh-list
2275438|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
2275439|NCT00209742|Tegafur|tegafur|mesh-list
2275440|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
2275441|NCT00209742|Antidotes|antidotes|mesh-ancestor
2275442|NCT00209742|Protective Agents|protective agents|mesh-ancestor
2275443|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275444|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
2275445|NCT00209742|Vitamins|vitamins|mesh-ancestor
2275446|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
2275447|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2275448|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
2275449|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275450|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275451|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2797391|NCT04240834|Ticagrelor|ticagrelor|mesh-list
2797392|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2797393|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2797394|NCT04240834|Analgesics|analgesics|mesh-ancestor
2797395|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
2797396|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797397|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797398|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2797399|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2797400|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2797401|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2797402|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797403|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2797404|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2797405|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797406|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
2797407|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2797408|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2797409|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2797410|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
2797411|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797412|NCT04240496|Clozapine|clozapine|mesh-list
2797413|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2797414|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
2797415|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275452|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
2275453|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2275454|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
2275455|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275456|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
2797416|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797417|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797418|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2797419|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2797420|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797421|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2797422|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
2797423|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
2797424|NCT04240626|Acetaminophen|acetaminophen|mesh-list
2797425|NCT04240626|Scopolamine|scopolamine|mesh-list
2797426|NCT04240626|Oxycodone|oxycodone|mesh-list
2797427|NCT04240626|Gabapentin|gabapentin|mesh-list
2797428|NCT04240626|Hydromorphone|hydromorphone|mesh-list
2797429|NCT04240626|Hydrocodone|hydrocodone|mesh-list
2797430|NCT04240626|Bupivacaine|bupivacaine|mesh-list
2797431|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
2797432|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2797433|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2797434|NCT04240626|Analgesics|analgesics|mesh-ancestor
2797435|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
2797436|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797437|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797438|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
2797439|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2797440|NCT04240626|Narcotics|narcotics|mesh-ancestor
2797441|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797442|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
2797443|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2797444|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2797445|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2797446|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2797447|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2797448|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797449|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797450|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
2275457|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2275458|NCT00209755|Ribavirin|ribavirin|mesh-list
2275459|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
2275460|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275461|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
2275462|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275463|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
2275464|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
2275465|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2275466|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
2275467|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2275468|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2275469|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275470|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2797451|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
2797452|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
2797453|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
2797454|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
2797455|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2797456|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
2797457|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
2797458|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2797459|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
2797460|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2797461|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
2797462|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2797463|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
2797464|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2797465|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
2797466|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2797467|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2797468|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2797469|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2797470|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2797471|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797472|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797473|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2275471|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275472|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275473|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2797474|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2797475|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797476|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
2275474|NCT00209781|Renal Agents|renal agents|mesh-ancestor
2275475|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
2275476|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
2275477|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2275478|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
2275479|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2275480|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2275481|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275482|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2275483|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275484|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797477|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797478|NCT04239794|Propofol|propofol|mesh-list
2797479|NCT04239794|Sevoflurane|sevoflurane|mesh-list
2797480|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2797481|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797482|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797483|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2797484|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
2797485|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
2797486|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2797487|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2797488|NCT04239833|Gefitinib|gefitinib|mesh-list
2797489|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797490|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2797491|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797492|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797493|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
2797494|NCT04239872|Calcium|calcium|mesh-list
2797495|NCT04239872|Fluorides|fluorides|mesh-list
2275485|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2797496|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2797497|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797498|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2797499|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
2797500|NCT04239872|Protective Agents|protective agents|mesh-ancestor
2797501|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
2797502|NCT04240171|Glimepiride|glimepiride|mesh-list
2797503|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2797504|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797505|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2797506|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797507|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2797508|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2797509|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
2797510|NCT04240106|Niraparib|niraparib|mesh-list
2797511|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2797512|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2797513|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797514|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797515|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797516|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2797517|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2797518|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
2797519|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2797520|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797521|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2103872|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
2103873|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2103874|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103875|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2103876|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103877|NCT02428192|Nivolumab|nivolumab|mesh-list
2103878|NCT02428192|Ipilimumab|ipilimumab|mesh-list
2103879|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2103880|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103881|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2103882|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103883|NCT02428296|Sirolimus|sirolimus|mesh-list
2103884|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2103885|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2103886|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2103887|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797522|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2797523|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2797524|NCT04239859|Cyclosporine|cyclosporine|mesh-list
2797525|NCT04239859|Methotrexate|methotrexate|mesh-list
2797526|NCT04239859|Acitretin|acitretin|mesh-list
2797527|NCT04239859|Cyclosporins|cyclosporins|mesh-list
2797528|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2797529|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
2275486|NCT00209794|Renal Agents|renal agents|mesh-ancestor
2275487|NCT00209807|Citalopram|citalopram|mesh-list
2275488|NCT00209807|Reboxetine|reboxetine|mesh-list
2797530|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2797531|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797532|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2797533|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
2797534|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275489|NCT00209807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2275490|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2275491|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2275492|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275493|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275494|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
2275495|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275496|NCT00209807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2275497|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
2275498|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2275499|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2275500|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
2275501|NCT00209833|Cytarabine|cytarabine|mesh-list
2275502|NCT00209833|Fludarabine|fludarabine|mesh-list
2275503|NCT00209833|Etoposide|etoposide|mesh-list
2275504|NCT00209833|Idarubicin|idarubicin|mesh-list
2275505|NCT00209833|Daunorubicin|daunorubicin|mesh-list
2275506|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275507|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2275508|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
2275509|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275510|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275511|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
2275512|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797535|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797536|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
2797537|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797538|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2797539|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2797540|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
2797541|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2797542|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2797543|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
2797544|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797545|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2797546|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
2797547|NCT04239560|Boron|boron|mesh-list
2797548|NCT04239560|Trace Elements|trace elements|mesh-ancestor
2797549|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
2797550|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797551|NCT04239599|Leuprolide|leuprolide|mesh-list
2797552|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2797553|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
2797554|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2797555|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797556|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2797557|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797558|NCT04239625|Vitamin A|vitamin a|mesh-list
2797559|NCT04239625|Retinol acetate|retinol acetate|mesh-list
2797560|NCT04239625|Vitamins|vitamins|mesh-ancestor
2797561|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
2797562|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797563|NCT04239625|Protective Agents|protective agents|mesh-ancestor
2797564|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2797565|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797566|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2797567|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
2275513|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2275514|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2275515|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2797568|NCT04239586|Glyburide|glyburide|mesh-list
2797569|NCT04239586|Glipizide|glipizide|mesh-list
2275516|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275517|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
2275518|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275519|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2275520|NCT00209846|Gaboxadol|gaboxadol|mesh-list
2275521|NCT00209846|Analgesics|analgesics|mesh-ancestor
2275522|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
2275523|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275524|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275525|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
2275526|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
2275527|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
2275528|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797570|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2797571|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797572|NCT04239755|Doxycycline|doxycycline|mesh-list
2797573|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2797574|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797575|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
2797576|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2797577|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2797578|NCT04239443|Apatinib|apatinib|mesh-list
2797579|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2797580|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275529|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275530|NCT00209859|Cyclosporine|cyclosporine|mesh-list
2275531|NCT00209859|Betamethasone|betamethasone|mesh-list
2275532|NCT00209859|Methotrexate|methotrexate|mesh-list
2275533|NCT00209859|Cyclosporins|cyclosporins|mesh-list
2275534|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2275535|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
2275536|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2275537|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275538|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2275539|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
2275540|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275541|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275542|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
2275543|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275544|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2275545|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275546|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
2275547|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2275548|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2275549|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
2275550|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275551|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2275552|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2275553|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
2275554|NCT00209859|Hormones|hormones|mesh-ancestor
2275555|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2797581|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2797582|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797583|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797584|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2797585|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2797586|NCT04238988|Paclitaxel|paclitaxel|mesh-list
2797587|NCT04238988|Carboplatin|carboplatin|mesh-list
2797588|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
2797589|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2797590|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797591|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
2797592|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
2797593|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
2797594|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797595|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2797596|NCT04239053|Bupivacaine|bupivacaine|mesh-list
2797597|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
2797598|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
2797599|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797600|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797601|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
2797602|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275556|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2275557|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
2797603|NCT04239313|Vaccines|vaccines|mesh-list
2797604|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
2797605|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275558|NCT00209872|Lidocaine|lidocaine|mesh-list
2275559|NCT00209872|Ketamine|ketamine|mesh-list
2275560|NCT00209872|Gabapentin|gabapentin|mesh-list
2275561|NCT00209872|Esketamine|esketamine|mesh-list
2275562|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
2275563|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
2275564|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275565|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275566|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
2275567|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275568|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2275569|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2275570|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2275571|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2275572|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275573|NCT00209872|Analgesics|analgesics|mesh-ancestor
2275574|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2275575|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2275576|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
2275577|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2275578|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2275579|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275580|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
2275581|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2275582|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2275583|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2275584|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
2275585|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
2275586|NCT00209885|Lidocaine|lidocaine|mesh-list
2275587|NCT00209885|Droperidol|droperidol|mesh-list
2275588|NCT00209885|Ketamine|ketamine|mesh-list
2275589|NCT00209885|Gabapentin|gabapentin|mesh-list
2275590|NCT00209885|Esketamine|esketamine|mesh-list
2275591|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
2275592|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
2275593|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275594|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275595|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
2275596|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275597|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2275598|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2275599|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2275600|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2275601|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275602|NCT00209885|Analgesics|analgesics|mesh-ancestor
2275603|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2275604|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2797606|NCT04239118|Hemostatics|hemostatics|mesh-list
2797607|NCT04239118|Coagulants|coagulants|mesh-ancestor
2797608|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
2797609|NCT04239092|Temozolomide|temozolomide|mesh-list
2797610|NCT04239092|Irinotecan|irinotecan|mesh-list
2797611|NCT04239092|Topotecan|topotecan|mesh-list
2797612|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2797613|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
2797614|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797615|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2797616|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2797617|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
2797618|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797619|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797620|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2797621|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2797622|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2797623|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797624|NCT04239170|Gemcitabine|gemcitabine|mesh-list
2797625|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
2797626|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2797627|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
2797628|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797629|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797630|NCT04239170|Antiviral Agents|antiviral agents|mesh-ancestor
2797631|NCT04239170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797632|NCT04239170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797633|NCT04239170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2797634|NCT04239170|Immunologic Factors|immunologic factors|mesh-ancestor
2797635|NCT04239170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797636|NCT04239014|Olaparib|olaparib|mesh-list
2797637|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2797638|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797639|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797640|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797641|NCT04238923|Vancomycin|vancomycin|mesh-list
2797642|NCT04238923|Gentamicins|gentamicins|mesh-list
2797643|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2797644|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797645|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2797646|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797647|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797648|NCT04238975|Vaccines|vaccines|mesh-list
2797649|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
2797650|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797651|NCT04238767|Dolutegravir|dolutegravir|mesh-list
2797652|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2797653|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2797654|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797655|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797656|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2797657|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2797658|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
2797659|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797660|NCT04238754|Cannabidiol|cannabidiol|mesh-list
2797661|NCT04238754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2797662|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
2275605|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
2275606|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2275607|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2275608|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275609|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
2275610|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2797663|NCT04238806|Desflurane|desflurane|mesh-list
2797664|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2797665|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
2797666|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
2797667|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797668|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797669|NCT04238832|Nicotine|nicotine|mesh-list
2797670|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2275611|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2275612|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2797671|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
2797672|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797673|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797674|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2797675|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2797676|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
2797677|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797678|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797679|NCT04238884|Voriconazole|voriconazole|mesh-list
2797680|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
2797681|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797682|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2797683|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2797684|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797685|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797686|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2797687|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
2797688|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2797689|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797690|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2797691|NCT04238637|Durvalumab|durvalumab|mesh-list
2797692|NCT04238637|Tremelimumab|tremelimumab|mesh-list
2797693|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2797694|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797695|NCT04238845|Vitamin A|vitamin a|mesh-list
2797696|NCT04238845|Vitamins|vitamins|mesh-ancestor
2797697|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
2797698|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797699|NCT04238702|Empagliflozin|empagliflozin|mesh-list
2797700|NCT04238702|Losartan|losartan|mesh-list
2797701|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2797702|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2797703|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2797704|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2797705|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797706|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2797707|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2797708|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797709|NCT04238208|Lidocaine|lidocaine|mesh-list
2797710|NCT04238208|Capsaicin|capsaicin|mesh-list
2797711|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
2797712|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
2797713|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797714|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797715|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
2797716|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797717|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2797718|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2797719|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2797720|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2797721|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797722|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
2797723|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
2797724|NCT04238221|Doxofylline|doxofylline|mesh-list
2797725|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
2797726|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
2797727|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2797728|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
2797729|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797730|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797731|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2797732|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2797733|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797734|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797735|NCT04238169|Bevacizumab|bevacizumab|mesh-list
2797736|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2797737|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797738|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2797739|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2797740|NCT04238169|Growth Substances|growth substances|mesh-ancestor
2275613|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
2797741|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275614|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
2275615|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2275616|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
2275617|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
2275618|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2275619|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2275620|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2275621|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2275622|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
2275623|NCT00209924|Gaboxadol|gaboxadol|mesh-list
2275624|NCT00209924|Analgesics|analgesics|mesh-ancestor
2275625|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
2275626|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275627|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797742|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
2797743|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
2797744|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2797745|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797746|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2797747|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2797748|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797749|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797750|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797751|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
2797752|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2797753|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797754|NCT04238143|Complement Factor H|complement factor h|mesh-list
2797755|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2797756|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2797757|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
2797758|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797759|NCT04237987|Cyclosporine|cyclosporine|mesh-list
2797760|NCT04237987|Aldesleukin|aldesleukin|mesh-list
2797761|NCT04237987|Interleukin-2|interleukin-2|mesh-list
2797762|NCT04237987|Cyclosporins|cyclosporins|mesh-list
2797763|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797764|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797765|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2797766|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
2797767|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797768|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
2797769|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797770|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
2797771|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2797772|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2797773|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797774|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2797775|NCT04237987|Analgesics|analgesics|mesh-ancestor
2797776|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
2797777|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797778|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2797779|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2797780|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
2797781|NCT04237922|Clopidogrel|clopidogrel|mesh-list
2797782|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2797783|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2797784|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2797785|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2797786|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2797787|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
2797788|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797789|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797790|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797791|NCT04237935|Clopidogrel|clopidogrel|mesh-list
2797792|NCT04237935|Ticagrelor|ticagrelor|mesh-list
2797793|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2797794|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2797795|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2797796|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2797797|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
2797798|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797799|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797800|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797801|NCT04237623|Sargramostim|sargramostim|mesh-list
2797802|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
2797803|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275628|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
2275629|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
2275630|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
2275631|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275632|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275633|NCT00209937|Gaboxadol|gaboxadol|mesh-list
2275634|NCT00209937|Analgesics|analgesics|mesh-ancestor
2275635|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
2275636|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275637|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275638|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
2275639|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
2275640|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
2275641|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797804|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
2797805|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2797806|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797807|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2797808|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797809|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
2797810|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2797811|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797812|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797813|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2797814|NCT04237532|Analgesics|analgesics|mesh-ancestor
2797815|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
2797816|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797817|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2797818|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2797819|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2797820|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
2797821|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797822|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797823|NCT04237675|Anesthetics|anesthetics|mesh-list
2797824|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797825|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797826|NCT04237246|Tacrolimus|tacrolimus|mesh-list
2797827|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2797828|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
2797829|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797830|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2103888|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
2103889|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2103890|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
2103891|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797831|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797832|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103892|NCT02428478|Desipramine|desipramine|mesh-list
2103893|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2103894|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
2103895|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2103896|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103897|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103898|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2103899|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2103900|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2103901|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
2103902|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103903|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103904|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2797833|NCT04237376|Tenofovir|tenofovir|mesh-list
2797834|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
2797835|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797836|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2797837|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2797838|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797839|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797840|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2797841|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2797842|NCT04237493|Insulin|insulin|mesh-list
2797843|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2797844|NCT04237493|Metformin|metformin|mesh-list
2275642|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275643|NCT00209950|Gaboxadol|gaboxadol|mesh-list
2275644|NCT00209950|Analgesics|analgesics|mesh-ancestor
2275645|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
2275646|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275647|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797845|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
2797846|NCT04237493|Glimepiride|glimepiride|mesh-list
2797847|NCT04237493|Vildagliptin|vildagliptin|mesh-list
2797848|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2797849|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797850|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2797851|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2797852|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
2797853|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2797854|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
2797855|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797856|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797857|NCT04237480|Vitamin D|vitamin d|mesh-list
2797858|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
2797859|NCT04237480|Vitamins|vitamins|mesh-list
2797860|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
2797861|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797862|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2797863|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2797864|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
2275648|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
2275649|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
2275650|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
2275651|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275652|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275653|NCT00209963|Gaboxadol|gaboxadol|mesh-list
2275654|NCT00209963|Analgesics|analgesics|mesh-ancestor
2275655|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
2275656|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275657|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275658|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
2275659|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
2797865|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2797866|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797867|NCT04237103|Methotrexate|methotrexate|mesh-list
2797868|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2797869|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
2797870|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2275660|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
2275661|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275662|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275663|NCT00209989|Tipifarnib|tipifarnib|mesh-list
2275664|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275665|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
2797871|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797872|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2797873|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
2797874|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797875|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797876|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
2797877|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797878|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2797879|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2797880|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
2797881|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2797882|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2275666|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2797883|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
2797884|NCT04237090|Promethazine|promethazine|mesh-list
2797885|NCT04237090|Cetirizine|cetirizine|mesh-list
2797886|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2797887|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2797888|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797889|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797890|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
2797891|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
2797892|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
2275667|NCT00210002|Hematinics|hematinics|mesh-ancestor
2275668|NCT00210028|Tamoxifen|tamoxifen|mesh-list
2275669|NCT00210028|Tipifarnib|tipifarnib|mesh-list
2797893|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797894|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
2797895|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
2103905|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2103906|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103907|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103908|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2103909|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2103910|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103911|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
2103912|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103913|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
2103914|NCT02428699|Liver Extracts|liver extracts|mesh-list
2103915|NCT02428699|Hematinics|hematinics|mesh-ancestor
2103916|NCT02428699|Vitamins|vitamins|mesh-ancestor
2797896|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2797897|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2797898|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
2797899|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
2797900|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2797901|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797902|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2797903|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
2797904|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
2797905|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2797906|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
2797907|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2797908|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797909|NCT04236778|Vancomycin|vancomycin|mesh-list
2797910|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2797911|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797912|NCT04237012|Dexamethasone|dexamethasone|mesh-list
2797913|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
2797914|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2797915|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
2797916|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
2797917|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797918|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797919|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2797920|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
2797921|NCT04237012|Hormones|hormones|mesh-ancestor
2797922|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2797923|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2797924|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797925|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2797926|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2275670|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2275671|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
2275672|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2275673|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275674|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2275675|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275676|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2275677|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2275678|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2275679|NCT00210041|Gemcitabine|gemcitabine|mesh-list
2275680|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797927|NCT04236609|Sirolimus|sirolimus|mesh-list
2797928|NCT04236609|Everolimus|everolimus|mesh-list
2797929|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797930|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2797931|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
2797932|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797933|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2797934|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797935|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2797936|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
2797937|NCT04236453|Tenofovir|tenofovir|mesh-list
2275681|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2275682|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
2275683|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275684|NCT00210041|Antiviral Agents|antiviral agents|mesh-ancestor
2275685|NCT00210041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275686|NCT00210041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275687|NCT00210041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275688|NCT00210041|Immunologic Factors|immunologic factors|mesh-ancestor
2275689|NCT00210041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275690|NCT00210132|Ropivacaine|ropivacaine|mesh-list
2275691|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
2275692|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
2797938|NCT04236453|Emtricitabine|emtricitabine|mesh-list
2797939|NCT04236453|Darunavir|darunavir|mesh-list
2797940|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2797941|NCT04236453|Cobicistat|cobicistat|mesh-list
2797942|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2797943|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
2797944|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797945|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2275693|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275694|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275695|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
2275696|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275697|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
2275698|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2275699|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
2275700|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
2275701|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275702|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275703|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2275704|NCT00210158|Analgesics|analgesics|mesh-ancestor
2275705|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
2275706|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275707|NCT00210210|Ketamine|ketamine|mesh-list
2275708|NCT00210210|Analgesics|analgesics|mesh-ancestor
2275709|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
2275710|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275711|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797946|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2797947|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797948|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797949|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2797950|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2797951|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2797952|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2797953|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
2797954|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2797955|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2797956|NCT04236323|Remifentanil|remifentanil|mesh-list
2797957|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2797958|NCT04236323|Narcotics|narcotics|mesh-ancestor
2797959|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797960|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797961|NCT04236323|Analgesics|analgesics|mesh-ancestor
2797962|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
2797963|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797964|NCT04236310|Trastuzumab|trastuzumab|mesh-list
2797965|NCT04236310|Anastrozole|anastrozole|mesh-list
2797966|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2797967|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2797968|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2797969|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2797970|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2797971|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2797972|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2797973|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2797974|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
2797975|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2797976|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797977|NCT04236219|Rasburicase|rasburicase|mesh-list
2275712|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2275713|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2275714|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
2275715|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
2275716|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275717|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2275718|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2275719|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275720|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275721|NCT00210301|Modafinil|modafinil|mesh-list
2275722|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2275723|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275724|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2275725|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2275726|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2275727|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275728|NCT00210314|Cytarabine|cytarabine|mesh-list
2275729|NCT00210314|Methotrexate|methotrexate|mesh-list
2275730|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2275731|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
2275732|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2797978|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
2797979|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2797980|NCT04236115|Felypressin|felypressin|mesh-list
2797981|NCT04236115|Carticaine|carticaine|mesh-list
2797982|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
2797983|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
2797984|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2797985|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2797986|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
2797987|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2797988|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2797989|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
2797990|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2797991|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2797992|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797993|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
2797994|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
2797995|NCT04235816|Azithromycin|azithromycin|mesh-list
2797996|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2797997|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2797998|NCT04236258|Enalapril|enalapril|mesh-list
2797999|NCT04236258|Nifedipine|nifedipine|mesh-list
2798000|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2798001|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2798002|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798003|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2798004|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798005|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
2798006|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
2798007|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2798008|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2798009|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
2798010|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798011|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2798014|NCT04235868|Mitogens|mitogens|mesh-list
2798015|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
2798016|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275733|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275734|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2275735|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
2275736|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275737|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275738|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
2275739|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275740|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2275741|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275742|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
2275743|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2275744|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2275745|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
2275746|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275747|NCT00210327|Bortezomib|bortezomib|mesh-list
2275748|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275749|NCT00210340|Rituximab|rituximab|mesh-list
2275750|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2275751|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275752|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
2275753|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275754|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2275755|NCT00210366|Idarubicin|idarubicin|mesh-list
2275756|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2275757|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798017|NCT04235959|Tirzepatide|tirzepatide|mesh-list
2798018|NCT04235959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2798019|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798020|NCT04235959|Incretins|incretins|mesh-ancestor
2798021|NCT04235959|Hormones|hormones|mesh-ancestor
2798022|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2798023|NCT04235478|Triamcinolone|triamcinolone|mesh-list
2798024|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2798025|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2798026|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
2798027|NCT04235478|Hormones|hormones|mesh-ancestor
2103917|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
2103918|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103919|NCT02428855|Dasatinib|dasatinib|mesh-list
2103920|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103921|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2103922|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103923|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103924|NCT02429258|Metformin|metformin|mesh-list
2103925|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
2103926|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2103927|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103928|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2798028|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2798029|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798030|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2798031|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
2275758|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2275759|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2275760|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275761|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275762|NCT00210379|Rituximab|rituximab|mesh-list
2275763|NCT00210379|Methotrexate|methotrexate|mesh-list
2798032|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
2798033|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
2798034|NCT04235426|Diclofenac|diclofenac|mesh-list
2798035|NCT04235426|Vitamins|vitamins|mesh-ancestor
2798036|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
2798037|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798038|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2798039|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2798040|NCT04235426|Analgesics|analgesics|mesh-ancestor
2798041|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
2798042|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798043|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2798044|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2798045|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2798046|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798047|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798048|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
2798049|NCT04235426|Hematinics|hematinics|mesh-ancestor
2798050|NCT04235569|Enoxaparin|enoxaparin|mesh-list
2798051|NCT04235569|Warfarin|warfarin|mesh-list
2798052|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
2798053|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
2798054|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2798055|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2798056|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798057|NCT04235673|Melatonin|melatonin|mesh-list
2798058|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
2798059|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798060|NCT04235673|Protective Agents|protective agents|mesh-ancestor
2798061|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798062|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798063|NCT04235270|Tadalafil|tadalafil|mesh-list
2798064|NCT04235270|Macitentan|macitentan|mesh-list
2798065|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
2798066|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2798067|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2798068|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798069|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798070|NCT04235270|Urological Agents|urological agents|mesh-ancestor
2798071|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2798072|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2798073|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2798074|NCT04235296|Mitogens|mitogens|mesh-list
2798075|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
2798076|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798077|NCT04235894|Propofol|propofol|mesh-list
2798078|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2798079|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798080|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798081|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2798082|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
2798083|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
2798084|NCT04236050|Rocuronium|rocuronium|mesh-list
2275764|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2275765|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275766|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
2275767|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275768|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2798085|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798086|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2798087|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2798088|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2798089|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798090|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
2798091|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2798092|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798093|NCT04235101|Trastuzumab|trastuzumab|mesh-list
2798094|NCT04235101|Niraparib|niraparib|mesh-list
2798095|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2798096|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103929|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103930|NCT02429427|Celecoxib|celecoxib|mesh-list
2103931|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2103932|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2103933|NCT02429427|Analgesics|analgesics|mesh-ancestor
2103934|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
2798097|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2798098|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798099|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798100|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
2798101|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2798102|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798103|NCT04234776|Ketamine|ketamine|mesh-list
2798104|NCT04234776|Aripiprazole|aripiprazole|mesh-list
2798105|NCT04234776|Citalopram|citalopram|mesh-list
2798106|NCT04234776|Analgesics|analgesics|mesh-ancestor
2798107|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
2798108|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798109|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798110|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2798111|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2798112|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
2798113|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
2103935|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103936|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103937|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2103938|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2103939|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2103940|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2103941|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798114|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798115|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2798116|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2798117|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2798118|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798119|NCT04234776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2798120|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2798121|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2798122|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
2798123|NCT04234776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2798124|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
2798125|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2103942|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103943|NCT02429869|Everolimus|everolimus|mesh-list
2103944|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103945|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2103946|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
2798126|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2798127|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2798128|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
2798129|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
2798130|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2798131|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2798132|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2798133|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2798134|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2798135|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2798136|NCT04235036|Rituximab|rituximab|mesh-list
2798137|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2798138|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798139|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
2798140|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798141|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2103947|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103948|NCT02429934|Abatacept|abatacept|mesh-list
2103949|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2103950|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275769|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2275770|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
2275771|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2275772|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2275773|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
2275774|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275775|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
2275776|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275777|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2275778|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2275779|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2275780|NCT00210392|Bortezomib|bortezomib|mesh-list
2275781|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275782|NCT00210405|Micronutrients|micronutrients|mesh-list
2275783|NCT00210405|Trace Elements|trace elements|mesh-list
2275784|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275785|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
2275786|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2275787|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2275788|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2275789|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2275790|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275791|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
2275792|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2103951|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103952|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2103953|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
2103954|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103955|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2103956|NCT02430090|Fentanyl|fentanyl|mesh-list
2103957|NCT02430090|Sufentanil|sufentanil|mesh-list
2103958|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
2103959|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2103960|NCT02430090|Narcotics|narcotics|mesh-ancestor
2103961|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2103962|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103963|NCT02430090|Analgesics|analgesics|mesh-ancestor
2103964|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
2103965|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103966|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2103967|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2103968|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
2103969|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
2275793|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275794|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2798183|NCT04235062|Furosemide|furosemide|mesh-list
2798184|NCT04235062|Calcium|calcium|mesh-list
2798185|NCT04235062|Diuretics|diuretics|mesh-list
2798186|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
2798187|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2798188|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798189|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
2798190|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2798191|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798192|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
2798193|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2798194|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798195|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2798196|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798197|NCT04234997|Suvorexant|suvorexant|mesh-list
2103970|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
2798198|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2798199|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2798200|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798201|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798202|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2798203|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2798204|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798205|NCT04234932|Latanoprost|latanoprost|mesh-list
2798206|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2798207|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2798208|NCT04234321|Mitogens|mitogens|mesh-list
2798209|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
2798210|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798211|NCT04234594|Panitumumab|panitumumab|mesh-list
2798212|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2798213|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798214|NCT04234607|Carboplatin|carboplatin|mesh-list
2798215|NCT04234607|Etoposide|etoposide|mesh-list
2798216|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798217|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2798218|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2798219|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2798220|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798221|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798222|NCT04234516|Morphine|morphine|mesh-list
2798223|NCT04234516|Buprenorphine|buprenorphine|mesh-list
2798224|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2798225|NCT04234516|Naloxone|naloxone|mesh-list
2798226|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2798227|NCT04234516|Narcotics|narcotics|mesh-ancestor
2798228|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798229|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798230|NCT04234516|Analgesics|analgesics|mesh-ancestor
2798231|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
2798232|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798233|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2798234|NCT04234217|Niacin|niacin|mesh-list
2275795|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275796|NCT00210457|Lanreotide|lanreotide|mesh-list
2275797|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275798|NCT00210483|Almotriptan|almotriptan|mesh-list
2275799|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2275800|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
2275801|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275802|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275803|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275804|NCT00210496|Topiramate|topiramate|mesh-list
2275805|NCT00210496|Almotriptan|almotriptan|mesh-list
2275806|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
2275807|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2275808|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275809|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2275810|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
2275811|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275812|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275813|NCT00210509|Almotriptan|almotriptan|mesh-list
2275814|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2275815|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
2275816|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275817|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275818|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275819|NCT00210535|Topiramate|topiramate|mesh-list
2275820|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
2275821|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2275822|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275823|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2275824|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2275825|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2275826|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275827|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275828|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2275829|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2275830|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2798235|NCT04234217|Niacinamide|niacinamide|mesh-list
2798236|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
2798237|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2798238|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
2798239|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798240|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2798241|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
2798242|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
2798243|NCT04234217|Vitamins|vitamins|mesh-ancestor
2798244|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
2798245|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798246|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
2798247|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2798248|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275831|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
2275832|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275833|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275834|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2275835|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2798249|NCT04234191|Buprenorphine|buprenorphine|mesh-list
2798250|NCT04234191|Hydromorphone|hydromorphone|mesh-list
2798251|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2798252|NCT04234191|Naloxone|naloxone|mesh-list
2798253|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2798254|NCT04234191|Narcotics|narcotics|mesh-ancestor
2798255|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798256|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798257|NCT04234191|Analgesics|analgesics|mesh-ancestor
2798258|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
2798259|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798260|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2798261|NCT04233996|Meropenem|meropenem|mesh-list
2798262|NCT04233996|Tazobactam|tazobactam|mesh-list
2798263|NCT04233996|Piperacillin|piperacillin|mesh-list
2798264|NCT04233996|Cefepime|cefepime|mesh-list
2798265|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2798266|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2798267|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2798268|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2798269|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798270|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798271|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
2798272|NCT04233866|Leucovorin|leucovorin|mesh-list
2798273|NCT04233866|Folic Acid|folic acid|mesh-list
2798274|NCT04233866|Gemcitabine|gemcitabine|mesh-list
2798275|NCT04233866|Paclitaxel|paclitaxel|mesh-list
2798276|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2798277|NCT04233866|Fluorouracil|fluorouracil|mesh-list
2275836|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
2275837|NCT00210561|Acetaminophen|acetaminophen|mesh-list
2275838|NCT00210561|Tramadol|tramadol|mesh-list
2275839|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2275840|NCT00210561|Analgesics|analgesics|mesh-ancestor
2275841|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
2275842|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275843|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275844|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
2275845|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2275846|NCT00210561|Narcotics|narcotics|mesh-ancestor
2275847|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275848|NCT00210574|Topiramate|topiramate|mesh-list
2275849|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
2798278|NCT04233866|Irinotecan|irinotecan|mesh-list
2798279|NCT04233866|Calcium|calcium|mesh-list
2798280|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
2798281|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2798282|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798283|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
2798284|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
2798285|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
2798286|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798287|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2798288|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
2798289|NCT04233866|Antiviral Agents|antiviral agents|mesh-ancestor
2798290|NCT04233866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2798291|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798292|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2798293|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
2798294|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798295|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2798296|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2798297|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2798298|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2798299|NCT04233866|Antidotes|antidotes|mesh-ancestor
2275850|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2275851|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275852|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
2798300|NCT04233866|Protective Agents|protective agents|mesh-ancestor
2798301|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
2798302|NCT04233866|Vitamins|vitamins|mesh-ancestor
2798303|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
2798304|NCT04233866|Hematinics|hematinics|mesh-ancestor
2275853|NCT00210587|Hematinics|hematinics|mesh-ancestor
2275854|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
2275855|NCT00210600|Hematinics|hematinics|mesh-ancestor
2798305|NCT04234048|Fenretinide|fenretinide|mesh-list
2798306|NCT04234048|Retinamide|retinamide|mesh-list
2798307|NCT04234048|Tretinoin|tretinoin|mesh-list
2798308|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798309|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2798310|NCT04234048|Protective Agents|protective agents|mesh-ancestor
2275856|NCT00210665|Trabectedin|trabectedin|mesh-list
2275857|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2275858|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
2798311|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798312|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
2798313|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
2798314|NCT04233697|Romidepsin|romidepsin|mesh-list
2798315|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2798316|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798317|NCT04233892|Estrogens|estrogens|mesh-list
2798318|NCT04233892|Hormones|hormones|mesh-ancestor
2798319|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2798320|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798321|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
2798322|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2798323|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2798324|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798325|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
2798326|NCT04233749|Coagulants|coagulants|mesh-ancestor
2798332|NCT04233294|Decitabine|decitabine|mesh-list
2798333|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2798334|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
2798335|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798336|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798337|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798338|NCT04233463|Budesonide|budesonide|mesh-list
2798339|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2798340|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2798341|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
2798342|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798343|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798344|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2798345|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
2798346|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
2798347|NCT04233463|Hormones|hormones|mesh-ancestor
2798348|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2798349|NCT04233346|Ponatinib|ponatinib|mesh-list
2798350|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798351|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2798352|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798353|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798354|NCT04233203|Insulin|insulin|mesh-list
2798355|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2798356|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2798357|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798358|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
2798359|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2798360|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2798361|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2798362|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
2798363|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
2798364|NCT04233359|Anesthetics|anesthetics|mesh-list
2798365|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
2798366|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798367|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798368|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
2798369|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798370|NCT04233229|Insulin|insulin|mesh-list
2798371|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2798372|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798373|NCT04233567|Infigratinib|infigratinib|mesh-list
2798374|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798375|NCT04233515|Anticoagulants|anticoagulants|mesh-list
2798376|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
2798377|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798378|NCT04233502|Melatonin|melatonin|mesh-list
2798379|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
2798380|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798381|NCT04233502|Protective Agents|protective agents|mesh-ancestor
2798382|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798383|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798384|NCT04232800|Riboflavin|riboflavin|mesh-list
2798385|NCT04232800|Vitamins|vitamins|mesh-ancestor
2798386|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
2798387|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798388|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
2798389|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2798390|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
2798391|NCT04232943|Vaccines|vaccines|mesh-list
2798392|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
2798393|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798394|NCT04232813|Estradiol|estradiol|mesh-list
2798395|NCT04232813|Estrogens|estrogens|mesh-ancestor
2798396|NCT04232813|Hormones|hormones|mesh-ancestor
2798397|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2798398|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275859|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275860|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275861|NCT00210691|Risperidone|risperidone|mesh-list
2275862|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2275863|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
2275864|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275865|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275866|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275867|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2275868|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2275869|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275870|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2275871|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2275872|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
2275873|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2275874|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2275875|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2275876|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275877|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275878|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2275879|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2275880|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2275881|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
2275882|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275883|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275884|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2275885|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2275886|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
2275887|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
2275888|NCT00210730|Hematinics|hematinics|mesh-ancestor
2275889|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
2275890|NCT00210743|Hematinics|hematinics|mesh-ancestor
2275891|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
2275892|NCT00210756|Hematinics|hematinics|mesh-ancestor
2275893|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2275894|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2275895|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2275896|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275897|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275898|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2275899|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2275900|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2275901|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
2798399|NCT04233112|Melatonin|melatonin|mesh-list
2798400|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
2798401|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798402|NCT04233112|Protective Agents|protective agents|mesh-ancestor
2798403|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798404|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798405|NCT04233021|Osimertinib|osimertinib|mesh-list
2798406|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798407|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2798408|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798409|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798410|NCT04232969|Exenatide|exenatide|mesh-list
2798411|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2798412|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798413|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2798414|NCT04232969|Incretins|incretins|mesh-ancestor
2275902|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2275903|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798415|NCT04232969|Hormones|hormones|mesh-ancestor
2798416|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2798417|NCT04232644|Amphetamine|amphetamine|mesh-list
2798418|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
2798419|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2798420|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798421|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
2798422|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
2798423|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798424|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
2275904|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2275905|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2275906|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
2275907|NCT00210782|Topiramate|topiramate|mesh-list
2275908|NCT00210782|Phenytoin|phenytoin|mesh-list
2275909|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
2275910|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2275911|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275912|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2275913|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2275914|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2275915|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798425|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2798426|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798427|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
2798428|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2798429|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2798430|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2798431|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2798432|NCT04232657|Denosumab|denosumab|mesh-list
2798433|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2798434|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275916|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2798435|NCT04232683|Tamsulosin|tamsulosin|mesh-list
2798436|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2798437|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2798438|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2798439|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
2798440|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2798441|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798442|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798443|NCT04232683|Urological Agents|urological agents|mesh-ancestor
2798444|NCT04232722|Sorafenib|sorafenib|mesh-list
2798445|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798446|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2798447|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798448|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798465|NCT04232358|Anesthetics|anesthetics|mesh-list
2798466|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798467|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798468|NCT04232332|Mitogens|mitogens|mesh-list
2798469|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
2798470|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798471|NCT04232306|Bupivacaine|bupivacaine|mesh-list
2798472|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
2798473|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
2798474|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798475|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798476|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
2798477|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798478|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2275917|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2275918|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
2275919|NCT00210795|Hematinics|hematinics|mesh-ancestor
2275920|NCT00210808|Topiramate|topiramate|mesh-list
2275921|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
2275922|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2275923|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275924|NCT00210821|Topiramate|topiramate|mesh-list
2275925|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
2275926|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2798479|NCT04232150|Midazolam|midazolam|mesh-list
2798480|NCT04232150|Anesthetics|anesthetics|mesh-list
2798481|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798482|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798483|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2798484|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2798485|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2798486|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2798487|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2798488|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2798489|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
2103971|NCT02430311|Paclitaxel|paclitaxel|mesh-list
2103972|NCT02430311|Olaparib|olaparib|mesh-list
2103973|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2798490|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
2798491|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
2798492|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2798493|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798494|NCT04231864|Durvalumab|durvalumab|mesh-list
2798495|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
2798496|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2275927|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798497|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
2798498|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2798499|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798500|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
2798501|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798512|NCT04232033|Mitogens|mitogens|mesh-list
2798513|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
2798514|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798515|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
2798516|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
2798517|NCT04232085|Melphalan|melphalan|mesh-list
2798518|NCT04232085|Fludarabine|fludarabine|mesh-list
2798519|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
2798520|NCT04232085|Tacrolimus|tacrolimus|mesh-list
2798521|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2798522|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
2798523|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798524|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2798525|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2275928|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
2275929|NCT00210834|Hematinics|hematinics|mesh-ancestor
2275930|NCT00210847|Acetaminophen|acetaminophen|mesh-list
2275931|NCT00210847|Tramadol|tramadol|mesh-list
2275932|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2275933|NCT00210847|Analgesics|analgesics|mesh-ancestor
2275934|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
2275935|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2275936|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798526|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
2798527|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798528|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798529|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2798530|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2798531|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798532|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2798533|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2798534|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
2798535|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2798536|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2798537|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2798538|NCT04231968|Ziresovir|ziresovir|mesh-list
2798539|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
2798540|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275937|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
2275938|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2275939|NCT00210847|Narcotics|narcotics|mesh-ancestor
2275940|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2275941|NCT00210860|Topiramate|topiramate|mesh-list
2275942|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
2275943|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2275944|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275945|NCT00210873|Topiramate|topiramate|mesh-list
2275946|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
2275947|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2275948|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275949|NCT00210886|Levofloxacin|levofloxacin|mesh-list
2275950|NCT00210886|Ofloxacin|ofloxacin|mesh-list
2275951|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2275952|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2798581|NCT04231851|Cytarabine|cytarabine|mesh-list
2798582|NCT04231851|Daunorubicin|daunorubicin|mesh-list
2798583|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2798584|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
2798585|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798586|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798587|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
2798588|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2798589|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2798590|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
2798591|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798592|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2798593|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2798594|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2798595|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798596|NCT04231643|Dronabinol|dronabinol|mesh-list
2275953|NCT00210886|Renal Agents|renal agents|mesh-ancestor
2275954|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2275955|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2275956|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2275957|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275958|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275959|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2275960|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2275961|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2275962|NCT00210899|Vancomycin|vancomycin|mesh-list
2275963|NCT00210899|Ceftazidime|ceftazidime|mesh-list
2275964|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
2275965|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2275966|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2275967|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275968|NCT00210912|Topiramate|topiramate|mesh-list
2275969|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
2275970|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2275971|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798597|NCT04231643|Cannabidiol|cannabidiol|mesh-list
2798598|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
2798599|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798600|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2798601|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2798602|NCT04231643|Analgesics|analgesics|mesh-ancestor
2798603|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
2798604|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798605|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2798606|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2798607|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2798608|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798609|NCT04231643|Hormones|hormones|mesh-ancestor
2798610|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2798611|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
2798612|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
2798613|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2798614|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798615|NCT04231435|Metformin|metformin|mesh-list
2798616|NCT04231435|Digoxin|digoxin|mesh-list
2798617|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2798618|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2798619|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798620|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2275972|NCT00210925|Topiramate|topiramate|mesh-list
2275973|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
2275974|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2275975|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2275976|NCT00210938|Doripenem|doripenem|mesh-list
2275977|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2275978|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275979|NCT00210964|Linezolid|linezolid|mesh-list
2275980|NCT00210964|Ceftazidime|ceftazidime|mesh-list
2275981|NCT00210964|Ceftobiprole|ceftobiprole|mesh-list
2275982|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2275983|NCT00210964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2275984|NCT00210964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275985|NCT00210964|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2275986|NCT00210964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2275987|NCT00210964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2275988|NCT00210990|Doripenem|doripenem|mesh-list
2275989|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2275990|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275991|NCT00211003|Doripenem|doripenem|mesh-list
2275992|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2275993|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275994|NCT00211016|Doripenem|doripenem|mesh-list
2275995|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2798621|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2798622|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
2798623|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798624|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2798625|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2798626|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798627|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2798628|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2798629|NCT04231435|Protective Agents|protective agents|mesh-ancestor
2798630|NCT04231617|Glyburide|glyburide|mesh-list
2798631|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2798632|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798633|NCT04231682|Denosumab|denosumab|mesh-list
2798634|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2798635|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798636|NCT04231539|Nicotine|nicotine|mesh-list
2275996|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2275997|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
2275998|NCT00211120|Hematinics|hematinics|mesh-ancestor
2275999|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
2276000|NCT00211133|Hematinics|hematinics|mesh-ancestor
2276001|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
2276002|NCT00211146|Hematinics|hematinics|mesh-ancestor
2276003|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
2798637|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2798638|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
2798639|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798640|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798641|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2798642|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2798643|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
2798644|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2798645|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798646|NCT04231448|Prednisone|prednisone|mesh-list
2798647|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
2798648|NCT04231448|Rituximab|rituximab|mesh-list
2798649|NCT04231448|Doxorubicin|doxorubicin|mesh-list
2798650|NCT04231448|Vincristine|vincristine|mesh-list
2276004|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276005|NCT00211224|Riluzole|riluzole|mesh-list
2276006|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
2276007|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2798651|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2276008|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2276009|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276010|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276011|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276012|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2276013|NCT00211224|Protective Agents|protective agents|mesh-ancestor
2276014|NCT00211250|Valproic Acid|valproic acid|mesh-list
2276015|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
2276016|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276017|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276018|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
2276019|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276020|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276021|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
2276022|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2276023|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2276024|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2276025|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
2276026|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276027|NCT00211302|Aripiprazole|aripiprazole|mesh-list
2276028|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
2276029|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2276030|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2276031|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2276032|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2276033|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276034|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
2276035|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
2276036|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276037|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276038|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2798652|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
2798653|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798654|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2798655|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2798656|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
2798657|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798658|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798659|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2798660|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2798661|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2798662|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2798663|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2798664|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798665|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2798666|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
2798667|NCT04231448|Hormones|hormones|mesh-ancestor
2798668|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2798669|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2798670|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2798671|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
2798672|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
2276039|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2276040|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
2276041|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2276042|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2276043|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2276044|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2276045|NCT00211315|Anecortave|anecortave|mesh-list
2276046|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2276047|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2276048|NCT00211315|Growth Substances|growth substances|mesh-ancestor
2276049|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276050|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
2276051|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276052|NCT00211328|Anecortave|anecortave|mesh-list
2276053|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2276054|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2276055|NCT00211328|Growth Substances|growth substances|mesh-ancestor
2276056|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276057|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
2276058|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276059|NCT00211341|Vitamin A|vitamin a|mesh-list
2798673|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
2798674|NCT04231370|Lenalidomide|lenalidomide|mesh-list
2798675|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
2798676|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798677|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2798678|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2798679|NCT04231370|Growth Substances|growth substances|mesh-ancestor
2798680|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
2798681|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798682|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
2798683|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2798684|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798685|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2798686|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103974|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103975|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
2103976|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
2103977|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
2103978|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2103979|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2103980|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2103981|NCT02430389|Remifentanil|remifentanil|mesh-list
2798706|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
2798707|NCT04231214|Olodaterol|olodaterol|mesh-list
2798708|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2798709|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
2798710|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798711|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798712|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2798713|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
2798714|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
2798715|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2798716|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
2798717|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2798718|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276060|NCT00211341|Vitamins|vitamins|mesh-ancestor
2276061|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
2276062|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276063|NCT00211354|Anecortave|anecortave|mesh-list
2276064|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2798719|NCT04231123|Anesthetics|anesthetics|mesh-list
2798720|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
2798721|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2276065|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2276066|NCT00211354|Growth Substances|growth substances|mesh-ancestor
2276067|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103982|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2103983|NCT02430389|Narcotics|narcotics|mesh-ancestor
2103984|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2103985|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103986|NCT02430389|Analgesics|analgesics|mesh-ancestor
2103987|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
2103988|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2103989|NCT02430480|Goserelin|goserelin|mesh-list
2276068|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
2798722|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276069|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276070|NCT00211367|Anecortave|anecortave|mesh-list
2276071|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2276072|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2276073|NCT00211367|Growth Substances|growth substances|mesh-ancestor
2276074|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276075|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
2276076|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276077|NCT00211380|Aripiprazole|aripiprazole|mesh-list
2276078|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
2276079|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2276080|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2276081|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2276082|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798723|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
2798724|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798725|NCT04231279|Secretin|secretin|mesh-list
2798726|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2798727|NCT04231279|Hormones|hormones|mesh-ancestor
2798728|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2798729|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798730|NCT04230980|Gabapentin|gabapentin|mesh-list
2798731|NCT04230980|Analgesics|analgesics|mesh-ancestor
2798732|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
2798733|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798734|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798735|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
2798736|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2798737|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2798738|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798739|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2798740|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2798741|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2798742|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2798743|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798744|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
2798745|NCT04230681|Fentanyl|fentanyl|mesh-list
2798746|NCT04230681|Hydromorphone|hydromorphone|mesh-list
2798747|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2798748|NCT04230681|Narcotics|narcotics|mesh-ancestor
2798749|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798750|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798751|NCT04230681|Analgesics|analgesics|mesh-ancestor
2798752|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
2798753|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798754|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2798755|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2798756|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
2798757|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
2276083|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798758|NCT04230564|Azacitidine|azacitidine|mesh-list
2798759|NCT04230564|Venetoclax|venetoclax|mesh-list
2798760|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2798761|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
2798762|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798763|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798764|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798765|NCT04230759|Fluorouracil|fluorouracil|mesh-list
2798766|NCT04230759|Durvalumab|durvalumab|mesh-list
2798767|NCT04230759|Mitomycins|mitomycins|mesh-list
2798768|NCT04230759|Mitomycin|mitomycin|mesh-list
2798769|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2798770|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
2798771|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798772|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2798773|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798774|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2798775|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
2798776|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798777|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2798778|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2798779|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
2798780|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2798781|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798782|NCT04230460|Ethanol|ethanol|mesh-list
2798783|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2798784|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2798785|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798786|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798787|NCT04230330|Gemcitabine|gemcitabine|mesh-list
2798788|NCT04230330|Dexamethasone|dexamethasone|mesh-list
2798789|NCT04230330|Nivolumab|nivolumab|mesh-list
2798790|NCT04230330|Asparaginase|asparaginase|mesh-list
2798791|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798792|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2798793|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
2798794|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
2798795|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798796|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798797|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2798798|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
2798799|NCT04230330|Hormones|hormones|mesh-ancestor
2798800|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2798801|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2276084|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
2276085|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
2276086|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276087|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276088|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2276089|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2276090|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
2276091|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2276092|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2276093|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2276094|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2276095|NCT00211393|Ketoconazole|ketoconazole|mesh-list
2276096|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
2276097|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2276098|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2276099|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2276100|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798802|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2798803|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
2798804|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798805|NCT04230330|Antiviral Agents|antiviral agents|mesh-ancestor
2798806|NCT04230330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2798807|NCT04230330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798808|NCT04230330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2798809|NCT04230330|Immunologic Factors|immunologic factors|mesh-ancestor
2798810|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2798811|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2798812|NCT04230304|Daratumumab|daratumumab|mesh-list
2798813|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798814|NCT04230252|Acetaminophen|acetaminophen|mesh-list
2798815|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2798816|NCT04230252|Analgesics|analgesics|mesh-ancestor
2276101|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276102|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2276103|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
2276104|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2276105|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276106|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2276107|NCT00211406|Anecortave|anecortave|mesh-list
2276108|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2276109|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2276110|NCT00211406|Growth Substances|growth substances|mesh-ancestor
2276111|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276112|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
2276113|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276114|NCT00211419|Triamcinolone|triamcinolone|mesh-list
2276115|NCT00211419|Anecortave|anecortave|mesh-list
2276116|NCT00211419|Verteporfin|verteporfin|mesh-list
2276117|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2798817|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
2798818|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798819|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798820|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
2798821|NCT04230083|Dienogest|dienogest|mesh-list
2798822|NCT04230083|Nandrolone|nandrolone|mesh-list
2798823|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2798824|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
2798825|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2798826|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798827|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2798828|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2798829|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2798830|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2798831|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
2798832|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2798833|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2798834|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798835|NCT04230083|Androgens|androgens|mesh-ancestor
2798836|NCT04230083|Hormones|hormones|mesh-ancestor
2798837|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
2798838|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2798839|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2798840|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
2798841|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2798842|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2798843|NCT04230070|Estradiol|estradiol|mesh-list
2798844|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2798845|NCT04230070|Estrogens|estrogens|mesh-ancestor
2798846|NCT04230070|Hormones|hormones|mesh-ancestor
2798847|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2798848|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798849|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2798850|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
2798851|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2798852|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2798853|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2798854|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2798855|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2798856|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2276118|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
2276119|NCT00211419|Hormones|hormones|mesh-ancestor
2798857|NCT04230187|Leucovorin|leucovorin|mesh-list
2798858|NCT04230187|Bevacizumab|bevacizumab|mesh-list
2798859|NCT04230187|Fluorouracil|fluorouracil|mesh-list
2798860|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
2798861|NCT04230187|Irinotecan|irinotecan|mesh-list
2798862|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
2276120|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2276121|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276122|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2276123|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
2276124|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2276125|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2276126|NCT00211419|Growth Substances|growth substances|mesh-ancestor
2276127|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
2798863|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2798864|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798865|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2798866|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2798867|NCT04230187|Growth Substances|growth substances|mesh-ancestor
2798868|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798869|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
2798870|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
2798871|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798872|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2798873|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2798874|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
2798875|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2798876|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2798877|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798878|NCT04230187|Antidotes|antidotes|mesh-ancestor
2798879|NCT04230187|Protective Agents|protective agents|mesh-ancestor
2798880|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
2798881|NCT04230187|Vitamins|vitamins|mesh-ancestor
2798882|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
2798883|NCT04230031|Daratumumab|daratumumab|mesh-list
2798884|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798885|NCT04229979|Cytarabine|cytarabine|mesh-list
2798886|NCT04229979|Azacitidine|azacitidine|mesh-list
2798887|NCT04229979|Decitabine|decitabine|mesh-list
2798888|NCT04229979|Venetoclax|venetoclax|mesh-list
2798889|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2798890|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
2798891|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798892|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798893|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
2798894|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2798895|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2276128|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276129|NCT00211432|Anecortave|anecortave|mesh-list
2276130|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2276131|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2276132|NCT00211432|Growth Substances|growth substances|mesh-ancestor
2276133|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276134|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
2276135|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276136|NCT00211445|Verteporfin|verteporfin|mesh-list
2276137|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2276138|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
2276139|NCT00211458|Anecortave|anecortave|mesh-list
2276140|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2276141|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2276142|NCT00211458|Growth Substances|growth substances|mesh-ancestor
2276143|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276144|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
2276145|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276146|NCT00211471|Anecortave|anecortave|mesh-list
2276147|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2276148|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2276149|NCT00211471|Growth Substances|growth substances|mesh-ancestor
2276150|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276151|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
2276152|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276153|NCT00211484|Anecortave|anecortave|mesh-list
2798896|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
2798897|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798898|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798899|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
2798900|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
2798901|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2798902|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2798903|NCT04230213|Adalimumab|adalimumab|mesh-list
2798904|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2798905|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2798906|NCT04229758|Anticoagulants|anticoagulants|mesh-list
2276154|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2276155|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2276156|NCT00211484|Growth Substances|growth substances|mesh-ancestor
2276157|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276158|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
2276159|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276160|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
2276161|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2276162|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
2276163|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2798907|NCT04229719|Melatonin|melatonin|mesh-list
2798908|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
2798909|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798910|NCT04229719|Protective Agents|protective agents|mesh-ancestor
2798911|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798912|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798913|NCT04229615|Apatinib|apatinib|mesh-list
2798914|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798915|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2798916|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798917|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798918|NCT04229459|Nivolumab|nivolumab|mesh-list
2798919|NCT04229459|Cetuximab|cetuximab|mesh-list
2798920|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798921|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2798922|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2798923|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798924|NCT04229212|Cimetidine|cimetidine|mesh-list
2798925|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2798926|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2798927|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2798928|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
2798929|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
2798930|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2798931|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798932|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798933|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2798934|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2798935|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798936|NCT04229264|Apixaban|apixaban|mesh-list
2798937|NCT04229264|Clopidogrel|clopidogrel|mesh-list
2798938|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2798939|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2276164|NCT00211562|Vitamin E|vitamin e|mesh-list
2276165|NCT00211562|Olanzapine|olanzapine|mesh-list
2276166|NCT00211562|Vitamins|vitamins|mesh-ancestor
2276167|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
2276168|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798940|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2798941|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2798942|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
2798943|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276169|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
2276170|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
2276171|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2798944|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798945|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798946|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2798947|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
2798948|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2798949|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
2798950|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798951|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
2798952|NCT04229355|Sorafenib|sorafenib|mesh-list
2798953|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
2798954|NCT04229355|Lenvatinib|lenvatinib|mesh-list
2798955|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2798956|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2798957|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2798958|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2798959|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798960|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2798961|NCT04229355|Estrogens|estrogens|mesh-ancestor
2798962|NCT04229355|Hormones|hormones|mesh-ancestor
2798963|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2798964|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798965|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2798966|NCT04229368|Vitamin D|vitamin d|mesh-list
2798967|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
2798968|NCT04229368|Vitamins|vitamins|mesh-ancestor
2276172|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2276173|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2276174|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2798969|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
2798970|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798971|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2798972|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2798982|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2798983|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2798984|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2798985|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2798986|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2798987|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2798988|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2798989|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2798990|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
2798991|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2276175|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2798992|NCT04229381|Coal Tar|coal tar|mesh-list
2798993|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
2798994|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
2798995|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2798996|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2798997|NCT04229407|Vitamins|vitamins|mesh-list
2798998|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
2798999|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
2799000|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799001|NCT04229004|Gemcitabine|gemcitabine|mesh-list
2799002|NCT04229004|Paclitaxel|paclitaxel|mesh-list
2799003|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2799004|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799005|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
2799006|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
2799007|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
2799008|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799009|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2799010|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
2799011|NCT04229004|Antiviral Agents|antiviral agents|mesh-ancestor
2799012|NCT04229004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799013|NCT04229004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799014|NCT04229004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2799015|NCT04229004|Immunologic Factors|immunologic factors|mesh-ancestor
2799016|NCT04229004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799017|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2799018|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2799019|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
2799020|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2799021|NCT04228757|Estrogens|estrogens|mesh-ancestor
2799022|NCT04228757|Hormones|hormones|mesh-ancestor
2799023|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2799024|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799025|NCT04228315|Primaquine|primaquine|mesh-list
2799026|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
2276176|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2276177|NCT00211562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2276178|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2276179|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372122|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799027|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2799028|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2799029|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799030|NCT04228263|Aspirin|aspirin|mesh-list
2799031|NCT04228263|Folic Acid|folic acid|mesh-list
2799032|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
2799033|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2799034|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2799035|NCT04228263|Analgesics|analgesics|mesh-ancestor
2799036|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
2799037|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799038|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799039|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2799040|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2799041|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2799042|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2799043|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799044|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2799045|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2799046|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799047|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
2799048|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
2799049|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2799050|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2799051|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799052|NCT04228263|Hematinics|hematinics|mesh-ancestor
2799053|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
2799054|NCT04228263|Vitamins|vitamins|mesh-ancestor
2799055|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
2799056|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
2799057|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
2799058|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799059|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2799060|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799061|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2799062|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
2799063|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799064|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2799065|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799066|NCT04228289|Oxytocin|oxytocin|mesh-list
2799067|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
2799068|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2799069|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799070|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
2799071|NCT04227990|Docetaxel|docetaxel|mesh-list
2799072|NCT04227990|Doxorubicin|doxorubicin|mesh-list
2799073|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2799074|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
2799075|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799076|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2799077|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2799078|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
2276180|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276181|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276182|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
2276183|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
2276184|NCT00211562|Protective Agents|protective agents|mesh-ancestor
2276185|NCT00211588|Galantamine|galantamine|mesh-list
2276186|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2276187|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276188|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276189|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
2276190|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276191|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276192|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2276193|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
2276194|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276195|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
2276196|NCT00211614|Lansoprazole|lansoprazole|mesh-list
2276197|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
2276198|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2799079|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799080|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799081|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2799082|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
2799083|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
2799084|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
2799085|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2799086|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2799087|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2799088|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799089|NCT04228042|Infigratinib|infigratinib|mesh-list
2799090|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799091|NCT04227886|Capecitabine|capecitabine|mesh-list
2799092|NCT04227886|Irinotecan|irinotecan|mesh-list
2799093|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2799094|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
2799095|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799096|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799097|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2799098|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2799099|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799100|NCT04227808|Lenvatinib|lenvatinib|mesh-list
2799101|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799102|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2799103|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799104|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799105|NCT04227678|Heparin|heparin|mesh-list
2799106|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
2799107|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2276199|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2276200|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2276201|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276202|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276203|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
2276204|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2276205|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
2276206|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2276207|NCT00211653|Expectorants|expectorants|mesh-ancestor
2276208|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
2276209|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2276210|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
2372123|NCT00591162|Tetracycline|tetracycline|mesh-list
2799108|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2276211|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276212|NCT00211653|Protective Agents|protective agents|mesh-ancestor
2276213|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276214|NCT00211653|Antidotes|antidotes|mesh-ancestor
2276215|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
2276216|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2276217|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2276218|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2276219|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2276220|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276221|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
2276222|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276223|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276224|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2276225|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276226|NCT00211705|Pravastatin|pravastatin|mesh-list
2276227|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2276228|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2276229|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
2276230|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276231|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2276232|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2276233|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276234|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
2276235|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2276236|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2276237|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2276238|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2276239|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799109|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799110|NCT04227704|Ketamine|ketamine|mesh-list
2799111|NCT04227704|Analgesics|analgesics|mesh-ancestor
2799112|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
2799113|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799114|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799115|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2799116|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2799117|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
2799118|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
2799119|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799120|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2799121|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2799122|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799123|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799125|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2799126|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2799127|NCT04227756|Psilocybin|psilocybin|mesh-list
2799128|NCT04227756|Mescaline|mescaline|mesh-list
2799129|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
2799130|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799131|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2799132|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2799133|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
2799134|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799135|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276240|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
2276241|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276242|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276243|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2276244|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276245|NCT00211744|Topiramate|topiramate|mesh-list
2276246|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
2276247|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2276248|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276249|NCT00211796|Valproic Acid|valproic acid|mesh-list
2276250|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
2276251|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276252|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276253|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
2276254|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276255|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276256|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
2799136|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2799137|NCT04227912|Anesthetics|anesthetics|mesh-list
2276257|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2276258|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2276259|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2276260|NCT00211848|Interferons|interferons|mesh-list
2276261|NCT00211848|Ribavirin|ribavirin|mesh-list
2276262|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276263|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
2276264|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2276265|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
2276266|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276267|NCT00211939|Atorvastatin|atorvastatin|mesh-list
2276268|NCT00211939|Calcium|calcium|mesh-list
2276269|NCT00211939|Sevelamer|sevelamer|mesh-list
2276270|NCT00211939|Calcium acetate|calcium acetate|mesh-list
2276271|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2276272|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276273|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2276274|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2799138|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
2799139|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799140|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799141|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
2799142|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799143|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2799144|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2799145|NCT04227912|Analgesics|analgesics|mesh-ancestor
2799146|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2799147|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2276275|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
2276276|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276277|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2276278|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2276279|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276280|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
2276281|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
2276282|NCT00211952|Celecoxib|celecoxib|mesh-list
2276283|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2276284|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2276285|NCT00211952|Analgesics|analgesics|mesh-ancestor
2276286|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
2276287|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276288|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276289|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2276290|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2276291|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2276292|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2276293|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276294|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276295|NCT00211978|Calcium|calcium|mesh-list
2276296|NCT00211978|Calcium acetate|calcium acetate|mesh-list
2276297|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2276298|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276299|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
2276300|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
2276301|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276302|NCT00212004|Pioglitazone|pioglitazone|mesh-list
2276303|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2276304|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276305|NCT00212017|Voglibose|voglibose|mesh-list
2276306|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2276307|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276308|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2276309|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276310|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799148|NCT04227652|Ibuprofen|ibuprofen|mesh-list
2799149|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2799150|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2799151|NCT04227652|Analgesics|analgesics|mesh-ancestor
2799152|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
2799153|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799154|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799155|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2799156|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2799157|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2799158|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799159|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799160|NCT04227210|Vaccines|vaccines|mesh-list
2799161|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
2799162|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799163|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
2799164|NCT04227275|Fludarabine|fludarabine|mesh-list
2799165|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2799166|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2799167|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
2799168|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799169|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2799170|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2799171|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
2799172|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799173|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799174|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2799175|NCT04227483|Prednisolone|prednisolone|mesh-list
2799176|NCT04227483|Deflazacort|deflazacort|mesh-list
2799177|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2799178|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
2799179|NCT04227483|Hormones|hormones|mesh-ancestor
2799180|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2799181|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799182|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2799183|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799184|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2799185|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
2799186|NCT04227522|Rucaparib|rucaparib|mesh-list
2799187|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2799188|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799189|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799190|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799191|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
2799192|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2799193|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799202|NCT04227184|Trospium chloride|trospium chloride|mesh-list
2799203|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
2799204|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
2799205|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799206|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799207|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2799208|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2799209|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
2799210|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799211|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799212|NCT04227184|Urological Agents|urological agents|mesh-ancestor
2799213|NCT04227431|Insulin|insulin|mesh-list
2799214|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2799215|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799216|NCT04227093|Acetazolamide|acetazolamide|mesh-list
2799217|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
2799218|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2276311|NCT00212030|Nicorandil|nicorandil|mesh-list
2276312|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2276313|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2276314|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
2276315|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
2276316|NCT00212030|Vitamins|vitamins|mesh-ancestor
2276317|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
2276318|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276319|NCT00212043|Gemcitabine|gemcitabine|mesh-list
2276320|NCT00212043|Carboplatin|carboplatin|mesh-list
2276321|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799219|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799220|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799221|NCT04227093|Diuretics|diuretics|mesh-ancestor
2799222|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
2799223|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799224|NCT04227041|Capecitabine|capecitabine|mesh-list
2799225|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2799226|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
2799227|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799228|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799238|NCT04226963|Ketamine|ketamine|mesh-list
2799239|NCT04226963|Analgesics|analgesics|mesh-ancestor
2799240|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
2799241|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799242|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799243|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2799244|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2799245|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
2799246|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
2799247|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799248|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2799249|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2799250|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799251|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799252|NCT04226885|Fentanyl|fentanyl|mesh-list
2799253|NCT04226885|Midazolam|midazolam|mesh-list
2799254|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
2799255|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2799256|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2276322|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2276323|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
2276324|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276325|NCT00212043|Antiviral Agents|antiviral agents|mesh-ancestor
2276326|NCT00212043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2276327|NCT00212043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276328|NCT00212043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2276329|NCT00212043|Immunologic Factors|immunologic factors|mesh-ancestor
2276330|NCT00212043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276331|NCT00212069|Gemcitabine|gemcitabine|mesh-list
2276332|NCT00212069|Carboplatin|carboplatin|mesh-list
2276333|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276334|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2276335|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
2276336|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276337|NCT00212069|Antiviral Agents|antiviral agents|mesh-ancestor
2276338|NCT00212069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2276339|NCT00212069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799257|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799258|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2799259|NCT04226885|Analgesics|analgesics|mesh-ancestor
2799260|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
2799261|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799262|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2799263|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2799264|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2799265|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
2799266|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799267|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799268|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2799269|NCT04226885|Narcotics|narcotics|mesh-ancestor
2799270|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2799271|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2799272|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
2799273|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
2799274|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2799275|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2799276|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2799277|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
2799278|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
2799279|NCT04226495|Sufentanil|sufentanil|mesh-list
2799280|NCT04226495|Dsuvia|dsuvia|mesh-list
2799281|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2799282|NCT04226495|Narcotics|narcotics|mesh-ancestor
2799283|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799284|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799285|NCT04226495|Analgesics|analgesics|mesh-ancestor
2799286|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
2799287|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799288|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2799289|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2799290|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
2799291|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
2799292|NCT04226625|Propofol|propofol|mesh-list
2799293|NCT04226625|Desflurane|desflurane|mesh-list
2799294|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2799295|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799296|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799297|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2799298|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
2799299|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
2799300|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2799301|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
2799302|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2799303|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
2799304|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799305|NCT04226456|Expectorants|expectorants|mesh-ancestor
2799306|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
2799307|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2799308|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
2799309|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799310|NCT04226456|Protective Agents|protective agents|mesh-ancestor
2799311|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799312|NCT04226456|Antidotes|antidotes|mesh-ancestor
2799313|NCT04226443|Midazolam|midazolam|mesh-list
2799314|NCT04226443|Remifentanil|remifentanil|mesh-list
2799315|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2799316|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2799317|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2103990|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2103991|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2103992|NCT02430818|Morphine|morphine|mesh-list
2799318|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799319|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2799320|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2799321|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2799322|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2799323|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
2799324|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
2799325|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
2799326|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
2799327|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799328|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799329|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2799330|NCT04226443|Narcotics|narcotics|mesh-ancestor
2103993|NCT02430818|Ketamine|ketamine|mesh-list
2799331|NCT04226443|Analgesics|analgesics|mesh-ancestor
2799332|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
2799333|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799334|NCT04226105|Insulin|insulin|mesh-list
2799335|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2799336|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
2799337|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
2799338|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2799339|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2799340|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2799341|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799342|NCT04226365|Nortriptyline|nortriptyline|mesh-list
2799343|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2799344|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
2799345|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2799346|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2799347|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2799348|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2799349|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799350|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
2799351|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799352|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799360|NCT04225780|Ganciclovir|ganciclovir|mesh-list
2799361|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2799362|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
2799363|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799364|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2799365|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799366|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799367|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2799368|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
2799369|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799370|NCT04225611|Dexamethasone|dexamethasone|mesh-list
2799371|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2799372|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
2799373|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
2799374|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799375|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799376|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2799377|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
2799378|NCT04225611|Hormones|hormones|mesh-ancestor
2799379|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2799380|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2799381|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799382|NCT04225598|Buprenorphine|buprenorphine|mesh-list
2799383|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2799384|NCT04225598|Narcotics|narcotics|mesh-ancestor
2799385|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799386|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799387|NCT04225598|Analgesics|analgesics|mesh-ancestor
2799388|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
2799389|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799390|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2799391|NCT04225819|Vitamin D|vitamin d|mesh-list
2799392|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
2799393|NCT04225819|Vitamins|vitamins|mesh-ancestor
2276340|NCT00212069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2276341|NCT00212069|Immunologic Factors|immunologic factors|mesh-ancestor
2276342|NCT00212069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276343|NCT00212082|Docetaxel|docetaxel|mesh-list
2276344|NCT00212082|Doxorubicin|doxorubicin|mesh-list
2276345|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276346|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
2276347|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
2276348|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
2276349|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276350|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2276351|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2276352|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2276353|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276354|NCT00212095|Ketoconazole|ketoconazole|mesh-list
2276355|NCT00212095|Docetaxel|docetaxel|mesh-list
2276356|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276357|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
2276358|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
2276359|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
2276360|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276361|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
2276362|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2276363|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2276364|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2276365|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276366|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2276367|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
2276368|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2276369|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276370|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2276371|NCT00212108|Celecoxib|celecoxib|mesh-list
2276372|NCT00212108|Gefitinib|gefitinib|mesh-list
2799394|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
2799395|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799396|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2799397|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2799398|NCT04225767|Calcium|calcium|mesh-list
2799399|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2799400|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799401|NCT04225728|Iron|iron|mesh-list
2799402|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2799403|NCT04225728|Teferrol|teferrol|mesh-list
2799404|NCT04225728|Trace Elements|trace elements|mesh-ancestor
2799405|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
2799406|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799407|NCT04225728|Hematinics|hematinics|mesh-ancestor
2799408|NCT04225390|Dacarbazine|dacarbazine|mesh-list
2799409|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2799410|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
2799411|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799412|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799413|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
2799414|NCT04225468|Narcotics|narcotics|mesh-ancestor
2799415|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799416|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799417|NCT04225468|Analgesics|analgesics|mesh-ancestor
2799418|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
2799419|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799420|NCT04225273|Lidocaine|lidocaine|mesh-list
2799421|NCT04225273|Anesthetics, Local|anesthetics, local|mesh-ancestor
2799422|NCT04225273|Anesthetics|anesthetics|mesh-ancestor
2799423|NCT04225273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799424|NCT04225273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799425|NCT04225273|Sensory System Agents|sensory system agents|mesh-ancestor
2799426|NCT04225273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799427|NCT04225273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2799428|NCT04225273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2276373|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2276374|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2276375|NCT00212108|Analgesics|analgesics|mesh-ancestor
2276376|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
2276377|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799429|NCT04225273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2103994|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2103995|NCT02430818|Narcotics|narcotics|mesh-ancestor
2103996|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2103997|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2103998|NCT02430818|Analgesics|analgesics|mesh-ancestor
2799430|NCT04225273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2799431|NCT04225273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799432|NCT04225364|Paclitaxel|paclitaxel|mesh-list
2799433|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2799434|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2799435|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799436|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
2799437|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
2799438|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
2799439|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799440|NCT04225260|Botulinum Toxins|botulinum toxins|mesh-list
2799441|NCT04225260|Neurotransmitter Agents|neurotransmitter agents|mesh-list
2799442|NCT04225260|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2799443|NCT04225260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2799444|NCT04225260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799445|NCT04225260|Cholinergic Agents|cholinergic agents|mesh-ancestor
2799446|NCT04225260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799447|NCT04225325|Dolutegravir|dolutegravir|mesh-list
2799448|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2799449|NCT04225325|Emtricitabine|emtricitabine|mesh-list
2799450|NCT04225325|Darunavir|darunavir|mesh-list
2799451|NCT04225325|Cobicistat|cobicistat|mesh-list
2799452|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2799453|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2799454|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799455|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799456|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2799457|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2799458|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
2799459|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799460|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2103999|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
2104000|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104001|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2104002|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2104003|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
2104004|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
2799461|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2799462|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2799463|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2276378|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276379|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2276380|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2276381|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2276382|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2276383|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276384|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276385|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276386|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2276387|NCT00212147|Anesthetics|anesthetics|mesh-list
2799464|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
2799465|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2799466|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2799467|NCT04225312|Natalizumab|natalizumab|mesh-list
2799468|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
2276388|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2276389|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276390|NCT00212173|Sibutramine|sibutramine|mesh-list
2276391|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
2276392|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2276393|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
2276394|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2276395|NCT00212186|Selenium|selenium|mesh-list
2276396|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
2799469|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799470|NCT04224922|Paclitaxel|paclitaxel|mesh-list
2799471|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
2799472|NCT04224922|Epirubicin|epirubicin|mesh-list
2799473|NCT04224922|Carboplatin|carboplatin|mesh-list
2799474|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2799475|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799476|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
2799477|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
2799478|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
2799479|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799480|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2799481|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
2799482|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799483|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2799484|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2799485|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
2799486|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2799487|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2799488|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2799489|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2799490|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799491|NCT04225221|Leuprolide|leuprolide|mesh-list
2799492|NCT04225221|Estradiol|estradiol|mesh-list
2799493|NCT04225221|Progesterone|progesterone|mesh-list
2799494|NCT04225221|Estrogens|estrogens|mesh-ancestor
2799495|NCT04225221|Hormones|hormones|mesh-ancestor
2276397|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276398|NCT00212186|Protective Agents|protective agents|mesh-ancestor
2276399|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276400|NCT00212186|Trace Elements|trace elements|mesh-ancestor
2276401|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
2276402|NCT00212199|Orlistat|orlistat|mesh-list
2276403|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276404|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276405|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2799496|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2799497|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799498|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2799499|NCT04225221|Progestins|progestins|mesh-ancestor
2799500|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2799501|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
2799502|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2799503|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799504|NCT04225195|Amphotericin B|amphotericin b|mesh-list
2799505|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2276406|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2276407|NCT00212212|Selenium|selenium|mesh-list
2799506|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
2799507|NCT04225195|Amebicides|amebicides|mesh-ancestor
2799508|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2799509|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2276408|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
2276409|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276410|NCT00212212|Protective Agents|protective agents|mesh-ancestor
2276411|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276412|NCT00212212|Trace Elements|trace elements|mesh-ancestor
2276413|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
2276414|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2276415|NCT00212277|Norethindrone|norethindrone|mesh-list
2276416|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
2276417|NCT00212277|Estradiol|estradiol|mesh-list
2276418|NCT00212277|Estrogens|estrogens|mesh-ancestor
2276419|NCT00212277|Hormones|hormones|mesh-ancestor
2276420|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2276421|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276422|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2276423|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
2276424|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2276425|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2276426|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2276427|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2276428|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2276429|NCT00212290|Pioglitazone|pioglitazone|mesh-list
2276430|NCT00212290|Nateglinide|nateglinide|mesh-list
2276431|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2276432|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276433|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2276434|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276435|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2276436|NCT00212342|Norethindrone|norethindrone|mesh-list
2276437|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
2276438|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2276439|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2276440|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2276441|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
2276442|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2276443|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276444|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2276445|NCT00212342|Estrogens|estrogens|mesh-ancestor
2276446|NCT00212342|Hormones|hormones|mesh-ancestor
2276447|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2276448|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2276449|NCT00212472|Factor VIII|factor viii|mesh-list
2276450|NCT00212472|Coagulants|coagulants|mesh-ancestor
2276451|NCT00212589|Leucovorin|leucovorin|mesh-list
2276452|NCT00212589|Folic Acid|folic acid|mesh-list
2276453|NCT00212589|Fluorouracil|fluorouracil|mesh-list
2276454|NCT00212589|Capecitabine|capecitabine|mesh-list
2276455|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
2276456|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
2276457|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799510|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799511|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2799512|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
2799513|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2799514|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
2799515|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799516|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799517|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2799518|NCT04225195|Protective Agents|protective agents|mesh-ancestor
2799519|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799520|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799526|NCT04225052|Varenicline|varenicline|mesh-list
2799527|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2799528|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2799529|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
2799530|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799531|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276458|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2276459|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276460|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2276461|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
2276462|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276463|NCT00212589|Antidotes|antidotes|mesh-ancestor
2276464|NCT00212589|Protective Agents|protective agents|mesh-ancestor
2276465|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
2276466|NCT00212589|Vitamins|vitamins|mesh-ancestor
2276467|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
2276468|NCT00212589|Hematinics|hematinics|mesh-ancestor
2276469|NCT00212602|Aprepitant|aprepitant|mesh-list
2276470|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
2276471|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
2799532|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799533|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
2799534|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
2799535|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2799536|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799537|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
2276472|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
2276473|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276474|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276475|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2276476|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2276477|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276478|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276479|NCT00212615|Capecitabine|capecitabine|mesh-list
2276480|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
2276481|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2276482|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
2276483|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276484|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276485|NCT00212654|Landiolol|landiolol|mesh-list
2276486|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2276487|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2276488|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
2276489|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276490|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276491|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276492|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2799538|NCT04224831|Mitogens|mitogens|mesh-list
2799539|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
2799540|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799541|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2799542|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2276493|NCT00212680|Landiolol|landiolol|mesh-list
2276494|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2276495|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2276496|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
2276497|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276498|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276499|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276500|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2276501|NCT00212771|Olanzapine|olanzapine|mesh-list
2276502|NCT00212771|Asenapine|asenapine|mesh-list
2276503|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
2276504|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
2276505|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276506|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276507|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2276508|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2276509|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2276510|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2276511|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2276512|NCT00212771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2276513|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2799543|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
2799544|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2799545|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
2799546|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2799547|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799548|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2799549|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2276514|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2276515|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799550|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799551|NCT04224766|Bupivacaine|bupivacaine|mesh-list
2799552|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
2799553|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
2799554|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799555|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799556|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
2799557|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799558|NCT04224701|Vaccines|vaccines|mesh-list
2799559|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
2799560|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799561|NCT04224649|Lidocaine|lidocaine|mesh-list
2799562|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
2799563|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
2799564|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
2799565|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799566|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799567|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
2799568|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799569|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2799570|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2799571|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2799572|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2799573|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799574|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2799575|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
2799576|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
2799577|NCT04224649|Protective Agents|protective agents|mesh-ancestor
2799578|NCT04224636|Bevacizumab|bevacizumab|mesh-list
2799579|NCT04224636|Atezolizumab|atezolizumab|mesh-list
2799580|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2799581|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799582|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2799583|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2799584|NCT04224636|Growth Substances|growth substances|mesh-ancestor
2799585|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799586|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
2799587|NCT04224571|Rituximab|rituximab|mesh-list
2799588|NCT04224571|Bortezomib|bortezomib|mesh-list
2799589|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2799590|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799591|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
2799592|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799593|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2799594|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
2799595|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2799596|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799597|NCT04224493|Rituximab|rituximab|mesh-list
2799598|NCT04224493|Lenalidomide|lenalidomide|mesh-list
2799599|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2799600|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799601|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
2799602|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799603|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2799604|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2799605|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2799606|NCT04224493|Growth Substances|growth substances|mesh-ancestor
2799607|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
2799608|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2799609|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2799610|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2799611|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2799612|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799613|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799614|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799615|NCT04224584|Analgesics|analgesics|mesh-ancestor
2799616|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
2799617|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799618|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
2799619|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2799620|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
2799621|NCT04224558|Acetaminophen|acetaminophen|mesh-list
2799622|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
2799623|NCT04224558|Promethazine|promethazine|mesh-list
2799624|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
2799625|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2799626|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
2799627|NCT04224558|Fludarabine|fludarabine|mesh-list
2799628|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
2799629|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2799630|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
2799631|NCT04224558|Antibodies|antibodies|mesh-list
2799632|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
2799633|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2799634|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2799635|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2799636|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
2799637|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799638|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2799639|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2799640|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
2799641|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799642|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799643|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2799644|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2799645|NCT04224558|Analgesics|analgesics|mesh-ancestor
2799646|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
2799647|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799648|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
2799649|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2799650|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
2799651|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
2799652|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2799653|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
2799654|NCT04224558|Hormones|hormones|mesh-ancestor
2799655|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2799656|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2799657|NCT04224558|Protective Agents|protective agents|mesh-ancestor
2799658|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2799659|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2799660|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2799661|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799662|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
2799663|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
2799664|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2799665|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
2799666|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
2799667|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799668|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2799669|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
2799670|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
2799671|NCT04224675|Atenolol|atenolol|mesh-list
2799672|NCT04224675|Captopril|captopril|mesh-list
2799673|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2799674|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2799675|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
2799676|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
2799677|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799678|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799679|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2799680|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2799681|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2799682|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
2799683|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799684|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799685|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2799686|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
2799687|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799688|NCT04224337|Doxorubicin|doxorubicin|mesh-list
2799689|NCT04224337|Durvalumab|durvalumab|mesh-list
2799690|NCT04224337|Ifosfamide|ifosfamide|mesh-list
2799691|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2799692|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799693|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2799694|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2799695|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799696|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799697|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2799698|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2799699|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
2799700|NCT04224441|Temozolomide|temozolomide|mesh-list
2799701|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
2799702|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2799703|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
2799704|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799705|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799706|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
2799707|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
2799708|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799709|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799710|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2799711|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2276516|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276517|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
2276518|NCT00212784|Olanzapine|olanzapine|mesh-list
2276519|NCT00212784|Asenapine|asenapine|mesh-list
2276520|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
2276521|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
2276522|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276523|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276524|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2276525|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2276526|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2276527|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799712|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2799713|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799714|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2799715|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2799716|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
2799717|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799718|NCT04224194|Adalimumab|adalimumab|mesh-list
2799719|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2799720|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2276528|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2276529|NCT00212784|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2276530|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2276531|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2276532|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276533|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276534|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
2276535|NCT00212810|Topiramate|topiramate|mesh-list
2276536|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
2276537|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2276538|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276539|NCT00212823|Almotriptan|almotriptan|mesh-list
2276540|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2276541|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
2276542|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276543|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276544|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276545|NCT00212836|Olanzapine|olanzapine|mesh-list
2276546|NCT00212836|Asenapine|asenapine|mesh-list
2799721|NCT04224415|Irinotecan|irinotecan|mesh-list
2799722|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2799723|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2799724|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799725|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799726|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799727|NCT04224428|Fexofenadine|fexofenadine|mesh-list
2799728|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2799729|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2799730|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2799731|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
2799732|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
2799733|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799734|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799735|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799736|NCT04224051|Metformin|metformin|mesh-list
2104005|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2104006|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2104007|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104008|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799737|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2799738|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799739|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
2799740|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2799741|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
2799742|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799743|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799744|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2276547|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
2276548|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
2276549|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276550|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276551|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2276552|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2799745|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
2799746|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2799747|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
2799748|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799749|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799750|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2799751|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
2799752|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
2799753|NCT04224103|Protective Agents|protective agents|mesh-ancestor
2799754|NCT04224272|Fulvestrant|fulvestrant|mesh-list
2799755|NCT04224272|Palbociclib|palbociclib|mesh-list
2799756|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2799757|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799758|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2799759|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2799760|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
2799761|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2799762|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799763|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2799764|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799765|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799766|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
2799767|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2799768|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2799769|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799770|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
2799771|NCT04224116|Coagulants|coagulants|mesh-ancestor
2799772|NCT04224350|Tacrolimus|tacrolimus|mesh-list
2799773|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2799774|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
2799775|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799776|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2799777|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799778|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799779|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
2799780|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2799781|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2799782|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
2799783|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
2799784|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799785|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799786|NCT04223973|Insulin|insulin|mesh-list
2799787|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2799788|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799789|NCT04223778|Islatravir|islatravir|mesh-list
2799790|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
2799791|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799792|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799793|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799794|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2799795|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2799796|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2799797|NCT04223791|Islatravir|islatravir|mesh-list
2799798|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
2799799|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799800|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799801|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799802|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2799803|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2799804|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2799805|NCT04223752|Tazobactam|tazobactam|mesh-list
2799806|NCT04223752|Ceftolozane|ceftolozane|mesh-list
2799807|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2799808|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2799809|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799810|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2799811|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799812|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799813|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2799814|NCT04223752|Renal Agents|renal agents|mesh-ancestor
2799834|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
2799835|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2799836|NCT04223518|Antibodies|antibodies|mesh-list
2799837|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
2799838|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799839|NCT04223739|Amiodarone|amiodarone|mesh-list
2799840|NCT04223739|Landiolol|landiolol|mesh-list
2799841|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2799842|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
2799843|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2799844|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2799845|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799846|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2799847|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2799848|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2799849|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799850|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2799851|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2799852|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2799853|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2799854|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2799855|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
2799856|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276553|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2799857|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799858|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
2799859|NCT04223219|Fentanyl|fentanyl|mesh-list
2799860|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
2799861|NCT04223219|Ketamine|ketamine|mesh-list
2799862|NCT04223219|Propofol|propofol|mesh-list
2276554|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2276555|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2276556|NCT00212836|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2276557|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2276558|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2276559|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276560|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276561|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
2276562|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
2276563|NCT00212875|Hematinics|hematinics|mesh-ancestor
2276564|NCT00213070|Miglitol|miglitol|mesh-list
2276565|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276566|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276567|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2276568|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276569|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2276570|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2276571|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2276572|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
2276573|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2276574|NCT00213096|ST 1435|st 1435|mesh-list
2276575|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
2276576|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
2799863|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2799864|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2799865|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799866|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2799867|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
2799868|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
2799869|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2799870|NCT04223219|Analgesics|analgesics|mesh-ancestor
2799871|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
2799872|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2799873|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2276577|NCT00213096|Estradiol|estradiol|mesh-list
2276578|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2276579|NCT00213096|Estrogens|estrogens|mesh-ancestor
2276580|NCT00213096|Hormones|hormones|mesh-ancestor
2276581|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2276582|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276583|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2276584|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2276585|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2276586|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2276587|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2276588|NCT00213109|Miglitol|miglitol|mesh-list
2799874|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2799875|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2799876|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
2799877|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2799878|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799879|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2799880|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2799881|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2799882|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2276589|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276590|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276591|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2276592|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276593|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2276594|NCT00213122|Miglitol|miglitol|mesh-list
2276595|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276596|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799883|NCT04223219|Narcotics|narcotics|mesh-ancestor
2799884|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2799885|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2799886|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
2799887|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2799888|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2799889|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2799890|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
2799891|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2799892|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
2799893|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2799894|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2799895|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799896|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
2799897|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
2799898|NCT04223037|Vaccines|vaccines|mesh-list
2799899|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
2799900|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276597|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2276598|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276599|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2276600|NCT00213200|Morphine|morphine|mesh-list
2276601|NCT00213200|Tetracaine|tetracaine|mesh-list
2799901|NCT04222842|Vorolanib|vorolanib|mesh-list
2799902|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2799903|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799904|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799905|NCT04222972|Gemcitabine|gemcitabine|mesh-list
2799906|NCT04222972|Paclitaxel|paclitaxel|mesh-list
2799907|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2799908|NCT04222972|Carboplatin|carboplatin|mesh-list
2799909|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
2799910|NCT04222972|Pemetrexed|pemetrexed|mesh-list
2799911|NCT04222972|Pralsetinib|pralsetinib|mesh-list
2799912|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2799913|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799914|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
2799915|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
2799916|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
2799917|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799918|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2799919|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
2276602|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2276603|NCT00213200|Narcotics|narcotics|mesh-ancestor
2276604|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2276605|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276606|NCT00213200|Analgesics|analgesics|mesh-ancestor
2276607|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
2276608|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276609|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
2276610|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
2276611|NCT00213226|Dexamethasone|dexamethasone|mesh-list
2276612|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2276613|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
2276614|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
2276615|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276616|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276617|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2276618|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
2276619|NCT00213226|Hormones|hormones|mesh-ancestor
2276620|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2799920|NCT04222972|Antiviral Agents|antiviral agents|mesh-ancestor
2799921|NCT04222972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799922|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2799923|NCT04222972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2799924|NCT04222972|Immunologic Factors|immunologic factors|mesh-ancestor
2799925|NCT04222972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799926|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2799927|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2799928|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2799929|NCT04222855|Diltiazem|diltiazem|mesh-list
2799930|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2799931|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2799932|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2799933|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799934|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2799935|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799936|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
2799937|NCT04222920|Adalimumab|adalimumab|mesh-list
2799938|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2799939|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2799940|NCT04222517|Hemostatics|hemostatics|mesh-list
2799941|NCT04222517|Coagulants|coagulants|mesh-ancestor
2799942|NCT04222595|Vaccines|vaccines|mesh-list
2799943|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
2799944|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799947|NCT04222686|Losartan|losartan|mesh-list
2799948|NCT04222686|Perindopril|perindopril|mesh-list
2799949|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2799950|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2799951|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2799952|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2799953|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799954|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2799955|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
2799956|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276621|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2276622|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799957|NCT04222712|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2799958|NCT04222712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2799959|NCT04222062|Carmustine|carmustine|mesh-list
2799960|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2799961|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
2799962|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2799963|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2799964|NCT04222348|Metformin|metformin|mesh-list
2799965|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
2799966|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2799967|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799968|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2799969|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2799970|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799971|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
2799972|NCT04222114|Catumaxomab|catumaxomab|mesh-list
2799973|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2799974|NCT04222088|Chloroquine|chloroquine|mesh-list
2799975|NCT04222088|Lumefantrine|lumefantrine|mesh-list
2799976|NCT04222088|Amebicides|amebicides|mesh-ancestor
2799977|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2799978|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2799979|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2799980|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
2799981|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2799982|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
2799983|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2799984|NCT04222023|Antibodies|antibodies|mesh-list
2799985|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
2799986|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2799987|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
2799988|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799989|NCT04221906|Betamethasone|betamethasone|mesh-list
2799990|NCT04221906|Calcipotriene|calcipotriene|mesh-list
2799991|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2799992|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2799993|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
2799994|NCT04221906|Hormones|hormones|mesh-ancestor
2799995|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2799996|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2799997|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2799998|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
2799999|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
2800000|NCT04222283|Emtricitabine|emtricitabine|mesh-list
2800001|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
2800002|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2800003|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2800004|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2800005|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800006|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800007|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2800008|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2800009|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2800010|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2800011|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
2800012|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800013|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276623|NCT00213252|Prednisolone|prednisolone|mesh-list
2800014|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800015|NCT04221997|Sertraline|sertraline|mesh-list
2800016|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
2800017|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2800018|NCT04221997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2800019|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2800020|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2800021|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800022|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800023|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
2800024|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800025|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
2800026|NCT04221971|Fludarabine|fludarabine|mesh-list
2800027|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2800028|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
2800029|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800030|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2800031|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2800032|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
2800033|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800034|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800035|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2800036|NCT04221828|Paclitaxel|paclitaxel|mesh-list
2800037|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2800038|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2800039|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800040|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
2800041|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
2800042|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
2800043|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800044|NCT04222010|Anesthetics|anesthetics|mesh-list
2800045|NCT04222010|Ropivacaine|ropivacaine|mesh-list
2800046|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2800047|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800048|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
2800049|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
2800050|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800051|NCT04221880|Lidocaine|lidocaine|mesh-list
2800052|NCT04221880|Bupivacaine|bupivacaine|mesh-list
2800053|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2800054|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
2800055|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
2800056|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2800057|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800058|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
2800059|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800060|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2800061|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2800062|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2800063|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2800064|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800065|NCT04221555|Docetaxel|docetaxel|mesh-list
2800066|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
2800067|NCT04221555|Durvalumab|durvalumab|mesh-list
2800068|NCT04221555|Tremelimumab|tremelimumab|mesh-list
2800069|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2800070|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800071|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
2800072|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
2800073|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
2800074|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800075|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2800076|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
2800077|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800078|NCT04221672|Terlipressin|terlipressin|mesh-list
2800079|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2800080|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2800081|NCT04221503|Niraparib|niraparib|mesh-list
2800082|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2800083|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800084|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800085|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800086|NCT04221477|Acetaminophen|acetaminophen|mesh-list
2800087|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
2800088|NCT04221477|Promethazine|promethazine|mesh-list
2800089|NCT04221477|Prednisone|prednisone|mesh-list
2800090|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
2800091|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
2800092|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2800093|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
2800094|NCT04221477|Hormones|hormones|mesh-ancestor
2800095|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2800096|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800097|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2800098|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800099|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2800100|NCT04221477|Analgesics|analgesics|mesh-ancestor
2800101|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
2800102|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800103|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
2800104|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
2800105|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
2800106|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2800107|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2800108|NCT04221477|Protective Agents|protective agents|mesh-ancestor
2276624|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2276625|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
2276626|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2276627|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
2276628|NCT00213252|Montelukast|montelukast|mesh-list
2276629|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2276630|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
2276631|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2276632|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
2800109|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2800110|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2800111|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2800112|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2800113|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
2800114|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
2800115|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2800116|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
2800117|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
2800118|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800119|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800120|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2800121|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
2800122|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
2800123|NCT04221438|Alovudine|alovudine|mesh-list
2800124|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
2800125|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2800126|NCT04221750|Metformin|metformin|mesh-list
2800127|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2800128|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800129|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2800130|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
2800131|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2800132|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2800133|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2800134|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800135|NCT04221256|Citalopram|citalopram|mesh-list
2800136|NCT04221256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2800137|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2800138|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2800139|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800140|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800141|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
2800142|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800143|NCT04221256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2800144|NCT04221256|Antidepressive Agents|antidepressive agents|mesh-ancestor
2800145|NCT04221256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2800146|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2800147|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
2800148|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2800149|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
2276633|NCT00213252|Hormones|hormones|mesh-ancestor
2276634|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2276635|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276636|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2800150|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800151|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
2800152|NCT04221165|Narcotics|narcotics|mesh-ancestor
2800153|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2800154|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800155|NCT04221165|Analgesics|analgesics|mesh-ancestor
2800156|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
2800157|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800158|NCT04221321|Atorvastatin|atorvastatin|mesh-list
2800159|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2800160|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2800161|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
2800162|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800163|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2800164|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2800165|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800166|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2800167|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2800168|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
2800169|NCT04221529|Atezolizumab|atezolizumab|mesh-list
2800170|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800171|NCT04221152|Empagliflozin|empagliflozin|mesh-list
2800172|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2800173|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800174|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2800175|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800176|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
2800177|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2800178|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2800179|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800180|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
2800181|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800182|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276637|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276638|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
2276639|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
2276640|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276641|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2276642|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2276643|NCT00213252|Protective Agents|protective agents|mesh-ancestor
2276644|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2276645|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
2800183|NCT04221087|Dexamethasone|dexamethasone|mesh-list
2800184|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2800185|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
2800186|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
2800187|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800188|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800189|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2800190|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
2800191|NCT04221087|Hormones|hormones|mesh-ancestor
2800192|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2800193|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2800194|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800195|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
2800196|NCT04221035|Melphalan|melphalan|mesh-list
2800197|NCT04221035|Busulfan|busulfan|mesh-list
2800198|NCT04221035|Ifosfamide|ifosfamide|mesh-list
2800199|NCT04221035|Thiotepa|thiotepa|mesh-list
2800200|NCT04221035|Dacarbazine|dacarbazine|mesh-list
2800201|NCT04221035|Carboplatin|carboplatin|mesh-list
2800202|NCT04221035|Doxorubicin|doxorubicin|mesh-list
2800203|NCT04221035|Etoposide|etoposide|mesh-list
2800204|NCT04221035|Vincristine|vincristine|mesh-list
2800205|NCT04221035|Vindesine|vindesine|mesh-list
2800206|NCT04221035|Dinutuximab|dinutuximab|mesh-list
2276646|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2800207|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2800208|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
2800209|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800210|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2276647|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
2276648|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2276649|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2276650|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276651|NCT00213265|Vaccines|vaccines|mesh-list
2276652|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2276653|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
2276654|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276655|NCT00213278|Vinblastine|vinblastine|mesh-list
2276656|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2276657|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276658|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
2276659|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
2276660|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
2276661|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276662|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
2800211|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2800212|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
2800213|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800214|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800215|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2800216|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2800217|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2800218|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2800219|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800220|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2800221|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
2800222|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
2800223|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
2800224|NCT04220996|Vortioxetine|vortioxetine|mesh-list
2800225|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
2800226|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2800227|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2800228|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2800229|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2800230|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800231|NCT04220996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2800232|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2800233|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2800234|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800235|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800236|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
2800237|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2800238|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2800239|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2800240|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2800241|NCT04220827|Paclitaxel|paclitaxel|mesh-list
2276663|NCT00213291|Hematinics|hematinics|mesh-ancestor
2276664|NCT00213486|Irinotecan|irinotecan|mesh-list
2276665|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2276666|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2276667|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276668|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276669|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276670|NCT00213512|Rituximab|rituximab|mesh-list
2276671|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2276672|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276673|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
2800242|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2800243|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2800244|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800245|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
2800246|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
2800247|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
2800248|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800249|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
2800250|NCT04220892|Pemetrexed|pemetrexed|mesh-list
2800251|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2800252|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800253|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800254|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800255|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2800256|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2800257|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
2800258|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2800259|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800260|NCT04220684|Vidarabine|vidarabine|mesh-list
2800261|NCT04220684|Cytarabine|cytarabine|mesh-list
2276674|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276675|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2276676|NCT00213538|Methotrexate|methotrexate|mesh-list
2276677|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2276678|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2276679|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
2276680|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2276681|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276682|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2276683|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
2276684|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276685|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276686|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
2276687|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276688|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2276689|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2276690|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
2276691|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2276692|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2276693|NCT00213551|Antioxidants|antioxidants|mesh-list
2276694|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276695|NCT00213551|Protective Agents|protective agents|mesh-ancestor
2276696|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276697|NCT00213564|Methotrexate|methotrexate|mesh-list
2276698|NCT00213564|Infliximab|infliximab|mesh-list
2276699|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2276700|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
2276701|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2276702|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276703|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2276704|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
2372124|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2800262|NCT04220684|Fludarabine|fludarabine|mesh-list
2800263|NCT04220684|Fludarabine phosphate|fludarabine phosphate|mesh-list
2800264|NCT04220684|Decitabine|decitabine|mesh-list
2800265|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800266|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2800267|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
2800268|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800269|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2800270|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
2800271|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800272|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
2800273|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2800274|NCT04220684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276705|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276706|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276707|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
2276708|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276709|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2276710|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2276711|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
2276712|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2276713|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2276714|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2276715|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
2276716|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2800275|NCT04220528|Capecitabine|capecitabine|mesh-list
2800276|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2800277|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
2800278|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800279|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800280|NCT04220398|Hormones|hormones|mesh-list
2276717|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2276718|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276719|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
2276720|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276721|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276722|NCT00213590|Cyclosporine|cyclosporine|mesh-list
2276723|NCT00213590|Cyclosporins|cyclosporins|mesh-list
2276724|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276725|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276726|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2800281|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2800282|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800283|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
2800284|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
2800285|NCT04220632|Prednisone|prednisone|mesh-list
2800286|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
2800287|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2800288|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2800289|NCT04220632|Prednisolone|prednisolone|mesh-list
2800290|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
2800291|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2800292|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
2800293|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2800294|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
2800295|NCT04220632|Hormones|hormones|mesh-ancestor
2800296|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2800297|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800298|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2800299|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800300|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
2800301|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
2800302|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800303|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2800304|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2800305|NCT04220632|Protective Agents|protective agents|mesh-ancestor
2800306|NCT04220476|Letrozole|letrozole|mesh-list
2800307|NCT04220476|Palbociclib|palbociclib|mesh-list
2800308|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800309|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2800310|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2800311|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800312|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800313|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2800314|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
2800315|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2800316|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800317|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2800318|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
2800319|NCT04220281|Propofol|propofol|mesh-list
2800320|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2800321|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2800322|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800323|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2800324|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
2800325|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
2800326|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
2800327|NCT04220008|Gemcitabine|gemcitabine|mesh-list
2800328|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
2800329|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
2800330|NCT04220008|Busulfan|busulfan|mesh-list
2800331|NCT04220008|Rituximab|rituximab|mesh-list
2800332|NCT04220008|Vorinostat|vorinostat|mesh-list
2800333|NCT04220008|Clofarabine|clofarabine|mesh-list
2800334|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2800335|NCT04220008|Tacrolimus|tacrolimus|mesh-list
2800336|NCT04220008|Antibodies|antibodies|mesh-list
2800337|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
2800338|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2800339|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2800340|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
2276727|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
2276728|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800341|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800342|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2800343|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2800344|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
2800345|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800346|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800347|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2800348|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2800349|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
2800350|NCT04220008|Antiviral Agents|antiviral agents|mesh-ancestor
2800351|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2800352|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800353|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2800354|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2800355|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2800356|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
2276729|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
2276730|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2276731|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
2276732|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2276733|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2276734|NCT00213694|Celecoxib|celecoxib|mesh-list
2800357|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2800358|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2800359|NCT04220021|Metformin|metformin|mesh-list
2800360|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2800361|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800362|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
2800363|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2800364|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2800365|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800366|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
2800367|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
2800368|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2800369|NCT04220125|Midazolam|midazolam|mesh-list
2800370|NCT04220125|Ketamine|ketamine|mesh-list
2800371|NCT04220125|Analgesics|analgesics|mesh-ancestor
2800372|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
2800373|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800374|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800375|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2800376|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2800377|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
2800378|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
2800379|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2800380|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2276735|NCT00213694|Docetaxel|docetaxel|mesh-list
2800381|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2800382|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276736|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276737|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
2276738|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
2276739|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
2276740|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276741|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2276742|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2276743|NCT00213694|Analgesics|analgesics|mesh-ancestor
2276744|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
2276745|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276746|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276747|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2276748|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2800383|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800384|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2800385|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2800386|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2800387|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2800388|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2800389|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
2800390|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
2800391|NCT04220073|Antibodies|antibodies|mesh-list
2800392|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2800393|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
2800394|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800395|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
2800396|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2800397|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2800398|NCT04219995|Prednisolone|prednisolone|mesh-list
2800399|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
2800400|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2800401|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
2800402|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2800403|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
2800404|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
2800405|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800406|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276749|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2276750|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2276751|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276752|NCT00213759|Lenograstim|lenograstim|mesh-list
2276753|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2276754|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
2276755|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276756|NCT00214032|Pycnogenols|pycnogenols|mesh-list
2276757|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2276758|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
2276759|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276760|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
2800407|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2800408|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
2800409|NCT04219995|Hormones|hormones|mesh-ancestor
2800410|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2800411|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2800412|NCT04219995|Protective Agents|protective agents|mesh-ancestor
2800413|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2800414|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800415|NCT04219865|Edaravone|edaravone|mesh-list
2800416|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2800417|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
2800418|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800419|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2800420|NCT04219865|Protective Agents|protective agents|mesh-ancestor
2800421|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800422|NCT04219982|Scopolamine|scopolamine|mesh-list
2800423|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2800424|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2800425|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
2800426|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
2800427|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800428|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800429|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2800430|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
2800431|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2800432|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
2800433|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800434|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800435|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2800436|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
2800437|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
2800438|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2800439|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2800440|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800441|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
2800442|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
2800443|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2800444|NCT04219579|Antithrombins|antithrombins|mesh-list
2800445|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
2800446|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2800447|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
2800448|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800449|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800450|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
2800451|NCT04219540|Buprenorphine|buprenorphine|mesh-list
2800452|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2800453|NCT04219540|Narcotics|narcotics|mesh-ancestor
2800454|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2800455|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800456|NCT04219540|Analgesics|analgesics|mesh-ancestor
2800457|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
2800458|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800459|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2800460|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
2800461|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2800462|NCT04219735|Minocycline|minocycline|mesh-list
2800463|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2800464|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2800465|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
2800466|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2800467|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
2800468|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800469|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
2800470|NCT04219722|Protective Agents|protective agents|mesh-ancestor
2276761|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276762|NCT00214032|Protective Agents|protective agents|mesh-ancestor
2800471|NCT04219449|Protein C|protein c|mesh-list
2800472|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
2800473|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2800474|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2800475|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800476|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
2800477|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2800478|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800479|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2800480|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800481|NCT04219358|Imiquimod|imiquimod|mesh-list
2800482|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
2800483|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2800484|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
2800485|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800486|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800487|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
2800488|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2800489|NCT04219358|Protective Agents|protective agents|mesh-ancestor
2800490|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
2800491|NCT04219280|Methylphenidate|methylphenidate|mesh-list
2800492|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2800493|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800494|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2800495|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2800496|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2800497|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800498|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
2800499|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800500|NCT04219046|Naloxegol|naloxegol|mesh-list
2800501|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2800502|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800503|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
2800504|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800505|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
2800506|NCT04218890|Thromboplastin|thromboplastin|mesh-list
2800507|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2800508|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2800509|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800510|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
2800511|NCT04218890|Coagulants|coagulants|mesh-ancestor
2800512|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
2800513|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2800514|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
2800515|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800516|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2800517|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
2800518|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
2800519|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
2800520|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800521|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2800522|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800523|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
2800524|NCT04218981|Paroxetine|paroxetine|mesh-list
2800525|NCT04218981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2800526|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2800527|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2800528|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800529|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800530|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
2800531|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800532|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2800533|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
2800534|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2800535|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2800536|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2800537|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800538|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2800539|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2800540|NCT04218968|Carvedilol|carvedilol|mesh-list
2800541|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2800542|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2276763|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2276764|NCT00214058|Carboplatin|carboplatin|mesh-list
2276765|NCT00214058|Docetaxel|docetaxel|mesh-list
2276766|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276767|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
2276768|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
2800543|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
2800544|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800545|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800546|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800547|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2800548|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
2800549|NCT04218968|Protective Agents|protective agents|mesh-ancestor
2800550|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2800551|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2800552|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2800553|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
2800554|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2800555|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2800556|NCT04218513|Edaravone|edaravone|mesh-list
2800557|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2800558|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
2800559|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800560|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2800561|NCT04218513|Protective Agents|protective agents|mesh-ancestor
2800562|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800563|NCT04218500|Niacinamide|niacinamide|mesh-list
2800564|NCT04218500|Niacin|niacin|mesh-list
2800565|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
2800566|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
2800567|NCT04218500|Vitamins|vitamins|mesh-ancestor
2800568|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
2800569|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800570|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2800571|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
2800572|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276769|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
2276770|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276771|NCT00214084|Allopurinol|allopurinol|mesh-list
2276772|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
2276773|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276774|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276775|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
2276776|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2276777|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2276778|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
2276779|NCT00214084|Protective Agents|protective agents|mesh-ancestor
2276780|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276781|NCT00214110|Tamoxifen|tamoxifen|mesh-list
2276782|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2276783|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
2276784|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2276785|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276786|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2276787|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276788|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2276789|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2276790|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2276791|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
2276792|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2276793|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276794|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
2276795|NCT00214240|Antibodies|antibodies|mesh-list
2276796|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
2800573|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2800574|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
2800575|NCT04218435|Valsartan|valsartan|mesh-list
2800576|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2800577|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2800578|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2800579|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800580|NCT04218760|Isosorbide|isosorbide|mesh-list
2800581|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2800582|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2800583|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2800584|NCT04218760|Diuretics|diuretics|mesh-ancestor
2800585|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
2800586|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800587|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
2800588|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2800589|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800590|NCT04218552|Amlodipine|amlodipine|mesh-list
2800591|NCT04218552|Telmisartan|telmisartan|mesh-list
2800592|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2800593|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2800594|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2800595|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800596|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2800597|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800598|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
2800599|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2800600|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2800601|NCT04218773|Phenylephrine|phenylephrine|mesh-list
2800602|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
2800603|NCT04218773|Norepinephrine|norepinephrine|mesh-list
2800604|NCT04218773|Synephrine|synephrine|mesh-list
2800605|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2800606|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
2800607|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
2800608|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800609|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276797|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2276798|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2276799|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
2276800|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276801|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2276802|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2276803|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276804|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
2800610|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
2800611|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2800612|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
2800613|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
2800614|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2800615|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2800616|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2800617|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
2800618|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800619|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800620|NCT04218773|Protective Agents|protective agents|mesh-ancestor
2800621|NCT04218565|Golimumab|golimumab|mesh-list
2800622|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2800623|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2800624|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2800625|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
2800626|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276805|NCT00214266|Rituximab|rituximab|mesh-list
2276806|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
2276807|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2276808|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276809|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
2276810|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276811|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2276812|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2276813|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2276814|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
2276815|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2276816|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2276817|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276818|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800635|NCT04218734|Metformin|metformin|mesh-list
2800636|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2800637|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800638|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
2800639|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2800640|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2800641|NCT04218149|Bupivacaine|bupivacaine|mesh-list
2800642|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
2800643|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
2800644|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2800645|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800646|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
2800647|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800648|NCT04218162|Lasmiditan|lasmiditan|mesh-list
2800649|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2800650|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
2800651|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800652|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800653|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276819|NCT00214318|Metoprolol|metoprolol|mesh-list
2276820|NCT00214318|Carvedilol|carvedilol|mesh-list
2276821|NCT00214318|Terbutaline|terbutaline|mesh-list
2276822|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2276823|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2276824|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
2276825|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
2276826|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276827|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276828|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2276829|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2276830|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2276831|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
2276832|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2276833|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276834|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
2276835|NCT00214318|Protective Agents|protective agents|mesh-ancestor
2276836|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2276837|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2276838|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2276839|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
2276840|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2276841|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2276842|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2276843|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2276844|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
2276845|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
2276846|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
2276847|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2276848|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2800659|NCT04217733|Ethosuximide|ethosuximide|mesh-list
2800660|NCT04217733|Mebeverine|mebeverine|mesh-list
2800661|NCT04217733|Alverine|alverine|mesh-list
2800662|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
2800663|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
2800664|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
2800665|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800666|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800667|NCT04217798|Etoposide|etoposide|mesh-list
2800668|NCT04217798|Niraparib|niraparib|mesh-list
2800669|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2800670|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800671|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2800672|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2800673|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800674|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800675|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2800676|NCT04217668|Isosorbide|isosorbide|mesh-list
2800677|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2800678|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2800679|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2800680|NCT04217668|Diuretics|diuretics|mesh-ancestor
2800681|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
2800682|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800683|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
2800684|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2800685|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800686|NCT04217694|Memantine|memantine|mesh-list
2800687|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2800688|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2800689|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
2276849|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2276850|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2276851|NCT00214331|Azithromycin|azithromycin|mesh-list
2800690|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800691|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800692|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800693|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2800694|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2800695|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2800696|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2800697|NCT04217265|Letrozole|letrozole|mesh-list
2800698|NCT04217265|Misoprostol|misoprostol|mesh-list
2800699|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800700|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2800701|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2276852|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
2276853|NCT00214331|Gentamicins|gentamicins|mesh-list
2276854|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2276855|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2276856|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2800702|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800703|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800704|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2800705|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
2800706|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2800707|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800708|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2800709|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
2800710|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2800711|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2800712|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2800713|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
2800714|NCT04217447|Aspirin|aspirin|mesh-list
2800715|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2800716|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2800717|NCT04217447|Analgesics|analgesics|mesh-ancestor
2800718|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
2800719|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800720|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800721|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2800722|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2800723|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2800724|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2800725|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800726|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2800727|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2800728|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800729|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
2800730|NCT04217421|Allopurinol|allopurinol|mesh-list
2800731|NCT04217421|Mannitol|mannitol|mesh-list
2800732|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
2800733|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800734|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800735|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
2800736|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2800737|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2800738|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
2800739|NCT04217421|Protective Agents|protective agents|mesh-ancestor
2800740|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800741|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2800742|NCT04217421|Diuretics|diuretics|mesh-ancestor
2800743|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
2800744|NCT04217512|Pantoprazole|pantoprazole|mesh-list
2800745|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2800746|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2800747|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2800748|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800749|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800750|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2800751|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2800752|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
2800753|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800754|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800755|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
2800756|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800757|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
2800758|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800759|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800760|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2800761|NCT04217148|Dexamethasone|dexamethasone|mesh-list
2800762|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
2800763|NCT04217148|Tretinoin|tretinoin|mesh-list
2800764|NCT04217148|BB 1101|bb 1101|mesh-list
2800765|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2800766|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
2800767|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
2800768|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800769|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800770|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2800771|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
2800772|NCT04217148|Hormones|hormones|mesh-ancestor
2800773|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2800774|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2800775|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800776|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
2800777|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800778|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800779|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
2800780|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
2800784|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
2800785|NCT04216836|Antacids|antacids|mesh-ancestor
2800786|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800787|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2800788|NCT04216953|Atezolizumab|atezolizumab|mesh-list
2800789|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800790|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
2800791|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2800792|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
2800793|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800794|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800795|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2800796|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
2800797|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2800798|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
2800799|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800800|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800801|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2800802|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
2104028|NCT02431260|INCB054329|incb054329|mesh-list
2104029|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104030|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
2104031|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2104032|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
2276857|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2276858|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276859|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276860|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276861|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2276862|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2276863|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2800803|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
2800804|NCT04216927|Protective Agents|protective agents|mesh-ancestor
2800805|NCT04217096|Paclitaxel|paclitaxel|mesh-list
2800806|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2800807|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800808|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
2800809|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
2800810|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
2800811|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800812|NCT04216758|Gemcitabine|gemcitabine|mesh-list
2800813|NCT04216758|Paclitaxel|paclitaxel|mesh-list
2800814|NCT04216758|Tegafur|tegafur|mesh-list
2800815|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2800816|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800817|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
2800818|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
2800819|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
2800820|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800821|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2800822|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
2800823|NCT04216758|Antiviral Agents|antiviral agents|mesh-ancestor
2800824|NCT04216758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2800825|NCT04216758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800826|NCT04216758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2800827|NCT04216758|Immunologic Factors|immunologic factors|mesh-ancestor
2800828|NCT04216758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800829|NCT04216784|Furosemide|furosemide|mesh-list
2800830|NCT04216784|Diuretics|diuretics|mesh-ancestor
2800831|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
2800832|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800833|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2800834|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2800835|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800836|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
2800837|NCT04216706|Sympatholytics|sympatholytics|mesh-list
2800838|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2800839|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800840|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2800841|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800842|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
2800843|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800844|NCT04216797|Diazepam|diazepam|mesh-list
2800845|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2800846|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
2800847|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
2800848|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
2800849|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800850|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800851|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2800852|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2800853|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2800854|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2800855|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2800856|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2104033|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104034|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104035|NCT02431533|Calcium|calcium|mesh-list
2104036|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2104037|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104038|NCT02431559|Doxorubicin|doxorubicin|mesh-list
2800857|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2800858|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2800859|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2800860|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
2800861|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
2800862|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
2800863|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
2800864|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800865|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800866|NCT04216888|Ketamine|ketamine|mesh-list
2800867|NCT04216888|Analgesics|analgesics|mesh-ancestor
2800868|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
2800869|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800870|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800871|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2800872|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2800873|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
2800874|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
2800875|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2800876|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2800877|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2800878|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800879|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800880|NCT04216628|Oxytocin|oxytocin|mesh-list
2800881|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
2800882|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2800883|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276864|NCT00214370|Fentanyl|fentanyl|mesh-list
2276865|NCT00214370|Propofol|propofol|mesh-list
2276866|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2276867|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2276868|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276869|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2276870|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
2276871|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
2276872|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2276873|NCT00214370|Narcotics|narcotics|mesh-ancestor
2276874|NCT00214370|Analgesics|analgesics|mesh-ancestor
2276875|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
2800884|NCT04216693|Digoxin|digoxin|mesh-list
2800885|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2800886|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2800887|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800888|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800889|NCT04216693|Protective Agents|protective agents|mesh-ancestor
2800890|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800891|NCT04216511|Autoantibodies|autoantibodies|mesh-list
2800892|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
2800893|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800894|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
2800895|NCT04216459|Ascorbic Acid|ascorbic acid|mesh-list
2800896|NCT04216459|Thiamine|thiamine|mesh-list
2800897|NCT04216459|Vitamins|vitamins|mesh-ancestor
2800898|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
2800899|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800900|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2800901|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2800902|NCT04216459|Antioxidants|antioxidants|mesh-ancestor
2800903|NCT04216459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800904|NCT04216459|Protective Agents|protective agents|mesh-ancestor
2800905|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
2800906|NCT04216355|Azacitidine|azacitidine|mesh-list
2800907|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2800908|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
2800909|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800910|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800911|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800912|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2800913|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2800914|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2800915|NCT04216771|Cytarabine|cytarabine|mesh-list
2276876|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276877|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2276878|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2800916|NCT04216771|Idarubicin|idarubicin|mesh-list
2800917|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2800918|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
2800919|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800920|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800921|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
2800922|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2800923|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2800924|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
2276879|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
2276880|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2276881|NCT00214552|Rabeprazole|rabeprazole|mesh-list
2276882|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2276883|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2276884|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2276885|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276886|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276887|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2276888|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
2276889|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2276890|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2800925|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800926|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2800927|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2800928|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2800929|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800930|NCT04216550|Apatinib|apatinib|mesh-list
2800931|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800932|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2800933|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800934|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800935|NCT04216472|Paclitaxel|paclitaxel|mesh-list
2800936|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2800937|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
2800938|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2800939|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2800940|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
2800941|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
2800942|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
2800943|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800944|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2800945|NCT04216134|Edetic Acid|edetic acid|mesh-list
2800946|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2800947|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
2800948|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
2800949|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276891|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2276892|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2276893|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276894|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2276895|NCT00214604|Pravastatin|pravastatin|mesh-list
2276896|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2276897|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2276898|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
2276899|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276900|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2276901|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2276902|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276903|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2276904|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2276905|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2276906|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
2276907|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276908|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2276909|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2276910|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276911|NCT00214630|Atorvastatin|atorvastatin|mesh-list
2276912|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2276913|NCT00214630|Calcium|calcium|mesh-list
2276914|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2104039|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2104040|NCT02431559|Durvalumab|durvalumab|mesh-list
2104041|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2104042|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104043|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2104044|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2104045|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104046|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104047|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2800950|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
2800951|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2800952|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2800953|NCT04216043|Caseins|caseins|mesh-list
2800954|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
2800955|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
2800956|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800957|NCT04216186|Ubiquinone|ubiquinone|mesh-list
2800958|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
2800959|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2276915|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276916|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2276917|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2276918|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
2276919|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276920|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2276921|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2276922|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276923|NCT00214643|Clindamycin|clindamycin|mesh-list
2276924|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
2276925|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
2276926|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
2276927|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2800960|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2800961|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2800962|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2276928|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2276929|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2276930|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276931|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276932|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
2276933|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
2800963|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800964|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
2800965|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2800966|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800967|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
2800968|NCT04216186|Vitamins|vitamins|mesh-ancestor
2800969|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2800970|NCT04216017|Lidocaine|lidocaine|mesh-list
2800971|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
2800972|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
2800973|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2800974|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2800975|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
2800976|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2800977|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2800978|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2800979|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2800980|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2800981|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800982|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2800983|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
2800984|NCT04216017|Hormones|hormones|mesh-ancestor
2800985|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2800986|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2800987|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
2800988|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
2800989|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2800990|NCT04215653|Rabeprazole|rabeprazole|mesh-list
2800991|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2800992|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2276934|NCT00214682|Vitamins|vitamins|mesh-ancestor
2800993|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2800994|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104048|NCT02431572|Vaccines|vaccines|mesh-list
2800995|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2800996|NCT04215731|Leucovorin|leucovorin|mesh-list
2800997|NCT04215731|Bevacizumab|bevacizumab|mesh-list
2800998|NCT04215731|Fluorouracil|fluorouracil|mesh-list
2800999|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
2801000|NCT04215731|Irinotecan|irinotecan|mesh-list
2801001|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
2801002|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2801003|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801004|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2801005|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2801006|NCT04215731|Growth Substances|growth substances|mesh-ancestor
2801007|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801008|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
2801009|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
2801010|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801011|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2801012|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2801013|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
2801014|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2801015|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2801016|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801017|NCT04215731|Antidotes|antidotes|mesh-ancestor
2801018|NCT04215731|Protective Agents|protective agents|mesh-ancestor
2801019|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
2801020|NCT04215731|Vitamins|vitamins|mesh-ancestor
2801021|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
2801022|NCT04215614|Lidocaine|lidocaine|mesh-list
2801023|NCT04215614|Bupivacaine|bupivacaine|mesh-list
2801024|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
2801025|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
2801026|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801027|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801028|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
2276935|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
2276936|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276937|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
2276938|NCT00214682|Hematinics|hematinics|mesh-ancestor
2276939|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
2276940|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2276941|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
2276942|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2276943|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2276944|NCT00214825|Eplerenone|eplerenone|mesh-list
2276945|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2276946|NCT00214825|Diuretics|diuretics|mesh-ancestor
2276947|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
2276948|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276949|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2276950|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2276951|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276952|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2276953|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
2276954|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2801029|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801030|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2801031|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2801032|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2801033|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2801034|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801035|NCT04215588|Hemostatics|hemostatics|mesh-list
2801036|NCT04215588|Coagulants|coagulants|mesh-ancestor
2801037|NCT04215835|Letrozole|letrozole|mesh-list
2801038|NCT04215835|Misoprostol|misoprostol|mesh-list
2801039|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801040|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2801041|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2801042|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801043|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801044|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2801045|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
2801046|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2801047|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801048|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2801049|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
2276955|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2276956|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2276957|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2801050|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2801051|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2801052|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2801053|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
2801054|NCT04215770|Penicillins|penicillins|mesh-list
2801055|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2801056|NCT04215770|Penicillin G|penicillin g|mesh-list
2801057|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2801058|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
2801059|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2801060|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801061|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2801062|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801063|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801064|NCT04215536|Empagliflozin|empagliflozin|mesh-list
2801065|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2801066|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2801067|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801068|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2801069|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801070|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
2801071|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801072|NCT04215471|Antibodies|antibodies|mesh-list
2801073|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
2801074|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
2801075|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801076|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2801077|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2801078|NCT04215159|Gemcitabine|gemcitabine|mesh-list
2801079|NCT04215159|Trastuzumab|trastuzumab|mesh-list
2801080|NCT04215159|Irinotecan|irinotecan|mesh-list
2801081|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2801082|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
2801083|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276958|NCT00214864|Docetaxel|docetaxel|mesh-list
2276959|NCT00214864|Capecitabine|capecitabine|mesh-list
2276960|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2276961|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
2276962|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
2276963|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
2276964|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276965|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2276966|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
2276967|NCT00214877|Methylene Blue|methylene blue|mesh-list
2276968|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2276969|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276970|NCT00214916|Insulin|insulin|mesh-list
2276971|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2276972|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2276973|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276974|NCT00214942|Fentanyl|fentanyl|mesh-list
2276975|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2276976|NCT00214942|Narcotics|narcotics|mesh-ancestor
2276977|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2276978|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276979|NCT00214942|Analgesics|analgesics|mesh-ancestor
2801084|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801085|NCT04215159|Antiviral Agents|antiviral agents|mesh-ancestor
2801086|NCT04215159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801087|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801088|NCT04215159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2801089|NCT04215159|Immunologic Factors|immunologic factors|mesh-ancestor
2801090|NCT04215159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801091|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2801092|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2801093|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2801094|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
2801095|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2801096|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2801097|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2276980|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
2276981|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801098|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2801099|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801100|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
2801101|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801102|NCT04215445|Empagliflozin|empagliflozin|mesh-list
2801103|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2801104|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801105|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2801106|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801107|NCT04215432|Propolis|propolis|mesh-list
2801108|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801109|NCT04215237|Atorvastatin|atorvastatin|mesh-list
2801110|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2801111|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2801112|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
2801113|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801114|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2801115|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2801116|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801117|NCT04214938|Lidocaine|lidocaine|mesh-list
2801118|NCT04214938|Xylometazoline|xylometazoline|mesh-list
2801119|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
2801120|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
2801121|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801122|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801123|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
2801124|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801125|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2801126|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2801127|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2104049|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
2104050|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104051|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2104052|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
2104053|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
2801128|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2801129|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801130|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
2801131|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2801132|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
2801133|NCT04214990|Aspirin|aspirin|mesh-list
2801134|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2801135|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2801136|NCT04214990|Analgesics|analgesics|mesh-ancestor
2801137|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
2801138|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801139|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801140|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2801141|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2801142|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2801143|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2801144|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801145|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2801146|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2801147|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801148|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
2801149|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
2801150|NCT04214886|Fludarabine|fludarabine|mesh-list
2801151|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2801152|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
2801153|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801154|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2801155|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2801156|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
2801157|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801158|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801159|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2801160|NCT04214977|Anesthetics|anesthetics|mesh-list
2801161|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801162|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801170|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
2801171|NCT04214821|Levofloxacin|levofloxacin|mesh-list
2801172|NCT04214821|Ofloxacin|ofloxacin|mesh-list
2801173|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2801174|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2801175|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2801176|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801177|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2801178|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2801179|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801180|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801181|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801182|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2801183|NCT04214821|Renal Agents|renal agents|mesh-ancestor
2801184|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2801185|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2801186|NCT04214808|Dutasteride|dutasteride|mesh-list
2801187|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2801188|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2801189|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801190|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801191|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
2801192|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2276982|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2276983|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2276984|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
2276985|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
2801193|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276986|NCT00214955|Fentanyl|fentanyl|mesh-list
2276987|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2276988|NCT00214955|Narcotics|narcotics|mesh-ancestor
2276989|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2276990|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2276991|NCT00214955|Analgesics|analgesics|mesh-ancestor
2276992|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
2276993|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2276994|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2801194|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
2801195|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
2801196|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801197|NCT04214665|Protective Agents|protective agents|mesh-ancestor
2801198|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801199|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
2801200|NCT04214665|Vitamins|vitamins|mesh-ancestor
2801201|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
2801202|NCT04214834|Morphine|morphine|mesh-list
2801203|NCT04214834|Methadone|methadone|mesh-list
2801204|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2801205|NCT04214834|Narcotics|narcotics|mesh-ancestor
2801206|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801207|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801208|NCT04214834|Analgesics|analgesics|mesh-ancestor
2801209|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
2801210|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801211|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
2801212|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
2801213|NCT04214691|Acetaminophen|acetaminophen|mesh-list
2801214|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2801215|NCT04214691|Analgesics|analgesics|mesh-ancestor
2801216|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
2801217|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801218|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801219|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
2801220|NCT04214626|Prednisone|prednisone|mesh-list
2801221|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
2801222|NCT04214626|Rituximab|rituximab|mesh-list
2801223|NCT04214626|Methotrexate|methotrexate|mesh-list
2801224|NCT04214626|Vincristine|vincristine|mesh-list
2801225|NCT04214626|Lenalidomide|lenalidomide|mesh-list
2801226|NCT04214626|Epirubicin|epirubicin|mesh-list
2801227|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2276995|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2276996|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
2276997|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
2801228|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
2801229|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801230|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2801231|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2801232|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
2801233|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801234|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801235|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2801236|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2801237|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2801238|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
2801239|NCT04214626|Hormones|hormones|mesh-ancestor
2801240|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2276998|NCT00214968|Modafinil|modafinil|mesh-list
2276999|NCT00214968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2277000|NCT00214968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277001|NCT00214968|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2277002|NCT00214968|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2277003|NCT00214968|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2277004|NCT00214968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277005|NCT00214981|Modafinil|modafinil|mesh-list
2277006|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2801241|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2801242|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2801243|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
2801244|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2801245|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2801246|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
2801247|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
2801248|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801249|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2801250|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2801251|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2801252|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
2801253|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
2801254|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
2801255|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2801256|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2801257|NCT04214626|Growth Substances|growth substances|mesh-ancestor
2801258|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
2801259|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2801260|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2801261|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2801262|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2801263|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2801264|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
2801265|NCT04214678|Hormones|hormones|mesh-ancestor
2801266|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2801267|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801268|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2801269|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801270|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2801271|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2104054|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104055|NCT02431637|Piperaquine|piperaquine|mesh-list
2104056|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
2104057|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2104058|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2104059|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104060|NCT02431650|Primaquine|primaquine|mesh-list
2104061|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
2104062|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2104063|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2104064|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801272|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801273|NCT04214145|Phenylephrine|phenylephrine|mesh-list
2801274|NCT04214145|Vasopressins|vasopressins|mesh-list
2801275|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
2801276|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
2801277|NCT04214145|Norepinephrine|norepinephrine|mesh-list
2801278|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2801279|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
2801280|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
2801281|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801282|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801283|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
2801284|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2801285|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
2801286|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
2277007|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277008|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2277009|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2277010|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2277011|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801287|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2104065|NCT02431676|Metformin|metformin|mesh-list
2104066|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2801288|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2801289|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2801290|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
2801291|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2801292|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801293|NCT04214145|Protective Agents|protective agents|mesh-ancestor
2801294|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
2801295|NCT04214145|Coagulants|coagulants|mesh-ancestor
2801296|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2801297|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
2801298|NCT04214444|Vaccines|vaccines|mesh-list
2801299|NCT04214444|Immunologic Factors|immunologic factors|mesh-ancestor
2801300|NCT04214444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801301|NCT04214106|Thiamine|thiamine|mesh-list
2801302|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
2801303|NCT04214106|Vitamins|vitamins|mesh-ancestor
2801304|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
2801305|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801306|NCT04213924|Ibuprofen|ibuprofen|mesh-list
2801307|NCT04213924|Lidocaine|lidocaine|mesh-list
2801308|NCT04213924|Bupivacaine|bupivacaine|mesh-list
2801309|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
2801310|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
2801311|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801312|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801313|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
2801314|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801315|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2801316|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2801317|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2801318|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2801319|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801320|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2801321|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2801322|NCT04213924|Analgesics|analgesics|mesh-ancestor
2801323|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2801324|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2801325|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2801326|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801327|NCT04213937|Paclitaxel|paclitaxel|mesh-list
2801328|NCT04213937|Topotecan|topotecan|mesh-list
2801329|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2801330|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801331|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
2801332|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
2801333|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
2801334|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801335|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2801336|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2801337|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801338|NCT04214054|Calcium|calcium|mesh-list
2801339|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2801340|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801341|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
2801342|NCT04213794|Cisplatin|cisplatin|mesh-list
2801343|NCT04213794|Doxorubicin|doxorubicin|mesh-list
2801344|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2801345|NCT04213794|Daunorubicin|daunorubicin|mesh-list
2801346|NCT04213794|Antidotes|antidotes|mesh-list
2801347|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801348|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2801349|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2801350|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2801351|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801352|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801353|NCT04213794|Protective Agents|protective agents|mesh-ancestor
2801354|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801355|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
2801356|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
2801357|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2801358|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801359|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
2801360|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
2801361|NCT04213898|Paclitaxel|paclitaxel|mesh-list
2801362|NCT04213898|Epirubicin|epirubicin|mesh-list
2277012|NCT00214994|Tiagabine|tiagabine|mesh-list
2277013|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
2277014|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
2277015|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2277016|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2277017|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277018|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
2277019|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277020|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277021|NCT00215007|Levofloxacin|levofloxacin|mesh-list
2277022|NCT00215007|Ofloxacin|ofloxacin|mesh-list
2277023|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2277024|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277025|NCT00215007|Renal Agents|renal agents|mesh-ancestor
2277026|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2277027|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2277028|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2277029|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277030|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277031|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277032|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2277033|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2277034|NCT00215046|Methotrexate|methotrexate|mesh-list
2277035|NCT00215046|Vinblastine|vinblastine|mesh-list
2801363|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2801364|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2801365|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801366|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
2277036|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2277037|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
2801367|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
2801368|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
2801369|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801370|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2801371|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2801372|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2801373|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801374|NCT04213833|Lidocaine|lidocaine|mesh-list
2801375|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
2801376|NCT04213833|Propofol|propofol|mesh-list
2801377|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
2801378|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
2801379|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801380|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801381|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
2801382|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801383|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2801384|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2801385|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2801386|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2801387|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801388|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2801389|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2801390|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
2801391|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2801392|NCT04213833|Analgesics|analgesics|mesh-ancestor
2801393|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2801394|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2801395|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2801396|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
2801397|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2801398|NCT04213781|Sufentanil|sufentanil|mesh-list
2801399|NCT04213781|Propofol|propofol|mesh-list
2801400|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2801401|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801402|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801403|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2801404|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
2801405|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
2801406|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2801407|NCT04213781|Narcotics|narcotics|mesh-ancestor
2801408|NCT04213781|Analgesics|analgesics|mesh-ancestor
2801409|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
2801410|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801411|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2801412|NCT04213885|Riboflavin|riboflavin|mesh-list
2801413|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
2801414|NCT04213885|Vitamins|vitamins|mesh-ancestor
2801415|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
2801416|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801417|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2801418|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
2801419|NCT04213378|Paclitaxel|paclitaxel|mesh-list
2801420|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2801421|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2801422|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801423|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
2801424|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
2801425|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
2801426|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801427|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
2801428|NCT04213716|Calcium|calcium|mesh-list
2801429|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2801430|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801431|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2801432|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
2801433|NCT04213612|Doxorubicin|doxorubicin|mesh-list
2801434|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2801435|NCT04213612|Vincristine|vincristine|mesh-list
2801436|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2801437|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
2801438|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801439|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2801440|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2801441|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
2801442|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801443|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801444|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2801445|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2801446|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2801447|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2801448|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801449|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2801450|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
2801451|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
2801452|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
2801453|NCT04213495|Anesthetics|anesthetics|mesh-list
2801454|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801455|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801456|NCT04213170|Bevacizumab|bevacizumab|mesh-list
2801457|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2801458|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801459|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2801460|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2801461|NCT04213170|Growth Substances|growth substances|mesh-ancestor
2801462|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801463|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
2801464|NCT04213404|Spartalizumab|spartalizumab|mesh-list
2801465|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2801466|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801467|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801468|NCT04213573|Fluorides|fluorides|mesh-list
2801469|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
2801470|NCT04213573|Protective Agents|protective agents|mesh-ancestor
2801471|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801472|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2801473|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801474|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2801475|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2801476|NCT04213287|Analgesics|analgesics|mesh-ancestor
2801477|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
2801478|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801479|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2801480|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2801481|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2801482|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2801483|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277038|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2277039|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277040|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2277041|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
2277042|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277043|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277044|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
2277045|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277046|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2277047|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2277048|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
2277049|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2277050|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2277051|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2277052|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
2277053|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
2277054|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
2277055|NCT00215124|Lenograstim|lenograstim|mesh-list
2277056|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2277057|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
2277058|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277059|NCT00215163|Paroxetine|paroxetine|mesh-list
2277060|NCT00215163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2277061|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2277062|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2277063|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277064|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277065|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
2277066|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277067|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2277068|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
2277069|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2277070|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2277071|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2277072|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277073|NCT00215176|Modafinil|modafinil|mesh-list
2277074|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2277075|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277076|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2277077|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2277078|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2277079|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801484|NCT04213391|Sulforaphane|sulforaphane|mesh-list
2801485|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2801486|NCT04213391|Protective Agents|protective agents|mesh-ancestor
2801487|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801488|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801489|NCT04213222|Bevacizumab|bevacizumab|mesh-list
2801490|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2801491|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801492|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2801493|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2801494|NCT04213222|Growth Substances|growth substances|mesh-ancestor
2801495|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801496|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
2801497|NCT04213105|Denosumab|denosumab|mesh-list
2801498|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2801499|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801500|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
2801501|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2801502|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801503|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2801504|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801505|NCT04212793|Bevacizumab|bevacizumab|mesh-list
2801506|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2801507|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801508|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2801509|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2801510|NCT04212793|Growth Substances|growth substances|mesh-ancestor
2801511|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801512|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
2801513|NCT04212832|Bupivacaine|bupivacaine|mesh-list
2801514|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
2801515|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
2801516|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801517|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801518|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
2801519|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801520|NCT04212845|Dexamethasone|dexamethasone|mesh-list
2801521|NCT04212845|Bupivacaine|bupivacaine|mesh-list
2801522|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2801523|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
2801524|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
2801525|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801526|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801527|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2801528|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
2801529|NCT04212845|Hormones|hormones|mesh-ancestor
2801530|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2801531|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2801532|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801533|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
2801534|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
2801535|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801536|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
2801537|NCT04212702|Everolimus|everolimus|mesh-list
2801538|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801539|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2801540|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
2801541|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801542|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
2801543|NCT04212429|Levofloxacin|levofloxacin|mesh-list
2801544|NCT04212429|Ofloxacin|ofloxacin|mesh-list
2801545|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2801546|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2801547|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2801548|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801549|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2801550|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2801551|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801552|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801553|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277080|NCT00215202|Gefitinib|gefitinib|mesh-list
2277081|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277082|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2277083|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277084|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277085|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2277086|NCT00215228|Citalopram|citalopram|mesh-list
2277087|NCT00215228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2277088|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2277089|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2277090|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801554|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2801555|NCT04212429|Renal Agents|renal agents|mesh-ancestor
2801556|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2801557|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2801558|NCT04212416|Leflunomide|leflunomide|mesh-list
2801559|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801560|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801561|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2801562|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
2801563|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801564|NCT04212650|Losartan|losartan|mesh-list
2801565|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2801566|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2801567|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2801568|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2801569|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801570|NCT04212403|Levofloxacin|levofloxacin|mesh-list
2801571|NCT04212403|Ofloxacin|ofloxacin|mesh-list
2801572|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2801573|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801574|NCT04212403|Renal Agents|renal agents|mesh-ancestor
2801575|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2801576|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2801577|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2801578|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801579|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801580|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801581|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2801582|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2801583|NCT04212533|Vitamin D|vitamin d|mesh-list
2801584|NCT04212533|Vitamins|vitamins|mesh-ancestor
2801585|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
2277091|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277092|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
2277093|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801586|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801587|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2277094|NCT00215228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2277095|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
2277096|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2277097|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277098|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2277099|NCT00215228|Analgesics|analgesics|mesh-ancestor
2277100|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
2277101|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
2277102|NCT00215241|Risperidone|risperidone|mesh-list
2277103|NCT00215241|Sertraline|sertraline|mesh-list
2801593|NCT04211896|Nivolumab|nivolumab|mesh-list
2801594|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2801595|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801596|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2801597|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801598|NCT04212026|Nivolumab|nivolumab|mesh-list
2277104|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2277105|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
2277106|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277107|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277108|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277109|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2277110|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2277111|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2277112|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2277113|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2277114|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
2277115|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
2277116|NCT00215241|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2277117|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2277118|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2277119|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2277120|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
2277121|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2277122|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2277123|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2277124|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2277125|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277126|NCT00215267|Praziquantel|praziquantel|mesh-list
2277127|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
2277128|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2801599|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2801600|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801601|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2801602|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801603|NCT04212039|Bupivacaine|bupivacaine|mesh-list
2801604|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
2801605|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
2801606|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801607|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801608|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
2801609|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801610|NCT04212078|Levofloxacin|levofloxacin|mesh-list
2801611|NCT04212078|Ofloxacin|ofloxacin|mesh-list
2801612|NCT04212078|Cefuroxime|cefuroxime|mesh-list
2801613|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
2801614|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2801615|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801616|NCT04212078|Renal Agents|renal agents|mesh-ancestor
2801617|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2801618|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2801619|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2801620|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801621|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801622|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801623|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2801624|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2801625|NCT04211961|Scopolamine|scopolamine|mesh-list
2801626|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2801627|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2801628|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
2801629|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
2801630|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801631|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801632|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2801633|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
2801634|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2801635|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
2801636|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2801637|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801638|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2277129|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277130|NCT00215280|Ivermectin|ivermectin|mesh-list
2277131|NCT00215280|Albendazole|albendazole|mesh-list
2277132|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2277133|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277134|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
2277135|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
2277136|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2277137|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2277138|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
2277139|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
2277140|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
2277141|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277142|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277143|NCT00215345|Celecoxib|celecoxib|mesh-list
2277144|NCT00215345|Docetaxel|docetaxel|mesh-list
2277145|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277146|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
2277147|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
2277148|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
2277149|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277150|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2277151|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2277152|NCT00215345|Analgesics|analgesics|mesh-ancestor
2277153|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
2277154|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277155|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277156|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2277157|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2277158|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2277159|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2277160|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277161|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
2277162|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2277163|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
2277164|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277165|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277166|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2277167|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
2277168|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2277169|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2277170|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2277171|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
2277172|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277173|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277174|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
2277175|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2277176|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
2277177|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801639|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
2801640|NCT04211987|Cytarabine|cytarabine|mesh-list
2801641|NCT04211987|Methotrexate|methotrexate|mesh-list
2801642|NCT04211987|Etoposide|etoposide|mesh-list
2801643|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2801644|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
2801645|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801646|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801647|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
2801648|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801649|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2801650|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
2801651|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801652|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2801653|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2801654|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2801655|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801656|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2801657|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
2801658|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2801659|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
2801660|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2801661|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2801662|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2277178|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277179|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2801663|NCT04212065|Buprenorphine|buprenorphine|mesh-list
2801664|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2801665|NCT04212065|Narcotics|narcotics|mesh-ancestor
2801666|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801667|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801668|NCT04212065|Analgesics|analgesics|mesh-ancestor
2801669|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
2801670|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801671|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2801672|NCT04212000|Ketoconazole|ketoconazole|mesh-list
2801673|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
2801674|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801675|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2801676|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2801677|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801678|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801679|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2801680|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
2801681|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2801682|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801683|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2801684|NCT04211805|Tenofovir|tenofovir|mesh-list
2801685|NCT04211805|Vaccines|vaccines|mesh-list
2801686|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
2801687|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801688|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
2801689|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801690|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2801691|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2801692|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801693|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801694|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2801695|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2277180|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
2277181|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2277182|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2277183|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2277184|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
2277185|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277186|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277187|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
2277188|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2277189|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
2277190|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277191|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277192|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2277193|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
2277194|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2277195|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2277196|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2277197|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
2277198|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277199|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277200|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
2277201|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2277202|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
2277203|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277204|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277205|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2801696|NCT04211558|Ozanimod|ozanimod|mesh-list
2801697|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2801698|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801699|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2801700|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
2801701|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801702|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
2801703|NCT04211844|Ledipasvir|ledipasvir|mesh-list
2801704|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
2801705|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801706|NCT04211545|Rabeprazole|rabeprazole|mesh-list
2801707|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2801708|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2801709|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2801710|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801711|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801712|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
2801713|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2801714|NCT04211272|Macitentan|macitentan|mesh-list
2801715|NCT04211272|Riociguat|riociguat|mesh-list
2801716|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2801717|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2801718|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
2801719|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801720|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2801721|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2801722|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801723|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
2801724|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2801725|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2801726|NCT04211272|Urological Agents|urological agents|mesh-ancestor
2801727|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2801728|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2801729|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2801730|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
2277206|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
2277207|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2277208|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2277209|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2277210|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
2277211|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277212|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277213|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
2277214|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2277215|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
2277216|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277217|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277218|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2277219|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
2277220|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2277221|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2277222|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2277223|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
2277224|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277225|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277226|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
2277227|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2277228|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
2277229|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277230|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277231|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2277232|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
2277233|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2277234|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2277235|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2277236|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
2277237|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277238|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277239|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
2277240|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2277241|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
2277242|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277243|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277244|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2277245|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
2277246|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2277247|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2277248|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2277249|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
2277250|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277251|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277252|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
2277253|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2277254|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
2801744|NCT04211259|Loratadine|loratadine|mesh-list
2801745|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
2801746|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
2801747|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2801748|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2801749|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2801750|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
2801751|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
2801752|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2801753|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801754|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801755|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
2801756|NCT04211298|Propofol|propofol|mesh-list
2801757|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2801758|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801759|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801760|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2801761|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
2801762|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
2801763|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2801764|NCT04211298|Analgesics|analgesics|mesh-ancestor
2801765|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
2801766|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801767|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2801768|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2801769|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2801770|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
2801771|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2801772|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801773|NCT04211012|Paclitaxel|paclitaxel|mesh-list
2801774|NCT04211012|Cisplatin|cisplatin|mesh-list
2801775|NCT04211012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2801776|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2801777|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801778|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
2801779|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
2801780|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
2801781|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801782|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
2801783|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2801784|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801785|NCT04211168|Lenvatinib|lenvatinib|mesh-list
2801786|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801787|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2801788|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801789|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801790|NCT04211090|Carboplatin|carboplatin|mesh-list
2801791|NCT04211090|Pemetrexed|pemetrexed|mesh-list
2801792|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801793|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277255|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277256|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277257|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2277258|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
2277259|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2277260|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2277261|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2277262|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
2277263|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277264|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277265|NCT00215462|Vinorelbine|vinorelbine|mesh-list
2277266|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2277267|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277268|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
2277269|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
2277270|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
2277271|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277272|NCT00215501|Fluorouracil|fluorouracil|mesh-list
2277273|NCT00215501|Capecitabine|capecitabine|mesh-list
2277274|NCT00215501|Irinotecan|irinotecan|mesh-list
2277275|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277276|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
2277277|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277278|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2277279|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2277280|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
2277281|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277282|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2277283|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2277284|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277285|NCT00215514|Fluorouracil|fluorouracil|mesh-list
2277286|NCT00215514|Epirubicin|epirubicin|mesh-list
2277287|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277288|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
2277289|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277290|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2277291|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2277292|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
2277293|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277294|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2277295|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2277296|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2277297|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277298|NCT00215579|Risperidone|risperidone|mesh-list
2277299|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2277300|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
2277301|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277302|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277303|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277304|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2277305|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2277306|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2277307|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2801794|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801795|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2801796|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2801797|NCT04210713|Minocycline|minocycline|mesh-list
2801798|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2801799|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801800|NCT04210739|Betamethasone|betamethasone|mesh-list
2801801|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
2801802|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2801803|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
2801804|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2801805|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
2801806|NCT04210739|Hormones|hormones|mesh-ancestor
2801807|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2801808|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801809|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2801810|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2801811|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
2801812|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
2801813|NCT04210505|Povidone|povidone|mesh-list
2801814|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
2801815|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
2801816|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2801817|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801818|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2801819|NCT04210427|Laxatives|laxatives|mesh-ancestor
2801820|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2801821|NCT04210453|Ascorbic Acid|ascorbic acid|mesh-list
2801822|NCT04210453|Vitamins|vitamins|mesh-ancestor
2801823|NCT04210453|Micronutrients|micronutrients|mesh-ancestor
2801824|NCT04210453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801825|NCT04210453|Antioxidants|antioxidants|mesh-ancestor
2801826|NCT04210453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801827|NCT04210453|Protective Agents|protective agents|mesh-ancestor
2801828|NCT04210765|Clomiphene|clomiphene|mesh-list
2801829|NCT04210765|Enclomiphene|enclomiphene|mesh-list
2801830|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
2801831|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2801832|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
2801833|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2277308|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2277309|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
2277310|NCT00215592|Zonisamide|zonisamide|mesh-list
2277311|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
2277312|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2277313|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2277314|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277315|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2277316|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277317|NCT00215631|Tadalafil|tadalafil|mesh-list
2277318|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
2801834|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801835|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2801836|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
2801837|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2801838|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2801839|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2277319|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2277320|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2277321|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277322|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277323|NCT00215631|Urological Agents|urological agents|mesh-ancestor
2277324|NCT00215709|Docetaxel|docetaxel|mesh-list
2277325|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277326|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
2277327|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
2277328|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
2277329|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277330|NCT00215722|Cetuximab|cetuximab|mesh-list
2277331|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2277332|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277333|NCT00215748|Dexamethasone|dexamethasone|mesh-list
2277334|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2277335|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
2277336|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
2277337|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277338|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277339|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2277340|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
2277341|NCT00215748|Hormones|hormones|mesh-ancestor
2801840|NCT04210544|Caseins|caseins|mesh-list
2801841|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
2801842|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
2801843|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801844|NCT04210180|Varenicline|varenicline|mesh-list
2801845|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2801846|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2801847|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
2801848|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2801849|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277342|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2277343|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2277344|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277345|NCT00215774|Flecainide|flecainide|mesh-list
2277346|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2277347|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2277348|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2277349|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2277350|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277351|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2277352|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
2277353|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277354|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2277355|NCT00215813|Poly I-C|poly i-c|mesh-list
2277356|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
2801850|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801851|NCT04210310|Oxytocin|oxytocin|mesh-list
2801852|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
2801853|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2277357|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277358|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
2801854|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801855|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
2801856|NCT04209933|Bismuth|bismuth|mesh-list
2801857|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801858|NCT04209933|Antacids|antacids|mesh-ancestor
2801859|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2801860|NCT04209933|Diuretics|diuretics|mesh-ancestor
2801861|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
2801862|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801863|NCT04209933|Expectorants|expectorants|mesh-ancestor
2104067|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801864|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
2801865|NCT04209920|Chromium|chromium|mesh-list
2801866|NCT04209920|Nickel|nickel|mesh-list
2801867|NCT04209920|Trace Elements|trace elements|mesh-ancestor
2801868|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
2801869|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801870|NCT04209699|BMS-986165|bms-986165|mesh-list
2801871|NCT04209699|Famotidine|famotidine|mesh-list
2801872|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2801873|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2801874|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2801875|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
2801876|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
2801877|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2801878|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801879|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801880|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
2801881|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2801882|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801883|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2801884|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801885|NCT04209959|Nifekalant|nifekalant|mesh-list
2801886|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2801895|NCT04209803|Minoxidil|minoxidil|mesh-list
2801896|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2277359|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
2801897|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
2801898|NCT04209595|Rucaparib|rucaparib|mesh-list
2801899|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2277360|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277361|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
2277362|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
2277363|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277364|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
2277365|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277366|NCT00215839|Ribavirin|ribavirin|mesh-list
2277367|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
2801900|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801901|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801902|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801903|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2801904|NCT04209439|Bupivacaine|bupivacaine|mesh-list
2801905|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
2801906|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
2801907|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801908|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801909|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
2801910|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277368|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277369|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
2277370|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277371|NCT00215852|Interferon-alpha|interferon-alpha|mesh-list
2277372|NCT00215852|Antiviral Agents|antiviral agents|mesh-ancestor
2277373|NCT00215852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2801911|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2801912|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2801913|NCT04209439|Analgesics|analgesics|mesh-ancestor
2801914|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2801915|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2801916|NCT04209478|Morphine|morphine|mesh-list
2801917|NCT04209478|Tramadol|tramadol|mesh-list
2801918|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2801919|NCT04209478|Narcotics|narcotics|mesh-ancestor
2801920|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801921|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801922|NCT04209478|Analgesics|analgesics|mesh-ancestor
2801923|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
2801924|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801932|NCT04209686|Paclitaxel|paclitaxel|mesh-list
2801933|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
2801934|NCT04209686|Olaparib|olaparib|mesh-list
2801935|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2801936|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801937|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
2801938|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
2801939|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
2801940|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801941|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2801942|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2801943|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801944|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
2801945|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
2801946|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2801947|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801948|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801949|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
2801950|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2801951|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801952|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801953|NCT04209296|Ketamine|ketamine|mesh-list
2801954|NCT04209296|Analgesics|analgesics|mesh-ancestor
2801955|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
2801956|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277374|NCT00215852|Immunologic Factors|immunologic factors|mesh-ancestor
2801957|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801958|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2801959|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2801960|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
2801961|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
2277375|NCT00215852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277376|NCT00215865|Ribavirin|ribavirin|mesh-list
2277377|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2277378|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
2277379|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277380|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
2277381|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277382|NCT00215891|Interferons|interferons|mesh-list
2277383|NCT00215891|Ribavirin|ribavirin|mesh-list
2277384|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277385|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
2277386|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277387|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
2277388|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277389|NCT00215956|Topotecan|topotecan|mesh-list
2277390|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2277391|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2277392|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277393|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277394|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277395|NCT00215982|Capecitabine|capecitabine|mesh-list
2277396|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
2277397|NCT00215982|Irinotecan|irinotecan|mesh-list
2277398|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2277399|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
2277400|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277401|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277402|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2277403|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2277404|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277405|NCT00215995|Cisplatin|cisplatin|mesh-list
2277406|NCT00215995|Irinotecan|irinotecan|mesh-list
2277407|NCT00215995|Gefitinib|gefitinib|mesh-list
2277408|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277409|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2277410|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2277411|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277412|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277413|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2277414|NCT00216008|Docetaxel|docetaxel|mesh-list
2277415|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277416|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
2801962|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2801963|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2801964|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2801965|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2801966|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801967|NCT04209426|Tacrine|tacrine|mesh-list
2801968|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2801969|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2801970|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801971|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
2801972|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2801973|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801974|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2801975|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
2801976|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801977|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
2801978|NCT04209218|Dexamethasone|dexamethasone|mesh-list
2801979|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
2801980|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2801981|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
2801982|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
2801983|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2801984|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2801985|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2801986|NCT04209218|Hormones|hormones|mesh-ancestor
2277417|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
2277418|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
2277419|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2801987|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2801988|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2801989|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2801990|NCT04209166|Norepinephrine|norepinephrine|mesh-list
2801991|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2801992|NCT04209166|Serotonin|serotonin|mesh-list
2801993|NCT04209166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2801994|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
2801995|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
2801996|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2801997|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2801998|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2801999|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802000|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802001|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2802002|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2277420|NCT00216021|Capecitabine|capecitabine|mesh-list
2277421|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
2277422|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2277423|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
2277424|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277425|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802003|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
2802004|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802005|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802006|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
2802007|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
2802008|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802009|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2802010|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2802011|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
2802012|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2802013|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2802014|NCT04209075|Metformin|metformin|mesh-list
2802015|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2802016|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802017|NCT04209192|Amikacin|amikacin|mesh-list
2802018|NCT04209192|Fosfomycin|fosfomycin|mesh-list
2802019|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2802020|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802021|NCT04208997|Amiodarone|amiodarone|mesh-list
2802022|NCT04208997|Sotalol|sotalol|mesh-list
2802023|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2802024|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
2802025|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2802026|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2802027|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802028|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2802029|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2802030|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2802031|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802032|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2802033|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2802034|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2802035|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2802036|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2802037|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
2802038|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802039|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802040|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
2802041|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
2802042|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802043|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
2802044|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802045|NCT04208854|Vinorelbine|vinorelbine|mesh-list
2802046|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2802047|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802048|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
2802049|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
2802050|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
2802051|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802052|NCT04208776|Propranolol|propranolol|mesh-list
2802053|NCT04208776|Midodrine|midodrine|mesh-list
2802054|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2802055|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2277426|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
2277427|NCT00216034|Tegafur|tegafur|mesh-list
2277428|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2277429|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
2277430|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277431|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277432|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2277433|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
2277434|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802056|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
2802057|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802058|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802059|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802060|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2802061|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2802062|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
2802063|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
2802064|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
2802065|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802066|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2802067|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2802068|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2802069|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2802070|NCT04208945|Colistin|colistin|mesh-list
2802071|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2802072|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802073|NCT04208958|Vancomycin|vancomycin|mesh-list
2802074|NCT04208958|Nivolumab|nivolumab|mesh-list
2802075|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2802076|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802077|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2802078|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802079|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2802080|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802081|NCT04208594|Propranolol|propranolol|mesh-list
2802082|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2802083|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2802084|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
2802085|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802086|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802087|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802088|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2802089|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2802090|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
2802091|NCT04208555|Terconazole|terconazole|mesh-list
2802092|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
2802093|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802094|NCT04208763|Imipenem|imipenem|mesh-list
2802095|NCT04208763|Colistin|colistin|mesh-list
2802096|NCT04208763|Tigecycline|tigecycline|mesh-list
2802097|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2802098|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802099|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2802100|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802101|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277435|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2277436|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
2277437|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277438|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
2277439|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2277440|NCT00216034|Protective Agents|protective agents|mesh-ancestor
2277441|NCT00216047|Trastuzumab|trastuzumab|mesh-list
2277442|NCT00216047|Vatalanib|vatalanib|mesh-list
2277443|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2277444|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277445|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2277446|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802102|NCT04208373|Itraconazole|itraconazole|mesh-list
2277447|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277448|NCT00216073|Capecitabine|capecitabine|mesh-list
2277449|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
2277450|NCT00216073|Trastuzumab|trastuzumab|mesh-list
2277451|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2277452|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
2277453|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277454|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277455|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2277456|NCT00216112|Docetaxel|docetaxel|mesh-list
2277457|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
2277458|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277459|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
2277460|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
2277461|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
2277462|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277463|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2277464|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277465|NCT00216138|Docetaxel|docetaxel|mesh-list
2277466|NCT00216138|Capecitabine|capecitabine|mesh-list
2277467|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277468|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
2277469|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
2277470|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
2277471|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277472|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2277473|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
2277474|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
2277475|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2802103|NCT04208373|Etravirine|etravirine|mesh-list
2802104|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
2802105|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802106|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2802107|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2802108|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802109|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802110|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2802111|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
2802112|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2802113|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802114|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2802115|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2802116|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2802117|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
2802118|NCT04208581|Fluticasone|fluticasone|mesh-list
2802119|NCT04208581|Xhance|xhance|mesh-list
2802120|NCT04208581|Budesonide|budesonide|mesh-list
2802121|NCT04208581|Bromides|bromides|mesh-list
2802122|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
2802123|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
2277476|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277477|NCT00216164|Gemcitabine|gemcitabine|mesh-list
2277478|NCT00216164|Rituximab|rituximab|mesh-list
2277479|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2277480|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277481|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
2277482|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277483|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2277484|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2277485|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
2277486|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802124|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2802125|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2802126|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2802127|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2802128|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
2802129|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802130|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802131|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2802132|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
2802133|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
2802134|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2802135|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
2802136|NCT04208581|Hormones|hormones|mesh-ancestor
2277487|NCT00216164|Antiviral Agents|antiviral agents|mesh-ancestor
2277488|NCT00216164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277489|NCT00216164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277490|NCT00216164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2802137|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2802138|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2802139|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2802140|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2802141|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
2802142|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802143|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802144|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
2802145|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2802146|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
2802147|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
2802148|NCT04208334|Curcumin|curcumin|mesh-list
2802149|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2802150|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2802151|NCT04208334|Analgesics|analgesics|mesh-ancestor
2802152|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
2802153|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802154|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802155|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2802156|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2802157|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802158|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802159|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802160|NCT04208516|Dexamethasone|dexamethasone|mesh-list
2802161|NCT04208516|Lidocaine|lidocaine|mesh-list
2802162|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
2802163|NCT04208516|Ropivacaine|ropivacaine|mesh-list
2802164|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2802165|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
2802166|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
2802167|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802168|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802169|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2802170|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
2802171|NCT04208516|Hormones|hormones|mesh-ancestor
2277491|NCT00216177|Adalimumab|adalimumab|mesh-list
2277492|NCT00216177|Infliximab|infliximab|mesh-list
2277493|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2277494|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2277495|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
2277496|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2277497|NCT00216190|Midazolam|midazolam|mesh-list
2277498|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
2802172|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2802173|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2802174|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802175|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
2802176|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
2802177|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802178|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
2802179|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2802180|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2802181|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2802182|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2277499|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2802183|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802184|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2802185|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2802186|NCT04208516|Analgesics|analgesics|mesh-ancestor
2802187|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2802188|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2802189|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2802190|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
2802191|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802192|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
2802193|NCT04208347|Apatinib|apatinib|mesh-list
2802194|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802195|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2802196|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802197|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802198|NCT04208178|Trastuzumab|trastuzumab|mesh-list
2802199|NCT04208178|Pertuzumab|pertuzumab|mesh-list
2802200|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2802201|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802202|NCT04207944|Sulindac|sulindac|mesh-list
2802203|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2802204|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2802205|NCT04207944|Analgesics|analgesics|mesh-ancestor
2277500|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2277501|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277502|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2277503|NCT00216190|Analgesics|analgesics|mesh-ancestor
2277504|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
2277505|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277506|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2277507|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2277508|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2277509|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
2802206|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
2802207|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802208|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802209|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2802210|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2802211|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802212|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2802213|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802214|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802215|NCT04208061|Ritonavir|ritonavir|mesh-list
2802216|NCT04208061|Darunavir|darunavir|mesh-list
2802217|NCT04208061|Dabigatran|dabigatran|mesh-list
2802218|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2802219|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2802220|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
2802221|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802222|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802223|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2802224|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2802225|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
2802226|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802227|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2802228|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2802229|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
2802230|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2802231|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
2802232|NCT04207957|Olorofim|olorofim|mesh-list
2802233|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
2802234|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802235|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
2802236|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
2802237|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
2802238|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802239|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802240|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
2802241|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802242|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
2802243|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2802244|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2802245|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2802246|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2802247|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802248|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
2802249|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802250|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802251|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2802252|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802253|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2802254|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802255|NCT04207684|Testosterone|testosterone|mesh-list
2802256|NCT04207684|Androgens|androgens|mesh-ancestor
2802257|NCT04207684|Hormones|hormones|mesh-ancestor
2802258|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2802259|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802262|NCT04207411|Lidocaine|lidocaine|mesh-list
2802263|NCT04207411|Bupivacaine|bupivacaine|mesh-list
2802264|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
2802265|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
2802266|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802267|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802268|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
2802269|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277510|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277511|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277512|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2277513|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2277514|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2802270|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2802271|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2802272|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2802273|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2802274|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802275|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2802276|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2802277|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2802278|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2802279|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802280|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802281|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802282|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2802283|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
2802284|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2802285|NCT04207515|Anesthetics|anesthetics|mesh-list
2802286|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802287|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802288|NCT04207450|Glutaral|glutaral|mesh-list
2802289|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
2802290|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802291|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2802292|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2802293|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
2802294|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802295|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802296|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802297|NCT04207723|Paroxetine|paroxetine|mesh-list
2802298|NCT04207723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2802299|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2802300|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2802301|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802302|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802303|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
2802304|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802305|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2802306|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
2802307|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2802308|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2802309|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2802310|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802311|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
2802312|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
2802313|NCT04207112|Linezolid|linezolid|mesh-list
2802314|NCT04207112|Bedaquiline|bedaquiline|mesh-list
2802315|NCT04207112|Clofazimine|clofazimine|mesh-list
2802316|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2802317|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802318|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2802319|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2802320|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104101|NCT02431754|Tadalafil|tadalafil|mesh-list
2104102|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
2104103|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2104104|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2104105|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104106|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104107|NCT02431754|Urological Agents|urological agents|mesh-ancestor
2104108|NCT02431806|Milnacipran|milnacipran|mesh-list
2104109|NCT02431806|Fluoxetine|fluoxetine|mesh-list
2104110|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
2104111|NCT02431806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2277515|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2277516|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2277517|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
2277518|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
2277519|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
2277520|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
2277521|NCT00216216|Pemetrexed|pemetrexed|mesh-list
2802321|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802322|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802323|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2802324|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
2802325|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2802326|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
2802327|NCT04207021|Curcumin|curcumin|mesh-list
2802328|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2802329|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2802330|NCT04207021|Analgesics|analgesics|mesh-ancestor
2802331|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
2802332|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802333|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802334|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2802335|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2802336|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802337|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802338|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802339|NCT04206865|Valsartan|valsartan|mesh-list
2802340|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
2802341|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2802342|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2802343|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2802344|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2802345|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802346|NCT04207060|Indomethacin|indomethacin|mesh-list
2802347|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2802348|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2802349|NCT04207060|Analgesics|analgesics|mesh-ancestor
2802350|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
2802351|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802352|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802353|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2802354|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2802355|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
2802356|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
2802357|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2277522|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277523|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277524|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277525|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2277526|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2277527|NCT00216268|Ribavirin|ribavirin|mesh-list
2277528|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
2277529|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277530|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
2277531|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277532|NCT00216281|Clozapine|clozapine|mesh-list
2277533|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2277534|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2277535|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2277536|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2277537|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277538|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
2277539|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277540|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277541|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2277542|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
2277543|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2277544|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2277545|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2277546|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2277547|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
2277548|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
2277549|NCT00216294|Secretin|secretin|mesh-list
2277550|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2277551|NCT00216294|Hormones|hormones|mesh-ancestor
2802358|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2802359|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802360|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802361|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
2802362|NCT04207177|Tacrolimus|tacrolimus|mesh-list
2802363|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2802364|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
2802365|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802366|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2802367|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802368|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802369|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2802370|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802371|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2802372|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
2802373|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2802374|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802384|NCT04206618|Denosumab|denosumab|mesh-list
2802385|NCT04206618|Teriparatide|teriparatide|mesh-list
2802386|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2802387|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802388|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2802389|NCT04206631|Doxycycline|doxycycline|mesh-list
2802390|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2802391|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802392|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
2802393|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2802394|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2802395|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2802396|NCT04206228|Hematinics|hematinics|mesh-ancestor
2277552|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2277553|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277554|NCT00216346|Amphotericin B|amphotericin b|mesh-list
2277555|NCT00216346|Paromomycin|paromomycin|mesh-list
2277556|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2277557|NCT00216346|Amebicides|amebicides|mesh-ancestor
2277558|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2277559|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2802397|NCT04206163|Edotreotide|edotreotide|mesh-list
2802398|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2802399|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802400|NCT04206358|Molgramostim|molgramostim|mesh-list
2802401|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802402|NCT04206046|Anesthetics|anesthetics|mesh-list
2802403|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802404|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802405|NCT04206176|Ticagrelor|ticagrelor|mesh-list
2802406|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2277560|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277561|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2277562|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
2277563|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2802407|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2802408|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2802409|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2802410|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
2802411|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802412|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802413|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802414|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
2802415|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2802416|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802417|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802418|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2802419|NCT04206059|Analgesics|analgesics|mesh-ancestor
2802420|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
2802421|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802422|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2802423|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2802424|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2802425|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
2802426|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802427|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802428|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
2802429|NCT04205916|Dexamethasone|dexamethasone|mesh-list
2802430|NCT04205916|Ketorolac|ketorolac|mesh-list
2802431|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2802432|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
2802433|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
2802434|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802435|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802436|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2802437|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
2802438|NCT04205916|Hormones|hormones|mesh-ancestor
2802439|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2802440|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2802441|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802442|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2802443|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802444|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2802445|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2802446|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277564|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
2277565|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
2277566|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277567|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2277568|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2277569|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277570|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2277571|NCT00216372|Lanreotide|lanreotide|mesh-list
2277572|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277573|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
2277574|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2277575|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277576|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2277577|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2277578|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2277579|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2277580|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277581|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802447|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802448|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2802449|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2802450|NCT04205916|Analgesics|analgesics|mesh-ancestor
2802451|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
2802452|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2802453|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2802454|NCT04205903|Paclitaxel|paclitaxel|mesh-list
2802455|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2802456|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2802457|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802458|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
2802459|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
2277582|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277583|NCT00216398|Lanreotide|lanreotide|mesh-list
2277584|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277585|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
2277586|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2277587|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2277588|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2277589|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2277590|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277591|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
2277592|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277593|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277594|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2277595|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802460|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
2802461|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802462|NCT04205929|Curcumin|curcumin|mesh-list
2802463|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2802464|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2802465|NCT04205929|Analgesics|analgesics|mesh-ancestor
2802466|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
2802467|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802468|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802469|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2802470|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2802471|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802472|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802473|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277596|NCT00216424|Capecitabine|capecitabine|mesh-list
2277597|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2277598|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
2277599|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277600|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277601|NCT00216437|Capecitabine|capecitabine|mesh-list
2277602|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2277603|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
2802482|NCT04205643|Infliximab|infliximab|mesh-list
2802483|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
2802484|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2802485|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2802486|NCT04205890|Ketamine|ketamine|mesh-list
2802487|NCT04205890|Analgesics|analgesics|mesh-ancestor
2802488|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
2802489|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802490|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802491|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2802492|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2802493|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
2802494|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
2802495|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802496|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2802497|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2802498|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802499|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802500|NCT04205682|Cannabidiol|cannabidiol|mesh-list
2802501|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
2277604|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277605|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277606|NCT00216450|Rabeprazole|rabeprazole|mesh-list
2277607|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2277608|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2277609|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2277610|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277611|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277612|NCT00216463|Mipomersen|mipomersen|mesh-list
2277613|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2277614|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2277615|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
2277616|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277617|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2277618|NCT00216489|Rabeprazole|rabeprazole|mesh-list
2277619|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2277620|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2277621|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2277622|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277623|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277624|NCT00216502|Galantamine|galantamine|mesh-list
2802533|NCT04205630|Trastuzumab|trastuzumab|mesh-list
2802534|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2802535|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802536|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
2802537|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2802538|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2802539|NCT04205578|Protective Agents|protective agents|mesh-ancestor
2802540|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802541|NCT04205565|Oxiracetam|oxiracetam|mesh-list
2802542|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2802543|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
2802544|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
2802545|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2802546|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802547|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802548|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2802549|NCT04205539|Analgesics|analgesics|mesh-ancestor
2802550|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
2802551|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802552|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2802553|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2802554|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2802555|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
2802556|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802557|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802558|NCT04205552|Nivolumab|nivolumab|mesh-list
2802559|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2802560|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2802561|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802562|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2802563|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802564|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
2802565|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
2802566|NCT04205240|Melphalan|melphalan|mesh-list
2802567|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
2802568|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2802569|NCT04205240|Fludarabine|fludarabine|mesh-list
2802570|NCT04205240|Daratumumab|daratumumab|mesh-list
2802571|NCT04205240|Tacrolimus|tacrolimus|mesh-list
2802572|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2802573|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
2802574|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802575|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2802576|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2802577|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
2802578|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802579|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802580|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2802581|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2802582|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802583|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2802584|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2277625|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2277626|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277627|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277628|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
2277629|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277630|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277631|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2277632|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
2277633|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277634|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
2277635|NCT00216515|Galantamine|galantamine|mesh-list
2277636|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2277637|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277638|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277639|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
2277640|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277641|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277642|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2277643|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
2802585|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
2802586|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2802587|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802588|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2802589|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2802590|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2802591|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2802592|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2802593|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
2802594|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802595|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802596|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802597|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
2802598|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2802599|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277644|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277645|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
2277646|NCT00216528|Risperidone|risperidone|mesh-list
2277647|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2277648|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
2277649|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277650|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277651|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277652|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2277653|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2277654|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2277655|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2277656|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2277657|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
2277658|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
2277659|NCT00216541|Hematinics|hematinics|mesh-ancestor
2277660|NCT00216554|Risperidone|risperidone|mesh-list
2277661|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2277662|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
2277663|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277664|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277665|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277666|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2277667|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2277668|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2277669|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2277670|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2277671|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
2277672|NCT00216567|Topiramate|topiramate|mesh-list
2277673|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
2277674|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2277675|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277676|NCT00216580|Risperidone|risperidone|mesh-list
2277677|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2277678|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
2277679|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802605|NCT04205305|Labetalol|labetalol|mesh-list
2802606|NCT04205305|Nicardipine|nicardipine|mesh-list
2802607|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2802608|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2802609|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
2802610|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802611|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802612|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802613|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2802614|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
2802615|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
2802616|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802617|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2802618|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2802619|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2802620|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2802621|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2802622|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
2802623|NCT04205344|Bupivacaine|bupivacaine|mesh-list
2802624|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
2802625|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
2802626|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802627|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802628|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
2802629|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104112|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2104113|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2104114|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104115|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104116|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
2104117|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104118|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2104119|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
2277680|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802630|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
2802631|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802632|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2277681|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277682|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2277683|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2277684|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2277685|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2802633|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2802634|NCT04205357|Analgesics|analgesics|mesh-ancestor
2802635|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
2802636|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802637|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802638|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2802639|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2802640|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2802641|NCT04205097|Neostigmine|neostigmine|mesh-list
2802642|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2802643|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802644|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802645|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
2277686|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2802646|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802647|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802648|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2802649|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
2802650|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802651|NCT04204837|Nivolumab|nivolumab|mesh-list
2802652|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2802653|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277687|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
2277688|NCT00216593|Galantamine|galantamine|mesh-list
2277689|NCT00216593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2802654|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2802655|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802656|NCT04204980|Daratumumab|daratumumab|mesh-list
2802657|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2802658|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802659|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
2802660|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802661|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
2802662|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
2802663|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2802664|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802665|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2802666|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2802667|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802668|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802669|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802670|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2802671|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2802672|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2802673|NCT04205058|Caffeine|caffeine|mesh-list
2802674|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2802675|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802676|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2802677|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802678|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802679|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2802680|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2802681|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
2277690|NCT00216593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277691|NCT00216593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277692|NCT00216593|Cholinergic Agents|cholinergic agents|mesh-ancestor
2802682|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802683|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
2802684|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2802685|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802686|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802687|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2802688|NCT04204798|Analgesics|analgesics|mesh-ancestor
2802689|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
2802690|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277693|NCT00216593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277694|NCT00216593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277695|NCT00216593|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2277696|NCT00216593|Autonomic Agents|autonomic agents|mesh-ancestor
2277697|NCT00216593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277698|NCT00216593|Nootropic Agents|nootropic agents|mesh-ancestor
2277699|NCT00216606|Topiramate|topiramate|mesh-list
2277700|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
2277701|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2277702|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277703|NCT00216619|Topiramate|topiramate|mesh-list
2277704|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
2277705|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2277706|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277707|NCT00216632|Risperidone|risperidone|mesh-list
2277708|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2277709|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
2277710|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277711|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802691|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2802692|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2802693|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2802694|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
2277712|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277713|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2802695|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802696|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802697|NCT04204772|Charcoal|charcoal|mesh-list
2802698|NCT04204772|Antidotes|antidotes|mesh-ancestor
2802699|NCT04204772|Protective Agents|protective agents|mesh-ancestor
2802700|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802701|NCT04204577|Apatinib|apatinib|mesh-list
2802702|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802703|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2802704|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802705|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802706|NCT04204941|Doxorubicin|doxorubicin|mesh-list
2802707|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2802708|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2802709|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802710|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2802711|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2802712|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802713|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802714|NCT04204902|Tepotinib|tepotinib|mesh-list
2802715|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802716|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
2802717|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2802718|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
2802719|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802720|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
2802721|NCT04204278|Protective Agents|protective agents|mesh-ancestor
2802722|NCT04204382|Levofloxacin|levofloxacin|mesh-list
2802723|NCT04204382|Ofloxacin|ofloxacin|mesh-list
2802724|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2802725|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802726|NCT04204382|Renal Agents|renal agents|mesh-ancestor
2802727|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2802728|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2802729|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2802730|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802731|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802732|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802733|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2802734|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2802735|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2802736|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
2802737|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2802738|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2802739|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
2802740|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802741|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802750|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
2802751|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2802752|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
2802753|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802754|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
2802755|NCT04204083|Protective Agents|protective agents|mesh-ancestor
2802756|NCT04204096|Vaccines|vaccines|mesh-list
2802757|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
2277714|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2277715|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2277716|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2277717|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2277718|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
2277719|NCT00216645|Doxorubicin|doxorubicin|mesh-list
2277720|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2277721|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2802758|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802759|NCT04204304|Isotretinoin|isotretinoin|mesh-list
2277722|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802760|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
2802761|NCT04204343|Bupivacaine|bupivacaine|mesh-list
2802762|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
2802763|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
2802764|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802765|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277723|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2277724|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2277725|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802766|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
2802767|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802768|NCT04204044|Folic Acid|folic acid|mesh-list
2802769|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
2802770|NCT04204044|Inositol|inositol|mesh-list
2802771|NCT04204044|Metformin|metformin|mesh-list
2802772|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2802773|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802774|NCT04204044|Hematinics|hematinics|mesh-ancestor
2802775|NCT04204044|Vitamins|vitamins|mesh-ancestor
2802776|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
2802777|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
2802778|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2802779|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
2802780|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802781|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
2802782|NCT04204265|Protective Agents|protective agents|mesh-ancestor
2802783|NCT04203641|Doxorubicin|doxorubicin|mesh-list
2802784|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2802785|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802786|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2802787|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2802788|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802789|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802790|NCT04203732|Anesthetics|anesthetics|mesh-list
2802791|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802792|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802793|NCT04203901|Nivolumab|nivolumab|mesh-list
2802794|NCT04203901|Ipilimumab|ipilimumab|mesh-list
2802795|NCT04203901|Everolimus|everolimus|mesh-list
2802796|NCT04203901|Lenvatinib|lenvatinib|mesh-list
2802797|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2802798|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802799|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2802800|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802801|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2802802|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
2802803|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277726|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277727|NCT00216658|Fentanyl|fentanyl|mesh-list
2277728|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2277729|NCT00216658|Narcotics|narcotics|mesh-ancestor
2277730|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2277731|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277732|NCT00216658|Analgesics|analgesics|mesh-ancestor
2277733|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
2277734|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802804|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2802805|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802806|NCT04203771|Ibuprofen|ibuprofen|mesh-list
2802807|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2802808|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2802809|NCT04203771|Analgesics|analgesics|mesh-ancestor
2802810|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
2802811|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802812|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802813|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2802814|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2277735|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2277736|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2277737|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
2277738|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
2277739|NCT00216684|Fentanyl|fentanyl|mesh-list
2277740|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2277741|NCT00216684|Narcotics|narcotics|mesh-ancestor
2277742|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802815|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2802816|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802817|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802818|NCT04203914|Empagliflozin|empagliflozin|mesh-list
2802819|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2802820|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802821|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2802822|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277743|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277744|NCT00216684|Analgesics|analgesics|mesh-ancestor
2277745|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
2277746|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277747|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2277748|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2802823|NCT04203927|Empagliflozin|empagliflozin|mesh-list
2277749|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
2277750|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
2277751|NCT00216697|Bortezomib|bortezomib|mesh-list
2277752|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277753|NCT00216723|Aripiprazole|aripiprazole|mesh-list
2277754|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
2277755|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2277756|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2277757|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2277758|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2277759|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277760|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
2277761|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
2277762|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277763|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277764|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2277765|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2277766|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
2277767|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2277768|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2277769|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2277770|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2277771|NCT00216762|Rituximab|rituximab|mesh-list
2277772|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2802824|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2802825|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802826|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2802827|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802828|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
2802829|NCT04203680|Tryptophan|tryptophan|mesh-list
2802830|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2802831|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2802832|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
2802833|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2802834|NCT04203186|Lumefantrine|lumefantrine|mesh-list
2802835|NCT04203186|Artemether|artemether|mesh-list
2802836|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2802837|NCT04203186|Atovaquone|atovaquone|mesh-list
2802838|NCT04203186|Proguanil|proguanil|mesh-list
2802839|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2802840|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
2802841|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2802842|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2802843|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802844|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802845|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802846|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
2802847|NCT04203342|Ketoconazole|ketoconazole|mesh-list
2802848|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
2802849|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802850|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2104120|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2104121|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2802851|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2802852|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802853|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802854|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2802855|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
2802856|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2802857|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802858|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2802859|NCT04203368|Adenosine|adenosine|mesh-list
2802860|NCT04203368|Verapamil|verapamil|mesh-list
2104122|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2104123|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104124|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2104125|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2104126|NCT02431806|Analgesics|analgesics|mesh-ancestor
2104127|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
2104128|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104129|NCT02432040|Atorvastatin|atorvastatin|mesh-list
2104130|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2104131|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2802861|NCT04203368|Analgesics|analgesics|mesh-ancestor
2802862|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
2802863|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802864|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802865|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2802866|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
2802867|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2802868|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
2802869|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
2277773|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277774|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
2277775|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277776|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2277777|NCT00216775|Interferons|interferons|mesh-list
2277778|NCT00216775|Ribavirin|ribavirin|mesh-list
2277779|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
2277780|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
2277781|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277782|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
2277783|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277784|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
2277785|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277786|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
2277787|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277788|NCT00216788|Esomeprazole|esomeprazole|mesh-list
2802870|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802871|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802872|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2802873|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2802874|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2802875|NCT04203472|Budesonide|budesonide|mesh-list
2802876|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2802877|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2802878|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
2802879|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802880|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802881|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2802882|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
2802883|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
2802884|NCT04203472|Hormones|hormones|mesh-ancestor
2802885|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2802886|NCT04203212|Goserelin|goserelin|mesh-list
2802887|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2802888|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802889|NCT04203498|Nabiximols|nabiximols|mesh-list
2802890|NCT04203498|Analgesics|analgesics|mesh-ancestor
2802891|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
2802892|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802893|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802894|NCT04203160|Gemcitabine|gemcitabine|mesh-list
2802895|NCT04203160|Cisplatin|cisplatin|mesh-list
2802896|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802897|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2802898|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
2277789|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2277790|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2277791|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2277792|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277793|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277794|NCT00216827|Betamethasone|betamethasone|mesh-list
2277795|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
2277796|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2277797|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
2277798|NCT00216827|Calcipotriene|calcipotriene|mesh-list
2277799|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2277800|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2277801|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
2277802|NCT00216827|Hormones|hormones|mesh-ancestor
2277803|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2277804|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277805|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2277806|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
2277807|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
2277808|NCT00216840|Betamethasone|betamethasone|mesh-list
2277809|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
2277810|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2802899|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802900|NCT04203160|Antiviral Agents|antiviral agents|mesh-ancestor
2802901|NCT04203160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802902|NCT04203160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802903|NCT04203160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2802904|NCT04203160|Immunologic Factors|immunologic factors|mesh-ancestor
2802905|NCT04203160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802906|NCT04203056|Aripiprazole|aripiprazole|mesh-list
2802907|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
2802908|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
2802909|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2277811|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
2277812|NCT00216840|Calcipotriene|calcipotriene|mesh-list
2802910|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2802911|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2802912|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802913|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802914|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
2802915|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
2802916|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2802917|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802918|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2802919|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2802920|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
2802921|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2802922|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2802923|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2802924|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2802925|NCT04203043|Pycnogenols|pycnogenols|mesh-list
2802926|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2802927|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
2802928|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802929|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
2802930|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802931|NCT04203043|Protective Agents|protective agents|mesh-ancestor
2802932|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2802933|NCT04203290|Bupivacaine|bupivacaine|mesh-list
2802934|NCT04203290|Sevoflurane|sevoflurane|mesh-list
2802935|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
2802936|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
2802937|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2802938|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802939|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
2802940|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2802941|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2802942|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2802943|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
2802944|NCT04202809|Durvalumab|durvalumab|mesh-list
2802945|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2802946|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802947|NCT04202978|Capecitabine|capecitabine|mesh-list
2802948|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
2802949|NCT04202978|Apatinib|apatinib|mesh-list
2802950|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2802951|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
2802952|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802953|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802954|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2802955|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277813|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2277814|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2277815|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
2277816|NCT00216840|Hormones|hormones|mesh-ancestor
2277817|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2277818|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277819|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2277820|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
2277821|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
2277822|NCT00216866|Dalteparin|dalteparin|mesh-list
2277823|NCT00216866|Tinzaparin|tinzaparin|mesh-list
2277824|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2277825|NCT00216866|Warfarin|warfarin|mesh-list
2277826|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
2277827|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2802956|NCT04203511|Paclitaxel|paclitaxel|mesh-list
2802957|NCT04203511|Etoposide|etoposide|mesh-list
2802958|NCT04203511|Carboplatin|carboplatin|mesh-list
2802959|NCT04203511|Pemetrexed|pemetrexed|mesh-list
2802960|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2802961|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802962|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
2802963|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
2802964|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
2802965|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277828|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2277829|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277830|NCT00216879|Betamethasone|betamethasone|mesh-list
2802966|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2802967|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2802968|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802969|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2802970|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2802971|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
2802972|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
2802973|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2802974|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
2802975|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
2802976|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2802977|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2802978|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
2802979|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2802980|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2802981|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2802982|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
2802983|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802984|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802985|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2802986|NCT04203485|Paclitaxel|paclitaxel|mesh-list
2802987|NCT04203485|Carboplatin|carboplatin|mesh-list
2802988|NCT04203485|Pemetrexed|pemetrexed|mesh-list
2802989|NCT04203485|Apatinib|apatinib|mesh-list
2802990|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2802991|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2802992|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
2802993|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
2802994|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
2802995|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2802996|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2802997|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2802998|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2802999|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2803000|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
2803001|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
2803002|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2803003|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
2803004|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803005|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
2803006|NCT04202692|Protective Agents|protective agents|mesh-ancestor
2803007|NCT04202692|Antacids|antacids|mesh-ancestor
2803008|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803009|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2803010|NCT04202887|Fentanyl|fentanyl|mesh-list
2803011|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2803012|NCT04202887|Narcotics|narcotics|mesh-ancestor
2803013|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803014|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803015|NCT04202887|Analgesics|analgesics|mesh-ancestor
2803016|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
2803017|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277831|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
2277832|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2277833|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
2277834|NCT00216879|Calcipotriene|calcipotriene|mesh-list
2277835|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2803018|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2803019|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2803020|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
2803021|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
2803022|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2803023|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803024|NCT04202536|Tenofovir|tenofovir|mesh-list
2803025|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
2803026|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803027|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2803028|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2803029|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803030|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803031|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2803032|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2803033|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
2803034|NCT04202484|Tegafur|tegafur|mesh-list
2277836|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2277837|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
2277838|NCT00216879|Hormones|hormones|mesh-ancestor
2277839|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2277840|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277841|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2277842|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
2277843|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
2277844|NCT00216892|Betamethasone|betamethasone|mesh-list
2277845|NCT00216892|Calcipotriene|calcipotriene|mesh-list
2277846|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2277847|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
2277848|NCT00216892|Hormones|hormones|mesh-ancestor
2803035|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803036|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2803037|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
2803038|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803039|NCT04202380|Azithromycin|azithromycin|mesh-list
2803040|NCT04202380|Ampicillin|ampicillin|mesh-list
2803041|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2803042|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803043|NCT04202367|Bupivacaine|bupivacaine|mesh-list
2803044|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
2803045|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
2803046|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803047|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803048|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
2803049|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277849|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2277850|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277851|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2803050|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
2803051|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2803052|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277852|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
2277853|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
2277854|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2277855|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2277856|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2277857|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2277858|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277859|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
2277860|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277861|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277862|NCT00216931|Iloprost|iloprost|mesh-list
2277863|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2277864|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
2277865|NCT00217009|Furocoumarins|furocoumarins|mesh-list
2803053|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
2803054|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
2803055|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2803056|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2803057|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803058|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2803059|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2803060|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
2803061|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2803062|NCT04202406|Acetaminophen|acetaminophen|mesh-list
2277866|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
2277867|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2277868|NCT00217048|Yohimbine|yohimbine|mesh-list
2277869|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
2277870|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
2277871|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277872|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277873|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2803063|NCT04202406|Codeine|codeine|mesh-list
2803064|NCT04202406|Caffeine|caffeine|mesh-list
2277874|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2803065|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2803066|NCT04202406|Analgesics|analgesics|mesh-ancestor
2803067|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
2803068|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803069|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803070|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
2803071|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2803072|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2803073|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803074|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803075|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2803076|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2803077|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
2803078|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2803079|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2803080|NCT04202406|Narcotics|narcotics|mesh-ancestor
2277875|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2277876|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
2277877|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2277878|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277879|NCT00217048|Urological Agents|urological agents|mesh-ancestor
2277880|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
2277881|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2277882|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277883|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2277884|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
2277885|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2277886|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277887|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277888|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803081|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803082|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
2803083|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
2803084|NCT04202224|Acetaminophen|acetaminophen|mesh-list
2803085|NCT04202224|Ibuprofen|ibuprofen|mesh-list
2803086|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2803087|NCT04202224|Analgesics|analgesics|mesh-ancestor
2803088|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
2803089|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803090|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803091|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
2803092|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2803093|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2803094|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2803095|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2803096|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803097|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803098|NCT04201964|Tenecteplase|tenecteplase|mesh-list
2803099|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2803100|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2277889|NCT00217178|Folic Acid|folic acid|mesh-list
2277890|NCT00217178|Vitamins|vitamins|mesh-ancestor
2277891|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
2277892|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277893|NCT00217178|Hematinics|hematinics|mesh-ancestor
2277894|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
2277895|NCT00217191|Ibuprofen|ibuprofen|mesh-list
2277896|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2277897|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2104132|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
2104133|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104134|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2104135|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2104136|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104137|NCT02432209|Orlistat|orlistat|mesh-list
2104138|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104139|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104140|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2104141|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2104142|NCT02432274|Etoposide|etoposide|mesh-list
2104143|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
2104144|NCT02432274|Ifosfamide|ifosfamide|mesh-list
2104145|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
2104146|NCT02432274|Lenvatinib|lenvatinib|mesh-list
2104147|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2104148|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104149|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2104150|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2104151|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803101|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803102|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
2803103|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2803104|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2803105|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803106|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
2803107|NCT04201951|Coagulants|coagulants|mesh-ancestor
2277898|NCT00217191|Analgesics|analgesics|mesh-ancestor
2277899|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
2277900|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277901|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277902|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2277903|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2277904|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2277905|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277906|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277907|NCT00217204|Pancrelipase|pancrelipase|mesh-list
2277908|NCT00217204|Pancreatin|pancreatin|mesh-list
2277909|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2277910|NCT00217243|Lidocaine|lidocaine|mesh-list
2277911|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
2277912|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
2277913|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2277914|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277915|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
2277916|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277917|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2277918|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2277919|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2803108|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
2803109|NCT04202068|Sulbactam|sulbactam|mesh-list
2803110|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2803111|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803112|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2803113|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803114|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803115|NCT04201808|Tenofovir|tenofovir|mesh-list
2803116|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
2803117|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803118|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2803119|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2803120|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803121|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277920|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2277921|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277922|NCT00217282|Gemcitabine|gemcitabine|mesh-list
2277923|NCT00217282|Bevacizumab|bevacizumab|mesh-list
2277924|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
2277925|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2277926|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277927|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2277928|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2277929|NCT00217282|Growth Substances|growth substances|mesh-ancestor
2803122|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2803123|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2803124|NCT04201873|Poly I-C|poly i-c|mesh-list
2803125|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
2803126|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2803127|NCT04201873|Vaccines|vaccines|mesh-list
2803128|NCT04201873|Poly ICLC|poly iclc|mesh-list
2803129|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
2803130|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803131|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2803132|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803133|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
2803134|NCT04201873|Laxatives|laxatives|mesh-ancestor
2803135|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2803136|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
2803137|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803138|NCT04201860|Hemostatics|hemostatics|mesh-list
2803139|NCT04201860|Coagulants|coagulants|mesh-ancestor
2803140|NCT04201990|Apatinib|apatinib|mesh-list
2803141|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803142|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2803143|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277930|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277931|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
2277932|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2277933|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
2277934|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803144|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803145|NCT04201665|Oxytocin|oxytocin|mesh-list
2803146|NCT04201665|Carbetocin|carbetocin|mesh-list
2803147|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
2803148|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2803149|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803150|NCT04201678|Anesthetics|anesthetics|mesh-list
2803151|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803152|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803153|NCT04201769|Dexamethasone|dexamethasone|mesh-list
2803154|NCT04201769|Palonosetron|palonosetron|mesh-list
2803155|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2803156|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
2803157|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
2803158|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803159|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803160|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2803161|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
2803162|NCT04201769|Hormones|hormones|mesh-ancestor
2803163|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2803164|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2803165|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277935|NCT00217282|Antiviral Agents|antiviral agents|mesh-ancestor
2803166|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2803167|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2803168|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
2277936|NCT00217282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277937|NCT00217282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277938|NCT00217282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2277939|NCT00217282|Immunologic Factors|immunologic factors|mesh-ancestor
2277940|NCT00217295|Topiramate|topiramate|mesh-list
2277941|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
2277942|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2803169|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2803170|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803171|NCT04201756|Afatinib|afatinib|mesh-list
2803172|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803173|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2803174|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803175|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803176|NCT04201561|Selenious Acid|selenious acid|mesh-list
2803177|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
2803178|NCT04201561|Paclitaxel|paclitaxel|mesh-list
2803179|NCT04201561|Carboplatin|carboplatin|mesh-list
2803180|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2803181|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803182|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
2803183|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
2803184|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
2803185|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803186|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803187|NCT04201561|Trace Elements|trace elements|mesh-ancestor
2803188|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
2803189|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
2803190|NCT04201457|Trametinib|trametinib|mesh-list
2803191|NCT04201457|Dabrafenib|dabrafenib|mesh-list
2803192|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2803193|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
2803194|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2803195|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2803196|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803197|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803198|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803199|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2803200|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803201|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2803202|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2803203|NCT04201457|Protective Agents|protective agents|mesh-ancestor
2803204|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803205|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2803206|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
2803207|NCT04201652|Anesthetics|anesthetics|mesh-list
2803208|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
2803209|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803210|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803211|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
2803212|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803213|NCT04201262|Ravulizumab|ravulizumab|mesh-list
2803214|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2803215|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2803216|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
2803217|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803218|NCT04200911|Sirolimus|sirolimus|mesh-list
2803219|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2803220|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803221|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2803222|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803223|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
2803224|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2803225|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
2803226|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803227|NCT04201054|Fluconazole|fluconazole|mesh-list
2803228|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
2803229|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803230|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2803231|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2803232|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803233|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803234|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2803235|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
2803236|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2803237|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803238|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2803239|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2803240|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
2803241|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2803242|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803243|NCT04200963|Nivolumab|nivolumab|mesh-list
2803244|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2803245|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803246|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2803247|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803248|NCT04201249|Piroxicam|piroxicam|mesh-list
2803249|NCT04201249|Lidocaine|lidocaine|mesh-list
2803250|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
2803251|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
2803252|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803253|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803254|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
2803255|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803256|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2803257|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2803258|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2803259|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2803260|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803261|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2803262|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2277943|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277944|NCT00217373|Interferons|interferons|mesh-list
2277945|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
2277946|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
2277947|NCT00217373|Metronidazole|metronidazole|mesh-list
2803263|NCT04201249|Analgesics|analgesics|mesh-ancestor
2803264|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2803265|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2803266|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2277948|NCT00217373|Vaccines|vaccines|mesh-list
2277949|NCT00217373|Sargramostim|sargramostim|mesh-list
2277950|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
2277951|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277952|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277953|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
2277954|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277955|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2277956|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2277957|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2277958|NCT00217386|Etanercept|etanercept|mesh-list
2277959|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2277960|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2104152|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104153|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2104154|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
2104155|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2104156|NCT02432287|Metformin|metformin|mesh-list
2104157|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2104158|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104159|NCT02432456|Acetaminophen|acetaminophen|mesh-list
2104160|NCT02432456|Ibuprofen|ibuprofen|mesh-list
2104161|NCT02432456|Ketamine|ketamine|mesh-list
2104162|NCT02432456|Narcotics|narcotics|mesh-list
2104163|NCT02432456|Methocarbamol|methocarbamol|mesh-list
2104164|NCT02432456|Pantoprazole|pantoprazole|mesh-list
2104165|NCT02432456|Analgesics|analgesics|mesh-ancestor
2104166|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
2104167|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104168|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104169|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2104170|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2104171|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
2104172|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
2104173|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2104174|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2104175|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2104176|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104177|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104178|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2104179|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
2277961|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2803267|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803268|NCT04200885|Dexamethasone|dexamethasone|mesh-list
2803269|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2803270|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2803271|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2803272|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
2803273|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
2803274|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803275|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803276|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2803277|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
2803278|NCT04200885|Hormones|hormones|mesh-ancestor
2803279|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2803280|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2803281|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803282|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2277962|NCT00217386|Analgesics|analgesics|mesh-ancestor
2277963|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
2277964|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2277965|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277966|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2277967|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2277968|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2277969|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2277970|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
2277971|NCT00217412|Vorinostat|vorinostat|mesh-list
2277972|NCT00217412|Isotretinoin|isotretinoin|mesh-list
2277973|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277974|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2277975|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277976|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277977|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
2277978|NCT00217451|Clindamycin|clindamycin|mesh-list
2277979|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
2277980|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
2277981|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
2277982|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2277983|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277984|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2277985|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277986|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277987|NCT00217477|Gemcitabine|gemcitabine|mesh-list
2277988|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2277989|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
2277990|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2277991|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2277992|NCT00217477|Antiviral Agents|antiviral agents|mesh-ancestor
2277993|NCT00217477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2277994|NCT00217477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2277995|NCT00217477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2803283|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2803284|NCT04200885|Analgesics|analgesics|mesh-ancestor
2803285|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
2803286|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2803287|NCT04200833|Golimumab|golimumab|mesh-list
2803288|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2803289|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2803290|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2803291|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
2803292|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803293|NCT04200599|Oxytocin|oxytocin|mesh-list
2803294|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
2803295|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2803296|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803297|NCT04200651|Dexamethasone|dexamethasone|mesh-list
2803298|NCT04200651|Prednisolone|prednisolone|mesh-list
2803299|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2803300|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
2803301|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2803302|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
2803303|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2803304|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
2803305|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2803306|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
2803307|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
2803308|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803309|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277996|NCT00217477|Immunologic Factors|immunologic factors|mesh-ancestor
2277997|NCT00217477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2277998|NCT00217503|Zidovudine|zidovudine|mesh-list
2277999|NCT00217503|Valganciclovir|valganciclovir|mesh-list
2278000|NCT00217503|Ganciclovir|ganciclovir|mesh-list
2803310|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2803311|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
2803312|NCT04200651|Hormones|hormones|mesh-ancestor
2803313|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2803314|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2803315|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803316|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2803317|NCT04200651|Protective Agents|protective agents|mesh-ancestor
2803318|NCT04200417|Mitomycins|mitomycins|mesh-list
2803319|NCT04200417|Mitomycin|mitomycin|mesh-list
2803320|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
2803321|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2278001|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
2278002|NCT00217503|Bevacizumab|bevacizumab|mesh-list
2278003|NCT00217503|Doxorubicin|doxorubicin|mesh-list
2278004|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2278005|NCT00217503|Etoposide|etoposide|mesh-list
2278006|NCT00217503|Bortezomib|bortezomib|mesh-list
2278007|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2278008|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
2803322|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803323|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
2803324|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803325|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2803326|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803327|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
2278009|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278010|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2278011|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2278012|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
2278013|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278014|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278015|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2278016|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2278017|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2278018|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2278019|NCT00217503|Growth Substances|growth substances|mesh-ancestor
2278020|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
2803328|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2803329|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803330|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2803331|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278021|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2278022|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2278023|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2278024|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278025|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2278026|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
2278027|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2803332|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
2803333|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2803334|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803335|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803336|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2803337|NCT04200235|Analgesics|analgesics|mesh-ancestor
2803338|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
2803339|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803340|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2803341|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2803342|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2803343|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
2803344|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2803345|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803346|NCT04200092|Granisetron|granisetron|mesh-list
2803347|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
2803348|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
2803349|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803350|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803351|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2803352|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2803353|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
2803354|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2803355|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803356|NCT04200222|Vanadium|vanadium|mesh-list
2803357|NCT04200222|Trace Elements|trace elements|mesh-ancestor
2803358|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
2803359|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803360|NCT04200248|Aflibercept|aflibercept|mesh-list
2803361|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2803362|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2803363|NCT04200248|Growth Substances|growth substances|mesh-ancestor
2803364|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803365|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
2803366|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803367|NCT04200040|Dacarbazine|dacarbazine|mesh-list
2803368|NCT04200040|Molgramostim|molgramostim|mesh-list
2803369|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2803370|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
2803371|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803372|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803373|NCT04199819|Entecavir|entecavir|mesh-list
2803374|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
2803375|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803376|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2803377|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803378|NCT04199624|Ascorbic Acid|ascorbic acid|mesh-list
2803379|NCT04199624|Omeprazole|omeprazole|mesh-list
2803380|NCT04199624|Vitamins|vitamins|mesh-ancestor
2803381|NCT04199624|Micronutrients|micronutrients|mesh-ancestor
2803382|NCT04199624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803383|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2803384|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2803385|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2803386|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803387|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803388|NCT04199624|Antioxidants|antioxidants|mesh-ancestor
2278028|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2278029|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
2278030|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2278031|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2278032|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2278033|NCT00217516|Selenium|selenium|mesh-list
2278034|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
2278035|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278036|NCT00217516|Protective Agents|protective agents|mesh-ancestor
2278037|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278038|NCT00217516|Trace Elements|trace elements|mesh-ancestor
2278039|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
2278040|NCT00217529|Carboplatin|carboplatin|mesh-list
2278041|NCT00217529|Docetaxel|docetaxel|mesh-list
2278042|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2278043|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803389|NCT04199624|Protective Agents|protective agents|mesh-ancestor
2278044|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
2803412|NCT04199364|Poractant alfa|poractant alfa|mesh-list
2803413|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2803414|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
2803415|NCT04199572|Acetaminophen|acetaminophen|mesh-list
2803416|NCT04199572|Diclofenac|diclofenac|mesh-list
2803417|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2803418|NCT04199572|Analgesics|analgesics|mesh-ancestor
2803419|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
2803420|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803421|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803422|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
2803423|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2803424|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2803425|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2803426|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2803427|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803428|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803429|NCT04199325|Uric Acid|uric acid|mesh-list
2803430|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
2803431|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803432|NCT04199325|Protective Agents|protective agents|mesh-ancestor
2803433|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803434|NCT04199221|Vaccines|vaccines|mesh-list
2803435|NCT04199221|Immunologic Factors|immunologic factors|mesh-ancestor
2803436|NCT04199221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803437|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
2803438|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2803439|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
2803440|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
2803441|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803442|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803443|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2803444|NCT04199143|Analgesics|analgesics|mesh-ancestor
2803445|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
2803446|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803447|NCT04199013|Fentanyl|fentanyl|mesh-list
2803448|NCT04199013|Ropivacaine|ropivacaine|mesh-list
2803449|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
2803450|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
2803451|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803452|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803453|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
2803454|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803455|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2803456|NCT04199013|Narcotics|narcotics|mesh-ancestor
2278045|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
2278046|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
2278047|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278048|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2278049|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278050|NCT00217542|Interferons|interferons|mesh-list
2278051|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
2278052|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
2278053|NCT00217542|Azacitidine|azacitidine|mesh-list
2278054|NCT00217542|Amifostine|amifostine|mesh-list
2803457|NCT04199013|Analgesics|analgesics|mesh-ancestor
2803458|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2803459|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2803460|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
2803461|NCT04199169|Vaccines|vaccines|mesh-list
2803462|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
2803463|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803464|NCT04198844|Warfarin|warfarin|mesh-list
2803465|NCT04198844|Apixaban|apixaban|mesh-list
2803466|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
2803467|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2803468|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
2803469|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2803470|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
2803471|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803472|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803473|NCT04198662|Epinephrine|epinephrine|mesh-list
2803474|NCT04198662|Ropivacaine|ropivacaine|mesh-list
2803475|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
2803476|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
2803477|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803478|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803479|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
2803480|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803481|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2803482|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2803483|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
2803484|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2803485|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803486|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2803487|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2803488|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
2803489|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2803490|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
2803491|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
2803492|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
2803493|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2803494|NCT04198727|Capecitabine|capecitabine|mesh-list
2803495|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2803496|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
2803497|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278055|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278056|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
2278057|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2278058|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278059|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
2278060|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278061|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278062|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
2278063|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278064|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2278065|NCT00217542|Protective Agents|protective agents|mesh-ancestor
2278066|NCT00217555|Gemcitabine|gemcitabine|mesh-list
2278067|NCT00217555|Topotecan|topotecan|mesh-list
2278068|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278069|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
2278070|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278071|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278072|NCT00217555|Antiviral Agents|antiviral agents|mesh-ancestor
2278073|NCT00217555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2278074|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278075|NCT00217555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2278076|NCT00217555|Immunologic Factors|immunologic factors|mesh-ancestor
2278077|NCT00217555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278078|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2278079|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2278080|NCT00217568|Carboplatin|carboplatin|mesh-list
2278081|NCT00217568|Docetaxel|docetaxel|mesh-list
2278082|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278083|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
2278084|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
2278085|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
2278086|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803498|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278087|NCT00217607|Paclitaxel|paclitaxel|mesh-list
2803499|NCT04198506|Tacrolimus|tacrolimus|mesh-list
2803500|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2803501|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
2803502|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803503|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2803504|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803505|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803506|NCT04198571|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2803507|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2803508|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803509|NCT04198636|Denosumab|denosumab|mesh-list
2803510|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2803511|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803512|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
2803513|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2803514|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
2803515|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803516|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
2803517|NCT04198467|Protective Agents|protective agents|mesh-ancestor
2803518|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2803519|NCT04198129|Amoxicillin|amoxicillin|mesh-list
2278088|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2278089|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278090|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
2278091|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
2803520|NCT04198129|Clindamycin|clindamycin|mesh-list
2803521|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
2803522|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
2803523|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2803524|NCT04198129|Ampicillin|ampicillin|mesh-list
2803525|NCT04198129|Sultamicillin|sultamicillin|mesh-list
2803526|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2803527|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803528|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
2803529|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2803530|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803531|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803532|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2803533|NCT04198233|Diazepam|diazepam|mesh-list
2803534|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2803535|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
2803536|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
2803537|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
2803538|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803539|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803540|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2803541|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2803542|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803543|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2803544|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2803545|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2803546|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2803547|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2803548|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2803549|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
2803550|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
2803551|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
2803552|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
2278092|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
2278093|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278094|NCT00217646|Sorafenib|sorafenib|mesh-list
2278095|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278096|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2278097|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278098|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278099|NCT00217659|Anastrozole|anastrozole|mesh-list
2278100|NCT00217659|Goserelin|goserelin|mesh-list
2278101|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2278102|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278103|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2803553|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2803554|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803555|NCT04198116|Guanfacine|guanfacine|mesh-list
2803556|NCT04198116|Varenicline|varenicline|mesh-list
2803557|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2803558|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2803559|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
2278104|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2278105|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278106|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278107|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2278108|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
2278109|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2278110|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278111|NCT00217698|Gemcitabine|gemcitabine|mesh-list
2278112|NCT00217698|Gefitinib|gefitinib|mesh-list
2278113|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278114|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278115|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
2278116|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278117|NCT00217698|Antiviral Agents|antiviral agents|mesh-ancestor
2278118|NCT00217698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2278119|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278120|NCT00217698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2278121|NCT00217698|Immunologic Factors|immunologic factors|mesh-ancestor
2278122|NCT00217698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278123|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2803560|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2803561|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803562|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803563|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2803564|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2803565|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2803566|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2803567|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
2803568|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2803569|NCT04197817|Antibodies|antibodies|mesh-list
2803570|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
2803571|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2803572|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
2803573|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803574|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278124|NCT00217711|Capecitabine|capecitabine|mesh-list
2278125|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
2278126|NCT00217711|Irinotecan|irinotecan|mesh-list
2278127|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278128|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
2278129|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803575|NCT04197752|Anesthetics|anesthetics|mesh-list
2803576|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803577|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803578|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
2803579|NCT04197570|Analgesics|analgesics|mesh-list
2803580|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
2803581|NCT04197570|Anesthetics|anesthetics|mesh-list
2803582|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803583|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803584|NCT04197570|Narcotics|narcotics|mesh-ancestor
2803585|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
2803586|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803587|NCT04197882|Molgramostim|molgramostim|mesh-list
2803588|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803589|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2803590|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2803591|NCT04197622|Diuretics|diuretics|mesh-ancestor
2803592|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
2803593|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803594|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2803595|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2803596|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803597|NCT04197739|Amikacin|amikacin|mesh-list
2803598|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2803599|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803600|NCT04197323|Alprostadil|alprostadil|mesh-list
2803601|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2803602|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
2803603|NCT04197323|Urological Agents|urological agents|mesh-ancestor
2803604|NCT04197349|Sumatriptan|sumatriptan|mesh-list
2803605|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2803606|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2803607|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2803608|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
2803609|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2803610|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803611|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803617|NCT04197089|Vitamin D|vitamin d|mesh-list
2803618|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
2803619|NCT04197089|Vitamins|vitamins|mesh-ancestor
2803620|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
2803621|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803622|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2803623|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2803624|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
2803625|NCT04197219|Axitinib|axitinib|mesh-list
2803626|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2803627|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803628|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2803629|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803630|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803631|NCT04196855|Teriparatide|teriparatide|mesh-list
2803632|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2803633|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803634|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2278130|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278131|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2278132|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2278133|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278134|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
2278135|NCT00217737|Leucovorin|leucovorin|mesh-list
2278136|NCT00217737|Folic Acid|folic acid|mesh-list
2278137|NCT00217737|Bevacizumab|bevacizumab|mesh-list
2278138|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2278139|NCT00217737|Fluorouracil|fluorouracil|mesh-list
2278140|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
2278141|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
2278142|NCT00217737|Antibodies|antibodies|mesh-list
2278143|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
2278144|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2278145|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
2278146|NCT00217737|Calcium|calcium|mesh-list
2278147|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
2278148|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278149|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2803635|NCT04196829|Fluorides|fluorides|mesh-list
2803636|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
2803637|NCT04196829|Protective Agents|protective agents|mesh-ancestor
2803638|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803639|NCT04196946|Fentanyl|fentanyl|mesh-list
2803640|NCT04196946|Alfentanil|alfentanil|mesh-list
2803641|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2803642|NCT04196946|Narcotics|narcotics|mesh-ancestor
2803643|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803644|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803645|NCT04196946|Analgesics|analgesics|mesh-ancestor
2803646|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
2803647|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803648|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2803649|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2803650|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
2803651|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
2803652|NCT04197050|Valsartan|valsartan|mesh-list
2803653|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2803654|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2803655|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2803656|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803657|NCT04197115|Vitamins|vitamins|mesh-list
2803658|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
2803659|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
2803660|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
2803661|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2803662|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2803663|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2803664|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
2803665|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803666|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2803667|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
2803668|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803669|NCT04197115|Protective Agents|protective agents|mesh-ancestor
2803670|NCT04196998|Tenofovir|tenofovir|mesh-list
2803671|NCT04196998|Entecavir|entecavir|mesh-list
2803672|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
2803673|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803674|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2803675|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2803676|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803677|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803678|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2803679|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2803680|NCT04196868|Metformin|metformin|mesh-list
2803681|NCT04196868|Methotrexate|methotrexate|mesh-list
2803682|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2803683|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803684|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2803685|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
2803686|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2278150|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2278151|NCT00217737|Growth Substances|growth substances|mesh-ancestor
2278152|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278153|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
2278154|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
2278155|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2278156|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2278157|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
2278158|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278159|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278160|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2278161|NCT00217737|Antidotes|antidotes|mesh-ancestor
2278162|NCT00217737|Protective Agents|protective agents|mesh-ancestor
2278163|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
2278164|NCT00217737|Vitamins|vitamins|mesh-ancestor
2278165|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
2278166|NCT00217737|Hematinics|hematinics|mesh-ancestor
2278167|NCT00217815|Efungumab|efungumab|mesh-list
2278168|NCT00217815|Docetaxel|docetaxel|mesh-list
2278169|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278170|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
2278171|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
2803687|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2803688|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
2278172|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
2803689|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803690|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803691|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
2803692|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803693|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2803694|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2803695|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
2803696|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2803697|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2803698|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
2803699|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2803700|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2803701|NCT04196452|Ipilimumab|ipilimumab|mesh-list
2803702|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2803703|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803704|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2803705|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803706|NCT04196400|Betamethasone|betamethasone|mesh-list
2803707|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2803708|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
2803709|NCT04196400|Hormones|hormones|mesh-ancestor
2278173|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278174|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
2278175|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2278176|NCT00217828|Citalopram|citalopram|mesh-list
2278177|NCT00217828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2278178|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2278179|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2278180|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278181|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278182|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
2278183|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278184|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2803710|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2803711|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803712|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2803713|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
2803714|NCT04196426|Calcium|calcium|mesh-list
2803715|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2803716|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803717|NCT04196309|Heparin|heparin|mesh-list
2803718|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2803719|NCT04196309|Tinzaparin|tinzaparin|mesh-list
2803720|NCT04196309|Dalteparin|dalteparin|mesh-list
2803721|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
2803722|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2803723|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2803724|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803725|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
2803726|NCT04196413|Fludarabine|fludarabine|mesh-list
2803727|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2803728|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
2803729|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803730|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2803731|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2803732|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
2803733|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803734|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803735|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2803736|NCT04196530|Atezolizumab|atezolizumab|mesh-list
2278185|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
2278186|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2278187|NCT00217932|Valproic Acid|valproic acid|mesh-list
2278188|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
2278189|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278190|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278191|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
2278192|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278193|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278194|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
2278195|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2278196|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2278197|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2278198|NCT00218049|Vanoxerine|vanoxerine|mesh-list
2803737|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803738|NCT04196608|Tazobactam|tazobactam|mesh-list
2803739|NCT04196608|Imipenem|imipenem|mesh-list
2803740|NCT04196608|Ceftolozane|ceftolozane|mesh-list
2803741|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2803742|NCT04196608|Relebactam|relebactam|mesh-list
2803743|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2803744|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803745|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2803746|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803747|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803748|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2803749|NCT04196608|Renal Agents|renal agents|mesh-ancestor
2803750|NCT04196270|Ropivacaine|ropivacaine|mesh-list
2803751|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
2803752|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
2803753|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803754|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803755|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
2803756|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803757|NCT04196439|Anesthetics|anesthetics|mesh-list
2803758|NCT04196439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2803759|NCT04196439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278199|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2278200|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2278201|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2278202|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278203|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
2278204|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278205|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278206|NCT00218075|Levodopa|levodopa|mesh-list
2278207|NCT00218075|Carbidopa|carbidopa|mesh-list
2278208|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2803782|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
2803783|NCT04196491|Fludarabine|fludarabine|mesh-list
2803784|NCT04196491|Lenalidomide|lenalidomide|mesh-list
2803785|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2803786|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
2803787|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803788|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2803789|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2803790|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
2803791|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803792|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803793|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2803794|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2803795|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2803796|NCT04196491|Growth Substances|growth substances|mesh-ancestor
2803797|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
2803798|NCT04195945|Cytarabine|cytarabine|mesh-list
2803799|NCT04195945|Daunorubicin|daunorubicin|mesh-list
2803800|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
2278209|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2803801|NCT04195945|Cladribine|cladribine|mesh-list
2803802|NCT04195945|Sargramostim|sargramostim|mesh-list
2803803|NCT04195945|Lenograstim|lenograstim|mesh-list
2803804|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2803805|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
2803806|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803807|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803808|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
2803809|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803810|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2803811|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
2803812|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803813|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2803814|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2278210|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
2278211|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278212|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278213|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278214|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2278215|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278216|NCT00218101|Buprenorphine|buprenorphine|mesh-list
2278217|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2803815|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2803816|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803817|NCT04195945|Analgesics|analgesics|mesh-ancestor
2803818|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
2803819|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803820|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2803821|NCT04196231|Insulin|insulin|mesh-list
2803822|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2803823|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2803824|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803825|NCT04195958|Omalizumab|omalizumab|mesh-list
2803826|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2803827|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2803828|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
2803829|NCT04195997|Heparin|heparin|mesh-list
2803830|NCT04195997|Bivalirudin|bivalirudin|mesh-list
2803831|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
2803832|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2803833|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2803834|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803835|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
2803836|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2803837|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
2803838|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803839|NCT04195828|Paclitaxel|paclitaxel|mesh-list
2803840|NCT04195828|Apatinib|apatinib|mesh-list
2803841|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2803842|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803843|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
2803844|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
2803845|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
2803846|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803847|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2803848|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803849|NCT04195698|Upadacitinib|upadacitinib|mesh-list
2803850|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2803851|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2803852|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803853|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803854|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2278218|NCT00218101|Narcotics|narcotics|mesh-ancestor
2278219|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2278220|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278221|NCT00218101|Analgesics|analgesics|mesh-ancestor
2278222|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
2278223|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278224|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2803883|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2803884|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2803885|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
2803886|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803887|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803888|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2803889|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
2803890|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2803891|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2803892|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2803893|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
2803894|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2803895|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803896|NCT04195373|Flucytosine|flucytosine|mesh-list
2803897|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
2803898|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803899|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
2803900|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104180|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2104181|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2104182|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2104183|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2104184|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104185|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2803912|NCT04195139|Nivolumab|nivolumab|mesh-list
2803913|NCT04195139|Temozolomide|temozolomide|mesh-list
2803914|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2803915|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803916|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2803917|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803918|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2803919|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
2803920|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
2803921|NCT04195243|Empagliflozin|empagliflozin|mesh-list
2803922|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2803923|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803924|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2803925|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803926|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2803927|NCT04195100|Pilocarpine|pilocarpine|mesh-list
2803928|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2803929|NCT04195100|Miotics|miotics|mesh-ancestor
2803930|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
2803931|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803932|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803933|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2803934|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2803935|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
2803936|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2803937|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803938|NCT04195321|Phenylephrine|phenylephrine|mesh-list
2803939|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
2803940|NCT04195321|Norepinephrine|norepinephrine|mesh-list
2803941|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2803942|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
2803943|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
2803944|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803945|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803946|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
2803947|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2803948|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
2803949|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
2803950|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2803951|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2803952|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2803953|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
2803954|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2803955|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803956|NCT04195321|Protective Agents|protective agents|mesh-ancestor
2803957|NCT04195074|Tenofovir|tenofovir|mesh-list
2803958|NCT04195074|Entecavir|entecavir|mesh-list
2803959|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
2803960|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2803961|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2803962|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2803963|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2803964|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803965|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2803966|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2803967|NCT04194827|Adalimumab|adalimumab|mesh-list
2803968|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2803969|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2803970|NCT04194957|Fluorouracil|fluorouracil|mesh-list
2803971|NCT04194957|Capecitabine|capecitabine|mesh-list
2803972|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
2803973|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2803974|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2803975|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803976|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2278225|NCT00218114|Valproic Acid|valproic acid|mesh-list
2278226|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
2278227|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278228|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278229|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
2278230|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278231|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278232|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
2803977|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
2803978|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278233|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2278234|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2278235|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2278236|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
2278237|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2278238|NCT00218127|Narcotics|narcotics|mesh-ancestor
2278239|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2104186|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2104187|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2104188|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2104189|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2104190|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
2104191|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104192|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104193|NCT02432716|Insulin|insulin|mesh-list
2104194|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2104195|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
2278240|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278241|NCT00218127|Analgesics|analgesics|mesh-ancestor
2278242|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
2278243|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278244|NCT00218140|Nicotine|nicotine|mesh-list
2278245|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2278246|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
2278247|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278248|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278249|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2278250|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2278251|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
2278252|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278253|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278254|NCT00218153|Naltrexone|naltrexone|mesh-list
2278255|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2278256|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2278257|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278258|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
2278259|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803979|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2803980|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2803981|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
2278260|NCT00218166|Triazolam|triazolam|mesh-list
2278261|NCT00218166|Tiagabine|tiagabine|mesh-list
2278262|NCT00218166|Baclofen|baclofen|mesh-list
2278263|NCT00218166|GABA Agonists|gaba agonists|mesh-list
2278264|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2278265|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278266|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2803982|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2803983|NCT04194905|Estradiol|estradiol|mesh-list
2803984|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2803985|NCT04194905|Estrogens|estrogens|mesh-ancestor
2803986|NCT04194905|Hormones|hormones|mesh-ancestor
2803987|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2803988|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2803989|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2803990|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
2803991|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2803992|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2803993|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2278267|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2803994|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2803995|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2803996|NCT04194658|Letrozole|letrozole|mesh-list
2803997|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2803998|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2803999|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2804000|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804001|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804002|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2804003|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
2804004|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804005|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804006|NCT04194684|Paclitaxel|paclitaxel|mesh-list
2804007|NCT04194684|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2804008|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2804009|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804010|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
2804011|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
2804012|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
2804013|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804014|NCT04194515|Metformin|metformin|mesh-list
2804015|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2278268|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2278269|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
2278270|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278271|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278272|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2278273|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2278274|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2278275|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2278276|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2278277|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
2804016|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804017|NCT04194359|Capecitabine|capecitabine|mesh-list
2804018|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
2804019|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804020|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2804021|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
2804022|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804023|NCT04194424|Metformin|metformin|mesh-list
2804024|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2804025|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804026|NCT04194294|Lidocaine|lidocaine|mesh-list
2804027|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
2804028|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
2804029|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804030|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804031|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
2804032|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804033|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2804034|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2804035|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2804036|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2804037|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804038|NCT04194125|Edotreotide|edotreotide|mesh-list
2804039|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2804040|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804041|NCT04194086|Posaconazole|posaconazole|mesh-list
2804042|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
2804043|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2804044|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2804045|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2804046|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2804047|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2804048|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2804049|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804050|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804051|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2804052|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
2804053|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2278278|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
2278279|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
2278280|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2278281|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2278282|NCT00218205|Celecoxib|celecoxib|mesh-list
2278283|NCT00218205|Epirubicin|epirubicin|mesh-list
2278284|NCT00218205|Estramustine|estramustine|mesh-list
2278285|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2278286|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2278287|NCT00218205|Analgesics|analgesics|mesh-ancestor
2278288|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
2278289|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278290|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278291|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2278292|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2278293|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2278294|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2278295|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278296|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804054|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804055|NCT04194216|Clindamycin|clindamycin|mesh-list
2804056|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
2804057|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
2804058|NCT04194216|Cephalexin|cephalexin|mesh-list
2804059|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2804060|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2804061|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2804062|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804063|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804064|NCT04194034|Flucytosine|flucytosine|mesh-list
2804065|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
2804066|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2804067|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
2804068|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804069|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
2804070|NCT04194255|Trace Elements|trace elements|mesh-ancestor
2804071|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
2804072|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804073|NCT04193930|Letrozole|letrozole|mesh-list
2804074|NCT04193930|Menotropins|menotropins|mesh-list
2804075|NCT04193930|Hormones|hormones|mesh-list
2804076|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2804077|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804078|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804079|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804080|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2804081|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2804082|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804083|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804084|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2804085|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
2804086|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2804087|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
2804088|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2804089|NCT04193878|Budesonide|budesonide|mesh-list
2804090|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
2804091|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2804092|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2804093|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
2804094|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804095|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804096|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2804097|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
2804098|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
2804099|NCT04193878|Hormones|hormones|mesh-ancestor
2804100|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804101|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2804102|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2804103|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2804104|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
2804105|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804106|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804107|NCT04193774|Benoxinate|benoxinate|mesh-list
2804108|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2804109|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
2804110|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2804111|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
2804112|NCT04193774|Anesthetics|anesthetics|mesh-ancestor
2804113|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804114|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804115|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
2804116|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804117|NCT04193982|Vitamin E|vitamin e|mesh-list
2804118|NCT04193982|Vitamins|vitamins|mesh-ancestor
2804119|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
2804120|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804121|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
2278297|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2278298|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278299|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2278300|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2278301|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2278302|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
2278303|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2278304|NCT00218218|Nicotine|nicotine|mesh-list
2278305|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2278306|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
2278307|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278308|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804122|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804123|NCT04193982|Protective Agents|protective agents|mesh-ancestor
2804124|NCT04193852|Dienogest|dienogest|mesh-list
2804125|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2804126|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2804127|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2804128|NCT04193852|Estradiol|estradiol|mesh-list
2804129|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2804130|NCT04193852|Nandrolone|nandrolone|mesh-list
2804131|NCT04193852|Estrogens|estrogens|mesh-ancestor
2804132|NCT04193852|Hormones|hormones|mesh-ancestor
2804133|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804134|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804135|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2804136|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
2278309|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2278310|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2278311|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
2278312|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278313|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278314|NCT00218231|Bupropion|bupropion|mesh-list
2278315|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2278316|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
2278317|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2278318|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2278319|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2278320|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2278321|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278322|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
2278323|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278324|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278325|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2278326|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2278327|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278328|NCT00218244|Lobeline|lobeline|mesh-list
2278329|NCT00218244|Nicotine|nicotine|mesh-list
2804137|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2804138|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2804139|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2804140|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2804141|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2804142|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
2804143|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2804144|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804145|NCT04193852|Androgens|androgens|mesh-ancestor
2804146|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
2804147|NCT04193631|Cannabidiol|cannabidiol|mesh-list
2804148|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
2278330|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2278331|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
2278332|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278333|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278334|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2278335|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2278336|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
2278337|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278338|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278339|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
2278340|NCT00218283|Nicotine|nicotine|mesh-list
2278341|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2804149|NCT04193592|Pirfenidone|pirfenidone|mesh-list
2804150|NCT04193592|Analgesics|analgesics|mesh-ancestor
2804151|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
2804152|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804153|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804154|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2804155|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2804156|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2804157|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2804158|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804159|NCT04193501|Melatonin|melatonin|mesh-list
2804160|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
2804161|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804162|NCT04193501|Protective Agents|protective agents|mesh-ancestor
2804163|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804164|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804165|NCT04193553|Lenvatinib|lenvatinib|mesh-list
2804166|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804167|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2804168|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804169|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804170|NCT04193319|Fluconazole|fluconazole|mesh-list
2804171|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
2804172|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2804173|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2804174|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2804175|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804176|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804177|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2804178|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
2804179|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804180|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804181|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2804182|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2804183|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
2804184|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2804185|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804186|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2804187|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804188|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
2804189|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2804190|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2804191|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804192|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804193|NCT04193215|Vaccines|vaccines|mesh-list
2804194|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
2804195|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804196|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
2804197|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2804198|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2804199|NCT04192981|GDC-0084|gdc-0084|mesh-list
2804200|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804201|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804202|NCT04193137|Captopril|captopril|mesh-list
2804203|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2804204|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
2804205|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804206|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804207|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2804208|NCT04192903|Cisplatin|cisplatin|mesh-list
2804209|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804210|NCT04193059|Paclitaxel|paclitaxel|mesh-list
2804211|NCT04193059|Docetaxel|docetaxel|mesh-list
2804212|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
2804213|NCT04193059|Carboplatin|carboplatin|mesh-list
2804214|NCT04193059|Trastuzumab|trastuzumab|mesh-list
2804215|NCT04193059|Epirubicin|epirubicin|mesh-list
2804216|NCT04193059|Pertuzumab|pertuzumab|mesh-list
2804217|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2804218|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804219|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
2804220|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
2804221|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
2804222|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804223|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2804224|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
2804225|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804226|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2804227|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2804228|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
2804229|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2804230|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2804231|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2804232|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2804233|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2804234|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804235|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
2804236|NCT04192916|Apixaban|apixaban|mesh-list
2804237|NCT04192916|Edoxaban|edoxaban|mesh-list
2804238|NCT04192916|Dabigatran|dabigatran|mesh-list
2804239|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2804240|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
2804241|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2804242|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
2804243|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804244|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804245|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
2804246|NCT04192812|Leuprolide|leuprolide|mesh-list
2804247|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2804248|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
2804249|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2804250|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804251|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2804252|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804253|NCT04192617|Methotrexate|methotrexate|mesh-list
2804254|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2804255|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
2804256|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2804257|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804258|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2804259|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
2804260|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804261|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804262|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
2804263|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804264|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2804265|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2804266|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
2804267|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2804268|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2804269|NCT04192773|Lidocaine|lidocaine|mesh-list
2804270|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
2804271|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
2804272|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804273|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804274|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
2804275|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804276|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2804277|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2804278|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2804279|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2804280|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804281|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
2804282|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2804283|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2278342|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
2804284|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804285|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
2804286|NCT04192643|Coagulants|coagulants|mesh-ancestor
2804287|NCT04192266|Estradiol|estradiol|mesh-list
2804288|NCT04192266|Estrogens|estrogens|mesh-ancestor
2804289|NCT04192266|Hormones|hormones|mesh-ancestor
2804290|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804291|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804294|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
2804295|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2804296|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2804297|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804298|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
2804299|NCT04192435|Coagulants|coagulants|mesh-ancestor
2278343|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278344|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278345|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2278346|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2278347|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
2278348|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278349|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278350|NCT00218309|Hydromorphone|hydromorphone|mesh-list
2278351|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2278352|NCT00218309|Narcotics|narcotics|mesh-ancestor
2804300|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2804301|NCT04192292|Gliclazide|gliclazide|mesh-list
2804302|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2804303|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2804304|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804305|NCT04192292|Incretins|incretins|mesh-ancestor
2804306|NCT04192292|Hormones|hormones|mesh-ancestor
2804307|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804308|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
2804309|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804310|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278353|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2278354|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278355|NCT00218309|Analgesics|analgesics|mesh-ancestor
2278356|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
2278357|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278358|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2278359|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2278360|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2278361|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2278362|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278363|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
2278364|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278365|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278366|NCT00218348|Amphetamine|amphetamine|mesh-list
2278367|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
2278368|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2278369|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278370|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
2278371|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
2278372|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278373|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
2278374|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278375|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278376|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
2278377|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2278378|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2804311|NCT04192253|Paclitaxel|paclitaxel|mesh-list
2804312|NCT04192253|Carboplatin|carboplatin|mesh-list
2804313|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2804314|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804315|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
2804316|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
2804317|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
2804318|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804319|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
2804320|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2804321|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2804322|NCT04192656|Prednisolone|prednisolone|mesh-list
2804323|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
2804324|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2804325|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
2804326|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2804327|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
2804328|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
2804329|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804330|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804331|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2804332|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
2804333|NCT04192656|Hormones|hormones|mesh-ancestor
2804334|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804335|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2804336|NCT04192656|Protective Agents|protective agents|mesh-ancestor
2804337|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2804338|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278379|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2278380|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2278381|NCT00218361|Hydromorphone|hydromorphone|mesh-list
2278382|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2278383|NCT00218361|Narcotics|narcotics|mesh-ancestor
2278384|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2278385|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804339|NCT04191889|Apatinib|apatinib|mesh-list
2804340|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804341|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2804342|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804343|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804344|NCT04191954|Fasudil|fasudil|mesh-list
2804345|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2804346|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
2278386|NCT00218361|Analgesics|analgesics|mesh-ancestor
2278387|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
2278388|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278389|NCT00218374|Gabapentin|gabapentin|mesh-list
2278390|NCT00218374|Analgesics|analgesics|mesh-ancestor
2278391|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
2278392|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278393|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278394|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
2278395|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2278396|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2278397|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2278398|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2278399|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2278400|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2278401|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804347|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2804348|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2804349|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2804350|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804351|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2804352|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804353|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
2804354|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2804355|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804356|NCT04192032|Nicotine|nicotine|mesh-list
2804357|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2804358|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
2804359|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804360|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804361|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2804362|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2804363|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
2804364|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804365|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804366|NCT04192019|Glucagon|glucagon|mesh-list
2804367|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2804368|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2804369|NCT04192019|Hormones|hormones|mesh-ancestor
2804370|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804371|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804372|NCT04192019|Incretins|incretins|mesh-ancestor
2804373|NCT04192331|Paclitaxel|paclitaxel|mesh-list
2804374|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2804375|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2804376|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804377|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
2804378|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
2804379|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
2804380|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804381|NCT04191694|Ondansetron|ondansetron|mesh-list
2804382|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
2804383|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
2804384|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804385|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804386|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2804387|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
2804388|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
2804389|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2804390|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
2804391|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804392|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804393|NCT04191694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2804394|NCT04191694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2804395|NCT04191694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804396|NCT04191694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2804397|NCT04191694|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2278402|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278403|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
2278404|NCT00218413|Vaccines|vaccines|mesh-list
2278405|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
2278406|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804398|NCT04191421|Spartalizumab|spartalizumab|mesh-list
2804399|NCT04191421|Siltuximab|siltuximab|mesh-list
2804400|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2804401|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804402|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804403|NCT04191681|Valsartan|valsartan|mesh-list
2804404|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2804405|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2804406|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2804407|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2804408|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804409|NCT04191863|Valproic Acid|valproic acid|mesh-list
2804410|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
2804411|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804412|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804413|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
2804414|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804415|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804416|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
2804417|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2804418|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804419|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2804420|NCT04191447|Budesonide|budesonide|mesh-list
2804421|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
2804422|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2804423|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2804424|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2804425|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
2804426|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804427|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804428|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2804429|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
2804430|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
2804431|NCT04191447|Hormones|hormones|mesh-ancestor
2804432|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804433|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2804434|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2804435|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2804436|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
2804437|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804438|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804439|NCT04191434|Budesonide|budesonide|mesh-list
2804440|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
2804441|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2804442|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2804443|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2804444|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
2804445|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804446|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804447|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2804448|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
2804449|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
2804450|NCT04191434|Hormones|hormones|mesh-ancestor
2804451|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804452|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2804453|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2804454|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2804455|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
2804456|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804457|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804458|NCT04191382|Letrozole|letrozole|mesh-list
2804459|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804460|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2804461|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2804462|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804463|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278407|NCT00218504|Dronabinol|dronabinol|mesh-list
2804464|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2804465|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
2804466|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804467|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804468|NCT04190927|Estradiol|estradiol|mesh-list
2804469|NCT04190927|Progesterone|progesterone|mesh-list
2804470|NCT04190927|Estrogens|estrogens|mesh-ancestor
2804471|NCT04190927|Hormones|hormones|mesh-ancestor
2804472|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804473|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804474|NCT04190927|Progestins|progestins|mesh-ancestor
2804475|NCT04191135|Gemcitabine|gemcitabine|mesh-list
2804476|NCT04191135|Carboplatin|carboplatin|mesh-list
2804477|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
2804478|NCT04191135|Olaparib|olaparib|mesh-list
2804479|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804480|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2804481|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
2804482|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804483|NCT04191135|Antiviral Agents|antiviral agents|mesh-ancestor
2804484|NCT04191135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2804485|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804486|NCT04191135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2804487|NCT04191135|Immunologic Factors|immunologic factors|mesh-ancestor
2804488|NCT04191135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804489|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2804490|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2804491|NCT04191148|Calcium|calcium|mesh-list
2804492|NCT04191148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2804493|NCT04191148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804494|NCT04191278|Varenicline|varenicline|mesh-list
2804495|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2804496|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2804497|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
2804498|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278408|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
2278409|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278410|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2804499|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804500|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804511|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
2804512|NCT04191096|Androgens|androgens|mesh-list
2804513|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2804514|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804515|NCT04191096|Hormones|hormones|mesh-ancestor
2804516|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804517|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804518|NCT04190745|Paclitaxel|paclitaxel|mesh-list
2804519|NCT04190745|Apatinib|apatinib|mesh-list
2804520|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2804521|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278411|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2278412|NCT00218504|Analgesics|analgesics|mesh-ancestor
2804522|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
2804523|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
2804524|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
2804525|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804526|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2804527|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278413|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
2278414|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278415|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2278416|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2278417|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278418|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278419|NCT00218504|Hormones|hormones|mesh-ancestor
2278420|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2278421|NCT00218517|Selegiline|selegiline|mesh-list
2278422|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
2278423|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2278424|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2278425|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2278426|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2278427|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278428|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278429|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2104196|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2104197|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104198|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
2104199|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2104200|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
2104201|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104202|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
2104203|NCT02432742|Protective Agents|protective agents|mesh-ancestor
2104204|NCT02433483|Cytarabine|cytarabine|mesh-list
2104205|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
2104206|NCT02433483|Methotrexate|methotrexate|mesh-list
2104207|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2104208|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
2104209|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2104210|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104211|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2104212|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
2104213|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104214|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278430|NCT00218517|Protective Agents|protective agents|mesh-ancestor
2278431|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278432|NCT00218530|Lofexidine|lofexidine|mesh-list
2278433|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2278434|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2278435|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104215|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
2804562|NCT04190173|Prucalopride|prucalopride|mesh-list
2804563|NCT04190173|Laxatives|laxatives|mesh-ancestor
2804564|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2804565|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2804566|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2804567|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
2278436|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
2278437|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278438|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2278439|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2278440|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2278441|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
2278442|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804568|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804569|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804570|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804571|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2804572|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
2804573|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2804574|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
2804575|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2804576|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804577|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2804578|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2804579|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804580|NCT04190160|Xultophy|xultophy|mesh-list
2804581|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2278443|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278444|NCT00218569|Naltrexone|naltrexone|mesh-list
2278445|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2278446|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2278447|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278448|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
2278449|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278450|NCT00218608|Disulfiram|disulfiram|mesh-list
2278451|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2278452|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2278453|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278454|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278455|NCT00218621|Buprenorphine|buprenorphine|mesh-list
2278456|NCT00218621|Methadone|methadone|mesh-list
2804582|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804583|NCT04190160|Incretins|incretins|mesh-ancestor
2804584|NCT04190160|Hormones|hormones|mesh-ancestor
2804585|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804586|NCT04190004|Vasopressins|vasopressins|mesh-list
2804587|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
2804588|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
2804589|NCT04190004|Coagulants|coagulants|mesh-ancestor
2804590|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2804591|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2804592|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
2804593|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278457|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2278458|NCT00218621|Narcotics|narcotics|mesh-ancestor
2278459|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2278460|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278461|NCT00218621|Analgesics|analgesics|mesh-ancestor
2278462|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
2278463|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278464|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2278465|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
2278466|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
2278467|NCT00218660|Naltrexone|naltrexone|mesh-list
2278468|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2278469|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2804610|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
2804611|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804612|NCT04189744|Metronidazole|metronidazole|mesh-list
2804613|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
2278470|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278471|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
2278472|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278473|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
2278474|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2278475|NCT00218855|Thalidomide|thalidomide|mesh-list
2278476|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2278477|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
2804614|NCT04189744|Piperaquine|piperaquine|mesh-list
2804615|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
2804616|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2278478|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278479|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
2278480|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2278481|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2278482|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2278483|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2278484|NCT00218855|Growth Substances|growth substances|mesh-ancestor
2278485|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
2278486|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278487|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
2278488|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2278489|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278490|NCT00219232|Rivastigmine|rivastigmine|mesh-list
2278491|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2278492|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278493|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278494|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
2278495|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278496|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278497|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2278498|NCT00219232|Protective Agents|protective agents|mesh-ancestor
2278499|NCT00219245|Rivastigmine|rivastigmine|mesh-list
2278500|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2278501|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278502|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278503|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
2278504|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278505|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278506|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2278507|NCT00219245|Protective Agents|protective agents|mesh-ancestor
2278508|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
2278509|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2278510|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278511|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
2278512|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2278513|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278514|NCT00219297|Epothilone B|epothilone b|mesh-list
2278515|NCT00219297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278516|NCT00219297|Tubulin Modulators|tubulin modulators|mesh-ancestor
2804617|NCT04189744|Artenimol|artenimol|mesh-list
2804618|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2804619|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2804620|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2804621|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2804622|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
2804623|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2278517|NCT00219297|Antimitotic Agents|antimitotic agents|mesh-ancestor
2278518|NCT00219297|Mitosis Modulators|mitosis modulators|mesh-ancestor
2278519|NCT00219297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278520|NCT00219310|Famciclovir|famciclovir|mesh-list
2804624|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804625|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804626|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2804627|NCT04189744|Renal Agents|renal agents|mesh-ancestor
2804628|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
2804629|NCT04189588|Promethazine|promethazine|mesh-list
2804630|NCT04189588|Cetirizine|cetirizine|mesh-list
2804631|NCT04189588|Paclitaxel|paclitaxel|mesh-list
2804632|NCT04189588|Rituximab|rituximab|mesh-list
2804633|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2804634|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804635|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
2804636|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
2804637|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
2804638|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804639|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2804640|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
2804641|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804642|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2804643|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2804644|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2804645|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804646|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
2804647|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
2804648|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
2278521|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
2278522|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2804649|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804650|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
2804651|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
2804652|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2804653|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2804654|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
2804655|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
2804656|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804657|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2804658|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
2804659|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
2278523|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2278524|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278525|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278526|NCT00219323|Omalizumab|omalizumab|mesh-list
2278527|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2278528|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2278529|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
2278530|NCT00219375|Sivelestat|sivelestat|mesh-list
2278531|NCT00219375|Glycine|glycine|mesh-list
2804660|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2804661|NCT04189783|Bupivacaine|bupivacaine|mesh-list
2804662|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
2804663|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
2804664|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804665|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804666|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
2804667|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804668|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
2804669|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
2804670|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804671|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2278532|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2278533|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
2278534|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278535|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278536|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
2278537|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278538|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278539|NCT00219388|Simendan|simendan|mesh-list
2278540|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2278541|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
2278542|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2278543|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2278544|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278545|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278546|NCT00219388|Protective Agents|protective agents|mesh-ancestor
2804672|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2804673|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804674|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
2804675|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
2804676|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804677|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
2804678|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804679|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804680|NCT04189484|Evolocumab|evolocumab|mesh-list
2804681|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2804682|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2804683|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2804684|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
2804685|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804686|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2804687|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
2804688|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278547|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278548|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2278549|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
2278550|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278551|NCT00219440|Metformin|metformin|mesh-list
2278552|NCT00219440|Pioglitazone|pioglitazone|mesh-list
2278553|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2278554|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278555|NCT00219466|Zinc|zinc|mesh-list
2278556|NCT00219466|Tocopherols|tocopherols|mesh-list
2278557|NCT00219466|Vitamin E|vitamin e|mesh-list
2278558|NCT00219466|Tocotrienols|tocotrienols|mesh-list
2278559|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
2278560|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
2278561|NCT00219466|Trace Elements|trace elements|mesh-ancestor
2278562|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
2278563|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278564|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
2278565|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278566|NCT00219466|Protective Agents|protective agents|mesh-ancestor
2804689|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
2804690|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
2804691|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
2804692|NCT04189211|Trastuzumab|trastuzumab|mesh-list
2804693|NCT04189211|Maytansine|maytansine|mesh-list
2804694|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2804695|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804696|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2804697|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
2804698|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
2804699|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
2804700|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804701|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2804702|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2804703|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804704|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804705|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2804706|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
2804707|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804708|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804709|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2804710|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
2804711|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2804712|NCT04189107|Dexamethasone|dexamethasone|mesh-list
2804713|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
2804714|NCT04189107|BB 1101|bb 1101|mesh-list
2804715|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2278567|NCT00219466|Vitamins|vitamins|mesh-ancestor
2278568|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
2278569|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
2278570|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2804716|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
2804717|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
2804718|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804719|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804720|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2804721|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
2804722|NCT04189107|Hormones|hormones|mesh-ancestor
2804723|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804724|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2278571|NCT00219479|Phenytoin|phenytoin|mesh-list
2278572|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
2804725|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804726|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
2804727|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804728|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804729|NCT04189094|Etoposide|etoposide|mesh-list
2804730|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804731|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2804732|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2804733|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2804734|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804735|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804736|NCT04189055|Irinotecan|irinotecan|mesh-list
2804737|NCT04189055|Cetuximab|cetuximab|mesh-list
2804738|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2804739|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2804740|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804741|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804742|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804743|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2278573|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2278574|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2278575|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2804744|NCT04188847|Apatinib|apatinib|mesh-list
2804745|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804746|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2804747|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804748|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804749|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
2804750|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2804751|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804752|NCT04188782|Sevoflurane|sevoflurane|mesh-list
2804753|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2804754|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2804755|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
2278576|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278577|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2278578|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2278579|NCT00219570|Clindamycin|clindamycin|mesh-list
2278580|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
2278581|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
2278582|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
2278583|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2278584|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2278585|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2278586|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278587|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804756|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
2804757|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804758|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804759|NCT04188860|Paclitaxel|paclitaxel|mesh-list
2804760|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2804761|NCT04188860|Antibodies|antibodies|mesh-list
2804762|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2804763|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804764|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
2804765|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
2804766|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
2804767|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804768|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
2804769|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804770|NCT04189666|Melatonin|melatonin|mesh-list
2804771|NCT04189666|Rivastigmine|rivastigmine|mesh-list
2804772|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
2804773|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804774|NCT04189666|Protective Agents|protective agents|mesh-ancestor
2804775|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804776|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804777|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2804778|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804779|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
2804780|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804781|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2804782|NCT04189198|Bupivacaine|bupivacaine|mesh-list
2804783|NCT04189198|Carticaine|carticaine|mesh-list
2804784|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
2804785|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
2804786|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804787|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804788|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
2278588|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2278589|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2278590|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278591|NCT00219596|Timolol|timolol|mesh-list
2278592|NCT00219596|Latanoprost|latanoprost|mesh-list
2278593|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2278594|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2278595|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
2278596|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278597|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278598|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278599|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2278600|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2278601|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2278602|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2278603|NCT00219700|Ibuprofen|ibuprofen|mesh-list
2278604|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2278605|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2278606|NCT00219700|Analgesics|analgesics|mesh-ancestor
2278607|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
2278608|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278609|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278610|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2278611|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2278612|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2278613|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278614|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278615|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
2278616|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2278617|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
2278618|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
2278619|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2278620|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278621|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2278622|NCT00219713|Analgesics|analgesics|mesh-ancestor
2278623|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
2278624|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278625|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
2278626|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278627|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2278628|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278629|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278630|NCT00219739|Interferons|interferons|mesh-list
2804789|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804790|NCT04188873|Varenicline|varenicline|mesh-list
2804791|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804792|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804793|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804794|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2804795|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2804796|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
2804797|NCT04188730|Lofexidine|lofexidine|mesh-list
2804798|NCT04188730|Clonidine|clonidine|mesh-list
2804799|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2804800|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2804801|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804802|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
2804803|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804804|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2804805|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2804806|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2804807|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
2804808|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804809|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804810|NCT04188730|Analgesics|analgesics|mesh-ancestor
2804811|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
2804812|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
2804813|NCT04188691|Vaccines|vaccines|mesh-list
2804814|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
2804815|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804816|NCT04188665|Lectins|lectins|mesh-list
2804817|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
2804818|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
2804819|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804820|NCT04188665|Coagulants|coagulants|mesh-ancestor
2804821|NCT04188483|Selenium|selenium|mesh-list
2804822|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804823|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
2804824|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804825|NCT04188483|Protective Agents|protective agents|mesh-ancestor
2804826|NCT04188483|Trace Elements|trace elements|mesh-ancestor
2804827|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
2804828|NCT04188392|Pimavanserin|pimavanserin|mesh-list
2804829|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2804830|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2804831|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2804832|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2804833|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804834|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804835|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2804836|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2804837|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2804838|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
2804839|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804840|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804841|NCT04188431|Dexamethasone|dexamethasone|mesh-list
2804842|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2804843|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
2804844|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
2804845|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804846|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804847|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2804848|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
2804849|NCT04188431|Hormones|hormones|mesh-ancestor
2804850|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2804851|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2804852|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804853|NCT04188574|Biguanides|biguanides|mesh-list
2804854|NCT04188574|Polihexanide|polihexanide|mesh-list
2804855|NCT04188574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2804856|NCT04188574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804857|NCT04188574|Disinfectants|disinfectants|mesh-ancestor
2804858|NCT04188574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2804859|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
2804860|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2804861|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
2804862|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804863|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
2278631|NCT00219739|Cytarabine|cytarabine|mesh-list
2278632|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
2278633|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278634|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
2278635|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2804864|NCT04188561|Protective Agents|protective agents|mesh-ancestor
2804865|NCT04188353|Mannitol|mannitol|mesh-list
2804866|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2804867|NCT04188353|Diuretics|diuretics|mesh-ancestor
2804868|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
2804869|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804870|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
2804871|NCT04188106|Varenicline|varenicline|mesh-list
2804872|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2804873|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2804874|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
2804875|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804876|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804877|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804878|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
2804879|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
2278636|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278637|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
2278638|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278639|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2278640|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
2278641|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278642|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2278643|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278644|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
2278645|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278646|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2278647|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278648|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278649|NCT00219765|Cytarabine|cytarabine|mesh-list
2278650|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
2278651|NCT00219765|Daunorubicin|daunorubicin|mesh-list
2804880|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2804881|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
2804882|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
2804883|NCT04188249|Golimumab|golimumab|mesh-list
2804884|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2278652|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278653|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
2278654|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278655|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278656|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
2278657|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2278658|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2278659|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
2278660|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278661|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2278662|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278663|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2278664|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2278665|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2278666|NCT00219778|Mifepristone|mifepristone|mesh-list
2278667|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2278668|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
2278669|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2278670|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278671|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2278672|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2278673|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2804885|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2804886|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2804887|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
2804888|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804889|NCT04188119|Aspirin|aspirin|mesh-list
2804890|NCT04188119|Avelumab|avelumab|mesh-list
2804891|NCT04188119|Lansoprazole|lansoprazole|mesh-list
2804892|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
2804893|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2804894|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2804895|NCT04188119|Analgesics|analgesics|mesh-ancestor
2804896|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
2804897|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804898|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804899|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2804900|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2804901|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2804902|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2804903|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804904|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2804905|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2804906|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804907|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
2804908|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2804909|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804910|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2804911|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2804912|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2804932|NCT04188158|Capecitabine|capecitabine|mesh-list
2804933|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
2804934|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2804935|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
2804936|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804937|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804938|NCT04188184|Epinephrine|epinephrine|mesh-list
2804939|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
2804940|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2804941|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2804942|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
2804943|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2804944|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804945|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804946|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2804947|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2804948|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
2804949|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2804950|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2804951|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
2804952|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
2804953|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
2804954|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2804955|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2804956|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2804957|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
2804958|NCT04188184|Coagulants|coagulants|mesh-ancestor
2804959|NCT04188171|Polidocanol|polidocanol|mesh-list
2804960|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2804961|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2804962|NCT04187833|Nivolumab|nivolumab|mesh-list
2804963|NCT04187833|Talazoparib|talazoparib|mesh-list
2804964|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2804965|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2804966|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2804967|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278674|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
2278675|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2278676|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2278677|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
2278678|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2278679|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
2278680|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2278681|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2278682|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
2278683|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2804968|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2804969|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2804970|NCT04188223|Vaccines|vaccines|mesh-list
2104216|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104217|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2104218|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2278684|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2278685|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2278686|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278687|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
2278688|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278689|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278690|NCT00219856|Propofol|propofol|mesh-list
2278691|NCT00219856|Desflurane|desflurane|mesh-list
2278692|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2278693|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2278694|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278695|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2278696|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
2278697|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
2278698|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2278699|NCT00219869|Galantamine|galantamine|mesh-list
2278700|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2278701|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104219|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
2104220|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2104221|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2104222|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
2104223|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2804971|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
2804972|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804973|NCT04188314|Desflurane|desflurane|mesh-list
2804974|NCT04188314|Isoflurane|isoflurane|mesh-list
2804975|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2804976|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
2804977|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
2804978|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804979|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804980|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
2804981|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2804982|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278702|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278703|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
2278704|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278705|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278706|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2278707|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
2278708|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278709|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
2278710|NCT00219882|Turmeric extract|turmeric extract|mesh-list
2278711|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
2278712|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278713|NCT00219882|Protective Agents|protective agents|mesh-ancestor
2278714|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278715|NCT00219895|Ibuprofen|ibuprofen|mesh-list
2278716|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2278717|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2278718|NCT00219895|Analgesics|analgesics|mesh-ancestor
2804983|NCT04187755|Ceftazidime|ceftazidime|mesh-list
2804984|NCT04187755|Cefepime|cefepime|mesh-list
2804985|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2804986|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2804987|NCT04187807|Melatonin|melatonin|mesh-list
2804988|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
2278719|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
2278720|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278721|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278722|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2278723|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2278724|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2278725|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278726|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278727|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
2278728|NCT00219908|Analgesics|analgesics|mesh-ancestor
2278729|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
2804989|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2804990|NCT04187807|Protective Agents|protective agents|mesh-ancestor
2104224|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2804991|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804992|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2804993|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
2804994|NCT04187898|Docetaxel|docetaxel|mesh-list
2804995|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2804996|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
2804997|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804998|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2278730|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278731|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278732|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278733|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2278734|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2278735|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278736|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278737|NCT00219921|Morphine|morphine|mesh-list
2278738|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2278739|NCT00219921|Narcotics|narcotics|mesh-ancestor
2278740|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2278741|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2804999|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2805000|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
2805001|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805002|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805003|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2805004|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
2805005|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
2805006|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
2805007|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
2805008|NCT04187469|Rifampin|rifampin|mesh-list
2805009|NCT04187469|Isoniazid|isoniazid|mesh-list
2805010|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
2805011|NCT04187469|Ethambutol|ethambutol|mesh-list
2805012|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2805013|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805014|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2805015|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2805016|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805017|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805018|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805019|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2805020|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
2805021|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
2805022|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2805023|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2805024|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2805025|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2805026|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2805027|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2805028|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2805029|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2805030|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2278742|NCT00219921|Analgesics|analgesics|mesh-ancestor
2278743|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
2278744|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278745|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2278746|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
2278747|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2278748|NCT00219973|Bemiparin|bemiparin|mesh-list
2278749|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
2278750|NCT00220051|Capecitabine|capecitabine|mesh-list
2278751|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
2278752|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278753|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
2278754|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278755|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278756|NCT00220064|Leucovorin|leucovorin|mesh-list
2278757|NCT00220064|Fluorouracil|fluorouracil|mesh-list
2278758|NCT00220064|Irinotecan|irinotecan|mesh-list
2278759|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
2805031|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
2805032|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2805033|NCT04187703|Azacitidine|azacitidine|mesh-list
2805034|NCT04187703|Decitabine|decitabine|mesh-list
2805035|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278760|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278761|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2805036|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
2805037|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805038|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805039|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805040|NCT04187352|Cisplatin|cisplatin|mesh-list
2805041|NCT04187352|Fluorouracil|fluorouracil|mesh-list
2805042|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805043|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
2805044|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805045|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2805046|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2805047|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
2805048|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805049|NCT04187417|Tetracaine|tetracaine|mesh-list
2805050|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
2805051|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
2805052|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2805053|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805054|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
2805055|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278762|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278763|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2278764|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
2278765|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278766|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2278767|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2278768|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278769|NCT00220064|Antidotes|antidotes|mesh-ancestor
2278770|NCT00220064|Protective Agents|protective agents|mesh-ancestor
2278771|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
2278772|NCT00220064|Vitamins|vitamins|mesh-ancestor
2278773|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
2278774|NCT00220103|Capecitabine|capecitabine|mesh-list
2278775|NCT00220103|Epirubicin|epirubicin|mesh-list
2278776|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278777|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278778|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
2805056|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
2805057|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2805058|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805059|NCT04187144|Renal Agents|renal agents|mesh-ancestor
2805060|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2805061|NCT04187456|Midazolam|midazolam|mesh-list
2805062|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2805063|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2805064|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2805065|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805066|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2278779|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278780|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2278781|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2278782|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2278783|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278784|NCT00220116|Capecitabine|capecitabine|mesh-list
2278785|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
2278786|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278787|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
2278788|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805067|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2805068|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2805069|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2805070|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
2805071|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
2805072|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
2805073|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
2805074|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805075|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805076|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
2805077|NCT04187105|Fludarabine|fludarabine|mesh-list
2805078|NCT04187105|Tacrolimus|tacrolimus|mesh-list
2805079|NCT04187105|Complement Factor H|complement factor h|mesh-list
2805080|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2805081|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
2805082|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805083|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2805084|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2805085|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
2805086|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805087|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805088|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2805089|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2805090|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805091|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2805092|NCT04186702|Ranibizumab|ranibizumab|mesh-list
2805093|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2278789|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278790|NCT00220129|Capecitabine|capecitabine|mesh-list
2278791|NCT00220129|Epirubicin|epirubicin|mesh-list
2278792|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278793|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278794|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
2278795|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278796|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2278797|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2278798|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2278799|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278800|NCT00220155|Gemcitabine|gemcitabine|mesh-list
2278801|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278802|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
2278803|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278804|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278805|NCT00220155|Antiviral Agents|antiviral agents|mesh-ancestor
2278806|NCT00220155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2278807|NCT00220155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278808|NCT00220155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2278809|NCT00220155|Immunologic Factors|immunologic factors|mesh-ancestor
2278810|NCT00220155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805094|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2805095|NCT04186702|Growth Substances|growth substances|mesh-ancestor
2805096|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805097|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
2805098|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278811|NCT00220168|Capecitabine|capecitabine|mesh-list
2278812|NCT00220168|Irinotecan|irinotecan|mesh-list
2278813|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2805101|NCT04186936|Simethicone|simethicone|mesh-list
2805102|NCT04186936|Loperamide|loperamide|mesh-list
2805103|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
2805104|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2805105|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
2805106|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805107|NCT04186936|Emollients|emollients|mesh-ancestor
2805108|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
2805109|NCT04187053|Methylene Blue|methylene blue|mesh-list
2805110|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805111|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805112|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
2805113|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
2805114|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2805115|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2805116|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805117|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
2805118|NCT04187014|Coagulants|coagulants|mesh-ancestor
2805119|NCT04186598|Nifedipine|nifedipine|mesh-list
2805120|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2805121|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2805122|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805123|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2805124|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805125|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
2805126|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
2805127|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2805128|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
2805129|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2805130|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805131|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805132|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2805133|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2805134|NCT04186559|Protective Agents|protective agents|mesh-ancestor
2805135|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805136|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
2805137|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2805138|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
2805139|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
2805140|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805141|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
2805142|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
2805143|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
2805150|NCT04186286|Propranolol|propranolol|mesh-list
2805151|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2805152|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2805153|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
2805154|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805155|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805156|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805157|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2805158|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2805159|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
2805160|NCT04186663|Fluorides|fluorides|mesh-list
2805161|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
2805162|NCT04186663|Protective Agents|protective agents|mesh-ancestor
2805163|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805164|NCT04186247|Azithromycin|azithromycin|mesh-list
2805165|NCT04186247|Metronidazole|metronidazole|mesh-list
2805166|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2278814|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
2278815|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278816|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278817|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2805167|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2278818|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2278819|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278820|NCT00220194|Leuprolide|leuprolide|mesh-list
2805168|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2805169|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2805170|NCT04186299|Clonidine|clonidine|mesh-list
2805171|NCT04186299|Epinephrine|epinephrine|mesh-list
2805172|NCT04186299|Carticaine|carticaine|mesh-list
2805173|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2805174|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2805175|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
2805176|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805177|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805178|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805179|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2805180|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2805181|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
2805182|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805183|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2805184|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
2805185|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
2805186|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
2805187|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2805188|NCT04186299|Analgesics|analgesics|mesh-ancestor
2805189|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
2805190|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2805191|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
2805192|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2805193|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
2805194|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
2805195|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2805196|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
2805197|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2805198|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2805199|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2805200|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2805201|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805202|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
2805203|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805204|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805205|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2805206|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805207|NCT04186013|Atezolizumab|atezolizumab|mesh-list
2805208|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805209|NCT04186026|Glucagon|glucagon|mesh-list
2805210|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2805211|NCT04186026|Incretins|incretins|mesh-ancestor
2805212|NCT04186026|Hormones|hormones|mesh-ancestor
2805213|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2805214|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805215|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2805216|NCT04185857|Olmesartan|olmesartan|mesh-list
2805217|NCT04185857|Canrenone|canrenone|mesh-list
2805218|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2805219|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2805220|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2805221|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805222|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2805223|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
2805224|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2805225|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805226|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2805227|NCT04185857|Diuretics|diuretics|mesh-ancestor
2805228|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
2805229|NCT04185675|Anesthetics|anesthetics|mesh-list
2805230|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2805231|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805232|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2805233|NCT04185831|Everolimus|everolimus|mesh-list
2805234|NCT04185831|Atezolizumab|atezolizumab|mesh-list
2805235|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805236|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2805237|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
2805238|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805239|NCT04185649|Capecitabine|capecitabine|mesh-list
2805240|NCT04185649|Lapatinib|lapatinib|mesh-list
2805241|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2805242|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
2805243|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805244|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805245|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2805246|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805254|NCT04185350|Exenatide|exenatide|mesh-list
2805255|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2805256|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805257|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2805258|NCT04185350|Incretins|incretins|mesh-ancestor
2805259|NCT04185350|Hormones|hormones|mesh-ancestor
2805260|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2805261|NCT04185402|Azithromycin|azithromycin|mesh-list
2805262|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2805263|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805264|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
2805265|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2805266|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
2805267|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
2805268|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2805269|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805270|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2805271|NCT04185233|Analgesics|analgesics|mesh-ancestor
2805272|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
2805273|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805274|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2805275|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278821|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2278822|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
2278823|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2278824|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278825|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2278826|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278827|NCT00220220|Amlodipine|amlodipine|mesh-list
2278828|NCT00220220|Olmesartan|olmesartan|mesh-list
2805276|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2805277|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805278|NCT04185077|Heparin|heparin|mesh-list
2805279|NCT04185077|Calcium heparin|calcium heparin|mesh-list
2805280|NCT04185077|Bivalirudin|bivalirudin|mesh-list
2805281|NCT04185077|Antithrombins|antithrombins|mesh-list
2278829|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2278830|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2278831|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2805282|NCT04185077|Thrombin|thrombin|mesh-list
2805283|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
2805284|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2805285|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2805286|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805287|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2805288|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
2805289|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805290|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
2805291|NCT04185077|Coagulants|coagulants|mesh-ancestor
2805292|NCT04185194|Lidocaine|lidocaine|mesh-list
2805293|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
2805294|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
2805295|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2805296|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805297|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
2805298|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805299|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2805300|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2278832|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2805301|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2805302|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2278833|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278834|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2278835|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278836|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
2278837|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2278838|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2278839|NCT00220233|Amlodipine|amlodipine|mesh-list
2278840|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2278841|NCT00220233|Olmesartan|olmesartan|mesh-list
2278842|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2278843|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2278844|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2278845|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2278846|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278847|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2278848|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278849|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
2278850|NCT00220233|Diuretics|diuretics|mesh-ancestor
2278851|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
2278852|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2278853|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2278854|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2278855|NCT00220259|Fluticasone|fluticasone|mesh-list
2278856|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2278857|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2278858|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
2278859|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2278860|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278861|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2278862|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
2278863|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
2278864|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2278865|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2278866|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
2278867|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278868|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
2278869|NCT00220298|Testosterone|testosterone|mesh-list
2278870|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
2278871|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
2278872|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2278873|NCT00220298|Androgens|androgens|mesh-ancestor
2805303|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805304|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2805305|NCT04184869|Belinostat|belinostat|mesh-list
2805306|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2805307|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2805308|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
2805309|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805310|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805311|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2805312|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2805313|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
2805314|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805315|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805316|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2805317|NCT04185103|Valsartan|valsartan|mesh-list
2805318|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2805319|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2805320|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2805321|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2805322|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805323|NCT04184921|Aspirin|aspirin|mesh-list
2805324|NCT04184921|Osimertinib|osimertinib|mesh-list
2805325|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2805326|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2278874|NCT00220298|Hormones|hormones|mesh-ancestor
2278875|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2805327|NCT04184921|Analgesics|analgesics|mesh-ancestor
2805328|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
2805329|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805330|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805331|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2805332|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2278876|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278877|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2278878|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278879|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
2278880|NCT00220311|Fludarabine|fludarabine|mesh-list
2278881|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
2278882|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278883|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278884|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
2278885|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278886|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2278887|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
2278888|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278889|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2278890|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2278891|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2278892|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2278893|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
2278894|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2278895|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278896|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2278897|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2278898|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2278899|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2278900|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2278901|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2805333|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2805334|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2805335|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805336|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2805337|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2805338|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805339|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
2805340|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805341|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2805342|NCT04184609|Bromides|bromides|mesh-list
2805343|NCT04184609|Albuterol|albuterol|mesh-list
2805344|NCT04184609|Ipratropium|ipratropium|mesh-list
2805345|NCT04184609|Anticonvulsants|anticonvulsants|mesh-ancestor
2805346|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2805347|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
2805348|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805349|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805350|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2805351|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
2805352|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
2805353|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2805354|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2805355|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2805356|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2805357|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
2805358|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805359|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805360|NCT04184609|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2805361|NCT04184609|Cholinergic Agents|cholinergic agents|mesh-ancestor
2805362|NCT04184518|Durvalumab|durvalumab|mesh-list
2805363|NCT04184518|Cediranib|cediranib|mesh-list
2805364|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2805365|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805366|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805367|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805368|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2805369|NCT04184466|Insulin|insulin|mesh-list
2278902|NCT00220337|Lacosamide|lacosamide|mesh-list
2278903|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
2278904|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2278905|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2278906|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2278907|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278908|NCT00220350|Leuprolide|leuprolide|mesh-list
2278909|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2278910|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
2805370|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2805371|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
2805372|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
2805373|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2805374|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2805375|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805376|NCT04184492|Insulin|insulin|mesh-list
2805377|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2805378|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
2805379|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
2805380|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2805381|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
2805382|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2805383|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
2805384|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2805385|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805386|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2805387|NCT04184505|Azacitidine|azacitidine|mesh-list
2805388|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2805389|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
2805390|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805391|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805392|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805393|NCT04183881|Brodalumab|brodalumab|mesh-list
2805394|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
2278911|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2278912|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278913|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2278914|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2278915|NCT00220428|Vaccines|vaccines|mesh-list
2278916|NCT00220428|Immunologic Factors|immunologic factors|mesh-ancestor
2278917|NCT00220428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278918|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
2278919|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2278920|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2278921|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2278922|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2278923|NCT00220480|Citalopram|citalopram|mesh-list
2278924|NCT00220480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2278925|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2278926|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2278927|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278928|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278929|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
2278930|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805395|NCT04184141|Alprazolam|alprazolam|mesh-list
2805396|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
2805397|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2805398|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2805399|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805400|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2805401|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2805402|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2805403|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
2805404|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
2805405|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805406|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805407|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
2805408|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
2805409|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2805410|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
2805411|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
2805412|NCT04184115|Scopolamine|scopolamine|mesh-list
2805413|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2805414|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
2805415|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
2805416|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805417|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805418|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2805419|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
2805420|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2805421|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
2805422|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805423|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805424|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2805425|NCT04183790|Ivacaftor|ivacaftor|mesh-list
2805426|NCT04183790|Elexacaftor|elexacaftor|mesh-list
2805427|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2805428|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2805429|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805439|NCT04183634|Rotigotine|rotigotine|mesh-list
2805440|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
2805441|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
2805442|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805443|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805444|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805445|NCT04183556|Naproxen|naproxen|mesh-list
2805446|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2805447|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2805448|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2805449|NCT04183556|Analgesics|analgesics|mesh-ancestor
2278931|NCT00220480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2278932|NCT00220480|Antidepressive Agents|antidepressive agents|mesh-ancestor
2278933|NCT00220480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2278934|NCT00220493|Methylphenidate|methylphenidate|mesh-list
2278935|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2278936|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278937|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2805450|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
2805451|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805452|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805453|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2805454|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
2805455|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2805456|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805457|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805458|NCT04183725|Oseltamivir|oseltamivir|mesh-list
2805459|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
2805460|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805461|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805462|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805463|NCT04183712|Gemcitabine|gemcitabine|mesh-list
2805464|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
2805465|NCT04183712|Afatinib|afatinib|mesh-list
2278938|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2805466|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2805467|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
2805468|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805469|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805470|NCT04183712|Antiviral Agents|antiviral agents|mesh-ancestor
2805471|NCT04183712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805472|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805473|NCT04183712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2805474|NCT04183712|Immunologic Factors|immunologic factors|mesh-ancestor
2805475|NCT04183712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805476|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2805477|NCT04183608|Adalimumab|adalimumab|mesh-list
2805478|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2805479|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2805480|NCT04183738|Ritonavir|ritonavir|mesh-list
2805481|NCT04183738|Darunavir|darunavir|mesh-list
2805482|NCT04183738|Dolutegravir|dolutegravir|mesh-list
2805483|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2805484|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2805485|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
2805486|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805487|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805488|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2805489|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2805490|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
2805491|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805492|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2805493|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2805494|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2805495|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2805496|NCT04183491|Interferons|interferons|mesh-list
2805497|NCT04183491|Interferon-beta|interferon-beta|mesh-list
2805498|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
2805499|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805500|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
2805501|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805502|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
2805503|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805504|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2805505|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2278939|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2278940|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278941|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
2278942|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278943|NCT00220506|Modafinil|modafinil|mesh-list
2278944|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2278945|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805506|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2805507|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2805508|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
2805509|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2805510|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805511|NCT04183452|Progestins|progestins|mesh-ancestor
2805512|NCT04183452|Hormones|hormones|mesh-ancestor
2805513|NCT04183361|Cortisone|cortisone|mesh-list
2805514|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2805515|NCT04183192|Reslizumab|reslizumab|mesh-list
2805516|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2805517|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
2805518|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2805519|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
2805520|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805521|NCT04183387|Simvastatin|simvastatin|mesh-list
2805522|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2805523|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2805524|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
2805525|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805526|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2805527|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2805528|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805529|NCT04183114|Vaccines|vaccines|mesh-list
2805530|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
2805531|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805532|NCT04183075|Vitamins|vitamins|mesh-list
2805533|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
2805534|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
2805535|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805536|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
2805537|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805538|NCT04183075|Protective Agents|protective agents|mesh-ancestor
2805539|NCT04183257|Vitamin D|vitamin d|mesh-list
2805540|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
2805541|NCT04183257|Vitamins|vitamins|mesh-list
2805542|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
2805543|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805544|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2805545|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2805546|NCT04183296|Propofol|propofol|mesh-list
2805547|NCT04183296|Sevoflurane|sevoflurane|mesh-list
2805548|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2805549|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2805550|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805551|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2805552|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
2805553|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
2805554|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2805555|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2805556|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
2805557|NCT04182984|Prednisone|prednisone|mesh-list
2805558|NCT04182984|Azathioprine|azathioprine|mesh-list
2805559|NCT04182984|Bromides|bromides|mesh-list
2805560|NCT04182984|Tacrolimus|tacrolimus|mesh-list
2805561|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2805562|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2805563|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2805564|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
2278946|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2278947|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2278948|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2278949|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278950|NCT00220532|Folic Acid|folic acid|mesh-list
2278951|NCT00220532|Riboflavin|riboflavin|mesh-list
2278952|NCT00220532|Hematinics|hematinics|mesh-ancestor
2278953|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
2278954|NCT00220532|Vitamins|vitamins|mesh-ancestor
2278955|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
2278956|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278957|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2278958|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
2278959|NCT00220584|Donepezil|donepezil|mesh-list
2278960|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2278961|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278962|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278963|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
2805565|NCT04182984|Hormones|hormones|mesh-ancestor
2805566|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2805567|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805568|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2805569|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805570|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
2805571|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2805572|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805573|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805574|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2805575|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2805576|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
2805577|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2805578|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805579|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
2805580|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
2805581|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2805582|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2805583|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2805584|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
2805585|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805593|NCT04183062|Gemcitabine|gemcitabine|mesh-list
2805594|NCT04183062|Docetaxel|docetaxel|mesh-list
2805595|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2805596|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
2805597|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805598|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805599|NCT04183062|Antiviral Agents|antiviral agents|mesh-ancestor
2805600|NCT04183062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805601|NCT04183062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805602|NCT04183062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2805603|NCT04183062|Immunologic Factors|immunologic factors|mesh-ancestor
2805604|NCT04183062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805605|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
2805606|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
2805607|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
2805608|NCT04182932|Vaccines|vaccines|mesh-list
2805609|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
2805610|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805611|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
2104225|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
2104226|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2104227|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104228|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2104229|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104230|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
2104231|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2805612|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2805613|NCT04182737|Antibodies|antibodies|mesh-list
2805614|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
2805615|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805616|NCT04182568|Paclitaxel|paclitaxel|mesh-list
2805617|NCT04182568|Docetaxel|docetaxel|mesh-list
2805618|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
2805619|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2805620|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805621|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
2805622|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
2805623|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
2805624|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805625|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2805626|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
2805627|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805628|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2805629|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2805630|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
2805631|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2805632|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2805633|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2805634|NCT04182854|Diuretics|diuretics|mesh-ancestor
2805635|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
2805636|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805637|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2805638|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2805639|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805640|NCT04182724|Paclitaxel|paclitaxel|mesh-list
2805641|NCT04182724|Apatinib|apatinib|mesh-list
2805642|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2805643|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805644|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
2805645|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
2805646|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
2805647|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805648|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2805649|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805650|NCT04182555|Bilirubin|bilirubin|mesh-list
2805651|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
2805652|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805653|NCT04182555|Protective Agents|protective agents|mesh-ancestor
2805654|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805655|NCT04182828|Lidocaine|lidocaine|mesh-list
2805656|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
2805657|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
2805658|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2805659|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805660|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
2805661|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805662|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2805663|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2805664|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2805665|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2805666|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805667|NCT04182191|Tenoxicam|tenoxicam|mesh-list
2805668|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2805669|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2805670|NCT04182191|Analgesics|analgesics|mesh-ancestor
2805671|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
2805672|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805673|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805674|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2805675|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2805676|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2805677|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805678|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805679|NCT04182373|Antithrombins|antithrombins|mesh-list
2805680|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
2805681|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2805682|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
2805683|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805684|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805685|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
2805686|NCT04182399|Zonisamide|zonisamide|mesh-list
2805687|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
2805688|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2805689|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2805690|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805691|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2805692|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805698|NCT04181996|Colchicine|colchicine|mesh-list
2805699|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
2805700|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2805701|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
2805702|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
2805703|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
2805704|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805705|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805706|NCT04182204|Gemcitabine|gemcitabine|mesh-list
2805707|NCT04182204|Rituximab|rituximab|mesh-list
2805708|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
2805709|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2805710|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805711|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
2805712|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805713|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2805714|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2805715|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
2805716|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805717|NCT04182204|Antiviral Agents|antiviral agents|mesh-ancestor
2805718|NCT04182204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805719|NCT04182204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805720|NCT04182204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2805721|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2805722|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2805723|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805724|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2805725|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2805726|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2805727|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805728|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
2805729|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805730|NCT04181645|Gemcitabine|gemcitabine|mesh-list
2805731|NCT04181645|Paclitaxel|paclitaxel|mesh-list
2805732|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2805733|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805734|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
2805735|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
2805736|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
2805737|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805738|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2805739|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
2805740|NCT04181645|Antiviral Agents|antiviral agents|mesh-ancestor
2805741|NCT04181645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805742|NCT04181645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805743|NCT04181645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2805744|NCT04181645|Immunologic Factors|immunologic factors|mesh-ancestor
2805745|NCT04181645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805746|NCT04181567|S 20098|s 20098|mesh-list
2805747|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2805748|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2805749|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805750|NCT04181736|Guanfacine|guanfacine|mesh-list
2805751|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2805752|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2805753|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2805754|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2278964|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2278965|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278966|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
2278967|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
2278968|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2278969|NCT00220649|Leucovorin|leucovorin|mesh-list
2278970|NCT00220649|Gemcitabine|gemcitabine|mesh-list
2805755|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
2805756|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805757|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805758|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805759|NCT04181749|Aspirin|aspirin|mesh-list
2805760|NCT04181749|Atorvastatin|atorvastatin|mesh-list
2805761|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2805762|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2278971|NCT00220649|Fluorouracil|fluorouracil|mesh-list
2278972|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
2278973|NCT00220649|Irinotecan|irinotecan|mesh-list
2278974|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2278975|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
2278976|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2278977|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805763|NCT04181749|Analgesics|analgesics|mesh-ancestor
2805764|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
2805765|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805766|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805767|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2805768|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2805769|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2805770|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2805771|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805772|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2805773|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2805774|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805775|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
2805776|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2805777|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2805778|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
2805779|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2805780|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2278978|NCT00220649|Antiviral Agents|antiviral agents|mesh-ancestor
2278979|NCT00220649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2278980|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2278981|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2278982|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
2278983|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278984|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2278985|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2278986|NCT00220649|Antidotes|antidotes|mesh-ancestor
2278987|NCT00220649|Protective Agents|protective agents|mesh-ancestor
2278988|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
2805786|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
2805787|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2805788|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
2805789|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805790|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805791|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2805792|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
2805793|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2805794|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
2805795|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805796|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805797|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2805798|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
2805799|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
2805800|NCT04181359|Protective Agents|protective agents|mesh-ancestor
2805801|NCT04181255|Poractant alfa|poractant alfa|mesh-list
2805802|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2805803|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
2805804|NCT04181385|Bromocriptine|bromocriptine|mesh-list
2805805|NCT04181385|Olanzapine|olanzapine|mesh-list
2805806|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
2805807|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
2805808|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805809|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805810|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2805811|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2805812|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2805813|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2805814|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2805815|NCT04181385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2805816|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2805817|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2805818|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805819|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805820|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
2805821|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2805822|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2805823|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
2805824|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2805825|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
2805826|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
2805827|NCT04181489|Prednisolone|prednisolone|mesh-list
2805828|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
2805829|NCT04181489|Rituximab|rituximab|mesh-list
2278989|NCT00220649|Vitamins|vitamins|mesh-ancestor
2278990|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
2278991|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
2278992|NCT00220675|Hematinics|hematinics|mesh-ancestor
2278993|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
2278994|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2278995|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2278996|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2278997|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2278998|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
2278999|NCT00220766|Antibodies|antibodies|mesh-list
2279000|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
2279001|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2279002|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2279003|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
2279004|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
2279005|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279006|NCT00220818|Lansoprazole|lansoprazole|mesh-list
2279007|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
2279008|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2279009|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2805830|NCT04181489|Doxorubicin|doxorubicin|mesh-list
2805831|NCT04181489|Vincristine|vincristine|mesh-list
2805832|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2805833|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
2805834|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805835|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2805836|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2805837|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
2805838|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805839|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805840|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2805841|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2805842|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2805843|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2805844|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2805845|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805846|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2805847|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
2805848|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
2805849|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
2805850|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2805851|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
2805852|NCT04181489|Hormones|hormones|mesh-ancestor
2279010|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2279011|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279012|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279013|NCT00220831|Vitamin E|vitamin e|mesh-list
2279014|NCT00220831|Vitamins|vitamins|mesh-ancestor
2279015|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
2279016|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279017|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
2279018|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279019|NCT00220831|Protective Agents|protective agents|mesh-ancestor
2279020|NCT00220844|Amitriptyline|amitriptyline|mesh-list
2279021|NCT00220844|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2279022|NCT00220844|Desipramine|desipramine|mesh-list
2279023|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2805853|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2805854|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2805855|NCT04181346|Pregabalin|pregabalin|mesh-list
2805856|NCT04181346|Analgesics|analgesics|mesh-ancestor
2805857|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
2805858|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805859|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805860|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
2805861|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2805862|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2805863|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805864|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2805865|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2805866|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2805867|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279024|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
2279025|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279026|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2279027|NCT00220844|Analgesics|analgesics|mesh-ancestor
2279028|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
2279029|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279030|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279031|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2279032|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2279033|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2279034|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279035|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
2805868|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2805869|NCT04181203|Leuprolide|leuprolide|mesh-list
2805870|NCT04181203|Goserelin|goserelin|mesh-list
2805871|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2805872|NCT04181203|Hormones|hormones|mesh-list
2805873|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2805874|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805875|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2805876|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
2805877|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2805878|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2805879|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805880|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
2805881|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2805882|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
2805883|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2805884|NCT04180982|Febuxostat|febuxostat|mesh-list
2805885|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
2805886|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2805887|NCT04180943|Bupivacaine|bupivacaine|mesh-list
2805888|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
2805889|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
2805890|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2805891|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805892|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
2805893|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805899|NCT04181008|Amiloride|amiloride|mesh-list
2805900|NCT04181008|Diuretics|diuretics|mesh-ancestor
2805901|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
2805902|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805903|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2805904|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2805905|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2805906|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805907|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2805908|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2805909|NCT04180657|Protein C|protein c|mesh-list
2805910|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
2805911|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2805912|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2805913|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279036|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279037|NCT00220844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2279038|NCT00220844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279039|NCT00220844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279040|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279041|NCT00220857|Rabeprazole|rabeprazole|mesh-list
2279042|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2279043|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2279044|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2279045|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104232|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2104233|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2104234|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2104235|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
2104236|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104237|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104238|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104239|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2104240|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
2104241|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279046|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279047|NCT00220896|Donepezil|donepezil|mesh-list
2279048|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2805914|NCT04180397|Furosemide|furosemide|mesh-list
2805915|NCT04180397|Diuretics|diuretics|mesh-ancestor
2805916|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
2805917|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805918|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2805919|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2805920|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805921|NCT04180384|Paclitaxel|paclitaxel|mesh-list
2805922|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2805923|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2805924|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805925|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
2805926|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
2805927|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
2805928|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805929|NCT04180085|Abatacept|abatacept|mesh-list
2805930|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2805931|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279049|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279050|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279051|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
2279052|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279053|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279054|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
2279055|NCT00220909|Lansoprazole|lansoprazole|mesh-list
2279056|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
2279057|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2279058|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2279059|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2279060|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279061|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279062|NCT00220922|Ethanol|ethanol|mesh-list
2279063|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2279064|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2805932|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805933|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2805934|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
2805935|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805936|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2805937|NCT04180072|Bevacizumab|bevacizumab|mesh-list
2805938|NCT04180072|Atezolizumab|atezolizumab|mesh-list
2805939|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2805940|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805941|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2805942|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2805943|NCT04180072|Growth Substances|growth substances|mesh-ancestor
2805944|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805945|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
2104242|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2104243|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
2104244|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2279065|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279066|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805953|NCT04180150|Entecavir|entecavir|mesh-list
2805954|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
2805955|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104245|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2104246|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2104247|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
2104248|NCT02434081|Nivolumab|nivolumab|mesh-list
2104249|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2104250|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805959|NCT04180007|Apatinib|apatinib|mesh-list
2805960|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2805961|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2805962|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805963|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805964|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
2805965|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805966|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
2805967|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2805968|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2805969|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805970|NCT04179747|Urological Agents|urological agents|mesh-ancestor
2805971|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
2805972|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2805973|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
2805974|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2805975|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805976|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2104251|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2104252|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805977|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
2805978|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2805979|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
2805980|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805981|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2805982|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2805983|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
2805984|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
2805985|NCT04179942|Protective Agents|protective agents|mesh-ancestor
2805986|NCT04179604|Simendan|simendan|mesh-list
2805987|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2805988|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
2805989|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2805990|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2805991|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2805992|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2805993|NCT04179604|Protective Agents|protective agents|mesh-ancestor
2805994|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2805995|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
2805996|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
2805997|NCT04179500|Bedaquiline|bedaquiline|mesh-list
2805998|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2805999|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806000|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2806001|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2806002|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806003|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806004|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806005|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
2806006|NCT04179396|Rucaparib|rucaparib|mesh-list
2806007|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2806008|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806009|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806010|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806011|NCT04179513|Methotrexate|methotrexate|mesh-list
2806012|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2806013|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
2806014|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2806015|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806016|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2806017|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
2806018|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806019|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806020|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
2806021|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806022|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2806023|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2806024|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
2806025|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2806026|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2806027|NCT04179617|Nicotine|nicotine|mesh-list
2806028|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2806029|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
2806030|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806031|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806032|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2806033|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2806034|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
2806035|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806036|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806037|NCT04179071|Famotidine|famotidine|mesh-list
2806038|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2806039|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2806040|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2806041|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
2806042|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
2806043|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806044|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806045|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806046|NCT04178863|Timolol|timolol|mesh-list
2806047|NCT04178863|Latanoprost|latanoprost|mesh-list
2806048|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2806049|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2806050|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
2806051|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806052|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806053|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806054|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2806055|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2806056|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2806057|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2806058|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
2806059|NCT04179110|Ramucirumab|ramucirumab|mesh-list
2806060|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2806061|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279067|NCT00220987|Insulin|insulin|mesh-list
2279068|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2279069|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2279070|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279071|NCT00221000|Methoxsalen|methoxsalen|mesh-list
2279072|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2279073|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
2279074|NCT00221026|Methoxsalen|methoxsalen|mesh-list
2279075|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2279076|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
2279077|NCT00221039|Methoxsalen|methoxsalen|mesh-list
2279078|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2279079|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
2279080|NCT00221052|Diclofenac|diclofenac|mesh-list
2279081|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2279082|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2279083|NCT00221052|Analgesics|analgesics|mesh-ancestor
2279084|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
2279085|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279086|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279087|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2279088|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2279089|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2279090|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279091|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279092|NCT00221156|Acarbose|acarbose|mesh-list
2279093|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2279094|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279095|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279096|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2279097|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806062|NCT04179045|Sirolimus|sirolimus|mesh-list
2806063|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2806064|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806065|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2806066|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806067|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
2806068|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2806069|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
2279098|NCT00221260|Anesthetics|anesthetics|mesh-list
2279099|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279100|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806070|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806071|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
2806072|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2806073|NCT04178980|Simvastatin|simvastatin|mesh-list
2806074|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2806075|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2806076|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
2806077|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806078|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2806079|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2806080|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806081|NCT04178850|Folic Acid|folic acid|mesh-list
2806082|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
2806083|NCT04178850|Infliximab|infliximab|mesh-list
2806084|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
2806085|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2806086|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2806087|NCT04178850|Hematinics|hematinics|mesh-ancestor
2806088|NCT04178850|Vitamins|vitamins|mesh-ancestor
2806089|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
2806090|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806094|NCT04178876|Ethanol|ethanol|mesh-list
2806095|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2806096|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806097|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806098|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806099|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
2806100|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2806101|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2806102|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806103|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
2806104|NCT04178655|Coagulants|coagulants|mesh-ancestor
2806107|NCT04178785|Remifentanil|remifentanil|mesh-list
2806108|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2806109|NCT04178785|Narcotics|narcotics|mesh-ancestor
2806110|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806111|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806112|NCT04178785|Analgesics|analgesics|mesh-ancestor
2806113|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
2806114|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806115|NCT04178642|Idarubicin|idarubicin|mesh-list
2806116|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
2806117|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2806118|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806119|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2806120|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2806121|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806122|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806123|NCT04178460|Niraparib|niraparib|mesh-list
2806124|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2806125|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806126|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806127|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806128|NCT04178291|Erythritol|erythritol|mesh-list
2806129|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
2806130|NCT04178512|Dexamethasone|dexamethasone|mesh-list
2806131|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
2806132|NCT04178512|Fentanyl|fentanyl|mesh-list
2806133|NCT04178512|BB 1101|bb 1101|mesh-list
2806134|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2806135|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
2806136|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
2806137|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806138|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806139|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2806140|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
2806141|NCT04178512|Hormones|hormones|mesh-ancestor
2806142|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2806143|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2806144|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806145|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
2806146|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806147|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806148|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2806149|NCT04178512|Narcotics|narcotics|mesh-ancestor
2806150|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806151|NCT04178512|Analgesics|analgesics|mesh-ancestor
2806152|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
2806153|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2806154|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2806155|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
2806156|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
2806157|NCT04178148|Amikacin|amikacin|mesh-list
2806158|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2806159|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806160|NCT04178200|Lidocaine|lidocaine|mesh-list
2806161|NCT04178200|Bupivacaine|bupivacaine|mesh-list
2806162|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2806163|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
2806164|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
2806165|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806166|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806167|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
2806168|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806169|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2806170|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2806171|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2806172|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2806173|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806174|NCT04178005|Cladribine|cladribine|mesh-list
2806175|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806176|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2806177|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
2806178|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806179|NCT04177953|Carboplatin|carboplatin|mesh-list
2806180|NCT04177953|Nivolumab|nivolumab|mesh-list
2806181|NCT04177953|Pemetrexed|pemetrexed|mesh-list
2806182|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806183|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2806184|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2806185|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806186|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806187|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2806188|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2806189|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2806190|NCT04178057|Antibodies|antibodies|mesh-list
2806191|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
2806192|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2806193|NCT04178057|Mitogens|mitogens|mesh-list
2806194|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
2806195|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
2806196|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806197|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806198|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
2806199|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806200|NCT04178057|Growth Substances|growth substances|mesh-ancestor
2806201|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2806202|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2806203|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2806204|NCT04177875|Paclitaxel|paclitaxel|mesh-list
2806205|NCT04177875|Docetaxel|docetaxel|mesh-list
2806206|NCT04177875|Cisplatin|cisplatin|mesh-list
2806207|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2806208|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2806209|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806210|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
2806211|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
2806212|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
2806213|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806214|NCT04177641|Antioxidants|antioxidants|mesh-list
2806215|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806216|NCT04177641|Protective Agents|protective agents|mesh-ancestor
2806217|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806232|NCT04178109|Acetaminophen|acetaminophen|mesh-list
2806233|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2806234|NCT04178109|Tramadol|tramadol|mesh-list
2806235|NCT04178109|Ropivacaine|ropivacaine|mesh-list
2806236|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
2806237|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
2806238|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
2279101|NCT00221286|Interferons|interferons|mesh-list
2279102|NCT00221286|Tenofovir|tenofovir|mesh-list
2279103|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
2279104|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
2279105|NCT00221286|Emtricitabine|emtricitabine|mesh-list
2279106|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2279107|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279108|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
2806239|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806240|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806241|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
2806242|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806243|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2806244|NCT04178109|Analgesics|analgesics|mesh-ancestor
2806245|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
2806246|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2806247|NCT04178109|Narcotics|narcotics|mesh-ancestor
2806248|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2806249|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2806250|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2806251|NCT04177810|Plerixafor|plerixafor|mesh-list
2806252|NCT04177810|Cemiplimab|cemiplimab|mesh-list
2279109|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279110|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2806253|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2279111|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2279112|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279113|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279114|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2279115|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2279116|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
2279117|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279118|NCT00221312|Alendronate|alendronate|mesh-list
2806254|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2806255|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
2806256|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806257|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2806258|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806259|NCT04177693|Letrozole|letrozole|mesh-list
2806260|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2806261|NCT04177693|Clomiphene|clomiphene|mesh-list
2806262|NCT04177693|Enclomiphene|enclomiphene|mesh-list
2806263|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
2806264|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806265|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806266|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2806267|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2806268|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806269|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2806270|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
2806271|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2806272|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806273|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2806274|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
2279119|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2279120|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279121|NCT00221325|Rituximab|rituximab|mesh-list
2279122|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2279123|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279124|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
2279125|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279126|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2279127|NCT00221364|Azithromycin|azithromycin|mesh-list
2279128|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2806275|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2806276|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2806277|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2806278|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
2806279|NCT04177693|Protective Agents|protective agents|mesh-ancestor
2806280|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2806281|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2806282|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2806283|NCT04177719|Oxytocin|oxytocin|mesh-list
2806284|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
2806285|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2806286|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806287|NCT04177602|Trifluridine|trifluridine|mesh-list
2806288|NCT04177602|Capecitabine|capecitabine|mesh-list
2806289|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2806290|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
2806291|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806292|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806293|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
2806294|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806295|NCT04177498|ON 01910|on 01910|mesh-list
2806296|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806297|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2806298|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806299|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806300|NCT04177342|Fentanyl|fentanyl|mesh-list
2806301|NCT04177342|Oxycodone|oxycodone|mesh-list
2806302|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2806303|NCT04177342|Narcotics|narcotics|mesh-ancestor
2806304|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806305|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806306|NCT04177342|Analgesics|analgesics|mesh-ancestor
2806307|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
2806308|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806309|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2806310|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2806311|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
2806312|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
2806313|NCT04177173|Methotrexate|methotrexate|mesh-list
2806314|NCT04177173|Simvastatin|simvastatin|mesh-list
2806315|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2806316|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
2806317|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2806318|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806319|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2806320|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
2806321|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806322|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806323|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
2806324|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806325|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2806326|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2806327|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
2806328|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2806329|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2806330|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2806331|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2806332|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2806333|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2806334|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
2806335|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2806336|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2806337|NCT04177433|Prednisolone|prednisolone|mesh-list
2806338|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
2279129|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279130|NCT00221390|Ropinirole|ropinirole|mesh-list
2279131|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2279132|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2279133|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
2279134|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
2104253|NCT02434328|Aflibercept|aflibercept|mesh-list
2104254|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2104255|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2104256|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2104257|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2104258|NCT02434328|Growth Substances|growth substances|mesh-ancestor
2104259|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104260|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
2104261|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806339|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2806340|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
2806341|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2104265|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2104266|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2104267|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2104268|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
2104269|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806342|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
2806343|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
2806344|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806345|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806346|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2806347|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
2279135|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806348|NCT04177433|Hormones|hormones|mesh-ancestor
2806349|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2806350|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2806351|NCT04177433|Protective Agents|protective agents|mesh-ancestor
2806352|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2806353|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806354|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
2806355|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2806356|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2806357|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806358|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
2806359|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806360|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806361|NCT04177108|Paclitaxel|paclitaxel|mesh-list
2806362|NCT04177108|Atezolizumab|atezolizumab|mesh-list
2806363|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2806364|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2806365|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806366|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
2806367|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
2806368|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
2806369|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806370|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
2806371|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806372|NCT04177004|Sirolimus|sirolimus|mesh-list
2806373|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
2806374|NCT04177004|Etoposide|etoposide|mesh-list
2806375|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
2806376|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
2806377|NCT04177004|Tacrolimus|tacrolimus|mesh-list
2806378|NCT04177004|Mitogens|mitogens|mesh-list
2279136|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279137|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279138|NCT00221416|Aripiprazole|aripiprazole|mesh-list
2279139|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
2279140|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279141|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2279142|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279143|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279144|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279145|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
2279146|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
2279147|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279148|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279149|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2279150|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2279151|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
2279152|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2279153|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2279154|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2806379|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2279155|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2279156|NCT00221429|Valproic Acid|valproic acid|mesh-list
2279157|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279158|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279159|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279160|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
2279161|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279162|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279163|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279164|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
2279165|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
2279166|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279167|NCT00221442|Zonisamide|zonisamide|mesh-list
2279168|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
2279169|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2279170|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2279171|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279172|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2279173|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279174|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2279175|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
2279176|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279177|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2279178|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2806380|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
2806381|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279179|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279180|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279181|NCT00221481|Valproic Acid|valproic acid|mesh-list
2279182|NCT00221481|Olanzapine|olanzapine|mesh-list
2806382|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2806383|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2806384|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
2806385|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806386|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806387|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2806388|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2806389|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2806390|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2806391|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806392|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2806393|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2806394|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806395|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2806396|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
2806397|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
2279183|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
2279184|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
2279185|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279186|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806398|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
2806399|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
2806400|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
2806401|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
2806402|NCT04177303|Metformin|metformin|mesh-list
2806403|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2806404|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806405|NCT04177043|Antibodies|antibodies|mesh-list
2806406|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
2806407|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
2806408|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806409|NCT04177082|Riboflavin|riboflavin|mesh-list
2806410|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
2806411|NCT04177082|Vitamins|vitamins|mesh-ancestor
2279187|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2806412|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
2806413|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806414|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2806415|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
2806416|NCT04176835|Oxytocin|oxytocin|mesh-list
2806417|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
2806418|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2806419|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806420|NCT04177095|Sirolimus|sirolimus|mesh-list
2806421|NCT04177095|Prednisone|prednisone|mesh-list
2104270|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2104271|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2104272|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104273|NCT02434523|Amitriptyline|amitriptyline|mesh-list
2104274|NCT02434523|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2806422|NCT04177095|Everolimus|everolimus|mesh-list
2806423|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2806424|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
2806425|NCT04177095|Hormones|hormones|mesh-ancestor
2806426|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2806427|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806428|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2806429|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806430|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2806431|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
2806432|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2806433|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2806434|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806435|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
2806436|NCT04176887|Phenytoin|phenytoin|mesh-list
2806437|NCT04176887|Levetiracetam|levetiracetam|mesh-list
2806438|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
2806439|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
2806440|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2806441|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2104275|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2104276|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
2806442|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2806443|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279188|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2279189|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279190|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279191|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279192|NCT00221481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2279193|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2279194|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2806444|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2806445|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2806446|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2806447|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2806448|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2806449|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
2806450|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806451|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2806452|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2806453|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806454|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
2806455|NCT04176783|Narcotics|narcotics|mesh-ancestor
2806456|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806457|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806458|NCT04176783|Analgesics|analgesics|mesh-ancestor
2806459|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
2806460|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279195|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279196|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279197|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
2279198|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
2279199|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279200|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
2279201|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
2279202|NCT00221494|Pindolol|pindolol|mesh-list
2279203|NCT00221494|Citalopram|citalopram|mesh-list
2279204|NCT00221494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2279205|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2279206|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2279207|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279208|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279209|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
2279210|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104277|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2104278|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2104279|NCT02434523|Analgesics|analgesics|mesh-ancestor
2104280|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
2104281|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104282|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104283|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2104284|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2104285|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2104286|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104287|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
2104288|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104289|NCT02434523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2806497|NCT04176354|Letrozole|letrozole|mesh-list
2806498|NCT04176354|Palbociclib|palbociclib|mesh-list
2806499|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2806500|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806501|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2806502|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806503|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279211|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2279212|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
2279213|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2806504|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2806505|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
2806506|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2806507|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806508|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2806509|NCT04176224|Edaravone|edaravone|mesh-list
2806510|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2806511|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
2806512|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806513|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2806514|NCT04176224|Protective Agents|protective agents|mesh-ancestor
2806515|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806516|NCT04176393|Ivosidenib|ivosidenib|mesh-list
2806517|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806518|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806519|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806520|NCT04176367|Nicergoline|nicergoline|mesh-list
2806521|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2279214|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2279215|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2279216|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
2279217|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2279218|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2279219|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
2806522|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2806523|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
2806524|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806525|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806526|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806527|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
2806528|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
2806529|NCT04176016|Edetic Acid|edetic acid|mesh-list
2806530|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
2806531|NCT04176016|Antidotes|antidotes|mesh-ancestor
2806532|NCT04176016|Protective Agents|protective agents|mesh-ancestor
2279220|NCT00221520|Midazolam|midazolam|mesh-list
2279221|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2279222|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2806533|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806534|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
2806535|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
2806536|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806537|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2806538|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
2806539|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2806540|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
2806541|NCT04175990|Progestins|progestins|mesh-ancestor
2806542|NCT04175990|Hormones|hormones|mesh-ancestor
2279223|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279224|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279225|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2279226|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279227|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279228|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2279229|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
2279230|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
2279231|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
2279232|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
2279233|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279234|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279235|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
2279236|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2279237|NCT00221611|Baclofen|baclofen|mesh-list
2279238|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2279239|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279240|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2279241|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279242|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2279243|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
2806543|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2806544|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806545|NCT04176328|Teicoplanin|teicoplanin|mesh-list
2806546|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2806547|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806548|NCT04176055|Haloperidol|haloperidol|mesh-list
2806549|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
2806550|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
2806551|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
2806552|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806553|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806554|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2806555|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2806556|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2806557|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806558|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2806559|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2279244|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
2279245|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279246|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279247|NCT00221624|Ribavirin|ribavirin|mesh-list
2279248|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2279249|NCT00221624|Amantadine|amantadine|mesh-list
2279250|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
2279251|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279252|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
2279253|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279254|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2279255|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2806560|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
2806561|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806562|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806563|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2806564|NCT04176068|Calcium|calcium|mesh-list
2806565|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2104290|NCT02434523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2104291|NCT02434523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2104292|NCT02434770|Vaccines|vaccines|mesh-list
2104293|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
2104294|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104295|NCT02434939|Morphine|morphine|mesh-list
2104296|NCT02434939|Ketamine|ketamine|mesh-list
2104297|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2104298|NCT02434939|Narcotics|narcotics|mesh-ancestor
2104299|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2104300|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104301|NCT02434939|Analgesics|analgesics|mesh-ancestor
2104302|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
2104303|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104304|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2104305|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2104306|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
2104307|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
2279256|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
2279257|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279258|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279259|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2279260|NCT00221624|Analgesics|analgesics|mesh-ancestor
2279261|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
2279262|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279263|NCT00221637|Valproic Acid|valproic acid|mesh-list
2279264|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
2279265|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279266|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279267|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
2279268|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279269|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279270|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
2279271|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279272|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279273|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279274|NCT00221650|Ribavirin|ribavirin|mesh-list
2806566|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806567|NCT04175886|Tofacitinib|tofacitinib|mesh-list
2806568|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2806569|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806570|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806574|NCT04175925|Famotidine|famotidine|mesh-list
2806575|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2806576|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2806577|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2806578|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
2806579|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
2806580|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806581|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806582|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279275|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2279276|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
2279277|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279278|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
2279279|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279280|NCT00221689|Baclofen|baclofen|mesh-list
2279281|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2279282|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279283|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2806592|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2806593|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
2806594|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2806595|NCT04175522|Antibodies|antibodies|mesh-list
2806596|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
2806597|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
2806598|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279284|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279285|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2279286|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
2279287|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
2279288|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279289|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279290|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2279291|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
2279292|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806599|NCT04175587|Tretinoin|tretinoin|mesh-list
2806600|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
2806601|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806602|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
2806603|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
2806618|NCT04175470|Tocotrienols|tocotrienols|mesh-list
2806619|NCT04175470|Vitamin E|vitamin e|mesh-list
2806620|NCT04175470|Tocopherols|tocopherols|mesh-list
2806621|NCT04175470|Bevacizumab|bevacizumab|mesh-list
2806622|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2806623|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806624|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2806625|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2806626|NCT04175470|Growth Substances|growth substances|mesh-ancestor
2806627|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806628|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
2806629|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
2806630|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806631|NCT04175470|Protective Agents|protective agents|mesh-ancestor
2806632|NCT04175470|Vitamins|vitamins|mesh-ancestor
2806633|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
2806634|NCT04175626|Sirolimus|sirolimus|mesh-list
2279293|NCT00221754|Pravastatin|pravastatin|mesh-list
2279294|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2279295|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2279296|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
2806635|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2806636|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806637|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2806638|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806639|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
2806640|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2806641|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
2806642|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806643|NCT04175171|Trastuzumab|trastuzumab|mesh-list
2806644|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2806645|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806646|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
2806647|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806648|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806649|NCT04175158|Bevacizumab|bevacizumab|mesh-list
2806650|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
2806651|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2806652|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806653|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2806654|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2279297|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806655|NCT04175158|Growth Substances|growth substances|mesh-ancestor
2806656|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806657|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
2806658|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2806659|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806660|NCT04175067|Antioxidants|antioxidants|mesh-list
2806661|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806662|NCT04175067|Protective Agents|protective agents|mesh-ancestor
2806663|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806664|NCT04175002|Progesterone|progesterone|mesh-list
2806665|NCT04175002|Progestins|progestins|mesh-ancestor
2806666|NCT04175002|Hormones|hormones|mesh-ancestor
2806667|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2806668|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806669|NCT04174872|Midazolam|midazolam|mesh-list
2806670|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
2806671|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2806672|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806673|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806674|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2806675|NCT04174872|Analgesics|analgesics|mesh-ancestor
2806676|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
2806677|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806678|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2806679|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2806680|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2806681|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
2806682|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806683|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806684|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2806685|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2806686|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2806687|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2806688|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2806689|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
2806690|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
2806691|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
2806692|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
2806710|NCT04174339|Apatinib|apatinib|mesh-list
2806711|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806712|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2806713|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279298|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2279299|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2279300|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806714|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806715|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2806716|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
2806717|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2806718|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
2806719|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2806720|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806721|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2806722|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2806723|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279301|NCT00221845|Telmisartan|telmisartan|mesh-list
2279302|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2279303|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2279304|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2279305|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806724|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
2806725|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
2806726|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806727|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806728|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806729|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
2806730|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
2806731|NCT04174352|Tamoxifen|tamoxifen|mesh-list
2806732|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2806733|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
2806734|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2806735|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806736|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2806737|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806738|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2806739|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2806740|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2806741|NCT04174261|Clopidogrel|clopidogrel|mesh-list
2806742|NCT04174261|Ticagrelor|ticagrelor|mesh-list
2806743|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2806744|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2806745|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2806746|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2806747|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
2806748|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806749|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806750|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279306|NCT00221871|Ketamine|ketamine|mesh-list
2279307|NCT00221871|Analgesics|analgesics|mesh-ancestor
2279308|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
2279309|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279310|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806751|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
2806752|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2806753|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2806754|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806755|NCT04173832|Amantadine|amantadine|mesh-list
2806756|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2806757|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2806758|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
2806759|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806760|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
2806761|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806762|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806763|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806764|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2806765|NCT04173832|Analgesics|analgesics|mesh-ancestor
2806766|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
2806767|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806768|NCT04174131|Lidocaine|lidocaine|mesh-list
2806769|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
2806770|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
2806771|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
2806772|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806773|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806774|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
2806775|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806776|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2806777|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2806778|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2806779|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2806780|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806781|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2806782|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
2806783|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
2806784|NCT04174131|Protective Agents|protective agents|mesh-ancestor
2806785|NCT04173858|Naloxegol|naloxegol|mesh-list
2104308|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2104309|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2104310|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104311|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104312|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2104313|NCT02435069|Glycerol|glycerol|mesh-list
2104314|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2104315|NCT02435069|Protective Agents|protective agents|mesh-ancestor
2104316|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104317|NCT02435147|Denosumab|denosumab|mesh-list
2104318|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2104319|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104320|NCT02435277|Metformin|metformin|mesh-list
2104321|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2104322|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104325|NCT02435680|Gemcitabine|gemcitabine|mesh-list
2104326|NCT02435680|Carboplatin|carboplatin|mesh-list
2806786|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2806787|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806788|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
2806789|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806790|NCT04173962|Midazolam|midazolam|mesh-list
2806791|NCT04173962|Ketamine|ketamine|mesh-list
2806792|NCT04173962|Analgesics|analgesics|mesh-ancestor
2806793|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
2806794|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806795|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806796|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2806797|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2806798|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
2806799|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
2806800|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806801|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2806802|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2806803|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806804|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806805|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2806806|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2806807|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2806808|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2806809|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2806810|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
2806811|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
2806812|NCT04174170|Sertraline|sertraline|mesh-list
2806813|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
2806814|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
2806815|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2806816|NCT04174170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2806817|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2806818|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2806819|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806820|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806821|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
2806822|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806823|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
2806824|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
2806825|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
2806826|NCT04173988|Fludarabine|fludarabine|mesh-list
2806827|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2806828|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
2806829|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806830|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2806831|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2806832|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
2806833|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279311|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2279312|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2279313|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
2279314|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
2279315|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279316|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2279317|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2279318|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279319|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279320|NCT00221962|Aripiprazole|aripiprazole|mesh-list
2806834|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806835|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2806836|NCT04173949|Ramipril|ramipril|mesh-list
2806837|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2806838|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
2806839|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806840|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806841|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2806842|NCT04173793|Ezetimibe|ezetimibe|mesh-list
2806843|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2806844|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2806845|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
2806846|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806847|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2806848|NCT04173780|Atropine|atropine|mesh-list
2806849|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2806850|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2806851|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2806852|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
2806853|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806854|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806855|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2806856|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
2806857|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
2806858|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
2806859|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2806860|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2806861|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
2806862|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806863|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806864|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
2806865|NCT04173416|Narcotics|narcotics|mesh-ancestor
2806866|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806867|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806868|NCT04173416|Analgesics|analgesics|mesh-ancestor
2806869|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
2806870|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806871|NCT04173403|Ezetimibe|ezetimibe|mesh-list
2806872|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2806873|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2806874|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
2806875|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806876|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2806877|NCT04173585|Bortezomib|bortezomib|mesh-list
2806878|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
2806879|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806880|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2806881|NCT04173390|Pregabalin|pregabalin|mesh-list
2806882|NCT04173390|Analgesics|analgesics|mesh-ancestor
2806883|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
2806884|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806885|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806886|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
2806887|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2806888|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2806889|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806890|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2806891|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2806892|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2806893|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806894|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2806895|NCT04173507|Avelumab|avelumab|mesh-list
2806896|NCT04173507|Talazoparib|talazoparib|mesh-list
2806897|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2806898|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2806899|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806900|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2806901|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806902|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806903|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
2806904|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806905|NCT04173494|Danazol|danazol|mesh-list
2806906|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2806907|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2806908|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
2806909|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2806910|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806911|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2806912|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806913|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806914|NCT04173611|Bupivacaine|bupivacaine|mesh-list
2806915|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
2806916|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
2806917|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806918|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806919|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
2279321|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
2279322|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279323|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2279324|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279325|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279326|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279327|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
2279328|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
2279329|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279330|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279331|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2279332|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2279333|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
2279334|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2279335|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2279336|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2279337|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2279338|NCT00221975|Lamotrigine|lamotrigine|mesh-list
2279339|NCT00221975|Valproic Acid|valproic acid|mesh-list
2279340|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279341|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279342|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279343|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
2279344|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2806920|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279345|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279346|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279347|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
2279348|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2279349|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2279350|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2279351|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2279352|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2279353|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
2279354|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2806921|NCT04173364|Ropivacaine|ropivacaine|mesh-list
2806922|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2806923|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
2806924|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
2806925|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806926|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806927|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
2806928|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806929|NCT04173338|Pemetrexed|pemetrexed|mesh-list
2806930|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806931|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806932|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806933|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2806934|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2806935|NCT04173325|Nivolumab|nivolumab|mesh-list
2806936|NCT04173325|Irinotecan|irinotecan|mesh-list
2806937|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2806938|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806939|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2806940|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806941|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2806942|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2806943|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806944|NCT04173039|Antibodies|antibodies|mesh-list
2806945|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
2806946|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806947|NCT04172961|Cyclosporine|cyclosporine|mesh-list
2806948|NCT04172961|Lifitegrast|lifitegrast|mesh-list
2806949|NCT04172961|Cyclosporins|cyclosporins|mesh-list
2806950|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2806951|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2806952|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2806953|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
2806954|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806955|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
2806956|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806957|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
2806958|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2806959|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2806960|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2806961|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2806962|NCT04172987|Tirzepatide|tirzepatide|mesh-list
2806963|NCT04172987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2806964|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806965|NCT04172987|Incretins|incretins|mesh-ancestor
2806966|NCT04172987|Hormones|hormones|mesh-ancestor
2806967|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2806968|NCT04173312|Bupivacaine|bupivacaine|mesh-list
2806969|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
2806970|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
2806971|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806972|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806973|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
2806974|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2806975|NCT04172922|Sirolimus|sirolimus|mesh-list
2806976|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2806977|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2806978|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2806979|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2806980|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
2806981|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2806982|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
2806983|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2806984|NCT04172727|Bupivacaine|bupivacaine|mesh-list
2806985|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
2279355|NCT00221988|Levetiracetam|levetiracetam|mesh-list
2279356|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
2279357|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
2279358|NCT00222053|Thalidomide|thalidomide|mesh-list
2806986|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
2806987|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2806988|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279359|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2279360|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
2806989|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
2806990|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807001|NCT04172844|Azacitidine|azacitidine|mesh-list
2807002|NCT04172844|Venetoclax|venetoclax|mesh-list
2807003|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2807004|NCT04172844|Pevonedistat|pevonedistat|mesh-list
2807005|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2807006|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
2807007|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807008|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807009|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
2807010|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2807011|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
2807012|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2807013|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2807014|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807015|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2807016|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807017|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279361|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279362|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
2279363|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2279364|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279365|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2279366|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2279367|NCT00222053|Growth Substances|growth substances|mesh-ancestor
2279368|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
2279369|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279370|NCT00222079|Esomeprazole|esomeprazole|mesh-list
2279371|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2279372|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2279373|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2807018|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279374|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807019|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2807020|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807021|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2807022|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807023|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807024|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
2807025|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
2807026|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807027|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807028|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279375|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279376|NCT00222144|Docetaxel|docetaxel|mesh-list
2279377|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
2279378|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279379|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
2279380|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
2279381|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
2279382|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279383|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2279384|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279385|NCT00222170|Rabeprazole|rabeprazole|mesh-list
2279386|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2279387|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2279388|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2279389|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279390|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279391|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
2279392|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2279393|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2279394|NCT00222183|Analgesics|analgesics|mesh-ancestor
2279395|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
2279396|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279397|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279398|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2279399|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2279400|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
2807029|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2807030|NCT04172740|Calcium|calcium|mesh-list
2807031|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2807032|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807033|NCT04172363|Octenidine|octenidine|mesh-list
2807034|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807035|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2807036|NCT04172311|Levetiracetam|levetiracetam|mesh-list
2807037|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
2807038|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
2807039|NCT04172220|Midazolam|midazolam|mesh-list
2807040|NCT04172220|Anesthetics|anesthetics|mesh-list
2807041|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807042|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807043|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2807044|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2807045|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2807046|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2807047|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2807048|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2807049|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
2807050|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
2807051|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
2807052|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807053|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807054|NCT04172064|Dobutamine|dobutamine|mesh-list
2807055|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2807056|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
2807057|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
2807058|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807059|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807060|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2807061|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2807062|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2807063|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
2807064|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807065|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807066|NCT04172064|Protective Agents|protective agents|mesh-ancestor
2279401|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2807067|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
2807068|NCT04172259|Docetaxel|docetaxel|mesh-list
2807069|NCT04172259|Doxorubicin|doxorubicin|mesh-list
2807070|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2807071|NCT04172259|Trastuzumab|trastuzumab|mesh-list
2807072|NCT04172259|Epirubicin|epirubicin|mesh-list
2807073|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2807074|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
2807075|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807076|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2807077|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2807078|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
2807079|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807080|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807081|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2807082|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
2807083|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
2807084|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
2807085|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2807086|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2807087|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2807088|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807089|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2807090|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
2807091|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807092|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2807093|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807094|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807095|NCT04171791|Venetoclax|venetoclax|mesh-list
2807096|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807097|NCT04171726|Edoxaban|edoxaban|mesh-list
2807098|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2807099|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
2807100|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2279402|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
2279403|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2279404|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279405|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279406|NCT00222235|Cycloserine|cycloserine|mesh-list
2279407|NCT00222235|Glycine|glycine|mesh-list
2279408|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2279409|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279410|NCT00222235|Renal Agents|renal agents|mesh-ancestor
2279411|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2279412|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
2279413|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2279414|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
2807101|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
2807102|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807103|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807104|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
2807110|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
2807111|NCT04171622|Lenvatinib|lenvatinib|mesh-list
2807112|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2807113|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807114|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2807115|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807116|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807117|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
2807118|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2807119|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807120|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
2807121|NCT04171687|Clopidogrel|clopidogrel|mesh-list
2807122|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2807123|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2807124|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2807125|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2807126|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
2807127|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807128|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807129|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807130|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
2807131|NCT04171843|Fludarabine|fludarabine|mesh-list
2807132|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2279415|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279416|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
2279417|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279418|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279419|NCT00222261|Aspirin|aspirin|mesh-list
2807133|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
2807134|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807135|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2807136|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2807137|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
2807138|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807139|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807140|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2807141|NCT04171388|Micronutrients|micronutrients|mesh-list
2807142|NCT04171388|Trace Elements|trace elements|mesh-list
2807143|NCT04171388|Azithromycin|azithromycin|mesh-list
2807144|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2807145|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807146|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807161|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
2807162|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
2807163|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2807164|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807165|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807166|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
2807167|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2807168|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807169|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807170|NCT04171739|Itraconazole|itraconazole|mesh-list
2807171|NCT04171739|Olorofim|olorofim|mesh-list
2807172|NCT04171739|Rifampin|rifampin|mesh-list
2807173|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
2807174|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279420|NCT00222261|Clopidogrel|clopidogrel|mesh-list
2279421|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2279422|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2279423|NCT00222261|Analgesics|analgesics|mesh-ancestor
2279424|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
2279425|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279426|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279427|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2279428|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2279429|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2279430|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2279431|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279432|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2279433|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2807175|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2807176|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2807177|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807178|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807179|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2807180|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
2807181|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2807182|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807183|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2807184|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2807185|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
2807186|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2807187|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
2807188|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2807189|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2279434|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279435|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
2279436|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2807190|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2807191|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2807192|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2807193|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2807194|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2807195|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
2807196|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2807197|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2807198|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807199|NCT04171466|Metronidazole|metronidazole|mesh-list
2807200|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
2807201|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807202|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2807203|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2807204|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2807205|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2807206|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2807207|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807208|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279437|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2279438|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2279439|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
2279440|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279441|NCT00222443|Irinotecan|irinotecan|mesh-list
2279442|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2279443|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2279444|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279445|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279446|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279447|NCT00222469|Gemcitabine|gemcitabine|mesh-list
2279448|NCT00222469|Bevacizumab|bevacizumab|mesh-list
2279449|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
2279450|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2279451|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279452|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2279453|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2279454|NCT00222469|Growth Substances|growth substances|mesh-ancestor
2279455|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279456|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
2279457|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2279458|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
2279459|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807209|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807210|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2807211|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2279460|NCT00222469|Antiviral Agents|antiviral agents|mesh-ancestor
2279461|NCT00222469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279462|NCT00222469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279463|NCT00222469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2279464|NCT00222469|Immunologic Factors|immunologic factors|mesh-ancestor
2279465|NCT00222482|Valproic Acid|valproic acid|mesh-list
2279466|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
2279467|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279468|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279469|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
2807212|NCT04171180|Budesonide|budesonide|mesh-list
2807213|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
2807214|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2807215|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2807216|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
2807217|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807218|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807219|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2807220|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
2807221|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
2807222|NCT04171180|Hormones|hormones|mesh-ancestor
2807223|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2807224|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2807225|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2807226|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2807227|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
2807228|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807229|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807230|NCT04171167|Fluticasone|fluticasone|mesh-list
2807231|NCT04171167|Xhance|xhance|mesh-list
2807232|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2807233|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2807234|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
2807235|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807236|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807237|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2807238|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
2807239|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
2807240|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2807241|NCT04171193|Isoflurane|isoflurane|mesh-list
2807242|NCT04171193|Sertraline|sertraline|mesh-list
2807243|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
2807244|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2807245|NCT04171193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2807246|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2807247|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2807248|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807249|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807250|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
2807251|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807252|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2807253|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
2807254|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
2807255|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807256|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
2807257|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2807258|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2807259|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2807260|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2807261|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807262|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
2807263|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807264|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807265|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2807266|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807267|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
2807268|NCT04171349|Carticaine|carticaine|mesh-list
2807269|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2807270|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807271|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807272|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2807273|NCT04171349|Analgesics|analgesics|mesh-ancestor
2807274|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
2807275|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807276|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2807277|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2807278|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2807279|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
2807280|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807281|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807282|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
2807283|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
2807284|NCT04171284|Docetaxel|docetaxel|mesh-list
2279470|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279471|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279472|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
2279473|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279474|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279475|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279476|NCT00222495|Olanzapine|olanzapine|mesh-list
2279477|NCT00222495|Risperidone|risperidone|mesh-list
2279478|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2807285|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279479|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2279480|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
2807286|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
2807287|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
2807288|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
2807289|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807290|NCT04171050|Anesthetics|anesthetics|mesh-list
2807291|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
2807292|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807293|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807294|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
2807295|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807312|NCT04170855|Furosemide|furosemide|mesh-list
2807313|NCT04170855|Diuretics|diuretics|mesh-ancestor
2807314|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
2807315|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807316|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2807317|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2807318|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807319|NCT04170751|Vasopressins|vasopressins|mesh-list
2807320|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
2807321|NCT04170751|Norepinephrine|norepinephrine|mesh-list
2807322|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2807323|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2807324|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
2807325|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807326|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807327|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807328|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
2807329|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
2807330|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807331|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2279481|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279482|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807332|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
2807333|NCT04170751|Coagulants|coagulants|mesh-ancestor
2807334|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2807335|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
2807336|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
2807337|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2807338|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807339|NCT04170946|Talazoparib|talazoparib|mesh-list
2807340|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2807341|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279483|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279484|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2279485|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279486|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279487|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279488|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2279489|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
2279490|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
2279491|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
2279492|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279493|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2279494|NCT00222495|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2279495|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2807342|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807343|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807344|NCT04170959|Metformin|metformin|mesh-list
2807345|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2807346|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807347|NCT04170595|Trastuzumab|trastuzumab|mesh-list
2807348|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2807349|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807350|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
2807351|NCT04170530|Irinotecan|irinotecan|mesh-list
2807352|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807353|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2807354|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2807355|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807356|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807360|NCT04170790|Saxagliptin|saxagliptin|mesh-list
2807361|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
2807362|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
2807363|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2807364|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2807365|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807366|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807367|NCT04170790|Urological Agents|urological agents|mesh-ancestor
2807368|NCT04170790|Incretins|incretins|mesh-ancestor
2807369|NCT04170790|Hormones|hormones|mesh-ancestor
2807370|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2807371|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807372|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2807373|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
2807374|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2807375|NCT04170647|Plasminogen|plasminogen|mesh-list
2807376|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2807377|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2807378|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807379|NCT04170439|Chromium|chromium|mesh-list
2807380|NCT04170439|Metformin|metformin|mesh-list
2807381|NCT04170439|Citric Acid|citric acid|mesh-list
2807382|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
2807383|NCT04170439|Clomiphene|clomiphene|mesh-list
2807384|NCT04170439|Enclomiphene|enclomiphene|mesh-list
2807385|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
2807386|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2807387|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807388|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
2807389|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2807390|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
2807391|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
2807392|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807393|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2807394|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
2807395|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2807396|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2807397|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
2807398|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2279496|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2279497|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
2279498|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
2279499|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2279500|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279501|NCT00222534|Acetazolamide|acetazolamide|mesh-list
2807399|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2807400|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2807401|NCT04170439|Trace Elements|trace elements|mesh-ancestor
2807402|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
2807403|NCT04170504|Methotrexate|methotrexate|mesh-list
2807404|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2807405|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
2807406|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2807407|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807408|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2807409|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
2807410|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807411|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807412|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
2807413|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807414|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2807415|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2807416|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
2807417|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2807418|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2807419|NCT04170556|Nivolumab|nivolumab|mesh-list
2807420|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2807421|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807422|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2807423|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807424|NCT04170270|Omeprazole|omeprazole|mesh-list
2807425|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2807426|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2807427|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2807428|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807429|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807435|NCT04170179|Lenvatinib|lenvatinib|mesh-list
2807436|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807437|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2807438|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807439|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807440|NCT04170465|Metformin|metformin|mesh-list
2807441|NCT04170465|Paclitaxel|paclitaxel|mesh-list
2807442|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
2807443|NCT04170465|Doxorubicin|doxorubicin|mesh-list
2807444|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2807445|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807446|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
2807447|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
2807448|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
2807449|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807450|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2807451|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
2807452|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807453|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2807454|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2807455|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
2807456|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2807457|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2807458|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2807459|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2279502|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
2279503|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2279504|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807460|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2279505|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279506|NCT00222534|Diuretics|diuretics|mesh-ancestor
2279507|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
2807461|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807462|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
2807463|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2807464|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2807465|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807466|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
2807467|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2279508|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279509|NCT00222547|Vitamin A|vitamin a|mesh-list
2279510|NCT00222547|Albendazole|albendazole|mesh-list
2279511|NCT00222547|Vitamins|vitamins|mesh-ancestor
2279512|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
2279513|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279514|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279515|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279516|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
2279517|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2279518|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279519|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
2279520|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2279521|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2279522|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
2279523|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
2104327|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104328|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2104329|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
2104330|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104331|NCT02435680|Antiviral Agents|antiviral agents|mesh-ancestor
2104332|NCT02435680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104333|NCT02435680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104334|NCT02435680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2104335|NCT02435680|Immunologic Factors|immunologic factors|mesh-ancestor
2104336|NCT02435680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104337|NCT02435836|Aripiprazole|aripiprazole|mesh-list
2279524|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
2279525|NCT00222573|Metoprolol|metoprolol|mesh-list
2279526|NCT00222573|Clopidogrel|clopidogrel|mesh-list
2279527|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2279528|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2279529|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2279530|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2279531|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
2279532|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279533|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279534|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279535|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2279536|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2279537|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
2279538|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
2279539|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279540|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2279541|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2279542|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2807468|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2807469|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807470|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
2807471|NCT04170088|Coagulants|coagulants|mesh-ancestor
2807472|NCT04169945|Erythritol|erythritol|mesh-list
2807473|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
2807474|NCT04169867|Nivolumab|nivolumab|mesh-list
2807475|NCT04169867|Ipilimumab|ipilimumab|mesh-list
2807476|NCT04169867|Atezolizumab|atezolizumab|mesh-list
2807477|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2807478|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807479|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2807480|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807481|NCT04169854|Lidocaine|lidocaine|mesh-list
2807482|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
2807483|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
2807484|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807485|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807486|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
2807487|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807488|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2807489|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2104338|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
2807490|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2807491|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2807492|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807493|NCT04169737|Venetoclax|venetoclax|mesh-list
2807494|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
2807495|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
2807496|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807497|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2807498|NCT04169841|Durvalumab|durvalumab|mesh-list
2807499|NCT04169841|Olaparib|olaparib|mesh-list
2807500|NCT04169841|Tremelimumab|tremelimumab|mesh-list
2807501|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2807502|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807503|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2807504|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807505|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807506|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
2807507|NCT04169919|Povidone|povidone|mesh-list
2807508|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
2807509|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
2807510|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2807511|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807512|NCT04169763|Nelfinavir|nelfinavir|mesh-list
2807513|NCT04169763|Cisplatin|cisplatin|mesh-list
2807514|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807515|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2807516|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2279543|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
2279544|NCT00222638|Vaccines|vaccines|mesh-list
2279545|NCT00222638|Immunologic Factors|immunologic factors|mesh-ancestor
2279546|NCT00222638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279547|NCT00222651|Tenecteplase|tenecteplase|mesh-list
2279548|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2279549|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2279550|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279551|NCT00222677|Aspirin|aspirin|mesh-list
2279552|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2279553|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2279554|NCT00222677|Analgesics|analgesics|mesh-ancestor
2279555|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
2279556|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279557|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807517|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
2807518|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807519|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807520|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2807521|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2807522|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
2807523|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807524|NCT04169438|Petrolatum|petrolatum|mesh-list
2807525|NCT04169438|Emollients|emollients|mesh-ancestor
2807526|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
2807527|NCT04169256|Bupivacaine|bupivacaine|mesh-list
2807528|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
2807529|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
2807530|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807531|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807532|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
2807533|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807534|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
2807535|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807536|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
2807537|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2807538|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2279558|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2279559|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2279560|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2807539|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807540|NCT04169191|Urological Agents|urological agents|mesh-ancestor
2807541|NCT04169347|Leucovorin|leucovorin|mesh-list
2807542|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
2807543|NCT04169347|Irinotecan|irinotecan|mesh-list
2807544|NCT04169347|Panitumumab|panitumumab|mesh-list
2807545|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807546|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2807547|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2807548|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807549|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807550|NCT04169347|Antidotes|antidotes|mesh-ancestor
2807551|NCT04169347|Protective Agents|protective agents|mesh-ancestor
2807552|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807553|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
2807554|NCT04169347|Vitamins|vitamins|mesh-ancestor
2807555|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
2807556|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2279561|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2279562|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279563|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2279564|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2279565|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279566|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
2807557|NCT04169451|Letrozole|letrozole|mesh-list
2807558|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807559|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2807560|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2807561|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807562|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807563|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2807564|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
2807565|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2807566|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807567|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
2807568|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
2807569|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807570|NCT04169230|Citalopram|citalopram|mesh-list
2807571|NCT04169230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2807572|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2807573|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2807574|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807575|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807576|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
2807577|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807578|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2807579|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
2807580|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2807581|NCT04169269|Enoxaparin|enoxaparin|mesh-list
2807582|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
2807583|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2807584|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
2807585|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2807586|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
2279567|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2279568|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2279569|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2279570|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2279571|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104339|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2104340|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2104341|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2104342|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2104343|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807587|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807588|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807589|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
2807590|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2807591|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2807592|NCT04168931|Trastuzumab|trastuzumab|mesh-list
2807593|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2807594|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807595|NCT04169100|Prednisone|prednisone|mesh-list
2807596|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2807597|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
2807598|NCT04169100|Hormones|hormones|mesh-ancestor
2807599|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2807600|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807601|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2807602|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807603|NCT04168879|Bupivacaine|bupivacaine|mesh-list
2807604|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
2807605|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
2807606|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807607|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807608|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
2807609|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807610|NCT04168944|Lenvatinib|lenvatinib|mesh-list
2807611|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2807612|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807613|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2104344|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
2104345|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
2104346|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104347|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104348|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2104349|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2807614|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807615|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807616|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
2807617|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807618|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
2807619|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2807620|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2807621|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807622|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2807623|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2279572|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
2279573|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279574|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279575|NCT00222820|Citalopram|citalopram|mesh-list
2279576|NCT00222820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2279577|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2104350|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
2104351|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2104352|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2104353|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2104354|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2104355|NCT02435901|Cyclosporine|cyclosporine|mesh-list
2104356|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
2104357|NCT02435901|Fludarabine|fludarabine|mesh-list
2104358|NCT02435901|Melphalan|melphalan|mesh-list
2104359|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
2104360|NCT02435901|Tacrolimus|tacrolimus|mesh-list
2104361|NCT02435901|Cyclosporins|cyclosporins|mesh-list
2104362|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104363|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104364|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2104365|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
2104366|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104367|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2104368|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104369|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
2807624|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807625|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807626|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807627|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2807628|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
2807629|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2807630|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279578|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2279579|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279580|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279581|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
2279582|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279583|NCT00222820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2279584|NCT00222820|Antidepressive Agents|antidepressive agents|mesh-ancestor
2279585|NCT00222820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279586|NCT00222833|Aripiprazole|aripiprazole|mesh-list
2279587|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
2279588|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279589|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2279590|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279591|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279592|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279593|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
2279594|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
2279595|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279596|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279597|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2279598|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2279599|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
2279600|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2279601|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2279602|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2279603|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2279604|NCT00222872|Hormones|hormones|mesh-list
2279605|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
2279606|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
2104370|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279607|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2279608|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279609|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2279610|NCT00222976|Naproxen|naproxen|mesh-list
2279611|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2279612|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2279613|NCT00222976|Analgesics|analgesics|mesh-ancestor
2279614|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
2279615|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279616|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279617|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2279618|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2279619|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
2279620|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2279621|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279622|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279623|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
2279624|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2279625|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807631|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2807632|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2807633|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2807634|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2807635|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807636|NCT04168619|Methotrexate|methotrexate|mesh-list
2807637|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2807638|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
2807639|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2807640|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807641|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2807642|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
2807643|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807644|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807645|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
2807646|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279626|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
2279627|NCT00223015|Tacrolimus|tacrolimus|mesh-list
2279628|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2279629|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
2279630|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279631|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2279632|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279633|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279634|NCT00223028|Sirolimus|sirolimus|mesh-list
2279635|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2279636|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279637|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2279638|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279639|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
2279640|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2279641|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
2279642|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279643|NCT00223054|Cyclosporine|cyclosporine|mesh-list
2279644|NCT00223054|Sirolimus|sirolimus|mesh-list
2279645|NCT00223054|Everolimus|everolimus|mesh-list
2279646|NCT00223054|Tacrolimus|tacrolimus|mesh-list
2279647|NCT00223054|Cyclosporins|cyclosporins|mesh-list
2279648|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2279649|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
2279650|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279651|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2279652|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279653|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279654|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
2279655|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279656|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
2279657|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2279658|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279659|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2279660|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2279661|NCT00223145|Goserelin|goserelin|mesh-list
2279662|NCT00223145|Bicalutamide|bicalutamide|mesh-list
2279663|NCT00223145|Androgens|androgens|mesh-list
2279664|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2279665|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104371|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
2104372|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2104373|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2104374|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2104375|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
2104376|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2807647|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2807648|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2807649|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
2807650|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2807651|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2807652|NCT04168203|Apixaban|apixaban|mesh-list
2807653|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2807654|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
2807655|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2807656|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
2807657|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807658|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807659|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
2807660|NCT04168294|Propofol|propofol|mesh-list
2279666|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
2279667|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
2279668|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2279669|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279670|NCT00223145|Hormones|hormones|mesh-ancestor
2279671|NCT00223171|Androgens|androgens|mesh-list
2279672|NCT00223171|Hormones|hormones|mesh-ancestor
2279673|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2279674|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104377|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2104378|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
2104379|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2104380|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2104381|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2104382|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2104383|NCT02435992|Ozanimod|ozanimod|mesh-list
2104384|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2279675|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2807661|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2807662|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807663|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807664|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2807665|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
2807666|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
2807667|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2807668|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
2807669|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807670|NCT04168138|Cytarabine|cytarabine|mesh-list
2807671|NCT04168138|Decitabine|decitabine|mesh-list
2807672|NCT04168138|Aclarubicin|aclarubicin|mesh-list
2807673|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2807674|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
2807675|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807676|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807677|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
2807678|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807679|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2807680|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
2807681|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807682|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807683|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2807684|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2807685|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2807689|NCT04168099|Cefotaxime|cefotaxime|mesh-list
2807690|NCT04168099|Cefoxitin|cefoxitin|mesh-list
2807691|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
2807692|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2807693|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807694|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2807695|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2807696|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807697|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279676|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
2279677|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279678|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2279679|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279680|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279681|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279682|NCT00223223|Levetiracetam|levetiracetam|mesh-list
2279683|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
2279684|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
2279685|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2279686|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
2279687|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2807698|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807699|NCT04167813|Ondansetron|ondansetron|mesh-list
2807700|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
2807701|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
2807702|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807703|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807704|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2807705|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
2807706|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
2807707|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2807708|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
2807709|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807710|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807711|NCT04167813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2807712|NCT04167813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279688|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2279689|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279690|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807713|NCT04167813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807714|NCT04167813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2807715|NCT04167813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2807716|NCT04167774|Paclitaxel|paclitaxel|mesh-list
2807717|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2807718|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2807719|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807720|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
2807721|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
2807722|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
2807723|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279691|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807724|NCT04167670|Amoxicillin|amoxicillin|mesh-list
2807725|NCT04167670|Clarithromycin|clarithromycin|mesh-list
2807726|NCT04167670|Lansoprazole|lansoprazole|mesh-list
2807727|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
2807728|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2807729|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807730|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2807731|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807732|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807733|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2807734|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2807735|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2807736|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2807737|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2807738|NCT04167982|Isotretinoin|isotretinoin|mesh-list
2807739|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2807740|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
2807741|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2807742|NCT04167566|Artemisinins|artemisinins|mesh-list
2807743|NCT04167566|Artemisinin|artemisinin|mesh-list
2807744|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
2807745|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2807746|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2807747|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807748|NCT04167306|Bupropion|bupropion|mesh-list
2807749|NCT04167306|Varenicline|varenicline|mesh-list
2807750|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2807751|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
2807752|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2807753|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2807754|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2807755|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2807756|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807757|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
2807758|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807759|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807760|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2807761|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2807762|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807763|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2807764|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2807765|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
2807766|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
2807767|NCT04167696|Fludarabine|fludarabine|mesh-list
2807768|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
2807769|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2807770|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
2807771|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807772|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2807773|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2807774|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
2807775|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807776|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807777|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2807778|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2279692|NCT00223275|Naltrexone|naltrexone|mesh-list
2279693|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2279694|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2279695|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807779|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
2807780|NCT04167592|Benzydamine|benzydamine|mesh-list
2807781|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2807782|NCT04167137|Atezolizumab|atezolizumab|mesh-list
2807783|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807784|NCT04167228|Ceftazidime|ceftazidime|mesh-list
2807785|NCT04167228|Avibactam|avibactam|mesh-list
2807786|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
2279696|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
2279697|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279698|NCT00223288|Citalopram|citalopram|mesh-list
2279699|NCT00223288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2279700|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2279701|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372125|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807787|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2807788|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807789|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2807790|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807791|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807792|NCT04167163|Abaloparatide|abaloparatide|mesh-list
2807793|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2807794|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807795|NCT04167280|Ipratropium|ipratropium|mesh-list
2807796|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2807797|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
2807798|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807799|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807800|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2807801|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
2807802|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2807803|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
2279702|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279703|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279704|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
2279705|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279706|NCT00223288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2279707|NCT00223288|Antidepressive Agents|antidepressive agents|mesh-ancestor
2279708|NCT00223288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279709|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
2279710|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2279711|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279712|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2279713|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
2279714|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2279715|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279716|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279717|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807804|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807805|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807806|NCT04167085|Doxycycline|doxycycline|mesh-list
2807807|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2807808|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807809|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
2807810|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2807811|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2807812|NCT04167111|Vitamin D|vitamin d|mesh-list
2807813|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
2807814|NCT04167111|Vitamins|vitamins|mesh-ancestor
2807815|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
2807816|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807817|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2807818|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2807819|NCT04166721|Atezolizumab|atezolizumab|mesh-list
2807820|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807821|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
2807822|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2807823|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807824|NCT04166890|Epinephrine|epinephrine|mesh-list
2807825|NCT04166890|Carticaine|carticaine|mesh-list
2807826|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2807827|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2807828|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
2807829|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807830|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807831|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807832|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2807833|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2807834|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
2807835|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807836|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2807837|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
2807838|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
2807839|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
2807840|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2807841|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
2807842|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
2807843|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807844|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
2807845|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
2807846|NCT04166877|Analgesics|analgesics|mesh-ancestor
2807847|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
2807848|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807849|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807850|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
2807851|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807852|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2279718|NCT00223418|Aripiprazole|aripiprazole|mesh-list
2279719|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
2279720|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279721|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2279722|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279723|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279724|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279725|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
2279726|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
2279727|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279728|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279729|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2279730|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2279731|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
2279732|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2279733|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2279734|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2279735|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2279736|NCT00223509|Lamotrigine|lamotrigine|mesh-list
2279737|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
2279738|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2279739|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2279740|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279741|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2279742|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279743|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2279744|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279745|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279746|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279747|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2279748|NCT00223548|Mesna|mesna|mesh-list
2279749|NCT00223548|Protective Agents|protective agents|mesh-ancestor
2279750|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279751|NCT00223561|Methylphenidate|methylphenidate|mesh-list
2279752|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2279753|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279754|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2807853|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
2807854|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2807855|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2807856|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807857|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2807858|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
2807859|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2807860|NCT04166604|Trifluridine|trifluridine|mesh-list
2807861|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
2807862|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807863|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
2807864|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807865|NCT04167007|Gemcitabine|gemcitabine|mesh-list
2807866|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2807867|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
2807868|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807869|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807870|NCT04167007|Antiviral Agents|antiviral agents|mesh-ancestor
2807871|NCT04167007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807872|NCT04167007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807873|NCT04167007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2807874|NCT04167007|Immunologic Factors|immunologic factors|mesh-ancestor
2807875|NCT04167007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807876|NCT04166786|Ethanol|ethanol|mesh-list
2807877|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
2807878|NCT04166786|Petrolatum|petrolatum|mesh-list
2807879|NCT04166786|Testosterone|testosterone|mesh-list
2279755|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2279756|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2279757|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279758|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
2807880|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
2279759|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279760|NCT00223613|Insulin|insulin|mesh-list
2279761|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2279762|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279763|NCT00223626|Topiramate|topiramate|mesh-list
2279764|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
2279765|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2279766|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279767|NCT00223639|Topiramate|topiramate|mesh-list
2279768|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
2279769|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2279770|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279771|NCT00223691|Acarbose|acarbose|mesh-list
2279772|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
2279773|NCT00223691|Promethazine|promethazine|mesh-list
2279774|NCT00223691|Ibuprofen|ibuprofen|mesh-list
2279775|NCT00223691|Celecoxib|celecoxib|mesh-list
2279776|NCT00223691|Indomethacin|indomethacin|mesh-list
2279777|NCT00223691|Octreotide|octreotide|mesh-list
2279778|NCT00223691|Phenylephrine|phenylephrine|mesh-list
2279779|NCT00223691|Acetazolamide|acetazolamide|mesh-list
2279780|NCT00223691|Midodrine|midodrine|mesh-list
2279781|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
2279782|NCT00223691|Ephedrine|ephedrine|mesh-list
2279783|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
2279784|NCT00223691|Ergotamine|ergotamine|mesh-list
2279785|NCT00223691|Bromides|bromides|mesh-list
2279786|NCT00223691|Levodopa|levodopa|mesh-list
2279787|NCT00223691|Carbidopa|carbidopa|mesh-list
2279788|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2279789|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
2279790|NCT00223691|Methylphenidate|methylphenidate|mesh-list
2807881|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
2807882|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2807883|NCT04166786|Androgens|androgens|mesh-ancestor
2807884|NCT04166786|Hormones|hormones|mesh-ancestor
2807885|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2807886|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807887|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2807888|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807889|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
2807890|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2807891|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807892|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807893|NCT04166786|Emollients|emollients|mesh-ancestor
2807894|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
2807895|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
2807896|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2807897|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
2807898|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807899|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807900|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2807901|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
2807902|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2807903|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
2807904|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807905|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2807906|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2807907|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
2807908|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
2807909|NCT04166812|Protective Agents|protective agents|mesh-ancestor
2807910|NCT04166435|Temozolomide|temozolomide|mesh-list
2807911|NCT04166435|Olaparib|olaparib|mesh-list
2807912|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2807913|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
2807914|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807915|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807916|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2807917|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807918|NCT04166578|Lidocaine|lidocaine|mesh-list
2807919|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
2807920|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
2807921|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2807922|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279791|NCT00223691|Caffeine|caffeine|mesh-list
2279792|NCT00223691|Modafinil|modafinil|mesh-list
2279793|NCT00223691|Rivastigmine|rivastigmine|mesh-list
2279794|NCT00223691|Ranitidine|ranitidine|mesh-list
2279795|NCT00223691|Yohimbine|yohimbine|mesh-list
2279796|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2807923|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
2807924|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807925|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2807926|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2807927|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2807928|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2807929|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279797|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2279798|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2279799|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2279800|NCT00223691|Analgesics|analgesics|mesh-ancestor
2279801|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
2279802|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279803|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807930|NCT04166396|Resveratrol|resveratrol|mesh-list
2807931|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
2807932|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807933|NCT04166396|Protective Agents|protective agents|mesh-ancestor
2807934|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807935|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807936|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2807937|NCT04166474|Dolutegravir|dolutegravir|mesh-list
2807938|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2807939|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2807940|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807941|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807942|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2807943|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2807944|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
2807945|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2807946|NCT04166565|Dexamethasone|dexamethasone|mesh-list
2807947|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
2807948|NCT04166565|Bortezomib|bortezomib|mesh-list
2807949|NCT04166565|Daratumumab|daratumumab|mesh-list
2807950|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2807951|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
2807952|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2807953|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2279804|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2279805|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2279806|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2279807|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279808|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279809|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2279810|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2279811|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2279812|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2279813|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2279814|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
2279815|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279816|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2279817|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2807954|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2807955|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
2104385|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104386|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2104387|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
2104388|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104389|NCT02436031|Desipramine|desipramine|mesh-list
2104390|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2104391|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
2104392|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2104393|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807956|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807957|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807958|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2807959|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2807960|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
2807961|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
2807962|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2807963|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2807964|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
2807965|NCT04166565|Hormones|hormones|mesh-ancestor
2807966|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2807967|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2807968|NCT04166487|Paclitaxel|paclitaxel|mesh-list
2807969|NCT04166487|Carboplatin|carboplatin|mesh-list
2807970|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
2807971|NCT04166487|Pemetrexed|pemetrexed|mesh-list
2807972|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2807973|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807974|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
2807975|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
2807976|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
2807977|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2807978|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2807979|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2807980|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2807981|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2279818|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2279819|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
2279820|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
2279821|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2279822|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2279823|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2279824|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2279825|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279826|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2279827|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2279828|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
2279829|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2279830|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2279831|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2279832|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
2279833|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
2279834|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
2279835|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
2279836|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2279837|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
2279838|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
2279839|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2279840|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
2279841|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
2279842|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2279843|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2279844|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2279845|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
2279846|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
2279847|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2279848|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2279849|NCT00223691|Diuretics|diuretics|mesh-ancestor
2279850|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
2279851|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2279852|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2279853|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2279854|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
2279855|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2279856|NCT00223691|Protective Agents|protective agents|mesh-ancestor
2279857|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
2279858|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2279859|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2807995|NCT04166006|Interleukin-2|interleukin-2|mesh-list
2807996|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2807997|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2807998|NCT04166006|Analgesics|analgesics|mesh-ancestor
2807999|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
2808000|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808001|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808002|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
2808003|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2808004|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2808005|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
2808006|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808007|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808008|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808009|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
2808010|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
2808011|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808012|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
2808013|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2808014|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
2808015|NCT04166292|Lidocaine|lidocaine|mesh-list
2808016|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
2808017|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
2808018|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808019|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808020|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
2808021|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808022|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2808023|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2808024|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2808025|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2808026|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808027|NCT04166253|Vitamin D|vitamin d|mesh-list
2808028|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
2808029|NCT04166253|Vitamins|vitamins|mesh-ancestor
2808030|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
2808031|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808032|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2808033|NCT04165967|Nivolumab|nivolumab|mesh-list
2808034|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2808035|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808036|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2808037|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808038|NCT04166318|Fluorouracil|fluorouracil|mesh-list
2808039|NCT04166318|Capecitabine|capecitabine|mesh-list
2808040|NCT04166318|Mitomycins|mitomycins|mesh-list
2808041|NCT04166318|Mitomycin|mitomycin|mesh-list
2808042|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
2808043|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808044|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2808045|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808046|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2808047|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
2808048|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808049|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2279860|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2808050|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
2808051|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2808052|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808053|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
2808054|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2279861|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2279862|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2279863|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
2279864|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
2279865|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2279866|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2279867|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
2279868|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
2279869|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2279870|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
2808055|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
2808056|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808057|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
2808058|NCT04165902|Protective Agents|protective agents|mesh-ancestor
2808059|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
2808060|NCT04165850|Celecoxib|celecoxib|mesh-list
2808061|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2808062|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2808063|NCT04165850|Analgesics|analgesics|mesh-ancestor
2808064|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
2808065|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808066|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808067|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808068|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808069|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2808070|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2808071|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808072|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808073|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2808074|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808075|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2808076|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2279871|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2279872|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2808077|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808078|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2808079|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2808080|NCT04165512|Triamcinolone|triamcinolone|mesh-list
2808081|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2808082|NCT04165512|Bupivacaine|bupivacaine|mesh-list
2808083|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
2808084|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
2808085|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808086|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808087|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
2808088|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808089|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808090|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
2808091|NCT04165512|Hormones|hormones|mesh-ancestor
2104394|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104395|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2104396|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2104397|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2104398|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
2104399|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104400|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104401|NCT02436135|Idelalisib|idelalisib|mesh-list
2104402|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104403|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104404|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104405|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2104406|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
2104407|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2104408|NCT02436239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2104409|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2104410|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2104411|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104412|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104413|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
2808092|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2808093|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2808094|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
2808095|NCT04165629|Aspirin|aspirin|mesh-list
2808096|NCT04165629|Clopidogrel|clopidogrel|mesh-list
2808097|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2808098|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2808099|NCT04165629|Analgesics|analgesics|mesh-ancestor
2808100|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
2808101|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808102|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808103|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808104|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808105|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2808106|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2808107|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808108|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2808109|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2808110|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808111|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
2808112|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2808113|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2808114|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2808115|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
2808116|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808117|NCT04165330|Nivolumab|nivolumab|mesh-list
2808118|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2808119|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808120|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2808121|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808122|NCT04165174|Apatinib|apatinib|mesh-list
2808123|NCT04165174|Antibodies|antibodies|mesh-list
2808124|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2808125|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
2808126|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808127|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808128|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2808129|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808130|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279873|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2279874|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2279875|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2279876|NCT00223691|Urological Agents|urological agents|mesh-ancestor
2279877|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
2279878|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2279879|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2279880|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2279881|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2279882|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
2279883|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2279884|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
2279885|NCT00223717|Aspirin|aspirin|mesh-list
2279886|NCT00223717|Losartan|losartan|mesh-list
2279887|NCT00223717|Metoprolol|metoprolol|mesh-list
2279888|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2279889|NCT00223717|Clonidine|clonidine|mesh-list
2279890|NCT00223717|Eplerenone|eplerenone|mesh-list
2279891|NCT00223717|Nebivolol|nebivolol|mesh-list
2279892|NCT00223717|Bosentan|bosentan|mesh-list
2279893|NCT00223717|Diltiazem|diltiazem|mesh-list
2279894|NCT00223717|Guanfacine|guanfacine|mesh-list
2279895|NCT00223717|Prazosin|prazosin|mesh-list
2279896|NCT00223717|Hydralazine|hydralazine|mesh-list
2279897|NCT00223717|Captopril|captopril|mesh-list
2279898|NCT00223717|Nifedipine|nifedipine|mesh-list
2279899|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2279900|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
2279901|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
2279902|NCT00223717|Dipyridamole|dipyridamole|mesh-list
2279903|NCT00223717|Carbidopa|carbidopa|mesh-list
2279904|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2279905|NCT00223717|Tamsulosin|tamsulosin|mesh-list
2808134|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
2279906|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2279907|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2279908|NCT00223717|Analgesics|analgesics|mesh-ancestor
2808135|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2808136|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808137|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2808138|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2808139|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
2808140|NCT04164823|Analgesics|analgesics|mesh-list
2808141|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
2808142|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808143|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808144|NCT04164615|Capecitabine|capecitabine|mesh-list
2808145|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2808146|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
2808147|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808148|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808149|NCT04164524|Gentamicins|gentamicins|mesh-list
2808150|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2808151|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808152|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2808153|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808154|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808155|NCT04164797|Endostar protein|endostar protein|mesh-list
2808156|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2808157|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2808158|NCT04164797|Growth Substances|growth substances|mesh-ancestor
2808159|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808160|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
2808161|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808162|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
2808163|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2808164|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2279909|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
2279910|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279911|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279912|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2279913|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2279914|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2279915|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2279916|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279917|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2279918|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2279919|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2279920|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
2279921|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
2279922|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2279923|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2279924|NCT00223717|Urological Agents|urological agents|mesh-ancestor
2279925|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2279926|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2279927|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2279928|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2279929|NCT00223717|Diuretics|diuretics|mesh-ancestor
2279930|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
2279931|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2279932|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2279933|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
2279934|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
2279935|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2279936|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2808165|NCT04164459|Latanoprost|latanoprost|mesh-list
2808166|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2808167|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2808168|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
2808169|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2808170|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
2808171|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2808172|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2808173|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808174|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2808175|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808176|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2808177|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808178|NCT04164693|Heparin|heparin|mesh-list
2808179|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2808180|NCT04164693|Tinzaparin|tinzaparin|mesh-list
2808181|NCT04164693|Dalteparin|dalteparin|mesh-list
2808182|NCT04164693|Warfarin|warfarin|mesh-list
2808183|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
2808184|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2808185|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2808186|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808187|NCT04164238|Paclitaxel|paclitaxel|mesh-list
2808188|NCT04164238|Carboplatin|carboplatin|mesh-list
2279937|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2279938|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
2279939|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2279940|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2808189|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2104414|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104415|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2104416|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2104417|NCT02436577|Ticagrelor|ticagrelor|mesh-list
2104418|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2104419|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2104420|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2104421|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2104422|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
2104423|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104424|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104425|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104426|NCT02436668|Gemcitabine|gemcitabine|mesh-list
2104427|NCT02436668|Paclitaxel|paclitaxel|mesh-list
2104428|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2104429|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104430|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
2808190|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808191|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
2808192|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
2808193|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
2808194|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808195|NCT04164212|Vaccines|vaccines|mesh-list
2808196|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
2808197|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808198|NCT04164355|Tadalafil|tadalafil|mesh-list
2808199|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
2808200|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2104431|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
2104432|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
2104433|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104434|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2104435|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
2104436|NCT02436668|Antiviral Agents|antiviral agents|mesh-ancestor
2104437|NCT02436668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104438|NCT02436668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104439|NCT02436668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2104440|NCT02436668|Immunologic Factors|immunologic factors|mesh-ancestor
2808201|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2808202|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808203|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808204|NCT04164355|Urological Agents|urological agents|mesh-ancestor
2808205|NCT04164368|Lenalidomide|lenalidomide|mesh-list
2808206|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
2808207|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808208|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2808209|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2808210|NCT04164368|Growth Substances|growth substances|mesh-ancestor
2808211|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
2808212|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808213|NCT04164329|Anesthetics|anesthetics|mesh-list
2808214|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
2808215|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808216|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808217|NCT04164264|Propofol|propofol|mesh-list
2808218|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2279941|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2279942|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2279943|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2279944|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2279945|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2808219|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808220|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808221|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2808222|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
2808223|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
2808224|NCT04164199|Capecitabine|capecitabine|mesh-list
2808225|NCT04164199|Pemetrexed|pemetrexed|mesh-list
2808226|NCT04164199|Temozolomide|temozolomide|mesh-list
2808227|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2808228|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
2808229|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808230|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808231|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808232|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2808233|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2808234|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2808235|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
2808245|NCT04163978|Budesonide|budesonide|mesh-list
2808246|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
2808247|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808248|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2808249|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
2808250|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808251|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808252|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2808253|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
2808254|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
2808255|NCT04163978|Hormones|hormones|mesh-ancestor
2808256|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2808257|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2808258|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
2808259|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808260|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808261|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2808262|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
2808263|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
2808264|NCT04163978|Protective Agents|protective agents|mesh-ancestor
2279946|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2279947|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
2279948|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2279949|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2279950|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2279951|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
2279952|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2279953|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2279954|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
2279955|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2279956|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2279957|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2279958|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2279959|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2279960|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
2279961|NCT00223717|Coagulants|coagulants|mesh-ancestor
2279962|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2279963|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2279964|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
2279965|NCT00223743|Zonisamide|zonisamide|mesh-list
2279966|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
2279967|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2279968|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2279969|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279970|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2279971|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279972|NCT00223769|Oxandrolone|oxandrolone|mesh-list
2279973|NCT00223769|Androgens|androgens|mesh-ancestor
2279974|NCT00223769|Hormones|hormones|mesh-ancestor
2279975|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2279976|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2279977|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
2808270|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
2808271|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808272|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2808273|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808274|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808275|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
2808276|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2808277|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2808278|NCT04163536|Prednisolone|prednisolone|mesh-list
2808279|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
2808280|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2808281|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
2279978|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2279979|NCT00223860|Hormones|hormones|mesh-list
2279980|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2279981|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2279982|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808282|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808283|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
2808284|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
2808285|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808286|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808287|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2808288|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
2808289|NCT04163536|Hormones|hormones|mesh-ancestor
2808290|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2808291|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2808292|NCT04163536|Protective Agents|protective agents|mesh-ancestor
2808293|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2808294|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808295|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
2808296|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808297|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2808298|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808299|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808300|NCT04163432|Carboplatin|carboplatin|mesh-list
2808301|NCT04163432|Pemetrexed|pemetrexed|mesh-list
2808302|NCT04163432|Durvalumab|durvalumab|mesh-list
2808303|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808304|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808305|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808306|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2808307|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2808308|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2808309|NCT04163419|Tanezumab|tanezumab|mesh-list
2808310|NCT04163419|Analgesics|analgesics|mesh-ancestor
2808311|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
2808312|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2279983|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2279984|NCT00223925|Maribavir|maribavir|mesh-list
2279985|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
2808313|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808314|NCT04163471|Hemostatics|hemostatics|mesh-list
2808315|NCT04163471|Coagulants|coagulants|mesh-ancestor
2808316|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2808317|NCT04163458|Menotropins|menotropins|mesh-list
2808318|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2808319|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
2808320|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2808321|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808322|NCT04163185|Meloxicam|meloxicam|mesh-list
2808323|NCT04163185|Rizatriptan|rizatriptan|mesh-list
2808324|NCT04163185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2808325|NCT04163185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2808326|NCT04163185|Analgesics|analgesics|mesh-ancestor
2808327|NCT04163185|Sensory System Agents|sensory system agents|mesh-ancestor
2808328|NCT04163185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808329|NCT04163185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808330|NCT04163185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808331|NCT04163185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808332|NCT04163185|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2808333|NCT04163185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2808334|NCT04163185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808335|NCT04163185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808336|NCT04163185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2808337|NCT04163185|Serotonin Agents|serotonin agents|mesh-ancestor
2808338|NCT04163185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808339|NCT04163354|Listerine|listerine|mesh-list
2808340|NCT04163354|Fluorides|fluorides|mesh-list
2808341|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
2808342|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
2808343|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
2808344|NCT04163354|Protective Agents|protective agents|mesh-ancestor
2808345|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808346|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2808347|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808348|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2808349|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2808350|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808351|NCT04163588|Metolazone|metolazone|mesh-list
2808352|NCT04163588|Diuretics|diuretics|mesh-list
2104441|NCT02436668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104442|NCT02436759|Phenylephrine|phenylephrine|mesh-list
2104443|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
2104444|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2104445|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2104446|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2104447|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2808353|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
2808354|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
2808355|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808356|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2808357|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808358|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2808359|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2808360|NCT04163237|Sorafenib|sorafenib|mesh-list
2808361|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808362|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2808363|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808364|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2279986|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2279987|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
2279988|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
2279989|NCT00223938|Hematinics|hematinics|mesh-ancestor
2279990|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
2279991|NCT00223964|Hematinics|hematinics|mesh-ancestor
2279992|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
2279993|NCT00224068|Hematinics|hematinics|mesh-ancestor
2279994|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
2279995|NCT00224081|Hematinics|hematinics|mesh-ancestor
2279996|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2279997|NCT00224094|Estrogens|estrogens|mesh-ancestor
2279998|NCT00224094|Hormones|hormones|mesh-ancestor
2279999|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2280000|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280001|NCT00224146|Oxybutynin|oxybutynin|mesh-list
2280002|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
2280003|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
2280004|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280005|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280006|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2280007|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2280008|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
2280009|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280010|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808365|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
2808366|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2808367|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
2808368|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808369|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808370|NCT04162743|Trazodone|trazodone|mesh-list
2808371|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2808372|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2808373|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808374|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808375|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2808376|NCT04162743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2808377|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2808378|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2808379|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808380|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808381|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
2808382|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2808383|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
2808384|NCT04162834|Papaverine|papaverine|mesh-list
2808385|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2808386|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808387|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808388|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
2808389|NCT04162834|Urological Agents|urological agents|mesh-ancestor
2808390|NCT04162873|Celecoxib|celecoxib|mesh-list
2280011|NCT00224146|Urological Agents|urological agents|mesh-ancestor
2280012|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2280013|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2280014|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2280015|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2280016|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280017|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808391|NCT04162873|Benzenesulfonamide|benzenesulfonamide|mesh-list
2808392|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2808393|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2808394|NCT04162873|Analgesics|analgesics|mesh-ancestor
2808395|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
2808396|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808397|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808398|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808399|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808400|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2808401|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2808402|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808403|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808404|NCT04162873|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2280018|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280019|NCT00224302|Analgesics|analgesics|mesh-ancestor
2280020|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
2280021|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808405|NCT04162535|Lidocaine|lidocaine|mesh-list
2808406|NCT04162535|Propofol|propofol|mesh-list
2808407|NCT04162535|Sevoflurane|sevoflurane|mesh-list
2808408|NCT04162535|Anesthetics|anesthetics|mesh-list
2808409|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
2808410|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
2808411|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808412|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808413|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
2808414|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808415|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2808416|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2808417|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2808418|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2808419|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808420|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2808421|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
2808422|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2808423|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2808424|NCT04162522|Citalopram|citalopram|mesh-list
2808425|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
2808426|NCT04162522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2808427|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2808428|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2808429|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808430|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808431|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
2808432|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808433|NCT04162522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2808434|NCT04162522|Antidepressive Agents|antidepressive agents|mesh-ancestor
2808435|NCT04162522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2808436|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
2808437|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
2280022|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
2280023|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280024|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
2280025|NCT00224315|Risperidone|risperidone|mesh-list
2280026|NCT00224315|Ziprasidone|ziprasidone|mesh-list
2280027|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2280028|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
2280029|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280030|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280031|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280032|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2280033|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2280034|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808456|NCT04162028|Ketamine|ketamine|mesh-list
2808457|NCT04162028|Analgesics|analgesics|mesh-ancestor
2808458|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
2808459|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808460|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808461|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2808462|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2808463|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
2808464|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
2808465|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808466|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2808467|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2808468|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808469|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808470|NCT04161989|Progesterone|progesterone|mesh-list
2808471|NCT04161989|Progestins|progestins|mesh-ancestor
2808472|NCT04161989|Hormones|hormones|mesh-ancestor
2808473|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2808474|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808475|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
2808476|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2808477|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808478|NCT04161768|Norfloxacin|norfloxacin|mesh-list
2808479|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2808480|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808481|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2808482|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2808483|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808484|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808485|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808486|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2808487|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2808488|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2808489|NCT04161690|Ropivacaine|ropivacaine|mesh-list
2808490|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
2808491|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
2808492|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808493|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808494|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
2808495|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808496|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2808497|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2808498|NCT04161690|Analgesics|analgesics|mesh-ancestor
2808499|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808500|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808501|NCT04161664|Paclitaxel|paclitaxel|mesh-list
2808502|NCT04161664|Carboplatin|carboplatin|mesh-list
2808503|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2808504|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808505|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
2808506|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
2808507|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
2280035|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280036|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2280037|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
2280038|NCT00224354|Interleukin-2|interleukin-2|mesh-list
2280039|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
2280040|NCT00224354|Immunotoxins|immunotoxins|mesh-list
2280041|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280042|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2280043|NCT00224354|Analgesics|analgesics|mesh-ancestor
2280044|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
2280045|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280046|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280047|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
2280048|NCT00224393|Etanercept|etanercept|mesh-list
2280049|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2280050|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2280051|NCT00224393|Analgesics|analgesics|mesh-ancestor
2280052|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
2280053|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280054|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280055|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808508|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808511|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
2808512|NCT04161729|Analgesics|analgesics|mesh-ancestor
2808513|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
2808514|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808515|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808516|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
2808517|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808518|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2808519|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
2808520|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2808521|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2808522|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808523|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2808524|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
2808525|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2808526|NCT04161599|Metronidazole|metronidazole|mesh-list
2808527|NCT04161599|Cefuroxime|cefuroxime|mesh-list
2808528|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
2808529|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
2808530|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
2808531|NCT04161599|Citric Acid|citric acid|mesh-list
2808532|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
2280056|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808533|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808534|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2808535|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2808536|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2808537|NCT04161599|Cathartics|cathartics|mesh-ancestor
2808538|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2808539|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
2808540|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2808541|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
2808542|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
2808543|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808544|NCT04161599|Antacids|antacids|mesh-ancestor
2808545|NCT04161586|Prilocaine|prilocaine|mesh-list
2808546|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
2104448|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
2104449|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104450|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104451|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104452|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
2104453|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
2104454|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104455|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
2104456|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2104457|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
2104458|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2104459|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
2104460|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2104461|NCT02436759|Protective Agents|protective agents|mesh-ancestor
2104462|NCT02436889|Mirabegron|mirabegron|mesh-list
2104463|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2104464|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2104465|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2104466|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2104467|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
2104468|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104469|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104470|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808547|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808548|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808549|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
2808550|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
2808551|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808552|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
2808553|NCT04161508|Neostigmine|neostigmine|mesh-list
2808554|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2808555|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808556|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808557|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
2808558|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808559|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808560|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2808561|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
2808562|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808563|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2808564|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2808565|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2808566|NCT04161560|Cetuximab|cetuximab|mesh-list
2808567|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2808568|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280057|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2280058|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2280059|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
2280060|NCT00224419|Nicotine|nicotine|mesh-list
2280061|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2280062|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
2280063|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280064|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280065|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2808594|NCT04161482|Furosemide|furosemide|mesh-list
2808595|NCT04161482|Diuretics|diuretics|mesh-ancestor
2808596|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
2808597|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808598|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2808599|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2808600|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808601|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
2808602|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
2808603|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2280066|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2280067|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
2280068|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808604|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2808605|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808606|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808607|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808608|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2280069|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280070|NCT00224445|Ritonavir|ritonavir|mesh-list
2280071|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2280072|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2280073|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2280074|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2280075|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
2280076|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280077|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280078|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2280079|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2280080|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
2280081|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808609|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
2808610|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2808611|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808612|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2280082|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2280083|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2280084|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2808613|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2808614|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808615|NCT04161430|Incretins|incretins|mesh-ancestor
2808616|NCT04161430|Hormones|hormones|mesh-ancestor
2808617|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2808618|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2808619|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
2808620|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280085|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2280086|NCT00224458|Efavirenz|efavirenz|mesh-list
2280087|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2280088|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2280089|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2280090|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280091|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280092|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
2280093|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2280094|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2280095|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2280096|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2280097|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2808621|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808622|NCT04161404|Metformin|metformin|mesh-list
2104471|NCT02436889|Urological Agents|urological agents|mesh-ancestor
2104472|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2104473|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2104474|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
2104475|NCT02437084|Atorvastatin|atorvastatin|mesh-list
2104476|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2104477|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2104478|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
2808623|NCT04161404|Andrographolide|andrographolide|mesh-list
2808624|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2808625|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808626|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808627|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2808628|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2808629|NCT04161404|Analgesics|analgesics|mesh-ancestor
2808630|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
2808631|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808632|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808633|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2808634|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2808635|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808636|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
2808637|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2808638|NCT04161209|Citalopram|citalopram|mesh-list
2808639|NCT04161209|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2808640|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2808641|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2808642|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808643|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808644|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
2808645|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808646|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2808647|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
2808648|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2104479|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104480|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2280098|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2280099|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2280100|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2280101|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2280102|NCT00224471|Vaccines|vaccines|mesh-list
2280103|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
2280104|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280105|NCT00224510|Lamotrigine|lamotrigine|mesh-list
2280106|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
2280107|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2280108|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2280109|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280110|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2280111|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280112|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2280113|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2808649|NCT04161456|Apremilast|apremilast|mesh-list
2808650|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2808651|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2808652|NCT04161456|Analgesics|analgesics|mesh-ancestor
2808653|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
2808654|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808655|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808656|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808657|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808658|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2808659|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2808660|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808661|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808662|NCT04161014|Nintedanib|nintedanib|mesh-list
2808663|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808664|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2808665|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808666|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808667|NCT04161053|Rifaximin|rifaximin|mesh-list
2808668|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
2808669|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2808670|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808671|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2808672|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2808673|NCT04161001|Amlodipine|amlodipine|mesh-list
2808674|NCT04161001|Olmesartan|olmesartan|mesh-list
2808675|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2808676|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
2808677|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2808678|NCT04161001|Ezetimibe|ezetimibe|mesh-list
2808679|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2808680|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2808681|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2808682|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808683|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2808684|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808685|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
2808686|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2808687|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2808688|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
2808689|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2808690|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2808691|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808692|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2808693|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2808694|NCT04160936|Ropivacaine|ropivacaine|mesh-list
2808695|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
2808696|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
2808697|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808698|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808699|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
2808700|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808701|NCT04161027|Pregabalin|pregabalin|mesh-list
2808702|NCT04161027|Analgesics|analgesics|mesh-ancestor
2808703|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
2808704|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280114|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808705|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808706|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
2808707|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2808708|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2808709|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808710|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2808711|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2808712|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2808713|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808714|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2808715|NCT04160897|Tenofovir|tenofovir|mesh-list
2808716|NCT04160897|Entecavir|entecavir|mesh-list
2808717|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
2808718|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808719|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2808720|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2808721|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808722|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808723|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2808724|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2808729|NCT04160598|Fentanyl|fentanyl|mesh-list
2808730|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2808731|NCT04160598|Narcotics|narcotics|mesh-ancestor
2808732|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808733|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808734|NCT04160598|Analgesics|analgesics|mesh-ancestor
2808735|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
2808736|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808737|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2808738|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2808739|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
2808740|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
2808741|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
2808742|NCT04160676|Thiamine|thiamine|mesh-list
2808743|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
2808744|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808745|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
2808746|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808747|NCT04160676|Protective Agents|protective agents|mesh-ancestor
2808748|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808749|NCT04160676|Vitamins|vitamins|mesh-ancestor
2808750|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
2808751|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
2808752|NCT04160416|Capecitabine|capecitabine|mesh-list
2808753|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
2808754|NCT04160416|Irinotecan|irinotecan|mesh-list
2808755|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2808756|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
2808757|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808758|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808759|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2808760|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2808761|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808762|NCT04160494|Atezolizumab|atezolizumab|mesh-list
2808763|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
2808764|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808765|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
2808766|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808767|NCT04160520|Morphine|morphine|mesh-list
2808768|NCT04160520|Pramipexole|pramipexole|mesh-list
2280115|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280116|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2280117|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
2280118|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808769|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2808770|NCT04160520|Narcotics|narcotics|mesh-ancestor
2808771|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808772|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808773|NCT04160520|Analgesics|analgesics|mesh-ancestor
2808774|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
2808775|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808776|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
2808777|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104481|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2104482|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104483|NCT02437162|Golimumab|golimumab|mesh-list
2808778|NCT04160520|Protective Agents|protective agents|mesh-ancestor
2808779|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2808780|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2808781|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
2808782|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
2808783|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808784|NCT04160546|Aspirin|aspirin|mesh-list
2808785|NCT04160546|Ponatinib|ponatinib|mesh-list
2808786|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2808787|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2808788|NCT04160546|Analgesics|analgesics|mesh-ancestor
2808789|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
2808790|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2808791|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808792|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2808793|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808794|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2808795|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2808796|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808797|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2808798|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2808799|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808800|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
2808801|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808802|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2808803|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
2808804|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2808805|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2808806|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808807|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808808|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2104484|NCT02437162|Ustekinumab|ustekinumab|mesh-list
2104485|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
2104486|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2104487|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2104488|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2104489|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
2808809|NCT04160377|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2808810|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2808811|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2808812|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808813|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808814|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
2808815|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2808816|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
2808817|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2808818|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2808819|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808820|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2808821|NCT04160325|Azathioprine|azathioprine|mesh-list
2808822|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
2808823|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808824|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2808825|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808826|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2808827|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
2808828|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808829|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808830|NCT04160611|Midazolam|midazolam|mesh-list
2808831|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2808832|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2808833|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2808834|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808835|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2808836|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2808837|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2808838|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2808839|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
2808840|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
2808841|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
2808842|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
2808843|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808844|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808845|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
2808846|NCT04160195|Fludarabine|fludarabine|mesh-list
2808847|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2280119|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
2280120|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2280121|NCT00224549|Amlodipine|amlodipine|mesh-list
2280122|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2280123|NCT00224549|Irbesartan|irbesartan|mesh-list
2280124|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2280125|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2280126|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2280127|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808848|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
2808849|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808850|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808851|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2808852|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
2808853|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808854|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808855|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2808856|NCT04159974|Durvalumab|durvalumab|mesh-list
2808857|NCT04159974|Tremelimumab|tremelimumab|mesh-list
2808858|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2808859|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280128|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2280129|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280130|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
2280131|NCT00224549|Diuretics|diuretics|mesh-ancestor
2280132|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
2280133|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2280134|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2280135|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2280136|NCT00224588|Ketamine|ketamine|mesh-list
2280137|NCT00224588|Analgesics|analgesics|mesh-ancestor
2808860|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
2808861|NCT04160026|Piperaquine|piperaquine|mesh-list
2808862|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
2808863|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2808864|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
2808865|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2808866|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2808867|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808868|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2808869|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808870|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808871|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2808872|NCT04160026|Renal Agents|renal agents|mesh-ancestor
2808873|NCT04159870|Rifaximin|rifaximin|mesh-list
2808874|NCT04159870|Norfloxacin|norfloxacin|mesh-list
2808875|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2808876|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808877|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2808878|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2808879|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2808880|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808881|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808882|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808883|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2808884|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2280138|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
2280139|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280140|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280141|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2280142|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2280143|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
2280144|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
2280145|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2280146|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2280147|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2280148|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808885|NCT04160117|Colchicine|colchicine|mesh-list
2808886|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
2808887|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808888|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
2808889|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
2808890|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
2808891|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808892|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808893|NCT04159818|Doxorubicin|doxorubicin|mesh-list
2808894|NCT04159818|Nivolumab|nivolumab|mesh-list
2808895|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808896|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2808897|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2808898|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2808899|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808900|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808901|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2808902|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2808903|NCT04159896|Nivolumab|nivolumab|mesh-list
2808904|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2808905|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280149|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280150|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
2280151|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
2280152|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
2280153|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280154|NCT00224679|Aspirin|aspirin|mesh-list
2280155|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2280156|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2808906|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2808907|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808908|NCT04159649|Letrozole|letrozole|mesh-list
2280157|NCT00224679|Analgesics|analgesics|mesh-ancestor
2280158|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
2280159|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280160|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280161|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2280162|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2280163|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2280164|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2280165|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280166|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2280167|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2280168|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280169|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
2280170|NCT00224692|Ketamine|ketamine|mesh-list
2280171|NCT00224692|Analgesics|analgesics|mesh-ancestor
2280172|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
2280173|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280174|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280175|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2280176|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2280177|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
2280178|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
2280179|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2280180|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2280181|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2280182|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280183|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280184|NCT00224809|Aspirin|aspirin|mesh-list
2280185|NCT00224809|Spironolactone|spironolactone|mesh-list
2280186|NCT00224809|Clopidogrel|clopidogrel|mesh-list
2280187|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2280188|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2280189|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2280190|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2280191|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2808909|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808910|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2808911|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2808912|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808913|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808914|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2808915|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
2808916|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2808917|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808918|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2808919|NCT04159597|Upadacitinib|upadacitinib|mesh-list
2808920|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2808921|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2808922|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808923|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808924|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808925|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
2808926|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2808927|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2808928|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2808929|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
2808930|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808931|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808932|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808933|NCT04159181|Lactulose|lactulose|mesh-list
2808934|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
2808935|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2808936|NCT04159181|Cathartics|cathartics|mesh-ancestor
2808937|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
2808938|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
2808939|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808940|NCT04159155|Paclitaxel|paclitaxel|mesh-list
2808941|NCT04159155|Carboplatin|carboplatin|mesh-list
2808942|NCT04159155|Niraparib|niraparib|mesh-list
2808943|NCT04159155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2808944|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808945|NCT04159155|Tubulin Modulators|tubulin modulators|mesh-ancestor
2808946|NCT04159155|Antimitotic Agents|antimitotic agents|mesh-ancestor
2808947|NCT04159155|Mitosis Modulators|mitosis modulators|mesh-ancestor
2280192|NCT00224809|Analgesics|analgesics|mesh-ancestor
2280193|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
2280194|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280195|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280196|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2280197|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2280198|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2280199|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2280200|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280201|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2280202|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2280203|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
2808948|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808949|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2808950|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808951|NCT04159142|Paclitaxel|paclitaxel|mesh-list
2808952|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2808953|NCT04159142|Carboplatin|carboplatin|mesh-list
2808954|NCT04159142|Capecitabine|capecitabine|mesh-list
2808955|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2808956|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808957|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
2808958|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
2808959|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
2808960|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808961|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2808962|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
2808963|NCT04159077|Tamsulosin|tamsulosin|mesh-list
2808964|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2808965|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2808966|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2808967|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
2808968|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2808969|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808970|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808971|NCT04159077|Urological Agents|urological agents|mesh-ancestor
2808972|NCT04158934|Factor VIII|factor viii|mesh-list
2808973|NCT04158934|BAX 855|bax 855|mesh-list
2280204|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2280205|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2808974|NCT04158934|Coagulants|coagulants|mesh-ancestor
2808975|NCT04158947|Trastuzumab|trastuzumab|mesh-list
2808976|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2808977|NCT04158947|Afatinib|afatinib|mesh-list
2808978|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2808979|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104490|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104491|NCT02437253|Adalimumab|adalimumab|mesh-list
2104492|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2104493|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2808980|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2808981|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2808982|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808983|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
2808984|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
2808985|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
2808986|NCT04158739|Cytarabine|cytarabine|mesh-list
2808987|NCT04158739|Antibodies|antibodies|mesh-list
2808988|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
2808989|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2808990|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
2808991|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2808992|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2808993|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
2808994|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2808995|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2808996|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
2808997|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2808998|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2808999|NCT04158674|Simendan|simendan|mesh-list
2809000|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2809001|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
2809002|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2809003|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2809004|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809005|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809006|NCT04158674|Protective Agents|protective agents|mesh-ancestor
2809007|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809008|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2809009|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
2809010|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809011|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2809012|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
2809013|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2809014|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809015|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2280206|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2280207|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
2280208|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280209|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2280210|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
2280211|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2280212|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2280213|NCT00224809|Diuretics|diuretics|mesh-ancestor
2280214|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
2280215|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
2280216|NCT00224822|Aripiprazole|aripiprazole|mesh-list
2280217|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
2280218|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280219|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2280220|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2280221|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2280222|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280223|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
2280224|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
2280225|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2809016|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2809017|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2809018|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
2809019|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
2809020|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2809021|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809022|NCT04158713|Piperaquine|piperaquine|mesh-list
2809023|NCT04158713|Artenimol|artenimol|mesh-list
2809024|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
2809025|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2809026|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2809027|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809028|NCT04158830|Aspirin|aspirin|mesh-list
2809029|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2809030|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2809031|NCT04158830|Analgesics|analgesics|mesh-ancestor
2809032|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
2809033|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809034|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809035|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2809036|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2809037|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2809038|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2809039|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809040|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2809041|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2809042|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809043|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
2809044|NCT04158856|Trastuzumab|trastuzumab|mesh-list
2280226|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280227|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2280228|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2280229|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
2280230|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2280231|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2280232|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2280233|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2280234|NCT00224978|Chloroquine|chloroquine|mesh-list
2280235|NCT00224978|Amebicides|amebicides|mesh-ancestor
2280236|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2280237|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2809045|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2809046|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809047|NCT04158440|Paclitaxel|paclitaxel|mesh-list
2809048|NCT04158440|Docetaxel|docetaxel|mesh-list
2809049|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2809050|NCT04158440|Cisplatin|cisplatin|mesh-list
2809051|NCT04158440|Carboplatin|carboplatin|mesh-list
2809052|NCT04158440|Pemetrexed|pemetrexed|mesh-list
2809053|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2809054|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809055|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
2809056|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
2809057|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
2809058|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809059|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809060|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2809061|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2809062|NCT04158076|Amlodipine|amlodipine|mesh-list
2809063|NCT04158076|Telmisartan|telmisartan|mesh-list
2809064|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2809065|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2809066|NCT04158076|Ezetimibe|ezetimibe|mesh-list
2809067|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2809068|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2809069|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2809070|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809071|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2809072|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809073|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
2809074|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2809075|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2809076|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
2809077|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2809078|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2809079|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809080|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2809081|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2809082|NCT04158102|Bupivacaine|bupivacaine|mesh-list
2809083|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
2809084|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
2809085|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2809086|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809087|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
2809088|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809089|NCT04158167|Oxytocin|oxytocin|mesh-list
2809090|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
2809091|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2809092|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809093|NCT04158362|Paclitaxel|paclitaxel|mesh-list
2280238|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2280239|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
2280240|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2280241|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
2809094|NCT04158362|Capecitabine|capecitabine|mesh-list
2809095|NCT04158362|Letrozole|letrozole|mesh-list
2809096|NCT04158362|Fulvestrant|fulvestrant|mesh-list
2809097|NCT04158362|Anastrozole|anastrozole|mesh-list
2809098|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2809099|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809100|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
2809101|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
2809102|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
2809103|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809104|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2809105|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
2809106|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2809107|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2809108|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809109|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2809110|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
2809111|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2809112|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809113|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2809114|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2809115|NCT04158050|Omalizumab|omalizumab|mesh-list
2809116|NCT04158050|Antibodies|antibodies|mesh-list
2809117|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
2809118|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809119|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2809120|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2809121|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
2280242|NCT00225043|Phenylephrine|phenylephrine|mesh-list
2280243|NCT00225043|Epinephrine|epinephrine|mesh-list
2280244|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
2280245|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2280246|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2280247|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
2280248|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280249|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280250|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280251|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2280252|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2280253|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
2280254|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280255|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2280256|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
2280257|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
2280258|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
2280259|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2280260|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2280261|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
2280262|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2809122|NCT04158388|Tryptophan|tryptophan|mesh-list
2809123|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2809124|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
2809125|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2809126|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
2809127|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809128|NCT04157881|Rabeprazole|rabeprazole|mesh-list
2809129|NCT04157881|Dabigatran|dabigatran|mesh-list
2809130|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
2809131|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2809132|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
2809133|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809134|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809135|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
2809136|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2809137|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2809138|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2809139|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
2809140|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
2809141|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2809142|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809143|NCT04157803|Acetic Acid|acetic acid|mesh-list
2809144|NCT04157803|Retinol acetate|retinol acetate|mesh-list
2809145|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2809146|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809147|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2809148|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
2809149|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809150|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2809151|NCT04157803|Protective Agents|protective agents|mesh-ancestor
2809152|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809153|NCT04157959|Febuxostat|febuxostat|mesh-list
2809154|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
2809155|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2809156|NCT04157751|Empagliflozin|empagliflozin|mesh-list
2280263|NCT00225043|Protective Agents|protective agents|mesh-ancestor
2280264|NCT00225056|Docetaxel|docetaxel|mesh-list
2280265|NCT00225056|Capecitabine|capecitabine|mesh-list
2809157|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2809158|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809159|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2809160|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809161|NCT04157998|Metoclopramide|metoclopramide|mesh-list
2809162|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
2809163|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
2809164|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809165|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809166|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2809167|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2809168|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2809169|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
2809170|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2809171|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809180|NCT04157725|Clomiphene|clomiphene|mesh-list
2809181|NCT04157725|Enclomiphene|enclomiphene|mesh-list
2809182|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
2809183|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2809184|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
2809185|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2809186|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809187|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2809188|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
2809189|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2809190|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2809191|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2809195|NCT04157491|Antibodies|antibodies|mesh-list
2809196|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
2280266|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280267|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
2280268|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
2280269|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
2280270|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280271|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2280272|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
2809197|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809198|NCT04157478|Temozolomide|temozolomide|mesh-list
2809199|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2809200|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
2809201|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809202|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809203|NCT04157153|Sirolimus|sirolimus|mesh-list
2809204|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2809205|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809206|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2809207|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809208|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
2809209|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2809210|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
2809211|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809212|NCT04157699|Tenofovir|tenofovir|mesh-list
2809213|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
2809214|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809215|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2809216|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2809217|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280279|NCT00225108|Tinzaparin|tinzaparin|mesh-list
2280280|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2280281|NCT00225108|Dalteparin|dalteparin|mesh-list
2280282|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
2280283|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2280284|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2280285|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809218|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809219|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2809220|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2809221|NCT04157075|Bupivacaine|bupivacaine|mesh-list
2809222|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
2809223|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
2809224|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2809225|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809226|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
2809227|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809228|NCT04157257|Tenofovir|tenofovir|mesh-list
2809229|NCT04157257|Entecavir|entecavir|mesh-list
2280286|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
2280287|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
2280288|NCT00225160|Vitamins|vitamins|mesh-ancestor
2280289|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
2280290|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280291|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
2280292|NCT00225173|Gemcitabine|gemcitabine|mesh-list
2280293|NCT00225173|Prednisone|prednisone|mesh-list
2280294|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
2280295|NCT00225173|Doxorubicin|doxorubicin|mesh-list
2280296|NCT00225173|Etoposide|etoposide|mesh-list
2280297|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
2280298|NCT00225173|Vincristine|vincristine|mesh-list
2280299|NCT00225173|Vinorelbine|vinorelbine|mesh-list
2280300|NCT00225173|Bleomycin|bleomycin|mesh-list
2280301|NCT00225173|Vinblastine|vinblastine|mesh-list
2280302|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2280303|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
2280304|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280305|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2809230|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
2809231|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809232|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2280306|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2280307|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
2809233|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2809234|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280308|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280309|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280310|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2280311|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2280312|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
2280313|NCT00225173|Antiviral Agents|antiviral agents|mesh-ancestor
2280314|NCT00225173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2280315|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280316|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2280317|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2280318|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2280319|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2280320|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
2280321|NCT00225173|Hormones|hormones|mesh-ancestor
2280322|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2280323|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2280324|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2280325|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
2280326|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
2280327|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
2280328|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
2280329|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2280330|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280331|NCT00225238|Esomeprazole|esomeprazole|mesh-list
2280332|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2809235|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809236|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2809237|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2809238|NCT04156984|Golimumab|golimumab|mesh-list
2809239|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2809240|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2809241|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2809242|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
2809243|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280333|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2280334|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2280335|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280336|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280337|NCT00225264|Pioglitazone|pioglitazone|mesh-list
2280338|NCT00225264|Glimepiride|glimepiride|mesh-list
2280339|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2280340|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280341|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2280342|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2280343|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
2809277|NCT04157010|Methotrexate|methotrexate|mesh-list
2809278|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2809279|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
2809280|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2809281|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809282|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2809283|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
2809284|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809285|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809286|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
2280344|NCT00225290|Thalidomide|thalidomide|mesh-list
2280345|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2809287|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809288|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2809289|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2809290|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
2809291|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2809292|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2809293|NCT04157036|Ibuprofen|ibuprofen|mesh-list
2809294|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
2809295|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2809296|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2809297|NCT04157036|Prednisolone|prednisolone|mesh-list
2809298|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
2809299|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2809300|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
2809301|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2809302|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2809303|NCT04157036|Analgesics|analgesics|mesh-ancestor
2809304|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
2809305|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809306|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809307|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2809308|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2809309|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2809310|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809311|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809312|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
2809313|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
2809314|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2809315|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
2809316|NCT04157036|Hormones|hormones|mesh-ancestor
2809317|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2809318|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2809319|NCT04157036|Protective Agents|protective agents|mesh-ancestor
2809320|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2809321|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809322|NCT04156750|Metformin|metformin|mesh-list
2809323|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2809324|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809325|NCT04156555|Amoxicillin|amoxicillin|mesh-list
2809326|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
2809327|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
2809328|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2809329|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2809330|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809331|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2809332|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809333|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809334|NCT04156815|Isotretinoin|isotretinoin|mesh-list
2809335|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
2280346|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
2809336|NCT04156425|Golimumab|golimumab|mesh-list
2809337|NCT04156425|Dexetimide|dexetimide|mesh-list
2809338|NCT04156425|Citalopram|citalopram|mesh-list
2809339|NCT04156425|Calcium|calcium|mesh-list
2809340|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2809341|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809342|NCT04156425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2809343|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2809344|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2809345|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809346|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280347|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280348|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
2280349|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2809347|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
2809348|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2809349|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
2809350|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2809351|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2809352|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2809353|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
2809354|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
2809355|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809356|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2809357|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2809358|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
2809359|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2809360|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2809361|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2280350|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2280351|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2280352|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2280353|NCT00225290|Growth Substances|growth substances|mesh-ancestor
2280354|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
2280355|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280356|NCT00225303|Etravirine|etravirine|mesh-list
2280357|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2280358|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2280359|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280360|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280361|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
2280362|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2280363|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
2280364|NCT00225342|Gliclazide|gliclazide|mesh-list
2280365|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2280366|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280367|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
2280368|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2280369|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280370|NCT00225381|Anesthetics|anesthetics|mesh-list
2280371|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2280372|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280373|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2280374|NCT00225433|Ganirelix|ganirelix|mesh-list
2280375|NCT00225433|Hormones|hormones|mesh-ancestor
2280376|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2280377|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280378|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
2280379|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2280380|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2280381|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2280382|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2809362|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
2809363|NCT04156451|Furosemide|furosemide|mesh-list
2809364|NCT04156451|Diuretics|diuretics|mesh-ancestor
2809365|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
2809366|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809367|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2809368|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2809369|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809370|NCT04156464|Lorazepam|lorazepam|mesh-list
2809371|NCT04156464|Phenobarbital|phenobarbital|mesh-list
2809372|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
2809373|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
2809374|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
2809375|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809376|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809377|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2809378|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2809379|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2809380|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2809381|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2809382|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2809383|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
2809384|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
2809385|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2809386|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809387|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2809388|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2809389|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2809390|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2809391|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2809392|NCT04156204|Tacrolimus|tacrolimus|mesh-list
2809393|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2809394|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
2809395|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809396|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2809397|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809398|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809399|NCT04156347|Topotecan|topotecan|mesh-list
2809400|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2809401|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2809402|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809403|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809404|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809405|NCT04156035|Lamotrigine|lamotrigine|mesh-list
2809406|NCT04156035|Ketamine|ketamine|mesh-list
2809407|NCT04156035|Analgesics|analgesics|mesh-ancestor
2809408|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
2809409|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280383|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280384|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2809410|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809411|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2809412|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2809413|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
2809414|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
2809415|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2809416|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2809417|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2809418|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2809419|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809420|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
2809421|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2809422|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2809423|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2809424|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2104502|NCT02437344|Naltrexone|naltrexone|mesh-list
2809425|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2809426|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2809427|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2809428|NCT04156074|Vitamin D|vitamin d|mesh-list
2809429|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
2809430|NCT04156074|Vitamins|vitamins|mesh-list
2809431|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
2809432|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809433|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2809434|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2809435|NCT04156152|Listerine|listerine|mesh-list
2809436|NCT04156152|Fluorides|fluorides|mesh-list
2809437|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
2809438|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
2809439|NCT04156152|Protective Agents|protective agents|mesh-ancestor
2809440|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809441|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2809442|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809443|NCT04156087|Gemcitabine|gemcitabine|mesh-list
2809444|NCT04156087|Durvalumab|durvalumab|mesh-list
2809445|NCT04156087|Tremelimumab|tremelimumab|mesh-list
2809446|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2809447|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
2809448|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809449|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809450|NCT04156087|Antiviral Agents|antiviral agents|mesh-ancestor
2809451|NCT04156087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809452|NCT04156087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809453|NCT04156087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2809454|NCT04156087|Immunologic Factors|immunologic factors|mesh-ancestor
2809455|NCT04156087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809456|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2809457|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2809458|NCT04155814|Hematinics|hematinics|mesh-ancestor
2809459|NCT04155879|Colchicine|colchicine|mesh-list
2809460|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
2809461|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2809462|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
2809463|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
2809464|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
2809465|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809466|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809467|NCT04155983|Ropivacaine|ropivacaine|mesh-list
2809468|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
2809469|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
2809470|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2809471|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809472|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
2809473|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809474|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
2280385|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280386|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2280387|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
2280388|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280389|NCT00225511|Milnacipran|milnacipran|mesh-list
2809475|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2104503|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2104504|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2104505|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104506|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
2104507|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104508|NCT02437383|Propranolol|propranolol|mesh-list
2104509|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2104510|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2104511|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
2104512|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104513|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104514|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104515|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2104516|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2104517|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
2104518|NCT02437669|Hydromorphone|hydromorphone|mesh-list
2104519|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2104520|NCT02437669|Narcotics|narcotics|mesh-ancestor
2104521|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2104522|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809476|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
2809477|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809478|NCT04155632|Expectorants|expectorants|mesh-ancestor
2809479|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
2809480|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2809481|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
2809482|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809483|NCT04155632|Protective Agents|protective agents|mesh-ancestor
2809484|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809485|NCT04155632|Antidotes|antidotes|mesh-ancestor
2809486|NCT04155658|Fluorides|fluorides|mesh-list
2809487|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
2809488|NCT04155658|Protective Agents|protective agents|mesh-ancestor
2809489|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809490|NCT04155918|Allopurinol|allopurinol|mesh-list
2809491|NCT04155918|Febuxostat|febuxostat|mesh-list
2809492|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
2809493|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809494|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809495|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
2809496|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2809497|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2809498|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
2809499|NCT04155918|Protective Agents|protective agents|mesh-ancestor
2809500|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809501|NCT04155710|Interleukin-2|interleukin-2|mesh-list
2809502|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809503|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2809504|NCT04155710|Analgesics|analgesics|mesh-ancestor
2809505|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
2809506|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809507|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809508|NCT04155840|Rituximab|rituximab|mesh-list
2809509|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2809510|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2280390|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2280391|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
2280392|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2809511|NCT04155840|Antibodies|antibodies|mesh-list
2809512|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
2809513|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2809514|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
2809515|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809516|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809517|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2809518|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2809519|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
2809520|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809521|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
2280393|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2280394|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2280395|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280396|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280397|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809522|NCT04155697|Ethanol|ethanol|mesh-list
2809523|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2809524|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809525|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
2809526|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2809527|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809528|NCT04155411|Dasatinib|dasatinib|mesh-list
2809529|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809530|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2809531|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809532|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809533|NCT04155424|Eculizumab|eculizumab|mesh-list
2809534|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2809535|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2809536|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
2809537|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809538|NCT04155554|Tenofovir|tenofovir|mesh-list
2809539|NCT04155554|Lamivudine|lamivudine|mesh-list
2809540|NCT04155554|Emtricitabine|emtricitabine|mesh-list
2809541|NCT04155554|Abacavir|abacavir|mesh-list
2809542|NCT04155554|Dolutegravir|dolutegravir|mesh-list
2809543|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2809544|NCT04155554|Triumeq|triumeq|mesh-list
2809545|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
2809546|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809547|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2809548|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2809549|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809550|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809551|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2809552|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2809553|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2280398|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2280399|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
2280400|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280401|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2280402|NCT00225511|Analgesics|analgesics|mesh-ancestor
2280403|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
2280404|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280405|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2280406|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2809554|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2809555|NCT04155515|Ribavirin|ribavirin|mesh-list
2809556|NCT04155515|Yimitasvir|yimitasvir|mesh-list
2809557|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
2809558|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809559|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
2809560|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809561|NCT04155164|Metformin|metformin|mesh-list
2809562|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2809563|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809564|NCT04155229|Acetaminophen|acetaminophen|mesh-list
2809565|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2809566|NCT04155229|Oxycodone|oxycodone|mesh-list
2809567|NCT04155229|Hydrocodone|hydrocodone|mesh-list
2809568|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2809569|NCT04155229|Analgesics|analgesics|mesh-ancestor
2809570|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
2809571|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280407|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2280408|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2280409|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280410|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280411|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280412|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2280413|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
2280414|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280415|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2280416|NCT00225589|Calcium|calcium|mesh-list
2280417|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2280418|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280419|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2809572|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809573|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
2809574|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2809575|NCT04155229|Narcotics|narcotics|mesh-ancestor
2809576|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2809577|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
2809578|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
2809579|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2809580|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2809581|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2809582|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
2809583|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2809584|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
2809585|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
2809586|NCT04154852|Folic Acid|folic acid|mesh-list
2809587|NCT04154852|Adalimumab|adalimumab|mesh-list
2809588|NCT04154852|Methotrexate|methotrexate|mesh-list
2809589|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2809590|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
2809591|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2809592|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809593|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2809594|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
2809595|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809596|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809597|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
2809598|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809599|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2809600|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2809601|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
2809602|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2280420|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2280421|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
2280422|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280423|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2280424|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2280425|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280426|NCT00225615|Verapamil|verapamil|mesh-list
2280427|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2280428|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2280429|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2280430|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280431|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2280432|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809603|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2280433|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
2280434|NCT00225667|Irbesartan|irbesartan|mesh-list
2280435|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2280436|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2280437|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2809604|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2809605|NCT04154852|Hematinics|hematinics|mesh-ancestor
2809606|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
2809607|NCT04154852|Vitamins|vitamins|mesh-ancestor
2809608|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
2809609|NCT04154813|Topiramate|topiramate|mesh-list
2809610|NCT04154813|Fluoxetine|fluoxetine|mesh-list
2809611|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
2809612|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2809613|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809614|NCT04154813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2809615|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2809616|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2809617|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809618|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2809619|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
2809620|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2809621|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
2809622|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2809623|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2809624|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2809625|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809626|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
2809627|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2809628|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
2809629|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809630|NCT04154982|Expectorants|expectorants|mesh-ancestor
2809631|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
2809632|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2809633|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
2809634|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809635|NCT04154982|Protective Agents|protective agents|mesh-ancestor
2809636|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809637|NCT04154982|Antidotes|antidotes|mesh-ancestor
2280438|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280439|NCT00225706|Ibuprofen|ibuprofen|mesh-list
2280440|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2280441|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2280442|NCT00225706|Analgesics|analgesics|mesh-ancestor
2280443|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
2280444|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280445|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280446|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2280447|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2809638|NCT04154748|Omeprazole|omeprazole|mesh-list
2809639|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2809640|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2809641|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2809642|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809643|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809644|NCT04155008|Dexamethasone|dexamethasone|mesh-list
2809645|NCT04155008|Dronabinol|dronabinol|mesh-list
2809646|NCT04155008|Mirtazapine|mirtazapine|mesh-list
2809647|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2809648|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
2809649|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
2809650|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809651|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809652|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2809653|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
2809654|NCT04155008|Hormones|hormones|mesh-ancestor
2809655|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2809656|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2809657|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809658|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
2809659|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2809660|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2809661|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
2280448|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2280449|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280450|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280451|NCT00225797|Oxymorphone|oxymorphone|mesh-list
2280452|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2280453|NCT00225797|Narcotics|narcotics|mesh-ancestor
2280454|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2280455|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280456|NCT00225797|Analgesics|analgesics|mesh-ancestor
2280457|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
2280458|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809662|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
2809663|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2809664|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809665|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2809666|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2809667|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2809668|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2809669|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2809670|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2809671|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
2809672|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2809673|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2809674|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
2809675|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2809676|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
2809677|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2809678|NCT04155008|Analgesics|analgesics|mesh-ancestor
2809679|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
2809680|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2809681|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2809682|NCT04154943|Cemiplimab|cemiplimab|mesh-list
2280459|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2280460|NCT00225849|Aspirin|aspirin|mesh-list
2280461|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2280462|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2280463|NCT00225849|Analgesics|analgesics|mesh-ancestor
2809683|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2809684|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809685|NCT04154735|Rifaximin|rifaximin|mesh-list
2809686|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
2809687|NCT04154735|Fludarabine|fludarabine|mesh-list
2809688|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
2809689|NCT04154735|Tacrolimus|tacrolimus|mesh-list
2809690|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2280464|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
2280465|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280466|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280467|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2280468|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2280469|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2809691|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
2809692|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809693|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2809694|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2809695|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
2809696|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280470|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2280471|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280472|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2280473|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2280474|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280475|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
2280476|NCT00225862|Ropinirole|ropinirole|mesh-list
2280477|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2280478|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2280479|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
2280480|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
2280481|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280482|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280483|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280484|NCT00225875|Rituximab|rituximab|mesh-list
2809697|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809698|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2809699|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2809700|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809701|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2809702|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2809703|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809704|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2809705|NCT04154722|Azithromycin|azithromycin|mesh-list
2809706|NCT04154722|Meropenem|meropenem|mesh-list
2809707|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2809708|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809709|NCT04154449|Insulin|insulin|mesh-list
2809710|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2809711|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809712|NCT04154319|Vaccines|vaccines|mesh-list
2809713|NCT04154319|Immunologic Factors|immunologic factors|mesh-ancestor
2809714|NCT04154319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809715|NCT04154150|Ketamine|ketamine|mesh-list
2809716|NCT04154150|Analgesics|analgesics|mesh-ancestor
2809717|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
2809718|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809719|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809720|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2809721|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2809722|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
2809723|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
2809724|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2809725|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2809726|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2809727|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2809728|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809729|NCT04154293|Isotretinoin|isotretinoin|mesh-list
2809730|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
2809731|NCT04153968|Retinol acetate|retinol acetate|mesh-list
2809732|NCT04153968|Protective Agents|protective agents|mesh-ancestor
2809733|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809734|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2809735|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
2809736|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2809737|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280485|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2280486|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280487|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
2280488|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280489|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2280490|NCT00225901|Mitogens|mitogens|mesh-list
2280491|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
2280492|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280493|NCT00225914|Paroxetine|paroxetine|mesh-list
2280494|NCT00225914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2280495|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2280496|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2809738|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
2809739|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2280497|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280498|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280499|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
2280500|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280501|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2280502|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
2280503|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280504|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2280505|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2280506|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280507|NCT00225979|Octreotide|octreotide|mesh-list
2280508|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2280509|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2280510|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280511|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
2280512|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280513|NCT00226005|Vatalanib|vatalanib|mesh-list
2280514|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2280515|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280516|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280517|NCT00226044|Omeprazole|omeprazole|mesh-list
2809740|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809741|NCT04154033|Naltrexone|naltrexone|mesh-list
2809742|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2809743|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2809744|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809745|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
2809746|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809747|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
2809748|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2809765|NCT04153708|Antibodies|antibodies|mesh-list
2809766|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
2809767|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
2809768|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
2809769|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809770|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
2809771|NCT04153487|Vitamins|vitamins|mesh-ancestor
2809772|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
2809773|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809774|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
2809775|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809776|NCT04153487|Protective Agents|protective agents|mesh-ancestor
2809777|NCT04153734|Paclitaxel|paclitaxel|mesh-list
2809778|NCT04153734|Carboplatin|carboplatin|mesh-list
2809779|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
2809780|NCT04153734|Pemetrexed|pemetrexed|mesh-list
2809781|NCT04153734|Cisplatin|cisplatin|mesh-list
2809782|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2809783|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809784|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
2809785|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
2809786|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
2809787|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809788|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2809789|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809790|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2809791|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2809792|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
2809793|NCT04153565|Pemetrexed|pemetrexed|mesh-list
2809794|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809795|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2809796|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809797|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809798|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2809799|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2809800|NCT04153422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2809801|NCT04153422|Immunologic Factors|immunologic factors|mesh-ancestor
2809802|NCT04153422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809803|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
2809804|NCT04153201|Antimalarials|antimalarials|mesh-list
2809805|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2809806|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2809807|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809808|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809809|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809810|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2809811|NCT04153188|Phenylephrine|phenylephrine|mesh-list
2809812|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
2809813|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2809814|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2809815|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
2809816|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2809817|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280518|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2280519|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2280520|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2280521|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280522|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280523|NCT00226096|Metoprolol|metoprolol|mesh-list
2280524|NCT00226096|Clonidine|clonidine|mesh-list
2280525|NCT00226096|Nitroprusside|nitroprusside|mesh-list
2280526|NCT00226096|Hydralazine|hydralazine|mesh-list
2280527|NCT00226096|Labetalol|labetalol|mesh-list
2280528|NCT00226096|Nicardipine|nicardipine|mesh-list
2280529|NCT00226096|Phentolamine|phentolamine|mesh-list
2280530|NCT00226096|Urapidil|urapidil|mesh-list
2280531|NCT00226096|Enalaprilat|enalaprilat|mesh-list
2280532|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
2280533|NCT00226096|Esmolol|esmolol|mesh-list
2280534|NCT00226096|Glycerol|glycerol|mesh-list
2280535|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2280536|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2280537|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
2280538|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
2809818|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809819|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
2809820|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
2809821|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809822|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
2809823|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2809824|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
2809825|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2809826|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
2809827|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2809828|NCT04153188|Protective Agents|protective agents|mesh-ancestor
2809829|NCT04153383|Milrinone|milrinone|mesh-list
2809830|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2809831|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2809832|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
2809833|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2809834|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2809835|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809836|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809837|NCT04153383|Protective Agents|protective agents|mesh-ancestor
2809838|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809839|NCT04153253|Aflibercept|aflibercept|mesh-list
2809840|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2809841|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2809842|NCT04153253|Growth Substances|growth substances|mesh-ancestor
2809843|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809844|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
2809845|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809846|NCT04153123|Epinephrine|epinephrine|mesh-list
2809847|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2809848|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2280539|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280540|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809849|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
2809850|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2809851|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809852|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809853|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2809854|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2809855|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
2809856|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280541|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2280542|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2280543|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2280544|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
2280545|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2809857|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2809858|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
2809859|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
2809860|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
2809861|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2104523|NCT02437669|Analgesics|analgesics|mesh-ancestor
2104524|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
2104525|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104526|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2104527|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
2104528|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2104529|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
2104530|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104531|NCT02438371|Indomethacin|indomethacin|mesh-list
2104532|NCT02438371|Nifedipine|nifedipine|mesh-list
2104533|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2104534|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2104535|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104536|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2104537|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104538|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
2104539|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
2104540|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2104541|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2104542|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2104543|NCT02438371|Analgesics|analgesics|mesh-ancestor
2104544|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
2104545|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104546|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2104547|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2104548|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
2104549|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2104550|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104551|NCT02438540|Metformin|metformin|mesh-list
2104552|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2809862|NCT04153435|Calcium|calcium|mesh-list
2280546|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280547|NCT00226096|Analgesics|analgesics|mesh-ancestor
2280548|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
2280549|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2280550|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2280551|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2280552|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
2280553|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2280554|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2280555|NCT00226096|Protective Agents|protective agents|mesh-ancestor
2809863|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2809864|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809865|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
2809866|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2809867|NCT04153084|Cathartics|cathartics|mesh-ancestor
2809868|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2809869|NCT04153084|Laxatives|laxatives|mesh-ancestor
2809870|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
2809871|NCT04152655|Idebenone|idebenone|mesh-list
2809872|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
2809873|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809874|NCT04152655|Vitamins|vitamins|mesh-ancestor
2809875|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
2809876|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809877|NCT04152655|Protective Agents|protective agents|mesh-ancestor
2809878|NCT04152694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2809879|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2809880|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2809881|NCT04152681|Apatinib|apatinib|mesh-list
2809882|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809883|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2809884|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809885|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809886|NCT04152759|Golimumab|golimumab|mesh-list
2809887|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2280556|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
2280557|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2280558|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2280559|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2280560|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2280561|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2280562|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2280563|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
2280564|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2809888|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2809889|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2809890|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
2809891|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809892|NCT04153032|Diltiazem|diltiazem|mesh-list
2809893|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2809894|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2809895|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2809896|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809897|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2809898|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809899|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
2809900|NCT04152889|Docetaxel|docetaxel|mesh-list
2809901|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809902|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
2809903|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
2809904|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
2809905|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809906|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
2809907|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2809908|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809909|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809910|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2809911|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2809912|NCT04152980|Protective Agents|protective agents|mesh-ancestor
2809913|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809914|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
2809915|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2809916|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
2809917|NCT04152564|Bupivacaine|bupivacaine|mesh-list
2809918|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
2809919|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
2809920|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
2809921|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2809922|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280565|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
2280566|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280567|NCT00226109|Spironolactone|spironolactone|mesh-list
2280568|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2280569|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
2280570|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2280571|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280572|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2280573|NCT00226109|Diuretics|diuretics|mesh-ancestor
2280574|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
2280575|NCT00226122|Indomethacin|indomethacin|mesh-list
2280576|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2280577|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2809923|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
2809924|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809925|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
2809926|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2809927|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2809928|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809929|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2809930|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809931|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2280578|NCT00226122|Analgesics|analgesics|mesh-ancestor
2280579|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
2280580|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280581|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280582|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2280583|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2809932|NCT04152434|Erenumab|erenumab|mesh-list
2809933|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2809934|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809935|NCT04152434|Analgesics|analgesics|mesh-ancestor
2809936|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
2809937|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2809938|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809939|NCT04152473|Proglumide|proglumide|mesh-list
2809940|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2809941|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2809942|NCT04152629|Methylphenidate|methylphenidate|mesh-list
2809943|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2809944|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2809945|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809946|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2809947|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2280584|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
2280585|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
2280586|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2280587|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2280588|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280589|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280590|NCT00226135|Lamotrigine|lamotrigine|mesh-list
2280591|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280592|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280593|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2280594|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2280595|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280596|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
2280597|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2280598|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2280599|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2280600|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2280601|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2280602|NCT00226200|Omalizumab|omalizumab|mesh-list
2280603|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2280604|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2280605|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
2809948|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2809949|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809950|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
2809951|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2809952|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2809953|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2809954|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2809955|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
2809956|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2809957|NCT04152317|Misoprostol|misoprostol|mesh-list
2809958|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2809959|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
2809960|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2809961|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809962|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2809963|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2809964|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
2809965|NCT04152356|Sorafenib|sorafenib|mesh-list
2809966|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809967|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2809968|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2809969|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809970|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
2809971|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2809972|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
2809973|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809974|NCT04152057|Paclitaxel|paclitaxel|mesh-list
2809975|NCT04152057|Trastuzumab|trastuzumab|mesh-list
2809976|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2809977|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2809978|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
2809979|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
2809980|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
2809981|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809982|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2809983|NCT04151823|Vitamin D|vitamin d|mesh-list
2809984|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
2809985|NCT04151823|Vitamins|vitamins|mesh-ancestor
2809986|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
2809987|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809988|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2809989|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2809990|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2809991|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2809992|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2809993|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2809994|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
2809995|NCT04151680|Apixaban|apixaban|mesh-list
2809996|NCT04151680|Edoxaban|edoxaban|mesh-list
2809997|NCT04151680|Dabigatran|dabigatran|mesh-list
2809998|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2809999|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
2810000|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2810001|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
2810002|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810003|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810004|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
2810005|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
2280606|NCT00226317|Aripiprazole|aripiprazole|mesh-list
2280607|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
2280608|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280609|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2280610|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2280611|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2810006|NCT04151706|Busulfan|busulfan|mesh-list
2810007|NCT04151706|Thiotepa|thiotepa|mesh-list
2810008|NCT04151706|Fludarabine|fludarabine|mesh-list
2810009|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2810010|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
2810011|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810012|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2810013|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2810014|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
2810015|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810016|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810017|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2810018|NCT04151472|Ubiquinone|ubiquinone|mesh-list
2810019|NCT04151472|Idebenone|idebenone|mesh-list
2810020|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
2810021|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810022|NCT04151472|Protective Agents|protective agents|mesh-ancestor
2810023|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810024|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
2810025|NCT04151563|Docetaxel|docetaxel|mesh-list
2810026|NCT04151563|Nivolumab|nivolumab|mesh-list
2810027|NCT04151563|Ipilimumab|ipilimumab|mesh-list
2810028|NCT04151563|Ramucirumab|ramucirumab|mesh-list
2810029|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810030|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
2810031|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
2810032|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
2810033|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810034|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2104553|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104554|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2104555|NCT02438722|Cetuximab|cetuximab|mesh-list
2104556|NCT02438722|Afatinib|afatinib|mesh-list
2104557|NCT02438722|Antibodies|antibodies|mesh-list
2104558|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
2104559|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2104560|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
2104561|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104562|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810035|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2810036|NCT04151719|Bromides|bromides|mesh-list
2810037|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
2280612|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280613|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
2280614|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
2280615|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280616|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280617|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2280618|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2280619|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
2280620|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2280621|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2280622|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2280623|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2280624|NCT00226330|Pioglitazone|pioglitazone|mesh-list
2280625|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2280626|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280627|NCT00226343|Valproic Acid|valproic acid|mesh-list
2280628|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
2280629|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280630|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280631|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
2280632|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280633|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280634|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
2810038|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
2810039|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2810040|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810041|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
2810042|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810043|NCT04151459|Metformin|metformin|mesh-list
2810044|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2810045|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810046|NCT04151355|Atorvastatin|atorvastatin|mesh-list
2810047|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2810048|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2810049|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
2810050|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810051|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2810052|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2810053|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810054|NCT04151381|Aminophylline|aminophylline|mesh-list
2810055|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2810056|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
2810057|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810058|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810059|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2810060|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
2810061|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2810062|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2810063|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810064|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810065|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2104563|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2810066|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2810067|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
2810068|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2810069|NCT04151381|Protective Agents|protective agents|mesh-ancestor
2810070|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
2810071|NCT04150900|Bavituximab|bavituximab|mesh-list
2810072|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2810073|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810074|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2810075|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
2810076|NCT04151017|Coagulants|coagulants|mesh-ancestor
2810077|NCT04151147|Mitogens|mitogens|mesh-list
2810078|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
2810079|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810080|NCT04151082|Prednisone|prednisone|mesh-list
2810081|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
2810082|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2810083|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2810084|NCT04151082|Prednisolone|prednisolone|mesh-list
2810085|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
2810086|NCT04151082|Cortisone|cortisone|mesh-list
2810087|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2810088|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
2810089|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2810090|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
2810091|NCT04151082|Hormones|hormones|mesh-ancestor
2810092|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2280635|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2280636|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2280637|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280638|NCT00226356|Betaine|betaine|mesh-list
2280639|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2280640|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
2280641|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2810093|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810094|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2810095|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810096|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
2810097|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
2810098|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810099|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2810100|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2810101|NCT04151082|Protective Agents|protective agents|mesh-ancestor
2810102|NCT04150965|Thalidomide|thalidomide|mesh-list
2810103|NCT04150965|Dexamethasone|dexamethasone|mesh-list
2810104|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
2810105|NCT04150965|Pomalidomide|pomalidomide|mesh-list
2810106|NCT04150965|Elotuzumab|elotuzumab|mesh-list
2810107|NCT04150965|BB 1101|bb 1101|mesh-list
2810108|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2280642|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
2280643|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280644|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2280645|NCT00226382|Interferons|interferons|mesh-list
2280646|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
2280647|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
2280648|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2810109|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
2810110|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
2810111|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810112|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810113|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2810114|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
2810115|NCT04150965|Hormones|hormones|mesh-ancestor
2810116|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2810117|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2810118|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810119|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
2810120|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280649|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280650|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
2280651|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2280652|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
2280653|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280654|NCT00226395|Oxymorphone|oxymorphone|mesh-list
2810121|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810122|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
2810123|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2810124|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2810125|NCT04150965|Growth Substances|growth substances|mesh-ancestor
2810126|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
2810127|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2810128|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
2810129|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2810130|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810131|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2280655|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2280656|NCT00226395|Narcotics|narcotics|mesh-ancestor
2280657|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2280658|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280659|NCT00226395|Analgesics|analgesics|mesh-ancestor
2280660|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
2280661|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810132|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810133|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
2810134|NCT04150939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
2810135|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810136|NCT04150575|Paclitaxel|paclitaxel|mesh-list
2810137|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2810138|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2810139|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810140|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
2810141|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
2810142|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
2810143|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810144|NCT04150614|Dexamethasone|dexamethasone|mesh-list
2810145|NCT04150614|Ondansetron|ondansetron|mesh-list
2810146|NCT04150614|Granisetron|granisetron|mesh-list
2810147|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2810148|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
2810149|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
2810150|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810151|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810152|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2810153|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
2810154|NCT04150614|Hormones|hormones|mesh-ancestor
2810155|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2810156|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2810157|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280662|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2280663|NCT00226408|Interferons|interferons|mesh-list
2280664|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
2280665|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
2280666|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280667|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
2810158|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
2810159|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
2810160|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2810161|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
2810162|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2810163|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810164|NCT04150614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2810165|NCT04150614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2810166|NCT04150614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2810167|NCT04150614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2810168|NCT04150614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2810169|NCT04150458|Choline|choline|mesh-list
2810170|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
2810171|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2810172|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
2810173|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810174|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2810175|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2810176|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
2810177|NCT04150640|Fluorouracil|fluorouracil|mesh-list
2280668|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2280669|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
2280670|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280671|NCT00226421|Oxymorphone|oxymorphone|mesh-list
2280672|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2280673|NCT00226421|Narcotics|narcotics|mesh-ancestor
2280674|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2280675|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280676|NCT00226421|Analgesics|analgesics|mesh-ancestor
2280677|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
2810178|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
2810179|NCT04150640|Trastuzumab|trastuzumab|mesh-list
2810180|NCT04150640|Irinotecan|irinotecan|mesh-list
2810181|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
2810182|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810183|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2280678|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280679|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2280680|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2280681|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
2280682|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2280683|NCT00226447|Interferons|interferons|mesh-list
2280684|NCT00226447|Lamivudine|lamivudine|mesh-list
2280685|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280686|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
2280687|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2280688|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2280689|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2280690|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280691|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280692|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2280693|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2280694|NCT00226473|Dacarbazine|dacarbazine|mesh-list
2280695|NCT00226473|Vindesine|vindesine|mesh-list
2280696|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280697|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2280698|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
2280699|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280700|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2280701|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
2280702|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
2280703|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
2280704|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
2280705|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2280706|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280707|NCT00226538|Fluconazole|fluconazole|mesh-list
2280708|NCT00226538|Rifampin|rifampin|mesh-list
2280709|NCT00226538|Diclofenac|diclofenac|mesh-list
2280710|NCT00226538|Phenytoin|phenytoin|mesh-list
2280711|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2280712|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2280713|NCT00226538|Analgesics|analgesics|mesh-ancestor
2280714|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
2280715|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280716|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280717|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2280718|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2280719|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2280720|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280721|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280722|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
2280723|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2280724|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2280725|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2280726|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2280727|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
2280728|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2280729|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2810184|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280730|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2280731|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2280732|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
2280733|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2810185|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2810186|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
2810187|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810188|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2810189|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2810190|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2810191|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810192|NCT04150562|Avelumab|avelumab|mesh-list
2810193|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2810194|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810195|NCT04150536|Lidocaine|lidocaine|mesh-list
2810196|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
2810197|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
2810198|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2810199|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810200|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
2810201|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810202|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2280734|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
2280735|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2280736|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2280737|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2280738|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2280739|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2280740|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2280741|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2280742|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
2280743|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2280744|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2280745|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2280746|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2280747|NCT00226551|Isoproterenol|isoproterenol|mesh-list
2280748|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2810203|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2810204|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2810205|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2810206|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810207|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2810208|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2810209|NCT04150731|Estradiol|estradiol|mesh-list
2810210|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2810211|NCT04150731|Estrogens|estrogens|mesh-ancestor
2810212|NCT04150731|Hormones|hormones|mesh-ancestor
2810213|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2810214|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810215|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2810216|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
2810217|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2104564|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104565|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104566|NCT02438787|Golimumab|golimumab|mesh-list
2104567|NCT02438787|Ustekinumab|ustekinumab|mesh-list
2104568|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
2104569|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2810218|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2810219|NCT04150757|Ketamine|ketamine|mesh-list
2810220|NCT04150757|Analgesics|analgesics|mesh-ancestor
2810221|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
2810222|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810223|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810224|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2810225|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2810226|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
2810227|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
2104570|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2104571|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2104572|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
2104573|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104574|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
2104575|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2104576|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2104577|NCT02439138|Idelalisib|idelalisib|mesh-list
2104578|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104579|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104580|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104581|NCT02439164|Midazolam|midazolam|mesh-list
2104582|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2104583|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2104584|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2104585|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104586|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2104587|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2104588|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2104589|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2810228|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2810229|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2810230|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2810231|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280749|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2280750|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
2280751|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280752|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280753|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280754|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2280755|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
2810232|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810233|NCT04150289|Panobinostat|panobinostat|mesh-list
2810234|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810235|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2810236|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810237|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810238|NCT04150367|Rifampin|rifampin|mesh-list
2810239|NCT04150367|Isoniazid|isoniazid|mesh-list
2810240|NCT04150367|Ethambutol|ethambutol|mesh-list
2810241|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2810242|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2810243|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
2810244|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2810245|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810246|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
2810247|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2810248|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810249|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810250|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2810251|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2810252|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2810253|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2810254|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2810255|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2810256|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2810257|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2810258|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
2810259|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2810260|NCT04150172|Rebamipide|rebamipide|mesh-list
2810261|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2810262|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2810263|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
2280756|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280757|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2280758|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
2280759|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2280760|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
2810264|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810265|NCT04150172|Protective Agents|protective agents|mesh-ancestor
2810266|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810267|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810268|NCT04149938|Lidocaine|lidocaine|mesh-list
2810269|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
2810270|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
2810271|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2810272|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810273|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
2810274|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810275|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2810276|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2810277|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2810278|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2810279|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810280|NCT04150146|Rebamipide|rebamipide|mesh-list
2810281|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2810282|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2810283|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
2810284|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810285|NCT04150146|Protective Agents|protective agents|mesh-ancestor
2810286|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810287|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810288|NCT04150107|Insulin|insulin|mesh-list
2810289|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2280761|NCT00226551|Protective Agents|protective agents|mesh-ancestor
2280762|NCT00226564|Alfentanil|alfentanil|mesh-list
2280763|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2280764|NCT00226564|Narcotics|narcotics|mesh-ancestor
2280765|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2280766|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280767|NCT00226564|Analgesics|analgesics|mesh-ancestor
2810290|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810291|NCT04149483|Atorvastatin|atorvastatin|mesh-list
2810292|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2810293|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2810294|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
2810295|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810296|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2810297|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2280768|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
2280769|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280770|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2280771|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
2280772|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
2280773|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
2280774|NCT00226668|Hormones|hormones|mesh-ancestor
2280775|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2280776|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810298|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810299|NCT04149678|Cyclosporine|cyclosporine|mesh-list
2810300|NCT04149678|Cyclosporins|cyclosporins|mesh-list
2810301|NCT04149678|Ozanimod|ozanimod|mesh-list
2810302|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810303|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810304|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2810305|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
2810306|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810307|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
2810308|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810309|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
2810310|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2810311|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2810312|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2280777|NCT00226694|Citalopram|citalopram|mesh-list
2280778|NCT00226694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2280779|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2280780|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2280781|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280782|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280783|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
2280784|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280785|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2280786|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
2280787|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280788|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
2280789|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2810322|NCT04149626|Midazolam|midazolam|mesh-list
2280790|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2280791|NCT00226707|Analgesics|analgesics|mesh-ancestor
2810323|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
2810324|NCT04149626|Remifentanil|remifentanil|mesh-list
2810325|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2810326|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2810327|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810328|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2810329|NCT04149626|Analgesics|analgesics|mesh-ancestor
2810330|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
2810331|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810332|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2810333|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2810334|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2280792|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
2280793|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280794|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280795|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2280796|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2280797|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
2280798|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2280799|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
2280800|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2280801|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280802|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280803|NCT00226746|Gemcitabine|gemcitabine|mesh-list
2280804|NCT00226746|Paclitaxel|paclitaxel|mesh-list
2280805|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2280806|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280807|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
2280808|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
2280809|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
2280810|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280811|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2280812|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
2280813|NCT00226746|Antiviral Agents|antiviral agents|mesh-ancestor
2280814|NCT00226746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810335|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
2810336|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2810337|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810338|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2810339|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2810340|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2810341|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280815|NCT00226746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280816|NCT00226746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2280817|NCT00226746|Immunologic Factors|immunologic factors|mesh-ancestor
2280818|NCT00226746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280819|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
2280820|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2280821|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2280822|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280823|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2280824|NCT00226785|Analgesics|analgesics|mesh-ancestor
2280825|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
2280826|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280827|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2280828|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2280829|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2280830|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
2280831|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280832|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280833|NCT00226798|Capecitabine|capecitabine|mesh-list
2280834|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2280835|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
2810342|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2810343|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
2810344|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
2810345|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
2810346|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
2810347|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2810348|NCT04149626|Narcotics|narcotics|mesh-ancestor
2810349|NCT04149470|Omeprazole|omeprazole|mesh-list
2810350|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2280836|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280837|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280838|NCT00226824|Galantamine|galantamine|mesh-list
2280839|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2280840|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280841|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280842|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
2280843|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280844|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810351|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2810352|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2810353|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810354|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810355|NCT04149444|Trifluridine|trifluridine|mesh-list
2810356|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
2810357|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810358|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
2810359|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810360|NCT04149210|Fluorometholone|fluorometholone|mesh-list
2810361|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
2810362|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2810363|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2810364|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2810365|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
2810366|NCT04149210|Hormones|hormones|mesh-ancestor
2810367|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2810368|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810369|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2810370|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
2810371|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2810372|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810378|NCT04149275|Nivolumab|nivolumab|mesh-list
2810379|NCT04149275|Ipilimumab|ipilimumab|mesh-list
2810380|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2810381|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280845|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2280846|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
2280847|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280848|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
2280849|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
2280850|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2280851|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
2280852|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
2280853|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2810382|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2810383|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810384|NCT04148963|Loxapine|loxapine|mesh-list
2810385|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2810386|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2810387|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2810388|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810389|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2810390|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2810391|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
2810392|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2810393|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810394|NCT04149327|Amoxicillin|amoxicillin|mesh-list
2810395|NCT04149327|Metronidazole|metronidazole|mesh-list
2810396|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2810397|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810398|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2810399|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2810400|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2810401|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
2810402|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2810403|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810404|NCT04149067|Incretins|incretins|mesh-ancestor
2810405|NCT04149067|Hormones|hormones|mesh-ancestor
2810406|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2280854|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280855|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2280856|NCT00226837|Analgesics|analgesics|mesh-ancestor
2280857|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
2810407|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2810408|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
2810409|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810410|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810411|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2810412|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
2810413|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
2810414|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2280858|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104590|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
2280859|NCT00226889|Bosentan|bosentan|mesh-list
2280860|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2280861|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2280862|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280863|NCT00226915|Paclitaxel|paclitaxel|mesh-list
2280864|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2280865|NCT00226915|Carboplatin|carboplatin|mesh-list
2280866|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2280867|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280868|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
2280869|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
2280870|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
2280871|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280872|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
2280873|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2280874|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280875|NCT00226967|Octreotide|octreotide|mesh-list
2280876|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2280877|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2280878|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280879|NCT00226980|Thalidomide|thalidomide|mesh-list
2280880|NCT00226980|Capecitabine|capecitabine|mesh-list
2280881|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2280882|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
2280883|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280884|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280885|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2280886|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
2280887|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280888|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
2280889|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2280890|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2280891|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2810415|NCT04149106|Amodiaquine|amodiaquine|mesh-list
2810416|NCT04149106|Artenimol|artenimol|mesh-list
2810417|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
2810418|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2810419|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2810420|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810421|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2810422|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810423|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810424|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2810425|NCT04149106|Renal Agents|renal agents|mesh-ancestor
2810426|NCT04149015|Paclitaxel|paclitaxel|mesh-list
2810427|NCT04149015|Fluorouracil|fluorouracil|mesh-list
2810428|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
2810429|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2810430|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810431|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
2810432|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
2810433|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
2810434|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810435|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
2810436|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2810437|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2810438|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
2810439|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810440|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
2810441|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2810442|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2810443|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810444|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
2810445|NCT04149171|Coagulants|coagulants|mesh-ancestor
2810446|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
2810447|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2810448|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810449|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
2810450|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2810451|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
2810452|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810453|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810454|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2810455|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
2810456|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2810457|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
2810458|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810459|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2810460|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2810461|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
2810462|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
2810463|NCT04149132|Protective Agents|protective agents|mesh-ancestor
2810464|NCT04148898|Bevacizumab|bevacizumab|mesh-list
2810465|NCT04148898|Osimertinib|osimertinib|mesh-list
2810466|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2810467|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810468|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2810469|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2810470|NCT04148898|Growth Substances|growth substances|mesh-ancestor
2810471|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810472|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
2810473|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2810474|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810475|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810476|NCT04148885|Paclitaxel|paclitaxel|mesh-list
2810477|NCT04148885|Carboplatin|carboplatin|mesh-list
2810478|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2810479|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810480|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
2810481|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
2810482|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
2810483|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810484|NCT04148820|Aspirin|aspirin|mesh-list
2810485|NCT04148820|Perindopril|perindopril|mesh-list
2810486|NCT04148820|Atorvastatin|atorvastatin|mesh-list
2810487|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2810488|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2810489|NCT04148820|Analgesics|analgesics|mesh-ancestor
2810490|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
2810491|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810492|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810493|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2810494|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2810495|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2810496|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2810497|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810498|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2810499|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2810500|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810501|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
2810502|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2810503|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2810504|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
2810505|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2810506|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2810507|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2280892|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2280893|NCT00226980|Growth Substances|growth substances|mesh-ancestor
2280894|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
2280895|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2280896|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2280897|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2280898|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2280899|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280900|NCT00227084|Hemostatics|hemostatics|mesh-list
2280901|NCT00227084|Coagulants|coagulants|mesh-ancestor
2280902|NCT00227097|Anticoagulants|anticoagulants|mesh-list
2280903|NCT00227110|Pioglitazone|pioglitazone|mesh-list
2280904|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2280905|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810508|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
2810509|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2810510|NCT04148833|Paclitaxel|paclitaxel|mesh-list
2810511|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2810512|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810513|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
2810514|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
2810515|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
2280906|NCT00227123|Risperidone|risperidone|mesh-list
2280907|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2810516|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810517|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
2810518|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2810519|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2810520|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810521|NCT04148495|Acetaminophen|acetaminophen|mesh-list
2810522|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2810523|NCT04148495|Analgesics|analgesics|mesh-ancestor
2810524|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
2810525|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810526|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810527|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
2810528|NCT04148599|Lidocaine|lidocaine|mesh-list
2810529|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
2810530|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
2810531|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
2810532|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2810533|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810534|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
2280908|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2280909|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
2280910|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280911|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280912|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280913|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2280914|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2280915|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2280916|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280917|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2280918|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
2280919|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
2280920|NCT00227136|Serotonin|serotonin|mesh-list
2280921|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2280922|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
2280923|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280924|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280925|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810535|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810536|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2810537|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2810538|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2810539|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2810540|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810541|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2810542|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2810543|NCT04148599|Analgesics|analgesics|mesh-ancestor
2810544|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2810545|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2810546|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2810547|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
2810548|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2810549|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
2810550|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2810551|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2810552|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810553|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810554|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2810555|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2810556|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810557|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810558|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2810559|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2810560|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810561|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
2810562|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2810563|NCT04148846|Dexamethasone|dexamethasone|mesh-list
2810564|NCT04148846|Ketoprofen|ketoprofen|mesh-list
2810565|NCT04148846|Theophylline|theophylline|mesh-list
2810566|NCT04148846|Gabapentin|gabapentin|mesh-list
2810567|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2810568|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
2810569|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
2810570|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810571|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810572|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2810573|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
2810574|NCT04148846|Hormones|hormones|mesh-ancestor
2810575|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2810576|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2810577|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810578|NCT04148846|Analgesics|analgesics|mesh-ancestor
2810579|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
2810580|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
2810581|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2810582|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2810583|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2810584|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2810585|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2810586|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2810587|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2810588|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810589|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
2810590|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2810591|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2810592|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2810593|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2810594|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810595|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2810596|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2810597|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
2810598|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2810599|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
2810600|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2810601|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2810602|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
2810603|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
2810604|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2810605|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2810606|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2810607|NCT04148261|Epinephrine|epinephrine|mesh-list
2810608|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2810609|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2810610|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
2810611|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2810612|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810613|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810614|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2810615|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2810616|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
2810617|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810618|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2810619|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
2810620|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
2810621|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
2810622|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2810623|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2280926|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2280927|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
2280928|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280929|NCT00227253|Hormones|hormones|mesh-list
2280930|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2280931|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280932|NCT00227292|Citalopram|citalopram|mesh-list
2810624|NCT04148183|Metformin|metformin|mesh-list
2810625|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
2810626|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2810627|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280933|NCT00227292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2280934|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2280935|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2280936|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280937|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280938|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
2280939|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280940|NCT00227292|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2280941|NCT00227292|Antidepressive Agents|antidepressive agents|mesh-ancestor
2280942|NCT00227292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280943|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
2810645|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
2810646|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2810647|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
2810648|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810649|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810650|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2810651|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
2280944|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2810652|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
2810653|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2810654|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
2810655|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2810656|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810657|NCT04147806|Dexamethasone|dexamethasone|mesh-list
2810658|NCT04147806|Tamsulosin|tamsulosin|mesh-list
2810659|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2810660|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
2810661|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
2810662|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810663|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810664|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2810665|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
2810666|NCT04147806|Hormones|hormones|mesh-ancestor
2810667|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2810668|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2810669|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810670|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2810671|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2810672|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2810673|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
2810674|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2810675|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810676|NCT04147806|Urological Agents|urological agents|mesh-ancestor
2810677|NCT04147754|Morphine|morphine|mesh-list
2810678|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2810679|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810680|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2810681|NCT04147754|Narcotics|narcotics|mesh-ancestor
2810682|NCT04147754|Analgesics|analgesics|mesh-ancestor
2810683|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
2810684|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810685|NCT04147845|Triamcinolone|triamcinolone|mesh-list
2810686|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2810687|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2810688|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2810689|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2810690|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
2810691|NCT04147845|Hormones|hormones|mesh-ancestor
2810692|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2810693|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810694|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2810695|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
2810696|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810697|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810698|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
2810699|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2810700|NCT04147728|Growth Substances|growth substances|mesh-ancestor
2810701|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810702|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
2810703|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810713|NCT04147286|Atorvastatin|atorvastatin|mesh-list
2810714|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2810715|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2810716|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
2810717|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810718|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2810719|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2810720|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810721|NCT04147221|Imipenem|imipenem|mesh-list
2810722|NCT04147221|Relebactam|relebactam|mesh-list
2810723|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2810724|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810725|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2810726|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810727|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810728|NCT04147208|Ritonavir|ritonavir|mesh-list
2810729|NCT04147208|Entecavir|entecavir|mesh-list
2810730|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2810731|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2810732|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
2810733|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810734|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810735|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2810736|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2810737|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
2810738|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810739|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2810740|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2810741|NCT04147481|Anesthetics|anesthetics|mesh-list
2810742|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
2810743|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2810744|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810745|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
2810746|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810747|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
2810748|NCT04147390|Tacrolimus|tacrolimus|mesh-list
2810749|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2810750|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
2810751|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810752|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2810753|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810754|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810755|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2810756|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810757|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2810758|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
2810759|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2810760|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810761|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
2810762|NCT04147533|Dasatinib|dasatinib|mesh-list
2810763|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810764|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2810765|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810766|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810767|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
2810768|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2810769|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810770|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2810771|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2810772|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810773|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810774|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810775|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2810776|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2810777|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2810778|NCT04146883|Cephalexin|cephalexin|mesh-list
2810779|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810780|NCT04147416|Propofol|propofol|mesh-list
2810781|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2810782|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2810783|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810784|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2810785|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
2810786|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
2810787|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
2810788|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2810789|NCT04146610|Antibodies|antibodies|mesh-list
2810790|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
2810791|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
2810792|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810793|NCT04146220|Prednisolone|prednisolone|mesh-list
2810794|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2810795|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
2810796|NCT04146220|Hormones|hormones|mesh-ancestor
2810797|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2810798|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810799|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2810800|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810801|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
2810802|NCT04146298|Fludarabine|fludarabine|mesh-list
2810803|NCT04146298|Antibodies|antibodies|mesh-list
2810804|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2810805|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2810806|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
2810807|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810808|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2810809|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2810810|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
2810811|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810812|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810813|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2810814|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
2810815|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2810816|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2810817|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810818|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
2810819|NCT04146376|Coagulants|coagulants|mesh-ancestor
2810820|NCT04146207|Prednisone|prednisone|mesh-list
2810821|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2810822|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
2810823|NCT04146207|Hormones|hormones|mesh-ancestor
2810824|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2810825|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810826|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2810827|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810828|NCT04146571|Ensartinib|ensartinib|mesh-list
2810829|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810830|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2810831|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810832|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810838|NCT04146493|Heparin|heparin|mesh-list
2810839|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
2810840|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2810841|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2810842|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810843|NCT04146532|Aspirin|aspirin|mesh-list
2810844|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2810845|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2810846|NCT04146532|Analgesics|analgesics|mesh-ancestor
2810847|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
2810848|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810849|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810850|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2810851|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2810852|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2810853|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2810854|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810855|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2810856|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2810857|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810858|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
2810859|NCT04146155|Liraglutide|liraglutide|mesh-list
2810860|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2810861|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810862|NCT04146155|Incretins|incretins|mesh-ancestor
2810863|NCT04146155|Hormones|hormones|mesh-ancestor
2810864|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2810865|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
2810866|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2810867|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
2810868|NCT04146259|Calcium|calcium|mesh-list
2810869|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2810870|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810871|NCT04146259|Antacids|antacids|mesh-ancestor
2810872|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810873|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2810874|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2810875|NCT04146259|Vitamins|vitamins|mesh-ancestor
2810876|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
2280945|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2280946|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2280947|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810877|NCT04145856|Simethicone|simethicone|mesh-list
2810878|NCT04145856|Alverine|alverine|mesh-list
2810879|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
2810880|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810881|NCT04145856|Emollients|emollients|mesh-ancestor
2810882|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
2810883|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
2810884|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
2810885|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810886|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810887|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2810888|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
2810889|NCT04146038|Azacitidine|azacitidine|mesh-list
2810890|NCT04146038|Decitabine|decitabine|mesh-list
2810891|NCT04146038|Venetoclax|venetoclax|mesh-list
2810892|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2810893|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
2810894|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810895|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810896|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810897|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2810898|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2810899|NCT04146038|Analgesics|analgesics|mesh-ancestor
2810900|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
2810901|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810902|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810903|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2810904|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2810905|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2810906|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
2810907|NCT04146116|Povidone|povidone|mesh-list
2810908|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
2810909|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
2810910|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2810911|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810912|NCT04145804|Insulin|insulin|mesh-list
2810913|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2810914|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810915|NCT04145583|Voriconazole|voriconazole|mesh-list
2810916|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
2810917|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2810918|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2810919|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2810920|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810921|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810922|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2810923|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
2810924|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2810925|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810926|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2810927|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2810928|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810929|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2810930|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810931|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810932|NCT04145492|Vitamin D|vitamin d|mesh-list
2810933|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
2810934|NCT04145492|Vitamins|vitamins|mesh-list
2810935|NCT04145492|Vitamin K|vitamin k|mesh-list
2810936|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
2810937|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
2810938|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810939|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2810940|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2810941|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2810942|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2810943|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810944|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
2810945|NCT04145492|Coagulants|coagulants|mesh-ancestor
2810946|NCT04145921|Tacrine|tacrine|mesh-list
2810947|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2810948|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810949|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810950|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
2810951|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2810952|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810953|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2810954|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
2810955|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810956|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
2810957|NCT04145687|Metformin|metformin|mesh-list
2810958|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2810959|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810960|NCT04145518|Naproxen|naproxen|mesh-list
2810961|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2810962|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2810963|NCT04145518|Analgesics|analgesics|mesh-ancestor
2810964|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
2810965|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810966|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810967|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2810968|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2810969|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
2810970|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2810971|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2810972|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280948|NCT00227331|Amoxicillin|amoxicillin|mesh-list
2280949|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2280950|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2280951|NCT00227357|Buprenorphine|buprenorphine|mesh-list
2280952|NCT00227357|Methadone|methadone|mesh-list
2280953|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2280954|NCT00227357|Naloxone|naloxone|mesh-list
2280955|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2280956|NCT00227357|Narcotics|narcotics|mesh-ancestor
2280957|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2280958|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810973|NCT04145193|Leucovorin|leucovorin|mesh-list
2810974|NCT04145193|Fluorouracil|fluorouracil|mesh-list
2810975|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
2810976|NCT04145193|Durvalumab|durvalumab|mesh-list
2810977|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2810978|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
2810979|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2810980|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2810981|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2810982|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2810983|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
2810984|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810985|NCT04145193|Antidotes|antidotes|mesh-ancestor
2810986|NCT04145193|Protective Agents|protective agents|mesh-ancestor
2810987|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
2810988|NCT04145193|Vitamins|vitamins|mesh-ancestor
2810989|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
2810990|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2810991|NCT04145258|Aspirin|aspirin|mesh-list
2280959|NCT00227357|Analgesics|analgesics|mesh-ancestor
2280960|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
2280961|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2810992|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2810993|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2810994|NCT04145258|Analgesics|analgesics|mesh-ancestor
2810995|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
2810996|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2280962|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2810997|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2810998|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2810999|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2811000|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2811001|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2811002|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811003|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2811004|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2811005|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811006|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
2811007|NCT04145076|Citalopram|citalopram|mesh-list
2811008|NCT04145076|Tianeptine|tianeptine|mesh-list
2811009|NCT04145076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2811010|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2811011|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2811012|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811013|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811014|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
2811015|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811016|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2811017|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
2811018|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2280963|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
2280964|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
2280965|NCT00227409|Edetic Acid|edetic acid|mesh-list
2811019|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2811020|NCT04145440|Felzartamab|felzartamab|mesh-list
2811021|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811022|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
2811023|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811024|NCT04145102|Propolis|propolis|mesh-list
2811025|NCT04145102|Fluorides|fluorides|mesh-list
2811026|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
2811027|NCT04145102|Protective Agents|protective agents|mesh-ancestor
2811028|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811029|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811030|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
2811031|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
2811032|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2811033|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2811034|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811035|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811036|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811037|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2811038|NCT04145336|Indomethacin|indomethacin|mesh-list
2811039|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2811040|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2811041|NCT04145336|Analgesics|analgesics|mesh-ancestor
2811042|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
2811043|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811044|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811045|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2811046|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2811047|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
2811048|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
2811049|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2811050|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2811051|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811052|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280966|NCT00227409|Calcium|calcium|mesh-list
2280967|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
2280968|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2280969|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280970|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
2280971|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2280972|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
2280973|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
2811053|NCT04145232|Nivolumab|nivolumab|mesh-list
2811054|NCT04145232|Ipilimumab|ipilimumab|mesh-list
2811055|NCT04145232|Atezolizumab|atezolizumab|mesh-list
2811056|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2811057|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811058|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2811059|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811060|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
2811061|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2811062|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2811063|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
2811064|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811065|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811066|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811067|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
2811068|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
2811069|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811070|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
2811071|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2811072|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
2811073|NCT04144712|Caffeine|caffeine|mesh-list
2811074|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
2811075|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811076|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2811077|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811078|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2811079|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811080|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2280974|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280975|NCT00227409|Antidotes|antidotes|mesh-ancestor
2280976|NCT00227409|Protective Agents|protective agents|mesh-ancestor
2280977|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2280978|NCT00227448|Phenylephrine|phenylephrine|mesh-list
2280979|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
2280980|NCT00227448|Midodrine|midodrine|mesh-list
2280981|NCT00227448|Norepinephrine|norepinephrine|mesh-list
2280982|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2280983|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
2811081|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2811082|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
2811083|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811084|NCT04144933|Acetaminophen|acetaminophen|mesh-list
2811085|NCT04144933|Dexamethasone|dexamethasone|mesh-list
2811086|NCT04144933|Lidocaine|lidocaine|mesh-list
2811087|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
2811088|NCT04144933|Sufentanil|sufentanil|mesh-list
2811089|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
2811090|NCT04144933|Ketamine|ketamine|mesh-list
2811091|NCT04144933|Gabapentin|gabapentin|mesh-list
2811092|NCT04144933|Dsuvia|dsuvia|mesh-list
2811093|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
2811094|NCT04144933|Ondansetron|ondansetron|mesh-list
2811095|NCT04144933|Sevoflurane|sevoflurane|mesh-list
2811096|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2811097|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2811098|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
2811099|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
2811100|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811101|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811102|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2811103|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
2811104|NCT04144933|Hormones|hormones|mesh-ancestor
2811105|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2811106|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2811107|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811108|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
2811109|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
2280984|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
2280985|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811110|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2811111|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
2811112|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2811113|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2280986|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2280987|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
2280988|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2280989|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
2280990|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
2280991|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2811114|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2811115|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2811116|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811117|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2811118|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2811119|NCT04144933|Analgesics|analgesics|mesh-ancestor
2811120|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2811121|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2811122|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2811123|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
2811124|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811125|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2811126|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2811127|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
2811128|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2811129|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2811130|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
2811131|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2811132|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2811133|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
2811134|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2811135|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2811136|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2811137|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
2811138|NCT04144933|Narcotics|narcotics|mesh-ancestor
2811139|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
2811140|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
2811141|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2811142|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
2811143|NCT04144933|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2811144|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2811145|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2811146|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
2811147|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2811148|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2811149|NCT04144582|Docetaxel|docetaxel|mesh-list
2811150|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811151|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
2811152|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
2811153|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
2811154|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811155|NCT04144439|Butyric Acid|butyric acid|mesh-list
2811156|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
2811157|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
2811158|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811159|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811160|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811161|NCT04144218|Lacosamide|lacosamide|mesh-list
2811162|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
2280992|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2280993|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2280994|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
2280995|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2280996|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2280997|NCT00227448|Protective Agents|protective agents|mesh-ancestor
2280998|NCT00227461|Levetiracetam|levetiracetam|mesh-list
2280999|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
2281000|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
2281001|NCT00227474|Vaccines|vaccines|mesh-list
2281002|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
2281003|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281004|NCT00227500|Pravastatin|pravastatin|mesh-list
2281005|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2281006|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2281007|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
2281008|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281009|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2281010|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2281011|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281012|NCT00227513|Bortezomib|bortezomib|mesh-list
2281013|NCT00227513|Vorinostat|vorinostat|mesh-list
2281014|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281015|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2281016|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281017|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281018|NCT00227565|Carboplatin|carboplatin|mesh-list
2281019|NCT00227565|Pemetrexed|pemetrexed|mesh-list
2281020|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281021|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281022|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281023|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2281024|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2281025|NCT00227630|Pemetrexed|pemetrexed|mesh-list
2281026|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281027|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281028|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281029|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2281030|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2281031|NCT00227656|Interferons|interferons|mesh-list
2281032|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
2281033|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
2281034|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2281035|NCT00227656|Capecitabine|capecitabine|mesh-list
2281036|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2281037|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
2281038|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281039|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281040|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
2281041|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281042|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
2281043|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281044|NCT00227669|Gemcitabine|gemcitabine|mesh-list
2811163|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2811164|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2811165|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2811166|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281045|NCT00227669|Docetaxel|docetaxel|mesh-list
2281046|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2281047|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
2281048|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281049|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281050|NCT00227669|Antiviral Agents|antiviral agents|mesh-ancestor
2281051|NCT00227669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281052|NCT00227669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281053|NCT00227669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281054|NCT00227669|Immunologic Factors|immunologic factors|mesh-ancestor
2281055|NCT00227669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281056|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
2281057|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
2281058|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
2281059|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
2281060|NCT00227682|Thalidomide|thalidomide|mesh-list
2811167|NCT04144465|Phenylephrine|phenylephrine|mesh-list
2811168|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
2811169|NCT04144465|Norepinephrine|norepinephrine|mesh-list
2811170|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2811171|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
2811172|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
2811173|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811174|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811175|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
2811176|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2811177|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
2811178|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
2811179|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2811180|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2811181|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2811182|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
2811183|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811184|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281061|NCT00227682|Dexamethasone|dexamethasone|mesh-list
2281062|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
2281063|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2281064|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
2281065|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
2811185|NCT04144465|Protective Agents|protective agents|mesh-ancestor
2281066|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281067|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281068|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2281069|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
2281070|NCT00227682|Hormones|hormones|mesh-ancestor
2811186|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
2811187|NCT04144153|Anesthetics|anesthetics|mesh-list
2811188|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2811189|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811190|NCT04144153|Narcotics|narcotics|mesh-ancestor
2811191|NCT04144153|Analgesics|analgesics|mesh-ancestor
2811192|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
2811193|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281071|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281072|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2281073|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281074|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281075|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
2811194|NCT04144101|Etoricoxib|etoricoxib|mesh-list
2811195|NCT04144101|Aceclofenac|aceclofenac|mesh-list
2811196|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2811197|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2811198|NCT04144101|Analgesics|analgesics|mesh-ancestor
2811199|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
2811200|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811201|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811202|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2281076|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
2281077|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2281078|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281079|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2281080|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2281081|NCT00227682|Growth Substances|growth substances|mesh-ancestor
2281082|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
2281083|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
2281084|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281085|NCT00227682|Protective Agents|protective agents|mesh-ancestor
2281086|NCT00227682|Vitamins|vitamins|mesh-ancestor
2281087|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
2811203|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2811204|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2811205|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2811206|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811207|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811208|NCT04143880|Progesterone|progesterone|mesh-list
2811209|NCT04143880|Progestins|progestins|mesh-ancestor
2811210|NCT04143880|Hormones|hormones|mesh-ancestor
2811211|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2811212|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811213|NCT04143906|Gemcitabine|gemcitabine|mesh-list
2811214|NCT04143906|Carboplatin|carboplatin|mesh-list
2811215|NCT04143906|Vinorelbine|vinorelbine|mesh-list
2811216|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811217|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2811218|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
2811219|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811220|NCT04143906|Antiviral Agents|antiviral agents|mesh-ancestor
2811221|NCT04143906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811222|NCT04143906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811223|NCT04143906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2811224|NCT04143906|Immunologic Factors|immunologic factors|mesh-ancestor
2811225|NCT04143906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811226|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2811227|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
2811228|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
2811229|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
2811230|NCT04144192|Lidocaine|lidocaine|mesh-list
2811231|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
2281088|NCT00227695|Rituximab|rituximab|mesh-list
2281089|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2281090|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281091|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
2281092|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281093|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2281094|NCT00227708|Docetaxel|docetaxel|mesh-list
2811232|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
2811233|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2811234|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811235|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
2811236|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811237|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2811238|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2811239|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2811240|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2811241|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811242|NCT04143802|Dulaglutide|dulaglutide|mesh-list
2281095|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281096|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
2281097|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
2281098|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
2281099|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281100|NCT00227734|Capecitabine|capecitabine|mesh-list
2281101|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
2281102|NCT00227734|Cetuximab|cetuximab|mesh-list
2281103|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2281104|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
2281105|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281106|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281107|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2281108|NCT00227747|Capecitabine|capecitabine|mesh-list
2281109|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
2281110|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2281111|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
2281112|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281113|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281114|NCT00227773|Octreotide|octreotide|mesh-list
2281115|NCT00227773|Hormones|hormones|mesh-list
2281116|NCT00227773|Somatostatin|somatostatin|mesh-list
2281117|NCT00227773|Mitogens|mitogens|mesh-list
2281118|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2281119|NCT00227773|Vatalanib|vatalanib|mesh-list
2372126|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2811243|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2811244|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811245|NCT04143685|Misoprostol|misoprostol|mesh-list
2811246|NCT04143685|Oxytocin|oxytocin|mesh-list
2811247|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
2104591|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
2104592|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
2104593|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
2811248|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2811249|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811250|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2811251|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
2811252|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2811253|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2811254|NCT04143724|Luspatercept|luspatercept|mesh-list
2811255|NCT04143724|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2811256|NCT04143724|Hematinics|hematinics|mesh-ancestor
2811257|NCT04143724|Immunologic Factors|immunologic factors|mesh-ancestor
2811258|NCT04143724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811259|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
2811260|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2811261|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2811262|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2811263|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2811264|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811265|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
2811266|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811267|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811268|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2811269|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811270|NCT04143581|Empagliflozin|empagliflozin|mesh-list
2811271|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2811272|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104594|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104595|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104596|NCT02439281|Clonidine|clonidine|mesh-list
2104597|NCT02439281|Ropivacaine|ropivacaine|mesh-list
2104598|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
2104599|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
2811273|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2811274|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281120|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281121|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104600|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2104601|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104602|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
2104603|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104604|NCT02439281|Analgesics|analgesics|mesh-ancestor
2104605|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2104606|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
2104607|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
2104608|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2104609|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2104610|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2104611|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
2281122|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
2281123|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281124|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2281125|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2281126|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281127|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2281128|NCT00227812|Bupropion|bupropion|mesh-list
2281129|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2281130|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
2281131|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281132|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2281133|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2281134|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2281135|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281136|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
2281137|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281138|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281139|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2281140|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2281141|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281142|NCT00227942|Zolpidem|zolpidem|mesh-list
2281143|NCT00227942|Estrogens|estrogens|mesh-list
2281144|NCT00227942|Hormones|hormones|mesh-ancestor
2281145|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281146|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281147|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2281148|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2281149|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2281150|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2281151|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
2281152|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
2281153|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281154|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281155|NCT00227955|Imipramine|imipramine|mesh-list
2281156|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2811275|NCT04143607|Gefitinib|gefitinib|mesh-list
2811276|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811277|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2811278|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811279|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811280|NCT04143451|Imiquimod|imiquimod|mesh-list
2811281|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2281157|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
2281158|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281159|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2281160|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2281161|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2281162|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281163|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
2281164|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281165|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281166|NCT00227981|Fluoxetine|fluoxetine|mesh-list
2281167|NCT00227981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2281168|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2281169|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2281170|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281171|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281172|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
2281173|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281174|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2281175|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
2281176|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281177|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2281178|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2281179|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281180|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
2811282|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
2811283|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811284|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811285|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
2811286|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
2811287|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2811288|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2811289|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2811290|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2811291|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811292|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
2811293|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811294|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811295|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2811296|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281181|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281182|NCT00228020|Cyclosporine|cyclosporine|mesh-list
2281183|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
2281184|NCT00228020|Prednisone|prednisone|mesh-list
2281185|NCT00228020|Cyclosporins|cyclosporins|mesh-list
2281186|NCT00228020|Basiliximab|basiliximab|mesh-list
2281187|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2281188|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
2281189|NCT00228020|Hormones|hormones|mesh-ancestor
2104612|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104613|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104614|NCT02439320|Lasmiditan|lasmiditan|mesh-list
2104615|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2104616|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
2104617|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811297|NCT04143321|Empagliflozin|empagliflozin|mesh-list
2811298|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2811299|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811300|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2811301|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811302|NCT04143165|Lidocaine|lidocaine|mesh-list
2811303|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
2811304|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
2811305|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2811306|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811307|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
2811308|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811309|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2811310|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2811311|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2811312|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2811313|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811314|NCT04143256|Menthol|menthol|mesh-list
2811315|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
2811316|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
2811317|NCT04143412|Ramipril|ramipril|mesh-list
2811318|NCT04143412|Eplerenone|eplerenone|mesh-list
2811319|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2811320|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
2811321|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811322|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811323|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2811324|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2811325|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
2811326|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2811327|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811328|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2811329|NCT04143412|Diuretics|diuretics|mesh-ancestor
2811330|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
2811331|NCT04143191|Sorafenib|sorafenib|mesh-list
2811332|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811333|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2811334|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811335|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811336|NCT04142931|Nivolumab|nivolumab|mesh-list
2811337|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2811338|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811339|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2811340|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811341|NCT04142892|Onapristone|onapristone|mesh-list
2811342|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811343|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2811344|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
2811345|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2811346|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811347|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
2811348|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2811349|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
2811350|NCT04142840|Propofol|propofol|mesh-list
2811351|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2811352|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2811353|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811354|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2281190|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281191|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281192|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2281193|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281194|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281195|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104618|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811355|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
2811356|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
2811357|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2811358|NCT04142840|Analgesics|analgesics|mesh-ancestor
2281196|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281197|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
2281198|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
2281199|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281200|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
2281201|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2811359|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
2811360|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811361|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2811362|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2811363|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2811364|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
2811365|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811366|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811367|NCT04142762|Itraconazole|itraconazole|mesh-list
2811368|NCT04142762|Rifampin|rifampin|mesh-list
2811369|NCT04142762|Midazolam|midazolam|mesh-list
2811370|NCT04142762|Esomeprazole|esomeprazole|mesh-list
2811371|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
2811372|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2811373|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2811374|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
2811375|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
2811376|NCT04142762|Estradiol|estradiol|mesh-list
2811377|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2281202|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2811378|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2811379|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2811380|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811381|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2811382|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2811383|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2811384|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2811385|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
2811386|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
2811387|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
2811388|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
2104619|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104620|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
2104621|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
2104622|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104623|NCT02439879|Protective Agents|protective agents|mesh-ancestor
2104624|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104625|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
2104626|NCT02439879|Vitamins|vitamins|mesh-ancestor
2104627|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
2104628|NCT02440178|Micafungin|micafungin|mesh-list
2104629|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
2104630|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104631|NCT02440204|Remifentanil|remifentanil|mesh-list
2104632|NCT02440204|Sevoflurane|sevoflurane|mesh-list
2104633|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2104634|NCT02440204|Narcotics|narcotics|mesh-ancestor
2104635|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2104636|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104637|NCT02440204|Analgesics|analgesics|mesh-ancestor
2104638|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
2104639|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104640|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2104641|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2104642|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
2104643|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
2104644|NCT02440308|Bombesin|bombesin|mesh-list
2104645|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104646|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104647|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104648|NCT02440425|Paclitaxel|paclitaxel|mesh-list
2104649|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
2104650|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2104651|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104652|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
2104653|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
2104654|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
2811389|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811390|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811391|NCT04142762|Estrogens|estrogens|mesh-ancestor
2811392|NCT04142762|Hormones|hormones|mesh-ancestor
2811393|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2811394|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2811395|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2811396|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2811397|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2811398|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2811399|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2811400|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811401|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
2811402|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811403|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2811404|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2811405|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2811406|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
2811407|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2811408|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2811409|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2811410|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
2811411|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2811412|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
2811413|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2811414|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2811415|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2811416|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2811417|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2811418|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2811419|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2811420|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2811421|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2811422|NCT04142749|Oltipraz|oltipraz|mesh-list
2811423|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
2811424|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811425|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
2811426|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2811427|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
2811428|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2811429|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2811430|NCT04142749|Protective Agents|protective agents|mesh-ancestor
2811431|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281203|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2281204|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2281205|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
2281206|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2281207|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
2281208|NCT00228033|Calcium|calcium|mesh-list
2281209|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2281210|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281211|NCT00228033|Antacids|antacids|mesh-ancestor
2281212|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281213|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2281214|NCT00228046|Valproic Acid|valproic acid|mesh-list
2281215|NCT00228046|Methylphenidate|methylphenidate|mesh-list
2281216|NCT00228046|Amphetamine|amphetamine|mesh-list
2281217|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
2281218|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2281219|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281220|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2281221|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2811432|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811433|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2811434|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2811435|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811436|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811437|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
2811438|NCT04142502|Propofol|propofol|mesh-list
2811439|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2811440|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2372127|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811441|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811442|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2811443|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
2811444|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
2811445|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2811446|NCT04142502|Analgesics|analgesics|mesh-ancestor
2811447|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
2811448|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811449|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2811450|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2811451|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2811452|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
2811453|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811454|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811455|NCT04142086|Vaccines|vaccines|mesh-list
2811456|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
2811457|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811458|NCT04142151|Aspirin|aspirin|mesh-list
2811459|NCT04142151|Clopidogrel|clopidogrel|mesh-list
2811460|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2811461|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2811462|NCT04142151|Analgesics|analgesics|mesh-ancestor
2811463|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
2811464|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811465|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811466|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2811467|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2104655|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104656|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2104657|NCT02440568|Cytarabine|cytarabine|mesh-list
2104658|NCT02440568|Idarubicin|idarubicin|mesh-list
2104659|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
2104660|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2104661|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
2104662|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104663|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104664|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
2104665|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104666|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2104667|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
2104668|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104669|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2104670|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2104671|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2104672|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104673|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2104674|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2811468|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2811469|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2811470|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811471|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2811472|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2811473|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811474|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
2811475|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2811476|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2811477|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2811478|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
2811479|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811480|NCT04142125|Aspirin|aspirin|mesh-list
2811481|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
2811482|NCT04142125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2811483|NCT04142125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2811484|NCT04142125|Analgesics|analgesics|mesh-ancestor
2811485|NCT04142125|Sensory System Agents|sensory system agents|mesh-ancestor
2811486|NCT04142125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811487|NCT04142125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811488|NCT04142125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2811489|NCT04142125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2811490|NCT04142125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2811491|NCT04142125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2811492|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811493|NCT04142125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2281222|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2281223|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281224|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
2811494|NCT04142125|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2811495|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811496|NCT04142125|Antipyretics|antipyretics|mesh-ancestor
2811497|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2811498|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
2811499|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2811500|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
2811501|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
2811502|NCT04141995|Leucovorin|leucovorin|mesh-list
2811503|NCT04141995|Fluorouracil|fluorouracil|mesh-list
2811504|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
2811505|NCT04141995|Irinotecan|irinotecan|mesh-list
2811506|NCT04141995|Camptothecin|camptothecin|mesh-list
2811507|NCT04141995|Digoxin|digoxin|mesh-list
2811508|NCT04141995|Calcium|calcium|mesh-list
2811509|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
2811510|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2811511|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811512|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
2811513|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811514|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2811515|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811516|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2811517|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
2811518|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2811519|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2811520|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811521|NCT04141995|Antidotes|antidotes|mesh-ancestor
2811522|NCT04141995|Protective Agents|protective agents|mesh-ancestor
2811523|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
2811524|NCT04141995|Vitamins|vitamins|mesh-ancestor
2811525|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
2811526|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2811527|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2811528|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2811529|NCT04142411|Insulin|insulin|mesh-list
2811530|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2811531|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
2811532|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2811533|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281225|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281226|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
2281227|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
2281228|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281229|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
2281230|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2281231|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
2281232|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281233|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
2281234|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
2281235|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2281236|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2281237|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281238|NCT00228163|Teriflunomide|teriflunomide|mesh-list
2281239|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2281240|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2281241|NCT00228163|Analgesics|analgesics|mesh-ancestor
2281242|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
2281243|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281244|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281245|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2281246|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2281247|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281248|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
2811534|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2811535|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
2811536|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
2811537|NCT04142411|Protective Agents|protective agents|mesh-ancestor
2811538|NCT04141904|Tofacitinib|tofacitinib|mesh-list
2811539|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2811540|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811541|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281249|NCT00228176|Rimonabant|rimonabant|mesh-list
2281250|NCT00228176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2281251|NCT00228176|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2281252|NCT00228176|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2811542|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2811543|NCT04141787|Cefazolin|cefazolin|mesh-list
2811544|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
2811545|NCT04141787|Daptomycin|daptomycin|mesh-list
2811546|NCT04141787|Cloxacillin|cloxacillin|mesh-list
2811547|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811548|NCT04141410|Simendan|simendan|mesh-list
2281253|NCT00228176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281254|NCT00228176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281255|NCT00228176|Hormones|hormones|mesh-ancestor
2281256|NCT00228176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281257|NCT00228176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811549|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2811550|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
2811551|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2811552|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2811553|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811554|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811555|NCT04141410|Protective Agents|protective agents|mesh-ancestor
2811556|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811557|NCT04141501|Psilocybin|psilocybin|mesh-list
2811558|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
2811559|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811560|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281258|NCT00228228|Vaccines|vaccines|mesh-list
2281259|NCT00228228|Immunologic Factors|immunologic factors|mesh-ancestor
2281260|NCT00228228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281261|NCT00228254|Vitamin A|vitamin a|mesh-list
2281262|NCT00228254|Vitamins|vitamins|mesh-ancestor
2281263|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
2281264|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281265|NCT00228267|Propofol|propofol|mesh-list
2281266|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2281267|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2281268|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281269|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2281270|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
2281271|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
2281272|NCT00228319|Vitamins|vitamins|mesh-list
2281273|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
2281274|NCT00228319|Vitamin E|vitamin e|mesh-list
2281275|NCT00228319|Vitamin A|vitamin a|mesh-list
2281276|NCT00228319|Carboplatin|carboplatin|mesh-list
2281277|NCT00228319|Carotenoids|carotenoids|mesh-list
2281278|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281279|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281280|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
2281281|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281282|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
2281283|NCT00228319|Protective Agents|protective agents|mesh-ancestor
2281284|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
2281285|NCT00228358|Interleukin-2|interleukin-2|mesh-list
2281286|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
2281287|NCT00228358|Immunotoxins|immunotoxins|mesh-list
2281288|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281289|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
2281290|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281291|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2281292|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2281293|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
2281294|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811567|NCT04141553|Diltiazem|diltiazem|mesh-list
2811568|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2811569|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2811570|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2811571|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281295|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281296|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2281297|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2811572|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2811573|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811574|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
2811575|NCT04141319|Ketorolac|ketorolac|mesh-list
2811576|NCT04141319|Epinephrine|epinephrine|mesh-list
2811577|NCT04141319|Ropivacaine|ropivacaine|mesh-list
2811578|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
2811579|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
2811580|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2811581|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811582|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
2811583|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811584|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2811585|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2811586|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
2811587|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811588|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811589|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2811590|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2811591|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
2811592|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2811593|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
2811594|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
2811595|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
2811596|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2811597|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2811598|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2811599|NCT04141319|Analgesics|analgesics|mesh-ancestor
2811600|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2811601|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2811602|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2811603|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281298|NCT00228358|Analgesics|analgesics|mesh-ancestor
2281299|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
2281300|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281301|NCT00228397|Sirolimus|sirolimus|mesh-list
2281302|NCT00228397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2281303|NCT00228397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281304|NCT00228397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2281305|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281306|NCT00228397|Antifungal Agents|antifungal agents|mesh-ancestor
2281307|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281308|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
2281309|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281310|NCT00228410|Vancomycin|vancomycin|mesh-list
2281311|NCT00228410|Tigecycline|tigecycline|mesh-list
2281312|NCT00228410|Aztreonam|aztreonam|mesh-list
2281313|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2281314|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281315|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2281316|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281317|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281318|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2281319|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
2281320|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281321|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2811604|NCT04141163|Metformin|metformin|mesh-list
2811605|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2811606|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811607|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2811608|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2811609|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811610|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
2811611|NCT04140786|Gentamicins|gentamicins|mesh-list
2811612|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2811613|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811614|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2811615|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811616|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811617|NCT04140968|Progesterone|progesterone|mesh-list
2811618|NCT04140968|Progestins|progestins|mesh-ancestor
2811619|NCT04140968|Hormones|hormones|mesh-ancestor
2811620|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2811621|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811622|NCT04140578|Ertapenem|ertapenem|mesh-list
2281322|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2811623|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2811624|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811625|NCT04140487|Azacitidine|azacitidine|mesh-list
2281323|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2281324|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281325|NCT00228475|Budesonide|budesonide|mesh-list
2281326|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2281327|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2811626|NCT04140487|Venetoclax|venetoclax|mesh-list
2811627|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2811628|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
2811629|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811630|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811631|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811632|NCT04140448|Ranibizumab|ranibizumab|mesh-list
2811633|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2811634|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2811635|NCT04140448|Growth Substances|growth substances|mesh-ancestor
2811636|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811637|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
2811638|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811639|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
2811640|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2811641|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2811642|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811643|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
2811644|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
2811645|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281328|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
2281329|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281330|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281331|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2281332|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
2281333|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
2281334|NCT00228475|Hormones|hormones|mesh-ancestor
2281335|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281336|NCT00228488|Gefitinib|gefitinib|mesh-list
2281337|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281338|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2281339|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281340|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281341|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2811646|NCT04140461|Amphotericin B|amphotericin b|mesh-list
2811647|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2811648|NCT04140461|Flucytosine|flucytosine|mesh-list
2811649|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811650|NCT04140461|Amebicides|amebicides|mesh-ancestor
2811651|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2811652|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2811653|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2811654|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
2811655|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
2811656|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811657|NCT04140591|Propranolol|propranolol|mesh-list
2811658|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2811659|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2281342|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2811660|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2811661|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
2811662|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811663|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811664|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811665|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2811666|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2811667|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
2811668|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811669|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2811670|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2811678|NCT04140409|Octreotide|octreotide|mesh-list
2811679|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2811680|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2811681|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811694|NCT04140214|Carbocysteine|carbocysteine|mesh-list
2811695|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2811696|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811697|NCT04140214|Expectorants|expectorants|mesh-ancestor
2811698|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
2811699|NCT04140318|Paclitaxel|paclitaxel|mesh-list
2811700|NCT04140318|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2811701|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2811702|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811703|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
2811704|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
2811705|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
2811706|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811707|NCT04140006|Alendronate|alendronate|mesh-list
2811708|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2811709|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811710|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
2811711|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
2811712|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811713|NCT04139928|Cathartics|cathartics|mesh-ancestor
2811714|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2811715|NCT04139928|Antacids|antacids|mesh-ancestor
2811716|NCT04140292|Vitamin D|vitamin d|mesh-list
2811717|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
2811718|NCT04140292|Vitamins|vitamins|mesh-ancestor
2811719|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
2811720|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811721|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2811722|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2811723|NCT04139915|Dactolisib|dactolisib|mesh-list
2811724|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811725|NCT04139941|Antibodies|antibodies|mesh-list
2811726|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
2811727|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
2811728|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811729|NCT04140058|Ondansetron|ondansetron|mesh-list
2811730|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
2811731|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
2811732|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811733|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811734|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2811735|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
2811736|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
2811737|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2811738|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
2811739|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811740|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811741|NCT04140058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2811742|NCT04140058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2811743|NCT04140058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2811744|NCT04140058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2811745|NCT04140058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2811746|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
2811747|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2811748|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811749|NCT04140136|Tocotrienols|tocotrienols|mesh-list
2811750|NCT04140136|Vitamin E|vitamin e|mesh-list
2811751|NCT04140136|Tocopherols|tocopherols|mesh-list
2811752|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
2811753|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811754|NCT04140136|Protective Agents|protective agents|mesh-ancestor
2811755|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811756|NCT04140136|Vitamins|vitamins|mesh-ancestor
2811757|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
2811758|NCT04140201|Simvastatin|simvastatin|mesh-list
2811759|NCT04140201|Fenofibrate|fenofibrate|mesh-list
2811760|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2811761|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2811762|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
2811763|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811764|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2811765|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2811766|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811767|NCT04139824|Naproxen|naproxen|mesh-list
2811768|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2811769|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2811770|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2811771|NCT04139824|Analgesics|analgesics|mesh-ancestor
2811772|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
2811773|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811774|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811775|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2811776|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
2811777|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2811778|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811779|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104675|NCT02440789|Sirolimus|sirolimus|mesh-list
2104676|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2104677|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104678|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2104679|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104680|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
2104681|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2104682|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
2104683|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104684|NCT02441062|Edotreotide|edotreotide|mesh-list
2104685|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2104686|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811780|NCT04139668|Naltrexone|naltrexone|mesh-list
2811781|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2811782|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2811783|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811784|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
2811785|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811786|NCT04139525|Heparin|heparin|mesh-list
2811787|NCT04139525|Calcium heparin|calcium heparin|mesh-list
2811788|NCT04139525|Citric Acid|citric acid|mesh-list
2811789|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
2811790|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
2811791|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2811792|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
2811793|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
2811794|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811795|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2811796|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2811797|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
2811798|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811799|NCT04139772|Docetaxel|docetaxel|mesh-list
2811800|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
2281343|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2281344|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
2281345|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281346|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2281347|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2281348|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281349|NCT00228527|Esomeprazole|esomeprazole|mesh-list
2281350|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2811801|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104687|NCT02441114|Fluticasone|fluticasone|mesh-list
2811802|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
2811803|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
2811804|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
2811805|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811806|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2811807|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811808|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
2811809|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281351|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2281352|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2811810|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811811|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2811812|NCT04139395|Citric Acid|citric acid|mesh-list
2811813|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
2811814|NCT04139395|Gallium citrate|gallium citrate|mesh-list
2811815|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
2811816|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2811817|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
2811818|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
2811819|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811820|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2811821|NCT04139629|Antibodies|antibodies|mesh-list
2811822|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
2811823|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811824|NCT04139681|Menthol|menthol|mesh-list
2811825|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
2281353|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281354|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281355|NCT00228540|Modafinil|modafinil|mesh-list
2281356|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2281357|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281358|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2811826|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
2811827|NCT04139213|Naltrexone|naltrexone|mesh-list
2811828|NCT04139213|Buprenorphine|buprenorphine|mesh-list
2811829|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2811830|NCT04139213|Naloxone|naloxone|mesh-list
2811831|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2811832|NCT04139213|Narcotics|narcotics|mesh-ancestor
2811833|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2811834|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811835|NCT04139213|Analgesics|analgesics|mesh-ancestor
2811836|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
2811837|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811838|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2811839|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2811840|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
2811841|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2811842|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
2811843|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811844|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2811845|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2281359|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2281360|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2281361|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281362|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
2281363|NCT00228592|Antibodies|antibodies|mesh-list
2281364|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
2281365|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2811846|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
2811847|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811848|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811849|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2811850|NCT04138992|Bevacizumab|bevacizumab|mesh-list
2811851|NCT04138992|Cisplatin|cisplatin|mesh-list
2811852|NCT04138992|Docetaxel|docetaxel|mesh-list
2811853|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2811854|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811855|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2811856|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2811857|NCT04138992|Growth Substances|growth substances|mesh-ancestor
2811858|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811859|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
2811860|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
2811861|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
2811862|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
2811863|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811864|NCT04139070|Bleomycin|bleomycin|mesh-list
2811865|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2811866|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811867|NCT04138901|Ropivacaine|ropivacaine|mesh-list
2811868|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
2811869|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
2811870|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2811871|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811872|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
2811873|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811877|NCT04138615|Morphine|morphine|mesh-list
2811878|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2811879|NCT04138615|Narcotics|narcotics|mesh-ancestor
2811880|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2811881|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811882|NCT04138615|Analgesics|analgesics|mesh-ancestor
2811883|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
2811884|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811885|NCT04138628|Atezolizumab|atezolizumab|mesh-list
2811886|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811887|NCT04138420|Bevacizumab|bevacizumab|mesh-list
2811888|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2811889|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811890|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2811891|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2811892|NCT04138420|Growth Substances|growth substances|mesh-ancestor
2811893|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811894|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
2811895|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
2281366|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2281367|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
2281368|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281369|NCT00228605|Fentanyl|fentanyl|mesh-list
2281370|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2281371|NCT00228605|Narcotics|narcotics|mesh-ancestor
2281372|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2281373|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811896|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811897|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2811898|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811899|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811900|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2811901|NCT04138888|Olmesartan|olmesartan|mesh-list
2811902|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2281374|NCT00228605|Analgesics|analgesics|mesh-ancestor
2281375|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
2281376|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281377|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2281378|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2281379|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
2281380|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
2281381|NCT00228839|Infliximab|infliximab|mesh-list
2281382|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
2281383|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2281384|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2281385|NCT00228852|Fludarabine|fludarabine|mesh-list
2281386|NCT00228852|Busulfan|busulfan|mesh-list
2281387|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281388|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811903|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2811904|NCT04138888|Diuretics|diuretics|mesh-ancestor
2811905|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
2811906|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811907|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2811908|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2811909|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811910|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2811911|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2811912|NCT04138836|Itraconazole|itraconazole|mesh-list
2811913|NCT04138836|Midazolam|midazolam|mesh-list
2811914|NCT04138836|Esomeprazole|esomeprazole|mesh-list
2811915|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2811916|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2811917|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2811918|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811919|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2811920|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2811921|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2811922|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2811923|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
2281389|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281390|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
2281391|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811924|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
2811925|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
2811926|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
2811927|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811928|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811929|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2811930|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2811931|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2811932|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811933|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
2281392|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
2811934|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811935|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2281393|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2281394|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2281395|NCT00228865|Insulin|insulin|mesh-list
2281396|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2281397|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
2281398|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2281399|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281400|NCT00228878|Insulin|insulin|mesh-list
2281401|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
2281402|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2281403|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281404|NCT00228891|Insulin|insulin|mesh-list
2811936|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2811937|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2811938|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
2811939|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281405|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2281406|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2281407|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104688|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
2104689|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2104690|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2104691|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2104692|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2104693|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
2104694|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104695|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104696|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2811940|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2811941|NCT04138719|Paclitaxel|paclitaxel|mesh-list
2811942|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2811943|NCT04138719|Carboplatin|carboplatin|mesh-list
2811944|NCT04138719|Epirubicin|epirubicin|mesh-list
2811945|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2811946|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2811947|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
2811948|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
2811949|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
2811950|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811951|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2811952|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2811953|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2811954|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281408|NCT00228904|Insulin|insulin|mesh-list
2281409|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
2281410|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
2281411|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2281412|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2281413|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281414|NCT00228930|Tamoxifen|tamoxifen|mesh-list
2281415|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2281416|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
2281417|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281418|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281419|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2281420|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281421|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2281422|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2281423|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2281424|NCT00228982|Vancomycin|vancomycin|mesh-list
2281425|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
2281426|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2281427|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2281428|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281429|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
2281430|NCT00228995|Hematinics|hematinics|mesh-ancestor
2281431|NCT00229008|Linezolid|linezolid|mesh-list
2281432|NCT00229008|Ceftazidime|ceftazidime|mesh-list
2281433|NCT00229008|Ceftobiprole|ceftobiprole|mesh-list
2811955|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
2811956|NCT04138277|Miglustat|miglustat|mesh-list
2811957|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2811958|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811959|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2811960|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2811961|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
2811962|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2811963|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2811964|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2811965|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281434|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2281435|NCT00229008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2281436|NCT00229008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281437|NCT00229008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2281438|NCT00229008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281439|NCT00229008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281440|NCT00229060|Doripenem|doripenem|mesh-list
2281441|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2281442|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281443|NCT00229112|Tazobactam|tazobactam|mesh-list
2281444|NCT00229112|Piperacillin|piperacillin|mesh-list
2281445|NCT00229112|Ertapenem|ertapenem|mesh-list
2281446|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2281447|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281448|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2811966|NCT04138316|Candesartan|candesartan|mesh-list
2811967|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2811968|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2811969|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2811970|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811971|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
2811972|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2811973|NCT04138472|Lidocaine|lidocaine|mesh-list
2811974|NCT04138472|Fentanyl|fentanyl|mesh-list
2811975|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
2811976|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
2811977|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
2811978|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2811979|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2811980|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
2811981|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2811982|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2811983|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2811984|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2811985|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2811986|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2811987|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2811988|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2811989|NCT04138472|Analgesics|analgesics|mesh-ancestor
2811990|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2811991|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2811992|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2811993|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
2811994|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2811995|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2811996|NCT04138472|Narcotics|narcotics|mesh-ancestor
2811997|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2811998|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2811999|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
2812000|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
2812001|NCT04138264|Narcotics|narcotics|mesh-ancestor
2812002|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2812003|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812004|NCT04138264|Analgesics|analgesics|mesh-ancestor
2812005|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
2812006|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812007|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
2812008|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
2281449|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281450|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2281451|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281452|NCT00229125|Gabapentin|gabapentin|mesh-list
2281453|NCT00229125|Lorazepam|lorazepam|mesh-list
2812009|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812010|NCT04138251|Empagliflozin|empagliflozin|mesh-list
2812011|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2812012|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812013|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2812014|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812015|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
2812016|NCT04137978|Diuretics|diuretics|mesh-ancestor
2812017|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
2812018|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812019|NCT04137978|Expectorants|expectorants|mesh-ancestor
2812020|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
2812021|NCT04138004|Lubiprostone|lubiprostone|mesh-list
2812022|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2812023|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2812024|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812025|NCT04137887|Vaccines|vaccines|mesh-list
2812026|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
2812027|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812028|NCT04138238|Sirolimus|sirolimus|mesh-list
2812029|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2812030|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2812031|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2812032|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812033|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
2812034|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2812035|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
2812036|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812037|NCT04138212|Paclitaxel|paclitaxel|mesh-list
2812038|NCT04138212|Cisplatin|cisplatin|mesh-list
2812039|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2812040|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812041|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
2812042|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
2812043|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
2812044|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812045|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
2812046|NCT04137640|Docetaxel|docetaxel|mesh-list
2812047|NCT04137640|Letrozole|letrozole|mesh-list
2812048|NCT04137640|Epirubicin|epirubicin|mesh-list
2812049|NCT04137640|Palbociclib|palbociclib|mesh-list
2812050|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2812051|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
2812052|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812053|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2812054|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2812055|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
2812056|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812057|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812058|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2812059|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
2812060|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
2812061|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
2812062|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2281454|NCT00229125|Analgesics|analgesics|mesh-ancestor
2281455|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
2281456|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812063|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2812064|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812065|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2812066|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
2812067|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2812068|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2812069|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2812070|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2812071|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2812072|NCT04137536|Antibodies|antibodies|mesh-list
2812073|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2812074|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
2812075|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812076|NCT04137770|Ketorolac|ketorolac|mesh-list
2281457|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281458|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
2281459|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2281460|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2281461|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2281462|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281463|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2281464|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2281465|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281466|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281467|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
2281468|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
2281469|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
2281470|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2281471|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2281472|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
2281473|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
2281474|NCT00229138|Tacrolimus|tacrolimus|mesh-list
2281475|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281476|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
2281477|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281478|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2281479|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281480|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281481|NCT00229216|Tinidazole|tinidazole|mesh-list
2281482|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
2281483|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812077|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2812078|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2812079|NCT04137770|Analgesics|analgesics|mesh-ancestor
2812080|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
2812081|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812082|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812083|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2812084|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2812085|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2812086|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812087|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812088|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2812089|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
2812090|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812091|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812092|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2812093|NCT04137588|Growth Substances|growth substances|mesh-ancestor
2812094|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812095|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
2812096|NCT04137653|Paclitaxel|paclitaxel|mesh-list
2281484|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2281485|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281486|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2281487|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2281488|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2281489|NCT00229242|Diuretics|diuretics|mesh-list
2281490|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
2281491|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281492|NCT00229333|Citalopram|citalopram|mesh-list
2281493|NCT00229333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2281494|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2281495|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2281496|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281497|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281498|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
2281499|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281500|NCT00229333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2281501|NCT00229333|Antidepressive Agents|antidepressive agents|mesh-ancestor
2281502|NCT00229333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281503|NCT00229385|Ziprasidone|ziprasidone|mesh-list
2812097|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2812098|NCT04137653|Carboplatin|carboplatin|mesh-list
2812099|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2812100|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812101|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
2812102|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
2812103|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
2812104|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812105|NCT04137432|Oxytocin|oxytocin|mesh-list
2812106|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
2812107|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2812108|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812109|NCT04137068|Benzocaine|benzocaine|mesh-list
2281504|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2281505|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
2812110|NCT04137068|Anesthetics, Local|anesthetics, local|mesh-ancestor
2812111|NCT04137068|Anesthetics|anesthetics|mesh-ancestor
2812112|NCT04137068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2812113|NCT04137068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812114|NCT04137068|Sensory System Agents|sensory system agents|mesh-ancestor
2812115|NCT04137068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812116|NCT04137198|Sufentanil|sufentanil|mesh-list
2812117|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2812118|NCT04137198|Narcotics|narcotics|mesh-ancestor
2812119|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2812120|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812121|NCT04137198|Analgesics|analgesics|mesh-ancestor
2812122|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
2812123|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812124|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2812125|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2812126|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
2812127|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
2812128|NCT04137185|Hormones|hormones|mesh-list
2812129|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2812130|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812131|NCT04137328|Liraglutide|liraglutide|mesh-list
2812132|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2812133|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812134|NCT04137328|Incretins|incretins|mesh-ancestor
2812135|NCT04137328|Hormones|hormones|mesh-ancestor
2812136|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2812137|NCT04137276|Vitamins|vitamins|mesh-list
2812138|NCT04137276|Ascorbic Acid|ascorbic acid|mesh-list
2812139|NCT04137276|Thiamine|thiamine|mesh-list
2812140|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
2812141|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
2812142|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812143|NCT04137276|Antioxidants|antioxidants|mesh-ancestor
2812144|NCT04137276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812145|NCT04137276|Protective Agents|protective agents|mesh-ancestor
2812146|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
2812147|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2812148|NCT04137380|Mirikizumab|mirikizumab|mesh-list
2812149|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2281506|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281507|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812150|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2812151|NCT04137380|Analgesics|analgesics|mesh-ancestor
2812152|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
2812153|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812154|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812155|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2812156|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2812157|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2812158|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2812159|NCT04137029|Bromides|bromides|mesh-list
2812160|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
2812161|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
2812162|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2812163|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
2812164|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812165|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812166|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2812167|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
2812168|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2812169|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2812170|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2812171|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
2812172|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2812173|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812174|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
2812175|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2812176|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
2812177|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
2812178|NCT04136886|Cisplatin|cisplatin|mesh-list
2812179|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812180|NCT04136613|Copper|copper|mesh-list
2812181|NCT04136613|Trace Elements|trace elements|mesh-ancestor
2812182|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
2812183|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812184|NCT04136743|Dexamethasone|dexamethasone|mesh-list
2812185|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2812186|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
2812187|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
2812188|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812189|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812190|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2812191|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
2812192|NCT04136743|Hormones|hormones|mesh-ancestor
2812193|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2812194|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2812195|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812196|NCT04136782|Paclitaxel|paclitaxel|mesh-list
2812197|NCT04136782|Docetaxel|docetaxel|mesh-list
2812198|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2812199|NCT04136782|Carboplatin|carboplatin|mesh-list
2812200|NCT04136782|Epirubicin|epirubicin|mesh-list
2812201|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2812202|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812203|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
2812204|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
2812205|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
2812206|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812207|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2812208|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2812209|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2812210|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812211|NCT04136535|Carboplatin|carboplatin|mesh-list
2812212|NCT04136535|Pemetrexed|pemetrexed|mesh-list
2812213|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812214|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812215|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812216|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2812217|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2812218|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
2812219|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
2812220|NCT04136639|Fluorides|fluorides|mesh-list
2812221|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
2812222|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
2812223|NCT04136639|Protective Agents|protective agents|mesh-ancestor
2812224|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812225|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2812226|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2812227|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812228|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
2812229|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281508|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281509|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2281510|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2812230|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2812231|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2812244|NCT04136470|Nivolumab|nivolumab|mesh-list
2812245|NCT04136470|Ipilimumab|ipilimumab|mesh-list
2812246|NCT04136470|Atezolizumab|atezolizumab|mesh-list
2812247|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2812248|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812249|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2812250|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281511|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2281512|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281513|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2281514|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
2281515|NCT00229424|Famotidine|famotidine|mesh-list
2281516|NCT00229424|Lafutidine|lafutidine|mesh-list
2281517|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2281518|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2812267|NCT04136600|Antibodies|antibodies|mesh-list
2812268|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
2812269|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812270|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2812271|NCT04136262|Methotrexate|methotrexate|mesh-list
2812272|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2812273|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
2812274|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2812275|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812276|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2812277|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
2812278|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812279|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812280|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
2812281|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812282|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2812283|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2812284|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
2812285|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2812286|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2281519|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2281520|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
2281521|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
2281522|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281523|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281524|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281525|NCT00229450|Estrogens|estrogens|mesh-list
2281526|NCT00229450|Hormones|hormones|mesh-ancestor
2281527|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281528|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281529|NCT00229476|Sertraline|sertraline|mesh-list
2281530|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
2281531|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281532|NCT00229476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2281533|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2281534|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2281535|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281536|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281537|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
2281538|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281539|NCT00229515|Sirolimus|sirolimus|mesh-list
2281540|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
2281541|NCT00229515|Tirofiban|tirofiban|mesh-list
2281542|NCT00229515|Abciximab|abciximab|mesh-list
2281543|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2281544|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2812309|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
2812310|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2812311|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812312|NCT04135989|Everolimus|everolimus|mesh-list
2812313|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812314|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2812315|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
2812316|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812317|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2812318|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2812319|NCT04135846|Doxazosin|doxazosin|mesh-list
2812320|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2812321|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2812322|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2812323|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2812324|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
2812325|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2812326|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812327|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812328|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2812329|NCT04136015|Dasatinib|dasatinib|mesh-list
2812330|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812331|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2812332|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812333|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812334|NCT04135898|Bevacizumab|bevacizumab|mesh-list
2812335|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2812336|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812337|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2812338|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2812339|NCT04135898|Growth Substances|growth substances|mesh-ancestor
2812340|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812341|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
2812342|NCT04135885|Folic Acid|folic acid|mesh-list
2812343|NCT04135885|Hematinics|hematinics|mesh-ancestor
2812344|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
2812345|NCT04135885|Vitamins|vitamins|mesh-ancestor
2812346|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
2812347|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812348|NCT04135833|Itraconazole|itraconazole|mesh-list
2812349|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
2812350|NCT04135833|Rifampin|rifampin|mesh-list
2812351|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
2812352|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2812353|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2281545|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2281546|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812354|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2812355|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812356|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812357|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2812358|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
2812359|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2812360|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812361|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2812362|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2812363|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
2812364|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2812365|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
2812366|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2812367|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2812368|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2812369|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2812370|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2812371|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2812372|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2812373|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
2812374|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2812375|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
2812376|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2812377|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
2812378|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812379|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812380|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
2812381|NCT04135781|Paclitaxel|paclitaxel|mesh-list
2812382|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2812383|NCT04135781|Capecitabine|capecitabine|mesh-list
2812384|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
2812385|NCT04135781|Tegafur|tegafur|mesh-list
2812386|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2812387|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812388|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
2812389|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
2812390|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
2812391|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281547|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
2281548|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281549|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
2281550|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281551|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
2281552|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2281553|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2812392|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2812393|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
2812394|NCT04135508|Adalimumab|adalimumab|mesh-list
2812395|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2812396|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2812397|NCT04135313|Capecitabine|capecitabine|mesh-list
2812398|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
2812399|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2812400|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
2812401|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812402|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812403|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
2812404|NCT04135378|Vitamins|vitamins|mesh-ancestor
2812405|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
2812406|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812407|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
2812408|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812409|NCT04135378|Protective Agents|protective agents|mesh-ancestor
2812410|NCT04135690|Sorafenib|sorafenib|mesh-list
2812411|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812412|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2281554|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2281555|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281556|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2281557|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
2281558|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
2281559|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2281560|NCT00229515|Protective Agents|protective agents|mesh-ancestor
2281561|NCT00229528|Paroxetine|paroxetine|mesh-list
2281562|NCT00229528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2281563|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2281564|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2281565|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281566|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281567|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
2281568|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281569|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2281570|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
2281571|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281572|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2281573|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2281574|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812413|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812414|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281575|NCT00229567|Lidocaine|lidocaine|mesh-list
2281576|NCT00229567|Ketamine|ketamine|mesh-list
2281577|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
2281578|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
2281579|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2281580|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281581|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
2104697|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
2104698|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
2104699|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2104700|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
2104701|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2104702|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
2104703|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104704|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104705|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2104706|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2104707|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2104708|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
2104709|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
2104710|NCT02441114|Hormones|hormones|mesh-ancestor
2281582|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281583|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2281584|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2281585|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2281586|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2281587|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281588|NCT00229567|Analgesics|analgesics|mesh-ancestor
2281589|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2812415|NCT04135456|Mannitol|mannitol|mesh-list
2812416|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2812417|NCT04135456|Diuretics|diuretics|mesh-ancestor
2812418|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
2812419|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812420|NCT04134884|Talazoparib|talazoparib|mesh-list
2812421|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2812422|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812423|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281590|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2281591|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
2281592|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2281593|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2281594|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281595|NCT00229593|ST 1435|st 1435|mesh-list
2281596|NCT00229593|Testosterone|testosterone|mesh-list
2281597|NCT00229593|Androgens|androgens|mesh-ancestor
2281598|NCT00229593|Hormones|hormones|mesh-ancestor
2281599|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2812424|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812425|NCT04134923|Corticosterone|corticosterone|mesh-list
2812426|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2812427|NCT04134897|Capecitabine|capecitabine|mesh-list
2812428|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
2812429|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2812430|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
2812431|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812432|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812433|NCT04134936|Lenalidomide|lenalidomide|mesh-list
2812434|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
2812435|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812436|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2812437|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2812438|NCT04134936|Growth Substances|growth substances|mesh-ancestor
2812439|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
2812440|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812441|NCT04135014|Midazolam|midazolam|mesh-list
2281600|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281601|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2281602|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
2281603|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2281604|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2281605|NCT00229632|Idebenone|idebenone|mesh-list
2281606|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
2281607|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281608|NCT00229632|Protective Agents|protective agents|mesh-ancestor
2281609|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281610|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2281611|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
2281612|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281613|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2281614|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2281615|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2281616|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281617|NCT00229684|Pioglitazone|pioglitazone|mesh-list
2812442|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
2812443|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2812444|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2812445|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812446|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2812447|NCT04135014|Analgesics|analgesics|mesh-ancestor
2812448|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
2812449|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812450|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2812451|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2812452|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2812453|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
2812454|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2812455|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812456|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2812457|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2812458|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2812459|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2812460|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2812461|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
2812462|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
2812463|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
2812464|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
2812465|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
2812466|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2812467|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
2812468|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812469|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
2812470|NCT04134611|Protective Agents|protective agents|mesh-ancestor
2812471|NCT04134650|Metformin|metformin|mesh-list
2812472|NCT04134650|Linagliptin|linagliptin|mesh-list
2812473|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2812474|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812475|NCT04134650|Incretins|incretins|mesh-ancestor
2812476|NCT04134650|Hormones|hormones|mesh-ancestor
2812477|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2812478|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2812479|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
2812480|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812481|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812482|NCT04134442|Bupivacaine|bupivacaine|mesh-list
2812483|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
2812484|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
2812485|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2812486|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812487|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
2812488|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812489|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
2812490|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
2812491|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2812492|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812493|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2812494|NCT04134468|Gemcitabine|gemcitabine|mesh-list
2812495|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2812496|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2812497|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
2812498|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812499|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812500|NCT04134468|Antiviral Agents|antiviral agents|mesh-ancestor
2812501|NCT04134468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2812502|NCT04134468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812503|NCT04134468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2812504|NCT04134468|Immunologic Factors|immunologic factors|mesh-ancestor
2812505|NCT04134468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812506|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2812507|NCT04134663|Oxytocin|oxytocin|mesh-list
2812508|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
2812509|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2812510|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812511|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
2812512|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2812513|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281618|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2281619|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281620|NCT00229697|Tamoxifen|tamoxifen|mesh-list
2281621|NCT00229697|Gefitinib|gefitinib|mesh-list
2281622|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2812514|NCT04134416|Donepezil|donepezil|mesh-list
2812515|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2812516|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812517|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812518|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
2812519|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2812520|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812521|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
2812522|NCT04134182|Nivolumab|nivolumab|mesh-list
2812523|NCT04134182|Ipilimumab|ipilimumab|mesh-list
2812524|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2812525|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812526|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2812527|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812528|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
2812529|NCT04134130|Testosterone|testosterone|mesh-list
2281623|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
2281624|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2812530|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
2812531|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
2812532|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2812533|NCT04134130|Androgens|androgens|mesh-ancestor
2812534|NCT04134130|Hormones|hormones|mesh-ancestor
2812535|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2812536|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812537|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2812538|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812539|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
2812540|NCT04134273|Clindamycin|clindamycin|mesh-list
2812541|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
2812542|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
2812543|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2812544|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2812545|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2812546|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812547|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812563|NCT04134598|Tamoxifen|tamoxifen|mesh-list
2812564|NCT04134598|Letrozole|letrozole|mesh-list
2812565|NCT04134598|Anastrozole|anastrozole|mesh-list
2812566|NCT04134598|Exemestane|exemestane|mesh-list
2812567|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812568|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2812569|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2812570|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812571|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812572|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2812573|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
2812574|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2812575|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812576|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2812577|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2812578|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2812579|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2812580|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
2812581|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2812582|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
2812583|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812584|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812585|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2812586|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
2812587|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2812588|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
2812589|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812590|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2812591|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2812592|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
2812593|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
2812594|NCT04134078|Protective Agents|protective agents|mesh-ancestor
2812595|NCT04134065|Vitamin D|vitamin d|mesh-list
2812596|NCT04134065|Vitamins|vitamins|mesh-ancestor
2812597|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
2812598|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812599|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2812600|NCT04134052|Midazolam|midazolam|mesh-list
2812601|NCT04134052|Ketamine|ketamine|mesh-list
2812602|NCT04134052|Analgesics|analgesics|mesh-ancestor
2812603|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
2812604|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812605|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281625|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281626|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2812606|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2812607|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2812608|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
2812609|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
2812610|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2812611|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2812612|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2812613|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2812614|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812615|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2812616|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2812617|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2812618|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2812619|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2812620|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
2812621|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
2812622|NCT04133961|Phenylephrine|phenylephrine|mesh-list
2812623|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
2812624|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2812625|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
2812626|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
2812627|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812628|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812629|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
2812630|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2812631|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
2812632|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
2812633|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2812634|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2812635|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2812636|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
2812637|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2812638|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812639|NCT04133961|Protective Agents|protective agents|mesh-ancestor
2281627|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281628|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2281629|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2281630|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2281631|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2281632|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281633|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281634|NCT00229775|Chloroquine|chloroquine|mesh-list
2281635|NCT00229775|Artemether|artemether|mesh-list
2281636|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
2281637|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
2281638|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2281639|NCT00229775|Amebicides|amebicides|mesh-ancestor
2281640|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2281641|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2281642|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281643|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
2281644|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2281645|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2812640|NCT04133922|Insulin|insulin|mesh-list
2812641|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2812642|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812643|NCT04133948|Nivolumab|nivolumab|mesh-list
2812644|NCT04133948|Ipilimumab|ipilimumab|mesh-list
2812645|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2812646|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812647|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2812648|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812649|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
2812650|NCT04134026|Hematinics|hematinics|mesh-ancestor
2812651|NCT04133974|Methadone|methadone|mesh-list
2812652|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2812653|NCT04133974|Narcotics|narcotics|mesh-ancestor
2812654|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2812655|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812656|NCT04133974|Analgesics|analgesics|mesh-ancestor
2812657|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
2812658|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812659|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
2281646|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104711|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2104712|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
2104713|NCT02441309|Ifosfamide|ifosfamide|mesh-list
2104714|NCT02441309|Mifamurtide|mifamurtide|mesh-list
2104715|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2104716|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
2104717|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104718|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104719|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2104720|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
2104721|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104722|NCT02441946|Anastrozole|anastrozole|mesh-list
2281647|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281648|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2281649|NCT00229775|Renal Agents|renal agents|mesh-ancestor
2281650|NCT00229918|Triamcinolone|triamcinolone|mesh-list
2281651|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2281652|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2281653|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2281654|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2281655|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
2812660|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
2812661|NCT04134000|Atezolizumab|atezolizumab|mesh-list
2812662|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812663|NCT04134637|Bupivacaine|bupivacaine|mesh-list
2812664|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
2812665|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
2812666|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2812667|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812668|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
2812669|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812670|NCT04133571|Lidocaine|lidocaine|mesh-list
2812671|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
2812672|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
2812673|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2812674|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812675|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
2812676|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812677|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2812678|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2812679|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2812680|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2812681|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281656|NCT00229918|Hormones|hormones|mesh-ancestor
2281657|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281658|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812682|NCT04133792|Simvastatin|simvastatin|mesh-list
2812683|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2812684|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2812685|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
2812686|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812687|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2812688|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2812689|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812690|NCT04133532|Metoprolol|metoprolol|mesh-list
2812691|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2812692|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2812693|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
2812694|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
2812695|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812696|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281659|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281660|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
2281661|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281662|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812697|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2812698|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2812699|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2812700|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
2812701|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2812702|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812703|NCT04133428|Valsartan|valsartan|mesh-list
2812704|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2812705|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2812706|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2812707|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2812708|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812709|NCT04133155|Gemcitabine|gemcitabine|mesh-list
2812710|NCT04133155|Paclitaxel|paclitaxel|mesh-list
2812711|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2812712|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812713|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
2812714|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
2812715|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
2281663|NCT00229944|Azithromycin|azithromycin|mesh-list
2281664|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2281665|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281666|NCT00229996|Leuprolide|leuprolide|mesh-list
2281667|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
2281668|NCT00229996|Norethindrone|norethindrone|mesh-list
2281669|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
2281670|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
2281671|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2812716|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812717|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2812718|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
2812719|NCT04133155|Antiviral Agents|antiviral agents|mesh-ancestor
2281672|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281673|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2281674|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
2281675|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2281676|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281677|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2281678|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2812720|NCT04133155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2812721|NCT04133155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812722|NCT04133155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2812723|NCT04133155|Immunologic Factors|immunologic factors|mesh-ancestor
2812724|NCT04133155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812725|NCT04133311|Latanoprost|latanoprost|mesh-list
2812726|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2812727|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2812728|NCT04133337|Apatinib|apatinib|mesh-list
2812729|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812730|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2812731|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812732|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812733|NCT04133506|Aspirin|aspirin|mesh-list
2281679|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2281680|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2281681|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
2281682|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
2281683|NCT00230035|Rituximab|rituximab|mesh-list
2281684|NCT00230035|Methotrexate|methotrexate|mesh-list
2281685|NCT00230035|Azathioprine|azathioprine|mesh-list
2281686|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
2812734|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2812735|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2812736|NCT04133506|Analgesics|analgesics|mesh-ancestor
2812737|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
2812738|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812739|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281687|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2281688|NCT00230035|Antibodies|antibodies|mesh-list
2281689|NCT00230035|Sargramostim|sargramostim|mesh-list
2281690|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2281691|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
2281692|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2281693|NCT00230035|Leflunomide|leflunomide|mesh-list
2281694|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
2281695|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2281696|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2281697|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281698|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
2812740|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2812741|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2812742|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2812743|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2812744|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812745|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2812746|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2812747|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812748|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
2812749|NCT04133194|Mesalamine|mesalamine|mesh-list
2812750|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2104723|NCT02441946|Loperamide|loperamide|mesh-list
2104724|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
2104725|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2104726|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104727|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2812751|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2812752|NCT04133194|Analgesics|analgesics|mesh-ancestor
2812753|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
2812754|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812755|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812756|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2812757|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2812758|NCT04133259|Tenofovir|tenofovir|mesh-list
2812759|NCT04133259|Entecavir|entecavir|mesh-list
2812760|NCT04133259|Antibodies|antibodies|mesh-list
2281699|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281700|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2281701|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2281702|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
2281703|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2812761|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2812762|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
2812763|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812764|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
2812765|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2812766|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2812767|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2812768|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812769|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812770|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2812771|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2281704|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2281705|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
2104728|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2104729|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104730|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104731|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2104732|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
2104733|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2104734|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104735|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2812772|NCT04133480|Cannabidiol|cannabidiol|mesh-list
2812773|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
2812774|NCT04132791|Aspirin|aspirin|mesh-list
2812775|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2812776|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2812777|NCT04132791|Analgesics|analgesics|mesh-ancestor
2812778|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
2812779|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281706|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281707|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
2281708|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281709|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2281710|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2281711|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2281712|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2281713|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
2281714|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2281715|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281716|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2281717|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
2281718|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
2812780|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812781|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2812782|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2812783|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2812784|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2812785|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812786|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2812787|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2812788|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812789|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
2812790|NCT04133051|Bupivacaine|bupivacaine|mesh-list
2812791|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
2812792|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
2812793|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2812794|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812795|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
2812796|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812797|NCT04132583|Diclofenac|diclofenac|mesh-list
2812798|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2812799|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2812800|NCT04132583|Analgesics|analgesics|mesh-ancestor
2812801|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
2812802|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812803|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812804|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2812805|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2812806|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2812807|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812808|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812809|NCT04132479|Amoxicillin|amoxicillin|mesh-list
2812810|NCT04132479|Clarithromycin|clarithromycin|mesh-list
2812811|NCT04132479|Tinidazole|tinidazole|mesh-list
2812812|NCT04132479|Rabeprazole|rabeprazole|mesh-list
2812813|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2812814|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2812815|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2812816|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812817|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812818|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2812819|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2812820|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2812821|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2812822|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2812823|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
2812824|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2812825|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2812826|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2812827|NCT04132674|Tenofovir|tenofovir|mesh-list
2812828|NCT04132674|Emtricitabine|emtricitabine|mesh-list
2812829|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2812830|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
2812831|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2812832|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2812833|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2812834|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812835|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812836|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2812837|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2812838|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
2281719|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281720|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2281721|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
2281722|NCT00230035|Hormones|hormones|mesh-ancestor
2281723|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281724|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2281725|NCT00230035|Protective Agents|protective agents|mesh-ancestor
2812839|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
2812840|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2812841|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2812842|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2812843|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812844|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812845|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2812846|NCT04132661|Bisacodyl|bisacodyl|mesh-list
2812847|NCT04132661|Cathartics|cathartics|mesh-ancestor
2812848|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2812849|NCT04132661|Laxatives|laxatives|mesh-ancestor
2812850|NCT04132713|Capecitabine|capecitabine|mesh-list
2812851|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2812852|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
2812853|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812854|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812855|NCT04132635|Mitogens|mitogens|mesh-list
2812856|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
2812857|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812858|NCT04132648|Curcumin|curcumin|mesh-list
2812859|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2812860|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2812861|NCT04132648|Analgesics|analgesics|mesh-ancestor
2812862|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
2812863|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281726|NCT00230204|Antibodies|antibodies|mesh-list
2281727|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
2281728|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281729|NCT00230217|Rasburicase|rasburicase|mesh-list
2281730|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
2281731|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2104736|NCT02442271|Ritonavir|ritonavir|mesh-list
2104737|NCT02442271|Ribavirin|ribavirin|mesh-list
2104738|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2104739|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2104740|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
2104741|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104742|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104743|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2104744|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2104745|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
2812864|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812865|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2812866|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2812867|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812868|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812869|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812870|NCT04132570|Budesonide|budesonide|mesh-list
2812871|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2812872|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2812873|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
2812874|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812875|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812876|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2812877|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
2812878|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
2812879|NCT04132570|Hormones|hormones|mesh-ancestor
2812880|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2812881|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
2812882|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2812883|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
2812884|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2104746|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281732|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
2812885|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812886|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2812887|NCT04132557|Methylphenidate|methylphenidate|mesh-list
2812888|NCT04132557|Amphetamine|amphetamine|mesh-list
2812889|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2812890|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
2812891|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2812892|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2812893|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812894|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2812895|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2812896|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2812897|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812898|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
2812899|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2812900|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2812901|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
2812902|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
2812903|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
2812904|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812905|NCT04132063|Levetiracetam|levetiracetam|mesh-list
2812906|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
2812907|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
2281733|NCT00230321|Hematinics|hematinics|mesh-ancestor
2281734|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
2281735|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281736|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2281737|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281738|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281739|NCT00230373|Imiquimod|imiquimod|mesh-list
2281740|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2281741|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
2281742|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281743|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104747|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2104748|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2104749|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
2104750|NCT02442284|Ritonavir|ritonavir|mesh-list
2104751|NCT02442284|Ribavirin|ribavirin|mesh-list
2104752|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2104753|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2104754|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
2104755|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104756|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812908|NCT04132115|Vancomycin|vancomycin|mesh-list
2812909|NCT04132115|Gentamicins|gentamicins|mesh-list
2812910|NCT04132115|Meropenem|meropenem|mesh-list
2812911|NCT04132115|Tazobactam|tazobactam|mesh-list
2812912|NCT04132115|Linezolid|linezolid|mesh-list
2812913|NCT04132115|Piperacillin|piperacillin|mesh-list
2812914|NCT04132115|Daptomycin|daptomycin|mesh-list
2812915|NCT04132115|Amikacin|amikacin|mesh-list
2812916|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2812917|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
2812918|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2812919|NCT04132115|Acyclovir|acyclovir|mesh-list
2812920|NCT04132115|Ganciclovir|ganciclovir|mesh-list
2812921|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2812922|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2812923|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2812924|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812925|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812926|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2812927|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
2281744|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
2281745|NCT00230399|Celecoxib|celecoxib|mesh-list
2281746|NCT00230399|Capecitabine|capecitabine|mesh-list
2281747|NCT00230399|Irinotecan|irinotecan|mesh-list
2281748|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2281749|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
2281750|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281751|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104757|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2281752|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2812928|NCT04132011|Morphine|morphine|mesh-list
2812929|NCT04132011|Oxycodone|oxycodone|mesh-list
2812930|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
2812931|NCT04132011|Hydromorphone|hydromorphone|mesh-list
2812932|NCT04132011|Narcotics|narcotics|mesh-ancestor
2812933|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2812934|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281753|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2281754|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281755|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2281756|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2281757|NCT00230399|Analgesics|analgesics|mesh-ancestor
2281758|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
2281759|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281760|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281761|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2281762|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2281763|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2281764|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2281765|NCT00230451|Paclitaxel|paclitaxel|mesh-list
2281766|NCT00230451|Fluorouracil|fluorouracil|mesh-list
2281767|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2281768|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281769|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
2812935|NCT04132011|Analgesics|analgesics|mesh-ancestor
2812936|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
2812937|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812938|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
2812939|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
2812940|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812941|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
2812942|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2812943|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812944|NCT04132102|Afatinib|afatinib|mesh-list
2812945|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812946|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2812947|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812948|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104758|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2104759|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
2104760|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104761|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2104762|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2104763|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
2104764|NCT02442310|Deferiprone|deferiprone|mesh-list
2104765|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2104766|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
2281770|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
2281771|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
2281772|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281773|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
2281774|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2281775|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281776|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
2281777|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281778|NCT00230464|Vildagliptin|vildagliptin|mesh-list
2281779|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2281780|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281781|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2281782|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
2281783|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281784|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281785|NCT00230477|Lamivudine|lamivudine|mesh-list
2281786|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2281787|NCT00230477|Adefovir|adefovir|mesh-list
2812949|NCT04131829|Fluoxetine|fluoxetine|mesh-list
2812950|NCT04131829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2812951|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2812952|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2812953|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812954|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2812955|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
2104767|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
2104768|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104769|NCT02442700|Pitavastatin|pitavastatin|mesh-list
2104770|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2104771|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2104772|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2104773|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
2104774|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104775|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281788|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2281789|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2281790|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281791|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281792|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
2281793|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281794|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2281795|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2281796|NCT00230490|Adefovir|adefovir|mesh-list
2281797|NCT00230490|Pradefovir|pradefovir|mesh-list
2281798|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
2281799|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2812956|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812957|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2812958|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
2812959|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2812960|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2812961|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2812962|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812963|NCT04131621|Nivolumab|nivolumab|mesh-list
2812964|NCT04131621|Ipilimumab|ipilimumab|mesh-list
2812965|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2812966|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2812967|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2281800|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2281801|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2281802|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281803|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281804|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2281805|NCT00230503|Adefovir|adefovir|mesh-list
2281806|NCT00230503|Pradefovir|pradefovir|mesh-list
2281807|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
2281808|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281809|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2281810|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2281811|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281812|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812968|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812969|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
2812970|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2812971|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2812972|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2812973|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2812974|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281813|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2281814|NCT00230516|Lansoprazole|lansoprazole|mesh-list
2281815|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2281816|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2281817|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2812975|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
2812976|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2812977|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812978|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2812979|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2812980|NCT04131504|Adalimumab|adalimumab|mesh-list
2812981|NCT04131504|Infliximab|infliximab|mesh-list
2812982|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2812983|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2812984|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
2812985|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2812986|NCT04131582|Metformin|metformin|mesh-list
2812987|NCT04131582|Empagliflozin|empagliflozin|mesh-list
2812988|NCT04131582|Linagliptin|linagliptin|mesh-list
2281818|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281819|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281820|NCT00230529|Infliximab|infliximab|mesh-list
2281821|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
2281822|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2281823|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2281824|NCT00230542|Carboplatin|carboplatin|mesh-list
2812989|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2812990|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2812991|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2104776|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2104777|NCT02443103|Guanabenz|guanabenz|mesh-list
2104778|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2104779|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2104780|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2104781|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2104782|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
2104783|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104784|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104785|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104786|NCT02443155|Liraglutide|liraglutide|mesh-list
2104787|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2104788|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104789|NCT02443155|Incretins|incretins|mesh-ancestor
2104790|NCT02443155|Hormones|hormones|mesh-ancestor
2281825|NCT00230542|Pemetrexed|pemetrexed|mesh-list
2281826|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281827|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281828|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281829|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2281830|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2281831|NCT00230568|Donepezil|donepezil|mesh-list
2281832|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2812992|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2812993|NCT04131582|Incretins|incretins|mesh-ancestor
2812994|NCT04131582|Hormones|hormones|mesh-ancestor
2812995|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2812996|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2812997|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
2812998|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2812999|NCT04131283|Epinephrine|epinephrine|mesh-list
2813000|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2813001|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2813002|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
2813003|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813004|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813005|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813006|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2813007|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2813008|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
2813009|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813010|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2813011|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
2813012|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
2813013|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
2813014|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2813015|NCT04131309|Dexamethasone|dexamethasone|mesh-list
2813016|NCT04131309|Bortezomib|bortezomib|mesh-list
2813017|NCT04131309|Daratumumab|daratumumab|mesh-list
2813018|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2813019|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
2813020|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
2813021|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813022|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813023|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2813024|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
2813025|NCT04131309|Hormones|hormones|mesh-ancestor
2813026|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813027|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2813028|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813029|NCT04131231|Aldesleukin|aldesleukin|mesh-list
2813030|NCT04131231|Methotrexate|methotrexate|mesh-list
2813031|NCT04131231|Interleukin-2|interleukin-2|mesh-list
2813032|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2813033|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
2813034|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2813035|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813036|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2813037|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
2813038|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813039|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813040|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
2813041|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813042|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2813043|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2813044|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
2813045|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813046|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2813047|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2813048|NCT04131231|Analgesics|analgesics|mesh-ancestor
2813049|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
2813050|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813051|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2813052|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2813053|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
2813054|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813055|NCT04131322|Adalimumab|adalimumab|mesh-list
2813056|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2813057|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2813058|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813059|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2813060|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2813061|NCT04131192|Gemcitabine|gemcitabine|mesh-list
2813062|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2813063|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
2813064|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813065|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813066|NCT04131192|Antiviral Agents|antiviral agents|mesh-ancestor
2813067|NCT04131192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813068|NCT04131192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813069|NCT04131192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2813070|NCT04131192|Immunologic Factors|immunologic factors|mesh-ancestor
2813071|NCT04131192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813072|NCT04130698|Nicotine|nicotine|mesh-list
2813073|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2813074|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
2813075|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813076|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813077|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2281833|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281834|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281835|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
2281836|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281837|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281838|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
2813078|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2813079|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
2813080|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813081|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813082|NCT04130659|Omeprazole|omeprazole|mesh-list
2813083|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2813084|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2813085|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2813086|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813087|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813088|NCT04130815|Furosemide|furosemide|mesh-list
2813089|NCT04130815|Diuretics|diuretics|mesh-ancestor
2813090|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
2813091|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813092|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2813093|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2813094|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813099|NCT04130802|Dexamethasone|dexamethasone|mesh-list
2813100|NCT04130802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2813101|NCT04130802|Antiemetics|antiemetics|mesh-ancestor
2813102|NCT04130802|Autonomic Agents|autonomic agents|mesh-ancestor
2813103|NCT04130802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813104|NCT04130802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813105|NCT04130802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2813106|NCT04130802|Glucocorticoids|glucocorticoids|mesh-ancestor
2813107|NCT04130802|Hormones|hormones|mesh-ancestor
2813108|NCT04130802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813109|NCT04130802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2813110|NCT04130802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813111|NCT04130672|Hemostatics|hemostatics|mesh-list
2813112|NCT04130672|Coagulants|coagulants|mesh-ancestor
2813113|NCT04130464|Ketorolac|ketorolac|mesh-list
2813114|NCT04130464|Ropivacaine|ropivacaine|mesh-list
2813115|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
2813116|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
2813117|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2813118|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281839|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2281840|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
2281841|NCT00230594|Coagulants|coagulants|mesh-ancestor
2281842|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2281843|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
2281844|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281845|NCT00230698|Topiramate|topiramate|mesh-list
2281846|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
2281847|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2281848|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281849|NCT00230763|Timolol|timolol|mesh-list
2281850|NCT00230763|Latanoprost|latanoprost|mesh-list
2281851|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2813119|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
2813120|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813121|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2813122|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2813123|NCT04130464|Analgesics|analgesics|mesh-ancestor
2813124|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2813125|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813126|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2813127|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813128|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813129|NCT04130399|Folfirinox|folfirinox|mesh-list
2813130|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281852|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2281853|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
2281854|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813131|NCT04130438|Nebivolol|nebivolol|mesh-list
2813132|NCT04130438|Diltiazem|diltiazem|mesh-list
2813133|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2813134|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
2813135|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2813136|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2813137|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2813138|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
2281855|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281856|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813139|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813140|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813141|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813142|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2813143|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2813144|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2281857|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2281858|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2281859|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2281860|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2281861|NCT00230776|Pregabalin|pregabalin|mesh-list
2281862|NCT00230776|Analgesics|analgesics|mesh-ancestor
2281863|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
2281864|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281865|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281866|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
2281867|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2281868|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2281869|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281870|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2281871|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2281872|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2281873|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2281874|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281875|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2281876|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2281877|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2813145|NCT04130477|Nickel|nickel|mesh-list
2813146|NCT04130477|Trace Elements|trace elements|mesh-ancestor
2813147|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
2813148|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813149|NCT04130230|Choline|choline|mesh-list
2813150|NCT04130230|Neostigmine|neostigmine|mesh-list
2281878|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
2281879|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281880|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281881|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281882|NCT00230789|Urological Agents|urological agents|mesh-ancestor
2281883|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2281884|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2281885|NCT00230815|Hormones|hormones|mesh-ancestor
2281886|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281887|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281888|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2281889|NCT00230867|Acyclovir|acyclovir|mesh-list
2281890|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
2281891|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281892|NCT00230958|Interferons|interferons|mesh-list
2281893|NCT00230958|Ribavirin|ribavirin|mesh-list
2813151|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2813152|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813153|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813154|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
2813155|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813156|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813157|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2813158|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
2813159|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813160|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
2813161|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2813162|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
2813163|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2813164|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2813165|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
2813166|NCT04130152|Letrozole|letrozole|mesh-list
2813167|NCT04130152|Palbociclib|palbociclib|mesh-list
2813168|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813169|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2813170|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2813171|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813172|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813173|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2813174|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
2281894|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
2281895|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
2281896|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2813175|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813176|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813177|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2813178|NCT04130087|Selegiline|selegiline|mesh-list
2813179|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
2813180|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2813181|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2813182|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2813183|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2813184|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813185|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813186|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2813187|NCT04130087|Protective Agents|protective agents|mesh-ancestor
2813188|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813189|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
2813190|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2813191|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
2281897|NCT00230958|Taribavirin|taribavirin|mesh-list
2813192|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813193|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
2813194|NCT04130100|Protective Agents|protective agents|mesh-ancestor
2281898|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281899|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
2281900|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281901|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
2281902|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281903|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
2281904|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281905|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
2813203|NCT04129788|Bisacodyl|bisacodyl|mesh-list
2813204|NCT04129788|Cathartics|cathartics|mesh-ancestor
2813205|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2813206|NCT04129788|Laxatives|laxatives|mesh-ancestor
2813207|NCT04129697|Dexamethasone|dexamethasone|mesh-list
2813208|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
2813209|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2813210|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2281906|NCT00230984|Testosterone|testosterone|mesh-list
2281907|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
2281908|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
2281909|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2281910|NCT00230984|Androgens|androgens|mesh-ancestor
2281911|NCT00230984|Hormones|hormones|mesh-ancestor
2281912|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281913|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281914|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2281915|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281916|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
2281917|NCT00230997|Galantamine|galantamine|mesh-list
2281918|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2281919|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281920|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281921|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
2281922|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2281923|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281924|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2281925|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
2281926|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281927|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
2281928|NCT00231023|Triamcinolone|triamcinolone|mesh-list
2281929|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2281930|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2281931|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2281932|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2281933|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
2281934|NCT00231023|Hormones|hormones|mesh-ancestor
2281935|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2281936|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281937|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281938|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
2281939|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2281940|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281941|NCT00231075|Paclitaxel|paclitaxel|mesh-list
2813211|NCT04129697|Prednisolone|prednisolone|mesh-list
2813212|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
2813213|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2813214|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
2813215|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2813216|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
2813217|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
2813218|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2281942|NCT00231075|Carboplatin|carboplatin|mesh-list
2281943|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2281944|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813219|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813220|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2281945|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
2281946|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
2281947|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
2281948|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281949|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2281950|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
2281951|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2281952|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2281953|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2281954|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2281955|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281956|NCT00231140|Thalidomide|thalidomide|mesh-list
2281957|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281958|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
2813221|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
2813222|NCT04129697|Hormones|hormones|mesh-ancestor
2813223|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813224|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2813225|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813226|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2813227|NCT04129697|Protective Agents|protective agents|mesh-ancestor
2813228|NCT04129736|Teriflunomide|teriflunomide|mesh-list
2813229|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2813230|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2813231|NCT04129736|Analgesics|analgesics|mesh-ancestor
2813232|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
2281959|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281960|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
2281961|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2281962|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281963|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2281964|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2281965|NCT00231140|Growth Substances|growth substances|mesh-ancestor
2281966|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
2281967|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281968|NCT00231192|Repaglinide|repaglinide|mesh-list
2813233|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813234|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813235|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2813236|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813237|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2813238|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
2813239|NCT04129710|Rituximab|rituximab|mesh-list
2813240|NCT04129710|Methotrexate|methotrexate|mesh-list
2813241|NCT04129710|Etoposide|etoposide|mesh-list
2813242|NCT04129710|Lenalidomide|lenalidomide|mesh-list
2813243|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2813244|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813245|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
2813246|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813247|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813248|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2813249|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
2813250|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2813251|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2813252|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
2813253|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813254|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
2813255|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813256|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2813257|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2813258|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2813259|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2813260|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2813261|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2813262|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2813263|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2813264|NCT04129710|Growth Substances|growth substances|mesh-ancestor
2281969|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2281970|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281971|NCT00231218|Ascorbic Acid|ascorbic acid|mesh-list
2281972|NCT00231218|Propolis|propolis|mesh-list
2281973|NCT00231218|Vitamins|vitamins|mesh-ancestor
2281974|NCT00231218|Micronutrients|micronutrients|mesh-ancestor
2281975|NCT00231218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281976|NCT00231218|Antioxidants|antioxidants|mesh-ancestor
2813265|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
2104791|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2104792|NCT02443337|Necitumumab|necitumumab|mesh-list
2104793|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2104794|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104795|NCT02443402|Insulin|insulin|mesh-list
2813270|NCT04129437|Ibuprofen|ibuprofen|mesh-list
2813271|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2813272|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2813273|NCT04129437|Analgesics|analgesics|mesh-ancestor
2813274|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
2813275|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813276|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813277|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2813278|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813279|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2813280|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813281|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813282|NCT04129424|Insulin|insulin|mesh-list
2813283|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2813284|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813285|NCT04129255|Octreotide|octreotide|mesh-list
2813286|NCT04129255|Somatostatin|somatostatin|mesh-list
2813287|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2813288|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2813289|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813290|NCT04129255|Hormones|hormones|mesh-ancestor
2813291|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813292|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813293|NCT04129489|Cannabidiol|cannabidiol|mesh-list
2813294|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
2813302|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
2813303|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2813304|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813305|NCT04128891|Valsartan|valsartan|mesh-list
2281977|NCT00231218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281978|NCT00231218|Protective Agents|protective agents|mesh-ancestor
2281979|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281980|NCT00231244|Sirolimus|sirolimus|mesh-list
2281981|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2281982|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281983|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2281984|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281985|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
2281986|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2281987|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
2281988|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281989|NCT00231257|Sirolimus|sirolimus|mesh-list
2281990|NCT00231257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2813306|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2813307|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2813308|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2813309|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2813310|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813311|NCT04128787|Omeprazole|omeprazole|mesh-list
2813312|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2813313|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2813314|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2813315|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104796|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2104797|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
2104798|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
2104799|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2813316|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813317|NCT04128800|Apatinib|apatinib|mesh-list
2281991|NCT00231257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2281992|NCT00231257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2281993|NCT00231257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2281994|NCT00231257|Antifungal Agents|antifungal agents|mesh-ancestor
2281995|NCT00231257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2813318|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813319|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2813320|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813321|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2281996|NCT00231257|Immunologic Factors|immunologic factors|mesh-ancestor
2281997|NCT00231257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2281998|NCT00231322|Praziquantel|praziquantel|mesh-list
2281999|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
2282000|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2282001|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282002|NCT00231335|Citalopram|citalopram|mesh-list
2282003|NCT00231335|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2282004|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2282005|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2813322|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
2813323|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2813324|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813325|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813326|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813327|NCT04129008|Aspirin|aspirin|mesh-list
2813328|NCT04129008|Indobufen|indobufen|mesh-list
2813329|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2813330|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2813331|NCT04129008|Analgesics|analgesics|mesh-ancestor
2813332|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
2813333|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813334|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813335|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2813336|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813337|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2813338|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2813339|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813340|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2813341|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2282006|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282007|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282008|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
2282009|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282010|NCT00231335|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2282011|NCT00231335|Antidepressive Agents|antidepressive agents|mesh-ancestor
2282012|NCT00231335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282013|NCT00231348|Nefazodone|nefazodone|mesh-list
2282014|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2813342|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813343|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
2813344|NCT04129086|Ketamine|ketamine|mesh-list
2813345|NCT04129086|Analgesics|analgesics|mesh-ancestor
2813346|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
2813347|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813348|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813349|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2813350|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2813351|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
2813352|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
2813353|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2813354|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2813355|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2813356|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813357|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813358|NCT04129112|Propofol|propofol|mesh-list
2813359|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
2813360|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2813361|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813362|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2813363|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2813364|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
2282015|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2282016|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282017|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282018|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282019|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282020|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2282021|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
2282022|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282023|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2282024|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2282025|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
2282026|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
2282027|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2282028|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282029|NCT00231452|Artesunate|artesunate|mesh-list
2282030|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
2282031|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
2282032|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2282033|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
2282034|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2282035|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2282036|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282037|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282038|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
2282039|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
2282040|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2282041|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
2282042|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2282043|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282044|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282045|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2282046|NCT00231452|Renal Agents|renal agents|mesh-ancestor
2282047|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
2282048|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2282049|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2282050|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2282051|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282052|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282053|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
2282054|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282055|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282056|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2282057|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282058|NCT00231517|Morphine|morphine|mesh-list
2282059|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2282060|NCT00231517|Narcotics|narcotics|mesh-ancestor
2282061|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2282062|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282063|NCT00231517|Analgesics|analgesics|mesh-ancestor
2282064|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
2282065|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282066|NCT00231530|Topiramate|topiramate|mesh-list
2282067|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
2282068|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2282069|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282070|NCT00231556|Topiramate|topiramate|mesh-list
2282071|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
2282072|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2282073|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813365|NCT04128878|Sotalol|sotalol|mesh-list
2813366|NCT04128878|Dofetilide|dofetilide|mesh-list
2813367|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2813368|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2813369|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
2813370|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813371|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813372|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282074|NCT00231569|Mipomersen|mipomersen|mesh-list
2282075|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2282076|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2282077|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
2282078|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282079|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2282080|NCT00231582|Paclitaxel|paclitaxel|mesh-list
2282081|NCT00231582|Etoposide|etoposide|mesh-list
2282082|NCT00231582|Carboplatin|carboplatin|mesh-list
2813373|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2813374|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
2813375|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
2813376|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813377|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2813378|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282083|NCT00231582|Epirubicin|epirubicin|mesh-list
2282084|NCT00231582|Ifosfamide|ifosfamide|mesh-list
2282085|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2282086|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282087|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
2282088|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
2282089|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
2282090|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282091|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2282092|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2282093|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282094|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2282095|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2282096|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
2282097|NCT00231595|Topiramate|topiramate|mesh-list
2282098|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
2282099|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2282100|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282101|NCT00231608|Topiramate|topiramate|mesh-list
2282102|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
2282103|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2282104|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282105|NCT00231621|Topiramate|topiramate|mesh-list
2282106|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
2282107|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2282108|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282109|NCT00231634|Topiramate|topiramate|mesh-list
2813379|NCT04128722|Sirolimus|sirolimus|mesh-list
2813380|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2813381|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813382|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2813383|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813384|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
2813385|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2813386|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
2813387|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813388|NCT04128748|Cytarabine|cytarabine|mesh-list
2813389|NCT04128748|Daunorubicin|daunorubicin|mesh-list
2813390|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2282110|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
2282111|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2813391|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
2813392|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813393|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813394|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
2813395|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813396|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2813397|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
2813398|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813399|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2813400|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2813401|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2813402|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813403|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
2813404|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2813405|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
2813406|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813407|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813408|NCT04128436|Progesterone|progesterone|mesh-list
2813409|NCT04128436|Progestins|progestins|mesh-ancestor
2813410|NCT04128436|Hormones|hormones|mesh-ancestor
2813411|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813412|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813413|NCT04128683|Bromocriptine|bromocriptine|mesh-list
2813414|NCT04128683|Amisulpride|amisulpride|mesh-list
2813415|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2813416|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2813417|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2813418|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813419|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282112|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282113|NCT00231647|Topiramate|topiramate|mesh-list
2282114|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
2282115|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2282116|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282117|NCT00231660|Topiramate|topiramate|mesh-list
2282118|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
2282119|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2282120|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282121|NCT00231673|Topiramate|topiramate|mesh-list
2282122|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
2282123|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2282124|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282125|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
2282126|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2282127|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282128|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2282129|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2282130|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2813420|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2813421|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
2813422|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282131|NCT00231764|Daclizumab|daclizumab|mesh-list
2282132|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282133|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
2282134|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282135|NCT00231829|Celecoxib|celecoxib|mesh-list
2282136|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2282137|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2282138|NCT00231829|Analgesics|analgesics|mesh-ancestor
2282139|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
2282140|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282141|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282142|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2282143|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2282144|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2282145|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2282146|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813423|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813424|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2813425|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
2813426|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2282147|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282148|NCT00231855|Docetaxel|docetaxel|mesh-list
2282149|NCT00231855|Topotecan|topotecan|mesh-list
2282150|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282151|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
2282152|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
2282153|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
2282154|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282155|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2282156|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2282157|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282158|NCT00231959|Pramipexole|pramipexole|mesh-list
2282159|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
2282160|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282161|NCT00231959|Protective Agents|protective agents|mesh-ancestor
2282162|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813427|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2813428|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
2813429|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813430|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
2813431|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
2813432|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2813433|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813434|NCT04128254|Apixaban|apixaban|mesh-list
2813435|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2813436|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
2813437|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2813438|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
2813439|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813440|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813441|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
2813442|NCT04128540|Fentanyl|fentanyl|mesh-list
2813443|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2813444|NCT04128540|Narcotics|narcotics|mesh-ancestor
2813445|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2282163|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2282164|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2282165|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
2282166|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
2282167|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282168|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
2282169|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2282170|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2282171|NCT00231998|Analgesics|analgesics|mesh-ancestor
2282172|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
2282173|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813446|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813447|NCT04128540|Analgesics|analgesics|mesh-ancestor
2813448|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
2813449|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813450|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2813451|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2813452|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
2282174|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282175|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2282176|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2282177|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
2282178|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282179|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
2282180|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2282181|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282182|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282183|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
2282184|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2282185|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2282186|NCT00232011|Analgesics|analgesics|mesh-ancestor
2282187|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
2282188|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813453|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
2813454|NCT04128501|Azacitidine|azacitidine|mesh-list
2813455|NCT04128501|Venetoclax|venetoclax|mesh-list
2813456|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2813457|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
2813458|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813459|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813460|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813461|NCT04128176|Omalizumab|omalizumab|mesh-list
2813462|NCT04128176|Rituximab|rituximab|mesh-list
2813463|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2813464|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813465|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
2813466|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813467|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813468|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2813469|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2813470|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
2813471|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
2813472|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2813473|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
2813474|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813475|NCT04127786|Vaccines|vaccines|mesh-list
2813476|NCT04127786|Immunologic Factors|immunologic factors|mesh-ancestor
2813477|NCT04127786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813478|NCT04127747|Rituximab|rituximab|mesh-list
2813479|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2813480|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813481|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
2813482|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813483|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813484|NCT04127851|Cyclosporine|cyclosporine|mesh-list
2813485|NCT04127851|Cyclosporins|cyclosporins|mesh-list
2813486|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813487|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813488|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2813489|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
2813490|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813491|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
2813492|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813493|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
2813494|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813495|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2813496|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2813497|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813498|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2813499|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
2813500|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813501|NCT04128020|Nivolumab|nivolumab|mesh-list
2813502|NCT04128020|Azacitidine|azacitidine|mesh-list
2813503|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2813504|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813505|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2282189|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282190|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2282191|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2282192|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
2282193|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2813506|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813507|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2813508|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
2813509|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282194|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
2282195|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2282196|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282197|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282198|NCT00232024|Tegaserod|tegaserod|mesh-list
2813514|NCT04127721|Methotrexate|methotrexate|mesh-list
2813515|NCT04127721|Fludarabine|fludarabine|mesh-list
2813516|NCT04127721|Busulfan|busulfan|mesh-list
2813517|NCT04127721|Tacrolimus|tacrolimus|mesh-list
2813518|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2813519|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
2813520|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2813521|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813522|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2813523|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
2813524|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813525|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813526|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
2813527|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813528|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2813529|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2813530|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
2813531|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813532|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2813533|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2813534|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
2813535|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2813536|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2813537|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2813538|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813539|NCT04127396|Sorafenib|sorafenib|mesh-list
2813540|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
2813541|NCT04127396|Lenvatinib|lenvatinib|mesh-list
2813542|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813543|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2813544|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813545|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813546|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2813547|NCT04127396|Estrogens|estrogens|mesh-ancestor
2813548|NCT04127396|Hormones|hormones|mesh-ancestor
2813549|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813550|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813551|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2813552|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
2813553|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2813554|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2813555|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813556|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2813557|NCT04127500|Analgesics|analgesics|mesh-ancestor
2813558|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
2813559|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813560|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2813561|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2813562|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2813563|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
2813564|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813565|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282199|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2282200|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
2813566|NCT04127357|Fluorides|fluorides|mesh-list
2813567|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
2813568|NCT04127357|Protective Agents|protective agents|mesh-ancestor
2813569|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813570|NCT04127084|Empagliflozin|empagliflozin|mesh-list
2813571|NCT04127084|Canagliflozin|canagliflozin|mesh-list
2282201|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282202|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282203|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282204|NCT00232037|Tegaserod|tegaserod|mesh-list
2282205|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2282206|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
2813572|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2813573|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813574|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2813575|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813576|NCT04126941|Calcium|calcium|mesh-list
2813577|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2813578|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813579|NCT04127058|Iloperidone|iloperidone|mesh-list
2813580|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2813581|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2813582|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2813583|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813584|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282207|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282208|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282209|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282210|NCT00232050|Omalizumab|omalizumab|mesh-list
2282211|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2282212|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2282213|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
2282214|NCT00232063|Cyclosporine|cyclosporine|mesh-list
2282215|NCT00232063|Cyclosporins|cyclosporins|mesh-list
2282216|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282217|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282218|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282219|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
2282220|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282221|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
2282222|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282223|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
2282224|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2282225|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2282226|NCT00232076|Cyclosporine|cyclosporine|mesh-list
2282227|NCT00232076|Cyclosporins|cyclosporins|mesh-list
2282228|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282229|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282230|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282231|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
2282232|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282233|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
2282234|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282235|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
2282236|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2282237|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2282238|NCT00232089|Tegaserod|tegaserod|mesh-list
2282239|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2282240|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
2282241|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813585|NCT04127019|Paclitaxel|paclitaxel|mesh-list
2813586|NCT04127019|Docetaxel|docetaxel|mesh-list
2813587|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
2813588|NCT04127019|Fluorouracil|fluorouracil|mesh-list
2813589|NCT04127019|Epirubicin|epirubicin|mesh-list
2813590|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2813591|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813592|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
2813593|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
2813594|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
2813595|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813596|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2813597|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
2813598|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813599|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813600|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2813601|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
2813602|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2813603|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
2813604|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2813605|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2813606|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2813607|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2813608|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813609|NCT04126993|Apatinib|apatinib|mesh-list
2813610|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813611|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2813612|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813613|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813614|NCT04127227|Gemcitabine|gemcitabine|mesh-list
2813615|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
2813616|NCT04127227|Pegaspargase|pegaspargase|mesh-list
2813617|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2813618|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
2813619|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813620|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813621|NCT04127227|Antiviral Agents|antiviral agents|mesh-ancestor
2813622|NCT04127227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813623|NCT04127227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813624|NCT04127227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2813625|NCT04127227|Immunologic Factors|immunologic factors|mesh-ancestor
2813626|NCT04127227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813627|NCT04126811|Apatinib|apatinib|mesh-list
2813628|NCT04126811|Ifosfamide|ifosfamide|mesh-list
2813629|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
2813630|NCT04126811|Pirarubicin|pirarubicin|mesh-list
2813631|NCT04126811|Doxorubicin|doxorubicin|mesh-list
2813632|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813633|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2813634|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813635|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282242|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282243|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282244|NCT00232102|Tegaserod|tegaserod|mesh-list
2282245|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2282246|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
2282247|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282248|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282249|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282250|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
2282251|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2282252|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2282253|NCT00232115|Analgesics|analgesics|mesh-ancestor
2282254|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
2813636|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2813637|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
2813638|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2813639|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2813640|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2813653|NCT04126668|Vorolanib|vorolanib|mesh-list
2813654|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2813655|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813656|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282255|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282256|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282257|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2282258|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2282259|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
2282260|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282261|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
2282262|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2282263|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282264|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282265|NCT00232154|Azithromycin|azithromycin|mesh-list
2282266|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2282267|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282268|NCT00232167|Indiplon|indiplon|mesh-list
2282269|NCT00232167|Sertraline|sertraline|mesh-list
2282270|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
2282271|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282272|NCT00232167|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2282273|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2282274|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282275|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282276|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282277|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
2282278|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282279|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2282280|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2282281|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
2282282|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
2282283|NCT00232206|Docetaxel|docetaxel|mesh-list
2282284|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282285|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
2282286|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
2282287|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
2282288|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813657|NCT04126681|Interferons|interferons|mesh-list
2813658|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
2813659|NCT04126681|Dasatinib|dasatinib|mesh-list
2813660|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
2813661|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
2813662|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813663|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
2813664|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813665|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2813666|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813667|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813668|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
2813669|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2813670|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2813671|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2813672|NCT04126330|Vitamin D|vitamin d|mesh-list
2813673|NCT04126330|Vitamins|vitamins|mesh-ancestor
2813674|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
2813675|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813676|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2282289|NCT00232271|Enoxaparin|enoxaparin|mesh-list
2282290|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
2282291|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2282292|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2282293|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282294|NCT00232284|Sertraline|sertraline|mesh-list
2282295|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
2282296|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282297|NCT00232284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2813677|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2813678|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
2813679|NCT04126096|Lactams|lactams|mesh-list
2813680|NCT04126096|beta-Lactams|beta-lactams|mesh-list
2813681|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2813682|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813683|NCT04126720|Vitamin E|vitamin e|mesh-list
2813684|NCT04126720|Vitamins|vitamins|mesh-ancestor
2813685|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
2813686|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813687|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
2813688|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813689|NCT04126720|Protective Agents|protective agents|mesh-ancestor
2282298|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2282299|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282300|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282301|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282302|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
2282303|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282304|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2282305|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
2282306|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282307|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2282308|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2282309|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2282310|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282311|NCT00232349|Galantamine|galantamine|mesh-list
2282312|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2282313|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813690|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2813691|NCT04126304|Azithromycin|azithromycin|mesh-list
2813692|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813693|NCT04126135|Nicotine|nicotine|mesh-list
2813694|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2813695|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
2813696|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813697|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813698|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2813699|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2813700|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
2813701|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813702|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813703|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
2813704|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813705|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
2813706|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2813707|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2813708|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813709|NCT04126252|Urological Agents|urological agents|mesh-ancestor
2813710|NCT04126044|Bevacizumab|bevacizumab|mesh-list
2813711|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2813712|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813713|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2104800|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
2104801|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2104802|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104803|NCT02443402|Incretins|incretins|mesh-ancestor
2104804|NCT02443402|Hormones|hormones|mesh-ancestor
2104805|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2104806|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2104807|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
2104808|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104809|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813714|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2813715|NCT04126044|Growth Substances|growth substances|mesh-ancestor
2813716|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813717|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
2813720|NCT04126070|Docetaxel|docetaxel|mesh-list
2813721|NCT04126070|Nivolumab|nivolumab|mesh-list
2813722|NCT04126070|Leuprolide|leuprolide|mesh-list
2813723|NCT04126070|Goserelin|goserelin|mesh-list
2813724|NCT04126070|Androgens|androgens|mesh-list
2813725|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813726|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
2813727|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
2813728|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
2813729|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813730|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2282314|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282315|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
2282316|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282317|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282318|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2282319|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
2282320|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813731|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2813732|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2813733|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
2813734|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2813735|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813736|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2813737|NCT04126070|Hormones|hormones|mesh-ancestor
2813738|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813739|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2282321|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
2282322|NCT00232362|Pioglitazone|pioglitazone|mesh-list
2282323|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
2282324|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2282325|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282326|NCT00232375|Insulin|insulin|mesh-list
2282327|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2282328|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282329|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2282330|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
2282331|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282332|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2282333|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2282334|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2282335|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282336|NCT00232492|Ketamine|ketamine|mesh-list
2282337|NCT00232492|Analgesics|analgesics|mesh-ancestor
2282338|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
2282339|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282340|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282341|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2282342|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2282343|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
2813740|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2813741|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813742|NCT04125927|Cysteamine|cysteamine|mesh-list
2813743|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2813744|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813745|NCT04125719|Nivolumab|nivolumab|mesh-list
2813746|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2813747|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813748|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2813749|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813750|NCT04125550|Propofol|propofol|mesh-list
2813751|NCT04125550|Sevoflurane|sevoflurane|mesh-list
2813752|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2813753|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2813754|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813755|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2813756|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
2813757|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
2813758|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2813759|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2813760|NCT04125563|Capsaicin|capsaicin|mesh-list
2813761|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
2813762|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
2813763|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
2813764|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813765|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813766|NCT04125706|Metronidazole|metronidazole|mesh-list
2813767|NCT04125706|Minocycline|minocycline|mesh-list
2813768|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813769|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2813770|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2813771|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2282344|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
2282345|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2282346|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2282347|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2282348|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282349|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282350|NCT00232531|Niacin|niacin|mesh-list
2282351|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
2282352|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2282353|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
2282354|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282355|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2282356|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
2282357|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
2282358|NCT00232531|Vitamins|vitamins|mesh-ancestor
2282359|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
2282360|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282361|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2282362|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
2282363|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282364|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2282365|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2282366|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2813772|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2813773|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2813774|NCT04125082|Insulin|insulin|mesh-list
2813775|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2813776|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2813777|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813778|NCT04124991|Durvalumab|durvalumab|mesh-list
2813779|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2813780|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813784|NCT04125121|Propofol|propofol|mesh-list
2813785|NCT04125121|Sevoflurane|sevoflurane|mesh-list
2813786|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2813787|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2813788|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813789|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2813790|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
2813791|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
2813792|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2813793|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2813794|NCT04124614|Sertraline|sertraline|mesh-list
2813795|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
2813796|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
2813797|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2813798|NCT04124614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2813799|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2813800|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2813801|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813802|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813803|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
2813804|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813805|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
2813806|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
2813807|NCT04124822|Prednisolone|prednisolone|mesh-list
2813808|NCT04124822|Piroxicam|piroxicam|mesh-list
2813809|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2282367|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282368|NCT00232622|Streptokinase|streptokinase|mesh-list
2282369|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2282370|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2282371|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282372|NCT00232648|Budesonide|budesonide|mesh-list
2282373|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2813810|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
2813811|NCT04124822|Hormones|hormones|mesh-ancestor
2813812|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813813|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813814|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2813815|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813816|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813817|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2813818|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2813819|NCT04124822|Analgesics|analgesics|mesh-ancestor
2282374|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2282375|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
2282376|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282377|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282378|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2282379|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
2282380|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
2282381|NCT00232648|Hormones|hormones|mesh-ancestor
2282382|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2282383|NCT00232661|Tamoxifen|tamoxifen|mesh-list
2282384|NCT00232661|Anastrozole|anastrozole|mesh-list
2813820|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
2813821|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813822|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2813823|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813824|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813825|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
2813826|NCT04124887|Listerine|listerine|mesh-list
2813827|NCT04124887|Calcium|calcium|mesh-list
2813828|NCT04124887|Fluorides|fluorides|mesh-list
2813829|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
2813830|NCT04124887|Caseins|caseins|mesh-list
2813831|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2813832|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813833|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2813834|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
2813835|NCT04124887|Protective Agents|protective agents|mesh-ancestor
2813836|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2813837|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813838|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
2813839|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
2813840|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813841|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2813842|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2813843|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2813844|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813845|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813846|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2813847|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2813848|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813849|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
2813850|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813851|NCT04124913|Progesterone|progesterone|mesh-list
2813852|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
2813853|NCT04124913|Progestins|progestins|mesh-ancestor
2813854|NCT04124913|Hormones|hormones|mesh-ancestor
2813855|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813856|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282385|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2282386|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
2282387|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2282388|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282389|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2282390|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282391|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2282392|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2282393|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2282394|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2282395|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2282396|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282397|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282398|NCT00232674|Budesonide|budesonide|mesh-list
2813857|NCT04124926|Lansoprazole|lansoprazole|mesh-list
2813858|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
2813859|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2813860|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2813861|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2813862|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282399|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2282400|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2282401|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
2282402|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282403|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282404|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2813863|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813864|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
2813865|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2813866|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
2813867|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813868|NCT04124757|Rocuronium|rocuronium|mesh-list
2813869|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2813870|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2813871|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2813872|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813873|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813874|NCT04124601|Nivolumab|nivolumab|mesh-list
2813875|NCT04124601|Ipilimumab|ipilimumab|mesh-list
2813876|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2813877|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813878|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2813879|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813880|NCT04124198|Nimorazole|nimorazole|mesh-list
2813881|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2813882|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2813883|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2813884|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813885|NCT04124302|Insulin|insulin|mesh-list
2813886|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2813887|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
2813888|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
2813889|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
2813890|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2813891|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813892|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
2813893|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2813894|NCT04124367|Protective Agents|protective agents|mesh-ancestor
2813895|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813896|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
2813897|NCT04124432|Nicotine|nicotine|mesh-list
2813898|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2813899|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
2813900|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813901|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813902|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2813903|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2813904|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
2813905|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813906|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813907|NCT04124497|Dexamethasone|dexamethasone|mesh-list
2813908|NCT04124497|Daratumumab|daratumumab|mesh-list
2813909|NCT04124497|Pomalidomide|pomalidomide|mesh-list
2282405|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
2282406|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
2282407|NCT00232674|Hormones|hormones|mesh-ancestor
2282408|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2282409|NCT00232687|Aripiprazole|aripiprazole|mesh-list
2282410|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
2282411|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282412|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2282413|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2282414|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2282415|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282416|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
2813910|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2813911|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
2813912|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
2813913|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813914|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813915|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2813916|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
2813917|NCT04124497|Hormones|hormones|mesh-ancestor
2813918|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813919|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2813920|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813921|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
2813922|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2813923|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2813924|NCT04124497|Growth Substances|growth substances|mesh-ancestor
2813925|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
2813926|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2813927|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2813928|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2813929|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
2813930|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813931|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2813932|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2813933|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813934|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
2813935|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2813936|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813937|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
2813938|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813939|NCT04124016|Protective Agents|protective agents|mesh-ancestor
2813940|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813941|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2813942|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2813943|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813944|NCT04124094|Fluticasone|fluticasone|mesh-list
2813945|NCT04124094|Xhance|xhance|mesh-list
2813946|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2813947|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2813948|NCT04124094|Charcoal|charcoal|mesh-list
2813949|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2813950|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2813951|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
2813952|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813953|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813954|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2813955|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
2813956|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
2813957|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2813958|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2813959|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2813960|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2813961|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
2813962|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2813963|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813964|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
2813965|NCT04124094|Hormones|hormones|mesh-ancestor
2813966|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813967|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
2813968|NCT04124094|Antidotes|antidotes|mesh-ancestor
2813969|NCT04124094|Protective Agents|protective agents|mesh-ancestor
2282417|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
2282418|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282419|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282420|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2813970|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2813971|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2813972|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813973|NCT04124081|Entecavir|entecavir|mesh-list
2813974|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
2813975|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2813976|NCT04123873|Acetaminophen|acetaminophen|mesh-list
2813977|NCT04123873|Dexamethasone|dexamethasone|mesh-list
2813978|NCT04123873|Ibuprofen|ibuprofen|mesh-list
2813979|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2813980|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
2813981|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
2813982|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2813983|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2813984|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2813985|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
2813986|NCT04123873|Hormones|hormones|mesh-ancestor
2813987|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2813988|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2813989|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2813990|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2813991|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2813992|NCT04123873|Analgesics|analgesics|mesh-ancestor
2813993|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
2813994|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2813995|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2813996|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2813997|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2813998|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
2813999|NCT04123925|Nivolumab|nivolumab|mesh-list
2814000|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2814001|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814002|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2814003|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814004|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2814005|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814006|NCT04123717|Acetaminophen|acetaminophen|mesh-list
2282421|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2282422|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
2282423|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2282424|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2282425|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2282426|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2282427|NCT00232700|Citalopram|citalopram|mesh-list
2282428|NCT00232700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2282429|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2282430|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282431|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282432|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282433|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
2282434|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282435|NCT00232700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2282436|NCT00232700|Antidepressive Agents|antidepressive agents|mesh-ancestor
2282437|NCT00232700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282438|NCT00232752|Sirolimus|sirolimus|mesh-list
2282439|NCT00232752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2282440|NCT00232752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282441|NCT00232752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2282442|NCT00232752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282443|NCT00232752|Antifungal Agents|antifungal agents|mesh-ancestor
2282444|NCT00232752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282445|NCT00232752|Immunologic Factors|immunologic factors|mesh-ancestor
2282446|NCT00232752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282447|NCT00232765|Sirolimus|sirolimus|mesh-list
2282448|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2282449|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282450|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2814007|NCT04123717|Ibuprofen|ibuprofen|mesh-list
2814008|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2814009|NCT04123717|Analgesics|analgesics|mesh-ancestor
2814010|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
2814011|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814012|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814013|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
2814014|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2814015|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814016|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814017|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2814018|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814019|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814020|NCT04123652|Lidocaine|lidocaine|mesh-list
2814021|NCT04123652|Ketamine|ketamine|mesh-list
2814022|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
2814023|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
2814024|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814025|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814026|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
2814027|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814028|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2814029|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2814030|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2814031|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2814032|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814033|NCT04123652|Analgesics|analgesics|mesh-ancestor
2814034|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2814035|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2814036|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
2814037|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2814038|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2814039|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2814040|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
2814041|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2814042|NCT04123743|Protective Agents|protective agents|mesh-ancestor
2814043|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814044|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
2814045|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
2814046|NCT04123392|Busulfan|busulfan|mesh-list
2814047|NCT04123392|Decitabine|decitabine|mesh-list
2814048|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2814049|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
2814050|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814051|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814052|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2814053|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
2814054|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814055|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814056|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2814057|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2814058|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
2814059|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814060|NCT04123470|Atezolizumab|atezolizumab|mesh-list
2814061|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814062|NCT04123288|ACT-709478|act-709478|mesh-list
2814063|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2814064|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2814065|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814066|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2814067|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814068|NCT04123210|Vitamin A|vitamin a|mesh-list
2814069|NCT04123210|Vitamins|vitamins|mesh-ancestor
2814070|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
2814071|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814072|NCT04123041|Nicotine|nicotine|mesh-list
2814073|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2814074|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
2814075|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814076|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814077|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2814078|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2814079|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
2814080|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2814081|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814082|NCT04123314|Psilocybin|psilocybin|mesh-list
2814083|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
2814084|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814085|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2814086|NCT04123249|Propofol|propofol|mesh-list
2814087|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
2282451|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282452|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
2282453|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282454|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
2282455|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282456|NCT00232817|Nicotine|nicotine|mesh-list
2282457|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2282458|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
2282459|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282460|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282461|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2282462|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2282463|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
2282464|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282465|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282466|NCT00232856|Sirolimus|sirolimus|mesh-list
2282467|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2814088|NCT04123249|Sevoflurane|sevoflurane|mesh-list
2814089|NCT04123249|Anesthetics|anesthetics|mesh-list
2814090|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2814091|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814092|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814093|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
2814094|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2814095|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2282468|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282469|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2282470|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282471|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
2282472|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282473|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
2814096|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
2814097|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814098|NCT04122911|Temozolomide|temozolomide|mesh-list
2814099|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2814100|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
2814101|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814102|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814103|NCT04122599|Melatonin|melatonin|mesh-list
2814104|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
2814105|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814106|NCT04122599|Protective Agents|protective agents|mesh-ancestor
2814107|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814108|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2282474|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282475|NCT00232882|Atenolol|atenolol|mesh-list
2282476|NCT00232882|Candesartan|candesartan|mesh-list
2282477|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
2282478|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
2282479|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2282480|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2282481|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2282482|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282483|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2282484|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
2282485|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
2282486|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282487|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282488|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2282489|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2282490|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2282491|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
2282492|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282493|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282494|NCT00232882|Diuretics|diuretics|mesh-ancestor
2814109|NCT04122716|Liraglutide|liraglutide|mesh-list
2814110|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2814111|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814112|NCT04122716|Incretins|incretins|mesh-ancestor
2814113|NCT04122716|Hormones|hormones|mesh-ancestor
2814114|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2814115|NCT04122560|Fluconazole|fluconazole|mesh-list
2814116|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
2814117|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282495|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
2282496|NCT00232895|Propofol|propofol|mesh-list
2282497|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2814118|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2814119|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2814120|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814121|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814122|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2814123|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
2814124|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2814125|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814126|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2814127|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2814128|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
2814129|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
2814130|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282498|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2282499|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282500|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2282501|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
2282502|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
2282503|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
2282504|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2282505|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2282506|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282507|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2282508|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2282509|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
2282510|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282511|NCT00232934|Thalidomide|thalidomide|mesh-list
2282512|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282513|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
2282514|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282515|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
2282516|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2282517|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282518|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2282519|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2282520|NCT00232934|Growth Substances|growth substances|mesh-ancestor
2282521|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
2814131|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
2814132|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
2814133|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2814134|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2814135|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814136|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814137|NCT04122105|Urological Agents|urological agents|mesh-ancestor
2814138|NCT04122222|Vaccines|vaccines|mesh-list
2814139|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
2814140|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814141|NCT04121975|Endostar protein|endostar protein|mesh-list
2814142|NCT04121975|Endostatins|endostatins|mesh-list
2814143|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814144|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2814145|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2814146|NCT04121975|Growth Substances|growth substances|mesh-ancestor
2814147|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282522|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282523|NCT00232947|Vaccines|vaccines|mesh-list
2282524|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
2282525|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282526|NCT00233012|Topiramate|topiramate|mesh-list
2282527|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
2282528|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2282529|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282530|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2282531|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2282532|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2282533|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282534|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282535|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282536|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282537|NCT00233025|Analgesics|analgesics|mesh-ancestor
2282538|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
2282539|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282540|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
2814148|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
2814149|NCT04122040|Roxithromycin|roxithromycin|mesh-list
2814150|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2814151|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814152|NCT04121910|Itraconazole|itraconazole|mesh-list
2814153|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
2814154|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814155|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2814156|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2814157|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814158|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814159|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2814160|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
2814161|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2814162|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814163|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2814164|NCT04121767|Warfarin|warfarin|mesh-list
2814165|NCT04121767|Edoxaban|edoxaban|mesh-list
2814166|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
2814167|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2814168|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
2814169|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2814170|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
2814171|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814172|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814173|NCT04121689|Caseins|caseins|mesh-list
2814174|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
2282541|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282542|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
2814175|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
2814176|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814177|NCT04121611|Aspirin|aspirin|mesh-list
2814178|NCT04121611|Heparin|heparin|mesh-list
2814179|NCT04121611|Calcium heparin|calcium heparin|mesh-list
2814180|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
2814181|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2282543|NCT00233038|Ethanol|ethanol|mesh-list
2282544|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2282545|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104810|NCT02443883|Ramucirumab|ramucirumab|mesh-list
2104811|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104812|NCT02444143|Tacrolimus|tacrolimus|mesh-list
2104813|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2104814|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
2104815|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282546|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2282547|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282548|NCT00233051|Fluticasone|fluticasone|mesh-list
2282549|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2282550|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2282551|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2282552|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
2282553|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282554|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282555|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2814182|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2814183|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814184|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2814185|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2814186|NCT04121611|Analgesics|analgesics|mesh-ancestor
2814187|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
2814188|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814189|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814190|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814191|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814192|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2814193|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2814194|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814195|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
2814196|NCT04121819|Cytarabine|cytarabine|mesh-list
2814197|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2814198|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
2104816|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2104817|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104818|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104819|NCT02444234|Tedizolid|tedizolid|mesh-list
2104820|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
2814199|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814200|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814201|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
2814202|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814203|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2814204|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
2814205|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814206|NCT04121780|Hormones|hormones|mesh-list
2814207|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2814208|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814209|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
2814210|NCT04121507|Thiotepa|thiotepa|mesh-list
2814211|NCT04121507|Fludarabine|fludarabine|mesh-list
2814212|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2814213|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
2814214|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814215|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814216|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2814217|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
2814218|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282556|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
2282557|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
2282558|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2282559|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2282560|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2282561|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2282562|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
2282563|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282564|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282565|NCT00233155|Capsaicin|capsaicin|mesh-list
2282566|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
2282567|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
2282568|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
2282569|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282570|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104821|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2282571|NCT00233337|Artemether|artemether|mesh-list
2282572|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2282573|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
2814219|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814220|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2814221|NCT04121533|Vitamin D|vitamin d|mesh-list
2814222|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
2814223|NCT04121533|Vitamins|vitamins|mesh-ancestor
2814224|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
2814225|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814226|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2814227|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2814228|NCT04121468|Metformin|metformin|mesh-list
2814229|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2814230|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814231|NCT04121416|Sufentanil|sufentanil|mesh-list
2814232|NCT04121416|Oxycodone|oxycodone|mesh-list
2814233|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2814234|NCT04121416|Narcotics|narcotics|mesh-ancestor
2814235|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814236|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814237|NCT04121416|Analgesics|analgesics|mesh-ancestor
2814238|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
2814239|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814240|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2814241|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2814242|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
2814243|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
2814244|NCT04121039|Apatinib|apatinib|mesh-list
2814245|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814246|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2282574|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2282575|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2282576|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282577|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2282578|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2282579|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282580|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
2282581|NCT00233532|Verapamil|verapamil|mesh-list
2282582|NCT00233532|Trandolapril|trandolapril|mesh-list
2282583|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2282584|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2282585|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282586|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282587|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2282588|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282589|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
2282590|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2814247|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814248|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814249|NCT04121338|Bupivacaine|bupivacaine|mesh-list
2814250|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
2814251|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
2814252|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814253|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814254|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
2814255|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814256|NCT04121403|Rituximab|rituximab|mesh-list
2814257|NCT04121403|Cladribine|cladribine|mesh-list
2814258|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2814259|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814260|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
2814261|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814262|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814263|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2814264|NCT04120870|Ketamine|ketamine|mesh-list
2814265|NCT04120870|Etomidate|etomidate|mesh-list
2814266|NCT04120870|Analgesics|analgesics|mesh-ancestor
2814267|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
2814268|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814269|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814270|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2814271|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2814272|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
2814273|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
2814274|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814275|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2282591|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
2282592|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282593|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2282594|NCT00233545|Miltefosine|miltefosine|mesh-list
2282595|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
2282596|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814276|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2814277|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2814278|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282597|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282598|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2282599|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2814279|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2814280|NCT04121091|Pramipexole|pramipexole|mesh-list
2814281|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
2282600|NCT00233558|Adalimumab|adalimumab|mesh-list
2282601|NCT00233558|Methotrexate|methotrexate|mesh-list
2282602|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2282603|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
2814282|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814283|NCT04121091|Protective Agents|protective agents|mesh-ancestor
2814284|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814285|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2814286|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2814287|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
2814288|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
2814289|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2814290|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
2814291|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
2814292|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2814293|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2814294|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814295|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814296|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814297|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814298|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
2814299|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814300|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2814301|NCT04120987|Lifitegrast|lifitegrast|mesh-list
2814302|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2814303|NCT04120753|Amlodipine|amlodipine|mesh-list
2814304|NCT04120753|Olmesartan|olmesartan|mesh-list
2814305|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2814306|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2814307|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2814308|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814309|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2814310|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814311|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
2814312|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2814313|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2814314|NCT04120974|Insulin|insulin|mesh-list
2814315|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2814316|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814317|NCT04120805|Hemostatics|hemostatics|mesh-list
2814318|NCT04120805|Coagulants|coagulants|mesh-ancestor
2814319|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
2814320|NCT04120922|Calcium|calcium|mesh-list
2814321|NCT04120922|Sevelamer|sevelamer|mesh-list
2814322|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2282604|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2282605|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282606|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2282607|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
2282608|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814323|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814324|NCT04120922|Antacids|antacids|mesh-ancestor
2814325|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814326|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2814327|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
2814328|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
2814329|NCT04120831|Abatacept|abatacept|mesh-list
2814330|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282609|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282610|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
2282611|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814331|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
2814332|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814333|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814334|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2814335|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814336|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2814337|NCT04120961|Hirudins|hirudins|mesh-list
2814338|NCT04120961|Bivalirudin|bivalirudin|mesh-list
2814339|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
2814340|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2814341|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
2814342|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814343|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814344|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
2814345|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2814346|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2814347|NCT04120636|Celecoxib|celecoxib|mesh-list
2814348|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2282612|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2282613|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282614|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
2814349|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2814350|NCT04120636|Analgesics|analgesics|mesh-ancestor
2814351|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
2814352|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814353|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814354|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814355|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814356|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2814357|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2814358|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814359|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814360|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
2814361|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
2814362|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2814363|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814364|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2814365|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814366|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
2814367|NCT04120363|Testosterone|testosterone|mesh-list
2814368|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
2814369|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
2814370|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2814371|NCT04120363|Androgens|androgens|mesh-ancestor
2814372|NCT04120363|Hormones|hormones|mesh-ancestor
2814373|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2814374|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814375|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2814376|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814377|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
2814378|NCT04120311|Dexamethasone|dexamethasone|mesh-list
2814379|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
2814380|NCT04120311|BB 1101|bb 1101|mesh-list
2814381|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814382|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
2814383|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
2814384|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814385|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814386|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2814387|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
2814388|NCT04120311|Hormones|hormones|mesh-ancestor
2814389|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2814390|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2814391|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814392|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
2814393|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814394|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282615|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2282616|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2282617|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2282618|NCT00233571|Adalimumab|adalimumab|mesh-list
2282619|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2282620|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2282621|NCT00233584|Budesonide|budesonide|mesh-list
2282622|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2282623|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2282624|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
2282625|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282626|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282627|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2282628|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
2814395|NCT04120259|Metformin|metformin|mesh-list
2814396|NCT04120259|Acetic Acid|acetic acid|mesh-list
2814397|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2814398|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814399|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2814400|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814401|NCT04120350|Rituximab|rituximab|mesh-list
2814402|NCT04120350|Methotrexate|methotrexate|mesh-list
2814403|NCT04120350|Lenalidomide|lenalidomide|mesh-list
2814404|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2814405|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814406|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
2814407|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814408|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814409|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2814410|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
2814411|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2814412|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2814413|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
2814414|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814415|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
2814416|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814417|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2814418|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2814419|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2814420|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2814421|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2814422|NCT04120350|Growth Substances|growth substances|mesh-ancestor
2814423|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
2814424|NCT04120519|Thalidomide|thalidomide|mesh-list
2814425|NCT04120519|Dexamethasone|dexamethasone|mesh-list
2814426|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
2814427|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2814428|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
2814429|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814430|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814431|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2814432|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
2814433|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814434|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814435|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2814436|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814437|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
2814438|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
2814439|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814440|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2814441|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
2814442|NCT04120519|Hormones|hormones|mesh-ancestor
2814443|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2814444|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2814445|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
2814446|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2814447|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814448|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2814449|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2814450|NCT04120519|Growth Substances|growth substances|mesh-ancestor
2814451|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
2814452|NCT04120415|Vedolizumab|vedolizumab|mesh-list
2814453|NCT04120415|Vaccines|vaccines|mesh-list
2814454|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
2814455|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814456|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2814457|NCT04120337|Lidocaine|lidocaine|mesh-list
2814458|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
2814459|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
2814460|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814461|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814462|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
2814463|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814464|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2814465|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2814466|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2814467|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2814468|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814469|NCT04119921|Ketorolac|ketorolac|mesh-list
2814470|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2814471|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
2814472|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2814473|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2814474|NCT04119921|Analgesics|analgesics|mesh-ancestor
2814475|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
2814476|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814477|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814478|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814479|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814480|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2814481|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814482|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814483|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2814484|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2814485|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
2814486|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2814487|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814488|NCT04120064|Vitamins|vitamins|mesh-ancestor
2814489|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
2814490|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2814491|NCT04119752|Curcumin|curcumin|mesh-list
2814492|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2814493|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2814494|NCT04119752|Analgesics|analgesics|mesh-ancestor
2814495|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
2814496|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814497|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814498|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814499|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814500|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814501|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282629|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
2282630|NCT00233584|Hormones|hormones|mesh-ancestor
2282631|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2282632|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2282633|NCT00233597|Hematinics|hematinics|mesh-ancestor
2282634|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2282635|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2282636|NCT00233610|Tamoxifen|tamoxifen|mesh-list
2282637|NCT00233610|Bicalutamide|bicalutamide|mesh-list
2282638|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2814502|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814503|NCT04119622|Capecitabine|capecitabine|mesh-list
2814504|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
2814505|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2814506|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
2814507|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814508|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814509|NCT04119453|Apatinib|apatinib|mesh-list
2814510|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814511|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2814512|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814513|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282639|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
2282640|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2282641|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282642|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2282643|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282644|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2282645|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2814514|NCT04119674|Temozolomide|temozolomide|mesh-list
2814515|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2814516|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
2814517|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814518|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814519|NCT04119297|Heparinoids|heparinoids|mesh-list
2814520|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814521|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
2814522|NCT04119739|Ibuprofen|ibuprofen|mesh-list
2814523|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2814524|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2814525|NCT04119739|Analgesics|analgesics|mesh-ancestor
2814526|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
2814527|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814528|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282646|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2282647|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
2282648|NCT00233623|Leucovorin|leucovorin|mesh-list
2282649|NCT00233623|Fluorouracil|fluorouracil|mesh-list
2282650|NCT00233623|Irinotecan|irinotecan|mesh-list
2282651|NCT00233623|Gefitinib|gefitinib|mesh-list
2282652|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
2282653|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282654|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2282655|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282656|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282657|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
2282658|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282659|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2282660|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2282661|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814529|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814530|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814531|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2814532|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814533|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814534|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
2814535|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2814536|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
2814537|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814538|NCT04119284|Protective Agents|protective agents|mesh-ancestor
2814539|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814540|NCT04119180|Midazolam|midazolam|mesh-list
2814541|NCT04119180|Ketamine|ketamine|mesh-list
2814542|NCT04119180|Analgesics|analgesics|mesh-ancestor
2814543|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
2814544|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814545|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814546|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2814547|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2814548|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
2814549|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
2814550|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814551|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2814552|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2814553|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2814554|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814555|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2814556|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2814557|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2814558|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2814559|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2814560|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
2814561|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
2814562|NCT04118920|Insulin|insulin|mesh-list
2814563|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2814564|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2814565|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814566|NCT04119336|Dexamethasone|dexamethasone|mesh-list
2814567|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
2814568|NCT04119336|Nivolumab|nivolumab|mesh-list
2814569|NCT04119336|Ixazomib|ixazomib|mesh-list
2814570|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2814571|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
2814572|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814573|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2282662|NCT00233623|Antidotes|antidotes|mesh-ancestor
2814574|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2814575|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
2814576|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814577|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814578|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2814579|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814580|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
2814581|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
2282663|NCT00233623|Protective Agents|protective agents|mesh-ancestor
2282664|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
2282665|NCT00233623|Vitamins|vitamins|mesh-ancestor
2282666|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
2282667|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2282668|NCT00233636|Gefitinib|gefitinib|mesh-list
2282669|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814582|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814583|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2814584|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
2814585|NCT04119336|Hormones|hormones|mesh-ancestor
2814586|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2814587|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2814588|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2814589|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2814590|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
2282670|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2282671|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282672|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282673|NCT00233662|Alefacept|alefacept|mesh-list
2282674|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
2282675|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
2282676|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282677|NCT00233675|Tiagabine|tiagabine|mesh-list
2282678|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
2282679|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
2282680|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2282681|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282682|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282683|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
2282684|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282685|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282686|NCT00233714|Sirolimus|sirolimus|mesh-list
2282687|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2282688|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282689|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2282690|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282691|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
2814591|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814592|NCT04119037|Morphine|morphine|mesh-list
2814593|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2814594|NCT04119037|Narcotics|narcotics|mesh-ancestor
2814595|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814596|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814597|NCT04119037|Analgesics|analgesics|mesh-ancestor
2814598|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
2814599|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814600|NCT04118855|Axitinib|axitinib|mesh-list
2814601|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814602|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2282692|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282693|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
2282694|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282695|NCT00233766|Sirolimus|sirolimus|mesh-list
2282696|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2282697|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282698|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2282699|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282700|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
2282701|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282702|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
2282703|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814603|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814604|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814605|NCT04118842|Rifampin|rifampin|mesh-list
2814606|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2282704|NCT00233779|Sirolimus|sirolimus|mesh-list
2282705|NCT00233779|Heparin|heparin|mesh-list
2814607|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
2282706|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2282707|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282708|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2282709|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282710|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
2282711|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282712|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
2282713|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282714|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
2282715|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2282716|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2282717|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814608|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2814609|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814610|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
2814611|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2814612|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814613|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814614|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2814615|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2814616|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2814617|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2814618|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2814619|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2104822|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104823|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2104824|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104825|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104826|NCT02444533|Bupivacaine|bupivacaine|mesh-list
2104827|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
2104828|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
2104829|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2104830|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104831|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
2104832|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282718|NCT00233792|Sirolimus|sirolimus|mesh-list
2282719|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2282720|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282721|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2282722|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282723|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
2282724|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282725|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
2282726|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282727|NCT00233805|Sirolimus|sirolimus|mesh-list
2282728|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2282729|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282730|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2282731|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282732|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
2282733|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282734|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
2282735|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282736|NCT00233818|Sirolimus|sirolimus|mesh-list
2282737|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2282738|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282739|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2282740|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282741|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
2282742|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282743|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
2282744|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282745|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
2282746|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2282747|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2282748|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282749|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2282750|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2282751|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
2282752|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282753|NCT00233896|Beclomethasone|beclomethasone|mesh-list
2282754|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2282755|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
2282756|NCT00233896|Hormones|hormones|mesh-ancestor
2282757|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2814620|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
2814621|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2814622|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814623|NCT04118556|Sirolimus|sirolimus|mesh-list
2814624|NCT04118556|Etanercept|etanercept|mesh-list
2814625|NCT04118556|Everolimus|everolimus|mesh-list
2814626|NCT04118556|Infliximab|infliximab|mesh-list
2814627|NCT04118556|Vedolizumab|vedolizumab|mesh-list
2814628|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814629|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2814630|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
2814631|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814632|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2814633|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814634|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2814635|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
2814636|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2814637|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2814638|NCT04118556|Analgesics|analgesics|mesh-ancestor
2814639|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
2814640|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814641|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814642|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814643|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2814644|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
2814645|NCT04118699|Rifaximin|rifaximin|mesh-list
2814646|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2814647|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814648|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2814649|NCT04118777|Ropivacaine|ropivacaine|mesh-list
2814650|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
2814651|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
2814652|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814653|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814654|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
2282758|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282759|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2282760|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
2282761|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
2282762|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2282763|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282764|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2282765|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
2282766|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282767|NCT00233935|Protective Agents|protective agents|mesh-ancestor
2282768|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282769|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2282770|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2282771|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282772|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2282773|NCT00233961|Lenograstim|lenograstim|mesh-list
2282774|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2282775|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
2282776|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282777|NCT00234000|Azacitidine|azacitidine|mesh-list
2814655|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282778|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
2282779|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2282780|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
2282781|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282782|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282783|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282784|NCT00234026|Gemcitabine|gemcitabine|mesh-list
2282785|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2282786|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
2282787|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814678|NCT04118153|Abatacept|abatacept|mesh-list
2814679|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2814680|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814681|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814682|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2814683|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
2814684|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814685|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814686|NCT04118010|Vitamin D|vitamin d|mesh-list
2814687|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
2814688|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
2814689|NCT04118010|Vitamins|vitamins|mesh-list
2814690|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
2814691|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282788|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282789|NCT00234026|Antiviral Agents|antiviral agents|mesh-ancestor
2282790|NCT00234026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282791|NCT00234026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282792|NCT00234026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282793|NCT00234026|Immunologic Factors|immunologic factors|mesh-ancestor
2814692|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2814693|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2814694|NCT04118166|Nivolumab|nivolumab|mesh-list
2814695|NCT04118166|Ipilimumab|ipilimumab|mesh-list
2814696|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2814697|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814698|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2814699|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814700|NCT04117932|Ustekinumab|ustekinumab|mesh-list
2814701|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
2814702|NCT04117919|Triamcinolone|triamcinolone|mesh-list
2814703|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2814704|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2814705|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
2814706|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2814707|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2814708|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2104833|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
2104834|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104835|NCT02444936|Vaccines|vaccines|mesh-list
2104836|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
2104837|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104838|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
2104839|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2104840|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2104841|NCT02445326|Dexamethasone|dexamethasone|mesh-list
2104842|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2104843|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
2104844|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
2104845|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814709|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2814710|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814711|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
2814712|NCT04117919|Hormones|hormones|mesh-ancestor
2814713|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2814714|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814715|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2814716|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
2814717|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282794|NCT00234026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282795|NCT00234091|Ritonavir|ritonavir|mesh-list
2282796|NCT00234091|Lopinavir|lopinavir|mesh-list
2282797|NCT00234091|Nelfinavir|nelfinavir|mesh-list
2282798|NCT00234091|Lamivudine|lamivudine|mesh-list
2282799|NCT00234091|Zidovudine|zidovudine|mesh-list
2282800|NCT00234091|Nevirapine|nevirapine|mesh-list
2282801|NCT00234091|Abacavir|abacavir|mesh-list
2282802|NCT00234091|Efavirenz|efavirenz|mesh-list
2282803|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2282804|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2282805|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
2282806|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282807|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814718|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814719|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2814720|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
2814721|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2814722|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2814723|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2814724|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814725|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2814726|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814727|NCT04117893|Analgesics|analgesics|mesh-ancestor
2814728|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
2814729|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814730|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
2814731|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2814732|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
2814733|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2814734|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
2814735|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
2814736|NCT04117893|Protective Agents|protective agents|mesh-ancestor
2814737|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
2814738|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2814739|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2814740|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814741|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
2814742|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
2814743|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
2814744|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
2814745|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2814746|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
2814747|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
2814748|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2814749|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814750|NCT04117750|Vitamins|vitamins|mesh-ancestor
2282808|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2282809|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2282810|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
2282811|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282812|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2282813|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2282814|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2282815|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2282816|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
2814751|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
2814752|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2814753|NCT04117750|Antacids|antacids|mesh-ancestor
2814754|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814755|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2282817|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2282818|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2282819|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2282820|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2282821|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2814756|NCT04117698|Ethambutol|ethambutol|mesh-list
2814757|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
2814758|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2814759|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814760|NCT04118322|Peppermint oil|peppermint oil|mesh-list
2814761|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
2814762|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
2814763|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814764|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814765|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2814766|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
2814767|NCT04117581|Vitamin D|vitamin d|mesh-list
2814768|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
2814769|NCT04117581|Vitamins|vitamins|mesh-ancestor
2814770|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
2814771|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814772|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2814773|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2814774|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
2814775|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2814776|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814777|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814778|NCT04117451|Propolis|propolis|mesh-list
2814779|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814780|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2814781|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2814782|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814783|NCT04117178|Memantine|memantine|mesh-list
2814784|NCT04117178|Donepezil|donepezil|mesh-list
2814785|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2814786|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814787|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814788|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
2814789|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2814790|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814791|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
2814792|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2814793|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2814794|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
2814795|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2814796|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2282822|NCT00234117|Rabeprazole|rabeprazole|mesh-list
2282823|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2282824|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2282825|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2282826|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814797|NCT04117009|Remifentanil|remifentanil|mesh-list
2814798|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2814799|NCT04117009|Narcotics|narcotics|mesh-ancestor
2814800|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814801|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814802|NCT04117009|Analgesics|analgesics|mesh-ancestor
2814803|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
2814804|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814805|NCT04117243|Misoprostol|misoprostol|mesh-list
2814806|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
2814807|NCT04117243|Oxytocin|oxytocin|mesh-list
2814808|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
2814809|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2282827|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282828|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
2282829|NCT00234143|Hematinics|hematinics|mesh-ancestor
2282830|NCT00234182|Interferons|interferons|mesh-list
2282831|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
2282832|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
2814810|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814811|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2814812|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2814813|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814814|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
2814815|NCT04117243|Coagulants|coagulants|mesh-ancestor
2814816|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2814817|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
2814818|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2282833|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282834|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
2282835|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282836|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
2282837|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282838|NCT00234195|Bupropion|bupropion|mesh-list
2282839|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2282840|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
2282841|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282842|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2282843|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2282844|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282845|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282846|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
2282847|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282848|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282849|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2282850|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2282851|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814819|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2814820|NCT04117074|Bupivacaine|bupivacaine|mesh-list
2814821|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
2814822|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
2814823|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814824|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814825|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
2814826|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814827|NCT04117191|Tryptophan|tryptophan|mesh-list
2814828|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2104846|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104847|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2104848|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
2104849|NCT02445326|Hormones|hormones|mesh-ancestor
2104850|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2104851|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2104852|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104853|NCT02445586|Docetaxel|docetaxel|mesh-list
2104854|NCT02445586|Trastuzumab|trastuzumab|mesh-list
2104855|NCT02445586|Pertuzumab|pertuzumab|mesh-list
2104856|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814829|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
2282852|NCT00234234|Adalimumab|adalimumab|mesh-list
2814830|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2814831|NCT04117087|Nivolumab|nivolumab|mesh-list
2282853|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2282854|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2282855|NCT00234299|Aspirin|aspirin|mesh-list
2104857|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
2104858|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
2104859|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
2104860|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104861|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2104862|NCT02445807|Clobetasol|clobetasol|mesh-list
2104863|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2104864|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
2104865|NCT02445807|Hormones|hormones|mesh-ancestor
2104866|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2104867|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104868|NCT02445859|Cefuroxime|cefuroxime|mesh-list
2104869|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
2104870|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2104871|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104872|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2104873|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
2104874|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2104875|NCT02446171|Naloxegol|naloxegol|mesh-list
2104876|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2104877|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104878|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
2104879|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104880|NCT02446418|Fluticasone|fluticasone|mesh-list
2104881|NCT02446418|Xhance|xhance|mesh-list
2104882|NCT02446418|Budesonide|budesonide|mesh-list
2104883|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
2104884|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2104885|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2104886|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2104887|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
2104888|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104889|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104890|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2104891|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
2104892|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
2104893|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2104894|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
2104895|NCT02446418|Hormones|hormones|mesh-ancestor
2104896|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2104897|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2104898|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2104899|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2104900|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
2104901|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104902|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104903|NCT02446483|Rabeprazole|rabeprazole|mesh-list
2104904|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2104905|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2104906|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2104907|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104908|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104909|NCT02446496|Cefadroxil|cefadroxil|mesh-list
2104910|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2104911|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104912|NCT02446600|Gemcitabine|gemcitabine|mesh-list
2814832|NCT04117087|Ipilimumab|ipilimumab|mesh-list
2814833|NCT04117087|Poly ICLC|poly iclc|mesh-list
2814834|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2814835|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814836|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2814837|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814838|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
2814839|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
2814840|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814841|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
2814842|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2814843|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814844|NCT04116931|Clopidogrel|clopidogrel|mesh-list
2814845|NCT04116931|Ticagrelor|ticagrelor|mesh-list
2814846|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2814847|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2814848|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2814849|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2814850|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
2814851|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2814852|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814853|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814854|NCT04116554|Bupivacaine|bupivacaine|mesh-list
2814855|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
2814856|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
2814857|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814858|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814859|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
2282856|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2282857|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2814860|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814861|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
2814862|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814863|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2814864|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814865|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814866|NCT04116398|Dexamethasone|dexamethasone|mesh-list
2814867|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814868|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
2814869|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
2814870|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814871|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814872|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2814873|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
2814874|NCT04116398|Hormones|hormones|mesh-ancestor
2814875|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2814876|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2814877|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814878|NCT04116528|Ketamine|ketamine|mesh-list
2814879|NCT04116528|Buprenorphine|buprenorphine|mesh-list
2814880|NCT04116528|Analgesics|analgesics|mesh-ancestor
2814881|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
2814882|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814883|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814884|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2814885|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2814886|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
2814887|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
2814888|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814889|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2814890|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2814891|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2814892|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814893|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2814894|NCT04116528|Narcotics|narcotics|mesh-ancestor
2814895|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2814896|NCT04116827|Tamoxifen|tamoxifen|mesh-list
2814897|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2814898|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
2814899|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2814900|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814901|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2814902|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814903|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2814904|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2814905|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2814906|NCT04116411|Valganciclovir|valganciclovir|mesh-list
2814907|NCT04116411|Temozolomide|temozolomide|mesh-list
2814908|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2814909|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
2814910|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814911|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814912|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
2814913|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814914|NCT04116359|Cisplatin|cisplatin|mesh-list
2814915|NCT04116359|Etoposide|etoposide|mesh-list
2814916|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
2814917|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
2814918|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814919|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2814920|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2282858|NCT00234299|Analgesics|analgesics|mesh-ancestor
2282859|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
2282860|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282861|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282862|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814921|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2814922|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814923|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814924|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
2814925|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
2814926|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
2814927|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
2814928|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
2814929|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
2282863|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2282864|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2814930|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2814931|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814932|NCT04115982|Vitamins|vitamins|mesh-ancestor
2282865|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2282866|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282867|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2282868|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2282869|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282870|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
2282871|NCT00234312|Citalopram|citalopram|mesh-list
2282872|NCT00234312|Sertraline|sertraline|mesh-list
2282873|NCT00234312|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2282874|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2282875|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282876|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282877|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282878|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
2814933|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
2814934|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2814935|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
2814936|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2814937|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
2814938|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
2814939|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
2814940|NCT04115904|Ibuprofen|ibuprofen|mesh-list
2814941|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2814942|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2814943|NCT04115904|Analgesics|analgesics|mesh-ancestor
2814944|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
2814945|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814946|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814947|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814948|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2282879|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282880|NCT00234312|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2282881|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
2282882|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282883|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2282884|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
2282885|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2282886|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2282887|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2282888|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2282889|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282890|NCT00234390|Budesonide|budesonide|mesh-list
2282891|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2282892|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2282893|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
2282894|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282895|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282896|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2104913|NCT02446600|Paclitaxel|paclitaxel|mesh-list
2104914|NCT02446600|Carboplatin|carboplatin|mesh-list
2104915|NCT02446600|Doxorubicin|doxorubicin|mesh-list
2104916|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2104917|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2104918|NCT02446600|Olaparib|olaparib|mesh-list
2104919|NCT02446600|Cediranib|cediranib|mesh-list
2104920|NCT02446600|Maleic acid|maleic acid|mesh-list
2104921|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2282897|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
2282898|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
2282899|NCT00234390|Hormones|hormones|mesh-ancestor
2282900|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2282901|NCT00234403|Gefitinib|gefitinib|mesh-list
2282902|NCT00234403|Fulvestrant|fulvestrant|mesh-list
2282903|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282904|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2282905|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282906|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282907|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2282908|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2282909|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2282910|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
2282911|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2282912|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282913|NCT00234416|Gemcitabine|gemcitabine|mesh-list
2282914|NCT00234416|Gefitinib|gefitinib|mesh-list
2282915|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2282916|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
2282917|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282918|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282919|NCT00234416|Antiviral Agents|antiviral agents|mesh-ancestor
2282920|NCT00234416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282921|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282922|NCT00234416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282923|NCT00234416|Immunologic Factors|immunologic factors|mesh-ancestor
2814949|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2814950|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2814951|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814952|NCT04116320|Imiquimod|imiquimod|mesh-list
2814953|NCT04116320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2814954|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
2814955|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814956|NCT04116320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2814957|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
2814958|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
2814959|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
2814960|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2814961|NCT04116073|Antibodies|antibodies|mesh-list
2814962|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
2814963|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814964|NCT04116203|Metformin|metformin|mesh-list
2814965|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2814966|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814967|NCT04115878|Oxybutynin|oxybutynin|mesh-list
2814968|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2814969|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2814970|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2814971|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2814972|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2814973|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
2814974|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2814975|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814976|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
2814977|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
2814978|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814979|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2814980|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2814981|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
2814982|NCT04115878|Urological Agents|urological agents|mesh-ancestor
2282924|NCT00234416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282925|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2282926|NCT00234429|Gefitinib|gefitinib|mesh-list
2282927|NCT00234429|Raltitrexed|raltitrexed|mesh-list
2282928|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282929|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2282930|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282931|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282932|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2282933|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
2814983|NCT04115748|Adalimumab|adalimumab|mesh-list
2814984|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814985|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2814986|NCT04115644|Triamcinolone|triamcinolone|mesh-list
2814987|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2814988|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2814989|NCT04115644|Ketorolac|ketorolac|mesh-list
2814990|NCT04115644|Bupivacaine|bupivacaine|mesh-list
2814991|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2814992|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
2814993|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
2814994|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2814995|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2814996|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
2814997|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2814998|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2814999|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
2815000|NCT04115644|Hormones|hormones|mesh-ancestor
2815001|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2815002|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815003|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
2815004|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815005|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815006|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2815007|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2815008|NCT04115644|Analgesics|analgesics|mesh-ancestor
2815009|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815010|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2815011|NCT04115800|Sirolimus|sirolimus|mesh-list
2815012|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2815013|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815014|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2815015|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815016|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
2815017|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815018|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
2815019|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815020|NCT04115423|Adalimumab|adalimumab|mesh-list
2815021|NCT04115423|Etanercept|etanercept|mesh-list
2815022|NCT04115423|Golimumab|golimumab|mesh-list
2815023|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
2815024|NCT04115423|Infliximab|infliximab|mesh-list
2815025|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2815026|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815027|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2815028|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2815029|NCT04115423|Analgesics|analgesics|mesh-ancestor
2282934|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2282935|NCT00234442|Gefitinib|gefitinib|mesh-list
2282936|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282937|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2282938|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282939|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282940|NCT00234455|Sirolimus|sirolimus|mesh-list
2282941|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2282942|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282943|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2282944|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282945|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
2282946|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2282947|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
2282948|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282949|NCT00234468|Gefitinib|gefitinib|mesh-list
2282950|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282951|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2282952|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815030|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
2282953|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282954|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
2282955|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2282956|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2282957|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2282958|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282959|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282960|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
2282961|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282962|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815031|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815032|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815033|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2815034|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815035|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
2815036|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
2815037|NCT04115774|Diphosphonates|diphosphonates|mesh-list
2815038|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2815039|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815040|NCT04115631|Cytarabine|cytarabine|mesh-list
2815041|NCT04115631|Rituximab|rituximab|mesh-list
2815042|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2815043|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2815044|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
2282963|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2282964|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282965|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
2282966|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2282967|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2282968|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2282969|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2282970|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282971|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
2815045|NCT04115631|Antibodies|antibodies|mesh-list
2815046|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
2815047|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2815048|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
2815049|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815050|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815051|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815052|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2815053|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
2815054|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815055|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
2282972|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282973|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282974|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2282975|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282976|NCT00234572|Lanreotide|lanreotide|mesh-list
2815056|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815057|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815058|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2815059|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
2815060|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
2815061|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2815062|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815063|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815064|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2815065|NCT04115449|Analgesics|analgesics|mesh-ancestor
2815066|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
2815067|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815068|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2815069|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2815070|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2815071|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
2815072|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2815073|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282977|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2282978|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
2282979|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2815074|NCT04115410|Gemcitabine|gemcitabine|mesh-list
2815075|NCT04115410|Cisplatin|cisplatin|mesh-list
2815076|NCT04115410|Carboplatin|carboplatin|mesh-list
2815077|NCT04115410|Docetaxel|docetaxel|mesh-list
2815078|NCT04115410|Pemetrexed|pemetrexed|mesh-list
2282980|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2282981|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2282982|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
2815079|NCT04115410|Vinorelbine|vinorelbine|mesh-list
2815080|NCT04115410|Gefitinib|gefitinib|mesh-list
2815081|NCT04115410|Mitomycins|mitomycins|mesh-list
2815082|NCT04115410|Mitomycin|mitomycin|mesh-list
2815083|NCT04115410|Vinblastine|vinblastine|mesh-list
2815084|NCT04115410|Afatinib|afatinib|mesh-list
2815085|NCT04115410|Osimertinib|osimertinib|mesh-list
2815086|NCT04115410|Crizotinib|crizotinib|mesh-list
2815087|NCT04115410|Ceritinib|ceritinib|mesh-list
2815088|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
2815089|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2815090|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2815091|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
2815092|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815093|NCT04115410|Antiviral Agents|antiviral agents|mesh-ancestor
2815094|NCT04115410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815095|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815096|NCT04115410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815097|NCT04115410|Immunologic Factors|immunologic factors|mesh-ancestor
2815098|NCT04115410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815099|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
2815100|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
2815101|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
2815102|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2815103|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2815104|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2815105|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2815106|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2815107|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
2815108|NCT04115462|Morphine|morphine|mesh-list
2815109|NCT04115462|Histamine|histamine|mesh-list
2815110|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
2815111|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2815112|NCT04115462|Narcotics|narcotics|mesh-ancestor
2815113|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815114|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815115|NCT04115462|Analgesics|analgesics|mesh-ancestor
2815116|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
2815117|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2282983|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
2282984|NCT00234637|Memantine|memantine|mesh-list
2282985|NCT00234637|Rivastigmine|rivastigmine|mesh-list
2282986|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2282987|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2282988|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
2282989|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2282990|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2282991|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2282992|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2282993|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2815118|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
2815119|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
2815120|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2815121|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815122|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
2815123|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2815124|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815125|NCT04116112|Hydralazine|hydralazine|mesh-list
2815126|NCT04116112|Labetalol|labetalol|mesh-list
2815127|NCT04116112|Nicardipine|nicardipine|mesh-list
2282994|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2282995|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2282996|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
2282997|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2282998|NCT00234637|Protective Agents|protective agents|mesh-ancestor
2282999|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2283000|NCT00234676|Estrogens|estrogens|mesh-ancestor
2283001|NCT00234676|Hormones|hormones|mesh-ancestor
2283002|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2283003|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283004|NCT00234689|Naltrexone|naltrexone|mesh-list
2283005|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2815128|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2815129|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
2815130|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2283006|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2283007|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283008|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
2283009|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283010|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
2283011|NCT00234819|Estrogens|estrogens|mesh-list
2283012|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2283013|NCT00234819|Hormones|hormones|mesh-ancestor
2283014|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2283015|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283016|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2283017|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2815131|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2815132|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
2815133|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2815134|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815135|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815136|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
2815137|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
2815138|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815139|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2815140|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2815141|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2815142|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2815143|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2815144|NCT04115189|Sunitinib|sunitinib|mesh-list
2815145|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815146|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2815147|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2815148|NCT04115189|Growth Substances|growth substances|mesh-ancestor
2815149|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815150|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
2815151|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2815152|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815153|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815154|NCT04115111|Durvalumab|durvalumab|mesh-list
2815155|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2815156|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815164|NCT04115163|Gemcitabine|gemcitabine|mesh-list
2815165|NCT04115163|Paclitaxel|paclitaxel|mesh-list
2815166|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2815167|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2104922|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104923|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
2104924|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
2104925|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
2104926|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104927|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2104928|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
2104929|NCT02446600|Antiviral Agents|antiviral agents|mesh-ancestor
2104930|NCT02446600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104931|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104932|NCT02446600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2104933|NCT02446600|Immunologic Factors|immunologic factors|mesh-ancestor
2104934|NCT02446600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104935|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2104936|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2104937|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2104938|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2104939|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2104940|NCT02446717|Ribavirin|ribavirin|mesh-list
2104941|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
2114042|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283018|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
2815168|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815169|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
2815170|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
2815171|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
2815172|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283019|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2283020|NCT00234845|Adalimumab|adalimumab|mesh-list
2283021|NCT00234845|Methotrexate|methotrexate|mesh-list
2283022|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2283023|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
2815173|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2815174|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
2815175|NCT04115163|Antiviral Agents|antiviral agents|mesh-ancestor
2815176|NCT04115163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815177|NCT04115163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815178|NCT04115163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815179|NCT04115163|Immunologic Factors|immunologic factors|mesh-ancestor
2815180|NCT04115163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815181|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
2815182|NCT04115020|Naltrexone|naltrexone|mesh-list
2283024|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2283025|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283026|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2283027|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
2283028|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283029|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283030|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
2283031|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283032|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2283033|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2283034|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
2283035|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2283036|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2283037|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283038|NCT00234858|Losartan|losartan|mesh-list
2283039|NCT00234858|Verapamil|verapamil|mesh-list
2283040|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2283041|NCT00234858|Trandolapril|trandolapril|mesh-list
2283042|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2283043|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2283044|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2283045|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2283046|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283047|NCT00234858|Diuretics|diuretics|mesh-ancestor
2283048|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
2283049|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283050|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2283051|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2283052|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2283053|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2283054|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
2283055|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2283056|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
2283057|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815183|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2815184|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2815185|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815186|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
2815187|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815188|NCT04115072|Praziquantel|praziquantel|mesh-list
2815189|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
2815190|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2815191|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815192|NCT04114890|Tenofovir|tenofovir|mesh-list
2815193|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
2815194|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815195|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2815196|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2815197|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815198|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815199|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2815200|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2815201|NCT04114643|Thrombin|thrombin|mesh-list
2815202|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
2815203|NCT04114643|Coagulants|coagulants|mesh-ancestor
2815204|NCT04114630|Erenumab|erenumab|mesh-list
2283058|NCT00234871|Verapamil|verapamil|mesh-list
2283059|NCT00234871|Amlodipine|amlodipine|mesh-list
2815205|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2815206|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815207|NCT04114630|Analgesics|analgesics|mesh-ancestor
2815208|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
2815209|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815210|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815211|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
2815212|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815213|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2815214|NCT04114383|Protective Agents|protective agents|mesh-ancestor
2815215|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815216|NCT04114526|Nicotine|nicotine|mesh-list
2815217|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2815218|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
2815219|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815220|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815221|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2815222|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2815223|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
2815224|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2815225|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815226|NCT04114461|Tofacitinib|tofacitinib|mesh-list
2815227|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815228|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2815229|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815230|NCT04114396|Antibodies|antibodies|mesh-list
2815231|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
2815232|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815233|NCT04114188|Prednisolone|prednisolone|mesh-list
2283060|NCT00234871|Benazepril|benazepril|mesh-list
2283061|NCT00234871|Trandolapril|trandolapril|mesh-list
2283062|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2283063|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2283064|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2283065|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815234|NCT04114188|Infliximab|infliximab|mesh-list
2815235|NCT04114188|Tacrolimus|tacrolimus|mesh-list
2815236|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
2815237|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2815238|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
2815239|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2815240|NCT04114188|Antibodies|antibodies|mesh-list
2815241|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815242|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
2815243|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815244|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2815245|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815246|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815247|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2815248|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
2815249|NCT04114188|Hormones|hormones|mesh-ancestor
2815250|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2815251|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2815252|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815253|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2815254|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
2815255|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815256|NCT04114136|Metformin|metformin|mesh-list
2815257|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
2815258|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
2815259|NCT04114136|Nivolumab|nivolumab|mesh-list
2815260|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2815261|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815262|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2815263|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815264|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2815265|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815266|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
2815267|NCT04114149|Narcotics|narcotics|mesh-ancestor
2815268|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815269|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815270|NCT04114149|Analgesics|analgesics|mesh-ancestor
2815271|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
2815272|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815273|NCT04113772|Nitisinone|nitisinone|mesh-list
2815274|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815275|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815276|NCT04113863|Anastrozole|anastrozole|mesh-list
2815277|NCT04113863|Tretinoin|tretinoin|mesh-list
2815278|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2815279|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815280|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2815281|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2815282|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815283|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815284|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2815285|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
2815286|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2815287|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815288|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
2815289|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
2815290|NCT04113954|Prilocaine|prilocaine|mesh-list
2815291|NCT04113954|Mepivacaine|mepivacaine|mesh-list
2815292|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
2815293|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
2815294|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815295|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815296|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
2815297|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815298|NCT04113915|Cyclosporine|cyclosporine|mesh-list
2815299|NCT04113915|Dexamethasone|dexamethasone|mesh-list
2815300|NCT04113915|Cyclosporins|cyclosporins|mesh-list
2815301|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2815302|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
2815303|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
2815304|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815305|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815306|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2815307|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
2815308|NCT04113915|Hormones|hormones|mesh-ancestor
2815309|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2815310|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2815311|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815312|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815313|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815314|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
2815315|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815316|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815317|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
2815318|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815319|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
2815320|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2815321|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
2815322|NCT04113889|Metformin|metformin|mesh-list
2815323|NCT04113889|Pioglitazone|pioglitazone|mesh-list
2815324|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283066|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2283067|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283068|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
2283069|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2283070|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2283071|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
2283072|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283073|NCT00234897|Adalimumab|adalimumab|mesh-list
2283074|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283075|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2283076|NCT00234910|Ritonavir|ritonavir|mesh-list
2283077|NCT00234910|Lopinavir|lopinavir|mesh-list
2283078|NCT00234910|Tenofovir|tenofovir|mesh-list
2815325|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815326|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
2815327|NCT04113889|Vitamins|vitamins|mesh-ancestor
2815328|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
2815329|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
2815330|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
2815331|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
2815332|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815333|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2815334|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815335|NCT04114097|Betamethasone|betamethasone|mesh-list
2283079|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2815336|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
2815337|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2815338|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
2815339|NCT04114097|Tacrolimus|tacrolimus|mesh-list
2815340|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2815341|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815342|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
2815343|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815344|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2815345|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815346|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815347|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2815348|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
2815349|NCT04114097|Hormones|hormones|mesh-ancestor
2815350|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2815351|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2815352|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
2815353|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2815354|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2815355|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815356|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815357|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2815358|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2815359|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815360|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
2815361|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2815362|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
2815363|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2815364|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2815365|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
2815366|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2815367|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815368|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2815369|NCT04113668|Diflunisal|diflunisal|mesh-list
2283080|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2283081|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
2283082|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283083|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283084|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2283085|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2283086|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
2283087|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283088|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2815370|NCT04113668|BMS-986165|bms-986165|mesh-list
2815371|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
2815372|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2815373|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815374|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815375|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2283089|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2283090|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2283091|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2283092|NCT00234923|Ritonavir|ritonavir|mesh-list
2815376|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2815377|NCT04113668|Analgesics|analgesics|mesh-ancestor
2815378|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
2815379|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815380|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815381|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2815382|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815383|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2815384|NCT04113616|Cytarabine|cytarabine|mesh-list
2815385|NCT04113616|Decitabine|decitabine|mesh-list
2815386|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2815387|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
2815388|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815389|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815390|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
2815391|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815392|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815393|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
2815394|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283093|NCT00234923|Lopinavir|lopinavir|mesh-list
2283094|NCT00234923|Lamivudine|lamivudine|mesh-list
2283095|NCT00234923|Zidovudine|zidovudine|mesh-list
2283096|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2283097|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2104942|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104943|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
2104944|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104945|NCT02446886|Hormones|hormones|mesh-list
2104946|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2104947|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2815395|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815396|NCT04113551|Guanfacine|guanfacine|mesh-list
2815397|NCT04113551|Methylphenidate|methylphenidate|mesh-list
2815398|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2815399|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2815400|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2815401|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2815402|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815403|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
2815404|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2815405|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815406|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2815407|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2815408|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
2815409|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2815410|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2815411|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2815412|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2815413|NCT04113317|Lenograstim|lenograstim|mesh-list
2815414|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2815415|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
2815416|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815417|NCT04113538|Aflibercept|aflibercept|mesh-list
2815418|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2815419|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2815420|NCT04113538|Growth Substances|growth substances|mesh-ancestor
2815421|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815422|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
2815423|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815424|NCT04113226|Rituximab|rituximab|mesh-list
2815425|NCT04113226|Lenalidomide|lenalidomide|mesh-list
2815426|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2815427|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815428|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
2815429|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815430|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815431|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2815432|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2815433|NCT04113226|Growth Substances|growth substances|mesh-ancestor
2815434|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
2815435|NCT04113109|Icatibant|icatibant|mesh-list
2815436|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2815437|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2283098|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2283099|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
2283100|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283101|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283102|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2283103|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2283104|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
2283105|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283106|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2283107|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2283108|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2104948|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
2104949|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2104950|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104951|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104952|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104953|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
2104954|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2104955|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2104956|NCT02447029|Lidocaine|lidocaine|mesh-list
2104957|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
2104958|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
2815438|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815439|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2815440|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2815441|NCT04113109|Analgesics|analgesics|mesh-ancestor
2815442|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
2815443|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815444|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815445|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2815446|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815447|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
2815448|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
2815449|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2815450|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815451|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
2815452|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2815453|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
2815454|NCT04113005|Coagulants|coagulants|mesh-ancestor
2815455|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2815456|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
2815457|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815458|NCT04113018|Dexamethasone|dexamethasone|mesh-list
2815459|NCT04113018|Lenalidomide|lenalidomide|mesh-list
2815460|NCT04113018|Daratumumab|daratumumab|mesh-list
2815461|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2815462|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
2815463|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
2815464|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815465|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815466|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2815467|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
2815468|NCT04113018|Hormones|hormones|mesh-ancestor
2815469|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2815470|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2815471|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815472|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
2815473|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2815474|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2815475|NCT04113018|Growth Substances|growth substances|mesh-ancestor
2815476|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
2815477|NCT04113187|Propranolol|propranolol|mesh-list
2815478|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2815479|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2815480|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
2815481|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2815482|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815483|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815484|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2815485|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2815486|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
2815487|NCT04112823|Dexamethasone|dexamethasone|mesh-list
2815488|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
2815489|NCT04112823|BB 1101|bb 1101|mesh-list
2815490|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2815491|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
2815492|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
2815493|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815494|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815495|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2283109|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2283110|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
2283111|NCT00234936|Adalimumab|adalimumab|mesh-list
2283112|NCT00234936|Methotrexate|methotrexate|mesh-list
2283113|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2283114|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
2283115|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2283116|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815496|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
2815497|NCT04112823|Hormones|hormones|mesh-ancestor
2815498|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2815499|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2815500|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283117|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2815501|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
2815502|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815503|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815504|NCT04112589|Cytarabine|cytarabine|mesh-list
2815505|NCT04112589|Fludarabine|fludarabine|mesh-list
2815506|NCT04112589|Idarubicin|idarubicin|mesh-list
2815507|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815508|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2815509|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
2815510|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815511|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815512|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
2815513|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815514|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
2815515|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815516|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2815517|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2815518|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2815519|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815520|NCT04112550|Acetaminophen|acetaminophen|mesh-list
2815521|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2815522|NCT04112550|Oxycodone|oxycodone|mesh-list
2815523|NCT04112550|Methadone|methadone|mesh-list
2815524|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2815525|NCT04112550|Analgesics|analgesics|mesh-ancestor
2815526|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
2815527|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815528|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815529|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
2815530|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2815531|NCT04112550|Narcotics|narcotics|mesh-ancestor
2815532|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815533|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
2815534|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
2815535|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2815536|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2815537|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815538|NCT04112212|Vedolizumab|vedolizumab|mesh-list
2815539|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2815540|NCT04112368|Estradiol|estradiol|mesh-list
2815541|NCT04112368|Progesterone|progesterone|mesh-list
2815542|NCT04112368|Estrogens|estrogens|mesh-ancestor
2815543|NCT04112368|Hormones|hormones|mesh-ancestor
2815544|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2815545|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815546|NCT04112368|Progestins|progestins|mesh-ancestor
2815547|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2815548|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
2815549|NCT04112095|Norgestrel|norgestrel|mesh-list
2815550|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2815551|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2815552|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2815553|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
2815554|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2815555|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283118|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
2283119|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283120|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283121|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
2283122|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283123|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2283124|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815556|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2815557|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2815558|NCT04112147|Ubiquinone|ubiquinone|mesh-list
2815559|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
2815560|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815561|NCT04112043|Niacinamide|niacinamide|mesh-list
2815562|NCT04112043|Niacin|niacin|mesh-list
2815563|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
2815564|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
2815565|NCT04112043|Vitamins|vitamins|mesh-ancestor
2815566|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
2815567|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283125|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
2283126|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2283127|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2283128|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283129|NCT00234949|Cephalexin|cephalexin|mesh-list
2283130|NCT00234949|Cefdinir|cefdinir|mesh-list
2283131|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2283132|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283133|NCT00234962|Ritonavir|ritonavir|mesh-list
2283134|NCT00234962|Lopinavir|lopinavir|mesh-list
2283135|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2283136|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2815568|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2815569|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
2815570|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815571|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2815572|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
2815573|NCT04112498|Nivolumab|nivolumab|mesh-list
2815574|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2815575|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815576|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2815577|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815578|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
2815579|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2815580|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
2815581|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283137|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
2283138|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283139|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283140|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2283141|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2283142|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
2815592|NCT04112394|Anesthetics|anesthetics|mesh-list
2815593|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
2815594|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815595|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815596|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
2815597|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815598|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
2815599|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2815600|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815601|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815602|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2815603|NCT04111926|Analgesics|analgesics|mesh-ancestor
2815604|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
2815605|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815606|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2815607|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2815608|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2815609|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
2815610|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2815611|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283143|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283144|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2283145|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2283146|NCT00234975|Ritonavir|ritonavir|mesh-list
2283147|NCT00234975|Lopinavir|lopinavir|mesh-list
2283148|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2283149|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2283150|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
2283151|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815625|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
2815626|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2815627|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2815628|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815629|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
2815630|NCT04111822|Coagulants|coagulants|mesh-ancestor
2815631|NCT04111614|Tofacitinib|tofacitinib|mesh-list
2815632|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2283152|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283153|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2283154|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2283155|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
2283156|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283157|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2283158|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2283159|NCT00234988|Sibutramine|sibutramine|mesh-list
2283160|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
2283161|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2283162|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
2283163|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2283164|NCT00235001|Verapamil|verapamil|mesh-list
2283165|NCT00235001|Trandolapril|trandolapril|mesh-list
2283166|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2283167|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2283168|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2283169|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283170|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2283171|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283172|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
2283173|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2283174|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
2815633|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815634|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815635|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
2815636|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2815637|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2815638|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
2815639|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815640|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815641|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2815642|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
2815643|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2815644|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
2815645|NCT04111484|Protective Agents|protective agents|mesh-ancestor
2815646|NCT04111432|Vaccines|vaccines|mesh-list
2815647|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
2815648|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815649|NCT04111328|Sufentanil|sufentanil|mesh-list
2815650|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
2815651|NCT04111328|Dsuvia|dsuvia|mesh-list
2815652|NCT04111328|Hydromorphone|hydromorphone|mesh-list
2815653|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2815654|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815655|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815656|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2815657|NCT04111328|Analgesics|analgesics|mesh-ancestor
2815658|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
2815659|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815660|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2815661|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2815662|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2815663|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
2104959|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2104960|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104961|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
2104962|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104963|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2104964|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2104965|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2104966|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2104967|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104968|NCT02447172|Gentamicins|gentamicins|mesh-list
2104969|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2104970|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2104971|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2104972|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2104973|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104974|NCT02447250|Albuterol|albuterol|mesh-list
2283175|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283176|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2283177|NCT00235014|Verapamil|verapamil|mesh-list
2283178|NCT00235014|Trandolapril|trandolapril|mesh-list
2283179|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2283180|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2283181|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2283182|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815664|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2815665|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815666|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2815667|NCT04111328|Narcotics|narcotics|mesh-ancestor
2815668|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2815669|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2815670|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
2815671|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
2815672|NCT04111159|Propofol|propofol|mesh-list
2815673|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2815674|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815675|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815676|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2815677|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
2815678|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
2815679|NCT04111315|Dipyrone|dipyrone|mesh-list
2815680|NCT04111315|Ibuprofen|ibuprofen|mesh-list
2815681|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2815682|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2815683|NCT04111315|Analgesics|analgesics|mesh-ancestor
2283183|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2283184|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283185|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
2283186|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2283187|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
2283188|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283189|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2283190|NCT00235053|Fluticasone|fluticasone|mesh-list
2283191|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2283192|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2283193|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283194|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2283195|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
2283196|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283197|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283198|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2283199|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
2283200|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
2283201|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2283202|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2283203|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2283204|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2283205|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
2283206|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283207|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283208|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
2283209|NCT00235053|Hormones|hormones|mesh-ancestor
2815684|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
2815685|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815686|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815687|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2815688|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815689|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2815690|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815691|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815692|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
2815693|NCT04111302|Dezocine|dezocine|mesh-list
2815694|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2815695|NCT04111302|Narcotics|narcotics|mesh-ancestor
2815696|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815697|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815698|NCT04111302|Analgesics|analgesics|mesh-ancestor
2815699|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
2815700|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815701|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2815702|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2815703|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
2815704|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2815705|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815706|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815707|NCT04111848|Ketamine|ketamine|mesh-list
2815708|NCT04111848|Analgesics|analgesics|mesh-ancestor
2815709|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
2815710|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815711|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815712|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2815713|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2815714|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
2815715|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
2815716|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815717|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2815718|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2815719|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2815720|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815721|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
2815722|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
2815723|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815724|NCT04111003|Anesthetics|anesthetics|mesh-list
2283210|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2283211|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
2283212|NCT00235079|Colchicine|colchicine|mesh-list
2283213|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
2283214|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815725|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283215|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
2283216|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
2283217|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
2283218|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283219|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283220|NCT00235092|Sirolimus|sirolimus|mesh-list
2283221|NCT00235092|Paclitaxel|paclitaxel|mesh-list
2283222|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2283223|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283224|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
2283225|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
2283226|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
2283227|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283228|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2815726|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104975|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2104976|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
2104977|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2104978|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2104979|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2104980|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
2104981|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
2104982|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2104983|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2104984|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2104985|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2104986|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
2104987|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2104988|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104989|NCT02447328|Fulvestrant|fulvestrant|mesh-list
2104990|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2104991|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815727|NCT04110665|Acetaminophen|acetaminophen|mesh-list
2815728|NCT04110665|Morphine|morphine|mesh-list
2815729|NCT04110665|Oxycodone|oxycodone|mesh-list
2815730|NCT04110665|Tramadol|tramadol|mesh-list
2815731|NCT04110665|Nefopam|nefopam|mesh-list
2815732|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2815733|NCT04110665|Narcotics|narcotics|mesh-ancestor
2815734|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815735|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815736|NCT04110665|Analgesics|analgesics|mesh-ancestor
2815737|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
2815738|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815739|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2815740|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
2815741|NCT04110873|Ubiquinone|ubiquinone|mesh-list
2815742|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
2815743|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815744|NCT04110834|Itraconazole|itraconazole|mesh-list
2815745|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
2815746|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
2815747|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815748|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2815749|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2815750|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815751|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815752|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2815753|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
2815754|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2815755|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815756|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2815757|NCT04110860|Voriconazole|voriconazole|mesh-list
2815758|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
2815759|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815760|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2815761|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2815762|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815763|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815764|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2815765|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
2815766|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2815767|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815768|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2815769|NCT04110808|Phentolamine|phentolamine|mesh-list
2815770|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
2815771|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
2815772|NCT04110808|Anesthetics|anesthetics|mesh-list
2815773|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815774|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815775|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
2815776|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2815777|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2815778|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
2283229|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283230|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2283231|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
2815779|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2815780|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283232|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2283233|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
2283234|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283235|NCT00235105|Adalimumab|adalimumab|mesh-list
2283236|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283237|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2283238|NCT00235144|Sirolimus|sirolimus|mesh-list
2283239|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2283240|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283241|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2283242|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283243|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
2815781|NCT04111380|Paclitaxel|paclitaxel|mesh-list
2815782|NCT04111380|Cisplatin|cisplatin|mesh-list
2815783|NCT04111380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2815784|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2815785|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815786|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
2815787|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
2815788|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
2815789|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815790|NCT04111289|Tirofiban|tirofiban|mesh-list
2815791|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2815792|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2815793|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815794|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2815795|NCT04110535|Midazolam|midazolam|mesh-list
2815796|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2815797|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2815798|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815799|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815800|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2815801|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2815802|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2815803|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2815804|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
2815805|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
2815806|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
2815807|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
2815808|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2815809|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815810|NCT04110418|Terlipressin|terlipressin|mesh-list
2815811|NCT04110418|Methylene Blue|methylene blue|mesh-list
2815812|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815813|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815814|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2815815|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2815816|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
2815817|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
2815818|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2283244|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2283245|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
2283246|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283247|NCT00235157|Sirolimus|sirolimus|mesh-list
2283248|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2283249|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283250|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2283251|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283252|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
2283253|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2283254|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
2283255|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283256|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
2815819|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2283257|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2283258|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
2283259|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2283260|NCT00235222|Stavudine|stavudine|mesh-list
2283261|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
2283262|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283263|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2283264|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2283265|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283266|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
2283267|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283268|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2283269|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2283270|NCT00235235|Gemcitabine|gemcitabine|mesh-list
2815820|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815821|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815822|NCT04110444|Urological Agents|urological agents|mesh-ancestor
2815823|NCT04110314|Vaccines|vaccines|mesh-list
2815824|NCT04110314|Immunologic Factors|immunologic factors|mesh-ancestor
2815825|NCT04110314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815826|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2283271|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
2283272|NCT00235235|Doxorubicin|doxorubicin|mesh-list
2283273|NCT00235235|Capecitabine|capecitabine|mesh-list
2283274|NCT00235235|Vinorelbine|vinorelbine|mesh-list
2815827|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2283275|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2283276|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
2283277|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283278|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2283279|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2283280|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
2283281|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283282|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283283|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2283284|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2283285|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
2283286|NCT00235235|Antiviral Agents|antiviral agents|mesh-ancestor
2283287|NCT00235235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815828|NCT04110587|Analgesics|analgesics|mesh-list
2815829|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
2815830|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815831|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2815832|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
2815833|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815834|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
2815835|NCT04110587|Protective Agents|protective agents|mesh-ancestor
2815836|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
2815837|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815838|NCT04110132|Bupivacaine|bupivacaine|mesh-list
2815839|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
2815840|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
2815841|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815842|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815843|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
2815844|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815845|NCT04110028|Niacinamide|niacinamide|mesh-list
2815846|NCT04110028|Niacin|niacin|mesh-list
2815847|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
2815848|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
2815849|NCT04110028|Vitamins|vitamins|mesh-ancestor
2815850|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
2815851|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815852|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2283288|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283289|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2283290|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2283291|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2283292|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2283293|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
2283294|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
2283295|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
2815853|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
2815854|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815855|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2815856|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
2815857|NCT04110080|Anesthetics|anesthetics|mesh-list
2815858|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815859|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815860|NCT04110210|Morphine|morphine|mesh-list
2815861|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2815862|NCT04110210|Narcotics|narcotics|mesh-ancestor
2815863|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2815864|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815865|NCT04110210|Analgesics|analgesics|mesh-ancestor
2815866|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
2815867|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815868|NCT04110301|Lenalidomide|lenalidomide|mesh-list
2815869|NCT04110301|Antibodies|antibodies|mesh-list
2815870|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2815871|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
2815872|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815873|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2815874|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2815875|NCT04110301|Growth Substances|growth substances|mesh-ancestor
2815876|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
2815877|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815878|NCT04110288|Paclitaxel|paclitaxel|mesh-list
2815879|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2815880|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815881|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
2815882|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
2815883|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
2815884|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815885|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
2815886|NCT04110340|Streptomycin|streptomycin|mesh-list
2815887|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2815888|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815889|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2815890|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2815891|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815892|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815893|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815894|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2815895|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2815896|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2815897|NCT04110275|Plasminogen|plasminogen|mesh-list
2815898|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2815899|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2815900|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2815901|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815902|NCT04110145|Linaclotide|linaclotide|mesh-list
2815903|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2815904|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
2815905|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815906|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2815907|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2815908|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283296|NCT00235248|Aspirin|aspirin|mesh-list
2283297|NCT00235248|Warfarin|warfarin|mesh-list
2283298|NCT00235248|Clopidogrel|clopidogrel|mesh-list
2283299|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2283300|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2104992|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2104993|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2104994|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
2104995|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2104996|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815909|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815910|NCT04110119|Diclofenac|diclofenac|mesh-list
2815911|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2815912|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2815913|NCT04110119|Analgesics|analgesics|mesh-ancestor
2815914|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
2815915|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815916|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815917|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2815918|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815919|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2815920|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815921|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815922|NCT04109872|Lenalidomide|lenalidomide|mesh-list
2283301|NCT00235248|Analgesics|analgesics|mesh-ancestor
2283302|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
2283303|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283304|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283305|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283306|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2283307|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2283308|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2283309|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2104997|NCT02447432|Vaccines|vaccines|mesh-list
2104998|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2104999|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
2105000|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105001|NCT02447718|Vaccines|vaccines|mesh-list
2105002|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2105003|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
2105004|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105005|NCT02447848|Sufentanil|sufentanil|mesh-list
2105006|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2105007|NCT02447848|Narcotics|narcotics|mesh-ancestor
2105008|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105009|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815923|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
2283310|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2283311|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2283312|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283313|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
2283314|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2283315|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2283316|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2283317|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
2283318|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283319|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
2283320|NCT00235261|Dexamethasone|dexamethasone|mesh-list
2283321|NCT00235261|Pregabalin|pregabalin|mesh-list
2815924|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815925|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2815926|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2815927|NCT04109872|Growth Substances|growth substances|mesh-ancestor
2815928|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
2815929|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815930|NCT04109742|Curcumin|curcumin|mesh-list
2815931|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2815932|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2815933|NCT04109742|Analgesics|analgesics|mesh-ancestor
2815934|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
2815935|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2815936|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815937|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2815938|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815939|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815940|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815941|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815942|NCT04109729|Nivolumab|nivolumab|mesh-list
2815943|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2815944|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815945|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2815946|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815947|NCT04109859|Methylene Blue|methylene blue|mesh-list
2815948|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815949|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815950|NCT04109924|Trifluridine|trifluridine|mesh-list
2815951|NCT04109924|Bevacizumab|bevacizumab|mesh-list
2815952|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2815953|NCT04109924|Irinotecan|irinotecan|mesh-list
2815954|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
2815955|NCT04109924|Antibodies|antibodies|mesh-list
2815956|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
2815957|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2815958|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815959|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2815960|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2815961|NCT04109924|Growth Substances|growth substances|mesh-ancestor
2815962|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815963|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
2815964|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
2815965|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2815966|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2815967|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815968|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815969|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
2815970|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
2815971|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2815972|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2815973|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2815974|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105010|NCT02447848|Analgesics|analgesics|mesh-ancestor
2105011|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
2105012|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105013|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2105014|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2815975|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
2105015|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
2105016|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
2105017|NCT02447991|Rizatriptan|rizatriptan|mesh-list
2105018|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2105019|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
2105020|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283322|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283323|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
2283324|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
2283325|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283326|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283327|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2283328|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
2283329|NCT00235261|Hormones|hormones|mesh-ancestor
2283330|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2283331|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2283332|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283333|NCT00235261|Analgesics|analgesics|mesh-ancestor
2283334|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
2283335|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
2283336|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2283337|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2283338|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283339|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2283340|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2283341|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2283342|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283343|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2283344|NCT00235274|Secretin|secretin|mesh-list
2283345|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2283346|NCT00235274|Hormones|hormones|mesh-ancestor
2283347|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2283348|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283349|NCT00235287|Candesartan|candesartan|mesh-list
2283350|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
2283351|NCT00235287|Enalapril|enalapril|mesh-list
2283352|NCT00235287|Enalaprilat|enalaprilat|mesh-list
2283353|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2283354|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2283355|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2283356|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283357|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2283358|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
2283359|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283360|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
2283361|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2815976|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2815977|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815978|NCT04109261|Palbociclib|palbociclib|mesh-list
2815979|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815980|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2815981|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2815982|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815983|NCT04109339|Oxytocin|oxytocin|mesh-list
2815984|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
2815985|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2815986|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815987|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
2283362|NCT00235300|Basiliximab|basiliximab|mesh-list
2283363|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
2283364|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283365|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2283366|NCT00235313|Nicotine|nicotine|mesh-list
2283367|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2283368|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
2283369|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283370|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283371|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2283372|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2283373|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
2283374|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283375|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283376|NCT00235508|Eszopiclone|eszopiclone|mesh-list
2283377|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2283378|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283379|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283380|NCT00235521|Iloprost|iloprost|mesh-list
2283381|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2283382|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
2283383|NCT00235560|Sirolimus|sirolimus|mesh-list
2815988|NCT04109482|Fludarabine|fludarabine|mesh-list
2815989|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2815990|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
2815991|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2815992|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2815993|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2815994|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
2283384|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2283385|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283386|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2283387|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283388|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
2283389|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2283390|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
2283391|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283392|NCT00235651|Amphotericin B|amphotericin b|mesh-list
2283393|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2283394|NCT00235651|Amebicides|amebicides|mesh-ancestor
2283395|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2815995|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2815996|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2815997|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2816001|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
2816002|NCT04109534|Miotics|miotics|mesh-ancestor
2816003|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
2816004|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816005|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816006|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2816007|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2816008|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
2816009|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2816010|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2283396|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2283397|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283398|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2283399|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
2283400|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
2283401|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2283402|NCT00235729|Lofexidine|lofexidine|mesh-list
2283403|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2283404|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2283405|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283406|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
2283407|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283408|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2283409|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2283410|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2283411|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
2283412|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283413|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283414|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
2283415|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
2283416|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283417|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2283418|NCT00235794|Sirolimus|sirolimus|mesh-list
2283419|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2283420|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283421|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2283422|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283423|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
2283424|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2283425|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
2816011|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
2816012|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816013|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816014|NCT04108897|Doxycycline|doxycycline|mesh-list
2816015|NCT04108897|Ivermectin|ivermectin|mesh-list
2816016|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2816017|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2816018|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
2816019|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2816020|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2283426|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283427|NCT00235820|Adalimumab|adalimumab|mesh-list
2816024|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2283428|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283429|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2283430|NCT00235859|Adalimumab|adalimumab|mesh-list
2283431|NCT00235859|Methotrexate|methotrexate|mesh-list
2283432|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2283433|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
2283434|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2283435|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283436|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2283437|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
2283438|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283439|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816025|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
2816026|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816027|NCT04108468|Golimumab|golimumab|mesh-list
2816028|NCT04108468|Methotrexate|methotrexate|mesh-list
2816029|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2816030|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
2816031|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2816032|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816033|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2816034|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
2816035|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816036|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816037|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
2816038|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816039|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2816040|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2816041|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
2816042|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2816043|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2816044|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2816045|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2816046|NCT04108676|Omeprazole|omeprazole|mesh-list
2816047|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2816048|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2816049|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2816050|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816051|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816052|NCT04108637|Penicillins|penicillins|mesh-list
2816053|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2816054|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2816055|NCT04108234|Ketamine|ketamine|mesh-list
2816056|NCT04108234|Analgesics|analgesics|mesh-ancestor
2816057|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
2816058|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816059|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816060|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2816061|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2816062|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
2816063|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
2816064|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816065|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2816066|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2816067|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816068|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816069|NCT04108039|Cetrorelix|cetrorelix|mesh-list
2283440|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
2283441|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283442|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2283443|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2283444|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
2283445|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2283446|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2283447|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283448|NCT00235885|Adalimumab|adalimumab|mesh-list
2283449|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283450|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2283451|NCT00235898|Leucovorin|leucovorin|mesh-list
2283452|NCT00235898|Fluorouracil|fluorouracil|mesh-list
2283453|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
2816070|NCT04108039|Progesterone|progesterone|mesh-list
2283454|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283455|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2283456|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283457|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2283458|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
2283459|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283460|NCT00235898|Antidotes|antidotes|mesh-ancestor
2283461|NCT00235898|Protective Agents|protective agents|mesh-ancestor
2283462|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
2283463|NCT00235898|Vitamins|vitamins|mesh-ancestor
2283464|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
2283465|NCT00235911|Budesonide|budesonide|mesh-list
2283466|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
2816071|NCT04108039|Ganirelix|ganirelix|mesh-list
2816072|NCT04108039|Progestins|progestins|mesh-ancestor
2816073|NCT04108039|Hormones|hormones|mesh-ancestor
2283467|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283468|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2283469|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
2283470|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283471|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283472|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2283473|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
2283474|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
2283475|NCT00235911|Hormones|hormones|mesh-ancestor
2283476|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2283477|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2283478|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2283479|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2816074|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2816075|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816076|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
2816077|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2816078|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
2816079|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2816080|NCT04108013|Paclitaxel|paclitaxel|mesh-list
2816081|NCT04108013|Carboplatin|carboplatin|mesh-list
2816082|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2283480|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
2283481|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283482|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283483|NCT00235937|Anastrozole|anastrozole|mesh-list
2283484|NCT00235937|Goserelin|goserelin|mesh-list
2283485|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2283486|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283487|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2283488|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2283489|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283490|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283491|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2816083|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816084|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
2816085|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
2816086|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
2816087|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816088|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
2816089|NCT04108104|Prazosin|prazosin|mesh-list
2816090|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2816091|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2816092|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2816093|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2816094|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
2816095|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816096|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816097|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816098|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
2816099|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
2816100|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2816101|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2816102|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
2816103|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
2816104|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2816105|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
2283492|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
2816106|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2816107|NCT04107896|Tamsulosin|tamsulosin|mesh-list
2816108|NCT04107896|Silodosin|silodosin|mesh-list
2816109|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2816110|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2816111|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2816112|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
2816113|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816114|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816115|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816116|NCT04107896|Urological Agents|urological agents|mesh-ancestor
2816117|NCT04108026|Durvalumab|durvalumab|mesh-list
2816118|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2816119|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816120|NCT04107805|Midazolam|midazolam|mesh-list
2816121|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2816122|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2816123|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816124|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816125|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2816126|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2816127|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2816128|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2816129|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
2816130|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
2816131|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
2816132|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
2816133|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816134|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816135|NCT04107740|TA 0910|ta 0910|mesh-list
2816136|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
2816137|NCT04107428|Somatostatin|somatostatin|mesh-list
2816138|NCT04107428|Hormones|hormones|mesh-ancestor
2816139|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2816140|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283493|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2283494|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283495|NCT00235950|Clopidogrel|clopidogrel|mesh-list
2283496|NCT00235950|Atorvastatin|atorvastatin|mesh-list
2283497|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2816141|NCT04107779|Menthol|menthol|mesh-list
2816142|NCT04107779|Nicotine|nicotine|mesh-list
2816143|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2816144|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
2816145|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816146|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816147|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2816148|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2816149|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
2816150|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816151|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816152|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
2816153|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
2816154|NCT04107675|Cyclosporine|cyclosporine|mesh-list
2816155|NCT04107675|Cyclosporins|cyclosporins|mesh-list
2816156|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816157|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816158|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2816159|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
2816160|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816161|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
2816162|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2816163|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
2816164|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2816165|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2283498|NCT00235950|Simvastatin|simvastatin|mesh-list
2283499|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2283500|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2283501|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
2283502|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283503|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2283504|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2283505|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283506|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2283507|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2283508|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2283509|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2283510|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
2816181|NCT04107480|Dopamine|dopamine|mesh-list
2816182|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
2816183|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2816184|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
2816185|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
2816186|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283511|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283512|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283513|NCT00235963|Simvastatin|simvastatin|mesh-list
2283514|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2283515|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2283516|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
2283517|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283518|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2283519|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2283520|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283521|NCT00236002|Alendronate|alendronate|mesh-list
2816187|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816188|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
2816189|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816190|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816191|NCT04107480|Protective Agents|protective agents|mesh-ancestor
2816192|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
2816193|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2816194|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816195|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816196|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2816197|NCT04106999|Analgesics|analgesics|mesh-ancestor
2816198|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
2816199|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816200|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2816201|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2816202|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2816203|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
2816204|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816205|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816217|NCT04107194|Amoxicillin|amoxicillin|mesh-list
2816218|NCT04107194|Metronidazole|metronidazole|mesh-list
2283522|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2283523|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283524|NCT00236015|Tiagabine|tiagabine|mesh-list
2283525|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
2283526|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
2283527|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2283528|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2283529|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283530|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
2283531|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283532|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283533|NCT00236028|Infliximab|infliximab|mesh-list
2283534|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
2283535|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2283536|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2283537|NCT00236054|Tiagabine|tiagabine|mesh-list
2283538|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
2283539|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
2283540|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2283541|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2283542|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283543|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
2816219|NCT04107194|Clarithromycin|clarithromycin|mesh-list
2816220|NCT04107194|Levofloxacin|levofloxacin|mesh-list
2816221|NCT04107194|Tetracycline|tetracycline|mesh-list
2816222|NCT04107194|Rifabutin|rifabutin|mesh-list
2816223|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
2816224|NCT04107194|Pantoprazole|pantoprazole|mesh-list
2816225|NCT04107194|Bismuth|bismuth|mesh-list
2816226|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2283544|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283545|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283546|NCT00236067|Tiagabine|tiagabine|mesh-list
2283547|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
2283548|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
2283549|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2283550|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2283551|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283552|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
2283553|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283554|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283555|NCT00236093|Fentanyl|fentanyl|mesh-list
2283556|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2283557|NCT00236093|Narcotics|narcotics|mesh-ancestor
2283558|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283559|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283560|NCT00236093|Analgesics|analgesics|mesh-ancestor
2283561|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
2283562|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283563|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2283564|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2283565|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
2283566|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
2816227|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2816228|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2283567|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
2283568|NCT00236106|Tacrolimus|tacrolimus|mesh-list
2283569|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2283570|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
2283571|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283572|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2283573|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816229|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2816230|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2816231|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816232|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816233|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2816234|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2816235|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2816236|NCT04107194|Renal Agents|renal agents|mesh-ancestor
2816237|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2283574|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816238|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2816239|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816240|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2816241|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2816242|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2816243|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2816244|NCT04107194|Antacids|antacids|mesh-ancestor
2816245|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2816246|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
2816247|NCT04107220|Valsartan|valsartan|mesh-list
2816248|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2816249|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2816250|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2816251|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816252|NCT04107103|Nivolumab|nivolumab|mesh-list
2816253|NCT04107103|Pemetrexed|pemetrexed|mesh-list
2816254|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2816255|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816256|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2816257|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816258|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816259|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2816260|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2816261|NCT04106856|Losartan|losartan|mesh-list
2816262|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2816263|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2816264|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2816265|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2816266|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816267|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
2816268|NCT04106830|Azathioprine|azathioprine|mesh-list
2816269|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816270|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
2816271|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816272|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2816273|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2816274|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2816275|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
2816276|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2816277|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2816278|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816279|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816280|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
2816281|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2283575|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283576|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
2283577|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2283578|NCT00236145|Fentanyl|fentanyl|mesh-list
2283579|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2283580|NCT00236145|Narcotics|narcotics|mesh-ancestor
2283581|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283582|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283583|NCT00236145|Analgesics|analgesics|mesh-ancestor
2283584|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
2283585|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283586|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2283587|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2283588|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
2283589|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
2283590|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
2283591|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283592|NCT00236223|Dexamethasone|dexamethasone|mesh-list
2283593|NCT00236223|Ketamine|ketamine|mesh-list
2283594|NCT00236223|Gabapentin|gabapentin|mesh-list
2283595|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2283596|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
2283597|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
2283598|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283599|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283600|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2816282|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2816283|NCT04106752|Caffeine|caffeine|mesh-list
2816284|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2816285|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283601|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
2283602|NCT00236223|Hormones|hormones|mesh-ancestor
2816286|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2816287|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816288|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816289|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2816290|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2816291|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
2816292|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816293|NCT04106700|Apixaban|apixaban|mesh-list
2816294|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2816295|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
2816296|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2816297|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
2816298|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816299|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816300|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
2816301|NCT04106804|Abatacept|abatacept|mesh-list
2816302|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2816303|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816304|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816305|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2816306|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
2816307|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816308|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2816309|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2816310|NCT04106557|Gaboxadol|gaboxadol|mesh-list
2816311|NCT04106557|Analgesics|analgesics|mesh-ancestor
2816312|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
2816313|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816314|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816315|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
2816316|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
2816317|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
2816318|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816319|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816320|NCT04106726|Ivermectin|ivermectin|mesh-list
2816321|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2816322|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2816323|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2816324|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816325|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2816326|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
2816327|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
2816328|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816329|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
2816330|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816331|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105021|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105022|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105023|NCT02448043|Bimatoprost|bimatoprost|mesh-list
2105024|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2105025|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
2105026|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
2816332|NCT04106362|Cisplatin|cisplatin|mesh-list
2816333|NCT04106362|Cetuximab|cetuximab|mesh-list
2816334|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2816335|NCT04106362|Antibodies|antibodies|mesh-list
2816336|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
2816337|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2816338|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
2816339|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816340|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816341|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
2283603|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2283604|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2283605|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283606|NCT00236223|Analgesics|analgesics|mesh-ancestor
2283607|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
2283608|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2283609|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2283610|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
2283611|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
2283612|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283613|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2283614|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2816342|NCT04105985|Tetracaine|tetracaine|mesh-list
2816343|NCT04105985|Carticaine|carticaine|mesh-list
2283615|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816344|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
2816345|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
2816346|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816347|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816348|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
2816349|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816350|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2816351|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2816352|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
2816353|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816354|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816355|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
2816356|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
2816357|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
2816358|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2816359|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
2816363|NCT04106011|Gabapentin|gabapentin|mesh-list
2283616|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283617|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
2283618|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2283619|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2283620|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2816364|NCT04106011|Analgesics|analgesics|mesh-ancestor
2816365|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
2816366|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816367|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816368|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
2816369|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2816370|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2816371|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816372|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2816373|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2816374|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2816375|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816376|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816377|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
2816378|NCT04106050|Lidocaine|lidocaine|mesh-list
2816379|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
2816380|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
2816381|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816382|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816383|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
2816384|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816385|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2816386|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2816387|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2816388|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2816389|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816390|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
2816391|NCT04105946|Remifentanil|remifentanil|mesh-list
2816392|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2816393|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816394|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816395|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2816396|NCT04105946|Analgesics|analgesics|mesh-ancestor
2816397|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
2283621|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
2283622|NCT00236249|Lidocaine|lidocaine|mesh-list
2283623|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
2283624|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
2283625|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283626|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283627|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
2283628|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283629|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2283630|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2283631|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2283632|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2283633|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816398|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816399|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2816400|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2105027|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2105028|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105029|NCT02448368|Verinurad|verinurad|mesh-list
2105030|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
2105031|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2105032|NCT02448446|Ranibizumab|ranibizumab|mesh-list
2105033|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2283634|NCT00236275|Telbivudine|telbivudine|mesh-list
2283635|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
2283636|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283637|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2283638|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283639|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283640|NCT00236288|Bupropion|bupropion|mesh-list
2816401|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2816402|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
2816403|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816404|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816405|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2816406|NCT04105946|Narcotics|narcotics|mesh-ancestor
2816407|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2816408|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
2816409|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2816410|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
2816411|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816412|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
2816413|NCT04105920|Protective Agents|protective agents|mesh-ancestor
2816414|NCT04105764|Bromides|bromides|mesh-list
2816415|NCT04105764|Rocuronium|rocuronium|mesh-list
2816416|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
2816417|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
2816418|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2816419|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2816420|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816421|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105034|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2105035|NCT02448446|Growth Substances|growth substances|mesh-ancestor
2105036|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105037|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
2105038|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105039|NCT02448537|Gemcitabine|gemcitabine|mesh-list
2105040|NCT02448537|Doxorubicin|doxorubicin|mesh-list
2105041|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2105042|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2105043|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
2105044|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105045|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105046|NCT02448537|Antiviral Agents|antiviral agents|mesh-ancestor
2105047|NCT02448537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105048|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105049|NCT02448537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2105050|NCT02448537|Immunologic Factors|immunologic factors|mesh-ancestor
2105051|NCT02448537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105052|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2105053|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2105054|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2105055|NCT02448654|Tolcapone|tolcapone|mesh-list
2105056|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2105057|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2816422|NCT04105374|Flucytosine|flucytosine|mesh-list
2816423|NCT04105374|Temozolomide|temozolomide|mesh-list
2816424|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2283641|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2283642|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
2283643|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2816425|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
2816426|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816427|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816428|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
2816429|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2816430|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
2816431|NCT04105426|Antioxidants|antioxidants|mesh-list
2816432|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816433|NCT04105426|Protective Agents|protective agents|mesh-ancestor
2816434|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816435|NCT04105140|Oxytocin|oxytocin|mesh-list
2816436|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
2816437|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2816438|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816439|NCT04105231|Cannabidiol|cannabidiol|mesh-list
2816440|NCT04105231|Risperidone|risperidone|mesh-list
2816441|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2816442|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
2816443|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816444|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816445|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816446|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2816447|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2816448|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816449|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2816450|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2816451|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
2816452|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
2816453|NCT04105205|Apramycin|apramycin|mesh-list
2816454|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2816455|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105058|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2105059|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105060|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105061|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
2105062|NCT02448771|Palbociclib|palbociclib|mesh-list
2105063|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105064|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2816456|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
2816457|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2816458|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816459|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
2816460|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2816461|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816462|NCT04105023|Genistein|genistein|mesh-list
2816463|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2816464|NCT04105023|Protective Agents|protective agents|mesh-ancestor
2816465|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816466|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816467|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2816468|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816469|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816470|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
2816471|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2816472|NCT04105023|Estrogens|estrogens|mesh-ancestor
2816473|NCT04105023|Hormones|hormones|mesh-ancestor
2816474|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2816475|NCT04105114|Buspirone|buspirone|mesh-list
2816476|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2105065|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105066|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105067|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2105068|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2105069|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
2105070|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2105071|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105072|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2816477|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2816478|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816479|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816480|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2816481|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2816482|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
2816483|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816484|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816485|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
2816486|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2816487|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816488|NCT04104867|Domperidone|domperidone|mesh-list
2816489|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
2816490|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
2816491|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816492|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816493|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2816494|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2816495|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
2816496|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816497|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816498|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
2816499|NCT04104984|Progesterone|progesterone|mesh-list
2816500|NCT04104984|Progestins|progestins|mesh-ancestor
2816501|NCT04104984|Hormones|hormones|mesh-ancestor
2816502|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2816503|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816504|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2816505|NCT04104646|Morphine|morphine|mesh-list
2816506|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2816507|NCT04104646|Narcotics|narcotics|mesh-ancestor
2816508|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816509|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816510|NCT04104646|Analgesics|analgesics|mesh-ancestor
2816511|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
2816512|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816513|NCT04104685|Minocycline|minocycline|mesh-list
2816514|NCT04104685|Adapalene|adapalene|mesh-list
2816515|NCT04104685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2816516|NCT04104685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2816517|NCT04104685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2816518|NCT04104685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2816519|NCT04104685|Analgesics|analgesics|mesh-ancestor
2816520|NCT04104685|Sensory System Agents|sensory system agents|mesh-ancestor
2816521|NCT04104685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816522|NCT04104685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816523|NCT04104685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2816524|NCT04104685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2816525|NCT04104685|Dermatologic Agents|dermatologic agents|mesh-ancestor
2816526|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
2816527|NCT04104789|Tetracaine|tetracaine|mesh-list
2816528|NCT04104789|Carticaine|carticaine|mesh-list
2816529|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
2816530|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
2816531|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816532|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816533|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
2816534|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816535|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2283644|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2283645|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2283646|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2283647|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283648|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
2283649|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105073|NCT02448810|Fluorouracil|fluorouracil|mesh-list
2105074|NCT02448810|Panitumumab|panitumumab|mesh-list
2105075|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
2105076|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105077|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2105078|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105079|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2105080|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
2283650|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283651|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2816536|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2816537|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
2816538|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816539|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816540|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
2816541|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
2816542|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
2816543|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2816544|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
2816545|NCT04104204|Morphine|morphine|mesh-list
2816546|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2816547|NCT04104204|Narcotics|narcotics|mesh-ancestor
2816548|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816549|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816550|NCT04104204|Analgesics|analgesics|mesh-ancestor
2816551|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
2816552|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816553|NCT04104178|Clindamycin|clindamycin|mesh-list
2816554|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
2816555|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
2816556|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2816557|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2816558|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2816559|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816560|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816561|NCT04104438|Everolimus|everolimus|mesh-list
2816562|NCT04104438|Basiliximab|basiliximab|mesh-list
2816563|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816564|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2816565|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
2816566|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283652|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2283653|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283654|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2283655|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2283656|NCT00236301|Estradiol|estradiol|mesh-list
2283657|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2283658|NCT00236301|Estrogens|estrogens|mesh-ancestor
2283659|NCT00236301|Hormones|hormones|mesh-ancestor
2283660|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2283661|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816567|NCT04104334|Remifentanil|remifentanil|mesh-list
2816568|NCT04104334|Desflurane|desflurane|mesh-list
2816569|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
2816570|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816571|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816572|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2816573|NCT04104334|Narcotics|narcotics|mesh-ancestor
2816574|NCT04104334|Analgesics|analgesics|mesh-ancestor
2816575|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
2816576|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816577|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2816578|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
2283662|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2283663|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
2283664|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2283665|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2283666|NCT00236327|Fentanyl|fentanyl|mesh-list
2283667|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2283668|NCT00236327|Narcotics|narcotics|mesh-ancestor
2283669|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283670|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283671|NCT00236327|Analgesics|analgesics|mesh-ancestor
2283672|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
2283673|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283674|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2283675|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2283676|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
2283677|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
2816579|NCT04103684|Dexamethasone|dexamethasone|mesh-list
2816580|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
2816581|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2816582|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2816583|NCT04103684|Prednisolone|prednisolone|mesh-list
2816584|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
2816585|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2816586|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
2816587|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2816588|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
2816589|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
2816590|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816591|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816592|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2816593|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
2816594|NCT04103684|Hormones|hormones|mesh-ancestor
2816595|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2816596|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2816597|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816598|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2283678|NCT00236353|Risperidone|risperidone|mesh-list
2283679|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2283680|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
2283681|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283682|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283683|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283684|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2283685|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2283686|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283687|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2283688|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2283689|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
2283690|NCT00236366|Fentanyl|fentanyl|mesh-list
2283691|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2283692|NCT00236366|Narcotics|narcotics|mesh-ancestor
2283693|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283694|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283695|NCT00236366|Analgesics|analgesics|mesh-ancestor
2283696|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
2816599|NCT04103684|Protective Agents|protective agents|mesh-ancestor
2283697|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816606|NCT04103905|Antibodies|antibodies|mesh-list
2283698|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2283699|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2283700|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
2283701|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
2283702|NCT00236379|Olanzapine|olanzapine|mesh-list
2283703|NCT00236379|Risperidone|risperidone|mesh-list
2283704|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2816607|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2816608|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
2816609|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283705|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
2283706|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283707|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283708|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283709|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2283710|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2816610|NCT04103697|Capecitabine|capecitabine|mesh-list
2816611|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
2816612|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2816613|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
2816614|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816615|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816616|NCT04103489|Eculizumab|eculizumab|mesh-list
2816617|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2816618|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2816619|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
2816620|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816621|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
2816622|NCT04103476|Estrogens|estrogens|mesh-list
2816623|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2816624|NCT04103476|Hormones|hormones|mesh-ancestor
2816625|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2816626|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816627|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2816628|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2816629|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
2816630|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2816631|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
2816632|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2816633|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2816634|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
2816635|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2816636|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2105081|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105082|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2105083|NCT02448862|Fentanyl|fentanyl|mesh-list
2105084|NCT02448862|Analgesics|analgesics|mesh-list
2105085|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2105086|NCT02448862|Narcotics|narcotics|mesh-ancestor
2105087|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105088|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105089|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
2105090|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105091|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2105092|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2105093|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
2105094|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
2105095|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2105096|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2105097|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
2105098|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105099|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2105100|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2105101|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
2105102|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
2105103|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105104|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105105|NCT02449044|Tolvaptan|tolvaptan|mesh-list
2105106|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2105107|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105108|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
2105109|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105110|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2105111|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2816637|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816638|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2816639|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816640|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2816641|NCT04103398|Sorafenib|sorafenib|mesh-list
2816642|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
2816643|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816644|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2816645|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816646|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816647|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2816648|NCT04103398|Estrogens|estrogens|mesh-ancestor
2816649|NCT04103398|Hormones|hormones|mesh-ancestor
2816650|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2816651|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816652|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2816653|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
2816654|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2816655|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
2816656|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816657|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
2816658|NCT04103125|Protective Agents|protective agents|mesh-ancestor
2816659|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2816660|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
2816661|NCT04103034|Coagulants|coagulants|mesh-ancestor
2816662|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2816663|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
2816664|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816665|NCT04102995|Pregnanolone|pregnanolone|mesh-list
2816666|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
2816667|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816668|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816669|NCT04102878|Anesthetics|anesthetics|mesh-list
2816670|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
2816671|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816672|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816673|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
2816674|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816675|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
2816676|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816677|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2816678|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
2816679|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
2816680|NCT04102670|Protective Agents|protective agents|mesh-ancestor
2816681|NCT04102800|Benralizumab|benralizumab|mesh-list
2816682|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2816683|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
2816684|NCT04102943|Tacrolimus|tacrolimus|mesh-list
2816685|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2816686|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
2816687|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816688|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2816689|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816690|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816691|NCT04102592|Permethrin|permethrin|mesh-list
2283711|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283712|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2283713|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2283714|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
2283715|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
2283716|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
2283717|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283718|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2283719|NCT00236379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2283720|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2283721|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2283722|NCT00236392|Rabeprazole|rabeprazole|mesh-list
2283723|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2283724|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2283725|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2283726|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283727|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816692|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816693|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283728|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
2283729|NCT00236405|Hematinics|hematinics|mesh-ancestor
2283730|NCT00236418|Topiramate|topiramate|mesh-list
2283731|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
2283732|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283733|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283734|NCT00236431|Galantamine|galantamine|mesh-list
2283735|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2283736|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283737|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283738|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
2283739|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283740|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283741|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2283742|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
2283743|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283744|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
2283745|NCT00236444|Risperidone|risperidone|mesh-list
2283746|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2283747|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
2283748|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283749|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283750|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283751|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2283752|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2283753|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283754|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2283755|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2283756|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
2283757|NCT00236457|Risperidone|risperidone|mesh-list
2283758|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2283759|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
2283760|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283761|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283762|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283763|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2283764|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2283765|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283766|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2283767|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2283768|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
2283769|NCT00236470|Risperidone|risperidone|mesh-list
2283770|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2283771|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
2283772|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283773|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816694|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
2816695|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2816696|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2283774|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283775|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2283776|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2283777|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283778|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2283779|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2283780|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
2283781|NCT00236483|Acetaminophen|acetaminophen|mesh-list
2283782|NCT00236483|Tramadol|tramadol|mesh-list
2283783|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2283784|NCT00236483|Analgesics|analgesics|mesh-ancestor
2283785|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
2283786|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283787|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283788|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
2283789|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2283790|NCT00236483|Narcotics|narcotics|mesh-ancestor
2283791|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283792|NCT00236496|Topiramate|topiramate|mesh-list
2283793|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
2283794|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283795|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283796|NCT00236509|Topiramate|topiramate|mesh-list
2283797|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
2283798|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283799|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283800|NCT00236522|Levofloxacin|levofloxacin|mesh-list
2283801|NCT00236522|Ofloxacin|ofloxacin|mesh-list
2283802|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2283803|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283804|NCT00236522|Renal Agents|renal agents|mesh-ancestor
2283805|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2283806|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2283807|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2283808|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283809|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816697|NCT04102267|Epinephrine|epinephrine|mesh-list
2816698|NCT04102267|Bupivacaine|bupivacaine|mesh-list
2816699|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
2816700|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
2816701|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816702|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816703|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
2816704|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816705|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2816706|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2816707|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
2816708|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816709|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816710|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2816711|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2816712|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
2816713|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2816714|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
2816715|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
2816716|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
2816717|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2816718|NCT04102449|Apremilast|apremilast|mesh-list
2816719|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2816720|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2816721|NCT04102449|Analgesics|analgesics|mesh-ancestor
2816722|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
2816723|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816724|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816725|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2816726|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2816727|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2816728|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2816729|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816730|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816731|NCT04102566|Ibuprofen|ibuprofen|mesh-list
2816732|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2105112|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105113|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2105114|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2105115|NCT02449902|Estradiol|estradiol|mesh-list
2105116|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2105117|NCT02449902|Estrogens|estrogens|mesh-ancestor
2105118|NCT02449902|Hormones|hormones|mesh-ancestor
2105119|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2105120|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283810|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283811|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2283812|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2283813|NCT00236535|Acetaminophen|acetaminophen|mesh-list
2283814|NCT00236535|Tramadol|tramadol|mesh-list
2283815|NCT00236535|Hydrocodone|hydrocodone|mesh-list
2283816|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2283817|NCT00236535|Analgesics|analgesics|mesh-ancestor
2283818|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
2283819|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283820|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283821|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
2283822|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2283823|NCT00236535|Narcotics|narcotics|mesh-ancestor
2283824|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816733|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2816734|NCT04102566|Analgesics|analgesics|mesh-ancestor
2816735|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
2816736|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816737|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816738|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2816739|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2816740|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2816741|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816742|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816743|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
2816744|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
2816745|NCT04102176|Protective Agents|protective agents|mesh-ancestor
2816746|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283825|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
2283826|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
2283827|NCT00236548|Risperidone|risperidone|mesh-list
2283828|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2283829|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
2283830|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816747|NCT04101877|Bevacizumab|bevacizumab|mesh-list
2816748|NCT04101877|Aflibercept|aflibercept|mesh-list
2816749|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2816750|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816751|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2816752|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2816753|NCT04101877|Growth Substances|growth substances|mesh-ancestor
2816754|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816755|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
2816756|NCT04101929|Irinotecan|irinotecan|mesh-list
2816757|NCT04101929|Apatinib|apatinib|mesh-list
2816758|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2816759|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2816760|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816761|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816762|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816763|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2816764|NCT04102072|Dobutamine|dobutamine|mesh-list
2816765|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2816766|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
2816767|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
2816768|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816769|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816770|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2816771|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2816772|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2816773|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
2816774|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816775|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816776|NCT04102072|Protective Agents|protective agents|mesh-ancestor
2816777|NCT04101838|Vaccines|vaccines|mesh-list
2816778|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
2816779|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816780|NCT04101812|Doxorubicin|doxorubicin|mesh-list
2816781|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2816782|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2816783|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816784|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2816785|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2816786|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816787|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816788|NCT04101500|Aminophylline|aminophylline|mesh-list
2816789|NCT04101500|Bromides|bromides|mesh-list
2816790|NCT04101500|Ipratropium|ipratropium|mesh-list
2816791|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
2816792|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2816793|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
2816794|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816795|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283831|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283832|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283833|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2283834|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2283835|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283836|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2283837|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2283838|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
2816796|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2816797|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
2816798|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2816799|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
2816800|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816801|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816802|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2816803|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2816804|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816805|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2816806|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2816807|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
2816808|NCT04101500|Protective Agents|protective agents|mesh-ancestor
2816809|NCT04101474|Ketamine|ketamine|mesh-list
2816810|NCT04101474|Analgesics|analgesics|mesh-ancestor
2816811|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
2816812|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816813|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816814|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2816815|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2816816|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
2816817|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
2816818|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816819|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2816820|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2283839|NCT00236561|Topiramate|topiramate|mesh-list
2283840|NCT00236561|Propranolol|propranolol|mesh-list
2283841|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2283842|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2283843|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
2283844|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283845|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283846|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283847|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2816821|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816822|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816823|NCT04101682|Bupivacaine|bupivacaine|mesh-list
2816824|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
2816825|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
2816826|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816827|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816828|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
2816829|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816830|NCT04101578|Cyclosporine|cyclosporine|mesh-list
2816831|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
2816832|NCT04101578|Prednisone|prednisone|mesh-list
2816833|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
2816834|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
2816835|NCT04101578|Methotrexate|methotrexate|mesh-list
2816836|NCT04101578|Azathioprine|azathioprine|mesh-list
2816837|NCT04101578|Bromides|bromides|mesh-list
2816838|NCT04101578|Tacrolimus|tacrolimus|mesh-list
2816839|NCT04101578|Cyclosporins|cyclosporins|mesh-list
2816840|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2816841|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
2283848|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2283849|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
2283850|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
2283851|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283852|NCT00236574|Galantamine|galantamine|mesh-list
2283853|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2283854|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283855|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283856|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
2283857|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283858|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283859|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2283860|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
2283861|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283862|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
2283863|NCT00236587|Risperidone|risperidone|mesh-list
2283864|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2283865|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
2283866|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283867|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283868|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816842|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2816843|NCT04101578|Antibodies|antibodies|mesh-list
2816844|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
2816845|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2816846|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2816847|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
2816848|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816849|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2816850|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2816851|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
2816852|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816853|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816854|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2816855|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2816856|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
2816857|NCT04101578|Hormones|hormones|mesh-ancestor
2816858|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2816859|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2816860|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2816861|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
2816862|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2816863|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2816864|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
2816865|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
2816866|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816867|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2816868|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2816869|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2816870|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
2816871|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2816872|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2816873|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2816874|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
2816875|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2283869|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2283870|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2283871|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283872|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2283873|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2283874|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
2283875|NCT00236600|Topiramate|topiramate|mesh-list
2283876|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
2283877|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283878|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283879|NCT00236613|Topiramate|topiramate|mesh-list
2283880|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
2283881|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283882|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283883|NCT00236626|Topiramate|topiramate|mesh-list
2283884|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
2283885|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283886|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283887|NCT00236639|Topiramate|topiramate|mesh-list
2816876|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
2816877|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
2816878|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816879|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2816880|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2816881|NCT04101578|Protective Agents|protective agents|mesh-ancestor
2816882|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
2816883|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2816884|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
2816885|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816886|NCT04101708|Amoxicillin|amoxicillin|mesh-list
2816887|NCT04101708|Clarithromycin|clarithromycin|mesh-list
2816888|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
2816889|NCT04101708|Lansoprazole|lansoprazole|mesh-list
2816890|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
2816891|NCT04101708|Bismuth|bismuth|mesh-list
2283888|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
2283889|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283890|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283891|NCT00236652|Levofloxacin|levofloxacin|mesh-list
2283892|NCT00236652|Ofloxacin|ofloxacin|mesh-list
2283893|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2283894|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2283895|NCT00236652|Renal Agents|renal agents|mesh-ancestor
2283896|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2816892|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2816893|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2816894|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2816895|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816896|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283897|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2283898|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2283899|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283900|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283901|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2283902|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2283903|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2283904|NCT00236665|Topiramate|topiramate|mesh-list
2283905|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
2283906|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283907|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283908|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
2816897|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2816898|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2816899|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2816900|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2816901|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2816902|NCT04101708|Antacids|antacids|mesh-ancestor
2816903|NCT04101760|Sargramostim|sargramostim|mesh-list
2816904|NCT04101760|Lenograstim|lenograstim|mesh-list
2816905|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
2816906|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816907|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2816908|NCT04101370|Bosentan|bosentan|mesh-list
2816909|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2816910|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2816911|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816912|NCT04101357|Carboplatin|carboplatin|mesh-list
2816913|NCT04101357|Etoposide|etoposide|mesh-list
2816914|NCT04101357|Atezolizumab|atezolizumab|mesh-list
2816915|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816916|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2816917|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2816918|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2816919|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816920|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816921|NCT04101227|Ondansetron|ondansetron|mesh-list
2816922|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
2816923|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
2816924|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816925|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816926|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2283909|NCT00236678|Hematinics|hematinics|mesh-ancestor
2283910|NCT00236691|Topiramate|topiramate|mesh-list
2283911|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
2283912|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283913|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283914|NCT00236704|Topiramate|topiramate|mesh-list
2283915|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
2816927|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
2816928|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
2816929|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2816930|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
2816931|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2816932|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816933|NCT04101227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2816934|NCT04101227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2816935|NCT04101227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816936|NCT04101227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2816937|NCT04101227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2816938|NCT04101136|Atorvastatin|atorvastatin|mesh-list
2816939|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2816940|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2816941|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
2816942|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816943|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2816944|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2816945|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816946|NCT04101019|Lidocaine|lidocaine|mesh-list
2816947|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
2283916|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283917|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283918|NCT00236717|Topiramate|topiramate|mesh-list
2283919|NCT00236717|Carbamazepine|carbamazepine|mesh-list
2283920|NCT00236717|Valproic Acid|valproic acid|mesh-list
2816948|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
2816949|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2816950|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816951|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
2816952|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2816953|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2816954|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2816955|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2816956|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2816957|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816958|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
2816959|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
2816960|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2816961|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2816962|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2816963|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816964|NCT04100759|Urological Agents|urological agents|mesh-ancestor
2816965|NCT04100772|Vaccines|vaccines|mesh-list
2816966|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
2816967|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283921|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
2283922|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283923|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283924|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2283925|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2283926|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
2283927|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2283928|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
2283929|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2283930|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2283931|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2283932|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2283933|NCT00236717|Analgesics|analgesics|mesh-ancestor
2283934|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
2283935|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2283936|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2283937|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2283938|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2283939|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2283940|NCT00236730|Topiramate|topiramate|mesh-list
2283941|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
2283942|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283943|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283944|NCT00236743|Topiramate|topiramate|mesh-list
2283945|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
2283946|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283947|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283948|NCT00236756|Topiramate|topiramate|mesh-list
2283949|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
2283950|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2283951|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283952|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2283953|NCT00236769|Norelgestromin|norelgestromin|mesh-list
2105121|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2105122|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
2105123|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2105124|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2105125|NCT02449915|Bupivacaine|bupivacaine|mesh-list
2816968|NCT04100655|Molgramostim|molgramostim|mesh-list
2816969|NCT04100655|Estradiol|estradiol|mesh-list
2816970|NCT04100655|Sargramostim|sargramostim|mesh-list
2816971|NCT04100655|Estrogens|estrogens|mesh-ancestor
2816972|NCT04100655|Hormones|hormones|mesh-ancestor
2283954|NCT00236769|Estradiol|estradiol|mesh-list
2283955|NCT00236769|Estrogens|estrogens|mesh-ancestor
2283956|NCT00236769|Hormones|hormones|mesh-ancestor
2283957|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2283958|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283959|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2283960|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
2283961|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2283962|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2283963|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2283964|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2283965|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2283966|NCT00236782|Norelgestromin|norelgestromin|mesh-list
2283967|NCT00236782|Estradiol|estradiol|mesh-list
2283968|NCT00236782|Estrogens|estrogens|mesh-ancestor
2283969|NCT00236782|Hormones|hormones|mesh-ancestor
2283970|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2283971|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283972|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2283973|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
2283974|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2816973|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2816974|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816975|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
2816976|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816977|NCT04101383|Insulin|insulin|mesh-list
2816978|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2816979|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
2816980|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2816981|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816982|NCT04100824|Nimodipine|nimodipine|mesh-list
2816983|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2816984|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2816985|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2816986|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816987|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2816988|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2816989|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
2816990|NCT04100330|Cytarabine|cytarabine|mesh-list
2816991|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2816992|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
2816993|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2816994|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2816995|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
2816996|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2816997|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2816998|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
2816999|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817000|NCT04100473|Insulin|insulin|mesh-list
2817001|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2817002|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
2817003|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2817004|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817005|NCT04100226|Vitamin D|vitamin d|mesh-list
2817006|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
2817007|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
2817008|NCT04100226|Vitamins|vitamins|mesh-ancestor
2105126|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
2105127|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
2105128|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105129|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105130|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
2105131|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105134|NCT02450487|Piroxicam|piroxicam|mesh-list
2105135|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2105136|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2105137|NCT02450487|Analgesics|analgesics|mesh-ancestor
2817009|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
2817010|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817011|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2817012|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2817013|NCT04100226|Antacids|antacids|mesh-ancestor
2817014|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817015|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2817016|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
2817017|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2817018|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2817019|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817020|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
2817021|NCT04100447|Coagulants|coagulants|mesh-ancestor
2817022|NCT04100434|Evolocumab|evolocumab|mesh-list
2817023|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2817024|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2817025|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
2817026|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817027|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2817028|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2817029|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2817030|NCT04100135|Clopidogrel|clopidogrel|mesh-list
2817031|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2817032|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2817033|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2817034|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2817035|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2817036|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
2817037|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817038|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817039|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817040|NCT04100083|Spironolactone|spironolactone|mesh-list
2817041|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2817042|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
2817043|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2817044|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817045|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2817046|NCT04100083|Diuretics|diuretics|mesh-ancestor
2817047|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
2817048|NCT04099849|Zinc|zinc|mesh-list
2817049|NCT04099849|Trace Elements|trace elements|mesh-ancestor
2817050|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
2817051|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817052|NCT04099771|Ketamine|ketamine|mesh-list
2817053|NCT04099771|Analgesics|analgesics|mesh-ancestor
2817054|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
2817055|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817056|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817057|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2817058|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2817059|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
2283975|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2283976|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2283977|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2283978|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2283979|NCT00236795|Norelgestromin|norelgestromin|mesh-list
2283980|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2283981|NCT00236795|Estradiol|estradiol|mesh-list
2283982|NCT00236795|Estrogens|estrogens|mesh-ancestor
2817060|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
2817061|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817062|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2817063|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2817064|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817065|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817066|NCT04099797|Cyclophosphamide|cyclophosphamide|mesh-list
2817067|NCT04099797|Fludarabine|fludarabine|mesh-list
2817068|NCT04099797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2817069|NCT04099797|Immunologic Factors|immunologic factors|mesh-ancestor
2817070|NCT04099797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817071|NCT04099797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2817072|NCT04099797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2817073|NCT04099797|Alkylating Agents|alkylating agents|mesh-ancestor
2283983|NCT00236795|Hormones|hormones|mesh-ancestor
2283984|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2283985|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2283986|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2283987|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
2283988|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2283989|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2283990|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2283991|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2283992|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2283993|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2283994|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2283995|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2283996|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2105138|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
2105139|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105140|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105141|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2105142|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2105143|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2817074|NCT04099797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817075|NCT04099797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817076|NCT04099797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2817077|NCT04099563|Abrocitinib|abrocitinib|mesh-list
2817078|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2817079|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817080|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817081|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
2817082|NCT04099641|Bavituximab|bavituximab|mesh-list
2817083|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2817084|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817085|NCT04099732|Dabigatran|dabigatran|mesh-list
2817086|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2817087|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2817088|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2817089|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
2817090|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817091|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2283997|NCT00236808|Levofloxacin|levofloxacin|mesh-list
2283998|NCT00236808|Ofloxacin|ofloxacin|mesh-list
2283999|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2284000|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284001|NCT00236808|Renal Agents|renal agents|mesh-ancestor
2284002|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284003|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2284004|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2284005|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284006|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284007|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284008|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2284009|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2284010|NCT00236821|Levofloxacin|levofloxacin|mesh-list
2284011|NCT00236821|Ofloxacin|ofloxacin|mesh-list
2284012|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2284013|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284014|NCT00236821|Renal Agents|renal agents|mesh-ancestor
2284015|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284016|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2105144|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105145|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105146|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
2105147|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2105148|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2105149|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2105150|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2105151|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284017|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2817092|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2817093|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817094|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
2817095|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2817096|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
2284018|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284019|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284020|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284021|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2284022|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2284023|NCT00236834|Levofloxacin|levofloxacin|mesh-list
2284024|NCT00236834|Ofloxacin|ofloxacin|mesh-list
2284025|NCT00236834|Imipenem|imipenem|mesh-list
2284026|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2284027|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284028|NCT00236834|Renal Agents|renal agents|mesh-ancestor
2284029|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2817097|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
2817098|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
2817099|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
2817100|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2817101|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2817102|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2817103|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2817104|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817105|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
2817106|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817107|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817108|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2817109|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817110|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2284030|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2284031|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2284032|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284033|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284034|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284035|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2284036|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2284037|NCT00236847|Topiramate|topiramate|mesh-list
2284038|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
2284039|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2284040|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284041|NCT00236860|Topiramate|topiramate|mesh-list
2284042|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
2284043|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2284044|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284045|NCT00236873|Topiramate|topiramate|mesh-list
2284046|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
2284047|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2284048|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284049|NCT00236886|Topiramate|topiramate|mesh-list
2284050|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
2284051|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2284052|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284053|NCT00236912|Metronidazole|metronidazole|mesh-list
2284054|NCT00236912|Levofloxacin|levofloxacin|mesh-list
2284055|NCT00236912|Ofloxacin|ofloxacin|mesh-list
2284056|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284057|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284058|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2284059|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2817118|NCT04099407|Pirfenidone|pirfenidone|mesh-list
2817119|NCT04099407|Analgesics|analgesics|mesh-ancestor
2817120|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
2817121|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817122|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817123|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2817124|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2817125|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2817126|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2817127|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817128|NCT04099238|Warfarin|warfarin|mesh-list
2817129|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
2284060|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2284061|NCT00236912|Renal Agents|renal agents|mesh-ancestor
2817130|NCT04099238|Dabigatran|dabigatran|mesh-list
2817131|NCT04099238|Apixaban|apixaban|mesh-list
2817132|NCT04099238|Edoxaban|edoxaban|mesh-list
2817133|NCT04099238|Anticoagulants|anticoagulants|mesh-list
2817134|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
2817135|NCT04099238|Phenindione|phenindione|mesh-list
2817136|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2817137|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
2817138|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2817139|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
2817140|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817141|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817142|NCT04099069|Anesthetics|anesthetics|mesh-list
2817143|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817144|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817145|NCT04099303|Vaccines|vaccines|mesh-list
2817146|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
2817147|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817148|NCT04098861|Timolol|timolol|mesh-list
2817149|NCT04098861|Latanoprost|latanoprost|mesh-list
2817150|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2817151|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2817152|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
2817153|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817154|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817155|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817156|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2817157|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2817158|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2817159|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2817160|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
2817161|NCT04098653|Busulfan|busulfan|mesh-list
2817162|NCT04098653|Decitabine|decitabine|mesh-list
2817163|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2817164|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
2817165|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817166|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2817167|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2817168|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
2817169|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817170|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817171|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2817172|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2817173|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
2817174|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817175|NCT04098874|Bupropion|bupropion|mesh-list
2817176|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2817177|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
2817178|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2817179|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2817180|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2817181|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2817182|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817183|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
2817184|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817185|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817186|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2817187|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2817188|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817189|NCT04098666|Metformin|metformin|mesh-list
2817190|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2817191|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817192|NCT04098718|Prednisolone|prednisolone|mesh-list
2817193|NCT04098718|Benralizumab|benralizumab|mesh-list
2817194|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2817195|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
2817196|NCT04098718|Hormones|hormones|mesh-ancestor
2817197|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2817198|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817199|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2817200|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817201|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2817202|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
2817203|NCT04098744|Artesunate|artesunate|mesh-list
2817204|NCT04098744|Artemisinins|artemisinins|mesh-list
2817205|NCT04098744|Artemisinin|artemisinin|mesh-list
2817206|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
2817207|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2817208|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2817209|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2817210|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817211|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
2817212|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
2817213|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2817214|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
2817215|NCT04098796|Antibodies|antibodies|mesh-list
2817216|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
2817217|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817218|NCT04098432|Nivolumab|nivolumab|mesh-list
2817219|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2817220|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284062|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2817221|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2817222|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817223|NCT04098250|Erenumab|erenumab|mesh-list
2817224|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2817225|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817226|NCT04098250|Analgesics|analgesics|mesh-ancestor
2817227|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
2817228|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817229|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817230|NCT04098302|Dutasteride|dutasteride|mesh-list
2817231|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2817232|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2284063|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2284064|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284065|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284066|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817233|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817234|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817235|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
2817236|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2817237|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817238|NCT04098081|Gemcitabine|gemcitabine|mesh-list
2817239|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
2817240|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2817241|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
2817242|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817243|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284067|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2284068|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2284069|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
2284070|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2284071|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
2284072|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2284073|NCT00236964|Hematinics|hematinics|mesh-ancestor
2284074|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
2284075|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
2284076|NCT00237016|Doxycycline|doxycycline|mesh-list
2284077|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284078|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284079|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
2284080|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2284081|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2284082|NCT00237068|Lansoprazole|lansoprazole|mesh-list
2284083|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
2284084|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2817244|NCT04098081|Antiviral Agents|antiviral agents|mesh-ancestor
2817245|NCT04098081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2817246|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817247|NCT04098081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2817248|NCT04098081|Immunologic Factors|immunologic factors|mesh-ancestor
2817249|NCT04098081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817250|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
2817251|NCT04098068|Antibodies|antibodies|mesh-list
2817252|NCT04098068|Immunologic Factors|immunologic factors|mesh-ancestor
2817253|NCT04098068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817254|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2817255|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817256|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2817257|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2284085|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2284086|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2284087|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284088|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284089|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
2284090|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284091|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2284092|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284093|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284094|NCT00237133|Letrozole|letrozole|mesh-list
2284095|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284096|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2284097|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2284098|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284099|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284100|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2284101|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
2284102|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284103|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284104|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
2284105|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2284106|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284107|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
2284108|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2284109|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284110|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
2817258|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2817259|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
2817260|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284111|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284112|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2284113|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284114|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284115|NCT00237198|Letrozole|letrozole|mesh-list
2284116|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284117|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2284118|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2284119|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284120|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284121|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2284122|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
2817261|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2817262|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2817263|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817264|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
2817265|NCT04097847|Tocopherols|tocopherols|mesh-list
2105152|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
2105153|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105154|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105155|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2105156|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105157|NCT02450539|Docetaxel|docetaxel|mesh-list
2105158|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105159|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
2105160|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
2105161|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
2105162|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105163|NCT02450552|Ezogabine|ezogabine|mesh-list
2105164|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
2105165|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2105166|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105167|NCT02450578|Atovaquone|atovaquone|mesh-list
2105168|NCT02450578|Proguanil|proguanil|mesh-list
2105169|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2105170|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105171|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
2105172|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2105173|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2105174|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105175|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105176|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
2105177|NCT02450903|Ceritinib|ceritinib|mesh-list
2105178|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105179|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2105180|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817266|NCT04097847|Vitamin E|vitamin e|mesh-list
2817267|NCT04097847|Tocotrienols|tocotrienols|mesh-list
2817268|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
2817269|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
2817270|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2817271|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817272|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817273|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2817274|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2817275|NCT04097847|Protective Agents|protective agents|mesh-ancestor
2817276|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817277|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
2817278|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2817279|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
2817280|NCT04097847|Vitamins|vitamins|mesh-ancestor
2817281|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
2817282|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2817283|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
2817284|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2817285|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2817286|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
2817287|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2817288|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2817289|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2817290|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817291|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817292|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2817293|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2817294|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
2817295|NCT04097613|Budesonide|budesonide|mesh-list
2817296|NCT04097613|Povidone|povidone|mesh-list
2817297|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2817298|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2817299|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
2817300|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817301|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817302|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2817303|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
2817304|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
2817305|NCT04097613|Hormones|hormones|mesh-ancestor
2817306|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284123|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284124|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284125|NCT00237211|Letrozole|letrozole|mesh-list
2284126|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284127|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2284128|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2284129|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284130|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284131|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2284132|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
2284133|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284134|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284135|NCT00237224|Letrozole|letrozole|mesh-list
2284136|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284137|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2284138|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2284139|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284140|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284141|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2284142|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
2817307|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
2817308|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
2817309|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2817310|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2817311|NCT04097574|Menthol|menthol|mesh-list
2817312|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
2817313|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
2284143|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284144|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284145|NCT00237237|Vildagliptin|vildagliptin|mesh-list
2284146|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2284147|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284148|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2284149|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
2284150|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284151|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284152|NCT00237250|Vildagliptin|vildagliptin|mesh-list
2284153|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2284154|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284155|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2284156|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
2817314|NCT04097444|Leucovorin|leucovorin|mesh-list
2817315|NCT04097444|Bevacizumab|bevacizumab|mesh-list
2817316|NCT04097444|Fluorouracil|fluorouracil|mesh-list
2817317|NCT04097444|Capecitabine|capecitabine|mesh-list
2817318|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
2817319|NCT04097444|Irinotecan|irinotecan|mesh-list
2817320|NCT04097444|Calcium|calcium|mesh-list
2817321|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
2817322|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2817323|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817324|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2817325|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2817326|NCT04097444|Growth Substances|growth substances|mesh-ancestor
2817327|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817328|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
2817329|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2817330|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
2817331|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817332|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2817333|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2817334|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
2284157|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284158|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284159|NCT00237263|Entacapone|entacapone|mesh-list
2284160|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2284161|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2284162|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2284163|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284164|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817335|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2817336|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2817337|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284165|NCT00237289|Topiramate|topiramate|mesh-list
2284166|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
2284167|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2284168|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284169|NCT00237302|Topiramate|topiramate|mesh-list
2284170|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
2284171|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2284172|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284173|NCT00237328|Heparin|heparin|mesh-list
2284174|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
2284175|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2284176|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2284177|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284178|NCT00237341|Fentanyl|fentanyl|mesh-list
2284179|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2284180|NCT00237341|Narcotics|narcotics|mesh-ancestor
2284181|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2284182|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284183|NCT00237341|Analgesics|analgesics|mesh-ancestor
2284184|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
2284185|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284186|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2284187|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2284188|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
2284189|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
2284190|NCT00237367|Rabeprazole|rabeprazole|mesh-list
2284191|NCT00237367|Pantoprazole|pantoprazole|mesh-list
2284192|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2284193|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2284194|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2284195|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284196|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284197|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2284198|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
2284199|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2284200|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2284201|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2284202|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2284203|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284204|NCT00237419|Infliximab|infliximab|mesh-list
2284205|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
2817338|NCT04097444|Antidotes|antidotes|mesh-ancestor
2817339|NCT04097444|Protective Agents|protective agents|mesh-ancestor
2817340|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
2817341|NCT04097444|Vitamins|vitamins|mesh-ancestor
2817342|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
2817343|NCT04097288|Dexetimide|dexetimide|mesh-list
2817344|NCT04097288|Citalopram|citalopram|mesh-list
2817345|NCT04097288|Reboxetine|reboxetine|mesh-list
2817346|NCT04097288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2817347|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2817348|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2817349|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817350|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817351|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
2284206|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2284207|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2284208|NCT00237445|Azithromycin|azithromycin|mesh-list
2284209|NCT00237445|Telithromycin|telithromycin|mesh-list
2284210|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284211|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284212|NCT00237471|Insulin|insulin|mesh-list
2284213|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2284214|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284215|NCT00237484|Interferons|interferons|mesh-list
2284216|NCT00237484|Ribavirin|ribavirin|mesh-list
2817352|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817353|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2817354|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
2817355|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2817356|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2817357|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2817358|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
2817359|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
2817360|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817361|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2817362|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2817363|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
2284217|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
2284218|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
2284219|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2284220|NCT00237484|Infliximab|infliximab|mesh-list
2284221|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284222|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
2284223|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284224|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
2284225|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284226|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
2817364|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2817365|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
2817377|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
2817378|NCT04096768|Ketamine|ketamine|mesh-list
2817379|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2817380|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817381|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817382|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2817383|NCT04096768|Analgesics|analgesics|mesh-ancestor
2817384|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
2817385|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817386|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2817387|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2817388|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2817389|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
2817390|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817391|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817392|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2817393|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2817394|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
2817395|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
2817396|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2817397|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2817398|NCT04097028|Trifluridine|trifluridine|mesh-list
2817399|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
2817400|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817401|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
2817402|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817403|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
2817404|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2817405|NCT04096599|Fluorides|fluorides|mesh-list
2817406|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
2817407|NCT04096599|Protective Agents|protective agents|mesh-ancestor
2817408|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817409|NCT04096742|Tretinoin|tretinoin|mesh-list
2817410|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817411|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
2817412|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
2817413|NCT04096638|Atezolizumab|atezolizumab|mesh-list
2817414|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817415|NCT04096690|Pegaspargase|pegaspargase|mesh-list
2817416|NCT04096690|Antibodies|antibodies|mesh-list
2817417|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2817418|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
2817419|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817420|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817421|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
2817422|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2817423|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
2817424|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2817425|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
2817426|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817427|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817428|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
2284227|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284228|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
2284229|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2284230|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2284231|NCT00237497|Zopiclone|zopiclone|mesh-list
2284232|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2284233|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2284234|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284235|NCT00237510|Terazosin|terazosin|mesh-list
2284236|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2284237|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2284238|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2817429|NCT04096391|Analgesics|analgesics|mesh-list
2817430|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
2817431|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817432|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817433|NCT04096066|Dexamethasone|dexamethasone|mesh-list
2817434|NCT04096066|Lenalidomide|lenalidomide|mesh-list
2817435|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2817436|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
2817437|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
2817438|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817439|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284239|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
2284240|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2284241|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284242|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284243|NCT00237510|Urological Agents|urological agents|mesh-ancestor
2284244|NCT00237523|Iodine|iodine|mesh-list
2284245|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
2284246|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2284247|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284248|NCT00237523|Trace Elements|trace elements|mesh-ancestor
2284249|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
2284250|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284251|NCT00237536|Lonidamine|lonidamine|mesh-list
2284252|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284253|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2284254|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284255|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2284256|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
2284257|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2284258|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2817440|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2817441|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
2817442|NCT04096066|Hormones|hormones|mesh-ancestor
2284259|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2284260|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2284261|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284262|NCT00237575|Gemcitabine|gemcitabine|mesh-list
2284263|NCT00237575|Sargramostim|sargramostim|mesh-list
2284264|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284265|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2284266|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
2284267|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284268|NCT00237575|Antiviral Agents|antiviral agents|mesh-ancestor
2284269|NCT00237575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284270|NCT00237575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284271|NCT00237575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2284272|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
2284273|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284274|NCT00237588|Losartan|losartan|mesh-list
2284275|NCT00237588|Amlodipine|amlodipine|mesh-list
2284276|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2284277|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2284278|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2284279|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284280|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2284281|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284282|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
2284283|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2284284|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2284285|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2284286|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
2284287|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2284288|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
2284289|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284290|NCT00237614|Expectorants|expectorants|mesh-ancestor
2284291|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
2284292|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2284293|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
2817443|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2817444|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2817445|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817446|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
2817447|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2817448|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2817449|NCT04096066|Growth Substances|growth substances|mesh-ancestor
2817450|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
2817451|NCT04096157|Isavuconazole|isavuconazole|mesh-list
2817452|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
2817453|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2817454|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
2817455|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2817456|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817457|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817458|NCT04096170|Lidocaine|lidocaine|mesh-list
2817459|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
2817460|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
2817461|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817462|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817463|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
2817464|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817465|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2817466|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2817467|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2817468|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2817469|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817470|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
2817471|NCT04095754|Anesthetics|anesthetics|mesh-list
2817472|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817473|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817474|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2817475|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2817476|NCT04095754|Analgesics|analgesics|mesh-ancestor
2817477|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
2817478|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817479|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2817480|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2817481|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2817482|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
2817483|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817484|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817485|NCT04095715|Hemostatics|hemostatics|mesh-list
2817486|NCT04095715|Coagulants|coagulants|mesh-ancestor
2284294|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284295|NCT00237614|Protective Agents|protective agents|mesh-ancestor
2284296|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284297|NCT00237614|Antidotes|antidotes|mesh-ancestor
2284298|NCT00237627|Doxorubicin|doxorubicin|mesh-list
2284299|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2284300|NCT00237627|Bortezomib|bortezomib|mesh-list
2284301|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2284302|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284303|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2284304|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2284305|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284306|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284307|NCT00237653|Valganciclovir|valganciclovir|mesh-list
2284308|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
2284309|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284310|NCT00237705|Metoclopramide|metoclopramide|mesh-list
2284311|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
2284312|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
2284313|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284314|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284315|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2284316|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2284317|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2284318|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
2284319|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2284320|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284321|NCT00237731|Morphine|morphine|mesh-list
2284322|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2284323|NCT00237731|Narcotics|narcotics|mesh-ancestor
2105181|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105182|NCT02451137|Insulin|insulin|mesh-list
2105183|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2105184|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
2284324|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105185|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
2105186|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2105187|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105188|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2105189|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2105190|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2817497|NCT04096027|Cabergoline|cabergoline|mesh-list
2817498|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2817499|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2284325|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284326|NCT00237731|Analgesics|analgesics|mesh-ancestor
2284327|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
2284328|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284329|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
2284330|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2284331|NCT00237861|Olanzapine|olanzapine|mesh-list
2284332|NCT00237861|Risperidone|risperidone|mesh-list
2284333|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2284334|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2284335|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
2284336|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2284337|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817500|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
2817501|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
2817502|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817503|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817504|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817505|NCT04095832|Anesthetics|anesthetics|mesh-list
2817506|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2284338|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284339|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2284340|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2284341|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2284342|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2284343|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2817507|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817508|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
2817509|NCT04095624|Narcotics|narcotics|mesh-ancestor
2817510|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817511|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817512|NCT04095624|Analgesics|analgesics|mesh-ancestor
2817513|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
2817514|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817515|NCT04095208|Nivolumab|nivolumab|mesh-list
2817516|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2817517|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817518|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2817519|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817520|NCT04095221|Irinotecan|irinotecan|mesh-list
2817521|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2817522|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2817523|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817524|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817525|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817526|NCT04095312|Pancrelipase|pancrelipase|mesh-list
2817527|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2817528|NCT04095390|Capecitabine|capecitabine|mesh-list
2817529|NCT04095390|Letrozole|letrozole|mesh-list
2817530|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2817531|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
2817532|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284344|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
2284345|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
2284346|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
2284347|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284348|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2284349|NCT00237861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2284350|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2284351|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2284352|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
2817533|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817534|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2817535|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2817536|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817537|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2817538|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
2817539|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2817540|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817541|NCT04095442|Benzocaine|benzocaine|mesh-list
2284353|NCT00237874|Aripiprazole|aripiprazole|mesh-list
2284354|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
2817542|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
2817543|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
2817544|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817545|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817546|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
2817547|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817548|NCT04095455|Ketamine|ketamine|mesh-list
2817549|NCT04095455|Analgesics|analgesics|mesh-ancestor
2817550|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
2817551|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817552|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817553|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2817554|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2817555|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
2817556|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
2817557|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817558|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2817559|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2817560|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817561|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817562|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2817563|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
2817564|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2817565|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2817566|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2817567|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817568|NCT04095299|Capecitabine|capecitabine|mesh-list
2817569|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2817570|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
2817571|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817572|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817573|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
2284355|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2284356|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2284357|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2284358|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2284359|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284360|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
2284361|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
2817574|NCT04095169|Complement C3|complement c3|mesh-list
2817575|NCT04095169|Complement C3d|complement c3d|mesh-list
2817576|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
2817577|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817578|NCT04094948|Clenbuterol|clenbuterol|mesh-list
2817579|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2817580|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2817581|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
2817582|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817583|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817584|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817585|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2817586|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
2817587|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284362|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2284363|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284364|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2284365|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2284366|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
2284367|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2284368|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2284369|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2284370|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2284371|NCT00237887|Adalimumab|adalimumab|mesh-list
2817588|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2817589|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
2817590|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
2817591|NCT04094961|Dexamethasone|dexamethasone|mesh-list
2817592|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
2817593|NCT04094961|Pomalidomide|pomalidomide|mesh-list
2817594|NCT04094961|Ixazomib|ixazomib|mesh-list
2817595|NCT04094961|BB 1101|bb 1101|mesh-list
2817596|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2817597|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
2817598|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
2105191|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105192|NCT02451202|Rocuronium|rocuronium|mesh-list
2105193|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2105194|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2105195|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2105196|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817599|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817600|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817601|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2284372|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2284373|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2284374|NCT00237900|Leucovorin|leucovorin|mesh-list
2284375|NCT00237900|Fluorouracil|fluorouracil|mesh-list
2284376|NCT00237900|Gefitinib|gefitinib|mesh-list
2284377|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
2284378|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284379|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2284380|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817602|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
2817603|NCT04094961|Hormones|hormones|mesh-ancestor
2817604|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2817605|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2817606|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817607|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
2817608|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817609|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817610|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
2817611|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2817612|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2817613|NCT04094961|Growth Substances|growth substances|mesh-ancestor
2284381|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2284382|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
2284383|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284384|NCT00237900|Antidotes|antidotes|mesh-ancestor
2284385|NCT00237900|Protective Agents|protective agents|mesh-ancestor
2284386|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
2284387|NCT00237900|Vitamins|vitamins|mesh-ancestor
2284388|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
2105197|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105198|NCT02451358|Vaccines|vaccines|mesh-list
2105199|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
2105200|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105201|NCT02451488|Sargramostim|sargramostim|mesh-list
2105202|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
2105203|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284389|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2284390|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284391|NCT00237913|Olanzapine|olanzapine|mesh-list
2284392|NCT00237913|Risperidone|risperidone|mesh-list
2284393|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2817614|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
2817615|NCT04095104|Topiramate|topiramate|mesh-list
2817616|NCT04095104|Phentermine|phentermine|mesh-list
2817617|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
2817618|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2817619|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817620|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2817621|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
2817622|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2817623|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
2817624|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
2817625|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817626|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
2817627|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817628|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817629|NCT04095013|Fentanyl|fentanyl|mesh-list
2817630|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
2817631|NCT04095013|Bupivacaine|bupivacaine|mesh-list
2817632|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
2817633|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
2817634|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817635|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817636|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
2817637|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817638|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2817639|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2284394|NCT00237913|Aripiprazole|aripiprazole|mesh-list
2284395|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2284396|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
2284397|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2284398|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284399|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284400|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2284401|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2284402|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2284403|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2284404|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2817640|NCT04095013|Analgesics|analgesics|mesh-ancestor
2817641|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2817642|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2817643|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2817644|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
2817645|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817646|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817647|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2817648|NCT04095013|Narcotics|narcotics|mesh-ancestor
2817649|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2817650|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2817651|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
2817652|NCT04094805|Calcitriol|calcitriol|mesh-list
2817653|NCT04094805|Dexamethasone|dexamethasone|mesh-list
2817654|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2817655|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
2817656|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
2817657|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817658|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817659|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2817660|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
2817661|NCT04094805|Hormones|hormones|mesh-ancestor
2817662|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2817663|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2817664|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817665|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2817666|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2817667|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2817668|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817669|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2817670|NCT04094805|Vitamins|vitamins|mesh-ancestor
2817671|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
2817672|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2817673|NCT04094909|Paclitaxel|paclitaxel|mesh-list
2817674|NCT04094909|Cisplatin|cisplatin|mesh-list
2817675|NCT04094909|Carboplatin|carboplatin|mesh-list
2817676|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
2817677|NCT04094909|Pemetrexed|pemetrexed|mesh-list
2817678|NCT04094909|Endostatins|endostatins|mesh-list
2817679|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2817680|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817681|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
2817682|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
2817683|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
2817684|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817685|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2817686|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817687|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2284405|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
2284406|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
2284407|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
2284408|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284409|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2284410|NCT00237913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2105204|NCT02451696|Everolimus|everolimus|mesh-list
2105205|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105206|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2105207|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
2105208|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105209|NCT02451917|Insulin|insulin|mesh-list
2105210|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2105211|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
2105212|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
2105213|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
2105214|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
2105215|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2284411|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2284412|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2284413|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
2284414|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
2284415|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2284416|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2284417|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2817688|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2817689|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2817690|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2817691|NCT04094909|Growth Substances|growth substances|mesh-ancestor
2817692|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817693|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
2817694|NCT04094727|Lumefantrine|lumefantrine|mesh-list
2817695|NCT04094727|Artemether|artemether|mesh-list
2817696|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2817697|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
2817698|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2817699|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2817700|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2817701|NCT04094584|Naltrexone|naltrexone|mesh-list
2817702|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2817703|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2817704|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284418|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2284419|NCT00237939|Aripiprazole|aripiprazole|mesh-list
2817705|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
2817706|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817707|NCT04094597|Lactoferrin|lactoferrin|mesh-list
2817708|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2817709|NCT04094532|Bupivacaine|bupivacaine|mesh-list
2817710|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
2817711|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
2817712|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817713|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817714|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
2817715|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817716|NCT04094467|Leuprolide|leuprolide|mesh-list
2817717|NCT04094467|Cetrorelix|cetrorelix|mesh-list
2817718|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2284420|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
2284421|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2284422|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2284423|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2284424|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817719|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
2817720|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2817721|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817722|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2817723|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817724|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
2817725|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2817726|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
2817727|NCT04094701|Narcotics|narcotics|mesh-ancestor
2817728|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817729|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817730|NCT04094701|Analgesics|analgesics|mesh-ancestor
2817731|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
2817732|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817733|NCT04094090|Riboflavin|riboflavin|mesh-list
2817734|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
2817735|NCT04094090|Vitamins|vitamins|mesh-ancestor
2817736|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
2817737|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817738|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2105216|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105217|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
2105218|NCT02451930|Necitumumab|necitumumab|mesh-list
2105219|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2105220|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817739|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
2105221|NCT02451943|Doxorubicin|doxorubicin|mesh-list
2105222|NCT02451943|Olaratumab|olaratumab|mesh-list
2105223|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2105224|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284425|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284426|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
2284427|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
2284428|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2284429|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284430|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2284431|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2284432|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
2284433|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2284434|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2284435|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2284436|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2284437|NCT00237952|Chelating Agents|chelating agents|mesh-list
2284438|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
2284439|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284440|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
2284441|NCT00238004|Niacin|niacin|mesh-list
2284442|NCT00238004|Niacinamide|niacinamide|mesh-list
2284443|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
2284444|NCT00238004|Vitamins|vitamins|mesh-ancestor
2284445|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
2284446|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284447|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2284448|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
2284449|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284450|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2817740|NCT04094142|Lenalidomide|lenalidomide|mesh-list
2817741|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
2817742|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817743|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
2817744|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817745|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2817746|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2817747|NCT04094142|Growth Substances|growth substances|mesh-ancestor
2817748|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
2817749|NCT04093895|Taurolidine|taurolidine|mesh-list
2817750|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2817751|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2817752|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817753|NCT04093765|Antimalarials|antimalarials|mesh-list
2817754|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2817755|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2817756|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2817757|NCT04093518|Estradiol|estradiol|mesh-list
2817758|NCT04093518|Estrogens|estrogens|mesh-ancestor
2817759|NCT04093518|Hormones|hormones|mesh-ancestor
2817760|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2817761|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817762|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
2817763|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2284451|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
2284452|NCT00238017|Artesunate|artesunate|mesh-list
2284453|NCT00238017|Amodiaquine|amodiaquine|mesh-list
2284454|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
2284455|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2284456|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2284457|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284458|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284459|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
2284460|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
2284461|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2284462|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
2284463|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
2284464|NCT00238043|Hematinics|hematinics|mesh-ancestor
2284465|NCT00238056|Domperidone|domperidone|mesh-list
2284466|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
2284467|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
2284468|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284469|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284470|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2284471|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2284472|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
2817764|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817765|NCT04093531|Ustekinumab|ustekinumab|mesh-list
2817766|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
2817767|NCT04093713|Nordefrin|nordefrin|mesh-list
2284473|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483646|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2817768|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2817769|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
2817770|NCT04093648|Fludarabine|fludarabine|mesh-list
2817771|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2817772|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
2817773|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817774|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2817775|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2817776|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
2817777|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817778|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817779|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2817780|NCT04093206|Vitamins|vitamins|mesh-list
2817781|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
2817782|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
2817783|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817784|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
2817785|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817786|NCT04093206|Protective Agents|protective agents|mesh-ancestor
2817787|NCT04093219|Acetaminophen|acetaminophen|mesh-list
2817788|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2817789|NCT04093219|Analgesics|analgesics|mesh-ancestor
2284474|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284475|NCT00238082|Beclomethasone|beclomethasone|mesh-list
2284476|NCT00238082|Norflurane|norflurane|mesh-list
2284477|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2284478|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
2284479|NCT00238082|Hormones|hormones|mesh-ancestor
2284480|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284481|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284482|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2284483|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
2284484|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
2284485|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2284486|NCT00238147|Carboplatin|carboplatin|mesh-list
2284487|NCT00238147|Docetaxel|docetaxel|mesh-list
2284488|NCT00238147|Capecitabine|capecitabine|mesh-list
2284489|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817790|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
2817791|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817792|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817793|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
2817794|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
2817795|NCT04093271|Promethazine|promethazine|mesh-list
2817796|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2817797|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2817798|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817799|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817800|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
2817801|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
2817802|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
2817803|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817804|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
2817805|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
2817806|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2817807|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2817808|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
2817809|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
2817810|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817811|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817812|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2817813|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
2817814|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
2284490|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
2284491|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
2284492|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
2284493|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284494|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2284495|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
2284496|NCT00238160|Fluorouracil|fluorouracil|mesh-list
2284497|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284498|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
2284499|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284500|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2284501|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2817827|NCT04093050|Vasopressins|vasopressins|mesh-list
2817828|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
2817829|NCT04093050|Coagulants|coagulants|mesh-ancestor
2817830|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2817831|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2817832|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
2817833|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817834|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
2817835|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
2817836|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2817837|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
2817838|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
2817839|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2817840|NCT04092894|Suvorexant|suvorexant|mesh-list
2817841|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2817842|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2817843|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817844|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817845|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2817846|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817847|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817848|NCT04092868|Protamines|protamines|mesh-list
2817849|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
2817850|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817851|NCT04092868|Coagulants|coagulants|mesh-ancestor
2817852|NCT04092621|Amiodarone|amiodarone|mesh-list
2817853|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2817854|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
2817855|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2817856|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2817857|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817858|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2817859|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2817860|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2817861|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817862|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2817863|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2817864|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2817865|NCT04092452|PF-06700841|pf-06700841|mesh-list
2817866|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2817867|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817868|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817869|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2817870|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2817871|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2817872|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
2817873|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817874|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2817875|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2817876|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817877|NCT04092387|Nicotine|nicotine|mesh-list
2284502|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
2284503|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284504|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
2284505|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
2284506|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
2284507|NCT00238173|Carboplatin|carboplatin|mesh-list
2284508|NCT00238173|Etoposide|etoposide|mesh-list
2284509|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
2284510|NCT00238173|Mannitol|mannitol|mesh-list
2284511|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2284512|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2284513|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
2817878|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2284514|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284515|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2817879|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
2284516|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2284517|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
2284518|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284519|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284520|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2284521|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2284522|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2284523|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2284524|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284525|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
2284526|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284527|NCT00238173|Expectorants|expectorants|mesh-ancestor
2284528|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
2817880|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817881|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817882|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2817883|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2817884|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
2817885|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817886|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817887|NCT04092478|Anesthetics|anesthetics|mesh-list
2817888|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817889|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284529|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2284530|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
2284531|NCT00238173|Protective Agents|protective agents|mesh-ancestor
2284532|NCT00238173|Antidotes|antidotes|mesh-ancestor
2284533|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2284534|NCT00238173|Diuretics|diuretics|mesh-ancestor
2284535|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
2284536|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
2284537|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284538|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
2284539|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
2284540|NCT00238199|Calcitriol|calcitriol|mesh-list
2817890|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
2817891|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
2817892|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
2817893|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817894|NCT04092309|Valsartan|valsartan|mesh-list
2817895|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2817896|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2817897|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2817898|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2817899|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2817900|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817901|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
2817902|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817903|NCT04091971|Ketamine|ketamine|mesh-list
2817904|NCT04091971|Analgesics|analgesics|mesh-ancestor
2817905|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
2817906|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817907|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817908|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2817909|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2817910|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
2817911|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
2284541|NCT00238199|Docetaxel|docetaxel|mesh-list
2284542|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284543|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
2284544|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
2284545|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
2284546|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284547|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2284548|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284549|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2284550|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2284551|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2284552|NCT00238199|Vitamins|vitamins|mesh-ancestor
2284553|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
2284554|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2817912|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817913|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2817914|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2817915|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817916|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817917|NCT04092101|Nicotine|nicotine|mesh-list
2817918|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2817919|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
2817920|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2817921|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817922|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2817923|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2817924|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
2817925|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817926|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817927|NCT04091880|Vaccines|vaccines|mesh-list
2817928|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
2817929|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817930|NCT04091815|Anesthetics|anesthetics|mesh-list
2817931|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2817932|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817933|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
2817934|NCT04091698|Ubiquinone|ubiquinone|mesh-list
2817935|NCT04091698|Vitamins|vitamins|mesh-ancestor
2284555|NCT00238212|Sorafenib|sorafenib|mesh-list
2284556|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817936|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
2817937|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817938|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
2817939|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2817940|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2817941|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817942|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817943|NCT04091763|Polidocanol|polidocanol|mesh-list
2817944|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2817945|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2817946|NCT04091503|Temozolomide|temozolomide|mesh-list
2817947|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2817948|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
2105225|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2105226|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2105227|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105228|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105229|NCT02452034|Posaconazole|posaconazole|mesh-list
2105230|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
2105231|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105232|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2105233|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2817949|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817950|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817951|NCT04091490|Nivolumab|nivolumab|mesh-list
2817952|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2817953|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2817954|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2817955|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817956|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
2817957|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2817958|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2817959|NCT04091412|Protective Agents|protective agents|mesh-ancestor
2817960|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817961|NCT04091204|Olaparib|olaparib|mesh-list
2817962|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2817963|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2817964|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817965|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284557|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2284558|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284559|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284560|NCT00238225|Calcitriol|calcitriol|mesh-list
2284561|NCT00238225|Ketoconazole|ketoconazole|mesh-list
2284562|NCT00238225|Dexamethasone|dexamethasone|mesh-list
2284563|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2284564|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
2284565|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
2284566|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284567|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284568|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2284569|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
2284570|NCT00238225|Hormones|hormones|mesh-ancestor
2284571|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284572|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2284573|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284574|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
2284575|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2817975|NCT04091074|Clopidogrel|clopidogrel|mesh-list
2817976|NCT04091074|Ticagrelor|ticagrelor|mesh-list
2817977|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2817978|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2105234|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2105235|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2105236|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2817979|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2817980|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2817981|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
2817982|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2817983|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2817984|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817985|NCT04091178|Vitamin D|vitamin d|mesh-list
2817986|NCT04091178|Vitamins|vitamins|mesh-ancestor
2817987|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
2817988|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2817989|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2818009|NCT04091009|Buprenorphine|buprenorphine|mesh-list
2818010|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2818011|NCT04091009|Naloxone|naloxone|mesh-list
2818012|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2818013|NCT04091009|Narcotics|narcotics|mesh-ancestor
2818014|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818015|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818016|NCT04091009|Analgesics|analgesics|mesh-ancestor
2818017|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
2818018|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818019|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2818020|NCT04090879|Nicotine|nicotine|mesh-list
2818021|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2818022|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
2818023|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818024|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818025|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2818026|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2818027|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
2818028|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818029|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818030|NCT04090697|Oxandrolone|oxandrolone|mesh-list
2818031|NCT04090697|Androgens|androgens|mesh-ancestor
2818032|NCT04090697|Hormones|hormones|mesh-ancestor
2818033|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2818034|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818035|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
2818036|NCT04090736|Azacitidine|azacitidine|mesh-list
2818037|NCT04090736|Pevonedistat|pevonedistat|mesh-list
2818038|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2818039|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
2818040|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818041|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818042|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818043|NCT04090801|Ethanol|ethanol|mesh-list
2818044|NCT04090801|Minoxidil|minoxidil|mesh-list
2818045|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2818046|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2818047|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818048|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818049|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2818050|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
2284576|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2284577|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2284578|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284579|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284580|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2284581|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
2284582|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2284583|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2284584|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2818051|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
2818052|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2818053|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818054|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
2818055|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2818056|NCT04090190|Oxybutynin|oxybutynin|mesh-list
2818057|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2818058|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2818059|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
2818060|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2284585|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2284586|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2284587|NCT00238225|Vitamins|vitamins|mesh-ancestor
2284588|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
2284589|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2818061|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818062|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818063|NCT04090190|Urological Agents|urological agents|mesh-ancestor
2818064|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
2818065|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
2818066|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818067|NCT04090112|Lidocaine|lidocaine|mesh-list
2818068|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
2818069|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
2818070|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818071|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818072|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
2818073|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818074|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2818075|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2818076|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2818077|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2818078|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818079|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
2818080|NCT04090775|Nivolumab|nivolumab|mesh-list
2818081|NCT04090775|Ipilimumab|ipilimumab|mesh-list
2818082|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2818083|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
2818084|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818085|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2818086|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2818087|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
2284590|NCT00238251|Temozolomide|temozolomide|mesh-list
2284591|NCT00238251|Gefitinib|gefitinib|mesh-list
2284592|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2284593|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
2284594|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284595|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284596|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2284597|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284598|NCT00238277|Temozolomide|temozolomide|mesh-list
2284599|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2284600|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
2284601|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284602|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284603|NCT00238290|Trastuzumab|trastuzumab|mesh-list
2284604|NCT00238290|Letrozole|letrozole|mesh-list
2284605|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2284606|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284607|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2284608|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2284609|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284610|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818088|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284611|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2284612|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
2284613|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284614|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284615|NCT00238316|Letrozole|letrozole|mesh-list
2284616|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284617|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2284618|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2284619|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818089|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818090|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2818091|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2818092|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2284620|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284621|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2284622|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
2284623|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284624|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284625|NCT00238329|Interferons|interferons|mesh-list
2284626|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
2818114|NCT04090047|Itraconazole|itraconazole|mesh-list
2818115|NCT04090047|PF-06700841|pf-06700841|mesh-list
2818116|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
2818117|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284627|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
2284628|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2284629|NCT00238329|Thalidomide|thalidomide|mesh-list
2284630|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284631|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
2818118|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2818119|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2818120|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818121|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818122|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2818123|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
2284632|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284633|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
2284634|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284635|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2284636|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
2284637|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284638|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2284639|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2284640|NCT00238329|Growth Substances|growth substances|mesh-ancestor
2284641|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
2284642|NCT00238368|Cytarabine|cytarabine|mesh-list
2284643|NCT00238368|Prednisone|prednisone|mesh-list
2284644|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
2284645|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
2284646|NCT00238368|Busulfan|busulfan|mesh-list
2284647|NCT00238368|Rituximab|rituximab|mesh-list
2284648|NCT00238368|Doxorubicin|doxorubicin|mesh-list
2284649|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2284650|NCT00238368|Etoposide|etoposide|mesh-list
2284651|NCT00238368|Vincristine|vincristine|mesh-list
2284652|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2284653|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2284654|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
2284655|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284656|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2284657|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2284658|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
2105237|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105238|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105239|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2105240|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
2105241|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2105242|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105243|NCT02452047|Imipenem|imipenem|mesh-list
2105244|NCT02452047|Relebactam|relebactam|mesh-list
2105245|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
2105246|NCT02452047|Cilastatin|cilastatin|mesh-list
2105247|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2105248|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105249|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
2105250|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105251|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105252|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2105253|NCT02452060|Ketamine|ketamine|mesh-list
2284659|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284660|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284661|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2284662|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2284663|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2818124|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2818125|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818126|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2818127|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2818128|NCT04090021|Amoxicillin|amoxicillin|mesh-list
2818129|NCT04090021|Metronidazole|metronidazole|mesh-list
2818130|NCT04090021|Clarithromycin|clarithromycin|mesh-list
2818131|NCT04090021|Levofloxacin|levofloxacin|mesh-list
2284664|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2284665|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2284666|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284667|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2284668|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
2284669|NCT00238368|Hormones|hormones|mesh-ancestor
2818132|NCT04090021|Ofloxacin|ofloxacin|mesh-list
2818133|NCT04090021|Rifabutin|rifabutin|mesh-list
2818134|NCT04090021|Esomeprazole|esomeprazole|mesh-list
2818135|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2818136|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2818137|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2818138|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2818139|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2818140|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2818141|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2818142|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818143|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818144|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2818145|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2818146|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2818147|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2818148|NCT04090021|Renal Agents|renal agents|mesh-ancestor
2818149|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2818150|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2818151|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818152|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2818153|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2818154|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
2818155|NCT04089657|Apatinib|apatinib|mesh-list
2818156|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818157|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2818158|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818159|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818160|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
2818161|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2818162|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2818163|NCT04089813|Metformin|metformin|mesh-list
2818164|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2818165|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818166|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
2818167|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2818168|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2818169|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818170|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
2818171|NCT04089865|Coagulants|coagulants|mesh-ancestor
2818172|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
2818173|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2818174|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
2818175|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
2818176|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818177|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818178|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2818179|NCT04089852|Analgesics|analgesics|mesh-ancestor
2818180|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
2818181|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818182|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
2818183|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2818184|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818185|NCT04089631|Capecitabine|capecitabine|mesh-list
2818186|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2818187|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
2818188|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818189|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818190|NCT04089605|Dexamethasone|dexamethasone|mesh-list
2818191|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
2818192|NCT04089605|Ranibizumab|ranibizumab|mesh-list
2818193|NCT04089605|BB 1101|bb 1101|mesh-list
2818194|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2818195|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
2818196|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
2284670|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284671|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2284672|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2818197|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818198|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818199|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2818200|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
2818201|NCT04089605|Hormones|hormones|mesh-ancestor
2818202|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2818203|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2818204|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818205|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
2818206|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818207|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818208|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2284673|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2284674|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
2284675|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
2284676|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284677|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
2818209|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2818210|NCT04089605|Growth Substances|growth substances|mesh-ancestor
2818211|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
2818212|NCT04089592|Fentanyl|fentanyl|mesh-list
2818213|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
2818214|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2818215|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818216|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818217|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2818218|NCT04089592|Analgesics|analgesics|mesh-ancestor
2818219|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
2818220|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105254|NCT02452060|Analgesics|analgesics|mesh-ancestor
2105255|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
2284678|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
2818221|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2818222|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2818223|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2818224|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
2818225|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818226|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818227|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2818228|NCT04089592|Narcotics|narcotics|mesh-ancestor
2818229|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2818230|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2818231|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
2818232|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
2818236|NCT04089345|Ustekinumab|ustekinumab|mesh-list
2818237|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
2818238|NCT04089163|Flucytosine|flucytosine|mesh-list
2818239|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
2818240|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2818241|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
2818242|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284679|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
2284680|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
2284681|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
2284682|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105256|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105257|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105258|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2105259|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2105260|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
2105261|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
2105262|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105263|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2105264|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2105265|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105266|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105267|NCT02452190|Reslizumab|reslizumab|mesh-list
2105268|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2105269|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
2105270|NCT02452320|Acetaminophen|acetaminophen|mesh-list
2105271|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2284683|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2284684|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2284685|NCT00238368|Protective Agents|protective agents|mesh-ancestor
2284686|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2284687|NCT00238394|Cediranib|cediranib|mesh-list
2284688|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284689|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284690|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284691|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2284692|NCT00238407|Docetaxel|docetaxel|mesh-list
2284693|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284694|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
2284695|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
2284696|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
2284697|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284698|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2818243|NCT04089072|Phenylephrine|phenylephrine|mesh-list
2818244|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
2818245|NCT04089072|Methylene Blue|methylene blue|mesh-list
2818246|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2818247|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
2818248|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
2818249|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818250|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818251|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
2818252|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2818253|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
2818254|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
2818255|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2818256|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2284699|NCT00238459|Vaccines|vaccines|mesh-list
2284700|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
2284701|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284702|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
2284703|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284704|NCT00238472|Nateglinide|nateglinide|mesh-list
2284705|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2284706|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818257|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2818258|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
2818259|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818260|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818261|NCT04089072|Protective Agents|protective agents|mesh-ancestor
2818262|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818263|NCT04089176|Oxytocin|oxytocin|mesh-list
2284707|NCT00238498|Vildagliptin|vildagliptin|mesh-list
2284708|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2284709|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284710|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2284711|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
2284712|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284713|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284714|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2284715|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2284716|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2284717|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284718|NCT00238563|Triamcinolone|triamcinolone|mesh-list
2284719|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2284720|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
2284721|NCT00238563|Hormones|hormones|mesh-ancestor
2284722|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284723|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284724|NCT00238628|Bexarotene|bexarotene|mesh-list
2284725|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284726|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
2284727|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
2284728|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2284729|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2284730|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2284731|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2284732|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284733|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
2284734|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2284735|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284736|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2284737|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284738|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2284739|NCT00238667|Aspirin|aspirin|mesh-list
2818264|NCT04089176|Carbetocin|carbetocin|mesh-list
2818265|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
2818266|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2818267|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818279|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
2284740|NCT00238667|Heparin|heparin|mesh-list
2284741|NCT00238667|Calcium heparin|calcium heparin|mesh-list
2284742|NCT00238667|Dipyridamole|dipyridamole|mesh-list
2284743|NCT00238667|Warfarin|warfarin|mesh-list
2284744|NCT00238667|Anticoagulants|anticoagulants|mesh-list
2284745|NCT00238667|Clopidogrel|clopidogrel|mesh-list
2284746|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2284747|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2284748|NCT00238667|Analgesics|analgesics|mesh-ancestor
2284749|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
2284750|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284751|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284752|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2818280|NCT04088864|Fludarabine|fludarabine|mesh-list
2818281|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2818282|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
2818283|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818284|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2818285|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2818286|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
2818287|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284753|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2818288|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818289|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2284754|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2284755|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2284756|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284757|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2284758|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2284759|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284760|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
2284761|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2284762|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2284763|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2284764|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
2284765|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2284766|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2284767|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
2284768|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2284769|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2284770|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2284771|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2284772|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284773|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2284774|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284775|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2818290|NCT04088851|Metformin|metformin|mesh-list
2818291|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2818292|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818293|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2818294|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2818295|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284776|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
2284777|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2284778|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
2284779|NCT00238732|Estrogens|estrogens|mesh-list
2284780|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2284781|NCT00238732|Hormones|hormones|mesh-ancestor
2284782|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284783|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284784|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2818296|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2818297|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
2818298|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818299|NCT04088903|Daratumumab|daratumumab|mesh-list
2818300|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818301|NCT04088604|Fluorouracil|fluorouracil|mesh-list
2818302|NCT04088604|Irinotecan|irinotecan|mesh-list
2818303|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
2818304|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818305|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2818306|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818307|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2818308|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
2818309|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818310|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2818311|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2818312|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818313|NCT04088513|Aspirin|aspirin|mesh-list
2818314|NCT04088513|Clopidogrel|clopidogrel|mesh-list
2818315|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2818316|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2818317|NCT04088513|Analgesics|analgesics|mesh-ancestor
2818318|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
2818319|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818320|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818321|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2818322|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2818323|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2818324|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2818325|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818326|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2818327|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2818328|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818329|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
2284785|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2284786|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
2284787|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2284788|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
2284789|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2284790|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2284791|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
2483647|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818330|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2818331|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2284792|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284793|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284794|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2284795|NCT00238784|Budesonide|budesonide|mesh-list
2284796|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
2284797|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2284798|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2284799|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
2284800|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284801|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284802|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2284803|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
2284804|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
2284805|NCT00238784|Hormones|hormones|mesh-ancestor
2818332|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2818333|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
2818334|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818335|NCT04088500|Nivolumab|nivolumab|mesh-list
2818336|NCT04088500|Ipilimumab|ipilimumab|mesh-list
2818337|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2818338|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818339|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2818340|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818341|NCT04088461|Metformin|metformin|mesh-list
2818342|NCT04088461|Linagliptin|linagliptin|mesh-list
2818343|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2818344|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818345|NCT04088461|Incretins|incretins|mesh-ancestor
2818346|NCT04088461|Hormones|hormones|mesh-ancestor
2818347|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2818348|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2818349|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
2818350|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818351|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818365|NCT04088448|Metformin|metformin|mesh-list
2818366|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2818367|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284806|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284807|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2284808|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2284809|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2284810|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
2284811|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2284812|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284813|NCT00238797|Gefitinib|gefitinib|mesh-list
2284814|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284815|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2284816|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284817|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284818|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
2284819|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284820|NCT00238901|Basiliximab|basiliximab|mesh-list
2284821|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2284822|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
2284823|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284824|NCT00238914|Naltrexone|naltrexone|mesh-list
2284825|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2284826|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2284827|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818368|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2818369|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2818370|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2818371|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818372|NCT04088266|Buprenorphine|buprenorphine|mesh-list
2818373|NCT04088266|Naloxone|naloxone|mesh-list
2818374|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2818375|NCT04088266|Narcotics|narcotics|mesh-ancestor
2818376|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818377|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818378|NCT04088266|Analgesics|analgesics|mesh-ancestor
2818379|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
2284828|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
2284829|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284830|NCT00238927|Fluticasone|fluticasone|mesh-list
2818380|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818381|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2818382|NCT04088032|Durvalumab|durvalumab|mesh-list
2818383|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2818384|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2818385|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818386|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2818387|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818388|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818389|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2818390|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
2818391|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2818392|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818393|NCT04088175|Menthol|menthol|mesh-list
2818394|NCT04088175|Nicotine|nicotine|mesh-list
2818395|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2818396|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
2818397|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818398|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818399|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2818400|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2818401|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
2818402|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818403|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818404|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
2818405|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
2818406|NCT04087915|Evolocumab|evolocumab|mesh-list
2818407|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2818408|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2818409|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
2818410|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818411|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2818412|NCT04088084|Palmidrol|palmidrol|mesh-list
2818413|NCT04088084|Analgesics|analgesics|mesh-ancestor
2818414|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
2818415|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818416|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818417|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2818418|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2818419|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2818420|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2818421|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
2818422|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2818423|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2818424|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2818425|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818426|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818427|NCT04088084|Hormones|hormones|mesh-ancestor
2818428|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2818429|NCT04088110|Trastuzumab|trastuzumab|mesh-list
2818430|NCT04088110|Letrozole|letrozole|mesh-list
2818431|NCT04088110|Anastrozole|anastrozole|mesh-list
2818432|NCT04088110|Exemestane|exemestane|mesh-list
2818433|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2818434|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2818435|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818436|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2818437|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818438|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818439|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2818440|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
2818441|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2818442|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818443|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2818444|NCT04087746|Ranibizumab|ranibizumab|mesh-list
2818445|NCT04087746|Aflibercept|aflibercept|mesh-list
2818446|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2818447|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2818448|NCT04087746|Growth Substances|growth substances|mesh-ancestor
2818449|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818450|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
2818451|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818452|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
2818453|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2818454|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
2818455|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818456|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
2818457|NCT04088006|Protective Agents|protective agents|mesh-ancestor
2818458|NCT04087967|Cytarabine|cytarabine|mesh-list
2818459|NCT04087967|Decitabine|decitabine|mesh-list
2818460|NCT04087967|Idarubicin|idarubicin|mesh-list
2818461|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2818462|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
2818463|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818464|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818465|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
2818466|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2818467|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2818468|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
2818469|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818470|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818471|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2818472|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2818473|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2818474|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
2818475|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
2818476|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2818477|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
2818478|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818479|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818480|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2818481|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
2818482|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2818483|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2818484|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2818485|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
2284831|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2284832|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2284833|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
2818486|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818487|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818488|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2818489|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2818490|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2818491|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
2818492|NCT04087460|Vaccines|vaccines|mesh-list
2818493|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2818494|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
2818495|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818496|NCT04087668|Anesthetics|anesthetics|mesh-list
2818497|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818498|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818499|NCT04087759|Bedaquiline|bedaquiline|mesh-list
2818500|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
2818501|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
2818502|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2818503|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2818504|NCT04087408|Hormones|hormones|mesh-list
2818505|NCT04087408|Progesterone|progesterone|mesh-list
2818506|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2818507|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818508|NCT04087408|Progestins|progestins|mesh-ancestor
2818509|NCT04087421|Glycerol|glycerol|mesh-list
2818510|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2818511|NCT04087421|Protective Agents|protective agents|mesh-ancestor
2818512|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818513|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2818514|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
2818515|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284834|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284835|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284836|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2284837|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
2284838|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
2284839|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2284840|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
2284841|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2284842|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284843|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2284844|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
2284845|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284846|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284847|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284848|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284849|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
2284850|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2284851|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284852|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2284853|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
2284854|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284855|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284856|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284857|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284858|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
2284859|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2284860|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284861|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2284862|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
2284863|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284864|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284865|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284866|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284867|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
2284868|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2284869|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284870|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2284871|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
2284872|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284873|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284874|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284875|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284876|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
2284877|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2284878|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284879|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2284880|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
2284881|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2483648|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
2284882|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284883|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284884|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284885|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
2284886|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2284887|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284888|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2284889|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
2818516|NCT04086940|Esmolol|esmolol|mesh-list
2818517|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2818518|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2818519|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2818520|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
2818521|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818522|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818523|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818524|NCT04087317|Acetaminophen|acetaminophen|mesh-list
2818525|NCT04087317|Ibuprofen|ibuprofen|mesh-list
2818526|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2284890|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284891|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284892|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284893|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284894|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
2284895|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2818527|NCT04087317|Analgesics|analgesics|mesh-ancestor
2818528|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
2818529|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818530|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818531|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
2818532|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2818533|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2818534|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2818535|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2818536|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818537|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818538|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
2818539|NCT04087096|Denosumab|denosumab|mesh-list
2818540|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2818541|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284896|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284897|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2284898|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
2284899|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284900|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284901|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284902|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284903|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
2284904|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2284905|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284906|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2284907|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
2284908|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284909|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284910|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284911|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284912|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
2284913|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2284914|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284915|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2284916|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
2284917|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284918|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284919|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284920|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284921|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
2818542|NCT04086537|Hepcidins|hepcidins|mesh-list
2818543|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2818544|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
2818545|NCT04086719|BMS-986165|bms-986165|mesh-list
2818546|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
2818547|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2818548|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2818549|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284922|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2284923|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284924|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2284925|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
2818550|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2818551|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818552|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818553|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
2818554|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2818555|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
2818556|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
2818557|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818558|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818559|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818560|NCT04086290|Androgens|androgens|mesh-list
2818561|NCT04086290|Hormones|hormones|mesh-ancestor
2818562|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2818563|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818564|NCT04086264|Azacitidine|azacitidine|mesh-list
2284926|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284927|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284928|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284929|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284930|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
2284931|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2284932|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284933|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2284934|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
2284935|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284936|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284937|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284938|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284939|NCT00239096|Losartan|losartan|mesh-list
2284940|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2284941|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2284942|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2284943|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2284944|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284945|NCT00239109|Olanzapine|olanzapine|mesh-list
2284946|NCT00239109|Ziprasidone|ziprasidone|mesh-list
2284947|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
2284948|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
2284949|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2284950|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818565|NCT04086264|Decitabine|decitabine|mesh-list
2818566|NCT04086264|Venetoclax|venetoclax|mesh-list
2818567|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2818568|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
2818569|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818570|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818571|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818572|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2818573|NCT04086212|Icodextrin|icodextrin|mesh-list
2818574|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
2818575|NCT04086186|Bupivacaine|bupivacaine|mesh-list
2818576|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
2818577|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
2818578|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818579|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818580|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
2818581|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818582|NCT04086238|Decitabine|decitabine|mesh-list
2818583|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
2818584|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2818585|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
2818586|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818587|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818588|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818589|NCT04085913|Lidocaine|lidocaine|mesh-list
2818590|NCT04085913|Epinephrine|epinephrine|mesh-list
2818591|NCT04085913|Racepinephrine|racepinephrine|mesh-list
2818592|NCT04085913|Bupivacaine|bupivacaine|mesh-list
2818593|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
2818594|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
2818595|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
2818596|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818597|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818598|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
2818599|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818600|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2818601|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2818602|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2818603|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2818604|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818605|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2818606|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2818607|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
2818608|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818609|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2818610|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2818611|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
2284951|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2284952|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2284953|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2284954|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2284955|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2284956|NCT00239109|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2284957|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2284958|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2483649|NCT01129323|Fludarabine|fludarabine|mesh-list
2818612|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2818613|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
2818614|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
2818615|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
2818616|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2818620|NCT04085562|Amlodipine|amlodipine|mesh-list
2818621|NCT04085562|Bisoprolol|bisoprolol|mesh-list
2818622|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2818623|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2818624|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2818625|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818626|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2818627|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818628|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
2818629|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
2818630|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
2818631|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818632|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2818633|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2818634|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2818635|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
2818636|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818637|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
2818638|NCT04085744|Lidocaine|lidocaine|mesh-list
2818639|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
2818640|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
2818641|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818642|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818643|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
2818644|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818645|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2818646|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2818647|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2818648|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2818649|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818650|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2818651|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
2818652|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2818653|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
2818654|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2818655|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
2818656|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2818657|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2818658|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818659|NCT04085770|Vitamins|vitamins|mesh-ancestor
2818660|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
2818661|NCT04085757|Dinoprostone|dinoprostone|mesh-list
2818662|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
2284959|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284960|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2284961|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
2284962|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2284963|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2284964|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
2284965|NCT00239161|Levofloxacin|levofloxacin|mesh-list
2284966|NCT00239161|Ofloxacin|ofloxacin|mesh-list
2284967|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2284968|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284969|NCT00239161|Renal Agents|renal agents|mesh-ancestor
2284970|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2284971|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2284972|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2284973|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2284974|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284975|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818663|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2818664|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818665|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
2818666|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2818667|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2818668|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818669|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
2818670|NCT04085575|Coagulants|coagulants|mesh-ancestor
2284976|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2284977|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2284978|NCT00239174|Surinabant|surinabant|mesh-list
2284979|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2284980|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2284981|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2284982|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284983|NCT00239174|Hormones|hormones|mesh-ancestor
2284984|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2284985|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2284986|NCT00239200|Lapatinib|lapatinib|mesh-list
2284987|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284988|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2284989|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818671|NCT04085627|Amlodipine|amlodipine|mesh-list
2818672|NCT04085627|Valsartan|valsartan|mesh-list
2818673|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
2818674|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2818675|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2818676|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2105272|NCT02452320|Analgesics|analgesics|mesh-ancestor
2105273|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
2105274|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105275|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105276|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
2105277|NCT02452346|Tosedostat|tosedostat|mesh-list
2105278|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105279|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105280|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
2105281|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2105282|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105283|NCT02452463|Durvalumab|durvalumab|mesh-list
2284990|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2284991|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
2284992|NCT00239239|Hematinics|hematinics|mesh-ancestor
2284993|NCT00239252|Interferons|interferons|mesh-list
2284994|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
2818677|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818678|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2818679|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818680|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
2818681|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2818682|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2818683|NCT04085393|Granisetron|granisetron|mesh-list
2818684|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
2818685|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
2818686|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818687|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818688|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2818689|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2818690|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
2818691|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818692|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818693|NCT04085640|Ropivacaine|ropivacaine|mesh-list
2818694|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
2818695|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
2818696|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818697|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818698|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
2818699|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818700|NCT04085094|Pilocarpine|pilocarpine|mesh-list
2818701|NCT04085094|Miotics|miotics|mesh-ancestor
2818702|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
2818703|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818704|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818705|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2818706|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2818707|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
2818708|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818709|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818710|NCT04085354|Vitamins|vitamins|mesh-list
2818711|NCT04085354|Folic Acid|folic acid|mesh-list
2818712|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
2818713|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
2818714|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
2284995|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2284996|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
2284997|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2284998|NCT00239278|Prednisolone|prednisolone|mesh-list
2284999|NCT00239278|Budesonide|budesonide|mesh-list
2285000|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
2285001|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285002|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
2285003|NCT00239278|Hormones|hormones|mesh-ancestor
2285004|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2818715|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818716|NCT04085354|Hematinics|hematinics|mesh-ancestor
2105284|NCT02452463|Nintedanib|nintedanib|mesh-list
2285005|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818717|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
2818718|NCT04085172|Guanfacine|guanfacine|mesh-list
2818719|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2818720|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2818721|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2818722|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2818723|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818724|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
2818725|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818726|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818727|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2818728|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2818729|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2818730|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2818731|NCT04085120|Dexamethasone|dexamethasone|mesh-list
2818732|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
2818733|NCT04085120|Lidocaine|lidocaine|mesh-list
2818734|NCT04085120|Ropivacaine|ropivacaine|mesh-list
2818735|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2818736|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
2818737|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
2818738|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818739|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818740|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2818741|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
2818742|NCT04085120|Hormones|hormones|mesh-ancestor
2818743|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2818744|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2818745|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818746|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
2818747|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
2818748|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818749|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
2818750|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2818751|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2818752|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2818753|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2818754|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818755|NCT04085276|Paclitaxel|paclitaxel|mesh-list
2818756|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2818757|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2818758|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818759|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
2818760|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
2818761|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
2818762|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818763|NCT04085250|Nivolumab|nivolumab|mesh-list
2818764|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2818765|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818766|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2818767|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818768|NCT04085315|Osimertinib|osimertinib|mesh-list
2818769|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818770|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2818771|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818772|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818773|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
2818774|NCT04085419|Denosumab|denosumab|mesh-list
2818775|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2818776|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818777|NCT04085237|Ropivacaine|ropivacaine|mesh-list
2818778|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
2818779|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
2818780|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818781|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818782|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
2818783|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818784|NCT04084977|Antibodies|antibodies|mesh-list
2818785|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
2818786|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818787|NCT04084860|Ketamine|ketamine|mesh-list
2818788|NCT04084860|Analgesics|analgesics|mesh-ancestor
2818789|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
2818790|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818791|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285006|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2285007|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285008|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
2285009|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285010|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2285011|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2285012|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
2285013|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2285014|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2285015|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2285016|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
2285017|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285018|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285019|NCT00239291|Gefitinib|gefitinib|mesh-list
2285020|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285021|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2285022|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818792|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2818793|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2818794|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
2818795|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
2818796|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818797|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2818798|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2818799|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818800|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818801|NCT04084912|Dexamethasone|dexamethasone|mesh-list
2285023|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285024|NCT00239304|Gefitinib|gefitinib|mesh-list
2285025|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285026|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2285027|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818802|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
2818803|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2818804|NCT04084912|BB 1101|bb 1101|mesh-list
2818805|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2818806|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
2818807|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
2818808|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818809|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818810|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2818811|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
2818812|NCT04084912|Hormones|hormones|mesh-ancestor
2818813|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2818814|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2818815|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818816|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
2818817|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818818|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818828|NCT04084548|Lidocaine|lidocaine|mesh-list
2818829|NCT04084548|Ketamine|ketamine|mesh-list
2818830|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
2818831|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
2818832|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818833|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818834|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
2818835|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818836|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2818837|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2818838|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2818839|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2818840|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818841|NCT04084548|Analgesics|analgesics|mesh-ancestor
2285028|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285029|NCT00239330|Atorvastatin|atorvastatin|mesh-list
2818842|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2818843|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2818844|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
2818845|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2818846|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2818847|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818848|NCT04084496|Folfirinox|folfirinox|mesh-list
2818849|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818850|NCT04084158|Paclitaxel|paclitaxel|mesh-list
2818851|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2818852|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2818853|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818854|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
2818855|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
2818856|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
2818857|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818858|NCT04084106|Amoxicillin|amoxicillin|mesh-list
2818859|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
2818860|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
2818861|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2818862|NCT04084106|Penicillin V|penicillin v|mesh-list
2818863|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2285030|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2285031|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2285032|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2285033|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
2285034|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285035|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2285036|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2818864|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2818865|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818866|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818867|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2818868|NCT04084171|Insulin|insulin|mesh-list
2818869|NCT04084171|Pancrelipase|pancrelipase|mesh-list
2285037|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285038|NCT00239343|Gefitinib|gefitinib|mesh-list
2285039|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285040|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2285041|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285042|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818870|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2818871|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818872|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2285043|NCT00239369|Telmisartan|telmisartan|mesh-list
2285044|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2285045|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2285046|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2285047|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2285048|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285049|NCT00239369|Diuretics|diuretics|mesh-ancestor
2285050|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
2285051|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285052|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2285053|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2285054|NCT00239382|Meloxicam|meloxicam|mesh-list
2285055|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2285056|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285057|NCT00239382|Analgesics|analgesics|mesh-ancestor
2285058|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
2285059|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285060|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285061|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285062|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285063|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2285064|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2285065|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285066|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285067|NCT00239395|Meloxicam|meloxicam|mesh-list
2285068|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2483650|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
2818873|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2818874|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
2818875|NCT04084210|Nicotine|nicotine|mesh-list
2818876|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2818877|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
2818878|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285069|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285070|NCT00239395|Analgesics|analgesics|mesh-ancestor
2285071|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
2285072|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285073|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818879|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818880|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2818881|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2818882|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
2818883|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818884|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285074|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285075|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285076|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2285077|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2285078|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285079|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285080|NCT00239408|Bromides|bromides|mesh-list
2285081|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
2285082|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2285083|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
2285084|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285085|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285086|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2285087|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
2285088|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
2285089|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2285090|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
2285091|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285092|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285093|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
2285094|NCT00239421|Fluticasone|fluticasone|mesh-list
2285095|NCT00239421|Xhance|xhance|mesh-list
2285096|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
2285097|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
2285098|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2285099|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285100|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2285101|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
2285102|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285103|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285104|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2285105|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
2285106|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
2285107|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2285108|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2285109|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2818906|NCT04083898|Prednisone|prednisone|mesh-list
2818907|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2818908|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2818909|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
2818910|NCT04083898|Hormones|hormones|mesh-ancestor
2818911|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2818912|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818913|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2818914|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818915|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2818916|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
2818917|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818918|NCT04083911|Cytarabine|cytarabine|mesh-list
2285110|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2285111|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
2285112|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285113|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285114|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
2285115|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2285116|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
2818919|NCT04083911|Decitabine|decitabine|mesh-list
2818920|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
2818921|NCT04083911|Aclarubicin|aclarubicin|mesh-list
2818922|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2818923|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
2818924|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818925|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818926|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
2818927|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2818928|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2818929|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
2818930|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818931|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818932|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2818933|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2818934|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2818935|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2818936|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2818937|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2818938|NCT04083807|Thrombin|thrombin|mesh-list
2818939|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
2818940|NCT04083807|Coagulants|coagulants|mesh-ancestor
2285117|NCT00239434|Bromides|bromides|mesh-list
2285118|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
2285119|NCT00239434|Ipratropium|ipratropium|mesh-list
2285120|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2285121|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
2818941|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
2818942|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
2818943|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
2818944|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2818945|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818946|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
2818947|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2818948|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2818949|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2818950|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818951|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
2818952|NCT04083755|Hematinics|hematinics|mesh-ancestor
2818953|NCT04083599|Gemcitabine|gemcitabine|mesh-list
2818954|NCT04083599|Paclitaxel|paclitaxel|mesh-list
2818955|NCT04083599|Carboplatin|carboplatin|mesh-list
2818956|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
2818957|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2818958|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2818959|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
2818960|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
2818961|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
2285122|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285123|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285124|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2285125|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
2285126|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
2285127|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2285128|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
2285129|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285130|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285131|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
2285132|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
2818962|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2818963|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2818964|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
2818965|NCT04083599|Antiviral Agents|antiviral agents|mesh-ancestor
2818966|NCT04083599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2818967|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2818968|NCT04083599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2818969|NCT04083599|Immunologic Factors|immunologic factors|mesh-ancestor
2818970|NCT04083599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818971|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2818972|NCT04083651|Bromides|bromides|mesh-list
2818973|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
2818974|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
2818975|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2818976|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818977|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
2818978|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285133|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2285134|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
2285135|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285136|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285137|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2285138|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
2285139|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
2285140|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2285141|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
2285142|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285143|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285144|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
2285145|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2285146|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
2818979|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2818980|NCT04083417|Penicillins|penicillins|mesh-list
2818981|NCT04083417|Penicillin V|penicillin v|mesh-list
2818982|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2818983|NCT04083664|Hepcidins|hepcidins|mesh-list
2818984|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2818985|NCT04083625|Carbetocin|carbetocin|mesh-list
2818986|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
2818987|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2818988|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818989|NCT04083144|Varenicline|varenicline|mesh-list
2818990|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2818991|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2818992|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
2818993|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2818994|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285147|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285148|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285149|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2285150|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
2285151|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
2285152|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2285153|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
2285154|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285155|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285156|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2285157|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
2285158|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2285159|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
2285160|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285161|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285162|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2285163|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
2285164|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
2285165|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2285166|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
2285167|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285168|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285169|NCT00239486|Pramipexole|pramipexole|mesh-list
2285170|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
2285171|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285172|NCT00239486|Protective Agents|protective agents|mesh-ancestor
2285173|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285174|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2285175|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2285176|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
2285177|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
2285178|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285179|NCT00239499|Fluticasone|fluticasone|mesh-list
2285180|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
2285181|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2285182|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285183|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2818995|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2818996|NCT04083105|Midazolam|midazolam|mesh-list
2818997|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
2818998|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2818999|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2819000|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2819001|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819002|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2819003|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2819004|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2819005|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2819006|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
2819007|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
2819008|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
2819009|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
2819010|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2819011|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819012|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2285184|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
2285185|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285186|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819013|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2819014|NCT04083105|Analgesics|analgesics|mesh-ancestor
2819015|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
2819016|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819017|NCT04083157|Imiquimod|imiquimod|mesh-list
2819018|NCT04083157|Vaccines|vaccines|mesh-list
2819019|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
2819020|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819021|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2819022|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819023|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
2819024|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
2819025|NCT04083209|Narcotics|narcotics|mesh-ancestor
2819026|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2819027|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819028|NCT04083209|Analgesics|analgesics|mesh-ancestor
2819029|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
2819030|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819031|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
2819032|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
2819033|NCT04083560|Hematinics|hematinics|mesh-ancestor
2819034|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
2819035|NCT04083560|Vitamins|vitamins|mesh-ancestor
2819036|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
2819037|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819038|NCT04083066|Cytarabine|cytarabine|mesh-list
2819039|NCT04083066|Dexamethasone|dexamethasone|mesh-list
2819040|NCT04083066|Rituximab|rituximab|mesh-list
2819041|NCT04083066|Methotrexate|methotrexate|mesh-list
2819042|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2819043|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
2819044|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
2819045|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819046|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819047|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2819048|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
2819049|NCT04083066|Hormones|hormones|mesh-ancestor
2819050|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2819051|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2819052|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819053|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2819054|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
2819055|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2819056|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2819057|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
2819058|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2819059|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2819060|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
2819061|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819062|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
2819063|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819064|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2819065|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2819066|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2819067|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
2819068|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819069|NCT04083118|Listerine|listerine|mesh-list
2819070|NCT04083118|Fluorides|fluorides|mesh-list
2819071|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
2819072|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
2819073|NCT04083118|Protective Agents|protective agents|mesh-ancestor
2819074|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819075|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2819076|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819077|NCT04083235|Leucovorin|leucovorin|mesh-list
2819078|NCT04083235|Gemcitabine|gemcitabine|mesh-list
2819079|NCT04083235|Paclitaxel|paclitaxel|mesh-list
2819080|NCT04083235|Fluorouracil|fluorouracil|mesh-list
2819081|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
2819082|NCT04083235|Irinotecan|irinotecan|mesh-list
2819083|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2819084|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819085|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
2819086|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
2819087|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
2819088|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819089|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2285187|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2285188|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
2285189|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
2285190|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2285191|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
2285192|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2285193|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
2285194|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285195|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285196|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2285197|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2819090|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
2819091|NCT04083235|Antiviral Agents|antiviral agents|mesh-ancestor
2819092|NCT04083235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819093|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819094|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2819095|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
2819096|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819097|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2819098|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2819099|NCT04083235|Antidotes|antidotes|mesh-ancestor
2819100|NCT04083235|Protective Agents|protective agents|mesh-ancestor
2819101|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
2819102|NCT04083235|Vitamins|vitamins|mesh-ancestor
2819103|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
2819104|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
2819105|NCT04083183|Sirolimus|sirolimus|mesh-list
2285198|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2285199|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
2285200|NCT00239512|Ibuprofen|ibuprofen|mesh-list
2285201|NCT00239512|Indomethacin|indomethacin|mesh-list
2285202|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2285203|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2819106|NCT04083183|Vidarabine|vidarabine|mesh-list
2819107|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
2819108|NCT04083183|Fludarabine|fludarabine|mesh-list
2819109|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
2819110|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2819111|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
2819112|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2819113|NCT04083183|Antibodies|antibodies|mesh-list
2819114|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
2819115|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2819116|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
2819117|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2819118|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2819119|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2819120|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
2819121|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819122|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2819123|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2819124|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
2819125|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285204|NCT00239512|Analgesics|analgesics|mesh-ancestor
2285205|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
2285206|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285207|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285208|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285209|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285210|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2285211|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285212|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285213|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
2285214|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
2285215|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2819126|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819127|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2819128|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2819129|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
2819130|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2285216|NCT00239538|Valsartan|valsartan|mesh-list
2285217|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2285218|NCT00239538|Telmisartan|telmisartan|mesh-list
2285219|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2285220|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2285221|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2285222|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285223|NCT00239538|Diuretics|diuretics|mesh-ancestor
2285224|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
2285225|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819131|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2819132|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
2819133|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2819134|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819135|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819136|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
2819137|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
2819138|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2819139|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
2819140|NCT04082949|Coagulants|coagulants|mesh-ancestor
2819141|NCT04082962|Dexamethasone|dexamethasone|mesh-list
2819142|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2819143|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
2819144|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
2819145|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819146|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819147|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2819148|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
2819149|NCT04082962|Hormones|hormones|mesh-ancestor
2819150|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2819151|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2819152|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819153|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2819154|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2819155|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819156|NCT04082897|Atezolizumab|atezolizumab|mesh-list
2819157|NCT04082897|Venetoclax|venetoclax|mesh-list
2819158|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
2819159|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819160|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2819161|NCT04082728|Dipyrone|dipyrone|mesh-list
2819162|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2819163|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2819164|NCT04082728|Analgesics|analgesics|mesh-ancestor
2819165|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
2819166|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819167|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819168|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2819169|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2819170|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
2819171|NCT04082650|Vitamin D|vitamin d|mesh-list
2285226|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2285227|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2285228|NCT00239551|Lansoprazole|lansoprazole|mesh-list
2285229|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2285230|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2285231|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2285232|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819172|NCT04082650|Vitamins|vitamins|mesh-ancestor
2819173|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
2819174|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819175|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2819176|NCT04082715|Celecoxib|celecoxib|mesh-list
2819177|NCT04082715|Levodopa|levodopa|mesh-list
2819178|NCT04082715|Carbidopa|carbidopa|mesh-list
2819179|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2819180|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2819181|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2819182|NCT04082715|Analgesics|analgesics|mesh-ancestor
2819183|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
2819184|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819185|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819186|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2819187|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2819188|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2819189|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2105285|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
2105286|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2105287|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
2819190|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819191|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819192|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2819193|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2819194|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
2819195|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2819196|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2819197|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2819198|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
2819199|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
2819200|NCT04082858|Midazolam|midazolam|mesh-list
2819201|NCT04082858|Ketamine|ketamine|mesh-list
2819202|NCT04082858|Analgesics|analgesics|mesh-ancestor
2819203|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
2819204|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819205|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819206|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2819207|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2819208|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
2819209|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
2105288|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2819210|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2819211|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2819212|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2819213|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2819214|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285233|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285234|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2285235|NCT00239616|Hematinics|hematinics|mesh-ancestor
2285236|NCT00239629|Teriparatide|teriparatide|mesh-list
2285237|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
2285238|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2285239|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285240|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2285241|NCT00239694|Vaccines|vaccines|mesh-list
2285242|NCT00239694|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2285243|NCT00239694|Immunologic Factors|immunologic factors|mesh-ancestor
2285244|NCT00239694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285245|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
2285246|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2819215|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2819216|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2819217|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2819218|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2819219|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2819220|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
2819221|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
2285247|NCT00239707|Incretins|incretins|mesh-ancestor
2285248|NCT00239707|Hormones|hormones|mesh-ancestor
2285249|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2285250|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285251|NCT00239746|Ibuprofen|ibuprofen|mesh-list
2285252|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2285253|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285254|NCT00239746|Analgesics|analgesics|mesh-ancestor
2285255|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
2285256|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285257|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285258|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285259|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285260|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2285261|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285262|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285263|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2285264|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2285265|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285266|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2285267|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
2819222|NCT04082793|Diclofenac|diclofenac|mesh-list
2819223|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2819224|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2819225|NCT04082793|Analgesics|analgesics|mesh-ancestor
2819226|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
2819227|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819228|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819229|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2819230|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2819231|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2819232|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819233|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819234|NCT04082754|Antibodies|antibodies|mesh-list
2819235|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2819236|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
2819237|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819238|NCT04082936|Immunoglobulin M|immunoglobulin m|mesh-list
2819239|NCT04082936|Immunologic Factors|immunologic factors|mesh-ancestor
2819240|NCT04082936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819241|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
2819242|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2819243|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819244|NCT04082910|Metoprolol|metoprolol|mesh-list
2819245|NCT04082910|Antibodies|antibodies|mesh-list
2819246|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
2285268|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819247|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819248|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2819249|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2819250|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
2819251|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
2819252|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819253|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2819254|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2819255|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2819256|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
2819257|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2819258|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819259|NCT04082676|Bupivacaine|bupivacaine|mesh-list
2819260|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
2819261|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
2285269|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2285270|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2285271|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285272|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2819262|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2819263|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819264|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
2819265|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819266|NCT04082806|Trazodone|trazodone|mesh-list
2819267|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2819268|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2819269|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2819270|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819271|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2819272|NCT04082806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2819273|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2819274|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2819275|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819276|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2819277|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
2819278|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2819279|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
2819280|NCT04082767|Midazolam|midazolam|mesh-list
2819281|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
2819282|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2819283|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2819284|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819285|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2819286|NCT04082767|Analgesics|analgesics|mesh-ancestor
2819287|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
2819288|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819289|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2819290|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2819291|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2819292|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
2819293|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2819294|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819295|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2819296|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2819297|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2819298|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2819299|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2819300|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
2819301|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
2819302|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
2819303|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
2819304|NCT04082598|Amoxicillin|amoxicillin|mesh-list
2819305|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
2819306|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
2819307|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2819308|NCT04082598|Lactoferrin|lactoferrin|mesh-list
2819309|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2819310|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819311|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2819312|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819313|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819314|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2819315|NCT04082559|Metronidazole|metronidazole|mesh-list
2819316|NCT04082559|Doxycycline|doxycycline|mesh-list
2285273|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
2105289|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105290|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
2105291|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105292|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2105293|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819317|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
2819318|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2819319|NCT04082559|Complement Factor H|complement factor h|mesh-list
2285274|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285275|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2285276|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2483651|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2819320|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819321|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
2819322|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2819323|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2819324|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
2819325|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2819326|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2819327|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819328|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819329|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819330|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2819331|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2819332|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2819333|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2819334|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
2819335|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819336|NCT04082286|Antibodies|antibodies|mesh-list
2819337|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2819338|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
2819339|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819342|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2819343|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819344|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2819345|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
2819346|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2819347|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819348|NCT04082182|Vaccines|vaccines|mesh-list
2819349|NCT04082182|Immunologic Factors|immunologic factors|mesh-ancestor
2819350|NCT04082182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285277|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285278|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2285279|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
2285280|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285281|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2285282|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2285283|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285284|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2285285|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
2819351|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2819352|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819353|NCT04081909|Fentanyl|fentanyl|mesh-list
2819354|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
2819355|NCT04081909|Ketamine|ketamine|mesh-list
2819356|NCT04081909|Remifentanil|remifentanil|mesh-list
2819357|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2819358|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2819359|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819360|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2819361|NCT04081909|Analgesics|analgesics|mesh-ancestor
2819362|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
2819363|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819364|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2819365|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2819366|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2819367|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
2819368|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2819369|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819370|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2819371|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2819372|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
2819373|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
2819374|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2819375|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2819376|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2819377|NCT04081909|Narcotics|narcotics|mesh-ancestor
2819378|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2819379|NCT04081831|Aspirin|aspirin|mesh-list
2819380|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2819381|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2819382|NCT04081831|Analgesics|analgesics|mesh-ancestor
2285286|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285287|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2285288|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2285289|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285290|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2285291|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
2285292|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285293|NCT00239889|Calcitonin|calcitonin|mesh-list
2285294|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
2285295|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2285296|NCT00239889|Katacalcin|katacalcin|mesh-list
2285297|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2285298|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285299|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2285300|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
2285301|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2285302|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2285303|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285304|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2285305|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
2285306|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285307|NCT00239954|Citalopram|citalopram|mesh-list
2285308|NCT00239954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2285309|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2285310|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2285311|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285312|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285313|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
2285314|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285315|NCT00239954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2819383|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
2819384|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819385|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819386|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2819387|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2819388|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2819389|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2819390|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819391|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2819392|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2819393|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819394|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
2285316|NCT00239954|Antidepressive Agents|antidepressive agents|mesh-ancestor
2285317|NCT00239954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2285318|NCT00239967|Rimonabant|rimonabant|mesh-list
2285319|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2285320|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2285321|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2285322|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285323|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819395|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
2819396|NCT04081545|Analgesics|analgesics|mesh-list
2819397|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
2819398|NCT04081545|Anesthetics|anesthetics|mesh-list
2819399|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2819400|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819401|NCT04081545|Narcotics|narcotics|mesh-ancestor
2819402|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
2819403|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819404|NCT04081805|Estradiol|estradiol|mesh-list
2819405|NCT04081805|Estrogens|estrogens|mesh-ancestor
2285324|NCT00239967|Hormones|hormones|mesh-ancestor
2285325|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2285326|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285327|NCT00239980|Dalteparin|dalteparin|mesh-list
2285328|NCT00239980|Tinzaparin|tinzaparin|mesh-list
2285329|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2285330|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
2285331|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2285332|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2285333|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285334|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
2285335|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
2285336|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2285337|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
2285338|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285339|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2285340|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285341|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2285342|NCT00240019|Furosemide|furosemide|mesh-list
2285343|NCT00240019|Diuretics|diuretics|mesh-ancestor
2285344|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
2285345|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285346|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2285347|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2285348|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285349|NCT00240032|Cetirizine|cetirizine|mesh-list
2285350|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
2285351|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
2285352|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2285353|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2285354|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2285355|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
2285356|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
2285357|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483652|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
2819406|NCT04081805|Hormones|hormones|mesh-ancestor
2819407|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2819408|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819409|NCT04081688|Atezolizumab|atezolizumab|mesh-list
2819410|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2819411|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
2819412|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
2819413|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819414|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
2819415|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819416|NCT04081389|Interferons|interferons|mesh-list
2285358|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285359|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285360|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2819417|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
2819418|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
2819419|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2819420|NCT04081389|Celecoxib|celecoxib|mesh-list
2819421|NCT04081389|Paclitaxel|paclitaxel|mesh-list
2819422|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
2819423|NCT04081389|Doxorubicin|doxorubicin|mesh-list
2819424|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2819425|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2819426|NCT04081389|Daunorubicin|daunorubicin|mesh-list
2819427|NCT04081389|Benzenesulfonamide|benzenesulfonamide|mesh-list
2819428|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2819429|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819430|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
2819431|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
2819432|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
2819433|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819434|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2285361|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
2285362|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2285363|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285364|NCT00240045|Octreotide|octreotide|mesh-list
2285365|NCT00240045|Midodrine|midodrine|mesh-list
2285366|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2285367|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2285368|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285369|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
2285370|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
2285371|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285372|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285373|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2285374|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2285375|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2285376|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2285377|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
2285378|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285379|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285380|NCT00240058|Phenylephrine|phenylephrine|mesh-list
2819435|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
2819436|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819437|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2819438|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2819439|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
2819440|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2819441|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2819442|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2819443|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2819444|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819445|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
2819446|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819447|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2819448|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2819449|NCT04081389|Analgesics|analgesics|mesh-ancestor
2819450|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
2819451|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819452|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2819453|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2819454|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2819455|NCT04081389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2819456|NCT04081376|Hydromorphone|hydromorphone|mesh-list
2819457|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2819458|NCT04081376|Narcotics|narcotics|mesh-ancestor
2819459|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2819460|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819461|NCT04081376|Analgesics|analgesics|mesh-ancestor
2819462|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
2819463|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819464|NCT04081480|Valacyclovir|valacyclovir|mesh-list
2819465|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
2819466|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819467|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
2819468|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2819469|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
2819470|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819471|NCT04081012|Expectorants|expectorants|mesh-ancestor
2819472|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
2819473|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2819474|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
2819475|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819476|NCT04081012|Protective Agents|protective agents|mesh-ancestor
2819477|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819478|NCT04081012|Antidotes|antidotes|mesh-ancestor
2285381|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
2285382|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
2285383|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2285384|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
2285385|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
2285386|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285387|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285388|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
2285389|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2285390|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
2285391|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
2285392|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2285393|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2285394|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2285395|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
2285396|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285397|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285398|NCT00240058|Protective Agents|protective agents|mesh-ancestor
2285399|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2285400|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2285401|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2285402|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
2285403|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2285404|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
2285405|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
2285406|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2285407|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
2819485|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
2819486|NCT04081077|Linezolid|linezolid|mesh-list
2819487|NCT04081077|Bedaquiline|bedaquiline|mesh-list
2819488|NCT04081077|Clofazimine|clofazimine|mesh-list
2819489|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2819490|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819491|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2819492|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2819493|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819494|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819495|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819496|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2819497|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
2819498|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2819499|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
2819500|NCT04080947|Montelukast|montelukast|mesh-list
2819501|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2819502|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
2819503|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2819504|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
2819505|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2819506|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819507|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2819508|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2819509|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819516|NCT04080895|Lumefantrine|lumefantrine|mesh-list
2285408|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819517|NCT04080895|Artemether|artemether|mesh-list
2285409|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
2285410|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2285411|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2285412|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2285413|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285414|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
2285415|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
2285416|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
2285417|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285418|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
2285419|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
2285420|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2285421|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2285422|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
2285423|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
2285424|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285425|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285426|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2285427|NCT00240149|Insulin|insulin|mesh-list
2285428|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2285429|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2285430|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285431|NCT00240214|Sirolimus|sirolimus|mesh-list
2285432|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2285433|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2285434|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2285435|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285436|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
2285437|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2285438|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
2285439|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285440|NCT00240253|Pramlintide|pramlintide|mesh-list
2285441|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2285442|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285443|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2285444|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2819518|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2819519|NCT04080895|Amodiaquine|amodiaquine|mesh-list
2819520|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
2819521|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2819522|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2819523|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819524|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2819525|NCT04080908|Hematinics|hematinics|mesh-ancestor
2819526|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2819527|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2819528|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
2819529|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2819530|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819531|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2819532|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819533|NCT04080726|Esomeprazole|esomeprazole|mesh-list
2819534|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2819535|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2819536|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2819537|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819538|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819542|NCT04080739|Ropivacaine|ropivacaine|mesh-list
2819543|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
2819544|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
2819545|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2819546|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819547|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
2819548|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285445|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2285446|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
2285447|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285448|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2285449|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2285450|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285451|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2285452|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2285453|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2285454|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
2285455|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285456|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2285457|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2285458|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285459|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2285460|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2285461|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2285462|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
2285463|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285464|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2285465|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2819549|NCT04080375|Dinoprostone|dinoprostone|mesh-list
2819550|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
2819551|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2819552|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819553|NCT04080388|Diuretics|diuretics|mesh-list
2285466|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285467|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2285468|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2285469|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2285470|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
2285471|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285472|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2285473|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2285474|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819554|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
2819555|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819556|NCT04080713|Budesonide|budesonide|mesh-list
2819557|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2819558|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2819559|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
2819560|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285475|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2285476|NCT00240318|Calcium|calcium|mesh-list
2285477|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2285478|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285479|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2285480|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2285481|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
2285482|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285483|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2285484|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2285485|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285486|NCT00240396|Narcotics|narcotics|mesh-list
2285487|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2285488|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285489|NCT00240396|Analgesics|analgesics|mesh-ancestor
2285490|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
2285491|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285492|NCT00240409|Pramipexole|pramipexole|mesh-list
2285493|NCT00240409|Bromocriptine|bromocriptine|mesh-list
2285494|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
2285495|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285496|NCT00240409|Protective Agents|protective agents|mesh-ancestor
2285497|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819561|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819562|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2819563|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
2819564|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
2819565|NCT04080713|Hormones|hormones|mesh-ancestor
2819566|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2285498|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2285499|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2285500|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
2285501|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
2819567|NCT04080284|Niraparib|niraparib|mesh-list
2819568|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2819569|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819570|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819571|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819572|NCT04080622|Selenium|selenium|mesh-list
2819573|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
2285502|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285503|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
2285504|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2285505|NCT00240422|Telmisartan|telmisartan|mesh-list
2285506|NCT00240422|Ramipril|ramipril|mesh-list
2285507|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2285508|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2285509|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2285510|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285511|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2285512|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
2285513|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285514|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2285515|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
2285516|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2285517|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
2285518|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285519|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285520|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2285521|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
2285522|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
2285523|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2285524|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
2819574|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819575|NCT04080622|Protective Agents|protective agents|mesh-ancestor
2819576|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819577|NCT04080622|Trace Elements|trace elements|mesh-ancestor
2819578|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
2819579|NCT04080349|Misoprostol|misoprostol|mesh-list
2819580|NCT04080349|Dinoprostone|dinoprostone|mesh-list
2819581|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2819582|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
2819583|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2819584|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819585|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2819586|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2819587|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
2819588|NCT04080323|Dinoprostone|dinoprostone|mesh-list
2819589|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
2819590|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2819591|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819592|NCT04080336|Misoprostol|misoprostol|mesh-list
2819593|NCT04080336|Dinoprostone|dinoprostone|mesh-list
2819594|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2819595|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
2819596|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2819597|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819598|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2819599|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2819600|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
2819601|NCT04080310|Ezetimibe|ezetimibe|mesh-list
2819602|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2819603|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2819604|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2819605|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
2819606|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819607|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2819608|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819609|NCT04080427|Dronabinol|dronabinol|mesh-list
2819610|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
2819611|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819612|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2819613|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2819614|NCT04080427|Analgesics|analgesics|mesh-ancestor
2819615|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
2819616|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819617|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2819618|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2819619|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2819620|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285525|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285526|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285527|NCT00240448|Valsartan|valsartan|mesh-list
2285528|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2285529|NCT00240448|Telmisartan|telmisartan|mesh-list
2285530|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2285531|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2285532|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2819621|NCT04080427|Hormones|hormones|mesh-ancestor
2819622|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2819623|NCT04080869|Vitamin A|vitamin a|mesh-list
2819624|NCT04080869|Tretinoin|tretinoin|mesh-list
2819625|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
2819626|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819627|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
2819628|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
2285533|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285534|NCT00240448|Diuretics|diuretics|mesh-ancestor
2285535|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
2285536|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285537|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2285538|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2285539|NCT00240474|Amlodipine|amlodipine|mesh-list
2285540|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2285541|NCT00240474|Telmisartan|telmisartan|mesh-list
2285542|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2285543|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2285544|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2285545|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285546|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2819629|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
2819630|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819631|NCT04080869|Protective Agents|protective agents|mesh-ancestor
2819632|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819633|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2819634|NCT04080869|Vitamins|vitamins|mesh-ancestor
2819635|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
2819636|NCT04079933|Nicotine|nicotine|mesh-list
2819637|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2819638|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
2819639|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285547|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285548|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
2285549|NCT00240474|Diuretics|diuretics|mesh-ancestor
2285550|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
2285551|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2819640|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819641|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2819642|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2819643|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
2819644|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2819645|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819646|NCT04080076|Tacrolimus|tacrolimus|mesh-list
2819647|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2819648|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
2819649|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819650|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2285552|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2285553|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2285554|NCT00240513|Minocycline|minocycline|mesh-list
2285555|NCT00240513|Tretinoin|tretinoin|mesh-list
2285556|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2285557|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819651|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819652|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819653|NCT04079881|Insulin|insulin|mesh-list
2819654|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2819655|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2819656|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819657|NCT04079517|Tamoxifen|tamoxifen|mesh-list
2819658|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2819659|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
2285558|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285559|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
2285560|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
2285561|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
2285562|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2285563|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2285564|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
2285565|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285566|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285567|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2285568|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2819660|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2819661|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819662|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2819663|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819664|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2819665|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2819666|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2819667|NCT04079686|Cefazolin|cefazolin|mesh-list
2819668|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2819669|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819670|NCT04079621|Primaquine|primaquine|mesh-list
2819671|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
2819672|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2819673|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2819674|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819675|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
2819676|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2819677|NCT04079725|Mitomycins|mitomycins|mesh-list
2819678|NCT04079725|Mitomycin|mitomycin|mesh-list
2819679|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2819680|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819681|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
2819682|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819683|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2819684|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819685|NCT04079738|Ixazomib|ixazomib|mesh-list
2819686|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819687|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
2819688|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819689|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819690|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2819691|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
2819692|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819693|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2819694|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2819695|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819696|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819697|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2819698|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2819699|NCT04079413|Insulin|insulin|mesh-list
2819700|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2819701|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
2819702|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
2819703|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2819704|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2819705|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819706|NCT04079192|Umirolimus|umirolimus|mesh-list
2819707|NCT04079192|Paclitaxel|paclitaxel|mesh-list
2819708|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2819709|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819710|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
2819711|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
2819712|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
2819713|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819714|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2819715|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2819716|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
2819717|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819718|NCT04079231|Aflibercept|aflibercept|mesh-list
2819719|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2819720|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2819721|NCT04079231|Growth Substances|growth substances|mesh-ancestor
2819722|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285569|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
2285570|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2285571|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
2285572|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2285573|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285574|NCT00240617|Naproxen|naproxen|mesh-list
2285575|NCT00240617|Sumatriptan|sumatriptan|mesh-list
2819723|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
2819724|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819725|NCT04079374|Etanercept|etanercept|mesh-list
2819726|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2819727|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2819728|NCT04079374|Analgesics|analgesics|mesh-ancestor
2819729|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
2819730|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819731|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819732|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285576|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2285577|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285578|NCT00240617|Analgesics|analgesics|mesh-ancestor
2285579|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
2819733|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2819734|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2819735|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2819736|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
2819737|NCT04079257|Eculizumab|eculizumab|mesh-list
2819738|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2819739|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2819740|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
2819741|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819742|NCT04079088|Interferons|interferons|mesh-list
2819743|NCT04079088|Interferon-beta|interferon-beta|mesh-list
2819744|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
2285580|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285581|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285582|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285583|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285584|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
2285585|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2285586|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285587|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819745|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
2819746|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
2819747|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819748|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
2819749|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819750|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
2819751|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819752|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2819753|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2819754|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2819755|NCT04079140|Dinoprostone|dinoprostone|mesh-list
2819756|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
2819757|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2819758|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285588|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2285589|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2285590|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2285591|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
2285592|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285593|NCT00240630|Naproxen|naproxen|mesh-list
2285594|NCT00240630|Sumatriptan|sumatriptan|mesh-list
2285595|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2285596|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285597|NCT00240630|Analgesics|analgesics|mesh-ancestor
2285598|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
2285599|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285600|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285601|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285602|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285603|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
2285604|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2285605|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285606|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285607|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2285608|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2285609|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2285610|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
2285611|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285612|NCT00240656|Carvedilol|carvedilol|mesh-list
2285613|NCT00240656|Captopril|captopril|mesh-list
2285614|NCT00240656|Spironolactone|spironolactone|mesh-list
2285615|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2285616|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
2285617|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2285618|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285619|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2285620|NCT00240656|Diuretics|diuretics|mesh-ancestor
2285621|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
2285622|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2285623|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2285624|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
2285625|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285626|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285627|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2285628|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
2285629|NCT00240656|Protective Agents|protective agents|mesh-ancestor
2285630|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2285631|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2285632|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2285633|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
2285634|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2285635|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2285636|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2285637|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
2285638|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285639|NCT00240682|Cetuximab|cetuximab|mesh-list
2285640|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2285641|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285642|NCT00240695|Galantamine|galantamine|mesh-list
2285643|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2285644|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819786|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
2819787|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2819788|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
2819789|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2819790|NCT04078711|Losartan|losartan|mesh-list
2819791|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2819792|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2819793|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2819794|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2819795|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819796|NCT04078659|Lidocaine|lidocaine|mesh-list
2819797|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
2819798|NCT04078659|Fentanyl|fentanyl|mesh-list
2819799|NCT04078659|Propofol|propofol|mesh-list
2819800|NCT04078659|Atracurium|atracurium|mesh-list
2819801|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
2819802|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
2819803|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2819804|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819805|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
2819806|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819807|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2819808|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2819809|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2819810|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2819811|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819812|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2819813|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2819814|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
2819815|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2819816|NCT04078659|Narcotics|narcotics|mesh-ancestor
2819817|NCT04078659|Analgesics|analgesics|mesh-ancestor
2819818|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2819819|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
2819820|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2819821|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2819822|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
2819823|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2819824|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2819825|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2819826|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2819827|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2819828|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2819829|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
2819830|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2819831|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
2819832|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
2819833|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819834|NCT04078880|Protective Agents|protective agents|mesh-ancestor
2819835|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819836|NCT04078880|Vitamins|vitamins|mesh-ancestor
2819837|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
2819838|NCT04078399|Interferons|interferons|mesh-list
2819839|NCT04078399|Azacitidine|azacitidine|mesh-list
2819840|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819841|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
2819842|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819843|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2819844|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
2819845|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819846|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819847|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
2285645|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285646|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
2819848|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
2819849|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2819850|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819851|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2819852|NCT04078425|Diuretics|diuretics|mesh-ancestor
2819853|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
2819854|NCT04078295|Nivolumab|nivolumab|mesh-list
2819855|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2819856|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819857|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2819858|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285647|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285648|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285649|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2285650|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
2285651|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819859|NCT04078269|Vaccines|vaccines|mesh-list
2819860|NCT04078269|Immunologic Factors|immunologic factors|mesh-ancestor
2819861|NCT04078269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819862|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
2819863|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2819864|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2819865|NCT04078204|Protective Agents|protective agents|mesh-ancestor
2819866|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819867|NCT04078048|Vitamins|vitamins|mesh-list
2819868|NCT04078048|Ascorbic Acid|ascorbic acid|mesh-list
2819869|NCT04078048|Vitamin E|vitamin e|mesh-list
2819870|NCT04078048|Antioxidants|antioxidants|mesh-list
2819871|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
2285652|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
2285653|NCT00240708|Risperidone|risperidone|mesh-list
2285654|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2285655|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
2285656|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285657|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285658|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285659|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2285660|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2285661|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2285662|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2285663|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2285664|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
2285665|NCT00240721|Topiramate|topiramate|mesh-list
2285666|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
2285667|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2285668|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285669|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
2285670|NCT00240734|Hematinics|hematinics|mesh-ancestor
2285671|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
2285672|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2285673|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2285674|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2285675|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285676|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285677|NCT00240760|Memantine|memantine|mesh-list
2285678|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2285679|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2285680|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
2285681|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285682|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285683|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285684|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2285685|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2285686|NCT00240773|Acetaminophen|acetaminophen|mesh-list
2285687|NCT00240773|Naproxen|naproxen|mesh-list
2285688|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285689|NCT00240773|Analgesics|analgesics|mesh-ancestor
2285690|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
2285691|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285692|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285693|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
2285694|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2285695|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285696|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2819872|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819873|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819874|NCT04078048|Protective Agents|protective agents|mesh-ancestor
2819875|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2819876|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2819877|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2819878|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
2819879|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2819880|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819881|NCT04077853|Progestins|progestins|mesh-ancestor
2819882|NCT04077853|Hormones|hormones|mesh-ancestor
2819883|NCT04077827|Propofol|propofol|mesh-list
2819884|NCT04077827|Desflurane|desflurane|mesh-list
2819885|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2819886|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2819887|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819888|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2819889|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
2819890|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
2819891|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2819892|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2819893|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2819894|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
2819895|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
2819896|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
2819897|NCT04077957|Etanercept|etanercept|mesh-list
2819898|NCT04077957|Methotrexate|methotrexate|mesh-list
2819899|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2819900|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
2819901|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2819902|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819903|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2819904|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
2819905|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819906|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819907|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
2819908|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819909|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2819910|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2819911|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
2819912|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285697|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
2285698|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2285699|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285700|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285701|NCT00240786|Acetaminophen|acetaminophen|mesh-list
2285702|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285703|NCT00240786|Analgesics|analgesics|mesh-ancestor
2285704|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
2285705|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285706|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285707|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
2285708|NCT00240799|Acetaminophen|acetaminophen|mesh-list
2285709|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285710|NCT00240799|Analgesics|analgesics|mesh-ancestor
2285711|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
2285712|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285713|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285714|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
2285715|NCT00240812|Ibuprofen|ibuprofen|mesh-list
2285716|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
2285717|NCT00240812|Ephedrine|ephedrine|mesh-list
2285718|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2285719|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285720|NCT00240812|Analgesics|analgesics|mesh-ancestor
2285721|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
2285722|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285723|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285724|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285725|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285726|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2285727|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285728|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285729|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2285730|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
2285731|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2285732|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
2285733|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
2285734|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2285735|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2285736|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
2285737|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
2285738|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285739|NCT00240825|Acetaminophen|acetaminophen|mesh-list
2285740|NCT00240825|Ibuprofen|ibuprofen|mesh-list
2285741|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285742|NCT00240825|Analgesics|analgesics|mesh-ancestor
2819913|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2819914|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
2819915|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2819916|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2819917|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819918|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2819919|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2819920|NCT04077957|Analgesics|analgesics|mesh-ancestor
2819921|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
2819922|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819923|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2819924|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2819925|NCT04077892|Budesonide|budesonide|mesh-list
2819926|NCT04077892|Montelukast|montelukast|mesh-list
2819927|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2819928|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2819929|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
2819930|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819931|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819932|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2819933|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
2819934|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
2819935|NCT04077892|Hormones|hormones|mesh-ancestor
2819936|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2819937|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2819938|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
2819939|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2819940|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2819941|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819942|NCT04077866|Temozolomide|temozolomide|mesh-list
2819943|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2819944|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
2819945|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819946|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819947|NCT04077983|Gemcitabine|gemcitabine|mesh-list
2819948|NCT04077983|Paclitaxel|paclitaxel|mesh-list
2819949|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2819950|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819951|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
2819952|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
2105294|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105295|NCT02452476|Poractant alfa|poractant alfa|mesh-list
2105296|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2105297|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
2105298|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
2105299|NCT02452528|Promethazine|promethazine|mesh-list
2105300|NCT02452528|Tenofovir|tenofovir|mesh-list
2105301|NCT02452528|Entecavir|entecavir|mesh-list
2105302|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
2105303|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105304|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2105305|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2105306|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105307|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105308|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2105309|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2105310|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2105311|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2819953|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
2819954|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819955|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2819956|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
2819957|NCT04077983|Antiviral Agents|antiviral agents|mesh-ancestor
2819958|NCT04077983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2285743|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
2285744|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285745|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285746|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
2285747|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2285748|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285749|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285750|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2285751|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285752|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285753|NCT00240838|Acetaminophen|acetaminophen|mesh-list
2105312|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105313|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105314|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
2105315|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
2105316|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
2105317|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105318|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
2105319|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
2105320|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2105321|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2105322|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
2105323|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
2105324|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105325|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2105326|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
2105327|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
2819959|NCT04077983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819960|NCT04077983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2819961|NCT04077983|Immunologic Factors|immunologic factors|mesh-ancestor
2819962|NCT04077983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819963|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
2819964|NCT04077905|Doxorubicin|doxorubicin|mesh-list
2819965|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2819966|NCT04077905|Etoposide|etoposide|mesh-list
2819967|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2819968|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819969|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2819970|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2819971|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2819972|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2819973|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2819974|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2819975|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
2819976|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
2819977|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819978|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819979|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2819980|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
2819981|NCT04077905|Hormones|hormones|mesh-ancestor
2819982|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2819983|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2819984|NCT04077905|Protective Agents|protective agents|mesh-ancestor
2819985|NCT04077736|Aldesleukin|aldesleukin|mesh-list
2819986|NCT04077736|Interleukin-2|interleukin-2|mesh-list
2819987|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2819988|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285754|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285755|NCT00240838|Analgesics|analgesics|mesh-ancestor
2285756|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
2285757|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285758|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285759|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
2285760|NCT00240851|Acetaminophen|acetaminophen|mesh-list
2285761|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285762|NCT00240851|Analgesics|analgesics|mesh-ancestor
2285763|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
2285764|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285765|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285766|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
2285767|NCT00240864|Acetaminophen|acetaminophen|mesh-list
2819989|NCT04077736|Analgesics|analgesics|mesh-ancestor
2819990|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
2819991|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2819992|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2819993|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2819994|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2819995|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
2819996|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2819997|NCT04077944|Trace Elements|trace elements|mesh-list
2819998|NCT04077944|Micronutrients|micronutrients|mesh-list
2819999|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820000|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2820001|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
2820002|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
2820003|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2285768|NCT00240864|Ibuprofen|ibuprofen|mesh-list
2820004|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
2820005|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820006|NCT04077515|Sirolimus|sirolimus|mesh-list
2820007|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2820008|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820009|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2820010|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820011|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
2820012|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2820013|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
2820014|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820015|NCT04077424|Vaccines|vaccines|mesh-list
2820016|NCT04077424|Hemagglutinins|hemagglutinins|mesh-list
2820017|NCT04077424|Immunologic Factors|immunologic factors|mesh-ancestor
2820018|NCT04077424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820019|NCT04077424|Agglutinins|agglutinins|mesh-ancestor
2820020|NCT04077580|Methenamine|methenamine|mesh-list
2820021|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
2820022|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
2820023|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2820024|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820025|NCT04077580|Renal Agents|renal agents|mesh-ancestor
2820026|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2285769|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2285770|NCT00240864|Analgesics|analgesics|mesh-ancestor
2285771|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
2285772|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285773|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285774|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
2285775|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2285776|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285777|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285778|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2285779|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285780|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285781|NCT00240916|Vaccines|vaccines|mesh-list
2285782|NCT00240916|Immunoglobulins|immunoglobulins|mesh-list
2285783|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
2285784|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820027|NCT04077684|Interleukin-2|interleukin-2|mesh-list
2820028|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820029|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2820030|NCT04077684|Analgesics|analgesics|mesh-ancestor
2820031|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
2820032|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820033|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820034|NCT04077398|Ropivacaine|ropivacaine|mesh-list
2820035|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
2820036|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
2820037|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820038|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820039|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
2820040|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285785|NCT00240929|Palivizumab|palivizumab|mesh-list
2820041|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2820042|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2820043|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2820044|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820045|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
2820046|NCT04077190|Cortisone|cortisone|mesh-list
2820047|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2820048|NCT04076865|Lidocaine|lidocaine|mesh-list
2820049|NCT04076865|Histamine|histamine|mesh-list
2820050|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
2285786|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
2285787|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2285788|NCT00240942|Letrozole|letrozole|mesh-list
2285789|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285790|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2285791|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2285792|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285793|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285794|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2285795|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
2285796|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2285797|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285798|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
2820051|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
2820052|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820053|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820054|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
2820055|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820056|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2820057|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2820058|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2820059|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2820060|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820061|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
2820062|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
2820063|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820064|NCT04077255|Paclitaxel|paclitaxel|mesh-list
2820065|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2820066|NCT04077255|Antibodies|antibodies|mesh-list
2820067|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2820068|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820069|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
2820070|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
2820071|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
2820072|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820073|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
2820074|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820075|NCT04077125|Rifaximin|rifaximin|mesh-list
2820076|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2820077|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820078|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2820079|NCT04076436|Fosfomycin|fosfomycin|mesh-list
2820080|NCT04076436|Lactams|lactams|mesh-list
2820081|NCT04076436|beta-Lactams|beta-lactams|mesh-list
2820082|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2820083|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820084|NCT04076709|Anesthetics|anesthetics|mesh-list
2820085|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820086|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820087|NCT04076826|Midazolam|midazolam|mesh-list
2820088|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
2820089|NCT04076826|Propofol|propofol|mesh-list
2820090|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2820091|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820092|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820093|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2820094|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
2820095|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
2285799|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2285800|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285801|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2285802|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
2285803|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2285804|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2285805|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820096|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2820097|NCT04076826|Analgesics|analgesics|mesh-ancestor
2820098|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
2820099|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820100|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2820101|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2820102|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2820103|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
2820104|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820105|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820106|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2820107|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2820108|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2820109|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2820110|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
2820111|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
2820112|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2820113|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2820114|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2820115|NCT04076371|Olanzapine|olanzapine|mesh-list
2820116|NCT04076371|Risperidone|risperidone|mesh-list
2820117|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2820118|NCT04076371|Ziprasidone|ziprasidone|mesh-list
2820119|NCT04076371|Sertraline|sertraline|mesh-list
2820120|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2820121|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
2820122|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820123|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820124|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820125|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2820126|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2820127|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820128|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2820129|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2820130|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
2820131|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
2820132|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
2820133|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820134|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2820135|NCT04076371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2820136|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2820137|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2820138|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
2820139|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2820140|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2820141|NCT04076098|Minocycline|minocycline|mesh-list
2820142|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2820143|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820144|NCT04076137|Decitabine|decitabine|mesh-list
2820145|NCT04076137|Antibodies|antibodies|mesh-list
2820146|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2820147|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
2820148|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820149|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2285806|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285807|NCT00241007|Valsartan|valsartan|mesh-list
2285808|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2285809|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2285810|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2820150|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
2820151|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820152|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820153|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820154|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
2820155|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2820156|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820157|NCT04075955|Olanzapine|olanzapine|mesh-list
2820158|NCT04075955|Aprepitant|aprepitant|mesh-list
2285811|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2285812|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285813|NCT00241007|Diuretics|diuretics|mesh-ancestor
2285814|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
2285815|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285816|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2285817|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2285818|NCT00241020|Octreotide|octreotide|mesh-list
2285819|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2285820|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2285821|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285822|NCT00241046|Letrozole|letrozole|mesh-list
2285823|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820159|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
2820160|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
2820161|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820162|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820163|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2820164|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2820165|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2820166|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820167|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2820168|NCT04075955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2820169|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2820170|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2820171|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820172|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820173|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
2820174|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2285824|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2285825|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2285826|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285827|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285828|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2285829|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
2285830|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2285831|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285832|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
2285833|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2285834|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285835|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2820175|NCT04075721|Dexamethasone|dexamethasone|mesh-list
2820176|NCT04075721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2820177|NCT04075721|Antiemetics|antiemetics|mesh-ancestor
2820178|NCT04075721|Autonomic Agents|autonomic agents|mesh-ancestor
2820179|NCT04075721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820180|NCT04075721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820181|NCT04075721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2820182|NCT04075721|Glucocorticoids|glucocorticoids|mesh-ancestor
2820183|NCT04075721|Hormones|hormones|mesh-ancestor
2820184|NCT04075721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2820185|NCT04075721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2820186|NCT04075721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820187|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2820188|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2820189|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
2820190|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820191|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820192|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820193|NCT04075747|Venetoclax|venetoclax|mesh-list
2820194|NCT04075747|Midostaurin|midostaurin|mesh-list
2820195|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820196|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2820197|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820198|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285836|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
2820199|NCT04075513|Insulin|insulin|mesh-list
2820200|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2820201|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
2820202|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
2820203|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2820204|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820205|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2820206|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2820207|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2820208|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820209|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820210|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2820211|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2820212|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285837|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2285838|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2285839|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285840|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820213|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
2820214|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820215|NCT04075474|Listerine|listerine|mesh-list
2820216|NCT04075474|Fluorides|fluorides|mesh-list
2820217|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
2820218|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
2820219|NCT04075474|Protective Agents|protective agents|mesh-ancestor
2820220|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820221|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2820222|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820223|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2820224|NCT04075227|Dexamethasone|dexamethasone|mesh-list
2820225|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2820226|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
2285841|NCT00241072|Valsartan|valsartan|mesh-list
2285842|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2285843|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2285844|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2285845|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285846|NCT00241085|Valsartan|valsartan|mesh-list
2285847|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2285848|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2285849|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2285850|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285851|NCT00241098|Valsartan|valsartan|mesh-list
2285852|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2285853|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2285854|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2285855|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285856|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
2285857|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2285858|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285859|NCT00241124|Valsartan|valsartan|mesh-list
2285860|NCT00241124|Lisinopril|lisinopril|mesh-list
2285861|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2285862|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2285863|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2285864|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285865|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2820227|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
2820228|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820229|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820230|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2820231|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
2820232|NCT04075227|Hormones|hormones|mesh-ancestor
2820233|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2820234|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2820235|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820236|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2820237|NCT04075526|Vancomycin|vancomycin|mesh-list
2820238|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
2820239|NCT04075526|Povidone|povidone|mesh-list
2820240|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2820241|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820242|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
2820243|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
2820244|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2820245|NCT04075006|Ketamine|ketamine|mesh-list
2820246|NCT04075006|Analgesics|analgesics|mesh-ancestor
2820247|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
2820248|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820249|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820250|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2820251|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2820252|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
2820253|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
2820254|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820255|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2820256|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2820257|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820258|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820265|NCT04075149|Spironolactone|spironolactone|mesh-list
2820266|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2820267|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
2820268|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2820269|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820270|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2820271|NCT04075149|Diuretics|diuretics|mesh-ancestor
2820272|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
2820273|NCT04075240|Aspirin|aspirin|mesh-list
2820274|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
2820275|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2820276|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2820277|NCT04075240|Analgesics|analgesics|mesh-ancestor
2820278|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
2820279|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820280|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820281|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2820282|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2820283|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2820284|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2820285|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820286|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2820287|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2820288|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820289|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
2820290|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2820291|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
2820292|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2820293|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
2820294|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
2820295|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
2820296|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2820297|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820298|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
2820299|NCT04075188|Aflibercept|aflibercept|mesh-list
2820300|NCT04075188|Verteporfin|verteporfin|mesh-list
2820301|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2820302|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2820303|NCT04075188|Growth Substances|growth substances|mesh-ancestor
2820304|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820305|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
2820306|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820307|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2820308|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
2820309|NCT04075604|Nivolumab|nivolumab|mesh-list
2820310|NCT04075604|Palbociclib|palbociclib|mesh-list
2820311|NCT04075604|Anastrozole|anastrozole|mesh-list
2820312|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2820313|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820314|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2820315|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820316|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2820317|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820318|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2285866|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
2285867|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285868|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2285869|NCT00241124|Protective Agents|protective agents|mesh-ancestor
2285870|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285871|NCT00241137|Valsartan|valsartan|mesh-list
2285872|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2285873|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2285874|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2285875|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285876|NCT00241150|Valsartan|valsartan|mesh-list
2285877|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2285878|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2285879|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2285880|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285881|NCT00241163|Thrombin|thrombin|mesh-list
2285882|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
2285883|NCT00241163|Coagulants|coagulants|mesh-ancestor
2285884|NCT00241189|Sirolimus|sirolimus|mesh-list
2285885|NCT00241189|Methotrexate|methotrexate|mesh-list
2285886|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2285887|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
2820319|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2820320|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2820321|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2820322|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
2820323|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2820324|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820325|NCT04075201|Vaccines|vaccines|mesh-list
2820326|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
2820327|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285888|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2285889|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285890|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2285891|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
2285892|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285893|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285894|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
2285895|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285896|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2285897|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2820328|NCT04074746|Vidarabine|vidarabine|mesh-list
2820329|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
2820330|NCT04074746|Fludarabine|fludarabine|mesh-list
2820331|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
2820332|NCT04074746|Antibodies|antibodies|mesh-list
2820333|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2820334|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2820335|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
2820336|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820337|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2820338|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2820339|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
2820340|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820341|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820342|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2820343|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2820344|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
2820345|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
2820346|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2285898|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
2285899|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285900|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2820355|NCT04074473|Propranolol|propranolol|mesh-list
2820356|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2820357|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2820358|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
2820359|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820360|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820361|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820362|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2820363|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2820364|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
2820365|NCT04074603|Insulin|insulin|mesh-list
2820366|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2820367|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820368|NCT04074564|Apatinib|apatinib|mesh-list
2820369|NCT04074564|Antibodies|antibodies|mesh-list
2820370|NCT04074564|Immunologic Factors|immunologic factors|mesh-ancestor
2820371|NCT04074564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820372|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820373|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2820374|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820375|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820376|NCT04074460|Propofol|propofol|mesh-list
2820377|NCT04074460|Sevoflurane|sevoflurane|mesh-list
2820378|NCT04074460|Desflurane|desflurane|mesh-list
2820379|NCT04074460|Isoflurane|isoflurane|mesh-list
2820380|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2820381|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2285901|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2285902|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2285903|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2285904|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
2285905|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
2285906|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2285907|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2285908|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285909|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
2285910|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2285911|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285912|NCT00241241|Interferons|interferons|mesh-list
2285913|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
2820382|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820383|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2820384|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
2820385|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
2820386|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2820387|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2820388|NCT04074551|Losartan|losartan|mesh-list
2820389|NCT04074551|Amlodipine|amlodipine|mesh-list
2820390|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2820391|NCT04074551|Ezetimibe|ezetimibe|mesh-list
2820392|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2820393|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2820394|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2820395|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820396|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2820397|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820398|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
2820399|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2820400|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2820401|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
2820402|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2820403|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2820404|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105338|NCT02452762|Vitamin D|vitamin d|mesh-list
2105339|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
2105340|NCT02452762|Vitamins|vitamins|mesh-ancestor
2105341|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
2105342|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105343|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2105344|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2105345|NCT02452866|Secnidazole|secnidazole|mesh-list
2820405|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2820406|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2820407|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2820411|NCT04074512|Copper|copper|mesh-list
2820412|NCT04074512|Trace Elements|trace elements|mesh-ancestor
2820413|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
2820414|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820415|NCT04074330|Rituximab|rituximab|mesh-list
2820416|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2820417|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820418|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
2820419|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820420|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2820421|NCT04074421|Rifaximin|rifaximin|mesh-list
2820422|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2820423|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820424|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2820425|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
2820426|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2105346|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2105347|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2105348|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105349|NCT02452931|Leuprolide|leuprolide|mesh-list
2105350|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2105351|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
2105352|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2105353|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105354|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2105355|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105356|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2105357|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2105358|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105359|NCT02453282|Gemcitabine|gemcitabine|mesh-list
2105360|NCT02453282|Paclitaxel|paclitaxel|mesh-list
2105361|NCT02453282|Cisplatin|cisplatin|mesh-list
2105362|NCT02453282|Carboplatin|carboplatin|mesh-list
2105363|NCT02453282|Pemetrexed|pemetrexed|mesh-list
2105364|NCT02453282|Durvalumab|durvalumab|mesh-list
2105365|NCT02453282|Tremelimumab|tremelimumab|mesh-list
2820427|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2820428|NCT04074187|Prednisolone|prednisolone|mesh-list
2820429|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
2820430|NCT04074187|Rituximab|rituximab|mesh-list
2820431|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2820432|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
2820433|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2820434|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2820435|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820436|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
2820437|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820438|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2820439|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2820440|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
2820441|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
2820442|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820443|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2820444|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
2820445|NCT04074187|Hormones|hormones|mesh-ancestor
2820446|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2820447|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2820448|NCT04074187|Protective Agents|protective agents|mesh-ancestor
2820449|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2820450|NCT04074213|Clozapine|clozapine|mesh-list
2820451|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2820452|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
2820453|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820454|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820455|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820456|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2820457|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2820458|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820459|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2820460|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
2820461|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
2105366|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2820462|NCT04073953|Primaquine|primaquine|mesh-list
2285914|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
2285915|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2285916|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285917|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
2285918|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820463|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
2820464|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2820465|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2820466|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820467|NCT04074317|Insulin|insulin|mesh-list
2820468|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2820469|NCT04074317|Pramlintide|pramlintide|mesh-list
2820470|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2820471|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820472|NCT04074343|Irinotecan|irinotecan|mesh-list
2820473|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2820474|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2820475|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820476|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820477|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285919|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
2285920|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285921|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
2285922|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2285923|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2285924|NCT00241254|Prednisolone|prednisolone|mesh-list
2285925|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
2285926|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
2285927|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2285928|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
2285929|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2285930|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
2285931|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285932|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2285933|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2285934|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
2285935|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285936|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285937|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2285938|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2285939|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
2105367|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2105368|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105369|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
2105370|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
2105371|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
2105372|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105373|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2105374|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
2105375|NCT02453282|Antiviral Agents|antiviral agents|mesh-ancestor
2105376|NCT02453282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105377|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105378|NCT02453282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2105379|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
2105380|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105381|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2105382|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2105383|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2820481|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
2820482|NCT04073849|Hematinics|hematinics|mesh-ancestor
2820483|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
2820484|NCT04073758|Remifentanil|remifentanil|mesh-list
2820485|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2820486|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820487|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820488|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2820489|NCT04073758|Analgesics|analgesics|mesh-ancestor
2285940|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
2285941|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285942|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2285943|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
2285944|NCT00241254|Hormones|hormones|mesh-ancestor
2285945|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2285946|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2285947|NCT00241254|Protective Agents|protective agents|mesh-ancestor
2285948|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2285949|NCT00241332|Fentanyl|fentanyl|mesh-list
2285950|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2285951|NCT00241332|Narcotics|narcotics|mesh-ancestor
2285952|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2285953|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285954|NCT00241332|Analgesics|analgesics|mesh-ancestor
2285955|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
2285956|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2285957|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2820490|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
2820491|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820492|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2820493|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2820494|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2820495|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
2820496|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820497|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820498|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2820499|NCT04073758|Narcotics|narcotics|mesh-ancestor
2105384|NCT02453321|Bupivacaine|bupivacaine|mesh-list
2105385|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
2105386|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
2105387|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105388|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820500|NCT04073784|Gemcitabine|gemcitabine|mesh-list
2820501|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2820502|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
2820503|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820504|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820505|NCT04073784|Antiviral Agents|antiviral agents|mesh-ancestor
2820506|NCT04073784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820507|NCT04073784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820508|NCT04073784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2820509|NCT04073784|Immunologic Factors|immunologic factors|mesh-ancestor
2820510|NCT04073784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820511|NCT04073797|Evolocumab|evolocumab|mesh-list
2820512|NCT04073797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2820513|NCT04073797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2820514|NCT04073797|Antimetabolites|antimetabolites|mesh-ancestor
2820515|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820516|NCT04073797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2820517|NCT04073615|Trifluridine|trifluridine|mesh-list
2820518|NCT04073615|Apatinib|apatinib|mesh-list
2820519|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820520|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2820521|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820522|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820523|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
2820524|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
2820525|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820526|NCT04073550|Topotecan|topotecan|mesh-list
2820527|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2820528|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2820529|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105389|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
2105390|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105391|NCT02453360|Bupivacaine|bupivacaine|mesh-list
2105392|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
2105393|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
2105394|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105395|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105396|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
2105397|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820530|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820531|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820532|NCT04073537|Paclitaxel|paclitaxel|mesh-list
2820533|NCT04073537|Carboplatin|carboplatin|mesh-list
2820534|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2820535|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820536|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
2820537|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
2820538|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
2820539|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820540|NCT04073719|Acetic Acid|acetic acid|mesh-list
2820541|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2820542|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820543|NCT04073602|Trastuzumab|trastuzumab|mesh-list
2820544|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2820545|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820546|NCT04073680|Canagliflozin|canagliflozin|mesh-list
2820547|NCT04073680|Serabelisib|serabelisib|mesh-list
2820548|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2820549|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820550|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2820551|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820552|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820553|NCT04073290|Rifaximin|rifaximin|mesh-list
2820554|NCT04073290|Lactulose|lactulose|mesh-list
2820555|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2820556|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820557|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2285958|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2285959|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
2285960|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
2285961|NCT00241345|Valganciclovir|valganciclovir|mesh-list
2820569|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
2105398|NCT02453555|Empagliflozin|empagliflozin|mesh-list
2105399|NCT02453555|Linagliptin|linagliptin|mesh-list
2105400|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2285962|NCT00241345|Ganciclovir|ganciclovir|mesh-list
2820570|NCT04073173|Analgesics|analgesics|mesh-list
2820571|NCT04073173|Narcotics|narcotics|mesh-ancestor
2820572|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820573|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820574|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
2820575|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820576|NCT04074265|Ketorolac|ketorolac|mesh-list
2820577|NCT04074265|Epinephrine|epinephrine|mesh-list
2820578|NCT04074265|Ropivacaine|ropivacaine|mesh-list
2820579|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
2820580|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
2820581|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820582|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820583|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
2820584|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820585|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2820586|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2820587|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
2820588|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820589|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820590|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2820591|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2820592|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
2285963|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2820593|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2820594|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
2820595|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
2820596|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
2820597|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2820598|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2820599|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2820600|NCT04074265|Analgesics|analgesics|mesh-ancestor
2820601|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2820602|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2820603|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2820604|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820605|NCT04073160|Durvalumab|durvalumab|mesh-list
2820606|NCT04073160|Tremelimumab|tremelimumab|mesh-list
2820607|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2820608|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820609|NCT04073134|Evolocumab|evolocumab|mesh-list
2820610|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2820611|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2820612|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
2820613|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285964|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
2285965|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105401|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105402|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2105403|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105404|NCT02453555|Incretins|incretins|mesh-ancestor
2105405|NCT02453555|Hormones|hormones|mesh-ancestor
2105406|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2105407|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2285966|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2820614|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2820615|NCT04074122|Adenosine|adenosine|mesh-list
2820616|NCT04074122|Isoproterenol|isoproterenol|mesh-list
2820617|NCT04074122|Epinephrine|epinephrine|mesh-list
2820618|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2820619|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2820620|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
2820621|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820622|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820623|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820624|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2820625|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2820626|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
2820627|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820628|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2285967|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285968|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285969|NCT00241371|Clofarabine|clofarabine|mesh-list
2285970|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2285971|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
2285972|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2285973|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285974|NCT00241423|Exenatide|exenatide|mesh-list
2285975|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2285976|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285977|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2285978|NCT00241423|Incretins|incretins|mesh-ancestor
2285979|NCT00241423|Hormones|hormones|mesh-ancestor
2285980|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2285981|NCT00241436|Anastrozole|anastrozole|mesh-list
2285982|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2285983|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2285984|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2285985|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2285986|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2285987|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820629|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
2820630|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
2820631|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
2820632|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2820633|NCT04074122|Analgesics|analgesics|mesh-ancestor
2820634|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
2820635|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2820636|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
2285988|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2285989|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
2820637|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2820638|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
2285990|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2285991|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2285992|NCT00241449|Tamoxifen|tamoxifen|mesh-list
2285993|NCT00241449|Fulvestrant|fulvestrant|mesh-list
2285994|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2285995|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
2285996|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2285997|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820639|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
2820640|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2820641|NCT04074122|Protective Agents|protective agents|mesh-ancestor
2820642|NCT04073927|Butyric Acid|butyric acid|mesh-list
2820643|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
2820644|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
2820645|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820646|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820647|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820652|NCT04073316|Warfarin|warfarin|mesh-list
2820653|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
2820654|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
2820655|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2820656|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
2820657|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2820658|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
2820659|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820660|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820661|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
2820662|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2820663|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2820664|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2820665|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2820666|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820667|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
2820668|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820669|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820670|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2820671|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820683|NCT04073056|Bupivacaine|bupivacaine|mesh-list
2820684|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
2285998|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2285999|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286000|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2286001|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2286002|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2286003|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2286004|NCT00241475|Gefitinib|gefitinib|mesh-list
2820685|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
2820686|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820687|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820688|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
2820689|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2820690|NCT04072822|Prednisone|prednisone|mesh-list
2820691|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2820692|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2820693|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
2820694|NCT04072822|Hormones|hormones|mesh-ancestor
2820695|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2820696|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820697|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2820698|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820699|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2820706|NCT04072640|Voriconazole|voriconazole|mesh-list
2820707|NCT04072640|Amphotericin B|amphotericin b|mesh-list
2820708|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2820709|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
2820710|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
2820711|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
2820712|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820713|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2820714|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2820715|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820716|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820717|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2820718|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
2820719|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2820720|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820721|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2820722|NCT04072640|Amebicides|amebicides|mesh-ancestor
2820723|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2820724|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2820725|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2820726|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2820727|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2820728|NCT04072835|Etripamil|etripamil|mesh-list
2820729|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2820730|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2820731|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820732|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2820733|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820734|NCT04072770|Caseins|caseins|mesh-list
2820735|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
2820736|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
2820737|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820738|NCT04072900|Imiquimod|imiquimod|mesh-list
2820739|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2820740|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
2820741|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820742|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820743|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
2820744|NCT04072952|Palbociclib|palbociclib|mesh-list
2820745|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820746|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2820747|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820748|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820749|NCT04072601|Atorvastatin|atorvastatin|mesh-list
2820750|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2820751|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2820752|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
2820753|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820754|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2820755|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2820756|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820757|NCT04072341|Propolis|propolis|mesh-list
2820758|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820759|NCT04072497|Vaccines|vaccines|mesh-list
2820760|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
2820761|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820762|NCT04072263|Interferons|interferons|mesh-list
2820763|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
2820764|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
2820765|NCT04072263|Paclitaxel|paclitaxel|mesh-list
2820766|NCT04072263|Carboplatin|carboplatin|mesh-list
2820767|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2820768|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820769|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
2820770|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
2820771|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
2820772|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820773|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
2820774|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820775|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
2820776|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820777|NCT04072471|Lesinurad|lesinurad|mesh-list
2820778|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
2820779|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2820780|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
2820781|NCT04072471|Renal Agents|renal agents|mesh-ancestor
2286005|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286006|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2286007|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286008|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286009|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2286010|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2286011|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2286012|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
2286013|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286014|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2286015|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2286016|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286017|NCT00241501|Esomeprazole|esomeprazole|mesh-list
2286018|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2286019|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286020|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2286021|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286022|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286023|NCT00241514|Esomeprazole|esomeprazole|mesh-list
2286024|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2286025|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286026|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2286027|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286028|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286029|NCT00241527|Esomeprazole|esomeprazole|mesh-list
2286030|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2286031|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286032|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2286033|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286034|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286035|NCT00241540|Esomeprazole|esomeprazole|mesh-list
2286036|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2286037|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286038|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2286039|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286040|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286041|NCT00241553|Esomeprazole|esomeprazole|mesh-list
2286042|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2286043|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286044|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2286045|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286046|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286047|NCT00241605|Metformin|metformin|mesh-list
2286048|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
2286049|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2286050|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286051|NCT00241618|Interferons|interferons|mesh-list
2286052|NCT00241618|Ribavirin|ribavirin|mesh-list
2286053|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
2286054|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
2286055|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286056|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
2286057|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2286058|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
2286059|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286060|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
2286061|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286062|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2286063|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2286064|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
2286065|NCT00241722|Alvimopan|alvimopan|mesh-list
2286066|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286067|NCT00241982|Prednisolone|prednisolone|mesh-list
2286068|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2286069|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
2820782|NCT04072445|Trifluridine|trifluridine|mesh-list
2820783|NCT04072445|Irinotecan|irinotecan|mesh-list
2820784|NCT04072445|Camptothecin|camptothecin|mesh-list
2820785|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2820786|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2820787|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820788|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820789|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820790|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2820791|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
2820792|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
2820793|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820794|NCT04072146|Varenicline|varenicline|mesh-list
2820795|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2820796|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2820797|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
2820798|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820799|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820800|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820801|NCT04072068|Edoxaban|edoxaban|mesh-list
2820802|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2820803|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
2820804|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2820805|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
2820806|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820807|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286070|NCT00241982|Hormones|hormones|mesh-ancestor
2286071|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286072|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286073|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2286074|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286075|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
2286076|NCT00242008|Rotigotine|rotigotine|mesh-list
2286077|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
2286078|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
2820808|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
2820809|NCT04072198|Leucovorin|leucovorin|mesh-list
2820810|NCT04072198|Bevacizumab|bevacizumab|mesh-list
2820811|NCT04072198|Nivolumab|nivolumab|mesh-list
2820812|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
2820813|NCT04072198|Irinotecan|irinotecan|mesh-list
2820814|NCT04072198|Fluorouracil|fluorouracil|mesh-list
2820815|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2820816|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820817|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2820818|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2820819|NCT04072198|Growth Substances|growth substances|mesh-ancestor
2820820|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820821|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
2820822|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2820823|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820824|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2820825|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2820826|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820827|NCT04072198|Antidotes|antidotes|mesh-ancestor
2820828|NCT04072198|Protective Agents|protective agents|mesh-ancestor
2820829|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
2820830|NCT04072198|Vitamins|vitamins|mesh-ancestor
2820831|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
2286079|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2286080|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286081|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286082|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
2286083|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2286084|NCT00242177|Pioglitazone|pioglitazone|mesh-list
2286085|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2286086|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286087|NCT00242190|Gemcitabine|gemcitabine|mesh-list
2820832|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
2820833|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2820834|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2820835|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
2820836|NCT04072107|Capecitabine|capecitabine|mesh-list
2820837|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2820838|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
2820839|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820840|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820841|NCT04072042|Apatinib|apatinib|mesh-list
2820842|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820843|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2820844|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820845|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820846|NCT04071977|Antioxidants|antioxidants|mesh-list
2820847|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820848|NCT04071977|Protective Agents|protective agents|mesh-ancestor
2820849|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820850|NCT04071756|Tazarotene|tazarotene|mesh-list
2820851|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
2820852|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
2820853|NCT04072328|Midazolam|midazolam|mesh-list
2820854|NCT04072328|Propofol|propofol|mesh-list
2820855|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2820856|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820857|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820858|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2820859|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
2820860|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
2820861|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2820862|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2820863|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2820864|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2286088|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
2286089|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2286090|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
2286091|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286092|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286093|NCT00242190|Antiviral Agents|antiviral agents|mesh-ancestor
2286094|NCT00242190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820865|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
2820866|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
2820867|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820868|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820874|NCT04071769|Xenon|xenon|mesh-list
2820875|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2820876|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
2820877|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
2820878|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2820879|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820880|NCT04071821|Cetirizine|cetirizine|mesh-list
2820881|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2820882|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2820883|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2820884|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
2820885|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
2820886|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820887|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820888|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820889|NCT04071639|Ubiquinone|ubiquinone|mesh-list
2820890|NCT04071639|Haloperidol|haloperidol|mesh-list
2820891|NCT04071639|Risperidone|risperidone|mesh-list
2820892|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
2820893|NCT04071639|Sertraline|sertraline|mesh-list
2820894|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
2820895|NCT04071639|Idebenone|idebenone|mesh-list
2820896|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2105408|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
2105409|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105410|NCT02453581|Artefenomel|artefenomel|mesh-list
2105411|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
2105412|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2105413|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2105414|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105415|NCT02453672|Bevacizumab|bevacizumab|mesh-list
2105416|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2105417|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820897|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
2820898|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2820899|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820900|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820901|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2820902|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2820903|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2286095|NCT00242190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286096|NCT00242190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2286097|NCT00242190|Immunologic Factors|immunologic factors|mesh-ancestor
2286098|NCT00242190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286099|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
2286100|NCT00242203|Docetaxel|docetaxel|mesh-list
2286101|NCT00242203|Trastuzumab|trastuzumab|mesh-list
2286102|NCT00242203|Epirubicin|epirubicin|mesh-list
2286103|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286104|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
2820904|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2820905|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2820906|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
2820907|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
2820908|NCT04071639|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2820909|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2820910|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2286105|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
2286106|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
2286107|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286108|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2286109|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2286110|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2286111|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2286112|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820911|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
2820912|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
2820913|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105418|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2286113|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2820914|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2820915|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2820916|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
2820917|NCT04071639|Protective Agents|protective agents|mesh-ancestor
2820918|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
2820919|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2820920|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
2820921|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2820922|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2820923|NCT04071574|Cetrorelix|cetrorelix|mesh-list
2820924|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2820925|NCT04071574|Hormones|hormones|mesh-ancestor
2820926|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2820927|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820928|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
2820929|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2820930|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
2820931|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2820932|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2286114|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286115|NCT00242268|Simvastatin|simvastatin|mesh-list
2286116|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2820933|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2820934|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820935|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2820936|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
2820937|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
2820938|NCT04071262|Prednisolone|prednisolone|mesh-list
2820939|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
2820940|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2820941|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
2820942|NCT04071262|Hormones|hormones|mesh-ancestor
2820943|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2820944|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820945|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2820946|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820947|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2820948|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820949|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820950|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
2820951|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2820952|NCT04071353|Interferons|interferons|mesh-list
2820953|NCT04071353|Ribavirin|ribavirin|mesh-list
2820954|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2820955|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
2820956|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820957|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
2820958|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820959|NCT04071119|Oxytocin|oxytocin|mesh-list
2820960|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
2820961|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2820962|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820963|NCT04071106|Betamethasone|betamethasone|mesh-list
2820964|NCT04071106|Calcipotriene|calcipotriene|mesh-list
2820965|NCT04071106|Petrolatum|petrolatum|mesh-list
2820966|NCT04071106|Turmeric extract|turmeric extract|mesh-list
2820967|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2820968|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
2820969|NCT04071106|Hormones|hormones|mesh-ancestor
2820970|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2820971|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820972|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2820973|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
2820974|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
2820975|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
2820976|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2820977|NCT04071106|Protective Agents|protective agents|mesh-ancestor
2820978|NCT04071106|Emollients|emollients|mesh-ancestor
2820979|NCT04070742|Minocycline|minocycline|mesh-list
2820980|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2820981|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820982|NCT04070755|Minocycline|minocycline|mesh-list
2820983|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2820984|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2820985|NCT04070794|Metformin|metformin|mesh-list
2820986|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2820987|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286117|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2286118|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
2286119|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286120|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2286121|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2286122|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2820988|NCT04070833|Vitamin D|vitamin d|mesh-list
2820989|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
2820990|NCT04070833|Vitamins|vitamins|mesh-list
2820991|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
2820992|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2820993|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2820994|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2105419|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2105420|NCT02453672|Growth Substances|growth substances|mesh-ancestor
2105421|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105422|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
2105423|NCT02453685|Insulin|insulin|mesh-list
2105424|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2105425|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
2105426|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
2105427|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
2105428|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2286123|NCT00242346|Candesartan|candesartan|mesh-list
2286124|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
2286125|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2286126|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2286127|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2286128|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286129|NCT00242359|Omalizumab|omalizumab|mesh-list
2286130|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2286131|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2286132|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
2286133|NCT00242372|Insulin|insulin|mesh-list
2286134|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2286135|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286136|NCT00242411|Budesonide|budesonide|mesh-list
2286137|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
2286138|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2286139|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2286140|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
2286141|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286142|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105429|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
2820995|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
2820996|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2820997|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
2820998|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2820999|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
2821000|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821001|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
2821002|NCT04070729|Protective Agents|protective agents|mesh-ancestor
2821003|NCT04070495|Clarithromycin|clarithromycin|mesh-list
2821004|NCT04070495|Rifampin|rifampin|mesh-list
2821005|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2821006|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821007|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2821008|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821009|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821010|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2821011|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2821012|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2821013|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
2821014|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
2821015|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2821016|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2821017|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2821018|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2821019|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2821020|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2821021|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2821022|NCT04070469|Amoxicillin|amoxicillin|mesh-list
2821023|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2821024|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821025|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
2821026|NCT04070391|Pyridoxal|pyridoxal|mesh-list
2821027|NCT04070391|Pyridoxine|pyridoxine|mesh-list
2821028|NCT04070391|Vitamins|vitamins|mesh-ancestor
2821029|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
2821030|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821031|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
2821032|NCT04070482|Tenofovir|tenofovir|mesh-list
2821033|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
2821034|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821035|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2821036|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2821037|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821038|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821039|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2821040|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2821041|NCT04070079|Tenofovir|tenofovir|mesh-list
2821042|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
2821043|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821044|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2821045|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2821046|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821047|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821048|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2821049|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2821050|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
2821051|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2821052|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821053|NCT04070157|Lofexidine|lofexidine|mesh-list
2821054|NCT04070157|Clonidine|clonidine|mesh-list
2821055|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2821056|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2286143|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2286144|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
2286145|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
2286146|NCT00242411|Hormones|hormones|mesh-ancestor
2286147|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286148|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2286149|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2286150|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2286151|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
2286152|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2286153|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286154|NCT00242437|Thrombin|thrombin|mesh-list
2286155|NCT00242437|Hemostatics|hemostatics|mesh-list
2286156|NCT00242437|Coagulants|coagulants|mesh-ancestor
2821057|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821058|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
2821059|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821060|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2821061|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2821062|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2286157|NCT00242450|Metoclopramide|metoclopramide|mesh-list
2286158|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
2286159|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
2286160|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286161|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286162|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2821063|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
2821064|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821065|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821066|NCT04070157|Analgesics|analgesics|mesh-ancestor
2821067|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
2821068|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
2821069|NCT04070001|Ibuprofen|ibuprofen|mesh-list
2821070|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2821071|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2821072|NCT04070001|Analgesics|analgesics|mesh-ancestor
2821073|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
2821074|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821075|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821076|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2821077|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2821078|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2821079|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821080|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821081|NCT04069949|Sorafenib|sorafenib|mesh-list
2821082|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821083|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2821084|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821085|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821086|NCT04069936|Nivolumab|nivolumab|mesh-list
2821087|NCT04069936|Tadalafil|tadalafil|mesh-list
2821088|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2821089|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821090|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2821091|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821092|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
2821093|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2821094|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2821095|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821096|NCT04069936|Urological Agents|urological agents|mesh-ancestor
2286163|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2286164|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2286165|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
2286166|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2286167|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286168|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
2286169|NCT00242463|Nandrolone|nandrolone|mesh-list
2286170|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
2286171|NCT00242463|Testosterone Congeners|testosterone congeners|mesh-list
2286172|NCT00242463|Androgens|androgens|mesh-ancestor
2286173|NCT00242463|Hormones|hormones|mesh-ancestor
2286174|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286175|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286176|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
2821097|NCT04069845|Doxorubicin|doxorubicin|mesh-list
2821098|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2821099|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2821100|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821101|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2821102|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2821103|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821104|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821105|NCT04069858|Entecavir|entecavir|mesh-list
2821106|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
2821107|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821108|NCT04069234|Clopidogrel|clopidogrel|mesh-list
2821109|NCT04069234|Ticagrelor|ticagrelor|mesh-list
2821110|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2286177|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2821111|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2821112|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2821113|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2821114|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
2821115|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821116|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821117|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821118|NCT04069169|Lidocaine|lidocaine|mesh-list
2821119|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
2821120|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
2821121|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2821122|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821123|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
2821124|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821125|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2821126|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2821127|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2821128|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2821129|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821130|NCT04069117|Letrozole|letrozole|mesh-list
2821131|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821132|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2821133|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2821134|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821135|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821136|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2821137|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
2821138|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2821139|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821140|NCT04069208|Cytarabine|cytarabine|mesh-list
2821141|NCT04069208|Idarubicin|idarubicin|mesh-list
2821142|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2821143|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
2821144|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821145|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821146|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
2821147|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821148|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2821149|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
2821150|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821151|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2821152|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2821153|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2821154|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821155|NCT04069325|Febuxostat|febuxostat|mesh-list
2821156|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
2821157|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2821158|NCT04069429|Heparin|heparin|mesh-list
2821159|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
2821160|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2821161|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2821162|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821163|NCT04069286|Amoxicillin|amoxicillin|mesh-list
2821164|NCT04069286|Omeprazole|omeprazole|mesh-list
2821165|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2821166|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821167|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2821168|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2821169|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2821170|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821171|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821172|NCT04069078|Scopolamine|scopolamine|mesh-list
2286178|NCT00242489|Diclofenac|diclofenac|mesh-list
2286179|NCT00242489|Etoricoxib|etoricoxib|mesh-list
2286180|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2286181|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2286182|NCT00242489|Analgesics|analgesics|mesh-ancestor
2286183|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
2286184|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286185|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286186|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2286187|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2821173|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2821174|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2286188|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2286189|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286190|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286191|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2286192|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
2286193|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2286194|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286195|NCT00242541|Octreotide|octreotide|mesh-list
2286196|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286197|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2286198|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286199|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
2286200|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2286201|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286202|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
2286203|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2286204|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286205|NCT00242606|Lamotrigine|lamotrigine|mesh-list
2286206|NCT00242606|Levetiracetam|levetiracetam|mesh-list
2286207|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
2286208|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
2286209|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2286210|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2286211|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286212|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2286213|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821175|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
2821176|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
2821177|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821178|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821179|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2821180|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
2821181|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2821182|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
2821183|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821184|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821185|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2821186|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
2821187|NCT04069065|Tacrolimus|tacrolimus|mesh-list
2821188|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2821189|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
2821190|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821191|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2821192|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821193|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821194|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
2821195|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2821196|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
2821197|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821198|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821199|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2821200|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
2821201|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2821202|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
2821203|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821204|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821205|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2821206|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
2821207|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
2286214|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2286215|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2286216|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2286217|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2286218|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2286219|NCT00242697|Anesthetics|anesthetics|mesh-list
2286220|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2286221|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286222|NCT00242736|Esomeprazole|esomeprazole|mesh-list
2286223|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2286224|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286225|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2286226|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286227|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286228|NCT00242749|Gefitinib|gefitinib|mesh-list
2286229|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286230|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2286231|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286232|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286233|NCT00242762|Docetaxel|docetaxel|mesh-list
2286234|NCT00242762|Gefitinib|gefitinib|mesh-list
2286235|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286236|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
2286237|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
2286238|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
2286239|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286240|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2286241|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286242|NCT00242775|Fluticasone|fluticasone|mesh-list
2286243|NCT00242775|Budesonide|budesonide|mesh-list
2286244|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
2286245|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2286246|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2821208|NCT04069052|Protective Agents|protective agents|mesh-ancestor
2821209|NCT04068753|Niraparib|niraparib|mesh-list
2821210|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2821211|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821212|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821213|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286247|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2286248|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
2286249|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286250|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286251|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2286252|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
2286253|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
2286254|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2286255|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
2286256|NCT00242775|Hormones|hormones|mesh-ancestor
2286257|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286258|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2286259|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2286260|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2286261|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
2286262|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2286263|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286264|NCT00242788|Capecitabine|capecitabine|mesh-list
2286265|NCT00242788|Gefitinib|gefitinib|mesh-list
2286266|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2286267|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
2286268|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286269|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286270|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2286271|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821214|NCT04068766|Bupivacaine|bupivacaine|mesh-list
2821215|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
2821216|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
2821217|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2821218|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821219|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
2821220|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821221|NCT04068974|Apatinib|apatinib|mesh-list
2821222|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821223|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2821224|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821225|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821233|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
2821234|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2821235|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821236|NCT04068948|Midazolam|midazolam|mesh-list
2821237|NCT04068948|Meperidine|meperidine|mesh-list
2821238|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
2821239|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2821240|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2821241|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2821242|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821243|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2821244|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2821245|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2821246|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2821247|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
2821248|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
2821249|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
2821250|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
2821251|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821252|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821253|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2821254|NCT04068948|Narcotics|narcotics|mesh-ancestor
2821255|NCT04068948|Analgesics|analgesics|mesh-ancestor
2821256|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
2821257|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821258|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
2821259|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
2821260|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2821261|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
2821262|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
2821263|NCT04068610|Leucovorin|leucovorin|mesh-list
2821264|NCT04068610|Bevacizumab|bevacizumab|mesh-list
2286272|NCT00242801|Gefitinib|gefitinib|mesh-list
2286273|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286274|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2286275|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286276|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286277|NCT00242814|Amlodipine|amlodipine|mesh-list
2286278|NCT00242814|Telmisartan|telmisartan|mesh-list
2286279|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2286280|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2286281|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2286282|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821265|NCT04068610|Durvalumab|durvalumab|mesh-list
2821266|NCT04068610|Fluorouracil|fluorouracil|mesh-list
2821267|NCT04068610|Oxaliplatin|oxaliplatin|mesh-list
2821268|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2821269|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821270|NCT04068610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2821271|NCT04068610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2821272|NCT04068610|Growth Substances|growth substances|mesh-ancestor
2286283|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2286284|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286285|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
2821273|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821274|NCT04068610|Growth Inhibitors|growth inhibitors|mesh-ancestor
2821275|NCT04068610|Antimetabolites|antimetabolites|mesh-ancestor
2821276|NCT04068610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821277|NCT04068610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2821278|NCT04068610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2821279|NCT04068610|Immunologic Factors|immunologic factors|mesh-ancestor
2821280|NCT04068610|Antidotes|antidotes|mesh-ancestor
2821281|NCT04068610|Protective Agents|protective agents|mesh-ancestor
2821282|NCT04068610|Vitamin B Complex|vitamin b complex|mesh-ancestor
2821283|NCT04068610|Vitamins|vitamins|mesh-ancestor
2821284|NCT04068610|Micronutrients|micronutrients|mesh-ancestor
2821285|NCT04068506|Gabapentin|gabapentin|mesh-list
2821286|NCT04068506|Analgesics|analgesics|mesh-ancestor
2821287|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
2821288|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821289|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821290|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
2821291|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2821292|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2821293|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2821294|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2821295|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2821296|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2821297|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821298|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821299|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
2821300|NCT04068272|Bosentan|bosentan|mesh-list
2821301|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2821302|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2821303|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821304|NCT04068207|Minocycline|minocycline|mesh-list
2821305|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2286286|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2286287|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2286288|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
2286289|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2286290|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
2286291|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286292|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286293|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2286294|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
2286295|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2286296|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
2286297|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286298|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821306|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821307|NCT04068246|Metformin|metformin|mesh-list
2821308|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2821309|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821310|NCT04067986|Apatinib|apatinib|mesh-list
2821311|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821312|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2821313|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821314|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821315|NCT04067791|Melatonin|melatonin|mesh-list
2821316|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
2821317|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821318|NCT04067791|Protective Agents|protective agents|mesh-ancestor
2821319|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821320|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2821321|NCT04067817|Phenylephrine|phenylephrine|mesh-list
2821322|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
2821323|NCT04067817|Norepinephrine|norepinephrine|mesh-list
2821324|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2821325|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2821326|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
2821327|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
2821328|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821329|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821330|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
2821331|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
2821332|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
2821333|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2821334|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2821335|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2821336|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
2821337|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821338|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821339|NCT04067817|Protective Agents|protective agents|mesh-ancestor
2821340|NCT04067726|Vitamin D|vitamin d|mesh-list
2821341|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
2821342|NCT04067726|Denosumab|denosumab|mesh-list
2821343|NCT04067726|Calcium|calcium|mesh-list
2821344|NCT04067726|Vitamins|vitamins|mesh-ancestor
2821345|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
2821346|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821347|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2821348|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2821349|NCT04067648|Sufentanil|sufentanil|mesh-list
2821350|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2821351|NCT04067648|Narcotics|narcotics|mesh-ancestor
2821352|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2821353|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821354|NCT04067648|Analgesics|analgesics|mesh-ancestor
2286299|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2286300|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
2286301|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
2286302|NCT00242853|Protective Agents|protective agents|mesh-ancestor
2286303|NCT00242879|Ritonavir|ritonavir|mesh-list
2286304|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2286305|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2286306|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
2286307|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286308|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286309|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2286310|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2286311|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
2286312|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2286313|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2821355|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
2821356|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821357|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2821358|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2821359|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
2286314|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2286315|NCT00242918|Docetaxel|docetaxel|mesh-list
2286316|NCT00242918|Gefitinib|gefitinib|mesh-list
2286317|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286318|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
2286319|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
2286320|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
2286321|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286322|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2821360|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
2821361|NCT04067609|Dexamethasone|dexamethasone|mesh-list
2821362|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2821363|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
2821364|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
2105430|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2105431|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2105432|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105433|NCT02453711|Liraglutide|liraglutide|mesh-list
2105434|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2105435|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105436|NCT02453711|Incretins|incretins|mesh-ancestor
2105437|NCT02453711|Hormones|hormones|mesh-ancestor
2105438|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2105439|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
2105440|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
2105441|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821365|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821366|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286323|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286324|NCT00242944|Atorvastatin|atorvastatin|mesh-list
2286325|NCT00242944|Pitavastatin|pitavastatin|mesh-list
2286326|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2286327|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2286328|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
2286329|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286330|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2286331|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2286332|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286333|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
2286334|NCT00242996|Carmustine|carmustine|mesh-list
2286335|NCT00242996|Rituximab|rituximab|mesh-list
2286336|NCT00242996|Etoposide|etoposide|mesh-list
2286337|NCT00242996|Sargramostim|sargramostim|mesh-list
2286338|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2286339|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
2286340|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821367|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2821368|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
2821369|NCT04067609|Hormones|hormones|mesh-ancestor
2821370|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2821371|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2821372|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821373|NCT04067856|Dexamethasone|dexamethasone|mesh-list
2821374|NCT04067856|Bevacizumab|bevacizumab|mesh-list
2821375|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2821376|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821377|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2821378|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2821379|NCT04067856|Growth Substances|growth substances|mesh-ancestor
2821380|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821381|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
2821382|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2821383|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
2821384|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
2821385|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821386|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2821387|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
2821388|NCT04067856|Hormones|hormones|mesh-ancestor
2821389|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2821390|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2821391|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
2286341|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286342|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2286343|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
2286344|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286345|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286346|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2286347|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2286348|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2286349|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2286350|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2286351|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286352|NCT00243009|Cyclosporine|cyclosporine|mesh-list
2821392|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2821393|NCT04067531|Clindamycin|clindamycin|mesh-list
2821394|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
2821395|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
2821396|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2821397|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821398|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2821399|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821400|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286353|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
2821401|NCT04067518|Pegaspargase|pegaspargase|mesh-list
2821402|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821403|NCT04067115|Alovudine|alovudine|mesh-list
2821404|NCT04067115|Irinotecan|irinotecan|mesh-list
2821405|NCT04067115|Trabectedin|trabectedin|mesh-list
2821406|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2821407|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2821408|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821409|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821410|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821411|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2821412|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
2821413|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
2821414|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821415|NCT04067505|Nadroparin|nadroparin|mesh-list
2821416|NCT04067505|Warfarin|warfarin|mesh-list
2821417|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
2821418|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
2821419|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2821420|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
2821421|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2821422|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
2821423|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821424|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821425|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2821426|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2821427|NCT04067492|Diclofenac|diclofenac|mesh-list
2821428|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2821429|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2821430|NCT04067492|Analgesics|analgesics|mesh-ancestor
2821431|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
2821432|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821433|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821434|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2821435|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2821436|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2821437|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821438|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821439|NCT04067024|Anesthetics|anesthetics|mesh-list
2821440|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2821441|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821442|NCT04067102|Paclitaxel|paclitaxel|mesh-list
2821443|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2821444|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
2821445|NCT04067102|Carboplatin|carboplatin|mesh-list
2821446|NCT04067102|Epirubicin|epirubicin|mesh-list
2821447|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2286354|NCT00243009|Fludarabine|fludarabine|mesh-list
2286355|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
2286356|NCT00243009|Cyclosporins|cyclosporins|mesh-list
2286357|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286358|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2286359|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
2286360|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286361|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2286362|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
2286363|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286364|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286365|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
2286366|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2286367|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
2286368|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286369|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2286370|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2286371|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2286372|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
2286373|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2286374|NCT00243035|Bortezomib|bortezomib|mesh-list
2286375|NCT00243035|Tipifarnib|tipifarnib|mesh-list
2286376|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286377|NCT00243100|Gemcitabine|gemcitabine|mesh-list
2286378|NCT00243100|Vorinostat|vorinostat|mesh-list
2821448|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821449|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
2821450|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
2821451|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
2821452|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286379|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2821453|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2821454|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
2821455|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821456|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2821457|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2821458|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
2821459|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2821460|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2821461|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2821462|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2821463|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821464|NCT04067037|Vincristine|vincristine|mesh-list
2821465|NCT04067037|Epirubicin|epirubicin|mesh-list
2821466|NCT04067037|Dacarbazine|dacarbazine|mesh-list
2821467|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2821468|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821469|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
2821470|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
2821471|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
2821472|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821473|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2821474|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2821475|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2821476|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821477|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2821478|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
2821479|NCT04066803|Folic Acid|folic acid|mesh-list
2821480|NCT04066803|Hematinics|hematinics|mesh-ancestor
2821481|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
2821482|NCT04066803|Vitamins|vitamins|mesh-ancestor
2821483|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
2821484|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821489|NCT04066790|Paclitaxel|paclitaxel|mesh-list
2821490|NCT04066790|Trastuzumab|trastuzumab|mesh-list
2821491|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2821492|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821493|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
2821494|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
2821495|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
2821496|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821497|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2821498|NCT04066764|Nadroparin|nadroparin|mesh-list
2821499|NCT04066764|Warfarin|warfarin|mesh-list
2821500|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
2821501|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
2821502|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2821503|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
2821504|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2821505|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
2821506|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821507|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821508|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2821509|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2821510|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
2821511|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821512|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821513|NCT04066881|Vaccines|vaccines|mesh-list
2821514|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
2821515|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821516|NCT04066725|Aspirin|aspirin|mesh-list
2821517|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2821518|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2821519|NCT04066725|Analgesics|analgesics|mesh-ancestor
2821520|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
2821521|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821522|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821523|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2821524|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2821525|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2821526|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2821527|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286380|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
2286381|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286382|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286383|NCT00243100|Antiviral Agents|antiviral agents|mesh-ancestor
2286384|NCT00243100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2286385|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286386|NCT00243100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2286387|NCT00243100|Immunologic Factors|immunologic factors|mesh-ancestor
2286388|NCT00243100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286389|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2821528|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2821529|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2821530|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821531|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
2821532|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
2821533|NCT04066621|Sulbactam|sulbactam|mesh-list
2821534|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2821535|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821536|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2821537|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821538|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821539|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2821540|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2821541|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
2821542|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821543|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
2821544|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2821545|NCT04066452|Antibodies|antibodies|mesh-list
2821546|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
2821547|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821548|NCT04066179|Prednisolone|prednisolone|mesh-list
2821549|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2821550|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
2821551|NCT04066179|Hormones|hormones|mesh-ancestor
2286390|NCT00243113|Docetaxel|docetaxel|mesh-list
2286391|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286392|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
2286393|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
2286394|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
2286395|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286396|NCT00243178|Clopidogrel|clopidogrel|mesh-list
2286397|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2286398|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2286399|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2286400|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2286401|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
2286402|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2286403|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286404|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286405|NCT00243204|Docetaxel|docetaxel|mesh-list
2286406|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286407|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
2286408|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
2286409|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
2286410|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286411|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
2286412|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2286413|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286414|NCT00243256|Vitamins|vitamins|mesh-ancestor
2286415|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
2286416|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2286417|NCT00243399|Oxandrolone|oxandrolone|mesh-list
2286418|NCT00243399|Androgens|androgens|mesh-ancestor
2286419|NCT00243399|Hormones|hormones|mesh-ancestor
2286420|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286421|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286422|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
2286423|NCT00243464|Betamethasone|betamethasone|mesh-list
2286424|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
2286425|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2286426|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
2286427|NCT00243464|Calcipotriene|calcipotriene|mesh-list
2286428|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2286429|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2821552|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2821553|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821554|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2821555|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821556|NCT04066296|Bupivacaine|bupivacaine|mesh-list
2821557|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
2821558|NCT04066296|Anesthetics|anesthetics|mesh-list
2821559|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2821560|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821561|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
2821562|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286430|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
2286431|NCT00243464|Hormones|hormones|mesh-ancestor
2286432|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286433|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286434|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2286435|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
2286436|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
2286437|NCT00243477|Citalopram|citalopram|mesh-list
2286438|NCT00243477|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2286439|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2286440|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2286441|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286442|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2286443|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
2286444|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286445|NCT00243477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2286446|NCT00243477|Antidepressive Agents|antidepressive agents|mesh-ancestor
2821563|NCT04066257|Metronidazole|metronidazole|mesh-list
2821564|NCT04066257|Tetracycline|tetracycline|mesh-list
2821565|NCT04066257|Bismuth|bismuth|mesh-list
2821566|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821567|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2821568|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2821569|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2286447|NCT00243477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2286448|NCT00243646|Bicalutamide|bicalutamide|mesh-list
2286449|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821570|NCT04066257|Antacids|antacids|mesh-ancestor
2821571|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821572|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2821573|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2821574|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821575|NCT04066231|Erythromycin|erythromycin|mesh-list
2821576|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
2821577|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2821578|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
2821579|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
2821580|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2821581|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821582|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2821583|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2821584|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821585|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821586|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
2821587|NCT04066114|Prednisone|prednisone|mesh-list
2286450|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286451|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
2286452|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
2286453|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2821588|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
2821589|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2821590|NCT04066114|Everolimus|everolimus|mesh-list
2821591|NCT04066114|Abatacept|abatacept|mesh-list
2821592|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
2821593|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2821594|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2821595|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
2821596|NCT04066114|Hormones|hormones|mesh-ancestor
2821597|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2821598|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821599|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2821600|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821601|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2821602|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
2821603|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2821604|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2821605|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
2821606|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2821607|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821608|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821609|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821610|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
2821611|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
2821612|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821613|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2821614|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2821615|NCT04066114|Protective Agents|protective agents|mesh-ancestor
2821616|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2821617|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2821618|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
2821619|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
2821620|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821621|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821622|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821623|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
2821624|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
2821625|NCT04066348|Etanercept|etanercept|mesh-list
2821626|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2821627|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2821628|NCT04066348|Analgesics|analgesics|mesh-ancestor
2821629|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
2821630|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821631|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821632|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2821633|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286454|NCT00243672|Atorvastatin|atorvastatin|mesh-list
2286455|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
2286456|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2286457|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2286458|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
2286459|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286460|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2286461|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2286462|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286463|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2286464|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2286465|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2286466|NCT00243711|Glycerol|glycerol|mesh-list
2286467|NCT00243711|Laxatives|laxatives|mesh-ancestor
2286468|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2821634|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2821635|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2821636|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
2821637|NCT04066660|Fucoidan|fucoidan|mesh-list
2821638|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2821639|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2821640|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
2821641|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821642|NCT04066088|Guanfacine|guanfacine|mesh-list
2821643|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2821644|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2821645|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2821646|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2821647|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
2821648|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821649|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821650|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821651|NCT04065906|Methylphenidate|methylphenidate|mesh-list
2821652|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2821653|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2821654|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821655|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2821656|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2821657|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2821658|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821659|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
2821660|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821661|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2821662|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
2821663|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
2821664|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2821665|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2821666|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
2821667|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821668|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821669|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821670|NCT04065919|Epinephrine|epinephrine|mesh-list
2821671|NCT04065919|Bupivacaine|bupivacaine|mesh-list
2821672|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
2821673|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
2821674|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2821675|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821676|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
2821677|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821678|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2821679|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2821680|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
2821681|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821682|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821683|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2821684|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2821685|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
2821686|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2821687|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
2821688|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
2821689|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
2821690|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2286469|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2286470|NCT00243711|Protective Agents|protective agents|mesh-ancestor
2286471|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286472|NCT00243724|Esomeprazole|esomeprazole|mesh-list
2286473|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2286474|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286475|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2821691|NCT04065932|BMS-986165|bms-986165|mesh-list
2821692|NCT04065932|Famotidine|famotidine|mesh-list
2821693|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2821694|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2821695|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2821696|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
2821697|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
2821698|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821699|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821700|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821701|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
2821702|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2821703|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286476|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286477|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286478|NCT00243737|Artesunate|artesunate|mesh-list
2286479|NCT00243737|Mefloquine|mefloquine|mesh-list
2286480|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
2286481|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2286482|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2286483|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2286484|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286485|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
2286486|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
2286487|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2286488|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
2286489|NCT00243750|Methotrexate|methotrexate|mesh-list
2286490|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2286491|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
2286492|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2821704|NCT04065529|Zinc|zinc|mesh-list
2821705|NCT04065529|Trace Elements|trace elements|mesh-ancestor
2821706|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
2821707|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821727|NCT04065451|Epinephrine|epinephrine|mesh-list
2821728|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2821729|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2821730|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
2821731|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821732|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821733|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821734|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2821735|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2821736|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
2821737|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821738|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2821739|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
2821740|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
2821741|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
2821742|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2821743|NCT04065581|Metformin|metformin|mesh-list
2821744|NCT04065581|Acarbose|acarbose|mesh-list
2821745|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2821746|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821747|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2821748|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821749|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821750|NCT04065555|Cetuximab|cetuximab|mesh-list
2821751|NCT04065555|Avelumab|avelumab|mesh-list
2821752|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2821753|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2821754|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821755|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
2286493|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286494|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2286495|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
2286496|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286497|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286498|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
2821756|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821757|NCT04065230|Tenofovir|tenofovir|mesh-list
2821758|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
2821759|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821760|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2821761|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2821762|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821763|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821764|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2821765|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2821766|NCT04065399|Cobicistat|cobicistat|mesh-list
2821767|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2821768|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2821769|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
2821770|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821771|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2821772|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2821773|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821774|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821775|NCT04065165|Lanreotide|lanreotide|mesh-list
2821776|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821777|NCT04065308|Daratumumab|daratumumab|mesh-list
2821778|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821779|NCT04065282|Capecitabine|capecitabine|mesh-list
2821780|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
2821781|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2821782|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
2821783|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821784|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821785|NCT04064918|Timolol|timolol|mesh-list
2821786|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2821787|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2821788|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
2821789|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821790|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821791|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821792|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2821793|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2821794|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2821795|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2821796|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821797|NCT04065269|Olaparib|olaparib|mesh-list
2821798|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2821799|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821800|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821801|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821802|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
2286499|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286500|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2286501|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2286502|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
2286503|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286504|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2286505|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
2286506|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2286507|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286508|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286509|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2286510|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2286511|NCT00243789|Protective Agents|protective agents|mesh-ancestor
2286512|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286513|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
2286514|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2286515|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
2286516|NCT00243815|Ibuprofen|ibuprofen|mesh-list
2286517|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2286518|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2286519|NCT00243815|Analgesics|analgesics|mesh-ancestor
2821803|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2821804|NCT04065035|Protective Agents|protective agents|mesh-ancestor
2821805|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821806|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
2821807|NCT04065009|Ropivacaine|ropivacaine|mesh-list
2821808|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
2821809|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
2821810|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2821811|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821812|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
2821813|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821814|NCT04065113|Ethanol|ethanol|mesh-list
2821815|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2821816|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821817|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2821818|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821819|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2821820|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
2821821|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2821822|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
2821823|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2821824|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821825|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2821826|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2286520|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
2286521|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286522|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286523|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2286524|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286525|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2286526|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286527|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286528|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2821827|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821828|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
2821829|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2821830|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2821831|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
2821832|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821833|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821834|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821835|NCT04064619|Urological Agents|urological agents|mesh-ancestor
2821847|NCT04064632|Darunavir|darunavir|mesh-list
2821848|NCT04064632|Cobicistat|cobicistat|mesh-list
2821849|NCT04064632|Rilpivirine|rilpivirine|mesh-list
2821850|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2821851|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2821852|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
2821853|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821854|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821855|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2821856|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2821857|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
2821858|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821859|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2821860|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2821861|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2821862|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2821863|NCT04064697|Valganciclovir|valganciclovir|mesh-list
2821864|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
2821865|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821866|NCT04064554|Vaccines|vaccines|mesh-list
2821867|NCT04064554|Immunologic Factors|immunologic factors|mesh-ancestor
2821868|NCT04064554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821878|NCT04064190|Durvalumab|durvalumab|mesh-list
2821879|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2821880|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821881|NCT04064125|Minocycline|minocycline|mesh-list
2821882|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2821883|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821884|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
2821885|NCT04063839|Grazoprevir|grazoprevir|mesh-list
2821886|NCT04063839|Ledipasvir|ledipasvir|mesh-list
2821887|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
2821888|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2821889|NCT04064138|Anesthetics|anesthetics|mesh-list
2821890|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2821891|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286529|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286530|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2821892|NCT04064073|Metformin|metformin|mesh-list
2821893|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2821894|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821895|NCT04064931|Niacin|niacin|mesh-list
2821896|NCT04064931|Vitamins|vitamins|mesh-ancestor
2821897|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
2821898|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821899|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2821900|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
2821901|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821902|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2821903|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
2286531|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286532|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286533|NCT00243867|Paclitaxel|paclitaxel|mesh-list
2286534|NCT00243867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2286535|NCT00243867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286536|NCT00243867|Tubulin Modulators|tubulin modulators|mesh-ancestor
2286537|NCT00243867|Antimitotic Agents|antimitotic agents|mesh-ancestor
2286538|NCT00243867|Mitosis Modulators|mitosis modulators|mesh-ancestor
2286539|NCT00243867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286540|NCT00243880|Lovastatin|lovastatin|mesh-list
2286541|NCT00243880|L 647318|l 647318|mesh-list
2821904|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
2821905|NCT04063904|Misoprostol|misoprostol|mesh-list
2821906|NCT04063904|Mifepristone|mifepristone|mesh-list
2286542|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
2286543|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2286544|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2286545|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
2286546|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286547|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2286548|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2286549|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286550|NCT00243893|Doxycycline|doxycycline|mesh-list
2286551|NCT00243893|Minocycline|minocycline|mesh-list
2286552|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2286553|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2286554|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
2286555|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2286556|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2286557|NCT00243906|Plasminogen|plasminogen|mesh-list
2286558|NCT00243906|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2286559|NCT00243906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2286560|NCT00243906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2286561|NCT00243906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286562|NCT00243945|Rotigotine|rotigotine|mesh-list
2286563|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
2286564|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
2286565|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2286566|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286567|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286568|NCT00243984|Topiramate|topiramate|mesh-list
2286569|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
2286570|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2286571|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286572|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
2286573|NCT00244023|Testosterone|testosterone|mesh-list
2286574|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
2286575|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
2821907|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2821908|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
2821909|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2821910|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821911|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2821912|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2821913|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
2821914|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2821915|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2821916|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2821917|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2821918|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
2821919|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2821920|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2821921|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
2286576|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2286577|NCT00244023|Androgens|androgens|mesh-ancestor
2286578|NCT00244023|Hormones|hormones|mesh-ancestor
2286579|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286580|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286581|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2286582|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286583|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
2821922|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2821923|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
2821924|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2821925|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2821926|NCT04064060|Luspatercept|luspatercept|mesh-list
2821927|NCT04064060|Hematinics|hematinics|mesh-ancestor
2821928|NCT04063865|Everolimus|everolimus|mesh-list
2821929|NCT04063865|Tacrolimus|tacrolimus|mesh-list
2821930|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2821931|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
2821932|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821933|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2821934|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2821935|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821936|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821937|NCT04063683|Paclitaxel|paclitaxel|mesh-list
2821938|NCT04063683|Cisplatin|cisplatin|mesh-list
2821939|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2821940|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821941|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
2821942|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
2821943|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
2821944|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821945|NCT04063527|Paclitaxel|paclitaxel|mesh-list
2821946|NCT04063527|Carboplatin|carboplatin|mesh-list
2286584|NCT00244075|Hormones|hormones|mesh-list
2286585|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286586|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286587|NCT00244127|Prednisone|prednisone|mesh-list
2286588|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
2286589|NCT00244127|Rituximab|rituximab|mesh-list
2286590|NCT00244127|Vincristine|vincristine|mesh-list
2286591|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2286592|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
2286593|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286594|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286595|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2286596|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
2286597|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286598|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286599|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2286600|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2286601|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2286602|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
2286603|NCT00244127|Hormones|hormones|mesh-ancestor
2821947|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2821948|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821949|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
2286604|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286605|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2286606|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2286607|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
2286608|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
2821950|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
2821951|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
2821952|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821953|NCT04063540|Amiloride|amiloride|mesh-list
2821954|NCT04063540|Diuretics|diuretics|mesh-ancestor
2821955|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
2821956|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821957|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2821958|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2821959|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2821960|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286609|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
2286610|NCT00244153|Dexamethasone|dexamethasone|mesh-list
2286611|NCT00244153|Morphine|morphine|mesh-list
2286612|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2286613|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
2286614|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
2286615|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286616|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286617|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286618|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
2286619|NCT00244153|Hormones|hormones|mesh-ancestor
2286620|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286621|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2286622|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286623|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2286624|NCT00244153|Narcotics|narcotics|mesh-ancestor
2286625|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2821961|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2821962|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2821963|NCT04063267|Nicotine|nicotine|mesh-list
2821964|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2821965|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
2821966|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821967|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821968|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2821969|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2821970|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
2821971|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2821972|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821973|NCT04063449|Endostar protein|endostar protein|mesh-list
2821974|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2821975|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2821976|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2821977|NCT04063449|Growth Substances|growth substances|mesh-ancestor
2821978|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821979|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
2821980|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821981|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2821985|NCT04063358|Ranibizumab|ranibizumab|mesh-list
2821986|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2821987|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2821988|NCT04063358|Growth Substances|growth substances|mesh-ancestor
2821989|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821990|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
2286626|NCT00244153|Analgesics|analgesics|mesh-ancestor
2286627|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
2286628|NCT00244166|Prednisolone|prednisolone|mesh-list
2286629|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2286630|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
2286631|NCT00244166|Hormones|hormones|mesh-ancestor
2286632|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286633|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2821991|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2821992|NCT04063189|Clarithromycin|clarithromycin|mesh-list
2821993|NCT04063189|Dexamethasone|dexamethasone|mesh-list
2821994|NCT04063189|Lenalidomide|lenalidomide|mesh-list
2821995|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2821996|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
2821997|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
2821998|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2821999|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822000|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2822001|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
2822002|NCT04063189|Hormones|hormones|mesh-ancestor
2822003|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2822004|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2822005|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822006|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
2822007|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2822008|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2822009|NCT04063189|Growth Substances|growth substances|mesh-ancestor
2286634|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2286635|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286636|NCT00244179|Interferons|interferons|mesh-list
2286637|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
2822010|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
2822011|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2822012|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822013|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2822014|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822015|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822016|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2822017|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2822018|NCT04063163|Carboplatin|carboplatin|mesh-list
2286638|NCT00244179|Infliximab|infliximab|mesh-list
2286639|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286640|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
2286641|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2286642|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
2286643|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286644|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286645|NCT00244192|Infliximab|infliximab|mesh-list
2286646|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
2286647|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286648|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286649|NCT00244283|Sevoflurane|sevoflurane|mesh-list
2822019|NCT04063163|Etoposide|etoposide|mesh-list
2822020|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822021|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2822022|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2822023|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2822024|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822025|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822026|NCT04063046|Anesthetics|anesthetics|mesh-list
2822027|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2822028|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822029|NCT04063124|Dasatinib|dasatinib|mesh-list
2822030|NCT04063124|Quercetin|quercetin|mesh-list
2822031|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822032|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2822033|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822034|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822035|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
2822036|NCT04063124|Protective Agents|protective agents|mesh-ancestor
2822037|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822038|NCT04062760|Diuretics|diuretics|mesh-list
2822039|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
2822040|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822041|NCT04062890|Vigabatrin|vigabatrin|mesh-list
2822042|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
2822043|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822044|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822045|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
2822046|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822047|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822048|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
2822049|NCT04063033|Hematinics|hematinics|mesh-ancestor
2822050|NCT04062695|Tofacitinib|tofacitinib|mesh-list
2822051|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2822052|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822053|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822054|NCT04062656|Leucovorin|leucovorin|mesh-list
2822055|NCT04062656|Folic Acid|folic acid|mesh-list
2822056|NCT04062656|Docetaxel|docetaxel|mesh-list
2822057|NCT04062656|Fluorouracil|fluorouracil|mesh-list
2822058|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
2822059|NCT04062656|Nivolumab|nivolumab|mesh-list
2822060|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822061|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
2822062|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
2822063|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
2822064|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822065|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
2286650|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2286651|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2286652|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
2286653|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
2286654|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2286655|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822066|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2822067|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2822068|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
2286656|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2286657|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2286658|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2822069|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822070|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2822071|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2822072|NCT04062656|Antidotes|antidotes|mesh-ancestor
2822073|NCT04062656|Protective Agents|protective agents|mesh-ancestor
2822074|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
2822075|NCT04062656|Vitamins|vitamins|mesh-ancestor
2822076|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
2822077|NCT04062656|Hematinics|hematinics|mesh-ancestor
2105442|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105443|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2105444|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
2105445|NCT02453841|Phenylephrine|phenylephrine|mesh-list
2105446|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
2105447|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2105448|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2105449|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
2286659|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2286660|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286661|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2286662|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286663|NCT00244296|Analgesics|analgesics|mesh-ancestor
2286664|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
2286665|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286666|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
2286667|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2286668|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
2286669|NCT00244309|Tamsulosin|tamsulosin|mesh-list
2286670|NCT00244309|Dutasteride|dutasteride|mesh-list
2286671|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2286672|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2286673|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2286674|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
2286675|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822078|NCT04062669|Vaccines|vaccines|mesh-list
2822079|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
2822080|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822081|NCT04062175|Azithromycin|azithromycin|mesh-list
2822082|NCT04062175|Cephalosporins|cephalosporins|mesh-list
2822083|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2822084|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822085|NCT04062123|Fentanyl|fentanyl|mesh-list
2822086|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
2822087|NCT04062123|Propofol|propofol|mesh-list
2822088|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2822089|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2286676|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286677|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286678|NCT00244309|Urological Agents|urological agents|mesh-ancestor
2286679|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2286680|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2286681|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286682|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
2286683|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286684|NCT00244348|Fluorouracil|fluorouracil|mesh-list
2286685|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
2286686|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
2286687|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286688|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2286689|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286690|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2286691|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
2286692|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286693|NCT00244361|Rituximab|rituximab|mesh-list
2286694|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2286695|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286696|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
2286697|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286698|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286699|NCT00244426|Aspirin|aspirin|mesh-list
2286700|NCT00244426|Indobufen|indobufen|mesh-list
2286701|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2286702|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822090|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822091|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2822092|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
2822093|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
2822094|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822095|NCT04062123|Analgesics|analgesics|mesh-ancestor
2822096|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
2822097|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822098|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2822099|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2822100|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2822101|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
2822102|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822103|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822104|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2822105|NCT04062123|Narcotics|narcotics|mesh-ancestor
2822106|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2822107|NCT04062591|Piroxicam|piroxicam|mesh-list
2822108|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2822109|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822110|NCT04062591|Analgesics|analgesics|mesh-ancestor
2822111|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
2822112|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822113|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822114|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822115|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2822116|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2822117|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822118|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822119|NCT04062565|Treprostinil|treprostinil|mesh-list
2822120|NCT04062565|Riociguat|riociguat|mesh-list
2822121|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2822122|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
2822123|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822124|NCT04062201|Levofloxacin|levofloxacin|mesh-list
2822125|NCT04062201|Ofloxacin|ofloxacin|mesh-list
2822126|NCT04062201|Isoniazid|isoniazid|mesh-list
2822127|NCT04062201|Linezolid|linezolid|mesh-list
2822128|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
2822129|NCT04062201|Ethambutol|ethambutol|mesh-list
2822130|NCT04062201|Bedaquiline|bedaquiline|mesh-list
2822131|NCT04062201|Clofazimine|clofazimine|mesh-list
2822132|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2822133|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822134|NCT04062201|Renal Agents|renal agents|mesh-ancestor
2822135|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2822136|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2822137|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2822138|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822139|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822140|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822141|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2822142|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2822143|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
2822144|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2822145|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2822146|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
2822147|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2822148|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2822149|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822150|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
2822151|NCT04062370|Ranibizumab|ranibizumab|mesh-list
2822152|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2822153|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2822154|NCT04062370|Growth Substances|growth substances|mesh-ancestor
2822155|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822156|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
2822157|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822158|NCT04062357|Lidocaine|lidocaine|mesh-list
2822159|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
2822160|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
2822161|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2822162|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822163|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
2822164|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822165|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2822166|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2822167|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2822168|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2822169|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822170|NCT04062097|Vitamin K|vitamin k|mesh-list
2822171|NCT04062097|Dabigatran|dabigatran|mesh-list
2286703|NCT00244426|Analgesics|analgesics|mesh-ancestor
2286704|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
2286705|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286706|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286707|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2286708|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286709|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2286710|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2286711|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286712|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2286713|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2822172|NCT04062097|Vitamins|vitamins|mesh-ancestor
2822173|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
2822174|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822175|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
2822176|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2822177|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
2822178|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822179|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822180|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
2822181|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2822182|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2822183|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
2822184|NCT04062097|Coagulants|coagulants|mesh-ancestor
2822185|NCT04061824|Olmesartan|olmesartan|mesh-list
2822186|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
2822187|NCT04061824|Giapreza|giapreza|mesh-list
2822188|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2822189|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
2822190|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2822191|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2822192|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2822193|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
2822194|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822195|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2822196|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2822197|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822198|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2822199|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2822200|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2105450|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105451|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105452|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105453|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
2105454|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
2286714|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286715|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
2286716|NCT00244439|Permethrin|permethrin|mesh-list
2286717|NCT00244439|Malathion|malathion|mesh-list
2286718|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286719|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286720|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2286721|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
2286722|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822201|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2822202|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
2822203|NCT04061772|Prednisone|prednisone|mesh-list
2822204|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
2822205|NCT04061772|Etoposide|etoposide|mesh-list
2822206|NCT04061772|Bortezomib|bortezomib|mesh-list
2822207|NCT04061772|Epirubicin|epirubicin|mesh-list
2822208|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2822209|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
2822210|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822211|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2822212|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2822213|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
2822214|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822215|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822216|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2822217|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822218|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
2822219|NCT04061772|Hormones|hormones|mesh-ancestor
2822220|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2822221|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2822222|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2822223|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2822224|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2822225|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822226|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2822227|NCT04062019|Aldesleukin|aldesleukin|mesh-list
2822228|NCT04062019|Interleukin-2|interleukin-2|mesh-list
2822229|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822230|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822231|NCT04062019|Analgesics|analgesics|mesh-ancestor
2822232|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
2822233|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822234|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822235|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2822236|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2822237|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
2822238|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822239|NCT04062045|Ropivacaine|ropivacaine|mesh-list
2822240|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
2822241|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
2822242|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2822243|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822244|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
2822245|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822246|NCT04061798|Heparin|heparin|mesh-list
2286723|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105455|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105456|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
2105457|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2105458|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
2105459|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2105460|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
2822247|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
2822248|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2822249|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2822250|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822251|NCT04061863|Nivolumab|nivolumab|mesh-list
2822252|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2822253|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822254|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2822255|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822256|NCT04062006|Aldesleukin|aldesleukin|mesh-list
2822257|NCT04062006|Interleukin-2|interleukin-2|mesh-list
2822258|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822259|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822260|NCT04062006|Analgesics|analgesics|mesh-ancestor
2822261|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
2822262|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822263|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822264|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2286724|NCT00244452|Cetrorelix|cetrorelix|mesh-list
2286725|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2286726|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
2286727|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2286728|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286729|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
2286730|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286731|NCT00244504|Moxonidine|moxonidine|mesh-list
2286732|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2286733|NCT00244517|Remifentanil|remifentanil|mesh-list
2286734|NCT00244517|Sevoflurane|sevoflurane|mesh-list
2286735|NCT00244517|Desflurane|desflurane|mesh-list
2286736|NCT00244517|Isoflurane|isoflurane|mesh-list
2286737|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
2286738|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2286739|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286740|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2286741|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2286742|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
2286743|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2286744|NCT00244517|Narcotics|narcotics|mesh-ancestor
2286745|NCT00244517|Analgesics|analgesics|mesh-ancestor
2286746|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
2822265|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2822266|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
2822267|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822268|NCT04061980|Nivolumab|nivolumab|mesh-list
2822269|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2822270|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822271|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2822272|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822273|NCT04062032|Aspirin|aspirin|mesh-list
2822274|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2822275|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822276|NCT04062032|Analgesics|analgesics|mesh-ancestor
2822277|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
2822278|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822279|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822280|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822281|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2822282|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2822283|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2822284|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822285|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2822286|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2822287|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822288|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
2822289|NCT04061512|Dexamethasone|dexamethasone|mesh-list
2822290|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
2822291|NCT04061512|Rituximab|rituximab|mesh-list
2822292|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2822293|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
2822294|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822295|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2822296|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2286747|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286748|NCT00244530|Nifedipine|nifedipine|mesh-list
2286749|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2286750|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2286751|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286752|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2286753|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286754|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
2286755|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
2286756|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2286757|NCT00244556|Etanercept|etanercept|mesh-list
2286758|NCT00244556|Methotrexate|methotrexate|mesh-list
2286759|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2286760|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
2286761|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2286762|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286763|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2286764|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
2286765|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286766|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822297|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
2822298|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822299|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822300|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2822301|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822302|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
2822303|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
2822304|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822305|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2822306|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
2822307|NCT04061512|Hormones|hormones|mesh-ancestor
2822308|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2822309|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2822310|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2822311|NCT04061655|Iron|iron|mesh-list
2822312|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2822313|NCT04061655|Trace Elements|trace elements|mesh-ancestor
2822314|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
2822315|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822316|NCT04061655|Hematinics|hematinics|mesh-ancestor
2822317|NCT04061447|Clarithromycin|clarithromycin|mesh-list
2822318|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2822319|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822320|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2822321|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822322|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286767|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
2286768|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286769|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2286770|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2286771|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
2286772|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286773|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2286774|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2286775|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2286776|NCT00244556|Analgesics|analgesics|mesh-ancestor
2286777|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
2286778|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286779|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2286780|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286781|NCT00244608|Budesonide|budesonide|mesh-list
2286782|NCT00244608|Terbutaline|terbutaline|mesh-list
2286783|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
2286784|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2286785|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2286786|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
2286787|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286788|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286789|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2286790|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
2286791|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
2286792|NCT00244608|Hormones|hormones|mesh-ancestor
2286793|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286794|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2286795|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2286796|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2822323|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2822324|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2822325|NCT04061265|Lidocaine|lidocaine|mesh-list
2822326|NCT04061265|Epinephrine|epinephrine|mesh-list
2822327|NCT04061265|Carticaine|carticaine|mesh-list
2822328|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
2822329|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
2822330|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2822331|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822332|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
2822333|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822334|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2822335|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2822336|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2822337|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2822338|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822339|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2822340|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2822341|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
2822342|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822343|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2822344|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2822345|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
2822346|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2822347|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
2822348|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
2822349|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
2822350|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2822357|NCT04061252|Brodalumab|brodalumab|mesh-list
2822358|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
2822359|NCT04061538|Zinc|zinc|mesh-list
2822360|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
2822361|NCT04061538|Trace Elements|trace elements|mesh-ancestor
2822362|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
2822363|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822364|NCT04061538|Astringents|astringents|mesh-ancestor
2822365|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
2822366|NCT04061590|Cisplatin|cisplatin|mesh-list
2822367|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
2822368|NCT04061590|Pemetrexed|pemetrexed|mesh-list
2822369|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822370|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2822371|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822372|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822373|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2822374|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2822375|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2822376|NCT04061473|Empagliflozin|empagliflozin|mesh-list
2822377|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2822378|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822379|NCT04061473|Incretins|incretins|mesh-ancestor
2822380|NCT04061473|Hormones|hormones|mesh-ancestor
2822381|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2822382|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2822383|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
2822384|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822385|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822386|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2822387|NCT04061200|Empagliflozin|empagliflozin|mesh-list
2822388|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2822389|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822390|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2822391|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822392|NCT04061161|Bromides|bromides|mesh-list
2822393|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
2822394|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2822395|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
2822396|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822397|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822398|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2105461|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2105462|NCT02453841|Protective Agents|protective agents|mesh-ancestor
2105463|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
2105464|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
2105465|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2105466|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105467|NCT02454283|Vanoxerine|vanoxerine|mesh-list
2105468|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2105469|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2105470|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2105471|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105472|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
2105473|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105474|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105475|NCT02454296|Lidocaine|lidocaine|mesh-list
2105476|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
2105477|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
2105478|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105479|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105480|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
2105481|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105482|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2105483|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2105484|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2105485|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2105486|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105487|NCT02454478|Everolimus|everolimus|mesh-list
2105488|NCT02454478|Lenvatinib|lenvatinib|mesh-list
2105489|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105490|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2286797|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
2822399|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
2822400|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
2822401|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2822402|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
2822403|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822404|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286798|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2286799|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286800|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
2286801|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
2286802|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2822405|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
2822406|NCT04060888|Ustekinumab|ustekinumab|mesh-list
2822407|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
2822408|NCT04061057|Lidocaine|lidocaine|mesh-list
2822409|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
2822410|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
2822411|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2822412|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822413|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
2822414|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822415|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2286803|NCT00244738|Castor Oil|castor oil|mesh-list
2286804|NCT00244738|Cathartics|cathartics|mesh-ancestor
2286805|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286806|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
2286807|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286808|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2286809|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286810|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286811|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
2286812|NCT00244907|Genistein|genistein|mesh-list
2286813|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2286814|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2286815|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286816|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2286817|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286818|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2286819|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2286820|NCT00244907|Protective Agents|protective agents|mesh-ancestor
2286821|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286822|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2286823|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286824|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
2286825|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2286826|NCT00244907|Estrogens|estrogens|mesh-ancestor
2286827|NCT00244907|Hormones|hormones|mesh-ancestor
2286828|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286829|NCT00244920|Squalamine|squalamine|mesh-list
2286830|NCT00244920|Leuprolide|leuprolide|mesh-list
2286831|NCT00244920|Bicalutamide|bicalutamide|mesh-list
2286832|NCT00244920|Hormones|hormones|mesh-list
2286833|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
2286834|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286835|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286836|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2822416|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2822417|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2822418|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2822419|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822420|NCT04061239|Cytarabine|cytarabine|mesh-list
2822421|NCT04061239|Azacitidine|azacitidine|mesh-list
2822422|NCT04061239|Daunorubicin|daunorubicin|mesh-list
2822423|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2822424|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
2822425|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822426|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822427|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
2822428|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822429|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2822430|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
2822431|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286837|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
2286838|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2286839|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2286840|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286841|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
2286842|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2286843|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2286844|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2286845|NCT00244920|Protective Agents|protective agents|mesh-ancestor
2286846|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2822432|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822433|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2822434|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2822435|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2286847|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2822436|NCT04060914|Clopidogrel|clopidogrel|mesh-list
2822437|NCT04060914|Ticagrelor|ticagrelor|mesh-list
2822438|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2822439|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2822440|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2822441|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2822442|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
2822443|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822444|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822445|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822446|NCT04060849|Ethanol|ethanol|mesh-list
2822447|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2286848|NCT00244920|Growth Substances|growth substances|mesh-ancestor
2286849|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
2286850|NCT00244946|Cytarabine|cytarabine|mesh-list
2286851|NCT00244946|Etoposide|etoposide|mesh-list
2286852|NCT00244946|Melphalan|melphalan|mesh-list
2286853|NCT00244946|Carmustine|carmustine|mesh-list
2286854|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2286855|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286856|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2822448|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2822449|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822450|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2822451|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822452|NCT04060771|Dexamethasone|dexamethasone|mesh-list
2822453|NCT04060771|Palonosetron|palonosetron|mesh-list
2286857|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2286858|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286859|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822454|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822455|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
2822456|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
2822457|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822458|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822459|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2822460|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
2822461|NCT04060771|Hormones|hormones|mesh-ancestor
2822462|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2822463|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2822464|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822465|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2822466|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2822467|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
2822468|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822469|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822470|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
2822471|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2822472|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822473|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
2822474|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2822475|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
2822476|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822477|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822478|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2822479|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
2822480|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2822481|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
2822482|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822483|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822484|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2822485|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
2822486|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
2822487|NCT04060979|Protective Agents|protective agents|mesh-ancestor
2822488|NCT04060836|Factor VIII|factor viii|mesh-list
2822489|NCT04060836|Coagulants|coagulants|mesh-ancestor
2822490|NCT04060862|Fulvestrant|fulvestrant|mesh-list
2822491|NCT04060862|Palbociclib|palbociclib|mesh-list
2822492|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2822493|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822494|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2822495|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2822496|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
2822497|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2105491|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
2105492|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105493|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2105494|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105495|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105496|NCT02454608|Verapamil|verapamil|mesh-list
2105497|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2822498|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822499|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2822500|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822501|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822502|NCT04060719|Rifampin|rifampin|mesh-list
2822503|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2822504|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
2822505|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2822506|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822507|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
2822508|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2822509|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822510|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822511|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2822512|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2822513|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2822514|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2822515|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2822516|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2822517|NCT04060628|Docetaxel|docetaxel|mesh-list
2822518|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822519|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
2822520|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
2822521|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
2822522|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822541|NCT04060381|Ibuprofen|ibuprofen|mesh-list
2822542|NCT04060381|Dopamine|dopamine|mesh-list
2822543|NCT04060381|Epinephrine|epinephrine|mesh-list
2822544|NCT04060381|Norepinephrine|norepinephrine|mesh-list
2822545|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2822546|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822547|NCT04060381|Analgesics|analgesics|mesh-ancestor
2822548|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
2822549|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822550|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822551|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822552|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2822553|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2822554|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822555|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822556|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2822557|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2822558|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
2822559|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822560|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2822561|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2822562|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
2822563|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2822564|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
2822565|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
2822566|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
2822567|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2822568|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2822569|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
2822570|NCT04060381|Protective Agents|protective agents|mesh-ancestor
2822571|NCT04060472|Paclitaxel|paclitaxel|mesh-list
2822572|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
2822573|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2822574|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2822575|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822576|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
2822577|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
2822578|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
2822579|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822580|NCT04060459|Paclitaxel|paclitaxel|mesh-list
2822581|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2822582|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822583|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
2822584|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
2286860|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2286861|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
2286862|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
2822585|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
2822586|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822587|NCT04060407|Nivolumab|nivolumab|mesh-list
2822588|NCT04060407|Ipilimumab|ipilimumab|mesh-list
2822589|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2822590|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822591|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2822592|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822593|NCT04060277|Acetic Acid|acetic acid|mesh-list
2822594|NCT04060277|Letermovir|letermovir|mesh-list
2822595|NCT04060277|Vaccines|vaccines|mesh-list
2822596|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
2822597|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822598|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2822599|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822600|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822601|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822602|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822603|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2822604|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
2822605|NCT04060264|Eculizumab|eculizumab|mesh-list
2822606|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2822607|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2822608|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
2822609|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822610|NCT04060550|Omalizumab|omalizumab|mesh-list
2822611|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2822612|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2822613|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
2822614|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2822615|NCT04059770|Amphotericin B|amphotericin b|mesh-list
2822616|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
2822617|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822618|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2822619|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2822620|NCT04059770|Amebicides|amebicides|mesh-ancestor
2822621|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2286863|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2286864|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2286865|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
2286866|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286867|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2286868|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
2286869|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2286870|NCT00244959|Anastrozole|anastrozole|mesh-list
2286871|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2286872|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286873|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2286874|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2286875|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286876|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286877|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2822622|NCT04060043|Goserelin|goserelin|mesh-list
2286878|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
2822623|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2822624|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822625|NCT04060095|Anesthetics|anesthetics|mesh-list
2822626|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2822627|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822628|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
2822629|NCT04060017|Leucovorin|leucovorin|mesh-list
2822630|NCT04060017|Calcium|calcium|mesh-list
2822631|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
2822632|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2822633|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822634|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2822635|NCT04060017|Antidotes|antidotes|mesh-ancestor
2822636|NCT04060017|Protective Agents|protective agents|mesh-ancestor
2822637|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
2822638|NCT04060017|Vitamins|vitamins|mesh-ancestor
2822639|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
2822640|NCT04059887|Atezolizumab|atezolizumab|mesh-list
2822641|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822642|NCT04059978|Remifentanil|remifentanil|mesh-list
2822643|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2822644|NCT04059978|Narcotics|narcotics|mesh-ancestor
2822645|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2822646|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822647|NCT04059978|Analgesics|analgesics|mesh-ancestor
2822648|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
2822649|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822650|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
2822651|NCT04060030|Leucovorin|leucovorin|mesh-list
2822652|NCT04060030|Calcium|calcium|mesh-list
2822653|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
2822654|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2822655|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822656|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2822657|NCT04060030|Antidotes|antidotes|mesh-ancestor
2822658|NCT04060030|Protective Agents|protective agents|mesh-ancestor
2822659|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
2822660|NCT04060030|Vitamins|vitamins|mesh-ancestor
2822661|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
2822662|NCT04059679|Aspirin|aspirin|mesh-list
2822663|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
2822664|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2822665|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822666|NCT04059679|Analgesics|analgesics|mesh-ancestor
2822667|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
2822668|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822669|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822670|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822671|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2822672|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2822673|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2822674|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822675|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2822676|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2822677|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822678|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
2822679|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2822680|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
2822681|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2822682|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
2822683|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
2822684|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
2822685|NCT04059445|Calcium|calcium|mesh-list
2822686|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2822687|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822688|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2822689|NCT04059536|Aspirin|aspirin|mesh-list
2822690|NCT04059536|Heparin|heparin|mesh-list
2822691|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2822692|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822693|NCT04059536|Analgesics|analgesics|mesh-ancestor
2822694|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
2822695|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822696|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822697|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822698|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2822699|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2822700|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2822701|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822702|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2822703|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2822704|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822705|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
2822706|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
2822707|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
2822708|NCT04059458|Calcium|calcium|mesh-list
2822709|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2822710|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822711|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2822712|NCT04059523|Tretinoin|tretinoin|mesh-list
2822713|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822714|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
2822715|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
2822716|NCT04059224|Trametinib|trametinib|mesh-list
2822717|NCT04059224|Dabrafenib|dabrafenib|mesh-list
2822718|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822719|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2822720|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822721|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822722|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
2822723|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2822724|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822725|NCT04059198|Tenofovir|tenofovir|mesh-list
2822726|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
2822727|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822728|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2822729|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2822730|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822731|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822732|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2822733|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2822736|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
2822737|NCT04058899|Nalbuphine|nalbuphine|mesh-list
2822738|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2822739|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2822740|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822741|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822742|NCT04058899|Analgesics|analgesics|mesh-ancestor
2822743|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
2822744|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822745|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2822746|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2822747|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2822748|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
2822749|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822750|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822751|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2822752|NCT04058899|Narcotics|narcotics|mesh-ancestor
2822753|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
2822754|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2822755|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822756|NCT04059172|Ibuprofen|ibuprofen|mesh-list
2822757|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2822758|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822759|NCT04059172|Analgesics|analgesics|mesh-ancestor
2822760|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
2822761|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822762|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822763|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822764|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2822765|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2822766|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822767|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822768|NCT04058522|Triamcinolone|triamcinolone|mesh-list
2822769|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822770|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
2822771|NCT04058522|Hormones|hormones|mesh-ancestor
2822772|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2822773|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822774|NCT04058678|Danazol|danazol|mesh-list
2822775|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2822776|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
2822777|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2822778|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822779|NCT04058717|Nicotine|nicotine|mesh-list
2822780|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2822781|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
2822782|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822783|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822784|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2822785|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2822786|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
2822787|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822788|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822789|NCT04058743|Cobalt|cobalt|mesh-list
2822790|NCT04058743|Chromium|chromium|mesh-list
2822791|NCT04058743|Nickel|nickel|mesh-list
2822792|NCT04058743|Trace Elements|trace elements|mesh-ancestor
2822793|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
2822794|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822795|NCT04058470|Prednisone|prednisone|mesh-list
2822796|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
2822797|NCT04058470|Doxorubicin|doxorubicin|mesh-list
2822798|NCT04058470|Vincristine|vincristine|mesh-list
2822799|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2822800|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
2822801|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822802|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2822803|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2822804|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
2822805|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822806|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822807|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2822808|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2822809|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2822810|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2822811|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822812|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822813|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
2822814|NCT04058470|Hormones|hormones|mesh-ancestor
2822815|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2822816|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2286879|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286880|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286881|NCT00244972|Sorafenib|sorafenib|mesh-list
2286882|NCT00244972|Tipifarnib|tipifarnib|mesh-list
2286883|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286884|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2822817|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2822818|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
2822819|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
2822820|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
2286885|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286886|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286887|NCT00244998|Fulvestrant|fulvestrant|mesh-list
2286888|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2286889|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286890|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2286891|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2286892|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
2286893|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2286894|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286895|NCT00245024|Sulindac|sulindac|mesh-list
2286896|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2822826|NCT04058236|Polygeline|polygeline|mesh-list
2822827|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
2822828|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
2822829|NCT04058145|Plerixafor|plerixafor|mesh-list
2822830|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
2822831|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2822832|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822833|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2822834|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2822835|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
2822836|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822837|NCT04058210|Ivacaftor|ivacaftor|mesh-list
2822838|NCT04058210|Elexacaftor|elexacaftor|mesh-list
2822839|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2822840|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2822841|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822842|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
2822843|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822844|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
2822845|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2822846|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2822847|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822848|NCT04058132|Urological Agents|urological agents|mesh-ancestor
2822849|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
2822850|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2822851|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2822852|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2822853|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2822854|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822855|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
2822856|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822857|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822858|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2822859|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822860|NCT04058054|Histamine|histamine|mesh-list
2822861|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
2822862|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
2822863|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822864|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822865|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286897|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2286898|NCT00245024|Analgesics|analgesics|mesh-ancestor
2822866|NCT04057989|Ketamine|ketamine|mesh-list
2822867|NCT04057989|Analgesics|analgesics|mesh-ancestor
2822868|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
2822869|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822870|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822871|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2822872|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2822873|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
2822874|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
2822875|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2822876|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2822877|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2822878|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822879|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286899|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
2286900|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286901|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286902|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2286903|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286904|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286905|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2286906|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286907|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286908|NCT00245089|Dactinomycin|dactinomycin|mesh-list
2286909|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
2286910|NCT00245089|Vincristine|vincristine|mesh-list
2286911|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2286912|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
2286913|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286914|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286915|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2286916|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
2286917|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286918|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286919|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2286920|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2286921|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
2286922|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
2286923|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
2286924|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2286925|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2286926|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2286927|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2286928|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286929|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2286930|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
2286931|NCT00245115|Busulfan|busulfan|mesh-list
2286932|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2822893|NCT04057365|Nivolumab|nivolumab|mesh-list
2822894|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2822895|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822896|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2822897|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822898|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2822899|NCT04057456|Nabilone|nabilone|mesh-list
2822900|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
2822901|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
2822902|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286933|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
2822903|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822904|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2822905|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2822906|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2822907|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2822908|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2822909|NCT04057261|Liraglutide|liraglutide|mesh-list
2822910|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2822911|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822912|NCT04057261|Incretins|incretins|mesh-ancestor
2822913|NCT04057261|Hormones|hormones|mesh-ancestor
2822914|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2822915|NCT04057300|Aspirin|aspirin|mesh-list
2822916|NCT04057300|Clopidogrel|clopidogrel|mesh-list
2822917|NCT04057300|Ticagrelor|ticagrelor|mesh-list
2822918|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2822919|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822920|NCT04057300|Analgesics|analgesics|mesh-ancestor
2822921|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
2822922|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822923|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822924|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822925|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2822926|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2822927|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2822928|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822929|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2822930|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2822931|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822932|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
2822933|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2822934|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2822935|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2822936|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
2822937|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2822938|NCT04057326|Pancreatin|pancreatin|mesh-list
2822939|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2822940|NCT04057131|Icatibant|icatibant|mesh-list
2822941|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2822942|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822943|NCT04057131|Analgesics|analgesics|mesh-ancestor
2822944|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
2822945|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822946|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822947|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822948|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2822949|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
2822950|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
2822951|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822952|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2822953|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2822954|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
2286934|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286935|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2286936|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2286937|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
2286938|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286939|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286940|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2286941|NCT00245141|Dactinomycin|dactinomycin|mesh-list
2286942|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
2286943|NCT00245141|Vincristine|vincristine|mesh-list
2286944|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2286945|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
2286946|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286947|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2822955|NCT04057482|Dequalinium|dequalinium|mesh-list
2822956|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2822957|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2286948|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2286949|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
2286950|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286951|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822965|NCT04056923|Methylene Blue|methylene blue|mesh-list
2822966|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2822967|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822968|NCT04056949|Paclitaxel|paclitaxel|mesh-list
2822969|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2822970|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2822971|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2822972|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
2822973|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
2822974|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
2822975|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2822976|NCT04056897|Teriflunomide|teriflunomide|mesh-list
2822977|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2822978|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2822979|NCT04056897|Analgesics|analgesics|mesh-ancestor
2822980|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
2822981|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2822982|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822983|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2822984|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2822985|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2822986|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
2822987|NCT04057014|Amoxicillin|amoxicillin|mesh-list
2822988|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2822989|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822990|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2822991|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2822992|NCT04056975|Antibodies|antibodies|mesh-list
2822993|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
2822994|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2822995|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
2822996|NCT04056806|Terlipressin|terlipressin|mesh-list
2822997|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2822998|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2822999|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2823000|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2823001|NCT04056910|Nivolumab|nivolumab|mesh-list
2823002|NCT04056910|Ivosidenib|ivosidenib|mesh-list
2823003|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2823004|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286952|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2823005|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2823006|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823007|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823008|NCT04056845|Acetaminophen|acetaminophen|mesh-list
2823009|NCT04056845|Diclofenac|diclofenac|mesh-list
2823010|NCT04056845|Analgesics|analgesics|mesh-list
2823011|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2823012|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2823013|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
2823014|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823015|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823016|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2823017|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2823018|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2823019|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823020|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823021|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
2823022|NCT04056650|Caffeine|caffeine|mesh-list
2823023|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2823024|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823025|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2823026|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823027|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823028|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2823029|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2823030|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
2823031|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2823032|NCT04056754|Prednisone|prednisone|mesh-list
2823033|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
2823034|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2823035|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
2823036|NCT04056754|Hormones|hormones|mesh-ancestor
2823037|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2823038|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823039|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2286953|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2286954|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
2286955|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
2286956|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
2286957|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2286958|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2286959|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2286960|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2286961|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286962|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2286963|NCT00245154|Paclitaxel|paclitaxel|mesh-list
2286964|NCT00245154|Carboplatin|carboplatin|mesh-list
2286965|NCT00245154|Cediranib|cediranib|mesh-list
2286966|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2286967|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2286968|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
2286969|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
2823040|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823041|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2823042|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823043|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823044|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
2286970|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
2286971|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286972|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2286973|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2286974|NCT00245206|Olanzapine|olanzapine|mesh-list
2286975|NCT00245206|Risperidone|risperidone|mesh-list
2286976|NCT00245206|Aripiprazole|aripiprazole|mesh-list
2823045|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2823046|NCT04056442|Cannabidiol|cannabidiol|mesh-list
2823047|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
2823048|NCT04056624|Carotenoids|carotenoids|mesh-list
2823049|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
2823050|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823051|NCT04056624|Protective Agents|protective agents|mesh-ancestor
2823052|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823053|NCT04056325|Ivermectin|ivermectin|mesh-list
2823054|NCT04056325|Moxidectin|moxidectin|mesh-list
2823055|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2823056|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823057|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
2823058|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
2823059|NCT04056702|Ivacaftor|ivacaftor|mesh-list
2823060|NCT04056702|Elexacaftor|elexacaftor|mesh-list
2823061|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2823062|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2823063|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823064|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2823065|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
2286977|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2286978|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
2286979|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2286980|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2286981|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2286982|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2286983|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2286984|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2286985|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2286986|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2286987|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
2286988|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
2286989|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
2286990|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2286991|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2286992|NCT00245206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2286993|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2286994|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2286995|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
2823066|NCT04056039|Colchicine|colchicine|mesh-list
2823067|NCT04056039|Atorvastatin|atorvastatin|mesh-list
2823068|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2823069|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2823070|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
2823071|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823072|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2823073|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2286996|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
2286997|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2286998|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2286999|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2287000|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2287001|NCT00245245|Factor VIII|factor viii|mesh-list
2287002|NCT00245245|Coagulants|coagulants|mesh-ancestor
2287003|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
2823074|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823075|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
2823076|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2823077|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
2823078|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
2823079|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
2823080|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105498|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2105499|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2105500|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105501|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2105502|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105503|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
2105504|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2105505|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2105506|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2105507|NCT02455050|Laxatives|laxatives|mesh-ancestor
2105508|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2105509|NCT02455076|Exenatide|exenatide|mesh-list
2823081|NCT04055909|Nangibotide|nangibotide|mesh-list
2823082|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2823083|NCT04055818|Niacinamide|niacinamide|mesh-list
2823084|NCT04055818|Niacin|niacin|mesh-list
2287004|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287005|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
2287006|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2287007|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2287008|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287009|NCT00245258|Urological Agents|urological agents|mesh-ancestor
2287010|NCT00245297|Factor VIII|factor viii|mesh-list
2287011|NCT00245297|Coagulants|coagulants|mesh-ancestor
2287012|NCT00245336|Thrombin|thrombin|mesh-list
2287013|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
2287014|NCT00245336|Coagulants|coagulants|mesh-ancestor
2287015|NCT00245375|Acetaminophen|acetaminophen|mesh-list
2287016|NCT00245375|Ibuprofen|ibuprofen|mesh-list
2287017|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2287018|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2287019|NCT00245375|Analgesics|analgesics|mesh-ancestor
2287020|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
2287021|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823085|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
2823086|NCT04055818|Decitabine|decitabine|mesh-list
2823087|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
2823088|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2823089|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
2823090|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823091|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823092|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823093|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
2823094|NCT04055818|Vitamins|vitamins|mesh-ancestor
2823095|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
2823096|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823097|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2823098|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2823099|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
2823100|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
2823101|NCT04056143|Apixaban|apixaban|mesh-list
2823102|NCT04056143|Edoxaban|edoxaban|mesh-list
2823103|NCT04056143|Dabigatran|dabigatran|mesh-list
2823104|NCT04056143|Thromboplastin|thromboplastin|mesh-list
2823105|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2823106|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
2823107|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2823108|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
2823109|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823110|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287022|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287023|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2287024|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2287025|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2287026|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287027|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287028|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
2287029|NCT00245401|Sirolimus|sirolimus|mesh-list
2287030|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2287031|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287032|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2823111|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
2823112|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
2823113|NCT04056143|Coagulants|coagulants|mesh-ancestor
2823114|NCT04055844|Decitabine|decitabine|mesh-list
2823115|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2823116|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
2823117|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823118|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823119|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823120|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2823121|NCT04056169|Ezetimibe|ezetimibe|mesh-list
2823122|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2823123|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2823124|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
2823125|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823126|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2823127|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2823128|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823129|NCT04056000|Caffeine|caffeine|mesh-list
2823130|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2823131|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287033|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287034|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
2287035|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2287036|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
2287037|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287038|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2287039|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
2287040|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
2287041|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287042|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
2287043|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287044|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2287045|NCT00245427|Lactams|lactams|mesh-list
2287046|NCT00245427|beta-Lactams|beta-lactams|mesh-list
2823132|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2823133|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823134|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823135|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2823136|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2823137|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
2823138|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2823146|NCT04055389|Antithrombins|antithrombins|mesh-list
2823147|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
2823148|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2823149|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
2823150|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823151|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823152|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
2823153|NCT04055480|Insulin|insulin|mesh-list
2287047|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2287048|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287049|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
2287050|NCT00245440|Azithromycin|azithromycin|mesh-list
2287051|NCT00245440|Telithromycin|telithromycin|mesh-list
2287052|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2287053|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287054|NCT00245453|Azithromycin|azithromycin|mesh-list
2287055|NCT00245453|Clarithromycin|clarithromycin|mesh-list
2287056|NCT00245453|Telithromycin|telithromycin|mesh-list
2287057|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2287058|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287059|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2287060|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287061|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287062|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2287063|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2287064|NCT00245505|Mesalamine|mesalamine|mesh-list
2287065|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2287066|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2287067|NCT00245505|Analgesics|analgesics|mesh-ancestor
2287068|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
2287069|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287070|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287071|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2287072|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2287073|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
2287074|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
2287075|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2287076|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2287077|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287078|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287079|NCT00245596|Urological Agents|urological agents|mesh-ancestor
2287080|NCT00245609|Pregabalin|pregabalin|mesh-list
2287081|NCT00245609|Alprazolam|alprazolam|mesh-list
2287082|NCT00245609|Analgesics|analgesics|mesh-ancestor
2287083|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
2823154|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2823155|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
2823156|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
2823157|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2823158|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823159|NCT04055506|Ritonavir|ritonavir|mesh-list
2823160|NCT04055506|BMS-986165|bms-986165|mesh-list
2823161|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2823162|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2823163|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
2823164|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823165|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823166|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2823167|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2823168|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
2823169|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823170|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2823171|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2823172|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
2823173|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2823174|NCT04055623|Aldesleukin|aldesleukin|mesh-list
2823175|NCT04055623|Interleukin-2|interleukin-2|mesh-list
2823176|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823177|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2823178|NCT04055623|Analgesics|analgesics|mesh-ancestor
2823179|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
2823180|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823181|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287084|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287085|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287086|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
2287087|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2823182|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2823183|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2823184|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
2823185|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823186|NCT04055649|Paclitaxel|paclitaxel|mesh-list
2823187|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2823188|NCT04055649|TIC10 compound|tic10 compound|mesh-list
2823189|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2823190|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823191|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
2823192|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
2287088|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287089|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287090|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2287091|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2287092|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287093|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287094|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287095|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2287096|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
2287097|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
2823193|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
2823194|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823195|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
2823196|NCT04055415|Expectorants|expectorants|mesh-list
2823197|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
2823198|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823199|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823200|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2823201|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
2823202|NCT04055012|Metformin|metformin|mesh-list
2823203|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2823204|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287098|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287099|NCT00245661|Temazepam|temazepam|mesh-list
2287100|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2287101|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287102|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287103|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2287104|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287105|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287106|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
2287107|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
2287108|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287109|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287110|NCT00245674|Amisulpride|amisulpride|mesh-list
2287111|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2823205|NCT04054960|Levodopa|levodopa|mesh-list
2823206|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2823207|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2823208|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
2823209|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2823210|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823211|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823212|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
2823213|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2823214|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2823215|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823216|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
2823217|NCT04055194|Coagulants|coagulants|mesh-ancestor
2823218|NCT04055142|Cidofovir|cidofovir|mesh-list
2823219|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
2823220|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823221|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823222|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823223|NCT04055233|Biguanides|biguanides|mesh-list
2823224|NCT04055233|Polihexanide|polihexanide|mesh-list
2823225|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823226|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
2823227|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2823228|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823229|NCT04054830|Diclofenac|diclofenac|mesh-list
2823230|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2823231|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2823232|NCT04054830|Analgesics|analgesics|mesh-ancestor
2823233|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
2823234|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823235|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823236|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2823237|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2823238|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2823239|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823240|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823241|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
2823242|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823243|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
2287112|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287113|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823244|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
2823245|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
2823246|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
2823247|NCT04054531|Paclitaxel|paclitaxel|mesh-list
2823248|NCT04054531|Carboplatin|carboplatin|mesh-list
2823249|NCT04054531|Pemetrexed|pemetrexed|mesh-list
2823250|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2823251|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823252|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
2823253|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
2823254|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
2823255|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823256|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823257|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2823258|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2823259|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
2823260|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2823261|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2823262|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823263|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
2823264|NCT04054687|Coagulants|coagulants|mesh-ancestor
2287114|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287115|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287116|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2287117|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
2287118|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287119|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287120|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2287121|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
2823275|NCT04054635|Fluorides|fluorides|mesh-list
2823276|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
2823277|NCT04054635|Protective Agents|protective agents|mesh-ancestor
2823278|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287122|NCT00245713|Levetiracetam|levetiracetam|mesh-list
2287123|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
2287124|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
2287125|NCT00245739|Darunavir|darunavir|mesh-list
2287126|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2287127|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2287128|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
2287129|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287130|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287131|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2287132|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2287133|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
2287134|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287135|NCT00245791|Levofloxacin|levofloxacin|mesh-list
2287136|NCT00245791|Ofloxacin|ofloxacin|mesh-list
2287137|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2287138|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287139|NCT00245791|Renal Agents|renal agents|mesh-ancestor
2287140|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2287141|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2287142|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2287143|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287144|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287145|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287146|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2823279|NCT04054518|Durvalumab|durvalumab|mesh-list
2823280|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2823281|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823282|NCT04054362|Gemcitabine|gemcitabine|mesh-list
2287147|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2287148|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
2287149|NCT00245895|Hematinics|hematinics|mesh-ancestor
2287150|NCT00245908|Azithromycin|azithromycin|mesh-list
2287151|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2287152|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287153|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
2287154|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2287155|NCT00245921|Estradiol|estradiol|mesh-list
2287156|NCT00245921|Estrogens|estrogens|mesh-ancestor
2287157|NCT00245921|Hormones|hormones|mesh-ancestor
2287158|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2287159|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287160|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2823283|NCT04054362|Paclitaxel|paclitaxel|mesh-list
2823284|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2823285|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2823286|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823287|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
2823288|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
2823289|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
2823290|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823291|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2823292|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
2823293|NCT04054362|Antiviral Agents|antiviral agents|mesh-ancestor
2823294|NCT04054362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823295|NCT04054362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823296|NCT04054362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2823297|NCT04054362|Immunologic Factors|immunologic factors|mesh-ancestor
2823298|NCT04054362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823299|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2823300|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823301|NCT04054206|Ibudilast|ibudilast|mesh-list
2823302|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2823303|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
2823304|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823305|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823306|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2823307|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
2823308|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2823309|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823310|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823311|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2287161|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
2287162|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2287163|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2287164|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2287165|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2287166|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2287167|NCT00245934|Etanercept|etanercept|mesh-list
2287168|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2287169|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2287170|NCT00245934|Analgesics|analgesics|mesh-ancestor
2287171|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
2287172|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823312|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
2823313|NCT04054024|Erenumab|erenumab|mesh-list
2823314|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2823315|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823316|NCT04054024|Analgesics|analgesics|mesh-ancestor
2823317|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
2823318|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823319|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823320|NCT04054089|Tenofovir|tenofovir|mesh-list
2823321|NCT04054089|Lamivudine|lamivudine|mesh-list
2823322|NCT04054089|Emtricitabine|emtricitabine|mesh-list
2823323|NCT04054089|Dolutegravir|dolutegravir|mesh-list
2823324|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
2823325|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823326|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2287173|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287174|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2287175|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2287176|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2287177|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2287178|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
2287179|NCT00246064|Infliximab|infliximab|mesh-list
2287180|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
2287181|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2287182|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2287183|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
2823327|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2823328|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823329|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823330|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2823331|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2823332|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2823333|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2823334|NCT04054063|Etomidate|etomidate|mesh-list
2823335|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2823336|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823337|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823338|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2823339|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
2823340|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
2287184|NCT00246103|Fluorouracil|fluorouracil|mesh-list
2287185|NCT00246103|Epirubicin|epirubicin|mesh-list
2287186|NCT00246103|Valproic Acid|valproic acid|mesh-list
2287187|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2287188|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
2287189|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287190|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2287191|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2287192|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
2287193|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287194|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287195|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2823341|NCT04053959|Insulin|insulin|mesh-list
2823342|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2823343|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2823344|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823345|NCT04053972|Lenvatinib|lenvatinib|mesh-list
2823346|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823347|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2823348|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823349|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823350|NCT04054115|Alprostadil|alprostadil|mesh-list
2823351|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2823352|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
2287196|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
2823353|NCT04054115|Urological Agents|urological agents|mesh-ancestor
2823354|NCT04054128|Heparin|heparin|mesh-list
2823355|NCT04054128|Calcium heparin|calcium heparin|mesh-list
2823356|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
2823357|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2823358|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2823359|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823360|NCT04053985|Lenvatinib|lenvatinib|mesh-list
2823361|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823362|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2823363|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823364|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823365|NCT04053712|Glucagon|glucagon|mesh-list
2823366|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2823367|NCT04053712|Hormones|hormones|mesh-ancestor
2287197|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2287198|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2287199|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2287200|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2287201|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287202|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
2287203|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
2823368|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2823369|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287204|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287205|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
2287206|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287207|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287208|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287209|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
2287210|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2287211|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2287212|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2287213|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287214|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287215|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
2287216|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287217|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287218|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2287219|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287220|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
2287221|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2287222|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2287223|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2287224|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287225|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287226|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
2287227|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287228|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287229|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2287230|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287231|NCT00246168|Acetaminophen|acetaminophen|mesh-list
2287232|NCT00246168|Tramadol|tramadol|mesh-list
2287233|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2105510|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
2105511|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2105512|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105513|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2105514|NCT02455076|Incretins|incretins|mesh-ancestor
2105515|NCT02455076|Hormones|hormones|mesh-ancestor
2105516|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2105517|NCT02455167|Ribavirin|ribavirin|mesh-list
2105518|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
2105519|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
2105520|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105521|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
2823370|NCT04053699|Factor VIII|factor viii|mesh-list
2823371|NCT04053699|Coagulants|coagulants|mesh-ancestor
2823372|NCT04053621|Thiamine|thiamine|mesh-list
2823373|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
2823374|NCT04053621|Metformin|metformin|mesh-list
2823375|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2823376|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287234|NCT00246168|Analgesics|analgesics|mesh-ancestor
2287235|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
2823377|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
2823378|NCT04053621|Vitamins|vitamins|mesh-ancestor
2287236|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287237|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287238|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
2287239|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2287240|NCT00246168|Narcotics|narcotics|mesh-ancestor
2287241|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287242|NCT00246194|Risperidone|risperidone|mesh-list
2287243|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2287244|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
2287245|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287246|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287247|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287248|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2287249|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287250|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287251|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287252|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2287253|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
2287254|NCT00246207|Methylphenidate|methylphenidate|mesh-list
2287255|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2287256|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287257|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2823379|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
2823380|NCT04053543|CXA-10|cxa-10|mesh-list
2823381|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2823382|NCT04053478|Phenylephrine|phenylephrine|mesh-list
2823383|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
2823384|NCT04053478|Norepinephrine|norepinephrine|mesh-list
2823385|NCT04053478|Ephedrine|ephedrine|mesh-list
2823386|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2823387|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
2823388|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
2823389|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823390|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823391|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
2823392|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2823393|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
2823394|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
2823395|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2823396|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2823397|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2823398|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
2823399|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2823400|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823401|NCT04053478|Protective Agents|protective agents|mesh-ancestor
2823402|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2823403|NCT04053400|Ketamine|ketamine|mesh-list
2823404|NCT04053400|Analgesics|analgesics|mesh-ancestor
2823405|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
2823406|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823407|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823408|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2823409|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2823410|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
2823411|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
2823412|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823413|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2823414|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2823415|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2823416|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823417|NCT04053491|Anesthetics|anesthetics|mesh-list
2823418|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823419|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823420|NCT04053140|Penicillins|penicillins|mesh-list
2823421|NCT04053140|Penicillin G|penicillin g|mesh-list
2823422|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2823423|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
2823424|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2823425|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823426|NCT04052932|Allopurinol|allopurinol|mesh-list
2823427|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
2823428|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823429|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823430|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
2823431|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2823432|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2823433|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
2823434|NCT04052932|Protective Agents|protective agents|mesh-ancestor
2823435|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287258|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2287259|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287260|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287261|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
2287262|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287263|NCT00246220|Methylphenidate|methylphenidate|mesh-list
2287264|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2287265|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287266|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2287267|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2287268|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287269|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287270|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
2287271|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287272|NCT00246233|Methylphenidate|methylphenidate|mesh-list
2287273|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2287274|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287275|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2287276|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2287277|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287278|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287279|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
2287280|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287281|NCT00246246|Risperidone|risperidone|mesh-list
2287282|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2287283|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
2287284|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287285|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287286|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287287|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2287288|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287289|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287290|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287291|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2287292|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
2287293|NCT00246272|Risperidone|risperidone|mesh-list
2287294|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2287295|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
2287296|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287297|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287298|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287299|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2287300|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287301|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287302|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287303|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2287304|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
2287305|NCT00246285|Risperidone|risperidone|mesh-list
2287306|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2287307|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
2287308|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287309|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287310|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287311|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2287312|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287313|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287314|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287315|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2287316|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
2287317|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
2287318|NCT00246298|Hematinics|hematinics|mesh-ancestor
2287319|NCT00246363|Silymarin|silymarin|mesh-list
2287320|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
2287321|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287322|NCT00246363|Protective Agents|protective agents|mesh-ancestor
2287323|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287324|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
2287325|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2287326|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
2287327|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287328|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2287329|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287330|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2287331|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287332|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287333|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287334|NCT00246402|Acipimox|acipimox|mesh-list
2287335|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2287336|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
2287337|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287338|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2287339|NCT00246415|Memantine|memantine|mesh-list
2287340|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2287341|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2287342|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
2287343|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287344|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287345|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287346|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2287347|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2287348|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2823436|NCT04052711|Minocycline|minocycline|mesh-list
2823437|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2823438|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823439|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
2823440|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823441|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2823442|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287349|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2823443|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287350|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
2287351|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287352|NCT00246467|Antacids|antacids|mesh-ancestor
2287353|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287354|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2823444|NCT04052867|Lidocaine|lidocaine|mesh-list
2823445|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
2823446|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
2823447|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823448|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823449|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
2823450|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823451|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2823452|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2823453|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2823454|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287355|NCT00246532|Morphine|morphine|mesh-list
2287356|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2287357|NCT00246532|Narcotics|narcotics|mesh-ancestor
2287358|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287359|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287360|NCT00246532|Analgesics|analgesics|mesh-ancestor
2287361|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
2287362|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287363|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
2287364|NCT00246597|Hematinics|hematinics|mesh-ancestor
2287365|NCT00246610|Nelfinavir|nelfinavir|mesh-list
2287366|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2287367|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2287368|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
2287369|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287370|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287371|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2287372|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2287373|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
2287374|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287375|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2287376|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287377|NCT00246636|Fenofibrate|fenofibrate|mesh-list
2287378|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2287379|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
2287380|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287381|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2287382|NCT00246675|Furosemide|furosemide|mesh-list
2287383|NCT00246675|Diuretics|diuretics|mesh-ancestor
2287384|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
2287385|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287386|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2287387|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287388|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287389|NCT00246688|Sagopilone|sagopilone|mesh-list
2287390|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287391|NCT00246701|Simvastatin|simvastatin|mesh-list
2287392|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2287393|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2287394|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
2287395|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287396|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2287397|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2287398|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287399|NCT00246909|Pantoprazole|pantoprazole|mesh-list
2287400|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2287401|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2287402|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2287403|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287404|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287405|NCT00246974|Gemcitabine|gemcitabine|mesh-list
2287406|NCT00246974|Gefitinib|gefitinib|mesh-list
2287407|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287408|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2287409|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
2287410|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287411|NCT00246974|Antiviral Agents|antiviral agents|mesh-ancestor
2287412|NCT00246974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823455|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823456|NCT04053205|Paclitaxel|paclitaxel|mesh-list
2823457|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2823458|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287413|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287414|NCT00246974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2287415|NCT00246974|Immunologic Factors|immunologic factors|mesh-ancestor
2287416|NCT00246974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287417|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2823459|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
2823460|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
2823461|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
2823462|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823463|NCT04052776|Levodopa|levodopa|mesh-list
2823464|NCT04052776|Carbidopa|carbidopa|mesh-list
2823465|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2823466|NCT04052776|Buspirone|buspirone|mesh-list
2287418|NCT00247026|Ubiquinone|ubiquinone|mesh-list
2287419|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
2287420|NCT00247026|Curcumin|curcumin|mesh-list
2287421|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2287422|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2287423|NCT00247026|Analgesics|analgesics|mesh-ancestor
2287424|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
2287425|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287426|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287427|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2287428|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2823467|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2823468|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2823469|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
2823470|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2823471|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823472|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823473|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2823474|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823475|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2823476|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2823477|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823478|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2823479|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2823480|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
2823481|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2823482|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
2823483|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
2823484|NCT04052659|Azacitidine|azacitidine|mesh-list
2823485|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2823486|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
2823487|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823488|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823489|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823490|NCT04052698|Factor VIII|factor viii|mesh-list
2823491|NCT04052698|Coagulants|coagulants|mesh-ancestor
2823492|NCT04052620|Diclofenac|diclofenac|mesh-list
2823493|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2823494|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2823495|NCT04052620|Analgesics|analgesics|mesh-ancestor
2823496|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
2823497|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823498|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823499|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2823500|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2823501|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2823502|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823503|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823504|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
2823505|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823506|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
2823507|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
2823508|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
2823509|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
2823510|NCT04052334|Fludarabine|fludarabine|mesh-list
2823511|NCT04052334|Interleukin-2|interleukin-2|mesh-list
2823512|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2287429|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287430|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823513|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
2823514|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823515|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2823516|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2823517|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
2823518|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823519|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823520|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2823521|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2823522|NCT04052334|Analgesics|analgesics|mesh-ancestor
2823523|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
2823524|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823525|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
2823526|NCT04052269|Tadalafil|tadalafil|mesh-list
2823527|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
2823528|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2823529|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2823530|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823531|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823532|NCT04052269|Urological Agents|urological agents|mesh-ancestor
2823533|NCT04052178|Capsaicin|capsaicin|mesh-list
2823534|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
2823535|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
2823536|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
2823537|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823538|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287431|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287432|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
2287433|NCT00247026|Vitamins|vitamins|mesh-ancestor
2287434|NCT00247052|Diclofenac|diclofenac|mesh-list
2287435|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2287436|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2287437|NCT00247052|Analgesics|analgesics|mesh-ancestor
2287438|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
2287439|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287440|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287441|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2287442|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2287443|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2287444|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287445|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287446|NCT00247078|Antivenins|antivenins|mesh-list
2287447|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
2287448|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287449|NCT00247117|Metformin|metformin|mesh-list
2287450|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2287451|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287452|NCT00247130|Omeprazole|omeprazole|mesh-list
2287453|NCT00247130|Ranitidine|ranitidine|mesh-list
2287454|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2287455|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2287456|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2287457|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2287458|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287459|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287460|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2287461|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
2287462|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
2287463|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287464|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287465|NCT00247143|Lopinavir|lopinavir|mesh-list
2287466|NCT00247143|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2287467|NCT00247143|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2287468|NCT00247143|Protease Inhibitors|protease inhibitors|mesh-ancestor
2287469|NCT00247143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823557|NCT04051723|Dexamethasone|dexamethasone|mesh-list
2823558|NCT04051723|Ropivacaine|ropivacaine|mesh-list
2823559|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2823560|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
2823561|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
2823562|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823563|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823564|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2823565|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
2823566|NCT04051723|Hormones|hormones|mesh-ancestor
2823567|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2823568|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2823569|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823570|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
2823571|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
2287470|NCT00247143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287471|NCT00247143|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2287472|NCT00247143|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2287473|NCT00247143|Antiviral Agents|antiviral agents|mesh-ancestor
2287474|NCT00247143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287475|NCT00247143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2287476|NCT00247143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2287477|NCT00247169|Progesterone|progesterone|mesh-list
2287478|NCT00247169|Progestins|progestins|mesh-ancestor
2287479|NCT00247169|Hormones|hormones|mesh-ancestor
2287480|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2287481|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287482|NCT00247208|Paclitaxel|paclitaxel|mesh-list
2287483|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2287484|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287485|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
2287486|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
2287487|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
2823572|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823573|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
2823574|NCT04051853|Sorafenib|sorafenib|mesh-list
2823575|NCT04051853|Midazolam|midazolam|mesh-list
2823576|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2823577|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2823578|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823579|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823580|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2823581|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2823582|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2823583|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2823584|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
2823585|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
2823586|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
2823587|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
2823588|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2823589|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823590|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823591|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2823592|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823593|NCT04051827|Midazolam|midazolam|mesh-list
2823594|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2823595|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2823596|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823597|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823598|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2823599|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2823600|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2823601|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2823602|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
2823603|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
2823604|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
2823605|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
2823606|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2823607|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823608|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2823609|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
2823610|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823611|NCT04051957|Isosorbide|isosorbide|mesh-list
2823612|NCT04051957|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2823613|NCT04051957|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2823614|NCT04051957|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2823615|NCT04051957|Diuretics|diuretics|mesh-ancestor
2823616|NCT04051957|Natriuretic Agents|natriuretic agents|mesh-ancestor
2105522|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105523|NCT02455336|Fenofibrate|fenofibrate|mesh-list
2105524|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2105525|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
2105526|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287488|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287489|NCT00247247|Entacapone|entacapone|mesh-list
2287490|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2287491|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2287492|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2287493|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287494|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287495|NCT00247364|Levetiracetam|levetiracetam|mesh-list
2287496|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
2287497|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
2287498|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
2287499|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
2287500|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287501|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
2287502|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823617|NCT04051957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823618|NCT04051957|Vasodilator Agents|vasodilator agents|mesh-ancestor
2823619|NCT04051957|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2823620|NCT04051957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823621|NCT04051632|Insulin|insulin|mesh-list
2823622|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2823623|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823624|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
2823625|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2823626|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2823631|NCT04051567|Aspirin|aspirin|mesh-list
2823632|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2823633|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2823634|NCT04051567|Analgesics|analgesics|mesh-ancestor
2823635|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
2823636|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823637|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823638|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2823639|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2823640|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2823641|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2823642|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823643|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2823644|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2823645|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823646|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
2105527|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2105528|NCT02455453|Estradiol|estradiol|mesh-list
2105529|NCT02455453|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2105530|NCT02455453|Estrogens|estrogens|mesh-ancestor
2105531|NCT02455453|Hormones|hormones|mesh-ancestor
2105532|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2105533|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105534|NCT02455453|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2105535|NCT02455453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105536|NCT02455518|Acetaminophen|acetaminophen|mesh-list
2105537|NCT02455518|Ibuprofen|ibuprofen|mesh-list
2105538|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2105539|NCT02455518|Oxycodone|oxycodone|mesh-list
2105540|NCT02455518|Hydrocodone|hydrocodone|mesh-list
2105541|NCT02455518|Codeine|codeine|mesh-list
2105542|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2823647|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
2823648|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2823649|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2823650|NCT04051203|Prednisolone|prednisolone|mesh-list
2287503|NCT00247481|Docetaxel|docetaxel|mesh-list
2287504|NCT00247481|Gefitinib|gefitinib|mesh-list
2287505|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287506|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
2287507|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
2287508|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
2287509|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287510|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2287511|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287512|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
2287513|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2287514|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287515|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2287516|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
2287517|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2287518|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287519|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287520|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287521|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
2823651|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
2823652|NCT04051203|Lidocaine|lidocaine|mesh-list
2823653|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2823654|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
2823655|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
2823656|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
2823657|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823658|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823659|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
2823660|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823661|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2823662|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2823663|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2823664|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2823665|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823666|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2823667|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
2823668|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
2823669|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2823670|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
2823671|NCT04051203|Hormones|hormones|mesh-ancestor
2823672|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2823673|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2823674|NCT04051203|Protective Agents|protective agents|mesh-ancestor
2823675|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2823676|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823677|NCT04051255|Metronidazole|metronidazole|mesh-list
2823678|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823679|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2823680|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2823681|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2287522|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2287523|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
2823682|NCT04051320|Leuprolide|leuprolide|mesh-list
2823683|NCT04051320|Estradiol|estradiol|mesh-list
2823684|NCT04051320|Progesterone|progesterone|mesh-list
2823685|NCT04051320|Estrogens|estrogens|mesh-ancestor
2823686|NCT04051320|Hormones|hormones|mesh-ancestor
2823687|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2823688|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823689|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2823690|NCT04051320|Progestins|progestins|mesh-ancestor
2823691|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2823692|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
2823693|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2823694|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823698|NCT04051047|Gemcitabine|gemcitabine|mesh-list
2823699|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2823700|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
2823701|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823702|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287524|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287525|NCT00247507|Expectorants|expectorants|mesh-ancestor
2287526|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
2287527|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2287528|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
2287529|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287530|NCT00247507|Protective Agents|protective agents|mesh-ancestor
2287531|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287532|NCT00247507|Antidotes|antidotes|mesh-ancestor
2287533|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
2287534|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2287535|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2287536|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2287537|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2823703|NCT04051047|Antiviral Agents|antiviral agents|mesh-ancestor
2823704|NCT04051047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823705|NCT04051047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823706|NCT04051047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2823707|NCT04051047|Immunologic Factors|immunologic factors|mesh-ancestor
2823708|NCT04051047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823709|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
2823710|NCT04051099|Bupivacaine|bupivacaine|mesh-list
2287538|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287539|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
2287540|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287541|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287542|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2287543|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287544|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2823711|NCT04051099|Propofol|propofol|mesh-list
2823712|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
2823713|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
2823714|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823715|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823716|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
2823717|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823718|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2823719|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2823720|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
2823721|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2823722|NCT04051099|Analgesics|analgesics|mesh-ancestor
2823723|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2823724|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2823725|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2823726|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
2823727|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2823728|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823729|NCT04050592|Estradiol|estradiol|mesh-list
2823730|NCT04050592|Estrogens|estrogens|mesh-ancestor
2823731|NCT04050592|Hormones|hormones|mesh-ancestor
2823732|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2823733|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823734|NCT04050670|Tirzepatide|tirzepatide|mesh-list
2823735|NCT04050670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2823736|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823737|NCT04050670|Incretins|incretins|mesh-ancestor
2823738|NCT04050670|Hormones|hormones|mesh-ancestor
2823739|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2823740|NCT04050826|Lidocaine|lidocaine|mesh-list
2823741|NCT04050826|Prilocaine|prilocaine|mesh-list
2823742|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
2823743|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
2823744|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823745|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823746|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
2823747|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823748|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2823749|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2823750|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2823751|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2823752|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823753|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
2823754|NCT04050488|Astringents|astringents|mesh-ancestor
2823755|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823756|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
2823757|NCT04050553|Tirzepatide|tirzepatide|mesh-list
2823758|NCT04050553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2823759|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823760|NCT04050553|Incretins|incretins|mesh-ancestor
2823761|NCT04050553|Hormones|hormones|mesh-ancestor
2823762|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2823763|NCT04050761|Nivolumab|nivolumab|mesh-list
2823764|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2823765|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287545|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2287546|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287547|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2287548|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2287549|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287550|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287551|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
2287552|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287553|NCT00247585|Ethanol|ethanol|mesh-list
2823766|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2823767|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823768|NCT04050735|Ethanol|ethanol|mesh-list
2823769|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2823770|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823771|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823772|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823773|NCT04050280|Cytarabine|cytarabine|mesh-list
2823774|NCT04050280|Cladribine|cladribine|mesh-list
2823775|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
2823776|NCT04050280|Sargramostim|sargramostim|mesh-list
2823777|NCT04050280|Lenograstim|lenograstim|mesh-list
2823778|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2823779|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
2823780|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823781|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823782|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
2823783|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823784|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2823785|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
2823786|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823787|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2823788|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2823789|NCT04050215|Edetic Acid|edetic acid|mesh-list
2823790|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2823791|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
2823792|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
2823793|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823794|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
2823795|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2823796|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2823799|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
2823800|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2823801|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
2823802|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
2823803|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823804|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823805|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2823806|NCT04050267|Analgesics|analgesics|mesh-ancestor
2823807|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
2823808|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823809|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2823810|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823811|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823812|NCT04049864|Lenalidomide|lenalidomide|mesh-list
2823813|NCT04049864|Vaccines|vaccines|mesh-list
2823814|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
2287554|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2287555|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287556|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287557|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287558|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
2287559|NCT00247650|Letrozole|letrozole|mesh-list
2287560|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287561|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2287562|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2287563|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287564|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105543|NCT02455518|Analgesics|analgesics|mesh-ancestor
2105544|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
2105545|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105546|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823815|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823816|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2823817|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2823818|NCT04049864|Growth Substances|growth substances|mesh-ancestor
2823819|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
2823820|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823821|NCT04050059|Lidocaine|lidocaine|mesh-list
2823822|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2823823|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
2823824|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
2823825|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823826|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823827|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
2823828|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823829|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2823830|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2823831|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2823832|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2823833|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823834|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2823835|NCT04049916|Artesunate|artesunate|mesh-list
2823836|NCT04049916|Piperaquine|piperaquine|mesh-list
2823837|NCT04049916|Primaquine|primaquine|mesh-list
2823838|NCT04049916|Artenimol|artenimol|mesh-list
2823839|NCT04049916|Pyronaridine|pyronaridine|mesh-list
2823840|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
2823841|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2823842|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2823843|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823844|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823845|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
2823846|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
2823847|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2823848|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
2823849|NCT04050098|Metformin|metformin|mesh-list
2823850|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2823851|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823852|NCT04049747|Bicalutamide|bicalutamide|mesh-list
2823853|NCT04049747|Finasteride|finasteride|mesh-list
2823854|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
2823855|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
2823856|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2823857|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823858|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823859|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2823860|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2105547|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
2105548|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2287565|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2287566|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
2287567|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2287568|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287569|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2287570|NCT00247663|Letrozole|letrozole|mesh-list
2287571|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287572|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2287573|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2287574|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823861|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823862|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823863|NCT04049747|Urological Agents|urological agents|mesh-ancestor
2823864|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
2823865|NCT04049799|Narcotics|narcotics|mesh-ancestor
2823866|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823867|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823868|NCT04049799|Analgesics|analgesics|mesh-ancestor
2823869|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
2823870|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823871|NCT04049786|Metoprolol|metoprolol|mesh-list
2823872|NCT04049786|Carvedilol|carvedilol|mesh-list
2823873|NCT04049786|Midazolam|midazolam|mesh-list
2823874|NCT04049786|Simvastatin|simvastatin|mesh-list
2823875|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2823876|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2823877|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823878|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823879|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2823880|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2823881|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2823882|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2823883|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
2823884|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
2823885|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
2823886|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
2823887|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2823888|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823889|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2823890|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2823891|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
2287575|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287576|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2287577|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
2287578|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2287579|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287580|NCT00247702|Warfarin|warfarin|mesh-list
2287581|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
2287582|NCT00247715|Pantoprazole|pantoprazole|mesh-list
2287583|NCT00247715|Ranitidine|ranitidine|mesh-list
2287584|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2287585|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
2287586|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2823892|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2823893|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2823894|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823895|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2823896|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2823897|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
2823898|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
2823899|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2823900|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2823901|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2823902|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2823903|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
2823904|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
2823905|NCT04049786|Protective Agents|protective agents|mesh-ancestor
2823906|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2823907|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2823908|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2823909|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
2823910|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2823911|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2287587|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2287588|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2287589|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2287590|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287591|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287592|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2287593|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
2287594|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
2287595|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287596|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287597|NCT00247715|Antacids|antacids|mesh-ancestor
2287598|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2287599|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
2823912|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
2823913|NCT04049669|Temozolomide|temozolomide|mesh-list
2823914|NCT04049669|Lomustine|lomustine|mesh-list
2823915|NCT04049669|Etoposide|etoposide|mesh-list
2823916|NCT04049669|Tryptophan|tryptophan|mesh-list
2823917|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2823918|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
2823919|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823920|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2823921|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2823922|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
2823923|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823924|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823925|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2823926|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2823927|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2823928|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2823929|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823930|NCT04049669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2823931|NCT04049669|Antidepressive Agents|antidepressive agents|mesh-ancestor
2287600|NCT00247741|Lidocaine|lidocaine|mesh-list
2823932|NCT04049669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2823933|NCT04049409|Trastuzumab|trastuzumab|mesh-list
2823934|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2823935|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823936|NCT04049539|Cytarabine|cytarabine|mesh-list
2823937|NCT04049539|Daunorubicin|daunorubicin|mesh-list
2823938|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2823939|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
2823940|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823941|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823942|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
2823943|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2823944|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2823945|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
2823946|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823947|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2823948|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2823949|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2823950|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287601|NCT00247741|Carticaine|carticaine|mesh-list
2287602|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
2287603|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
2287604|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287605|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287606|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
2287607|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287608|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2287609|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2287610|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2287611|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287612|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823963|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
2287613|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2287614|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2823964|NCT04049513|Fludarabine|fludarabine|mesh-list
2823965|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2823966|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
2823967|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823968|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2823969|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2823970|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
2823971|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823972|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823973|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2823974|NCT04049266|Aflibercept|aflibercept|mesh-list
2823975|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2823976|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2823977|NCT04049266|Growth Substances|growth substances|mesh-ancestor
2823978|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823979|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
2823980|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823981|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
2823982|NCT04049344|Decitabine|decitabine|mesh-list
2823983|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2823984|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2823985|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
2823986|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2823987|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2823988|NCT04049201|Midazolam|midazolam|mesh-list
2823989|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2823990|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2823991|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2823992|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2823993|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2823994|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2823995|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2823996|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2823997|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
2823998|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
2823999|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
2824000|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
2824001|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824002|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824003|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2824004|NCT04048889|Ropivacaine|ropivacaine|mesh-list
2824005|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2824006|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
2824007|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
2824008|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287615|NCT00247910|Diuretics|diuretics|mesh-ancestor
2287616|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
2287617|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287618|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2824009|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824010|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
2824011|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824012|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
2824013|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2824014|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824015|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2824016|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824017|NCT04049227|Letrozole|letrozole|mesh-list
2824018|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824019|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2824020|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2824021|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824022|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824023|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2824024|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
2824025|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2824026|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824027|NCT04049045|Empagliflozin|empagliflozin|mesh-list
2824028|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2287619|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287620|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287621|NCT00247988|Carboplatin|carboplatin|mesh-list
2287622|NCT00247988|Docetaxel|docetaxel|mesh-list
2287623|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287624|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
2287625|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
2287626|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
2287627|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287628|NCT00248053|Curcumin|curcumin|mesh-list
2287629|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2824029|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824030|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2824031|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824032|NCT04048863|Imidacloprid|imidacloprid|mesh-list
2824033|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
2824034|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824035|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824036|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824037|NCT04048811|Propofol|propofol|mesh-list
2824038|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2824039|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2824040|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824041|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2824042|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
2824043|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
2824044|NCT04048850|Grazoprevir|grazoprevir|mesh-list
2824045|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
2824046|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
2824047|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824048|NCT04048577|Natalizumab|natalizumab|mesh-list
2824049|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
2824050|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824051|NCT04048655|Neostigmine|neostigmine|mesh-list
2824052|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2824053|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824054|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824055|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
2824056|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824057|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824058|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2824059|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
2824060|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824061|NCT04048707|Octreotide|octreotide|mesh-list
2824062|NCT04048707|Midodrine|midodrine|mesh-list
2824063|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
2824064|NCT04048707|Giapreza|giapreza|mesh-list
2824065|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
2824066|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2824067|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2824068|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824069|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
2824070|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
2824071|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287630|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2287631|NCT00248053|Analgesics|analgesics|mesh-ancestor
2287632|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
2287633|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287634|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287635|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2287636|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2824072|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824073|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2824074|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2824075|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2824076|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2824077|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
2824078|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824079|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824080|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2287637|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287638|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287639|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287640|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2824081|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
2824082|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824083|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2824084|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
2824085|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824086|NCT04048317|Doxorubicin|doxorubicin|mesh-list
2824087|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2824088|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
2824089|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2824090|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824091|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2824092|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2824093|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824094|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824095|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
2824096|NCT04048226|Ketamine|ketamine|mesh-list
2824097|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
2824098|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2824099|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824100|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2824101|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2824102|NCT04048226|Analgesics|analgesics|mesh-ancestor
2824103|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
2824104|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824105|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2824106|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2824107|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2824108|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
2824109|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824110|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824111|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2824112|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2824113|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
2824114|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2824115|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2824116|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2824117|NCT04048304|Vancomycin|vancomycin|mesh-list
2824118|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824119|NCT04048200|Fentanyl|fentanyl|mesh-list
2824120|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
2824121|NCT04048200|Ketamine|ketamine|mesh-list
2824122|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
2824123|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
2824124|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2824125|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824126|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2824127|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2824128|NCT04048200|Analgesics|analgesics|mesh-ancestor
2824129|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
2824130|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824131|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2824132|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2824133|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2824134|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
2824135|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824136|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824137|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2824138|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2824139|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
2824140|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2824141|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2824142|NCT04048200|Narcotics|narcotics|mesh-ancestor
2824143|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2824144|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
2824145|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
2824146|NCT04048070|Sufentanil|sufentanil|mesh-list
2824147|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2824148|NCT04048070|Narcotics|narcotics|mesh-ancestor
2824149|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2824150|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824151|NCT04048070|Analgesics|analgesics|mesh-ancestor
2824152|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
2824153|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824154|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2824155|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2824156|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
2824157|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
2824158|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2824159|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2824160|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2824161|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2824162|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2824163|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824164|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824165|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
2824166|NCT04048161|Tacrolimus|tacrolimus|mesh-list
2824167|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2824168|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
2824169|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824170|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2824171|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824172|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824173|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2824174|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824175|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2824176|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
2824177|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2824178|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824179|NCT04048278|Lidocaine|lidocaine|mesh-list
2824180|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
2824181|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
2824182|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2824183|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824184|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
2824185|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824186|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2824187|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2824188|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2824189|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2824190|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824191|NCT04047654|Anticoagulants|anticoagulants|mesh-list
2824192|NCT04047706|Nivolumab|nivolumab|mesh-list
2824193|NCT04047706|Temozolomide|temozolomide|mesh-list
2824194|NCT04047706|Linrodostat|linrodostat|mesh-list
2824195|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2824196|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824197|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2824198|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824199|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2824200|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
2824201|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824202|NCT04047940|Metformin|metformin|mesh-list
2824203|NCT04047940|Valsartan|valsartan|mesh-list
2824204|NCT04047940|Atorvastatin|atorvastatin|mesh-list
2824205|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2824206|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824207|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2824208|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2824209|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
2824210|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824211|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2824212|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2824213|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824214|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2824215|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2824216|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2824217|NCT04047758|Letrozole|letrozole|mesh-list
2824218|NCT04047758|Palbociclib|palbociclib|mesh-list
2824219|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824220|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2824221|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2824222|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824223|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824224|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2824225|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
2824226|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2824227|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824228|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2287641|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2287642|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287643|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2287644|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2287645|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287646|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287647|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
2287648|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287649|NCT00248118|Bupropion|bupropion|mesh-list
2287650|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2287651|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
2287652|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287653|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2287654|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2287655|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287656|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287657|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
2287658|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287659|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287660|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2287661|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2287662|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287663|NCT00248131|Octreotide|octreotide|mesh-list
2287664|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2287665|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2287666|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287667|NCT00248144|Famciclovir|famciclovir|mesh-list
2287668|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
2287669|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287670|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2287671|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287672|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287673|NCT00248157|Octreotide|octreotide|mesh-list
2287674|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2287675|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2287676|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287677|NCT00248183|Naluzotan|naluzotan|mesh-list
2287678|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2287679|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2287680|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
2287681|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287682|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287683|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287684|NCT00248209|Bupropion|bupropion|mesh-list
2287685|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2287686|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
2824229|NCT04047641|Cytarabine|cytarabine|mesh-list
2824230|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
2824231|NCT04047641|Idarubicin|idarubicin|mesh-list
2824232|NCT04047641|Cladribine|cladribine|mesh-list
2824233|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2824234|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
2824235|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824236|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824237|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
2824238|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824239|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2824240|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
2824241|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824242|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2824243|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2824244|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2824245|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824246|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2287687|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287688|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2287689|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2287690|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287691|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287692|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
2287693|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287694|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287695|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2287696|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2287697|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287698|NCT00248248|Doxorubicin|doxorubicin|mesh-list
2287699|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2287700|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2287701|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287702|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2287703|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2287704|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824247|NCT04047849|Amoxicillin|amoxicillin|mesh-list
2824248|NCT04047849|Azithromycin|azithromycin|mesh-list
2824249|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824250|NCT04047914|Mupirocin|mupirocin|mesh-list
2287705|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287706|NCT00248261|Ziprasidone|ziprasidone|mesh-list
2824251|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2824252|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824253|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2824254|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824255|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287707|NCT00248261|Sertraline|sertraline|mesh-list
2287708|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
2287709|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287710|NCT00248261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2287711|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2287712|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287713|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287714|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287715|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
2287716|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287717|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2287718|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2287719|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287720|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287721|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2287722|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
2287723|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
2287724|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2824265|NCT04047875|Norethindrone|norethindrone|mesh-list
2824266|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
2824267|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2824268|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2824269|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2824270|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
2824271|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2824272|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824273|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2287725|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287726|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
2287727|NCT00248313|Sirolimus|sirolimus|mesh-list
2287728|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2287729|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824274|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2824275|NCT04047745|Bupivacaine|bupivacaine|mesh-list
2824276|NCT04047745|Ropivacaine|ropivacaine|mesh-list
2824277|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
2824278|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
2824279|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2824280|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824281|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
2824282|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824283|NCT04047680|Ritonavir|ritonavir|mesh-list
2824284|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
2824285|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2824286|NCT04047680|Grazoprevir|grazoprevir|mesh-list
2824287|NCT04047680|Ledipasvir|ledipasvir|mesh-list
2824288|NCT04047680|Velpatasvir|velpatasvir|mesh-list
2824289|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2824290|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2824291|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
2824292|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824293|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824294|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2824295|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2824296|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
2824297|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824298|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2824299|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2824300|NCT04047576|Sirolimus|sirolimus|mesh-list
2824301|NCT04047576|Prednisone|prednisone|mesh-list
2824302|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2824303|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
2824304|NCT04047576|Hormones|hormones|mesh-ancestor
2824305|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2824306|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824307|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2824308|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824309|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2824310|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824311|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2824312|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
2824313|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2824314|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
2824315|NCT04047797|Rituximab|rituximab|mesh-list
2824316|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2824317|NCT04047797|Ixazomib|ixazomib|mesh-list
2824318|NCT04047797|Antibodies|antibodies|mesh-list
2824319|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
2824320|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2824321|NCT04047797|Glycine|glycine|mesh-list
2824322|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
2287730|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2287731|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287732|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
2287733|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2287734|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
2824323|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824324|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824325|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2824326|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824327|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
2824328|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824329|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
2824330|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824331|NCT04047836|Nicotine|nicotine|mesh-list
2824332|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2824333|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
2824334|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287735|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287736|NCT00248339|Ribavirin|ribavirin|mesh-list
2287737|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2287738|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
2287739|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
2287740|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287741|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
2287742|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287743|NCT00248339|Hematinics|hematinics|mesh-ancestor
2287744|NCT00248430|Aldesleukin|aldesleukin|mesh-list
2824335|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824336|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2287745|NCT00248430|Melphalan|melphalan|mesh-list
2824337|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2824338|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
2824339|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824340|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824341|NCT04047329|Anesthetics|anesthetics|mesh-list
2824342|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2824343|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824344|NCT04047394|Rasburicase|rasburicase|mesh-list
2824345|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
2824346|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2824347|NCT04047355|Propranolol|propranolol|mesh-list
2824348|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2824349|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2287746|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2287747|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
2287748|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287749|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287750|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2824350|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
2824351|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824352|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824353|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824354|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2824355|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2824356|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
2824357|NCT04047446|Dexamethasone|dexamethasone|mesh-list
2287751|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2287752|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
2287753|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824358|NCT04047446|Bupivacaine|bupivacaine|mesh-list
2824359|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2824360|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
2824361|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
2824362|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824363|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824364|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2824365|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
2824366|NCT04047446|Hormones|hormones|mesh-ancestor
2824367|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2824368|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2824369|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824370|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
2824371|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
2824372|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2824373|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
2824374|NCT04046887|Gemcitabine|gemcitabine|mesh-list
2824375|NCT04046887|Paclitaxel|paclitaxel|mesh-list
2824376|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2824377|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824378|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
2824379|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
2824380|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
2824381|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824382|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2824383|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
2824384|NCT04046887|Antiviral Agents|antiviral agents|mesh-ancestor
2824385|NCT04046887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824386|NCT04046887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824387|NCT04046887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2824388|NCT04046887|Immunologic Factors|immunologic factors|mesh-ancestor
2824389|NCT04046887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824390|NCT04047017|Apatinib|apatinib|mesh-list
2824391|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287754|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2287755|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2824392|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2824393|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824394|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824395|NCT04046874|Analgesics|analgesics|mesh-list
2287756|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
2287757|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287758|NCT00248456|Betamethasone|betamethasone|mesh-list
2287759|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
2287760|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2824396|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
2824397|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824398|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824399|NCT04046744|Lidocaine|lidocaine|mesh-list
2824400|NCT04046744|Analgesics|analgesics|mesh-list
2287761|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
2287762|NCT00248456|Calcipotriene|calcipotriene|mesh-list
2287763|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2287764|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2287765|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
2287766|NCT00248456|Hormones|hormones|mesh-ancestor
2287767|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2824401|NCT04046744|Ropivacaine|ropivacaine|mesh-list
2824402|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
2824403|NCT04046744|Anesthetics|anesthetics|mesh-list
2824404|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2824405|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824406|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
2824407|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824408|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2824409|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2824410|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2824411|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2824412|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824413|NCT04047186|Nivolumab|nivolumab|mesh-list
2824414|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2824415|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824416|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2824417|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824418|NCT04047004|Doxorubicin|doxorubicin|mesh-list
2824419|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824420|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2824421|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2824422|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2824423|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824424|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824425|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
2824426|NCT04046861|Vitamins|vitamins|mesh-ancestor
2824427|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
2824428|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824429|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
2824430|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824431|NCT04046861|Protective Agents|protective agents|mesh-ancestor
2824432|NCT04046822|Liraglutide|liraglutide|mesh-list
2824433|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2824434|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824435|NCT04046822|Incretins|incretins|mesh-ancestor
2824436|NCT04046822|Hormones|hormones|mesh-ancestor
2824437|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2824438|NCT04046510|Oxytocin|oxytocin|mesh-list
2824439|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
2824440|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2824441|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824442|NCT04046653|Sulforaphane|sulforaphane|mesh-list
2824443|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2824444|NCT04046653|Protective Agents|protective agents|mesh-ancestor
2824445|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824446|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287768|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287769|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2287770|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
2287771|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
2287772|NCT00248482|Cisplatin|cisplatin|mesh-list
2287773|NCT00248482|Irinotecan|irinotecan|mesh-list
2287774|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
2287775|NCT00248482|Camptothecin|camptothecin|mesh-list
2287776|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287777|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2287778|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2287779|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287780|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824455|NCT04046679|Bleomycin|bleomycin|mesh-list
2824456|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2824457|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824458|NCT04046029|Heparin|heparin|mesh-list
2824459|NCT04046029|Bivalirudin|bivalirudin|mesh-list
2824460|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
2824461|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2824462|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2824463|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824464|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
2824465|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2824466|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
2824467|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824468|NCT04046016|Paclitaxel|paclitaxel|mesh-list
2824469|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2824470|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824471|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
2824472|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
2824473|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
2824474|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105549|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2105550|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2105551|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2105552|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105553|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105554|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2105555|NCT02455518|Narcotics|narcotics|mesh-ancestor
2105556|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105557|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
2105558|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
2105559|NCT02455557|Temozolomide|temozolomide|mesh-list
2105560|NCT02455557|Sargramostim|sargramostim|mesh-list
2105561|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2105562|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
2105563|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287781|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2287782|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2287783|NCT00248703|Docetaxel|docetaxel|mesh-list
2287784|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287785|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
2287786|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
2287787|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
2287788|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287789|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
2824475|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
2824476|NCT04046094|Vitamins|vitamins|mesh-ancestor
2824477|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
2824478|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824479|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
2824480|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824481|NCT04046094|Protective Agents|protective agents|mesh-ancestor
2824482|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
2824483|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
2824484|NCT04046289|Calcium|calcium|mesh-list
2824485|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2824486|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824487|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2824488|NCT04046289|Antacids|antacids|mesh-ancestor
2824489|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824490|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2824491|NCT04046133|Capecitabine|capecitabine|mesh-list
2824492|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
2824493|NCT04046133|Mitomycins|mitomycins|mesh-list
2824494|NCT04046133|Mitomycin|mitomycin|mesh-list
2824495|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2824496|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
2824497|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824498|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824499|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2824500|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2824501|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
2824502|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2287790|NCT00248716|Hematinics|hematinics|mesh-ancestor
2287791|NCT00248729|Midazolam|midazolam|mesh-list
2287792|NCT00248729|Etomidate|etomidate|mesh-list
2287793|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2287794|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2287795|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287796|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287797|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2287798|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287799|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287800|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2287801|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
2287802|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
2287803|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
2287804|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
2287805|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287806|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287807|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
2824503|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824504|NCT04046302|Dinoprostone|dinoprostone|mesh-list
2287808|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2287809|NCT00248963|Estradiol|estradiol|mesh-list
2287810|NCT00248963|Estrogens|estrogens|mesh-ancestor
2287811|NCT00248963|Hormones|hormones|mesh-ancestor
2287812|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2287813|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824505|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
2824506|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2824507|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824508|NCT04045678|Rotigotine|rotigotine|mesh-list
2824509|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
2824510|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
2287814|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2287815|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
2287816|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2287817|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2287818|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2287819|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2824511|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824512|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824513|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824514|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
2824515|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2824516|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824517|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2824518|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2824519|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824520|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824521|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824522|NCT04045730|Gemcitabine|gemcitabine|mesh-list
2824523|NCT04045730|Paclitaxel|paclitaxel|mesh-list
2824524|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
2824525|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2824526|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824527|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
2824528|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
2824529|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
2287820|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2287821|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2287822|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2287823|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
2287824|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287825|NCT00249041|Etanercept|etanercept|mesh-list
2287826|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2287827|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2287828|NCT00249041|Analgesics|analgesics|mesh-ancestor
2824530|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824531|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2824532|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
2824533|NCT04045730|Antiviral Agents|antiviral agents|mesh-ancestor
2824534|NCT04045730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824535|NCT04045730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824536|NCT04045730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2824537|NCT04045730|Immunologic Factors|immunologic factors|mesh-ancestor
2824538|NCT04045730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824539|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2824540|NCT04045613|Atezolizumab|atezolizumab|mesh-list
2824541|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2824542|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824543|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
2824544|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824545|NCT04045821|Plerixafor|plerixafor|mesh-list
2824546|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2824547|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2287829|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
2287830|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287831|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824548|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
2824549|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824551|NCT04045548|Dinoprostone|dinoprostone|mesh-list
2824552|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
2824553|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2824554|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824555|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
2824556|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2824557|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824558|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2824559|NCT04046185|Progesterone|progesterone|mesh-list
2824560|NCT04046185|Progestins|progestins|mesh-ancestor
2824561|NCT04046185|Hormones|hormones|mesh-ancestor
2824562|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2287832|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2287833|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2287834|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2824563|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824564|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824565|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824566|NCT04046159|Tamoxifen|tamoxifen|mesh-list
2824567|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2824568|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
2824569|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2824570|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824571|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2824572|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824573|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2824574|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2824575|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2824576|NCT04045431|Hylan|hylan|mesh-list
2824577|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
2824578|NCT04045431|Protective Agents|protective agents|mesh-ancestor
2105564|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105565|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
2105566|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287835|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2287836|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
2287837|NCT00249106|Vaccines|vaccines|mesh-list
2287838|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
2287839|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287840|NCT00249119|Risperidone|risperidone|mesh-list
2287841|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2287842|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
2287843|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287844|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287845|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287846|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2287847|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287848|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287849|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287850|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2287851|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
2287852|NCT00249132|Risperidone|risperidone|mesh-list
2287853|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2287854|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
2287855|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287856|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287857|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287858|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2287859|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287860|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2824579|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824587|NCT04045093|Warfarin|warfarin|mesh-list
2824588|NCT04045093|Dabigatran|dabigatran|mesh-list
2824589|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
2824590|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
2824591|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2824592|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
2824593|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824594|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824595|NCT04044976|Caffeine|caffeine|mesh-list
2287861|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287862|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2287863|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
2287864|NCT00249145|Risperidone|risperidone|mesh-list
2287865|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2287866|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
2287867|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287868|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287869|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287870|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2824596|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
2824597|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824598|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2824599|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824600|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2824601|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824602|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2287871|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287872|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287873|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287874|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2287875|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
2287876|NCT00249158|Risperidone|risperidone|mesh-list
2824603|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2824604|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
2824605|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824606|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
2824607|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2824608|NCT04044690|Antibodies|antibodies|mesh-list
2824609|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
2824610|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
2824611|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824612|NCT04044729|Cannabidiol|cannabidiol|mesh-list
2824613|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
2824614|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
2824615|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2824616|NCT04044651|Nivolumab|nivolumab|mesh-list
2824617|NCT04044651|Lenvatinib|lenvatinib|mesh-list
2824618|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2824619|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824620|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2287877|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2287878|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
2287879|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287880|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287881|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287882|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2287883|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287884|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287885|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287886|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2287887|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
2287888|NCT00249171|Risperidone|risperidone|mesh-list
2287889|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2287890|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
2824621|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824622|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2824623|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824624|NCT04044703|Vancomycin|vancomycin|mesh-list
2824625|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2824626|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824627|NCT04044378|Ifosfamide|ifosfamide|mesh-list
2824628|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2287891|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287892|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287893|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287894|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2287895|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287896|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287897|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287898|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2287899|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
2287900|NCT00249197|Levofloxacin|levofloxacin|mesh-list
2824629|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
2824630|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824631|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824632|NCT04044430|Nivolumab|nivolumab|mesh-list
2824633|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2824634|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824635|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2824636|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824637|NCT04044560|Blinatumomab|blinatumomab|mesh-list
2824638|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287901|NCT00249197|Ofloxacin|ofloxacin|mesh-list
2824639|NCT04044417|Curcumin|curcumin|mesh-list
2824640|NCT04044417|Simvastatin|simvastatin|mesh-list
2824641|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2824642|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2824643|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
2824644|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824645|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2824646|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2824647|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824648|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2824649|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2824650|NCT04044417|Analgesics|analgesics|mesh-ancestor
2824651|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
2824652|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824653|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824654|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2824655|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2824656|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824657|NCT04044534|Insulin|insulin|mesh-list
2824658|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2824659|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824660|NCT04044547|Rotigotine|rotigotine|mesh-list
2824661|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
2824662|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
2824663|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824664|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824665|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824666|NCT04044313|Lenvatinib|lenvatinib|mesh-list
2824667|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824668|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2824669|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824670|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824671|NCT04044287|Misoprostol|misoprostol|mesh-list
2824672|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2824673|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
2824674|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2824675|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824676|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2824677|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2824678|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
2824679|NCT04043897|Rifaximin|rifaximin|mesh-list
2824680|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2824681|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824682|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2824683|NCT04043858|Midodrine|midodrine|mesh-list
2824684|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
2287902|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2287903|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287904|NCT00249197|Renal Agents|renal agents|mesh-ancestor
2287905|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2287906|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2287907|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2287908|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287909|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287910|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287911|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2287912|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2287913|NCT00249210|Levofloxacin|levofloxacin|mesh-list
2287914|NCT00249210|Ofloxacin|ofloxacin|mesh-list
2287915|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2287916|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2287917|NCT00249210|Renal Agents|renal agents|mesh-ancestor
2287918|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2287919|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2287920|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2287921|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2287922|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287923|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2287924|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2287925|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2287926|NCT00249223|Risperidone|risperidone|mesh-list
2287927|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2287928|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
2824685|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
2824686|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824687|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824688|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2824689|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2824690|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2824691|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2824692|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
2824693|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824694|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824695|NCT04044131|Sorbitol|sorbitol|mesh-list
2824696|NCT04044131|Cathartics|cathartics|mesh-ancestor
2287929|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287930|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287931|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287932|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2287933|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287934|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287935|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2824697|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2824698|NCT04044079|Misoprostol|misoprostol|mesh-list
2824699|NCT04044079|Dinoprostone|dinoprostone|mesh-list
2824700|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2824701|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
2824702|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2287936|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2287937|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
2287938|NCT00249236|Risperidone|risperidone|mesh-list
2287939|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2287940|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
2287941|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287942|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287943|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287944|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2105567|NCT02456662|Ondansetron|ondansetron|mesh-list
2105568|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
2105569|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
2824703|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824704|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2824705|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2824706|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
2824712|NCT04044222|Carboplatin|carboplatin|mesh-list
2824713|NCT04044222|Etoposide|etoposide|mesh-list
2824714|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
2824715|NCT04044222|Ifosfamide|ifosfamide|mesh-list
2824716|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
2824717|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824718|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2824719|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2824720|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2824721|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824722|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824723|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2824724|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
2824725|NCT04043676|Ponatinib|ponatinib|mesh-list
2824726|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824727|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2824728|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824729|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824730|NCT04043520|Estradiol|estradiol|mesh-list
2824731|NCT04043520|Estrogens|estrogens|mesh-list
2824732|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2824733|NCT04043520|Hormones|hormones|mesh-ancestor
2105570|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105571|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105572|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2105573|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
2105574|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
2105575|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2105576|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
2105577|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105578|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287945|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287946|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287947|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287948|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2287949|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
2287950|NCT00249353|Methylphenidate|methylphenidate|mesh-list
2287951|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2287952|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287953|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2287954|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2287955|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287956|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287957|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
2287958|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287959|NCT00249366|Lorazepam|lorazepam|mesh-list
2287960|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
2287961|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
2287962|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
2287963|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2287964|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287965|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2287966|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2287967|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2287968|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2824734|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2824735|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824736|NCT04043806|Ivacaftor|ivacaftor|mesh-list
2824737|NCT04043806|Elexacaftor|elexacaftor|mesh-list
2824738|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2824739|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2824740|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824741|NCT04043702|Topiramate|topiramate|mesh-list
2824742|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
2287969|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2287970|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287971|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
2287972|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
2287973|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287974|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287975|NCT00249405|Citalopram|citalopram|mesh-list
2287976|NCT00249405|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2287977|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2287978|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287979|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287980|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287981|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
2287982|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287983|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2287984|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
2287985|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287986|NCT00249431|Sertraline|sertraline|mesh-list
2287987|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
2824743|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2824744|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824745|NCT04043624|Lidocaine|lidocaine|mesh-list
2824746|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
2824747|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
2824748|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2824749|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824750|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
2824751|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824752|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2824753|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2824754|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2824755|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2824756|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824757|NCT04043494|Cytarabine|cytarabine|mesh-list
2824758|NCT04043494|Dexamethasone|dexamethasone|mesh-list
2824759|NCT04043494|Prednisone|prednisone|mesh-list
2824760|NCT04043494|Prednisolone|prednisolone|mesh-list
2824761|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
2824762|NCT04043494|Ifosfamide|ifosfamide|mesh-list
2824763|NCT04043494|Doxorubicin|doxorubicin|mesh-list
2824764|NCT04043494|Methotrexate|methotrexate|mesh-list
2824765|NCT04043494|Vincristine|vincristine|mesh-list
2824766|NCT04043494|Daunorubicin|daunorubicin|mesh-list
2824767|NCT04043494|Asparaginase|asparaginase|mesh-list
2824768|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
2824769|NCT04043494|Thioguanine|thioguanine|mesh-list
2824770|NCT04043494|Pegaspargase|pegaspargase|mesh-list
2824771|NCT04043494|Vindesine|vindesine|mesh-list
2824772|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2824773|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
2824774|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824775|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2824776|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2824777|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
2824778|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824779|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824780|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2287988|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2287989|NCT00249431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2287990|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2287991|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2287992|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2287993|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2287994|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
2287995|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2287996|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2287997|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2287998|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2287999|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2288000|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288001|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288002|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288003|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2288004|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
2288005|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2288006|NCT00249509|Bupropion|bupropion|mesh-list
2288007|NCT00249509|Nefazodone|nefazodone|mesh-list
2288008|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2288009|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
2288010|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2288011|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2288012|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2288013|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2288014|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288015|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
2288016|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288017|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288018|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2824781|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2824782|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
2824783|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
2824784|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824785|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2824786|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
2824787|NCT04043494|Hormones|hormones|mesh-ancestor
2824788|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2824789|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2824790|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2824791|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2824792|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2824793|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824794|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2824795|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
2824796|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2824797|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2824798|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
2824799|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
2824800|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2288019|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2288020|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288021|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2288022|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2288023|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2824801|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2824802|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
2824803|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824804|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2824805|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
2824806|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
2824807|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
2824808|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
2824809|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824810|NCT04043325|Antibodies|antibodies|mesh-list
2824811|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
2824812|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824813|NCT04042948|Acetaminophen|acetaminophen|mesh-list
2824814|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2824815|NCT04042948|Analgesics|analgesics|mesh-ancestor
2824816|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
2824817|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824818|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824819|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
2824820|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
2824821|NCT04043195|Nivolumab|nivolumab|mesh-list
2824822|NCT04043195|Ipilimumab|ipilimumab|mesh-list
2824823|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824824|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2824825|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2824826|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824827|NCT04042974|Dinoprostone|dinoprostone|mesh-list
2824828|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
2824829|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2824830|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824831|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
2824832|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2824833|NCT04042805|Lenvatinib|lenvatinib|mesh-list
2824834|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824835|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2824836|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824837|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824838|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
2824839|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2824840|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2824841|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824842|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2824843|NCT04042727|Analgesics|analgesics|mesh-ancestor
2824844|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
2824845|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2824846|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2824847|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2824848|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2824849|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
2824850|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2824851|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824857|NCT04042506|Nivolumab|nivolumab|mesh-list
2824858|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2824859|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824860|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2824861|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824867|NCT04042441|Insulin|insulin|mesh-list
2824868|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
2824869|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2824870|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824871|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
2824872|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2824873|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2824874|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824875|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
2824876|NCT04042688|Coagulants|coagulants|mesh-ancestor
2824877|NCT04042558|Bevacizumab|bevacizumab|mesh-list
2824878|NCT04042558|Carboplatin|carboplatin|mesh-list
2824879|NCT04042558|Pemetrexed|pemetrexed|mesh-list
2824880|NCT04042558|Atezolizumab|atezolizumab|mesh-list
2824881|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2824882|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2824883|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824884|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2824885|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2824886|NCT04042558|Growth Substances|growth substances|mesh-ancestor
2824887|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824888|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
2824889|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824890|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824891|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2824892|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2824893|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
2824894|NCT04042714|Trifluridine|trifluridine|mesh-list
2824895|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
2824896|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824897|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
2824898|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824899|NCT04042753|Nivolumab|nivolumab|mesh-list
2824900|NCT04042753|Ipilimumab|ipilimumab|mesh-list
2824901|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2824902|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824903|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2824904|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824905|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
2824906|NCT04042155|Apixaban|apixaban|mesh-list
2824907|NCT04042155|Edoxaban|edoxaban|mesh-list
2288024|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
2288025|NCT00249574|Buprenorphine|buprenorphine|mesh-list
2288026|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2288027|NCT00249574|Naloxone|naloxone|mesh-list
2288028|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2288029|NCT00249574|Narcotics|narcotics|mesh-ancestor
2824908|NCT04042155|Dabigatran|dabigatran|mesh-list
2824909|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2824910|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
2824911|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2824912|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
2824913|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824914|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824915|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
2824916|NCT04042233|Vancomycin|vancomycin|mesh-list
2824917|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2824918|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824919|NCT04041934|Tryptophan|tryptophan|mesh-list
2824920|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2824921|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
2824922|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2824928|NCT04042051|Trastuzumab|trastuzumab|mesh-list
2824929|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2824930|NCT04042051|Maytansine|maytansine|mesh-list
2824931|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2824932|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2824933|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2824934|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
2824935|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
2824936|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
2824937|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824938|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
2824939|NCT04042220|Hormones|hormones|mesh-ancestor
2824940|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2824941|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824942|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
2824943|NCT04041856|Povidone|povidone|mesh-list
2288030|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2288031|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288032|NCT00249574|Analgesics|analgesics|mesh-ancestor
2288033|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
2288034|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288035|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2288036|NCT00249587|Methadone|methadone|mesh-list
2288037|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2288038|NCT00249587|Narcotics|narcotics|mesh-ancestor
2824944|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
2824945|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
2824946|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2288039|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2288040|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288041|NCT00249587|Analgesics|analgesics|mesh-ancestor
2288042|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
2288043|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288044|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
2288045|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
2288046|NCT00249691|Topiramate|topiramate|mesh-list
2288047|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
2288048|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2288049|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288050|NCT00249704|Vitamin D|vitamin d|mesh-list
2288051|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
2288052|NCT00249704|Vitamins|vitamins|mesh-list
2288053|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
2288054|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288055|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2288056|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2288057|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
2288058|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
2288059|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2288060|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2288061|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824947|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824948|NCT04041973|Lumefantrine|lumefantrine|mesh-list
2824949|NCT04041973|Artemether|artemether|mesh-list
2824950|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2824951|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
2824952|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2824953|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2824954|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824955|NCT04042142|Glucagon|glucagon|mesh-list
2824956|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2824957|NCT04042142|Hormones|hormones|mesh-ancestor
2824958|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2824959|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824960|NCT04041843|Apixaban|apixaban|mesh-list
2824961|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2824962|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
2824963|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2824964|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
2824965|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288062|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288063|NCT00249730|Urological Agents|urological agents|mesh-ancestor
2288064|NCT00249782|Metronidazole|metronidazole|mesh-list
2824966|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824967|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
2824968|NCT04041492|Vitamin D|vitamin d|mesh-list
2824969|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
2824970|NCT04041492|Vitamins|vitamins|mesh-ancestor
2824971|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
2824972|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2824973|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2824974|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2824975|NCT04041791|Amoxicillin|amoxicillin|mesh-list
2824976|NCT04041791|Gentamicins|gentamicins|mesh-list
2824977|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
2824978|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
2824979|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
2824980|NCT04041791|Penicillins|penicillins|mesh-list
2824981|NCT04041791|Ampicillin|ampicillin|mesh-list
2824982|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2824983|NCT04041791|Penicillin G|penicillin g|mesh-list
2824984|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2824985|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
2288065|NCT00249782|Dapsone|dapsone|mesh-list
2288066|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2288067|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2288068|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2288069|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2288070|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
2288071|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2288072|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288073|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288074|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
2288075|NCT00249847|Paroxetine|paroxetine|mesh-list
2288076|NCT00249847|Estrogens|estrogens|mesh-list
2824986|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2824987|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824988|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2824989|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2824990|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824991|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2824992|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2824993|NCT04041362|UB-421|ub-421|mesh-list
2824994|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
2824995|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2824996|NCT04041349|Mitogens|mitogens|mesh-list
2824997|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
2824998|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2824999|NCT04041427|Albendazole|albendazole|mesh-list
2825000|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
2825001|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2825002|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2288077|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2288078|NCT00249847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2288079|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2825003|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
2825004|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2825005|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2825006|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
2825007|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
2825008|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
2825009|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288080|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2288081|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288082|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288083|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
2288084|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288085|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2825010|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825011|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
2825012|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
2825013|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825014|NCT04041167|Protective Agents|protective agents|mesh-ancestor
2825015|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825016|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
2825017|NCT04041167|Vitamins|vitamins|mesh-ancestor
2825018|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
2825019|NCT04041128|Olaparib|olaparib|mesh-list
2825020|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2825021|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825022|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825023|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288086|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
2288087|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2288088|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2288089|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2288090|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288091|NCT00249847|Hormones|hormones|mesh-ancestor
2288092|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2288093|NCT00249860|Interferons|interferons|mesh-list
2288094|NCT00249860|Ribavirin|ribavirin|mesh-list
2288095|NCT00249860|Interferon-beta|interferon-beta|mesh-list
2288096|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
2288097|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288098|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
2288099|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2288100|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
2288101|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288102|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
2825024|NCT04040946|Choline|choline|mesh-list
2825025|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
2825026|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2825027|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
2825028|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825029|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2825030|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2825031|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
2825032|NCT04041648|Treprostinil|treprostinil|mesh-list
2825033|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2825034|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2288103|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288104|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2288105|NCT00249886|Citalopram|citalopram|mesh-list
2288106|NCT00249886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2288107|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2288108|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2288109|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288110|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288111|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
2288112|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288113|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2288114|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
2288115|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2288116|NCT00249899|Atorvastatin|atorvastatin|mesh-list
2288117|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2288118|NCT00249899|Simvastatin|simvastatin|mesh-list
2825047|NCT04040491|Gemcitabine|gemcitabine|mesh-list
2825048|NCT04040491|Lenalidomide|lenalidomide|mesh-list
2288119|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2288120|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2288121|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2288122|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
2288123|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288124|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2288125|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288126|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2288127|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2288128|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2288129|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
2288130|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288131|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2288132|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2288133|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825049|NCT04040491|Antibodies|antibodies|mesh-list
2825050|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
2825051|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
2825052|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825053|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2825054|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
2825055|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825056|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825057|NCT04040491|Antiviral Agents|antiviral agents|mesh-ancestor
2825058|NCT04040491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825059|NCT04040491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825060|NCT04040491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2825061|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2825062|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2825063|NCT04040491|Growth Substances|growth substances|mesh-ancestor
2825064|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
2825065|NCT04040322|Iloprost|iloprost|mesh-list
2825066|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2825067|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
2825068|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
2825069|NCT04040361|Ramucirumab|ramucirumab|mesh-list
2825070|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2825071|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825072|NCT04040465|Aspirin|aspirin|mesh-list
2825073|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2825074|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2825075|NCT04040465|Analgesics|analgesics|mesh-ancestor
2825076|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
2825077|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288134|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2288135|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2288136|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2288137|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
2288138|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288139|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2288140|NCT00249964|Paclitaxel|paclitaxel|mesh-list
2288141|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2288142|NCT00249964|Carboplatin|carboplatin|mesh-list
2288143|NCT00249964|Temozolomide|temozolomide|mesh-list
2288144|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2288145|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288146|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
2825078|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825079|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2825080|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2825081|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2825082|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2825083|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825084|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2825085|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2825086|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825087|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
2825088|NCT04040452|Ketorolac|ketorolac|mesh-list
2825089|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2825090|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2825091|NCT04040452|Analgesics|analgesics|mesh-ancestor
2825092|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
2825093|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825094|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825095|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2825096|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2825097|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2825098|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825099|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825100|NCT04040309|Lidocaine|lidocaine|mesh-list
2825101|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
2825102|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
2825103|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825104|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825105|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
2825106|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825107|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2825108|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2825109|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2288147|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
2288148|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
2288149|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825110|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2825111|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825112|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
2825113|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
2825114|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
2825115|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825116|NCT04039854|Propofol|propofol|mesh-list
2825117|NCT04039854|Sevoflurane|sevoflurane|mesh-list
2825118|NCT04039854|Desflurane|desflurane|mesh-list
2825119|NCT04039854|Isoflurane|isoflurane|mesh-list
2825120|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2825121|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825122|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825123|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2825124|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
2825125|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
2825126|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2825127|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2825128|NCT04039828|Zinc|zinc|mesh-list
2825129|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
2825130|NCT04039828|Trace Elements|trace elements|mesh-ancestor
2825131|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
2288150|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2288151|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
2288152|NCT00249977|Capecitabine|capecitabine|mesh-list
2288153|NCT00249977|Irinotecan|irinotecan|mesh-list
2288154|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288155|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2288156|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
2288157|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288158|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2288159|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2288160|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288161|NCT00250029|Capecitabine|capecitabine|mesh-list
2288162|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
2288163|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2288164|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
2288165|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288166|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288167|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
2288168|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
2288169|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288170|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2288171|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288172|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288173|NCT00250068|Rubitecan|rubitecan|mesh-list
2825132|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825133|NCT04039828|Astringents|astringents|mesh-ancestor
2825134|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
2825135|NCT04039880|Olorofim|olorofim|mesh-list
2825136|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
2825137|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825138|NCT04040023|Vitamins|vitamins|mesh-list
2825139|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
2825140|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825141|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
2825142|NCT04039815|Thiamine|thiamine|mesh-list
2825143|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
2825144|NCT04039815|Vitamins|vitamins|mesh-ancestor
2825145|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
2288174|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288175|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2288176|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2288177|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288178|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288179|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
2288180|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2288181|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2288182|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288183|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
2288184|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288185|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825146|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825147|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2825148|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
2825149|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
2825150|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288186|NCT00250094|Topotecan|topotecan|mesh-list
2288187|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2288188|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2288189|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825151|NCT04039815|Protective Agents|protective agents|mesh-ancestor
2825152|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
2825153|NCT04039698|Velpatasvir|velpatasvir|mesh-list
2825154|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
2825155|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825156|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2825157|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
2825158|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105579|NCT02456662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2105580|NCT02456662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2105581|NCT02456662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105582|NCT02456662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2105583|NCT02456662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2105584|NCT02456740|Erenumab|erenumab|mesh-list
2825165|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
2825166|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2825167|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825168|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2825169|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
2825170|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2825171|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825172|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288190|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288191|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288192|NCT00250120|Camptothecin|camptothecin|mesh-list
2288193|NCT00250120|Rubitecan|rubitecan|mesh-list
2288194|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2288195|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288196|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2288197|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2288198|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825173|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825174|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2825175|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2825176|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288199|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288200|NCT00250172|Rolipram|rolipram|mesh-list
2288201|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
2288202|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2288203|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2288204|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2288205|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288206|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288207|NCT00250185|Acetylcholine|acetylcholine|mesh-list
2288208|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
2288209|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2288210|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
2288211|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288212|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825177|NCT04039347|Cyclosporine|cyclosporine|mesh-list
2825178|NCT04039347|Cyclosporins|cyclosporins|mesh-list
2825179|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825180|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825181|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2825182|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
2825183|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825184|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
2825185|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825186|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
2825187|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2825188|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2825189|NCT04039126|Iodine|iodine|mesh-list
2825190|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
2825191|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
2825192|NCT04039126|Tetracycline|tetracycline|mesh-list
2825193|NCT04039126|Povidone|povidone|mesh-list
2825194|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2825195|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825196|NCT04039126|Trace Elements|trace elements|mesh-ancestor
2825197|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
2825198|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825199|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
2825200|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
2825201|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2825202|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2825203|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825204|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825205|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
2825206|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
2825207|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2825208|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2825209|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825210|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825211|NCT04039087|Urological Agents|urological agents|mesh-ancestor
2825212|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2825213|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825214|NCT04038970|Methotrexate|methotrexate|mesh-list
2825215|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2825216|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
2825217|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2825218|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825219|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2825220|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
2825221|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825222|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825223|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
2825224|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825225|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2825226|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2825227|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
2825228|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2825229|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2825230|NCT04038853|Vitamin D|vitamin d|mesh-list
2825231|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
2825232|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
2825233|NCT04038853|Vitamins|vitamins|mesh-ancestor
2825234|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
2825235|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825236|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2825237|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2825238|NCT04038749|Cabergoline|cabergoline|mesh-list
2825239|NCT04038749|Bromocriptine|bromocriptine|mesh-list
2825240|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2825241|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2825242|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
2825243|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
2825244|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2825245|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825246|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825247|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
2825248|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2825249|NCT04038411|Etoposide|etoposide|mesh-list
2825250|NCT04038411|Lenalidomide|lenalidomide|mesh-list
2825251|NCT04038411|Antibodies|antibodies|mesh-list
2825252|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
2105585|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2105586|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105587|NCT02456740|Analgesics|analgesics|mesh-ancestor
2105588|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
2105589|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105590|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105591|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
2288213|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825253|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825254|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2825255|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825256|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2825257|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2825258|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825259|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825260|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2825261|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2825262|NCT04038411|Growth Substances|growth substances|mesh-ancestor
2825263|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
2825264|NCT04038437|Venetoclax|venetoclax|mesh-list
2825265|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825266|NCT04038502|Carboplatin|carboplatin|mesh-list
2825267|NCT04038502|Olaparib|olaparib|mesh-list
2825268|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825269|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2288214|NCT00250237|Haloperidol|haloperidol|mesh-list
2288215|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
2288216|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
2288217|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
2288218|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288219|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288220|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2288221|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2288222|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2288223|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2288224|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2825270|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825271|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825272|NCT04038619|Loperamide|loperamide|mesh-list
2825273|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
2825274|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2825288|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
2825289|NCT04038320|Ledipasvir|ledipasvir|mesh-list
2825290|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
2825291|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825292|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
2825293|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2825294|NCT04038671|Charcoal|charcoal|mesh-list
2825295|NCT04038671|Antidotes|antidotes|mesh-ancestor
2825296|NCT04038671|Protective Agents|protective agents|mesh-ancestor
2825297|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825298|NCT04038307|Acetaminophen|acetaminophen|mesh-list
2825299|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2825300|NCT04038307|Analgesics|analgesics|mesh-ancestor
2288225|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2288226|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
2288227|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288228|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288229|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2825301|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
2825302|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825303|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825304|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
2825305|NCT04038008|Fluconazole|fluconazole|mesh-list
2825306|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
2825307|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825308|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2825309|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2825310|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825311|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825312|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2825313|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
2825314|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2825315|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825316|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2825317|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2825318|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
2825319|NCT04038034|Vitamins|vitamins|mesh-ancestor
2825320|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
2825321|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825322|NCT04037878|Tramadol|tramadol|mesh-list
2825323|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2825324|NCT04037878|Narcotics|narcotics|mesh-ancestor
2825325|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825326|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825327|NCT04037878|Analgesics|analgesics|mesh-ancestor
2825328|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
2825329|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825330|NCT04038125|Dexamethasone|dexamethasone|mesh-list
2825331|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2825332|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
2825333|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
2825334|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825335|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825336|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2825337|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
2825338|NCT04038125|Hormones|hormones|mesh-ancestor
2825339|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2825340|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2825341|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825342|NCT04038086|Insulin|insulin|mesh-list
2825343|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2825344|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825345|NCT04038073|Antibodies|antibodies|mesh-list
2825346|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
2825347|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
2825348|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825349|NCT04038255|Nicotine|nicotine|mesh-list
2825350|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2825351|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
2825352|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825353|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288230|NCT00250315|Dobutamine|dobutamine|mesh-list
2288231|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2288232|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
2288233|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
2288234|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288235|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288236|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2288237|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2825354|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2825355|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2825356|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
2825357|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2825358|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825359|NCT04037683|Misoprostol|misoprostol|mesh-list
2825360|NCT04037683|Oxytocin|oxytocin|mesh-list
2825361|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
2825362|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2825363|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825364|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2825365|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
2825366|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2825367|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2825368|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
2825369|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2825370|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825371|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825372|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2825373|NCT04037774|Analgesics|analgesics|mesh-ancestor
2825374|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
2825375|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825376|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2825377|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2825378|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2288238|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2288239|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
2288240|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288241|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288242|NCT00250315|Protective Agents|protective agents|mesh-ancestor
2288243|NCT00250354|Risperidone|risperidone|mesh-list
2288244|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2288245|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
2288246|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288247|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288248|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288249|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2288250|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2288251|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2288252|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2288253|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2288254|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
2288255|NCT00250367|Risperidone|risperidone|mesh-list
2825379|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
2825380|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2825381|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825382|NCT04037527|Gemcitabine|gemcitabine|mesh-list
2825383|NCT04037527|Docetaxel|docetaxel|mesh-list
2825384|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2825385|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
2825386|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825387|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825388|NCT04037527|Antiviral Agents|antiviral agents|mesh-ancestor
2825389|NCT04037527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825390|NCT04037527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825391|NCT04037527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2825392|NCT04037527|Immunologic Factors|immunologic factors|mesh-ancestor
2825393|NCT04037527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825394|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
2825395|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
2825396|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
2825397|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
2825398|NCT04037566|Fludarabine|fludarabine|mesh-list
2825399|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2825400|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
2825401|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825402|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2825403|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2825404|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
2825405|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825406|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825407|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2825408|NCT04037657|Propofol|propofol|mesh-list
2825409|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2825410|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825411|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825412|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2825413|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
2825414|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
2825415|NCT04037072|Mitomycins|mitomycins|mesh-list
2825416|NCT04037072|Mitomycin|mitomycin|mesh-list
2825417|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2825418|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825419|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
2825420|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825421|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2825422|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825423|NCT04037176|Omalizumab|omalizumab|mesh-list
2825424|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2825425|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2825426|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
2825427|NCT04037514|Acetaminophen|acetaminophen|mesh-list
2825428|NCT04037514|Ibuprofen|ibuprofen|mesh-list
2825429|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2825430|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2825431|NCT04037514|Analgesics|analgesics|mesh-ancestor
2825432|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
2825433|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825434|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825435|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2825436|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2825437|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2825438|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825439|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825440|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
2288256|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2288257|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
2288258|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288259|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288260|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288261|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2288262|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2288263|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2288264|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2288265|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2288266|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
2288267|NCT00250393|Istradefylline|istradefylline|mesh-list
2288268|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2288269|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2288270|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2288271|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
2288272|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288273|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825441|NCT04037085|Ketamine|ketamine|mesh-list
2825442|NCT04037085|Analgesics|analgesics|mesh-ancestor
2825443|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
2825444|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825445|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825446|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2825447|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2825448|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
2825449|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
2825450|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825451|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2825452|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2825453|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2825454|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825455|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2825456|NCT04037241|Leucovorin|leucovorin|mesh-list
2825457|NCT04037241|Gemcitabine|gemcitabine|mesh-list
2825458|NCT04037241|Paclitaxel|paclitaxel|mesh-list
2825459|NCT04037241|Capecitabine|capecitabine|mesh-list
2825460|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2825461|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825462|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
2825463|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
2825464|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
2825465|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825466|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2825467|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
2825468|NCT04037241|Antiviral Agents|antiviral agents|mesh-ancestor
2825469|NCT04037241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825470|NCT04037241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825471|NCT04037241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2825472|NCT04037241|Immunologic Factors|immunologic factors|mesh-ancestor
2288274|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288275|NCT00250445|Diclofenac|diclofenac|mesh-list
2288276|NCT00250445|Etoricoxib|etoricoxib|mesh-list
2288277|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2288278|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2288279|NCT00250445|Analgesics|analgesics|mesh-ancestor
2288280|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
2825473|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825474|NCT04037241|Antidotes|antidotes|mesh-ancestor
2825475|NCT04037241|Protective Agents|protective agents|mesh-ancestor
2825476|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
2825477|NCT04037241|Vitamins|vitamins|mesh-ancestor
2825478|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
2825479|NCT04036721|Prednisone|prednisone|mesh-list
2825480|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2825481|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
2825482|NCT04036721|Hormones|hormones|mesh-ancestor
2825483|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2825484|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825485|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2825486|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825487|NCT04036890|Minocycline|minocycline|mesh-list
2825488|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2825489|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825490|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
2825491|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2825492|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2825493|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2825494|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2825495|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825496|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
2825497|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2825498|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825499|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2825500|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825501|NCT04036487|Propofol|propofol|mesh-list
2825502|NCT04036487|Desflurane|desflurane|mesh-list
2825503|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2825504|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825505|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825506|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2825507|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
2825508|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
2825509|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2825510|NCT04036500|Estradiol|estradiol|mesh-list
2825511|NCT04036500|Estrogens|estrogens|mesh-ancestor
2825512|NCT04036500|Hormones|hormones|mesh-ancestor
2825513|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2825514|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825515|NCT04036448|Lenalidomide|lenalidomide|mesh-list
2825516|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
2825517|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825518|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2825519|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2825520|NCT04036448|Growth Substances|growth substances|mesh-ancestor
2825521|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
2825522|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825523|NCT04036526|Vaccines|vaccines|mesh-list
2825524|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
2825525|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825526|NCT04036305|Lidocaine|lidocaine|mesh-list
2825527|NCT04036305|Bupivacaine|bupivacaine|mesh-list
2825528|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
2825529|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
2825530|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825531|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825532|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
2825533|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825534|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2825535|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2825536|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2825537|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2825538|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288281|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288282|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288283|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2288284|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2288285|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2288286|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288287|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288288|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2288289|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
2288290|NCT00250536|Nandrolone|nandrolone|mesh-list
2288291|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
2288292|NCT00250536|Androgens|androgens|mesh-ancestor
2825539|NCT04036201|Bupivacaine|bupivacaine|mesh-list
2825540|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
2825541|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
2825542|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
2825543|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825544|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825545|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
2825546|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825547|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2825548|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
2825549|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
2288293|NCT00250536|Hormones|hormones|mesh-ancestor
2288294|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2288295|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288296|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
2288297|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2288298|NCT00250562|Valsartan|valsartan|mesh-list
2825550|NCT04036201|Protective Agents|protective agents|mesh-ancestor
2825551|NCT04036188|Vitamin D|vitamin d|mesh-list
2825552|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
2825553|NCT04036188|Triamcinolone|triamcinolone|mesh-list
2825554|NCT04036188|Vitamins|vitamins|mesh-ancestor
2825555|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
2825556|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825557|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2825558|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2825559|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2825560|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
2825561|NCT04036188|Hormones|hormones|mesh-ancestor
2825562|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2825563|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
2825564|NCT04036253|Hematinics|hematinics|mesh-ancestor
2825565|NCT04035850|Vortioxetine|vortioxetine|mesh-list
2825566|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
2825567|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2288299|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2288300|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2288301|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2288302|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2288303|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288304|NCT00250562|Diuretics|diuretics|mesh-ancestor
2288305|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
2288306|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288307|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2825568|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2825569|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2825570|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825571|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825572|NCT04035850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2825573|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2825574|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2825575|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825576|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2825577|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
2825578|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2825579|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2825580|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2825581|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2825582|NCT04035876|Apatinib|apatinib|mesh-list
2825583|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825584|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2825585|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825586|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825587|NCT04035889|Melatonin|melatonin|mesh-list
2825588|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
2825589|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825590|NCT04035889|Protective Agents|protective agents|mesh-ancestor
2288308|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2288309|NCT00250575|Clozapine|clozapine|mesh-list
2288310|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2288311|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
2288312|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288313|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288314|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288315|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2288316|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2288317|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2288318|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2288319|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
2288320|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
2288321|NCT00250640|Iloprost|iloprost|mesh-list
2288322|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2288323|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
2288324|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
2288325|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2288326|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
2288327|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
2288328|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2288329|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288330|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2288331|NCT00250692|Analgesics|analgesics|mesh-ancestor
2288332|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
2288333|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288334|NCT00250744|Gabapentin|gabapentin|mesh-list
2288335|NCT00250744|Aprepitant|aprepitant|mesh-list
2288336|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
2288337|NCT00250744|Analgesics|analgesics|mesh-ancestor
2288338|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
2288339|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288340|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288341|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
2288342|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2288343|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2288344|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2288345|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2825591|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825592|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825593|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2825594|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825595|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2825596|NCT04035798|Memantine|memantine|mesh-list
2825597|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2825598|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2825599|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
2825600|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2825601|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825602|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825603|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2825604|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2825605|NCT04035707|Rocuronium|rocuronium|mesh-list
2825606|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825607|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2825608|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2825609|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2825610|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825611|NCT04035603|Cycloserine|cycloserine|mesh-list
2825612|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2825613|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825614|NCT04035603|Renal Agents|renal agents|mesh-ancestor
2825615|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2825616|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
2825617|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2825618|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
2825619|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825620|NCT04035473|Paclitaxel|paclitaxel|mesh-list
2288346|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2288347|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2288348|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2825621|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2825622|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825623|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
2825624|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
2825625|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
2825626|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825627|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
2825628|NCT04035525|Ubiquinone|ubiquinone|mesh-list
2825629|NCT04035525|Vitamins|vitamins|mesh-ancestor
2825630|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
2825631|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825632|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
2825633|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2825634|NCT04035135|Antibodies|antibodies|mesh-list
2825635|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
2825636|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2825637|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
2825638|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825639|NCT04035187|Itraconazole|itraconazole|mesh-list
2825640|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
2825641|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2825642|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
2825643|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825644|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2825645|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2825646|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825647|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825648|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2825649|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
2825650|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2825651|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105592|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
2105593|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2105594|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2105595|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2105596|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105597|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2105598|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2105599|NCT02456909|Morphine|morphine|mesh-list
2105600|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2105601|NCT02456909|Narcotics|narcotics|mesh-ancestor
2105602|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105603|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288349|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825652|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2825653|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
2825654|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2825655|NCT04035330|Eusol|eusol|mesh-list
2825656|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
2825657|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825658|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2288350|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
2288351|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
2288352|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
2825659|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288353|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2288354|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2288355|NCT00250796|Interferons|interferons|mesh-list
2288356|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
2288357|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2288358|NCT00250796|Thalidomide|thalidomide|mesh-list
2288359|NCT00250796|Octreotide|octreotide|mesh-list
2288360|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288361|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
2288362|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825660|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
2825661|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
2825662|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825663|NCT04035096|Protective Agents|protective agents|mesh-ancestor
2825664|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825665|NCT04035096|Vitamins|vitamins|mesh-ancestor
2825666|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
2825667|NCT04035382|Misoprostol|misoprostol|mesh-list
2288363|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2288364|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
2825668|NCT04035382|Oxytocin|oxytocin|mesh-list
2825669|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
2825670|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2825671|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825672|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2825673|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
2825674|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2825675|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2288365|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288366|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
2288367|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2825676|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2825677|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2825678|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
2825679|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
2825680|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825681|NCT04034823|Docetaxel|docetaxel|mesh-list
2825682|NCT04034823|Trastuzumab|trastuzumab|mesh-list
2825683|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288368|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2288369|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2288370|NCT00250796|Growth Substances|growth substances|mesh-ancestor
2288371|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
2288372|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2288373|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2288374|NCT00250822|Gemcitabine|gemcitabine|mesh-list
2288375|NCT00250822|Oxaliplatin|oxaliplatin|mesh-list
2825684|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
2825685|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
2825686|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
2288376|NCT00250822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2288377|NCT00250822|Antimetabolites|antimetabolites|mesh-ancestor
2288378|NCT00250822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825687|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825688|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2825689|NCT04035070|Clindamycin|clindamycin|mesh-list
2825690|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
2825691|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
2825692|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2825693|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2825694|NCT04035070|Eusol|eusol|mesh-list
2825695|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2825696|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825697|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2825698|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825699|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105604|NCT02456909|Analgesics|analgesics|mesh-ancestor
2105605|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
2105606|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105607|NCT02457195|Granisetron|granisetron|mesh-list
2105608|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
2105609|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
2105610|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825700|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
2825701|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2825702|NCT04034771|Propofol|propofol|mesh-list
2825703|NCT04034771|Melatonin|melatonin|mesh-list
2825704|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2825705|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825706|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825707|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2288379|NCT00250822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288380|NCT00250822|Antiviral Agents|antiviral agents|mesh-ancestor
2825708|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
2825709|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
2825710|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
2825711|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825712|NCT04034771|Protective Agents|protective agents|mesh-ancestor
2825713|NCT04034862|Lamivudine|lamivudine|mesh-list
2825714|NCT04034862|Dolutegravir|dolutegravir|mesh-list
2825715|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2825716|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2288381|NCT00250822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2288382|NCT00250822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825717|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825718|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825719|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
2825720|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825721|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2825722|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2825723|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2825724|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2825725|NCT04034836|Parecoxib|parecoxib|mesh-list
2825726|NCT04034836|Ropivacaine|ropivacaine|mesh-list
2825727|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
2825728|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
2825729|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825730|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825731|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
2825732|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825733|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2825734|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2825735|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825736|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288383|NCT00250822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2288384|NCT00250822|Immunologic Factors|immunologic factors|mesh-ancestor
2288385|NCT00250822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288386|NCT00250861|Aldesleukin|aldesleukin|mesh-list
2288387|NCT00250861|Rituximab|rituximab|mesh-list
2288388|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2288389|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288390|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
2288391|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288392|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2288393|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2288394|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2288395|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
2288396|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2288397|NCT00250874|Docetaxel|docetaxel|mesh-list
2288398|NCT00250874|Doxorubicin|doxorubicin|mesh-list
2288399|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2288400|NCT00250874|Trastuzumab|trastuzumab|mesh-list
2288401|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288402|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
2825737|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2825738|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2825739|NCT04034836|Analgesics|analgesics|mesh-ancestor
2825740|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2825741|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2288403|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
2288404|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
2288405|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288406|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2288407|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2288408|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2288409|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288410|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2288411|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2288412|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2288413|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2288414|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288415|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288416|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2288417|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2288418|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825742|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
2825743|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2825744|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825745|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2825746|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288419|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
2288420|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288421|NCT00250978|Bevacizumab|bevacizumab|mesh-list
2825747|NCT04034524|Insulin|insulin|mesh-list
2825748|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2825749|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2825750|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825751|NCT04034589|Fulvestrant|fulvestrant|mesh-list
2825752|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2825753|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825754|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2825755|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2825756|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
2825757|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2825758|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825759|NCT04034238|Tofacitinib|tofacitinib|mesh-list
2825760|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2825761|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825762|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825763|NCT04034485|Evolocumab|evolocumab|mesh-list
2825764|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2825765|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2825766|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
2825767|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825768|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2825769|NCT04034368|Tenofovir|tenofovir|mesh-list
2825770|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
2825771|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825772|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2288422|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2288423|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288424|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2288425|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2288426|NCT00250978|Growth Substances|growth substances|mesh-ancestor
2288427|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288428|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
2288429|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2288430|NCT00250991|Eptifibatide|eptifibatide|mesh-list
2825773|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2825774|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825775|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825776|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2825777|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2825778|NCT04034251|Paclitaxel|paclitaxel|mesh-list
2825779|NCT04034251|Capecitabine|capecitabine|mesh-list
2825780|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2825781|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825782|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
2825783|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
2825784|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
2825785|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825786|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2825787|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
2825791|NCT04034173|Leucovorin|leucovorin|mesh-list
2825792|NCT04034173|Folic Acid|folic acid|mesh-list
2825793|NCT04034173|Irinotecan|irinotecan|mesh-list
2825794|NCT04034173|Panitumumab|panitumumab|mesh-list
2825795|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
2825796|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2825797|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2825798|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825799|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825800|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825801|NCT04034173|Antidotes|antidotes|mesh-ancestor
2825802|NCT04034173|Protective Agents|protective agents|mesh-ancestor
2825803|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825804|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
2825805|NCT04034173|Vitamins|vitamins|mesh-ancestor
2825806|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
2825807|NCT04034173|Hematinics|hematinics|mesh-ancestor
2825808|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2825809|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
2825810|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2825811|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825812|NCT04034004|Naloxone|naloxone|mesh-list
2825813|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2288431|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2288432|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2288433|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288434|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2288435|NCT00251017|Vancomycin|vancomycin|mesh-list
2288436|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2288437|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2288438|NCT00251030|Nelfinavir|nelfinavir|mesh-list
2288439|NCT00251030|Omeprazole|omeprazole|mesh-list
2288440|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2288441|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2288442|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2825814|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825815|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
2825816|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825817|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
2825818|NCT04034199|Denosumab|denosumab|mesh-list
2825819|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2825820|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825821|NCT04033991|Sunitinib|sunitinib|mesh-list
2825822|NCT04033991|Axitinib|axitinib|mesh-list
2825823|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825824|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2825825|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2825826|NCT04033991|Growth Substances|growth substances|mesh-ancestor
2825827|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825828|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
2825829|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2825830|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825831|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825832|NCT04033939|Propofol|propofol|mesh-list
2825833|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2825834|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825835|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825836|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2825837|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
2825838|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
2288443|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288444|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288445|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2288446|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2288447|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
2288448|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2825839|NCT04033575|Listerine|listerine|mesh-list
2825840|NCT04033575|Fluorides|fluorides|mesh-list
2825841|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
2825842|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
2825843|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
2825844|NCT04033575|Protective Agents|protective agents|mesh-ancestor
2825845|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825846|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2825847|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825848|NCT04033562|Lidocaine|lidocaine|mesh-list
2825849|NCT04033562|Bupivacaine|bupivacaine|mesh-list
2825850|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
2825851|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
2825852|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825853|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825854|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
2825855|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825856|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2825857|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2825858|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2825859|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2825860|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825861|NCT04033471|Midazolam|midazolam|mesh-list
2825862|NCT04033471|Morphine|morphine|mesh-list
2825863|NCT04033471|Bupivacaine|bupivacaine|mesh-list
2825864|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
2825865|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
2825866|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2288449|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2825867|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825868|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
2825869|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825870|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2825871|NCT04033471|Narcotics|narcotics|mesh-ancestor
2825872|NCT04033471|Analgesics|analgesics|mesh-ancestor
2825873|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2825874|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2825875|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2825876|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2825877|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2825878|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2825879|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
2825880|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
2825881|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
2825882|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2825883|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825884|NCT04033354|Paclitaxel|paclitaxel|mesh-list
2825885|NCT04033354|Carboplatin|carboplatin|mesh-list
2825886|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2825887|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825888|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
2825889|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
2825890|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
2825891|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825892|NCT04033250|Bisacodyl|bisacodyl|mesh-list
2825893|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
2825894|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
2825895|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
2825896|NCT04033250|Citric Acid|citric acid|mesh-list
2825897|NCT04033250|Cathartics|cathartics|mesh-ancestor
2825898|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2825899|NCT04033250|Laxatives|laxatives|mesh-ancestor
2825900|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
2825901|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2825902|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
2825903|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
2825904|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825905|NCT04033250|Antacids|antacids|mesh-ancestor
2288450|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
2288451|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2288452|NCT00251056|Mannitol|mannitol|mesh-list
2288453|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2288454|NCT00251056|Diuretics|diuretics|mesh-ancestor
2288455|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
2288456|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288457|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2288458|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2288459|NCT00251082|Estradiol|estradiol|mesh-list
2288460|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2288461|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
2288462|NCT00251082|Estrogens|estrogens|mesh-ancestor
2288463|NCT00251082|Hormones|hormones|mesh-ancestor
2288464|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2288465|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288466|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2288467|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
2288468|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2825906|NCT04033172|Fulvestrant|fulvestrant|mesh-list
2825907|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2825908|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825909|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2825910|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2825911|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
2288469|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2288470|NCT00251082|Progestins|progestins|mesh-ancestor
2288471|NCT00251095|Paclitaxel|paclitaxel|mesh-list
2288472|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2288473|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288474|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
2288475|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
2288476|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
2288477|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288478|NCT00251186|Capecitabine|capecitabine|mesh-list
2288479|NCT00251186|Cetuximab|cetuximab|mesh-list
2288480|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2288481|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
2288482|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288483|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288484|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2288485|NCT00251277|Rituximab|rituximab|mesh-list
2825912|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2825913|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825914|NCT04033237|Nicotine|nicotine|mesh-list
2288486|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2288487|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288488|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
2288489|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288490|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2288491|NCT00251355|Gemcitabine|gemcitabine|mesh-list
2288492|NCT00251355|Fluorouracil|fluorouracil|mesh-list
2288493|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2288494|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
2288495|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288496|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288497|NCT00251355|Antiviral Agents|antiviral agents|mesh-ancestor
2288498|NCT00251355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2288499|NCT00251355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288500|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2288501|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
2288502|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288503|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
2825915|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2825916|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
2825917|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825918|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825919|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2825920|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2825921|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
2825922|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2825923|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825924|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2825925|NCT04033029|Tazobactam|tazobactam|mesh-list
2825926|NCT04033029|Piperacillin|piperacillin|mesh-list
2825927|NCT04033029|Daptomycin|daptomycin|mesh-list
2825928|NCT04033029|Ceftazidime|ceftazidime|mesh-list
2825929|NCT04033029|Cefepime|cefepime|mesh-list
2825930|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2825931|NCT04033029|Ceftolozane|ceftolozane|mesh-list
2825932|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2825933|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2825934|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825935|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825936|NCT04033055|Ropivacaine|ropivacaine|mesh-list
2825937|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
2825938|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
2825939|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825940|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825941|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
2825942|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2825952|NCT04033094|Morphine|morphine|mesh-list
2825953|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2825954|NCT04033094|Narcotics|narcotics|mesh-ancestor
2825955|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2825956|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825957|NCT04033094|Analgesics|analgesics|mesh-ancestor
2825958|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
2825959|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288504|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288505|NCT00251381|Cetuximab|cetuximab|mesh-list
2288506|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2288507|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288508|NCT00251394|Rituximab|rituximab|mesh-list
2288509|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2288510|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288511|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
2288512|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288513|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2288514|NCT00251407|Docetaxel|docetaxel|mesh-list
2288515|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288516|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
2288517|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
2288518|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
2288519|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288520|NCT00251433|Docetaxel|docetaxel|mesh-list
2288521|NCT00251433|Trastuzumab|trastuzumab|mesh-list
2288522|NCT00251433|Lapatinib|lapatinib|mesh-list
2288523|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288524|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
2288525|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
2288526|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
2288527|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288528|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2288529|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2288530|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288531|NCT00251459|Ranibizumab|ranibizumab|mesh-list
2288532|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2288533|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2288534|NCT00251459|Growth Substances|growth substances|mesh-ancestor
2288535|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288536|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
2288537|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288538|NCT00251472|Paclitaxel|paclitaxel|mesh-list
2825960|NCT04033263|Fluorides|fluorides|mesh-list
2825961|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
2825962|NCT04033263|Protective Agents|protective agents|mesh-ancestor
2825963|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825964|NCT04033419|Memantine|memantine|mesh-list
2825965|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2825966|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2825967|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
2825968|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2825969|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825970|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825971|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2825972|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2825973|NCT04033276|Rituximab|rituximab|mesh-list
2825974|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
2825975|NCT04033276|Antibodies|antibodies|mesh-list
2825976|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
2825977|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2825978|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2825979|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2825980|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825981|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
2825982|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825983|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2825984|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
2825985|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2825986|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
2825987|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825988|NCT04032964|Doxorubicin|doxorubicin|mesh-list
2825989|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2825990|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2825991|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2825992|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2825993|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2825994|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2825995|NCT04032626|Lenalidomide|lenalidomide|mesh-list
2825996|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
2825997|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2825998|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2825999|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2288539|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2288540|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288541|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
2288542|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
2288543|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
2288544|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826000|NCT04032626|Growth Substances|growth substances|mesh-ancestor
2826001|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
2826002|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826003|NCT04032691|Clonidine|clonidine|mesh-list
2826004|NCT04032691|Analgesics|analgesics|mesh-ancestor
2826005|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
2826006|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826007|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826008|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2826009|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
2826010|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
2826011|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2826012|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2826013|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2826014|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
2826015|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288545|NCT00251485|Cetuximab|cetuximab|mesh-list
2288546|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2288547|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826016|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826017|NCT04032860|Tenofovir|tenofovir|mesh-list
2826018|NCT04032860|Entecavir|entecavir|mesh-list
2826019|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
2826020|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826021|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2826022|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2826023|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826024|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826025|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2826026|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2826027|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
2826028|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2826029|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
2826030|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2826031|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
2826032|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826033|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826034|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
2288548|NCT00251498|Cetuximab|cetuximab|mesh-list
2288549|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2288550|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288551|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
2288552|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288553|NCT00251524|Bevacizumab|bevacizumab|mesh-list
2288554|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
2288555|NCT00251524|Pemetrexed|pemetrexed|mesh-list
2288556|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2288557|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288558|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2288559|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2288560|NCT00251524|Growth Substances|growth substances|mesh-ancestor
2288561|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288562|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
2288563|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288564|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826035|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
2826036|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2826037|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826038|NCT04032834|Budesonide|budesonide|mesh-list
2826039|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2826040|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2826041|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
2826042|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826043|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826044|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2826045|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
2826046|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
2826047|NCT04032834|Hormones|hormones|mesh-ancestor
2826048|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2288565|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2826049|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
2288566|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2288567|NCT00251550|Pemetrexed|pemetrexed|mesh-list
2826050|NCT04032548|Propolis|propolis|mesh-list
2826051|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2826052|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826053|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
2826054|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
2826055|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2826056|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826071|NCT04032236|Caffeine|caffeine|mesh-list
2826072|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2826073|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826074|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2826075|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826076|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826077|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2826078|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2826079|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
2826080|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826081|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
2826082|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2826083|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
2826084|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826085|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826086|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2826087|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
2826088|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2826089|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
2826090|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826091|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826092|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2288568|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288569|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288570|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288571|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2288572|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2288573|NCT00251576|Heparin|heparin|mesh-list
2288574|NCT00251576|Calcium heparin|calcium heparin|mesh-list
2288575|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2288576|NCT00251576|Tinzaparin|tinzaparin|mesh-list
2288577|NCT00251576|Dalteparin|dalteparin|mesh-list
2288578|NCT00251576|Tirofiban|tirofiban|mesh-list
2288579|NCT00251576|Simvastatin|simvastatin|mesh-list
2105611|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105612|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2105613|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2105614|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
2105615|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105616|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105617|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
2105618|NCT02457247|Antacids|antacids|mesh-ancestor
2105619|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288580|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
2826093|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
2826094|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
2826095|NCT04032366|Protective Agents|protective agents|mesh-ancestor
2826096|NCT04032067|Finasteride|finasteride|mesh-list
2826097|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2826098|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2826099|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288581|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2288582|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2288583|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288584|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2288585|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2288586|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
2288587|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2288588|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2826100|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826101|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
2826102|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2826103|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826104|NCT04032067|Urological Agents|urological agents|mesh-ancestor
2288589|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288590|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2288591|NCT00251602|Propranolol|propranolol|mesh-list
2288592|NCT00251602|Atropine|atropine|mesh-list
2288593|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2288594|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2288595|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
2288596|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288597|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288598|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288599|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2826105|NCT04032132|Curcumin|curcumin|mesh-list
2826106|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2826107|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2826108|NCT04032132|Analgesics|analgesics|mesh-ancestor
2826109|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
2826110|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826111|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826112|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2826113|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2826114|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826115|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826116|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826117|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
2826118|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2826119|NCT04032184|Fluorides|fluorides|mesh-list
2826120|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
2826121|NCT04032184|Protective Agents|protective agents|mesh-ancestor
2826122|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826123|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2826124|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826125|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
2826126|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
2826127|NCT04032119|Epinephrine|epinephrine|mesh-list
2826128|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2826129|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2826130|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
2826131|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826132|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826133|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826134|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2826135|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2826136|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
2826137|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826138|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2826139|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
2826140|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
2826141|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
2826142|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2826143|NCT04032210|Zinc|zinc|mesh-list
2826144|NCT04032210|Fluorides|fluorides|mesh-list
2826145|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
2288600|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2288601|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
2288602|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2288603|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2288604|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
2288605|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288606|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2288607|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
2288608|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
2826146|NCT04032210|Protective Agents|protective agents|mesh-ancestor
2826147|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826148|NCT04032210|Trace Elements|trace elements|mesh-ancestor
2826149|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
2288609|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
2288610|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2288611|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2288612|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
2288613|NCT00251654|Anesthetics|anesthetics|mesh-list
2288614|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2288615|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288616|NCT00251680|Atorvastatin|atorvastatin|mesh-list
2288617|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2288618|NCT00251680|Simvastatin|simvastatin|mesh-list
2288619|NCT00251680|Fenofibrate|fenofibrate|mesh-list
2288620|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2288621|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2288622|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
2288623|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288624|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2288625|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2288626|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288627|NCT00251706|Amiodarone|amiodarone|mesh-list
2288628|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2288629|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
2288630|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2288631|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2288632|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288633|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2288634|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2288635|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2288636|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288637|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2288638|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2288639|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2288640|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
2288641|NCT00251732|Nortriptyline|nortriptyline|mesh-list
2288642|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
2288643|NCT00251732|Rabeprazole|rabeprazole|mesh-list
2288644|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2826150|NCT04031859|Aspirin|aspirin|mesh-list
2826151|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2826152|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2826153|NCT04031859|Analgesics|analgesics|mesh-ancestor
2826154|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
2826155|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826156|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826157|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2826158|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2826159|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2826160|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2826161|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826162|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2826163|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2826164|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826165|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
2288645|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2288646|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2288647|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288648|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288649|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2288650|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2288651|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2288652|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2288653|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
2288654|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288655|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288656|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
2288657|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
2288658|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2288659|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2288660|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288661|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288662|NCT00251784|Urological Agents|urological agents|mesh-ancestor
2288663|NCT00251797|Thalidomide|thalidomide|mesh-list
2826166|NCT04031833|Amphotericin B|amphotericin b|mesh-list
2826167|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2826168|NCT04031833|Amebicides|amebicides|mesh-ancestor
2826169|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2826170|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2826171|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826172|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2826173|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
2826174|NCT04031872|Capecitabine|capecitabine|mesh-list
2826175|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2826176|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
2826177|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826178|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826179|NCT04031729|Aspirin|aspirin|mesh-list
2826180|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2826181|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2826182|NCT04031729|Analgesics|analgesics|mesh-ancestor
2826183|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
2826184|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826185|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826186|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2826187|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2826188|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2826189|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2288664|NCT00251797|Irinotecan|irinotecan|mesh-list
2288665|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2288666|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2288667|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288668|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288669|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288670|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2288671|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
2105620|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2105621|NCT02457325|Carticaine|carticaine|mesh-list
2105622|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
2288672|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288673|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
2288674|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2288675|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2288676|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2288677|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2288678|NCT00251797|Growth Substances|growth substances|mesh-ancestor
2288679|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
2288680|NCT00251823|Eptifibatide|eptifibatide|mesh-list
2288681|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2288682|NCT00251849|KRM 1648|krm 1648|mesh-list
2288683|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2288684|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
2288685|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2288686|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2288687|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
2288688|NCT00251888|Irinotecan|irinotecan|mesh-list
2288689|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288690|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2288691|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2288692|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288693|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288694|NCT00251901|Esomeprazole|esomeprazole|mesh-list
2288695|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2288696|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2288697|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2288698|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288699|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288700|NCT00251914|Esomeprazole|esomeprazole|mesh-list
2288701|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2288702|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2288703|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2288704|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288705|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288706|NCT00251940|Glyburide|glyburide|mesh-list
2288707|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2288708|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288709|NCT00251953|Metformin|metformin|mesh-list
2105623|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
2826190|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826191|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2826192|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2826193|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826194|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
2826195|NCT04031755|Minocycline|minocycline|mesh-list
2826196|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2826197|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826198|NCT04031703|Paclitaxel|paclitaxel|mesh-list
2826199|NCT04031703|Docetaxel|docetaxel|mesh-list
2826200|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
2826201|NCT04031703|Carboplatin|carboplatin|mesh-list
2826202|NCT04031703|Fluorouracil|fluorouracil|mesh-list
2826203|NCT04031703|Epirubicin|epirubicin|mesh-list
2826204|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2826205|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826206|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
2826207|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
2826208|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
2826209|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826210|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2826211|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
2826212|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826213|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2826214|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2826215|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
2826216|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2826217|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
2826218|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2826219|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2826220|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2826221|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2105624|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105625|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105626|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
2105627|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105628|NCT02457520|Isotretinoin|isotretinoin|mesh-list
2105629|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
2105630|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2105631|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
2105632|NCT02457546|Coagulants|coagulants|mesh-ancestor
2105633|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
2826222|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288710|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2288711|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288712|NCT00251966|Esomeprazole|esomeprazole|mesh-list
2288713|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2288714|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2288715|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2288716|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288717|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288718|NCT00251992|Esomeprazole|esomeprazole|mesh-list
2288719|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2288720|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2288721|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2826230|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
2826231|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2826232|NCT04031027|Apremilast|apremilast|mesh-list
2826233|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2826234|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2826235|NCT04031027|Analgesics|analgesics|mesh-ancestor
2826236|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
2826237|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826238|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826239|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2826240|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2826241|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2288722|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288723|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288724|NCT00252005|Apixaban|apixaban|mesh-list
2288725|NCT00252005|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2288726|NCT00252005|Antithrombins|antithrombins|mesh-ancestor
2288727|NCT00252005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2288728|NCT00252005|Protease Inhibitors|protease inhibitors|mesh-ancestor
2288729|NCT00252005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826242|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2826243|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826244|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826245|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
2826246|NCT04030663|Papaverine|papaverine|mesh-list
2826247|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
2826248|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2826249|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826250|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826251|NCT04030663|Urological Agents|urological agents|mesh-ancestor
2826252|NCT04030988|Dexamethasone|dexamethasone|mesh-list
2826253|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2826254|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
2826255|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
2826256|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826257|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826258|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2826259|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
2826260|NCT04030988|Hormones|hormones|mesh-ancestor
2826261|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2826262|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2826263|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826264|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2826265|NCT04030715|Bismuth|bismuth|mesh-list
2826266|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826267|NCT04030715|Antacids|antacids|mesh-ancestor
2826268|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826269|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2826270|NCT04030741|Metronidazole|metronidazole|mesh-list
2288730|NCT00252005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288731|NCT00252005|Anticoagulants|anticoagulants|mesh-ancestor
2288732|NCT00252044|Pergolide|pergolide|mesh-list
2826271|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826272|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2826273|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2826274|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2826275|NCT04030442|Morphine|morphine|mesh-list
2826276|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2826277|NCT04030442|Narcotics|narcotics|mesh-ancestor
2826278|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826279|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826280|NCT04030442|Analgesics|analgesics|mesh-ancestor
2826281|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
2826282|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826288|NCT04030533|Ustekinumab|ustekinumab|mesh-list
2826289|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2826290|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
2826291|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
2826292|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826293|NCT04030572|Clonidine|clonidine|mesh-list
2826294|NCT04030572|Analgesics|analgesics|mesh-ancestor
2826295|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
2826296|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826297|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826298|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2826299|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
2826300|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
2826301|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2826302|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2826303|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2826304|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
2826305|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826306|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826307|NCT04030143|Aripiprazole|aripiprazole|mesh-list
2826308|NCT04030143|Antidepressive Agents|antidepressive agents|mesh-ancestor
2826309|NCT04030143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2826310|NCT04030143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2826311|NCT04030143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2826312|NCT04030143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826313|NCT04030143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826314|NCT04030143|Dopamine Agonists|dopamine agonists|mesh-ancestor
2826315|NCT04030143|Dopamine Agents|dopamine agents|mesh-ancestor
2826316|NCT04030143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826317|NCT04030143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826318|NCT04030143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2826319|NCT04030143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2826320|NCT04030143|Serotonin Agents|serotonin agents|mesh-ancestor
2826321|NCT04030143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2826322|NCT04030143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2826323|NCT04030143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2826324|NCT04030143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2826325|NCT04030481|Anesthetics|anesthetics|mesh-list
2826326|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826327|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826328|NCT04030260|Nivolumab|nivolumab|mesh-list
2826329|NCT04030260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2826330|NCT04030260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826331|NCT04030260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2826332|NCT04030260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826333|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
2826334|NCT04030195|Fludarabine|fludarabine|mesh-list
2826335|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2826336|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
2826337|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826338|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2826339|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2826340|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
2826341|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826342|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826343|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2288733|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
2288734|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
2288735|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288736|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288737|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288738|NCT00252122|Ketamine|ketamine|mesh-list
2288739|NCT00252122|Analgesics|analgesics|mesh-ancestor
2288740|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
2288741|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288742|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288743|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2288744|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2288745|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
2826344|NCT04030039|Interferons|interferons|mesh-list
2826345|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826346|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
2826347|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826348|NCT04030429|Crizotinib|crizotinib|mesh-list
2826349|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288746|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
2288747|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2288748|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2288749|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2288750|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288751|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288752|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2826350|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2826351|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826352|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826353|NCT04030455|Cisplatin|cisplatin|mesh-list
2826354|NCT04030455|Carboplatin|carboplatin|mesh-list
2826355|NCT04030455|Docetaxel|docetaxel|mesh-list
2826356|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
2826357|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826358|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
2826359|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
2826360|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
2826361|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826362|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2826363|NCT04030091|Insulin|insulin|mesh-list
2826364|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2826365|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
2826366|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2826367|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826368|NCT04029831|Ketamine|ketamine|mesh-list
2826369|NCT04029831|Propofol|propofol|mesh-list
2826370|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2826371|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826372|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826373|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2826374|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
2826375|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
2826376|NCT04029831|Analgesics|analgesics|mesh-ancestor
2826377|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
2826378|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826379|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2826380|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2826381|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2826382|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826383|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826384|NCT04029610|Lidocaine|lidocaine|mesh-list
2826385|NCT04029610|Epinephrine|epinephrine|mesh-list
2826386|NCT04029610|Racepinephrine|racepinephrine|mesh-list
2826387|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
2826388|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
2826389|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
2288753|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
2288754|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288755|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2288756|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
2288757|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2288758|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2288759|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2288760|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2288761|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288762|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2288763|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2288764|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2288765|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2288766|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288767|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
2288768|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288769|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826390|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826391|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826392|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
2826393|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826394|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2826395|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2826396|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2826397|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2826398|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826399|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2826400|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2826401|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
2826402|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826403|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2826404|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2826405|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
2826406|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2826407|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
2826408|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
2826409|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
2826410|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2826411|NCT04029675|Ascorbic Acid|ascorbic acid|mesh-list
2826412|NCT04029675|Vitamins|vitamins|mesh-ancestor
2826413|NCT04029675|Micronutrients|micronutrients|mesh-ancestor
2826414|NCT04029675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826415|NCT04029675|Antioxidants|antioxidants|mesh-ancestor
2826416|NCT04029675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826417|NCT04029675|Protective Agents|protective agents|mesh-ancestor
2288770|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
2288771|NCT00252291|Miotics|miotics|mesh-ancestor
2288772|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
2288773|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288774|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288775|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2288776|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2826418|NCT04029636|Xenon|xenon|mesh-list
2826419|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2826420|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
2826421|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
2826422|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826423|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826424|NCT04029428|Octreotide|octreotide|mesh-list
2826425|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2826426|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2826427|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826428|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2826429|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2826430|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826431|NCT04029454|Vaccines|vaccines|mesh-list
2826432|NCT04029454|Immunologic Factors|immunologic factors|mesh-ancestor
2826433|NCT04029454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826434|NCT04029350|Osimertinib|osimertinib|mesh-list
2826435|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826436|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2826437|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288777|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
2288778|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2288779|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2288780|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
2288781|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826438|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826439|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
2826440|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2826441|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826442|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826443|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2826444|NCT04029467|Analgesics|analgesics|mesh-ancestor
2826445|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
2826446|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826447|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2826448|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2826449|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2826450|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
2826451|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826452|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826453|NCT04029090|Edaravone|edaravone|mesh-list
2826454|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2826455|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
2826456|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826457|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2826458|NCT04029090|Protective Agents|protective agents|mesh-ancestor
2826459|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826460|NCT04029116|Fluconazole|fluconazole|mesh-list
2826461|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
2826462|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
2826463|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826464|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2826465|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2826466|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826467|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826468|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2826469|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
2826470|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2826471|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826472|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2826473|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2826474|NCT04029272|Metformin|metformin|mesh-list
2826475|NCT04029272|Exenatide|exenatide|mesh-list
2826476|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2826477|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826478|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2288782|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288783|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
2288784|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826479|NCT04029272|Incretins|incretins|mesh-ancestor
2826480|NCT04029272|Hormones|hormones|mesh-ancestor
2826481|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2826482|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
2826483|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2826484|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
2826485|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2826486|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288785|NCT00252304|Astringents|astringents|mesh-ancestor
2288786|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
2288787|NCT00252317|Captopril|captopril|mesh-list
2288788|NCT00252317|Trandolapril|trandolapril|mesh-list
2288789|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2288790|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
2288791|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288792|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288793|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2288794|NCT00252330|Amibegron|amibegron|mesh-list
2288795|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2288796|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2288797|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
2288798|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288799|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826487|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2826494|NCT04028778|Gefitinib|gefitinib|mesh-list
2826495|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826496|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2826497|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826498|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826499|NCT04028856|Interferons|interferons|mesh-list
2826500|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826501|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
2826502|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826503|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2826504|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2826505|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826506|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
2826507|NCT04028765|Misoprostol|misoprostol|mesh-list
2826508|NCT04028765|Oxytocin|oxytocin|mesh-list
2826509|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
2826510|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2826511|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826512|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2826513|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
2826514|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2826515|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2826516|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
2826517|NCT04028804|Fluorides|fluorides|mesh-list
2826518|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
2826519|NCT04028804|Protective Agents|protective agents|mesh-ancestor
2826520|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826521|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
2826522|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826523|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
2826524|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826525|NCT04028739|Curcumin|curcumin|mesh-list
2826526|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2826527|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2826528|NCT04028739|Analgesics|analgesics|mesh-ancestor
2826529|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
2826530|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826531|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826532|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2826533|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2826534|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826535|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826536|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826537|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
2826538|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2288800|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288801|NCT00252343|Amibegron|amibegron|mesh-list
2288802|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2288803|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2288804|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
2826539|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
2826540|NCT04029038|Fludarabine|fludarabine|mesh-list
2826541|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2826542|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
2826543|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826544|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2826545|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2826546|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
2826547|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826548|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826549|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2826550|NCT04028622|Anesthetics|anesthetics|mesh-list
2826551|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826552|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826553|NCT04028596|Acetaminophen|acetaminophen|mesh-list
2826554|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2826555|NCT04028596|Analgesics|analgesics|mesh-ancestor
2826556|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
2826557|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826558|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826559|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
2826560|NCT04028505|Terlipressin|terlipressin|mesh-list
2826561|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2826562|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2826563|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2826564|NCT04028518|Plasminogen|plasminogen|mesh-list
2826565|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2826566|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2826567|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826568|NCT04028245|Spartalizumab|spartalizumab|mesh-list
2826569|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2826570|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826571|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826572|NCT04028323|Octreotide|octreotide|mesh-list
2826573|NCT04028323|Terlipressin|terlipressin|mesh-list
2826574|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2826575|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2826576|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826577|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2826578|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2826579|NCT04028466|Omeprazole|omeprazole|mesh-list
2826580|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2288805|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288806|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288807|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288808|NCT00252356|Amibegron|amibegron|mesh-list
2288809|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2288810|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2288811|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
2288812|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288813|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288814|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288815|NCT00252369|Infliximab|infliximab|mesh-list
2288816|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2288817|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
2288818|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2288819|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2288820|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
2288821|NCT00252369|Coagulants|coagulants|mesh-ancestor
2288822|NCT00252408|Hormones|hormones|mesh-list
2288823|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2288824|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288825|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
2288826|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
2288827|NCT00252434|Methamphetamine|methamphetamine|mesh-list
2288828|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2288829|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288830|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
2288831|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
2288832|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288833|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
2288834|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288835|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288836|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
2826581|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2826582|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2826583|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826584|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826585|NCT04028141|Ketamine|ketamine|mesh-list
2826586|NCT04028141|Propofol|propofol|mesh-list
2826587|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2826588|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826589|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826590|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2826591|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
2826592|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
2826593|NCT04028141|Analgesics|analgesics|mesh-ancestor
2826594|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
2826595|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826596|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2826597|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2826598|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2826599|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826600|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826601|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
2826602|NCT04027972|Neostigmine|neostigmine|mesh-list
2826603|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2826604|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826605|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826606|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
2288837|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2288838|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2288839|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2288840|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2288841|NCT00252603|Galantamine|galantamine|mesh-list
2288842|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2288843|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288844|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288845|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
2826607|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826608|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826609|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2826610|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
2826611|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826612|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2826613|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2826614|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2826622|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
2826623|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2826624|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826625|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826626|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2826627|NCT04027829|Analgesics|analgesics|mesh-ancestor
2826628|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
2826629|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826630|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2826631|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2826632|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2826633|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
2826634|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826635|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826636|NCT04027764|Paclitaxel|paclitaxel|mesh-list
2826637|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2826638|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826639|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
2288846|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288847|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288848|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2288849|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
2288850|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288851|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
2288852|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2288853|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
2288854|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2288855|NCT00252655|Sirolimus|sirolimus|mesh-list
2288856|NCT00252655|Tacrolimus|tacrolimus|mesh-list
2288857|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2288858|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
2288859|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826640|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
2826641|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
2288860|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2288861|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288862|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288863|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2288864|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2288865|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2288866|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288867|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
2288868|NCT00252668|Etanercept|etanercept|mesh-list
2288869|NCT00252668|Methotrexate|methotrexate|mesh-list
2288870|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2288871|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
2288872|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2826642|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826643|NCT04027751|Tropisetron|tropisetron|mesh-list
2826644|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
2826645|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
2826646|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826647|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826648|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2826649|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2826650|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2826651|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
2826652|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826653|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826654|NCT04028024|Urinastatin|urinastatin|mesh-list
2826655|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2826656|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2826657|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
2826658|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826659|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826660|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
2826661|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
2826662|NCT04027959|Vitamins|vitamins|mesh-ancestor
2826663|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
2826664|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826665|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
2826666|NCT04027959|Hematinics|hematinics|mesh-ancestor
2826667|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
2826668|NCT04027517|Hematinics|hematinics|mesh-ancestor
2826669|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
2826670|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2826671|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826672|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2826673|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826674|NCT04027361|Amphetamine|amphetamine|mesh-list
2826675|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2826676|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826677|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
2826678|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
2826679|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826680|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
2826681|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826682|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826683|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
2826684|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2826685|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2826686|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2826687|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2826688|NCT04027894|Rifamycins|rifamycins|mesh-list
2826689|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
2826690|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2826691|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826692|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2826693|NCT04027322|Dexamethasone|dexamethasone|mesh-list
2826694|NCT04027322|Budesonide|budesonide|mesh-list
2826695|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2826696|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
2826697|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
2826698|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826699|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826700|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2826701|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
2826702|NCT04027322|Hormones|hormones|mesh-ancestor
2826703|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2826704|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2826705|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826706|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2826707|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2826708|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
2826709|NCT04027309|Midostaurin|midostaurin|mesh-list
2826710|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826711|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2826712|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826713|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826714|NCT04027192|Midazolam|midazolam|mesh-list
2826715|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2826716|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2826717|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826718|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826719|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2826720|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2826721|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2826722|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2826723|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
2826724|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
2826725|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
2826726|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
2826727|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826728|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826729|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
2826730|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2826731|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2826732|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826733|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
2826734|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
2826735|NCT04026984|Rifamycins|rifamycins|mesh-list
2826736|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
2826737|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2826738|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826739|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2826740|NCT04026958|Clarithromycin|clarithromycin|mesh-list
2826741|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2826742|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826743|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2826744|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826745|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826746|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2826747|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2826748|NCT04027166|Methadone|methadone|mesh-list
2826749|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2826750|NCT04027166|Narcotics|narcotics|mesh-ancestor
2288873|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288874|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2288875|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
2288876|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288877|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288878|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
2288879|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288880|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2288881|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2288882|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
2288883|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2288884|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2288885|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2288886|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2288887|NCT00252668|Analgesics|analgesics|mesh-ancestor
2288888|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
2288889|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288890|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2288891|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2288892|NCT00252707|Docetaxel|docetaxel|mesh-list
2288893|NCT00252707|Gefitinib|gefitinib|mesh-list
2288894|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288895|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
2288896|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
2288897|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
2288898|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288899|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2288900|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288901|NCT00252785|Budesonide|budesonide|mesh-list
2288902|NCT00252785|Theophylline|theophylline|mesh-list
2288903|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
2288904|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2288905|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2288906|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
2288907|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288908|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288909|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2288910|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
2288911|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
2288912|NCT00252785|Hormones|hormones|mesh-ancestor
2288913|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2826751|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826752|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826753|NCT04027166|Analgesics|analgesics|mesh-ancestor
2826754|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
2826755|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288914|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2288915|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2288916|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2288917|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
2288918|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288919|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288920|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2826756|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
2826757|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
2826758|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
2826759|NCT04026880|Testosterone|testosterone|mesh-list
2826760|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
2826761|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
2826762|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2826763|NCT04026880|Androgens|androgens|mesh-ancestor
2826764|NCT04026880|Hormones|hormones|mesh-ancestor
2826765|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2826766|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826767|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2826768|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826769|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
2288921|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288922|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
2826770|NCT04027283|Erythritol|erythritol|mesh-list
2288923|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2288924|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2288925|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
2288926|NCT00252798|Paclitaxel|paclitaxel|mesh-list
2288927|NCT00252798|Carboplatin|carboplatin|mesh-list
2826771|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
2826772|NCT04026841|Antibodies|antibodies|mesh-list
2826773|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
2826774|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826775|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
2288928|NCT00252798|Gefitinib|gefitinib|mesh-list
2288929|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2288930|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288931|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
2288932|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
2288933|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
2288934|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288935|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2288936|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288937|NCT00252811|Gefitinib|gefitinib|mesh-list
2826776|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2826777|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2826778|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826779|NCT04026776|Allopurinol|allopurinol|mesh-list
2826780|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
2826781|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826782|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826783|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
2826784|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2826785|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2826786|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
2826787|NCT04026776|Protective Agents|protective agents|mesh-ancestor
2826788|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288938|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2288939|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2288940|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288941|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288942|NCT00252824|Budesonide|budesonide|mesh-list
2288943|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
2288944|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2288945|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2826789|NCT04026685|Phenylephrine|phenylephrine|mesh-list
2826790|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
2826791|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2826792|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
2826793|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
2826794|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826795|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826796|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
2826797|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2826798|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
2826799|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
2826800|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2826801|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2826802|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2826803|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
2826804|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826805|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826806|NCT04026685|Protective Agents|protective agents|mesh-ancestor
2826807|NCT04026451|Propofol|propofol|mesh-list
2826808|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2826809|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826810|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826811|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2826812|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
2826813|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
2288946|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
2288947|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288948|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288949|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2826814|NCT04026464|Acetaminophen|acetaminophen|mesh-list
2826815|NCT04026464|Ibuprofen|ibuprofen|mesh-list
2826816|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2826817|NCT04026464|Analgesics|analgesics|mesh-ancestor
2826818|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
2826819|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826820|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826821|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
2826822|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2826823|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2826824|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2826825|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2826826|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826827|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826828|NCT04026074|Clonidine|clonidine|mesh-list
2826829|NCT04026074|Fentanyl|fentanyl|mesh-list
2826830|NCT04026074|Remifentanil|remifentanil|mesh-list
2826831|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2826832|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2826833|NCT04026074|Narcotics|narcotics|mesh-ancestor
2826834|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2288950|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
2288951|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
2288952|NCT00252824|Hormones|hormones|mesh-ancestor
2288953|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2288954|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2288955|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2826835|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826836|NCT04026074|Analgesics|analgesics|mesh-ancestor
2826837|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
2826838|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826839|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2826840|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2826841|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
2826842|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
2826843|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2826844|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
2288956|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2288957|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
2288958|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288959|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288960|NCT00252863|Fluticasone|fluticasone|mesh-list
2288961|NCT00252863|Xhance|xhance|mesh-list
2288962|NCT00252863|Budesonide|budesonide|mesh-list
2288963|NCT00252863|Theophylline|theophylline|mesh-list
2288964|NCT00252863|Albuterol|albuterol|mesh-list
2288965|NCT00252863|Terbutaline|terbutaline|mesh-list
2288966|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
2288967|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2288968|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2288969|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2826845|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
2826846|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2826847|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2826848|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2826849|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
2826850|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826851|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826852|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
2826853|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2826854|NCT04026022|Fentanyl|fentanyl|mesh-list
2826855|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2826856|NCT04026022|Narcotics|narcotics|mesh-ancestor
2826857|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2826858|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826859|NCT04026022|Analgesics|analgesics|mesh-ancestor
2826860|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
2826861|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826862|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2826863|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2826864|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
2826865|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
2826866|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2288970|NCT00252863|Montelukast|montelukast|mesh-list
2288971|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2826867|NCT04026282|Hormones|hormones|mesh-ancestor
2826868|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2826869|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826870|NCT04026256|Denosumab|denosumab|mesh-list
2826871|NCT04026256|Teriparatide|teriparatide|mesh-list
2826872|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2826873|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826874|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2826875|NCT04026230|Atorvastatin|atorvastatin|mesh-list
2826876|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2826877|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2288972|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2288973|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
2288974|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2288975|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2288976|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2288977|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
2288978|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
2288979|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2288980|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
2288981|NCT00252863|Hormones|hormones|mesh-ancestor
2826878|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
2826879|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826880|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2826881|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2826882|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826887|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
2826888|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2826889|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2826890|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826891|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
2826892|NCT04025736|Coagulants|coagulants|mesh-ancestor
2826893|NCT04025671|Naloxone|naloxone|mesh-list
2826894|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2826895|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826896|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
2826897|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826898|NCT04025775|Insulin|insulin|mesh-list
2826899|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2826900|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826901|NCT04025840|Dexamethasone|dexamethasone|mesh-list
2826902|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
2826903|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2826904|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
2826905|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
2826906|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826907|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826908|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2826909|NCT04025840|Hormones|hormones|mesh-ancestor
2826910|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2826911|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2826912|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826913|NCT04025918|Phenylephrine|phenylephrine|mesh-list
2826914|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
2826915|NCT04025918|Ephedrine|ephedrine|mesh-list
2826916|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2826917|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2826918|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
2826919|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
2826920|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826921|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826922|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
2826923|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
2826924|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
2826925|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2826926|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2826927|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2826928|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
2826929|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826930|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826931|NCT04025918|Protective Agents|protective agents|mesh-ancestor
2483653|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826932|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2826933|NCT04025567|Vancomycin|vancomycin|mesh-list
2826934|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2826935|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2826936|NCT04025593|Prednisone|prednisone|mesh-list
2826937|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
2826938|NCT04025593|Rituximab|rituximab|mesh-list
2826939|NCT04025593|Doxorubicin|doxorubicin|mesh-list
2826940|NCT04025593|Vincristine|vincristine|mesh-list
2826941|NCT04025593|Lenalidomide|lenalidomide|mesh-list
2288982|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2288983|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2288984|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2288985|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2288986|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
2288987|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2288988|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2288989|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
2288990|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2288991|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2288992|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
2288993|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2288994|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2288995|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2288996|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2288997|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
2826942|NCT04025593|Decitabine|decitabine|mesh-list
2826943|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2826944|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
2826945|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826946|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2826947|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2826948|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
2826949|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826950|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826951|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2826952|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2826953|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2826954|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2826955|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2826956|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2826957|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2826958|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
2826959|NCT04025593|Hormones|hormones|mesh-ancestor
2826960|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2826961|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2288998|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2288999|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2289000|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
2289001|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
2289002|NCT00252889|Doxorubicin|doxorubicin|mesh-list
2289003|NCT00252889|Topotecan|topotecan|mesh-list
2289004|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
2289005|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2289006|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289007|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2289008|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2289009|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289010|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289011|NCT00252928|Troclosene|troclosene|mesh-list
2289012|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
2289013|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2289014|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
2289015|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
2289016|NCT00252954|Levetiracetam|levetiracetam|mesh-list
2289017|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
2289018|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
2289019|NCT00253058|Cetirizine|cetirizine|mesh-list
2289020|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2289021|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2289022|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2289023|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
2826962|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2826963|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
2826964|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
2826965|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
2826966|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2826967|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2826968|NCT04025593|Growth Substances|growth substances|mesh-ancestor
2826969|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
2826970|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2826971|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
2826972|NCT04025372|Bicalutamide|bicalutamide|mesh-list
2826973|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
2826974|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
2826975|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2826976|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826977|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2826978|NCT04025359|Dronabinol|dronabinol|mesh-list
2826979|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
2826980|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2826981|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2826982|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2826983|NCT04025359|Analgesics|analgesics|mesh-ancestor
2826984|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
2826985|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2826986|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2289024|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
2289025|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289026|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289027|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289028|NCT00253110|Haloperidol|haloperidol|mesh-list
2826987|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2826988|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2826989|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2826990|NCT04025359|Hormones|hormones|mesh-ancestor
2826991|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2826992|NCT04025203|Ibuprofen|ibuprofen|mesh-list
2826993|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
2826994|NCT04025203|Gabapentin|gabapentin|mesh-list
2826995|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2826996|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2826997|NCT04025203|Analgesics|analgesics|mesh-ancestor
2826998|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
2826999|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827000|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827001|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2827002|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2827003|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2827004|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827005|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827006|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
2827007|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2827008|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2827009|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2827010|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2827011|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2827012|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2827013|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827014|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
2827015|NCT04025177|Indomethacin|indomethacin|mesh-list
2827016|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2827017|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2827018|NCT04025177|Analgesics|analgesics|mesh-ancestor
2827019|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
2827020|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827021|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827022|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2827023|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2827024|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
2827025|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
2827026|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2827027|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2827028|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827029|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827030|NCT04025489|Vitamin D|vitamin d|mesh-list
2827031|NCT04025489|Vitamins|vitamins|mesh-ancestor
2827032|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
2827033|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827034|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2827035|NCT04025060|Caffeine|caffeine|mesh-list
2827036|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2827037|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827038|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2827039|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827040|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827041|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2827042|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2827043|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
2827044|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827045|NCT04024683|Ropivacaine|ropivacaine|mesh-list
2827046|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
2827047|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
2827048|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2827049|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827050|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
2827051|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827063|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
2827064|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2827065|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289029|NCT00253110|Risperidone|risperidone|mesh-list
2289030|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
2289031|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2289032|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
2289033|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289034|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289035|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289036|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289037|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289038|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289039|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289040|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2289041|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
2289042|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
2289043|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
2289044|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289045|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2289046|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2289047|NCT00253123|Risperidone|risperidone|mesh-list
2289048|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2289049|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
2289050|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289051|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289052|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289053|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289054|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289055|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2827066|NCT04024696|Abexinostat|abexinostat|mesh-list
2827067|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2827068|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827069|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827070|NCT04024865|Domperidone|domperidone|mesh-list
2827071|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
2827072|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
2827073|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827074|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827075|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2827076|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2827077|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
2827078|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827079|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827080|NCT04024813|Seladelpar|seladelpar|mesh-list
2827081|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2827082|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
2827083|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827084|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2827085|NCT04024527|Amoxicillin|amoxicillin|mesh-list
2827086|NCT04024527|Metronidazole|metronidazole|mesh-list
2827087|NCT04024527|Esomeprazole|esomeprazole|mesh-list
2827088|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2827089|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827090|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2827091|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2827092|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2827093|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2827094|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2289056|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289057|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2289058|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
2289059|NCT00253136|Risperidone|risperidone|mesh-list
2289060|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2289061|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
2289062|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827095|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827096|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827097|NCT04024878|Nivolumab|nivolumab|mesh-list
2827098|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2827099|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827100|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2827101|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827102|NCT04024891|Phentolamine|phentolamine|mesh-list
2827103|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2827104|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2827105|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2827106|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2827107|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
2827108|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827109|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827110|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827111|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2827112|NCT04024254|Folic Acid|folic acid|mesh-list
2827113|NCT04024254|Hematinics|hematinics|mesh-ancestor
2827114|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
2827115|NCT04024254|Vitamins|vitamins|mesh-ancestor
2827116|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
2827117|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827118|NCT04024384|Daratumumab|daratumumab|mesh-list
2827119|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827120|NCT04024241|Cytarabine|cytarabine|mesh-list
2827121|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
2827122|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2827123|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
2827124|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827125|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827126|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
2827127|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827128|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2827129|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
2289063|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827130|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827131|NCT04024241|Analgesics|analgesics|mesh-ancestor
2105634|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2105635|NCT02457611|Ledipasvir|ledipasvir|mesh-list
2105636|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
2105637|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105638|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
2289064|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289065|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289066|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289067|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289068|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289069|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2289070|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
2289071|NCT00253149|Risperidone|risperidone|mesh-list
2289072|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2289073|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
2289074|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289075|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289076|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289077|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289078|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289079|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289080|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2827132|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
2827133|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827134|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2827135|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2827136|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827137|NCT04024163|Benzonidazole|benzonidazole|mesh-list
2827138|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2827139|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
2827140|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827141|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2105639|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105640|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2105641|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105642|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105643|NCT02458235|Azacitidine|azacitidine|mesh-list
2105644|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2105645|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
2105646|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105647|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105648|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105649|NCT02458287|Bococizumab|bococizumab|mesh-list
2105650|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2105651|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2105652|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
2105653|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105654|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2105655|NCT02458469|Buspirone|buspirone|mesh-list
2105656|NCT02458469|Trazodone|trazodone|mesh-list
2105657|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2827142|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2827143|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2827144|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827145|NCT04024436|Fulvestrant|fulvestrant|mesh-list
2827146|NCT04024436|Futibatinib|futibatinib|mesh-list
2827147|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2827148|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827149|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2827150|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2827151|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
2289081|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2289082|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
2289083|NCT00253162|Risperidone|risperidone|mesh-list
2289084|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2289085|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
2289086|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827152|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2827153|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827154|NCT04024072|Brinzolamide|brinzolamide|mesh-list
2827155|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2827156|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827157|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827158|NCT04023760|Apixaban|apixaban|mesh-list
2827159|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2289087|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289088|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289089|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289090|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289091|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289092|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289093|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2289094|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
2289095|NCT00253175|Topiramate|topiramate|mesh-list
2289096|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
2289097|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2289098|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289099|NCT00253188|Galantamine|galantamine|mesh-list
2289100|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2289101|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289102|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289103|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
2289104|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289105|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289106|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2289107|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
2289108|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289109|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
2289110|NCT00253201|Galantamine|galantamine|mesh-list
2827160|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
2827161|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2827162|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
2827163|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827164|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827165|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
2827166|NCT04023669|Gemcitabine|gemcitabine|mesh-list
2827167|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
2827168|NCT04023669|Lenograstim|lenograstim|mesh-list
2827169|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2827170|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
2827171|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827172|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2827173|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2827174|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
2827175|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827176|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827177|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2827178|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2827179|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
2827180|NCT04023669|Antiviral Agents|antiviral agents|mesh-ancestor
2827181|NCT04023669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827182|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827183|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2827184|NCT04023565|Perindopril|perindopril|mesh-list
2827185|NCT04023565|Moxonidine|moxonidine|mesh-list
2827186|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2827187|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
2827188|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827189|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827190|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2827191|NCT04023617|Docetaxel|docetaxel|mesh-list
2289111|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2289112|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289113|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289114|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
2289115|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289116|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289117|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2289118|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
2289119|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289120|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
2289121|NCT00253214|Galantamine|galantamine|mesh-list
2289122|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2289123|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289124|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289125|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
2827192|NCT04023617|Nivolumab|nivolumab|mesh-list
2827193|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289126|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289127|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289128|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2289129|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
2289130|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289131|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
2289132|NCT00253227|Galantamine|galantamine|mesh-list
2289133|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2289134|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289135|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827194|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
2827195|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
2827196|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
2827197|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827198|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2827199|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2827200|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
2827201|NCT04023630|Clopidogrel|clopidogrel|mesh-list
2827202|NCT04023630|Ticagrelor|ticagrelor|mesh-list
2827203|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2827204|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2827205|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2827206|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2827207|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
2827208|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827209|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827210|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827211|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2827212|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
2827213|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2827214|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
2827215|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827216|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
2827217|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
2827218|NCT04023253|Mirabegron|mirabegron|mesh-list
2827219|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2827220|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2827221|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
2827222|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827223|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827224|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827225|NCT04023253|Urological Agents|urological agents|mesh-ancestor
2827226|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2827227|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2827228|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2827229|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
2827230|NCT04023149|Aldesleukin|aldesleukin|mesh-list
2827231|NCT04023149|Interleukin-2|interleukin-2|mesh-list
2827232|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827233|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2827234|NCT04023149|Analgesics|analgesics|mesh-ancestor
2827235|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
2827236|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827237|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827238|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2827239|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2827240|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
2827241|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827242|NCT04023331|Copper|copper|mesh-list
2827243|NCT04023331|Trace Elements|trace elements|mesh-ancestor
2827244|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
2827245|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827246|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
2827247|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2827248|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827249|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
2827250|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2827251|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
2827252|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827253|NCT04023266|Expectorants|expectorants|mesh-ancestor
2827254|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
2827255|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2827256|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
2827257|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827258|NCT04023266|Protective Agents|protective agents|mesh-ancestor
2827259|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827260|NCT04023266|Antidotes|antidotes|mesh-ancestor
2827261|NCT04023292|Tamoxifen|tamoxifen|mesh-list
2827262|NCT04023292|Letrozole|letrozole|mesh-list
2827263|NCT04023292|Exemestane|exemestane|mesh-list
2827264|NCT04023292|Anastrozole|anastrozole|mesh-list
2827265|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827266|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2289136|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
2289137|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289138|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289139|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2289140|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
2289141|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289142|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
2827267|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2827268|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827269|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827270|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2827271|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
2827272|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2827273|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827274|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2827275|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2827276|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2827277|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2289143|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2289144|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2289145|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
2289146|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289147|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289148|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289149|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289150|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289151|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2289152|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2289153|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2827278|NCT04023305|Sevoflurane|sevoflurane|mesh-list
2827279|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2827280|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2827281|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
2827282|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
2827283|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2827284|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827285|NCT04023110|Carvedilol|carvedilol|mesh-list
2827286|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2827287|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2827288|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
2289154|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289155|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289156|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2289157|NCT00253305|Terbinafine|terbinafine|mesh-list
2289158|NCT00253305|Naftifine|naftifine|mesh-list
2289159|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
2289160|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2289161|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289162|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827289|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827290|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827291|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827292|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2827293|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
2827294|NCT04023110|Protective Agents|protective agents|mesh-ancestor
2827295|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2827296|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2827297|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2827298|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
2827299|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2827300|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2289163|NCT00253318|Dexamethasone|dexamethasone|mesh-list
2289164|NCT00253318|Docetaxel|docetaxel|mesh-list
2289165|NCT00253318|Everolimus|everolimus|mesh-list
2289166|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2289167|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
2289168|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
2289169|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289170|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289171|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2289172|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
2289173|NCT00253318|Hormones|hormones|mesh-ancestor
2289174|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2827315|NCT04022837|Pantoprazole|pantoprazole|mesh-list
2827316|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2827317|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2827318|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2827319|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827320|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289175|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2289176|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289177|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
2289178|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
2289179|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
2289180|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289181|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2289182|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
2289183|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
2289184|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
2827321|NCT04023019|Thrombin|thrombin|mesh-list
2827322|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
2827323|NCT04023019|Coagulants|coagulants|mesh-ancestor
2827324|NCT04022811|Tobramycin|tobramycin|mesh-list
2827325|NCT04022811|Dexamethasone|dexamethasone|mesh-list
2827326|NCT04022811|Bromfenac|bromfenac|mesh-list
2827327|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
2827328|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2827329|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
2827330|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
2827331|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827332|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827333|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2827334|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
2827335|NCT04022811|Hormones|hormones|mesh-ancestor
2827336|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2827337|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2827338|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827339|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2827340|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
2827341|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
2827342|NCT04022811|Protective Agents|protective agents|mesh-ancestor
2827343|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2827344|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827345|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2827346|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2827347|NCT04022811|Analgesics|analgesics|mesh-ancestor
2827348|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
2827349|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2827350|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
2827351|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
2827352|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827353|NCT04022876|Carboplatin|carboplatin|mesh-list
2827354|NCT04022876|Pemetrexed|pemetrexed|mesh-list
2827355|NCT04022876|Topotecan|topotecan|mesh-list
2827356|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289185|NCT00253344|Docetaxel|docetaxel|mesh-list
2289186|NCT00253344|Lenalidomide|lenalidomide|mesh-list
2289187|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289188|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
2289189|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
2289190|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
2289191|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289192|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
2289193|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289194|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2289195|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2289196|NCT00253344|Growth Substances|growth substances|mesh-ancestor
2289197|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
2289198|NCT00253396|Heparin|heparin|mesh-list
2289199|NCT00253396|Enoxaparin|enoxaparin|mesh-list
2289200|NCT00253396|Calcium heparin|calcium heparin|mesh-list
2289201|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
2289202|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2289203|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2289204|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827357|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827358|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827359|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2289205|NCT00253422|Fulvestrant|fulvestrant|mesh-list
2827360|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2827361|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2827362|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2827363|NCT04022785|Azacitidine|azacitidine|mesh-list
2827364|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2827365|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
2827366|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827367|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827368|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827369|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
2827370|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2827371|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2827372|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827373|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
2289206|NCT00253422|Anastrozole|anastrozole|mesh-list
2289207|NCT00253422|Exemestane|exemestane|mesh-list
2289208|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2289209|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289210|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2289211|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2289212|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
2827374|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2827375|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827376|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2827377|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
2827378|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2827379|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
2827380|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827381|NCT04022525|Leflunomide|leflunomide|mesh-list
2827382|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827383|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827384|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2289213|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2289214|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289215|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2289216|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2289217|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289218|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289219|NCT00253461|Topotecan|topotecan|mesh-list
2289220|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2289221|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2289222|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2289223|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289224|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289225|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289226|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2289227|NCT00253474|Interferons|interferons|mesh-list
2289228|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
2289229|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
2289230|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2827385|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
2827386|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827387|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
2289231|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289232|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
2289233|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827388|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2827389|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
2827390|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827391|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827392|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2827393|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
2827394|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2827395|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
2827396|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827397|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827398|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2827399|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
2827400|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
2827401|NCT04022161|Protective Agents|protective agents|mesh-ancestor
2827402|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
2827403|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
2827404|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2827405|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2827406|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827407|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827408|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827409|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2289234|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
2289235|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289236|NCT00253487|Temozolomide|temozolomide|mesh-list
2827410|NCT04022096|Lansoprazole|lansoprazole|mesh-list
2827411|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
2827412|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2827413|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2827414|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2827415|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827416|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827417|NCT04022291|Insulin|insulin|mesh-list
2827418|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2827419|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2827420|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827421|NCT04022317|Insulin|insulin|mesh-list
2827422|NCT04022317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2827423|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2827424|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827425|NCT04022200|Paclitaxel|paclitaxel|mesh-list
2827426|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2827427|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827428|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
2827429|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
2827430|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
2827431|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827432|NCT04022226|Ketamine|ketamine|mesh-list
2827433|NCT04022226|Methohexital|methohexital|mesh-list
2827434|NCT04022226|Analgesics|analgesics|mesh-ancestor
2827435|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
2827436|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827437|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827438|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2827439|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2289237|NCT00253487|Busulfan|busulfan|mesh-list
2289238|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2289239|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2289240|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
2289241|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289242|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289243|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2827440|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
2827441|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
2827442|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2827443|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2827444|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2827445|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827446|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827447|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
2827448|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
2827449|NCT04022239|Melphalan|melphalan|mesh-list
2827450|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2827451|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
2827452|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2827453|NCT04022239|Rituximab|rituximab|mesh-list
2827454|NCT04022239|Fludarabine|fludarabine|mesh-list
2827455|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2827456|NCT04022239|Tacrolimus|tacrolimus|mesh-list
2827457|NCT04022239|Antibodies|antibodies|mesh-list
2827458|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
2827459|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2827460|NCT04022239|Lenograstim|lenograstim|mesh-list
2827461|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2827462|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
2827463|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827464|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2827465|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2827466|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
2827467|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827468|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827469|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2827470|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2827471|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2827472|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827473|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2827474|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2827475|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
2827476|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2827477|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827478|NCT04022135|Folic Acid|folic acid|mesh-list
2105658|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2105659|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105660|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105661|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2105662|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2105663|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
2105664|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105665|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105666|NCT02458469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2105667|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2105668|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2105669|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2105670|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
2105671|NCT02458638|Atezolizumab|atezolizumab|mesh-list
2105672|NCT02458638|Antibodies|antibodies|mesh-list
2827479|NCT04022135|Hematinics|hematinics|mesh-ancestor
2827480|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
2827481|NCT04022135|Vitamins|vitamins|mesh-ancestor
2827482|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
2827483|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827484|NCT04021992|Gemcitabine|gemcitabine|mesh-list
2827485|NCT04021992|Rituximab|rituximab|mesh-list
2827486|NCT04021992|Doxorubicin|doxorubicin|mesh-list
2827487|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2827488|NCT04021992|Vinorelbine|vinorelbine|mesh-list
2827489|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2827490|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827491|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
2827492|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827493|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2827494|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2827495|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
2827496|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827497|NCT04021992|Antiviral Agents|antiviral agents|mesh-ancestor
2827498|NCT04021992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827499|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827500|NCT04021992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2105673|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
2105674|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105675|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105676|NCT02458690|Dopamine|dopamine|mesh-list
2105677|NCT02458690|Norepinephrine|norepinephrine|mesh-list
2105678|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
2105679|NCT02458690|Serotonin|serotonin|mesh-list
2105680|NCT02458690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2105681|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
2105682|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2105683|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2105684|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
2105685|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105686|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105687|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105688|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
2105689|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
2105690|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105691|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2105692|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2105693|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2105694|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
2105695|NCT02458690|Protective Agents|protective agents|mesh-ancestor
2289244|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
2289245|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289246|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2289247|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289248|NCT00253500|Epirubicin|epirubicin|mesh-list
2289249|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2289250|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289251|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2289252|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2289253|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827501|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2105696|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2483654|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2827502|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2289254|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289255|NCT00253526|Gemcitabine|gemcitabine|mesh-list
2289256|NCT00253526|Bevacizumab|bevacizumab|mesh-list
2289257|NCT00253526|Antibodies|antibodies|mesh-list
2289258|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
2289259|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2827503|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2827504|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2827505|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
2827506|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
2827507|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
2827508|NCT04022005|Gemcitabine|gemcitabine|mesh-list
2827509|NCT04022005|Rituximab|rituximab|mesh-list
2827510|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
2827511|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2827512|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827513|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
2827514|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827515|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2827516|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2827517|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
2827518|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827519|NCT04022005|Antiviral Agents|antiviral agents|mesh-ancestor
2827520|NCT04022005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827521|NCT04022005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827522|NCT04022005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2827523|NCT04022057|Ropivacaine|ropivacaine|mesh-list
2827524|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
2827525|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
2827526|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289260|NCT00253526|Mitogens|mitogens|mesh-list
2289261|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2289262|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289263|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2289264|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2289265|NCT00253526|Growth Substances|growth substances|mesh-ancestor
2289266|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289267|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
2289268|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
2827527|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827528|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
2827529|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827530|NCT04021862|Antibodies|antibodies|mesh-list
2827531|NCT04021862|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2827532|NCT04021862|Immunologic Factors|immunologic factors|mesh-ancestor
2827533|NCT04021862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827534|NCT04021498|Simvastatin|simvastatin|mesh-list
2827535|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2827536|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2827537|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
2827538|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827539|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2827540|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2827541|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827542|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
2827543|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2827544|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2827545|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2827546|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827547|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
2827548|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
2827549|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
2827550|NCT04021550|Telmisartan|telmisartan|mesh-list
2827551|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2827552|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2827553|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2289269|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2289270|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
2289271|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289272|NCT00253526|Antiviral Agents|antiviral agents|mesh-ancestor
2289273|NCT00253526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2289274|NCT00253526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827554|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289275|NCT00253526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2289276|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
2289277|NCT00253539|Tamoxifen|tamoxifen|mesh-list
2289278|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2289279|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
2289280|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2827555|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
2827556|NCT04021550|Protective Agents|protective agents|mesh-ancestor
2827557|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827558|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
2827559|NCT04021550|Vitamins|vitamins|mesh-ancestor
2827560|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
2827561|NCT04021433|Ketamine|ketamine|mesh-list
2827562|NCT04021433|Analgesics|analgesics|mesh-ancestor
2827563|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
2827564|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289281|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289282|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2289283|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289284|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2289285|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2289286|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2289287|NCT00253552|Cyclosporine|cyclosporine|mesh-list
2289288|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
2289289|NCT00253552|Busulfan|busulfan|mesh-list
2827565|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827566|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2827567|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2827568|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
2827569|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
2827570|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2827571|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2827572|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2827573|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827574|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289290|NCT00253552|Methotrexate|methotrexate|mesh-list
2289291|NCT00253552|Etoposide|etoposide|mesh-list
2289292|NCT00253552|Cyclosporins|cyclosporins|mesh-list
2289293|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2289294|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
2289295|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289296|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2289297|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2289298|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
2289299|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289300|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289301|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2289302|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2827575|NCT04021420|Nivolumab|nivolumab|mesh-list
2827576|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2827577|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827578|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2827579|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827580|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2827581|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2827582|NCT04021264|Sufentanil|sufentanil|mesh-list
2827583|NCT04021264|Ropivacaine|ropivacaine|mesh-list
2289303|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
2289304|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2289305|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2289306|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
2289307|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
2289308|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289309|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2289310|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2289311|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2289312|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2289313|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2289314|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
2289315|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2289316|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2289317|NCT00253565|Capecitabine|capecitabine|mesh-list
2289318|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
2289319|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2289320|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
2289321|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289322|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289323|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2289324|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289325|NCT00253578|Sorafenib|sorafenib|mesh-list
2289326|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289327|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2289328|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289329|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289330|NCT00253591|Vinorelbine|vinorelbine|mesh-list
2289331|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827584|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
2827585|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
2827586|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2827587|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827588|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
2827589|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289332|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2289333|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
2289334|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
2289335|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
2289336|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289337|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2289338|NCT00253617|Trioxsalen|trioxsalen|mesh-list
2289339|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289340|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
2289341|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2289342|NCT00253721|Melphalan|melphalan|mesh-list
2289343|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2289344|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
2289345|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289346|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289347|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2289348|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2289349|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
2289350|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289351|NCT00253773|Acetaminophen|acetaminophen|mesh-list
2289352|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2827590|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2827591|NCT04021264|Narcotics|narcotics|mesh-ancestor
2827592|NCT04021264|Analgesics|analgesics|mesh-ancestor
2827593|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2827594|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2289353|NCT00253773|Analgesics|analgesics|mesh-ancestor
2289354|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
2289355|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289356|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289357|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
2289358|NCT00253799|Hylan|hylan|mesh-list
2289359|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
2289360|NCT00253799|Protective Agents|protective agents|mesh-ancestor
2289361|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289362|NCT00253851|Heparin|heparin|mesh-list
2289363|NCT00253851|Calcium heparin|calcium heparin|mesh-list
2827595|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
2827596|NCT04021108|Nivolumab|nivolumab|mesh-list
2827597|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2827598|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827599|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2827600|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827601|NCT04020913|Hormones|hormones|mesh-list
2827602|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2827603|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827604|NCT04021121|Linezolid|linezolid|mesh-list
2827605|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2827606|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827607|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2827608|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827609|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827610|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2827611|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2827612|NCT04021017|Estradiol|estradiol|mesh-list
2827613|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2827614|NCT04021017|Estrogens|estrogens|mesh-ancestor
2827615|NCT04021017|Hormones|hormones|mesh-ancestor
2827616|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2827617|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827618|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2827619|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
2827620|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2827621|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2827622|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
2827623|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2827624|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2827625|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827626|NCT04020718|Nicotine|nicotine|mesh-list
2827627|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2827628|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
2827629|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827630|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827631|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2827632|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2105697|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
2105698|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2105699|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2105700|NCT02458768|Menotropins|menotropins|mesh-list
2105701|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2827633|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
2827634|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827635|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827636|NCT04020666|Kallikreins|kallikreins|mesh-list
2827637|NCT04020666|Coagulants|coagulants|mesh-ancestor
2827638|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
2827639|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
2827640|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2827641|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827642|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
2827643|NCT04020653|Lumefantrine|lumefantrine|mesh-list
2827644|NCT04020653|Artemether|artemether|mesh-list
2827645|NCT04020653|Artemisinins|artemisinins|mesh-list
2827646|NCT04020653|Artemisinin|artemisinin|mesh-list
2827647|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2827648|NCT04020653|Citric Acid|citric acid|mesh-list
2827649|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
2827650|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
2827651|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2827652|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
2827653|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
2827654|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827655|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
2827656|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2827657|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2105702|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
2289364|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
2289365|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2827658|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827659|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2827660|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
2827661|NCT04020653|Trace Elements|trace elements|mesh-ancestor
2827662|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
2827663|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827664|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2827665|NCT04021043|Nivolumab|nivolumab|mesh-list
2827666|NCT04021043|Ipilimumab|ipilimumab|mesh-list
2827667|NCT04021043|Antibodies|antibodies|mesh-list
2827668|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
2827669|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2827670|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
2827671|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827672|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827673|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2827674|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827677|NCT04020601|Ropivacaine|ropivacaine|mesh-list
2827678|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
2827679|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
2827680|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2827681|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827682|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
2827683|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827684|NCT04020848|Melatonin|melatonin|mesh-list
2827685|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
2827686|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827687|NCT04020848|Protective Agents|protective agents|mesh-ancestor
2827688|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827689|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289366|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2289367|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289368|NCT00253903|SR 46349B|sr 46349b|mesh-list
2289369|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2289370|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2289371|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289372|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2289373|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2289374|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
2289375|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289376|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827690|NCT04020588|Minocycline|minocycline|mesh-list
2827691|NCT04020588|Celecoxib|celecoxib|mesh-list
2827692|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2827693|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2827694|NCT04020588|Analgesics|analgesics|mesh-ancestor
2827695|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
2827696|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827697|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827698|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2827699|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2827700|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2827701|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2827702|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827703|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827704|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2827705|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827706|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2827707|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2827708|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2827709|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
2827710|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2827711|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827712|NCT04020380|Azithromycin|azithromycin|mesh-list
2105703|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2105704|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105705|NCT02459275|Metoclopramide|metoclopramide|mesh-list
2105706|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
2105707|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
2827713|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2827714|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827715|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2105708|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827716|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827717|NCT04020445|Insulin|insulin|mesh-list
2827718|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2827719|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827720|NCT04020328|Prednisone|prednisone|mesh-list
2827721|NCT04020328|Leflunomide|leflunomide|mesh-list
2827722|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2827723|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
2827724|NCT04020328|Hormones|hormones|mesh-ancestor
2827725|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2827726|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827727|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2827728|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827729|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827730|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827731|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2827732|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
2827733|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
2827734|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2827735|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827736|NCT04020341|Renal Agents|renal agents|mesh-ancestor
2827737|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2827738|NCT04020263|Simendan|simendan|mesh-list
2827739|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2827740|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
2827741|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2827742|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2827743|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827744|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827745|NCT04020263|Protective Agents|protective agents|mesh-ancestor
2827746|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827747|NCT04020094|Atezolizumab|atezolizumab|mesh-list
2827748|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827749|NCT04020016|Nalbuphine|nalbuphine|mesh-list
2827750|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2827751|NCT04020016|Narcotics|narcotics|mesh-ancestor
2827752|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2827753|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827754|NCT04020016|Analgesics|analgesics|mesh-ancestor
2827755|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
2289377|NCT00253929|Adenosine|adenosine|mesh-list
2289378|NCT00253929|Nitroprusside|nitroprusside|mesh-list
2289379|NCT00253929|Acetylcholine|acetylcholine|mesh-list
2289380|NCT00253929|Caffeine|caffeine|mesh-list
2289381|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2289382|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289383|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2289384|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289385|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289386|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2289387|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2289388|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
2827756|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289389|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289390|NCT00253929|Analgesics|analgesics|mesh-ancestor
2289391|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
2289392|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289393|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2289394|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
2289395|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2827757|NCT04020003|Simendan|simendan|mesh-list
2827758|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2827759|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
2827760|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2827761|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2827762|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827763|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827764|NCT04020003|Protective Agents|protective agents|mesh-ancestor
2827765|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827766|NCT04020172|Dobutamine|dobutamine|mesh-list
2827767|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2827768|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
2827769|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
2827770|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827771|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289396|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
2289397|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2289398|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2289399|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2289400|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
2289401|NCT00253955|Levofloxacin|levofloxacin|mesh-list
2289402|NCT00253955|Ofloxacin|ofloxacin|mesh-list
2289403|NCT00253955|Tazobactam|tazobactam|mesh-list
2289404|NCT00253955|Piperacillin|piperacillin|mesh-list
2289405|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2289406|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2289407|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2289408|NCT00253955|Renal Agents|renal agents|mesh-ancestor
2289409|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2289410|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2289411|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2289412|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289413|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289414|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289415|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2827772|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2827773|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2827774|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2827775|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
2827776|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827777|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827778|NCT04020172|Protective Agents|protective agents|mesh-ancestor
2827779|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2827780|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827781|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827782|NCT04020133|Epinephrine|epinephrine|mesh-list
2827783|NCT04020133|Bupivacaine|bupivacaine|mesh-list
2827784|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
2827785|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
2827786|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2827787|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827788|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
2827789|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827790|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2827791|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2827792|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
2827793|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827794|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827795|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2827796|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2827797|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
2827798|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2827799|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
2105709|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105710|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2105711|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2105712|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2105713|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
2105714|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105715|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105716|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2105717|NCT02459418|Hormones|hormones|mesh-ancestor
2105718|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2827800|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
2827801|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
2827802|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2827803|NCT04019873|Lamivudine|lamivudine|mesh-list
2827804|NCT04019873|Rilpivirine|rilpivirine|mesh-list
2827805|NCT04019873|Dolutegravir|dolutegravir|mesh-list
2827806|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2827807|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2827808|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827809|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827810|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
2827811|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827812|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2827813|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2827814|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2827815|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2827816|NCT04019964|Nivolumab|nivolumab|mesh-list
2827817|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2289416|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2289417|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2289418|NCT00253968|SR 46349B|sr 46349b|mesh-list
2827818|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827819|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2827820|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827828|NCT04019782|Hylan|hylan|mesh-list
2827829|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
2827830|NCT04019782|Protective Agents|protective agents|mesh-ancestor
2827831|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289419|NCT00253968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2289420|NCT00253968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2289421|NCT00253968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289422|NCT00253968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2289423|NCT00253968|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2289424|NCT00253968|Serotonin Agents|serotonin agents|mesh-ancestor
2827832|NCT04019496|Calcitonin|calcitonin|mesh-list
2827833|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
2827834|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2827835|NCT04019496|Antibodies|antibodies|mesh-list
2827836|NCT04019496|Katacalcin|katacalcin|mesh-list
2827837|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
2827838|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827839|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2827840|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2827841|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
2827842|NCT04019548|Cisplatin|cisplatin|mesh-list
2827843|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827844|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
2827845|NCT04019379|Calcium|calcium|mesh-list
2827846|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2827847|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827848|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2827849|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2827850|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
2827851|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827852|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
2827853|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2827854|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827855|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2827856|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2827857|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827858|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827859|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827860|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
2827861|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2827862|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2827863|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827864|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2827865|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2827866|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827867|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827868|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289425|NCT00253968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289426|NCT00253968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289427|NCT00254007|Citalopram|citalopram|mesh-list
2289428|NCT00254007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2289429|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2289430|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2289431|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289432|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289433|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
2289434|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289435|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2289436|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
2289437|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289438|NCT00254020|Citalopram|citalopram|mesh-list
2289439|NCT00254020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2827869|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2827870|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
2827871|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2827872|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827873|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2827874|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2827875|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2827881|NCT04018937|Fludarabine|fludarabine|mesh-list
2827882|NCT04018937|Melphalan|melphalan|mesh-list
2827883|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
2827884|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827885|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827886|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2827887|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
2827888|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827889|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2827890|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
2827891|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2827892|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2827893|NCT04019015|Thrombin|thrombin|mesh-list
2827894|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
2289440|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2289441|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2289442|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289443|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289444|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
2289445|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289446|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2289447|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
2289448|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289449|NCT00254033|Methylphenidate|methylphenidate|mesh-list
2289450|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
2289451|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2289452|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289453|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2289454|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2289455|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2289456|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289457|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
2289458|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289459|NCT00254046|Etravirine|etravirine|mesh-list
2289460|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2289461|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2289462|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289463|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289464|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
2289465|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2289466|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
2289467|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2289468|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289469|NCT00254137|Capecitabine|capecitabine|mesh-list
2289470|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
2289471|NCT00254137|Irinotecan|irinotecan|mesh-list
2289472|NCT00254137|Cetuximab|cetuximab|mesh-list
2289473|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2289474|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
2289475|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289476|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289477|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2289478|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2289479|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289480|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2289481|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
2289482|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2289483|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2289484|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
2289485|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2289486|NCT00254189|Estradiol|estradiol|mesh-list
2289487|NCT00254189|Estrogens|estrogens|mesh-ancestor
2289488|NCT00254189|Hormones|hormones|mesh-ancestor
2289489|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2289490|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289491|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2289492|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
2289493|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2289494|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2289495|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2289496|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2289497|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2289498|NCT00254202|Iloperidone|iloperidone|mesh-list
2289499|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289500|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289501|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289502|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289503|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289504|NCT00254241|Risperidone|risperidone|mesh-list
2827895|NCT04019015|Coagulants|coagulants|mesh-ancestor
2827896|NCT04019093|Ethanol|ethanol|mesh-list
2827897|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2827898|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827899|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2827900|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827901|NCT04019106|Budesonide|budesonide|mesh-list
2827902|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2827903|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2827904|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2827905|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
2827906|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827907|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827908|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2827909|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
2827910|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
2827911|NCT04019106|Hormones|hormones|mesh-ancestor
2827912|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2827913|NCT04018833|Ranibizumab|ranibizumab|mesh-list
2827914|NCT04018833|Aflibercept|aflibercept|mesh-list
2827915|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2827916|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2827917|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2827918|NCT04018833|Growth Substances|growth substances|mesh-ancestor
2827919|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827920|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
2827921|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2827922|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
2827923|NCT04018482|Povidone|povidone|mesh-list
2827924|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
2827925|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
2827926|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2827927|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827928|NCT04018612|Acetaminophen|acetaminophen|mesh-list
2827929|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2827930|NCT04018612|Analgesics|analgesics|mesh-ancestor
2827931|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
2827932|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289505|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2289506|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2827933|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289507|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
2289508|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289509|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289510|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289511|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2827934|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
2827935|NCT04018703|Midazolam|midazolam|mesh-list
2827936|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
2827937|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2827938|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2827939|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827940|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2827941|NCT04018703|Analgesics|analgesics|mesh-ancestor
2827942|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
2827943|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827944|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2827945|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2827946|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2827947|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
2827948|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2827949|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827950|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2827951|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2827952|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2827953|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2827954|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2827955|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
2289512|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289513|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289514|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289515|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2289516|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
2289517|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
2827956|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
2827957|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
2827958|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
2827959|NCT04018690|Triamcinolone|triamcinolone|mesh-list
2827960|NCT04018690|Ropivacaine|ropivacaine|mesh-list
2827961|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
2827962|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
2827963|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105719|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105720|NCT02459665|Metronidazole|metronidazole|mesh-list
2105721|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105722|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2105723|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2827964|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827965|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
2827966|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827967|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2827968|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
2827969|NCT04018690|Hormones|hormones|mesh-ancestor
2827970|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2827971|NCT04018417|Amphotericin B|amphotericin b|mesh-list
2827972|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2827973|NCT04018417|Amebicides|amebicides|mesh-ancestor
2827974|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2827975|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2827976|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2827977|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2827978|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
2827979|NCT04018365|Empagliflozin|empagliflozin|mesh-list
2827980|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2827981|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2827982|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2827983|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289518|NCT00254254|Exenatide|exenatide|mesh-list
2289519|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2289520|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289521|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2289522|NCT00254254|Incretins|incretins|mesh-ancestor
2289523|NCT00254254|Hormones|hormones|mesh-ancestor
2289524|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2827984|NCT04018768|Acetaminophen|acetaminophen|mesh-list
2827985|NCT04018768|Ibuprofen|ibuprofen|mesh-list
2827986|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2827987|NCT04018768|Oxycodone|oxycodone|mesh-list
2289525|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
2289526|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2289527|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289528|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289529|NCT00254319|Bevacizumab|bevacizumab|mesh-list
2289530|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2289531|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289532|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2289533|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2289534|NCT00254319|Growth Substances|growth substances|mesh-ancestor
2289535|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289536|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
2289537|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2289538|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
2289539|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2289540|NCT00254345|Protective Agents|protective agents|mesh-ancestor
2289541|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289542|NCT00254371|Androgens|androgens|mesh-list
2289543|NCT00254371|Hormones|hormones|mesh-ancestor
2289544|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2289545|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289546|NCT00254384|Cisplatin|cisplatin|mesh-list
2289547|NCT00254384|Docetaxel|docetaxel|mesh-list
2289548|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2827988|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2827989|NCT04018768|Analgesics|analgesics|mesh-ancestor
2827990|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
2827991|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2827992|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2827993|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
2827994|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2827995|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2827996|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2827997|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2827998|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2827999|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828000|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2828001|NCT04018768|Narcotics|narcotics|mesh-ancestor
2828002|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828003|NCT04018378|Varenicline|varenicline|mesh-list
2828004|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2828005|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2828006|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
2828007|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828008|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289549|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289550|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
2289551|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
2289552|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
2289553|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289554|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2289555|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289556|NCT00254423|Dasatinib|dasatinib|mesh-list
2289557|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828009|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828010|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
2828011|NCT04018157|Ketamine|ketamine|mesh-list
2828012|NCT04018157|Propofol|propofol|mesh-list
2105724|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2105725|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2828013|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2828014|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828015|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828016|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2828017|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
2828018|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
2828019|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2828020|NCT04018157|Analgesics|analgesics|mesh-ancestor
2828021|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
2828022|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289558|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2289559|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289560|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289561|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
2828023|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2828024|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2828025|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2828026|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
2828027|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828028|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289562|NCT00254436|Hematinics|hematinics|mesh-ancestor
2289563|NCT00254449|Capsaicin|capsaicin|mesh-list
2289564|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
2289565|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
2289566|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
2828029|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2828030|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2828031|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2828032|NCT04018313|Omalizumab|omalizumab|mesh-list
2828033|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2828034|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2828035|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2828036|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
2828037|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
2289567|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289568|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289569|NCT00254475|Valsartan|valsartan|mesh-list
2289570|NCT00254475|Simvastatin|simvastatin|mesh-list
2289571|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2289572|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2289573|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
2289574|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289575|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2289576|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2289577|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289578|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2289579|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2828038|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828039|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
2828040|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2828041|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
2828042|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
2828043|NCT04018274|Estradiol|estradiol|mesh-list
2828044|NCT04018274|Estrogens|estrogens|mesh-ancestor
2828045|NCT04018274|Hormones|hormones|mesh-ancestor
2289580|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2289581|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
2289582|NCT00254553|Testosterone|testosterone|mesh-list
2289583|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
2289584|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
2289585|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2289586|NCT00254553|Androgens|androgens|mesh-ancestor
2289587|NCT00254553|Hormones|hormones|mesh-ancestor
2289588|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2289589|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289590|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2289591|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289592|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
2289593|NCT00254579|Tremelimumab|tremelimumab|mesh-list
2289594|NCT00254579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289595|NCT00254618|Mesalamine|mesalamine|mesh-list
2289596|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2289597|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2289598|NCT00254618|Analgesics|analgesics|mesh-ancestor
2828046|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2828047|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828048|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2828049|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2828050|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2828051|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2828052|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2828053|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
2828054|NCT04017897|Nivolumab|nivolumab|mesh-list
2828055|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2289599|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
2828056|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828057|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2828058|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828059|NCT04018105|Metformin|metformin|mesh-list
2828060|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2828061|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828062|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
2828063|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2828064|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2828065|NCT04017741|Prednisolone|prednisolone|mesh-list
2828066|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
2828067|NCT04017741|Lidocaine|lidocaine|mesh-list
2828068|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2289600|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289601|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289602|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2289603|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2289604|NCT00254631|Oxycodone|oxycodone|mesh-list
2289605|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2289606|NCT00254631|Narcotics|narcotics|mesh-ancestor
2289607|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289608|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289609|NCT00254631|Analgesics|analgesics|mesh-ancestor
2289610|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
2289611|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289612|NCT00254657|Levetiracetam|levetiracetam|mesh-list
2289613|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
2289614|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
2828069|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
2828070|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
2828071|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
2828072|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828073|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828074|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
2828075|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828076|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2828077|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2828078|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2828079|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2828080|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828081|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2828082|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
2828083|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
2828084|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2828085|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
2828086|NCT04017741|Hormones|hormones|mesh-ancestor
2828087|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2828088|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2828089|NCT04017741|Protective Agents|protective agents|mesh-ancestor
2828090|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2828091|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828092|NCT04018131|Cimetidine|cimetidine|mesh-list
2828093|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2828094|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2828095|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2828096|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
2289615|NCT00254670|Naltrexone|naltrexone|mesh-list
2289616|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2289617|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2289618|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289619|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
2289620|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289621|NCT00254709|Sirolimus|sirolimus|mesh-list
2289622|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2289623|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2289624|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2289625|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289626|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
2289627|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2289628|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
2289629|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289630|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2289631|NCT00254735|Clomipramine|clomipramine|mesh-list
2289632|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
2828097|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
2289633|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2828098|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828099|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828100|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828101|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2828102|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2828103|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828104|NCT04017845|Tribenoside|tribenoside|mesh-list
2828105|NCT04017845|Lidocaine|lidocaine|mesh-list
2828106|NCT04017845|Diltiazem|diltiazem|mesh-list
2828107|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
2828108|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
2828109|NCT04017845|Bisacodyl|bisacodyl|mesh-list
2828110|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
2828111|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
2828112|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828113|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828114|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
2828115|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105726|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2105727|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105728|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2105729|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105730|NCT02459964|Fentanyl|fentanyl|mesh-list
2105731|NCT02459964|Hydromorphone|hydromorphone|mesh-list
2105732|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2105733|NCT02459964|Narcotics|narcotics|mesh-ancestor
2105734|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105735|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105736|NCT02459964|Analgesics|analgesics|mesh-ancestor
2105737|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
2828116|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2828117|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2828118|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2828119|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2828120|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828121|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2828122|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
2828123|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2828124|NCT04017845|Cathartics|cathartics|mesh-ancestor
2828125|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2828126|NCT04017845|Laxatives|laxatives|mesh-ancestor
2828127|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2828128|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2828129|NCT04017845|Analgesics|analgesics|mesh-ancestor
2828130|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2828131|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2828132|NCT04017988|Ethanol|ethanol|mesh-list
2828133|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2828134|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2828135|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828136|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828137|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2828138|NCT04017650|Nivolumab|nivolumab|mesh-list
2828139|NCT04017650|Cetuximab|cetuximab|mesh-list
2828140|NCT04017650|Antibodies|antibodies|mesh-list
2828141|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
2828142|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2828143|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
2828144|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828145|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828146|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2828147|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828148|NCT04017624|Nicotine|nicotine|mesh-list
2828149|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2289634|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289635|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289636|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289637|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828150|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
2828151|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828152|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828153|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2828154|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2828155|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
2828156|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289638|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2289639|NCT00254735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2289640|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2289641|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2289642|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289643|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289644|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
2289645|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2289646|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
2289647|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289648|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289649|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289650|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289651|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289652|NCT00254774|Valproic Acid|valproic acid|mesh-list
2289653|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2289654|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
2289655|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289656|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289657|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289658|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289659|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289660|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
2828157|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828158|NCT04017377|Paclitaxel|paclitaxel|mesh-list
2828159|NCT04017377|Cisplatin|cisplatin|mesh-list
2828160|NCT04017377|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2828161|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2828162|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828163|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
2828164|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
2828165|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
2828166|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828167|NCT04017247|Oxytocin|oxytocin|mesh-list
2828168|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
2828169|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2828170|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828171|NCT04017598|Iron|iron|mesh-list
2828172|NCT04017598|Trace Elements|trace elements|mesh-ancestor
2828173|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
2828174|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828175|NCT04017455|Bevacizumab|bevacizumab|mesh-list
2828176|NCT04017455|Atezolizumab|atezolizumab|mesh-list
2828177|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2828178|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828179|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2828180|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2828181|NCT04017455|Growth Substances|growth substances|mesh-ancestor
2828182|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828183|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
2828184|NCT04017546|Venetoclax|venetoclax|mesh-list
2828185|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828188|NCT04017468|Vancomycin|vancomycin|mesh-list
2828189|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2828190|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2828191|NCT04017338|Ezetimibe|ezetimibe|mesh-list
2828192|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2828193|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2828194|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
2828195|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828196|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2828197|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2828198|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
2828199|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828200|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828201|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2828202|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828203|NCT04017013|Lidocaine|lidocaine|mesh-list
2828204|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
2828205|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
2828206|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828207|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289661|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828208|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
2828209|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289662|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289663|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
2289664|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289665|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
2289666|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2289667|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
2289668|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289669|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289670|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289671|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289672|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289673|NCT00254800|Exenatide|exenatide|mesh-list
2289674|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2289675|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2289676|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
2289677|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2289678|NCT00254800|Estradiol|estradiol|mesh-list
2289679|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2289680|NCT00254800|Estrogens|estrogens|mesh-ancestor
2289681|NCT00254800|Hormones|hormones|mesh-ancestor
2289682|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2289683|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289684|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2289685|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
2289686|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2289687|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2289688|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2289689|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2289690|NCT00254800|Incretins|incretins|mesh-ancestor
2289691|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2289692|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2289693|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2289694|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2289695|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
2289696|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289697|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289698|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289699|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289700|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289701|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2289702|NCT00254865|Norelgestromin|norelgestromin|mesh-list
2289703|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
2289704|NCT00254865|Estradiol|estradiol|mesh-list
2289705|NCT00254865|Estrogens|estrogens|mesh-ancestor
2289706|NCT00254865|Hormones|hormones|mesh-ancestor
2289707|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2289708|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289709|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2828210|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2828211|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2828212|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2828213|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2828214|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828215|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2828216|NCT04016922|Hematinics|hematinics|mesh-ancestor
2828217|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2828218|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2828219|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289710|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2289711|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2289712|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2828220|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2828221|NCT04017104|Edotreotide|edotreotide|mesh-list
2828222|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2828223|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828224|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2828225|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2828226|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2828227|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2828228|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
2828229|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2828230|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828231|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2828232|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2828233|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2828234|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2828235|NCT04016389|Paclitaxel|paclitaxel|mesh-list
2828236|NCT04016389|Carboplatin|carboplatin|mesh-list
2828237|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2828238|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828239|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
2828240|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
2828241|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
2828242|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828243|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
2828244|NCT04016740|Ketamine|ketamine|mesh-list
2828245|NCT04016740|Remifentanil|remifentanil|mesh-list
2828246|NCT04016740|Propofol|propofol|mesh-list
2828247|NCT04016740|Ropivacaine|ropivacaine|mesh-list
2828248|NCT04016740|Sevoflurane|sevoflurane|mesh-list
2828249|NCT04016740|Rocuronium|rocuronium|mesh-list
2828250|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2828251|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828252|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828253|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2828254|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
2828255|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
2828256|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2828257|NCT04016740|Analgesics|analgesics|mesh-ancestor
2828258|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
2828259|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828260|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2828261|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2828262|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2828263|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
2828264|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828265|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828266|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2828267|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2828268|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2828269|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
2828270|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2828271|NCT04016740|Narcotics|narcotics|mesh-ancestor
2828272|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2828273|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2828274|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2828275|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2828276|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2828277|NCT04016246|Propofol|propofol|mesh-list
2289713|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2289714|NCT00254878|Methylphenidate|methylphenidate|mesh-list
2289715|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2289716|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289717|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2289718|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2289719|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2289720|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289721|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
2289722|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289723|NCT00254891|Paclitaxel|paclitaxel|mesh-list
2289724|NCT00254891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2289725|NCT00254891|Carboplatin|carboplatin|mesh-list
2289726|NCT00254891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2828278|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2828279|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828280|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828281|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2828282|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
2289727|NCT00254891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289728|NCT00254891|Tubulin Modulators|tubulin modulators|mesh-ancestor
2289729|NCT00254891|Antimitotic Agents|antimitotic agents|mesh-ancestor
2828283|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
2828284|NCT04016233|Tenofovir|tenofovir|mesh-list
2828285|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
2828286|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2828287|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2828288|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2289730|NCT00254891|Mitosis Modulators|mitosis modulators|mesh-ancestor
2289731|NCT00254891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289732|NCT00254904|Gemcitabine|gemcitabine|mesh-list
2289733|NCT00254904|Cisplatin|cisplatin|mesh-list
2289734|NCT00254904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289735|NCT00254904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2289736|NCT00254904|Antimetabolites|antimetabolites|mesh-ancestor
2289737|NCT00254904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289738|NCT00254904|Antiviral Agents|antiviral agents|mesh-ancestor
2289739|NCT00254904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2289740|NCT00254904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289741|NCT00254904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2289742|NCT00254904|Immunologic Factors|immunologic factors|mesh-ancestor
2289743|NCT00254904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289744|NCT00254917|Vaccines|vaccines|mesh-list
2289745|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
2289746|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289747|NCT00254930|Risperidone|risperidone|mesh-list
2828289|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828290|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828291|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2828292|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2828293|NCT04016051|Clarithromycin|clarithromycin|mesh-list
2828294|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2828295|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2828296|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2828297|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828298|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289748|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2289749|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
2289750|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289751|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289752|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289753|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289754|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2828299|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2828300|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2828301|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
2828302|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2828303|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828304|NCT04016142|Paclitaxel|paclitaxel|mesh-list
2828305|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2828306|NCT04016142|Carboplatin|carboplatin|mesh-list
2828307|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2828308|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828309|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
2828310|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
2828311|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
2828312|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828313|NCT04016090|Folic Acid|folic acid|mesh-list
2828314|NCT04016090|Hematinics|hematinics|mesh-ancestor
2828315|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
2828316|NCT04016090|Vitamins|vitamins|mesh-ancestor
2828317|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
2828318|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828319|NCT04016220|Budesonide|budesonide|mesh-list
2828320|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2828321|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2828322|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
2828323|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828324|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828325|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2289755|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2289756|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289757|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2289758|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
2289759|NCT00254956|Ciclesonide|ciclesonide|mesh-list
2289760|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
2289761|NCT00254956|Hormones|hormones|mesh-ancestor
2289762|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2289763|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289764|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2289765|NCT00255073|Baclofen|baclofen|mesh-list
2289766|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2289767|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289768|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2828326|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
2828327|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
2828328|NCT04016220|Hormones|hormones|mesh-ancestor
2105738|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105739|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2105740|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2105741|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
2105742|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
2105743|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
2105744|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2105745|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105746|NCT02460380|Vitamin D|vitamin d|mesh-list
2105747|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
2105748|NCT02460380|Vitamins|vitamins|mesh-ancestor
2105749|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
2105750|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105751|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2105752|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2105753|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
2105754|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2828329|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2828330|NCT04015908|Acetaminophen|acetaminophen|mesh-list
2828331|NCT04015908|Celecoxib|celecoxib|mesh-list
2828332|NCT04015908|Pregabalin|pregabalin|mesh-list
2828333|NCT04015908|Oxycodone|oxycodone|mesh-list
2828334|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2289769|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289770|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2289771|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
2289772|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
2289773|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289774|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289775|NCT00255099|Etravirine|etravirine|mesh-list
2289776|NCT00255099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2289777|NCT00255099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2289778|NCT00255099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289779|NCT00255099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289780|NCT00255099|Antiviral Agents|antiviral agents|mesh-ancestor
2289781|NCT00255099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2289782|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2289783|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2289784|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2289785|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2289786|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289787|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
2289788|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289789|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289790|NCT00255216|Policosanol|policosanol|mesh-list
2289791|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2289792|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2289793|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
2289794|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289795|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2289796|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2289797|NCT00255242|Simvastatin|simvastatin|mesh-list
2289798|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2289799|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2289800|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
2828335|NCT04015908|Analgesics|analgesics|mesh-ancestor
2828336|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
2828337|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828338|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828339|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
2828340|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
2828341|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2828342|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2828343|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828344|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2828345|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2828346|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2828347|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828348|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2828349|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2828350|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2828351|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2828352|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2828353|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2828354|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828355|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2828356|NCT04015908|Narcotics|narcotics|mesh-ancestor
2828357|NCT04016207|Guanfacine|guanfacine|mesh-list
2828358|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2828359|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2828360|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2828361|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2828362|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
2828363|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828364|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828365|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828366|NCT04015869|Pregnanolone|pregnanolone|mesh-list
2828367|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
2828368|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828369|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828370|NCT04015596|Naproxen|naproxen|mesh-list
2828371|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2828372|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2828373|NCT04015596|Analgesics|analgesics|mesh-ancestor
2828374|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
2828375|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828376|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828377|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2828378|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2828379|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
2828380|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2828381|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828382|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828383|NCT04015414|Varenicline|varenicline|mesh-list
2828384|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2828385|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2828386|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
2828387|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828388|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828389|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828396|NCT04015700|Coal Tar|coal tar|mesh-list
2828397|NCT04015700|Vaccines|vaccines|mesh-list
2828398|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
2828399|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828400|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
2828401|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
2828402|NCT04015557|Acetaminophen|acetaminophen|mesh-list
2828403|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
2828404|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2289801|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289802|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2289803|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2289804|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289805|NCT00255255|Budesonide|budesonide|mesh-list
2828405|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2828406|NCT04015557|Analgesics|analgesics|mesh-ancestor
2828407|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
2828408|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828409|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828410|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
2828411|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
2828412|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2289806|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
2289807|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2289808|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2289809|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
2289810|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289811|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289812|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2289813|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
2289814|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
2289815|NCT00255255|Hormones|hormones|mesh-ancestor
2289816|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2289817|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2289818|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2289819|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2289820|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
2289821|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289822|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289823|NCT00255268|Goserelin|goserelin|mesh-list
2289824|NCT00255268|Bicalutamide|bicalutamide|mesh-list
2289825|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2289826|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289827|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
2289828|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
2289829|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2828413|NCT04015557|Expectorants|expectorants|mesh-ancestor
2828414|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
2828415|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2828416|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
2828417|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828418|NCT04015557|Protective Agents|protective agents|mesh-ancestor
2828419|NCT04015557|Antidotes|antidotes|mesh-ancestor
2828420|NCT04015492|Factor VIII|factor viii|mesh-list
2828421|NCT04015492|BAX 855|bax 855|mesh-list
2828422|NCT04015492|Coagulants|coagulants|mesh-ancestor
2828423|NCT04015687|Lamotrigine|lamotrigine|mesh-list
2828424|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
2828425|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2828426|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2289830|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289831|NCT00255372|Lactulose|lactulose|mesh-list
2289832|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2289833|NCT00255385|Micronutrients|micronutrients|mesh-list
2289834|NCT00255385|Trace Elements|trace elements|mesh-list
2289835|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828427|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828428|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2828429|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828430|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2828431|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2828432|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828433|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2828434|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2828435|NCT04015778|Paclitaxel|paclitaxel|mesh-list
2828436|NCT04015778|Carboplatin|carboplatin|mesh-list
2828437|NCT04015778|Nivolumab|nivolumab|mesh-list
2828438|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2828439|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828440|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
2828441|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
2828442|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
2828443|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828444|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2828445|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2828446|NCT04015661|Paclitaxel|paclitaxel|mesh-list
2828447|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2828448|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2828449|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828450|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
2828451|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
2289836|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2828452|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
2828453|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828454|NCT04015375|Dapsone|dapsone|mesh-list
2828455|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2828456|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
2828457|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2828458|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2828459|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2828460|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828461|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828462|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
2828463|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2828464|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
2828465|NCT04015115|Narcotics|narcotics|mesh-ancestor
2828466|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828467|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828468|NCT04015115|Analgesics|analgesics|mesh-ancestor
2828469|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
2828470|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289837|NCT00255424|Hematinics|hematinics|mesh-ancestor
2289838|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2289839|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2289840|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2289841|NCT00255437|Hematinics|hematinics|mesh-ancestor
2289842|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2289843|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2289844|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2289845|NCT00255450|Hematinics|hematinics|mesh-ancestor
2289846|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2289847|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2289848|NCT00255463|Gefitinib|gefitinib|mesh-list
2289849|NCT00255463|Anastrozole|anastrozole|mesh-list
2289850|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289851|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2289852|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289853|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289854|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2289855|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2289856|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2289857|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2289858|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
2289859|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2289860|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289861|NCT00255476|Gefitinib|gefitinib|mesh-list
2289862|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289863|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2828471|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2828472|NCT04015219|Lifitegrast|lifitegrast|mesh-list
2828473|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2828474|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
2828475|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2828476|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2828477|NCT04014634|Prednisolone|prednisolone|mesh-list
2828478|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
2828479|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2828480|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
2828481|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2828482|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
2828483|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
2828484|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828485|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828486|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2828487|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
2828488|NCT04014634|Hormones|hormones|mesh-ancestor
2828489|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2828490|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2828491|NCT04014634|Protective Agents|protective agents|mesh-ancestor
2828492|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2289864|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289865|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289866|NCT00255489|Gefitinib|gefitinib|mesh-list
2289867|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289868|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2289869|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828493|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828494|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
2828495|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2828496|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828497|NCT04014790|KRN 7000|krn 7000|mesh-list
2828498|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2828499|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
2828500|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828501|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828502|NCT04014855|Lactoferrin|lactoferrin|mesh-list
2828503|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2828504|NCT04014556|Aflibercept|aflibercept|mesh-list
2828505|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2828506|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2828507|NCT04014556|Growth Substances|growth substances|mesh-ancestor
2828508|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828509|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
2828510|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828511|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
2828512|NCT04014192|Empagliflozin|empagliflozin|mesh-list
2828513|NCT04014192|Canagliflozin|canagliflozin|mesh-list
2828514|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2828515|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828516|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2828517|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828518|NCT04014387|Zolpidem|zolpidem|mesh-list
2828519|NCT04014387|Suvorexant|suvorexant|mesh-list
2289870|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289871|NCT00255502|Metoprolol|metoprolol|mesh-list
2289872|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2289873|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2289874|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
2828520|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2828521|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2828522|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828523|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828524|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2828525|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
2828526|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
2828527|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828528|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828529|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2828530|NCT04014101|Apatinib|apatinib|mesh-list
2828531|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289875|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
2828532|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2828533|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828534|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828535|NCT04014244|Triamcinolone|triamcinolone|mesh-list
2828536|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2828537|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2828538|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2828539|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2828540|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
2828541|NCT04014244|Hormones|hormones|mesh-ancestor
2828542|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2828543|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828544|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2828545|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
2828546|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828547|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828548|NCT04014361|Itraconazole|itraconazole|mesh-list
2828549|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
2828550|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2828551|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2828552|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2828553|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828554|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828555|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2828556|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
2828557|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2828558|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828559|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2828560|NCT04014283|Selenium|selenium|mesh-list
2828561|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
2828562|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828563|NCT04014283|Protective Agents|protective agents|mesh-ancestor
2828564|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828565|NCT04014283|Trace Elements|trace elements|mesh-ancestor
2828566|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
2828570|NCT04013815|Ropivacaine|ropivacaine|mesh-list
2828571|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
2828572|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
2828573|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828574|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828575|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
2828576|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828577|NCT04013581|Empagliflozin|empagliflozin|mesh-list
2828578|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2828579|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828580|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2828581|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828582|NCT04013919|Insulin|insulin|mesh-list
2828583|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2828584|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2828585|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828586|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
2828587|NCT04013646|Hematinics|hematinics|mesh-ancestor
2828588|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2828589|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2828590|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2828591|NCT04013620|Abatacept|abatacept|mesh-list
2828592|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2828593|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289876|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289877|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828594|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828595|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2828596|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
2828597|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828598|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2828599|NCT04013958|Ketamine|ketamine|mesh-list
2828600|NCT04013958|Analgesics|analgesics|mesh-ancestor
2828601|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
2828602|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828603|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828604|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2828605|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2828606|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
2828607|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
2828608|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828609|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2828610|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2828611|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828612|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828613|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
2828614|NCT04013672|Sargramostim|sargramostim|mesh-list
2828615|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2828616|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828617|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
2828618|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828619|NCT04013880|Decitabine|decitabine|mesh-list
2828620|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2828621|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
2828622|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828623|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828624|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289878|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2289879|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2289880|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2289881|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
2289882|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289883|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289884|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2105755|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105756|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2105757|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105758|NCT02460991|Sorafenib|sorafenib|mesh-list
2105759|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105760|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2105761|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105762|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105763|NCT02461134|Ponesimod|ponesimod|mesh-list
2289885|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
2289886|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289887|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2289888|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2289889|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828625|NCT04013854|Nivolumab|nivolumab|mesh-list
2828626|NCT04013854|Ipilimumab|ipilimumab|mesh-list
2828627|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2828628|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828629|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2828630|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828631|NCT04013542|Nivolumab|nivolumab|mesh-list
2828632|NCT04013542|Ipilimumab|ipilimumab|mesh-list
2828633|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2828634|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828635|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2828636|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828637|NCT04013386|Dexamethasone|dexamethasone|mesh-list
2828638|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
2828639|NCT04013386|Aprepitant|aprepitant|mesh-list
2828640|NCT04013386|Mirtazapine|mirtazapine|mesh-list
2828641|NCT04013386|BB 1101|bb 1101|mesh-list
2828642|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2828643|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
2828644|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
2828645|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828646|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828647|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2828648|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
2828649|NCT04013386|Hormones|hormones|mesh-ancestor
2828650|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2828651|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2828652|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828653|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
2828654|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828655|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828656|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2828657|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828658|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
2828659|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2828660|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2828661|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
2828662|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
2828663|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2828664|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2828665|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828666|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2828667|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2828668|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2828669|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
2105764|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2105765|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105766|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2105767|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
2105768|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105769|NCT02461160|Midazolam|midazolam|mesh-list
2105770|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2105771|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2105772|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105773|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105774|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2105775|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2105776|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2105777|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2105778|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
2105779|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
2105780|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
2105781|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
2105782|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105783|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105784|NCT02461290|Rituximab|rituximab|mesh-list
2828670|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2828671|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2828672|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
2828673|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2828674|NCT04013334|Nivolumab|nivolumab|mesh-list
2828675|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2828676|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828677|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2828678|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828679|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2828680|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2828681|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
2828682|NCT04013438|Estradiol|estradiol|mesh-list
2828683|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2828684|NCT04013438|Estrogens|estrogens|mesh-ancestor
2828685|NCT04013438|Hormones|hormones|mesh-ancestor
2828686|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2828687|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828688|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2828689|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
2289890|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289891|NCT00255528|Metoprolol|metoprolol|mesh-list
2289892|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2289893|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2289894|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
2289895|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
2289896|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2289897|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289898|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2289899|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2289900|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2289901|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
2289902|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289903|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289904|NCT00255541|Glyburide|glyburide|mesh-list
2289905|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2289906|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289907|NCT00255554|Citalopram|citalopram|mesh-list
2289908|NCT00255554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2289909|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2289910|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2289911|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289912|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2289913|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
2828690|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2828691|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2828692|NCT04013438|Urological Agents|urological agents|mesh-ancestor
2828693|NCT04013477|Donepezil|donepezil|mesh-list
2828694|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2828695|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828696|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828697|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
2828698|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828699|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828700|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
2828701|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
2828702|NCT04013243|Analgesics|analgesics|mesh-ancestor
2828703|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
2828704|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828705|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289914|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289915|NCT00255554|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2289916|NCT00255554|Antidepressive Agents|antidepressive agents|mesh-ancestor
2289917|NCT00255554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2289918|NCT00255567|Paromomycin|paromomycin|mesh-list
2289919|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
2289920|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2289921|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2289922|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2289923|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2289924|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
2289925|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2289926|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
2289927|NCT00255593|Rituximab|rituximab|mesh-list
2289928|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2289929|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828706|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
2105785|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2105786|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105787|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
2105788|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105789|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2105790|NCT02461589|Liraglutide|liraglutide|mesh-list
2105791|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2105792|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105793|NCT02461589|Incretins|incretins|mesh-ancestor
2105794|NCT02461589|Hormones|hormones|mesh-ancestor
2105795|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2105796|NCT02461693|Caffeine|caffeine|mesh-list
2105797|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2105798|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105799|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2828707|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828708|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2828709|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
2828710|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2828711|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2828712|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828713|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2828714|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
2828715|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2828716|NCT04013464|Citalopram|citalopram|mesh-list
2828717|NCT04013464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2828718|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2828719|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2828720|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828721|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828722|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
2828723|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828724|NCT04013464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2828725|NCT04013464|Antidepressive Agents|antidepressive agents|mesh-ancestor
2828726|NCT04013464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2828727|NCT04012918|Capecitabine|capecitabine|mesh-list
2828728|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2828729|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2828730|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
2828731|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828732|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828733|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2828734|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828735|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2828736|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
2289930|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
2289931|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289932|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2289933|NCT00255606|Prednisone|prednisone|mesh-list
2289934|NCT00255606|Docetaxel|docetaxel|mesh-list
2289935|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289936|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
2289937|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
2289938|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
2289939|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289940|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2289941|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
2289942|NCT00255606|Hormones|hormones|mesh-ancestor
2289943|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2289944|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289945|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2289946|NCT00255658|Sirolimus|sirolimus|mesh-list
2289947|NCT00255658|Sorafenib|sorafenib|mesh-list
2289948|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289949|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2289950|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289951|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289952|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2289953|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2289954|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2289955|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
2289956|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2289957|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
2289958|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289959|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
2289960|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
2289961|NCT00255710|Fludarabine|fludarabine|mesh-list
2289962|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
2289963|NCT00255710|Tacrolimus|tacrolimus|mesh-list
2289964|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2289965|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
2289966|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2289967|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2289968|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2289969|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
2289970|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289971|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289972|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2289973|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2289974|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
2289975|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2289976|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2289977|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2289978|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2289979|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
2289980|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2289981|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2289982|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
2828737|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2828738|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828739|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2828740|NCT04012619|Cisplatin|cisplatin|mesh-list
2828741|NCT04012619|Carboplatin|carboplatin|mesh-list
2828742|NCT04012619|Pemetrexed|pemetrexed|mesh-list
2828743|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828744|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828745|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828746|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2828747|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2828748|NCT04012775|Insulin|insulin|mesh-list
2828749|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2828750|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2828751|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828752|NCT04012606|Carboplatin|carboplatin|mesh-list
2828753|NCT04012606|Etoposide|etoposide|mesh-list
2828754|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289983|NCT00255749|Hematinics|hematinics|mesh-ancestor
2289984|NCT00255762|Paclitaxel|paclitaxel|mesh-list
2289985|NCT00255762|Bevacizumab|bevacizumab|mesh-list
2289986|NCT00255762|Carboplatin|carboplatin|mesh-list
2289987|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2289988|NCT00255762|Antibodies|antibodies|mesh-list
2289989|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
2289990|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2289991|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2289992|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2289993|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
2289994|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
2289995|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
2289996|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2289997|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2289998|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2289999|NCT00255762|Growth Substances|growth substances|mesh-ancestor
2290000|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290001|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
2290002|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
2290003|NCT00255788|Everolimus|everolimus|mesh-list
2290004|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290005|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2290006|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
2290007|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290008|NCT00255879|Olanzapine|olanzapine|mesh-list
2290009|NCT00255879|Risperidone|risperidone|mesh-list
2290010|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2290011|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2290012|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
2290013|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290014|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290015|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290016|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2290017|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2290018|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2290019|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2290020|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2828755|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2105800|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105801|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105802|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2105803|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2105804|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
2105805|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105806|NCT02461745|Ribavirin|ribavirin|mesh-list
2105807|NCT02461745|Ritonavir|ritonavir|mesh-list
2828756|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2828757|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2828758|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828759|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828760|NCT04012450|Anesthetics|anesthetics|mesh-list
2828761|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828762|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290021|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
2290022|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
2290023|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
2290024|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290025|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2290026|NCT00255879|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2290027|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2290028|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2290029|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
2290030|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
2828763|NCT04012424|Curcumin|curcumin|mesh-list
2828764|NCT04012424|Analgesics|analgesics|mesh-list
2828765|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2828766|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2828767|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
2828768|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828769|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828770|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2828771|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2828772|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828773|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828774|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828775|NCT04012307|Candesartan|candesartan|mesh-list
2828776|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
2828777|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2828778|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2828779|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2828780|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828781|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
2828782|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2828783|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828784|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828785|NCT04012268|Aspirin|aspirin|mesh-list
2828786|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2828787|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2828788|NCT04012268|Analgesics|analgesics|mesh-ancestor
2828789|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
2828790|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828791|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828792|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2828793|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2828794|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2828795|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2828796|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828797|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2828798|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2828799|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290031|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2290032|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2290033|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
2290034|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290035|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105808|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
2105809|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105810|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
2105811|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290036|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290037|NCT00255996|Linezolid|linezolid|mesh-list
2290038|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290039|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290040|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2290041|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290042|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290043|NCT00256009|Misoprostol|misoprostol|mesh-list
2290044|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2828800|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
2828801|NCT04012047|Cromakalim|cromakalim|mesh-list
2828802|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2828803|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2828804|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
2828805|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828806|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828807|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2828808|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
2828809|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
2828810|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
2105812|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2105813|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2105814|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
2290045|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
2290046|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2290047|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290048|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2290049|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2290050|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
2290051|NCT00256100|PENTA|penta|mesh-list
2290052|NCT00256100|Fondaparinux|fondaparinux|mesh-list
2290053|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2290054|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
2290055|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2290056|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
2290057|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290058|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290059|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
2290060|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2290061|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2290062|NCT00256178|Simvastatin|simvastatin|mesh-list
2290063|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2290064|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2290065|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
2290066|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290067|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2290068|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2290069|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290070|NCT00256230|Disulfiram|disulfiram|mesh-list
2290071|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2290072|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2290073|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290074|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290075|NCT00256256|Glucagon|glucagon|mesh-list
2290076|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2290077|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2290078|NCT00256256|Hormones|hormones|mesh-ancestor
2290079|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2290080|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290081|NCT00256256|Incretins|incretins|mesh-ancestor
2290082|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
2290083|NCT00256269|Irinotecan|irinotecan|mesh-list
2290084|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290085|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2290086|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2290087|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290088|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290089|NCT00256321|Celecoxib|celecoxib|mesh-list
2290090|NCT00256321|Capecitabine|capecitabine|mesh-list
2290091|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
2290092|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2105815|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105816|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2105817|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2105818|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2105819|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2290093|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
2290094|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290095|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290096|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2290097|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2290098|NCT00256321|Analgesics|analgesics|mesh-ancestor
2290099|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
2290100|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290101|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290102|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2290103|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2290104|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2290105|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2828811|NCT04012138|Insulin|insulin|mesh-list
2828812|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2828813|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
2828814|NCT04012138|Albuterol|albuterol|mesh-list
2828815|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2828816|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828817|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2290106|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290107|NCT00256334|Resveratrol|resveratrol|mesh-list
2290108|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
2290109|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290110|NCT00256334|Protective Agents|protective agents|mesh-ancestor
2290111|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290112|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290113|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2290114|NCT00256347|Morphine|morphine|mesh-list
2290115|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2290116|NCT00256347|Narcotics|narcotics|mesh-ancestor
2290117|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2290118|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290119|NCT00256347|Analgesics|analgesics|mesh-ancestor
2290120|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
2290121|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290122|NCT00256399|Alfuzosin|alfuzosin|mesh-list
2290123|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2290124|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2828818|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
2828819|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828820|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2828821|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
2828822|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
2828823|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2290125|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2290126|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
2290127|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290128|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290129|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290130|NCT00256399|Urological Agents|urological agents|mesh-ancestor
2828824|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2828825|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2828826|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2828827|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
2828828|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828829|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290131|NCT00256542|Lidocaine|lidocaine|mesh-list
2290132|NCT00256542|Heparin|heparin|mesh-list
2290133|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
2290134|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
2290135|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2290136|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290137|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
2290138|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290139|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2290140|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2290141|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2290142|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2290143|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290144|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
2290145|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2290146|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2290147|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
2290148|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2290149|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290150|NCT00256711|Vinorelbine|vinorelbine|mesh-list
2290151|NCT00256711|Gefitinib|gefitinib|mesh-list
2290152|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2290153|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290154|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
2290155|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
2290156|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
2290157|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290158|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2290159|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290160|NCT00256737|Omeprazole|omeprazole|mesh-list
2290161|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2290162|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2290163|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2290164|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290165|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290166|NCT00256828|Lamivudine|lamivudine|mesh-list
2828830|NCT04012294|Allopurinol|allopurinol|mesh-list
2828831|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
2828832|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828833|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828834|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
2828835|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2828836|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2828837|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
2828838|NCT04012294|Protective Agents|protective agents|mesh-ancestor
2828839|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828840|NCT04011930|Vitamin D|vitamin d|mesh-list
2828841|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
2828842|NCT04011930|Calcitriol|calcitriol|mesh-list
2828843|NCT04011930|Vitamins|vitamins|mesh-ancestor
2828844|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
2828845|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828846|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2828847|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2828848|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2828849|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2828850|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828851|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2828852|NCT04011813|Antioxidants|antioxidants|mesh-list
2828853|NCT04011813|Hypotaurine|hypotaurine|mesh-list
2828854|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290167|NCT00256828|Efavirenz|efavirenz|mesh-list
2290168|NCT00256828|Didanosine|didanosine|mesh-list
2290169|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2290170|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2290171|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828855|NCT04011813|Protective Agents|protective agents|mesh-ancestor
2828856|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828857|NCT04011670|Caffeine|caffeine|mesh-list
2828858|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2828859|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828860|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2828861|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828862|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828863|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2828864|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2828865|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
2828866|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828867|NCT04011748|Minoxidil|minoxidil|mesh-list
2828868|NCT04011748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2828869|NCT04011748|Vasodilator Agents|vasodilator agents|mesh-ancestor
2828870|NCT04011878|Mitomycins|mitomycins|mesh-list
2828871|NCT04011878|Mitomycin|mitomycin|mesh-list
2828872|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2290172|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290173|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
2290174|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290175|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2290176|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2290177|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2290178|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2290179|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2290180|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2290181|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2290182|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2290183|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
2290184|NCT00256893|Ropinirole|ropinirole|mesh-list
2290185|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2290186|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2290187|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
2290188|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
2290189|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290190|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290191|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290192|NCT00256932|Alvimopan|alvimopan|mesh-list
2828873|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828874|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
2828875|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828876|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2828877|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828878|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
2828879|NCT04011475|Olodaterol|olodaterol|mesh-list
2828880|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2828881|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
2828882|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828883|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828884|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2290193|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2290194|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2290195|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2828885|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
2828886|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
2828887|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2828888|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
2828889|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828890|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828891|NCT04011345|Folic Acid|folic acid|mesh-list
2828892|NCT04011345|Hematinics|hematinics|mesh-ancestor
2828893|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
2828894|NCT04011345|Vitamins|vitamins|mesh-ancestor
2828895|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
2828896|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290196|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2290197|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828897|NCT04011280|Varenicline|varenicline|mesh-list
2828898|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2828899|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2828900|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
2828901|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2828902|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828903|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828904|NCT04011124|Rifampin|rifampin|mesh-list
2828905|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2828906|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
2828907|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2828908|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2828909|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
2828910|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2828911|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828912|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828913|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2828914|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2828915|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2828916|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2828917|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2828918|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2828919|NCT04010955|Edoxaban|edoxaban|mesh-list
2828920|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2828921|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
2828922|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2828923|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
2828924|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828925|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828926|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
2828927|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
2828928|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
2828929|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2828930|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2828931|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2828932|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828933|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828934|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2828935|NCT04011241|Itraconazole|itraconazole|mesh-list
2828936|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
2828937|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2828938|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2828939|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2828940|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2828941|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828942|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2828943|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
2828944|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2828945|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290198|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290199|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2290200|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2290201|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2290202|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
2290203|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290204|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290205|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2290206|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2290207|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
2290208|NCT00257036|Levofloxacin|levofloxacin|mesh-list
2290209|NCT00257036|Ofloxacin|ofloxacin|mesh-list
2828946|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2828947|NCT04011098|Fentanyl|fentanyl|mesh-list
2828948|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2828949|NCT04011098|Narcotics|narcotics|mesh-ancestor
2828950|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828951|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828952|NCT04011098|Analgesics|analgesics|mesh-ancestor
2828953|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
2828954|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828955|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2828956|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2828957|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
2828958|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
2828959|NCT04010968|Venetoclax|venetoclax|mesh-list
2828960|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828961|NCT04011150|Fentanyl|fentanyl|mesh-list
2828962|NCT04011150|Ropivacaine|ropivacaine|mesh-list
2828963|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
2828964|NCT04011150|Anesthetics|anesthetics|mesh-list
2828965|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828966|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290210|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2290211|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290212|NCT00257036|Renal Agents|renal agents|mesh-ancestor
2290213|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290214|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2290215|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2290216|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290217|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290218|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290219|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2290220|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2828967|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
2828968|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828969|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2828970|NCT04011150|Narcotics|narcotics|mesh-ancestor
2828971|NCT04011150|Analgesics|analgesics|mesh-ancestor
2828972|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2828973|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2828974|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
2828975|NCT04011163|Morphine|morphine|mesh-list
2828976|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2828977|NCT04011163|Narcotics|narcotics|mesh-ancestor
2828978|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2828979|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828980|NCT04011163|Analgesics|analgesics|mesh-ancestor
2828981|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
2828982|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290221|NCT00257049|Levofloxacin|levofloxacin|mesh-list
2290222|NCT00257049|Ofloxacin|ofloxacin|mesh-list
2290223|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2290224|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290225|NCT00257049|Renal Agents|renal agents|mesh-ancestor
2290226|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290227|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2290228|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2290229|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290230|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290231|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290232|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2828983|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
2828984|NCT04011033|Interleukin-2|interleukin-2|mesh-list
2828985|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2828986|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
2828987|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2828988|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2828989|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2828990|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
2828991|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2828992|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2828993|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2828994|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2828995|NCT04011033|Analgesics|analgesics|mesh-ancestor
2828996|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
2828997|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2828998|NCT04010929|Pemetrexed|pemetrexed|mesh-list
2828999|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829000|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829001|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829002|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2290233|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2290234|NCT00257062|Levofloxacin|levofloxacin|mesh-list
2290235|NCT00257062|Ofloxacin|ofloxacin|mesh-list
2290236|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2290237|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290238|NCT00257062|Renal Agents|renal agents|mesh-ancestor
2290239|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2829003|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2290240|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2290241|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2290242|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290243|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290244|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290245|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2290246|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2290247|NCT00257075|Risperidone|risperidone|mesh-list
2290248|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2290249|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
2290250|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290251|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290252|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290253|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2290254|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2290255|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2829004|NCT04010942|Metformin|metformin|mesh-list
2829005|NCT04010942|Clomiphene|clomiphene|mesh-list
2829006|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2829007|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829008|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2829009|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
2829010|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829011|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2829012|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
2829013|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2829014|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2829015|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2829016|NCT04010903|Insulin|insulin|mesh-list
2829017|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2829018|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829019|NCT04010669|Somatostatin|somatostatin|mesh-list
2829020|NCT04010669|Hormones|hormones|mesh-ancestor
2829021|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829022|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829023|NCT04010578|Vitamin D|vitamin d|mesh-list
2829024|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
2829025|NCT04010578|Vitamins|vitamins|mesh-ancestor
2829026|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
2829027|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829028|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2829029|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2290256|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2290257|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2290258|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
2105820|NCT02461758|Vaccines|vaccines|mesh-list
2105821|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
2105822|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105823|NCT02462148|Dexamethasone|dexamethasone|mesh-list
2105824|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
2105825|NCT02462148|Epinephrine|epinephrine|mesh-list
2290259|NCT00257114|Bortezomib|bortezomib|mesh-list
2290260|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290261|NCT00257127|Vaccines|vaccines|mesh-list
2290262|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2290263|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
2290264|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829030|NCT04010318|Anesthetics|anesthetics|mesh-list
2829031|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2829032|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829033|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
2829034|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2829035|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2829036|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829037|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2829038|NCT04010305|Analgesics|analgesics|mesh-ancestor
2829039|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
2829040|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829041|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2829042|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2829043|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2829044|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
2829045|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829046|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829047|NCT04010071|Axitinib|axitinib|mesh-list
2829048|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829049|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2829050|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829051|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829052|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
2829053|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2829054|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829055|NCT04009668|Adalimumab|adalimumab|mesh-list
2829056|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2829057|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2829058|NCT04009759|Morphine|morphine|mesh-list
2829059|NCT04009759|Ketamine|ketamine|mesh-list
2829060|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2829061|NCT04009759|Narcotics|narcotics|mesh-ancestor
2829062|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2829063|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829064|NCT04009759|Analgesics|analgesics|mesh-ancestor
2829065|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
2829066|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829067|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2829068|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2829069|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
2829070|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
2829071|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2829072|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2829073|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829074|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829075|NCT04009772|Metronidazole|metronidazole|mesh-list
2829076|NCT04009772|Cefepime|cefepime|mesh-list
2829077|NCT04009772|Cefuroxime|cefuroxime|mesh-list
2829078|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
2829079|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829080|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2829081|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2829082|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2829083|NCT04009889|Silicon|silicon|mesh-list
2829084|NCT04009889|Trace Elements|trace elements|mesh-ancestor
2829085|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
2829086|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829087|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2829088|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2829089|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
2829090|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829091|NCT04009824|Antacids|antacids|mesh-ancestor
2829092|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829093|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2829094|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
2829095|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2829096|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829097|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
2829098|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
2829099|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829100|NCT04009603|Metformin|metformin|mesh-list
2829101|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2829102|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829103|NCT04009525|Cyclosporine|cyclosporine|mesh-list
2829104|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
2829105|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
2829106|NCT04009525|Busulfan|busulfan|mesh-list
2829107|NCT04009525|Methotrexate|methotrexate|mesh-list
2829108|NCT04009525|Fludarabine|fludarabine|mesh-list
2829109|NCT04009525|Tacrolimus|tacrolimus|mesh-list
2829110|NCT04009525|Cyclosporins|cyclosporins|mesh-list
2829111|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
2829112|NCT04009525|Basiliximab|basiliximab|mesh-list
2829113|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2829114|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
2829115|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829116|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2829117|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2829118|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
2829119|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829120|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829121|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2829122|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2829123|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
2829124|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2829125|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2829126|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
2829127|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
2829128|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829129|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2829130|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2290265|NCT00257140|Levofloxacin|levofloxacin|mesh-list
2290266|NCT00257140|Ofloxacin|ofloxacin|mesh-list
2290267|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2290268|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829131|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2829132|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
2829133|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829134|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2829135|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2829136|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
2829137|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2829138|NCT04009317|Crizotinib|crizotinib|mesh-list
2829139|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829140|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2290269|NCT00257140|Renal Agents|renal agents|mesh-ancestor
2290270|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290271|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2290272|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2290273|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290274|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290275|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290276|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2290277|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2290278|NCT00257205|Temozolomide|temozolomide|mesh-list
2290279|NCT00257205|Dacarbazine|dacarbazine|mesh-list
2290280|NCT00257205|Tremelimumab|tremelimumab|mesh-list
2290281|NCT00257205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2290282|NCT00257205|Alkylating Agents|alkylating agents|mesh-ancestor
2290283|NCT00257205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290284|NCT00257205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290285|NCT00257257|Rimonabant|rimonabant|mesh-list
2290286|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2290287|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2290288|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2290289|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829141|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829142|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829143|NCT04009109|Dexamethasone|dexamethasone|mesh-list
2290290|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290291|NCT00257257|Hormones|hormones|mesh-ancestor
2290292|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2290293|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290294|NCT00257270|Gabapentin|gabapentin|mesh-list
2290295|NCT00257270|Analgesics|analgesics|mesh-ancestor
2829144|NCT04009109|Lenalidomide|lenalidomide|mesh-list
2829145|NCT04009109|Daratumumab|daratumumab|mesh-list
2829146|NCT04009109|Ixazomib|ixazomib|mesh-list
2290296|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
2290297|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290298|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290299|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
2290300|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2290301|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2290302|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2290303|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2290304|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2290305|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2290306|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829147|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2829148|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
2829149|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
2829150|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829151|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829152|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2829153|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
2829154|NCT04009109|Hormones|hormones|mesh-ancestor
2829155|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829156|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2829157|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829158|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
2829159|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2829160|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2829161|NCT04009109|Growth Substances|growth substances|mesh-ancestor
2829162|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
2829163|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
2829164|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829165|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829166|NCT04009343|Lumefantrine|lumefantrine|mesh-list
2105826|NCT02462148|Bupivacaine|bupivacaine|mesh-list
2105827|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2290307|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290308|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
2290309|NCT00257348|Docetaxel|docetaxel|mesh-list
2290310|NCT00257348|Capecitabine|capecitabine|mesh-list
2290311|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290312|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
2290313|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
2290314|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
2290315|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290316|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2290317|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
2290318|NCT00257361|Cycloserine|cycloserine|mesh-list
2290319|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2829167|NCT04009343|Artemether|artemether|mesh-list
2829168|NCT04009343|Piperaquine|piperaquine|mesh-list
2829169|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2829170|NCT04009343|Artenimol|artenimol|mesh-list
2829171|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
2829172|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2829173|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2829174|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829175|NCT04008979|Aspirin|aspirin|mesh-list
2829176|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2829177|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2829178|NCT04008979|Analgesics|analgesics|mesh-ancestor
2829179|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
2829180|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829181|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829182|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2829183|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2829184|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2829185|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2829186|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829187|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2829188|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2829189|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829190|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
2829191|NCT04009018|Anesthetics|anesthetics|mesh-list
2829192|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2829193|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829194|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
2290320|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829195|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
2829196|NCT04009044|Tamoxifen|tamoxifen|mesh-list
2829197|NCT04009044|Afimoxifene|afimoxifene|mesh-list
2829198|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2829199|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
2829200|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829201|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829202|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2829203|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829204|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2829205|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2829206|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2829207|NCT04008784|Triamcinolone|triamcinolone|mesh-list
2829208|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2829209|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2829210|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2829211|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2829212|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
2829213|NCT04008784|Hormones|hormones|mesh-ancestor
2829214|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829215|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829216|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2829217|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
2829218|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829219|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290321|NCT00257361|Renal Agents|renal agents|mesh-ancestor
2290322|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2290323|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
2290324|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290325|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
2290326|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290327|NCT00257387|Cyclosporine|cyclosporine|mesh-list
2290328|NCT00257387|Cyclosporins|cyclosporins|mesh-list
2290329|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290330|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290331|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2290332|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
2290333|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290334|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
2290335|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290336|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
2290337|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2290338|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2290339|NCT00257426|Octreotide|octreotide|mesh-list
2829230|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2829231|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2290340|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2290341|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2290342|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290343|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
2290344|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
2290345|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290346|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290347|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2290348|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2290349|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290350|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290351|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290352|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290353|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2290354|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
2290355|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290356|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2105828|NCT02462148|BB 1101|bb 1101|mesh-list
2290357|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
2290358|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
2290359|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2290360|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
2829232|NCT04008966|Cetrorelix|cetrorelix|mesh-list
2829233|NCT04008966|Progesterone|progesterone|mesh-list
2829234|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2829235|NCT04008966|Progestins|progestins|mesh-ancestor
2829236|NCT04008966|Hormones|hormones|mesh-ancestor
2829237|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829238|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829239|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
2829240|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2829241|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
2829242|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2829243|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2829244|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2829245|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829246|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2829247|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
2829248|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
2290361|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290362|NCT00257465|Vaccines|vaccines|mesh-list
2290363|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
2290364|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290365|NCT00257491|Telmisartan|telmisartan|mesh-list
2290366|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2290367|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2290368|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2290369|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290370|NCT00257530|Imiquimod|imiquimod|mesh-list
2290371|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2290372|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
2290373|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290374|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290375|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
2105829|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2105830|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
2105831|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
2105832|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105833|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105834|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2105835|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
2105836|NCT02462148|Hormones|hormones|mesh-ancestor
2105837|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2105838|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2105839|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105840|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
2105841|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105842|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105843|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
2105844|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
2105845|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105846|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
2105847|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2105848|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2290376|NCT00257569|Cetirizine|cetirizine|mesh-list
2829249|NCT04008888|Dexamethasone|dexamethasone|mesh-list
2829250|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
2829251|NCT04008888|Fludarabine|fludarabine|mesh-list
2829252|NCT04008888|Melphalan|melphalan|mesh-list
2829253|NCT04008888|BB 1101|bb 1101|mesh-list
2829254|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2829255|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
2829256|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
2829257|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829258|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829259|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2829260|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
2829261|NCT04008888|Hormones|hormones|mesh-ancestor
2829262|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829263|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2829264|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829265|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
2829266|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829267|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829268|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2829269|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
2829270|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2829271|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
2829272|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2829273|NCT04008511|Capecitabine|capecitabine|mesh-list
2829274|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
2829275|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2829276|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
2829277|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829278|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829279|NCT04008290|Liraglutide|liraglutide|mesh-list
2829280|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2829281|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829282|NCT04008290|Incretins|incretins|mesh-ancestor
2829283|NCT04008290|Hormones|hormones|mesh-ancestor
2829284|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829285|NCT04008238|Trabectedin|trabectedin|mesh-list
2829286|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2829287|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
2829288|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829289|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290377|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2290378|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2290379|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2290380|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
2290381|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
2290382|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829290|NCT04008264|Scopolamine|scopolamine|mesh-list
2829291|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2829292|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2829293|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
2829294|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
2829295|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829296|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829297|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2829298|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
2829299|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2829300|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
2829301|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829302|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829303|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2829304|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
2829305|NCT04008186|Metformin|metformin|mesh-list
2829306|NCT04008186|Repaglinide|repaglinide|mesh-list
2829307|NCT04008186|Itraconazole|itraconazole|mesh-list
2829308|NCT04008186|Digoxin|digoxin|mesh-list
2829309|NCT04008186|Verapamil|verapamil|mesh-list
2290383|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829310|NCT04008186|Midazolam|midazolam|mesh-list
2829311|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2829312|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
2829313|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2829314|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829315|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2829316|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2829317|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2829318|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2290384|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290385|NCT00257582|Cetirizine|cetirizine|mesh-list
2290386|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2290387|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2290388|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2290389|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
2829319|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2829320|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2829321|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2829322|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
2829323|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
2829324|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
2829325|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
2829326|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829327|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829328|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2829329|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2829330|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
2829331|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2829332|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2829333|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829334|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
2829335|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829336|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2829337|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2829338|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2829339|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
2829340|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829341|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2829342|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2829343|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2829344|NCT04008186|Protective Agents|protective agents|mesh-ancestor
2829345|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2829346|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2829347|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2829348|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
2829349|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2829350|NCT04008433|Lidocaine|lidocaine|mesh-list
2829351|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
2829352|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
2829353|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2829354|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290390|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
2290391|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290392|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290393|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290394|NCT00257595|Cetirizine|cetirizine|mesh-list
2290395|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2290396|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2290397|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2290398|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
2290399|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
2290400|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290401|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290402|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290403|NCT00257621|Ritonavir|ritonavir|mesh-list
2290404|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2290405|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2290406|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
2290407|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829355|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
2829356|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829357|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2829358|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2829359|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2829360|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2829361|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829362|NCT04008316|Colchicine|colchicine|mesh-list
2829363|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
2829364|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2829365|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
2829366|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
2829367|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
2829368|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829369|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290408|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290409|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2290410|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2290411|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
2829370|NCT04008043|Acetaminophen|acetaminophen|mesh-list
2829371|NCT04008043|Dexamethasone|dexamethasone|mesh-list
2829372|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2829373|NCT04008043|Hydrocodone|hydrocodone|mesh-list
2829374|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2829375|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
2829376|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
2829377|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829378|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829379|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2829380|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
2829381|NCT04008043|Hormones|hormones|mesh-ancestor
2829382|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829383|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2829384|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829385|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2829386|NCT04008043|Analgesics|analgesics|mesh-ancestor
2829387|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
2829388|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
2829389|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2829390|NCT04008043|Narcotics|narcotics|mesh-ancestor
2829391|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2829392|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
2829393|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
2829394|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2829395|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2829396|NCT04007809|Glucagon|glucagon|mesh-list
2829397|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2290412|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290413|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2290414|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2290415|NCT00257634|Dexamethasone|dexamethasone|mesh-list
2290416|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2290417|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
2290418|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
2290419|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290420|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290421|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2290422|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
2290423|NCT00257634|Hormones|hormones|mesh-ancestor
2290424|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2290425|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2290426|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290427|NCT00257699|Metronidazole|metronidazole|mesh-list
2290428|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
2290429|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290430|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290431|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2290432|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2290433|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2290434|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2290435|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290436|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290437|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290438|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2290439|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2290440|NCT00257712|Hormones|hormones|mesh-list
2290441|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
2290442|NCT00257712|Tesamorelin|tesamorelin|mesh-list
2290443|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2290444|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290445|NCT00257712|Growth Substances|growth substances|mesh-ancestor
2290446|NCT00257790|Tobramycin|tobramycin|mesh-list
2290447|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290448|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290449|NCT00257803|Oxytocin|oxytocin|mesh-list
2829398|NCT04007809|Hormones|hormones|mesh-ancestor
2829399|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829400|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829401|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
2829402|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2829403|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829404|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2829405|NCT04007835|Gefitinib|gefitinib|mesh-list
2829406|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829407|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2829408|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829409|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829410|NCT04008030|Leucovorin|leucovorin|mesh-list
2829411|NCT04008030|Bevacizumab|bevacizumab|mesh-list
2290450|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
2290451|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2290452|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290453|NCT00257816|Topotecan|topotecan|mesh-list
2290454|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290455|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2290456|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2290457|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290458|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290459|NCT00257829|Methazolamide|methazolamide|mesh-list
2829412|NCT04008030|Nivolumab|nivolumab|mesh-list
2829413|NCT04008030|Cetuximab|cetuximab|mesh-list
2829414|NCT04008030|Ipilimumab|ipilimumab|mesh-list
2829415|NCT04008030|Fluorouracil|fluorouracil|mesh-list
2829416|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
2829417|NCT04008030|Irinotecan|irinotecan|mesh-list
2829418|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2829419|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829420|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2829421|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2829422|NCT04008030|Growth Substances|growth substances|mesh-ancestor
2829423|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829424|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
2829425|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
2829426|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829427|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2829428|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2829429|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
2829430|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2829431|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2829432|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2829433|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829434|NCT04008030|Antidotes|antidotes|mesh-ancestor
2829435|NCT04008030|Protective Agents|protective agents|mesh-ancestor
2829436|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
2829437|NCT04008030|Vitamins|vitamins|mesh-ancestor
2829438|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
2829439|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
2829440|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
2829441|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829442|NCT04007874|Vitamin E|vitamin e|mesh-list
2829443|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
2829444|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2829445|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2829446|NCT04007874|Vitamins|vitamins|mesh-ancestor
2829447|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
2829448|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829449|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
2829450|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829451|NCT04007874|Protective Agents|protective agents|mesh-ancestor
2829452|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2829453|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
2829454|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2829455|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2829456|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2829457|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2829458|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2829459|NCT04007874|Estrogens|estrogens|mesh-ancestor
2829460|NCT04007874|Hormones|hormones|mesh-ancestor
2829461|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829462|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2829463|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
2829464|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
2829465|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2829466|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2290460|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2290461|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290462|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290463|NCT00257829|Diuretics|diuretics|mesh-ancestor
2290464|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
2290465|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829467|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829468|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829469|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829470|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2829471|NCT04007588|Nivolumab|nivolumab|mesh-list
2829472|NCT04007588|Ipilimumab|ipilimumab|mesh-list
2829473|NCT04007588|Linrodostat|linrodostat|mesh-list
2829474|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2829475|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829476|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2829477|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829478|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829479|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2829480|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2829481|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2829482|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2829483|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2829484|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2829485|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2829486|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
2829487|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829488|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829489|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829490|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
2829491|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2829492|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2829493|NCT04007328|Prednisolone|prednisolone|mesh-list
2829494|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
2829495|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2829496|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
2829497|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2829498|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
2829499|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
2829500|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829501|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829502|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2829503|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
2829504|NCT04007328|Hormones|hormones|mesh-ancestor
2829505|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829506|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2829507|NCT04007328|Protective Agents|protective agents|mesh-ancestor
2829508|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2829509|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829510|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
2829511|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2829512|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2829513|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829514|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2829515|NCT04007341|Analgesics|analgesics|mesh-ancestor
2829516|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
2829517|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829518|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2829519|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2829520|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2829521|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
2829522|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829523|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290466|NCT00257855|Lamotrigine|lamotrigine|mesh-list
2290467|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
2290468|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2290469|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2290470|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290471|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2290472|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290473|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2290474|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2829524|NCT04007393|Topiramate|topiramate|mesh-list
2829525|NCT04007393|Phentermine|phentermine|mesh-list
2829526|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
2829527|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2829528|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829529|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2829530|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
2829531|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2829532|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
2829533|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
2829534|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829535|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
2829536|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829537|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829538|NCT04007289|Apixaban|apixaban|mesh-list
2829539|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2829540|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
2829541|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2829542|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
2829543|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829544|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829545|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
2829546|NCT04007003|Insulin|insulin|mesh-list
2829547|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2829548|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105849|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
2105850|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105851|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2105852|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2105853|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2105854|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
2829549|NCT04007055|Ticagrelor|ticagrelor|mesh-list
2829550|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2829551|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2829552|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2829553|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2829554|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
2290475|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2290476|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2290477|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2290478|NCT00257868|Rivastigmine|rivastigmine|mesh-list
2290479|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2290480|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290481|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290482|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
2290483|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290484|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290485|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2290486|NCT00257868|Protective Agents|protective agents|mesh-ancestor
2290487|NCT00257959|Amiodarone|amiodarone|mesh-list
2290488|NCT00257959|Sotalol|sotalol|mesh-list
2290489|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2290490|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2290491|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
2290492|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2290493|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2829555|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290494|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290495|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2290496|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2290497|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2290498|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290499|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2290500|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2290501|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2829556|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829557|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829558|NCT04006873|Ivacaftor|ivacaftor|mesh-list
2829559|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2829560|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2829561|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829562|NCT04007029|Vidarabine|vidarabine|mesh-list
2829563|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
2829564|NCT04007029|Fludarabine|fludarabine|mesh-list
2829565|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
2829566|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
2829567|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
2829568|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2829569|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
2829570|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829571|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2829572|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2829573|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
2829574|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829575|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829576|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2829577|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2829578|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
2829579|NCT04007029|Antiviral Agents|antiviral agents|mesh-ancestor
2829580|NCT04007029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829581|NCT04006847|Dasatinib|dasatinib|mesh-list
2829582|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829583|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2829584|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829585|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829586|NCT04006821|Apatinib|apatinib|mesh-list
2829587|NCT04006821|Antibodies|antibodies|mesh-list
2829588|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
2829589|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829590|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829591|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2829592|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829593|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829594|NCT04006470|Fluorides|fluorides|mesh-list
2829595|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
2829596|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
2829597|NCT04006470|Protective Agents|protective agents|mesh-ancestor
2829598|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829601|NCT04006639|Analgesics|analgesics|mesh-list
2829602|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
2829603|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829604|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829605|NCT04006483|Fluorides|fluorides|mesh-list
2829606|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
2829607|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
2829608|NCT04006483|Protective Agents|protective agents|mesh-ancestor
2829609|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829610|NCT04006262|Nivolumab|nivolumab|mesh-list
2829611|NCT04006262|Ipilimumab|ipilimumab|mesh-list
2829612|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2829613|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829614|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2829615|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829616|NCT04006691|Mitomycins|mitomycins|mesh-list
2829617|NCT04006691|Mitomycin|mitomycin|mesh-list
2829618|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2829619|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829620|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
2829621|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829622|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2829623|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829624|NCT04006080|Vedolizumab|vedolizumab|mesh-list
2829625|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2829626|NCT04006093|Apixaban|apixaban|mesh-list
2829627|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2829628|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
2829629|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2829630|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
2829631|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829632|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829633|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
2829634|NCT04006041|Paclitaxel|paclitaxel|mesh-list
2829635|NCT04006041|Cisplatin|cisplatin|mesh-list
2829636|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2829637|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829638|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
2829639|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
2829640|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
2829641|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829642|NCT04006353|Rifampin|rifampin|mesh-list
2829643|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2829644|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
2829645|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2829646|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829647|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
2829648|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2829649|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829650|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829651|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2829652|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2829653|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2829654|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2829655|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2829656|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2829657|NCT04006054|Midazolam|midazolam|mesh-list
2829658|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
2829659|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2829660|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2829661|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829662|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2829663|NCT04006054|Analgesics|analgesics|mesh-ancestor
2829664|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
2829665|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829666|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2829667|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2829668|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2829669|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
2829670|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829671|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829672|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2829673|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2829674|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2829675|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2829676|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2829677|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
2829678|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
2829679|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
2829680|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
2829681|NCT04005872|Calcium|calcium|mesh-list
2829682|NCT04005872|Fluorides|fluorides|mesh-list
2829683|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2829684|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829685|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
2829686|NCT04005872|Protective Agents|protective agents|mesh-ancestor
2829687|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
2829688|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
2829689|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2829690|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2829691|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829692|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829693|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829694|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2829695|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
2829696|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
2829697|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2829698|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2829699|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829700|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829701|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829702|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2829703|NCT04005612|Vitamin D|vitamin d|mesh-list
2829704|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
2829705|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
2829706|NCT04005612|Vitamins|vitamins|mesh-list
2829707|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
2829708|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829709|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2829710|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2829711|NCT04005716|Cisplatin|cisplatin|mesh-list
2829712|NCT04005716|Carboplatin|carboplatin|mesh-list
2829713|NCT04005716|Etoposide|etoposide|mesh-list
2829714|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
2829715|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829716|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2829717|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2829718|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2829719|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829720|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829721|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
2829722|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829728|NCT04005664|Phenylephrine|phenylephrine|mesh-list
2829729|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
2829730|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2829731|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
2829732|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
2829733|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829734|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829735|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
2829736|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2829737|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
2829738|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
2829739|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2829740|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2829741|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2829742|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
2829743|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829744|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829745|NCT04005664|Protective Agents|protective agents|mesh-ancestor
2829746|NCT04005469|Treprostinil|treprostinil|mesh-list
2829747|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2829748|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
2829749|NCT04005599|Remifentanil|remifentanil|mesh-list
2829750|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2829751|NCT04005599|Narcotics|narcotics|mesh-ancestor
2829752|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2829753|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829754|NCT04005599|Analgesics|analgesics|mesh-ancestor
2829755|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
2290502|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2290503|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
2290504|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290505|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290506|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
2290507|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
2290508|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290509|NCT00257972|Aripiprazole|aripiprazole|mesh-list
2290510|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
2290511|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2290512|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2829756|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829757|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
2829758|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2829759|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
2829760|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2829761|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2829762|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829763|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2829764|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
2829765|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2290513|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2290514|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2290515|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290516|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
2290517|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
2290518|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829766|NCT04005430|Dexamethasone|dexamethasone|mesh-list
2829767|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
2829768|NCT04005430|BB 1101|bb 1101|mesh-list
2829769|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2829770|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
2829771|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
2290519|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290520|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2290521|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2290522|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
2290523|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2290524|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2290525|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2290526|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2290527|NCT00258050|Lapatinib|lapatinib|mesh-list
2290528|NCT00258050|Midazolam|midazolam|mesh-list
2290529|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2290530|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2290531|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2290532|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290533|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2290534|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2290535|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2829772|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829773|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829774|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2829775|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
2829776|NCT04005430|Hormones|hormones|mesh-ancestor
2829777|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829778|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2829779|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829780|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
2829781|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829782|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829783|NCT04005365|Propranolol|propranolol|mesh-list
2829784|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2829785|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2829786|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
2829787|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829788|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829789|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829790|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2829791|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2829792|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
2829793|NCT04005326|Anesthetics|anesthetics|mesh-list
2829794|NCT04005326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2829795|NCT04005326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829796|NCT04005222|Selenium|selenium|mesh-list
2829797|NCT04005222|Melatonin|melatonin|mesh-list
2829798|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
2829799|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829800|NCT04005222|Protective Agents|protective agents|mesh-ancestor
2829801|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829802|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2829803|NCT04005222|Trace Elements|trace elements|mesh-ancestor
2829804|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
2829805|NCT04005417|Fluorides|fluorides|mesh-list
2829806|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
2829807|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
2829808|NCT04005417|Protective Agents|protective agents|mesh-ancestor
2829809|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829810|NCT04005287|Pirenzepine|pirenzepine|mesh-list
2829811|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2829812|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2829813|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2829814|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2829815|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
2829816|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829817|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829818|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290536|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2290537|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
2290538|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
2290539|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
2290540|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
2290541|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290542|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290543|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290544|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2290545|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290546|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2290547|NCT00258063|Norelgestromin|norelgestromin|mesh-list
2290548|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
2290549|NCT00258063|Estradiol|estradiol|mesh-list
2290550|NCT00258063|Estrogens|estrogens|mesh-ancestor
2290551|NCT00258063|Hormones|hormones|mesh-ancestor
2290552|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2290553|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290554|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2290555|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2290556|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2290557|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2290558|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2290559|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
2290560|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2290561|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290562|NCT00258089|Levofloxacin|levofloxacin|mesh-list
2290563|NCT00258089|Ofloxacin|ofloxacin|mesh-list
2290564|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2290565|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290566|NCT00258089|Renal Agents|renal agents|mesh-ancestor
2290567|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290568|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2290569|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2290570|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829833|NCT04005079|Ofloxacin|ofloxacin|mesh-list
2829834|NCT04005079|Prednisolone|prednisolone|mesh-list
2829835|NCT04005079|Pilocarpine|pilocarpine|mesh-list
2829836|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2829837|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
2829838|NCT04005079|Hormones|hormones|mesh-ancestor
2829839|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829840|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829841|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2829842|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829843|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
2829844|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2829845|NCT04005079|Miotics|miotics|mesh-ancestor
2829846|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2829847|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2829848|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
2829849|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829850|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829851|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2829852|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829853|NCT04005079|Renal Agents|renal agents|mesh-ancestor
2290571|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290572|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829854|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2829855|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2829856|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2829857|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829858|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2829859|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2829860|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
2829861|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2290573|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2290574|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2290575|NCT00258102|Levofloxacin|levofloxacin|mesh-list
2290576|NCT00258102|Ofloxacin|ofloxacin|mesh-list
2290577|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2290578|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290579|NCT00258102|Renal Agents|renal agents|mesh-ancestor
2290580|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290581|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2290582|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2290583|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829862|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
2829863|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829864|NCT04005053|Expectorants|expectorants|mesh-ancestor
2829865|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
2829866|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2829867|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
2829868|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829869|NCT04005053|Protective Agents|protective agents|mesh-ancestor
2829870|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829871|NCT04005053|Antidotes|antidotes|mesh-ancestor
2829872|NCT04004845|Misoprostol|misoprostol|mesh-list
2829873|NCT04004845|Oxytocin|oxytocin|mesh-list
2829874|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
2829875|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2829876|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829877|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2829878|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
2829879|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2829880|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2829881|NCT04004754|Miltefosine|miltefosine|mesh-list
2829882|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
2829883|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829884|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829885|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2829886|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2829887|NCT04004819|Rituximab|rituximab|mesh-list
2829888|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2829889|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829890|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
2829891|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829892|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2829893|NCT04005170|Paclitaxel|paclitaxel|mesh-list
2829894|NCT04005170|Cisplatin|cisplatin|mesh-list
2829895|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2829896|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829897|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
2829898|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
2829899|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
2829900|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829901|NCT04004910|Paclitaxel|paclitaxel|mesh-list
2829902|NCT04004910|Carboplatin|carboplatin|mesh-list
2829903|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
2829904|NCT04004910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2829905|NCT04004910|Tubulin Modulators|tubulin modulators|mesh-ancestor
2829906|NCT04004910|Antimitotic Agents|antimitotic agents|mesh-ancestor
2829907|NCT04004910|Mitosis Modulators|mitosis modulators|mesh-ancestor
2829908|NCT04004910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829909|NCT04004871|Paclitaxel|paclitaxel|mesh-list
2829910|NCT04004871|Cisplatin|cisplatin|mesh-list
2829911|NCT04004871|Fluorouracil|fluorouracil|mesh-list
2829912|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2290584|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290585|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290586|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2290587|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2290588|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2290589|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2290590|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2290591|NCT00258115|Analgesics|analgesics|mesh-ancestor
2290592|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
2290593|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290594|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290595|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2290596|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2290597|NCT00258193|Linaclotide|linaclotide|mesh-list
2290598|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2290599|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
2290600|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290601|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2290602|NCT00258232|Celecoxib|celecoxib|mesh-list
2829913|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829914|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
2829915|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
2829916|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
2829917|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829918|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
2829919|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2829920|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2829921|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
2829922|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829923|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
2829924|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2829925|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829926|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2829927|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829928|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
2829929|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2829930|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
2829931|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2829932|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829933|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2829934|NCT04004988|Tirzepatide|tirzepatide|mesh-list
2829935|NCT04004988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2829936|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829937|NCT04004988|Incretins|incretins|mesh-ancestor
2829938|NCT04004988|Hormones|hormones|mesh-ancestor
2829939|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829940|NCT04004702|Levetiracetam|levetiracetam|mesh-list
2829941|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
2829942|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
2829943|NCT04004507|Phentolamine|phentolamine|mesh-list
2829944|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2829945|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2829946|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2829947|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2829948|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
2829949|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2829950|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290603|NCT00258232|Capecitabine|capecitabine|mesh-list
2290604|NCT00258232|Irinotecan|irinotecan|mesh-list
2290605|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2290606|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
2829951|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829952|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2829969|NCT04004572|Pegaspargase|pegaspargase|mesh-list
2829970|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829971|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
2829972|NCT04004078|Clotrimazole|clotrimazole|mesh-list
2829973|NCT04004078|Miconazole|miconazole|mesh-list
2829974|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2829975|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2290607|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290608|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290609|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2290610|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2290611|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290612|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2290613|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2290614|NCT00258232|Analgesics|analgesics|mesh-ancestor
2290615|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
2290616|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290617|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290618|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2290619|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2290620|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2290621|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2290622|NCT00258245|Aspirin|aspirin|mesh-list
2290623|NCT00258245|Vitamins|vitamins|mesh-list
2290624|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
2290625|NCT00258245|Thalidomide|thalidomide|mesh-list
2290626|NCT00258245|Dexamethasone|dexamethasone|mesh-list
2290627|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
2829976|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2829977|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2829978|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2829979|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105855|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
2105856|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
2105857|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2105858|NCT02462382|Ropivacaine|ropivacaine|mesh-list
2105859|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
2105860|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
2105861|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105862|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105863|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
2105864|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105865|NCT02462473|Olanzapine|olanzapine|mesh-list
2105866|NCT02462473|Risperidone|risperidone|mesh-list
2105867|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2290628|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
2290629|NCT00258245|Bortezomib|bortezomib|mesh-list
2290630|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
2829980|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2290631|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2290632|NCT00258245|BB 1101|bb 1101|mesh-list
2290633|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
2290634|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829981|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
2829982|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2829983|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2829984|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2290635|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2290636|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
2290637|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
2829985|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2829986|NCT04004234|Manganese|manganese|mesh-list
2829987|NCT04004234|Gemcitabine|gemcitabine|mesh-list
2829988|NCT04004234|Paclitaxel|paclitaxel|mesh-list
2829989|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2829990|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2829991|NCT04004234|Antibodies|antibodies|mesh-list
2829992|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
2829993|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2829994|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2829995|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
2829996|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
2829997|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
2829998|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2829999|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
2830000|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830001|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2830002|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
2830003|NCT04004234|Antiviral Agents|antiviral agents|mesh-ancestor
2830004|NCT04004234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830005|NCT04004234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290638|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290639|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2290640|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
2290641|NCT00258245|Hormones|hormones|mesh-ancestor
2290642|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2290643|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2290644|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290645|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
2290646|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290647|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290648|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2290649|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2290650|NCT00258245|Analgesics|analgesics|mesh-ancestor
2290651|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
2290652|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2290653|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2290654|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2290655|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2290656|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2290657|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
2290658|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
2290659|NCT00258245|Protective Agents|protective agents|mesh-ancestor
2290660|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2290661|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
2290662|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
2290663|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290664|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290665|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2290666|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2290667|NCT00258245|Growth Substances|growth substances|mesh-ancestor
2830006|NCT04004234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2830007|NCT04004234|Trace Elements|trace elements|mesh-ancestor
2830008|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
2830009|NCT04004208|Aflibercept|aflibercept|mesh-list
2830010|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2830011|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2830012|NCT04004208|Growth Substances|growth substances|mesh-ancestor
2830013|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830014|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
2830015|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830016|NCT04003987|Bupivacaine|bupivacaine|mesh-list
2830017|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
2830018|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
2830019|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830020|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830021|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
2830022|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830023|NCT04004117|Fentanyl|fentanyl|mesh-list
2830024|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2830025|NCT04004117|Narcotics|narcotics|mesh-ancestor
2830026|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830027|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830028|NCT04004117|Analgesics|analgesics|mesh-ancestor
2830029|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
2830030|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830031|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2830032|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2830033|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
2830034|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
2830035|NCT04003948|Ibogaine|ibogaine|mesh-list
2830036|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
2830037|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830038|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2830039|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2830040|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2830041|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830042|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290668|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
2290669|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
2830043|NCT04003844|Aspirin|aspirin|mesh-list
2830044|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
2830045|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2830046|NCT04003844|Antibodies|antibodies|mesh-list
2830047|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
2830048|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
2830049|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830050|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2830051|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2830052|NCT04003844|Analgesics|analgesics|mesh-ancestor
2830053|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
2830054|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830055|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2830056|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2830057|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2830058|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2830059|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830060|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2830061|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2830062|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830063|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
2830064|NCT04003818|Teicoplanin|teicoplanin|mesh-list
2830065|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2830066|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830067|NCT04003922|Adalimumab|adalimumab|mesh-list
2290670|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2290671|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290672|NCT00258271|Cytarabine|cytarabine|mesh-list
2290673|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
2290674|NCT00258271|Cladribine|cladribine|mesh-list
2290675|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
2290676|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290677|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2290678|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
2290679|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290680|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290681|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
2290682|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290683|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2290684|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2290685|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290686|NCT00258284|Docetaxel|docetaxel|mesh-list
2290687|NCT00258284|Capecitabine|capecitabine|mesh-list
2290688|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290689|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
2290690|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
2290691|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
2830068|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2830069|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2830080|NCT04003792|Bevacizumab|bevacizumab|mesh-list
2830081|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
2830082|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2830083|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830084|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2830085|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2830086|NCT04003792|Growth Substances|growth substances|mesh-ancestor
2830087|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830088|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
2830089|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
2830090|NCT04003688|Analgesics|analgesics|mesh-ancestor
2830091|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
2830092|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830093|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830094|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
2830095|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830096|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2830097|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
2830098|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2830099|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2830100|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830101|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2830102|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
2830103|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2830104|NCT04003376|Vitamin D|vitamin d|mesh-list
2830105|NCT04003376|Triamcinolone|triamcinolone|mesh-list
2830106|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2830107|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2830108|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2830109|NCT04003376|Vitamins|vitamins|mesh-ancestor
2830110|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
2830111|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830112|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2830113|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2830114|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
2830115|NCT04003376|Hormones|hormones|mesh-ancestor
2830116|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830117|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2830118|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
2830119|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830120|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830121|NCT04003467|Teriparatide|teriparatide|mesh-list
2830122|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2830123|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830124|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2830125|NCT04003402|Ethanol|ethanol|mesh-list
2830126|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2830127|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830128|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830129|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830130|NCT04003610|Gemcitabine|gemcitabine|mesh-list
2830131|NCT04003610|Carboplatin|carboplatin|mesh-list
2830132|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
2830133|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830134|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2830135|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
2830136|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830137|NCT04003610|Antiviral Agents|antiviral agents|mesh-ancestor
2830138|NCT04003610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830139|NCT04003610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830140|NCT04003610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2290692|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830141|NCT04003610|Immunologic Factors|immunologic factors|mesh-ancestor
2830142|NCT04003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290693|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2290694|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
2290695|NCT00258297|Gefitinib|gefitinib|mesh-list
2830143|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2830148|NCT04003350|Acetaminophen|acetaminophen|mesh-list
2830149|NCT04003350|Meloxicam|meloxicam|mesh-list
2830150|NCT04003350|Oxycodone|oxycodone|mesh-list
2830151|NCT04003350|Tramadol|tramadol|mesh-list
2830152|NCT04003350|Gabapentin|gabapentin|mesh-list
2830153|NCT04003350|Esomeprazole|esomeprazole|mesh-list
2830154|NCT04003350|Metaxalone|metaxalone|mesh-list
2830155|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2830156|NCT04003350|Narcotics|narcotics|mesh-ancestor
2830157|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830158|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830159|NCT04003350|Analgesics|analgesics|mesh-ancestor
2830160|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
2830161|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830162|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
2830163|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2830164|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2830165|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2830166|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2290696|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2290697|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290698|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2290699|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290700|NCT00258323|Fluorouracil|fluorouracil|mesh-list
2290701|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830167|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2830168|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830169|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830170|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
2830171|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2830172|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2830173|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2830174|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830175|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2830176|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
2830177|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2290702|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
2290703|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290704|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2290705|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2290706|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
2290707|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290708|NCT00258336|Rituximab|rituximab|mesh-list
2290709|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
2290710|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2290711|NCT00258336|Antibodies|antibodies|mesh-list
2290712|NCT00258336|Sargramostim|sargramostim|mesh-list
2290713|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2290714|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2290715|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290716|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
2105868|NCT02462473|Aripiprazole|aripiprazole|mesh-list
2105869|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2105870|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2105871|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
2105872|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105873|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105874|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105875|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2105876|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2105877|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2105878|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2105879|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2105880|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
2105881|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
2290717|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290718|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2830178|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2830179|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2830180|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2830181|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2830182|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2830183|NCT04003246|Durvalumab|durvalumab|mesh-list
2830184|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2830185|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2830186|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830187|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
2830188|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830189|NCT04003207|Hormones|hormones|mesh-list
2830190|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830191|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830192|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2830193|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
2830194|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830195|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2830196|NCT04003103|Islatravir|islatravir|mesh-list
2830197|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
2830198|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830199|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830200|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830201|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2830202|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2830203|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2830204|NCT04003012|Lidocaine|lidocaine|mesh-list
2830205|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
2830206|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
2830207|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830208|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830209|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
2830210|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830211|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2830212|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2830213|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2830214|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2830215|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830216|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2830217|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
2830218|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
2830219|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2830220|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2830221|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
2830222|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830223|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830224|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2830225|NCT04002635|Letrozole|letrozole|mesh-list
2830226|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2830227|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2830228|NCT04002635|Estradiol|estradiol|mesh-list
2830229|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2830230|NCT04002635|Progesterone|progesterone|mesh-list
2830231|NCT04002635|Estrogens|estrogens|mesh-ancestor
2830232|NCT04002635|Hormones|hormones|mesh-ancestor
2830233|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830234|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830235|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2830236|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
2830237|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2830238|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2830239|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105882|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
2105883|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105884|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2105885|NCT02462473|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2105886|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2105887|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2105888|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
2105889|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
2105890|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2105891|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2105892|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2105893|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2290719|NCT00258375|Docetaxel|docetaxel|mesh-list
2290720|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830240|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2830241|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2830242|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830243|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290721|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
2290722|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
2290723|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
2290724|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290725|NCT00258388|Prednisone|prednisone|mesh-list
2290726|NCT00258388|Docetaxel|docetaxel|mesh-list
2290727|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290728|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
2290729|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
2290730|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
2290731|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290732|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2290733|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
2830244|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2830245|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
2830246|NCT04002635|Progestins|progestins|mesh-ancestor
2830247|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
2830248|NCT04002401|Rituximab|rituximab|mesh-list
2830249|NCT04002401|Fludarabine|fludarabine|mesh-list
2830250|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2830251|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
2830252|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830253|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2830254|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2105894|NCT02462486|Ranibizumab|ranibizumab|mesh-list
2105895|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2105896|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2105897|NCT02462486|Growth Substances|growth substances|mesh-ancestor
2105898|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105899|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
2105900|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105901|NCT02462720|Polidocanol|polidocanol|mesh-list
2105902|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2105903|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2105904|NCT02462928|Ranibizumab|ranibizumab|mesh-list
2105905|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2105906|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2105907|NCT02462928|Growth Substances|growth substances|mesh-ancestor
2105908|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105909|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
2105910|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105911|NCT02463097|Insulin|insulin|mesh-list
2105912|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2105913|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105914|NCT02463331|Chloroquine|chloroquine|mesh-list
2105915|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2105916|NCT02463331|Prednisone|prednisone|mesh-list
2105917|NCT02463331|Azathioprine|azathioprine|mesh-list
2105918|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2105919|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
2105920|NCT02463331|Hormones|hormones|mesh-ancestor
2105921|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2105922|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105923|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2105924|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2105925|NCT02463331|Amebicides|amebicides|mesh-ancestor
2105926|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2105927|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2105928|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2105929|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
2105930|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2105931|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2105932|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2105933|NCT02463331|Analgesics|analgesics|mesh-ancestor
2105934|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
2105935|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105936|NCT02463331|Filaricides|filaricides|mesh-ancestor
2105937|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
2105938|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
2105939|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
2105940|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830255|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
2290734|NCT00258388|Hormones|hormones|mesh-ancestor
2290735|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2290736|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290737|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2830256|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830257|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830258|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2830259|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2830260|NCT04002323|Lamivudine|lamivudine|mesh-list
2830261|NCT04002323|Dolutegravir|dolutegravir|mesh-list
2830262|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2830263|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2830264|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830265|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830266|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
2830267|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830268|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2830269|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2830270|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2830271|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2830272|NCT04002271|Propofol|propofol|mesh-list
2830273|NCT04002271|Sevoflurane|sevoflurane|mesh-list
2830274|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
2830275|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830276|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830277|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2830278|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2830279|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
2830280|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2830281|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2830282|NCT04002700|Haloperidol|haloperidol|mesh-list
2830283|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
2830284|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
2830285|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
2830286|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
2830287|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830288|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830289|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2830290|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2830291|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830292|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2830293|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2830294|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
2830295|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830296|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830297|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2830298|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2830299|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830300|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
2830301|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2830302|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2830303|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2830304|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830305|NCT04002349|Budesonide|budesonide|mesh-list
2830306|NCT04002349|Levocabastine|levocabastine|mesh-list
2830307|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2830308|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2830309|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
2830310|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830311|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830312|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2830313|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
2830314|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
2830315|NCT04002349|Hormones|hormones|mesh-ancestor
2830316|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830317|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2830318|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2830319|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
2830320|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
2830321|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830322|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830323|NCT04002518|Cimetidine|cimetidine|mesh-list
2830324|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2290738|NCT00258479|Modafinil|modafinil|mesh-list
2830325|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2830326|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2830327|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
2830328|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
2830329|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830330|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830331|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830332|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2830333|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2830334|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830335|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
2830336|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
2830337|NCT04002115|Busulfan|busulfan|mesh-list
2830338|NCT04002115|Fludarabine|fludarabine|mesh-list
2830339|NCT04002115|Clofarabine|clofarabine|mesh-list
2830340|NCT04002115|Tacrolimus|tacrolimus|mesh-list
2830341|NCT04002115|Lenograstim|lenograstim|mesh-list
2830342|NCT04002115|Sargramostim|sargramostim|mesh-list
2830343|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2830344|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
2830345|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830346|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2830347|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2830348|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
2830349|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830350|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830351|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2830352|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2830353|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
2830354|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2830355|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2830356|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830357|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2830358|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2830359|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
2830360|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2830361|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830362|NCT04002141|Letrozole|letrozole|mesh-list
2830363|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830364|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2830365|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2830366|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830367|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830368|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2830369|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
2830370|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830371|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830384|NCT04001959|Fluorides|fluorides|mesh-list
2830385|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
2830386|NCT04001959|Protective Agents|protective agents|mesh-ancestor
2105941|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2105942|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2105943|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
2105944|NCT02463357|Metformin|metformin|mesh-list
2105945|NCT02463357|Nifedipine|nifedipine|mesh-list
2105946|NCT02463357|Methazolamide|methazolamide|mesh-list
2105947|NCT02463357|Quercetin|quercetin|mesh-list
2105948|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2105949|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105950|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2105951|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2105952|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105953|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2105954|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
2105955|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
2105956|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2105957|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
2105958|NCT02463357|Protective Agents|protective agents|mesh-ancestor
2105959|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2105960|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105961|NCT02463357|Diuretics|diuretics|mesh-ancestor
2105962|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
2105963|NCT02463409|Theophylline|theophylline|mesh-list
2105964|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2105965|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
2105966|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2105967|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105968|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2105969|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
2105970|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2105971|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2105972|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2105973|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
2105974|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2105975|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2105976|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
2105977|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2105978|NCT02464033|Vitamin D|vitamin d|mesh-list
2105979|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
2105980|NCT02464033|Etanercept|etanercept|mesh-list
2105981|NCT02464033|Vitamins|vitamins|mesh-ancestor
2105982|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
2105983|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2105984|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2105985|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2105986|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2105987|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2105988|NCT02464033|Analgesics|analgesics|mesh-ancestor
2105989|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
2105990|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830387|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830388|NCT04002089|Bupivacaine|bupivacaine|mesh-list
2830389|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
2830390|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
2830391|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830392|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830393|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
2830394|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830395|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2830396|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830397|NCT04002011|Warfarin|warfarin|mesh-list
2830398|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
2830399|NCT04002011|Dabigatran|dabigatran|mesh-list
2830400|NCT04002011|Apixaban|apixaban|mesh-list
2830401|NCT04002011|Edoxaban|edoxaban|mesh-list
2830402|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
2830403|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2830404|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
2290739|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2290740|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290741|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2290742|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2290743|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2290744|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290745|NCT00258557|Darunavir|darunavir|mesh-list
2290746|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2290747|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2290748|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
2290749|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290750|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290751|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2290752|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2290753|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
2290754|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290755|NCT00258596|Sirolimus|sirolimus|mesh-list
2290756|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290757|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290758|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2290759|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290760|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
2290761|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2290762|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
2290763|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290764|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
2290765|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2290766|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2830405|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2830406|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
2830407|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830408|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830409|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
2830410|NCT04002024|Salicylates|salicylates|mesh-list
2830411|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830412|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
2830413|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
2830414|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
2105991|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2105992|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2105993|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2105994|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2105995|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
2105996|NCT02464059|Vitamin D|vitamin d|mesh-list
2105997|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
2105998|NCT02464059|Vitamins|vitamins|mesh-ancestor
2105999|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
2106000|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106001|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2106002|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2106003|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
2106004|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
2106005|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
2106006|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106007|NCT02464176|Dexamethasone|dexamethasone|mesh-list
2106008|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
2106009|NCT02464176|Epinephrine|epinephrine|mesh-list
2106010|NCT02464176|Bupivacaine|bupivacaine|mesh-list
2830415|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2830416|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2830417|NCT04002024|Analgesics|analgesics|mesh-ancestor
2830418|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
2830419|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830420|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830421|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2830422|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2830423|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2830424|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830425|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830426|NCT04001712|Caffeine|caffeine|mesh-list
2830427|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
2830428|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290767|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2290768|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2290769|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290770|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
2290771|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290772|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830429|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2830430|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830431|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2830432|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830433|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2830434|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2830435|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
2830436|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830437|NCT04001855|Acetic Acid|acetic acid|mesh-list
2830438|NCT04001855|Retinol acetate|retinol acetate|mesh-list
2830439|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2830440|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290773|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2290774|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290775|NCT00258622|Lidocaine|lidocaine|mesh-list
2290776|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
2290777|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
2290778|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2290779|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290780|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
2290781|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290782|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2830441|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2830442|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
2106011|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2106012|NCT02464176|BB 1101|bb 1101|mesh-list
2106013|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2106014|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
2106015|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
2106016|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106017|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106018|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106019|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
2106020|NCT02464176|Hormones|hormones|mesh-ancestor
2106021|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2106022|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2106023|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106024|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
2106025|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106026|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106027|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
2106028|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
2106029|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106030|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
2106031|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2106032|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2106033|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
2106034|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106035|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2106036|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2106037|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2106038|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
2106039|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
2106040|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
2106041|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2106042|NCT02464657|Cytarabine|cytarabine|mesh-list
2830443|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830444|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2830445|NCT04001855|Protective Agents|protective agents|mesh-ancestor
2830446|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830447|NCT04001725|Metformin|metformin|mesh-list
2830448|NCT04001725|Dexamethasone|dexamethasone|mesh-list
2830449|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2830450|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
2830451|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
2290783|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2290784|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2290785|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2290786|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290787|NCT00258739|Gemcitabine|gemcitabine|mesh-list
2290788|NCT00258739|Carboplatin|carboplatin|mesh-list
2290789|NCT00258739|Docetaxel|docetaxel|mesh-list
2290790|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290791|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2830452|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830453|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830454|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2830455|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
2830456|NCT04001725|Hormones|hormones|mesh-ancestor
2830457|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830458|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2830459|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830460|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2830461|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
2830462|NCT04001647|Nitroprusside|nitroprusside|mesh-list
2830463|NCT04001647|Acetylcholine|acetylcholine|mesh-list
2830464|NCT04001647|Vitamins|vitamins|mesh-ancestor
2830465|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
2290792|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
2290793|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290794|NCT00258739|Antiviral Agents|antiviral agents|mesh-ancestor
2290795|NCT00258739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290796|NCT00258739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290797|NCT00258739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2290798|NCT00258739|Immunologic Factors|immunologic factors|mesh-ancestor
2290799|NCT00258739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290800|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
2290801|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
2290802|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
2290803|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
2290804|NCT00258765|Docetaxel|docetaxel|mesh-list
2290805|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290806|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
2290807|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
2290808|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
2290809|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290810|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2290811|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290812|NCT00258791|Ibuprofen|ibuprofen|mesh-list
2290813|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2290814|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2290815|NCT00258791|Analgesics|analgesics|mesh-ancestor
2290816|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
2830466|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830467|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
2830468|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830469|NCT04001647|Protective Agents|protective agents|mesh-ancestor
2290817|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290818|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290819|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2290820|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2290821|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2290822|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106043|NCT02464657|Dexamethasone|dexamethasone|mesh-list
2106044|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
2106045|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2106046|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2106047|NCT02464657|Prednisolone|prednisolone|mesh-list
2106048|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
2290823|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830470|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2830471|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
2106049|NCT02464657|Nivolumab|nivolumab|mesh-list
2106050|NCT02464657|Idarubicin|idarubicin|mesh-list
2106051|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2106052|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
2106053|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2106054|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
2106055|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
2106056|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106057|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106058|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106059|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
2106060|NCT02464657|Hormones|hormones|mesh-ancestor
2106061|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830472|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2830473|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2830474|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
2830475|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830476|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
2830477|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
2830478|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830479|NCT04001621|Capecitabine|capecitabine|mesh-list
2830480|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2830481|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
2830482|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830483|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830484|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
2830485|NCT04001465|Miotics|miotics|mesh-ancestor
2830486|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
2830487|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830488|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830489|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2290824|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
2290825|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2290826|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290827|NCT00258843|Vaccines|vaccines|mesh-list
2290828|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
2290829|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290830|NCT00259051|Omeprazole|omeprazole|mesh-list
2106062|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2106063|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106064|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2106065|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2106066|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106067|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2106068|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
2106069|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
2106070|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106071|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2106072|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
2106073|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2106074|NCT02464657|Protective Agents|protective agents|mesh-ancestor
2106075|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2106076|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2106077|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2106078|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106079|NCT02465489|Deferiprone|deferiprone|mesh-list
2106080|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2106081|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
2106082|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
2106083|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106084|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
2106085|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2106086|NCT02465515|Incretins|incretins|mesh-ancestor
2106087|NCT02465515|Hormones|hormones|mesh-ancestor
2106088|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2106089|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106090|NCT02465528|Ceritinib|ceritinib|mesh-list
2106091|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106092|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2106093|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106094|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106095|NCT02465632|Clindamycin|clindamycin|mesh-list
2106096|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
2106097|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
2106098|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2290831|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2830490|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2830491|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
2830492|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2830493|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2830494|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
2830495|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830496|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830497|NCT04001231|Exenatide|exenatide|mesh-list
2830498|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2830499|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830500|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2830501|NCT04001231|Incretins|incretins|mesh-ancestor
2830502|NCT04001231|Hormones|hormones|mesh-ancestor
2830503|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830504|NCT04001400|Rabeprazole|rabeprazole|mesh-list
2830505|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2830506|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2830507|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2830508|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830509|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830510|NCT04001387|Anesthetics|anesthetics|mesh-list
2830511|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830512|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830513|NCT04001413|Durvalumab|durvalumab|mesh-list
2830514|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2830515|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830516|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2830517|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
2830518|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2830519|NCT04001374|Ticagrelor|ticagrelor|mesh-list
2830520|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2830521|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2106099|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2106100|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106101|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2106102|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106103|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106104|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
2106105|NCT02465866|Promethazine|promethazine|mesh-list
2106106|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
2106107|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
2106108|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2106109|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
2106110|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
2106111|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106112|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106113|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106114|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2106115|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2106116|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2106117|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106118|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2106119|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2106120|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2106121|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106122|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
2106123|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106124|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2106125|NCT02466399|Latanoprost|latanoprost|mesh-list
2106126|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2106127|NCT02466958|Milnacipran|milnacipran|mesh-list
2106128|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
2106129|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2106130|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2106131|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2106132|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106133|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106134|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106135|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
2106136|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2106137|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2106138|NCT02466958|Analgesics|analgesics|mesh-ancestor
2106139|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
2830522|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2290832|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2290833|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2290834|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290835|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290836|NCT00259064|Gefitinib|gefitinib|mesh-list
2290837|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290838|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2290839|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830523|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2830524|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
2830525|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830526|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830527|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830528|NCT04001322|Vaccines|vaccines|mesh-list
2830529|NCT04001322|Immunologic Factors|immunologic factors|mesh-ancestor
2830530|NCT04001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830531|NCT04001569|Paclitaxel|paclitaxel|mesh-list
2830532|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2830533|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830534|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
2830535|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
2830536|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
2830537|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830538|NCT04001348|Diazepam|diazepam|mesh-list
2830539|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2830540|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
2290840|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290841|NCT00259077|Omeprazole|omeprazole|mesh-list
2290842|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2290843|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2290844|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2290845|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290846|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290847|NCT00259116|Methocarbamol|methocarbamol|mesh-list
2290848|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2290849|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290850|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2290851|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290852|NCT00259129|Sorafenib|sorafenib|mesh-list
2290853|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290854|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2290855|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290856|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290857|NCT00259142|Chloroquine|chloroquine|mesh-list
2290858|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
2290859|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
2290860|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2290861|NCT00259142|Amebicides|amebicides|mesh-ancestor
2290862|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2830541|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
2106140|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106146|NCT02467504|Folic Acid|folic acid|mesh-list
2106147|NCT02467504|Loxoprofen|loxoprofen|mesh-list
2106148|NCT02467504|Hematinics|hematinics|mesh-ancestor
2106149|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
2106150|NCT02467504|Vitamins|vitamins|mesh-ancestor
2106151|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
2106152|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106153|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2106154|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2106155|NCT02467504|Analgesics|analgesics|mesh-ancestor
2106156|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
2106157|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106158|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2106159|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2106160|NCT02467621|Pantoprazole|pantoprazole|mesh-list
2106161|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2106162|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106163|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2106164|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106165|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830542|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
2290863|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2290864|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290865|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
2290866|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2290867|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2290868|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290869|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290870|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2290871|NCT00259142|Renal Agents|renal agents|mesh-ancestor
2290872|NCT00259155|Rifaximin|rifaximin|mesh-list
2830543|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830544|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830545|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2830546|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2830547|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830548|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2830549|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2830550|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2830551|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2830552|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2830553|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2830554|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
2830555|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
2830556|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
2830557|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
2830558|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830559|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830560|NCT04000919|Carbidopa|carbidopa|mesh-list
2830561|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2830562|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2830563|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
2830564|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830565|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830566|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830567|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2830568|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830569|NCT04000789|Vitamins|vitamins|mesh-list
2830570|NCT04000789|Vitamin E|vitamin e|mesh-list
2830571|NCT04000789|Vitamin A|vitamin a|mesh-list
2830572|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
2830573|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
2830574|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830575|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
2830576|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830577|NCT04000789|Protective Agents|protective agents|mesh-ancestor
2830578|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2830579|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
2830580|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
2830581|NCT04000906|Paclitaxel|paclitaxel|mesh-list
2830582|NCT04000906|Cisplatin|cisplatin|mesh-list
2830583|NCT04000906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2830584|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2830585|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106166|NCT02468557|Paclitaxel|paclitaxel|mesh-list
2106167|NCT02468557|Idelalisib|idelalisib|mesh-list
2106168|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2106169|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106170|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
2106171|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
2106172|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
2106173|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106174|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106175|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
2106176|NCT02468648|Velpatasvir|velpatasvir|mesh-list
2106177|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
2106178|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106179|NCT02468700|Dexamethasone|dexamethasone|mesh-list
2106180|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2106181|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
2106182|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
2106183|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106184|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106185|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106186|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
2106187|NCT02468700|Hormones|hormones|mesh-ancestor
2106188|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2290873|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290874|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290875|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2290876|NCT00259168|Nateglinide|nateglinide|mesh-list
2106189|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2106190|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106191|NCT02468830|Mirabegron|mirabegron|mesh-list
2106192|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2106193|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2106194|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2106195|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
2106196|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106197|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106198|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106199|NCT02468830|Urological Agents|urological agents|mesh-ancestor
2106200|NCT02469077|Morphine|morphine|mesh-list
2106201|NCT02469077|Naloxone|naloxone|mesh-list
2106202|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2106203|NCT02469077|Narcotics|narcotics|mesh-ancestor
2106204|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106205|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106206|NCT02469077|Analgesics|analgesics|mesh-ancestor
2106207|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
2106208|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106209|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2106210|NCT02469090|Apomorphine|apomorphine|mesh-list
2106211|NCT02469090|Emetics|emetics|mesh-ancestor
2106212|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106213|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
2106214|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106215|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106216|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
2106217|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
2106218|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106219|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106220|NCT02469116|Carboplatin|carboplatin|mesh-list
2106221|NCT02469116|Docetaxel|docetaxel|mesh-list
2106222|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106223|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
2106224|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
2106225|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
2106226|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106227|NCT02469246|Lamivudine|lamivudine|mesh-list
2106228|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2106229|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2106230|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106231|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106232|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
2106233|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106234|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2106235|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2106236|NCT02469298|Oseltamivir|oseltamivir|mesh-list
2106237|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
2106238|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106239|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106240|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106241|NCT02469597|Furosemide|furosemide|mesh-list
2106242|NCT02469597|Diuretics|diuretics|mesh-ancestor
2106243|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
2106244|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106245|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2106246|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2106247|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106248|NCT02469610|Bupivacaine|bupivacaine|mesh-list
2106249|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
2106250|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
2106251|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106252|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106253|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
2106254|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106255|NCT02469701|Nivolumab|nivolumab|mesh-list
2106256|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2106257|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106258|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2106259|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290877|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2830586|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
2830587|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
2830588|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
2830589|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830590|NCT04000854|Calcium|calcium|mesh-list
2830591|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2830592|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830593|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
2830594|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2830595|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
2830596|NCT04000932|Hormones|hormones|mesh-ancestor
2830597|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830598|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830599|NCT04000633|Lidocaine|lidocaine|mesh-list
2830600|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
2830601|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
2830602|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830603|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830604|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
2830605|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290878|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290879|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
2830606|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2830607|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2106260|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
2106261|NCT02469961|Propofol|propofol|mesh-list
2106262|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2106263|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106264|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106265|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2106266|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
2106267|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
2106268|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2106269|NCT02469961|Analgesics|analgesics|mesh-ancestor
2106270|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
2106271|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106272|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2106273|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2106274|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2106275|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
2106276|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106277|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106278|NCT02470091|Denosumab|denosumab|mesh-list
2106279|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2106280|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106281|NCT02470234|Methylphenidate|methylphenidate|mesh-list
2106282|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2106283|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106284|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2106285|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2106286|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2106287|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106288|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
2106289|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106290|NCT02470390|Fentanyl|fentanyl|mesh-list
2106291|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2106292|NCT02470390|Narcotics|narcotics|mesh-ancestor
2106293|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106294|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106295|NCT02470390|Analgesics|analgesics|mesh-ancestor
2106296|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
2106297|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106298|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2106299|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2106300|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
2106301|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
2106302|NCT02470403|Licogliflozin|licogliflozin|mesh-list
2106303|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2106304|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106305|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2106306|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106307|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2290880|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2290881|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2290882|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2290883|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830608|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2830609|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2290884|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
2290885|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
2290886|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
2290887|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2290888|NCT00259181|Protective Agents|protective agents|mesh-ancestor
2290889|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290890|NCT00259220|Erythromycin|erythromycin|mesh-list
2290891|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
2290892|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2290893|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
2290894|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2290895|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290896|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106308|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
2106309|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2106310|NCT02470585|Paclitaxel|paclitaxel|mesh-list
2106311|NCT02470585|Carboplatin|carboplatin|mesh-list
2106312|NCT02470585|Veliparib|veliparib|mesh-list
2106313|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2106314|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106315|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
2106316|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
2106317|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
2106318|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106319|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2106320|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106321|NCT02470741|Letrozole|letrozole|mesh-list
2106322|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106323|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2106324|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2106325|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106326|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106327|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2106328|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
2106329|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2106330|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106331|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2106332|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
2106333|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106347|NCT02471183|Selexipag|selexipag|mesh-list
2106348|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2106349|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
2106350|NCT02471404|Glimepiride|glimepiride|mesh-list
2106351|NCT02471404|Saxagliptin|saxagliptin|mesh-list
2106352|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2106353|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106354|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2106355|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106356|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2106357|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2106358|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
2106359|NCT02471404|Incretins|incretins|mesh-ancestor
2106360|NCT02471404|Hormones|hormones|mesh-ancestor
2106361|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2290897|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2830610|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830611|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
2830612|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
2830613|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
2830614|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2830615|NCT04000386|Protective Agents|protective agents|mesh-ancestor
2830616|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830617|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2830618|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
2290898|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290899|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290900|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
2290901|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290902|NCT00259376|Dronedarone|dronedarone|mesh-list
2290903|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2290904|NCT00259402|Fluorouracil|fluorouracil|mesh-list
2290905|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
2290906|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106362|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2106363|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
2106364|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290907|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
2290908|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290909|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2290910|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2290911|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
2290912|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290913|NCT00259428|Dronedarone|dronedarone|mesh-list
2290914|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2290915|NCT00259441|Simvastatin|simvastatin|mesh-list
2290916|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2290917|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2290918|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
2290919|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830619|NCT04000295|Paclitaxel|paclitaxel|mesh-list
2830620|NCT04000295|Etoposide|etoposide|mesh-list
2830621|NCT04000295|Apatinib|apatinib|mesh-list
2830622|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2830623|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830624|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
2830625|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
2830626|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
2830627|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830628|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2830629|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2830630|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830631|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2830632|NCT04000009|Pimavanserin|pimavanserin|mesh-list
2830633|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2830634|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2830635|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2830636|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2290920|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2290921|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2290922|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290923|NCT00259636|Zonisamide|zonisamide|mesh-list
2290924|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
2290925|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2290926|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2290927|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290928|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2290929|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290930|NCT00259662|Atorvastatin|atorvastatin|mesh-list
2830637|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830638|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830639|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2830640|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2830641|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2830642|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
2830643|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830644|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830645|NCT04000126|Lidocaine|lidocaine|mesh-list
2830646|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
2830647|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
2830648|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106365|NCT02471521|Rocuronium|rocuronium|mesh-list
2106366|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2106367|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2106368|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2106369|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106370|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106371|NCT02471651|Dexamethasone|dexamethasone|mesh-list
2106372|NCT02471651|Ranibizumab|ranibizumab|mesh-list
2106373|NCT02471651|Aflibercept|aflibercept|mesh-list
2106374|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106375|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2106376|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2106377|NCT02471651|Growth Substances|growth substances|mesh-ancestor
2106378|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106379|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
2106380|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2106381|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
2106382|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
2106383|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106384|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106385|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
2106386|NCT02471651|Hormones|hormones|mesh-ancestor
2830649|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830650|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
2830651|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830652|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2830653|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2830654|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2830655|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2830656|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830657|NCT03999710|Durvalumab|durvalumab|mesh-list
2830658|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2830659|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830660|NCT03999580|Vitamin D|vitamin d|mesh-list
2830661|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
2830662|NCT03999580|Vitamins|vitamins|mesh-ancestor
2830663|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
2830664|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830665|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2830666|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2830667|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
2830668|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
2106387|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2106388|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2106389|NCT02472145|Decitabine|decitabine|mesh-list
2106390|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2106391|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
2106392|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106393|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106394|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106395|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
2106396|NCT02472223|Povidone|povidone|mesh-list
2106397|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
2106398|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
2106399|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
2106400|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2106401|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106402|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2106403|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2106404|NCT02472314|Bupivacaine|bupivacaine|mesh-list
2106405|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
2106406|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
2106407|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106408|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106409|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
2106410|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106411|NCT02472353|Metformin|metformin|mesh-list
2106412|NCT02472353|Doxorubicin|doxorubicin|mesh-list
2106413|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2106414|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106415|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2106416|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106417|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2106418|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2106419|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106420|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106421|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2106422|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2106423|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
2106424|NCT02472366|Hormones|hormones|mesh-ancestor
2106425|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2106426|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106427|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
2106428|NCT02472522|Ropivacaine|ropivacaine|mesh-list
2106429|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
2106430|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2106431|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106432|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106433|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2106434|NCT02472522|Analgesics|analgesics|mesh-ancestor
2106435|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
2106436|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106437|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2106438|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2106439|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
2106440|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830669|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
2830670|NCT03999749|Nivolumab|nivolumab|mesh-list
2830671|NCT03999749|Ipilimumab|ipilimumab|mesh-list
2830672|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2830673|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830674|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2290931|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2290932|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2290933|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
2290934|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290935|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2290936|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2290937|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2290938|NCT00259675|Gemcitabine|gemcitabine|mesh-list
2290939|NCT00259675|Carboplatin|carboplatin|mesh-list
2290940|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2290941|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2290942|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
2290943|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290944|NCT00259675|Antiviral Agents|antiviral agents|mesh-ancestor
2830675|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830676|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
2830677|NCT03999775|Vitamin D|vitamin d|mesh-list
2830678|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
2830679|NCT03999775|Vitamins|vitamins|mesh-list
2830680|NCT03999775|Calcium|calcium|mesh-list
2830681|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
2830682|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830683|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2830684|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2830685|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
2830686|NCT03999723|Vitamins|vitamins|mesh-ancestor
2106441|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106442|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
2106443|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
2106444|NCT02472652|Aripiprazole|aripiprazole|mesh-list
2106445|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
2106446|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2106447|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2106448|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2106449|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106450|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106451|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
2106452|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
2106453|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106454|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106455|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2106456|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2106457|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
2106458|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2106459|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2106460|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2106461|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2106462|NCT02472756|Rituximab|rituximab|mesh-list
2106463|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2106464|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106465|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
2106466|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106467|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2106468|NCT02472847|Dronabinol|dronabinol|mesh-list
2106469|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
2106470|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106471|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2106472|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2106473|NCT02472847|Analgesics|analgesics|mesh-ancestor
2106474|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
2106475|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106476|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2106477|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2106478|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106479|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106480|NCT02472847|Hormones|hormones|mesh-ancestor
2106481|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2106482|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
2830687|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
2830688|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830689|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
2830690|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830691|NCT03999723|Protective Agents|protective agents|mesh-ancestor
2830692|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
2830693|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2830694|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
2830695|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830696|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
2830697|NCT03999372|Protective Agents|protective agents|mesh-ancestor
2830698|NCT03999437|Terbinafine|terbinafine|mesh-list
2830699|NCT03999437|Butenafine|butenafine|mesh-list
2830700|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
2830701|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830702|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830703|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830713|NCT03999554|Vaccines|vaccines|mesh-list
2830714|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
2830715|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830716|NCT03999099|Suvorexant|suvorexant|mesh-list
2830717|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2830718|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2830719|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830720|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830721|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2830722|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830723|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830724|NCT03999216|Diuretics|diuretics|mesh-list
2830725|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
2830726|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
2830727|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
2830728|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830729|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2830730|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830731|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
2830732|NCT03999203|Citric Acid|citric acid|mesh-list
2830733|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
2830734|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2830735|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
2830736|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830737|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830738|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2830739|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
2830740|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2830741|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
2830742|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830743|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830744|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2830745|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
2830746|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
2830747|NCT03999203|Protective Agents|protective agents|mesh-ancestor
2830748|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
2830749|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2830750|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
2830751|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
2830752|NCT03999190|Raclopride|raclopride|mesh-list
2830753|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
2830754|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2830755|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830756|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2830757|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2830758|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2290945|NCT00259675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2290946|NCT00259675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830759|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830760|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
2830761|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830762|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2830763|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2830764|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830765|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2830766|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2290947|NCT00259675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2290948|NCT00259675|Immunologic Factors|immunologic factors|mesh-ancestor
2290949|NCT00259675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290950|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
2290951|NCT00259701|Acetylcholine|acetylcholine|mesh-list
2106483|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2106484|NCT02472886|Ledipasvir|ledipasvir|mesh-list
2106485|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
2106486|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106487|NCT02472964|Paclitaxel|paclitaxel|mesh-list
2106488|NCT02472964|Docetaxel|docetaxel|mesh-list
2106489|NCT02472964|Trastuzumab|trastuzumab|mesh-list
2106490|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2106491|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106492|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
2106493|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
2106494|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
2106495|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106496|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2106497|NCT02472977|Nivolumab|nivolumab|mesh-list
2106498|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2106499|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106500|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2106501|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106502|NCT02473250|Fluoxetine|fluoxetine|mesh-list
2106503|NCT02473250|Citalopram|citalopram|mesh-list
2106504|NCT02473250|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2106505|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2106506|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2106507|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106508|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106509|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
2106510|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106511|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2106512|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
2106513|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2106514|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2106515|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2106516|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106517|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
2106518|NCT02473367|Antacids|antacids|mesh-list
2106519|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2106520|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2106521|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
2106522|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106523|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2106524|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2106525|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106526|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106527|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106528|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
2106529|NCT02473640|Esomeprazole|esomeprazole|mesh-list
2106530|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2106531|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106532|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2106533|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106534|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106535|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2106536|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106537|NCT02473783|Sertraline|sertraline|mesh-list
2106538|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
2106539|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2106540|NCT02473783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2106541|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2106542|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2106543|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830767|NCT03999008|Budesonide|budesonide|mesh-list
2830768|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2830769|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2830770|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
2830771|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830772|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830773|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2830774|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
2290952|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
2290953|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2290954|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
2290955|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290956|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830775|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
2830776|NCT03999008|Hormones|hormones|mesh-ancestor
2830777|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830778|NCT03999268|Insulin|insulin|mesh-list
2830779|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2830780|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106544|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106545|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
2106546|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106547|NCT02473913|Silymarin|silymarin|mesh-list
2106548|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
2106549|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106550|NCT02473913|Protective Agents|protective agents|mesh-ancestor
2106551|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106552|NCT02474199|Acetaminophen|acetaminophen|mesh-list
2106553|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
2106554|NCT02474199|Promethazine|promethazine|mesh-list
2106555|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2106556|NCT02474199|Analgesics|analgesics|mesh-ancestor
2106557|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
2106558|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106559|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106560|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
2106561|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2106562|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2106563|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106564|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
2106565|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
2106566|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
2106567|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
2106568|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106569|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2106570|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
2106571|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
2106572|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106573|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106574|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2106575|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
2106576|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
2106577|NCT02474355|Osimertinib|osimertinib|mesh-list
2106578|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106579|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2106580|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106581|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106582|NCT02474407|Diazepam|diazepam|mesh-list
2106583|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2106584|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
2106585|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
2106586|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
2106587|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106588|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106589|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106590|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2106591|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106592|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2106593|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2106594|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2106595|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2106596|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2106597|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2106598|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
2106599|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
2106600|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
2106601|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
2106602|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290957|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830781|NCT03999125|Dexamethasone|dexamethasone|mesh-list
2830782|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
2830783|NCT03999125|Ranibizumab|ranibizumab|mesh-list
2830784|NCT03999125|Aflibercept|aflibercept|mesh-list
2830785|NCT03999125|BB 1101|bb 1101|mesh-list
2830786|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2830787|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
2830788|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
2830789|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830790|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830791|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2830792|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
2830793|NCT03999125|Hormones|hormones|mesh-ancestor
2830794|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2290958|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
2290959|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2106603|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106604|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
2106605|NCT02475070|Vildagliptin|vildagliptin|mesh-list
2106606|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2106607|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106608|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2106609|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106610|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2106611|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
2106612|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106613|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
2106614|NCT02475265|Estradiol|estradiol|mesh-list
2106615|NCT02475265|Estrogens|estrogens|mesh-ancestor
2106616|NCT02475265|Hormones|hormones|mesh-ancestor
2106617|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2106618|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106619|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2106620|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
2106621|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2106622|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2106623|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2106624|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2106625|NCT02475369|Pancrelipase|pancrelipase|mesh-list
2106626|NCT02475369|Pancreatin|pancreatin|mesh-list
2106627|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106628|NCT02475564|Resveratrol|resveratrol|mesh-list
2106629|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
2106630|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106631|NCT02475564|Protective Agents|protective agents|mesh-ancestor
2106632|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106633|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106634|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2106635|NCT02475629|Ibalizumab|ibalizumab|mesh-list
2106636|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2106637|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2106638|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
2106639|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106640|NCT02475733|Metronidazole|metronidazole|mesh-list
2106641|NCT02475733|Meropenem|meropenem|mesh-list
2106642|NCT02475733|Ceftazidime|ceftazidime|mesh-list
2106643|NCT02475733|Avibactam|avibactam|mesh-list
2106644|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
2106645|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106646|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2106647|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2106648|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2106649|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2106650|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106651|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106652|NCT02475837|Vorapaxar|vorapaxar|mesh-list
2106653|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2106654|NCT02476006|Atorvastatin|atorvastatin|mesh-list
2106655|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2106656|NCT02476006|Simvastatin|simvastatin|mesh-list
2106657|NCT02476006|Ezetimibe|ezetimibe|mesh-list
2106658|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2106659|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2106660|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
2106661|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290960|NCT00259766|Budesonide|budesonide|mesh-list
2830795|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2830796|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830797|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
2830798|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830799|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830800|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2830801|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2830802|NCT03999125|Growth Substances|growth substances|mesh-ancestor
2830803|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
2830804|NCT03998982|Dexamethasone|dexamethasone|mesh-list
2830805|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
2830806|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2830807|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
2830808|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
2830809|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830810|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830811|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2830812|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
2830813|NCT03998982|Hormones|hormones|mesh-ancestor
2830814|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830815|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2830816|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106662|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2106663|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2106664|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106665|NCT02476175|Mirabegron|mirabegron|mesh-list
2106666|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2106667|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2106668|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2106669|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
2106670|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106671|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106672|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106673|NCT02476175|Urological Agents|urological agents|mesh-ancestor
2106674|NCT02476422|Ibuprofen|ibuprofen|mesh-list
2106675|NCT02476422|Diclofenac|diclofenac|mesh-list
2106676|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2106677|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2106678|NCT02476422|Analgesics|analgesics|mesh-ancestor
2106679|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
2106680|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106681|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106682|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2106683|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2106684|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2106685|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106686|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106687|NCT02476617|Ritonavir|ritonavir|mesh-list
2106688|NCT02476617|Ribavirin|ribavirin|mesh-list
2106689|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2106690|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2106691|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
2106692|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106693|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106694|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2106695|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2106696|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
2106697|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106698|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2106699|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2106700|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
2106706|NCT02477215|Dexamethasone|dexamethasone|mesh-list
2106707|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2106708|NCT02477215|Ixazomib|ixazomib|mesh-list
2106709|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2106710|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
2106711|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
2106712|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106713|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106714|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106715|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
2290961|NCT00259766|Terbutaline|terbutaline|mesh-list
2290962|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
2290963|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2290964|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2290965|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
2290966|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290967|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106716|NCT02477215|Hormones|hormones|mesh-ancestor
2106717|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2106718|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2106719|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106720|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2106721|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
2106722|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106723|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
2106724|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106725|NCT02477332|Omalizumab|omalizumab|mesh-list
2106726|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2106727|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2106728|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
2106729|NCT02477423|Gentamicins|gentamicins|mesh-list
2106730|NCT02477423|Ampicillin|ampicillin|mesh-list
2106731|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2106732|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106733|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2106734|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106735|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106736|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2106737|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2106738|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2106739|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
2106740|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106748|NCT02477839|Lacosamide|lacosamide|mesh-list
2106749|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
2106750|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2106751|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2106752|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2106753|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106754|NCT02478164|Ponatinib|ponatinib|mesh-list
2106755|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106756|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2106757|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106758|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106759|NCT02478372|Bupivacaine|bupivacaine|mesh-list
2106760|NCT02478372|Ropivacaine|ropivacaine|mesh-list
2106761|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
2106762|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
2106763|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
2106764|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106765|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106766|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
2106767|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106768|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
2106769|NCT02478398|Loratadine|loratadine|mesh-list
2106770|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2106771|NCT02478398|Epinephrine|epinephrine|mesh-list
2106772|NCT02478398|Albuterol|albuterol|mesh-list
2106773|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2106774|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2106775|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
2106776|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106777|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106778|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106779|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2106780|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2106781|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
2106782|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830817|NCT03998969|Pantoprazole|pantoprazole|mesh-list
2830818|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2830819|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2830820|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2830821|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830822|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106783|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2106784|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
2106785|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
2106786|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
2106787|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2106788|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
2106789|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2106790|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2106791|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2106792|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
2106793|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2106794|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
2106795|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2106796|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2106797|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
2106798|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
2106799|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2106800|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2106801|NCT02478398|Analgesics|analgesics|mesh-ancestor
2106802|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
2106803|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2106804|NCT02478463|Cabotegravir|cabotegravir|mesh-list
2106805|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2106806|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2106807|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106808|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106809|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2106810|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2106811|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
2106812|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106813|NCT02478489|Naltrexone|naltrexone|mesh-list
2106814|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2106815|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2106816|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106817|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
2106818|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106819|NCT02478580|Modafinil|modafinil|mesh-list
2106820|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2106821|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106822|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2106823|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2106824|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2106825|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106826|NCT02479412|Albuterol|albuterol|mesh-list
2106827|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2106828|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
2106829|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106830|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106831|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2106832|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
2106833|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
2106834|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2106835|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2106836|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2106837|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2106838|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
2106839|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106840|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106841|NCT02479880|Tenofovir|tenofovir|mesh-list
2106842|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
2106843|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106844|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2830823|NCT03998696|Cisplatin|cisplatin|mesh-list
2830824|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830825|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2830826|NCT03998709|Somatostatin|somatostatin|mesh-list
2830827|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830828|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2290968|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2290969|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
2290970|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
2290971|NCT00259766|Hormones|hormones|mesh-ancestor
2290972|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2290973|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2290974|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2290975|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2290976|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
2290977|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2290978|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2290979|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
2106845|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2106846|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106847|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106848|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2106849|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2106850|NCT02480010|Pertuzumab|pertuzumab|mesh-list
2106851|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2106852|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106853|NCT02480114|Acetaminophen|acetaminophen|mesh-list
2106854|NCT02480114|Ibuprofen|ibuprofen|mesh-list
2106855|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2106856|NCT02480114|Fentanyl|fentanyl|mesh-list
2106857|NCT02480114|Oxycodone|oxycodone|mesh-list
2106858|NCT02480114|Hydrocodone|hydrocodone|mesh-list
2106859|NCT02480114|Gabapentin|gabapentin|mesh-list
2106860|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2106861|NCT02480114|Narcotics|narcotics|mesh-ancestor
2106862|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106863|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106864|NCT02480114|Analgesics|analgesics|mesh-ancestor
2106865|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
2106866|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106867|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2106868|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2106869|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
2106870|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
2106871|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2106872|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
2106873|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2106874|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2106875|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2106876|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2106877|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106878|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106879|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
2106880|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2106881|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2106882|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2106883|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2106884|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2106885|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106886|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
2106887|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
2106888|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
2106889|NCT02480153|Adalimumab|adalimumab|mesh-list
2106890|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2106891|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2106892|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2106893|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
2106894|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106895|NCT02480621|Bupivacaine|bupivacaine|mesh-list
2106896|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
2106897|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
2106898|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106899|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106900|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
2106901|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106902|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
2290980|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
2290981|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2290982|NCT00259779|Prednisolone|prednisolone|mesh-list
2290983|NCT00259779|Budesonide|budesonide|mesh-list
2290984|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
2290985|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2290986|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
2290987|NCT00259779|Hormones|hormones|mesh-ancestor
2106903|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2106904|NCT02480712|Velpatasvir|velpatasvir|mesh-list
2106905|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
2106906|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106907|NCT02480764|Valsartan|valsartan|mesh-list
2106908|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2106909|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2106910|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2106911|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2106912|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106913|NCT02480998|Vaccines|vaccines|mesh-list
2106914|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
2106915|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106916|NCT02481219|Erythromycin|erythromycin|mesh-list
2106917|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
2106918|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2106919|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
2106920|NCT02481219|Metoclopramide|metoclopramide|mesh-list
2106921|NCT02481219|Bisacodyl|bisacodyl|mesh-list
2106922|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2106923|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
2106924|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
2106925|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106926|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106927|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106928|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2106929|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2106930|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
2106931|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2106932|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106933|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2106934|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2106935|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2106936|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106937|NCT02481219|Cathartics|cathartics|mesh-ancestor
2106938|NCT02481219|Laxatives|laxatives|mesh-ancestor
2106939|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
2106940|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
2106941|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106942|NCT02481297|Rituximab|rituximab|mesh-list
2106943|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2106944|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106945|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
2106946|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106947|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2106948|NCT02481375|Iron|iron|mesh-list
2106949|NCT02481375|Trace Elements|trace elements|mesh-list
2106950|NCT02481375|Micronutrients|micronutrients|mesh-list
2106951|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106952|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
2106953|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
2106954|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
2106955|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2106956|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106957|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
2106958|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106959|NCT02481830|Nivolumab|nivolumab|mesh-list
2106960|NCT02481830|Topotecan|topotecan|mesh-list
2106961|NCT02481830|Amrubicin|amrubicin|mesh-list
2106962|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2106963|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106964|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2106965|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106966|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2106967|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2106968|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2106969|NCT02481934|Lenalidomide|lenalidomide|mesh-list
2106970|NCT02481934|Bortezomib|bortezomib|mesh-list
2483655|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2290988|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2290989|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290990|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2290991|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106971|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
2106972|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106973|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2106974|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2106975|NCT02481934|Growth Substances|growth substances|mesh-ancestor
2106976|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
2106977|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106978|NCT02481947|Laxatives|laxatives|mesh-list
2106979|NCT02481947|Lubiprostone|lubiprostone|mesh-list
2106980|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2106981|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2106982|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2106983|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106984|NCT02482129|Dexamethasone|dexamethasone|mesh-list
2106985|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2106986|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2106987|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2106988|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
2106989|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
2106990|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2106991|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2106992|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2106993|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
2106994|NCT02482129|Hormones|hormones|mesh-ancestor
2106995|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2106996|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2106997|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2106998|NCT02482233|Nicotine|nicotine|mesh-list
2106999|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2107000|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
2107001|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107002|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107003|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2107004|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2107005|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
2107006|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107007|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107008|NCT02482298|Ticagrelor|ticagrelor|mesh-list
2107009|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2107010|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2107011|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2107012|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2107013|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
2107014|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107015|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107016|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107017|NCT02482428|Imiquimod|imiquimod|mesh-list
2107018|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2107019|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
2107020|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107021|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107022|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
2107023|NCT02482675|Caseins|caseins|mesh-list
2107024|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
2107025|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
2107026|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107027|NCT02483000|Biotin|biotin|mesh-list
2107028|NCT02483000|Cytarabine|cytarabine|mesh-list
2107029|NCT02483000|Etoposide|etoposide|mesh-list
2107030|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
2107031|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
2107032|NCT02483000|Melphalan|melphalan|mesh-list
2107033|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
2107034|NCT02483000|Carmustine|carmustine|mesh-list
2107035|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2107036|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
2107037|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2107038|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107039|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2107040|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2107041|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830829|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2830830|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2830831|NCT03998709|Hormones|hormones|mesh-ancestor
2830832|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830833|NCT03998670|Methamphetamine|methamphetamine|mesh-list
2830834|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2830835|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830836|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
2830837|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
2830838|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830839|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
2830840|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830841|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830842|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
2830843|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2830844|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2830845|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2830846|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2830847|NCT03998761|Progesterone|progesterone|mesh-list
2830848|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
2830849|NCT03998761|Progestins|progestins|mesh-ancestor
2830850|NCT03998761|Hormones|hormones|mesh-ancestor
2830851|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2830852|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830865|NCT03998826|Piroxicam|piroxicam|mesh-list
2830866|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2830867|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2830868|NCT03998826|Analgesics|analgesics|mesh-ancestor
2830869|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
2830870|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830871|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830872|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2830873|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2830874|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2830875|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830876|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830884|NCT03998592|Vaccines|vaccines|mesh-list
2830885|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
2830886|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2290992|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
2290993|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2290994|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2290995|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2290996|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
2290997|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2290998|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2290999|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2291000|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
2291001|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291002|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291003|NCT00259792|Budesonide|budesonide|mesh-list
2291004|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
2830887|NCT03998176|Tenofovir|tenofovir|mesh-list
2830888|NCT03998176|Emtricitabine|emtricitabine|mesh-list
2830889|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2830890|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
2830891|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830892|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2830893|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2830894|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830895|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830896|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2830897|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2830898|NCT03998215|Vaccines|vaccines|mesh-list
2830899|NCT03998215|Immunologic Factors|immunologic factors|mesh-ancestor
2830900|NCT03998215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830901|NCT03998449|Vaccines|vaccines|mesh-list
2830902|NCT03998449|Immunologic Factors|immunologic factors|mesh-ancestor
2830903|NCT03998449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830904|NCT03998436|Esmolol|esmolol|mesh-list
2830905|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2830906|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2830907|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2830908|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
2291005|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2291006|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2291007|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
2291008|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291009|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291010|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2291011|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
2291012|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
2291013|NCT00259792|Hormones|hormones|mesh-ancestor
2291014|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2291015|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2291016|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2291017|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2291018|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
2291019|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830909|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830910|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830911|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830912|NCT03997968|Gemcitabine|gemcitabine|mesh-list
2830913|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2830914|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830915|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
2830916|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830917|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2830918|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
2830919|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830920|NCT03997968|Antiviral Agents|antiviral agents|mesh-ancestor
2830921|NCT03997968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830922|NCT03997968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830923|NCT03997968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2830924|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2830925|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
2830926|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
2830927|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830928|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2830929|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830930|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830931|NCT03997864|Prazosin|prazosin|mesh-list
2830932|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2830933|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2830934|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2830935|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2830936|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
2830937|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830938|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830939|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291020|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291021|NCT00259805|Rituximab|rituximab|mesh-list
2291022|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2291023|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291024|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
2291025|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291026|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291027|NCT00259870|Olanzapine|olanzapine|mesh-list
2291028|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
2291029|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
2291030|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107042|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107043|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2107044|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
2107045|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
2107046|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107047|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2107048|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
2107049|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107050|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2107051|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
2107052|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2107053|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
2107054|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
2830940|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
2830941|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2830942|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830943|NCT03997539|Vinorelbine|vinorelbine|mesh-list
2830944|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2830945|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2830946|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
2830947|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
2830948|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
2830949|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830950|NCT03997500|Norepinephrine|norepinephrine|mesh-list
2830951|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2830952|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2830953|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
2830954|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2830955|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830956|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830957|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
2830958|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
2830959|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2830960|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2830961|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2830962|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2830963|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2830964|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830965|NCT03997279|Amoxicillin|amoxicillin|mesh-list
2830966|NCT03997279|Metronidazole|metronidazole|mesh-list
2830967|NCT03997279|Clarithromycin|clarithromycin|mesh-list
2830968|NCT03997279|Rabeprazole|rabeprazole|mesh-list
2830969|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2830970|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830971|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2830972|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2830973|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2830974|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830975|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830976|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2830977|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2830978|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2830979|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2830980|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2830981|NCT03997266|Gentamicins|gentamicins|mesh-list
2830982|NCT03997266|Ampicillin|ampicillin|mesh-list
2830983|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2830984|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2830985|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2830986|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2830987|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2830995|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
2830996|NCT03997019|Narcotics|narcotics|mesh-ancestor
2830997|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2830998|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2830999|NCT03997019|Analgesics|analgesics|mesh-ancestor
2831000|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
2831001|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831002|NCT03997006|Atropine|atropine|mesh-list
2831003|NCT03997006|Aminophylline|aminophylline|mesh-list
2831004|NCT03997006|Acefyllin piperazinate|acefyllin piperazinate|mesh-list
2831005|NCT03997006|Neostigmine|neostigmine|mesh-list
2831006|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2831007|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2831008|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2831009|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
2831010|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831011|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831012|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2831013|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
2831014|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
2831015|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
2831016|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2831017|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2831018|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
2831019|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831020|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831021|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2831022|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291031|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291032|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2291033|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2291034|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2291035|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2291036|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2291037|NCT00259870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2291038|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2291039|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2291040|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291041|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291042|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
2291043|NCT00259883|Paroxetine|paroxetine|mesh-list
2831023|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2831024|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2831025|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2831026|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2831027|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2831028|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
2831029|NCT03997006|Protective Agents|protective agents|mesh-ancestor
2831030|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2831031|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2831032|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831033|NCT03997058|Estazolam|estazolam|mesh-list
2831034|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
2831035|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2831036|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2831037|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831038|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831039|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2831040|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
2831041|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
2831042|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831043|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831044|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
2831045|NCT03996772|Apixaban|apixaban|mesh-list
2831046|NCT03996772|Edoxaban|edoxaban|mesh-list
2831047|NCT03996772|Dabigatran|dabigatran|mesh-list
2831048|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2831049|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
2831050|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2831051|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
2831052|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291044|NCT00259883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2291045|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2291046|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2291047|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291048|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831053|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831054|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
2831055|NCT03996993|Bicalutamide|bicalutamide|mesh-list
2831056|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
2831057|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
2831058|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831059|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831060|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831061|NCT03996538|Metformin|metformin|mesh-list
2831062|NCT03996538|Vaccines|vaccines|mesh-list
2831063|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
2831064|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831065|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2291049|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
2291050|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291051|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2291052|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
2291053|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2291054|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2291055|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2831066|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
2831067|NCT03996421|Trace Elements|trace elements|mesh-ancestor
2831068|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
2831069|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831070|NCT03996577|Lidocaine|lidocaine|mesh-list
2831071|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
2831072|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
2831073|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831074|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831075|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
2831076|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831077|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2831078|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2831079|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2831080|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2831081|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831082|NCT03996603|Estrogens|estrogens|mesh-list
2831083|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2831084|NCT03996603|Hormones|hormones|mesh-ancestor
2831085|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831086|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831087|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
2831088|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
2831089|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
2831090|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2831091|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
2831092|NCT03996486|Paraproteins|paraproteins|mesh-list
2831093|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
2831094|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831095|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
2831096|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2831097|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2831098|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831099|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2831100|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
2831101|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831102|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2831103|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
2831104|NCT03996564|Acetaminophen|acetaminophen|mesh-list
2831105|NCT03996564|Diclofenac|diclofenac|mesh-list
2831106|NCT03996564|Ketorolac|ketorolac|mesh-list
2831107|NCT03996564|Diazepam|diazepam|mesh-list
2831108|NCT03996564|Hydrocodone|hydrocodone|mesh-list
2831109|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2831110|NCT03996564|Analgesics|analgesics|mesh-ancestor
2831111|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
2831112|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831113|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831114|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
2831115|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2831116|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2831117|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2831118|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2831119|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831120|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831121|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2831122|NCT03996564|Narcotics|narcotics|mesh-ancestor
2291056|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291057|NCT00259896|Exenatide|exenatide|mesh-list
2291058|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2291059|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291060|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2291061|NCT00259896|Incretins|incretins|mesh-ancestor
2291062|NCT00259896|Hormones|hormones|mesh-ancestor
2831123|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831124|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
2831125|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
2831126|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2831127|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
2831128|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
2831129|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
2831130|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2831131|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2831132|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2831133|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2831134|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2831135|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2831136|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2831137|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2831138|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
2831139|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
2831140|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
2831141|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
2831142|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831143|NCT03996434|Cetrorelix|cetrorelix|mesh-list
2831144|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2831145|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
2831146|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2831147|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831148|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
2831149|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831150|NCT03996655|Neostigmine|neostigmine|mesh-list
2831151|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2831152|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831153|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831154|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
2831155|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831156|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831157|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2831158|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
2831159|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831160|NCT03996057|Methenamine|methenamine|mesh-list
2831161|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
2831162|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
2831163|NCT03996057|Estrogens|estrogens|mesh-list
2831164|NCT03996057|Hormones|hormones|mesh-ancestor
2831165|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831166|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831167|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2107055|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
2107056|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
2107057|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
2107058|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
2107059|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
2107060|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
2107061|NCT02483000|Vitamins|vitamins|mesh-ancestor
2831168|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2831169|NCT03996057|Renal Agents|renal agents|mesh-ancestor
2831170|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2831171|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
2831172|NCT03996148|Remifentanil|remifentanil|mesh-list
2831173|NCT03996148|Propofol|propofol|mesh-list
2107062|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
2107063|NCT02483585|Erenumab|erenumab|mesh-list
2291063|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831174|NCT03996148|Desflurane|desflurane|mesh-list
2831175|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2831176|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831177|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831178|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2831179|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
2831180|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
2831181|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2831182|NCT03996148|Analgesics|analgesics|mesh-ancestor
2831183|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
2831184|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831185|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2831186|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2831187|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2831188|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
2831189|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831190|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831191|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2831192|NCT03996148|Narcotics|narcotics|mesh-ancestor
2831193|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2831194|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
2831195|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2831196|NCT03996252|Calcitriol|calcitriol|mesh-list
2831197|NCT03996252|Fluorouracil|fluorouracil|mesh-list
2291064|NCT00259922|Alvimopan|alvimopan|mesh-list
2291065|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2291066|NCT00259935|Topotecan|topotecan|mesh-list
2291067|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2291068|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2291069|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291070|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291071|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831198|NCT03996252|Calcipotriene|calcipotriene|mesh-list
2831199|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
2831200|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831201|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2831202|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831203|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2831204|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
2831205|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831206|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
2831207|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2831208|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2831209|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2831210|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2831211|NCT03996252|Vitamins|vitamins|mesh-ancestor
2831212|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
2831213|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2831214|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
2291072|NCT00259974|Rituximab|rituximab|mesh-list
2291073|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2291074|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291075|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
2291076|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291077|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291078|NCT00259987|Lapatinib|lapatinib|mesh-list
2291079|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291080|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2291081|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291082|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291083|NCT00260026|Docetaxel|docetaxel|mesh-list
2291084|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291085|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
2291086|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
2291087|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
2291088|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291089|NCT00260039|Vaccines|vaccines|mesh-list
2291090|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
2291091|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831215|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
2831216|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831217|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2831218|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2831219|NCT03995641|Bupivacaine|bupivacaine|mesh-list
2831220|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
2831221|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
2831222|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831223|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831224|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
2291092|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
2291093|NCT00260052|Hematinics|hematinics|mesh-ancestor
2291094|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
2291095|NCT00260143|Testosterone|testosterone|mesh-list
2291096|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
2291097|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
2291098|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2291099|NCT00260143|Androgens|androgens|mesh-ancestor
2291100|NCT00260143|Hormones|hormones|mesh-ancestor
2291101|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2291102|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291103|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2291104|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291105|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
2291106|NCT00260156|Vildagliptin|vildagliptin|mesh-list
2291107|NCT00260156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2291108|NCT00260156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291109|NCT00260156|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2291110|NCT00260156|Protease Inhibitors|protease inhibitors|mesh-ancestor
2291111|NCT00260156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291112|NCT00260156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291113|NCT00260247|Carbamazepine|carbamazepine|mesh-list
2291114|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
2291115|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
2291116|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
2831225|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831226|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2831227|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
2831228|NCT03995641|Hormones|hormones|mesh-ancestor
2831229|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831230|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2831231|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
2831232|NCT03995628|Dexamethasone|dexamethasone|mesh-list
2831233|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2831234|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
2831235|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
2831236|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831237|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831238|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2831239|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
2831240|NCT03995628|Hormones|hormones|mesh-ancestor
2831241|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831242|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2831243|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291117|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2291118|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2291119|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291120|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2831244|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
2831245|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
2831246|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2831247|NCT03995563|Dexamethasone|dexamethasone|mesh-list
2831248|NCT03995563|Ropivacaine|ropivacaine|mesh-list
2831249|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2831250|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
2831251|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
2831252|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831253|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831254|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2831255|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
2831256|NCT03995563|Hormones|hormones|mesh-ancestor
2831257|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831258|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2831259|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831260|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
2831261|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
2831262|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831263|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
2831264|NCT03995251|Testosterone|testosterone|mesh-list
2831265|NCT03995251|Androgens|androgens|mesh-ancestor
2831266|NCT03995251|Hormones|hormones|mesh-ancestor
2831267|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831268|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831269|NCT03995147|Prednisone|prednisone|mesh-list
2831270|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
2831271|NCT03995147|Doxorubicin|doxorubicin|mesh-list
2831272|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
2831273|NCT03995147|Vincristine|vincristine|mesh-list
2831274|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2831275|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
2291121|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2291122|NCT00260247|Analgesics|analgesics|mesh-ancestor
2291123|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
2291124|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291125|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2291126|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2291127|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291128|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2291129|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2291130|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2291131|NCT00260260|Oxycodone|oxycodone|mesh-list
2291132|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2291133|NCT00260260|Narcotics|narcotics|mesh-ancestor
2291134|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2291135|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291136|NCT00260260|Analgesics|analgesics|mesh-ancestor
2291137|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
2291138|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291139|NCT00260325|Valdecoxib|valdecoxib|mesh-list
2291140|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2291141|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2291142|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291143|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291144|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2291145|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2291146|NCT00260325|Analgesics|analgesics|mesh-ancestor
2831276|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831277|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2831278|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2831279|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
2831280|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831281|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831282|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2831283|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2831284|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2831285|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2831286|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2291147|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
2291148|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291149|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291150|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2291151|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2831287|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291152|NCT00260351|Vaccines|vaccines|mesh-list
2291153|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
2291154|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291155|NCT00260364|Gemcitabine|gemcitabine|mesh-list
2291156|NCT00260364|Bevacizumab|bevacizumab|mesh-list
2291157|NCT00260364|Capecitabine|capecitabine|mesh-list
2291158|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2291159|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2291160|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291161|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2291162|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2291163|NCT00260364|Growth Substances|growth substances|mesh-ancestor
2831288|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2831289|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
2831290|NCT03995147|Hormones|hormones|mesh-ancestor
2831291|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831292|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2831293|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2831294|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
2831295|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
2831296|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
2831297|NCT03995277|Biotin|biotin|mesh-list
2831298|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
2831299|NCT03995277|Vitamins|vitamins|mesh-ancestor
2831300|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
2831301|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831302|NCT03995134|Remifentanil|remifentanil|mesh-list
2831303|NCT03995134|Propofol|propofol|mesh-list
2831304|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2831305|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831306|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831307|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2831308|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
2831309|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
2831310|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2831311|NCT03995134|Narcotics|narcotics|mesh-ancestor
2831312|NCT03995134|Analgesics|analgesics|mesh-ancestor
2831313|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
2831314|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831315|NCT03995017|Nivolumab|nivolumab|mesh-list
2831316|NCT03995017|Ramucirumab|ramucirumab|mesh-list
2291164|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291165|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
2291166|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2291167|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
2291168|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291169|NCT00260364|Antiviral Agents|antiviral agents|mesh-ancestor
2291170|NCT00260364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2291171|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291172|NCT00260364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2831317|NCT03995017|Rucaparib|rucaparib|mesh-list
2831318|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2831319|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831320|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2831321|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831322|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2831323|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831324|NCT03994874|Furosemide|furosemide|mesh-list
2831325|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
2831326|NCT03994874|Diuretics|diuretics|mesh-list
2831327|NCT03994874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
2831328|NCT03994874|Natriuretic Agents|natriuretic agents|mesh-ancestor
2831329|NCT03994874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831330|NCT03994874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2831331|NCT03994874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831332|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2831333|NCT03994965|Pimavanserin|pimavanserin|mesh-list
2831334|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2831335|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2831336|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2831337|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2831338|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831339|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831340|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2831341|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2291173|NCT00260364|Immunologic Factors|immunologic factors|mesh-ancestor
2831342|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2831343|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
2831344|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831345|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831346|NCT03994731|Methotrexate|methotrexate|mesh-list
2831347|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2831348|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
2831349|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2831350|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831351|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2831352|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
2831353|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831354|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831355|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
2831356|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831357|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2831358|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2831359|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
2831360|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2831361|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2831362|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
2831363|NCT03994783|Rituximab|rituximab|mesh-list
2831364|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
2831365|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2831366|NCT03994783|Antibodies|antibodies|mesh-list
2831367|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
2831368|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2831369|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2831370|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831371|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
2831372|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831373|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2831374|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2831375|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
2831376|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
2831377|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831378|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2831379|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
2831380|NCT03994783|Hormones|hormones|mesh-ancestor
2831381|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831382|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2831383|NCT03994783|Protective Agents|protective agents|mesh-ancestor
2831384|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
2831385|NCT03994705|Fludarabine|fludarabine|mesh-list
2831386|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2831387|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
2831388|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831389|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2831390|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2831391|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
2831392|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831393|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831394|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2831395|NCT03994692|Ether|ether|mesh-list
2831396|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2831397|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
2831398|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
2831399|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831400|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831401|NCT03994744|Metformin|metformin|mesh-list
2831402|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2831403|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2831404|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831405|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831406|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831407|NCT03994211|Itraconazole|itraconazole|mesh-list
2831408|NCT03994211|Rifampin|rifampin|mesh-list
2831409|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
2831410|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2831411|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2831412|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2831413|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831414|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831415|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2831416|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
2831417|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831418|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831419|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2831420|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2831421|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
2831422|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2831423|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
2831424|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2831425|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2831426|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2831427|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2831428|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2831429|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2831430|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2831431|NCT03994107|Paclitaxel|paclitaxel|mesh-list
2831432|NCT03994107|Doxorubicin|doxorubicin|mesh-list
2831433|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2831434|NCT03994107|Trastuzumab|trastuzumab|mesh-list
2831435|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2831436|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2831437|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831438|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
2831439|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
2831440|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
2831441|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831442|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2831443|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2831444|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2831445|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831446|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2291174|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2291175|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
2291176|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2291177|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291178|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
2291179|NCT00260390|Hormones|hormones|mesh-ancestor
2291180|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2291181|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291182|NCT00260416|Abciximab|abciximab|mesh-list
2291183|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
2291184|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2291185|NCT00260520|Dalteparin|dalteparin|mesh-list
2291186|NCT00260520|Tinzaparin|tinzaparin|mesh-list
2291187|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2291188|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
2291189|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2291190|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2291191|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831447|NCT03994146|Remifentanil|remifentanil|mesh-list
2831448|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2291192|NCT00260611|Docetaxel|docetaxel|mesh-list
2291193|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
2291194|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291195|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
2291196|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
2831449|NCT03994146|Narcotics|narcotics|mesh-ancestor
2831450|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2291197|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
2291198|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291199|NCT00260624|Citalopram|citalopram|mesh-list
2291200|NCT00260624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2291201|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2107064|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2107065|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107066|NCT02483585|Analgesics|analgesics|mesh-ancestor
2107067|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
2107068|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107069|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107070|NCT02483611|Lidocaine|lidocaine|mesh-list
2831451|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291202|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2291203|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831452|NCT03994146|Analgesics|analgesics|mesh-ancestor
2831453|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
2831454|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831455|NCT03994055|Antioxidants|antioxidants|mesh-list
2831456|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831457|NCT03994055|Protective Agents|protective agents|mesh-ancestor
2831458|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831459|NCT03994393|Durvalumab|durvalumab|mesh-list
2831460|NCT03994393|Tremelimumab|tremelimumab|mesh-list
2831461|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2831462|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831463|NCT03993912|Dexamethasone|dexamethasone|mesh-list
2831464|NCT03993912|Lenalidomide|lenalidomide|mesh-list
2831465|NCT03993912|Daratumumab|daratumumab|mesh-list
2831466|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2831467|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
2831468|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
2831469|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831470|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831471|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2831472|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
2831473|NCT03993912|Hormones|hormones|mesh-ancestor
2831474|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831475|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2831476|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831477|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
2831478|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2831479|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2831480|NCT03993912|Growth Substances|growth substances|mesh-ancestor
2831481|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
2291204|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291205|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
2291206|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291207|NCT00260624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2291208|NCT00260624|Antidepressive Agents|antidepressive agents|mesh-ancestor
2291209|NCT00260624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2291210|NCT00260702|Omalizumab|omalizumab|mesh-list
2291211|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2291212|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2291213|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
2291214|NCT00260793|Ropinirole|ropinirole|mesh-list
2291215|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2291216|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2291217|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
2291218|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
2291219|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291220|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291221|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291222|NCT00260819|Bosentan|bosentan|mesh-list
2291223|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2291224|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2291225|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291226|NCT00260988|Dalteparin|dalteparin|mesh-list
2291227|NCT00260988|Tinzaparin|tinzaparin|mesh-list
2291228|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2291229|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
2291230|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2291231|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2291232|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291233|NCT00261027|Exemestane|exemestane|mesh-list
2291234|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291235|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2291236|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2831482|NCT03993717|Vaccines|vaccines|mesh-list
2831483|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
2831484|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831485|NCT03993431|Methamphetamine|methamphetamine|mesh-list
2831486|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2831487|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291237|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291238|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291239|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2291240|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
2291241|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2291242|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291243|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2291244|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2291245|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2291246|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
2291247|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291248|NCT00261079|Fexofenadine|fexofenadine|mesh-list
2291249|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2831488|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
2831489|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
2831490|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831491|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
2831492|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831493|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831494|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
2831495|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2831496|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2831497|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2831498|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2831499|NCT03993626|Nivolumab|nivolumab|mesh-list
2831500|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2831501|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831502|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2831503|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831504|NCT03993535|Serotonin|serotonin|mesh-list
2831505|NCT03993535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2831506|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2831507|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
2831508|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831509|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831510|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831511|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2831512|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2831513|NCT03993327|Iodine|iodine|mesh-list
2831514|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2831515|NCT03993327|Antibodies|antibodies|mesh-list
2831516|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
2831517|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2831518|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
2831519|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831520|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831521|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2831522|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2831523|NCT03993327|Trace Elements|trace elements|mesh-ancestor
2831524|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
2291250|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2291251|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2291252|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
2291253|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
2291254|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831525|NCT03993457|Citalopram|citalopram|mesh-list
2831526|NCT03993457|Bupropion|bupropion|mesh-list
2831527|NCT03993457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2831528|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2831529|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2831530|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831531|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831532|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
2831533|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831534|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2831535|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
2831536|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2831537|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2831538|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
2831539|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2831540|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2831541|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831542|NCT03993366|Pramlintide|pramlintide|mesh-list
2831543|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
2831544|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2831545|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831546|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
2291255|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291256|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291257|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
2291258|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291259|NCT00261105|Telithromycin|telithromycin|mesh-list
2291260|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2291261|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2291262|NCT00261118|Rituximab|rituximab|mesh-list
2291263|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2291264|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291265|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
2291266|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291267|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291268|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
2291269|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2291270|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2291271|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2291272|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2291273|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291274|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
2291275|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291276|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831547|NCT03993353|Tadalafil|tadalafil|mesh-list
2831548|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2831549|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831550|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
2831551|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2831552|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2831553|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831554|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831555|NCT03993353|Urological Agents|urological agents|mesh-ancestor
2831556|NCT03993249|Nivolumab|nivolumab|mesh-list
2831557|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2831558|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831559|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2831560|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831561|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2831562|NCT03993236|Ezetimibe|ezetimibe|mesh-list
2831563|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2831564|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2831565|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
2831566|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831567|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2831568|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2831569|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831570|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
2831571|NCT03992937|Progesterone|progesterone|mesh-list
2831572|NCT03992937|Progestins|progestins|mesh-ancestor
2831573|NCT03992937|Hormones|hormones|mesh-ancestor
2831574|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831575|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831576|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2831577|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
2831578|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2831579|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2831580|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2831581|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2831582|NCT03992885|Pemetrexed|pemetrexed|mesh-list
2831583|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831584|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291277|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2291278|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291279|NCT00261170|Bupropion|bupropion|mesh-list
2291280|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2291281|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
2291282|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2831585|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831586|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2831587|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2831588|NCT03993262|Bortezomib|bortezomib|mesh-list
2831589|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831590|NCT03992911|Carboplatin|carboplatin|mesh-list
2831591|NCT03992911|Etoposide|etoposide|mesh-list
2831592|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
2831593|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831594|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2831595|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2831596|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2831597|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831598|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831599|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2831600|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
2831601|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
2831602|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831603|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831604|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
2831605|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831606|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2831607|NCT03992443|Reteplase|reteplase|mesh-list
2831608|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2831609|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2831610|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831611|NCT03992586|Methamphetamine|methamphetamine|mesh-list
2831612|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2831613|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831614|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
2831615|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
2831616|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831617|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
2831618|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831619|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831620|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
2831621|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2831622|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2831623|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2831624|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2831625|NCT03992755|Treprostinil|treprostinil|mesh-list
2831626|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2831627|NCT03992170|Daratumumab|daratumumab|mesh-list
2831628|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831629|NCT03992131|Rucaparib|rucaparib|mesh-list
2831630|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2831631|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831632|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831633|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831634|NCT03992144|Amoxicillin|amoxicillin|mesh-list
2831635|NCT03992144|Metronidazole|metronidazole|mesh-list
2831636|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2831637|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2831638|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2831639|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2291283|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2291284|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2291285|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2291286|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291287|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
2291288|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291289|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291290|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2291291|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2291292|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291293|NCT00261183|Melatonin|melatonin|mesh-list
2291294|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
2291295|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831640|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
2831641|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
2831642|NCT03992066|Hematinics|hematinics|mesh-ancestor
2831643|NCT03992196|Rotigotine|rotigotine|mesh-list
2831644|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
2831645|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
2831646|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831647|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831648|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831649|NCT03992261|Halobetasol|halobetasol|mesh-list
2831650|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2831651|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
2831652|NCT03992326|Fludarabine|fludarabine|mesh-list
2831653|NCT03992326|Interleukin-2|interleukin-2|mesh-list
2831654|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2291296|NCT00261183|Protective Agents|protective agents|mesh-ancestor
2291297|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291298|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2291299|NCT00261222|Amodiaquine|amodiaquine|mesh-list
2291300|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
2291301|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2291302|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2291303|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2291304|NCT00261248|Vaccines|vaccines|mesh-list
2291305|NCT00261248|Immunologic Factors|immunologic factors|mesh-ancestor
2291306|NCT00261248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291307|NCT00261261|Midazolam|midazolam|mesh-list
2291308|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2291309|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2291310|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2291311|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291312|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2291313|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2291314|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2291315|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2291316|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
2291317|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
2831655|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
2831656|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831657|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2831658|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2291318|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
2291319|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
2291320|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291321|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831659|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
2831660|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831661|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831662|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2831663|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2831664|NCT03992326|Analgesics|analgesics|mesh-ancestor
2831665|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
2831666|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831667|NCT03992365|Bisacodyl|bisacodyl|mesh-list
2831668|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
2831669|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2831670|NCT03992365|Cathartics|cathartics|mesh-ancestor
2831671|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2831672|NCT03992365|Laxatives|laxatives|mesh-ancestor
2831673|NCT03991936|Triamcinolone|triamcinolone|mesh-list
2291322|NCT00261287|Ciclesonide|ciclesonide|mesh-list
2831674|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2831675|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2831676|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2831677|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2831678|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
2831679|NCT03991936|Hormones|hormones|mesh-ancestor
2831680|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831681|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831682|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2831683|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
2831684|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831685|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831686|NCT03991845|Levocetirizine|levocetirizine|mesh-list
2831687|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2831688|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2831689|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
2831690|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
2831691|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831692|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831693|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831694|NCT03991910|Ramipril|ramipril|mesh-list
2831695|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2831696|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
2831697|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831698|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831699|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2107071|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
2107072|NCT02483611|Cisatracurium|cisatracurium|mesh-list
2107073|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
2107074|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
2107075|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831700|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
2831701|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2831702|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831703|NCT03991442|Amlodipine|amlodipine|mesh-list
2831704|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2831705|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2831706|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2831707|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831708|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2831709|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291323|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
2291324|NCT00261287|Hormones|hormones|mesh-ancestor
2291325|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2291326|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291327|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2291328|NCT00261300|Pantoprazole|pantoprazole|mesh-list
2291329|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2291330|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2831710|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
2831711|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2831712|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2831713|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831714|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831715|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2831716|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2831717|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831718|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
2831719|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831720|NCT03991364|Methamphetamine|methamphetamine|mesh-list
2831721|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2831722|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831723|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
2831724|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
2831725|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831726|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
2107076|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107077|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
2107078|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107079|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2107080|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2107081|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2107082|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2107083|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831727|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2831728|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831729|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
2831730|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2831731|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2831732|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2831733|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2831734|NCT03991559|Manganese|manganese|mesh-list
2831735|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2831736|NCT03991559|Antibodies|antibodies|mesh-list
2831737|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
2831738|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
2831739|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831740|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831741|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831742|NCT03991559|Trace Elements|trace elements|mesh-ancestor
2831743|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
2831744|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2831745|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2831746|NCT03991312|Itraconazole|itraconazole|mesh-list
2831747|NCT03991312|Rifampin|rifampin|mesh-list
2831748|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
2831749|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2831750|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2831751|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2831752|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831753|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831754|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2831755|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
2831756|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2831757|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831758|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2831759|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2831760|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
2831761|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2831762|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
2831763|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2831764|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2831765|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2831766|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2831767|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2831768|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2831769|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2831770|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
2831771|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2831772|NCT03990883|Lidocaine|lidocaine|mesh-list
2831773|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
2831774|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
2291331|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2291332|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291333|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291334|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
2291335|NCT00261313|Hematinics|hematinics|mesh-ancestor
2291336|NCT00261326|Simvastatin|simvastatin|mesh-list
2291337|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2291338|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2291339|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
2291340|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291341|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2291342|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2291343|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291344|NCT00261339|Pantoprazole|pantoprazole|mesh-list
2291345|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2291346|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2291347|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2291348|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291349|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291350|NCT00261352|Metformin|metformin|mesh-list
2291351|NCT00261352|Fenofibrate|fenofibrate|mesh-list
2291352|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2291353|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291354|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2291355|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
2831775|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831776|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107084|NCT02483611|Analgesics|analgesics|mesh-ancestor
2291356|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291357|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2291358|NCT00261365|Ipilimumab|ipilimumab|mesh-list
2291359|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2831777|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
2831778|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831779|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2831780|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2831781|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2831782|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2831783|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831784|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2831785|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
2831786|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2831787|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2831788|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2831789|NCT03991091|Oxytocin|oxytocin|mesh-list
2831790|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
2831791|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2831792|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831793|NCT03991130|Nivolumab|nivolumab|mesh-list
2831794|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2831795|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831796|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2831797|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831798|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
2831799|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831800|NCT03990896|Talazoparib|talazoparib|mesh-list
2831801|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2831802|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831803|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831804|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831805|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
2831806|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2831807|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831808|NCT03990766|Theophylline|theophylline|mesh-list
2291360|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291361|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2291362|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291363|NCT00261378|Doxorubicin|doxorubicin|mesh-list
2291364|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2291365|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2291366|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291367|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2291368|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2291369|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483656|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
2831809|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2831810|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
2831811|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831812|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831813|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2831814|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
2831815|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2831816|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831817|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831818|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
2831819|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2107085|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
2107086|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2107087|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2107088|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
2107089|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2107090|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2107091|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2107092|NCT02483975|Albuterol|albuterol|mesh-list
2107093|NCT02483975|Montelukast|montelukast|mesh-list
2107094|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2107095|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
2291370|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291371|NCT00261391|Marimastat|marimastat|mesh-list
2291372|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291373|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291374|NCT00261469|Topiramate|topiramate|mesh-list
2291375|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
2291376|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2291377|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291378|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2291379|NCT00261482|Norelgestromin|norelgestromin|mesh-list
2291380|NCT00261482|Estradiol|estradiol|mesh-list
2291381|NCT00261482|Estrogens|estrogens|mesh-ancestor
2291382|NCT00261482|Hormones|hormones|mesh-ancestor
2291383|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2291384|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291385|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2291386|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
2291387|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2291388|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2291389|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2291390|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2291391|NCT00261508|Risperidone|risperidone|mesh-list
2291392|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2291393|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
2291394|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291395|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291396|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291397|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2291398|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2291399|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2291400|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2291401|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2291402|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
2291403|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
2291404|NCT00261521|Hematinics|hematinics|mesh-ancestor
2291405|NCT00261547|Rituximab|rituximab|mesh-list
2291406|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2291407|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291408|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
2291409|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291410|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291411|NCT00261560|Acetaminophen|acetaminophen|mesh-list
2291412|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2291413|NCT00261560|Analgesics|analgesics|mesh-ancestor
2291414|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
2291415|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831820|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2831821|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
2831822|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291416|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291417|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
2291418|NCT00261573|Galantamine|galantamine|mesh-list
2291419|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2291420|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291421|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291422|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
2291423|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291424|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291425|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2291426|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
2831823|NCT03991013|Dolutegravir|dolutegravir|mesh-list
2831824|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2831825|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2831826|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831827|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291427|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291428|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
2291429|NCT00261586|Aspirin|aspirin|mesh-list
2291430|NCT00261586|Acetaminophen|acetaminophen|mesh-list
2291431|NCT00261586|Ibuprofen|ibuprofen|mesh-list
2291432|NCT00261586|Celecoxib|celecoxib|mesh-list
2291433|NCT00261586|Naproxen|naproxen|mesh-list
2291434|NCT00261586|Rofecoxib|rofecoxib|mesh-list
2291435|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2291436|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2291437|NCT00261586|Analgesics|analgesics|mesh-ancestor
2291438|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
2831828|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2831829|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2831830|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
2831831|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2831832|NCT03990701|Metomidate|metomidate|mesh-list
2831833|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2831834|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831835|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831836|NCT03990922|Morphine|morphine|mesh-list
2831837|NCT03990922|Ropivacaine|ropivacaine|mesh-list
2831838|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2831839|NCT03990922|Narcotics|narcotics|mesh-ancestor
2831840|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831841|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831842|NCT03990922|Analgesics|analgesics|mesh-ancestor
2831843|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
2831844|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831845|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
2831846|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
2291439|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291440|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291441|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2291442|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291443|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2291444|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2291445|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291446|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2291447|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2291448|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291449|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
2291450|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2291451|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
2291452|NCT00261599|Midazolam|midazolam|mesh-list
2291453|NCT00261599|Fospropofol|fospropofol|mesh-list
2291454|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2291455|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2291456|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2291457|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291458|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2291459|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2291460|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2291461|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2291462|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
2831847|NCT03990480|Amlodipine|amlodipine|mesh-list
2831848|NCT03990480|Valsartan|valsartan|mesh-list
2831849|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2831850|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2831851|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2831852|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831853|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2831854|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831855|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
2831856|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2831857|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2831858|NCT03990623|Liver Extracts|liver extracts|mesh-list
2831859|NCT03990623|Hematinics|hematinics|mesh-ancestor
2831860|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2831861|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2831862|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
2831874|NCT03990129|Dipyrone|dipyrone|mesh-list
2831875|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2831876|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2291463|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
2291464|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
2291465|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
2291466|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291467|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831877|NCT03990129|Analgesics|analgesics|mesh-ancestor
2831878|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
2831879|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831880|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831881|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2831882|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2831883|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
2831884|NCT03990194|Leuprolide|leuprolide|mesh-list
2831885|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2831886|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
2831887|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2831888|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831889|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2831890|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831891|NCT03990103|Paclitaxel|paclitaxel|mesh-list
2831892|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2831893|NCT03990103|Bevacizumab|bevacizumab|mesh-list
2831894|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
2831895|NCT03990103|Tegafur|tegafur|mesh-list
2831896|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2831897|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831898|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
2831899|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
2831900|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
2831901|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831902|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2831903|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2291468|NCT00261612|Dexamethasone|dexamethasone|mesh-list
2291469|NCT00261612|Rituximab|rituximab|mesh-list
2291470|NCT00261612|Bortezomib|bortezomib|mesh-list
2291471|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2291472|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
2291473|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
2831904|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2291474|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291475|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291476|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2291477|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
2291478|NCT00261612|Hormones|hormones|mesh-ancestor
2291479|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2291480|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2291481|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291482|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2291483|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
2291484|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291485|NCT00261625|Alendronate|alendronate|mesh-list
2291486|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2291487|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291488|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
2831905|NCT03990103|Growth Substances|growth substances|mesh-ancestor
2831906|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831907|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
2831908|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2831909|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
2831910|NCT03990038|Ropivacaine|ropivacaine|mesh-list
2831911|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
2831912|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
2831913|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2291489|NCT00261677|Hematinics|hematinics|mesh-ancestor
2291490|NCT00261703|Cisplatin|cisplatin|mesh-list
2291491|NCT00261703|Docetaxel|docetaxel|mesh-list
2291492|NCT00261703|Fluorouracil|fluorouracil|mesh-list
2291493|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291494|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
2291495|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
2291496|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
2291497|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291498|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
2291499|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2291500|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2291501|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
2291502|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291503|NCT00261729|Prazosin|prazosin|mesh-list
2291504|NCT00261729|Paroxetine|paroxetine|mesh-list
2291505|NCT00261729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2831914|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831915|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
2831916|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831917|NCT03990571|Avelumab|avelumab|mesh-list
2831918|NCT03990571|Axitinib|axitinib|mesh-list
2831919|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2831920|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2831921|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831922|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2831923|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2831924|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831925|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
2831926|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831927|NCT03989609|Midazolam|midazolam|mesh-list
2831928|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
2831929|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2831930|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2831931|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831932|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2831933|NCT03989609|Analgesics|analgesics|mesh-ancestor
2291506|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2291507|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2291508|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291509|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291510|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
2291511|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831934|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
2831935|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2831936|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2831937|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2831938|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2831939|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
2831940|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291512|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2291513|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
2291514|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2291515|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2291516|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2291517|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291518|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2291519|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2291520|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2291521|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2291522|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
2291523|NCT00261742|Penicillins|penicillins|mesh-list
2831941|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831942|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2831943|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2831944|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2831945|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2831946|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2831947|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
2831948|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
2831949|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
2831950|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
2831951|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
2831952|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2831953|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
2291524|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2291525|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2291526|NCT00261755|Analgesics|analgesics|mesh-list
2291527|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
2291528|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291529|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291530|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
2291531|NCT00261820|Sirolimus|sirolimus|mesh-list
2291532|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
2291533|NCT00261820|Prednisolone|prednisolone|mesh-list
2291534|NCT00261820|Tacrolimus|tacrolimus|mesh-list
2291535|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2291536|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
2291537|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291538|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2291539|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291540|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291541|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2291542|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291543|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2291544|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
2291545|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2291546|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2831954|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2831955|NCT03989817|Protective Agents|protective agents|mesh-ancestor
2831956|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831957|NCT03989778|Vitamin D|vitamin d|mesh-list
2831958|NCT03989778|Vitamins|vitamins|mesh-ancestor
2831959|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
2831960|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831961|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2831962|NCT03989830|Endostatins|endostatins|mesh-list
2831963|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2831964|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2831965|NCT03989830|Growth Substances|growth substances|mesh-ancestor
2831966|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291547|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
2291548|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2291549|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
2291550|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
2291551|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291552|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2291553|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
2291554|NCT00261820|Hormones|hormones|mesh-ancestor
2291555|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2291556|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2291557|NCT00261820|Protective Agents|protective agents|mesh-ancestor
2291558|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2291559|NCT00261872|Methylphenidate|methylphenidate|mesh-list
2291560|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2831967|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
2831968|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831969|NCT03989336|Manganese|manganese|mesh-list
2831970|NCT03989336|Paclitaxel|paclitaxel|mesh-list
2831971|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2831972|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2831973|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2831974|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831975|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
2831976|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
2831977|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
2831978|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831979|NCT03989336|Trace Elements|trace elements|mesh-ancestor
2831980|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
2831981|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831982|NCT03989310|Manganese|manganese|mesh-list
2831983|NCT03989310|Gemcitabine|gemcitabine|mesh-list
2291561|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291562|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2291563|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2291564|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2291565|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291566|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
2291567|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291568|NCT00261911|Sibutramine|sibutramine|mesh-list
2291569|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
2291570|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2291571|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
2291572|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2291573|NCT00261937|Furosemide|furosemide|mesh-list
2291574|NCT00261937|Diuretics|diuretics|mesh-ancestor
2291575|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
2291576|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291577|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2831984|NCT03989310|Paclitaxel|paclitaxel|mesh-list
2831985|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2831986|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2831987|NCT03989310|Antibodies|antibodies|mesh-list
2831988|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
2831989|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2831990|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2831991|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
2831992|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
2831993|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
2831994|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2831995|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
2831996|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2831997|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2831998|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
2831999|NCT03989310|Antiviral Agents|antiviral agents|mesh-ancestor
2832000|NCT03989310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832001|NCT03989310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832002|NCT03989310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2832003|NCT03989310|Trace Elements|trace elements|mesh-ancestor
2832004|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
2832005|NCT03989700|Thiamine|thiamine|mesh-list
2832006|NCT03989700|Vitamins|vitamins|mesh-ancestor
2832007|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
2832008|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832009|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
2832010|NCT03989557|Aspirin|aspirin|mesh-list
2832011|NCT03989557|Clopidogrel|clopidogrel|mesh-list
2832012|NCT03989557|Ticagrelor|ticagrelor|mesh-list
2832013|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2832014|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2832015|NCT03989557|Analgesics|analgesics|mesh-ancestor
2832016|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
2832017|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832018|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832019|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2832020|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2832021|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2832022|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2832023|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832024|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2832025|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2832026|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832027|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
2832028|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2832029|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2832030|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2832031|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
2832032|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2832033|NCT03989271|Quercetin|quercetin|mesh-list
2832034|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
2832035|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832036|NCT03989271|Protective Agents|protective agents|mesh-ancestor
2832037|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832038|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2832039|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
2832040|NCT03989466|Antibodies|antibodies|mesh-list
2832041|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
2832042|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2832043|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
2291578|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2291579|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291580|NCT00261976|Infliximab|infliximab|mesh-list
2291581|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
2291582|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2291583|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291584|NCT00262015|Vaccines|vaccines|mesh-list
2832044|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832045|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832046|NCT03989115|Osimertinib|osimertinib|mesh-list
2832047|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832048|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2832049|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832050|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291585|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
2291586|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291587|NCT00262054|Heparin|heparin|mesh-list
2291588|NCT00262054|Calcium heparin|calcium heparin|mesh-list
2291589|NCT00262054|Bivalirudin|bivalirudin|mesh-list
2291590|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
2291591|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2291592|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2291593|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291594|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
2291595|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2291596|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
2291597|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291598|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
2291599|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2291600|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291601|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2291602|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
2291603|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2291604|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2291605|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291606|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291607|NCT00262210|Prednisolone|prednisolone|mesh-list
2832055|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
2832056|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2832057|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832058|NCT03989037|Carboplatin|carboplatin|mesh-list
2832059|NCT03989037|Docetaxel|docetaxel|mesh-list
2832060|NCT03989037|Trastuzumab|trastuzumab|mesh-list
2832061|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832062|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
2832063|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
2832064|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
2832065|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832066|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2832067|NCT03989024|Clomiphene|clomiphene|mesh-list
2832068|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2832069|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2832070|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
2832071|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2832072|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832073|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2832074|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
2832075|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2832076|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2832077|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2832078|NCT03989024|Hormones|hormones|mesh-ancestor
2832079|NCT03988725|Vitamin E|vitamin e|mesh-list
2832080|NCT03988725|Vitamins|vitamins|mesh-ancestor
2832081|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
2832082|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832083|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
2832084|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832085|NCT03988725|Protective Agents|protective agents|mesh-ancestor
2832086|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
2832087|NCT03988530|Scopolamine|scopolamine|mesh-list
2832088|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2832089|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2291608|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
2291609|NCT00262210|Etoposide|etoposide|mesh-list
2291610|NCT00262210|Epirubicin|epirubicin|mesh-list
2291611|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2291612|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
2291613|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291614|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291615|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2291616|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
2291617|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291618|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291619|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2291620|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2291621|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2291622|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2291623|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291624|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2291625|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
2832090|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
2832091|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
2832092|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832093|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832094|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2832095|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
2832096|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2832097|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
2832098|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2832099|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832100|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2832101|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
2832102|NCT03988387|Tenofovir|tenofovir|mesh-list
2832103|NCT03988387|Emtricitabine|emtricitabine|mesh-list
2832104|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
2832105|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832106|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2832107|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2832108|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832109|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832110|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2832111|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2832112|NCT03988231|Enoxaparin|enoxaparin|mesh-list
2832113|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
2832114|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2832115|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2832116|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832117|NCT03988205|Cytarabine|cytarabine|mesh-list
2832118|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2832119|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
2832120|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832121|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832122|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
2832123|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832124|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2832125|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
2832126|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291626|NCT00262210|Hormones|hormones|mesh-ancestor
2291627|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2291628|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2291629|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2291630|NCT00262262|Levetiracetam|levetiracetam|mesh-list
2291631|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
2291632|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
2291633|NCT00262275|Aspirin|aspirin|mesh-list
2291634|NCT00262275|Clopidogrel|clopidogrel|mesh-list
2291635|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2291636|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2291637|NCT00262275|Analgesics|analgesics|mesh-ancestor
2291638|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
2291639|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291640|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291641|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2291642|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291643|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2291644|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2291645|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291646|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2291647|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2291648|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291649|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
2291650|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2291651|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2291652|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2832127|NCT03988452|Ritonavir|ritonavir|mesh-list
2832128|NCT03988452|Darunavir|darunavir|mesh-list
2832129|NCT03988452|Tenofovir|tenofovir|mesh-list
2832130|NCT03988452|Lamivudine|lamivudine|mesh-list
2832131|NCT03988452|Zidovudine|zidovudine|mesh-list
2832132|NCT03988452|Dolutegravir|dolutegravir|mesh-list
2832133|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2832134|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2832135|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
2832136|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832137|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291653|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
2291654|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291655|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2291656|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2291657|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2832138|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2832139|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2832140|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
2832141|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832142|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2832143|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2832144|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2832145|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2832146|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
2832147|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2291658|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
2291659|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291660|NCT00262327|Endostatins|endostatins|mesh-list
2832148|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2832149|NCT03988257|Ascorbic Acid|ascorbic acid|mesh-list
2832150|NCT03988257|Vitamins|vitamins|mesh-ancestor
2832151|NCT03988257|Micronutrients|micronutrients|mesh-ancestor
2832152|NCT03988257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832153|NCT03988257|Antioxidants|antioxidants|mesh-ancestor
2832154|NCT03988257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832155|NCT03988257|Protective Agents|protective agents|mesh-ancestor
2832156|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2832157|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2832158|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2832159|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
2832160|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832161|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2832162|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2832163|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832164|NCT03988010|Amantadine|amantadine|mesh-list
2832165|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2832166|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2832167|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
2832168|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832169|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
2832170|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2832171|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832172|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832173|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2832174|NCT03988010|Analgesics|analgesics|mesh-ancestor
2832175|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
2832176|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832177|NCT03987919|Tirzepatide|tirzepatide|mesh-list
2832178|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2832179|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832180|NCT03987919|Incretins|incretins|mesh-ancestor
2832181|NCT03987919|Hormones|hormones|mesh-ancestor
2832182|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2832183|NCT03987867|Paclitaxel|paclitaxel|mesh-list
2832184|NCT03987867|Carboplatin|carboplatin|mesh-list
2832185|NCT03987867|Pemetrexed|pemetrexed|mesh-list
2832186|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2832187|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2832188|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832189|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
2832190|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
2832191|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
2832192|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832193|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832194|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2832195|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2832196|NCT03988075|Acetaminophen|acetaminophen|mesh-list
2832197|NCT03988075|Ibuprofen|ibuprofen|mesh-list
2832198|NCT03988075|Hydrocodone|hydrocodone|mesh-list
2832199|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2832200|NCT03988075|Analgesics|analgesics|mesh-ancestor
2832201|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
2832202|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832203|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832204|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
2832205|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2832206|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2832207|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2832208|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2832209|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832210|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832211|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2832212|NCT03988075|Narcotics|narcotics|mesh-ancestor
2832213|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2832214|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
2832215|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
2832216|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2832217|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
2832218|NCT03988036|Trastuzumab|trastuzumab|mesh-list
2832219|NCT03988036|Pertuzumab|pertuzumab|mesh-list
2832220|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2832221|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832222|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2832223|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2832224|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832225|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832226|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2832227|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
2832228|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2832229|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832239|NCT03987685|Topotecan|topotecan|mesh-list
2832240|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2832241|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2832242|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832243|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832244|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832245|NCT03987893|Lactulose|lactulose|mesh-list
2832246|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2832247|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2832248|NCT03987893|Laxatives|laxatives|mesh-ancestor
2832249|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
2832250|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2832251|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832252|NCT03987815|Nivolumab|nivolumab|mesh-list
2832253|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2832254|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832255|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2832256|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832257|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2832258|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832259|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832260|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
2832261|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2832262|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291661|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291662|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2291663|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2291664|NCT00262327|Growth Substances|growth substances|mesh-ancestor
2291665|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291666|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
2291667|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
2291668|NCT00262379|Hematinics|hematinics|mesh-ancestor
2291669|NCT00262392|Pamidronate|pamidronate|mesh-list
2291670|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2291671|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291672|NCT00262405|Prednisone|prednisone|mesh-list
2291673|NCT00262405|Zileuton|zileuton|mesh-list
2291674|NCT00262405|Azathioprine|azathioprine|mesh-list
2291675|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2291676|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
2291677|NCT00262405|Hormones|hormones|mesh-ancestor
2291678|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2291679|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291680|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2291681|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291682|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
2291683|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291684|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2291685|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2291686|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
2291687|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291688|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2832263|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2832264|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
2832265|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832266|NCT03987529|Propofol|propofol|mesh-list
2832267|NCT03987529|Sevoflurane|sevoflurane|mesh-list
2832268|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2832269|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2832270|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832271|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2832272|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
2832273|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
2832274|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2832275|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2832276|NCT03987152|Sirolimus|sirolimus|mesh-list
2832277|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2291689|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2291690|NCT00262405|Analgesics|analgesics|mesh-ancestor
2291691|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
2291692|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291693|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2291694|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291695|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2291696|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
2291697|NCT00262418|Ivermectin|ivermectin|mesh-list
2291698|NCT00262418|Permethrin|permethrin|mesh-list
2291699|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2832278|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832279|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2832280|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832281|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
2832282|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2832283|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
2832284|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832285|NCT03986970|Tenofovir|tenofovir|mesh-list
2832286|NCT03986970|Emtricitabine|emtricitabine|mesh-list
2832287|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
2832288|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832289|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2832290|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2832291|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832292|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832293|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2832294|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2832295|NCT03987022|Acetaminophen|acetaminophen|mesh-list
2832296|NCT03987022|Ketorolac|ketorolac|mesh-list
2832297|NCT03987022|Oxycodone|oxycodone|mesh-list
2832298|NCT03987022|Hydromorphone|hydromorphone|mesh-list
2291700|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2291701|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291702|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291703|NCT00262470|Indomethacin|indomethacin|mesh-list
2291704|NCT00262470|Octreotide|octreotide|mesh-list
2291705|NCT00262470|Propranolol|propranolol|mesh-list
2291706|NCT00262470|Clonidine|clonidine|mesh-list
2291707|NCT00262470|Mecamylamine|mecamylamine|mesh-list
2291708|NCT00262470|Acetazolamide|acetazolamide|mesh-list
2291709|NCT00262470|Isosorbide|isosorbide|mesh-list
2291710|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2291711|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2291712|NCT00262470|Midodrine|midodrine|mesh-list
2291713|NCT00262470|Memantine|memantine|mesh-list
2291714|NCT00262470|Entacapone|entacapone|mesh-list
2291715|NCT00262470|Melatonin|melatonin|mesh-list
2291716|NCT00262470|Modafinil|modafinil|mesh-list
2291717|NCT00262470|Sertraline|sertraline|mesh-list
2291718|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2291719|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
2291720|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291721|NCT00262470|Protective Agents|protective agents|mesh-ancestor
2291722|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291723|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2291724|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
2291725|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2291726|NCT00262470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2291727|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2291728|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2291729|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291730|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
2291731|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2832299|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2291732|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2291733|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
2832300|NCT03987022|Narcotics|narcotics|mesh-ancestor
2832301|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2832302|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832303|NCT03987022|Analgesics|analgesics|mesh-ancestor
2832304|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
2832305|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832306|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2832307|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2832308|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2832309|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2832310|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2832311|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832312|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832313|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
2291734|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2291735|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2291736|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
2832314|NCT03986996|Amoxicillin|amoxicillin|mesh-list
2832315|NCT03986996|Metronidazole|metronidazole|mesh-list
2832316|NCT03986996|Doxycycline|doxycycline|mesh-list
2832317|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2291737|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2291738|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2291739|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
2291740|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2832318|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832319|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2832320|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2832321|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
2832322|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
2832323|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
2832324|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2832325|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832326|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832327|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832328|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2832329|NCT03986905|Scopolamine|scopolamine|mesh-list
2832330|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2832331|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2832332|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
2832333|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
2832334|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832335|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832336|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2832337|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
2832338|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2832339|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
2832340|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291741|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2291742|NCT00262470|Analgesics|analgesics|mesh-ancestor
2291743|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
2291744|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291745|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
2291746|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
2291747|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2291748|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2291749|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2291750|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2291751|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2832341|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832342|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2832343|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
2832344|NCT03986515|Apatinib|apatinib|mesh-list
2832345|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832346|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2832347|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832348|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832349|NCT03986268|Vitamin D|vitamin d|mesh-list
2832350|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
2832351|NCT03986268|Vitamins|vitamins|mesh-ancestor
2832352|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
2832353|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832354|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2832355|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2832356|NCT03986385|Capecitabine|capecitabine|mesh-list
2832357|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
2291752|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291753|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2291754|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2291755|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2291756|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2291757|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2291758|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2291759|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2291760|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2291761|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291762|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
2291763|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
2291764|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2291765|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2291766|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291767|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
2291768|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2291769|NCT00262470|Diuretics|diuretics|mesh-ancestor
2291770|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
2291771|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
2291772|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2291773|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2832358|NCT03986385|Apatinib|apatinib|mesh-list
2832359|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2832360|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
2832361|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832362|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832363|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2832364|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832365|NCT03986294|Leucovorin|leucovorin|mesh-list
2832366|NCT03986294|Antidotes|antidotes|mesh-ancestor
2832367|NCT03986294|Protective Agents|protective agents|mesh-ancestor
2832368|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832369|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
2832370|NCT03986294|Vitamins|vitamins|mesh-ancestor
2832371|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
2832372|NCT03986073|Linagliptin|linagliptin|mesh-list
2832373|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2832374|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832375|NCT03986073|Incretins|incretins|mesh-ancestor
2832376|NCT03986073|Hormones|hormones|mesh-ancestor
2832377|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2832378|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2832379|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
2832380|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832381|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832382|NCT03985891|Antibodies|antibodies|mesh-list
2832383|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2832384|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
2832385|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832386|NCT03986008|Liraglutide|liraglutide|mesh-list
2832387|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2832388|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832389|NCT03986008|Incretins|incretins|mesh-ancestor
2832390|NCT03986008|Hormones|hormones|mesh-ancestor
2291774|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2291775|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2832391|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2832392|NCT03985969|Indomethacin|indomethacin|mesh-list
2832393|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2832394|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2832395|NCT03985969|Analgesics|analgesics|mesh-ancestor
2832396|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
2832397|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832398|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832399|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2832400|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2832401|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
2832402|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
2832403|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2832404|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2832405|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832406|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832407|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
2832408|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2832409|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2832410|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2832411|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2832412|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832413|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
2832414|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291776|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2291777|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2832415|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832416|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2832417|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832418|NCT03985865|Quinine|quinine|mesh-list
2832419|NCT03985865|Denatonium|denatonium|mesh-list
2832420|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
2832421|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2832422|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2832423|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832424|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2832425|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832426|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2832427|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832428|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2832429|NCT03985865|Analgesics|analgesics|mesh-ancestor
2832430|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
2832431|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
2832432|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832433|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
2832434|NCT03985540|Methamphetamine|methamphetamine|mesh-list
2832435|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2832436|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832437|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
2832438|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
2832439|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832440|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
2832441|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2832442|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832443|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
2832444|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2832445|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2832446|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2832447|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2291778|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2291779|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2291780|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
2291781|NCT00262483|Ribavirin|ribavirin|mesh-list
2291782|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2291783|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
2291784|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291785|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
2832448|NCT03985735|Anesthetics|anesthetics|mesh-list
2832449|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2832450|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832451|NCT03985722|Trabectedin|trabectedin|mesh-list
2832452|NCT03985722|Olaratumab|olaratumab|mesh-list
2832453|NCT03985722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2832454|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2832455|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
2832456|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832457|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832458|NCT03985722|Immunologic Factors|immunologic factors|mesh-ancestor
2832459|NCT03985722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832462|NCT03985319|Esomeprazole|esomeprazole|mesh-list
2832463|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2832464|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2832465|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2832466|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832467|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832468|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
2832469|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2832470|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832471|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2832472|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2832473|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832474|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832475|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832476|NCT03985280|Anesthetics|anesthetics|mesh-list
2832477|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
2832478|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2832479|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832480|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
2832481|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832482|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2832483|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
2832484|NCT03985514|Tazobactam|tazobactam|mesh-list
2832485|NCT03985514|Piperacillin|piperacillin|mesh-list
2832486|NCT03985514|Metronidazole|metronidazole|mesh-list
2832487|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2832488|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2832489|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832490|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
2832491|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2832492|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2832493|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832494|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832495|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832496|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2832497|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2832498|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2832499|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2832500|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2832501|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
2832502|NCT03985358|Narcotics|narcotics|mesh-ancestor
2832503|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2832504|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832505|NCT03985358|Analgesics|analgesics|mesh-ancestor
2832506|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
2832507|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832508|NCT03984955|Mannitol|mannitol|mesh-list
2832509|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
2832510|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2832511|NCT03984955|Diuretics|diuretics|mesh-ancestor
2832512|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
2832513|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832514|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2832515|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
2291786|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2291787|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2291788|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2291789|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2291790|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
2291791|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832516|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
2832517|NCT03984955|Protective Agents|protective agents|mesh-ancestor
2832518|NCT03984656|Lidocaine|lidocaine|mesh-list
2832519|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
2832520|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
2832521|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2832522|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832523|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
2832524|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832525|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2832526|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2832527|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2832528|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2832529|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832530|NCT03984565|Cannabidiol|cannabidiol|mesh-list
2832531|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
2832532|NCT03984760|Sevelamer|sevelamer|mesh-list
2832533|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
2832534|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
2832535|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832536|NCT03984890|Vitamin D|vitamin d|mesh-list
2832537|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
2832538|NCT03984890|Vitamins|vitamins|mesh-ancestor
2832539|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
2832540|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832541|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2832542|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2832543|NCT03984591|Eplerenone|eplerenone|mesh-list
2832544|NCT03984591|Spironolactone|spironolactone|mesh-list
2832545|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2832546|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
2832547|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2832548|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832549|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2832550|NCT03984591|Diuretics|diuretics|mesh-ancestor
2832551|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
2832552|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2832553|NCT03984578|Capecitabine|capecitabine|mesh-list
2832554|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
2832555|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2832556|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
2832557|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832558|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832559|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2832560|NCT03984526|Atropine|atropine|mesh-list
2832561|NCT03984526|Ephedrine|ephedrine|mesh-list
2832562|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2832563|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2832564|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2832565|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
2832566|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832567|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832568|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2832569|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
2832570|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
2832571|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
2832572|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2832573|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2832574|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
2832575|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2832576|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832577|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2832578|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
2832579|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2832580|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
2832581|NCT03984188|Theophylline|theophylline|mesh-list
2832582|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2832583|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
2832584|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832585|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107096|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2107097|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
2107098|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2832586|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2832587|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
2832588|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2832589|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832590|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832591|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
2832592|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2832593|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2291792|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2291793|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2291794|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291795|NCT00262561|Aspirin|aspirin|mesh-list
2291796|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2291797|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2291798|NCT00262561|Analgesics|analgesics|mesh-ancestor
2832594|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
2832595|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2832610|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
2832611|NCT03984409|Diuretics|diuretics|mesh-ancestor
2832612|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
2832613|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832614|NCT03984409|Expectorants|expectorants|mesh-ancestor
2832615|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
2832616|NCT03984110|Dexamethasone|dexamethasone|mesh-list
2832617|NCT03984110|Aflibercept|aflibercept|mesh-list
2832618|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2832619|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
2832620|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
2832621|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832622|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832623|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2832624|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
2832625|NCT03984110|Hormones|hormones|mesh-ancestor
2832626|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2832627|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2832628|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832629|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2832630|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2832631|NCT03984110|Growth Substances|growth substances|mesh-ancestor
2832632|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
2832633|NCT03984240|Midazolam|midazolam|mesh-list
2832634|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
2832635|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2832636|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2832637|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832638|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2832639|NCT03984240|Analgesics|analgesics|mesh-ancestor
2832640|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
2832641|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832642|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2832643|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2832644|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2832645|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
2832646|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2832647|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291799|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
2291800|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291801|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291802|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2291803|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291804|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2291805|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2832648|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2832649|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2832650|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2832651|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2832652|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2832653|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
2832654|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
2832655|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
2832656|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
2291806|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291807|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2291808|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2291809|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291810|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
2291811|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2291812|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
2291813|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291814|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2291815|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2832657|NCT03984357|Gemcitabine|gemcitabine|mesh-list
2832658|NCT03984357|Antibodies|antibodies|mesh-list
2832659|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
2832660|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
2832661|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832662|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832663|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2832664|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
2832665|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832666|NCT03984357|Antiviral Agents|antiviral agents|mesh-ancestor
2832667|NCT03984357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832668|NCT03984357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832669|NCT03984357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2832670|NCT03984097|Dexamethasone|dexamethasone|mesh-list
2832671|NCT03984097|Lenalidomide|lenalidomide|mesh-list
2832672|NCT03984097|Bortezomib|bortezomib|mesh-list
2832673|NCT03984097|Pomalidomide|pomalidomide|mesh-list
2832674|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2832675|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
2832676|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
2832677|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832678|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832679|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2832680|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
2832681|NCT03984097|Hormones|hormones|mesh-ancestor
2832682|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2832683|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2832684|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832685|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
2832686|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2832687|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2832688|NCT03984097|Growth Substances|growth substances|mesh-ancestor
2832689|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
2832690|NCT03983954|Durvalumab|durvalumab|mesh-list
2832691|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
2832692|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2832693|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
2832694|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2832695|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832696|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
2832697|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832698|NCT03983876|Adalimumab|adalimumab|mesh-list
2832699|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2832700|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2832701|NCT03983889|Fentanyl|fentanyl|mesh-list
2832702|NCT03983889|Midazolam|midazolam|mesh-list
2832703|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
2832704|NCT03983889|Remifentanil|remifentanil|mesh-list
2832705|NCT03983889|Propofol|propofol|mesh-list
2832706|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2832707|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2832708|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832709|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2832710|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
2832711|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
2832712|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2832713|NCT03983889|Analgesics|analgesics|mesh-ancestor
2832714|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
2832715|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832716|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2832717|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2832718|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2832719|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
2832720|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2832721|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832722|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2832723|NCT03983889|Narcotics|narcotics|mesh-ancestor
2832724|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2832725|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2832726|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2832727|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2832728|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
2832729|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
2832730|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
2832731|NCT03983915|Remifentanil|remifentanil|mesh-list
2832732|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2832733|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2832734|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832735|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2832736|NCT03983915|Analgesics|analgesics|mesh-ancestor
2832737|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
2832738|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832739|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2832740|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2832741|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2832742|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
2832743|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2832744|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832745|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2832746|NCT03983915|Narcotics|narcotics|mesh-ancestor
2832747|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2832748|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
2832749|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832750|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832751|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2832752|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832753|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
2832754|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2832755|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832756|NCT03983460|Betamethasone|betamethasone|mesh-list
2832757|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
2832758|NCT03983460|Clobetasol|clobetasol|mesh-list
2832759|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2832760|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
2832761|NCT03983460|Hormones|hormones|mesh-ancestor
2832762|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2832763|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832764|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2291816|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
2291817|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291818|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291819|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2291820|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
2291821|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
2291822|NCT00262587|Hormones|hormones|mesh-ancestor
2291823|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2291824|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
2291825|NCT00262769|Gemcitabine|gemcitabine|mesh-list
2291826|NCT00262769|Cisplatin|cisplatin|mesh-list
2291827|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832765|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
2832766|NCT03983239|Efavirenz|efavirenz|mesh-list
2832767|NCT03983239|Rifampin|rifampin|mesh-list
2832768|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2832769|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2832770|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832771|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832772|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
2832773|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832774|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2291828|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2291829|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
2291830|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291831|NCT00262769|Antiviral Agents|antiviral agents|mesh-ancestor
2291832|NCT00262769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2291833|NCT00262769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291834|NCT00262769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2291835|NCT00262769|Immunologic Factors|immunologic factors|mesh-ancestor
2291836|NCT00262769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291837|NCT00262782|Fludarabine|fludarabine|mesh-list
2291838|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291839|NCT00262795|Fludarabine|fludarabine|mesh-list
2291840|NCT00262795|Chlorambucil|chlorambucil|mesh-list
2291841|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291842|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291843|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2291844|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
2291845|NCT00262808|Leucovorin|leucovorin|mesh-list
2291846|NCT00262808|Fluorouracil|fluorouracil|mesh-list
2291847|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
2291848|NCT00262808|Calcium|calcium|mesh-list
2291849|NCT00262808|Sargramostim|sargramostim|mesh-list
2291850|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
2291851|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2291852|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291853|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
2291854|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291855|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2291856|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291857|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2291858|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
2291859|NCT00262808|Antidotes|antidotes|mesh-ancestor
2291860|NCT00262808|Protective Agents|protective agents|mesh-ancestor
2291861|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
2291862|NCT00262808|Vitamins|vitamins|mesh-ancestor
2832775|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2832776|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2832777|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2832778|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2832779|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2832780|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2832781|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
2832782|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2832783|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
2832784|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2832785|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2832786|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2832787|NCT03983226|Gemcitabine|gemcitabine|mesh-list
2832788|NCT03983226|Carboplatin|carboplatin|mesh-list
2832789|NCT03983226|Doxorubicin|doxorubicin|mesh-list
2832790|NCT03983226|Niraparib|niraparib|mesh-list
2832791|NCT03983226|Taxane|taxane|mesh-list
2832792|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832793|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2832794|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
2832795|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832796|NCT03983226|Antiviral Agents|antiviral agents|mesh-ancestor
2832797|NCT03983226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832798|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832799|NCT03983226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2832800|NCT03983226|Immunologic Factors|immunologic factors|mesh-ancestor
2832801|NCT03983226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832802|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2832803|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2832804|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2832805|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2832806|NCT03982992|Blinatumomab|blinatumomab|mesh-list
2832807|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291863|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
2291864|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
2291865|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
2291866|NCT00262886|Fludarabine|fludarabine|mesh-list
2291867|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
2291868|NCT00262886|Tacrolimus|tacrolimus|mesh-list
2291869|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2291870|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2291871|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
2291872|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291873|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291874|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2291875|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
2291876|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291877|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291878|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2832808|NCT03983031|Rituximab|rituximab|mesh-list
2832809|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2832810|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832811|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
2832812|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832813|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2832814|NCT03983057|Antibodies|antibodies|mesh-list
2832815|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2832816|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
2832817|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832818|NCT03983018|Rituximab|rituximab|mesh-list
2832819|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2832820|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832821|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
2291879|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2832822|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832823|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2832824|NCT03982862|Triamcinolone|triamcinolone|mesh-list
2832825|NCT03982862|Lidocaine|lidocaine|mesh-list
2832826|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
2832827|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2832828|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2832829|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
2832830|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
2832831|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2832832|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832833|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
2832834|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832835|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2832836|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2832837|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2832838|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2832839|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832840|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2832841|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
2832842|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2832843|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2832844|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
2832845|NCT03982862|Hormones|hormones|mesh-ancestor
2832846|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2832847|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2832848|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
2832849|NCT03982771|Bortezomib|bortezomib|mesh-list
2832850|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2832851|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
2832852|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832853|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2832854|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2832855|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
2832856|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832857|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832858|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2832859|NCT03982849|Silymarin|silymarin|mesh-list
2832860|NCT03982849|Hydroquinone|hydroquinone|mesh-list
2832861|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
2832862|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832863|NCT03982849|Protective Agents|protective agents|mesh-ancestor
2832864|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832865|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2832866|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2832867|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2832868|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832869|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
2832870|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
2832871|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2832872|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
2832873|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832874|NCT03982537|Expectorants|expectorants|mesh-ancestor
2832875|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
2291880|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
2291881|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2291882|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291883|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2291884|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2291885|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
2291886|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2291887|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2291888|NCT00262977|Aspirin|aspirin|mesh-list
2291889|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2291890|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2291891|NCT00262977|Analgesics|analgesics|mesh-ancestor
2291892|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
2291893|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291894|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291895|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2291896|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291897|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2291898|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2291899|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291900|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2832876|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2832877|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
2832878|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832879|NCT03982537|Protective Agents|protective agents|mesh-ancestor
2832880|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832881|NCT03982537|Antidotes|antidotes|mesh-ancestor
2291901|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2291902|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291903|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
2291904|NCT00262990|Doxorubicin|doxorubicin|mesh-list
2291905|NCT00262990|Epothilone B|epothilone b|mesh-list
2291906|NCT00262990|Epothilones|epothilones|mesh-list
2291907|NCT00262990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2291908|NCT00262990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291909|NCT00262990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2291910|NCT00262990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2291911|NCT00262990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291912|NCT00262990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291913|NCT00262990|Tubulin Modulators|tubulin modulators|mesh-ancestor
2291914|NCT00262990|Antimitotic Agents|antimitotic agents|mesh-ancestor
2291915|NCT00262990|Mitosis Modulators|mitosis modulators|mesh-ancestor
2291916|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2291917|NCT00263003|Irbesartan|irbesartan|mesh-list
2291918|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2291919|NCT00263003|Diuretics|diuretics|mesh-ancestor
2291920|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
2832892|NCT03982693|Edetic Acid|edetic acid|mesh-list
2832893|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
2832894|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
2832895|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2291921|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291922|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2291923|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2483662|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2832896|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
2832897|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
2832898|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832899|NCT03982693|Antidotes|antidotes|mesh-ancestor
2832900|NCT03982693|Protective Agents|protective agents|mesh-ancestor
2832901|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832902|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2107099|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107100|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2107101|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2107102|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107103|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2107104|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
2107105|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107106|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
2291924|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291925|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2291926|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2832903|NCT03982784|Morphine|morphine|mesh-list
2832904|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2832905|NCT03982784|Narcotics|narcotics|mesh-ancestor
2832906|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2832907|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832908|NCT03982784|Analgesics|analgesics|mesh-ancestor
2832909|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
2832910|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2832911|NCT03982381|Metformin|metformin|mesh-list
2832912|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
2832913|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2832914|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832915|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2832916|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832917|NCT03982680|Gemcitabine|gemcitabine|mesh-list
2832918|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2832919|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
2832920|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832921|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832922|NCT03982680|Antiviral Agents|antiviral agents|mesh-ancestor
2832923|NCT03982680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832924|NCT03982680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832925|NCT03982680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2832926|NCT03982680|Immunologic Factors|immunologic factors|mesh-ancestor
2832927|NCT03982680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832928|NCT03982134|Panobinostat|panobinostat|mesh-list
2832929|NCT03982134|Spartalizumab|spartalizumab|mesh-list
2832930|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291927|NCT00263016|Docetaxel|docetaxel|mesh-list
2291928|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291929|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
2291930|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
2291931|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
2291932|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291933|NCT00263029|Capecitabine|capecitabine|mesh-list
2291934|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
2832931|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2832932|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832933|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832934|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2832935|NCT03982277|Rifampin|rifampin|mesh-list
2832936|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2832937|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
2832938|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2832939|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832940|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
2832941|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2832942|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291935|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2291936|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
2291937|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291938|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291939|NCT00263042|Rimonabant|rimonabant|mesh-list
2291940|NCT00263042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2291941|NCT00263042|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2291942|NCT00263042|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2291943|NCT00263042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291944|NCT00263042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291945|NCT00263042|Hormones|hormones|mesh-ancestor
2291946|NCT00263042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2291947|NCT00263042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291948|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
2291949|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291950|NCT00263068|Rotigotine|rotigotine|mesh-list
2832943|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832944|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2832945|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2832946|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2832947|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2832948|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2291951|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
2291952|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
2291953|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291954|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291955|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291956|NCT00263094|Rofecoxib|rofecoxib|mesh-list
2291957|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2291958|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2291959|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832949|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2832950|NCT03982082|Coal Tar|coal tar|mesh-list
2832951|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
2832952|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
2832953|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
2832954|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
2832955|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2832956|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
2832957|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832958|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2832959|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2832960|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
2832961|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2832962|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
2832963|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832964|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2832965|NCT03982030|Dalbavancin|dalbavancin|mesh-list
2832966|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2832967|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832968|NCT03982173|Durvalumab|durvalumab|mesh-list
2832969|NCT03982173|Tremelimumab|tremelimumab|mesh-list
2832970|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2832971|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832972|NCT03982238|Metformin|metformin|mesh-list
2832973|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
2832974|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2291960|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291961|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2291962|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2832975|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832976|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2832977|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832978|NCT03982121|Nivolumab|nivolumab|mesh-list
2832979|NCT03982121|Ipilimumab|ipilimumab|mesh-list
2291963|NCT00263094|Analgesics|analgesics|mesh-ancestor
2291964|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
2291965|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2291966|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291967|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2291968|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2291969|NCT00263133|Sertraline|sertraline|mesh-list
2832980|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2832981|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832982|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2832983|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832984|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
2832985|NCT03982004|Imiquimod|imiquimod|mesh-list
2832986|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2832987|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2832988|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2832989|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
2832990|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2832991|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
2832992|NCT03981887|Nafithromycin|nafithromycin|mesh-list
2832993|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2832994|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2832995|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2832996|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2832997|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2832998|NCT03981900|Tofacitinib|tofacitinib|mesh-list
2832999|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2833000|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833001|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833002|NCT03981601|Lovastatin|lovastatin|mesh-list
2833003|NCT03981601|L 647318|l 647318|mesh-list
2833004|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
2833005|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2833006|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2833007|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
2833008|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833009|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2833010|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2833011|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833012|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
2833013|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2833014|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833024|NCT03981770|Anesthetics|anesthetics|mesh-list
2833025|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833026|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833027|NCT03981484|Thrombin|thrombin|mesh-list
2833028|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
2833029|NCT03981484|Coagulants|coagulants|mesh-ancestor
2833030|NCT03981523|Benzonidazole|benzonidazole|mesh-list
2833031|NCT03981523|Nifurtimox|nifurtimox|mesh-list
2833032|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2833033|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
2833034|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833035|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2833036|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2833037|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2833038|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833039|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
2833040|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2833041|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
2833042|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833043|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
2833044|NCT03981458|Protective Agents|protective agents|mesh-ancestor
2833045|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
2833046|NCT03981341|Estrogens|estrogens|mesh-list
2833047|NCT03981341|Hormones|hormones|mesh-ancestor
2833048|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2833049|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833050|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2833051|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2833052|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
2833053|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2833054|NCT03981146|Nivolumab|nivolumab|mesh-list
2833055|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2833056|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833057|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2833058|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833059|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
2833060|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
2833061|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833062|NCT03981068|Nimorazole|nimorazole|mesh-list
2833063|NCT03981068|Cisplatin|cisplatin|mesh-list
2833064|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833065|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2833066|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2833067|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2833068|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833069|NCT03981081|Prednisone|prednisone|mesh-list
2833070|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833071|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
2833072|NCT03981081|Hormones|hormones|mesh-ancestor
2833073|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2833074|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833075|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2833076|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833077|NCT03981094|Pirfenidone|pirfenidone|mesh-list
2833078|NCT03981094|Analgesics|analgesics|mesh-ancestor
2833079|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
2833080|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833081|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833082|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2833083|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2833084|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833085|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2833086|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291970|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
2291971|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2291972|NCT00263133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2291973|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2291974|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2291975|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291976|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2291977|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
2291978|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291979|NCT00263185|Vitamin D|vitamin d|mesh-list
2291980|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
2291981|NCT00263185|Vitamins|vitamins|mesh-list
2291982|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
2291983|NCT00263185|Calcium|calcium|mesh-list
2291984|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
2291985|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2291986|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2291987|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2291988|NCT00263185|Antacids|antacids|mesh-ancestor
2291989|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291990|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2291991|NCT00263198|Letrozole|letrozole|mesh-list
2291992|NCT00263198|Vatalanib|vatalanib|mesh-list
2291993|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2291994|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2291995|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2291996|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2291997|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2291998|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2291999|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
2292000|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2292001|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292002|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2292003|NCT00263263|Sirolimus|sirolimus|mesh-list
2292004|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2292005|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292006|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2292007|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833087|NCT03981029|Folic Acid|folic acid|mesh-list
2833088|NCT03981029|Hematinics|hematinics|mesh-ancestor
2833089|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
2833090|NCT03981029|Vitamins|vitamins|mesh-ancestor
2833091|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
2833092|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833093|NCT03980847|Alendronate|alendronate|mesh-list
2833094|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2833095|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833096|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
2833097|NCT03980951|Narcotics|narcotics|mesh-ancestor
2833098|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833099|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833100|NCT03980951|Analgesics|analgesics|mesh-ancestor
2833101|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
2833102|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292008|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
2833103|NCT03980925|Carboplatin|carboplatin|mesh-list
2833104|NCT03980925|Nivolumab|nivolumab|mesh-list
2833105|NCT03980925|Etoposide|etoposide|mesh-list
2833106|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833107|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2833108|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2833109|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833110|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2833111|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2833112|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2833113|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833114|NCT03980990|Metformin|metformin|mesh-list
2292009|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2292010|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
2292011|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292012|NCT00263276|Metformin|metformin|mesh-list
2292013|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
2833115|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2833116|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833117|NCT03980756|Esomeprazole|esomeprazole|mesh-list
2833118|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2833119|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2833120|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2833121|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833122|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833123|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
2833124|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292014|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2292015|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292016|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2292017|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292018|NCT00263302|Dexamethasone|dexamethasone|mesh-list
2292019|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2292020|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
2833125|NCT03980379|Rituximab|rituximab|mesh-list
2833126|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2833127|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833128|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
2833129|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833130|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2833131|NCT03980496|Omeprazole|omeprazole|mesh-list
2833132|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2833133|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2833134|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2833135|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833136|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292021|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
2292022|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292023|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292024|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2292025|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
2292026|NCT00263302|Hormones|hormones|mesh-ancestor
2292027|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2292028|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2292029|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292030|NCT00263315|Amphotericin B|amphotericin b|mesh-list
2833137|NCT03980509|Curcumin|curcumin|mesh-list
2833138|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2833139|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2833140|NCT03980509|Analgesics|analgesics|mesh-ancestor
2833141|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
2833142|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833143|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833144|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833145|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2833146|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833147|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833148|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833149|NCT03980223|Doxycycline|doxycycline|mesh-list
2833150|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2833151|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833152|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
2833153|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2833154|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2833155|NCT03980249|Carvedilol|carvedilol|mesh-list
2833156|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2833157|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2833158|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
2292031|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2292032|NCT00263315|Amebicides|amebicides|mesh-ancestor
2292033|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2292034|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2292035|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292036|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2292037|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
2292038|NCT00263341|Contraceptive Agents|contraceptive agents|mesh-list
2292039|NCT00263341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2292040|NCT00263341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2833159|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833160|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833161|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833162|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2833163|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
2833164|NCT03980249|Protective Agents|protective agents|mesh-ancestor
2833165|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2833166|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2833167|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2833168|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
2833169|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2833170|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2833171|NCT03980041|Nivolumab|nivolumab|mesh-list
2833172|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2833173|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833174|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2833175|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833176|NCT03980184|Guanfacine|guanfacine|mesh-list
2833177|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2833178|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2833179|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2833180|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2833181|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
2833182|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833183|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833184|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833185|NCT03979976|Ramipril|ramipril|mesh-list
2833186|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2833187|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2292041|NCT00263341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292042|NCT00263341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2292043|NCT00263341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2292044|NCT00263341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2292045|NCT00263341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2292046|NCT00263341|Estrogens|estrogens|mesh-ancestor
2292047|NCT00263341|Hormones|hormones|mesh-ancestor
2292048|NCT00263341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2292049|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
2292050|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292051|NCT00263393|Atenolol|atenolol|mesh-list
2292052|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2292053|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2292054|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2292055|NCT00263393|Diuretics|diuretics|mesh-ancestor
2292056|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
2292057|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292058|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2292059|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2292060|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292061|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2292062|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
2292063|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
2292064|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292065|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2292066|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2292067|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2292068|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
2292069|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833188|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
2833189|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833190|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2833191|NCT03980171|Lenalidomide|lenalidomide|mesh-list
2833192|NCT03980171|Venetoclax|venetoclax|mesh-list
2833193|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
2833194|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
2833195|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833196|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2833197|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2833198|NCT03980171|Growth Substances|growth substances|mesh-ancestor
2833199|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
2833200|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833201|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2833202|NCT03980002|Thalidomide|thalidomide|mesh-list
2833203|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2833204|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
2292070|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
2292071|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292072|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2292073|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
2292074|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833205|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833206|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
2833207|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2833208|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833209|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2833210|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2833211|NCT03980002|Growth Substances|growth substances|mesh-ancestor
2833212|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
2833213|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833214|NCT03979859|Nafithromycin|nafithromycin|mesh-list
2833215|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2833216|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833217|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2833218|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833219|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833220|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2833221|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833222|NCT03979989|Tapentadol|tapentadol|mesh-list
2833223|NCT03979989|Omeprazole|omeprazole|mesh-list
2833224|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2833225|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2833226|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2833227|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833228|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833229|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2833230|NCT03979989|Narcotics|narcotics|mesh-ancestor
2833231|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833232|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833233|NCT03979989|Analgesics|analgesics|mesh-ancestor
2833234|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
2833235|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833236|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2833237|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2833238|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2833239|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
2292075|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292076|NCT00263458|Buprenorphine|buprenorphine|mesh-list
2292077|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2292078|NCT00263458|Narcotics|narcotics|mesh-ancestor
2292079|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2292080|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833240|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833251|NCT03979664|Dexamethasone|dexamethasone|mesh-list
2292081|NCT00263458|Analgesics|analgesics|mesh-ancestor
2833252|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833253|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
2833254|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
2833255|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833256|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833257|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2833258|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
2833259|NCT03979664|Hormones|hormones|mesh-ancestor
2833260|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2833261|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2833262|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833263|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
2833264|NCT03979651|Trametinib|trametinib|mesh-list
2833265|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
2833266|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2833267|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2833268|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833269|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833270|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833271|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2833272|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833273|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2833274|NCT03979456|Rituximab|rituximab|mesh-list
2833275|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2833276|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833277|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
2833278|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833279|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2833280|NCT03979469|Fentanyl|fentanyl|mesh-list
2833281|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
2833282|NCT03979469|Ketamine|ketamine|mesh-list
2833283|NCT03979469|Remifentanil|remifentanil|mesh-list
2833284|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2833285|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833286|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833287|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2833288|NCT03979469|Analgesics|analgesics|mesh-ancestor
2833289|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
2833290|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833291|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2833292|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2833293|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2833294|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
2833295|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833296|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833297|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2833298|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2833299|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
2833300|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
2833301|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2833302|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2833303|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2833304|NCT03979469|Narcotics|narcotics|mesh-ancestor
2833305|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2292082|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
2292083|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292084|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2292085|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
2292086|NCT00263484|Thalidomide|thalidomide|mesh-list
2292087|NCT00263484|Dexamethasone|dexamethasone|mesh-list
2292088|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
2292089|NCT00263484|BB 1101|bb 1101|mesh-list
2292090|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2292091|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
2292092|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
2292093|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292094|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292095|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2292096|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
2292097|NCT00263484|Hormones|hormones|mesh-ancestor
2107107|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2107108|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2107109|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2107110|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2107111|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
2292098|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2833313|NCT03979248|BMS-986165|bms-986165|mesh-list
2833314|NCT03979248|Rabeprazole|rabeprazole|mesh-list
2833315|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2833316|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2833317|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2833318|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833319|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833320|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
2833321|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2833322|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
2833323|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2833324|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
2833325|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833326|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
2833327|NCT03979586|Protective Agents|protective agents|mesh-ancestor
2833328|NCT03979352|Empagliflozin|empagliflozin|mesh-list
2833329|NCT03979352|Pancrelipase|pancrelipase|mesh-list
2833330|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2833331|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833332|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2833333|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833334|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2833335|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
2833336|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
2833337|NCT03979599|Analgesics|analgesics|mesh-ancestor
2833338|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
2833339|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833340|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833341|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
2833342|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833343|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2833344|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
2833345|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2833346|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2833347|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833348|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2833349|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
2833350|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2833351|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
2292099|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2292100|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292101|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
2292102|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292103|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292104|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2292105|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
2292106|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
2292107|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2292108|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292109|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2292110|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2292111|NCT00263484|Growth Substances|growth substances|mesh-ancestor
2292112|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
2292113|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2292114|NCT00263705|Capecitabine|capecitabine|mesh-list
2292115|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2292116|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
2292117|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292118|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292119|NCT00263718|Betamethasone|betamethasone|mesh-list
2292120|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
2833352|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
2833353|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833354|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
2833355|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2833356|NCT03978988|Aspirin|aspirin|mesh-list
2833357|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2833358|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2833359|NCT03978988|Analgesics|analgesics|mesh-ancestor
2833360|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
2833361|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833362|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833363|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833364|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2833365|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2833366|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2833367|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833368|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2833369|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2833370|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833371|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
2833372|NCT03979105|Ketamine|ketamine|mesh-list
2833373|NCT03979105|Analgesics|analgesics|mesh-ancestor
2833374|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
2833375|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833376|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833377|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2833378|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2833379|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
2833380|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
2833381|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833382|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2833383|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2833384|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833385|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292121|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2292122|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
2292123|NCT00263718|Calcipotriene|calcipotriene|mesh-list
2292124|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2292125|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833386|NCT03978884|Losartan|losartan|mesh-list
2833387|NCT03978884|Amlodipine|amlodipine|mesh-list
2833388|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2833389|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2833390|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2833391|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2833392|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833393|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2833394|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833395|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
2833396|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2833397|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2833398|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2833399|NCT03978884|Diuretics|diuretics|mesh-ancestor
2833400|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
2833401|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2833402|NCT03979131|Avelumab|avelumab|mesh-list
2833403|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2833404|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833405|NCT03978845|Lidocaine|lidocaine|mesh-list
2833406|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
2833407|NCT03978845|Anesthetics|anesthetics|mesh-list
2107112|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107113|NCT02484222|Fentanyl|fentanyl|mesh-list
2107114|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2107115|NCT02484222|Narcotics|narcotics|mesh-ancestor
2107116|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107117|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107118|NCT02484222|Analgesics|analgesics|mesh-ancestor
2107119|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
2107120|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292126|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
2292127|NCT00263718|Hormones|hormones|mesh-ancestor
2292128|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2292129|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292130|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2292131|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
2833408|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833409|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833410|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
2833411|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833412|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2833413|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2833414|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2833415|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2833416|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833417|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
2833418|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2833419|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833420|NCT03978598|Etonogestrel|etonogestrel|mesh-list
2833421|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2833422|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
2833423|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2833424|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833425|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2833426|NCT03978442|Bupropion|bupropion|mesh-list
2833427|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2833428|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
2833429|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2833430|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2833431|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2833432|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2833433|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833434|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
2833435|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292132|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
2292133|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2292134|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2292135|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
2292136|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292137|NCT00263744|Antacids|antacids|mesh-ancestor
2292138|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292139|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2292140|NCT00263796|Oxytocin|oxytocin|mesh-list
2292141|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
2292142|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2292143|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292144|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2292145|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292146|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2292147|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292148|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292149|NCT00263965|Metformin|metformin|mesh-list
2292150|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2292151|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292152|NCT00263978|Defibrotide|defibrotide|mesh-list
2292153|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2292154|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2292155|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292156|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2292157|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
2833436|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833437|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2107121|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2833438|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2833439|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833440|NCT03978494|Tacrolimus|tacrolimus|mesh-list
2833441|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2833442|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
2833443|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833444|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2833445|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833446|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833447|NCT03978559|Trimethoprim|trimethoprim|mesh-list
2833448|NCT03978559|Caspofungin|caspofungin|mesh-list
2833449|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
2833450|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
2292158|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
2292159|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2292160|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2292161|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2292162|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292163|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
2292164|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2292165|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292166|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
2292167|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
2292168|NCT00264108|Hematinics|hematinics|mesh-ancestor
2292169|NCT00264134|Carboplatin|carboplatin|mesh-list
2292170|NCT00264134|Docetaxel|docetaxel|mesh-list
2292171|NCT00264134|Irinotecan|irinotecan|mesh-list
2292172|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292173|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
2292174|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
2292175|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
2292176|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292177|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2833451|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833452|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
2833453|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
2833454|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833455|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833456|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2833457|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
2833458|NCT03978559|Hormones|hormones|mesh-ancestor
2833459|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2833460|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2833461|NCT03978559|Protective Agents|protective agents|mesh-ancestor
2833462|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2833463|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833464|NCT03978559|Renal Agents|renal agents|mesh-ancestor
2833465|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
2833466|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2833467|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2833468|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2833469|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833470|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833471|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2833472|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2833473|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2292178|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2292179|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292180|NCT00264173|Valproic Acid|valproic acid|mesh-list
2292181|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
2292182|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292183|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292184|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
2292185|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292186|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292187|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
2292188|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2833474|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
2833475|NCT03978364|Azacitidine|azacitidine|mesh-list
2833476|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2833477|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
2833478|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833479|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833480|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292189|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833481|NCT03978286|Vortioxetine|vortioxetine|mesh-list
2833482|NCT03978286|Sertraline|sertraline|mesh-list
2833483|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
2833484|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2833485|NCT03978286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2833486|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2833487|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2833488|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833489|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833490|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
2833491|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833492|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2833493|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2292190|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2292191|NCT00264186|Norepinephrine|norepinephrine|mesh-list
2292192|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
2292193|NCT00264186|Acetylcholine|acetylcholine|mesh-list
2292194|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2292195|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2292196|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
2292197|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292198|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292199|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292200|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
2292201|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
2833494|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833495|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2833496|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2833497|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2833498|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2833499|NCT03978208|Naproxen|naproxen|mesh-list
2833500|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2833501|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2833502|NCT03978208|Analgesics|analgesics|mesh-ancestor
2833503|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
2833504|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833505|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833506|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833507|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2833508|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
2833509|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2833510|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833511|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833512|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2833513|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
2833514|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833515|NCT03978052|Protective Agents|protective agents|mesh-ancestor
2833516|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833517|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2833518|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2833519|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833520|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2833521|NCT03978156|Dronabinol|dronabinol|mesh-list
2833522|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
2833523|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833524|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2292202|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292203|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2292204|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
2292205|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2292206|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
2292207|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2833525|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2833526|NCT03978156|Analgesics|analgesics|mesh-ancestor
2833527|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
2833528|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833529|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2833530|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2833531|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833532|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833533|NCT03978156|Hormones|hormones|mesh-ancestor
2833534|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2833535|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2833536|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2292208|NCT00264212|Irbesartan|irbesartan|mesh-list
2292209|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2292210|NCT00264212|Diuretics|diuretics|mesh-ancestor
2292211|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
2292212|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292213|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2292214|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2292215|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833537|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2833538|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2833539|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833540|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
2833541|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833542|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833543|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2833544|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833545|NCT03977675|Ketamine|ketamine|mesh-list
2833546|NCT03977675|Analgesics|analgesics|mesh-ancestor
2833547|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
2833548|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833549|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833550|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2833551|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2833552|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
2833553|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
2833554|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833555|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2833556|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2833557|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833558|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833559|NCT03977792|Docosanol|docosanol|mesh-list
2833560|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
2833561|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833562|NCT03977649|Erenumab|erenumab|mesh-list
2833563|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2833564|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833565|NCT03977649|Analgesics|analgesics|mesh-ancestor
2833566|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
2833567|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833568|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833569|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2833570|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2833571|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833572|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833573|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2833574|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2833575|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833576|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
2833577|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833578|NCT03977441|Pramipexole|pramipexole|mesh-list
2833579|NCT03977441|S 20098|s 20098|mesh-list
2833580|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
2833581|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833582|NCT03977441|Protective Agents|protective agents|mesh-ancestor
2292216|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2292217|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2292218|NCT00264225|Codeine|codeine|mesh-list
2292219|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2292220|NCT00264225|Narcotics|narcotics|mesh-ancestor
2292221|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2292222|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292223|NCT00264225|Analgesics|analgesics|mesh-ancestor
2292224|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
2292225|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292226|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
2292227|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
2292228|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
2292229|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2292230|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292231|NCT00264277|Vitamin K|vitamin k|mesh-list
2292232|NCT00264277|Anticoagulants|anticoagulants|mesh-list
2292233|NCT00264277|Vitamins|vitamins|mesh-ancestor
2292234|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
2292235|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292236|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2292237|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2292238|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833583|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833584|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2833585|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2833586|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
2833587|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
2833588|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833589|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2833590|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833591|NCT03977571|Nivolumab|nivolumab|mesh-list
2833592|NCT03977571|Ipilimumab|ipilimumab|mesh-list
2833593|NCT03977571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2833594|NCT03977571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833595|NCT03977571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2833596|NCT03977571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833597|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
2833598|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2833599|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833600|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
2833601|NCT03977467|Atezolizumab|atezolizumab|mesh-list
2833602|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107122|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2107123|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
2107124|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
2107125|NCT02484443|Dinutuximab|dinutuximab|mesh-list
2107126|NCT02484443|Sargramostim|sargramostim|mesh-list
2107127|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
2107128|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292239|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
2292240|NCT00264277|Coagulants|coagulants|mesh-ancestor
2292241|NCT00264355|Cyclosporine|cyclosporine|mesh-list
2292242|NCT00264355|Cyclosporins|cyclosporins|mesh-list
2292243|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292244|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292245|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2292246|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
2292247|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107129|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107130|NCT02484651|Rocuronium|rocuronium|mesh-list
2107131|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2107132|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2107133|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2107134|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292248|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
2292249|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292250|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
2292251|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2292252|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2292253|NCT00264368|Ganciclovir|ganciclovir|mesh-list
2292254|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2292255|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
2292256|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292257|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2292258|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292259|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292260|NCT00264407|Hormones|hormones|mesh-list
2292261|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2292262|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292263|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
2292264|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2833603|NCT03977220|Paclitaxel|paclitaxel|mesh-list
2833604|NCT03977220|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2833605|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2833606|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833607|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
2833608|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
2833609|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
2833610|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833611|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
2833612|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2833613|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833614|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
2833615|NCT03977454|Ropivacaine|ropivacaine|mesh-list
2833616|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
2833617|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
2292265|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292266|NCT00264446|Eniluracil|eniluracil|mesh-list
2292267|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292268|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292269|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
2292270|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292271|NCT00264472|Eniluracil|eniluracil|mesh-list
2292272|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292273|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292274|NCT00264485|Fentanyl|fentanyl|mesh-list
2292275|NCT00264485|Morphine|morphine|mesh-list
2292276|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2292277|NCT00264485|Narcotics|narcotics|mesh-ancestor
2292278|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2292279|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292280|NCT00264485|Analgesics|analgesics|mesh-ancestor
2292281|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
2292282|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292283|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2292284|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2833618|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833619|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833620|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
2833621|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833622|NCT03977363|Anticoagulants|anticoagulants|mesh-list
2833623|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
2833624|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2833625|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833626|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
2833627|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
2833628|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2833629|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
2833630|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833631|NCT03976973|Expectorants|expectorants|mesh-ancestor
2292285|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
2292286|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
2292287|NCT00264615|Lamotrigine|lamotrigine|mesh-list
2292288|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
2833632|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
2833633|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2833634|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
2833635|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833636|NCT03976973|Protective Agents|protective agents|mesh-ancestor
2833637|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833638|NCT03976973|Antidotes|antidotes|mesh-ancestor
2292289|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2292290|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2292291|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292292|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2292293|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292294|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2292295|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2292296|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2292297|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2292298|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2292299|NCT00264628|Casopitant|casopitant|mesh-list
2292300|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
2292301|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
2292302|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292303|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833639|NCT03977012|Buprenorphine|buprenorphine|mesh-list
2833640|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2833641|NCT03977012|Narcotics|narcotics|mesh-ancestor
2833642|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833643|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833644|NCT03977012|Analgesics|analgesics|mesh-ancestor
2833645|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
2292304|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2292305|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2292306|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292307|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292308|NCT00264654|Paroxetine|paroxetine|mesh-list
2292309|NCT00264654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2292310|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2292311|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2292312|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292313|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292314|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
2292315|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292316|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2292317|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
2292318|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2292319|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2292320|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2292321|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833646|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833647|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2833648|NCT03977233|Leucovorin|leucovorin|mesh-list
2833649|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
2833650|NCT03977233|Irinotecan|irinotecan|mesh-list
2833651|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833652|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2833653|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2833654|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833655|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833656|NCT03977233|Antidotes|antidotes|mesh-ancestor
2833657|NCT03977233|Protective Agents|protective agents|mesh-ancestor
2833658|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833659|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
2833660|NCT03977233|Vitamins|vitamins|mesh-ancestor
2833661|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
2833662|NCT03976713|Bromides|bromides|mesh-list
2833663|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
2833664|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2833665|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
2833666|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833667|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833668|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2833669|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
2833670|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
2833671|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2833672|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
2833673|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833674|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833675|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
2833676|NCT03976518|Atezolizumab|atezolizumab|mesh-list
2833677|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833678|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2833679|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2833680|NCT03976544|Estradiol|estradiol|mesh-list
2833681|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2833682|NCT03976544|Progesterone|progesterone|mesh-list
2833683|NCT03976544|Estrogens|estrogens|mesh-ancestor
2833684|NCT03976544|Hormones|hormones|mesh-ancestor
2833685|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2292322|NCT00264680|Lamotrigine|lamotrigine|mesh-list
2292323|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
2833686|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833687|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2833688|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
2833689|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2833690|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2833691|NCT03976544|Progestins|progestins|mesh-ancestor
2833704|NCT03976245|Etanercept|etanercept|mesh-list
2833705|NCT03976245|Tofacitinib|tofacitinib|mesh-list
2833706|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2833707|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2833708|NCT03976245|Analgesics|analgesics|mesh-ancestor
2833709|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
2833710|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833711|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833712|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833713|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2833714|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2833715|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2833716|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
2833717|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2833718|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833719|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833720|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2833721|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833722|NCT03976258|Naltrexone|naltrexone|mesh-list
2833723|NCT03976258|Buprenorphine|buprenorphine|mesh-list
2833724|NCT03976258|Methadone|methadone|mesh-list
2833725|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2833726|NCT03976258|Heroin|heroin|mesh-list
2833727|NCT03976258|Naloxone|naloxone|mesh-list
2833728|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2833729|NCT03976258|Narcotics|narcotics|mesh-ancestor
2833730|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833731|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833732|NCT03976258|Analgesics|analgesics|mesh-ancestor
2833733|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
2833734|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833735|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2833736|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2833737|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
2833738|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
2833739|NCT03976102|Rituximab|rituximab|mesh-list
2833740|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2833741|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833742|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
2833743|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833744|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2833745|NCT03976063|Nifedipine|nifedipine|mesh-list
2833746|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2833747|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2833748|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833749|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2833750|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833751|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
2833752|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
2833753|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2833754|NCT03975829|Trametinib|trametinib|mesh-list
2292324|NCT00264680|Valproic Acid|valproic acid|mesh-list
2833755|NCT03975829|Dabrafenib|dabrafenib|mesh-list
2833756|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833757|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2833758|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833759|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833760|NCT03976037|Misoprostol|misoprostol|mesh-list
2833761|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2833762|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
2833763|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2833764|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833765|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2833766|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2833767|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
2292325|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2292326|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2292327|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292328|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2292329|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292330|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2292331|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2292332|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2292333|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2292334|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2292335|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292336|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
2833768|NCT03975374|Tobramycin|tobramycin|mesh-list
2833769|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
2833770|NCT03975374|Dexamethasone|dexamethasone|mesh-list
2833771|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2833772|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833773|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
2833774|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
2833775|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833776|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833777|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2833778|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
2833779|NCT03975374|Hormones|hormones|mesh-ancestor
2833780|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2833781|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2833782|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833783|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2833784|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833785|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2833786|NCT03975283|Bupivacaine|bupivacaine|mesh-list
2833787|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
2833788|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
2833789|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833790|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833791|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
2833792|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833793|NCT03975270|Paclitaxel|paclitaxel|mesh-list
2833794|NCT03975270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2833795|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2833796|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833797|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
2833798|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
2833799|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
2833800|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833801|NCT03975114|Durvalumab|durvalumab|mesh-list
2833802|NCT03975114|Tremelimumab|tremelimumab|mesh-list
2833803|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2833804|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833805|NCT03975088|Ranibizumab|ranibizumab|mesh-list
2833806|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2833807|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2833808|NCT03975088|Growth Substances|growth substances|mesh-ancestor
2833809|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833810|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
2833811|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833812|NCT03975231|Trametinib|trametinib|mesh-list
2833813|NCT03975231|Dabrafenib|dabrafenib|mesh-list
2833814|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833815|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2833816|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833817|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833818|NCT03975166|Fluticasone|fluticasone|mesh-list
2833819|NCT03975166|Xhance|xhance|mesh-list
2833820|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2833821|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2833822|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833823|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2833824|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
2833825|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833826|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833827|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2833828|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
2833829|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
2833830|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2292337|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292338|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
2292339|NCT00264719|Metoclopramide|metoclopramide|mesh-list
2292340|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
2292341|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
2833831|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2833832|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2833833|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2833834|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
2833835|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833836|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833837|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
2833838|NCT03975166|Hormones|hormones|mesh-ancestor
2292342|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292343|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292344|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2292345|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2292346|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2292347|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
2292348|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833839|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2833840|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
2833841|NCT03975205|Doxorubicin|doxorubicin|mesh-list
2833842|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2833843|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292349|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292350|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
2292351|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2292352|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292353|NCT00264914|Satavaptan|satavaptan|mesh-list
2292354|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2292355|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292356|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
2292357|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292358|NCT00264927|Satavaptan|satavaptan|mesh-list
2292359|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2292360|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292361|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
2292362|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292363|NCT00264953|Prednisone|prednisone|mesh-list
2292364|NCT00264953|Etoposide|etoposide|mesh-list
2292365|NCT00264953|Vincristine|vincristine|mesh-list
2292366|NCT00264953|Doxorubicin|doxorubicin|mesh-list
2292367|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2292368|NCT00264953|Bleomycin|bleomycin|mesh-list
2292369|NCT00264953|Vinblastine|vinblastine|mesh-list
2292370|NCT00264953|Procarbazine|procarbazine|mesh-list
2292371|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2292372|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
2292373|NCT00264953|Hormones|hormones|mesh-ancestor
2292374|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2833844|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2833845|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2833846|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833847|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833848|NCT03975036|Antibodies|antibodies|mesh-list
2833849|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
2833850|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833851|NCT03975010|Naltrexone|naltrexone|mesh-list
2833852|NCT03975010|Buprenorphine|buprenorphine|mesh-list
2833853|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2833854|NCT03975010|Narcotics|narcotics|mesh-ancestor
2833855|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833856|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833857|NCT03975010|Analgesics|analgesics|mesh-ancestor
2833858|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
2833859|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833860|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2833861|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2833862|NCT03975062|Dabigatran|dabigatran|mesh-list
2833863|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
2833864|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2833865|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
2833866|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833867|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833868|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
2833869|NCT03974984|Anesthetics|anesthetics|mesh-list
2833870|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833871|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833872|NCT03974789|Dexamethasone|dexamethasone|mesh-list
2833873|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833874|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
2833875|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
2833876|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833877|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833878|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2292375|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292376|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2292377|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292378|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2292379|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2292380|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2833879|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
2833880|NCT03974789|Hormones|hormones|mesh-ancestor
2833881|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2833882|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2833883|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833884|NCT03974854|Gemcitabine|gemcitabine|mesh-list
2833885|NCT03974854|Capecitabine|capecitabine|mesh-list
2833886|NCT03974854|Irinotecan|irinotecan|mesh-list
2833887|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2833888|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
2833889|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833890|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292381|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292382|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292383|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
2292384|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
2292385|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
2292386|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2833891|NCT03974854|Antiviral Agents|antiviral agents|mesh-ancestor
2833892|NCT03974854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833893|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833894|NCT03974854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2833895|NCT03974854|Immunologic Factors|immunologic factors|mesh-ancestor
2833896|NCT03974854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833897|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2833898|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2833899|NCT03974932|Acetaminophen|acetaminophen|mesh-list
2833900|NCT03974932|Ibuprofen|ibuprofen|mesh-list
2833901|NCT03974932|Celecoxib|celecoxib|mesh-list
2833902|NCT03974932|Bupivacaine|bupivacaine|mesh-list
2833903|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
2833904|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
2833905|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2292387|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2292388|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2292389|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2292390|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292391|NCT00265018|Doxorubicin|doxorubicin|mesh-list
2292392|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2292393|NCT00265018|Bleomycin|bleomycin|mesh-list
2292394|NCT00265018|Vinblastine|vinblastine|mesh-list
2292395|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2292396|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292397|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2833906|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833907|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
2833908|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833909|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2833910|NCT03974932|Analgesics|analgesics|mesh-ancestor
2833911|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
2833912|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2833913|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833914|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2833915|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2833916|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833917|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833918|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2833919|NCT03974594|Trifluridine|trifluridine|mesh-list
2833920|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
2833921|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833922|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
2833923|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2833924|NCT03974685|Niacinamide|niacinamide|mesh-list
2833925|NCT03974685|Niacin|niacin|mesh-list
2833926|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
2833927|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
2833928|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
2833929|NCT03974685|Vitamins|vitamins|mesh-ancestor
2833930|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
2833931|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833932|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2833933|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
2292398|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2833934|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833935|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2833936|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
2833937|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833938|NCT03974828|Anesthetics|anesthetics|mesh-list
2833939|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2833940|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833941|NCT03974867|Prednisone|prednisone|mesh-list
2833942|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
2833943|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2833944|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2833945|NCT03974867|Prednisolone|prednisolone|mesh-list
2833946|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
2833947|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2292399|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833948|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
2833949|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2833950|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
2833951|NCT03974867|Hormones|hormones|mesh-ancestor
2833952|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2833953|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833954|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2833955|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833956|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
2833957|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
2833958|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833959|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2833960|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2833961|NCT03974867|Protective Agents|protective agents|mesh-ancestor
2833962|NCT03974243|Chiauranib|chiauranib|mesh-list
2833963|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833964|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2833965|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833966|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833967|NCT03974217|Talazoparib|talazoparib|mesh-list
2833968|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2833969|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2833970|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833971|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2833972|NCT03974139|Metformin|metformin|mesh-list
2833973|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2833974|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833975|NCT03974152|Nicotine|nicotine|mesh-list
2833976|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2833977|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
2833978|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833979|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833980|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2833981|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2833982|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
2833983|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2833984|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833985|NCT03974360|Erenumab|erenumab|mesh-list
2833986|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2833987|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2833988|NCT03974360|Analgesics|analgesics|mesh-ancestor
2833989|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
2833990|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2833991|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833992|NCT03974425|Aflibercept|aflibercept|mesh-list
2833993|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2107135|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107136|NCT02484690|Ranibizumab|ranibizumab|mesh-list
2107137|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2107138|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2107139|NCT02484690|Growth Substances|growth substances|mesh-ancestor
2107140|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107141|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
2107142|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107143|NCT02484859|Metoprolol|metoprolol|mesh-list
2107144|NCT02484859|Remifentanil|remifentanil|mesh-list
2107145|NCT02484859|Tramadol|tramadol|mesh-list
2107146|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2107147|NCT02484859|Narcotics|narcotics|mesh-ancestor
2833994|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2833995|NCT03974425|Growth Substances|growth substances|mesh-ancestor
2833996|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833997|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
2833998|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292400|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292401|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2292402|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
2292403|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
2292404|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
2292405|NCT00265031|Prednisone|prednisone|mesh-list
2292406|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
2292407|NCT00265031|Etoposide|etoposide|mesh-list
2292408|NCT00265031|Vincristine|vincristine|mesh-list
2292409|NCT00265031|Doxorubicin|doxorubicin|mesh-list
2292410|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2292411|NCT00265031|Bleomycin|bleomycin|mesh-list
2292412|NCT00265031|Procarbazine|procarbazine|mesh-list
2292413|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2292414|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
2292415|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292416|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2292417|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2292418|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
2292419|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292420|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292421|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2292422|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2292423|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
2292424|NCT00265031|Hormones|hormones|mesh-ancestor
2292425|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2292426|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2292427|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2292428|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2292429|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2292430|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292431|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
2292432|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
2292433|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
2292434|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2292435|NCT00265070|Gefitinib|gefitinib|mesh-list
2292436|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292437|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2292438|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292439|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292440|NCT00265135|Siltuximab|siltuximab|mesh-list
2292441|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292442|NCT00265252|Alendronate|alendronate|mesh-list
2292443|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2292444|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2833999|NCT03974100|Denosumab|denosumab|mesh-list
2834000|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2834001|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834002|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
2292445|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2292446|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2292447|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2292448|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2292449|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292450|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
2292451|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292452|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834003|NCT03973840|Testosterone|testosterone|mesh-list
2834004|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
2834005|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
2834006|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2834007|NCT03973840|Androgens|androgens|mesh-ancestor
2834008|NCT03973840|Hormones|hormones|mesh-ancestor
2834009|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2834010|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834011|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2834012|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834013|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
2834014|NCT03973775|Permethrin|permethrin|mesh-list
2834015|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834016|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834017|NCT03973879|Atezolizumab|atezolizumab|mesh-list
2834018|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834019|NCT03973957|Fentanyl|fentanyl|mesh-list
2292453|NCT00265278|Modafinil|modafinil|mesh-list
2292454|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2292455|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292456|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2292457|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2292458|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2292459|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292460|NCT00265291|Fluoxetine|fluoxetine|mesh-list
2292461|NCT00265291|Desipramine|desipramine|mesh-list
2292462|NCT00265291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2292463|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2292464|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2292465|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292466|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292467|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
2292468|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292469|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2292470|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
2292471|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2834020|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2834021|NCT03973957|Narcotics|narcotics|mesh-ancestor
2834022|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834023|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834024|NCT03973957|Analgesics|analgesics|mesh-ancestor
2834025|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
2834026|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834027|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2834028|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2834029|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
2834030|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
2834031|NCT03974035|Ropivacaine|ropivacaine|mesh-list
2834032|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
2834033|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
2834034|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834035|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834036|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
2834037|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834038|NCT03973489|Methamphetamine|methamphetamine|mesh-list
2834039|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2834040|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834041|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
2834042|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
2834043|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292472|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2834044|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
2834045|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2834046|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834047|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
2834048|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2834049|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2834050|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2834051|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2834052|NCT03973177|Phenol|phenol|mesh-list
2834053|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
2834054|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2834055|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2834056|NCT03973177|Prednisolone|prednisolone|mesh-list
2834057|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
2834058|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2834059|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
2834060|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2292473|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2292474|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292475|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2292476|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2292477|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
2292478|NCT00265304|Ketoprofen|ketoprofen|mesh-list
2834061|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
2834062|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
2834063|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834064|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834065|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2834066|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
2834067|NCT03973177|Hormones|hormones|mesh-ancestor
2834068|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2834069|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2834070|NCT03973177|Protective Agents|protective agents|mesh-ancestor
2834071|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2834072|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834073|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2834074|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834075|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
2834076|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2834077|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2834078|NCT03973567|Norepinephrine|norepinephrine|mesh-list
2834079|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
2834080|NCT03973567|Serotonin|serotonin|mesh-list
2834081|NCT03973567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2834082|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2834083|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2834084|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
2834085|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2834086|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834087|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834088|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2834089|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2834090|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
2834091|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
2834092|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
2834093|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834094|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2834095|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2834096|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2834097|NCT03973138|Ranibizumab|ranibizumab|mesh-list
2834098|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2834099|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2834100|NCT03973138|Growth Substances|growth substances|mesh-ancestor
2834101|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834102|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
2834103|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834104|NCT03973411|Ondansetron|ondansetron|mesh-list
2834105|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
2834106|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
2834107|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834108|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834109|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2834110|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
2834111|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
2834112|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2834113|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
2834114|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2834115|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834116|NCT03973411|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2834117|NCT03973411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2834118|NCT03973411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834119|NCT03973411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2834120|NCT03973411|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2834121|NCT03973229|Estradiol|estradiol|mesh-list
2292479|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2292480|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2292481|NCT00265304|Analgesics|analgesics|mesh-ancestor
2834122|NCT03973229|Estrogens|estrogens|mesh-ancestor
2834123|NCT03973229|Hormones|hormones|mesh-ancestor
2834124|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2834125|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834126|NCT03973203|Niacin|niacin|mesh-list
2834127|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
2834128|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2834129|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
2834130|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834131|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2834132|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
2834133|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
2834134|NCT03973203|Vitamins|vitamins|mesh-ancestor
2834135|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
2834136|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834137|NCT03973268|Ketamine|ketamine|mesh-list
2834138|NCT03973268|Analgesics|analgesics|mesh-ancestor
2834139|NCT03973268|Sensory System Agents|sensory system agents|mesh-ancestor
2834140|NCT03973268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834141|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834142|NCT03973268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2834143|NCT03973268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2834144|NCT03973268|Anesthetics, General|anesthetics, general|mesh-ancestor
2834145|NCT03973268|Anesthetics|anesthetics|mesh-ancestor
2292482|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
2292483|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292484|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292485|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2292486|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2834146|NCT03973268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834147|NCT03973268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2834148|NCT03973268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2834149|NCT03973268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2834150|NCT03973268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834151|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
2834152|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2834153|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2834154|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834155|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834156|NCT03973086|Protective Agents|protective agents|mesh-ancestor
2834157|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834158|NCT03972748|Itraconazole|itraconazole|mesh-list
2834159|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
2834160|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834161|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2834162|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2834163|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834164|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834165|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2834166|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
2834167|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2834168|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834169|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2834170|NCT03972982|Insulin|insulin|mesh-list
2834171|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2834172|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2834173|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834174|NCT03973047|Ondansetron|ondansetron|mesh-list
2834175|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
2834176|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
2834177|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834178|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834179|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2292487|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2292488|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292489|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292490|NCT00265408|Aspirin|aspirin|mesh-list
2292491|NCT00265408|Warfarin|warfarin|mesh-list
2292492|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2292493|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2292494|NCT00265408|Analgesics|analgesics|mesh-ancestor
2292495|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
2292496|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292497|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292498|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2292499|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2292500|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2834180|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
2834181|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
2834182|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2834183|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
2834184|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2834185|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834186|NCT03973047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2834187|NCT03973047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2834188|NCT03973047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834189|NCT03973047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2834190|NCT03973047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2834191|NCT03972657|Cemiplimab|cemiplimab|mesh-list
2834192|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2834193|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834194|NCT03972592|Sirolimus|sirolimus|mesh-list
2834195|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2834196|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834197|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2834198|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834199|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
2834200|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2834201|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
2834202|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834203|NCT03972683|Atropine|atropine|mesh-list
2834204|NCT03972683|Adenosine|adenosine|mesh-list
2834205|NCT03972683|Nitroprusside|nitroprusside|mesh-list
2834206|NCT03972683|Phenylephrine|phenylephrine|mesh-list
2834207|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
2834208|NCT03972683|Acetylcholine|acetylcholine|mesh-list
2834209|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2834210|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
2834211|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
2834212|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834213|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834214|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
2834215|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2834216|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
2834217|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
2834218|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2292501|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2292502|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292503|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2292504|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2292505|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292506|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
2292507|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
2292508|NCT00265460|Lobeline|lobeline|mesh-list
2292509|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2292510|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
2292511|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292512|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292513|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2292514|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2292515|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
2292516|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292517|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292518|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
2292519|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
2292520|NCT00265486|Hematinics|hematinics|mesh-ancestor
2292521|NCT00265551|Olanzapine|olanzapine|mesh-list
2292522|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
2292523|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
2292524|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292525|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292526|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2834219|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2834220|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2834221|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
2834222|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2834223|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834224|NCT03972683|Protective Agents|protective agents|mesh-ancestor
2834225|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2834226|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2834227|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2834228|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2292527|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2292528|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2292529|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2292530|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2292531|NCT00265551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2292532|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2292533|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2292534|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292535|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292536|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
2292537|NCT00265642|Irbesartan|irbesartan|mesh-list
2292538|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2292539|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2292540|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2834229|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
2834230|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2834231|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2834232|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
2834233|NCT03972683|Analgesics|analgesics|mesh-ancestor
2834234|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
2834235|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
2834236|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2834237|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
2834238|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
2834239|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2834240|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2834241|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2834242|NCT03972527|Analgesics|analgesics|mesh-list
2834243|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
2834244|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834245|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292541|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834246|NCT03972397|Bupivacaine|bupivacaine|mesh-list
2834247|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
2834248|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
2834249|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834250|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292542|NCT00265655|Satraplatin|satraplatin|mesh-list
2292543|NCT00265655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292544|NCT00265694|Gemcitabine|gemcitabine|mesh-list
2292545|NCT00265694|Carboplatin|carboplatin|mesh-list
2834251|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
2834252|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834253|NCT03972358|Misoprostol|misoprostol|mesh-list
2834254|NCT03972358|Mifepristone|mifepristone|mesh-list
2834255|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2834256|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
2834257|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2834258|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834259|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2834260|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2834261|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
2834262|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2834263|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2834264|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2834265|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2834266|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
2834267|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2834268|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2834269|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
2834270|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2834271|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
2834272|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2834273|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2834274|NCT03972462|Sirolimus|sirolimus|mesh-list
2107148|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107149|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107150|NCT02484859|Analgesics|analgesics|mesh-ancestor
2107151|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
2107152|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107153|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2107154|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2107155|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
2107156|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
2292546|NCT00265694|Vinorelbine|vinorelbine|mesh-list
2292547|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292548|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2292549|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
2292550|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292551|NCT00265694|Antiviral Agents|antiviral agents|mesh-ancestor
2292552|NCT00265694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292553|NCT00265694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292554|NCT00265694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2292555|NCT00265694|Immunologic Factors|immunologic factors|mesh-ancestor
2292556|NCT00265694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292557|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2292558|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
2292559|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
2292560|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
2292561|NCT00265733|Paclitaxel|paclitaxel|mesh-list
2292562|NCT00265733|Capecitabine|capecitabine|mesh-list
2292563|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2292564|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2292565|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292566|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
2834275|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2834276|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834277|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2292567|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
2107157|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2107158|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2107159|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2834278|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834279|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
2834280|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2834281|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
2834282|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834283|NCT03972046|Trametinib|trametinib|mesh-list
2834284|NCT03972046|Dabrafenib|dabrafenib|mesh-list
2834285|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2834286|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834287|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2834288|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834289|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834290|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2834291|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
2292568|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
2292569|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292570|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2292571|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
2292572|NCT00265746|Metformin|metformin|mesh-list
2292573|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2292574|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292575|NCT00265772|Prednisolone|prednisolone|mesh-list
2292576|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2292577|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
2292578|NCT00265772|Hormones|hormones|mesh-ancestor
2292579|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2292580|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292581|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2292582|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292583|NCT00265811|Cetuximab|cetuximab|mesh-list
2292584|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2292585|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834300|NCT03971643|Vilobelimab|vilobelimab|mesh-list
2834301|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2834302|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2834303|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
2834304|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834305|NCT03971877|Polymyxins|polymyxins|mesh-list
2834306|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2834307|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834308|NCT03971708|Lidocaine|lidocaine|mesh-list
2834309|NCT03971708|Ropivacaine|ropivacaine|mesh-list
2834310|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
2834311|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
2834312|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834313|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834314|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
2834315|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834316|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2834317|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2834318|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2834319|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2834320|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834321|NCT03971604|Vitamins|vitamins|mesh-list
2834322|NCT03971604|Vitamin E|vitamin e|mesh-list
2834323|NCT03971604|Vitamin A|vitamin a|mesh-list
2834324|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
2834325|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834326|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
2834327|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834328|NCT03971604|Protective Agents|protective agents|mesh-ancestor
2834329|NCT03971409|Doxorubicin|doxorubicin|mesh-list
2834330|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2834331|NCT03971409|Avelumab|avelumab|mesh-list
2292586|NCT00265824|Bevacizumab|bevacizumab|mesh-list
2292587|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2292588|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2292589|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292590|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2292591|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2834332|NCT03971409|Camptothecin|camptothecin|mesh-list
2834333|NCT03971409|Antibodies|antibodies|mesh-list
2834334|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2834335|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
2834336|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
2834337|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
2834338|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107160|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
2107161|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107162|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107163|NCT02484911|Dexamethasone|dexamethasone|mesh-list
2107164|NCT02484911|Olanzapine|olanzapine|mesh-list
2107165|NCT02484911|Aprepitant|aprepitant|mesh-list
2107166|NCT02484911|Palonosetron|palonosetron|mesh-list
2107167|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2107168|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
2107169|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
2834339|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2834340|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834341|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2834342|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2834343|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834344|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834345|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2834346|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2834347|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2834348|NCT03971370|Vaccines|vaccines|mesh-list
2834349|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
2834350|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834351|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2834352|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2834353|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834354|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
2834355|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
2834356|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834357|NCT03971201|Sorafenib|sorafenib|mesh-list
2834358|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834359|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2834360|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834361|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834362|NCT03971279|Dexamethasone|dexamethasone|mesh-list
2834363|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2834364|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
2834365|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
2834366|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834367|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834368|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2834369|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
2834370|NCT03971279|Hormones|hormones|mesh-ancestor
2834371|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2834372|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2834373|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834374|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2834375|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834376|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834377|NCT03970798|Midazolam|midazolam|mesh-list
2292592|NCT00265824|Growth Substances|growth substances|mesh-ancestor
2292593|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292594|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
2292595|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2292596|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292597|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292598|NCT00265863|Mitomycins|mitomycins|mesh-list
2292599|NCT00265863|Mitomycin|mitomycin|mesh-list
2292600|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2292601|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292602|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
2107170|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292603|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834378|NCT03970798|Caffeine|caffeine|mesh-list
2834379|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2834380|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2834381|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2834382|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834383|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834384|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2834385|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2834386|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2834387|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2834388|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
2834389|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
2834390|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
2834391|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
2834392|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2834393|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834394|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2834395|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2834396|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
2834397|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2834398|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2292604|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2292605|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292606|NCT00265876|Gemcitabine|gemcitabine|mesh-list
2292607|NCT00265876|Saracatinib|saracatinib|mesh-list
2292608|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2292609|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
2292610|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292611|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292612|NCT00265876|Antiviral Agents|antiviral agents|mesh-ancestor
2292613|NCT00265876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834399|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834400|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2834401|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2834402|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2834403|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2834404|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
2834405|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
2834406|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
2834407|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2292614|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292615|NCT00265876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2292616|NCT00265876|Immunologic Factors|immunologic factors|mesh-ancestor
2292617|NCT00265876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292618|NCT00265915|Rituximab|rituximab|mesh-list
2292619|NCT00265915|Sargramostim|sargramostim|mesh-list
2292620|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2292621|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292622|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
2292623|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292624|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2292625|NCT00265928|Rituximab|rituximab|mesh-list
2292626|NCT00265928|Bortezomib|bortezomib|mesh-list
2292627|NCT00265928|Antibodies|antibodies|mesh-list
2292628|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
2292629|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2292630|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2292631|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
2292632|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292633|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2292634|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292635|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2292636|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292637|NCT00265967|Irbesartan|irbesartan|mesh-list
2292638|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2834408|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
2834409|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834410|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2834411|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2834412|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
2834413|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834414|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834415|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2834416|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2834417|NCT03970954|Interleukin-2|interleukin-2|mesh-list
2834418|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834419|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2834420|NCT03970954|Analgesics|analgesics|mesh-ancestor
2834421|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
2834422|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834423|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834424|NCT03970772|Glucagon|glucagon|mesh-list
2834425|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2834426|NCT03970772|Hormones|hormones|mesh-ancestor
2834427|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2834428|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292639|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2292640|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2292641|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292642|NCT00265993|Enoxaparin|enoxaparin|mesh-list
2292643|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
2292644|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2292645|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2292646|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292647|NCT00266058|Ritonavir|ritonavir|mesh-list
2292648|NCT00266058|Lopinavir|lopinavir|mesh-list
2834429|NCT03970616|Durvalumab|durvalumab|mesh-list
2834430|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2834431|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834432|NCT03970720|Metoclopramide|metoclopramide|mesh-list
2834433|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
2834434|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
2834435|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834436|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834437|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2834438|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2834439|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2834440|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
2834441|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2834442|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834443|NCT03970694|Capecitabine|capecitabine|mesh-list
2834444|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
2834445|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2834446|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
2834447|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834448|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834449|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
2834450|NCT03971019|Atorvastatin|atorvastatin|mesh-list
2834451|NCT03971019|Simvastatin|simvastatin|mesh-list
2834452|NCT03971019|Calcium|calcium|mesh-list
2834453|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2834454|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834455|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2834456|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2834457|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2834458|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
2834459|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834460|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2834461|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2834462|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834463|NCT03970759|Fluorides|fluorides|mesh-list
2834464|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
2834465|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
2834466|NCT03970759|Protective Agents|protective agents|mesh-ancestor
2834467|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834468|NCT03970577|Prednisone|prednisone|mesh-list
2834469|NCT03970577|Rituximab|rituximab|mesh-list
2834470|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2834471|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834472|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
2834473|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834474|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2834475|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2834476|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
2834477|NCT03970577|Hormones|hormones|mesh-ancestor
2834478|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2834479|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2834480|NCT03970668|Insulin|insulin|mesh-list
2834481|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2834482|NCT03970668|Linagliptin|linagliptin|mesh-list
2834483|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2834484|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834485|NCT03970668|Incretins|incretins|mesh-ancestor
2834486|NCT03970668|Hormones|hormones|mesh-ancestor
2834487|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2834488|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2834489|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
2834490|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834491|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834492|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2834493|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834496|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
2834497|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2834498|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2834499|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292649|NCT00266058|Efavirenz|efavirenz|mesh-list
2292650|NCT00266058|Lumefantrine|lumefantrine|mesh-list
2292651|NCT00266058|Artemether|artemether|mesh-list
2834500|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
2834501|NCT03970213|Coagulants|coagulants|mesh-ancestor
2834502|NCT03970239|Ketanserin|ketanserin|mesh-list
2834503|NCT03970239|Fluorides|fluorides|mesh-list
2834504|NCT03970239|Altanserin|altanserin|mesh-list
2834505|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
2834506|NCT03970239|Protective Agents|protective agents|mesh-ancestor
2834507|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292652|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2292653|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2292654|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2292655|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
2292656|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292657|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292658|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2292659|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2292660|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
2292661|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292662|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2292663|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2292664|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2292665|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2292666|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2292667|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2292668|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2292669|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2292670|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2292671|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
2292672|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2834508|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2834509|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
2834510|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2834511|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834512|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2834513|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2834514|NCT03970382|Aldesleukin|aldesleukin|mesh-list
2834515|NCT03970382|Nivolumab|nivolumab|mesh-list
2834516|NCT03970382|Interleukin-2|interleukin-2|mesh-list
2292673|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2292674|NCT00266097|Gemcitabine|gemcitabine|mesh-list
2292675|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
2292676|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2292677|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2834517|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2834518|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834519|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2834520|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834521|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2834522|NCT03970382|Analgesics|analgesics|mesh-ancestor
2834523|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
2834524|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834525|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834526|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2834527|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2834528|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
2834529|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834530|NCT03970330|Naltrexone|naltrexone|mesh-list
2834531|NCT03970330|Norethindrone|norethindrone|mesh-list
2834532|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
2834533|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2834534|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2834535|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834536|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
2834537|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834538|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2834539|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2834540|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2834541|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
2834542|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2834543|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2834544|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2834576|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
2834577|NCT03970044|Exenatide|exenatide|mesh-list
2834578|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2834579|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834580|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2834581|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834582|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2834583|NCT03970044|Incretins|incretins|mesh-ancestor
2834584|NCT03970044|Hormones|hormones|mesh-ancestor
2834585|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2834586|NCT03969823|Osimertinib|osimertinib|mesh-list
2834587|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834588|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2834589|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834590|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834591|NCT03969758|Metronidazole|metronidazole|mesh-list
2834592|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
2292678|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
2292679|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292680|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292681|NCT00266097|Antiviral Agents|antiviral agents|mesh-ancestor
2292682|NCT00266097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292683|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292684|NCT00266097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2292685|NCT00266097|Immunologic Factors|immunologic factors|mesh-ancestor
2292686|NCT00266097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292687|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2292688|NCT00266123|Sirolimus|sirolimus|mesh-list
2292689|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2292690|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292691|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2292692|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292693|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
2292694|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2292695|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
2292696|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292697|NCT00266136|Cytarabine|cytarabine|mesh-list
2292698|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
2292699|NCT00266136|Daunorubicin|daunorubicin|mesh-list
2292700|NCT00266136|Thioguanine|thioguanine|mesh-list
2292701|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2292702|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
2834593|NCT03969758|Cefixime|cefixime|mesh-list
2834594|NCT03969758|Liver Extracts|liver extracts|mesh-list
2834595|NCT03969758|Hematinics|hematinics|mesh-ancestor
2834596|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834597|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2834598|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2834599|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2834600|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2292703|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292704|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2834601|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2834602|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834603|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834604|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834605|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2834606|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2292705|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2292706|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
2292707|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292708|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292709|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2292710|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2292711|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
2107171|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107172|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2107173|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
2107174|NCT02484911|Hormones|hormones|mesh-ancestor
2107175|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2107176|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2107177|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107178|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2107179|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2107180|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107181|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2107182|NCT02484911|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2107183|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2292712|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
2292713|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292714|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2292715|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2292716|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2292717|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107184|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2107185|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107186|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107187|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
2107188|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2107189|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2107190|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2107191|NCT02485158|Dronabinol|dronabinol|mesh-list
2107192|NCT02485158|Amphetamine|amphetamine|mesh-list
2107193|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
2107194|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2107195|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107196|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
2107197|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
2834612|NCT03969004|Cemiplimab|cemiplimab|mesh-list
2834613|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2834614|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834615|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2834616|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2834617|NCT03969017|Interferons|interferons|mesh-list
2834618|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834619|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
2834620|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834621|NCT03968835|Bacitracin|bacitracin|mesh-list
2834622|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2834623|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834624|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2834625|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
2834626|NCT03968640|Vitamins|vitamins|mesh-ancestor
2834627|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
2834628|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834629|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
2834630|NCT03968588|Tacrolimus|tacrolimus|mesh-list
2834631|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2834632|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
2834633|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834634|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2834635|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834636|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834637|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2834638|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834639|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2834640|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
2834641|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2834642|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834643|NCT03968861|Xenon|xenon|mesh-list
2834644|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2834645|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
2834646|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
2834647|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834648|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834649|NCT03968263|Hydrocodone|hydrocodone|mesh-list
2834650|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2834651|NCT03968263|Narcotics|narcotics|mesh-ancestor
2834652|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834653|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834654|NCT03968263|Analgesics|analgesics|mesh-ancestor
2834655|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
2292718|NCT00266149|Lamotrigine|lamotrigine|mesh-list
2292719|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
2292720|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2834656|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834657|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
2834658|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
2834659|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2292721|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2292722|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292723|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2834660|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834661|NCT03968393|Rivaroxaban|rivaroxaban|mesh-list
2834662|NCT03968393|Apixaban|apixaban|mesh-list
2834663|NCT03968393|Edoxaban|edoxaban|mesh-list
2834664|NCT03968393|Dabigatran|dabigatran|mesh-list
2834665|NCT03968393|Anticoagulants|anticoagulants|mesh-list
2834666|NCT03968393|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2834667|NCT03968393|Antithrombins|antithrombins|mesh-ancestor
2834668|NCT03968393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2834669|NCT03968393|Protease Inhibitors|protease inhibitors|mesh-ancestor
2834670|NCT03968393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834671|NCT03968393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292724|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292725|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2292726|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2292727|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2292728|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2292729|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2292730|NCT00266162|Bosentan|bosentan|mesh-list
2292731|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2292732|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2292733|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292734|NCT00266214|Lidocaine|lidocaine|mesh-list
2292735|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
2292736|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
2292737|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834672|NCT03968185|Analgesics|analgesics|mesh-list
2834673|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
2834674|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834675|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834676|NCT03968146|Acetaminophen|acetaminophen|mesh-list
2834677|NCT03968146|Ketorolac|ketorolac|mesh-list
2834678|NCT03968146|Fentanyl|fentanyl|mesh-list
2292738|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292739|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
2292740|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834679|NCT03968146|Meperidine|meperidine|mesh-list
2834680|NCT03968146|Morphine|morphine|mesh-list
2834681|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2834682|NCT03968146|Narcotics|narcotics|mesh-ancestor
2834683|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834684|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834685|NCT03968146|Analgesics|analgesics|mesh-ancestor
2834686|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
2834687|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834688|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2834689|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2834690|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
2834691|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
2834692|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2292741|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2834693|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
2834694|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2834695|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2834696|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2834697|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2834698|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834699|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834700|NCT03968224|Metformin|metformin|mesh-list
2834701|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
2834702|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2834703|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834704|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2834705|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834706|NCT03968406|Talazoparib|talazoparib|mesh-list
2834707|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2834708|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834709|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834710|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834711|NCT03968237|Buprenorphine|buprenorphine|mesh-list
2834712|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2834713|NCT03968237|Naloxone|naloxone|mesh-list
2834714|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2834715|NCT03968237|Narcotics|narcotics|mesh-ancestor
2834716|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834717|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834718|NCT03968237|Analgesics|analgesics|mesh-ancestor
2834719|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
2834720|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834721|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2834722|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
2834723|NCT03967964|Testosterone|testosterone|mesh-list
2834724|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
2834725|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
2834726|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2834727|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2834728|NCT03967964|Androgens|androgens|mesh-ancestor
2292742|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2292743|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2292744|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2292745|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834729|NCT03967964|Hormones|hormones|mesh-ancestor
2834730|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2834731|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834732|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2834733|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834734|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
2834735|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2834736|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
2834737|NCT03967977|Gemcitabine|gemcitabine|mesh-list
2834738|NCT03967977|Carboplatin|carboplatin|mesh-list
2834739|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834740|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2834741|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
2834742|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834743|NCT03967977|Antiviral Agents|antiviral agents|mesh-ancestor
2834744|NCT03967977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834745|NCT03967977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834746|NCT03967977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2834747|NCT03967977|Immunologic Factors|immunologic factors|mesh-ancestor
2834748|NCT03967977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834749|NCT03967886|Esomeprazole|esomeprazole|mesh-list
2834750|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2834751|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2834752|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2834753|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834754|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834755|NCT03967925|Prednisone|prednisone|mesh-list
2834756|NCT03967925|Prednisolone|prednisolone|mesh-list
2834757|NCT03967925|Rituximab|rituximab|mesh-list
2834758|NCT03967925|Belimumab|belimumab|mesh-list
2834759|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2834760|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292746|NCT00266253|Metformin|metformin|mesh-list
2292747|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2834761|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
2834762|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834763|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2834764|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2834765|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
2834766|NCT03967925|Hormones|hormones|mesh-ancestor
2834767|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2834768|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2834769|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2834770|NCT03968042|Thiamine|thiamine|mesh-list
2834771|NCT03968042|Edaravone|edaravone|mesh-list
2834772|NCT03968042|Mitogens|mitogens|mesh-list
2834773|NCT03968042|Vitamins|vitamins|mesh-ancestor
2834774|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
2834775|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834776|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
2834777|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834778|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
2834779|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2834780|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
2834781|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2834782|NCT03968042|Protective Agents|protective agents|mesh-ancestor
2834783|NCT03967847|Ketorolac|ketorolac|mesh-list
2834784|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2834785|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2834786|NCT03967847|Analgesics|analgesics|mesh-ancestor
2834787|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
2834788|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834789|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834790|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2834791|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2834792|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2834793|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834794|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834795|NCT03967938|Olaparib|olaparib|mesh-list
2834796|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2834797|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834798|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834799|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834800|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
2834801|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2834802|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
2834803|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834804|NCT03967665|Expectorants|expectorants|mesh-ancestor
2834805|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
2834806|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2834807|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
2834808|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834809|NCT03967665|Protective Agents|protective agents|mesh-ancestor
2834810|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292748|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292749|NCT00266318|Interferons|interferons|mesh-list
2292750|NCT00266318|Ribavirin|ribavirin|mesh-list
2292751|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
2292752|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292753|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
2292754|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292755|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
2292756|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292757|NCT00266344|Gaboxadol|gaboxadol|mesh-list
2292758|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292759|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834811|NCT03967665|Antidotes|antidotes|mesh-ancestor
2292760|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292761|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292762|NCT00266344|Analgesics|analgesics|mesh-ancestor
2292763|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
2292764|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
2292765|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
2292766|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
2292767|NCT00266357|Gaboxadol|gaboxadol|mesh-list
2292768|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292769|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292770|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292771|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834812|NCT03967392|Lidocaine|lidocaine|mesh-list
2834813|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
2834814|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
2834815|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2292772|NCT00266357|Analgesics|analgesics|mesh-ancestor
2292773|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
2292774|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
2292775|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
2292776|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
2292777|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
2292778|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2292779|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292780|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
2292781|NCT00266487|Vitamins|vitamins|mesh-list
2292782|NCT00266487|Folic Acid|folic acid|mesh-list
2292783|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
2292784|NCT00266487|Hydroxocobalamin|hydroxocobalamin|mesh-list
2292785|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
2292786|NCT00266487|Pyridoxal|pyridoxal|mesh-list
2292787|NCT00266487|Pyridoxine|pyridoxine|mesh-list
2292788|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
2292789|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
2292790|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834816|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834817|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
2834818|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834819|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2834820|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2834821|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2834822|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2834823|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834824|NCT03967054|Ivermectin|ivermectin|mesh-list
2834825|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2834826|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2834827|NCT03967171|Oxytocin|oxytocin|mesh-list
2834828|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
2834829|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2834830|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834831|NCT03967496|Metformin|metformin|mesh-list
2834832|NCT03967496|Amlodipine|amlodipine|mesh-list
2834833|NCT03967496|Lisinopril|lisinopril|mesh-list
2834834|NCT03967496|Bisoprolol|bisoprolol|mesh-list
2834835|NCT03967496|Hydralazine|hydralazine|mesh-list
2834836|NCT03967496|Anesthetics|anesthetics|mesh-list
2834837|NCT03967496|Atorvastatin|atorvastatin|mesh-list
2834838|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2834839|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834840|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834841|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2834842|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2834843|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
2834844|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834845|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2834846|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2834847|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834848|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2834849|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2834850|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2834851|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2834852|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
2834853|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2834854|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
2834855|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2834856|NCT03967496|Protective Agents|protective agents|mesh-ancestor
2834857|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
2834858|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
2834859|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834860|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2292791|NCT00266487|Hematinics|hematinics|mesh-ancestor
2292792|NCT00266539|Fentanyl|fentanyl|mesh-list
2292793|NCT00266539|Morphine|morphine|mesh-list
2834861|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2834862|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2834863|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
2292794|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2292795|NCT00266539|Narcotics|narcotics|mesh-ancestor
2292796|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2292797|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834864|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2834865|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2834866|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2834867|NCT03967327|Morphine|morphine|mesh-list
2834868|NCT03967327|Buprenorphine|buprenorphine|mesh-list
2834869|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2834870|NCT03967327|Narcotics|narcotics|mesh-ancestor
2834871|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834872|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834873|NCT03967327|Analgesics|analgesics|mesh-ancestor
2834874|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
2834875|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834876|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2834877|NCT03967288|Bupivacaine|bupivacaine|mesh-list
2834878|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
2834879|NCT03967288|Procaine|procaine|mesh-list
2834880|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
2834881|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
2834882|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834883|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834884|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
2834885|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834886|NCT03967197|Lidocaine|lidocaine|mesh-list
2834887|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
2834888|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
2834889|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834890|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834891|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
2834892|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834893|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2834894|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2834895|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2834896|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2834897|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834898|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2834899|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2834900|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834901|NCT03966560|Timolol|timolol|mesh-list
2834902|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2834903|NCT03966560|Bimatoprost|bimatoprost|mesh-list
2834904|NCT03966560|Travoprost|travoprost|mesh-list
2834905|NCT03966560|Dorzolamide|dorzolamide|mesh-list
2834906|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2834907|NCT03966560|Latanoprost|latanoprost|mesh-list
2834908|NCT03966560|Brinzolamide|brinzolamide|mesh-list
2834909|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2834910|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2834911|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2292798|NCT00266539|Analgesics|analgesics|mesh-ancestor
2292799|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
2292800|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292801|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2292802|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2292803|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
2292804|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
2292805|NCT00266552|Risperidone|risperidone|mesh-list
2292806|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2292807|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
2292808|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292809|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834912|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
2834913|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107198|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107199|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
2107200|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107201|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107202|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
2107203|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2107204|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2107205|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2107206|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2107207|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
2107208|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2107209|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2107210|NCT02485158|Analgesics|analgesics|mesh-ancestor
2107211|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
2107212|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2107213|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2107214|NCT02485158|Hormones|hormones|mesh-ancestor
2107215|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2107216|NCT02485353|Cytarabine|cytarabine|mesh-list
2107217|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2107218|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
2107219|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107220|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107221|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
2107222|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107223|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2107224|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
2107225|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834914|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834915|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834916|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2107229|NCT02485834|Docetaxel|docetaxel|mesh-list
2107230|NCT02485834|Capecitabine|capecitabine|mesh-list
2107231|NCT02485834|Irinotecan|irinotecan|mesh-list
2107232|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107233|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
2292810|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834917|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2834918|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834919|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2834920|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2292811|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2292812|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2292813|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2292814|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2292815|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2292816|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
2834921|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2834922|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2834923|NCT03966859|Atorvastatin|atorvastatin|mesh-list
2834924|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2834925|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2834926|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
2834927|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834928|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2292817|NCT00266578|Fluticasone|fluticasone|mesh-list
2292818|NCT00266578|Xhance|xhance|mesh-list
2292819|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2292820|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2292821|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
2292822|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292823|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292824|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2292825|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
2292826|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
2834929|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2834930|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834931|NCT03966950|Melatonin|melatonin|mesh-list
2834932|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
2834933|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834934|NCT03966950|Protective Agents|protective agents|mesh-ancestor
2834935|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834936|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834937|NCT03966547|Anesthetics|anesthetics|mesh-list
2834938|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
2834939|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834940|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834941|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
2834942|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834943|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
2834944|NCT03966378|Calcium|calcium|mesh-list
2834945|NCT03966378|Caseins|caseins|mesh-list
2834946|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2834947|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834948|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
2834949|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
2834950|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834951|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2292827|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2834952|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834953|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
2834954|NCT03966378|Protective Agents|protective agents|mesh-ancestor
2834955|NCT03966898|Letrozole|letrozole|mesh-list
2834956|NCT03966898|Anastrozole|anastrozole|mesh-list
2834957|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2834958|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2834959|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2834960|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2834961|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834962|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2834963|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
2834964|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2834965|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834966|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2834967|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2834968|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
2834972|NCT03966326|Fentanyl|fentanyl|mesh-list
2834973|NCT03966326|Anesthetics|anesthetics|mesh-list
2834974|NCT03966326|Sevoflurane|sevoflurane|mesh-list
2834975|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834976|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834977|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2834978|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2834979|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
2834980|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2834981|NCT03966326|Narcotics|narcotics|mesh-ancestor
2834982|NCT03966326|Analgesics|analgesics|mesh-ancestor
2834983|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
2834984|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2834985|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2834986|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2834987|NCT03966235|Melatonin|melatonin|mesh-list
2834988|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
2834989|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292828|NCT00266591|Topiramate|topiramate|mesh-list
2292829|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
2292830|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2292831|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292832|NCT00266604|Topiramate|topiramate|mesh-list
2292833|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
2292834|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2292835|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292836|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
2292837|NCT00266617|Hematinics|hematinics|mesh-ancestor
2292838|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2292839|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2292840|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2292841|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2292842|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292843|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292844|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292845|NCT00266643|Analgesics|analgesics|mesh-ancestor
2292846|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
2292847|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292848|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
2292849|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2292850|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
2834990|NCT03966235|Protective Agents|protective agents|mesh-ancestor
2834991|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2834992|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2834993|NCT03966079|Plasminogen|plasminogen|mesh-list
2834994|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2834995|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2834996|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2834997|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2834998|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2834999|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835000|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835001|NCT03966040|Vaccines|vaccines|mesh-list
2835002|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
2292851|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
2292852|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
2292853|NCT00266721|Pancrelipase|pancrelipase|mesh-list
2292854|NCT00266721|Pancreatin|pancreatin|mesh-list
2292855|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2292856|NCT00266747|Amibegron|amibegron|mesh-list
2292857|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2292858|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2292859|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
2292860|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292861|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292862|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292863|NCT00266786|Ketorolac|ketorolac|mesh-list
2292864|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2292865|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2292866|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2835003|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835004|NCT03965962|Vaccines|vaccines|mesh-list
2835005|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
2835006|NCT03965962|Antibodies|antibodies|mesh-list
2835007|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
2835008|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2835009|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2835010|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
2835011|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835012|NCT03965871|Esketamine|esketamine|mesh-list
2292867|NCT00266786|Analgesics|analgesics|mesh-ancestor
2292868|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
2292869|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292870|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292871|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2292872|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2835013|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
2835014|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2835015|NCT03966014|Amoxicillin|amoxicillin|mesh-list
2835016|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2835017|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292873|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2292874|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292875|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835018|NCT03966118|Paclitaxel|paclitaxel|mesh-list
2835019|NCT03966118|Avelumab|avelumab|mesh-list
2835020|NCT03966118|Ramucirumab|ramucirumab|mesh-list
2835021|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2835022|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835023|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
2835024|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
2835025|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
2835026|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835027|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2835028|NCT03965949|Hormones|hormones|mesh-list
2835029|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2835030|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835031|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
2835032|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2835033|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2835034|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835035|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
2835036|NCT03965767|Coagulants|coagulants|mesh-ancestor
2835037|NCT03965858|Esketamine|esketamine|mesh-list
2835038|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
2835039|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2835040|NCT03965819|Acetaminophen|acetaminophen|mesh-list
2835041|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2835042|NCT03965819|Analgesics|analgesics|mesh-ancestor
2835043|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
2835044|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835045|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835046|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
2835047|NCT03966066|Erythromycin|erythromycin|mesh-list
2835048|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
2835049|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2835050|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
2835051|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2835052|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835053|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2835054|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2835055|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835056|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835068|NCT03965546|Sorafenib|sorafenib|mesh-list
2835069|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835070|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2835071|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835072|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835073|NCT03965624|Ixazomib|ixazomib|mesh-list
2835074|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835075|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
2835076|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835077|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835078|NCT03965468|Paclitaxel|paclitaxel|mesh-list
2835079|NCT03965468|Carboplatin|carboplatin|mesh-list
2835080|NCT03965468|Durvalumab|durvalumab|mesh-list
2835081|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2835082|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835083|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
2835084|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
2835085|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
2835086|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835087|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2835088|NCT03965442|Esmolol|esmolol|mesh-list
2835089|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2835090|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2835091|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2835092|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
2835093|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292876|NCT00266838|Dexamethasone|dexamethasone|mesh-list
2292877|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2292878|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
2292879|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
2292880|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292881|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292882|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2292883|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
2292884|NCT00266838|Hormones|hormones|mesh-ancestor
2835094|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835095|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835096|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
2835097|NCT03965637|Vitamins|vitamins|mesh-ancestor
2835098|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
2835099|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835100|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
2835101|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835102|NCT03965637|Protective Agents|protective agents|mesh-ancestor
2835103|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
2835104|NCT03965286|Ledipasvir|ledipasvir|mesh-list
2835105|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2835106|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
2835107|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835108|NCT03965117|Norepinephrine|norepinephrine|mesh-list
2835109|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2835110|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2835111|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
2835112|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835113|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835114|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835115|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
2835116|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
2835117|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835118|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2835119|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2835120|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2835121|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2835127|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
2835128|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
2835129|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2292885|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2292886|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2292887|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292888|NCT00267163|Donepezil|donepezil|mesh-list
2292889|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2292890|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292891|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292892|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
2292893|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2292894|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292895|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
2292896|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
2292897|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2292898|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2292899|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292900|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292901|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2292902|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2292903|NCT00267176|Analgesics|analgesics|mesh-ancestor
2292904|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
2292905|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292906|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292907|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2292908|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2292909|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
2292910|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2292911|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2292912|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292913|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107234|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
2107235|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
2107236|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107237|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2107238|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
2107239|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2107240|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2107241|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107242|NCT02486016|Fentanyl|fentanyl|mesh-list
2107243|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2107244|NCT02486016|Narcotics|narcotics|mesh-ancestor
2107245|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835130|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835131|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835132|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
2835133|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2835134|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835135|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835136|NCT03965208|Heparin|heparin|mesh-list
2835137|NCT03965208|Calcium heparin|calcium heparin|mesh-list
2835138|NCT03965208|Bivalirudin|bivalirudin|mesh-list
2835139|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
2835140|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2835141|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2835142|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835143|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
2835144|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2835145|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
2835146|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835147|NCT03964935|Minocycline|minocycline|mesh-list
2835148|NCT03964935|Lycopene|lycopene|mesh-list
2835149|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2835150|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835151|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2835152|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
2835153|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835154|NCT03964935|Protective Agents|protective agents|mesh-ancestor
2835155|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835156|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2835157|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2835158|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835159|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
2835160|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2835161|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835162|NCT03965195|Vaccines|vaccines|mesh-list
2292914|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2292915|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2292916|NCT00267215|Analgesics|analgesics|mesh-ancestor
2292917|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
2292918|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2292919|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292920|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2292921|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2292922|NCT00267254|Atorvastatin|atorvastatin|mesh-list
2292923|NCT00267254|Simvastatin|simvastatin|mesh-list
2292924|NCT00267254|Torcetrapib|torcetrapib|mesh-list
2292925|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2292926|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2292927|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
2292928|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292929|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2835163|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
2835164|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835165|NCT03964753|Paclitaxel|paclitaxel|mesh-list
2835166|NCT03964753|Cisplatin|cisplatin|mesh-list
2835167|NCT03964753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2835168|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2835169|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835170|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
2835171|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
2835172|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
2835173|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835174|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
2835175|NCT03964688|Vitamins|vitamins|mesh-ancestor
2835176|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
2835177|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835178|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
2835179|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835180|NCT03964688|Protective Agents|protective agents|mesh-ancestor
2835181|NCT03964779|Antibodies|antibodies|mesh-list
2835182|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
2835183|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
2835184|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835185|NCT03964493|Vancomycin|vancomycin|mesh-list
2835186|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2835187|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835188|NCT03964350|Ethanol|ethanol|mesh-list
2835189|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2835190|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835191|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835192|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835193|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
2835194|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2835195|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
2835196|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835197|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835198|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2835199|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
2835200|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2835201|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
2835202|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835203|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835204|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2835205|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
2835206|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
2835207|NCT03964324|Protective Agents|protective agents|mesh-ancestor
2835208|NCT03963895|Thrombin|thrombin|mesh-list
2835209|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
2835210|NCT03963895|Coagulants|coagulants|mesh-ancestor
2835211|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
2835212|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2835213|NCT03964051|Omalizumab|omalizumab|mesh-list
2835214|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2835215|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2835216|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
2835217|NCT03963752|Megestrol|megestrol|mesh-list
2835218|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
2835219|NCT03963752|Leuprolide|leuprolide|mesh-list
2835220|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2835221|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2835222|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2835223|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
2835224|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2835225|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835226|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2835227|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2835228|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2835229|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835230|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
2835231|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2835232|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2835233|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
2835255|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
2835256|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2835257|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
2835258|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835259|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835260|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2835261|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
2835262|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2835263|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
2835264|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835265|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835266|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2835267|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
2835268|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
2835269|NCT03963648|Protective Agents|protective agents|mesh-ancestor
2835270|NCT03963375|Cladribine|cladribine|mesh-list
2835271|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835272|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2835273|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
2835274|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835275|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
2835276|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2835277|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2835278|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835279|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
2835280|NCT03963466|Coagulants|coagulants|mesh-ancestor
2835281|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
2835282|NCT03963479|Pyridoxal|pyridoxal|mesh-list
2835283|NCT03963479|Pyridoxine|pyridoxine|mesh-list
2835284|NCT03963479|Vitamins|vitamins|mesh-ancestor
2835285|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
2835286|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835287|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
2835288|NCT03963414|Carboplatin|carboplatin|mesh-list
2835289|NCT03963414|Etoposide|etoposide|mesh-list
2835290|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
2835291|NCT03963414|Durvalumab|durvalumab|mesh-list
2835292|NCT03963414|Tremelimumab|tremelimumab|mesh-list
2835293|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2835294|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835295|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2835296|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2835297|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2835298|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835299|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835300|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2835301|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
2835302|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835303|NCT03963336|Acetazolamide|acetazolamide|mesh-list
2835304|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
2835305|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2835306|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835307|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835308|NCT03963336|Diuretics|diuretics|mesh-ancestor
2835309|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
2835310|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835311|NCT03963193|Cisplatin|cisplatin|mesh-list
2835312|NCT03963193|Irinotecan|irinotecan|mesh-list
2835313|NCT03963193|Etoposide|etoposide|mesh-list
2835314|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835315|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2835316|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2835317|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835318|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835319|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2835320|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2835321|NCT03963115|Epinephrine|epinephrine|mesh-list
2835322|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2107246|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107247|NCT02486016|Analgesics|analgesics|mesh-ancestor
2107248|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
2107249|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107250|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2292930|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2292931|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292932|NCT00267267|Atorvastatin|atorvastatin|mesh-list
2292933|NCT00267267|Simvastatin|simvastatin|mesh-list
2292934|NCT00267267|Ezetimibe|ezetimibe|mesh-list
2292935|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2292936|NCT00267267|Torcetrapib|torcetrapib|mesh-list
2292937|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2292938|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2835323|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2835324|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
2835325|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835326|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835327|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835328|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2835329|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2835330|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
2835331|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835332|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2835333|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
2835334|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
2835335|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
2835336|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2835337|NCT03963024|Treosulfan|treosulfan|mesh-list
2835338|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2835339|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
2835340|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835341|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835342|NCT03963128|Vitamin D|vitamin d|mesh-list
2835343|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
2835344|NCT03963128|Vitamins|vitamins|mesh-ancestor
2107251|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2107252|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
2107253|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
2107254|NCT02486211|Amantadine|amantadine|mesh-list
2292939|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
2292940|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292941|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2292942|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2292943|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292944|NCT00267280|Atorvastatin|atorvastatin|mesh-list
2292945|NCT00267280|Simvastatin|simvastatin|mesh-list
2292946|NCT00267280|Torcetrapib|torcetrapib|mesh-list
2292947|NCT00267280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2292948|NCT00267280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2292949|NCT00267280|Antimetabolites|antimetabolites|mesh-ancestor
2292950|NCT00267280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835345|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
2835346|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835347|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2835348|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2835349|NCT03962881|Vaccines|vaccines|mesh-list
2835350|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
2835351|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835352|NCT03962920|Tigecycline|tigecycline|mesh-list
2835353|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2835354|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835355|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2835356|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835357|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835358|NCT03962855|Ifetroban|ifetroban|mesh-list
2835359|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2835360|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
2835361|NCT03962907|Mupirocin|mupirocin|mesh-list
2835362|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2835363|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835364|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
2835365|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2835366|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2835367|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292951|NCT00267280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2292952|NCT00267280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2292953|NCT00267280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2292954|NCT00267306|Visilizumab|visilizumab|mesh-list
2292955|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
2292956|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292957|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
2292958|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
2292959|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2292960|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
2292961|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292962|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2835368|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292963|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2292964|NCT00267332|Modafinil|modafinil|mesh-list
2292965|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2292966|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292967|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2292968|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2292969|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2292970|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292971|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
2292972|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2292973|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
2292974|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2292975|NCT00267384|Expectorants|expectorants|mesh-ancestor
2292976|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
2292977|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2292978|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
2292979|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292980|NCT00267384|Protective Agents|protective agents|mesh-ancestor
2292981|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292982|NCT00267384|Antidotes|antidotes|mesh-ancestor
2292983|NCT00267514|Sevelamer|sevelamer|mesh-list
2292984|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
2292985|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
2292986|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2292987|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
2292988|NCT00267540|Vitamins|vitamins|mesh-ancestor
2292989|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
2292990|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292991|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2835406|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
2835407|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2835408|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
2835409|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835410|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835411|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835412|NCT03962647|Letrozole|letrozole|mesh-list
2835413|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835414|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2835415|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2835416|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835417|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835418|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2835419|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
2835420|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2835421|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835422|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
2835423|NCT03962725|Ketamine|ketamine|mesh-list
2835424|NCT03962725|Propofol|propofol|mesh-list
2835425|NCT03962725|Anesthetics|anesthetics|mesh-list
2835426|NCT03962725|Rocuronium|rocuronium|mesh-list
2835427|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
2835428|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2835429|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835430|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835431|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2835432|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
2835433|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2835434|NCT03962725|Analgesics|analgesics|mesh-ancestor
2835435|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
2835436|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835437|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2835438|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2835439|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2292992|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2292993|NCT00267553|Toremifene|toremifene|mesh-list
2835440|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
2835441|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835442|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835443|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2835444|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2835445|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2835446|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2835447|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2835448|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
2835449|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2835450|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835451|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
2835452|NCT03962803|Vaccines|vaccines|mesh-list
2835453|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
2835454|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835455|NCT03962816|Vaccines|vaccines|mesh-list
2835456|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
2835457|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2292994|NCT00267553|Letrozole|letrozole|mesh-list
2292995|NCT00267553|Atamestane|atamestane|mesh-list
2292996|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2292997|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2292998|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2292999|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293000|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293001|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2293002|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
2293003|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2293004|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293005|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2293006|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2293007|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2293008|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2293009|NCT00267592|Temozolomide|temozolomide|mesh-list
2293010|NCT00267592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2293011|NCT00267592|Alkylating Agents|alkylating agents|mesh-ancestor
2293012|NCT00267592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293013|NCT00267592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293014|NCT00267657|Reserpine|reserpine|mesh-list
2293015|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2293016|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2293017|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2293018|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2293019|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293020|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2293021|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2293022|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2293023|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2293024|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293025|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
2293026|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293027|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
2293028|NCT00267683|Glyburide|glyburide|mesh-list
2293029|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2293030|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293031|NCT00267709|Visilizumab|visilizumab|mesh-list
2293032|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
2293033|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293034|NCT00267722|Visilizumab|visilizumab|mesh-list
2293035|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
2835458|NCT03962686|Metformin|metformin|mesh-list
2835459|NCT03962686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2835460|NCT03962686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835461|NCT03962062|Moxidectin|moxidectin|mesh-list
2835462|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
2293036|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293037|NCT00267813|Bupropion|bupropion|mesh-list
2293038|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2293039|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
2293040|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2293041|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2293042|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2293043|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2835463|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2835464|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835465|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
2835466|NCT03962114|Niacinamide|niacinamide|mesh-list
2835467|NCT03962114|Vitamins|vitamins|mesh-ancestor
2835468|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
2835469|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835470|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
2835471|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
2835472|NCT03962296|Calcium|calcium|mesh-list
2835473|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2835474|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835475|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
2835476|NCT03962296|Coagulants|coagulants|mesh-ancestor
2835477|NCT03962283|Rifaximin|rifaximin|mesh-list
2835478|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2835479|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835480|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2835481|NCT03961867|Docetaxel|docetaxel|mesh-list
2835482|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
2835483|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835484|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
2835485|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
2835486|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
2835487|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835488|NCT03961958|Propofol|propofol|mesh-list
2835489|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2835490|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835491|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835492|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2835493|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
2835494|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
2835495|NCT03961919|Fludarabine|fludarabine|mesh-list
2835496|NCT03961919|Treosulfan|treosulfan|mesh-list
2835497|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835498|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835499|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2835500|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
2835501|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
2835502|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835503|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
2835504|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2835505|NCT03961828|Ledipasvir|ledipasvir|mesh-list
2835506|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
2835507|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835508|NCT03961659|Metformin|metformin|mesh-list
2835509|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
2835510|NCT03961659|Acarbose|acarbose|mesh-list
2835511|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2835512|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835513|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2835514|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835515|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2835516|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293044|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293045|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
2293046|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293047|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293048|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2293049|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2293050|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293051|NCT00267826|Rituximab|rituximab|mesh-list
2293052|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2835524|NCT03961464|Cycloserine|cycloserine|mesh-list
2835525|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2835526|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835527|NCT03961464|Renal Agents|renal agents|mesh-ancestor
2835528|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2835529|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
2835530|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2835531|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
2835532|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835533|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2835534|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2835535|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
2835536|NCT03961503|Vancomycin|vancomycin|mesh-list
2835537|NCT03961503|Daptomycin|daptomycin|mesh-list
2835538|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2835539|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835540|NCT03961698|Paclitaxel|paclitaxel|mesh-list
2835541|NCT03961698|Bevacizumab|bevacizumab|mesh-list
2835542|NCT03961698|Atezolizumab|atezolizumab|mesh-list
2835543|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2835544|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835545|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
2835546|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
2835547|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
2835548|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835549|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2835550|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2835551|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2835552|NCT03961698|Growth Substances|growth substances|mesh-ancestor
2835553|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835554|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
2835555|NCT03961360|Aspirin|aspirin|mesh-list
2835556|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2835557|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2835558|NCT03961360|Analgesics|analgesics|mesh-ancestor
2835559|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
2835560|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835561|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835562|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2835563|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2835564|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2835565|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2835566|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835567|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2835568|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2835569|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835570|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
2835571|NCT03960970|Azithromycin|azithromycin|mesh-list
2835572|NCT03960970|Cefoxitin|cefoxitin|mesh-list
2835573|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2835574|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835575|NCT03961334|Aspirin|aspirin|mesh-list
2835576|NCT03961334|Dabigatran|dabigatran|mesh-list
2835577|NCT03961334|Apixaban|apixaban|mesh-list
2835578|NCT03961334|Edoxaban|edoxaban|mesh-list
2835579|NCT03961334|Clopidogrel|clopidogrel|mesh-list
2835580|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2835581|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2835582|NCT03961334|Analgesics|analgesics|mesh-ancestor
2835583|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
2835584|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835585|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835586|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2835587|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2835588|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2835589|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2835590|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835591|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2835592|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2835593|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835594|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
2835595|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2835596|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2835597|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2835598|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
2835599|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835600|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
2835601|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2835602|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
2835603|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
2835604|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2835605|NCT03961126|Clobetasol|clobetasol|mesh-list
2835606|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2835607|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
2835608|NCT03961126|Hormones|hormones|mesh-ancestor
2835609|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2835610|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835611|NCT03961165|Scopolamine|scopolamine|mesh-list
2835612|NCT03961165|Bromides|bromides|mesh-list
2835613|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2835614|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
2835615|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
2835616|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
2835617|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835618|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835619|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2835620|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2835621|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
2835622|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835623|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835624|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2835625|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
2835626|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2835627|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
2835628|NCT03961048|Ropivacaine|ropivacaine|mesh-list
2835629|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2835630|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
2835631|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
2293053|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293054|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
2293055|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293056|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2293057|NCT00267917|Fenoterol|fenoterol|mesh-list
2293058|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2293059|NCT00267917|Ipratropium|ipratropium|mesh-list
2293060|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2293061|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
2293062|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2293063|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293064|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2293065|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
2293066|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
2835632|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835633|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835634|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
2835635|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835636|NCT03961256|Exenatide|exenatide|mesh-list
2835637|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2835638|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835639|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2835640|NCT03961256|Incretins|incretins|mesh-ancestor
2835641|NCT03961256|Hormones|hormones|mesh-ancestor
2293067|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
2835642|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2293068|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2293069|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2293070|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2293071|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2293072|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
2293073|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293074|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293075|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2293076|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
2293077|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2293078|NCT00267943|Telmisartan|telmisartan|mesh-list
2293079|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2293080|NCT00267943|Diuretics|diuretics|mesh-ancestor
2293081|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
2293082|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835643|NCT03960905|Meropenem|meropenem|mesh-list
2835644|NCT03960905|Ceftazidime|ceftazidime|mesh-list
2835645|NCT03960905|Cefepime|cefepime|mesh-list
2835646|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
2835647|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2293083|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2293084|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2293085|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835648|NCT03961087|Ubiquinone|ubiquinone|mesh-list
2835649|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
2835650|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
2835651|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
2835652|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835653|NCT03961087|Vitamins|vitamins|mesh-ancestor
2835654|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2835655|NCT03961087|Protective Agents|protective agents|mesh-ancestor
2835656|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
2835657|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
2835658|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2835659|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835660|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835661|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2835662|NCT03960775|Analgesics|analgesics|mesh-ancestor
2835663|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
2835664|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835665|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2835666|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2835667|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2835668|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
2835669|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835670|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835671|NCT03960866|Phentolamine|phentolamine|mesh-list
2835672|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2835673|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2835674|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2835675|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2835676|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
2835677|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835678|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835679|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835680|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2293086|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2293087|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2293088|NCT00268138|Fluorides|fluorides|mesh-list
2293089|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
2835681|NCT03960801|Remifentanil|remifentanil|mesh-list
2835682|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2835683|NCT03960801|Narcotics|narcotics|mesh-ancestor
2835684|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835685|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835686|NCT03960801|Analgesics|analgesics|mesh-ancestor
2835687|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
2835688|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835689|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
2835690|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2835691|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835692|NCT03960671|Midazolam|midazolam|mesh-list
2835693|NCT03960671|Diazepam|diazepam|mesh-list
2835694|NCT03960671|Propofol|propofol|mesh-list
2835695|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2835696|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835697|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835698|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2835699|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
2835700|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
2835701|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2835702|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2835703|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2835704|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2835705|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
2835706|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
2835707|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835708|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835709|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
2835710|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
2835711|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
2835712|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835713|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2835714|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2835715|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2835716|NCT03960554|Denosumab|denosumab|mesh-list
2835717|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2835718|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835719|NCT03960268|Brodalumab|brodalumab|mesh-list
2835720|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
2835721|NCT03960411|Doxycycline|doxycycline|mesh-list
2835722|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2835723|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835724|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
2835725|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2835726|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2835727|NCT03960151|Dexamethasone|dexamethasone|mesh-list
2835728|NCT03960151|Olanzapine|olanzapine|mesh-list
2835729|NCT03960151|Palonosetron|palonosetron|mesh-list
2835730|NCT03960151|Rolapitant|rolapitant|mesh-list
2835731|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2835732|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
2835733|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
2835734|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835735|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835736|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2835737|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
2293090|NCT00268138|Protective Agents|protective agents|mesh-ancestor
2293091|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293092|NCT00268151|Capecitabine|capecitabine|mesh-list
2293093|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
2293094|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2293095|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
2835738|NCT03960151|Hormones|hormones|mesh-ancestor
2835739|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2835740|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2835741|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835742|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2835743|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2835744|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835745|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2835746|NCT03960151|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2835747|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2835748|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2835749|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835750|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835751|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
2835752|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2835753|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2835754|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2835755|NCT03960008|Doxorubicin|doxorubicin|mesh-list
2107255|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2107256|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2107257|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
2107258|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107259|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
2107260|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107261|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835756|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2835757|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2835758|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835759|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2835760|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2835761|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835762|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835763|NCT03960125|Imipramine|imipramine|mesh-list
2835764|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2835765|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
2835766|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2835767|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2835768|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2835769|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2835770|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835771|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
2835772|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835773|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835774|NCT03959852|Fentanyl|fentanyl|mesh-list
2835775|NCT03959852|Ketamine|ketamine|mesh-list
2835776|NCT03959852|Analgesics|analgesics|mesh-ancestor
2835777|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
2835778|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835779|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835780|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2835781|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2835782|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
2835783|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
2835784|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835785|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2835786|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2835787|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835788|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835789|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2835790|NCT03959852|Narcotics|narcotics|mesh-ancestor
2835791|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2835792|NCT03959761|Nivolumab|nivolumab|mesh-list
2835793|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2835794|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835795|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2835796|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835797|NCT03959969|Ibuprofen|ibuprofen|mesh-list
2835798|NCT03959969|Oxycodone|oxycodone|mesh-list
2835799|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2835800|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2835801|NCT03959969|Analgesics|analgesics|mesh-ancestor
2835802|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
2835803|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835804|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835805|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2835806|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2835807|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2835808|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835809|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835810|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2835811|NCT03959969|Narcotics|narcotics|mesh-ancestor
2835812|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835813|NCT03959865|Glucagon|glucagon|mesh-list
2835814|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2835815|NCT03959865|Incretins|incretins|mesh-ancestor
2835816|NCT03959865|Hormones|hormones|mesh-ancestor
2835817|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2835818|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835819|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2835820|NCT03959527|Azithromycin|azithromycin|mesh-list
2835821|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
2835822|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2835823|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835824|NCT03959436|Carbetocin|carbetocin|mesh-list
2835825|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
2835826|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2835827|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835828|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2835829|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835830|NCT03959540|Levodopa|levodopa|mesh-list
2835831|NCT03959540|Opicapone|opicapone|mesh-list
2835832|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2293096|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293097|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293098|NCT00268177|Fluticasone|fluticasone|mesh-list
2293099|NCT00268177|Xhance|xhance|mesh-list
2293100|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2293101|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2293102|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2293103|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
2293104|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2293105|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293106|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2293107|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
2293108|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
2293109|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2293110|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2293111|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2293112|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2835833|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2835834|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
2835835|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835836|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835837|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835838|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2835839|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835840|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2835841|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
2835842|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2835843|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835844|NCT03959501|Incretins|incretins|mesh-ancestor
2835845|NCT03959501|Hormones|hormones|mesh-ancestor
2835846|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2835847|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2835848|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
2835849|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293113|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
2293114|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293115|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293116|NCT00268216|Fluticasone|fluticasone|mesh-list
2293117|NCT00268216|Xhance|xhance|mesh-list
2293118|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2835850|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835851|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2835852|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
2835853|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2835854|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835855|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
2835856|NCT03959566|Bedaquiline|bedaquiline|mesh-list
2835857|NCT03959566|Midazolam|midazolam|mesh-list
2835858|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2835859|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2835860|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835861|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835862|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2835863|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2107262|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107263|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2107264|NCT02486211|Analgesics|analgesics|mesh-ancestor
2107265|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
2107266|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107267|NCT02486302|Etanercept|etanercept|mesh-list
2107268|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2107269|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2107270|NCT02486302|Analgesics|analgesics|mesh-ancestor
2107271|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
2107272|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107273|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107274|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2107275|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2107276|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2107277|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2107278|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
2107279|NCT02486328|Midazolam|midazolam|mesh-list
2107280|NCT02486328|Meperidine|meperidine|mesh-list
2107281|NCT02486328|Remifentanil|remifentanil|mesh-list
2107282|NCT02486328|Propofol|propofol|mesh-list
2107283|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2107284|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107285|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107286|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2293119|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2293120|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2293121|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
2293122|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2293123|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293124|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2293125|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
2293126|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
2293127|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2293128|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2293129|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2293130|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2293131|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
2293132|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835864|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2835865|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2835866|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
2835867|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
2835868|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
2835869|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
2835870|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835871|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835872|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2835873|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2835874|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2835875|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2835876|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835877|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835878|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
2835879|NCT03959384|Poractant alfa|poractant alfa|mesh-list
2835880|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2835881|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
2835882|NCT03959293|Durvalumab|durvalumab|mesh-list
2835883|NCT03959293|Tremelimumab|tremelimumab|mesh-list
2835884|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2835885|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835886|NCT03959397|Paclitaxel|paclitaxel|mesh-list
2835887|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2835888|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2835889|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835890|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293133|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293134|NCT00268229|Cytarabine|cytarabine|mesh-list
2293135|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
2293136|NCT00268229|Daunorubicin|daunorubicin|mesh-list
2293137|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2293138|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
2293139|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835891|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
2835892|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
2835893|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835894|NCT03959592|Carotenoids|carotenoids|mesh-list
2835895|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
2835896|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835897|NCT03959592|Protective Agents|protective agents|mesh-ancestor
2835898|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835899|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2835900|NCT03959176|Phenylephrine|phenylephrine|mesh-list
2835901|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
2835902|NCT03959176|Tropicamide|tropicamide|mesh-list
2835903|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2835904|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
2835905|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
2835906|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835907|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835908|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
2835909|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2835910|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
2835911|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
2835912|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2835913|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2835914|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2835915|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
2835916|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835917|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835918|NCT03959176|Protective Agents|protective agents|mesh-ancestor
2835919|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2835920|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2835921|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2835922|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2293140|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293141|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
2293142|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2293143|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2293144|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
2293145|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293146|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2293147|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293148|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2293149|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2293150|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2293151|NCT00268255|Gefitinib|gefitinib|mesh-list
2293152|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2293153|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293154|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2293155|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293156|NCT00268333|Leucovorin|leucovorin|mesh-list
2293157|NCT00268333|Fluorouracil|fluorouracil|mesh-list
2293158|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
2293159|NCT00268333|Calcium|calcium|mesh-list
2293160|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
2293161|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2293162|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293163|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
2293164|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293165|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2293166|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835923|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
2835924|NCT03959150|Capecitabine|capecitabine|mesh-list
2835925|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2835926|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
2835927|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835928|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835929|NCT03958942|Bupivacaine|bupivacaine|mesh-list
2835930|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
2835931|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
2835932|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2835933|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835934|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
2835935|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835936|NCT03959124|Memantine|memantine|mesh-list
2835937|NCT03959124|Rivastigmine|rivastigmine|mesh-list
2835938|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2835939|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2835940|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
2835941|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2835942|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835943|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835944|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2835945|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2293167|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2835946|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2835947|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2835948|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
2835949|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2835950|NCT03959124|Protective Agents|protective agents|mesh-ancestor
2835951|NCT03959085|Calcium, Dietary|calcium, dietary|mesh-list
2835952|NCT03959085|Leucovorin|leucovorin|mesh-list
2835953|NCT03959085|Folic Acid|folic acid|mesh-list
2835954|NCT03959085|Cytarabine|cytarabine|mesh-list
2835955|NCT03959085|Dexamethasone|dexamethasone|mesh-list
2835956|NCT03959085|Dexamethasone acetate|dexamethasone acetate|mesh-list
2835957|NCT03959085|Prednisolone|prednisolone|mesh-list
2835958|NCT03959085|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2835959|NCT03959085|Methylprednisolone|methylprednisolone|mesh-list
2835960|NCT03959085|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2835961|NCT03959085|Prednisolone acetate|prednisolone acetate|mesh-list
2835962|NCT03959085|Hydrocortisone|hydrocortisone|mesh-list
2835963|NCT03959085|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2835964|NCT03959085|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2835965|NCT03959085|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2835966|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
2835967|NCT03959085|Doxorubicin|doxorubicin|mesh-list
2835968|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2835969|NCT03959085|Methotrexate|methotrexate|mesh-list
2835970|NCT03959085|Vincristine|vincristine|mesh-list
2835971|NCT03959085|Daunorubicin|daunorubicin|mesh-list
2835972|NCT03959085|Asparaginase|asparaginase|mesh-list
2835973|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
2835974|NCT03959085|Pegaspargase|pegaspargase|mesh-list
2835975|NCT03959085|Thioguanine|thioguanine|mesh-list
2835976|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2835977|NCT03959085|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2835978|NCT03959085|Prednisolone phosphate|prednisolone phosphate|mesh-list
2835979|NCT03959085|BB 1101|bb 1101|mesh-list
2835980|NCT03959085|Calcium|calcium|mesh-list
2835981|NCT03959085|2-Aminopurine|2-aminopurine|mesh-list
2835982|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
2835983|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2835984|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
2835985|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2835986|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2835987|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2835988|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
2835989|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2835990|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2835991|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2835992|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2835993|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
2835994|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
2835995|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2835996|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2835997|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
2835998|NCT03959085|Hormones|hormones|mesh-ancestor
2835999|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2836000|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2836001|NCT03959085|Protease Inhibitors|protease inhibitors|mesh-ancestor
2836002|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836003|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2836004|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2836005|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2836006|NCT03959085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2836007|NCT03959085|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2836008|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2836009|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
2836010|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2836011|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2836012|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
2836013|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
2836014|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2836015|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2836016|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
2836017|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836018|NCT03959085|Antidotes|antidotes|mesh-ancestor
2836019|NCT03959085|Protective Agents|protective agents|mesh-ancestor
2836020|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
2836021|NCT03959085|Vitamins|vitamins|mesh-ancestor
2836022|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
2836023|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2836024|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293168|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
2293169|NCT00268333|Antidotes|antidotes|mesh-ancestor
2293170|NCT00268333|Protective Agents|protective agents|mesh-ancestor
2293171|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
2836025|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
2836026|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
2836027|NCT03959085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2836028|NCT03959085|Hematinics|hematinics|mesh-ancestor
2836029|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2836030|NCT03958799|Vaccines|vaccines|mesh-list
2293172|NCT00268333|Vitamins|vitamins|mesh-ancestor
2293173|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
2293174|NCT00268359|Bevacizumab|bevacizumab|mesh-list
2293175|NCT00268359|Irinotecan|irinotecan|mesh-list
2293176|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2293177|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293178|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2293179|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2293180|NCT00268359|Growth Substances|growth substances|mesh-ancestor
2293181|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293182|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
2293183|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2293184|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2293185|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293186|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293187|NCT00268372|Docetaxel|docetaxel|mesh-list
2293188|NCT00268372|Fluorouracil|fluorouracil|mesh-list
2293189|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293190|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293191|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
2293192|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
2293193|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293194|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
2293195|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2293196|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2293197|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
2293198|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293199|NCT00268398|Leucovorin|leucovorin|mesh-list
2293200|NCT00268398|Folic Acid|folic acid|mesh-list
2293201|NCT00268398|Fluorouracil|fluorouracil|mesh-list
2293202|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
2293203|NCT00268398|Irinotecan|irinotecan|mesh-list
2293204|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
2293205|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
2293206|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293207|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2293208|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293209|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2293210|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
2293211|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293212|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2293213|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2293214|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293215|NCT00268398|Antidotes|antidotes|mesh-ancestor
2293216|NCT00268398|Protective Agents|protective agents|mesh-ancestor
2293217|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
2293218|NCT00268398|Vitamins|vitamins|mesh-ancestor
2293219|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
2293220|NCT00268398|Hematinics|hematinics|mesh-ancestor
2293221|NCT00268411|Gemcitabine|gemcitabine|mesh-list
2293222|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
2293223|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2293224|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
2836031|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
2836032|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836033|NCT03958877|Interferons|interferons|mesh-list
2836034|NCT03958877|Interferon-beta|interferon-beta|mesh-list
2836035|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836036|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
2836037|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836038|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
2836039|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836040|NCT03958721|Capecitabine|capecitabine|mesh-list
2836041|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2836042|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
2836043|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836044|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293225|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293226|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293227|NCT00268411|Antiviral Agents|antiviral agents|mesh-ancestor
2293228|NCT00268411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2293229|NCT00268411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293230|NCT00268411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2836045|NCT03958708|Rifaximin|rifaximin|mesh-list
2836046|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2836047|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836048|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2836049|NCT03958513|Bupivacaine|bupivacaine|mesh-list
2836050|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
2836051|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
2836052|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836053|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836054|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
2836055|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836056|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
2836057|NCT03958500|Methylene Blue|methylene blue|mesh-list
2836058|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836059|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836066|NCT03958344|Prednisolone|prednisolone|mesh-list
2836067|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2836068|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
2836069|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2836070|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
2836071|NCT03958344|Triamcinolone|triamcinolone|mesh-list
2836072|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2836073|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
2836074|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2836075|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
2836076|NCT03958344|Hormones|hormones|mesh-ancestor
2293231|NCT00268411|Immunologic Factors|immunologic factors|mesh-ancestor
2293232|NCT00268411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293233|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
2293234|NCT00268476|Metformin|metformin|mesh-list
2293235|NCT00268476|Prednisone|prednisone|mesh-list
2293236|NCT00268476|Prednisolone|prednisolone|mesh-list
2293237|NCT00268476|Celecoxib|celecoxib|mesh-list
2836077|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2836078|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836079|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2836080|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836081|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
2836082|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
2836083|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836084|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2836085|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2836086|NCT03958344|Protective Agents|protective agents|mesh-ancestor
2836087|NCT03958201|Rocuronium|rocuronium|mesh-list
2836088|NCT03958201|Neostigmine|neostigmine|mesh-list
2836089|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2836090|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2836091|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2836092|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836093|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293238|NCT00268476|Docetaxel|docetaxel|mesh-list
2293239|NCT00268476|Estradiol|estradiol|mesh-list
2293240|NCT00268476|Androgens|androgens|mesh-list
2836094|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2836095|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836096|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293241|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2293242|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293243|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293244|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293245|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
2293246|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
2293247|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293248|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2293249|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
2293250|NCT00268476|Hormones|hormones|mesh-ancestor
2293251|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2293252|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2293253|NCT00268476|Estrogens|estrogens|mesh-ancestor
2836097|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
2836098|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2836099|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2836100|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
2836101|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
2836102|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2836103|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2836104|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836105|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2836106|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2836107|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836108|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836109|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836110|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2836111|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
2836112|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2836113|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836114|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2836115|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2836116|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2836117|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2836118|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2836119|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836120|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
2836121|NCT03958396|Remifentanil|remifentanil|mesh-list
2836122|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2836123|NCT03958396|Narcotics|narcotics|mesh-ancestor
2836124|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836125|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836126|NCT03958396|Analgesics|analgesics|mesh-ancestor
2836127|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
2836128|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836129|NCT03958097|Antibodies|antibodies|mesh-list
2836130|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
2836131|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836132|NCT03957902|Aspirin|aspirin|mesh-list
2836133|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2836134|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2836135|NCT03957902|Analgesics|analgesics|mesh-ancestor
2836136|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
2836137|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836138|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836139|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2836140|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2836141|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2836142|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2836143|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836144|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2836145|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2836146|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836147|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
2836148|NCT03958045|Nivolumab|nivolumab|mesh-list
2836149|NCT03958045|Rucaparib|rucaparib|mesh-list
2836150|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2836151|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836152|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2836153|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836154|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2836155|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836156|NCT03957720|Penicillamine|penicillamine|mesh-list
2836157|NCT03957720|Succimer|succimer|mesh-list
2836158|NCT03957720|Antidotes|antidotes|mesh-ancestor
2836159|NCT03957720|Protective Agents|protective agents|mesh-ancestor
2836160|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836161|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
2836162|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
2836163|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836164|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2836165|NCT03957876|Cytarabine|cytarabine|mesh-list
2836166|NCT03957876|Daunorubicin|daunorubicin|mesh-list
2836167|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2836168|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
2293254|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836169|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836170|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836171|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
2836172|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836173|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2836174|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
2836175|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836176|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2836177|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2836178|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2836179|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293255|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2293256|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2293257|NCT00268476|Analgesics|analgesics|mesh-ancestor
2293258|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
2293259|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2293260|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2293261|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2293262|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293263|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2293264|NCT00268489|Bevacizumab|bevacizumab|mesh-list
2293265|NCT00268489|Pemetrexed|pemetrexed|mesh-list
2293266|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2293267|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293268|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2293269|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2293270|NCT00268489|Growth Substances|growth substances|mesh-ancestor
2293271|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293272|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
2293273|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293274|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293275|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2293276|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2293277|NCT00268515|Cyclosporine|cyclosporine|mesh-list
2293278|NCT00268515|Prednisone|prednisone|mesh-list
2836180|NCT03957681|Brodalumab|brodalumab|mesh-list
2836181|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
2836182|NCT03957668|Lactulose|lactulose|mesh-list
2836183|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2836184|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2836185|NCT03957668|Laxatives|laxatives|mesh-ancestor
2836186|NCT03957499|Dexamethasone|dexamethasone|mesh-list
2836187|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
2836188|NCT03957499|Bupivacaine|bupivacaine|mesh-list
2836189|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2836190|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
2836191|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
2836192|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836193|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836194|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2836195|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
2836196|NCT03957499|Hormones|hormones|mesh-ancestor
2836197|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2836198|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2836199|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836200|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
2836201|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
2836202|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836203|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
2836204|NCT03957499|Analgesics|analgesics|mesh-ancestor
2836205|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2836206|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
2836207|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2836208|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2836209|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836210|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2836211|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
2836212|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2836213|NCT03957629|Interferons|interferons|mesh-list
2836214|NCT03957629|Tenofovir|tenofovir|mesh-list
2836215|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
2836216|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
2836217|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2836218|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836219|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
2836220|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836221|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2836222|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2836223|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836224|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836225|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2836226|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2836227|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
2836228|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293279|NCT00268515|Azathioprine|azathioprine|mesh-list
2293280|NCT00268515|Tacrolimus|tacrolimus|mesh-list
2293281|NCT00268515|Cyclosporins|cyclosporins|mesh-list
2293282|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2293283|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
2293284|NCT00268515|Hormones|hormones|mesh-ancestor
2293285|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2293286|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293287|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2293288|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293289|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2293290|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
2293291|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2293292|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293293|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836229|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
2836230|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2836231|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836232|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
2293294|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
2293295|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2293296|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
2293297|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2293298|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
2293299|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2293300|NCT00268528|Methotrexate|methotrexate|mesh-list
2293301|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
2836233|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2836234|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
2836235|NCT03957291|Povidone|povidone|mesh-list
2836236|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2836237|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836238|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
2836239|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
2836240|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
2836241|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
2836242|NCT03957174|Rivastigmine|rivastigmine|mesh-list
2836243|NCT03957174|Reboxetine|reboxetine|mesh-list
2836244|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2836245|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836246|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836247|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
2836248|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2836249|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836250|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2836251|NCT03957174|Protective Agents|protective agents|mesh-ancestor
2836252|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
2836253|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2836254|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2836255|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2836256|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2836257|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
2836258|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
2836259|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2836260|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836261|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836262|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2836263|NCT03957304|Analgesics|analgesics|mesh-ancestor
2836264|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
2836265|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836266|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2836267|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2836268|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2836269|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
2836270|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2836271|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836272|NCT03957057|Iron|iron|mesh-list
2836273|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2836274|NCT03957057|Trace Elements|trace elements|mesh-ancestor
2836275|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
2836276|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836277|NCT03957057|Hematinics|hematinics|mesh-ancestor
2836278|NCT03956966|Dexamethasone|dexamethasone|mesh-list
2836279|NCT03956966|Bupivacaine|bupivacaine|mesh-list
2836280|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2836281|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
2836282|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
2836283|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836284|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836285|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2836286|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
2836287|NCT03956966|Hormones|hormones|mesh-ancestor
2836288|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2836289|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2836290|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836291|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
2836292|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
2836293|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836294|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
2836295|NCT03957109|Anesthetics|anesthetics|mesh-list
2836296|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836297|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836298|NCT03956953|BMS-986165|bms-986165|mesh-list
2836299|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
2836300|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2836301|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836302|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836303|NCT03956732|Vitamin D|vitamin d|mesh-list
2836304|NCT03956732|Caseins|caseins|mesh-list
2836305|NCT03956732|Vitamins|vitamins|mesh-ancestor
2836306|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
2836307|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836308|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2836309|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
2836310|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
2836311|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836312|NCT03956823|Amlodipine|amlodipine|mesh-list
2836313|NCT03956823|Telmisartan|telmisartan|mesh-list
2836314|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2836315|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2836316|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2836317|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836318|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2836319|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836320|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
2293302|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2293303|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
2293304|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2293305|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293306|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2293307|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
2293308|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293309|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293310|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
2293311|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836321|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2836322|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2836323|NCT03957083|Oxytocin|oxytocin|mesh-list
2836324|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
2836325|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2836326|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836327|NCT03956797|Anesthetics|anesthetics|mesh-list
2836328|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836329|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836330|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
2836331|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2836332|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
2836333|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107287|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
2107288|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
2107289|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2107290|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2107291|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2107292|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2107293|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
2107294|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
2107295|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2836334|NCT03956888|Expectorants|expectorants|mesh-ancestor
2836335|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
2836336|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2836337|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
2836338|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836339|NCT03956888|Protective Agents|protective agents|mesh-ancestor
2836340|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836341|NCT03956888|Antidotes|antidotes|mesh-ancestor
2836342|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
2836343|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
2836344|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
2836345|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836346|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836347|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
2836348|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836349|NCT03956680|Nivolumab|nivolumab|mesh-list
2836350|NCT03956680|Ipilimumab|ipilimumab|mesh-list
2836351|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2107296|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107297|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2107298|NCT02486328|Narcotics|narcotics|mesh-ancestor
2836352|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836353|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2836354|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836355|NCT03956212|Doxycycline|doxycycline|mesh-list
2836356|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2836357|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836358|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
2836359|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2836360|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2836361|NCT03956446|Doxycycline|doxycycline|mesh-list
2836362|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2836363|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836364|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
2836365|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2836366|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2836367|NCT03956056|Poly I-C|poly i-c|mesh-list
2836368|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2836369|NCT03956056|Poly ICLC|poly iclc|mesh-list
2836370|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
2836371|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
2836372|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836373|NCT03956056|Laxatives|laxatives|mesh-ancestor
2836374|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2836375|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
2836376|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836377|NCT03956017|Ubiquinone|ubiquinone|mesh-list
2836378|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
2836379|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
2836380|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836381|NCT03956017|Vitamins|vitamins|mesh-ancestor
2836382|NCT03955939|Midazolam|midazolam|mesh-list
2836383|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2836384|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2836385|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836386|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836387|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2836388|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2836389|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2836390|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2836391|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
2836392|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
2836393|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
2836394|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
2836395|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2836396|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836397|NCT03955809|Ketamine|ketamine|mesh-list
2836398|NCT03955809|Analgesics|analgesics|mesh-ancestor
2836399|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
2836400|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836401|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836402|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2836403|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2836404|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
2293312|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2293313|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2293314|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
2293315|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2293316|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2293317|NCT00268554|Dipyridamole|dipyridamole|mesh-list
2293318|NCT00268554|Caffeine|caffeine|mesh-list
2293319|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2293320|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293321|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2293322|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293323|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293324|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2293325|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2293326|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
2293327|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293328|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2293329|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
2293330|NCT00268567|Prednisone|prednisone|mesh-list
2293331|NCT00268567|Leflunomide|leflunomide|mesh-list
2293332|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2293333|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
2293334|NCT00268567|Hormones|hormones|mesh-ancestor
2293335|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2836405|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
2836406|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836407|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2836408|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2836409|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2836410|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293336|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293337|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2293338|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293339|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293340|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293341|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2293342|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
2293343|NCT00268593|Prednisone|prednisone|mesh-list
2836411|NCT03956134|Tapentadol|tapentadol|mesh-list
2836412|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2836413|NCT03956134|Narcotics|narcotics|mesh-ancestor
2836414|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836415|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836416|NCT03956134|Analgesics|analgesics|mesh-ancestor
2836417|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
2836418|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836419|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2836420|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2836421|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2836422|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836423|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
2836424|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293344|NCT00268593|Docetaxel|docetaxel|mesh-list
2293345|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293346|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293347|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
2293348|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
2293349|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293350|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2293351|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
2293352|NCT00268593|Hormones|hormones|mesh-ancestor
2293353|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2293354|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836425|NCT03955861|Adalimumab|adalimumab|mesh-list
2836426|NCT03955861|Etanercept|etanercept|mesh-list
2836427|NCT03955861|Golimumab|golimumab|mesh-list
2293355|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2293356|NCT00268619|Ramipril|ramipril|mesh-list
2293357|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2293358|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
2293359|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293360|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293361|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2293362|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
2836428|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
2836429|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2836430|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2836431|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2836432|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2836433|NCT03955861|Analgesics|analgesics|mesh-ancestor
2836434|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
2836435|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836436|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293363|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2293364|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2293365|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293366|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2293367|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836437|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2836438|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2836439|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
2836440|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2836441|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2836442|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836443|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
2836444|NCT03956121|Analgesics|analgesics|mesh-ancestor
2836445|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
2836446|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836447|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836448|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
2836449|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836450|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2293368|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2293369|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
2293370|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2293371|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293372|NCT00268671|Docetaxel|docetaxel|mesh-list
2293373|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293374|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293375|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
2293376|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
2293377|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293378|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2293379|NCT00268684|Temozolomide|temozolomide|mesh-list
2293380|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836451|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
2836452|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2836453|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2836454|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836455|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2836456|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
2836457|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2836458|NCT03955783|Venetoclax|venetoclax|mesh-list
2836459|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836460|NCT03955575|Liraglutide|liraglutide|mesh-list
2293381|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2293382|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293383|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293384|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2293385|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
2293386|NCT00268697|Ezetimibe|ezetimibe|mesh-list
2293387|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2293388|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2293389|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
2293390|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836461|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2836462|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2836463|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836464|NCT03955575|Incretins|incretins|mesh-ancestor
2836465|NCT03955575|Hormones|hormones|mesh-ancestor
2293391|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2293392|NCT00268710|Docetaxel|docetaxel|mesh-list
2293393|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293394|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293395|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
2293396|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
2293397|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293398|NCT00268723|Albuterol|albuterol|mesh-list
2293399|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2293400|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
2836466|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2836467|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2836468|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2836469|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
2836470|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836471|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2836472|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
2836473|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2836474|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
2836475|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836476|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2836477|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2836478|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
2836479|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836480|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836481|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2836482|NCT03955705|Nefopam|nefopam|mesh-list
2836483|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2836484|NCT03955705|Analgesics|analgesics|mesh-ancestor
2836485|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
2836486|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836487|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836488|NCT03955406|Anesthetics|anesthetics|mesh-list
2836489|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836490|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836491|NCT03955354|Apatinib|apatinib|mesh-list
2836492|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293401|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2293402|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293403|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2293404|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
2293405|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
2293406|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2293407|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2293408|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2293409|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2293410|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
2293411|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293412|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293413|NCT00268749|Glycine|glycine|mesh-list
2836493|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2836494|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836495|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836496|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
2293414|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
2293415|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293416|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293417|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293418|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
2293419|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2293420|NCT00268788|Antibodies|antibodies|mesh-list
2293421|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
2293422|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2293423|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
2293424|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293425|NCT00268814|Methadone|methadone|mesh-list
2293426|NCT00268814|Heroin|heroin|mesh-list
2293427|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2293428|NCT00268814|Narcotics|narcotics|mesh-ancestor
2293429|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2293430|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293431|NCT00268814|Analgesics|analgesics|mesh-ancestor
2836497|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2836498|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836499|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
2836500|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
2836501|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2836502|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836503|NCT03955458|Bupivacaine|bupivacaine|mesh-list
2836504|NCT03955458|Ropivacaine|ropivacaine|mesh-list
2836505|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
2836506|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
2836507|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107299|NCT02486328|Analgesics|analgesics|mesh-ancestor
2107300|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
2107301|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107302|NCT02486406|Ritonavir|ritonavir|mesh-list
2107303|NCT02486406|Ribavirin|ribavirin|mesh-list
2107304|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2107305|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2107306|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
2107307|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107308|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107309|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2107310|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2107311|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
2107312|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107313|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2107314|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2293432|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
2293433|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2293434|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
2293435|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
2293436|NCT00268827|Lopinavir|lopinavir|mesh-list
2293437|NCT00268827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2293438|NCT00268827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2293439|NCT00268827|Protease Inhibitors|protease inhibitors|mesh-ancestor
2293440|NCT00268827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293441|NCT00268827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293442|NCT00268827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2293443|NCT00268827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2293444|NCT00268827|Antiviral Agents|antiviral agents|mesh-ancestor
2836508|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836509|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
2836510|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836511|NCT03955172|Everolimus|everolimus|mesh-list
2836512|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836513|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2836514|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
2836515|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836516|NCT03955211|Acetaminophen|acetaminophen|mesh-list
2836517|NCT03955211|Ibuprofen|ibuprofen|mesh-list
2836518|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2836519|NCT03955211|Analgesics|analgesics|mesh-ancestor
2836520|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
2836521|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836522|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836523|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
2836524|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2836525|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2836526|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2836527|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2836528|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836529|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836530|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
2836531|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2836532|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
2836533|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836534|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
2836535|NCT03955497|Protective Agents|protective agents|mesh-ancestor
2836536|NCT03954990|Metronidazole|metronidazole|mesh-list
2836537|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836538|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2836539|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2293445|NCT00268827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836540|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2107315|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
2293446|NCT00268827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2836541|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
2836542|NCT03954964|Narcotics|narcotics|mesh-ancestor
2836543|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836544|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836545|NCT03954964|Analgesics|analgesics|mesh-ancestor
2836546|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
2836547|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836548|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
2836549|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2836550|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2836551|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836552|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
2836553|NCT03954860|Coagulants|coagulants|mesh-ancestor
2836554|NCT03954873|Glucagon|glucagon|mesh-list
2836555|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2836556|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836557|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2836558|NCT03954873|Hormones|hormones|mesh-ancestor
2836559|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2836560|NCT03954873|Incretins|incretins|mesh-ancestor
2836561|NCT03955042|Pemetrexed|pemetrexed|mesh-list
2836562|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836563|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836564|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836565|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2836566|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2836567|NCT03954899|Melatonin|melatonin|mesh-list
2836568|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
2836569|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836570|NCT03954899|Protective Agents|protective agents|mesh-ancestor
2836571|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836572|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836573|NCT03954639|Bupivacaine|bupivacaine|mesh-list
2293447|NCT00268827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2293448|NCT00268840|Gemcitabine|gemcitabine|mesh-list
2293449|NCT00268840|Docetaxel|docetaxel|mesh-list
2836574|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
2836575|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
2836576|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836577|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836578|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
2836579|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836580|NCT03954366|Rucaparib|rucaparib|mesh-list
2836581|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2836582|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
2293450|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2293451|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
2293452|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293453|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293454|NCT00268840|Antiviral Agents|antiviral agents|mesh-ancestor
2293455|NCT00268840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2293456|NCT00268840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293457|NCT00268840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2293458|NCT00268840|Immunologic Factors|immunologic factors|mesh-ancestor
2293459|NCT00268840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293460|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293461|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
2293462|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
2293463|NCT00268879|Renzapride|renzapride|mesh-list
2293464|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2293465|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
2293466|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293467|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293468|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293469|NCT00268918|Docetaxel|docetaxel|mesh-list
2293470|NCT00268918|Vatalanib|vatalanib|mesh-list
2293471|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836583|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
2836584|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2836585|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2836586|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
2836587|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836588|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2836589|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2293472|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293473|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
2107316|NCT02486627|Levofloxacin|levofloxacin|mesh-list
2107317|NCT02486627|Ofloxacin|ofloxacin|mesh-list
2107318|NCT02486627|Meropenem|meropenem|mesh-list
2107319|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2107320|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107321|NCT02486627|Renal Agents|renal agents|mesh-ancestor
2107322|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2107323|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2836590|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836591|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2836592|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836593|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2836594|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2836595|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836596|NCT03954379|Analgesics|analgesics|mesh-list
2836597|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
2836598|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836599|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836600|NCT03954756|Apatinib|apatinib|mesh-list
2836601|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836602|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2836603|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836604|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836605|NCT03954483|Triazolam|triazolam|mesh-list
2836606|NCT03954483|Buspirone|buspirone|mesh-list
2836607|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2836608|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2836609|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836610|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836611|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2836612|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2836613|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
2836614|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2836615|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836616|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2836617|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
2836618|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
2293474|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
2293475|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293476|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2293477|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293478|NCT00268957|Sevelamer|sevelamer|mesh-list
2293479|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
2107324|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2836619|NCT03954327|Tenofovir|tenofovir|mesh-list
2836620|NCT03954327|Emtricitabine|emtricitabine|mesh-list
2836621|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
2836622|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
2836623|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836624|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2836625|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2836626|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836627|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836628|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2836629|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2836630|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2836631|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2836632|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
2836633|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2293480|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
2293481|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293482|NCT00268970|Paclitaxel|paclitaxel|mesh-list
2293483|NCT00268970|Satraplatin|satraplatin|mesh-list
2293484|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2293485|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293486|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293487|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
2293488|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
2836634|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2836635|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836636|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
2836637|NCT03954314|Coagulants|coagulants|mesh-ancestor
2836638|NCT03954197|Hormones|hormones|mesh-list
2836639|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2293489|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293490|NCT00269035|Risperidone|risperidone|mesh-list
2293491|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2293492|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
2293493|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293494|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293495|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293496|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2293497|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2293498|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2293499|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2293500|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2293501|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
2293502|NCT00269061|Pioglitazone|pioglitazone|mesh-list
2293503|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2293504|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293505|NCT00269126|Fluticasone|fluticasone|mesh-list
2293506|NCT00269126|Xhance|xhance|mesh-list
2293507|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2293508|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2293509|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2293510|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2293511|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
2293512|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2293513|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293514|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2293515|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
2293516|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
2293517|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2293518|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2293519|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2293520|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2293521|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
2293522|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293523|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293524|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
2293525|NCT00269126|Hormones|hormones|mesh-ancestor
2293526|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2293527|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
2293528|NCT00269191|Ibuprofen|ibuprofen|mesh-list
2293529|NCT00269191|Etoricoxib|etoricoxib|mesh-list
2293530|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2293531|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2293532|NCT00269191|Analgesics|analgesics|mesh-ancestor
2293533|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
2836640|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836641|NCT03953989|Ranolazine|ranolazine|mesh-list
2836642|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2836643|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2836644|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836645|NCT03953950|Losartan|losartan|mesh-list
2836646|NCT03953950|Spironolactone|spironolactone|mesh-list
2836647|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2836648|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2836649|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2836650|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2293534|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2293535|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293536|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2836651|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836652|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2836653|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
2836654|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2836655|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836656|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2836657|NCT03953950|Diuretics|diuretics|mesh-ancestor
2836658|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
2836659|NCT03953833|Antibodies|antibodies|mesh-list
2836660|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2836661|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
2836662|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836663|NCT03954262|Propofol|propofol|mesh-list
2293537|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2293538|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2293539|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293540|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836664|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2836665|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836666|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836667|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2836668|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
2836669|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
2836670|NCT03953807|Dexamethasone|dexamethasone|mesh-list
2836671|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2836672|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
2836673|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
2836674|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836675|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836676|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2836677|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
2836678|NCT03953807|Hormones|hormones|mesh-ancestor
2836679|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2836680|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2836681|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836682|NCT03953781|Levetiracetam|levetiracetam|mesh-list
2836683|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
2836684|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
2836685|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
2836686|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2836687|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2836688|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836689|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836690|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2836691|NCT03953677|Analgesics|analgesics|mesh-ancestor
2836692|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
2836693|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836694|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2836695|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2836696|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2836697|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
2836698|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2836699|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836700|NCT03953729|Ibuprofen|ibuprofen|mesh-list
2836701|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2836702|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2293541|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2293542|NCT00269204|Niacin|niacin|mesh-list
2293543|NCT00269204|Niacinamide|niacinamide|mesh-list
2836703|NCT03953729|Analgesics|analgesics|mesh-ancestor
2293544|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
2293545|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2293546|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
2293547|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293548|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2293549|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
2293550|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
2293551|NCT00269204|Vitamins|vitamins|mesh-ancestor
2293552|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
2293553|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293554|NCT00269217|Niacin|niacin|mesh-list
2293555|NCT00269217|Niacinamide|niacinamide|mesh-list
2293556|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
2293557|NCT00269217|Simvastatin|simvastatin|mesh-list
2293558|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2293559|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2293560|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
2293561|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293562|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2293563|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2836704|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
2836705|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836706|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836707|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2836708|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2836709|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2836710|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836711|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836712|NCT03953716|Desogestrel|desogestrel|mesh-list
2836713|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2836714|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2107325|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107326|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107327|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107328|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2107329|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2107330|NCT02486653|Tamsulosin|tamsulosin|mesh-list
2107331|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2107332|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2107333|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2107334|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
2107335|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2836715|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2836716|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
2836717|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2836718|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836719|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2836720|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2836721|NCT03953716|Progestins|progestins|mesh-ancestor
2836722|NCT03953716|Hormones|hormones|mesh-ancestor
2836723|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2836724|NCT03953261|Curcumin|curcumin|mesh-list
2836725|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2836726|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2836727|NCT03953261|Analgesics|analgesics|mesh-ancestor
2836728|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
2836729|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836730|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836731|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2836732|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2836733|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836734|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836735|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836736|NCT03953300|Benralizumab|benralizumab|mesh-list
2836737|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2836738|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
2836739|NCT03953326|Nitroprusside|nitroprusside|mesh-list
2836740|NCT03953326|Acetylcholine|acetylcholine|mesh-list
2836741|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2836742|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
2293564|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293565|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
2293566|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
2293567|NCT00269217|Vitamins|vitamins|mesh-ancestor
2293568|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
2836743|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2836744|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836745|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2836746|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
2836747|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2836748|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836749|NCT03953235|Nivolumab|nivolumab|mesh-list
2836750|NCT03953235|Ipilimumab|ipilimumab|mesh-list
2836751|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2836752|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836753|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2836754|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836755|NCT03953170|Teduglutide|teduglutide|mesh-list
2836756|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2836757|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2836758|NCT03953170|Protective Agents|protective agents|mesh-ancestor
2293569|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293570|NCT00269243|Quinapril|quinapril|mesh-list
2293571|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2836759|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836760|NCT03953001|Lidocaine|lidocaine|mesh-list
2836761|NCT03953001|Epinephrine|epinephrine|mesh-list
2836762|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
2836763|NCT03953001|Anesthetics|anesthetics|mesh-list
2836764|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836765|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836766|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
2836767|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836768|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2836769|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2836770|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2836771|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2836772|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836773|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2836774|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2836775|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
2836776|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2836777|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2836778|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2836779|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
2836780|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2836781|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
2836782|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
2836783|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
2293572|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
2293573|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293574|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293575|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2293576|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
2293577|NCT00269334|Paroxetine|paroxetine|mesh-list
2293578|NCT00269334|Citalopram|citalopram|mesh-list
2293579|NCT00269334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2293580|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2836784|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2836785|NCT03953287|Acetaminophen|acetaminophen|mesh-list
2836786|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2836787|NCT03953287|Analgesics|analgesics|mesh-ancestor
2836788|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
2836789|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836790|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293581|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2293582|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293583|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293584|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
2836791|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
2836792|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
2836793|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
2836794|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
2836795|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836796|NCT03953209|Spironolactone|spironolactone|mesh-list
2836797|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2836798|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
2836799|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2293585|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293586|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2293587|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
2293588|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2293589|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2293590|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2293591|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293592|NCT00269386|Clarithromycin|clarithromycin|mesh-list
2293593|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2293594|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2293595|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2293596|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836800|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836801|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2836802|NCT03953209|Diuretics|diuretics|mesh-ancestor
2836803|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
2107336|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107337|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107338|NCT02486653|Urological Agents|urological agents|mesh-ancestor
2107339|NCT02486757|Estradiol|estradiol|mesh-list
2107340|NCT02486757|Progesterone|progesterone|mesh-list
2836804|NCT03953066|Melatonin|melatonin|mesh-list
2836805|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
2836806|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836807|NCT03953066|Protective Agents|protective agents|mesh-ancestor
2836808|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836809|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836810|NCT03952715|Ibuprofen|ibuprofen|mesh-list
2836811|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2836812|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2836813|NCT03952715|Analgesics|analgesics|mesh-ancestor
2836814|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
2836815|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836816|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836817|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2836818|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2836819|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2836820|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836821|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836822|NCT03953118|Azithromycin|azithromycin|mesh-list
2836823|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2836824|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836825|NCT03952832|Leflunomide|leflunomide|mesh-list
2836826|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836827|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836828|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2836829|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
2836830|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293597|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293598|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2293599|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2293600|NCT00269412|Rifaximin|rifaximin|mesh-list
2293601|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2293602|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2293603|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2293604|NCT00269542|Iron|iron|mesh-list
2293605|NCT00269542|Folic Acid|folic acid|mesh-list
2293606|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
2293607|NCT00269542|Trace Elements|trace elements|mesh-ancestor
2293608|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
2293609|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293610|NCT00269542|Hematinics|hematinics|mesh-ancestor
2293611|NCT00269542|Vitamins|vitamins|mesh-ancestor
2293612|NCT00269555|Genistein|genistein|mesh-list
2293613|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2293614|NCT00269555|Protective Agents|protective agents|mesh-ancestor
2293615|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293616|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107341|NCT02486757|Estrogens|estrogens|mesh-ancestor
2107342|NCT02486757|Hormones|hormones|mesh-ancestor
2107343|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2293617|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2293618|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293619|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293620|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
2293621|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2293622|NCT00269555|Estrogens|estrogens|mesh-ancestor
2293623|NCT00269555|Hormones|hormones|mesh-ancestor
2293624|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2293625|NCT00269568|Misoprostol|misoprostol|mesh-list
2836842|NCT03952650|Chloroquine|chloroquine|mesh-list
2836843|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2836844|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
2836845|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2836846|NCT03952650|Ibuprofen|ibuprofen|mesh-list
2836847|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2836848|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2836849|NCT03952650|Analgesics|analgesics|mesh-ancestor
2836850|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
2293626|NCT00269568|Mifepristone|mifepristone|mesh-list
2293627|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2293628|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
2293629|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2293630|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293631|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2293632|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2293633|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
2293634|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2293635|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2293636|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2293637|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2836851|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836852|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836853|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2836854|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2836855|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2836856|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836857|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836858|NCT03952650|Amebicides|amebicides|mesh-ancestor
2836859|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2836860|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2836861|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836862|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
2836863|NCT03952650|Filaricides|filaricides|mesh-ancestor
2836864|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
2836865|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
2836866|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2836867|NCT03952572|Prednisone|prednisone|mesh-list
2836868|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
2836869|NCT03952572|Doxorubicin|doxorubicin|mesh-list
2836870|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2836871|NCT03952572|Vincristine|vincristine|mesh-list
2836872|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2836873|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
2836874|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836875|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2836876|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2836877|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
2836878|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836879|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836880|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2836881|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2836882|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2836883|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2836884|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836885|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2836886|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
2836887|NCT03952572|Hormones|hormones|mesh-ancestor
2836888|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2836889|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2836890|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2836891|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
2836892|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
2836893|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
2836894|NCT03952637|Sirolimus|sirolimus|mesh-list
2836895|NCT03952637|Prednisone|prednisone|mesh-list
2836896|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
2836897|NCT03952637|Rituximab|rituximab|mesh-list
2836898|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2836899|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836900|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
2836901|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836902|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2836903|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2293638|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
2836904|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
2836905|NCT03952637|Hormones|hormones|mesh-ancestor
2836906|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2836907|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2836908|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2836909|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2293639|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2293640|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2293641|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
2293642|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2293643|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
2293644|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2293645|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2293646|NCT00269594|Lamotrigine|lamotrigine|mesh-list
2293647|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
2293648|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2293649|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2293650|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293651|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2293652|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836910|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2836911|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
2836912|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2836913|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
2836914|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
2836915|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836916|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2836917|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2836918|NCT03952637|Protective Agents|protective agents|mesh-ancestor
2836919|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2836920|NCT03952481|Lifitegrast|lifitegrast|mesh-list
2836921|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2836922|NCT03952403|Bevacizumab|bevacizumab|mesh-list
2836923|NCT03952403|Carboplatin|carboplatin|mesh-list
2836924|NCT03952403|Pemetrexed|pemetrexed|mesh-list
2836925|NCT03952403|Antibodies|antibodies|mesh-list
2836926|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2836927|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836928|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2836929|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2836930|NCT03952403|Growth Substances|growth substances|mesh-ancestor
2293653|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2293654|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2293655|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2293656|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2293657|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2293658|NCT00269607|Naltrexone|naltrexone|mesh-list
2836931|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836932|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
2836933|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
2836934|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2836935|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836936|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2836937|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2836938|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
2836939|NCT03952299|Oxybutynin|oxybutynin|mesh-list
2293659|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2293660|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2293661|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293662|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
2293663|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836940|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
2836941|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
2836942|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2836943|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836944|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2836945|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2836946|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
2836947|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2836948|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836949|NCT03952299|Urological Agents|urological agents|mesh-ancestor
2836950|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2293664|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2293665|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2836951|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836952|NCT03952299|Renal Agents|renal agents|mesh-ancestor
2293666|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2293667|NCT00269620|Etonogestrel|etonogestrel|mesh-list
2293668|NCT00269620|NuvaRing|nuvaring|mesh-list
2293669|NCT00269620|Norelgestromin|norelgestromin|mesh-list
2293670|NCT00269620|Ortho Evra|ortho evra|mesh-list
2293671|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
2293672|NCT00269620|Estradiol|estradiol|mesh-list
2293673|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2293674|NCT00269620|Estrogens|estrogens|mesh-ancestor
2293675|NCT00269620|Hormones|hormones|mesh-ancestor
2293676|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2293677|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293678|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2293679|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2293680|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2293681|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2293682|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2293683|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2293684|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
2836953|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
2836954|NCT03952325|Nivolumab|nivolumab|mesh-list
2836955|NCT03952325|Atezolizumab|atezolizumab|mesh-list
2836956|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2836957|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836958|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2836959|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2836960|NCT03952273|Sirolimus|sirolimus|mesh-list
2836961|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2836962|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2836963|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2836964|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2836965|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
2293685|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293686|NCT00269685|Vasopressins|vasopressins|mesh-list
2293687|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
2293688|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
2293689|NCT00269685|Coagulants|coagulants|mesh-ancestor
2293690|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2293691|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2293692|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
2293693|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293694|NCT00269724|Oxybutynin|oxybutynin|mesh-list
2293695|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
2293696|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
2293697|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2293698|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293699|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2293700|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2293701|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
2836966|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2836967|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
2836968|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836974|NCT03952143|Insulin|insulin|mesh-list
2836975|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2836976|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
2836977|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
2836978|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2836979|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836980|NCT03952260|Anesthetics|anesthetics|mesh-list
2836981|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2836982|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836983|NCT03951987|Charcoal|charcoal|mesh-list
2836984|NCT03951987|Antidotes|antidotes|mesh-ancestor
2836985|NCT03951987|Protective Agents|protective agents|mesh-ancestor
2836986|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2836987|NCT03952130|Insulin|insulin|mesh-list
2836988|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2836989|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
2836990|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
2836991|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2836992|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293702|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293703|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293704|NCT00269724|Urological Agents|urological agents|mesh-ancestor
2293705|NCT00269737|Fentanyl|fentanyl|mesh-list
2293706|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2836996|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2836997|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2836998|NCT03951558|Diuretics|diuretics|mesh-ancestor
2836999|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
2837000|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293707|NCT00269737|Narcotics|narcotics|mesh-ancestor
2293708|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2293709|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293710|NCT00269737|Analgesics|analgesics|mesh-ancestor
2293711|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
2293712|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2293713|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2293714|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2293715|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
2293716|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
2837001|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2837002|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2837003|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837004|NCT03951649|Acetaminophen|acetaminophen|mesh-list
2837005|NCT03951649|Caffeine|caffeine|mesh-list
2837006|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2837007|NCT03951649|Analgesics|analgesics|mesh-ancestor
2837008|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
2837009|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837010|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837011|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
2837012|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2837013|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2837014|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837015|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837016|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2837017|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2837018|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
2837019|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837020|NCT03951831|Docetaxel|docetaxel|mesh-list
2837021|NCT03951831|Leuprolide|leuprolide|mesh-list
2837022|NCT03951831|Cemiplimab|cemiplimab|mesh-list
2837023|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837024|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
2837025|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
2837026|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
2837027|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837028|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2837029|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
2837030|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2837031|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293717|NCT00269750|Oxybutynin|oxybutynin|mesh-list
2293718|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
2293719|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
2293720|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837032|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2837033|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2837034|NCT03951636|Chlorhexidine|chlorhexidine|mesh-list
2837035|NCT03951636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2837036|NCT03951636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837037|NCT03951636|Disinfectants|disinfectants|mesh-ancestor
2837038|NCT03951753|Tirzepatide|tirzepatide|mesh-list
2837039|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2837040|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837041|NCT03951753|Incretins|incretins|mesh-ancestor
2837042|NCT03951753|Hormones|hormones|mesh-ancestor
2837043|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2837044|NCT03951597|Gemcitabine|gemcitabine|mesh-list
2837045|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
2837046|NCT03951597|Lenvatinib|lenvatinib|mesh-list
2837047|NCT03951597|Antibodies|antibodies|mesh-list
2837048|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
2837049|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837050|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2293721|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837051|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
2293722|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2293723|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2293724|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
2293725|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293726|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293727|NCT00269750|Urological Agents|urological agents|mesh-ancestor
2293728|NCT00269763|Fentanyl|fentanyl|mesh-list
2293729|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2293730|NCT00269763|Narcotics|narcotics|mesh-ancestor
2293731|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2293732|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293733|NCT00269763|Analgesics|analgesics|mesh-ancestor
2293734|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
2293735|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837052|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837053|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837054|NCT03951597|Antiviral Agents|antiviral agents|mesh-ancestor
2837055|NCT03951597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837056|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837057|NCT03951597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2837058|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2837059|NCT03951415|Durvalumab|durvalumab|mesh-list
2837060|NCT03951415|Olaparib|olaparib|mesh-list
2837061|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2837062|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2837063|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837064|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837065|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837066|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
2837067|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2837068|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837069|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
2837070|NCT03951402|Tapentadol|tapentadol|mesh-list
2837071|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2837072|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2837073|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837074|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2837075|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2837076|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837077|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837078|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837079|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2837080|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
2837081|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2837082|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837083|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2837084|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2837085|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2837086|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2837087|NCT03951402|Narcotics|narcotics|mesh-ancestor
2837088|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2837089|NCT03951402|Analgesics|analgesics|mesh-ancestor
2837090|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
2837091|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837092|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2837093|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2837094|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2837095|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
2837096|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293736|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2293737|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2293738|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
2293739|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
2293740|NCT00269776|Methylphenidate|methylphenidate|mesh-list
2293741|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2837097|NCT03951285|Niacinamide|niacinamide|mesh-list
2837098|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
2837099|NCT03951285|Vitamins|vitamins|mesh-ancestor
2837100|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
2837101|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293742|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293743|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2293744|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2293745|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2107344|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107345|NCT02486757|Progestins|progestins|mesh-ancestor
2107346|NCT02486796|Ubiquinone|ubiquinone|mesh-list
2107347|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
2107348|NCT02486796|Melatonin|melatonin|mesh-list
2107349|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
2107350|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107351|NCT02486796|Protective Agents|protective agents|mesh-ancestor
2837102|NCT03951025|Melatonin|melatonin|mesh-list
2837103|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
2837104|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837105|NCT03951025|Protective Agents|protective agents|mesh-ancestor
2837106|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837107|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2293746|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293747|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
2293748|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293749|NCT00269789|Methylphenidate|methylphenidate|mesh-list
2293750|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2293751|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293752|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2293753|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2293754|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2293755|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293756|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
2293757|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293758|NCT00269802|Methylphenidate|methylphenidate|mesh-list
2293759|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2293760|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107352|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293761|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2293762|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2293763|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2293764|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293765|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
2293766|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293767|NCT00269815|Methylphenidate|methylphenidate|mesh-list
2293768|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2293769|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293770|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2293771|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2293772|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2837108|NCT03951207|Amlodipine|amlodipine|mesh-list
2837109|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
2837110|NCT03951207|Atorvastatin|atorvastatin|mesh-list
2837111|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2837112|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2837113|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
2837114|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837115|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2837116|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2293773|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293774|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
2293775|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2293776|NCT00269828|Paclitaxel|paclitaxel|mesh-list
2293777|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2293778|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2293779|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2293780|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293781|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293782|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
2293783|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
2293784|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293785|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2293786|NCT00269841|Infliximab|infliximab|mesh-list
2293787|NCT00269841|Antibodies|antibodies|mesh-list
2293788|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
2293789|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2293790|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
2293791|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293792|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293793|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
2293794|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2293795|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2293796|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2293797|NCT00269854|Infliximab|infliximab|mesh-list
2293798|NCT00269854|Antibodies|antibodies|mesh-list
2293799|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
2293800|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2293801|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
2293802|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293803|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293804|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
2293805|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2293806|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2293807|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2293808|NCT00269867|Infliximab|infliximab|mesh-list
2837117|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837118|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2837119|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2837120|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2837121|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2837122|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837123|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
2837124|NCT03950830|Disulfiram|disulfiram|mesh-list
2837125|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2837126|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2837127|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837128|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837129|NCT03950960|Itraconazole|itraconazole|mesh-list
2837130|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
2837131|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837132|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2293809|NCT00269867|Antibodies|antibodies|mesh-list
2293810|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
2293811|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2293812|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
2293813|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837133|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2837134|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837135|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837136|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2837137|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
2837138|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2837139|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837140|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2837141|NCT03951051|Olmesartan|olmesartan|mesh-list
2837142|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2837143|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2837144|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2837145|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2837146|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837147|NCT03951142|Losartan|losartan|mesh-list
2837148|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2837149|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2837150|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2837151|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2837152|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837153|NCT03950700|Epinephrine|epinephrine|mesh-list
2837154|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2837155|NCT03950700|Bupivacaine|bupivacaine|mesh-list
2837156|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2837157|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
2837158|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
2837159|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2837160|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837161|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
2837162|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837163|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2837164|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2837165|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
2837166|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837167|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837168|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2837169|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2837170|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
2837171|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2837172|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
2293814|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293815|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
2293816|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2293817|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2293818|NCT00269880|Heparin|heparin|mesh-list
2293819|NCT00269880|Abciximab|abciximab|mesh-list
2293820|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
2293821|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2293822|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2837173|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
2837174|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
2837175|NCT03950739|Treprostinil|treprostinil|mesh-list
2837176|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2837177|NCT03950804|Eculizumab|eculizumab|mesh-list
2837178|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2837179|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2837180|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
2837181|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837182|NCT03950817|Ketamine|ketamine|mesh-list
2837183|NCT03950817|Analgesics|analgesics|mesh-ancestor
2837184|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
2837185|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837186|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837187|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2837188|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2837189|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
2837190|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
2293823|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293824|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2293825|NCT00269893|Abciximab|abciximab|mesh-list
2293826|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
2293827|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2293828|NCT00269906|Abciximab|abciximab|mesh-list
2293829|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
2293830|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2293831|NCT00269932|Levofloxacin|levofloxacin|mesh-list
2293832|NCT00269932|Ofloxacin|ofloxacin|mesh-list
2293833|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2293834|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2293835|NCT00269932|Renal Agents|renal agents|mesh-ancestor
2293836|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2293837|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2293838|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2293839|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293840|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293841|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293842|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2293843|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2293844|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
2293845|NCT00269945|Hematinics|hematinics|mesh-ancestor
2293846|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
2293847|NCT00269958|Hematinics|hematinics|mesh-ancestor
2293848|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
2293849|NCT00269971|Hematinics|hematinics|mesh-ancestor
2293850|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
2293851|NCT00269984|Hematinics|hematinics|mesh-ancestor
2293852|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
2293853|NCT00269997|Hematinics|hematinics|mesh-ancestor
2293854|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
2293855|NCT00270010|Hematinics|hematinics|mesh-ancestor
2293856|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
2293857|NCT00270023|Hematinics|hematinics|mesh-ancestor
2293858|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
2837191|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2837192|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2837193|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2837194|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837195|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837196|NCT03950505|Pioglitazone|pioglitazone|mesh-list
2837197|NCT03950505|Alogliptin|alogliptin|mesh-list
2293859|NCT00270036|Hematinics|hematinics|mesh-ancestor
2293860|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
2293861|NCT00270049|Hematinics|hematinics|mesh-ancestor
2293862|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
2293863|NCT00270062|Hematinics|hematinics|mesh-ancestor
2293864|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
2293865|NCT00270075|Hematinics|hematinics|mesh-ancestor
2293866|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
2293867|NCT00270088|Hematinics|hematinics|mesh-ancestor
2293868|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
2293869|NCT00270101|Hematinics|hematinics|mesh-ancestor
2293870|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
2837198|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2837199|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837200|NCT03950505|Incretins|incretins|mesh-ancestor
2837201|NCT03950505|Hormones|hormones|mesh-ancestor
2837202|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2837203|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2837204|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
2837205|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837206|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837207|NCT03950518|Levamisole|levamisole|mesh-list
2837208|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2837209|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
2837210|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837211|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
2837212|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
2837213|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2837214|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837215|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2837216|NCT03950427|Bupropion|bupropion|mesh-list
2837217|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2837218|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
2837219|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2293871|NCT00270114|Hematinics|hematinics|mesh-ancestor
2293872|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
2293873|NCT00270127|Hematinics|hematinics|mesh-ancestor
2293874|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
2293875|NCT00270140|Hematinics|hematinics|mesh-ancestor
2293876|NCT00270153|Enalapril|enalapril|mesh-list
2293877|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2837220|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2837221|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2837222|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2837223|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837224|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
2837225|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837226|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837227|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2837228|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2293878|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
2293879|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293880|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293881|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2293882|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
2293883|NCT00270166|Hematinics|hematinics|mesh-ancestor
2293884|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
2293885|NCT00270179|Hematinics|hematinics|mesh-ancestor
2293886|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
2293887|NCT00270270|Hematinics|hematinics|mesh-ancestor
2293888|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
2293889|NCT00270283|Hematinics|hematinics|mesh-ancestor
2293890|NCT00270322|Fentanyl|fentanyl|mesh-list
2293891|NCT00270322|Morphine|morphine|mesh-list
2293892|NCT00270322|Bupivacaine|bupivacaine|mesh-list
2293893|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2293894|NCT00270322|Narcotics|narcotics|mesh-ancestor
2293895|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2293896|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293897|NCT00270322|Analgesics|analgesics|mesh-ancestor
2293898|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
2293899|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2293900|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2293901|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2293902|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
2293903|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
2293904|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
2293905|NCT00270335|Propofol|propofol|mesh-list
2837229|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837230|NCT03950544|Meropenem|meropenem|mesh-list
2837231|NCT03950544|Fosfomycin|fosfomycin|mesh-list
2837232|NCT03950544|Tigecycline|tigecycline|mesh-list
2837233|NCT03950544|Polymyxins|polymyxins|mesh-list
2837234|NCT03950544|Polymyxin B|polymyxin b|mesh-list
2837235|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2837236|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837237|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2293906|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2293907|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2293908|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293909|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2293910|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
2293911|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
2293912|NCT00270348|Ciclesonide|ciclesonide|mesh-list
2293913|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
2293914|NCT00270348|Hormones|hormones|mesh-ancestor
2293915|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2293916|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293917|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2293918|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2293919|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
2293920|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293921|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2293922|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
2293923|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293924|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2293925|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
2837238|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837239|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837240|NCT03950037|Albendazole|albendazole|mesh-list
2837241|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
2837242|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2837243|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837244|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
2837245|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2837246|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2293926|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293927|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2293928|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
2293929|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293930|NCT00270413|Sunitinib|sunitinib|mesh-list
2293931|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293932|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2293933|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2293934|NCT00270413|Growth Substances|growth substances|mesh-ancestor
2107353|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107354|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
2107355|NCT02486796|Vitamins|vitamins|mesh-ancestor
2107356|NCT02486952|Prednisone|prednisone|mesh-list
2107357|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
2293935|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293936|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
2293937|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2293938|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293939|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293940|NCT00270426|Benazepril|benazepril|mesh-list
2293941|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2837247|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
2837248|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
2837249|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
2837250|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837251|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837252|NCT03950141|Apatinib|apatinib|mesh-list
2837253|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837254|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2837255|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837256|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837257|NCT03950362|Avelumab|avelumab|mesh-list
2837258|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2837259|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293942|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
2293943|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293944|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293945|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2293946|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
2293947|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
2293948|NCT00270478|Hematinics|hematinics|mesh-ancestor
2293949|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293950|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
2293951|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293952|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293953|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2293954|NCT00270491|Paclitaxel|paclitaxel|mesh-list
2293955|NCT00270491|Capecitabine|capecitabine|mesh-list
2837260|NCT03950154|Bevacizumab|bevacizumab|mesh-list
2837261|NCT03950154|Capecitabine|capecitabine|mesh-list
2837262|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
2837263|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2837264|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837265|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2837266|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2837267|NCT03950154|Growth Substances|growth substances|mesh-ancestor
2837268|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837269|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
2837270|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2837271|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
2837272|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837273|NCT03950271|Capecitabine|capecitabine|mesh-list
2837274|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
2837275|NCT03950271|Trastuzumab|trastuzumab|mesh-list
2837276|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2837277|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
2837278|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837279|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837280|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2837281|NCT03950050|Ambroxol|ambroxol|mesh-list
2837282|NCT03950050|Expectorants|expectorants|mesh-ancestor
2837283|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
2107358|NCT02486952|Rituximab|rituximab|mesh-list
2107359|NCT02486952|Vincristine|vincristine|mesh-list
2107360|NCT02486952|Doxorubicin|doxorubicin|mesh-list
2107361|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2107362|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2837291|NCT03949673|Celecoxib|celecoxib|mesh-list
2837292|NCT03949673|Diclofenac|diclofenac|mesh-list
2837293|NCT03949673|Naproxen|naproxen|mesh-list
2837294|NCT03949673|Fasinumab|fasinumab|mesh-list
2837295|NCT03949673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2837296|NCT03949673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2837297|NCT03949673|Analgesics|analgesics|mesh-ancestor
2837298|NCT03949673|Sensory System Agents|sensory system agents|mesh-ancestor
2837299|NCT03949673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837300|NCT03949673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837301|NCT03949673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2837302|NCT03949673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2837303|NCT03949673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2837304|NCT03949673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2837305|NCT03949673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837306|NCT03949673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837307|NCT03949673|Gout Suppressants|gout suppressants|mesh-ancestor
2837308|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
2837309|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2837310|NCT03949764|Velpatasvir|velpatasvir|mesh-list
2837311|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
2837312|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837313|NCT03949985|Hemostatics|hemostatics|mesh-list
2837314|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
2837315|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2837316|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837317|NCT03949985|Coagulants|coagulants|mesh-ancestor
2837318|NCT03949855|Rituximab|rituximab|mesh-list
2837319|NCT03949855|Belimumab|belimumab|mesh-list
2837320|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2837321|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837322|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
2837323|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837324|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2293956|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2293957|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293958|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293959|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
2293960|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
2837325|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2837326|NCT03949686|Bupivacaine|bupivacaine|mesh-list
2837327|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
2837328|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
2837329|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2837330|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837331|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
2837332|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837333|NCT03949842|Fluticasone|fluticasone|mesh-list
2837334|NCT03949842|Xhance|xhance|mesh-list
2837335|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
2837336|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
2837337|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
2837338|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2837339|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2837340|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
2837341|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837342|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837343|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2293961|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293962|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2293963|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
2293964|NCT00270517|Telithromycin|telithromycin|mesh-list
2293965|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2293966|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2293967|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
2293968|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
2837344|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
2837345|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
2837346|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2837347|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837348|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837349|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2837350|NCT03949517|Piperidine|piperidine|mesh-list
2293969|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2293970|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
2293971|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2293972|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2293973|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2293974|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2293975|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293976|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293977|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2293978|NCT00270530|Renal Agents|renal agents|mesh-ancestor
2837351|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2837352|NCT03949517|Bombesin|bombesin|mesh-list
2837353|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837354|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2837355|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837356|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837357|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2837358|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2837359|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2837360|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2837361|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2837362|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2837363|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
2837364|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837365|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2837366|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2837367|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2293979|NCT00270543|Leucovorin|leucovorin|mesh-list
2293980|NCT00270543|Fluorouracil|fluorouracil|mesh-list
2293981|NCT00270543|Docetaxel|docetaxel|mesh-list
2293982|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
2293983|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2293984|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2293985|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2293986|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2293987|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
2293988|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2293989|NCT00270543|Antidotes|antidotes|mesh-ancestor
2293990|NCT00270543|Protective Agents|protective agents|mesh-ancestor
2837368|NCT03949634|Paclitaxel|paclitaxel|mesh-list
2837369|NCT03949634|Docetaxel|docetaxel|mesh-list
2837370|NCT03949634|Doxorubicin|doxorubicin|mesh-list
2837371|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2837372|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837373|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293991|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
2293992|NCT00270543|Vitamins|vitamins|mesh-ancestor
2293993|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
2293994|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
2293995|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
2293996|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
2293997|NCT00270556|Tenofovir|tenofovir|mesh-list
2293998|NCT00270556|Abacavir|abacavir|mesh-list
2293999|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
2294000|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837374|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
2837375|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
2837376|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837377|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2837378|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2837379|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2837380|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294001|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2294002|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2294003|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294004|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294005|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2294006|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2294007|NCT00270569|Cisplatin|cisplatin|mesh-list
2294008|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294009|NCT00270582|Gemcitabine|gemcitabine|mesh-list
2294010|NCT00270582|Docetaxel|docetaxel|mesh-list
2294011|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294012|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2294013|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
2294014|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294015|NCT00270582|Antiviral Agents|antiviral agents|mesh-ancestor
2294016|NCT00270582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294017|NCT00270582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294018|NCT00270582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2294019|NCT00270582|Immunologic Factors|immunologic factors|mesh-ancestor
2294020|NCT00270582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294021|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
2294022|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
2294023|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
2294024|NCT00270647|Vitamins|vitamins|mesh-list
2294025|NCT00270647|Ascorbic Acid|ascorbic acid|mesh-list
2294026|NCT00270647|Vitamin E|vitamin e|mesh-list
2294027|NCT00270647|Beta Carotene|beta carotene|mesh-list
2294028|NCT00270647|Carotenoids|carotenoids|mesh-list
2294029|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
2294030|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294031|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
2294032|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294033|NCT00270647|Protective Agents|protective agents|mesh-ancestor
2294034|NCT00270647|Provitamins|provitamins|mesh-ancestor
2294035|NCT00270751|Minocycline|minocycline|mesh-list
2294036|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2294037|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294038|NCT00270777|Promethazine|promethazine|mesh-list
2294039|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
2294040|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
2294041|NCT00270777|Epinephrine|epinephrine|mesh-list
2294042|NCT00270777|Racepinephrine|racepinephrine|mesh-list
2294043|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
2294044|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2294045|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2294046|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2294047|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
2294048|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294049|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294050|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837381|NCT03949478|Ibuprofen|ibuprofen|mesh-list
2294051|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2294052|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2294053|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
2294054|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294055|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2837382|NCT03949478|Nifedipine|nifedipine|mesh-list
2837383|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2837384|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2837385|NCT03949478|Analgesics|analgesics|mesh-ancestor
2294056|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
2294057|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
2837386|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
2837387|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837388|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837389|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2837390|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2837391|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2837392|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837393|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837394|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2837395|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2837396|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2837397|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
2837398|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
2837399|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2837400|NCT03949101|Atropine|atropine|mesh-list
2837401|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2837402|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2837403|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2837404|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2837405|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2837406|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
2837407|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837408|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837409|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2837410|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
2837411|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
2837412|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
2837413|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2837414|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2837415|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
2837416|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837417|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837418|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2837419|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
2837420|NCT03949062|Rituximab|rituximab|mesh-list
2837421|NCT03949062|Lenalidomide|lenalidomide|mesh-list
2837422|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2837423|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837424|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
2837425|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294058|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
2294059|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2294060|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
2294061|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
2294062|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2294063|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
2294064|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
2294065|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2294066|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2294067|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2294068|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2294069|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
2294070|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
2294071|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
2294072|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
2294073|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2294074|NCT00270816|Interferons|interferons|mesh-list
2294075|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294076|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
2294077|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294078|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2837426|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2837427|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2837428|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2837429|NCT03949062|Growth Substances|growth substances|mesh-ancestor
2837430|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
2837431|NCT03949075|Enalapril|enalapril|mesh-list
2837432|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2837433|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
2837434|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294079|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
2837435|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837436|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2837437|NCT03948568|Tamoxifen|tamoxifen|mesh-list
2837438|NCT03948568|Letrozole|letrozole|mesh-list
2837439|NCT03948568|Anastrozole|anastrozole|mesh-list
2837440|NCT03948568|Exemestane|exemestane|mesh-list
2837441|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837442|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2837443|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2837444|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837445|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837446|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2837447|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
2837448|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2837449|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837450|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2837451|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2837452|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2837453|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2837454|NCT03948685|Carvedilol|carvedilol|mesh-list
2837455|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2837456|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2837457|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
2837458|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107363|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
2107364|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107365|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2107366|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2107367|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
2107368|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107369|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107370|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2107371|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2107372|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2107373|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
2107374|NCT02486952|Hormones|hormones|mesh-ancestor
2107375|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2107376|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2107377|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2107378|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
2107379|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
2107380|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
2107381|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2294080|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294081|NCT00270881|Cytarabine|cytarabine|mesh-list
2294082|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
2294083|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2294084|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
2294085|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294086|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2294087|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2294088|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
2294089|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294090|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837459|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837460|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837461|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2837462|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
2837463|NCT03948685|Protective Agents|protective agents|mesh-ancestor
2294091|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2837464|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2837465|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2837466|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2837467|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
2837468|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2837469|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2837470|NCT03948737|Tocopherols|tocopherols|mesh-list
2837471|NCT03948737|Vitamin E|vitamin e|mesh-list
2837472|NCT03948737|Tocotrienols|tocotrienols|mesh-list
2837473|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
2837474|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
2837475|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837476|NCT03948737|Protective Agents|protective agents|mesh-ancestor
2837477|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837478|NCT03948737|Vitamins|vitamins|mesh-ancestor
2837479|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
2837480|NCT03948620|Penicillins|penicillins|mesh-list
2837481|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2294092|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2294093|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
2294094|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
2294095|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294096|NCT00270907|Gemcitabine|gemcitabine|mesh-list
2294097|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2294098|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2294099|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
2294100|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294101|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294102|NCT00270907|Antiviral Agents|antiviral agents|mesh-ancestor
2294103|NCT00270907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294104|NCT00270907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294105|NCT00270907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2294106|NCT00270907|Immunologic Factors|immunologic factors|mesh-ancestor
2294107|NCT00270907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294108|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2294109|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
2294110|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294111|NCT00271063|Annamycin|annamycin|mesh-list
2294112|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2294113|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294114|NCT00271206|Progesterone|progesterone|mesh-list
2294115|NCT00271206|Progestins|progestins|mesh-ancestor
2837482|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837485|NCT03948464|Morphine|morphine|mesh-list
2837486|NCT03948464|Methadone|methadone|mesh-list
2837487|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2837488|NCT03948464|Narcotics|narcotics|mesh-ancestor
2837489|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2837490|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837491|NCT03948464|Analgesics|analgesics|mesh-ancestor
2837492|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
2837493|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837494|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
2837495|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
2837496|NCT03948477|Pantoprazole|pantoprazole|mesh-list
2837497|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2837498|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2837499|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2837500|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837501|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837502|NCT03948347|Liraglutide|liraglutide|mesh-list
2837503|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2837504|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837505|NCT03948347|Incretins|incretins|mesh-ancestor
2837506|NCT03948347|Hormones|hormones|mesh-ancestor
2837507|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2837508|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2837509|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2837510|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
2294116|NCT00271206|Hormones|hormones|mesh-ancestor
2294117|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2294118|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294119|NCT00271245|Selenium|selenium|mesh-list
2294120|NCT00271245|Selenic Acid|selenic acid|mesh-list
2294121|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
2294122|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294123|NCT00271245|Protective Agents|protective agents|mesh-ancestor
2294124|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294125|NCT00271245|Trace Elements|trace elements|mesh-ancestor
2294126|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
2837511|NCT03948243|Tolbutamide|tolbutamide|mesh-list
2837512|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
2837513|NCT03948243|Alprazolam|alprazolam|mesh-list
2837514|NCT03948243|Caffeine|caffeine|mesh-list
2837515|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2837516|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837517|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2294127|NCT00271271|Gemcitabine|gemcitabine|mesh-list
2837518|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837519|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837520|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2837521|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2837522|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
2837523|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837524|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
2837525|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
2837526|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2837527|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2837528|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2837529|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2837530|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2837531|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2837532|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2837533|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
2837534|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
2294128|NCT00271271|Vinorelbine|vinorelbine|mesh-list
2294129|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
2294130|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2294131|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
2294132|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294133|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294134|NCT00271271|Antiviral Agents|antiviral agents|mesh-ancestor
2294135|NCT00271271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294136|NCT00271271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294137|NCT00271271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2837535|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2837556|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
2837557|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
2837558|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2837559|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2837560|NCT03948191|Prednisolone|prednisolone|mesh-list
2837561|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
2837562|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2837563|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
2837564|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
2837565|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2837566|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
2837567|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
2837568|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294138|NCT00271271|Immunologic Factors|immunologic factors|mesh-ancestor
2294139|NCT00271271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294140|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2294141|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
2294142|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
2294143|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
2294144|NCT00271284|Insulin|insulin|mesh-list
2294145|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2294146|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
2294147|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
2294148|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
2294149|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2294150|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294151|NCT00271323|Docetaxel|docetaxel|mesh-list
2294152|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837569|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837570|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2294153|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
2294154|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
2294155|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
2294156|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294157|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
2294158|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2294159|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294160|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294161|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2294162|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2294163|NCT00271336|Protective Agents|protective agents|mesh-ancestor
2294164|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294165|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
2294166|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2294167|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
2294168|NCT00271349|Budesonide|budesonide|mesh-list
2294169|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2294170|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2294171|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
2294172|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294173|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837571|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
2837572|NCT03948191|Hormones|hormones|mesh-ancestor
2837573|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2837574|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2837575|NCT03948191|Protective Agents|protective agents|mesh-ancestor
2837576|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2837577|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837578|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2837579|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2837580|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837581|NCT03947827|Minocycline|minocycline|mesh-list
2837582|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2837583|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294174|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2294175|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
2294176|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
2294177|NCT00271349|Hormones|hormones|mesh-ancestor
2294178|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2294179|NCT00271401|Heparin|heparin|mesh-list
2294180|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
2294181|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2294182|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2294183|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837584|NCT03948074|Dronabinol|dronabinol|mesh-list
2837585|NCT03948074|Cannabidiol|cannabidiol|mesh-list
2837586|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
2837587|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
2837588|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837589|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2837590|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2837591|NCT03948074|Analgesics|analgesics|mesh-ancestor
2837592|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
2837593|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837594|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2837595|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2837596|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837597|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837598|NCT03948074|Hormones|hormones|mesh-ancestor
2837599|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2837600|NCT03947775|Vaccines|vaccines|mesh-list
2837601|NCT03947775|Immunologic Factors|immunologic factors|mesh-ancestor
2837602|NCT03947775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837603|NCT03947671|Acetaminophen|acetaminophen|mesh-list
2837604|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2837605|NCT03947671|Analgesics|analgesics|mesh-ancestor
2837606|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
2837607|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837608|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837609|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
2294184|NCT00271414|Fentanyl|fentanyl|mesh-list
2294185|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2294186|NCT00271414|Narcotics|narcotics|mesh-ancestor
2294187|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2294188|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294189|NCT00271414|Analgesics|analgesics|mesh-ancestor
2294190|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
2294191|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294192|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2294193|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2837610|NCT03948178|Simendan|simendan|mesh-list
2837611|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2837612|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
2837613|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2837614|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2837615|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837616|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837617|NCT03948178|Protective Agents|protective agents|mesh-ancestor
2837618|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837619|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
2837620|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2837621|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2837622|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837623|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2837624|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2837625|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
2837626|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837627|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837628|NCT03947242|Trastuzumab|trastuzumab|mesh-list
2837629|NCT03947242|Vinorelbine|vinorelbine|mesh-list
2837630|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2837631|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837632|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2837633|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
2837634|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
2837635|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
2837636|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837637|NCT03947229|Clopidogrel|clopidogrel|mesh-list
2837638|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2837639|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2837640|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2837641|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2837642|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
2837643|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837644|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837645|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837646|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
2837647|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2837648|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2837649|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837650|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2837651|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2837652|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
2837653|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837654|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837655|NCT03947411|Oseltamivir|oseltamivir|mesh-list
2837656|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
2837657|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837658|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837659|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294194|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
2294195|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
2294196|NCT00271427|Selenium|selenium|mesh-list
2294197|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
2294198|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294199|NCT00271427|Protective Agents|protective agents|mesh-ancestor
2294200|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294201|NCT00271427|Trace Elements|trace elements|mesh-ancestor
2294202|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
2294203|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
2294204|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2294205|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294206|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
2294207|NCT00271453|Fentanyl|fentanyl|mesh-list
2294208|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2294209|NCT00271453|Narcotics|narcotics|mesh-ancestor
2294210|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2294211|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294212|NCT00271453|Analgesics|analgesics|mesh-ancestor
2294213|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
2294214|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294215|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2294216|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2294217|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
2294218|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
2294219|NCT00271466|Fentanyl|fentanyl|mesh-list
2294220|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2294221|NCT00271466|Narcotics|narcotics|mesh-ancestor
2294222|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2294223|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294224|NCT00271466|Analgesics|analgesics|mesh-ancestor
2294225|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
2294226|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294227|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2294228|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2294229|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
2294230|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
2294231|NCT00271492|Atrasentan|atrasentan|mesh-list
2294232|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294233|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2837673|NCT03947125|Buprenorphine|buprenorphine|mesh-list
2837674|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2837675|NCT03947125|Narcotics|narcotics|mesh-ancestor
2837676|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2837677|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837678|NCT03947125|Analgesics|analgesics|mesh-ancestor
2837679|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
2837680|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837681|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2837682|NCT03946878|Venetoclax|venetoclax|mesh-list
2837683|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
2837684|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837685|NCT03946657|Anesthetics|anesthetics|mesh-list
2837686|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
2837687|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2837688|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837689|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
2837690|NCT03946891|Furosemide|furosemide|mesh-list
2837691|NCT03946891|Diuretics|diuretics|mesh-ancestor
2837692|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
2837693|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837694|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2837695|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2837696|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837697|NCT03946826|Halometasone|halometasone|mesh-list
2837698|NCT03946826|Petrolatum|petrolatum|mesh-list
2837699|NCT03946826|Emollients|emollients|mesh-ancestor
2837700|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
2837701|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2837702|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
2294234|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2837703|NCT03946826|Hormones|hormones|mesh-ancestor
2837704|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2837705|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837706|NCT03946514|Losartan|losartan|mesh-list
2294235|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294236|NCT00271518|Hormones|hormones|mesh-list
2294237|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2294238|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294239|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2294240|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
2294241|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294242|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
2294243|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2294244|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
2294245|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2294246|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294247|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2294248|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2294249|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2294250|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
2294251|NCT00271635|Vitamins|vitamins|mesh-ancestor
2294252|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
2294253|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294254|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
2294255|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837707|NCT03946514|Amlodipine|amlodipine|mesh-list
2837708|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2837709|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2294256|NCT00271635|Protective Agents|protective agents|mesh-ancestor
2294257|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
2294258|NCT00271713|Vitamin D|vitamin d|mesh-list
2294259|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
2294260|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
2294261|NCT00271713|Vitamins|vitamins|mesh-list
2294262|NCT00271713|Calcium|calcium|mesh-list
2294263|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
2294264|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837710|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2837711|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2837712|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837713|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2837714|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837715|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
2837716|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2294265|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2294266|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2294267|NCT00271791|Prednisone|prednisone|mesh-list
2294268|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2294269|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
2294270|NCT00271791|Hormones|hormones|mesh-ancestor
2294271|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2294272|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294273|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2294274|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294275|NCT00271804|Bortezomib|bortezomib|mesh-list
2294276|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294277|NCT00271973|Oxycodone|oxycodone|mesh-list
2294278|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2294279|NCT00271973|Narcotics|narcotics|mesh-ancestor
2294280|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2294281|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294282|NCT00271973|Analgesics|analgesics|mesh-ancestor
2294283|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
2294284|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294285|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
2294286|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2837717|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2837718|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2837719|NCT03946514|Diuretics|diuretics|mesh-ancestor
2837720|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
2837721|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2294287|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294288|NCT00272025|Citalopram|citalopram|mesh-list
2294289|NCT00272025|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2294290|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2837722|NCT03946358|Atezolizumab|atezolizumab|mesh-list
2837723|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294291|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2294292|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294293|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294294|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
2294295|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294296|NCT00272025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2294297|NCT00272025|Antidepressive Agents|antidepressive agents|mesh-ancestor
2294298|NCT00272025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2294299|NCT00272051|Xaliproden|xaliproden|mesh-list
2294300|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2294301|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2294302|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
2294303|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294304|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294305|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294306|NCT00272064|Insulin|insulin|mesh-list
2294307|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2294308|NCT00272064|Metformin|metformin|mesh-list
2294309|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
2294310|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
2294311|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2294312|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294313|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
2837743|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
2837744|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2837748|NCT03945903|Golimumab|golimumab|mesh-list
2837749|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2837750|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2837751|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2837752|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
2837753|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837754|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2837755|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2837756|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837757|NCT03945656|Insulin|insulin|mesh-list
2294314|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2294315|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294316|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
2294317|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2294318|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837758|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2837759|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
2837760|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2837761|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837762|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
2837763|NCT03945591|Bortezomib|bortezomib|mesh-list
2837764|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2837765|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
2837766|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837767|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2837768|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2837769|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
2837770|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837771|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837772|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2837773|NCT03945955|Melatonin|melatonin|mesh-list
2837774|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
2837775|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837776|NCT03945955|Protective Agents|protective agents|mesh-ancestor
2837777|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837778|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2837779|NCT03945539|Itraconazole|itraconazole|mesh-list
2837780|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
2837781|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837782|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2837783|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2837784|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837785|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837786|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2837787|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
2837788|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2837789|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837790|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2837791|NCT03945513|Dienogest|dienogest|mesh-list
2837792|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2837793|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2837794|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2837795|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2837796|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
2837797|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2837798|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837799|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2837800|NCT03945513|Estrogens|estrogens|mesh-ancestor
2837801|NCT03945513|Hormones|hormones|mesh-ancestor
2837802|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2837803|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2837804|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
2837805|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2837806|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837807|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
2837808|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
2837809|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2837810|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2294319|NCT00272116|Vitamins|vitamins|mesh-list
2837811|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837812|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837813|NCT03945643|Urological Agents|urological agents|mesh-ancestor
2837814|NCT03945604|Apatinib|apatinib|mesh-list
2837815|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837816|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2837817|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837818|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837819|NCT03945227|Spartalizumab|spartalizumab|mesh-list
2837820|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2837821|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837822|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837823|NCT03945019|Infliximab|infliximab|mesh-list
2837824|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
2837825|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2837826|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2837827|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
2837828|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2837829|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
2837830|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837831|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837832|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2837833|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
2837834|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
2837835|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2837836|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
2837837|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837838|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837839|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
2837840|NCT03945396|Antacids|antacids|mesh-ancestor
2837841|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837842|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2837843|NCT03945084|Niraparib|niraparib|mesh-list
2837844|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2837845|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837846|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837847|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837848|NCT03944980|Docetaxel|docetaxel|mesh-list
2837849|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837850|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
2837851|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
2837852|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
2837853|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837854|NCT03944889|Capsaicin|capsaicin|mesh-list
2837855|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
2837856|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
2837857|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
2837858|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837859|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837860|NCT03944915|Paclitaxel|paclitaxel|mesh-list
2837861|NCT03944915|Carboplatin|carboplatin|mesh-list
2837862|NCT03944915|Fluorouracil|fluorouracil|mesh-list
2837863|NCT03944915|Nivolumab|nivolumab|mesh-list
2837864|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
2837865|NCT03944915|Lenograstim|lenograstim|mesh-list
2837866|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2837867|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837868|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
2837869|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
2837870|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
2837871|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837872|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
2837873|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2837874|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2837875|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
2837876|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837877|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2837878|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2837879|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2837880|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
2837881|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837882|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2837883|NCT03944954|Dronabinol|dronabinol|mesh-list
2837884|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
2837885|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294320|NCT00272116|Vitamin A|vitamin a|mesh-list
2294321|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
2294322|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
2294323|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294324|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
2294325|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294326|NCT00272116|Protective Agents|protective agents|mesh-ancestor
2294327|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2294328|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837886|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2837887|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2837888|NCT03944954|Analgesics|analgesics|mesh-ancestor
2837889|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
2837890|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837891|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2837892|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2837893|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837894|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837895|NCT03944954|Hormones|hormones|mesh-ancestor
2837896|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2837897|NCT03944733|Iron|iron|mesh-list
2837898|NCT03944733|Trace Elements|trace elements|mesh-ancestor
2837899|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
2837900|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837901|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2837902|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837903|NCT03944655|Anesthetics|anesthetics|mesh-list
2837904|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2837905|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837906|NCT03944681|Droperidol|droperidol|mesh-list
2837907|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2837908|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
2837909|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
2837910|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837911|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837912|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2837913|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2837914|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2837915|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2837916|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2837917|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2837918|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2837919|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
2294329|NCT00272207|Nabilone|nabilone|mesh-list
2294330|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
2294331|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
2294332|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294333|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294334|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2294335|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2837920|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837921|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294336|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2294337|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2294338|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2294339|NCT00272285|Granisetron|granisetron|mesh-list
2294340|NCT00272285|Ramosetron|ramosetron|mesh-list
2294341|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
2294342|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
2294343|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294344|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294345|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2294346|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2294347|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
2294348|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294349|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294350|NCT00272324|Aspirin|aspirin|mesh-list
2294351|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2294352|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2294353|NCT00272324|Analgesics|analgesics|mesh-ancestor
2294354|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
2294355|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294356|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294357|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2294358|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2294359|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2294360|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2294361|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294362|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2294363|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2837928|NCT03944473|Neostigmine|neostigmine|mesh-list
2837929|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2837930|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837931|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837932|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
2837933|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2837934|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837935|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2837936|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
2837937|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837938|NCT03944512|Pravastatin|pravastatin|mesh-list
2837939|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2837940|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2837941|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
2837942|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837943|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2837944|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2837945|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837946|NCT03944317|Azithromycin|azithromycin|mesh-list
2837947|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
2837948|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
2837949|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2837950|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2837951|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2837952|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
2837953|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2837954|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2837955|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2837956|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837957|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837958|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2837959|NCT03944317|Renal Agents|renal agents|mesh-ancestor
2837960|NCT03944291|Bupivacaine|bupivacaine|mesh-list
2837961|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
2837962|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
2837963|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2837964|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837965|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
2837966|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2837967|NCT03944434|Leuprolide|leuprolide|mesh-list
2837968|NCT03944434|Goserelin|goserelin|mesh-list
2837969|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2837970|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2294364|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294365|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
2294366|NCT00272415|Temozolomide|temozolomide|mesh-list
2294367|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2294368|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
2294369|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294370|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294371|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
2294372|NCT00272428|Vitamin E|vitamin e|mesh-list
2294373|NCT00272428|Beta Carotene|beta carotene|mesh-list
2294374|NCT00272428|Selenium|selenium|mesh-list
2294375|NCT00272428|Carotenoids|carotenoids|mesh-list
2294376|NCT00272428|Vitamins|vitamins|mesh-ancestor
2837971|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2837972|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
2837973|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2837974|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2837975|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2294377|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
2294378|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294379|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
2294380|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294381|NCT00272428|Protective Agents|protective agents|mesh-ancestor
2294382|NCT00272428|Trace Elements|trace elements|mesh-ancestor
2294383|NCT00272428|Provitamins|provitamins|mesh-ancestor
2294384|NCT00272454|Aspirin|aspirin|mesh-list
2294385|NCT00272454|Cilostazol|cilostazol|mesh-list
2294386|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2294387|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2294388|NCT00272454|Analgesics|analgesics|mesh-ancestor
2294389|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
2294390|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294391|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294392|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2294393|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2294394|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2294395|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2294396|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294397|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2294398|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2294399|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294400|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
2294401|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2837976|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837977|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2837978|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2837979|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837980|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2837981|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
2837982|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2837983|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
2837984|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2837985|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
2837986|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2837987|NCT03944304|Paclitaxel|paclitaxel|mesh-list
2837988|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2837989|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837990|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
2837991|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
2837992|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
2837993|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2837994|NCT03944252|Cetuximab|cetuximab|mesh-list
2837995|NCT03944252|Avelumab|avelumab|mesh-list
2837996|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2837997|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2837998|NCT03944070|Ranibizumab|ranibizumab|mesh-list
2837999|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2838000|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2838001|NCT03944070|Growth Substances|growth substances|mesh-ancestor
2838002|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838003|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
2838004|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838005|NCT03944044|Acetaminophen|acetaminophen|mesh-list
2838006|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2838007|NCT03944044|Analgesics|analgesics|mesh-ancestor
2838008|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
2838009|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838010|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838011|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
2838012|NCT03943888|Atropine|atropine|mesh-list
2838013|NCT03943888|Neostigmine|neostigmine|mesh-list
2838014|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2838015|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2838016|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2838017|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
2294402|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
2294403|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2294404|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
2294405|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
2294406|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2294407|NCT00272454|Protective Agents|protective agents|mesh-ancestor
2294408|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2294409|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2294410|NCT00272467|Omeprazole|omeprazole|mesh-list
2294411|NCT00272467|Rebamipide|rebamipide|mesh-list
2294412|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2294413|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2294414|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2294415|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294416|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294417|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
2294418|NCT00272467|Protective Agents|protective agents|mesh-ancestor
2838018|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838019|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838020|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2838021|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
2838022|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
2838023|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
2838024|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2838025|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2838026|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
2838027|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838028|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838029|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2838030|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838031|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2838032|NCT03943927|Metoprolol|metoprolol|mesh-list
2838033|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2838034|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2838035|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
2838036|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
2838037|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838038|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838039|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2838040|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2838041|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2838042|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
2838043|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838044|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838045|NCT03944005|Anesthetics|anesthetics|mesh-list
2838046|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838047|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838048|NCT03943992|Esomeprazole|esomeprazole|mesh-list
2838049|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2838050|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2838051|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2838052|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838053|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838054|NCT03943459|Atorvastatin|atorvastatin|mesh-list
2838055|NCT03943459|Quercetin|quercetin|mesh-list
2838056|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2838057|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2838058|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
2838059|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838060|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2838061|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2838062|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838063|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
2838064|NCT03943459|Protective Agents|protective agents|mesh-ancestor
2838065|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838066|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
2838067|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
2838068|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
2838069|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838070|NCT03943537|Insulin|insulin|mesh-list
2838071|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2838072|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838073|NCT03943784|Propranolol|propranolol|mesh-list
2838074|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2838075|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2838076|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
2838077|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294419|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838078|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838079|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838080|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2838081|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2838082|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
2838099|NCT03943823|Estrogens|estrogens|mesh-list
2838100|NCT03943823|Hormones|hormones|mesh-ancestor
2838101|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2838102|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838103|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
2838104|NCT03943472|Fludarabine|fludarabine|mesh-list
2838105|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2838106|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
2838107|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838108|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2838109|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2838110|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
2838111|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838112|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838113|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2838114|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
2838115|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2838116|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
2107382|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2107383|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2107384|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107385|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
2107386|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2838117|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838118|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
2838119|NCT03943186|Protective Agents|protective agents|mesh-ancestor
2838120|NCT03943407|Imiquimod|imiquimod|mesh-list
2838121|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
2838122|NCT03943407|Doxepin|doxepin|mesh-list
2838123|NCT03943407|Menthol|menthol|mesh-list
2838124|NCT03943407|Histamine|histamine|mesh-list
2838125|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
2294420|NCT00272480|Lamivudine|lamivudine|mesh-list
2294421|NCT00272480|Zidovudine|zidovudine|mesh-list
2294422|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2294423|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2294424|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294425|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294426|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
2294427|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838126|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
2838127|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
2838128|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
2838129|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838130|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838131|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838132|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2838133|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
2838134|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838135|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
2838136|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2838137|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2838138|NCT03943407|Protective Agents|protective agents|mesh-ancestor
2838139|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2107387|NCT02487030|Ledipasvir|ledipasvir|mesh-list
2294428|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2294429|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2294430|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
2294431|NCT00272493|Vaccines|vaccines|mesh-list
2294432|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
2294433|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294434|NCT00272558|Carboplatin|carboplatin|mesh-list
2294435|NCT00272558|Vinorelbine|vinorelbine|mesh-list
2294436|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838140|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2838141|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838142|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2838143|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
2838144|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2838145|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
2838146|NCT03943043|Gemcitabine|gemcitabine|mesh-list
2838147|NCT03943043|Paclitaxel|paclitaxel|mesh-list
2838148|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
2838149|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2838150|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838151|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
2838152|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
2838153|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
2838154|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838155|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2838156|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
2838157|NCT03943043|Antiviral Agents|antiviral agents|mesh-ancestor
2838158|NCT03943043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838159|NCT03943043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838160|NCT03943043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2838161|NCT03943043|Immunologic Factors|immunologic factors|mesh-ancestor
2838162|NCT03943043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838163|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
2838164|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2838165|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2838166|NCT03942861|Prednisolone|prednisolone|mesh-list
2838167|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
2838168|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2838169|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
2838170|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2838171|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
2838172|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
2838173|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838174|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838175|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2838176|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
2838177|NCT03942861|Hormones|hormones|mesh-ancestor
2294437|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2294438|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
2294439|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
2294440|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
2294441|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294442|NCT00272584|Risperidone|risperidone|mesh-list
2294443|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2294444|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
2294445|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294446|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294447|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294448|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2294449|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2294450|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2294451|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2294452|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2294453|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
2294454|NCT00272597|Risperidone|risperidone|mesh-list
2294455|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2294456|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
2294457|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294458|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294459|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294460|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2294461|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2294462|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2294463|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2294464|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2294465|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
2294466|NCT00272610|Vitamin A|vitamin a|mesh-list
2838178|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2838179|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2838180|NCT03942861|Protective Agents|protective agents|mesh-ancestor
2838181|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2838182|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838183|NCT03942991|Mepivacaine|mepivacaine|mesh-list
2838184|NCT03942991|Carticaine|carticaine|mesh-list
2838185|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
2838186|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
2838187|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838188|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838189|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
2838190|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838191|NCT03942757|Bilirubin|bilirubin|mesh-list
2838192|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
2838193|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838194|NCT03942757|Protective Agents|protective agents|mesh-ancestor
2838195|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838196|NCT03942926|Sirolimus|sirolimus|mesh-list
2294467|NCT00272610|Vitamins|vitamins|mesh-ancestor
2294468|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
2294469|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294470|NCT00272636|Amiodarone|amiodarone|mesh-list
2294471|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2294472|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
2294473|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2294474|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2294475|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294476|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2294477|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2294478|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2838197|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2838198|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838199|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2838200|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838201|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
2838202|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2294479|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294480|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2294481|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2294482|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2294483|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
2294484|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2294485|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2294486|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294487|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
2294488|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
2294489|NCT00272688|Levodopa|levodopa|mesh-list
2294490|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2294491|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2294492|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
2294493|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294494|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838203|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
2838204|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838205|NCT03942796|Pregabalin|pregabalin|mesh-list
2838206|NCT03942796|Analgesics|analgesics|mesh-ancestor
2838207|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
2838208|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838209|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838210|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
2838211|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2838212|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2838213|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838214|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2838215|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2838216|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2838217|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838218|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2838219|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
2838220|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2838221|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2838222|NCT03942887|Prednisolone|prednisolone|mesh-list
2838223|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
2838224|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
2838225|NCT03942887|Rituximab|rituximab|mesh-list
2838226|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2838227|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
2838228|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2838229|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
2838230|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838231|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2838232|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2838233|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
2838234|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838235|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838236|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2838237|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2838238|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2838239|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
2838240|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
2838241|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294495|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294496|NCT00272701|Esomeprazole|esomeprazole|mesh-list
2294497|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2294498|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2294499|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2294500|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838242|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2838243|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
2838244|NCT03942887|Hormones|hormones|mesh-ancestor
2838245|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2838246|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2838247|NCT03942887|Protective Agents|protective agents|mesh-ancestor
2838248|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2838249|NCT03942601|Sirolimus|sirolimus|mesh-list
2838250|NCT03942601|Dexamethasone|dexamethasone|mesh-list
2838251|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
2838252|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2838253|NCT03942601|BB 1101|bb 1101|mesh-list
2838254|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2838255|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
2838256|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
2838257|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294501|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294502|NCT00272714|Afimoxifene|afimoxifene|mesh-list
2838258|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838259|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2838260|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
2838261|NCT03942601|Hormones|hormones|mesh-ancestor
2838262|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2838263|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2838264|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838265|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2294503|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294504|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2294505|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
2294506|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2294507|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838266|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294508|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2294509|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2294510|NCT00272740|Fulvestrant|fulvestrant|mesh-list
2294511|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2294512|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294513|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2294514|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2294515|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
2294516|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2294517|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294518|NCT00272753|Budesonide|budesonide|mesh-list
2838267|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2838268|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
2838269|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2838270|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
2838271|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
2838272|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838273|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838274|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
2838275|NCT03942354|Linezolid|linezolid|mesh-list
2838276|NCT03942354|Bedaquiline|bedaquiline|mesh-list
2838277|NCT03942354|Clofazimine|clofazimine|mesh-list
2838278|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2838279|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838280|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2294519|NCT00272753|Albuterol|albuterol|mesh-list
2294520|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
2294521|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2294522|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2294523|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
2838281|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2838282|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838283|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838284|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838285|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2838286|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
2294524|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294525|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294526|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2294527|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
2294528|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
2294529|NCT00272753|Hormones|hormones|mesh-ancestor
2294530|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2294531|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2838287|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2838288|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
2838289|NCT03942289|Norepinephrine|norepinephrine|mesh-list
2838290|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2838291|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2838292|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
2838293|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838294|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838295|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838296|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
2838297|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
2838298|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838299|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2294532|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2294533|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2294534|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
2294535|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294536|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294537|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
2294538|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2294539|NCT00272805|Carvedilol|carvedilol|mesh-list
2294540|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2294541|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2294542|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
2294543|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294544|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294545|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294546|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2294547|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
2838318|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
2838319|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2838320|NCT03941925|Levan|levan|mesh-list
2838321|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838322|NCT03941964|Azacitidine|azacitidine|mesh-list
2838323|NCT03941964|Decitabine|decitabine|mesh-list
2838324|NCT03941964|Venetoclax|venetoclax|mesh-list
2294548|NCT00272805|Protective Agents|protective agents|mesh-ancestor
2294549|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2294550|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2294551|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2838325|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2838326|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
2838327|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838328|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838329|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838330|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
2838331|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2838332|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
2838333|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
2838334|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838335|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838336|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2838337|NCT03941990|Analgesics|analgesics|mesh-ancestor
2838338|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
2838339|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838340|NCT03942029|Fluconazole|fluconazole|mesh-list
2838341|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
2838342|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838343|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2838344|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2838345|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838346|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838347|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2838348|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
2838349|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2838350|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838351|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2838352|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2838353|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
2838354|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
2838355|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
2838356|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838357|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838358|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
2838359|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838360|NCT03941886|Aspirin|aspirin|mesh-list
2838361|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2838362|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2294552|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
2294553|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2294554|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2294555|NCT00272831|Cilostazol|cilostazol|mesh-list
2294556|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2838363|NCT03941886|Analgesics|analgesics|mesh-ancestor
2838364|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
2294557|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
2838365|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838366|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838367|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2838368|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2838369|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2838370|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2838371|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838372|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2838373|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2838374|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838375|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
2838376|NCT03942068|Paclitaxel|paclitaxel|mesh-list
2838377|NCT03942068|Apatinib|apatinib|mesh-list
2838378|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2838379|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2838380|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838381|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
2838382|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
2838383|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
2838384|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838385|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2838386|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838387|NCT03942458|Clopidogrel|clopidogrel|mesh-list
2838388|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2838389|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2838390|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2838391|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2838392|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
2838393|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838394|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838395|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838396|NCT03941561|Tegafur|tegafur|mesh-list
2838397|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2294558|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294559|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838398|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
2838399|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838400|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838401|NCT03941795|Axitinib|axitinib|mesh-list
2838402|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838403|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2838404|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838405|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838408|NCT03941587|Aflibercept|aflibercept|mesh-list
2838409|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2838410|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2838411|NCT03941587|Growth Substances|growth substances|mesh-ancestor
2838412|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838413|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
2838414|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838415|NCT03941496|Azacitidine|azacitidine|mesh-list
2838416|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2838417|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
2838418|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838419|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838420|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838421|NCT03941535|Vitamin K|vitamin k|mesh-list
2838422|NCT03941535|Vitamins|vitamins|mesh-ancestor
2838423|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
2294560|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2294561|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
2294562|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2294563|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2294564|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294565|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2294566|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
2294567|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2294568|NCT00272831|Protective Agents|protective agents|mesh-ancestor
2294569|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2294570|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2294571|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838424|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838425|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2838426|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2838427|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838428|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
2838429|NCT03941535|Coagulants|coagulants|mesh-ancestor
2838430|NCT03941340|Aflutinib|aflutinib|mesh-list
2294572|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2294573|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294574|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294575|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294576|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
2294577|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2294578|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
2294579|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2294580|NCT00272896|Protective Agents|protective agents|mesh-ancestor
2294581|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294582|NCT00272909|Piclozotan|piclozotan|mesh-list
2294583|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2294584|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2294585|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
2294586|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294587|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294588|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294589|NCT00272935|Estrogens|estrogens|mesh-list
2294590|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2294591|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
2294592|NCT00272935|Hormones|hormones|mesh-ancestor
2294593|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2294594|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294595|NCT00272948|Defibrotide|defibrotide|mesh-list
2294596|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2294597|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2294598|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294599|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2294600|NCT00273013|Montelukast|montelukast|mesh-list
2294601|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2294602|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
2294603|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2294604|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
2294605|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2294606|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294607|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2294608|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2294609|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294610|NCT00273026|Fluticasone|fluticasone|mesh-list
2294611|NCT00273026|Xhance|xhance|mesh-list
2294612|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2294613|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2294614|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2294615|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
2294616|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294617|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294618|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2294619|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
2294620|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
2294621|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2838431|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2838432|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838433|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838434|NCT03941093|Leucovorin|leucovorin|mesh-list
2838435|NCT03941093|Gemcitabine|gemcitabine|mesh-list
2838436|NCT03941093|Paclitaxel|paclitaxel|mesh-list
2838437|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2838438|NCT03941093|Irinotecan|irinotecan|mesh-list
2838439|NCT03941093|Fluorouracil|fluorouracil|mesh-list
2838440|NCT03941093|Folfirinox|folfirinox|mesh-list
2838441|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
2838442|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2838443|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838444|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
2838445|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
2838446|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
2838447|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838448|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2838449|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
2838450|NCT03941093|Antiviral Agents|antiviral agents|mesh-ancestor
2838451|NCT03941093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838452|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838453|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2838454|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
2838455|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838456|NCT03941093|Antidotes|antidotes|mesh-ancestor
2838457|NCT03941093|Protective Agents|protective agents|mesh-ancestor
2838458|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
2838459|NCT03941093|Vitamins|vitamins|mesh-ancestor
2838460|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
2838461|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2838462|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2838463|NCT03941288|Cannabidiol|cannabidiol|mesh-list
2838464|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
2294622|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2294623|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2294624|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2294625|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
2294626|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294627|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294628|NCT00273039|Paroxetine|paroxetine|mesh-list
2294629|NCT00273039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2294630|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2294631|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2294632|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294633|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294634|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
2294635|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294636|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2294637|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
2294638|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2294639|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2294640|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2294641|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294642|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
2294643|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2294644|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2294645|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294646|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294647|NCT00273247|Interferons|interferons|mesh-list
2294648|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
2294649|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
2294650|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294651|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
2294652|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294653|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
2294654|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294655|NCT00273299|Valsartan|valsartan|mesh-list
2294656|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2294657|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2294658|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2294659|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2294660|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294661|NCT00273299|Diuretics|diuretics|mesh-ancestor
2294662|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
2294663|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294664|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2294665|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2294666|NCT00273312|Epothilone B|epothilone b|mesh-list
2294667|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294668|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
2294669|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
2294670|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
2294671|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294672|NCT00273338|Calcitriol|calcitriol|mesh-list
2294673|NCT00273338|Docetaxel|docetaxel|mesh-list
2294674|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107388|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
2107389|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107390|NCT02487199|Ritonavir|ritonavir|mesh-list
2107391|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2107392|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2838465|NCT03940976|Afatinib|afatinib|mesh-list
2838466|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838467|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2838468|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838469|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838470|NCT03940742|Tirzepatide|tirzepatide|mesh-list
2838471|NCT03940742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2838472|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838473|NCT03940742|Incretins|incretins|mesh-ancestor
2838474|NCT03940742|Hormones|hormones|mesh-ancestor
2838475|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2838476|NCT03940664|Formaldehyde|formaldehyde|mesh-list
2838477|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
2838478|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838479|NCT03940807|Estradiol|estradiol|mesh-list
2838480|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2838481|NCT03940807|Estrogens|estrogens|mesh-ancestor
2838482|NCT03940807|Hormones|hormones|mesh-ancestor
2838483|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2294675|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
2294676|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
2294677|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
2294678|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294679|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2294680|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294681|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2294682|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2294683|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2294684|NCT00273338|Vitamins|vitamins|mesh-ancestor
2294685|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
2838484|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838485|NCT03940651|Anesthetics|anesthetics|mesh-list
2838486|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
2838487|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838488|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838489|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
2838490|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2838491|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838492|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
2838493|NCT03940378|Levamisole|levamisole|mesh-list
2838494|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2838495|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
2838496|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838497|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
2107393|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
2107394|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107395|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107396|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2107397|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2107398|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
2107399|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107400|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2107401|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2107402|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
2107403|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2294686|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2294687|NCT00273377|Dexamethasone|dexamethasone|mesh-list
2294688|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2294689|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
2294690|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
2294691|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294692|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294693|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2294694|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
2294695|NCT00273377|Hormones|hormones|mesh-ancestor
2294696|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2294697|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2294698|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294699|NCT00273390|Infliximab|infliximab|mesh-list
2294700|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
2294701|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2294702|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2294703|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
2294704|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
2294705|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2294706|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2294707|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294708|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294709|NCT00273416|Urological Agents|urological agents|mesh-ancestor
2294710|NCT00273429|Timolol|timolol|mesh-list
2294711|NCT00273429|Dorzolamide|dorzolamide|mesh-list
2294712|NCT00273429|Latanoprost|latanoprost|mesh-list
2294713|NCT00273429|Maleic acid|maleic acid|mesh-list
2294714|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2294715|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2294716|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
2838498|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
2838499|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2838500|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838501|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2838502|NCT03940131|Panitumumab|panitumumab|mesh-list
2838503|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2838504|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838505|NCT03940235|Androgens|androgens|mesh-list
2838506|NCT03940235|Hormones|hormones|mesh-ancestor
2838507|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2838508|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838509|NCT03940326|Levetiracetam|levetiracetam|mesh-list
2838510|NCT03940326|Valproic Acid|valproic acid|mesh-list
2294717|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294718|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294719|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294720|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2294721|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2294722|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294723|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2294724|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2294725|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2294726|NCT00273442|Timolol|timolol|mesh-list
2294727|NCT00273442|Dorzolamide|dorzolamide|mesh-list
2294728|NCT00273442|Maleic acid|maleic acid|mesh-list
2294729|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2294730|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2294731|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
2294732|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294733|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294734|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294735|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2294736|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2294737|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294738|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2294739|NCT00273455|Timolol|timolol|mesh-list
2838511|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
2838512|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
2838513|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838514|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838515|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
2838516|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838517|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838518|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
2838519|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2838520|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2294740|NCT00273455|Bimatoprost|bimatoprost|mesh-list
2294741|NCT00273455|Dorzolamide|dorzolamide|mesh-list
2294742|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2294743|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2294744|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
2294745|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294746|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294747|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294748|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2294749|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2294750|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294751|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2294752|NCT00273468|Granisetron|granisetron|mesh-list
2294753|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
2294754|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
2294755|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294756|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294757|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2294758|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2294759|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
2294760|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294761|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294762|NCT00273481|Timolol|timolol|mesh-list
2294763|NCT00273481|Dorzolamide|dorzolamide|mesh-list
2294764|NCT00273481|Latanoprost|latanoprost|mesh-list
2294765|NCT00273481|Maleic acid|maleic acid|mesh-list
2294766|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2294767|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2294768|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
2294769|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294770|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294771|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838521|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2838522|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
2838523|NCT03940391|Midazolam|midazolam|mesh-list
2838524|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2838525|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2838526|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838527|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838528|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2838529|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2838530|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2838531|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2838532|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
2838533|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
2838534|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
2838535|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
2838536|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838537|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838538|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
2838539|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
2838540|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2838541|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
2838542|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
2838543|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2838544|NCT03940430|Lactoferrin|lactoferrin|mesh-list
2838545|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838546|NCT03940469|Dexamethasone|dexamethasone|mesh-list
2838547|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
2838548|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
2838549|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2838550|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
2838551|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
2838552|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838553|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838554|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2838555|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
2838556|NCT03940469|Hormones|hormones|mesh-ancestor
2838557|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2838558|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2838559|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838560|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2838561|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838562|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2838563|NCT03940469|Analgesics|analgesics|mesh-ancestor
2838564|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
2294772|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2294773|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2294774|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294775|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2838565|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2838566|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2838567|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2838568|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
2838569|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838570|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838571|NCT03939663|Misoprostol|misoprostol|mesh-list
2838572|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2838573|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
2838574|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2838575|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838576|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2838577|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2838578|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
2838579|NCT03939884|Diclofenac|diclofenac|mesh-list
2838580|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2838581|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2838582|NCT03939884|Analgesics|analgesics|mesh-ancestor
2838583|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
2838584|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838585|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838586|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2838587|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2838588|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2838589|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838590|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838591|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
2838592|NCT03939923|Rocuronium|rocuronium|mesh-list
2838593|NCT03939923|Neostigmine|neostigmine|mesh-list
2838594|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2838595|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2838596|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2294776|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2294777|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2294778|NCT00273507|Paclitaxel|paclitaxel|mesh-list
2294779|NCT00273507|Carboplatin|carboplatin|mesh-list
2294780|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2294781|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294782|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
2294783|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
2294784|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
2294785|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294786|NCT00273520|Telithromycin|telithromycin|mesh-list
2294787|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2294788|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294789|NCT00273533|Ramipril|ramipril|mesh-list
2294790|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2294791|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
2294792|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294793|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294794|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2294795|NCT00273546|Docetaxel|docetaxel|mesh-list
2294796|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838597|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838598|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838599|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2838600|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838601|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838602|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
2838603|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838604|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2838605|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
2838606|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2838607|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2838608|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2838609|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
2838610|NCT03939637|Antibodies|antibodies|mesh-list
2838611|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
2838612|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2838613|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2838614|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
2294797|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
2294798|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
2294799|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
2294800|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294801|NCT00273559|Prednisone|prednisone|mesh-list
2294802|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2294803|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
2294804|NCT00273559|Hormones|hormones|mesh-ancestor
2294805|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2294806|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838615|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838616|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
2838617|NCT03939975|Nivolumab|nivolumab|mesh-list
2838618|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2838619|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838620|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2838621|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838622|NCT03939871|Vinorelbine|vinorelbine|mesh-list
2838623|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2838624|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838625|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
2838626|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
2838627|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
2838628|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838629|NCT03940001|Paclitaxel|paclitaxel|mesh-list
2838630|NCT03940001|Carboplatin|carboplatin|mesh-list
2838631|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2838632|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838633|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
2838634|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
2838635|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
2838636|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838637|NCT03939806|Oxytocin|oxytocin|mesh-list
2838638|NCT03939806|Carbetocin|carbetocin|mesh-list
2838639|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
2838640|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2294807|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2294808|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294809|NCT00273611|Vitamin D|vitamin d|mesh-list
2294810|NCT00273611|Vitamins|vitamins|mesh-ancestor
2294811|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
2294812|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294813|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2294814|NCT00273624|Olanzapine|olanzapine|mesh-list
2294815|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
2294816|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
2294817|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294818|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294819|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2294820|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2294821|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2294822|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2294823|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2294824|NCT00273624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2294825|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2294826|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2294827|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294828|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838641|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294829|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
2294830|NCT00273650|Vitamin B 12|vitamin b 12|mesh-list
2838656|NCT03939182|Abexinostat|abexinostat|mesh-list
2838657|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2838658|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838659|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838676|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2838677|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
2838678|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838679|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838680|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2294831|NCT00273650|Vitamins|vitamins|mesh-ancestor
2294832|NCT00273650|Micronutrients|micronutrients|mesh-ancestor
2294833|NCT00273650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294834|NCT00273650|Vitamin B Complex|vitamin b complex|mesh-ancestor
2294835|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2294836|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2294837|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294838|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
2294839|NCT00273689|Albuterol|albuterol|mesh-list
2294840|NCT00273689|Montelukast|montelukast|mesh-list
2294841|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2294842|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
2294843|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2294844|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
2294845|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2294846|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294847|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2294848|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2294849|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294850|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2294851|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
2294852|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294853|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
2294854|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2294855|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2294856|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2294857|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2294858|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
2294859|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294860|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
2294861|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2294862|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
2294863|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294864|NCT00273702|Expectorants|expectorants|mesh-ancestor
2294865|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
2838681|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838682|NCT03939273|Metronidazole|metronidazole|mesh-list
2838683|NCT03939273|Vancomycin|vancomycin|mesh-list
2838684|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
2838685|NCT03939273|Fluconazole|fluconazole|mesh-list
2838686|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838687|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2838688|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2838689|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2838690|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2838691|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2838692|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838693|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838694|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838695|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2838696|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2838697|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
2838698|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2838699|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2838700|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
2838701|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2838702|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838703|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2838704|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2838705|NCT03938740|Insulin|insulin|mesh-list
2838706|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2838707|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
2838708|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
2838709|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2838710|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294866|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2294867|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
2294868|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838711|NCT03938831|Fentanyl|fentanyl|mesh-list
2838712|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
2838713|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2838714|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838715|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838716|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2838717|NCT03938831|Analgesics|analgesics|mesh-ancestor
2838718|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
2838719|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838720|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2838721|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2838722|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2838723|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
2838724|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838725|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838726|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2838727|NCT03938831|Narcotics|narcotics|mesh-ancestor
2838728|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2838729|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2838730|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
2838731|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
2838732|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
2294869|NCT00273702|Protective Agents|protective agents|mesh-ancestor
2294870|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294871|NCT00273702|Antidotes|antidotes|mesh-ancestor
2294872|NCT00273741|Methylphenidate|methylphenidate|mesh-list
2294873|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2294874|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294875|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2294876|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2294877|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2294878|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294879|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
2838733|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2838734|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
2838735|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838736|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
2838737|NCT03938883|Protective Agents|protective agents|mesh-ancestor
2294880|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294881|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
2294882|NCT00273767|Hematinics|hematinics|mesh-ancestor
2294883|NCT00273871|Cyclosporine|cyclosporine|mesh-list
2294884|NCT00273871|Tacrolimus|tacrolimus|mesh-list
2294885|NCT00273871|Cyclosporins|cyclosporins|mesh-list
2838745|NCT03938662|Choline|choline|mesh-list
2838746|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
2838747|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2838748|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
2838749|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838750|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2838751|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2838752|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
2838753|NCT03938389|Valsartan|valsartan|mesh-list
2838754|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2838755|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2838756|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2838757|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2838758|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838759|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2838760|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838761|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
2838762|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2838763|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2838764|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838765|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
2838766|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838767|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838768|NCT03937843|Carboplatin|carboplatin|mesh-list
2838769|NCT03937843|Etoposide|etoposide|mesh-list
2838770|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838771|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2838772|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2838773|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2838774|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838775|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838776|NCT03938259|Fentanyl|fentanyl|mesh-list
2838777|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2838778|NCT03938259|Narcotics|narcotics|mesh-ancestor
2838779|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838780|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838781|NCT03938259|Analgesics|analgesics|mesh-ancestor
2838782|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
2838783|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838784|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2838785|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2838786|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
2838787|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
2838788|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
2838789|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2838790|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294886|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2294887|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
2294888|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294889|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2294890|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483663|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2294891|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294892|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
2294893|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294894|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
2294895|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2294896|NCT00273884|Cytarabine|cytarabine|mesh-list
2294897|NCT00273884|Amonafide|amonafide|mesh-list
2838791|NCT03937869|Secnidazole|secnidazole|mesh-list
2838792|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2838793|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2838794|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838795|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
2838796|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2838797|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838798|NCT03937713|Eszopiclone|eszopiclone|mesh-list
2838799|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2838800|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838801|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838802|NCT03937687|Caffeine|caffeine|mesh-list
2838803|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2838804|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838805|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2838806|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838807|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838808|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2838809|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2838810|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
2838811|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838812|NCT03937609|Infliximab|infliximab|mesh-list
2838813|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
2838814|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2838815|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2838816|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
2838817|NCT03937544|Fludarabine|fludarabine|mesh-list
2838818|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2838819|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
2838820|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838821|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2838822|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2838823|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
2294898|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2294899|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
2294900|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294901|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2294902|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
2294903|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294904|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2294905|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
2294906|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294907|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294908|NCT00273949|Lactulose|lactulose|mesh-list
2294909|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2294910|NCT00273962|Albuterol|albuterol|mesh-list
2294911|NCT00273962|Ipratropium|ipratropium|mesh-list
2294912|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2294913|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
2294914|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294915|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294916|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2294917|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
2294918|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
2294919|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2294920|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2294921|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2838824|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838825|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838826|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2838836|NCT03937648|Lasmiditan|lasmiditan|mesh-list
2838837|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2838838|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
2838839|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838840|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838841|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838842|NCT03937401|Oxytocin|oxytocin|mesh-list
2838843|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
2838844|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2294922|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2294923|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
2294924|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838845|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838846|NCT03937219|Nivolumab|nivolumab|mesh-list
2838847|NCT03937219|Ipilimumab|ipilimumab|mesh-list
2838848|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2838849|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838850|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2838851|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838852|NCT03937258|Probenecid|probenecid|mesh-list
2838853|NCT03937258|Abrocitinib|abrocitinib|mesh-list
2838854|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
2838855|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
2838856|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2838857|NCT03937258|Renal Agents|renal agents|mesh-ancestor
2838858|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2838859|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838860|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838861|NCT03936907|Nabiximols|nabiximols|mesh-list
2838862|NCT03936907|Analgesics|analgesics|mesh-ancestor
2294925|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294926|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2294927|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
2294928|NCT00273975|Lamivudine|lamivudine|mesh-list
2294929|NCT00273975|Zidovudine|zidovudine|mesh-list
2294930|NCT00273975|Nevirapine|nevirapine|mesh-list
2294931|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2294932|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2294933|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294934|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294935|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
2294936|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294937|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2294938|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2294939|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
2294940|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2294941|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2294942|NCT00273988|Nevirapine|nevirapine|mesh-list
2838863|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
2838864|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838865|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838866|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2838867|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
2838868|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838869|NCT03936998|Vancomycin|vancomycin|mesh-list
2838870|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2838871|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2838872|NCT03936790|Fentanyl|fentanyl|mesh-list
2838873|NCT03936790|Ropivacaine|ropivacaine|mesh-list
2838874|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
2838875|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
2838876|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838877|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838878|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
2838879|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838880|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2294943|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2294944|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2838881|NCT03936790|Narcotics|narcotics|mesh-ancestor
2838882|NCT03936790|Analgesics|analgesics|mesh-ancestor
2838883|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2838884|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2838885|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
2838886|NCT03936777|Fenfluramine|fenfluramine|mesh-list
2838887|NCT03936777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2294945|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294946|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294947|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
2294948|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294949|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2294950|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2294951|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2294952|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2294953|NCT00274001|Nevirapine|nevirapine|mesh-list
2294954|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2294955|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2294956|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2294957|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294958|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
2294959|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2294960|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2294961|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2294962|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2294963|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2294964|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
2294965|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2294966|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
2294967|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294968|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294969|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2294970|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
2294971|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
2294972|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2294973|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
2294974|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838888|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2838889|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2838890|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838891|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838892|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
2838893|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838894|NCT03936517|Prednisolone|prednisolone|mesh-list
2838895|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
2838896|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2838897|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
2838898|NCT03936517|Hormones|hormones|mesh-ancestor
2838899|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2838900|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838901|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2838902|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2838903|NCT03936491|Methylphenidate|methylphenidate|mesh-list
2838904|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2838905|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2838906|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838907|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2838908|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2838909|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2838910|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838911|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
2838912|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838913|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2838914|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
2838915|NCT03936192|Meloxicam|meloxicam|mesh-list
2838916|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2838917|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2838918|NCT03936192|Analgesics|analgesics|mesh-ancestor
2838919|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
2838920|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838921|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838922|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2838923|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2838924|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2838925|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2838926|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838927|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838928|NCT03936426|Copper|copper|mesh-list
2838929|NCT03936426|Trace Elements|trace elements|mesh-ancestor
2838930|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
2838931|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838944|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2838945|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2838946|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838947|NCT03936062|Incretins|incretins|mesh-ancestor
2838948|NCT03936062|Hormones|hormones|mesh-ancestor
2838949|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2838950|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2838951|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
2838952|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838953|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838954|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2838955|NCT03936374|Omeprazole|omeprazole|mesh-list
2838956|NCT03936374|Linrodostat|linrodostat|mesh-list
2838957|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2838958|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2294975|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294976|NCT00274027|Bromides|bromides|mesh-list
2294977|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
2294978|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2294979|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
2294980|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294981|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294982|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2294983|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
2294984|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
2294985|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2294986|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
2294987|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2294988|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2294989|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
2294990|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
2294991|NCT00274040|Ipratropium|ipratropium|mesh-list
2294992|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2294993|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
2294994|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2294995|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2294996|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2294997|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
2294998|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
2294999|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2295000|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
2295001|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295002|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295003|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
2295004|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2838959|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2838960|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838961|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295005|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
2295006|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838962|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
2838963|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2838964|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2838965|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838966|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2838967|NCT03936205|Analgesics|analgesics|mesh-ancestor
2838968|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
2838969|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2838970|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2838971|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2838972|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2838973|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
2838974|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2838975|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838976|NCT03936049|Liraglutide|liraglutide|mesh-list
2838977|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2838978|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2838979|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838980|NCT03936049|Incretins|incretins|mesh-ancestor
2838981|NCT03936049|Hormones|hormones|mesh-ancestor
2838982|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2838983|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
2838984|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838985|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838986|NCT03936153|Abexinostat|abexinostat|mesh-list
2838987|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2838988|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2838989|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2838990|NCT03936140|Iloprost|iloprost|mesh-list
2838991|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2838992|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
2838993|NCT03936036|Linagliptin|linagliptin|mesh-list
2838994|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2838995|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2838996|NCT03936036|Incretins|incretins|mesh-ancestor
2838997|NCT03936036|Hormones|hormones|mesh-ancestor
2838998|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2838999|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2839000|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
2839001|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839002|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839003|NCT03936023|Saxagliptin|saxagliptin|mesh-list
2839004|NCT03936023|Incretins|incretins|mesh-ancestor
2839005|NCT03936023|Hormones|hormones|mesh-ancestor
2839006|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839007|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295007|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295008|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2295009|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
2295010|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
2295011|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2295012|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
2839008|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2839009|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
2839010|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839011|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839012|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2839013|NCT03936010|Canagliflozin|canagliflozin|mesh-list
2839014|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2839015|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2839016|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839017|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2839018|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839019|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
2839020|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839021|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
2839022|NCT03935893|Fludarabine|fludarabine|mesh-list
2839023|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2839024|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
2839025|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839026|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2839027|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2839028|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
2839029|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839030|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839031|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2839032|NCT03935958|Curcumin|curcumin|mesh-list
2839033|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2839034|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2839035|NCT03935958|Analgesics|analgesics|mesh-ancestor
2839036|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
2839037|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839038|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839039|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2839040|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2839041|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839042|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839043|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295013|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295014|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295015|NCT00274066|Fenoterol|fenoterol|mesh-list
2295016|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
2107404|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107405|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107406|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2107407|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2107408|NCT02487225|Protective Agents|protective agents|mesh-ancestor
2107409|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107410|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
2295017|NCT00274066|Ipratropium|ipratropium|mesh-list
2839044|NCT03935685|Mirtazapine|mirtazapine|mesh-list
2839045|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
2839046|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2839047|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2839048|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
2295018|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2295019|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
2295020|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839049|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
2839050|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839051|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839052|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839053|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2839054|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2839055|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839056|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2839057|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2839058|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2839059|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
2839060|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2839061|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2839062|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
2839063|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2295021|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295022|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2839064|NCT03935815|Ropivacaine|ropivacaine|mesh-list
2839065|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
2839066|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
2839067|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839068|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295023|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
2295024|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
2295025|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2295026|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
2295027|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295028|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295029|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
2295030|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
2295031|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2295032|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2839069|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
2839070|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839071|NCT03935984|Calcitonin|calcitonin|mesh-list
2839072|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
2839073|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2839074|NCT03935984|Katacalcin|katacalcin|mesh-list
2295033|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2295034|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2295035|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
2839075|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2839076|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839077|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2839078|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
2839079|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
2839080|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839081|NCT03935646|Adderall|adderall|mesh-list
2839082|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2295036|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
2839083|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839084|NCT03935451|Apixaban|apixaban|mesh-list
2839085|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2839086|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
2839087|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2839088|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
2839089|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839090|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839091|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
2839092|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
2839093|NCT03935152|Progestins|progestins|mesh-ancestor
2839094|NCT03935152|Hormones|hormones|mesh-ancestor
2839095|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839096|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839097|NCT03935139|Glycerol|glycerol|mesh-list
2839098|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2839099|NCT03935139|Protective Agents|protective agents|mesh-ancestor
2839100|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839101|NCT03935217|Secnidazole|secnidazole|mesh-list
2839102|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2839103|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2839104|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839105|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2839106|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2839107|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2839108|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2839109|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839110|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
2839111|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839112|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295037|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2295038|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
2295039|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295040|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295041|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2295042|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
2295043|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
2295044|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2295045|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
2295046|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295047|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839113|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2839114|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839115|NCT03935074|Melphalan|melphalan|mesh-list
2839116|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2839117|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
2839118|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839119|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839120|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2839121|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2839122|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
2839123|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839124|NCT03935347|Vidarabine|vidarabine|mesh-list
2839125|NCT03935347|Aldesleukin|aldesleukin|mesh-list
2839126|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
2839127|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
2839128|NCT03935347|Fludarabine|fludarabine|mesh-list
2839129|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
2839130|NCT03935347|Interleukin-2|interleukin-2|mesh-list
2839131|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
2839132|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
2839133|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2839134|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
2295048|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
2295049|NCT00274092|Ipratropium|ipratropium|mesh-list
2295050|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2295051|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
2295052|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295053|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107411|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2107412|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
2107413|NCT02487303|Acetaminophen|acetaminophen|mesh-list
2107414|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2107415|NCT02487303|Analgesics|analgesics|mesh-ancestor
2107416|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
2107417|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107418|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107419|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
2107420|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
2107421|NCT02487446|Bromides|bromides|mesh-list
2107422|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
2107423|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839135|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839136|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2839137|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2839138|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
2839139|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839140|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839141|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2839142|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2839143|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2839144|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
2839145|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
2839146|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839147|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2839148|NCT03935347|Analgesics|analgesics|mesh-ancestor
2839149|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
2839150|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839151|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2839152|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2839153|NCT03935256|Paclitaxel|paclitaxel|mesh-list
2839154|NCT03935256|Carboplatin|carboplatin|mesh-list
2839155|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2839156|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839157|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
2839158|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
2839159|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
2839160|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839161|NCT03934840|Prednisone|prednisone|mesh-list
2839162|NCT03934840|Carboplatin|carboplatin|mesh-list
2839163|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839164|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2839165|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
2839166|NCT03934840|Hormones|hormones|mesh-ancestor
2839167|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839168|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839169|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2839170|NCT03934567|Abexinostat|abexinostat|mesh-list
2839171|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2839172|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839173|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107424|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2295054|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2295055|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
2295056|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
2295057|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2295058|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
2295059|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295060|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295061|NCT00274105|Telmisartan|telmisartan|mesh-list
2295062|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2107425|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2107426|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2295063|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2295064|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2295065|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295066|NCT00274118|Telmisartan|telmisartan|mesh-list
2295067|NCT00274118|Enalapril|enalapril|mesh-list
2295068|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2295069|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2295070|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2295071|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295072|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2295073|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
2295074|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295075|NCT00274131|Pramipexole|pramipexole|mesh-list
2295076|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
2295077|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839174|NCT03934710|Serotonin|serotonin|mesh-list
2839175|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
2839176|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
2839177|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839178|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839179|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839180|NCT03934450|Primaquine|primaquine|mesh-list
2839181|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
2839182|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2839183|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2839184|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839185|NCT03934411|Tramadol|tramadol|mesh-list
2839186|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2295078|NCT00274131|Protective Agents|protective agents|mesh-ancestor
2295079|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295080|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2295081|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2295082|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
2295083|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
2295084|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295085|NCT00274144|Telmisartan|telmisartan|mesh-list
2295086|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2295087|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2295088|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2295089|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295090|NCT00274170|Octreotide|octreotide|mesh-list
2295091|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2295092|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2295093|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295094|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
2295095|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
2295096|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2295097|NCT00274235|Mefloquine|mefloquine|mesh-list
2295098|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
2295099|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2295100|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2295101|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839187|NCT03934411|Narcotics|narcotics|mesh-ancestor
2107427|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
2107428|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107429|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107430|NCT02487485|Sirolimus|sirolimus|mesh-list
2107431|NCT02487485|Ketamine|ketamine|mesh-list
2107432|NCT02487485|Analgesics|analgesics|mesh-ancestor
2107433|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
2107434|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107435|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107436|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2107437|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2107438|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
2839188|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839189|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839190|NCT03934411|Analgesics|analgesics|mesh-ancestor
2839191|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
2839192|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839193|NCT03934216|BMS-986165|bms-986165|mesh-list
2839194|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
2839195|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2839196|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839197|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839198|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
2839199|NCT03934203|BI 409306|bi 409306|mesh-list
2839200|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2839201|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839202|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2839203|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2839204|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839205|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839206|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839207|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2839208|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
2839209|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2839210|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2839211|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839212|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
2839213|NCT03934047|Coagulants|coagulants|mesh-ancestor
2839214|NCT03934294|Metoclopramide|metoclopramide|mesh-list
2839215|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
2839216|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
2839217|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839218|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839219|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2839220|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2839221|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2839222|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
2839223|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839224|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839225|NCT03933956|Empagliflozin|empagliflozin|mesh-list
2839226|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2839227|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839228|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2839229|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839230|NCT03934333|Budesonide|budesonide|mesh-list
2839231|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2839232|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2839233|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
2839234|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839235|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839236|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2839237|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
2839238|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
2839239|NCT03934333|Hormones|hormones|mesh-ancestor
2839240|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839241|NCT03933982|Vinorelbine|vinorelbine|mesh-list
2839242|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2839243|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839244|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
2839245|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
2839246|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
2839247|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839248|NCT03933865|Ketamine|ketamine|mesh-list
2839249|NCT03933865|Hydromorphone|hydromorphone|mesh-list
2839250|NCT03933865|Analgesics|analgesics|mesh-ancestor
2839251|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
2839252|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839253|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839254|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2839255|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2839256|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
2839257|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
2839258|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839259|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2839260|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2295102|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2839261|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839262|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839263|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2839264|NCT03933865|Narcotics|narcotics|mesh-ancestor
2839265|NCT03933631|Ofloxacin|ofloxacin|mesh-list
2839266|NCT03933631|Prednisolone|prednisolone|mesh-list
2839267|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
2839268|NCT03933631|Pilocarpine|pilocarpine|mesh-list
2839269|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2839270|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
2839271|NCT03933631|Hormones|hormones|mesh-ancestor
2839272|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839273|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839274|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2839275|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839276|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
2839277|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839278|NCT03933631|Miotics|miotics|mesh-ancestor
2839279|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2839280|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2839281|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
2839282|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839283|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839284|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2839285|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839286|NCT03933631|Renal Agents|renal agents|mesh-ancestor
2839287|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2839288|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2839289|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2839290|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839291|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2839292|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2839293|NCT03933787|Saxagliptin|saxagliptin|mesh-list
2839294|NCT03933787|Incretins|incretins|mesh-ancestor
2839295|NCT03933787|Hormones|hormones|mesh-ancestor
2839296|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839297|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839298|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2839299|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
2839300|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839301|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295103|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295104|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839302|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2839303|NCT03933748|Teicoplanin|teicoplanin|mesh-list
2839304|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2839305|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839306|NCT03933384|Tenofovir|tenofovir|mesh-list
2839307|NCT03933384|Entecavir|entecavir|mesh-list
2839308|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
2839309|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839310|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2839311|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2839312|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839313|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839314|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2839315|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2839316|NCT03933501|Amoxicillin|amoxicillin|mesh-list
2839317|NCT03933501|Metronidazole|metronidazole|mesh-list
2839318|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2839319|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839320|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2839321|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2839322|NCT03933397|Morphine|morphine|mesh-list
2839323|NCT03933397|Hydromorphone|hydromorphone|mesh-list
2839324|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2839325|NCT03933397|Narcotics|narcotics|mesh-ancestor
2839326|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839327|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839328|NCT03933397|Analgesics|analgesics|mesh-ancestor
2839329|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
2839330|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839331|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
2839332|NCT03933280|Nalbuphine|nalbuphine|mesh-list
2839333|NCT03933280|Propofol|propofol|mesh-list
2839334|NCT03933280|Benoxinate|benoxinate|mesh-list
2839335|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2295105|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2295106|NCT00274235|Renal Agents|renal agents|mesh-ancestor
2295107|NCT00274274|Insulin|insulin|mesh-list
2295108|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2107439|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
2107440|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107441|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2107442|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2107443|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107444|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107445|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2107446|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107447|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2107448|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295109|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
2839336|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
2839337|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839338|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839339|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2839340|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2839341|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
2839342|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2839343|NCT03933280|Analgesics|analgesics|mesh-ancestor
2839344|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
2839345|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839346|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2839347|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2839348|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2839349|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
2839350|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839351|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295110|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
2295111|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2295112|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295113|NCT00274326|Satavaptan|satavaptan|mesh-list
2295114|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2295115|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295116|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
2295117|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295118|NCT00274339|Lansoprazole|lansoprazole|mesh-list
2295119|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2295120|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2839352|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2839353|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2839354|NCT03933280|Narcotics|narcotics|mesh-ancestor
2839355|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
2839356|NCT03933605|Midazolam|midazolam|mesh-list
2839357|NCT03933605|Palonosetron|palonosetron|mesh-list
2839358|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2839359|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2295121|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2295122|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295123|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295124|NCT00274352|Adalimumab|adalimumab|mesh-list
2295125|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2295126|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2295127|NCT00274391|Amiloride|amiloride|mesh-list
2295128|NCT00274391|Diuretics|diuretics|mesh-ancestor
2295129|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
2295130|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295131|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2295132|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2295133|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2295134|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295135|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2839360|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839361|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839362|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2839363|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2839364|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2839365|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2839366|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
2839367|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
2839368|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
2839369|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
2839370|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839371|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839372|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
2839373|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
2839374|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839375|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2839376|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2839377|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2839378|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
2839379|NCT03933293|Ezetimibe|ezetimibe|mesh-list
2839380|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2839381|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2839382|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
2839383|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839384|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2839385|NCT03933345|Naloxone|naloxone|mesh-list
2839386|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2839387|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839388|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
2839389|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839390|NCT03933358|Hormones|hormones|mesh-list
2839391|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839392|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839393|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
2839394|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2295136|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2295137|NCT00274404|Valacyclovir|valacyclovir|mesh-list
2295138|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
2295139|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295140|NCT00274417|Dutasteride|dutasteride|mesh-list
2295141|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2295142|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2839395|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839396|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839397|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2839398|NCT03933306|Analgesics|analgesics|mesh-ancestor
2839399|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
2839400|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839401|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2839402|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2839403|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2839404|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
2839405|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839406|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839407|NCT03933319|Doxorubicin|doxorubicin|mesh-list
2839408|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2839409|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2839410|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839411|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2839412|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2839413|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839414|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839415|NCT03932916|Donepezil|donepezil|mesh-list
2839416|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2839417|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839418|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839419|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
2839420|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839421|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839422|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
2839423|NCT03932864|Plerixafor|plerixafor|mesh-list
2839424|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2839425|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2839426|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
2839427|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839428|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
2839429|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2839430|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
2839431|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
2839432|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839433|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839434|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2839435|NCT03932825|Analgesics|analgesics|mesh-ancestor
2839436|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
2839437|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839438|NCT03932981|Temozolomide|temozolomide|mesh-list
2839439|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2839440|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
2839441|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839442|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295143|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295144|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295145|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
2295146|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2295147|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839443|NCT03933098|Vaccines|vaccines|mesh-list
2839444|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
2839445|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839446|NCT03932578|Atropine|atropine|mesh-list
2839447|NCT03932578|Metoclopramide|metoclopramide|mesh-list
2839448|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2839449|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2839450|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2839451|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
2839452|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839453|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839454|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2839455|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
2839456|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
2839457|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
2839458|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2839459|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2839460|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
2839461|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839462|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839463|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
2839464|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2839465|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2839466|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2839467|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
2839468|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
2839469|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2839470|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
2839471|NCT03932643|TIC10 compound|tic10 compound|mesh-list
2839472|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839473|NCT03932721|Evolocumab|evolocumab|mesh-list
2839474|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2839475|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2839476|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
2839477|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839478|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2839479|NCT03932292|Calcium|calcium|mesh-list
2839480|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2839481|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839482|NCT03932409|Paclitaxel|paclitaxel|mesh-list
2839483|NCT03932409|Carboplatin|carboplatin|mesh-list
2839484|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
2839485|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2839486|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839487|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
2839488|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
2295148|NCT00274430|Dexamethasone|dexamethasone|mesh-list
2295149|NCT00274430|Tadalafil|tadalafil|mesh-list
2295150|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2295151|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
2295152|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
2295153|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295154|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295155|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2295156|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
2295157|NCT00274430|Hormones|hormones|mesh-ancestor
2295158|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2295159|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2295160|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295161|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
2295162|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2295163|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2295164|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295165|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295166|NCT00274430|Urological Agents|urological agents|mesh-ancestor
2295167|NCT00274443|Carboplatin|carboplatin|mesh-list
2295168|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2295169|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295170|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
2295171|NCT00274495|Ribavirin|ribavirin|mesh-list
2295172|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2839489|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
2839490|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839491|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2839492|NCT03932526|Apatinib|apatinib|mesh-list
2295173|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
2839493|NCT03932526|Vinorelbine|vinorelbine|mesh-list
2839494|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295174|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295175|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
2295176|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295177|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2839495|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2839496|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839497|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839498|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2839499|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
2839500|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
2839501|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
2839502|NCT03932318|Azacitidine|azacitidine|mesh-list
2839503|NCT03932318|Venetoclax|venetoclax|mesh-list
2839504|NCT03932318|Lintuzumab|lintuzumab|mesh-list
2839505|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2839506|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
2839507|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839508|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839509|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839510|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2839515|NCT03932123|Vancomycin|vancomycin|mesh-list
2839516|NCT03932123|Meropenem|meropenem|mesh-list
2839517|NCT03932123|Tazobactam|tazobactam|mesh-list
2839518|NCT03932123|Piperacillin|piperacillin|mesh-list
2839519|NCT03932123|Cefotaxime|cefotaxime|mesh-list
2839520|NCT03932123|Cefoxitin|cefoxitin|mesh-list
2839521|NCT03932123|Azlocillin|azlocillin|mesh-list
2839522|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2839523|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839524|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2839525|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839526|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839527|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2839528|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2839529|NCT03932266|Docetaxel|docetaxel|mesh-list
2839530|NCT03932266|Endostar protein|endostar protein|mesh-list
2839531|NCT03932266|Endostatins|endostatins|mesh-list
2839532|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839533|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
2839534|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
2839535|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
2839536|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839537|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2839538|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2839539|NCT03932266|Growth Substances|growth substances|mesh-ancestor
2839540|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839541|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
2295178|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295179|NCT00274508|Bromides|bromides|mesh-list
2295180|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
2295181|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2295182|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
2295183|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295184|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295185|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2295186|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
2295187|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
2295188|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2295189|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
2295190|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295191|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295192|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
2295193|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
2295194|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2295195|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
2295196|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295197|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295198|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2295199|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
2295200|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
2295201|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2295202|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
2295203|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295204|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295205|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
2295206|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2295207|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2295208|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
2295209|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295210|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107449|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
2107450|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2107451|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
2107452|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
2107453|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2107454|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2107455|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2839549|NCT03931915|Leuprolide|leuprolide|mesh-list
2839550|NCT03931915|Relugolix|relugolix|mesh-list
2839551|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2839552|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
2839553|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2839554|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839555|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2839556|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839557|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
2839558|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
2839559|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839560|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
2839561|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2839562|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839563|NCT03931668|Maleic acid|maleic acid|mesh-list
2839564|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839565|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839566|NCT03931863|Ondansetron|ondansetron|mesh-list
2839567|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
2839568|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
2839569|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839570|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839571|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2839572|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
2839573|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
2839574|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2839575|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
2839576|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839577|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839578|NCT03931863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2839579|NCT03931863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2839580|NCT03931863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839581|NCT03931863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2839582|NCT03931863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2295211|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2295212|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
2295213|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
2295214|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2295215|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
2295216|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295217|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295218|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2295219|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2295220|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2107456|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
2107457|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107458|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107459|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107460|NCT02487563|Decitabine|decitabine|mesh-list
2107461|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2107462|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
2107463|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107464|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295221|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
2295222|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
2295223|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2295224|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
2295225|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295226|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295227|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2295228|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
2295229|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
2295230|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2295231|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
2839583|NCT03931928|Tamoxifen|tamoxifen|mesh-list
2839584|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2839585|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
2839586|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839587|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839588|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2839589|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839590|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2839591|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2839592|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2839593|NCT03931889|Vitamin D|vitamin d|mesh-list
2839594|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
2839595|NCT03931889|Vitamins|vitamins|mesh-ancestor
2839596|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
2839597|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839598|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2839599|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2839600|NCT03931408|Gentamicins|gentamicins|mesh-list
2839601|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2839602|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839603|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2839604|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839605|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839606|NCT03931551|Trastuzumab|trastuzumab|mesh-list
2839607|NCT03931551|Olaparib|olaparib|mesh-list
2839608|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2839609|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839610|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2839611|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839612|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839613|NCT03931343|Epinephrine|epinephrine|mesh-list
2839614|NCT03931343|Racepinephrine|racepinephrine|mesh-list
2839615|NCT03931343|Bupivacaine|bupivacaine|mesh-list
2839616|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
2839617|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
2839618|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
2839619|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839620|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839621|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
2839622|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839623|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2295232|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295233|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295234|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
2295235|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2295236|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2295237|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
2295238|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295239|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295240|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2295241|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
2295242|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
2295243|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2295244|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
2295245|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295246|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295247|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2295248|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2295249|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2295250|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
2295251|NCT00274573|Bromides|bromides|mesh-list
2295252|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
2295253|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2295254|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
2295255|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295256|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295257|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2295258|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
2295259|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
2839624|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2839625|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
2839626|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839627|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839628|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2839629|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2839630|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
2839631|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2839632|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
2839633|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
2839634|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
2839635|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2295260|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2295261|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
2295262|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295263|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295264|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
2295265|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2839636|NCT03931642|Blinatumomab|blinatumomab|mesh-list
2839637|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839638|NCT03931239|Vaccines|vaccines|mesh-list
2839639|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
2839640|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839641|NCT03931317|Timolol|timolol|mesh-list
2839642|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2839643|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2839644|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
2839645|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839646|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839647|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839648|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2839649|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2839650|NCT03931135|Dexamethasone|dexamethasone|mesh-list
2839651|NCT03931135|Morphine|morphine|mesh-list
2839652|NCT03931135|Cyclizine|cyclizine|mesh-list
2839653|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2839654|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
2839655|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
2839656|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839657|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839658|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2839659|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
2839660|NCT03931135|Hormones|hormones|mesh-ancestor
2839661|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839662|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2839663|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839664|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2839665|NCT03931135|Narcotics|narcotics|mesh-ancestor
2839666|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2295266|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2295267|NCT00274599|Telmisartan|telmisartan|mesh-list
2295268|NCT00274599|Ramipril|ramipril|mesh-list
2295269|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2295270|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2295271|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2295272|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295273|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2295274|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
2295275|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295276|NCT00274612|Telmisartan|telmisartan|mesh-list
2295277|NCT00274612|Ramipril|ramipril|mesh-list
2295278|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2295279|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2295280|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2295281|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295282|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2295283|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
2295284|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295285|NCT00274638|Losartan|losartan|mesh-list
2295286|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2295287|NCT00274638|Telmisartan|telmisartan|mesh-list
2295288|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2295289|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2295290|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2839667|NCT03931135|Analgesics|analgesics|mesh-ancestor
2839668|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
2839669|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2839670|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
2839671|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
2839672|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839673|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839680|NCT03931057|Midazolam|midazolam|mesh-list
2839681|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2839682|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2839683|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839684|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839685|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2839686|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2839687|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2839688|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2839689|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
2839690|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
2839691|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
2295291|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2295292|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295293|NCT00274638|Diuretics|diuretics|mesh-ancestor
2295294|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
2295295|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295296|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2295297|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2295298|NCT00274677|Lamotrigine|lamotrigine|mesh-list
2295299|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
2295300|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2295301|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2295302|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839692|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
2839693|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839694|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839695|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
2839696|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2839697|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839698|NCT03931369|Tolvaptan|tolvaptan|mesh-list
2839699|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2839700|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839701|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
2839702|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839703|NCT03930875|Aspirin|aspirin|mesh-list
2839704|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2839705|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2839706|NCT03930875|Analgesics|analgesics|mesh-ancestor
2839707|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
2839708|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839709|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839710|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2839711|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2839712|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2839713|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2839714|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839715|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2839716|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2839717|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839718|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
2839719|NCT03931161|Evolocumab|evolocumab|mesh-list
2839720|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2839721|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2839722|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
2839723|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839724|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2839725|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
2839726|NCT03930680|Razoxane|razoxane|mesh-list
2839727|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839728|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2839729|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2839730|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2839731|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839732|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839733|NCT03930680|Protective Agents|protective agents|mesh-ancestor
2839734|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839735|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
2839736|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
2839737|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2839738|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2839739|NCT03930706|Estradiol|estradiol|mesh-list
2839740|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2839741|NCT03930706|Estrogens|estrogens|mesh-ancestor
2839742|NCT03930706|Hormones|hormones|mesh-ancestor
2839743|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839744|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839745|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2839746|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
2839747|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2295303|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2295304|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295305|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2295306|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2295307|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2295308|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2295309|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2295310|NCT00274690|Casopitant|casopitant|mesh-list
2295311|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
2839748|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2839749|NCT03930433|Nebivolol|nebivolol|mesh-list
2839750|NCT03930433|Diltiazem|diltiazem|mesh-list
2839751|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2839752|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
2839753|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2839754|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2839755|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2839756|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
2839757|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839758|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839759|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839760|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2839761|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2839762|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2839763|NCT03930446|Ethanol|ethanol|mesh-list
2839764|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2839765|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839766|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839767|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839768|NCT03930069|Vasopressins|vasopressins|mesh-list
2839769|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
2839770|NCT03930069|Misoprostol|misoprostol|mesh-list
2839771|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2839772|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
2839773|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2839774|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839775|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2839776|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2839777|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
2839778|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
2839779|NCT03930069|Coagulants|coagulants|mesh-ancestor
2839780|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2839781|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2839782|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
2839783|NCT03930212|Progesterone|progesterone|mesh-list
2839784|NCT03930212|Progestins|progestins|mesh-ancestor
2839785|NCT03930212|Hormones|hormones|mesh-ancestor
2839786|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839787|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839788|NCT03929861|Fluconazole|fluconazole|mesh-list
2839789|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
2839790|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839791|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2839792|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2839793|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839794|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839795|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2839796|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
2839797|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839798|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839799|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2839800|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2839801|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
2839802|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2839803|NCT03929835|Protective Agents|protective agents|mesh-ancestor
2839804|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839818|NCT03929718|Spironolactone|spironolactone|mesh-list
2839819|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2839820|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
2839821|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2839822|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839823|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2839824|NCT03929718|Diuretics|diuretics|mesh-ancestor
2839825|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
2839826|NCT03929419|Insulin|insulin|mesh-list
2839827|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2839828|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839829|NCT03929640|Acetaminophen|acetaminophen|mesh-list
2839830|NCT03929640|Ibuprofen|ibuprofen|mesh-list
2839831|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2839832|NCT03929640|Analgesics|analgesics|mesh-ancestor
2839833|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
2839834|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839835|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839836|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
2839837|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2839838|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2839839|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2839840|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2839841|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839842|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839843|NCT03929601|Rituximab|rituximab|mesh-list
2839844|NCT03929601|Abatacept|abatacept|mesh-list
2839845|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2839846|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839847|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
2839848|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839849|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2839850|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2839851|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839852|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2839853|NCT03929744|Midazolam|midazolam|mesh-list
2839854|NCT03929744|Atorvastatin|atorvastatin|mesh-list
2839855|NCT03929744|Simvastatin|simvastatin|mesh-list
2839856|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2839857|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2839858|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
2839859|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839860|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2839861|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2839862|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839863|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2839864|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2839865|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839866|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839867|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2839868|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2839869|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2839870|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2295312|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
2295313|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295314|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295315|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2295316|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2295317|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839871|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
2839872|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
2839873|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
2839874|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
2295318|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295319|NCT00274794|Rituximab|rituximab|mesh-list
2295320|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2295321|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295322|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
2295323|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295324|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2295325|NCT00274807|Cytarabine|cytarabine|mesh-list
2295326|NCT00274807|Etoposide|etoposide|mesh-list
2295327|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
2295328|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2295329|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295330|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2295331|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2295332|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295333|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295334|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
2839875|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839876|NCT03929575|Calcium|calcium|mesh-list
2839877|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2839878|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839879|NCT03929666|Leucovorin|leucovorin|mesh-list
2839880|NCT03929666|Gemcitabine|gemcitabine|mesh-list
2839881|NCT03929666|Bevacizumab|bevacizumab|mesh-list
2839882|NCT03929666|Fluorouracil|fluorouracil|mesh-list
2839883|NCT03929666|Capecitabine|capecitabine|mesh-list
2839884|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
2839885|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2839886|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839887|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2839888|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2839889|NCT03929666|Growth Substances|growth substances|mesh-ancestor
2839890|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839891|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
2839892|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2839893|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
2839894|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839895|NCT03929666|Antiviral Agents|antiviral agents|mesh-ancestor
2839896|NCT03929666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839897|NCT03929666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839898|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2839899|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
2839900|NCT03929666|Antidotes|antidotes|mesh-ancestor
2839901|NCT03929666|Protective Agents|protective agents|mesh-ancestor
2839902|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
2839903|NCT03929666|Vitamins|vitamins|mesh-ancestor
2839904|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
2839905|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
2839906|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2839907|NCT03929224|Bacitracin|bacitracin|mesh-list
2839908|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2839909|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295335|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295336|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2295337|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
2295338|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
2295339|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295340|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2295341|NCT00274807|Analgesics|analgesics|mesh-ancestor
2295342|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
2295343|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295344|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
2295345|NCT00274820|Thalidomide|thalidomide|mesh-list
2295346|NCT00274820|Dexamethasone|dexamethasone|mesh-list
2295347|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
2295348|NCT00274820|Vitamins|vitamins|mesh-ancestor
2295349|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
2295350|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295351|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2295352|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
2295353|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
2295354|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295355|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2295356|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
2839910|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2839911|NCT03929094|Gemcitabine|gemcitabine|mesh-list
2839912|NCT03929094|Paclitaxel|paclitaxel|mesh-list
2839913|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2839914|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2839915|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839916|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
2839917|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
2839918|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
2839919|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839920|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2839921|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
2839922|NCT03929094|Antiviral Agents|antiviral agents|mesh-ancestor
2839923|NCT03929094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839924|NCT03929094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839925|NCT03929094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2839926|NCT03929094|Immunologic Factors|immunologic factors|mesh-ancestor
2839927|NCT03929094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839928|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
2839929|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
2839930|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2839931|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2839932|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839933|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839934|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839935|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2839936|NCT03929068|Levodopa|levodopa|mesh-list
2839937|NCT03929068|Carbidopa|carbidopa|mesh-list
2839938|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2839939|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2839940|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2839941|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
2839942|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839943|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839944|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839945|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2295357|NCT00274820|Hormones|hormones|mesh-ancestor
2295358|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2295359|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2295360|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295361|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
2295362|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839946|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839947|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2839948|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
2839949|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
2839950|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2839951|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2839952|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2839953|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2839954|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839955|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
2839956|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295363|NCT00274820|Protective Agents|protective agents|mesh-ancestor
2295364|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2839957|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839958|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2839959|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839960|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
2839961|NCT03928691|Analgesics|analgesics|mesh-ancestor
2839962|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
2839963|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2839964|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839965|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
2839966|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2295365|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
2295366|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
2295367|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2295368|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2839967|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2839968|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
2839969|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2839970|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2839971|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295369|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2295370|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2839972|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2839973|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
2839974|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2295371|NCT00274820|Growth Substances|growth substances|mesh-ancestor
2295372|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
2295373|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2295374|NCT00274833|Temozolomide|temozolomide|mesh-list
2295375|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295376|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2295377|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2839975|NCT03928340|Metformin|metformin|mesh-list
2839976|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2839977|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839978|NCT03928353|Ticagrelor|ticagrelor|mesh-list
2839979|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2839980|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2839981|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2839982|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2839983|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
2839984|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2839985|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839986|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2839987|NCT03928314|Paclitaxel|paclitaxel|mesh-list
2839988|NCT03928314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2839989|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2839990|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2839991|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
2839992|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
2839993|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
2839994|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2839995|NCT03928366|Remifentanil|remifentanil|mesh-list
2839996|NCT03928366|Propofol|propofol|mesh-list
2839997|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2839998|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2839999|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840000|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2295378|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295379|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2295380|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
2295381|NCT00274859|Gemcitabine|gemcitabine|mesh-list
2295382|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
2295383|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2295384|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
2295385|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295386|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295387|NCT00274859|Antiviral Agents|antiviral agents|mesh-ancestor
2295388|NCT00274859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295389|NCT00274859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295390|NCT00274859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2295391|NCT00274859|Immunologic Factors|immunologic factors|mesh-ancestor
2295392|NCT00274859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840001|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
2840002|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
2840003|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2840004|NCT03928366|Narcotics|narcotics|mesh-ancestor
2840005|NCT03928366|Analgesics|analgesics|mesh-ancestor
2840006|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
2840007|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840014|NCT03928184|Lorecivivint|lorecivivint|mesh-list
2840015|NCT03928184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2840016|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2840017|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
2840018|NCT03928145|Amiloride|amiloride|mesh-list
2840019|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2840020|NCT03928145|Diuretics|diuretics|mesh-ancestor
2840021|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
2840022|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840023|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2840024|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2295393|NCT00274872|Leucovorin|leucovorin|mesh-list
2295394|NCT00274872|Fluorouracil|fluorouracil|mesh-list
2295395|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
2295396|NCT00274872|Calcium|calcium|mesh-list
2295397|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
2295398|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2295399|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295400|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
2295401|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295402|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2295403|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295404|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2295405|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
2840025|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840026|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2840027|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2840028|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2840029|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2840030|NCT03928262|Benralizumab|benralizumab|mesh-list
2840031|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2840032|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
2295406|NCT00274872|Antidotes|antidotes|mesh-ancestor
2295407|NCT00274872|Protective Agents|protective agents|mesh-ancestor
2295408|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
2295409|NCT00274872|Vitamins|vitamins|mesh-ancestor
2295410|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
2295411|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
2295412|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295413|NCT00274898|Celecoxib|celecoxib|mesh-list
2295414|NCT00274898|Docetaxel|docetaxel|mesh-list
2840033|NCT03928275|Aldesleukin|aldesleukin|mesh-list
2840034|NCT03928275|Interleukin-2|interleukin-2|mesh-list
2840035|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
2840036|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840037|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2840038|NCT03928275|Analgesics|analgesics|mesh-ancestor
2840039|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
2840040|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840041|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840042|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2840043|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2840044|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
2840045|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840046|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2840047|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
2840048|NCT03928288|Cabergoline|cabergoline|mesh-list
2840049|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2840050|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2840051|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
2840052|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
2840053|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840054|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840055|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840056|NCT03928600|Misoprostol|misoprostol|mesh-list
2840057|NCT03928600|Dinoprostone|dinoprostone|mesh-list
2840058|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2840059|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
2840060|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2840061|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840062|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2840063|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2840064|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
2295415|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295416|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
2295417|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
2840065|NCT03928210|Digoxin|digoxin|mesh-list
2840066|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2840067|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2840068|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840069|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840070|NCT03928210|Protective Agents|protective agents|mesh-ancestor
2840071|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840072|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
2840073|NCT03927963|Propofol|propofol|mesh-list
2840074|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2840075|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840076|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840077|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2840078|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
2840079|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
2295418|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
2295419|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295420|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2295421|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2295422|NCT00274898|Analgesics|analgesics|mesh-ancestor
2840080|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2840081|NCT03927963|Analgesics|analgesics|mesh-ancestor
2840082|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
2840083|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840084|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2840085|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2840086|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2840087|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
2840088|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840089|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840090|NCT03928093|Pregabalin|pregabalin|mesh-list
2840091|NCT03928093|Analgesics|analgesics|mesh-ancestor
2840092|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
2840093|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840094|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840095|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
2840096|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2840097|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2840098|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840099|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2840100|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2840101|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2840102|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840103|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2840104|NCT03927807|Misoprostol|misoprostol|mesh-list
2840105|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2840106|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
2840107|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2840108|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840109|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2840110|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2840111|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
2295423|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
2295424|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295425|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295426|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2295427|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2295428|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2295429|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2295430|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295431|NCT00274911|Vincristine|vincristine|mesh-list
2295432|NCT00274911|Lomustine|lomustine|mesh-list
2295433|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295434|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2840112|NCT03927989|Nicotine|nicotine|mesh-list
2840113|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2840114|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
2840115|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840116|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840117|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2840118|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2840119|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
2840120|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840121|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840122|NCT03928015|Analgesics|analgesics|mesh-list
2840123|NCT03928015|Dronabinol|dronabinol|mesh-list
2840124|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
2840125|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840126|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840127|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
2840128|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2840129|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2840130|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2840131|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2840132|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840133|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840134|NCT03928015|Hormones|hormones|mesh-ancestor
2840135|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2840136|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
2840137|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2840138|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
2840139|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
2840140|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840141|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840142|NCT03927378|Ketamine|ketamine|mesh-list
2840143|NCT03927378|Esketamine|esketamine|mesh-list
2840144|NCT03927378|Analgesics|analgesics|mesh-ancestor
2840145|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
2840146|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840147|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840148|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2840149|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2840150|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
2840151|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
2840152|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840153|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2840154|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2840155|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840156|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840157|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
2840158|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2840159|NCT03927352|Adalimumab|adalimumab|mesh-list
2840160|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2840161|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2840162|NCT03927456|Fulvestrant|fulvestrant|mesh-list
2840163|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2840164|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840165|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2840166|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2840167|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
2840168|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2840169|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840170|NCT03927495|Paclitaxel|paclitaxel|mesh-list
2840171|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2840172|NCT03927495|Cisplatin|cisplatin|mesh-list
2840173|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2840174|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840175|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
2840176|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
2840177|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
2840178|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840179|NCT03927118|Dexamethasone|dexamethasone|mesh-list
2840180|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
2840181|NCT03927118|BB 1101|bb 1101|mesh-list
2840182|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2840183|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
2840184|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
2840185|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840186|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840187|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2840188|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
2840189|NCT03927118|Hormones|hormones|mesh-ancestor
2840190|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2840191|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2840192|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840193|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
2840194|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840195|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295435|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
2295436|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
2840196|NCT03927170|Metformin|metformin|mesh-list
2840197|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2840198|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2840199|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840200|NCT03927170|Incretins|incretins|mesh-ancestor
2840201|NCT03927170|Hormones|hormones|mesh-ancestor
2840202|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2840203|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2840204|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
2840205|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295437|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
2295438|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295439|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2295440|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
2295441|NCT00274950|Carboplatin|carboplatin|mesh-list
2840206|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840210|NCT03927313|Aspirin|aspirin|mesh-list
2840211|NCT03927313|Rifampin|rifampin|mesh-list
2840212|NCT03927313|Linezolid|linezolid|mesh-list
2840213|NCT03927313|Dexamethasone|dexamethasone|mesh-list
2840214|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2840215|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
2840216|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
2840217|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840218|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840219|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2840220|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
2840221|NCT03927313|Hormones|hormones|mesh-ancestor
2840222|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2840223|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2840224|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840225|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2840226|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2295442|NCT00274950|Etoposide|etoposide|mesh-list
2295443|NCT00274950|Ifosfamide|ifosfamide|mesh-list
2295444|NCT00274950|Bleomycin|bleomycin|mesh-list
2295445|NCT00274950|Vinblastine|vinblastine|mesh-list
2295446|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295447|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2295448|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2295449|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2295450|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295451|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295452|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2295453|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
2295454|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2295455|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
2295456|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
2295457|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
2295458|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2295459|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
2295460|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2295461|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
2295462|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295463|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295464|NCT00274963|Analgesics|analgesics|mesh-ancestor
2295465|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
2295466|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295467|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295468|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2295469|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2295470|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295471|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
2295472|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2295473|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295474|NCT00274989|Rituximab|rituximab|mesh-list
2295475|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2295476|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2295477|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295478|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
2840227|NCT03927313|Analgesics|analgesics|mesh-ancestor
2840228|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
2840229|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2840230|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2840231|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2840232|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840233|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2840234|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2840235|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840236|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
2840237|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2840238|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
2840239|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2840240|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840241|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
2840242|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2840243|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2840244|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2840245|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2840246|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2840247|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2840248|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2840249|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2840250|NCT03927222|Temozolomide|temozolomide|mesh-list
2840251|NCT03927222|Molgramostim|molgramostim|mesh-list
2840252|NCT03927222|Sargramostim|sargramostim|mesh-list
2840253|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
2840254|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840255|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2840256|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
2840257|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840258|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840259|NCT03927248|Nivolumab|nivolumab|mesh-list
2840260|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2840261|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840262|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2840263|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840264|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2840265|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2840266|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840267|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
2840268|NCT03926780|Warfarin|warfarin|mesh-list
2840269|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
2840270|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
2840271|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2840272|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
2840273|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2840274|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
2840275|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840276|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840277|NCT03926806|Vitamins|vitamins|mesh-list
2840278|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
2840279|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
2840280|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840281|NCT03926962|Nafithromycin|nafithromycin|mesh-list
2840282|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2840283|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840284|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2840285|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840286|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840287|NCT03926936|Fulvestrant|fulvestrant|mesh-list
2840288|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2840289|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840290|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2840291|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2840292|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
2840293|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2295479|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295480|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2295481|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2840294|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840295|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
2840296|NCT03926663|Bupivacaine|bupivacaine|mesh-list
2840297|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
2840298|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
2840299|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840300|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840301|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
2840302|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840303|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2840304|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2840305|NCT03926663|Analgesics|analgesics|mesh-ancestor
2840306|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2840307|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2840308|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2840309|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
2840310|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840311|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840312|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
2840313|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840314|NCT03926754|Mirabegron|mirabegron|mesh-list
2840315|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2840316|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2840317|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2840318|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
2840319|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840320|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840321|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840322|NCT03926754|Urological Agents|urological agents|mesh-ancestor
2840323|NCT03926559|Morphine|morphine|mesh-list
2840324|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2840325|NCT03926559|Narcotics|narcotics|mesh-ancestor
2840326|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840327|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840328|NCT03926559|Analgesics|analgesics|mesh-ancestor
2840329|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
2840330|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840331|NCT03926377|Clobetasol|clobetasol|mesh-list
2840332|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2840333|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
2295482|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
2295483|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295484|NCT00275015|Cytarabine|cytarabine|mesh-list
2840334|NCT03926377|Hormones|hormones|mesh-ancestor
2840335|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2840336|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840337|NCT03926299|Clobetasol|clobetasol|mesh-list
2840338|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2840339|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
2840340|NCT03926299|Hormones|hormones|mesh-ancestor
2840341|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2840342|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840343|NCT03926403|Anesthetics|anesthetics|mesh-list
2840344|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840345|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840346|NCT03926338|Celecoxib|celecoxib|mesh-list
2840347|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
2840348|NCT03926338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2840349|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2840350|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2840351|NCT03926338|Analgesics|analgesics|mesh-ancestor
2840352|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
2840353|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840354|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840355|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2840356|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2840357|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2840358|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840359|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840360|NCT03926338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840361|NCT03926182|Aflutinib|aflutinib|mesh-list
2840362|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2840363|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840364|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840368|NCT03926156|Warfarin|warfarin|mesh-list
2840369|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
2840370|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
2840371|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2840372|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
2840373|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2840374|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
2840375|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295485|NCT00275015|Dexamethasone|dexamethasone|mesh-list
2295486|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
2295487|NCT00275015|Melphalan|melphalan|mesh-list
2295488|NCT00275015|Carmustine|carmustine|mesh-list
2295489|NCT00275015|Fludarabine|fludarabine|mesh-list
2295490|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
2295491|NCT00275015|Etoposide|etoposide|mesh-list
2840376|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840386|NCT03926026|Fluticasone|fluticasone|mesh-list
2840387|NCT03926026|Xhance|xhance|mesh-list
2840388|NCT03926026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2840389|NCT03926026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2840390|NCT03926026|Autonomic Agents|autonomic agents|mesh-ancestor
2840391|NCT03926026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840392|NCT03926026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840393|NCT03926026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2840394|NCT03926026|Respiratory System Agents|respiratory system agents|mesh-ancestor
2840395|NCT03926026|Dermatologic Agents|dermatologic agents|mesh-ancestor
2840396|NCT03926026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2840397|NCT03926000|Pregabalin|pregabalin|mesh-list
2840398|NCT03926000|Analgesics|analgesics|mesh-ancestor
2840399|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
2840400|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840401|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840402|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
2840403|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2295492|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2295493|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
2840404|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2840405|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840406|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2840407|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2840408|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2295494|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295495|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2295496|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2295497|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
2295498|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295499|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295500|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2295501|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2295502|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
2295503|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
2295504|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295505|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2295506|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
2295507|NCT00275015|Hormones|hormones|mesh-ancestor
2295508|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2295509|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2295510|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2295511|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
2295512|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2295513|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2295514|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2840409|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840410|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2840411|NCT03925818|Metronidazole|metronidazole|mesh-list
2840412|NCT03925818|Tetracycline|tetracycline|mesh-list
2840413|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
2840414|NCT03925818|Pantoprazole|pantoprazole|mesh-list
2840415|NCT03925818|Bismuth|bismuth|mesh-list
2840416|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840417|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2840418|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2840419|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2840420|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2840421|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2840422|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2840423|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840424|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840425|NCT03925818|Antacids|antacids|mesh-ancestor
2840426|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2840427|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
2840428|NCT03926091|Docetaxel|docetaxel|mesh-list
2840429|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2840430|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
2840431|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840432|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2840433|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2840434|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
2840435|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840436|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840437|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2840438|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
2840439|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
2840440|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
2840441|NCT03925714|Metformin|metformin|mesh-list
2840442|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2840443|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840444|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
2840445|NCT03925779|Remifentanil|remifentanil|mesh-list
2840446|NCT03925779|Propofol|propofol|mesh-list
2840447|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2840448|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840449|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840450|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2840451|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
2840452|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
2840453|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2840454|NCT03925779|Analgesics|analgesics|mesh-ancestor
2840455|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
2840456|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840457|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2840458|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2840459|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2840460|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
2840461|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840462|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840463|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2295515|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295516|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
2295517|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295518|NCT00275041|Irinotecan|irinotecan|mesh-list
2295519|NCT00275041|Cetuximab|cetuximab|mesh-list
2295520|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2295521|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2295522|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295523|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295524|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295525|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2295526|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
2295527|NCT00275054|Rituximab|rituximab|mesh-list
2295528|NCT00275054|Fludarabine|fludarabine|mesh-list
2840464|NCT03925779|Narcotics|narcotics|mesh-ancestor
2840465|NCT03925740|Listerine|listerine|mesh-list
2840466|NCT03925740|Fluorides|fluorides|mesh-list
2840467|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
2840468|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
2840469|NCT03925740|Protective Agents|protective agents|mesh-ancestor
2840470|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840471|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2840472|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840473|NCT03925701|Metformin|metformin|mesh-list
2295529|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2295530|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
2295531|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840474|NCT03925701|Vildagliptin|vildagliptin|mesh-list
2840475|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2840476|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840477|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2840478|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
2840479|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840480|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840481|NCT03925662|Mebendazole|mebendazole|mesh-list
2840482|NCT03925662|Piperazine|piperazine|mesh-list
2840483|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
2840484|NCT03925662|Bevacizumab|bevacizumab|mesh-list
2840485|NCT03925662|DMP 777|dmp 777|mesh-list
2295532|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2295533|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2295534|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
2295535|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295536|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295537|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2840486|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2840487|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840488|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2840489|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2840490|NCT03925662|Growth Substances|growth substances|mesh-ancestor
2840491|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840492|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
2840493|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
2295538|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2295539|NCT00275067|Temozolomide|temozolomide|mesh-list
2295540|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
2295541|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2295542|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
2295543|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295544|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295545|NCT00275080|Decitabine|decitabine|mesh-list
2295546|NCT00275080|Azacitidine|azacitidine|mesh-list
2295547|NCT00275080|Vorinostat|vorinostat|mesh-list
2840494|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
2840495|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2840496|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840497|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
2840498|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
2840499|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
2295548|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2840500|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840501|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840502|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2840503|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2840504|NCT03925233|Tamoxifen|tamoxifen|mesh-list
2840505|NCT03925233|Toremifene|toremifene|mesh-list
2840506|NCT03925233|Gemcitabine|gemcitabine|mesh-list
2840507|NCT03925233|Vinorelbine|vinorelbine|mesh-list
2840508|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
2840509|NCT03925233|Bevacizumab|bevacizumab|mesh-list
2840510|NCT03925233|Carboplatin|carboplatin|mesh-list
2840511|NCT03925233|Doxorubicin|doxorubicin|mesh-list
2840512|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2840513|NCT03925233|Fluorouracil|fluorouracil|mesh-list
2840514|NCT03925233|Capecitabine|capecitabine|mesh-list
2840515|NCT03925233|Methotrexate|methotrexate|mesh-list
2840516|NCT03925233|Trastuzumab|trastuzumab|mesh-list
2840517|NCT03925233|Letrozole|letrozole|mesh-list
2840518|NCT03925233|Apatinib|apatinib|mesh-list
2840519|NCT03925233|Epirubicin|epirubicin|mesh-list
2840520|NCT03925233|Olaparib|olaparib|mesh-list
2840521|NCT03925233|Fulvestrant|fulvestrant|mesh-list
2840522|NCT03925233|Anastrozole|anastrozole|mesh-list
2840523|NCT03925233|Exemestane|exemestane|mesh-list
2840524|NCT03925233|Endostatins|endostatins|mesh-list
2840525|NCT03925233|Pirarubicin|pirarubicin|mesh-list
2840526|NCT03925233|Citric Acid|citric acid|mesh-list
2840527|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
2840528|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2840529|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840530|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
2840531|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
2840532|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
2295549|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
2295550|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295551|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295552|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295553|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2295554|NCT00275093|Sirolimus|sirolimus|mesh-list
2295555|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2295556|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295557|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2295558|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295559|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
2295560|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2295561|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
2295562|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840533|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840534|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2840535|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
2840536|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840537|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2840538|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2840539|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
2840540|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2840541|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2840542|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2840543|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2840544|NCT03925233|Growth Substances|growth substances|mesh-ancestor
2840545|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
2840546|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2840547|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
2840548|NCT03925233|Antiviral Agents|antiviral agents|mesh-ancestor
2840549|NCT03925233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840550|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840551|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2840552|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2840553|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2840554|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2840555|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
2840556|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2840557|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
2840558|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2295563|NCT00275106|Leucovorin|leucovorin|mesh-list
2840559|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2840560|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
2840561|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2840562|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
2840563|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
2840564|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2840565|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2295564|NCT00275106|Cytarabine|cytarabine|mesh-list
2295565|NCT00275106|Dexamethasone|dexamethasone|mesh-list
2295566|NCT00275106|Prednisolone|prednisolone|mesh-list
2295567|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
2295568|NCT00275106|Doxorubicin|doxorubicin|mesh-list
2295569|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2295570|NCT00275106|Methotrexate|methotrexate|mesh-list
2295571|NCT00275106|Vincristine|vincristine|mesh-list
2295572|NCT00275106|Daunorubicin|daunorubicin|mesh-list
2295573|NCT00275106|Asparaginase|asparaginase|mesh-list
2295574|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
2295575|NCT00275106|Thioguanine|thioguanine|mesh-list
2295576|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
2295577|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2295578|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
2295579|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295580|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2840566|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2840567|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
2840568|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2840569|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2840570|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2840571|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2840572|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2840573|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2840574|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2840575|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2840576|NCT03925285|Bevacizumab|bevacizumab|mesh-list
2840577|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2840578|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840579|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2840580|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2840581|NCT03925285|Growth Substances|growth substances|mesh-ancestor
2840582|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840583|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
2840584|NCT03925428|Entinostat|entinostat|mesh-list
2840585|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2840586|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840587|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840588|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840589|NCT03925402|Ertapenem|ertapenem|mesh-list
2840590|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2840591|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840592|NCT03925480|Azithromycin|azithromycin|mesh-list
2840593|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2840594|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840595|NCT03925090|Cisplatin|cisplatin|mesh-list
2840596|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840597|NCT03925155|Iodine|iodine|mesh-list
2840598|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
2840599|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2840600|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840601|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
2840602|NCT03925155|Trace Elements|trace elements|mesh-ancestor
2840603|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
2840604|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840605|NCT03925051|Denosumab|denosumab|mesh-list
2840606|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2840607|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840608|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
2840609|NCT03925025|Nimodipine|nimodipine|mesh-list
2840610|NCT03925025|Analgesics|analgesics|mesh-ancestor
2840611|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
2840612|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840613|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840614|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
2840615|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840616|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2840617|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
2295581|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2295582|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
2295583|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295584|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295585|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2295586|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2295587|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
2295588|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
2295589|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295590|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2295591|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
2295592|NCT00275106|Hormones|hormones|mesh-ancestor
2295593|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2295594|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2295595|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2295596|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2295597|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2295598|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295599|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2295600|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
2295601|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2295602|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2295603|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
2295604|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
2295605|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2295606|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2295607|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
2295608|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295609|NCT00275106|Antidotes|antidotes|mesh-ancestor
2295610|NCT00275106|Protective Agents|protective agents|mesh-ancestor
2295611|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
2295612|NCT00275106|Vitamins|vitamins|mesh-ancestor
2295613|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
2295614|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2107465|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295615|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
2295616|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
2295617|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
2295618|NCT00275119|Gemcitabine|gemcitabine|mesh-list
2295619|NCT00275119|Fluorouracil|fluorouracil|mesh-list
2295620|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
2295621|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2295622|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
2295623|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295624|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295625|NCT00275119|Antiviral Agents|antiviral agents|mesh-ancestor
2840618|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2840619|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2840620|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840621|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2840622|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
2840623|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2840624|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2840625|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
2840626|NCT03924791|Dexamethasone|dexamethasone|mesh-list
2840627|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
2840628|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2840629|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2295626|NCT00275119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295627|NCT00275119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295628|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2295629|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
2295630|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295631|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2295632|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295633|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2295634|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840630|NCT03924791|Prednisolone|prednisolone|mesh-list
2840631|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
2840632|NCT03924791|Lidocaine|lidocaine|mesh-list
2840633|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2840634|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
2840635|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2840636|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
2840637|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
2840638|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295635|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840639|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840640|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2840641|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
2840642|NCT03924791|Hormones|hormones|mesh-ancestor
2840643|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2840644|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2840645|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840646|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
2840647|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
2840648|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840649|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
2840650|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2840651|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2840652|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2295636|NCT00275184|Metoclopramide|metoclopramide|mesh-list
2295637|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
2295638|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
2295639|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295640|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840653|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2840654|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840655|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2840656|NCT03924791|Protective Agents|protective agents|mesh-ancestor
2840657|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
2840658|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2840659|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295641|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2295642|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2295643|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2295644|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
2295645|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295646|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295647|NCT00275197|Sertraline|sertraline|mesh-list
2295648|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
2840660|NCT03924544|Mitomycins|mitomycins|mesh-list
2840661|NCT03924544|Mitomycin|mitomycin|mesh-list
2840662|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2840663|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840664|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
2840665|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840666|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2840667|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840668|NCT03924596|Boswellic acid|boswellic acid|mesh-list
2840669|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2840670|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2840671|NCT03924596|Analgesics|analgesics|mesh-ancestor
2840672|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
2840673|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840674|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840675|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2840676|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2840677|NCT03924401|Abatacept|abatacept|mesh-list
2840678|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2840679|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840680|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840681|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2840682|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
2840683|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840684|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2840685|NCT03924427|BMS-986165|bms-986165|mesh-list
2840686|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
2840687|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2840688|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840689|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840690|NCT03924323|Citalopram|citalopram|mesh-list
2840691|NCT03924323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2840692|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2840693|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2840694|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840695|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840696|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
2840697|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840698|NCT03924323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2840699|NCT03924323|Antidepressive Agents|antidepressive agents|mesh-ancestor
2840700|NCT03924323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2840701|NCT03924518|Granisetron|granisetron|mesh-list
2840702|NCT03924518|Serotonin|serotonin|mesh-list
2840703|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
2840704|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
2840705|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840706|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840707|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2840708|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2840709|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
2840710|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840711|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840712|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2840722|NCT03924245|Olaparib|olaparib|mesh-list
2840723|NCT03924245|Entinostat|entinostat|mesh-list
2295649|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2295650|NCT00275197|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2295651|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2295652|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2295653|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295654|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295655|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
2295656|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295657|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
2295658|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295659|NCT00275236|Rotigotine|rotigotine|mesh-list
2295660|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
2840724|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2840725|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840726|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840727|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840728|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2840729|NCT03924440|Nonoxynol|nonoxynol|mesh-list
2840730|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2840731|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2295661|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
2295662|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295663|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295664|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295665|NCT00275249|Levorphanol|levorphanol|mesh-list
2295666|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2840732|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840733|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2840734|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
2840735|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2840736|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2840737|NCT03924492|Pregnanolone|pregnanolone|mesh-list
2840738|NCT03924492|Brexanolone|brexanolone|mesh-list
2840739|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
2840740|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840741|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840742|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840743|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
2840744|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
2840745|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
2840746|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840747|NCT03923881|Cetuximab|cetuximab|mesh-list
2840748|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2840749|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840750|NCT03923842|Denosumab|denosumab|mesh-list
2840751|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2840752|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840753|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
2840754|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2840755|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2840756|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840757|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
2840758|NCT03923959|Coagulants|coagulants|mesh-ancestor
2840759|NCT03923725|Artesunate|artesunate|mesh-list
2840760|NCT03923725|Lumefantrine|lumefantrine|mesh-list
2840761|NCT03923725|Artemether|artemether|mesh-list
2840762|NCT03923725|Piperaquine|piperaquine|mesh-list
2840763|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2840764|NCT03923725|Amodiaquine|amodiaquine|mesh-list
2840765|NCT03923725|Mefloquine|mefloquine|mesh-list
2840766|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
2840767|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2840768|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2840769|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840770|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840771|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
2840772|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
2840773|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2840774|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
2840775|NCT03923803|Calcitonin|calcitonin|mesh-list
2840776|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
2840777|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2840778|NCT03923803|Katacalcin|katacalcin|mesh-list
2840779|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2840780|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840781|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2840782|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
2840783|NCT03923556|Neostigmine|neostigmine|mesh-list
2840784|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2840785|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840786|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840787|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
2840788|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840789|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295667|NCT00275249|Narcotics|narcotics|mesh-ancestor
2840790|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2840791|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
2840792|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840796|NCT03923829|Zinc|zinc|mesh-list
2840797|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
2840798|NCT03923829|Trace Elements|trace elements|mesh-ancestor
2840799|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
2840800|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840801|NCT03923829|Astringents|astringents|mesh-ancestor
2840802|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
2840803|NCT03923751|Anesthetics|anesthetics|mesh-list
2840804|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840805|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295668|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2295669|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295670|NCT00275249|Analgesics|analgesics|mesh-ancestor
2295671|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
2295672|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295673|NCT00275314|Valganciclovir|valganciclovir|mesh-list
2295674|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
2295675|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295676|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
2295677|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
2295678|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295679|NCT00275405|Protective Agents|protective agents|mesh-ancestor
2295680|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295681|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2840806|NCT03923114|Exenatide|exenatide|mesh-list
2840807|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2840808|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840809|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2840810|NCT03923114|Incretins|incretins|mesh-ancestor
2840811|NCT03923114|Hormones|hormones|mesh-ancestor
2840812|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2840813|NCT03923166|Capecitabine|capecitabine|mesh-list
2840814|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2840815|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
2840816|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840817|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840818|NCT03923361|Propofol|propofol|mesh-list
2840819|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2840820|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840821|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840822|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2840823|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
2295682|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840824|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
2840825|NCT03923218|Vitamin D|vitamin d|mesh-list
2840826|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
2840827|NCT03923218|Vitamins|vitamins|mesh-ancestor
2840828|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
2840829|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840830|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2840831|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2840832|NCT03923140|Tranilast|tranilast|mesh-list
2840833|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2107474|NCT02488070|Edetic Acid|edetic acid|mesh-list
2107475|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
2107476|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
2107477|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107478|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
2107479|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2840834|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2840835|NCT03923140|Analgesics|analgesics|mesh-ancestor
2107480|NCT02488330|Bevacizumab|bevacizumab|mesh-list
2107481|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2107482|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2107483|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107484|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2107485|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2107486|NCT02488330|Growth Substances|growth substances|mesh-ancestor
2107487|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107488|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
2840836|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
2840837|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840838|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840839|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2840840|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2840841|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2840842|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2840843|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840844|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2840845|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2840846|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
2840847|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
2840848|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840849|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2840850|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2840851|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
2840852|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2840853|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840854|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840855|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2840856|NCT03923075|Analgesics|analgesics|mesh-ancestor
2840857|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
2840858|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840859|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2840860|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2840861|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2840862|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
2840863|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840864|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840865|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2840866|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2840867|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840868|NCT03923374|Buprenorphine|buprenorphine|mesh-list
2840869|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2840870|NCT03923374|Narcotics|narcotics|mesh-ancestor
2840871|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840872|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840873|NCT03923374|Analgesics|analgesics|mesh-ancestor
2840874|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
2840875|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840876|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2840877|NCT03923231|Ritonavir|ritonavir|mesh-list
2840878|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2840879|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2840880|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2840881|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
2840882|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840883|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840884|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2840885|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2840886|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
2840887|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840888|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2840889|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2840890|NCT03923179|Etoposide|etoposide|mesh-list
2295683|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2295684|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295685|NCT00275418|Beta Carotene|beta carotene|mesh-list
2295686|NCT00275418|Carotenoids|carotenoids|mesh-list
2295687|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
2295688|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295689|NCT00275418|Protective Agents|protective agents|mesh-ancestor
2295690|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295691|NCT00275418|Provitamins|provitamins|mesh-ancestor
2295692|NCT00275418|Vitamins|vitamins|mesh-ancestor
2295693|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
2295694|NCT00275431|Gossypol acetic acid|gossypol acetic acid|mesh-list
2295695|NCT00275431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2295696|NCT00275431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295697|NCT00275431|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2295698|NCT00275431|Contraceptive Agents|contraceptive agents|mesh-ancestor
2295699|NCT00275431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2295700|NCT00275431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295701|NCT00275431|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2840891|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2840892|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840893|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2840894|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2840895|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840896|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295702|NCT00275431|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2295703|NCT00275431|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2295704|NCT00275444|Tipranavir|tipranavir|mesh-list
2295705|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2295706|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2295707|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
2295708|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295709|NCT00275457|Pramipexole|pramipexole|mesh-list
2295710|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
2295711|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295712|NCT00275457|Protective Agents|protective agents|mesh-ancestor
2295713|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295714|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2295715|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2295716|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
2295717|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
2295718|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295719|NCT00275522|Sirolimus|sirolimus|mesh-list
2295720|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2295721|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295722|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2295723|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295724|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
2295725|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2295726|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
2295727|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295728|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
2295729|NCT00275535|Sirolimus|sirolimus|mesh-list
2295730|NCT00275535|Prednisone|prednisone|mesh-list
2295731|NCT00275535|Tacrolimus|tacrolimus|mesh-list
2295732|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
2295733|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2295734|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2295735|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
2295736|NCT00275535|Hormones|hormones|mesh-ancestor
2295737|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2295738|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295739|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2295740|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295741|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2295742|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
2295743|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2295744|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295745|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295746|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2295747|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2295748|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
2295749|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2295750|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295751|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
2295752|NCT00275548|Ribavirin|ribavirin|mesh-list
2295753|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2840897|NCT03923010|Itraconazole|itraconazole|mesh-list
2840898|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
2840899|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840900|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2840901|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2840902|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840903|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840904|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2840905|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
2840906|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2840907|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840908|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2840923|NCT03922815|Fentanyl|fentanyl|mesh-list
2840924|NCT03922815|Propofol|propofol|mesh-list
2840925|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2840926|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2840927|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840928|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2840929|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
2840930|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
2840931|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2840932|NCT03922815|Narcotics|narcotics|mesh-ancestor
2840933|NCT03922815|Analgesics|analgesics|mesh-ancestor
2840934|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
2840935|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840936|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2840943|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
2295754|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
2483664|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2840944|NCT03922919|Cefotaxime|cefotaxime|mesh-list
2840945|NCT03922919|Cefoxitin|cefoxitin|mesh-list
2295755|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295756|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
2295757|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295758|NCT00275600|Vitamin E|vitamin e|mesh-list
2295759|NCT00275600|Vitamins|vitamins|mesh-ancestor
2295760|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
2295761|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295762|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
2295763|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295764|NCT00275600|Protective Agents|protective agents|mesh-ancestor
2840946|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2840947|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840948|NCT03922451|Cefazolin|cefazolin|mesh-list
2840949|NCT03922451|Tazobactam|tazobactam|mesh-list
2840950|NCT03922451|Piperacillin|piperacillin|mesh-list
2840951|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2840952|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2295765|NCT00275613|Rituximab|rituximab|mesh-list
2295766|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2295767|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295768|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
2295769|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295770|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2295771|NCT00275639|Losartan|losartan|mesh-list
2295772|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2295773|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2295774|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2295775|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2295776|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295777|NCT00275652|Lamivudine|lamivudine|mesh-list
2295778|NCT00275652|Telbivudine|telbivudine|mesh-list
2295779|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2295780|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2295781|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840953|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2840954|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2840955|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840956|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840957|NCT03922477|Atezolizumab|atezolizumab|mesh-list
2295782|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295783|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
2295784|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295785|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2295786|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2295787|NCT00275665|Valganciclovir|valganciclovir|mesh-list
2295788|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
2295789|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295790|NCT00275730|Indomethacin|indomethacin|mesh-list
2295791|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2295792|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2295793|NCT00275730|Analgesics|analgesics|mesh-ancestor
2295794|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
2295795|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295796|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295797|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2295798|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2295799|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
2295800|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
2295801|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2295802|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2295803|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295804|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295805|NCT00275756|Timolol|timolol|mesh-list
2295806|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2295807|NCT00275756|Dorzolamide|dorzolamide|mesh-list
2295808|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2295809|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2295810|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
2295811|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295812|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295813|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295814|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2295815|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2295816|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2295817|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2295818|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2295819|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2295820|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295821|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
2295822|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
2295823|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2295824|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2295825|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2840958|NCT03922477|Magrolimab|magrolimab|mesh-list
2840959|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840960|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2840961|NCT03923036|Cetuximab|cetuximab|mesh-list
2840962|NCT03923036|Panitumumab|panitumumab|mesh-list
2840963|NCT03923036|Aflibercept|aflibercept|mesh-list
2840964|NCT03923036|Capecitabine|capecitabine|mesh-list
2840965|NCT03923036|Irinotecan|irinotecan|mesh-list
2840966|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
2840967|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2295826|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295827|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2295828|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2295829|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
2295830|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
2295831|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2295832|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2295833|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2295834|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295835|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2295836|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2295837|NCT00275938|Interferons|interferons|mesh-list
2295838|NCT00275938|Ribavirin|ribavirin|mesh-list
2840968|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2840969|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2840970|NCT03923036|Growth Substances|growth substances|mesh-ancestor
2840971|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840972|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
2840973|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2840974|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
2840975|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840976|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2840977|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2840978|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2840979|NCT03922542|Riboflavin|riboflavin|mesh-list
2840980|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
2840981|NCT03922542|Vitamins|vitamins|mesh-ancestor
2840982|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
2840983|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840984|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2840985|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
2840986|NCT03922373|Benzonatate|benzonatate|mesh-list
2295839|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
2295840|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
2295841|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295842|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
2295843|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295844|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
2295845|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295846|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
2295847|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295848|NCT00275951|Cetuximab|cetuximab|mesh-list
2295849|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2295850|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2840987|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
2840988|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
2840989|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2840990|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2840991|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2840992|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2840993|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2840994|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2840995|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2840996|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2840997|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
2840998|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2840999|NCT03922048|Bupivacaine|bupivacaine|mesh-list
2295851|NCT00276003|Gemcitabine|gemcitabine|mesh-list
2295852|NCT00276003|Irinotecan|irinotecan|mesh-list
2295853|NCT00276003|Allopurinol|allopurinol|mesh-list
2295854|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2295855|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
2295856|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295857|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841000|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
2841001|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
2841002|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2841003|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841004|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
2841005|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295858|NCT00276003|Antiviral Agents|antiviral agents|mesh-ancestor
2295859|NCT00276003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295860|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295861|NCT00276003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2295862|NCT00276003|Immunologic Factors|immunologic factors|mesh-ancestor
2841006|NCT03921684|Capecitabine|capecitabine|mesh-list
2841007|NCT03921684|Nivolumab|nivolumab|mesh-list
2841008|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2841009|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
2841010|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841011|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841012|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2841013|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2841014|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2841015|NCT03921736|Perindopril|perindopril|mesh-list
2841016|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2841017|NCT03921736|Diuretics|diuretics|mesh-ancestor
2841018|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
2841019|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841020|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2841021|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2841022|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295863|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295864|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2295865|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2295866|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
2295867|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2295868|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2295869|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
2295870|NCT00276003|Protective Agents|protective agents|mesh-ancestor
2295871|NCT00276029|Etanercept|etanercept|mesh-list
2295872|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2295873|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2295874|NCT00276029|Analgesics|analgesics|mesh-ancestor
2295875|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
2295876|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295877|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295878|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2295879|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2295880|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2295881|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2295882|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
2295883|NCT00276055|Gemcitabine|gemcitabine|mesh-list
2295884|NCT00276055|Bevacizumab|bevacizumab|mesh-list
2295885|NCT00276055|Docetaxel|docetaxel|mesh-list
2295886|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2841023|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2841024|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
2841025|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841026|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2295887|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295888|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2295889|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2295890|NCT00276055|Growth Substances|growth substances|mesh-ancestor
2295891|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295892|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
2295893|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2295894|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
2295895|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295896|NCT00276055|Antiviral Agents|antiviral agents|mesh-ancestor
2295897|NCT00276055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2295898|NCT00276055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841027|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841028|NCT03921671|Paclitaxel|paclitaxel|mesh-list
2841029|NCT03921671|Carboplatin|carboplatin|mesh-list
2841030|NCT03921671|Ramucirumab|ramucirumab|mesh-list
2841031|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2841032|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841033|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
2841034|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
2841035|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
2841036|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295899|NCT00276055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2295900|NCT00276055|Immunologic Factors|immunologic factors|mesh-ancestor
2295901|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
2295902|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
2295903|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
2295904|NCT00276068|Lidocaine|lidocaine|mesh-list
2295905|NCT00276068|Desipramine|desipramine|mesh-list
2295906|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
2295907|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
2295908|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2295909|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295910|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
2295911|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295912|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2295913|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2295914|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2295915|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2295916|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295917|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2295918|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
2295919|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2295920|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295921|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2295922|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2295923|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
2295924|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841037|NCT03921593|Pancrelipase|pancrelipase|mesh-list
2841038|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2841039|NCT03921567|Lidocaine|lidocaine|mesh-list
2841040|NCT03921567|Ketamine|ketamine|mesh-list
2841041|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
2841042|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
2841043|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2841044|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841045|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
2841046|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841047|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2841048|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2841049|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2841050|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2841051|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841052|NCT03921567|Analgesics|analgesics|mesh-ancestor
2841053|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2841054|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2841055|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
2841056|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2841057|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2841058|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295925|NCT00276081|Gabapentin|gabapentin|mesh-list
2295926|NCT00276081|Estrogens|estrogens|mesh-list
2295927|NCT00276081|Analgesics|analgesics|mesh-ancestor
2295928|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
2295929|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2295930|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295931|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
2295932|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2295933|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2295934|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2295935|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2295936|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2295937|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2295938|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295939|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295940|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
2841059|NCT03921775|Propofol|propofol|mesh-list
2841060|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2841061|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2841062|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841063|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2841064|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
2841065|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
2841066|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
2841067|NCT03921177|Micronutrients|micronutrients|mesh-list
2841068|NCT03921177|Trace Elements|trace elements|mesh-list
2841069|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841070|NCT03921034|Ropivacaine|ropivacaine|mesh-list
2841071|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
2295941|NCT00276081|Hormones|hormones|mesh-ancestor
2295942|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2295943|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2295944|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
2295945|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295946|NCT00276133|Atorvastatin|atorvastatin|mesh-list
2295947|NCT00276133|Probucol|probucol|mesh-list
2295948|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2295949|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2295950|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
2295951|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295952|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2295953|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2295954|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295955|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
2295956|NCT00276133|Protective Agents|protective agents|mesh-ancestor
2295957|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295958|NCT00276146|Dipyridamole|dipyridamole|mesh-list
2295959|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2841072|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
2841073|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2841074|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841075|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
2841076|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841077|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
2841078|NCT03921099|Vitamins|vitamins|mesh-ancestor
2841079|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
2841080|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841081|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
2841082|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841083|NCT03921099|Protective Agents|protective agents|mesh-ancestor
2841084|NCT03920657|Deferasirox|deferasirox|mesh-list
2841085|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2841086|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
2841087|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
2841088|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841089|NCT03920631|Nivolumab|nivolumab|mesh-list
2841090|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2841091|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841092|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2841093|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841094|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
2841095|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
2841096|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841097|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2841098|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841099|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2841100|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
2841101|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841102|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2841103|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841104|NCT03921008|Paclitaxel|paclitaxel|mesh-list
2841105|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2841106|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841107|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
2841108|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
2841109|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
2841110|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841111|NCT03920878|Aflibercept|aflibercept|mesh-list
2841112|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2841113|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2841114|NCT03920878|Growth Substances|growth substances|mesh-ancestor
2841115|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841116|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
2841117|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841118|NCT03920618|Tenofovir|tenofovir|mesh-list
2841119|NCT03920618|Entecavir|entecavir|mesh-list
2841120|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
2841121|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841122|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2841123|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2841124|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841125|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841126|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2841127|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2841128|NCT03920839|Gemcitabine|gemcitabine|mesh-list
2841129|NCT03920839|Paclitaxel|paclitaxel|mesh-list
2841130|NCT03920839|Carboplatin|carboplatin|mesh-list
2841131|NCT03920839|Pemetrexed|pemetrexed|mesh-list
2841132|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2841133|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295960|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295961|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295962|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2295963|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
2295964|NCT00276172|Natalizumab|natalizumab|mesh-list
2295965|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
2295966|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295967|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
2295968|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2295969|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2295970|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295971|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
2295972|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2295973|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295974|NCT00276198|Vitamin D|vitamin d|mesh-list
2295975|NCT00276198|Vitamin A|vitamin a|mesh-list
2295976|NCT00276198|Vitamins|vitamins|mesh-ancestor
2295977|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
2295978|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295979|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2295980|NCT00276276|Topotecan|topotecan|mesh-list
2295981|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2295982|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2295983|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2295984|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2295985|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2295986|NCT00276289|Spironolactone|spironolactone|mesh-list
2295987|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2295988|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
2295989|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2295990|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2295991|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2295992|NCT00276289|Diuretics|diuretics|mesh-ancestor
2295993|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
2295994|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
2295995|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2295996|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2295997|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2295998|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2295999|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296000|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
2296001|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296002|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841134|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
2841135|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
2841136|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
2841137|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841138|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2841139|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
2841140|NCT03920839|Antiviral Agents|antiviral agents|mesh-ancestor
2841141|NCT03920839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841142|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841143|NCT03920839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2841144|NCT03920839|Immunologic Factors|immunologic factors|mesh-ancestor
2841145|NCT03920839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841146|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2841147|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2841148|NCT03920644|Scopolamine|scopolamine|mesh-list
2841149|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2841150|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2841151|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
2841152|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
2841153|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841154|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841155|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2841156|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
2841157|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2841158|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
2841159|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841160|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841161|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2841162|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
2841169|NCT03920605|Tenofovir|tenofovir|mesh-list
2841170|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2841171|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2841172|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
2841173|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841174|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2841175|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2841176|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841177|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841178|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2841179|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2841180|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
2841181|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2841182|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
2841183|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841184|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
2841185|NCT03920553|Protective Agents|protective agents|mesh-ancestor
2841186|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2841187|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2841188|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841189|NCT03920150|Vitamin D|vitamin d|mesh-list
2841190|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
2841191|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
2841192|NCT03920150|Vitamins|vitamins|mesh-list
2841193|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
2841194|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841195|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2841196|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2841197|NCT03920137|Nicotine|nicotine|mesh-list
2841198|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2841199|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
2841200|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841201|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841202|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2841203|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2841204|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
2841205|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296003|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2296004|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2296005|NCT00276393|Insulin|insulin|mesh-list
2296006|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2296007|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296008|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
2296009|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2296010|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
2296011|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296012|NCT00276497|Pioglitazone|pioglitazone|mesh-list
2296013|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2296014|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296015|NCT00276523|Interferons|interferons|mesh-list
2296016|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
2296017|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
2296018|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2296019|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296020|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
2296021|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296022|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
2296023|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296024|NCT00276536|Interferons|interferons|mesh-list
2296025|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
2296026|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2296027|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296028|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
2296029|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296030|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
2296031|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296032|NCT00276575|Bevacizumab|bevacizumab|mesh-list
2296033|NCT00276575|Everolimus|everolimus|mesh-list
2296034|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2296035|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2296036|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296037|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2296038|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2296039|NCT00276575|Growth Substances|growth substances|mesh-ancestor
2296040|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296041|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
2296042|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296043|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
2841206|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841207|NCT03920475|Sertraline|sertraline|mesh-list
2841208|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2841209|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
2841210|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2841211|NCT03920475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2841212|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2841213|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2841214|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841215|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841216|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
2841217|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841218|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2841219|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2841220|NCT03920319|Bupropion|bupropion|mesh-list
2841221|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2296044|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2296045|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296046|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296047|NCT00276588|Gemcitabine|gemcitabine|mesh-list
2296048|NCT00276588|Paclitaxel|paclitaxel|mesh-list
2296049|NCT00276588|Carboplatin|carboplatin|mesh-list
2841222|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
2841223|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2296050|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296051|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296052|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
2296053|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
2296054|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
2296055|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296056|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2296057|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
2296058|NCT00276588|Antiviral Agents|antiviral agents|mesh-ancestor
2296059|NCT00276588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296060|NCT00276588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296061|NCT00276588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296062|NCT00276588|Immunologic Factors|immunologic factors|mesh-ancestor
2296063|NCT00276588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296064|NCT00276601|Cytarabine|cytarabine|mesh-list
2296065|NCT00276601|Methotrexate|methotrexate|mesh-list
2296066|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
2296067|NCT00276601|Daunorubicin|daunorubicin|mesh-list
2296068|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
2296069|NCT00276601|Tretinoin|tretinoin|mesh-list
2296070|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2841224|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2841225|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2841226|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2841227|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841228|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
2841229|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841230|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841231|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2841232|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2841233|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841234|NCT03920293|Ravulizumab|ravulizumab|mesh-list
2841235|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2296071|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
2296072|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2296073|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296074|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2296075|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
2296076|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296077|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296078|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
2296079|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296080|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2296081|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296082|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
2296083|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2296084|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2296085|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
2296086|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296087|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2296088|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2296089|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296090|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
2841236|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2841237|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
2841238|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841239|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
2841240|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2841241|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841242|NCT03920397|Vitamins|vitamins|mesh-ancestor
2841243|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
2841244|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2841248|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
2841249|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2841250|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2841251|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841252|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
2841253|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841254|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841255|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
2841256|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2841257|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841258|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2841259|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
2841260|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2841261|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841262|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841263|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841264|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2841265|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841266|NCT03919786|Anesthetics|anesthetics|mesh-list
2841267|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2841268|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841269|NCT03919617|Volagidemab|volagidemab|mesh-list
2841270|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2841271|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841272|NCT03919955|Oxybutynin|oxybutynin|mesh-list
2841273|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2841274|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2841275|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2841276|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2841277|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841278|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
2841279|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841280|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841281|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
2841282|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
2841283|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841284|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2841285|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2841286|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
2841287|NCT03919955|Urological Agents|urological agents|mesh-ancestor
2296091|NCT00276640|Carboplatin|carboplatin|mesh-list
2296092|NCT00276640|Etoposide|etoposide|mesh-list
2296093|NCT00276640|Vincristine|vincristine|mesh-list
2296094|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296095|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296096|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2296097|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296098|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296099|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296100|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
2296101|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
2296102|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
2296103|NCT00276666|Vincristine|vincristine|mesh-list
2296104|NCT00276666|Lomustine|lomustine|mesh-list
2296105|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296106|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296107|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
2296108|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
2296109|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
2296110|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296111|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2296112|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
2841288|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
2841289|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2841290|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841291|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
2841292|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
2841293|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2841294|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841295|NCT03919812|Vitamins|vitamins|mesh-ancestor
2841296|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
2841297|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2841298|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
2841299|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2841300|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841301|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2841302|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296113|NCT00276679|Temozolomide|temozolomide|mesh-list
2296114|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2296115|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
2296116|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296117|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841309|NCT03919552|Cisplatin|cisplatin|mesh-list
2841310|NCT03919552|Carboplatin|carboplatin|mesh-list
2841311|NCT03919552|Docetaxel|docetaxel|mesh-list
2841312|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841313|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
2841314|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
2841315|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
2841316|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841317|NCT03919565|Tenofovir|tenofovir|mesh-list
2841318|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2841319|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2841320|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
2841321|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841322|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2841323|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2841324|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841325|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841326|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2841327|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2841328|NCT03919253|Paclitaxel|paclitaxel|mesh-list
2841329|NCT03919253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2841330|NCT03919253|Maleic acid|maleic acid|mesh-list
2841331|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2841332|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841333|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
2841334|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
2841335|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
2841336|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841337|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841338|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
2841339|NCT03919526|Fludarabine|fludarabine|mesh-list
2841340|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2841341|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
2841342|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841343|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841344|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2841345|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
2841346|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841347|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841348|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2841349|NCT03919383|Lenvatinib|lenvatinib|mesh-list
2841350|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841351|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2841352|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841353|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841354|NCT03919448|Bevacizumab|bevacizumab|mesh-list
2841355|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2841356|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841357|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2841358|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2841359|NCT03919448|Growth Substances|growth substances|mesh-ancestor
2841360|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841361|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
2296118|NCT00276692|Irinotecan|irinotecan|mesh-list
2296119|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2296120|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296121|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296122|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296123|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296124|NCT00276705|Thalidomide|thalidomide|mesh-list
2296125|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
2296126|NCT00276705|Doxorubicin|doxorubicin|mesh-list
2296127|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2296128|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296129|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
2296130|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296131|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2296132|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2296133|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
2296134|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296135|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296136|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2296137|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2296138|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2296139|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296140|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296141|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
2296142|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2296143|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296144|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2296145|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2296146|NCT00276705|Growth Substances|growth substances|mesh-ancestor
2296147|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
2296148|NCT00276718|Carboplatin|carboplatin|mesh-list
2296149|NCT00276718|Etoposide|etoposide|mesh-list
2296150|NCT00276718|Bleomycin|bleomycin|mesh-list
2296151|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296152|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296153|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2296154|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296155|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296156|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296157|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2296158|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
2296159|NCT00276731|Carboplatin|carboplatin|mesh-list
2296160|NCT00276731|Etoposide|etoposide|mesh-list
2296161|NCT00276731|Vincristine|vincristine|mesh-list
2296162|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296163|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
2296164|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296165|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841362|NCT03919084|Nicotine|nicotine|mesh-list
2841363|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2841364|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
2841365|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841366|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841367|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2841368|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2841369|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
2841370|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841371|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841372|NCT03919461|Etodolac|etodolac|mesh-list
2841373|NCT03919461|Propranolol|propranolol|mesh-list
2841374|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2841375|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2841376|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
2841377|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841378|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841379|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841380|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2841381|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2841382|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
2841383|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2296166|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2296167|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
2296168|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296169|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841384|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2841385|NCT03919461|Analgesics|analgesics|mesh-ancestor
2841386|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
2841387|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841388|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2841389|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841390|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2841391|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2841392|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841393|NCT03919175|Rituximab|rituximab|mesh-list
2841394|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2841395|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841396|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
2841397|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841398|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841399|NCT03918993|Tadalafil|tadalafil|mesh-list
2841400|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
2841401|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2841402|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2841403|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841404|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841405|NCT03918993|Urological Agents|urological agents|mesh-ancestor
2841406|NCT03918616|Dopamine|dopamine|mesh-list
2841407|NCT03918616|Memantine|memantine|mesh-list
2841408|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
2841409|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2841410|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2841411|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
2841412|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841413|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841414|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841415|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2841416|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2841417|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2841418|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
2841419|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
2841420|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841421|NCT03918616|Protective Agents|protective agents|mesh-ancestor
2841422|NCT03918590|Nepafenac|nepafenac|mesh-list
2841423|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2841424|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2841425|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2296170|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2296171|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296172|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2296173|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296174|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296175|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
2841426|NCT03918590|Analgesics|analgesics|mesh-ancestor
2841427|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
2841428|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841429|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841430|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2841431|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841432|NCT03918590|Laxatives|laxatives|mesh-ancestor
2841433|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2841434|NCT03918694|Ascorbic Acid|ascorbic acid|mesh-list
2841435|NCT03918694|Vitamins|vitamins|mesh-ancestor
2841436|NCT03918694|Micronutrients|micronutrients|mesh-ancestor
2841437|NCT03918694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296176|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
2841438|NCT03918694|Antioxidants|antioxidants|mesh-ancestor
2841439|NCT03918694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841440|NCT03918694|Protective Agents|protective agents|mesh-ancestor
2841441|NCT03918889|Midazolam|midazolam|mesh-list
2841442|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
2841443|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2841444|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2841445|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296177|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
2841446|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2841447|NCT03918889|Analgesics|analgesics|mesh-ancestor
2841448|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
2841449|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841450|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2841451|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2841452|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2841453|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
2841454|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841455|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841456|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2841457|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2841458|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2841459|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2841460|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2841461|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
2841462|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
2841463|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
2841464|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
2841465|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
2841466|NCT03918798|Procaine|procaine|mesh-list
2841467|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2841468|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
2841469|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
2841470|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2841471|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841472|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
2841473|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841474|NCT03918915|Atropine|atropine|mesh-list
2841475|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2841476|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2841477|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2841478|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
2841479|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841480|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841481|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2841482|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
2841483|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
2841484|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
2841485|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2841486|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2841487|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
2841488|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841489|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841490|NCT03918551|Febuxostat|febuxostat|mesh-list
2841491|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
2841492|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841493|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
2841494|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
2841495|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2841496|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
2841497|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841498|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841499|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2841500|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
2841501|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296178|NCT00276757|Leucovorin|leucovorin|mesh-list
2296179|NCT00276757|Prednisolone|prednisolone|mesh-list
2296180|NCT00276757|Methotrexate|methotrexate|mesh-list
2296181|NCT00276757|Vinblastine|vinblastine|mesh-list
2296182|NCT00276757|Calcium|calcium|mesh-list
2296183|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
2296184|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2296185|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296186|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2296187|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
2296188|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2296189|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2296190|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
2841502|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841503|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2841504|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2841505|NCT03918265|Tacrolimus|tacrolimus|mesh-list
2841506|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2841507|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
2841508|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841509|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2841510|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841511|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841512|NCT03918252|Nivolumab|nivolumab|mesh-list
2841513|NCT03918252|Ipilimumab|ipilimumab|mesh-list
2841514|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2841515|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841516|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2841517|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107489|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2107490|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107491|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107492|NCT02488980|Mefloquine|mefloquine|mesh-list
2107493|NCT02488980|Tafenoquine|tafenoquine|mesh-list
2107494|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
2107495|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2107496|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2107497|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107498|NCT02489227|Adalimumab|adalimumab|mesh-list
2107499|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2107500|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2296191|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296192|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296193|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
2296194|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296195|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2296196|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296197|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
2296198|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2296199|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2296200|NCT00276757|Antidotes|antidotes|mesh-ancestor
2296201|NCT00276757|Protective Agents|protective agents|mesh-ancestor
2296202|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
2296203|NCT00276757|Vitamins|vitamins|mesh-ancestor
2296204|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
2296205|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2296206|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
2296207|NCT00276757|Hormones|hormones|mesh-ancestor
2296208|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2296209|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2296210|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296211|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
2296212|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
2296213|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
2296214|NCT00276770|Fluorides|fluorides|mesh-list
2296215|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
2296216|NCT00276770|Protective Agents|protective agents|mesh-ancestor
2296217|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296218|NCT00276783|Pemetrexed|pemetrexed|mesh-list
2296219|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841518|NCT03918187|Midazolam|midazolam|mesh-list
2841519|NCT03918187|Nalbuphine|nalbuphine|mesh-list
2841520|NCT03918187|Bupivacaine|bupivacaine|mesh-list
2841521|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
2841522|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
2841523|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2841524|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841525|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
2841526|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841527|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2841528|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2841529|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2841530|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2841531|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2841532|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2841533|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
2841534|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
2841535|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
2841536|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841537|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841538|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2296220|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296221|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296222|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2296223|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2296224|NCT00276796|Paclitaxel|paclitaxel|mesh-list
2296225|NCT00276796|Topotecan|topotecan|mesh-list
2296226|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296227|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296228|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
2296229|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
2841539|NCT03918187|Narcotics|narcotics|mesh-ancestor
2841540|NCT03918187|Analgesics|analgesics|mesh-ancestor
2841541|NCT03917914|Bisoprolol|bisoprolol|mesh-list
2841542|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2841543|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
2841544|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
2841545|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841546|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841547|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2841548|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2841549|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2296230|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
2296231|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296232|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2296233|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296234|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296235|NCT00276809|Cytarabine|cytarabine|mesh-list
2296236|NCT00276809|Dexamethasone|dexamethasone|mesh-list
2296237|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
2296238|NCT00276809|Melphalan|melphalan|mesh-list
2296239|NCT00276809|Carmustine|carmustine|mesh-list
2296240|NCT00276809|Fludarabine|fludarabine|mesh-list
2296241|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
2296242|NCT00276809|Etoposide|etoposide|mesh-list
2296243|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
2296244|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296245|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
2296246|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296247|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2296248|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2296249|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
2296250|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841550|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
2841551|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841552|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841553|NCT03918135|Acetaminophen|acetaminophen|mesh-list
2841554|NCT03918135|Ibuprofen|ibuprofen|mesh-list
2841555|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2841556|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2841557|NCT03918135|Analgesics|analgesics|mesh-ancestor
2841558|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
2841559|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2296251|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296252|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2296253|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2841560|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296254|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
2296255|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
2296256|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2296257|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2296258|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
2296259|NCT00276809|Hormones|hormones|mesh-ancestor
2296260|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2296261|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2841561|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2841562|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841563|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2841564|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841565|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841566|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
2841567|NCT03917940|Glimepiride|glimepiride|mesh-list
2841568|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2841569|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2841570|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841571|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2841572|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
2841573|NCT03917784|Curcumin|curcumin|mesh-list
2841574|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2841575|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2841576|NCT03917784|Analgesics|analgesics|mesh-ancestor
2296262|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2296263|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
2296264|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296265|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2296266|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296267|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296268|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
2296269|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296270|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2296271|NCT00276835|Aldesleukin|aldesleukin|mesh-list
2296272|NCT00276835|Interleukin-2|interleukin-2|mesh-list
2296273|NCT00276835|Genistein|genistein|mesh-list
2296274|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296275|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2296276|NCT00276835|Analgesics|analgesics|mesh-ancestor
2296277|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
2296278|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2296279|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296280|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2296281|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2296282|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
2296283|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296284|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2296285|NCT00276835|Protective Agents|protective agents|mesh-ancestor
2296286|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2296287|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296288|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296289|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
2296290|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2296291|NCT00276835|Estrogens|estrogens|mesh-ancestor
2296292|NCT00276835|Hormones|hormones|mesh-ancestor
2296293|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2296294|NCT00276848|Vidarabine|vidarabine|mesh-list
2296295|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
2296296|NCT00276848|Fludarabine|fludarabine|mesh-list
2296297|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
2841577|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
2841578|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841579|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841580|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2841581|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841582|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841583|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841584|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841585|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
2841586|NCT03917758|Empagliflozin|empagliflozin|mesh-list
2841587|NCT03917758|Canagliflozin|canagliflozin|mesh-list
2841588|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2841589|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841590|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2841591|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841592|NCT03917966|Docetaxel|docetaxel|mesh-list
2841593|NCT03917966|Nedaplatin|nedaplatin|mesh-list
2841594|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841595|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
2841596|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
2841597|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
2841598|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841599|NCT03917459|Enalapril|enalapril|mesh-list
2107501|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
2107502|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2107503|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107504|NCT02489500|Bortezomib|bortezomib|mesh-list
2107505|NCT02489500|Melphalan|melphalan|mesh-list
2107506|NCT02489500|Sargramostim|sargramostim|mesh-list
2107507|NCT02489500|Lenograstim|lenograstim|mesh-list
2296298|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296299|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
2296300|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296301|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2296302|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2296303|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
2296304|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296305|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841600|NCT03917459|Enalaprilat|enalaprilat|mesh-list
2841601|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2841602|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2841603|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
2841604|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841605|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841606|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2841607|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2841608|NCT03917446|Propofol|propofol|mesh-list
2841609|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2841610|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2841611|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841612|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2841613|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
2841614|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
2841615|NCT03917537|Nivolumab|nivolumab|mesh-list
2841616|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2841617|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841618|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2841619|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841620|NCT03917628|Adalimumab|adalimumab|mesh-list
2841621|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2841622|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841623|NCT03917420|Tenofovir|tenofovir|mesh-list
2841624|NCT03917420|Emtricitabine|emtricitabine|mesh-list
2841625|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2841626|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
2841627|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841628|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2841629|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2841630|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841631|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841632|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2841633|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2841634|NCT03917303|Adalimumab|adalimumab|mesh-list
2841635|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2841636|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841637|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
2841638|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
2841639|NCT03917095|Mesalamine|mesalamine|mesh-list
2841640|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2841641|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2841642|NCT03917095|Analgesics|analgesics|mesh-ancestor
2841643|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
2841644|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841645|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841646|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2841647|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841648|NCT03916926|Fluorides|fluorides|mesh-list
2841649|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
2841650|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
2841651|NCT03916926|Protective Agents|protective agents|mesh-ancestor
2107508|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296306|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2296307|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2296308|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
2841652|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841653|NCT03917134|Metronidazole|metronidazole|mesh-list
2841654|NCT03917134|Cephalosporins|cephalosporins|mesh-list
2841655|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841656|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2841657|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2841658|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2841659|NCT03917082|Tamoxifen|tamoxifen|mesh-list
2841660|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2841661|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841662|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2841663|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
2841664|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2841665|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841666|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2841667|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841668|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2841669|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2841670|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2841671|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2841672|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841673|NCT03917394|Iron|iron|mesh-list
2841674|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2841675|NCT03917394|Trace Elements|trace elements|mesh-ancestor
2841676|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
2841677|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841678|NCT03917394|Hematinics|hematinics|mesh-ancestor
2841679|NCT03917186|Sevoflurane|sevoflurane|mesh-list
2841680|NCT03917186|Desflurane|desflurane|mesh-list
2841681|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2841682|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2841683|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
2841684|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
2841685|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2841686|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841687|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
2841688|NCT03916679|Fludarabine|fludarabine|mesh-list
2841689|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2841690|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
2841691|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841692|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841693|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2841694|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
2841695|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841696|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841697|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2841698|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
2841699|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2841700|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841701|NCT03916601|Insulin|insulin|mesh-list
2841702|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2841703|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
2841704|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
2841705|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2841706|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2841707|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841708|NCT03916250|Petrolatum|petrolatum|mesh-list
2841709|NCT03916250|PF-06700841|pf-06700841|mesh-list
2841710|NCT03916250|Emollients|emollients|mesh-ancestor
2841711|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
2841712|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2841713|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841714|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841715|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2841716|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2841717|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
2841718|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2841719|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841720|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2841721|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2841722|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2841723|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296309|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
2296310|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296311|NCT00276874|Aripiprazole|aripiprazole|mesh-list
2841724|NCT03916510|Capecitabine|capecitabine|mesh-list
2841725|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2841726|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
2841727|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841728|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841729|NCT03916432|Sirolimus|sirolimus|mesh-list
2841730|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2841731|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841732|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2841733|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296312|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
2296313|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2296314|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2296315|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2296316|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2296317|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296318|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
2296319|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
2296320|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841734|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
2841735|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2841736|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
2841737|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841738|NCT03916406|Midazolam|midazolam|mesh-list
2841739|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2841740|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2841741|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2841742|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841743|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2841744|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2841745|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2841746|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2841747|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
2841748|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
2841749|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
2841750|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
2841751|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841752|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841753|NCT03916068|Vitamin E|vitamin e|mesh-list
2841754|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
2296321|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296322|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2296323|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2296324|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
2841755|NCT03916068|Vitamins|vitamins|mesh-ancestor
2841756|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
2841757|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841758|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
2841759|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841760|NCT03916068|Protective Agents|protective agents|mesh-ancestor
2841761|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2841762|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841763|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2841764|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2841765|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
2841766|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2841767|NCT03916042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2841768|NCT03916042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2841769|NCT03916003|Primaquine|primaquine|mesh-list
2841770|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
2841771|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2841772|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2841773|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841774|NCT03915964|Adalimumab|adalimumab|mesh-list
2841775|NCT03915964|Etanercept|etanercept|mesh-list
2841776|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
2296325|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2296326|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2296327|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2296328|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2296329|NCT00276900|Sertraline|sertraline|mesh-list
2841777|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2841778|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841779|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2841780|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2841781|NCT03915964|Analgesics|analgesics|mesh-ancestor
2841782|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
2841783|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841784|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296330|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
2296331|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2296332|NCT00276900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2296333|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2296334|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2296335|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296336|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296337|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
2296338|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296339|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
2296340|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296341|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2296342|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296343|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841785|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2841786|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2841787|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
2841788|NCT03915938|Ketamine|ketamine|mesh-list
2841789|NCT03915938|Analgesics|analgesics|mesh-ancestor
2841790|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
2841791|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841792|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841793|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2841794|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2841795|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
2296344|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
2296345|NCT00276965|Sertraline|sertraline|mesh-list
2296346|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
2296347|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2296348|NCT00276965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2296349|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2296350|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2296351|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296352|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296353|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
2296354|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296355|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296356|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
2296357|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2296358|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2296359|NCT00276978|Aripiprazole|aripiprazole|mesh-list
2296360|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
2296361|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2296362|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2296363|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2296364|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2296365|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296366|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
2296367|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
2296368|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296369|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296370|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2296371|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2296372|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
2296373|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2296374|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2296375|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2296376|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2296377|NCT00277017|Interferons|interferons|mesh-list
2296378|NCT00277017|Thalidomide|thalidomide|mesh-list
2296379|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296380|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
2296381|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296382|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296383|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
2296384|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296385|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
2296386|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2841796|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
2841797|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2841798|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2841799|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2841800|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841801|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841802|NCT03915769|Ozanimod|ozanimod|mesh-list
2841803|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2841804|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841805|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2841806|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
2841807|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841808|NCT03916094|Trastuzumab|trastuzumab|mesh-list
2841809|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2841810|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841811|NCT03915678|Atezolizumab|atezolizumab|mesh-list
2841812|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2841813|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841814|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
2841815|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841816|NCT03915626|Rivastigmine|rivastigmine|mesh-list
2296387|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2296388|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2296389|NCT00277017|Growth Substances|growth substances|mesh-ancestor
2296390|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
2296391|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2296392|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
2296393|NCT00277043|Paclitaxel|paclitaxel|mesh-list
2296394|NCT00277043|Docetaxel|docetaxel|mesh-list
2296395|NCT00277043|Taxane|taxane|mesh-list
2296396|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296397|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296398|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
2296399|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
2296400|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
2296401|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296402|NCT00277069|Carboplatin|carboplatin|mesh-list
2841817|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2841818|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841819|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841820|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
2841821|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841822|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841823|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2841824|NCT03915626|Protective Agents|protective agents|mesh-ancestor
2841825|NCT03915366|Valganciclovir|valganciclovir|mesh-list
2841826|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
2841827|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
2841828|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841829|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2841830|NCT03915405|Avelumab|avelumab|mesh-list
2841831|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2841832|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841833|NCT03915327|Dextrans|dextrans|mesh-list
2841834|NCT03915327|Iron-Dextran Complex|iron-dextran complex|mesh-list
2841835|NCT03915327|Anticoagulants|anticoagulants|mesh-ancestor
2841836|NCT03915327|Plasma Substitutes|plasma substitutes|mesh-ancestor
2841837|NCT03915327|Blood Substitutes|blood substitutes|mesh-ancestor
2841838|NCT03915327|Hematinics|hematinics|mesh-ancestor
2841839|NCT03915444|Gemcitabine|gemcitabine|mesh-list
2841840|NCT03915444|Paclitaxel|paclitaxel|mesh-list
2841841|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2841842|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841843|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
2841844|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
2841845|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
2841846|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841847|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2841848|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
2841849|NCT03915444|Antiviral Agents|antiviral agents|mesh-ancestor
2841850|NCT03915444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2841851|NCT03915444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841852|NCT03915444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2841853|NCT03915444|Immunologic Factors|immunologic factors|mesh-ancestor
2841854|NCT03915444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841855|NCT03915561|Parecoxib|parecoxib|mesh-list
2296403|NCT00277069|Capecitabine|capecitabine|mesh-list
2296404|NCT00277069|Vinorelbine|vinorelbine|mesh-list
2841856|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2841857|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2841858|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841859|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841860|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2841861|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2841862|NCT03915561|Analgesics|analgesics|mesh-ancestor
2841863|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
2841864|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841865|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841866|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2841867|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2841868|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
2841869|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2841870|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296405|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296406|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2296407|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
2296408|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296409|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296410|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
2841871|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
2841872|NCT03915340|Propafenone|propafenone|mesh-list
2841873|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2841874|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2841875|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2841876|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2841877|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296411|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
2296412|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
2296413|NCT00277082|Camptothecin|camptothecin|mesh-list
2296414|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296415|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296416|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2296417|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296418|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296419|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296420|NCT00277108|Citalopram|citalopram|mesh-list
2296421|NCT00277108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2296422|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2296423|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2296424|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296425|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296426|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
2841878|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2841879|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
2841880|NCT03914963|Coagulants|coagulants|mesh-ancestor
2841881|NCT03915067|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2841882|NCT03915067|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2841883|NCT03915067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2841884|NCT03915067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841885|NCT03915067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841886|NCT03915067|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2841887|NCT03915067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2841888|NCT03915067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841889|NCT03915067|Cholinergic Agents|cholinergic agents|mesh-ancestor
2841890|NCT03915067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841891|NCT03915223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2841892|NCT03915223|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2841893|NCT03915223|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2841894|NCT03915223|Methylprednisolone|methylprednisolone|mesh-list
2841895|NCT03915223|Prednisolone|prednisolone|mesh-list
2841896|NCT03915223|Prednisolone acetate|prednisolone acetate|mesh-list
2841897|NCT03915223|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2841898|NCT03915223|Prednisolone phosphate|prednisolone phosphate|mesh-list
2841899|NCT03915223|Glucocorticoids|glucocorticoids|mesh-ancestor
2841900|NCT03915223|Hormones|hormones|mesh-ancestor
2841901|NCT03915223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2841902|NCT03915223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841903|NCT03915223|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2841904|NCT03915223|Protective Agents|protective agents|mesh-ancestor
2841905|NCT03915223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2296427|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296428|NCT00277108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2841906|NCT03915223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841907|NCT03915223|Antiemetics|antiemetics|mesh-ancestor
2841908|NCT03915223|Autonomic Agents|autonomic agents|mesh-ancestor
2841909|NCT03915223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841910|NCT03915223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2296429|NCT00277108|Antidepressive Agents|antidepressive agents|mesh-ancestor
2296430|NCT00277108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2296431|NCT00277199|Abatacept|abatacept|mesh-list
2296432|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2296433|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296434|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296435|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296436|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
2296437|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296438|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2296439|NCT00277225|Abatacept|abatacept|mesh-list
2296440|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2296441|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296442|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296443|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296444|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
2296445|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296446|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2296447|NCT00277251|Alendronate|alendronate|mesh-list
2296448|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2296449|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296450|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
2296451|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2296452|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
2296453|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2296454|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296455|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2296456|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
2296457|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
2296458|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2296459|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
2296460|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296461|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296462|NCT00277342|Insulin|insulin|mesh-list
2296463|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2296464|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296465|NCT00277472|Valsartan|valsartan|mesh-list
2296466|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2296467|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2107509|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2107510|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
2107511|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107512|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2296468|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2107513|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2107514|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
2107515|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107516|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2107517|NCT02489630|Ketamine|ketamine|mesh-list
2107518|NCT02489630|Analgesics|analgesics|mesh-list
2296469|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2296470|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296471|NCT00277472|Diuretics|diuretics|mesh-ancestor
2296472|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
2296473|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296474|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2296475|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2296476|NCT00277498|Timolol|timolol|mesh-list
2296477|NCT00277498|Latanoprost|latanoprost|mesh-list
2296478|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2296479|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2296480|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
2296481|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841918|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
2841919|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2841920|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841921|NCT03914755|Tucatinib|tucatinib|mesh-list
2841922|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841923|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2841924|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841925|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841926|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
2841927|NCT03914690|Hematinics|hematinics|mesh-ancestor
2841928|NCT03914638|Albuterol|albuterol|mesh-list
2841929|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2841930|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
2841931|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841932|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841933|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2296482|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296483|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296484|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2841934|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
2841935|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
2841936|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2841937|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2841938|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2841939|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2841940|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
2841941|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841942|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841943|NCT03914443|Cisplatin|cisplatin|mesh-list
2841944|NCT03914443|Docetaxel|docetaxel|mesh-list
2841945|NCT03914443|Fluorouracil|fluorouracil|mesh-list
2841946|NCT03914443|Nivolumab|nivolumab|mesh-list
2841947|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2841948|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
2296485|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2296486|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2296487|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2296488|NCT00277511|Levofloxacin|levofloxacin|mesh-list
2296489|NCT00277511|Ofloxacin|ofloxacin|mesh-list
2296490|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2296491|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296492|NCT00277511|Renal Agents|renal agents|mesh-ancestor
2296493|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2296494|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2296495|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296496|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296497|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296498|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296499|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2296500|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2841949|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
2841950|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
2841951|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841952|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
2841953|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2296501|NCT00277537|Mannitol|mannitol|mesh-list
2296502|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2296503|NCT00277537|Diuretics|diuretics|mesh-ancestor
2296504|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
2296505|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841954|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2841955|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
2841956|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841957|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2841958|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2841959|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
2841960|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
2841961|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841962|NCT03914404|Protective Agents|protective agents|mesh-ancestor
2841963|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841964|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
2841965|NCT03914404|Vitamins|vitamins|mesh-ancestor
2841966|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
2841967|NCT03914677|Mecamylamine|mecamylamine|mesh-list
2841968|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2841969|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2841970|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
2841971|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2841972|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841973|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2841974|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2841975|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
2841976|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2841977|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841978|NCT03914534|Valproic Acid|valproic acid|mesh-list
2841979|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
2841980|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2841981|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841982|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
2841983|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107519|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
2107520|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107521|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107522|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2107523|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2107524|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
2107525|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
2107526|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107527|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2107528|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2107529|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107530|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296506|NCT00277550|Tegaserod|tegaserod|mesh-list
2841984|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841985|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
2841986|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2841987|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2841988|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2841989|NCT03914352|Antibodies|antibodies|mesh-list
2841990|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
2841991|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841992|NCT03914118|Modafinil|modafinil|mesh-list
2841993|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2841994|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2841995|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2841996|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2841997|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2841998|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2841999|NCT03914092|Triamcinolone|triamcinolone|mesh-list
2842000|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2842001|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2842002|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2842003|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2842004|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
2842005|NCT03914092|Hormones|hormones|mesh-ancestor
2842006|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2296507|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2296508|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
2296509|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296510|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296511|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296512|NCT00277589|Iodine|iodine|mesh-list
2296513|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2296514|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296515|NCT00277589|Trace Elements|trace elements|mesh-ancestor
2296516|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
2842007|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842008|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2842009|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
2842010|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842011|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842012|NCT03913884|Mitogens|mitogens|mesh-list
2842013|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
2842014|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842015|NCT03914235|Lidocaine|lidocaine|mesh-list
2842016|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
2842017|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
2842018|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842019|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842020|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
2842021|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842022|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2842023|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2842024|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2842025|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2842026|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842027|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2842028|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
2842029|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842030|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842031|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842032|NCT03913858|Anesthetics|anesthetics|mesh-list
2842033|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842034|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296517|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296518|NCT00277602|Riluzole|riluzole|mesh-list
2296519|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
2296520|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2296521|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2296522|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296523|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296524|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842035|NCT03913832|Sirolimus|sirolimus|mesh-list
2842036|NCT03913832|Paclitaxel|paclitaxel|mesh-list
2842037|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2842038|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842039|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
2842040|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
2842041|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
2842042|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842043|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2842044|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2842045|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2842046|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
2842047|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2842048|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
2842049|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842050|NCT03913650|Bupivacaine|bupivacaine|mesh-list
2842051|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
2842052|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
2842053|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842054|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842055|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
2842056|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842057|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
2842058|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2842059|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2842060|NCT03913702|Prednisolone|prednisolone|mesh-list
2842061|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
2842062|NCT03913702|Ketorolac|ketorolac|mesh-list
2842063|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2842064|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2842065|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
2842066|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2842067|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
2842068|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
2842069|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842070|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842071|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2842072|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
2842073|NCT03913702|Hormones|hormones|mesh-ancestor
2842074|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2296525|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2296526|NCT00277602|Protective Agents|protective agents|mesh-ancestor
2296527|NCT00277641|Lamotrigine|lamotrigine|mesh-list
2296528|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
2296529|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2296530|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2296531|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296532|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2296533|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296534|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2296535|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2296536|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2296537|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2296538|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2296539|NCT00277654|Risperidone|risperidone|mesh-list
2296540|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2296541|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
2296542|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296543|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296544|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296545|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2296546|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2296547|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2296548|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2842075|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2842076|NCT03913702|Protective Agents|protective agents|mesh-ancestor
2842077|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2842078|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842079|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2842080|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2842081|NCT03913702|Analgesics|analgesics|mesh-ancestor
2842082|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
2842083|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2842084|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2842085|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842086|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842087|NCT03913806|Bevacizumab|bevacizumab|mesh-list
2842088|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2842089|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842090|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2842091|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2842092|NCT03913806|Growth Substances|growth substances|mesh-ancestor
2842093|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842094|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
2842095|NCT03913455|Carboplatin|carboplatin|mesh-list
2842096|NCT03913455|Guadecitabine|guadecitabine|mesh-list
2842097|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842098|NCT03913559|Acetaminophen|acetaminophen|mesh-list
2842099|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
2842100|NCT03913559|Promethazine|promethazine|mesh-list
2842101|NCT03913559|Cytarabine|cytarabine|mesh-list
2842102|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
2842103|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2842104|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
2842105|NCT03913559|Methotrexate|methotrexate|mesh-list
2842106|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2842107|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2842108|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
2842109|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2842110|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842111|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2842112|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
2842113|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842114|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842115|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
2842116|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842117|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2842118|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2842119|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
2842120|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2842121|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2842122|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
2842123|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2842124|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2842125|NCT03913559|Analgesics|analgesics|mesh-ancestor
2842126|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
2842127|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842128|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
2842129|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2842130|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
2842131|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
2842132|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2842133|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
2842134|NCT03913559|Hormones|hormones|mesh-ancestor
2842135|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2842136|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2842137|NCT03913559|Protective Agents|protective agents|mesh-ancestor
2842138|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2842139|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2842140|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2842141|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842142|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
2842143|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
2842144|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2296549|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2296550|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
2296551|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2842145|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
2842146|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
2842147|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842148|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2842149|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
2842150|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2842151|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2296552|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
2296553|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2296554|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2296555|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2296556|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2296557|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296558|NCT00277693|Spironolactone|spironolactone|mesh-list
2842152|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
2842153|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
2842154|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842155|NCT03913468|Protective Agents|protective agents|mesh-ancestor
2842156|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842157|NCT03913468|Vitamins|vitamins|mesh-ancestor
2842158|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
2842159|NCT03913442|Colchicine|colchicine|mesh-list
2842160|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
2842161|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2842162|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
2842163|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
2842164|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
2842165|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842166|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842167|NCT03913234|Trastuzumab|trastuzumab|mesh-list
2842168|NCT03913234|Letrozole|letrozole|mesh-list
2842169|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2842170|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842171|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2842172|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2842173|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842174|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842175|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2842176|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
2842177|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2842178|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842179|NCT03913221|Caffeine|caffeine|mesh-list
2842180|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
2842181|NCT03913221|Citric Acid|citric acid|mesh-list
2842182|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
2842183|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
2842184|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2842185|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
2842186|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
2842187|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842188|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2842189|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296559|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2296560|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
2296561|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2296562|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296563|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2296564|NCT00277693|Diuretics|diuretics|mesh-ancestor
2296565|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
2296566|NCT00277706|Vitamin D|vitamin d|mesh-list
2296567|NCT00277706|Calcium|calcium|mesh-list
2296568|NCT00277706|Vitamins|vitamins|mesh-ancestor
2296569|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
2296570|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842190|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2842191|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842192|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2842193|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2842194|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
2842195|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842196|NCT03912974|Citalopram|citalopram|mesh-list
2842197|NCT03912974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2842198|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2842199|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2842200|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842201|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842202|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
2842203|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842204|NCT03912974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2842205|NCT03912974|Antidepressive Agents|antidepressive agents|mesh-ancestor
2842206|NCT03912974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2842207|NCT03912857|Apatinib|apatinib|mesh-list
2842208|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842209|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2842210|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842211|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842217|NCT03912909|Empagliflozin|empagliflozin|mesh-list
2842218|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2842219|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296571|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2296572|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2296573|NCT00277758|Interferons|interferons|mesh-list
2296574|NCT00277758|Ribavirin|ribavirin|mesh-list
2296575|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
2296576|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2296577|NCT00277758|Interleukin-2|interleukin-2|mesh-list
2296578|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296579|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
2296580|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2842220|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2842221|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842222|NCT03913182|Apatinib|apatinib|mesh-list
2842223|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842224|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2842225|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842226|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296581|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
2296582|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296583|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
2296584|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296585|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2842234|NCT03913052|Viscosupplements|viscosupplements|mesh-list
2842235|NCT03913052|Protective Agents|protective agents|mesh-ancestor
2842236|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842237|NCT03912805|Botulinum Toxins|botulinum toxins|mesh-list
2842238|NCT03912805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2842239|NCT03912805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2842240|NCT03912805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2842241|NCT03912805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2842242|NCT03912805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842243|NCT03912805|Cholinergic Agents|cholinergic agents|mesh-ancestor
2842244|NCT03912805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842245|NCT03912805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842246|NCT03912805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2842247|NCT03912805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842248|NCT03912818|Gemcitabine|gemcitabine|mesh-list
2842249|NCT03912818|Carboplatin|carboplatin|mesh-list
2842250|NCT03912818|Doxorubicin|doxorubicin|mesh-list
2842251|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2842252|NCT03912818|Methotrexate|methotrexate|mesh-list
2842253|NCT03912818|Durvalumab|durvalumab|mesh-list
2842254|NCT03912818|Daunorubicin|daunorubicin|mesh-list
2842255|NCT03912818|Vinblastine|vinblastine|mesh-list
2842256|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842257|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2842258|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
2842259|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842260|NCT03912818|Antiviral Agents|antiviral agents|mesh-ancestor
2842261|NCT03912818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2842262|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296586|NCT00277758|Analgesics|analgesics|mesh-ancestor
2296587|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
2296588|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2296589|NCT00277862|Ribavirin|ribavirin|mesh-list
2296590|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
2296591|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
2296592|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2296593|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2842263|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2842264|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
2842265|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842266|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2842267|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2842268|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2842269|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2842270|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
2842271|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2842272|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
2842273|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2842274|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2842275|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2842276|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2842277|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2842278|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
2842279|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
2842280|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
2842281|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
2842282|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
2842283|NCT03912766|Coagulants|coagulants|mesh-ancestor
2842284|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2842285|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2842286|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
2842287|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842288|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
2842289|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
2842290|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842291|NCT03912727|Protective Agents|protective agents|mesh-ancestor
2842292|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842293|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
2842294|NCT03912727|Vitamins|vitamins|mesh-ancestor
2842295|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
2842296|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
2842297|NCT03912740|Remifentanil|remifentanil|mesh-list
2842298|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2842299|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842300|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842301|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2842302|NCT03912740|Analgesics|analgesics|mesh-ancestor
2842303|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
2842304|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842305|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2842306|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2842307|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2842308|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
2842309|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842310|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842311|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2842312|NCT03912740|Narcotics|narcotics|mesh-ancestor
2842313|NCT03912428|Celecoxib|celecoxib|mesh-list
2842314|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2842315|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2842316|NCT03912428|Analgesics|analgesics|mesh-ancestor
2842317|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
2842318|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842319|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842320|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2842321|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2842322|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2842323|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2842324|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842325|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842326|NCT03912402|Paclitaxel|paclitaxel|mesh-list
2842327|NCT03912402|Bevacizumab|bevacizumab|mesh-list
2842328|NCT03912402|Carboplatin|carboplatin|mesh-list
2842329|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2842330|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842331|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
2842332|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
2842333|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
2842334|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842335|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2842336|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2842337|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2842338|NCT03912402|Growth Substances|growth substances|mesh-ancestor
2842339|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842340|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
2842341|NCT03912389|Carboplatin|carboplatin|mesh-list
2842342|NCT03912389|Pemetrexed|pemetrexed|mesh-list
2842343|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842344|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842345|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842346|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2842347|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2842348|NCT03912233|Ivacaftor|ivacaftor|mesh-list
2842349|NCT03912233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2842350|NCT03912233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2842351|NCT03912233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842352|NCT03912220|Niacinamide|niacinamide|mesh-list
2842353|NCT03912220|Niacin|niacin|mesh-list
2842354|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
2842355|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
2842356|NCT03912220|Vitamins|vitamins|mesh-ancestor
2842357|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
2842358|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842359|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2842360|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
2842361|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296594|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
2296595|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296596|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
2296597|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296598|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
2296599|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296600|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296601|NCT00278070|Vinorelbine|vinorelbine|mesh-list
2296602|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296603|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296604|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
2296605|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
2842362|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2842363|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
2842364|NCT03912415|Paclitaxel|paclitaxel|mesh-list
2842365|NCT03912415|Bevacizumab|bevacizumab|mesh-list
2842366|NCT03912415|Carboplatin|carboplatin|mesh-list
2842367|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2842368|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107531|NCT02489734|Sevoflurane|sevoflurane|mesh-list
2107532|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2107533|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2107534|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
2107535|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
2107536|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107537|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107538|NCT02489968|Empagliflozin|empagliflozin|mesh-list
2107539|NCT02489968|Linagliptin|linagliptin|mesh-list
2107540|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2107541|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107542|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2107543|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107544|NCT02489968|Incretins|incretins|mesh-ancestor
2107545|NCT02489968|Hormones|hormones|mesh-ancestor
2107546|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2107547|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2107548|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
2296606|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
2842369|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
2842370|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
2842371|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
2842372|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842373|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2296607|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296608|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
2296609|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2296610|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
2296611|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2296612|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296613|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2842374|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2842375|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2842376|NCT03912415|Growth Substances|growth substances|mesh-ancestor
2842377|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842378|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
2842379|NCT03912285|Losartan|losartan|mesh-list
2842380|NCT03912285|Amlodipine|amlodipine|mesh-list
2842381|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2842382|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2842383|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2842384|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842385|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2842386|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842387|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
2842388|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2842389|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2842390|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2842396|NCT03911817|Midodrine|midodrine|mesh-list
2842397|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
2842398|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
2842399|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842400|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842401|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2842402|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2842403|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2842404|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2842405|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
2842406|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842407|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296614|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
2296615|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2296616|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
2296617|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296618|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296619|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2296620|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
2296621|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
2296622|NCT00278083|Protective Agents|protective agents|mesh-ancestor
2296623|NCT00278122|Paclitaxel|paclitaxel|mesh-list
2296624|NCT00278122|Sargramostim|sargramostim|mesh-list
2296625|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296626|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842421|NCT03911648|Lidocaine|lidocaine|mesh-list
2842422|NCT03911648|Bupivacaine|bupivacaine|mesh-list
2296627|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
2296628|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
2296629|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
2296630|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296631|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
2296632|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296633|NCT00278174|Interferons|interferons|mesh-list
2842423|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
2842424|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
2296634|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
2296635|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2296636|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296637|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
2296638|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296639|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
2296640|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296641|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2296642|NCT00278187|Volociximab|volociximab|mesh-list
2296643|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107549|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107550|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
2107551|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2107552|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
2107553|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107554|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107555|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2107556|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
2107557|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
2107558|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2107559|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
2107560|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107561|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107562|NCT02490293|Cephalosporins|cephalosporins|mesh-list
2842425|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842426|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842427|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
2842428|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842429|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2842430|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2842431|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2842432|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2842433|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296644|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2296645|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296646|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296647|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2296648|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2296649|NCT00278187|Growth Substances|growth substances|mesh-ancestor
2842434|NCT03911440|Azithromycin|azithromycin|mesh-list
2842435|NCT03911440|Doxycycline|doxycycline|mesh-list
2842436|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2842437|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2842438|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
2842439|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2842440|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2842441|NCT03911336|Acetaminophen|acetaminophen|mesh-list
2842442|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2842443|NCT03911336|Ketoprofen|ketoprofen|mesh-list
2842444|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2842445|NCT03911336|Analgesics|analgesics|mesh-ancestor
2842446|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
2842447|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842448|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842449|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
2842450|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2842451|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2842452|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2842453|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842454|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842455|NCT03911570|Acetaminophen|acetaminophen|mesh-list
2842456|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2842457|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2842458|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2842459|NCT03911570|Analgesics|analgesics|mesh-ancestor
2842460|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
2842461|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842462|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842463|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
2842464|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2842465|NCT03911557|Durvalumab|durvalumab|mesh-list
2842466|NCT03911557|Tremelimumab|tremelimumab|mesh-list
2842467|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2842468|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842469|NCT03911453|Rucaparib|rucaparib|mesh-list
2296650|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296651|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
2296652|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
2842470|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2842471|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842472|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842473|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842474|NCT03911414|Inositol|inositol|mesh-list
2842475|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
2842476|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2842477|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
2842478|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2842479|NCT03911414|Expectorants|expectorants|mesh-ancestor
2842480|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
2842481|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2842482|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
2842483|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842484|NCT03911414|Protective Agents|protective agents|mesh-ancestor
2842485|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842486|NCT03911414|Antidotes|antidotes|mesh-ancestor
2842487|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
2842488|NCT03911414|Vitamins|vitamins|mesh-ancestor
2842489|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
2842490|NCT03911271|Atropine|atropine|mesh-list
2842491|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2842492|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2842493|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2842494|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
2842495|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842496|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842497|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2842498|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
2842499|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
2842500|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
2842501|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2842502|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2842503|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
2842504|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842505|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842506|NCT03910998|Rocuronium|rocuronium|mesh-list
2842507|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2296653|NCT00278213|Fludarabine|fludarabine|mesh-list
2842508|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2842509|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2842510|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842511|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842512|NCT03911102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2842513|NCT03911102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2842514|NCT03911102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2842515|NCT03911102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842516|NCT03911102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842517|NCT03911102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2842518|NCT03911102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2842519|NCT03911102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842520|NCT03911102|Cholinergic Agents|cholinergic agents|mesh-ancestor
2842521|NCT03911102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842522|NCT03910803|Brodalumab|brodalumab|mesh-list
2842523|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
2842524|NCT03910647|Pantoprazole|pantoprazole|mesh-list
2842525|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2842526|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2296654|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
2296655|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
2296656|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
2296657|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296658|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
2296659|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296660|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2296661|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2296662|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
2296663|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296664|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296665|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2296666|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2296667|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
2296668|NCT00278213|Analgesics|analgesics|mesh-ancestor
2296669|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
2296670|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2296671|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2296672|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296673|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296674|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2296675|NCT00278252|Etoposide|etoposide|mesh-list
2296676|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296677|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296678|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2296679|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296680|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296681|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296682|NCT00278265|Vidarabine|vidarabine|mesh-list
2296683|NCT00278265|Methotrexate|methotrexate|mesh-list
2296684|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
2296685|NCT00278265|Fludarabine|fludarabine|mesh-list
2296686|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2296687|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
2296688|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2296689|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296690|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2296691|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
2296692|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296693|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296694|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
2296695|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842527|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2842528|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842529|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842533|NCT03910634|Carboplatin|carboplatin|mesh-list
2842534|NCT03910634|Fluorouracil|fluorouracil|mesh-list
2842535|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842536|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
2842537|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842538|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2842539|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2842540|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
2842541|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842542|NCT03910712|Trastuzumab|trastuzumab|mesh-list
2842543|NCT03910712|Letrozole|letrozole|mesh-list
2842544|NCT03910712|Anastrozole|anastrozole|mesh-list
2842545|NCT03910712|Exemestane|exemestane|mesh-list
2842546|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2842547|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2842548|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842549|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2842550|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296696|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2296697|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296698|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
2296699|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2296700|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2842551|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842552|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2842553|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
2842554|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2842555|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842556|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2842565|NCT03910556|Propofol|propofol|mesh-list
2842566|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2842567|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842568|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842569|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2842570|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
2842571|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
2842572|NCT03910543|Tofacitinib|tofacitinib|mesh-list
2842573|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2842574|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842575|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842576|NCT03910361|Pioglitazone|pioglitazone|mesh-list
2842577|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2842578|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842579|NCT03910452|Sirolimus|sirolimus|mesh-list
2296701|NCT00278265|Antiviral Agents|antiviral agents|mesh-ancestor
2296702|NCT00278265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296703|NCT00278278|Prednisone|prednisone|mesh-list
2296704|NCT00278278|Methotrexate|methotrexate|mesh-list
2842580|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
2842581|NCT03910452|Busulfan|busulfan|mesh-list
2842582|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
2842583|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2842584|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
2842585|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842586|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2842587|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2842588|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
2842589|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842590|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296705|NCT00278278|Etoposide|etoposide|mesh-list
2296706|NCT00278278|Vincristine|vincristine|mesh-list
2296707|NCT00278278|Ifosfamide|ifosfamide|mesh-list
2296708|NCT00278278|Lomustine|lomustine|mesh-list
2296709|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296710|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2296711|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
2296712|NCT00278278|Hormones|hormones|mesh-ancestor
2296713|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2296714|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296715|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2296716|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2296717|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
2842591|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2842592|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2842593|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296718|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2296719|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2296720|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
2296721|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296722|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
2296723|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296724|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2296725|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296726|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
2296727|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2296728|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2296729|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296730|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2296731|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296732|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
2296733|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
2296734|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
2296735|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2296736|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
2296737|NCT00278330|Vorinostat|vorinostat|mesh-list
2296738|NCT00278330|Alvocidib|alvocidib|mesh-list
2842594|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2842595|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
2842596|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2842597|NCT03910504|Rocuronium|rocuronium|mesh-list
2842598|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2842599|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2842600|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2842601|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842602|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842603|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
2842604|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2842605|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2842606|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842607|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
2842608|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842609|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842610|NCT03910244|Pomalidomide|pomalidomide|mesh-list
2842611|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
2842612|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107563|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2107564|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107565|NCT02490475|Docetaxel|docetaxel|mesh-list
2107566|NCT02490475|Pertuzumab|pertuzumab|mesh-list
2107567|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107568|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
2107569|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
2107570|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
2107571|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107572|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2107573|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
2107574|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2107575|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2107576|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296739|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842613|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2842614|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2842615|NCT03910244|Growth Substances|growth substances|mesh-ancestor
2842616|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
2842617|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296740|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2296741|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296742|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296743|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
2842618|NCT03910231|Tolvaptan|tolvaptan|mesh-list
2842619|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2842620|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842621|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
2842622|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842623|NCT03910088|Acetaminophen|acetaminophen|mesh-list
2842624|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
2842625|NCT03910088|Diclofenac|diclofenac|mesh-list
2842626|NCT03910088|Pregabalin|pregabalin|mesh-list
2842627|NCT03910088|Caffeine|caffeine|mesh-list
2842628|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2842629|NCT03910088|Analgesics|analgesics|mesh-ancestor
2842630|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
2842631|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842632|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842633|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
2842634|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
2842635|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2842636|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2842637|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296744|NCT00278330|Growth Substances|growth substances|mesh-ancestor
2296745|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296746|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2296747|NCT00278343|Cediranib|cediranib|mesh-list
2296748|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296749|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296750|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296751|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2296752|NCT00278369|Aldesleukin|aldesleukin|mesh-list
2296753|NCT00278369|Interleukin-2|interleukin-2|mesh-list
2296754|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
2296755|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296756|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2296757|NCT00278369|Analgesics|analgesics|mesh-ancestor
2296758|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
2296759|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2296760|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296761|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2296762|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2842638|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2842639|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2842640|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2842641|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842642|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2842643|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2842644|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2842645|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2842646|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2842647|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842648|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2842649|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2842650|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2842651|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2842652|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
2296763|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
2296764|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296765|NCT00278382|Sorafenib|sorafenib|mesh-list
2296766|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296767|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2296768|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296769|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296770|NCT00278408|Prednisone|prednisone|mesh-list
2296771|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
2296772|NCT00278408|Rituximab|rituximab|mesh-list
2296773|NCT00278408|Doxorubicin|doxorubicin|mesh-list
2296774|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2296775|NCT00278408|Vincristine|vincristine|mesh-list
2296776|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296777|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
2296778|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296779|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2296780|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2296781|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
2296782|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296783|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842653|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842654|NCT03909776|Cisplatin|cisplatin|mesh-list
2842655|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842656|NCT03909594|Ketamine|ketamine|mesh-list
2842657|NCT03909594|Bupivacaine|bupivacaine|mesh-list
2842658|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
2842659|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
2842660|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842661|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842662|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
2842663|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842664|NCT03909594|Analgesics|analgesics|mesh-ancestor
2842665|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2842666|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2842667|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
2842668|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2842669|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2842670|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842671|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842672|NCT03909477|Xenon|xenon|mesh-list
2842673|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2842674|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
2842675|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
2842676|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842677|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842678|NCT03909724|Sunitinib|sunitinib|mesh-list
2842679|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842680|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2842681|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2842682|NCT03909724|Growth Substances|growth substances|mesh-ancestor
2842683|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842684|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
2842685|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2842686|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842687|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842688|NCT03909737|Azithromycin|azithromycin|mesh-list
2842689|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2842690|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2842691|NCT03909529|Digoxin|digoxin|mesh-list
2842692|NCT03909529|Spironolactone|spironolactone|mesh-list
2842693|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2842694|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
2842695|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2842696|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842697|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2842698|NCT03909529|Diuretics|diuretics|mesh-ancestor
2842699|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
2842700|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2842701|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2842702|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842703|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842704|NCT03909529|Protective Agents|protective agents|mesh-ancestor
2842705|NCT03909607|Ketamine|ketamine|mesh-list
2842706|NCT03909607|Analgesics|analgesics|mesh-ancestor
2842707|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
2842708|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842709|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296784|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2296785|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2296786|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2296787|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2296788|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296789|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296790|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2296791|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
2296792|NCT00278408|Hormones|hormones|mesh-ancestor
2296793|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2296794|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2296795|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296796|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
2296797|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
2296798|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
2296799|NCT00278421|Prednisone|prednisone|mesh-list
2296800|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
2842710|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2842711|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2842712|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
2842713|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
2842714|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842715|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2842716|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2842717|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842718|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842719|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2842720|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2842721|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842722|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2842723|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842724|NCT03909412|Dexamethasone|dexamethasone|mesh-list
2842725|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
2296801|NCT00278421|Rituximab|rituximab|mesh-list
2296802|NCT00278421|Doxorubicin|doxorubicin|mesh-list
2296803|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2296804|NCT00278421|Vincristine|vincristine|mesh-list
2842726|NCT03909412|Lenograstim|lenograstim|mesh-list
2842727|NCT03909412|Sargramostim|sargramostim|mesh-list
2842728|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2842729|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
2842730|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842731|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2842732|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2842733|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
2842734|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842735|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842736|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2842737|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2842738|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
2842739|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
2842740|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842741|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2842742|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
2842743|NCT03909412|Hormones|hormones|mesh-ancestor
2296805|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296806|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
2296807|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296808|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2296809|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2296810|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
2296811|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296812|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296813|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2296814|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2296815|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2296816|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2842744|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2842745|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2842746|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2842747|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
2842748|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
2842749|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842750|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
2842751|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842752|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842753|NCT03909646|Fluorouracil|fluorouracil|mesh-list
2842754|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2842755|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2842756|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
2842757|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842758|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2842759|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842760|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2842761|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
2842762|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842763|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2842764|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
2842765|NCT03909152|Anastrozole|anastrozole|mesh-list
2842766|NCT03909152|Onapristone|onapristone|mesh-list
2842767|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2296817|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2296818|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296819|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2296820|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
2296821|NCT00278421|Hormones|hormones|mesh-ancestor
2296822|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2296823|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2296824|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296825|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
2296826|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
2296827|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
2296828|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
2842768|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842769|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2842770|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2842771|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842772|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842773|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2842774|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
2842775|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2842776|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842777|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2842778|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
2842779|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2842780|NCT03909074|Vaccines|vaccines|mesh-list
2842781|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
2842782|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842783|NCT03908892|Tetracycline|tetracycline|mesh-list
2842784|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2842785|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2842786|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2842787|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842788|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842789|NCT03908944|Methadone|methadone|mesh-list
2842790|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2842791|NCT03908944|Narcotics|narcotics|mesh-ancestor
2842792|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842793|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842794|NCT03908944|Analgesics|analgesics|mesh-ancestor
2842795|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
2842796|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842797|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
2842798|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
2842799|NCT03908619|Esomeprazole|esomeprazole|mesh-list
2842800|NCT03908619|Omeprazole|omeprazole|mesh-list
2842801|NCT03908619|Rabeprazole|rabeprazole|mesh-list
2842802|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2842803|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2842804|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2842805|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842806|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842807|NCT03908736|Picolinic acid|picolinic acid|mesh-list
2842808|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2842809|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
2842810|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
2842811|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842812|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2842813|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2842814|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842815|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842816|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2842817|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2296829|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2296830|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296831|NCT00278460|Gemcitabine|gemcitabine|mesh-list
2296832|NCT00278460|Docetaxel|docetaxel|mesh-list
2296833|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2296834|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
2296835|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296836|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296837|NCT00278460|Antiviral Agents|antiviral agents|mesh-ancestor
2296838|NCT00278460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296839|NCT00278460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842818|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842819|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
2842820|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842821|NCT03908593|Pantoprazole|pantoprazole|mesh-list
2842822|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2842823|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2842824|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2842825|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842826|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842827|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
2842828|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
2842829|NCT03908528|Doxorubicin|doxorubicin|mesh-list
2842830|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2842831|NCT03908528|Paclitaxel|paclitaxel|mesh-list
2842832|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2842833|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2842834|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
2842835|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842836|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2842837|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2842838|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
2842839|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842840|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842841|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2842842|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2842843|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2842844|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2842845|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842846|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2842847|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
2842848|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
2842849|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
2842850|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
2842851|NCT03908528|Protective Agents|protective agents|mesh-ancestor
2842852|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
2842853|NCT03908528|Vitamins|vitamins|mesh-ancestor
2842854|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
2842855|NCT03908814|Antibodies|antibodies|mesh-list
2842856|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
2842857|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842858|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
2842859|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
2842860|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842861|NCT03908489|Protective Agents|protective agents|mesh-ancestor
2842862|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842863|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2842864|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842865|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2842866|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842867|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
2842868|NCT03908333|Gemcitabine|gemcitabine|mesh-list
2842869|NCT03908333|Paclitaxel|paclitaxel|mesh-list
2842870|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2842871|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2842872|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842873|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
2842874|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
2842875|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
2842876|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842877|NCT03908333|Vitamins|vitamins|mesh-ancestor
2842878|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
2842879|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842880|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2842881|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
2842882|NCT03908333|Antiviral Agents|antiviral agents|mesh-ancestor
2842883|NCT03908333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2842884|NCT03908333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842885|NCT03908333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2842886|NCT03908333|Immunologic Factors|immunologic factors|mesh-ancestor
2842887|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
2842888|NCT03908333|Protective Agents|protective agents|mesh-ancestor
2842889|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
2842890|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842891|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842892|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842893|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2842894|NCT03908060|Morphine|morphine|mesh-list
2842895|NCT03908060|Methadone|methadone|mesh-list
2842896|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2842897|NCT03908060|Narcotics|narcotics|mesh-ancestor
2842898|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842899|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842900|NCT03908060|Analgesics|analgesics|mesh-ancestor
2842901|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
2842902|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842903|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
2842904|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
2842905|NCT03908372|Docetaxel|docetaxel|mesh-list
2842906|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842907|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
2842908|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
2842909|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
2842910|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296840|NCT00278460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296841|NCT00278460|Immunologic Factors|immunologic factors|mesh-ancestor
2296842|NCT00278460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296843|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
2296844|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
2296845|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
2296846|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
2296847|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296848|NCT00278772|Valproic Acid|valproic acid|mesh-list
2842911|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
2842912|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2842913|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2842914|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2842915|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2842916|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842917|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
2842918|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2842919|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296849|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
2296850|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296851|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296852|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
2296853|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296854|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296855|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
2296856|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2842920|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2842921|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842925|NCT03908307|Dexamethasone|dexamethasone|mesh-list
2842926|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
2842927|NCT03908307|BB 1101|bb 1101|mesh-list
2842928|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2842929|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
2842930|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
2842931|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842932|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842933|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2842934|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
2842935|NCT03908307|Hormones|hormones|mesh-ancestor
2842936|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2842937|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2842938|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842939|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
2296857|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2296858|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2296859|NCT00278824|Fentanyl|fentanyl|mesh-list
2296860|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2296861|NCT00278824|Narcotics|narcotics|mesh-ancestor
2296862|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842940|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842941|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842942|NCT03907800|Paclitaxel|paclitaxel|mesh-list
2842943|NCT03907800|Carboplatin|carboplatin|mesh-list
2842944|NCT03907800|Trastuzumab|trastuzumab|mesh-list
2842945|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2842946|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842947|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
2842948|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
2842949|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
2842950|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842951|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2842956|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
2842957|NCT03907852|Fludarabine|fludarabine|mesh-list
2842958|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2842959|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
2842960|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842961|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2842962|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2842963|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
2842964|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842965|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2842966|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2842967|NCT03907813|Bupivacaine|bupivacaine|mesh-list
2842968|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
2842969|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
2842970|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2842971|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842972|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
2296863|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296864|NCT00278824|Analgesics|analgesics|mesh-ancestor
2296865|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
2296866|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2296867|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2296868|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2296869|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
2296870|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
2296871|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2296872|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2296873|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2296874|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2296875|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2296876|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
2296877|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2296878|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2296879|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2296880|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2296881|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296882|NCT00278967|Bisacodyl|bisacodyl|mesh-list
2296883|NCT00278967|Cathartics|cathartics|mesh-ancestor
2296884|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2296885|NCT00278967|Laxatives|laxatives|mesh-ancestor
2296886|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
2842973|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2842974|NCT03907423|Metformin|metformin|mesh-list
2842975|NCT03907423|Glimepiride|glimepiride|mesh-list
2842976|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2842977|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2842978|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2842979|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2842980|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2842981|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
2842982|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2842983|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2842984|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2842985|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2842986|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2842987|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2842988|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
2842989|NCT03907475|Gemcitabine|gemcitabine|mesh-list
2842990|NCT03907475|Paclitaxel|paclitaxel|mesh-list
2842991|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2842992|NCT03907475|Carboplatin|carboplatin|mesh-list
2296887|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2296888|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
2107577|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
2107578|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
2107579|NCT02490670|Cephalexin|cephalexin|mesh-list
2107580|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2107581|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107582|NCT02490878|Bevacizumab|bevacizumab|mesh-list
2107583|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2107584|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107585|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2107586|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2107587|NCT02490878|Growth Substances|growth substances|mesh-ancestor
2107588|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107589|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
2107590|NCT02491437|Progesterone|progesterone|mesh-list
2107591|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
2107592|NCT02491437|Progestins|progestins|mesh-ancestor
2107593|NCT02491437|Hormones|hormones|mesh-ancestor
2107594|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2107595|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107596|NCT02491463|Vaccines|vaccines|mesh-list
2107597|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
2107598|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107599|NCT02491684|Interferons|interferons|mesh-list
2842993|NCT03907475|Doxorubicin|doxorubicin|mesh-list
2842994|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2842995|NCT03907475|Capecitabine|capecitabine|mesh-list
2842996|NCT03907475|Durvalumab|durvalumab|mesh-list
2842997|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
2842998|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2842999|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
2843000|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2296889|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843001|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843002|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
2843003|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
2843004|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
2843005|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843006|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2843007|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
2843008|NCT03907475|Antiviral Agents|antiviral agents|mesh-ancestor
2843009|NCT03907475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843010|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843011|NCT03907475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2296890|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296891|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2296892|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
2296893|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
2296894|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2296895|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
2296896|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296897|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296898|NCT00279045|Metformin|metformin|mesh-list
2296899|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
2296900|NCT00279045|Glyburide|glyburide|mesh-list
2296901|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2296902|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296903|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
2296904|NCT00279084|Hematinics|hematinics|mesh-ancestor
2296905|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2296906|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
2296907|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2296908|NCT00279123|Pantoprazole|pantoprazole|mesh-list
2296909|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2296910|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2296911|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2296912|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2296913|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296914|NCT00279162|Betamethasone|betamethasone|mesh-list
2296915|NCT00279162|Calcipotriene|calcipotriene|mesh-list
2296916|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2296917|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
2296918|NCT00279162|Hormones|hormones|mesh-ancestor
2296919|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2296920|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296921|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2296922|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
2296923|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
2296924|NCT00279240|Metformin|metformin|mesh-list
2296925|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2296926|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296927|NCT00279253|Clonidine|clonidine|mesh-list
2296928|NCT00279253|Analgesics|analgesics|mesh-ancestor
2296929|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
2296930|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843012|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
2843013|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843014|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2843015|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2843016|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2843017|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843018|NCT03907371|Donepezil|donepezil|mesh-list
2843019|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2843020|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843021|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843022|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
2843023|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843024|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843025|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
2843026|NCT03907098|Endostar protein|endostar protein|mesh-list
2843027|NCT03907098|Endostatins|endostatins|mesh-list
2843028|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2843029|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2843030|NCT03907098|Growth Substances|growth substances|mesh-ancestor
2843031|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843032|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
2296931|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296932|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2296933|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
2296934|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
2843033|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843034|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
2843035|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2843036|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
2843037|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843038|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
2843039|NCT03906877|Protective Agents|protective agents|mesh-ancestor
2843040|NCT03906916|Micafungin|micafungin|mesh-list
2843041|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
2843042|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843043|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
2843044|NCT03907215|Citalopram|citalopram|mesh-list
2296935|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2296936|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2296937|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2296938|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
2296939|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2296940|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296941|NCT00279266|Thiamine|thiamine|mesh-list
2296942|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
2296943|NCT00279266|Vitamins|vitamins|mesh-ancestor
2296944|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
2296945|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296946|NCT00279344|Fentanyl|fentanyl|mesh-list
2296947|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2296948|NCT00279344|Narcotics|narcotics|mesh-ancestor
2296949|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2296950|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296951|NCT00279344|Analgesics|analgesics|mesh-ancestor
2296952|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
2296953|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2296954|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2296955|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2296956|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
2296957|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
2296958|NCT00279383|Thrombin|thrombin|mesh-list
2296959|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
2296960|NCT00279383|Coagulants|coagulants|mesh-ancestor
2843045|NCT03907215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2843046|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2843047|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2843048|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843049|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843050|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
2843051|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843052|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2843053|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
2843054|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2843055|NCT03907163|Dronabinol|dronabinol|mesh-list
2843056|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
2843057|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843058|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2843059|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2843060|NCT03907163|Analgesics|analgesics|mesh-ancestor
2843061|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
2296961|NCT00279422|Visilizumab|visilizumab|mesh-list
2296962|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
2296963|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296964|NCT00279435|Visilizumab|visilizumab|mesh-list
2296965|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
2296966|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296967|NCT00279448|Tamoxifen|tamoxifen|mesh-list
2296968|NCT00279448|Exemestane|exemestane|mesh-list
2296969|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2296970|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
2296971|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2296972|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296973|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2296974|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2296975|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2296976|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2843062|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843063|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2843064|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2843065|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843066|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296977|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2843067|NCT03907163|Hormones|hormones|mesh-ancestor
2843068|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2843069|NCT03907111|Chitosan|chitosan|mesh-list
2843070|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2843071|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2843072|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
2843073|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843074|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2843075|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
2843076|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
2843077|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
2296978|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2296979|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2296980|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843078|NCT03907111|Coagulants|coagulants|mesh-ancestor
2843079|NCT03907176|Acetaminophen|acetaminophen|mesh-list
2843080|NCT03907176|Ibuprofen|ibuprofen|mesh-list
2843081|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2843082|NCT03907176|Analgesics|analgesics|mesh-ancestor
2843083|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
2843084|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843085|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843086|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
2843087|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2843088|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2843089|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2843090|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2843091|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843092|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843093|NCT03906721|Oxycodone|oxycodone|mesh-list
2843094|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2843095|NCT03906721|Narcotics|narcotics|mesh-ancestor
2843096|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843097|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843098|NCT03906721|Analgesics|analgesics|mesh-ancestor
2843099|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
2843100|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843101|NCT03906838|Ropivacaine|ropivacaine|mesh-list
2843102|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
2843103|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
2843104|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843105|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843106|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
2843107|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2296981|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2296982|NCT00279461|Vitamin D|vitamin d|mesh-list
2296983|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
2296984|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
2296985|NCT00279461|Vitamins|vitamins|mesh-list
2296986|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
2296987|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296988|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2296989|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2296990|NCT00279487|Gabapentin|gabapentin|mesh-list
2296991|NCT00279487|Analgesics|analgesics|mesh-ancestor
2296992|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
2296993|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2296994|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2296995|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
2296996|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2296997|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2296998|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2296999|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2297000|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2297001|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2297002|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297003|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297004|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
2297005|NCT00279539|Mitogens|mitogens|mesh-list
2297006|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
2297007|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
2297008|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297009|NCT00279539|Growth Substances|growth substances|mesh-ancestor
2297010|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297011|NCT00279565|Interferons|interferons|mesh-list
2843108|NCT03906669|Tamoxifen|tamoxifen|mesh-list
2843109|NCT03906669|Letrozole|letrozole|mesh-list
2843110|NCT03906669|Progesterone|progesterone|mesh-list
2843111|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843112|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2843113|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2843114|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843115|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843116|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2843117|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
2297012|NCT00279565|Ribavirin|ribavirin|mesh-list
2297013|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
2297014|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
2297015|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2297016|NCT00279565|Buprenorphine|buprenorphine|mesh-list
2297017|NCT00279565|Methadone|methadone|mesh-list
2297018|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297019|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
2843118|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2843119|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843120|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2843121|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2843122|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2843123|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2843124|NCT03906669|Progestins|progestins|mesh-ancestor
2843125|NCT03906669|Hormones|hormones|mesh-ancestor
2297020|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2297021|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
2297022|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843153|NCT03905798|Lorazepam|lorazepam|mesh-list
2843154|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
2843155|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
2843156|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
2843157|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843158|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843159|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2297023|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
2843160|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2843161|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843162|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2843163|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2843164|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2843165|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
2843166|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
2843167|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843168|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843169|NCT03905928|Nicotine|nicotine|mesh-list
2843170|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2843171|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
2843172|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843173|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843174|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2843175|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2843176|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
2843177|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843178|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843179|NCT03905837|Lidocaine|lidocaine|mesh-list
2843180|NCT03905837|Piperidine|piperidine|mesh-list
2843181|NCT03905837|Remifentanil|remifentanil|mesh-list
2843182|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
2843183|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
2843184|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843185|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843186|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
2843187|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843188|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2843189|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2843190|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2843191|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2843192|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843193|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2843194|NCT03905837|Narcotics|narcotics|mesh-ancestor
2843195|NCT03905837|Analgesics|analgesics|mesh-ancestor
2843196|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2843197|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2843198|NCT03905941|Metformin|metformin|mesh-list
2843199|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
2843200|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2843201|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843202|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2843203|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
2843204|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2843205|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2297024|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297025|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2297026|NCT00279565|Narcotics|narcotics|mesh-ancestor
2297027|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2297028|NCT00279565|Analgesics|analgesics|mesh-ancestor
2297029|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
2297030|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297031|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2297032|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
2297033|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
2297034|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
2297035|NCT00279578|Factor VIII|factor viii|mesh-list
2297036|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2297037|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2297038|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297039|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
2297040|NCT00279578|Coagulants|coagulants|mesh-ancestor
2297041|NCT00279617|Levetiracetam|levetiracetam|mesh-list
2297042|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
2297043|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
2297044|NCT00279734|Abatacept|abatacept|mesh-list
2297045|NCT00279734|Vaccines|vaccines|mesh-list
2297046|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
2297047|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297048|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2297049|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297050|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297051|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2297052|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2297053|NCT00279747|Naproxen|naproxen|mesh-list
2297054|NCT00279747|Meloxicam|meloxicam|mesh-list
2843206|NCT03906123|Protective Agents|protective agents|mesh-ancestor
2843207|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843208|NCT03905967|Lenvatinib|lenvatinib|mesh-list
2843209|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843210|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2297055|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2297056|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2297057|NCT00279747|Analgesics|analgesics|mesh-ancestor
2297058|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
2297059|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297060|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843211|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843212|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843213|NCT03905759|Colchicine|colchicine|mesh-list
2297061|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2297062|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2297063|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
2297064|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2297065|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297066|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297067|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2297068|NCT00279760|Abatacept|abatacept|mesh-list
2297069|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2297070|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297071|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297072|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2297073|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
2843214|NCT03905759|Amiodarone|amiodarone|mesh-list
2843215|NCT03905759|Dronedarone|dronedarone|mesh-list
2843216|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
2843217|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2843218|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
2843219|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
2843220|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
2843221|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843222|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843223|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2843224|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
2843225|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2843226|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2843227|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2843228|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2843229|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2843230|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843231|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2843232|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2843233|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2843234|NCT03905603|Cosyntropin|cosyntropin|mesh-list
2843235|NCT03905603|Hormones|hormones|mesh-ancestor
2297074|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297075|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2297076|NCT00279825|Levodopa|levodopa|mesh-list
2297077|NCT00279825|Carbidopa|carbidopa|mesh-list
2297078|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2297079|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2297080|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2297081|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
2843236|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2843237|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843238|NCT03905317|Bevacizumab|bevacizumab|mesh-list
2843239|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843240|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843241|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2843242|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2843243|NCT03905317|Growth Substances|growth substances|mesh-ancestor
2843244|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843245|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
2843246|NCT03905486|Pregabalin|pregabalin|mesh-list
2843247|NCT03905486|Analgesics|analgesics|mesh-ancestor
2843248|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
2843249|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843250|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843251|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
2843252|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2843253|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2843254|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843255|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2843256|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2843257|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2843258|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843259|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2843260|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
2843261|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2843262|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843263|NCT03905564|Pyridoxine|pyridoxine|mesh-list
2843264|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
2843265|NCT03905564|Doxylamine|doxylamine|mesh-list
2843266|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
2843267|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
2843268|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
2843269|NCT03905564|Vitamins|vitamins|mesh-ancestor
2843270|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
2843271|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843272|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
2843273|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
2843274|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843275|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2297082|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297083|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297084|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297085|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2297086|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297087|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2297088|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
2297089|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
2297090|NCT00279903|Cortisone|cortisone|mesh-list
2843276|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2843277|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
2843278|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
2843279|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843280|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297091|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
2297092|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2297093|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2297094|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2297095|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2297096|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297097|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
2297098|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297099|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297100|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2297101|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297102|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2843281|NCT03904849|Cannabidiol|cannabidiol|mesh-list
2843282|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
2843283|NCT03905018|Tadalafil|tadalafil|mesh-list
2843284|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
2843285|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2843286|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2843287|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843288|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843289|NCT03905018|Urological Agents|urological agents|mesh-ancestor
2843290|NCT03904836|Tobramycin|tobramycin|mesh-list
2843291|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2843292|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843293|NCT03904888|Anesthetics|anesthetics|mesh-list
2843294|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
2843295|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843296|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843297|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
2843298|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843299|NCT03904680|Vitamin D|vitamin d|mesh-list
2843300|NCT03904680|Methotrexate|methotrexate|mesh-list
2843301|NCT03904680|Vitamins|vitamins|mesh-ancestor
2843302|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
2843303|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843304|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2843305|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2843306|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
2843307|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2843308|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2843309|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
2843310|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843311|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843312|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
2843313|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843314|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2843315|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2843316|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
2843317|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2843318|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2843319|NCT03904498|Tolcapone|tolcapone|mesh-list
2843320|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2843321|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2843322|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2843323|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843324|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843325|NCT03904550|Rocuronium|rocuronium|mesh-list
2843326|NCT03904550|Cisatracurium|cisatracurium|mesh-list
2843327|NCT03904550|Neostigmine|neostigmine|mesh-list
2843328|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2843329|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2843330|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2843331|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843332|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843333|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2843334|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843335|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843336|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
2843337|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843338|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2843339|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
2843340|NCT03904719|Vorolanib|vorolanib|mesh-list
2843341|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2843342|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843343|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843344|NCT03904446|Methylergonovine|methylergonovine|mesh-list
2843345|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
2843346|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2297103|NCT00280007|Bevacizumab|bevacizumab|mesh-list
2297104|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2297105|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297106|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2843347|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843348|NCT03904745|Atosiban|atosiban|mesh-list
2843349|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
2843350|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2843351|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843352|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
2843353|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2843354|NCT03904563|Bevacizumab|bevacizumab|mesh-list
2843355|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843356|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843357|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2297107|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2297108|NCT00280007|Growth Substances|growth substances|mesh-ancestor
2843358|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2843359|NCT03904563|Growth Substances|growth substances|mesh-ancestor
2843360|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843361|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
2297109|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297110|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
2297111|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2843362|NCT03904732|Aspirin|aspirin|mesh-list
2843363|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2843364|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2843365|NCT03904732|Analgesics|analgesics|mesh-ancestor
2843366|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
2843367|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843368|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843369|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2843370|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2843371|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2843372|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2107600|NCT02491684|Interferon-beta|interferon-beta|mesh-list
2107601|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
2107602|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107603|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
2107604|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107605|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
2107606|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107607|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2107608|NCT02491788|Suvorexant|suvorexant|mesh-list
2297112|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2297113|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
2297114|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297115|NCT00280033|Antacids|antacids|mesh-ancestor
2297116|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297117|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2297118|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
2297119|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
2297120|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2297121|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297122|NCT00280098|Docetaxel|docetaxel|mesh-list
2297123|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297124|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
2297125|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
2297126|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
2297127|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297128|NCT00280176|Fluorouracil|fluorouracil|mesh-list
2297129|NCT00280176|Bortezomib|bortezomib|mesh-list
2297130|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
2297131|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297132|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2297133|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297134|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2297135|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
2297136|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297137|NCT00280215|Losartan|losartan|mesh-list
2297138|NCT00280215|Lisinopril|lisinopril|mesh-list
2297139|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2297140|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2297141|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2297142|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2297143|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2297144|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2297145|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843373|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843374|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2843375|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2843376|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843377|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
2843378|NCT03904537|Antibodies|antibodies|mesh-list
2297146|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
2297147|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2297148|NCT00280215|Protective Agents|protective agents|mesh-ancestor
2297149|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297150|NCT00280267|Testosterone|testosterone|mesh-list
2297151|NCT00280267|Androgens|androgens|mesh-ancestor
2297152|NCT00280267|Hormones|hormones|mesh-ancestor
2297153|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2843379|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
2843380|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843381|NCT03904381|Fluorouracil|fluorouracil|mesh-list
2843382|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
2843383|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843384|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2843385|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843386|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2843387|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
2843388|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843389|NCT03904329|Anticoagulants|anticoagulants|mesh-list
2843390|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2843391|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2843392|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843393|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2843394|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2843395|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843396|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
2843397|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
2843398|NCT03903952|Vitamins|vitamins|mesh-ancestor
2843399|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
2843400|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843401|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
2843402|NCT03903952|Hematinics|hematinics|mesh-ancestor
2297154|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297155|NCT00280280|Baclofen|baclofen|mesh-list
2297156|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2297157|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297158|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2297159|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297160|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2297161|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
2297162|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
2297163|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297164|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297165|NCT00280358|Fluticasone|fluticasone|mesh-list
2297166|NCT00280358|Xhance|xhance|mesh-list
2297167|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
2297168|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2297169|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2297170|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
2297171|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297172|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297173|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2297174|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
2297175|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
2843403|NCT03904108|Ramucirumab|ramucirumab|mesh-list
2843404|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843405|NCT03904251|Cytarabine|cytarabine|mesh-list
2843406|NCT03904251|Daunorubicin|daunorubicin|mesh-list
2843407|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
2843408|NCT03904251|Calicheamicins|calicheamicins|mesh-list
2843409|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2843410|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
2843411|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843412|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843413|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
2843414|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843415|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2843416|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
2843417|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843418|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2843419|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2843420|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2843421|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297176|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2297177|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2297178|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2297179|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2297180|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
2297181|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297182|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297183|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
2843422|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843423|NCT03904225|Tegafur|tegafur|mesh-list
2843424|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2843425|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
2297184|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2297185|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
2297186|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297187|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297188|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2843426|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843427|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843428|NCT03903835|Prednisone|prednisone|mesh-list
2843429|NCT03903835|Carboplatin|carboplatin|mesh-list
2843430|NCT03903835|Docetaxel|docetaxel|mesh-list
2843431|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
2843432|NCT03903835|Niraparib|niraparib|mesh-list
2843433|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2843434|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2843435|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843436|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
2843437|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
2843438|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
2843439|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843440|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2843441|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
2843442|NCT03903835|Hormones|hormones|mesh-ancestor
2843443|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2843444|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843445|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2843446|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2843447|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843448|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
2843449|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2843450|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2843451|NCT03904056|Ranibizumab|ranibizumab|mesh-list
2843452|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2843453|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2843454|NCT03904056|Growth Substances|growth substances|mesh-ancestor
2843455|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843456|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
2843457|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843458|NCT03903887|Antibodies|antibodies|mesh-list
2843459|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
2843460|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843461|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
2843462|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2843463|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2843464|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843465|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
2843466|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843467|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843468|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
2843469|NCT03903809|Hematinics|hematinics|mesh-ancestor
2297189|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
2297190|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2297191|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2297192|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2297193|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
2297194|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297195|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297196|NCT00280423|Casopitant|casopitant|mesh-list
2843470|NCT03903718|Oseltamivir|oseltamivir|mesh-list
2843471|NCT03903718|MEDI8852|medi8852|mesh-list
2843472|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
2107609|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2107610|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2107611|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107612|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107613|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2297197|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
2843473|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843474|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843475|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843476|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
2107614|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107615|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107616|NCT02491892|Pertuzumab|pertuzumab|mesh-list
2107617|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843477|NCT03903783|Cefotaxime|cefotaxime|mesh-list
2843478|NCT03903783|Cefoxitin|cefoxitin|mesh-list
2843479|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2843480|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843481|NCT03903640|Nivolumab|nivolumab|mesh-list
2843482|NCT03903640|Ipilimumab|ipilimumab|mesh-list
2843483|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843484|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843485|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2843486|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843487|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2843488|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2843489|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843490|NCT03903367|Fentanyl|fentanyl|mesh-list
2843491|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2843492|NCT03903367|Narcotics|narcotics|mesh-ancestor
2843493|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843494|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843495|NCT03903367|Analgesics|analgesics|mesh-ancestor
2843496|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
2843497|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843498|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2843499|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2843500|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
2843501|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
2843502|NCT03903458|Nivolumab|nivolumab|mesh-list
2843503|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843504|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843505|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2843506|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843507|NCT03903302|Valproic Acid|valproic acid|mesh-list
2843508|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
2843509|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843510|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843511|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
2843512|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843513|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843514|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
2843515|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2843516|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843517|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2297198|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
2297199|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297200|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297201|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2297202|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2297203|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297204|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297205|NCT00280436|Casopitant|casopitant|mesh-list
2297206|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
2297207|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
2297208|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297209|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297210|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2297211|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2843518|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
2843519|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2843520|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2843521|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2843522|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2843523|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843524|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
2843525|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843526|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843527|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2843528|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843529|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
2843530|NCT03903185|Ledipasvir|ledipasvir|mesh-list
2843531|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2843532|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
2843533|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843534|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2843535|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2843536|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2843537|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
2843538|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843539|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2843540|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2843541|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843542|NCT03903133|Vitamin E|vitamin e|mesh-list
2843543|NCT03903133|Antioxidants|antioxidants|mesh-list
2843544|NCT03903133|Vitamins|vitamins|mesh-ancestor
2843545|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
2843546|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843547|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843548|NCT03903133|Protective Agents|protective agents|mesh-ancestor
2843549|NCT03902912|Prednisolone|prednisolone|mesh-list
2843550|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2843551|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
2843552|NCT03902912|Hormones|hormones|mesh-ancestor
2843553|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2843554|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843555|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2843556|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843557|NCT03902925|Lidocaine|lidocaine|mesh-list
2843558|NCT03902925|Ropivacaine|ropivacaine|mesh-list
2843559|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
2843560|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
2843561|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843562|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843563|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
2843564|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843565|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2843566|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2843567|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2297212|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297213|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297214|NCT00280462|Nifedipine|nifedipine|mesh-list
2297215|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2297216|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2297217|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297218|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2297219|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297220|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
2297221|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
2297222|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2297223|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2297224|NCT00280501|Sulpiride|sulpiride|mesh-list
2297225|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
2843568|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2843569|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297226|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2297227|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2297228|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2297229|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843584|NCT03903016|Insulin|insulin|mesh-list
2843585|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2843586|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
2843587|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2843588|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843589|NCT03902782|Dexamethasone|dexamethasone|mesh-list
2843590|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
2843591|NCT03902782|Epinephrine|epinephrine|mesh-list
2843592|NCT03902782|Bupivacaine|bupivacaine|mesh-list
2843593|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2843594|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
2843595|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
2843596|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843597|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843598|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2843599|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
2843600|NCT03902782|Hormones|hormones|mesh-ancestor
2843601|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2297230|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297231|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2297232|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
2297233|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297234|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297235|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2297236|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
2297237|NCT00280514|Cefpirome|cefpirome|mesh-list
2297238|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2297239|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2297240|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2843602|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2843603|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843604|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
2843605|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
2843606|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843607|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
2843608|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2843609|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2843610|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
2843611|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843612|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843613|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2843614|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2843615|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2843616|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
2843617|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
2843618|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
2297241|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2297242|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297243|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297244|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297245|NCT00280540|Valsartan|valsartan|mesh-list
2297246|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2107618|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107619|NCT02491944|Osimertinib|osimertinib|mesh-list
2107620|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107621|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2107622|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107623|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107624|NCT02492165|Vaccines|vaccines|mesh-list
2107625|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
2107626|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107627|NCT02492451|Progesterone|progesterone|mesh-list
2107628|NCT02492451|Progestins|progestins|mesh-ancestor
2107629|NCT02492451|Hormones|hormones|mesh-ancestor
2297247|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2843619|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2297248|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2297249|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2297250|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297251|NCT00280540|Diuretics|diuretics|mesh-ancestor
2297252|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
2297253|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843620|NCT03902418|Tenofovir|tenofovir|mesh-list
2843621|NCT03902418|Emtricitabine|emtricitabine|mesh-list
2843622|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
2843623|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843624|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2843625|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2843626|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843627|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843628|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2843629|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2297254|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2297255|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2297256|NCT00280553|Bupivacaine|bupivacaine|mesh-list
2297257|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
2297258|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
2297259|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2297260|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297261|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
2297262|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297263|NCT00280605|Alfuzosin|alfuzosin|mesh-list
2843642|NCT03902522|Leronlimab|leronlimab|mesh-list
2843643|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2843644|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2843645|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843646|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2843647|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2843648|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
2843649|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843650|NCT03902106|Albuterol|albuterol|mesh-list
2843651|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2843652|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
2843653|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843654|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843655|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2843656|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
2843657|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
2843658|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2843659|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2843660|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2843661|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2843662|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
2843663|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843664|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843665|NCT03902340|Analgesics|analgesics|mesh-list
2843666|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
2843667|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843668|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843669|NCT03902249|Dexamethasone|dexamethasone|mesh-list
2843670|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2843671|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
2843672|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
2843673|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843674|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843675|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2843676|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
2843677|NCT03902249|Hormones|hormones|mesh-ancestor
2843678|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2297264|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2297265|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2297266|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2297267|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
2297268|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297269|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297270|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297271|NCT00280605|Urological Agents|urological agents|mesh-ancestor
2297272|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
2297273|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297274|NCT00280644|Leflunomide|leflunomide|mesh-list
2843679|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2843680|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297275|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297276|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297277|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2297278|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
2297279|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297280|NCT00280696|Levetiracetam|levetiracetam|mesh-list
2297281|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
2297282|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
2843681|NCT03901729|Furosemide|furosemide|mesh-list
2843682|NCT03901729|Diuretics|diuretics|mesh-ancestor
2843683|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
2843684|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843685|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2843686|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2843687|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843688|NCT03901716|Fentanyl|fentanyl|mesh-list
2843689|NCT03901716|Midazolam|midazolam|mesh-list
2843690|NCT03901716|Sufentanil|sufentanil|mesh-list
2843691|NCT03901716|Remifentanil|remifentanil|mesh-list
2843692|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2843693|NCT03901716|Narcotics|narcotics|mesh-ancestor
2843694|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843695|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843696|NCT03901716|Analgesics|analgesics|mesh-ancestor
2843697|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
2843698|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843699|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2843700|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2843701|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
2843702|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
2843703|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2843704|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2843705|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2843706|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2843707|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
2843708|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
2843709|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843710|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843711|NCT03901612|Ropivacaine|ropivacaine|mesh-list
2843712|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
2843713|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
2843714|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843715|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843716|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
2843717|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843718|NCT03901768|Dexamethasone|dexamethasone|mesh-list
2843719|NCT03901768|Triamcinolone|triamcinolone|mesh-list
2843720|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2843721|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
2843722|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
2843723|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843724|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843725|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2843726|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
2843727|NCT03901768|Hormones|hormones|mesh-ancestor
2843728|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2843729|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2843730|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843731|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
2843732|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2843733|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
2843734|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
2843735|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843736|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843737|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843738|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2843739|NCT03901482|Analgesics|analgesics|mesh-ancestor
2843740|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
2843741|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843742|NCT03901469|Talazoparib|talazoparib|mesh-list
2843743|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2843744|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843745|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843746|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843747|NCT03901690|Imiquimod|imiquimod|mesh-list
2297292|NCT00280774|Memantine|memantine|mesh-list
2297293|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2297294|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2297295|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
2843748|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2843749|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
2843750|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843751|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297296|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297297|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297298|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297299|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2297300|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2297301|NCT00280787|Paclitaxel|paclitaxel|mesh-list
2297302|NCT00280787|Carboplatin|carboplatin|mesh-list
2297303|NCT00280787|Irinotecan|irinotecan|mesh-list
2297304|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2297305|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297306|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
2297307|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
2107630|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2107631|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107632|NCT02492750|Dexamethasone|dexamethasone|mesh-list
2107633|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
2107634|NCT02492750|Lenalidomide|lenalidomide|mesh-list
2107635|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2107636|NCT02492750|Ichthammol|ichthammol|mesh-list
2107637|NCT02492750|BB 1101|bb 1101|mesh-list
2107638|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2107639|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
2107640|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
2107641|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107642|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107643|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2107644|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
2107645|NCT02492750|Hormones|hormones|mesh-ancestor
2107646|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2107647|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2107648|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107649|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
2107650|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2107651|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2107652|NCT02492750|Growth Substances|growth substances|mesh-ancestor
2107653|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
2107654|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
2107655|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107656|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107657|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2107658|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
2107659|NCT02492763|Metformin|metformin|mesh-list
2107660|NCT02492763|Liraglutide|liraglutide|mesh-list
2107661|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2107662|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107663|NCT02492763|Incretins|incretins|mesh-ancestor
2107664|NCT02492763|Hormones|hormones|mesh-ancestor
2107665|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2297308|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
2843752|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
2843753|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
2843754|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843755|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843756|NCT03901118|Paclitaxel|paclitaxel|mesh-list
2843757|NCT03901118|Etoposide|etoposide|mesh-list
2843758|NCT03901118|Chiauranib|chiauranib|mesh-list
2843759|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2843760|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843761|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
2843762|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
2843763|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
2843764|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843765|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2843766|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2843767|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843768|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2843769|NCT03901170|Letrozole|letrozole|mesh-list
2843770|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843771|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2843772|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2843773|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843774|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843775|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2843776|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
2297309|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297310|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2297311|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2297312|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297313|NCT00280839|Topiramate|topiramate|mesh-list
2297314|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
2297315|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2297316|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297317|NCT00280865|Pioglitazone|pioglitazone|mesh-list
2297318|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2297319|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297320|NCT00280878|Gemcitabine|gemcitabine|mesh-list
2297321|NCT00280878|Rituximab|rituximab|mesh-list
2843777|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2843778|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843779|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
2843780|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2843781|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
2843782|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843783|NCT03900988|Expectorants|expectorants|mesh-ancestor
2843784|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
2843785|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2843786|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
2843787|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843788|NCT03900988|Protective Agents|protective agents|mesh-ancestor
2843789|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843790|NCT03900988|Antidotes|antidotes|mesh-ancestor
2843791|NCT03901001|Sirolimus|sirolimus|mesh-list
2843792|NCT03901001|Oseltamivir|oseltamivir|mesh-list
2297322|NCT00280878|Vinorelbine|vinorelbine|mesh-list
2297323|NCT00280878|Ifosfamide|ifosfamide|mesh-list
2297324|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2297325|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297326|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
2297327|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297328|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2297329|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2297330|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
2297331|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297332|NCT00280878|Antiviral Agents|antiviral agents|mesh-ancestor
2843793|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2843794|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843795|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2843796|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843797|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
2843798|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2843799|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
2843800|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843801|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
2843802|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843803|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843804|NCT03900949|Cytarabine|cytarabine|mesh-list
2843805|NCT03900949|Daunorubicin|daunorubicin|mesh-list
2843806|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
2843807|NCT03900949|Midostaurin|midostaurin|mesh-list
2843808|NCT03900949|Calicheamicins|calicheamicins|mesh-list
2843809|NCT03900949|Staurosporine|staurosporine|mesh-list
2297333|NCT00280878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2297334|NCT00280878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843810|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2843811|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
2843812|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843813|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843814|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
2107666|NCT02492802|Posaconazole|posaconazole|mesh-list
2107667|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
2107668|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107669|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2107670|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2107671|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2843815|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843816|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2843817|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
2107672|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2107673|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2107674|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107675|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843818|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843819|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2843820|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2843821|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2843822|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843823|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843824|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2843825|NCT03900884|Letrozole|letrozole|mesh-list
2843826|NCT03900884|Venetoclax|venetoclax|mesh-list
2843827|NCT03900884|Palbociclib|palbociclib|mesh-list
2843828|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843829|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2843830|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2843831|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843832|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843833|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2843834|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
2843835|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2843836|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843837|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2843838|NCT03900871|Aspirin|aspirin|mesh-list
2843839|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2843840|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2843841|NCT03900871|Analgesics|analgesics|mesh-ancestor
2843842|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
2843843|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843844|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843845|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2843846|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2843847|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2843848|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2297335|NCT00280878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2297336|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2297337|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
2297338|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
2297339|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
2297340|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2297341|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
2297342|NCT00280930|Letrozole|letrozole|mesh-list
2297343|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297344|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2297345|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2297346|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297347|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297348|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2297349|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
2297350|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2297351|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297352|NCT00280956|Natalizumab|natalizumab|mesh-list
2297353|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
2297354|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297355|NCT00280969|Efavirenz|efavirenz|mesh-list
2297356|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2297357|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2297358|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2297359|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297360|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297361|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
2297362|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2297363|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2297364|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2297365|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2297366|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2297367|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2843849|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843850|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2843851|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2843852|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843853|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
2843854|NCT03900858|Isoniazid|isoniazid|mesh-list
2843855|NCT03900858|Rifapentine|rifapentine|mesh-list
2843856|NCT03900858|Rifampin|rifampin|mesh-list
2843857|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
2297368|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2297369|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2297370|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2297371|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
2297372|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2297373|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2297374|NCT00280995|Mipomersen|mipomersen|mesh-list
2297375|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2297376|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2297377|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
2297378|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297379|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2297380|NCT00281008|Mipomersen|mipomersen|mesh-list
2297381|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2297382|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2843858|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2843859|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843860|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2843861|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2843862|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
2843863|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843864|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2843865|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2297383|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
2297384|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297385|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2297386|NCT00281125|Pemetrexed|pemetrexed|mesh-list
2297387|NCT00281125|Vatalanib|vatalanib|mesh-list
2297388|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297389|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297390|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297391|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2297392|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2843866|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
2843867|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2843868|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843869|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2843870|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2843871|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2843872|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2843873|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2843874|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2843875|NCT03900793|Sunitinib|sunitinib|mesh-list
2843876|NCT03900793|Losartan|losartan|mesh-list
2843877|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843878|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2843879|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2843880|NCT03900793|Growth Substances|growth substances|mesh-ancestor
2843881|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843882|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
2843883|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2843884|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843885|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843886|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2843887|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2843888|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2843889|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2843890|NCT03900624|Dexamethasone|dexamethasone|mesh-list
2843891|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2843892|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
2843893|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
2843894|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843895|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843896|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2843897|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
2843898|NCT03900624|Hormones|hormones|mesh-ancestor
2843899|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2843900|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2843901|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843904|NCT03900637|Letrozole|letrozole|mesh-list
2843905|NCT03900637|Leuprolide|leuprolide|mesh-list
2297393|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2843906|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843907|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2843908|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2843909|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843910|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843911|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2843912|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
2843913|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2843914|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843915|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2843916|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
2843917|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2843918|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2297394|NCT00281255|Allopurinol|allopurinol|mesh-list
2297395|NCT00281255|Dobutamine|dobutamine|mesh-list
2297396|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
2297397|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297398|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297399|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
2843923|NCT03900377|Rituximab|rituximab|mesh-list
2843924|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843925|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843926|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
2843927|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843928|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2297400|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2297401|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2297402|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
2297403|NCT00281255|Protective Agents|protective agents|mesh-ancestor
2297404|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297405|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2297406|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
2297407|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
2843929|NCT03900026|Evolocumab|evolocumab|mesh-list
2843930|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2843931|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2843932|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
2843933|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843934|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2843935|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
2843936|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843937|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297408|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297409|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2297410|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2297411|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2297412|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
2297413|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297414|NCT00281281|Vancomycin|vancomycin|mesh-list
2297415|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2297416|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2297417|NCT00281307|Tocopherols|tocopherols|mesh-list
2297418|NCT00281307|Vitamin E|vitamin e|mesh-list
2297419|NCT00281307|Tocotrienols|tocotrienols|mesh-list
2297420|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
2297421|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
2297422|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297423|NCT00281307|Protective Agents|protective agents|mesh-ancestor
2297424|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297425|NCT00281307|Vitamins|vitamins|mesh-ancestor
2297426|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
2297427|NCT00281476|Simvastatin|simvastatin|mesh-list
2297428|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2843938|NCT03899987|Aspirin|aspirin|mesh-list
2843939|NCT03899987|Interferons|interferons|mesh-list
2843940|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
2843941|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
2843942|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2843943|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843944|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
2843945|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2843946|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2843947|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2843948|NCT03899987|Analgesics|analgesics|mesh-ancestor
2843949|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
2843950|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2843951|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843952|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2843953|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2843954|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2843955|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2843956|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843957|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2843958|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2843959|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843960|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
2843961|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
2843962|NCT03899675|Caffeine|caffeine|mesh-list
2843963|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2297429|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2297430|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
2297431|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297432|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2297433|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2297434|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297435|NCT00281489|Anesthetics|anesthetics|mesh-list
2297436|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2297437|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297438|NCT00281502|Rifaximin|rifaximin|mesh-list
2843964|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843965|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2843966|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843967|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843968|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2843969|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2843970|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
2843971|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2843972|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
2843973|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843974|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843975|NCT03899961|Oxytocin|oxytocin|mesh-list
2843976|NCT03899961|Carbetocin|carbetocin|mesh-list
2843977|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
2843978|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2843979|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2843980|NCT03899610|Durvalumab|durvalumab|mesh-list
2843981|NCT03899610|Tremelimumab|tremelimumab|mesh-list
2297439|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2297440|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2297441|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2297442|NCT00281515|Lonafarnib|lonafarnib|mesh-list
2297443|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297444|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297445|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
2843982|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843983|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843984|NCT03899636|Folfirinox|folfirinox|mesh-list
2843985|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843986|NCT03899428|Sorafenib|sorafenib|mesh-list
2843987|NCT03899428|Durvalumab|durvalumab|mesh-list
2843988|NCT03899428|Lenvatinib|lenvatinib|mesh-list
2297446|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2297447|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
2297448|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297449|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297450|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2297451|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
2297452|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
2297453|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2297454|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
2297455|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297456|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297457|NCT00281593|Telmisartan|telmisartan|mesh-list
2297458|NCT00281593|Ramipril|ramipril|mesh-list
2297459|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2297460|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2297461|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2297462|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297463|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2297464|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
2297465|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297466|NCT00281606|Ritonavir|ritonavir|mesh-list
2297467|NCT00281606|Lopinavir|lopinavir|mesh-list
2297468|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2297469|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2297470|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
2297471|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297472|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843989|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2843990|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2843991|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2843992|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2843993|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2843994|NCT03899506|Midazolam|midazolam|mesh-list
2843995|NCT03899506|Olanzapine|olanzapine|mesh-list
2843996|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2843997|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2843998|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2843999|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844000|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2844001|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2844002|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2844003|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2844004|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
2844005|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
2844006|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
2844007|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
2844008|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844009|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844010|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
2297473|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2297474|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2844011|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
2844012|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844013|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2844014|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2844015|NCT03899506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2844016|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2297475|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
2297476|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2297477|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2297478|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2297479|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
2297480|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2297481|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297482|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2297483|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
2297484|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2297485|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2297486|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297487|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297488|NCT00281645|Analgesics|analgesics|mesh-list
2297489|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
2297490|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844017|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2844018|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
2844019|NCT03899337|Prednisolone|prednisolone|mesh-list
2844020|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
2844021|NCT03899337|Rituximab|rituximab|mesh-list
2844022|NCT03899337|Doxorubicin|doxorubicin|mesh-list
2844023|NCT03899337|Vincristine|vincristine|mesh-list
2297491|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297492|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
2844024|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
2844025|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2844026|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
2844027|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844028|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2844029|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2844030|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
2844031|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844032|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844033|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2844034|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2844035|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2844036|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2844037|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2844038|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844039|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2844040|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
2844041|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
2844042|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
2844043|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2844044|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
2297493|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2844045|NCT03899337|Hormones|hormones|mesh-ancestor
2844046|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2844047|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2844055|NCT03899246|Capsaicin|capsaicin|mesh-list
2844056|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
2844057|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
2844058|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
2844059|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844060|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844061|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
2844062|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2844063|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2844064|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844065|NCT03899571|Oseltamivir|oseltamivir|mesh-list
2844066|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
2844067|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844068|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844069|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844070|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
2297494|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2297495|NCT00281710|Prednisolone|prednisolone|mesh-list
2297496|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
2297497|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2297498|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
2844071|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2844072|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844073|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2844074|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844075|NCT03899597|Oxytocin|oxytocin|mesh-list
2844076|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
2844077|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2844078|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844079|NCT03899324|Bumetanide|bumetanide|mesh-list
2297499|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2297500|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
2297501|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
2297502|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297503|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297504|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2297505|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
2297506|NCT00281710|Hormones|hormones|mesh-ancestor
2297507|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2297508|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2297509|NCT00281710|Protective Agents|protective agents|mesh-ancestor
2297510|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2297511|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297512|NCT00281788|Paclitaxel|paclitaxel|mesh-list
2297513|NCT00281788|Carboplatin|carboplatin|mesh-list
2297514|NCT00281788|Capecitabine|capecitabine|mesh-list
2297515|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2297516|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297517|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
2297518|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
2297519|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
2297520|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297521|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2297522|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
2297523|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2297524|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297525|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2297526|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297527|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297528|NCT00281892|Vidarabine|vidarabine|mesh-list
2297529|NCT00281892|Fludarabine|fludarabine|mesh-list
2297530|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
2297531|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297532|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2297533|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
2297534|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297535|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2297536|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
2297537|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297538|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
2297539|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844080|NCT03899324|Diuretics|diuretics|mesh-ancestor
2844081|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
2844082|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844083|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2844084|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2844085|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844086|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
2844087|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2844088|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2844089|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844090|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
2844091|NCT03899233|Coagulants|coagulants|mesh-ancestor
2844092|NCT03899194|Citalopram|citalopram|mesh-list
2844093|NCT03899194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2844094|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2844095|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2844096|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297540|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
2844097|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844098|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
2844099|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844100|NCT03899194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2844101|NCT03899194|Antidepressive Agents|antidepressive agents|mesh-ancestor
2844102|NCT03899194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2844103|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
2844104|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2844105|NCT03899142|Antibodies|antibodies|mesh-list
2844106|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
2844107|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844108|NCT03898986|Vaccines|vaccines|mesh-list
2844109|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
2844110|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844111|NCT03899077|Goserelin|goserelin|mesh-list
2844112|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2844113|NCT03899077|Leuprolide|leuprolide|mesh-list
2844114|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2844115|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844116|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
2844117|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2844118|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
2844119|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2844120|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844121|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2844122|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2844123|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
2844124|NCT03899038|Anesthetics|anesthetics|mesh-list
2844125|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2844126|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844127|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
2844128|NCT03899103|Rituximab|rituximab|mesh-list
2844129|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2844130|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844131|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
2844132|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844133|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2297541|NCT00281905|Carboplatin|carboplatin|mesh-list
2297542|NCT00281905|Methotrexate|methotrexate|mesh-list
2297543|NCT00281905|Vincristine|vincristine|mesh-list
2297544|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2297545|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
2297546|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297547|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2297548|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2297549|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
2297550|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297551|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297552|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2297553|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2297554|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
2844134|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2844135|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2844136|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
2844137|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2844138|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844139|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844140|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844141|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
2844142|NCT03898752|Vitamins|vitamins|mesh-ancestor
2844143|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
2844144|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844145|NCT03899285|Citalopram|citalopram|mesh-list
2844146|NCT03899285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2297555|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2297556|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2297557|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
2297558|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
2844147|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2844148|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2844149|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844150|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844151|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
2844152|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844153|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2844154|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
2844155|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2844156|NCT03898882|Oxytocin|oxytocin|mesh-list
2844157|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
2844158|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2844159|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297559|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297560|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2297561|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2297562|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2297563|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
2297564|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
2297565|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
2297566|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
2297567|NCT00281931|Rituximab|rituximab|mesh-list
2297568|NCT00281931|Fludarabine|fludarabine|mesh-list
2297569|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
2297570|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2297571|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
2297572|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297573|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2297574|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2297575|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
2297576|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297577|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297578|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2297579|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2297580|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2297581|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
2297582|NCT00281944|Leucovorin|leucovorin|mesh-list
2844160|NCT03898895|Gemcitabine|gemcitabine|mesh-list
2844161|NCT03898895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844162|NCT03898895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2844163|NCT03898895|Antimetabolites|antimetabolites|mesh-ancestor
2844164|NCT03898895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844165|NCT03898895|Antiviral Agents|antiviral agents|mesh-ancestor
2844166|NCT03898895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844167|NCT03898895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297583|NCT00281944|Fluorouracil|fluorouracil|mesh-list
2297584|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
2297585|NCT00281944|Calcium|calcium|mesh-list
2297586|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
2297587|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2297588|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297589|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
2297590|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297591|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2297592|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297593|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2297594|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
2297595|NCT00281944|Antidotes|antidotes|mesh-ancestor
2297596|NCT00281944|Protective Agents|protective agents|mesh-ancestor
2297597|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
2297598|NCT00281944|Vitamins|vitamins|mesh-ancestor
2297599|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
2297600|NCT00281970|Docetaxel|docetaxel|mesh-list
2297601|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297602|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
2297603|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
2297604|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
2297605|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297606|NCT00281983|Cyclosporine|cyclosporine|mesh-list
2297607|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
2297608|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
2297609|NCT00281983|Busulfan|busulfan|mesh-list
2297610|NCT00281983|Rituximab|rituximab|mesh-list
2297611|NCT00281983|Methotrexate|methotrexate|mesh-list
2297612|NCT00281983|Fludarabine|fludarabine|mesh-list
2297613|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
2297614|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
2297615|NCT00281983|Cyclosporins|cyclosporins|mesh-list
2297616|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2297617|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2297618|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
2844168|NCT03898895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2844169|NCT03898895|Immunologic Factors|immunologic factors|mesh-ancestor
2844170|NCT03898895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844171|NCT03898635|Linezolid|linezolid|mesh-list
2297619|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297620|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2297621|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2844172|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2844173|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844174|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2297622|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
2297623|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297624|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297625|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2297626|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2844175|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844176|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844177|NCT03898583|Calcitriol|calcitriol|mesh-list
2844178|NCT03898583|Betamethasone|betamethasone|mesh-list
2297627|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2297628|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
2844179|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
2844180|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2844181|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
2844182|NCT03898583|Calcipotriene|calcipotriene|mesh-list
2844183|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2844184|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2844185|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
2844186|NCT03898583|Hormones|hormones|mesh-ancestor
2844187|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2844188|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297629|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2297630|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2297631|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
2297632|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
2297633|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297634|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2297635|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2297636|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
2297637|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844189|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2844190|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
2844191|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
2844192|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2844193|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2844194|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2844195|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844196|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2844197|NCT03898583|Vitamins|vitamins|mesh-ancestor
2844198|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
2844199|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2844200|NCT03898193|Montelukast|montelukast|mesh-list
2844201|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2844202|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
2297638|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2297639|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2297640|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2297641|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
2297642|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2297643|NCT00281996|Gemcitabine|gemcitabine|mesh-list
2844203|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2844204|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
2844205|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2844206|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844207|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2844208|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2844209|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844210|NCT03898466|Fluticasone|fluticasone|mesh-list
2844211|NCT03898466|Xhance|xhance|mesh-list
2844212|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2844213|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2844214|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
2844215|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844216|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844217|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2844218|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
2844219|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
2844220|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2844221|NCT03898011|Lamotrigine|lamotrigine|mesh-list
2844222|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
2844223|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2844224|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2844225|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844226|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2844227|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844228|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2844229|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2844230|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2844231|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2844232|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2844233|NCT03898128|Immunotoxins|immunotoxins|mesh-list
2297644|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
2297645|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2297646|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
2844234|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
2844235|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844236|NCT03898336|Micronutrients|micronutrients|mesh-list
2844237|NCT03898336|Trace Elements|trace elements|mesh-list
2844238|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844239|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
2844240|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2844241|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2844242|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844243|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
2844244|NCT03897621|Coagulants|coagulants|mesh-ancestor
2844245|NCT03897660|Vitamins|vitamins|mesh-list
2844246|NCT03897660|Vitamin K|vitamin k|mesh-list
2844247|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
2844248|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
2844249|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844250|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2844251|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2844252|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844253|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
2844254|NCT03897660|Coagulants|coagulants|mesh-ancestor
2844255|NCT03897868|Losartan|losartan|mesh-list
2844256|NCT03897868|Amlodipine|amlodipine|mesh-list
2297647|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297648|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297649|NCT00281996|Antiviral Agents|antiviral agents|mesh-ancestor
2297650|NCT00281996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2297651|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297652|NCT00281996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2297653|NCT00281996|Immunologic Factors|immunologic factors|mesh-ancestor
2297654|NCT00281996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297655|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2297656|NCT00282061|Melatonin|melatonin|mesh-list
2297657|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
2297658|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297659|NCT00282061|Protective Agents|protective agents|mesh-ancestor
2297660|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297661|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2297662|NCT00282100|Gefitinib|gefitinib|mesh-list
2844257|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2844258|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2844259|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2844260|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844261|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2297663|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297664|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2844262|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844263|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
2844264|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2844265|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2844266|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2844267|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2297665|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297666|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297667|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
2297668|NCT00282126|Diuretics|diuretics|mesh-ancestor
2297669|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
2297670|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297671|NCT00282126|Expectorants|expectorants|mesh-ancestor
2297672|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
2297673|NCT00282139|Aripiprazole|aripiprazole|mesh-list
2297674|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
2297675|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2297676|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2297677|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2297678|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2297679|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297680|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
2297681|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
2297682|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297683|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297684|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2297685|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2297686|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
2844268|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2844269|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
2844270|NCT03897439|Bupropion|bupropion|mesh-list
2844271|NCT03897439|Nicotine|nicotine|mesh-list
2844272|NCT03897439|Varenicline|varenicline|mesh-list
2844273|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2844274|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
2844275|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844276|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844277|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2844278|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2844279|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
2844280|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844281|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844282|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2844283|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
2844284|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2844285|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2844286|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2844287|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2844288|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
2844289|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2844290|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2844291|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844292|NCT03897309|Vaccines|vaccines|mesh-list
2844293|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
2844294|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844295|NCT03897335|Aminophylline|aminophylline|mesh-list
2844296|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2844297|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
2844298|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844299|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844300|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2844301|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
2844302|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2844303|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2844304|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844305|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844306|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2844307|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2844308|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
2844309|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844310|NCT03897335|Protective Agents|protective agents|mesh-ancestor
2844327|NCT03897413|Antacids|antacids|mesh-list
2844328|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
2844329|NCT03897413|Calcium|calcium|mesh-list
2844330|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2844331|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844332|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844333|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2844334|NCT03897452|Fentanyl|fentanyl|mesh-list
2297687|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2297688|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2297689|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2297690|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2844335|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2844336|NCT03897452|Narcotics|narcotics|mesh-ancestor
2844337|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2844338|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844339|NCT03897452|Analgesics|analgesics|mesh-ancestor
2297691|NCT00282165|Naratriptan|naratriptan|mesh-list
2844340|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
2844341|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844342|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2844343|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2844344|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
2844345|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
2844346|NCT03896971|Cyclosporine|cyclosporine|mesh-list
2844347|NCT03896971|Cyclosporins|cyclosporins|mesh-list
2844348|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297692|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2297693|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2297694|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2297695|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
2297696|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297697|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297698|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297699|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2297700|NCT00282178|Candesartan|candesartan|mesh-list
2297701|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2297702|NCT00282178|Diuretics|diuretics|mesh-ancestor
2844349|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844350|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2844351|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
2844352|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844353|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
2844354|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844355|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
2844356|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2844357|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2844358|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2844359|NCT03896880|Clotrimazole|clotrimazole|mesh-list
2844360|NCT03896880|Miconazole|miconazole|mesh-list
2844361|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
2844362|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844363|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2844364|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2844365|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2844366|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844367|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844368|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2844369|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
2844370|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2844371|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844372|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2844373|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2844374|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
2844375|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2844376|NCT03896932|Antibodies|antibodies|mesh-list
2844377|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
2844378|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2844379|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
2844380|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844381|NCT03897062|Suvorexant|suvorexant|mesh-list
2844382|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2844383|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2297703|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
2297704|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297705|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2297706|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2297707|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297708|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2297709|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2297710|NCT00282217|Sirolimus|sirolimus|mesh-list
2297711|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2297712|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2297713|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2297714|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297715|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
2297716|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2297717|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
2297718|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297719|NCT00282360|Trimetazidine|trimetazidine|mesh-list
2844384|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2844385|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297720|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
2297721|NCT00282386|Rofecoxib|rofecoxib|mesh-list
2844386|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2844387|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844388|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844389|NCT03896893|Emollients|emollients|mesh-list
2844390|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
2297722|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297723|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297724|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297725|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2297726|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2297727|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297728|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2297729|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2297730|NCT00282386|Analgesics|analgesics|mesh-ancestor
2297731|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
2297732|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2297733|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2297734|NCT00282399|Decitabine|decitabine|mesh-list
2297735|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2297736|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
2297737|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297738|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297739|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844391|NCT03896685|Linezolid|linezolid|mesh-list
2844392|NCT03896685|Bedaquiline|bedaquiline|mesh-list
2844393|NCT03896685|Clofazimine|clofazimine|mesh-list
2844394|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2844395|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844396|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2844397|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844398|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844399|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
2844400|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2844401|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
2844402|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
2844403|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2844404|NCT03896737|Thalidomide|thalidomide|mesh-list
2844405|NCT03896737|Dexamethasone|dexamethasone|mesh-list
2844406|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
2844407|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
2844408|NCT03896737|Bortezomib|bortezomib|mesh-list
2844409|NCT03896737|Daratumumab|daratumumab|mesh-list
2844410|NCT03896737|BB 1101|bb 1101|mesh-list
2844411|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2844412|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
2844413|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844414|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2844415|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2844416|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
2844417|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844418|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844419|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2844420|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2297740|NCT00282451|Insulin|insulin|mesh-list
2297741|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2297742|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
2297743|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
2297744|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2297745|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
2297746|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2297747|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297748|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
2844421|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
2844422|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
2844423|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844424|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2844425|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
2844426|NCT03896737|Hormones|hormones|mesh-ancestor
2844427|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2844428|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2844429|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
2844430|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844431|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
2844432|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2844433|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844434|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2844435|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2844436|NCT03896737|Growth Substances|growth substances|mesh-ancestor
2844437|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
2844438|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2844439|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
2844440|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844441|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
2844442|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
2844443|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
2844444|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844445|NCT03896321|Anticoagulants|anticoagulants|mesh-list
2844446|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2844447|NCT03896256|Ketamine|ketamine|mesh-list
2844448|NCT03896256|Analgesics|analgesics|mesh-ancestor
2844449|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
2844450|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844451|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844452|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2844453|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2297749|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2297750|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2297751|NCT00282503|Prednisolone|prednisolone|mesh-list
2844454|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
2297752|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
2297753|NCT00282503|Methoxsalen|methoxsalen|mesh-list
2297754|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2297755|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
2297756|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2297757|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
2297758|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
2297759|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297760|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297761|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2297762|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
2297763|NCT00282503|Hormones|hormones|mesh-ancestor
2297764|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2297765|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2297766|NCT00282503|Protective Agents|protective agents|mesh-ancestor
2297767|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2297768|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297769|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2844455|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
2844456|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2844457|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2844458|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2844459|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844460|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844461|NCT03896113|Celecoxib|celecoxib|mesh-list
2844462|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2844463|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2844464|NCT03896113|Analgesics|analgesics|mesh-ancestor
2844465|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
2844466|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844467|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844468|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2844469|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2844470|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2844471|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2844472|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844473|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844474|NCT03896074|Bevacizumab|bevacizumab|mesh-list
2844475|NCT03896074|Atezolizumab|atezolizumab|mesh-list
2844476|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2844477|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844478|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2297770|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
2297771|NCT00282594|Insulin|insulin|mesh-list
2297772|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2297773|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297774|NCT00282607|Udenafil|udenafil|mesh-list
2297775|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2297776|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2297777|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297778|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297779|NCT00282698|Insulin|insulin|mesh-list
2297780|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2297781|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297782|NCT00282724|Liarozole|liarozole|mesh-list
2844479|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2844480|NCT03896074|Growth Substances|growth substances|mesh-ancestor
2844481|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844482|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
2844483|NCT03896269|Cytarabine|cytarabine|mesh-list
2844484|NCT03896269|Daunorubicin|daunorubicin|mesh-list
2844485|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2844486|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
2844487|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297783|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
2297784|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
2297785|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2297786|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297787|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
2297788|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297789|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297790|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2297791|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297792|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2297793|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2844488|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844489|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
2844490|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844491|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2844492|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
2844493|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844494|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2844495|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2844496|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2844497|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844498|NCT03895892|Caffeine|caffeine|mesh-list
2844499|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2844500|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844501|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2844502|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844503|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844504|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2297794|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2297795|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
2297796|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844505|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2844506|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
2844507|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844508|NCT03896009|Meloxicam|meloxicam|mesh-list
2844509|NCT03896009|Rizatriptan|rizatriptan|mesh-list
2844510|NCT03896009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2844511|NCT03896009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2844512|NCT03896009|Analgesics|analgesics|mesh-ancestor
2844513|NCT03896009|Sensory System Agents|sensory system agents|mesh-ancestor
2844514|NCT03896009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844515|NCT03896009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844516|NCT03896009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2844517|NCT03896009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2844518|NCT03896009|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2844519|NCT03896009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2844520|NCT03896009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844521|NCT03896009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844522|NCT03896009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2844523|NCT03896009|Serotonin Agents|serotonin agents|mesh-ancestor
2844524|NCT03896009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844525|NCT03896217|Simvastatin|simvastatin|mesh-list
2844526|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2844527|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2844528|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
2844529|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844530|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2844531|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2844532|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297797|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297798|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297799|NCT00282932|Urological Agents|urological agents|mesh-ancestor
2297800|NCT00282945|Metformin|metformin|mesh-list
2844547|NCT03895788|Niraparib|niraparib|mesh-list
2844548|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2844549|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297801|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
2297802|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2297803|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844550|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844551|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844552|NCT03895840|Triamcinolone|triamcinolone|mesh-list
2844553|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2844554|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2844555|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2844556|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2844557|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
2844558|NCT03895840|Hormones|hormones|mesh-ancestor
2844559|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2844560|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844561|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2844562|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
2844563|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844564|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844565|NCT03895801|Prednisone|prednisone|mesh-list
2844566|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
2844567|NCT03895801|Vilobelimab|vilobelimab|mesh-list
2844568|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2844569|NCT03895801|Hormones|hormones|mesh-ancestor
2844570|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2844571|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844572|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2844573|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844574|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2844575|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2844576|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
2844577|NCT03895671|Azacitidine|azacitidine|mesh-list
2844578|NCT03895671|Ponatinib|ponatinib|mesh-list
2844579|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2844580|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
2844581|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844582|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844583|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844584|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2844585|NCT03895528|Lonafarnib|lonafarnib|mesh-list
2844586|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297804|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
2297805|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2297806|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2297807|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2297808|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2297809|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297810|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
2297811|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297812|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844587|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844588|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
2844589|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2844590|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844591|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
2297813|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2297814|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297815|NCT00282997|Pregabalin|pregabalin|mesh-list
2297816|NCT00282997|Analgesics|analgesics|mesh-ancestor
2297817|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
2297818|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297819|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297820|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
2297821|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2297822|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2297823|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297824|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2297825|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2297826|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2297827|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2297828|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2297829|NCT00283036|Irbesartan|irbesartan|mesh-list
2297830|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2297831|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2297832|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2297833|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297834|NCT00283088|Plasminogen|plasminogen|mesh-list
2297835|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2297836|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2297837|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2297838|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297839|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
2297840|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2297841|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844592|NCT03895970|Lenvatinib|lenvatinib|mesh-list
2844593|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2844594|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844595|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2844596|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844597|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844598|NCT03895502|Edoxaban|edoxaban|mesh-list
2844599|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2844600|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
2844601|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2297842|NCT00283114|Lintuzumab|lintuzumab|mesh-list
2297843|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2297844|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297845|NCT00283179|Risperidone|risperidone|mesh-list
2297846|NCT00283179|Aripiprazole|aripiprazole|mesh-list
2297847|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2297848|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
2297849|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297850|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297851|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297852|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2297853|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2297854|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2297855|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2297856|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2844602|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
2844603|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844604|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844605|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
2844606|NCT03895229|Empagliflozin|empagliflozin|mesh-list
2844607|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2297857|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
2297858|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
2297859|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
2297860|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2297861|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2844608|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844609|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2844610|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844611|NCT03895411|Sotalol|sotalol|mesh-list
2844612|NCT03895411|Propafenone|propafenone|mesh-list
2844613|NCT03895411|Metoprolol|metoprolol|mesh-list
2844614|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2844615|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2844616|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
2844617|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844618|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844619|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844620|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2844621|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
2844622|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
2844623|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844624|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2844625|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2844626|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2844627|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2844628|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2297862|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2297863|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2297864|NCT00283192|Sertraline|sertraline|mesh-list
2107676|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2107677|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
2107678|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2107679|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107680|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
2107681|NCT02492841|Calcium|calcium|mesh-list
2107682|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2107683|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107684|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2297865|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
2297866|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2297867|NCT00283192|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2297868|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2844629|NCT03894904|Heparin|heparin|mesh-list
2844630|NCT03894904|Papaverine|papaverine|mesh-list
2844631|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
2844632|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2844633|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2844634|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844635|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2844636|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844637|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
2844638|NCT03894904|Urological Agents|urological agents|mesh-ancestor
2844639|NCT03894891|Docetaxel|docetaxel|mesh-list
2844640|NCT03894891|Nivolumab|nivolumab|mesh-list
2297869|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2297870|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297871|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297872|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
2297873|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297874|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
2297875|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2297876|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2297877|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297878|NCT00283309|Riluzole|riluzole|mesh-list
2297879|NCT00283309|Memantine|memantine|mesh-list
2297880|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2297881|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2297882|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
2297883|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844641|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844642|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
2844643|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
2844644|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
2844645|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844646|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2844647|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2844648|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
2844649|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2844650|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2844651|NCT03894839|Glutaral|glutaral|mesh-list
2844652|NCT03894839|Eusol|eusol|mesh-list
2844653|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2844654|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844655|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
2844656|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
2844657|NCT03894826|Vorinostat|vorinostat|mesh-list
2844658|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844659|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2844660|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844661|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844662|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
2844663|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2844664|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844665|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
2844666|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2844667|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2844668|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2844669|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2844670|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844671|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
2844672|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844673|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844674|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2844675|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2297884|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297885|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297886|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2297887|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2297888|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
2297889|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2297890|NCT00283309|Protective Agents|protective agents|mesh-ancestor
2297891|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
2297892|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2297893|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
2297894|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297895|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2297896|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2297897|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2297898|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297899|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
2297900|NCT00283465|Hematinics|hematinics|mesh-ancestor
2297901|NCT00283478|Gemcitabine|gemcitabine|mesh-list
2297902|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2297903|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
2297904|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297905|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297906|NCT00283478|Antiviral Agents|antiviral agents|mesh-ancestor
2297907|NCT00283478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107685|NCT02492984|Factor VIII|factor viii|mesh-list
2107686|NCT02492984|Coagulants|coagulants|mesh-ancestor
2107687|NCT02492997|Glycerol|glycerol|mesh-list
2107688|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2107689|NCT02492997|Protective Agents|protective agents|mesh-ancestor
2107690|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107691|NCT02493257|Ethanol|ethanol|mesh-list
2107692|NCT02493257|Capsaicin|capsaicin|mesh-list
2107693|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2107694|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107695|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107696|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107697|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
2107698|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
2107699|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
2844676|NCT03894800|Fentanyl|fentanyl|mesh-list
2844677|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
2844678|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2844679|NCT03894800|Narcotics|narcotics|mesh-ancestor
2844680|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2844681|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844682|NCT03894800|Analgesics|analgesics|mesh-ancestor
2844683|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
2844684|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844685|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2844686|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2844687|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
2844688|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
2844689|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2297908|NCT00283478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297909|NCT00283478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2297910|NCT00283478|Immunologic Factors|immunologic factors|mesh-ancestor
2297911|NCT00283478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297912|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
2297913|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2297914|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2297915|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297916|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2297917|NCT00283543|Temozolomide|temozolomide|mesh-list
2297918|NCT00283543|Carmustine|carmustine|mesh-list
2297919|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2297920|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
2297921|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297922|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297923|NCT00283556|Irinotecan|irinotecan|mesh-list
2297924|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2297925|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2297926|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297927|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297928|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844700|NCT03894683|Melatonin|melatonin|mesh-list
2844701|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
2844702|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844703|NCT03894683|Protective Agents|protective agents|mesh-ancestor
2844704|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844705|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2844706|NCT03894189|Theophylline|theophylline|mesh-list
2844707|NCT03894189|Doxapram|doxapram|mesh-list
2844708|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2844709|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
2844710|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844711|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844712|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2844713|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
2844714|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2844715|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844716|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844717|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
2844718|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2844719|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2844720|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
2844721|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844722|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2844723|NCT03894085|Paroxetine|paroxetine|mesh-list
2844724|NCT03894085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2844725|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2844726|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2844727|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844728|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844729|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
2844730|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844731|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2844732|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
2297929|NCT00283621|Doxorubicin|doxorubicin|mesh-list
2297930|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2297931|NCT00283621|Ifosfamide|ifosfamide|mesh-list
2297932|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
2297933|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2297934|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297935|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2297936|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2297937|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297938|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297939|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2297940|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
2297941|NCT00283621|Hematinics|hematinics|mesh-ancestor
2844733|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2844734|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2844735|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2844736|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844737|NCT03894345|Prazosin|prazosin|mesh-list
2844738|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2844739|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2844740|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2844741|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2844742|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
2844743|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844744|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844745|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844746|NCT03894280|Fluticasone|fluticasone|mesh-list
2844747|NCT03894280|Xhance|xhance|mesh-list
2844748|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2844749|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2844750|NCT03894280|Charcoal|charcoal|mesh-list
2844751|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2297942|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2844752|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2844753|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
2844754|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844755|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297943|NCT00283634|Bortezomib|bortezomib|mesh-list
2297944|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297945|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2297946|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2297947|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844756|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2844757|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
2844758|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
2844759|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2844760|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2844761|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2844762|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2844763|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
2844764|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844765|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844766|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
2844767|NCT03894280|Hormones|hormones|mesh-ancestor
2844768|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2844769|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
2844770|NCT03894280|Antidotes|antidotes|mesh-ancestor
2844771|NCT03894280|Protective Agents|protective agents|mesh-ancestor
2844772|NCT03894046|Imipenem|imipenem|mesh-list
2844773|NCT03894046|Colistin|colistin|mesh-list
2297948|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
2297949|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
2297950|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
2297951|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2297952|NCT00283660|Protective Agents|protective agents|mesh-ancestor
2297953|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297954|NCT00283699|Albendazole|albendazole|mesh-list
2297955|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
2297956|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2297957|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2297958|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
2297959|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2297960|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2297961|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
2297962|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
2297963|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
2844774|NCT03894046|Sulbactam|sulbactam|mesh-list
2844775|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2844776|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844777|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2844778|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844779|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844780|NCT03894007|Maytansine|maytansine|mesh-list
2844781|NCT03894007|Docetaxel|docetaxel|mesh-list
2844782|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2844783|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
2844784|NCT03894007|Carboplatin|carboplatin|mesh-list
2844785|NCT03894007|Trastuzumab|trastuzumab|mesh-list
2844786|NCT03894007|Atezolizumab|atezolizumab|mesh-list
2844787|NCT03894007|Epirubicin|epirubicin|mesh-list
2844788|NCT03894007|Pertuzumab|pertuzumab|mesh-list
2844789|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2844790|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844791|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
2844792|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
2844793|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
2844794|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844795|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2844796|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
2844797|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844798|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2844799|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2844800|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
2844801|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2844802|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2844803|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2297964|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844804|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2844805|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2844806|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844807|NCT03893903|Avelumab|avelumab|mesh-list
2844808|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2297965|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297966|NCT00283751|Insulin|insulin|mesh-list
2297967|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2297968|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
2297969|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
2297970|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2297971|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297972|NCT00283764|Latanoprost|latanoprost|mesh-list
2297973|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2297974|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2297975|NCT00283777|Chromium|chromium|mesh-list
2297976|NCT00283777|Picolinic acid|picolinic acid|mesh-list
2844809|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844810|NCT03893695|Nivolumab|nivolumab|mesh-list
2844811|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2844812|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844813|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2844814|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844815|NCT03893734|Methadone|methadone|mesh-list
2844816|NCT03893734|Hydromorphone|hydromorphone|mesh-list
2844817|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2844818|NCT03893734|Narcotics|narcotics|mesh-ancestor
2844819|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2844820|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844821|NCT03893734|Analgesics|analgesics|mesh-ancestor
2844822|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
2844823|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844824|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
2844825|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
2844826|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2844827|NCT03893591|Dalteparin|dalteparin|mesh-list
2844828|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
2844829|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2844830|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2844831|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844837|NCT03893864|Ubiquinone|ubiquinone|mesh-list
2844838|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
2844839|NCT03893864|Antioxidants|antioxidants|mesh-list
2844840|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844841|NCT03893864|Protective Agents|protective agents|mesh-ancestor
2844842|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844843|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
2844844|NCT03893864|Vitamins|vitamins|mesh-ancestor
2844845|NCT03893630|Aspirin|aspirin|mesh-list
2844846|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2844847|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2844848|NCT03893630|Analgesics|analgesics|mesh-ancestor
2844849|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
2844850|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844851|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844852|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2844853|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2844854|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2844855|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2844856|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844857|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2844858|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2844859|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844860|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
2844861|NCT03893747|Vaccines|vaccines|mesh-list
2844862|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
2844863|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844864|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2844865|NCT03893526|Valsartan|valsartan|mesh-list
2844866|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2844867|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2844868|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297977|NCT00283777|Trace Elements|trace elements|mesh-ancestor
2297978|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
2297979|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297980|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2844869|NCT03893526|Incretins|incretins|mesh-ancestor
2844870|NCT03893526|Hormones|hormones|mesh-ancestor
2844871|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2844872|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2844873|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
2844874|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844875|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844876|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2844877|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2844878|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2844879|NCT03893435|Valsartan|valsartan|mesh-list
2297981|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
2297982|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
2297983|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297984|NCT00283790|Zolpidem|zolpidem|mesh-list
2297985|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2297986|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2297987|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2297988|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2297989|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2297990|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
2297991|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
2297992|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2297993|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2297994|NCT00283829|Docetaxel|docetaxel|mesh-list
2297995|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2297996|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
2297997|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
2297998|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
2297999|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298000|NCT00283946|Zolpidem|zolpidem|mesh-list
2844880|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2844881|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2844882|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2298001|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2298002|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2298003|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298004|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298005|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2298006|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
2298007|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
2298008|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298009|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298010|NCT00283985|Dexamethasone|dexamethasone|mesh-list
2844883|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2844884|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298011|NCT00283985|Methotrexate|methotrexate|mesh-list
2298012|NCT00283985|Asparaginase|asparaginase|mesh-list
2298013|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2298014|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
2298015|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
2298016|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844885|NCT03893097|Artesunate|artesunate|mesh-list
2844886|NCT03893097|Mefloquine|mefloquine|mesh-list
2844887|NCT03893097|Praziquantel|praziquantel|mesh-list
2844888|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
2844889|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2844890|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2844891|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844892|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844893|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
2844894|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
2844895|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2844896|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
2844897|NCT03893175|Acetaminophen|acetaminophen|mesh-list
2844898|NCT03893175|Ibuprofen|ibuprofen|mesh-list
2844899|NCT03893175|Oxycodone|oxycodone|mesh-list
2844900|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2844901|NCT03893175|Analgesics|analgesics|mesh-ancestor
2844902|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
2844903|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844904|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844905|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
2844906|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2844907|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2844908|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2844909|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2844910|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844911|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844912|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2844913|NCT03893175|Narcotics|narcotics|mesh-ancestor
2844914|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2844915|NCT03893032|Modafinil|modafinil|mesh-list
2844916|NCT03893032|Amphetamine|amphetamine|mesh-list
2844917|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2844918|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844919|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2844920|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2844921|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2844922|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844923|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
2844924|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
2844925|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844926|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
2298017|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298018|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2298019|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
2298020|NCT00283985|Hormones|hormones|mesh-ancestor
2298021|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298022|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2298023|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298024|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2298025|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
2298026|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2298027|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2298028|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
2298029|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298030|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
2298031|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298032|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2298033|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2298034|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
2298035|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2298036|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2298037|NCT00284024|Domperidone|domperidone|mesh-list
2298038|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
2298039|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
2298040|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298041|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298042|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2844927|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844928|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
2844929|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2844930|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2844931|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2844932|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2844933|NCT03893136|Leflunomide|leflunomide|mesh-list
2844934|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298043|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2298044|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
2298045|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298046|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298047|NCT00284128|Losartan|losartan|mesh-list
2298048|NCT00284128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2298049|NCT00284128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2298050|NCT00284128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2298051|NCT00284128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2298052|NCT00284128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298053|NCT00284193|Thrombin|thrombin|mesh-list
2298054|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
2298055|NCT00284193|Factor VIII|factor viii|mesh-list
2298056|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
2298057|NCT00284193|Coagulants|coagulants|mesh-ancestor
2298058|NCT00284206|Risperidone|risperidone|mesh-list
2298059|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2298060|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
2298061|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298062|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298063|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298064|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2298065|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2298066|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298067|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2298068|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2298069|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
2298070|NCT00284232|Insulin|insulin|mesh-list
2298071|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2298072|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298073|NCT00284258|Irinotecan|irinotecan|mesh-list
2298074|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2298075|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2298076|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298077|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298078|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298079|NCT00284271|Prednisone|prednisone|mesh-list
2298080|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
2298081|NCT00284271|Vincristine|vincristine|mesh-list
2298082|NCT00284271|Bleomycin|bleomycin|mesh-list
2298083|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
2298084|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2298085|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
2298086|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298087|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2298088|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2298089|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
2298090|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298091|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298092|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2298093|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2298094|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
2844935|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844936|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2844937|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
2844938|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844939|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2844940|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2844941|NCT03893045|Hematinics|hematinics|mesh-ancestor
2844942|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2844943|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2844944|NCT03893240|Antibodies|antibodies|mesh-list
2844945|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
2844946|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
2844947|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844948|NCT03892902|Zopiclone|zopiclone|mesh-list
2844949|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2844950|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2844951|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844952|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
2844953|NCT03892668|Oxytocin|oxytocin|mesh-list
2844954|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
2844955|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2844956|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844957|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2844958|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2298095|NCT00284271|Hormones|hormones|mesh-ancestor
2844959|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844960|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
2844961|NCT03892668|Coagulants|coagulants|mesh-ancestor
2844962|NCT03892525|Atezolizumab|atezolizumab|mesh-list
2844963|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2844964|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
2844965|NCT03892928|Propofol|propofol|mesh-list
2844966|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2844967|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2844968|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844969|NCT03892928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2844970|NCT03892928|Anesthetics, General|anesthetics, general|mesh-ancestor
2844971|NCT03892928|Anesthetics|anesthetics|mesh-ancestor
2844972|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2844973|NCT03892928|Analgesics|analgesics|mesh-ancestor
2844974|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
2844975|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2844976|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2844977|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2844978|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2844979|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
2844980|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2844981|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844982|NCT03892499|Itraconazole|itraconazole|mesh-list
2844983|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
2844984|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2844985|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2844986|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2844987|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2844988|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2844989|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2844990|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
2844991|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2844992|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2844993|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2844994|NCT03892447|Ferulic acid|ferulic acid|mesh-list
2844995|NCT03892447|Dopamine|dopamine|mesh-list
2844996|NCT03892447|Alprostadil|alprostadil|mesh-list
2844997|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2844998|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
2844999|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
2845000|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845001|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845002|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
2845003|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845004|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845005|NCT03892447|Protective Agents|protective agents|mesh-ancestor
2845006|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2845007|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
2845008|NCT03892447|Urological Agents|urological agents|mesh-ancestor
2845009|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2845010|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2845011|NCT03892447|Analgesics|analgesics|mesh-ancestor
2845012|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
2298096|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298097|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2298098|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2298099|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
2298100|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
2298101|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
2298102|NCT00284271|Hematinics|hematinics|mesh-ancestor
2298103|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2298104|NCT00284323|Adenosine|adenosine|mesh-list
2298105|NCT00284323|Analgesics|analgesics|mesh-ancestor
2298106|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
2298107|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845013|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2845014|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2845015|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
2845016|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2845017|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2845018|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2845019|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2845020|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
2845021|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
2845022|NCT03892512|Esmolol|esmolol|mesh-list
2845023|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2845024|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845025|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845026|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2845027|NCT03892512|Analgesics|analgesics|mesh-ancestor
2845028|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
2845029|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845030|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2845031|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2845032|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2298108|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298109|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2298110|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
2845033|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
2845034|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845035|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845036|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2845037|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2845038|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2845039|NCT03892434|Dexamethasone|dexamethasone|mesh-list
2845040|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
2298111|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2298112|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
2298113|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
2298114|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298115|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298116|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
2298117|NCT00284336|Doxorubicin|doxorubicin|mesh-list
2845041|NCT03892434|Bevacizumab|bevacizumab|mesh-list
2845042|NCT03892434|BB 1101|bb 1101|mesh-list
2845043|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2845044|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845045|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2845046|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2845047|NCT03892434|Growth Substances|growth substances|mesh-ancestor
2845048|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845049|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
2845050|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2845051|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
2845052|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
2845053|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845054|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2845055|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
2845056|NCT03892434|Hormones|hormones|mesh-ancestor
2845057|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2845058|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2845059|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
2845060|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845061|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845062|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
2845063|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
2845064|NCT03892330|Doxorubicin|doxorubicin|mesh-list
2845065|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2845066|NCT03892330|Vincristine|vincristine|mesh-list
2845067|NCT03892330|Pirarubicin|pirarubicin|mesh-list
2845068|NCT03892330|Epirubicin|epirubicin|mesh-list
2845069|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2298118|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2298119|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2298120|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
2298121|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298122|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2298123|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2298124|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
2298125|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298126|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845070|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
2845071|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845072|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2845073|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2845074|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
2845075|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845076|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845077|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2845078|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2845079|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2845080|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2845081|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845082|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2845083|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
2845084|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
2845085|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
2845086|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2845087|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845088|NCT03892642|Avelumab|avelumab|mesh-list
2845089|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2845090|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845091|NCT03892785|Prednisone|prednisone|mesh-list
2845092|NCT03892785|Methotrexate|methotrexate|mesh-list
2845093|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2845094|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
2845095|NCT03892785|Hormones|hormones|mesh-ancestor
2845096|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2845097|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845098|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2845099|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845100|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2845101|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
2845102|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2845103|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2845104|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
2845105|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845106|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2845107|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845108|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2845109|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2845110|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
2845111|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2845112|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2845113|NCT03892421|Cytarabine|cytarabine|mesh-list
2845114|NCT03892421|Dexamethasone|dexamethasone|mesh-list
2845115|NCT03892421|Rituximab|rituximab|mesh-list
2845116|NCT03892421|Carboplatin|carboplatin|mesh-list
2845117|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2845118|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
2845119|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
2845120|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845121|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845122|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2845123|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
2845124|NCT03892421|Hormones|hormones|mesh-ancestor
2845125|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298127|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2298128|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2298129|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2298130|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2298131|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298132|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
2298133|NCT00284427|Vitamins|vitamins|mesh-ancestor
2298134|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
2298135|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298136|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
2298137|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298138|NCT00284427|Protective Agents|protective agents|mesh-ancestor
2298139|NCT00284505|Thalidomide|thalidomide|mesh-list
2298140|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2298141|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
2298142|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845126|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2845127|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845128|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2845129|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
2845130|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2845131|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2845132|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
2845133|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298143|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
2298144|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2845134|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
2298145|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298146|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2298147|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2845135|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845136|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2845137|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
2845138|NCT03892122|Propofol|propofol|mesh-list
2845139|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2845140|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845141|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845142|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2845143|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
2845144|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
2845145|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2845146|NCT03892122|Analgesics|analgesics|mesh-ancestor
2845147|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
2845148|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845149|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2845150|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2845151|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2845152|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
2845153|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845154|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845155|NCT03892395|Vitamin D|vitamin d|mesh-list
2845156|NCT03892395|Ergocalciferols|ergocalciferols|mesh-list
2845157|NCT03892395|Vitamins|vitamins|mesh-list
2845158|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
2845159|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
2845160|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845161|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2845162|NCT03892395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2845163|NCT03892213|Benzonidazole|benzonidazole|mesh-list
2845164|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2845165|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
2845166|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845167|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2845168|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2845169|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2845170|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845171|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2298148|NCT00284505|Growth Substances|growth substances|mesh-ancestor
2298149|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
2298150|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298151|NCT00284531|Daclizumab|daclizumab|mesh-list
2298152|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2298153|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
2298154|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298155|NCT00284583|Lidocaine|lidocaine|mesh-list
2298156|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
2298157|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
2298158|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298159|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298160|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
2298161|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298162|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2845172|NCT03892148|Furosemide|furosemide|mesh-list
2845173|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2845174|NCT03892148|Diuretics|diuretics|mesh-ancestor
2845175|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
2845176|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845177|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2845178|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2845179|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845180|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2845181|NCT03892044|Nivolumab|nivolumab|mesh-list
2845182|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2845183|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845184|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2845185|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845186|NCT03891979|Metronidazole|metronidazole|mesh-list
2845187|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
2845188|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
2845189|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2845190|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845191|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298163|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2298164|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2298165|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2298166|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298167|NCT00284687|Artesunate|artesunate|mesh-list
2298168|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
2298169|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2298170|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2845192|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2845193|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2845194|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2845195|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2845196|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2845197|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845198|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845199|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2845200|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2845201|NCT03892070|Mannitol|mannitol|mesh-list
2845202|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2845203|NCT03892070|Diuretics|diuretics|mesh-ancestor
2845204|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
2845205|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845206|NCT03892161|Ritonavir|ritonavir|mesh-list
2298171|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298172|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298173|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
2298174|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
2298175|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2298176|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
2845207|NCT03892161|Darunavir|darunavir|mesh-list
2845208|NCT03892161|Rifampin|rifampin|mesh-list
2845209|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2845210|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2845211|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
2845212|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845213|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298177|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2298178|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298179|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
2845214|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2845215|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2845216|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
2845217|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845218|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2845219|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2845220|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2845221|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
2845222|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2845223|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
2845224|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2845225|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2845226|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2845227|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2845228|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2845229|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2845230|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2845231|NCT03892018|Paclitaxel|paclitaxel|mesh-list
2845232|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2845233|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845234|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
2845235|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
2845236|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
2845237|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845238|NCT03891667|Disulfiram|disulfiram|mesh-list
2845239|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2845240|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2845241|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845242|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845243|NCT03891615|Niraparib|niraparib|mesh-list
2845244|NCT03891615|Osimertinib|osimertinib|mesh-list
2845245|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2845246|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845247|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845248|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845249|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2107700|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107701|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
2107702|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2107703|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107704|NCT02493452|Plecanatide|plecanatide|mesh-list
2107705|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2107706|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
2107707|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107708|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2107709|NCT02493517|Lanreotide|lanreotide|mesh-list
2107710|NCT02493517|Somatostatin|somatostatin|mesh-list
2107711|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107712|NCT02493517|Hormones|hormones|mesh-ancestor
2107713|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2107714|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845250|NCT03891472|Fluorouracil|fluorouracil|mesh-list
2845251|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
2845252|NCT03891472|Irinotecan|irinotecan|mesh-list
2845253|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
2845254|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845255|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2845256|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845257|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2845258|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
2845259|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298180|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2298181|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2298182|NCT00284765|Analgesics|analgesics|mesh-ancestor
2298183|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
2298184|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298185|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298186|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2298187|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2298188|NCT00284778|Docetaxel|docetaxel|mesh-list
2298189|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298190|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
2298191|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
2298192|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
2298193|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298194|NCT00284791|Lamotrigine|lamotrigine|mesh-list
2298195|NCT00284791|Sertraline|sertraline|mesh-list
2298196|NCT00284791|Fluoxetine|fluoxetine|mesh-list
2298197|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
2298198|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2298199|NCT00284791|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2298200|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2298201|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2298202|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298203|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298204|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
2298205|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298206|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2298207|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2298208|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2298209|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298210|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
2298211|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2298212|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2298213|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2298214|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2298215|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298216|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2298217|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
2298218|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2298219|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845260|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2845261|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2845262|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845263|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2845264|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2845265|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845266|NCT03891524|Enoxaparin|enoxaparin|mesh-list
2845267|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
2845268|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2845269|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2845270|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845271|NCT03891420|Galidesivir|galidesivir|mesh-list
2845272|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
2845273|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845274|NCT03891433|Meropenem|meropenem|mesh-list
2845275|NCT03891433|Tazobactam|tazobactam|mesh-list
2845276|NCT03891433|Piperacillin|piperacillin|mesh-list
2845277|NCT03891433|Ertapenem|ertapenem|mesh-list
2845278|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2845279|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845280|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2845281|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845282|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845283|NCT03891576|Niraparib|niraparib|mesh-list
2845284|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2298220|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2298221|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
2298222|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2298223|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298224|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298225|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298226|NCT00284947|Prednisone|prednisone|mesh-list
2298227|NCT00284947|Prednisolone|prednisolone|mesh-list
2298228|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
2845285|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845286|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845287|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845288|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2845289|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
2845290|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845291|NCT03891264|Cannabidiol|cannabidiol|mesh-list
2845292|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
2845293|NCT03891316|Sevoflurane|sevoflurane|mesh-list
2845294|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2845295|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2845296|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
2845297|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
2845298|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845299|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845300|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
2845301|NCT03891277|Hematinics|hematinics|mesh-ancestor
2845302|NCT03891095|Oxytocin|oxytocin|mesh-list
2845303|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
2845304|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2845305|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845306|NCT03891238|Avelumab|avelumab|mesh-list
2845307|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2845308|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845309|NCT03890952|Bevacizumab|bevacizumab|mesh-list
2845310|NCT03890952|Nivolumab|nivolumab|mesh-list
2845311|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
2845312|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2845313|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845314|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2845315|NCT03890952|Growth Substances|growth substances|mesh-ancestor
2845316|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845317|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
2845318|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2845319|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845320|NCT03891173|Vinorelbine|vinorelbine|mesh-list
2845321|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845322|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2845323|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
2845324|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
2845325|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
2845326|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845327|NCT03890809|BMS-986165|bms-986165|mesh-list
2845328|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
2845329|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2845330|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845331|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845332|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
2845333|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2845334|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2845335|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2845336|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2845337|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845338|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
2845339|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845340|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845341|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2845342|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845343|NCT03891043|Selenium|selenium|mesh-list
2845344|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
2845345|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845346|NCT03891043|Protective Agents|protective agents|mesh-ancestor
2845347|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845348|NCT03891043|Trace Elements|trace elements|mesh-ancestor
2845349|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
2845350|NCT03890770|BMS-986165|bms-986165|mesh-list
2845351|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
2845352|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2845353|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845354|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845355|NCT03890341|Drospirenone|drospirenone|mesh-list
2845356|NCT03890341|Midazolam|midazolam|mesh-list
2845357|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2845358|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2845359|NCT03890341|Betadex|betadex|mesh-list
2845360|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2845361|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2845362|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845363|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845364|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2845365|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2845366|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2845367|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2845368|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
2845369|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
2845370|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
2845371|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
2845372|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845373|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845374|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2845375|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2845376|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2845377|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
2845378|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2845379|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2845380|NCT03890341|Estrogens|estrogens|mesh-ancestor
2845381|NCT03890341|Hormones|hormones|mesh-ancestor
2845382|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2845383|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2845384|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
2845385|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2845386|NCT03890341|Diuretics|diuretics|mesh-ancestor
2845387|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
2845388|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
2845389|NCT03890406|Rocuronium|rocuronium|mesh-list
2845390|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2845391|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2845392|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2845393|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845394|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845395|NCT03890510|Anesthetics|anesthetics|mesh-list
2845396|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845397|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845398|NCT03890094|Sufentanil|sufentanil|mesh-list
2845399|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2845400|NCT03890094|Narcotics|narcotics|mesh-ancestor
2845401|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845402|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845403|NCT03890094|Analgesics|analgesics|mesh-ancestor
2845404|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
2845405|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845406|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2845407|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2845408|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
2845409|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
2845410|NCT03889717|Vitamin D|vitamin d|mesh-list
2845411|NCT03889717|Vitamins|vitamins|mesh-ancestor
2845412|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
2845413|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845414|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2845415|NCT03889808|Antitoxins|antitoxins|mesh-list
2845416|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
2845417|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845418|NCT03890042|Dienogest|dienogest|mesh-list
2845419|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2845420|NCT03890042|Gestodene|gestodene|mesh-list
2845421|NCT03890042|Femovan|femovan|mesh-list
2845422|NCT03890042|Estradiol|estradiol|mesh-list
2845423|NCT03890042|Estrogens|estrogens|mesh-ancestor
2845424|NCT03890042|Hormones|hormones|mesh-ancestor
2845425|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2845426|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845427|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2845428|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
2845429|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2845430|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2845431|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2845432|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2845433|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2845434|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
2845435|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2845436|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845437|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2845438|NCT03890042|Progestins|progestins|mesh-ancestor
2845439|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2845440|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2298229|NCT00284947|Basiliximab|basiliximab|mesh-list
2298230|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2298231|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
2298232|NCT00284947|Hormones|hormones|mesh-ancestor
2298233|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298234|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298235|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2298236|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298237|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
2298238|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
2298239|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298240|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2298241|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2298242|NCT00284947|Protective Agents|protective agents|mesh-ancestor
2298243|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2298244|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
2298249|NCT00285051|Ondansetron|ondansetron|mesh-list
2298250|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
2298251|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
2298252|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298253|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298254|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2845441|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2845442|NCT03889756|Midazolam|midazolam|mesh-list
2845443|NCT03889756|Ketamine|ketamine|mesh-list
2845444|NCT03889756|Analgesics|analgesics|mesh-ancestor
2845445|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
2845446|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845447|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845448|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2845449|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2845450|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
2845451|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
2845452|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845453|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2845454|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2845455|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845456|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845457|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2845458|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2845459|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2845460|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2845461|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2845462|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
2845463|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
2845464|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
2845465|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2845466|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845467|NCT03889912|Cemiplimab|cemiplimab|mesh-list
2845468|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2845469|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298255|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
2298256|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
2298257|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2298258|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
2298259|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298260|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298261|NCT00285051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2298262|NCT00285051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2298263|NCT00285051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298264|NCT00285051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2298265|NCT00285051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2298266|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
2298267|NCT00285090|Vitamin D|vitamin d|mesh-list
2298268|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
2298269|NCT00285090|Vitamins|vitamins|mesh-list
2298270|NCT00285090|Calcium|calcium|mesh-list
2298271|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
2298272|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298273|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2298274|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2298275|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
2298276|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2298277|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298278|NCT00285155|Bupropion|bupropion|mesh-list
2298279|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2298280|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
2845470|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
2845471|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
2845472|NCT03889288|Analgesics|analgesics|mesh-list
2845473|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
2845474|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298281|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2298282|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2298283|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2298284|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2298285|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298286|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
2298287|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298288|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845475|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845483|NCT03889379|Albuterol|albuterol|mesh-list
2845484|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2845485|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
2845486|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845487|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845488|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2845489|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
2845490|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
2845491|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2845492|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2845493|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2845494|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2845495|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
2845496|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845497|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845498|NCT03889626|Capecitabine|capecitabine|mesh-list
2845499|NCT03889626|Apatinib|apatinib|mesh-list
2845500|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2845501|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
2845502|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845503|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845504|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2845505|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845506|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2845507|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2845508|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2845509|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
2845510|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845511|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2845512|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2845513|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845514|NCT03889366|Aprepitant|aprepitant|mesh-list
2845515|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
2845516|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
2845517|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845518|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845519|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2845520|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2845521|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845522|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845523|NCT03888924|Vaccines|vaccines|mesh-list
2845524|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
2845525|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
2845526|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845527|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2845528|NCT03888846|Colchicine|colchicine|mesh-list
2845529|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
2845530|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
2845531|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2845532|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
2845533|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
2845534|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
2845535|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845536|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845537|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2845538|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845539|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2845540|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2845541|NCT03888846|Protective Agents|protective agents|mesh-ancestor
2845542|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845543|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
2845544|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2845545|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
2845546|NCT03889145|Amlodipine|amlodipine|mesh-list
2845547|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2845548|NCT03889145|Telmisartan|telmisartan|mesh-list
2845549|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2298289|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2298290|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2298291|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298292|NCT00285181|Simvastatin|simvastatin|mesh-list
2298293|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2298294|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2298295|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
2845550|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2845551|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2845552|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845553|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2845554|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845555|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
2845556|NCT03889145|Diuretics|diuretics|mesh-ancestor
2845557|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
2845558|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2845559|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2845560|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2845561|NCT03889106|Ribavirin|ribavirin|mesh-list
2845562|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
2845563|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845564|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
2845565|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845566|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
2845567|NCT03888677|Epirubicin|epirubicin|mesh-list
2845568|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2845569|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
2845570|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845571|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2845572|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2845573|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
2845574|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845575|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845576|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2845577|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2845578|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2845579|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2845580|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845581|NCT03888664|Interferons|interferons|mesh-list
2845582|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
2845583|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845584|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
2845585|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845586|NCT03888729|Velpatasvir|velpatasvir|mesh-list
2845587|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
2845588|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845589|NCT03888534|Ixazomib|ixazomib|mesh-list
2845590|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845591|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
2845592|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845593|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845594|NCT03888378|Minocycline|minocycline|mesh-list
2298296|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298297|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2298298|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2298299|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298300|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
2298301|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2298302|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298303|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845595|NCT03888378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2845596|NCT03888378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298304|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2298305|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2298306|NCT00285298|Protective Agents|protective agents|mesh-ancestor
2298307|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298308|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
2298309|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2298310|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
2298311|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
2298312|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2298313|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298314|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2298315|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
2298316|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2298317|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298318|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298319|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298320|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2298321|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
2298322|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2298323|NCT00285376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2298324|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2845597|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
2845598|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2845599|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2845600|NCT03888157|Liraglutide|liraglutide|mesh-list
2845601|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2845602|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845603|NCT03888157|Incretins|incretins|mesh-ancestor
2298325|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2298326|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298327|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298328|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
2298329|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298330|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2298331|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2298332|NCT00285389|Dexamethasone|dexamethasone|mesh-list
2298333|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
2298334|NCT00285389|Melphalan|melphalan|mesh-list
2298335|NCT00285389|Chlorambucil|chlorambucil|mesh-list
2298336|NCT00285389|Rituximab|rituximab|mesh-list
2298337|NCT00285389|Vincristine|vincristine|mesh-list
2298338|NCT00285389|Doxorubicin|doxorubicin|mesh-list
2298339|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2298340|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
2298341|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298342|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2298343|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2298344|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
2298345|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298346|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298347|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2107715|NCT02493712|Mesalamine|mesalamine|mesh-list
2107716|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2107717|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2107718|NCT02493712|Analgesics|analgesics|mesh-ancestor
2107719|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
2107720|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107721|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107722|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2107723|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2107724|NCT02493751|Avelumab|avelumab|mesh-list
2107725|NCT02493751|Axitinib|axitinib|mesh-list
2107726|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2107727|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845604|NCT03888157|Hormones|hormones|mesh-ancestor
2845605|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2845606|NCT03888144|Ketorolac|ketorolac|mesh-list
2845607|NCT03888144|Oxycodone|oxycodone|mesh-list
2845608|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2845609|NCT03888144|Narcotics|narcotics|mesh-ancestor
2845610|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845611|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845612|NCT03888144|Analgesics|analgesics|mesh-ancestor
2845613|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
2845614|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845615|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2845616|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2845617|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2845618|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2845619|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2845620|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845621|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845622|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2845623|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2845624|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
2845625|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2845626|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2845627|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
2845628|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845629|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2845630|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2845631|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
2845632|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
2845633|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845634|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845635|NCT03887702|Tenofovir|tenofovir|mesh-list
2845636|NCT03887702|Entecavir|entecavir|mesh-list
2845637|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
2845638|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845639|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2845640|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2845641|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298348|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2298349|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
2298350|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
2298351|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298352|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2298353|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
2298354|NCT00285389|Hormones|hormones|mesh-ancestor
2298355|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298356|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2298357|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2298358|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2845642|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845643|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2845644|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2845645|NCT03887650|Dexamethasone|dexamethasone|mesh-list
2845646|NCT03887650|Epinephrine|epinephrine|mesh-list
2845647|NCT03887650|Bupivacaine|bupivacaine|mesh-list
2845648|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2845649|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
2845650|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
2845651|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845652|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845653|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2845654|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
2845655|NCT03887650|Hormones|hormones|mesh-ancestor
2845656|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2845657|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2845658|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845659|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845660|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
2845661|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
2845662|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845663|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
2845664|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2845665|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2845666|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
2845667|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845668|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2845669|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2845670|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2845671|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
2845672|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
2845673|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
2845674|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2845675|NCT03887754|Risperidone|risperidone|mesh-list
2845676|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2845677|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
2845678|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845679|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845680|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845681|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2845682|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2845683|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845684|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2845685|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2845686|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
2845687|NCT03887871|Tamsulosin|tamsulosin|mesh-list
2845688|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2845689|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2845690|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2845691|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
2845692|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845693|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845694|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845695|NCT03887871|Urological Agents|urological agents|mesh-ancestor
2845696|NCT03887858|Tamsulosin|tamsulosin|mesh-list
2845697|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2845698|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2845699|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2845700|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
2845701|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845702|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845703|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845704|NCT03887858|Urological Agents|urological agents|mesh-ancestor
2845705|NCT03887624|Ethosuximide|ethosuximide|mesh-list
2845706|NCT03887624|Citalopram|citalopram|mesh-list
2845707|NCT03887624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2845708|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2845709|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2845710|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845711|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845712|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
2845713|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845714|NCT03887624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2298359|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
2298360|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
2298361|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
2298362|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2298363|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2298364|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2298365|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298366|NCT00285415|Carboplatin|carboplatin|mesh-list
2298367|NCT00285415|Docetaxel|docetaxel|mesh-list
2298368|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298369|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
2298370|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
2298371|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
2298372|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298373|NCT00285428|Veltuzumab|veltuzumab|mesh-list
2298374|NCT00285428|Antibodies|antibodies|mesh-list
2298375|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
2298376|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298377|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298378|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2298379|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298380|NCT00285519|Doxazosin|doxazosin|mesh-list
2298381|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2298382|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2298383|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2298384|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2298385|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
2298386|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845715|NCT03887624|Antidepressive Agents|antidepressive agents|mesh-ancestor
2845716|NCT03887624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2845717|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
2845718|NCT03888079|Anesthetics|anesthetics|mesh-list
2845719|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
2845720|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
2845721|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845722|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845723|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
2845724|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845725|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
2845726|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2845727|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845728|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2845729|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845730|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
2845731|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2845732|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2845733|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2845734|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845735|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
2845736|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845737|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845738|NCT03887260|Fentanyl|fentanyl|mesh-list
2845739|NCT03887260|Morphine|morphine|mesh-list
2845740|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2845741|NCT03887260|Narcotics|narcotics|mesh-ancestor
2845742|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845743|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845744|NCT03887260|Analgesics|analgesics|mesh-ancestor
2845745|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
2845746|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845747|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2845748|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2845749|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
2845750|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
2845751|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
2845752|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
2845753|NCT03887169|Vitamins|vitamins|mesh-ancestor
2845754|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
2845755|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845756|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
2845757|NCT03887169|Hematinics|hematinics|mesh-ancestor
2845758|NCT03887130|Gemcitabine|gemcitabine|mesh-list
2845759|NCT03887130|Paclitaxel|paclitaxel|mesh-list
2845760|NCT03887130|Vinorelbine|vinorelbine|mesh-list
2845761|NCT03887130|Docetaxel|docetaxel|mesh-list
2845762|NCT03887130|Capecitabine|capecitabine|mesh-list
2298387|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298388|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298389|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2298390|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2298391|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2298392|NCT00285623|Thrombin|thrombin|mesh-list
2298393|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
2298394|NCT00285623|Coagulants|coagulants|mesh-ancestor
2298395|NCT00285662|Artesunate|artesunate|mesh-list
2298396|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
2298397|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
2298398|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2298399|NCT00285662|Amodiaquine|amodiaquine|mesh-list
2845763|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2845764|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845765|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
2845766|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
2845767|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
2845768|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845769|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2845770|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
2845771|NCT03887130|Antiviral Agents|antiviral agents|mesh-ancestor
2845772|NCT03887130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845773|NCT03887130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845774|NCT03887130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2845775|NCT03887130|Immunologic Factors|immunologic factors|mesh-ancestor
2845776|NCT03887130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845777|NCT03886896|Lidocaine|lidocaine|mesh-list
2845778|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
2845779|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
2845780|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845781|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845782|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
2845783|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845784|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2845785|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2845786|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2845787|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2845788|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845789|NCT03886779|Nepafenac|nepafenac|mesh-list
2845790|NCT03886779|Bromfenac|bromfenac|mesh-list
2845791|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2845792|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2845793|NCT03886779|Analgesics|analgesics|mesh-ancestor
2845794|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
2298400|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
2298401|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2845795|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845796|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845797|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2845798|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2845799|NCT03886948|Mirikizumab|mirikizumab|mesh-list
2845800|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2298402|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2298403|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298404|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298405|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
2298406|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
2845801|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2845802|NCT03886948|Analgesics|analgesics|mesh-ancestor
2845803|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
2298407|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2298408|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
2298409|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2298410|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845804|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845805|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845806|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2845807|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2845808|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2845809|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2845810|NCT03886922|Cromakalim|cromakalim|mesh-list
2845811|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2845812|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2845813|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
2845814|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845815|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845816|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2845817|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
2845818|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
2845819|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
2845820|NCT03887013|Trimetazidine|trimetazidine|mesh-list
2845821|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
2845822|NCT03886766|Efavirenz|efavirenz|mesh-list
2845823|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2845824|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2845825|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845826|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845827|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
2845828|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845829|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2845830|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2845831|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2845832|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2845833|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2845834|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2298411|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845835|NCT03886441|Beclomethasone|beclomethasone|mesh-list
2845836|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2845837|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
2845838|NCT03886441|Hormones|hormones|mesh-ancestor
2845839|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2845840|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845841|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2845842|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
2845843|NCT03886662|LB100|lb100|mesh-list
2845844|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845845|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845846|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845847|NCT03886311|Nivolumab|nivolumab|mesh-list
2845848|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2845849|NCT03886311|Trabectedin|trabectedin|mesh-list
2845850|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2845851|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845852|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2845853|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845854|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2845855|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
2845856|NCT03885947|Fludarabine|fludarabine|mesh-list
2845857|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
2845858|NCT03885947|Thiotepa|thiotepa|mesh-list
2845859|NCT03885947|Valproic Acid|valproic acid|mesh-list
2845860|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845861|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845862|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2845863|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
2845864|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845865|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2845866|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2845867|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
2845868|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2845869|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
2845870|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845871|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
2845872|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845873|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
2845874|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2845875|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845876|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2845877|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
2845878|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2845879|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2845880|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845881|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
2845882|NCT03885895|Coagulants|coagulants|mesh-ancestor
2845883|NCT03885921|Atorvastatin|atorvastatin|mesh-list
2845884|NCT03885921|Simvastatin|simvastatin|mesh-list
2845885|NCT03885921|Ezetimibe|ezetimibe|mesh-list
2845886|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2845887|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2845888|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
2298412|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2298413|NCT00285662|Renal Agents|renal agents|mesh-ancestor
2298414|NCT00285675|Calcitriol|calcitriol|mesh-list
2298415|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2298416|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298417|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2298418|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2298419|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298420|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2298421|NCT00285675|Vitamins|vitamins|mesh-ancestor
2298422|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
2298423|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2298424|NCT00285727|Ropinirole|ropinirole|mesh-list
2298425|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2298426|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2298427|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
2298428|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
2298429|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298430|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298431|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298432|NCT00285766|Selegiline|selegiline|mesh-list
2845889|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845890|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2845891|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2845892|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845893|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2845894|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
2845895|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845896|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
2845897|NCT03885830|Dasatinib|dasatinib|mesh-list
2845898|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845899|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2845900|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845901|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845902|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
2845903|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2845904|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845905|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845906|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2845907|NCT03885804|Analgesics|analgesics|mesh-ancestor
2845908|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
2845909|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845910|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2845911|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2845912|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2845913|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
2845914|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845915|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845916|NCT03885713|Adalimumab|adalimumab|mesh-list
2845917|NCT03885713|Golimumab|golimumab|mesh-list
2845918|NCT03885713|Infliximab|infliximab|mesh-list
2845919|NCT03885713|Ustekinumab|ustekinumab|mesh-list
2845920|NCT03885713|Vedolizumab|vedolizumab|mesh-list
2845921|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2845922|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2845923|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
2845924|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2845925|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2845926|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2845927|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
2845928|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845929|NCT03885258|Melatonin|melatonin|mesh-list
2845930|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
2845931|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845932|NCT03885258|Protective Agents|protective agents|mesh-ancestor
2845933|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845934|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845935|NCT03885427|Ketamine|ketamine|mesh-list
2845936|NCT03885427|Analgesics|analgesics|mesh-ancestor
2845937|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
2845938|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2845939|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845940|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2845941|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2845942|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
2845943|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
2845944|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298433|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
2298434|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2298435|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2298436|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2298437|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2298438|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298439|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298440|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2298441|NCT00285766|Protective Agents|protective agents|mesh-ancestor
2298442|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298443|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
2298444|NCT00285805|Amiloride|amiloride|mesh-list
2298445|NCT00285805|Furosemide|furosemide|mesh-list
2298446|NCT00285805|Diuretics|diuretics|mesh-ancestor
2298447|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
2298448|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298449|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2298450|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2298451|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298452|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2298453|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2298454|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2298455|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2298456|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2298457|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2845945|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2845946|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2845947|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845948|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845949|NCT03885219|Paclitaxel|paclitaxel|mesh-list
2845950|NCT03885219|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2845951|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2845952|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845953|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
2845954|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
2845955|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
2845956|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845957|NCT03885180|Warfarin|warfarin|mesh-list
2845958|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
2845959|NCT03885388|Dactinomycin|dactinomycin|mesh-list
2845960|NCT03885388|Methotrexate|methotrexate|mesh-list
2845961|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2845962|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
2845963|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2845964|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845965|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2845966|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
2298458|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2298459|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298460|NCT00285883|Saquinavir|saquinavir|mesh-list
2298461|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2298462|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2298463|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
2298464|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845967|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2845968|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2845969|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
2845970|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2845971|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2845972|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2845973|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
2845974|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2845975|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2298465|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298466|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2298467|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2298468|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
2298469|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298470|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2298471|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2298472|NCT00285896|Glucagon|glucagon|mesh-list
2298473|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2298474|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2298475|NCT00285896|Hormones|hormones|mesh-ancestor
2298476|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298477|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298478|NCT00285896|Incretins|incretins|mesh-ancestor
2298479|NCT00286013|Gemcitabine|gemcitabine|mesh-list
2298480|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
2298481|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2298482|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
2298483|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298484|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298485|NCT00286013|Antiviral Agents|antiviral agents|mesh-ancestor
2298486|NCT00286013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298487|NCT00286013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298488|NCT00286013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2298489|NCT00286013|Immunologic Factors|immunologic factors|mesh-ancestor
2298490|NCT00286013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298491|NCT00286026|Azithromycin|azithromycin|mesh-list
2298492|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2298493|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298494|NCT00286052|Naloxone|naloxone|mesh-list
2298495|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2845976|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2845977|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298496|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298497|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
2298498|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298499|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2298500|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845978|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2845979|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2298501|NCT00286117|Tamoxifen|tamoxifen|mesh-list
2298502|NCT00286117|Anastrozole|anastrozole|mesh-list
2107728|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2107729|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107730|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107731|NCT02493764|Tazobactam|tazobactam|mesh-list
2107732|NCT02493764|Linezolid|linezolid|mesh-list
2107733|NCT02493764|Piperacillin|piperacillin|mesh-list
2107734|NCT02493764|Imipenem|imipenem|mesh-list
2107735|NCT02493764|Relebactam|relebactam|mesh-list
2107736|NCT02493764|Cilastatin|cilastatin|mesh-list
2107737|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2107738|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107739|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2107740|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107741|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107742|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2107743|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
2107744|NCT02493777|Methylphenidate|methylphenidate|mesh-list
2107745|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2107746|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107747|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2107748|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2107749|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2845980|NCT03885297|Liraglutide|liraglutide|mesh-list
2845981|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2845982|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845983|NCT03885297|Incretins|incretins|mesh-ancestor
2845984|NCT03885297|Hormones|hormones|mesh-ancestor
2845985|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2845986|NCT03884881|Meropenem|meropenem|mesh-list
2845987|NCT03884881|Imipenem|imipenem|mesh-list
2845988|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2845989|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2845990|NCT03885141|Zolpidem|zolpidem|mesh-list
2845991|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2845992|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2845993|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2845994|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845995|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2845996|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
2298503|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2298504|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
2298505|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298506|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2845997|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
2845998|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2845999|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846000|NCT03884972|Venetoclax|venetoclax|mesh-list
2846001|NCT03884972|Trabectedin|trabectedin|mesh-list
2846002|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846003|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2846004|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
2846005|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846006|NCT03884998|Nivolumab|nivolumab|mesh-list
2846007|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2846008|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846009|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2846010|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846011|NCT03884556|Gemcitabine|gemcitabine|mesh-list
2846012|NCT03884556|Paclitaxel|paclitaxel|mesh-list
2846013|NCT03884556|Docetaxel|docetaxel|mesh-list
2846014|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
2846015|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2846016|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846017|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
2846018|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
2846019|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
2846020|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846021|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2846022|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
2298507|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2298508|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298509|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2298510|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2298511|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2298512|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2298513|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2298514|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298515|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298516|NCT00286130|Leucovorin|leucovorin|mesh-list
2298517|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
2298518|NCT00286130|Irinotecan|irinotecan|mesh-list
2846023|NCT03884556|Antiviral Agents|antiviral agents|mesh-ancestor
2846024|NCT03884556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2846025|NCT03884556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846026|NCT03884556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2846027|NCT03884556|Immunologic Factors|immunologic factors|mesh-ancestor
2846028|NCT03884556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846029|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2846030|NCT03884491|Vortioxetine|vortioxetine|mesh-list
2846031|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
2298519|NCT00286130|Cetuximab|cetuximab|mesh-list
2298520|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298521|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2298522|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2298523|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298524|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846032|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2298525|NCT00286130|Antidotes|antidotes|mesh-ancestor
2298526|NCT00286130|Protective Agents|protective agents|mesh-ancestor
2298527|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298528|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
2298529|NCT00286130|Vitamins|vitamins|mesh-ancestor
2298530|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
2298531|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2298532|NCT00286143|Fentanyl|fentanyl|mesh-list
2298533|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2298534|NCT00286143|Narcotics|narcotics|mesh-ancestor
2298535|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298536|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298537|NCT00286143|Analgesics|analgesics|mesh-ancestor
2107750|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107751|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
2107752|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107753|NCT02493855|Ritonavir|ritonavir|mesh-list
2107754|NCT02493855|Ribavirin|ribavirin|mesh-list
2107755|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2107756|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2107757|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
2107758|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107759|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846033|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2846034|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2846035|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846036|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846037|NCT03884491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2846038|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2846039|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2846040|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846041|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846042|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
2846043|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2846044|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2846045|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2846046|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2846047|NCT03884348|Amoxicillin|amoxicillin|mesh-list
2846048|NCT03884348|Metronidazole|metronidazole|mesh-list
2846049|NCT03884348|Clarithromycin|clarithromycin|mesh-list
2846050|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2846051|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2846052|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2846053|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2846054|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2846055|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2846056|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846057|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846058|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2846059|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2846060|NCT03884452|Atorvastatin|atorvastatin|mesh-list
2846061|NCT03884452|Simvastatin|simvastatin|mesh-list
2846062|NCT03884452|Ezetimibe|ezetimibe|mesh-list
2846063|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2846064|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2846065|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
2846066|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846067|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2846068|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2846069|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846070|NCT03884465|Treprostinil|treprostinil|mesh-list
2846071|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2846072|NCT03884530|Aspirin|aspirin|mesh-list
2846073|NCT03884530|Ticagrelor|ticagrelor|mesh-list
2846074|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2298538|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
2298539|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298540|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2298541|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2298542|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
2298543|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
2298544|NCT00286169|Amrubicin|amrubicin|mesh-list
2298545|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298546|NCT00286208|Misoprostol|misoprostol|mesh-list
2298547|NCT00286208|Mifepristone|mifepristone|mesh-list
2298548|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2846075|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2846076|NCT03884530|Analgesics|analgesics|mesh-ancestor
2846077|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
2846078|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846079|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846080|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2846081|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2846082|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2846083|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2846084|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846085|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2846086|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2298549|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
2298550|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2298551|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298552|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2298553|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2298554|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
2298555|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2298556|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2298557|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2298558|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2298559|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
2298560|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2298561|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2298562|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
2298563|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298564|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
2298565|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2298566|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2298567|NCT00286260|Levetiracetam|levetiracetam|mesh-list
2298568|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
2298569|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
2298570|NCT00286273|Heparin|heparin|mesh-list
2298571|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2298572|NCT00286273|Tinzaparin|tinzaparin|mesh-list
2298573|NCT00286273|Dalteparin|dalteparin|mesh-list
2298574|NCT00286273|Nadroparin|nadroparin|mesh-list
2298575|NCT00286273|Citric Acid|citric acid|mesh-list
2298576|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
2298577|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
2298578|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2298579|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
2846087|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846088|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
2846089|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2846090|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2846091|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2846092|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
2846093|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846094|NCT03884127|Orlistat|orlistat|mesh-list
2846095|NCT03884127|Ezetimibe|ezetimibe|mesh-list
2846096|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2846097|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2298580|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
2298581|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298582|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2298583|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2298584|NCT00286312|Atorvastatin|atorvastatin|mesh-list
2298585|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2298586|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2846098|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
2846099|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846100|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2846101|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846102|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2846103|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2298587|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
2298588|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298589|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2298590|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2298591|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298592|NCT00286351|Goserelin|goserelin|mesh-list
2846104|NCT03883841|Hematinics|hematinics|mesh-ancestor
2846105|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2298593|NCT00286351|Anastrozole|anastrozole|mesh-list
2846106|NCT03883880|Capsaicin|capsaicin|mesh-list
2298594|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2298595|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846107|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
2846108|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
2846109|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
2846110|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846111|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846112|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
2846113|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298596|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2298597|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2298598|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298599|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298600|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2298601|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
2298602|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298603|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298604|NCT00286364|Androgens|androgens|mesh-list
2298605|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2298606|NCT00286364|Hormones|hormones|mesh-ancestor
2298607|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298608|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298609|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2298610|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298611|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298612|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2298613|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
2298614|NCT00286403|Fenoldopam|fenoldopam|mesh-list
2298615|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298616|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2298617|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
2298618|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
2298619|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
2298620|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298621|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298622|NCT00286416|Omalizumab|omalizumab|mesh-list
2298623|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2298624|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2298625|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
2846114|NCT03883880|Protective Agents|protective agents|mesh-ancestor
2846115|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2846116|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2846117|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846118|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2846119|NCT03883919|Vitamin D|vitamin d|mesh-list
2846120|NCT03883919|Leucovorin|leucovorin|mesh-list
2846121|NCT03883919|Fluorouracil|fluorouracil|mesh-list
2846122|NCT03883919|Irinotecan|irinotecan|mesh-list
2846123|NCT03883919|Vitamins|vitamins|mesh-ancestor
2846124|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
2846125|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846126|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2846127|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
2298626|NCT00286481|Simvastatin|simvastatin|mesh-list
2298627|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2298628|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2846128|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846129|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2846130|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846131|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2846132|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
2846133|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2846134|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2846135|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846136|NCT03883919|Antidotes|antidotes|mesh-ancestor
2846137|NCT03883919|Protective Agents|protective agents|mesh-ancestor
2846138|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
2846139|NCT03884101|Paclitaxel|paclitaxel|mesh-list
2846140|NCT03884101|Carboplatin|carboplatin|mesh-list
2846141|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
2846142|NCT03884101|Lenvatinib|lenvatinib|mesh-list
2846143|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2846144|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846145|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
2846146|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
2846147|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
2298629|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
2298630|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298631|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2298632|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2298633|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298634|NCT00286585|Propofol|propofol|mesh-list
2298635|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
2298636|NCT00286585|Anesthetics|anesthetics|mesh-list
2298637|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2298638|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298639|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298640|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
2298641|NCT00286611|Amifostine|amifostine|mesh-list
2298642|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2298643|NCT00286611|Protective Agents|protective agents|mesh-ancestor
2846148|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846149|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2846150|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2846151|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846152|NCT03884036|Vitamin D|vitamin d|mesh-list
2846153|NCT03884036|Vitamins|vitamins|mesh-ancestor
2846154|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
2846155|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846156|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2846168|NCT03883984|Cysteamine|cysteamine|mesh-list
2846169|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2846170|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846171|NCT03883776|Octreotide|octreotide|mesh-list
2846172|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2846173|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2846174|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846175|NCT03883763|Bupivacaine|bupivacaine|mesh-list
2846176|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
2846177|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
2846178|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846179|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846180|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
2846181|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846182|NCT03883893|Acetaminophen|acetaminophen|mesh-list
2846183|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2846184|NCT03883893|Analgesics|analgesics|mesh-ancestor
2846185|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
2846186|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846187|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846188|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
2298644|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298645|NCT00286624|Cyclosporine|cyclosporine|mesh-list
2298646|NCT00286624|Everolimus|everolimus|mesh-list
2298647|NCT00286624|Cyclosporins|cyclosporins|mesh-list
2298648|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2298649|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298650|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298651|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2298652|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
2846189|NCT03883412|Liraglutide|liraglutide|mesh-list
2846190|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2846191|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846192|NCT03883412|Incretins|incretins|mesh-ancestor
2846193|NCT03883412|Hormones|hormones|mesh-ancestor
2846194|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2846195|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
2846196|NCT03883347|Remifentanil|remifentanil|mesh-list
2846197|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2846198|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846199|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846200|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2846201|NCT03883347|Analgesics|analgesics|mesh-ancestor
2846202|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
2298653|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298654|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
2298655|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298656|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
2298657|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2298658|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2298659|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298660|NCT00286689|Hormones|hormones|mesh-list
2298661|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298662|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298663|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
2298664|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2846203|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846204|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2846205|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2846206|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2846207|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
2846208|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298665|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298666|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2298667|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
2298668|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2298669|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298670|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2298671|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2298672|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2298673|NCT00286793|Gossypol acetic acid|gossypol acetic acid|mesh-list
2846209|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846210|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2846211|NCT03883347|Narcotics|narcotics|mesh-ancestor
2846212|NCT03883360|Cannabidiol|cannabidiol|mesh-list
2846213|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
2846214|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
2846215|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
2846216|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2846217|NCT03883269|Ethanol|ethanol|mesh-list
2846218|NCT03883269|Clindamycin|clindamycin|mesh-list
2846219|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
2846220|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
2846221|NCT03883269|Erythromycin|erythromycin|mesh-list
2846222|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
2846223|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2846224|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
2846225|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2846226|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2846227|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846228|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846229|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2846230|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2846231|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846232|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846233|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2846234|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
2846235|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2298674|NCT00286793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2298675|NCT00286793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298676|NCT00286793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2298677|NCT00286793|Contraceptive Agents|contraceptive agents|mesh-ancestor
2298678|NCT00286793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2298679|NCT00286793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298680|NCT00286793|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2298681|NCT00286793|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2298682|NCT00286793|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2298683|NCT00286806|Gossypol acetic acid|gossypol acetic acid|mesh-list
2298684|NCT00286806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2298685|NCT00286806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298686|NCT00286806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2298687|NCT00286806|Contraceptive Agents|contraceptive agents|mesh-ancestor
2298688|NCT00286806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2298689|NCT00286806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298690|NCT00286806|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2298691|NCT00286806|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2298692|NCT00286806|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2846236|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
2846237|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846238|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
2846239|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2846240|NCT03882996|Atorvastatin|atorvastatin|mesh-list
2846241|NCT03882996|Ezetimibe|ezetimibe|mesh-list
2846242|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2846243|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2846244|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
2298693|NCT00286871|Tacrolimus|tacrolimus|mesh-list
2298694|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2298695|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
2298696|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298697|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2298698|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846245|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846246|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2846247|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2846248|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846249|NCT03882918|Gaboxadol|gaboxadol|mesh-list
2846250|NCT03882918|Analgesics|analgesics|mesh-ancestor
2846251|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
2846252|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846253|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846254|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
2846255|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
2846256|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
2846257|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846258|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846259|NCT03882905|Ezetimibe|ezetimibe|mesh-list
2846260|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2846261|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2846262|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
2846263|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846264|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2298699|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298700|NCT00286923|Topiramate|topiramate|mesh-list
2298701|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
2298702|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2298703|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298704|NCT00286936|Zolpidem|zolpidem|mesh-list
2298705|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2298706|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2298707|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298708|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298709|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2298710|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
2298711|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
2298712|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298713|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298714|NCT00286962|Insulin|insulin|mesh-list
2298715|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2298716|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2846271|NCT03883022|Vancomycin|vancomycin|mesh-list
2846272|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2846273|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2846274|NCT03882892|Ezetimibe|ezetimibe|mesh-list
2846275|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2846276|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2846277|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
2846278|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846279|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2846280|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
2846281|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
2846282|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2846283|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
2846284|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846285|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
2846286|NCT03883074|Protective Agents|protective agents|mesh-ancestor
2846287|NCT03883074|Antacids|antacids|mesh-ancestor
2846288|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846289|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2846290|NCT03883204|Risperidone|risperidone|mesh-list
2846291|NCT03883204|Aripiprazole|aripiprazole|mesh-list
2846292|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2846293|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
2846294|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846295|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846296|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846297|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2846298|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2846299|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846300|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2846301|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2846302|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
2846303|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
2846304|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
2846305|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2846306|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2846307|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2298717|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298718|NCT00286988|Topiramate|topiramate|mesh-list
2298719|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
2298720|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2846308|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2846309|NCT03882463|Insulin|insulin|mesh-list
2846310|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2846311|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846312|NCT03882710|Metoprolol|metoprolol|mesh-list
2846313|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2846314|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2846315|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
2846316|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
2846317|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846318|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846319|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2846320|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2846321|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2846322|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
2846323|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846324|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846325|NCT03882814|Meperidine|meperidine|mesh-list
2846326|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2846327|NCT03882814|Narcotics|narcotics|mesh-ancestor
2846328|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846329|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846330|NCT03882814|Analgesics|analgesics|mesh-ancestor
2846331|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
2846332|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298721|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298722|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
2298723|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298724|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2298725|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846333|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2846334|NCT03882775|Heparin|heparin|mesh-list
2846335|NCT03882775|Bivalirudin|bivalirudin|mesh-list
2846336|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
2846337|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2846338|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2846339|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846340|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
2846341|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2846342|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
2846343|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846344|NCT03882788|Fentanyl|fentanyl|mesh-list
2846345|NCT03882788|Isoflurane|isoflurane|mesh-list
2846346|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2846347|NCT03882788|Narcotics|narcotics|mesh-ancestor
2846348|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846349|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846350|NCT03882788|Analgesics|analgesics|mesh-ancestor
2298726|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2298727|NCT00287066|Insulin|insulin|mesh-list
2298728|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2298729|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2298730|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298731|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
2298732|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298733|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2298734|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298735|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298736|NCT00287157|Tizanidine|tizanidine|mesh-list
2298737|NCT00287157|Analgesics|analgesics|mesh-ancestor
2298738|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
2298739|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298740|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298741|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
2298742|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2298743|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2298744|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
2298745|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
2298746|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2298747|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2298748|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2298749|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
2298750|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298751|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298752|NCT00287170|Calcitriol|calcitriol|mesh-list
2298753|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
2298754|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2298755|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298756|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2298757|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2298758|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846351|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
2846352|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846353|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2846354|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2846355|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
2846356|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
2846357|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2846358|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
2846359|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
2846360|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
2846361|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298759|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2298760|NCT00287170|Vitamins|vitamins|mesh-ancestor
2298761|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
2298762|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2298763|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
2298764|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2298765|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298766|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2298767|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
2298768|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2298769|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298770|NCT00287209|Amiodarone|amiodarone|mesh-list
2298771|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2846362|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846363|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
2846364|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846365|NCT03882541|Midazolam|midazolam|mesh-list
2846366|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2846367|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2846368|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846369|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846370|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2846371|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2846372|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2846373|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2846374|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
2846375|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
2846376|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
2846377|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
2846378|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846379|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846380|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
2846381|NCT03882099|Vitamin D|vitamin d|mesh-list
2846382|NCT03882099|Vitamins|vitamins|mesh-ancestor
2846383|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
2846384|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846385|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2846386|NCT03882164|Tacrolimus|tacrolimus|mesh-list
2846387|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2846388|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
2846389|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846390|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2846391|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846392|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846393|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
2846394|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
2846395|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2846396|NCT03882255|Propranolol|propranolol|mesh-list
2846397|NCT03882255|Ponesimod|ponesimod|mesh-list
2846398|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2846399|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2846400|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
2846401|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846402|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846403|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846404|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2846405|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2846406|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
2846407|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2846408|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2846409|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
2846410|NCT03882008|Abatacept|abatacept|mesh-list
2846411|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2846412|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846413|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846414|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2846415|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
2846416|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846417|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2846418|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
2846419|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2846420|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846421|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
2846422|NCT03882060|Hematinics|hematinics|mesh-ancestor
2846423|NCT03881943|Aspirin|aspirin|mesh-list
2846424|NCT03881943|Ticagrelor|ticagrelor|mesh-list
2846425|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2846426|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2846427|NCT03881943|Analgesics|analgesics|mesh-ancestor
2846428|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
2846429|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846430|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846431|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2846432|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2846433|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2846434|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2846435|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846436|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2846437|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2846438|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846439|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
2298772|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
2298773|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2298774|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2298775|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298776|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2298777|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2298778|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2298779|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298780|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2298781|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2298782|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2298783|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
2298784|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2298785|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298786|NCT00287300|Azithromycin|azithromycin|mesh-list
2298787|NCT00287300|Artesunate|artesunate|mesh-list
2298788|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
2298789|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
2846440|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2846441|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2846442|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2846443|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
2846444|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298790|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2298791|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2298792|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298793|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
2846445|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2846446|NCT03881904|Gestodene|gestodene|mesh-list
2846447|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2846448|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2846449|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2846450|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
2846451|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2298794|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2298795|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2298796|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298797|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
2298798|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
2298799|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2298800|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
2298801|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2298802|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298803|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298804|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2298805|NCT00287300|Renal Agents|renal agents|mesh-ancestor
2298806|NCT00287313|Vitamin K|vitamin k|mesh-list
2298807|NCT00287313|Vitamins|vitamins|mesh-ancestor
2298808|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
2298809|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846452|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846453|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2846454|NCT03881904|Estrogens|estrogens|mesh-ancestor
2846455|NCT03881904|Hormones|hormones|mesh-ancestor
2846456|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2846457|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2846458|NCT03881904|Progestins|progestins|mesh-ancestor
2846459|NCT03881644|Sumatriptan|sumatriptan|mesh-list
2846460|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
2846461|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2846462|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2846463|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2846464|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
2846465|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846466|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846467|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846468|NCT03881644|Growth Substances|growth substances|mesh-ancestor
2846469|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
2846470|NCT03881696|Omalizumab|omalizumab|mesh-list
2846471|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
2846472|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2846473|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846474|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2846475|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2846476|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
2846477|NCT03881787|Cetuximab|cetuximab|mesh-list
2846478|NCT03881787|Antibodies|antibodies|mesh-list
2846479|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2846480|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
2846481|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846482|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2846483|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846484|NCT03881852|Reboxetine|reboxetine|mesh-list
2846485|NCT03881852|Antidepressive Agents|antidepressive agents|mesh-ancestor
2846486|NCT03881852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2846487|NCT03881852|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2846488|NCT03881852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2846489|NCT03881852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2298810|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2298811|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2298812|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298813|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
2298814|NCT00287313|Coagulants|coagulants|mesh-ancestor
2298815|NCT00287326|Clonidine|clonidine|mesh-list
2298816|NCT00287326|Morphine|morphine|mesh-list
2298817|NCT00287326|Bupivacaine|bupivacaine|mesh-list
2298818|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
2298819|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
2846490|NCT03881852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298820|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298821|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298822|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
2846491|NCT03881852|Adrenergic Agents|adrenergic agents|mesh-ancestor
2846492|NCT03881852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846493|NCT03881852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846494|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
2846495|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846496|NCT03881423|Bromides|bromides|mesh-list
2846497|NCT03881423|Rocuronium|rocuronium|mesh-list
2846498|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
2846499|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
2846500|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2846501|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2846502|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846503|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846504|NCT03881293|Lidocaine|lidocaine|mesh-list
2846505|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
2846506|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
2846507|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846508|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846509|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
2846510|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846511|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2846512|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2846513|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2846514|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2298823|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298824|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2298825|NCT00287326|Narcotics|narcotics|mesh-ancestor
2298826|NCT00287326|Analgesics|analgesics|mesh-ancestor
2298827|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2298828|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
2298829|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
2298830|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2298831|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2298832|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2298833|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
2846515|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846516|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
2846517|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846518|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2846519|NCT03881449|Aripiprazole|aripiprazole|mesh-list
2846520|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
2846521|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2846522|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2846523|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2846524|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846525|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846526|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
2846527|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
2846528|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846529|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846530|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2846531|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2846532|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
2846533|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2846534|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2846535|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2846536|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2846537|NCT03881345|Anticoagulants|anticoagulants|mesh-list
2846538|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
2846539|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
2846540|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2846541|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846542|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2846543|NCT03880981|Acetaminophen|acetaminophen|mesh-list
2846544|NCT03880981|Ibuprofen|ibuprofen|mesh-list
2846545|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2846546|NCT03880981|Analgesics|analgesics|mesh-ancestor
2846547|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
2846548|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846549|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846550|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
2846551|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2846552|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2846553|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2846554|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2298834|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846555|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846556|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846557|NCT03880903|Albuterol|albuterol|mesh-list
2846558|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2846559|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
2846560|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846561|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846562|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2846563|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
2846564|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
2846565|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2846566|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2846567|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2846568|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2846569|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
2846570|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846571|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846572|NCT03880968|Etanercept|etanercept|mesh-list
2846573|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2846574|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2846575|NCT03880968|Analgesics|analgesics|mesh-ancestor
2846576|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
2846577|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846578|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298835|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298836|NCT00287352|Amantadine|amantadine|mesh-list
2298837|NCT00287352|Olanzapine|olanzapine|mesh-list
2298838|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
2298839|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
2298840|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298841|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298842|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2298843|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2298844|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2298845|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298846|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2298847|NCT00287352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2298848|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2298849|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2298850|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298851|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298852|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
2298853|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2298854|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2298855|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
2298856|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2298857|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
2298858|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2298859|NCT00287352|Analgesics|analgesics|mesh-ancestor
2298860|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
2298861|NCT00287378|Omalizumab|omalizumab|mesh-list
2298862|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2298863|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2298864|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
2298865|NCT00287391|Rabeprazole|rabeprazole|mesh-list
2298866|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2298867|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2298868|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2298869|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298870|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298871|NCT00287430|Hormones|hormones|mesh-list
2298872|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298873|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298874|NCT00287443|Hormones|hormones|mesh-list
2298875|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298876|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298877|NCT00287456|Insulin|insulin|mesh-list
2298878|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2298879|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2298880|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298881|NCT00287495|Sorafenib|sorafenib|mesh-list
2298882|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846579|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2298883|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2846580|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2846581|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2846582|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2846583|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
2846584|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2846585|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2846586|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2846587|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2846588|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846589|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846590|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846591|NCT03880916|Analgesics|analgesics|mesh-ancestor
2846592|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
2846593|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846594|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
2846595|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2846596|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
2846597|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
2846598|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2846599|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846600|NCT03880734|Vitamins|vitamins|mesh-ancestor
2846601|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
2846602|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2846603|NCT03880877|Leucovorin|leucovorin|mesh-list
2846604|NCT03880877|Antidotes|antidotes|mesh-ancestor
2846605|NCT03880877|Protective Agents|protective agents|mesh-ancestor
2846606|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846607|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
2846608|NCT03880877|Vitamins|vitamins|mesh-ancestor
2846609|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
2846610|NCT03880695|Doxorubicin|doxorubicin|mesh-list
2846611|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2846612|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2846613|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846614|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2846615|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2846616|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846617|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846618|NCT03880448|Metronidazole|metronidazole|mesh-list
2846619|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2846620|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2846621|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2846622|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2846623|NCT03880539|Vancomycin|vancomycin|mesh-list
2846624|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2846625|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2846626|NCT03880487|Oxycodone|oxycodone|mesh-list
2846627|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2846628|NCT03880487|Narcotics|narcotics|mesh-ancestor
2846629|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846630|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846631|NCT03880487|Analgesics|analgesics|mesh-ancestor
2846632|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
2846633|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846634|NCT03880825|Metformin|metformin|mesh-list
2846635|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2846636|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846637|NCT03880357|Betamethasone|betamethasone|mesh-list
2846638|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
2846639|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2846640|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
2846641|NCT03880357|Calcipotriene|calcipotriene|mesh-list
2846642|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2846643|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2846644|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
2846645|NCT03880357|Hormones|hormones|mesh-ancestor
2846646|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2846647|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846648|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2298884|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846649|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
2846650|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
2846651|NCT03880396|Cisplatin|cisplatin|mesh-list
2846652|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846653|NCT03880409|Lidocaine|lidocaine|mesh-list
2846654|NCT03880409|Epinephrine|epinephrine|mesh-list
2846655|NCT03880409|Racepinephrine|racepinephrine|mesh-list
2846656|NCT03880409|Carticaine|carticaine|mesh-list
2846657|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
2298885|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298886|NCT00287521|Timolol|timolol|mesh-list
2298887|NCT00287521|Latanoprost|latanoprost|mesh-list
2298888|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2298889|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2298890|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
2298891|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298892|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298893|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298894|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2298895|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2298896|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2298897|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2298898|NCT00287534|Tamoxifen|tamoxifen|mesh-list
2298899|NCT00287534|Anastrozole|anastrozole|mesh-list
2298900|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2298901|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
2298902|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298903|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298904|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2298905|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298906|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2298907|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2298908|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2298909|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2298910|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2298911|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2298912|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298913|NCT00287547|Abatacept|abatacept|mesh-list
2298914|NCT00287547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2298915|NCT00287547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298916|NCT00287547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298917|NCT00287547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2298918|NCT00287547|Immunologic Factors|immunologic factors|mesh-ancestor
2298919|NCT00287547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298920|NCT00287547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2298921|NCT00287560|Propofol|propofol|mesh-list
2298922|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2298923|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298924|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298925|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2298926|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
2298927|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
2298928|NCT00287651|Insulin|insulin|mesh-list
2298929|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2298930|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2298931|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298932|NCT00287664|Terlipressin|terlipressin|mesh-list
2298933|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2298934|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2298935|NCT00287677|Hormones|hormones|mesh-list
2298936|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2298937|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298938|NCT00287742|Risperidone|risperidone|mesh-list
2298939|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2298940|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
2298941|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298942|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298943|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298944|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2298945|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2846658|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
2846659|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
2846660|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298946|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298947|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2298948|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2298949|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
2298950|NCT00287768|Docetaxel|docetaxel|mesh-list
2298951|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298952|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
2298953|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
2298954|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
2846661|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846662|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
2846663|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846664|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2846665|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2846666|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2846667|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2846668|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846669|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2846670|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2846671|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
2846672|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846673|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2846674|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2846675|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
2298955|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298956|NCT00287781|Lidocaine|lidocaine|mesh-list
2298957|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
2298958|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
2298959|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298960|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298961|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
2298962|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298963|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2298964|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2846676|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2846677|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
2846678|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
2846679|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
2846680|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2298965|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2298966|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2298967|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298968|NCT00287794|Diazepam|diazepam|mesh-list
2298969|NCT00287794|Melatonin|melatonin|mesh-list
2298970|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
2298971|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298972|NCT00287794|Protective Agents|protective agents|mesh-ancestor
2298973|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2298974|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2298975|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2298976|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
2298977|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
2298978|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
2298979|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298980|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2298981|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2298982|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2298983|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2298984|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2846681|NCT03880045|Vasopressins|vasopressins|mesh-list
2846682|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
2846683|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
2846684|NCT03880045|Coagulants|coagulants|mesh-ancestor
2846685|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2846686|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2846687|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
2846688|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846689|NCT03879889|Nicotine|nicotine|mesh-list
2846690|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2846691|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
2846692|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2298985|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2298986|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2298987|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2298988|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
2298989|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
2298990|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
2298991|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
2298992|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846693|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846694|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2846695|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2846696|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
2846697|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846698|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846699|NCT03880123|Ixazomib|ixazomib|mesh-list
2846700|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846701|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
2846702|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846703|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846704|NCT03879863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2846705|NCT03879863|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2846706|NCT03879837|Fluticasone|fluticasone|mesh-list
2846707|NCT03879837|Xhance|xhance|mesh-list
2846708|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2846709|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2846710|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
2846711|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846712|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846713|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2846714|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
2846715|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
2846716|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2846717|NCT03879811|Nivolumab|nivolumab|mesh-list
2846718|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2846719|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846720|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2846721|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846722|NCT03879798|Irinotecan|irinotecan|mesh-list
2846723|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2846724|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2846725|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846726|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846727|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2298993|NCT00287820|Olanzapine|olanzapine|mesh-list
2298994|NCT00287820|Risperidone|risperidone|mesh-list
2846744|NCT03879707|Melatonin|melatonin|mesh-list
2846745|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
2846746|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846747|NCT03879707|Protective Agents|protective agents|mesh-ancestor
2846748|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846749|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846750|NCT03879577|Tamoxifen|tamoxifen|mesh-list
2846751|NCT03879577|Docetaxel|docetaxel|mesh-list
2846752|NCT03879577|Trastuzumab|trastuzumab|mesh-list
2846753|NCT03879577|Letrozole|letrozole|mesh-list
2846754|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846755|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
2846756|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
2846757|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
2846758|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846759|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2846760|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2846761|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2298995|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2298996|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
2298997|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2298998|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2298999|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846762|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846763|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2846764|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
2846765|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2846766|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846767|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2846768|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2846769|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2846770|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2846771|NCT03879694|Octreotide|octreotide|mesh-list
2846772|NCT03879694|Sargramostim|sargramostim|mesh-list
2846773|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
2846774|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
2846775|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846776|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846777|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2846778|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2846779|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2846780|NCT03879746|Paroxetine|paroxetine|mesh-list
2846781|NCT03879746|Tamsulosin|tamsulosin|mesh-list
2846782|NCT03879746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2846783|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2846784|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2846785|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846786|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846787|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
2846788|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299000|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2299001|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2299002|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2299003|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2299004|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2299005|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
2299006|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
2299007|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
2299008|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846789|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2846790|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
2846791|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2846792|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2846793|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2846794|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846795|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2846796|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2846797|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2846798|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
2846799|NCT03879746|Urological Agents|urological agents|mesh-ancestor
2846800|NCT03879590|Budesonide|budesonide|mesh-list
2846801|NCT03879590|Doxofylline|doxofylline|mesh-list
2846802|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2299009|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2299010|NCT00287820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2299011|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2299012|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2299013|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
2299014|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299015|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2299016|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299017|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299018|NCT00287859|Topotecan|topotecan|mesh-list
2299019|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2299020|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2299021|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846803|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2846804|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
2846805|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846806|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846807|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2846808|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
2846809|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
2846810|NCT03879590|Hormones|hormones|mesh-ancestor
2846811|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2846812|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
2846813|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2846814|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846815|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846826|NCT03879460|Naltrexone|naltrexone|mesh-list
2846827|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2846828|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2846829|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846830|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
2846831|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846832|NCT03879564|Ketamine|ketamine|mesh-list
2846833|NCT03879564|Analgesics|analgesics|mesh-ancestor
2846834|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
2846835|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846836|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846837|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2846838|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2846839|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
2846840|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
2846841|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846842|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2846843|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2846844|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846845|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846846|NCT03879408|Acetaminophen|acetaminophen|mesh-list
2846847|NCT03879408|Naproxen|naproxen|mesh-list
2846848|NCT03879408|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2846849|NCT03879408|Hydrocodone|hydrocodone|mesh-list
2846850|NCT03879408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2846851|NCT03879408|Analgesics|analgesics|mesh-ancestor
2846852|NCT03879408|Sensory System Agents|sensory system agents|mesh-ancestor
2846853|NCT03879408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846854|NCT03879408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846855|NCT03879408|Antipyretics|antipyretics|mesh-ancestor
2846856|NCT03879408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2846857|NCT03879408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2846858|NCT03879408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2846859|NCT03879408|Gout Suppressants|gout suppressants|mesh-ancestor
2846860|NCT03879408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2846861|NCT03879408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299022|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846862|NCT03879408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846863|NCT03879408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2846864|NCT03879408|Narcotics|narcotics|mesh-ancestor
2846865|NCT03879408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846866|NCT03879408|Antitussive Agents|antitussive agents|mesh-ancestor
2846867|NCT03879408|Respiratory System Agents|respiratory system agents|mesh-ancestor
2846868|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
2846869|NCT03879486|Formaldehyde|formaldehyde|mesh-list
2846870|NCT03879486|Povidone|povidone|mesh-list
2846871|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
2846872|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
2846873|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2846874|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2846875|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
2846876|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
2846877|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2846878|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
2846879|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2846880|NCT03879356|Expectorants|expectorants|mesh-ancestor
2846881|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
2846882|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2846883|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
2846884|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846885|NCT03879356|Protective Agents|protective agents|mesh-ancestor
2846886|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846887|NCT03879356|Antidotes|antidotes|mesh-ancestor
2846888|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
2846889|NCT03879382|Fludarabine|fludarabine|mesh-list
2846890|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2846891|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
2846892|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846893|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2846894|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2846895|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
2846896|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846897|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846898|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2846899|NCT03879174|Tamoxifen|tamoxifen|mesh-list
2846900|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
2846901|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2846902|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846903|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2846904|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
2846905|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2846906|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846907|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2299023|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299024|NCT00287885|Docetaxel|docetaxel|mesh-list
2299025|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299026|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
2299027|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
2299028|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
2299029|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299030|NCT00287911|Topotecan|topotecan|mesh-list
2299031|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299032|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2299033|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2299034|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299035|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299036|NCT00287924|Methotrexate|methotrexate|mesh-list
2846908|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2846909|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2846910|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2846911|NCT03879122|Docetaxel|docetaxel|mesh-list
2846912|NCT03879122|Nivolumab|nivolumab|mesh-list
2846913|NCT03879122|Ipilimumab|ipilimumab|mesh-list
2846914|NCT03879122|Androgens|androgens|mesh-list
2846915|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846916|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
2846917|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
2846918|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
2846919|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846920|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2846921|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2846922|NCT03879122|Hormones|hormones|mesh-ancestor
2299037|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2846923|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2846924|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846925|NCT03879135|Factor VIII|factor viii|mesh-list
2846926|NCT03879135|Coagulants|coagulants|mesh-ancestor
2846927|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
2846928|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
2846929|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
2846930|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846931|NCT03879057|Antibodies|antibodies|mesh-list
2846932|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2846933|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
2846934|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846935|NCT03878888|Bupivacaine|bupivacaine|mesh-list
2846936|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
2846937|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
2846938|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846939|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846940|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
2846941|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846942|NCT03878979|Nivolumab|nivolumab|mesh-list
2846943|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2846944|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846945|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2846946|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846947|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
2846948|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2846949|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846950|NCT03878771|Clobetasol|clobetasol|mesh-list
2846951|NCT03878771|Benzocaine|benzocaine|mesh-list
2846952|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2846953|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
2846954|NCT03878771|Hormones|hormones|mesh-ancestor
2846955|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2846956|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846957|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
2846958|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
2846959|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2846960|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
2846961|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2846962|NCT03878784|Sumatriptan|sumatriptan|mesh-list
2846963|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2846964|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2846965|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2846966|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
2846967|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2846968|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846969|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846970|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
2846971|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
2846972|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2846973|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2846974|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2846975|NCT03878693|Fomepizole|fomepizole|mesh-list
2846976|NCT03878693|Antidotes|antidotes|mesh-ancestor
2846977|NCT03878693|Protective Agents|protective agents|mesh-ancestor
2846978|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846979|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2846980|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846981|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
2846982|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
2846983|NCT03878667|Calcium|calcium|mesh-list
2846984|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2846985|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846986|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2846987|NCT03878667|Antacids|antacids|mesh-ancestor
2846988|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2846989|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2846990|NCT03878368|Sulforaphane|sulforaphane|mesh-list
2846991|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2846992|NCT03878368|Protective Agents|protective agents|mesh-ancestor
2846993|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2846994|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2846995|NCT03878524|Vitamins|vitamins|mesh-list
2846996|NCT03878524|Leucovorin|leucovorin|mesh-list
2846997|NCT03878524|Vitamin A|vitamin a|mesh-list
2846998|NCT03878524|Sirolimus|sirolimus|mesh-list
2846999|NCT03878524|Celecoxib|celecoxib|mesh-list
2847000|NCT03878524|Paclitaxel|paclitaxel|mesh-list
2847001|NCT03878524|Maytansine|maytansine|mesh-list
2847002|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2847003|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2847004|NCT03878524|Bevacizumab|bevacizumab|mesh-list
2847005|NCT03878524|Carboplatin|carboplatin|mesh-list
2847006|NCT03878524|Doxorubicin|doxorubicin|mesh-list
2847007|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2847008|NCT03878524|Fluorouracil|fluorouracil|mesh-list
2847009|NCT03878524|Capecitabine|capecitabine|mesh-list
2299038|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
2299039|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2299040|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299041|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2299042|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
2299043|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299044|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299045|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
2299046|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299047|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2299048|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2299049|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
2299050|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2847010|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
2847011|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
2847012|NCT03878524|Nivolumab|nivolumab|mesh-list
2847013|NCT03878524|Trastuzumab|trastuzumab|mesh-list
2847014|NCT03878524|Everolimus|everolimus|mesh-list
2847015|NCT03878524|Bortezomib|bortezomib|mesh-list
2847016|NCT03878524|Sorafenib|sorafenib|mesh-list
2847017|NCT03878524|Ipilimumab|ipilimumab|mesh-list
2847018|NCT03878524|Durvalumab|durvalumab|mesh-list
2847019|NCT03878524|Sunitinib|sunitinib|mesh-list
2847020|NCT03878524|Daunorubicin|daunorubicin|mesh-list
2847021|NCT03878524|Dasatinib|dasatinib|mesh-list
2847022|NCT03878524|Olaparib|olaparib|mesh-list
2847023|NCT03878524|Venetoclax|venetoclax|mesh-list
2847024|NCT03878524|Palbociclib|palbociclib|mesh-list
2847025|NCT03878524|Lenvatinib|lenvatinib|mesh-list
2847026|NCT03878524|Vorinostat|vorinostat|mesh-list
2847027|NCT03878524|Pertuzumab|pertuzumab|mesh-list
2847028|NCT03878524|Trametinib|trametinib|mesh-list
2847029|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
2847030|NCT03878524|Tretinoin|tretinoin|mesh-list
2847031|NCT03878524|Bicalutamide|bicalutamide|mesh-list
2847032|NCT03878524|Afatinib|afatinib|mesh-list
2847033|NCT03878524|Panobinostat|panobinostat|mesh-list
2847034|NCT03878524|Vemurafenib|vemurafenib|mesh-list
2847035|NCT03878524|Dabrafenib|dabrafenib|mesh-list
2847036|NCT03878524|Ponatinib|ponatinib|mesh-list
2847037|NCT03878524|Idelalisib|idelalisib|mesh-list
2847038|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2847039|NCT03878524|Losartan|losartan|mesh-list
2847040|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
2847041|NCT03878524|Antibodies|antibodies|mesh-list
2847042|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
2847043|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2847044|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2847045|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
2847046|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
2847047|NCT03878524|Entrectinib|entrectinib|mesh-list
2847048|NCT03878524|Benzenesulfonamide|benzenesulfonamide|mesh-list
2847049|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2847050|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847051|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
2847052|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
2847053|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
2847054|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847055|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2847056|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2847057|NCT03878524|Growth Substances|growth substances|mesh-ancestor
2847058|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847059|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
2847060|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
2299051|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2299052|NCT00287937|Paclitaxel|paclitaxel|mesh-list
2299053|NCT00287937|Carboplatin|carboplatin|mesh-list
2299054|NCT00287937|Vorinostat|vorinostat|mesh-list
2299055|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2299056|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299057|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
2299058|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
2299059|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
2299060|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299061|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2299062|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299063|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
2299064|NCT00287950|Carboplatin|carboplatin|mesh-list
2299065|NCT00287950|Etoposide|etoposide|mesh-list
2299066|NCT00287950|Vincristine|vincristine|mesh-list
2299067|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2299068|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
2299069|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299070|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299071|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2299072|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
2299073|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299074|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299075|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2299076|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2299077|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2299078|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2299079|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299080|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
2299081|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
2299082|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
2299083|NCT00287963|Topotecan|topotecan|mesh-list
2107760|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2107761|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2107762|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
2107763|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107764|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2107765|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2107766|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
2107767|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2107768|NCT02493868|Citalopram|citalopram|mesh-list
2107769|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2107770|NCT02493868|Sertraline|sertraline|mesh-list
2107771|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
2107772|NCT02493868|Esketamine|esketamine|mesh-list
2107773|NCT02493868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2107774|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2107775|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2107776|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107777|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107778|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
2107779|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107780|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2107781|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2299084|NCT00287963|Vinorelbine|vinorelbine|mesh-list
2299085|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2299086|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2299087|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299088|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299089|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299090|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2299091|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
2299092|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
2299093|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
2299094|NCT00287976|Irinotecan|irinotecan|mesh-list
2299095|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2299096|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2299097|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299098|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299099|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299100|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
2299101|NCT00288002|Docetaxel|docetaxel|mesh-list
2299102|NCT00288002|Capecitabine|capecitabine|mesh-list
2847061|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
2847062|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2847063|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2847064|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2847065|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847066|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
2847067|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2847068|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2847069|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2847070|NCT03878524|Antidotes|antidotes|mesh-ancestor
2847071|NCT03878524|Protective Agents|protective agents|mesh-ancestor
2847072|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
2847073|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2847074|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2847075|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847076|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
2847077|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2847078|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2847079|NCT03878524|Analgesics|analgesics|mesh-ancestor
2847080|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
2847081|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847082|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847083|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2847084|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2299103|NCT00288002|Trastuzumab|trastuzumab|mesh-list
2299104|NCT00288002|Epirubicin|epirubicin|mesh-list
2299105|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2299106|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
2299107|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299108|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299109|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2299110|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
2299111|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299112|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299113|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2299114|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
2299115|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
2299116|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
2847085|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2847086|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2847087|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2847088|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2847089|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2847090|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2847091|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2847092|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
2847093|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2847094|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
2847095|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
2847096|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
2847097|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
2847098|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2847099|NCT03878524|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2847100|NCT03878264|Cortisone|cortisone|mesh-list
2847101|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847102|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
2847103|NCT03878472|Apatinib|apatinib|mesh-list
2847104|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847105|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2847106|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847107|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299117|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2299118|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
2299119|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2299120|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2299121|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2299122|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2299123|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299124|NCT00288028|Bortezomib|bortezomib|mesh-list
2299125|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299126|NCT00288041|Paclitaxel|paclitaxel|mesh-list
2299127|NCT00288041|Carboplatin|carboplatin|mesh-list
2299128|NCT00288041|Bortezomib|bortezomib|mesh-list
2299129|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2299130|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299131|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
2299132|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
2299133|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
2299134|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299135|NCT00288158|Allopurinol|allopurinol|mesh-list
2299136|NCT00288158|Probenecid|probenecid|mesh-list
2299137|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
2299138|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299139|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299140|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
2299141|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299142|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2847125|NCT03878069|Elapegademase|elapegademase|mesh-list
2847126|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2847127|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847128|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847129|NCT03878082|Acetaminophen|acetaminophen|mesh-list
2847130|NCT03878082|Propacetamol|propacetamol|mesh-list
2847131|NCT03878082|Analgesics|analgesics|mesh-ancestor
2847132|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
2847133|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847134|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847135|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2847136|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2847137|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847138|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2847139|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
2847140|NCT03877991|Cannabidiol|cannabidiol|mesh-list
2299143|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
2299144|NCT00288158|Protective Agents|protective agents|mesh-ancestor
2299145|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299146|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
2299147|NCT00288158|Renal Agents|renal agents|mesh-ancestor
2299148|NCT00288171|Allopurinol|allopurinol|mesh-list
2299149|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
2299150|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299151|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299152|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
2299153|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299154|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2299155|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
2847141|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
2847142|NCT03877705|Listerine|listerine|mesh-list
2847143|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
2847144|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2847145|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847146|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
2847147|NCT03877705|Protective Agents|protective agents|mesh-ancestor
2847148|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847149|NCT03877718|Promethazine|promethazine|mesh-list
2847150|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
2847151|NCT03877718|Sumatriptan|sumatriptan|mesh-list
2847152|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2299156|NCT00288171|Protective Agents|protective agents|mesh-ancestor
2299157|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299158|NCT00288184|Allopurinol|allopurinol|mesh-list
2299159|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
2299160|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299161|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299162|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
2299163|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299164|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2299165|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
2299166|NCT00288184|Protective Agents|protective agents|mesh-ancestor
2299167|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299168|NCT00288197|Voriconazole|voriconazole|mesh-list
2299169|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
2299170|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2299171|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2299172|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2299173|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299174|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299175|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2299176|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
2299177|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2299178|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847153|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2847154|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2847155|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
2847156|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847157|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847158|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847159|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
2847160|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
2847161|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2847162|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
2847163|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
2847164|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2847165|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2847166|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2847167|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2847168|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
2847169|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
2847170|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
2847171|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847172|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
2847173|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
2847174|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2299179|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2299180|NCT00288223|Telithromycin|telithromycin|mesh-list
2299181|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2299182|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2299183|NCT00288236|Rimonabant|rimonabant|mesh-list
2299184|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2299185|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2299186|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2299187|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299188|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299189|NCT00288236|Hormones|hormones|mesh-ancestor
2847175|NCT03877965|Digoxin|digoxin|mesh-list
2847176|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2847177|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2847178|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847179|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847180|NCT03877965|Protective Agents|protective agents|mesh-ancestor
2847181|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847182|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2847183|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2847184|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2847185|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
2847186|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847187|NCT03877549|Dexamethasone|dexamethasone|mesh-list
2847188|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847189|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
2847190|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
2847191|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847192|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847193|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2299190|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2299191|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299192|NCT00288249|Sagopilone|sagopilone|mesh-list
2299193|NCT00288249|Epothilones|epothilones|mesh-list
2299194|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299195|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
2299196|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
2299197|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
2299198|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299199|NCT00288262|Melatonin|melatonin|mesh-list
2299200|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
2299201|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299202|NCT00288262|Protective Agents|protective agents|mesh-ancestor
2299203|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299204|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2299205|NCT00288353|Aripiprazole|aripiprazole|mesh-list
2299206|NCT00288353|Ziprasidone|ziprasidone|mesh-list
2299207|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
2299208|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2299209|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2299210|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2299211|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2299212|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299213|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
2299214|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
2299215|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299216|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299217|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2299218|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2299219|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
2299220|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2299221|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2299222|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2299223|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2299224|NCT00288379|Budesonide|budesonide|mesh-list
2299225|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
2299226|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2299227|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2299228|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
2299229|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299230|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299231|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2299232|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
2299233|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
2299234|NCT00288379|Hormones|hormones|mesh-ancestor
2483665|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2847194|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
2847195|NCT03877549|Hormones|hormones|mesh-ancestor
2847196|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2847197|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2847198|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847199|NCT03877809|Sirolimus|sirolimus|mesh-list
2847200|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2847201|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847202|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2847203|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847204|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
2847205|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2847206|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
2847207|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847208|NCT03877874|Terbutaline|terbutaline|mesh-list
2847209|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2847210|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
2847211|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847212|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847213|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2847214|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
2847215|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
2847216|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
2847217|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2847218|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2847219|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2847220|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2847221|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
2847222|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847223|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847224|NCT03877692|Labetalol|labetalol|mesh-list
2847225|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2847226|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2847227|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
2847228|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847229|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847230|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847231|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2847232|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
2847233|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
2847234|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299235|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2299236|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2299237|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2299238|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2299239|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
2299240|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299241|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299242|NCT00288431|Sirolimus|sirolimus|mesh-list
2299243|NCT00288431|Doxorubicin|doxorubicin|mesh-list
2299244|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2299245|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847235|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2847236|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2847237|NCT03877679|Triamcinolone|triamcinolone|mesh-list
2847238|NCT03877679|Curcumin|curcumin|mesh-list
2847239|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847240|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
2847241|NCT03877679|Hormones|hormones|mesh-ancestor
2847242|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2847243|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847244|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847245|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847246|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2847247|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2847248|NCT03877679|Analgesics|analgesics|mesh-ancestor
2847249|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
2847250|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847251|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2847252|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847253|NCT03877562|Olanzapine|olanzapine|mesh-list
2847254|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
2847255|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
2847256|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847257|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847258|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2847259|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2847260|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2847261|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2847262|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2847263|NCT03877562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2847264|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2847265|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2847266|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847267|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847268|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
2847269|NCT03877601|Bevacizumab|bevacizumab|mesh-list
2847270|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2847271|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847272|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2847273|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2847274|NCT03877601|Growth Substances|growth substances|mesh-ancestor
2847275|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847276|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
2847280|NCT03877315|Cimetidine|cimetidine|mesh-list
2847281|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2847282|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2847283|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2847284|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
2847285|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
2847286|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847287|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847288|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847289|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2847290|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2847291|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847292|NCT03877289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2847293|NCT03877289|Oxybutynin|oxybutynin|mesh-list
2847294|NCT03877289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847295|NCT03877289|Parasympatholytics|parasympatholytics|mesh-ancestor
2847296|NCT03877289|Autonomic Agents|autonomic agents|mesh-ancestor
2847297|NCT03877289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847298|NCT03877289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847299|NCT03877289|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2847300|NCT03877289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2847301|NCT03877289|Cholinergic Agents|cholinergic agents|mesh-ancestor
2847302|NCT03877289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847303|NCT03877289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847304|NCT03877289|Urological Agents|urological agents|mesh-ancestor
2847305|NCT03877406|Empagliflozin|empagliflozin|mesh-list
2847306|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2847307|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2847308|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299246|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2299247|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2299248|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847309|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847310|NCT03877120|Diazepam|diazepam|mesh-list
2847311|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
2847312|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2847313|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2847314|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847315|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2847316|NCT03877120|Analgesics|analgesics|mesh-ancestor
2847317|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
2847318|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847319|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2847320|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2847321|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2847322|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
2847323|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847324|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847325|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2847326|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
2847327|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
2847328|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
2847329|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2847330|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2847331|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2847332|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2847333|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2847334|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2847335|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2847336|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
2847337|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
2847338|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
2847339|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
2847340|NCT03877003|Choline|choline|mesh-list
2847341|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
2847342|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2847343|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
2847344|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847345|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2847346|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2847347|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
2847348|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
2847349|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2847350|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2847351|NCT03876899|Analgesics|analgesics|mesh-ancestor
2847352|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
2847353|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847354|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847355|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847356|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299249|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299250|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2299251|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2299252|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
2299253|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2299254|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
2299255|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299256|NCT00288444|Docetaxel|docetaxel|mesh-list
2847357|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2847358|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
2847359|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847360|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2847361|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
2847362|NCT03876873|Anesthetics|anesthetics|mesh-list
2847363|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2847364|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299257|NCT00288444|Lonafarnib|lonafarnib|mesh-list
2847365|NCT03876704|Vitamins|vitamins|mesh-list
2847366|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
2847367|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847368|NCT03876938|Olanzapine|olanzapine|mesh-list
2847369|NCT03876938|Aprepitant|aprepitant|mesh-list
2847370|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
2847371|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
2847372|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847373|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847374|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2847375|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2299258|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299259|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
2299260|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
2299261|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
2299262|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299263|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299264|NCT00288470|Hylan|hylan|mesh-list
2299265|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
2299266|NCT00288470|Protective Agents|protective agents|mesh-ancestor
2299267|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299268|NCT00288483|Policosanol|policosanol|mesh-list
2299269|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2299270|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2299271|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
2299272|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299273|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2299274|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2299275|NCT00288522|Lanreotide|lanreotide|mesh-list
2299276|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299277|NCT00288535|Sirolimus|sirolimus|mesh-list
2299278|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2299279|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2299280|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2299281|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299282|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
2299283|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2847376|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2847377|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2847378|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2847379|NCT03876938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2847380|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2847381|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2847382|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847383|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847384|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
2847385|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2847386|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2847387|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2847388|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2847389|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
2847390|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847391|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2847392|NCT03876886|Paclitaxel|paclitaxel|mesh-list
2847393|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2847394|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
2847395|NCT03876886|Carboplatin|carboplatin|mesh-list
2847396|NCT03876886|Epirubicin|epirubicin|mesh-list
2847397|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2299284|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
2299285|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299286|NCT00288548|Metoprolol|metoprolol|mesh-list
2299287|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2299288|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2107782|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107783|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2107784|NCT02493868|Analgesics|analgesics|mesh-ancestor
2107785|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
2107786|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
2107787|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
2107788|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2847398|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847399|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
2847400|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
2107789|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2299289|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
2299290|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
2847401|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
2847402|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847403|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2847404|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
2847405|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847406|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2847407|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2847408|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
2847409|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2847410|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2847411|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2847412|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2847413|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847414|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
2847415|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2847416|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2847417|NCT03876444|Prednisolone|prednisolone|mesh-list
2847418|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
2847419|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2847420|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
2847421|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847422|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
2847423|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
2847424|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847425|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847426|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2847427|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
2847428|NCT03876444|Hormones|hormones|mesh-ancestor
2847429|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2847430|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2847431|NCT03876444|Protective Agents|protective agents|mesh-ancestor
2847432|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2847433|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847434|NCT03876548|Iodine|iodine|mesh-list
2847435|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
2847436|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2847437|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847438|NCT03876548|Trace Elements|trace elements|mesh-ancestor
2847439|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
2847440|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847441|NCT03876587|Docetaxel|docetaxel|mesh-list
2847442|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107790|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2107791|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2107792|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107793|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
2107794|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299291|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299292|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299293|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2299294|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2299295|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2299296|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
2299297|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299298|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299299|NCT00288561|Ranibizumab|ranibizumab|mesh-list
2299300|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2299301|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2299302|NCT00288561|Growth Substances|growth substances|mesh-ancestor
2299303|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847443|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
2847444|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
2847445|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
2847446|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847447|NCT03876574|Gemcitabine|gemcitabine|mesh-list
2847448|NCT03876574|Dexamethasone|dexamethasone|mesh-list
2847449|NCT03876574|Floxuridine|floxuridine|mesh-list
2847450|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847451|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
2847452|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
2847453|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847454|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847455|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2847456|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
2299304|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
2299305|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299306|NCT00288652|Reboxetine|reboxetine|mesh-list
2299307|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
2299308|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2299309|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2299310|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2299311|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2299312|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299313|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
2299314|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299315|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299316|NCT00288717|Telmisartan|telmisartan|mesh-list
2299317|NCT00288717|Candesartan|candesartan|mesh-list
2299318|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2299319|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2299320|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2299321|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299322|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2299323|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
2299324|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299325|NCT00288743|Insulin|insulin|mesh-list
2299326|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2299327|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299328|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
2299329|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
2299330|NCT00288769|Vitamins|vitamins|mesh-ancestor
2299331|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
2299332|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299333|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
2299334|NCT00288769|Hematinics|hematinics|mesh-ancestor
2299335|NCT00288782|Mirtazapine|mirtazapine|mesh-list
2299336|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
2299337|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2299338|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2299339|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
2299340|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
2299341|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847457|NCT03876574|Hormones|hormones|mesh-ancestor
2847458|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2847459|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2847460|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299342|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299343|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299344|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2299345|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2299346|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2299347|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2299348|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2299349|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2299350|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
2299351|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2299352|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2299353|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
2299354|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2299355|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
2299356|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
2299357|NCT00288873|Vitamin D|vitamin d|mesh-list
2299358|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2299359|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299360|NCT00288873|Vitamins|vitamins|mesh-ancestor
2299361|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
2299362|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2299363|NCT00288951|Travoprost|travoprost|mesh-list
2299364|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2299365|NCT00289042|Enoxaparin|enoxaparin|mesh-list
2299366|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
2299367|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2299368|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2299369|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299370|NCT00289250|Artesunate|artesunate|mesh-list
2299371|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
2299372|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
2299373|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2299374|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
2299375|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2847461|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2847462|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
2847463|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847464|NCT03876574|Antiviral Agents|antiviral agents|mesh-ancestor
2847465|NCT03876574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847466|NCT03876574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847467|NCT03876574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2847468|NCT03876574|Immunologic Factors|immunologic factors|mesh-ancestor
2847469|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
2299376|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2299377|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2299378|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299379|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
2299380|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
2299381|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2299382|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
2299383|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2299384|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299385|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299386|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2299387|NCT00289250|Renal Agents|renal agents|mesh-ancestor
2847470|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2847471|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
2847472|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2847473|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
2847474|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847475|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2847476|NCT03876119|Plasminogen|plasminogen|mesh-list
2847477|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2847478|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2847479|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847480|NCT03876262|Ivermectin|ivermectin|mesh-list
2847481|NCT03876262|Moxidectin|moxidectin|mesh-list
2847482|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2847483|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847484|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
2847485|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
2847486|NCT03876041|Dexamethasone|dexamethasone|mesh-list
2847487|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
2847488|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
2847489|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2847490|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2847491|NCT03876041|BB 1101|bb 1101|mesh-list
2847492|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847493|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
2847494|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
2847495|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847496|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847497|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2847498|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
2847499|NCT03876041|Hormones|hormones|mesh-ancestor
2847500|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2847501|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2847502|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847503|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
2847504|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847505|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847506|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2847507|NCT03876041|Protective Agents|protective agents|mesh-ancestor
2847508|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2299388|NCT00289263|Paclitaxel|paclitaxel|mesh-list
2299389|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2299390|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299391|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
2299392|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
2299393|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
2299394|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299395|NCT00289354|Chromium|chromium|mesh-list
2299396|NCT00289354|Biotin|biotin|mesh-list
2299397|NCT00289354|Picolinic acid|picolinic acid|mesh-list
2299398|NCT00289354|Trace Elements|trace elements|mesh-ancestor
2299399|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
2299400|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299401|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
2299402|NCT00289354|Vitamins|vitamins|mesh-ancestor
2299403|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2299404|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
2299405|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
2847509|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847510|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
2847511|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2847512|NCT03875911|Mitomycins|mitomycins|mesh-list
2847513|NCT03875911|Mitomycin|mitomycin|mesh-list
2847514|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2847515|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847516|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
2847517|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847518|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2847519|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847520|NCT03875872|Propofol|propofol|mesh-list
2847521|NCT03875872|Anesthetics|anesthetics|mesh-list
2847522|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
2847523|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2847524|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2847525|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847526|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2847527|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
2847528|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
2847529|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2847530|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2847531|NCT03875690|Prednisolone|prednisolone|mesh-list
2847532|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
2847533|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2847534|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
2847535|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847536|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
2847537|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
2847538|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847539|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847540|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2847541|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
2847542|NCT03875690|Hormones|hormones|mesh-ancestor
2847543|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2847544|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2847545|NCT03875690|Protective Agents|protective agents|mesh-ancestor
2847546|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2847547|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847548|NCT03875573|Durvalumab|durvalumab|mesh-list
2847549|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2847550|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847551|NCT03875755|Inositol|inositol|mesh-list
2847552|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
2299406|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299407|NCT00289406|Amlodipine|amlodipine|mesh-list
2299408|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2299409|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2299410|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2299411|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299412|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2299413|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299414|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
2299415|NCT00289419|Ketorolac|ketorolac|mesh-list
2299416|NCT00289419|Epinephrine|epinephrine|mesh-list
2299417|NCT00289419|Racepinephrine|racepinephrine|mesh-list
2299418|NCT00289419|Morphine|morphine|mesh-list
2299419|NCT00289419|Ropivacaine|ropivacaine|mesh-list
2299420|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
2299421|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2299422|NCT00289419|Narcotics|narcotics|mesh-ancestor
2299423|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2299424|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299425|NCT00289419|Analgesics|analgesics|mesh-ancestor
2847553|NCT03875755|Vitamins|vitamins|mesh-ancestor
2847554|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
2847555|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299426|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
2299427|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299428|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
2299429|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
2299430|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2299431|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2299432|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2299433|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299434|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2299435|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847556|NCT03875391|Oxytocin|oxytocin|mesh-list
2847557|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
2847558|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2847559|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847560|NCT03875274|Morphine|morphine|mesh-list
2847561|NCT03875274|Ropivacaine|ropivacaine|mesh-list
2847562|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2847563|NCT03875274|Narcotics|narcotics|mesh-ancestor
2299436|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299437|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2299438|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2299439|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
2299440|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299441|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2299442|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2299443|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
2299444|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2299445|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
2299446|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
2299447|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
2299448|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2299449|NCT00289445|Leucovorin|leucovorin|mesh-list
2299450|NCT00289445|Folic Acid|folic acid|mesh-list
2299451|NCT00289445|Mitomycins|mitomycins|mesh-list
2847564|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2847565|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847566|NCT03875274|Analgesics|analgesics|mesh-ancestor
2299452|NCT00289445|Mitomycin|mitomycin|mesh-list
2299453|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
2299454|NCT00289445|Antidotes|antidotes|mesh-ancestor
2299455|NCT00289445|Protective Agents|protective agents|mesh-ancestor
2299456|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299457|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
2299458|NCT00289445|Vitamins|vitamins|mesh-ancestor
2299459|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
2299460|NCT00289445|Hematinics|hematinics|mesh-ancestor
2299461|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2299462|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299463|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
2299464|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299465|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2299466|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299467|NCT00289510|Vaccines|vaccines|mesh-list
2299468|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
2299469|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299470|NCT00289588|Mupirocin|mupirocin|mesh-list
2299471|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2299472|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2299473|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2299474|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299475|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299476|NCT00289601|Eptifibatide|eptifibatide|mesh-list
2299477|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2299478|NCT00289627|Ipilimumab|ipilimumab|mesh-list
2299479|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2299480|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299481|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2299482|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299483|NCT00289640|Ipilimumab|ipilimumab|mesh-list
2299484|NCT00289640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2299485|NCT00289640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299486|NCT00289640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2299487|NCT00289640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299488|NCT00289809|Ifosfamide|ifosfamide|mesh-list
2299489|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2299490|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
2299491|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299492|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847567|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
2847568|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847569|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
2847570|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
2847571|NCT03875313|Talazoparib|talazoparib|mesh-list
2847572|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2299493|NCT00289835|Paclitaxel|paclitaxel|mesh-list
2299494|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2299495|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2847573|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847574|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299496|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299497|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
2299498|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
2299499|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
2299500|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299501|NCT00289861|Risperidone|risperidone|mesh-list
2299502|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2299503|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
2299504|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299505|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299506|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299507|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2299508|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2299509|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2847575|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847576|NCT03874975|Vitamin D|vitamin d|mesh-list
2847577|NCT03874975|Vitamins|vitamins|mesh-ancestor
2847578|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
2847579|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107795|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107796|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2107797|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299510|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2299511|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2299512|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
2299513|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2299514|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2299515|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
2299516|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299517|NCT00289952|Valproic Acid|valproic acid|mesh-list
2299518|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
2299519|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299520|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299521|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
2847580|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2299522|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299523|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299524|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
2299525|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2299526|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2299527|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2299528|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
2299529|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299530|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2299531|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
2299532|NCT00290017|Pemetrexed|pemetrexed|mesh-list
2299533|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299534|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299535|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299536|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2299537|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2299538|NCT00290030|Alfuzosin|alfuzosin|mesh-list
2299539|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2299540|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2847581|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
2847582|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2847583|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
2847584|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
2847585|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299541|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2299542|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
2299543|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847586|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847587|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847588|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2847589|NCT03874832|Analgesics|analgesics|mesh-ancestor
2847590|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
2847591|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847592|NCT03874936|Dexamethasone|dexamethasone|mesh-list
2847593|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2847594|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847595|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
2847596|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
2847597|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847598|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847599|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2847600|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
2847601|NCT03874936|Hormones|hormones|mesh-ancestor
2847602|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2847603|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2847604|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847605|NCT03874884|Olaparib|olaparib|mesh-list
2847606|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2847607|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847608|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847609|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299544|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299545|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299546|NCT00290030|Urological Agents|urological agents|mesh-ancestor
2299547|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
2299548|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2299549|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299550|NCT00290069|Sirolimus|sirolimus|mesh-list
2299551|NCT00290069|Tacrolimus|tacrolimus|mesh-list
2299552|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2299553|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
2299554|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299555|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2299556|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847610|NCT03874806|Ropivacaine|ropivacaine|mesh-list
2847611|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2847612|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
2847613|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
2847614|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2847615|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847616|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
2847617|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847618|NCT03874741|Cetuximab|cetuximab|mesh-list
2847619|NCT03874741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2847620|NCT03874741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847621|NCT03874585|Nicotine|nicotine|mesh-list
2847622|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2847623|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
2847624|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847625|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847626|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2847627|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2847628|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
2847629|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299557|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299558|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2299559|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2299560|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2299561|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299562|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
2299563|NCT00290082|Midazolam|midazolam|mesh-list
2299564|NCT00290082|Loxapine|loxapine|mesh-list
2847630|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847631|NCT03874715|Insulin|insulin|mesh-list
2847632|NCT03874715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2847633|NCT03874715|Insulin Glargine|insulin glargine|mesh-list
2847634|NCT03874715|Insulin Aspart|insulin aspart|mesh-list
2847635|NCT03874715|Insulin, Long-Acting|insulin, long-acting|mesh-list
2847636|NCT03874715|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2847637|NCT03874715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2847638|NCT03874715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847639|NCT03874364|Lidocaine|lidocaine|mesh-list
2847640|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
2847641|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
2847642|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2847643|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847644|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
2847645|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847646|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2847647|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2847648|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2847649|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2847650|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847651|NCT03874338|Colchicine|colchicine|mesh-list
2847652|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
2847653|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2847654|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
2847655|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
2847656|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
2847657|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847658|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847659|NCT03874273|Crizotinib|crizotinib|mesh-list
2847660|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847661|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2847662|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299565|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2299566|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2299567|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2299568|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299569|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2299570|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2299571|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2299572|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2847663|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299573|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
2299574|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
2299575|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
2299576|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
2299577|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299578|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299579|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2847679|NCT03874286|Liver Extracts|liver extracts|mesh-list
2847680|NCT03874286|Hematinics|hematinics|mesh-ancestor
2847681|NCT03874130|Scopolamine|scopolamine|mesh-list
2847682|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2847683|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2847684|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
2847685|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
2847686|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847687|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847688|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2847689|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
2847690|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2847691|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
2299580|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2847692|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847693|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847694|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2847695|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
2847696|NCT03874260|Fenofibrate|fenofibrate|mesh-list
2847697|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2847698|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
2847699|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847700|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2847701|NCT03874000|Metformin|metformin|mesh-list
2847702|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2847703|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847704|NCT03874026|Cetuximab|cetuximab|mesh-list
2847705|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2847706|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847707|NCT03874052|Venetoclax|venetoclax|mesh-list
2847708|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2847709|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847710|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2847711|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299581|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
2299582|NCT00290108|Propofol|propofol|mesh-list
2299583|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2299584|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2299585|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299586|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2299587|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
2299588|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
2299589|NCT00290121|Olanzapine|olanzapine|mesh-list
2299590|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
2299591|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
2299592|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299593|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847712|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847713|NCT03874156|Atorvastatin|atorvastatin|mesh-list
2847714|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2847715|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2847716|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
2847717|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847718|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2847719|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2847720|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847721|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
2847722|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
2847723|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
2847724|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847725|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
2847726|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2847727|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847728|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2847729|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
2847730|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847731|NCT03873805|Vidarabine|vidarabine|mesh-list
2847732|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
2847733|NCT03873805|Fludarabine|fludarabine|mesh-list
2847734|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
2847735|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2847736|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
2847737|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847738|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2847739|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2847740|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
2847741|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847742|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847743|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2847744|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2847745|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
2847746|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
2847747|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847748|NCT03873857|Venetoclax|venetoclax|mesh-list
2847749|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847750|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
2847751|NCT03873818|Ipilimumab|ipilimumab|mesh-list
2847752|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2299594|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2847753|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847754|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2847755|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847761|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
2847762|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
2847763|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847764|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
2847765|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2847766|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
2847767|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847768|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847769|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2847770|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
2847771|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2847772|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
2847773|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847774|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847775|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2847776|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
2847777|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
2847778|NCT03873298|Protective Agents|protective agents|mesh-ancestor
2847779|NCT03873337|Nicotine|nicotine|mesh-list
2847780|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2847781|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
2847782|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847783|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847784|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2847785|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2847786|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
2847787|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847788|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847789|NCT03873311|Cytarabine|cytarabine|mesh-list
2299595|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2299596|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2299597|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2299598|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2299599|NCT00290121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2299600|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2299601|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2299602|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299603|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299604|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
2299605|NCT00290173|Ritodrine|ritodrine|mesh-list
2299606|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
2299607|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
2299608|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299609|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299610|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
2299611|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2299612|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2299613|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2847790|NCT03873311|Azacitidine|azacitidine|mesh-list
2847791|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2847792|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
2847793|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847794|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847795|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
2847796|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847797|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2847798|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
2847799|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847800|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847801|NCT03873740|Vaccines|vaccines|mesh-list
2847802|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
2847803|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847804|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
2847805|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2847806|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299614|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2299615|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
2299616|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299617|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299618|NCT00290264|Budesonide|budesonide|mesh-list
2299619|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
2299620|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2299621|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2299622|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
2299623|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299624|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847807|NCT03872661|Bevacizumab|bevacizumab|mesh-list
2847808|NCT03872661|Carboplatin|carboplatin|mesh-list
2847809|NCT03872661|Pemetrexed|pemetrexed|mesh-list
2847810|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2847811|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847812|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2847813|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2847814|NCT03872661|Growth Substances|growth substances|mesh-ancestor
2847815|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847816|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
2847817|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847818|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847819|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2847820|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2847821|NCT03872700|Fentanyl|fentanyl|mesh-list
2847822|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2847823|NCT03872700|Narcotics|narcotics|mesh-ancestor
2847824|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2847825|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847826|NCT03872700|Analgesics|analgesics|mesh-ancestor
2847827|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
2847828|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847829|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2847830|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2847831|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
2847832|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
2847833|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
2847834|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2847835|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2847836|NCT03872830|Analgesics|analgesics|mesh-ancestor
2847837|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
2847838|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847839|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847840|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847841|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2847842|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2847843|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
2847844|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2847845|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2847846|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2299625|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2299626|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
2299627|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
2299628|NCT00290264|Hormones|hormones|mesh-ancestor
2299629|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2299630|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2299631|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2847847|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2847848|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847849|NCT03872570|Phenylephrine|phenylephrine|mesh-list
2847850|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
2847851|NCT03872570|Norepinephrine|norepinephrine|mesh-list
2847852|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2847853|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
2847854|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
2847855|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847856|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847857|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
2847858|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2847859|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
2847860|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
2847861|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2847862|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2847863|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2847864|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
2847865|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847866|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847867|NCT03872570|Protective Agents|protective agents|mesh-ancestor
2847868|NCT03872505|Paclitaxel|paclitaxel|mesh-list
2847869|NCT03872505|Carboplatin|carboplatin|mesh-list
2847870|NCT03872505|Durvalumab|durvalumab|mesh-list
2847871|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2847872|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847873|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
2847874|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
2847875|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
2847876|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847877|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2847878|NCT03872336|Labetalol|labetalol|mesh-list
2847879|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2847880|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2847881|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
2847882|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847883|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847884|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847885|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2847886|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
2847887|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
2847888|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847889|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2847890|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2847891|NCT03873415|BMS-986165|bms-986165|mesh-list
2847892|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
2299632|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2299633|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
2299634|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299635|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299636|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
2299637|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2299638|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299639|NCT00290420|Chloroquine|chloroquine|mesh-list
2299640|NCT00290420|Amebicides|amebicides|mesh-ancestor
2299641|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2847893|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2847894|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847895|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847896|NCT03873532|Capecitabine|capecitabine|mesh-list
2847897|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2847898|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
2847899|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847900|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847901|NCT03872232|Telmisartan|telmisartan|mesh-list
2847902|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2847903|NCT03872232|Ezetimibe|ezetimibe|mesh-list
2847904|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2847905|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2847906|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
2847907|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847908|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2847909|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2847910|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847911|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2847912|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2847913|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2847914|NCT03872388|Capecitabine|capecitabine|mesh-list
2847915|NCT03872388|Atorvastatin|atorvastatin|mesh-list
2847916|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2847917|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
2847918|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847919|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847920|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2847921|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2847922|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2299642|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2847923|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2847924|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299643|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2299644|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
2299645|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299646|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
2299647|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299648|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2847925|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2847926|NCT03872180|Venetoclax|venetoclax|mesh-list
2847927|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
2847928|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2847929|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
2847930|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847931|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847932|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2847933|NCT03871972|Sirolimus|sirolimus|mesh-list
2847934|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2299649|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299650|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299651|NCT00290511|Vidarabine|vidarabine|mesh-list
2299652|NCT00290511|Dexamethasone|dexamethasone|mesh-list
2299653|NCT00290511|Rituximab|rituximab|mesh-list
2299654|NCT00290511|Fludarabine|fludarabine|mesh-list
2299655|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
2299656|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
2847935|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847936|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2847937|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847938|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
2847939|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2847940|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
2847941|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847942|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
2847943|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2847944|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847945|NCT03872011|Vitamins|vitamins|mesh-list
2847946|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
2847947|NCT03872011|Thiamine|thiamine|mesh-list
2847948|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
2847949|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
2847950|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847951|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847952|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
2847953|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847954|NCT03872011|Protective Agents|protective agents|mesh-ancestor
2847955|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
2847956|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
2847957|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2299657|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2299658|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
2299659|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
2299660|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299661|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299662|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2299663|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
2299664|NCT00290511|Hormones|hormones|mesh-ancestor
2299665|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2299666|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2299667|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299668|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2299669|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
2299670|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299671|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2847958|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847959|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
2847960|NCT03871621|Metformin|metformin|mesh-list
2847961|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
2847962|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2847963|NCT03871621|Meglitinide|meglitinide|mesh-list
2847964|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2847965|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847966|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2847967|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847968|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2299672|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
2483666|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
2847969|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2847970|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
2847971|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2847972|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847973|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299673|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299674|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2299675|NCT00290511|Antiviral Agents|antiviral agents|mesh-ancestor
2299676|NCT00290511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2299677|NCT00290511|Analgesics|analgesics|mesh-ancestor
2299678|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
2847974|NCT03871517|Aspirin|aspirin|mesh-list
2847975|NCT03871517|Indobufen|indobufen|mesh-list
2299679|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2847976|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2847977|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2847978|NCT03871517|Analgesics|analgesics|mesh-ancestor
2847979|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
2847980|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2847981|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2847982|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2847983|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2847984|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2847985|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2847986|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847987|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2299680|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2299681|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299682|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
2299683|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2299684|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2299685|NCT00290602|Prednisolone|prednisolone|mesh-list
2299686|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
2299687|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2299688|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
2299689|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2299690|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
2299691|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
2299692|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299693|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299694|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2299695|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
2847988|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2847989|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2847990|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
2847991|NCT03871491|Azithromycin|azithromycin|mesh-list
2847992|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2847993|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2847994|NCT03871361|Abatacept|abatacept|mesh-list
2299696|NCT00290602|Hormones|hormones|mesh-ancestor
2299697|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2299698|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2299699|NCT00290602|Protective Agents|protective agents|mesh-ancestor
2299700|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2299701|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299702|NCT00290628|Cyclosporine|cyclosporine|mesh-list
2299703|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
2299704|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
2299705|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
2299706|NCT00290628|Melphalan|melphalan|mesh-list
2847995|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2847996|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2847997|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2847998|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2847999|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
2848000|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848001|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2848002|NCT03871465|Triamcinolone|triamcinolone|mesh-list
2848003|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2848004|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2848005|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2848006|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848007|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
2848008|NCT03871465|Hormones|hormones|mesh-ancestor
2848009|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2848010|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848011|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2299707|NCT00290628|Busulfan|busulfan|mesh-list
2299708|NCT00290628|Cyclosporins|cyclosporins|mesh-list
2299709|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2299710|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2299711|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
2299712|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299713|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299714|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2299715|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
2299716|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299717|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299718|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2299719|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299720|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
2299721|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2299722|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
2299723|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2299724|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2299725|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2299726|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
2299727|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2299728|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2299729|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
2299730|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
2299731|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299732|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2299733|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
2299734|NCT00290628|Hormones|hormones|mesh-ancestor
2299735|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2299736|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2299737|NCT00290628|Protective Agents|protective agents|mesh-ancestor
2299738|NCT00290641|Cyclosporine|cyclosporine|mesh-list
2299739|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
2299740|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
2299741|NCT00290641|Fludarabine|fludarabine|mesh-list
2299742|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
2299743|NCT00290641|Cyclosporins|cyclosporins|mesh-list
2299744|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2299745|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
2299746|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299747|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299748|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2299749|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
2299750|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299751|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299752|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2299753|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2299754|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
2299755|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299756|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
2299757|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848012|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
2848013|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848014|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848015|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
2848016|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2848017|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
2848018|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848019|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
2848020|NCT03871218|Protective Agents|protective agents|mesh-ancestor
2848021|NCT03871322|Vitamin D|vitamin d|mesh-list
2848022|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
2848023|NCT03871322|Vitamins|vitamins|mesh-list
2848024|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
2299758|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
2299759|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2299760|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2299761|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2299762|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
2848025|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848026|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2848027|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2848028|NCT03871478|Lidocaine|lidocaine|mesh-list
2848029|NCT03871478|Bupivacaine|bupivacaine|mesh-list
2848030|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
2848031|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
2848032|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848033|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848034|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
2848035|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848036|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2848037|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2848038|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2299763|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2299764|NCT00290667|Prednisone|prednisone|mesh-list
2848039|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2299765|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
2299766|NCT00290667|Rituximab|rituximab|mesh-list
2299767|NCT00290667|Doxorubicin|doxorubicin|mesh-list
2299768|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2299769|NCT00290667|Vincristine|vincristine|mesh-list
2299770|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2299771|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
2299772|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299773|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299774|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2299775|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
2299776|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299777|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299778|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2299779|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2299780|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2299781|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2299782|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2299783|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299784|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2299785|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
2299786|NCT00290667|Hormones|hormones|mesh-ancestor
2299787|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2299788|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2299789|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2299790|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
2299791|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
2299792|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
2848040|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848041|NCT03871036|Paclitaxel|paclitaxel|mesh-list
2848042|NCT03871036|Durvalumab|durvalumab|mesh-list
2848043|NCT03871036|Tremelimumab|tremelimumab|mesh-list
2848044|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2848045|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848046|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
2848047|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
2848048|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
2848049|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848050|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2848051|NCT03871062|Anesthetics|anesthetics|mesh-list
2848052|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848053|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848054|NCT03871049|Dexamethasone|dexamethasone|mesh-list
2848055|NCT03871049|Bupivacaine|bupivacaine|mesh-list
2848056|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848057|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
2848058|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
2848059|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848060|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848061|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2848062|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
2848063|NCT03871049|Hormones|hormones|mesh-ancestor
2848064|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2848065|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2848066|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848067|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
2848068|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
2848069|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848070|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
2848071|NCT03871114|Triamcinolone|triamcinolone|mesh-list
2848072|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2848073|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2848074|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2848075|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848076|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
2848077|NCT03871114|Hormones|hormones|mesh-ancestor
2848078|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2848079|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848080|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2848081|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
2848082|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848083|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848084|NCT03870880|Risperidone|risperidone|mesh-list
2848085|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2848086|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
2848087|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848088|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848089|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848090|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2848091|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2848092|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848093|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2848094|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2848095|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
2848096|NCT03871153|Paclitaxel|paclitaxel|mesh-list
2848097|NCT03871153|Carboplatin|carboplatin|mesh-list
2848098|NCT03871153|Durvalumab|durvalumab|mesh-list
2848099|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2848100|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848101|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
2848102|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
2848103|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
2848104|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848105|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2848106|NCT03870919|Palbociclib|palbociclib|mesh-list
2848107|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848108|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2848109|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848110|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848111|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2848112|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
2848113|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2848114|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
2848115|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848116|NCT03870581|Warfarin|warfarin|mesh-list
2848117|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
2848118|NCT03870711|Lidocaine|lidocaine|mesh-list
2848119|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
2848120|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
2848121|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848122|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848123|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
2848124|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848125|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2848126|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2848127|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2848128|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2848129|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848130|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
2848131|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2848132|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
2848133|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848134|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
2848135|NCT03870646|Protective Agents|protective agents|mesh-ancestor
2848136|NCT03870503|Misoprostol|misoprostol|mesh-list
2848137|NCT03870503|Oxytocin|oxytocin|mesh-list
2848138|NCT03870503|Carbetocin|carbetocin|mesh-list
2848139|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
2107798|NCT02494102|Modafinil|modafinil|mesh-list
2107799|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2107800|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107801|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2107802|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2107803|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2107804|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107805|NCT02494180|Fentanyl|fentanyl|mesh-list
2107806|NCT02494180|Midazolam|midazolam|mesh-list
2107807|NCT02494180|Diazepam|diazepam|mesh-list
2107808|NCT02494180|Meperidine|meperidine|mesh-list
2107809|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2107810|NCT02494180|Narcotics|narcotics|mesh-ancestor
2107811|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107812|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107813|NCT02494180|Analgesics|analgesics|mesh-ancestor
2107814|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
2107815|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107816|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2107817|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2107818|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
2107819|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
2299793|NCT00290680|Celecoxib|celecoxib|mesh-list
2299794|NCT00290680|Bortezomib|bortezomib|mesh-list
2848140|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2848141|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848142|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2848143|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
2848144|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2848145|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2848146|NCT03870490|Cefepime|cefepime|mesh-list
2848147|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2848148|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848149|NCT03870256|Misoprostol|misoprostol|mesh-list
2848150|NCT03870256|Carbetocin|carbetocin|mesh-list
2848151|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2299795|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299796|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2299797|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2299798|NCT00290680|Analgesics|analgesics|mesh-ancestor
2299799|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
2299800|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299801|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299802|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2299803|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299804|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2299805|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2299806|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299807|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299808|NCT00290719|Irinotecan|irinotecan|mesh-list
2299809|NCT00290719|Gefitinib|gefitinib|mesh-list
2299810|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299811|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2299812|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2299813|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299814|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299815|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2299816|NCT00290758|Genistein|genistein|mesh-list
2848152|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
2848153|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2848154|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848155|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2848156|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2848157|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
2848158|NCT03870399|Tamoxifen|tamoxifen|mesh-list
2848159|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2848160|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
2848161|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2848162|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848163|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2848164|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848165|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2848166|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2848167|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2848168|NCT03869944|Lamivudine|lamivudine|mesh-list
2848169|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2848170|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2848171|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848172|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299817|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2299818|NCT00290758|Protective Agents|protective agents|mesh-ancestor
2299819|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299820|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299821|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2299822|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299823|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299824|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
2299825|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2299826|NCT00290758|Estrogens|estrogens|mesh-ancestor
2299827|NCT00290758|Hormones|hormones|mesh-ancestor
2299828|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2848173|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
2848174|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848175|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2848176|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2848177|NCT03869866|Vaccines|vaccines|mesh-list
2848178|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
2848179|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299829|NCT00290823|Albendazole|albendazole|mesh-list
2107820|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2107821|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2107822|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2107823|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2107824|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
2107825|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
2107826|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107827|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107828|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
2107829|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
2848180|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
2848181|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
2848182|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848183|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
2848184|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848185|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848186|NCT03869996|Cytarabine|cytarabine|mesh-list
2848187|NCT03869996|Methotrexate|methotrexate|mesh-list
2848188|NCT03869996|Etoposide|etoposide|mesh-list
2848189|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2299830|NCT00290823|Dexamethasone|dexamethasone|mesh-list
2299831|NCT00290823|Omeprazole|omeprazole|mesh-list
2299832|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2299833|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
2299834|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
2848190|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
2848191|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848192|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848193|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
2848194|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848195|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2848196|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
2848197|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848198|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2848199|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2848200|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2299835|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299836|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299837|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2299838|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
2299839|NCT00290823|Hormones|hormones|mesh-ancestor
2299840|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2299841|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2299842|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299843|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2299844|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2299845|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299846|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299847|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
2299848|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2299849|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2299850|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
2299851|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2299852|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2299853|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
2299854|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
2299855|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
2299856|NCT00290836|Thrombin|thrombin|mesh-list
2299857|NCT00290836|Aprotinin|aprotinin|mesh-list
2299858|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
2299859|NCT00290836|Coagulants|coagulants|mesh-ancestor
2299860|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2299861|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2299862|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
2299863|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299864|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299865|NCT00290849|Bivalirudin|bivalirudin|mesh-list
2299866|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
2299867|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2299868|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
2299869|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299870|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299871|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
2299872|NCT00290901|Celecoxib|celecoxib|mesh-list
2299873|NCT00290901|Tramadol|tramadol|mesh-list
2299874|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2299875|NCT00290901|Narcotics|narcotics|mesh-ancestor
2299876|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2299877|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848201|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848202|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2848203|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
2848204|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2848205|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
2848206|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2848207|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2848208|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2107830|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
2107831|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2107832|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2107833|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2107834|NCT02494336|Ropivacaine|ropivacaine|mesh-list
2107835|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
2107836|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
2107837|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107838|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107839|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
2107840|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107841|NCT02494583|Capecitabine|capecitabine|mesh-list
2107842|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
2107843|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107844|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2107845|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
2299878|NCT00290901|Analgesics|analgesics|mesh-ancestor
2299879|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
2299880|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299881|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2848209|NCT03869931|Fenofibrate|fenofibrate|mesh-list
2848210|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2848211|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
2299882|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2299883|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2299884|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299885|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2299886|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2299887|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299888|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299889|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2299890|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
2299891|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2299892|NCT00290914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2299893|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2299894|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2299895|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299896|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299897|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
2299898|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299899|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2299900|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2299901|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
2299902|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2299903|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299904|NCT00290940|Metformin|metformin|mesh-list
2299905|NCT00290940|Pioglitazone|pioglitazone|mesh-list
2299906|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2299907|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299908|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
2299909|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2299910|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299911|NCT00290992|Rasburicase|rasburicase|mesh-list
2299912|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
2299913|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299914|NCT00291005|Docetaxel|docetaxel|mesh-list
2299915|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848212|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848213|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2848214|NCT03869762|Denosumab|denosumab|mesh-list
2848215|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2848216|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848217|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
2848218|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2848219|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
2848220|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
2848221|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2299916|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
2299917|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
2299918|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
2299919|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299920|NCT00291109|Letrozole|letrozole|mesh-list
2299921|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299922|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2299923|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2299924|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299925|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299926|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2299927|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
2299928|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2299929|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299930|NCT00291122|Celecoxib|celecoxib|mesh-list
2299931|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2299932|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2299933|NCT00291122|Analgesics|analgesics|mesh-ancestor
2848222|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848223|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2848224|NCT03869736|Analgesics|analgesics|mesh-ancestor
2848225|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
2848226|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848227|NCT03869528|Lidocaine|lidocaine|mesh-list
2848228|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
2848229|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
2848230|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848231|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299934|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
2299935|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299936|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299937|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2299938|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2299939|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2848232|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
2848233|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848234|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2848235|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2848236|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2848237|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2848238|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848239|NCT03869281|Pancrelipase|pancrelipase|mesh-list
2848240|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2848241|NCT03869398|Calcitriol|calcitriol|mesh-list
2848242|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2848243|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848244|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2299940|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2299941|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299942|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299943|NCT00291148|Pregabalin|pregabalin|mesh-list
2299944|NCT00291148|Paroxetine|paroxetine|mesh-list
2299945|NCT00291148|Analgesics|analgesics|mesh-ancestor
2299946|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
2299947|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299948|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299949|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
2299950|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2299951|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2848245|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2848246|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848247|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2848248|NCT03869398|Vitamins|vitamins|mesh-ancestor
2848249|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
2848250|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2848251|NCT03869268|Aspirin|aspirin|mesh-list
2848252|NCT03869268|Ticagrelor|ticagrelor|mesh-list
2848253|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2848254|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2299952|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299953|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2299954|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2299955|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2299956|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2299957|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2299958|NCT00291148|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2299959|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2848255|NCT03869268|Analgesics|analgesics|mesh-ancestor
2848256|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
2848257|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848258|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848259|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848260|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2848261|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2848262|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2848263|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848264|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2848265|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2848266|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848267|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
2848268|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2848269|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2848270|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2848271|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
2848272|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848273|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
2299960|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2299961|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
2299962|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2299963|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
2848274|NCT03869047|Bupivacaine|bupivacaine|mesh-list
2848275|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
2848276|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
2848277|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848278|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848279|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
2848280|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848281|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2848282|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2848283|NCT03869047|Analgesics|analgesics|mesh-ancestor
2848284|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2848285|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2848286|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2848287|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
2848288|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848289|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848290|NCT03868852|Apatinib|apatinib|mesh-list
2848291|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848292|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2848293|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848294|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848295|NCT03869073|Evolocumab|evolocumab|mesh-list
2848296|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2848297|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2848298|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
2848299|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848300|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2848301|NCT03868969|Fosfomycin|fosfomycin|mesh-list
2848302|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2299964|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2299965|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2848303|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848304|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
2848305|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2848306|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2848307|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848308|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
2848309|NCT03868956|Coagulants|coagulants|mesh-ancestor
2848310|NCT03868839|Telmisartan|telmisartan|mesh-list
2848311|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2848312|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2848313|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2848314|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848315|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
2299966|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2299967|NCT00291213|Levetiracetam|levetiracetam|mesh-list
2299968|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
2848316|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2848317|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
2848318|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
2848319|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848320|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848321|NCT03868722|Venetoclax|venetoclax|mesh-list
2848322|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
2848323|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848324|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
2848325|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2848326|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848327|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2848328|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2848329|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848330|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848331|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848332|NCT03868072|Tofacitinib|tofacitinib|mesh-list
2848333|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2848334|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848335|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848336|NCT03868124|Travoprost|travoprost|mesh-list
2848337|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2848338|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2848339|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2299969|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
2299970|NCT00291369|Interferons|interferons|mesh-list
2299971|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
2299972|NCT00291369|Interleukin-2|interleukin-2|mesh-list
2299973|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2299974|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
2299975|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2299976|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
2848340|NCT03868137|Ibuprofen|ibuprofen|mesh-list
2848341|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2848342|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2848343|NCT03868137|Analgesics|analgesics|mesh-ancestor
2848344|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
2848345|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848346|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848347|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848348|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2848349|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2848350|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848351|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848352|NCT03868111|Sufentanil|sufentanil|mesh-list
2848353|NCT03868111|Remifentanil|remifentanil|mesh-list
2848354|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2848355|NCT03868111|Narcotics|narcotics|mesh-ancestor
2848356|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848357|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848358|NCT03868111|Analgesics|analgesics|mesh-ancestor
2848359|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
2848360|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848361|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2848362|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2848363|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
2848364|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
2848365|NCT03868202|Estradiol|estradiol|mesh-list
2848366|NCT03868202|Progesterone|progesterone|mesh-list
2848367|NCT03868202|Estrogens|estrogens|mesh-ancestor
2848368|NCT03868202|Hormones|hormones|mesh-ancestor
2848369|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2848370|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848371|NCT03868202|Progestins|progestins|mesh-ancestor
2848372|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
2848373|NCT03868033|Denosumab|denosumab|mesh-list
2848374|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2848375|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848376|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2848377|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848378|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848379|NCT03867929|Vitamin D|vitamin d|mesh-list
2848380|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2848381|NCT03867929|Calcifediol|calcifediol|mesh-list
2848382|NCT03867929|Vitamins|vitamins|mesh-ancestor
2848383|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
2848384|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848385|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2848386|NCT03867994|Carvedilol|carvedilol|mesh-list
2848387|NCT03867994|Atorvastatin|atorvastatin|mesh-list
2848388|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2848389|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2848390|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
2107846|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107847|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2107848|NCT02494596|Capecitabine|capecitabine|mesh-list
2107849|NCT02494596|Pertuzumab|pertuzumab|mesh-list
2107850|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2107851|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
2107852|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299977|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2299978|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
2299979|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2299980|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2299981|NCT00291369|Analgesics|analgesics|mesh-ancestor
2299982|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
2299983|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2299984|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2299985|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2299986|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2848391|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2299987|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
2299988|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2299989|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2299990|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2299991|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2299992|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2299993|NCT00291382|Fluticasone|fluticasone|mesh-list
2299994|NCT00291382|Xhance|xhance|mesh-list
2299995|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2299996|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848392|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2848393|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2848394|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848395|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2848396|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2848397|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
2848398|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848399|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848400|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2848401|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
2848402|NCT03867994|Protective Agents|protective agents|mesh-ancestor
2848403|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2848404|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2848405|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2848406|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
2848407|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2848408|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2848409|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2848410|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
2848411|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848412|NCT03867500|Niacin|niacin|mesh-list
2848413|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2848414|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
2848415|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848416|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2848417|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
2848418|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
2299997|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2299998|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
2299999|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300000|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300001|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2300002|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
2300003|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
2300004|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2300005|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2300006|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2300007|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2300008|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
2300009|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300010|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848419|NCT03867500|Vitamins|vitamins|mesh-ancestor
2848420|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
2848421|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848422|NCT03867695|Ropivacaine|ropivacaine|mesh-list
2848423|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
2848424|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
2848425|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848426|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848427|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
2848428|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848429|NCT03867799|Nivolumab|nivolumab|mesh-list
2848430|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2848431|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848432|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2300011|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
2300012|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2300013|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
2300014|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300015|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300016|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2300017|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
2300018|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2300019|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
2848433|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848437|NCT03867851|Heparin|heparin|mesh-list
2848438|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
2848439|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2848440|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2848441|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848442|NCT03867682|Venetoclax|venetoclax|mesh-list
2107853|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107854|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2107855|NCT02494713|Ketoconazole|ketoconazole|mesh-list
2107856|NCT02494713|Docetaxel|docetaxel|mesh-list
2107857|NCT02494713|Doxorubicin|doxorubicin|mesh-list
2107858|NCT02494713|Estramustine|estramustine|mesh-list
2107859|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107860|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
2107861|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
2848443|NCT03867682|Lintuzumab|lintuzumab|mesh-list
2848444|NCT03867682|Spironolactone|spironolactone|mesh-list
2848445|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848446|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2848447|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
2848448|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2848449|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848450|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2848451|NCT03867682|Diuretics|diuretics|mesh-ancestor
2848452|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
2848453|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2848454|NCT03867487|Empagliflozin|empagliflozin|mesh-list
2848455|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2848456|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848457|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2848458|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848459|NCT03867188|Bupivacaine|bupivacaine|mesh-list
2848460|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
2848461|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
2848462|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848463|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848464|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
2848465|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848466|NCT03867097|Iloprost|iloprost|mesh-list
2848467|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2848468|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
2848469|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
2848470|NCT03867383|Calcium|calcium|mesh-list
2848471|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2848472|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848473|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2848474|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
2848475|NCT03867071|Hematinics|hematinics|mesh-ancestor
2848476|NCT03867110|Atorvastatin|atorvastatin|mesh-list
2848477|NCT03867110|Ezetimibe|ezetimibe|mesh-list
2848478|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2848479|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2848480|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
2848481|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848482|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2848483|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2848484|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848488|NCT03867370|Lenvatinib|lenvatinib|mesh-list
2848489|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848490|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2848491|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848492|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848493|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
2848494|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2848495|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848496|NCT03867214|Tranexamic Acid|tranexamic acid|mesh-list
2848497|NCT03867214|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2848498|NCT03867214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2107862|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
2848499|NCT03867214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848500|NCT03867214|Hemostatics|hemostatics|mesh-ancestor
2848501|NCT03867214|Coagulants|coagulants|mesh-ancestor
2848502|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2848503|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848504|NCT03867318|Atorvastatin|atorvastatin|mesh-list
2848505|NCT03867318|Ezetimibe|ezetimibe|mesh-list
2848506|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2848507|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2848508|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
2848509|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848510|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2848511|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2848512|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848513|NCT03867123|Temozolomide|temozolomide|mesh-list
2848514|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2848515|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
2848516|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848517|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848518|NCT03867240|Gabapentin|gabapentin|mesh-list
2848519|NCT03867240|Analgesics|analgesics|mesh-ancestor
2848520|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
2848521|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300020|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300021|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300022|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2300023|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
2300024|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
2300025|NCT00291408|Protective Agents|protective agents|mesh-ancestor
2300035|NCT00291525|Warfarin|warfarin|mesh-list
2300036|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
2848522|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848523|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
2848524|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2848525|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2848526|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848527|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2848528|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2848529|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2848530|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848531|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848532|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
2848533|NCT03866980|Carboplatin|carboplatin|mesh-list
2300037|NCT00291538|Bortezomib|bortezomib|mesh-list
2300038|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300039|NCT00291616|Interferons|interferons|mesh-list
2300040|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
2300041|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
2300042|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2300043|NCT00291616|Thymalfasin|thymalfasin|mesh-list
2300044|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848534|NCT03866980|Pemetrexed|pemetrexed|mesh-list
2848535|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848536|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848537|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848538|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2848539|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2848540|NCT03866993|Paclitaxel|paclitaxel|mesh-list
2848541|NCT03866993|Carboplatin|carboplatin|mesh-list
2848542|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2848543|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848544|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
2848545|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
2848546|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
2848547|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300045|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
2848548|NCT03866928|Stiripentol|stiripentol|mesh-list
2848549|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
2848550|NCT03866746|Aflibercept|aflibercept|mesh-list
2848551|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2848552|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2848553|NCT03866746|Growth Substances|growth substances|mesh-ancestor
2848554|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848555|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
2848556|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848557|NCT03866837|Micronutrients|micronutrients|mesh-list
2848558|NCT03866837|Trace Elements|trace elements|mesh-list
2848559|NCT03866837|Lactoferrin|lactoferrin|mesh-list
2848560|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848561|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848562|NCT03866681|Sirolimus|sirolimus|mesh-list
2848563|NCT03866681|Warfarin|warfarin|mesh-list
2848564|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2848565|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848566|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2848567|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848568|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
2848569|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2848570|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
2848571|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848572|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
2848573|NCT03866629|Lifitegrast|lifitegrast|mesh-list
2848574|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2848575|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2848576|NCT03866733|Narcotics|narcotics|mesh-list
2848577|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848578|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848579|NCT03866733|Analgesics|analgesics|mesh-ancestor
2848580|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
2848581|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848582|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
2848583|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2848584|NCT03866577|Antibodies|antibodies|mesh-list
2848585|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
2848586|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2848587|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
2848588|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848589|NCT03866772|Misoprostol|misoprostol|mesh-list
2848590|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2848591|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
2848592|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2848593|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848594|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2848595|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2848596|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
2848597|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
2848598|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2848599|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848600|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2848601|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2848602|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848603|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848604|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848605|NCT03866499|Gefitinib|gefitinib|mesh-list
2848606|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848607|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2848608|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848609|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848610|NCT03866525|Irinotecan|irinotecan|mesh-list
2848611|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2848612|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2848613|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848614|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848615|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848616|NCT03866668|Esomeprazole|esomeprazole|mesh-list
2848617|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2848618|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2848619|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2848620|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848621|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848622|NCT03866421|Liver Extracts|liver extracts|mesh-list
2848623|NCT03866421|Hematinics|hematinics|mesh-ancestor
2848624|NCT03866408|Pioglitazone|pioglitazone|mesh-list
2848625|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2848626|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848627|NCT03866447|Vitamin D|vitamin d|mesh-list
2848628|NCT03866447|Adapalene|adapalene|mesh-list
2848629|NCT03866447|Vitamins|vitamins|mesh-ancestor
2848630|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
2848631|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848632|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2848633|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2848634|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2848635|NCT03866447|Analgesics|analgesics|mesh-ancestor
2848636|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
2848637|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848638|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848639|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2848640|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
2300046|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300047|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
2300048|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300049|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2300050|NCT00291707|Pemetrexed|pemetrexed|mesh-list
2300051|NCT00291707|Cetuximab|cetuximab|mesh-list
2300052|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300053|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300054|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300055|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2300056|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2300057|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2300058|NCT00291720|Spironolactone|spironolactone|mesh-list
2300059|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2300060|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
2300061|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2300062|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300063|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2300064|NCT00291720|Diuretics|diuretics|mesh-ancestor
2300065|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
2300066|NCT00291733|Levetiracetam|levetiracetam|mesh-list
2300067|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
2300068|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
2300069|NCT00291746|Esomeprazole|esomeprazole|mesh-list
2848641|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
2848642|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
2848643|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848644|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2848645|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2848646|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
2848647|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848648|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848649|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2848650|NCT03865940|Lidocaine|lidocaine|mesh-list
2848651|NCT03865940|Guanfacine|guanfacine|mesh-list
2848652|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
2848653|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
2848654|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848655|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848656|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
2848657|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848658|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2848659|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2848660|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2848661|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2848662|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848663|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2848664|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2848665|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2848666|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2848667|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
2848668|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848669|NCT03865992|Curcumin|curcumin|mesh-list
2848670|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2848671|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2848672|NCT03865992|Analgesics|analgesics|mesh-ancestor
2848673|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
2848674|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848675|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848676|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848677|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2848678|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848679|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848680|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848681|NCT03865888|Cyclosporine|cyclosporine|mesh-list
2848682|NCT03865888|Tacrolimus|tacrolimus|mesh-list
2848683|NCT03865888|Cyclosporins|cyclosporins|mesh-list
2848684|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2848685|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
2848686|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848687|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2848688|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848689|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848690|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
2848691|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848692|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
2848693|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2848694|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2848695|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2848696|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848697|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
2300070|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2300071|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2300072|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2300073|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300074|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300075|NCT00291759|Tamoxifen|tamoxifen|mesh-list
2300076|NCT00291759|Anastrozole|anastrozole|mesh-list
2300077|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2300078|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
2300079|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2300080|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300081|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2300082|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107863|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107864|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2107865|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2848698|NCT03865615|Oxytocin|oxytocin|mesh-list
2848699|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
2848700|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2848701|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848702|NCT03865550|Ketamine|ketamine|mesh-list
2848703|NCT03865550|Analgesics|analgesics|mesh-ancestor
2848704|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
2848705|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848706|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848707|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2848708|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2848709|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
2300083|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2300084|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2300085|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2300086|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2300087|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2300088|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300089|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300090|NCT00291772|Pramlintide|pramlintide|mesh-list
2300091|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2848710|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
2848711|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848712|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2848713|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2848714|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848715|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300092|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300093|NCT00291785|Leucovorin|leucovorin|mesh-list
2300094|NCT00291785|Folic Acid|folic acid|mesh-list
2300095|NCT00291785|Fluorouracil|fluorouracil|mesh-list
2300096|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
2300097|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
2300098|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300099|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2300100|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300101|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2300102|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
2848716|NCT03865563|Gemcitabine|gemcitabine|mesh-list
2848717|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
2848718|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2848719|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
2848720|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848721|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848722|NCT03865563|Antiviral Agents|antiviral agents|mesh-ancestor
2848723|NCT03865563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848724|NCT03865563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848725|NCT03865563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2848726|NCT03865563|Immunologic Factors|immunologic factors|mesh-ancestor
2848727|NCT03865563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848728|NCT03865680|Fluorides|fluorides|mesh-list
2848729|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
2848730|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
2848731|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
2848732|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848733|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
2848734|NCT03865680|Protective Agents|protective agents|mesh-ancestor
2848735|NCT03865732|Pregnanolone|pregnanolone|mesh-list
2848736|NCT03865732|Ganaxolone|ganaxolone|mesh-list
2848737|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
2848738|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848739|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848740|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848741|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
2848742|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
2848743|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
2848744|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848745|NCT03865511|Osimertinib|osimertinib|mesh-list
2848746|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848747|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2848748|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848749|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848750|NCT03865290|Ondansetron|ondansetron|mesh-list
2848751|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
2848752|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
2848753|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848754|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848755|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2848756|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
2848757|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
2848758|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2848759|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
2848760|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848761|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848762|NCT03865290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2848763|NCT03865290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2848764|NCT03865290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848765|NCT03865290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2848766|NCT03865290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2848767|NCT03865160|Atropine|atropine|mesh-list
2848768|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2848769|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2848770|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2848771|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2300103|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300104|NCT00291785|Antidotes|antidotes|mesh-ancestor
2300105|NCT00291785|Protective Agents|protective agents|mesh-ancestor
2300106|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
2300107|NCT00291785|Vitamins|vitamins|mesh-ancestor
2300108|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
2300109|NCT00291785|Hematinics|hematinics|mesh-ancestor
2300110|NCT00291811|Plerixafor|plerixafor|mesh-list
2300111|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2300112|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2300113|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
2300114|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300115|NCT00291850|Paclitaxel|paclitaxel|mesh-list
2300116|NCT00291850|Cisplatin|cisplatin|mesh-list
2300117|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2848772|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2848773|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
2300118|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300119|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
2300120|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
2300121|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
2300122|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848774|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848775|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848776|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2848777|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
2848778|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
2848779|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
2848780|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2848781|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2848782|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
2848783|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848784|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848785|NCT03865004|Acetaminophen|acetaminophen|mesh-list
2848786|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2848787|NCT03865004|Morphine|morphine|mesh-list
2848788|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2848789|NCT03865004|Narcotics|narcotics|mesh-ancestor
2848790|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848791|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848792|NCT03865004|Analgesics|analgesics|mesh-ancestor
2848793|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
2848794|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848795|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2848796|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
2848797|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2848798|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848799|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2848800|NCT03864913|Testosterone|testosterone|mesh-list
2848801|NCT03864913|Androgens|androgens|mesh-ancestor
2848802|NCT03864913|Hormones|hormones|mesh-ancestor
2848803|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2848804|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848805|NCT03865147|Acetaminophen|acetaminophen|mesh-list
2848806|NCT03865147|Cetrimonium|cetrimonium|mesh-list
2848807|NCT03865147|Ibuprofen|ibuprofen|mesh-list
2848808|NCT03865147|Lidocaine|lidocaine|mesh-list
2300123|NCT00291863|Simvastatin|simvastatin|mesh-list
2300124|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2300125|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2848809|NCT03865147|Epinephrine|epinephrine|mesh-list
2848810|NCT03865147|Racepinephrine|racepinephrine|mesh-list
2848811|NCT03865147|Bupivacaine|bupivacaine|mesh-list
2848812|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2848813|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
2848814|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
2848815|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
2848816|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848817|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848818|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
2848819|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848820|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2848821|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2848822|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2848823|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2848824|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848825|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2848826|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2848827|NCT03865147|Analgesics|analgesics|mesh-ancestor
2848828|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848829|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2848830|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2848831|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848832|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
2848833|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2848834|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2848835|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
2848836|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848837|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2848838|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2848839|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
2300126|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
2300127|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300128|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2300129|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2300130|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300131|NCT00291915|Adalimumab|adalimumab|mesh-list
2300132|NCT00291915|Methotrexate|methotrexate|mesh-list
2300133|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2300134|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
2300135|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2300136|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300137|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2848840|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2848841|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
2848842|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
2848843|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
2848844|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2848845|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2848846|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2848847|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848848|NCT03865082|Nivolumab|nivolumab|mesh-list
2848849|NCT03865082|Ipilimumab|ipilimumab|mesh-list
2848850|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2848851|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848852|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2848853|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848854|NCT03865121|Nicotine|nicotine|mesh-list
2848855|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2848856|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
2848857|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848858|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300138|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
2300139|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300140|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300141|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
2300142|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300143|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2300144|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2300145|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
2300146|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2300147|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2848859|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2848860|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2848861|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
2300148|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2300149|NCT00291980|Vaccines|vaccines|mesh-list
2300150|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
2300151|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300152|NCT00292071|Caspofungin|caspofungin|mesh-list
2300153|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
2300154|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300155|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300156|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300157|NCT00292110|Methadone|methadone|mesh-list
2300158|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2300159|NCT00292110|Narcotics|narcotics|mesh-ancestor
2848862|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2848863|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300160|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2300161|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300162|NCT00292110|Analgesics|analgesics|mesh-ancestor
2300163|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
2300164|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300165|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
2300166|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
2300167|NCT00292123|Methadone|methadone|mesh-list
2300168|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2300169|NCT00292123|Narcotics|narcotics|mesh-ancestor
2300170|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2300171|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300172|NCT00292123|Analgesics|analgesics|mesh-ancestor
2300173|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
2300174|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300175|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
2300176|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
2300177|NCT00292201|Atorvastatin|atorvastatin|mesh-list
2300178|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2300179|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2848864|NCT03864926|Tacrolimus|tacrolimus|mesh-list
2848865|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2848866|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
2848867|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848868|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2848869|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848870|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848871|NCT03864978|Rifaximin|rifaximin|mesh-list
2848872|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2848873|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2848874|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2848875|NCT03864783|Curcumin|curcumin|mesh-list
2848876|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2848877|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2848878|NCT03864783|Analgesics|analgesics|mesh-ancestor
2848879|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
2848880|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848881|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848882|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848883|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2848884|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300180|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
2300181|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300182|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2300183|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2848885|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848886|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848887|NCT03864666|Cilostazol|cilostazol|mesh-list
2848888|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2848889|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
2848890|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848891|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848892|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2848893|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
2848894|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2848895|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2848896|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848897|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2848898|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
2848899|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2848900|NCT03864666|Protective Agents|protective agents|mesh-ancestor
2848901|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2848902|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2848903|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848904|NCT03864705|Metformin|metformin|mesh-list
2848905|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2848906|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848907|NCT03864250|Prednisone|prednisone|mesh-list
2848908|NCT03864250|Tacrolimus|tacrolimus|mesh-list
2848909|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848910|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
2848911|NCT03864250|Hormones|hormones|mesh-ancestor
2848912|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2848913|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848914|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2848915|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848916|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2848917|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
2848918|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2848919|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848920|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848921|NCT03864523|Pioglitazone|pioglitazone|mesh-list
2848922|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2848923|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848924|NCT03864419|Prednisone|prednisone|mesh-list
2848925|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
2848926|NCT03864419|Rituximab|rituximab|mesh-list
2848927|NCT03864419|Doxorubicin|doxorubicin|mesh-list
2848928|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2848929|NCT03864419|Methotrexate|methotrexate|mesh-list
2848930|NCT03864419|Etoposide|etoposide|mesh-list
2848931|NCT03864419|Vincristine|vincristine|mesh-list
2848932|NCT03864419|Daunorubicin|daunorubicin|mesh-list
2848933|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
2848934|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2848935|NCT03864419|Antibodies|antibodies|mesh-list
2848936|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
2848937|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2848938|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2848939|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
2848940|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848941|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2848942|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2848943|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
2848944|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848945|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848946|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2848947|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2848948|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2848949|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2300184|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300185|NCT00292214|Acetaminophen|acetaminophen|mesh-list
2300186|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2300187|NCT00292214|Analgesics|analgesics|mesh-ancestor
2300188|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
2300189|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300190|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300191|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
2300192|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
2300193|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2300194|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
2300195|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300196|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300197|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
2300198|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300199|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
2300200|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2300201|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
2300202|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300203|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300204|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
2300205|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300206|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2300207|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2300208|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2300209|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2848950|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848951|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848952|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
2848953|NCT03864419|Hormones|hormones|mesh-ancestor
2848954|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2848955|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2848956|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2848957|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
2848958|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2848959|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2848960|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
2848961|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
2848962|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2848963|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2848964|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2848965|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
2848966|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
2848967|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
2848968|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
2848969|NCT03864588|Ropivacaine|ropivacaine|mesh-list
2848970|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
2848971|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
2848972|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2848973|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848974|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
2848975|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848976|NCT03864575|Celecoxib|celecoxib|mesh-list
2848977|NCT03864575|Nivolumab|nivolumab|mesh-list
2848978|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2848979|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848980|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2848981|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2848982|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2300210|NCT00292344|Rifaximin|rifaximin|mesh-list
2848983|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2848984|NCT03864575|Analgesics|analgesics|mesh-ancestor
2848985|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
2848986|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2848987|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848988|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2848989|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2848990|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2848991|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2848992|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2848993|NCT03864185|Rituximab|rituximab|mesh-list
2848994|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2848995|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2848996|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
2848997|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2848998|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2848999|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
2849000|NCT03864172|Calcium|calcium|mesh-list
2300211|NCT00292344|Loperamide|loperamide|mesh-list
2300212|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
2300213|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2300214|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300215|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2300216|NCT00292396|Antibodies|antibodies|mesh-list
2300217|NCT00292396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2300218|NCT00292396|Immunologic Factors|immunologic factors|mesh-ancestor
2300219|NCT00292396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300220|NCT00292409|Aripiprazole|aripiprazole|mesh-list
2300221|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
2300222|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2300223|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2300224|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2300225|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2300226|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300227|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
2300228|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
2300229|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300230|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300231|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2300232|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2300233|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
2300234|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2300235|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2849001|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2849002|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849003|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2849004|NCT03864068|Inositol|inositol|mesh-list
2849005|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
2849006|NCT03864068|Vitamins|vitamins|mesh-ancestor
2849007|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
2849008|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849009|NCT03863925|Propofol|propofol|mesh-list
2849010|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2849011|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849012|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849013|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2849014|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
2849015|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
2849016|NCT03863977|Dexamethasone|dexamethasone|mesh-list
2849017|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
2849018|NCT03863977|Bupivacaine|bupivacaine|mesh-list
2300236|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2300237|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2300238|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
2300239|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2300240|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
2300241|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300242|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300243|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2300244|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
2300245|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
2849019|NCT03863977|BB 1101|bb 1101|mesh-list
2849020|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2849021|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
2849022|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
2300246|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2849023|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849024|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849025|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2849026|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
2849027|NCT03863977|Hormones|hormones|mesh-ancestor
2849028|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2849029|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2849030|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849031|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
2849032|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107866|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2107867|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107868|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
2107869|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107870|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2107871|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2107872|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2107873|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
2107874|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2107875|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300247|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
2300248|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300249|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300250|NCT00292526|Enalapril|enalapril|mesh-list
2300251|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2300252|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
2300253|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300254|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300255|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2300256|NCT00292695|Ifosfamide|ifosfamide|mesh-list
2300257|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300258|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2300259|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
2300260|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300261|NCT00292708|Cefmetazole|cefmetazole|mesh-list
2300262|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2300263|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300264|NCT00292721|Celecoxib|celecoxib|mesh-list
2300265|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2300266|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2300267|NCT00292721|Analgesics|analgesics|mesh-ancestor
2300268|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
2300269|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300270|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300271|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2300272|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2300273|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2300274|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2300275|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300276|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300277|NCT00292734|Zolpidem|zolpidem|mesh-list
2300278|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2300279|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2300280|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2300281|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300282|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2300283|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
2300284|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
2300285|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849033|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849034|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
2849035|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
2849036|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849037|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
2849038|NCT03864016|Sufentanil|sufentanil|mesh-list
2849039|NCT03864016|Dsuvia|dsuvia|mesh-list
2849040|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
2849041|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849042|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849043|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2849044|NCT03864016|Narcotics|narcotics|mesh-ancestor
2849045|NCT03864016|Analgesics|analgesics|mesh-ancestor
2849046|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
2849047|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107876|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2107877|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2107878|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
2107879|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2107880|NCT02495038|Rocuronium|rocuronium|mesh-list
2107881|NCT02495038|Atracurium|atracurium|mesh-list
2849048|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2849049|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2849050|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
2849051|NCT03864094|Phenylephrine|phenylephrine|mesh-list
2849052|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
2849053|NCT03864094|Norepinephrine|norepinephrine|mesh-list
2849054|NCT03864094|Ephedrine|ephedrine|mesh-list
2849055|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
2849056|NCT03864094|Remifentanil|remifentanil|mesh-list
2849057|NCT03864094|Propofol|propofol|mesh-list
2849058|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2849059|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849060|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849061|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2849062|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
2849063|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
2849064|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2849065|NCT03864094|Narcotics|narcotics|mesh-ancestor
2849066|NCT03864094|Analgesics|analgesics|mesh-ancestor
2849067|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
2849068|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849069|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2849070|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
2849071|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
2849072|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
2849073|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2849074|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
2849075|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
2849076|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2849077|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2849078|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2849079|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
2849080|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849081|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849082|NCT03864094|Protective Agents|protective agents|mesh-ancestor
2849083|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2849084|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2849085|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2849086|NCT03863899|Anesthetics|anesthetics|mesh-list
2849087|NCT03863899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849088|NCT03863899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849089|NCT03863691|Amisulpride|amisulpride|mesh-list
2300286|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300287|NCT00292747|Ibuprofen|ibuprofen|mesh-list
2300288|NCT00292747|Drotaverin|drotaverin|mesh-list
2300289|NCT00292747|Papaverine|papaverine|mesh-list
2300290|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2300291|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2300292|NCT00292747|Analgesics|analgesics|mesh-ancestor
2300293|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
2300294|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300295|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300296|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2300297|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2300298|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2300299|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300300|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300301|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
2300302|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
2300303|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
2300304|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2300305|NCT00292747|Urological Agents|urological agents|mesh-ancestor
2300306|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
2300307|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2300308|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300309|NCT00292799|Metformin|metformin|mesh-list
2300310|NCT00292799|Orlistat|orlistat|mesh-list
2300311|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2107882|NCT02495038|Cisatracurium|cisatracurium|mesh-list
2107883|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2300312|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849090|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2849091|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2849092|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849093|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849094|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2849095|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2849096|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
2849097|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849098|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849099|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2849100|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
2849101|NCT03863405|Metformin|metformin|mesh-list
2849102|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2849103|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849104|NCT03863587|Ramucirumab|ramucirumab|mesh-list
2849105|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849106|NCT03863392|Misoprostol|misoprostol|mesh-list
2849107|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2849108|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
2849109|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2300313|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300314|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300315|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2300316|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2300317|NCT00292838|Fluticasone|fluticasone|mesh-list
2300318|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2300319|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2300320|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
2300321|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300322|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300323|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2300324|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
2849110|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849111|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2849112|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2849113|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
2849114|NCT03863626|Furosemide|furosemide|mesh-list
2849115|NCT03863626|Diuretics|diuretics|mesh-ancestor
2849116|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
2849117|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849118|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2849119|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2849120|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849121|NCT03863613|Progesterone|progesterone|mesh-list
2849122|NCT03863613|Progestins|progestins|mesh-ancestor
2849123|NCT03863613|Hormones|hormones|mesh-ancestor
2849124|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2849125|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849126|NCT03863366|Prucalopride|prucalopride|mesh-list
2849127|NCT03863366|Laxatives|laxatives|mesh-ancestor
2849128|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2849129|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2849130|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2849131|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
2849132|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849133|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849134|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849135|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2849136|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2849137|NCT03863288|Oxytocin|oxytocin|mesh-list
2849138|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
2849139|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2849140|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849141|NCT03863223|Docetaxel|docetaxel|mesh-list
2849142|NCT03863223|Trastuzumab|trastuzumab|mesh-list
2849143|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849144|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
2849145|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
2849146|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
2849147|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300325|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
2300326|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2300327|NCT00292890|Insulin|insulin|mesh-list
2300328|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2300329|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300330|NCT00292929|Artesunate|artesunate|mesh-list
2300331|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
2300332|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2849148|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2849149|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
2849150|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2849151|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849152|NCT03862950|Metformin|metformin|mesh-list
2849153|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2849154|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849155|NCT03862716|Insulin|insulin|mesh-list
2849156|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2849157|NCT03862716|Metformin|metformin|mesh-list
2849158|NCT03862716|Liraglutide|liraglutide|mesh-list
2849159|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
2849160|NCT03862716|Xultophy|xultophy|mesh-list
2849161|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2849162|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849163|NCT03862716|Incretins|incretins|mesh-ancestor
2849164|NCT03862716|Hormones|hormones|mesh-ancestor
2849165|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2849166|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2849167|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2849168|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849169|NCT03862768|Sunitinib|sunitinib|mesh-list
2849170|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
2849171|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849172|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2849173|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2849174|NCT03862768|Growth Substances|growth substances|mesh-ancestor
2849175|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849176|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
2849177|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2849178|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849179|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849180|NCT03862456|Azithromycin|azithromycin|mesh-list
2849181|NCT03862456|Metronidazole|metronidazole|mesh-list
2849182|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2849183|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2849184|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2849185|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2849186|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
2849187|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2849188|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
2849189|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2849190|NCT03862586|Expectorants|expectorants|mesh-ancestor
2849191|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
2849192|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2849193|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
2849194|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849195|NCT03862586|Protective Agents|protective agents|mesh-ancestor
2849196|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849197|NCT03862586|Antidotes|antidotes|mesh-ancestor
2849198|NCT03862495|Azithromycin|azithromycin|mesh-list
2849199|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2849200|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300333|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2849201|NCT03862651|Cangrelor|cangrelor|mesh-list
2849202|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2849203|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2300334|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300335|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300336|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
2300337|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
2300338|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2300339|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
2300340|NCT00292955|Cetuximab|cetuximab|mesh-list
2300341|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2849204|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2849205|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2849206|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
2849207|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849208|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849209|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849210|NCT03862612|Anesthetics|anesthetics|mesh-list
2849211|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849212|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849213|NCT03862404|Epinephrine|epinephrine|mesh-list
2849214|NCT03862404|Bupivacaine|bupivacaine|mesh-list
2849215|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
2849216|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
2849217|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849218|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849219|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
2849220|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849221|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2849222|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2849223|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
2849224|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849225|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849226|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2849227|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2849228|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
2849229|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2849230|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
2849231|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
2849232|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
2849233|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2849234|NCT03862391|Analgesics|analgesics|mesh-list
2849235|NCT03862391|Antiemetics|antiemetics|mesh-list
2849236|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
2849237|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849238|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849239|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
2849240|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2300342|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300343|NCT00293072|Rituximab|rituximab|mesh-list
2300344|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2300345|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300346|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
2300347|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300348|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2300349|NCT00293085|Docetaxel|docetaxel|mesh-list
2300350|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300351|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
2300352|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
2300353|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
2300354|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300355|NCT00293098|Deferiprone|deferiprone|mesh-list
2300356|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2849241|NCT03861988|Ketamine|ketamine|mesh-list
2849242|NCT03861988|Analgesics|analgesics|mesh-ancestor
2849243|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
2849244|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849245|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849246|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2849247|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2849248|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
2849249|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
2849250|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849251|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2849252|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2300357|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
2300358|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
2300359|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300360|NCT00293111|Etodolac|etodolac|mesh-list
2849253|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849254|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849255|NCT03862287|Lidocaine|lidocaine|mesh-list
2849256|NCT03862287|Bupivacaine|bupivacaine|mesh-list
2849257|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
2849258|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
2849259|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849260|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849261|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
2849262|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849263|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2849264|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2849265|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2849266|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2849267|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849268|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2849269|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2849270|NCT03862079|Tazobactam|tazobactam|mesh-list
2849271|NCT03862079|Piperacillin|piperacillin|mesh-list
2849272|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2849273|NCT03862079|Nystatin|nystatin|mesh-list
2849274|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2849275|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300361|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2300362|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2300363|NCT00293111|Analgesics|analgesics|mesh-ancestor
2300364|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
2300365|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300366|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300367|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2300368|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2300369|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2300370|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2300371|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300372|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300373|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
2300374|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300375|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2300376|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300377|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300378|NCT00293150|Eplerenone|eplerenone|mesh-list
2300379|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2849276|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2849277|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849278|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849279|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
2300380|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
2300381|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2300382|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300383|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2300384|NCT00293150|Diuretics|diuretics|mesh-ancestor
2300385|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
2300386|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2300387|NCT00293163|Hylan|hylan|mesh-list
2300388|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
2300389|NCT00293163|Protective Agents|protective agents|mesh-ancestor
2849280|NCT03862079|Ionophores|ionophores|mesh-ancestor
2849281|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2849282|NCT03862157|Azacitidine|azacitidine|mesh-list
2849283|NCT03862157|Venetoclax|venetoclax|mesh-list
2849284|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2849285|NCT03862157|Pevonedistat|pevonedistat|mesh-list
2849286|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2849287|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
2849288|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300390|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300391|NCT00293176|Donepezil|donepezil|mesh-list
2300392|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2300393|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300394|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300395|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
2849289|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849290|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
2849291|NCT03862170|Cefazolin|cefazolin|mesh-list
2300396|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300397|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300398|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
2300399|NCT00293228|Isoniazid|isoniazid|mesh-list
2300400|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
2300401|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2300402|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300403|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2300404|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2300405|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
2300406|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849292|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2849293|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2849294|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2849295|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2849296|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300407|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2300408|NCT00293280|Lomustine|lomustine|mesh-list
2300409|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2849297|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849298|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849299|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2849300|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2849301|NCT03862144|Palonosetron|palonosetron|mesh-list
2849302|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
2849303|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
2849304|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849305|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849306|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2849307|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2849308|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2849309|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
2849310|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849311|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849312|NCT03861871|Fenfluramine|fenfluramine|mesh-list
2849313|NCT03861871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2849314|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2849315|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2849316|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849317|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849318|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
2849319|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849320|NCT03861767|Metformin|metformin|mesh-list
2849321|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2849322|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849323|NCT03861598|Carvedilol|carvedilol|mesh-list
2849324|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2849325|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2849326|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
2849327|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849328|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849329|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849330|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2849331|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
2849332|NCT03861598|Protective Agents|protective agents|mesh-ancestor
2849333|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2849334|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2849335|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2849336|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
2849337|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2849338|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2300410|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
2300411|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300412|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300413|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2300414|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300415|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300416|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300417|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2300418|NCT00293332|Bevacizumab|bevacizumab|mesh-list
2300419|NCT00293332|Carboplatin|carboplatin|mesh-list
2300420|NCT00293332|Docetaxel|docetaxel|mesh-list
2300421|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2849339|NCT03861611|Ibuprofen|ibuprofen|mesh-list
2849340|NCT03861611|Diclofenac|diclofenac|mesh-list
2849341|NCT03861611|Ketorolac|ketorolac|mesh-list
2849342|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2849343|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2849344|NCT03861611|Analgesics|analgesics|mesh-ancestor
2849345|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
2849346|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849347|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849348|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2849349|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2849350|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2849351|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849352|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849353|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
2849354|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2849355|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849356|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
2849357|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2849358|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
2849359|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300422|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300423|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2300424|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2300425|NCT00293332|Growth Substances|growth substances|mesh-ancestor
2300426|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300427|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
2300428|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
2300429|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
2300430|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
2300431|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300432|NCT00293345|Gemcitabine|gemcitabine|mesh-list
2300433|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2300434|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
2300435|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300436|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300437|NCT00293345|Antiviral Agents|antiviral agents|mesh-ancestor
2300438|NCT00293345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300439|NCT00293345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300440|NCT00293345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2300441|NCT00293345|Immunologic Factors|immunologic factors|mesh-ancestor
2300442|NCT00293345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300443|NCT00293358|Carboplatin|carboplatin|mesh-list
2300444|NCT00293358|Etoposide|etoposide|mesh-list
2300445|NCT00293358|Ifosfamide|ifosfamide|mesh-list
2300446|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
2300447|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300448|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2300449|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2300450|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2300451|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300452|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300453|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2300454|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
2300455|NCT00293371|Prednisone|prednisone|mesh-list
2300456|NCT00293371|Docetaxel|docetaxel|mesh-list
2300457|NCT00293371|Vatalanib|vatalanib|mesh-list
2300458|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300459|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
2300460|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
2300461|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
2300462|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300463|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2300464|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
2300465|NCT00293371|Hormones|hormones|mesh-ancestor
2300466|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2300467|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300468|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2300469|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2300470|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300471|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
2300472|NCT00293410|Clofarabine|clofarabine|mesh-list
2300473|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2300474|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
2849368|NCT03861299|Anesthetics|anesthetics|mesh-list
2849369|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849370|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849371|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
2849372|NCT03861403|Avelumab|avelumab|mesh-list
2849373|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2849374|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
2849375|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849376|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2849377|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2849378|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
2849379|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300475|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300476|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2849380|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849381|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2849382|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2849383|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2849384|NCT03861377|Remifentanil|remifentanil|mesh-list
2849385|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2849386|NCT03861377|Narcotics|narcotics|mesh-ancestor
2849387|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849388|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849389|NCT03861377|Analgesics|analgesics|mesh-ancestor
2849390|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
2849391|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849392|NCT03861364|Propofol|propofol|mesh-list
2849393|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2849394|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849395|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300477|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2300478|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
2300479|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300480|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300481|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2300482|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2300483|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
2300484|NCT00293436|Celecoxib|celecoxib|mesh-list
2300485|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2300486|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300487|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2300488|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300489|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300490|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2300491|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2300492|NCT00293436|Analgesics|analgesics|mesh-ancestor
2300493|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
2300494|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300495|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300496|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2300497|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2300498|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2300499|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2849396|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2849397|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
2849398|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
2849399|NCT03861052|Dulaglutide|dulaglutide|mesh-list
2849400|NCT03861052|Tirzepatide|tirzepatide|mesh-list
2849401|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2849402|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849403|NCT03861052|Incretins|incretins|mesh-ancestor
2849404|NCT03861052|Hormones|hormones|mesh-ancestor
2849405|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2849406|NCT03861039|Tirzepatide|tirzepatide|mesh-list
2849407|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2849408|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849409|NCT03861039|Incretins|incretins|mesh-ancestor
2849410|NCT03861039|Hormones|hormones|mesh-ancestor
2849411|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2849412|NCT03860870|Clenbuterol|clenbuterol|mesh-list
2849413|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2849414|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2849415|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
2849416|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849417|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849418|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849419|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2849420|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
2849421|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849422|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2849423|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
2849424|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
2849425|NCT03860597|Memantine|memantine|mesh-list
2849426|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2849427|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2849428|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
2849429|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849430|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300500|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
2849431|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849432|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2849433|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2849434|NCT03860831|Midazolam|midazolam|mesh-list
2849435|NCT03860831|Ketamine|ketamine|mesh-list
2849436|NCT03860831|Analgesics|analgesics|mesh-ancestor
2849437|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
2849438|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849439|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849440|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2849441|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2849442|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
2849443|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
2849444|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849445|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2849446|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2849447|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849448|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849449|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2849450|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2849451|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2849452|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2849453|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2849454|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
2849455|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
2849456|NCT03860662|Baclofen|baclofen|mesh-list
2849457|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2849458|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849459|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2849460|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849461|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2849462|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
2849463|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
2849464|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849465|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849466|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2849467|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2849468|NCT03860636|Estradiol|estradiol|mesh-list
2849469|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2849470|NCT03860636|Progesterone|progesterone|mesh-list
2849471|NCT03860636|Estrogens|estrogens|mesh-ancestor
2849472|NCT03860636|Hormones|hormones|mesh-ancestor
2849473|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2849474|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849475|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2849476|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
2849477|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2849478|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2849479|NCT03860636|Progestins|progestins|mesh-ancestor
2849480|NCT03860480|Bupivacaine|bupivacaine|mesh-list
2849481|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
2849482|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
2849483|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849484|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849485|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
2849486|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849487|NCT03860428|Acetaminophen|acetaminophen|mesh-list
2849488|NCT03860428|Ibuprofen|ibuprofen|mesh-list
2849489|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
2849490|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2849491|NCT03860428|Analgesics|analgesics|mesh-ancestor
2849492|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
2849493|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849494|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849495|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
2849496|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2849497|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2849498|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2849499|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849500|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849501|NCT03860233|Oxytocin|oxytocin|mesh-list
2849502|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
2849503|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2849504|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849505|NCT03860012|Folic Acid|folic acid|mesh-list
2300501|NCT00293475|Rituximab|rituximab|mesh-list
2849506|NCT03860012|Hematinics|hematinics|mesh-ancestor
2849507|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
2300502|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2300503|NCT00293475|Carboplatin|carboplatin|mesh-list
2300504|NCT00293475|Methotrexate|methotrexate|mesh-list
2300505|NCT00293475|Mannitol|mannitol|mesh-list
2849508|NCT03860012|Vitamins|vitamins|mesh-ancestor
2849509|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
2849510|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849511|NCT03860129|Sevoflurane|sevoflurane|mesh-list
2849512|NCT03860129|Desflurane|desflurane|mesh-list
2849513|NCT03860129|Isoflurane|isoflurane|mesh-list
2849514|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2849515|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2849516|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
2849517|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
2849518|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849519|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849520|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
2849521|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2849522|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2849523|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
2849524|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849525|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2849526|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2849527|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2849528|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2849529|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2849530|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849531|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2849532|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849533|NCT03860207|Antibodies|antibodies|mesh-list
2849534|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
2849535|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2849536|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
2849537|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849538|NCT03859934|Melatonin|melatonin|mesh-list
2849539|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
2849540|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849541|NCT03859934|Protective Agents|protective agents|mesh-ancestor
2849542|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849543|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2300506|NCT00293475|Antibodies|antibodies|mesh-list
2300507|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
2300508|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2300509|NCT00293475|Antidotes|antidotes|mesh-list
2300510|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
2300511|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300512|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300513|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2300514|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2300515|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
2300516|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2300517|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2300518|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
2300519|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300520|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
2300521|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300522|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2300523|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2300524|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2300525|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2300526|NCT00293475|Diuretics|diuretics|mesh-ancestor
2300527|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
2849544|NCT03859908|Ethanol|ethanol|mesh-list
2849545|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
2849546|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2849547|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2849548|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2849549|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849550|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849551|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
2849552|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
2849553|NCT03860077|Nicotine|nicotine|mesh-list
2849554|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2849555|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
2849556|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849557|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849558|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2849559|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2849560|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
2849561|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300528|NCT00293475|Protective Agents|protective agents|mesh-ancestor
2300529|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
2300530|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
2300531|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2300532|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300533|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
2300534|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
2300535|NCT00293501|Tinzaparin|tinzaparin|mesh-list
2300536|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2300537|NCT00293501|Dalteparin|dalteparin|mesh-list
2300538|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
2300539|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2300540|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2300541|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300542|NCT00293514|Thrombin|thrombin|mesh-list
2300543|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
2300544|NCT00293514|Coagulants|coagulants|mesh-ancestor
2300545|NCT00293527|Interferons|interferons|mesh-list
2300546|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
2300547|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
2300548|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849562|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849563|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
2849564|NCT03859921|Progestins|progestins|mesh-ancestor
2849565|NCT03859921|Hormones|hormones|mesh-ancestor
2849566|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2849567|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849568|NCT03859856|Hormones|hormones|mesh-list
2849569|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2849570|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849571|NCT03859583|Capsaicin|capsaicin|mesh-list
2849572|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
2849573|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
2849574|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
2849575|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849576|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849577|NCT03859869|Pancrelipase|pancrelipase|mesh-list
2849578|NCT03859869|Pancreatin|pancreatin|mesh-list
2849579|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2849580|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
2849581|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2849582|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849583|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849584|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2849585|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2849586|NCT03859570|Protective Agents|protective agents|mesh-ancestor
2849587|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300549|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
2300550|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300551|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
2300552|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300553|NCT00293592|Dexamethasone|dexamethasone|mesh-list
2300554|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2300555|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
2300556|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
2849588|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
2849589|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2849590|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
2849591|NCT03859687|Vitamins|vitamins|mesh-list
2849592|NCT03859687|Vitamin A|vitamin a|mesh-list
2849593|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
2849594|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
2849595|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849596|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
2849597|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849598|NCT03859687|Protective Agents|protective agents|mesh-ancestor
2849599|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2849600|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300557|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300558|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300559|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2300560|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
2300561|NCT00293592|Hormones|hormones|mesh-ancestor
2300562|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2300563|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2300564|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300565|NCT00293631|Ketorolac|ketorolac|mesh-list
2300566|NCT00293631|Lornoxicam|lornoxicam|mesh-list
2300567|NCT00293631|Piroxicam|piroxicam|mesh-list
2849601|NCT03859635|Bupivacaine|bupivacaine|mesh-list
2849602|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
2849603|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
2849604|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849605|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849606|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
2300568|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2300569|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2300570|NCT00293631|Analgesics|analgesics|mesh-ancestor
2849607|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849608|NCT03859362|Ertapenem|ertapenem|mesh-list
2849609|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2849610|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2849611|NCT03859375|Disinfectants|disinfectants|mesh-list
2849612|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2849613|NCT03859141|Vaccines|vaccines|mesh-list
2849614|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
2849615|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849616|NCT03859024|Acetaminophen|acetaminophen|mesh-list
2849617|NCT03859024|Dexamethasone|dexamethasone|mesh-list
2849618|NCT03859024|Ibuprofen|ibuprofen|mesh-list
2849619|NCT03859024|Celecoxib|celecoxib|mesh-list
2849620|NCT03859024|Oxycodone|oxycodone|mesh-list
2849621|NCT03859024|Gabapentin|gabapentin|mesh-list
2849622|NCT03859024|Bupivacaine|bupivacaine|mesh-list
2849623|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2849624|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
2849625|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
2849626|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849627|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849628|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2849629|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
2849630|NCT03859024|Hormones|hormones|mesh-ancestor
2849631|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2849632|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2849633|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849634|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
2849635|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
2849636|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849637|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
2849638|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2849639|NCT03859024|Analgesics|analgesics|mesh-ancestor
2849640|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
2849641|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2300571|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
2300572|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849642|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2849643|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2849644|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300573|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300574|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2300575|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2300576|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2300577|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300578|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300579|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
2300580|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
2300581|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
2849645|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849646|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2849647|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2849648|NCT03859024|Narcotics|narcotics|mesh-ancestor
2849649|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
2849650|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2849651|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2849652|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2849653|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2849654|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2849655|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849656|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
2849657|NCT03859102|Acetaminophen|acetaminophen|mesh-list
2849658|NCT03859102|Dexamethasone|dexamethasone|mesh-list
2849659|NCT03859102|Gabapentin|gabapentin|mesh-list
2849660|NCT03859102|Ondansetron|ondansetron|mesh-list
2849661|NCT03859102|Anesthetics|anesthetics|mesh-list
2849662|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
2849663|NCT03859102|Lansoprazole|lansoprazole|mesh-list
2849664|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
2849665|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2849666|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
2849667|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
2849668|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849669|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849670|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2849671|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
2849672|NCT03859102|Hormones|hormones|mesh-ancestor
2849673|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2300582|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300583|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300584|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2300585|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2300586|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
2300587|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
2300588|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300589|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300590|NCT00293657|Lornoxicam|lornoxicam|mesh-list
2300591|NCT00293657|Piroxicam|piroxicam|mesh-list
2300592|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2300593|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2300594|NCT00293657|Analgesics|analgesics|mesh-ancestor
2849674|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2849675|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849676|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2849677|NCT03859102|Analgesics|analgesics|mesh-ancestor
2849678|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
2849679|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
2849680|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849681|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
2849682|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2849683|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2849684|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2849685|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2849686|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2849687|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849688|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849689|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
2849690|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
2849691|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
2849692|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2849693|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
2849694|NCT03859102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2849695|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2849696|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2849697|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849698|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
2849699|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2107884|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2300595|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
2300596|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300597|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300598|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2300599|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2300600|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2300601|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300602|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300603|NCT00293670|Goserelin|goserelin|mesh-list
2300604|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2300605|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300606|NCT00293696|Goserelin|goserelin|mesh-list
2300607|NCT00293696|Bicalutamide|bicalutamide|mesh-list
2300608|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2300609|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300610|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
2300611|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
2300612|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2300613|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300614|NCT00293735|Labetalol|labetalol|mesh-list
2300615|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2300616|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2300617|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
2300618|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300619|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300620|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300621|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2300622|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
2300623|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
2300624|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300625|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2300626|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2300627|NCT00293761|Travoprost|travoprost|mesh-list
2300628|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2300629|NCT00293787|Timolol|timolol|mesh-list
2300630|NCT00293787|Travoprost|travoprost|mesh-list
2300631|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2300632|NCT00293787|Latanoprost|latanoprost|mesh-list
2300633|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2300634|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2300635|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2300636|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
2300637|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300638|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300639|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300640|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2300641|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2300642|NCT00293800|Timolol|timolol|mesh-list
2300643|NCT00293800|Travoprost|travoprost|mesh-list
2849700|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
2849701|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849702|NCT03858972|Capecitabine|capecitabine|mesh-list
2849703|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2849704|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
2849705|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849706|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849707|NCT03858621|Fentanyl|fentanyl|mesh-list
2849708|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2849709|NCT03858621|Narcotics|narcotics|mesh-ancestor
2849710|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107885|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2107886|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107887|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107888|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2107889|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2107890|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
2107891|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107892|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107893|NCT02495103|Metformin|metformin|mesh-list
2107894|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2107895|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107896|NCT02495168|Budesonide|budesonide|mesh-list
2107897|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
2849711|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849712|NCT03858621|Analgesics|analgesics|mesh-ancestor
2849713|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
2849714|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849715|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2849716|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2849717|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
2849718|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
2849719|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
2849720|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2849721|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849722|NCT03858465|Phenylephrine|phenylephrine|mesh-list
2849723|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
2849724|NCT03858465|Ephedrine|ephedrine|mesh-list
2849725|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2849726|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
2849727|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
2849728|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849729|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849730|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
2849731|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2849732|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
2849733|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
2849734|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2849735|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2849736|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2849737|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
2849738|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849739|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849740|NCT03858465|Protective Agents|protective agents|mesh-ancestor
2849741|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2849742|NCT03858491|Cobicistat|cobicistat|mesh-list
2849743|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2849744|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2849745|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
2849746|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2849747|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2849748|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2849749|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849750|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300644|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2300645|NCT00293800|Latanoprost|latanoprost|mesh-list
2300646|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2300647|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2300648|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2300649|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
2300650|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300651|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300652|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300653|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2300654|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2300655|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2300656|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
2300657|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300658|NCT00293839|Oxybutynin|oxybutynin|mesh-list
2300659|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
2300660|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
2300661|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300662|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300663|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2300664|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2300665|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
2300666|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300667|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300668|NCT00293839|Urological Agents|urological agents|mesh-ancestor
2300669|NCT00293891|Tacrolimus|tacrolimus|mesh-list
2300670|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2300671|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
2849767|NCT03858387|Meropenem|meropenem|mesh-list
2849768|NCT03858387|Imipenem|imipenem|mesh-list
2849769|NCT03858387|Cilastatin|cilastatin|mesh-list
2849770|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2849771|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300672|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300673|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2300674|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300675|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300676|NCT00293917|Tacrolimus|tacrolimus|mesh-list
2300677|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2300678|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
2300679|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300680|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2300681|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300682|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849772|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
2849773|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849774|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300683|NCT00293930|Tacrolimus|tacrolimus|mesh-list
2300684|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2300685|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
2300686|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300687|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2300688|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300689|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300690|NCT00293969|Morphine|morphine|mesh-list
2300691|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2300692|NCT00293969|Narcotics|narcotics|mesh-ancestor
2849775|NCT03858231|Acetaminophen|acetaminophen|mesh-list
2849776|NCT03858231|Ibuprofen|ibuprofen|mesh-list
2849777|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2849778|NCT03858231|Analgesics|analgesics|mesh-ancestor
2849779|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
2849780|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849781|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849782|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
2849783|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2849784|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2849785|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2849786|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2849787|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849788|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849789|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2849790|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2849791|NCT03858270|Memantine|memantine|mesh-list
2849792|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2849793|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2849794|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
2849795|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849796|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849797|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849798|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2849799|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2849800|NCT03858062|Insulin|insulin|mesh-list
2849801|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2849802|NCT03858062|Pancrelipase|pancrelipase|mesh-list
2849803|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2849804|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849805|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2849806|NCT03857854|Pirfenidone|pirfenidone|mesh-list
2849807|NCT03857854|Analgesics|analgesics|mesh-ancestor
2849808|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
2849809|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849810|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300693|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2300694|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300695|NCT00293969|Analgesics|analgesics|mesh-ancestor
2300696|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
2300697|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300698|NCT00294008|Risperidone|risperidone|mesh-list
2300699|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2300700|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
2300701|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300702|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300703|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300704|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2300705|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2300706|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2300707|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2300708|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2849811|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2849812|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2849813|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2849814|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2849815|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849816|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2849817|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849818|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849819|NCT03857399|Caspofungin|caspofungin|mesh-list
2849820|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
2849821|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2849822|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849823|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849824|NCT03857711|Amiodarone|amiodarone|mesh-list
2849825|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2300709|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
2300710|NCT00294086|Valsartan|valsartan|mesh-list
2300711|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2300712|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2300713|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2107898|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2107899|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2107900|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2107901|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
2107902|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107903|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107904|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2107905|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
2107906|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
2107907|NCT02495168|Hormones|hormones|mesh-ancestor
2107908|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2107909|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2107910|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2107911|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2107912|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
2107913|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107914|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107915|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2107916|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107917|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2107918|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300714|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300715|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2849826|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
2849827|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2849828|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2849829|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849830|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2849831|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2849832|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2849833|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849834|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2849835|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2849836|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2849837|NCT03857646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2849838|NCT03857646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2849839|NCT03857646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2849840|NCT03857646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2849841|NCT03857763|Paclitaxel|paclitaxel|mesh-list
2849842|NCT03857763|Apatinib|apatinib|mesh-list
2849843|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2849844|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849845|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
2849846|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
2849847|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
2849848|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849849|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2300716|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2300717|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
2300718|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300719|NCT00294099|Antacids|antacids|mesh-ancestor
2300720|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300721|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2300722|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
2300723|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2300724|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
2300725|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300726|NCT00294164|Hormones|hormones|mesh-list
2300727|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2300728|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300729|NCT00294190|Topotecan|topotecan|mesh-list
2300730|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2300731|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2300732|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300733|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300734|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300735|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
2300736|NCT00294203|Hematinics|hematinics|mesh-ancestor
2300737|NCT00294255|Risperidone|risperidone|mesh-list
2300738|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2300739|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
2300740|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849850|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849851|NCT03857386|Anesthetics|anesthetics|mesh-list
2849852|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849853|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849854|NCT03857321|Insulin|insulin|mesh-list
2849855|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2849856|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
2849857|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2849858|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849859|NCT03857815|Antibodies|antibodies|mesh-list
2849860|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
2849861|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849862|NCT03857581|Olanzapine|olanzapine|mesh-list
2849863|NCT03857581|Clozapine|clozapine|mesh-list
2300741|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300742|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300743|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2300744|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2300745|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2300746|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2300747|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2300748|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
2300749|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2300750|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
2300751|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300752|NCT00294320|Imiquimod|imiquimod|mesh-list
2849864|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
2849865|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
2849866|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849867|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849868|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2849869|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2849870|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2849871|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849872|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2849873|NCT03857581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2849874|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2849875|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2849876|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849877|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300753|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2300754|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
2300755|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300756|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300757|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
2300758|NCT00294359|Bevacizumab|bevacizumab|mesh-list
2300759|NCT00294359|Capecitabine|capecitabine|mesh-list
2300760|NCT00294359|Mitomycins|mitomycins|mesh-list
2300761|NCT00294359|Mitomycin|mitomycin|mesh-list
2300762|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2300763|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300764|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2300765|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2300766|NCT00294359|Growth Substances|growth substances|mesh-ancestor
2300767|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849878|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
2849879|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2849880|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
2849881|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
2849882|NCT03857334|Cortivazol|cortivazol|mesh-list
2849883|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2849884|NCT03857139|Nicotine|nicotine|mesh-list
2849885|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2849886|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
2849887|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849888|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849889|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2849890|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2300768|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
2300769|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2300770|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
2300771|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849891|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
2849892|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849893|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849894|NCT03856853|Pirfenidone|pirfenidone|mesh-list
2849895|NCT03856853|Analgesics|analgesics|mesh-ancestor
2300772|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2300773|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
2300774|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2300775|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300776|NCT00294385|Gemcitabine|gemcitabine|mesh-list
2300777|NCT00294385|Docetaxel|docetaxel|mesh-list
2300778|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2300779|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
2300780|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300781|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849896|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
2849897|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849898|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849899|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2300782|NCT00294385|Antiviral Agents|antiviral agents|mesh-ancestor
2300783|NCT00294385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300784|NCT00294385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300785|NCT00294385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2300786|NCT00294385|Immunologic Factors|immunologic factors|mesh-ancestor
2300787|NCT00294385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300788|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
2300789|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
2300790|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
2300791|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
2300792|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2300793|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300794|NCT00294463|Tibolone|tibolone|mesh-list
2300795|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2300796|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2300797|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2300798|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
2300799|NCT00294463|Estradiol|estradiol|mesh-list
2300800|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2300801|NCT00294463|Progesterone|progesterone|mesh-list
2300802|NCT00294463|Estrogens|estrogens|mesh-ancestor
2300803|NCT00294463|Hormones|hormones|mesh-ancestor
2300804|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2300805|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300806|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2300807|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
2300808|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2300809|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2849900|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2849901|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2849902|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2849903|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849904|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
2849905|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
2849906|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2849907|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2849908|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2849909|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849910|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849911|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2849912|NCT03856970|Glyburide|glyburide|mesh-list
2849913|NCT03856970|Digoxin|digoxin|mesh-list
2849914|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2849915|NCT03856970|Norethindrone|norethindrone|mesh-list
2849916|NCT03856970|Estradiol|estradiol|mesh-list
2849917|NCT03856970|Estrogens|estrogens|mesh-ancestor
2849918|NCT03856970|Hormones|hormones|mesh-ancestor
2849919|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2849920|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849921|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2849922|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
2849923|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2849924|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2849925|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2849926|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2849927|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2849928|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2849929|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849930|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300810|NCT00294463|Progestins|progestins|mesh-ancestor
2300811|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
2849931|NCT03856970|Protective Agents|protective agents|mesh-ancestor
2849932|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2849933|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2849934|NCT03856658|Floxuridine|floxuridine|mesh-list
2849935|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2849936|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
2849937|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849938|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300812|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
2300813|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2300814|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2300815|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849939|NCT03856437|Vaccines|vaccines|mesh-list
2849940|NCT03856437|Immunologic Factors|immunologic factors|mesh-ancestor
2849941|NCT03856437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300816|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2300817|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
2300818|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2300819|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2300820|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2300821|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2300822|NCT00294502|Minocycline|minocycline|mesh-list
2300823|NCT00294502|Gentamicins|gentamicins|mesh-list
2107919|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107920|NCT02495389|Mirabegron|mirabegron|mesh-list
2107921|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2107922|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2107923|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2107924|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
2107925|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107926|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107927|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107928|NCT02495389|Urological Agents|urological agents|mesh-ancestor
2107929|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
2849942|NCT03856515|Nicotine|nicotine|mesh-list
2849943|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2849944|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
2849945|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849946|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849947|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2849948|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2849949|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
2849950|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2849951|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849952|NCT03856671|Metronidazole|metronidazole|mesh-list
2849953|NCT03856671|Neomycin|neomycin|mesh-list
2849954|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2849955|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2849956|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2849957|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2849958|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2849959|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849960|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849961|NCT03856632|Liraglutide|liraglutide|mesh-list
2300824|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300825|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2300826|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300827|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2300828|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300829|NCT00294567|Amlodipine|amlodipine|mesh-list
2300830|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
2300831|NCT00294567|Calcium|calcium|mesh-list
2300832|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2300833|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300834|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2300835|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2300836|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300837|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
2300838|NCT00294580|Maloprim|maloprim|mesh-list
2300839|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
2300840|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2300841|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2300842|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300843|NCT00294593|Leucovorin|leucovorin|mesh-list
2300844|NCT00294593|Folic Acid|folic acid|mesh-list
2300845|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
2300846|NCT00294593|Antidotes|antidotes|mesh-ancestor
2300847|NCT00294593|Protective Agents|protective agents|mesh-ancestor
2300848|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300849|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
2300850|NCT00294593|Vitamins|vitamins|mesh-ancestor
2300851|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
2300852|NCT00294593|Hematinics|hematinics|mesh-ancestor
2300853|NCT00294606|Phenylephrine|phenylephrine|mesh-list
2300854|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
2300855|NCT00294606|Norepinephrine|norepinephrine|mesh-list
2300856|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2300857|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
2300858|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
2300859|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849962|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2849963|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2849964|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2849965|NCT03856632|Incretins|incretins|mesh-ancestor
2849966|NCT03856632|Hormones|hormones|mesh-ancestor
2849967|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2849968|NCT03856697|Gefitinib|gefitinib|mesh-list
2300860|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300861|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
2300862|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2300863|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
2300864|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
2300865|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2300866|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2300867|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2300868|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
2300869|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300870|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300871|NCT00294606|Protective Agents|protective agents|mesh-ancestor
2300872|NCT00294619|Hormones|hormones|mesh-list
2300873|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2849969|NCT03856697|Maleic acid|maleic acid|mesh-list
2849970|NCT03856697|Abivertinib|abivertinib|mesh-list
2849971|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849972|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300874|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300875|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2300876|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300877|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2300878|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300879|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300880|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
2300881|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2300882|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300883|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2300884|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2300885|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849973|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849974|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2849975|NCT03856502|Dexamethasone|dexamethasone|mesh-list
2849976|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
2849977|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
2849978|NCT03856502|BB 1101|bb 1101|mesh-list
2849979|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2849980|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
2849981|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
2849982|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2849983|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300886|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300887|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300888|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2300889|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2300890|NCT00294775|Candesartan|candesartan|mesh-list
2300891|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2300892|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2300893|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2300894|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300895|NCT00294853|Calcium|calcium|mesh-list
2300896|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2300897|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300898|NCT00294892|Nevirapine|nevirapine|mesh-list
2300899|NCT00294892|Carbamazepine|carbamazepine|mesh-list
2300900|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2300901|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2300902|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300903|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849984|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2849985|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
2849986|NCT03856502|Hormones|hormones|mesh-ancestor
2849987|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2849988|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2849989|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2849990|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
2849991|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2849992|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2849993|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
2849994|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
2849995|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2849996|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
2849997|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
2849998|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
2849999|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2850000|NCT03856216|Rituximab|rituximab|mesh-list
2300904|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
2300905|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300906|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2300907|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2300908|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2300909|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2300910|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
2300911|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
2300912|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2850001|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2850002|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2850003|NCT03856216|Methotrexate|methotrexate|mesh-list
2850004|NCT03856216|Fludarabine|fludarabine|mesh-list
2850005|NCT03856216|Melphalan|melphalan|mesh-list
2850006|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2850007|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
2850008|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2850009|NCT03856216|Antibodies|antibodies|mesh-list
2850010|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
2850011|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2850012|NCT03856216|Lenograstim|lenograstim|mesh-list
2850013|NCT03856216|Tacrolimus|tacrolimus|mesh-list
2850014|NCT03856216|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2850015|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
2850016|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850017|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850018|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2850019|NCT03856216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2850020|NCT03856216|Abortifacient Agents|abortifacient agents|mesh-ancestor
2850021|NCT03856216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2850022|NCT03856216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2850023|NCT03856216|Antimetabolites|antimetabolites|mesh-ancestor
2850024|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850025|NCT03856216|Dermatologic Agents|dermatologic agents|mesh-ancestor
2300913|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2300914|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300915|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2300916|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2300917|NCT00294892|Analgesics|analgesics|mesh-ancestor
2850026|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850027|NCT03856216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2850028|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2850029|NCT03856216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2850030|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2850031|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2850032|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2850033|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
2850034|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2300918|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
2300919|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300920|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2850035|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2850036|NCT03856242|Tamsulosin|tamsulosin|mesh-list
2850037|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2850038|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2300921|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2300922|NCT00294918|Hormones|hormones|mesh-list
2300923|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2300924|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300925|NCT00294931|Bevacizumab|bevacizumab|mesh-list
2300926|NCT00294931|Carboplatin|carboplatin|mesh-list
2300927|NCT00294931|Irinotecan|irinotecan|mesh-list
2300928|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2850039|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2850040|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
2850041|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2850042|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850043|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850044|NCT03856242|Urological Agents|urological agents|mesh-ancestor
2850045|NCT03856112|Dexamethasone|dexamethasone|mesh-list
2850046|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
2850047|NCT03856112|Venetoclax|venetoclax|mesh-list
2850048|NCT03856112|Ixazomib|ixazomib|mesh-list
2850049|NCT03856112|Ichthammol|ichthammol|mesh-list
2850050|NCT03856112|BB 1101|bb 1101|mesh-list
2850051|NCT03856112|Glycine|glycine|mesh-list
2850052|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2850053|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
2850054|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
2850055|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850056|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850057|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2850058|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
2850059|NCT03856112|Hormones|hormones|mesh-ancestor
2850060|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2850061|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2850062|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850063|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850064|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
2850065|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300929|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300930|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2300931|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2300932|NCT00294931|Growth Substances|growth substances|mesh-ancestor
2300933|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300934|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
2300935|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2300936|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2300937|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300938|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300939|NCT00294944|Idazoxan|idazoxan|mesh-list
2300940|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2300941|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2300942|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2850066|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
2850067|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2850068|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
2850069|NCT03855865|Vortioxetine|vortioxetine|mesh-list
2850070|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
2850071|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2850072|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2850073|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2850074|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2300943|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
2300944|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2300945|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300946|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300947|NCT00294996|Doxorubicin|doxorubicin|mesh-list
2300948|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2300949|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300950|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2300951|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2300952|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300953|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300954|NCT00295035|Celecoxib|celecoxib|mesh-list
2300955|NCT00295035|Curcumin|curcumin|mesh-list
2300956|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2300957|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2300958|NCT00295035|Analgesics|analgesics|mesh-ancestor
2300959|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
2300960|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2300961|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850075|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850076|NCT03855865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2850077|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2850078|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2850079|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850080|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2850081|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
2850082|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2850083|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2850084|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2850085|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2850086|NCT03855826|Amiodarone|amiodarone|mesh-list
2850087|NCT03855826|Nifekalant|nifekalant|mesh-list
2850088|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2850089|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
2850090|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2850091|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2850092|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850093|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2850094|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2850095|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2850096|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850097|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2850098|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2850099|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2850100|NCT03855501|Calcium|calcium|mesh-list
2850101|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2850102|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850103|NCT03855579|Simendan|simendan|mesh-list
2850104|NCT03855579|Milrinone|milrinone|mesh-list
2850105|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2850106|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
2850107|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2850108|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2850109|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850110|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850111|NCT03855579|Protective Agents|protective agents|mesh-ancestor
2850112|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850113|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2850114|NCT03855423|Tocotrienols|tocotrienols|mesh-list
2850115|NCT03855423|Vitamin E|vitamin e|mesh-list
2850116|NCT03855423|Tocopherols|tocopherols|mesh-list
2850117|NCT03855423|Tocovid|tocovid|mesh-list
2850118|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
2850119|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850120|NCT03855423|Protective Agents|protective agents|mesh-ancestor
2850121|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850122|NCT03855423|Vitamins|vitamins|mesh-ancestor
2850123|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
2850124|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
2850125|NCT03855527|Fluorides|fluorides|mesh-list
2850126|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
2850127|NCT03855527|Protective Agents|protective agents|mesh-ancestor
2850128|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850129|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2850130|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2850131|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
2850132|NCT03855306|Glyburide|glyburide|mesh-list
2850133|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2850134|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850135|NCT03855384|Cisplatin|cisplatin|mesh-list
2850136|NCT03855384|Carboplatin|carboplatin|mesh-list
2850137|NCT03855384|Fluorouracil|fluorouracil|mesh-list
2850138|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850139|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
2850140|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300962|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2300963|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2300964|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2850141|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2850142|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2850143|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
2850144|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850145|NCT03855332|Cilostazol|cilostazol|mesh-list
2850146|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
2850147|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
2850148|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2850149|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2850150|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850151|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850152|NCT03855332|Urological Agents|urological agents|mesh-ancestor
2850153|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2850154|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
2850155|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850156|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850157|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2850158|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
2850159|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2850160|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2850161|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2850162|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2850163|NCT03855332|Protective Agents|protective agents|mesh-ancestor
2850164|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2850165|NCT03855267|Propofol|propofol|mesh-list
2850166|NCT03855267|Etomidate|etomidate|mesh-list
2850167|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2850168|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850169|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850170|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2850171|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
2850172|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
2850173|NCT03855371|Decitabine|decitabine|mesh-list
2850174|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
2850175|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2850176|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
2850177|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850178|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300965|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2300966|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2300967|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300968|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300969|NCT00295100|Tamoxifen|tamoxifen|mesh-list
2300970|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2300971|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
2300972|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2300973|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300974|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2300975|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300976|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2300977|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2300978|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2300979|NCT00295165|Sargramostim|sargramostim|mesh-list
2300980|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
2300981|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300982|NCT00295178|Vancomycin|vancomycin|mesh-list
2300983|NCT00295178|Daptomycin|daptomycin|mesh-list
2300984|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2300985|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2850179|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850189|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
2850190|NCT03855007|Prednisone|prednisone|mesh-list
2850191|NCT03855007|Methotrexate|methotrexate|mesh-list
2850192|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2850193|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
2850194|NCT03855007|Hormones|hormones|mesh-ancestor
2850195|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2850196|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850197|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2850198|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850199|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2850200|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
2850201|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2850202|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2850203|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
2850204|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850205|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
2850206|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850207|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2850208|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2850209|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
2850210|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2850211|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2850212|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
2850213|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2850214|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2850215|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2300986|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
2300987|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2300988|NCT00295243|Topotecan|topotecan|mesh-list
2300989|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2300990|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2850228|NCT03854799|Capecitabine|capecitabine|mesh-list
2850229|NCT03854799|Avelumab|avelumab|mesh-list
2850230|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2850231|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
2850232|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850233|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850234|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2850235|NCT03854929|Azithromycin|azithromycin|mesh-list
2850236|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
2850237|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2850238|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2850239|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2850240|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2850241|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850242|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850243|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850244|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2850245|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2850246|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
2850247|NCT03854812|Fentanyl|fentanyl|mesh-list
2850248|NCT03854812|Propofol|propofol|mesh-list
2850249|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2850250|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850251|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850252|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2850253|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
2850254|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
2850255|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2850256|NCT03854812|Narcotics|narcotics|mesh-ancestor
2850257|NCT03854812|Analgesics|analgesics|mesh-ancestor
2850258|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
2850259|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850260|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2850261|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2850262|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
2850263|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2850264|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2850265|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850266|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2850267|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
2850268|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2850269|NCT03854942|Naltrexone|naltrexone|mesh-list
2850270|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2850271|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2850272|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850273|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
2850274|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850275|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
2850276|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2850277|NCT03854708|Hormones|hormones|mesh-ancestor
2850278|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2850279|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850280|NCT03854383|Isosorbide|isosorbide|mesh-list
2850281|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2850282|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2850283|NCT03854383|Misoprostol|misoprostol|mesh-list
2850284|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2300991|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850285|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
2850286|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2850287|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850288|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2850289|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2850290|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
2850291|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2850292|NCT03854383|Diuretics|diuretics|mesh-ancestor
2850293|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
2850294|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
2850295|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2850296|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850297|NCT03854617|Vinorelbine|vinorelbine|mesh-list
2850298|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2850299|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850300|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
2850301|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
2850302|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
2850303|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850304|NCT03854409|Aripiprazole|aripiprazole|mesh-list
2850305|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
2850306|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2850307|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2850308|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2850309|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850310|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300992|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2300993|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2300994|NCT00295282|Antibodies|antibodies|mesh-list
2300995|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2300996|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
2300997|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2300998|NCT00295308|Clonidine|clonidine|mesh-list
2300999|NCT00295308|Analgesics|analgesics|mesh-ancestor
2301000|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
2850311|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
2850312|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
2850313|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2850314|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850315|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2850316|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2850317|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
2850318|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2850319|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2850320|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2850321|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2850322|NCT03854344|Lidocaine|lidocaine|mesh-list
2850323|NCT03854344|Bupivacaine|bupivacaine|mesh-list
2850324|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
2850325|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
2850326|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850327|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850328|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
2850329|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850330|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2850331|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2850332|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2850333|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2850334|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850335|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2850336|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2850337|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
2850338|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850339|NCT03854266|Heparin|heparin|mesh-list
2850340|NCT03854266|Calcium heparin|calcium heparin|mesh-list
2850341|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2850342|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
2850343|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2850344|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2850345|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850357|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
2850358|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2850359|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2850360|NCT03854175|Estradiol|estradiol|mesh-list
2850361|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2850362|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850363|NCT03854175|Estrogens|estrogens|mesh-ancestor
2850364|NCT03854175|Hormones|hormones|mesh-ancestor
2850365|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2850366|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850367|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2850368|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
2850369|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2850370|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2850371|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
2850372|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2850373|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2850374|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850375|NCT03854175|Urological Agents|urological agents|mesh-ancestor
2850376|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
2850377|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2850378|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
2850379|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
2850380|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850381|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850382|NCT03853993|Vaccines|vaccines|mesh-list
2850383|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
2850384|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850385|NCT03854019|Quinidine|quinidine|mesh-list
2850386|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
2850387|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
2850388|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
2850389|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2850390|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2850391|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2850392|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850393|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850394|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2850395|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2850396|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
2850397|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2850398|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
2850399|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2850400|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2850401|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2850402|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850403|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2850404|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2850405|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
2850406|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2850407|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2850408|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2850409|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2850410|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2850411|NCT03853785|Podophyllin|podophyllin|mesh-list
2301001|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301002|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301003|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2301004|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
2301005|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
2301006|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2301007|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2301008|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2850412|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2850413|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850414|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
2850415|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2850416|NCT03853707|Paclitaxel|paclitaxel|mesh-list
2850417|NCT03853707|Carboplatin|carboplatin|mesh-list
2301009|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
2301010|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301011|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301012|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
2301013|NCT00295347|Spironolactone|spironolactone|mesh-list
2301014|NCT00295347|Citalopram|citalopram|mesh-list
2301015|NCT00295347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2301016|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2850418|NCT03853707|Capecitabine|capecitabine|mesh-list
2850419|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2850420|NCT03853707|Atezolizumab|atezolizumab|mesh-list
2850421|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2850422|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2850423|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850424|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
2850425|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
2850426|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
2850427|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850428|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2850429|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
2850430|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
2301017|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2301018|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301019|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301020|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
2301021|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850431|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850432|NCT03853525|Petrolatum|petrolatum|mesh-list
2850433|NCT03853525|Emollients|emollients|mesh-ancestor
2850434|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
2850435|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
2850436|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
2850437|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850438|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
2850439|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2850440|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
2850441|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850442|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850443|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2850444|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
2850445|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2850446|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
2850447|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850448|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2850449|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2850450|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
2850451|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
2850452|NCT03853642|Protective Agents|protective agents|mesh-ancestor
2850453|NCT03853538|Petrolatum|petrolatum|mesh-list
2850454|NCT03853538|Emollients|emollients|mesh-ancestor
2301022|NCT00295347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2301023|NCT00295347|Antidepressive Agents|antidepressive agents|mesh-ancestor
2301024|NCT00295347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301025|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2301026|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
2301027|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2301028|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2301029|NCT00295347|Diuretics|diuretics|mesh-ancestor
2301030|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
2301031|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2301032|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2301033|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2301034|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2301035|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
2301036|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301037|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2301038|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2301039|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301040|NCT00295386|Zopiclone|zopiclone|mesh-list
2301041|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2301042|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2301043|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850455|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
2850456|NCT03853694|Morphine|morphine|mesh-list
2850457|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2850458|NCT03853694|Narcotics|narcotics|mesh-ancestor
2850459|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850460|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850461|NCT03853694|Analgesics|analgesics|mesh-ancestor
2850462|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
2850463|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850464|NCT03853304|Folic Acid|folic acid|mesh-list
2850465|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
2850466|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
2850467|NCT03853304|Vitamins|vitamins|mesh-ancestor
2850468|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
2301044|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2301045|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
2301046|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301047|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2301048|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2301049|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2301050|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301051|NCT00295425|Cyclosporine|cyclosporine|mesh-list
2301052|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
2850469|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850470|NCT03853304|Hematinics|hematinics|mesh-ancestor
2850471|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
2850472|NCT03853512|Petrolatum|petrolatum|mesh-list
2850473|NCT03853512|Emollients|emollients|mesh-ancestor
2850474|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
2301053|NCT00295425|Cyclosporins|cyclosporins|mesh-list
2301054|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301055|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301056|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301057|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
2301058|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301059|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
2301060|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301061|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
2301062|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2301063|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2301064|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2301065|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301066|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2301067|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
2301068|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2301069|NCT00295464|Betamethasone|betamethasone|mesh-list
2301070|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2301071|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
2850475|NCT03853369|Nifekalant|nifekalant|mesh-list
2850476|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2850477|NCT03853395|Antibodies|antibodies|mesh-list
2850478|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
2850479|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850480|NCT03853330|Bupivacaine|bupivacaine|mesh-list
2850481|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
2850482|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
2850483|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850484|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850485|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
2850486|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850490|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
2850491|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2850492|NCT03853200|Acetic Acid|acetic acid|mesh-list
2850493|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
2850494|NCT03853200|Edetic Acid|edetic acid|mesh-list
2850495|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
2850496|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2850497|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2850498|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
2850499|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
2850500|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
2850501|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2850502|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
2850503|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
2850504|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850505|NCT03853200|Antidotes|antidotes|mesh-ancestor
2850506|NCT03853200|Protective Agents|protective agents|mesh-ancestor
2850507|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850508|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2850509|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2850510|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
2850511|NCT03853096|Cefazolin|cefazolin|mesh-list
2850512|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2850513|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2850514|NCT03852979|Paclitaxel|paclitaxel|mesh-list
2850515|NCT03852979|Carboplatin|carboplatin|mesh-list
2850516|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2850517|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850518|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
2850519|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
2850520|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
2850521|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850522|NCT03852992|Minoxidil|minoxidil|mesh-list
2850523|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2850524|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
2850525|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
2850526|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2850527|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
2850528|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850529|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
2850530|NCT03852914|Protective Agents|protective agents|mesh-ancestor
2850531|NCT03853044|Prednisone|prednisone|mesh-list
2850532|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
2850533|NCT03853044|Doxorubicin|doxorubicin|mesh-list
2850534|NCT03853044|Vincristine|vincristine|mesh-list
2850535|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2850536|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
2850537|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850538|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2850539|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2850540|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
2850541|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850542|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850543|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2850544|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2850545|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2850546|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2850547|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850548|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2850549|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
2850550|NCT03853044|Hormones|hormones|mesh-ancestor
2850551|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2850552|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2850553|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2850554|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
2850555|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
2850556|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
2850557|NCT03852797|Ketamine|ketamine|mesh-list
2850558|NCT03852797|Propofol|propofol|mesh-list
2850559|NCT03852797|Etomidate|etomidate|mesh-list
2850560|NCT03852797|Oxytocin|oxytocin|mesh-list
2850561|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2850562|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850563|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850564|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2850565|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
2850566|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
2301072|NCT00295464|Hormones|hormones|mesh-ancestor
2301073|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2301074|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301075|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2301076|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
2301077|NCT00295542|Atenolol|atenolol|mesh-list
2301078|NCT00295542|Valsartan|valsartan|mesh-list
2301079|NCT00295542|Telmisartan|telmisartan|mesh-list
2301080|NCT00295542|Carvedilol|carvedilol|mesh-list
2301081|NCT00295542|Olmesartan|olmesartan|mesh-list
2301082|NCT00295542|Enalapril|enalapril|mesh-list
2301083|NCT00295542|Lisinopril|lisinopril|mesh-list
2301084|NCT00295542|Nebivolol|nebivolol|mesh-list
2301085|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
2301086|NCT00295542|Doxazosin|doxazosin|mesh-list
2850567|NCT03852797|Analgesics|analgesics|mesh-ancestor
2850568|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
2850569|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850570|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2850571|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2850572|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2850573|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2850574|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850575|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
2850576|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2850577|NCT03852628|Naltrexone|naltrexone|mesh-list
2850578|NCT03852628|Buprenorphine|buprenorphine|mesh-list
2850579|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2850580|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2850581|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850582|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
2850583|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850584|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2301087|NCT00295542|Indapamide|indapamide|mesh-list
2301088|NCT00295542|Quinapril|quinapril|mesh-list
2301089|NCT00295542|Torsemide|torsemide|mesh-list
2301090|NCT00295542|Spirapril|spirapril|mesh-list
2301091|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2301092|NCT00295542|Diuretics|diuretics|mesh-list
2301093|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2301094|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2301095|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301096|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2301097|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
2301098|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301099|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301100|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
2301101|NCT00295542|Protective Agents|protective agents|mesh-ancestor
2301102|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2301103|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2301104|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2850585|NCT03852628|Narcotics|narcotics|mesh-ancestor
2850586|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850587|NCT03852628|Analgesics|analgesics|mesh-ancestor
2301105|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
2301106|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2850600|NCT03852303|Ivermectin|ivermectin|mesh-list
2850601|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
2850602|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2850603|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2850604|NCT03852602|Analgesics|analgesics|mesh-list
2850605|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
2850606|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850607|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850608|NCT03852446|Tryptophan|tryptophan|mesh-list
2850609|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2107930|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2107931|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2107932|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
2107933|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
2301107|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2301108|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2301109|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
2301110|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301111|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2301112|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
2301113|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2301114|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
2301115|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
2301116|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301117|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2301118|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2301119|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2301120|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2301121|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2850610|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
2850611|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2850612|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
2850613|NCT03852407|Melphalan|melphalan|mesh-list
2850614|NCT03852407|Fludarabine|fludarabine|mesh-list
2850615|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
2850616|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2850617|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
2850618|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850619|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2850620|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2850621|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
2850622|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850623|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850624|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2850625|NCT03852563|Petrolatum|petrolatum|mesh-list
2850626|NCT03852563|Emollients|emollients|mesh-ancestor
2850627|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
2850628|NCT03852251|Capecitabine|capecitabine|mesh-list
2850629|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
2850630|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2850631|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
2850632|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850633|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850634|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2850635|NCT03852160|Mirtazapine|mirtazapine|mesh-list
2850636|NCT03852160|Trazodone|trazodone|mesh-list
2850637|NCT03852160|S 20098|s 20098|mesh-list
2850638|NCT03852160|Citalopram|citalopram|mesh-list
2850639|NCT03852160|Bupropion|bupropion|mesh-list
2850640|NCT03852160|Sertraline|sertraline|mesh-list
2850641|NCT03852160|Esketamine|esketamine|mesh-list
2850642|NCT03852160|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2107934|NCT02495779|Tenofovir|tenofovir|mesh-list
2107935|NCT02495779|Emtricitabine|emtricitabine|mesh-list
2107936|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
2107937|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107938|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2107939|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2107940|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107941|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107942|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2107943|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2107944|NCT02495831|Diclofenac|diclofenac|mesh-list
2301122|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2301123|NCT00295555|Doxazosin|doxazosin|mesh-list
2301124|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2301125|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2301126|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2850643|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2850644|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2850645|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850646|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2850647|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
2850648|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850649|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2850650|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
2850651|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2850652|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850653|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2850654|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
2850655|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2850656|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2850657|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850658|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2850659|NCT03852160|Analgesics|analgesics|mesh-ancestor
2850660|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
2850661|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2850662|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
2301127|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2301128|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
2301129|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301130|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301131|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301132|NCT00295594|Tacrolimus|tacrolimus|mesh-list
2301133|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301134|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
2301135|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301136|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2301137|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301138|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301139|NCT00295607|Antibodies|antibodies|mesh-list
2301140|NCT00295607|Tacrolimus|tacrolimus|mesh-list
2301141|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
2301142|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850663|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
2850664|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2850665|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2850666|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850667|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2850668|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2850669|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2850670|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
2850671|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2850672|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2850673|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2850674|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2850675|NCT03852056|Fluorides|fluorides|mesh-list
2850676|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
2850677|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
2850678|NCT03852056|Protective Agents|protective agents|mesh-ancestor
2850679|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850680|NCT03851835|Ondansetron|ondansetron|mesh-list
2850681|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
2850682|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
2107945|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2107946|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2107947|NCT02495831|Analgesics|analgesics|mesh-ancestor
2107948|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
2107949|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107950|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107951|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2301143|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301144|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2301145|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301146|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850683|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850684|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850685|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2850686|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
2301147|NCT00295646|Tamoxifen|tamoxifen|mesh-list
2301148|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
2301149|NCT00295646|Anastrozole|anastrozole|mesh-list
2301150|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2301151|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
2301152|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2301153|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301154|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2301155|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301156|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2301157|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2301158|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2301159|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2301160|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2301161|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301162|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301163|NCT00295672|Vinorelbine|vinorelbine|mesh-list
2301164|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2301165|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301166|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
2301167|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
2301168|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
2301169|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301170|NCT00295685|Antacids|antacids|mesh-list
2301171|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850687|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
2850688|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2850689|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
2850690|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2850691|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850692|NCT03851835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2850693|NCT03851835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2850694|NCT03851835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850695|NCT03851835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2850696|NCT03851835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2107952|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2107953|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2107954|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107955|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107956|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
2107957|NCT02495857|Viscosupplements|viscosupplements|mesh-list
2107958|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2107959|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
2107960|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107961|NCT02495857|Protective Agents|protective agents|mesh-ancestor
2107962|NCT02495883|Ethanol|ethanol|mesh-list
2107963|NCT02495883|Propranolol|propranolol|mesh-list
2107964|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2107965|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2107966|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
2301172|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2301173|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
2301174|NCT00295698|Filaricides|filaricides|mesh-ancestor
2301175|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
2301176|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
2301177|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2301178|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301179|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2301180|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850697|NCT03851731|Naltrexone|naltrexone|mesh-list
2850698|NCT03851731|Naloxone|naloxone|mesh-list
2850699|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2850700|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2850701|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850702|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
2850703|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850704|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2850705|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
2850706|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850707|NCT03851432|Metformin|metformin|mesh-list
2850708|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2850709|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850710|NCT03851562|Alprostadil|alprostadil|mesh-list
2850711|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2850712|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
2301181|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301182|NCT00295776|Lamotrigine|lamotrigine|mesh-list
2301183|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
2301184|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2301185|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2301186|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301187|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2301188|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301189|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2301190|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2301191|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2301192|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301193|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2850713|NCT03851562|Urological Agents|urological agents|mesh-ancestor
2850714|NCT03851289|Calcium|calcium|mesh-list
2850715|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2850716|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850717|NCT03851341|Metformin|metformin|mesh-list
2850718|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2850719|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2850720|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850721|NCT03851341|Incretins|incretins|mesh-ancestor
2850722|NCT03851341|Hormones|hormones|mesh-ancestor
2850723|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2850724|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2850725|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
2850726|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850727|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850728|NCT03851614|Durvalumab|durvalumab|mesh-list
2850729|NCT03851614|Olaparib|olaparib|mesh-list
2850730|NCT03851614|Cediranib|cediranib|mesh-list
2850731|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2850732|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850733|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2850734|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301194|NCT00295789|Paclitaxel|paclitaxel|mesh-list
2301195|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2301196|NCT00295789|Carboplatin|carboplatin|mesh-list
2301197|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2301198|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301199|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
2850735|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850736|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2850737|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
2850738|NCT03851627|Testosterone|testosterone|mesh-list
2850739|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
2850740|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
2850741|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2850742|NCT03851627|Androgens|androgens|mesh-ancestor
2850743|NCT03851627|Hormones|hormones|mesh-ancestor
2850744|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2850745|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850746|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2850747|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850748|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
2850749|NCT03851588|Dolutegravir|dolutegravir|mesh-list
2850750|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2850751|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2850752|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850753|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850754|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2850755|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2850756|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
2850757|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2850758|NCT03851172|Ketorolac|ketorolac|mesh-list
2850759|NCT03851172|Nepafenac|nepafenac|mesh-list
2850760|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
2850761|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2850762|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2850763|NCT03851172|Analgesics|analgesics|mesh-ancestor
2850764|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
2850765|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850766|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850767|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2850768|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2850769|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2850770|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850771|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850772|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
2850773|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
2850774|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
2850775|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2850776|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2850777|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
2850778|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2850779|NCT03851393|Citric Acid|citric acid|mesh-list
2850780|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
2850781|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
2850782|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2850783|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
2850784|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
2850785|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850786|NCT03851159|Mannitol|mannitol|mesh-list
2850787|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2850788|NCT03851159|Diuretics|diuretics|mesh-ancestor
2850789|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
2850790|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850791|NCT03851263|Evolocumab|evolocumab|mesh-list
2850792|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2850793|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2850794|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
2850795|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850796|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2850797|NCT03850886|Niacinamide|niacinamide|mesh-list
2850798|NCT03850886|Niacin|niacin|mesh-list
2850799|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
2850800|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2850801|NCT03850886|Vitamins|vitamins|mesh-ancestor
2850802|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
2850803|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850804|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
2850805|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2850806|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
2850807|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850808|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2850809|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
2850810|NCT03850769|Paclitaxel|paclitaxel|mesh-list
2850811|NCT03850769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2850812|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2850813|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850814|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
2850815|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
2850816|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
2850817|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850818|NCT03850561|Ubiquinone|ubiquinone|mesh-list
2850819|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
2850820|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
2850821|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850822|NCT03850561|Vitamins|vitamins|mesh-ancestor
2850823|NCT03850652|Iron|iron|mesh-list
2301200|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
2301201|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
2301202|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301203|NCT00295815|Lomustine|lomustine|mesh-list
2301204|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2301205|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
2301206|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301207|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301208|NCT00295841|Cytarabine|cytarabine|mesh-list
2301209|NCT00295841|Clofarabine|clofarabine|mesh-list
2301210|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2301211|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
2301212|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301213|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301214|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
2301215|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301216|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301217|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
2301218|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301219|NCT00295893|Paclitaxel|paclitaxel|mesh-list
2301220|NCT00295893|Docetaxel|docetaxel|mesh-list
2301221|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
2301222|NCT00295893|Carboplatin|carboplatin|mesh-list
2301223|NCT00295893|Doxorubicin|doxorubicin|mesh-list
2301224|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2301225|NCT00295893|Trastuzumab|trastuzumab|mesh-list
2301226|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2301227|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850824|NCT03850652|Trace Elements|trace elements|mesh-ancestor
2850825|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
2850826|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850827|NCT03850691|Aldesleukin|aldesleukin|mesh-list
2850828|NCT03850691|Nivolumab|nivolumab|mesh-list
2850829|NCT03850691|Ipilimumab|ipilimumab|mesh-list
2850830|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2850831|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850832|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2850833|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850834|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2850835|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2850836|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
2850837|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2850838|NCT03850483|PF-06700841|pf-06700841|mesh-list
2850839|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2850840|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850841|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850842|NCT03850587|Celecoxib|celecoxib|mesh-list
2850843|NCT03850587|Tramadol|tramadol|mesh-list
2850844|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2850845|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2850846|NCT03850587|Analgesics|analgesics|mesh-ancestor
2850847|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
2850848|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850849|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850850|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2850851|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2850852|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2850853|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2850854|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850855|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850856|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2850857|NCT03850587|Narcotics|narcotics|mesh-ancestor
2850858|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850859|NCT03850535|Cytarabine|cytarabine|mesh-list
2850860|NCT03850535|Daunorubicin|daunorubicin|mesh-list
2850861|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2850862|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
2850863|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850864|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850865|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
2850866|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2850867|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2850868|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
2850869|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850870|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2301228|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
2301229|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
2301230|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
2301231|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301232|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301233|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
2301234|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301235|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2301236|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2301237|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
2301238|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2301239|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2301240|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2301241|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2301242|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301243|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2301244|NCT00295919|Ketoconazole|ketoconazole|mesh-list
2301245|NCT00295919|Fenretinide|fenretinide|mesh-list
2301246|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
2850871|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2850872|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2850873|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850874|NCT03850314|Glycine|glycine|mesh-list
2850875|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
2850876|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2850877|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850878|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850879|NCT03850301|Etifoxine|etifoxine|mesh-list
2850880|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2850881|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2850882|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850883|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850884|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301247|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301248|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2301249|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2301250|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301251|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301252|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2301253|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
2301254|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2301255|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301256|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2301257|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301258|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2301259|NCT00295919|Protective Agents|protective agents|mesh-ancestor
2301260|NCT00295945|Fentanyl|fentanyl|mesh-list
2301261|NCT00295945|Hydromorphone|hydromorphone|mesh-list
2301262|NCT00295945|Ropivacaine|ropivacaine|mesh-list
2301263|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
2850885|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2850886|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
2850887|NCT03850028|Atezolizumab|atezolizumab|mesh-list
2850888|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2850889|NCT03849833|Vitamin D|vitamin d|mesh-list
2850890|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
2850891|NCT03849833|Vitamins|vitamins|mesh-ancestor
2850892|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
2850893|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850894|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2850895|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2850896|NCT03849625|Aspirin|aspirin|mesh-list
2301264|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
2301265|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2301266|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301267|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
2301268|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301269|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2301270|NCT00295945|Narcotics|narcotics|mesh-ancestor
2301271|NCT00295945|Analgesics|analgesics|mesh-ancestor
2301272|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2301273|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2301274|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
2301275|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
2301276|NCT00295958|Immunotoxins|immunotoxins|mesh-list
2301277|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2301278|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
2301279|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301280|NCT00295971|Fludarabine|fludarabine|mesh-list
2301281|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
2301282|NCT00295971|Thiotepa|thiotepa|mesh-list
2850897|NCT03849625|Acetaminophen|acetaminophen|mesh-list
2850898|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2850899|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2850900|NCT03849625|Analgesics|analgesics|mesh-ancestor
2850901|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
2850902|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850903|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301283|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2301284|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301285|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2301286|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
2850904|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2850905|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2850906|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2850907|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2850908|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850909|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2850910|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2850911|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2850912|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
2850913|NCT03849508|Phenylephrine|phenylephrine|mesh-list
2301287|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301288|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301289|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
2301290|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301291|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2301292|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
2301293|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2301294|NCT00295984|Nicotine|nicotine|mesh-list
2301295|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2301296|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
2850914|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
2850915|NCT03849508|Norepinephrine|norepinephrine|mesh-list
2850916|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2850917|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
2850918|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
2850919|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850920|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850921|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
2850922|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2850923|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
2850924|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
2850925|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2850926|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2850927|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2850928|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
2850929|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2850930|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850931|NCT03849508|Protective Agents|protective agents|mesh-ancestor
2850932|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
2850933|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2850934|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850935|NCT03849664|Riboflavin|riboflavin|mesh-list
2850936|NCT03849664|Niacinamide|niacinamide|mesh-list
2301297|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301298|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301299|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2301300|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2301301|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
2301302|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301303|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301304|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
2301305|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
2301306|NCT00295997|Busulfan|busulfan|mesh-list
2301307|NCT00295997|Methotrexate|methotrexate|mesh-list
2301308|NCT00295997|Fludarabine|fludarabine|mesh-list
2301309|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
2301310|NCT00295997|Tacrolimus|tacrolimus|mesh-list
2301311|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2850937|NCT03849664|Niacin|niacin|mesh-list
2850938|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
2850939|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
2850940|NCT03849664|Povidone|povidone|mesh-list
2850941|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2850942|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301312|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301313|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
2301314|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301315|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2301316|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2301317|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
2850943|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
2850944|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
2850945|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
2850946|NCT03849664|Vitamins|vitamins|mesh-ancestor
2850947|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
2850948|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2850949|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
2850950|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2850951|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
2850952|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850953|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2850954|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
2850955|NCT03849729|Phentermine|phentermine|mesh-list
2850956|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2850957|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850958|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
2850959|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2850960|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
2850961|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
2850962|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2850963|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
2850964|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2850965|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850966|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
2850967|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2850968|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
2850969|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
2850970|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
2850971|NCT03849404|Adalimumab|adalimumab|mesh-list
2850972|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2850973|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2850974|NCT03849209|Pancrelipase|pancrelipase|mesh-list
2850975|NCT03849209|Pancreatin|pancreatin|mesh-list
2850976|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2850977|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
2850978|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
2850979|NCT03849235|Glucagon|glucagon|mesh-list
2850980|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2850981|NCT03849235|Hormones|hormones|mesh-ancestor
2850982|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2850983|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850984|NCT03849313|Adalimumab|adalimumab|mesh-list
2301318|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2850985|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2850986|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2850987|NCT03849196|Bisacodyl|bisacodyl|mesh-list
2850988|NCT03849196|Cathartics|cathartics|mesh-ancestor
2850989|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2850990|NCT03849196|Laxatives|laxatives|mesh-ancestor
2850991|NCT03849170|Vaccines|vaccines|mesh-list
2850992|NCT03849170|Immunologic Factors|immunologic factors|mesh-ancestor
2850993|NCT03849170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2850994|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
2850995|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2850996|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
2850997|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
2850998|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2850999|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851000|NCT03848611|Vorolanib|vorolanib|mesh-list
2851001|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2851002|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851003|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851004|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
2851005|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2851006|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851007|NCT03848806|Calcitriol|calcitriol|mesh-list
2851008|NCT03848806|Calcipotriene|calcipotriene|mesh-list
2851009|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
2851010|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2851011|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851012|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2851013|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2851014|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851015|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2851016|NCT03848806|Vitamins|vitamins|mesh-ancestor
2851017|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
2851018|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2851025|NCT03848533|Metformin|metformin|mesh-list
2851026|NCT03848533|Melatonin|melatonin|mesh-list
2851027|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2851028|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851029|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
2851030|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851031|NCT03848533|Protective Agents|protective agents|mesh-ancestor
2851032|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851033|NCT03848182|Gemcitabine|gemcitabine|mesh-list
2851034|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2851035|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
2851036|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851037|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851038|NCT03848182|Antiviral Agents|antiviral agents|mesh-ancestor
2851039|NCT03848182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851040|NCT03848182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851041|NCT03848182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2851042|NCT03848182|Immunologic Factors|immunologic factors|mesh-ancestor
2851043|NCT03848182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851044|NCT03848780|Desflurane|desflurane|mesh-list
2851045|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2851046|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
2851047|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
2851048|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851049|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851050|NCT03848234|Estradiol|estradiol|mesh-list
2851051|NCT03848234|Estrogens|estrogens|mesh-ancestor
2851052|NCT03848234|Hormones|hormones|mesh-ancestor
2851053|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851054|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851055|NCT03848104|Cefoxitin|cefoxitin|mesh-list
2851056|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2851057|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851058|NCT03848065|Vaccines|vaccines|mesh-list
2851059|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
2851060|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851061|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2851062|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851063|NCT03848039|Vaccines|vaccines|mesh-list
2851064|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
2851065|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851066|NCT03847818|Carboplatin|carboplatin|mesh-list
2851067|NCT03847818|Docetaxel|docetaxel|mesh-list
2851068|NCT03847818|Trastuzumab|trastuzumab|mesh-list
2851069|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851070|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
2851071|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
2851072|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
2851073|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851074|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2851075|NCT03847792|Dexamethasone|dexamethasone|mesh-list
2851076|NCT03847792|Fentanyl|fentanyl|mesh-list
2851077|NCT03847792|Bupivacaine|bupivacaine|mesh-list
2851078|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2851079|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
2851080|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
2851081|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851082|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851083|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2851084|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
2851085|NCT03847792|Hormones|hormones|mesh-ancestor
2851086|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851087|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2851088|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851089|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
2851090|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
2851091|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851092|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
2851093|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2851094|NCT03847792|Narcotics|narcotics|mesh-ancestor
2851095|NCT03847792|Analgesics|analgesics|mesh-ancestor
2851096|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2851097|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2851098|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
2851109|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2851110|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
2851111|NCT03847857|Coagulants|coagulants|mesh-ancestor
2851112|NCT03847571|Acetazolamide|acetazolamide|mesh-list
2851113|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
2851114|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2851115|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851116|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851117|NCT03847571|Diuretics|diuretics|mesh-ancestor
2851118|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
2851119|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851120|NCT03847922|Lidocaine|lidocaine|mesh-list
2851121|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
2851122|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
2851123|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
2851124|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851125|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851126|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
2851127|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301319|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301320|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2301321|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2301322|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
2301323|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2301324|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2301325|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
2301326|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
2301327|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301328|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2301329|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2301330|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2301331|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2301332|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2301333|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
2301334|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2851128|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2851129|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2851130|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2851131|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2851132|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851133|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2851134|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
2851135|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2851136|NCT03847922|Analgesics|analgesics|mesh-ancestor
2851137|NCT03847896|Budesonide|budesonide|mesh-list
2851138|NCT03847896|Albuterol|albuterol|mesh-list
2851139|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2851140|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2851141|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
2851142|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851143|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851144|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2851145|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
2851146|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
2851147|NCT03847896|Hormones|hormones|mesh-ancestor
2301335|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301336|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
2301337|NCT00296010|Doxorubicin|doxorubicin|mesh-list
2301338|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2301339|NCT00296010|Methotrexate|methotrexate|mesh-list
2301340|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301341|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
2301342|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301343|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2301344|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2301345|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
2301346|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301347|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301348|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2301349|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2301350|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2301351|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2301352|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301353|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2301354|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
2301355|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2301356|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2301357|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
2301358|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
2301359|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2301360|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2301361|NCT00296023|Methotrexate|methotrexate|mesh-list
2301362|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
2301363|NCT00296023|Fludarabine|fludarabine|mesh-list
2851148|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851149|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
2851150|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2851151|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2301364|NCT00296023|Busulfan|busulfan|mesh-list
2301365|NCT00296023|Tacrolimus|tacrolimus|mesh-list
2301366|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2301367|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2301368|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
2301369|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2851152|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2851153|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2851154|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
2851155|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851156|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851157|NCT03847506|Amlodipine|amlodipine|mesh-list
2851158|NCT03847506|Candesartan|candesartan|mesh-list
2301370|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301371|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2301372|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
2301373|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301374|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301375|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
2301376|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851159|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
2851160|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2851161|NCT03847506|Ezetimibe|ezetimibe|mesh-list
2851162|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2301377|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2301378|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301379|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
2301380|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2301381|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2301382|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2301383|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
2301384|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2301385|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2301386|NCT00296049|Vancomycin|vancomycin|mesh-list
2301387|NCT00296049|Daptomycin|daptomycin|mesh-list
2301388|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2301389|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301390|NCT00296062|Bevacizumab|bevacizumab|mesh-list
2301391|NCT00296062|Capecitabine|capecitabine|mesh-list
2301392|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
2301393|NCT00296062|Irinotecan|irinotecan|mesh-list
2301394|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2301395|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301396|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2301397|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2301398|NCT00296062|Growth Substances|growth substances|mesh-ancestor
2301399|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301400|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
2301401|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2301402|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
2301403|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301404|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2301405|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2301406|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301407|NCT00296127|Celecoxib|celecoxib|mesh-list
2301408|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2301409|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2301410|NCT00296127|Analgesics|analgesics|mesh-ancestor
2851163|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2851164|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2851165|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851166|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2851167|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851168|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
2851169|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2851170|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2851171|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
2851172|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2851173|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2851174|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851175|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2851176|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2851180|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
2851181|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2851182|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2851183|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851184|NCT03847623|Curcumin|curcumin|mesh-list
2851185|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2851186|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2851187|NCT03847623|Analgesics|analgesics|mesh-ancestor
2851188|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
2851189|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851190|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851191|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2851192|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2851193|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851194|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851195|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851196|NCT03847558|Hormones|hormones|mesh-list
2851197|NCT03847558|Testosterone|testosterone|mesh-list
2851198|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2851199|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851200|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851201|NCT03847558|Androgens|androgens|mesh-ancestor
2851202|NCT03847363|Anesthetics|anesthetics|mesh-list
2851203|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851204|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851205|NCT03847207|Pasireotide|pasireotide|mesh-list
2851206|NCT03847207|Hormones|hormones|mesh-ancestor
2851207|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851208|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851209|NCT03847246|Entecavir|entecavir|mesh-list
2851210|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
2851211|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851212|NCT03847155|Nicotine|nicotine|mesh-list
2851213|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2851214|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
2851215|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851216|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851217|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2851218|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2851219|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
2851220|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851221|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851222|NCT03847272|Prednisone|prednisone|mesh-list
2851223|NCT03847272|Ustekinumab|ustekinumab|mesh-list
2851224|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2851225|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
2851226|NCT03847272|Hormones|hormones|mesh-ancestor
2851227|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851228|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851229|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2851230|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851231|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
2851243|NCT03847441|Vitamin D|vitamin d|mesh-list
2851244|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
2851245|NCT03847441|Calcipotriene|calcipotriene|mesh-list
2851246|NCT03847441|Vitamins|vitamins|mesh-ancestor
2851247|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
2851248|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851249|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2301411|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
2301412|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301413|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301414|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2301415|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2301416|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2301417|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2301418|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851250|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2851251|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
2851252|NCT03847376|Rilpivirine|rilpivirine|mesh-list
2851253|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2851254|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2851255|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851256|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851257|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
2851258|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851259|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2851260|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2851261|NCT03846739|Oxytocin|oxytocin|mesh-list
2851262|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
2851263|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2851264|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851265|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
2851266|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2851267|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2851268|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851269|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
2851270|NCT03846973|Coagulants|coagulants|mesh-ancestor
2851271|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
2851272|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2851273|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2851274|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
2851275|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851276|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851277|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2851278|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
2851279|NCT03846765|Phenylephrine|phenylephrine|mesh-list
2851280|NCT03846765|Dobutamine|dobutamine|mesh-list
2851281|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
2851282|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2851283|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
2851284|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
2851285|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851286|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851287|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
2851288|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2851289|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
2851290|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
2851291|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2851292|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2851293|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2851294|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
2851295|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851296|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851297|NCT03846765|Protective Agents|protective agents|mesh-ancestor
2851298|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2851299|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2301419|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301420|NCT00296179|Zolpidem|zolpidem|mesh-list
2301421|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2301422|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2301423|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2301424|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851300|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2851301|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2851302|NCT03846271|Oxytocin|oxytocin|mesh-list
2851303|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
2851304|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2851305|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851306|NCT03846570|Beclomethasone|beclomethasone|mesh-list
2851307|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
2851308|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2851309|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
2851310|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851311|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851312|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2851313|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
2851314|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2851315|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2851316|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2851317|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
2851318|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851319|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851320|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2851321|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
2851322|NCT03846570|Hormones|hormones|mesh-ancestor
2851323|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851324|NCT03846388|Hormones|hormones|mesh-list
2851325|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2851326|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851327|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851328|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2851329|NCT03846583|Trastuzumab|trastuzumab|mesh-list
2851330|NCT03846583|Tucatinib|tucatinib|mesh-list
2851331|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2851332|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2851333|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851334|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2851335|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851336|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851337|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2851338|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
2851339|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851340|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851341|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2851342|NCT03846310|Carboplatin|carboplatin|mesh-list
2851343|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
2851344|NCT03846310|Pemetrexed|pemetrexed|mesh-list
2851345|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851346|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2851347|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851348|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851349|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2851350|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2851351|NCT03846180|Octreotide|octreotide|mesh-list
2851352|NCT03846180|Terlipressin|terlipressin|mesh-list
2851353|NCT03846180|Somatostatin|somatostatin|mesh-list
2851354|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2851355|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2851356|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851357|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2851358|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2851359|NCT03846180|Hormones|hormones|mesh-ancestor
2851360|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851361|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851362|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
2851363|NCT03846284|Bupivacaine|bupivacaine|mesh-list
2851364|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
2851365|NCT03846284|Anesthetics|anesthetics|mesh-list
2851366|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
2851367|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851368|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851369|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
2851370|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851371|NCT03846284|Analgesics|analgesics|mesh-ancestor
2851372|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2851373|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
2301425|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2301426|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
2851374|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2851375|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2851376|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851377|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2851378|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
2851379|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2851380|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2851381|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2851382|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851383|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
2851384|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851385|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2851386|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851387|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851388|NCT03846102|Acetaminophen|acetaminophen|mesh-list
2851389|NCT03846102|Morphine|morphine|mesh-list
2851390|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
2851391|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2851392|NCT03846102|Narcotics|narcotics|mesh-ancestor
2851393|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851394|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851395|NCT03846102|Analgesics|analgesics|mesh-ancestor
2851396|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
2851397|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851398|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2851399|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
2851400|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
2851401|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
2851402|NCT03845894|Bupivacaine|bupivacaine|mesh-list
2851403|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
2851404|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
2851405|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851406|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851407|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
2851408|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851409|NCT03845699|Fentanyl|fentanyl|mesh-list
2851410|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2851411|NCT03845699|Narcotics|narcotics|mesh-ancestor
2851412|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851413|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851414|NCT03845699|Analgesics|analgesics|mesh-ancestor
2851415|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
2851416|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851417|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2851418|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2851419|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
2851420|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
2851421|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2851422|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851423|NCT03845881|Oxycodone|oxycodone|mesh-list
2851424|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2851425|NCT03845881|Narcotics|narcotics|mesh-ancestor
2851426|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851427|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851428|NCT03845881|Analgesics|analgesics|mesh-ancestor
2851429|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
2851430|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851431|NCT03845543|Paclitaxel|paclitaxel|mesh-list
2851432|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2851433|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851434|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
2851435|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
2851436|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
2851437|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851438|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
2851439|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851440|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
2851441|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
2851442|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
2851443|NCT03845673|Psyllium|psyllium|mesh-list
2851444|NCT03845673|Cathartics|cathartics|mesh-ancestor
2851445|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2851446|NCT03845582|Vitamin A|vitamin a|mesh-list
2851447|NCT03845582|Retinol acetate|retinol acetate|mesh-list
2851448|NCT03845582|Vitamins|vitamins|mesh-ancestor
2851449|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
2851450|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851451|NCT03845582|Protective Agents|protective agents|mesh-ancestor
2851452|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2851453|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851454|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2851455|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
2851456|NCT03845387|Pramipexole|pramipexole|mesh-list
2851457|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
2851458|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851459|NCT03845387|Protective Agents|protective agents|mesh-ancestor
2851460|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851461|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2851462|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2851463|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
2851464|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
2851465|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851466|NCT03845348|Ketoconazole|ketoconazole|mesh-list
2851467|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
2851468|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851469|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2851470|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2851471|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851472|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851473|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2851474|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
2851475|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851476|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851477|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2851478|NCT03845322|Curcumin|curcumin|mesh-list
2301427|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
2301428|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301429|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851479|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2851480|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2851481|NCT03845322|Analgesics|analgesics|mesh-ancestor
2851482|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
2851483|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851484|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851485|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2851486|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2851487|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851488|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851489|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851490|NCT03845270|Docetaxel|docetaxel|mesh-list
2851491|NCT03845270|Trastuzumab|trastuzumab|mesh-list
2851492|NCT03845270|Pertuzumab|pertuzumab|mesh-list
2851493|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851494|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
2851495|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
2851496|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
2851497|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851498|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2851499|NCT03845296|Rucaparib|rucaparib|mesh-list
2851500|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2851501|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851502|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851503|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851504|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2851505|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2851506|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2851507|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851508|NCT03845179|Incretins|incretins|mesh-ancestor
2851509|NCT03845179|Hormones|hormones|mesh-ancestor
2851510|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851511|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
2851512|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851513|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851514|NCT03845153|Metformin|metformin|mesh-list
2851515|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2851516|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851517|NCT03845010|Verapamil|verapamil|mesh-list
2851518|NCT03845010|Sotalol|sotalol|mesh-list
2851519|NCT03845010|Flecainide|flecainide|mesh-list
2301430|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
2851520|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2851521|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2851522|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2851523|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851524|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2851525|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851526|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
2851527|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2851528|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2851529|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
2851530|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851531|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
2851532|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
2851533|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851534|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2851535|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2851536|NCT03845049|Aflibercept|aflibercept|mesh-list
2851537|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2851538|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2851539|NCT03845049|Growth Substances|growth substances|mesh-ancestor
2851540|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851541|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
2851542|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851551|NCT03844997|Palbociclib|palbociclib|mesh-list
2851552|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851553|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2851554|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851555|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851556|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
2851557|NCT03844841|Propofol|propofol|mesh-list
2851558|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2851559|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851560|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851561|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2851562|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
2851563|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
2851564|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2851565|NCT03844841|Analgesics|analgesics|mesh-ancestor
2851566|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
2851567|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851568|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2851569|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2851570|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2851571|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
2851572|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851573|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851574|NCT03844984|Lidocaine|lidocaine|mesh-list
2851575|NCT03844984|Midazolam|midazolam|mesh-list
2851576|NCT03844984|Ketamine|ketamine|mesh-list
2851577|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
2851578|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
2851579|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851580|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851581|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
2851582|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851583|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2851584|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2851585|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2851586|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2851587|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851588|NCT03844984|Analgesics|analgesics|mesh-ancestor
2851589|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2851590|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2301431|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301432|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
2301433|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851591|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
2301434|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2301435|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2301436|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
2301437|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301438|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301439|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2301440|NCT00296218|Irbesartan|irbesartan|mesh-list
2301441|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2301442|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2851592|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2851593|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2851594|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851595|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2851596|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2851597|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2851598|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2851599|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2851600|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
2851601|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
2851602|NCT03844932|Cyclosporine|cyclosporine|mesh-list
2851603|NCT03844932|Cyclosporins|cyclosporins|mesh-list
2851604|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851605|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851606|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2851607|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
2851608|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851609|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
2851610|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851611|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
2851612|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2851613|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2107967|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107968|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2107969|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107970|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2107971|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2107972|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
2107973|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2107974|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107975|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107976|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2107977|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2107978|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2107979|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2107980|NCT02496000|Insulin|insulin|mesh-list
2107981|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2107982|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107983|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
2107984|NCT02496221|Incretins|incretins|mesh-ancestor
2107985|NCT02496221|Hormones|hormones|mesh-ancestor
2107986|NCT02496221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2107987|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301443|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2851614|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
2851615|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851616|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
2851617|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
2851618|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
2851619|NCT03844815|Decitabine|decitabine|mesh-list
2301444|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301445|NCT00296257|Rimacalib|rimacalib|mesh-list
2301446|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2301447|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301448|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301449|NCT00296309|Tacrolimus|tacrolimus|mesh-list
2301450|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301451|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
2301452|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851620|NCT03844815|Venetoclax|venetoclax|mesh-list
2851621|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2851622|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
2851623|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851624|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851625|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851626|NCT03844581|Propiverine|propiverine|mesh-list
2851627|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
2851628|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
2851629|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851630|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851631|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2851632|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2851633|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
2851634|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851635|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851636|NCT03844581|Urological Agents|urological agents|mesh-ancestor
2851637|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2851638|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
2851639|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2851640|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
2851641|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2851642|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851643|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2851644|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2851645|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2851646|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851647|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2851648|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2851649|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2851650|NCT03844451|Epinephrine|epinephrine|mesh-list
2851651|NCT03844451|Bupivacaine|bupivacaine|mesh-list
2851652|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
2851653|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
2851654|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851655|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851656|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
2851657|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301453|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2301454|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301455|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301456|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
2301457|NCT00296348|Tacrolimus|tacrolimus|mesh-list
2301458|NCT00296348|Daclizumab|daclizumab|mesh-list
2301459|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301460|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
2301461|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301462|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2301463|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851658|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2851659|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2851660|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
2851661|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851662|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851663|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2851664|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2851665|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
2851666|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2851667|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
2851668|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
2851669|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
2851670|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2851671|NCT03844776|Acetaminophen|acetaminophen|mesh-list
2851672|NCT03844776|Amoxicillin|amoxicillin|mesh-list
2851673|NCT03844776|Metronidazole|metronidazole|mesh-list
2851674|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2851675|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
2851676|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2851677|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851678|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2851679|NCT03844776|Analgesics|analgesics|mesh-ancestor
2851680|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
2851681|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851682|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851683|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
2851684|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2851685|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
2851686|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2851687|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2851688|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2851689|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851690|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851691|NCT03844620|Trifluridine|trifluridine|mesh-list
2851692|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
2851693|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851694|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
2851695|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851696|NCT03844529|Lidocaine|lidocaine|mesh-list
2851697|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
2851698|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
2851699|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851700|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851701|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
2851702|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851703|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2851704|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2301464|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301465|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2301466|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301467|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2301468|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
2301469|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2301470|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301471|NCT00296361|Tacrolimus|tacrolimus|mesh-list
2301472|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301473|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
2301474|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301475|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2301476|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301477|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851705|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2851706|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2851707|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851708|NCT03844594|Eptifibatide|eptifibatide|mesh-list
2851709|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2851710|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
2851711|NCT03844763|Avelumab|avelumab|mesh-list
2851712|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2851713|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
2851714|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851715|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2851716|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2851717|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
2851718|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851719|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851720|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2851721|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2851722|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2851723|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2851724|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2851725|NCT03844139|Glycerol|glycerol|mesh-list
2851726|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2851727|NCT03844139|Protective Agents|protective agents|mesh-ancestor
2301478|NCT00296387|Atorvastatin|atorvastatin|mesh-list
2301479|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2851728|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851729|NCT03844256|Capecitabine|capecitabine|mesh-list
2851730|NCT03844256|Nivolumab|nivolumab|mesh-list
2851731|NCT03844256|Ipilimumab|ipilimumab|mesh-list
2851732|NCT03844256|Mitomycins|mitomycins|mesh-list
2851733|NCT03844256|Mitomycin|mitomycin|mesh-list
2851734|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2851735|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
2851736|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851737|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851738|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2851739|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2851740|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2851741|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
2851742|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2851743|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851744|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
2851745|NCT03844061|Rituximab|rituximab|mesh-list
2851746|NCT03844061|Belimumab|belimumab|mesh-list
2851747|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2851748|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851749|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
2851750|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851751|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2851752|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2851753|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2851754|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
2851755|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2851756|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851757|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851758|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851759|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2851760|NCT03844217|Tryptophan|tryptophan|mesh-list
2851761|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2851762|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
2851763|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2851764|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
2851765|NCT03844360|Bortezomib|bortezomib|mesh-list
2851766|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
2851767|NCT03844360|Dasatinib|dasatinib|mesh-list
2851768|NCT03844360|Pegaspargase|pegaspargase|mesh-list
2851769|NCT03844360|Sargramostim|sargramostim|mesh-list
2851770|NCT03844360|Lenograstim|lenograstim|mesh-list
2851771|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851772|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2851773|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851774|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851775|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
2851776|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851777|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2851778|NCT03844074|Bevacizumab|bevacizumab|mesh-list
2851779|NCT03844074|Ranibizumab|ranibizumab|mesh-list
2851780|NCT03844074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2851781|NCT03844074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851782|NCT03844074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2851783|NCT03844074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2851784|NCT03844074|Growth Substances|growth substances|mesh-ancestor
2851785|NCT03844074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851786|NCT03844074|Growth Inhibitors|growth inhibitors|mesh-ancestor
2851787|NCT03844243|Mitogens|mitogens|mesh-list
2851788|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
2851789|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851790|NCT03843970|Bupivacaine|bupivacaine|mesh-list
2851791|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
2851792|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2851793|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
2851794|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
2851795|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851796|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851797|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
2851798|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851799|NCT03843749|Trastuzumab|trastuzumab|mesh-list
2851800|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2851801|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851802|NCT03844178|Tetracaine|tetracaine|mesh-list
2851803|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
2851804|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
2851805|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851806|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851807|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
2851808|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851809|NCT03843853|Bevacizumab|bevacizumab|mesh-list
2851810|NCT03843853|Pemetrexed|pemetrexed|mesh-list
2851811|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2851812|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851813|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2851814|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2851815|NCT03843853|Growth Substances|growth substances|mesh-ancestor
2851816|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851817|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
2851818|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851819|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851820|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2851821|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2851822|NCT03843879|Lidocaine|lidocaine|mesh-list
2851823|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
2851824|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
2851825|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851826|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851827|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
2851828|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851829|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2851830|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2851831|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2851832|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2851833|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851834|NCT03843736|Drospirenone|drospirenone|mesh-list
2851835|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
2851836|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2851837|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
2851838|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2851839|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2851840|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851841|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2851842|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2851843|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2851844|NCT03843736|Estrogens|estrogens|mesh-ancestor
2851845|NCT03843736|Hormones|hormones|mesh-ancestor
2851846|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851847|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2851848|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
2851849|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2851850|NCT03843736|Diuretics|diuretics|mesh-ancestor
2851851|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
2851852|NCT03843645|Anesthetics|anesthetics|mesh-list
2851853|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851854|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851855|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
2851856|NCT03843541|Ambroxol|ambroxol|mesh-list
2851857|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2851858|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
2851859|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2851860|NCT03843541|Expectorants|expectorants|mesh-ancestor
2851861|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
2851862|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2851863|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
2851864|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851865|NCT03843541|Protective Agents|protective agents|mesh-ancestor
2851866|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851867|NCT03843541|Antidotes|antidotes|mesh-ancestor
2851868|NCT03843528|Azacitidine|azacitidine|mesh-list
2851869|NCT03843528|Vorinostat|vorinostat|mesh-list
2851870|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2851871|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
2851872|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851873|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851874|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851875|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2851876|NCT03843463|Dexetimide|dexetimide|mesh-list
2851877|NCT03843463|Citalopram|citalopram|mesh-list
2851878|NCT03843463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2851879|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2851880|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2851881|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851882|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851883|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
2851884|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851885|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2851886|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
2851887|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2851888|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2851889|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2851890|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
2851891|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
2851892|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851893|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2851894|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2851895|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
2851896|NCT03843281|Acetaminophen|acetaminophen|mesh-list
2851897|NCT03843281|Morphine|morphine|mesh-list
2851898|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2851899|NCT03843281|Narcotics|narcotics|mesh-ancestor
2851900|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851901|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851902|NCT03843281|Analgesics|analgesics|mesh-ancestor
2851903|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
2851904|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851905|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2851906|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
2851907|NCT03843294|Nivolumab|nivolumab|mesh-list
2851908|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2851909|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851910|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2851911|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851912|NCT03843229|Bufanolides|bufanolides|mesh-list
2851913|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2851914|NCT03843229|Protective Agents|protective agents|mesh-ancestor
2851915|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851916|NCT03843515|Nivolumab|nivolumab|mesh-list
2851917|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2851918|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851919|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2851920|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851921|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
2851922|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851923|NCT03843060|Itraconazole|itraconazole|mesh-list
2851924|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
2851925|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301480|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2301481|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2301482|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
2301483|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301484|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2301485|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2301486|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301487|NCT00296465|Citric Acid|citric acid|mesh-list
2301488|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
2301489|NCT00296465|Clomiphene|clomiphene|mesh-list
2301490|NCT00296465|Enclomiphene|enclomiphene|mesh-list
2301491|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
2301492|NCT00296465|Hormones|hormones|mesh-list
2301493|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2301494|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
2301495|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2301496|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
2301497|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
2851926|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2851927|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2851928|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2851929|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851930|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2851931|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
2851932|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2851933|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851934|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2851935|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
2851936|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2851937|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2851938|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2851939|NCT03843047|Nicotine|nicotine|mesh-list
2851940|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2851941|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
2851942|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851943|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851944|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2851945|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2851946|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
2851947|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851948|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851949|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
2851950|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2851951|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
2851952|NCT03842800|Ketamine|ketamine|mesh-list
2851953|NCT03842800|Analgesics|analgesics|mesh-ancestor
2851954|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
2851955|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851956|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851957|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2851958|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2851959|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
2851960|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
2851961|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2851962|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2851963|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2851964|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851965|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301498|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301499|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2301500|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301501|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2301502|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
2301503|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2301504|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
2301505|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2301506|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2301507|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2301508|NCT00296478|Progesterone|progesterone|mesh-list
2301509|NCT00296478|Progestins|progestins|mesh-ancestor
2301510|NCT00296478|Hormones|hormones|mesh-ancestor
2301511|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2301512|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301513|NCT00296530|Fluticasone|fluticasone|mesh-list
2301514|NCT00296530|Xhance|xhance|mesh-list
2301515|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2301516|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2301517|NCT00296530|Montelukast|montelukast|mesh-list
2301518|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2301519|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2301520|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
2301521|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301522|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301523|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2301524|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
2301525|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
2301526|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2851966|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
2851967|NCT03842839|Olodaterol|olodaterol|mesh-list
2851968|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2851969|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
2851970|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2851971|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851972|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2851973|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
2851974|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
2851975|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2851976|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
2851977|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2107988|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2107989|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2851978|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851979|NCT03842709|Pramipexole|pramipexole|mesh-list
2851980|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
2851981|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851982|NCT03842709|Protective Agents|protective agents|mesh-ancestor
2851983|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851984|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2851985|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2851986|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
2851987|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
2851988|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851989|NCT03842631|Timolol|timolol|mesh-list
2851990|NCT03842631|Maleic acid|maleic acid|mesh-list
2851991|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2851992|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2851993|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
2851994|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2851995|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2851996|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2851997|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2851998|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2851999|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852000|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
2852001|NCT03842488|Darunavir|darunavir|mesh-list
2852002|NCT03842488|Cobicistat|cobicistat|mesh-list
2852003|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2301527|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2301528|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2301529|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2301530|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
2301531|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301532|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301533|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2301534|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
2301535|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2301536|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2301537|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2301538|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
2301539|NCT00296530|Hormones|hormones|mesh-ancestor
2301540|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
2301541|NCT00296608|Leucovorin|leucovorin|mesh-list
2301542|NCT00296608|Fluorouracil|fluorouracil|mesh-list
2301543|NCT00296608|Calcium|calcium|mesh-list
2301544|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
2301545|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2301546|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301547|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
2852004|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2852005|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
2852006|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2852007|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2852008|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2852009|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852010|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852011|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2852012|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2852013|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
2852014|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2852015|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2852016|NCT03842423|Anesthetics|anesthetics|mesh-list
2852017|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2852018|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852019|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
2852020|NCT03842254|Hematinics|hematinics|mesh-ancestor
2852021|NCT03842085|Antibodies|antibodies|mesh-list
2852022|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2852023|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2852024|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
2852025|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852026|NCT03842046|Phenylephrine|phenylephrine|mesh-list
2852027|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
2852028|NCT03842046|Norepinephrine|norepinephrine|mesh-list
2852029|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2852030|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
2852031|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
2301548|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301549|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2301550|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301551|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301552|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
2301553|NCT00296608|Antidotes|antidotes|mesh-ancestor
2301554|NCT00296608|Protective Agents|protective agents|mesh-ancestor
2852032|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852033|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852034|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
2852035|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2852036|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
2852037|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
2852038|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2852039|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2852040|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2852041|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
2852042|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852043|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852044|NCT03842046|Protective Agents|protective agents|mesh-ancestor
2852045|NCT03842020|Amiodarone|amiodarone|mesh-list
2852046|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2852047|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
2852048|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2852049|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2852050|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852051|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2852052|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2852053|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2852054|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852055|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2301555|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
2301556|NCT00296608|Vitamins|vitamins|mesh-ancestor
2301557|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
2852056|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2852057|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2852058|NCT03841617|Hormones|hormones|mesh-list
2852059|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2301558|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2301559|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2301560|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
2301561|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852060|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852061|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
2852062|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2852063|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
2852064|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2852065|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2852066|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852067|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2852068|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852069|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2852070|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2852071|NCT03841890|Tolnaftate|tolnaftate|mesh-list
2852072|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
2852073|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2852074|NCT03841721|Linezolid|linezolid|mesh-list
2852075|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2852076|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2852077|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2852078|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2107990|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
2107991|NCT02497040|Bupivacaine|bupivacaine|mesh-list
2107992|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
2107993|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
2107994|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
2107995|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2107996|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2107997|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
2107998|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2107999|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2301562|NCT00296634|Antacids|antacids|mesh-ancestor
2852079|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301563|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301564|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2301565|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
2301566|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
2301567|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2301568|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301569|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2301570|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2301571|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2301572|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301573|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
2301574|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301575|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
2301576|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301577|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2301578|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301579|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2301580|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2301581|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2301582|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2301583|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2301584|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2301585|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2301586|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852080|NCT03841747|Paclitaxel|paclitaxel|mesh-list
2852081|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
2852082|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2852083|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852084|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
2852085|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
2852086|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
2852087|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852088|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2852089|NCT03841526|Glucagon|glucagon|mesh-list
2852090|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2852091|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2852092|NCT03841526|Hormones|hormones|mesh-ancestor
2852093|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2852094|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852095|NCT03841526|Incretins|incretins|mesh-ancestor
2852096|NCT03841812|Propofol|propofol|mesh-list
2852097|NCT03841812|Sevoflurane|sevoflurane|mesh-list
2852098|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2852099|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2852100|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852101|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2852102|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
2852103|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
2852104|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2852105|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2852106|NCT03841591|Metformin|metformin|mesh-list
2852107|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2852108|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852109|NCT03841292|Varenicline|varenicline|mesh-list
2852110|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2852111|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2852112|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
2852113|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852114|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852115|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852116|NCT03841383|Dipyridamole|dipyridamole|mesh-list
2852117|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2852118|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852119|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852120|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2852121|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
2852122|NCT03841305|Liver Extracts|liver extracts|mesh-list
2852123|NCT03841305|Hematinics|hematinics|mesh-ancestor
2852124|NCT03841357|Abatacept|abatacept|mesh-list
2852125|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2852126|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852127|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852128|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2852129|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
2852130|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301587|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301588|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301589|NCT00296699|Analgesics|analgesics|mesh-ancestor
2301590|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
2301591|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301592|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
2301593|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301594|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
2301595|NCT00296712|Dexetimide|dexetimide|mesh-list
2301596|NCT00296712|Citalopram|citalopram|mesh-list
2301597|NCT00296712|Bupropion|bupropion|mesh-list
2301598|NCT00296712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2301599|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2301600|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108000|NCT02497287|Citalopram|citalopram|mesh-list
2108001|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2108002|NCT02497287|Sertraline|sertraline|mesh-list
2108003|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
2108004|NCT02497287|Esketamine|esketamine|mesh-list
2108005|NCT02497287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2108006|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2108007|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108008|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108009|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483667|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301601|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301602|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301603|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
2301604|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301605|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2301606|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
2301607|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301608|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2852131|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2852132|NCT03841474|Citalopram|citalopram|mesh-list
2852133|NCT03841474|Sertraline|sertraline|mesh-list
2852134|NCT03841474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2852135|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2852136|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2852137|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852138|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852139|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
2852140|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852141|NCT03841474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2852142|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
2852143|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2852144|NCT03841136|Etoposide|etoposide|mesh-list
2852145|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2852146|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852147|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2852148|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2852149|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852150|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852151|NCT03841201|Nivolumab|nivolumab|mesh-list
2852152|NCT03841201|Lenvatinib|lenvatinib|mesh-list
2852153|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2852154|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852155|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2301609|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2301610|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
2301611|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
2301612|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301613|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2301614|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2301615|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
2301616|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2301617|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
2301618|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2301619|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2301620|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301621|NCT00296751|Fentanyl|fentanyl|mesh-list
2301622|NCT00296751|Meperidine|meperidine|mesh-list
2301623|NCT00296751|Bupivacaine|bupivacaine|mesh-list
2301624|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
2301625|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
2301626|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2301627|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301628|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
2301629|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301630|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2301631|NCT00296751|Narcotics|narcotics|mesh-ancestor
2301632|NCT00296751|Analgesics|analgesics|mesh-ancestor
2301633|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2852156|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852157|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2852158|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852159|NCT03841097|Tacrolimus|tacrolimus|mesh-list
2852160|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2852161|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
2852162|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852163|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2852164|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852165|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852166|NCT03841058|Abaloparatide|abaloparatide|mesh-list
2852167|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2852168|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852169|NCT03840915|Gemcitabine|gemcitabine|mesh-list
2852170|NCT03840915|Paclitaxel|paclitaxel|mesh-list
2852171|NCT03840915|Docetaxel|docetaxel|mesh-list
2301634|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2852172|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2852173|NCT03840915|Carboplatin|carboplatin|mesh-list
2852174|NCT03840915|Pemetrexed|pemetrexed|mesh-list
2852175|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2852176|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852177|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
2852178|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
2852179|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
2852180|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852181|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2852182|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
2852183|NCT03840915|Antiviral Agents|antiviral agents|mesh-ancestor
2852184|NCT03840915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2852185|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852186|NCT03840915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2852187|NCT03840915|Immunologic Factors|immunologic factors|mesh-ancestor
2852188|NCT03840915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852189|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2852190|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2852191|NCT03840616|Fluconazole|fluconazole|mesh-list
2852192|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
2852193|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301635|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
2301636|NCT00296777|Citalopram|citalopram|mesh-list
2301637|NCT00296777|Bupropion|bupropion|mesh-list
2301638|NCT00296777|Imipramine|imipramine|mesh-list
2301639|NCT00296777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2301640|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2301641|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2301642|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852194|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2852195|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2852196|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852197|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852198|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2852199|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
2852200|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2852201|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852202|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2852203|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2852204|NCT03840421|Gemcitabine|gemcitabine|mesh-list
2852205|NCT03840421|Cisplatin|cisplatin|mesh-list
2852206|NCT03840421|Fluorouracil|fluorouracil|mesh-list
2852207|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852208|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2852209|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
2852210|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852211|NCT03840421|Antiviral Agents|antiviral agents|mesh-ancestor
2852212|NCT03840421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2852213|NCT03840421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852214|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2852215|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
2852216|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852217|NCT03840291|Edoxaban|edoxaban|mesh-list
2852218|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2852219|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
2852220|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2852221|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
2852222|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852223|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852224|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
2852225|NCT03840239|Capecitabine|capecitabine|mesh-list
2108010|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
2108011|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108012|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2108013|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2108014|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108015|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2108016|NCT02497287|Analgesics|analgesics|mesh-ancestor
2108017|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
2108018|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
2108019|NCT02497391|Evacetrapib|evacetrapib|mesh-list
2108020|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2108021|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2852226|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
2852227|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2852228|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
2852229|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852230|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852231|NCT03840122|Anesthetics|anesthetics|mesh-list
2852232|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
2852233|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2852234|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852235|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
2852236|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852237|NCT03839888|Atropine|atropine|mesh-list
2852238|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2852239|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2852240|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2852241|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
2852242|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852243|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852244|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2852245|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
2852246|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
2852247|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
2852248|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2852249|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2852250|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
2852251|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852252|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852253|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
2852254|NCT03840226|Antacids|antacids|mesh-ancestor
2852255|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852256|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2852257|NCT03840057|Azithromycin|azithromycin|mesh-list
2852258|NCT03840057|Metoclopramide|metoclopramide|mesh-list
2852259|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2852260|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2852261|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
2852262|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
2852263|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852264|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852265|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2852266|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2852267|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2852268|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
2852269|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852270|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301643|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301644|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
2301645|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301646|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2301647|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
2301648|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301649|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2301650|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
2852271|NCT03839914|Vancomycin|vancomycin|mesh-list
2852272|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2852273|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2852279|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
2852280|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2852281|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
2852282|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852283|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
2852284|NCT03840070|Protective Agents|protective agents|mesh-ancestor
2852285|NCT03839693|Botulinum Toxins|botulinum toxins|mesh-list
2852286|NCT03839693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2852287|NCT03839693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2852288|NCT03839693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2852289|NCT03839693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2852290|NCT03839693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852291|NCT03839693|Cholinergic Agents|cholinergic agents|mesh-ancestor
2852292|NCT03839693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852293|NCT03839693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852294|NCT03839693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2852295|NCT03839693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852296|NCT03839771|Ivosidenib|ivosidenib|mesh-list
2852297|NCT03839771|Glycine|glycine|mesh-list
2852298|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852299|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852300|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852301|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
2852302|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852303|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852304|NCT03839940|Dexamethasone|dexamethasone|mesh-list
2852305|NCT03839940|Everolimus|everolimus|mesh-list
2852306|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2852307|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
2852308|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
2852309|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852310|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301651|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2301652|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2301653|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301654|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2301655|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2301656|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
2301657|NCT00296790|Zolpidem|zolpidem|mesh-list
2301658|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2301659|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2301660|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2301661|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301662|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2301663|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
2301664|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
2301665|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301666|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301667|NCT00296803|Clopidogrel|clopidogrel|mesh-list
2301668|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2301669|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2301670|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2852311|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2852312|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
2852313|NCT03839940|Hormones|hormones|mesh-ancestor
2852314|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2852315|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2852316|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852317|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2852318|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
2852319|NCT03839550|Apatinib|apatinib|mesh-list
2852320|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852321|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2852322|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852323|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852324|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
2852325|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
2852326|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2852327|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
2852328|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852329|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852330|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2852331|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
2852332|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2852333|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
2852334|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852335|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852336|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2852337|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
2852338|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
2852339|NCT03839537|Protective Agents|protective agents|mesh-ancestor
2852340|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
2301671|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2301672|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
2301673|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301674|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301675|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301676|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
2301677|NCT00296868|Vitamins|vitamins|mesh-ancestor
2301678|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
2301679|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301680|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
2852341|NCT03839498|Axitinib|axitinib|mesh-list
2852342|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852343|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2852344|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852345|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852346|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2852347|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2852348|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2852349|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
2852350|NCT03839251|Aripiprazole|aripiprazole|mesh-list
2852351|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
2852352|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2852353|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2301681|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301682|NCT00296868|Protective Agents|protective agents|mesh-ancestor
2301683|NCT00296894|Adalimumab|adalimumab|mesh-list
2301684|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2301685|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2301686|NCT00296933|Citalopram|citalopram|mesh-list
2301687|NCT00296933|Bupropion|bupropion|mesh-list
2301688|NCT00296933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2301689|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2301690|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2301691|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301692|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301693|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
2301694|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301695|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2301696|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
2301697|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301698|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2301699|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
2301700|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2301701|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2301702|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301703|NCT00296946|Bromides|bromides|mesh-list
2301704|NCT00296946|Ipratropium|ipratropium|mesh-list
2301705|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
2301706|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2301707|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
2301708|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852354|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2852355|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2852356|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852357|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
2852358|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
2852359|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852360|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852361|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2852362|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2852363|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
2852364|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2852365|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2852366|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2852367|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2852368|NCT03839459|Denosumab|denosumab|mesh-list
2852369|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2852370|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852371|NCT03839160|Morphine|morphine|mesh-list
2852372|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2852373|NCT03839160|Narcotics|narcotics|mesh-ancestor
2852374|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2852375|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852376|NCT03839160|Analgesics|analgesics|mesh-ancestor
2852377|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
2852378|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852379|NCT03839134|Lidocaine|lidocaine|mesh-list
2301709|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301710|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2301711|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
2301712|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2301713|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
2301714|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852380|NCT03839134|Epinephrine|epinephrine|mesh-list
2852381|NCT03839134|Racepinephrine|racepinephrine|mesh-list
2852382|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
2852383|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
2301715|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301716|NCT00296959|Topiramate|topiramate|mesh-list
2301717|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
2301718|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2301719|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301720|NCT00296972|Interferons|interferons|mesh-list
2301721|NCT00296972|Ribavirin|ribavirin|mesh-list
2301722|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301723|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
2852384|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
2852385|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2852386|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852387|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
2852388|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852389|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2852390|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2852391|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2852392|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2852393|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852394|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2852395|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2852396|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
2852397|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852398|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2852399|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2852400|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
2852401|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2852402|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
2852403|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
2852404|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
2852405|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2852406|NCT03839446|Etoposide|etoposide|mesh-list
2852407|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
2301724|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301725|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
2301726|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301727|NCT00297011|Valacyclovir|valacyclovir|mesh-list
2301728|NCT00297011|Clobetasol|clobetasol|mesh-list
2301729|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
2301730|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301731|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2301732|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
2301733|NCT00297011|Hormones|hormones|mesh-ancestor
2301734|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2301735|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301736|NCT00297050|Peramivir|peramivir|mesh-list
2852408|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
2852409|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2852410|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852411|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2852412|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2852413|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852414|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852415|NCT03839446|Analgesics|analgesics|mesh-ancestor
2852416|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
2852417|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852418|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301737|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
2301738|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301739|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301740|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301741|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
2301742|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2852419|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2852420|NCT03839433|Ciclesonide|ciclesonide|mesh-list
2852421|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
2852422|NCT03839433|Hormones|hormones|mesh-ancestor
2852423|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2852424|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852425|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2301743|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301744|NCT00297076|Aplaviroc|aplaviroc|mesh-list
2301745|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2301746|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2301747|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301748|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2301749|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2301750|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
2301751|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301752|NCT00297089|Pemetrexed|pemetrexed|mesh-list
2301753|NCT00297089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301754|NCT00297089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301755|NCT00297089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301756|NCT00297089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2301757|NCT00297089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2301758|NCT00297128|Capecitabine|capecitabine|mesh-list
2301759|NCT00297128|Cetuximab|cetuximab|mesh-list
2301760|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2301761|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
2301762|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301763|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301764|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2301765|NCT00297141|Capecitabine|capecitabine|mesh-list
2301766|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
2301767|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2301768|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
2301769|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301770|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301771|NCT00297206|Valacyclovir|valacyclovir|mesh-list
2301772|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
2301773|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301774|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
2301775|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
2301776|NCT00297219|Calcium|calcium|mesh-list
2301777|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2301778|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301779|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2301780|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2301781|NCT00297284|Modafinil|modafinil|mesh-list
2301782|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2301783|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301784|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2301785|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2301786|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2852426|NCT03838926|Trichostatin A|trichostatin a|mesh-list
2852427|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
2852428|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2852429|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2852430|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852431|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852432|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2852433|NCT03838783|Insulin|insulin|mesh-list
2852434|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2852435|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852436|NCT03838796|Lenvatinib|lenvatinib|mesh-list
2852437|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852438|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2852439|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852440|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852454|NCT03838484|Nicotine|nicotine|mesh-list
2852455|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2852456|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
2852457|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852458|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852459|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2852460|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2852461|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
2301787|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301788|NCT00297310|Tacrolimus|tacrolimus|mesh-list
2301789|NCT00297310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301790|NCT00297310|Immunologic Factors|immunologic factors|mesh-ancestor
2301791|NCT00297310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301792|NCT00297310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2852462|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852463|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852464|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2852465|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
2852466|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852467|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
2852468|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2852469|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2301793|NCT00297310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301794|NCT00297310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301795|NCT00297323|Topiramate|topiramate|mesh-list
2301796|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
2301797|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2301798|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301799|NCT00297336|Topiramate|topiramate|mesh-list
2301800|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
2301801|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2301802|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301803|NCT00297349|Topiramate|topiramate|mesh-list
2301804|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
2301805|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2301806|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301807|NCT00297362|Galantamine|galantamine|mesh-list
2301808|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2301809|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301810|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301811|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
2301812|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852470|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852471|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
2852472|NCT03838328|Coagulants|coagulants|mesh-ancestor
2852473|NCT03838263|Cisplatin|cisplatin|mesh-list
2852474|NCT03838263|Nivolumab|nivolumab|mesh-list
2852475|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852476|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2852477|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2852478|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852479|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
2852480|NCT03838575|Gentamicins|gentamicins|mesh-list
2852481|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
2852482|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2852483|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2852484|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
2852485|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2852486|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852487|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301813|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301814|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2108022|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
2108023|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108024|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2108025|NCT02497404|Fludarabine|fludarabine|mesh-list
2108026|NCT02497404|Azacitidine|azacitidine|mesh-list
2108027|NCT02497404|Melphalan|melphalan|mesh-list
2108028|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
2108029|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108030|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2108031|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
2108032|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108033|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2108034|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
2108035|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301815|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
2301816|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301817|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
2301818|NCT00297375|Acetaminophen|acetaminophen|mesh-list
2301819|NCT00297375|Tramadol|tramadol|mesh-list
2301820|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2301821|NCT00297375|Analgesics|analgesics|mesh-ancestor
2301822|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
2301823|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301824|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301825|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
2852488|NCT03838068|Anesthetics|anesthetics|mesh-list
2852489|NCT03838068|Procaine|procaine|mesh-list
2852490|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
2852491|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852492|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2852493|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
2852494|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852495|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
2852496|NCT03837886|Calcium|calcium|mesh-list
2301826|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2301827|NCT00297375|Narcotics|narcotics|mesh-ancestor
2301828|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2301829|NCT00297388|Risperidone|risperidone|mesh-list
2301830|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2301831|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
2301832|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301833|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301834|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301835|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2301836|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2301837|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2301838|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301839|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2301840|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
2301841|NCT00297401|Ruboxistaurin|ruboxistaurin|mesh-list
2301842|NCT00297401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301843|NCT00297401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301844|NCT00297466|Nicotine|nicotine|mesh-list
2301845|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2301846|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
2301847|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301848|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301849|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2852497|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2852498|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852499|NCT03837886|Antacids|antacids|mesh-ancestor
2852500|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852501|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2852502|NCT03838094|Calcium|calcium|mesh-list
2852503|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2852504|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852505|NCT03838133|Bupivacaine|bupivacaine|mesh-list
2852506|NCT03838133|Ropivacaine|ropivacaine|mesh-list
2852507|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
2852508|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
2852509|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2852510|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852511|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
2852512|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852513|NCT03837743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2852514|NCT03837977|Leucovorin|leucovorin|mesh-list
2852515|NCT03837977|Folic Acid|folic acid|mesh-list
2852516|NCT03837977|Docetaxel|docetaxel|mesh-list
2852517|NCT03837977|Fluorouracil|fluorouracil|mesh-list
2852518|NCT03837977|Irinotecan|irinotecan|mesh-list
2108036|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108037|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2108038|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
2108039|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2108040|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2852519|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
2852520|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852521|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
2852522|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
2852523|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
2852524|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852525|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
2852526|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2852527|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2852528|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
2108041|NCT02497469|Adalimumab|adalimumab|mesh-list
2108042|NCT02497469|Vedolizumab|vedolizumab|mesh-list
2108043|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2108044|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2108045|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2108046|NCT02497612|Artefenomel|artefenomel|mesh-list
2108047|NCT02497612|Ferroquine|ferroquine|mesh-list
2108048|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
2852529|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852530|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2852531|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2852532|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852533|NCT03837977|Antidotes|antidotes|mesh-ancestor
2852534|NCT03837977|Protective Agents|protective agents|mesh-ancestor
2852535|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
2852536|NCT03837977|Vitamins|vitamins|mesh-ancestor
2852537|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
2852538|NCT03837977|Hematinics|hematinics|mesh-ancestor
2852539|NCT03838029|Etodolac|etodolac|mesh-list
2852540|NCT03838029|Propranolol|propranolol|mesh-list
2852541|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2852542|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2852543|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
2852544|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852545|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852546|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852547|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2852548|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2852549|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
2852550|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2852551|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2852552|NCT03838029|Analgesics|analgesics|mesh-ancestor
2852553|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
2852554|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852555|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2852556|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2852557|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2852558|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2852559|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852560|NCT03837938|Dipropizine|dipropizine|mesh-list
2852561|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
2852562|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
2852563|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
2852564|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852565|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2852566|NCT03837925|Atorvastatin|atorvastatin|mesh-list
2852567|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2852568|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2852569|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
2852570|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852571|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2852572|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2852573|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301850|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2301851|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
2301852|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301853|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301854|NCT00297505|Citalopram|citalopram|mesh-list
2301855|NCT00297505|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2301856|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2301857|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2301858|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301859|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301860|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
2301861|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301862|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2301863|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
2301864|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301865|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
2301866|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
2301867|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2301868|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2301869|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301870|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301871|NCT00297544|Urological Agents|urological agents|mesh-ancestor
2301872|NCT00297570|Interferons|interferons|mesh-list
2301873|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
2301874|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301875|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
2852617|NCT03837509|Daratumumab|daratumumab|mesh-list
2852618|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301876|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301877|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2301878|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301879|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301880|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
2301881|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2301882|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301883|NCT00297661|Sirolimus|sirolimus|mesh-list
2301884|NCT00297661|Paclitaxel|paclitaxel|mesh-list
2301885|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2301886|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301887|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
2301888|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
2301889|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
2301890|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301891|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2301892|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301893|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2852619|NCT03837353|Docetaxel|docetaxel|mesh-list
2852620|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852621|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
2852622|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
2852623|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
2852624|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852625|NCT03837626|Amiloride|amiloride|mesh-list
2852626|NCT03837626|Diuretics|diuretics|mesh-ancestor
2852627|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
2852628|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852629|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2852630|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2852631|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2852632|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852633|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2852634|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2301894|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
2301895|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2852635|NCT03837470|Furosemide|furosemide|mesh-list
2852636|NCT03837470|Diuretics|diuretics|mesh-ancestor
2852637|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
2852638|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852639|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2852640|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2852641|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852642|NCT03836807|Ketoprofen|ketoprofen|mesh-list
2852643|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
2852644|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2852645|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2852646|NCT03836807|Analgesics|analgesics|mesh-ancestor
2852647|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
2852648|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852649|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852650|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2852651|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2852652|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2852653|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852654|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852655|NCT03836703|Iron|iron|mesh-list
2852656|NCT03836703|Trace Elements|trace elements|mesh-ancestor
2852657|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
2852658|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852659|NCT03836885|Apremilast|apremilast|mesh-list
2852660|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2852661|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2852662|NCT03836885|Analgesics|analgesics|mesh-ancestor
2852663|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
2852664|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852665|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852666|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2852667|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2852668|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2852669|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2852670|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852671|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852672|NCT03836833|Lamivudine|lamivudine|mesh-list
2852673|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2852674|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2852675|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852676|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852677|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
2852678|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2852679|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2852680|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2852681|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
2852682|NCT03836781|Ketorolac|ketorolac|mesh-list
2852683|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2852684|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2852685|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
2852686|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2852687|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2852688|NCT03836781|Analgesics|analgesics|mesh-ancestor
2852689|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
2852690|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852691|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852692|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2852693|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2852694|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2852695|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852696|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852697|NCT03836651|Antioxidants|antioxidants|mesh-list
2852698|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852699|NCT03836651|Protective Agents|protective agents|mesh-ancestor
2301896|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
2301897|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301898|NCT00297674|Clarithromycin|clarithromycin|mesh-list
2301899|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2301900|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301901|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2301902|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301903|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301904|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2301905|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2301906|NCT00297739|Risperidone|risperidone|mesh-list
2301907|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2301908|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
2301909|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301910|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301911|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301912|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2301913|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2301914|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2301915|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301916|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2301917|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
2301918|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2301919|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2301920|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2301921|NCT00297765|Tacrolimus|tacrolimus|mesh-list
2301922|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2852700|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852701|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
2852702|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2852703|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2301923|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
2301924|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301925|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2301926|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301927|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852704|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852705|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
2852706|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852707|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301928|NCT00297804|Paclitaxel|paclitaxel|mesh-list
2301929|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2301930|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301931|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
2301932|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
2301933|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
2301934|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301935|NCT00297817|Vaccines|vaccines|mesh-list
2301936|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
2301937|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301938|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2301939|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
2301940|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301941|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2301942|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2301943|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2301944|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301945|NCT00297960|Olanzapine|olanzapine|mesh-list
2301946|NCT00297960|Ziprasidone|ziprasidone|mesh-list
2301947|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
2301948|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
2301949|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2301950|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301951|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2301952|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2301953|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2301954|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2301955|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2301956|NCT00297960|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2301957|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2301958|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2301959|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301960|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2301961|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
2301962|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2301963|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2301964|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
2301965|NCT00298012|Methotrexate|methotrexate|mesh-list
2301966|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2301967|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
2301968|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2852710|NCT03836599|Allopurinol|allopurinol|mesh-list
2852711|NCT03836599|Verinurad|verinurad|mesh-list
2852712|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
2852713|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852714|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852715|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
2852716|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2852717|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2852718|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
2852719|NCT03836599|Protective Agents|protective agents|mesh-ancestor
2852720|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852738|NCT03836560|Nicotine|nicotine|mesh-list
2852739|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2301969|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301970|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2301971|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
2301972|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2301973|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301974|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
2301975|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2301976|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2301977|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2301978|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
2301979|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2301980|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2301981|NCT00298025|Cetrorelix|cetrorelix|mesh-list
2301982|NCT00298025|Menotropins|menotropins|mesh-list
2301983|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2301984|NCT00298025|Hormones|hormones|mesh-list
2301985|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2301986|NCT00298025|Ganirelix|ganirelix|mesh-list
2852740|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
2852741|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852742|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852743|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2852744|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2852745|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
2852746|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852747|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852748|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
2852749|NCT03836144|Diuretics|diuretics|mesh-ancestor
2852750|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
2852751|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852752|NCT03836144|Expectorants|expectorants|mesh-ancestor
2852753|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
2852754|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
2852755|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
2852756|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2852757|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
2852758|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852759|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2301987|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2852760|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2852761|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
2852762|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852763|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852764|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2852765|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2852769|NCT03836040|Erenumab|erenumab|mesh-list
2852770|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2852771|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2852772|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852773|NCT03836040|Analgesics|analgesics|mesh-ancestor
2301988|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301989|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
2301990|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2852774|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
2852775|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852776|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852777|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
2852778|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
2852779|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2852780|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852781|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852782|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2852783|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2852784|NCT03836222|Protective Agents|protective agents|mesh-ancestor
2852785|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852786|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
2852787|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2852788|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
2852789|NCT03836157|Bevacizumab|bevacizumab|mesh-list
2852790|NCT03836157|Maytansine|maytansine|mesh-list
2852791|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2852792|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852793|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2301991|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
2301992|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2301993|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
2301994|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2301995|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
2301996|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2301997|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2301998|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2301999|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
2302000|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302001|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
2302002|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2302003|NCT00298168|Protective Agents|protective agents|mesh-ancestor
2302004|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
2302005|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2302006|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
2302007|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302008|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2302009|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302010|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
2302011|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302012|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
2852794|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2852795|NCT03836157|Growth Substances|growth substances|mesh-ancestor
2852796|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852797|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
2852798|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2852799|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
2852800|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
2852801|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
2302013|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2302014|NCT00298181|Protective Agents|protective agents|mesh-ancestor
2302015|NCT00298194|Z 338|z 338|mesh-list
2302016|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2302017|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302018|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302019|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
2302020|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108049|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2108050|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2108051|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108052|NCT02497781|Ceftazidime|ceftazidime|mesh-list
2108053|NCT02497781|Cefepime|cefepime|mesh-list
2108054|NCT02497781|Avibactam|avibactam|mesh-list
2108055|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
2108056|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2108057|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108058|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2108059|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108060|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108061|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
2108062|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2108063|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
2108064|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302021|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302022|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2302023|NCT00298285|Enoxaparin|enoxaparin|mesh-list
2302024|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
2302025|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2302026|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2302027|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302028|NCT00298324|Cyclosporine|cyclosporine|mesh-list
2302029|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
2302030|NCT00298324|Prednisone|prednisone|mesh-list
2302031|NCT00298324|Cyclosporins|cyclosporins|mesh-list
2302032|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2302033|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
2302034|NCT00298324|Hormones|hormones|mesh-ancestor
2302035|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302036|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302037|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2302038|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302039|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852802|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852803|NCT03836001|Serlopitant|serlopitant|mesh-list
2852804|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2852805|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852806|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852807|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852808|NCT03836014|Dexamethasone|dexamethasone|mesh-list
2302040|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302041|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2302042|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
2302043|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
2302044|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302045|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
2302046|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2302047|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2302048|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2302049|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2302050|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
2302051|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2302052|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
2302053|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
2302054|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302055|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302056|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2302057|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2302058|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
2302059|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302060|NCT00298415|Gemcitabine|gemcitabine|mesh-list
2302061|NCT00298415|Paclitaxel|paclitaxel|mesh-list
2302062|NCT00298415|Vinorelbine|vinorelbine|mesh-list
2302063|NCT00298415|Carboplatin|carboplatin|mesh-list
2852809|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
2852810|NCT03836014|Lenalidomide|lenalidomide|mesh-list
2852811|NCT03836014|Daratumumab|daratumumab|mesh-list
2852812|NCT03836014|BB 1101|bb 1101|mesh-list
2852813|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2852814|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2852815|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
2852816|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
2852817|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852818|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852819|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2852820|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
2852821|NCT03836014|Hormones|hormones|mesh-ancestor
2852822|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2852823|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2852824|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852825|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
2852826|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852827|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852828|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
2852829|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2852830|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2852831|NCT03836014|Growth Substances|growth substances|mesh-ancestor
2852832|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
2852833|NCT03835676|Treprostinil|treprostinil|mesh-list
2852834|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2852835|NCT03835715|Vortioxetine|vortioxetine|mesh-list
2852836|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
2852837|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2852838|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2852839|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2852840|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2852841|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852842|NCT03835715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2852843|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2852844|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2852845|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852846|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852847|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
2852848|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2852849|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2852850|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2852851|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2852852|NCT03835442|Baclofen|baclofen|mesh-list
2852853|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2852854|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852855|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2852856|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852857|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2852858|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
2852859|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
2852860|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852861|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852862|NCT03835871|Beclomethasone|beclomethasone|mesh-list
2852863|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2852864|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
2852865|NCT03835871|Hormones|hormones|mesh-ancestor
2852866|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2852867|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852868|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2852869|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
2852870|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
2852871|NCT03835507|Hematinics|hematinics|mesh-ancestor
2852872|NCT03835533|Nivolumab|nivolumab|mesh-list
2852873|NCT03835533|Poly ICLC|poly iclc|mesh-list
2302064|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2302065|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2302066|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302067|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
2302068|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
2302069|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
2302070|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852874|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2852875|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852876|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2852877|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852878|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
2852879|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
2852880|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852881|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
2852882|NCT03835286|Vitamins|vitamins|mesh-ancestor
2852883|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
2852884|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852885|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
2852886|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852887|NCT03835286|Protective Agents|protective agents|mesh-ancestor
2852888|NCT03834766|Amphetamine|amphetamine|mesh-list
2852889|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2852890|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852891|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
2852892|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
2852893|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852894|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
2302071|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2302072|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
2302073|NCT00298415|Antiviral Agents|antiviral agents|mesh-ancestor
2302074|NCT00298415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302075|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302076|NCT00298415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2302077|NCT00298415|Immunologic Factors|immunologic factors|mesh-ancestor
2302078|NCT00298415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302079|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2302080|NCT00298454|Furosemide|furosemide|mesh-list
2302081|NCT00298454|Diuretics|diuretics|mesh-ancestor
2302082|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
2302083|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302084|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2302085|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2302086|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852895|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852896|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852897|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
2852898|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2852899|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2302087|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
2302088|NCT00298506|Tacrolimus|tacrolimus|mesh-list
2302089|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2302090|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
2852900|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2852901|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2852902|NCT03834831|Selenium|selenium|mesh-list
2852903|NCT03834831|Ubiquinone|ubiquinone|mesh-list
2852904|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
2852905|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
2852906|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852907|NCT03834831|Protective Agents|protective agents|mesh-ancestor
2852908|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852909|NCT03834831|Trace Elements|trace elements|mesh-ancestor
2852910|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
2852911|NCT03834831|Vitamins|vitamins|mesh-ancestor
2852912|NCT03834948|Paclitaxel|paclitaxel|mesh-list
2852913|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
2852914|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2852915|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852916|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
2852917|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
2852918|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
2852919|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852920|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2302091|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302092|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2302093|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302094|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302095|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2302096|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302097|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2302098|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
2852921|NCT03834740|Everolimus|everolimus|mesh-list
2852922|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852923|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2852924|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
2852925|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852926|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
2852927|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2852928|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2852929|NCT03834935|Analgesics|analgesics|mesh-ancestor
2852930|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
2852931|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852932|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852933|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2852934|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2852935|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
2852936|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2852937|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
2852938|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2852939|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852940|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108065|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2108066|NCT02498236|Oxytocin|oxytocin|mesh-list
2108067|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
2108068|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2108069|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108070|NCT02498418|Rifaximin|rifaximin|mesh-list
2108071|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2108072|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108073|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2852941|NCT03834883|Ibutilide|ibutilide|mesh-list
2852942|NCT03834883|Progesterone|progesterone|mesh-list
2852943|NCT03834883|Progestins|progestins|mesh-ancestor
2852944|NCT03834883|Hormones|hormones|mesh-ancestor
2852945|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2852946|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852947|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2852948|NCT03834909|Tenofovir|tenofovir|mesh-list
2852949|NCT03834909|Emtricitabine|emtricitabine|mesh-list
2852950|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2302099|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2302100|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302101|NCT00298545|Calcitriol|calcitriol|mesh-list
2302102|NCT00298545|Calcium|calcium|mesh-list
2302103|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2302104|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302105|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2302106|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2302107|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302108|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2302109|NCT00298545|Vitamins|vitamins|mesh-ancestor
2302110|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
2302111|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2302112|NCT00298571|Epinephrine|epinephrine|mesh-list
2302113|NCT00298571|Bupivacaine|bupivacaine|mesh-list
2302114|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
2302115|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
2302116|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2302117|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302118|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
2302119|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302120|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2302121|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2302122|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
2302123|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2852951|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
2852952|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2852953|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2852954|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2852955|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852956|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852957|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2852958|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2302124|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302125|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2852959|NCT03835065|Calpastatin|calpastatin|mesh-list
2852960|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2852961|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
2852962|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852963|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852964|NCT03834610|Tadalafil|tadalafil|mesh-list
2852965|NCT03834610|Testosterone|testosterone|mesh-list
2852966|NCT03834610|Androgens|androgens|mesh-ancestor
2852967|NCT03834610|Hormones|hormones|mesh-ancestor
2852968|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2852969|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852970|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
2852971|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2852972|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2852973|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2852974|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852975|NCT03834610|Urological Agents|urological agents|mesh-ancestor
2852976|NCT03834623|Nivolumab|nivolumab|mesh-list
2852977|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2852978|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852979|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2852980|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2852981|NCT03834454|Bupivacaine|bupivacaine|mesh-list
2852982|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
2852983|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
2852984|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2852985|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852986|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
2852987|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2852988|NCT03834519|Prednisone|prednisone|mesh-list
2852989|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
2852990|NCT03834519|Olaparib|olaparib|mesh-list
2852991|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
2852992|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2852993|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
2852994|NCT03834519|Hormones|hormones|mesh-ancestor
2852995|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2852996|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2852997|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2852998|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2852999|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853000|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2853001|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853002|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853003|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2853004|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
2853005|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2853006|NCT03834506|Dexamethasone|dexamethasone|mesh-list
2853007|NCT03834506|Prednisone|prednisone|mesh-list
2302126|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2302127|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
2302128|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2302129|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
2302130|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
2302131|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
2302132|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2302133|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
2302134|NCT00298597|Sargramostim|sargramostim|mesh-list
2302135|NCT00298597|Immunologic Factors|immunologic factors|mesh-ancestor
2302136|NCT00298597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302137|NCT00298597|Hematinics|hematinics|mesh-ancestor
2302138|NCT00298636|Adenosine|adenosine|mesh-list
2853008|NCT03834506|Docetaxel|docetaxel|mesh-list
2853009|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
2853010|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853011|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
2853012|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
2853013|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853014|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853015|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2853016|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
2302139|NCT00298636|Analgesics|analgesics|mesh-ancestor
2302140|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
2302141|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302142|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302143|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2302144|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
2853017|NCT03834506|Hormones|hormones|mesh-ancestor
2853018|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853019|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2853020|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853021|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
2853022|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
2853023|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
2853024|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302145|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2302146|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
2302147|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
2302148|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2853025|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853037|NCT03834571|Paclitaxel|paclitaxel|mesh-list
2853038|NCT03834571|Cisplatin|cisplatin|mesh-list
2853039|NCT03834571|Carboplatin|carboplatin|mesh-list
2853040|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2853041|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2853042|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853043|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
2853044|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
2853045|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
2853046|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853047|NCT03834233|Nivolumab|nivolumab|mesh-list
2853048|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853049|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853050|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2853051|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853052|NCT03833999|Ondansetron|ondansetron|mesh-list
2853053|NCT03833999|Lactulose|lactulose|mesh-list
2853054|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
2853055|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
2853056|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853057|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853058|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2302149|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302150|NCT00298662|Interferons|interferons|mesh-list
2302151|NCT00298662|Interferon-beta|interferon-beta|mesh-list
2302152|NCT00298662|Tacrolimus|tacrolimus|mesh-list
2302153|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
2302154|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302155|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
2302156|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302157|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2302158|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
2302159|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302160|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2302161|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302162|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302163|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2853059|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
2853060|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
2853061|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2853062|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
2853063|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2853064|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853065|NCT03833999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2853066|NCT03833999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2853067|NCT03833999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2853068|NCT03833999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2853069|NCT03833999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2853070|NCT03834012|Beclomethasone|beclomethasone|mesh-list
2853071|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2302164|NCT00298675|Irinotecan|irinotecan|mesh-list
2302165|NCT00298675|Iniparib|iniparib|mesh-list
2302166|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2302167|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2302168|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302169|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302170|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302171|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2302172|NCT00298688|Gefitinib|gefitinib|mesh-list
2302173|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302174|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2302175|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302176|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302177|NCT00298714|Losartan|losartan|mesh-list
2302178|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2302179|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2302180|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2302181|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2302182|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302183|NCT00298779|Bortezomib|bortezomib|mesh-list
2302184|NCT00298779|Omeprazole|omeprazole|mesh-list
2302185|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853072|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
2853073|NCT03834012|Hormones|hormones|mesh-ancestor
2853074|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853075|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853076|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2853077|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
2853078|NCT03833921|Prednisone|prednisone|mesh-list
2853079|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
2302186|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2302187|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2302188|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2302189|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302190|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302191|NCT00298857|Valproic Acid|valproic acid|mesh-list
2302192|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
2302193|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302194|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302195|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
2302196|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302197|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302198|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
2302199|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2302200|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2302201|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2302202|NCT00298870|Isoniazid|isoniazid|mesh-list
2302203|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
2302204|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2302205|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2853080|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853081|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
2853082|NCT03833921|Hormones|hormones|mesh-ancestor
2853083|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853084|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853085|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2853086|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853087|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2853088|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853089|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853090|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
2853091|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2853092|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
2853093|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2853094|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2853095|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853096|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2853097|NCT03834129|Analgesics|analgesics|mesh-ancestor
2853098|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
2853099|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853100|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2302206|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2302207|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2302208|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
2853101|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2853102|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2853103|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
2853104|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2853105|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853106|NCT03833895|Phenylephrine|phenylephrine|mesh-list
2853107|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
2853108|NCT03833895|Norepinephrine|norepinephrine|mesh-list
2853109|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2853110|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
2853111|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
2302209|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302210|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2302211|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
2302212|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2302213|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302214|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2853112|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853113|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853114|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
2853115|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2853116|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
2853117|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
2853118|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2853119|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2853120|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2853121|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
2853122|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2853123|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853124|NCT03833895|Protective Agents|protective agents|mesh-ancestor
2853125|NCT03833947|Dexamethasone|dexamethasone|mesh-list
2853126|NCT03833947|Lidocaine|lidocaine|mesh-list
2853127|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853128|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
2302215|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
2302216|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2302217|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302218|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302219|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302220|NCT00298909|Niacin|niacin|mesh-list
2302221|NCT00298909|Niacinamide|niacinamide|mesh-list
2302222|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
2302223|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2302224|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
2302225|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302226|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2302227|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
2302228|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
2302229|NCT00298909|Vitamins|vitamins|mesh-ancestor
2302230|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
2853129|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
2853130|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853131|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853132|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2853133|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
2853134|NCT03833947|Hormones|hormones|mesh-ancestor
2853135|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853136|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2853137|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853138|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
2853139|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
2853140|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2853141|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
2853142|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2853143|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2853144|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2853145|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2853146|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853147|NCT03833596|Prednisone|prednisone|mesh-list
2853148|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853149|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
2853150|NCT03833596|Hormones|hormones|mesh-ancestor
2853151|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302231|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853152|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853153|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2853154|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853155|NCT03833466|Metformin|metformin|mesh-list
2853156|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2853157|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853158|NCT03833570|Melatonin|melatonin|mesh-list
2853159|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
2853160|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853161|NCT03833570|Protective Agents|protective agents|mesh-ancestor
2853162|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853163|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2302232|NCT00298922|Azithromycin|azithromycin|mesh-list
2302233|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2302234|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302235|NCT00298974|Acetaminophen|acetaminophen|mesh-list
2302236|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2302237|NCT00298974|Hydrocodone|hydrocodone|mesh-list
2302238|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2302239|NCT00298974|Analgesics|analgesics|mesh-ancestor
2302240|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
2302241|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302242|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302243|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
2302244|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2302245|NCT00298974|Narcotics|narcotics|mesh-ancestor
2302246|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2302247|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
2302248|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
2302249|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2302250|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2302251|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2302252|NCT00298987|Dasatinib|dasatinib|mesh-list
2302253|NCT00298987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302254|NCT00298987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2302255|NCT00298987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302256|NCT00298987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302257|NCT00299013|Prednisolone|prednisolone|mesh-list
2302258|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2853164|NCT03833362|Interferons|interferons|mesh-list
2853165|NCT03833362|Ritonavir|ritonavir|mesh-list
2853166|NCT03833362|Ribavirin|ribavirin|mesh-list
2853167|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
2853168|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
2853169|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2853170|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2853171|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853172|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
2853173|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2853174|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2853175|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2853176|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
2853177|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853178|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853179|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2853180|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2853181|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2853182|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2853183|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
2853184|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
2853185|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853186|NCT03833440|Docetaxel|docetaxel|mesh-list
2853187|NCT03833440|Durvalumab|durvalumab|mesh-list
2853188|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853189|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
2853190|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
2853191|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
2853192|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853193|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853194|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2853195|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2853196|NCT03832972|Estrogens|estrogens|mesh-list
2853197|NCT03832972|Hormones|hormones|mesh-ancestor
2853198|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853199|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853200|NCT03833154|Durvalumab|durvalumab|mesh-list
2853201|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853202|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853203|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
2853204|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2853205|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2853206|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2853207|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2853208|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853209|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
2853210|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2853211|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853212|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2853213|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853214|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2853215|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2853216|NCT03832894|Estradiol|estradiol|mesh-list
2853217|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2853218|NCT03832894|Progesterone|progesterone|mesh-list
2853219|NCT03832894|Estrogens|estrogens|mesh-ancestor
2853220|NCT03832894|Hormones|hormones|mesh-ancestor
2853221|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853222|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853223|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2853224|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
2853225|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2302259|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
2302260|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2302261|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
2302262|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2302263|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
2302264|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2302265|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
2302266|NCT00299013|Hormones|hormones|mesh-ancestor
2302267|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302268|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302269|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2108074|NCT02498483|Acetaminophen|acetaminophen|mesh-list
2108075|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2108076|NCT02498483|Analgesics|analgesics|mesh-ancestor
2108077|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
2108078|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108079|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108080|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
2108081|NCT02498522|Metformin|metformin|mesh-list
2108082|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2108083|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108084|NCT02498600|Nivolumab|nivolumab|mesh-list
2108085|NCT02498600|Ipilimumab|ipilimumab|mesh-list
2108086|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2108087|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108088|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2108089|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108090|NCT02498652|Allopurinol|allopurinol|mesh-list
2108091|NCT02498652|Verinurad|verinurad|mesh-list
2108092|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
2108093|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108094|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108095|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
2108096|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2108097|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2108098|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
2108099|NCT02498652|Protective Agents|protective agents|mesh-ancestor
2853226|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2853227|NCT03832894|Progestins|progestins|mesh-ancestor
2853228|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
2853229|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853230|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108100|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108101|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
2853231|NCT03832660|Valsartan|valsartan|mesh-list
2853232|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2853233|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2853234|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2853235|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853236|NCT03832816|Dronabinol|dronabinol|mesh-list
2853237|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
2302270|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302271|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
2302272|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
2302273|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302274|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2302275|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2302276|NCT00299013|Protective Agents|protective agents|mesh-ancestor
2302277|NCT00299026|Paclitaxel|paclitaxel|mesh-list
2302278|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2302279|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853238|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853239|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2853240|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2853241|NCT03832816|Analgesics|analgesics|mesh-ancestor
2853242|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
2853243|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853244|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2853245|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2853246|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2853247|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853248|NCT03832816|Hormones|hormones|mesh-ancestor
2853249|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853250|NCT03832621|Nivolumab|nivolumab|mesh-list
2853251|NCT03832621|Ipilimumab|ipilimumab|mesh-list
2853252|NCT03832621|Temozolomide|temozolomide|mesh-list
2853253|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853254|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853255|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2853256|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853257|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2853258|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
2302280|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
2302281|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
2302282|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
2302283|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302284|NCT00299039|Acetaminophen|acetaminophen|mesh-list
2302285|NCT00299039|Ibuprofen|ibuprofen|mesh-list
2302286|NCT00299039|Codeine|codeine|mesh-list
2302287|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2302288|NCT00299039|Analgesics|analgesics|mesh-ancestor
2853259|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
2853260|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853261|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853262|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
2853263|NCT03832699|Progesterone|progesterone|mesh-list
2853264|NCT03832699|Progestins|progestins|mesh-ancestor
2853265|NCT03832699|Hormones|hormones|mesh-ancestor
2853266|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853267|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853268|NCT03832465|Levofloxacin|levofloxacin|mesh-list
2853269|NCT03832465|Ofloxacin|ofloxacin|mesh-list
2853270|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2853271|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2853272|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2853273|NCT03832465|Renal Agents|renal agents|mesh-ancestor
2302289|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
2302290|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302291|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302292|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
2302293|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2302294|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2302295|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2302296|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2853274|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2853275|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2853276|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2853277|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853278|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853279|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853280|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2853281|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2853282|NCT03832361|Maytansine|maytansine|mesh-list
2853283|NCT03832361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2853284|NCT03832361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853285|NCT03832361|Tubulin Modulators|tubulin modulators|mesh-ancestor
2853286|NCT03832361|Antimitotic Agents|antimitotic agents|mesh-ancestor
2853287|NCT03832361|Mitosis Modulators|mitosis modulators|mesh-ancestor
2853288|NCT03832361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853289|NCT03832049|Vaccines|vaccines|mesh-list
2853290|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
2853291|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853292|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
2853293|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
2853294|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2853295|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2853296|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2853297|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2853298|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853299|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853300|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853301|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
2853302|NCT03832179|Dexamethasone|dexamethasone|mesh-list
2853303|NCT03832179|Bevacizumab|bevacizumab|mesh-list
2853304|NCT03832179|Ranibizumab|ranibizumab|mesh-list
2853305|NCT03832179|Aflibercept|aflibercept|mesh-list
2853306|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853307|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853308|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2853309|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2853310|NCT03832179|Growth Substances|growth substances|mesh-ancestor
2853311|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853312|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
2853313|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853314|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
2853315|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
2853316|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853317|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2853318|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
2853319|NCT03832179|Hormones|hormones|mesh-ancestor
2853320|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853321|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2853322|NCT03832426|Ritonavir|ritonavir|mesh-list
2853323|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2853324|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2853325|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
2302297|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302298|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302299|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2302300|NCT00299039|Narcotics|narcotics|mesh-ancestor
2302301|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2302302|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
2302303|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
2302304|NCT00299065|Zileuton|zileuton|mesh-list
2302305|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2853326|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853327|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853328|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2853329|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2853330|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
2853331|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2853332|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2853333|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2853334|NCT03831984|Bromfenac|bromfenac|mesh-list
2853335|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
2853336|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2853337|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
2853338|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853339|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
2853340|NCT03831984|Protective Agents|protective agents|mesh-ancestor
2853341|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2853342|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2853343|NCT03831984|Analgesics|analgesics|mesh-ancestor
2853344|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
2853345|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853346|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853347|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2853348|NCT03831815|Rocuronium|rocuronium|mesh-list
2853349|NCT03831815|Cisatracurium|cisatracurium|mesh-list
2853350|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2853351|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2853352|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2853353|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853354|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302306|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2302307|NCT00299065|Analgesics|analgesics|mesh-ancestor
2302308|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
2302309|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302310|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302311|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2108102|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2108103|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2108104|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2108105|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108106|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108107|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
2108108|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108109|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108110|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2108111|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108112|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
2108113|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2108114|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
2108115|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302312|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2302313|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2302314|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302315|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302316|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2302317|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
2302318|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302319|NCT00299091|Efavirenz|efavirenz|mesh-list
2302320|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2853355|NCT03831334|Minoxidil|minoxidil|mesh-list
2853356|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2853357|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
2853358|NCT03831321|Diclofenac|diclofenac|mesh-list
2853359|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2853360|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2853361|NCT03831321|Analgesics|analgesics|mesh-ancestor
2853362|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
2853363|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853364|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853365|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853366|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2853367|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2853368|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853369|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853370|NCT03831464|Metformin|metformin|mesh-list
2853371|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2853372|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853373|NCT03831269|Azithromycin|azithromycin|mesh-list
2853374|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2853375|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302321|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2302322|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302323|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302324|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
2302325|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2853376|NCT03831113|Buprenorphine|buprenorphine|mesh-list
2853377|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2853378|NCT03831113|Narcotics|narcotics|mesh-ancestor
2853379|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2853380|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853381|NCT03831113|Analgesics|analgesics|mesh-ancestor
2853382|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
2853383|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853384|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2853385|NCT03831126|Betamethasone|betamethasone|mesh-list
2853386|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
2853387|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2853388|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
2853389|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2853390|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
2853391|NCT03831126|Hormones|hormones|mesh-ancestor
2853392|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853393|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853394|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853395|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2853396|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
2108116|NCT02499029|Expectorants|expectorants|mesh-ancestor
2108117|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
2108118|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2108119|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
2108120|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108121|NCT02499029|Protective Agents|protective agents|mesh-ancestor
2108122|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108123|NCT02499029|Antidotes|antidotes|mesh-ancestor
2108124|NCT02499081|Ixazomib|ixazomib|mesh-list
2108125|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853406|NCT03831425|Ubiquinone|ubiquinone|mesh-list
2853407|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
2853408|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
2853409|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853410|NCT03831425|Vitamins|vitamins|mesh-ancestor
2108126|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
2853411|NCT03831295|Antibodies|antibodies|mesh-list
2853412|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
2853413|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853414|NCT03830827|Vortioxetine|vortioxetine|mesh-list
2853415|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
2853416|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2853417|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2302326|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2302327|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2302328|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2302329|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2302330|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2302331|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2302332|NCT00299208|Azithromycin|azithromycin|mesh-list
2302333|NCT00299208|Artesunate|artesunate|mesh-list
2302334|NCT00299208|Quinine|quinine|mesh-list
2302335|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2302336|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302337|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
2302338|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2302339|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2302340|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302341|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
2302342|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
2302343|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2302344|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
2302345|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2302346|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302347|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2302348|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302349|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2302350|NCT00299208|Analgesics|analgesics|mesh-ancestor
2302351|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
2302352|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2302353|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2302354|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2302355|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2302356|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302357|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
2302358|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302359|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302360|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
2302361|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
2302362|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
2302363|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2853418|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2853419|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2853420|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853421|NCT03830827|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2853422|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2853423|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2853424|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853425|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2853426|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
2853427|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2853428|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2853429|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2853430|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2853431|NCT03830918|Temozolomide|temozolomide|mesh-list
2853432|NCT03830918|Atezolizumab|atezolizumab|mesh-list
2853433|NCT03830918|Niraparib|niraparib|mesh-list
2853434|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2853435|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2853436|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
2853437|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853438|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853439|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
2853440|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302364|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2302365|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302366|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2302367|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302368|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853441|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2853442|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853443|NCT03830957|Metoprolol|metoprolol|mesh-list
2853444|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2853445|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2853446|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
2853447|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
2853448|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853449|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853450|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2853451|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2853452|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2853453|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
2853454|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2853455|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853456|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
2853457|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
2853458|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853459|NCT03830489|Protective Agents|protective agents|mesh-ancestor
2853460|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853461|NCT03830489|Vitamins|vitamins|mesh-ancestor
2853462|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
2853463|NCT03830684|Baicalein|baicalein|mesh-list
2853464|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
2853465|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853466|NCT03830684|Protective Agents|protective agents|mesh-ancestor
2853467|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853468|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853469|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
2853470|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
2853471|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853476|NCT03830606|Paclitaxel|paclitaxel|mesh-list
2853477|NCT03830606|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2853478|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2853479|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853480|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
2853481|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
2853482|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
2853483|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853484|NCT03830398|Acetaminophen|acetaminophen|mesh-list
2853485|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2853486|NCT03830398|Analgesics|analgesics|mesh-ancestor
2853487|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
2853488|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853489|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853490|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
2853491|NCT03830164|Vitamins|vitamins|mesh-list
2853492|NCT03830164|Vitamin E|vitamin e|mesh-list
2853493|NCT03830164|Tocopherols|tocopherols|mesh-list
2853494|NCT03830164|Tocotrienols|tocotrienols|mesh-list
2853495|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
2853496|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
2853497|NCT03830164|Atorvastatin|atorvastatin|mesh-list
2853498|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
2853499|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853500|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2853501|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2302369|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2302370|NCT00299247|Renal Agents|renal agents|mesh-ancestor
2302371|NCT00299286|Lapatinib|lapatinib|mesh-list
2302372|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302373|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2302374|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302375|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302376|NCT00299325|Rimonabant|rimonabant|mesh-list
2302377|NCT00299325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2302378|NCT00299325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2302379|NCT00299325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2302380|NCT00299325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302381|NCT00299325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302382|NCT00299325|Hormones|hormones|mesh-ancestor
2302383|NCT00299325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302384|NCT00299325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302385|NCT00299351|Romidepsin|romidepsin|mesh-list
2302386|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2302387|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302388|NCT00299364|Tibolone|tibolone|mesh-list
2302389|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
2302390|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
2302391|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302392|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302393|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2853502|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
2853503|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853504|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2853505|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2853506|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853507|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
2853508|NCT03830164|Protective Agents|protective agents|mesh-ancestor
2853509|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2853510|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2853511|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2853512|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
2853513|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2853514|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2853515|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2853516|NCT03830385|Carboplatin|carboplatin|mesh-list
2853517|NCT03830385|Bleomycin|bleomycin|mesh-list
2853518|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853519|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2853520|NCT03830086|Midazolam|midazolam|mesh-list
2853521|NCT03830086|Sufentanil|sufentanil|mesh-list
2853522|NCT03830086|Bupivacaine|bupivacaine|mesh-list
2853523|NCT03830086|Propofol|propofol|mesh-list
2853524|NCT03830086|Sevoflurane|sevoflurane|mesh-list
2302394|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2302395|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302396|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2302397|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
2302398|NCT00299364|Hormones|hormones|mesh-ancestor
2302399|NCT00299377|Abciximab|abciximab|mesh-list
2302400|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
2302401|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2302402|NCT00299390|Sagopilone|sagopilone|mesh-list
2302403|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302404|NCT00299455|Amoxicillin|amoxicillin|mesh-list
2302405|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
2853525|NCT03830086|Rocuronium|rocuronium|mesh-list
2853526|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
2853527|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
2853528|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2853529|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853530|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
2853531|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853532|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2853533|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2853534|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
2853535|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2853536|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2853537|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2853538|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2853539|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
2853540|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
2853541|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2853542|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853543|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2853544|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2853545|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2853546|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2853547|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2853548|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2853549|NCT03830086|Narcotics|narcotics|mesh-ancestor
2853550|NCT03830086|Analgesics|analgesics|mesh-ancestor
2853551|NCT03830216|Insulin|insulin|mesh-list
2853552|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2853553|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2853554|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302406|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
2853555|NCT03830034|Iron|iron|mesh-list
2853556|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
2853557|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
2853558|NCT03830034|Trace Elements|trace elements|mesh-ancestor
2853559|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
2853560|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853561|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
2853562|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
2853563|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302407|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2302408|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2302409|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108127|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108128|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108129|NCT02499120|Cetuximab|cetuximab|mesh-list
2108130|NCT02499120|Palbociclib|palbociclib|mesh-list
2108131|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853564|NCT03829696|Misoprostol|misoprostol|mesh-list
2853565|NCT03829696|Mifepristone|mifepristone|mesh-list
2853566|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
2853567|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2853568|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
2853569|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2853570|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853571|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2853572|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2853573|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
2853574|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2853575|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2853576|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2853577|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2853578|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
2853579|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2853580|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2853581|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
2853582|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853583|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
2853584|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2853585|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2853586|NCT03829839|Lorazepam|lorazepam|mesh-list
2853587|NCT03829839|Oxytocin|oxytocin|mesh-list
2853588|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
2853589|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2853590|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853591|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
2853592|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
2853593|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
2853594|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853595|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2853596|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2853597|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2302410|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2302411|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302412|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302413|NCT00299507|Hydrocortisone|hydrocortisone|mesh-list
2302414|NCT00299507|Anecortave|anecortave|mesh-list
2302415|NCT00299507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2302416|NCT00299507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2302417|NCT00299507|Growth Substances|growth substances|mesh-ancestor
2302418|NCT00299507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302419|NCT00299507|Growth Inhibitors|growth inhibitors|mesh-ancestor
2302420|NCT00299507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302421|NCT00299507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2302422|NCT00299520|Linezolid|linezolid|mesh-list
2302423|NCT00299520|Iclaprim|iclaprim|mesh-list
2302424|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2302425|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302426|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2302427|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302428|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302429|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2302430|NCT00299559|Camphor|camphor|mesh-list
2302431|NCT00299559|Menthol|menthol|mesh-list
2302432|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
2302433|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
2302434|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2302435|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2853598|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2853599|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2853600|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2853601|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
2853602|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
2853603|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2853604|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853608|NCT03829943|Vitamin D|vitamin d|mesh-list
2853609|NCT03829943|Vitamins|vitamins|mesh-ancestor
2853610|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
2853611|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853612|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2853613|NCT03829774|Acetaminophen|acetaminophen|mesh-list
2853614|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2853615|NCT03829774|Analgesics|analgesics|mesh-ancestor
2853616|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
2853617|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853618|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853619|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
2853620|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
2853621|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853622|NCT03829917|Paromomycin|paromomycin|mesh-list
2853623|NCT03829917|Miltefosine|miltefosine|mesh-list
2853624|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2853625|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2853626|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2853627|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2853628|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
2853629|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853630|NCT03829930|Entinostat|entinostat|mesh-list
2853631|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853632|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2853633|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853634|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853647|NCT03829371|Dexamethasone|dexamethasone|mesh-list
2853648|NCT03829371|Prednisone|prednisone|mesh-list
2853649|NCT03829371|Lenalidomide|lenalidomide|mesh-list
2853650|NCT03829371|Melphalan|melphalan|mesh-list
2853651|NCT03829371|Bortezomib|bortezomib|mesh-list
2853652|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853653|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
2853654|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
2853655|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853656|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853657|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2853658|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
2853659|NCT03829371|Hormones|hormones|mesh-ancestor
2853660|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853661|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2853662|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853663|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
2853664|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2853665|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2853666|NCT03829371|Growth Substances|growth substances|mesh-ancestor
2853667|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
2853668|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2853669|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
2853670|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853671|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2853672|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2853673|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
2853674|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2853675|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2853676|NCT03829566|Prednisolone|prednisolone|mesh-list
2853677|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
2853678|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
2853679|NCT03829566|Rituximab|rituximab|mesh-list
2853680|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
2853681|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2853682|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2853683|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
2853684|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2853685|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
2853686|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853687|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2853688|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2853689|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
2853690|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853691|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853692|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2853693|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853694|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853695|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
2853696|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
2853697|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853698|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2853699|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
2853700|NCT03829566|Hormones|hormones|mesh-ancestor
2853701|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853702|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2853703|NCT03829566|Protective Agents|protective agents|mesh-ancestor
2853704|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2853705|NCT03829592|Misoprostol|misoprostol|mesh-list
2853706|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2302436|NCT00299572|Alendronate|alendronate|mesh-list
2302437|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2302438|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302439|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2302440|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2853707|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
2853708|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2853709|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853710|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2853711|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2853712|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
2853713|NCT03829345|Olaparib|olaparib|mesh-list
2853714|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2853715|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853716|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853717|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853718|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
2853719|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2853720|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2853721|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
2853722|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
2853723|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2853724|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853725|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853726|NCT03829514|Fenofibrate|fenofibrate|mesh-list
2853727|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2853728|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
2853729|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302441|NCT00299611|Levetiracetam|levetiracetam|mesh-list
2302442|NCT00299611|Sertraline|sertraline|mesh-list
2302443|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
2302444|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2302445|NCT00299611|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2302446|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2302447|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2302448|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302449|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302450|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
2302451|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302452|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
2302453|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
2302454|NCT00299650|Cisatracurium|cisatracurium|mesh-list
2302455|NCT00299650|Atracurium|atracurium|mesh-list
2302456|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2853730|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2853731|NCT03829319|Carboplatin|carboplatin|mesh-list
2853732|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
2853733|NCT03829319|Pemetrexed|pemetrexed|mesh-list
2853734|NCT03829319|Lenvatinib|lenvatinib|mesh-list
2853735|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853736|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853737|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853738|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853739|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2853740|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2853741|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2853742|NCT03829436|Nivolumab|nivolumab|mesh-list
2853743|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2302457|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2302458|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302459|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302460|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2853744|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853745|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2853746|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853747|NCT03829124|Ketamine|ketamine|mesh-list
2853748|NCT03829124|Propofol|propofol|mesh-list
2853749|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2853750|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2853751|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853752|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2853753|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
2853754|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
2853755|NCT03829124|Analgesics|analgesics|mesh-ancestor
2853756|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
2853757|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853758|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2853759|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2853760|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2853761|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2853762|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853763|NCT03829150|Amoxicillin|amoxicillin|mesh-list
2853764|NCT03829150|Metronidazole|metronidazole|mesh-list
2853765|NCT03829150|Clarithromycin|clarithromycin|mesh-list
2853766|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
2853767|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2853768|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2853769|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2853770|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2853771|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2853772|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853773|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853774|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2853775|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2853776|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2853777|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2853778|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2853779|NCT03829020|Metformin|metformin|mesh-list
2853780|NCT03829020|Nelfinavir|nelfinavir|mesh-list
2302461|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2302462|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2302463|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
2302464|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302465|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302466|NCT00299676|Galantamine|galantamine|mesh-list
2853781|NCT03829020|Bortezomib|bortezomib|mesh-list
2853782|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2853783|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853784|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853785|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2853786|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2853787|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
2853788|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853789|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853790|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2853791|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2853792|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
2853793|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2853794|NCT03829111|Nivolumab|nivolumab|mesh-list
2853795|NCT03829111|Ipilimumab|ipilimumab|mesh-list
2853796|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853797|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853798|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2853799|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853800|NCT03828929|Ascorbic Acid|ascorbic acid|mesh-list
2302467|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2302468|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302469|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302470|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
2302471|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302472|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302473|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2302474|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
2302475|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853801|NCT03828929|Thiamine|thiamine|mesh-list
2853802|NCT03828929|Vitamins|vitamins|mesh-ancestor
2853803|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
2853804|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853805|NCT03828929|Antioxidants|antioxidants|mesh-ancestor
2302476|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
2302477|NCT00299715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2302478|NCT00299715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2302479|NCT00299715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2302480|NCT00299715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2302481|NCT00299715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302482|NCT00299715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2302483|NCT00299715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2302484|NCT00299715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2302485|NCT00299715|Serotonin Agents|serotonin agents|mesh-ancestor
2302486|NCT00299715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302487|NCT00299715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302488|NCT00299715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2302489|NCT00299715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2302490|NCT00299715|Dopamine Agents|dopamine agents|mesh-ancestor
2302491|NCT00299754|Misoprostol|misoprostol|mesh-list
2302492|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2302493|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
2302494|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2302495|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302496|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2853806|NCT03828929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853807|NCT03828929|Protective Agents|protective agents|mesh-ancestor
2853808|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
2853809|NCT03829046|Evolocumab|evolocumab|mesh-list
2853810|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2853811|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2853812|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
2853813|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853814|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2853815|NCT03828838|177Lu-PSMA-617|177lu-psma-617|mesh-list
2853816|NCT03828838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2853817|NCT03828838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853818|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2853819|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
2853820|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853821|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
2853822|NCT03828682|Prednisone|prednisone|mesh-list
2853823|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
2853824|NCT03828682|Tacrolimus|tacrolimus|mesh-list
2853825|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
2853826|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2853827|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853828|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
2853829|NCT03828682|Hormones|hormones|mesh-ancestor
2853830|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853831|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853832|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2853833|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853834|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2853835|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
2853836|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2853837|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853838|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853839|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2853840|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2853841|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
2853842|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2853843|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2853844|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
2853845|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
2853846|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853847|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2853848|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2853849|NCT03828682|Protective Agents|protective agents|mesh-ancestor
2853850|NCT03828773|Fluconazole|fluconazole|mesh-list
2853851|NCT03828773|Posaconazole|posaconazole|mesh-list
2853852|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
2853853|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2853854|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2853855|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2853856|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853857|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853858|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2853859|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
2853860|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853861|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853862|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2853863|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2853864|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2853865|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2853866|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2853867|NCT03828292|Dexamethasone|dexamethasone|mesh-list
2853868|NCT03828292|Bortezomib|bortezomib|mesh-list
2853869|NCT03828292|Pomalidomide|pomalidomide|mesh-list
2853870|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853871|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
2853872|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
2853873|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853874|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853875|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2853876|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
2853877|NCT03828292|Hormones|hormones|mesh-ancestor
2853878|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853879|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2853880|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853881|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
2853882|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2853883|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2853884|NCT03828292|Growth Substances|growth substances|mesh-ancestor
2853885|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
2853886|NCT03828474|Acetazolamide|acetazolamide|mesh-list
2853887|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
2853888|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2853889|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853890|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853891|NCT03828474|Diuretics|diuretics|mesh-ancestor
2853892|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
2853893|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302497|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2302498|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
2302499|NCT00299819|Sifalimumab|sifalimumab|mesh-list
2302500|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2302501|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
2302502|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302503|NCT00299845|Lansoprazole|lansoprazole|mesh-list
2302504|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
2302505|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2302506|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2302507|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2302508|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302509|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302510|NCT00299858|Theophylline|theophylline|mesh-list
2302511|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2302512|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
2853894|NCT03828175|Anesthetics|anesthetics|mesh-list
2853895|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2853896|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853897|NCT03828227|Bevacizumab|bevacizumab|mesh-list
2853898|NCT03828227|Capecitabine|capecitabine|mesh-list
2853899|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2853900|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853901|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2853902|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2853903|NCT03828227|Growth Substances|growth substances|mesh-ancestor
2853904|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853905|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
2853906|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2853907|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
2853908|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853909|NCT03828006|Red yeast rice|red yeast rice|mesh-list
2853910|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2853911|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2853912|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2853913|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
2853914|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853915|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853916|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2853917|NCT03828032|Mannitol|mannitol|mesh-list
2853918|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2853919|NCT03828032|Diuretics|diuretics|mesh-ancestor
2853920|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
2853921|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853922|NCT03828019|Cyclosporine|cyclosporine|mesh-list
2853923|NCT03828019|Adalimumab|adalimumab|mesh-list
2853924|NCT03828019|Methotrexate|methotrexate|mesh-list
2853925|NCT03828019|Azathioprine|azathioprine|mesh-list
2853926|NCT03828019|Tacrolimus|tacrolimus|mesh-list
2853927|NCT03828019|Cyclosporins|cyclosporins|mesh-list
2853928|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2853929|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
2853930|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2853931|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853932|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2853933|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
2853934|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853935|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853936|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
2853937|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853938|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2853939|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2853940|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
2853941|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2853942|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2853943|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2853944|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
2853945|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302513|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302514|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302515|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2302516|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
2302517|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2302518|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302519|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302520|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
2853946|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853947|NCT03827876|Calcitriol|calcitriol|mesh-list
2108132|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853948|NCT03827876|Betamethasone|betamethasone|mesh-list
2853949|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2853950|NCT03827876|Calcipotriene|calcipotriene|mesh-list
2108133|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2108134|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108135|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108136|NCT02499146|Letrozole|letrozole|mesh-list
2108137|NCT02499146|Palbociclib|palbociclib|mesh-list
2108138|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108139|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2108140|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2108141|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302521|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2302522|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2302523|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
2302524|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302525|NCT00299871|Lixisenatide|lixisenatide|mesh-list
2302526|NCT00299871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2302527|NCT00299871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302528|NCT00299884|Atorvastatin|atorvastatin|mesh-list
2302529|NCT00299884|Ezetimibe|ezetimibe|mesh-list
2302530|NCT00299884|Fenofibrate|fenofibrate|mesh-list
2302531|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2302532|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2302533|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
2302534|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302535|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2302536|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2853951|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2853952|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
2853953|NCT03827876|Hormones|hormones|mesh-ancestor
2853954|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2853955|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853956|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2853957|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
2853958|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2853959|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2853960|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2853961|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853962|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2853963|NCT03827876|Vitamins|vitamins|mesh-ancestor
2853964|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
2853965|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2853966|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
2853967|NCT03828084|Decitabine|decitabine|mesh-list
2853968|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
2853969|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2853970|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
2853971|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853972|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2853973|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853974|NCT03828058|Tacrolimus|tacrolimus|mesh-list
2853975|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2853976|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
2853977|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853978|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2853979|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2853980|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2853981|NCT03827889|Fluorides|fluorides|mesh-list
2853982|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
2853983|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
2853984|NCT03827889|Protective Agents|protective agents|mesh-ancestor
2853985|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853986|NCT03827642|Naloxone|naloxone|mesh-list
2853987|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2853988|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853989|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
2853990|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853991|NCT03827629|Naloxone|naloxone|mesh-list
2853992|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2853993|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2853994|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
2853995|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2853996|NCT03827408|Midazolam|midazolam|mesh-list
2853997|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
2853998|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2853999|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854000|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854001|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2854002|NCT03827408|Analgesics|analgesics|mesh-ancestor
2854003|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
2854004|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854005|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2854006|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2854007|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2854008|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
2302537|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854009|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302538|NCT00299910|Montelukast|montelukast|mesh-list
2302539|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2302540|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
2302541|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2302542|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
2302543|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302544|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302545|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2302546|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2302547|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302548|NCT00299923|Ribavirin|ribavirin|mesh-list
2302549|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2302550|NCT00299923|Amantadine|amantadine|mesh-list
2854010|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854011|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2854012|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2854013|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2854014|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2854015|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2854016|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
2854017|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
2854018|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
2854019|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
2854020|NCT03827070|Afatinib|afatinib|mesh-list
2854021|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854022|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2302551|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
2302552|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302553|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
2302554|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302555|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2302556|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2302557|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
2302558|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854023|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854024|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854025|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2854026|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2854027|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2854028|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854029|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854030|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2302559|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302560|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2302561|NCT00299923|Analgesics|analgesics|mesh-ancestor
2302562|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
2302563|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302564|NCT00299936|Ribavirin|ribavirin|mesh-list
2302565|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2302566|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
2302567|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302568|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
2854031|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2854032|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854033|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
2854034|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854035|NCT03827018|Prednisone|prednisone|mesh-list
2854036|NCT03827018|Mavrilimumab|mavrilimumab|mesh-list
2854037|NCT03827018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2854038|NCT03827018|Glucocorticoids|glucocorticoids|mesh-ancestor
2854039|NCT03827018|Hormones|hormones|mesh-ancestor
2302569|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302570|NCT00299962|Interferons|interferons|mesh-list
2302571|NCT00299962|Interferon-beta|interferon-beta|mesh-list
2302572|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302573|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
2854040|NCT03827018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2854041|NCT03827018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854042|NCT03827018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2854043|NCT03827018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302574|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302575|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
2302576|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302577|NCT00300014|Triamcinolone|triamcinolone|mesh-list
2854044|NCT03827018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854045|NCT03827044|Avelumab|avelumab|mesh-list
2854046|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2854047|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854048|NCT03827200|Ambrisentan|ambrisentan|mesh-list
2854049|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2854050|NCT03827278|Itraconazole|itraconazole|mesh-list
2854051|NCT03827278|Voriconazole|voriconazole|mesh-list
2854052|NCT03827278|Amphotericin B|amphotericin b|mesh-list
2854053|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
2854054|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854055|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2854056|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2854057|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854058|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854059|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2854060|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
2854061|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2854062|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854063|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2854064|NCT03827278|Amebicides|amebicides|mesh-ancestor
2854065|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2854066|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2854067|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2854068|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
2854069|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2854070|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
2854071|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
2854072|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854073|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854074|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2854075|NCT03826693|Analgesics|analgesics|mesh-ancestor
2854076|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
2854077|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854078|NCT03826940|Lovastatin|lovastatin|mesh-list
2854079|NCT03826940|L 647318|l 647318|mesh-list
2854080|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
2854081|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2854082|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2854083|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
2854084|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854085|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2854086|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2854087|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854088|NCT03826875|Fluoxetine|fluoxetine|mesh-list
2854089|NCT03826875|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2854090|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2854091|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2854092|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854093|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854094|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
2854095|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854096|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2854097|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
2854098|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2854099|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2854100|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2854101|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854102|NCT03826589|Avelumab|avelumab|mesh-list
2854103|NCT03826589|Axitinib|axitinib|mesh-list
2854104|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2854105|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854106|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2854107|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854108|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854109|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
2854110|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
2854111|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
2854112|NCT03826628|Sirolimus|sirolimus|mesh-list
2854113|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2854114|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302578|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2302579|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
2302580|NCT00300014|Hormones|hormones|mesh-ancestor
2302581|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302582|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302583|NCT00300040|HBOC 201|hboc 201|mesh-list
2854115|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2854116|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854117|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
2854118|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2854119|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
2854120|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854121|NCT03826615|Gabapentin|gabapentin|mesh-list
2854122|NCT03826615|Analgesics|analgesics|mesh-ancestor
2854123|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
2854124|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854125|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854126|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
2854127|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2854128|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2854129|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854130|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2854131|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2854132|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2854133|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854134|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854135|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
2854136|NCT03826602|Metformin|metformin|mesh-list
2854137|NCT03826602|Tucatinib|tucatinib|mesh-list
2854138|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2854139|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854140|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854141|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2854142|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854143|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854144|NCT03826563|Melatonin|melatonin|mesh-list
2854145|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
2854146|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854147|NCT03826563|Protective Agents|protective agents|mesh-ancestor
2854148|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854149|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854150|NCT03826550|Diclofenac|diclofenac|mesh-list
2854151|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2854152|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2854153|NCT03826550|Analgesics|analgesics|mesh-ancestor
2854154|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
2854155|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854156|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854157|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2854158|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854159|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2854160|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854161|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854162|NCT03826485|Pranlukast|pranlukast|mesh-list
2854163|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2854164|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
2854165|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2854166|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
2854167|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2854168|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854169|NCT03826524|Epinephrine|epinephrine|mesh-list
2854170|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2302584|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
2302585|NCT00300079|Brinzolamide|brinzolamide|mesh-list
2302586|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2302587|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302588|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302589|NCT00300118|Budesonide|budesonide|mesh-list
2302590|NCT00300118|Mesalamine|mesalamine|mesh-list
2302591|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2302592|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2302593|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
2302594|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302595|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302596|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2302597|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
2302598|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
2302599|NCT00300118|Hormones|hormones|mesh-ancestor
2302600|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302601|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2302602|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2302603|NCT00300118|Analgesics|analgesics|mesh-ancestor
2302604|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
2302605|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2302606|NCT00300131|Everolimus|everolimus|mesh-list
2302607|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302608|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2302609|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
2302610|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302611|NCT00300196|Ancrod|ancrod|mesh-list
2302612|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
2854171|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2854172|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
2854173|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854174|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854175|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854176|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2854177|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2854178|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
2854179|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854180|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2854181|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
2854182|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
2854183|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
2854184|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2854185|NCT03826368|Cannabidiol|cannabidiol|mesh-list
2854186|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
2854187|NCT03826316|Nalbuphine|nalbuphine|mesh-list
2854188|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2854189|NCT03826316|Narcotics|narcotics|mesh-ancestor
2854190|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854191|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302613|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2302614|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2302615|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302616|NCT00300222|Capsaicin|capsaicin|mesh-list
2302617|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
2302618|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
2302619|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
2302620|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302621|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302622|NCT00300287|Vildagliptin|vildagliptin|mesh-list
2302623|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2302624|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302625|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2302626|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
2302627|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302628|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302629|NCT00300313|Citalopram|citalopram|mesh-list
2302630|NCT00300313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2854192|NCT03826316|Analgesics|analgesics|mesh-ancestor
2854193|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
2854194|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854195|NCT03826303|Ethanol|ethanol|mesh-list
2854196|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2854197|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854198|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854199|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854200|NCT03825965|Cannabidiol|cannabidiol|mesh-list
2854201|NCT03825965|Anticonvulsants|anticonvulsants|mesh-ancestor
2854202|NCT03825887|Morphine|morphine|mesh-list
2854203|NCT03825887|Nalbuphine|nalbuphine|mesh-list
2854204|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2854205|NCT03825887|Narcotics|narcotics|mesh-ancestor
2854206|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2302631|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2302632|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2854207|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854208|NCT03825887|Analgesics|analgesics|mesh-ancestor
2854209|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
2854210|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854211|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2854212|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2854213|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2854214|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854215|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854216|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
2854217|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854218|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2854219|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2854220|NCT03826004|Clemastine|clemastine|mesh-list
2854221|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
2854222|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
2854223|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2854224|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
2302633|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302634|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302635|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
2302636|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302637|NCT00300313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2302638|NCT00300313|Antidepressive Agents|antidepressive agents|mesh-ancestor
2302639|NCT00300313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2302640|NCT00300339|Clopidogrel|clopidogrel|mesh-list
2302641|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2302642|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2302643|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2302644|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2302645|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
2302646|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302647|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302648|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302649|NCT00300352|Folic Acid|folic acid|mesh-list
2302650|NCT00300352|Hematinics|hematinics|mesh-ancestor
2302651|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
2302652|NCT00300352|Vitamins|vitamins|mesh-ancestor
2302653|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
2302654|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302655|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2302656|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2302657|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2302658|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2854225|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
2854226|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854227|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854228|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854229|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2854230|NCT03825861|Folfirinox|folfirinox|mesh-list
2854231|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854232|NCT03825809|Acetaminophen|acetaminophen|mesh-list
2854233|NCT03825809|Celecoxib|celecoxib|mesh-list
2854234|NCT03825809|Ketorolac|ketorolac|mesh-list
2854235|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2854236|NCT03825809|Diazepam|diazepam|mesh-list
2854237|NCT03825809|Gabapentin|gabapentin|mesh-list
2854238|NCT03825809|Hydrocodone|hydrocodone|mesh-list
2302659|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302660|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302661|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302662|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
2302663|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2302664|NCT00300404|Leucovorin|leucovorin|mesh-list
2302665|NCT00300404|Folic Acid|folic acid|mesh-list
2302666|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
2302667|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
2302668|NCT00300404|Antidotes|antidotes|mesh-ancestor
2302669|NCT00300404|Protective Agents|protective agents|mesh-ancestor
2302670|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302671|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
2302672|NCT00300404|Vitamins|vitamins|mesh-ancestor
2302673|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
2302674|NCT00300404|Hematinics|hematinics|mesh-ancestor
2302675|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
2854239|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2854240|NCT03825809|Analgesics|analgesics|mesh-ancestor
2854241|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
2854242|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854243|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854244|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
2854245|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2854246|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2854247|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854248|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2854249|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2854250|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854251|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302676|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2302677|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2302678|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302679|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2302680|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302681|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302682|NCT00300443|Bimatoprost|bimatoprost|mesh-list
2302683|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2302684|NCT00300508|Anastrozole|anastrozole|mesh-list
2854252|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
2854253|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2854254|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2854255|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854256|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2854257|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2854258|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2854259|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302685|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2302686|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302687|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2302688|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2302689|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854260|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
2854261|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2854262|NCT03825809|Narcotics|narcotics|mesh-ancestor
2854263|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
2854264|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
2854265|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2854266|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
2854267|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
2854268|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2854269|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2854270|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2854271|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2854272|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2854273|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
2854274|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
2854275|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
2854276|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
2854277|NCT03825601|Flumazenil|flumazenil|mesh-list
2854278|NCT03825601|Antidotes|antidotes|mesh-ancestor
2854279|NCT03825601|Protective Agents|protective agents|mesh-ancestor
2854280|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854281|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
2854282|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
2854283|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854284|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854285|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
2854286|NCT03825471|Anesthetics|anesthetics|mesh-list
2854287|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854288|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854289|NCT03825471|Narcotics|narcotics|mesh-ancestor
2854290|NCT03825471|Analgesics|analgesics|mesh-ancestor
2854291|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
2854292|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854293|NCT03825757|Aspirin|aspirin|mesh-list
2854294|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
2854295|NCT03825757|Salicylates|salicylates|mesh-list
2854296|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854297|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
2854298|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
2854299|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
2854300|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2854301|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2854302|NCT03825757|Analgesics|analgesics|mesh-ancestor
2854303|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
2854304|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854305|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854306|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2854307|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854308|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2854309|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854310|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854311|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2854312|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2854313|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2854314|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
2854315|NCT03825380|Bimatoprost|bimatoprost|mesh-list
2854316|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2854317|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
2854318|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854319|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
2854320|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854321|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854322|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2854323|NCT03825302|Mannitol|mannitol|mesh-list
2854324|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
2854325|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2854326|NCT03825302|Diuretics|diuretics|mesh-ancestor
2854327|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
2854328|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854329|NCT03825302|Miotics|miotics|mesh-ancestor
2854330|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
2854331|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854332|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2854333|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2854334|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
2854335|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2854336|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2854337|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
2854338|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854339|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854340|NCT03825250|Valproic Acid|valproic acid|mesh-list
2854341|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
2854342|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854343|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854344|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
2854345|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854346|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854347|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
2854348|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2854349|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854350|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2854351|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2854352|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2854353|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854354|NCT03825198|Dexamethasone|dexamethasone|mesh-list
2854355|NCT03825198|Ketorolac|ketorolac|mesh-list
2854356|NCT03825198|Sufentanil|sufentanil|mesh-list
2854357|NCT03825198|Morphine|morphine|mesh-list
2854358|NCT03825198|Bromides|bromides|mesh-list
2854359|NCT03825198|Propofol|propofol|mesh-list
2854360|NCT03825198|Sevoflurane|sevoflurane|mesh-list
2854361|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
2302690|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854362|NCT03825198|Rocuronium|rocuronium|mesh-list
2854363|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2854364|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
2854365|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
2854366|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854367|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854368|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2854369|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
2854370|NCT03825198|Hormones|hormones|mesh-ancestor
2854371|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2854372|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2854373|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854374|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
2854375|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854376|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2854377|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2854378|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
2854379|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2302691|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2302692|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
2302693|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302694|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302695|NCT00300560|Colistin|colistin|mesh-list
2302696|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2302697|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302698|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
2302699|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2302700|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2302701|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302702|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302703|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
2302704|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302705|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2302706|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2302707|NCT00300586|Gemcitabine|gemcitabine|mesh-list
2302708|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2302709|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2302710|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
2302711|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302712|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302713|NCT00300586|Antiviral Agents|antiviral agents|mesh-ancestor
2302714|NCT00300586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302715|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302716|NCT00300586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2302717|NCT00300586|Immunologic Factors|immunologic factors|mesh-ancestor
2302718|NCT00300586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302719|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2302720|NCT00300664|Hormones|hormones|mesh-list
2302721|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302722|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302723|NCT00300716|Memantine|memantine|mesh-list
2302724|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2302725|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2302726|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
2854380|NCT03825198|Narcotics|narcotics|mesh-ancestor
2854381|NCT03825198|Analgesics|analgesics|mesh-ancestor
2854382|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
2854383|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2854384|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2854385|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2854386|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
2854387|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2854388|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854389|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2854390|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854391|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854392|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2854393|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2854394|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2854395|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
2854396|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2854397|NCT03825367|Nivolumab|nivolumab|mesh-list
2854398|NCT03825367|Azacitidine|azacitidine|mesh-list
2854399|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2854400|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854401|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2854402|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854403|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2854404|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
2854405|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854406|NCT03825536|Methamphetamine|methamphetamine|mesh-list
2854407|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2854408|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854409|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
2854410|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
2854411|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854412|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
2854413|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854414|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854415|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
2854416|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2302727|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302728|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302729|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302730|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2302731|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2302732|NCT00300729|Celecoxib|celecoxib|mesh-list
2302733|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2302734|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2302735|NCT00300729|Analgesics|analgesics|mesh-ancestor
2302736|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
2302737|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854417|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2854418|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2854419|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2854420|NCT03825328|Gemcitabine|gemcitabine|mesh-list
2854421|NCT03825328|Paclitaxel|paclitaxel|mesh-list
2854422|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
2854423|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2854424|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2854425|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854426|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
2854427|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
2854428|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
2854429|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302738|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302739|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2302740|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2302741|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2302742|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2302743|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302744|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302745|NCT00300768|Ivermectin|ivermectin|mesh-list
2302746|NCT00300768|Moxidectin|moxidectin|mesh-list
2302747|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2302748|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302749|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
2302750|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
2302751|NCT00300794|Ketamine|ketamine|mesh-list
2854430|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2854431|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
2854432|NCT03825328|Antiviral Agents|antiviral agents|mesh-ancestor
2854433|NCT03825328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854434|NCT03825328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854435|NCT03825328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2854436|NCT03825328|Immunologic Factors|immunologic factors|mesh-ancestor
2854437|NCT03825328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108142|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108143|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2108144|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
2108145|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302752|NCT00300794|Analgesics|analgesics|mesh-ancestor
2854438|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
2854439|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2854440|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
2854441|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854442|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
2854443|NCT03825133|Protective Agents|protective agents|mesh-ancestor
2854444|NCT03824847|Clarithromycin|clarithromycin|mesh-list
2854445|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2302753|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
2302754|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302755|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302756|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2302757|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2302758|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
2302759|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
2302760|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2302761|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2854446|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854447|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2854448|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854449|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854450|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2854451|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2854452|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
2854453|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2854454|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2854455|NCT03824925|Zinc|zinc|mesh-list
2854456|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
2854457|NCT03824925|Trace Elements|trace elements|mesh-ancestor
2854458|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
2854459|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854460|NCT03824925|Astringents|astringents|mesh-ancestor
2854461|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
2854462|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2854463|NCT03825081|Pilocarpine|pilocarpine|mesh-list
2854464|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2854465|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2854466|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2854467|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2854468|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
2854469|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854470|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854471|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854472|NCT03825081|Miotics|miotics|mesh-ancestor
2854473|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
2854474|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854475|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2854476|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2854477|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
2854478|NCT03825068|Anesthetics|anesthetics|mesh-list
2854479|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
2854480|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854481|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854482|NCT03824665|Fentanyl|fentanyl|mesh-list
2854483|NCT03824665|Nalbuphine|nalbuphine|mesh-list
2854484|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2854485|NCT03824665|Narcotics|narcotics|mesh-ancestor
2854486|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854487|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302762|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2302763|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302764|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302765|NCT00300833|Tirofiban|tirofiban|mesh-list
2302766|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2302767|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2302768|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302769|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2302770|NCT00300846|Aripiprazole|aripiprazole|mesh-list
2302771|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
2302772|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2854488|NCT03824665|Analgesics|analgesics|mesh-ancestor
2854489|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
2854490|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854491|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2854492|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2854493|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
2302773|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2302774|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2302775|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2302776|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302777|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
2302778|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
2302779|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302780|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302781|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2302782|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2302783|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
2302784|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2302785|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2302786|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2302787|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2302788|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
2302789|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2302790|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302791|NCT00300924|Acetaminophen|acetaminophen|mesh-list
2302792|NCT00300924|Rizatriptan|rizatriptan|mesh-list
2302793|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2302794|NCT00300924|Analgesics|analgesics|mesh-ancestor
2302795|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
2302796|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302797|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302798|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
2302799|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2302800|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
2302801|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302802|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302803|NCT00300937|Ubiquinone|ubiquinone|mesh-list
2302804|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
2302805|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
2302806|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302807|NCT00300937|Vitamins|vitamins|mesh-ancestor
2854494|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
2854495|NCT03824938|Aspirin|aspirin|mesh-list
2854496|NCT03824938|Acetaminophen|acetaminophen|mesh-list
2854497|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2854498|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2854499|NCT03824938|Analgesics|analgesics|mesh-ancestor
2854500|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
2854501|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854502|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854503|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2854504|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854505|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2854506|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2854507|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302808|NCT00300950|Gemcitabine|gemcitabine|mesh-list
2302809|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2302810|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
2302811|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302812|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854508|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2854509|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2854510|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854511|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
2854512|NCT03825016|Diclofenac|diclofenac|mesh-list
2854513|NCT03825016|Lidocaine|lidocaine|mesh-list
2854514|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
2854515|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
2854516|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854517|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854518|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
2854519|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854520|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2854521|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2854522|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2854523|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2854524|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854525|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2854526|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2854527|NCT03825016|Analgesics|analgesics|mesh-ancestor
2854528|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2302813|NCT00300950|Antiviral Agents|antiviral agents|mesh-ancestor
2302814|NCT00300950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302815|NCT00300950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302816|NCT00300950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2302817|NCT00300950|Immunologic Factors|immunologic factors|mesh-ancestor
2854529|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854530|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2854531|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854532|NCT03824717|Ropivacaine|ropivacaine|mesh-list
2854533|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
2854534|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
2854535|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854536|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854537|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
2854538|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854539|NCT03824834|Morphine|morphine|mesh-list
2854540|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2854541|NCT03824834|Narcotics|narcotics|mesh-ancestor
2854542|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854543|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854544|NCT03824834|Analgesics|analgesics|mesh-ancestor
2854545|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
2854546|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854547|NCT03824691|Durvalumab|durvalumab|mesh-list
2302818|NCT00300950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302819|NCT00301002|Alefacept|alefacept|mesh-list
2302820|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
2302821|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
2302822|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302823|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
2302824|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
2302825|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2302826|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
2302827|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2302828|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2302829|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302830|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2302831|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302832|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302833|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2302834|NCT00301054|Renal Agents|renal agents|mesh-ancestor
2302835|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
2302836|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302837|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2302838|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302839|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302840|NCT00301106|Interleukin-12|interleukin-12|mesh-list
2302841|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2302842|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
2302843|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302844|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2302845|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2302846|NCT00301106|Growth Substances|growth substances|mesh-ancestor
2302847|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
2302848|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302849|NCT00301145|Varenicline|varenicline|mesh-list
2302850|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2302851|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2302852|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
2302853|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302854|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302855|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302856|NCT00301171|Fluticasone|fluticasone|mesh-list
2302857|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2302858|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2854548|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2854549|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854550|NCT03824483|Venetoclax|venetoclax|mesh-list
2854551|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
2854552|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
2302859|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
2302860|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302861|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302862|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2302863|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
2854553|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854554|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2854555|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2854556|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854557|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854558|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2854559|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
2854560|NCT03824379|Cathartics|cathartics|mesh-ancestor
2854561|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2854562|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854563|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
2854564|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2854565|NCT03824535|Fluorides|fluorides|mesh-list
2302864|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
2302865|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2302866|NCT00301210|Tramadol|tramadol|mesh-list
2302867|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2302868|NCT00301210|Narcotics|narcotics|mesh-ancestor
2302869|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2302870|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302871|NCT00301210|Analgesics|analgesics|mesh-ancestor
2302872|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
2302873|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302874|NCT00301223|Pregabalin|pregabalin|mesh-list
2302875|NCT00301223|Analgesics|analgesics|mesh-ancestor
2302876|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
2302877|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302878|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302879|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
2302880|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2854566|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2854567|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854568|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
2854569|NCT03824535|Protective Agents|protective agents|mesh-ancestor
2854570|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854571|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
2854572|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
2854573|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854574|NCT03824561|Vedolizumab|vedolizumab|mesh-list
2854575|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2854576|NCT03824327|Papaverine|papaverine|mesh-list
2854577|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2854578|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854579|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854580|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
2854581|NCT03824327|Urological Agents|urological agents|mesh-ancestor
2854582|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
2854583|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2854584|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2854585|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854586|NCT03824171|Vitamins|vitamins|mesh-ancestor
2854587|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
2854588|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2854589|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2854590|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
2854591|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302881|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2302882|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302883|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2302884|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2302885|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2854592|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2854593|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2854594|NCT03824587|Calcium, Dietary|calcium, dietary|mesh-list
2854595|NCT03824587|Calcium Carbonate|calcium carbonate|mesh-list
2854596|NCT03824587|Calcium|calcium|mesh-list
2854597|NCT03824587|Sevelamer|sevelamer|mesh-list
2854598|NCT03824587|Calcium acetate|calcium acetate|mesh-list
2854599|NCT03824587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2854600|NCT03824587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854601|NCT03824587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2854602|NCT03824587|Chelating Agents|chelating agents|mesh-ancestor
2302886|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2302887|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2854603|NCT03824587|Sequestering Agents|sequestering agents|mesh-ancestor
2854604|NCT03824587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302888|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
2302889|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2302890|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302891|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2854605|NCT03824587|Antacids|antacids|mesh-ancestor
2854606|NCT03824587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2854612|NCT03824314|Fentanyl|fentanyl|mesh-list
2854613|NCT03824314|Midazolam|midazolam|mesh-list
2854614|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2854615|NCT03824314|Narcotics|narcotics|mesh-ancestor
2854616|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854617|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854618|NCT03824314|Analgesics|analgesics|mesh-ancestor
2854619|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
2854620|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854621|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2854622|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2854623|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
2854624|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
2854625|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2854626|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2854627|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2854628|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2854629|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
2854630|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
2854631|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854632|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854633|NCT03824119|Ibuprofen|ibuprofen|mesh-list
2854634|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2854635|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2302892|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2302893|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2302894|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302895|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
2302896|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2302897|NCT00301301|Gemcitabine|gemcitabine|mesh-list
2302898|NCT00301301|Rituximab|rituximab|mesh-list
2302899|NCT00301301|Cisplatin|cisplatin|mesh-list
2302900|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2302901|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302902|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
2302903|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302904|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854636|NCT03824119|Analgesics|analgesics|mesh-ancestor
2854637|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
2854638|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854639|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854640|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2854641|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854642|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2854643|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854644|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854645|NCT03824340|Doxycycline|doxycycline|mesh-list
2854646|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2854647|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854648|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
2854649|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2854650|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2854651|NCT03824002|Insulin|insulin|mesh-list
2854652|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2854653|NCT03824002|Metformin|metformin|mesh-list
2854654|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
2854655|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
2854656|NCT03824002|Dulaglutide|dulaglutide|mesh-list
2854657|NCT03824002|Repaglinide|repaglinide|mesh-list
2854658|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
2854659|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2854660|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2854661|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854662|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
2854663|NCT03823911|Grazoprevir|grazoprevir|mesh-list
2854664|NCT03823911|Ledipasvir|ledipasvir|mesh-list
2854665|NCT03823911|Velpatasvir|velpatasvir|mesh-list
2854666|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
2854667|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2854668|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
2854669|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854670|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
2854671|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
2854672|NCT03823846|Parecoxib|parecoxib|mesh-list
2854673|NCT03823846|Dezocine|dezocine|mesh-list
2854674|NCT03823846|Analgesics|analgesics|mesh-ancestor
2854675|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
2854676|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854677|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854678|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2854679|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2854680|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2854681|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854682|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2854683|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854684|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854685|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2854686|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2854687|NCT03823846|Narcotics|narcotics|mesh-ancestor
2854688|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854689|NCT03823703|Cortisone|cortisone|mesh-list
2854690|NCT03823703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2854691|NCT03823976|Anesthetics|anesthetics|mesh-list
2854692|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854693|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854694|NCT03823768|Tacrolimus|tacrolimus|mesh-list
2854695|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2854696|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
2854697|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854698|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2854699|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854700|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854709|NCT03823950|Sargramostim|sargramostim|mesh-list
2854710|NCT03823950|Lenograstim|lenograstim|mesh-list
2854711|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
2854712|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854713|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2854714|NCT03823612|Calcium|calcium|mesh-list
2854715|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2854716|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854717|NCT03823638|Mannitol|mannitol|mesh-list
2854718|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2854719|NCT03823638|Diuretics|diuretics|mesh-ancestor
2854720|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
2854721|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302905|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2302906|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
2302907|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302908|NCT00301301|Antiviral Agents|antiviral agents|mesh-ancestor
2302909|NCT00301301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302910|NCT00301301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302911|NCT00301301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2302912|NCT00301392|Pitavastatin|pitavastatin|mesh-list
2302913|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2302914|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2302915|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2854722|NCT03823625|Nivolumab|nivolumab|mesh-list
2854723|NCT03823625|Ipilimumab|ipilimumab|mesh-list
2854724|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2854725|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854726|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2854727|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854728|NCT03823781|Milrinone|milrinone|mesh-list
2854729|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2302916|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
2302917|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302918|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302919|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2302920|NCT00301405|Thalidomide|thalidomide|mesh-list
2302921|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2302922|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
2302923|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302924|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
2302925|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2302926|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302927|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2854730|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2854731|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
2854732|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2854733|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2854734|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854735|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854736|NCT03823781|Protective Agents|protective agents|mesh-ancestor
2854737|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854738|NCT03823339|Liraglutide|liraglutide|mesh-list
2854739|NCT03823339|Xultophy|xultophy|mesh-list
2854740|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2854741|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854742|NCT03823339|Incretins|incretins|mesh-ancestor
2302928|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2302929|NCT00301405|Growth Substances|growth substances|mesh-ancestor
2302930|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
2302931|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302932|NCT00301457|Anastrozole|anastrozole|mesh-list
2302933|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2302934|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302935|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2302936|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2302937|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302938|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302939|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2302940|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
2302941|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302942|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302943|NCT00301483|HBOC 201|hboc 201|mesh-list
2302944|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
2302945|NCT00301509|Ribavirin|ribavirin|mesh-list
2302946|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
2302947|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302948|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
2854743|NCT03823339|Hormones|hormones|mesh-ancestor
2854744|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2854745|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
2854746|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2854747|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2854748|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854749|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
2854750|NCT03823417|Coagulants|coagulants|mesh-ancestor
2854751|NCT03823079|Irinotecan|irinotecan|mesh-list
2854752|NCT03823079|Raltitrexed|raltitrexed|mesh-list
2854753|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2854754|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2854755|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854756|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854757|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854758|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2854759|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
2854760|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2854761|NCT03823274|Aspirin|aspirin|mesh-list
2854762|NCT03823274|Clopidogrel|clopidogrel|mesh-list
2302949|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302950|NCT00301522|Paclitaxel|paclitaxel|mesh-list
2854763|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2854764|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2854765|NCT03823274|Analgesics|analgesics|mesh-ancestor
2854766|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
2854767|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854768|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854769|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2854770|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854771|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2854772|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2854773|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854774|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2854775|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2854776|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854777|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
2854778|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2854779|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2854780|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2854781|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
2854782|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854783|NCT03823482|Lidocaine|lidocaine|mesh-list
2854784|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
2854785|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
2854786|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2854787|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854788|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
2854789|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854790|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2854791|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2854792|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2854793|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2854794|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854795|NCT03823040|Oxiconazole|oxiconazole|mesh-list
2302951|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2302952|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302953|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
2302954|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
2302955|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
2302956|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302957|NCT00301535|HBOC 201|hboc 201|mesh-list
2302958|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
2302959|NCT00301574|Galantamine|galantamine|mesh-list
2302960|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2302961|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302962|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854796|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
2854797|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854798|NCT03823248|Folic Acid|folic acid|mesh-list
2854799|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
2854800|NCT03823248|Hematinics|hematinics|mesh-ancestor
2854801|NCT03823248|Vitamins|vitamins|mesh-ancestor
2854802|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
2854803|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854804|NCT03822975|Heparin|heparin|mesh-list
2854805|NCT03822975|Calcium heparin|calcium heparin|mesh-list
2854806|NCT03822975|Bivalirudin|bivalirudin|mesh-list
2302963|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
2302964|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854807|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
2854808|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2854809|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2854810|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854811|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
2854812|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2854813|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
2854814|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854815|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2854816|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2854817|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854818|NCT03822936|Fluorouracil|fluorouracil|mesh-list
2854819|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
2854820|NCT03822936|Irinotecan|irinotecan|mesh-list
2854821|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
2854822|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302965|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302966|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2302967|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
2302968|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2302969|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
2302970|NCT00301587|Folic Acid|folic acid|mesh-list
2854823|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2854824|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854825|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2854826|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
2854827|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854828|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2854829|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2854830|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854831|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
2854832|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
2854833|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2854834|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2854835|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854836|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854837|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854838|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854839|NCT03822962|Acetaminophen|acetaminophen|mesh-list
2854840|NCT03822962|Ibuprofen|ibuprofen|mesh-list
2854841|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2854842|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2854843|NCT03822962|Analgesics|analgesics|mesh-ancestor
2854844|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
2854845|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854846|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854847|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2854848|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854849|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2854850|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854851|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854852|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
2854853|NCT03822754|Vaccines|vaccines|mesh-list
2854854|NCT03822754|Immunologic Factors|immunologic factors|mesh-ancestor
2854855|NCT03822754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302971|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
2302972|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2302973|NCT00301587|Norgestimate|norgestimate|mesh-list
2302974|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2302975|NCT00301587|Estradiol|estradiol|mesh-list
2302976|NCT00301587|Estrogens|estrogens|mesh-ancestor
2302977|NCT00301587|Hormones|hormones|mesh-ancestor
2302978|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2302979|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302980|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2302981|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
2302982|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2302983|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2302984|NCT00301587|Hematinics|hematinics|mesh-ancestor
2302985|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
2302986|NCT00301587|Vitamins|vitamins|mesh-ancestor
2302987|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
2302988|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2302989|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2302990|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2302991|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2302992|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2302993|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2302994|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2854856|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2854857|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2854858|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854859|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854860|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2854861|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
2854862|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2854863|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854864|NCT03822663|Caffeine|caffeine|mesh-list
2854865|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2854866|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2302995|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2302996|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2302997|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2302998|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2302999|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
2303000|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2303001|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303002|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2303003|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
2303004|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2303005|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303006|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303007|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303008|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
2303009|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2854867|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2854868|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854869|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854870|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2854871|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2854872|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
2854873|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854874|NCT03822767|Vaccines|vaccines|mesh-list
2854875|NCT03822767|Immunologic Factors|immunologic factors|mesh-ancestor
2854876|NCT03822767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854901|NCT03822507|Cinacalcet|cinacalcet|mesh-list
2854902|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2854903|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854904|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2854905|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
2854906|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2854907|NCT03822559|Timolol|timolol|mesh-list
2854908|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2854909|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2854910|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2854911|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2854912|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
2854913|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854914|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854915|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854916|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2854917|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2854918|NCT03822845|Edetic Acid|edetic acid|mesh-list
2854919|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
2854920|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
2854921|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854922|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
2854923|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2854924|NCT03822546|Nicotine|nicotine|mesh-list
2854925|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2854926|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
2854927|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854928|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854929|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2854930|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2108146|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108147|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2108148|NCT02499159|Bupivacaine|bupivacaine|mesh-list
2108149|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
2108150|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
2108151|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108152|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303010|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303011|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2303012|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
2303013|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2303014|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303015|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303016|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854931|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
2854932|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854933|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854934|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
2854935|NCT03822520|Celecoxib|celecoxib|mesh-list
2854936|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2854937|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854938|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2303017|NCT00301639|Methylphenidate|methylphenidate|mesh-list
2303018|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2303019|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303020|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2303021|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2303022|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2303023|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303024|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
2303025|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303026|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
2854939|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2854940|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854941|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303027|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2303028|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303029|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2303030|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
2303031|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2303032|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303033|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303034|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303035|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
2303036|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2303037|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2303038|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2303039|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2303040|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303041|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
2303042|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303043|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303044|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2854942|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108153|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
2108154|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108155|NCT02499328|Durvalumab|durvalumab|mesh-list
2108156|NCT02499328|Tremelimumab|tremelimumab|mesh-list
2108157|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2108158|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108159|NCT02499497|Androgens|androgens|mesh-list
2108160|NCT02499497|Hormones|hormones|mesh-ancestor
2108161|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2108162|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108163|NCT02499575|Bupivacaine|bupivacaine|mesh-list
2108164|NCT02499575|Ropivacaine|ropivacaine|mesh-list
2108165|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
2108166|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
2854943|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854944|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2854945|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2854946|NCT03822520|Analgesics|analgesics|mesh-ancestor
2854947|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
2854948|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854949|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2854950|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2854951|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2854952|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2854953|NCT03822091|Terlipressin|terlipressin|mesh-list
2854954|NCT03822091|Norepinephrine|norepinephrine|mesh-list
2854955|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2854956|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2854957|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2854958|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2854959|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
2854960|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854961|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854962|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854963|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
2854964|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
2854965|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2854966|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2854967|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2854968|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2854969|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2854970|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854971|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2854972|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303045|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2303046|NCT00301730|Aldesleukin|aldesleukin|mesh-list
2854973|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
2854974|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2854975|NCT03822312|Tobramycin|tobramycin|mesh-list
2303047|NCT00301730|Paclitaxel|paclitaxel|mesh-list
2303048|NCT00301730|Trastuzumab|trastuzumab|mesh-list
2303049|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2303050|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2854976|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2854977|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854978|NCT03822169|Choline|choline|mesh-list
2854979|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
2854980|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2854981|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
2854982|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854983|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2854984|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2854985|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
2854986|NCT03822013|Miglustat|miglustat|mesh-list
2854987|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2854988|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2854989|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2854990|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2854991|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
2854992|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2854993|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2854994|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2854995|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2854996|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
2854997|NCT03821987|Busulfan|busulfan|mesh-list
2854998|NCT03821987|Fludarabine|fludarabine|mesh-list
2854999|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
2855000|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2855001|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
2855002|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855003|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2855004|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2855005|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
2855006|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855007|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855008|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2855009|NCT03821792|Prednisone|prednisone|mesh-list
2855010|NCT03821792|Cortisone|cortisone|mesh-list
2855011|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
2855012|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855013|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
2855014|NCT03821792|Hormones|hormones|mesh-ancestor
2303051|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
2303052|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
2303053|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
2303054|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303055|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2303056|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2303057|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2303058|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
2303059|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303060|NCT00301782|Carboplatin|carboplatin|mesh-list
2303061|NCT00301782|Etoposide|etoposide|mesh-list
2303062|NCT00301782|Vincristine|vincristine|mesh-list
2303063|NCT00301782|Bleomycin|bleomycin|mesh-list
2303064|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
2303065|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303066|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2303067|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2303068|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2303069|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855015|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2855016|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855017|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2855018|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855019|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2855020|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855021|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855022|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
2855023|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2855024|NCT03821649|Naloxone|naloxone|mesh-list
2855025|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2855026|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855027|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
2855028|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855029|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2855030|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2855031|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855032|NCT03821623|Niacinamide|niacinamide|mesh-list
2855033|NCT03821623|Niacin|niacin|mesh-list
2855034|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
2855035|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
2303070|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303071|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
2303072|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
2303073|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
2303074|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2303075|NCT00301795|Rituximab|rituximab|mesh-list
2303076|NCT00301795|Oblimersen|oblimersen|mesh-list
2303077|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2303078|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303079|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
2303080|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303081|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2303082|NCT00301847|Sorafenib|sorafenib|mesh-list
2303083|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303084|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2303085|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303086|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303087|NCT00301860|Cyclosporine|cyclosporine|mesh-list
2303088|NCT00301860|Methotrexate|methotrexate|mesh-list
2855036|NCT03821623|Vitamins|vitamins|mesh-ancestor
2855037|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
2855038|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855039|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2855040|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
2855041|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855042|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2855043|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
2855044|NCT03821714|Vitamins|vitamins|mesh-list
2855045|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
2303089|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
2855046|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2855047|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2855048|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2108167|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108168|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108169|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
2108170|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108171|NCT02499770|Carboplatin|carboplatin|mesh-list
2108172|NCT02499770|Etoposide|etoposide|mesh-list
2855049|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
2855050|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
2855051|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855052|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855053|NCT03821714|Hormones|hormones|mesh-ancestor
2855054|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2855055|NCT03821480|Fluconazole|fluconazole|mesh-list
2303090|NCT00301860|Fludarabine|fludarabine|mesh-list
2303091|NCT00301860|Melphalan|melphalan|mesh-list
2303092|NCT00301860|Cyclosporins|cyclosporins|mesh-list
2303093|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2303094|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2303095|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
2303096|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2303097|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303098|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2303099|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
2303100|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303101|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303102|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
2303103|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303104|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2303105|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303106|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
2303107|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2303108|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2303109|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
2303110|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303111|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2303112|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2303113|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
2303114|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2303115|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
2303116|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
2303117|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2303118|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303119|NCT00301899|Trastuzumab|trastuzumab|mesh-list
2855056|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
2855057|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855058|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2855059|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2855060|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855061|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855062|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2855063|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
2855064|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2855065|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855066|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2855067|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2855068|NCT03821415|Estradiol|estradiol|mesh-list
2855069|NCT03821415|Estrogens|estrogens|mesh-ancestor
2303120|NCT00301899|Pertuzumab|pertuzumab|mesh-list
2303121|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2303122|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303123|NCT00301912|Methotrexate|methotrexate|mesh-list
2303124|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
2303125|NCT00301912|Fludarabine|fludarabine|mesh-list
2303126|NCT00301912|Busulfan|busulfan|mesh-list
2303127|NCT00301912|Tacrolimus|tacrolimus|mesh-list
2303128|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2303129|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
2303130|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2303131|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303132|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2303133|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
2108173|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303134|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303135|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303136|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
2303137|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303138|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2303139|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303140|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
2303141|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2303142|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2303143|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2303144|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
2303145|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2303146|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2303147|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
2303148|NCT00301925|Fluorouracil|fluorouracil|mesh-list
2855070|NCT03821415|Hormones|hormones|mesh-ancestor
2855071|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2855072|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855073|NCT03821454|Capecitabine|capecitabine|mesh-list
2855074|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2855075|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
2855076|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855077|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855078|NCT03821493|Itraconazole|itraconazole|mesh-list
2855079|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2855080|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
2855081|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855082|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2855083|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2855084|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303149|NCT00301925|Capecitabine|capecitabine|mesh-list
2303150|NCT00301925|Methotrexate|methotrexate|mesh-list
2303151|NCT00301925|Epirubicin|epirubicin|mesh-list
2303152|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303153|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
2303154|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303155|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2855085|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855086|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2855087|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
2855088|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2855089|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303156|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2303157|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
2303158|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303159|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303160|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2303161|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
2303162|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2303163|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2303164|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
2303165|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2303166|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
2303167|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855090|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2855091|NCT03821168|Bevacizumab|bevacizumab|mesh-list
2855092|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
2855093|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2855094|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855095|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2855096|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2855097|NCT03821168|Growth Substances|growth substances|mesh-ancestor
2855098|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855099|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
2855100|NCT03821168|Hematinics|hematinics|mesh-ancestor
2855101|NCT03820830|Palbociclib|palbociclib|mesh-list
2855102|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855103|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2855104|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855105|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855106|NCT03820622|Paclitaxel|paclitaxel|mesh-list
2855107|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2855108|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2855109|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855110|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
2855111|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
2855112|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
2855113|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855114|NCT03820531|Pancrelipase|pancrelipase|mesh-list
2855115|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2855116|NCT03820518|Calcitriol|calcitriol|mesh-list
2855117|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2855118|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855119|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2855120|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2855121|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855122|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2303168|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2303169|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2303170|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2303171|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2303172|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2855123|NCT03820518|Vitamins|vitamins|mesh-ancestor
2855124|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
2855125|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2855126|NCT03820466|Aspirin|aspirin|mesh-list
2855127|NCT03820466|Atorvastatin|atorvastatin|mesh-list
2855128|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2855129|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2855130|NCT03820466|Analgesics|analgesics|mesh-ancestor
2855131|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
2855132|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855133|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855134|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855135|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2855136|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2855137|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2855138|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855139|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2855140|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2855141|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855142|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
2855143|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2855144|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2855145|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
2855146|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2855147|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2855148|NCT03820245|Lycopene|lycopene|mesh-list
2855149|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855150|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
2855151|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855152|NCT03820245|Protective Agents|protective agents|mesh-ancestor
2855153|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855154|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2855155|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2855156|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855157|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
2855158|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2855159|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2855160|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855161|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
2855162|NCT03820206|Coagulants|coagulants|mesh-ancestor
2855163|NCT03820193|Acetaminophen|acetaminophen|mesh-list
2855164|NCT03820193|Celecoxib|celecoxib|mesh-list
2855165|NCT03820193|Ketorolac|ketorolac|mesh-list
2855166|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2855167|NCT03820193|Diazepam|diazepam|mesh-list
2855168|NCT03820193|Gabapentin|gabapentin|mesh-list
2855169|NCT03820193|Hydrocodone|hydrocodone|mesh-list
2855170|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2855171|NCT03820193|Analgesics|analgesics|mesh-ancestor
2855172|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
2855173|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855174|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855175|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
2855176|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2855177|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855178|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2855179|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2855180|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2855181|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855182|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855183|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
2855184|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2855185|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2855186|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855187|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2855188|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2303173|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2303174|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303175|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2303176|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303177|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303178|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
2303179|NCT00301951|Fludarabine|fludarabine|mesh-list
2303180|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
2303181|NCT00301951|Busulfan|busulfan|mesh-list
2303182|NCT00301951|Tacrolimus|tacrolimus|mesh-list
2303183|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2303184|NCT00301951|Sargramostim|sargramostim|mesh-list
2855189|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2855190|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2855191|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
2855192|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2855193|NCT03820193|Narcotics|narcotics|mesh-ancestor
2855194|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
2855195|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
2855196|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2855197|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
2855198|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
2855199|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2855200|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2855201|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2855202|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2855203|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2855204|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
2303185|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303186|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2303187|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
2303188|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303189|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303190|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
2303191|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303192|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2303193|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303194|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2303195|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2303196|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
2303197|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2303198|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303199|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
2303200|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2303201|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2303202|NCT00301990|Aldesleukin|aldesleukin|mesh-list
2303203|NCT00301990|Bevacizumab|bevacizumab|mesh-list
2303204|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2303205|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303206|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2303207|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2303208|NCT00301990|Growth Substances|growth substances|mesh-ancestor
2303209|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303210|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
2303211|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2303212|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2855205|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
2855206|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
2303213|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
2303214|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303215|NCT00302224|Ketoconazole|ketoconazole|mesh-list
2303216|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
2303217|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303218|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2303219|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2303220|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855207|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
2855208|NCT03820141|Trastuzumab|trastuzumab|mesh-list
2855209|NCT03820141|Durvalumab|durvalumab|mesh-list
2855210|NCT03820141|Pertuzumab|pertuzumab|mesh-list
2855211|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2855212|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855213|NCT03820180|Fluticasone|fluticasone|mesh-list
2855214|NCT03820180|Xhance|xhance|mesh-list
2303221|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303222|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2303223|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
2303224|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2303225|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303226|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2303227|NCT00302289|Caffeine|caffeine|mesh-list
2303228|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2303229|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303230|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2303231|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303232|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303233|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2303234|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2303235|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
2303236|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303237|NCT00302341|Trimethoprim|trimethoprim|mesh-list
2303238|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2303239|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
2303240|NCT00302341|Pafuramidine|pafuramidine|mesh-list
2303241|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303242|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303243|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2303244|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303245|NCT00302341|Renal Agents|renal agents|mesh-ancestor
2303246|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
2303247|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2303248|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2303249|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2303250|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2303251|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2855215|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2855216|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2855217|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855218|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2855219|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
2108174|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2108175|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2108176|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2108177|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108178|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108179|NCT02499783|Adalimumab|adalimumab|mesh-list
2108180|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2108181|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2855220|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855221|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855222|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2855223|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
2855224|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
2855225|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2855226|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2108189|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
2108190|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2108191|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303252|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2303253|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2303254|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2855227|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2855228|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2855229|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
2855230|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2855231|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855232|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
2855233|NCT03820180|Hormones|hormones|mesh-ancestor
2855234|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2855235|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
2855236|NCT03820037|Opicapone|opicapone|mesh-list
2855237|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2855238|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855239|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855240|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2855241|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2303255|NCT00302354|Methylphenidate|methylphenidate|mesh-list
2303256|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2303257|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303258|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2303259|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2303260|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2303261|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303262|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
2303263|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303264|NCT00302367|Methylphenidate|methylphenidate|mesh-list
2303265|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2303266|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303267|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2303268|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2303269|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2855242|NCT03819790|Insulin|insulin|mesh-list
2855243|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2855244|NCT03819790|Metformin|metformin|mesh-list
2855245|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
2855246|NCT03819790|Lixisenatide|lixisenatide|mesh-list
2855247|NCT03819790|Gliclazide|gliclazide|mesh-list
2855248|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2855249|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855250|NCT03819660|Amifampridine|amifampridine|mesh-list
2855251|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2855252|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855253|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855254|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2855255|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2855256|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855257|NCT03819647|Stiripentol|stiripentol|mesh-list
2855258|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
2855259|NCT03819556|Caseins|caseins|mesh-list
2855260|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
2855261|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
2855262|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855263|NCT03821545|Lidocaine|lidocaine|mesh-list
2855264|NCT03821545|Ketamine|ketamine|mesh-list
2855265|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
2855266|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
2855267|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855268|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855269|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
2855270|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855271|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2855272|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2855273|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2855274|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2855275|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855276|NCT03821545|Analgesics|analgesics|mesh-ancestor
2855277|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2855278|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2855279|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
2855280|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2855281|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2303270|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303271|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
2303272|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303273|NCT00302393|Methylphenidate|methylphenidate|mesh-list
2303274|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2303275|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303276|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2303277|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2303278|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2303279|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303280|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
2303281|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303282|NCT00302406|Methylphenidate|methylphenidate|mesh-list
2303283|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2303284|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303285|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2303286|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2303287|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2303288|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303289|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
2303290|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303291|NCT00302419|Streptokinase|streptokinase|mesh-list
2303292|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2303293|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2303294|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855282|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2855283|NCT03819530|Micronutrients|micronutrients|mesh-list
2855284|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855285|NCT03819517|Resveratrol|resveratrol|mesh-list
2855286|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
2855287|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855288|NCT03819517|Protective Agents|protective agents|mesh-ancestor
2855289|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855290|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855291|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2855292|NCT03819296|Prednisone|prednisone|mesh-list
2855293|NCT03819296|Cortisone|cortisone|mesh-list
2855294|NCT03819296|Infliximab|infliximab|mesh-list
2855295|NCT03819296|Vedolizumab|vedolizumab|mesh-list
2855296|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
2855297|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
2855298|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855299|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
2855300|NCT03819296|Hormones|hormones|mesh-ancestor
2855301|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2855302|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855303|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2855304|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855305|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
2855306|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
2855307|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2855308|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2855309|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
2855310|NCT03819348|Clotrimazole|clotrimazole|mesh-list
2855311|NCT03819348|Miconazole|miconazole|mesh-list
2855312|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855313|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2855314|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2855315|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2855316|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855317|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855318|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2855319|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
2855320|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2855321|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855322|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2855323|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2855324|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
2855325|NCT03820986|Lenvatinib|lenvatinib|mesh-list
2855326|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2855327|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855328|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2855329|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855330|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855331|NCT03819231|Oxytocin|oxytocin|mesh-list
2855332|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
2303295|NCT00302432|Menthol|menthol|mesh-list
2303296|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
2303297|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
2303298|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
2303299|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2303300|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303301|NCT00302497|Basiliximab|basiliximab|mesh-list
2303302|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303303|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
2303304|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303305|NCT00302523|Tacrolimus|tacrolimus|mesh-list
2303306|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303307|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
2303308|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855333|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2855334|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855335|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
2855336|NCT03819322|Velpatasvir|velpatasvir|mesh-list
2855337|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
2855338|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855339|NCT03820908|Bisantrene|bisantrene|mesh-list
2855340|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2855341|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855342|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2855343|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2855344|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855345|NCT03819101|Aspirin|aspirin|mesh-list
2855346|NCT03819101|Atorvastatin|atorvastatin|mesh-list
2855347|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2855348|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2855349|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
2303309|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2303310|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108192|NCT02500602|Doxazosin|doxazosin|mesh-list
2108193|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2108194|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2108195|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2108196|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2855350|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855351|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2855352|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2855353|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855354|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2855355|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2855356|NCT03819101|Analgesics|analgesics|mesh-ancestor
2855357|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
2855358|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855359|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855360|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855361|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2855362|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2855363|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2855364|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2855365|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2855366|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
2855367|NCT03819088|Zinc|zinc|mesh-list
2855368|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
2855369|NCT03819088|Trace Elements|trace elements|mesh-ancestor
2855370|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
2855371|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855372|NCT03819088|Astringents|astringents|mesh-ancestor
2303311|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303312|NCT00302536|Tacrolimus|tacrolimus|mesh-list
2303313|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303314|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
2303315|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303316|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2303317|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303318|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303319|NCT00302549|Tacrolimus|tacrolimus|mesh-list
2303320|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303321|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
2303322|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303323|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2303324|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303325|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303326|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
2303327|NCT00302627|Vitamin D|vitamin d|mesh-list
2855373|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
2855374|NCT03819127|Metformin|metformin|mesh-list
2855375|NCT03819127|Vildagliptin|vildagliptin|mesh-list
2855376|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2855377|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855378|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2855379|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
2855380|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855381|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855382|NCT03819010|Letrozole|letrozole|mesh-list
2303328|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
2303329|NCT00302627|Pamidronate|pamidronate|mesh-list
2303330|NCT00302627|Vitamins|vitamins|mesh-list
2303331|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
2303332|NCT00302627|Calcium|calcium|mesh-list
2303333|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
2303334|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303335|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2303336|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2303337|NCT00302627|Antacids|antacids|mesh-ancestor
2303338|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303339|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2303340|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
2303341|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2303342|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303343|NCT00302653|Rasburicase|rasburicase|mesh-list
2855383|NCT03819010|Palbociclib|palbociclib|mesh-list
2855384|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108197|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
2108198|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108199|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855385|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2855386|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2855387|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303344|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
2303345|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2303346|NCT00302666|Dienogest|dienogest|mesh-list
2303347|NCT00302666|Nandrolone|nandrolone|mesh-list
2303348|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2303349|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
2303350|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2303351|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303352|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2855388|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855389|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2855390|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
2855391|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2855392|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855393|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2855394|NCT03818997|Paclitaxel|paclitaxel|mesh-list
2855395|NCT03818997|Atezolizumab|atezolizumab|mesh-list
2855396|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2855397|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855398|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
2855399|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
2855400|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
2855401|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855402|NCT03818828|Iodine|iodine|mesh-list
2855403|NCT03818828|Cadexomer iodine|cadexomer iodine|mesh-list
2855404|NCT03818828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2855405|NCT03818828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855406|NCT03818828|Trace Elements|trace elements|mesh-ancestor
2855407|NCT03818828|Micronutrients|micronutrients|mesh-ancestor
2855408|NCT03818828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855409|NCT03818945|Listerine|listerine|mesh-list
2855410|NCT03818945|Fluorides|fluorides|mesh-list
2855411|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
2855412|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
2855413|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
2855414|NCT03818945|Protective Agents|protective agents|mesh-ancestor
2855415|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303353|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2303354|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2303355|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2303356|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
2303357|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2303358|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2303359|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303360|NCT00302666|Androgens|androgens|mesh-ancestor
2303361|NCT00302666|Hormones|hormones|mesh-ancestor
2303362|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
2303363|NCT00302692|Metoprolol|metoprolol|mesh-list
2303364|NCT00302692|Esmolol|esmolol|mesh-list
2303365|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2303366|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2303367|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
2303368|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
2303369|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2303370|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303371|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2303372|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2303373|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2303374|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
2855416|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2855417|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855418|NCT03818932|Acetaminophen|acetaminophen|mesh-list
2855419|NCT03818932|Celecoxib|celecoxib|mesh-list
2855420|NCT03818932|Ketorolac|ketorolac|mesh-list
2855421|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2855422|NCT03818932|Diazepam|diazepam|mesh-list
2303375|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303376|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303377|NCT00302705|Valsartan|valsartan|mesh-list
2303378|NCT00302705|Enalapril|enalapril|mesh-list
2303379|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2303380|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2303381|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2855423|NCT03818932|Gabapentin|gabapentin|mesh-list
2303382|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303383|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2303384|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
2855424|NCT03818932|Hydrocodone|hydrocodone|mesh-list
2855425|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2855426|NCT03818932|Analgesics|analgesics|mesh-ancestor
2855427|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
2855428|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855429|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855430|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
2855431|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2855432|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855433|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2855434|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2855435|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2855436|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855437|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855438|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
2855439|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2855440|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2855441|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855442|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2855443|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2855444|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2855445|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2855446|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
2855447|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2855448|NCT03818932|Narcotics|narcotics|mesh-ancestor
2855449|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
2855450|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
2855451|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2855452|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
2855453|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
2855454|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2855455|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2855456|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2855457|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2855458|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2855459|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
2855460|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
2855461|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
2303385|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303386|NCT00302744|Psilocybin|psilocybin|mesh-list
2303387|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
2303388|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303389|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2855462|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
2855463|NCT03818919|Acetaminophen|acetaminophen|mesh-list
2855464|NCT03818919|Celecoxib|celecoxib|mesh-list
2855465|NCT03818919|Ketorolac|ketorolac|mesh-list
2855466|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2855467|NCT03818919|Diazepam|diazepam|mesh-list
2855468|NCT03818919|Gabapentin|gabapentin|mesh-list
2855469|NCT03818919|Hydrocodone|hydrocodone|mesh-list
2855470|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2855471|NCT03818919|Analgesics|analgesics|mesh-ancestor
2855472|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
2855473|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855474|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855475|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
2855476|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2855477|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855478|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2855479|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2855480|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2855481|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855482|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855483|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
2855484|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2855485|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2855486|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855487|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2855488|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2855489|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2855490|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303390|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2855491|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
2303391|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
2303392|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2303393|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2303394|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2855492|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2855493|NCT03818919|Narcotics|narcotics|mesh-ancestor
2855494|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
2855495|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
2855496|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2855497|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
2855498|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
2855499|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2855500|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2855501|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2855502|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2855503|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2855504|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
2855505|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
2855506|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
2855507|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
2855508|NCT03818685|Capecitabine|capecitabine|mesh-list
2855509|NCT03818685|Nivolumab|nivolumab|mesh-list
2855510|NCT03818685|Ipilimumab|ipilimumab|mesh-list
2855511|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2855512|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
2855513|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855514|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855515|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2855516|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2855537|NCT03818581|Suvorexant|suvorexant|mesh-list
2855538|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2855539|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2855540|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855541|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855542|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2855543|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2855544|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855557|NCT03818672|Rifaximin|rifaximin|mesh-list
2855558|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2855559|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855560|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2855561|NCT03818282|Paclitaxel|paclitaxel|mesh-list
2855562|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2303395|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2303396|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303397|NCT00302822|Tenofovir|tenofovir|mesh-list
2303398|NCT00302822|Emtricitabine|emtricitabine|mesh-list
2303399|NCT00302822|Efavirenz|efavirenz|mesh-list
2303400|NCT00302822|Lopinavir|lopinavir|mesh-list
2855563|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855564|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
2855565|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
2855566|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
2855567|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855568|NCT03818191|Acamprosate|acamprosate|mesh-list
2855569|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2855570|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
2855571|NCT03818308|Velpatasvir|velpatasvir|mesh-list
2855572|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
2855573|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855574|NCT03817970|Ondansetron|ondansetron|mesh-list
2855575|NCT03817970|Palonosetron|palonosetron|mesh-list
2855576|NCT03817970|Granisetron|granisetron|mesh-list
2855577|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
2855578|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
2855579|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855580|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855581|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2855582|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
2855583|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
2303401|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
2303402|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
2303403|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303404|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2303405|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2303406|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303407|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303408|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2303409|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2303410|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2303411|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2855584|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2855585|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
2855586|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2855587|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855588|NCT03817970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2855589|NCT03817970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2855590|NCT03817970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855591|NCT03817970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2855592|NCT03817970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2855593|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2855594|NCT03818295|Praliciguat|praliciguat|mesh-list
2855595|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2855596|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
2303412|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2303413|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2303414|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2303415|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2303416|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2303417|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2303418|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
2303419|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2303420|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2303421|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2303422|NCT00302835|Analgesics|analgesics|mesh-list
2303423|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
2303424|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2303425|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855597|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855598|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2855599|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
2855600|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2855601|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
2303426|NCT00302913|Clopidogrel|clopidogrel|mesh-list
2303427|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2855602|NCT03817931|Mirabegron|mirabegron|mesh-list
2855603|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2855604|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
2855605|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
2855606|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
2855607|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2855608|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
2855609|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2855610|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855611|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855612|NCT03817931|Urological Agents|urological agents|mesh-ancestor
2855613|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2855614|NCT03818061|Bevacizumab|bevacizumab|mesh-list
2855615|NCT03818061|Atezolizumab|atezolizumab|mesh-list
2855616|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2855617|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855618|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2855619|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2855620|NCT03818061|Growth Substances|growth substances|mesh-ancestor
2855621|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855622|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
2855623|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2855624|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2855625|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2855626|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2855627|NCT03818048|Propofol|propofol|mesh-list
2855628|NCT03818048|Sevoflurane|sevoflurane|mesh-list
2855629|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2855630|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855631|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855632|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2855633|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
2855634|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
2855635|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2855636|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2855637|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
2855638|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
2855639|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2855640|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
2855641|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855642|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2303428|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2303429|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2303430|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2303431|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
2303432|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303433|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303434|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303435|NCT00303004|Bosentan|bosentan|mesh-list
2303436|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
2303437|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
2303438|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2303439|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2303440|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303441|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855643|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2855644|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
2855645|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855646|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855647|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2855648|NCT03818321|Methenamine|methenamine|mesh-list
2855649|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
2855650|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
2855651|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2855652|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855653|NCT03818321|Renal Agents|renal agents|mesh-ancestor
2855654|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2855655|NCT03817541|Propofol|propofol|mesh-list
2855656|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2855657|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855658|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855659|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2855660|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
2855661|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
2855662|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
2855663|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
2303442|NCT00303004|Urological Agents|urological agents|mesh-ancestor
2303443|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2303444|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2303445|NCT00303017|Naproxen|naproxen|mesh-list
2303446|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2303447|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2303448|NCT00303017|Analgesics|analgesics|mesh-ancestor
2303449|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
2303450|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2303451|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303452|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855664|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855665|NCT03817567|Cetuximab|cetuximab|mesh-list
2855666|NCT03817567|Antibodies|antibodies|mesh-list
2855667|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2855668|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
2855669|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855670|NCT03817567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2855671|NCT03817567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855672|NCT03817502|Cariprazine|cariprazine|mesh-list
2855673|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2855674|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2855675|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855676|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855677|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2855678|NCT03817515|Sirolimus|sirolimus|mesh-list
2855679|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2855680|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855681|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2855682|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855683|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
2855684|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2855685|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
2855686|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855687|NCT03817411|Capecitabine|capecitabine|mesh-list
2855688|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
2855689|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2303453|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2303454|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
2303455|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2303456|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303457|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303458|NCT00303056|Icatibant|icatibant|mesh-list
2303459|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2303460|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2855690|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
2855691|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855692|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855693|NCT03817476|BI 425809|bi 425809|mesh-list
2855694|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
2855695|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2855696|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855697|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855698|NCT03817359|Remifentanil|remifentanil|mesh-list
2855699|NCT03817359|Propofol|propofol|mesh-list
2855700|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2303461|NCT00303056|Analgesics|analgesics|mesh-ancestor
2303462|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
2303463|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2303464|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303465|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2303466|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2303467|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
2303468|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
2303469|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303470|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2303471|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303472|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
2303473|NCT00303160|Ascorbic Acid|ascorbic acid|mesh-list
2303474|NCT00303160|Vitamins|vitamins|mesh-ancestor
2303475|NCT00303160|Micronutrients|micronutrients|mesh-ancestor
2303476|NCT00303160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303477|NCT00303160|Antioxidants|antioxidants|mesh-ancestor
2303478|NCT00303160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303479|NCT00303160|Protective Agents|protective agents|mesh-ancestor
2108200|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108201|NCT02500628|Metformin|metformin|mesh-list
2108202|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2108203|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855701|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855702|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855703|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2855704|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
2855705|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
2855706|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2855707|NCT03817359|Narcotics|narcotics|mesh-ancestor
2303480|NCT00303264|Esomeprazole|esomeprazole|mesh-list
2303481|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2303482|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2303483|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2303484|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303485|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303486|NCT00303277|Simvastatin|simvastatin|mesh-list
2303487|NCT00303277|Pravastatin|pravastatin|mesh-list
2303488|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2855708|NCT03817359|Analgesics|analgesics|mesh-ancestor
2855709|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
2855710|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855711|NCT03816982|Bupivacaine|bupivacaine|mesh-list
2855712|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
2855713|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
2855714|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855715|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855716|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
2855717|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855718|NCT03817320|Dexamethasone|dexamethasone|mesh-list
2855719|NCT03817320|Doxorubicin|doxorubicin|mesh-list
2855720|NCT03817320|Vincristine|vincristine|mesh-list
2855721|NCT03817320|Asparaginase|asparaginase|mesh-list
2855722|NCT03817320|Ixazomib|ixazomib|mesh-list
2855723|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855724|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
2855725|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
2303489|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2303490|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
2303491|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303492|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2303493|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2303494|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303495|NCT00303290|Interferons|interferons|mesh-list
2303496|NCT00303290|Cytarabine|cytarabine|mesh-list
2303497|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
2303498|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
2303499|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2303500|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855726|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855727|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855728|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2855729|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
2855730|NCT03817320|Hormones|hormones|mesh-ancestor
2855731|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2855732|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2855733|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855734|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2855735|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2855736|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2855737|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855738|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855739|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2855740|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
2855741|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
2855742|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
2855743|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
2855744|NCT03817268|Capecitabine|capecitabine|mesh-list
2855745|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2855746|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
2855747|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855748|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855749|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
2855750|NCT03817112|Propofol|propofol|mesh-list
2303501|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
2303502|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855751|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2855752|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855753|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855754|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2855755|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
2303503|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2303504|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
2303505|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855756|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
2855757|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2855758|NCT03817112|Analgesics|analgesics|mesh-ancestor
2855759|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
2855760|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855761|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2855762|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2855763|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2855764|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
2855765|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2855766|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303506|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303507|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
2303508|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303509|NCT00303381|Interferons|interferons|mesh-list
2303510|NCT00303381|Interferon-beta|interferon-beta|mesh-list
2303511|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
2303512|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303513|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
2303514|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855767|NCT03816774|Simethicone|simethicone|mesh-list
2855768|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
2855769|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855770|NCT03816774|Emollients|emollients|mesh-ancestor
2855771|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
2855772|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
2303515|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
2303516|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303517|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2855773|NCT03816592|Anesthetics|anesthetics|mesh-list
2855774|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855775|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855776|NCT03816592|Narcotics|narcotics|mesh-ancestor
2855777|NCT03816592|Analgesics|analgesics|mesh-ancestor
2855778|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
2855779|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855780|NCT03816488|Metformin|metformin|mesh-list
2855781|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2855782|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2855783|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855784|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2855785|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2855786|NCT03816488|Analgesics|analgesics|mesh-ancestor
2855787|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
2855788|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855789|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855790|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2855791|NCT03816553|Apatinib|apatinib|mesh-list
2303518|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2303519|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2303520|NCT00303407|Nadroparin|nadroparin|mesh-list
2303521|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
2303522|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2303523|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2303524|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303525|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2303526|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2303527|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2303528|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303529|NCT00303433|Memantine|memantine|mesh-list
2303530|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2303531|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2303532|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
2303533|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303534|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303535|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855792|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855793|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2855794|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855795|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855796|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
2855797|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2855798|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855799|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2855800|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855801|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855802|NCT03816397|Adalimumab|adalimumab|mesh-list
2855803|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2303536|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2303537|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2303538|NCT00303498|Sitaxsentan|sitaxsentan|mesh-list
2303539|NCT00303498|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2303540|NCT00303498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303541|NCT00303524|Goserelin|goserelin|mesh-list
2303542|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2303543|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303544|NCT00303537|Metformin|metformin|mesh-list
2303545|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2303546|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303547|NCT00303550|Linezolid|linezolid|mesh-list
2303548|NCT00303550|Iclaprim|iclaprim|mesh-list
2303549|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2855804|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2855805|NCT03816267|Albuterol|albuterol|mesh-list
2855806|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2303550|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2855807|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
2855808|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855809|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855810|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2855811|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
2855812|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
2855813|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2855814|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2855815|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2855816|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2855817|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
2855818|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2855819|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855820|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2855821|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2855822|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855823|NCT03816020|Niacinamide|niacinamide|mesh-list
2855824|NCT03816020|Niacin|niacin|mesh-list
2855825|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
2855826|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
2855827|NCT03816020|Vitamins|vitamins|mesh-ancestor
2855828|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
2855829|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855830|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2855831|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
2855832|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855833|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2855834|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
2855835|NCT03816072|Phenylephrine|phenylephrine|mesh-list
2855836|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
2855837|NCT03816072|Propofol|propofol|mesh-list
2303551|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2303552|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303553|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303554|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2303555|NCT00303576|Dapivirine|dapivirine|mesh-list
2303556|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2303557|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2303558|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
2303559|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303560|NCT00303589|Lactams|lactams|mesh-list
2303561|NCT00303589|beta-Lactams|beta-lactams|mesh-list
2303562|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2303563|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303564|NCT00303615|Anastrozole|anastrozole|mesh-list
2303565|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
2303566|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2303567|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303568|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2303569|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2303570|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303571|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303572|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2303573|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
2303574|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2303575|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855838|NCT03816072|Sevoflurane|sevoflurane|mesh-list
2855839|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2855840|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855841|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855842|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2855843|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
2855844|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
2855845|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2855846|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2855847|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2855848|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
2855849|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
2855850|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855851|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
2855852|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2855853|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
2855854|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
2855855|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2855856|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2855857|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2855858|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
2855859|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2855860|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855861|NCT03816072|Protective Agents|protective agents|mesh-ancestor
2855862|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
2855863|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2855864|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2855865|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2855866|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2855867|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855868|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
2855869|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303576|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
2303577|NCT00303615|Hormones|hormones|mesh-ancestor
2303578|NCT00303732|Everolimus|everolimus|mesh-list
2303579|NCT00303732|Vatalanib|vatalanib|mesh-list
2303580|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855870|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855871|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2855872|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855873|NCT03815864|Antibodies|antibodies|mesh-list
2855874|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
2855875|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
2855876|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855877|NCT03815942|Nivolumab|nivolumab|mesh-list
2855878|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2855879|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303581|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303582|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
2303583|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303584|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2303585|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303586|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303587|NCT00303745|Capecitabine|capecitabine|mesh-list
2303588|NCT00303745|Irinotecan|irinotecan|mesh-list
2855880|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2855881|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855882|NCT03815890|Nivolumab|nivolumab|mesh-list
2855883|NCT03815890|Ipilimumab|ipilimumab|mesh-list
2855884|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2855885|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855886|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2855887|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855888|NCT03815838|Fallypride|fallypride|mesh-list
2855889|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2303589|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2303590|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
2303591|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108204|NCT02500641|Naproxen|naproxen|mesh-list
2108205|NCT02500641|Colchicine|colchicine|mesh-list
2108206|NCT02500641|Allopurinol|allopurinol|mesh-list
2108207|NCT02500641|Febuxostat|febuxostat|mesh-list
2108208|NCT02500641|Omeprazole|omeprazole|mesh-list
2108209|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2108210|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2108211|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2108212|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108213|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108214|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2108215|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2108216|NCT02500641|Analgesics|analgesics|mesh-ancestor
2108217|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
2108218|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108219|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108220|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855890|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2855891|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
2855892|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2855893|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855894|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855895|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
2855896|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2855897|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
2855898|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303592|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303593|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2303594|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2303595|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303596|NCT00303758|Leucovorin|leucovorin|mesh-list
2303597|NCT00303758|Gemcitabine|gemcitabine|mesh-list
2303598|NCT00303758|Fluorouracil|fluorouracil|mesh-list
2855899|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
2855900|NCT03815539|Protective Agents|protective agents|mesh-ancestor
2855901|NCT03815487|Insulin|insulin|mesh-list
2855902|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2855903|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2855904|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855905|NCT03815474|Epirubicin|epirubicin|mesh-list
2855906|NCT03815474|Ifosfamide|ifosfamide|mesh-list
2855907|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2855908|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855909|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2855910|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2855911|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855912|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855913|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2855914|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
2855915|NCT03815461|Paclitaxel|paclitaxel|mesh-list
2303599|NCT00303758|Calcium|calcium|mesh-list
2303600|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
2855916|NCT03815461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2855917|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2855918|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855919|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
2855920|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
2855921|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
2855922|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855923|NCT03815448|Methotrexate|methotrexate|mesh-list
2855924|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2855925|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
2855926|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2855927|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855928|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2855929|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
2108221|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2108222|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
2108223|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2108224|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
2855930|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855931|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855932|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
2855933|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2855934|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2855935|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2855936|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
2855937|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2855938|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2855939|NCT03815344|Misoprostol|misoprostol|mesh-list
2855940|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2855941|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
2855942|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2855943|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855944|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2855945|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2855946|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
2855947|NCT03815305|Petrolatum|petrolatum|mesh-list
2108225|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
2108226|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
2108227|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108228|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
2108229|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2108230|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
2108231|NCT02500641|Protective Agents|protective agents|mesh-ancestor
2108232|NCT02500706|Insulin|insulin|mesh-list
2108233|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2108234|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
2108235|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
2108236|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2108237|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2108238|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108239|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2855948|NCT03815305|Emollients|emollients|mesh-ancestor
2855949|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
2855953|NCT03815435|Anesthetics|anesthetics|mesh-list
2855954|NCT03815435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2855955|NCT03815435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303601|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303602|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2303603|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
2303604|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303605|NCT00303758|Antiviral Agents|antiviral agents|mesh-ancestor
2303606|NCT00303758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303607|NCT00303758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303608|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303609|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
2303610|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303611|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2303612|NCT00303758|Antidotes|antidotes|mesh-ancestor
2303613|NCT00303758|Protective Agents|protective agents|mesh-ancestor
2855956|NCT03815279|Dexamethasone|dexamethasone|mesh-list
2855957|NCT03815279|Lenalidomide|lenalidomide|mesh-list
2855958|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2855959|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
2855960|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
2855961|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2855962|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855963|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2303614|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
2303615|NCT00303758|Vitamins|vitamins|mesh-ancestor
2303616|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
2303617|NCT00303771|Leucovorin|leucovorin|mesh-list
2303618|NCT00303771|Fluorouracil|fluorouracil|mesh-list
2303619|NCT00303771|Irinotecan|irinotecan|mesh-list
2303620|NCT00303771|Calcium|calcium|mesh-list
2303621|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
2303622|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2303623|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303624|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
2303625|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303626|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2303627|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303628|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303629|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
2303630|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2303631|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2855964|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
2855965|NCT03815279|Hormones|hormones|mesh-ancestor
2855966|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2855967|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2303632|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303633|NCT00303771|Antidotes|antidotes|mesh-ancestor
2303634|NCT00303771|Protective Agents|protective agents|mesh-ancestor
2855968|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855969|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
2855970|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2855971|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2855972|NCT03815279|Growth Substances|growth substances|mesh-ancestor
2855973|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
2855974|NCT03815019|Megestrol|megestrol|mesh-list
2855975|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
2855976|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2855977|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2855978|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2855979|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
2855980|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2855981|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855982|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2855983|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2855984|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2108240|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2108241|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2108242|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108243|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108244|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
2108245|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108246|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108247|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
2108248|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2108249|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108250|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
2108251|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
2108252|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2303635|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
2303636|NCT00303771|Vitamins|vitamins|mesh-ancestor
2303637|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
2303638|NCT00303784|Goserelin|goserelin|mesh-list
2303639|NCT00303784|Estradiol|estradiol|mesh-list
2303640|NCT00303784|Estrogens|estrogens|mesh-ancestor
2303641|NCT00303784|Hormones|hormones|mesh-ancestor
2303642|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2855985|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2855986|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
2855987|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2855988|NCT03814954|Epinephrine|epinephrine|mesh-list
2303643|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855989|NCT03814954|Albuterol|albuterol|mesh-list
2855990|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2855991|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2855992|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
2855993|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2855994|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2855995|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2855996|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2855997|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2855998|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
2855999|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856000|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2856001|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
2856002|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
2856003|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
2856004|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2856005|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
2856006|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2856007|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2856008|NCT03814941|Anesthetics|anesthetics|mesh-list
2856009|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856010|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303644|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2303645|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303646|NCT00303797|Bortezomib|bortezomib|mesh-list
2856011|NCT03814733|Ketamine|ketamine|mesh-list
2856012|NCT03814733|Alprazolam|alprazolam|mesh-list
2856013|NCT03814733|Analgesics|analgesics|mesh-ancestor
2856014|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
2856015|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856016|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856017|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2856018|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2856019|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
2856020|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
2856021|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856022|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2856023|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2856024|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856025|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856026|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2856027|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2856028|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2856029|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2856030|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
2856031|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
2856032|NCT03814759|Cisplatin|cisplatin|mesh-list
2856033|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856034|NCT03814577|Antioxidants|antioxidants|mesh-list
2856035|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856036|NCT03814577|Protective Agents|protective agents|mesh-ancestor
2856037|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856038|NCT03814629|Vitamins|vitamins|mesh-list
2856039|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
2856040|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856041|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
2856042|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2856043|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
2856044|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856045|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
2856046|NCT03814707|Protective Agents|protective agents|mesh-ancestor
2856047|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
2856048|NCT03814447|Fludarabine|fludarabine|mesh-list
2856049|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2856050|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
2856051|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856052|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2856053|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2856054|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
2856055|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856056|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856057|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2856058|NCT03814616|Artesunate|artesunate|mesh-list
2856059|NCT03814616|Pyronaridine|pyronaridine|mesh-list
2856060|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
2856061|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2856062|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2303647|NCT00303797|Sorafenib|sorafenib|mesh-list
2303648|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303649|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2303650|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303651|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303652|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
2303653|NCT00303810|Thiotepa|thiotepa|mesh-list
2856063|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2856064|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856065|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
2303654|NCT00303810|Lomustine|lomustine|mesh-list
2303655|NCT00303810|Carboplatin|carboplatin|mesh-list
2303656|NCT00303810|Methotrexate|methotrexate|mesh-list
2303657|NCT00303810|Etoposide|etoposide|mesh-list
2303658|NCT00303810|Vincristine|vincristine|mesh-list
2303659|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
2303660|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303661|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
2303662|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303663|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2303664|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2303665|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
2303666|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303667|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303668|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2303669|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2303670|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
2303671|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2303672|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2303673|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
2303674|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
2303675|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303676|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2303677|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2303678|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2303679|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2303680|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2303681|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
2303682|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
2303683|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
2303684|NCT00303836|Aldesleukin|aldesleukin|mesh-list
2303685|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
2303686|NCT00303836|Fludarabine|fludarabine|mesh-list
2303687|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
2303688|NCT00303836|Interleukin-2|interleukin-2|mesh-list
2303689|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
2303690|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303691|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
2303692|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303693|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2303694|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2303695|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
2303696|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303697|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303698|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2856066|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
2856067|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2856068|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
2856069|NCT03814642|Esomeprazole|esomeprazole|mesh-list
2856070|NCT03814642|Clopidogrel|clopidogrel|mesh-list
2856071|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2856072|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2856073|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2856074|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2856075|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
2856076|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856077|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856078|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856079|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2856080|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2856081|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2856082|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856083|NCT03814356|Methylphenidate|methylphenidate|mesh-list
2856084|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2856085|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303699|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2856086|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2303700|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
2303701|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2303702|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2303703|NCT00303836|Analgesics|analgesics|mesh-ancestor
2303704|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
2303705|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2303706|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2303707|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2303708|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
2856087|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2856088|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2856089|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856090|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
2856091|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856092|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2856093|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
2856094|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856095|NCT03814343|Amphotericin B|amphotericin b|mesh-list
2856096|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2856097|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2856098|NCT03814343|Amebicides|amebicides|mesh-ancestor
2856099|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2856100|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2856101|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2856102|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2856103|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
2303709|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303710|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
2303711|NCT00303849|Carboplatin|carboplatin|mesh-list
2303712|NCT00303849|Etoposide|etoposide|mesh-list
2303713|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
2856104|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2856105|NCT03814343|Protective Agents|protective agents|mesh-ancestor
2856106|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856107|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2856108|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
2856109|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856110|NCT03814200|Rifampin|rifampin|mesh-list
2856111|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2856112|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
2856113|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2856114|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2856115|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
2856116|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2856117|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303714|NCT00303849|Melphalan|melphalan|mesh-list
2303715|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
2303716|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
2303717|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2303718|NCT00303849|Mannitol|mannitol|mesh-list
2303719|NCT00303849|Antidotes|antidotes|mesh-list
2303720|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108253|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
2108254|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2303721|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2303722|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2303723|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2303724|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303725|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303726|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2856118|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856119|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2856120|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2856121|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2856122|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2856123|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2303727|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
2108261|NCT02500836|Cocaine|cocaine|mesh-list
2303728|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2303729|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303730|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
2303731|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303732|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2303733|NCT00303849|Diuretics|diuretics|mesh-ancestor
2303734|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
2303735|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
2303736|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
2303737|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
2303738|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
2303739|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
2856124|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2856125|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
2856126|NCT03814226|Growth Substances|growth substances|mesh-ancestor
2856127|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856128|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
2856129|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856130|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856131|NCT03813875|Fentanyl|fentanyl|mesh-list
2856132|NCT03813875|Midazolam|midazolam|mesh-list
2856133|NCT03813875|Alfentanil|alfentanil|mesh-list
2856134|NCT03813875|Propofol|propofol|mesh-list
2856135|NCT03813875|Sevoflurane|sevoflurane|mesh-list
2856136|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2856137|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856138|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856139|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2856140|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
2856141|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
2856142|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2856143|NCT03813875|Narcotics|narcotics|mesh-ancestor
2856144|NCT03813875|Analgesics|analgesics|mesh-ancestor
2856145|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
2856146|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856147|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2856148|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2856149|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2856150|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2856151|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
2856152|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
2856153|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856154|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856155|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2856156|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2856157|NCT03813784|Capecitabine|capecitabine|mesh-list
2856158|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
2856159|NCT03813784|Apatinib|apatinib|mesh-list
2856160|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2856161|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
2856162|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856163|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856164|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2856165|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856166|NCT03813979|Dolutegravir|dolutegravir|mesh-list
2856167|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2856168|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2856169|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856170|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856171|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2856172|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2856173|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
2856174|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2856175|NCT03814148|Indapamide|indapamide|mesh-list
2856176|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2856177|NCT03814148|Diuretics|diuretics|mesh-ancestor
2856178|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
2856179|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856180|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2303740|NCT00303849|Protective Agents|protective agents|mesh-ancestor
2303741|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
2303742|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
2856181|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2856182|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303743|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2303744|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2856183|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
2303745|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
2856184|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
2856185|NCT03814109|Niacin|niacin|mesh-list
2856186|NCT03814109|Indapamide|indapamide|mesh-list
2856187|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2856188|NCT03814109|Diuretics|diuretics|mesh-ancestor
2856189|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
2856190|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856191|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2856192|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2856193|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856194|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2856195|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
2856196|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2856197|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
2856198|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
2303746|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
2303747|NCT00303888|Docetaxel|docetaxel|mesh-list
2303748|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303749|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
2303750|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
2303751|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
2303752|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303753|NCT00303927|Capecitabine|capecitabine|mesh-list
2303754|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2303755|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
2303756|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303757|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303758|NCT00303940|Carboplatin|carboplatin|mesh-list
2303759|NCT00303940|Temozolomide|temozolomide|mesh-list
2303760|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303761|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2303762|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
2303763|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856199|NCT03814109|Vitamins|vitamins|mesh-ancestor
2856200|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
2856201|NCT03813927|Vitamin D|vitamin d|mesh-list
2856202|NCT03813927|Vitamins|vitamins|mesh-ancestor
2303764|NCT00303992|Trastuzumab|trastuzumab|mesh-list
2303765|NCT00303992|Irinotecan|irinotecan|mesh-list
2303766|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2303767|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303768|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2303769|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2303770|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303771|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303772|NCT00304018|Prednisone|prednisone|mesh-list
2856203|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
2856204|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856205|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2856206|NCT03813940|Vaccines|vaccines|mesh-list
2856207|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
2856208|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856209|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
2856210|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
2856211|NCT03813771|Etanercept|etanercept|mesh-list
2856212|NCT03813771|Methotrexate|methotrexate|mesh-list
2856213|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2856214|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
2856215|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2856216|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856217|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2856218|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
2856219|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856220|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856221|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
2856222|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856223|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2856224|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2856225|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
2856226|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2856227|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2856228|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
2856229|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2303773|NCT00304018|Fludarabine|fludarabine|mesh-list
2303774|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
2303775|NCT00304018|Etoposide|etoposide|mesh-list
2856230|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2303776|NCT00304018|Busulfan|busulfan|mesh-list
2303777|NCT00304018|Tacrolimus|tacrolimus|mesh-list
2303778|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2303779|NCT00304018|Sargramostim|sargramostim|mesh-list
2303780|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2303781|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
2303782|NCT00304018|Hormones|hormones|mesh-ancestor
2856231|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2856232|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2856233|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2856234|NCT03813771|Analgesics|analgesics|mesh-ancestor
2856235|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
2856236|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856237|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2856238|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2856239|NCT03813641|Capecitabine|capecitabine|mesh-list
2856240|NCT03813641|Raltitrexed|raltitrexed|mesh-list
2856241|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2856242|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
2856243|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856244|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856245|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2856246|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856247|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
2856248|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2856249|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2303783|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2303784|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303785|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2303786|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303787|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2303788|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
2303789|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303790|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303791|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
2303792|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2303793|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2303794|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2303795|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303796|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2303797|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
2303798|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2303799|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2303800|NCT00304135|Gemcitabine|gemcitabine|mesh-list
2303801|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
2856250|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2856251|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
2856252|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
2856253|NCT03813394|Bevacizumab|bevacizumab|mesh-list
2856254|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
2856255|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2856256|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856257|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2856258|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2856259|NCT03813394|Growth Substances|growth substances|mesh-ancestor
2856260|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856261|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
2303802|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303803|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2303804|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
2303805|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303806|NCT00304135|Antiviral Agents|antiviral agents|mesh-ancestor
2303807|NCT00304135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303808|NCT00304135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303809|NCT00304135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2303810|NCT00304135|Immunologic Factors|immunologic factors|mesh-ancestor
2303811|NCT00304135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303812|NCT00304200|Temozolomide|temozolomide|mesh-list
2303813|NCT00304200|Sunitinib|sunitinib|mesh-list
2303814|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2856262|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
2856263|NCT03813329|Calcium|calcium|mesh-list
2856264|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2856265|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856266|NCT03813329|Antacids|antacids|mesh-ancestor
2856267|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856268|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2856269|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
2856270|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2856271|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2303815|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
2303816|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303817|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303818|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2303819|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2303820|NCT00304200|Growth Substances|growth substances|mesh-ancestor
2303821|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303822|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
2303823|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2303824|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303825|NCT00304213|Testosterone|testosterone|mesh-list
2303826|NCT00304213|Androgens|androgens|mesh-ancestor
2303827|NCT00304213|Hormones|hormones|mesh-ancestor
2303828|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2303829|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303830|NCT00304226|Amlodipine|amlodipine|mesh-list
2303831|NCT00304226|Valsartan|valsartan|mesh-list
2303832|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2303833|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2303834|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2303835|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303836|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2856272|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856273|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2856274|NCT03813277|Analgesics|analgesics|mesh-ancestor
2856275|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
2856276|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856277|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2856278|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2856279|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2856280|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
2856281|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856282|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856283|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2856284|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
2856285|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2856286|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2856287|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2303837|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303838|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
2303839|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2303840|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2303841|NCT00304239|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2303842|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2303843|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2303844|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
2856288|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856289|NCT03813316|Incretins|incretins|mesh-ancestor
2856290|NCT03813316|Hormones|hormones|mesh-ancestor
2856291|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2856292|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
2856293|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856294|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856295|NCT03813303|Fentanyl|fentanyl|mesh-list
2856296|NCT03813303|Midazolam|midazolam|mesh-list
2856297|NCT03813303|Propofol|propofol|mesh-list
2856298|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2856299|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856300|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856301|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2856302|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
2856303|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
2856304|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2856305|NCT03813303|Narcotics|narcotics|mesh-ancestor
2856306|NCT03813303|Analgesics|analgesics|mesh-ancestor
2856307|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
2856308|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856309|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2856310|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2856311|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2856312|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2856313|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
2856314|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
2856315|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856316|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856317|NCT03813043|Midazolam|midazolam|mesh-list
2856318|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2856319|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2856320|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856321|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856322|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2856323|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2856324|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2856325|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2856326|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
2856327|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
2856328|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
2856329|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
2856330|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856331|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856332|NCT03813147|Cytarabine|cytarabine|mesh-list
2856333|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
2856334|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2856335|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2856336|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2856337|NCT03813147|Methotrexate|methotrexate|mesh-list
2856338|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
2856339|NCT03813147|Azacitidine|azacitidine|mesh-list
2856340|NCT03813147|Fludarabine|fludarabine|mesh-list
2856341|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2856342|NCT03813147|Pevonedistat|pevonedistat|mesh-list
2856343|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2856344|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
2856345|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2856346|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856347|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2856348|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
2303845|NCT00304252|Interferons|interferons|mesh-list
2303846|NCT00304252|Interferon-beta|interferon-beta|mesh-list
2303847|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
2303848|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303849|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
2303850|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303851|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
2303852|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303853|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2303854|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
2856349|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856350|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856351|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
2856352|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2856353|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2856354|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
2856355|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2856356|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2856357|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
2856358|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2856359|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2856360|NCT03813199|Methotrexate|methotrexate|mesh-list
2856361|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2856362|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
2303855|NCT00304291|Analgesics|analgesics|mesh-ancestor
2856363|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2856364|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856365|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2856366|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
2856367|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856368|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856369|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
2303856|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
2303857|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2303858|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303859|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303860|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2303861|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2303862|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303863|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303864|NCT00304317|Celecoxib|celecoxib|mesh-list
2303865|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2856370|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856371|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2856372|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2856373|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
2856374|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2856375|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2856376|NCT03813069|Permethrin|permethrin|mesh-list
2856377|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856378|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856379|NCT03813108|Lumefantrine|lumefantrine|mesh-list
2856380|NCT03813108|Mefloquine|mefloquine|mesh-list
2856381|NCT03813108|Atovaquone|atovaquone|mesh-list
2856382|NCT03813108|Proguanil|proguanil|mesh-list
2856383|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2856384|NCT03813108|Vaccines|vaccines|mesh-list
2856385|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
2856386|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2303866|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2303867|NCT00304317|Analgesics|analgesics|mesh-ancestor
2303868|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
2303869|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856387|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2856388|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2856389|NCT03813108|Immunologic Factors|immunologic factors|mesh-ancestor
2856390|NCT03813108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856391|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856392|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856393|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
2856394|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2856395|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
2856396|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2856397|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
2856398|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2856399|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2856400|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2856401|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2856402|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856403|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
2856404|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856405|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856406|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2856407|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856408|NCT03813186|Decitabine|decitabine|mesh-list
2856409|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2856410|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
2856411|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856412|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856413|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856414|NCT03812939|Octreotide|octreotide|mesh-list
2856415|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2856416|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2856417|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856418|NCT03813030|Lidocaine|lidocaine|mesh-list
2856419|NCT03813030|Prilocaine|prilocaine|mesh-list
2856420|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
2856421|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
2856422|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856423|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856424|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
2856425|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856426|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2856427|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2856428|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2856429|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2856430|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856431|NCT03812783|Sorafenib|sorafenib|mesh-list
2856432|NCT03812783|Folfirinox|folfirinox|mesh-list
2856433|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856434|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2856435|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856436|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856437|NCT03812796|Avelumab|avelumab|mesh-list
2856438|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2856439|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856440|NCT03812731|Fentanyl|fentanyl|mesh-list
2856441|NCT03812731|Ropivacaine|ropivacaine|mesh-list
2856442|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
2856443|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
2856444|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856445|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303870|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303871|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2303872|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2303873|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2303874|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2303875|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303876|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303877|NCT00304369|Metronidazole|metronidazole|mesh-list
2303878|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303879|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2303880|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2303881|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2303882|NCT00304382|Vaccines|vaccines|mesh-list
2303883|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2303884|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
2303885|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303886|NCT00304421|Rabeprazole|rabeprazole|mesh-list
2303887|NCT00304421|Pantoprazole|pantoprazole|mesh-list
2303888|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2303889|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2303890|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2303891|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303892|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303893|NCT00304434|Oseltamivir|oseltamivir|mesh-list
2303894|NCT00304434|Probenecid|probenecid|mesh-list
2303895|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
2303896|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303897|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856446|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
2856447|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856448|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2856449|NCT03812731|Narcotics|narcotics|mesh-ancestor
2856450|NCT03812731|Analgesics|analgesics|mesh-ancestor
2856451|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2856452|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2856453|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
2856454|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
2856455|NCT03812380|Cathartics|cathartics|mesh-ancestor
2856456|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2856457|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2856458|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2856459|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2856460|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2856461|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856462|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856463|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856464|NCT03812523|Analgesics|analgesics|mesh-ancestor
2856465|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
2856466|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856467|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
2856468|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2856469|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
2856470|NCT03812562|Nivolumab|nivolumab|mesh-list
2856471|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2856472|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856473|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2856474|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856475|NCT03812419|Esomeprazole|esomeprazole|mesh-list
2856476|NCT03812419|Pantoprazole|pantoprazole|mesh-list
2856477|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2856478|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2856479|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2856480|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856481|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856482|NCT03812770|Leucovorin|leucovorin|mesh-list
2856483|NCT03812770|Fluorouracil|fluorouracil|mesh-list
2856484|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
2856485|NCT03812770|Sorafenib|sorafenib|mesh-list
2856486|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
2856487|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856488|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2856489|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856490|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2856491|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
2856492|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856493|NCT03812770|Antidotes|antidotes|mesh-ancestor
2856494|NCT03812770|Protective Agents|protective agents|mesh-ancestor
2856495|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
2856496|NCT03812770|Vitamins|vitamins|mesh-ancestor
2856497|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
2856498|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2856499|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856500|NCT03812588|Citalopram|citalopram|mesh-list
2856501|NCT03812588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2856502|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2856503|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2856504|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856505|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856506|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
2856507|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856508|NCT03812588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2856509|NCT03812588|Antidepressive Agents|antidepressive agents|mesh-ancestor
2856510|NCT03812588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2303898|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303899|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
2303900|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
2303901|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2303902|NCT00304434|Renal Agents|renal agents|mesh-ancestor
2303903|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
2856511|NCT03812354|Nicotine|nicotine|mesh-list
2856512|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2856513|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
2856514|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856515|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856516|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2856517|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2856518|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
2856519|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856520|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856521|NCT03812315|Propolis|propolis|mesh-list
2856522|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2856523|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2856524|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
2856525|NCT03812120|Coagulants|coagulants|mesh-ancestor
2856526|NCT03812003|Remifentanil|remifentanil|mesh-list
2856527|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2856528|NCT03812003|Narcotics|narcotics|mesh-ancestor
2856529|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856530|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856531|NCT03812003|Analgesics|analgesics|mesh-ancestor
2856532|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
2856533|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856534|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
2856535|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
2856536|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2856537|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856538|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856539|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
2856540|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2856541|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856542|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303904|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2303905|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303906|NCT00304460|Aldesleukin|aldesleukin|mesh-list
2303907|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2303908|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2303909|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2303910|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
2856543|NCT03811847|Methylphenidate|methylphenidate|mesh-list
2856544|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2856545|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856546|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2856547|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2303911|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303912|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2303913|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
2303914|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2303915|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2303916|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2303917|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2303918|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303919|NCT00304499|Oxybutynin|oxybutynin|mesh-list
2303920|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
2303921|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
2303922|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2303923|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856548|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2856549|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856550|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
2856551|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856552|NCT03811418|Docetaxel|docetaxel|mesh-list
2856553|NCT03811418|Trastuzumab|trastuzumab|mesh-list
2856554|NCT03811418|Vinorelbine|vinorelbine|mesh-list
2856555|NCT03811418|Pertuzumab|pertuzumab|mesh-list
2856556|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856557|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
2856558|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
2856559|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
2856560|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856561|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2856562|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2856563|NCT03811509|Denosumab|denosumab|mesh-list
2856564|NCT03811509|Diphosphonates|diphosphonates|mesh-list
2856565|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2856566|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856567|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
2856568|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
2856569|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
2856570|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856571|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856572|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
2856573|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856574|NCT03810872|Paclitaxel|paclitaxel|mesh-list
2856575|NCT03810872|Afatinib|afatinib|mesh-list
2856576|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2856577|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856578|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
2856579|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
2856580|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
2856581|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856582|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2856583|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856584|NCT03811223|Evolocumab|evolocumab|mesh-list
2856585|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2303924|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2303925|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2303926|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
2303927|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303928|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303929|NCT00304499|Urological Agents|urological agents|mesh-ancestor
2303930|NCT00304538|Glucagon|glucagon|mesh-list
2856586|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2856587|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
2856588|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856589|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2856590|NCT03811054|Apatinib|apatinib|mesh-list
2303931|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2856591|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856592|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2856593|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856594|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856595|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2856596|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2303932|NCT00304538|Hormones|hormones|mesh-ancestor
2303933|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2303934|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303935|NCT00304551|Ribavirin|ribavirin|mesh-list
2303936|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2303937|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
2303938|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
2303939|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303940|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
2303941|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303942|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
2303943|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856597|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856598|NCT03810976|Gemcitabine|gemcitabine|mesh-list
2856599|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2856600|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
2856601|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856602|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856603|NCT03810976|Antiviral Agents|antiviral agents|mesh-ancestor
2856604|NCT03810976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2856605|NCT03810976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856606|NCT03810976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2856607|NCT03810976|Immunologic Factors|immunologic factors|mesh-ancestor
2856608|NCT03810976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856609|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
2856610|NCT03810911|Hematinics|hematinics|mesh-ancestor
2856611|NCT03810794|Donepezil|donepezil|mesh-list
2856612|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2856613|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856614|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856615|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
2856616|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856617|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856618|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
2303944|NCT00304616|Olanzapine|olanzapine|mesh-list
2303945|NCT00304616|Risperidone|risperidone|mesh-list
2303946|NCT00304616|Aripiprazole|aripiprazole|mesh-list
2303947|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2303948|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2303949|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
2303950|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303951|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303952|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2303953|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2303954|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2303955|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2303956|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2303957|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2303958|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
2303959|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
2303960|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
2303961|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2303962|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2303963|NCT00304616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2303964|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2303965|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2303966|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
2303967|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
2303968|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2303969|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2303970|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2856619|NCT03810703|Amphetamine|amphetamine|mesh-list
2856620|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
2856621|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2856622|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856623|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
2856624|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
2856625|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856626|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
2856627|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856628|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856629|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
2856630|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2856631|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2856632|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2856633|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2856634|NCT03810742|Irinotecan|irinotecan|mesh-list
2856635|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2856636|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2856637|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856638|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856639|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856640|NCT03810547|Ketamine|ketamine|mesh-list
2856641|NCT03810547|Propofol|propofol|mesh-list
2856642|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2856643|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856644|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856645|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2856646|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
2856647|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
2856648|NCT03810547|Analgesics|analgesics|mesh-ancestor
2856649|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
2856650|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856651|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2856652|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2856653|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2856654|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856655|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303971|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2303972|NCT00304629|Galantamine|galantamine|mesh-list
2303973|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2303974|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303975|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303976|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
2303977|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303978|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856662|NCT03810287|Domperidone|domperidone|mesh-list
2856663|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
2856664|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
2856665|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856666|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856667|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2856668|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2856669|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
2856670|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856671|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856672|NCT03810105|Durvalumab|durvalumab|mesh-list
2856673|NCT03810105|Olaparib|olaparib|mesh-list
2856674|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2856675|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856676|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2856677|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2303979|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2303980|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
2303981|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2303982|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
2303983|NCT00304642|Dapivirine|dapivirine|mesh-list
2856678|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856679|NCT03810391|Butorphanol|butorphanol|mesh-list
2856680|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2856681|NCT03810391|Narcotics|narcotics|mesh-ancestor
2856682|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856683|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856684|NCT03810391|Analgesics|analgesics|mesh-ancestor
2856685|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
2856686|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856687|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
2856688|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
2856689|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2856690|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
2856691|NCT03810209|Analgesics|analgesics|mesh-ancestor
2856692|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
2856693|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856694|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856695|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
2856696|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856697|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2856698|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
2856699|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2856700|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2856701|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856702|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2856703|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
2856704|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2856705|NCT03810066|Osimertinib|osimertinib|mesh-list
2856706|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856707|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2856708|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856709|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856710|NCT03809949|Fentanyl|fentanyl|mesh-list
2856711|NCT03809949|Anesthetics|anesthetics|mesh-list
2856712|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856713|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856714|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2856715|NCT03809949|Narcotics|narcotics|mesh-ancestor
2856716|NCT03809949|Analgesics|analgesics|mesh-ancestor
2856717|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
2856718|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856719|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2856720|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2856721|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
2856726|NCT03809780|Dexamethasone|dexamethasone|mesh-list
2856727|NCT03809780|Lenalidomide|lenalidomide|mesh-list
2856728|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2856729|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
2303984|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2303985|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2303986|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
2303987|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2303988|NCT00304655|Aripiprazole|aripiprazole|mesh-list
2856730|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
2856731|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856732|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856733|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2856734|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
2856735|NCT03809780|Hormones|hormones|mesh-ancestor
2856736|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2856737|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2856738|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856739|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
2856740|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2856741|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2856742|NCT03809780|Growth Substances|growth substances|mesh-ancestor
2856743|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
2856744|NCT03809793|Acipimox|acipimox|mesh-list
2856745|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2856746|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
2108262|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2108263|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
2303989|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
2856747|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856748|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2856749|NCT03809702|Pregabalin|pregabalin|mesh-list
2856750|NCT03809702|Analgesics|analgesics|mesh-ancestor
2856751|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
2856752|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856753|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856754|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
2856755|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2856756|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2856757|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856758|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2856759|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2856760|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2856761|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856762|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2856763|NCT03810261|Vitamin D|vitamin d|mesh-list
2856764|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
2856765|NCT03810261|Vitamins|vitamins|mesh-list
2856766|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
2856767|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856768|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2856769|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2856770|NCT03809897|Nicotine|nicotine|mesh-list
2856771|NCT03809897|Varenicline|varenicline|mesh-list
2856772|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2856773|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
2856774|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856775|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856776|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2856777|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2856778|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
2856779|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856780|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108264|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
2108265|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108266|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108267|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
2108268|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856781|NCT03809923|Lidocaine|lidocaine|mesh-list
2856782|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
2856783|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
2856784|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
2856785|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856786|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856787|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
2856788|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856789|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2856790|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2856791|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2856792|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2856793|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856794|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2856795|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2856796|NCT03809923|Analgesics|analgesics|mesh-ancestor
2856797|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2856798|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2856799|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2856800|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
2856801|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856802|NCT03809988|Letrozole|letrozole|mesh-list
2303990|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2303991|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2303992|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2303993|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2303994|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856803|NCT03809988|Fulvestrant|fulvestrant|mesh-list
2856804|NCT03809988|Palbociclib|palbociclib|mesh-list
2856805|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856806|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2856807|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2856808|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856809|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303995|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
2856810|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2856811|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
2856812|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2856813|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856814|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2856815|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2856816|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2856817|NCT03809637|Pemetrexed|pemetrexed|mesh-list
2856818|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856819|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856820|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856821|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2856822|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2303996|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
2303997|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2303998|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2303999|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2304000|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2304001|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
2304002|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2304003|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2304004|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2304005|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2304006|NCT00304668|Dapivirine|dapivirine|mesh-list
2304007|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2304008|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2304009|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
2856823|NCT03809650|Macitentan|macitentan|mesh-list
2856824|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2856825|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2856826|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856827|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2856828|NCT03809546|Dronabinol|dronabinol|mesh-list
2856829|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
2856830|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856831|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2856832|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2856833|NCT03809546|Analgesics|analgesics|mesh-ancestor
2856834|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
2856835|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856836|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2856837|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2856838|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856839|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856840|NCT03809546|Hormones|hormones|mesh-ancestor
2856841|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2856842|NCT03809312|Amoxicillin|amoxicillin|mesh-list
2856843|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
2856844|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
2856845|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2856846|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2856847|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2856848|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856849|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2856850|NCT03809481|Danaparoid|danaparoid|mesh-list
2856851|NCT03809481|Argatroban|argatroban|mesh-list
2856852|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
2856853|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2856854|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
2856855|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304010|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304011|NCT00304681|Methylphenidate|methylphenidate|mesh-list
2304012|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2304013|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304014|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2304015|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2304016|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2304017|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856856|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856857|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
2856858|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2856859|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2304018|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
2304019|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304020|NCT00304720|Tacrolimus|tacrolimus|mesh-list
2304021|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2304022|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
2304023|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304024|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2304025|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304026|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304027|NCT00304772|Fluconazole|fluconazole|mesh-list
2304028|NCT00304772|Micafungin|micafungin|mesh-list
2304029|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
2304030|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304031|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2304032|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2304033|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304034|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304035|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2304036|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
2304037|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2304038|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304039|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2304040|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2856860|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2856861|NCT03809442|Dexamethasone|dexamethasone|mesh-list
2856862|NCT03809442|Midazolam|midazolam|mesh-list
2856863|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
2856864|NCT03809442|Ketamine|ketamine|mesh-list
2856865|NCT03809442|Tramadol|tramadol|mesh-list
2856866|NCT03809442|Ropivacaine|ropivacaine|mesh-list
2856867|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2856868|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
2856869|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
2856870|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856871|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856872|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2856873|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
2856874|NCT03809442|Hormones|hormones|mesh-ancestor
2856875|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2856876|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2304041|NCT00304785|Latanoprost|latanoprost|mesh-list
2304042|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2304043|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2304044|NCT00304811|Vancomycin|vancomycin|mesh-list
2304045|NCT00304811|Rifampin|rifampin|mesh-list
2304046|NCT00304811|Gentamicins|gentamicins|mesh-list
2304047|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2304048|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304049|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2304050|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
2304051|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
2304052|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2304053|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304054|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304055|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2304056|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2304057|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2304058|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2304059|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2304060|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2304061|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2304062|NCT00304850|Ketamine|ketamine|mesh-list
2304063|NCT00304850|Analgesics|analgesics|mesh-ancestor
2304064|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
2304065|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2304066|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304067|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2304068|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2304069|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
2304070|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
2304071|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2304072|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2304073|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2856877|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856878|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2856879|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856880|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2856881|NCT03809442|Analgesics|analgesics|mesh-ancestor
2856882|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
2856883|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2856884|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2856885|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2856886|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
2856887|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856888|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856889|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2856890|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2856891|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
2304074|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304075|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304076|NCT00304980|Lumefantrine|lumefantrine|mesh-list
2304077|NCT00304980|Artemether|artemether|mesh-list
2304078|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
2304079|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
2304080|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2304081|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2304082|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
2304083|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2304084|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2304085|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304086|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2856892|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
2856893|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2856894|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2856895|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
2856896|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2856897|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2856898|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2304087|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304088|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304089|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2856899|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2856900|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
2856901|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
2856902|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2856903|NCT03809442|Narcotics|narcotics|mesh-ancestor
2856904|NCT03809455|Fentanyl|fentanyl|mesh-list
2856905|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2856906|NCT03809455|Narcotics|narcotics|mesh-ancestor
2856907|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856908|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856909|NCT03809455|Analgesics|analgesics|mesh-ancestor
2304090|NCT00304980|Renal Agents|renal agents|mesh-ancestor
2304091|NCT00304993|Niacin|niacin|mesh-list
2304092|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
2304093|NCT00304993|Fenofibrate|fenofibrate|mesh-list
2856910|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
2856911|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856912|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2856913|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2856914|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
2856915|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
2304094|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2304095|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304096|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2304097|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
2856916|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2856917|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2856918|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2856919|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856920|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856921|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2856922|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2856923|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2856924|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
2856925|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856926|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856927|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2304098|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304099|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2304100|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
2304101|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
2304102|NCT00304993|Vitamins|vitamins|mesh-ancestor
2304103|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
2304104|NCT00305019|Clevudine|clevudine|mesh-list
2304105|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
2304106|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304107|NCT00305188|Leucovorin|leucovorin|mesh-list
2304108|NCT00305188|Fluorouracil|fluorouracil|mesh-list
2304109|NCT00305188|Oxaliplatin|oxaliplatin|mesh-list
2304110|NCT00305188|Xaliproden|xaliproden|mesh-list
2856928|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2856929|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
2856930|NCT03809260|Metformin|metformin|mesh-list
2856931|NCT03809260|Vancomycin|vancomycin|mesh-list
2856932|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2856933|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856934|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2856935|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2856936|NCT03809273|Trimetazidine|trimetazidine|mesh-list
2856937|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
2856938|NCT03809013|Trastuzumab|trastuzumab|mesh-list
2856939|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2856940|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856941|NCT03809065|Labetalol|labetalol|mesh-list
2856942|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
2856943|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
2856944|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2856945|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2856946|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
2856947|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2856948|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856949|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856950|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2856951|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
2856952|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
2304111|NCT00305188|Antimetabolites|antimetabolites|mesh-ancestor
2304112|NCT00305188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304113|NCT00305188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2304114|NCT00305188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304115|NCT00305188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2304116|NCT00305188|Immunologic Factors|immunologic factors|mesh-ancestor
2304117|NCT00305188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304118|NCT00305188|Antidotes|antidotes|mesh-ancestor
2304119|NCT00305188|Protective Agents|protective agents|mesh-ancestor
2304120|NCT00305188|Vitamin B Complex|vitamin b complex|mesh-ancestor
2304121|NCT00305188|Vitamins|vitamins|mesh-ancestor
2856953|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856954|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2856955|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2856956|NCT03808961|Vitamins|vitamins|mesh-list
2856957|NCT03808961|Niacin|niacin|mesh-list
2856958|NCT03808961|Niacinamide|niacinamide|mesh-list
2856959|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
2856960|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
2856961|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
2856962|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856963|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2856964|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
2856965|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304122|NCT00305188|Micronutrients|micronutrients|mesh-ancestor
2304123|NCT00305188|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2304124|NCT00305188|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2304125|NCT00305188|Serotonin Agents|serotonin agents|mesh-ancestor
2304126|NCT00305188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304127|NCT00305201|Pravastatin|pravastatin|mesh-list
2304128|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2304129|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2304130|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
2304131|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304132|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2304133|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2304134|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304135|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
2304136|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
2304137|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304138|NCT00305292|Modafinil|modafinil|mesh-list
2856966|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2856967|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
2304139|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2304140|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304141|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2304142|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2304143|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2304144|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304145|NCT00305331|Domperidone|domperidone|mesh-list
2304146|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
2304147|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
2304148|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2304149|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304150|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2304151|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2304152|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
2304153|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304154|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304155|NCT00305370|Aripiprazole|aripiprazole|mesh-list
2304156|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
2304157|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2304158|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2304159|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2304160|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2304161|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304162|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
2304163|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
2304164|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304165|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304166|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2304167|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2304168|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
2304169|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2304170|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2304171|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2304172|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2304173|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2304174|NCT00305383|Taribavirin|taribavirin|mesh-list
2304175|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
2856968|NCT03809143|Buprenorphine|buprenorphine|mesh-list
2856969|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2856970|NCT03809143|Narcotics|narcotics|mesh-ancestor
2856971|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856972|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856973|NCT03809143|Analgesics|analgesics|mesh-ancestor
2856974|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
2856975|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2856976|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2856977|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2856978|NCT03809221|Hormones|hormones|mesh-list
2856979|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2856980|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2856981|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856982|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
2856983|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2856984|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
2856985|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2856986|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2856987|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2856988|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856989|NCT03809156|Ambrisentan|ambrisentan|mesh-list
2856990|NCT03809156|Riociguat|riociguat|mesh-list
2856991|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2856992|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
2856993|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2856994|NCT03808844|Propofol|propofol|mesh-list
2856995|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2304176|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304177|NCT00305396|Sirolimus|sirolimus|mesh-list
2304178|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2304179|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304180|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2304181|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2856996|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2856997|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2856998|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2856999|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
2857000|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
2857001|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2857002|NCT03809078|Bombesin|bombesin|mesh-list
2857003|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2857004|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857005|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857006|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857007|NCT03809234|Ondansetron|ondansetron|mesh-list
2857008|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
2857009|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
2857010|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857011|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857012|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2857013|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
2857014|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
2857015|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2857016|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
2857017|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857018|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857019|NCT03809234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2857020|NCT03809234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2857021|NCT03809234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857022|NCT03809234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2857023|NCT03809234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2857024|NCT03808818|Nicotine|nicotine|mesh-list
2857025|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2857026|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
2857027|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857028|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857029|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2857030|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2857031|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
2857032|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857033|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857034|NCT03808805|Aprepitant|aprepitant|mesh-list
2857035|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
2857036|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
2857037|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
2857038|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
2857039|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857040|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857041|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2857042|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2857043|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857044|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857045|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
2857046|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
2857047|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2857048|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
2857049|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
2857050|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2857051|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2857052|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2857053|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2857054|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857055|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
2857056|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857057|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857058|NCT03808649|Mannitol|mannitol|mesh-list
2857059|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2857060|NCT03808649|Diuretics|diuretics|mesh-ancestor
2857061|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
2857062|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108269|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2108270|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2108271|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2108272|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108273|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108274|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
2108275|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304182|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
2304183|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2304184|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
2304185|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304186|NCT00305409|Sulfalene|sulfalene|mesh-list
2304187|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304188|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2304189|NCT00305409|Renal Agents|renal agents|mesh-ancestor
2304190|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
2304191|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2304192|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2304193|NCT00305422|Risperidone|risperidone|mesh-list
2304194|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2304195|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2304196|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
2304197|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304198|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304199|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304200|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2304201|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2304202|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2304203|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2304204|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2304205|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
2304206|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
2304207|NCT00305461|Ciclesonide|ciclesonide|mesh-list
2304208|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
2304209|NCT00305461|Hormones|hormones|mesh-ancestor
2304210|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2304211|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857115|NCT03808480|Nivolumab|nivolumab|mesh-list
2857116|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2857117|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857118|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2857119|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857120|NCT03808168|Nivolumab|nivolumab|mesh-list
2857121|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2857122|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857123|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2857124|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304212|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2304213|NCT00305474|Risperidone|risperidone|mesh-list
2304214|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2304215|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
2304216|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304217|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304218|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304219|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2304220|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2857125|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
2857126|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2857127|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
2857128|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857129|NCT03808259|Ketamine|ketamine|mesh-list
2857130|NCT03808259|Esketamine|esketamine|mesh-list
2857131|NCT03808259|Analgesics|analgesics|mesh-ancestor
2857132|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
2857133|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857134|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857135|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2857136|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2857137|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
2857138|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
2857139|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857140|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2857141|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2857142|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857143|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857144|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
2857145|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2857146|NCT03808129|Lidocaine|lidocaine|mesh-list
2857147|NCT03808129|Bupivacaine|bupivacaine|mesh-list
2857148|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
2857149|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
2857150|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857151|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857152|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
2857153|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857154|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2857155|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2857156|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2857157|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2857158|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857159|NCT03808155|Tamsulosin|tamsulosin|mesh-list
2857160|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2857161|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2857162|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2857163|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
2857164|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857165|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857166|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857167|NCT03808155|Urological Agents|urological agents|mesh-ancestor
2857168|NCT03808090|Calcium|calcium|mesh-list
2857169|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2857170|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857171|NCT03807999|Gemcitabine|gemcitabine|mesh-list
2857172|NCT03807999|Paclitaxel|paclitaxel|mesh-list
2857173|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2857174|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857175|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
2857176|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
2857177|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
2857178|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857179|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2304221|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2304222|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2304223|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2857180|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
2857181|NCT03807999|Antiviral Agents|antiviral agents|mesh-ancestor
2857182|NCT03807999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2857183|NCT03807999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857184|NCT03807999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2857185|NCT03807999|Immunologic Factors|immunologic factors|mesh-ancestor
2857186|NCT03807999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857187|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
2857188|NCT03808025|Narcotics|narcotics|mesh-ancestor
2857189|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857190|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857191|NCT03808025|Analgesics|analgesics|mesh-ancestor
2857192|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
2857193|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857194|NCT03807921|Aspirin|aspirin|mesh-list
2857195|NCT03807921|Warfarin|warfarin|mesh-list
2857196|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2857197|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2857198|NCT03807921|Analgesics|analgesics|mesh-ancestor
2857199|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
2857200|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857201|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304224|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
2304225|NCT00305487|Ciclesonide|ciclesonide|mesh-list
2304226|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
2304227|NCT00305487|Hormones|hormones|mesh-ancestor
2304228|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2304229|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304230|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2857202|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2857203|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2857204|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2857205|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2857206|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857207|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2857208|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2857209|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857210|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
2857211|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
2857212|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
2857213|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2304231|NCT00305500|Citalopram|citalopram|mesh-list
2304232|NCT00305500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2304233|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2304234|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2304235|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304236|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857214|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
2857215|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857216|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
2857217|NCT03807596|Protective Agents|protective agents|mesh-ancestor
2857218|NCT03807856|Dabigatran|dabigatran|mesh-list
2857219|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
2857220|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2857221|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
2857222|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857223|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857224|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
2304237|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
2304238|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304239|NCT00305500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2304240|NCT00305500|Antidepressive Agents|antidepressive agents|mesh-ancestor
2304241|NCT00305500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2304242|NCT00305513|Caffeine|caffeine|mesh-list
2304243|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2304244|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304245|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2304246|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304247|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304248|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2857225|NCT03807843|Vaccines|vaccines|mesh-list
2857226|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
2857227|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857228|NCT03807882|Clozapine|clozapine|mesh-list
2857229|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2857230|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
2857231|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857232|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857233|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857234|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2857235|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2857236|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857237|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2857238|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
2857239|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
2857240|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
2857241|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
2857242|NCT03807297|Propofol|propofol|mesh-list
2857243|NCT03807297|Sevoflurane|sevoflurane|mesh-list
2857244|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2857245|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857246|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857247|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2857248|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
2857249|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
2857250|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2857251|NCT03807297|Analgesics|analgesics|mesh-ancestor
2857252|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
2857253|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857254|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2857255|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2857256|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2857257|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
2857258|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857259|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857260|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2857261|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2857262|NCT03807271|Anesthetics|anesthetics|mesh-list
2857263|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857264|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304249|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2304250|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
2304251|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304252|NCT00305539|Adalimumab|adalimumab|mesh-list
2304253|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2304254|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2304255|NCT00305552|Thalidomide|thalidomide|mesh-list
2857265|NCT03807479|Ponatinib|ponatinib|mesh-list
2857266|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857267|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2857268|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857269|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857286|NCT03806985|Psilocybin|psilocybin|mesh-list
2857287|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
2857288|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857289|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2304256|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2857290|NCT03806816|Melatonin|melatonin|mesh-list
2857291|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
2857292|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857293|NCT03806816|Protective Agents|protective agents|mesh-ancestor
2857294|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857295|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857296|NCT03806933|Botulinum Toxins|botulinum toxins|mesh-list
2857297|NCT03806933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2857298|NCT03806933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2857299|NCT03806933|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2857300|NCT03806933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2857301|NCT03806933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2857302|NCT03806933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857303|NCT03806933|Cholinergic Agents|cholinergic agents|mesh-ancestor
2857304|NCT03806933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857305|NCT03806933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857306|NCT03806933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2857307|NCT03806933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857308|NCT03807011|Fentanyl|fentanyl|mesh-list
2857309|NCT03807011|Remifentanil|remifentanil|mesh-list
2857310|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2857311|NCT03807011|Narcotics|narcotics|mesh-ancestor
2857312|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857313|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857314|NCT03807011|Analgesics|analgesics|mesh-ancestor
2857315|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
2857316|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857317|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2857318|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2857319|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
2857320|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
2857321|NCT03806673|Bupivacaine|bupivacaine|mesh-list
2857322|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
2857323|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
2857324|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857325|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857326|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
2857327|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857328|NCT03806751|Acetazolamide|acetazolamide|mesh-list
2857329|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
2304257|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
2304258|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304259|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
2304260|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2304261|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304262|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2304263|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2304264|NCT00305552|Growth Substances|growth substances|mesh-ancestor
2304265|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
2304266|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304267|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
2304268|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2304269|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2304270|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304271|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304272|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304273|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
2304274|NCT00305630|Triamcinolone|triamcinolone|mesh-list
2304275|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2304276|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2857330|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2857331|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857332|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857333|NCT03806751|Diuretics|diuretics|mesh-ancestor
2857334|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
2857335|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857336|NCT03806595|Lidocaine|lidocaine|mesh-list
2857337|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2857338|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
2857339|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
2857340|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2304277|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2304278|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2304279|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
2304280|NCT00305630|Hormones|hormones|mesh-ancestor
2304281|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2304282|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304283|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2304284|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
2857341|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857342|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
2857343|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857344|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2857345|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2857346|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2857347|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2857348|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857349|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
2857350|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2857351|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857352|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857353|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2857354|NCT03806777|Analgesics|analgesics|mesh-ancestor
2857355|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
2857356|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857357|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2857358|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2857359|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2857360|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
2857361|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857362|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857363|NCT03807037|Tocotrienols|tocotrienols|mesh-list
2857364|NCT03807037|Vitamin E|vitamin e|mesh-list
2857365|NCT03807037|Tocopherols|tocopherols|mesh-list
2857366|NCT03807037|Tocovid|tocovid|mesh-list
2857367|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
2857368|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857369|NCT03807037|Protective Agents|protective agents|mesh-ancestor
2857370|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857371|NCT03807037|Vitamins|vitamins|mesh-ancestor
2857372|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
2857373|NCT03806582|Norepinephrine|norepinephrine|mesh-list
2857374|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2857375|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2857376|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
2857377|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857378|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857379|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857380|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
2857381|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
2857382|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857383|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2857384|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
2857385|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857386|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
2857387|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857388|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857389|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2857390|NCT03806530|Gabapentin|gabapentin|mesh-list
2857391|NCT03806530|Ropinirole|ropinirole|mesh-list
2857392|NCT03806530|Analgesics|analgesics|mesh-ancestor
2857393|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
2857394|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857395|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857396|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
2304285|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304286|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304287|NCT00305656|Cediranib|cediranib|mesh-list
2304288|NCT00305656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304289|NCT00305656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304290|NCT00305656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304291|NCT00305656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2304292|NCT00305669|Sargramostim|sargramostim|mesh-list
2304293|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
2304294|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304295|NCT00305708|Fludarabine|fludarabine|mesh-list
2304296|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
2304297|NCT00305708|Busulfan|busulfan|mesh-list
2304298|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2857397|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2857398|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2857399|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857400|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2857401|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2857402|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2857403|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857404|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857405|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
2857406|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2857407|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2857408|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
2857409|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
2857410|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
2857411|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2857412|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857416|NCT03806062|Domperidone|domperidone|mesh-list
2857417|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
2857418|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
2857419|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857420|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857421|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2857422|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2857423|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
2857424|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857425|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857426|NCT03806036|Vitamin D|vitamin d|mesh-list
2857427|NCT03806036|Clomiphene|clomiphene|mesh-list
2857428|NCT03806036|Enclomiphene|enclomiphene|mesh-list
2857429|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
2857430|NCT03806036|Vitamins|vitamins|mesh-ancestor
2857431|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
2857432|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857433|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2857434|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2857435|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
2857436|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2857437|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2857438|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
2857439|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2857440|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2857441|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2857444|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
2857445|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2857446|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857447|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857448|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2857449|NCT03805945|Analgesics|analgesics|mesh-ancestor
2857450|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
2857451|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857452|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2857453|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2857454|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2857455|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
2857456|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857457|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857458|NCT03806374|Lidocaine|lidocaine|mesh-list
2857459|NCT03806374|Fentanyl|fentanyl|mesh-list
2857460|NCT03806374|Ketamine|ketamine|mesh-list
2857461|NCT03806374|Propofol|propofol|mesh-list
2857462|NCT03806374|Cisatracurium|cisatracurium|mesh-list
2857463|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
2857464|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
2857465|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857466|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857467|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
2857468|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857469|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2857470|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2857471|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2857472|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2857473|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857474|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2857475|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2857476|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
2857477|NCT03806374|Analgesics|analgesics|mesh-ancestor
2857478|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2857479|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2857480|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2857481|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857482|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2857483|NCT03806374|Narcotics|narcotics|mesh-ancestor
2857484|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2857485|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2857486|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2857487|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2857488|NCT03806101|Abrocitinib|abrocitinib|mesh-list
2857489|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2857490|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2857491|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
2857492|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857493|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2857494|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2857495|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857496|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2857497|NCT03806049|Paclitaxel|paclitaxel|mesh-list
2857498|NCT03806049|Bevacizumab|bevacizumab|mesh-list
2857499|NCT03806049|Carboplatin|carboplatin|mesh-list
2857500|NCT03806049|Niraparib|niraparib|mesh-list
2857501|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2857502|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857503|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
2857504|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
2857505|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
2857506|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857507|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2857508|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2857509|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2857510|NCT03806049|Growth Substances|growth substances|mesh-ancestor
2857511|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857512|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
2857513|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2857514|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857515|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
2857516|NCT03805594|177Lu-PSMA-617|177lu-psma-617|mesh-list
2857517|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2857518|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857519|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2857520|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857521|NCT03805607|Ketorolac|ketorolac|mesh-list
2304299|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304300|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2304301|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
2304302|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304303|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2304304|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
2304305|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304306|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
2857522|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2857523|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2857524|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2108276|NCT02500979|Insulin|insulin|mesh-list
2108277|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2108278|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
2857525|NCT03805607|Analgesics|analgesics|mesh-ancestor
2857526|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
2857527|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857528|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857529|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2857530|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2857531|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2857532|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857533|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108279|NCT02500979|Pramlintide|pramlintide|mesh-list
2857534|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
2857535|NCT03805568|Remifentanil|remifentanil|mesh-list
2857536|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2857537|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857538|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857539|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2857540|NCT03805568|Analgesics|analgesics|mesh-ancestor
2857541|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
2857542|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857543|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2857544|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2857545|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2857546|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
2857547|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857548|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857549|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2857550|NCT03805568|Narcotics|narcotics|mesh-ancestor
2857551|NCT03805633|Pancrelipase|pancrelipase|mesh-list
2857552|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2857553|NCT03805399|Sirolimus|sirolimus|mesh-list
2857554|NCT03805399|Paclitaxel|paclitaxel|mesh-list
2857555|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2857556|NCT03805399|Capecitabine|capecitabine|mesh-list
2857557|NCT03805399|Everolimus|everolimus|mesh-list
2857558|NCT03805399|Apatinib|apatinib|mesh-list
2857559|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2857560|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2857561|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857562|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
2857563|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
2857564|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
2857565|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857566|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2857567|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
2857568|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2857569|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
2857570|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857571|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857572|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2857573|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2857574|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2857575|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2857576|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
2857577|NCT03805282|Lidocaine|lidocaine|mesh-list
2857578|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
2857579|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
2857580|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857581|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857582|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
2857583|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857584|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2857585|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2857586|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2857587|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2857588|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857589|NCT03805477|Nintedanib|nintedanib|mesh-list
2857590|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857591|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2857592|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857593|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857594|NCT03805360|Ropivacaine|ropivacaine|mesh-list
2857595|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
2857596|NCT03805360|Anesthetics|anesthetics|mesh-list
2857597|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857598|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857599|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
2857600|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857601|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
2857602|NCT03805503|Procaine|procaine|mesh-list
2857603|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
2857604|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
2857605|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857606|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857607|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
2857608|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857609|NCT03805178|Abatacept|abatacept|mesh-list
2857610|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2857611|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857612|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857613|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2857614|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
2857615|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857616|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2304307|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2304308|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2304309|NCT00305734|Gemcitabine|gemcitabine|mesh-list
2304310|NCT00305734|Bortezomib|bortezomib|mesh-list
2304311|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2304312|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
2304313|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304314|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304315|NCT00305734|Antiviral Agents|antiviral agents|mesh-ancestor
2304316|NCT00305734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304317|NCT00305734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304318|NCT00305734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2304319|NCT00305734|Immunologic Factors|immunologic factors|mesh-ancestor
2304320|NCT00305734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304321|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
2304322|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2304323|NCT00305747|Protective Agents|protective agents|mesh-ancestor
2857617|NCT03805022|Doxorubicin|doxorubicin|mesh-list
2857618|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2857619|NCT03805022|Ifosfamide|ifosfamide|mesh-list
2857620|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
2857621|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2857622|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304324|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304325|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304326|NCT00305786|Gemcitabine|gemcitabine|mesh-list
2304327|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
2304328|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2304329|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
2304330|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857623|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2857624|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2857625|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857626|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857627|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2857628|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
2857629|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
2857630|NCT03804931|Prednisone|prednisone|mesh-list
2857631|NCT03804931|Mesalamine|mesalamine|mesh-list
2857632|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2857633|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
2857634|NCT03804931|Hormones|hormones|mesh-ancestor
2304331|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304332|NCT00305786|Antiviral Agents|antiviral agents|mesh-ancestor
2304333|NCT00305786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304334|NCT00305786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304335|NCT00305786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2304336|NCT00305786|Immunologic Factors|immunologic factors|mesh-ancestor
2304337|NCT00305786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304338|NCT00305812|Dexamethasone|dexamethasone|mesh-list
2304339|NCT00305812|Lenalidomide|lenalidomide|mesh-list
2304340|NCT00305812|Melphalan|melphalan|mesh-list
2304341|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2304342|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
2857635|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2857636|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857637|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2857638|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857639|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2857640|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2857641|NCT03804931|Analgesics|analgesics|mesh-ancestor
2857642|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
2857643|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857644|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2304343|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
2304344|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2304345|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304346|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2304347|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
2304348|NCT00305812|Hormones|hormones|mesh-ancestor
2304349|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2304350|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2304351|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304352|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
2304353|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2304354|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2304355|NCT00305812|Growth Substances|growth substances|mesh-ancestor
2304356|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
2304357|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2304358|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
2304359|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304360|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2304361|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2304362|NCT00305825|Bevacizumab|bevacizumab|mesh-list
2304363|NCT00305825|Letrozole|letrozole|mesh-list
2304364|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2304365|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304366|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2857645|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
2857646|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2857647|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2857648|NCT03805100|Ranibizumab|ranibizumab|mesh-list
2857649|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2304367|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2304368|NCT00305825|Growth Substances|growth substances|mesh-ancestor
2304369|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857650|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2857651|NCT03805100|Growth Substances|growth substances|mesh-ancestor
2857652|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857653|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
2857654|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857655|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2857656|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2304370|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
2304371|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2304372|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2304373|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304374|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304375|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2304376|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
2304377|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2304378|NCT00305838|Tamoxifen|tamoxifen|mesh-list
2304379|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2304380|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
2304381|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2304382|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304383|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2304384|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304385|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2304386|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2304387|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2857657|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2857658|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2857659|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304388|NCT00305903|Memantine|memantine|mesh-list
2304389|NCT00305903|Rivastigmine|rivastigmine|mesh-list
2304390|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2304391|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2304392|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
2304393|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304394|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304395|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304396|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2304397|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2304398|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2304399|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304400|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
2304401|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2857660|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
2857661|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857662|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857663|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2857664|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108280|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
2108281|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2108282|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108283|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
2108284|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2857665|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
2857666|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2857667|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857668|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
2857669|NCT03805035|Maleic acid|maleic acid|mesh-list
2857670|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
2304402|NCT00305903|Protective Agents|protective agents|mesh-ancestor
2304403|NCT00306020|Morphine|morphine|mesh-list
2857671|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
2857672|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2857673|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857674|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857675|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
2108285|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
2108286|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108287|NCT02501135|Bupivacaine|bupivacaine|mesh-list
2108288|NCT02501135|Ropivacaine|ropivacaine|mesh-list
2108289|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
2857676|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857677|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857678|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
2857679|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
2857680|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2857681|NCT03804866|Doxorubicin|doxorubicin|mesh-list
2857682|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2857683|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2857684|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857685|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2857686|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2857687|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857688|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857689|NCT03804840|Dronabinol|dronabinol|mesh-list
2857690|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
2857691|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857692|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2857693|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2857694|NCT03804840|Analgesics|analgesics|mesh-ancestor
2857695|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
2857696|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857697|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2857698|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2857699|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857700|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857701|NCT03804840|Hormones|hormones|mesh-ancestor
2857702|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2857703|NCT03804749|Suramin|suramin|mesh-list
2857704|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
2857705|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
2857706|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2857707|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2857708|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857709|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2857710|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2857711|NCT03804580|Osimertinib|osimertinib|mesh-list
2857712|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857713|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2857714|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857715|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857716|NCT03804372|Tenofovir|tenofovir|mesh-list
2857717|NCT03804372|Rituximab|rituximab|mesh-list
2857718|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2857719|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304404|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2304405|NCT00306020|Narcotics|narcotics|mesh-ancestor
2304406|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2304407|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304408|NCT00306020|Analgesics|analgesics|mesh-ancestor
2304409|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
2304410|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2304411|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2304412|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
2304413|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2304414|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
2304415|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
2857720|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
2857721|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857722|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2857723|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
2857724|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2857725|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2857726|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2857727|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857728|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857729|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2857730|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2857731|NCT03804541|Ensartinib|ensartinib|mesh-list
2857732|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857733|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2857734|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857735|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857736|NCT03804723|Prednisone|prednisone|mesh-list
2304416|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304417|NCT00306046|Diphosphonates|diphosphonates|mesh-list
2304418|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2304419|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304420|NCT00306124|Levodopa|levodopa|mesh-list
2304421|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2304422|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2304423|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
2304424|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304425|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304426|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304427|NCT00306137|Aprotinin|aprotinin|mesh-list
2304428|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
2304429|NCT00306137|Coagulants|coagulants|mesh-ancestor
2304430|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2304431|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2304432|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
2304433|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304434|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304435|NCT00306150|Aprotinin|aprotinin|mesh-list
2304436|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
2304437|NCT00306150|Coagulants|coagulants|mesh-ancestor
2304438|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2304439|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2304440|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
2304441|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304442|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857737|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2857738|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
2857739|NCT03804723|Hormones|hormones|mesh-ancestor
2857740|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2857741|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857742|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2857743|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857744|NCT03804359|Rituximab|rituximab|mesh-list
2857745|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2857746|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857747|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
2857748|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857749|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2857750|NCT03804034|Molybdenum|molybdenum|mesh-list
2857751|NCT03804034|Trace Elements|trace elements|mesh-ancestor
2857752|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
2857753|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857754|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
2857755|NCT03804177|Melatonin|melatonin|mesh-list
2857756|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
2857757|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
2857758|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857759|NCT03804177|Protective Agents|protective agents|mesh-ancestor
2857760|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857761|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857762|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2857763|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
2857764|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
2857765|NCT03804177|Vitamins|vitamins|mesh-ancestor
2857766|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
2857767|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
2857768|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2857769|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2857770|NCT03804229|Protective Agents|protective agents|mesh-ancestor
2857771|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857772|NCT03803553|Fluorouracil|fluorouracil|mesh-list
2857773|NCT03803553|Nivolumab|nivolumab|mesh-list
2857774|NCT03803553|Irinotecan|irinotecan|mesh-list
2857775|NCT03803553|Cetuximab|cetuximab|mesh-list
2857776|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
2857777|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857778|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2857779|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857780|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2857781|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
2857782|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857783|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2857784|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2857785|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2857786|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2304443|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
2857787|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857788|NCT03803787|Budesonide|budesonide|mesh-list
2857789|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2857790|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2857791|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
2857792|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857793|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857794|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2857795|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
2857796|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
2857797|NCT03803787|Hormones|hormones|mesh-ancestor
2857798|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2857799|NCT03803514|Epoetin Alfa|epoetin alfa|mesh-list
2857800|NCT03803514|Hematinics|hematinics|mesh-ancestor
2857801|NCT03803449|Fentanyl|fentanyl|mesh-list
2857802|NCT03803449|Midazolam|midazolam|mesh-list
2857803|NCT03803449|Propofol|propofol|mesh-list
2857804|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2857805|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2304444|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2304445|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304446|NCT00306254|Enoxaparin|enoxaparin|mesh-list
2304447|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
2304448|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
2304449|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2304450|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2304451|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304452|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2304453|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
2304454|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2304455|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
2304456|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304457|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
2304458|NCT00306267|Hematinics|hematinics|mesh-ancestor
2304459|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
2304460|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2304461|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2857806|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857807|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2857808|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
2857809|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
2857810|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2857811|NCT03803449|Narcotics|narcotics|mesh-ancestor
2857812|NCT03803449|Analgesics|analgesics|mesh-ancestor
2857813|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
2857814|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857815|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2857816|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2857817|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2857818|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2857819|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
2857820|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
2857821|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857822|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857823|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
2857824|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2857825|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857826|NCT03803371|Acetaminophen|acetaminophen|mesh-list
2857827|NCT03803371|Tramadol|tramadol|mesh-list
2857828|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2857829|NCT03803371|Analgesics|analgesics|mesh-ancestor
2857830|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
2857831|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857832|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857833|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
2857834|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2857835|NCT03803371|Narcotics|narcotics|mesh-ancestor
2857836|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857837|NCT03803254|Lenvatinib|lenvatinib|mesh-list
2857838|NCT03803254|Antibodies|antibodies|mesh-list
2857839|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
2857840|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857841|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857842|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2857843|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857844|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857845|NCT03803124|Tolvaptan|tolvaptan|mesh-list
2857846|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2857847|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857848|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
2857849|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857850|NCT03803267|Fentanyl|fentanyl|mesh-list
2857851|NCT03803267|Propofol|propofol|mesh-list
2304462|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2304463|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2304464|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304465|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304466|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857852|NCT03803267|Atracurium|atracurium|mesh-list
2857853|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
2857854|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857855|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857856|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2857857|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2857858|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
2857859|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2304467|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
2304468|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
2304469|NCT00306358|Vitamins|vitamins|mesh-ancestor
2304470|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
2304471|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304472|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
2304473|NCT00306358|Hematinics|hematinics|mesh-ancestor
2304474|NCT00306397|Sirolimus|sirolimus|mesh-list
2304475|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2304476|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304477|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2304478|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304479|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
2304480|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2304481|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
2304482|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304483|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
2857860|NCT03803267|Narcotics|narcotics|mesh-ancestor
2857861|NCT03803267|Analgesics|analgesics|mesh-ancestor
2857862|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
2857863|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857864|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2857865|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2857866|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2857867|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2857868|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2857869|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2857870|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
2857871|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857872|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857873|NCT03803202|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2857874|NCT03803202|Immunologic Factors|immunologic factors|mesh-ancestor
2857875|NCT03803202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857876|NCT03803007|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2857877|NCT03803007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2857878|NCT03803007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2857879|NCT03803007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857880|NCT03803215|Theophylline|theophylline|mesh-list
2857881|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2857882|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
2857883|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857884|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857885|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2857886|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
2857887|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2857888|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857889|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857890|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
2857891|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2857892|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2857893|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
2857894|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857895|NCT03803163|Treprostinil|treprostinil|mesh-list
2857896|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2857897|NCT03802747|Durvalumab|durvalumab|mesh-list
2857898|NCT03802747|Tremelimumab|tremelimumab|mesh-list
2304484|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2857899|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2857900|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2304485|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304486|NCT00306410|Vitamins|vitamins|mesh-ancestor
2304487|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
2304488|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2304489|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
2304490|NCT00306462|Nifedipine|nifedipine|mesh-list
2304491|NCT00306462|Analgesics|analgesics|mesh-ancestor
2304492|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
2857901|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857902|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
2857903|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857904|NCT03802838|Amisulpride|amisulpride|mesh-list
2857905|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2857906|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2857907|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857908|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857909|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2857910|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2857911|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
2857912|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2857913|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857914|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2857915|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
2857916|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
2857917|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2857918|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
2857919|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304493|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2304494|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304495|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
2304496|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2304497|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2304498|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
2304499|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2304500|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2304501|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304502|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2304503|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
2304504|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2304505|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
2304506|NCT00306475|Valproic Acid|valproic acid|mesh-list
2304507|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
2304508|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304509|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857920|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2857921|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2857922|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
2304510|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
2304511|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304512|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304513|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
2304514|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2304515|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2304516|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2304517|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2304518|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
2108290|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
2108291|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108292|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108293|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
2108294|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108295|NCT02501161|Insulin|insulin|mesh-list
2108296|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2108297|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
2108298|NCT02501161|Liraglutide|liraglutide|mesh-list
2108299|NCT02501161|Xultophy|xultophy|mesh-list
2108300|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2108301|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108302|NCT02501161|Incretins|incretins|mesh-ancestor
2108303|NCT02501161|Hormones|hormones|mesh-ancestor
2108304|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2108305|NCT02501265|Nicotine|nicotine|mesh-list
2108306|NCT02501265|Varenicline|varenicline|mesh-list
2304519|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2857923|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857924|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857925|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2857928|NCT03802604|Atezolizumab|atezolizumab|mesh-list
2857929|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2857930|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857931|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2304520|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2304521|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2304522|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2304523|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304524|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
2304525|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304526|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
2304527|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
2304528|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
2304529|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304530|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
2304531|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2304532|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304533|NCT00306683|Diazoxide|diazoxide|mesh-list
2857942|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2857943|NCT03802487|Charcoal|charcoal|mesh-list
2857944|NCT03802487|Antidotes|antidotes|mesh-ancestor
2857945|NCT03802487|Protective Agents|protective agents|mesh-ancestor
2857946|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857947|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2857948|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857949|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2857950|NCT03802552|Cephalexin|cephalexin|mesh-list
2857951|NCT03802552|Cefadroxil|cefadroxil|mesh-list
2857952|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2857953|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2857954|NCT03802318|Amoxicillin|amoxicillin|mesh-list
2857955|NCT03802318|Rabeprazole|rabeprazole|mesh-list
2857956|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2857957|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2857958|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2857959|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2857960|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2857961|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857962|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857963|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
2857964|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
2857965|NCT03802422|Vitamins|vitamins|mesh-ancestor
2857966|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
2857967|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857968|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
2857969|NCT03802422|Hematinics|hematinics|mesh-ancestor
2857970|NCT03802071|Doxorubicin|doxorubicin|mesh-list
2857971|NCT03802071|Durvalumab|durvalumab|mesh-list
2857972|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2857973|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2857974|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2857975|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2857976|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2857977|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857978|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2857979|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
2857980|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2857981|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
2857982|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2857983|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857984|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2857985|NCT03802032|Lidocaine|lidocaine|mesh-list
2857986|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
2857987|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
2857988|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2857989|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2857990|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
2857991|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2857992|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2857993|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2857994|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2857995|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2857996|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2857997|NCT03802058|Paclitaxel|paclitaxel|mesh-list
2857998|NCT03802058|Carboplatin|carboplatin|mesh-list
2857999|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2858000|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304534|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2304535|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
2304536|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
2304537|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2304538|NCT00306696|Spironolactone|spironolactone|mesh-list
2304539|NCT00306696|Furosemide|furosemide|mesh-list
2304540|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2304541|NCT00306696|Diuretics|diuretics|mesh-ancestor
2304542|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
2304543|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304544|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2304545|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2304546|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304547|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2304548|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
2858001|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
2858002|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
2858003|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
2858004|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858005|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
2858006|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2858007|NCT03802214|Vedolizumab|vedolizumab|mesh-list
2858008|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2858009|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
2858010|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858011|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2858012|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858013|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858014|NCT03802162|Memantine|memantine|mesh-list
2858015|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2858016|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2858017|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
2304549|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2304550|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2304551|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2304552|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2304553|NCT00306722|Fospropofol|fospropofol|mesh-list
2304554|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2304555|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2304556|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304557|NCT00306735|Palonosetron|palonosetron|mesh-list
2304558|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
2304559|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
2858018|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2858019|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858020|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858021|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2858022|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2108307|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2304560|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2304561|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304562|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2304563|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2304564|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2304565|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
2304566|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304567|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304568|NCT00306748|Linaclotide|linaclotide|mesh-list
2304569|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2304570|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
2304571|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304572|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2304573|NCT00306774|Vitamin D|vitamin d|mesh-list
2304574|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
2304575|NCT00306774|Vitamins|vitamins|mesh-ancestor
2858023|NCT03802240|Pemetrexed|pemetrexed|mesh-list
2858024|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858025|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858026|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858027|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2858028|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2304576|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
2304577|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304578|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2304579|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2304580|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2304581|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2304582|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2304583|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
2304584|NCT00306813|Lenalidomide|lenalidomide|mesh-list
2304585|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
2304586|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108308|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
2108309|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108310|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108311|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2108312|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2108313|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
2108314|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108315|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304587|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2304588|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2304589|NCT00306813|Growth Substances|growth substances|mesh-ancestor
2304590|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
2304591|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304592|NCT00306826|Pioglitazone|pioglitazone|mesh-list
2304593|NCT00306826|Simvastatin|simvastatin|mesh-list
2304594|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2304595|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2304596|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
2304597|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858045|NCT03801603|Vaccines|vaccines|mesh-list
2858046|NCT03801603|Immunologic Factors|immunologic factors|mesh-ancestor
2858047|NCT03801603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858048|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
2858049|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2858050|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858051|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2858052|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858053|NCT03801746|Cyclosporine|cyclosporine|mesh-list
2304598|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2304599|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2304600|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304601|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2858054|NCT03801746|Rifampin|rifampin|mesh-list
2858055|NCT03801746|Probenecid|probenecid|mesh-list
2858056|NCT03801746|Cyclosporins|cyclosporins|mesh-list
2858057|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858058|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858059|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2858060|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
2858061|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858062|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
2858063|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858064|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
2858065|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2858066|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2858067|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2858068|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
2858069|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2858070|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
2858071|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2858072|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2858073|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2858074|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2858075|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2858076|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2858077|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2858078|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
2858079|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
2858080|NCT03801746|Renal Agents|renal agents|mesh-ancestor
2858081|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
2304602|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304603|NCT00306878|Abatacept|abatacept|mesh-list
2304604|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2858082|NCT03801733|Atorvastatin|atorvastatin|mesh-list
2858083|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2304605|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304606|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304607|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2304608|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
2858084|NCT03801733|Simvastatin|simvastatin|mesh-list
2108316|NCT02501473|Rituximab|rituximab|mesh-list
2108317|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
2108318|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2108319|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108320|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
2108321|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108322|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2108323|NCT02501629|Reslizumab|reslizumab|mesh-list
2108324|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2108325|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
2108326|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
2108327|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2858085|NCT03801733|Pravastatin|pravastatin|mesh-list
2858086|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2858087|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2858088|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
2858089|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858090|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2858091|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2858092|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858093|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858094|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2858095|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2858096|NCT03801733|Analgesics|analgesics|mesh-ancestor
2858097|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
2858098|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858099|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858100|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2108328|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2858101|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2304609|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304610|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2304611|NCT00306969|Bexarotene|bexarotene|mesh-list
2304612|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304613|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2304614|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
2304615|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304616|NCT00307060|Losartan|losartan|mesh-list
2304617|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2304618|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2304619|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2304620|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2304621|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2304622|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304623|NCT00307060|Diuretics|diuretics|mesh-ancestor
2304624|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
2304625|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304626|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2304627|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2304628|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2304629|NCT00307099|Meropenem|meropenem|mesh-list
2304630|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304631|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2304632|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
2858102|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2858103|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
2858104|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2858105|NCT03801707|Velpatasvir|velpatasvir|mesh-list
2858106|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
2858107|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858108|NCT03801668|Paclitaxel|paclitaxel|mesh-list
2858109|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
2858110|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2858111|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2858112|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858113|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
2858114|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
2858115|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
2858116|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858117|NCT03801629|Morphine|morphine|mesh-list
2858118|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2858119|NCT03801629|Narcotics|narcotics|mesh-ancestor
2858120|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858121|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858122|NCT03801629|Analgesics|analgesics|mesh-ancestor
2858123|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
2858124|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858125|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
2858126|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2858127|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
2858128|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858129|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
2858130|NCT03801564|Protective Agents|protective agents|mesh-ancestor
2858131|NCT03801590|Riboflavin|riboflavin|mesh-list
2858132|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
2858133|NCT03801590|Vitamins|vitamins|mesh-ancestor
2858134|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
2858135|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858136|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2858137|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
2858138|NCT03801759|Adefovir|adefovir|mesh-list
2858139|NCT03801759|Digoxin|digoxin|mesh-list
2858140|NCT03801759|Furosemide|furosemide|mesh-list
2858141|NCT03801759|Diuretics|diuretics|mesh-ancestor
2858142|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
2858143|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858144|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2858145|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2858146|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858147|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2858148|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2858149|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858150|NCT03801759|Protective Agents|protective agents|mesh-ancestor
2858151|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
2858152|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858153|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2108329|NCT02501902|Paclitaxel|paclitaxel|mesh-list
2108330|NCT02501902|Palbociclib|palbociclib|mesh-list
2108331|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2858154|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2858155|NCT03801499|Lenvatinib|lenvatinib|mesh-list
2858156|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858157|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2858158|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858159|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858160|NCT03801304|Atezolizumab|atezolizumab|mesh-list
2858161|NCT03801304|Vinorelbine|vinorelbine|mesh-list
2858162|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858163|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2858164|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
2858165|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
2858166|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
2858167|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858168|NCT03801252|Azithromycin|azithromycin|mesh-list
2858169|NCT03801252|Cefazolin|cefazolin|mesh-list
2858170|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2858171|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858172|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
2858173|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2858174|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858175|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
2858176|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
2858177|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2858178|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2858179|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858180|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
2858181|NCT03801122|Coagulants|coagulants|mesh-ancestor
2858182|NCT03801200|Apatinib|apatinib|mesh-list
2858183|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858184|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2858185|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858186|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858187|NCT03801226|Calcium|calcium|mesh-list
2858188|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2858189|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858190|NCT03801031|Lidocaine|lidocaine|mesh-list
2858191|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
2858192|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
2858193|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858194|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858195|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
2858196|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858197|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2858198|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2858199|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2858200|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2858201|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858202|NCT03800979|Tofacitinib|tofacitinib|mesh-list
2858203|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2858204|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858205|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858206|NCT03801317|Micronutrients|micronutrients|mesh-list
2858207|NCT03801317|Trace Elements|trace elements|mesh-list
2858208|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858209|NCT03800953|Avelumab|avelumab|mesh-list
2858210|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2858211|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858212|NCT03801369|Durvalumab|durvalumab|mesh-list
2858213|NCT03801369|Olaparib|olaparib|mesh-list
2858214|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2858215|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
2858216|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2858217|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
2858218|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2858219|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858220|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
2858221|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858222|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858223|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108332|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304633|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
2304634|NCT00307177|Vaccines|vaccines|mesh-list
2304635|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
2304636|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304637|NCT00307203|Bupropion|bupropion|mesh-list
2304638|NCT00307203|Nicotine|nicotine|mesh-list
2304639|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2304640|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
2304641|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2304642|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304643|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2304644|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2858247|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
2858248|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2858249|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
2858250|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858251|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
2858252|NCT03800810|Protective Agents|protective agents|mesh-ancestor
2858253|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
2858254|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
2858255|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858256|NCT03800667|Protective Agents|protective agents|mesh-ancestor
2858257|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858258|NCT03800667|Vitamins|vitamins|mesh-ancestor
2858259|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
2858260|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2858261|NCT03800745|Laxatives|laxatives|mesh-ancestor
2858262|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2304645|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
2304646|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2858271|NCT03800693|Leucovorin|leucovorin|mesh-list
2858272|NCT03800693|Fluorouracil|fluorouracil|mesh-list
2858273|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
2858274|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
2858275|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858276|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2858277|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858278|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2858279|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
2858280|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108333|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
2108334|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
2108335|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
2108336|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108337|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2108338|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858281|NCT03800693|Antidotes|antidotes|mesh-ancestor
2858282|NCT03800693|Protective Agents|protective agents|mesh-ancestor
2858283|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
2858284|NCT03800693|Vitamins|vitamins|mesh-ancestor
2858285|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
2858286|NCT03800381|Rifampin|rifampin|mesh-list
2858287|NCT03800381|Isoniazid|isoniazid|mesh-list
2858288|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
2858289|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2858290|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
2858291|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2858292|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858293|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
2858294|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2858295|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858296|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858297|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2858298|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2858299|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2858300|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2858301|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2858302|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2858303|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2858304|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2858305|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
2858306|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2858307|NCT03800550|Clarithromycin|clarithromycin|mesh-list
2858308|NCT03800550|Bedaquiline|bedaquiline|mesh-list
2858309|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2858310|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858311|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2858312|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858313|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858314|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2858315|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2858316|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
2858317|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
2858318|NCT03800264|Bisoprolol|bisoprolol|mesh-list
2858319|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2858320|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2858321|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
2858322|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
2858323|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858324|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858325|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2858326|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2858327|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2858328|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
2858329|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108339|NCT02501928|Fesoterodine|fesoterodine|mesh-list
2108340|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2108341|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2108342|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
2858330|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858331|NCT03800797|Loxoprofen|loxoprofen|mesh-list
2858332|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2858333|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2858334|NCT03800797|Analgesics|analgesics|mesh-ancestor
2858335|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
2858336|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858337|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858338|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2858339|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2858340|NCT03800290|Clenbuterol|clenbuterol|mesh-list
2858341|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2304647|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304648|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2858342|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2858343|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
2858344|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2858345|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858346|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858347|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2858348|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
2858349|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858350|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2858351|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
2858352|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
2858353|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
2858354|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
2858355|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858356|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2858357|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2858358|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
2858359|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2858360|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858361|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858362|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2858363|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2858364|NCT03800433|Protective Agents|protective agents|mesh-ancestor
2858365|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858366|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
2858367|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2858368|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
2858369|NCT03799835|Atezolizumab|atezolizumab|mesh-list
2858370|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
2858371|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858372|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2858373|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
2858374|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858381|NCT03799809|Voriconazole|voriconazole|mesh-list
2858382|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
2858383|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858384|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2858385|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2858386|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858387|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858388|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2858389|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
2858390|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2858391|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858392|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2858393|NCT03799744|Durvalumab|durvalumab|mesh-list
2108343|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108344|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108345|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108346|NCT02501928|Urological Agents|urological agents|mesh-ancestor
2108347|NCT02502149|Factor VIII|factor viii|mesh-list
2108348|NCT02502149|Coagulants|coagulants|mesh-ancestor
2108349|NCT02502487|Ropivacaine|ropivacaine|mesh-list
2108350|NCT02502487|Tetracaine|tetracaine|mesh-list
2108351|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
2108352|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
2108353|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108354|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108355|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
2108356|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108357|NCT02502734|Fluticasone|fluticasone|mesh-list
2108358|NCT02502734|Xhance|xhance|mesh-list
2108359|NCT02502734|Albuterol|albuterol|mesh-list
2108360|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2858394|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2858395|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858396|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
2858397|NCT03799731|Trifluridine|trifluridine|mesh-list
2858398|NCT03799731|Antibodies|antibodies|mesh-list
2858399|NCT03799731|Immunologic Factors|immunologic factors|mesh-ancestor
2858400|NCT03799731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304649|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
2304650|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2304651|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2304652|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2304653|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2304654|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
2304655|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2304656|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2304657|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304658|NCT00307255|Gemcitabine|gemcitabine|mesh-list
2304659|NCT00307255|Paclitaxel|paclitaxel|mesh-list
2304660|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2304661|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2858401|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
2858402|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858403|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
2858404|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858405|NCT03799627|Epoetin Alfa|epoetin alfa|mesh-list
2858406|NCT03799627|Glycine|glycine|mesh-list
2858407|NCT03799627|Hematinics|hematinics|mesh-ancestor
2858408|NCT03799627|Glycine Agents|glycine agents|mesh-ancestor
2858409|NCT03799627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2858410|NCT03799627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858411|NCT03799627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858412|NCT03799536|Sotalol|sotalol|mesh-list
2858413|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2858414|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2858415|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
2858416|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2858417|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858418|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858419|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2858420|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
2858421|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
2858422|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858423|NCT03799406|Vitamin D|vitamin d|mesh-list
2858424|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
2858425|NCT03799406|Vitamins|vitamins|mesh-ancestor
2858426|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
2858427|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858428|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2858429|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2858430|NCT03799224|Decitabine|decitabine|mesh-list
2858431|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2858432|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
2858433|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858434|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858435|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858436|NCT03799315|Nicotine|nicotine|mesh-list
2858437|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2858438|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
2858439|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858440|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858441|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2858442|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2858443|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
2858444|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108361|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2108362|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
2108363|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108364|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108365|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2108366|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
2108367|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
2108368|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2108369|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
2108370|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2108371|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2858445|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858446|NCT03799172|Echinocandins|echinocandins|mesh-list
2858447|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
2858448|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858449|NCT03799120|Tamsulosin|tamsulosin|mesh-list
2858450|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2858451|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2858452|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2858453|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
2858454|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2858455|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858456|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858457|NCT03799120|Urological Agents|urological agents|mesh-ancestor
2858458|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
2858459|NCT03799094|Vitamins|vitamins|mesh-ancestor
2858460|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
2858461|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858462|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
2858463|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858464|NCT03799094|Protective Agents|protective agents|mesh-ancestor
2858465|NCT03798912|Octreotide|octreotide|mesh-list
2858466|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2858467|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2304662|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304663|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
2304664|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
2304665|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
2304666|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304667|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2304668|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
2304669|NCT00307255|Antiviral Agents|antiviral agents|mesh-ancestor
2304670|NCT00307255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304671|NCT00307255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304672|NCT00307255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2304673|NCT00307255|Immunologic Factors|immunologic factors|mesh-ancestor
2304674|NCT00307255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304675|NCT00307307|Niacin|niacin|mesh-list
2304676|NCT00307307|Simvastatin|simvastatin|mesh-list
2304677|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2858468|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858469|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
2858470|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2858471|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
2858472|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
2858473|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858474|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858475|NCT03798834|Anesthetics|anesthetics|mesh-list
2858476|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858477|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858478|NCT03798821|Sulfalene|sulfalene|mesh-list
2858479|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858480|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2858481|NCT03798821|Renal Agents|renal agents|mesh-ancestor
2858482|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
2858483|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2858484|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2858485|NCT03798678|Dexamethasone|dexamethasone|mesh-list
2858486|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
2858487|NCT03798678|Ichthammol|ichthammol|mesh-list
2858488|NCT03798678|BB 1101|bb 1101|mesh-list
2858489|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2858490|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
2858491|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
2858492|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858493|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858494|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2858495|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
2858496|NCT03798678|Hormones|hormones|mesh-ancestor
2858497|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2858498|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2858499|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858500|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
2858501|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858502|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858503|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
2858504|NCT03798743|Docetaxel|docetaxel|mesh-list
2304678|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2858505|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858506|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
2858507|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
2858508|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
2858509|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858510|NCT03798639|Nivolumab|nivolumab|mesh-list
2858511|NCT03798639|Ipilimumab|ipilimumab|mesh-list
2858512|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2858513|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304679|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
2304680|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304681|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2304682|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2304683|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304684|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
2304685|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
2304686|NCT00307307|Vitamins|vitamins|mesh-ancestor
2304687|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
2858514|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2858515|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858516|NCT03798600|Caspofungin|caspofungin|mesh-list
2858517|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
2858518|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858519|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858520|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858521|NCT03798522|Nalbuphine|nalbuphine|mesh-list
2858522|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2858523|NCT03798522|Narcotics|narcotics|mesh-ancestor
2858524|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858525|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858526|NCT03798522|Analgesics|analgesics|mesh-ancestor
2858527|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
2858528|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858529|NCT03798405|Analgesics|analgesics|mesh-list
2858530|NCT03798405|Narcotics|narcotics|mesh-list
2858531|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
2858532|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858533|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858534|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858535|NCT03798392|Anesthetics|anesthetics|mesh-list
2858536|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108372|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2108373|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2108374|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
2108375|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108376|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108377|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
2108378|NCT02502864|Docetaxel|docetaxel|mesh-list
2108379|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2108380|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
2108381|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108382|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2108383|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2108384|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
2108385|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108386|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858537|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858538|NCT03798314|Nivolumab|nivolumab|mesh-list
2858539|NCT03798314|Pomalidomide|pomalidomide|mesh-list
2858540|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2858541|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858542|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2858543|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858544|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
2858545|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858546|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2858547|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2858548|NCT03798314|Growth Substances|growth substances|mesh-ancestor
2858549|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
2858550|NCT03798106|Durvalumab|durvalumab|mesh-list
2858551|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2858552|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858553|NCT03798119|Tenofovir|tenofovir|mesh-list
2858554|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
2858555|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858556|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2858557|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2858558|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858559|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304688|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304689|NCT00307398|Hydrocortisone|hydrocortisone|mesh-list
2304690|NCT00307398|Anecortave|anecortave|mesh-list
2858560|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2858561|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2858562|NCT03798080|Insulin|insulin|mesh-list
2858563|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2858564|NCT03798080|Metformin|metformin|mesh-list
2858565|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
2858566|NCT03798080|Lixisenatide|lixisenatide|mesh-list
2858567|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2858568|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858569|NCT03798054|Insulin|insulin|mesh-list
2858570|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2858571|NCT03798054|Metformin|metformin|mesh-list
2858572|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
2858573|NCT03798054|Lixisenatide|lixisenatide|mesh-list
2858574|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2858575|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2858576|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304691|NCT00307398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2304692|NCT00307398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2304693|NCT00307398|Growth Substances|growth substances|mesh-ancestor
2304694|NCT00307398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304695|NCT00307398|Growth Inhibitors|growth inhibitors|mesh-ancestor
2304696|NCT00307398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858577|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858578|NCT03799822|Vitamin K|vitamin k|mesh-list
2858579|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
2858580|NCT03799822|Vitamins|vitamins|mesh-ancestor
2858581|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
2858582|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858583|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2858584|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
2858585|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2858586|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
2858587|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858588|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858589|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
2858590|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2858591|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2858592|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
2858593|NCT03799822|Coagulants|coagulants|mesh-ancestor
2858594|NCT03799900|Ketamine|ketamine|mesh-list
2858595|NCT03799900|Analgesics|analgesics|mesh-ancestor
2858596|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
2858597|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858598|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858599|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2858600|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2858601|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
2858602|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
2858603|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858604|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2858605|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2858606|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2858607|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858608|NCT03799757|Bupivacaine|bupivacaine|mesh-list
2858609|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
2858610|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
2858611|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858612|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858613|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
2858614|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858615|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
2858616|NCT03799913|Fludarabine|fludarabine|mesh-list
2858617|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2858618|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
2858619|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858620|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2858621|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2858622|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
2858623|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858624|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858625|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2858626|NCT03797833|Anesthetics|anesthetics|mesh-list
2858627|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858628|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858629|NCT03799601|Carboplatin|carboplatin|mesh-list
2858630|NCT03799601|Docetaxel|docetaxel|mesh-list
2858631|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858632|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
2858633|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
2858634|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
2858635|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858636|NCT03797703|Lidocaine|lidocaine|mesh-list
2858637|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
2858638|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
2858639|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858640|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858641|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
2858642|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858643|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2858644|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2858645|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2858646|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2858647|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858648|NCT03797729|Tirofiban|tirofiban|mesh-list
2858649|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2858650|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2858651|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304697|NCT00307398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2304698|NCT00307411|Hormones|hormones|mesh-list
2304699|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2304700|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304701|NCT00307450|Levetiracetam|levetiracetam|mesh-list
2304702|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
2304703|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
2304704|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
2304705|NCT00307502|Ritonavir|ritonavir|mesh-list
2304706|NCT00307502|Lopinavir|lopinavir|mesh-list
2304707|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2304708|NCT00307502|Darunavir|darunavir|mesh-list
2304709|NCT00307502|Nelfinavir|nelfinavir|mesh-list
2304710|NCT00307502|Indinavir|indinavir|mesh-list
2304711|NCT00307502|Saquinavir|saquinavir|mesh-list
2858652|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2858653|NCT03797924|Ropivacaine|ropivacaine|mesh-list
2858654|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
2858655|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
2858656|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858657|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858658|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
2858659|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858660|NCT03797625|Cisplatin|cisplatin|mesh-list
2858661|NCT03797625|Irinotecan|irinotecan|mesh-list
2858662|NCT03797625|Endostar protein|endostar protein|mesh-list
2858663|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858664|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2858665|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2858666|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304712|NCT00307502|Amprenavir|amprenavir|mesh-list
2304713|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
2304714|NCT00307502|Nevirapine|nevirapine|mesh-list
2304715|NCT00307502|Tipranavir|tipranavir|mesh-list
2304716|NCT00307502|Efavirenz|efavirenz|mesh-list
2304717|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2304718|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2304719|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
2304720|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304721|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304722|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2304723|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2304724|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
2304725|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858667|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858668|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2858669|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2304726|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2304727|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2304728|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2304729|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2304730|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2858670|NCT03797625|Growth Substances|growth substances|mesh-ancestor
2858671|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858672|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
2304731|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2304732|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2304733|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2304734|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2858673|NCT03799445|Nivolumab|nivolumab|mesh-list
2858674|NCT03799445|Ipilimumab|ipilimumab|mesh-list
2858675|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2858676|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858677|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2858678|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858679|NCT03797508|Progesterone|progesterone|mesh-list
2858680|NCT03797508|Progestins|progestins|mesh-ancestor
2858681|NCT03797508|Hormones|hormones|mesh-ancestor
2858682|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2858683|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304735|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2304736|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
2304737|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2858695|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
2858696|NCT03797196|Everolimus|everolimus|mesh-list
2858697|NCT03797196|Tacrolimus|tacrolimus|mesh-list
2858698|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2858699|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
2858700|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858701|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2858702|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858703|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858704|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858705|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2858706|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2858707|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
2858708|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2858709|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858710|NCT03797079|Bupivacaine|bupivacaine|mesh-list
2858711|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
2858712|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
2858713|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858714|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304738|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2304739|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
2304740|NCT00307515|Coagulants|coagulants|mesh-ancestor
2304741|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2304742|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
2304743|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304744|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2304745|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2304746|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2304747|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304748|NCT00307593|Rituximab|rituximab|mesh-list
2304749|NCT00307593|Infliximab|infliximab|mesh-list
2304750|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2858715|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
2858716|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858717|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
2858718|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
2858719|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858720|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
2858721|NCT03797443|Gemcitabine|gemcitabine|mesh-list
2858722|NCT03797443|Paclitaxel|paclitaxel|mesh-list
2858723|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2858724|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858725|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
2858726|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
2858727|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
2858728|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858729|NCT03797443|Vitamins|vitamins|mesh-ancestor
2858730|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
2858731|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858732|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2858733|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
2858734|NCT03797443|Antiviral Agents|antiviral agents|mesh-ancestor
2858735|NCT03797443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858736|NCT03797443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858737|NCT03797443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2858738|NCT03797443|Immunologic Factors|immunologic factors|mesh-ancestor
2858739|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
2858740|NCT03797443|Protective Agents|protective agents|mesh-ancestor
2858741|NCT03796884|Linaclotide|linaclotide|mesh-list
2858742|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2108387|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2108388|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
2108389|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
2108390|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
2108391|NCT02503085|Ibuprofen|ibuprofen|mesh-list
2108392|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2108393|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2108394|NCT02503085|Analgesics|analgesics|mesh-ancestor
2108395|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
2108396|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858743|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
2858744|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858745|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2858746|NCT03797222|Vitamin E|vitamin e|mesh-list
2304751|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304752|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
2304753|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304754|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2304755|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
2304756|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2304757|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
2304758|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2304759|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2304760|NCT00307606|Prednisolone|prednisolone|mesh-list
2304761|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
2304762|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2304763|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
2304764|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2858747|NCT03797222|Tocopherols|tocopherols|mesh-list
2858748|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
2858749|NCT03797222|Vitamins|vitamins|mesh-ancestor
2858750|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
2858751|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858752|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
2858753|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858754|NCT03797222|Protective Agents|protective agents|mesh-ancestor
2858755|NCT03796975|Metformin|metformin|mesh-list
2858756|NCT03796975|Pioglitazone|pioglitazone|mesh-list
2858757|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2304765|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
2304766|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
2304767|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2304768|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304769|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2304770|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
2304771|NCT00307606|Hormones|hormones|mesh-ancestor
2858758|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108397|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858759|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2858760|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2858761|NCT03796650|Vancomycin|vancomycin|mesh-list
2858762|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2858763|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858764|NCT03796572|Ropivacaine|ropivacaine|mesh-list
2858765|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
2858766|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
2858767|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858768|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858769|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
2858770|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858771|NCT03796585|Vaccines|vaccines|mesh-list
2858772|NCT03796585|Immunologic Factors|immunologic factors|mesh-ancestor
2858773|NCT03796585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858774|NCT03796533|Posaconazole|posaconazole|mesh-list
2858775|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
2858776|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858777|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2858778|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2858779|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2858780|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2858781|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2858782|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858783|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858784|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2858785|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
2858786|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2858787|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858788|NCT03796403|Diclofenac|diclofenac|mesh-list
2858789|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2858790|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2858791|NCT03796403|Analgesics|analgesics|mesh-ancestor
2858792|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
2858793|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858794|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858795|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2858796|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2858797|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2858798|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304772|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2304773|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2304774|NCT00307606|Protective Agents|protective agents|mesh-ancestor
2304775|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2304776|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304777|NCT00307619|Topiramate|topiramate|mesh-list
2304778|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
2304779|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2858799|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858800|NCT03796507|Temozolomide|temozolomide|mesh-list
2858801|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2858802|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
2858803|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858804|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858805|NCT03796416|Misoprostol|misoprostol|mesh-list
2858806|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2858807|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
2858808|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2858809|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858810|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2858811|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2858812|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
2858813|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
2858814|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2858815|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
2858816|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2858817|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
2858818|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858819|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858820|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
2304780|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304781|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2304782|NCT00307632|Estradiol|estradiol|mesh-list
2304783|NCT00307632|Estrogens|estrogens|mesh-ancestor
2304784|NCT00307632|Hormones|hormones|mesh-ancestor
2304785|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2858821|NCT03796364|Endostar protein|endostar protein|mesh-list
2858822|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2858823|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2858824|NCT03796364|Growth Substances|growth substances|mesh-ancestor
2858825|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858826|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
2858827|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304786|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304787|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2304788|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
2304789|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2304790|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2304791|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2304792|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2304793|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
2304794|NCT00307645|Prednisone|prednisone|mesh-list
2304795|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
2304796|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
2304797|NCT00307645|Azathioprine|azathioprine|mesh-list
2304798|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2304799|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
2304800|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304801|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2304802|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2304803|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
2304804|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304805|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304806|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2304807|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2304808|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
2304809|NCT00307645|Hormones|hormones|mesh-ancestor
2304810|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2304811|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2858844|NCT03796195|Bupivacaine|bupivacaine|mesh-list
2858845|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
2858846|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
2858847|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858848|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858849|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
2858850|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858851|NCT03795909|Dexamethasone|dexamethasone|mesh-list
2858852|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2858853|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
2858854|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
2858855|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858856|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858857|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2304812|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2304813|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2304814|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
2304815|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2304816|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304817|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304818|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
2858858|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
2858859|NCT03795909|Hormones|hormones|mesh-ancestor
2858860|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2858861|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2858862|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858863|NCT03795844|Liver Extracts|liver extracts|mesh-list
2858864|NCT03795844|Hematinics|hematinics|mesh-ancestor
2858865|NCT03795792|Curcumin|curcumin|mesh-list
2858866|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2858867|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2858868|NCT03795792|Analgesics|analgesics|mesh-ancestor
2858869|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
2858870|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858871|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858872|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2858873|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2858874|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858875|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858876|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858877|NCT03795584|Hemostatics|hemostatics|mesh-list
2858878|NCT03795584|Coagulants|coagulants|mesh-ancestor
2858879|NCT03795571|Gemcitabine|gemcitabine|mesh-list
2858880|NCT03795571|Dexamethasone|dexamethasone|mesh-list
2858881|NCT03795571|Rituximab|rituximab|mesh-list
2858882|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
2858883|NCT03795571|Lenalidomide|lenalidomide|mesh-list
2858884|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2858885|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
2858886|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
2858887|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858888|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858889|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2858890|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
2858891|NCT03795571|Hormones|hormones|mesh-ancestor
2858892|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2858893|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2304819|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
2304820|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2304821|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2304822|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2304823|NCT00307645|Protective Agents|protective agents|mesh-ancestor
2858894|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858895|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2858896|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
2304824|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
2304825|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2304826|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
2304827|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2304828|NCT00307658|Antibodies|antibodies|mesh-list
2304829|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
2304830|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
2304831|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2304832|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
2304833|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304834|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
2304835|NCT00307671|Prednisone|prednisone|mesh-list
2304836|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
2304837|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2304838|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2304839|NCT00307671|Prednisolone|prednisolone|mesh-list
2858897|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2858898|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2858899|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
2858900|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858901|NCT03795571|Antiviral Agents|antiviral agents|mesh-ancestor
2858902|NCT03795571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858903|NCT03795571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858904|NCT03795571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2858905|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2858906|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2858907|NCT03795571|Growth Substances|growth substances|mesh-ancestor
2858908|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
2858909|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
2858910|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2858911|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2858912|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858913|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
2858914|NCT03795649|Coagulants|coagulants|mesh-ancestor
2858915|NCT03795597|Melphalan|melphalan|mesh-list
2858916|NCT03795597|Busulfan|busulfan|mesh-list
2858917|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2304840|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
2858918|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
2858919|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858920|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858921|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2858922|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2858923|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
2858924|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858925|NCT03795805|Lidocaine|lidocaine|mesh-list
2858926|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
2858927|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
2858928|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2858929|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858930|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
2858931|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858932|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2858933|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2858934|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2858935|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2858936|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858937|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
2858938|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2304841|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
2304842|NCT00307671|Methotrexate|methotrexate|mesh-list
2304843|NCT00307671|Azathioprine|azathioprine|mesh-list
2304844|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2304845|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
2304846|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2304847|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
2304848|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304849|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2304850|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2304851|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
2304852|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304853|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304854|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2304855|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2304856|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
2304857|NCT00307671|Hormones|hormones|mesh-ancestor
2304858|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2858941|NCT03795259|Rocuronium|rocuronium|mesh-list
2858942|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2858943|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2858944|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2858945|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858946|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858947|NCT03795272|Rucaparib|rucaparib|mesh-list
2858948|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2858949|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858950|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858951|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858952|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
2858953|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2858954|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
2858955|NCT03795194|Ampicillin|ampicillin|mesh-list
2858956|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2858957|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2858958|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858959|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2858960|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2858961|NCT03795311|Bevacizumab|bevacizumab|mesh-list
2858962|NCT03795311|Folfirinox|folfirinox|mesh-list
2858963|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2858964|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858965|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2858966|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2858967|NCT03795311|Growth Substances|growth substances|mesh-ancestor
2858968|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858969|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
2304859|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2304860|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2304861|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
2304862|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2304863|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2304864|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
2304865|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
2304866|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304867|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2304868|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2304869|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2304870|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2304871|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
2304872|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2858970|NCT03795207|Durvalumab|durvalumab|mesh-list
2858971|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2858972|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2858973|NCT03795350|Beclomethasone|beclomethasone|mesh-list
2858974|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
2858975|NCT03795350|Bromides|bromides|mesh-list
2304873|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304874|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
2304875|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
2304876|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2304877|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2304878|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2304879|NCT00307671|Protective Agents|protective agents|mesh-ancestor
2304880|NCT00307723|Gemcitabine|gemcitabine|mesh-list
2304881|NCT00307723|Bevacizumab|bevacizumab|mesh-list
2304882|NCT00307723|Fluorouracil|fluorouracil|mesh-list
2304883|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
2304884|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2304885|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304886|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2304887|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2304888|NCT00307723|Growth Substances|growth substances|mesh-ancestor
2304889|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304890|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
2858976|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
2858977|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2858978|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
2858979|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2858980|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2858981|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2858982|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
2858983|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2858984|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2858985|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2858986|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
2858987|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2858988|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2858989|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
2858990|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2858991|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2858992|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2858993|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
2858994|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2858995|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
2858996|NCT03795350|Hormones|hormones|mesh-ancestor
2858997|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2858998|NCT03794765|Metronidazole|metronidazole|mesh-list
2858999|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
2859000|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2859001|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2859002|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2859003|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2859004|NCT03794843|Nimodipine|nimodipine|mesh-list
2859005|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2859006|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2859007|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2859008|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859009|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2859010|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304891|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2859011|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
2859012|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
2859013|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2859014|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2859015|NCT03794505|Prednisolone|prednisolone|mesh-list
2859016|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
2859017|NCT03794505|Lidocaine|lidocaine|mesh-list
2859018|NCT03794505|Ropivacaine|ropivacaine|mesh-list
2859019|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2859020|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
2859021|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
2859022|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
2859023|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859024|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304892|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
2304893|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304894|NCT00307723|Antiviral Agents|antiviral agents|mesh-ancestor
2304895|NCT00307723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304896|NCT00307723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304897|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2859025|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
2859026|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859027|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2859028|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2859029|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2859030|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2859031|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859032|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2859033|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
2859034|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
2304898|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
2304899|NCT00307775|Estradiol|estradiol|mesh-list
2304900|NCT00307775|Estrogens|estrogens|mesh-ancestor
2304901|NCT00307775|Hormones|hormones|mesh-ancestor
2304902|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2304903|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304904|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
2304905|NCT00307814|Hematinics|hematinics|mesh-ancestor
2859035|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2859036|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
2859037|NCT03794505|Hormones|hormones|mesh-ancestor
2859038|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859039|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2859040|NCT03794505|Protective Agents|protective agents|mesh-ancestor
2859041|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2859042|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859043|NCT03794544|Durvalumab|durvalumab|mesh-list
2859044|NCT03794544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2859045|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2859046|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859047|NCT03794544|Immunologic Factors|immunologic factors|mesh-ancestor
2859048|NCT03794544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859049|NCT03794778|Paclitaxel|paclitaxel|mesh-list
2859050|NCT03794778|Carboplatin|carboplatin|mesh-list
2859051|NCT03794778|Doxorubicin|doxorubicin|mesh-list
2859052|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2859053|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2859054|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859055|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
2859056|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
2859057|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
2859058|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859059|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2859060|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2859061|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2859062|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859063|NCT03794518|Pioglitazone|pioglitazone|mesh-list
2859064|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2859065|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859066|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
2859067|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
2859068|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
2859069|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
2859070|NCT03794492|Prednisolone|prednisolone|mesh-list
2859071|NCT03794492|Tacrolimus|tacrolimus|mesh-list
2859072|NCT03794492|Basiliximab|basiliximab|mesh-list
2859073|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2859074|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
2859075|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859076|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2304906|NCT00307827|Visilizumab|visilizumab|mesh-list
2304907|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
2304908|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304909|NCT00307944|Pantoprazole|pantoprazole|mesh-list
2304910|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2304911|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2859077|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859078|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859079|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2859080|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859081|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2859082|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
2859083|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2859084|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2859085|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2859086|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
2859087|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
2859088|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859089|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2859090|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
2859091|NCT03794492|Hormones|hormones|mesh-ancestor
2859092|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859093|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2859094|NCT03794492|Protective Agents|protective agents|mesh-ancestor
2859095|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2859096|NCT03794596|Aspirin|aspirin|mesh-list
2859097|NCT03794596|Avelumab|avelumab|mesh-list
2859098|NCT03794596|Lansoprazole|lansoprazole|mesh-list
2859099|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
2859100|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2304912|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2304913|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304914|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304915|NCT00307996|Ubiquinone|ubiquinone|mesh-list
2304916|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
2304917|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
2304918|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304919|NCT00307996|Vitamins|vitamins|mesh-ancestor
2304920|NCT00308048|Interferons|interferons|mesh-list
2304921|NCT00308048|Ribavirin|ribavirin|mesh-list
2304922|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
2304923|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
2304924|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2304925|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304926|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
2859101|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2859102|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2859103|NCT03794596|Analgesics|analgesics|mesh-ancestor
2859104|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
2859105|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859106|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859107|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2859108|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2859109|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2859110|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2859111|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859112|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2859113|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2859114|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859115|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
2859116|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2859117|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859118|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2304927|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2304928|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
2304929|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304930|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
2304931|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304932|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2304933|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
2304934|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
2304935|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2304936|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
2304937|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
2859119|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2859120|NCT03794219|Naproxen|naproxen|mesh-list
2859121|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2859122|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2859123|NCT03794219|Analgesics|analgesics|mesh-ancestor
2859124|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
2859125|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859126|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859127|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2859128|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2859129|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
2859130|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2859131|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859132|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859136|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
2859137|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
2859138|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
2859139|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859140|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2859141|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2859142|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
2859143|NCT03794440|Sorafenib|sorafenib|mesh-list
2859144|NCT03794440|Bevacizumab|bevacizumab|mesh-list
2859145|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859146|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2859147|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859148|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859149|NCT03794440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2859150|NCT03794440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2859151|NCT03794440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2859152|NCT03794440|Growth Substances|growth substances|mesh-ancestor
2859153|NCT03794440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859154|NCT03794440|Growth Inhibitors|growth inhibitors|mesh-ancestor
2859155|NCT03794037|Montelukast|montelukast|mesh-list
2859156|NCT03794037|Progesterone|progesterone|mesh-list
2859157|NCT03794037|Progestins|progestins|mesh-ancestor
2859158|NCT03794037|Hormones|hormones|mesh-ancestor
2859159|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859160|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859161|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2859162|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
2859163|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2859164|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
2304938|NCT00308165|Topotecan|topotecan|mesh-list
2304939|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2304940|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2304941|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304942|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304943|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304944|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2304945|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304946|NCT00308191|Bromides|bromides|mesh-list
2304947|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
2304948|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
2304949|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2304950|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
2859165|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2859166|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2859167|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859168|NCT03794271|Anesthetics|anesthetics|mesh-list
2859169|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859170|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859171|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2859172|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2859173|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2304951|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2304952|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304953|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2304954|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
2304955|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2304956|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2859174|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2859175|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859176|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859177|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859178|NCT03794154|Analgesics|analgesics|mesh-ancestor
2859179|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
2859180|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859181|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
2859182|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2859183|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
2304957|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2304958|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
2304959|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2304960|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304961|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
2304962|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2304963|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
2859184|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
2859185|NCT03794167|Melphalan|melphalan|mesh-list
2859186|NCT03794167|Busulfan|busulfan|mesh-list
2859187|NCT03794167|Etoposide|etoposide|mesh-list
2859188|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2859189|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
2859190|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859191|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2859192|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2859193|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
2859194|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859195|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859196|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2859197|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2859198|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2859199|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2859200|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859201|NCT03794336|Aspirin|aspirin|mesh-list
2859202|NCT03794336|Metformin|metformin|mesh-list
2859203|NCT03794336|Alogliptin|alogliptin|mesh-list
2859204|NCT03794336|Acarbose|acarbose|mesh-list
2859205|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2859206|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859207|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2859208|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2859209|NCT03794336|Analgesics|analgesics|mesh-ancestor
2859210|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
2859211|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859212|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2859213|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2859214|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2859215|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2859216|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859217|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2859218|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2859219|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859220|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
2859221|NCT03794336|Incretins|incretins|mesh-ancestor
2859222|NCT03794336|Hormones|hormones|mesh-ancestor
2859223|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859224|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2859225|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
2859226|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2859227|NCT03794297|Trametinib|trametinib|mesh-list
2859228|NCT03794297|Dabrafenib|dabrafenib|mesh-list
2859229|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2859230|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859231|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2859232|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859233|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859234|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2859235|NCT03794297|Protective Agents|protective agents|mesh-ancestor
2859236|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859237|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2859238|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
2859239|NCT03793725|Apatinib|apatinib|mesh-list
2859240|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859241|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2859242|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859243|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304964|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
2304965|NCT00308269|Folic Acid|folic acid|mesh-list
2304966|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
2304967|NCT00308269|Hematinics|hematinics|mesh-ancestor
2304968|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
2304969|NCT00308269|Vitamins|vitamins|mesh-ancestor
2304970|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
2304971|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304972|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304973|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
2304974|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
2304975|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
2304976|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2304977|NCT00308321|Prednisolone|prednisolone|mesh-list
2304978|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2304979|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
2304980|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2304981|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
2304982|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2304983|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
2304984|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2304985|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
2304986|NCT00308321|Hormones|hormones|mesh-ancestor
2304987|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2304988|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2304989|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2304990|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2304991|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
2304992|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
2304993|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2304994|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2859244|NCT03793517|Decitabine|decitabine|mesh-list
2859245|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2859246|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
2859247|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859248|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859249|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2304995|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2304996|NCT00308321|Protective Agents|protective agents|mesh-ancestor
2304997|NCT00308334|Domperidone|domperidone|mesh-list
2304998|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
2304999|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
2305000|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305001|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305002|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2305003|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2859250|NCT03793439|Prednisone|prednisone|mesh-list
2859251|NCT03793439|Tofacitinib|tofacitinib|mesh-list
2859252|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2859253|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
2859254|NCT03793439|Hormones|hormones|mesh-ancestor
2859255|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859256|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859257|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2859258|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859259|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2859260|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859261|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859262|NCT03793309|Vitamin D|vitamin d|mesh-list
2859263|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
2859264|NCT03793309|Vitamins|vitamins|mesh-list
2859265|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
2859266|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859267|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2859268|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2859269|NCT03793283|Insulin|insulin|mesh-list
2859270|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2859271|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2859272|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859273|NCT03793075|Ketamine|ketamine|mesh-list
2859274|NCT03793075|Propofol|propofol|mesh-list
2859275|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2859276|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859277|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859278|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2859279|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
2859280|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
2859281|NCT03793075|Analgesics|analgesics|mesh-ancestor
2859282|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
2859283|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859284|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2859285|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2859286|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2859287|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859288|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859289|NCT03793205|Lenograstim|lenograstim|mesh-list
2859290|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2859291|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
2859292|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859293|NCT03793114|Cosyntropin|cosyntropin|mesh-list
2859294|NCT03793114|Hormones|hormones|mesh-ancestor
2859295|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859296|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859297|NCT03792867|Doxorubicin|doxorubicin|mesh-list
2859298|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2859299|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859300|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2859301|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2859302|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305004|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
2859303|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859304|NCT03792776|Lidocaine|lidocaine|mesh-list
2859305|NCT03792776|Anesthetics|anesthetics|mesh-list
2859306|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
2859307|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859308|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859309|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
2859310|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859311|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2859312|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2859313|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2859314|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2859315|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859316|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2859317|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2859318|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2859319|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2859320|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305005|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305006|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305007|NCT00308347|Losartan|losartan|mesh-list
2305008|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2305009|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2305010|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2305011|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2305012|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305013|NCT00308360|Valproic Acid|valproic acid|mesh-list
2305014|NCT00308360|Risperidone|risperidone|mesh-list
2305015|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2305016|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
2305017|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305018|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305019|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305020|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2305021|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2305022|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2305023|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2305024|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2305025|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
2305026|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
2305027|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305028|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
2305029|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
2305030|NCT00308373|Metformin|metformin|mesh-list
2305031|NCT00308373|Pioglitazone|pioglitazone|mesh-list
2305032|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2305033|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2305034|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305035|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
2305036|NCT00308425|Valsartan|valsartan|mesh-list
2305037|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2305038|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305039|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2305040|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
2305041|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2305042|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2305043|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305044|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305045|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2305046|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2305047|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2305048|NCT00308438|Teduglutide|teduglutide|mesh-list
2305049|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2305050|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2305051|NCT00308438|Protective Agents|protective agents|mesh-ancestor
2305052|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305053|NCT00308451|Chromium|chromium|mesh-list
2305054|NCT00308451|Biotin|biotin|mesh-list
2305055|NCT00308451|Picolinic acid|picolinic acid|mesh-list
2305056|NCT00308451|Trace Elements|trace elements|mesh-ancestor
2305057|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
2305058|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305059|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
2859321|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859322|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859323|NCT03792828|Analgesics|analgesics|mesh-ancestor
2859324|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
2859325|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859326|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
2859327|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2859328|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
2859329|NCT03792724|Nivolumab|nivolumab|mesh-list
2859330|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2859331|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859332|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2859333|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859334|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
2859335|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
2859336|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
2859337|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
2859338|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2859339|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2859340|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859341|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859342|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859343|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
2859344|NCT03792971|Protective Agents|protective agents|mesh-ancestor
2859345|NCT03792984|Vitamin D|vitamin d|mesh-list
2859346|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
2859347|NCT03792984|Metformin|metformin|mesh-list
2859348|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
2859349|NCT03792984|Calcium|calcium|mesh-list
2859350|NCT03792984|Vitamins|vitamins|mesh-ancestor
2859351|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
2859352|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859353|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2859354|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2859355|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2859356|NCT03792984|Antacids|antacids|mesh-ancestor
2859357|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859358|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2859359|NCT03792815|Etoposide|etoposide|mesh-list
2859360|NCT03792815|Melphalan|melphalan|mesh-list
2859361|NCT03792815|Busulfan|busulfan|mesh-list
2305060|NCT00308451|Vitamins|vitamins|mesh-ancestor
2305061|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2305062|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
2305063|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
2305064|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305065|NCT00308477|Dexamethasone|dexamethasone|mesh-list
2859362|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2859363|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859364|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2859365|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2859366|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859367|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859368|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2859369|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
2859370|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2859371|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2859372|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
2859373|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859374|NCT03792906|Norepinephrine|norepinephrine|mesh-list
2859375|NCT03792906|Bupivacaine|bupivacaine|mesh-list
2859376|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
2859377|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
2859378|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859379|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859380|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
2859381|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859382|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2859383|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2859384|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
2859385|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859386|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859387|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
2859388|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
2859389|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2859390|NCT03792763|Denosumab|denosumab|mesh-list
2859391|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2859392|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2859393|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305066|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2305067|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
2305068|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
2305069|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305070|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305071|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2305072|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
2305073|NCT00308477|Hormones|hormones|mesh-ancestor
2305074|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2305075|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2305076|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305077|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2305078|NCT00308490|Hematinics|hematinics|mesh-ancestor
2305079|NCT00308503|SR 46349B|sr 46349b|mesh-list
2305080|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2305081|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2305082|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305083|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2305084|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2305085|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
2305086|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305087|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305088|NCT00308529|Bevacizumab|bevacizumab|mesh-list
2305089|NCT00308529|Carboplatin|carboplatin|mesh-list
2305090|NCT00308529|Irinotecan|irinotecan|mesh-list
2305091|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2305092|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305093|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2305094|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2305095|NCT00308529|Growth Substances|growth substances|mesh-ancestor
2305096|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305097|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
2305098|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2305099|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2305100|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305101|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305102|NCT00308542|Dexamethasone|dexamethasone|mesh-list
2305103|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2305104|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
2305105|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
2859394|NCT03792620|Daratumumab|daratumumab|mesh-list
2859395|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859396|NCT03792503|Pemetrexed|pemetrexed|mesh-list
2859397|NCT03792503|Apatinib|apatinib|mesh-list
2859398|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859399|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859400|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859401|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2859402|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2859403|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2859404|NCT03792490|Fasudil|fasudil|mesh-list
2859405|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2859406|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2859407|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859408|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2305106|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305107|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305108|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2305109|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
2305110|NCT00308542|Hormones|hormones|mesh-ancestor
2305111|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2305112|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2305113|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305114|NCT00308594|Dexamethasone|dexamethasone|mesh-list
2305115|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2305116|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
2305117|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
2305118|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305119|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305120|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2305121|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
2859409|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305122|NCT00308594|Hormones|hormones|mesh-ancestor
2305123|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2305124|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2305125|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305126|NCT00308607|Interferons|interferons|mesh-list
2305127|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
2305128|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
2305129|NCT00308607|Bevacizumab|bevacizumab|mesh-list
2305130|NCT00308607|Dacarbazine|dacarbazine|mesh-list
2305131|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2305132|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305133|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2305134|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2305135|NCT00308607|Growth Substances|growth substances|mesh-ancestor
2305136|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305137|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
2305138|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
2305139|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2305140|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
2305141|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2305142|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
2305143|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305144|NCT00308763|Bupropion|bupropion|mesh-list
2305145|NCT00308763|Nicotine|nicotine|mesh-list
2305146|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2305147|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
2305148|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305149|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305150|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2305151|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2305152|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
2305153|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305154|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305155|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2305156|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
2305157|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2305158|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2305159|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2305160|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2305161|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
2305162|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2305163|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2305164|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305165|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
2305166|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2305167|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2305168|NCT00308841|Lidocaine|lidocaine|mesh-list
2305169|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
2305170|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
2305171|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2305172|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305173|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
2305174|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305175|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2305176|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2305177|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2305178|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2305179|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305180|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
2305181|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2305182|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2305183|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305184|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
2305185|NCT00308880|Coagulants|coagulants|mesh-ancestor
2305186|NCT00308945|Travoprost|travoprost|mesh-list
2305187|NCT00308945|Latanoprost|latanoprost|mesh-list
2305188|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2305189|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2305190|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2859410|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
2859411|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2859412|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859413|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2859414|NCT03792217|Eusol|eusol|mesh-list
2305191|NCT00308971|Vitamin E|vitamin e|mesh-list
2305192|NCT00308971|Tocopherols|tocopherols|mesh-list
2305193|NCT00308971|Tocotrienols|tocotrienols|mesh-list
2305194|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
2305195|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
2305196|NCT00308971|Vitamins|vitamins|mesh-ancestor
2305197|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
2305198|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859415|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
2859416|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2859417|NCT03792256|Cytarabine|cytarabine|mesh-list
2859418|NCT03792256|Prednisone|prednisone|mesh-list
2859419|NCT03792256|Prednisolone|prednisolone|mesh-list
2859420|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
2859421|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2859422|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2859423|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2859424|NCT03792256|Doxorubicin|doxorubicin|mesh-list
2859425|NCT03792256|Methotrexate|methotrexate|mesh-list
2859426|NCT03792256|Vincristine|vincristine|mesh-list
2305199|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
2305200|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305201|NCT00308971|Protective Agents|protective agents|mesh-ancestor
2859427|NCT03792256|Palbociclib|palbociclib|mesh-list
2859428|NCT03792256|Pegaspargase|pegaspargase|mesh-list
2859429|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2859430|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859431|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2859432|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2859433|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859434|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108398|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2108399|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2108400|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2108401|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108402|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108403|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
2108404|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2108405|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108406|NCT02503540|Aflibercept|aflibercept|mesh-list
2108407|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2108408|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2108409|NCT02503540|Growth Substances|growth substances|mesh-ancestor
2108410|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108411|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
2108412|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108413|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
2108414|NCT02503735|Ledipasvir|ledipasvir|mesh-list
2108415|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
2108416|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108417|NCT02503865|Orlistat|orlistat|mesh-list
2108418|NCT02503865|Diltiazem|diltiazem|mesh-list
2108419|NCT02503865|Atorvastatin|atorvastatin|mesh-list
2108420|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2108421|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2108422|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
2108423|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305202|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
2305203|NCT00309049|Epothilones|epothilones|mesh-list
2305204|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
2305205|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
2305206|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
2305207|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305208|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305209|NCT00309088|Tacrolimus|tacrolimus|mesh-list
2305210|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2305211|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
2305212|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305213|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2305214|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305215|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305216|NCT00309101|Tacrolimus|tacrolimus|mesh-list
2305217|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2305218|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
2305219|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305220|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2305221|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859435|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2859436|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
2859437|NCT03792256|Hormones|hormones|mesh-ancestor
2859438|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859439|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859440|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2859441|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2859442|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
2859443|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2859444|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2859445|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
2305222|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305223|NCT00309179|Cetuximab|cetuximab|mesh-list
2305224|NCT00309179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2305225|NCT00309179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305226|NCT00309192|Triamcinolone|triamcinolone|mesh-list
2859446|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
2859447|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2859448|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2859449|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
2859450|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2859451|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2859452|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
2859453|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2859454|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2859455|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
2859456|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
2859457|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
2859458|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2305227|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2305228|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2305229|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2305230|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2305231|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
2305232|NCT00309192|Hormones|hormones|mesh-ancestor
2305233|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2305234|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305235|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2305236|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
2305237|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305238|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305239|NCT00309205|Dapivirine|dapivirine|mesh-list
2305240|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2305241|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2305242|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
2305243|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2305244|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
2305245|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2305246|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2305247|NCT00309218|Prednisolone|prednisolone|mesh-list
2305248|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
2305249|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2305250|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
2305251|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2305252|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
2305253|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
2305254|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305255|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305256|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2305257|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
2305258|NCT00309218|Hormones|hormones|mesh-ancestor
2305259|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2305260|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2859459|NCT03792139|Itraconazole|itraconazole|mesh-list
2859460|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
2859461|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2859462|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2859463|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2859464|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859465|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859466|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2859467|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
2859468|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859469|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859470|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2859471|NCT03792269|Capecitabine|capecitabine|mesh-list
2859472|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
2859473|NCT03792269|Irinotecan|irinotecan|mesh-list
2859474|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2859475|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
2859476|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859477|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305261|NCT00309218|Protective Agents|protective agents|mesh-ancestor
2305262|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2305263|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305264|NCT00309257|Valsartan|valsartan|mesh-list
2305265|NCT00309257|Benazepril|benazepril|mesh-list
2305266|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2305267|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2305268|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2305269|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305270|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2305271|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
2305272|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305273|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
2305274|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2305275|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859478|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2859479|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2859480|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859481|NCT03792295|Acetaminophen|acetaminophen|mesh-list
2859482|NCT03792295|Ibuprofen|ibuprofen|mesh-list
2859483|NCT03792295|Oxycodone|oxycodone|mesh-list
2859484|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2859485|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2305276|NCT00309283|Somatostatin|somatostatin|mesh-list
2305277|NCT00309283|Hormones|hormones|mesh-ancestor
2859486|NCT03792295|Analgesics|analgesics|mesh-ancestor
2859487|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
2859488|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859489|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859490|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2859491|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2859492|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2859493|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859494|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859495|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2859496|NCT03792295|Narcotics|narcotics|mesh-ancestor
2859497|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859498|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
2859499|NCT03792152|Warfarin|warfarin|mesh-list
2859500|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
2859501|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
2859502|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2859503|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
2859504|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2859505|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
2859506|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859507|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859508|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
2859509|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2859510|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859511|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
2859512|NCT03792321|Testosterone|testosterone|mesh-list
2859513|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
2859514|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
2859515|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2859516|NCT03792321|Androgens|androgens|mesh-ancestor
2859517|NCT03792321|Hormones|hormones|mesh-ancestor
2859518|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859519|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859520|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2859521|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859522|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
2859523|NCT03792009|Bupivacaine|bupivacaine|mesh-list
2859524|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
2859525|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
2859526|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859527|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859528|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
2859529|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859530|NCT03792074|Paclitaxel|paclitaxel|mesh-list
2859531|NCT03792074|Bevacizumab|bevacizumab|mesh-list
2859532|NCT03792074|Carboplatin|carboplatin|mesh-list
2859533|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2859534|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859535|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
2859536|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
2859537|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
2859538|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859539|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2859540|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2859541|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2859542|NCT03792074|Growth Substances|growth substances|mesh-ancestor
2859543|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859544|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
2859545|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2859546|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
2859547|NCT03792113|Coagulants|coagulants|mesh-ancestor
2305278|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2305279|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305280|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
2305281|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2305282|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305283|NCT00309322|Phentolamine|phentolamine|mesh-list
2859548|NCT03791905|Leucovorin|leucovorin|mesh-list
2859549|NCT03791905|Paclitaxel|paclitaxel|mesh-list
2859550|NCT03791905|Fluorouracil|fluorouracil|mesh-list
2859551|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
2859552|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2305284|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2305285|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2305286|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
2305287|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305288|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305289|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859553|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859554|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
2859555|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
2859556|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
2859557|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859558|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
2859559|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2859560|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2859561|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
2859562|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859563|NCT03791905|Antidotes|antidotes|mesh-ancestor
2859564|NCT03791905|Protective Agents|protective agents|mesh-ancestor
2859565|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
2859566|NCT03791905|Vitamins|vitamins|mesh-ancestor
2859567|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
2859568|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
2859569|NCT03791918|Lenvatinib|lenvatinib|mesh-list
2859570|NCT03791918|Antibodies|antibodies|mesh-list
2859571|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
2859572|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
2859573|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859574|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2859575|NCT03791918|Estrogens|estrogens|mesh-ancestor
2859576|NCT03791918|Hormones|hormones|mesh-ancestor
2859577|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859578|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2859579|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859580|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2859581|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859582|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859583|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
2859584|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
2859585|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2859586|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
2859587|NCT03791801|Rocuronium|rocuronium|mesh-list
2859588|NCT03791801|Neostigmine|neostigmine|mesh-list
2859589|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2859590|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2859591|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2859592|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859593|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859594|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2859595|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859596|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859597|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
2859598|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859599|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2859600|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
2859601|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2859602|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2859603|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2859604|NCT03791775|Polidocanol|polidocanol|mesh-list
2859605|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2859606|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2859607|NCT03791827|Cyclosporine|cyclosporine|mesh-list
2859608|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
2859609|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
2859610|NCT03791827|Prednisone|prednisone|mesh-list
2305290|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2305291|NCT00309335|Phentolamine|phentolamine|mesh-list
2305292|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2305293|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2305294|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
2305295|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305296|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305297|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305298|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2305299|NCT00309361|Phentolamine|phentolamine|mesh-list
2305300|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2305301|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2305302|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
2305303|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305304|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305305|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305306|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2305307|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2305308|NCT00309374|Simvastatin|simvastatin|mesh-list
2305309|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2305310|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2305311|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
2305312|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305313|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2305314|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2305315|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305316|NCT00309413|Cannabidiol|cannabidiol|mesh-list
2305317|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
2305318|NCT00309478|Tamoxifen|tamoxifen|mesh-list
2305319|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
2305320|NCT00309478|Fluorouracil|fluorouracil|mesh-list
2305321|NCT00309478|Methotrexate|methotrexate|mesh-list
2305322|NCT00309478|Goserelin|goserelin|mesh-list
2305323|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2305324|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
2305325|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305326|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2305327|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2305328|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
2305329|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305330|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305331|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2305332|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
2305333|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2305334|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2305335|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
2305336|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2305337|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
2305338|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305339|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2305340|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2305341|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2305342|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
2859611|NCT03791827|Prednisolone|prednisolone|mesh-list
2859612|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
2859613|NCT03791827|Rituximab|rituximab|mesh-list
2859614|NCT03791827|Azathioprine|azathioprine|mesh-list
2859615|NCT03791827|Tacrolimus|tacrolimus|mesh-list
2859616|NCT03791827|Cyclosporins|cyclosporins|mesh-list
2859617|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2859618|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
2305343|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2305344|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2305345|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2305346|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2305347|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2305348|NCT00309491|Tamoxifen|tamoxifen|mesh-list
2305349|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
2305350|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2305351|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
2305352|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2305353|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305354|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2305355|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305356|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2305357|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2859619|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859620|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2859621|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2859622|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
2859623|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859624|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859625|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2859626|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2859627|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2859628|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
2859629|NCT03791827|Hormones|hormones|mesh-ancestor
2859630|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859631|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2859632|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2859633|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859634|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
2859635|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2859636|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
2859637|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2859638|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2859639|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
2859640|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2859641|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
2859642|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2859643|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2859644|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
2859645|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2859646|NCT03791736|Octreotide|octreotide|mesh-list
2859647|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2859648|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2859649|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859650|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2859651|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
2859652|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2859653|NCT03791762|Protective Agents|protective agents|mesh-ancestor
2859654|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859655|NCT03791723|Valsartan|valsartan|mesh-list
2859656|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2859657|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2859658|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2859659|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2859660|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859661|NCT03791515|Calcitonin|calcitonin|mesh-list
2859662|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
2859663|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2859664|NCT03791515|Katacalcin|katacalcin|mesh-list
2305358|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2305359|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2305360|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2305361|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305362|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305363|NCT00309517|Leucovorin|leucovorin|mesh-list
2305364|NCT00309517|Edrecolomab|edrecolomab|mesh-list
2859665|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2859666|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859667|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2859668|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
2859669|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
2859670|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859671|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859672|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859673|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2859674|NCT03791398|Nivolumab|nivolumab|mesh-list
2859675|NCT03791398|TIC10 compound|tic10 compound|mesh-list
2859676|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2859677|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859678|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2859679|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859680|NCT03791424|Midazolam|midazolam|mesh-list
2859681|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2859682|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2859683|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859684|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859685|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2859686|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2859687|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2859688|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2859689|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
2859690|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
2859691|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
2859692|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
2859693|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859694|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859695|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
2859696|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
2859697|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2859698|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
2859699|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859700|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
2859701|NCT03791294|Protective Agents|protective agents|mesh-ancestor
2859702|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
2859703|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2859704|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
2859705|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2859706|NCT03791099|Metronidazole|metronidazole|mesh-list
2859707|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2859708|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2859709|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2859710|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2859711|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
2859712|NCT03791255|Calcium|calcium|mesh-list
2859713|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2859714|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859715|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2859716|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2859717|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2859718|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859719|NCT03790839|Incretins|incretins|mesh-ancestor
2305365|NCT00309517|Antidotes|antidotes|mesh-ancestor
2305366|NCT00309517|Protective Agents|protective agents|mesh-ancestor
2305367|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305368|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
2305369|NCT00309517|Vitamins|vitamins|mesh-ancestor
2305370|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
2305371|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2305372|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
2305373|NCT00309530|Interferons|interferons|mesh-list
2305374|NCT00309530|Fluorouracil|fluorouracil|mesh-list
2305375|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
2305376|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305377|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2305378|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305379|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2305380|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
2305381|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305382|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
2305383|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2305384|NCT00309543|Leucovorin|leucovorin|mesh-list
2305385|NCT00309543|Fluorouracil|fluorouracil|mesh-list
2305386|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
2305387|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859720|NCT03790839|Hormones|hormones|mesh-ancestor
2859721|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859722|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2859723|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
2859724|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859725|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859726|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
2859727|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859728|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859729|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859730|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2859731|NCT03790800|Urapidil|urapidil|mesh-list
2859732|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2859733|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
2859734|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2859735|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
2859736|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859737|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859738|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859739|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2859740|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2859741|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2859742|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
2859743|NCT03790787|Empagliflozin|empagliflozin|mesh-list
2859744|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2859745|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859746|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2859747|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859748|NCT03790670|Sargramostim|sargramostim|mesh-list
2859749|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
2859750|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859751|NCT03790540|Benzocaine|benzocaine|mesh-list
2859752|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
2859753|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
2859754|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859755|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859756|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
2859757|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859758|NCT03790605|Curcumin|curcumin|mesh-list
2859759|NCT03790605|Iproplatin|iproplatin|mesh-list
2859760|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2859761|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2859762|NCT03790605|Analgesics|analgesics|mesh-ancestor
2859763|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
2859764|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859765|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859766|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2305388|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2305389|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305390|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2305391|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
2305392|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305393|NCT00309543|Antidotes|antidotes|mesh-ancestor
2305394|NCT00309543|Protective Agents|protective agents|mesh-ancestor
2305395|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
2305396|NCT00309543|Vitamins|vitamins|mesh-ancestor
2305397|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
2305398|NCT00309556|Docetaxel|docetaxel|mesh-list
2859767|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2859768|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859769|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859770|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305399|NCT00309556|Capecitabine|capecitabine|mesh-list
2305400|NCT00309556|Trastuzumab|trastuzumab|mesh-list
2305401|NCT00309556|Epirubicin|epirubicin|mesh-list
2305402|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305403|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
2859771|NCT03790345|Vitamins|vitamins|mesh-list
2859772|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
2859773|NCT03790345|Pyridoxine|pyridoxine|mesh-list
2859774|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
2859775|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
2859776|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
2859777|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859778|NCT03790618|Methamphetamine|methamphetamine|mesh-list
2859779|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2859780|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
2859781|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859782|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2305404|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
2305405|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
2305406|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305407|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2305408|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
2305409|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2305410|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2305411|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2305412|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2305413|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305414|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
2305415|NCT00309569|Fluorouracil|fluorouracil|mesh-list
2305416|NCT00309569|Methotrexate|methotrexate|mesh-list
2305417|NCT00309569|Epirubicin|epirubicin|mesh-list
2305418|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2305419|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
2305420|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305421|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2305422|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2305423|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
2305424|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305425|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305426|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2305427|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
2305428|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2305429|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2305430|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
2305431|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2305432|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
2305433|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305434|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2305435|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2305436|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2305437|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2305438|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2305439|NCT00309621|Alitretinoin|alitretinoin|mesh-list
2305440|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305441|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
2305442|NCT00309634|Vaccines|vaccines|mesh-list
2305443|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
2305444|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305445|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
2305446|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2305447|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305448|NCT00309673|Lidocaine|lidocaine|mesh-list
2305449|NCT00309673|Prilocaine|prilocaine|mesh-list
2305450|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2305451|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
2305452|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
2305453|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2305454|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305455|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
2305456|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305457|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2305458|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2305459|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2305460|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2305461|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305462|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2305463|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2305464|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2305465|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2859783|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
2859784|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859785|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859786|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2305466|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2305467|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305468|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2305469|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2305470|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2305471|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
2305472|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305473|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305474|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2305475|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2305476|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
2305477|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2305478|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2305479|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
2305480|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2305481|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2305482|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2305483|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2305484|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305485|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2305486|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2305487|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
2305488|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859787|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2859788|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2859789|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
2859790|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2859791|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
2859792|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
2859793|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859794|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
2859795|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2859796|NCT03790566|Bupivacaine|bupivacaine|mesh-list
2859797|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
2859798|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
2859799|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859800|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859801|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
2859802|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859803|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
2859804|NCT03790215|Progestins|progestins|mesh-ancestor
2859805|NCT03790215|Hormones|hormones|mesh-ancestor
2859806|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859807|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859808|NCT03790228|Carboplatin|carboplatin|mesh-list
2859809|NCT03790228|Pemetrexed|pemetrexed|mesh-list
2859810|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859811|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859812|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859813|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2305489|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305490|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2305491|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2305492|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
2305493|NCT00309712|Simvastatin|simvastatin|mesh-list
2305494|NCT00309712|Fenofibrate|fenofibrate|mesh-list
2305495|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2305496|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2305497|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
2305498|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305499|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2305500|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2305501|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305502|NCT00309725|Galantamine|galantamine|mesh-list
2305503|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2305504|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305505|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305506|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
2305507|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305508|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305509|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2305510|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
2305511|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305512|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
2859814|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2859815|NCT03790371|Misoprostol|misoprostol|mesh-list
2859816|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2859817|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
2859818|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2859819|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859820|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2859821|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2859822|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
2859823|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
2859824|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
2859825|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
2859826|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859827|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859828|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
2859829|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859830|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
2859831|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
2859832|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859833|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2859834|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2859835|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
2859836|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859837|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859838|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2859839|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2859840|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859841|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859842|NCT03790384|Mitomycins|mitomycins|mesh-list
2859843|NCT03790384|Mitomycin|mitomycin|mesh-list
2859844|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
2859845|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2859846|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859847|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
2859848|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859849|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2859850|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859851|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2859852|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
2859853|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859854|NCT03790397|Osimertinib|osimertinib|mesh-list
2859855|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859856|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2859857|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859858|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859859|NCT03790293|Rituximab|rituximab|mesh-list
2859860|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2859861|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859862|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
2859863|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859864|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2859865|NCT03790020|Bupivacaine|bupivacaine|mesh-list
2859866|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
2859867|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
2859868|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859869|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859870|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
2859871|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859872|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
2859873|NCT03790072|Fludarabine|fludarabine|mesh-list
2859874|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2859875|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
2859876|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859877|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2859878|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2859879|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
2859880|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859881|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2859882|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2859883|NCT03789890|Itraconazole|itraconazole|mesh-list
2305513|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
2305514|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
2305515|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2859884|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
2859885|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2859886|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2859887|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2859888|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859889|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859890|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2859891|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
2859892|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2859893|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859894|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2859895|NCT03790085|Olanzapine|olanzapine|mesh-list
2859896|NCT03790085|Risperidone|risperidone|mesh-list
2859897|NCT03790085|Aripiprazole|aripiprazole|mesh-list
2859898|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2859899|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
2859900|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859901|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859902|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859903|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2859904|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2859905|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859906|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2859907|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2859908|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
2859909|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
2859910|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
2859911|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859912|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2859913|NCT03790085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2305516|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2305517|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305518|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305519|NCT00309790|Urological Agents|urological agents|mesh-ancestor
2305520|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
2305521|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
2305522|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2305523|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2859914|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2859915|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2859916|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
2859917|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
2859918|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2859919|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2859920|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2859921|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2859922|NCT03789916|Aspirin|aspirin|mesh-list
2859923|NCT03789916|Ticagrelor|ticagrelor|mesh-list
2859924|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2859925|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2859926|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2859927|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2859928|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
2859929|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859930|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859931|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859932|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2859933|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2859934|NCT03789916|Analgesics|analgesics|mesh-ancestor
2859935|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
2859936|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859937|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2859938|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2859939|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2859940|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2859941|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2859942|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859943|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
2859944|NCT03790137|Fenfluramine|fenfluramine|mesh-list
2108424|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2108425|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2108426|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108427|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2108428|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2108429|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108430|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2305524|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305525|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305526|NCT00309816|Urological Agents|urological agents|mesh-ancestor
2305527|NCT00309855|Anastrozole|anastrozole|mesh-list
2305528|NCT00309855|Testosterone|testosterone|mesh-list
2305529|NCT00309855|Dutasteride|dutasteride|mesh-list
2305530|NCT00309855|Androgens|androgens|mesh-ancestor
2305531|NCT00309855|Hormones|hormones|mesh-ancestor
2305532|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2305533|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305534|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2305535|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305536|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2305537|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2305538|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305539|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305540|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
2305541|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2305542|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2305543|NCT00309881|Prednisone|prednisone|mesh-list
2305544|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
2305545|NCT00309881|Rituximab|rituximab|mesh-list
2305546|NCT00309881|Doxorubicin|doxorubicin|mesh-list
2305547|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2305548|NCT00309881|Vincristine|vincristine|mesh-list
2305549|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2305550|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
2305551|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305552|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2305553|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2305554|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
2305555|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305556|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305557|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2305558|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2305559|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2305560|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2305561|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2305562|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305563|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2305564|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
2859945|NCT03790137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2859946|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2859947|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2859948|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2859949|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2859950|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
2859951|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305565|NCT00309881|Hormones|hormones|mesh-ancestor
2305566|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2305567|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2305568|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2859964|NCT03790007|Bupivacaine|bupivacaine|mesh-list
2859965|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
2859966|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
2305569|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
2305570|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
2305571|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
2305572|NCT00309894|Ketoconazole|ketoconazole|mesh-list
2305573|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
2305574|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2305575|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2305576|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2305577|NCT00309894|Sargramostim|sargramostim|mesh-list
2305578|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2305579|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
2305580|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305581|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
2305582|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2305583|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2305584|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2305585|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305586|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305587|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2305588|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
2305589|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2305590|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2305591|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
2859967|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859968|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859969|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
2859970|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2859971|NCT03789695|Dabigatran|dabigatran|mesh-list
2859972|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
2859973|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2859974|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
2859975|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2859976|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305592|NCT00309920|Docetaxel|docetaxel|mesh-list
2305593|NCT00309920|Doxorubicin|doxorubicin|mesh-list
2305594|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2305595|NCT00309920|Fluorouracil|fluorouracil|mesh-list
2305596|NCT00309920|Epirubicin|epirubicin|mesh-list
2859977|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
2859978|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
2859979|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
2859980|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2859981|NCT03789799|Protective Agents|protective agents|mesh-ancestor
2859982|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859983|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
2859984|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2859985|NCT03789370|Propofol|propofol|mesh-list
2859986|NCT03789370|Sevoflurane|sevoflurane|mesh-list
2859987|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2859988|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2859989|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859990|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2859991|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
2859992|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
2859993|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2859994|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2859995|NCT03789539|Vaccines|vaccines|mesh-list
2859996|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
2859997|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2859998|NCT03789422|Cetirizine|cetirizine|mesh-list
2859999|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
2860000|NCT03789422|Levocetirizine|levocetirizine|mesh-list
2860001|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2860002|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2860003|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860004|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
2305597|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
2305598|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2305599|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
2305600|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305601|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2305602|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2305603|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
2305604|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305605|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860005|NCT03789422|Coagulants|coagulants|mesh-ancestor
2860006|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2860007|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2860008|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
2860009|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
2860010|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860011|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860012|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2860013|NCT03789110|Nivolumab|nivolumab|mesh-list
2305606|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2305607|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
2305608|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
2305609|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
2305610|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2305611|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2305612|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2860014|NCT03789110|Ipilimumab|ipilimumab|mesh-list
2860015|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2860016|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860017|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2860018|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860019|NCT03789123|Dienogest|dienogest|mesh-list
2860020|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2860021|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2860022|NCT03789123|Estradiol|estradiol|mesh-list
2860023|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2860024|NCT03789123|Nandrolone|nandrolone|mesh-list
2860025|NCT03789123|Estrogens|estrogens|mesh-ancestor
2860026|NCT03789123|Hormones|hormones|mesh-ancestor
2108431|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108432|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
2108433|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2108434|NCT02503982|Valganciclovir|valganciclovir|mesh-list
2108435|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
2305613|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305614|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
2305615|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2305616|NCT00309920|Hematinics|hematinics|mesh-ancestor
2305617|NCT00309998|Bevacizumab|bevacizumab|mesh-list
2305618|NCT00309998|Vinorelbine|vinorelbine|mesh-list
2305619|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2305620|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305621|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2305622|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2305623|NCT00309998|Growth Substances|growth substances|mesh-ancestor
2305624|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305625|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
2305626|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2305627|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
2305628|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
2305629|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
2305630|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305631|NCT00310011|Gemcitabine|gemcitabine|mesh-list
2305632|NCT00310011|Paclitaxel|paclitaxel|mesh-list
2305633|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2305634|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305635|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
2305636|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
2305637|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
2860027|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2860028|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860029|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2860030|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
2305638|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305639|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2305640|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
2305641|NCT00310011|Antiviral Agents|antiviral agents|mesh-ancestor
2305642|NCT00310011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2860031|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2860032|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2860033|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2860034|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2860035|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2860036|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
2860037|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2305643|NCT00310011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305644|NCT00310011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2860038|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860039|NCT03789123|Androgens|androgens|mesh-ancestor
2305645|NCT00310011|Immunologic Factors|immunologic factors|mesh-ancestor
2305646|NCT00310011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305647|NCT00310024|Bortezomib|bortezomib|mesh-list
2305648|NCT00310024|Vorinostat|vorinostat|mesh-list
2305649|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305650|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2305651|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305652|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305653|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
2305654|NCT00310089|Docetaxel|docetaxel|mesh-list
2305655|NCT00310089|Doxorubicin|doxorubicin|mesh-list
2305656|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2305657|NCT00310089|Cediranib|cediranib|mesh-list
2305658|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2305659|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
2305660|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305661|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2305662|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2305663|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
2305664|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305665|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305666|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2305667|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
2305668|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
2305669|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
2860040|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
2860041|NCT03789214|Suvorexant|suvorexant|mesh-list
2305670|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2305671|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2305672|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2305673|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305674|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2860042|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2860043|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2860044|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860045|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860046|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2860047|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860048|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860049|NCT03788967|Ertapenem|ertapenem|mesh-list
2860050|NCT03788967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2860051|NCT03788967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2860052|NCT03789058|Ibuprofen|ibuprofen|mesh-list
2860053|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2860054|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2860055|NCT03789058|Analgesics|analgesics|mesh-ancestor
2860056|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
2860057|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860058|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860059|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2860060|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2860061|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2860062|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860063|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860064|NCT03788889|Ketamine|ketamine|mesh-list
2860065|NCT03788889|Lorazepam|lorazepam|mesh-list
2860066|NCT03788889|Phenobarbital|phenobarbital|mesh-list
2860067|NCT03788889|Analgesics|analgesics|mesh-ancestor
2860068|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
2860069|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860070|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860071|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2860072|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2860073|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
2860074|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
2860075|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860076|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2860077|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2860078|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860079|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860080|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
2860081|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
2305675|NCT00310128|Cytarabine|cytarabine|mesh-list
2305676|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
2860082|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
2860083|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2860084|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2860085|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2860086|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2860087|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2860088|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
2860089|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
2860090|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2860091|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2860092|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2860093|NCT03788902|Methylphenidate|methylphenidate|mesh-list
2860094|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2860095|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860096|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2860097|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2860098|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2860099|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860100|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
2860101|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860102|NCT03788863|Diflucortolone|diflucortolone|mesh-list
2860103|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
2860104|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2860105|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
2860106|NCT03788863|Hormones|hormones|mesh-ancestor
2860107|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2860108|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305677|NCT00310128|Rituximab|rituximab|mesh-list
2305678|NCT00310128|Etoposide|etoposide|mesh-list
2305679|NCT00310128|Antibodies|antibodies|mesh-list
2305680|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
2305681|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2305682|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305683|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
2305684|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305685|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2305686|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2305687|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2305688|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2305689|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2305690|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305691|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305692|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2305693|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
2305694|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
2860109|NCT03789032|Rabeprazole|rabeprazole|mesh-list
2860110|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2860111|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2860112|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2860113|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860114|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860115|NCT03788733|Melatonin|melatonin|mesh-list
2860116|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
2860117|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860118|NCT03788733|Protective Agents|protective agents|mesh-ancestor
2860119|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860120|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2305695|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2305696|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2305697|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2305698|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
2305699|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
2305700|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305701|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2305702|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
2860121|NCT03788694|Ketamine|ketamine|mesh-list
2860122|NCT03788694|Analgesics|analgesics|mesh-ancestor
2860123|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
2860124|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860125|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860126|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2860127|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2860128|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
2860129|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
2860130|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860131|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2860132|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2860133|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860134|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860135|NCT03789006|Interleukin-2|interleukin-2|mesh-list
2860136|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
2860137|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2860138|NCT03789006|Antibodies|antibodies|mesh-list
2860139|NCT03789006|Basiliximab|basiliximab|mesh-list
2860140|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
2860141|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2860142|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
2860143|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860144|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860145|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2860146|NCT03789006|Analgesics|analgesics|mesh-ancestor
2305703|NCT00310128|Hormones|hormones|mesh-ancestor
2305704|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2305705|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2305706|NCT00310128|Protective Agents|protective agents|mesh-ancestor
2305707|NCT00310141|Nicotine|nicotine|mesh-list
2860147|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
2860148|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860149|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2860150|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
2860151|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
2860152|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860153|NCT03788759|Protective Agents|protective agents|mesh-ancestor
2860154|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860155|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
2860156|NCT03788759|Vitamins|vitamins|mesh-ancestor
2305708|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2305709|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
2305710|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305711|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860157|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
2860158|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2860159|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2860160|NCT03788681|Estradiol|estradiol|mesh-list
2860161|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2860162|NCT03788681|Estrogens|estrogens|mesh-ancestor
2860163|NCT03788681|Hormones|hormones|mesh-ancestor
2860164|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2860165|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860166|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2860167|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
2860168|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2860169|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2860170|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
2860171|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2860172|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860173|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860174|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2860175|NCT03788538|Analgesics|analgesics|mesh-ancestor
2860176|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
2305712|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2305713|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2305714|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
2305715|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305716|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305717|NCT00310154|Docetaxel|docetaxel|mesh-list
2305718|NCT00310154|Gefitinib|gefitinib|mesh-list
2305719|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305720|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
2305721|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
2305722|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
2305723|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305724|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2305725|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860177|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860178|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2860179|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2860180|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2860181|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
2860182|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860183|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860184|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2860185|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2860186|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
2860187|NCT03788291|Rituximab|rituximab|mesh-list
2860188|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
2860189|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2860190|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860191|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
2860192|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860193|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2860194|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
2860195|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2860196|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2860197|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2860198|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2305726|NCT00310206|Vaccines|vaccines|mesh-list
2305727|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
2305728|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305729|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
2305730|NCT00310232|Hematinics|hematinics|mesh-ancestor
2305731|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
2305732|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2305733|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305734|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
2305735|NCT00310323|Caffeine|caffeine|mesh-list
2860199|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860200|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
2860201|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860202|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860203|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2860204|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860205|NCT03787992|Gefitinib|gefitinib|mesh-list
2860206|NCT03787992|Aflutinib|aflutinib|mesh-list
2305736|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2305737|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305738|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2305739|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860207|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860208|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2860209|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860210|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860211|NCT03787940|Isoniazid|isoniazid|mesh-list
2860212|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
2860213|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2860214|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2860215|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2860216|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2860217|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
2860218|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305740|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305741|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2305742|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2305743|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
2305744|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305745|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
2305746|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
2305747|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2305748|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2305749|NCT00310336|Interferons|interferons|mesh-list
2305750|NCT00310336|Ribavirin|ribavirin|mesh-list
2305751|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
2305752|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
2860219|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2860220|NCT03787953|Antibodies|antibodies|mesh-list
2860221|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
2860222|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860223|NCT03788018|Lidocaine|lidocaine|mesh-list
2860224|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
2860225|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
2860226|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
2860227|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860228|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860229|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
2860230|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860231|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2860232|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2860233|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2860234|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2860235|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860236|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2860237|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2860238|NCT03788018|Analgesics|analgesics|mesh-ancestor
2860239|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2860240|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2860241|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2860242|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
2108436|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108437|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
2108438|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2108439|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
2108440|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2108441|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
2108442|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108443|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108444|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
2108445|NCT02504268|Methotrexate|methotrexate|mesh-list
2108446|NCT02504268|Abatacept|abatacept|mesh-list
2108447|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2108448|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
2108449|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2108450|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108451|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2108452|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
2108453|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108454|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108455|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
2108456|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108457|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2108458|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2108459|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
2108460|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2108461|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2108462|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2108463|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
2108464|NCT02504294|Hematinics|hematinics|mesh-ancestor
2108465|NCT02504320|Febuxostat|febuxostat|mesh-list
2860243|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860244|NCT03788174|Apatinib|apatinib|mesh-list
2860245|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860246|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2860247|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860248|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860249|NCT03787927|Aspirin|aspirin|mesh-list
2860250|NCT03787927|Clopidogrel|clopidogrel|mesh-list
2860251|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2860252|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2860253|NCT03787927|Analgesics|analgesics|mesh-ancestor
2860254|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
2860255|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860256|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860257|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2860258|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2860259|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2860260|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2860261|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860262|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2860263|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2860264|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860265|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
2860266|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2860267|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2860268|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2860269|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
2860270|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860271|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2860272|NCT03787550|Analgesics|analgesics|mesh-list
2860273|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2305753|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2305754|NCT00310336|Betaine|betaine|mesh-list
2305755|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305756|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
2305757|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2305758|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
2305759|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305760|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
2305761|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305762|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2305763|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
2305764|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2305765|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2305766|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2305767|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
2305768|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305769|NCT00310388|Ezogabine|ezogabine|mesh-list
2305770|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
2305771|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2305772|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305773|NCT00310505|Amphotericin B|amphotericin b|mesh-list
2305774|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2305775|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
2305776|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
2305777|NCT00310505|Amebicides|amebicides|mesh-ancestor
2305778|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2305779|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2305780|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2305781|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2305782|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
2305783|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2305784|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2305785|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
2305786|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2860274|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2860275|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
2860276|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860277|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860278|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860279|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
2860280|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2860281|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2305787|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2305788|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2305789|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305790|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305791|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
2860282|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
2860283|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860284|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860285|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860286|NCT03787654|Urological Agents|urological agents|mesh-ancestor
2860287|NCT03787680|Olaparib|olaparib|mesh-list
2860288|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2860289|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305792|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2305793|NCT00310531|Estradiol|estradiol|mesh-list
2305794|NCT00310531|Estrogens|estrogens|mesh-ancestor
2305795|NCT00310531|Hormones|hormones|mesh-ancestor
2305796|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2305797|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305798|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2305799|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
2305800|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2305801|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2305802|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2305803|NCT00310583|Pregabalin|pregabalin|mesh-list
2305804|NCT00310583|Analgesics|analgesics|mesh-ancestor
2860290|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860291|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860292|NCT03787641|Protamines|protamines|mesh-list
2860293|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
2860294|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860295|NCT03787641|Coagulants|coagulants|mesh-ancestor
2860296|NCT03787251|Apatinib|apatinib|mesh-list
2860297|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860298|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2860299|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860300|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305805|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
2305806|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305807|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305808|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
2305809|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2305810|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2305811|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305812|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2305813|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2305814|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2305815|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860307|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2860308|NCT03787264|Venetoclax|venetoclax|mesh-list
2860309|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
2860310|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
2860311|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2860312|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
2860313|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860314|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860315|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2860316|NCT03787147|Lidocaine|lidocaine|mesh-list
2860317|NCT03787147|Bupivacaine|bupivacaine|mesh-list
2860318|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
2860319|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
2860320|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860321|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860322|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
2860323|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860324|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2860325|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2860326|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2860327|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2860328|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860329|NCT03786887|Nalbuphine|nalbuphine|mesh-list
2860330|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2860331|NCT03786887|Narcotics|narcotics|mesh-ancestor
2860332|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860333|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860334|NCT03786887|Analgesics|analgesics|mesh-ancestor
2860335|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
2860336|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860337|NCT03786796|Olaparib|olaparib|mesh-list
2860338|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2860339|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860340|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860341|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860342|NCT03787043|Metformin|metformin|mesh-list
2860343|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2860344|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860345|NCT03787017|Metformin|metformin|mesh-list
2860346|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2860347|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860348|NCT03786770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2860349|NCT03786770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2860350|NCT03786770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2860351|NCT03786770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860352|NCT03786770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860353|NCT03786770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2860354|NCT03786770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2860355|NCT03786770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860356|NCT03786770|Cholinergic Agents|cholinergic agents|mesh-ancestor
2860357|NCT03786770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860358|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
2860359|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2860360|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
2860361|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2860362|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
2860363|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305816|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2305817|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
2305818|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2305819|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2305820|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2305821|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2305822|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2305823|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860364|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860365|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
2860366|NCT03787030|Vitamin E|vitamin e|mesh-list
2860367|NCT03787030|Tocopherols|tocopherols|mesh-list
2860368|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
2860369|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
2860370|NCT03787030|Vitamins|vitamins|mesh-ancestor
2860371|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
2860372|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860373|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
2860374|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860375|NCT03787030|Protective Agents|protective agents|mesh-ancestor
2860376|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
2860377|NCT03787069|Lidocaine|lidocaine|mesh-list
2305824|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305825|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305826|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2305827|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
2305828|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2305829|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305830|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2305831|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2305832|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2305833|NCT00310765|Pregabalin|pregabalin|mesh-list
2305834|NCT00310765|Gabapentin|gabapentin|mesh-list
2305835|NCT00310765|Analgesics|analgesics|mesh-ancestor
2305836|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
2305837|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305838|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305839|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
2305840|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2305841|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2305842|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305843|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2305844|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2305845|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2305846|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2305847|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2305848|NCT00310765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2305849|NCT00310765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2305850|NCT00310765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305851|NCT00310765|Antimanic Agents|antimanic agents|mesh-ancestor
2305852|NCT00310778|Atenolol|atenolol|mesh-list
2305853|NCT00310778|Valsartan|valsartan|mesh-list
2305854|NCT00310778|Candesartan|candesartan|mesh-list
2305855|NCT00310778|Ramipril|ramipril|mesh-list
2860378|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
2860379|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
2860380|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860381|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860382|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
2860383|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860384|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2860385|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2860386|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2860387|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2860388|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860389|NCT03786562|Morphine|morphine|mesh-list
2860390|NCT03786562|Nalbuphine|nalbuphine|mesh-list
2860391|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2860392|NCT03786562|Narcotics|narcotics|mesh-ancestor
2860393|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860394|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860395|NCT03786562|Analgesics|analgesics|mesh-ancestor
2860396|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
2860397|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860398|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
2860399|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2860400|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
2860401|NCT03786289|Hematinics|hematinics|mesh-ancestor
2860402|NCT03786419|Atezolizumab|atezolizumab|mesh-list
2860403|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860404|NCT03786120|Zolpidem|zolpidem|mesh-list
2860405|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2860406|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2860407|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108466|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
2108467|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2108468|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
2305856|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2305857|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2305858|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2305859|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305860|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2305861|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
2305862|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305863|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2305864|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
2305865|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
2305866|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305867|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305868|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2305869|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2305870|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2305871|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
2305872|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305873|NCT00310830|Bosentan|bosentan|mesh-list
2860408|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860409|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2860410|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
2860411|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
2860412|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860413|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860425|NCT03785873|Leucovorin|leucovorin|mesh-list
2860426|NCT03785873|Fluorouracil|fluorouracil|mesh-list
2860427|NCT03785873|Nivolumab|nivolumab|mesh-list
2860428|NCT03785873|Irinotecan|irinotecan|mesh-list
2860429|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
2860430|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860431|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2860432|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860433|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2860434|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
2860435|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860436|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2860437|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2860438|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2860439|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2860440|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860441|NCT03785873|Antidotes|antidotes|mesh-ancestor
2860442|NCT03785873|Protective Agents|protective agents|mesh-ancestor
2860443|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
2860444|NCT03785873|Vitamins|vitamins|mesh-ancestor
2860445|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
2860446|NCT03786237|ON 01910|on 01910|mesh-list
2860447|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860448|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2860449|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860450|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860451|NCT03786029|Acetaminophen|acetaminophen|mesh-list
2860452|NCT03786029|Ibuprofen|ibuprofen|mesh-list
2860453|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2860454|NCT03786029|Analgesics|analgesics|mesh-ancestor
2305874|NCT00310830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2305875|NCT00310830|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2305876|NCT00310830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305877|NCT00310843|Nevirapine|nevirapine|mesh-list
2860455|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
2860456|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860457|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860458|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
2860459|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2860460|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2860461|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2860462|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2860463|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860464|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860465|NCT03785756|Ibuprofen|ibuprofen|mesh-list
2860466|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2860467|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2860468|NCT03785756|Analgesics|analgesics|mesh-ancestor
2860469|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
2860470|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860471|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860472|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2860473|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2860474|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2860475|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860476|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860477|NCT03785496|Spartalizumab|spartalizumab|mesh-list
2860478|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2860479|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860480|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305878|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2305879|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2305880|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305881|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305882|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
2305883|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2305884|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2305885|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2305886|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2305887|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2305888|NCT00310895|Imetelstat|imetelstat|mesh-list
2305889|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
2305890|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305891|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305892|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2305893|NCT00310908|Tramadol|tramadol|mesh-list
2305894|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2305895|NCT00310908|Narcotics|narcotics|mesh-ancestor
2305896|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2305897|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305898|NCT00310908|Analgesics|analgesics|mesh-ancestor
2305899|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
2305900|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305901|NCT00310921|Misoprostol|misoprostol|mesh-list
2305902|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2305903|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
2305904|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2305905|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305906|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2305907|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2305908|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
2305909|NCT00310934|Buprenorphine|buprenorphine|mesh-list
2305910|NCT00310934|Methadone|methadone|mesh-list
2305911|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2305912|NCT00310934|Narcotics|narcotics|mesh-ancestor
2305913|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860481|NCT03785587|Bromides|bromides|mesh-list
2860482|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
2860483|NCT03785691|Ondansetron|ondansetron|mesh-list
2860484|NCT03785691|Mirtazapine|mirtazapine|mesh-list
2860485|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
2860486|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
2860487|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860488|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860489|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2305914|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305915|NCT00310934|Analgesics|analgesics|mesh-ancestor
2305916|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
2305917|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2305918|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2305919|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
2305920|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
2305921|NCT00311038|Landiolol|landiolol|mesh-list
2305922|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2305923|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2305924|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
2305925|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305926|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305927|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860490|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
2860491|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
2860492|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2860493|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
2860494|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860495|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860496|NCT03785691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2860497|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2305928|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2305929|NCT00311051|Ramatroban|ramatroban|mesh-list
2305930|NCT00311051|Montelukast|montelukast|mesh-list
2860498|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860499|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2860500|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2860501|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
2860502|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2860503|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
2860504|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
2860505|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2860506|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2860507|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2860508|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
2860509|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2860510|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2860511|NCT03785613|Buprenorphine|buprenorphine|mesh-list
2860512|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2860513|NCT03785613|Narcotics|narcotics|mesh-ancestor
2860514|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860515|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860516|NCT03785613|Analgesics|analgesics|mesh-ancestor
2860517|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
2305931|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2305932|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
2305933|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2305934|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
2305935|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2860518|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860519|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2860520|NCT03785522|Insulin|insulin|mesh-list
2860521|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2860522|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860523|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2860524|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2860525|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2860526|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2860527|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2305936|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305937|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2305938|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2305939|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305940|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2305941|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
2305942|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2305943|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305944|NCT00311090|Idraparinux|idraparinux|mesh-list
2305945|NCT00311090|Idrabiotaparinux|idrabiotaparinux|mesh-list
2305946|NCT00311090|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2305947|NCT00311090|Antithrombins|antithrombins|mesh-ancestor
2305948|NCT00311090|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2860528|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
2860529|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860530|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860531|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860532|NCT03785158|Melatonin|melatonin|mesh-list
2860533|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
2860534|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860535|NCT03785158|Protective Agents|protective agents|mesh-ancestor
2860536|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860537|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860538|NCT03785223|Methylphenidate|methylphenidate|mesh-list
2860539|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2860540|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860541|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2860542|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2860543|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2860544|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860545|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
2860546|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860547|NCT03785106|Vitamins|vitamins|mesh-list
2860548|NCT03785106|Pyridoxine|pyridoxine|mesh-list
2860549|NCT03785106|Pyridoxal|pyridoxal|mesh-list
2860550|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
2860551|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
2860552|NCT03785106|Isoniazid|isoniazid|mesh-list
2860553|NCT03785106|Rifapentine|rifapentine|mesh-list
2860554|NCT03785106|Rifampin|rifampin|mesh-list
2860555|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
2860556|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860557|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
2860558|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2860559|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2860560|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2860561|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2860562|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
2305949|NCT00311090|Protease Inhibitors|protease inhibitors|mesh-ancestor
2305950|NCT00311090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2305951|NCT00311090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305952|NCT00311090|Anticoagulants|anticoagulants|mesh-ancestor
2305953|NCT00311116|Vitamin E|vitamin e|mesh-list
2305954|NCT00311116|Vitamins|vitamins|mesh-ancestor
2305955|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
2305956|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305957|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
2305958|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305959|NCT00311116|Protective Agents|protective agents|mesh-ancestor
2305960|NCT00311129|Rituximab|rituximab|mesh-list
2305961|NCT00311129|Fludarabine|fludarabine|mesh-list
2860563|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860564|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2860565|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2860566|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
2860567|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2860568|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860569|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2860570|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2860571|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2860572|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2860573|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2305962|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
2305963|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2305964|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2305965|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
2305966|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305967|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2305968|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2305969|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
2305970|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305971|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2860574|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2860575|NCT03785015|Aspirin|aspirin|mesh-list
2860576|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2860577|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2860578|NCT03785015|Analgesics|analgesics|mesh-ancestor
2860579|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
2305972|NCT00311259|Melatonin|melatonin|mesh-list
2305973|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
2305974|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305975|NCT00311259|Protective Agents|protective agents|mesh-ancestor
2305976|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305977|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2305978|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
2305979|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2305980|NCT00311337|Bortezomib|bortezomib|mesh-list
2305981|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860580|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860581|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860582|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2860583|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2860584|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2860585|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2860586|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860587|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2860588|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2860589|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860590|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
2860591|NCT03785184|Dexamethasone|dexamethasone|mesh-list
2860592|NCT03785184|Lenalidomide|lenalidomide|mesh-list
2860593|NCT03785184|Venetoclax|venetoclax|mesh-list
2860594|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2860595|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
2860596|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
2860597|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860598|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305982|NCT00311389|Timolol|timolol|mesh-list
2305983|NCT00311389|Travoprost|travoprost|mesh-list
2305984|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2305985|NCT00311389|Latanoprost|latanoprost|mesh-list
2305986|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2305987|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2305988|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2305989|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
2305990|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2305991|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305992|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2305993|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2305994|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2305995|NCT00311467|Interferons|interferons|mesh-list
2305996|NCT00311467|Capecitabine|capecitabine|mesh-list
2860599|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2860600|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
2860601|NCT03785184|Hormones|hormones|mesh-ancestor
2860602|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2860603|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2860604|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860605|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
2860606|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2860607|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2860608|NCT03785184|Growth Substances|growth substances|mesh-ancestor
2860609|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
2860610|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
2860611|NCT03785249|Cetuximab|cetuximab|mesh-list
2860612|NCT03785249|Afatinib|afatinib|mesh-list
2860613|NCT03785249|Adagrasib|adagrasib|mesh-list
2860614|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2860615|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860616|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2860617|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860618|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860619|NCT03785041|Tramadol|tramadol|mesh-list
2860620|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
2860621|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2860622|NCT03785041|Narcotics|narcotics|mesh-ancestor
2860623|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860624|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860625|NCT03785041|Analgesics|analgesics|mesh-ancestor
2860626|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
2860627|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860628|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
2860629|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
2860630|NCT03784794|Thrombin|thrombin|mesh-list
2860631|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
2860632|NCT03784794|Coagulants|coagulants|mesh-ancestor
2860633|NCT03785067|Amlodipine|amlodipine|mesh-list
2860634|NCT03785067|Telmisartan|telmisartan|mesh-list
2860635|NCT03785067|Indapamide|indapamide|mesh-list
2860636|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2860637|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2860638|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2860639|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2305997|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2305998|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
2305999|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306000|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306001|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
2306002|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306003|NCT00311545|Siltuximab|siltuximab|mesh-list
2306004|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860640|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2860641|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860642|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
2860643|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2860644|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2860645|NCT03785067|Diuretics|diuretics|mesh-ancestor
2860646|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
2860647|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2860648|NCT03784495|Melatonin|melatonin|mesh-list
2860649|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
2860650|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860651|NCT03784495|Protective Agents|protective agents|mesh-ancestor
2860652|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860653|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860654|NCT03784599|Trastuzumab|trastuzumab|mesh-list
2860655|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2860656|NCT03784599|Osimertinib|osimertinib|mesh-list
2860657|NCT03784599|Maytansine|maytansine|mesh-list
2860658|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2860659|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860660|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2860661|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860662|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860663|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2860664|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
2860665|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
2860666|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
2860667|NCT03784703|Atorvastatin|atorvastatin|mesh-list
2860668|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2860669|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2860670|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2860671|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
2306005|NCT00311558|Interferons|interferons|mesh-list
2860672|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860673|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2860674|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2860675|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860676|NCT03784677|SOR-C13|sor-c13|mesh-list
2860677|NCT03784677|Calcium|calcium|mesh-list
2860678|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2860679|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860680|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860681|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2860682|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2860683|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860684|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2860685|NCT03784443|Ranibizumab|ranibizumab|mesh-list
2860686|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2860687|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2860688|NCT03784443|Growth Substances|growth substances|mesh-ancestor
2860689|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860690|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
2860691|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860692|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2860693|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
2860694|NCT03784443|Hormones|hormones|mesh-ancestor
2860695|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2860696|NCT03784378|Agerafenib|agerafenib|mesh-list
2860697|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2860698|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860699|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860700|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
2860701|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
2860702|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860703|NCT03784391|Nifurtimox|nifurtimox|mesh-list
2860704|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2860705|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2860706|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2860707|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2860708|NCT03784066|Durvalumab|durvalumab|mesh-list
2860709|NCT03784066|Tremelimumab|tremelimumab|mesh-list
2860710|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2860711|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2860712|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860713|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
2860714|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860715|NCT03784105|Codeine|codeine|mesh-list
2860716|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2860717|NCT03784105|Narcotics|narcotics|mesh-ancestor
2860718|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860719|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860720|NCT03784105|Analgesics|analgesics|mesh-ancestor
2860721|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
2860722|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860723|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
2860724|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
2860725|NCT03784014|Durvalumab|durvalumab|mesh-list
2860726|NCT03784014|Olaparib|olaparib|mesh-list
2860727|NCT03784014|Lapatinib|lapatinib|mesh-list
2860728|NCT03784014|Palbociclib|palbociclib|mesh-list
2860729|NCT03784014|Trametinib|trametinib|mesh-list
2860730|NCT03784014|Dabrafenib|dabrafenib|mesh-list
2860731|NCT03784014|Ceritinib|ceritinib|mesh-list
2860732|NCT03784014|Futibatinib|futibatinib|mesh-list
2860733|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2860734|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860735|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2860736|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860737|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860738|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2860739|NCT03784326|Fluorouracil|fluorouracil|mesh-list
2860740|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
2860741|NCT03784326|Atezolizumab|atezolizumab|mesh-list
2860742|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2860743|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
2860744|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860745|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2860746|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860747|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2860748|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
2860749|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306006|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
2306007|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
2306008|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
2306009|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306010|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
2306011|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306012|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
2306013|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306014|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2306015|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2306016|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
2306017|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2306018|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
2306019|NCT00311636|Paclitaxel|paclitaxel|mesh-list
2306020|NCT00311636|Docetaxel|docetaxel|mesh-list
2306021|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
2306022|NCT00311636|Doxorubicin|doxorubicin|mesh-list
2306023|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2306024|NCT00311636|Fluorouracil|fluorouracil|mesh-list
2306025|NCT00311636|Methotrexate|methotrexate|mesh-list
2306026|NCT00311636|Epirubicin|epirubicin|mesh-list
2306027|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2306028|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2306029|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306030|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
2306031|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
2306032|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
2306033|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306034|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2306035|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
2306036|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306037|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2306038|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2306039|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
2306040|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2306041|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2306042|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2306043|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2306044|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306045|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
2306046|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2306047|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2306048|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
2306049|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2306050|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
2306051|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2306052|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2306053|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
2306054|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2306055|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
2306056|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2306057|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2306058|NCT00311688|Interleukin-2|interleukin-2|mesh-list
2306059|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306060|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2306061|NCT00311688|Analgesics|analgesics|mesh-ancestor
2306062|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
2306063|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306064|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306065|NCT00311740|Valsartan|valsartan|mesh-list
2860750|NCT03784261|Abatacept|abatacept|mesh-list
2860751|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2860752|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860753|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860754|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2860755|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
2860756|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860757|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2860758|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2860759|NCT03783897|Norgestimate|norgestimate|mesh-list
2860760|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
2860761|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
2860762|NCT03783897|Estradiol|estradiol|mesh-list
2306066|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2306067|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2306068|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2306069|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2306070|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306071|NCT00311740|Diuretics|diuretics|mesh-ancestor
2306072|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
2306073|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306074|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2306075|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2306076|NCT00311753|Heparin|heparin|mesh-list
2306077|NCT00311753|Certoparin|certoparin|mesh-list
2306078|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
2306079|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2306080|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2306081|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306082|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
2306083|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2306084|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306085|NCT00311844|Desloratadine|desloratadine|mesh-list
2306086|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2306087|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
2306088|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306089|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306090|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306091|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2306092|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2306093|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
2306094|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
2306095|NCT00311857|Cetuximab|cetuximab|mesh-list
2306096|NCT00311857|Temozolomide|temozolomide|mesh-list
2306097|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2306098|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306099|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2306100|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
2306101|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306102|NCT00311870|Lisinopril|lisinopril|mesh-list
2306103|NCT00311870|Nisoldipine|nisoldipine|mesh-list
2860763|NCT03783897|Estrogens|estrogens|mesh-ancestor
2306104|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2306105|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
2306106|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860764|NCT03783897|Hormones|hormones|mesh-ancestor
2860765|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2860766|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860767|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2860768|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2860769|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2860770|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2860771|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2860772|NCT03783949|Gemcitabine|gemcitabine|mesh-list
2860773|NCT03783949|Paclitaxel|paclitaxel|mesh-list
2860774|NCT03783949|Carboplatin|carboplatin|mesh-list
2860775|NCT03783949|Niraparib|niraparib|mesh-list
2860776|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2860777|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306107|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306108|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2306109|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2306110|NCT00311870|Protective Agents|protective agents|mesh-ancestor
2306111|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306112|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2306113|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2306114|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2306115|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
2306116|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
2860778|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
2860779|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
2860780|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
2860781|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860782|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2860783|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
2860784|NCT03783949|Antiviral Agents|antiviral agents|mesh-ancestor
2860785|NCT03783949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2860786|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860787|NCT03783949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2860788|NCT03783949|Immunologic Factors|immunologic factors|mesh-ancestor
2860789|NCT03783949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860790|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2860791|NCT03783936|Leucovorin|leucovorin|mesh-list
2860792|NCT03783936|Fluorouracil|fluorouracil|mesh-list
2860793|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
2860794|NCT03783936|Trastuzumab|trastuzumab|mesh-list
2860795|NCT03783936|Avelumab|avelumab|mesh-list
2860796|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
2860797|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860798|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2860799|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860800|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2860801|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
2860802|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860803|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2860804|NCT03783936|Antidotes|antidotes|mesh-ancestor
2860805|NCT03783936|Protective Agents|protective agents|mesh-ancestor
2860806|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
2860807|NCT03783936|Vitamins|vitamins|mesh-ancestor
2860808|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
2860809|NCT03784040|Nivolumab|nivolumab|mesh-list
2860810|NCT03784040|Ipilimumab|ipilimumab|mesh-list
2860811|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2860812|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860813|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2860814|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860815|NCT03783845|Amoxicillin|amoxicillin|mesh-list
2860816|NCT03783845|Metronidazole|metronidazole|mesh-list
2860817|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2860818|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2860819|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2860820|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2860821|NCT03783728|Pyridoxine|pyridoxine|mesh-list
2860822|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
2860823|NCT03783728|Isoniazid|isoniazid|mesh-list
2860824|NCT03783728|Rifapentine|rifapentine|mesh-list
2860825|NCT03783728|Vitamins|vitamins|mesh-ancestor
2860826|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
2860827|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306117|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
2306118|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2306119|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2306120|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306121|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306122|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306123|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2306124|NCT00311896|Bemiparin|bemiparin|mesh-list
2306125|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
2860828|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
2860829|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
2860830|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2860831|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2860832|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2860833|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2860834|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
2860835|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860836|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2860837|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2306126|NCT00311961|Prednisolone|prednisolone|mesh-list
2306127|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2306128|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
2306129|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2306130|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
2306131|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2306132|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
2306133|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2306134|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
2306135|NCT00311961|Hormones|hormones|mesh-ancestor
2306136|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2306137|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306138|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2860838|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
2860839|NCT03783754|Amlodipine|amlodipine|mesh-list
2860840|NCT03783754|Telmisartan|telmisartan|mesh-list
2860841|NCT03783754|Indapamide|indapamide|mesh-list
2860842|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2860843|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2860844|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2860845|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306139|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306140|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
2306141|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
2306142|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306143|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2306144|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2306145|NCT00311961|Protective Agents|protective agents|mesh-ancestor
2306146|NCT00311974|Dihydralazine|dihydralazine|mesh-list
2306147|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2306148|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
2306149|NCT00311987|Hormones|hormones|mesh-ancestor
2306150|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2306151|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860846|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2860847|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860848|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
2860849|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2306152|NCT00312000|Capecitabine|capecitabine|mesh-list
2306153|NCT00312000|Irinotecan|irinotecan|mesh-list
2306154|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2306155|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
2306156|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306157|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306158|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2306159|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2306160|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306161|NCT00312013|Nadroparin|nadroparin|mesh-list
2306162|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
2306163|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2306164|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2306165|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306166|NCT00312039|Lamivudine|lamivudine|mesh-list
2306167|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
2306168|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2306169|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2860850|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2860851|NCT03783754|Diuretics|diuretics|mesh-ancestor
2860852|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
2860853|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2860854|NCT03783715|Ketoprofen|ketoprofen|mesh-list
2860855|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2860856|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2860857|NCT03783715|Analgesics|analgesics|mesh-ancestor
2860858|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
2860859|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860860|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860861|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2306170|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306171|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306172|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
2306173|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306174|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2306175|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2306176|NCT00312091|Lamivudine|lamivudine|mesh-list
2306177|NCT00312091|Nevirapine|nevirapine|mesh-list
2306178|NCT00312091|Stavudine|stavudine|mesh-list
2306179|NCT00312091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2306180|NCT00312091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2306181|NCT00312091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306182|NCT00312091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306183|NCT00312091|Antiviral Agents|antiviral agents|mesh-ancestor
2306184|NCT00312091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306185|NCT00312091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2306186|NCT00312091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2860862|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2860863|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2860864|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860865|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860866|NCT03783494|Propofol|propofol|mesh-list
2860867|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2860868|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2306187|NCT00312091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2306188|NCT00312091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2306189|NCT00312091|Antimetabolites|antimetabolites|mesh-ancestor
2860869|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860870|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2306190|NCT00312104|Insulin|insulin|mesh-list
2306191|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2306192|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
2306193|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
2306194|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
2306195|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2306196|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306197|NCT00312130|Vildagliptin|vildagliptin|mesh-list
2306198|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2306199|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306200|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2306201|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
2306202|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306203|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306204|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
2306205|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2306206|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306207|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2306208|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
2306209|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2306210|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306211|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306212|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306213|NCT00312156|Insulin|insulin|mesh-list
2306214|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2860871|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
2860872|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
2306215|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
2306216|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
2306217|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
2306218|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
2306219|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
2306220|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2306221|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306222|NCT00312182|Nelfinavir|nelfinavir|mesh-list
2860873|NCT03783442|Paclitaxel|paclitaxel|mesh-list
2306223|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2306224|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2306225|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
2306226|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306227|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306228|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2306229|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2306230|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
2306231|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306232|NCT00312260|Gabapentin|gabapentin|mesh-list
2306233|NCT00312260|Amitriptyline|amitriptyline|mesh-list
2306234|NCT00312260|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2306235|NCT00312260|Analgesics|analgesics|mesh-ancestor
2306236|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
2860874|NCT03783442|Fluorouracil|fluorouracil|mesh-list
2860875|NCT03783442|Capecitabine|capecitabine|mesh-list
2860876|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
2860877|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2860878|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860879|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
2860880|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
2860881|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
2860882|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860883|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
2860884|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2860885|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2860886|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
2860887|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860888|NCT03783676|Remifentanil|remifentanil|mesh-list
2306237|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306238|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306239|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
2306240|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2306241|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2306242|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2306243|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2306244|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2306245|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2306246|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306247|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306248|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
2306249|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2306250|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
2306251|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2306252|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2306253|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2306254|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2306255|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
2306256|NCT00312260|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2306257|NCT00312273|Aminophylline|aminophylline|mesh-list
2306258|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2306259|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
2306260|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306261|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306262|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2306263|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
2306264|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2306265|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2860889|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2860890|NCT03783676|Narcotics|narcotics|mesh-ancestor
2860891|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2860892|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860893|NCT03783676|Analgesics|analgesics|mesh-ancestor
2860894|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
2860895|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860896|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
2860897|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2860898|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
2860899|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860900|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
2860901|NCT03783455|Protective Agents|protective agents|mesh-ancestor
2860902|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2860903|NCT03783520|Eusol|eusol|mesh-list
2860904|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
2860905|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2860906|NCT03783338|Vitamin D|vitamin d|mesh-list
2860907|NCT03783338|Vitamins|vitamins|mesh-ancestor
2860908|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
2860909|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860910|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2860911|NCT03783416|Ixazomib|ixazomib|mesh-list
2860912|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860913|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
2860914|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860915|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860916|NCT03783312|Acetaminophen|acetaminophen|mesh-list
2860917|NCT03783312|Ibuprofen|ibuprofen|mesh-list
2860918|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2860919|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2860920|NCT03783312|Analgesics|analgesics|mesh-ancestor
2860921|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
2860922|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2860923|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860924|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2860925|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2860926|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2860927|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306266|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306267|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306268|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2306269|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2306270|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
2306271|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306272|NCT00312273|Protective Agents|protective agents|mesh-ancestor
2306273|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2306274|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
2306275|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2306276|NCT00312299|Protective Agents|protective agents|mesh-ancestor
2306277|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306278|NCT00312325|Prednisolone|prednisolone|mesh-list
2306279|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2860928|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860929|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
2860930|NCT03783429|Digoxin|digoxin|mesh-list
2860931|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2860932|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2860933|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860934|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306280|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
2306281|NCT00312325|Hormones|hormones|mesh-ancestor
2306282|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2306283|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306284|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2306285|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306286|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2306287|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2306288|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2306289|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2306290|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2306291|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
2306292|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306293|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860935|NCT03783429|Protective Agents|protective agents|mesh-ancestor
2860936|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860937|NCT03783182|Betamethasone|betamethasone|mesh-list
2860938|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
2860939|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2860940|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
2860941|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2860942|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
2860943|NCT03783182|Hormones|hormones|mesh-ancestor
2860944|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2860945|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860946|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2860947|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2860948|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
2306294|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306295|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
2306296|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
2306297|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
2860949|NCT03783299|Lumefantrine|lumefantrine|mesh-list
2860950|NCT03783299|Artemether|artemether|mesh-list
2860951|NCT03783299|Primaquine|primaquine|mesh-list
2860952|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2860953|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
2860954|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2860955|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2860956|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2860957|NCT03783273|Vitamin D|vitamin d|mesh-list
2860958|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
2860959|NCT03783273|Vitamins|vitamins|mesh-ancestor
2860960|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
2860961|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860962|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2860963|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2860964|NCT03782987|Itraconazole|itraconazole|mesh-list
2860965|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
2860966|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2860967|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2860968|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2860969|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2860970|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860971|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2860972|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
2860973|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2860974|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860975|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2860976|NCT03783065|Propranolol|propranolol|mesh-list
2860977|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2860978|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2860979|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
2860980|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2860981|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860982|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860983|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2860984|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2860985|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
2860986|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
2860987|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2860988|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2860989|NCT03782935|Choline|choline|mesh-list
2860990|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
2860991|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2860992|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
2860993|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2860994|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2860995|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2860996|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
2860997|NCT03783013|Lycopene|lycopene|mesh-list
2306298|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2306299|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306300|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
2306301|NCT00312481|Protective Agents|protective agents|mesh-ancestor
2306302|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306303|NCT00312481|Vitamins|vitamins|mesh-ancestor
2306304|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
2306305|NCT00312481|Cathartics|cathartics|mesh-ancestor
2306306|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2306307|NCT00312481|Laxatives|laxatives|mesh-ancestor
2306308|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2306309|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
2306310|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
2306311|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2306312|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2306313|NCT00312520|Prednisolone|prednisolone|mesh-list
2306314|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
2306315|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2306316|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
2306317|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2306318|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
2306319|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
2306320|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306321|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2860998|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2860999|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
2861000|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861001|NCT03783013|Protective Agents|protective agents|mesh-ancestor
2861002|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861003|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2861004|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2861005|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861006|NCT03782740|Melatonin|melatonin|mesh-list
2861007|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
2861008|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861009|NCT03782740|Protective Agents|protective agents|mesh-ancestor
2861010|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861011|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861012|NCT03782831|Antibodies|antibodies|mesh-list
2861013|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
2861014|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861015|NCT03783000|BI 425809|bi 425809|mesh-list
2861016|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
2861017|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
2861018|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2861019|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861020|NCT03782805|Vitamins|vitamins|mesh-ancestor
2861021|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
2861022|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2861023|NCT03782818|Olaparib|olaparib|mesh-list
2861024|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2861025|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861026|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861027|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861028|NCT03782662|Itraconazole|itraconazole|mesh-list
2861029|NCT03782662|Rifampin|rifampin|mesh-list
2861030|NCT03782662|Verapamil|verapamil|mesh-list
2861031|NCT03782662|Midazolam|midazolam|mesh-list
2861032|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2861033|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2861034|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861035|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861036|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2861037|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2861038|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2861039|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2861040|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
2861041|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
2861042|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
2861043|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
2861044|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861045|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861046|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
2861047|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861048|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2861049|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2861050|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306322|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2306323|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
2306324|NCT00312520|Hormones|hormones|mesh-ancestor
2306325|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2306326|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2306327|NCT00312520|Protective Agents|protective agents|mesh-ancestor
2306328|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2306329|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306330|NCT00312533|Hylan|hylan|mesh-list
2306331|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
2306332|NCT00312533|Protective Agents|protective agents|mesh-ancestor
2306333|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306334|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
2306335|NCT00312546|Valproic Acid|valproic acid|mesh-list
2306336|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
2306337|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306338|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306339|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
2306340|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861051|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2861052|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
2306341|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306342|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
2306343|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2306344|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2306345|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2306346|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2861053|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2861054|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2861055|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2861056|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
2861057|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2861058|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
2861059|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2861060|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2861061|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2861062|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2861063|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2861064|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2861065|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2861066|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2861067|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2861068|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2861069|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2861070|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
2861071|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2861072|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2861073|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
2861074|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306347|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2306348|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2306349|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2306350|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
2306351|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306352|NCT00312598|Aripiprazole|aripiprazole|mesh-list
2306353|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
2306354|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2306355|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2306356|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2306357|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2306358|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306359|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
2306360|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
2306361|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306362|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306363|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2306364|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2306365|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
2306366|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2306367|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2306368|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2306369|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2306370|NCT00312650|Gemcitabine|gemcitabine|mesh-list
2306371|NCT00312650|Doxorubicin|doxorubicin|mesh-list
2306372|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2306373|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2306374|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
2306375|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306376|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306377|NCT00312650|Antiviral Agents|antiviral agents|mesh-ancestor
2306378|NCT00312650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306379|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306380|NCT00312650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2861075|NCT03782415|Temozolomide|temozolomide|mesh-list
2861076|NCT03782415|Ibudilast|ibudilast|mesh-list
2861077|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2861078|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
2861079|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861080|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861081|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2861082|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
2861083|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861084|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861085|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2861086|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
2861087|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2861088|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861089|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2861090|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
2861091|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
2861092|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2861093|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2861094|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861095|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
2861096|NCT03782025|Coagulants|coagulants|mesh-ancestor
2861097|NCT03782025|Vitamins|vitamins|mesh-ancestor
2861098|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
2861099|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861100|NCT03781947|Antarelix|antarelix|mesh-list
2861101|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
2861102|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2861103|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861104|NCT03782103|Ethanol|ethanol|mesh-list
2861105|NCT03782103|Chlorhexidine|chlorhexidine|mesh-list
2861106|NCT03782103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2861107|NCT03782103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2861108|NCT03782103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861109|NCT03782103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861110|NCT03782103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861111|NCT03782103|Disinfectants|disinfectants|mesh-ancestor
2861112|NCT03782103|Dermatologic Agents|dermatologic agents|mesh-ancestor
2861113|NCT03782064|Nivolumab|nivolumab|mesh-list
2861114|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2861115|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861116|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2861117|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861118|NCT03781960|Nivolumab|nivolumab|mesh-list
2861119|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2861120|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861121|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2306381|NCT00312650|Immunologic Factors|immunologic factors|mesh-ancestor
2306382|NCT00312650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306383|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2306384|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2306385|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2306386|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2306387|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2306388|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2306389|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
2306390|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306391|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306392|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2306393|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2306394|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
2306395|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306396|NCT00312806|Pantoprazole|pantoprazole|mesh-list
2306397|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2306398|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2306399|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2861122|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861123|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
2861124|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2861125|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861126|NCT03782142|Tenofovir|tenofovir|mesh-list
2861127|NCT03782142|Dolutegravir|dolutegravir|mesh-list
2861128|NCT03782142|Rilpivirine|rilpivirine|mesh-list
2861129|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
2861130|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
2861131|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306400|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306401|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306402|NCT00312819|Disulfiram|disulfiram|mesh-list
2306403|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2306404|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2861132|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2861133|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2861134|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861135|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861136|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2861137|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2306405|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306406|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306407|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
2306408|NCT00312871|Hematinics|hematinics|mesh-ancestor
2861138|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2861139|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2861140|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
2861141|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2861142|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2861143|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
2306409|NCT00312975|Tremelimumab|tremelimumab|mesh-list
2306410|NCT00312975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306411|NCT00312988|Gemcitabine|gemcitabine|mesh-list
2306412|NCT00312988|Topotecan|topotecan|mesh-list
2306413|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2306414|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
2306415|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306416|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306417|NCT00312988|Antiviral Agents|antiviral agents|mesh-ancestor
2861144|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2861145|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861146|NCT03781895|Vitamins|vitamins|mesh-ancestor
2861147|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
2861148|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2861149|NCT03781765|Methylphenidate|methylphenidate|mesh-list
2861150|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2861151|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2861152|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861153|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2861154|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2861155|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2861156|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861157|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
2861158|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861159|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2861160|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
2306418|NCT00312988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306419|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306420|NCT00312988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2861161|NCT03781843|Lidocaine|lidocaine|mesh-list
2861162|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
2861163|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
2861164|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861165|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861166|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
2861167|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861168|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2861169|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2861170|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2861171|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108469|NCT02504541|Testosterone|testosterone|mesh-list
2108470|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
2108471|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
2108472|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2306421|NCT00312988|Immunologic Factors|immunologic factors|mesh-ancestor
2861172|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861173|NCT03781869|Cisplatin|cisplatin|mesh-list
2861174|NCT03781869|Etoposide|etoposide|mesh-list
2861175|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
2861176|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861177|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2861178|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2861179|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2861180|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861181|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861182|NCT03781687|Morphine|morphine|mesh-list
2861183|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2861184|NCT03781687|Narcotics|narcotics|mesh-ancestor
2861185|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861186|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861187|NCT03781687|Analgesics|analgesics|mesh-ancestor
2861188|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
2861189|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861190|NCT03781596|Fluticasone|fluticasone|mesh-list
2861191|NCT03781596|Omeprazole|omeprazole|mesh-list
2861192|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2861193|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2861194|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
2861195|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861196|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861197|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2861198|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
2861199|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
2861200|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2861201|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2861202|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2861203|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2861204|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861205|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861206|NCT03781674|Progesterone|progesterone|mesh-list
2861207|NCT03781674|Progestins|progestins|mesh-ancestor
2861208|NCT03781674|Hormones|hormones|mesh-ancestor
2861209|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2861210|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861211|NCT03781752|Methylphenidate|methylphenidate|mesh-list
2861212|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2861213|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861214|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2861215|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2861216|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108473|NCT02504541|Androgens|androgens|mesh-ancestor
2108474|NCT02504541|Hormones|hormones|mesh-ancestor
2861217|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861218|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
2861219|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861220|NCT03781635|Ketamine|ketamine|mesh-list
2861221|NCT03781635|Analgesics|analgesics|mesh-ancestor
2861222|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
2861223|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861224|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861225|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2861226|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2861227|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
2861228|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
2861229|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861230|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2861231|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2861232|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861233|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861234|NCT03781544|Acetaminophen|acetaminophen|mesh-list
2861235|NCT03781544|Diclofenac|diclofenac|mesh-list
2861236|NCT03781544|Tramadol|tramadol|mesh-list
2861237|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2861238|NCT03781544|Analgesics|analgesics|mesh-ancestor
2861239|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
2861240|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861241|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861242|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
2861243|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2861244|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2861245|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2861246|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2861247|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861248|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861249|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2861250|NCT03781544|Narcotics|narcotics|mesh-ancestor
2861251|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861252|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
2861253|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2861254|NCT03781505|Acetaminophen|acetaminophen|mesh-list
2861255|NCT03781505|Ropivacaine|ropivacaine|mesh-list
2861256|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
2861257|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
2861258|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861259|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861260|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
2861261|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861262|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2861263|NCT03781505|Analgesics|analgesics|mesh-ancestor
2861264|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
2861265|NCT03781700|Prednisolone|prednisolone|mesh-list
2861266|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2861267|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
2861268|NCT03781700|Hormones|hormones|mesh-ancestor
2861269|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2861270|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861271|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2861272|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861273|NCT03781466|Progesterone|progesterone|mesh-list
2861274|NCT03781466|Progestins|progestins|mesh-ancestor
2861275|NCT03781466|Hormones|hormones|mesh-ancestor
2861276|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2861277|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861278|NCT03781388|Bupivacaine|bupivacaine|mesh-list
2861279|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
2861280|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
2861281|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861282|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861283|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
2861284|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861297|NCT03781258|Warfarin|warfarin|mesh-list
2861298|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
2861299|NCT03781063|Fulvestrant|fulvestrant|mesh-list
2861300|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2861301|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861302|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2861303|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2861304|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
2861305|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2861306|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861312|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
2861313|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
2861314|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861315|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2861316|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2861317|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
2861318|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306422|NCT00312988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306423|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2306424|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2306425|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
2306426|NCT00313001|Exenatide|exenatide|mesh-list
2306427|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
2306428|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2306429|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306430|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2306431|NCT00313001|Incretins|incretins|mesh-ancestor
2306432|NCT00313001|Hormones|hormones|mesh-ancestor
2306433|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2306434|NCT00313053|Vincristine|vincristine|mesh-list
2306435|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2306436|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306437|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
2306438|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
2306439|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
2306440|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306441|NCT00313079|Vincristine|vincristine|mesh-list
2306442|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2306443|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861319|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861320|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2861321|NCT03781115|Olanzapine|olanzapine|mesh-list
2861322|NCT03781115|Ziprasidone|ziprasidone|mesh-list
2861323|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
2861324|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
2861325|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861326|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861327|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2861328|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2861329|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2861330|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861331|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2861332|NCT03781115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2861333|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2861334|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2861335|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861336|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861337|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
2861338|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2861339|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2861340|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
2861341|NCT03781050|Sirolimus|sirolimus|mesh-list
2861342|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2861343|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861344|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2861345|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861346|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
2861347|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2861348|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
2861349|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861350|NCT03781011|Choline|choline|mesh-list
2861351|NCT03781011|Lipotropic Agents|lipotropic agents|mesh-ancestor
2861352|NCT03781011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2861353|NCT03781011|Antimetabolites|antimetabolites|mesh-ancestor
2861354|NCT03781011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861355|NCT03781011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2861356|NCT03781011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2861357|NCT03781011|Nootropic Agents|nootropic agents|mesh-ancestor
2861358|NCT03780933|Ascorbic Acid|ascorbic acid|mesh-list
2861359|NCT03780933|Vitamins|vitamins|mesh-ancestor
2861360|NCT03780933|Micronutrients|micronutrients|mesh-ancestor
2861361|NCT03780933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861362|NCT03780933|Antioxidants|antioxidants|mesh-ancestor
2861363|NCT03780933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861364|NCT03780933|Protective Agents|protective agents|mesh-ancestor
2861365|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
2861366|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2861367|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2861368|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861369|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
2861370|NCT03780894|Coagulants|coagulants|mesh-ancestor
2861371|NCT03780673|Rifaximin|rifaximin|mesh-list
2306444|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
2861372|NCT03780673|Simvastatin|simvastatin|mesh-list
2861373|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2861374|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2861375|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
2861376|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861377|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2861378|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2861379|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861380|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2861381|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861382|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2861383|NCT03780686|Dopamine|dopamine|mesh-list
2861384|NCT03780686|Norepinephrine|norepinephrine|mesh-list
2861385|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2861386|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2861387|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
2861388|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861389|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861390|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861391|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
2861392|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
2861393|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861394|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2861395|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2861396|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
2861397|NCT03780686|Protective Agents|protective agents|mesh-ancestor
2861398|NCT03780556|Lornoxicam|lornoxicam|mesh-list
2861399|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2861400|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2861401|NCT03780556|Analgesics|analgesics|mesh-ancestor
2861402|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
2861403|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861404|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861405|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2861406|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2861407|NCT03780621|Andrographolide|andrographolide|mesh-list
2306445|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
2306446|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
2306447|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306448|NCT00313105|Lobeline|lobeline|mesh-list
2306449|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2306450|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
2306451|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306452|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306453|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2306454|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2306455|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
2306456|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306457|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861408|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2861409|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2861410|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2861411|NCT03780621|Analgesics|analgesics|mesh-ancestor
2861412|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
2861413|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861414|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861415|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2861416|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2861417|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2861418|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861419|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
2306458|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
2306459|NCT00313131|Metronidazole|metronidazole|mesh-list
2306460|NCT00313131|Fluconazole|fluconazole|mesh-list
2306461|NCT00313131|Clotrimazole|clotrimazole|mesh-list
2306462|NCT00313131|Miconazole|miconazole|mesh-list
2306463|NCT00313131|Tinidazole|tinidazole|mesh-list
2306464|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306465|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2306466|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2306467|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2306468|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
2306469|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2306470|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2306471|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861420|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2861421|NCT03780634|Sorafenib|sorafenib|mesh-list
2861422|NCT03780634|Antibodies|antibodies|mesh-list
2861423|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
2861424|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
2306472|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306473|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2306474|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
2306475|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2306476|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306477|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2306478|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2306479|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2306480|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2306481|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
2306482|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2306483|NCT00313157|Metoprolol|metoprolol|mesh-list
2306484|NCT00313157|Verapamil|verapamil|mesh-list
2306485|NCT00313157|Carvedilol|carvedilol|mesh-list
2306486|NCT00313157|Diltiazem|diltiazem|mesh-list
2306487|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2306488|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2306489|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
2306490|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
2306491|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306492|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306493|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2306494|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2306495|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2306496|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
2306497|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306498|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306499|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
2306500|NCT00313157|Protective Agents|protective agents|mesh-ancestor
2306501|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2306502|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2306503|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2306504|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
2306505|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2306506|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2861425|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861426|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861427|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2861428|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861429|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861430|NCT03780829|Cycloserine|cycloserine|mesh-list
2861431|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2861432|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861433|NCT03780829|Renal Agents|renal agents|mesh-ancestor
2861434|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2861435|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
2861436|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2861437|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
2861438|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861439|NCT03780790|Bupivacaine|bupivacaine|mesh-list
2861440|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
2861441|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
2861442|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861443|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861444|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
2861445|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861446|NCT03780192|Sirolimus|sirolimus|mesh-list
2861447|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2861448|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861449|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2861450|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861451|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
2861452|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2861453|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
2861454|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861455|NCT03780244|Mannitol|mannitol|mesh-list
2861456|NCT03780244|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2861457|NCT03780244|Diuretics|diuretics|mesh-ancestor
2861458|NCT03780244|Natriuretic Agents|natriuretic agents|mesh-ancestor
2861459|NCT03780244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861460|NCT03780569|Temozolomide|temozolomide|mesh-list
2861461|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2861462|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
2861463|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861464|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861465|NCT03780205|Methamphetamine|methamphetamine|mesh-list
2861466|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2861467|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861468|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
2861469|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
2861470|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861471|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
2861472|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861473|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861474|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
2861475|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2861476|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2861477|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2861478|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2861479|NCT03780361|Aflibercept|aflibercept|mesh-list
2861480|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2861481|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2861482|NCT03780361|Growth Substances|growth substances|mesh-ancestor
2861483|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861484|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
2861485|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861486|NCT03780270|Fluorides|fluorides|mesh-list
2861487|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
2861488|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
2861489|NCT03780270|Protective Agents|protective agents|mesh-ancestor
2861490|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861491|NCT03780543|Tenofovir|tenofovir|mesh-list
2861492|NCT03780543|Entecavir|entecavir|mesh-list
2861493|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
2861494|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861495|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2861496|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2861497|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861498|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861499|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2861500|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2861501|NCT03780127|Fenfluramine|fenfluramine|mesh-list
2861502|NCT03780127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2861503|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2861504|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2306507|NCT00313183|Pramlintide|pramlintide|mesh-list
2306508|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2306509|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861505|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861506|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861507|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
2861508|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861509|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
2861510|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2861511|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861512|NCT03779776|Vitamins|vitamins|mesh-list
2861513|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
2861514|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861515|NCT03780049|Leucovorin|leucovorin|mesh-list
2861516|NCT03780049|Fluorouracil|fluorouracil|mesh-list
2861517|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
2861518|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
2861519|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861520|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2861521|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861522|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2861523|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
2306510|NCT00313196|Bosentan|bosentan|mesh-list
2306511|NCT00313196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2306512|NCT00313196|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2861524|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861525|NCT03780049|Antidotes|antidotes|mesh-ancestor
2861526|NCT03780049|Protective Agents|protective agents|mesh-ancestor
2861527|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
2861528|NCT03780049|Vitamins|vitamins|mesh-ancestor
2861529|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
2861530|NCT03780608|Durvalumab|durvalumab|mesh-list
2861531|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2861532|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861533|NCT03779854|Vidarabine|vidarabine|mesh-list
2861534|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
2861535|NCT03779854|Busulfan|busulfan|mesh-list
2861536|NCT03779854|Thiotepa|thiotepa|mesh-list
2861537|NCT03779854|Methotrexate|methotrexate|mesh-list
2861538|NCT03779854|Fludarabine|fludarabine|mesh-list
2861539|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
2861540|NCT03779854|Tacrolimus|tacrolimus|mesh-list
2861541|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2861542|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
2861543|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861544|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2861545|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2306513|NCT00313196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306514|NCT00313222|Bosentan|bosentan|mesh-list
2306515|NCT00313222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2306516|NCT00313222|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2306517|NCT00313222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306518|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
2306519|NCT00313235|Vaccines|vaccines|mesh-list
2306520|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
2306521|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306522|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2306523|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2861546|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
2861547|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861548|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861549|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2861550|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2861551|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
2861552|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2861553|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2861554|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
2861555|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
2861556|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861557|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2861558|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2861559|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2861560|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
2861561|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861562|NCT03779789|Vortioxetine|vortioxetine|mesh-list
2861563|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
2861564|NCT03779789|Citalopram|citalopram|mesh-list
2861565|NCT03779789|Fluoxetine|fluoxetine|mesh-list
2861566|NCT03779789|Paroxetine|paroxetine|mesh-list
2861567|NCT03779789|Sertraline|sertraline|mesh-list
2861568|NCT03779789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2861569|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2861570|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2861571|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861572|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861573|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
2861574|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861575|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2861576|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
2861577|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2861578|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2861579|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2861580|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861581|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2861582|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2861583|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861584|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2861585|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2861586|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2861587|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2861588|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2861589|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2861590|NCT03779685|Anesthetics|anesthetics|mesh-list
2861591|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861592|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861593|NCT03779633|Estradiol|estradiol|mesh-list
2861594|NCT03779633|Estrogens|estrogens|mesh-ancestor
2861595|NCT03779633|Hormones|hormones|mesh-ancestor
2861596|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2861597|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861598|NCT03779516|Lidocaine|lidocaine|mesh-list
2861599|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
2861600|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
2861601|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861602|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861603|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
2861604|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861605|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2861606|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2861607|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2861608|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2861609|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861610|NCT03779451|Progesterone|progesterone|mesh-list
2861611|NCT03779451|Progestins|progestins|mesh-ancestor
2861612|NCT03779451|Hormones|hormones|mesh-ancestor
2861613|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2861614|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861615|NCT03779594|Acetazolamide|acetazolamide|mesh-list
2861616|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
2861617|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2861618|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861619|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306524|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2306525|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
2306526|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306527|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306528|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2306529|NCT00313248|Sagopilone|sagopilone|mesh-list
2306530|NCT00313248|Epothilones|epothilones|mesh-list
2306531|NCT00313248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861620|NCT03779594|Diuretics|diuretics|mesh-ancestor
2861621|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
2861622|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861623|NCT03779464|Gemcitabine|gemcitabine|mesh-list
2861624|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2861625|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
2861626|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861627|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861628|NCT03779464|Antiviral Agents|antiviral agents|mesh-ancestor
2306532|NCT00313248|Tubulin Modulators|tubulin modulators|mesh-ancestor
2306533|NCT00313248|Antimitotic Agents|antimitotic agents|mesh-ancestor
2306534|NCT00313248|Mitosis Modulators|mitosis modulators|mesh-ancestor
2306535|NCT00313248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306536|NCT00313261|Clevudine|clevudine|mesh-list
2306537|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
2306538|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306539|NCT00313274|Clevudine|clevudine|mesh-list
2306540|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
2861629|NCT03779464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861630|NCT03779464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861631|NCT03779464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2861632|NCT03779464|Immunologic Factors|immunologic factors|mesh-ancestor
2861633|NCT03779464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861634|NCT03779568|Bupivacaine|bupivacaine|mesh-list
2861635|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
2861636|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
2861637|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861638|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861639|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
2861640|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861641|NCT03779659|Anesthetics|anesthetics|mesh-list
2861642|NCT03779659|Benzocaine|benzocaine|mesh-list
2861643|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
2861644|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861645|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861646|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
2861647|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861648|NCT03779646|Bisoprolol|bisoprolol|mesh-list
2861649|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2861650|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
2861651|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
2861652|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861653|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861654|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2861655|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2861656|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2861657|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
2861658|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861659|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861660|NCT03779672|Memantine|memantine|mesh-list
2861661|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2861662|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2861663|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
2861664|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861665|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861666|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861667|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2861668|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2861669|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
2861670|NCT03779282|Ketamine|ketamine|mesh-list
2861671|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2861672|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861673|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861674|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2861675|NCT03779282|Analgesics|analgesics|mesh-ancestor
2861676|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
2861677|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861678|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2861679|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2861680|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2861681|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
2861682|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306541|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306542|NCT00313287|Clevudine|clevudine|mesh-list
2306543|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
2306544|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306545|NCT00313391|Risperidone|risperidone|mesh-list
2306546|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2306547|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
2306548|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306549|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861683|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861684|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2861685|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2306550|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306551|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2306552|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2306553|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2306554|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2306555|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2306556|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
2306557|NCT00313456|Satraplatin|satraplatin|mesh-list
2306558|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306559|NCT00313482|Prednisone|prednisone|mesh-list
2306560|NCT00313482|Docetaxel|docetaxel|mesh-list
2306561|NCT00313482|Sargramostim|sargramostim|mesh-list
2306562|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306563|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
2306564|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
2306565|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
2306566|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306567|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2306568|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
2306569|NCT00313482|Hormones|hormones|mesh-ancestor
2306570|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2306571|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306572|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2306573|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
2306574|NCT00313508|Vidarabine|vidarabine|mesh-list
2306575|NCT00313508|Fludarabine|fludarabine|mesh-list
2306576|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
2306577|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306578|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2306579|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
2306580|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306581|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2306582|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
2306583|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306584|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
2306585|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306586|NCT00313521|Thiotepa|thiotepa|mesh-list
2306587|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2306588|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
2306589|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306590|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306591|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2306592|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2306593|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
2861686|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
2861687|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
2861688|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2861689|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2861690|NCT03779295|Clindamycin|clindamycin|mesh-list
2306594|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306595|NCT00313534|Masoprocol|masoprocol|mesh-list
2306596|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
2306597|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306598|NCT00313534|Protective Agents|protective agents|mesh-ancestor
2306599|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306600|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2306601|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306602|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2306603|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2306604|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2306605|NCT00313534|Analgesics|analgesics|mesh-ancestor
2306606|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
2306607|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306608|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2861691|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
2861692|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
2861693|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2861694|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861695|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2861696|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861697|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861698|NCT03779360|Clindamycin|clindamycin|mesh-list
2861699|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
2861700|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
2861701|NCT03779360|Erythromycin|erythromycin|mesh-list
2306609|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2306610|NCT00313547|Amlodipine|amlodipine|mesh-list
2861702|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
2861703|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2861704|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
2861705|NCT03779360|Prednisolone|prednisolone|mesh-list
2861706|NCT03779360|Clobetasol|clobetasol|mesh-list
2861707|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2861708|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
2861709|NCT03779360|Hormones|hormones|mesh-ancestor
2861710|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2861711|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861712|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2861713|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861714|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2861715|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2861716|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861717|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2861718|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861719|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861720|NCT03779347|Praziquantel|praziquantel|mesh-list
2861721|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
2861722|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2861723|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861724|NCT03779178|Landiolol|landiolol|mesh-list
2861725|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2861726|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2861727|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
2861728|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861729|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861730|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861731|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2861732|NCT03779035|Gemcitabine|gemcitabine|mesh-list
2861733|NCT03779035|Capecitabine|capecitabine|mesh-list
2861734|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2861735|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
2861736|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861737|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861738|NCT03779035|Antiviral Agents|antiviral agents|mesh-ancestor
2861739|NCT03779035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861740|NCT03779035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861741|NCT03779035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2861742|NCT03779035|Immunologic Factors|immunologic factors|mesh-ancestor
2861743|NCT03779035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861744|NCT03779191|Bevacizumab|bevacizumab|mesh-list
2861745|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2861746|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861747|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2861748|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2861749|NCT03779191|Growth Substances|growth substances|mesh-ancestor
2861750|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861751|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
2861752|NCT03778931|Fulvestrant|fulvestrant|mesh-list
2861753|NCT03778931|Anastrozole|anastrozole|mesh-list
2861754|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2861755|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861756|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2861757|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2861758|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
2861759|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2861760|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861761|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2861762|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2861763|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861764|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861765|NCT03779087|Amoxicillin|amoxicillin|mesh-list
2861766|NCT03779087|Levofloxacin|levofloxacin|mesh-list
2861767|NCT03779087|Ofloxacin|ofloxacin|mesh-list
2861768|NCT03779087|Tetracycline|tetracycline|mesh-list
2861769|NCT03779087|Esomeprazole|esomeprazole|mesh-list
2861770|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2861771|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861772|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2861773|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2861774|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2861775|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306611|NCT00313547|Quinapril|quinapril|mesh-list
2306612|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2306613|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2306614|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2306615|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306616|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2306617|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306618|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
2306619|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2306620|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
2306621|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306622|NCT00313599|Paclitaxel|paclitaxel|mesh-list
2306623|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2306624|NCT00313599|Lapatinib|lapatinib|mesh-list
2306625|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2306626|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306627|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
2306628|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
2306629|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
2306630|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306631|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2306632|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306633|NCT00313625|Methotrexate|methotrexate|mesh-list
2306634|NCT00313625|Melphalan|melphalan|mesh-list
2306635|NCT00313625|Busulfan|busulfan|mesh-list
2306636|NCT00313625|Tacrolimus|tacrolimus|mesh-list
2306637|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2306638|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
2306639|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2306640|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861776|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861777|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2861778|NCT03779087|Renal Agents|renal agents|mesh-ancestor
2861779|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2861780|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2861781|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861782|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2861783|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2861784|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2861785|NCT03779100|Lenvatinib|lenvatinib|mesh-list
2861786|NCT03779100|Antibodies|antibodies|mesh-list
2306641|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2306642|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
2306643|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306644|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306645|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
2306646|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306647|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2306648|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2306649|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
2861787|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
2861788|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
2861789|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861790|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861791|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2861792|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861793|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861794|NCT03778944|Dopamine|dopamine|mesh-list
2861795|NCT03778944|Mannitol|mannitol|mesh-list
2861796|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2861797|NCT03778944|Diuretics|diuretics|mesh-ancestor
2861798|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
2861799|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861800|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2861801|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
2861802|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
2861803|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861804|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
2861805|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861806|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861807|NCT03778944|Protective Agents|protective agents|mesh-ancestor
2861808|NCT03778996|Sirolimus|sirolimus|mesh-list
2306650|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2306651|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2306652|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2306653|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2306654|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
2306655|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2306656|NCT00313690|Docetaxel|docetaxel|mesh-list
2306657|NCT00313690|Bortezomib|bortezomib|mesh-list
2861809|NCT03778996|Phenytoin|phenytoin|mesh-list
2861810|NCT03778996|Methoxsalen|methoxsalen|mesh-list
2861811|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
2861812|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2861813|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861814|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2861815|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861816|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
2861817|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2861818|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
2861819|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861820|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
2861821|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2861822|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2861823|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2861824|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861825|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2861826|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2861827|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2861828|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
2861829|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861830|NCT03779048|Phentermine|phentermine|mesh-list
2861831|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2861832|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861833|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
2861834|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2306658|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861835|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
2861836|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
2861837|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861838|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
2861839|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861840|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861841|NCT03778723|Fentanyl|fentanyl|mesh-list
2861842|NCT03778723|Anesthetics|anesthetics|mesh-list
2861843|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861844|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861845|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2861846|NCT03778723|Narcotics|narcotics|mesh-ancestor
2861847|NCT03778723|Analgesics|analgesics|mesh-ancestor
2861848|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
2861849|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861850|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2861851|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2861852|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
2861853|NCT03779061|Propofol|propofol|mesh-list
2861854|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2861855|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861856|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861857|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2861858|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
2861859|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
2861860|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
2861861|NCT03778619|Rituximab|rituximab|mesh-list
2861862|NCT03778619|Fludarabine|fludarabine|mesh-list
2861863|NCT03778619|Interleukin-2|interleukin-2|mesh-list
2861864|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2861865|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
2861866|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861867|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2861868|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2861869|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
2861870|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861871|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861872|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2861873|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2861874|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2861875|NCT03778619|Analgesics|analgesics|mesh-ancestor
2861876|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
2861877|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861878|NCT03779074|Amoxicillin|amoxicillin|mesh-list
2861879|NCT03779074|Metronidazole|metronidazole|mesh-list
2861880|NCT03779074|Clarithromycin|clarithromycin|mesh-list
2861881|NCT03779074|Tetracycline|tetracycline|mesh-list
2861882|NCT03779074|Rabeprazole|rabeprazole|mesh-list
2861883|NCT03779074|Bismuth|bismuth|mesh-list
2861884|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2861885|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861886|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2861887|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2861888|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2861889|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861890|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861891|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2861892|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2861893|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2861894|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2861895|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2861896|NCT03779074|Antacids|antacids|mesh-ancestor
2861897|NCT03778645|Epinephrine|epinephrine|mesh-list
2861898|NCT03778645|Racepinephrine|racepinephrine|mesh-list
2861899|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
2861900|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2861901|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2861902|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
2861903|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861904|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861905|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861906|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2861907|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2861908|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
2861909|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861910|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2861911|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
2861912|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
2861913|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
2861914|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2861915|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
2861916|NCT03778450|Analgesics|analgesics|mesh-list
2861917|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
2861918|NCT03778450|Narcotics|narcotics|mesh-ancestor
2861919|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861920|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861921|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
2861922|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861923|NCT03778359|Leuprolide|leuprolide|mesh-list
2861924|NCT03778359|Dienogest|dienogest|mesh-list
2861925|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
2861926|NCT03778359|Progestins|progestins|mesh-list
2861927|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2861928|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
2861929|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2861930|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861931|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2861932|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2861933|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2861934|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2861935|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
2861936|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2861937|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861938|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2861939|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2861940|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
2306659|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
2306660|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
2306661|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
2306662|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306663|NCT00313742|Insulin|insulin|mesh-list
2306664|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2306665|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
2306666|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
2306667|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
2306668|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
2306669|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
2306670|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2306671|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306672|NCT00313768|Paclitaxel|paclitaxel|mesh-list
2306673|NCT00313768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2306674|NCT00313768|Bevacizumab|bevacizumab|mesh-list
2306675|NCT00313768|Carboplatin|carboplatin|mesh-list
2306676|NCT00313768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2306677|NCT00313768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306678|NCT00313768|Tubulin Modulators|tubulin modulators|mesh-ancestor
2306679|NCT00313768|Antimitotic Agents|antimitotic agents|mesh-ancestor
2306680|NCT00313768|Mitosis Modulators|mitosis modulators|mesh-ancestor
2306681|NCT00313768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861941|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2861942|NCT03778359|Hormones|hormones|mesh-ancestor
2861943|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
2861944|NCT03778502|Apixaban|apixaban|mesh-list
2861945|NCT03778502|Edoxaban|edoxaban|mesh-list
2861946|NCT03778502|Dabigatran|dabigatran|mesh-list
2861947|NCT03778502|Anticoagulants|anticoagulants|mesh-list
2861948|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2861949|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
2861950|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2861951|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
2861952|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861953|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861954|NCT03778281|Baclofen|baclofen|mesh-list
2861955|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2861956|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861957|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2861958|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108475|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2108476|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108477|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2306682|NCT00313768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2861959|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2861960|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
2861961|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
2306683|NCT00313768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2306684|NCT00313768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2306685|NCT00313768|Growth Substances|growth substances|mesh-ancestor
2306686|NCT00313768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306687|NCT00313768|Growth Inhibitors|growth inhibitors|mesh-ancestor
2306688|NCT00313794|Tremelimumab|tremelimumab|mesh-list
2306689|NCT00313794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306690|NCT00313833|Buprenorphine|buprenorphine|mesh-list
2306691|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2306692|NCT00313833|Narcotics|narcotics|mesh-ancestor
2306693|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2306694|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306695|NCT00313833|Analgesics|analgesics|mesh-ancestor
2306696|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
2861962|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2861963|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861964|NCT03778567|Lamivudine|lamivudine|mesh-list
2861965|NCT03778567|Telbivudine|telbivudine|mesh-list
2861966|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2861967|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2861968|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2861969|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861970|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
2861971|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2861972|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2861973|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2861974|NCT03778541|Temozolomide|temozolomide|mesh-list
2861975|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2861976|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
2861977|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2861978|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2861979|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
2861980|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
2861981|NCT03778580|Vitamins|vitamins|mesh-ancestor
2861982|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
2861983|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861984|NCT03778372|Methadone|methadone|mesh-list
2861985|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2861986|NCT03778372|Narcotics|narcotics|mesh-ancestor
2861987|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2861988|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2861989|NCT03778372|Analgesics|analgesics|mesh-ancestor
2861990|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
2861991|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2861992|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
2861993|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
2861994|NCT03778593|Leucovorin|leucovorin|mesh-list
2861995|NCT03778593|Fluorouracil|fluorouracil|mesh-list
2861996|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
2861997|NCT03778593|Irinotecan|irinotecan|mesh-list
2861998|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
2861999|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862000|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2862001|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862002|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2862003|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
2306697|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306698|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2306699|NCT00313859|Simvastatin|simvastatin|mesh-list
2306700|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2306701|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2306702|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
2306703|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306704|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2306705|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2306706|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306707|NCT00313885|SR 46349B|sr 46349b|mesh-list
2306708|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2306709|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2862004|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862005|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2862006|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2862007|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862008|NCT03778593|Antidotes|antidotes|mesh-ancestor
2862009|NCT03778593|Protective Agents|protective agents|mesh-ancestor
2862010|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
2862011|NCT03778593|Vitamins|vitamins|mesh-ancestor
2306710|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306711|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2306712|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2306713|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
2306714|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306715|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306716|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
2306717|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
2306718|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2306719|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2306720|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306721|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306722|NCT00313898|Urological Agents|urological agents|mesh-ancestor
2862012|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
2862013|NCT03778554|Metoprolol|metoprolol|mesh-list
2862014|NCT03778554|Carvedilol|carvedilol|mesh-list
2862015|NCT03778554|Nebivolol|nebivolol|mesh-list
2862016|NCT03778554|Bisoprolol|bisoprolol|mesh-list
2862017|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2862018|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2862019|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
2306723|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2306724|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2862020|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
2862021|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862022|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862023|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2862024|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2862025|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2862026|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
2862027|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2862028|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862029|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
2862030|NCT03778554|Protective Agents|protective agents|mesh-ancestor
2862031|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2862032|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2862033|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2862034|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
2862035|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2862036|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2862037|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2862038|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2862039|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2862040|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
2862041|NCT03778008|Hydroxocobalamin|hydroxocobalamin|mesh-list
2862042|NCT03778008|Gentamicins|gentamicins|mesh-list
2862043|NCT03778008|Dexamethasone|dexamethasone|mesh-list
2862044|NCT03778008|Lidocaine|lidocaine|mesh-list
2862045|NCT03778008|Mitogens|mitogens|mesh-list
2862046|NCT03778008|Vitamins|vitamins|mesh-ancestor
2862047|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
2862048|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862049|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2862050|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
2862051|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
2862052|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862053|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2862054|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
2862055|NCT03778008|Hormones|hormones|mesh-ancestor
2862056|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2862057|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2862058|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862059|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
2862060|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
2862061|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862062|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
2862063|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2862064|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2862065|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2862066|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2862067|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862068|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
2862069|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
2862070|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2862071|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862072|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2862073|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862074|NCT03778008|Hematinics|hematinics|mesh-ancestor
2862075|NCT03778242|Oxytocin|oxytocin|mesh-list
2862076|NCT03778242|Oxytocics|oxytocics|mesh-ancestor
2862077|NCT03778242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2862078|NCT03778242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862079|NCT03778138|Pemetrexed|pemetrexed|mesh-list
2862080|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862081|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862082|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862083|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2862084|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2862085|NCT03777956|Lacosamide|lacosamide|mesh-list
2862086|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
2862087|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2862088|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2862089|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2862090|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862091|NCT03777878|Oxytocin|oxytocin|mesh-list
2862092|NCT03777878|Carbetocin|carbetocin|mesh-list
2862093|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
2862094|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2862095|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862096|NCT03777904|Iron|iron|mesh-list
2862097|NCT03777904|Trace Elements|trace elements|mesh-ancestor
2862098|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
2862099|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862100|NCT03777813|Leucovorin|leucovorin|mesh-list
2862101|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
2862102|NCT03777813|Durvalumab|durvalumab|mesh-list
2862103|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
2862104|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862105|NCT03777813|Antidotes|antidotes|mesh-ancestor
2862106|NCT03777813|Protective Agents|protective agents|mesh-ancestor
2862107|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862108|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
2862109|NCT03777813|Vitamins|vitamins|mesh-ancestor
2862110|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
2862111|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2862112|NCT03777917|Hyaluronic Acid|hyaluronic acid|mesh-list
2862113|NCT03777917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2862114|NCT03777917|Immunologic Factors|immunologic factors|mesh-ancestor
2862115|NCT03777917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862116|NCT03777917|Viscosupplements|viscosupplements|mesh-ancestor
2862117|NCT03777917|Protective Agents|protective agents|mesh-ancestor
2862118|NCT03777930|Thalidomide|thalidomide|mesh-list
2862119|NCT03777930|Megestrol|megestrol|mesh-list
2862120|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
2862121|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2862122|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
2862123|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862124|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
2862125|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2862126|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862127|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2862128|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2862129|NCT03777930|Growth Substances|growth substances|mesh-ancestor
2862130|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
2862131|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862132|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2862133|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2306725|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2306726|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
2306727|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306728|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306729|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306730|NCT00313924|Urological Agents|urological agents|mesh-ancestor
2306731|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
2306732|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2306733|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306734|NCT00313950|Vaccines|vaccines|mesh-list
2306735|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
2306736|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862134|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2862135|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
2862136|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2862137|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2862138|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2862139|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2862140|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
2306737|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
2306738|NCT00313963|Analgesics|analgesics|mesh-ancestor
2306739|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
2306740|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306741|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306742|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
2306743|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2306744|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2306745|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
2306746|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2306747|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2306748|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306749|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2306750|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
2306751|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2306752|NCT00313976|Interferons|interferons|mesh-list
2306753|NCT00313976|Interferon-beta|interferon-beta|mesh-list
2306754|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
2306755|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306756|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
2306757|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306758|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
2306759|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306760|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2306761|NCT00314080|Antitoxins|antitoxins|mesh-list
2306762|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
2306763|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
2306764|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306765|NCT00314158|Timolol|timolol|mesh-list
2306766|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2306767|NCT00314158|Brinzolamide|brinzolamide|mesh-list
2306768|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2306769|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2306770|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2306771|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
2306772|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306773|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306774|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306775|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2306776|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2862141|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2862142|NCT03777579|Paclitaxel|paclitaxel|mesh-list
2862143|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2862144|NCT03777579|Antibodies|antibodies|mesh-list
2862145|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
2862146|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2862147|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862148|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
2862149|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
2862150|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
2862151|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306777|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2306778|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306779|NCT00314171|Timolol|timolol|mesh-list
2306780|NCT00314171|Dorzolamide|dorzolamide|mesh-list
2306781|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2306782|NCT00314171|Brinzolamide|brinzolamide|mesh-list
2306783|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2306784|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2306785|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2862152|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
2862153|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862154|NCT03777696|Misoprostol|misoprostol|mesh-list
2862155|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2862156|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
2862157|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2862158|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862159|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2862160|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2862161|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
2862162|NCT03777423|Cobalt|cobalt|mesh-list
2862163|NCT03777423|Chromium|chromium|mesh-list
2862164|NCT03777423|Trace Elements|trace elements|mesh-ancestor
2306786|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
2306787|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306788|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306789|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306790|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2306791|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2306792|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2306793|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108478|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108479|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
2108480|NCT02504554|Vancomycin|vancomycin|mesh-list
2108481|NCT02504554|Omeprazole|omeprazole|mesh-list
2108482|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2862165|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
2862166|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862167|NCT03777787|Denatonium|denatonium|mesh-list
2862168|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
2862169|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862170|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
2862171|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862172|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
2862173|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862174|NCT03777462|Gemcitabine|gemcitabine|mesh-list
2862175|NCT03777462|Paclitaxel|paclitaxel|mesh-list
2862176|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2862177|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2862178|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862179|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
2862180|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
2862181|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
2306794|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2306795|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
2306796|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2306797|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2306798|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2306799|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2306800|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306801|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2306802|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
2306803|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2306804|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2306805|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2306806|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2306807|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862182|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862183|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2862184|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
2862185|NCT03777462|Antiviral Agents|antiviral agents|mesh-ancestor
2862186|NCT03777462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862187|NCT03777462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862188|NCT03777462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2862189|NCT03777462|Immunologic Factors|immunologic factors|mesh-ancestor
2862190|NCT03777462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862191|NCT03777644|Morphine|morphine|mesh-list
2862192|NCT03777644|Ropivacaine|ropivacaine|mesh-list
2862193|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2862194|NCT03777644|Narcotics|narcotics|mesh-ancestor
2862195|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862196|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862197|NCT03777644|Analgesics|analgesics|mesh-ancestor
2862198|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
2862199|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862200|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
2108483|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108484|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2108485|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2108486|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2108487|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108488|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108489|NCT02504671|Folic Acid|folic acid|mesh-list
2108490|NCT02504671|Hematinics|hematinics|mesh-ancestor
2108491|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
2108492|NCT02504671|Vitamins|vitamins|mesh-ancestor
2108493|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
2108494|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108495|NCT02504723|Carvedilol|carvedilol|mesh-list
2108496|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2862201|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
2306808|NCT00314314|Insulin|insulin|mesh-list
2306809|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2306810|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306811|NCT00314379|Vitamin E|vitamin e|mesh-list
2306812|NCT00314379|Vitamins|vitamins|mesh-ancestor
2306813|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
2306814|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306815|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
2306816|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306817|NCT00314379|Protective Agents|protective agents|mesh-ancestor
2306818|NCT00314405|Methylene Blue|methylene blue|mesh-list
2306819|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306820|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306821|NCT00314457|Bupivacaine|bupivacaine|mesh-list
2306822|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
2306823|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
2306824|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2306825|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306826|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
2306827|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306828|NCT00314509|Ciclesonide|ciclesonide|mesh-list
2306829|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
2306830|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2306831|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
2306832|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306833|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306834|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2862202|NCT03777657|Capecitabine|capecitabine|mesh-list
2862203|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
2862204|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862205|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2862206|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
2862207|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862208|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
2862209|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
2862210|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
2862211|NCT03777761|Tucatinib|tucatinib|mesh-list
2862212|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2862213|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862214|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2306835|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
2306836|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2306837|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2306838|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2306839|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
2306840|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306841|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306842|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
2306843|NCT00314509|Hormones|hormones|mesh-ancestor
2306844|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2306845|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2306846|NCT00314548|Epoprostenol|epoprostenol|mesh-list
2306847|NCT00314548|Alprostadil|alprostadil|mesh-list
2306848|NCT00314548|Tezosentan|tezosentan|mesh-list
2306849|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2306850|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
2306851|NCT00314548|Urological Agents|urological agents|mesh-ancestor
2306852|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2306853|NCT00314561|Pioglitazone|pioglitazone|mesh-list
2306854|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
2306855|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2306856|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306857|NCT00314613|Risperidone|risperidone|mesh-list
2306858|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
2306859|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2306860|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
2306861|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306862|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306863|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306864|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2306865|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2306866|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2306867|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2306868|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
2306869|NCT00314626|Lamivudine|lamivudine|mesh-list
2306870|NCT00314626|Efavirenz|efavirenz|mesh-list
2306871|NCT00314626|Abacavir|abacavir|mesh-list
2306872|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2306873|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2306874|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306875|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306876|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
2306877|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306878|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2306879|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2306880|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2306881|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2306882|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2306883|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2306884|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2306885|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2306886|NCT00314639|Modafinil|modafinil|mesh-list
2306887|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2306888|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306889|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2306890|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2306891|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2306892|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306893|NCT00314652|Buprenorphine|buprenorphine|mesh-list
2306894|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2306895|NCT00314652|Narcotics|narcotics|mesh-ancestor
2306896|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862215|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2862216|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862217|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862218|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862219|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2862220|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
2862221|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2862222|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2862223|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862224|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
2862225|NCT03777488|Coagulants|coagulants|mesh-ancestor
2306897|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306898|NCT00314652|Analgesics|analgesics|mesh-ancestor
2306899|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
2306900|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306901|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2306902|NCT00314665|Thalidomide|thalidomide|mesh-list
2306903|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2306904|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
2306905|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306906|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
2306907|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2306908|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2306909|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2306910|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2306911|NCT00314665|Growth Substances|growth substances|mesh-ancestor
2306912|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
2306913|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306914|NCT00314678|Paclitaxel|paclitaxel|mesh-list
2306915|NCT00314678|Topotecan|topotecan|mesh-list
2306916|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2306917|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306918|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
2306919|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
2306920|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
2306921|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306922|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2306923|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2306924|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306925|NCT00314704|Dopamine|dopamine|mesh-list
2306926|NCT00314704|Norepinephrine|norepinephrine|mesh-list
2306927|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2306928|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2306929|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
2306930|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306931|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306932|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306933|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
2306934|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
2306935|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306936|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2306937|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2306938|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
2306939|NCT00314704|Protective Agents|protective agents|mesh-ancestor
2306940|NCT00314743|Dexamethasone|dexamethasone|mesh-list
2306941|NCT00314743|Ondansetron|ondansetron|mesh-list
2306942|NCT00314743|Aprepitant|aprepitant|mesh-list
2306943|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2306944|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
2306945|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
2306946|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2306947|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306948|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2306949|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
2306950|NCT00314743|Hormones|hormones|mesh-ancestor
2306951|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2306952|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2306953|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306954|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
2306955|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
2306956|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2306957|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
2306958|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306959|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306960|NCT00314743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2306961|NCT00314743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2306962|NCT00314743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2306963|NCT00314743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2306964|NCT00314743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2306965|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2306966|NCT00314756|Imiquimod|imiquimod|mesh-list
2306967|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2306968|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
2306969|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306970|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306971|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
2306972|NCT00314782|Docetaxel|docetaxel|mesh-list
2306973|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306974|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
2306975|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
2306976|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
2306977|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306978|NCT00314821|Ropinirole|ropinirole|mesh-list
2306979|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2862226|NCT03777514|Ascorbic Acid|ascorbic acid|mesh-list
2862227|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2862228|NCT03777514|Vitamins|vitamins|mesh-ancestor
2862229|NCT03777514|Micronutrients|micronutrients|mesh-ancestor
2862230|NCT03777514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862231|NCT03777514|Antioxidants|antioxidants|mesh-ancestor
2862232|NCT03777514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862233|NCT03777514|Protective Agents|protective agents|mesh-ancestor
2862234|NCT03777514|Hematinics|hematinics|mesh-ancestor
2862235|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2862236|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2862237|NCT03777085|Rituximab|rituximab|mesh-list
2862238|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2862239|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862240|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
2862241|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862242|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2862243|NCT03777124|Carboplatin|carboplatin|mesh-list
2862244|NCT03777124|Pemetrexed|pemetrexed|mesh-list
2862245|NCT03777124|Apatinib|apatinib|mesh-list
2862246|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862247|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862248|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862249|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2862250|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2862251|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2862252|NCT03777280|Cobalt|cobalt|mesh-list
2306980|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2306981|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
2306982|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
2306983|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306984|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862253|NCT03777280|Chromium|chromium|mesh-list
2862254|NCT03777280|Trace Elements|trace elements|mesh-ancestor
2862255|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
2862256|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862257|NCT03777163|Vaccines|vaccines|mesh-list
2862258|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
2862259|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862260|NCT03777033|Alfacalcidol|alfacalcidol|mesh-list
2862261|NCT03777033|Calcium|calcium|mesh-list
2862262|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2862263|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862264|NCT03777033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2862265|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
2862266|NCT03776851|Hematinics|hematinics|mesh-ancestor
2862267|NCT03776916|Simethicone|simethicone|mesh-list
2862268|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
2862269|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862270|NCT03776916|Emollients|emollients|mesh-ancestor
2862271|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
2862272|NCT03776838|Fentanyl|fentanyl|mesh-list
2862273|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2862274|NCT03776838|Narcotics|narcotics|mesh-ancestor
2862275|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862276|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862277|NCT03776838|Analgesics|analgesics|mesh-ancestor
2862278|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
2862279|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862280|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2862281|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2862282|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
2306985|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306986|NCT00314860|Ropinirole|ropinirole|mesh-list
2306987|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2306988|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2306989|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
2306990|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
2306991|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2306992|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306993|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2306994|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
2306995|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2306996|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2306997|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2306998|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2306999|NCT00314912|Tramiprosate|tramiprosate|mesh-list
2307000|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
2307001|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
2307002|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
2307003|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307004|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307005|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307006|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
2862283|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
2862284|NCT03777345|Cobalt|cobalt|mesh-list
2862285|NCT03777345|Chromium|chromium|mesh-list
2862286|NCT03777345|Trace Elements|trace elements|mesh-ancestor
2862287|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
2862288|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862289|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
2862290|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
2862291|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
2862292|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2862293|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862294|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
2862295|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862296|NCT03776955|Carvedilol|carvedilol|mesh-list
2862297|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2862298|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2862299|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
2862300|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2862301|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862302|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862303|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2862304|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
2862305|NCT03776955|Protective Agents|protective agents|mesh-ancestor
2862306|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2862307|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2862308|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2862309|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
2862310|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2862311|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2862312|NCT03776656|Allopurinol|allopurinol|mesh-list
2862313|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
2862314|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862315|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862316|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
2862317|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2862318|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2862319|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
2307007|NCT00314977|Docetaxel|docetaxel|mesh-list
2307008|NCT00314977|Doxorubicin|doxorubicin|mesh-list
2307009|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2307010|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307011|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
2307012|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307013|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2862320|NCT03776656|Protective Agents|protective agents|mesh-ancestor
2862321|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862322|NCT03776994|Vaccines|vaccines|mesh-list
2862323|NCT03776994|Immunologic Factors|immunologic factors|mesh-ancestor
2862324|NCT03776994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862325|NCT03776409|Vancomycin|vancomycin|mesh-list
2862326|NCT03776409|Tazobactam|tazobactam|mesh-list
2862327|NCT03776409|Piperacillin|piperacillin|mesh-list
2862328|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2862329|NCT03776409|Lactams|lactams|mesh-list
2307014|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2307015|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
2307016|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307017|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307018|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2307019|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
2307020|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
2307021|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
2307022|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2307023|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2862330|NCT03776409|beta-Lactams|beta-lactams|mesh-list
2862331|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2862332|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862333|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2862334|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862335|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862336|NCT03776448|Charcoal|charcoal|mesh-list
2862337|NCT03776448|Antidotes|antidotes|mesh-ancestor
2307024|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2307025|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307026|NCT00314990|Folic Acid|folic acid|mesh-list
2307027|NCT00314990|Pyridoxine|pyridoxine|mesh-list
2307028|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
2307029|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
2307030|NCT00314990|Hematinics|hematinics|mesh-ancestor
2307031|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
2307032|NCT00314990|Vitamins|vitamins|mesh-ancestor
2307033|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
2307034|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307035|NCT00315003|Azithromycin|azithromycin|mesh-list
2862338|NCT03776448|Protective Agents|protective agents|mesh-ancestor
2862339|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862340|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2862341|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862342|NCT03776487|Fluorouracil|fluorouracil|mesh-list
2862343|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
2862344|NCT03776487|Nivolumab|nivolumab|mesh-list
2862345|NCT03776487|Ipilimumab|ipilimumab|mesh-list
2862346|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
2862347|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862348|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2862349|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862350|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2862351|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
2862352|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862353|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2862354|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2862355|NCT03776500|Macozinone|macozinone|mesh-list
2862356|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
2862357|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2862358|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862359|NCT03776812|Paclitaxel|paclitaxel|mesh-list
2862360|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2862361|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2862362|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862363|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
2862364|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
2862365|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
2862366|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862367|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2862368|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2862369|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862370|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2862371|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862372|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
2862373|NCT03776279|Analgesics|analgesics|mesh-ancestor
2862374|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
2862375|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862376|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307036|NCT00315003|Telithromycin|telithromycin|mesh-list
2307037|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2307038|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307039|NCT00315016|Eplerenone|eplerenone|mesh-list
2307040|NCT00315016|Fosinopril|fosinopril|mesh-list
2307041|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2307042|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
2307043|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2307044|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307045|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2307046|NCT00315016|Diuretics|diuretics|mesh-ancestor
2307047|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
2307048|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2862377|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862378|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2862379|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2862380|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862381|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862382|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
2862383|NCT03776136|Lenvatinib|lenvatinib|mesh-list
2862384|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2862385|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862386|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2862387|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862388|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862389|NCT03776305|Imipenem|imipenem|mesh-list
2862390|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2862391|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862392|NCT03776240|Trastuzumab|trastuzumab|mesh-list
2862393|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2862394|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862395|NCT03776058|Cinacalcet|cinacalcet|mesh-list
2862396|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2862397|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862398|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2862399|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
2862400|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2862401|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
2862402|NCT03776032|Hematinics|hematinics|mesh-ancestor
2862403|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
2307049|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2307050|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
2862404|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862405|NCT03775993|Hormones|hormones|mesh-list
2862406|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2862407|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307051|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307052|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307053|NCT00315042|Penicillins|penicillins|mesh-list
2307054|NCT00315042|Telithromycin|telithromycin|mesh-list
2307055|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2862408|NCT03775629|Tramadol|tramadol|mesh-list
2862409|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2862410|NCT03775629|Narcotics|narcotics|mesh-ancestor
2862411|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862412|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307056|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307057|NCT00315081|Bromocriptine|bromocriptine|mesh-list
2307058|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2307059|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2307060|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
2307061|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2307062|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307063|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
2862413|NCT03775629|Analgesics|analgesics|mesh-ancestor
2862414|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
2862415|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862416|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
2862417|NCT03775876|Propofol|propofol|mesh-list
2862418|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2862419|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862420|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862421|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2862422|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
2862423|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
2862424|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2862425|NCT03775876|Analgesics|analgesics|mesh-ancestor
2862426|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
2307064|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
2307065|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307066|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307067|NCT00315185|Cetuximab|cetuximab|mesh-list
2307068|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2307069|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307070|NCT00315211|Docetaxel|docetaxel|mesh-list
2307071|NCT00315211|Topotecan|topotecan|mesh-list
2307072|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307073|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
2307074|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
2307075|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
2307076|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862427|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862428|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2862429|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2862430|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2862431|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
2862432|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2862433|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862434|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
2307077|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2307078|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2307079|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307080|NCT00315276|Modafinil|modafinil|mesh-list
2307081|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2307082|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307083|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2307084|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2307085|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2307086|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307087|NCT00315367|Donepezil|donepezil|mesh-list
2307088|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2307089|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307090|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307091|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
2307092|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307093|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307094|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
2307095|NCT00315432|Interferons|interferons|mesh-list
2307096|NCT00315432|Ribavirin|ribavirin|mesh-list
2307097|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307098|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
2307099|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862435|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2862436|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862437|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862438|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2108497|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2108498|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
2108499|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108500|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108501|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108502|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2108503|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
2108504|NCT02504723|Protective Agents|protective agents|mesh-ancestor
2108505|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2108506|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108507|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2108508|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
2108509|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2108510|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2108511|NCT02504775|Acetaminophen|acetaminophen|mesh-list
2108512|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2108513|NCT02504775|Analgesics|analgesics|mesh-ancestor
2108514|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
2108515|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108516|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108517|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
2108518|NCT02504827|Ceftazidime|ceftazidime|mesh-list
2108519|NCT02504827|Avibactam|avibactam|mesh-list
2108520|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
2108521|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2307100|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
2307101|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862439|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862440|NCT03775863|Liver Extracts|liver extracts|mesh-list
2862441|NCT03775863|Hematinics|hematinics|mesh-ancestor
2862442|NCT03775707|Lenvatinib|lenvatinib|mesh-list
2862443|NCT03775707|Antibodies|antibodies|mesh-list
2862444|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
2862445|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862446|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862447|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2862448|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862449|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862450|NCT03775902|Nicorandil|nicorandil|mesh-list
2862451|NCT03775902|Glimepiride|glimepiride|mesh-list
2862452|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2862453|NCT03775902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2862454|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862455|NCT03775902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2862456|NCT03775902|Immunologic Factors|immunologic factors|mesh-ancestor
2862457|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2862458|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
2862459|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
2862460|NCT03775902|Vitamins|vitamins|mesh-ancestor
2862461|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
2862462|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
2862463|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2862464|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862465|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862466|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2862467|NCT03775655|Analgesics|analgesics|mesh-ancestor
2862468|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
2862469|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862470|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2862471|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2862472|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2862473|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
2862474|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2862475|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862476|NCT03775590|Acetic Acid|acetic acid|mesh-list
2862477|NCT03775590|Retinol acetate|retinol acetate|mesh-list
2862478|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2862479|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862480|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2862481|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
2862482|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862483|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2862484|NCT03775590|Protective Agents|protective agents|mesh-ancestor
2862485|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862486|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
2862487|NCT03775746|Clopidogrel|clopidogrel|mesh-list
2862488|NCT03775746|Ticagrelor|ticagrelor|mesh-list
2862489|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2862490|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2862491|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2862492|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2862493|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
2862494|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2862495|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862496|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862497|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2862498|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
2862499|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2862500|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
2307102|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
2307103|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
2307104|NCT00315484|Hematinics|hematinics|mesh-ancestor
2307105|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2307106|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2307107|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2862501|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862502|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
2862503|NCT03775928|Capecitabine|capecitabine|mesh-list
2862504|NCT03775928|Apatinib|apatinib|mesh-list
2862505|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2862506|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
2862507|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862508|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862509|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2862510|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862511|NCT03775538|Dopamine|dopamine|mesh-list
2862512|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2862513|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
2862514|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
2862515|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862516|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862517|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
2862518|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2862519|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862520|NCT03775538|Protective Agents|protective agents|mesh-ancestor
2862521|NCT03775460|Prednisolone|prednisolone|mesh-list
2862522|NCT03775460|Methotrexate|methotrexate|mesh-list
2862523|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2862524|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
2862525|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2862526|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862527|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2862528|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
2862529|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862530|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862531|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
2862532|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862533|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2862534|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2862535|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
2862536|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2862537|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2862538|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2862539|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
2862540|NCT03775460|Hormones|hormones|mesh-ancestor
2862541|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2862542|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2862547|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
2862548|NCT03775382|Vitamins|vitamins|mesh-ancestor
2862549|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
2862550|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862551|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
2862552|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307108|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
2307109|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862553|NCT03775382|Protective Agents|protective agents|mesh-ancestor
2862554|NCT03775096|Carvedilol|carvedilol|mesh-list
2862555|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2862556|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2862557|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
2862558|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2862559|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307110|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2307111|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2307112|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307113|NCT00315523|Levocetirizine|levocetirizine|mesh-list
2307114|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2307115|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2307116|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
2307117|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
2307118|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307119|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307120|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307121|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
2307122|NCT00315536|Remifentanil|remifentanil|mesh-list
2862560|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862561|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2862562|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
2862563|NCT03775096|Protective Agents|protective agents|mesh-ancestor
2862564|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2862565|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2862566|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2862567|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
2307123|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2307124|NCT00315536|Narcotics|narcotics|mesh-ancestor
2307125|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2307126|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307127|NCT00315536|Analgesics|analgesics|mesh-ancestor
2307128|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
2307129|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307130|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2307131|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2307132|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2307133|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
2307134|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307135|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307136|NCT00315549|Penicillins|penicillins|mesh-list
2307137|NCT00315549|Telithromycin|telithromycin|mesh-list
2307138|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2862568|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2862569|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2862570|NCT03775395|Sorafenib|sorafenib|mesh-list
2862571|NCT03775395|Lenvatinib|lenvatinib|mesh-list
2307139|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307140|NCT00315601|Azithromycin|azithromycin|mesh-list
2307141|NCT00315601|Telithromycin|telithromycin|mesh-list
2862572|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862573|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2862574|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862575|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862576|NCT03775356|Anesthetics|anesthetics|mesh-list
2862577|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862578|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862579|NCT03775070|Simvastatin|simvastatin|mesh-list
2862580|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2862581|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2862582|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
2862583|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862584|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2862585|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2862586|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862587|NCT03774901|Avelumab|avelumab|mesh-list
2307142|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2307143|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307144|NCT00315640|Hydrocortisone|hydrocortisone|mesh-list
2307145|NCT00315640|Anecortave|anecortave|mesh-list
2307146|NCT00315640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2307147|NCT00315640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2862588|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2862589|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862590|NCT03774732|Paclitaxel|paclitaxel|mesh-list
2862591|NCT03774732|Cisplatin|cisplatin|mesh-list
2307148|NCT00315640|Growth Substances|growth substances|mesh-ancestor
2108522|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108523|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2108524|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307149|NCT00315640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307150|NCT00315640|Growth Inhibitors|growth inhibitors|mesh-ancestor
2307151|NCT00315640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307152|NCT00315640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2307153|NCT00315666|Memantine|memantine|mesh-list
2307154|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2307155|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2307156|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
2862592|NCT03774732|Carboplatin|carboplatin|mesh-list
2862593|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
2862594|NCT03774732|Pemetrexed|pemetrexed|mesh-list
2862595|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2862596|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862597|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
2862598|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
2307157|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307158|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307159|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862599|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
2862600|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862601|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2307160|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2307161|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2307162|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
2307163|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2307164|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307165|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307166|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2307167|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2862602|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862603|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2862604|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2862605|NCT03774654|Cyclophosphamide|cyclophosphamide|mesh-list
2862606|NCT03774654|Fludarabine|fludarabine|mesh-list
2862607|NCT03774654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2862608|NCT03774654|Immunologic Factors|immunologic factors|mesh-ancestor
2862609|NCT03774654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862610|NCT03774654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2862611|NCT03774654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2862612|NCT03774654|Alkylating Agents|alkylating agents|mesh-ancestor
2862613|NCT03774654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862614|NCT03774654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862615|NCT03774654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2862616|NCT03774953|Vitamins|vitamins|mesh-list
2862617|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
2862618|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862619|NCT03774706|Misoprostol|misoprostol|mesh-list
2862620|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
2862621|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2862622|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2862623|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862624|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
2862625|NCT03774706|Coagulants|coagulants|mesh-ancestor
2862626|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2862627|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
2862628|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2862629|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862630|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2862631|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2862632|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
2862633|NCT03774771|Cinacalcet|cinacalcet|mesh-list
2862634|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2862635|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108525|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108526|NCT02504892|Everolimus|everolimus|mesh-list
2108527|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108528|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2108529|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
2108530|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108531|NCT02504931|Sertraline|sertraline|mesh-list
2108532|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
2307168|NCT00315679|Protective Agents|protective agents|mesh-ancestor
2307169|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307170|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
2307171|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2307172|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
2307173|NCT00315744|Fluticasone|fluticasone|mesh-list
2307174|NCT00315744|Xhance|xhance|mesh-list
2307175|NCT00315744|Albuterol|albuterol|mesh-list
2307176|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2307177|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2307178|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2307179|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
2307180|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307181|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307182|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2307183|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
2307184|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
2307185|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2862636|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2862637|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
2862638|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2862639|NCT03774693|Fentanyl|fentanyl|mesh-list
2862640|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
2862641|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862642|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862643|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2862644|NCT03774693|Narcotics|narcotics|mesh-ancestor
2862645|NCT03774693|Analgesics|analgesics|mesh-ancestor
2307186|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2307187|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2307188|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2307189|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
2307190|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307191|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307192|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
2307193|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2307194|NCT00315757|Bortezomib|bortezomib|mesh-list
2307195|NCT00315757|Mapatumumab|mapatumumab|mesh-list
2307196|NCT00315757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2307197|NCT00315757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307198|NCT00315757|Immunologic Factors|immunologic factors|mesh-ancestor
2307199|NCT00315757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307200|NCT00315835|Buprenorphine|buprenorphine|mesh-list
2307201|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2307202|NCT00315835|Narcotics|narcotics|mesh-ancestor
2307203|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2307204|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307205|NCT00315835|Analgesics|analgesics|mesh-ancestor
2307206|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
2307207|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307208|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2307209|NCT00315848|Buprenorphine|buprenorphine|mesh-list
2307210|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2307211|NCT00315848|Narcotics|narcotics|mesh-ancestor
2307212|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862646|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
2862647|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862648|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2307213|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307214|NCT00315848|Analgesics|analgesics|mesh-ancestor
2307215|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
2307216|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307217|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2307218|NCT00315861|Pemetrexed|pemetrexed|mesh-list
2307219|NCT00315861|Topotecan|topotecan|mesh-list
2307220|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307221|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307222|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307223|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2307224|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2307225|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2307226|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2307227|NCT00315874|Buprenorphine|buprenorphine|mesh-list
2307228|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2307229|NCT00315874|Narcotics|narcotics|mesh-ancestor
2862649|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2862650|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
2862651|NCT03774836|Morphine|morphine|mesh-list
2108533|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2108534|NCT02504931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2108535|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2108536|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2307230|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862652|NCT03774836|Tramadol|tramadol|mesh-list
2862653|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2862654|NCT03774836|Narcotics|narcotics|mesh-ancestor
2862655|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862656|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862657|NCT03774836|Analgesics|analgesics|mesh-ancestor
2862658|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
2862659|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862663|NCT03774680|Cetuximab|cetuximab|mesh-list
2862664|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2862665|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307231|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862666|NCT03774615|Ferric maltol|ferric maltol|mesh-list
2862667|NCT03774615|Hematinics|hematinics|mesh-ancestor
2862668|NCT03774810|Zolpidem|zolpidem|mesh-list
2862669|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2862670|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2862671|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862672|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862673|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2862674|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
2862675|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
2862676|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2862677|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862678|NCT03774524|Misoprostol|misoprostol|mesh-list
2862679|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2862680|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
2862681|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2862682|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862683|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2862684|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2862685|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
2862686|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
2862687|NCT03774472|Letrozole|letrozole|mesh-list
2862688|NCT03774472|Palbociclib|palbociclib|mesh-list
2862689|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862690|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2862691|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2862692|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862693|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862694|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2862695|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
2862696|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2862697|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862698|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
2862699|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2862700|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2862701|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862702|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2862703|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2862704|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
2862705|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2862706|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
2862707|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862708|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862709|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2862710|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
2307232|NCT00315874|Analgesics|analgesics|mesh-ancestor
2307233|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
2307234|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307235|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2307236|NCT00315887|Buprenorphine|buprenorphine|mesh-list
2862711|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2862712|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
2862713|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862714|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2862715|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2862716|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
2862717|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
2307237|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2307238|NCT00315887|Narcotics|narcotics|mesh-ancestor
2307239|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2307240|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307241|NCT00315887|Analgesics|analgesics|mesh-ancestor
2307242|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
2307243|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307244|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2307245|NCT00315900|Valproic Acid|valproic acid|mesh-list
2307246|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2307247|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
2307248|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2307249|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2862718|NCT03773991|Protective Agents|protective agents|mesh-ancestor
2862719|NCT03774108|Metformin|metformin|mesh-list
2862720|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2862721|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862722|NCT03774446|Roscovitine|roscovitine|mesh-list
2862723|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862724|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
2862725|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862726|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2862727|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862728|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862729|NCT03774095|Pycnogenols|pycnogenols|mesh-list
2307250|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2307251|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2307252|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307253|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
2307254|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307255|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307256|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
2307257|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307258|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
2307259|NCT00315913|Propranolol|propranolol|mesh-list
2307260|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2862730|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2862731|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
2862732|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307261|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2307262|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
2307263|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307264|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307265|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307266|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2307267|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2307268|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
2307269|NCT00315926|Melatonin|melatonin|mesh-list
2307270|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
2307271|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307272|NCT00315926|Protective Agents|protective agents|mesh-ancestor
2307273|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307274|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2307275|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
2307276|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
2307277|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2862733|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
2307278|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
2307279|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307280|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307281|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2307282|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
2307283|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2307284|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
2307285|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307286|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307287|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2307288|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
2307289|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
2307290|NCT00315965|Protective Agents|protective agents|mesh-ancestor
2307291|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
2307292|NCT00316030|Bexarotene|bexarotene|mesh-list
2307293|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307294|NCT00316095|Telmisartan|telmisartan|mesh-list
2307295|NCT00316095|Simvastatin|simvastatin|mesh-list
2307296|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2307297|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2307298|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
2307299|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862734|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862735|NCT03774095|Protective Agents|protective agents|mesh-ancestor
2862736|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2862737|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
2862738|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2862739|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
2862740|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
2862741|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2862742|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
2862743|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862744|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2862745|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2862746|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
2862747|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862748|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862749|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2862750|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2862751|NCT03773562|Erenumab|erenumab|mesh-list
2862752|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2862753|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862754|NCT03773562|Analgesics|analgesics|mesh-ancestor
2862755|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
2862756|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862757|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862758|NCT03773536|Artesunate|artesunate|mesh-list
2862759|NCT03773536|Primaquine|primaquine|mesh-list
2862760|NCT03773536|Amodiaquine|amodiaquine|mesh-list
2862761|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
2862762|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2862763|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2862764|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2862765|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862766|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
2862767|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
2862768|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2862769|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
2862770|NCT03773809|Vitamin D|vitamin d|mesh-list
2862771|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
2862772|NCT03773809|Vitamins|vitamins|mesh-list
2862773|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
2862774|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862775|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2862776|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2862777|NCT03773588|Propofol|propofol|mesh-list
2862778|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2862779|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2307300|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2307301|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2307302|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307303|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2307304|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2307305|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2307306|NCT00316160|Bupropion|bupropion|mesh-list
2307307|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2307308|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2307309|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
2307310|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2307311|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2307312|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2307313|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2307314|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862780|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862781|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2307315|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
2307316|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307317|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307318|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2307319|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2307320|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307321|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2307322|NCT00316212|INS 50589|ins 50589|mesh-list
2307323|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2307324|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2307325|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
2307326|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307327|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307328|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307329|NCT00316238|Olanzapine|olanzapine|mesh-list
2307330|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
2307331|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
2862782|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
2862783|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
2862784|NCT03773510|Trabectedin|trabectedin|mesh-list
2862785|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2862786|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
2862787|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862788|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862789|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
2862790|NCT03773484|Narcotics|narcotics|mesh-ancestor
2862791|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862792|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862793|NCT03773484|Analgesics|analgesics|mesh-ancestor
2862794|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
2862795|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862796|NCT03773445|Golimumab|golimumab|mesh-list
2862797|NCT03773445|Antibodies|antibodies|mesh-list
2862798|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2862799|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
2862800|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862801|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2862802|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2862803|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2862804|NCT03773367|Fluorouracil|fluorouracil|mesh-list
2862805|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
2862806|NCT03773367|Irinotecan|irinotecan|mesh-list
2862807|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
2862808|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862809|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2862810|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862811|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2862812|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
2862813|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862814|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2862815|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2862816|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307332|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307333|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307334|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2307335|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2307336|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2307337|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862817|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2862818|NCT03773237|SMOFlipid|smoflipid|mesh-list
2862819|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2862820|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2862821|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2862822|NCT03773107|Dexamethasone|dexamethasone|mesh-list
2862823|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2862824|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
2862825|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
2862826|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862827|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862828|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2862829|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
2862830|NCT03773107|Hormones|hormones|mesh-ancestor
2862831|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2862832|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2862833|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862834|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
2862835|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2862836|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2862837|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307338|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2307339|NCT00316238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2307340|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2307341|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2307342|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307343|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307344|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
2307345|NCT00316329|Artesunate|artesunate|mesh-list
2307346|NCT00316329|Amodiaquine|amodiaquine|mesh-list
2307347|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
2307348|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2307349|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2307350|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307351|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307352|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
2307353|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
2307354|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2307355|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
2307356|NCT00316407|Paclitaxel|paclitaxel|mesh-list
2307357|NCT00316407|Carboplatin|carboplatin|mesh-list
2307358|NCT00316407|Lapatinib|lapatinib|mesh-list
2307359|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2307360|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307361|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
2307362|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
2862838|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
2862839|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
2862840|NCT03773042|Propofol|propofol|mesh-list
2862841|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2862842|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862843|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862844|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2862845|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
2862846|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
2862847|NCT03772834|Methylphenidate|methylphenidate|mesh-list
2862848|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2862849|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862850|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2862851|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2862852|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2862853|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862854|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
2307363|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
2307364|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307365|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2307366|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307367|NCT00316420|Gemcitabine|gemcitabine|mesh-list
2307368|NCT00316420|Capecitabine|capecitabine|mesh-list
2307369|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2862855|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307370|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
2307371|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307372|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307373|NCT00316420|Antiviral Agents|antiviral agents|mesh-ancestor
2307374|NCT00316420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307375|NCT00316420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862868|NCT03772964|Metformin|metformin|mesh-list
2862869|NCT03772964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2862870|NCT03772964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862871|NCT03772613|Heparin|heparin|mesh-list
2862872|NCT03772613|Calcium heparin|calcium heparin|mesh-list
2862873|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
2862874|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2862875|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2862876|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862877|NCT03772990|Calcium|calcium|mesh-list
2862878|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2862879|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307376|NCT00316420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307377|NCT00316420|Immunologic Factors|immunologic factors|mesh-ancestor
2307378|NCT00316420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307379|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
2307380|NCT00316433|Irinotecan|irinotecan|mesh-list
2307381|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307382|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2307383|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2307384|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307385|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307386|NCT00316472|Niacinamide|niacinamide|mesh-list
2307387|NCT00316472|Niacin|niacin|mesh-list
2307388|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
2307389|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
2307390|NCT00316472|Vitamins|vitamins|mesh-ancestor
2307391|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
2307392|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307393|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2307394|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
2307395|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307396|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2307397|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
2307398|NCT00316498|Miglustat|miglustat|mesh-list
2307399|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307400|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307401|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2307402|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2307403|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
2307404|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307405|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2307406|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2307407|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307408|NCT00316563|Dronabinol|dronabinol|mesh-list
2307409|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
2862880|NCT03772574|Nicotine|nicotine|mesh-list
2862881|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2862882|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
2862883|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862884|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862885|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2862886|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2862887|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
2862888|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2862889|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862890|NCT03772483|Anesthetics|anesthetics|mesh-list
2862891|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862892|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862893|NCT03772561|Durvalumab|durvalumab|mesh-list
2862894|NCT03772561|Olaparib|olaparib|mesh-list
2862895|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2862896|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862897|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2862898|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862899|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862900|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
2862901|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2862902|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
2862903|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2862904|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
2862905|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862906|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862907|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
2862908|NCT03772353|Letrozole|letrozole|mesh-list
2862909|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2862910|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862911|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2862912|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862913|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862914|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2862915|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
2307410|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307411|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2307412|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2307413|NCT00316563|Analgesics|analgesics|mesh-ancestor
2307414|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
2307415|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307416|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2307417|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2307418|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307419|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307420|NCT00316563|Hormones|hormones|mesh-ancestor
2307421|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2307422|NCT00316680|Vaccines|vaccines|mesh-list
2307423|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
2307424|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307425|NCT00316745|Leucovorin|leucovorin|mesh-list
2307426|NCT00316745|Fluorouracil|fluorouracil|mesh-list
2307427|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
2307428|NCT00316745|Irinotecan|irinotecan|mesh-list
2307429|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
2307430|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307431|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2307432|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307433|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307434|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
2862916|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2862917|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862918|NCT03772314|Modafinil|modafinil|mesh-list
2862919|NCT03772314|Amphetamine|amphetamine|mesh-list
2862920|NCT03772314|Adderall|adderall|mesh-list
2862921|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
2862922|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2862923|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862924|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2862925|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2862926|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2862927|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862928|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
2307435|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307436|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2862929|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
2862930|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862931|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
2862932|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2862933|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
2307437|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2307438|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307439|NCT00316745|Antidotes|antidotes|mesh-ancestor
2307440|NCT00316745|Protective Agents|protective agents|mesh-ancestor
2307441|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
2307442|NCT00316745|Vitamins|vitamins|mesh-ancestor
2307443|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
2307444|NCT00316758|Metformin|metformin|mesh-list
2307445|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2307446|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307447|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
2307448|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
2307449|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2307450|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2862934|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2862935|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2862936|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2862937|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2862938|NCT03772262|Metformin|metformin|mesh-list
2862939|NCT03772262|Furosemide|furosemide|mesh-list
2862940|NCT03772262|Midazolam|midazolam|mesh-list
2862941|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2862942|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2862943|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862944|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2862945|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2862946|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862947|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2862948|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2862949|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2862950|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2307451|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
2307452|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307453|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307454|NCT00316849|Sirolimus|sirolimus|mesh-list
2307455|NCT00316849|Temozolomide|temozolomide|mesh-list
2307456|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2307457|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
2307458|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307459|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307460|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2307461|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307462|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2307463|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
2307464|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307465|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
2307466|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307467|NCT00316875|Doxorubicin|doxorubicin|mesh-list
2307468|NCT00316875|Lapatinib|lapatinib|mesh-list
2307469|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2307470|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307471|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2307472|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2307473|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307474|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307475|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2307476|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2307477|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2307478|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307479|NCT00316927|Aspirin|aspirin|mesh-list
2307480|NCT00316927|Dexamethasone|dexamethasone|mesh-list
2307481|NCT00316927|Fosfestrol|fosfestrol|mesh-list
2307482|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
2307483|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2307484|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
2307485|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
2307486|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307487|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307488|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2307489|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
2307490|NCT00316927|Hormones|hormones|mesh-ancestor
2862951|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
2862952|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
2862953|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
2862954|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
2862955|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2862956|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862957|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2862958|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2862959|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
2862960|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2862961|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2862962|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2862963|NCT03772262|Diuretics|diuretics|mesh-ancestor
2862964|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
2862965|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2862966|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2862967|NCT03772223|Budesonide|budesonide|mesh-list
2862968|NCT03772223|Albuterol|albuterol|mesh-list
2862969|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2862970|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2862971|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
2862972|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2862973|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862974|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2862975|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
2862976|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
2862977|NCT03772223|Hormones|hormones|mesh-ancestor
2862978|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2862979|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
2862980|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2862981|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2862982|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2862983|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2862984|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
2862985|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307491|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2307492|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2307493|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307494|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2307495|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2307496|NCT00316927|Analgesics|analgesics|mesh-ancestor
2307497|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
2307498|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2307499|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2307500|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2307501|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307502|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2307503|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2307504|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307505|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
2307506|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2307507|NCT00316927|Estrogens|estrogens|mesh-ancestor
2307508|NCT00316940|Bortezomib|bortezomib|mesh-list
2307509|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
2307510|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307511|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2862986|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2862987|NCT03772106|Propofol|propofol|mesh-list
2862988|NCT03772106|Sevoflurane|sevoflurane|mesh-list
2862989|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2862990|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2862991|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2862992|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2862993|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
2862994|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
2862995|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2862996|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2862997|NCT03772054|Propofol|propofol|mesh-list
2862998|NCT03772054|Sevoflurane|sevoflurane|mesh-list
2862999|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2863000|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863001|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863002|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2863003|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
2863004|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
2863005|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2863006|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2863007|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
2307512|NCT00316940|Analgesics|analgesics|mesh-ancestor
2307513|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
2307514|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307515|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307516|NCT00316953|Dasatinib|dasatinib|mesh-list
2307517|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307518|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2307519|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307520|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863008|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2863009|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863010|NCT03771846|Leucovorin|leucovorin|mesh-list
2863011|NCT03771846|Gemcitabine|gemcitabine|mesh-list
2863012|NCT03771846|Fluorouracil|fluorouracil|mesh-list
2863013|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
2863014|NCT03771846|Irinotecan|irinotecan|mesh-list
2863015|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2863016|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
2863017|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863018|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863019|NCT03771846|Antiviral Agents|antiviral agents|mesh-ancestor
2863020|NCT03771846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863021|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863022|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2863023|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
2863024|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863025|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2863026|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2863027|NCT03771846|Antidotes|antidotes|mesh-ancestor
2863028|NCT03771846|Protective Agents|protective agents|mesh-ancestor
2863029|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
2863030|NCT03771846|Vitamins|vitamins|mesh-ancestor
2863031|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
2863032|NCT03771755|Acetaminophen|acetaminophen|mesh-list
2863033|NCT03771755|Ibuprofen|ibuprofen|mesh-list
2863034|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2863035|NCT03771755|Analgesics|analgesics|mesh-ancestor
2863036|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
2863037|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863038|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863039|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
2863040|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2863041|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2863042|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2863043|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2863044|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863045|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863046|NCT03771729|Valsartan|valsartan|mesh-list
2863047|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2863048|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2863049|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2307521|NCT00317031|Naltrexone|naltrexone|mesh-list
2307522|NCT00317031|Acamprosate|acamprosate|mesh-list
2307523|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2307524|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2307525|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307526|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
2307527|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307528|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2307529|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2307530|NCT00317070|Protective Agents|protective agents|mesh-ancestor
2307531|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307532|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2307533|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
2863050|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2863051|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863052|NCT03772067|Insulin|insulin|mesh-list
2863053|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2863054|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2863055|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2863056|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863057|NCT03772067|Incretins|incretins|mesh-ancestor
2863058|NCT03772067|Hormones|hormones|mesh-ancestor
2307534|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307535|NCT00317096|Rituximab|rituximab|mesh-list
2307536|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2307537|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307538|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
2307539|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307540|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2307541|NCT00317135|Vaccines|vaccines|mesh-list
2307542|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
2307543|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307544|NCT00317187|Vaccines|vaccines|mesh-list
2307545|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
2863059|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863060|NCT03771677|Interferons|interferons|mesh-list
2863061|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
2863062|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
2863063|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863064|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
2863065|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863066|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
2863067|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863068|NCT03772028|Cisplatin|cisplatin|mesh-list
2863069|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863070|NCT03771781|Empagliflozin|empagliflozin|mesh-list
2863071|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2863072|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863073|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2863074|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863075|NCT03771768|Triamcinolone|triamcinolone|mesh-list
2863076|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2863077|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2863078|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2863079|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2863080|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
2863081|NCT03771768|Hormones|hormones|mesh-ancestor
2863082|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863083|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863084|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2863085|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
2863086|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863087|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863088|NCT03771638|Tenofovir|tenofovir|mesh-list
2307546|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307547|NCT00317200|Paclitaxel|paclitaxel|mesh-list
2863089|NCT03771638|Emtricitabine|emtricitabine|mesh-list
2863090|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
2863091|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863092|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2307548|NCT00317200|Bevacizumab|bevacizumab|mesh-list
2307549|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2307550|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307551|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
2307552|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
2307553|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
2307554|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863093|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2863094|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863095|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863096|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2863097|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2863112|NCT03771222|Decitabine|decitabine|mesh-list
2307555|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2307556|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2307557|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2307558|NCT00317200|Growth Substances|growth substances|mesh-ancestor
2307559|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307560|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
2307561|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2307562|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
2307563|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307564|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307565|NCT00317330|Rifampin|rifampin|mesh-list
2307566|NCT00317330|Isoniazid|isoniazid|mesh-list
2307567|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
2307568|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2863113|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2863114|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
2863115|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863116|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863117|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863118|NCT03771157|Vaccines|vaccines|mesh-list
2863119|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
2863120|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863121|NCT03771066|Bisphenol A|bisphenol a|mesh-list
2863122|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2863123|NCT03771066|Estrogens|estrogens|mesh-ancestor
2863124|NCT03771066|Hormones|hormones|mesh-ancestor
2863125|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863126|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863127|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2863128|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
2863129|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863130|NCT03771066|Protective Agents|protective agents|mesh-ancestor
2307569|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
2307570|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2307571|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307572|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
2307573|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2307574|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307575|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307576|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2307577|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2307578|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2307579|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2307580|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2307581|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2307582|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2307583|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2307584|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
2307585|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2307586|NCT00317343|Anticoagulants|anticoagulants|mesh-list
2307587|NCT00317343|Bivalirudin|bivalirudin|mesh-list
2307588|NCT00317343|Thrombin|thrombin|mesh-list
2307589|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
2307590|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2307591|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
2307592|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307593|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307594|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
2307595|NCT00317343|Coagulants|coagulants|mesh-ancestor
2307596|NCT00317395|Heparin|heparin|mesh-list
2307597|NCT00317395|Calcium heparin|calcium heparin|mesh-list
2307598|NCT00317395|Otamixaban|otamixaban|mesh-list
2863131|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
2863132|NCT03771092|Hematinics|hematinics|mesh-ancestor
2863133|NCT03771651|Aspirin|aspirin|mesh-list
2863134|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2863135|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2863136|NCT03771651|Analgesics|analgesics|mesh-ancestor
2863137|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
2863138|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863139|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863140|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2307599|NCT00317395|Eptifibatide|eptifibatide|mesh-list
2307600|NCT00317395|Anticoagulants|anticoagulants|mesh-ancestor
2863141|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2863142|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2863143|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2863144|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863145|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2863146|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2863147|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863148|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
2307601|NCT00317395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2307602|NCT00317395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2307603|NCT00317395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307604|NCT00317395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2307605|NCT00317395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2307606|NCT00317395|Antithrombins|antithrombins|mesh-ancestor
2307607|NCT00317395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2307608|NCT00317395|Protease Inhibitors|protease inhibitors|mesh-ancestor
2307609|NCT00317395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307610|NCT00317408|Leucovorin|leucovorin|mesh-list
2307611|NCT00317408|Cytarabine|cytarabine|mesh-list
2307612|NCT00317408|Cyclosporine|cyclosporine|mesh-list
2307613|NCT00317408|Dexamethasone|dexamethasone|mesh-list
2307614|NCT00317408|Prednisolone|prednisolone|mesh-list
2307615|NCT00317408|Carboplatin|carboplatin|mesh-list
2307616|NCT00317408|Methotrexate|methotrexate|mesh-list
2307617|NCT00317408|Etoposide|etoposide|mesh-list
2307618|NCT00317408|Melphalan|melphalan|mesh-list
2307619|NCT00317408|Busulfan|busulfan|mesh-list
2307620|NCT00317408|Ifosfamide|ifosfamide|mesh-list
2307621|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
2307622|NCT00317408|Thiotepa|thiotepa|mesh-list
2307623|NCT00317408|Idarubicin|idarubicin|mesh-list
2307624|NCT00317408|Carmustine|carmustine|mesh-list
2307625|NCT00317408|Vinblastine|vinblastine|mesh-list
2307626|NCT00317408|Lomustine|lomustine|mesh-list
2307627|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
2307628|NCT00317408|Vindesine|vindesine|mesh-list
2307629|NCT00317408|Cyclosporins|cyclosporins|mesh-list
2307630|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2307631|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
2307632|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2307633|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
2307634|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
2307635|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307636|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307637|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2307638|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
2307639|NCT00317408|Hormones|hormones|mesh-ancestor
2307640|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2307641|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2307642|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307643|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2307644|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
2307645|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2307646|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2307647|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
2307648|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863149|NCT03770923|Montelukast|montelukast|mesh-list
2863150|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2307649|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
2307650|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307651|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2307652|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307653|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
2307654|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2307655|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2307656|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2307657|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2307658|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2307659|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
2307660|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307661|NCT00317408|Antidotes|antidotes|mesh-ancestor
2307662|NCT00317408|Protective Agents|protective agents|mesh-ancestor
2307663|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
2307664|NCT00317408|Vitamins|vitamins|mesh-ancestor
2307665|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
2307666|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
2307667|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2307668|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2307669|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
2307670|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2307671|NCT00317408|Analgesics|analgesics|mesh-ancestor
2307672|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
2863151|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
2863152|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2863153|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
2863154|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863155|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863156|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2863157|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2863158|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863159|NCT03770936|Candesartan|candesartan|mesh-list
2863160|NCT03770936|Ramipril|ramipril|mesh-list
2863161|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2863162|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2863163|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2863164|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863165|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2863166|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
2863167|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863168|NCT03770806|Acetaminophen|acetaminophen|mesh-list
2863169|NCT03770806|Celecoxib|celecoxib|mesh-list
2863170|NCT03770806|Oxycodone|oxycodone|mesh-list
2307673|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2307674|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
2307675|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
2863171|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2863172|NCT03770806|Analgesics|analgesics|mesh-ancestor
2863173|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
2863174|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863175|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863176|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
2863177|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2863178|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2863179|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2863180|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2863181|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2863182|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863183|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863184|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2863185|NCT03770806|Narcotics|narcotics|mesh-ancestor
2863186|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863187|NCT03771053|Simvastatin|simvastatin|mesh-list
2863188|NCT03771053|Ezetimibe|ezetimibe|mesh-list
2863189|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2863190|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2863191|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
2863192|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863193|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2863194|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2863195|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863196|NCT03770416|Nivolumab|nivolumab|mesh-list
2863197|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2307676|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
2307677|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
2307678|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307679|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
2307680|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2307681|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2307682|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307683|NCT00317421|Urological Agents|urological agents|mesh-ancestor
2307684|NCT00317434|Lapatinib|lapatinib|mesh-list
2307685|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307686|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2307687|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307688|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307689|NCT00317447|Prednisone|prednisone|mesh-list
2307690|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2307691|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
2307692|NCT00317447|Hormones|hormones|mesh-ancestor
2307693|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863198|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863199|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2863200|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863201|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2863202|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863206|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
2863207|NCT03770663|Azathioprine|azathioprine|mesh-list
2863208|NCT03770663|Tacrolimus|tacrolimus|mesh-list
2863209|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2863210|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
2863211|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863212|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2863213|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2863214|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
2307694|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307695|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2307696|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863215|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863216|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863217|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2863218|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2863219|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863220|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
2863221|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2863222|NCT03770637|Glucagon|glucagon|mesh-list
2307697|NCT00317486|Bosentan|bosentan|mesh-list
2307698|NCT00317486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2307699|NCT00317486|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2307700|NCT00317486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307701|NCT00317499|Etanercept|etanercept|mesh-list
2307702|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2307703|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2307704|NCT00317499|Analgesics|analgesics|mesh-ancestor
2307705|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
2307706|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307707|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307708|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2307709|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2307710|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2307711|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307712|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
2307713|NCT00317512|HBOC 201|hboc 201|mesh-list
2307714|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
2307715|NCT00317538|Etanercept|etanercept|mesh-list
2307716|NCT00317538|Infliximab|infliximab|mesh-list
2307717|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2307718|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2307719|NCT00317538|Analgesics|analgesics|mesh-ancestor
2307720|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
2307721|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307722|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307723|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2307724|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2307725|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2307726|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307727|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
2307728|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
2307729|NCT00317577|Timolol|timolol|mesh-list
2307730|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2307731|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2307732|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2307733|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
2307734|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307735|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307736|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307737|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2307738|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2307739|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2307740|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2307741|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2307742|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2307743|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
2307744|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2307745|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
2307746|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307747|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307748|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2307749|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
2307750|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2307751|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
2307752|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307753|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307754|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2307755|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
2307756|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
2307757|NCT00317629|Protective Agents|protective agents|mesh-ancestor
2307758|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2307759|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2307760|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307761|NCT00317655|Ibuprofen|ibuprofen|mesh-list
2863223|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2863224|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2863225|NCT03770637|Hormones|hormones|mesh-ancestor
2863226|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863227|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863228|NCT03770637|Incretins|incretins|mesh-ancestor
2863229|NCT03770767|Insulin|insulin|mesh-list
2863230|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2863231|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
2863232|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2863233|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863241|NCT03770338|Teriparatide|teriparatide|mesh-list
2863242|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2863243|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863244|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2863245|NCT03770208|Lidocaine|lidocaine|mesh-list
2863246|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
2863247|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
2863248|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863249|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863250|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
2863251|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863252|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2863253|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2863254|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2863255|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2863256|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863257|NCT03770000|Romidepsin|romidepsin|mesh-list
2863258|NCT03770000|Tenalisib|tenalisib|mesh-list
2863259|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2863260|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863261|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
2863262|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863263|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863264|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2307762|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2307763|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2307764|NCT00317655|Analgesics|analgesics|mesh-ancestor
2307765|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
2307766|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307767|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307768|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2863265|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2863266|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2863267|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
2863268|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863269|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863270|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2863271|NCT03770299|Gemcitabine|gemcitabine|mesh-list
2863272|NCT03770299|Paclitaxel|paclitaxel|mesh-list
2863273|NCT03770299|Vinorelbine|vinorelbine|mesh-list
2863274|NCT03770299|Docetaxel|docetaxel|mesh-list
2863275|NCT03770299|Carboplatin|carboplatin|mesh-list
2863276|NCT03770299|Nivolumab|nivolumab|mesh-list
2863277|NCT03770299|Pemetrexed|pemetrexed|mesh-list
2863278|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2863279|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863280|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
2863281|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
2307769|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2307770|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2307771|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307772|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307773|NCT00317681|Tacrolimus|tacrolimus|mesh-list
2307774|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307775|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
2307776|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307777|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2307778|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307779|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307780|NCT00317733|Ketoprofen|ketoprofen|mesh-list
2307781|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2307782|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2307783|NCT00317733|Analgesics|analgesics|mesh-ancestor
2307784|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
2307785|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307786|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863282|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
2863283|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863284|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2863285|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
2863286|NCT03770299|Antiviral Agents|antiviral agents|mesh-ancestor
2863287|NCT03770299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863288|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863289|NCT03770299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2863290|NCT03770299|Immunologic Factors|immunologic factors|mesh-ancestor
2863291|NCT03770299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307787|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2307788|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2307789|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2307790|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307791|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307792|NCT00317746|Citalopram|citalopram|mesh-list
2307793|NCT00317746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2307794|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2307795|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2307796|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307797|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307798|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
2307799|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307800|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2307801|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
2863292|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2863293|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2863294|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2863295|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2863310|NCT03770039|PF-06700841|pf-06700841|mesh-list
2863311|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2863312|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863313|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863314|NCT03770026|Clomiphene|clomiphene|mesh-list
2863315|NCT03770026|Enclomiphene|enclomiphene|mesh-list
2307802|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2307803|NCT00317759|Fludarabine|fludarabine|mesh-list
2307804|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
2307805|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307806|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2863316|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
2863317|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2863318|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
2307807|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
2307808|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307809|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307810|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
2307811|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307812|NCT00317772|Topotecan|topotecan|mesh-list
2307813|NCT00317772|Gefitinib|gefitinib|mesh-list
2307814|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2307815|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2307816|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307817|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307818|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307819|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2307820|NCT00317785|Cyclosporine|cyclosporine|mesh-list
2307821|NCT00317785|Sirolimus|sirolimus|mesh-list
2307822|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
2307823|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
2307824|NCT00317785|Methotrexate|methotrexate|mesh-list
2307825|NCT00317785|Tacrolimus|tacrolimus|mesh-list
2307826|NCT00317785|Cyclosporins|cyclosporins|mesh-list
2863319|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863320|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863321|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2863322|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
2863323|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2863324|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2863325|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2863326|NCT03770013|Clonidine|clonidine|mesh-list
2863327|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
2863328|NCT03770013|Bupivacaine|bupivacaine|mesh-list
2863329|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
2307827|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307828|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
2307829|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307830|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2307831|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2863330|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
2863331|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863332|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863333|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
2863334|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307832|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
2307833|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863335|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2863336|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2863337|NCT03770013|Analgesics|analgesics|mesh-ancestor
2863338|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2307834|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307835|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2307836|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2307837|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
2307838|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2307839|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2307840|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
2307841|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2307842|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307843|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2307844|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2307845|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2863339|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2863340|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2863341|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
2863342|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2863343|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863344|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2863345|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
2863346|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
2863347|NCT03769935|Etoposide|etoposide|mesh-list
2863348|NCT03769935|Cisplatin|cisplatin|mesh-list
2863349|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2863350|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863351|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2863352|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2863353|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863354|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863355|NCT03769870|Atorvastatin|atorvastatin|mesh-list
2863356|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2863357|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2863358|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
2863359|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863360|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2863361|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2863362|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307846|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
2307847|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307848|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2863363|NCT03769844|Molgramostim|molgramostim|mesh-list
2863364|NCT03769844|Sargramostim|sargramostim|mesh-list
2863365|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
2863366|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863367|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863368|NCT03769818|Dexamethasone|dexamethasone|mesh-list
2863369|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
2863370|NCT03769818|Bupivacaine|bupivacaine|mesh-list
2863371|NCT03769818|BB 1101|bb 1101|mesh-list
2863372|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2863373|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
2863374|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
2863375|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863376|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863377|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2863378|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
2863379|NCT03769818|Hormones|hormones|mesh-ancestor
2863380|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863381|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2863382|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863383|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
2863384|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863385|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863386|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
2863387|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
2307849|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2307850|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
2307851|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2307852|NCT00317798|Sirolimus|sirolimus|mesh-list
2307853|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2307854|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2863388|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863389|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
2863402|NCT03769714|Bupivacaine|bupivacaine|mesh-list
2863403|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
2863404|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
2863405|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863406|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863407|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
2863408|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863409|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
2863410|NCT03769532|Azacitidine|azacitidine|mesh-list
2863411|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2863412|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863413|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2863414|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
2863415|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863416|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863417|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
2863418|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2863419|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863420|NCT03769402|Citric Acid|citric acid|mesh-list
2863421|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
2863422|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
2863423|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2863424|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
2863425|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
2863426|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863427|NCT03769311|Cetuximab|cetuximab|mesh-list
2863428|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2863429|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863430|NCT03769298|Tacrolimus|tacrolimus|mesh-list
2863431|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2863432|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
2863433|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863434|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2863435|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863436|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863437|NCT03769285|Niacinamide|niacinamide|mesh-list
2863438|NCT03769285|Niacin|niacin|mesh-list
2863439|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
2863440|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
2863441|NCT03769285|Vitamins|vitamins|mesh-ancestor
2863442|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
2863443|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863444|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2863445|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
2863446|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863447|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2863448|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
2307855|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307856|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2307857|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307858|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
2307859|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307860|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
2307861|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307862|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
2863452|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
2863453|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2863454|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863455|NCT03769103|Osimertinib|osimertinib|mesh-list
2863456|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863457|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2863458|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863459|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863460|NCT03769090|Budesonide|budesonide|mesh-list
2863461|NCT03769090|Albuterol|albuterol|mesh-list
2863462|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2863463|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2863464|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
2863465|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863466|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863467|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2863468|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
2863469|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
2863470|NCT03769090|Hormones|hormones|mesh-ancestor
2863471|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863472|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
2863473|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2863474|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2863475|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2863476|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2863477|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
2863478|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2863479|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863480|NCT03769064|Methylphenidate|methylphenidate|mesh-list
2863481|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2863482|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863483|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2863484|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2863485|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2863486|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863487|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
2863488|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2863489|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2863490|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2863491|NCT03769025|Narcotics|narcotics|mesh-ancestor
2863492|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863493|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863494|NCT03769025|Analgesics|analgesics|mesh-ancestor
2863495|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
2863496|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863497|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2863498|NCT03768908|Artesunate|artesunate|mesh-list
2863499|NCT03768908|Lumefantrine|lumefantrine|mesh-list
2863500|NCT03768908|Artemether|artemether|mesh-list
2863501|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2863502|NCT03768908|Amodiaquine|amodiaquine|mesh-list
2863503|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
2863504|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2863505|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2863506|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863507|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863508|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
2863509|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
2863510|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2863511|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
2863512|NCT03768882|Acetaminophen|acetaminophen|mesh-list
2863513|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2863514|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2863515|NCT03768882|Analgesics|analgesics|mesh-ancestor
2307863|NCT00317811|Bortezomib|bortezomib|mesh-list
2307864|NCT00317811|Melphalan|melphalan|mesh-list
2307865|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863516|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
2863517|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863518|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863519|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
2863520|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2863521|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2863522|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2863523|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2863524|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2863525|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863526|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
2863527|NCT03768713|Suvorexant|suvorexant|mesh-list
2863528|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2863529|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2863530|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863531|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863532|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2307866|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2307867|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
2307868|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307869|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2307870|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307871|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
2863533|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2863534|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863535|NCT03768609|Cyclosporine|cyclosporine|mesh-list
2863536|NCT03768609|Cyclosporins|cyclosporins|mesh-list
2863537|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863538|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863539|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2863540|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
2863541|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863542|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
2863543|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863544|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
2863545|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2863546|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2863547|NCT03768596|Vaccines|vaccines|mesh-list
2863548|NCT03768596|Immunologic Factors|immunologic factors|mesh-ancestor
2863549|NCT03768596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863550|NCT03768557|Minocycline|minocycline|mesh-list
2863551|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2863552|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863553|NCT03768531|Nivolumab|nivolumab|mesh-list
2863554|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2863555|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863556|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2863557|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863558|NCT03768518|Exenatide|exenatide|mesh-list
2863559|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2863560|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863561|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2863562|NCT03768518|Incretins|incretins|mesh-ancestor
2863563|NCT03768518|Hormones|hormones|mesh-ancestor
2863564|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863565|NCT03768492|Caffeine|caffeine|mesh-list
2863566|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2863567|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863568|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2863569|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863570|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863571|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2307872|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307873|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
2307874|NCT00317811|Protective Agents|protective agents|mesh-ancestor
2307875|NCT00317811|Vitamins|vitamins|mesh-ancestor
2307876|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
2307877|NCT00317850|Gabapentin|gabapentin|mesh-list
2307878|NCT00317850|Analgesics|analgesics|mesh-ancestor
2863572|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2863573|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
2863574|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2863575|NCT03768440|Ropivacaine|ropivacaine|mesh-list
2863576|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
2863577|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
2863578|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863579|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307879|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
2307880|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307881|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307882|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
2863580|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
2863581|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863582|NCT03768427|Atorvastatin|atorvastatin|mesh-list
2863583|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2863584|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2863585|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
2863586|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863587|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2863588|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2863589|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863590|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
2863591|NCT03768258|Anastrozole|anastrozole|mesh-list
2863592|NCT03768258|Testosterone|testosterone|mesh-list
2863593|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
2863594|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
2863595|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2863596|NCT03768258|Androgens|androgens|mesh-ancestor
2863597|NCT03768258|Hormones|hormones|mesh-ancestor
2863598|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863599|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863600|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2863601|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863602|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
2863603|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2863604|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2863605|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863606|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863607|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2863608|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
2863609|NCT03768089|Ivacaftor|ivacaftor|mesh-list
2307883|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2307884|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2307885|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2307886|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2307887|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2307888|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2307889|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2307890|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863610|NCT03768089|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2863611|NCT03768089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2863612|NCT03768089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863613|NCT03768037|Pemetrexed|pemetrexed|mesh-list
2863614|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863615|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863616|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863617|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2863618|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2863619|NCT03768024|Hydromorphone|hydromorphone|mesh-list
2863620|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2863621|NCT03768024|Narcotics|narcotics|mesh-ancestor
2863622|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863623|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863624|NCT03768024|Analgesics|analgesics|mesh-ancestor
2863625|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
2863626|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863627|NCT03767920|Dexamethasone|dexamethasone|mesh-list
2863628|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
2863629|NCT03767920|Bupivacaine|bupivacaine|mesh-list
2863630|NCT03767920|BB 1101|bb 1101|mesh-list
2863631|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2863632|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
2863633|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
2863634|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863635|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863636|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2863637|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
2863638|NCT03767920|Hormones|hormones|mesh-ancestor
2863639|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863640|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2863641|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863642|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
2863643|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863644|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307891|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
2863645|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
2863646|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
2863647|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863648|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
2863649|NCT03767660|Sirolimus|sirolimus|mesh-list
2863650|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2863651|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863652|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2863653|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863654|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
2863655|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2863656|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
2863657|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863666|NCT03767569|Folic Acid|folic acid|mesh-list
2863667|NCT03767569|Inositol|inositol|mesh-list
2863668|NCT03767569|Hematinics|hematinics|mesh-ancestor
2863669|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
2863670|NCT03767569|Vitamins|vitamins|mesh-ancestor
2863671|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
2863672|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863673|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
2863674|NCT03767543|Lixisenatide|lixisenatide|mesh-list
2863675|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2863676|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863677|NCT03767504|Thymol|thymol|mesh-list
2863678|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863679|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2863680|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
2307892|NCT00317876|Cyclosporine|cyclosporine|mesh-list
2307893|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
2307894|NCT00317876|Methotrexate|methotrexate|mesh-list
2307895|NCT00317876|Cyclosporins|cyclosporins|mesh-list
2863681|NCT03767439|Nivolumab|nivolumab|mesh-list
2863682|NCT03767439|Ipilimumab|ipilimumab|mesh-list
2863683|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2863684|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863685|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2863686|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863692|NCT03767335|Trastuzumab|trastuzumab|mesh-list
2863693|NCT03767335|Fulvestrant|fulvestrant|mesh-list
2863694|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2863695|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863696|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2307896|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2307897|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
2307898|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307899|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2307900|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2307901|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
2307902|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307903|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2307904|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2307905|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2307906|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
2307907|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2307908|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2307909|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
2307910|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
2307911|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307912|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2307913|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2307914|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
2307915|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863697|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2863698|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2863699|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
2863700|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863701|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863702|NCT03767322|Allopurinol|allopurinol|mesh-list
2307916|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2307917|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
2307918|NCT00317902|Hematinics|hematinics|mesh-ancestor
2307919|NCT00317915|Irbesartan|irbesartan|mesh-list
2307920|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2307921|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2307922|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2307923|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307924|NCT00317928|Metformin|metformin|mesh-list
2307925|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2307926|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307927|NCT00317954|Spironolactone|spironolactone|mesh-list
2307928|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2307929|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
2307930|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2307931|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307932|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2307933|NCT00317954|Diuretics|diuretics|mesh-ancestor
2307934|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
2307935|NCT00317967|Atorvastatin|atorvastatin|mesh-list
2307936|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2307937|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2307938|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
2307939|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307940|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2307941|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2307942|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307943|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2863703|NCT03767322|Febuxostat|febuxostat|mesh-list
2863704|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
2307944|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2307945|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2863705|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863706|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863707|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
2307946|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307947|NCT00317993|Simvastatin|simvastatin|mesh-list
2307948|NCT00317993|Ezetimibe|ezetimibe|mesh-list
2307949|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2307950|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2307951|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
2307952|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307953|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2307954|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2307955|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307956|NCT00318084|Esomeprazole|esomeprazole|mesh-list
2307957|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2307958|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2307959|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2307960|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863708|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2863709|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2307961|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307962|NCT00318162|Naltrexone|naltrexone|mesh-list
2307963|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2307964|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2307965|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307966|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
2307967|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2307968|NCT00318175|Bosentan|bosentan|mesh-list
2307969|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2307970|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2307971|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307972|NCT00318201|Erythromycin|erythromycin|mesh-list
2307973|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
2307974|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2307975|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
2307976|NCT00318201|Diltiazem|diltiazem|mesh-list
2307977|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2307978|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2307979|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2307980|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2307981|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2307982|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307983|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
2307984|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2307985|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2307986|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2863710|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
2863711|NCT03767322|Protective Agents|protective agents|mesh-ancestor
2863712|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863713|NCT03767296|Phenylephrine|phenylephrine|mesh-list
2863714|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
2863715|NCT03767296|Ephedrine|ephedrine|mesh-list
2863716|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
2863717|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2863718|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
2863719|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
2863720|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863721|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307987|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2307988|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2307989|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2307990|NCT00318318|Estrogens|estrogens|mesh-ancestor
2307991|NCT00318318|Hormones|hormones|mesh-ancestor
2307992|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863722|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
2863723|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2863724|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
2863725|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
2863726|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2863727|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2863728|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2863729|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
2863730|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2863731|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863732|NCT03767296|Protective Agents|protective agents|mesh-ancestor
2863733|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2863734|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2863735|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2863736|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2863737|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2863738|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2863739|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
2863740|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863741|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2863742|NCT03767075|Atezolizumab|atezolizumab|mesh-list
2863743|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863744|NCT03767036|Ketorolac|ketorolac|mesh-list
2863745|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2863746|NCT03767036|Tramadol|tramadol|mesh-list
2863747|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2863748|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2863749|NCT03767036|Analgesics|analgesics|mesh-ancestor
2863750|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
2863751|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863752|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863753|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2863754|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2863755|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2863756|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863757|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863758|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2863759|NCT03767036|Narcotics|narcotics|mesh-ancestor
2863760|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863761|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
2863762|NCT03766997|Betamethasone|betamethasone|mesh-list
2863763|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
2307993|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307994|NCT00318383|Vaccines|vaccines|mesh-list
2307995|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
2307996|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2307997|NCT00318422|Liraglutide|liraglutide|mesh-list
2307998|NCT00318422|Glimepiride|glimepiride|mesh-list
2307999|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
2308000|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2308001|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308002|NCT00318422|Incretins|incretins|mesh-ancestor
2308003|NCT00318422|Hormones|hormones|mesh-ancestor
2308004|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2308005|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2308006|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2308007|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
2308008|NCT00318448|Zolpidem|zolpidem|mesh-list
2308009|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2308010|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2308011|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2308012|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308013|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2308014|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
2308015|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
2308016|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308017|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308018|NCT00318513|Bevacizumab|bevacizumab|mesh-list
2308019|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2308020|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308021|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2308022|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2308023|NCT00318513|Growth Substances|growth substances|mesh-ancestor
2863764|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2863765|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
2863766|NCT03766997|Hormones|hormones|mesh-ancestor
2863767|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863768|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863769|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2863770|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
2863771|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
2863772|NCT03766984|Diclofenac|diclofenac|mesh-list
2863773|NCT03766984|Tramadol|tramadol|mesh-list
2863774|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2863775|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2863776|NCT03766984|Analgesics|analgesics|mesh-ancestor
2863777|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
2863778|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863779|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863780|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2863781|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2863782|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2863783|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863784|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863785|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2863786|NCT03766984|Narcotics|narcotics|mesh-ancestor
2863787|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2308024|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308025|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
2308026|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2308027|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
2308028|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2308029|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2308030|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2308031|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2308032|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308033|NCT00318552|Meropenem|meropenem|mesh-list
2308034|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2863788|NCT03766893|Naltrexone|naltrexone|mesh-list
2863789|NCT03766893|Buprenorphine|buprenorphine|mesh-list
2863790|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2863791|NCT03766893|Naloxone|naloxone|mesh-list
2863792|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2863793|NCT03766893|Narcotics|narcotics|mesh-ancestor
2308035|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2308036|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
2308037|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2863794|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863795|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863796|NCT03766893|Analgesics|analgesics|mesh-ancestor
2863797|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
2863798|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863799|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2863800|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2863801|NCT03766867|Vortioxetine|vortioxetine|mesh-list
2863802|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
2863803|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2863804|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2863805|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2863806|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863807|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863808|NCT03766867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2863809|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2863810|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2863811|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863812|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2863813|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
2863814|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2863815|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2863816|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2863817|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2863818|NCT03766854|Insulin|insulin|mesh-list
2863819|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2863820|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
2863821|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2863822|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863823|NCT03766763|Venetoclax|venetoclax|mesh-list
2863824|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863825|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
2863826|NCT03766750|Linagliptin|linagliptin|mesh-list
2308038|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308039|NCT00318669|Paroxetine|paroxetine|mesh-list
2308040|NCT00318669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2308041|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2308042|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2308043|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308044|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308045|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
2863827|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2308046|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308047|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2308048|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
2308049|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2308050|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2308051|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2308052|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308053|NCT00318760|Clonidine|clonidine|mesh-list
2308054|NCT00318760|Analgesics|analgesics|mesh-ancestor
2308055|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
2308056|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308057|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308058|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2308059|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
2308060|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
2308061|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2308062|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2308063|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2308064|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
2308065|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308066|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308067|NCT00318773|Sertraline|sertraline|mesh-list
2308068|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
2308069|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2308070|NCT00318773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2308071|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2308072|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2308073|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863828|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863829|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2863830|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863831|NCT03766750|Incretins|incretins|mesh-ancestor
2863832|NCT03766750|Hormones|hormones|mesh-ancestor
2863833|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863834|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2863835|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
2863836|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863837|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
2863838|NCT03766724|Empagliflozin|empagliflozin|mesh-list
2308074|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308075|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
2863839|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2863840|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863841|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2863842|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863843|NCT03766607|Paclitaxel|paclitaxel|mesh-list
2863844|NCT03766607|Trastuzumab|trastuzumab|mesh-list
2863845|NCT03766607|Ramucirumab|ramucirumab|mesh-list
2863846|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2863847|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863848|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
2863849|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
2863850|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
2308076|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308077|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
2308078|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
2308079|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2308080|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308081|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
2308082|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2308083|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
2308084|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
2308085|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2308086|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308087|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2308088|NCT00318825|Analgesics|analgesics|mesh-ancestor
2308089|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
2308090|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308091|NCT00318838|Azimilide|azimilide|mesh-list
2308092|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2308093|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2308094|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2308095|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863851|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863852|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2863853|NCT03766594|Folic Acid|folic acid|mesh-list
2863854|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
2863855|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863856|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
2863857|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2863858|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2863859|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863860|NCT03766594|Urological Agents|urological agents|mesh-ancestor
2863861|NCT03766594|Hematinics|hematinics|mesh-ancestor
2863862|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
2863863|NCT03766594|Vitamins|vitamins|mesh-ancestor
2863864|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
2863865|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863866|NCT03766581|Aspirin|aspirin|mesh-list
2863867|NCT03766581|Clopidogrel|clopidogrel|mesh-list
2863868|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2308096|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2308097|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308098|NCT00318890|Docetaxel|docetaxel|mesh-list
2308099|NCT00318890|Amifostine|amifostine|mesh-list
2308100|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308101|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
2308102|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
2863869|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2863870|NCT03766581|Analgesics|analgesics|mesh-ancestor
2863871|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
2863872|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863873|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863874|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2863875|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2863876|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2863877|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2863878|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863879|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2863880|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2863881|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863882|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
2863883|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2863884|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2863885|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2863886|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
2863887|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2863888|NCT03766490|Gefitinib|gefitinib|mesh-list
2863889|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863890|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2863891|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863892|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863893|NCT03766425|Aflibercept|aflibercept|mesh-list
2108537|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108538|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108539|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
2108540|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108541|NCT02505269|Doxorubicin|doxorubicin|mesh-list
2863894|NCT03766425|Mitomycins|mitomycins|mesh-list
2863895|NCT03766425|Mitomycin|mitomycin|mesh-list
2863896|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2863897|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2863898|NCT03766425|Growth Substances|growth substances|mesh-ancestor
2863899|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863900|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
2863901|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863902|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2863903|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
2863904|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863905|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2863906|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863907|NCT03766295|Gemcitabine|gemcitabine|mesh-list
2863908|NCT03766295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2863909|NCT03766295|Antimetabolites|antimetabolites|mesh-ancestor
2308103|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
2863910|NCT03766295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108542|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2108543|NCT02505269|Dacarbazine|dacarbazine|mesh-list
2308104|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863911|NCT03766295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863912|NCT03766295|Antiviral Agents|antiviral agents|mesh-ancestor
2863913|NCT03766295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863914|NCT03766295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863915|NCT03766295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2863916|NCT03766295|Immunologic Factors|immunologic factors|mesh-ancestor
2863917|NCT03766295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863918|NCT03766269|Dronabinol|dronabinol|mesh-list
2863919|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
2863920|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863921|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2863922|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2863923|NCT03766269|Analgesics|analgesics|mesh-ancestor
2863924|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
2863925|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2863926|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2863927|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2863928|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2863929|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863930|NCT03766269|Hormones|hormones|mesh-ancestor
2863931|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863932|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
2863933|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2863934|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308105|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2308106|NCT00318890|Protective Agents|protective agents|mesh-ancestor
2308107|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308108|NCT00318903|Docetaxel|docetaxel|mesh-list
2308109|NCT00318903|Irinotecan|irinotecan|mesh-list
2308110|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863946|NCT03766074|Vitamin D|vitamin d|mesh-list
2863947|NCT03766074|Vitamins|vitamins|mesh-ancestor
2863948|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
2863949|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863950|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2863951|NCT03765983|Trastuzumab|trastuzumab|mesh-list
2863952|NCT03765983|GDC-0084|gdc-0084|mesh-list
2863953|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2863954|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863955|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2863956|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308111|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
2863957|NCT03765944|Sirolimus|sirolimus|mesh-list
2863958|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2863959|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863960|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2863961|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863962|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
2863963|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2863964|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
2863965|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863966|NCT03765931|Amoxicillin|amoxicillin|mesh-list
2863967|NCT03765931|Doxycycline|doxycycline|mesh-list
2863968|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2863969|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2863970|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
2863971|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2863972|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2863973|NCT03765827|Vitamins|vitamins|mesh-list
2863974|NCT03765827|Vitamin E|vitamin e|mesh-list
2863975|NCT03765827|Tocopherols|tocopherols|mesh-list
2863976|NCT03765827|Tocotrienols|tocotrienols|mesh-list
2863977|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
2863978|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
2863979|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863980|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
2863981|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2863982|NCT03765827|Protective Agents|protective agents|mesh-ancestor
2863983|NCT03765788|Prednisolone|prednisolone|mesh-list
2863984|NCT03765788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2863985|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2863986|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
2863987|NCT03765788|Hormones|hormones|mesh-ancestor
2863988|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2863989|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863990|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2863991|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2863992|NCT03765788|Immunologic Factors|immunologic factors|mesh-ancestor
2863993|NCT03765697|Lidocaine|lidocaine|mesh-list
2863994|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
2863995|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
2863996|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2863997|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2863998|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
2863999|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864000|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2864001|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2864002|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2864003|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2864004|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864005|NCT03765645|Tazobactam|tazobactam|mesh-list
2864006|NCT03765645|Piperacillin|piperacillin|mesh-list
2864007|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2864008|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2864009|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864010|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2308112|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
2308113|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
2308114|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308115|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2308116|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2308117|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308118|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
2308119|NCT00318955|Propofol|propofol|mesh-list
2308120|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2864011|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864012|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864013|NCT03765619|Aspirin|aspirin|mesh-list
2864014|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2864015|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2864016|NCT03765619|Analgesics|analgesics|mesh-ancestor
2864017|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
2864018|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864019|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864020|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2864021|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2864022|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2864023|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2864024|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864025|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2864026|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2864027|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864028|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
2864029|NCT03765554|PF-06700841|pf-06700841|mesh-list
2864030|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2864031|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864032|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864033|NCT03765541|Cytarabine|cytarabine|mesh-list
2864034|NCT03765541|Dexamethasone|dexamethasone|mesh-list
2864035|NCT03765541|Azacitidine|azacitidine|mesh-list
2864036|NCT03765541|Amsacrine|amsacrine|mesh-list
2864037|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2864038|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
2864039|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
2864040|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864041|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864042|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2864043|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
2864044|NCT03765541|Hormones|hormones|mesh-ancestor
2864045|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864046|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2864047|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864048|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2864049|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
2864050|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864051|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
2864052|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864053|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2864054|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
2864055|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864056|NCT03765450|Infliximab|infliximab|mesh-list
2864057|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
2308121|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2308122|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308123|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2308124|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
2308125|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
2308126|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2308127|NCT00318955|Analgesics|analgesics|mesh-ancestor
2308128|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
2308129|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308130|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2308131|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2308132|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2864058|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2864059|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2864060|NCT03765346|Oxycodone|oxycodone|mesh-list
2864061|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2864062|NCT03765346|Narcotics|narcotics|mesh-ancestor
2864063|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864064|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864065|NCT03765346|Analgesics|analgesics|mesh-ancestor
2864066|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
2864067|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864068|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
2864069|NCT03765229|Entinostat|entinostat|mesh-list
2864070|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2864071|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864072|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2864073|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864074|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864075|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
2864076|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2864077|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2864078|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864079|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
2864080|NCT03765021|Coagulants|coagulants|mesh-ancestor
2864081|NCT03764722|Simendan|simendan|mesh-list
2864082|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2864083|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
2864084|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2864085|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2864086|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864087|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308133|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
2308134|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308135|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864088|NCT03764722|Protective Agents|protective agents|mesh-ancestor
2864089|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864090|NCT03764683|Suvorexant|suvorexant|mesh-list
2864091|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2864092|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2864093|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864094|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864095|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2864096|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864097|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864098|NCT03764631|Empagliflozin|empagliflozin|mesh-list
2308136|NCT00318968|Esomeprazole|esomeprazole|mesh-list
2308137|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2308138|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2308139|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2308140|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308141|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308142|NCT00318981|Methylphenidate|methylphenidate|mesh-list
2308143|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2308144|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308145|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2308146|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2308147|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2308148|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308149|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
2308150|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308151|NCT00318994|Meropenem|meropenem|mesh-list
2308152|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2308153|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2308154|NCT00319007|Sulindac|sulindac|mesh-list
2308155|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2308156|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2308157|NCT00319007|Analgesics|analgesics|mesh-ancestor
2864099|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2864100|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2864101|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864102|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2864103|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864104|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
2864105|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864106|NCT03764605|Metformin|metformin|mesh-list
2864107|NCT03764605|Tolvaptan|tolvaptan|mesh-list
2864108|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2864109|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864110|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2864111|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864112|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
2864113|NCT03764553|Leucovorin|leucovorin|mesh-list
2864114|NCT03764553|Carboplatin|carboplatin|mesh-list
2864115|NCT03764553|Fluorouracil|fluorouracil|mesh-list
2864116|NCT03764553|Capecitabine|capecitabine|mesh-list
2864117|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
2864118|NCT03764553|Irinotecan|irinotecan|mesh-list
2864119|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864120|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
2864121|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864122|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2864123|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2864124|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
2864125|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864126|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2864127|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2864128|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864129|NCT03764553|Antidotes|antidotes|mesh-ancestor
2864130|NCT03764553|Protective Agents|protective agents|mesh-ancestor
2864131|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
2864132|NCT03764553|Vitamins|vitamins|mesh-ancestor
2864133|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
2864134|NCT03764540|Prednisone|prednisone|mesh-list
2864135|NCT03764540|Docetaxel|docetaxel|mesh-list
2864136|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308158|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
2308159|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308160|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864137|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
2864138|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
2864139|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
2864140|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864141|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2864142|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
2308161|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2308162|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2308163|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308164|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2308165|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308166|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308167|NCT00319033|Bosentan|bosentan|mesh-list
2308168|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2864143|NCT03764540|Hormones|hormones|mesh-ancestor
2864144|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864145|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308169|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2308170|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308171|NCT00319059|Annexin A5|annexin a5|mesh-list
2308172|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308173|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308174|NCT00319072|Hormones|hormones|mesh-list
2308175|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2308176|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308177|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
2308178|NCT00319150|Hematinics|hematinics|mesh-ancestor
2308179|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
2308180|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2308181|NCT00319163|Estradiol|estradiol|mesh-list
2308182|NCT00319163|Estrogens|estrogens|mesh-ancestor
2308183|NCT00319163|Hormones|hormones|mesh-ancestor
2864146|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2864147|NCT03764527|Artesunate|artesunate|mesh-list
2864148|NCT03764527|Lumefantrine|lumefantrine|mesh-list
2864149|NCT03764527|Artemether|artemether|mesh-list
2864150|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2864151|NCT03764527|Amodiaquine|amodiaquine|mesh-list
2864152|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
2864153|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2864154|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2864155|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864156|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308184|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2308185|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308186|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2308187|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
2308188|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2308189|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2308190|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2308191|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2308192|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2308193|NCT00319189|Nateglinide|nateglinide|mesh-list
2308194|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2308195|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308196|NCT00319202|Candesartan|candesartan|mesh-list
2308197|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2308198|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2308199|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2308200|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308201|NCT00319215|Zopiclone|zopiclone|mesh-list
2308202|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2308203|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2308204|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308205|NCT00319267|Bosentan|bosentan|mesh-list
2308206|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2308207|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2308208|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308209|NCT00319293|Metformin|metformin|mesh-list
2308210|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2308211|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308212|NCT00319306|Budesonide|budesonide|mesh-list
2308213|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
2308214|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2308215|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2308216|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2308217|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
2864157|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
2864158|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
2864159|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2864160|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
2864161|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
2864162|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2864163|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864164|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2864165|NCT03764462|AD 101|ad 101|mesh-list
2864166|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2864167|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
2308218|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308219|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308220|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2308221|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
2308222|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
2308223|NCT00319306|Hormones|hormones|mesh-ancestor
2864168|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864169|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864170|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2864171|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2864172|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2864173|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2864174|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864175|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2308224|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2308225|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2308226|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2308227|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2308228|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
2308229|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308230|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308231|NCT00319319|Mecamylamine|mecamylamine|mesh-list
2308232|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2308233|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2308234|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
2308235|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308236|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308237|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2308238|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2864176|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2864177|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
2864178|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864179|NCT03764293|Sorafenib|sorafenib|mesh-list
2864180|NCT03764293|Apatinib|apatinib|mesh-list
2864181|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864182|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2864183|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864184|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864185|NCT03764280|Insulin|insulin|mesh-list
2864186|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
2864187|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2864188|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864189|NCT03764267|Lidocaine|lidocaine|mesh-list
2864190|NCT03764267|Remifentanil|remifentanil|mesh-list
2864191|NCT03764267|Anesthetics|anesthetics|mesh-list
2864192|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
2864193|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
2864194|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864195|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864196|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
2864197|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864198|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2864199|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2864200|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2864201|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2864202|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864203|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2864204|NCT03764267|Narcotics|narcotics|mesh-ancestor
2864205|NCT03764267|Analgesics|analgesics|mesh-ancestor
2864206|NCT03764241|Vitamin K|vitamin k|mesh-list
2864207|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
2864208|NCT03764241|Vitamins|vitamins|mesh-ancestor
2864209|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
2864210|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864211|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2864212|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
2864213|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2864214|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
2864215|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864216|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308239|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
2308240|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308241|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308242|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
2308243|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308244|NCT00319345|Mannitol|mannitol|mesh-list
2308245|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2308246|NCT00319345|Diuretics|diuretics|mesh-ancestor
2308247|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
2308248|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308249|NCT00319358|Antioxidants|antioxidants|mesh-list
2308250|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308251|NCT00319358|Protective Agents|protective agents|mesh-ancestor
2308252|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308253|NCT00319488|Budesonide|budesonide|mesh-list
2308254|NCT00319488|Albuterol|albuterol|mesh-list
2308255|NCT00319488|Montelukast|montelukast|mesh-list
2308256|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
2308257|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2308258|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2308259|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
2864217|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
2864218|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2864219|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2864220|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
2864221|NCT03764241|Coagulants|coagulants|mesh-ancestor
2864222|NCT03764202|Sufentanil|sufentanil|mesh-list
2864223|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2864224|NCT03764202|Narcotics|narcotics|mesh-ancestor
2864225|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864226|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864227|NCT03764202|Analgesics|analgesics|mesh-ancestor
2864228|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
2864229|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864230|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2864231|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2308260|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864232|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
2864233|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
2864234|NCT03764163|Xenon|xenon|mesh-list
2864235|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2864236|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
2864237|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
2864238|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864239|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864240|NCT03764098|Guanfacine|guanfacine|mesh-list
2864241|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2864242|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2864243|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2864244|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2864245|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
2864246|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864247|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864248|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864249|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
2864250|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2864251|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864252|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
2864253|NCT03764020|Melatonin|melatonin|mesh-list
2864254|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
2308261|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308262|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2308263|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
2308264|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
2308265|NCT00319488|Hormones|hormones|mesh-ancestor
2308266|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2308267|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
2308268|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2308269|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2308270|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308271|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
2308272|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2308273|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2308274|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2308275|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2308276|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
2308277|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308278|NCT00319514|Docetaxel|docetaxel|mesh-list
2308279|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308280|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
2308281|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
2308282|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
2308283|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308284|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2308285|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
2308286|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2308287|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2308288|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2864255|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864256|NCT03764020|Protective Agents|protective agents|mesh-ancestor
2864257|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864258|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864259|NCT03763786|Cetrorelix|cetrorelix|mesh-list
2864260|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2864261|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
2864262|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2864263|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864264|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
2864265|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864266|NCT03763760|Dexamethasone|dexamethasone|mesh-list
2864267|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2864268|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
2864269|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
2864270|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864271|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864272|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2864273|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
2864274|NCT03763760|Hormones|hormones|mesh-ancestor
2864275|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864276|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2864277|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864278|NCT03763734|Dexamethasone|dexamethasone|mesh-list
2864279|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2864280|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
2864281|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
2308289|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2308290|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
2308291|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2308292|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308293|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2308294|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2308295|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2864282|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864283|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864284|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2864285|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
2864286|NCT03763734|Hormones|hormones|mesh-ancestor
2864287|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864288|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2864289|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864290|NCT03763669|Folic Acid|folic acid|mesh-list
2864291|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
2864292|NCT03763669|Inositol|inositol|mesh-list
2864293|NCT03763669|Hematinics|hematinics|mesh-ancestor
2864294|NCT03763669|Vitamins|vitamins|mesh-ancestor
2864295|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
2308296|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2308297|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308298|NCT00319566|Estrogens|estrogens|mesh-ancestor
2308299|NCT00319566|Hormones|hormones|mesh-ancestor
2308300|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2308301|NCT00319605|Levetiracetam|levetiracetam|mesh-list
2308302|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
2308303|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
2308304|NCT00319618|Docetaxel|docetaxel|mesh-list
2308305|NCT00319618|Gefitinib|gefitinib|mesh-list
2308306|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308307|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
2308308|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
2308309|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
2864296|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864297|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
2864298|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864299|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
2864300|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864301|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864302|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2864303|NCT03763409|Losartan|losartan|mesh-list
2864304|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2864305|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2864306|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2864307|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2864308|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864309|NCT03763396|Ketoconazole|ketoconazole|mesh-list
2864310|NCT03763396|Posaconazole|posaconazole|mesh-list
2864311|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
2864312|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864313|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2864314|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2864315|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864316|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864317|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2864318|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
2864319|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864320|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864321|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2864322|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2864323|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2864324|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2864325|NCT03763305|Fentanyl|fentanyl|mesh-list
2864326|NCT03763305|Remifentanil|remifentanil|mesh-list
2864327|NCT03763305|Propofol|propofol|mesh-list
2864328|NCT03763305|Sevoflurane|sevoflurane|mesh-list
2864329|NCT03763305|Desflurane|desflurane|mesh-list
2864330|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2864331|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2864332|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864333|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864334|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2308310|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308311|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2308312|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308313|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2308314|NCT00319670|Laxatives|laxatives|mesh-ancestor
2308315|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2308316|NCT00319683|Eniluracil|eniluracil|mesh-list
2308317|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308318|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308319|NCT00319709|Amibegron|amibegron|mesh-list
2308320|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2864335|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
2864336|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
2864337|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2864338|NCT03763305|Narcotics|narcotics|mesh-ancestor
2864339|NCT03763305|Analgesics|analgesics|mesh-ancestor
2864340|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
2864341|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864342|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2864343|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2864344|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2864345|NCT03763279|Triclosan|triclosan|mesh-list
2864346|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2864347|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864348|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2864349|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2864350|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
2864351|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864352|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2108544|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2108545|NCT02505269|Imidazole|imidazole|mesh-list
2308321|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2308322|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
2864353|NCT03763227|Ranibizumab|ranibizumab|mesh-list
2864354|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
2864355|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2864356|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2864357|NCT03763227|Growth Substances|growth substances|mesh-ancestor
2864358|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864359|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
2864360|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864361|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864362|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864363|NCT03763162|Dexamethasone|dexamethasone|mesh-list
2864364|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
2864365|NCT03763162|Bortezomib|bortezomib|mesh-list
2864366|NCT03763162|Daratumumab|daratumumab|mesh-list
2864367|NCT03763162|Ixazomib|ixazomib|mesh-list
2864368|NCT03763162|Ichthammol|ichthammol|mesh-list
2864369|NCT03763162|BB 1101|bb 1101|mesh-list
2864370|NCT03763162|Glycine|glycine|mesh-list
2864371|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2864372|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
2864373|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
2864374|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864375|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864376|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2864377|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
2864378|NCT03763162|Hormones|hormones|mesh-ancestor
2864379|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864380|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2864381|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864382|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
2864383|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108546|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2108547|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108548|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2108549|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2108550|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108551|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108552|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2108553|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
2108554|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2108555|NCT02505334|Liraglutide|liraglutide|mesh-list
2108556|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2108557|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108558|NCT02505334|Incretins|incretins|mesh-ancestor
2108559|NCT02505334|Hormones|hormones|mesh-ancestor
2864384|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864385|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
2864386|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
2864387|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864388|NCT03763123|Paclitaxel|paclitaxel|mesh-list
2864389|NCT03763123|Topotecan|topotecan|mesh-list
2308323|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308324|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308325|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864390|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2864391|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864392|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
2864393|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
2864394|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
2864395|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864396|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2864397|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2864398|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864399|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2864400|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2864401|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864402|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
2864403|NCT03763084|Acetaminophen|acetaminophen|mesh-list
2864404|NCT03763084|Sufentanil|sufentanil|mesh-list
2864405|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2864406|NCT03763084|Analgesics|analgesics|mesh-ancestor
2864407|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
2864408|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864409|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864410|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
2864411|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2864412|NCT03763084|Narcotics|narcotics|mesh-ancestor
2864413|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864414|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2864415|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2864416|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
2864417|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
2864418|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
2864419|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
2864420|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2864421|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2864422|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864423|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864424|NCT03763045|Urological Agents|urological agents|mesh-ancestor
2864425|NCT03762967|Hormones|hormones|mesh-list
2864426|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864427|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864428|NCT03762928|Efavirenz|efavirenz|mesh-list
2864429|NCT03762928|Midazolam|midazolam|mesh-list
2864430|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2864431|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2864432|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864433|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308326|NCT00319761|Calcitriol|calcitriol|mesh-list
2308327|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2308328|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308329|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2308330|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2308331|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308332|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2308333|NCT00319761|Vitamins|vitamins|mesh-ancestor
2308334|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
2308335|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2308336|NCT00319787|Gefitinib|gefitinib|mesh-list
2308337|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308338|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2308339|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308340|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308341|NCT00319800|Irinotecan|irinotecan|mesh-list
2308342|NCT00319800|Gefitinib|gefitinib|mesh-list
2308343|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2308344|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2308345|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308346|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864434|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2864435|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2864436|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2864437|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2864438|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
2864439|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
2864440|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
2864441|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
2864442|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864443|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864444|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2864445|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2864446|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864447|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
2864448|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864449|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2864450|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2864451|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2864452|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2308347|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308348|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2308349|NCT00319852|Vaccines|vaccines|mesh-list
2864453|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2864454|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2864455|NCT03762915|Minocycline|minocycline|mesh-list
2864456|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2864457|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864458|NCT03762889|Anesthetics|anesthetics|mesh-list
2864459|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864460|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308350|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
2308351|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308352|NCT00319865|Thalidomide|thalidomide|mesh-list
2308353|NCT00319865|Dexamethasone|dexamethasone|mesh-list
2308354|NCT00319865|Doxorubicin|doxorubicin|mesh-list
2308355|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2864461|NCT03762850|Irbesartan|irbesartan|mesh-list
2864462|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2864463|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2864464|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2864465|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308356|NCT00319865|Bortezomib|bortezomib|mesh-list
2308357|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2308358|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
2308359|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
2308360|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308361|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308362|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2308363|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
2308364|NCT00319865|Hormones|hormones|mesh-ancestor
2864466|NCT03762824|Vaccines|vaccines|mesh-list
2864467|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2864468|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
2864469|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864470|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
2864471|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2864472|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864473|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864474|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2864475|NCT03762785|Analgesics|analgesics|mesh-ancestor
2864476|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
2864477|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864478|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2864479|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2864480|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2864481|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
2864482|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864483|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308365|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2308366|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2308367|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308368|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2308369|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2308370|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2864484|NCT03762759|Edetic Acid|edetic acid|mesh-list
2864485|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2864486|NCT03762759|Anticoagulants|anticoagulants|mesh-ancestor
2864487|NCT03762759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2864488|NCT03762759|Chelating Agents|chelating agents|mesh-ancestor
2864489|NCT03762759|Sequestering Agents|sequestering agents|mesh-ancestor
2864490|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864491|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2864492|NCT03762564|Paclitaxel|paclitaxel|mesh-list
2864493|NCT03762564|Ramucirumab|ramucirumab|mesh-list
2864494|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2864495|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864496|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
2864497|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
2864498|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
2864499|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864500|NCT03762538|Propofol|propofol|mesh-list
2864501|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2864502|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864503|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864504|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2864505|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
2864506|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
2864507|NCT03762473|Tacrolimus|tacrolimus|mesh-list
2864508|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2864509|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
2864510|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864511|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2864512|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864513|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864514|NCT03762395|CXA-10|cxa-10|mesh-list
2864515|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2864516|NCT03762382|Tenofovir|tenofovir|mesh-list
2864517|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
2864518|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
2864519|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864520|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2864521|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2864522|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864523|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864524|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2864525|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2864526|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2864527|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
2864528|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2864529|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308371|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308372|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308373|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2308374|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
2308375|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
2308376|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2308377|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2308378|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2308379|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2308380|NCT00319865|Growth Substances|growth substances|mesh-ancestor
2308381|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
2308382|NCT00319878|Cyclosporine|cyclosporine|mesh-list
2308383|NCT00319878|Sirolimus|sirolimus|mesh-list
2308384|NCT00319878|Cyclosporins|cyclosporins|mesh-list
2308385|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308386|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864530|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2864531|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2864532|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2864533|NCT03762369|Latanoprost|latanoprost|mesh-list
2864534|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2864535|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2864536|NCT03762317|Clonidine|clonidine|mesh-list
2864537|NCT03762317|Analgesics|analgesics|mesh-ancestor
2864538|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
2864539|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864540|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864541|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2308387|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2308388|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
2864542|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
2864543|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
2864544|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2308389|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308390|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
2308391|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864545|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2864546|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2864547|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
2864548|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864549|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864550|NCT03762226|Bevacizumab|bevacizumab|mesh-list
2864551|NCT03762226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2864552|NCT03762226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864553|NCT03762226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2864554|NCT03762226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2864555|NCT03762226|Growth Substances|growth substances|mesh-ancestor
2864556|NCT03762226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864557|NCT03762226|Growth Inhibitors|growth inhibitors|mesh-ancestor
2864558|NCT03762148|Vitamins|vitamins|mesh-list
2864559|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
2864560|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
2864561|NCT03762148|Iron|iron|mesh-list
2864562|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
2864563|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864564|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
2864565|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864566|NCT03762148|Protective Agents|protective agents|mesh-ancestor
2864567|NCT03762148|Trace Elements|trace elements|mesh-ancestor
2864568|NCT03762109|Dantrolene|dantrolene|mesh-list
2864569|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2864570|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864571|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2864572|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864573|NCT03762096|Resveratrol|resveratrol|mesh-list
2864574|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
2864575|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864576|NCT03762096|Protective Agents|protective agents|mesh-ancestor
2864577|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864578|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864579|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2864580|NCT03762018|Bevacizumab|bevacizumab|mesh-list
2864581|NCT03762018|Carboplatin|carboplatin|mesh-list
2864582|NCT03762018|Pemetrexed|pemetrexed|mesh-list
2864583|NCT03762018|Atezolizumab|atezolizumab|mesh-list
2864584|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2864585|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864586|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2864587|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2864588|NCT03762018|Growth Substances|growth substances|mesh-ancestor
2864589|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864590|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
2864591|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864592|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308392|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
2308393|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2308394|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2308395|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2308396|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2308397|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308398|NCT00319917|Tacrolimus|tacrolimus|mesh-list
2308399|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2308400|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
2308401|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308402|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2308403|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308404|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308405|NCT00319969|Topotecan|topotecan|mesh-list
2308406|NCT00319969|Amrubicin|amrubicin|mesh-list
2308407|NCT00319969|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2308408|NCT00319969|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2308409|NCT00319969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308410|NCT00319969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308411|NCT00319969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308412|NCT00319995|Loratadine|loratadine|mesh-list
2308413|NCT00319995|Montelukast|montelukast|mesh-list
2308414|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2308415|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
2308416|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2308417|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
2308418|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2308419|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308420|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2308421|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2864593|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2864594|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2864595|NCT03761953|Oritavancin|oritavancin|mesh-list
2864596|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2864597|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864598|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
2864599|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2864600|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864601|NCT03761511|Niacinamide|niacinamide|mesh-list
2864602|NCT03761511|Niacin|niacin|mesh-list
2864603|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
2864604|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
2864605|NCT03761511|Vitamins|vitamins|mesh-ancestor
2864606|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
2864607|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864608|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2864609|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
2864610|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864611|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2864612|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
2864613|NCT03761485|Fluorides|fluorides|mesh-list
2864614|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
2864615|NCT03761485|Protective Agents|protective agents|mesh-ancestor
2864616|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864617|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
2864618|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2864619|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
2864620|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864621|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
2864622|NCT03761472|Protective Agents|protective agents|mesh-ancestor
2864623|NCT03761329|Lidocaine|lidocaine|mesh-list
2864624|NCT03761329|Anesthetics|anesthetics|mesh-list
2864625|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
2864626|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864627|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864628|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
2864629|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864630|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2308422|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308423|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
2308424|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
2308425|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2308426|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2308427|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2308428|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
2308429|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
2308430|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308431|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
2308432|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
2308433|NCT00320021|Vitamins|vitamins|mesh-ancestor
2308434|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
2308435|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308436|NCT00320034|Albuterol|albuterol|mesh-list
2308437|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2308438|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
2308439|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308440|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308441|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2308442|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
2308443|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
2308444|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2308445|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2308446|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2308447|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2308448|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
2308449|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864631|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2864632|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2864633|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2864634|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864635|NCT03761264|Amoxicillin|amoxicillin|mesh-list
2864636|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
2864637|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864638|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2864639|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864640|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
2864641|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
2864642|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2864643|NCT03761264|Protective Agents|protective agents|mesh-ancestor
2864644|NCT03761225|Prednisone|prednisone|mesh-list
2864645|NCT03761225|Docetaxel|docetaxel|mesh-list
2864646|NCT03761225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864647|NCT03761225|Tubulin Modulators|tubulin modulators|mesh-ancestor
2864648|NCT03761225|Antimitotic Agents|antimitotic agents|mesh-ancestor
2864649|NCT03761225|Mitosis Modulators|mitosis modulators|mesh-ancestor
2864650|NCT03761225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864651|NCT03761225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2864652|NCT03761225|Glucocorticoids|glucocorticoids|mesh-ancestor
2864653|NCT03761225|Hormones|hormones|mesh-ancestor
2864654|NCT03761225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864655|NCT03761225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864656|NCT03761225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2864657|NCT03761134|Metformin|metformin|mesh-list
2864658|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2864659|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2864660|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864661|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2864662|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864663|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
2864664|NCT03761056|Fludarabine|fludarabine|mesh-list
2864665|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2864666|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
2864667|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864668|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2864669|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2864670|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
2864671|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864672|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864673|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2864674|NCT03761030|Levodopa|levodopa|mesh-list
2864675|NCT03761030|Carbidopa|carbidopa|mesh-list
2864676|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2864677|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2864678|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2864679|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
2864680|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864681|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864682|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864683|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2864684|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864685|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2864686|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
2864687|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
2864688|NCT03761004|Levodopa|levodopa|mesh-list
2308450|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308451|NCT00320047|Baclofen|baclofen|mesh-list
2308452|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2308453|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308454|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2308455|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308456|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2864689|NCT03761004|Carbidopa|carbidopa|mesh-list
2864690|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2864691|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2864692|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2864693|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
2864694|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864695|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864696|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864697|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2864698|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864699|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2864700|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
2864701|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
2308457|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
2308458|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
2308459|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308460|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308461|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
2308462|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
2308463|NCT00320060|Vitamins|vitamins|mesh-ancestor
2308464|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
2308465|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308466|NCT00320073|Pemetrexed|pemetrexed|mesh-list
2308467|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2864702|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
2864703|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2864704|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864705|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
2864706|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2864707|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864708|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864709|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2864710|NCT03760978|Analgesics|analgesics|mesh-ancestor
2864711|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
2864712|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864713|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2864714|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2308468|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308469|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308470|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308471|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2308472|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2308473|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2308474|NCT00320099|Insulin|insulin|mesh-list
2864715|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2864716|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
2864717|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864718|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864719|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2864720|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2864721|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864722|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2864723|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864724|NCT03760848|Midazolam|midazolam|mesh-list
2864725|NCT03760848|Atorvastatin|atorvastatin|mesh-list
2864726|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2864727|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2864728|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
2308475|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2308476|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
2308477|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2308478|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2308479|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2308480|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
2308481|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2308482|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308483|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2308484|NCT00320125|Calcium|calcium|mesh-list
2308485|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2308486|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308487|NCT00320203|Hydrocortisone|hydrocortisone|mesh-list
2308488|NCT00320203|Anecortave|anecortave|mesh-list
2308489|NCT00320203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2308490|NCT00320203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2308491|NCT00320203|Growth Substances|growth substances|mesh-ancestor
2308492|NCT00320203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308493|NCT00320203|Growth Inhibitors|growth inhibitors|mesh-ancestor
2308494|NCT00320203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308495|NCT00320203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2308496|NCT00320229|Abciximab|abciximab|mesh-list
2308497|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
2308498|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2864729|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864730|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2864731|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2864732|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864733|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2864734|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2308499|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2308500|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
2308501|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2308502|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2308503|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2308504|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2308505|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308506|NCT00320294|Irinotecan|irinotecan|mesh-list
2308507|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308508|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2308509|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2308510|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308511|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308512|NCT00320307|Abacavir|abacavir|mesh-list
2308513|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2308514|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2308515|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308516|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308517|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
2308518|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864735|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864736|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864737|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2864738|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2864739|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2864740|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2864741|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
2864742|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
2864743|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
2864744|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
2864745|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864746|NCT03760835|Dexamethasone|dexamethasone|mesh-list
2864747|NCT03760835|Prednisone|prednisone|mesh-list
2864748|NCT03760835|Prednisolone|prednisolone|mesh-list
2864749|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
2864750|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2864751|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2864752|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2864753|NCT03760835|Cortisone|cortisone|mesh-list
2864754|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
2864755|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2864756|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
2864757|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
2864758|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864759|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864760|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2864761|NCT03760835|Hormones|hormones|mesh-ancestor
2864762|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864763|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2864764|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864765|NCT03760822|Paclitaxel|paclitaxel|mesh-list
2864766|NCT03760822|Ramucirumab|ramucirumab|mesh-list
2864767|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2864768|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864769|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
2864770|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
2864771|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
2864772|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864773|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
2864774|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2864775|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864776|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864777|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2864778|NCT03760809|Analgesics|analgesics|mesh-ancestor
2864779|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
2864780|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864781|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2864782|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2864783|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2864784|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
2864785|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864786|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864787|NCT03760770|Riboflavin|riboflavin|mesh-list
2864788|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
2864789|NCT03760770|Vitamins|vitamins|mesh-ancestor
2864790|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
2864791|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864792|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2864793|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
2864794|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
2864795|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2864796|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864797|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
2864798|NCT03760666|Ribavirin|ribavirin|mesh-list
2864799|NCT03760666|Brequinar|brequinar|mesh-list
2864800|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
2308519|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2308520|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2308521|NCT00320320|Irinotecan|irinotecan|mesh-list
2308522|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2308523|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2308524|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308525|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308526|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308527|NCT00320359|Cisplatin|cisplatin|mesh-list
2308528|NCT00320359|Etoposide|etoposide|mesh-list
2308529|NCT00320359|Topotecan|topotecan|mesh-list
2308530|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308531|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2864801|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864802|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
2864803|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864804|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864805|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864806|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2864807|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
2864808|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864809|NCT03760614|Entinostat|entinostat|mesh-list
2308532|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2308533|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2308534|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308535|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308536|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2308537|NCT00320476|Bortezomib|bortezomib|mesh-list
2308538|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308539|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2308540|NCT00320567|Norgestimate|norgestimate|mesh-list
2308541|NCT00320567|Estradiol|estradiol|mesh-list
2308542|NCT00320567|Estrogens|estrogens|mesh-ancestor
2308543|NCT00320567|Hormones|hormones|mesh-ancestor
2864810|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864811|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2864812|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864813|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864814|NCT03760588|Valsartan|valsartan|mesh-list
2864815|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2864816|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2864817|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2864818|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864819|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
2864820|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2864821|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864822|NCT03760445|Cytarabine|cytarabine|mesh-list
2864823|NCT03760445|Posaconazole|posaconazole|mesh-list
2308544|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2308545|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308546|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2308547|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
2308548|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2308549|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2308550|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2308551|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2308552|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2308553|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2308554|NCT00320580|Norelgestromin|norelgestromin|mesh-list
2308555|NCT00320580|Estradiol|estradiol|mesh-list
2308556|NCT00320580|Estrogens|estrogens|mesh-ancestor
2308557|NCT00320580|Hormones|hormones|mesh-ancestor
2308558|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2308559|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308560|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2308561|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
2308562|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2308563|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2308564|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2308565|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2308566|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
2308567|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2308568|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2308569|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308570|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
2864824|NCT03760445|Daunorubicin|daunorubicin|mesh-list
2308571|NCT00320619|Coagulants|coagulants|mesh-ancestor
2308572|NCT00320632|Desipramine|desipramine|mesh-list
2308573|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2308574|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
2308575|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2308576|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308577|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308578|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2308579|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2308580|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2308581|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
2308582|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308583|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308584|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2308585|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2308586|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
2308587|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308588|NCT00320658|Antacids|antacids|mesh-ancestor
2308589|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308590|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2308591|NCT00320697|Bupropion|bupropion|mesh-list
2308592|NCT00320697|Nicotine|nicotine|mesh-list
2308593|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2308594|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
2864825|NCT03760445|Idarubicin|idarubicin|mesh-list
2864826|NCT03760445|Midostaurin|midostaurin|mesh-list
2864827|NCT03760445|Midazolam|midazolam|mesh-list
2864828|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2864829|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
2864830|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864831|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864832|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
2864833|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864834|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2864835|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
2864836|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864837|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2864838|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2864839|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864840|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2864841|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2864842|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2864843|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2864844|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
2108560|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2108561|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
2108562|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2108563|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
2108564|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308595|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308596|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308597|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2864845|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
2864846|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
2864847|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
2864848|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864849|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2864850|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2864851|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2864852|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864853|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
2864854|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2864855|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2308598|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2864856|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2864857|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2864858|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2864859|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2864860|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
2864861|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864862|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2108565|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2108566|NCT02505945|Omeprazole|omeprazole|mesh-list
2108567|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2108568|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2864863|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
2864864|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2864865|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2864866|NCT03760354|Prednisolone|prednisolone|mesh-list
2864867|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
2864868|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2864869|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
2864870|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2308599|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
2308600|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308601|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308602|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2308603|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
2308604|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2308605|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2308606|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2308607|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2308608|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
2308609|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2308610|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2308611|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308612|NCT00320723|Bupropion|bupropion|mesh-list
2308613|NCT00320723|Nicotine|nicotine|mesh-list
2308614|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2308615|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
2308616|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308617|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864871|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
2864872|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
2864873|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864874|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864875|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2864876|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
2864877|NCT03760354|Hormones|hormones|mesh-ancestor
2864878|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864879|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2864880|NCT03760354|Protective Agents|protective agents|mesh-ancestor
2864881|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2864882|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864883|NCT03760302|Analgesics|analgesics|mesh-list
2864884|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2864885|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
2864886|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864887|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864888|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2864889|NCT03760276|Voriconazole|voriconazole|mesh-list
2864890|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
2864891|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864892|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2864893|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2864894|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864895|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864896|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2864897|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
2864898|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864899|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864900|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2864901|NCT03760263|Tacrolimus|tacrolimus|mesh-list
2864902|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2864903|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
2864904|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864905|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2864906|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864907|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864908|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2864909|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2864910|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2864911|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864912|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2864913|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2864914|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864915|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
2864916|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864917|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2864918|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2864919|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2864920|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2864921|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2864922|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
2864923|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2864924|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864925|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864926|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
2864927|NCT03759938|Apixaban|apixaban|mesh-list
2864928|NCT03759938|Edoxaban|edoxaban|mesh-list
2864929|NCT03759938|Dabigatran|dabigatran|mesh-list
2864930|NCT03759938|Anticoagulants|anticoagulants|mesh-list
2864931|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2864932|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
2864933|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2864934|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
2864935|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864936|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864937|NCT03759886|Metronidazole|metronidazole|mesh-list
2864938|NCT03759886|Paromomycin|paromomycin|mesh-list
2864939|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864940|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2864941|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2864942|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2864943|NCT03759860|Ranibizumab|ranibizumab|mesh-list
2864944|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2864945|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2864946|NCT03759860|Growth Substances|growth substances|mesh-ancestor
2864947|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864948|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
2864949|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2864950|NCT03759782|Tenofovir|tenofovir|mesh-list
2864951|NCT03759782|Ribavirin|ribavirin|mesh-list
2864952|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
2864953|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2308618|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2308619|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2308620|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
2308621|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308622|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308623|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2308624|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
2308625|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2308626|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2308627|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2308628|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2308629|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
2308630|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2308631|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2864954|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2864955|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2864956|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2864957|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864958|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2864959|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2864960|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
2864961|NCT03759496|Durvalumab|durvalumab|mesh-list
2864962|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2864963|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308632|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308633|NCT00320736|Galantamine|galantamine|mesh-list
2308634|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2308635|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308636|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308637|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
2308638|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308639|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308640|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2308641|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
2308642|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308643|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
2308644|NCT00320775|Aflibercept|aflibercept|mesh-list
2308645|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2308646|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2308647|NCT00320775|Growth Substances|growth substances|mesh-ancestor
2308648|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864964|NCT03759353|Lactoferrin|lactoferrin|mesh-list
2864965|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864966|NCT03759301|Cetrorelix|cetrorelix|mesh-list
2864967|NCT03759301|Hormones|hormones|mesh-list
2864968|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2864969|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864970|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2864971|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
2864972|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2864973|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
2864974|NCT03759262|Vitamin D|vitamin d|mesh-list
2864975|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
2864976|NCT03759262|Vitamins|vitamins|mesh-ancestor
2864977|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
2864978|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864979|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2864980|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2864981|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
2864982|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2864983|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
2864984|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2864985|NCT03759158|Expectorants|expectorants|mesh-ancestor
2864986|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
2864987|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2864988|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
2864989|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2864990|NCT03759158|Protective Agents|protective agents|mesh-ancestor
2864991|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2864992|NCT03759158|Antidotes|antidotes|mesh-ancestor
2864993|NCT03759093|Thalidomide|thalidomide|mesh-list
2864994|NCT03759093|Dexamethasone|dexamethasone|mesh-list
2864995|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
2308649|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
2308650|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308651|NCT00320814|Aflibercept|aflibercept|mesh-list
2308652|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2308653|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2308654|NCT00320814|Growth Substances|growth substances|mesh-ancestor
2864996|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
2864997|NCT03759093|Bortezomib|bortezomib|mesh-list
2864998|NCT03759093|BB 1101|bb 1101|mesh-list
2864999|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2865000|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
2865001|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865002|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2865003|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2865004|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
2865005|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865006|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865007|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2865008|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2308655|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308656|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
2308657|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308658|NCT00320827|Antibodies|antibodies|mesh-list
2308659|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
2308660|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308661|NCT00320853|Vitamin D|vitamin d|mesh-list
2308662|NCT00320853|Vitamins|vitamins|mesh-ancestor
2865009|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
2865010|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
2308663|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
2308664|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308665|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2308666|NCT00320879|Irbesartan|irbesartan|mesh-list
2308667|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2308668|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2308669|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2865011|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865012|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2865013|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
2865014|NCT03759093|Hormones|hormones|mesh-ancestor
2865015|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2865016|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2865017|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
2865018|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865019|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
2865020|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2865021|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865022|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2865023|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2865024|NCT03759093|Growth Substances|growth substances|mesh-ancestor
2865025|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
2865026|NCT03759067|Clopidogrel|clopidogrel|mesh-list
2865027|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2865028|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2865029|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2865030|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2865031|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
2865032|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2865033|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865034|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865035|NCT03759028|Acetaminophen|acetaminophen|mesh-list
2865036|NCT03759028|Ibuprofen|ibuprofen|mesh-list
2865037|NCT03759028|Oxycodone|oxycodone|mesh-list
2865038|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2865039|NCT03759028|Analgesics|analgesics|mesh-ancestor
2865040|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
2865041|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865042|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865043|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
2865044|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2865045|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2865046|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2865047|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2865048|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865049|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865050|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2865051|NCT03759028|Narcotics|narcotics|mesh-ancestor
2865052|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865053|NCT03758989|Prednisone|prednisone|mesh-list
2865054|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
2865055|NCT03758989|Rituximab|rituximab|mesh-list
2865056|NCT03758989|Doxorubicin|doxorubicin|mesh-list
2865057|NCT03758989|Vincristine|vincristine|mesh-list
2865058|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2865059|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
2865060|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865061|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2865062|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2865063|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
2865064|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865065|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865066|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2865067|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2308670|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308671|NCT00320892|Atropine|atropine|mesh-list
2308672|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2308673|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2308674|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2308675|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2308676|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
2308677|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308678|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308679|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2865068|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2865069|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2865070|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2865071|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865072|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2865073|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
2865074|NCT03758989|Hormones|hormones|mesh-ancestor
2865075|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2865076|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2865077|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2865078|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
2865079|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
2865080|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
2865081|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
2865082|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2865083|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
2865084|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2865085|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2865086|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
2865087|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2865088|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
2865089|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865090|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
2865091|NCT03758859|Protective Agents|protective agents|mesh-ancestor
2865092|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2865098|NCT03758729|Nivolumab|nivolumab|mesh-list
2865099|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2865100|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865101|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2865102|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865103|NCT03758677|Gemcitabine|gemcitabine|mesh-list
2865104|NCT03758677|Docetaxel|docetaxel|mesh-list
2865105|NCT03758677|Pemetrexed|pemetrexed|mesh-list
2865106|NCT03758677|Apatinib|apatinib|mesh-list
2865107|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2865108|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
2865109|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865110|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865111|NCT03758677|Antiviral Agents|antiviral agents|mesh-ancestor
2865112|NCT03758677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865113|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865114|NCT03758677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2865115|NCT03758677|Immunologic Factors|immunologic factors|mesh-ancestor
2865116|NCT03758677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865117|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
2865118|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
2865119|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
2865120|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2865121|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2865122|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2865123|NCT03758469|Rifampin|rifampin|mesh-list
2865124|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2865125|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
2865126|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2865127|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865128|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
2865129|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2865130|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865131|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865132|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2865133|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2865134|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2865135|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2865136|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2865137|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2865138|NCT03758339|Tucatinib|tucatinib|mesh-list
2865139|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865140|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2865141|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865142|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865143|NCT03758287|Gefitinib|gefitinib|mesh-list
2865144|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865145|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2865146|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865147|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865148|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2865149|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2865150|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2308680|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
2308681|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
2308682|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
2308683|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2308684|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2308685|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
2308686|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308687|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308688|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2865151|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2865152|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865153|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308689|NCT00320970|Candesartan|candesartan|mesh-list
2308690|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2308691|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2308692|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2308693|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865154|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2865155|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2865156|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308694|NCT00320983|Topotecan|topotecan|mesh-list
2308695|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308696|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2308697|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2308698|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308699|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308700|NCT00321009|Enoxaparin|enoxaparin|mesh-list
2308701|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
2308702|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2308703|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2308704|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308705|NCT00321074|Tacrolimus|tacrolimus|mesh-list
2308706|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2865157|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
2865158|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2865159|NCT03758170|Dexamethasone|dexamethasone|mesh-list
2865160|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2865161|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
2865162|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
2865163|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865164|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865165|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2865166|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
2865167|NCT03758170|Hormones|hormones|mesh-ancestor
2865168|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2865169|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2308707|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
2308708|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308709|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2308710|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308711|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865170|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865171|NCT03758144|Rifaximin|rifaximin|mesh-list
2865172|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2865173|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865174|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2865175|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2865176|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
2865177|NCT03758079|Gabapentin|gabapentin|mesh-list
2865178|NCT03758079|Doxepin|doxepin|mesh-list
2865179|NCT03758079|Analgesics|analgesics|mesh-ancestor
2865180|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
2865181|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865182|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865183|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
2865184|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2865185|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2865186|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865187|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2865188|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2865189|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2865190|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2865191|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865192|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
2865193|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2865194|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2865195|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2865196|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
2865197|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
2308726|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
2308727|NCT00321113|Tacrolimus|tacrolimus|mesh-list
2308728|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2308729|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
2308730|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308731|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2308732|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865198|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
2865199|NCT03758014|Lomustine|lomustine|mesh-list
2865200|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2865201|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
2865202|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865203|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865204|NCT03757923|Metformin|metformin|mesh-list
2865205|NCT03757923|Pioglitazone|pioglitazone|mesh-list
2865206|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2865207|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865208|NCT03757910|Corticosterone|corticosterone|mesh-list
2865209|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2865210|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
2865211|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2865212|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865213|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865214|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2865215|NCT03757897|Analgesics|analgesics|mesh-ancestor
2865216|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
2865217|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865218|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2865219|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2865220|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2865221|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
2865222|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2865223|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865224|NCT03757858|Antibodies|antibodies|mesh-list
2865225|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
2865226|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865227|NCT03757715|Dexamethasone|dexamethasone|mesh-list
2865228|NCT03757715|Bupivacaine|bupivacaine|mesh-list
2865229|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2865230|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
2865231|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
2865232|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865233|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865234|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2865235|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
2865236|NCT03757715|Hormones|hormones|mesh-ancestor
2865237|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2865238|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2865239|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865240|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
2865241|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
2865242|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865243|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
2865247|NCT03757650|Amoxicillin|amoxicillin|mesh-list
2865248|NCT03757650|Clarithromycin|clarithromycin|mesh-list
2865249|NCT03757650|Omeprazole|omeprazole|mesh-list
2865250|NCT03757650|Bismuth|bismuth|mesh-list
2865251|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2865252|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2865253|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865254|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2865255|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2865256|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2865257|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865258|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865259|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2308733|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308734|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2308735|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308736|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2308737|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
2865260|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2865261|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2865262|NCT03757650|Antacids|antacids|mesh-ancestor
2865263|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
2865264|NCT03757585|Inositol|inositol|mesh-list
2865265|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
2865266|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2865267|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
2865268|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865269|NCT03757585|Expectorants|expectorants|mesh-ancestor
2865270|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
2865271|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2865272|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
2308738|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2308739|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2308740|NCT00321126|Zinc|zinc|mesh-list
2308741|NCT00321126|Trace Elements|trace elements|mesh-ancestor
2308742|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
2308743|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308744|NCT00321165|Taurolidine|taurolidine|mesh-list
2308745|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2308746|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2308747|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308748|NCT00321178|Clarithromycin|clarithromycin|mesh-list
2308749|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2308750|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2308751|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2308752|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308753|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865273|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865274|NCT03757585|Protective Agents|protective agents|mesh-ancestor
2865275|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865276|NCT03757585|Antidotes|antidotes|mesh-ancestor
2865277|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
2865278|NCT03757585|Vitamins|vitamins|mesh-ancestor
2865279|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
2865280|NCT03757559|Hydromorphone|hydromorphone|mesh-list
2865281|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2865282|NCT03757559|Narcotics|narcotics|mesh-ancestor
2865283|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2308754|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2308755|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2308756|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
2308757|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2308758|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
2308759|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
2308760|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2308761|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308762|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2865284|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865285|NCT03757559|Analgesics|analgesics|mesh-ancestor
2865286|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
2865287|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865288|NCT03757403|Mebendazole|mebendazole|mesh-list
2865289|NCT03757403|Piperazine|piperazine|mesh-list
2865290|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
2865291|NCT03757403|DMP 777|dmp 777|mesh-list
2865292|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
2865293|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
2865294|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2865295|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865296|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
2865297|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
2865298|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
2865299|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865300|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865301|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865302|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
2865303|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2865304|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2865305|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2865306|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
2865307|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865308|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2865309|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2865310|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865311|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2865312|NCT03757364|Methotrexate|methotrexate|mesh-list
2865313|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2865314|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
2865315|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2865316|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865317|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2865318|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
2865319|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865320|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865321|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
2865322|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865323|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2865324|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2865325|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
2865326|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2865327|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2865328|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2865329|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2865330|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308763|NCT00321191|Analgesics|analgesics|mesh-ancestor
2308764|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
2308765|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308766|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
2308767|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2308768|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
2308769|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308770|NCT00321230|Protective Agents|protective agents|mesh-ancestor
2308771|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308772|NCT00321230|Vitamins|vitamins|mesh-ancestor
2308773|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
2308774|NCT00321230|Laxatives|laxatives|mesh-ancestor
2865331|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2865332|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
2865333|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865334|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
2865335|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2308775|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2308776|NCT00321308|Pemetrexed|pemetrexed|mesh-list
2865336|NCT03757221|Daratumumab|daratumumab|mesh-list
2865337|NCT03757221|Ixazomib|ixazomib|mesh-list
2865338|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865339|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
2865340|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865341|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865342|NCT03757156|Aspirin|aspirin|mesh-list
2865343|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2865344|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2865345|NCT03757156|Analgesics|analgesics|mesh-ancestor
2865346|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
2865347|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865348|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865349|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2865350|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2865351|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2865352|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2865353|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865354|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2865355|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2865356|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865357|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
2865358|NCT03757143|Ethanol|ethanol|mesh-list
2865359|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
2308777|NCT00321308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308778|NCT00321308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308779|NCT00321308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308780|NCT00321308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2308781|NCT00321308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2308782|NCT00321347|Lidocaine|lidocaine|mesh-list
2308783|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
2308784|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
2308785|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2308786|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308787|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
2308788|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308789|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2308790|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2308791|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2308792|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2308793|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308794|NCT00321360|Propofol|propofol|mesh-list
2308795|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2308796|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2308797|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308798|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2308799|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
2308800|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
2308801|NCT00321477|Casopitant|casopitant|mesh-list
2308802|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
2308803|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
2308804|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308805|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308806|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2308807|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2308808|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308809|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308810|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2308811|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2308812|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
2308813|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2308814|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2308815|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2308816|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2308817|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308818|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2308819|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2308820|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2865360|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
2865361|NCT03757143|Povidone|povidone|mesh-list
2865362|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2865363|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865364|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865365|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865366|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
2865367|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
2865368|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
2865369|NCT03757117|Hormones|hormones|mesh-list
2865370|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2865371|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865372|NCT03757052|Amoxicillin|amoxicillin|mesh-list
2865373|NCT03757052|Penicillins|penicillins|mesh-list
2865374|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2865375|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865376|NCT03756987|Ropivacaine|ropivacaine|mesh-list
2865377|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
2865378|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
2865379|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865380|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865381|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
2865382|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865383|NCT03756961|Lidocaine|lidocaine|mesh-list
2865384|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
2865385|NCT03756961|Remifentanil|remifentanil|mesh-list
2865386|NCT03756961|Oxycodone|oxycodone|mesh-list
2865387|NCT03756961|Propofol|propofol|mesh-list
2865388|NCT03756961|Desflurane|desflurane|mesh-list
2865389|NCT03756961|Esketamine|esketamine|mesh-list
2865390|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
2865391|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
2865392|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865393|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865394|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
2865395|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865396|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2865397|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2865398|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2865399|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2865400|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865401|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2865402|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2865403|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
2865404|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2865405|NCT03756961|Analgesics|analgesics|mesh-ancestor
2865406|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2865407|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2865408|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2865409|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
2865410|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308821|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308822|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308823|NCT00321490|Analgesics|analgesics|mesh-ancestor
2308824|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
2308825|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308826|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
2308827|NCT00321516|Aripiprazole|aripiprazole|mesh-list
2308828|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
2308829|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2308830|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2308831|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2308832|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2308833|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308834|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
2308835|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
2308836|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2308837|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308838|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2308839|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2308840|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
2308841|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2308842|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2308843|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2308844|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2308845|NCT00321581|Cediranib|cediranib|mesh-list
2308846|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308847|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2865411|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2865412|NCT03756961|Narcotics|narcotics|mesh-ancestor
2865413|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2308848|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308849|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308850|NCT00321633|Carboplatin|carboplatin|mesh-list
2308851|NCT00321633|Docetaxel|docetaxel|mesh-list
2308852|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308853|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
2308854|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
2308855|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
2865414|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
2865415|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2865416|NCT03756896|Dexamethasone|dexamethasone|mesh-list
2865417|NCT03756896|Pomalidomide|pomalidomide|mesh-list
2865418|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2865419|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
2865420|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
2865421|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865422|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865423|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2865424|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
2865425|NCT03756896|Hormones|hormones|mesh-ancestor
2865426|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2865427|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2865428|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865429|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
2865430|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2865431|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2865432|NCT03756896|Growth Substances|growth substances|mesh-ancestor
2865433|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
2865434|NCT03756818|Paclitaxel|paclitaxel|mesh-list
2865435|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2865436|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2865437|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865438|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
2865439|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
2865440|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
2865441|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865442|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
2865443|NCT03756727|Vitamins|vitamins|mesh-ancestor
2865444|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
2865445|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865446|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
2865447|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865448|NCT03756727|Protective Agents|protective agents|mesh-ancestor
2865449|NCT03756623|Metformin|metformin|mesh-list
2865450|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2865451|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865452|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2865453|NCT03756324|Cefdinir|cefdinir|mesh-list
2865454|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2865455|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865456|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
2865457|NCT03756311|Paclitaxel|paclitaxel|mesh-list
2865458|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2865459|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2865460|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865461|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
2865462|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
2865463|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
2865464|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865465|NCT03756298|Capecitabine|capecitabine|mesh-list
2865466|NCT03756298|Atezolizumab|atezolizumab|mesh-list
2865467|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2865468|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
2865469|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865470|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865471|NCT03756272|Bupivacaine|bupivacaine|mesh-list
2865472|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
2865473|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
2865474|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865475|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865476|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
2865477|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865478|NCT03756246|Vaccines|vaccines|mesh-list
2865479|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
2865480|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865481|NCT03756233|Remifentanil|remifentanil|mesh-list
2865482|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2865483|NCT03756233|Narcotics|narcotics|mesh-ancestor
2865484|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865485|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308856|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308857|NCT00321724|Cediranib|cediranib|mesh-list
2308858|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865486|NCT03756233|Analgesics|analgesics|mesh-ancestor
2865487|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
2865488|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865489|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
2865490|NCT03756220|Thiamine|thiamine|mesh-list
2865491|NCT03756220|Vitamins|vitamins|mesh-ancestor
2865492|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
2308859|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308860|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308861|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2308862|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
2308863|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2308864|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2308865|NCT00321750|Analgesics|analgesics|mesh-ancestor
2308866|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
2308867|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308868|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308869|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2308870|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2308871|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
2108569|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2108570|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108571|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108572|NCT02506114|Ipilimumab|ipilimumab|mesh-list
2865493|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865494|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
2865495|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865496|NCT03756220|Protective Agents|protective agents|mesh-ancestor
2865497|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
2865498|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2108573|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2108574|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108575|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2108576|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108577|NCT02506257|Biguanides|biguanides|mesh-list
2108578|NCT02506257|Polihexanide|polihexanide|mesh-list
2108579|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2108580|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108581|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
2108582|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108583|NCT02506634|Esomeprazole|esomeprazole|mesh-list
2108584|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2108585|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2108586|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2108587|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308872|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2308873|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
2308874|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2308875|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308876|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308877|NCT00321802|Simvastatin|simvastatin|mesh-list
2308878|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2308879|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2308880|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
2308881|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308882|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2865499|NCT03756116|Epinephrine|epinephrine|mesh-list
2865500|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2865501|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2865502|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
2865503|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2865504|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865505|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865506|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2865507|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2865508|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
2865509|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865510|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2865511|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
2865512|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
2865513|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
2865514|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2865515|NCT03756090|Paclitaxel|paclitaxel|mesh-list
2865516|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
2865517|NCT03756090|Epirubicin|epirubicin|mesh-list
2865518|NCT03756090|Palbociclib|palbociclib|mesh-list
2865519|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2865520|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865521|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
2865522|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
2865523|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
2865524|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865525|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2865526|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
2865527|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865528|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2308883|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2308884|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308885|NCT00321815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2308886|NCT00321815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308887|NCT00321815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2308888|NCT00321815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308889|NCT00321815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308890|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2308891|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2308892|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
2308893|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308894|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308895|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
2308896|NCT00322036|Analgesics|analgesics|mesh-ancestor
2308897|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
2308898|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308899|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308900|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2308901|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2308902|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2308903|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2308904|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2308905|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308906|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865529|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2865530|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
2865531|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2865532|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2865533|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2865534|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2865535|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865536|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2865537|NCT03756077|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2865538|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2865539|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2865540|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865541|NCT03756064|Carboplatin|carboplatin|mesh-list
2865542|NCT03756064|Docetaxel|docetaxel|mesh-list
2865543|NCT03756064|Trastuzumab|trastuzumab|mesh-list
2865544|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865545|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
2865546|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
2865547|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
2865548|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865549|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2865550|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2865551|NCT03755973|Hormones|hormones|mesh-ancestor
2865552|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2865553|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865554|NCT03755947|Venetoclax|venetoclax|mesh-list
2865555|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
2865556|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865557|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2865558|NCT03755804|Prednisone|prednisone|mesh-list
2865559|NCT03755804|Prednisolone|prednisolone|mesh-list
2865560|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
2865561|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2865562|NCT03755804|Dacarbazine|dacarbazine|mesh-list
2865563|NCT03755804|Doxorubicin|doxorubicin|mesh-list
2865564|NCT03755804|Etoposide|etoposide|mesh-list
2865565|NCT03755804|Vincristine|vincristine|mesh-list
2865566|NCT03755804|Bleomycin|bleomycin|mesh-list
2865567|NCT03755804|Vinblastine|vinblastine|mesh-list
2865568|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2865569|NCT03755804|Imidazole|imidazole|mesh-list
2865570|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2865571|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
2865572|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865573|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2865574|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2865575|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
2865576|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865577|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865578|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2865579|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2865580|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2865581|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2865582|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865583|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2865584|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
2865585|NCT03755804|Hormones|hormones|mesh-ancestor
2865586|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2865587|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2865588|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2865589|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
2865590|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
2865591|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
2865592|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2308907|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
2308908|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2308909|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
2865593|NCT03755791|Sorafenib|sorafenib|mesh-list
2865594|NCT03755791|Atezolizumab|atezolizumab|mesh-list
2865595|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865596|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2865597|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865598|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865599|NCT03755778|Itraconazole|itraconazole|mesh-list
2865600|NCT03755778|Rifampin|rifampin|mesh-list
2865601|NCT03755778|Quinidine|quinidine|mesh-list
2865602|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
2865603|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865604|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2865605|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2865606|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865607|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865608|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2865609|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
2865610|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2865611|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865612|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2865613|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2865614|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
2865615|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2865616|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
2865617|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2865618|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2308910|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308911|NCT00322062|Protective Agents|protective agents|mesh-ancestor
2308912|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308913|NCT00322062|Vitamins|vitamins|mesh-ancestor
2308914|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
2308915|NCT00322062|Laxatives|laxatives|mesh-ancestor
2308916|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2308917|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
2308918|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2308919|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308920|NCT00322114|Lycopene|lycopene|mesh-list
2308921|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2308922|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
2308923|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308924|NCT00322114|Protective Agents|protective agents|mesh-ancestor
2308925|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308926|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2308927|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2308928|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308929|NCT00322127|Plerixafor|plerixafor|mesh-list
2308930|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2308931|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2865619|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2865620|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2865621|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2865622|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2865623|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2865624|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2865625|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2865626|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
2865627|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2865628|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2308932|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
2308933|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2308934|NCT00322166|Calcium|calcium|mesh-list
2308935|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2308936|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308937|NCT00322257|Insulin|insulin|mesh-list
2308938|NCT00322257|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2308939|NCT00322257|Insulin Aspart|insulin aspart|mesh-list
2308940|NCT00322257|Insulin Detemir|insulin detemir|mesh-list
2308941|NCT00322257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2308942|NCT00322257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308943|NCT00322296|Bexarotene|bexarotene|mesh-list
2308944|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308945|NCT00322400|Paclitaxel|paclitaxel|mesh-list
2308946|NCT00322400|Docetaxel|docetaxel|mesh-list
2308947|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
2308948|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2865629|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
2865630|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2865631|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2865632|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2865633|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2865634|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
2865635|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2865636|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2865637|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2865638|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2865639|NCT03755765|Amoxicillin|amoxicillin|mesh-list
2865640|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
2865641|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
2865642|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2308949|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308950|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
2308951|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
2865643|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2865644|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865645|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2865646|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865647|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865648|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
2865649|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2865650|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2865651|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865652|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2865653|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
2865654|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2865655|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865656|NCT03755700|Vitamin E|vitamin e|mesh-list
2865657|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
2865658|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2865659|NCT03755700|Vitamins|vitamins|mesh-ancestor
2865660|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
2865661|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865662|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
2865663|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865664|NCT03755700|Protective Agents|protective agents|mesh-ancestor
2865665|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
2865666|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865667|NCT03755700|Expectorants|expectorants|mesh-ancestor
2865668|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
2865669|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2865670|NCT03755700|Antidotes|antidotes|mesh-ancestor
2865671|NCT03755609|Fentanyl|fentanyl|mesh-list
2865672|NCT03755609|Oxycodone|oxycodone|mesh-list
2865673|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2865674|NCT03755609|Narcotics|narcotics|mesh-ancestor
2308952|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
2308953|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308954|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2308955|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865675|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865676|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865677|NCT03755609|Analgesics|analgesics|mesh-ancestor
2865678|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
2308956|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
2308957|NCT00322413|Hematinics|hematinics|mesh-ancestor
2308958|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
2308959|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2308960|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2308961|NCT00322543|Analgesics|analgesics|mesh-ancestor
2308962|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
2308963|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308964|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308965|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2308966|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2308967|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
2308968|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2865679|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865680|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2865681|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2865682|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
2865683|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
2865684|NCT03755557|Budesonide|budesonide|mesh-list
2865685|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2865686|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2865687|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
2865688|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865689|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865690|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2865691|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
2865692|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
2865693|NCT03755557|Hormones|hormones|mesh-ancestor
2865694|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2865695|NCT03755531|Oxytocin|oxytocin|mesh-list
2865696|NCT03755531|Carbetocin|carbetocin|mesh-list
2865697|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
2865698|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2308969|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
2308970|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2308971|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865699|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865700|NCT03755518|Luspatercept|luspatercept|mesh-list
2865701|NCT03755518|Hematinics|hematinics|mesh-ancestor
2865702|NCT03755479|Insulin|insulin|mesh-list
2865703|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2865704|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865705|NCT03755466|Tofacitinib|tofacitinib|mesh-list
2865706|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2865707|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865708|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865709|NCT03755440|Antibodies|antibodies|mesh-list
2865710|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
2865711|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865712|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2865713|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2865714|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
2865715|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865716|NCT03755427|Antacids|antacids|mesh-ancestor
2865717|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865718|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2308972|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308973|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
2308974|NCT00322569|Paclitaxel|paclitaxel|mesh-list
2308975|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2308976|NCT00322569|Tacrolimus|tacrolimus|mesh-list
2308977|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2308978|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2308979|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
2308980|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
2308981|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
2308982|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2308983|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2308984|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2308985|NCT00322569|Analgesics|analgesics|mesh-ancestor
2308986|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
2308987|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2308988|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2308989|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2308990|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2308991|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
2308992|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2308993|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
2308994|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2308995|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2308996|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2308997|NCT00322595|Paroxetine|paroxetine|mesh-list
2308998|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
2308999|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2309000|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2309001|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2865719|NCT03755310|Suvorexant|suvorexant|mesh-list
2865720|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2865721|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2865722|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865723|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865724|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2865725|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2865726|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865727|NCT03755193|Diphosphonates|diphosphonates|mesh-list
2865728|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2865729|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865730|NCT03755115|Epirubicin|epirubicin|mesh-list
2865731|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2865732|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865733|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2865734|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2865735|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865736|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865737|NCT03755102|Osimertinib|osimertinib|mesh-list
2865738|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865739|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2865740|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865741|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865742|NCT03755089|Lidocaine|lidocaine|mesh-list
2865743|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
2865744|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
2865745|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2309002|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2309003|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309004|NCT00322595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2309005|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2309006|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2309007|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309008|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309009|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
2309010|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2309011|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2865746|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865747|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
2865748|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865749|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2865750|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2865751|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2865752|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2865753|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865754|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2865755|NCT03755037|Estradiol|estradiol|mesh-list
2865756|NCT03755037|Estrogens|estrogens|mesh-ancestor
2865757|NCT03755037|Hormones|hormones|mesh-ancestor
2865758|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2865759|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865760|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2865761|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
2865762|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2865763|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2865764|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2865765|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2865766|NCT03754959|Midazolam|midazolam|mesh-list
2865767|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2865768|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2865769|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865770|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865771|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2865772|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2865773|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2865774|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2865775|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
2865776|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
2865777|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
2865778|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
2865779|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2865780|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865781|NCT03754933|Fludarabine|fludarabine|mesh-list
2865782|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
2865783|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865784|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2865785|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
2865786|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865787|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2865788|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
2865789|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865790|NCT03754842|Niacinamide|niacinamide|mesh-list
2865791|NCT03754842|Niacin|niacin|mesh-list
2865792|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
2865793|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
2865794|NCT03754842|Vitamins|vitamins|mesh-ancestor
2865795|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
2865796|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865797|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2865798|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
2865799|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865800|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2865801|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
2865802|NCT03754816|Anesthetics|anesthetics|mesh-list
2309012|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2309013|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309014|NCT00322660|Epinephrine|epinephrine|mesh-list
2309015|NCT00322660|Racepinephrine|racepinephrine|mesh-list
2309016|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
2309017|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2309018|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2865803|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
2865804|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865805|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865806|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
2865807|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
2865808|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865809|NCT03754725|Deferiprone|deferiprone|mesh-list
2865810|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2309019|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
2309020|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309021|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309022|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309023|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2309024|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2309025|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
2309026|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309027|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2309028|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
2309029|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
2309030|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
2309031|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2309032|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2309033|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
2309034|NCT00322699|Trioxsalen|trioxsalen|mesh-list
2309035|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309036|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
2865811|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
2865812|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
2865813|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865814|NCT03754712|Vitamin D|vitamin d|mesh-list
2865815|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
2865816|NCT03754712|Vitamins|vitamins|mesh-ancestor
2865817|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
2865818|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865819|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2865820|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2309037|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2309038|NCT00322751|Topotecan|topotecan|mesh-list
2309039|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2865821|NCT03754686|Acetaminophen|acetaminophen|mesh-list
2865822|NCT03754686|Oseltamivir|oseltamivir|mesh-list
2865823|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2865824|NCT03754686|Analgesics|analgesics|mesh-ancestor
2865825|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
2865826|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865827|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309040|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2309041|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309042|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309043|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309044|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
2309045|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
2309046|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2309047|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2309048|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2309049|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309050|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2865828|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
2865829|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
2865830|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865831|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865832|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865833|NCT03754647|Ascorbic Acid|ascorbic acid|mesh-list
2865834|NCT03754647|Vitamins|vitamins|mesh-ancestor
2865835|NCT03754647|Micronutrients|micronutrients|mesh-ancestor
2865836|NCT03754647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865837|NCT03754647|Antioxidants|antioxidants|mesh-ancestor
2865838|NCT03754647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865839|NCT03754647|Protective Agents|protective agents|mesh-ancestor
2865840|NCT03754634|Diacetylrhein|diacetylrhein|mesh-list
2865841|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2865842|NCT03754543|Iron|iron|mesh-list
2865843|NCT03754543|Trace Elements|trace elements|mesh-ancestor
2865844|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
2865845|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865846|NCT03754387|Ceftazidime|ceftazidime|mesh-list
2865847|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2865848|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865849|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
2865850|NCT03754179|Trametinib|trametinib|mesh-list
2865851|NCT03754179|Dabrafenib|dabrafenib|mesh-list
2865852|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
2865853|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2865854|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2865855|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865856|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865857|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865858|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2865859|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865860|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2865861|NCT03754140|Polidocanol|polidocanol|mesh-list
2108588|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108589|NCT02506660|Dexamethasone|dexamethasone|mesh-list
2108590|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
2108591|NCT02506660|Bupivacaine|bupivacaine|mesh-list
2309051|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2309052|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
2309053|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
2309054|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309055|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309056|NCT00322907|Mefloquine|mefloquine|mesh-list
2309057|NCT00322907|Quinine|quinine|mesh-list
2309058|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
2309059|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2309060|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2309061|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309062|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2309063|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309064|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2309065|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309066|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2309067|NCT00322907|Analgesics|analgesics|mesh-ancestor
2309068|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
2309069|NCT00322920|Topotecan|topotecan|mesh-list
2309070|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309071|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2309072|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2309073|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309074|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309075|NCT00322972|Azithromycin|azithromycin|mesh-list
2309076|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2309077|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309078|NCT00322985|Lenalidomide|lenalidomide|mesh-list
2309079|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
2309080|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309081|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2309082|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2309083|NCT00322985|Growth Substances|growth substances|mesh-ancestor
2309084|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
2309085|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309086|NCT00323011|Leucovorin|leucovorin|mesh-list
2309087|NCT00323011|Folic Acid|folic acid|mesh-list
2309088|NCT00323011|Bevacizumab|bevacizumab|mesh-list
2309089|NCT00323011|Fluorouracil|fluorouracil|mesh-list
2309090|NCT00323011|Irinotecan|irinotecan|mesh-list
2309091|NCT00323011|Dalteparin|dalteparin|mesh-list
2309092|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
2865862|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2865863|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2865864|NCT03754062|Haloperidol|haloperidol|mesh-list
2865865|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
2865866|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
2309093|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2865867|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
2865868|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865869|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108592|NCT02506660|BB 1101|bb 1101|mesh-list
2108593|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2108594|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
2865870|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2309094|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309095|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2309096|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2309097|NCT00323011|Growth Substances|growth substances|mesh-ancestor
2865871|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2865872|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2865873|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2865874|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2865875|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2865876|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
2865877|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2865878|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865879|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2865880|NCT03754049|Dexamethasone|dexamethasone|mesh-list
2865881|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
2865882|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2865883|NCT03754049|BB 1101|bb 1101|mesh-list
2865884|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2865885|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
2865886|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
2865887|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2865888|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865889|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2865890|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
2865891|NCT03754049|Hormones|hormones|mesh-ancestor
2865892|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2865893|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2865894|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865895|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
2865896|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865897|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865898|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
2865899|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2865900|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
2865901|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865902|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
2865903|NCT03754010|Protective Agents|protective agents|mesh-ancestor
2865904|NCT03753919|Durvalumab|durvalumab|mesh-list
2865905|NCT03753919|Tremelimumab|tremelimumab|mesh-list
2865906|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2865907|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865908|NCT03753867|Acitretin|acitretin|mesh-list
2865909|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
2865910|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
2865911|NCT03753685|Ensartinib|ensartinib|mesh-list
2865912|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865913|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2865914|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865915|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865916|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
2108595|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
2108596|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108597|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108598|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2108599|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
2108600|NCT02506660|Hormones|hormones|mesh-ancestor
2108601|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2309098|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865917|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2865918|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865919|NCT03753581|Cytarabine|cytarabine|mesh-list
2865920|NCT03753581|Methotrexate|methotrexate|mesh-list
2865921|NCT03753581|Etoposide|etoposide|mesh-list
2865922|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2865923|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
2309099|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
2309100|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
2309101|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309102|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2309103|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2309104|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
2309105|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2309106|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2309107|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309108|NCT00323011|Antidotes|antidotes|mesh-ancestor
2865924|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865925|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2865926|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
2865927|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865928|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2865929|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
2865930|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309109|NCT00323011|Protective Agents|protective agents|mesh-ancestor
2309110|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
2309111|NCT00323011|Vitamins|vitamins|mesh-ancestor
2309112|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
2309113|NCT00323011|Hematinics|hematinics|mesh-ancestor
2309114|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
2309115|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2309116|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2309117|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
2309118|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2309119|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309120|NCT00323154|Nalbuphine|nalbuphine|mesh-list
2309121|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2309122|NCT00323154|Narcotics|narcotics|mesh-ancestor
2309123|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2309124|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309125|NCT00323154|Analgesics|analgesics|mesh-ancestor
2309126|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
2309127|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309128|NCT00323206|Interleukin-12|interleukin-12|mesh-list
2865931|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2865932|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2865933|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2865934|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865935|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2865936|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
2865937|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2865938|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
2865939|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2865940|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2865941|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2309129|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2309130|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
2309131|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309132|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2309133|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2309134|NCT00323206|Growth Substances|growth substances|mesh-ancestor
2309135|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
2309136|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309137|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
2309138|NCT00323219|Cefazolin|cefazolin|mesh-list
2309139|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2309140|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309141|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2309142|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2309143|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309144|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309145|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309146|NCT00323323|Prednisone|prednisone|mesh-list
2309147|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
2309148|NCT00323323|Doxorubicin|doxorubicin|mesh-list
2309149|NCT00323323|Vincristine|vincristine|mesh-list
2309150|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
2309151|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2309152|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
2309153|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309154|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2309155|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2309156|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
2309157|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309158|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309159|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2309160|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2309161|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2309162|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2309163|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309164|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2309165|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
2309166|NCT00323323|Hormones|hormones|mesh-ancestor
2309167|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2309168|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2309169|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2309170|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
2309171|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
2309172|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
2309173|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2309174|NCT00323375|Chloroquine|chloroquine|mesh-list
2309175|NCT00323375|Amebicides|amebicides|mesh-ancestor
2309176|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2309177|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2309178|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2865958|NCT03753477|Amlodipine|amlodipine|mesh-list
2865959|NCT03753477|Olmesartan|olmesartan|mesh-list
2865960|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2865961|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
2865962|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2865963|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2865964|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2309179|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
2309180|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2309181|NCT00323505|Interferons|interferons|mesh-list
2309182|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
2309183|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
2865965|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2865966|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865967|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2865968|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865969|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
2865970|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2865971|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2865972|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
2865973|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2865974|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2865975|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865976|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2865977|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2865978|NCT03753269|Fasudil|fasudil|mesh-list
2865979|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2865980|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2865981|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2865982|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2865983|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2865984|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
2865985|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2865986|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2865987|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
2865988|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2865989|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309184|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309185|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
2865995|NCT03752931|Celiprolol|celiprolol|mesh-list
2865996|NCT03752931|Diltiazem|diltiazem|mesh-list
2865997|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2865998|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2865999|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2866000|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309186|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309187|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
2309188|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309189|NCT00323544|Tenofovir|tenofovir|mesh-list
2309190|NCT00323544|Lamivudine|lamivudine|mesh-list
2866001|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2866002|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866003|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
2866004|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2866005|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
2866006|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
2866007|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866008|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2866009|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2866010|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2866011|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
2866012|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866013|NCT03752918|Niacin|niacin|mesh-list
2866014|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
2866015|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2866016|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2866017|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
2866018|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866019|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2866020|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
2866021|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
2866022|NCT03752918|Vitamins|vitamins|mesh-ancestor
2866023|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
2866024|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866025|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
2866026|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2866027|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
2866028|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866029|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2866030|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2866031|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2866032|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
2866033|NCT03752749|Prednisolone|prednisolone|mesh-list
2866034|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2866035|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
2866036|NCT03752749|Hormones|hormones|mesh-ancestor
2866037|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2866038|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866039|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2866040|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866041|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
2866042|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2866043|NCT03752736|Protective Agents|protective agents|mesh-ancestor
2866044|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866045|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
2866046|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
2866047|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
2866048|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2866049|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
2866050|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866051|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2866052|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2866053|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
2866054|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866055|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866056|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2309191|NCT00323544|Zidovudine|zidovudine|mesh-list
2309192|NCT00323544|Emtricitabine|emtricitabine|mesh-list
2309193|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2309194|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
2309195|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309196|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2309197|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2309198|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309199|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309200|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2309201|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2309202|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
2309203|NCT00323583|Leucovorin|leucovorin|mesh-list
2309204|NCT00323583|Paclitaxel|paclitaxel|mesh-list
2309205|NCT00323583|Fluorouracil|fluorouracil|mesh-list
2309206|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
2309207|NCT00323583|Calcium|calcium|mesh-list
2309208|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2866057|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2866058|NCT03752658|Tenofovir|tenofovir|mesh-list
2866059|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
2866060|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2866061|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2866062|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2866063|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309209|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309210|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
2309211|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
2309212|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
2309213|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309214|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2309215|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309216|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
2309217|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2309218|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2309219|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
2309220|NCT00323583|Antidotes|antidotes|mesh-ancestor
2309221|NCT00323583|Protective Agents|protective agents|mesh-ancestor
2309222|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
2309223|NCT00323583|Vitamins|vitamins|mesh-ancestor
2309224|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
2309225|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2309226|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309227|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2309228|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2309229|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2309230|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309231|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309232|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
2309233|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309234|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2309235|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2309236|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
2866064|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866065|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2866066|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2866067|NCT03752476|Lactams|lactams|mesh-list
2866068|NCT03752476|beta-Lactams|beta-lactams|mesh-list
2309237|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2309238|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
2309239|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309240|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
2309241|NCT00323778|Protective Agents|protective agents|mesh-ancestor
2309242|NCT00323791|Gemcitabine|gemcitabine|mesh-list
2309243|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
2309244|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2309245|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
2309246|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309247|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309248|NCT00323791|Antiviral Agents|antiviral agents|mesh-ancestor
2309249|NCT00323791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309250|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309251|NCT00323791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2309252|NCT00323791|Immunologic Factors|immunologic factors|mesh-ancestor
2309253|NCT00323791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309254|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2309255|NCT00323804|Ribavirin|ribavirin|mesh-list
2866069|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2866070|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2866071|NCT03752437|Heparin|heparin|mesh-list
2866072|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
2866073|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2866074|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2866075|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866076|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
2866077|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2866078|NCT03752398|Ipilimumab|ipilimumab|mesh-list
2866079|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2866080|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866081|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2866082|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866083|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
2866084|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2866085|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866111|NCT03752294|Dabigatran|dabigatran|mesh-list
2866112|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
2866113|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2866114|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
2866115|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866116|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866117|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
2866118|NCT03752229|Diazepam|diazepam|mesh-list
2866119|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2866120|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
2866121|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
2866122|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
2866123|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866124|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866125|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2866126|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2866127|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866128|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2866129|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2866130|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2309256|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2309257|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
2866131|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2866132|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2866133|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2866134|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
2866135|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
2866136|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
2866137|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
2866138|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866139|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866140|NCT03752216|Niraparib|niraparib|mesh-list
2866141|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2866142|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866143|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309258|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309259|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
2309260|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309261|NCT00323817|Z 338|z 338|mesh-list
2866144|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866145|NCT03752190|Cosyntropin|cosyntropin|mesh-list
2866146|NCT03752190|Hormones|hormones|mesh-ancestor
2866147|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2866148|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866149|NCT03752138|Decitabine|decitabine|mesh-list
2866150|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2866151|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
2866152|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309262|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2309263|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309264|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309265|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
2309266|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309267|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309268|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2309269|NCT00323830|Capecitabine|capecitabine|mesh-list
2309270|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309271|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2309272|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
2309273|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866153|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866154|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866155|NCT03752125|Caffeine|caffeine|mesh-list
2866156|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2866157|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866158|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2866159|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866160|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866161|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2866162|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2866163|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
2866164|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866165|NCT03752112|Penicillins|penicillins|mesh-list
2866166|NCT03752112|Cefixime|cefixime|mesh-list
2309274|NCT00323843|Isoproterenol|isoproterenol|mesh-list
2309275|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2309276|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2309277|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
2309278|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309279|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309280|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309281|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2309282|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
2309283|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866167|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2866168|NCT03752112|Penicillin G|penicillin g|mesh-list
2866169|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
2866170|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2866171|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2866172|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
2866173|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866174|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2866175|NCT03751800|Dienogest|dienogest|mesh-list
2866176|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
2866177|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
2866178|NCT03751800|Estradiol|estradiol|mesh-list
2866179|NCT03751800|Estrogens|estrogens|mesh-ancestor
2866180|NCT03751800|Hormones|hormones|mesh-ancestor
2309284|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2309285|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
2309286|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2309287|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
2309288|NCT00323843|Protective Agents|protective agents|mesh-ancestor
2309289|NCT00323856|Factor VIII|factor viii|mesh-list
2309290|NCT00323856|Coagulants|coagulants|mesh-ancestor
2309291|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
2309292|NCT00323934|Mocetinostat|mocetinostat|mesh-list
2309293|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2309294|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309295|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309296|NCT00323947|Methylphenidate|methylphenidate|mesh-list
2309297|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2309298|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309299|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2309300|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2309301|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2309302|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309303|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
2309304|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866181|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2866182|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866183|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2866184|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
2866185|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2866186|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2866187|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2866188|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2866189|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2866190|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2866191|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2866192|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866193|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
2309305|NCT00323973|Bisoprolol|bisoprolol|mesh-list
2309306|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2309307|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
2309308|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
2309309|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309310|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309311|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2309312|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2866194|NCT03751761|Paclitaxel|paclitaxel|mesh-list
2866195|NCT03751761|Durvalumab|durvalumab|mesh-list
2866196|NCT03751761|Tremelimumab|tremelimumab|mesh-list
2866197|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2866198|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866199|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
2866200|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
2866201|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
2866202|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866203|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2866204|NCT03751631|Phenylephrine|phenylephrine|mesh-list
2866205|NCT03751631|Oxymetazoline|oxymetazoline|mesh-list
2866206|NCT03751631|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2866207|NCT03751631|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2866208|NCT03751631|Tropicamide|tropicamide|mesh-list
2866209|NCT03751631|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2866210|NCT03751631|Mydriatics|mydriatics|mesh-ancestor
2866211|NCT03751631|Autonomic Agents|autonomic agents|mesh-ancestor
2866212|NCT03751631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866213|NCT03751631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866214|NCT03751631|Sympathomimetics|sympathomimetics|mesh-ancestor
2866215|NCT03751631|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2866216|NCT03751631|Nasal Decongestants|nasal decongestants|mesh-ancestor
2866217|NCT03751631|Respiratory System Agents|respiratory system agents|mesh-ancestor
2866218|NCT03751631|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2866219|NCT03751631|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2866220|NCT03751631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2866221|NCT03751631|Adrenergic Agents|adrenergic agents|mesh-ancestor
2866222|NCT03751631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866223|NCT03751631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866224|NCT03751631|Protective Agents|protective agents|mesh-ancestor
2866225|NCT03751631|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2108602|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2108603|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108604|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
2108605|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108606|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108607|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
2108608|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
2108609|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108610|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
2108611|NCT02506673|Midazolam|midazolam|mesh-list
2108612|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2108613|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2309313|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2309314|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
2309315|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309316|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309317|NCT00323986|Azithromycin|azithromycin|mesh-list
2309318|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2309319|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309320|NCT00324012|Docetaxel|docetaxel|mesh-list
2309321|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309322|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
2309323|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
2866226|NCT03751631|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2866227|NCT03751631|Cholinergic Agents|cholinergic agents|mesh-ancestor
2309324|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
2309325|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309326|NCT00324025|Efungumab|efungumab|mesh-list
2309327|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
2309328|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309329|NCT00324051|Olanzapine|olanzapine|mesh-list
2309330|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
2309331|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
2309332|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309333|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309334|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2309335|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2309336|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2309337|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2309338|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2309339|NCT00324051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2309340|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2309341|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2309342|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309343|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309344|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
2309345|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
2309346|NCT00324077|Dasatinib|dasatinib|mesh-list
2866228|NCT03751514|Azithromycin|azithromycin|mesh-list
2866229|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2866230|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2866231|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2866232|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2866233|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2866234|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866235|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866236|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2866237|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2866238|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2866239|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
2866240|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866241|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866242|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2866243|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2866244|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
2866245|NCT03751436|Venetoclax|venetoclax|mesh-list
2866246|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866247|NCT03751423|Fentanyl|fentanyl|mesh-list
2866248|NCT03751423|Morphine|morphine|mesh-list
2866249|NCT03751423|Ketamine|ketamine|mesh-list
2866250|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2866251|NCT03751423|Narcotics|narcotics|mesh-ancestor
2866252|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866253|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866254|NCT03751423|Analgesics|analgesics|mesh-ancestor
2866255|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
2866256|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866257|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2866258|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2866259|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
2866260|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
2309347|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309348|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2309349|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866261|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2866262|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2866263|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866264|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866265|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2866266|NCT03751358|Anesthetics|anesthetics|mesh-list
2866267|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
2866268|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866269|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866270|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
2866271|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866272|NCT03751332|Tacrolimus|tacrolimus|mesh-list
2866273|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2866274|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
2866275|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866276|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2866277|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866278|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866279|NCT03751228|BMS-986165|bms-986165|mesh-list
2866280|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
2866281|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2866282|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866283|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866284|NCT03751202|Fluticasone|fluticasone|mesh-list
2866285|NCT03751202|Xhance|xhance|mesh-list
2866286|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2866287|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2866288|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2866289|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2866290|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
2866291|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866292|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866293|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2866294|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
2866295|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
2866296|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2866297|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2866298|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2866299|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2866300|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
2866301|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866302|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866303|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
2866304|NCT03751202|Hormones|hormones|mesh-ancestor
2866305|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2866306|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
2866307|NCT03751176|Leucovorin|leucovorin|mesh-list
2866308|NCT03751176|Folic Acid|folic acid|mesh-list
2866309|NCT03751176|Fluorouracil|fluorouracil|mesh-list
2866310|NCT03751176|Irinotecan|irinotecan|mesh-list
2866311|NCT03751176|Panitumumab|panitumumab|mesh-list
2866312|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
2866313|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
2309350|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309351|NCT00324129|Mocetinostat|mocetinostat|mesh-list
2309352|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2309353|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309354|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309355|NCT00324142|Tinidazole|tinidazole|mesh-list
2309356|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
2309357|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309358|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2309359|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309360|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2309361|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2309362|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2309363|NCT00324194|Mocetinostat|mocetinostat|mesh-list
2309364|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2309365|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309366|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309367|NCT00324220|Mocetinostat|mocetinostat|mesh-list
2309368|NCT00324220|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2309369|NCT00324220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309370|NCT00324220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309371|NCT00324298|Etoposide|etoposide|mesh-list
2309372|NCT00324298|Bleomycin|bleomycin|mesh-list
2309373|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309374|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2309375|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2309376|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2309377|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309378|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309379|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2309380|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
2866314|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866315|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2866316|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309381|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2309382|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2309383|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309384|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2309385|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2309386|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309387|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309388|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309389|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2309390|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
2309391|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2309392|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309393|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2309394|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2309395|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2309396|NCT00324363|Exenatide|exenatide|mesh-list
2309397|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2866317|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2866318|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
2866319|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866320|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2866321|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2866322|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866323|NCT03751176|Antidotes|antidotes|mesh-ancestor
2866324|NCT03751176|Protective Agents|protective agents|mesh-ancestor
2866325|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
2866326|NCT03751176|Vitamins|vitamins|mesh-ancestor
2309398|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309399|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2309400|NCT00324363|Incretins|incretins|mesh-ancestor
2309401|NCT00324363|Hormones|hormones|mesh-ancestor
2309402|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2309403|NCT00324376|Sevelamer|sevelamer|mesh-list
2309404|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
2309405|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
2309406|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309407|NCT00324389|Interferons|interferons|mesh-list
2309408|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
2309409|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309410|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
2309411|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309412|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
2309413|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309414|NCT00324454|Levetiracetam|levetiracetam|mesh-list
2309415|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
2309416|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
2309417|NCT00324467|Acetaminophen|acetaminophen|mesh-list
2309418|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
2309419|NCT00324467|Promethazine|promethazine|mesh-list
2309420|NCT00324467|Dexamethasone|dexamethasone|mesh-list
2309421|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
2866327|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
2866328|NCT03751176|Hematinics|hematinics|mesh-ancestor
2866329|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2866330|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
2866331|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
2866332|NCT03751163|Hydroquinone|hydroquinone|mesh-list
2866333|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2866334|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2866335|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866336|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
2866337|NCT03751163|Coagulants|coagulants|mesh-ancestor
2866338|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2866339|NCT03751163|Protective Agents|protective agents|mesh-ancestor
2866340|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866341|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
2866342|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
2866343|NCT03751111|Naloxone|naloxone|mesh-list
2866344|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2866345|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866346|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
2866347|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866348|NCT03751098|Phenylephrine|phenylephrine|mesh-list
2866349|NCT03751098|Oxymetazoline|oxymetazoline|mesh-list
2866350|NCT03751098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2866351|NCT03751098|Tropicamide|tropicamide|mesh-list
2866352|NCT03751098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2866353|NCT03751098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2866354|NCT03751098|Mydriatics|mydriatics|mesh-ancestor
2866355|NCT03751098|Autonomic Agents|autonomic agents|mesh-ancestor
2866356|NCT03751098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866357|NCT03751098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866358|NCT03751098|Sympathomimetics|sympathomimetics|mesh-ancestor
2866359|NCT03751098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2866360|NCT03751098|Nasal Decongestants|nasal decongestants|mesh-ancestor
2866361|NCT03751098|Respiratory System Agents|respiratory system agents|mesh-ancestor
2866362|NCT03751098|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2866363|NCT03751098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2866364|NCT03751098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2866365|NCT03751098|Adrenergic Agents|adrenergic agents|mesh-ancestor
2866366|NCT03751098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866367|NCT03751098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866368|NCT03751098|Protective Agents|protective agents|mesh-ancestor
2866369|NCT03751098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2866370|NCT03751098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2866371|NCT03751098|Cholinergic Agents|cholinergic agents|mesh-ancestor
2866372|NCT03751059|Dexamethasone|dexamethasone|mesh-list
2866373|NCT03751059|Bromfenac|bromfenac|mesh-list
2866374|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2866375|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
2309422|NCT00324467|Prednisone|prednisone|mesh-list
2309423|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
2866376|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
2866377|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866378|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866379|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2866380|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
2866381|NCT03751059|Hormones|hormones|mesh-ancestor
2866382|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2866383|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2866384|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866385|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2866386|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2866387|NCT03751059|Analgesics|analgesics|mesh-ancestor
2866388|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
2866389|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2866390|NCT03750968|Carotenoids|carotenoids|mesh-list
2866391|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
2866392|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866393|NCT03750968|Protective Agents|protective agents|mesh-ancestor
2866394|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866395|NCT03750916|Docetaxel|docetaxel|mesh-list
2866396|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866397|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
2866398|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
2866399|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
2866400|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866401|NCT03750786|Leucovorin|leucovorin|mesh-list
2866402|NCT03750786|Antidotes|antidotes|mesh-ancestor
2866403|NCT03750786|Protective Agents|protective agents|mesh-ancestor
2866404|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866405|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
2866406|NCT03750786|Vitamins|vitamins|mesh-ancestor
2866407|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
2866408|NCT03750773|Gabapentin|gabapentin|mesh-list
2866409|NCT03750773|Analgesics|analgesics|mesh-ancestor
2866410|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
2866411|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866412|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866413|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
2866414|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2866415|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2866416|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866417|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2866418|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2866419|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2866420|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866421|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866422|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
2866423|NCT03750760|Atorvastatin|atorvastatin|mesh-list
2866424|NCT03750760|Ezetimibe|ezetimibe|mesh-list
2309424|NCT00324467|Ifosfamide|ifosfamide|mesh-list
2309425|NCT00324467|Rituximab|rituximab|mesh-list
2309426|NCT00324467|Carboplatin|carboplatin|mesh-list
2309427|NCT00324467|Doxorubicin|doxorubicin|mesh-list
2309428|NCT00324467|Etoposide|etoposide|mesh-list
2309429|NCT00324467|Vincristine|vincristine|mesh-list
2866425|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2866426|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2866427|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
2866428|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866429|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2866430|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2866431|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866432|NCT03750721|Rifampin|rifampin|mesh-list
2866433|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2866434|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
2866435|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2309430|NCT00324467|Ondansetron|ondansetron|mesh-list
2309431|NCT00324467|BB 1101|bb 1101|mesh-list
2309432|NCT00324467|Mesna|mesna|mesh-list
2309433|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2309434|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
2309435|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309436|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2309437|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2309438|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
2309439|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309440|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309441|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2309442|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2309443|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
2309444|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
2309445|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309446|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2309447|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
2309448|NCT00324467|Hormones|hormones|mesh-ancestor
2309449|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2866436|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2866437|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
2866438|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2866439|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866440|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866441|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2866442|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2866443|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2866444|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2866445|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2866446|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2866447|NCT03750669|Folic Acid|folic acid|mesh-list
2866448|NCT03750669|Gemcitabine|gemcitabine|mesh-list
2866449|NCT03750669|Paclitaxel|paclitaxel|mesh-list
2866450|NCT03750669|Fluorouracil|fluorouracil|mesh-list
2309450|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2309451|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
2309452|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309453|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2866451|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
2866452|NCT03750669|Irinotecan|irinotecan|mesh-list
2866453|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2866454|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866455|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
2866456|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
2866457|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
2866458|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866459|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2866460|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
2866461|NCT03750669|Antiviral Agents|antiviral agents|mesh-ancestor
2866462|NCT03750669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2866463|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866464|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2866465|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
2866466|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866467|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2866468|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2866469|NCT03750669|Hematinics|hematinics|mesh-ancestor
2866470|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
2866471|NCT03750669|Vitamins|vitamins|mesh-ancestor
2866472|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
2866473|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
2866474|NCT03750656|Tamsulosin|tamsulosin|mesh-list
2866475|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2866476|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2866477|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2866478|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
2866479|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866480|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866481|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866482|NCT03750656|Urological Agents|urological agents|mesh-ancestor
2866483|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2866484|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2866485|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2866486|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
2866487|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866488|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2866489|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
2866490|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
2866491|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
2866492|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2866493|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2866494|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
2866495|NCT03750383|Cyclosporine|cyclosporine|mesh-list
2866496|NCT03750383|Prednisone|prednisone|mesh-list
2866497|NCT03750383|Cyclosporins|cyclosporins|mesh-list
2866498|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2866499|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
2866500|NCT03750383|Hormones|hormones|mesh-ancestor
2866501|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2309454|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2866502|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866503|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2866504|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866505|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866506|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866507|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2309455|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2309456|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2309457|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2309458|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
2309459|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
2309460|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
2309461|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2309462|NCT00324467|Analgesics|analgesics|mesh-ancestor
2309463|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
2309464|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
2309465|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
2309466|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
2309467|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2309468|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
2866508|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
2866509|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
2866510|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2866511|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
2866512|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2866513|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2866514|NCT03750136|Furosemide|furosemide|mesh-list
2866515|NCT03750136|Diuretics|diuretics|mesh-ancestor
2866516|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
2866517|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309469|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309470|NCT00324467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2309471|NCT00324467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2309472|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2309473|NCT00324467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2309474|NCT00324467|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2309475|NCT00324467|Protective Agents|protective agents|mesh-ancestor
2309476|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2309477|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2309478|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
2866518|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2866519|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2866520|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866521|NCT03750071|Avelumab|avelumab|mesh-list
2866522|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2866523|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309479|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
2309480|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2309481|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
2309482|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
2309483|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2309484|NCT00324480|Vorinostat|vorinostat|mesh-list
2309485|NCT00324480|Alvocidib|alvocidib|mesh-list
2309486|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309487|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2309488|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866524|NCT03749915|Tetracaine|tetracaine|mesh-list
2866525|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
2866526|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
2866527|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866528|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866529|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
2866530|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866531|NCT03749902|Misoprostol|misoprostol|mesh-list
2866532|NCT03749902|Oxytocin|oxytocin|mesh-list
2866533|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
2866534|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2866535|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309489|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309490|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
2309491|NCT00324480|Growth Substances|growth substances|mesh-ancestor
2309492|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309493|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2309494|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
2309495|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2309496|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309497|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2309498|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
2309499|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2866536|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2866537|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
2866538|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2866539|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2866540|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
2866541|NCT03749850|Doxorubicin|doxorubicin|mesh-list
2309500|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309501|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309502|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309503|NCT00324519|Misoprostol|misoprostol|mesh-list
2309504|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2309505|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
2309506|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2309507|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309508|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2309509|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2309510|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
2309511|NCT00324558|Bemiparin|bemiparin|mesh-list
2309512|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
2309513|NCT00324571|Calcium|calcium|mesh-list
2866542|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2866543|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2866544|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
2866545|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866546|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2866547|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2866548|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
2866549|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866550|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866551|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2866552|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2309514|NCT00324571|Sevelamer|sevelamer|mesh-list
2309515|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2309516|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309517|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
2309518|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
2866553|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2866554|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2866555|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866556|NCT03749733|Megestrol|megestrol|mesh-list
2866557|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2866558|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2866559|NCT03749733|Estradiol|estradiol|mesh-list
2866560|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2866561|NCT03749733|Estrogens|estrogens|mesh-ancestor
2866562|NCT03749733|Hormones|hormones|mesh-ancestor
2866563|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2866564|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866565|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2866566|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
2309519|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866567|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2309520|NCT00324597|Gemcitabine|gemcitabine|mesh-list
2309521|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
2309522|NCT00324597|Imetelstat|imetelstat|mesh-list
2866568|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2866569|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2866570|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2866571|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2866572|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2866573|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866574|NCT03749642|Gabapentin|gabapentin|mesh-list
2866575|NCT03749642|Trazodone|trazodone|mesh-list
2866576|NCT03749642|Analgesics|analgesics|mesh-ancestor
2866577|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
2866578|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866579|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866580|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
2866581|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2866582|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2866583|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866584|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2866585|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2866586|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2866587|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866588|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866589|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
2866590|NCT03749642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2866591|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2866592|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2866593|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
2866594|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2866595|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
2866596|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
2866597|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
2866598|NCT03749590|Analgesics|analgesics|mesh-ancestor
2866599|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
2866600|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866601|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866602|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
2866603|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108614|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108615|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108616|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2108617|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2108618|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2108619|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2108620|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
2108621|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
2108622|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
2108623|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
2108624|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108625|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309523|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2309524|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
2309525|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309526|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309527|NCT00324597|Antiviral Agents|antiviral agents|mesh-ancestor
2309528|NCT00324597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309529|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309530|NCT00324597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2309531|NCT00324597|Immunologic Factors|immunologic factors|mesh-ancestor
2309532|NCT00324597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309533|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2309534|NCT00324610|Capecitabine|capecitabine|mesh-list
2309535|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2309536|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
2866604|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2866605|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
2866606|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2866607|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2866608|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866609|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2866610|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
2866611|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2108626|NCT02506816|Olaparib|olaparib|mesh-list
2866618|NCT03749408|Mannitol|mannitol|mesh-list
2866619|NCT03749408|Bupivacaine|bupivacaine|mesh-list
2866620|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
2866621|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
2866622|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866623|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866624|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
2866625|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866626|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2866627|NCT03749408|Diuretics|diuretics|mesh-ancestor
2866628|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
2866629|NCT03749356|Tacrolimus|tacrolimus|mesh-list
2866630|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2866631|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
2866632|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866633|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2866634|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866635|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866636|NCT03749226|Aztreonam|aztreonam|mesh-list
2866637|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2866638|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2866639|NCT03749174|Anesthetics|anesthetics|mesh-list
2866640|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866641|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866642|NCT03749109|Quinagolide|quinagolide|mesh-list
2866643|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
2866644|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
2866645|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866646|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866647|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866648|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
2866649|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2866650|NCT03749096|Antibodies|antibodies|mesh-list
2866651|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
2866652|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2866653|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
2866654|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866660|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
2866661|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2866662|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
2866663|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2866664|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
2866665|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866666|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866667|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
2866668|NCT03749018|Prednisone|prednisone|mesh-list
2866669|NCT03749018|Cortisone|cortisone|mesh-list
2866670|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
2866671|NCT03749018|Rituximab|rituximab|mesh-list
2866672|NCT03749018|Doxorubicin|doxorubicin|mesh-list
2866673|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2866674|NCT03749018|Nivolumab|nivolumab|mesh-list
2866675|NCT03749018|Etoposide|etoposide|mesh-list
2866676|NCT03749018|Vincristine|vincristine|mesh-list
2866677|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
2866678|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
2866679|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2866680|NCT03749018|Antibodies|antibodies|mesh-list
2866681|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
2309537|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309538|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309539|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
2309540|NCT00324623|Fludarabine|fludarabine|mesh-list
2309541|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
2309542|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2309543|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
2866682|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2866683|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2866684|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
2309544|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309545|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2309546|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2866685|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866686|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2866687|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2866688|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
2866689|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866690|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866691|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2866692|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2866693|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2866694|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2866695|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866696|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2866697|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
2866698|NCT03749018|Hormones|hormones|mesh-ancestor
2866699|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2866700|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2866701|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2866702|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2866703|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
2866704|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
2866705|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
2866706|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
2866707|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
2866708|NCT03748966|Calcitriol|calcitriol|mesh-list
2866709|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
2866710|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2866711|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866712|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2866713|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2866714|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866715|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2866716|NCT03748966|Vitamins|vitamins|mesh-ancestor
2866717|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
2866718|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2866719|NCT03748940|Mirikizumab|mirikizumab|mesh-list
2866720|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2866721|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2866722|NCT03748940|Analgesics|analgesics|mesh-ancestor
2866723|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
2866724|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866725|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866726|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2866727|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2866728|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2866729|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2866730|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
2866731|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866732|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
2866733|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2866734|NCT03748446|Xenon|xenon|mesh-list
2866735|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2866736|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
2866737|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
2866738|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866739|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866740|NCT03748433|Insulin|insulin|mesh-list
2866741|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2866742|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866743|NCT03748303|Pregnanolone|pregnanolone|mesh-list
2866744|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
2866745|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866746|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866747|NCT03748290|Pregabalin|pregabalin|mesh-list
2866748|NCT03748290|Analgesics|analgesics|mesh-ancestor
2866749|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
2866750|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866751|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866752|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
2866753|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2866754|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2866755|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309547|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
2309548|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309549|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309550|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2309551|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2309552|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
2309553|NCT00324688|Tenofovir|tenofovir|mesh-list
2309554|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
2309555|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309556|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2309557|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2866756|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2866757|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2866758|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2866759|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866760|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2866761|NCT03748173|Calfactant|calfactant|mesh-list
2866762|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2866763|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
2866764|NCT03748147|Misoprostol|misoprostol|mesh-list
2866765|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2866766|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
2866767|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2866768|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866769|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2866770|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2866771|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
2866772|NCT03748108|Lidocaine|lidocaine|mesh-list
2866773|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
2866774|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
2866775|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866776|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866777|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
2866778|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866779|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2866780|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2866781|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2866782|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2866783|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866784|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
2866785|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2866786|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
2866787|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866788|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866789|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2866790|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
2866791|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2866792|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
2866793|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866794|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866795|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2866796|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
2866797|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
2866798|NCT03748082|Protective Agents|protective agents|mesh-ancestor
2866799|NCT03748043|Lactoferrin|lactoferrin|mesh-list
2866800|NCT03748043|Teferrol|teferrol|mesh-list
2866801|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2866802|NCT03748043|Hematinics|hematinics|mesh-ancestor
2866803|NCT03747978|Amlodipine|amlodipine|mesh-list
2866804|NCT03747978|Perindopril|perindopril|mesh-list
2866805|NCT03747978|Indapamide|indapamide|mesh-list
2866806|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
2866807|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2866808|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2866809|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2866810|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866811|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2866812|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866813|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
2866814|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2866815|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
2866816|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866817|NCT03747978|Diuretics|diuretics|mesh-ancestor
2866818|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
2866819|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2866820|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
2866821|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2866822|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2866823|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2866824|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2866825|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866826|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
2866827|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866828|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866829|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2866830|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866831|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2866832|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2866833|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866834|NCT03747679|Mannitol|mannitol|mesh-list
2866835|NCT03747679|Sorbitol|sorbitol|mesh-list
2866836|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2866837|NCT03747679|Diuretics|diuretics|mesh-ancestor
2866838|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
2866839|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866840|NCT03747679|Cathartics|cathartics|mesh-ancestor
2866841|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2866842|NCT03747614|Fluorometholone|fluorometholone|mesh-list
2866843|NCT03747614|Tacrolimus|tacrolimus|mesh-list
2866844|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2866845|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
2866846|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866847|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2866848|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866849|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866850|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2866851|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
2866852|NCT03747614|Hormones|hormones|mesh-ancestor
2866853|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2866854|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2866855|NCT03747562|Gabapentin|gabapentin|mesh-list
2866856|NCT03747562|Analgesics|analgesics|mesh-ancestor
2866857|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
2866858|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866859|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866860|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
2866861|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2866862|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2866863|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866864|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2866865|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2866866|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2866867|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866868|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866869|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
2866870|NCT03747536|Bromides|bromides|mesh-list
2309558|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309559|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309560|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2309561|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2309562|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
2309563|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2309564|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2309565|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309566|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2309567|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309568|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2309569|NCT00324727|Melphalan|melphalan|mesh-list
2309570|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2309571|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
2309572|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309573|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309574|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2309575|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2309576|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
2309577|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309578|NCT00324766|Simendan|simendan|mesh-list
2309579|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2309580|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
2309581|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2866871|NCT03747536|Ipratropium|ipratropium|mesh-list
2866872|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
2866873|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2866874|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
2866875|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866876|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866877|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2866878|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
2866879|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2309582|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2309583|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309584|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309585|NCT00324766|Protective Agents|protective agents|mesh-ancestor
2309586|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309587|NCT00324779|Rituximab|rituximab|mesh-list
2866880|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
2866881|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866882|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866883|NCT03747523|Vitamin D|vitamin d|mesh-list
2866884|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
2866885|NCT03747523|Vitamins|vitamins|mesh-ancestor
2866886|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
2866887|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866888|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2866889|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2866890|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
2866891|NCT03747432|Propofol|propofol|mesh-list
2866892|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2866893|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866894|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866895|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2866896|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
2866897|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
2866898|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2866899|NCT03747432|Analgesics|analgesics|mesh-ancestor
2866900|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
2866901|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866902|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2866903|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2866904|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2866905|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
2866906|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866907|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866908|NCT03747419|Avelumab|avelumab|mesh-list
2866909|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2866910|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866911|NCT03747341|Fentanyl|fentanyl|mesh-list
2866912|NCT03747341|Oxycodone|oxycodone|mesh-list
2866913|NCT03747341|Buprenorphine|buprenorphine|mesh-list
2866914|NCT03747341|Ondansetron|ondansetron|mesh-list
2866915|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2866916|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2866917|NCT03747341|Narcotics|narcotics|mesh-ancestor
2866918|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866919|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866920|NCT03747341|Analgesics|analgesics|mesh-ancestor
2866921|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
2866922|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866923|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2866924|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2866925|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
2866926|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
2309588|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2309589|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309590|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
2309591|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309592|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2309593|NCT00324792|Insulin|insulin|mesh-list
2309594|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2309595|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309596|NCT00324818|Azithromycin|azithromycin|mesh-list
2309597|NCT00324818|Metronidazole|metronidazole|mesh-list
2309598|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2309599|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309600|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2309601|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2309602|NCT00324831|Prednisone|prednisone|mesh-list
2309603|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
2309604|NCT00324831|Rituximab|rituximab|mesh-list
2309605|NCT00324831|Doxorubicin|doxorubicin|mesh-list
2309606|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2309607|NCT00324831|Vincristine|vincristine|mesh-list
2309608|NCT00324831|Vaccines|vaccines|mesh-list
2309609|NCT00324831|Antibodies|antibodies|mesh-list
2309610|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
2866927|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2866928|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
2866929|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
2866930|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2866931|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
2866932|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
2866933|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2866934|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
2866935|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866936|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866937|NCT03747341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2866938|NCT03747341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2866939|NCT03747341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2866940|NCT03747341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2866941|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
2866942|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2866943|NCT03747159|Belimumab|belimumab|mesh-list
2866944|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2866945|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
2866946|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866947|NCT03747120|Paclitaxel|paclitaxel|mesh-list
2866948|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
2866949|NCT03747120|Trastuzumab|trastuzumab|mesh-list
2866950|NCT03747120|Pertuzumab|pertuzumab|mesh-list
2866951|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2866952|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866953|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
2866954|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
2866955|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
2866956|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866957|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2866958|NCT03747094|Fentanyl|fentanyl|mesh-list
2866959|NCT03747094|Ketamine|ketamine|mesh-list
2309611|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2309612|NCT00324831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2309613|NCT00324831|Sargramostim|sargramostim|mesh-list
2866960|NCT03747094|Analgesics|analgesics|mesh-ancestor
2866961|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
2866962|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2866963|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866964|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2866965|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2866966|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
2866967|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
2866968|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866969|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2866970|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2866971|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866972|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866973|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2309614|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2309615|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
2866974|NCT03747094|Narcotics|narcotics|mesh-ancestor
2108627|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2108628|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108629|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108630|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108631|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
2108632|NCT02506868|Hematinics|hematinics|mesh-ancestor
2108633|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
2108634|NCT02506881|Hematinics|hematinics|mesh-ancestor
2108635|NCT02507011|Carvedilol|carvedilol|mesh-list
2108636|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2108637|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2108638|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
2309616|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309617|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2309618|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2866975|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2866976|NCT03747081|Warfarin|warfarin|mesh-list
2866977|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
2866978|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
2866979|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2866980|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
2866981|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2866982|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
2866983|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866984|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866985|NCT03747042|Letrozole|letrozole|mesh-list
2866986|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2866987|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2866988|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2309619|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2309620|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
2309621|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309622|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309623|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2309624|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2309625|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2309626|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2309627|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2309628|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309629|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2309630|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
2309631|NCT00324831|Hormones|hormones|mesh-ancestor
2309632|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2309633|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2309634|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2309635|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
2309636|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
2309637|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
2309638|NCT00324922|Vancomycin|vancomycin|mesh-list
2309639|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2309640|NCT00324922|Trimethoprim|trimethoprim|mesh-list
2309641|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
2309642|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2309643|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309644|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2309645|NCT00324922|Renal Agents|renal agents|mesh-ancestor
2309646|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
2309647|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2309648|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2309649|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2866989|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2866990|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2866991|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2866992|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
2866993|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2866994|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2866995|NCT03746951|Ropivacaine|ropivacaine|mesh-list
2866996|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
2309650|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309651|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309652|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2309653|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2309654|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2108639|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2866997|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
2866998|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2866999|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867000|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
2867001|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309655|NCT00324948|Alprostadil|alprostadil|mesh-list
2309656|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2309657|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
2309658|NCT00324948|Urological Agents|urological agents|mesh-ancestor
2309659|NCT00324974|Lansoprazole|lansoprazole|mesh-list
2309660|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
2309661|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2309662|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2309663|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2309664|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867002|NCT03746821|Biotin|biotin|mesh-list
2867003|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
2867004|NCT03746821|Vitamins|vitamins|mesh-ancestor
2867005|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
2867006|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867007|NCT03746782|Thrombin|thrombin|mesh-list
2867008|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
2867009|NCT03746782|Coagulants|coagulants|mesh-ancestor
2867010|NCT03746769|Gastrins|gastrins|mesh-list
2867011|NCT03746769|Hormones|hormones|mesh-ancestor
2867012|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2867013|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867014|NCT03746691|Citalopram|citalopram|mesh-list
2867015|NCT03746691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2867016|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2867017|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2867018|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867019|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2867020|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
2867021|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867022|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2867023|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
2867024|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2867025|NCT03746652|Dexamethasone|dexamethasone|mesh-list
2867026|NCT03746652|Daratumumab|daratumumab|mesh-list
2867027|NCT03746652|Ixazomib|ixazomib|mesh-list
2867028|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867029|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
2867030|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
2867031|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867032|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867033|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2867034|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
2867035|NCT03746652|Hormones|hormones|mesh-ancestor
2867036|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2309665|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309666|NCT00325000|Amitriptyline|amitriptyline|mesh-list
2309667|NCT00325000|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2309668|NCT00325000|Sertraline|sertraline|mesh-list
2309669|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
2309670|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2309671|NCT00325000|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2309672|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2309673|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2309674|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867037|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2867038|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867039|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
2867040|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867041|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867042|NCT03746444|Anesthetics|anesthetics|mesh-list
2867043|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867044|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867045|NCT03746366|Corticosterone|corticosterone|mesh-list
2867046|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867047|NCT03746340|Propofol|propofol|mesh-list
2867048|NCT03746340|Sevoflurane|sevoflurane|mesh-list
2867049|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2867050|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867051|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867052|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2867053|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
2867054|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
2867055|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2867056|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2867057|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
2867058|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2867059|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2867060|NCT03746275|Aspirin|aspirin|mesh-list
2867061|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
2867062|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2867063|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2867064|NCT03746275|Analgesics|analgesics|mesh-ancestor
2867065|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
2867066|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867067|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867068|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867069|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2867070|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2867071|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2867072|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867073|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2867074|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2867075|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867076|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
2867077|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2867078|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
2867079|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2867080|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
2867081|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
2867082|NCT03746249|Lenvatinib|lenvatinib|mesh-list
2867083|NCT03746249|Antibodies|antibodies|mesh-list
2867084|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
2867085|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
2867086|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867087|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867088|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2867089|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867090|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867091|NCT03746223|Rituximab|rituximab|mesh-list
2867092|NCT03746223|Methotrexate|methotrexate|mesh-list
2867093|NCT03746223|Lenalidomide|lenalidomide|mesh-list
2867094|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2867095|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867096|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
2867097|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867098|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2867099|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2867100|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
2867101|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2867102|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2867103|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
2309675|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309676|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
2309677|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309678|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2309679|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2309680|NCT00325000|Analgesics|analgesics|mesh-ancestor
2309681|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
2309682|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309683|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2309684|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
2309685|NCT00325000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2309686|NCT00325000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2309687|NCT00325000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2309688|NCT00325026|Misoprostol|misoprostol|mesh-list
2867104|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867105|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
2867106|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867107|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2867108|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2867109|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2867110|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2309689|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2309690|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
2309691|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2309692|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309693|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2309694|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2309695|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
2309696|NCT00325104|Calcium|calcium|mesh-list
2309697|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
2309698|NCT00325104|Hormones|hormones|mesh-list
2309699|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2309700|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309701|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2309702|NCT00325117|Vildagliptin|vildagliptin|mesh-list
2867111|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2867112|NCT03746223|Growth Substances|growth substances|mesh-ancestor
2867113|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
2309703|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2108640|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108641|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108642|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2108643|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
2108644|NCT02507011|Protective Agents|protective agents|mesh-ancestor
2108645|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2867114|NCT03746158|Curcumin|curcumin|mesh-list
2867115|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2867116|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2867117|NCT03746158|Analgesics|analgesics|mesh-ancestor
2867118|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
2867119|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867120|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867121|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867122|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2867123|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867124|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867125|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867126|NCT03746119|Nicotine|nicotine|mesh-list
2867127|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2867128|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
2867129|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867130|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867131|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2867132|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2867133|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
2867134|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2867135|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867136|NCT03746106|Thiamine|thiamine|mesh-list
2867137|NCT03746106|Metformin|metformin|mesh-list
2867138|NCT03746106|Trimethoprim|trimethoprim|mesh-list
2867139|NCT03746106|Vitamins|vitamins|mesh-ancestor
2867140|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
2867141|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867142|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2867143|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
2867144|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2867145|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2867146|NCT03746106|Renal Agents|renal agents|mesh-ancestor
2867147|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
2867148|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2867149|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2867150|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2867151|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867152|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867153|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2867154|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2867155|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2867156|NCT03746080|Plerixafor|plerixafor|mesh-list
2867157|NCT03746080|Temozolomide|temozolomide|mesh-list
2867158|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2867159|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
2867160|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867161|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867162|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2867163|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2867164|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
2867165|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108646|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108647|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2108648|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
2108649|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2108650|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2108651|NCT02507219|Ibuprofen|ibuprofen|mesh-list
2108652|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2108653|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2108654|NCT02507219|Analgesics|analgesics|mesh-ancestor
2108655|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
2108656|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108657|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108658|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2108659|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2867176|NCT03745950|Olaparib|olaparib|mesh-list
2867177|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2867178|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867179|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867180|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867181|NCT03745911|Paclitaxel|paclitaxel|mesh-list
2867182|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2867183|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867184|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
2867185|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
2867186|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
2867187|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867188|NCT03745807|Nivolumab|nivolumab|mesh-list
2867189|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2867190|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867191|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2867192|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867193|NCT03745716|Azacitidine|azacitidine|mesh-list
2867194|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2867195|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
2867196|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867197|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867198|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867199|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
2867200|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2867201|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2867202|NCT03745664|Prednisolone|prednisolone|mesh-list
2867203|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
2867204|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2867205|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
2867206|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867207|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
2867208|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
2867209|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867210|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867211|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2867212|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
2867213|NCT03745664|Hormones|hormones|mesh-ancestor
2309704|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309705|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2309706|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
2309707|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309708|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309709|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
2309710|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2309711|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2309712|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
2309713|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309714|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309715|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2867214|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2867215|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2867216|NCT03745664|Protective Agents|protective agents|mesh-ancestor
2867217|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2867218|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867219|NCT03745625|Propofol|propofol|mesh-list
2867220|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2867221|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867222|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867223|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2867224|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
2867225|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
2867226|NCT03745599|Diclofenac|diclofenac|mesh-list
2867227|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
2867228|NCT03745599|Benzydamine|benzydamine|mesh-list
2867229|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2108660|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2108661|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108662|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108663|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2108664|NCT02507375|Pertuzumab|pertuzumab|mesh-list
2108665|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108666|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2108667|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867230|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2867231|NCT03745599|Analgesics|analgesics|mesh-ancestor
2867232|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
2867233|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867234|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867235|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867236|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2867237|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2867238|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867239|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867240|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
2867241|NCT03745586|Hormones|hormones|mesh-ancestor
2867242|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2867243|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867244|NCT03745404|Lidocaine|lidocaine|mesh-list
2867245|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
2867246|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
2867247|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867248|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867249|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
2867250|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867251|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2867252|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2867253|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2867254|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2867255|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867256|NCT03745352|Azacitidine|azacitidine|mesh-list
2309716|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
2309717|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
2309718|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2309719|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
2309720|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309721|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309722|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
2309723|NCT00325169|Hormones|hormones|mesh-ancestor
2309724|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2309725|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
2867257|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2867258|NCT03745352|Pevonedistat|pevonedistat|mesh-list
2867259|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2867260|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
2867261|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867262|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867263|NCT03745326|Aldesleukin|aldesleukin|mesh-list
2867264|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
2867265|NCT03745326|Fludarabine|fludarabine|mesh-list
2867266|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2867267|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
2867268|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309726|NCT00325182|Levetiracetam|levetiracetam|mesh-list
2309727|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
2309728|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
2309729|NCT00325286|Carbamazepine|carbamazepine|mesh-list
2309730|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2309731|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309732|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
2309733|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2309734|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2309735|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309736|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
2309737|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2309738|NCT00325286|Analgesics|analgesics|mesh-ancestor
2309739|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
2309740|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309741|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2867269|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2867270|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2867271|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
2867272|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867273|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867274|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2867275|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2867276|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2867277|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
2867278|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309742|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2309743|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2309744|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2309745|NCT00325325|Everolimus|everolimus|mesh-list
2309746|NCT00325325|Tacrolimus|tacrolimus|mesh-list
2309747|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2309748|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
2309749|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309750|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2867279|NCT03745300|Atorvastatin|atorvastatin|mesh-list
2867280|NCT03745300|Simvastatin|simvastatin|mesh-list
2867281|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2309751|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309752|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309753|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309754|NCT00325351|Carboplatin|carboplatin|mesh-list
2309755|NCT00325351|Sagopilone|sagopilone|mesh-list
2309756|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867282|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2867283|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
2867284|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867285|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2867286|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2867287|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309757|NCT00325364|Insulin|insulin|mesh-list
2309758|NCT00325364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2309759|NCT00325364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2309760|NCT00325364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309761|NCT00325390|Clopidogrel|clopidogrel|mesh-list
2309762|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2309763|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2309764|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2309765|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2309766|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
2309767|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309768|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309769|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309770|NCT00325429|Vildagliptin|vildagliptin|mesh-list
2309771|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2309772|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867288|NCT03745261|Fluticasone|fluticasone|mesh-list
2867289|NCT03745261|Xhance|xhance|mesh-list
2867290|NCT03745261|Bromides|bromides|mesh-list
2867291|NCT03745261|Albuterol|albuterol|mesh-list
2867292|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
2867293|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2867294|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2867295|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867296|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2867297|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
2867298|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867299|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867300|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2867301|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
2867302|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
2867303|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2867304|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
2867305|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2867306|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
2309773|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2309774|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
2309775|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309776|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867307|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2867308|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867309|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2867310|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2867311|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2867312|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
2867313|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
2867314|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
2867315|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2867316|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
2867317|NCT03745261|Hormones|hormones|mesh-ancestor
2867318|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2867319|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
2867320|NCT03745170|Capecitabine|capecitabine|mesh-list
2867321|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
2867322|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2867323|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
2867324|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867325|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867326|NCT03745157|Insulin|insulin|mesh-list
2867327|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
2867328|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2867329|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867330|NCT03745105|Dexamethasone|dexamethasone|mesh-list
2867331|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
2867332|NCT03745105|Piroxicam|piroxicam|mesh-list
2867333|NCT03745105|Mepivacaine|mepivacaine|mesh-list
2867334|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2867335|NCT03745105|BB 1101|bb 1101|mesh-list
2867336|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867337|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
2867338|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
2867339|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867340|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867341|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2867342|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
2867343|NCT03745105|Hormones|hormones|mesh-ancestor
2867344|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2867345|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2867346|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867347|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
2867348|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
2867349|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867350|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
2867351|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
2309777|NCT00325455|Anacetrapib|anacetrapib|mesh-list
2309778|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2309779|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2309780|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
2309781|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309782|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2309783|NCT00325546|Rimonabant|rimonabant|mesh-list
2309784|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2309785|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2309786|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2309787|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309788|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309789|NCT00325546|Hormones|hormones|mesh-ancestor
2309790|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2309791|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309792|NCT00325637|Losartan|losartan|mesh-list
2309793|NCT00325637|Cilnidipine|cilnidipine|mesh-list
2309794|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2309795|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2309796|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2309797|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2309798|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309799|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2309800|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2867352|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867353|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867354|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2867355|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2867356|NCT03745105|Analgesics|analgesics|mesh-ancestor
2867357|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2867358|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2867359|NCT03745040|Bupivacaine|bupivacaine|mesh-list
2867360|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
2867361|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
2867362|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867363|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867364|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
2867365|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867366|NCT03744988|Androgens|androgens|mesh-list
2867367|NCT03744988|Hormones|hormones|mesh-ancestor
2309801|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2309802|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309803|NCT00325650|Rimonabant|rimonabant|mesh-list
2309804|NCT00325650|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2309805|NCT00325650|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2309806|NCT00325650|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2309807|NCT00325650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309808|NCT00325650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309809|NCT00325650|Hormones|hormones|mesh-ancestor
2309810|NCT00325650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2309811|NCT00325650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309812|NCT00325676|Pantoprazole|pantoprazole|mesh-list
2309813|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2309814|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2309815|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2309816|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309817|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309818|NCT00325689|Risperidone|risperidone|mesh-list
2309819|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2309820|NCT00325689|Aripiprazole|aripiprazole|mesh-list
2309821|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2309822|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
2309823|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309824|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309825|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309826|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2309827|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2309828|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2309829|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2309830|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2309831|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
2309832|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
2309833|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
2867368|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2867369|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867370|NCT03744949|Remifentanil|remifentanil|mesh-list
2867371|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2867372|NCT03744949|Narcotics|narcotics|mesh-ancestor
2867373|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867374|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867375|NCT03744949|Analgesics|analgesics|mesh-ancestor
2867376|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
2867377|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867378|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2867379|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867380|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867381|NCT03744806|Bevacizumab|bevacizumab|mesh-list
2867382|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2867383|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867384|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2867385|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2867386|NCT03744806|Growth Substances|growth substances|mesh-ancestor
2867387|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867388|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
2867389|NCT03744767|Spironolactone|spironolactone|mesh-list
2867390|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2867391|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
2867392|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2867393|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867394|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2867395|NCT03744767|Diuretics|diuretics|mesh-ancestor
2867396|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
2867397|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
2867398|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
2867399|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867400|NCT03744702|Protective Agents|protective agents|mesh-ancestor
2867401|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867402|NCT03744702|Vitamins|vitamins|mesh-ancestor
2867403|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
2867404|NCT03744689|Bupivacaine|bupivacaine|mesh-list
2867405|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
2867406|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
2867407|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867408|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867409|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
2867410|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867411|NCT03744663|Buprenorphine|buprenorphine|mesh-list
2867412|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2867413|NCT03744663|Naloxone|naloxone|mesh-list
2867414|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2867415|NCT03744663|Narcotics|narcotics|mesh-ancestor
2867416|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867417|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867418|NCT03744663|Analgesics|analgesics|mesh-ancestor
2867419|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
2867420|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867421|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2867422|NCT03744364|Misoprostol|misoprostol|mesh-list
2867423|NCT03744364|Dinoprostone|dinoprostone|mesh-list
2867424|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2867425|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
2867426|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2867427|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867428|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2309834|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2309835|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2309836|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2309837|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2309838|NCT00325715|Esomeprazole|esomeprazole|mesh-list
2309839|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2309840|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2309841|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2309842|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309843|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867429|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2867430|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
2867431|NCT03744247|Lenvatinib|lenvatinib|mesh-list
2867432|NCT03744247|Antibodies|antibodies|mesh-list
2867433|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
2867434|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
2867435|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867436|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867437|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2867438|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867439|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867440|NCT03744208|Cetuximab|cetuximab|mesh-list
2867441|NCT03744208|Antibodies|antibodies|mesh-list
2867442|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2867443|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
2867444|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867445|NCT03744208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2309844|NCT00325767|Albuterol|albuterol|mesh-list
2309845|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2309846|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
2309847|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309848|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309849|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2309850|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
2309851|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
2309852|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2309853|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2309854|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2309855|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2867446|NCT03744208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867447|NCT03744104|Vaccines|vaccines|mesh-list
2867448|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
2867449|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867450|NCT03744091|Dronabinol|dronabinol|mesh-list
2867451|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
2867452|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867453|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2867454|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2867455|NCT03744091|Analgesics|analgesics|mesh-ancestor
2867456|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
2867457|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867458|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2867459|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2867460|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2867461|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867462|NCT03744091|Hormones|hormones|mesh-ancestor
2867463|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2867464|NCT03743987|Pemetrexed|pemetrexed|mesh-list
2867465|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867466|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867467|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867468|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2867469|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2867470|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
2867471|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
2867472|NCT03743922|Vitamin D|vitamin d|mesh-list
2867473|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2867474|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867475|NCT03743922|Vitamins|vitamins|mesh-ancestor
2867476|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
2867477|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2867478|NCT03743896|Capsaicin|capsaicin|mesh-list
2867479|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
2867480|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
2867481|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
2867482|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867483|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867484|NCT03743883|Aspirin|aspirin|mesh-list
2867485|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2867486|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2867487|NCT03743883|Analgesics|analgesics|mesh-ancestor
2867488|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
2867489|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867490|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867491|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867492|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2309856|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
2309857|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309858|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309859|NCT00325793|Nicardipine|nicardipine|mesh-list
2309860|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2309861|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2309862|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2309863|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309864|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2309865|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309866|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
2309867|NCT00325806|Ramipril|ramipril|mesh-list
2309868|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2309869|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
2309870|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309871|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867493|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2867494|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2867495|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867496|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2867497|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2867498|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867499|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
2867500|NCT03743870|Bupivacaine|bupivacaine|mesh-list
2867501|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
2867502|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
2867503|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
2309872|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2309873|NCT00325845|Hylan|hylan|mesh-list
2309874|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
2309875|NCT00325845|Protective Agents|protective agents|mesh-ancestor
2309876|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309877|NCT00325858|Tramadol|tramadol|mesh-list
2309878|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2309879|NCT00325858|Narcotics|narcotics|mesh-ancestor
2309880|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867504|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867505|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867506|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
2867507|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867508|NCT03743805|Naloxone|naloxone|mesh-list
2867509|NCT03743805|Flumazenil|flumazenil|mesh-list
2867510|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2867511|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867512|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
2867513|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867514|NCT03743805|Antidotes|antidotes|mesh-ancestor
2867515|NCT03743805|Protective Agents|protective agents|mesh-ancestor
2867516|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
2867517|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
2867518|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2867519|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867520|NCT03743766|Nivolumab|nivolumab|mesh-list
2867521|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2867522|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867523|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2867524|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867525|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
2867526|NCT03743727|Ledipasvir|ledipasvir|mesh-list
2867527|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2867528|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
2867529|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2867530|NCT03743649|Lorazepam|lorazepam|mesh-list
2867531|NCT03743649|Haloperidol|haloperidol|mesh-list
2867532|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
2867533|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
2867534|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
2867535|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867536|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867537|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2867538|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2867539|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2867540|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867541|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2867542|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2309881|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867543|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
2867544|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2867545|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867546|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2867547|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
2867548|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2867549|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2867550|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
2867551|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
2867552|NCT03743636|Niacinamide|niacinamide|mesh-list
2867553|NCT03743636|Niacin|niacin|mesh-list
2309882|NCT00325858|Analgesics|analgesics|mesh-ancestor
2309883|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
2309884|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309885|NCT00325910|Metformin|metformin|mesh-list
2309886|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2309887|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309888|NCT00325936|Cilnidipine|cilnidipine|mesh-list
2309889|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2309890|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2309891|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309892|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2309893|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309894|NCT00325949|Acetaminophen|acetaminophen|mesh-list
2309895|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2309896|NCT00325949|Hydrocodone|hydrocodone|mesh-list
2309897|NCT00325949|Oxycodone|oxycodone|mesh-list
2309898|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2309899|NCT00325949|Analgesics|analgesics|mesh-ancestor
2309900|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
2309901|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309902|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309903|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
2309904|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2309905|NCT00325949|Narcotics|narcotics|mesh-ancestor
2309906|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2309907|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
2309908|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
2309909|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2309910|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2309911|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2309912|NCT00325962|Verapamil|verapamil|mesh-list
2309913|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2309914|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2309915|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2309916|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309917|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2309918|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309919|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
2309920|NCT00326027|Pantoprazole|pantoprazole|mesh-list
2309921|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2309922|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2309923|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2309924|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309925|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309926|NCT00326053|Budesonide|budesonide|mesh-list
2309927|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
2309928|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2309929|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2309930|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
2309931|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309932|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309933|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2309934|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
2309935|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
2309936|NCT00326053|Hormones|hormones|mesh-ancestor
2309937|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2309938|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2309939|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2867554|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
2867555|NCT03743636|Resveratrol|resveratrol|mesh-list
2867556|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
2867557|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867558|NCT03743636|Protective Agents|protective agents|mesh-ancestor
2867559|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867560|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867561|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2867562|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
2867563|NCT03743636|Vitamins|vitamins|mesh-ancestor
2867564|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
2309940|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2309941|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
2309942|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309943|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309944|NCT00326092|Timolol|timolol|mesh-list
2309945|NCT00326092|Brinzolamide|brinzolamide|mesh-list
2309946|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2309947|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2309948|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
2309949|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309950|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867565|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2867566|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
2867567|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2867568|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
2309951|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309952|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2309953|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2309954|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2309955|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2309956|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2309957|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
2309958|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2309959|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2309960|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2309961|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2309962|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309963|NCT00326131|Taxane|taxane|mesh-list
2309964|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2309965|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2309966|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
2309967|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2309968|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2309969|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2309970|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2309971|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309972|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2309973|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
2309974|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2309975|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2309976|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2309977|NCT00326235|Buspirone|buspirone|mesh-list
2309978|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2309979|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2309980|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2309981|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309982|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2867569|NCT03743428|Bevacizumab|bevacizumab|mesh-list
2867570|NCT03743428|Apatinib|apatinib|mesh-list
2867571|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2867572|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867573|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2867574|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2309983|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2309984|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
2309985|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309986|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309987|NCT00326248|Casopitant|casopitant|mesh-list
2309988|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
2309989|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
2309990|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2309991|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2309992|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2309993|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2309994|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2309995|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2309996|NCT00326287|Ceftriaxone|ceftriaxone|mesh-list
2309997|NCT00326287|Linezolid|linezolid|mesh-list
2309998|NCT00326287|Ceftobiprole|ceftobiprole|mesh-list
2867575|NCT03743428|Growth Substances|growth substances|mesh-ancestor
2867576|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867577|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
2867578|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2867579|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867580|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867581|NCT03743376|UB-421|ub-421|mesh-list
2867582|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2867583|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
2867584|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2867585|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
2867586|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2867587|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867588|NCT03743259|Charcoal|charcoal|mesh-list
2867589|NCT03743259|Antidotes|antidotes|mesh-ancestor
2867590|NCT03743259|Protective Agents|protective agents|mesh-ancestor
2867591|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867592|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
2867593|NCT03743246|Fludarabine|fludarabine|mesh-list
2867594|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2867595|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
2867596|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867597|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2867598|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2867599|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
2309999|NCT00326287|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2310000|NCT00326287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2310001|NCT00326287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2867600|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867601|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867602|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2867603|NCT03743103|Nitroprusside|nitroprusside|mesh-list
2867604|NCT03743103|Esmolol|esmolol|mesh-list
2867605|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2867606|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
2867607|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2867608|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867609|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2867610|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2867611|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2867612|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
2867613|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2867614|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310002|NCT00326287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2867615|NCT03743025|Dulaglutide|dulaglutide|mesh-list
2867616|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2867617|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867618|NCT03742986|Paclitaxel|paclitaxel|mesh-list
2867619|NCT03742986|Docetaxel|docetaxel|mesh-list
2867620|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2867621|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
2867622|NCT03742986|Doxorubicin|doxorubicin|mesh-list
2867623|NCT03742986|Nivolumab|nivolumab|mesh-list
2867624|NCT03742986|Trastuzumab|trastuzumab|mesh-list
2867625|NCT03742986|Pertuzumab|pertuzumab|mesh-list
2867626|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2867627|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867628|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
2867629|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
2867630|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
2867631|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867632|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2867633|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
2867634|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867635|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2867636|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2867637|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
2867638|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2867639|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2867640|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2867641|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2867642|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867643|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2310003|NCT00326287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310004|NCT00326287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310005|NCT00326300|Methylphenidate|methylphenidate|mesh-list
2310006|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2310007|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310008|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2310009|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2310010|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2310011|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310012|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
2310013|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310014|NCT00326352|Remifentanil|remifentanil|mesh-list
2867644|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2867645|NCT03742947|Hemostatics|hemostatics|mesh-list
2867646|NCT03742947|Coagulants|coagulants|mesh-ancestor
2867647|NCT03742921|Romidepsin|romidepsin|mesh-list
2867648|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2867649|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867650|NCT03742908|Clindamycin|clindamycin|mesh-list
2867651|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
2867652|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
2310015|NCT00326352|Propofol|propofol|mesh-list
2310016|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2310017|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2310018|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310019|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2310020|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
2310021|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
2310022|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2310023|NCT00326352|Narcotics|narcotics|mesh-ancestor
2867653|NCT03742908|Cefazolin|cefazolin|mesh-list
2867654|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2867655|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2867656|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2867657|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867658|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867659|NCT03742713|Docetaxel|docetaxel|mesh-list
2867660|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867661|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
2867662|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
2867663|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
2867664|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867665|NCT03742557|Ketamine|ketamine|mesh-list
2867666|NCT03742557|Analgesics|analgesics|mesh-ancestor
2867667|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
2867668|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867669|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867670|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2867671|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2867672|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
2867673|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
2867674|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867675|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2867676|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2867677|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2867678|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867679|NCT03742531|Oxytocin|oxytocin|mesh-list
2867680|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
2867681|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2867682|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867683|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
2867684|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2867685|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2867686|NCT03742466|Prednisolone|prednisolone|mesh-list
2867687|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
2867688|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2867689|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
2867690|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867691|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
2867692|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
2867693|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867694|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867695|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2867696|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
2867697|NCT03742466|Hormones|hormones|mesh-ancestor
2867698|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2867699|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2867700|NCT03742466|Protective Agents|protective agents|mesh-ancestor
2867701|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2867702|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867703|NCT03742336|Dabigatran|dabigatran|mesh-list
2867704|NCT03742336|Abrocitinib|abrocitinib|mesh-list
2867705|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
2867706|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2867707|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
2867708|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867709|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867710|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
2867711|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2867712|NCT03742323|Idelalisib|idelalisib|mesh-list
2867713|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867714|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867715|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867716|NCT03742310|Vitamin D|vitamin d|mesh-list
2867717|NCT03742310|Calcitriol|calcitriol|mesh-list
2867718|NCT03742310|Vitamins|vitamins|mesh-ancestor
2867719|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
2867720|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867721|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2867722|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2867723|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2867724|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2867725|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867726|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2867727|NCT03742297|Dexamethasone|dexamethasone|mesh-list
2867728|NCT03742297|Prednisone|prednisone|mesh-list
2867729|NCT03742297|Lenalidomide|lenalidomide|mesh-list
2867730|NCT03742297|Bortezomib|bortezomib|mesh-list
2867731|NCT03742297|Melphalan|melphalan|mesh-list
2867732|NCT03742297|Daratumumab|daratumumab|mesh-list
2867733|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867734|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
2867735|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
2867736|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867737|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867738|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2867739|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
2867740|NCT03742297|Hormones|hormones|mesh-ancestor
2867741|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2867742|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2310024|NCT00326352|Analgesics|analgesics|mesh-ancestor
2310025|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
2867743|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867744|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
2867745|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2867746|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2867747|NCT03742297|Growth Substances|growth substances|mesh-ancestor
2867748|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
2867749|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2867750|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
2867751|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867752|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2310026|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310027|NCT00326378|Docetaxel|docetaxel|mesh-list
2310028|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310029|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
2310030|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
2310031|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
2867753|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2867754|NCT03742258|Prednisone|prednisone|mesh-list
2867755|NCT03742258|Cortisone|cortisone|mesh-list
2867756|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
2867757|NCT03742258|Rituximab|rituximab|mesh-list
2310032|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310033|NCT00326391|Methylphenidate|methylphenidate|mesh-list
2310034|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2310035|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310036|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2310037|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2310038|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2310039|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310040|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
2867758|NCT03742258|Doxorubicin|doxorubicin|mesh-list
2867759|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2867760|NCT03742258|Vincristine|vincristine|mesh-list
2867761|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2867762|NCT03742258|Antibodies|antibodies|mesh-list
2867763|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
2867764|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2867765|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2867766|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
2867767|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867768|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2867769|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2867770|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
2867771|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867772|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867773|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2867774|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2867775|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2867776|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2867777|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867778|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867779|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
2867780|NCT03742258|Hormones|hormones|mesh-ancestor
2867781|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2867782|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2867783|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2310041|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310042|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2310043|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2310044|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2310045|NCT00326404|Desogestrel|desogestrel|mesh-list
2867784|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
2867785|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
2867786|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
2867787|NCT03742245|Olaparib|olaparib|mesh-list
2867788|NCT03742245|Vorinostat|vorinostat|mesh-list
2867789|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2867790|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867791|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867792|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867793|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2867794|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2867795|NCT03742232|Laxatives|laxatives|mesh-ancestor
2867796|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2867797|NCT03742193|Apatinib|apatinib|mesh-list
2867798|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867799|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2867800|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867801|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867802|NCT03742180|Ketorolac|ketorolac|mesh-list
2867803|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
2867804|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2867805|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867806|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867807|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2867808|NCT03742180|Analgesics|analgesics|mesh-ancestor
2867809|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
2867810|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867811|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2867812|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2867813|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2867814|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
2867815|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2867816|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867817|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2867818|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867819|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2867820|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2867821|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867822|NCT03742115|Dexamethasone|dexamethasone|mesh-list
2867823|NCT03742115|Etoposide|etoposide|mesh-list
2867824|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
2867825|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867826|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
2867827|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
2867828|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867829|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310046|NCT00326404|Estradiol|estradiol|mesh-list
2310047|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2310048|NCT00326404|Estrogens|estrogens|mesh-ancestor
2310049|NCT00326404|Hormones|hormones|mesh-ancestor
2310050|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2310051|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310052|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2310053|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
2867830|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2867831|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
2867832|NCT03742115|Hormones|hormones|mesh-ancestor
2867833|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2867834|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2867835|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867836|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2867837|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2867838|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2867839|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867840|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867841|NCT03741933|Apremilast|apremilast|mesh-list
2867842|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2867843|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2867844|NCT03741933|Analgesics|analgesics|mesh-ancestor
2310054|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2310055|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2310056|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2310057|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2310058|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2310059|NCT00326404|Progestins|progestins|mesh-ancestor
2310060|NCT00326456|Paclitaxel|paclitaxel|mesh-list
2310061|NCT00326456|Carboplatin|carboplatin|mesh-list
2310062|NCT00326456|Doxorubicin|doxorubicin|mesh-list
2310063|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2310064|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2310065|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310066|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
2310067|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
2310068|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
2310069|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310070|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2867845|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
2867846|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310071|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2310072|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2310073|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310074|NCT00326469|Lanreotide|lanreotide|mesh-list
2310075|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310076|NCT00326508|Daclizumab|daclizumab|mesh-list
2310077|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2310078|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
2310079|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310080|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
2310081|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
2867847|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867848|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867849|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2867850|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2867851|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2867852|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867853|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867854|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
2867855|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2867856|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2867857|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
2310082|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
2310083|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2310084|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310085|NCT00326664|Cediranib|cediranib|mesh-list
2310086|NCT00326664|Maleic acid|maleic acid|mesh-list
2310087|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310088|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310089|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310090|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2310091|NCT00326768|Telmisartan|telmisartan|mesh-list
2310092|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2310093|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2310094|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2310095|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2310096|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310097|NCT00326768|Diuretics|diuretics|mesh-ancestor
2310098|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
2310099|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310100|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2867858|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2867859|NCT03741686|Cathartics|cathartics|mesh-ancestor
2867860|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2867861|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2867862|NCT03741660|Cathartics|cathartics|mesh-ancestor
2867863|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2867864|NCT03741621|Psyllium|psyllium|mesh-list
2867865|NCT03741621|Cathartics|cathartics|mesh-ancestor
2867866|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2867867|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2867868|NCT03741517|Edotreotide|edotreotide|mesh-list
2867869|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2310101|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2310102|NCT00326807|Naltrexone|naltrexone|mesh-list
2867870|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867871|NCT03741478|Insulin|insulin|mesh-list
2867872|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2867873|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
2867874|NCT03741478|Olanzapine|olanzapine|mesh-list
2867875|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2867876|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867877|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
2867878|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
2867879|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867880|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2867881|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2867882|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2867883|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867884|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2867885|NCT03741478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2867886|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2867887|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2867888|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867889|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2867890|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
2867891|NCT03741426|Durvalumab|durvalumab|mesh-list
2867892|NCT03741426|Olaparib|olaparib|mesh-list
2867893|NCT03741426|Cediranib|cediranib|mesh-list
2867894|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2867895|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867896|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2867897|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867898|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867899|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2867900|NCT03741309|Calcium|calcium|mesh-list
2867901|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2867902|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867903|NCT03741244|Temozolomide|temozolomide|mesh-list
2867904|NCT03741244|Apatinib|apatinib|mesh-list
2867905|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2867906|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
2867907|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867908|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867909|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2867910|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867911|NCT03741101|Trametinib|trametinib|mesh-list
2867912|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867913|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2867914|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867915|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867916|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
2867917|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2867918|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2867919|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867920|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
2867921|NCT03741075|Coagulants|coagulants|mesh-ancestor
2867922|NCT03740958|Argatroban|argatroban|mesh-list
2867923|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
2867924|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2867925|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
2867926|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867927|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867928|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
2867929|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2867930|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2867931|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2867932|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
2867933|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867937|NCT03740893|Durvalumab|durvalumab|mesh-list
2867938|NCT03740893|Olaparib|olaparib|mesh-list
2867939|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2867940|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2867941|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2867942|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867943|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867944|NCT03740581|Insulin|insulin|mesh-list
2108668|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108669|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2108670|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
2108671|NCT02508077|Leucovorin|leucovorin|mesh-list
2108672|NCT02508077|Folic Acid|folic acid|mesh-list
2108673|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2108674|NCT02508077|Panitumumab|panitumumab|mesh-list
2108675|NCT02508077|Fluorouracil|fluorouracil|mesh-list
2108676|NCT02508077|Irinotecan|irinotecan|mesh-list
2108677|NCT02508077|Camptothecin|camptothecin|mesh-list
2108678|NCT02508077|Antibodies|antibodies|mesh-list
2108679|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
2108680|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2108681|NCT02508077|Calcium|calcium|mesh-list
2108682|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
2108683|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
2108684|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108685|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108686|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2867945|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2867946|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867947|NCT03740568|Progesterone|progesterone|mesh-list
2867948|NCT03740568|Progestins|progestins|mesh-ancestor
2867949|NCT03740568|Hormones|hormones|mesh-ancestor
2867950|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2867951|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867959|NCT03740516|Apremilast|apremilast|mesh-list
2867960|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2867961|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2867962|NCT03740516|Analgesics|analgesics|mesh-ancestor
2867963|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
2867964|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867965|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867966|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867967|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2867968|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2867969|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2867970|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2867971|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867972|NCT03740464|Sargramostim|sargramostim|mesh-list
2867973|NCT03740464|Lenograstim|lenograstim|mesh-list
2867974|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
2867975|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867976|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2867977|NCT03740399|Anesthetics|anesthetics|mesh-list
2867978|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2867979|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867980|NCT03740386|Phentolamine|phentolamine|mesh-list
2867981|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2310103|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2310104|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2310105|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310106|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
2310107|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867982|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2867983|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
2867984|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2867985|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2867986|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867987|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2867988|NCT03740373|Budesonide|budesonide|mesh-list
2867989|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
2867990|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
2867991|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2867992|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2867993|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
2310108|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
2310109|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
2310110|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2310111|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310112|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
2310113|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
2310114|NCT00326833|Vitamins|vitamins|mesh-ancestor
2310115|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
2310116|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310117|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
2310118|NCT00326833|Hematinics|hematinics|mesh-ancestor
2867994|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2867995|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2867996|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2867997|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
2867998|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
2867999|NCT03740373|Hormones|hormones|mesh-ancestor
2868000|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2868001|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2868002|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2868003|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2868004|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
2868005|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868006|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868007|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2868008|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2868009|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2868010|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
2868026|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2868027|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
2868028|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868029|NCT03740295|Protective Agents|protective agents|mesh-ancestor
2868030|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868031|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2868032|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2868033|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868034|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2868035|NCT03740243|Buprenorphine|buprenorphine|mesh-list
2868036|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2868037|NCT03740243|Naloxone|naloxone|mesh-list
2868038|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2868039|NCT03740243|Narcotics|narcotics|mesh-ancestor
2868040|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2868041|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868042|NCT03740243|Analgesics|analgesics|mesh-ancestor
2868043|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
2868044|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868045|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2868046|NCT03740178|Donepezil|donepezil|mesh-list
2868047|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2868048|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868049|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310119|NCT00326859|Remifentanil|remifentanil|mesh-list
2310120|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2868050|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
2868051|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868052|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868053|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
2868054|NCT03740165|Paclitaxel|paclitaxel|mesh-list
2868055|NCT03740165|Docetaxel|docetaxel|mesh-list
2868056|NCT03740165|Bevacizumab|bevacizumab|mesh-list
2868057|NCT03740165|Carboplatin|carboplatin|mesh-list
2868058|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
2868059|NCT03740165|Olaparib|olaparib|mesh-list
2868060|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2868061|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310121|NCT00326859|Narcotics|narcotics|mesh-ancestor
2310122|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2310123|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310124|NCT00326859|Analgesics|analgesics|mesh-ancestor
2310125|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
2310126|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310127|NCT00327080|Acetylcholine|acetylcholine|mesh-list
2310128|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
2310129|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2310130|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
2310131|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310132|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868062|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
2868063|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
2868064|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
2868065|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868066|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2868067|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2868068|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2868069|NCT03740165|Growth Substances|growth substances|mesh-ancestor
2868070|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868071|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
2868072|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2868073|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868074|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2868075|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2868076|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868086|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
2868087|NCT03739853|Adalimumab|adalimumab|mesh-list
2868088|NCT03739853|Methotrexate|methotrexate|mesh-list
2868089|NCT03739853|Leflunomide|leflunomide|mesh-list
2868090|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2868091|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
2868092|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2868093|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868094|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2868095|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
2868096|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868097|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868098|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
2868099|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868100|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2868101|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2868102|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
2868103|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868104|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2868105|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2868106|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108687|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2108688|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
2108689|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108690|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2868107|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2868108|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2868109|NCT03739853|Analgesics|analgesics|mesh-ancestor
2868110|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
2868111|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868112|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2868113|NCT03739801|Irinotecan|irinotecan|mesh-list
2868114|NCT03739801|Ramucirumab|ramucirumab|mesh-list
2868115|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2868116|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2868117|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868118|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868119|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868120|NCT03739788|BMS-986165|bms-986165|mesh-list
2868121|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
2868122|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2868123|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868124|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868125|NCT03739671|Vitamin D|vitamin d|mesh-list
2868126|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
2868127|NCT03739671|Vitamins|vitamins|mesh-list
2868128|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
2868129|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868130|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2868131|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2868132|NCT03739619|Gemcitabine|gemcitabine|mesh-list
2868133|NCT03739619|Nivolumab|nivolumab|mesh-list
2868134|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2868135|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2310133|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310134|NCT00327093|Bevacizumab|bevacizumab|mesh-list
2310135|NCT00327093|Cetuximab|cetuximab|mesh-list
2310136|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2310137|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310138|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2310139|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2310140|NCT00327093|Growth Substances|growth substances|mesh-ancestor
2310141|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310142|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
2310143|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
2868136|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
2868137|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868138|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868139|NCT03739619|Antiviral Agents|antiviral agents|mesh-ancestor
2868140|NCT03739619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2868141|NCT03739619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868142|NCT03739619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2868143|NCT03739619|Immunologic Factors|immunologic factors|mesh-ancestor
2868144|NCT03739619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868145|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2868146|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2868147|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2868148|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
2868149|NCT03739606|Antibodies|antibodies|mesh-list
2868150|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
2868151|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2868152|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2868153|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
2868154|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868155|NCT03739554|Venetoclax|venetoclax|mesh-list
2868156|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868157|NCT03739541|Benzonidazole|benzonidazole|mesh-list
2868158|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2868159|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
2868160|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868161|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2868162|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2868163|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2868164|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2868165|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2868166|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
2868167|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2868168|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2868169|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2868170|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2868171|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868172|NCT03739411|Temozolomide|temozolomide|mesh-list
2868173|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2868174|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
2868175|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310144|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2310145|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2310146|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310147|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
2310148|NCT00327106|Coagulants|coagulants|mesh-ancestor
2310149|NCT00327119|Panitumumab|panitumumab|mesh-list
2310150|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2310151|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310152|NCT00327132|Amoxicillin|amoxicillin|mesh-list
2868176|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868177|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
2868178|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2868179|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868180|NCT03739294|Fluticasone|fluticasone|mesh-list
2868181|NCT03739294|Xhance|xhance|mesh-list
2868182|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2868183|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2868184|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
2868185|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868186|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868187|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2868188|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
2868189|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
2868190|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2868191|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
2868192|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2868193|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868194|NCT03739112|Vaccines|vaccines|mesh-list
2868195|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
2868196|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868197|NCT03739021|Ropivacaine|ropivacaine|mesh-list
2868198|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
2868199|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
2868200|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2868201|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868202|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
2868203|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868204|NCT03738956|Tofacitinib|tofacitinib|mesh-list
2868205|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2868206|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868207|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868208|NCT03738943|Pyridoxine|pyridoxine|mesh-list
2868209|NCT03738943|Pyridoxal|pyridoxal|mesh-list
2868210|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
2868211|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
2868212|NCT03738943|Adenosine|adenosine|mesh-list
2868213|NCT03738943|Nitroprusside|nitroprusside|mesh-list
2868214|NCT03738943|Acetylcholine|acetylcholine|mesh-list
2868215|NCT03738943|Vitamins|vitamins|mesh-ancestor
2868216|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
2868217|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868218|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
2868219|NCT03738943|Analgesics|analgesics|mesh-ancestor
2868220|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
2868221|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868222|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2868223|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
2868224|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2868225|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
2868226|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
2868227|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868228|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868229|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2868230|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2868231|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2868232|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
2868233|NCT03738917|Bromides|bromides|mesh-list
2310153|NCT00327132|Clarithromycin|clarithromycin|mesh-list
2310154|NCT00327132|Omeprazole|omeprazole|mesh-list
2310155|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2310156|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2310157|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2310158|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2310159|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2310160|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868234|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
2868235|NCT03738917|Ipratropium|ipratropium|mesh-list
2868236|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2868237|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
2310161|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310162|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2310163|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2310164|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2310165|NCT00327145|Amlodipine|amlodipine|mesh-list
2310166|NCT00327145|Valsartan|valsartan|mesh-list
2310167|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2310168|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2310169|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2310170|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2310171|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310172|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2310173|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310174|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
2310175|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2310176|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2310177|NCT00327145|Diuretics|diuretics|mesh-ancestor
2310178|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
2310179|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2310180|NCT00327184|PENTA|penta|mesh-list
2310181|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
2310182|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2310183|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2310184|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310185|NCT00327197|Prednisolone|prednisolone|mesh-list
2310186|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2310187|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
2310188|NCT00327197|Hormones|hormones|mesh-ancestor
2868238|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
2868239|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
2868240|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2868241|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2868242|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868243|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868244|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868245|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2868246|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
2868247|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868248|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2868249|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
2868250|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2868251|NCT03738878|Valsartan|valsartan|mesh-list
2868252|NCT03738878|Bradykinin|bradykinin|mesh-list
2868253|NCT03738878|Kininogens|kininogens|mesh-list
2868254|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2868255|NCT03738878|Substance P|substance p|mesh-list
2868256|NCT03738878|Neurokinin A|neurokinin a|mesh-list
2868257|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2868258|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868259|NCT03738878|Incretins|incretins|mesh-ancestor
2868260|NCT03738878|Hormones|hormones|mesh-ancestor
2868261|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2868262|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2868263|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
2868264|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868265|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868266|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2868267|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2868268|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2868269|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
2868270|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2868271|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868272|NCT03738852|Insulin|insulin|mesh-list
2868273|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2868274|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868275|NCT03738800|Trifarotene|trifarotene|mesh-list
2868276|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
2868277|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2868278|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2868279|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
2868280|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2868281|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2868282|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868283|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
2868284|NCT03738527|Coagulants|coagulants|mesh-ancestor
2310189|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2310190|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310191|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2310192|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310193|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
2310194|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310195|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2310196|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310197|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310198|NCT00327288|Docetaxel|docetaxel|mesh-list
2310199|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310200|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
2310201|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
2310202|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
2310203|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310204|NCT00327327|Gemcitabine|gemcitabine|mesh-list
2310205|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2310206|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
2868285|NCT03738397|Upadacitinib|upadacitinib|mesh-list
2868286|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2868287|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2310207|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310208|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310209|NCT00327327|Antiviral Agents|antiviral agents|mesh-ancestor
2310210|NCT00327327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2310211|NCT00327327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310212|NCT00327327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2868288|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868289|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868290|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868291|NCT03738176|Triamcinolone|triamcinolone|mesh-list
2868292|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2868293|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
2868294|NCT03738176|Hormones|hormones|mesh-ancestor
2868295|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2868296|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868297|NCT03738137|Lidocaine|lidocaine|mesh-list
2868298|NCT03738137|Midazolam|midazolam|mesh-list
2868299|NCT03738137|Sufentanil|sufentanil|mesh-list
2868300|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
2868301|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
2868302|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2868303|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868304|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
2868305|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868306|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2868307|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2868308|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2868309|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2868310|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868311|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2868312|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2868313|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2868314|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2868315|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2868316|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2868317|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
2868318|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
2868319|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
2868320|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868321|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2868322|NCT03738137|Narcotics|narcotics|mesh-ancestor
2868323|NCT03738137|Analgesics|analgesics|mesh-ancestor
2868324|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
2868325|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2868326|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2310213|NCT00327327|Immunologic Factors|immunologic factors|mesh-ancestor
2868327|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868328|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2868329|NCT03738059|Analgesics|analgesics|mesh-ancestor
2868330|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
2868331|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868332|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2868333|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2868334|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2868335|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
2868336|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868337|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868338|NCT03737968|Durvalumab|durvalumab|mesh-list
2108691|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2108692|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2108693|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2108694|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108695|NCT02508077|Antidotes|antidotes|mesh-ancestor
2108696|NCT02508077|Protective Agents|protective agents|mesh-ancestor
2108697|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
2108698|NCT02508077|Vitamins|vitamins|mesh-ancestor
2108699|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
2108700|NCT02508077|Hematinics|hematinics|mesh-ancestor
2108701|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2108702|NCT02508103|Oxytocin|oxytocin|mesh-list
2108703|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
2108704|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2108705|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108706|NCT02508207|Ivacaftor|ivacaftor|mesh-list
2868339|NCT03737968|Tremelimumab|tremelimumab|mesh-list
2868340|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2868341|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2868342|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868343|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
2868344|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868345|NCT03737773|Methamphetamine|methamphetamine|mesh-list
2868346|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2868347|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868348|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
2868349|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
2868350|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868351|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
2868352|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868353|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868354|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
2868355|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2868356|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2868357|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2868358|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2868359|NCT03737721|Avelumab|avelumab|mesh-list
2868360|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2868361|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868362|NCT03737708|Adalimumab|adalimumab|mesh-list
2868363|NCT03737708|Methotrexate|methotrexate|mesh-list
2868364|NCT03737708|Abatacept|abatacept|mesh-list
2310214|NCT00327327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310215|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
2310216|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2310217|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2310218|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
2310219|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310220|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310221|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2310222|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
2310223|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2868365|NCT03737708|Tacrolimus|tacrolimus|mesh-list
2868366|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2868367|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
2868368|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2868369|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868370|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2108707|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2108708|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108709|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108710|NCT02508259|Suramin|suramin|mesh-list
2108711|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
2108712|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
2108713|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2108714|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108715|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108716|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2108717|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2108718|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
2108719|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
2108720|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108721|NCT02508389|Protective Agents|protective agents|mesh-ancestor
2108722|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108723|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
2108724|NCT02508428|Diuretics|diuretics|mesh-ancestor
2108725|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
2108726|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108727|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2108728|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108729|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108730|NCT02508636|Leuprolide|leuprolide|mesh-list
2108731|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2108732|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
2108733|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2108734|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108735|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2108736|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108737|NCT02508701|Vaccines|vaccines|mesh-list
2108738|NCT02508701|Immunologic Factors|immunologic factors|mesh-ancestor
2868371|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
2868372|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868373|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868374|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
2868375|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868376|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2868377|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2868378|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
2868379|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868380|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2310224|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2310225|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2310226|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
2310227|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310228|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310229|NCT00327379|Aprotinin|aprotinin|mesh-list
2310230|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
2310231|NCT00327379|Coagulants|coagulants|mesh-ancestor
2310232|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2310233|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2310234|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
2310235|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310236|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310237|NCT00327418|Atorvastatin|atorvastatin|mesh-list
2310238|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2310239|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2310240|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
2310241|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310242|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2310243|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2310244|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310245|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2310246|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
2310247|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310248|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
2310249|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
2310250|NCT00327535|Hematinics|hematinics|mesh-ancestor
2310251|NCT00327587|Amlodipine|amlodipine|mesh-list
2310252|NCT00327587|Valsartan|valsartan|mesh-list
2310253|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2310254|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2310255|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2310256|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2310257|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310258|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2310259|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310260|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
2310261|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2310262|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2310263|NCT00327587|Diuretics|diuretics|mesh-ancestor
2310264|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
2310265|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2310266|NCT00327665|Vaccines|vaccines|mesh-list
2310267|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2310268|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
2868381|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2868382|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2868383|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2868384|NCT03737656|Progesterone|progesterone|mesh-list
2868385|NCT03737656|Progestins|progestins|mesh-ancestor
2868386|NCT03737656|Hormones|hormones|mesh-ancestor
2868387|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2868388|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868389|NCT03737604|Bupivacaine|bupivacaine|mesh-list
2868390|NCT03737604|Ropivacaine|ropivacaine|mesh-list
2868391|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
2310269|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310270|NCT00327678|Rituximab|rituximab|mesh-list
2310271|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
2310272|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2310273|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310274|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
2310275|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310276|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868392|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
2868393|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2868394|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868395|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
2868396|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868401|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
2868402|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
2868403|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868404|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868405|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868406|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
2868407|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
2868408|NCT03737448|Trimetazidine|trimetazidine|mesh-list
2868409|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
2868410|NCT03737370|Docetaxel|docetaxel|mesh-list
2868411|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868412|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
2868413|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
2868414|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
2868415|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868416|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2868417|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868418|NCT03737292|Bupivacaine|bupivacaine|mesh-list
2868419|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
2868420|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
2868421|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2868422|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868423|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
2868424|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868425|NCT03737253|Menotropins|menotropins|mesh-list
2868426|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2868427|NCT03737253|Hormones|hormones|mesh-ancestor
2868428|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2868429|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868430|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2868431|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
2868432|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2868433|NCT03737240|Insulin|insulin|mesh-list
2868434|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2868435|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
2868436|NCT03737240|Liraglutide|liraglutide|mesh-list
2868437|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
2310277|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2310278|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868438|NCT03737240|Xultophy|xultophy|mesh-list
2868439|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2868440|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868441|NCT03737240|Incretins|incretins|mesh-ancestor
2868442|NCT03737240|Hormones|hormones|mesh-ancestor
2868443|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2868444|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
2868445|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2868446|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2868447|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2868448|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
2868449|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
2868452|NCT03737123|Gemcitabine|gemcitabine|mesh-list
2868453|NCT03737123|Carboplatin|carboplatin|mesh-list
2868454|NCT03737123|Docetaxel|docetaxel|mesh-list
2868455|NCT03737123|Atezolizumab|atezolizumab|mesh-list
2868456|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868457|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2868458|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
2868459|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868460|NCT03737123|Antiviral Agents|antiviral agents|mesh-ancestor
2868461|NCT03737123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2868462|NCT03737123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868463|NCT03737123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2868464|NCT03737123|Immunologic Factors|immunologic factors|mesh-ancestor
2868465|NCT03737123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868466|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
2868467|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
2310279|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310280|NCT00327691|Atorvastatin|atorvastatin|mesh-list
2310281|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2310282|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2310283|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
2868468|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
2868469|NCT03736980|Psilocybin|psilocybin|mesh-list
2868470|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
2868471|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868472|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2868473|NCT03736863|Apatinib|apatinib|mesh-list
2868474|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868475|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2868476|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868477|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310284|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310285|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2310286|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2310287|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310288|NCT00327730|Eperisone|eperisone|mesh-list
2310289|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
2310290|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2310291|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2310292|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310293|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2310294|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310295|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2310296|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2310297|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310298|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
2310299|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
2310300|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
2310301|NCT00327743|Capecitabine|capecitabine|mesh-list
2310302|NCT00327743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2310303|NCT00327743|Antimetabolites|antimetabolites|mesh-ancestor
2310304|NCT00327743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310305|NCT00327743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310306|NCT00327756|Ubiquinone|ubiquinone|mesh-list
2310307|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
2310308|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
2310309|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310310|NCT00327756|Vitamins|vitamins|mesh-ancestor
2310311|NCT00327769|Fulvestrant|fulvestrant|mesh-list
2310312|NCT00327769|Anastrozole|anastrozole|mesh-list
2868478|NCT03736720|Leucovorin|leucovorin|mesh-list
2868479|NCT03736720|Fluorouracil|fluorouracil|mesh-list
2868480|NCT03736720|Irinotecan|irinotecan|mesh-list
2868481|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
2868482|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868483|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2868484|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868485|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2868486|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
2868487|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868488|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2868489|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2868490|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868491|NCT03736720|Antidotes|antidotes|mesh-ancestor
2868492|NCT03736720|Protective Agents|protective agents|mesh-ancestor
2868493|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
2868494|NCT03736720|Vitamins|vitamins|mesh-ancestor
2868495|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
2868496|NCT03736616|Cytarabine|cytarabine|mesh-list
2868497|NCT03736616|Rituximab|rituximab|mesh-list
2868498|NCT03736616|Carboplatin|carboplatin|mesh-list
2868499|NCT03736616|Etoposide|etoposide|mesh-list
2868500|NCT03736616|Melphalan|melphalan|mesh-list
2868501|NCT03736616|Ifosfamide|ifosfamide|mesh-list
2868502|NCT03736616|Carmustine|carmustine|mesh-list
2868503|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
2868504|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2868505|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868506|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
2868507|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868508|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868509|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2868510|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2868511|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2868512|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868513|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868514|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2868515|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
2868516|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
2868517|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2868518|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2868519|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2868520|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
2868521|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2868522|NCT03736369|Esomeprazole|esomeprazole|mesh-list
2868523|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2868524|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2868525|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2868526|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868527|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868528|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
2868529|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2868530|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310313|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2310314|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310315|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2310316|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2310317|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
2868547|NCT03736187|Metronidazole|metronidazole|mesh-list
2868548|NCT03736187|Cephalexin|cephalexin|mesh-list
2868549|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2868550|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2868551|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2868552|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2868553|NCT03736161|Methotrexate|methotrexate|mesh-list
2868554|NCT03736161|Tofacitinib|tofacitinib|mesh-list
2868555|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2868556|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
2868557|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2868558|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868559|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2868560|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
2868561|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868562|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868563|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
2868564|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868565|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2868566|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2868567|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
2868568|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868569|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2868570|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2868571|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
2868572|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2868573|NCT03735979|Argatroban|argatroban|mesh-list
2310318|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2310319|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310320|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2310321|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2310322|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310323|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310324|NCT00327808|Budesonide|budesonide|mesh-list
2310325|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2868574|NCT03735979|Eptifibatide|eptifibatide|mesh-list
2868575|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
2868576|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2868577|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
2868578|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868579|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868580|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
2868581|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2868582|NCT03735966|Carboplatin|carboplatin|mesh-list
2868583|NCT03735966|Docetaxel|docetaxel|mesh-list
2868584|NCT03735966|Trastuzumab|trastuzumab|mesh-list
2868585|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868586|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
2868587|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
2868588|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
2868589|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868590|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2868591|NCT03735901|Levodopa|levodopa|mesh-list
2868592|NCT03735901|Carbidopa|carbidopa|mesh-list
2868593|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2868594|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2868595|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
2868596|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868597|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868598|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868599|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2868600|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868601|NCT03735875|Venetoclax|venetoclax|mesh-list
2868602|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868603|NCT03735771|Bupivacaine|bupivacaine|mesh-list
2868604|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
2868605|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
2868606|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2868607|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868608|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
2868609|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868610|NCT03735563|Fentanyl|fentanyl|mesh-list
2868611|NCT03735563|Ketamine|ketamine|mesh-list
2868612|NCT03735563|Analgesics|analgesics|mesh-ancestor
2868613|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
2868614|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868615|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868616|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2868617|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2868618|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
2868619|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
2868620|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2868621|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2868622|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2868623|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868624|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868625|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2868626|NCT03735563|Narcotics|narcotics|mesh-ancestor
2868627|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2868628|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
2868629|NCT03735537|Teriparatide|teriparatide|mesh-list
2868630|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2868631|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2868632|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868633|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2868634|NCT03735446|Cytarabine|cytarabine|mesh-list
2868635|NCT03735446|Etoposide|etoposide|mesh-list
2868636|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
2868637|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2868638|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868639|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2868640|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2868641|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868642|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868643|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2868644|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
2868645|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
2868646|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2868647|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2868648|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
2868649|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868650|NCT03735446|Analgesics|analgesics|mesh-ancestor
2868651|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
2868652|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310326|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2310327|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
2310328|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310329|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310330|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2310331|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
2310332|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
2310333|NCT00327808|Hormones|hormones|mesh-ancestor
2310334|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2310335|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2310336|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2310337|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2310338|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2310339|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868653|NCT03735433|Aspirin|aspirin|mesh-list
2868654|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2868655|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2868656|NCT03735433|Analgesics|analgesics|mesh-ancestor
2868657|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
2310340|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
2310341|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310342|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310343|NCT00327847|Vitamin D|vitamin d|mesh-list
2310344|NCT00327847|Vitamins|vitamins|mesh-ancestor
2310345|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
2310346|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310347|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2310348|NCT00327925|Antibodies|antibodies|mesh-list
2310349|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
2310350|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310351|NCT00327990|Alendronate|alendronate|mesh-list
2310352|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
2310353|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2310354|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310355|NCT00328029|Busulfan|busulfan|mesh-list
2310356|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
2868658|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868659|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310357|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310358|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2868660|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2868661|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868662|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2868663|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2868664|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868665|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2868666|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2868667|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868668|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
2310359|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
2310360|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310361|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2868676|NCT03735368|Pregabalin|pregabalin|mesh-list
2868677|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
2868678|NCT03735368|Benoxinate|benoxinate|mesh-list
2310362|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310363|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2310364|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
2310365|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
2310366|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
2310367|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310368|NCT00328120|Fulvestrant|fulvestrant|mesh-list
2310369|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2310370|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310371|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2310372|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2310373|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
2310374|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2868679|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
2868680|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2868681|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868682|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2868683|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2868684|NCT03735368|Analgesics|analgesics|mesh-ancestor
2868685|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
2868686|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868687|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2868688|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2868689|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2868690|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
2868691|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868692|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868693|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
2868694|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2868695|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2868696|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2868697|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2868698|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2868699|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2868700|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
2868701|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
2868702|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
2868703|NCT03735316|Vitamins|vitamins|mesh-ancestor
2868704|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
2868705|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868706|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
2868707|NCT03735316|Hematinics|hematinics|mesh-ancestor
2310375|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310376|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
2310377|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2310378|NCT00328302|Candesartan|candesartan|mesh-list
2310379|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2310380|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2310381|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2868708|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
2868709|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2868710|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868711|NCT03735264|Docetaxel|docetaxel|mesh-list
2310382|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310383|NCT00328367|Aripiprazole|aripiprazole|mesh-list
2310384|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
2310385|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2310386|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2310387|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2310388|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2310389|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310390|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
2310391|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
2310392|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310393|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310394|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2310395|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2310396|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
2310397|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2310398|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2310399|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2868712|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868713|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
2868714|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
2868715|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
2868716|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868717|NCT03735251|Metoprolol|metoprolol|mesh-list
2868718|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2868719|NCT03735251|Diuretics|diuretics|mesh-list
2868720|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
2868721|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868722|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2868723|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2868724|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
2868725|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
2868726|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868727|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2868728|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2868729|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2868730|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
2868731|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868732|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868733|NCT03735134|Colchicine|colchicine|mesh-list
2868734|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
2310400|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2310401|NCT00328380|Rifaximin|rifaximin|mesh-list
2310402|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2310403|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2310404|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2310405|NCT00328393|Pioglitazone|pioglitazone|mesh-list
2310406|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2868735|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868736|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
2868737|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
2868738|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
2868739|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868740|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310407|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868741|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2868742|NCT03735095|Trioxsalen|trioxsalen|mesh-list
2868743|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868744|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
2868745|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2868746|NCT03735082|Paclitaxel|paclitaxel|mesh-list
2868747|NCT03735082|Carboplatin|carboplatin|mesh-list
2868748|NCT03735082|Apatinib|apatinib|mesh-list
2868749|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2868750|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868751|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
2868752|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
2868753|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
2868754|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868755|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2868756|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868757|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
2868758|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2868759|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868760|NCT03734770|Progesterone|progesterone|mesh-list
2868761|NCT03734770|Progestins|progestins|mesh-ancestor
2868762|NCT03734770|Hormones|hormones|mesh-ancestor
2868763|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2868764|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868765|NCT03734744|Vitamin D|vitamin d|mesh-list
2868766|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
2868767|NCT03734744|Vitamins|vitamins|mesh-ancestor
2868768|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
2868769|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868770|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2868771|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2868772|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2868773|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
2868774|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868775|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2868776|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
2868777|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2868783|NCT03734627|Acetaminophen|acetaminophen|mesh-list
2868784|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
2868785|NCT03734627|Octreotide|octreotide|mesh-list
2868786|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2868787|NCT03734627|Analgesics|analgesics|mesh-ancestor
2868788|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
2868789|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868790|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868791|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
2310408|NCT00328432|Celecoxib|celecoxib|mesh-list
2310409|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2310410|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2310411|NCT00328432|Analgesics|analgesics|mesh-ancestor
2310412|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
2310413|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310414|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310415|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2310416|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868792|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2108739|NCT02508701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108740|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2108741|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2108742|NCT02508935|Narcotics|narcotics|mesh-ancestor
2108743|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108744|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108745|NCT02508935|Analgesics|analgesics|mesh-ancestor
2108746|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
2108747|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108748|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2108749|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2868793|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2868794|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868795|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2868796|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2868797|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2868798|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868799|NCT03734614|Aspirin|aspirin|mesh-list
2868800|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2868801|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2868802|NCT03734614|Analgesics|analgesics|mesh-ancestor
2868803|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
2868804|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868805|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868806|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2868807|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868808|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2868809|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2868810|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868811|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2868812|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2868813|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868814|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
2868815|NCT03734562|Amiodarone|amiodarone|mesh-list
2868816|NCT03734562|Sotalol|sotalol|mesh-list
2868817|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2868818|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
2868819|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2868820|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2868821|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868822|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2868823|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2868824|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2868825|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868826|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2868827|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2868828|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2868829|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2868830|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2868831|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
2310417|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2310418|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2310419|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310420|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310421|NCT00328458|Epothilones|epothilones|mesh-list
2310422|NCT00328458|Epothilone B|epothilone b|mesh-list
2868832|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868833|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868834|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
2868835|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
2868836|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868837|NCT03734445|Vitamins|vitamins|mesh-list
2868838|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
2868839|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868840|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
2868841|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
2868842|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868843|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868844|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868845|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
2868846|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
2868847|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
2868848|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
2868849|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868850|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868851|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868852|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
2868853|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
2108750|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2108751|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2108752|NCT02509026|Etanercept|etanercept|mesh-list
2108753|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2108754|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2108755|NCT02509026|Analgesics|analgesics|mesh-ancestor
2108756|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
2108757|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108758|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868857|NCT03734211|Evolocumab|evolocumab|mesh-list
2868858|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2868859|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2868860|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
2868861|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868862|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2868863|NCT03734198|Daratumumab|daratumumab|mesh-list
2868864|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2868865|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310423|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
2310424|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
2310425|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
2310426|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310427|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310428|NCT00328497|Bevacizumab|bevacizumab|mesh-list
2310429|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
2310430|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2310431|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868866|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
2868867|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868868|NCT03734159|Ropivacaine|ropivacaine|mesh-list
2868869|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
2868870|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
2868871|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2868872|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868873|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
2868874|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2868875|NCT03734068|Doxorubicin|doxorubicin|mesh-list
2868876|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2868877|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868878|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2868879|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2868880|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868881|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108759|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2108760|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2108761|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2108762|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2108763|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
2108764|NCT02509065|Pancrelipase|pancrelipase|mesh-list
2108765|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2108766|NCT02509078|Cisatracurium|cisatracurium|mesh-list
2108767|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2108768|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2108769|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108770|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108771|NCT02509481|Ivermectin|ivermectin|mesh-list
2108772|NCT02509481|Albendazole|albendazole|mesh-list
2108773|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2108774|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108775|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
2108776|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
2108777|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2108778|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2108779|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
2108780|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
2310432|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2310433|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2310434|NCT00328497|Growth Substances|growth substances|mesh-ancestor
2310435|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310436|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
2310437|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
2310438|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
2310439|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
2310440|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310441|NCT00328523|Ezetimibe|ezetimibe|mesh-list
2868906|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2868907|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
2868908|NCT03733873|Coagulants|coagulants|mesh-ancestor
2868909|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2868910|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
2868911|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868912|NCT03733860|Alprostadil|alprostadil|mesh-list
2310442|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2310443|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2310444|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
2310445|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310446|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2310447|NCT00328549|Interferons|interferons|mesh-list
2310448|NCT00328549|Ribavirin|ribavirin|mesh-list
2310449|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310450|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
2310451|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2310452|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
2310453|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310454|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
2310455|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
2868913|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2868914|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
2868915|NCT03733860|Urological Agents|urological agents|mesh-ancestor
2868916|NCT03733691|Lenalidomide|lenalidomide|mesh-list
2868917|NCT03733691|Ixazomib|ixazomib|mesh-list
2868918|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
2868919|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868920|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2868921|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2868922|NCT03733691|Growth Substances|growth substances|mesh-ancestor
2868923|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
2868924|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868925|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
2868926|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868927|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868928|NCT03733652|Interferons|interferons|mesh-list
2868929|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
2868930|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
2868931|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868932|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
2868933|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2868934|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
2868935|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868936|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2868937|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
2868938|NCT03733639|Coagulants|coagulants|mesh-ancestor
2868939|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
2868940|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2868941|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
2868942|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868943|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868944|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2868945|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
2868946|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868947|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868948|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2868949|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2868950|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2868951|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2310456|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310457|NCT00328601|Protective Agents|protective agents|mesh-ancestor
2868952|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2868953|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868954|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868955|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868956|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
2868957|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2868958|NCT03733561|Rotigotine|rotigotine|mesh-list
2868959|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
2868960|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
2868961|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2868962|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868963|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868964|NCT03733535|Benralizumab|benralizumab|mesh-list
2868965|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2868966|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
2868967|NCT03733379|Amoxicillin|amoxicillin|mesh-list
2868968|NCT03733379|Metronidazole|metronidazole|mesh-list
2868969|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2868970|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2868971|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2868972|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2868973|NCT03733340|Imipenem|imipenem|mesh-list
2868974|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2868975|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2310458|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310459|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
2310460|NCT00328601|Vitamins|vitamins|mesh-ancestor
2310461|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
2868976|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
2868977|NCT03733327|Busulfan|busulfan|mesh-list
2868978|NCT03733327|Etoposide|etoposide|mesh-list
2868979|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2868980|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
2868981|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868982|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2868983|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2868984|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
2868985|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2868986|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2868987|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2868988|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2868989|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2868990|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2868991|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2868992|NCT03733275|Lidocaine|lidocaine|mesh-list
2310474|NCT00328692|Rolofylline|rolofylline|mesh-list
2310475|NCT00328692|Diuretics|diuretics|mesh-ancestor
2310476|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
2310477|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310478|NCT00328718|Fluticasone|fluticasone|mesh-list
2310479|NCT00328718|Xhance|xhance|mesh-list
2310480|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2310481|NCT00328718|Montelukast|montelukast|mesh-list
2310482|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2310483|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2310484|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
2310485|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310486|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310487|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2310488|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
2310489|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
2310490|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2310491|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2310492|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2310493|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2310494|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
2310495|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310496|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310497|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2310498|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
2310499|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2310500|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2310501|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2868993|NCT03733275|Bupivacaine|bupivacaine|mesh-list
2868994|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
2868995|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
2868996|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2868997|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2868998|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
2868999|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869000|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2869001|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2869002|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2869003|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2869004|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869005|NCT03733210|Panitumumab|panitumumab|mesh-list
2869006|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2869007|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869008|NCT03733171|Epinephrine|epinephrine|mesh-list
2310502|NCT00328796|Lidocaine|lidocaine|mesh-list
2869009|NCT03733171|Hemostatics|hemostatics|mesh-list
2310503|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
2310504|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
2310505|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2310506|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310507|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
2869010|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2869011|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2869012|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
2869013|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869014|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869015|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869016|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2869017|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2869018|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
2869019|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869020|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2310508|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310509|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2310510|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2869021|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
2869022|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
2869023|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
2869024|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2869025|NCT03733171|Coagulants|coagulants|mesh-ancestor
2869026|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
2869027|NCT03733145|Giapreza|giapreza|mesh-list
2869028|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
2310511|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2310512|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2310513|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310514|NCT00328809|Spironolactone|spironolactone|mesh-list
2310515|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2310516|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
2310517|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2310518|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310519|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2310520|NCT00328809|Diuretics|diuretics|mesh-ancestor
2310521|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
2310522|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2310523|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
2310524|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2310525|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2310526|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2310527|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2310528|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310529|NCT00328874|Ubiquinone|ubiquinone|mesh-list
2310530|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
2869029|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2869030|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2869031|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
2310531|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
2310532|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310533|NCT00328874|Vitamins|vitamins|mesh-ancestor
2310534|NCT00328900|Atropine|atropine|mesh-list
2310535|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2310536|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2310537|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2310538|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
2310539|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869032|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869033|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869034|NCT03732963|Melatonin|melatonin|mesh-list
2869035|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
2869036|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869037|NCT03732963|Protective Agents|protective agents|mesh-ancestor
2869038|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869039|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869051|NCT03732703|Thalidomide|thalidomide|mesh-list
2869052|NCT03732703|Dexamethasone|dexamethasone|mesh-list
2869053|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
2869054|NCT03732703|Venetoclax|venetoclax|mesh-list
2869055|NCT03732703|Daratumumab|daratumumab|mesh-list
2869056|NCT03732703|Pomalidomide|pomalidomide|mesh-list
2869057|NCT03732703|Ixazomib|ixazomib|mesh-list
2869058|NCT03732703|BB 1101|bb 1101|mesh-list
2869059|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2869060|NCT03732703|Glycine|glycine|mesh-list
2869061|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2869062|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
2869063|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
2869064|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869065|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869066|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2869067|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
2869068|NCT03732703|Hormones|hormones|mesh-ancestor
2869069|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2869070|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2869071|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310540|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310541|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2310542|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
2310543|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
2310544|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
2310545|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2310546|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2310547|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
2310548|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310549|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310550|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
2310551|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2310552|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
2310553|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2310554|NCT00328939|Enoxaparin|enoxaparin|mesh-list
2310555|NCT00328939|PENTA|penta|mesh-list
2310556|NCT00328939|Fondaparinux|fondaparinux|mesh-list
2310557|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
2310558|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2310559|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2310560|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310561|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2310562|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
2310563|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2310564|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
2310565|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310566|NCT00328965|Lacidipine|lacidipine|mesh-list
2310567|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2869072|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
2869073|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869074|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869075|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
2869076|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2869077|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2310568|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2310569|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2310570|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310571|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2310572|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310573|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2310574|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
2310575|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2310576|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2310577|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2310578|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2310579|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310580|NCT00329043|Sunitinib|sunitinib|mesh-list
2310581|NCT00329043|Leuprolide|leuprolide|mesh-list
2310582|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310583|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2869078|NCT03732703|Growth Substances|growth substances|mesh-ancestor
2869079|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
2869080|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2869081|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
2869082|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2869083|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2869084|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
2869085|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869099|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
2310584|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2310585|NCT00329043|Growth Substances|growth substances|mesh-ancestor
2310586|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310587|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
2869100|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2869101|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2869102|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
2869103|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2869104|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2869105|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2869106|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869107|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869108|NCT03732547|Poly I-C|poly i-c|mesh-list
2869109|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
2869110|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2869111|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
2869112|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
2869113|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869114|NCT03732508|Fluorouracil|fluorouracil|mesh-list
2869115|NCT03732508|Irinotecan|irinotecan|mesh-list
2869116|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
2869117|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869118|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2310588|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2310589|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310590|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869119|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869120|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2869121|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
2869122|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869123|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2869124|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2869125|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869126|NCT03732495|Denosumab|denosumab|mesh-list
2869127|NCT03732495|Lenvatinib|lenvatinib|mesh-list
2310591|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2310592|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
2310593|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2310594|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2310595|NCT00329069|Atorvastatin|atorvastatin|mesh-list
2310596|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2310597|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2869128|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869129|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2869130|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869131|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869132|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2869133|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869134|NCT03732482|Temozolomide|temozolomide|mesh-list
2869135|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2869136|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
2869137|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869138|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869139|NCT03732469|Acetaminophen|acetaminophen|mesh-list
2869140|NCT03732469|Fentanyl|fentanyl|mesh-list
2869141|NCT03732469|Propofol|propofol|mesh-list
2869142|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2869143|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869144|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869145|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2869146|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
2869147|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
2869148|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2869149|NCT03732469|Narcotics|narcotics|mesh-ancestor
2310598|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
2310599|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310600|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2310601|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2310602|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310603|NCT00329095|Bimatoprost|bimatoprost|mesh-list
2310604|NCT00329095|Travoprost|travoprost|mesh-list
2310605|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
2310606|NCT00329095|Latanoprost|latanoprost|mesh-list
2310607|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2310608|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2310609|NCT00329134|Quinine|quinine|mesh-list
2310610|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
2310611|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2310612|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2310613|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2310614|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2310615|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869150|NCT03732469|Analgesics|analgesics|mesh-ancestor
2869151|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
2869152|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869153|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2869154|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2869155|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
2869156|NCT03732391|Carboplatin|carboplatin|mesh-list
2869157|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
2869158|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869159|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2869160|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2869161|NCT03732365|Cefazolin|cefazolin|mesh-list
2869162|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2869163|NCT03732287|Anesthetics|anesthetics|mesh-list
2869164|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869165|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869166|NCT03732235|Bevacizumab|bevacizumab|mesh-list
2869167|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
2869168|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2869169|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869170|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2869171|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2869172|NCT03732235|Growth Substances|growth substances|mesh-ancestor
2869173|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869174|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
2869175|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2869176|NCT03732235|Estrogens|estrogens|mesh-ancestor
2869177|NCT03732235|Hormones|hormones|mesh-ancestor
2869178|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2869179|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2310616|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2310617|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310618|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2310619|NCT00329134|Analgesics|analgesics|mesh-ancestor
2310620|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
2310621|NCT00329147|Paroxetine|paroxetine|mesh-list
2869180|NCT03732105|Apatinib|apatinib|mesh-list
2869181|NCT03732105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
2869182|NCT03732105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869183|NCT03732105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2869184|NCT03732105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869185|NCT03732105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869186|NCT03732105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2869187|NCT03732105|Growth Substances|growth substances|mesh-ancestor
2869188|NCT03732105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869189|NCT03732105|Growth Inhibitors|growth inhibitors|mesh-ancestor
2869190|NCT03732040|Fluorides|fluorides|mesh-list
2869191|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
2869192|NCT03732040|Protective Agents|protective agents|mesh-ancestor
2869193|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869194|NCT03732001|Docetaxel|docetaxel|mesh-list
2869195|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869196|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
2869197|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
2310622|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2310623|NCT00329147|Desipramine|desipramine|mesh-list
2310624|NCT00329147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2310625|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2310626|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2310627|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310628|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310629|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
2310630|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310631|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2310632|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
2310633|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2869198|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
2869199|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869200|NCT03731988|Lidocaine|lidocaine|mesh-list
2869201|NCT03731988|Prilocaine|prilocaine|mesh-list
2869202|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2869203|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
2869204|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
2869205|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869206|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869207|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
2869208|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869209|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2869210|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2869211|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2869212|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2869213|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869214|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2869215|NCT03731897|Lidocaine|lidocaine|mesh-list
2869216|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
2869217|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
2869218|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869219|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869220|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
2869221|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869222|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2869223|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2310634|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2310635|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2310636|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869224|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2869225|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2869226|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310637|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2310638|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2310639|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2310640|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
2310641|NCT00329173|Atorvastatin|atorvastatin|mesh-list
2869227|NCT03731832|Dexamethasone|dexamethasone|mesh-list
2869228|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
2869229|NCT03731832|Pomalidomide|pomalidomide|mesh-list
2869230|NCT03731832|Ixazomib|ixazomib|mesh-list
2869231|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2869232|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
2869233|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869234|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2869235|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2869236|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
2869237|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869238|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869239|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2869240|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2869241|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
2869242|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
2869243|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869244|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2869245|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
2310642|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2310643|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2310644|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2310645|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
2310646|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310647|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2310648|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2310649|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310650|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2310651|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2310652|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2310653|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2310654|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2310655|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310656|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869246|NCT03731832|Hormones|hormones|mesh-ancestor
2869247|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2869248|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2869249|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2869250|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2869251|NCT03731832|Growth Substances|growth substances|mesh-ancestor
2869252|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
2869253|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
2869254|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869255|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
2869256|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2869257|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2869258|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
2869259|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
2869260|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2869261|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869262|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869263|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2869264|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2869265|NCT03731741|Protective Agents|protective agents|mesh-ancestor
2869266|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869267|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
2869268|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2869269|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
2310657|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310658|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2310659|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
2310660|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2869270|NCT03731494|Nickel|nickel|mesh-list
2869271|NCT03731494|Trace Elements|trace elements|mesh-ancestor
2869272|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
2869273|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869274|NCT03731468|Dexamethasone|dexamethasone|mesh-list
2869275|NCT03731468|Anesthetics|anesthetics|mesh-list
2869276|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
2869277|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2869278|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
2869279|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
2869280|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869281|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869282|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2310661|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
2310662|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2310663|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310664|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2310665|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
2310666|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2310667|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2310668|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2310669|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2310670|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310671|NCT00329316|Progesterone|progesterone|mesh-list
2310672|NCT00329316|Progestins|progestins|mesh-ancestor
2310673|NCT00329316|Hormones|hormones|mesh-ancestor
2869283|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
2869284|NCT03731468|Hormones|hormones|mesh-ancestor
2869285|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2869286|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2869287|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869288|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869289|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
2310674|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2310675|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310676|NCT00329329|Capecitabine|capecitabine|mesh-list
2310677|NCT00329329|Satraplatin|satraplatin|mesh-list
2310678|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2310679|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
2310680|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310681|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310682|NCT00329355|Naproxen|naproxen|mesh-list
2310683|NCT00329355|Sumatriptan|sumatriptan|mesh-list
2310684|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2310685|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2310686|NCT00329355|Analgesics|analgesics|mesh-ancestor
2310687|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
2310688|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310689|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310690|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2310691|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2310692|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
2310693|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2310694|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310695|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869290|NCT03731442|Paclitaxel|paclitaxel|mesh-list
2869291|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2869292|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869293|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
2869294|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
2869295|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
2869296|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869297|NCT03731429|Lidocaine|lidocaine|mesh-list
2869298|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
2869299|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
2869300|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869301|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869302|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
2869303|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869304|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2869305|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2869306|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2869307|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2869308|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869309|NCT03731403|Fluorides|fluorides|mesh-list
2869310|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
2869311|NCT03731403|Protective Agents|protective agents|mesh-ancestor
2869312|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869313|NCT03731286|Caffeine|caffeine|mesh-list
2869314|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2869315|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869316|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2869317|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310696|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2310697|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2310698|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2869318|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869319|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2869320|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2869321|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
2869322|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869323|NCT03731169|Voriconazole|voriconazole|mesh-list
2869324|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
2869325|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2869326|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2869327|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2869328|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869329|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869330|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2869331|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
2869332|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2869333|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869334|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2869335|NCT03731117|Furosemide|furosemide|mesh-list
2869336|NCT03731117|Diuretics|diuretics|mesh-ancestor
2869337|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
2869338|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869339|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2869340|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2869341|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869342|NCT03731091|Calcitriol|calcitriol|mesh-list
2869343|NCT03731091|Betamethasone|betamethasone|mesh-list
2869344|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
2869345|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2869346|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
2869347|NCT03731091|Calcipotriene|calcipotriene|mesh-list
2869348|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2869349|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2869350|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
2869351|NCT03731091|Hormones|hormones|mesh-ancestor
2869352|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2869353|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869354|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2869355|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
2869356|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
2869357|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2869358|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2869359|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2869360|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869361|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2869362|NCT03731091|Vitamins|vitamins|mesh-ancestor
2869363|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
2869364|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2869365|NCT03730857|Olanzapine|olanzapine|mesh-list
2869366|NCT03730857|Risperidone|risperidone|mesh-list
2869367|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2869368|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
2869369|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2869370|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
2869371|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869372|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869373|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869374|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2869375|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869376|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2869377|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2869378|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
2869379|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
2869380|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
2869381|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869382|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2869383|NCT03730857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2869384|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2869385|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2869386|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2869387|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2869388|NCT03730766|Amoxicillin|amoxicillin|mesh-list
2869389|NCT03730766|Metronidazole|metronidazole|mesh-list
2869390|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
2869391|NCT03730766|Esomeprazole|esomeprazole|mesh-list
2869392|NCT03730766|Bismuth|bismuth|mesh-list
2869393|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869394|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2869395|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2869396|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2869397|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2869398|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2869399|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2869400|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2869401|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869402|NCT03730766|Antacids|antacids|mesh-ancestor
2869403|NCT03730766|Diuretics|diuretics|mesh-ancestor
2869404|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
2869405|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869406|NCT03730766|Expectorants|expectorants|mesh-ancestor
2869407|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
2310699|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
2310700|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310701|NCT00329368|Folic Acid|folic acid|mesh-list
2310702|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
2310703|NCT00329368|Interferons|interferons|mesh-list
2310704|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
2310705|NCT00329368|Interleukin-2|interleukin-2|mesh-list
2310706|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2310707|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310708|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
2310709|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2310710|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
2310711|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869408|NCT03730740|Lenalidomide|lenalidomide|mesh-list
2869409|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
2869410|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869411|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2869412|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2869413|NCT03730740|Growth Substances|growth substances|mesh-ancestor
2869414|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
2869415|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869416|NCT03730714|Epinephrine|epinephrine|mesh-list
2869417|NCT03730714|Racepinephrine|racepinephrine|mesh-list
2869418|NCT03730714|Morphine|morphine|mesh-list
2869419|NCT03730714|Anesthetics|anesthetics|mesh-list
2869420|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
2869421|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
2869422|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2869423|NCT03730714|Narcotics|narcotics|mesh-ancestor
2869424|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869425|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869426|NCT03730714|Analgesics|analgesics|mesh-ancestor
2869427|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
2869428|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869429|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2869430|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2869431|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
2869432|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869433|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869434|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2869435|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2869436|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
2869437|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2869438|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
2310712|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2310713|NCT00329368|Analgesics|analgesics|mesh-ancestor
2310714|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
2310715|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310716|NCT00329368|Hematinics|hematinics|mesh-ancestor
2310717|NCT00329368|Vitamins|vitamins|mesh-ancestor
2310718|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
2310719|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2310720|NCT00329381|Omalizumab|omalizumab|mesh-list
2310721|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2310722|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2310723|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2310724|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
2310725|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
2310726|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310727|NCT00329394|Ketamine|ketamine|mesh-list
2310728|NCT00329394|Analgesics|analgesics|mesh-ancestor
2310729|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
2310730|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310731|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310732|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2310733|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2869439|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
2869440|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
2869441|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2869442|NCT03730675|Sorafenib|sorafenib|mesh-list
2869443|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869444|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2869445|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869446|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869447|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
2869448|NCT03730662|Tirzepatide|tirzepatide|mesh-list
2869449|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2869450|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869451|NCT03730662|Incretins|incretins|mesh-ancestor
2310734|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
2310735|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
2310736|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2310737|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2310738|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2310739|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310740|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310741|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2310742|NCT00329446|Citalopram|citalopram|mesh-list
2310743|NCT00329446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2310744|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2310745|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2310746|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869452|NCT03730662|Hormones|hormones|mesh-ancestor
2869453|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2869454|NCT03730649|Sulforaphane|sulforaphane|mesh-list
2869455|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2869456|NCT03730649|Protective Agents|protective agents|mesh-ancestor
2869457|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869458|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869459|NCT03730584|Ropivacaine|ropivacaine|mesh-list
2869460|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
2869461|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
2869462|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869463|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869464|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
2869465|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869466|NCT03730558|Aflibercept|aflibercept|mesh-list
2869467|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2869468|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2869469|NCT03730558|Growth Substances|growth substances|mesh-ancestor
2869470|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869471|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
2869472|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869473|NCT03730402|Bupivacaine|bupivacaine|mesh-list
2869474|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
2869475|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
2869476|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869477|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869478|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
2869479|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310747|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310748|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
2310749|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310750|NCT00329446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2310751|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
2310752|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2869480|NCT03730363|Pentamidine|pentamidine|mesh-list
2869481|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
2869482|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2869483|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2869484|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2869485|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2869486|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
2869487|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2869488|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2869489|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
2869490|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2869491|NCT03730272|Analgesics|analgesics|mesh-list
2869492|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
2869493|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869494|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310753|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2310754|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2310755|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2310756|NCT00329459|Naproxen|naproxen|mesh-list
2310757|NCT00329459|Sumatriptan|sumatriptan|mesh-list
2310758|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2310759|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2310760|NCT00329459|Analgesics|analgesics|mesh-ancestor
2310761|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
2310762|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310763|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310764|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2310765|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2310766|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
2310767|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2310768|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310769|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310770|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2310771|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2310772|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2310773|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
2310774|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310775|NCT00329472|Gemcitabine|gemcitabine|mesh-list
2310776|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310777|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2310778|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
2310779|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310780|NCT00329472|Antiviral Agents|antiviral agents|mesh-ancestor
2310781|NCT00329472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2310782|NCT00329472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310783|NCT00329472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2310784|NCT00329472|Immunologic Factors|immunologic factors|mesh-ancestor
2310785|NCT00329472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310786|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
2310787|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
2310788|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310789|NCT00329498|Protective Agents|protective agents|mesh-ancestor
2310790|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310791|NCT00329498|Vitamins|vitamins|mesh-ancestor
2310792|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
2310793|NCT00329511|Clonidine|clonidine|mesh-list
2869495|NCT03730194|Melatonin|melatonin|mesh-list
2869496|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
2869497|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869498|NCT03730194|Protective Agents|protective agents|mesh-ancestor
2869499|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869500|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869501|NCT03730181|Isoniazid|isoniazid|mesh-list
2869502|NCT03730181|Rifapentine|rifapentine|mesh-list
2869503|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
2869504|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2869505|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2869506|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2869507|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2869508|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
2869509|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869510|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2869511|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2869512|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
2869513|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
2869514|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2869515|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
2869516|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2869517|NCT03730064|Expectorants|expectorants|mesh-ancestor
2869518|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
2869519|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2869520|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
2869521|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869522|NCT03730064|Protective Agents|protective agents|mesh-ancestor
2869523|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869524|NCT03730064|Antidotes|antidotes|mesh-ancestor
2310794|NCT00329511|Methyldopa|methyldopa|mesh-list
2310795|NCT00329511|Analgesics|analgesics|mesh-ancestor
2310796|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
2310797|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310798|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310799|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2310800|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
2310801|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
2310802|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2310803|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2310804|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2310805|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
2310806|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310807|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310808|NCT00329537|Sargramostim|sargramostim|mesh-list
2310809|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
2310810|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310811|NCT00329589|Bortezomib|bortezomib|mesh-list
2310812|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310813|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
2869529|NCT03730038|Pitavastatin|pitavastatin|mesh-list
2869530|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2869531|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2869532|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2869533|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
2869534|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869535|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869536|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2869537|NCT03730012|Atezolizumab|atezolizumab|mesh-list
2869538|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869539|NCT03729973|Lidocaine|lidocaine|mesh-list
2869540|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
2869541|NCT03729973|Ketamine|ketamine|mesh-list
2869542|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2869543|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
2869544|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
2869545|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869546|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869547|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
2869548|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869549|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2869550|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2869551|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2869552|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2869553|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310814|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
2310815|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
2310816|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2310817|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310818|NCT00329628|Enoxaparin|enoxaparin|mesh-list
2310819|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
2310820|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2310821|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
2310822|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2869554|NCT03729973|Analgesics|analgesics|mesh-ancestor
2869555|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2869556|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2869557|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
2869558|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2869559|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2869560|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869561|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
2869562|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2869563|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2310823|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
2310824|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310825|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310826|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
2310827|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2869564|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
2869565|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2869566|NCT03729869|Progesterone|progesterone|mesh-list
2869567|NCT03729869|Progestins|progestins|mesh-ancestor
2869568|NCT03729869|Hormones|hormones|mesh-ancestor
2310828|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2310829|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
2310830|NCT00329680|Antioxidants|antioxidants|mesh-list
2310831|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869569|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2869570|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869571|NCT03729804|Dexamethasone|dexamethasone|mesh-list
2869572|NCT03729804|Lenalidomide|lenalidomide|mesh-list
2869573|NCT03729804|Bortezomib|bortezomib|mesh-list
2869574|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2869575|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
2869576|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
2869577|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869578|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869579|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2869580|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
2869581|NCT03729804|Hormones|hormones|mesh-ancestor
2869582|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2310832|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310833|NCT00329680|Protective Agents|protective agents|mesh-ancestor
2310834|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2310835|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2310836|NCT00329680|Analgesics|analgesics|mesh-ancestor
2310837|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
2869583|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2869584|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869585|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
2869586|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2869587|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2869588|NCT03729804|Growth Substances|growth substances|mesh-ancestor
2869589|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
2869590|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2869591|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
2869592|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869593|NCT03729687|Capecitabine|capecitabine|mesh-list
2869594|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
2869595|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2869596|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
2869597|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869598|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869599|NCT03729674|Infliximab|infliximab|mesh-list
2310838|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869600|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
2869601|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2869602|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2869603|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2869604|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2869605|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869606|NCT03729505|Lidocaine|lidocaine|mesh-list
2869607|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
2869608|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
2869609|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
2869610|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869611|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869612|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
2869613|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869614|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2869615|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2869616|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2869617|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2869618|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869619|NCT03729505|Analgesics|analgesics|mesh-ancestor
2869620|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
2869621|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2869622|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2869623|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
2869624|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2869625|NCT03729401|Aspirin|aspirin|mesh-list
2869626|NCT03729401|Clopidogrel|clopidogrel|mesh-list
2869627|NCT03729401|Ticagrelor|ticagrelor|mesh-list
2869628|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2869629|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2869630|NCT03729401|Analgesics|analgesics|mesh-ancestor
2869631|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
2869632|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869633|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869634|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2869635|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2869636|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2869637|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2869638|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869639|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2869640|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2869641|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869642|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
2869643|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2310839|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2310840|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2310841|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2310842|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
2310843|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2310844|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
2869644|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2869645|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2869646|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
2869647|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869648|NCT03729375|Bupivacaine|bupivacaine|mesh-list
2869649|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
2869650|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
2869651|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869652|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869653|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
2869654|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869655|NCT03729310|Triamcinolone|triamcinolone|mesh-list
2869656|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2869657|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
2869658|NCT03729310|Hormones|hormones|mesh-ancestor
2869659|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2869660|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869661|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2869662|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2869663|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2869664|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2869665|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310845|NCT00329693|Quinagolide|quinagolide|mesh-list
2310846|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
2869666|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869667|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869668|NCT03729284|Analgesics|analgesics|mesh-ancestor
2869669|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
2869670|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869671|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
2869672|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2869673|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
2869674|NCT03729128|Memantine|memantine|mesh-list
2869675|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
2869676|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2869677|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2869678|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
2869679|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869680|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869681|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869682|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2869683|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2869684|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
2869685|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
2869686|NCT03729102|Vaccines|vaccines|mesh-list
2869687|NCT03729102|Immunologic Factors|immunologic factors|mesh-ancestor
2869688|NCT03729102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869689|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
2869690|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
2869691|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869692|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
2869693|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869694|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869695|NCT03729011|Propofol|propofol|mesh-list
2869696|NCT03729011|Sevoflurane|sevoflurane|mesh-list
2869697|NCT03729011|Desflurane|desflurane|mesh-list
2869698|NCT03729011|Isoflurane|isoflurane|mesh-list
2869699|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2869700|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869701|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869702|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2869703|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
2869704|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
2869705|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2869706|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2869707|NCT03728946|Bupivacaine|bupivacaine|mesh-list
2869708|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
2869709|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
2869710|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869711|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869712|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
2869713|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869714|NCT03728933|Rotigotine|rotigotine|mesh-list
2869715|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
2869716|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
2869717|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869718|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869719|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869720|NCT03728894|Midazolam|midazolam|mesh-list
2869721|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
2869722|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2869723|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2310847|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
2310848|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310849|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310850|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310851|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2310852|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2310853|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2310854|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
2310855|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310856|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2310857|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2310858|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310859|NCT00329810|Aripiprazole|aripiprazole|mesh-list
2310860|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
2869724|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869725|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869726|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2869727|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2869728|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2869729|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2869730|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
2869731|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
2310861|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2310862|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2310863|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2310864|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2310865|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310866|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
2310867|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
2310868|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310869|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310870|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2310871|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2310872|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
2869732|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
2869733|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
2869734|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310873|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2869735|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869736|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
2869737|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
2869738|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2869739|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
2869740|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
2869744|NCT03728829|Carboplatin|carboplatin|mesh-list
2869745|NCT03728829|Docetaxel|docetaxel|mesh-list
2869746|NCT03728829|Trastuzumab|trastuzumab|mesh-list
2869747|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869748|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
2869749|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
2869750|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
2869751|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869752|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2869753|NCT03728777|Resveratrol|resveratrol|mesh-list
2869754|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
2869755|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310874|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2310875|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2310876|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2310877|NCT00329823|Etanercept|etanercept|mesh-list
2310878|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2310879|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2310880|NCT00329823|Analgesics|analgesics|mesh-ancestor
2310881|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
2310882|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2310883|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310884|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2310885|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2310886|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2310887|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2310888|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
2310889|NCT00329914|Progesterone|progesterone|mesh-list
2310890|NCT00329914|Progestins|progestins|mesh-ancestor
2310891|NCT00329914|Hormones|hormones|mesh-ancestor
2310892|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2310893|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310894|NCT00329940|Letrozole|letrozole|mesh-list
2869756|NCT03728777|Protective Agents|protective agents|mesh-ancestor
2869757|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869758|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869759|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2869760|NCT03728673|Dexetimide|dexetimide|mesh-list
2869761|NCT03728673|Citalopram|citalopram|mesh-list
2869762|NCT03728673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2869763|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2869764|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2869765|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869766|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869767|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
2869768|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869769|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2869770|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
2869771|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2869772|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2869773|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2869774|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
2869775|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
2869776|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869777|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2869778|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2869779|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
2310895|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310896|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2310897|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2310898|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310899|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310900|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2310901|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
2310902|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2310903|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310904|NCT00330018|Valganciclovir|valganciclovir|mesh-list
2310905|NCT00330018|Acyclovir|acyclovir|mesh-list
2310906|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
2310907|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2310908|NCT00330044|Carboplatin|carboplatin|mesh-list
2310909|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310910|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
2310911|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2310912|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
2310913|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310914|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
2310915|NCT00330135|Protective Agents|protective agents|mesh-ancestor
2310916|NCT00330148|Eflornithine|eflornithine|mesh-list
2310917|NCT00330148|Nifurtimox|nifurtimox|mesh-list
2310918|NCT00330148|Melarsoprol|melarsoprol|mesh-list
2869784|NCT03728478|Etanercept|etanercept|mesh-list
2869785|NCT03728478|Methotrexate|methotrexate|mesh-list
2869786|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2869787|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
2869788|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2869789|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869790|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2869791|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
2869792|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869793|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869794|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
2869795|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869796|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2869797|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2869798|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
2869799|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2869800|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2869801|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2869802|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2869803|NCT03728478|Analgesics|analgesics|mesh-ancestor
2869804|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
2869805|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869806|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2869807|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2869808|NCT03728465|Nivolumab|nivolumab|mesh-list
2869809|NCT03728465|Ipilimumab|ipilimumab|mesh-list
2869810|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2869811|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869812|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2869813|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869814|NCT03728426|Letermovir|letermovir|mesh-list
2869815|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2869816|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869817|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869818|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869819|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
2869820|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2869821|NCT03728361|Nivolumab|nivolumab|mesh-list
2869822|NCT03728361|Temozolomide|temozolomide|mesh-list
2869823|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2869824|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869825|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2869826|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869827|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2869828|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
2869829|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
2869830|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2869831|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
2869832|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310919|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310920|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2310921|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2310922|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2310923|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2310924|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2310925|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310926|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310927|NCT00330239|Paroxetine|paroxetine|mesh-list
2310928|NCT00330239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2310929|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2310930|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2310931|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310932|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2310933|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
2310934|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310935|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2310936|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
2310937|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2310938|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2310939|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2869833|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
2869834|NCT03728244|Protective Agents|protective agents|mesh-ancestor
2869835|NCT03728192|Camptothecin|camptothecin|mesh-list
2869836|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2869837|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869838|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2869839|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2869840|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310940|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310941|NCT00330252|Rituximab|rituximab|mesh-list
2310942|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
2310943|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2310944|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310945|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
2310946|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869841|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869871|NCT03728153|Fluoxetine|fluoxetine|mesh-list
2869872|NCT03728153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2869873|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2869874|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2869875|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869876|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869877|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
2869878|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869879|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2869880|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
2869881|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2869882|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2869883|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2869884|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869885|NCT03728101|Dabigatran|dabigatran|mesh-list
2869886|NCT03728101|Simvastatin|simvastatin|mesh-list
2869887|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2869888|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2869889|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
2310947|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2310948|NCT00330278|Cefazolin|cefazolin|mesh-list
2310949|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2310950|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2310951|NCT00330304|Isoniazid|isoniazid|mesh-list
2310952|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2310953|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
2310954|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2310955|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2310956|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2310957|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2310958|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
2310959|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310960|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2310961|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2310962|NCT00330304|Renal Agents|renal agents|mesh-ancestor
2310963|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
2869890|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869891|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2869892|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2869893|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869894|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
2869895|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2869896|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
2869897|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
2869902|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
2869903|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2869904|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869905|NCT03727867|Mitogens|mitogens|mesh-list
2869906|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
2869907|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869916|NCT03727763|Cetuximab|cetuximab|mesh-list
2869917|NCT03727763|Vemurafenib|vemurafenib|mesh-list
2869918|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2869919|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869920|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2869921|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869922|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869923|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
2869924|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2108781|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
2108782|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108783|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108784|NCT02509624|Selonsertib|selonsertib|mesh-list
2108785|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2108786|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108787|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108788|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2108789|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
2108790|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2108791|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2108792|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2108793|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
2108794|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2108795|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108796|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2108797|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2108798|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2108799|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2108800|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108801|NCT02510001|Crizotinib|crizotinib|mesh-list
2310964|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2310965|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2310966|NCT00330317|Letrozole|letrozole|mesh-list
2310967|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310968|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2310969|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2310970|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310971|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310972|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2310973|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
2310974|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2310975|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310976|NCT00330369|Darusentan|darusentan|mesh-list
2310977|NCT00330369|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2310978|NCT00330369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869925|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2869926|NCT03727646|Niacinamide|niacinamide|mesh-list
2310979|NCT00330395|Caspofungin|caspofungin|mesh-list
2310980|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
2310981|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2310982|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2310983|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2310984|NCT00330473|Insulin|insulin|mesh-list
2310985|NCT00330473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2310986|NCT00330473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2310987|NCT00330473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2310988|NCT00330486|Acamprosate|acamprosate|mesh-list
2869927|NCT03727646|Niacin|niacin|mesh-list
2869928|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
2869929|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
2310989|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2310990|NCT00330499|Cisplatin|cisplatin|mesh-list
2310991|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2310992|NCT00330525|Sibutramine|sibutramine|mesh-list
2310993|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
2310994|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2310995|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
2310996|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2310997|NCT00330577|Timolol|timolol|mesh-list
2310998|NCT00330577|Latanoprost|latanoprost|mesh-list
2310999|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
2311000|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2311001|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2869930|NCT03727646|Vitamins|vitamins|mesh-ancestor
2869931|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
2869932|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869933|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2869934|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
2869935|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869936|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2311002|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
2311003|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311004|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311005|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311006|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2311007|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2311008|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2311009|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2311010|NCT00330655|Memantine|memantine|mesh-list
2311011|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2311012|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2311013|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
2311014|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311015|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311016|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311017|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2311018|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2311019|NCT00330707|Interferons|interferons|mesh-list
2869937|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
2869938|NCT03727620|Amoxicillin|amoxicillin|mesh-list
2869939|NCT03727620|Metronidazole|metronidazole|mesh-list
2869940|NCT03727620|Doxycycline|doxycycline|mesh-list
2869941|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2869942|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2869943|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2311020|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
2311021|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
2869944|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2311022|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311023|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
2311024|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2311025|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
2311026|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311027|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2311028|NCT00330746|Gemcitabine|gemcitabine|mesh-list
2311029|NCT00330746|Cetuximab|cetuximab|mesh-list
2311030|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2311031|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
2311032|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311033|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311034|NCT00330746|Antiviral Agents|antiviral agents|mesh-ancestor
2311035|NCT00330746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2311036|NCT00330746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311037|NCT00330746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2311038|NCT00330746|Immunologic Factors|immunologic factors|mesh-ancestor
2311039|NCT00330746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311040|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2311041|NCT00330772|Aspirin|aspirin|mesh-list
2311042|NCT00330772|Clopidogrel|clopidogrel|mesh-list
2311043|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2311044|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2311045|NCT00330772|Analgesics|analgesics|mesh-ancestor
2311046|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
2311047|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311048|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311049|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311050|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2311051|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2311052|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2311053|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311054|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2311055|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2311056|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311057|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
2311058|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2311059|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2311060|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2311061|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
2311062|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311063|NCT00330785|Amlodipine|amlodipine|mesh-list
2311064|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
2311065|NCT00330785|Atorvastatin|atorvastatin|mesh-list
2311066|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2311067|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2311068|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
2311069|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311070|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2869945|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
2869946|NCT03727607|Propofol|propofol|mesh-list
2869947|NCT03727607|Desflurane|desflurane|mesh-list
2869948|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2869949|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2869950|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869951|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2869952|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
2869953|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
2869954|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2869955|NCT03727464|Propofol|propofol|mesh-list
2869956|NCT03727464|Sevoflurane|sevoflurane|mesh-list
2869957|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2869958|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108802|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108803|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2108804|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108805|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108806|NCT02510014|Buprenorphine|buprenorphine|mesh-list
2108807|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2108808|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2108809|NCT02510014|Narcotics|narcotics|mesh-ancestor
2108810|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108811|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108812|NCT02510014|Analgesics|analgesics|mesh-ancestor
2108813|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
2869959|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869960|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2869961|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
2869962|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
2869963|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2869964|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2869965|NCT03727412|Naproxen|naproxen|mesh-list
2869966|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2311071|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2311072|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311073|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2311074|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2311075|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2311076|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2311077|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311078|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
2311079|NCT00330798|Ketorolac|ketorolac|mesh-list
2311080|NCT00330798|Nepafenac|nepafenac|mesh-list
2311081|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2311082|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2869967|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2869968|NCT03727412|Analgesics|analgesics|mesh-ancestor
2869969|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
2869970|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869971|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869972|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2869973|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2869974|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
2869975|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2869976|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2869977|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869978|NCT03727295|Idebenone|idebenone|mesh-list
2869979|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
2869980|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869981|NCT03727295|Protective Agents|protective agents|mesh-ancestor
2311083|NCT00330798|Analgesics|analgesics|mesh-ancestor
2311084|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
2311085|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311086|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311087|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311088|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2311089|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2311090|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311091|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311092|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2311093|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
2311094|NCT00330824|Dexamethasone|dexamethasone|mesh-list
2311095|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
2311096|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2311097|NCT00330824|BB 1101|bb 1101|mesh-list
2311098|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311099|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
2311100|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
2311101|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311102|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311103|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2311104|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
2311105|NCT00330824|Hormones|hormones|mesh-ancestor
2311106|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311107|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2311108|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311109|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
2311110|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311111|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311112|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2311113|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2311114|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2869982|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869983|NCT03727282|Dobutamine|dobutamine|mesh-list
2869984|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2869985|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
2869986|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
2869987|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2869988|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2869989|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2869990|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2869991|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2869992|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
2869993|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2869994|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2869995|NCT03727282|Protective Agents|protective agents|mesh-ancestor
2869996|NCT03727100|Clonidine|clonidine|mesh-list
2869997|NCT03727100|Analgesics|analgesics|mesh-ancestor
2869998|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
2869999|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870000|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870001|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2870002|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
2870003|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
2870004|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2870005|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2870006|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2870007|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
2870008|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870009|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870010|NCT03727061|Carboplatin|carboplatin|mesh-list
2870011|NCT03727061|Fluorouracil|fluorouracil|mesh-list
2870012|NCT03727061|Pembrolizumab|pembrolizumab|mesh-list
2870013|NCT03727061|Nivolumab|nivolumab|mesh-list
2870014|NCT03727061|Cetuximab|cetuximab|mesh-list
2870015|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2870016|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
2870017|NCT03727061|Trioxsalen|trioxsalen|mesh-list
2870018|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870019|NCT03727061|Antimetabolites|antimetabolites|mesh-ancestor
2870020|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870021|NCT03727061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2870022|NCT03727061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2870023|NCT03727061|Immunologic Factors|immunologic factors|mesh-ancestor
2870024|NCT03727061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870025|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2870026|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2870027|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
2870028|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2870029|NCT03727048|Ketorolac|ketorolac|mesh-list
2311115|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2311116|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
2311117|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2311118|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2311119|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2311120|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2311121|NCT00330902|Artesunate|artesunate|mesh-list
2311122|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
2311123|NCT00330902|Primaquine|primaquine|mesh-list
2311124|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
2311125|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2311126|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
2311127|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2311128|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2311129|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870030|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2870031|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2870032|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2870033|NCT03727048|Analgesics|analgesics|mesh-ancestor
2870034|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
2870035|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870036|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870037|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2870038|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2870039|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2870040|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870041|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870042|NCT03727022|Lorecivivint|lorecivivint|mesh-list
2870043|NCT03727022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2870044|NCT03726788|Triamcinolone|triamcinolone|mesh-list
2870045|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2870046|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2870047|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
2870048|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2870049|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2870050|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2311130|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311131|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
2311132|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
2870051|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2870052|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2870053|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870054|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
2870055|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870056|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870057|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2870058|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870059|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2870060|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
2870061|NCT03726788|Hormones|hormones|mesh-ancestor
2870062|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2870063|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2870064|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
2870065|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870066|NCT03726775|Durvalumab|durvalumab|mesh-list
2870067|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2870068|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870069|NCT03726749|Prednisone|prednisone|mesh-list
2870070|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
2870071|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2870072|NCT03726749|Hormones|hormones|mesh-ancestor
2311133|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2311134|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
2311135|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2311136|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311137|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311138|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2311139|NCT00330902|Renal Agents|renal agents|mesh-ancestor
2870073|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2870074|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870075|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2311140|NCT00330941|Lidocaine|lidocaine|mesh-list
2311141|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
2311142|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
2311143|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108814|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108815|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2108816|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
2108817|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2108818|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108819|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108820|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
2311144|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870076|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870077|NCT03726736|Docetaxel|docetaxel|mesh-list
2870078|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870079|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
2870080|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
2870081|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
2870082|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870083|NCT03726593|Artesunate|artesunate|mesh-list
2870084|NCT03726593|Mefloquine|mefloquine|mesh-list
2870085|NCT03726593|Atovaquone|atovaquone|mesh-list
2870086|NCT03726593|Proguanil|proguanil|mesh-list
2870087|NCT03726593|Pyronaridine|pyronaridine|mesh-list
2870088|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2870089|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
2870090|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2870091|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2870092|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870093|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311145|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
2311146|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870094|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
2870095|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
2870096|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2870097|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
2870098|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870099|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870100|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
2870101|NCT03726580|Propofol|propofol|mesh-list
2870102|NCT03726580|Sevoflurane|sevoflurane|mesh-list
2870103|NCT03726580|Isoflurane|isoflurane|mesh-list
2870104|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2870105|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870106|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870107|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2870108|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
2870109|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
2870110|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2870111|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2870112|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
2870113|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2870114|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870115|NCT03726398|Macitentan|macitentan|mesh-list
2870116|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2870117|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2870118|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870119|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2870120|NCT03726372|Bromides|bromides|mesh-list
2870121|NCT03726372|Rocuronium|rocuronium|mesh-list
2870122|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
2870123|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2870124|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2311147|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2311148|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2311149|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2311150|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2870125|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2870126|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870127|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870128|NCT03726281|Nivolumab|nivolumab|mesh-list
2870129|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2870130|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870131|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2870132|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870133|NCT03726268|Fentanyl|fentanyl|mesh-list
2870134|NCT03726268|Sufentanil|sufentanil|mesh-list
2311151|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311152|NCT00330980|Simvastatin|simvastatin|mesh-list
2311153|NCT00330980|Pravastatin|pravastatin|mesh-list
2311154|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2311155|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2311156|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
2311157|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311158|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2311159|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2311160|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311161|NCT00330993|Misoprostol|misoprostol|mesh-list
2311162|NCT00330993|Mifepristone|mifepristone|mesh-list
2311163|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2311164|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
2311165|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2311166|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311167|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2311168|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2311169|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
2311170|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2311171|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2311172|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2870135|NCT03726268|Morphine|morphine|mesh-list
2870136|NCT03726268|Methadone|methadone|mesh-list
2870137|NCT03726268|Hydromorphone|hydromorphone|mesh-list
2870138|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2870139|NCT03726268|Narcotics|narcotics|mesh-ancestor
2870140|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870141|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870142|NCT03726268|Analgesics|analgesics|mesh-ancestor
2870143|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
2311173|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2311174|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
2311175|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2311176|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2311177|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
2311178|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311179|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
2311180|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2311181|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2311182|NCT00331045|Alvimopan|alvimopan|mesh-list
2311183|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2870144|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870145|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2311184|NCT00331058|Prednisolone|prednisolone|mesh-list
2311185|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311186|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
2311187|NCT00331058|Hormones|hormones|mesh-ancestor
2311188|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311189|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311190|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2311191|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311192|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
2311193|NCT00331071|Ortho Evra|ortho evra|mesh-list
2311194|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
2311195|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2870146|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2870147|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
2870148|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
2870149|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
2870150|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
2870151|NCT03726242|Cromakalim|cromakalim|mesh-list
2870152|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2870153|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2870154|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
2870155|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870156|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870157|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2870158|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
2870159|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
2870160|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
2870161|NCT03726216|Dalbavancin|dalbavancin|mesh-list
2870162|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2870163|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870164|NCT03726177|Aspirin|aspirin|mesh-list
2870165|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2870166|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2870167|NCT03726177|Analgesics|analgesics|mesh-ancestor
2870168|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
2870169|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870170|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870171|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2870172|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2870173|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2870174|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2870175|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870176|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2870177|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2870178|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870179|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
2870180|NCT03726125|Insulin|insulin|mesh-list
2870181|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2870182|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
2870183|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2870184|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870185|NCT03726099|Amoxicillin|amoxicillin|mesh-list
2870186|NCT03726099|Tetracycline|tetracycline|mesh-list
2870187|NCT03726099|Furazolidone|furazolidone|mesh-list
2311196|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311197|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2311198|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2311199|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2311200|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
2311201|NCT00331084|Dexamethasone|dexamethasone|mesh-list
2311202|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
2311203|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2311204|NCT00331084|BB 1101|bb 1101|mesh-list
2870188|NCT03726099|Esomeprazole|esomeprazole|mesh-list
2870189|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2870190|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870191|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2870192|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2870193|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2870194|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870195|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870196|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2870197|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2870198|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2870199|NCT03726099|Renal Agents|renal agents|mesh-ancestor
2870200|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2870201|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2870202|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2870203|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2870204|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
2870205|NCT03726021|Irinotecan|irinotecan|mesh-list
2870206|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870207|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2870208|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2870209|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870210|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870211|NCT03725995|Lidocaine|lidocaine|mesh-list
2870212|NCT03725995|Midazolam|midazolam|mesh-list
2870213|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
2870214|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
2870215|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870216|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870217|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
2870218|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870219|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2870220|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2870221|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2870222|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2870223|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870224|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2870225|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2870226|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2870227|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2870228|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2870229|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2311205|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311206|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
2311207|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
2311208|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311209|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311210|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2311211|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
2870230|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
2870231|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
2870232|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
2870233|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870234|NCT03725930|Clonidine|clonidine|mesh-list
2870235|NCT03725930|Analgesics|analgesics|mesh-ancestor
2870236|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
2870237|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870238|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870239|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2870240|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
2870241|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
2870242|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2870243|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2870244|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2870245|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
2870246|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870247|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870248|NCT03725904|Progesterone|progesterone|mesh-list
2870249|NCT03725904|Progestins|progestins|mesh-ancestor
2870250|NCT03725904|Hormones|hormones|mesh-ancestor
2870251|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2870252|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870253|NCT03725891|Aspirin|aspirin|mesh-list
2870254|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2870255|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2870256|NCT03725891|Analgesics|analgesics|mesh-ancestor
2870257|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
2870258|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870259|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870260|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2870261|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2870262|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2870263|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2870264|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870265|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2870266|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2870267|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870268|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
2870269|NCT03725878|Folic Acid|folic acid|mesh-list
2870270|NCT03725878|Hematinics|hematinics|mesh-ancestor
2870271|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
2870272|NCT03725878|Vitamins|vitamins|mesh-ancestor
2870273|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
2870274|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870275|NCT03725709|Anesthetics|anesthetics|mesh-list
2870276|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870277|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870278|NCT03725553|Vasopressins|vasopressins|mesh-list
2870279|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
2870280|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
2870281|NCT03725553|Coagulants|coagulants|mesh-ancestor
2870282|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2870283|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2870284|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
2870285|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311212|NCT00331084|Hormones|hormones|mesh-ancestor
2311213|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311214|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2311215|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311216|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
2311217|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311218|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311219|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2311220|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2311221|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2311222|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2311223|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
2311224|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2311225|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2311226|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2311227|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2311228|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
2311229|NCT00331097|Docetaxel|docetaxel|mesh-list
2311230|NCT00331097|Fluorouracil|fluorouracil|mesh-list
2311231|NCT00331097|Methotrexate|methotrexate|mesh-list
2311232|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2311233|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
2311234|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311235|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2311236|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2311237|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
2311238|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311239|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311240|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2311241|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
2311242|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
2311243|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
2311244|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
2311245|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2311246|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2311247|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
2311248|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2311249|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
2311250|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311251|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2311252|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2870286|NCT03725501|Ranibizumab|ranibizumab|mesh-list
2870287|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2870288|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2870289|NCT03725501|Growth Substances|growth substances|mesh-ancestor
2870290|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870291|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
2870292|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870293|NCT03725436|Paclitaxel|paclitaxel|mesh-list
2870294|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2870295|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2870296|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870297|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
2870298|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
2870299|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
2870300|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870301|NCT03725423|Apatinib|apatinib|mesh-list
2870302|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870303|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2870304|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870305|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870306|NCT03725267|Melatonin|melatonin|mesh-list
2311253|NCT00331123|Testosterone|testosterone|mesh-list
2311254|NCT00331123|Androgens|androgens|mesh-ancestor
2311255|NCT00331123|Hormones|hormones|mesh-ancestor
2311256|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311257|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870307|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
2870308|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870309|NCT03725267|Protective Agents|protective agents|mesh-ancestor
2870310|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870311|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870312|NCT03725228|Lidocaine|lidocaine|mesh-list
2870313|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
2870314|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
2870315|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
2870316|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870317|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870318|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
2870319|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870320|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2870321|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2870322|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2870323|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2870324|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870325|NCT03725228|Analgesics|analgesics|mesh-ancestor
2870326|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
2870327|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2311258|NCT00331149|Ropinirole|ropinirole|mesh-list
2311259|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2311260|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2311261|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
2311262|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
2311263|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311264|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311265|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311266|NCT00331188|Vapreotide|vapreotide|mesh-list
2311267|NCT00331188|Analgesics|analgesics|mesh-ancestor
2311268|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
2311269|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311270|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311271|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311272|NCT00331214|Testosterone|testosterone|mesh-list
2311273|NCT00331214|Androgens|androgens|mesh-ancestor
2311274|NCT00331214|Hormones|hormones|mesh-ancestor
2311275|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311276|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870328|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2870329|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
2870330|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2870331|NCT03725020|Fluorides|fluorides|mesh-list
2870332|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
2870333|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
2870334|NCT03725020|Protective Agents|protective agents|mesh-ancestor
2870335|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870336|NCT03724994|Gemcitabine|gemcitabine|mesh-list
2870337|NCT03724994|Paclitaxel|paclitaxel|mesh-list
2870338|NCT03724994|Fluorouracil|fluorouracil|mesh-list
2870339|NCT03724994|Folfirinox|folfirinox|mesh-list
2870340|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2870341|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870342|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
2870343|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
2870344|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
2870345|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870346|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2870347|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
2870348|NCT03724994|Antiviral Agents|antiviral agents|mesh-ancestor
2870349|NCT03724994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870350|NCT03724994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870351|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2870352|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
2870353|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870354|NCT03724955|Estradiol|estradiol|mesh-list
2870355|NCT03724955|Estrogens|estrogens|mesh-ancestor
2870356|NCT03724955|Hormones|hormones|mesh-ancestor
2870357|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2870358|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311277|NCT00331240|Timolol|timolol|mesh-list
2311278|NCT00331240|Travoprost|travoprost|mesh-list
2311279|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
2870366|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
2870367|NCT03724838|Esomeprazole|esomeprazole|mesh-list
2870368|NCT03724838|Citric Acid|citric acid|mesh-list
2870369|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
2870370|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
2870371|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2870372|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
2870373|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
2870374|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870375|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
2870376|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2108821|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108822|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108823|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
2108824|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2108825|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2311280|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2311281|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2311282|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
2870377|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2870378|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108826|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108827|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
2108828|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
2108829|NCT02510794|Ranibizumab|ranibizumab|mesh-list
2108830|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2108831|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2108832|NCT02510794|Growth Substances|growth substances|mesh-ancestor
2108833|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108834|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
2108835|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108836|NCT02511106|Osimertinib|osimertinib|mesh-list
2108837|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870379|NCT03724838|Urological Agents|urological agents|mesh-ancestor
2870380|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2870381|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2870382|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2870383|NCT03724825|Testosterone|testosterone|mesh-list
2870384|NCT03724825|Androgens|androgens|mesh-ancestor
2870385|NCT03724825|Hormones|hormones|mesh-ancestor
2870386|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2870387|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870388|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
2870389|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2870390|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
2870391|NCT03724578|Fluorides|fluorides|mesh-list
2870392|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
2870393|NCT03724578|Protective Agents|protective agents|mesh-ancestor
2870394|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870395|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2870396|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870397|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
2870398|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870399|NCT03724409|Octreotide|octreotide|mesh-list
2870400|NCT03724409|Edotreotide|edotreotide|mesh-list
2870401|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2870402|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2870403|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870404|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2870405|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870406|NCT03724266|Chitosan|chitosan|mesh-list
2870407|NCT03724266|Calcium|calcium|mesh-list
2870408|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2870409|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870410|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2870411|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2870412|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
2870413|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870414|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2870415|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
2870416|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
2870417|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
2870418|NCT03724266|Coagulants|coagulants|mesh-ancestor
2870419|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2870420|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2870421|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2311283|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311284|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311285|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311286|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2311287|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2311288|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2311289|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2311290|NCT00331305|Sertraline|sertraline|mesh-list
2311291|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
2311292|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2311293|NCT00331305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2311294|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2311295|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2311296|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311297|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311298|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
2311299|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311300|NCT00331435|Verteporfin|verteporfin|mesh-list
2311301|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2311302|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
2311303|NCT00331487|Pioglitazone|pioglitazone|mesh-list
2311304|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
2311305|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2870422|NCT03724084|Cytarabine|cytarabine|mesh-list
2870423|NCT03724084|Daunorubicin|daunorubicin|mesh-list
2870424|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2311306|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311307|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2311308|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2311309|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2870425|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
2870426|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870427|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870428|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
2870429|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870430|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2870431|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
2311310|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2311311|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2311312|NCT00331500|Analgesics|analgesics|mesh-ancestor
2311313|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
2311314|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311315|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311316|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311317|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2311318|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2311319|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2311320|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2311321|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
2311322|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
2311323|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311324|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311325|NCT00331513|Vorinostat|vorinostat|mesh-list
2311326|NCT00331513|Idarubicin|idarubicin|mesh-list
2870432|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870433|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2870434|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2870435|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2870436|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870437|NCT03724071|Flucytosine|flucytosine|mesh-list
2870438|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
2870439|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870440|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
2870441|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870442|NCT03724019|Ketamine|ketamine|mesh-list
2870443|NCT03724019|Analgesics|analgesics|mesh-ancestor
2870444|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
2870445|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870446|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870447|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2870448|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2870449|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
2870450|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
2870451|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870452|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2870453|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2870454|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870455|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870456|NCT03723967|Paclitaxel|paclitaxel|mesh-list
2870457|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2870458|NCT03723967|Carboplatin|carboplatin|mesh-list
2870459|NCT03723967|Durvalumab|durvalumab|mesh-list
2870460|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2870461|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2870462|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870463|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
2870464|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
2870465|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
2870466|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870467|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2870468|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
2870469|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870470|NCT03723941|Etoposide|etoposide|mesh-list
2870471|NCT03723941|Mitotane|mitotane|mesh-list
2870472|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870473|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2870474|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2870475|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2870476|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870477|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870478|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2870479|NCT03723824|Grazoprevir|grazoprevir|mesh-list
2870480|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
2311327|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311328|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2311329|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870481|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
2870482|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870483|NCT03723785|Insulin|insulin|mesh-list
2870484|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2870485|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2870486|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870487|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
2870488|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
2870489|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2870490|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2870491|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311330|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311331|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2311332|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2311333|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2311334|NCT00331526|Aldesleukin|aldesleukin|mesh-list
2311335|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311336|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2311337|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2311338|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
2311339|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2311340|NCT00331604|Insulin|insulin|mesh-list
2311341|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2311342|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
2311343|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
2311344|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2311345|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
2311346|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2311347|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311348|NCT00331643|Epothilones|epothilones|mesh-list
2311349|NCT00331643|Epothilone B|epothilone b|mesh-list
2311350|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
2311351|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
2311352|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
2311353|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311354|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311355|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2311356|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2311357|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2311358|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
2311359|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311360|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311361|NCT00331695|Progestins|progestins|mesh-ancestor
2311362|NCT00331695|Hormones|hormones|mesh-ancestor
2311363|NCT00331708|Artesunate|artesunate|mesh-list
2311364|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
2311365|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
2870492|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2870493|NCT03723395|Repaglinide|repaglinide|mesh-list
2870494|NCT03723395|Tolbutamide|tolbutamide|mesh-list
2870495|NCT03723395|Itraconazole|itraconazole|mesh-list
2870496|NCT03723395|Rifampin|rifampin|mesh-list
2870497|NCT03723395|Tucatinib|tucatinib|mesh-list
2870498|NCT03723395|Digoxin|digoxin|mesh-list
2870499|NCT03723395|Midazolam|midazolam|mesh-list
2870500|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
2870501|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2870502|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2870503|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870504|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870505|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2870506|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2311366|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2311367|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
2311368|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2311369|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2311370|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2311371|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311372|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
2870507|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2870508|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2870509|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
2870510|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
2870511|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
2870512|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
2870513|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870514|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870515|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
2870516|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870517|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2870518|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2870519|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870520|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2311373|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
2311374|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2311375|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
2870521|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
2870522|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2870523|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2870524|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2870525|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
2870526|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2870527|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
2870528|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2870529|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2870530|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2870531|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2870532|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2870533|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2870534|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2870535|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2870536|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2870537|NCT03723395|Protective Agents|protective agents|mesh-ancestor
2870538|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2870539|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870540|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2870541|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2870542|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
2870543|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2870544|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2870545|NCT03723291|Tocopherols|tocopherols|mesh-list
2870546|NCT03723291|Vitamin E|vitamin e|mesh-list
2870547|NCT03723291|Tocotrienols|tocotrienols|mesh-list
2870548|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
2870549|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
2870550|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2870551|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870552|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870553|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2870554|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2870555|NCT03723291|Protective Agents|protective agents|mesh-ancestor
2870556|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870557|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
2311376|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2311377|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311378|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311379|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2311380|NCT00331708|Renal Agents|renal agents|mesh-ancestor
2311381|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
2870558|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2870559|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
2870560|NCT03723291|Vitamins|vitamins|mesh-ancestor
2870561|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
2870562|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
2870563|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2870564|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870565|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2870566|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870567|NCT03723187|Heparin|heparin|mesh-list
2870568|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
2870569|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2870570|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2870571|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870572|NCT03723135|Azacitidine|azacitidine|mesh-list
2311382|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
2311383|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2311384|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
2311385|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311386|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2311387|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2311388|NCT00331786|Aspirin|aspirin|mesh-list
2311389|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
2311390|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
2311391|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2311392|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2311393|NCT00331786|Analgesics|analgesics|mesh-ancestor
2870573|NCT03723135|Cc-486|cc-486|mesh-list
2870574|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2870575|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
2870576|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870577|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870578|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870579|NCT03723109|Anesthetics|anesthetics|mesh-list
2870580|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870581|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870582|NCT03723096|Pomalidomide|pomalidomide|mesh-list
2870583|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
2311394|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
2311395|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311396|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311397|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311398|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2311399|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2311400|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2311401|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311402|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2311403|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2870584|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870585|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2870586|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2870587|NCT03723096|Growth Substances|growth substances|mesh-ancestor
2870588|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
2311404|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311405|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
2311406|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2311407|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
2311408|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2870589|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870590|NCT03723083|Thalidomide|thalidomide|mesh-list
2870591|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2870592|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
2870593|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870594|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
2870595|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2870596|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870597|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2870598|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2870599|NCT03723083|Growth Substances|growth substances|mesh-ancestor
2311409|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
2870600|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
2870601|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870602|NCT03723031|Misoprostol|misoprostol|mesh-list
2870603|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2870604|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
2870605|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2870606|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870607|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2870608|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2870609|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
2870610|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
2870611|NCT03722940|Analgesics|analgesics|mesh-ancestor
2870612|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
2870613|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870614|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870615|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
2870616|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870617|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2870618|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
2870619|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2870620|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2870621|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870622|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2870623|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
2870624|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2870625|NCT03722927|Bupivacaine|bupivacaine|mesh-list
2870626|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
2870627|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
2870628|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870629|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870630|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
2870631|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870632|NCT03722914|Benzonatate|benzonatate|mesh-list
2870633|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
2870634|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
2870635|NCT03722875|Apatinib|apatinib|mesh-list
2870636|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870637|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2870638|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870639|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870640|NCT03722849|Adenosine|adenosine|mesh-list
2870641|NCT03722849|Capsaicin|capsaicin|mesh-list
2870642|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
2870643|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
2870644|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
2870645|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870646|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870647|NCT03722849|Analgesics|analgesics|mesh-ancestor
2870648|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2870649|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
2870650|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2870651|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
2870652|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
2870653|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870654|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870655|NCT03722823|Tucatinib|tucatinib|mesh-list
2870656|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870657|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2870658|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870659|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870660|NCT03722680|Riluzole|riluzole|mesh-list
2870661|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
2870662|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2870663|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2870664|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870665|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870666|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870667|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2870668|NCT03722680|Protective Agents|protective agents|mesh-ancestor
2870669|NCT03722498|Leucovorin|leucovorin|mesh-list
2870670|NCT03722498|Fluorouracil|fluorouracil|mesh-list
2870671|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
2870672|NCT03722498|Sorafenib|sorafenib|mesh-list
2870673|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
2870674|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311410|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2311411|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
2311412|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311413|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2311414|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
2870675|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2870676|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870677|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2870678|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
2870679|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870680|NCT03722498|Antidotes|antidotes|mesh-ancestor
2870681|NCT03722498|Protective Agents|protective agents|mesh-ancestor
2870682|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
2870683|NCT03722498|Vitamins|vitamins|mesh-ancestor
2870684|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
2870685|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2870686|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870687|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
2870688|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870689|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2870690|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870691|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870692|NCT03722381|Amlodipine|amlodipine|mesh-list
2870693|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2311415|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
2870694|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2870695|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2870696|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870697|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2870698|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870699|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
2870700|NCT03722355|Carmustine|carmustine|mesh-list
2870701|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2870702|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
2870703|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870704|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870705|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
2870706|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2870707|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311416|NCT00331786|Protective Agents|protective agents|mesh-ancestor
2311417|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2311418|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
2311419|NCT00331825|Olanzapine|olanzapine|mesh-list
2311420|NCT00331825|Risperidone|risperidone|mesh-list
2311421|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2311422|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
2311423|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870708|NCT03722329|Eculizumab|eculizumab|mesh-list
2870709|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2870710|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2870711|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
2870712|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870713|NCT03722303|Cortisone|cortisone|mesh-list
2870714|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2870715|NCT03722290|Metformin|metformin|mesh-list
2870716|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2870717|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870718|NCT03722173|Itraconazole|itraconazole|mesh-list
2870719|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
2870720|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870721|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2870722|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2870723|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870724|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870725|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2870726|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
2870727|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2870728|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870729|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2311424|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311425|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311426|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2311427|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2311428|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2311429|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2311430|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2311431|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
2311432|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
2870730|NCT03721991|Butyric Acid|butyric acid|mesh-list
2870731|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870732|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870733|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870734|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
2870735|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
2870736|NCT03721965|Prednisone|prednisone|mesh-list
2870737|NCT03721965|Methylprednisolone|methylprednisolone|mesh-list
2870738|NCT03721965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2870739|NCT03721965|Glucocorticoids|glucocorticoids|mesh-ancestor
2870740|NCT03721965|Hormones|hormones|mesh-ancestor
2870741|NCT03721965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2870742|NCT03721965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870743|NCT03721965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2870744|NCT03721965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870745|NCT03721965|Antiemetics|antiemetics|mesh-ancestor
2870746|NCT03721965|Autonomic Agents|autonomic agents|mesh-ancestor
2870747|NCT03721965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870748|NCT03721965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2870749|NCT03721965|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2870750|NCT03721965|Protective Agents|protective agents|mesh-ancestor
2870751|NCT03721900|Ketamine|ketamine|mesh-list
2870752|NCT03721900|Analgesics|analgesics|mesh-ancestor
2870753|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
2870754|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870755|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870756|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2870757|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2870758|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
2870759|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
2870760|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870761|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2870762|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2870763|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870764|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870765|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
2870766|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2870767|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870768|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2311433|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
2311434|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311435|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2311436|NCT00331825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2311437|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2311438|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2311439|NCT00331838|Enoxaparin|enoxaparin|mesh-list
2311440|NCT00331838|Semuloparin|semuloparin|mesh-list
2311441|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2311442|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
2311443|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
2311444|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2311445|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2311446|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311447|NCT00331851|Metformin|metformin|mesh-list
2311448|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
2311449|NCT00331851|Liraglutide|liraglutide|mesh-list
2311450|NCT00331851|Glimepiride|glimepiride|mesh-list
2311451|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2311452|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311453|NCT00331851|Incretins|incretins|mesh-ancestor
2311454|NCT00331851|Hormones|hormones|mesh-ancestor
2311455|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311456|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2311457|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2311458|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
2311459|NCT00331890|Choline|choline|mesh-list
2311460|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2311461|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
2311462|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2311463|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
2311464|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311465|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2311466|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2311467|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
2311468|NCT00331955|Doxorubicin|doxorubicin|mesh-list
2311469|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2311470|NCT00331955|Vorinostat|vorinostat|mesh-list
2311471|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2311472|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311473|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2311474|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2311475|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870769|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870770|NCT03721757|Nivolumab|nivolumab|mesh-list
2870771|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2870772|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870773|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2870774|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870775|NCT03721744|Gemcitabine|gemcitabine|mesh-list
2870776|NCT03721744|Paclitaxel|paclitaxel|mesh-list
2870777|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2870778|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870779|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
2870780|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
2870781|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
2870782|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870783|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2870784|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
2870785|NCT03721744|Antiviral Agents|antiviral agents|mesh-ancestor
2870786|NCT03721744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2311476|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311477|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2311478|NCT00331981|Amisulpride|amisulpride|mesh-list
2311479|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2311480|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2311481|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2311482|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311483|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2311484|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2311485|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
2311486|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311487|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311488|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2311489|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
2311490|NCT00331994|Metronidazole|metronidazole|mesh-list
2311491|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2311492|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2311493|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2311494|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2311495|NCT00332020|Enoxaparin|enoxaparin|mesh-list
2311496|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
2870787|NCT03721744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870788|NCT03721744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2870789|NCT03721744|Immunologic Factors|immunologic factors|mesh-ancestor
2870790|NCT03721744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870791|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
2870792|NCT03721679|Nivolumab|nivolumab|mesh-list
2870793|NCT03721679|Durvalumab|durvalumab|mesh-list
2870794|NCT03721679|Atezolizumab|atezolizumab|mesh-list
2870795|NCT03721679|Poly ICLC|poly iclc|mesh-list
2870796|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2870797|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870798|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2870799|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870800|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
2870801|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
2870802|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311497|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2311498|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
2311499|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2311500|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
2870803|NCT03721653|Leucovorin|leucovorin|mesh-list
2311501|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311502|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311503|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
2311504|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2311505|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2311506|NCT00332033|Pirfenidone|pirfenidone|mesh-list
2311507|NCT00332033|Analgesics|analgesics|mesh-ancestor
2311508|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
2311509|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311510|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311511|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2311512|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2311513|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311514|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2311515|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311516|NCT00332046|Casopitant|casopitant|mesh-list
2311517|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
2311518|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
2311519|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311520|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311521|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2311522|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2311523|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311524|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311525|NCT00332059|Timolol|timolol|mesh-list
2311526|NCT00332059|Bimatoprost|bimatoprost|mesh-list
2311527|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2311528|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2311529|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
2311530|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311531|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311532|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311533|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2311534|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2311535|NCT00332072|Timolol|timolol|mesh-list
2870804|NCT03721653|Bevacizumab|bevacizumab|mesh-list
2870805|NCT03721653|Fluorouracil|fluorouracil|mesh-list
2870806|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
2870807|NCT03721653|Irinotecan|irinotecan|mesh-list
2870808|NCT03721653|Atezolizumab|atezolizumab|mesh-list
2870809|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
2870810|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2870811|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870812|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2870813|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2870814|NCT03721653|Growth Substances|growth substances|mesh-ancestor
2870815|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870816|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
2870817|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
2870818|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870819|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2870820|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2870821|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
2870822|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2870823|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2870824|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870825|NCT03721653|Antidotes|antidotes|mesh-ancestor
2870826|NCT03721653|Protective Agents|protective agents|mesh-ancestor
2870827|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
2870828|NCT03721653|Vitamins|vitamins|mesh-ancestor
2870829|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
2870830|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
2870831|NCT03721627|Ledipasvir|ledipasvir|mesh-list
2870832|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2870833|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
2870834|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870835|NCT03721614|Sirolimus|sirolimus|mesh-list
2870836|NCT03721614|Everolimus|everolimus|mesh-list
2870837|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870838|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2870839|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
2870840|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870841|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2870842|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870843|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2870844|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
2870845|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
2870846|NCT03721497|Testosterone|testosterone|mesh-list
2870847|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
2870848|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
2870849|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2870850|NCT03721497|Androgens|androgens|mesh-ancestor
2870851|NCT03721497|Hormones|hormones|mesh-ancestor
2870852|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2870853|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870854|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2870855|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870856|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
2870857|NCT03721432|Pregabalin|pregabalin|mesh-list
2870858|NCT03721432|Analgesics|analgesics|mesh-ancestor
2870859|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
2870860|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870861|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870862|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
2870863|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2870864|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2870865|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870866|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2311536|NCT00332072|Bimatoprost|bimatoprost|mesh-list
2311537|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2311538|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2870867|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2870868|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2870869|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870870|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2870871|NCT03721406|Ropivacaine|ropivacaine|mesh-list
2870872|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
2870873|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
2870874|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870875|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870876|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
2870877|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870878|NCT03721380|Methadone|methadone|mesh-list
2870879|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2870880|NCT03721380|Narcotics|narcotics|mesh-ancestor
2870881|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870882|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870883|NCT03721380|Analgesics|analgesics|mesh-ancestor
2870884|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
2870885|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870886|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
2870887|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
2870888|NCT03721081|Lidocaine|lidocaine|mesh-list
2870889|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
2870890|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
2870891|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2870892|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870893|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
2870894|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870895|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2870896|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2870897|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2870898|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2870899|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870900|NCT03720990|Cholic Acids|cholic acids|mesh-list
2870901|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2870902|NCT03720899|Nicotine|nicotine|mesh-list
2870903|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2870904|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
2870905|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870906|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870907|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2870908|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2311539|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
2311540|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311541|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311542|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311543|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2311544|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2311545|NCT00332085|Chromium|chromium|mesh-list
2311546|NCT00332085|Picolinic acid|picolinic acid|mesh-list
2311547|NCT00332085|Trace Elements|trace elements|mesh-ancestor
2311548|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
2870909|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
2870910|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870911|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870912|NCT03720886|Teriparatide|teriparatide|mesh-list
2870913|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2870914|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870915|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2870916|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2870917|NCT03720873|Gefitinib|gefitinib|mesh-list
2870918|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870919|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2870920|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870921|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870922|NCT03720756|Nickel|nickel|mesh-list
2870923|NCT03720756|Trace Elements|trace elements|mesh-ancestor
2870924|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
2870925|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870926|NCT03720717|Baclofen|baclofen|mesh-list
2311549|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311550|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2311551|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
2311552|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
2311553|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311554|NCT00332124|Choline|choline|mesh-list
2311555|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
2311556|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2311557|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
2311558|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311559|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2311560|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2311561|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
2311562|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2311563|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2311564|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2311565|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
2311566|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311567|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311568|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870927|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2870928|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870929|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2870930|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870931|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2870932|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
2870933|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
2870934|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870935|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870936|NCT03720665|Caffeine|caffeine|mesh-list
2870937|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2870938|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870939|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2870940|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870941|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870942|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2870943|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2870944|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
2870945|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870946|NCT03720613|Naloxegol|naloxegol|mesh-list
2870947|NCT03720613|Lubiprostone|lubiprostone|mesh-list
2870948|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2870949|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2870950|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870951|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2870952|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870953|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
2311569|NCT00332137|Urological Agents|urological agents|mesh-ancestor
2311570|NCT00332176|Ribavirin|ribavirin|mesh-list
2311571|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2311572|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
2311573|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311574|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
2311575|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2311576|NCT00332228|Naltrexone|naltrexone|mesh-list
2311577|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2311578|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2311579|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311580|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
2311581|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311582|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2311583|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2311584|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
2311585|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2311586|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2311587|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2311588|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2311589|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2311590|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2311591|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2870954|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870955|NCT03720522|Adenosine|adenosine|mesh-list
2870956|NCT03720522|Analgesics|analgesics|mesh-ancestor
2870957|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
2870958|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2870959|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870960|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2870961|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
2311592|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311593|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311594|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311595|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2311596|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
2311597|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2311598|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311599|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2311600|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2311601|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2311602|NCT00332306|Lamivudine|lamivudine|mesh-list
2311603|NCT00332306|Efavirenz|efavirenz|mesh-list
2311604|NCT00332306|Nevirapine|nevirapine|mesh-list
2311605|NCT00332306|Didanosine|didanosine|mesh-list
2311606|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2311607|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2311608|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311609|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311610|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
2311611|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870962|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2870963|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
2870964|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
2870965|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2870966|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311612|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2311613|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2311614|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2870967|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
2870968|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2870969|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
2870970|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2870971|NCT03720483|Expectorants|expectorants|mesh-ancestor
2870972|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
2870973|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2870974|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
2870975|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870976|NCT03720483|Protective Agents|protective agents|mesh-ancestor
2870977|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870978|NCT03720483|Antidotes|antidotes|mesh-ancestor
2870979|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
2870980|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2870981|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870982|NCT03720340|Oprelvekin|oprelvekin|mesh-list
2870983|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2870984|NCT03720288|Acetazolamide|acetazolamide|mesh-list
2870985|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
2870986|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2870987|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2870988|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2870989|NCT03720288|Diuretics|diuretics|mesh-ancestor
2870990|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
2870991|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870992|NCT03720249|Vitamins|vitamins|mesh-list
2870993|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
2870994|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
2870995|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
2870996|NCT03720249|Betaine|betaine|mesh-list
2870997|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
2870998|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2870999|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2871000|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
2871001|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2871002|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
2871003|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871004|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2871005|NCT03720223|Bupivacaine|bupivacaine|mesh-list
2871006|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
2871007|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
2871008|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2871009|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871010|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
2871011|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871012|NCT03720067|Propranolol|propranolol|mesh-list
2871013|NCT03720067|Carvedilol|carvedilol|mesh-list
2871014|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2871015|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2871016|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2871017|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
2871018|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871019|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2871020|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2871021|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871022|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2871023|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2871024|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
2871025|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871026|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871027|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2871028|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2871029|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
2871030|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
2871031|NCT03720067|Protective Agents|protective agents|mesh-ancestor
2871032|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2871033|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2871034|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2871035|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2871036|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2871037|NCT03720041|Dexamethasone|dexamethasone|mesh-list
2871038|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
2871039|NCT03720041|Lenalidomide|lenalidomide|mesh-list
2871040|NCT03720041|Ixazomib|ixazomib|mesh-list
2871041|NCT03720041|BB 1101|bb 1101|mesh-list
2871042|NCT03720041|Glycine|glycine|mesh-list
2871043|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2871044|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
2871045|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
2871046|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871047|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871048|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2871049|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
2871050|NCT03720041|Hormones|hormones|mesh-ancestor
2311615|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2311616|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2311617|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2311618|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2311619|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2311620|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
2871051|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2871052|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2871053|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871054|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
2871055|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871056|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871057|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
2871058|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2871059|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2871060|NCT03720041|Growth Substances|growth substances|mesh-ancestor
2871061|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
2871062|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
2871063|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871064|NCT03719989|Azacitidine|azacitidine|mesh-list
2871065|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2871066|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
2871067|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311621|NCT00332319|Casopitant|casopitant|mesh-list
2311622|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
2311623|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
2871068|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871069|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871070|NCT03719820|Aspirin|aspirin|mesh-list
2871071|NCT03719820|Clopidogrel|clopidogrel|mesh-list
2871072|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2871073|NCT03719820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2871074|NCT03719820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2871075|NCT03719820|Analgesics|analgesics|mesh-ancestor
2871076|NCT03719820|Sensory System Agents|sensory system agents|mesh-ancestor
2871077|NCT03719820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871078|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871079|NCT03719820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2871080|NCT03719820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2871081|NCT03719820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2871082|NCT03719820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2871083|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871084|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2871085|NCT03719820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2871086|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871087|NCT03719820|Antipyretics|antipyretics|mesh-ancestor
2871088|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2871089|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2871090|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2871091|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
2871092|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871093|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2871094|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2871095|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
2871096|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2871097|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2871098|NCT03719729|Rifaximin|rifaximin|mesh-list
2871099|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2871100|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871101|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2871102|NCT03719690|Tipifarnib|tipifarnib|mesh-list
2871103|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871104|NCT03719625|Norepinephrine|norepinephrine|mesh-list
2871105|NCT03719625|Ephedrine|ephedrine|mesh-list
2871106|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2871107|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2871108|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
2871109|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311624|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311625|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311626|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2311627|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2311628|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311629|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311630|NCT00332345|Timolol|timolol|mesh-list
2311631|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2311632|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2311633|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2311634|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
2311635|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311636|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311637|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311638|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2311639|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2311640|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2311641|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2871110|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871111|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871112|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
2871113|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
2871114|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871115|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2871116|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2871117|NCT03719560|Cytarabine|cytarabine|mesh-list
2871118|NCT03719560|Methotrexate|methotrexate|mesh-list
2871119|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2871120|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
2311642|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2311643|NCT00332384|Timolol|timolol|mesh-list
2311644|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2311645|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2311646|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2311647|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
2311648|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311649|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311650|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311651|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2311652|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2311653|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2311654|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2311655|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2311656|NCT00332397|Sirolimus|sirolimus|mesh-list
2311657|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2871121|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2871122|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871123|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2871124|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
2871125|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871126|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871127|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
2871128|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311658|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2311659|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2311660|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311661|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
2311662|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2311663|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
2311664|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311665|NCT00332436|Timolol|timolol|mesh-list
2311666|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2311667|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2311668|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2311669|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
2311670|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311671|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311672|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311673|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2311674|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2311675|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2311676|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2311677|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2311678|NCT00332540|Timolol|timolol|mesh-list
2311679|NCT00332540|Bimatoprost|bimatoprost|mesh-list
2311680|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2311681|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2311682|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
2311683|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311684|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311685|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311686|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2311687|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2871129|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2871130|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2871131|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
2871132|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2871133|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2871134|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
2871135|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871136|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
2871137|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2871138|NCT03719404|Eusol|eusol|mesh-list
2311688|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2311689|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2311690|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2311691|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2311692|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
2311693|NCT00332553|Estradiol|estradiol|mesh-list
2311694|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2311695|NCT00332553|Estrogens|estrogens|mesh-list
2311696|NCT00332553|Hormones|hormones|mesh-ancestor
2311697|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311698|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311699|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2311700|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
2311701|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2311702|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2871139|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2871140|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871141|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
2871142|NCT03719391|Nicotine|nicotine|mesh-list
2871143|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2871144|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
2871145|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871146|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871147|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2871148|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2871149|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
2871150|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871151|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871152|NCT03719326|Paclitaxel|paclitaxel|mesh-list
2871153|NCT03719326|Doxorubicin|doxorubicin|mesh-list
2871154|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2871155|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2871156|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2871157|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871158|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
2871159|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
2871160|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
2871161|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311703|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2311704|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2311705|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2871162|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2871163|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2871164|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2871165|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871166|NCT03719313|Interferons|interferons|mesh-list
2871167|NCT03719313|Ritonavir|ritonavir|mesh-list
2871168|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
2871169|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2871170|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
2871171|NCT03719313|Lonafarnib|lonafarnib|mesh-list
2871172|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871173|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
2871174|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871175|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2871176|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2871177|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
2871178|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871179|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871180|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2871181|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2871182|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2871183|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2871184|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
2871185|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871186|NCT03719274|Ascorbic Acid|ascorbic acid|mesh-list
2871187|NCT03719274|Vitamins|vitamins|mesh-ancestor
2871188|NCT03719274|Micronutrients|micronutrients|mesh-ancestor
2871189|NCT03719274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871190|NCT03719274|Antioxidants|antioxidants|mesh-ancestor
2871191|NCT03719274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871192|NCT03719274|Protective Agents|protective agents|mesh-ancestor
2871193|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2871194|NCT03719261|Eusol|eusol|mesh-list
2871195|NCT03719261|Chitosan|chitosan|mesh-list
2871196|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2871197|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2871198|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
2871199|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871200|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2871201|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
2871202|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
2871203|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
2871204|NCT03719261|Coagulants|coagulants|mesh-ancestor
2871205|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
2871206|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871207|NCT03719157|Anesthetics|anesthetics|mesh-list
2871208|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
2871209|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2871210|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871211|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
2871212|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871213|NCT03719131|Rituximab|rituximab|mesh-list
2871214|NCT03719131|Nivolumab|nivolumab|mesh-list
2871215|NCT03719131|Ipilimumab|ipilimumab|mesh-list
2871216|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2871217|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871218|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
2871219|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871220|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2871221|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2871222|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871223|NCT03719105|Dexamethasone|dexamethasone|mesh-list
2871224|NCT03719105|Prednisone|prednisone|mesh-list
2871225|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
2871226|NCT03719105|Ifosfamide|ifosfamide|mesh-list
2871227|NCT03719105|Doxorubicin|doxorubicin|mesh-list
2871228|NCT03719105|Methotrexate|methotrexate|mesh-list
2871229|NCT03719105|Etoposide|etoposide|mesh-list
2871230|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2871231|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2871232|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
2871233|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871234|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2871235|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2871236|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
2311706|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2311707|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2311708|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311709|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2311710|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
2871237|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871238|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871239|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2871240|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2871241|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
2871242|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
2871243|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871244|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2871245|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
2871246|NCT03719105|Hormones|hormones|mesh-ancestor
2871247|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2871248|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2871249|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2871250|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2311711|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2311712|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2311713|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2311714|NCT00332618|Glycerol|glycerol|mesh-list
2311715|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2311716|NCT00332618|Protective Agents|protective agents|mesh-ancestor
2311717|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871251|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2871252|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871253|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2871254|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
2871255|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2871256|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2871257|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
2871258|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
2871259|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2311718|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
2311719|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2311720|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
2311721|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2311722|NCT00332631|Expectorants|expectorants|mesh-ancestor
2311723|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
2311724|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2311725|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
2871260|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2871261|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2871262|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2871263|NCT03719092|Vitamins|vitamins|mesh-list
2871264|NCT03719092|Vitamin A|vitamin a|mesh-list
2871265|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
2871266|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
2871267|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871268|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
2871269|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871270|NCT03719092|Protective Agents|protective agents|mesh-ancestor
2871271|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2871272|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311726|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311727|NCT00332631|Protective Agents|protective agents|mesh-ancestor
2871273|NCT03719053|Tenofovir|tenofovir|mesh-list
2871274|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
2871275|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871276|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2871277|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2871278|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871279|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871280|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2871281|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2871282|NCT03719001|Clevidipine|clevidipine|mesh-list
2871283|NCT03719001|Phenylephrine|phenylephrine|mesh-list
2871284|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
2871285|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
2871286|NCT03719001|Calcium|calcium|mesh-list
2871287|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2871288|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871289|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2871290|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2871291|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2871292|NCT03719001|Analgesics|analgesics|mesh-ancestor
2871293|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
2871294|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871295|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2871296|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2871297|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2311728|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311729|NCT00332631|Antidotes|antidotes|mesh-ancestor
2311730|NCT00332657|Hydrocortisone|hydrocortisone|mesh-list
2311731|NCT00332657|Anecortave|anecortave|mesh-list
2871298|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
2871299|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871300|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871301|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2871302|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
2871303|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
2871304|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
2871305|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2311732|NCT00332657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2311733|NCT00332657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2311734|NCT00332657|Growth Substances|growth substances|mesh-ancestor
2311735|NCT00332657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311736|NCT00332657|Growth Inhibitors|growth inhibitors|mesh-ancestor
2311737|NCT00332657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311738|NCT00332657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311739|NCT00332735|Bupivacaine|bupivacaine|mesh-list
2311740|NCT00332735|Carticaine|carticaine|mesh-list
2311741|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
2311742|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
2311743|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2311744|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311745|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
2311746|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311747|NCT00332748|Taxane|taxane|mesh-list
2311748|NCT00332748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311749|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
2311750|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2311751|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2311752|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
2871306|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
2871307|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
2871308|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2871309|NCT03719001|Protective Agents|protective agents|mesh-ancestor
2871310|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2871311|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2311753|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311754|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2311755|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2311756|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2311757|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2871312|NCT03718884|Mirikizumab|mirikizumab|mesh-list
2871313|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2871314|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2871315|NCT03718884|Analgesics|analgesics|mesh-ancestor
2871316|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
2871317|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871318|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871319|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2871320|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2871321|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2871322|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2871323|NCT03718715|Metformin|metformin|mesh-list
2871324|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2871325|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871326|NCT03718676|Pemetrexed|pemetrexed|mesh-list
2871327|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871328|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871329|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871330|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2871331|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2871332|NCT03718624|Paclitaxel|paclitaxel|mesh-list
2871333|NCT03718624|Apatinib|apatinib|mesh-list
2871334|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2871335|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871336|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
2871337|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
2871338|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
2871339|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871340|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2871341|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871342|NCT03718559|Edoxaban|edoxaban|mesh-list
2871343|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2871344|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2871345|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
2311758|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2311759|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311760|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2311761|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311762|NCT00332774|Ketorolac|ketorolac|mesh-list
2311763|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2311764|NCT00332774|Nepafenac|nepafenac|mesh-list
2311765|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2311766|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2311767|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2311768|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2311769|NCT00332774|Analgesics|analgesics|mesh-ancestor
2311770|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
2311771|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871346|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2871347|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
2871348|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871349|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871350|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
2871351|NCT03718507|Atropine|atropine|mesh-list
2871352|NCT03718507|Fentanyl|fentanyl|mesh-list
2871353|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2311772|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311773|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311774|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2311775|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2311776|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311777|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311778|NCT00332787|Fluoxetine|fluoxetine|mesh-list
2311779|NCT00332787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2311780|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2311781|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2311782|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311783|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871354|NCT03718507|Narcotics|narcotics|mesh-ancestor
2871355|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2871356|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871357|NCT03718507|Analgesics|analgesics|mesh-ancestor
2871358|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
2871359|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871360|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2871361|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2871362|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
2871363|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
2871364|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2871365|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2871366|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
2871367|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2871368|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
2871369|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
2871370|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
2871371|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2871372|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2871373|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
2871374|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871375|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871376|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
2871377|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2871378|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
2871379|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2871380|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
2871381|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871382|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871383|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
2871384|NCT03718403|Theophylline|theophylline|mesh-list
2871385|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2871386|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
2871387|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871388|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871389|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2871390|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
2871391|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2871392|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871393|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871394|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
2871395|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2871396|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2871397|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
2871398|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871399|NCT03718377|Anesthetics|anesthetics|mesh-list
2871400|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2871401|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871402|NCT03718273|Digoxin|digoxin|mesh-list
2871403|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2871404|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2871405|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871406|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871407|NCT03718273|Protective Agents|protective agents|mesh-ancestor
2871408|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871409|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
2871410|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2871411|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2871412|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2871413|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
2871414|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2871415|NCT03718234|Hormones|hormones|mesh-ancestor
2871416|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2871417|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871418|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
2871419|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2871420|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871421|NCT03718182|Vitamins|vitamins|mesh-ancestor
2871422|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
2871423|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2871424|NCT03718130|Vaccines|vaccines|mesh-list
2311784|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
2311785|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311786|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2311787|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
2311788|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2871425|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
2871426|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871427|NCT03718065|Lofexidine|lofexidine|mesh-list
2311789|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2311790|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2311791|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311792|NCT00332826|Insulin|insulin|mesh-list
2311793|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2311794|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311795|NCT00332852|Letrozole|letrozole|mesh-list
2311796|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311797|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2311798|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2311799|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311800|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311801|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2311802|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
2311803|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311804|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311805|NCT00332891|Amibegron|amibegron|mesh-list
2311806|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2311807|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2311808|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
2311809|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311810|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311811|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311812|NCT00332904|Propranolol|propranolol|mesh-list
2311813|NCT00332904|Spironolactone|spironolactone|mesh-list
2311814|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2311815|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2311816|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
2311817|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311818|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311819|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311820|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2311821|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2311822|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
2871428|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2871429|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2871430|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871431|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
2871432|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871433|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2871434|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2871435|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2871436|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
2871437|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871438|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871439|NCT03718039|Aprepitant|aprepitant|mesh-list
2871440|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
2871441|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
2871442|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311823|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2311824|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
2311825|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311826|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2311827|NCT00332904|Diuretics|diuretics|mesh-ancestor
2311828|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
2871443|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871444|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2871445|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2871446|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871447|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871448|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
2871449|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2871450|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2871451|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2871452|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2871453|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871454|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
2871455|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871456|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311829|NCT00332930|Interferons|interferons|mesh-list
2311830|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
2311831|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311832|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
2311833|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871457|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2871458|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871459|NCT03717909|Valproic Acid|valproic acid|mesh-list
2871460|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
2871461|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871462|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871463|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
2871464|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871465|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871466|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
2871467|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2871468|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2871469|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2871470|NCT03717740|Esomeprazole|esomeprazole|mesh-list
2871471|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2871472|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2871473|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2311834|NCT00332956|Vaccines|vaccines|mesh-list
2311835|NCT00332956|Immunologic Factors|immunologic factors|mesh-ancestor
2311836|NCT00332956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311837|NCT00332969|Octreotide|octreotide|mesh-list
2311838|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2311839|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2311840|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311841|NCT00332995|Dapivirine|dapivirine|mesh-list
2311842|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2311843|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2311844|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
2311845|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2311846|NCT00333008|Prednisone|prednisone|mesh-list
2871474|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871475|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871476|NCT03717701|Metformin|metformin|mesh-list
2871477|NCT03717701|Esomeprazole|esomeprazole|mesh-list
2871478|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2871479|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871480|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2871481|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2871482|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2871483|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871484|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871485|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2871486|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2871487|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2871488|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2871489|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871490|NCT03717688|Incretins|incretins|mesh-ancestor
2871491|NCT03717688|Hormones|hormones|mesh-ancestor
2871492|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2871493|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
2871494|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311847|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
2311848|NCT00333008|Rituximab|rituximab|mesh-list
2311849|NCT00333008|Vincristine|vincristine|mesh-list
2311850|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2311851|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
2311852|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311853|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2311854|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2311855|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
2311856|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311857|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311858|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2311859|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2311860|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311861|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
2311862|NCT00333008|Hormones|hormones|mesh-ancestor
2871495|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311863|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311864|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2871496|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2871497|NCT03717662|Nicotine|nicotine|mesh-list
2871498|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2871499|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
2871500|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871501|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871502|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2871503|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2871504|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
2871505|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871506|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871507|NCT03717623|Posaconazole|posaconazole|mesh-list
2871508|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
2871509|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871510|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2871511|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2871512|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2871513|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2871514|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2871515|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871516|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311865|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2311866|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
2311867|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
2311868|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
2871517|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2871518|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
2871519|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2871520|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871521|NCT03717558|Ivermectin|ivermectin|mesh-list
2871522|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2871523|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871524|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
2871525|NCT03717467|Analgesics|analgesics|mesh-ancestor
2871526|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
2871527|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871528|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871529|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
2871530|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2871531|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2871532|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
2871533|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2871534|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2871535|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871536|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2871537|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
2871538|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2311869|NCT00333021|PENTA|penta|mesh-list
2311870|NCT00333021|Fondaparinux|fondaparinux|mesh-list
2311871|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2311872|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
2311873|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2311874|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
2311875|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311876|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311877|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
2311878|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2311879|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2311880|NCT00333034|Etanercept|etanercept|mesh-list
2311881|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2311882|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2311883|NCT00333034|Analgesics|analgesics|mesh-ancestor
2311884|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
2311885|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311886|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311887|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311888|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2311889|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2311890|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2311891|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
2311892|NCT00333047|Letrozole|letrozole|mesh-list
2311893|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311894|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2311895|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2311896|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871539|NCT03717415|Carboplatin|carboplatin|mesh-list
2871540|NCT03717415|Rebastinib|rebastinib|mesh-list
2871541|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871542|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2871543|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871544|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871545|NCT03717350|Meropenem|meropenem|mesh-list
2871546|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2871547|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871548|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
2871549|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2871550|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871551|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2871552|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871553|NCT03717168|Hormones|hormones|mesh-list
2871554|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2871555|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871556|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
2871557|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2871558|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871559|NCT03717103|Rituximab|rituximab|mesh-list
2871560|NCT03717103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2871561|NCT03717103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871562|NCT03717103|Immunologic Factors|immunologic factors|mesh-ancestor
2871563|NCT03717103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871564|NCT03717103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2871565|NCT03717038|Trifluridine|trifluridine|mesh-list
2871566|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
2871567|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871568|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
2871569|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871570|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2871571|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2871572|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2871573|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871574|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
2871575|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
2871576|NCT03716856|Fludarabine|fludarabine|mesh-list
2311897|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311898|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2311899|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
2311900|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311901|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311902|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2311903|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2311904|NCT00333086|Letrozole|letrozole|mesh-list
2311905|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871577|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2311906|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2311907|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2311908|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311909|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311910|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2311911|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
2311912|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311913|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311914|NCT00333112|Tamsulosin|tamsulosin|mesh-list
2311915|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
2311916|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2311917|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2311918|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2311919|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
2311920|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311921|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311922|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311923|NCT00333112|Urological Agents|urological agents|mesh-ancestor
2311924|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2311925|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2311926|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
2871578|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
2871579|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871580|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2871581|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2871582|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
2871583|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871584|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871585|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2871586|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
2311927|NCT00333125|Timolol|timolol|mesh-list
2311928|NCT00333125|Travoprost|travoprost|mesh-list
2311929|NCT00333125|Dorzolamide|dorzolamide|mesh-list
2311930|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2311931|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2311932|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2871587|NCT03716804|Cefuroxime|cefuroxime|mesh-list
2871588|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
2871589|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
2871590|NCT03716804|Cefixime|cefixime|mesh-list
2871591|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2871592|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871593|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2871594|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2871595|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311933|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2311934|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
2311935|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311936|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311937|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311938|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2311939|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2311940|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2311941|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311942|NCT00333151|Metformin|metformin|mesh-list
2311943|NCT00333151|Liraglutide|liraglutide|mesh-list
2311944|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
2311945|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2311946|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311947|NCT00333151|Incretins|incretins|mesh-ancestor
2311948|NCT00333151|Hormones|hormones|mesh-ancestor
2311949|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2311950|NCT00333164|Cilostazol|cilostazol|mesh-list
2311951|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2311952|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
2311953|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311954|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311955|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2311956|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
2311957|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2311958|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2311959|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311960|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2311961|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
2871596|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871597|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871598|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2871599|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2871600|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2871601|NCT03716804|Renal Agents|renal agents|mesh-ancestor
2871602|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
2871603|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2871604|NCT03716765|Vitamin D|vitamin d|mesh-list
2871605|NCT03716765|Vitamins|vitamins|mesh-ancestor
2871606|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
2871607|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871608|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2871609|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
2871610|NCT03716739|Testosterone|testosterone|mesh-list
2871611|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
2871612|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
2871613|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2871614|NCT03716739|Androgens|androgens|mesh-ancestor
2871615|NCT03716739|Hormones|hormones|mesh-ancestor
2871616|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2871617|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871618|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2871619|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871620|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
2871621|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
2871622|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
2871623|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2871624|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2871625|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
2871626|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871627|NCT03716622|Clarithromycin|clarithromycin|mesh-list
2871628|NCT03716622|Furazolidone|furazolidone|mesh-list
2871629|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2871630|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871631|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2871632|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871633|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871634|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2871635|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2871636|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2871637|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2871638|NCT03716622|Renal Agents|renal agents|mesh-ancestor
2871639|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2871640|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2871641|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2871642|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2871653|NCT03716596|Antibodies|antibodies|mesh-list
2871654|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
2871655|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871656|NCT03716583|Melatonin|melatonin|mesh-list
2871657|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2871658|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
2871659|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871660|NCT03716583|Protective Agents|protective agents|mesh-ancestor
2871661|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871662|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2871663|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2311962|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2311963|NCT00333164|Protective Agents|protective agents|mesh-ancestor
2311964|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2311965|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2311966|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311967|NCT00333216|Hydrocortisone|hydrocortisone|mesh-list
2311968|NCT00333216|Anecortave|anecortave|mesh-list
2311969|NCT00333216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2871664|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2871665|NCT03716427|Tolbutamide|tolbutamide|mesh-list
2871666|NCT03716427|Midazolam|midazolam|mesh-list
2311970|NCT00333216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2311971|NCT00333216|Growth Substances|growth substances|mesh-ancestor
2311972|NCT00333216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871667|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
2871668|NCT03716427|Omeprazole|omeprazole|mesh-list
2871669|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2871670|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2871671|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2871672|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871673|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2871674|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2871675|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2871676|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2871677|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
2871678|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
2871679|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
2871680|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
2311973|NCT00333216|Growth Inhibitors|growth inhibitors|mesh-ancestor
2311974|NCT00333216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2311975|NCT00333216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311976|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
2311977|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
2311978|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
2311979|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2311980|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2311981|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2311982|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311983|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311984|NCT00333255|Nepafenac|nepafenac|mesh-list
2311985|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2311986|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2311987|NCT00333255|Analgesics|analgesics|mesh-ancestor
2311988|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
2311989|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2311990|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2311991|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2311992|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2311993|NCT00333281|Tadalafil|tadalafil|mesh-list
2311994|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
2871681|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871682|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871683|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2871684|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2871685|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2871686|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311995|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2311996|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2311997|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2311998|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2311999|NCT00333281|Urological Agents|urological agents|mesh-ancestor
2312000|NCT00333294|Vinorelbine|vinorelbine|mesh-list
2312001|NCT00333294|Gefitinib|gefitinib|mesh-list
2312002|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312003|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2312004|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
2312005|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
2312006|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
2312007|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871687|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
2871688|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
2871689|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2871690|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2871691|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2871692|NCT03716388|Mesalamine|mesalamine|mesh-list
2871693|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2312008|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2312009|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312010|NCT00333307|Methocarbamol|methocarbamol|mesh-list
2312011|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2312012|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312013|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2871694|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2871695|NCT03716388|Analgesics|analgesics|mesh-ancestor
2871696|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
2871697|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871698|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871699|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2871700|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2871701|NCT03716180|Paclitaxel|paclitaxel|mesh-list
2871702|NCT03716180|Trastuzumab|trastuzumab|mesh-list
2871703|NCT03716180|Pertuzumab|pertuzumab|mesh-list
2871704|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2871705|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871706|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
2312014|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312015|NCT00333346|Tramadol|tramadol|mesh-list
2312016|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2312017|NCT00333346|Narcotics|narcotics|mesh-ancestor
2312018|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2312019|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312020|NCT00333346|Analgesics|analgesics|mesh-ancestor
2312021|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
2312022|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312023|NCT00333372|Z 338|z 338|mesh-list
2312024|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2312025|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312026|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312027|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
2312028|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312029|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312030|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2312031|NCT00333385|Ceftazidime|ceftazidime|mesh-list
2312032|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2312033|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312034|NCT00333398|Vaccines|vaccines|mesh-list
2312035|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
2312036|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312037|NCT00333424|Vaccines|vaccines|mesh-list
2312038|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
2312039|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312040|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2312041|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
2312042|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312043|NCT00333476|Squalamine|squalamine|mesh-list
2312044|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2312045|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312046|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2312047|NCT00333476|Protective Agents|protective agents|mesh-ancestor
2312048|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312049|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312050|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2871707|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
2871708|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
2871709|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871710|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2871711|NCT03716115|Budesonide|budesonide|mesh-list
2871712|NCT03716115|Teduglutide|teduglutide|mesh-list
2871713|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2871714|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2871715|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
2871716|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871717|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871718|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2871719|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
2871720|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
2871721|NCT03716115|Hormones|hormones|mesh-ancestor
2871722|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2871723|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2871724|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2312051|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2312052|NCT00333476|Growth Substances|growth substances|mesh-ancestor
2312053|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
2312054|NCT00333489|Valsartan|valsartan|mesh-list
2312055|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2312056|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2312057|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2312058|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312059|NCT00333502|Camptothecin|camptothecin|mesh-list
2312060|NCT00333502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2312061|NCT00333502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871725|NCT03716115|Protective Agents|protective agents|mesh-ancestor
2871726|NCT03715998|Ramipril|ramipril|mesh-list
2871727|NCT03715998|Firibastat|firibastat|mesh-list
2871728|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2871729|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
2871730|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871731|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871732|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2871733|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
2871734|NCT03715972|Acetazolamide|acetazolamide|mesh-list
2871735|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871736|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
2871737|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871738|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871739|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2871740|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
2871741|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2871742|NCT03715972|Diuretics|diuretics|mesh-ancestor
2871743|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
2871744|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871745|NCT03715946|Nivolumab|nivolumab|mesh-list
2871746|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2871747|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871748|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2871749|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312062|NCT00333502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2312063|NCT00333502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2312064|NCT00333502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312065|NCT00333502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312066|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
2312067|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2312068|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2312069|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312070|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312071|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2312072|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2312073|NCT00333567|Analgesics|analgesics|mesh-ancestor
2312074|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
2312075|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312076|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312077|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2312078|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2312079|NCT00333632|Fentanyl|fentanyl|mesh-list
2312080|NCT00333632|Midazolam|midazolam|mesh-list
2312081|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
2312082|NCT00333632|Propofol|propofol|mesh-list
2312083|NCT00333632|Isoflurane|isoflurane|mesh-list
2312084|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2312085|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2312086|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871769|NCT03715881|Prednisolone|prednisolone|mesh-list
2871770|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
2871771|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2871772|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
2871773|NCT03715881|Hormones|hormones|mesh-ancestor
2871774|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2871775|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871776|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2871777|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871778|NCT03715881|Hematinics|hematinics|mesh-ancestor
2871779|NCT03715829|PF-06700841|pf-06700841|mesh-list
2871780|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2871781|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871782|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871783|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2871784|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2871785|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871786|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871787|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2871788|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2871789|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871790|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
2871791|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871792|NCT03715725|Warfarin|warfarin|mesh-list
2871793|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
2871794|NCT03715725|Dabigatran|dabigatran|mesh-list
2871795|NCT03715725|Apixaban|apixaban|mesh-list
2871796|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
2871797|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2871798|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
2871799|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2871800|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
2871801|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871802|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312087|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2312088|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
2312089|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
2312090|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2312091|NCT00333632|Analgesics|analgesics|mesh-ancestor
2312092|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
2312093|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312094|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2312095|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2312096|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2312097|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
2312098|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2871803|NCT03715699|Prednisone|prednisone|mesh-list
2871804|NCT03715699|Leflunomide|leflunomide|mesh-list
2871805|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2871806|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
2871807|NCT03715699|Hormones|hormones|mesh-ancestor
2871808|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2871809|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871810|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2871811|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871812|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871813|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871814|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2871815|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
2871816|NCT03715634|Buprenorphine|buprenorphine|mesh-list
2871817|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2871818|NCT03715634|Narcotics|narcotics|mesh-ancestor
2871819|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2871820|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871821|NCT03715634|Analgesics|analgesics|mesh-ancestor
2871822|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
2871823|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871824|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2871825|NCT03715582|Trimetazidine|trimetazidine|mesh-list
2871826|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
2871827|NCT03715556|Amiodarone|amiodarone|mesh-list
2871828|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2871829|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
2871830|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2871831|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2871832|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871833|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2871834|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2871835|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2871836|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871837|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2871838|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2871839|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2871840|NCT03715517|Morphine|morphine|mesh-list
2871841|NCT03715517|Hydromorphone|hydromorphone|mesh-list
2871842|NCT03715517|Bupivacaine|bupivacaine|mesh-list
2871843|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2871844|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
2871845|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
2871846|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2871847|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871848|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
2871849|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871850|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2871851|NCT03715517|Narcotics|narcotics|mesh-ancestor
2871852|NCT03715517|Analgesics|analgesics|mesh-ancestor
2871853|NCT03715478|Dexamethasone|dexamethasone|mesh-list
2312099|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312100|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2312101|NCT00333632|Narcotics|narcotics|mesh-ancestor
2312102|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2312103|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2312104|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2312105|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2312106|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
2312107|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
2871854|NCT03715478|Pomalidomide|pomalidomide|mesh-list
2871855|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2871856|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
2871857|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
2871858|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871859|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871860|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2871861|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
2871862|NCT03715478|Hormones|hormones|mesh-ancestor
2871863|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2871864|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2871865|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871866|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
2312108|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2312109|NCT00333645|Caspofungin|caspofungin|mesh-list
2312110|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
2312111|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312112|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312113|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312114|NCT00333671|Glycerol|glycerol|mesh-list
2312115|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2312116|NCT00333671|Protective Agents|protective agents|mesh-ancestor
2312117|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312118|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
2312119|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2312120|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871867|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2312121|NCT00333918|Bromfenac|bromfenac|mesh-list
2312122|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2312123|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2312124|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2312125|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2871868|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2871869|NCT03715478|Growth Substances|growth substances|mesh-ancestor
2871870|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
2871871|NCT03715413|Tamoxifen|tamoxifen|mesh-list
2871872|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2871873|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
2871874|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2871875|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871876|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2871877|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871878|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2871879|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2871880|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2871881|NCT03715387|Bacitracin|bacitracin|mesh-list
2312126|NCT00333918|Analgesics|analgesics|mesh-ancestor
2312127|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
2312128|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871882|NCT03715387|Polymyxin B|polymyxin b|mesh-list
2871883|NCT03715387|Tacrolimus|tacrolimus|mesh-list
2871884|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2871885|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
2871886|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871887|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2871888|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871889|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871890|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2871891|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871892|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2871893|NCT03715348|Thrombin|thrombin|mesh-list
2871894|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
2871895|NCT03715348|Coagulants|coagulants|mesh-ancestor
2871896|NCT03715322|Tobramycin|tobramycin|mesh-list
2871897|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2871898|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871899|NCT03715309|Lenalidomide|lenalidomide|mesh-list
2871900|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
2871901|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871902|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2312129|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312130|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2312131|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2312132|NCT00333931|Phenytoin|phenytoin|mesh-list
2312133|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
2312134|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2312135|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2871903|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2871904|NCT03715309|Growth Substances|growth substances|mesh-ancestor
2871905|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
2871906|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871907|NCT03715296|Lenalidomide|lenalidomide|mesh-list
2871908|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
2871909|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871910|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2871911|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2871912|NCT03715296|Growth Substances|growth substances|mesh-ancestor
2871913|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
2871914|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871915|NCT03715244|Anesthetics|anesthetics|mesh-list
2871916|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
2871917|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2871918|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871919|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
2871920|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871921|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
2871922|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2871923|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871938|NCT03715127|Psilocybin|psilocybin|mesh-list
2312136|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2312137|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312138|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2312139|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2312140|NCT00333944|Pralidoxime|pralidoxime|mesh-list
2312141|NCT00333944|Antidotes|antidotes|mesh-ancestor
2312142|NCT00333944|Protective Agents|protective agents|mesh-ancestor
2312143|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312144|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
2312145|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
2312146|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312147|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
2312148|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312149|NCT00333996|Dexamethasone|dexamethasone|mesh-list
2312150|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2312151|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
2312152|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
2312153|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312154|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312155|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2312156|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
2312157|NCT00333996|Hormones|hormones|mesh-ancestor
2312158|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2312159|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2871939|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
2871940|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871941|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2871942|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2871943|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2871944|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2871945|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
2871946|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871947|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2871948|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2871949|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871950|NCT03715023|PC-786|pc-786|mesh-list
2871951|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
2871952|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2871953|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312160|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312161|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
2312162|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2312163|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2312164|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312165|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2312166|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2312167|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
2312168|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312169|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2312170|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
2312171|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2312172|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2312173|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2312174|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2312175|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871954|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871955|NCT03714958|Trametinib|trametinib|mesh-list
2871956|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871957|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2871958|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2871959|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871960|NCT03714880|Mifepristone|mifepristone|mesh-list
2312176|NCT00334048|Ropinirole|ropinirole|mesh-list
2871961|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2871962|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
2871963|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2871964|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871965|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2871966|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2871967|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2871968|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
2871969|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2871970|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2871971|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
2871972|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2871973|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
2312177|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2312178|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2312179|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
2312180|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
2312181|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312182|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312183|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312184|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2312185|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2312186|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
2312187|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2312188|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2312189|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2312190|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2312191|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312192|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2312193|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2312194|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
2312195|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312196|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312197|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2312198|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2871974|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2871975|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2871976|NCT03714867|Pregabalin|pregabalin|mesh-list
2871977|NCT03714867|Analgesics|analgesics|mesh-ancestor
2871978|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
2871979|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2871980|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871981|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
2871982|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2871983|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2871984|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312199|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
2312200|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
2312201|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2312202|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312203|NCT00334152|Casopitant|casopitant|mesh-list
2312204|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
2871985|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2871986|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2871987|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2871988|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2871989|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2312205|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
2312206|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312207|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312208|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2312209|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2312210|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312211|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312212|NCT00334256|Tenofovir|tenofovir|mesh-list
2312213|NCT00334256|Emtricitabine|emtricitabine|mesh-list
2312214|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
2312215|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312216|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2312217|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2312218|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312219|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2871990|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2871991|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2871992|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2871993|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
2871994|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2871995|NCT03714737|Vaccines|vaccines|mesh-list
2871996|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
2871997|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2871998|NCT03714685|Firibastat|firibastat|mesh-list
2871999|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2872000|NCT03714620|Ketamine|ketamine|mesh-list
2872001|NCT03714620|Analgesics|analgesics|mesh-ancestor
2872002|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
2872003|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312220|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2312221|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2312222|NCT00334308|Caseins|caseins|mesh-list
2312223|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
2872004|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872005|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2872006|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2312224|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
2312225|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312226|NCT00334321|Paclitaxel|paclitaxel|mesh-list
2312227|NCT00334321|Carboplatin|carboplatin|mesh-list
2312228|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2312229|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312230|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
2312231|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
2312232|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
2312233|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872007|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
2872008|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
2872009|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2872010|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2872011|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2872012|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2872013|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872014|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
2872015|NCT03714594|Saxagliptin|saxagliptin|mesh-list
2872016|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2872017|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872018|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2872019|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872020|NCT03714594|Incretins|incretins|mesh-ancestor
2872021|NCT03714594|Hormones|hormones|mesh-ancestor
2872022|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2872023|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2872024|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
2872025|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872026|NCT03714555|Copper|copper|mesh-list
2312234|NCT00334347|Valproic Acid|valproic acid|mesh-list
2312235|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
2312236|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312237|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312238|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
2312239|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312240|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312241|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
2312242|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2312243|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2312244|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2312245|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
2312246|NCT00334360|Buspirone|buspirone|mesh-list
2872027|NCT03714555|Gemcitabine|gemcitabine|mesh-list
2872028|NCT03714555|Paclitaxel|paclitaxel|mesh-list
2872029|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2872030|NCT03714555|Folfirinox|folfirinox|mesh-list
2872031|NCT03714555|Disulfiram|disulfiram|mesh-list
2872032|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2872033|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872034|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
2872035|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
2872036|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
2312247|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2312248|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2872037|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872038|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2872039|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
2872040|NCT03714555|Antiviral Agents|antiviral agents|mesh-ancestor
2872041|NCT03714555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872042|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872043|NCT03714555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2872044|NCT03714555|Immunologic Factors|immunologic factors|mesh-ancestor
2872045|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872046|NCT03714555|Trace Elements|trace elements|mesh-ancestor
2872047|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
2872048|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2872049|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2872050|NCT03714490|Capecitabine|capecitabine|mesh-list
2872051|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
2872052|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2872053|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
2872054|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872055|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872056|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
2872057|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2872058|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2872059|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872060|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
2872061|NCT03714360|Coagulants|coagulants|mesh-ancestor
2312249|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312250|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2312251|NCT00334360|Analgesics|analgesics|mesh-ancestor
2312252|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
2312253|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312254|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2312255|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2312256|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2312257|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
2312258|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312259|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312260|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2312261|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2312262|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2312263|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2312264|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
2312265|NCT00334386|Torsemide|torsemide|mesh-list
2312266|NCT00334386|Diuretics|diuretics|mesh-list
2312267|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
2312268|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
2312269|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312270|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2312271|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312272|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2312273|NCT00334399|Miglitol|miglitol|mesh-list
2312274|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312275|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312276|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2312277|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312278|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2312279|NCT00334412|Caspofungin|caspofungin|mesh-list
2312280|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2312281|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
2872062|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2872063|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
2872064|NCT03714165|Defensins|defensins|mesh-list
2872065|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872066|NCT03714113|Antibodies|antibodies|mesh-list
2872067|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
2872068|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872069|NCT03713944|Bevacizumab|bevacizumab|mesh-list
2872070|NCT03713944|Carboplatin|carboplatin|mesh-list
2872071|NCT03713944|Pemetrexed|pemetrexed|mesh-list
2872072|NCT03713944|Atezolizumab|atezolizumab|mesh-list
2872073|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2872074|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872075|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2872076|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2872077|NCT03713944|Growth Substances|growth substances|mesh-ancestor
2312282|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312283|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312284|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312285|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2312286|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2312287|NCT00334425|Menotropins|menotropins|mesh-list
2312288|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2872078|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872079|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
2872080|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872081|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872082|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2872083|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2872084|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
2872085|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
2872086|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2872087|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872088|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872089|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
2872090|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2872091|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2872092|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872093|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2872094|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872095|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872096|NCT03713879|Indomethacin|indomethacin|mesh-list
2872097|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2872098|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2872099|NCT03713879|Analgesics|analgesics|mesh-ancestor
2872100|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
2872101|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872102|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872103|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2872104|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2872105|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
2872106|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
2872107|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2872108|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2872109|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872110|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872111|NCT03713801|Metformin|metformin|mesh-list
2872112|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2872113|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872114|NCT03713762|Lidocaine|lidocaine|mesh-list
2872115|NCT03713762|Fentanyl|fentanyl|mesh-list
2872116|NCT03713762|Bupivacaine|bupivacaine|mesh-list
2872117|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
2872118|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
2872119|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2872120|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872121|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
2872122|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872123|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2872124|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2872125|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2872126|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2872127|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872128|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2312289|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
2872129|NCT03713762|Narcotics|narcotics|mesh-ancestor
2872130|NCT03713762|Analgesics|analgesics|mesh-ancestor
2312290|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2312291|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312292|NCT00334438|Rituximab|rituximab|mesh-list
2312293|NCT00334438|Bortezomib|bortezomib|mesh-list
2872131|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2872132|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2872133|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
2872134|NCT03713658|Risperidone|risperidone|mesh-list
2872135|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2312294|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2312295|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2312296|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312297|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
2312298|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312299|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2312300|NCT00334464|Warfarin|warfarin|mesh-list
2312301|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
2312302|NCT00334477|Tadalafil|tadalafil|mesh-list
2312303|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
2312304|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2312305|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2312306|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312307|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312308|NCT00334477|Urological Agents|urological agents|mesh-ancestor
2312309|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
2312310|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
2312311|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2312312|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2312313|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312314|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312315|NCT00334490|Urological Agents|urological agents|mesh-ancestor
2872136|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2872137|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
2872138|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2872139|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872140|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872141|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2872142|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2872143|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2872144|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2872145|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2872146|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
2312316|NCT00334503|Miglitol|miglitol|mesh-list
2312317|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312318|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312319|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2872147|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2872148|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2872149|NCT03713645|Tacrolimus|tacrolimus|mesh-list
2872150|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2872151|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
2872152|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872153|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2872154|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872155|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872156|NCT03713528|Vancomycin|vancomycin|mesh-list
2872157|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2872158|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872159|NCT03713437|Insulin|insulin|mesh-list
2872160|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2872161|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872162|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
2872163|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
2872164|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2872165|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872166|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872167|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872168|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2872169|NCT03713372|Cetuximab|cetuximab|mesh-list
2872170|NCT03713372|Antibodies|antibodies|mesh-list
2872171|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2872172|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
2872173|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872174|NCT03713372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2872175|NCT03713372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872176|NCT03713346|Caseins|caseins|mesh-list
2872177|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
2872178|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
2872179|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872180|NCT03713320|Vorinostat|vorinostat|mesh-list
2872181|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872182|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2872183|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872184|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872185|NCT03713216|Morphine|morphine|mesh-list
2872186|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2872187|NCT03713216|Narcotics|narcotics|mesh-ancestor
2872188|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2872189|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872190|NCT03713216|Analgesics|analgesics|mesh-ancestor
2872191|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
2312320|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312321|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2312322|NCT00334529|Oseltamivir|oseltamivir|mesh-list
2312323|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
2312324|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312325|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312326|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312327|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
2312328|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2312329|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312330|NCT00334581|Irbesartan|irbesartan|mesh-list
2312331|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2312332|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2312333|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2312334|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312335|NCT00334594|Pemetrexed|pemetrexed|mesh-list
2312336|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312337|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312338|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872192|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872193|NCT03713190|Empagliflozin|empagliflozin|mesh-list
2872194|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2872195|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872196|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2872197|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872198|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2872199|NCT03712956|Doxorubicin|doxorubicin|mesh-list
2872200|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2872201|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872202|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2872203|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2872204|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312339|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2312340|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2312341|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
2312342|NCT00334646|Casopitant|casopitant|mesh-list
2872205|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872206|NCT03712904|Aflibercept|aflibercept|mesh-list
2872207|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
2872208|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2872209|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2872210|NCT03712904|Growth Substances|growth substances|mesh-ancestor
2872211|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872212|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
2872213|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872214|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
2872215|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
2872216|NCT03712878|Tacrolimus|tacrolimus|mesh-list
2872217|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2872218|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
2872219|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872220|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2872221|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2312343|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2312344|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
2312345|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872222|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
2872223|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872224|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872225|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2872226|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2872227|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872228|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2872229|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2872230|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
2872231|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2312346|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2312347|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2312348|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
2312349|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312350|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312351|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2312352|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
2312353|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
2312354|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312355|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2312356|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2312357|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312358|NCT00334672|Cyclosporine|cyclosporine|mesh-list
2872232|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872233|NCT03712826|Ustekinumab|ustekinumab|mesh-list
2872234|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
2872235|NCT03712735|Fentanyl|fentanyl|mesh-list
2872236|NCT03712735|Bupivacaine|bupivacaine|mesh-list
2872237|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
2872238|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
2312359|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
2312360|NCT00334672|Dexamethasone|dexamethasone|mesh-list
2312361|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
2872239|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2872240|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872241|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
2872242|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872243|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2872244|NCT03712735|Narcotics|narcotics|mesh-ancestor
2872245|NCT03712735|Analgesics|analgesics|mesh-ancestor
2872246|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2872247|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2872248|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
2872249|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
2872250|NCT03712670|Aflibercept|aflibercept|mesh-list
2872251|NCT03712670|Carotenoids|carotenoids|mesh-list
2872252|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2872253|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2872254|NCT03712670|Growth Substances|growth substances|mesh-ancestor
2872255|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872256|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
2872257|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872258|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
2872259|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872260|NCT03712670|Protective Agents|protective agents|mesh-ancestor
2872261|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2872262|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2872263|NCT03712670|Analgesics|analgesics|mesh-ancestor
2872264|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
2872265|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872266|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2872267|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2872268|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
2872269|NCT03712540|Rifampin|rifampin|mesh-list
2872270|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2872271|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
2872272|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2872273|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872274|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
2872275|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2872276|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872277|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872278|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2872279|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2872280|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2872281|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2872282|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2872283|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2872284|NCT03712475|Pregabalin|pregabalin|mesh-list
2872285|NCT03712475|Analgesics|analgesics|mesh-ancestor
2872286|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
2872287|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872288|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872289|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
2872290|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2872291|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2872292|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872293|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2872294|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2872295|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2872296|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2872297|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2872298|NCT03712423|Docetaxel|docetaxel|mesh-list
2872299|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872300|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
2872301|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
2872302|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
2108838|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2108839|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108840|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108841|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
2872303|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872304|NCT03712397|Irinotecan|irinotecan|mesh-list
2872305|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2872306|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2872307|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872308|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872309|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872310|NCT03712345|Vilobelimab|vilobelimab|mesh-list
2872311|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2872312|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2872313|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
2872314|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872315|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
2872316|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
2872317|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2872318|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2872319|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872320|NCT03712241|Indomethacin|indomethacin|mesh-list
2872321|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2872322|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2872323|NCT03712241|Analgesics|analgesics|mesh-ancestor
2872324|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
2872325|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872326|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872327|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2872328|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2872329|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
2872330|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
2872331|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2872332|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2872333|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872334|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872335|NCT03712163|Ketotifen|ketotifen|mesh-list
2872336|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
2872337|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
2872338|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2108842|NCT02511184|Crizotinib|crizotinib|mesh-list
2108843|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2108844|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108845|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2108846|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108847|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108848|NCT02511236|Nicotine|nicotine|mesh-list
2108849|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2108850|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
2872339|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
2872340|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
2872341|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2872342|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872343|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872344|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2872345|NCT03712111|Norepinephrine|norepinephrine|mesh-list
2872346|NCT03712111|Bupivacaine|bupivacaine|mesh-list
2872347|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
2872348|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
2872349|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2872350|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872351|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
2872352|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872353|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2872354|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2872355|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
2872356|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2872357|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872358|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
2872359|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
2872360|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2872361|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2872362|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2872363|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108851|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872376|NCT03711708|Sertraline|sertraline|mesh-list
2872377|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
2872378|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2872379|NCT03711708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2872380|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2872381|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2872382|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872383|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2872384|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
2872385|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872386|NCT03711474|Dexamethasone|dexamethasone|mesh-list
2872387|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2872388|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
2872389|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
2872390|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872391|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872392|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2872393|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
2872394|NCT03711474|Hormones|hormones|mesh-ancestor
2872395|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2312362|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2312363|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2312364|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2312365|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
2312366|NCT00334672|Busulfan|busulfan|mesh-list
2312367|NCT00334672|Methotrexate|methotrexate|mesh-list
2312368|NCT00334672|Etoposide|etoposide|mesh-list
2312369|NCT00334672|Cyclosporins|cyclosporins|mesh-list
2312370|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2312371|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2312372|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
2312373|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312374|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2312375|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2312376|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
2312377|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312378|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312379|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2312380|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2312381|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
2312382|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
2312383|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312384|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2872396|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2872397|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872398|NCT03711448|Prednisone|prednisone|mesh-list
2872399|NCT03711448|Ustekinumab|ustekinumab|mesh-list
2872400|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2872401|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
2872402|NCT03711448|Hormones|hormones|mesh-ancestor
2872403|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2872404|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872405|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2312385|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
2312386|NCT00334672|Hormones|hormones|mesh-ancestor
2312387|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2312388|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2312389|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2872406|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872407|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
2872408|NCT03711422|Afatinib|afatinib|mesh-list
2872409|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872410|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2872411|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312390|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
2312391|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2872412|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872413|NCT03711318|Buprenorphine|buprenorphine|mesh-list
2872414|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2872415|NCT03711318|Naloxone|naloxone|mesh-list
2872416|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2872417|NCT03711318|Narcotics|narcotics|mesh-ancestor
2872418|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2872419|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872420|NCT03711318|Analgesics|analgesics|mesh-ancestor
2872421|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
2872422|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872423|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2872424|NCT03711305|Carboplatin|carboplatin|mesh-list
2872425|NCT03711305|Etoposide|etoposide|mesh-list
2872426|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872427|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2872428|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2872429|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2872430|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872431|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872432|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2872433|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872434|NCT03711279|Apatinib|apatinib|mesh-list
2872435|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872436|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2872437|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872438|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872439|NCT03711253|Tenofovir|tenofovir|mesh-list
2872440|NCT03711253|Emtricitabine|emtricitabine|mesh-list
2872441|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
2872442|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872443|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2872444|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2872445|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872446|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872447|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2872448|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2312392|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2872449|NCT03711240|Leucovorin|leucovorin|mesh-list
2872450|NCT03711240|Bevacizumab|bevacizumab|mesh-list
2872451|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
2872452|NCT03711240|Irinotecan|irinotecan|mesh-list
2872453|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2872454|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872455|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2872456|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2872457|NCT03711240|Growth Substances|growth substances|mesh-ancestor
2872458|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872459|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
2872460|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2872461|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2872462|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872463|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872464|NCT03711240|Antidotes|antidotes|mesh-ancestor
2872465|NCT03711240|Protective Agents|protective agents|mesh-ancestor
2872466|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
2872467|NCT03711240|Vitamins|vitamins|mesh-ancestor
2872468|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
2872469|NCT03711188|Nivolumab|nivolumab|mesh-list
2872470|NCT03711188|Ipilimumab|ipilimumab|mesh-list
2312393|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
2312394|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
2312395|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872471|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2872472|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872473|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2872474|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872480|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
2872481|NCT03710863|Vorolanib|vorolanib|mesh-list
2872482|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2872483|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872484|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872485|NCT03710811|Insulin|insulin|mesh-list
2872486|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2872487|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872488|NCT03710772|Cytarabine|cytarabine|mesh-list
2872489|NCT03710772|Dexamethasone|dexamethasone|mesh-list
2872490|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
2872491|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
2872492|NCT03710772|Rituximab|rituximab|mesh-list
2872493|NCT03710772|Doxorubicin|doxorubicin|mesh-list
2872494|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2872495|NCT03710772|Methotrexate|methotrexate|mesh-list
2872496|NCT03710772|Vincristine|vincristine|mesh-list
2872497|NCT03710772|Venetoclax|venetoclax|mesh-list
2872498|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2872499|NCT03710772|Antibodies|antibodies|mesh-list
2872500|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
2872501|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2872502|NCT03710772|BB 1101|bb 1101|mesh-list
2872503|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2872504|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
2872505|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872506|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2872507|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2872508|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
2872509|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872510|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872511|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2872512|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2872513|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
2872514|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
2872515|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872516|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2872517|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
2872518|NCT03710772|Hormones|hormones|mesh-ancestor
2872519|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2872520|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2872521|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
2872522|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872523|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2872524|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2872525|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2872526|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2872527|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
2872528|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2872529|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2872530|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
2872531|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
2872532|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2872533|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2872534|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
2872535|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872536|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2872537|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
2872538|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
2872539|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
2872540|NCT03710655|Histamine|histamine|mesh-list
2872541|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
2872542|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
2872543|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2872544|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872545|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872546|NCT03710642|Prazosin|prazosin|mesh-list
2872547|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2872548|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2872549|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2872550|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2872551|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
2872552|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2872553|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872554|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872555|NCT03710603|Dexamethasone|dexamethasone|mesh-list
2872556|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
2872557|NCT03710603|Lenalidomide|lenalidomide|mesh-list
2872558|NCT03710603|Bortezomib|bortezomib|mesh-list
2872559|NCT03710603|Daratumumab|daratumumab|mesh-list
2872560|NCT03710603|BB 1101|bb 1101|mesh-list
2872561|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2872562|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
2872563|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
2872564|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872565|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872566|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2872567|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
2872568|NCT03710603|Hormones|hormones|mesh-ancestor
2872569|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2872570|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2872571|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872572|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
2872573|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872574|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872575|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
2872576|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2872577|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2872578|NCT03710603|Growth Substances|growth substances|mesh-ancestor
2872579|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
2872580|NCT03710460|Metformin|metformin|mesh-list
2872581|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
2872582|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2872583|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872584|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2872585|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872586|NCT03710434|Lansoprazole|lansoprazole|mesh-list
2872587|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
2872588|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2872589|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2872590|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2872591|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872592|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872593|NCT03710395|Nifedipine|nifedipine|mesh-list
2872594|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2872595|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2872596|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872597|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2872598|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872599|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
2872600|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
2872601|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2872602|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
2872603|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
2872604|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2872605|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2872606|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872607|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872608|NCT03710369|Urological Agents|urological agents|mesh-ancestor
2312396|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2312397|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2312398|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2312399|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2312400|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2312401|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
2312402|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312403|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2312404|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2312405|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2312406|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
2312407|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2312408|NCT00334685|Pregabalin|pregabalin|mesh-list
2312409|NCT00334685|Reboxetine|reboxetine|mesh-list
2312410|NCT00334685|Analgesics|analgesics|mesh-ancestor
2312411|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
2312412|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312413|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312414|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
2312415|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2312416|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2312417|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312418|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2312419|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2312420|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2312421|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2312422|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2872609|NCT03710356|Danazol|danazol|mesh-list
2872610|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2872611|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
2872612|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2872613|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872614|NCT03710343|Metformin|metformin|mesh-list
2872615|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2312423|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
2312424|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2312425|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2312426|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
2312427|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312428|NCT00334698|Cetirizine|cetirizine|mesh-list
2312429|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
2872616|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872617|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
2872618|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2872619|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2872620|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872621|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
2872622|NCT03710330|Coagulants|coagulants|mesh-ancestor
2872623|NCT03710317|Misoprostol|misoprostol|mesh-list
2872624|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
2872625|NCT03710317|Carbetocin|carbetocin|mesh-list
2872626|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2872627|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2872628|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872629|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
2872630|NCT03710317|Coagulants|coagulants|mesh-ancestor
2872631|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2872632|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
2872633|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2872634|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872635|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2872636|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2872637|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
2872638|NCT03710304|Misoprostol|misoprostol|mesh-list
2312430|NCT00334698|Ephedrine|ephedrine|mesh-list
2312431|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2312432|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2872639|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
2872640|NCT03710304|Oxytocin|oxytocin|mesh-list
2872641|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
2872642|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2872643|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872644|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2872645|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2872646|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872647|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
2872648|NCT03710304|Coagulants|coagulants|mesh-ancestor
2872649|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2872650|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
2872651|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2872652|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2872653|NCT03710252|Ritonavir|ritonavir|mesh-list
2872654|NCT03710252|Ribavirin|ribavirin|mesh-list
2872655|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2872656|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2872657|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
2872658|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872659|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872660|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2872661|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2872662|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
2872663|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872664|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2872665|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2872666|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
2872667|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
2872668|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872669|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
2872670|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
2872671|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
2872672|NCT03710122|Vancomycin|vancomycin|mesh-list
2872673|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2872674|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872675|NCT03710044|Cyclosporine|cyclosporine|mesh-list
2872676|NCT03710044|Cyclosporins|cyclosporins|mesh-list
2872677|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312433|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2312434|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
2312435|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
2312436|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312437|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872678|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872679|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2872680|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
2872681|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872682|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
2872683|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872684|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
2872685|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2872686|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2872687|NCT03709992|Tamsulosin|tamsulosin|mesh-list
2872688|NCT03709992|Trospium chloride|trospium chloride|mesh-list
2872689|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2872690|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2872691|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2872692|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
2872693|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2872694|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872695|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872696|NCT03709992|Urological Agents|urological agents|mesh-ancestor
2872697|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
2872698|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
2872699|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872700|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2872701|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2872702|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
2872703|NCT03709953|Apatinib|apatinib|mesh-list
2872704|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872705|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2872706|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872707|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872708|NCT03709940|Methylphenidate|methylphenidate|mesh-list
2872709|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2872710|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872711|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2872712|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2872713|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2872714|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872715|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
2872716|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2872717|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
2872718|NCT03709927|Fosfomycin|fosfomycin|mesh-list
2872719|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2872720|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872721|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2312438|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312439|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2312440|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
2312441|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312442|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2312443|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
2312444|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
2312445|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2312446|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2312447|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
2312448|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
2312449|NCT00334763|Paclitaxel|paclitaxel|mesh-list
2312450|NCT00334763|Bevacizumab|bevacizumab|mesh-list
2312451|NCT00334763|Carboplatin|carboplatin|mesh-list
2312452|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2872722|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2872723|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872724|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872725|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872726|NCT03709914|Fosfomycin|fosfomycin|mesh-list
2872727|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2872728|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872729|NCT03709888|Pregabalin|pregabalin|mesh-list
2872730|NCT03709888|Memantine|memantine|mesh-list
2872731|NCT03709888|Analgesics|analgesics|mesh-ancestor
2872732|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
2872733|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2872734|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872735|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
2872736|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2872737|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2872738|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872739|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2872740|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2872741|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2872742|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2872743|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2872744|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2872745|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2872746|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
2872747|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2872748|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2872749|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2872750|NCT03709849|Citric Acid|citric acid|mesh-list
2312453|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312454|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
2312455|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
2312456|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
2312457|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312458|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2312459|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2312460|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2312461|NCT00334763|Growth Substances|growth substances|mesh-ancestor
2312462|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312463|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
2312464|NCT00334789|Vitamin A|vitamin a|mesh-list
2312465|NCT00334789|Tretinoin|tretinoin|mesh-list
2312466|NCT00334789|Belinostat|belinostat|mesh-list
2312467|NCT00334789|Isotretinoin|isotretinoin|mesh-list
2312468|NCT00334789|Vitamins|vitamins|mesh-ancestor
2312469|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
2312470|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312471|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312472|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312473|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
2872751|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
2872752|NCT03709849|Clomiphene|clomiphene|mesh-list
2872753|NCT03709849|Enclomiphene|enclomiphene|mesh-list
2872754|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
2872755|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
2872756|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2872757|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
2872758|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
2872759|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872760|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2872761|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
2872762|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2872763|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872764|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2872765|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
2872766|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2872767|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2872768|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2872769|NCT03709745|Ranibizumab|ranibizumab|mesh-list
2872770|NCT03709745|Aflibercept|aflibercept|mesh-list
2872771|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2872772|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2872773|NCT03709745|Growth Substances|growth substances|mesh-ancestor
2872774|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312474|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
2312475|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2312476|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872775|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
2872776|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872777|NCT03709719|Blinatumomab|blinatumomab|mesh-list
2872778|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312477|NCT00334854|Doxorubicin|doxorubicin|mesh-list
2312478|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2312479|NCT00334854|Ifosfamide|ifosfamide|mesh-list
2312480|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2312481|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312482|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2312483|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2312484|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312485|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312486|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2312487|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
2312488|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
2312489|NCT00334867|Ifosfamide|ifosfamide|mesh-list
2312490|NCT00334867|Doxorubicin|doxorubicin|mesh-list
2312491|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2312492|NCT00334867|Etoposide|etoposide|mesh-list
2312493|NCT00334867|Vincristine|vincristine|mesh-list
2312494|NCT00334867|Topotecan|topotecan|mesh-list
2312495|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
2312496|NCT00334867|Razoxane|razoxane|mesh-list
2312497|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2312498|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
2312499|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312500|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2312501|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2312502|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
2312503|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312504|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312505|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2872782|NCT03709550|Decitabine|decitabine|mesh-list
2872783|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2872784|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
2872785|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872786|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872787|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872788|NCT03709459|Doxycycline|doxycycline|mesh-list
2312506|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2312507|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2312508|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2312509|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312510|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2312511|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
2312512|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
2312513|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
2312514|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2312515|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2312516|NCT00334867|Protective Agents|protective agents|mesh-ancestor
2312517|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2312518|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2312519|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312520|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2312521|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2312522|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2312523|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312524|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
2312525|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312526|NCT00334906|Memantine|memantine|mesh-list
2312527|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2312528|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2312529|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
2872789|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2872790|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872791|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
2872792|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2872793|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2872794|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2872795|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2872796|NCT03709381|Cosyntropin|cosyntropin|mesh-list
2872797|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
2872798|NCT03709381|Hormones|hormones|mesh-ancestor
2872799|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2872800|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872801|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2872802|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312530|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312531|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312532|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312533|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2312534|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2312535|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2312536|NCT00334932|Doxorubicin|doxorubicin|mesh-list
2312537|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2312538|NCT00334932|Bortezomib|bortezomib|mesh-list
2312539|NCT00334932|Melphalan|melphalan|mesh-list
2312540|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2312541|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312542|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2312543|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2312544|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312545|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312546|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2312547|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
2312548|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2312549|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2312550|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
2312551|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312552|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
2312553|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
2312554|NCT00335075|Temozolomide|temozolomide|mesh-list
2312555|NCT00335075|Semustine|semustine|mesh-list
2312556|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2312557|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
2312558|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312559|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312560|NCT00335088|Iodine|iodine|mesh-list
2312561|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
2312562|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
2312563|NCT00335088|Povidone|povidone|mesh-list
2312564|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2312565|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312566|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2312567|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2312568|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312569|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312570|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312571|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312572|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2872852|NCT03709160|Bumetanide|bumetanide|mesh-list
2872853|NCT03709160|Diuretics|diuretics|mesh-ancestor
2872854|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
2872855|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872856|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2872857|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2312573|NCT00335088|Trace Elements|trace elements|mesh-ancestor
2312574|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
2312575|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
2312576|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
2312577|NCT00335114|Cyclosporine|cyclosporine|mesh-list
2872858|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872859|NCT03709147|Metformin|metformin|mesh-list
2312578|NCT00335114|Cyclosporins|cyclosporins|mesh-list
2312579|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312580|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312581|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2312582|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
2312583|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312584|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
2312585|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312586|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
2312587|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2872860|NCT03709147|Carboplatin|carboplatin|mesh-list
2872861|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
2872862|NCT03709147|Pemetrexed|pemetrexed|mesh-list
2872863|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872864|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2872865|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872866|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2312588|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2312589|NCT00335166|Pramipexole|pramipexole|mesh-list
2312590|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
2312591|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312592|NCT00335166|Protective Agents|protective agents|mesh-ancestor
2312593|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312594|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2312595|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2872867|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872868|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872869|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2872870|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2872871|NCT03709121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2872872|NCT03709121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2872873|NCT03709082|Trastuzumab|trastuzumab|mesh-list
2872874|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2872875|NCT03709082|Letrozole|letrozole|mesh-list
2872876|NCT03709082|Palbociclib|palbociclib|mesh-list
2312596|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
2312597|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
2312598|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312599|NCT00335179|Imiquimod|imiquimod|mesh-list
2312600|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2312601|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
2312602|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312603|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312604|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
2312605|NCT00335192|Tenofovir|tenofovir|mesh-list
2312606|NCT00335192|Lamivudine|lamivudine|mesh-list
2312607|NCT00335192|Lopinavir|lopinavir|mesh-list
2312608|NCT00335192|Abacavir|abacavir|mesh-list
2312609|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
2312610|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312611|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2312612|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2312613|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312614|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312615|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2312616|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2312617|NCT00335192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2312618|NCT00335192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2312619|NCT00335192|Protease Inhibitors|protease inhibitors|mesh-ancestor
2312620|NCT00335192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2312621|NCT00335192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2312622|NCT00335205|Ropinirole|ropinirole|mesh-list
2312623|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2312624|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2312625|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
2312626|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
2312627|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312628|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312629|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312630|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
2312631|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2312632|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312633|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2312634|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2872877|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2872878|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872879|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2872880|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2872881|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872882|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872883|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2872884|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
2872885|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2872886|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872887|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2872888|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
2872889|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
2872890|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
2872891|NCT03709056|Propofol|propofol|mesh-list
2872892|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2872893|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2312635|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2312636|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2312637|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312638|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312639|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312640|NCT00335270|Ritonavir|ritonavir|mesh-list
2312641|NCT00335270|Amprenavir|amprenavir|mesh-list
2312642|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
2312643|NCT00335270|Lamivudine|lamivudine|mesh-list
2312644|NCT00335270|Abacavir|abacavir|mesh-list
2312645|NCT00335270|Calcium|calcium|mesh-list
2312646|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2312647|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312648|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2312649|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2312650|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
2872894|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872895|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2872896|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
2872897|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
2872898|NCT03709017|Ponatinib|ponatinib|mesh-list
2872899|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872900|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2872901|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872902|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872903|NCT03708926|Abaloparatide|abaloparatide|mesh-list
2872904|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2872905|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872906|NCT03708861|Ritonavir|ritonavir|mesh-list
2872907|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2872908|NCT03708861|Maraviroc|maraviroc|mesh-list
2312651|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312652|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312653|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2312654|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2312655|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
2312656|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872909|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2872910|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2872911|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
2872912|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872913|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872914|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2872915|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2872916|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
2872917|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872918|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2872919|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2872920|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2872921|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2872922|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2872923|NCT03708848|Metronidazole|metronidazole|mesh-list
2872924|NCT03708848|Clarithromycin|clarithromycin|mesh-list
2872925|NCT03708848|Levofloxacin|levofloxacin|mesh-list
2872926|NCT03708848|Ofloxacin|ofloxacin|mesh-list
2872927|NCT03708848|Tetracycline|tetracycline|mesh-list
2872928|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
2312657|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2312658|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2312659|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2872929|NCT03708848|Esomeprazole|esomeprazole|mesh-list
2872930|NCT03708848|Bismuth|bismuth|mesh-list
2872931|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872932|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2872933|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2872934|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2872935|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2872936|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2872937|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2872938|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2872939|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2872940|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2872941|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2872942|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2872943|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2872944|NCT03708848|Renal Agents|renal agents|mesh-ancestor
2872945|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2872946|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2872947|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872948|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2872949|NCT03708848|Antacids|antacids|mesh-ancestor
2872950|NCT03708848|Diuretics|diuretics|mesh-ancestor
2872951|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
2872952|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872953|NCT03708848|Expectorants|expectorants|mesh-ancestor
2872954|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
2872955|NCT03708822|Docetaxel|docetaxel|mesh-list
2872956|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
2872957|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872958|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
2872959|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
2872960|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
2872961|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872962|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2872963|NCT03708718|Prednisolone|prednisolone|mesh-list
2872964|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2872965|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
2872966|NCT03708718|Hormones|hormones|mesh-ancestor
2872967|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2872968|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872969|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2872970|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872971|NCT03708627|Bimatoprost|bimatoprost|mesh-list
2872972|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2872973|NCT03708588|Ticagrelor|ticagrelor|mesh-list
2872974|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2872975|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2872976|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2872977|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2872978|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
2872979|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2872980|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872981|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872982|NCT03708536|Bevacizumab|bevacizumab|mesh-list
2872983|NCT03708536|Capecitabine|capecitabine|mesh-list
2872984|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2872985|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2872986|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2872987|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2872988|NCT03708536|Growth Substances|growth substances|mesh-ancestor
2872989|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2872990|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
2872991|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2872992|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
2872993|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2872994|NCT03708497|Misoprostol|misoprostol|mesh-list
2872995|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
2312660|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2872996|NCT03708497|Carbetocin|carbetocin|mesh-list
2872997|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2872998|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2872999|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873000|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
2873001|NCT03708497|Coagulants|coagulants|mesh-ancestor
2312661|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2312662|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
2873002|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2873003|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
2873004|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2873005|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873006|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2873007|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2873008|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
2873009|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
2873010|NCT03708458|Indomethacin|indomethacin|mesh-list
2873011|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2873012|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
2873013|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873014|NCT03708458|Expectorants|expectorants|mesh-ancestor
2873015|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
2873016|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2873017|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
2873018|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873019|NCT03708458|Protective Agents|protective agents|mesh-ancestor
2312663|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2312664|NCT00335309|Amoxicillin|amoxicillin|mesh-list
2312665|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
2312666|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
2312667|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2312668|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873020|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873021|NCT03708458|Antidotes|antidotes|mesh-ancestor
2873022|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2312669|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2312670|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312671|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312672|NCT00335348|Dexamethasone|dexamethasone|mesh-list
2312673|NCT00335348|Bortezomib|bortezomib|mesh-list
2312674|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2312675|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
2312676|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
2312677|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312678|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312679|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2312680|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
2312681|NCT00335348|Hormones|hormones|mesh-ancestor
2312682|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2312683|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2873023|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2873024|NCT03708458|Analgesics|analgesics|mesh-ancestor
2873025|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
2873026|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873027|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2873028|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2312684|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312685|NCT00335400|Anesthetics|anesthetics|mesh-list
2312686|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2312687|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312688|NCT00335413|Spironolactone|spironolactone|mesh-list
2312689|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2312690|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
2312691|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2312692|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312693|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2312694|NCT00335413|Diuretics|diuretics|mesh-ancestor
2312695|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
2312696|NCT00335439|Ketorolac|ketorolac|mesh-list
2312697|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2312698|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2312699|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2312700|NCT00335439|Analgesics|analgesics|mesh-ancestor
2312701|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
2873029|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
2873030|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
2873031|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2873032|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2873033|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873034|NCT03708354|Tocotrienols|tocotrienols|mesh-list
2873035|NCT03708354|Vitamin E|vitamin e|mesh-list
2873036|NCT03708354|Tocopherols|tocopherols|mesh-list
2873037|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
2873038|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873039|NCT03708354|Protective Agents|protective agents|mesh-ancestor
2873040|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873041|NCT03708354|Vitamins|vitamins|mesh-ancestor
2873042|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
2873043|NCT03708341|Melatonin|melatonin|mesh-list
2312702|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312703|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312704|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2312705|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2312706|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2312707|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312708|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312709|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
2312710|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2312711|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312712|NCT00335543|Gemcitabine|gemcitabine|mesh-list
2873044|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
2873045|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873046|NCT03708341|Protective Agents|protective agents|mesh-ancestor
2873047|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873048|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2873063|NCT03708237|Gabapentin|gabapentin|mesh-list
2873064|NCT03708237|Ropinirole|ropinirole|mesh-list
2873065|NCT03708237|Analgesics|analgesics|mesh-ancestor
2873066|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
2873067|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873068|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873069|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
2873070|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2873071|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2873072|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2873073|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2873074|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2873075|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2873076|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873077|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873078|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
2873079|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2873080|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2873081|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
2873082|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
2873083|NCT03708224|Atezolizumab|atezolizumab|mesh-list
2873084|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873085|NCT03708198|Bupivacaine|bupivacaine|mesh-list
2873086|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
2873087|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
2873088|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2873089|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873090|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
2873091|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312713|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312714|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2312715|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
2312716|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312717|NCT00335543|Antiviral Agents|antiviral agents|mesh-ancestor
2312718|NCT00335543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312719|NCT00335543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873092|NCT03708146|Zamicastat|zamicastat|mesh-list
2873093|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873094|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873095|NCT03708133|Nifurtimox|nifurtimox|mesh-list
2312720|NCT00335543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2312721|NCT00335543|Immunologic Factors|immunologic factors|mesh-ancestor
2312722|NCT00335543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312723|NCT00335582|Clonidine|clonidine|mesh-list
2312724|NCT00335582|Analgesics|analgesics|mesh-ancestor
2312725|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
2312726|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312727|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312728|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2312729|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
2312730|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
2312731|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2312732|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2312733|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2312734|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
2312735|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312736|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312737|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
2312738|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2312739|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
2312740|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312741|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312742|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2312743|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
2312744|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
2312745|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2312746|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
2312747|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312748|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312749|NCT00335647|Fluphenazine|fluphenazine|mesh-list
2312750|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
2312751|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
2312752|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2312753|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2312754|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2312755|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312756|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2873096|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2873097|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2873098|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2873099|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873100|NCT03708120|Insect Repellents|insect repellents|mesh-list
2873101|NCT03708120|Protective Agents|protective agents|mesh-ancestor
2873102|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873103|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
2873104|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2873105|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
2873106|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873107|NCT03707951|Expectorants|expectorants|mesh-ancestor
2873108|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
2873109|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2873110|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
2873111|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873112|NCT03707951|Protective Agents|protective agents|mesh-ancestor
2873113|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873114|NCT03707951|Antidotes|antidotes|mesh-ancestor
2873115|NCT03707899|Amlodipine|amlodipine|mesh-list
2873116|NCT03707899|Telmisartan|telmisartan|mesh-list
2873117|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2873118|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2312757|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2312758|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
2873119|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2873120|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2873121|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2873122|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873123|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2873124|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873125|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
2873126|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2873127|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2873128|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
2312759|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312760|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312761|NCT00335673|Irbesartan|irbesartan|mesh-list
2312762|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2312763|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2312764|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2312765|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873129|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2873130|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2873131|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873132|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2873133|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2873134|NCT03707847|Etoposide|etoposide|mesh-list
2873135|NCT03707847|Crizotinib|crizotinib|mesh-list
2873136|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2312766|NCT00335686|Lopinavir|lopinavir|mesh-list
2312767|NCT00335686|Nevirapine|nevirapine|mesh-list
2312768|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2312769|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2312770|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
2312771|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312772|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312773|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2312774|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2312775|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
2312776|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312777|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2312778|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2312779|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2312780|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2312781|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2312782|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2312783|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2312784|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2312785|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2312786|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
2312787|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312788|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2312789|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2873137|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873138|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2873139|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2873140|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873141|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873142|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2873143|NCT03707808|Nivolumab|nivolumab|mesh-list
2873144|NCT03707808|Ipilimumab|ipilimumab|mesh-list
2873145|NCT03707808|Avelumab|avelumab|mesh-list
2873146|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2873147|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873148|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2873149|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873150|NCT03707795|Betamethasone|betamethasone|mesh-list
2873151|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
2873152|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2873153|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
2873154|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
2873155|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
2873156|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2873157|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2873158|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
2873159|NCT03707795|Hormones|hormones|mesh-ancestor
2873160|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2873161|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873162|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2873163|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
2873164|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2873165|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
2873166|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873167|NCT03707678|Albuterol|albuterol|mesh-list
2873168|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2873169|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
2312790|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312791|NCT00335816|Leucovorin|leucovorin|mesh-list
2312792|NCT00335816|Fluorouracil|fluorouracil|mesh-list
2312793|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
2312794|NCT00335816|Calcium|calcium|mesh-list
2873170|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873171|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873172|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2873173|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
2873174|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
2873175|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2873176|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2873177|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2873178|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2873179|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
2873180|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873181|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873182|NCT03707652|Vitamins|vitamins|mesh-list
2873183|NCT03707652|Niacinamide|niacinamide|mesh-list
2873184|NCT03707652|Niacin|niacin|mesh-list
2873185|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
2873186|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
2873187|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
2873188|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873189|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2873190|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
2873191|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873192|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2873193|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
2873194|NCT03707639|Apatinib|apatinib|mesh-list
2873195|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873196|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2873197|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873198|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873199|NCT03707535|Infliximab|infliximab|mesh-list
2873200|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
2873201|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2873202|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2873203|NCT03707509|Gemcitabine|gemcitabine|mesh-list
2873204|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873205|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2873206|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
2312795|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
2312796|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2873207|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873208|NCT03707509|Antiviral Agents|antiviral agents|mesh-ancestor
2873209|NCT03707509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873210|NCT03707509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873211|NCT03707509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2873212|NCT03707509|Immunologic Factors|immunologic factors|mesh-ancestor
2873213|NCT03707509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873214|NCT03707483|Ascorbic Acid|ascorbic acid|mesh-list
2873215|NCT03707483|Vitamins|vitamins|mesh-ancestor
2312797|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312798|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
2312799|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312800|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2312801|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312802|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2312803|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
2312804|NCT00335816|Antidotes|antidotes|mesh-ancestor
2312805|NCT00335816|Protective Agents|protective agents|mesh-ancestor
2873216|NCT03707483|Micronutrients|micronutrients|mesh-ancestor
2873217|NCT03707483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873218|NCT03707483|Antioxidants|antioxidants|mesh-ancestor
2873219|NCT03707483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873220|NCT03707483|Protective Agents|protective agents|mesh-ancestor
2873221|NCT03707457|Nivolumab|nivolumab|mesh-list
2873222|NCT03707457|Ipilimumab|ipilimumab|mesh-list
2873223|NCT03707457|Antibodies|antibodies|mesh-list
2312806|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
2312807|NCT00335816|Vitamins|vitamins|mesh-ancestor
2312808|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
2312809|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2312810|NCT00335920|Dexamethasone|dexamethasone|mesh-list
2312811|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2312812|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
2312813|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
2312814|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873224|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2873225|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
2873226|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873227|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2873228|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873229|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2873230|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873231|NCT03707418|Heparin|heparin|mesh-list
2873232|NCT03707418|Calcium heparin|calcium heparin|mesh-list
2873233|NCT03707418|Bivalirudin|bivalirudin|mesh-list
2873234|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
2873235|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2873236|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2873237|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873238|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
2873239|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2873240|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
2873241|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873242|NCT03707353|Vaccines|vaccines|mesh-list
2873243|NCT03707353|Immunologic Factors|immunologic factors|mesh-ancestor
2873244|NCT03707353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873245|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
2873246|NCT03707249|Hematinics|hematinics|mesh-ancestor
2873247|NCT03707171|Liraglutide|liraglutide|mesh-list
2873248|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2873249|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873250|NCT03707171|Incretins|incretins|mesh-ancestor
2873251|NCT03707171|Hormones|hormones|mesh-ancestor
2873252|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2873253|NCT03707028|Paclitaxel|paclitaxel|mesh-list
2873254|NCT03707028|Apatinib|apatinib|mesh-list
2873255|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2873256|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873257|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
2873258|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
2873259|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
2873260|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873261|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2873262|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873263|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2873264|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
2873265|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2873266|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2873267|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873268|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312815|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312816|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2312817|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
2312818|NCT00335920|Hormones|hormones|mesh-ancestor
2312819|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2312820|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2312821|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312822|NCT00335933|Gabapentin|gabapentin|mesh-list
2312823|NCT00335933|Analgesics|analgesics|mesh-ancestor
2312824|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
2312825|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312826|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873269|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
2873270|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873271|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2873272|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2873284|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
2873285|NCT03706781|Benzydamine|benzydamine|mesh-list
2873286|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2873287|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873288|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2873289|NCT03706755|Norepinephrine|norepinephrine|mesh-list
2873290|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2873291|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2873292|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
2873293|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873294|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873295|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873296|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
2873297|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
2873298|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873299|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2873300|NCT03706703|Carboplatin|carboplatin|mesh-list
2873301|NCT03706703|Docetaxel|docetaxel|mesh-list
2873302|NCT03706703|Pemetrexed|pemetrexed|mesh-list
2873303|NCT03706703|Endostar protein|endostar protein|mesh-list
2873304|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873305|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
2873306|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
2873307|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
2873308|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873309|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873310|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2873311|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2873312|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2873313|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2873314|NCT03706703|Growth Substances|growth substances|mesh-ancestor
2873315|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873316|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
2312827|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
2312828|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2312829|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2312830|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2312831|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2312832|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2312833|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2312834|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873317|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
2312835|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312836|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
2312837|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
2312838|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2873318|NCT03706547|Fludarabine|fludarabine|mesh-list
2873319|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2873320|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
2873321|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873322|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2873323|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2873324|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
2312839|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
2312840|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2312841|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
2312842|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312843|NCT00335998|Cisplatin|cisplatin|mesh-list
2312844|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312845|NCT00336141|Vorinostat|vorinostat|mesh-list
2312846|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312847|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2312848|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312849|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312850|NCT00336154|Tetracycline|tetracycline|mesh-list
2312851|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2312852|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312853|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2312854|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312855|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873325|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873326|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873327|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2873328|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
2873329|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2873330|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2873331|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312856|NCT00336167|Bezafibrate|bezafibrate|mesh-list
2312857|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2312858|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
2312859|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312860|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2873332|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
2873333|NCT03706339|Coagulants|coagulants|mesh-ancestor
2873334|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
2873335|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
2873336|NCT03706300|Ephedrine|ephedrine|mesh-list
2873337|NCT03706300|Guaifenesin|guaifenesin|mesh-list
2873338|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2873339|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2873340|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
2873341|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873342|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873343|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2873344|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
2873345|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
2873346|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2873347|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2873348|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
2873349|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
2873350|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873351|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873352|NCT03706300|Expectorants|expectorants|mesh-ancestor
2873353|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2873354|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2873355|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
2873356|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2873357|NCT03706287|Cisplatin|cisplatin|mesh-list
2873358|NCT03706287|Carboplatin|carboplatin|mesh-list
2873359|NCT03706287|Pemetrexed|pemetrexed|mesh-list
2873360|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873361|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873362|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873363|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2873364|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2312861|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
2873365|NCT03706222|Grazoprevir|grazoprevir|mesh-list
2312862|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2312863|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312864|NCT00336219|Pantoprazole|pantoprazole|mesh-list
2312865|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2312866|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2312867|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2312868|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873366|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
2873367|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873368|NCT03706157|Doxorubicin|doxorubicin|mesh-list
2873369|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2873370|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2873371|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873372|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2873373|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2873374|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873375|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873376|NCT03706053|Midodrine|midodrine|mesh-list
2873377|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
2873378|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
2873379|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873380|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873381|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2873382|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2873383|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2873384|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2873385|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
2873386|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873387|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873388|NCT03705962|Tobramycin|tobramycin|mesh-list
2873389|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2873390|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873391|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
2873392|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
2873393|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2873394|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
2873395|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873396|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
2873397|NCT03705949|Protective Agents|protective agents|mesh-ancestor
2873398|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2873399|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2873400|NCT03705884|Prednisolone|prednisolone|mesh-list
2873401|NCT03705884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2873402|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2873403|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
2873404|NCT03705884|Hormones|hormones|mesh-ancestor
2873405|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2873406|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873407|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2873408|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873409|NCT03705884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2108852|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108853|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2108854|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2108855|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
2108856|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108857|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108858|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2108859|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2873410|NCT03705884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873411|NCT03705858|Lintuzumab|lintuzumab|mesh-list
2873412|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2873413|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873414|NCT03705845|Tocotrienols|tocotrienols|mesh-list
2873415|NCT03705845|Vitamin E|vitamin e|mesh-list
2873416|NCT03705845|Tocopherols|tocopherols|mesh-list
2873417|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
2312869|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312870|NCT00336245|Copper|copper|mesh-list
2312871|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
2312872|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2312873|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312874|NCT00336245|Trace Elements|trace elements|mesh-ancestor
2312875|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
2312876|NCT00336310|Repaglinide|repaglinide|mesh-list
2312877|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2312878|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312879|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2312880|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2312881|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2312882|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
2312883|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312884|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2312885|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2312886|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312887|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
2312888|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2312889|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2312890|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2312891|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2312892|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312893|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
2312894|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2312895|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873418|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873419|NCT03705845|Protective Agents|protective agents|mesh-ancestor
2873420|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873421|NCT03705845|Vitamins|vitamins|mesh-ancestor
2873422|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
2873423|NCT03705780|Fentanyl|fentanyl|mesh-list
2873424|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2873425|NCT03705780|Narcotics|narcotics|mesh-ancestor
2873426|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2873427|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873428|NCT03705780|Analgesics|analgesics|mesh-ancestor
2873429|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
2873430|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312896|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2312897|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312898|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
2312899|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312900|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
2312901|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312902|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873431|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2873432|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2873433|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
2873434|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
2873435|NCT03705728|Remifentanil|remifentanil|mesh-list
2873436|NCT03705728|Propofol|propofol|mesh-list
2873437|NCT03705728|Sevoflurane|sevoflurane|mesh-list
2873438|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2873439|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2873440|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873441|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2873442|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
2312903|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2312904|NCT00336375|Lumefantrine|lumefantrine|mesh-list
2312905|NCT00336375|Artemether|artemether|mesh-list
2312906|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2312907|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
2312908|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2312909|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2312910|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873443|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
2873444|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2873445|NCT03705728|Narcotics|narcotics|mesh-ancestor
2873446|NCT03705728|Analgesics|analgesics|mesh-ancestor
2873447|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
2873448|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312911|NCT00336401|Propofol|propofol|mesh-list
2312912|NCT00336401|Sevoflurane|sevoflurane|mesh-list
2312913|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2312914|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2312915|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312916|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2873449|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2873450|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2873451|NCT03705585|Vaccines|vaccines|mesh-list
2873452|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
2873453|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873454|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
2873455|NCT03705559|Narcotics|narcotics|mesh-ancestor
2873456|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2873457|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873458|NCT03705559|Analgesics|analgesics|mesh-ancestor
2873459|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
2873460|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873461|NCT03705533|Telmisartan|telmisartan|mesh-list
2873462|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2873463|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2873464|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2873465|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312917|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
2312918|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
2312919|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2312920|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2312921|NCT00336414|Prednisone|prednisone|mesh-list
2312922|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
2312923|NCT00336414|Azathioprine|azathioprine|mesh-list
2312924|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2312925|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
2312926|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312927|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2312928|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2312929|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
2312930|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312931|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312932|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2312933|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2312934|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
2312935|NCT00336414|Hormones|hormones|mesh-ancestor
2312936|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2312937|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2312938|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
2312939|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2312940|NCT00336453|Vaccines|vaccines|mesh-list
2312941|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
2312942|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
2312943|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312944|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
2312945|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
2873478|NCT05177666|Trastuzumab|trastuzumab|mesh-list
2873479|NCT05177666|Pertuzumab|pertuzumab|mesh-list
2873480|NCT05177666|Vemurafenib|vemurafenib|mesh-list
2873481|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2873482|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873483|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2873484|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873485|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873486|NCT05177614|Micronutrients|micronutrients|mesh-list
2873487|NCT05177614|Trace Elements|trace elements|mesh-list
2873488|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873489|NCT05177601|Cycloserine|cycloserine|mesh-list
2873490|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2873491|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312946|NCT00336466|Hematinics|hematinics|mesh-ancestor
2312947|NCT00336518|Ribavirin|ribavirin|mesh-list
2312948|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2312949|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
2312950|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312951|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
2312952|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312953|NCT00336531|Itraconazole|itraconazole|mesh-list
2312954|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
2312955|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312956|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2312957|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2312958|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312959|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312960|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2312961|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
2312962|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2312963|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312964|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2312965|NCT00336648|Gemcitabine|gemcitabine|mesh-list
2873492|NCT05177601|Renal Agents|renal agents|mesh-ancestor
2873493|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2873494|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
2873495|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2873496|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
2873497|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873498|NCT05177588|Metformin|metformin|mesh-list
2873499|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2873500|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873501|NCT05177510|Mifepristone|mifepristone|mesh-list
2873502|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2873503|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
2873504|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2873505|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873506|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2873507|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2873508|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2873509|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
2873510|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2873511|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2873512|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
2873513|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2873514|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
2873515|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2873516|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2873519|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
2873520|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
2873521|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873522|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2873523|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2873524|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
2873525|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873526|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873527|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2873528|NCT05177406|Erenumab|erenumab|mesh-list
2873529|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2873530|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873531|NCT05177406|Analgesics|analgesics|mesh-ancestor
2873532|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
2873533|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2312966|NCT00336648|Bevacizumab|bevacizumab|mesh-list
2312967|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2312968|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312969|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2312970|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2312971|NCT00336648|Growth Substances|growth substances|mesh-ancestor
2312972|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312973|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
2312974|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2312975|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
2312976|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312977|NCT00336648|Antiviral Agents|antiviral agents|mesh-ancestor
2873534|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873535|NCT05177276|Irinotecan|irinotecan|mesh-list
2873536|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2873537|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2873538|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873539|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873540|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873541|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2873542|NCT05177237|Endostar protein|endostar protein|mesh-list
2873543|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2873544|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2873545|NCT05177237|Growth Substances|growth substances|mesh-ancestor
2873546|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873547|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
2873548|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873549|NCT05177198|Clindamycin|clindamycin|mesh-list
2873550|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
2873551|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
2873552|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2873553|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873554|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2873555|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873556|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873557|NCT05177146|Ketamine|ketamine|mesh-list
2873558|NCT05177146|Analgesics|analgesics|mesh-ancestor
2873559|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
2312978|NCT00336648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2312979|NCT00336648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312980|NCT00336648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2312981|NCT00336648|Immunologic Factors|immunologic factors|mesh-ancestor
2312982|NCT00336674|Insulin|insulin|mesh-list
2312983|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2312984|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312985|NCT00336739|Cinacalcet|cinacalcet|mesh-list
2312986|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2312987|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2312988|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2312989|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
2312990|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2312991|NCT00336765|XL647|xl647|mesh-list
2312992|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2312993|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2312994|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2312995|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2312996|NCT00336791|Paclitaxel|paclitaxel|mesh-list
2312997|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
2312998|NCT00336791|Doxorubicin|doxorubicin|mesh-list
2312999|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2313000|NCT00336791|Fluorouracil|fluorouracil|mesh-list
2313001|NCT00336791|Epirubicin|epirubicin|mesh-list
2313002|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2313003|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313004|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
2873560|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873561|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873562|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2873563|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2873564|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
2873565|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
2873566|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2873567|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2873568|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2873569|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873570|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873577|NCT05177055|Methamphetamine|methamphetamine|mesh-list
2873578|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2873579|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873580|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
2873581|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
2873582|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873583|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
2873584|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873585|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873586|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
2873587|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2873588|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2873589|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2873590|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2873597|NCT05176951|Treprostinil|treprostinil|mesh-list
2873598|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2313005|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
2313006|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
2313007|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313008|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2313009|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
2313010|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313011|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2873599|NCT05176821|Amoxicillin|amoxicillin|mesh-list
2873600|NCT05176821|Furazolidone|furazolidone|mesh-list
2873601|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
2873602|NCT05176821|Esomeprazole|esomeprazole|mesh-list
2873603|NCT05176821|Bismuth|bismuth|mesh-list
2873604|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873605|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2873606|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873607|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2873608|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2873609|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2873610|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873611|NCT05176821|Antacids|antacids|mesh-ancestor
2313012|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2313013|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
2313014|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2313015|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2313016|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2313017|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2313018|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313019|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
2313020|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2313021|NCT00336882|Midazolam|midazolam|mesh-list
2313022|NCT00336882|Propofol|propofol|mesh-list
2313023|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2313024|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2873612|NCT05176821|Diuretics|diuretics|mesh-ancestor
2873613|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
2873614|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873615|NCT05176821|Expectorants|expectorants|mesh-ancestor
2313025|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313026|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2313027|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
2313028|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
2313029|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2313030|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2313031|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2313032|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2313033|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
2313034|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
2313035|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313036|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313037|NCT00336921|Alfuzosin|alfuzosin|mesh-list
2313038|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2313039|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2313040|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2313041|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
2313042|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313043|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313044|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313045|NCT00336921|Urological Agents|urological agents|mesh-ancestor
2313046|NCT00336947|Tegafur|tegafur|mesh-list
2313047|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2313048|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
2313049|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313050|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313051|NCT00336960|Celecoxib|celecoxib|mesh-list
2313052|NCT00336960|Fluorouracil|fluorouracil|mesh-list
2313053|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
2313054|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313055|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2873616|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
2873617|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2873618|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2873619|NCT05176821|Renal Agents|renal agents|mesh-ancestor
2873620|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2873621|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2313056|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313057|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2313058|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
2313059|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873622|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2873623|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2873624|NCT05176626|Phentermine|phentermine|mesh-list
2873625|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2873626|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313060|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2313061|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2313062|NCT00336960|Analgesics|analgesics|mesh-ancestor
2313063|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
2313064|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873627|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
2873628|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2873629|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
2873630|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
2873631|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873632|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
2873633|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873634|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873635|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2873636|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
2873637|NCT05176548|Paraproteins|paraproteins|mesh-list
2873638|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
2873639|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873640|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
2873641|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2873642|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873649|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
2873650|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
2873651|NCT05176470|Fludarabine|fludarabine|mesh-list
2873652|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2873653|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
2873654|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873655|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2873656|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2873657|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
2873658|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873659|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873660|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2873661|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2873662|NCT05176418|Nicotine|nicotine|mesh-list
2873663|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2873664|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
2873665|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873666|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873667|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2873668|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2873669|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
2873670|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873671|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873672|NCT05176379|Fluconazole|fluconazole|mesh-list
2873673|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
2873674|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873675|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2873676|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2873677|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873678|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313065|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2313066|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2313067|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2313068|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2313069|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313070|NCT00337051|Propofol|propofol|mesh-list
2873679|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2873680|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
2873681|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2873682|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873683|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2873684|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2873693|NCT05176288|Palbociclib|palbociclib|mesh-list
2873694|NCT05176288|Avelumab|avelumab|mesh-list
2873695|NCT05176288|Axitinib|axitinib|mesh-list
2873696|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873697|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2873698|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873699|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873700|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2873701|NCT05176223|Edetic Acid|edetic acid|mesh-list
2873702|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2873703|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
2873704|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
2873705|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313071|NCT00337051|Sevoflurane|sevoflurane|mesh-list
2313072|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2313073|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2313074|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313075|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2313076|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
2873706|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
2873707|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2873708|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2313077|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
2313078|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2313079|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2313080|NCT00337090|Mirabegron|mirabegron|mesh-list
2313081|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2313082|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2313083|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2313084|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
2313085|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313086|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313087|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313088|NCT00337090|Urological Agents|urological agents|mesh-ancestor
2873718|NCT05176119|Ketamine|ketamine|mesh-list
2873719|NCT05176119|Nalbuphine|nalbuphine|mesh-list
2313089|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2313090|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313091|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
2313092|NCT00337246|Rituximab|rituximab|mesh-list
2313093|NCT00337246|Fludarabine|fludarabine|mesh-list
2313094|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
2313095|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
2313096|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2313097|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
2313098|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313099|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2313100|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2313101|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
2313102|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313103|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313104|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2313105|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2313106|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2313107|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
2313108|NCT00337246|Analgesics|analgesics|mesh-ancestor
2313109|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
2313110|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313111|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2313112|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2313113|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313114|NCT00337259|Gemcitabine|gemcitabine|mesh-list
2313115|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2313116|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
2313117|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313118|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313119|NCT00337259|Antiviral Agents|antiviral agents|mesh-ancestor
2313120|NCT00337259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313121|NCT00337259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313122|NCT00337259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2313123|NCT00337259|Immunologic Factors|immunologic factors|mesh-ancestor
2313124|NCT00337259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313125|NCT00337298|Amlodipine|amlodipine|mesh-list
2313126|NCT00337298|Lisinopril|lisinopril|mesh-list
2313127|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2873720|NCT05176119|Analgesics|analgesics|mesh-ancestor
2873721|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
2873722|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873723|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873724|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2873725|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2873726|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
2873727|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
2873728|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2873729|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2873730|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2873731|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873732|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873733|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2873734|NCT05176119|Narcotics|narcotics|mesh-ancestor
2108860|NCT02511431|Ritonavir|ritonavir|mesh-list
2108861|NCT02511431|Lonafarnib|lonafarnib|mesh-list
2108862|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2108863|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2108864|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
2108865|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108866|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108867|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2108868|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2108869|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
2873776|NCT05175703|Paclitaxel|paclitaxel|mesh-list
2873777|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2873778|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873779|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
2873780|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
2873781|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
2873782|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873783|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
2873784|NCT05175625|Paraproteins|paraproteins|mesh-list
2873785|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
2873786|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873787|NCT05175547|Clevidipine|clevidipine|mesh-list
2873788|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2873789|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2873790|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873791|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2873792|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873793|NCT05175508|Azacitidine|azacitidine|mesh-list
2873794|NCT05175508|Tretinoin|tretinoin|mesh-list
2873795|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2873796|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
2873797|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873798|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873799|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873800|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
2873801|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
2873802|NCT05175430|Paroxetine|paroxetine|mesh-list
2873803|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
2873804|NCT05175430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2873805|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2873806|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2873807|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873808|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873809|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
2873810|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313128|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2313129|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2313130|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313131|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2313132|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313133|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
2313134|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2313135|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
2313136|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313137|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2313138|NCT00337298|Protective Agents|protective agents|mesh-ancestor
2313139|NCT00337376|Sirolimus|sirolimus|mesh-list
2313140|NCT00337376|Paclitaxel|paclitaxel|mesh-list
2313141|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2313142|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2313143|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313144|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
2313145|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
2313146|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
2313147|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313148|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2313149|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313150|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2313151|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
2313152|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2873811|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2873812|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
2873813|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2313153|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
2313154|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313155|NCT00337389|Leucovorin|leucovorin|mesh-list
2313156|NCT00337389|Bevacizumab|bevacizumab|mesh-list
2313157|NCT00337389|Fluorouracil|fluorouracil|mesh-list
2313158|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2873814|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2873815|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2873816|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873817|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
2873818|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2873819|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2873820|NCT05175274|Colchicine|colchicine|mesh-list
2873821|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
2873822|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2313159|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313160|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2313161|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2313162|NCT00337389|Growth Substances|growth substances|mesh-ancestor
2313163|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313164|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
2313165|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
2313166|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873823|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
2873824|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
2873825|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
2873826|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313167|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2313168|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2313169|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
2313170|NCT00337389|Antidotes|antidotes|mesh-ancestor
2873827|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873828|NCT05175235|Nivolumab|nivolumab|mesh-list
2313171|NCT00337389|Protective Agents|protective agents|mesh-ancestor
2313172|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
2313173|NCT00337389|Vitamins|vitamins|mesh-ancestor
2313174|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
2313175|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
2873829|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2873830|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873831|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2873832|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873833|NCT05175131|Mebeverine|mebeverine|mesh-list
2873834|NCT05175131|Simethicone|simethicone|mesh-list
2873835|NCT05175131|Alverine|alverine|mesh-list
2873836|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
2873837|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873838|NCT05175131|Emollients|emollients|mesh-ancestor
2873839|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
2313176|NCT00337441|Hematinics|hematinics|mesh-ancestor
2313177|NCT00337454|Dasatinib|dasatinib|mesh-list
2313178|NCT00337454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313179|NCT00337454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2313180|NCT00337454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313181|NCT00337454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313182|NCT00337493|Cyclosporine|cyclosporine|mesh-list
2313183|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
2313184|NCT00337493|Tacrolimus|tacrolimus|mesh-list
2313185|NCT00337493|Cyclosporins|cyclosporins|mesh-list
2313186|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2873840|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
2873841|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
2873842|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
2873843|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873844|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873845|NCT05175066|Bisoprolol|bisoprolol|mesh-list
2873846|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2873847|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
2873848|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
2873849|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873850|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873851|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2873852|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2873853|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2873854|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
2873855|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873856|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873857|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
2873858|NCT05175027|Povidone|povidone|mesh-list
2873859|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
2873860|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
2873861|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2873862|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2873863|NCT05175001|Betamethasone|betamethasone|mesh-list
2873864|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
2313187|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
2313188|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313189|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2873865|NCT05175001|Ropivacaine|ropivacaine|mesh-list
2873866|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
2313190|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313191|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313192|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
2313193|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313194|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
2313195|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2313196|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2313197|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313198|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2313199|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
2313200|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2313201|NCT00337506|Dexamethasone|dexamethasone|mesh-list
2313202|NCT00337506|Bortezomib|bortezomib|mesh-list
2313203|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2313204|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
2313205|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
2313206|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313207|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313208|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2313209|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
2313210|NCT00337506|Hormones|hormones|mesh-ancestor
2313211|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2313212|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2873867|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
2873868|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2873869|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873870|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
2873871|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873872|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2873873|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
2873874|NCT05175001|Hormones|hormones|mesh-ancestor
2873875|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2873876|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2873877|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
2873878|NCT05174884|Etonogestrel|etonogestrel|mesh-list
2873879|NCT05174884|Desogestrel|desogestrel|mesh-list
2873880|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2873881|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
2873882|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2873883|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873884|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2873885|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2873886|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2873887|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2873888|NCT05174884|Progestins|progestins|mesh-ancestor
2873889|NCT05174884|Hormones|hormones|mesh-ancestor
2873890|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2873891|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
2873892|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
2873893|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873894|NCT05174845|Protective Agents|protective agents|mesh-ancestor
2873895|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873896|NCT05174845|Vitamins|vitamins|mesh-ancestor
2873897|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
2873898|NCT05174832|Paclitaxel|paclitaxel|mesh-list
2873899|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
2873900|NCT05174832|Olaparib|olaparib|mesh-list
2873901|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2873902|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873903|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
2873904|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
2873905|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
2873906|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873907|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2873908|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2873909|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873910|NCT05174650|Atezolizumab|atezolizumab|mesh-list
2313213|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313214|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
2313215|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2873911|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873912|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
2873913|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
2873914|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873915|NCT05174611|Vitamin D|vitamin d|mesh-list
2313216|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313217|NCT00337532|Paclitaxel|paclitaxel|mesh-list
2313218|NCT00337532|Cisplatin|cisplatin|mesh-list
2313219|NCT00337532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2313220|NCT00337532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313221|NCT00337532|Tubulin Modulators|tubulin modulators|mesh-ancestor
2313222|NCT00337532|Antimitotic Agents|antimitotic agents|mesh-ancestor
2313223|NCT00337532|Mitosis Modulators|mitosis modulators|mesh-ancestor
2873916|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
2873917|NCT05174611|Vitamins|vitamins|mesh-ancestor
2873918|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
2873919|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873920|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2873921|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2873922|NCT05174598|Calcitriol|calcitriol|mesh-list
2873923|NCT05174598|Calcipotriene|calcipotriene|mesh-list
2873924|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
2873925|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2873926|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873927|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2873928|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2313224|NCT00337532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313225|NCT00337545|Everolimus|everolimus|mesh-list
2313226|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313227|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2313228|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
2313229|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313230|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
2313231|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2313232|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2313233|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
2313234|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873929|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873930|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2873931|NCT05174598|Vitamins|vitamins|mesh-ancestor
2873932|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
2873933|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2873934|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2873935|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
2873936|NCT05174585|Antibodies|antibodies|mesh-list
2873937|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
2873938|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2873939|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
2873940|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873941|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2873942|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
2873943|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2873944|NCT05173441|Antibodies|antibodies|mesh-list
2873945|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
2873946|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873947|NCT05170919|Olanzapine|olanzapine|mesh-list
2873948|NCT05170919|Mirtazapine|mirtazapine|mesh-list
2873949|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
2873950|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
2873951|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2873952|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873953|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2873954|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2873955|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2873956|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2873957|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2873958|NCT05170919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2873959|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2873960|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2873961|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873962|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2873963|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
2873964|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
2873965|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2873966|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
2873967|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
2873968|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2873969|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2313235|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313236|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313237|NCT00337558|Urological Agents|urological agents|mesh-ancestor
2313238|NCT00337623|Prednisolone|prednisolone|mesh-list
2313239|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2873970|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2873971|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2873972|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
2873973|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2873974|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2873975|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2873980|NCT05156684|Zinc|zinc|mesh-list
2313240|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
2313241|NCT00337623|Hormones|hormones|mesh-ancestor
2313242|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2313243|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313244|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2313245|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313246|NCT00337649|Trastuzumab|trastuzumab|mesh-list
2313247|NCT00337649|Epothilones|epothilones|mesh-list
2873981|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
2873982|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
2873983|NCT05156684|Trace Elements|trace elements|mesh-ancestor
2873984|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
2873985|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2873986|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2873987|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2873988|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2873989|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2873990|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2873991|NCT05156684|Protective Agents|protective agents|mesh-ancestor
2873992|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
2873993|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2873994|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
2873995|NCT05156684|Astringents|astringents|mesh-ancestor
2873996|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
2874004|NCT05155540|Plasminogen|plasminogen|mesh-list
2874005|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2874006|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2874007|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2874008|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874035|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
2874036|NCT05148637|Lidocaine|lidocaine|mesh-list
2874037|NCT05148637|Fentanyl|fentanyl|mesh-list
2874038|NCT05148637|Anesthetics|anesthetics|mesh-list
2874039|NCT05148637|Sevoflurane|sevoflurane|mesh-list
2874040|NCT05148637|Desflurane|desflurane|mesh-list
2874041|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
2874042|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2874043|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874044|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
2874045|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874046|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2874047|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2874048|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2874049|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2874050|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313248|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
2313249|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2313250|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313251|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
2313252|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
2313253|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
2874051|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2874052|NCT05148637|Narcotics|narcotics|mesh-ancestor
2874053|NCT05148637|Analgesics|analgesics|mesh-ancestor
2108870|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108871|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2108872|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2313254|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313255|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
2313256|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2313257|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2313258|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313259|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2313260|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2874054|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2874055|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2874056|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
2874057|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2874058|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2874065|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
2874066|NCT05147558|Lenvatinib|lenvatinib|mesh-list
2874067|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2874068|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874069|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2874070|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874071|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874072|NCT05133310|Simvastatin|simvastatin|mesh-list
2874073|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2874074|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2874075|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
2874076|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874077|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2874078|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2874079|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874080|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
2874081|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2874082|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
2874083|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2874084|NCT05122559|Expectorants|expectorants|mesh-ancestor
2874085|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
2874086|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2874087|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
2874088|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874089|NCT05122559|Protective Agents|protective agents|mesh-ancestor
2874090|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874091|NCT05122559|Antidotes|antidotes|mesh-ancestor
2108873|NCT02511535|Vaccines|vaccines|mesh-list
2108874|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
2108875|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108876|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
2313261|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
2313262|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313263|NCT00337740|Propranolol|propranolol|mesh-list
2313264|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2313265|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2313266|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
2313267|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313268|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313269|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313270|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2313271|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2313272|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
2313273|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2313274|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
2313275|NCT00337766|Coagulants|coagulants|mesh-ancestor
2313276|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2313277|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
2313278|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313279|NCT00337792|Fentanyl|fentanyl|mesh-list
2313280|NCT00337792|Midazolam|midazolam|mesh-list
2313281|NCT00337792|Oxycodone|oxycodone|mesh-list
2313282|NCT00337792|Lorazepam|lorazepam|mesh-list
2313283|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2313284|NCT00337792|Narcotics|narcotics|mesh-ancestor
2313285|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2313286|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313287|NCT00337792|Analgesics|analgesics|mesh-ancestor
2874120|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
2313288|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
2313289|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313290|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2313291|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2874121|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2874122|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874123|NCT05104983|Sirolimus|sirolimus|mesh-list
2874124|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2874125|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2874126|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2874127|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874128|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
2874129|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2874130|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
2874131|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874136|NCT05095831|Pancrelipase|pancrelipase|mesh-list
2874137|NCT05095831|Pancreatin|pancreatin|mesh-list
2874138|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2874139|NCT05084248|Vitamin D|vitamin d|mesh-list
2874140|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
2874141|NCT05084248|Vitamins|vitamins|mesh-ancestor
2874142|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
2874143|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874144|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2874145|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2313292|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
2313293|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
2313294|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2313295|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2313296|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2313297|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2313298|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
2313299|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
2313300|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313301|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313302|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
2313303|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
2313304|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
2313305|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2313306|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2313307|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
2313308|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
2313309|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2313310|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313311|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2313312|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313313|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313314|NCT00337922|Lamivudine|lamivudine|mesh-list
2313315|NCT00337922|Abacavir|abacavir|mesh-list
2313316|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2313317|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2313318|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313319|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313320|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
2313321|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313322|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2313323|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2313324|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
2313325|NCT00337948|Hematinics|hematinics|mesh-ancestor
2313326|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
2313327|NCT00338000|Hematinics|hematinics|mesh-ancestor
2313328|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2313329|NCT00338052|Norethindrone|norethindrone|mesh-list
2313330|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
2313331|NCT00338052|Estradiol|estradiol|mesh-list
2313332|NCT00338052|Estrogens|estrogens|mesh-ancestor
2313333|NCT00338052|Hormones|hormones|mesh-ancestor
2313334|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2313335|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313336|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2313337|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
2313338|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2313339|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2313340|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2313341|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2313342|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2313343|NCT00338091|Losartan|losartan|mesh-list
2313344|NCT00338091|Benazepril|benazepril|mesh-list
2313345|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2313346|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2313347|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2313348|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2313349|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313350|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2313351|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
2313352|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313353|NCT00338117|Galantamine|galantamine|mesh-list
2313354|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2313355|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313356|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313357|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
2313358|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108877|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2108878|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108879|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2108880|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2108881|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108882|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108883|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108884|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2108885|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2108886|NCT02511587|Vaccines|vaccines|mesh-list
2108887|NCT02511587|Immunologic Factors|immunologic factors|mesh-ancestor
2108888|NCT02511587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108889|NCT02512042|Brinzolamide|brinzolamide|mesh-list
2874214|NCT05065801|Folfirinox|folfirinox|mesh-list
2874215|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874216|NCT05052307|Vaccines|vaccines|mesh-list
2874217|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
2874218|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874219|NCT05051436|Tadalafil|tadalafil|mesh-list
2874220|NCT05051436|Mirabegron|mirabegron|mesh-list
2874221|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
2874222|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2874223|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2874224|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874225|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874226|NCT05051436|Urological Agents|urological agents|mesh-ancestor
2874227|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2874228|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2874229|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2874230|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
2874231|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2874232|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313359|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313360|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2313361|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
2313362|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313363|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
2313364|NCT00338130|Temozolomide|temozolomide|mesh-list
2313365|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2313366|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
2313367|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313368|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313369|NCT00338195|Caffeine|caffeine|mesh-list
2313370|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2313371|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313372|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2313373|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313374|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313375|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2313376|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2313377|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
2313378|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313379|NCT00338221|Glycine|glycine|mesh-list
2313380|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
2313381|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313382|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313383|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313384|NCT00338247|Capecitabine|capecitabine|mesh-list
2313385|NCT00338247|Lapatinib|lapatinib|mesh-list
2313386|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2313387|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
2313388|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313389|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313390|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2313391|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313392|NCT00338260|Atenolol|atenolol|mesh-list
2313393|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
2313394|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313395|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313396|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313397|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
2313398|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313399|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2313400|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2313401|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
2313402|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2313403|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2313404|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2874262|NCT05047172|Aspirin|aspirin|mesh-list
2874263|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
2874264|NCT05047172|Clopidogrel|clopidogrel|mesh-list
2874265|NCT05047172|Ticagrelor|ticagrelor|mesh-list
2874266|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2874267|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2874268|NCT05047172|Analgesics|analgesics|mesh-ancestor
2874269|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
2874270|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874271|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874272|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2874273|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2874274|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2874275|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2874276|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874277|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2874278|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2874279|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874280|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
2874281|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2874282|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2874283|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2874284|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
2874285|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2874286|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2874287|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
2874288|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2874289|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
2874290|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
2874291|NCT05041842|Trastuzumab|trastuzumab|mesh-list
2874292|NCT05041842|Pertuzumab|pertuzumab|mesh-list
2874293|NCT05041842|Tucatinib|tucatinib|mesh-list
2874294|NCT05041842|Hormones|hormones|mesh-list
2874295|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2874296|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874297|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2874298|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874299|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2874300|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874301|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874302|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
2874303|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313405|NCT00338273|Aripiprazole|aripiprazole|mesh-list
2313406|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
2313407|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2313408|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2313409|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2874320|NCT05035277|Aspirin|aspirin|mesh-list
2874321|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
2874322|NCT05035277|Apixaban|apixaban|mesh-list
2313410|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2313411|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313412|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
2313413|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
2313414|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313415|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874323|NCT05035277|Edoxaban|edoxaban|mesh-list
2874324|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2874325|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
2874326|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2874327|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
2874328|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874329|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874330|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
2874331|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2874332|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2874333|NCT05035277|Analgesics|analgesics|mesh-ancestor
2874334|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
2874335|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874336|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874337|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2874338|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2874339|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2874340|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2874341|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2874342|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2874343|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
2874344|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2874345|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2874367|NCT05022147|Dopamine|dopamine|mesh-list
2874368|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
2874369|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2874370|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
2874371|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
2874372|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874373|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874374|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
2874375|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2874376|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874377|NCT05022147|Protective Agents|protective agents|mesh-ancestor
2874382|NCT05011188|Antibodies|antibodies|mesh-list
2874383|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
2874384|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
2874385|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
2874386|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874390|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
2874391|NCT05005559|Paraproteins|paraproteins|mesh-list
2874392|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
2874393|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874394|NCT05003037|Carboplatin|carboplatin|mesh-list
2874395|NCT05003037|Pemetrexed|pemetrexed|mesh-list
2874396|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874397|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874398|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874399|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2874400|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2874401|NCT04996771|Cisplatin|cisplatin|mesh-list
2874402|NCT04996771|Etoposide|etoposide|mesh-list
2874403|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
2874404|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874405|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2874406|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2874407|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2874408|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874409|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313416|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2313417|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2313418|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
2313419|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2313420|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2313421|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2313422|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2313423|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
2313424|NCT00338299|Hematinics|hematinics|mesh-ancestor
2313425|NCT00338312|Testosterone|testosterone|mesh-list
2313426|NCT00338312|Androgens|androgens|mesh-ancestor
2313427|NCT00338312|Hormones|hormones|mesh-ancestor
2313428|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2313429|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313430|NCT00338338|Amlodipine|amlodipine|mesh-list
2313431|NCT00338338|Lacidipine|lacidipine|mesh-list
2313432|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2313433|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2313434|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2313435|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313436|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2313437|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313438|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
2313439|NCT00338377|Vidarabine|vidarabine|mesh-list
2313440|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
2313441|NCT00338377|Fludarabine|fludarabine|mesh-list
2313442|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
2313443|NCT00338377|Interleukin-2|interleukin-2|mesh-list
2313444|NCT00338377|Vaccines|vaccines|mesh-list
2313445|NCT00338377|Mesna|mesna|mesh-list
2313446|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2313447|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
2313448|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313449|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2313450|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2313451|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
2313452|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313453|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313454|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2874428|NCT04982029|Cannabidiol|cannabidiol|mesh-list
2874429|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
2874432|NCT04977232|Citalopram|citalopram|mesh-list
2874433|NCT04977232|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2874434|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2874435|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2874436|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874437|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313455|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2313456|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
2874438|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
2874439|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874440|NCT04977232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2874441|NCT04977232|Antidepressive Agents|antidepressive agents|mesh-ancestor
2874442|NCT04977232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2874443|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
2874444|NCT04976790|Analgesics|analgesics|mesh-ancestor
2874445|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
2874446|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874447|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874448|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2874449|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2874450|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2874451|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2874452|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2874453|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874454|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874455|NCT04974996|Prednisone|prednisone|mesh-list
2874456|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
2874457|NCT04974996|Rituximab|rituximab|mesh-list
2874458|NCT04974996|Doxorubicin|doxorubicin|mesh-list
2874459|NCT04974996|Vincristine|vincristine|mesh-list
2874460|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
2874461|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2874462|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
2874463|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874464|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2874465|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2874466|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
2874467|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874468|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874469|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2874470|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2874471|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2874472|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2874473|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2874474|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874475|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2874476|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
2874477|NCT04974996|Hormones|hormones|mesh-ancestor
2874478|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2874479|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2874480|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2874481|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
2874482|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
2874483|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
2874484|NCT04973930|Citalopram|citalopram|mesh-list
2874485|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2874486|NCT04973930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2874487|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2874488|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2874489|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874490|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2874491|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
2874492|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874493|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2313457|NCT00338377|Antiviral Agents|antiviral agents|mesh-ancestor
2313458|NCT00338377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313459|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2313460|NCT00338377|Analgesics|analgesics|mesh-ancestor
2313461|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
2313462|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874494|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
2874495|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2313463|NCT00338377|Protective Agents|protective agents|mesh-ancestor
2313464|NCT00338390|Lamivudine|lamivudine|mesh-list
2313465|NCT00338390|Abacavir|abacavir|mesh-list
2313466|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
2313467|NCT00338390|Didanosine|didanosine|mesh-list
2313468|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2313469|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2313470|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313471|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313472|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
2874496|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2874497|NCT04973670|Sivelestat|sivelestat|mesh-list
2874498|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2874499|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
2874500|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874501|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874502|NCT04969198|Nicotine|nicotine|mesh-list
2874503|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2874504|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
2874505|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874506|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874507|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2874508|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2874509|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
2874510|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2874511|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874512|NCT04954287|Vaccines|vaccines|mesh-list
2874513|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
2874514|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874515|NCT04952402|Vaccines|vaccines|mesh-list
2874516|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
2874517|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874523|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2874524|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2874525|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2874526|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874527|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874528|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2874529|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2874530|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874531|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
2874532|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2874540|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
2874541|NCT04944368|Paraproteins|paraproteins|mesh-list
2874542|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
2874543|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874544|NCT04940338|Dexamethasone|dexamethasone|mesh-list
2874545|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
2874546|NCT04940338|Bromfenac|bromfenac|mesh-list
2874547|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2874548|NCT04940338|BB 1101|bb 1101|mesh-list
2874549|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2874550|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
2874551|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
2874552|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874553|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313473|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313474|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2313475|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2313476|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
2874554|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2874555|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
2874556|NCT04940338|Hormones|hormones|mesh-ancestor
2874557|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2874558|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2874559|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874560|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
2874561|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874562|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874563|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2874564|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2874565|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2313477|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
2874566|NCT04940338|Analgesics|analgesics|mesh-ancestor
2874567|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
2874568|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2874569|NCT04937166|Azacitidine|azacitidine|mesh-list
2874570|NCT04937166|Venetoclax|venetoclax|mesh-list
2874571|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2874572|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
2874573|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874574|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874575|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313478|NCT00338416|Hematinics|hematinics|mesh-ancestor
2313479|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
2313480|NCT00338468|Hematinics|hematinics|mesh-ancestor
2313481|NCT00338481|Morphine|morphine|mesh-list
2313482|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2313483|NCT00338481|Narcotics|narcotics|mesh-ancestor
2313484|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2313485|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313486|NCT00338481|Analgesics|analgesics|mesh-ancestor
2313487|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
2313488|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313489|NCT00338494|Clofarabine|clofarabine|mesh-list
2313490|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2313491|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
2313492|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313493|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313494|NCT00338507|Erdosteine|erdosteine|mesh-list
2313495|NCT00338507|Expectorants|expectorants|mesh-ancestor
2313496|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
2313497|NCT00338546|Cocaine|cocaine|mesh-list
2313498|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
2313499|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2313500|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2313501|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313502|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2313503|NCT00338546|Analgesics|analgesics|mesh-ancestor
2313504|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
2313505|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313506|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2313507|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2313508|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2313509|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
2313510|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313511|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313512|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
2313513|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
2313514|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2313515|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2313516|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2313517|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2313518|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
2313519|NCT00338624|Oxybutynin|oxybutynin|mesh-list
2313520|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
2313521|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
2313522|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313523|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313524|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2874618|NCT04929041|Paclitaxel|paclitaxel|mesh-list
2874619|NCT04929041|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2874620|NCT04929041|Carboplatin|carboplatin|mesh-list
2874621|NCT04929041|Pembrolizumab|pembrolizumab|mesh-list
2874622|NCT04929041|Nivolumab|nivolumab|mesh-list
2874623|NCT04929041|Pemetrexed|pemetrexed|mesh-list
2874624|NCT04929041|Ipilimumab|ipilimumab|mesh-list
2874625|NCT04929041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2874626|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874627|NCT04929041|Tubulin Modulators|tubulin modulators|mesh-ancestor
2874628|NCT04929041|Antimitotic Agents|antimitotic agents|mesh-ancestor
2874629|NCT04929041|Mitosis Modulators|mitosis modulators|mesh-ancestor
2874630|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874631|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2874632|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2874633|NCT04929041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874634|NCT04929041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2874635|NCT04929041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2874636|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
2874637|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2874638|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874639|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2874640|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
2874641|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2874642|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2874643|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874644|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874645|NCT04926818|Ofatumumab|ofatumumab|mesh-list
2874646|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2874647|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2874648|NCT04926818|Siponimod|siponimod|mesh-list
2874649|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874650|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
2874651|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874652|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2874653|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874654|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2874690|NCT04911361|Dexamethasone|dexamethasone|mesh-list
2874691|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2874692|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
2874693|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
2874694|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874695|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874696|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2874697|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
2874698|NCT04911361|Hormones|hormones|mesh-ancestor
2874699|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2874700|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2874701|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874715|NCT04901689|Leronlimab|leronlimab|mesh-list
2874716|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2874717|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2874718|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874719|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2874720|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2874721|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
2874722|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2874723|NCT04901676|Leronlimab|leronlimab|mesh-list
2874724|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2874725|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2874726|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874727|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2874728|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2874729|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
2874730|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2874731|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2874732|NCT04899193|Hormones|hormones|mesh-ancestor
2874733|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2874734|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874740|NCT04895280|Triamcinolone|triamcinolone|mesh-list
2874741|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2874742|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2874743|NCT04895280|Ketorolac|ketorolac|mesh-list
2313525|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2313526|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
2313527|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313528|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313529|NCT00338624|Urological Agents|urological agents|mesh-ancestor
2313530|NCT00338650|Adalimumab|adalimumab|mesh-list
2313531|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2313532|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2313533|NCT00338754|Adalimumab|adalimumab|mesh-list
2313534|NCT00338754|Antibodies|antibodies|mesh-list
2874744|NCT04895280|Bupivacaine|bupivacaine|mesh-list
2874745|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2874746|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
2874747|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
2874748|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2874749|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874750|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
2874751|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874752|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2874753|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
2874754|NCT04895280|Hormones|hormones|mesh-ancestor
2874755|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2874756|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2313535|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2313536|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
2313537|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313538|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2313539|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2313540|NCT00338767|Fluoxetine|fluoxetine|mesh-list
2874757|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
2874758|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874759|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874760|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2874761|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2874762|NCT04895280|Analgesics|analgesics|mesh-ancestor
2874763|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2874764|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2874765|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2874766|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2874767|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2874768|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
2874779|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
2874780|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2874781|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313541|NCT00338767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2313542|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2313543|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2313544|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313545|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313546|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
2313547|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313548|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2313549|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
2313550|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2313551|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2313552|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2313553|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313554|NCT00338780|Lamivudine|lamivudine|mesh-list
2313555|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2313556|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2313557|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313558|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313559|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
2874782|NCT04870034|Palbociclib|palbociclib|mesh-list
2313560|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313561|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2313562|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2313563|NCT00338793|Prednisolone|prednisolone|mesh-list
2313564|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2313565|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
2313566|NCT00338793|Hormones|hormones|mesh-ancestor
2313567|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2313568|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874783|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874784|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2874785|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874786|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874787|NCT04869371|Prednisone|prednisone|mesh-list
2874788|NCT04869371|Docetaxel|docetaxel|mesh-list
2874789|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2874790|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874791|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
2874792|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
2874793|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
2874794|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874795|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2874796|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
2874797|NCT04869371|Hormones|hormones|mesh-ancestor
2874798|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2874799|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874800|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2874801|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
2874802|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2874803|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
2874804|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2874805|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2313569|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2313570|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313571|NCT00338910|Metronidazole|metronidazole|mesh-list
2313572|NCT00338910|Budesonide|budesonide|mesh-list
2313573|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2313574|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2313575|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
2313576|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313577|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313578|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2313579|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
2313580|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
2313581|NCT00338910|Hormones|hormones|mesh-ancestor
2874806|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
2874807|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2874808|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874809|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2874810|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874811|NCT04860518|Dexamethasone|dexamethasone|mesh-list
2874812|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2874813|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
2874814|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
2874815|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874816|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874817|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2874818|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
2874819|NCT04860518|Hormones|hormones|mesh-ancestor
2874820|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2874821|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2874822|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313582|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2313583|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313584|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2313585|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2313586|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2313587|NCT00338936|Valsartan|valsartan|mesh-list
2313588|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2313589|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2313590|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2313591|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2874835|NCT04817254|Nivolumab|nivolumab|mesh-list
2874836|NCT04817254|Ipilimumab|ipilimumab|mesh-list
2874837|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2313592|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313593|NCT00338936|Diuretics|diuretics|mesh-ancestor
2313594|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
2313595|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313596|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2313597|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2313598|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
2313599|NCT00339001|Hematinics|hematinics|mesh-ancestor
2313600|NCT00339014|Zonisamide|zonisamide|mesh-list
2313601|NCT00339014|Bupropion|bupropion|mesh-list
2313602|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2874838|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874839|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2874840|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874847|NCT04799288|Teriflunomide|teriflunomide|mesh-list
2874848|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2874849|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2874850|NCT04799288|Analgesics|analgesics|mesh-ancestor
2874851|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
2874852|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874853|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874854|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2874855|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2874856|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2874857|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
2874858|NCT04799249|Gemcitabine|gemcitabine|mesh-list
2874859|NCT04799249|Carboplatin|carboplatin|mesh-list
2874860|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874861|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2874862|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
2874863|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874864|NCT04799249|Antiviral Agents|antiviral agents|mesh-ancestor
2874865|NCT04799249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2874866|NCT04799249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874867|NCT04799249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2874868|NCT04799249|Immunologic Factors|immunologic factors|mesh-ancestor
2874869|NCT04799249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874873|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
2874874|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2313603|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
2313604|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2313605|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2313606|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2313607|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2313608|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313609|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
2313610|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313611|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313612|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2313613|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2313614|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313615|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
2874875|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874876|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2874877|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313616|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2313617|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2313618|NCT00339066|Sertraline|sertraline|mesh-list
2313619|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
2313620|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2313621|NCT00339066|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2313622|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2313623|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2313624|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313625|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313626|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
2313627|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313628|NCT00339118|Doxorubicin|doxorubicin|mesh-list
2313629|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
2313630|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2313631|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313632|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2874905|NCT04777357|Cariprazine|cariprazine|mesh-list
2874906|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2874907|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2874908|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2874909|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874910|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2874911|NCT04763928|Decitabine|decitabine|mesh-list
2874912|NCT04763928|Venetoclax|venetoclax|mesh-list
2874913|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2874914|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
2874915|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874916|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874917|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874918|NCT04761822|Vaccines|vaccines|mesh-list
2874919|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
2874920|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874921|NCT04749108|Folfirinox|folfirinox|mesh-list
2313633|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2313634|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313635|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313636|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2313637|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
2313638|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313639|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2313640|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2313641|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
2313642|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2874922|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874923|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
2313643|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2313644|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313645|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313646|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313647|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2313648|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2313649|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2874924|NCT04748224|Bupivacaine|bupivacaine|mesh-list
2874925|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
2874926|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
2874927|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2874928|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874929|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
2874930|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874931|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2874932|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2874933|NCT04748224|Analgesics|analgesics|mesh-ancestor
2874934|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2313650|NCT00339196|Azacitidine|azacitidine|mesh-list
2313651|NCT00339196|Tretinoin|tretinoin|mesh-list
2313652|NCT00339196|Valproic Acid|valproic acid|mesh-list
2313653|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2313654|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
2313655|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313656|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313657|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313658|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
2874935|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2874936|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2874937|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
2874938|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2874939|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874940|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2874941|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2874942|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874943|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874944|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
2874945|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874946|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2874947|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874948|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874949|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
2874950|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2874951|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874952|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2874953|NCT04724668|Melatonin|melatonin|mesh-list
2874954|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
2874955|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874956|NCT04724668|Protective Agents|protective agents|mesh-ancestor
2874957|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874958|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2874959|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
2874960|NCT04722848|Blinatumomab|blinatumomab|mesh-list
2874961|NCT04722848|Ponatinib|ponatinib|mesh-list
2874962|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2874963|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2874964|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313659|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
2313660|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
2313661|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
2313662|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313663|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313664|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
2313665|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2313666|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2313667|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2313668|NCT00339417|Ivermectin|ivermectin|mesh-list
2313669|NCT00339417|Albendazole|albendazole|mesh-list
2313670|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2313671|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313672|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
2313673|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
2313674|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2313675|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2874965|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874979|NCT04684511|Rofecoxib|rofecoxib|mesh-list
2874980|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2874981|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2874982|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2874983|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2874984|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2874985|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2874986|NCT04684511|Analgesics|analgesics|mesh-ancestor
2874987|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
2874988|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2874989|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2874990|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2874991|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2874995|NCT04682860|Scopolamine|scopolamine|mesh-list
2874996|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2874997|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2874998|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
2874999|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
2875000|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2875001|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875002|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2875003|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
2875004|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2875005|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
2875006|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2875007|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875008|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2875009|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
2875010|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2875011|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2875012|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2875013|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
2875014|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2875015|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2875016|NCT04669041|Ezetimibe|ezetimibe|mesh-list
2875017|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2875018|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2875019|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
2875020|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875021|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2875022|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2875023|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875024|NCT04666636|Mirabegron|mirabegron|mesh-list
2875025|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2875026|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2875027|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2875028|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
2875029|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2875030|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875031|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875032|NCT04666636|Urological Agents|urological agents|mesh-ancestor
2108890|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2875043|NCT04665856|Carboplatin|carboplatin|mesh-list
2875044|NCT04665856|Etoposide|etoposide|mesh-list
2875045|NCT04665856|Atezolizumab|atezolizumab|mesh-list
2875046|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875047|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2875048|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2875049|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2875050|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875051|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875052|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
2875053|NCT04664946|Protective Agents|protective agents|mesh-ancestor
2875054|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875055|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
2875056|NCT04664933|Protective Agents|protective agents|mesh-ancestor
2875057|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875088|NCT04654052|Clopidogrel|clopidogrel|mesh-list
2875089|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2875090|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2875091|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2875092|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2875093|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
2875094|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2875095|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875096|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875133|NCT04626128|Aflibercept|aflibercept|mesh-list
2875134|NCT04626128|Axitinib|axitinib|mesh-list
2875135|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875136|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2875137|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2875138|NCT04626128|Growth Substances|growth substances|mesh-ancestor
2875139|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875140|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
2875141|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2875142|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875143|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313676|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
2313677|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
2313678|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
2313679|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313680|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313681|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2313682|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313683|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2313684|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313685|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313686|NCT00339768|Amoxicillin|amoxicillin|mesh-list
2313687|NCT00339768|Omeprazole|omeprazole|mesh-list
2313688|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2313689|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313690|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2313691|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2313692|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2313693|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875155|NCT04621500|Vitamin D|vitamin d|mesh-list
2875156|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
2875157|NCT04621500|Vitamins|vitamins|mesh-ancestor
2875158|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
2875159|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875160|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2875161|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2875167|NCT04613453|Midazolam|midazolam|mesh-list
2313694|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875168|NCT04613453|Ketamine|ketamine|mesh-list
2875169|NCT04613453|Analgesics|analgesics|mesh-ancestor
2875170|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
2875171|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313695|NCT00340080|Abacavir|abacavir|mesh-list
2313696|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2313697|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2313698|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313699|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313700|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
2313701|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313702|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2313703|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2313704|NCT00340184|Paclitaxel|paclitaxel|mesh-list
2313705|NCT00340184|Carboplatin|carboplatin|mesh-list
2313706|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2875172|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875173|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2875174|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2875175|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
2875176|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
2875177|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2875178|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2875179|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2875180|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2875181|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875182|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2875183|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2875184|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2875185|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2875186|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2875187|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
2875188|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
2875189|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
2875190|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2875191|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875192|NCT04602507|Ivermectin|ivermectin|mesh-list
2875193|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2875194|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2875195|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
2875196|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2875197|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2875198|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2875199|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2875200|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875201|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
2313707|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313708|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
2313709|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
2313710|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
2313711|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313712|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2875202|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2875203|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875204|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2875205|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313713|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2313714|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2313715|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
2313716|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313717|NCT00340574|Antacids|antacids|mesh-ancestor
2313718|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313719|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2313720|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
2313721|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2313722|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313723|NCT00340691|Doxycycline|doxycycline|mesh-list
2313724|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2313725|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313726|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
2313727|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2313728|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2313729|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
2313730|NCT00341055|Hematinics|hematinics|mesh-ancestor
2313731|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2313732|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2313733|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
2313734|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313735|NCT00341250|Antacids|antacids|mesh-ancestor
2313736|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313737|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2313738|NCT00341432|Nicotine|nicotine|mesh-list
2313739|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2313740|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
2313741|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313742|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313743|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2313744|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2875229|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2875230|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2875231|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875232|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875244|NCT04552197|Tofacitinib|tofacitinib|mesh-list
2875245|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2875246|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875247|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313745|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
2313746|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313747|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313748|NCT00342381|Amifampridine|amifampridine|mesh-list
2313749|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2313750|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313751|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313752|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2313753|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2313754|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313755|NCT00342849|Succimer|succimer|mesh-list
2313756|NCT00342849|Antidotes|antidotes|mesh-ancestor
2313757|NCT00342849|Protective Agents|protective agents|mesh-ancestor
2313758|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313759|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
2313760|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
2313761|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313762|NCT00342862|Alefacept|alefacept|mesh-list
2313763|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
2313764|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
2313765|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313766|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2313767|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2313768|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
2313769|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313770|NCT00343005|Antacids|antacids|mesh-ancestor
2313771|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313772|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2313773|NCT00343070|Citalopram|citalopram|mesh-list
2313774|NCT00343070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2313775|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2313776|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2313777|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313778|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313779|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
2313780|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313781|NCT00343070|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2313782|NCT00343070|Antidepressive Agents|antidepressive agents|mesh-ancestor
2313783|NCT00343070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2313784|NCT00343096|Lorazepam|lorazepam|mesh-list
2313785|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
2313786|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
2875345|NCT04538664|Carboplatin|carboplatin|mesh-list
2875346|NCT04538664|Pemetrexed|pemetrexed|mesh-list
2313787|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
2313788|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313789|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313790|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2313791|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2313792|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2313793|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2313794|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2313795|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2313796|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
2875347|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
2875348|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875349|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875350|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875351|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2875352|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2875353|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2875354|NCT04537793|Ivacaftor|ivacaftor|mesh-list
2875355|NCT04537793|Elexacaftor|elexacaftor|mesh-list
2875356|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2875357|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2875358|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875359|NCT04533568|Ibuprofen|ibuprofen|mesh-list
2875360|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2875361|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2875362|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2875363|NCT04533568|Analgesics|analgesics|mesh-ancestor
2875364|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
2875365|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2875366|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875367|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2875368|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2875369|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2875370|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875371|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313797|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
2313798|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313799|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313800|NCT00343109|Sargramostim|sargramostim|mesh-list
2313801|NCT00343109|Vaccines|vaccines|mesh-list
2313802|NCT00343109|Immunologic Factors|immunologic factors|mesh-ancestor
2313803|NCT00343109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313804|NCT00343135|Amoxicillin|amoxicillin|mesh-list
2313805|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
2313806|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
2313807|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2313808|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2313809|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313810|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2313811|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313812|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313813|NCT00343161|Esomeprazole|esomeprazole|mesh-list
2313814|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2313815|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
2313816|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2313817|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2313818|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2313819|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313820|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313821|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2313822|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
2313823|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313824|NCT00343161|Antacids|antacids|mesh-ancestor
2313825|NCT00343174|Ancrod|ancrod|mesh-list
2313826|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
2313827|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2313828|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2313829|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313830|NCT00343187|Dapsone|dapsone|mesh-list
2313831|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313832|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
2313833|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2313834|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2313835|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2313836|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313837|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313838|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
2313839|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2313840|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
2313841|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313842|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
2313843|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2313844|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2313845|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313846|NCT00343200|Urological Agents|urological agents|mesh-ancestor
2875384|NCT04518228|Ritonavir|ritonavir|mesh-list
2875385|NCT04518228|Lopinavir|lopinavir|mesh-list
2875386|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2875387|NCT04518228|Darunavir|darunavir|mesh-list
2875388|NCT04518228|Tenofovir|tenofovir|mesh-list
2875389|NCT04518228|Dolutegravir|dolutegravir|mesh-list
2875390|NCT04518228|Cobicistat|cobicistat|mesh-list
2875391|NCT04518228|Cabotegravir|cabotegravir|mesh-list
2875392|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2875393|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2875394|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
2875395|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875396|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875397|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2875398|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2313847|NCT00343226|Basiliximab|basiliximab|mesh-list
2875399|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
2875400|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2875401|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2875402|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2875403|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2875404|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2875405|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2875406|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2875407|NCT04511078|Panitumumab|panitumumab|mesh-list
2875408|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2875409|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875410|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
2875411|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2875412|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2875413|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875414|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2875415|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
2875416|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875417|NCT04508634|Metformin|metformin|mesh-list
2875418|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2875419|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875420|NCT04507373|Simvastatin|simvastatin|mesh-list
2875421|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2875422|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2875423|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
2875424|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875425|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2875426|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2875427|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875428|NCT04501653|Methylphenidate|methylphenidate|mesh-list
2313848|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2313849|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
2313850|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313851|NCT00343239|Docetaxel|docetaxel|mesh-list
2313852|NCT00343239|Fluorouracil|fluorouracil|mesh-list
2313853|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313854|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
2313855|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
2313856|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
2313857|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313858|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
2313859|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2313860|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2313861|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
2313862|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313863|NCT00343265|Progesterone|progesterone|mesh-list
2313864|NCT00343265|Progestins|progestins|mesh-ancestor
2313865|NCT00343265|Hormones|hormones|mesh-ancestor
2313866|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2875429|NCT04501653|Psilocybin|psilocybin|mesh-list
2875430|NCT04501653|Psilocin|psilocin|mesh-list
2875431|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2875432|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875433|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2875434|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2875435|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2875436|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875437|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
2875438|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2875439|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
2875440|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2313867|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313868|NCT00343278|Valacyclovir|valacyclovir|mesh-list
2313869|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
2313870|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313871|NCT00343317|Cefoxitin|cefoxitin|mesh-list
2313872|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2313873|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313874|NCT00343369|Cytarabine|cytarabine|mesh-list
2313875|NCT00343369|Dexamethasone|dexamethasone|mesh-list
2313876|NCT00343369|Prednisolone|prednisolone|mesh-list
2313877|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
2313878|NCT00343369|Doxorubicin|doxorubicin|mesh-list
2313879|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2313880|NCT00343369|Methotrexate|methotrexate|mesh-list
2313881|NCT00343369|Vincristine|vincristine|mesh-list
2313882|NCT00343369|Daunorubicin|daunorubicin|mesh-list
2313883|NCT00343369|Asparaginase|asparaginase|mesh-list
2313884|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
2313885|NCT00343369|Thioguanine|thioguanine|mesh-list
2875465|NCT04481009|Gemcitabine|gemcitabine|mesh-list
2875466|NCT04481009|Paclitaxel|paclitaxel|mesh-list
2875467|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2875468|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875469|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
2875470|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
2875471|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
2875472|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875473|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2875474|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
2875475|NCT04481009|Antiviral Agents|antiviral agents|mesh-ancestor
2875476|NCT04481009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2875477|NCT04481009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875478|NCT04481009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2875479|NCT04481009|Immunologic Factors|immunologic factors|mesh-ancestor
2875480|NCT04481009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313886|NCT00343369|Pegaspargase|pegaspargase|mesh-list
2313887|NCT00343369|Teniposide|teniposide|mesh-list
2313888|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2313889|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
2313890|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313891|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2313892|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2313893|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
2313894|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313895|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875500|NCT04475731|Ponatinib|ponatinib|mesh-list
2313896|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2313897|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2313898|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
2313899|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
2313900|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313901|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2313902|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
2313903|NCT00343369|Hormones|hormones|mesh-ancestor
2313904|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2875501|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875502|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2875503|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875504|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875505|NCT04469491|Interferons|interferons|mesh-list
2313905|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2313906|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2313907|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2313908|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2313909|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313910|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2313911|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
2313912|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2313913|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2313914|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
2313915|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
2313916|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2313917|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2875506|NCT04469491|Interferon Type I|interferon type i|mesh-list
2875507|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875508|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
2875509|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2875514|NCT04410445|Nivolumab|nivolumab|mesh-list
2875515|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2875516|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875517|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2875518|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313918|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
2313919|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313920|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2313921|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
2313922|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
2313923|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
2313924|NCT00343408|Leucovorin|leucovorin|mesh-list
2313925|NCT00343408|Gemcitabine|gemcitabine|mesh-list
2313926|NCT00343408|Fluorouracil|fluorouracil|mesh-list
2313927|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
2313928|NCT00343408|Cediranib|cediranib|mesh-list
2313929|NCT00343408|Calcium|calcium|mesh-list
2313930|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
2313931|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313932|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2313933|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
2313934|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313935|NCT00343408|Antiviral Agents|antiviral agents|mesh-ancestor
2313936|NCT00343408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2313937|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313938|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2313939|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
2313940|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313941|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2313942|NCT00343408|Antidotes|antidotes|mesh-ancestor
2313943|NCT00343408|Protective Agents|protective agents|mesh-ancestor
2313944|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
2313945|NCT00343408|Vitamins|vitamins|mesh-ancestor
2313946|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
2313947|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2313948|NCT00343421|Vaccines|vaccines|mesh-list
2313949|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2313950|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
2313951|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313952|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
2313953|NCT00343447|Rituximab|rituximab|mesh-list
2313954|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2875526|NCT04398524|Cemiplimab|cemiplimab|mesh-list
2875527|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2875528|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875529|NCT04397354|Dexamethasone|dexamethasone|mesh-list
2875530|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
2875531|NCT04397354|BB 1101|bb 1101|mesh-list
2108891|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108892|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108893|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
2108894|NCT02512302|Bromides|bromides|mesh-list
2108895|NCT02512302|Charcoal|charcoal|mesh-list
2108896|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
2108897|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2108898|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2108899|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2108900|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
2108901|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108902|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108903|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108904|NCT02512302|Antidotes|antidotes|mesh-ancestor
2108905|NCT02512302|Protective Agents|protective agents|mesh-ancestor
2108906|NCT02512575|Prednisolone|prednisolone|mesh-list
2108907|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2108908|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
2108909|NCT02512575|Hormones|hormones|mesh-ancestor
2108910|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2875532|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2875533|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
2875534|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
2875535|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2875536|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875537|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2875538|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
2875539|NCT04397354|Hormones|hormones|mesh-ancestor
2875540|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2875541|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2875542|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875543|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
2875544|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875545|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875546|NCT04394481|Dexamethasone|dexamethasone|mesh-list
2875547|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
2875548|NCT04394481|Ropivacaine|ropivacaine|mesh-list
2875549|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2875550|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
2875551|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
2875552|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2875553|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875554|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2875555|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
2875556|NCT04394481|Hormones|hormones|mesh-ancestor
2875557|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2875558|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2875559|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875560|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2875561|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2875562|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2875563|NCT04394481|Analgesics|analgesics|mesh-ancestor
2875564|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
2875565|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2875566|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2875567|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2875568|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
2875569|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2875570|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875571|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
2875572|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
2313955|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
2313956|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313957|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2313958|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2313959|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
2313960|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313961|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313962|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2313963|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2313964|NCT00343486|Solabegron|solabegron|mesh-list
2313965|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2313966|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2875590|NCT04370847|Ephedrine|ephedrine|mesh-list
2313967|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2313968|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
2313969|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2313970|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313971|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875591|NCT04370847|Fentanyl|fentanyl|mesh-list
2875592|NCT04370847|Bupivacaine|bupivacaine|mesh-list
2875593|NCT04370847|Oxytocin|oxytocin|mesh-list
2875594|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
2875595|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
2875596|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2875597|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875598|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
2875599|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2875600|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2875601|NCT04370847|Narcotics|narcotics|mesh-ancestor
2875602|NCT04370847|Analgesics|analgesics|mesh-ancestor
2875603|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2875604|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2313972|NCT00343499|Valsartan|valsartan|mesh-list
2313973|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2313974|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2875605|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
2875606|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
2875607|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2875608|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2875609|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
2875610|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
2875611|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2875612|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
2875613|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2875614|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875629|NCT04356430|Prednisone|prednisone|mesh-list
2875630|NCT04356430|Goserelin|goserelin|mesh-list
2875631|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
2875632|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2875633|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
2875634|NCT04356430|Hormones|hormones|mesh-ancestor
2875635|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2875636|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875637|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2875638|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875639|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2875640|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875641|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875642|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
2875643|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2875644|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
2875645|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
2313975|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2313976|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313977|NCT00343525|Bavituximab|bavituximab|mesh-list
2313978|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2313979|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313980|NCT00343629|Sulindac|sulindac|mesh-list
2313981|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2313982|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2313983|NCT00343629|Analgesics|analgesics|mesh-ancestor
2313984|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
2313985|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2313986|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2313987|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2313988|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2313989|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2313990|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2313991|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2313992|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875646|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2875647|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2875648|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2875649|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875650|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875651|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2313993|NCT00343655|Atorvastatin|atorvastatin|mesh-list
2313994|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2313995|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2313996|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
2313997|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2313998|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2875687|NCT04335669|Paclitaxel|paclitaxel|mesh-list
2875688|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2875689|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
2875690|NCT04335669|Carboplatin|carboplatin|mesh-list
2875691|NCT04335669|Capecitabine|capecitabine|mesh-list
2875692|NCT04335669|Epirubicin|epirubicin|mesh-list
2875693|NCT04335669|Taxane|taxane|mesh-list
2875694|NCT04335669|Antimetabolites|antimetabolites|mesh-list
2875695|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2875696|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875697|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
2875698|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
2875699|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
2875700|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875701|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2875702|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
2875703|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875704|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2875705|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2313999|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2314000|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314001|NCT00343668|Irinotecan|irinotecan|mesh-list
2314002|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2314003|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2314004|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314005|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314006|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314007|NCT00343707|Paroxetine|paroxetine|mesh-list
2314008|NCT00343707|Vestipitant|vestipitant|mesh-list
2314009|NCT00343707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2314010|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2314011|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2314012|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314013|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2314014|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
2314015|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314016|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2314017|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
2314018|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2314019|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2875706|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
2108911|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108912|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2108913|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108914|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
2108915|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2108916|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
2108917|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108918|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2875707|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2875708|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2875709|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2875710|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2875711|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2875712|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875713|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
2875714|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2875715|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2875716|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2875717|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2875718|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875719|NCT04323189|Incretins|incretins|mesh-ancestor
2875720|NCT04323189|Hormones|hormones|mesh-ancestor
2875721|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2875722|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2875723|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
2875724|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875725|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875726|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
2875727|NCT04313153|Hematinics|hematinics|mesh-ancestor
2875739|NCT04286295|Nicotine|nicotine|mesh-list
2875740|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2875741|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
2875742|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2875743|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875744|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2875745|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2875746|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
2875747|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2875748|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875749|NCT04282811|Venetoclax|venetoclax|mesh-list
2875750|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875751|NCT04279197|Ascorbic Acid|ascorbic acid|mesh-list
2875752|NCT04279197|Vitamins|vitamins|mesh-ancestor
2875753|NCT04279197|Micronutrients|micronutrients|mesh-ancestor
2875754|NCT04279197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875755|NCT04279197|Antioxidants|antioxidants|mesh-ancestor
2875756|NCT04279197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875757|NCT04279197|Protective Agents|protective agents|mesh-ancestor
2875758|NCT04274426|Gemcitabine|gemcitabine|mesh-list
2875759|NCT04274426|Paclitaxel|paclitaxel|mesh-list
2875760|NCT04274426|Maytansine|maytansine|mesh-list
2875761|NCT04274426|Carboplatin|carboplatin|mesh-list
2875762|NCT04274426|Doxorubicin|doxorubicin|mesh-list
2875763|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2875764|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2875765|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875766|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
2875767|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
2875768|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
2875769|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875770|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2875771|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
2875772|NCT04274426|Antiviral Agents|antiviral agents|mesh-ancestor
2875773|NCT04274426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2875774|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314020|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2314021|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314022|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2314023|NCT00343720|Bortezomib|bortezomib|mesh-list
2875775|NCT04274426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2875776|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
2875777|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875778|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2875779|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2875780|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2875781|NCT04272242|Pyridoxine|pyridoxine|mesh-list
2875782|NCT04272242|Pyridoxal|pyridoxal|mesh-list
2875783|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
2875784|NCT04272242|Isoniazid|isoniazid|mesh-list
2875785|NCT04272242|Rifapentine|rifapentine|mesh-list
2875786|NCT04272242|Dolutegravir|dolutegravir|mesh-list
2875787|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2875788|NCT04272242|Vitamins|vitamins|mesh-ancestor
2875789|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
2875790|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875791|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
2875792|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
2875793|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2875794|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2875795|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2875796|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2875797|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
2875798|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875799|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2875800|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2875801|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2875802|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314024|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314025|NCT00343733|Fentanyl|fentanyl|mesh-list
2314026|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2314027|NCT00343733|Narcotics|narcotics|mesh-ancestor
2314028|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2875803|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2875804|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
2875805|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2875806|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
2875812|NCT04256421|Carboplatin|carboplatin|mesh-list
2875813|NCT04256421|Etoposide|etoposide|mesh-list
2875814|NCT04256421|Atezolizumab|atezolizumab|mesh-list
2875815|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875816|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2875817|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2875818|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2875819|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875820|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875821|NCT04251065|Daratumumab|daratumumab|mesh-list
2875822|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875830|NCT04245085|Paclitaxel|paclitaxel|mesh-list
2875831|NCT04245085|Bevacizumab|bevacizumab|mesh-list
2875832|NCT04245085|Carboplatin|carboplatin|mesh-list
2875833|NCT04245085|Pemetrexed|pemetrexed|mesh-list
2875834|NCT04245085|Atezolizumab|atezolizumab|mesh-list
2875835|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2875836|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875837|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
2875838|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
2875839|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
2875840|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875841|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2875842|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2875843|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2875844|NCT04245085|Growth Substances|growth substances|mesh-ancestor
2875845|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875846|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
2875847|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875848|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2875849|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2875850|NCT04235855|Liver Extracts|liver extracts|mesh-list
2875851|NCT04235855|Hematinics|hematinics|mesh-ancestor
2875852|NCT04234945|Doxycycline|doxycycline|mesh-list
2875853|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2875854|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2875855|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
2875856|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2875857|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2875858|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
2875859|NCT04234906|Amiodarone|amiodarone|mesh-list
2875860|NCT04234906|Procainamide|procainamide|mesh-list
2875861|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
2875862|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2875863|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2875864|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875865|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2314029|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314030|NCT00343733|Analgesics|analgesics|mesh-ancestor
2314031|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
2314032|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314033|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2875866|NCT04234906|Analgesics|analgesics|mesh-ancestor
2875867|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
2875868|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2875869|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2314034|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2314035|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
2314036|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
2314037|NCT00343759|Lapatinib|lapatinib|mesh-list
2314038|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314039|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2314040|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314041|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314042|NCT00343798|Cyclosporine|cyclosporine|mesh-list
2875870|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2875871|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2875872|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
2875873|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2875874|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875875|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
2875876|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2875877|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
2875878|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2875879|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2875880|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2875881|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
2875882|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2875883|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
2875884|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2875885|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2875886|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2875887|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2875888|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875889|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2875890|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2875891|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2875892|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2875894|NCT04209543|Progesterone|progesterone|mesh-list
2875895|NCT04209543|Progestins|progestins|mesh-ancestor
2314043|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
2314044|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
2314045|NCT00343798|Fludarabine|fludarabine|mesh-list
2314046|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
2314047|NCT00343798|Cyclosporins|cyclosporins|mesh-list
2314048|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314049|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
2314050|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314051|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2314052|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2314053|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
2314054|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314055|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314056|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2314057|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2314058|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
2314059|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875896|NCT04209543|Hormones|hormones|mesh-ancestor
2875897|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2875898|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875907|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
2875908|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2875909|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
2875910|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314060|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
2875918|NCT04192370|Cannabidiol|cannabidiol|mesh-list
2875919|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
2875920|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
2875921|NCT04188028|Paroxetine|paroxetine|mesh-list
2875922|NCT04188028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2875923|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2875924|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2875925|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875926|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2875927|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
2875928|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875929|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2875930|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
2875931|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2875932|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2875933|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2875934|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875935|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
2875936|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
2875937|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2875938|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2875939|NCT04174612|Cytarabine|cytarabine|mesh-list
2875940|NCT04174612|Daunorubicin|daunorubicin|mesh-list
2875941|NCT04174612|Midostaurin|midostaurin|mesh-list
2875942|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2875943|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
2875944|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875945|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875946|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
2875947|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2875948|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2875949|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
2875950|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875951|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2875952|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2875953|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2875954|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875955|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2314061|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314062|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
2314063|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2875972|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
2875973|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2875974|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2875975|NCT04154800|Itraconazole|itraconazole|mesh-list
2875976|NCT04154800|Diltiazem|diltiazem|mesh-list
2875977|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
2875978|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2875979|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2875980|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2875981|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2875982|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2875983|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2875984|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
2875985|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2875986|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2875987|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2875988|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2875989|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2875990|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2875991|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2875992|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
2876002|NCT04141696|Midazolam|midazolam|mesh-list
2876003|NCT04141696|Ketamine|ketamine|mesh-list
2876004|NCT04141696|Analgesics|analgesics|mesh-ancestor
2876005|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
2876006|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2876007|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314064|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2314065|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2314066|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
2314067|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2314068|NCT00343811|Modafinil|modafinil|mesh-list
2314069|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2314070|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314071|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2314072|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2314073|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2314074|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314075|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2876008|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2876009|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2876010|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
2876011|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
2876012|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2876013|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2876014|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2876015|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2876016|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876017|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2876018|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2876019|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2876020|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2876021|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2876022|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
2876023|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
2314076|NCT00343824|Laxatives|laxatives|mesh-ancestor
2314077|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2314078|NCT00343850|Mesalamine|mesalamine|mesh-list
2876036|NCT04127968|Vitamin A|vitamin a|mesh-list
2876037|NCT04127968|Vitamins|vitamins|mesh-ancestor
2876038|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
2876039|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314079|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2314080|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2314081|NCT00343850|Analgesics|analgesics|mesh-ancestor
2876065|NCT04076059|Androgens|androgens|mesh-list
2876066|NCT04076059|Hormones|hormones|mesh-ancestor
2876067|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2876068|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876069|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
2876070|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2876071|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876072|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2876073|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876086|NCT04056962|Tacrolimus|tacrolimus|mesh-list
2314082|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
2314083|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314084|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314085|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2314086|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2314087|NCT00343876|Aspirin|aspirin|mesh-list
2314088|NCT00343876|Clopidogrel|clopidogrel|mesh-list
2314089|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2314090|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2314091|NCT00343876|Analgesics|analgesics|mesh-ancestor
2314092|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
2314093|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314094|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314095|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2314096|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2314097|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2314098|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2876087|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2876088|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
2876089|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876090|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2314099|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314100|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2314101|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2314102|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314103|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
2314104|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2314105|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2314106|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2314107|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
2314108|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2876091|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876092|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876096|NCT04051268|Vaccines|vaccines|mesh-list
2876097|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
2876098|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876099|NCT04045665|Anticoagulants|anticoagulants|mesh-list
2876100|NCT04038515|Menthol|menthol|mesh-list
2876101|NCT04038515|Nicotine|nicotine|mesh-list
2314109|NCT00343980|Insulin|insulin|mesh-list
2314110|NCT00343980|Glimepiride|glimepiride|mesh-list
2314111|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
2314112|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2314113|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2314114|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314115|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2314116|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314117|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
2314118|NCT00344006|Artesunate|artesunate|mesh-list
2314119|NCT00344006|Lumefantrine|lumefantrine|mesh-list
2314120|NCT00344006|Artemether|artemether|mesh-list
2314121|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2314122|NCT00344006|Dapsone|dapsone|mesh-list
2314123|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
2314124|NCT00344006|Proguanil|proguanil|mesh-list
2314125|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
2314126|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2314127|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2314128|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314129|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314130|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
2314131|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
2314132|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2876102|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2876103|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
2876104|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2876105|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876106|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2876107|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2876108|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
2876109|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2876110|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876111|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
2876112|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
2314133|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
2314134|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2314135|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314136|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314137|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
2314138|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2314139|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
2314140|NCT00344045|Acetaminophen|acetaminophen|mesh-list
2314141|NCT00344045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2876130|NCT04031508|SMOFlipid|smoflipid|mesh-list
2876131|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2876132|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2876133|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2314142|NCT00344045|Analgesics|analgesics|mesh-ancestor
2314143|NCT00344045|Sensory System Agents|sensory system agents|mesh-ancestor
2876134|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
2876135|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876136|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876143|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2876144|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2876145|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876146|NCT04017832|Incretins|incretins|mesh-ancestor
2876147|NCT04017832|Hormones|hormones|mesh-ancestor
2876148|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2876149|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2876150|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
2876151|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876152|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876153|NCT04006522|Atezolizumab|atezolizumab|mesh-list
2876154|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876155|NCT04002947|Rituximab|rituximab|mesh-list
2876156|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
2876157|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876158|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876159|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
2314144|NCT00344045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314145|NCT00344045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314146|NCT00344045|Antipyretics|antipyretics|mesh-ancestor
2314147|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
2314148|NCT00344058|Analgesics|analgesics|mesh-ancestor
2314149|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
2314150|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314151|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314152|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
2314153|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2876160|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876161|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2876162|NCT03965091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2876163|NCT03965091|Immunologic Factors|immunologic factors|mesh-ancestor
2876164|NCT03965091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314154|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2314155|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
2314156|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2314157|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2314158|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876186|NCT03945825|Vaccines|vaccines|mesh-list
2876187|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
2876188|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876189|NCT03942419|Atropine|atropine|mesh-list
2876190|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2876191|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2876192|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2876193|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2876194|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2876195|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
2876196|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2876197|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876198|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2876199|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
2876200|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
2876201|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
2876202|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2876203|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2876204|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
2876205|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2876206|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314159|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2314160|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
2314161|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2314162|NCT00344123|Ritonavir|ritonavir|mesh-list
2314163|NCT00344123|Tipranavir|tipranavir|mesh-list
2314164|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2314165|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2314166|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2314167|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
2314168|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314169|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314170|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2314171|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2314172|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
2314173|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314174|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2314175|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2314176|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2314177|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2314178|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
2314179|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2314180|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2314181|NCT00344149|Rituximab|rituximab|mesh-list
2314182|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2314183|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314184|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
2314185|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314186|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2314187|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2314188|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
2314189|NCT00344201|Coagulants|coagulants|mesh-ancestor
2314190|NCT00344227|Ranibizumab|ranibizumab|mesh-list
2314191|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2314192|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2314193|NCT00344227|Growth Substances|growth substances|mesh-ancestor
2314194|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314195|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
2314196|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314197|NCT00344253|Interferons|interferons|mesh-list
2314198|NCT00344253|Interferon-beta|interferon-beta|mesh-list
2314199|NCT00344253|Methotrexate|methotrexate|mesh-list
2314200|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2314201|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
2314202|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2314203|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314204|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2314205|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
2314206|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314207|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314208|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
2314209|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314210|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2314211|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314212|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
2314213|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2314214|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2314215|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
2314216|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314217|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2314218|NCT00344383|Norgestimate|norgestimate|mesh-list
2314219|NCT00344383|Estradiol|estradiol|mesh-list
2314220|NCT00344383|Estrogens|estrogens|mesh-ancestor
2314221|NCT00344383|Hormones|hormones|mesh-ancestor
2314222|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2314223|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314224|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2314225|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
2314226|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2314227|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2314228|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2314229|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2314230|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2314231|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
2314232|NCT00344409|Hematinics|hematinics|mesh-ancestor
2314233|NCT00344422|Dexamethasone|dexamethasone|mesh-list
2314234|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
2314235|NCT00344422|Doxorubicin|doxorubicin|mesh-list
2314236|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2314237|NCT00344422|Vincristine|vincristine|mesh-list
2314238|NCT00344422|BB 1101|bb 1101|mesh-list
2314239|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2314240|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
2314241|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
2314242|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314243|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314244|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2314245|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
2314246|NCT00344422|Hormones|hormones|mesh-ancestor
2314247|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2314248|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2314249|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314250|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
2314251|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314252|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314253|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2314254|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2314255|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2314256|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2314257|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
2314258|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
2876286|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
2876287|NCT03889418|Narcotics|narcotics|mesh-ancestor
2876288|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2876289|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876290|NCT03889418|Analgesics|analgesics|mesh-ancestor
2876291|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
2876292|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2876293|NCT03877354|Anesthetics|anesthetics|mesh-list
2876294|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2876295|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876313|NCT03828201|Levofloxacin|levofloxacin|mesh-list
2876314|NCT03828201|Ofloxacin|ofloxacin|mesh-list
2876315|NCT03828201|Linezolid|linezolid|mesh-list
2876316|NCT03828201|Bedaquiline|bedaquiline|mesh-list
2876317|NCT03828201|Clofazimine|clofazimine|mesh-list
2876318|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2876319|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2876320|NCT03828201|Renal Agents|renal agents|mesh-ancestor
2876321|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2876322|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2876323|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2314259|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
2314260|NCT00344513|Carvedilol|carvedilol|mesh-list
2314261|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2314262|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2314263|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2314264|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
2314265|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2314266|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314267|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314268|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2314269|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
2314270|NCT00344513|Protective Agents|protective agents|mesh-ancestor
2314271|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2314272|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2314273|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2314274|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
2314275|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2314276|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2314277|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
2314278|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314279|NCT00344526|Dexamethasone|dexamethasone|mesh-list
2314280|NCT00344526|Melphalan|melphalan|mesh-list
2314281|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2314282|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
2314283|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
2876324|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876325|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876326|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876327|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2876328|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2876329|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2876330|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
2876331|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2876332|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
2314284|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314285|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314286|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2314287|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
2314288|NCT00344526|Hormones|hormones|mesh-ancestor
2314289|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2314290|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2314291|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314292|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2314293|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
2314294|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314295|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2314296|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314297|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
2314298|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2314299|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2314300|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
2314301|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314302|NCT00344539|Antacids|antacids|mesh-ancestor
2314303|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314304|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2314305|NCT00344552|Paclitaxel|paclitaxel|mesh-list
2314306|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2314307|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314308|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
2314309|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
2314310|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
2314311|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314312|NCT00344565|Modafinil|modafinil|mesh-list
2314313|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2314314|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314315|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2314316|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2314317|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2314318|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314319|NCT00344617|Bevacizumab|bevacizumab|mesh-list
2314320|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2314321|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314322|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2314323|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2314324|NCT00344617|Growth Substances|growth substances|mesh-ancestor
2314325|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314326|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
2314327|NCT00344669|Albendazole|albendazole|mesh-list
2876371|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
2876372|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876373|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876401|NCT03733925|Golimumab|golimumab|mesh-list
2876402|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2876403|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2876404|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2876405|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
2876406|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876407|NCT03733314|Quetmolimab|quetmolimab|mesh-list
2876408|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2876429|NCT03670355|Tenofovir|tenofovir|mesh-list
2314328|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
2314329|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2314330|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314331|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
2314332|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2314333|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2314334|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
2314335|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
2314336|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
2314337|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314338|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314339|NCT00344695|Bupropion|bupropion|mesh-list
2876430|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
2876431|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2876432|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2876433|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2876434|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876435|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876436|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2876437|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2876438|NCT03668392|Asparaginase|asparaginase|mesh-list
2876439|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876440|NCT03662542|Golimumab|golimumab|mesh-list
2876441|NCT03662542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2876442|NCT03662542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2876443|NCT03662542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2876444|NCT03662542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2876445|NCT03662542|Immunologic Factors|immunologic factors|mesh-ancestor
2876446|NCT03662542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314340|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2314341|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
2314342|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2314343|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2314344|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2314345|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2314346|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314347|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
2314348|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2314349|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314350|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2314351|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2314352|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314353|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2314354|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314355|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314356|NCT00344760|Tenofovir|tenofovir|mesh-list
2314357|NCT00344760|Lamivudine|lamivudine|mesh-list
2314358|NCT00344760|Efavirenz|efavirenz|mesh-list
2314359|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
2314360|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
2314361|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314362|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2314363|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2314364|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876462|NCT03659578|Thymalfasin|thymalfasin|mesh-list
2876463|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2876464|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
2876465|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314365|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314366|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2314367|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2314368|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2314369|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2314370|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2314371|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2314372|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2314373|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2314374|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2314375|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2108919|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2108920|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
2108921|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108922|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2108923|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2108924|NCT02512783|Lidocaine|lidocaine|mesh-list
2108925|NCT02512783|Propofol|propofol|mesh-list
2108926|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
2108927|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
2108928|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108929|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108930|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
2108931|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108932|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2108933|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2108934|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2314376|NCT00344812|Buprenorphine|buprenorphine|mesh-list
2314377|NCT00344812|Methadone|methadone|mesh-list
2314378|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2314379|NCT00344812|Narcotics|narcotics|mesh-ancestor
2314380|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2314381|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314382|NCT00344812|Analgesics|analgesics|mesh-ancestor
2314383|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
2314384|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314385|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2314386|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
2314387|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
2314388|NCT00344825|Fludarabine|fludarabine|mesh-list
2314389|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
2314390|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
2314391|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876512|NCT03629873|Cytarabine|cytarabine|mesh-list
2876513|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
2314392|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2314393|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
2314394|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314395|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314396|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
2314397|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314398|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2314399|NCT00344851|Metformin|metformin|mesh-list
2314400|NCT00344851|Exenatide|exenatide|mesh-list
2876514|NCT03629873|Carmustine|carmustine|mesh-list
2876515|NCT03629873|Etoposide|etoposide|mesh-list
2876516|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2876517|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
2314401|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2314402|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314403|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2314404|NCT00344851|Incretins|incretins|mesh-ancestor
2314405|NCT00344851|Hormones|hormones|mesh-ancestor
2314406|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2314407|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2314408|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108935|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2108936|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314409|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876518|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876519|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2876520|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2876521|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
2876522|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876523|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876524|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2876525|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2876526|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2876527|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2876528|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314410|NCT00344942|Triamcinolone|triamcinolone|mesh-list
2314411|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2314412|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2314413|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2314414|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2314415|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
2314416|NCT00344942|Hormones|hormones|mesh-ancestor
2314417|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2314418|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314419|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314420|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
2876529|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2876530|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
2876531|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
2876532|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2876533|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2876534|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876535|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876536|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2876537|NCT03608865|Durvalumab|durvalumab|mesh-list
2876538|NCT03608865|Tremelimumab|tremelimumab|mesh-list
2876539|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876540|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876554|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
2876555|NCT03602235|Melphalan|melphalan|mesh-list
2876556|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2876557|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
2314421|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314422|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314423|NCT00344955|Atorvastatin|atorvastatin|mesh-list
2314424|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2314425|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2314426|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
2314427|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314428|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2314429|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2314430|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314431|NCT00344981|Tenofovir|tenofovir|mesh-list
2314432|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
2314433|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
2314434|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314435|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2314436|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2314437|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314438|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314439|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2314440|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2314441|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314442|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
2314443|NCT00344994|Pramipexole|pramipexole|mesh-list
2314444|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
2876558|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876559|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876560|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2876561|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2876562|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
2876563|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314445|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314446|NCT00344994|Protective Agents|protective agents|mesh-ancestor
2314447|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314448|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2876564|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
2314449|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2876565|NCT03602235|Protective Agents|protective agents|mesh-ancestor
2876566|NCT03602235|Vitamins|vitamins|mesh-ancestor
2876567|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
2876574|NCT03583307|Sirolimus|sirolimus|mesh-list
2876575|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2876576|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2876577|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2876578|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876579|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
2876580|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2876581|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
2876582|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876586|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
2876587|NCT03560193|Ethanol|ethanol|mesh-list
2876588|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
2876589|NCT03560193|Povidone|povidone|mesh-list
2876590|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2876591|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2876592|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
2876593|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2876594|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876595|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
2876596|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
2876597|NCT03557281|GSK656|gsk656|mesh-list
2876598|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2876599|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2876600|NCT03557242|Aspirin|aspirin|mesh-list
2876601|NCT03557242|Warfarin|warfarin|mesh-list
2876602|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2876603|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2876604|NCT03557242|Analgesics|analgesics|mesh-ancestor
2876605|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
2314450|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
2314451|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
2314452|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2314453|NCT00345059|Gemcitabine|gemcitabine|mesh-list
2314454|NCT00345059|Capecitabine|capecitabine|mesh-list
2314455|NCT00345059|Docetaxel|docetaxel|mesh-list
2314456|NCT00345059|Vinorelbine|vinorelbine|mesh-list
2314457|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2314458|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
2314459|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314460|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314461|NCT00345059|Antiviral Agents|antiviral agents|mesh-ancestor
2314462|NCT00345059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314463|NCT00345059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314464|NCT00345059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314465|NCT00345059|Immunologic Factors|immunologic factors|mesh-ancestor
2314466|NCT00345059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314467|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
2314468|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
2314469|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
2314470|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2314471|NCT00345098|Amibegron|amibegron|mesh-list
2314472|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2876606|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2876607|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876608|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2876609|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2876610|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2876611|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2876612|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876613|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2876614|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2314473|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2314474|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
2314475|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2876615|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314476|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876616|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
2876617|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
2314477|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314478|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2314479|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314480|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314481|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2314482|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314483|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314484|NCT00345163|Bevacizumab|bevacizumab|mesh-list
2314485|NCT00345163|Irinotecan|irinotecan|mesh-list
2314486|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2314487|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314488|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2314489|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2314490|NCT00345163|Growth Substances|growth substances|mesh-ancestor
2876618|NCT03540420|Atezolizumab|atezolizumab|mesh-list
2876619|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876628|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
2876629|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
2876630|NCT03516279|Dasatinib|dasatinib|mesh-list
2876631|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876632|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876633|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2314491|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314492|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
2314493|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2314494|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2314495|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314496|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314497|NCT00345202|Atorvastatin|atorvastatin|mesh-list
2314498|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2314499|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2314500|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
2314501|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314502|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2314503|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2314504|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314505|NCT00345306|Progesterone|progesterone|mesh-list
2314506|NCT00345306|Progestins|progestins|mesh-ancestor
2314507|NCT00345306|Hormones|hormones|mesh-ancestor
2314508|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2314509|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876634|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876635|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876636|NCT03509012|Paclitaxel|paclitaxel|mesh-list
2876637|NCT03509012|Etoposide|etoposide|mesh-list
2876638|NCT03509012|Cisplatin|cisplatin|mesh-list
2876639|NCT03509012|Carboplatin|carboplatin|mesh-list
2876640|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
2876641|NCT03509012|Pemetrexed|pemetrexed|mesh-list
2876642|NCT03509012|Durvalumab|durvalumab|mesh-list
2876643|NCT03509012|Tremelimumab|tremelimumab|mesh-list
2876644|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2876645|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876646|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
2876647|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
2876648|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
2876649|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876650|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2876651|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2876652|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876653|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2876654|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2876655|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876656|NCT03508739|Valsartan|valsartan|mesh-list
2876657|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2876658|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2876659|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2876660|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314510|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2314511|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
2314512|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314513|NCT00345501|Iloprost|iloprost|mesh-list
2314514|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2314515|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
2314516|NCT00345618|Biotin|biotin|mesh-list
2314517|NCT00345618|Enoxaparin|enoxaparin|mesh-list
2314518|NCT00345618|Warfarin|warfarin|mesh-list
2314519|NCT00345618|Idraparinux|idraparinux|mesh-list
2314520|NCT00345618|Idrabiotaparinux|idrabiotaparinux|mesh-list
2314521|NCT00345618|Anticoagulants|anticoagulants|mesh-ancestor
2314522|NCT00345618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2314523|NCT00345618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2314524|NCT00345618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314525|NCT00345618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2314526|NCT00345618|Antithrombins|antithrombins|mesh-ancestor
2314527|NCT00345618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2314528|NCT00345618|Protease Inhibitors|protease inhibitors|mesh-ancestor
2314529|NCT00345618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314530|NCT00345618|Vitamin B Complex|vitamin b complex|mesh-ancestor
2314531|NCT00345618|Vitamins|vitamins|mesh-ancestor
2314532|NCT00345618|Micronutrients|micronutrients|mesh-ancestor
2314533|NCT00345618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314534|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
2314535|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
2314536|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2876661|NCT03484819|Nivolumab|nivolumab|mesh-list
2876662|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876663|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876664|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2876665|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876668|NCT03473561|Racecadotril|racecadotril|mesh-list
2876669|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
2876670|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2876671|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
2876672|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876673|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876674|NCT03455517|Rituximab|rituximab|mesh-list
2876675|NCT03455517|Venetoclax|venetoclax|mesh-list
2876676|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876677|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876678|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
2876679|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876680|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2876694|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
2314537|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2314538|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314539|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2314540|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314541|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2314542|NCT00345657|Niacin|niacin|mesh-list
2314543|NCT00345657|Lovastatin|lovastatin|mesh-list
2876695|NCT03419234|Prednisone|prednisone|mesh-list
2876696|NCT03419234|Cortisone|cortisone|mesh-list
2876697|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
2314544|NCT00345657|L 647318|l 647318|mesh-list
2314545|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
2876698|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
2876699|NCT03419234|Hormones|hormones|mesh-list
2876700|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2876701|NCT03419234|Androgens|androgens|mesh-list
2876702|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
2876703|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2876704|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
2876705|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2876706|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876707|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2876708|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876709|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2876710|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876711|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876712|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
2876713|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2876714|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
2876715|NCT03419234|Protective Agents|protective agents|mesh-ancestor
2876716|NCT03419234|Vitamins|vitamins|mesh-ancestor
2876717|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
2876718|NCT03419234|Estrogens|estrogens|mesh-ancestor
2876719|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
2314546|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2314547|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
2314548|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314549|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2314550|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
2314551|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
2314552|NCT00345657|Vitamins|vitamins|mesh-ancestor
2314553|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
2314554|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314555|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2314556|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2314557|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314558|NCT00345696|Bevacizumab|bevacizumab|mesh-list
2314559|NCT00345696|Capecitabine|capecitabine|mesh-list
2314560|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
2314561|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2314562|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314563|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2314564|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2314565|NCT00345696|Growth Substances|growth substances|mesh-ancestor
2314566|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876771|NCT03383679|Capecitabine|capecitabine|mesh-list
2876772|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2876773|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
2876774|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314567|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
2314568|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2314569|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
2314570|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314571|NCT00345735|Fentanyl|fentanyl|mesh-list
2876775|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314572|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2314573|NCT00345735|Narcotics|narcotics|mesh-ancestor
2314574|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2314575|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314576|NCT00345735|Analgesics|analgesics|mesh-ancestor
2314577|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
2314578|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314579|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2314580|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2314581|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
2314582|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
2876792|NCT03375307|Olaparib|olaparib|mesh-list
2876793|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2876794|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876795|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876796|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876797|NCT03367299|Blinatumomab|blinatumomab|mesh-list
2876798|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876799|NCT03341806|Avelumab|avelumab|mesh-list
2876800|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876801|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876802|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
2876803|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876804|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314583|NCT00345748|Abatacept|abatacept|mesh-list
2314584|NCT00345748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2314585|NCT00345748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314586|NCT00345748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314587|NCT00345748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314588|NCT00345748|Immunologic Factors|immunologic factors|mesh-ancestor
2314589|NCT00345748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314590|NCT00345748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2876820|NCT03271047|Nivolumab|nivolumab|mesh-list
2876821|NCT03271047|Ipilimumab|ipilimumab|mesh-list
2876822|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876823|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876824|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2876825|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876826|NCT03258593|Durvalumab|durvalumab|mesh-list
2314591|NCT00345761|Bevacizumab|bevacizumab|mesh-list
2314592|NCT00345761|Capecitabine|capecitabine|mesh-list
2314593|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
2314594|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2314595|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314596|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2314597|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2314598|NCT00345761|Growth Substances|growth substances|mesh-ancestor
2314599|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314600|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
2314601|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2314602|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
2314603|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314604|NCT00345787|Buprenorphine|buprenorphine|mesh-list
2314605|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2314606|NCT00345787|Narcotics|narcotics|mesh-ancestor
2314607|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2314608|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876827|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876828|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876829|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
2876830|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876831|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876853|NCT03171480|Isosorbide|isosorbide|mesh-list
2876854|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2314609|NCT00345787|Analgesics|analgesics|mesh-ancestor
2314610|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
2314611|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314612|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2314613|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
2314614|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2314615|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2314616|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
2314617|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
2876855|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2876856|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2876857|NCT03171480|Diuretics|diuretics|mesh-ancestor
2876858|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
2876859|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876860|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
2876861|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2876862|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876863|NCT03164655|Leucovorin|leucovorin|mesh-list
2876864|NCT03164655|Bevacizumab|bevacizumab|mesh-list
2876865|NCT03164655|Cetuximab|cetuximab|mesh-list
2876866|NCT03164655|Panitumumab|panitumumab|mesh-list
2876867|NCT03164655|Fluorouracil|fluorouracil|mesh-list
2876868|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
2876869|NCT03164655|Irinotecan|irinotecan|mesh-list
2876870|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876871|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876872|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2876873|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2876874|NCT03164655|Growth Substances|growth substances|mesh-ancestor
2876875|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876876|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
2876877|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
2876878|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876879|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2876880|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314618|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2314619|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314620|NCT00345826|Dasatinib|dasatinib|mesh-list
2314621|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314622|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2314623|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314624|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314625|NCT00345982|Sertindole|sertindole|mesh-list
2314626|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2314627|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2314628|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2314629|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314630|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2314631|NCT00346047|Buprenorphine|buprenorphine|mesh-list
2314632|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2314633|NCT00346047|Narcotics|narcotics|mesh-ancestor
2314634|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2314635|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314636|NCT00346047|Analgesics|analgesics|mesh-ancestor
2314637|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
2314638|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314639|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2314640|NCT00346099|Capecitabine|capecitabine|mesh-list
2314641|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
2314642|NCT00346099|Panitumumab|panitumumab|mesh-list
2314643|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2314644|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
2314645|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314646|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314647|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2314648|NCT00346125|Doxorubicin|doxorubicin|mesh-list
2876881|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
2876882|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2876883|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2876884|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876885|NCT03164655|Antidotes|antidotes|mesh-ancestor
2876886|NCT03164655|Protective Agents|protective agents|mesh-ancestor
2876887|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
2876888|NCT03164655|Vitamins|vitamins|mesh-ancestor
2876889|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
2876890|NCT03162627|Olaparib|olaparib|mesh-list
2876891|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2876892|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876893|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876894|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876895|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
2876896|NCT03139370|Fludarabine|fludarabine|mesh-list
2876897|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2876898|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
2876899|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876900|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2314649|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2314650|NCT00346125|Ifosfamide|ifosfamide|mesh-list
2314651|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2314652|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2314653|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314654|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2314655|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2314656|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314657|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314658|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2314659|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
2314660|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2314661|NCT00346190|Alendronate|alendronate|mesh-list
2876901|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2876902|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
2876903|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876904|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876905|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2876906|NCT03115424|Liraglutide|liraglutide|mesh-list
2876907|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2876908|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876909|NCT03115424|Incretins|incretins|mesh-ancestor
2876910|NCT03115424|Hormones|hormones|mesh-ancestor
2876911|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2876912|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
2876913|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2314662|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2314663|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314664|NCT00346229|Doxorubicin|doxorubicin|mesh-list
2314665|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2314666|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2314667|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314668|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2314669|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2314670|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314671|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314672|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
2314673|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2314674|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314675|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
2314676|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2314677|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314678|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2314679|NCT00346294|Etanercept|etanercept|mesh-list
2314680|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2314681|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2314682|NCT00346294|Analgesics|analgesics|mesh-ancestor
2876914|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2876915|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876916|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
2314683|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
2314684|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314685|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314686|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2314687|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2314688|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2314689|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314690|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
2314691|NCT00346359|Methotrexate|methotrexate|mesh-list
2314692|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
2314693|NCT00346359|Fludarabine|fludarabine|mesh-list
2876917|NCT03113253|Coagulants|coagulants|mesh-ancestor
2876918|NCT03094052|Trastuzumab|trastuzumab|mesh-list
2876919|NCT03094052|Atropine|atropine|mesh-list
2876920|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
2876921|NCT03094052|Loperamide|loperamide|mesh-list
2876922|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
2876923|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
2876924|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2876925|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876926|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2876927|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2876928|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2876929|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
2876930|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2876931|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876932|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2876933|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
2876934|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
2876935|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
2876936|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2876937|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2876938|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
2876939|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2876940|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876941|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2876942|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2876943|NCT03094052|Narcotics|narcotics|mesh-ancestor
2876944|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2876945|NCT03094052|Analgesics|analgesics|mesh-ancestor
2876946|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
2876947|NCT03074240|Anesthetics|anesthetics|mesh-list
2876948|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
2876949|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2876950|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876951|NCT03060473|Amoxicillin|amoxicillin|mesh-list
2314694|NCT00346359|Busulfan|busulfan|mesh-list
2314695|NCT00346359|Tacrolimus|tacrolimus|mesh-list
2314696|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2314697|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2314698|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
2314699|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2314700|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314701|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2314702|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
2314703|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314704|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314705|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
2314706|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314707|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2314708|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314709|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
2314710|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2314711|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2314712|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2314713|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
2876952|NCT03060473|Azithromycin|azithromycin|mesh-list
2876953|NCT03060473|Erythromycin|erythromycin|mesh-list
2876954|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
2876955|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2108937|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2108938|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2108939|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
2108940|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
2108941|NCT02512809|Isoflurane|isoflurane|mesh-list
2108942|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2108943|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108944|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108945|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2108946|NCT02512809|Analgesics|analgesics|mesh-ancestor
2108947|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
2108948|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108949|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2876956|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
2876957|NCT03060473|Ampicillin|ampicillin|mesh-list
2876958|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2876959|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2876960|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2876961|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2876962|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876963|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876964|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
2876965|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2876966|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
2876967|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876968|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2876971|NCT03027388|LB100|lb100|mesh-list
2108950|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2876972|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876973|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2876974|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314714|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2314715|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2314716|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
2314717|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2314718|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2876975|NCT03008382|Metoprolol|metoprolol|mesh-list
2876976|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2876977|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2876978|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
2876979|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
2876980|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2876981|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876982|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2876983|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2876984|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2876985|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
2876986|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2876987|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2876988|NCT02988401|Insulin|insulin|mesh-list
2876989|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2876990|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2876991|NCT02987530|Tenofovir|tenofovir|mesh-list
2876992|NCT02987530|Emtricitabine|emtricitabine|mesh-list
2876993|NCT02987530|Darunavir|darunavir|mesh-list
2876994|NCT02987530|Dolutegravir|dolutegravir|mesh-list
2876995|NCT02987530|Cobicistat|cobicistat|mesh-list
2876996|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
2876997|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2876998|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2876999|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2314719|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2314720|NCT00346463|Allopurinol|allopurinol|mesh-list
2314721|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
2314722|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314723|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314724|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
2314725|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2314726|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2314727|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
2314728|NCT00346463|Protective Agents|protective agents|mesh-ancestor
2314729|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314730|NCT00346489|Fluorouracil|fluorouracil|mesh-list
2314731|NCT00346489|Mitomycins|mitomycins|mesh-list
2314732|NCT00346489|Mitomycin|mitomycin|mesh-list
2314733|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
2314734|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314735|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2314736|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314737|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314738|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
2314739|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314740|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2877000|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877001|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877002|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2877003|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2877004|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2877005|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2877006|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
2877007|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2877008|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2108951|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2108952|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
2108953|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2108954|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108955|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2108956|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
2108957|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
2108958|NCT02512861|Bupivacaine|bupivacaine|mesh-list
2877009|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2877010|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2877011|NCT02965690|Cimetidine|cimetidine|mesh-list
2877012|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2314741|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
2314742|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2314743|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314744|NCT00346502|Betulinic acid|betulinic acid|mesh-list
2314745|NCT00346502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2314746|NCT00346502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2314747|NCT00346502|Analgesics|analgesics|mesh-ancestor
2314748|NCT00346502|Sensory System Agents|sensory system agents|mesh-ancestor
2314749|NCT00346502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314750|NCT00346502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877013|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2877014|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2877015|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
2314751|NCT00346502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2314752|NCT00346502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2314753|NCT00346502|Antimalarials|antimalarials|mesh-ancestor
2314754|NCT00346502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2314755|NCT00346502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2314756|NCT00346502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314757|NCT00346502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2314758|NCT00346502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314759|NCT00346502|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
2877016|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
2877017|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2877018|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877019|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877020|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2877021|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2877022|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877023|NCT02964182|Nicotine|nicotine|mesh-list
2877024|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2877025|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
2314760|NCT00346502|Hormone Antagonists|hormone antagonists|mesh-ancestor
2314761|NCT00346502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2314762|NCT00346502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2877026|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2877027|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877028|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2877029|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2877030|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
2877031|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2877032|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877062|NCT02889809|Fluticasone|fluticasone|mesh-list
2877063|NCT02889809|Xhance|xhance|mesh-list
2877064|NCT02889809|Montelukast|montelukast|mesh-list
2877065|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2877066|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2314763|NCT00346502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2314764|NCT00346502|Antiviral Agents|antiviral agents|mesh-ancestor
2314765|NCT00346567|Tenofovir|tenofovir|mesh-list
2314766|NCT00346567|Lamivudine|lamivudine|mesh-list
2314767|NCT00346567|Zidovudine|zidovudine|mesh-list
2314768|NCT00346567|Emtricitabine|emtricitabine|mesh-list
2314769|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2314770|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2314771|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
2314772|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314773|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2314774|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2314775|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314776|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314777|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2314778|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2314779|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
2314780|NCT00346580|Nelfinavir|nelfinavir|mesh-list
2314781|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2314782|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2314783|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
2314784|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314785|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314786|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2314787|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2314788|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
2314789|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314790|NCT00346619|Nelfinavir|nelfinavir|mesh-list
2314791|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2314792|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2314793|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
2314794|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314795|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877067|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
2877068|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2877069|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877070|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2877071|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
2877072|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
2877073|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2314796|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2314797|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2314798|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
2314799|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314800|NCT00346645|Bortezomib|bortezomib|mesh-list
2314801|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314802|NCT00346684|Rituximab|rituximab|mesh-list
2314803|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2314804|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314805|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
2314806|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314807|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2314808|NCT00346749|Fluticasone|fluticasone|mesh-list
2877074|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2877075|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
2877076|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2877077|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2877078|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2877079|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877080|NCT02884648|Bevacizumab|bevacizumab|mesh-list
2877081|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877082|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877083|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2314809|NCT00346749|Xhance|xhance|mesh-list
2314810|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2314811|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2877084|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2877085|NCT02884648|Growth Substances|growth substances|mesh-ancestor
2877086|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877087|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
2877088|NCT02859558|Tenofovir|tenofovir|mesh-list
2877089|NCT02859558|Emtricitabine|emtricitabine|mesh-list
2877090|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2314812|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2314813|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
2877091|NCT02859558|Cobicistat|cobicistat|mesh-list
2877092|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2877093|NCT02859558|Elvitegravir|elvitegravir|mesh-list
2877094|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2877095|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
2877096|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2877097|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2877098|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2877099|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877100|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877101|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2877102|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2877103|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2877104|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2877105|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
2877106|NCT02818023|Vemurafenib|vemurafenib|mesh-list
2877107|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877108|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877109|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2877110|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877111|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877112|NCT02815540|Cannabidiol|cannabidiol|mesh-list
2877113|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
2877114|NCT02808572|Mitogens|mitogens|mesh-list
2877115|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
2314814|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314815|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314816|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2314817|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
2314818|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
2314819|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2314820|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2314821|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2314822|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2314823|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
2314824|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2877116|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877117|NCT02785224|Vasopressins|vasopressins|mesh-list
2877118|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
2877119|NCT02785224|Epinephrine|epinephrine|mesh-list
2877120|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2877121|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2877122|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
2877123|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2877124|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877125|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877126|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2877127|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2877128|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
2877129|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2877130|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2877131|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
2877132|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
2877133|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
2877134|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2877135|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
2877136|NCT02785224|Coagulants|coagulants|mesh-ancestor
2877137|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2877138|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
2314825|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314826|NCT00346801|Celecoxib|celecoxib|mesh-list
2314827|NCT00346801|Cisplatin|cisplatin|mesh-list
2314828|NCT00346801|Irinotecan|irinotecan|mesh-list
2314829|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314830|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2314831|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2314832|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314833|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314834|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2314835|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2314836|NCT00346801|Analgesics|analgesics|mesh-ancestor
2314837|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
2314838|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314839|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314840|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2314841|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2314842|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2877160|NCT02781883|Decitabine|decitabine|mesh-list
2877161|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2877162|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
2877163|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877164|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877165|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877166|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2877167|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2877168|NCT02778204|Maraviroc|maraviroc|mesh-list
2314843|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2314844|NCT00346827|Apomorphine|apomorphine|mesh-list
2314845|NCT00346827|Emetics|emetics|mesh-ancestor
2314846|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314847|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
2314848|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314849|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2314850|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
2314851|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
2314852|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2877169|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2877170|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2877171|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877172|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2877173|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2877174|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
2877175|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2877176|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2877177|NCT02743364|Simvastatin|simvastatin|mesh-list
2877178|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2877179|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2877180|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
2877181|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877182|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2877183|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2877184|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877185|NCT02670044|Venetoclax|venetoclax|mesh-list
2877186|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877187|NCT02648997|Nivolumab|nivolumab|mesh-list
2314853|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314854|NCT00346840|Misoprostol|misoprostol|mesh-list
2314855|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2314856|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
2314857|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2314858|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314859|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2314860|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2314861|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
2877188|NCT02648997|Ipilimumab|ipilimumab|mesh-list
2877189|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877190|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877191|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2314862|NCT00346853|Fomepizole|fomepizole|mesh-list
2314863|NCT00346853|Antidotes|antidotes|mesh-ancestor
2314864|NCT00346853|Protective Agents|protective agents|mesh-ancestor
2314865|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314866|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877192|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314867|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314868|NCT00346866|Anecortave|anecortave|mesh-list
2314869|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2314870|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2314871|NCT00346866|Growth Substances|growth substances|mesh-ancestor
2314872|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314873|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
2314874|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314875|NCT00346879|PENTA|penta|mesh-list
2314876|NCT00346879|Fondaparinux|fondaparinux|mesh-list
2314877|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2314878|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
2314879|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2314880|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
2314881|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314882|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314883|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
2877211|NCT02625441|Trastuzumab|trastuzumab|mesh-list
2877212|NCT02625441|Pertuzumab|pertuzumab|mesh-list
2877213|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877214|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314884|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2314885|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2314886|NCT00346918|Sirolimus|sirolimus|mesh-list
2314887|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2314888|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314889|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2314890|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314891|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
2314892|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2877247|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
2877248|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877249|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877250|NCT02560298|Paclitaxel|paclitaxel|mesh-list
2877251|NCT02560298|Cisplatin|cisplatin|mesh-list
2877252|NCT02560298|Carboplatin|carboplatin|mesh-list
2877253|NCT02560298|Fluorouracil|fluorouracil|mesh-list
2877254|NCT02560298|Capecitabine|capecitabine|mesh-list
2877255|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2877256|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2877257|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877258|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
2877259|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
2877260|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
2877261|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877262|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
2877263|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2314893|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
2314894|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314895|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
2314896|NCT00346957|Anecortave|anecortave|mesh-list
2314897|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2314898|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2314899|NCT00346957|Growth Substances|growth substances|mesh-ancestor
2314900|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314901|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
2314902|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314903|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2314904|NCT00346970|Niacin|niacin|mesh-list
2314905|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2314906|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
2314907|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314908|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2314909|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
2314910|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
2314911|NCT00346970|Vitamins|vitamins|mesh-ancestor
2314912|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
2314913|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314914|NCT00346996|Insulin|insulin|mesh-list
2314915|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2314916|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
2877264|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2877265|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
2877266|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877267|NCT02551991|Leucovorin|leucovorin|mesh-list
2877268|NCT02551991|Fluorouracil|fluorouracil|mesh-list
2877269|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
2877270|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
2877271|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877272|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2877273|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877274|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2877275|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
2877276|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877277|NCT02551991|Antidotes|antidotes|mesh-ancestor
2877278|NCT02551991|Protective Agents|protective agents|mesh-ancestor
2877279|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
2877280|NCT02551991|Vitamins|vitamins|mesh-ancestor
2877281|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
2877282|NCT02547493|Abatacept|abatacept|mesh-list
2877283|NCT02547493|Vaccines|vaccines|mesh-list
2877284|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2877285|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
2877286|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877287|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2877288|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877289|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877290|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314917|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
2314918|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
2314919|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
2314920|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2314921|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314922|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2877291|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2877306|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
2877307|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877308|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877319|NCT02496611|Exenatide|exenatide|mesh-list
2877320|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2877321|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877322|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2877323|NCT02496611|Incretins|incretins|mesh-ancestor
2877324|NCT02496611|Hormones|hormones|mesh-ancestor
2877325|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2877326|NCT02476097|Esomeprazole|esomeprazole|mesh-list
2877327|NCT02476097|Omeprazole|omeprazole|mesh-list
2877328|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2877329|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2877330|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2877331|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877332|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877333|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2877334|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
2314923|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2314924|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2314925|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2314926|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2314927|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
2314928|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2314929|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314930|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314931|NCT00347048|Tacrolimus|tacrolimus|mesh-list
2314932|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2314933|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
2314934|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314935|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2314936|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314937|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314938|NCT00347087|Irbesartan|irbesartan|mesh-list
2314939|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2314940|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2314941|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2314942|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314943|NCT00347100|Metformin|metformin|mesh-list
2314944|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
2314945|NCT00347100|Glyburide|glyburide|mesh-list
2314946|NCT00347100|Glipizide|glipizide|mesh-list
2314947|NCT00347100|Gliclazide|gliclazide|mesh-list
2314948|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2877335|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2877336|NCT02459392|Prednisolone|prednisolone|mesh-list
2877337|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
2877338|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
2877339|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2314949|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314950|NCT00347113|Albendazole|albendazole|mesh-list
2314951|NCT00347113|Praziquantel|praziquantel|mesh-list
2314952|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
2314953|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2314954|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2314955|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
2314956|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2314957|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2314958|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
2314959|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
2314960|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
2314961|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314962|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314963|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2314964|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2314965|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
2877340|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
2877341|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2877342|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
2877343|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877344|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
2877345|NCT02459392|Protective Agents|protective agents|mesh-ancestor
2877346|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2877347|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
2877348|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
2877349|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2877350|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2877351|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
2877352|NCT02459392|Hormones|hormones|mesh-ancestor
2877353|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2877354|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2877355|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2877356|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314966|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2314967|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314968|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2314969|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
2314970|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2314971|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2314972|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2314973|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
2314974|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2314975|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314976|NCT00347152|Valproic Acid|valproic acid|mesh-list
2314977|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
2877360|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
2877361|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877362|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2877363|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877364|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314978|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2314979|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2314980|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
2314981|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2314982|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314983|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
2314984|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2314985|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2877377|NCT02361125|Methylphenidate|methylphenidate|mesh-list
2877378|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2877379|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877380|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2877381|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2877382|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2877383|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877384|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
2877385|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2877386|NCT02338921|Metformin|metformin|mesh-list
2877387|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2877388|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
2877389|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2877390|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877391|NCT02338921|Incretins|incretins|mesh-ancestor
2877392|NCT02338921|Hormones|hormones|mesh-ancestor
2877393|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2877394|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2877395|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
2877396|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877397|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877398|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2314986|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2314987|NCT00347165|Bevacizumab|bevacizumab|mesh-list
2314988|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877429|NCT02245308|Bupropion|bupropion|mesh-list
2877430|NCT02245308|Nicotine|nicotine|mesh-list
2877431|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2877432|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
2877433|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2877434|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877435|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2877436|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2877437|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
2877438|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2877439|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877440|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2877441|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
2877442|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2877443|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2877444|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2877445|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2877446|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
2314989|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2314990|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2314991|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2314992|NCT00347165|Growth Substances|growth substances|mesh-ancestor
2314993|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2314994|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
2314995|NCT00347204|Ketorolac|ketorolac|mesh-list
2314996|NCT00347204|Nepafenac|nepafenac|mesh-list
2314997|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2314998|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2314999|NCT00347204|Analgesics|analgesics|mesh-ancestor
2315000|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
2315001|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315002|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877447|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2877448|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2877449|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877450|NCT02227199|Carboplatin|carboplatin|mesh-list
2877451|NCT02227199|Etoposide|etoposide|mesh-list
2877452|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
2877453|NCT02227199|Ifosfamide|ifosfamide|mesh-list
2877454|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
2877455|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2877456|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
2877457|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2877458|NCT02227199|Antibodies|antibodies|mesh-list
2877459|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
2877460|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2877461|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
2877462|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
2877463|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877464|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877465|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2877466|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2877467|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2877468|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877469|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877470|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2877471|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
2877472|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
2877473|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
2877474|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
2877475|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
2877476|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
2877477|NCT02223208|Prednisone|prednisone|mesh-list
2877478|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
2877479|NCT02223208|Doxorubicin|doxorubicin|mesh-list
2877480|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2877481|NCT02223208|Etoposide|etoposide|mesh-list
2877482|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
2877483|NCT02223208|Romidepsin|romidepsin|mesh-list
2877484|NCT02223208|Vincristine|vincristine|mesh-list
2877485|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2877486|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
2877487|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877488|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2877489|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2877490|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
2877491|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877492|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877493|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2877494|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2877495|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2877496|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2877497|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877498|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2877499|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
2877500|NCT02223208|Hormones|hormones|mesh-ancestor
2877501|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2877502|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2877503|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2877504|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
2877505|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
2877506|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
2877507|NCT02177695|Gemcitabine|gemcitabine|mesh-list
2877508|NCT02177695|Doxorubicin|doxorubicin|mesh-list
2877509|NCT02177695|Methotrexate|methotrexate|mesh-list
2877510|NCT02177695|Vinblastine|vinblastine|mesh-list
2877511|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877512|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2877513|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
2877514|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877515|NCT02177695|Antiviral Agents|antiviral agents|mesh-ancestor
2877516|NCT02177695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2877517|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877518|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2877519|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
2877520|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877521|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2877522|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2877523|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2315003|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2315004|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315005|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2315006|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315007|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315008|NCT00347256|Cisplatin|cisplatin|mesh-list
2315009|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315010|NCT00347295|Estazolam|estazolam|mesh-list
2315011|NCT00347295|Brotizolam|brotizolam|mesh-list
2315012|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2315013|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2315014|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315015|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
2315016|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2315017|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2315018|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2315019|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
2315020|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
2315021|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315022|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315023|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
2315024|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315025|NCT00347386|Astringents|astringents|mesh-ancestor
2315026|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
2315027|NCT00347399|Bevacizumab|bevacizumab|mesh-list
2315028|NCT00347399|Verteporfin|verteporfin|mesh-list
2877524|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2877525|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
2877526|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2877527|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
2877528|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2877529|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315029|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2315030|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315031|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2315032|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2315033|NCT00347399|Growth Substances|growth substances|mesh-ancestor
2315034|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315035|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
2877530|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2877531|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2877532|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
2877533|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
2877534|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
2877535|NCT02176148|Fluocinonide|fluocinonide|mesh-list
2877536|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2877537|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
2877538|NCT02176148|Hormones|hormones|mesh-ancestor
2877539|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2877540|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877541|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2877542|NCT02145403|Tacrolimus|tacrolimus|mesh-list
2877543|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2877544|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
2877545|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877546|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2877547|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877548|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315036|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2315037|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
2315038|NCT00347412|Paclitaxel|paclitaxel|mesh-list
2877549|NCT02107976|Vitamins|vitamins|mesh-list
2877550|NCT02107976|Ascorbic Acid|ascorbic acid|mesh-list
2877551|NCT02107976|Vitamin E|vitamin e|mesh-list
2877552|NCT02107976|Micronutrients|micronutrients|mesh-ancestor
2877553|NCT02107976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877554|NCT02107976|Antioxidants|antioxidants|mesh-ancestor
2877555|NCT02107976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877556|NCT02107976|Protective Agents|protective agents|mesh-ancestor
2877557|NCT02105636|Docetaxel|docetaxel|mesh-list
2877558|NCT02105636|Methotrexate|methotrexate|mesh-list
2877559|NCT02105636|Nivolumab|nivolumab|mesh-list
2877560|NCT02105636|Cetuximab|cetuximab|mesh-list
2877561|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877562|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
2877563|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
2877564|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
2877565|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877566|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2877567|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
2877568|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2315039|NCT00347412|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2315040|NCT00347412|Carboplatin|carboplatin|mesh-list
2315041|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2315042|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315043|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
2315044|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
2315045|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
2315046|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315047|NCT00347425|Olanzapine|olanzapine|mesh-list
2315048|NCT00347425|Risperidone|risperidone|mesh-list
2315049|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2315050|NCT00347425|Aripiprazole|aripiprazole|mesh-list
2315051|NCT00347425|Ziprasidone|ziprasidone|mesh-list
2315052|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2315053|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
2315054|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315055|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315056|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315057|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2315058|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2315059|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2315060|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2315061|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2315062|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
2315063|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
2315064|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
2315065|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315066|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2315067|NCT00347425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2315068|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2315069|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2315070|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
2315071|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
2315072|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2315073|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2315074|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2315075|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2315076|NCT00347490|Enoxaparin|enoxaparin|mesh-list
2315077|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
2315078|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2315079|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2877569|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877570|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2877571|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
2877572|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
2877573|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877574|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2877575|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2877576|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
2877577|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2877578|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2877579|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877580|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2877600|NCT02038946|Nivolumab|nivolumab|mesh-list
2877601|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877602|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877603|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2877604|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315080|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315081|NCT00347503|Ketorolac|ketorolac|mesh-list
2315082|NCT00347503|Bromfenac|bromfenac|mesh-list
2315083|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2315084|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2315085|NCT00347503|Analgesics|analgesics|mesh-ancestor
2315086|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
2315087|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315088|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315089|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2315090|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315091|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2315092|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315093|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315094|NCT00347542|Vitamin D|vitamin d|mesh-list
2315095|NCT00347542|Vitamins|vitamins|mesh-ancestor
2315096|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
2315097|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315098|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2315099|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
2315100|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2877612|NCT01988571|Atorvastatin|atorvastatin|mesh-list
2877613|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2877614|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2877615|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
2877616|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877617|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2877618|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2315101|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
2315102|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315103|NCT00347555|Antacids|antacids|mesh-ancestor
2315104|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315105|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2315106|NCT00347581|Methamphetamine|methamphetamine|mesh-list
2315107|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2315108|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315109|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
2315110|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
2315111|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315112|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
2315113|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315114|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315115|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
2315116|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2315117|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2315118|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2315119|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2315120|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
2315121|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2877619|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877620|NCT01979367|Analgesics|analgesics|mesh-list
2877621|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
2877622|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2877623|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877653|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
2315122|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2315123|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315124|NCT00347685|Tramadol|tramadol|mesh-list
2315125|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2315126|NCT00347685|Narcotics|narcotics|mesh-ancestor
2315127|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2315128|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315129|NCT00347685|Analgesics|analgesics|mesh-ancestor
2315130|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
2877654|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2877655|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2877656|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877657|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2877658|NCT01973452|Analgesics|analgesics|mesh-ancestor
2877659|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
2877660|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2877661|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2877662|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2877663|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2877664|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
2315131|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315132|NCT00347698|Bevacizumab|bevacizumab|mesh-list
2315133|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2315134|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315135|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2315136|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2315137|NCT00347698|Growth Substances|growth substances|mesh-ancestor
2315138|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315139|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
2315140|NCT00347724|Tramadol|tramadol|mesh-list
2315141|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2315142|NCT00347724|Narcotics|narcotics|mesh-ancestor
2315143|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2315144|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315145|NCT00347724|Analgesics|analgesics|mesh-ancestor
2877665|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315146|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
2315147|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315148|NCT00347737|Teriparatide|teriparatide|mesh-list
2877666|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877667|NCT01964560|Lacosamide|lacosamide|mesh-list
2877668|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
2877669|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2877670|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2877671|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2877672|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877697|NCT01863550|Dexamethasone|dexamethasone|mesh-list
2877698|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
2877699|NCT01863550|Lenalidomide|lenalidomide|mesh-list
2877700|NCT01863550|Bortezomib|bortezomib|mesh-list
2877701|NCT01863550|Ichthammol|ichthammol|mesh-list
2877702|NCT01863550|BB 1101|bb 1101|mesh-list
2877703|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2877704|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
2877705|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
2877706|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2877707|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877708|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2877709|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
2877710|NCT01863550|Hormones|hormones|mesh-ancestor
2877711|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2877712|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2315149|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2315150|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315151|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2315152|NCT00347750|Lopinavir|lopinavir|mesh-list
2315153|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2315154|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2877713|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877714|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
2877715|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2877716|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2877717|NCT01863550|Growth Substances|growth substances|mesh-ancestor
2877718|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
2877719|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
2877720|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877721|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877722|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
2877723|NCT01824875|Capecitabine|capecitabine|mesh-list
2877724|NCT01824875|Temozolomide|temozolomide|mesh-list
2877725|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2877726|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
2315155|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
2315156|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315157|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315158|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2315159|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2315160|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
2315161|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2877727|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877728|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877729|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2877730|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
2877731|NCT01792583|Modafinil|modafinil|mesh-list
2877732|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2877733|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315162|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2315163|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2315164|NCT00347763|Permethrin|permethrin|mesh-list
2315165|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315166|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315167|NCT00347802|Bimatoprost|bimatoprost|mesh-list
2315168|NCT00347802|Travoprost|travoprost|mesh-list
2315169|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2315170|NCT00347815|Buprenorphine|buprenorphine|mesh-list
2315171|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2315172|NCT00347815|Narcotics|narcotics|mesh-ancestor
2315173|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2315174|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315175|NCT00347815|Analgesics|analgesics|mesh-ancestor
2877734|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2877735|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2877736|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2877737|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877738|NCT01776840|Rituximab|rituximab|mesh-list
2877739|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2877740|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877741|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877742|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
2877743|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877744|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2877745|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2877746|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
2877747|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877748|NCT01755975|Lenalidomide|lenalidomide|mesh-list
2877749|NCT01755975|Romidepsin|romidepsin|mesh-list
2877750|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
2877751|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877752|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2877753|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2877754|NCT01755975|Growth Substances|growth substances|mesh-ancestor
2877755|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
2877756|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877757|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2877758|NCT01715285|Prednisone|prednisone|mesh-list
2877759|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
2877760|NCT01715285|Androgens|androgens|mesh-list
2877761|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2877762|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
2877763|NCT01715285|Hormones|hormones|mesh-ancestor
2877764|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2877765|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877766|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2877767|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877768|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2877769|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877770|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877771|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
2877772|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2877773|NCT01670409|Cisplatin|cisplatin|mesh-list
2877774|NCT01670409|Fluorouracil|fluorouracil|mesh-list
2877775|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877776|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
2877777|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877778|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2877779|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2877780|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
2877781|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877782|NCT01659606|Cyclosporine|cyclosporine|mesh-list
2877783|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
2877784|NCT01659606|Fludarabine|fludarabine|mesh-list
2877785|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
2877786|NCT01659606|Cyclosporins|cyclosporins|mesh-list
2877787|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877788|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877789|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2877790|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
2877791|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877792|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877793|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
2877794|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2877795|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
2877796|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315176|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
2315177|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2877797|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2877798|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2877799|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2877800|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
2877801|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2877802|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877803|NCT01532310|Belimumab|belimumab|mesh-list
2877804|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2877805|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
2877806|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877807|NCT01526135|Gemcitabine|gemcitabine|mesh-list
2877808|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2877809|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
2877810|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315178|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2315179|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
2315180|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
2315181|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2315182|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2315183|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2315184|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2315185|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2315186|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2315187|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315188|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315189|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315190|NCT00347841|Bimatoprost|bimatoprost|mesh-list
2315191|NCT00347841|Latanoprost|latanoprost|mesh-list
2877811|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877812|NCT01526135|Antiviral Agents|antiviral agents|mesh-ancestor
2877813|NCT01526135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2877814|NCT01526135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877815|NCT01526135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2877816|NCT01526135|Immunologic Factors|immunologic factors|mesh-ancestor
2877817|NCT01526135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877828|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
2877829|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877830|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2877831|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877832|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877833|NCT01445509|Bevacizumab|bevacizumab|mesh-list
2877834|NCT01445509|Dasatinib|dasatinib|mesh-list
2877835|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877836|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877837|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2877838|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2877839|NCT01445509|Growth Substances|growth substances|mesh-ancestor
2877840|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877841|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
2877842|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2877843|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877844|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877845|NCT01415752|Rituximab|rituximab|mesh-list
2315192|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2877846|NCT01415752|Lenalidomide|lenalidomide|mesh-list
2877847|NCT01415752|Bortezomib|bortezomib|mesh-list
2877848|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2877849|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877850|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877851|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
2877852|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877853|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2877854|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2877855|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2877856|NCT01415752|Growth Substances|growth substances|mesh-ancestor
2877857|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
2877858|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2877859|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
2877860|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877861|NCT01398852|Riboflavin|riboflavin|mesh-list
2877862|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
2877863|NCT01398852|Vitamins|vitamins|mesh-ancestor
2877864|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
2877865|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877866|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2877867|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
2315193|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2315194|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2315195|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2315196|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2315197|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
2315198|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2315199|NCT00347854|Laxatives|laxatives|mesh-ancestor
2315200|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2315201|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
2315202|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
2315203|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2315204|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2315205|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315206|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315207|NCT00347867|Urological Agents|urological agents|mesh-ancestor
2315208|NCT00347971|Rituximab|rituximab|mesh-list
2315209|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2315210|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315211|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
2315212|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315213|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315214|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2315215|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
2315216|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2315217|NCT00348010|Tramadol|tramadol|mesh-list
2315218|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2315219|NCT00348010|Narcotics|narcotics|mesh-ancestor
2877896|NCT01332266|Cetuximab|cetuximab|mesh-list
2877897|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2877898|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315220|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2315221|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315222|NCT00348010|Analgesics|analgesics|mesh-ancestor
2315223|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
2315224|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315225|NCT00348023|Timolol|timolol|mesh-list
2315226|NCT00348023|Bimatoprost|bimatoprost|mesh-list
2315227|NCT00348023|Travoprost|travoprost|mesh-list
2315228|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2315229|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2315230|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
2315231|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315232|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315233|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315234|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2315235|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2315236|NCT00348062|Bimatoprost|bimatoprost|mesh-list
2315237|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2315238|NCT00348101|Enoximone|enoximone|mesh-list
2315239|NCT00348101|Esmolol|esmolol|mesh-list
2877899|NCT01328808|Acetaminophen|acetaminophen|mesh-list
2877900|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2877901|NCT01328808|Analgesics|analgesics|mesh-ancestor
2877902|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
2877903|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2877904|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877905|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
2315240|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2315241|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2315242|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2877922|NCT01261728|Gemcitabine|gemcitabine|mesh-list
2877923|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877924|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2877925|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
2877926|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315243|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
2315244|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315245|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315246|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315247|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2315248|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
2315249|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2315250|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2315251|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315252|NCT00348101|Protective Agents|protective agents|mesh-ancestor
2315253|NCT00348153|Adalimumab|adalimumab|mesh-list
2315254|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2315255|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315256|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
2315257|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
2315258|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
2315259|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315260|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315261|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
2315262|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2315263|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2315264|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
2877927|NCT01261728|Antiviral Agents|antiviral agents|mesh-ancestor
2315265|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315266|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315267|NCT00348192|Donepezil|donepezil|mesh-list
2315268|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2315269|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315270|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315271|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
2315272|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315273|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315274|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
2315275|NCT00348231|Insulin|insulin|mesh-list
2315276|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2315277|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315278|NCT00348244|Prednisolone|prednisolone|mesh-list
2315279|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2315280|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
2315281|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2315282|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
2315283|NCT00348244|Ketorolac|ketorolac|mesh-list
2315284|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2315285|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
2315286|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2315287|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
2315288|NCT00348244|Hormones|hormones|mesh-ancestor
2315289|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2315290|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877928|NCT01261728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2877929|NCT01261728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877930|NCT01261728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2877931|NCT01261728|Immunologic Factors|immunologic factors|mesh-ancestor
2877932|NCT01261728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877933|NCT01222754|Lenalidomide|lenalidomide|mesh-list
2877934|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
2877935|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877936|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2877937|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2877938|NCT01222754|Growth Substances|growth substances|mesh-ancestor
2877939|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
2877940|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877941|NCT01150890|Brodalumab|brodalumab|mesh-list
2877942|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
2877943|NCT01143779|Telbivudine|telbivudine|mesh-list
2315291|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2315292|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315293|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
2315294|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
2877944|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
2877945|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2877946|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2877947|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877948|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877949|NCT01140867|Zonisamide|zonisamide|mesh-list
2877950|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
2877951|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2877952|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2877953|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877954|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2877955|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877956|NCT01137773|Insulin|insulin|mesh-list
2877957|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2877958|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2877959|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877960|NCT01127256|Carbamazepine|carbamazepine|mesh-list
2877961|NCT01127256|Zonisamide|zonisamide|mesh-list
2877962|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
2877963|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
2877964|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2877965|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2877966|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2877967|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2877968|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2877969|NCT01127256|Analgesics|analgesics|mesh-ancestor
2877970|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
2877971|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2877972|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2877973|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2877974|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877975|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2877976|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2877977|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2877978|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2315295|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315296|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2315297|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2315298|NCT00348244|Protective Agents|protective agents|mesh-ancestor
2315299|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2315300|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2315301|NCT00348244|Analgesics|analgesics|mesh-ancestor
2315302|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
2315303|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2877979|NCT00978458|Temozolomide|temozolomide|mesh-list
2877980|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2877981|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
2877982|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877983|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315304|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2315305|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315306|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315307|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
2315308|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2315309|NCT00348296|Antibodies|antibodies|mesh-list
2315310|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
2877984|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
2877985|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2877986|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2877987|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2877988|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2877991|NCT00482833|Methotrexate|methotrexate|mesh-list
2877992|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
2877993|NCT00482833|Idarubicin|idarubicin|mesh-list
2877994|NCT00482833|Tretinoin|tretinoin|mesh-list
2877995|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
2877996|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2877997|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
2877998|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2877999|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878000|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2878001|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
2878002|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878003|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878004|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
2878005|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878006|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2878007|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2878008|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
2878009|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2878010|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2878011|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2878012|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2878013|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2878014|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
2878015|NCT00381381|Donepezil|donepezil|mesh-list
2878016|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2878017|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878018|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878019|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
2878020|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2878021|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878022|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
2878040|NCT00102648|Temozolomide|temozolomide|mesh-list
2878041|NCT00102648|Lonafarnib|lonafarnib|mesh-list
2878042|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2878043|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
2878044|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878045|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878046|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878047|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
2878048|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878049|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2878050|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878051|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315311|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2315312|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
2315313|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315314|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2315315|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
2315316|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2315317|NCT00348335|Cyclosporine|cyclosporine|mesh-list
2315318|NCT00348335|Cyclosporins|cyclosporins|mesh-list
2315319|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315320|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315321|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2315322|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
2315323|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315324|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
2315325|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2315326|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
2315327|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315328|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2315329|NCT00348361|Fluticasone|fluticasone|mesh-list
2315330|NCT00348361|Xhance|xhance|mesh-list
2315331|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2315332|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2315333|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
2315334|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315335|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878088|NCT05179733|Rituximab|rituximab|mesh-list
2878089|NCT05179733|Lenalidomide|lenalidomide|mesh-list
2878090|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
2315336|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2315337|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
2315338|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
2315339|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2315340|NCT00348387|Vaccines|vaccines|mesh-list
2315341|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
2315342|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315343|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2315344|NCT00348400|Dorzolamide|dorzolamide|mesh-list
2315345|NCT00348400|Latanoprost|latanoprost|mesh-list
2315346|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2878091|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2878092|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878093|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
2878094|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878095|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2878096|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2878097|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2878098|NCT05179733|Growth Substances|growth substances|mesh-ancestor
2878099|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
2878100|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2878101|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878102|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878108|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
2878109|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2878110|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878111|NCT05179525|Risperidone|risperidone|mesh-list
2878112|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2878113|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
2878114|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2878115|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878116|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315347|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2315348|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2315349|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2315350|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2315351|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2315352|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
2315353|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315354|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315355|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315356|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2315357|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315358|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
2315359|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2315360|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2315361|NCT00348413|Prednisolone|prednisolone|mesh-list
2878117|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2878118|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2878119|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2878120|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2878121|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2878122|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
2878123|NCT05179512|Fluticasone|fluticasone|mesh-list
2878124|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
2878125|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2878126|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2878127|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2878128|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2878129|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
2315362|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
2315363|NCT00348413|Methotrexate|methotrexate|mesh-list
2315364|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2315365|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
2315366|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2315367|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
2315368|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2315369|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315370|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2315371|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
2315372|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315373|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315374|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
2315375|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315376|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2315377|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2315378|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
2315379|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315380|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2315381|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2315382|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
2315383|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
2878130|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2878131|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878132|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2878133|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
2878134|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
2878135|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2878136|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
2878137|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2878138|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
2878139|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2878140|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878141|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2878142|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2878143|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2878144|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
2878145|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
2878146|NCT05179512|Hormones|hormones|mesh-ancestor
2878147|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2878148|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
2878149|NCT05179499|Norepinephrine|norepinephrine|mesh-list
2878150|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2878151|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2878152|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
2878153|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2878154|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878155|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878156|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
2878157|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
2878158|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315384|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2878159|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2878160|NCT05179421|Oxytocin|oxytocin|mesh-list
2878161|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
2878162|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2878163|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878164|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
2878165|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2878166|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878167|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2878168|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878169|NCT05179239|Paclitaxel|paclitaxel|mesh-list
2878170|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2878171|NCT05179239|Cisplatin|cisplatin|mesh-list
2878172|NCT05179239|Carboplatin|carboplatin|mesh-list
2878173|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2878174|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878175|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
2878176|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
2878177|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
2878178|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878179|NCT05179213|Azacitidine|azacitidine|mesh-list
2878180|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2878181|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
2878182|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878183|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878184|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878185|NCT05179070|Carvedilol|carvedilol|mesh-list
2878186|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2878187|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2878188|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
2878189|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2878190|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878191|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878192|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2878193|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
2878194|NCT05179070|Protective Agents|protective agents|mesh-ancestor
2878195|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2878196|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2878197|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2878198|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
2878199|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2878200|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2878201|NCT05179018|Autoantibodies|autoantibodies|mesh-list
2878202|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
2878203|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878204|NCT05179005|Imidacloprid|imidacloprid|mesh-list
2878205|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
2878206|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2878207|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878208|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878209|NCT05178953|Zinc|zinc|mesh-list
2878210|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
2878211|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
2878212|NCT05178953|Trace Elements|trace elements|mesh-ancestor
2878213|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
2878214|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878215|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2878216|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878217|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878218|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2878219|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2878220|NCT05178953|Protective Agents|protective agents|mesh-ancestor
2878221|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
2315385|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2315386|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
2315387|NCT00348413|Hormones|hormones|mesh-ancestor
2315388|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2315389|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2315390|NCT00348413|Protective Agents|protective agents|mesh-ancestor
2315391|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2315392|NCT00348426|Antitoxins|antitoxins|mesh-list
2315393|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
2315394|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
2315395|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315396|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
2878222|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2878223|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
2878224|NCT05178953|Astringents|astringents|mesh-ancestor
2878225|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
2315397|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2315398|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2315399|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315400|NCT00348452|Celecoxib|celecoxib|mesh-list
2315401|NCT00348452|Tramadol|tramadol|mesh-list
2315402|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2315403|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2315404|NCT00348452|Analgesics|analgesics|mesh-ancestor
2315405|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
2315406|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315407|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315408|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2315409|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315410|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2315411|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2315412|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315413|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315414|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2315415|NCT00348452|Narcotics|narcotics|mesh-ancestor
2315416|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2315417|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
2315418|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2315419|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2315420|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2108959|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
2108960|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
2108961|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2108962|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108963|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
2878232|NCT05178862|Fluconazole|fluconazole|mesh-list
2878233|NCT05178862|Caspofungin|caspofungin|mesh-list
2878234|NCT05178862|Micafungin|micafungin|mesh-list
2878235|NCT05178862|Anidulafungin|anidulafungin|mesh-list
2878236|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
2878237|NCT05178862|Echinocandins|echinocandins|mesh-list
2878238|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
2878239|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2878240|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2878241|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2878242|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878243|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878244|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2878245|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
2878246|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2878247|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878248|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2108964|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108965|NCT02513095|Dantrolene|dantrolene|mesh-list
2108966|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2108967|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108968|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2108969|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108970|NCT02513160|Beclomethasone|beclomethasone|mesh-list
2108971|NCT02513160|Albuterol|albuterol|mesh-list
2108972|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2108973|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
2108974|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2108975|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108976|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2108977|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
2108978|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
2108979|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2108980|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2108981|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2878249|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2878250|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
2878251|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
2878252|NCT05178823|Fluorides|fluorides|mesh-list
2878253|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
2878254|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
2878255|NCT05178823|Protective Agents|protective agents|mesh-ancestor
2878256|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878257|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2878258|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2878259|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
2878260|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
2878261|NCT05178745|Fluorouracil|fluorouracil|mesh-list
2878262|NCT05178745|Irinotecan|irinotecan|mesh-list
2878263|NCT05178745|Aflibercept|aflibercept|mesh-list
2315421|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315422|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2315423|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2315424|NCT00348491|Analgesics|analgesics|mesh-ancestor
2315425|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
2315426|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2878264|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
2878265|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878266|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2878267|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878268|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2878269|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
2878270|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878271|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2878272|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2878273|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878274|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2878275|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2878276|NCT05178745|Growth Substances|growth substances|mesh-ancestor
2878277|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
2315427|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315428|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2315429|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315430|NCT00348504|Simendan|simendan|mesh-list
2315431|NCT00348504|Dobutamine|dobutamine|mesh-list
2315432|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2315433|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
2315434|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2315435|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2315436|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315437|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315438|NCT00348504|Protective Agents|protective agents|mesh-ancestor
2315439|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315440|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
2315441|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
2315442|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315443|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2315444|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2315445|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2315446|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
2315447|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315448|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2878278|NCT05178628|Gemcitabine|gemcitabine|mesh-list
2878279|NCT05178628|Paclitaxel|paclitaxel|mesh-list
2878280|NCT05178628|Tinzaparin|tinzaparin|mesh-list
2878281|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2878282|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878283|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
2878284|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
2878285|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
2878286|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878287|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2878288|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
2878289|NCT05178628|Antiviral Agents|antiviral agents|mesh-ancestor
2878290|NCT05178628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2878291|NCT05178628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878292|NCT05178628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2315449|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2878293|NCT05178628|Immunologic Factors|immunologic factors|mesh-ancestor
2878294|NCT05178628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878295|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
2878296|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2878297|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2878303|NCT05178511|Ensartinib|ensartinib|mesh-list
2878304|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878305|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2878306|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878307|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315450|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
2315451|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2315452|NCT00348517|Laxatives|laxatives|mesh-ancestor
2315453|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2315454|NCT00348530|Verapamil|verapamil|mesh-list
2315455|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2315456|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2315457|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2315458|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315459|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2315460|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315461|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
2315462|NCT00348582|Ketorolac|ketorolac|mesh-list
2878322|NCT05178407|Micronutrients|micronutrients|mesh-list
2878323|NCT05178407|Trace Elements|trace elements|mesh-list
2878324|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878337|NCT05178043|Nivolumab|nivolumab|mesh-list
2878338|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2878339|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878340|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2878341|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878342|NCT05177991|Bupivacaine|bupivacaine|mesh-list
2878343|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
2878344|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
2878345|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2878346|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878347|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
2878348|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2878374|NCT05177926|Tenofovir|tenofovir|mesh-list
2878375|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
2878376|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2878377|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2878378|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2878379|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878380|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878381|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2878382|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2878383|NCT05177848|Nicotine|nicotine|mesh-list
2878384|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2878385|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
2878386|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2878387|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878388|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2878389|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2878390|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
2878391|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2878392|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878393|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2878394|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2878395|NCT05177796|Paclitaxel|paclitaxel|mesh-list
2878396|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
2878397|NCT05177796|Carboplatin|carboplatin|mesh-list
2878398|NCT05177796|Doxorubicin|doxorubicin|mesh-list
2878399|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2878400|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
2878401|NCT05177796|Panitumumab|panitumumab|mesh-list
2878402|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2878403|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878404|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
2878405|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
2878406|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
2878407|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878408|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2878409|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
2878410|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878411|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2878412|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2878413|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
2878414|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2878415|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2878416|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2878417|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2878418|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878419|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2315463|NCT00348582|Nepafenac|nepafenac|mesh-list
2315464|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2315465|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2315466|NCT00348582|Analgesics|analgesics|mesh-ancestor
2315467|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
2878420|NCT05177731|Cytarabine|cytarabine|mesh-list
2878421|NCT05177731|Decitabine|decitabine|mesh-list
2878422|NCT05177731|Venetoclax|venetoclax|mesh-list
2878423|NCT05177731|Idarubicin|idarubicin|mesh-list
2878424|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2878425|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
2878426|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878427|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878428|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
2878429|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2878430|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2315468|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315469|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315470|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2315471|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315472|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2315473|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315474|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315475|NCT00348634|Tegaserod|tegaserod|mesh-list
2315476|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2315477|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
2315478|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315479|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315480|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315481|NCT00348712|Insulin|insulin|mesh-list
2315482|NCT00348712|Metformin|metformin|mesh-list
2315483|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
2315484|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2315485|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2315486|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315487|NCT00348725|Metformin|metformin|mesh-list
2315488|NCT00348725|Fenofibrate|fenofibrate|mesh-list
2315489|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2878431|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
2878432|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878433|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315490|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315491|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2315492|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
2315493|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315494|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2315495|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
2315496|NCT00348738|Hematinics|hematinics|mesh-ancestor
2315497|NCT00348764|Polidocanol|polidocanol|mesh-list
2315498|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2315499|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2315500|NCT00348894|Reboxetine|reboxetine|mesh-list
2315501|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
2878434|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2878435|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2878436|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2878444|NCT05161468|Triamcinolone|triamcinolone|mesh-list
2878445|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2878446|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2878447|NCT05161468|Lidocaine|lidocaine|mesh-list
2878448|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
2315502|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2315503|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2315504|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2878449|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
2878450|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2878451|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
2878452|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
2878453|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2878454|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878455|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
2878456|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2878457|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2878458|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2878459|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2878460|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2878461|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878462|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
2878463|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2878464|NCT05161468|Hormones|hormones|mesh-ancestor
2878465|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2878466|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2878467|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
2878468|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878469|NCT05158491|Irinotecan|irinotecan|mesh-list
2878470|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2878471|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2878472|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315505|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2315506|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315507|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
2315508|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315509|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315510|NCT00348920|Bupivacaine|bupivacaine|mesh-list
2878473|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878474|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878475|NCT05157464|Losartan|losartan|mesh-list
2878476|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2878477|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2878478|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2878479|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2315511|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
2315512|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
2315513|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2315514|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315515|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
2315516|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315517|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
2315518|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2315519|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878480|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878481|NCT05156905|Docetaxel|docetaxel|mesh-list
2878482|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878483|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
2878484|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
2878485|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
2315520|NCT00348985|Bortezomib|bortezomib|mesh-list
2315521|NCT00348985|Belinostat|belinostat|mesh-list
2315522|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315523|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2315524|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315525|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315526|NCT00348998|Bevacizumab|bevacizumab|mesh-list
2315527|NCT00348998|Goserelin|goserelin|mesh-list
2315528|NCT00348998|Bicalutamide|bicalutamide|mesh-list
2315529|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2315530|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315531|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2315532|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2315533|NCT00348998|Growth Substances|growth substances|mesh-ancestor
2315534|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315535|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
2315536|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2315537|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
2315538|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
2315539|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2315540|NCT00349024|Povidone|povidone|mesh-list
2315541|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
2315542|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2315543|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
2315544|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315545|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
2315546|NCT00349024|Protective Agents|protective agents|mesh-ancestor
2315547|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
2315548|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
2315549|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
2315550|NCT00349076|Fluorouracil|fluorouracil|mesh-list
2878486|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315551|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315552|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
2315553|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315554|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2315555|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2878495|NCT05153174|Sulforaphane|sulforaphane|mesh-list
2878496|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2878497|NCT05153174|Protective Agents|protective agents|mesh-ancestor
2878498|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878499|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878506|NCT05135910|Terbinafine|terbinafine|mesh-list
2878507|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
2878508|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2878509|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878510|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878511|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
2878512|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2878513|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
2878514|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878515|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2878516|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878517|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2108982|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2108983|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
2108984|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315556|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
2315557|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315558|NCT00349089|Pemetrexed|pemetrexed|mesh-list
2315559|NCT00349089|Vinorelbine|vinorelbine|mesh-list
2315560|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315561|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315562|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315563|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2315564|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2315565|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2315566|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
2315567|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
2315568|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
2315569|NCT00349115|Thalidomide|thalidomide|mesh-list
2315570|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2315571|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
2315572|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315573|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
2315574|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2315575|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2315576|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2315577|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2315578|NCT00349115|Growth Substances|growth substances|mesh-ancestor
2315579|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
2315580|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315581|NCT00349128|Metformin|metformin|mesh-list
2315582|NCT00349128|Fenofibrate|fenofibrate|mesh-list
2315583|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2315584|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878530|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
2878531|NCT05121714|Caffeine|caffeine|mesh-list
2878532|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2878533|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878534|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2878535|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878536|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878537|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2878538|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2878539|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
2878540|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2878541|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2878542|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2878543|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2878544|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2878545|NCT05121714|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2878546|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2878547|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2878548|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
2878549|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2878550|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
2878551|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2878552|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2878553|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2878554|NCT05117710|Ebselen|ebselen|mesh-list
2878555|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2878556|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2878557|NCT05117710|Analgesics|analgesics|mesh-ancestor
2878558|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
2878559|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2878560|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878561|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2878562|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2878563|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2878564|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2878565|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
2878566|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878567|NCT05117710|Protective Agents|protective agents|mesh-ancestor
2878568|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2878569|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878570|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2878571|NCT05113940|Midazolam|midazolam|mesh-list
2878572|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2878573|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2878574|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2878575|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878576|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2878577|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2878578|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2878579|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2878580|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
2878581|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
2878582|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
2878583|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
2878584|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2878585|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315585|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2315586|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
2315587|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315588|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2315589|NCT00349180|Enoxaparin|enoxaparin|mesh-list
2315590|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
2315591|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
2315592|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2315593|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2315594|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315595|NCT00349206|Sirolimus|sirolimus|mesh-list
2315596|NCT00349206|Sorafenib|sorafenib|mesh-list
2315597|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315598|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2315599|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315600|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315601|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2315602|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2315603|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2315604|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
2878611|NCT05107219|Linaclotide|linaclotide|mesh-list
2878612|NCT05107219|Plecanatide|plecanatide|mesh-list
2878613|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2878614|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
2878615|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878616|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2878628|NCT05069545|Insulin|insulin|mesh-list
2878629|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2878630|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
2315605|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2315606|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
2315607|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315608|NCT00349219|Gemcitabine|gemcitabine|mesh-list
2315609|NCT00349219|Cisplatin|cisplatin|mesh-list
2315610|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2315611|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315612|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2315613|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
2315614|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315615|NCT00349219|Antiviral Agents|antiviral agents|mesh-ancestor
2315616|NCT00349219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2315617|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315618|NCT00349219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2315619|NCT00349219|Immunologic Factors|immunologic factors|mesh-ancestor
2878631|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2878632|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878633|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
2878634|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878635|NCT05065411|Everolimus|everolimus|mesh-list
2878636|NCT05065411|Fulvestrant|fulvestrant|mesh-list
2878637|NCT05065411|Exemestane|exemestane|mesh-list
2315620|NCT00349219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315621|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2315622|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
2315623|NCT00349245|Remifentanil|remifentanil|mesh-list
2315624|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2315625|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2315626|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315627|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2315628|NCT00349245|Analgesics|analgesics|mesh-ancestor
2315629|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
2315630|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315631|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2315632|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2315633|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2315634|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
2878638|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878639|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2878640|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
2878641|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878642|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2878643|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2878644|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2878645|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
2878646|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2878647|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2878648|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2878649|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878650|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878674|NCT05060315|Treprostinil|treprostinil|mesh-list
2878675|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2315635|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315636|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315637|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2315638|NCT00349245|Narcotics|narcotics|mesh-ancestor
2315639|NCT00349258|Leuprolide|leuprolide|mesh-list
2315640|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2315641|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
2315642|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2315643|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315644|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2315645|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315646|NCT00349284|Ezetimibe|ezetimibe|mesh-list
2315647|NCT00349284|Fenofibrate|fenofibrate|mesh-list
2315648|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2315649|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2315650|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
2878701|NCT05043870|Infliximab|infliximab|mesh-list
2878702|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2878703|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
2315651|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315652|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2315653|NCT00349310|Pramipexole|pramipexole|mesh-list
2315654|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
2315655|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878704|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2878705|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2878706|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
2878707|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878708|NCT05039619|Acetaminophen|acetaminophen|mesh-list
2878709|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
2878710|NCT05039619|Promethazine|promethazine|mesh-list
2878711|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
2878712|NCT05039619|Prednisone|prednisone|mesh-list
2878713|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
2878714|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
2878715|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2878716|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
2878717|NCT05039619|Hormones|hormones|mesh-ancestor
2878718|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2878719|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878720|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2878721|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878722|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2878723|NCT05039619|Analgesics|analgesics|mesh-ancestor
2878724|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
2878725|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2878726|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
2878727|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2878728|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2878729|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
2878730|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2878731|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2878732|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878733|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878734|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
2878735|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
2878736|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2878737|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2878738|NCT05039619|Protective Agents|protective agents|mesh-ancestor
2315656|NCT00349310|Protective Agents|protective agents|mesh-ancestor
2315657|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315658|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2315659|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2315660|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
2315661|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
2315662|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315663|NCT00349362|Testosterone|testosterone|mesh-list
2315664|NCT00349362|Androgens|androgens|mesh-ancestor
2315665|NCT00349362|Hormones|hormones|mesh-ancestor
2315666|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2315667|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315668|NCT00349375|Simvastatin|simvastatin|mesh-list
2315669|NCT00349375|Fenofibrate|fenofibrate|mesh-list
2315670|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2315671|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2315672|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
2315673|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315674|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2315675|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2315676|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315677|NCT00349401|Ketorolac|ketorolac|mesh-list
2878739|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2878740|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2878741|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2878742|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2878743|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
2878744|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
2878745|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2878746|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
2878747|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
2878748|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2878749|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2878750|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
2878751|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
2315678|NCT00349401|Morphine|morphine|mesh-list
2315679|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2315680|NCT00349401|Narcotics|narcotics|mesh-ancestor
2315681|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2315682|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315683|NCT00349401|Analgesics|analgesics|mesh-ancestor
2878775|NCT05035303|Epinephrine|epinephrine|mesh-list
2878776|NCT05035303|Norepinephrine|norepinephrine|mesh-list
2878777|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2878778|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2108985|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108986|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2108987|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
2108988|NCT02513160|Hormones|hormones|mesh-ancestor
2108989|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2108990|NCT02513212|Fluorides|fluorides|mesh-list
2108991|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
2108992|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
2108993|NCT02513212|Protective Agents|protective agents|mesh-ancestor
2315684|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
2878779|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
2878780|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2878781|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878782|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878783|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2878784|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2878785|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
2878786|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2878787|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2878788|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
2878789|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
2878790|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
2878791|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2878796|NCT05029960|Brivaracetam|brivaracetam|mesh-list
2878797|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
2315685|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315686|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2315687|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2315688|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2315689|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2878819|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
2878820|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2315690|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2315691|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315692|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315693|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
2315694|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2315695|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315696|NCT00349440|Cyclosporine|cyclosporine|mesh-list
2315697|NCT00349440|Cyclosporins|cyclosporins|mesh-list
2315698|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315699|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315700|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2315701|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
2315702|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315703|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
2315704|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2315705|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
2315706|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315707|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2315708|NCT00349453|Deferiprone|deferiprone|mesh-list
2315709|NCT00349453|Deferoxamine|deferoxamine|mesh-list
2315710|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2315711|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
2315712|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
2315713|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315714|NCT00349453|Siderophores|siderophores|mesh-ancestor
2315715|NCT00349492|Cisplatin|cisplatin|mesh-list
2315716|NCT00349492|Irinotecan|irinotecan|mesh-list
2315717|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315718|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2315719|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2315720|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315721|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315722|NCT00349518|Dasatinib|dasatinib|mesh-list
2315723|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315724|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2315725|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315726|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315727|NCT00349531|Pramipexole|pramipexole|mesh-list
2315728|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
2315729|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315730|NCT00349531|Protective Agents|protective agents|mesh-ancestor
2315731|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315732|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2315733|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2315734|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
2315735|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
2315736|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315737|NCT00349557|Bevacizumab|bevacizumab|mesh-list
2315738|NCT00349557|Goserelin|goserelin|mesh-list
2315739|NCT00349557|Bicalutamide|bicalutamide|mesh-list
2315740|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2315741|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315742|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2315743|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2315744|NCT00349557|Growth Substances|growth substances|mesh-ancestor
2315745|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315746|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
2315747|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2315748|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
2878821|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
2878822|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878823|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
2878824|NCT05025865|Protective Agents|protective agents|mesh-ancestor
2878850|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
2878851|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2878852|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
2878853|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315749|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
2315750|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2315751|NCT00349583|Cyclosporine|cyclosporine|mesh-list
2315752|NCT00349583|Cyclosporins|cyclosporins|mesh-list
2315753|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878854|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
2878855|NCT05018481|Protective Agents|protective agents|mesh-ancestor
2878856|NCT05011149|Ibuprofen|ibuprofen|mesh-list
2878857|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2878858|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2878859|NCT05011149|Analgesics|analgesics|mesh-ancestor
2878860|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
2878861|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2878862|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878863|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2878864|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2878865|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2878866|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878867|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878874|NCT05006794|Gemcitabine|gemcitabine|mesh-list
2878875|NCT05006794|Docetaxel|docetaxel|mesh-list
2878876|NCT05006794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2878877|NCT05006794|Antimetabolites|antimetabolites|mesh-ancestor
2878878|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878879|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878880|NCT05006794|Antiviral Agents|antiviral agents|mesh-ancestor
2878881|NCT05006794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2878882|NCT05006794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878883|NCT05006794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2878884|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
2878885|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878886|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
2878887|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
2878888|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
2878889|NCT04995978|Pioglitazone|pioglitazone|mesh-list
2878890|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2878891|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878892|NCT04994808|Fludarabine|fludarabine|mesh-list
2315754|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315755|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2315756|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
2315757|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315758|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
2878893|NCT04994808|Clofarabine|clofarabine|mesh-list
2878894|NCT04994808|Treosulfan|treosulfan|mesh-list
2878895|NCT04994808|Busulfan|busulfan|mesh-list
2878896|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878897|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2878898|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
2878899|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878900|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2878901|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
2878902|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878903|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2878904|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
2878905|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2878911|NCT04987372|Lidocaine|lidocaine|mesh-list
2878912|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
2878913|NCT04987372|Pregabalin|pregabalin|mesh-list
2878914|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
2878915|NCT04987372|Ketamine|ketamine|mesh-list
2878916|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
2878917|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
2878918|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2878919|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878920|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
2315759|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2315760|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
2315761|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315762|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2315763|NCT00349596|Decitabine|decitabine|mesh-list
2315764|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2315765|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
2878921|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2878922|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2878923|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2878924|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2878925|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2878926|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878927|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2878928|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2878929|NCT04987372|Analgesics|analgesics|mesh-ancestor
2878930|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2878931|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2878932|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2878933|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
2878934|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2878935|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2878936|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2878937|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
2878938|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2878939|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2878940|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
2878941|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2878942|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2878943|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2878944|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2878945|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2878946|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
2878947|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2878948|NCT04965597|Vidarabine|vidarabine|mesh-list
2878949|NCT04965597|Methotrexate|methotrexate|mesh-list
2878950|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
2878951|NCT04965597|Fludarabine|fludarabine|mesh-list
2878952|NCT04965597|Treosulfan|treosulfan|mesh-list
2878953|NCT04965597|Busulfan|busulfan|mesh-list
2878954|NCT04965597|Tacrolimus|tacrolimus|mesh-list
2878955|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
2878956|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2878957|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2878958|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
2878959|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2878960|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878961|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2878962|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
2878963|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2878964|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878965|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
2878966|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2878967|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2878968|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2878969|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
2315766|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315767|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315768|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315769|NCT00349635|Metformin|metformin|mesh-list
2315770|NCT00349635|Fenofibrate|fenofibrate|mesh-list
2315771|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2315772|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315773|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2315774|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
2315775|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315776|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2315777|NCT00349674|Methotrexate|methotrexate|mesh-list
2315778|NCT00349674|Azathioprine|azathioprine|mesh-list
2315779|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2315780|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
2315781|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2315782|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315783|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2315784|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
2315785|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315786|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315787|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
2315788|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315789|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2315790|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2315791|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
2315792|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315793|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2315794|NCT00349726|Inositol|inositol|mesh-list
2315795|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
2315796|NCT00349726|Vitamins|vitamins|mesh-ancestor
2315797|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
2315798|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315799|NCT00349739|Anecortave|anecortave|mesh-list
2315800|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2878970|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2878971|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2878972|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2878973|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2878974|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
2878975|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2878976|NCT04965597|Antiviral Agents|antiviral agents|mesh-ancestor
2878977|NCT04965597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2878978|NCT04963296|Acetaminophen|acetaminophen|mesh-list
2878979|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
2878980|NCT04963296|Promethazine|promethazine|mesh-list
2878981|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
2878982|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
2878983|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2878984|NCT04963296|Analgesics|analgesics|mesh-ancestor
2878985|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
2878986|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2878987|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2878988|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
2315801|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2315802|NCT00349739|Growth Substances|growth substances|mesh-ancestor
2315803|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315804|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
2315805|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315806|NCT00349791|Testosterone|testosterone|mesh-list
2315807|NCT00349791|Androgens|androgens|mesh-ancestor
2315808|NCT00349791|Hormones|hormones|mesh-ancestor
2315809|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2878989|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2878990|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
2878991|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
2878992|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2878993|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
2878994|NCT04963296|Hormones|hormones|mesh-ancestor
2878995|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2878996|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2878997|NCT04963296|Protective Agents|protective agents|mesh-ancestor
2878998|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2878999|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2879000|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2315810|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315811|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
2315812|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2315813|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315814|NCT00350038|Irbesartan|irbesartan|mesh-list
2315815|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
2879001|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2879002|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2879003|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
2879004|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
2879005|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2879006|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
2879007|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
2879008|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2879009|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879010|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2879011|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
2879012|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
2879018|NCT04950426|Propranolol|propranolol|mesh-list
2879019|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2879020|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2879021|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
2879022|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315816|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2315817|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2315818|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2315819|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315820|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2315821|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
2315822|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2315823|NCT00350051|Prednisone|prednisone|mesh-list
2315824|NCT00350051|Sagopilone|sagopilone|mesh-list
2315825|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2315826|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
2315827|NCT00350051|Hormones|hormones|mesh-ancestor
2315828|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2315829|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315830|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2315831|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315832|NCT00350077|Vitamins|vitamins|mesh-list
2315833|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
2315834|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
2315835|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315836|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
2315837|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315838|NCT00350077|Protective Agents|protective agents|mesh-ancestor
2315839|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
2315840|NCT00350090|Hematinics|hematinics|mesh-ancestor
2315841|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
2879023|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879024|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879025|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2879026|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2879027|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
2879028|NCT04950322|Leucovorin|leucovorin|mesh-list
2879029|NCT04950322|Fluorouracil|fluorouracil|mesh-list
2879030|NCT04950322|Oxaliplatin|oxaliplatin|mesh-list
2879031|NCT04950322|Antimetabolites|antimetabolites|mesh-ancestor
2879032|NCT04950322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315842|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
2879033|NCT04950322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2879034|NCT04950322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879035|NCT04950322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2879036|NCT04950322|Immunologic Factors|immunologic factors|mesh-ancestor
2879037|NCT04950322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879038|NCT04950322|Antidotes|antidotes|mesh-ancestor
2879039|NCT04950322|Protective Agents|protective agents|mesh-ancestor
2879040|NCT04950322|Vitamin B Complex|vitamin b complex|mesh-ancestor
2879041|NCT04950322|Vitamins|vitamins|mesh-ancestor
2879042|NCT04950322|Micronutrients|micronutrients|mesh-ancestor
2879043|NCT04939636|Vitamin D|vitamin d|mesh-list
2879044|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
2879045|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
2879046|NCT04939636|Vitamins|vitamins|mesh-list
2879047|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
2879048|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879049|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2879050|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2315843|NCT00350116|Vitamins|vitamins|mesh-ancestor
2315844|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
2315845|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315846|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
2315847|NCT00350116|Hematinics|hematinics|mesh-ancestor
2315848|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
2315849|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2315850|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2315851|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315852|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315853|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2315854|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2315855|NCT00350155|Analgesics|analgesics|mesh-ancestor
2315856|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
2315857|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315858|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315859|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2315860|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315861|NCT00350168|Amlodipine|amlodipine|mesh-list
2315862|NCT00350168|Valsartan|valsartan|mesh-list
2315863|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2315864|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2315865|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2315866|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2108994|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2108995|NCT02513446|Itraconazole|itraconazole|mesh-list
2108996|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
2108997|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2108998|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2108999|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2109000|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109001|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109002|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2109003|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
2109004|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109005|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315867|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2315868|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879093|NCT04929548|Maleic acid|maleic acid|mesh-list
2879094|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879095|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315869|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
2315870|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2315871|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2315872|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
2315873|NCT00350181|Sirolimus|sirolimus|mesh-list
2315874|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
2879110|NCT04921722|Sirolimus|sirolimus|mesh-list
2879111|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2879112|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2879113|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2879114|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879115|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
2879116|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2879117|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
2879118|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879119|NCT04919629|Bevacizumab|bevacizumab|mesh-list
2315875|NCT00350181|Busulfan|busulfan|mesh-list
2315876|NCT00350181|Carmustine|carmustine|mesh-list
2315877|NCT00350181|Etoposide|etoposide|mesh-list
2315878|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2315879|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
2315880|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315881|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315882|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2315883|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
2315884|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315885|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315886|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2315887|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2315888|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2315889|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2315890|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315891|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2315892|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2879120|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2879121|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
2879122|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
2879123|NCT04919629|Antibodies|antibodies|mesh-list
2879124|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
2879125|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2879126|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
2879127|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879128|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2879129|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2879130|NCT04919629|Growth Substances|growth substances|mesh-ancestor
2879131|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879132|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
2879133|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
2879183|NCT04900038|Lamivudine|lamivudine|mesh-list
2879184|NCT04900038|Dolutegravir|dolutegravir|mesh-list
2879185|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2879186|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2879187|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879188|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879189|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
2879190|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2879191|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2879192|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2879193|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2879194|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2315893|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
2315894|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2315895|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2315896|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
2315897|NCT00350311|Nicotine|nicotine|mesh-list
2315898|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2315899|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
2315900|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315901|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315902|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2315903|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2315904|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
2315905|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315906|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315907|NCT00350415|Mesalamine|mesalamine|mesh-list
2315908|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2315909|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2315910|NCT00350415|Analgesics|analgesics|mesh-ancestor
2315911|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
2315912|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315913|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315914|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2315915|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2315916|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
2315917|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315918|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
2315919|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2315920|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2315921|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2315922|NCT00350441|Urological Agents|urological agents|mesh-ancestor
2315923|NCT00350454|Sirolimus|sirolimus|mesh-list
2315924|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2315925|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2315926|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2315927|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315928|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
2315929|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2315930|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
2315931|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315932|NCT00350467|Olanzapine|olanzapine|mesh-list
2315933|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2315934|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
2315935|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
2315936|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2315937|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315938|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2315939|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2315940|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2315941|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2315942|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2315943|NCT00350467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2315944|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2315945|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2315946|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315947|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2315948|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
2315949|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2315950|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2315951|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2315952|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2315953|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
2315954|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2315955|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
2315956|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2315957|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2315958|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
2315959|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2315960|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315961|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2315962|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2315963|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2315964|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315965|NCT00350597|Molgramostim|molgramostim|mesh-list
2315966|NCT00350597|Sargramostim|sargramostim|mesh-list
2315967|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
2315968|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315969|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315970|NCT00350662|Deferiprone|deferiprone|mesh-list
2315971|NCT00350662|Deferoxamine|deferoxamine|mesh-list
2315972|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2315973|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
2315974|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
2315975|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2315976|NCT00350662|Siderophores|siderophores|mesh-ancestor
2315977|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
2315978|NCT00350701|Testosterone|testosterone|mesh-list
2879226|NCT04865835|Metformin|metformin|mesh-list
2879227|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2879228|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879239|NCT04842045|Midazolam|midazolam|mesh-list
2879240|NCT04842045|Psilocybin|psilocybin|mesh-list
2879241|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2879242|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2879243|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2879244|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879245|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2879246|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2879247|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2879248|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2879249|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
2879250|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
2879251|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
2879252|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
2879253|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2879254|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879255|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
2315979|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
2879261|NCT04805125|Vaccines|vaccines|mesh-list
2879262|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
2879263|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879264|NCT04781972|Methylphenidate|methylphenidate|mesh-list
2879265|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2879266|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879267|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2879268|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2879269|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2879270|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879271|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
2879272|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2879281|NCT04772274|Ustekinumab|ustekinumab|mesh-list
2879282|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
2879283|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2879284|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2879285|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2879286|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879287|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
2879288|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2879289|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879300|NCT04745845|Norepinephrine|norepinephrine|mesh-list
2879301|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2879302|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2879303|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
2879304|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2879305|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879306|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879307|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
2879308|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
2879309|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2879310|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2879311|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
2879312|NCT04740294|Analgesics|analgesics|mesh-ancestor
2315980|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
2315981|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2315982|NCT00350701|Androgens|androgens|mesh-ancestor
2879313|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
2879314|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2879315|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879316|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
2879317|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2879318|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2879319|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
2879320|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2879321|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2879322|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879323|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2879324|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
2879325|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2315983|NCT00350701|Hormones|hormones|mesh-ancestor
2315984|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2315985|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315986|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2315987|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315988|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
2315989|NCT00350753|Bevacizumab|bevacizumab|mesh-list
2315990|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2315991|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2315992|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2315993|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2315994|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2315995|NCT00350753|Growth Substances|growth substances|mesh-ancestor
2315996|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2315997|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
2315998|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2315999|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316000|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316001|NCT00350818|Azacitidine|azacitidine|mesh-list
2316002|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2316003|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
2316004|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879370|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2879371|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2879372|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2879373|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879374|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
2879375|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2879376|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879377|NCT04730349|Nivolumab|nivolumab|mesh-list
2879378|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2879379|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879380|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2879381|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879382|NCT04728646|Dexamethasone|dexamethasone|mesh-list
2879383|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2316005|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316006|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316007|NCT00350857|Carbamazepine|carbamazepine|mesh-list
2316008|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
2316009|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
2879384|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
2879385|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
2879386|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2879387|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879388|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2879389|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
2879390|NCT04728646|Hormones|hormones|mesh-ancestor
2316010|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2316011|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316012|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316013|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2316014|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2316015|NCT00350857|Analgesics|analgesics|mesh-ancestor
2316016|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
2316017|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316018|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2316019|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316020|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316021|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2316022|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2879391|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2879392|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2879393|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879408|NCT04718155|Atorvastatin|atorvastatin|mesh-list
2879409|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2879410|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2879411|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
2879412|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879413|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2879414|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2879415|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879416|NCT04708886|Alendronate|alendronate|mesh-list
2879417|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2879418|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879427|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2879428|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
2879429|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316023|NCT00350948|Doxorubicin|doxorubicin|mesh-list
2316024|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2316025|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2316026|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316027|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2316028|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2316029|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316030|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316031|NCT00350961|Gemcitabine|gemcitabine|mesh-list
2879435|NCT04671043|Caffeine|caffeine|mesh-list
2879436|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2879437|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879438|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2879439|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879440|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879441|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2879442|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2879443|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
2879444|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2879445|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2879446|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
2879447|NCT04664738|Coagulants|coagulants|mesh-ancestor
2879448|NCT04652960|Nivolumab|nivolumab|mesh-list
2879449|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2316032|NCT00350961|Capecitabine|capecitabine|mesh-list
2316033|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
2316034|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2316035|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
2316036|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879450|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879451|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2879452|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879453|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
2879454|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2879455|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316037|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316038|NCT00350961|Antiviral Agents|antiviral agents|mesh-ancestor
2879456|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879477|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
2879478|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2879479|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879480|NCT04631029|Carboplatin|carboplatin|mesh-list
2879481|NCT04631029|Etoposide|etoposide|mesh-list
2879482|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
2879483|NCT04631029|Atezolizumab|atezolizumab|mesh-list
2879484|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
2879485|NCT04631029|Entinostat|entinostat|mesh-list
2879486|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2879487|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2879488|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879489|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2879490|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2879491|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2879492|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879493|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879494|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
2879495|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879496|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
2879497|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
2879498|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
2879499|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
2879500|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
2879538|NCT04626596|Etonogestrel|etonogestrel|mesh-list
2879539|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2879540|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
2879541|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2879542|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316039|NCT00350961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316040|NCT00350961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316041|NCT00350961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2316042|NCT00350961|Immunologic Factors|immunologic factors|mesh-ancestor
2316043|NCT00350961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316044|NCT00351026|Methadone|methadone|mesh-list
2316045|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2316046|NCT00351026|Narcotics|narcotics|mesh-ancestor
2316047|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316048|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879543|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2879544|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
2879545|NCT04616547|Antidotes|antidotes|mesh-ancestor
2879546|NCT04616547|Protective Agents|protective agents|mesh-ancestor
2879547|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316049|NCT00351026|Analgesics|analgesics|mesh-ancestor
2316050|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
2316051|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316052|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
2879548|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
2879549|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
2879550|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879551|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2879552|NCT04594408|Epinephrine|epinephrine|mesh-list
2879553|NCT04594408|Racepinephrine|racepinephrine|mesh-list
2879554|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
2879555|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
2879556|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2316053|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
2879557|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2879558|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
2879559|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2879560|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879561|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879562|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2879563|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2879564|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
2879565|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2879566|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2879567|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
2879568|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
2879569|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
2879570|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2879571|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2879572|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2879573|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
2879574|NCT04594408|Coagulants|coagulants|mesh-ancestor
2879575|NCT04593940|Remdesivir|remdesivir|mesh-list
2879576|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
2879577|NCT04593940|Abatacept|abatacept|mesh-list
2879578|NCT04593940|Infliximab|infliximab|mesh-list
2879579|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
2879580|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2879581|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2879582|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2879583|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879584|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879585|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2879586|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
2879587|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879588|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
2879589|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
2879590|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2879591|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2316054|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
2316055|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2316056|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2316057|NCT00351052|Analgesics|analgesics|mesh-ancestor
2316058|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
2316059|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316060|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316061|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2316062|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2316063|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
2316064|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2316065|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
2316066|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2316067|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316068|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316069|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
2316070|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2316071|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316072|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879592|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2879593|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2879594|NCT04585958|Trastuzumab|trastuzumab|mesh-list
2879595|NCT04585958|Olaparib|olaparib|mesh-list
2879596|NCT04585958|Camptothecin|camptothecin|mesh-list
2879597|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2879598|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
2879599|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2879600|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879601|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879602|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879603|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2879604|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2879605|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2879606|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
2879607|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879608|NCT04580134|Risperidone|risperidone|mesh-list
2879609|NCT04580134|Clozapine|clozapine|mesh-list
2879610|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2879611|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
2879612|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2879613|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316073|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2316074|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316075|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2316076|NCT00351104|Ketoprofen|ketoprofen|mesh-list
2316077|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2316078|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2316079|NCT00351104|Analgesics|analgesics|mesh-ancestor
2316080|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
2316081|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316082|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316083|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2316084|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2316085|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2316086|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316087|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316088|NCT00351130|Amlodipine|amlodipine|mesh-list
2316089|NCT00351130|Valsartan|valsartan|mesh-list
2316090|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2879614|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879615|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2879616|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2879617|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2879618|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2879619|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2879620|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
2879621|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
2879622|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
2879623|NCT04580121|Acetaminophen|acetaminophen|mesh-list
2879624|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
2879625|NCT04580121|Promethazine|promethazine|mesh-list
2879626|NCT04580121|Dexamethasone|dexamethasone|mesh-list
2879627|NCT04580121|Dasatinib|dasatinib|mesh-list
2879628|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2879629|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
2879630|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
2879631|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2879632|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879633|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2879634|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
2879635|NCT04580121|Hormones|hormones|mesh-ancestor
2879636|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2879637|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2879638|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879639|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2879640|NCT04580121|Analgesics|analgesics|mesh-ancestor
2879641|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
2879642|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
2879643|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2879644|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879645|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879646|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2879647|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2879648|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2879649|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
2879650|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
2879651|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2879652|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
2879653|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
2879654|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2879655|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2879656|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
2879657|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
2879677|NCT04576104|Metformin|metformin|mesh-list
2879678|NCT04576104|Megestrol|megestrol|mesh-list
2879679|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
2879680|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2879681|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879682|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2879683|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2109006|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2109007|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2879684|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2879685|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
2879686|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2879687|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2879688|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2879689|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2879690|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879691|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
2879692|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2879693|NCT04567420|Fulvestrant|fulvestrant|mesh-list
2879694|NCT04567420|Palbociclib|palbociclib|mesh-list
2879695|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2879696|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879697|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2879698|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2879699|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
2879700|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2879701|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879702|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2879703|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879704|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316091|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2316092|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316093|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316094|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2316095|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316096|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
2316097|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2316098|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2316099|NCT00351143|Fluticasone|fluticasone|mesh-list
2316100|NCT00351143|Xhance|xhance|mesh-list
2316101|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2316102|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2879716|NCT04565990|Selexipag|selexipag|mesh-list
2879717|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2879722|NCT04555811|Rituximab|rituximab|mesh-list
2879723|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2879724|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879725|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
2879726|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879727|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2879728|NCT04550260|Cisplatin|cisplatin|mesh-list
2316103|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2316104|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
2316105|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316106|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879729|NCT04550260|Fluorouracil|fluorouracil|mesh-list
2879730|NCT04550260|Capecitabine|capecitabine|mesh-list
2879731|NCT04550260|Durvalumab|durvalumab|mesh-list
2879732|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879733|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
2879734|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879735|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2879736|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2879737|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
2879738|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879739|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2316107|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2316108|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
2316109|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
2316110|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2316111|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2316112|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2316113|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2316114|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
2316115|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316116|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316117|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2316118|NCT00351169|Citalopram|citalopram|mesh-list
2316119|NCT00351169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2879747|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
2879748|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2879749|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2879750|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109008|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
2109009|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109010|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
2109011|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2109012|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109013|NCT02513498|Ixazomib|ixazomib|mesh-list
2109014|NCT02513498|Glycine|glycine|mesh-list
2109015|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109016|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109017|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
2109018|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316120|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2316121|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316122|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316123|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316124|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
2316125|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316126|NCT00351169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2316127|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
2316128|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2316129|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2316130|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2316131|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316132|NCT00351182|Doxycycline|doxycycline|mesh-list
2316133|NCT00351182|Telithromycin|telithromycin|mesh-list
2316134|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2316135|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316136|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
2316137|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2316138|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2316139|NCT00351195|Capecitabine|capecitabine|mesh-list
2316140|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
2316141|NCT00351195|Etoposide|etoposide|mesh-list
2316142|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2316143|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
2316144|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879751|NCT04543383|Thrombin|thrombin|mesh-list
2879752|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
2879753|NCT04543383|Coagulants|coagulants|mesh-ancestor
2879754|NCT04529720|Vaccines|vaccines|mesh-list
2879755|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
2879756|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879757|NCT04527380|Adalimumab|adalimumab|mesh-list
2879758|NCT04527380|Ixekizumab|ixekizumab|mesh-list
2879759|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2879760|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2879761|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
2879762|NCT04522284|Capecitabine|capecitabine|mesh-list
2879763|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2879764|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
2879765|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879766|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879767|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2879768|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879769|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
2879770|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2879771|NCT04509791|Antibodies|antibodies|mesh-list
2316145|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316146|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2316147|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2316148|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2316149|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316150|NCT00351221|Mecasermin|mecasermin|mesh-list
2316151|NCT00351221|Growth Substances|growth substances|mesh-ancestor
2316152|NCT00351221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316153|NCT00351286|Simvastatin|simvastatin|mesh-list
2316154|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2316155|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2316156|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
2316157|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316158|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2316159|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2316160|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316161|NCT00351364|Montelukast|montelukast|mesh-list
2316162|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2316163|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
2316164|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2316165|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
2316166|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2316167|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316168|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2316169|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2316170|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316171|NCT00351403|Ribavirin|ribavirin|mesh-list
2316172|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2316173|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
2316174|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316175|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
2316176|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316177|NCT00351507|Vildagliptin|vildagliptin|mesh-list
2316178|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2316179|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879772|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
2879773|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
2879774|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879775|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2879776|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
2879777|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2879778|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
2879779|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2879780|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
2879781|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879782|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879783|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
2879784|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
2879785|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2879786|NCT04475848|Midazolam|midazolam|mesh-list
2879787|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2879788|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2879789|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2879790|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879791|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2879792|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2879793|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2879794|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2879795|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
2879796|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
2316180|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2316181|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
2316182|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316183|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316184|NCT00351546|Vildagliptin|vildagliptin|mesh-list
2316185|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2316186|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316187|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2316188|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
2316189|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316190|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316191|NCT00351585|Vildagliptin|vildagliptin|mesh-list
2316192|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2316193|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316194|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2316195|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
2316196|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316197|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316198|NCT00351637|Methadone|methadone|mesh-list
2316199|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2316200|NCT00351637|Narcotics|narcotics|mesh-ancestor
2316201|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316202|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316203|NCT00351637|Analgesics|analgesics|mesh-ancestor
2879797|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
2879798|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
2879799|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2879800|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879801|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
2879802|NCT04460456|Cemiplimab|cemiplimab|mesh-list
2879803|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2316204|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
2316205|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316206|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
2316207|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
2316208|NCT00351663|Enoxaparin|enoxaparin|mesh-list
2316209|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
2316210|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2316211|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2316212|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316213|NCT00351702|Isoniazid|isoniazid|mesh-list
2316214|NCT00351702|Ethambutol|ethambutol|mesh-list
2316215|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
2316216|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2316217|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316218|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2316219|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2316220|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
2316221|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316222|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2316223|NCT00351715|Methadone|methadone|mesh-list
2316224|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2316225|NCT00351715|Narcotics|narcotics|mesh-ancestor
2316226|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316227|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316228|NCT00351715|Analgesics|analgesics|mesh-ancestor
2879804|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879805|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
2879806|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2879807|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879808|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2879809|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2879810|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2879811|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879812|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
2879813|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316229|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
2316230|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316231|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
2316232|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
2879826|NCT04439188|GSK2636771|gsk2636771|mesh-list
2879827|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879828|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2879829|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879830|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879831|NCT04439149|GSK2636771|gsk2636771|mesh-list
2879832|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879833|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2879834|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879835|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879836|NCT04435782|Selexipag|selexipag|mesh-list
2316233|NCT00351832|Vildagliptin|vildagliptin|mesh-list
2316234|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2316235|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316236|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2316237|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
2316238|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316239|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316240|NCT00351871|Ribavirin|ribavirin|mesh-list
2316241|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2316242|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
2316243|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316244|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
2316245|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316246|NCT00351884|Vildagliptin|vildagliptin|mesh-list
2316247|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2316248|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316249|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2316250|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
2316251|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316252|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316253|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2879837|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2879838|NCT04429685|Ketamine|ketamine|mesh-list
2879839|NCT04429685|Analgesics|analgesics|mesh-ancestor
2879840|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
2879841|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2879842|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879843|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2879844|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2879845|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
2879846|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
2879847|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2879848|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2316254|NCT00351910|Amitriptyline|amitriptyline|mesh-list
2316255|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2316256|NCT00351910|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2316257|NCT00351910|Citalopram|citalopram|mesh-list
2316258|NCT00351910|Bupropion|bupropion|mesh-list
2316259|NCT00351910|Fluoxetine|fluoxetine|mesh-list
2316260|NCT00351910|Paroxetine|paroxetine|mesh-list
2316261|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2316262|NCT00351910|Sertraline|sertraline|mesh-list
2316263|NCT00351910|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2316264|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2316265|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316266|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316267|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316268|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
2316269|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316270|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2316271|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
2316272|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2316273|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316274|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2316275|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
2879849|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2316276|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2316277|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2316278|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316279|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2316280|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2316281|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316282|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2879850|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2879851|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879852|NCT04423237|Deferasirox|deferasirox|mesh-list
2879853|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2879854|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
2879855|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
2879856|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879857|NCT04415151|Tofacitinib|tofacitinib|mesh-list
2879858|NCT04415151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2879859|NCT04415151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879860|NCT04415151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879861|NCT04413266|Curcumin|curcumin|mesh-list
2879862|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2879863|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2879864|NCT04413266|Analgesics|analgesics|mesh-ancestor
2879865|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
2879866|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2879867|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879868|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2879869|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2879870|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879871|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879872|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879873|NCT04409795|Metformin|metformin|mesh-list
2879874|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2879875|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2879876|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879877|NCT04409795|Incretins|incretins|mesh-ancestor
2879878|NCT04409795|Hormones|hormones|mesh-ancestor
2879879|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2879880|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2316283|NCT00351910|Analgesics|analgesics|mesh-ancestor
2316284|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
2879881|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
2879882|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879883|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316285|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2316286|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2316287|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2316288|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
2316289|NCT00351975|Azacitidine|azacitidine|mesh-list
2316290|NCT00351975|Belinostat|belinostat|mesh-list
2316291|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2316292|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
2316293|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316294|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316295|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109019|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
2109020|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109021|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109022|NCT02513550|Ixekizumab|ixekizumab|mesh-list
2109023|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
2316296|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2316297|NCT00352079|Gefitinib|gefitinib|mesh-list
2316298|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
2316299|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316300|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2316301|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316302|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316303|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2316304|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
2316305|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316306|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
2316307|NCT00352092|Sirolimus|sirolimus|mesh-list
2316308|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2316309|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2316310|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316311|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2316312|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
2316313|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2316314|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316315|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316316|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316317|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
2316318|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2316319|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
2316320|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879914|NCT04384484|Gemcitabine|gemcitabine|mesh-list
2879915|NCT04384484|Rituximab|rituximab|mesh-list
2316321|NCT00352144|Eszopiclone|eszopiclone|mesh-list
2316322|NCT00352144|Zopiclone|zopiclone|mesh-list
2316323|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2316324|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316325|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316326|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
2879916|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
2879917|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
2879918|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2879919|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879920|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
2879921|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879922|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2879923|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2879924|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
2879925|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879926|NCT04384484|Antiviral Agents|antiviral agents|mesh-ancestor
2879927|NCT04384484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2879928|NCT04384484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879929|NCT04384484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2879930|NCT04375033|Buprenorphine|buprenorphine|mesh-list
2879931|NCT04375033|Naloxone|naloxone|mesh-list
2879932|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2879933|NCT04375033|Narcotics|narcotics|mesh-ancestor
2879934|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2879935|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879936|NCT04375033|Analgesics|analgesics|mesh-ancestor
2879937|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
2879938|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2879939|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2316327|NCT00352170|Vitamin D|vitamin d|mesh-list
2316328|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
2316329|NCT00352170|Calcium|calcium|mesh-list
2316330|NCT00352170|Vitamins|vitamins|mesh-ancestor
2316331|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
2316332|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316333|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2316334|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2316335|NCT00352183|Simvastatin|simvastatin|mesh-list
2316336|NCT00352183|Fenofibrate|fenofibrate|mesh-list
2316337|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2316338|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2879954|NCT04367740|Antibodies|antibodies|mesh-list
2879955|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
2879956|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
2879957|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879958|NCT04348747|Interferons|interferons|mesh-list
2879959|NCT04348747|Interferon-alpha|interferon-alpha|mesh-list
2879960|NCT04348747|Interferon alpha-2|interferon alpha-2|mesh-list
2879961|NCT04348747|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2879962|NCT04348747|Celecoxib|celecoxib|mesh-list
2879963|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
2879964|NCT04348747|Vaccines|vaccines|mesh-list
2879965|NCT04348747|Benzenesulfonamide|benzenesulfonamide|mesh-list
2879966|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
2879967|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879968|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2879969|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879970|NCT04348747|Antiviral Agents|antiviral agents|mesh-ancestor
2879971|NCT04348747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2879972|NCT04348747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2879973|NCT04348747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2879974|NCT04348747|Analgesics|analgesics|mesh-ancestor
2879975|NCT04348747|Sensory System Agents|sensory system agents|mesh-ancestor
2879976|NCT04348747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2879977|NCT04348747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2879978|NCT04348747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2316339|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
2316340|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316341|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2316342|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2316343|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316344|NCT00352196|Risperidone|risperidone|mesh-list
2316345|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2316346|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
2316347|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316348|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316349|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316350|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2316351|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2316352|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316353|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2316354|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2316355|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
2316356|NCT00352235|KRN 7000|krn 7000|mesh-list
2316357|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2316358|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
2316359|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316360|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316361|NCT00352261|Esomeprazole|esomeprazole|mesh-list
2316362|NCT00352261|Lansoprazole|lansoprazole|mesh-list
2316363|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
2316364|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2316365|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2316366|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2879979|NCT04348747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2879980|NCT04348747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2879981|NCT04348747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2879982|NCT04348747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879983|NCT04348747|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2879984|NCT04344873|Abatacept|abatacept|mesh-list
2879985|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2879986|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2879987|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2879988|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2879989|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
2879990|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2879991|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2316367|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316368|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316369|NCT00352287|Pioglitazone|pioglitazone|mesh-list
2316370|NCT00352287|Hormones|hormones|mesh-list
2316371|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2316372|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316373|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2316374|NCT00352300|Paclitaxel|paclitaxel|mesh-list
2316375|NCT00352300|Carboplatin|carboplatin|mesh-list
2316376|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2316377|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316378|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
2316379|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
2316380|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
2316381|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316382|NCT00352313|Carboplatin|carboplatin|mesh-list
2316383|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316384|NCT00352339|Aripiprazole|aripiprazole|mesh-list
2316385|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
2880047|NCT04301843|Eflornithine|eflornithine|mesh-list
2880048|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880049|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2880050|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2880051|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2880052|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2880053|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2880054|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880055|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880056|NCT04297605|Paclitaxel|paclitaxel|mesh-list
2880057|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
2880058|NCT04297605|Pemetrexed|pemetrexed|mesh-list
2880059|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2880060|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880061|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
2880062|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
2880063|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
2880064|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880065|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2880066|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880067|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2880068|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2880069|NCT04288778|Metformin|metformin|mesh-list
2880070|NCT04288778|Canagliflozin|canagliflozin|mesh-list
2880071|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2880072|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880073|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2880074|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880075|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
2880076|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2880077|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
2880078|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2880079|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2880080|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
2880081|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
2880082|NCT04273945|Macitentan|macitentan|mesh-list
2880083|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2880084|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2880085|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316386|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2316387|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2316388|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2316389|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316390|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316391|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
2316392|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
2316393|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316394|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316395|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2316396|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2316397|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
2880086|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2880087|NCT04271475|Macitentan|macitentan|mesh-list
2880088|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2880089|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2880090|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880091|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2316398|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2316399|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2316400|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2316401|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2316402|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
2316403|NCT00352378|Docetaxel|docetaxel|mesh-list
2316404|NCT00352378|Doxorubicin|doxorubicin|mesh-list
2316405|NCT00352378|Capecitabine|capecitabine|mesh-list
2316406|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2316407|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
2316408|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316409|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2316410|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2316411|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
2316412|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316413|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316414|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2316415|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
2316416|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
2316417|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
2316418|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2316419|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2316420|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2316421|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316422|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2316423|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
2316424|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
2316425|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2316426|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
2316427|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316428|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316429|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2316430|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
2316431|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2316432|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
2316433|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316434|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316435|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2316436|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
2316437|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
2880127|NCT04262024|Cabergoline|cabergoline|mesh-list
2880128|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2880129|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2880130|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
2880131|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
2880132|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2880133|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880134|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316438|NCT00352430|Protective Agents|protective agents|mesh-ancestor
2316439|NCT00352443|Everolimus|everolimus|mesh-list
2316440|NCT00352443|Lapatinib|lapatinib|mesh-list
2316441|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316442|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2316443|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
2316444|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316445|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2316446|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316447|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316448|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2316449|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
2316450|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2316451|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2316452|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2316453|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316454|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316455|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
2316456|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
2316457|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2316458|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2316459|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316460|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316461|NCT00352482|Urological Agents|urological agents|mesh-ancestor
2316462|NCT00352495|Carboplatin|carboplatin|mesh-list
2316463|NCT00352495|Vinblastine|vinblastine|mesh-list
2316464|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316465|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2316466|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
2880175|NCT04222426|Atezolizumab|atezolizumab|mesh-list
2880176|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316467|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
2316468|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
2316469|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316470|NCT00352521|Bevacizumab|bevacizumab|mesh-list
2316471|NCT00352521|Irinotecan|irinotecan|mesh-list
2316472|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2316473|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316474|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2316475|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2316476|NCT00352521|Growth Substances|growth substances|mesh-ancestor
2316477|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316478|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
2316479|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2316480|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2316481|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316482|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316483|NCT00352560|Irbesartan|irbesartan|mesh-list
2316484|NCT00352560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2316485|NCT00352560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2316486|NCT00352560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2316487|NCT00352560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316488|NCT00352599|Lovastatin|lovastatin|mesh-list
2316489|NCT00352599|L 647318|l 647318|mesh-list
2316490|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
2316491|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2316492|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2316493|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
2316494|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880225|NCT04207736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2880226|NCT04207736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2880235|NCT04195204|Tropisetron|tropisetron|mesh-list
2109024|NCT02513719|Everolimus|everolimus|mesh-list
2109025|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109026|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2109027|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
2109028|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880236|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
2880237|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
2880238|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2880239|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880240|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2880241|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2880242|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2880243|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
2880244|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2880245|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880266|NCT04183101|Enalapril|enalapril|mesh-list
2880267|NCT04183101|Enalaprilat|enalaprilat|mesh-list
2880268|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2880269|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
2880270|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880271|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880272|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2316495|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2316496|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2316497|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316498|NCT00352625|Ketoprofen|ketoprofen|mesh-list
2316499|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2316500|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2316501|NCT00352625|Analgesics|analgesics|mesh-ancestor
2316502|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
2316503|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316504|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316505|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2316506|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2316507|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2316508|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880291|NCT04175600|Selexipag|selexipag|mesh-list
2880292|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2880293|NCT04175431|Prednisone|prednisone|mesh-list
2880294|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
2880295|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2880296|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
2880297|NCT04175431|Hormones|hormones|mesh-ancestor
2880298|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2880299|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880300|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2880301|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880302|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2880303|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880304|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880305|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
2880306|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2316509|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316510|NCT00352651|Pregabalin|pregabalin|mesh-list
2316511|NCT00352651|Analgesics|analgesics|mesh-ancestor
2316512|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
2316513|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316514|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316515|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
2316516|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2316517|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316518|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316519|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2316520|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2316521|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2316522|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316523|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2316524|NCT00352677|Bafetinib|bafetinib|mesh-list
2316525|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2316526|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316527|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316528|NCT00352742|Bortezomib|bortezomib|mesh-list
2316529|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2880373|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2880374|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
2880375|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2880376|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880377|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
2880378|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316530|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316531|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
2316532|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
2316533|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316534|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316535|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2316536|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2316537|NCT00352742|Growth Substances|growth substances|mesh-ancestor
2316538|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316539|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
2316540|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
2316541|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316542|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316543|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2316544|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2316545|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316546|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316547|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2316548|NCT00352768|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2316549|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2316550|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316551|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316552|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
2316553|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2316554|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
2316555|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2316556|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2316557|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2316558|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2316559|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2316560|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2316561|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2316562|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2316563|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
2316564|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316565|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316566|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316567|NCT00352833|Catumaxomab|catumaxomab|mesh-list
2316568|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2316569|NCT00352859|Gemcitabine|gemcitabine|mesh-list
2316570|NCT00352859|Interferons|interferons|mesh-list
2316571|NCT00352859|Sorafenib|sorafenib|mesh-list
2316572|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2316573|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
2316574|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316575|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316576|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
2316577|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316578|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316579|NCT00352859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2316580|NCT00352859|Immunologic Factors|immunologic factors|mesh-ancestor
2316581|NCT00352859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316582|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2316583|NCT00352950|Panitumumab|panitumumab|mesh-list
2316584|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2316585|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316586|NCT00353002|Lidocaine|lidocaine|mesh-list
2316587|NCT00353002|Tetracaine|tetracaine|mesh-list
2316588|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
2316589|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
2316590|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316591|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316592|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
2316593|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316594|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2316595|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2316596|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2316597|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316598|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316599|NCT00353015|Cisplatin|cisplatin|mesh-list
2316600|NCT00353015|Irinotecan|irinotecan|mesh-list
2316601|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316602|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2316603|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2316604|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316605|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316606|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
2316607|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316608|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316609|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2316610|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2316611|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316612|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316613|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2316614|NCT00353028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2316615|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2316616|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316617|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316618|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
2316619|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2316620|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
2316621|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2316622|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2316623|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2316624|NCT00353041|Lidocaine|lidocaine|mesh-list
2316625|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
2316626|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
2316627|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2316628|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316629|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
2316630|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316631|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2880463|NCT04084626|Lenalidomide|lenalidomide|mesh-list
2880464|NCT04084626|Antibodies|antibodies|mesh-list
2880465|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
2880466|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880467|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2880468|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2880469|NCT04084626|Growth Substances|growth substances|mesh-ancestor
2316632|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2316633|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2316634|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316635|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316636|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
2316637|NCT00353054|Antacids|antacids|mesh-ancestor
2316638|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316639|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2316640|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
2316641|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2316642|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2316643|NCT00353067|Analgesics|analgesics|mesh-ancestor
2316644|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
2316645|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316646|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316647|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2316648|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2316649|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2316650|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316651|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316652|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
2316653|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2880470|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
2880471|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880472|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
2880473|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2880474|NCT04081337|Tirzepatide|tirzepatide|mesh-list
2880475|NCT04081337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2880476|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880477|NCT04081337|Incretins|incretins|mesh-ancestor
2880478|NCT04081337|Hormones|hormones|mesh-ancestor
2880479|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2880480|NCT04078568|Aspirin|aspirin|mesh-list
2880481|NCT04078568|Prednisolone|prednisolone|mesh-list
2880482|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
2880483|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2880484|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
2880485|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2880486|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2880487|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2880488|NCT04078568|Analgesics|analgesics|mesh-ancestor
2880489|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
2880490|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2880491|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880492|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2880493|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2880494|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2316654|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316655|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316656|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2316657|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316658|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2316659|NCT00353145|Gemcitabine|gemcitabine|mesh-list
2880495|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2880496|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880497|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2880498|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2880499|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880500|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
2880501|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
2880502|NCT04078568|Hormones|hormones|mesh-ancestor
2880503|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2880504|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2880505|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880506|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
2316660|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
2316661|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2316662|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
2316663|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316664|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316665|NCT00353145|Antiviral Agents|antiviral agents|mesh-ancestor
2316666|NCT00353145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316667|NCT00353145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316668|NCT00353145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2316669|NCT00353145|Immunologic Factors|immunologic factors|mesh-ancestor
2316670|NCT00353145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880527|NCT04015180|Aflibercept|aflibercept|mesh-list
2880528|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2880529|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2316671|NCT00353184|Montelukast|montelukast|mesh-list
2316672|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2316673|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
2316674|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2316675|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
2316676|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2316677|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316678|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2316679|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2880530|NCT04015180|Growth Substances|growth substances|mesh-ancestor
2880531|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880532|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
2880533|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880545|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
2880546|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880547|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2880548|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880549|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880550|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
2880551|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2880552|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880553|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2880554|NCT03994601|Nivolumab|nivolumab|mesh-list
2880555|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2880556|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880557|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2880558|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880559|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2880560|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2316680|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316681|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
2316682|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2316683|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
2316684|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316685|NCT00353340|Expectorants|expectorants|mesh-ancestor
2316686|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
2880600|NCT03979365|Tacrolimus|tacrolimus|mesh-list
2880601|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2880602|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
2880603|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880604|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2880605|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880606|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880607|NCT03962465|Cytarabine|cytarabine|mesh-list
2880608|NCT03962465|Prednisone|prednisone|mesh-list
2880609|NCT03962465|Methotrexate|methotrexate|mesh-list
2880610|NCT03962465|Vincristine|vincristine|mesh-list
2880611|NCT03962465|Daunorubicin|daunorubicin|mesh-list
2880612|NCT03962465|Pegaspargase|pegaspargase|mesh-list
2316687|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2316688|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
2316689|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316690|NCT00353340|Protective Agents|protective agents|mesh-ancestor
2880613|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2880614|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2880615|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
2880616|NCT03962465|Hormones|hormones|mesh-ancestor
2880617|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2880618|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316691|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316692|NCT00353340|Antidotes|antidotes|mesh-ancestor
2316693|NCT00353379|Guanfacine|guanfacine|mesh-list
2316694|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2316695|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2316696|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2316697|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2316698|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
2316699|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2880619|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2880620|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880621|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2880622|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
2880623|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2880624|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2880625|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
2880626|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316700|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316701|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316702|NCT00353457|Capecitabine|capecitabine|mesh-list
2316703|NCT00353457|Oxaliplatin|oxaliplatin|mesh-list
2316704|NCT00353457|Cetuximab|cetuximab|mesh-list
2316705|NCT00353457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2316706|NCT00353457|Antimetabolites|antimetabolites|mesh-ancestor
2316707|NCT00353457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316708|NCT00353457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316709|NCT00353457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2316710|NCT00353561|Fluconazole|fluconazole|mesh-list
2316711|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
2316712|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316713|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2316714|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2316715|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316716|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316717|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2316718|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
2316719|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2316720|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316721|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2316722|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2316723|NCT00353574|Darusentan|darusentan|mesh-list
2316724|NCT00353574|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2316725|NCT00353574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316726|NCT00353665|Riluzole|riluzole|mesh-list
2316727|NCT00353665|Memantine|memantine|mesh-list
2316728|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2316729|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2316730|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
2316731|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316732|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316733|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316734|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2316735|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2316736|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
2316737|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2316738|NCT00353665|Protective Agents|protective agents|mesh-ancestor
2316739|NCT00353678|Darexaban|darexaban|mesh-list
2880627|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
2880628|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880629|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2880630|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2880631|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
2880632|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2880633|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2880634|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
2880635|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2880636|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2880637|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
2880638|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
2880639|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
2880640|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2880641|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2880642|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2880643|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2316740|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2316741|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
2316742|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2316743|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
2316744|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316745|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316746|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
2316747|NCT00353691|Metformin|metformin|mesh-list
2316748|NCT00353691|Glimepiride|glimepiride|mesh-list
2316749|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2880644|NCT03953898|Olaparib|olaparib|mesh-list
2316750|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316751|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2316752|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2880645|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2880646|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880647|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880648|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880655|NCT03948035|Dexamethasone|dexamethasone|mesh-list
2880656|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
2880657|NCT03948035|Lenalidomide|lenalidomide|mesh-list
2880658|NCT03948035|Elotuzumab|elotuzumab|mesh-list
2880659|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2880660|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
2880661|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
2880662|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2880663|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880664|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2880665|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
2880666|NCT03948035|Hormones|hormones|mesh-ancestor
2880667|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2880668|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2880669|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880670|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
2880671|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2880672|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2880673|NCT03948035|Growth Substances|growth substances|mesh-ancestor
2880674|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
2880675|NCT03942211|Selexipag|selexipag|mesh-list
2880676|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2880692|NCT03933202|Cladribine|cladribine|mesh-list
2880693|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880694|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2316753|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
2316754|NCT00353717|Paclitaxel|paclitaxel|mesh-list
2316755|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2316756|NCT00353717|Cetuximab|cetuximab|mesh-list
2880695|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
2880696|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880697|NCT03926169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2316757|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2316758|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880698|NCT03926169|Immunologic Factors|immunologic factors|mesh-ancestor
2880699|NCT03926169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316759|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
2316760|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
2316761|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
2316762|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316763|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2316764|NCT00353743|Metronidazole|metronidazole|mesh-list
2316765|NCT00353743|Doxycycline|doxycycline|mesh-list
2316766|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316767|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2316768|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2316769|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2316770|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
2316771|NCT00353808|Reboxetine|reboxetine|mesh-list
2880711|NCT03910621|Miglustat|miglustat|mesh-list
2880712|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880713|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880714|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2880715|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2880716|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
2880717|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2880718|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2880719|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2880720|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880750|NCT03904693|Tadalafil|tadalafil|mesh-list
2880751|NCT03904693|Macitentan|macitentan|mesh-list
2880752|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
2880753|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2880754|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2880755|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880756|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316772|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
2316773|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2316774|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2316775|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2316776|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316777|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316778|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
2316779|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316780|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316781|NCT00353912|Amlodipine|amlodipine|mesh-list
2316782|NCT00353912|Valsartan|valsartan|mesh-list
2316783|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2316784|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2316785|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316786|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880757|NCT03904693|Urological Agents|urological agents|mesh-ancestor
2880758|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2880759|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2880760|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2880772|NCT03861390|Prednisone|prednisone|mesh-list
2880773|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2880774|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
2880775|NCT03861390|Hormones|hormones|mesh-ancestor
2880776|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2880777|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880778|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2880779|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880780|NCT03861078|Nicotine|nicotine|mesh-list
2880781|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2880782|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
2880783|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2880784|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880785|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2880786|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2880787|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
2880788|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2880789|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880790|NCT03849443|Ascorbic Acid|ascorbic acid|mesh-list
2880791|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
2880792|NCT03849443|Vitamins|vitamins|mesh-ancestor
2880793|NCT03849443|Micronutrients|micronutrients|mesh-ancestor
2880794|NCT03849443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880795|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2880796|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2880797|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880798|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
2880799|NCT03849443|Coagulants|coagulants|mesh-ancestor
2880800|NCT03849443|Antioxidants|antioxidants|mesh-ancestor
2880801|NCT03849443|Protective Agents|protective agents|mesh-ancestor
2880802|NCT03842228|Durvalumab|durvalumab|mesh-list
2316787|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2316788|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316789|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
2316790|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2316791|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2316792|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
2316793|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2316794|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316795|NCT00354068|Temozolomide|temozolomide|mesh-list
2316796|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
2316797|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2316798|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
2316799|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316800|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316801|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2316802|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316803|NCT00354081|Vitamins|vitamins|mesh-list
2316804|NCT00354081|Folic Acid|folic acid|mesh-list
2316805|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
2316806|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
2880803|NCT03842228|Olaparib|olaparib|mesh-list
2880804|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2316807|NCT00354081|Pyridoxine|pyridoxine|mesh-list
2316808|NCT00354081|Pyridoxal|pyridoxal|mesh-list
2316809|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
2316810|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
2316811|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
2316812|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316813|NCT00354081|Hematinics|hematinics|mesh-ancestor
2316814|NCT00354094|Reboxetine|reboxetine|mesh-list
2316815|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
2880805|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
2880806|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2880807|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
2880808|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2880809|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880810|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
2880811|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880812|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880813|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109029|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2109030|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2316816|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2880840|NCT03810417|Digoxin|digoxin|mesh-list
2880841|NCT03810417|Antibodies|antibodies|mesh-list
2880842|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
2880843|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
2880844|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880845|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2880846|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2880847|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2880848|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880849|NCT03810417|Protective Agents|protective agents|mesh-ancestor
2316817|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2316818|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2316819|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316820|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316821|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
2316822|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316823|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316824|NCT00354146|Tipifarnib|tipifarnib|mesh-list
2316825|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316826|NCT00354185|Belinostat|belinostat|mesh-list
2316827|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316828|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2316829|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316830|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316831|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2316832|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
2316833|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2316834|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316835|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316836|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2316837|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2316838|NCT00354198|Protective Agents|protective agents|mesh-ancestor
2316839|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316840|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
2316841|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2316842|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
2316843|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2316844|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
2316845|NCT00354198|Hormones|hormones|mesh-ancestor
2316846|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2316847|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2316848|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2316849|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316850|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2316851|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316852|NCT00354276|Cytarabine|cytarabine|mesh-list
2316853|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2316854|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
2316855|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316856|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316857|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
2880933|NCT03781362|Capecitabine|capecitabine|mesh-list
2880934|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2880935|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
2880936|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2880937|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316858|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316859|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2880974|NCT03746041|Abaloparatide|abaloparatide|mesh-list
2880975|NCT03746041|Bevacizumab|bevacizumab|mesh-list
2316860|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
2316861|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316862|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
2316863|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
2316864|NCT00354302|Alendronate|alendronate|mesh-list
2316865|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
2316866|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
2316867|NCT00354302|Calcium|calcium|mesh-list
2316868|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2316869|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2880976|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2880977|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2880978|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2880979|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2880980|NCT03746041|Growth Substances|growth substances|mesh-ancestor
2880981|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316870|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2316871|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316872|NCT00354302|Vitamins|vitamins|mesh-ancestor
2316873|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
2316874|NCT00354302|Antacids|antacids|mesh-ancestor
2880982|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
2880983|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2316875|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2316876|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2316877|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2316878|NCT00354354|Ipratropium|ipratropium|mesh-list
2316879|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2316880|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
2316881|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2316882|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316883|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2316884|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
2316885|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2316886|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316887|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2316888|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
2316889|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
2316890|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2316891|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
2316892|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316893|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2316894|NCT00354380|Artesunate|artesunate|mesh-list
2316895|NCT00354380|Amodiaquine|amodiaquine|mesh-list
2316896|NCT00354380|Methylene Blue|methylene blue|mesh-list
2316897|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
2316898|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2316899|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2316900|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316901|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316902|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
2316903|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
2316904|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2316905|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
2316906|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881061|NCT03689582|Edetic Acid|edetic acid|mesh-list
2881062|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2881063|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2881064|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881065|NCT03689582|Anticoagulants|anticoagulants|mesh-ancestor
2881066|NCT03689582|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2881067|NCT03689582|Chelating Agents|chelating agents|mesh-ancestor
2881068|NCT03689582|Sequestering Agents|sequestering agents|mesh-ancestor
2881069|NCT03689244|Selexipag|selexipag|mesh-list
2881070|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2881075|NCT03668119|Nivolumab|nivolumab|mesh-list
2881076|NCT03668119|Ipilimumab|ipilimumab|mesh-list
2881077|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881078|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881079|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2881080|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881081|NCT03661320|Gemcitabine|gemcitabine|mesh-list
2881082|NCT03661320|Nivolumab|nivolumab|mesh-list
2881083|NCT03661320|Linrodostat|linrodostat|mesh-list
2881084|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881085|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2881086|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
2316907|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316908|NCT00354393|Methotrexate|methotrexate|mesh-list
2316909|NCT00354393|Vinorelbine|vinorelbine|mesh-list
2316910|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316911|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2316912|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
2316913|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2316914|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316915|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2316916|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
2316917|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316918|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
2316919|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881087|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881088|NCT03661320|Antiviral Agents|antiviral agents|mesh-ancestor
2881089|NCT03661320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2881090|NCT03661320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881091|NCT03661320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2881092|NCT03661320|Immunologic Factors|immunologic factors|mesh-ancestor
2881093|NCT03661320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881094|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881095|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2881111|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
2881112|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881113|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316920|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2316921|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2316922|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
2316923|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2316924|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2316925|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2316926|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
2881144|NCT03598257|Olaparib|olaparib|mesh-list
2881145|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2881146|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881147|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881148|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881149|NCT03597568|Resveratrol|resveratrol|mesh-list
2881150|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
2881151|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316927|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
2316928|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
2316929|NCT00354406|Abciximab|abciximab|mesh-list
2316930|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
2881152|NCT03597568|Protective Agents|protective agents|mesh-ancestor
2881153|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881154|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881155|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2881156|NCT03591770|Vaccines|vaccines|mesh-list
2881157|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
2881158|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316931|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2316932|NCT00354419|Cyclosporine|cyclosporine|mesh-list
2316933|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
2316934|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
2316935|NCT00354419|Cyclosporins|cyclosporins|mesh-list
2316936|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
2316937|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2316938|NCT00354419|Lenograstim|lenograstim|mesh-list
2316939|NCT00354419|Sargramostim|sargramostim|mesh-list
2316940|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
2316941|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2316942|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
2316943|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316944|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2881166|NCT03535727|Gemcitabine|gemcitabine|mesh-list
2881167|NCT03535727|Paclitaxel|paclitaxel|mesh-list
2881168|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2881169|NCT03535727|Cisplatin|cisplatin|mesh-list
2881170|NCT03535727|Capecitabine|capecitabine|mesh-list
2881171|NCT03535727|Irinotecan|irinotecan|mesh-list
2881172|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2881173|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881174|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
2881175|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
2881176|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
2881177|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881178|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2881179|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
2881180|NCT03535727|Antiviral Agents|antiviral agents|mesh-ancestor
2881181|NCT03535727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2881182|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881183|NCT03535727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2881184|NCT03535727|Immunologic Factors|immunologic factors|mesh-ancestor
2881185|NCT03535727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881186|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2881187|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2316945|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2316946|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
2316947|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316948|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316949|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2316950|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2316951|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316952|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
2316953|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316954|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
2316955|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2316956|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2316957|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2316958|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
2316959|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2316960|NCT00354458|Rolofylline|rolofylline|mesh-list
2316961|NCT00354458|Diuretics|diuretics|mesh-ancestor
2316962|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
2316963|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316964|NCT00354523|Capecitabine|capecitabine|mesh-list
2316965|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
2316966|NCT00354523|Dacarbazine|dacarbazine|mesh-list
2316967|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2881197|NCT03532555|Zinc|zinc|mesh-list
2881198|NCT03532555|Trace Elements|trace elements|mesh-ancestor
2881199|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
2881200|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881201|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
2881202|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
2881203|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2881204|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2881205|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316968|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
2316969|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316970|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316971|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2316972|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316973|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2316974|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
2316975|NCT00354549|Gemcitabine|gemcitabine|mesh-list
2316976|NCT00354549|Bevacizumab|bevacizumab|mesh-list
2316977|NCT00354549|Carboplatin|carboplatin|mesh-list
2316978|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2316979|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2316980|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316981|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2881206|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2881207|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
2881208|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2881209|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881210|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
2881211|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
2881215|NCT03511599|Cycloserine|cycloserine|mesh-list
2881216|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2881217|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2881218|NCT03511599|Renal Agents|renal agents|mesh-ancestor
2881219|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2881220|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
2881221|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2881222|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
2881223|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881224|NCT03503318|Risperidone|risperidone|mesh-list
2881225|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2881226|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
2881227|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2881228|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881229|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881230|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2881231|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2881232|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2881233|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2881234|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2881235|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
2881236|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
2881237|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881238|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881239|NCT03492177|Selexipag|selexipag|mesh-list
2881240|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2881241|NCT03441282|Fentanyl|fentanyl|mesh-list
2881242|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2881243|NCT03441282|Narcotics|narcotics|mesh-ancestor
2881244|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2881245|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881246|NCT03441282|Analgesics|analgesics|mesh-ancestor
2881247|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
2881248|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2881249|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2881250|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2881251|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
2316982|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2316983|NCT00354549|Growth Substances|growth substances|mesh-ancestor
2316984|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2316985|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
2316986|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2316987|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
2316988|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2316989|NCT00354549|Antiviral Agents|antiviral agents|mesh-ancestor
2316990|NCT00354549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2316991|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2316992|NCT00354549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2316993|NCT00354549|Immunologic Factors|immunologic factors|mesh-ancestor
2316994|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2316995|NCT00354562|Docetaxel|docetaxel|mesh-list
2881252|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
2881253|NCT03432741|Gemcitabine|gemcitabine|mesh-list
2881254|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
2881255|NCT03432741|Rituximab|rituximab|mesh-list
2881256|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2881257|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
2881258|NCT03432741|Nivolumab|nivolumab|mesh-list
2881259|NCT03432741|Trastuzumab|trastuzumab|mesh-list
2881260|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
2881261|NCT03432741|Daratumumab|daratumumab|mesh-list
2881262|NCT03432741|Romidepsin|romidepsin|mesh-list
2881263|NCT03432741|Belinostat|belinostat|mesh-list
2881264|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2881265|NCT03432741|Antibodies|antibodies|mesh-list
2881266|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
2881267|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2881268|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2881269|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
2881270|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881271|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881272|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2881273|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2881274|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
2881275|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881276|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
2881277|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2881278|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881279|NCT03432741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2881280|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2881281|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2881282|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2881283|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2881284|NCT03422822|Abrocitinib|abrocitinib|mesh-list
2881285|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2881286|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881287|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881288|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
2881289|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2881290|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
2881291|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2881292|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
2881293|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881294|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881295|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
2881296|NCT03406715|Nivolumab|nivolumab|mesh-list
2881297|NCT03406715|Ipilimumab|ipilimumab|mesh-list
2881298|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881299|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881300|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2881301|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881302|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2881303|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
2881304|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881329|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2881330|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
2881331|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881332|NCT03278925|Protective Agents|protective agents|mesh-ancestor
2881333|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881334|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2881335|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2881336|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881337|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2316996|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2316997|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
2316998|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
2316999|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
2317000|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317001|NCT00354627|Etravirine|etravirine|mesh-list
2317002|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2317003|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2317004|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317005|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317006|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
2317007|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317008|NCT00354653|Lamivudine|lamivudine|mesh-list
2317009|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2317010|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2881384|NCT03248479|Azacitidine|azacitidine|mesh-list
2881385|NCT03248479|Magrolimab|magrolimab|mesh-list
2881386|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2881387|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
2881388|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881389|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881390|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881391|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881392|NCT03232073|Ponesimod|ponesimod|mesh-list
2881393|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2881394|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881395|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2881396|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
2881397|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881398|NCT03223883|Curcumin|curcumin|mesh-list
2881399|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2881400|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2881401|NCT03223883|Analgesics|analgesics|mesh-ancestor
2881402|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
2881403|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2881404|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881405|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2881406|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2881407|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881408|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881409|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317011|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317012|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317013|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
2317014|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317015|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2317016|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2317017|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2317018|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
2317019|NCT00354692|Hematinics|hematinics|mesh-ancestor
2317020|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
2317021|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2317022|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317023|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317024|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2317025|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2317026|NCT00354731|Protective Agents|protective agents|mesh-ancestor
2317027|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317028|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
2317029|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2317030|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
2317031|NCT00354757|Rabeprazole|rabeprazole|mesh-list
2317032|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2317033|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2317034|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2317035|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317036|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317037|NCT00354809|Casopitant|casopitant|mesh-list
2317038|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
2317039|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
2317040|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317041|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317042|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2317043|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2317044|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2317045|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317046|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
2317047|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2317048|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
2317049|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317050|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2317051|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2317052|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
2317053|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317054|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881434|NCT03170518|Canagliflozin|canagliflozin|mesh-list
2881435|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2881436|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881437|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2881438|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317055|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2317056|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
2317057|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2881449|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
2881450|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881451|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881452|NCT03125642|Cytarabine|cytarabine|mesh-list
2881453|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
2881454|NCT03125642|Melphalan|melphalan|mesh-list
2881455|NCT03125642|Carmustine|carmustine|mesh-list
2317058|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2317059|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2317060|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
2317061|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2317062|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317063|NCT00354900|Aprotinin|aprotinin|mesh-list
2317064|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
2317065|NCT00354900|Coagulants|coagulants|mesh-ancestor
2317066|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2317067|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2317068|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
2317069|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881456|NCT03125642|Etoposide|etoposide|mesh-list
2881457|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2881458|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
2881459|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881460|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2881461|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2881462|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
2881463|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881464|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881465|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2109031|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109032|NCT02513771|Incretins|incretins|mesh-ancestor
2109033|NCT02513771|Hormones|hormones|mesh-ancestor
2109034|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109035|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2109036|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
2109037|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109038|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109039|NCT02513823|Vitamin D|vitamin d|mesh-list
2109040|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
2109041|NCT02513823|Vitamins|vitamins|mesh-ancestor
2109042|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
2109043|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109044|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2109045|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2109046|NCT02513940|Ibutilide|ibutilide|mesh-list
2109047|NCT02513940|Testosterone|testosterone|mesh-list
2109048|NCT02513940|Progesterone|progesterone|mesh-list
2109049|NCT02513940|Androgens|androgens|mesh-ancestor
2109050|NCT02513940|Hormones|hormones|mesh-ancestor
2109051|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2881466|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2881467|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2881468|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2881469|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881470|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2881471|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
2881472|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
2881473|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2881474|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
2881475|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881476|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881477|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
2881478|NCT03103971|Fludarabine|fludarabine|mesh-list
2317070|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317071|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
2317072|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2317073|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317074|NCT00354952|Azithromycin|azithromycin|mesh-list
2317075|NCT00354952|Clarithromycin|clarithromycin|mesh-list
2317076|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2317077|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317078|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2317079|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317080|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317081|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2317082|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2317083|NCT00354965|Amoxicillin|amoxicillin|mesh-list
2317084|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
2317085|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
2317086|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2317087|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2317088|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317089|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2317090|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317091|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317092|NCT00354991|Losartan|losartan|mesh-list
2317093|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2317094|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2317095|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2317096|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2317097|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2317098|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317099|NCT00354991|Diuretics|diuretics|mesh-ancestor
2317100|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
2317101|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881479|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2881480|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
2881481|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881482|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2881483|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2881484|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
2109052|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881485|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881486|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881487|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2881488|NCT03086616|Irinotecan|irinotecan|mesh-list
2881489|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2881490|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2881491|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881492|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881493|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317102|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2317103|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2317104|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
2317105|NCT00355043|Astringents|astringents|mesh-ancestor
2317106|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317107|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
2317108|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
2881513|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2881514|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2881515|NCT03007030|Antibodies|antibodies|mesh-list
2881516|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
2881517|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2881518|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
2881519|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
2881520|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881521|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881522|NCT03006172|Metformin|metformin|mesh-list
2881523|NCT03006172|Trastuzumab|trastuzumab|mesh-list
2881524|NCT03006172|Pertuzumab|pertuzumab|mesh-list
2881525|NCT03006172|Letrozole|letrozole|mesh-list
2881526|NCT03006172|Fulvestrant|fulvestrant|mesh-list
2881527|NCT03006172|Palbociclib|palbociclib|mesh-list
2881528|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2881529|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881530|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881531|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881532|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2881533|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2881534|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317109|NCT00355095|Hematinics|hematinics|mesh-ancestor
2317110|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
2317111|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2881535|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881536|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2881537|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
2881538|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2881539|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2881540|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2881541|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2881542|NCT02995252|Tenofovir|tenofovir|mesh-list
2881543|NCT02995252|Liver Extracts|liver extracts|mesh-list
2881544|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
2881545|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2881546|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2881547|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2881548|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881549|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881550|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2881551|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2881552|NCT02995252|Hematinics|hematinics|mesh-ancestor
2881553|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
2881554|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317112|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2317113|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317114|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
2317115|NCT00355108|Coagulants|coagulants|mesh-ancestor
2317116|NCT00355251|Atorvastatin|atorvastatin|mesh-list
2317117|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2317118|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2317119|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
2317120|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881555|NCT02991144|Prednisone|prednisone|mesh-list
2881556|NCT02991144|Prednisolone|prednisolone|mesh-list
2881557|NCT02991144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2881558|NCT02991144|Glucocorticoids|glucocorticoids|mesh-ancestor
2881559|NCT02991144|Hormones|hormones|mesh-ancestor
2881560|NCT02991144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2881561|NCT02991144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881562|NCT02991144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2881563|NCT02991144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881573|NCT02953509|Gemcitabine|gemcitabine|mesh-list
2881574|NCT02953509|Rituximab|rituximab|mesh-list
2881575|NCT02953509|Magrolimab|magrolimab|mesh-list
2881576|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
2881577|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881578|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317121|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2317122|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2317123|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317124|NCT00355277|Amitriptyline|amitriptyline|mesh-list
2317125|NCT00355277|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2317126|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2317127|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
2317128|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2317129|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2317130|NCT00355277|Analgesics|analgesics|mesh-ancestor
2317131|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
2881579|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
2881580|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881581|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2881582|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2881583|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
2881584|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881585|NCT02953509|Antiviral Agents|antiviral agents|mesh-ancestor
2881586|NCT02953509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2881587|NCT02953509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881588|NCT02953509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2881594|NCT02923739|Paclitaxel|paclitaxel|mesh-list
2881595|NCT02923739|Bevacizumab|bevacizumab|mesh-list
2881596|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2881597|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2317132|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317133|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317134|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2881598|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
2881599|NCT02923739|Antibodies|antibodies|mesh-list
2881600|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
2881601|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2881602|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
2881603|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2881604|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881605|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
2881606|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
2881607|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
2881608|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881609|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2881610|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2881611|NCT02923739|Growth Substances|growth substances|mesh-ancestor
2881612|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881613|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
2881614|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
2881615|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
2881616|NCT02921789|Prednisone|prednisone|mesh-list
2881617|NCT02921789|Tacrolimus|tacrolimus|mesh-list
2881618|NCT02921789|Basiliximab|basiliximab|mesh-list
2881619|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2881620|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
2881621|NCT02921789|Hormones|hormones|mesh-ancestor
2881622|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2881623|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881624|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2881625|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881626|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2881627|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
2881628|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2881629|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881630|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881631|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2881632|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2881633|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
2881634|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2881635|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2881636|NCT02918500|Nicotine|nicotine|mesh-list
2881637|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2881638|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
2881639|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317135|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2317136|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2317137|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317138|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
2881640|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881641|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2881642|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2881643|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
2881644|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2881645|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881670|NCT02903381|Dexamethasone|dexamethasone|mesh-list
2881671|NCT02903381|Nivolumab|nivolumab|mesh-list
2881672|NCT02903381|Lenalidomide|lenalidomide|mesh-list
2881673|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2881674|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
2881675|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
2881676|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2881677|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881678|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2881679|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
2881680|NCT02903381|Hormones|hormones|mesh-ancestor
2881681|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2881682|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2881683|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881684|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881685|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2881686|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881687|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
2881688|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2881689|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2881690|NCT02903381|Growth Substances|growth substances|mesh-ancestor
2881691|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
2317139|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2317140|NCT00355277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2317141|NCT00355277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2317142|NCT00355277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2317143|NCT00355290|Vitamin K|vitamin k|mesh-list
2881692|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
2881693|NCT02866279|Etonogestrel|etonogestrel|mesh-list
2881694|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2881695|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881696|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2881697|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2881704|NCT02825160|Iloprost|iloprost|mesh-list
2881705|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2881706|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
2881728|NCT02774265|Aspirin|aspirin|mesh-list
2881729|NCT02774265|Heparin|heparin|mesh-list
2317144|NCT00355290|Vitamins|vitamins|mesh-ancestor
2317145|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
2317146|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317147|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2317148|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2317149|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317150|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
2317151|NCT00355290|Coagulants|coagulants|mesh-ancestor
2317152|NCT00355303|Misoprostol|misoprostol|mesh-list
2881730|NCT02774265|Enoxaparin|enoxaparin|mesh-list
2881731|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2881732|NCT02774265|Tinzaparin|tinzaparin|mesh-list
2317153|NCT00355303|Dinoprostone|dinoprostone|mesh-list
2317154|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2317155|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
2317156|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2317157|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317158|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2881733|NCT02774265|Dalteparin|dalteparin|mesh-list
2881734|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2881735|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2881736|NCT02774265|Analgesics|analgesics|mesh-ancestor
2881737|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
2881738|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2881739|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881740|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2881741|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2881742|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2881743|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2881744|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881745|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2881746|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2881747|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881748|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
2317159|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2317160|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
2317161|NCT00355355|Talaporfin|talaporfin|mesh-list
2317162|NCT00355355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317163|NCT00355355|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2317164|NCT00355355|Dermatologic Agents|dermatologic agents|mesh-ancestor
2372128|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372129|NCT00591188|Interferons|interferons|mesh-list
2372130|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
2372131|NCT00591188|Capecitabine|capecitabine|mesh-list
2372132|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2109053|NCT02513940|Progestins|progestins|mesh-ancestor
2109054|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2109055|NCT02514044|Adderall|adderall|mesh-list
2372133|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
2372134|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372135|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372136|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
2372137|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372138|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
2372139|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372140|NCT00591201|Infliximab|infliximab|mesh-list
2372141|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
2372142|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2372143|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2881749|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
2109056|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
2109057|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2109058|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109059|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2109060|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2109061|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2109062|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109063|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
2372147|NCT00591357|Loperamide|loperamide|mesh-list
2372148|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
2372149|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2372150|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2372151|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372152|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2372153|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372154|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372155|NCT00591487|Lidocaine|lidocaine|mesh-list
2372156|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
2372157|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
2881765|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
2881766|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881767|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881768|NCT02717455|Panobinostat|panobinostat|mesh-list
2881769|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881770|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2881771|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881772|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881773|NCT02695992|Metoprolol|metoprolol|mesh-list
2881774|NCT02695992|Diltiazem|diltiazem|mesh-list
2881775|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2881776|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2881777|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
2881778|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
2881779|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2881780|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881781|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2881782|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2881783|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2881784|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
2881785|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2881786|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881787|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2881788|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2881789|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2881790|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
2881791|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
2881792|NCT02693535|Nivolumab|nivolumab|mesh-list
2881793|NCT02693535|Trastuzumab|trastuzumab|mesh-list
2881794|NCT02693535|Ipilimumab|ipilimumab|mesh-list
2881795|NCT02693535|Pertuzumab|pertuzumab|mesh-list
2881796|NCT02693535|Atezolizumab|atezolizumab|mesh-list
2881797|NCT02693535|Sunitinib|sunitinib|mesh-list
2881798|NCT02693535|Olaparib|olaparib|mesh-list
2881799|NCT02693535|Palbociclib|palbociclib|mesh-list
2881800|NCT02693535|Afatinib|afatinib|mesh-list
2881801|NCT02693535|Vemurafenib|vemurafenib|mesh-list
2881802|NCT02693535|Crizotinib|crizotinib|mesh-list
2881803|NCT02693535|Talazoparib|talazoparib|mesh-list
2881804|NCT02693535|Tucatinib|tucatinib|mesh-list
2881805|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2881806|NCT02693535|Entrectinib|entrectinib|mesh-list
2881807|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881808|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881809|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2881810|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881811|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
2881812|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881813|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2881814|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2881815|NCT02693535|Growth Substances|growth substances|mesh-ancestor
2881816|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
2881817|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2881818|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881819|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2881820|NCT02667418|Vancomycin|vancomycin|mesh-list
2881821|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
2881822|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2881823|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2881824|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
2881825|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
2881826|NCT02652468|Rituximab|rituximab|mesh-list
2881827|NCT02652468|Fludarabine|fludarabine|mesh-list
2881828|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
2881829|NCT02652468|Tacrolimus|tacrolimus|mesh-list
2881830|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2881831|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
2881832|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881833|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2881834|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2881835|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
2881836|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881837|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881838|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2881839|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2881840|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2881841|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
2317165|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
2317166|NCT00355407|Hematinics|hematinics|mesh-ancestor
2317167|NCT00355446|Bimatoprost|bimatoprost|mesh-list
2317168|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2317169|NCT00355459|Doxycycline|doxycycline|mesh-list
2317170|NCT00355459|Tetracycline|tetracycline|mesh-list
2317171|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2881842|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2881843|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881844|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2881845|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2881846|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
2881847|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2881848|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2881867|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2881868|NCT02579265|SMOFlipid|smoflipid|mesh-list
2881869|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
2881870|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2881871|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2317172|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317173|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
2317174|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2317175|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2317176|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2317177|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317178|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317179|NCT00355524|Ritonavir|ritonavir|mesh-list
2317180|NCT00355524|Darunavir|darunavir|mesh-list
2317181|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2317182|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2317183|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
2317184|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317185|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317186|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2317187|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2317188|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
2317189|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317190|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2317191|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2317192|NCT00355537|Testosterone|testosterone|mesh-list
2317193|NCT00355537|Androgens|androgens|mesh-ancestor
2317194|NCT00355537|Hormones|hormones|mesh-ancestor
2317195|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2317196|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317197|NCT00355576|Minocycline|minocycline|mesh-list
2317198|NCT00355576|Celecoxib|celecoxib|mesh-list
2317199|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2317200|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2881905|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2881906|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2881907|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881929|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
2881930|NCT02484391|Cytarabine|cytarabine|mesh-list
2881931|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
2881932|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2881933|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
2881934|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881935|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881936|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
2881937|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2881938|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2881939|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
2881940|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317201|NCT00355576|Analgesics|analgesics|mesh-ancestor
2317202|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
2317203|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317204|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317205|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2317206|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2317207|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2317208|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2317209|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317210|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317211|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2317212|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317213|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2317214|NCT00355589|Ramipril|ramipril|mesh-list
2317215|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2317216|NCT00355589|Diuretics|diuretics|mesh-ancestor
2317217|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
2317218|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2881941|NCT02484391|Analgesics|analgesics|mesh-ancestor
2317219|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2317220|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2881942|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
2881943|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2881944|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2881945|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2881946|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881947|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
2881948|NCT02484391|Protective Agents|protective agents|mesh-ancestor
2317221|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317222|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2317223|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
2317224|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317225|NCT00355602|Metronidazole|metronidazole|mesh-list
2317226|NCT00355602|Vancomycin|vancomycin|mesh-list
2317227|NCT00355602|Clarithromycin|clarithromycin|mesh-list
2317228|NCT00355602|Doxycycline|doxycycline|mesh-list
2317229|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
2317230|NCT00355602|Rifaximin|rifaximin|mesh-list
2317231|NCT00355602|Cefuroxime|cefuroxime|mesh-list
2317232|NCT00355602|Neomycin|neomycin|mesh-list
2317233|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2317234|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2317235|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317236|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2317237|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2317238|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2317239|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2317240|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317241|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317242|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2881949|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
2881950|NCT02484391|Vitamins|vitamins|mesh-ancestor
2881951|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
2317243|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2317244|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
2317245|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2317246|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2317247|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317248|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2317249|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2317250|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2317251|NCT00355602|Renal Agents|renal agents|mesh-ancestor
2317252|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2317253|NCT00355628|Fentanyl|fentanyl|mesh-list
2317254|NCT00355628|Citric Acid|citric acid|mesh-list
2317255|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
2317256|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2317257|NCT00355628|Narcotics|narcotics|mesh-ancestor
2317258|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2317259|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317260|NCT00355628|Analgesics|analgesics|mesh-ancestor
2317261|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
2317262|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317263|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2317264|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2317265|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
2317266|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
2317267|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
2317268|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2317269|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
2317270|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
2317271|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881991|NCT02448095|Ponatinib|ponatinib|mesh-list
2881992|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881993|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2881994|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2881995|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2881996|NCT02398825|Ponatinib|ponatinib|mesh-list
2317272|NCT00355641|Ropinirole|ropinirole|mesh-list
2317273|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2317274|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2317275|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
2317276|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
2317277|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2317278|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317279|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317280|NCT00355667|Furosemide|furosemide|mesh-list
2317281|NCT00355667|Azosemide|azosemide|mesh-list
2317282|NCT00355667|Diuretics|diuretics|mesh-ancestor
2317283|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
2317284|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317285|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2317286|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2317287|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317288|NCT00355693|Propofol|propofol|mesh-list
2881997|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2881998|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2881999|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882000|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882001|NCT02393248|Gemcitabine|gemcitabine|mesh-list
2882002|NCT02393248|Docetaxel|docetaxel|mesh-list
2882003|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
2882004|NCT02393248|Trastuzumab|trastuzumab|mesh-list
2882005|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882006|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2317289|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2317290|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2317291|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317292|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2317293|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
2317294|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
2317295|NCT00355719|Ritonavir|ritonavir|mesh-list
2317296|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2317297|NCT00355719|Nevirapine|nevirapine|mesh-list
2317298|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2317299|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2317300|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
2317301|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317302|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317303|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2317304|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2317305|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
2317306|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317307|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2317308|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2317309|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2317310|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2317311|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2317312|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2882007|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
2882008|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882009|NCT02393248|Antiviral Agents|antiviral agents|mesh-ancestor
2882010|NCT02393248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2882011|NCT02393248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882012|NCT02393248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2882013|NCT02393248|Immunologic Factors|immunologic factors|mesh-ancestor
2882014|NCT02393248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882015|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
2882016|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
2882017|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
2882018|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2882028|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2882029|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
2882030|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
2882031|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2317313|NCT00355771|Levocetirizine|levocetirizine|mesh-list
2317314|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2317315|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2317316|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
2317317|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
2317318|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2317319|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317320|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317321|NCT00355849|Insulin|insulin|mesh-list
2317322|NCT00355849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2317323|NCT00355849|Insulin Glargine|insulin glargine|mesh-list
2317324|NCT00355849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2317325|NCT00355849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317326|NCT00355862|Cyclosporine|cyclosporine|mesh-list
2317327|NCT00355862|Sirolimus|sirolimus|mesh-list
2317328|NCT00355862|Prednisolone|prednisolone|mesh-list
2317329|NCT00355862|Azathioprine|azathioprine|mesh-list
2317330|NCT00355862|Tacrolimus|tacrolimus|mesh-list
2317331|NCT00355862|Cyclosporins|cyclosporins|mesh-list
2317332|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2317333|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
2317334|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317335|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2317336|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317337|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317338|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
2317339|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317340|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
2317341|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2317342|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2317343|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2317344|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317345|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2317346|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
2317347|NCT00355862|Hormones|hormones|mesh-ancestor
2317348|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2317349|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2317350|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
2317351|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2317352|NCT00355901|Visilizumab|visilizumab|mesh-list
2317353|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
2317354|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317355|NCT00355927|Propofol|propofol|mesh-list
2317356|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2317357|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2317358|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882032|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882033|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
2882034|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2882035|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2882036|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2882037|NCT02307656|Cobicistat|cobicistat|mesh-list
2882038|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2882039|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2882040|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
2317359|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2317360|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
2317361|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
2317362|NCT00355953|Genistein|genistein|mesh-list
2317363|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2317364|NCT00355953|Protective Agents|protective agents|mesh-ancestor
2882041|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882042|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882043|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2882044|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2882045|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
2882046|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2882047|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2882048|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2109064|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109067|NCT02514122|Ketamine|ketamine|mesh-list
2109068|NCT02514122|Analgesics|analgesics|mesh-ancestor
2109069|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
2109070|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109071|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317365|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882079|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
2882080|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2882081|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2882082|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2882083|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2882084|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882085|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
2882086|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2882087|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882088|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2882089|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109072|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2109073|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2109074|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
2109075|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
2109076|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109077|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2317366|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317367|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2317368|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317369|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317370|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
2317371|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2317372|NCT00355953|Estrogens|estrogens|mesh-ancestor
2317373|NCT00355953|Hormones|hormones|mesh-ancestor
2317374|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2317375|NCT00355966|Misoprostol|misoprostol|mesh-list
2317376|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2317377|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
2317378|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2317379|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882118|NCT02091141|Trastuzumab|trastuzumab|mesh-list
2882119|NCT02091141|Pertuzumab|pertuzumab|mesh-list
2882120|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2882121|NCT02091141|Atezolizumab|atezolizumab|mesh-list
2882122|NCT02091141|Vemurafenib|vemurafenib|mesh-list
2882123|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2882124|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882125|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2882126|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882127|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882128|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
2882129|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
2882130|NCT02090114|Testosterone|testosterone|mesh-list
2317380|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2317381|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2317382|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
2317383|NCT00356005|Azithromycin|azithromycin|mesh-list
2317384|NCT00356005|Artesunate|artesunate|mesh-list
2317385|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2882131|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
2882132|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
2882133|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2882134|NCT02090114|Androgens|androgens|mesh-ancestor
2882135|NCT02090114|Hormones|hormones|mesh-ancestor
2882136|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2882137|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882138|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2882139|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882140|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
2882141|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2882142|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882143|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882144|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
2882145|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2882146|NCT02060721|Macitentan|macitentan|mesh-list
2882147|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2882148|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2882149|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882150|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2882151|NCT02031250|Carboplatin|carboplatin|mesh-list
2882152|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882153|NCT02016924|Cobicistat|cobicistat|mesh-list
2882154|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882155|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882156|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2882157|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2882158|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
2882159|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2882160|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2317386|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317387|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
2317388|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2317389|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2317390|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317391|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
2317392|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
2317393|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2317394|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
2317395|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2317396|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2317397|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2317398|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2317399|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317400|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
2317401|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2317402|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317403|NCT00356083|Methadone|methadone|mesh-list
2882161|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2882162|NCT02015351|Bevacizumab|bevacizumab|mesh-list
2882163|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2882164|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882165|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2882166|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2882167|NCT02015351|Growth Substances|growth substances|mesh-ancestor
2882168|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882169|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
2882170|NCT02013167|Blinatumomab|blinatumomab|mesh-list
2882171|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882172|NCT02004522|Ofatumumab|ofatumumab|mesh-list
2882173|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882174|NCT02000427|Blinatumomab|blinatumomab|mesh-list
2882175|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882176|NCT01996436|Verapamil|verapamil|mesh-list
2882177|NCT01996436|Nicardipine|nicardipine|mesh-list
2882178|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
2882179|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
2882180|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2882181|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2882182|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2882183|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882184|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2882185|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882186|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2882194|NCT01957332|Trastuzumab|trastuzumab|mesh-list
2882195|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2882196|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882210|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
2882211|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882212|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2882213|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882214|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317404|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2317405|NCT00356083|Narcotics|narcotics|mesh-ancestor
2317406|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2317407|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317408|NCT00356083|Analgesics|analgesics|mesh-ancestor
2317409|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
2317410|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317411|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
2317412|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
2317413|NCT00356096|Pramipexole|pramipexole|mesh-list
2317414|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
2317415|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317416|NCT00356096|Protective Agents|protective agents|mesh-ancestor
2317417|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317418|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2317419|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2317420|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
2317421|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
2317422|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2317423|NCT00356109|Insulin|insulin|mesh-list
2317424|NCT00356109|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2317425|NCT00356109|Insulin Glargine|insulin glargine|mesh-list
2317426|NCT00356109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2317427|NCT00356109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317428|NCT00356226|Clonidine|clonidine|mesh-list
2317429|NCT00356226|Analgesics|analgesics|mesh-ancestor
2317430|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
2882230|NCT01807182|Aldesleukin|aldesleukin|mesh-list
2882231|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
2882232|NCT01807182|Fludarabine|fludarabine|mesh-list
2882233|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
2882234|NCT01807182|Interleukin-2|interleukin-2|mesh-list
2882235|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2882236|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
2882237|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882238|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2882239|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2882240|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
2882241|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882242|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882243|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2882244|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2882245|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
2882246|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2882247|NCT01807182|Analgesics|analgesics|mesh-ancestor
2317431|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317432|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317433|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2317434|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
2317435|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
2317436|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2882248|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
2882249|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2882250|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2882251|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2882252|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
2882253|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2882254|NCT01765140|Amifampridine|amifampridine|mesh-list
2882255|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2882256|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2882257|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882258|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2882259|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2882260|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882261|NCT01761890|Dasatinib|dasatinib|mesh-list
2882262|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882263|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2317437|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2317438|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2317439|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
2317440|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2317441|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317442|NCT00356252|Carotenoids|carotenoids|mesh-list
2317443|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
2317444|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317445|NCT00356252|Protective Agents|protective agents|mesh-ancestor
2317446|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317447|NCT00356356|Etanercept|etanercept|mesh-list
2882264|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882265|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882266|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2882267|NCT01703949|Nivolumab|nivolumab|mesh-list
2882268|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2882269|NCT01703949|Antibodies|antibodies|mesh-list
2882270|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
2882271|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2882272|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
2882273|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
2882274|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882275|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882276|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2882277|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882278|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
2882279|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2882280|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2882281|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2882282|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2317448|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2317449|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2317450|NCT00356356|Analgesics|analgesics|mesh-ancestor
2317451|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
2317452|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317453|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317454|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2317455|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2317456|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2317457|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2317458|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
2317459|NCT00356395|Candesartan|candesartan|mesh-list
2317460|NCT00356395|Ramipril|ramipril|mesh-list
2317461|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2317462|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2317463|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2317464|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317465|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2882283|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882284|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
2882285|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2882286|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882287|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2882288|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317466|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
2317467|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317468|NCT00356447|Estradiol|estradiol|mesh-list
2317469|NCT00356447|Estrogens|estrogens|mesh-ancestor
2317470|NCT00356447|Hormones|hormones|mesh-ancestor
2317471|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2317472|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317473|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2317474|NCT00356460|Antibodies|antibodies|mesh-list
2317475|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
2317476|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2317477|NCT00356460|Mitogens|mitogens|mesh-list
2317478|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
2317479|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317480|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882295|NCT01595321|Leucovorin|leucovorin|mesh-list
2882296|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
2882297|NCT01595321|Fluorouracil|fluorouracil|mesh-list
2882298|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
2882299|NCT01595321|Irinotecan|irinotecan|mesh-list
2882300|NCT01595321|Folfirinox|folfirinox|mesh-list
2882301|NCT01595321|Vaccines|vaccines|mesh-list
2882302|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
2882303|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882304|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2882305|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2882306|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2882307|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
2882308|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882309|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882310|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2882311|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
2882312|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2882313|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2882314|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2882315|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882316|NCT01595321|Antidotes|antidotes|mesh-ancestor
2882317|NCT01595321|Protective Agents|protective agents|mesh-ancestor
2882318|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
2882319|NCT01595321|Vitamins|vitamins|mesh-ancestor
2882320|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
2882321|NCT01556776|Lenalidomide|lenalidomide|mesh-list
2882322|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
2882323|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882324|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2882325|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2882326|NCT01556776|Growth Substances|growth substances|mesh-ancestor
2882327|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
2882328|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882329|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2882330|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
2882331|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
2882332|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317481|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
2317482|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317483|NCT00356473|Atorvastatin|atorvastatin|mesh-list
2882333|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
2882334|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317484|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2317485|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2317486|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
2317487|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882378|NCT01186640|Vidarabine|vidarabine|mesh-list
2882379|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
2882380|NCT01186640|Fludarabine|fludarabine|mesh-list
2882381|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
2882382|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
2882383|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
2882384|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2882385|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
2882386|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882387|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2882388|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2882389|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
2882390|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882391|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882392|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2882393|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2882394|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
2882395|NCT01186640|Antiviral Agents|antiviral agents|mesh-ancestor
2882396|NCT01186640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2882397|NCT01186640|Analgesics|analgesics|mesh-ancestor
2882398|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
2882399|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2882400|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2882401|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2882402|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882403|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2882404|NCT01112306|Selexipag|selexipag|mesh-list
2882405|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2882406|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
2882407|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2882408|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317488|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2317489|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2317490|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317491|NCT00356486|Ribavirin|ribavirin|mesh-list
2317492|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2317493|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
2317494|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
2317495|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317496|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
2317497|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317498|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
2317499|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317500|NCT00356616|Tenofovir|tenofovir|mesh-list
2317501|NCT00356616|Abacavir|abacavir|mesh-list
2317502|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
2317503|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2882424|NCT00694850|Riociguat|riociguat|mesh-list
2882425|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
2882426|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882427|NCT00688376|Donepezil|donepezil|mesh-list
2882428|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2882429|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882430|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882431|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
2882432|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2882433|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882434|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
2882435|NCT00669734|Metronidazole|metronidazole|mesh-list
2882436|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
2882437|NCT00669734|Vaccines|vaccines|mesh-list
2882438|NCT00669734|Sargramostim|sargramostim|mesh-list
2882439|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
2882440|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882441|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882442|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2882443|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2882444|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2882445|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2882446|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
2882447|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882448|NCT00669734|Protective Agents|protective agents|mesh-ancestor
2882449|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
2882450|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
2317504|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2317505|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2317506|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317507|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317508|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2317509|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2317510|NCT00356681|Niacinamide|niacinamide|mesh-list
2317511|NCT00356681|Paclitaxel|paclitaxel|mesh-list
2317512|NCT00356681|Bevacizumab|bevacizumab|mesh-list
2317513|NCT00356681|Motesanib diphosphate|motesanib diphosphate|mesh-list
2317514|NCT00356681|Imetelstat|imetelstat|mesh-list
2882451|NCT00669734|Growth Substances|growth substances|mesh-ancestor
2882452|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2882453|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882454|NCT00492349|Varenicline|varenicline|mesh-list
2882455|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2317515|NCT00356681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2317516|NCT00356681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317517|NCT00356681|Tubulin Modulators|tubulin modulators|mesh-ancestor
2317518|NCT00356681|Antimitotic Agents|antimitotic agents|mesh-ancestor
2882456|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2882457|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
2882458|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2882459|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882460|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882461|NCT00003102|Antibodies|antibodies|mesh-list
2882462|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2882463|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
2882464|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317519|NCT00356681|Mitosis Modulators|mitosis modulators|mesh-ancestor
2317520|NCT00356681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317521|NCT00356681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2317522|NCT00356681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2317523|NCT00356681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2317524|NCT00356681|Growth Substances|growth substances|mesh-ancestor
2317525|NCT00356681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317526|NCT00356681|Growth Inhibitors|growth inhibitors|mesh-ancestor
2317527|NCT00356681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2317528|NCT00356681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317529|NCT00356681|Vitamin B Complex|vitamin b complex|mesh-ancestor
2317530|NCT00356681|Vitamins|vitamins|mesh-ancestor
2317531|NCT00356681|Micronutrients|micronutrients|mesh-ancestor
2317532|NCT00356720|Azithromycin|azithromycin|mesh-list
2317533|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2317534|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317535|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
2317536|NCT00356733|Hematinics|hematinics|mesh-ancestor
2317537|NCT00356772|Azithromycin|azithromycin|mesh-list
2882481|NCT05181852|Pregabalin|pregabalin|mesh-list
2882482|NCT05181852|Analgesics|analgesics|mesh-ancestor
2882483|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
2882484|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2882485|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882486|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
2882487|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2882488|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2882489|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882490|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2317538|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2317539|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317540|NCT00356824|Artesunate|artesunate|mesh-list
2317541|NCT00356824|Amodiaquine|amodiaquine|mesh-list
2317542|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
2317543|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2317544|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2317545|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317546|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317547|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
2317548|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
2317549|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2317550|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
2317551|NCT00356850|Azithromycin|azithromycin|mesh-list
2317552|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2317553|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317554|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
2317555|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2882491|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2882492|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2882493|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2882494|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2882495|NCT05181735|Luspatercept|luspatercept|mesh-list
2882496|NCT05181735|Hematinics|hematinics|mesh-ancestor
2882497|NCT05181605|Folfirinox|folfirinox|mesh-list
2882498|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882499|NCT05181592|Luspatercept|luspatercept|mesh-list
2882500|NCT05181592|Hematinics|hematinics|mesh-ancestor
2882509|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2882510|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2882511|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2882512|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2882513|NCT05181462|Gemcitabine|gemcitabine|mesh-list
2882514|NCT05181462|Carboplatin|carboplatin|mesh-list
2882515|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882516|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2882517|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
2882518|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882519|NCT05181462|Antiviral Agents|antiviral agents|mesh-ancestor
2882520|NCT05181462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2882521|NCT05181462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882522|NCT05181462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2882523|NCT05181462|Immunologic Factors|immunologic factors|mesh-ancestor
2882524|NCT05181462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882525|NCT05181150|Glucagon|glucagon|mesh-list
2882526|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2882527|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2882528|NCT05181150|Hormones|hormones|mesh-ancestor
2882529|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2882530|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882531|NCT05181150|Incretins|incretins|mesh-ancestor
2317556|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
2317557|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317558|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2882532|NCT05181124|Naproxen|naproxen|mesh-list
2882533|NCT05181124|Meloxicam|meloxicam|mesh-list
2882534|NCT05181124|Aceclofenac|aceclofenac|mesh-list
2317559|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2317560|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
2317561|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317562|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317563|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2317564|NCT00356941|Docetaxel|docetaxel|mesh-list
2317565|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
2317566|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317567|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
2317568|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
2317569|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
2317570|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317571|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
2317572|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
2317573|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317574|NCT00356954|Protective Agents|protective agents|mesh-ancestor
2317575|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317576|NCT00356954|Vitamins|vitamins|mesh-ancestor
2317577|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
2317578|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
2317579|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2317580|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
2317581|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317582|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317583|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2317584|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
2317585|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2317586|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
2317587|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
2317588|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2317589|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317590|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2317591|NCT00357019|Protective Agents|protective agents|mesh-ancestor
2317592|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2317593|NCT00357045|Paroxetine|paroxetine|mesh-list
2882535|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2882536|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2882537|NCT05181124|Analgesics|analgesics|mesh-ancestor
2882538|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
2882539|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2882540|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882541|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2882542|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2882543|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
2882544|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2882545|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882546|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882547|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2882548|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2882549|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2882550|NCT05181033|Letrozole|letrozole|mesh-list
2882551|NCT05181033|Fulvestrant|fulvestrant|mesh-list
2882552|NCT05181033|Lenvatinib|lenvatinib|mesh-list
2882553|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882554|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2882555|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2882556|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882557|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882558|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2882559|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
2882560|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2882561|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882562|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2882563|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2882564|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2882565|NCT05181007|Valproic Acid|valproic acid|mesh-list
2882566|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
2882567|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882568|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882569|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
2882570|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2882571|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882572|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
2882573|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2882574|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2882575|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2882576|NCT05180994|Infliximab|infliximab|mesh-list
2882577|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
2882578|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2882579|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2882580|NCT05180968|Dronabinol|dronabinol|mesh-list
2882581|NCT05180968|Nabilone|nabilone|mesh-list
2882582|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
2882583|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
2882584|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2882585|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882586|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2882587|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2882588|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2882589|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2882590|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2317594|NCT00357045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2317595|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2317596|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2317597|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317598|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2317599|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
2317600|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317601|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2317602|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
2317603|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2317604|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2317605|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2317606|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882591|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
2882592|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2882593|NCT05180968|Analgesics|analgesics|mesh-ancestor
2882594|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
2882595|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2882596|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2882597|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2882598|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882599|NCT05180968|Hormones|hormones|mesh-ancestor
2882600|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2882601|NCT05180942|Atorvastatin|atorvastatin|mesh-list
2882602|NCT05180942|Calcium|calcium|mesh-list
2882603|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2882604|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882605|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2109078|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2109079|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109080|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109081|NCT02514174|Afatinib|afatinib|mesh-list
2109082|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109083|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2882606|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2882607|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
2882608|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882609|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2882610|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2882611|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882612|NCT05180825|Trametinib|trametinib|mesh-list
2882613|NCT05180825|Vinblastine|vinblastine|mesh-list
2882614|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882615|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2882616|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882617|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882618|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2882619|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
2882620|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
2882621|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
2882622|NCT05180799|Nivolumab|nivolumab|mesh-list
2882623|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2882624|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882625|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2317607|NCT00357084|Prednisone|prednisone|mesh-list
2317608|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
2317609|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2317610|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2317611|NCT00357084|Prednisolone|prednisolone|mesh-list
2317612|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
2882626|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882644|NCT05180708|Sirolimus|sirolimus|mesh-list
2882645|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2882646|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2882647|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2882648|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882649|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
2882650|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2882651|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
2882652|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882653|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
2882654|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2882655|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
2882656|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882657|NCT05180474|Antibodies|antibodies|mesh-list
2882658|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2882659|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
2317613|NCT00357084|Methotrexate|methotrexate|mesh-list
2317614|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2317615|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
2317616|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2317617|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
2317618|NCT00357084|Hormones|hormones|mesh-ancestor
2317619|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2317620|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317621|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2317622|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317623|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2317624|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
2317625|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2882660|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882661|NCT05180461|Ivermectin|ivermectin|mesh-list
2882662|NCT05180461|Emodepside|emodepside|mesh-list
2882663|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2882664|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2882668|NCT05180318|Ketamine|ketamine|mesh-list
2882669|NCT05180318|Esketamine|esketamine|mesh-list
2882670|NCT05180318|Analgesics|analgesics|mesh-ancestor
2882671|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
2882672|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2882673|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882674|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2882675|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2882676|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
2882677|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
2882678|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2882679|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2882680|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2882681|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2882682|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882683|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
2317626|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2317627|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
2317628|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317629|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
2317630|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317631|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2317632|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2317633|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
2317634|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2317635|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2317636|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
2317637|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
2317638|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317639|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2317640|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2317641|NCT00357084|Protective Agents|protective agents|mesh-ancestor
2317642|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2317643|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2317644|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2317645|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
2317646|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317647|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2317648|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2317649|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317650|NCT00357149|Cisplatin|cisplatin|mesh-list
2317651|NCT00357149|Docetaxel|docetaxel|mesh-list
2317652|NCT00357149|Fluorouracil|fluorouracil|mesh-list
2317653|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317654|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
2317655|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
2317656|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
2317657|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882684|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2882701|NCT05180240|Cannabidiol|cannabidiol|mesh-list
2882702|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
2317658|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
2317659|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2317660|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2317661|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
2317662|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317663|NCT00357188|Ritonavir|ritonavir|mesh-list
2317664|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2317665|NCT00357188|Efavirenz|efavirenz|mesh-list
2317666|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2317667|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2317668|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
2317669|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317670|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882746|NCT05180006|Bevacizumab|bevacizumab|mesh-list
2882747|NCT05180006|Trastuzumab|trastuzumab|mesh-list
2882748|NCT05180006|Pertuzumab|pertuzumab|mesh-list
2882749|NCT05180006|Atezolizumab|atezolizumab|mesh-list
2882750|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2882751|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317671|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2317672|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2317673|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
2317674|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317675|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2317676|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2882752|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2882753|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2882754|NCT05180006|Growth Substances|growth substances|mesh-ancestor
2882755|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882756|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
2882757|NCT05173298|Bevacizumab|bevacizumab|mesh-list
2882758|NCT05173298|Atezolizumab|atezolizumab|mesh-list
2317677|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2317678|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2317679|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2317680|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2317681|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2317682|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2317683|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2317684|NCT00357240|Ritonavir|ritonavir|mesh-list
2317685|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2317686|NCT00357240|Omeprazole|omeprazole|mesh-list
2317687|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2317688|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2317689|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
2317690|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317691|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317692|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2317693|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2317694|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
2317695|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317696|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2317697|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2882759|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2882760|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317698|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2317699|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2317700|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2317701|NCT00357253|Capecitabine|capecitabine|mesh-list
2317702|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2317703|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
2317704|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317705|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317706|NCT00357279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2317707|NCT00357292|Azithromycin|azithromycin|mesh-list
2317708|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2317709|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2882761|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2882762|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2882763|NCT05173298|Growth Substances|growth substances|mesh-ancestor
2882764|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882765|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
2317710|NCT00357305|Cytarabine|cytarabine|mesh-list
2317711|NCT00357305|Etoposide|etoposide|mesh-list
2317712|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
2317713|NCT00357305|Vorinostat|vorinostat|mesh-list
2317714|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2317715|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317716|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2317717|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2317718|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317719|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317720|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2317721|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
2317722|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
2317723|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317724|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2317725|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
2317726|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317727|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2317728|NCT00357318|Bevacizumab|bevacizumab|mesh-list
2317729|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2317730|NCT00357318|Sunitinib|sunitinib|mesh-list
2317731|NCT00357318|Antibodies|antibodies|mesh-list
2882775|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
2882776|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
2882777|NCT05156814|Progestins|progestins|mesh-ancestor
2882778|NCT05156814|Hormones|hormones|mesh-ancestor
2882779|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2882780|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882789|NCT05154734|Belimumab|belimumab|mesh-list
2882790|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2882791|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
2882792|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882793|NCT05152888|Evolocumab|evolocumab|mesh-list
2882794|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2882795|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2882796|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
2882797|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882798|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2882799|NCT05152017|Vaccines|vaccines|mesh-list
2882800|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
2882801|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882802|NCT05151744|Ranibizumab|ranibizumab|mesh-list
2317732|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
2317733|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2882803|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2882804|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2882805|NCT05151744|Growth Substances|growth substances|mesh-ancestor
2882806|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882807|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
2882808|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882809|NCT05151731|Ranibizumab|ranibizumab|mesh-list
2882810|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2882811|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2882812|NCT05151731|Growth Substances|growth substances|mesh-ancestor
2882813|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882814|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
2882815|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317734|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317735|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2317736|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2317737|NCT00357318|Growth Substances|growth substances|mesh-ancestor
2317738|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317739|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
2317740|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
2317741|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2317742|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317743|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317744|NCT00357383|Azithromycin|azithromycin|mesh-list
2317745|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2317746|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317747|NCT00357422|Ethanol|ethanol|mesh-list
2317748|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2317749|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317750|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2317751|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317752|NCT00357448|Interleukin-2|interleukin-2|mesh-list
2317753|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
2317754|NCT00357448|Immunotoxins|immunotoxins|mesh-list
2317755|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317756|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2317757|NCT00357448|Analgesics|analgesics|mesh-ancestor
2317758|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
2317759|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317760|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317761|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
2317762|NCT00357461|Ipilimumab|ipilimumab|mesh-list
2317763|NCT00357461|Vaccines|vaccines|mesh-list
2317764|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
2317765|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
2317766|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317767|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2317768|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317769|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2882822|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
2882823|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2882824|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
2882825|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2882826|NCT05142735|Expectorants|expectorants|mesh-ancestor
2882827|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
2882828|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2882829|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
2882830|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317770|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317771|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2317772|NCT00357474|Ethanol|ethanol|mesh-list
2317773|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2317774|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317775|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2317776|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317777|NCT00357539|Azithromycin|azithromycin|mesh-list
2317778|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2317779|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2882831|NCT05142735|Protective Agents|protective agents|mesh-ancestor
2882832|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882833|NCT05142735|Antidotes|antidotes|mesh-ancestor
2882834|NCT05140694|Empagliflozin|empagliflozin|mesh-list
2882835|NCT05140694|Dulaglutide|dulaglutide|mesh-list
2882836|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2109084|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109085|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109086|NCT02514473|Ivacaftor|ivacaftor|mesh-list
2109087|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2109088|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2109089|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109090|NCT02514551|Paclitaxel|paclitaxel|mesh-list
2109091|NCT02514551|Ramucirumab|ramucirumab|mesh-list
2109092|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2109093|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882837|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2882838|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882839|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2882840|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882841|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
2882862|NCT05135312|Etanercept|etanercept|mesh-list
2882863|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2882864|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2882865|NCT05135312|Analgesics|analgesics|mesh-ancestor
2882866|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
2882867|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2882868|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882869|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2882870|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2882871|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2882872|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2882873|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
2317807|NCT00357604|Ritonavir|ritonavir|mesh-list
2317808|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2317809|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
2317810|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2317811|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2317812|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2317813|NCT00357604|Norgestimate|norgestimate|mesh-list
2317814|NCT00357604|Norgestrel|norgestrel|mesh-list
2317815|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2317816|NCT00357604|Estradiol|estradiol|mesh-list
2317817|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2317818|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2317819|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2317820|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
2317821|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317822|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317823|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2317824|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2317825|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
2317826|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317827|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2317828|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2317829|NCT00357604|Estrogens|estrogens|mesh-ancestor
2317830|NCT00357604|Hormones|hormones|mesh-ancestor
2317831|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2317832|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317833|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2317834|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
2317835|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2317836|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2317837|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2317838|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2317839|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2317840|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2317841|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2882894|NCT05116774|Eculizumab|eculizumab|mesh-list
2882895|NCT05116774|Ravulizumab|ravulizumab|mesh-list
2882896|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2882897|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2882898|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
2882899|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317842|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2317843|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2317844|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317845|NCT00357617|Celecoxib|celecoxib|mesh-list
2317846|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2317847|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2317848|NCT00357617|Analgesics|analgesics|mesh-ancestor
2317849|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
2317850|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2882900|NCT05116202|Nivolumab|nivolumab|mesh-list
2882901|NCT05116202|Ipilimumab|ipilimumab|mesh-list
2882902|NCT05116202|Atezolizumab|atezolizumab|mesh-list
2317851|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317852|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2317853|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2317854|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2317855|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2882903|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2882904|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882905|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2882906|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882907|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
2882908|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2882909|NCT05109104|Protective Agents|protective agents|mesh-ancestor
2317856|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317857|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317858|NCT00357630|Gemcitabine|gemcitabine|mesh-list
2317859|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2317860|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
2317861|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317862|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317863|NCT00357630|Antiviral Agents|antiviral agents|mesh-ancestor
2317864|NCT00357630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317865|NCT00357630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882910|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882911|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
2317866|NCT00357630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2317867|NCT00357630|Immunologic Factors|immunologic factors|mesh-ancestor
2317868|NCT00357630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317869|NCT00357643|Vitamin D|vitamin d|mesh-list
2317870|NCT00357643|Calcium|calcium|mesh-list
2317871|NCT00357643|Vitamins|vitamins|mesh-ancestor
2317872|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
2317873|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882926|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
2882927|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2109094|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
2109095|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
2109096|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
2882928|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882929|NCT05089123|Vaccines|vaccines|mesh-list
2882930|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
2882931|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882932|NCT05083182|Ustekinumab|ustekinumab|mesh-list
2882933|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
2882934|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
2882935|NCT05081193|Testosterone|testosterone|mesh-list
2882936|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
2882937|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
2882938|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2882939|NCT05081193|Androgens|androgens|mesh-ancestor
2882940|NCT05081193|Hormones|hormones|mesh-ancestor
2882941|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2882942|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882943|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2882944|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109097|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109098|NCT02514772|Rituximab|rituximab|mesh-list
2109099|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2109100|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109101|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
2109102|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882945|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
2882946|NCT05081180|Lenvatinib|lenvatinib|mesh-list
2882947|NCT05081180|Avelumab|avelumab|mesh-list
2882948|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317874|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2317875|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2317876|NCT00357669|Brivaracetam|brivaracetam|mesh-list
2317877|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
2317878|NCT00357682|Aspirin|aspirin|mesh-list
2317879|NCT00357682|Esomeprazole|esomeprazole|mesh-list
2317880|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2317881|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2317882|NCT00357682|Analgesics|analgesics|mesh-ancestor
2317883|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
2882949|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2882950|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2882951|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2882952|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2317884|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317885|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317886|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2317887|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2317888|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2317889|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2317890|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317891|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2317892|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2317893|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317894|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
2317895|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2317896|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2317897|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2317898|NCT00357708|Decitabine|decitabine|mesh-list
2317899|NCT00357708|Azacitidine|azacitidine|mesh-list
2317900|NCT00357708|Vorinostat|vorinostat|mesh-list
2317901|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2317902|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
2317903|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317904|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317905|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317906|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2317907|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2317908|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2317909|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2882970|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
2882971|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2882972|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2882981|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2882982|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
2882983|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
2882984|NCT05064332|Estradiol|estradiol|mesh-list
2882985|NCT05064332|Estrogens|estrogens|mesh-ancestor
2882986|NCT05064332|Hormones|hormones|mesh-ancestor
2882987|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2882988|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882989|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2882990|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2882991|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2882992|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2109103|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2109104|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
2109105|NCT02515045|Prednisolone|prednisolone|mesh-list
2109106|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2109107|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
2109108|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2109109|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
2109110|NCT02515045|Nepafenac|nepafenac|mesh-list
2109111|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2109112|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
2109113|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109114|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
2109115|NCT02515045|Hormones|hormones|mesh-ancestor
2109116|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109117|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109118|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2109119|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109120|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
2882993|NCT05063656|Gabapentin|gabapentin|mesh-list
2882994|NCT05063656|Analgesics|analgesics|mesh-ancestor
2882995|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
2882996|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2882997|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2882998|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
2882999|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2883000|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2883001|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2883002|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883003|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2883004|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2883005|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883006|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883007|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
2883008|NCT05063565|Durvalumab|durvalumab|mesh-list
2883009|NCT05063565|Tremelimumab|tremelimumab|mesh-list
2883010|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
2883011|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2883012|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883013|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317910|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
2317911|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317912|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317913|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2317914|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2317915|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
2317916|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317917|NCT00357747|Docetaxel|docetaxel|mesh-list
2317918|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317919|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
2109121|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
2317920|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
2317921|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
2317922|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317923|NCT00357773|Azithromycin|azithromycin|mesh-list
2317924|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2317925|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317926|NCT00357825|Reboxetine|reboxetine|mesh-list
2317927|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
2317928|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2317929|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2317930|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2317931|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2317932|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317933|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
2317934|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2317935|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317936|NCT00357851|Aprotinin|aprotinin|mesh-list
2317937|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
2317938|NCT00357851|Coagulants|coagulants|mesh-ancestor
2317939|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2317940|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2317941|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
2317942|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2317943|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317944|NCT00357864|Carbachol|carbachol|mesh-list
2317945|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2317946|NCT00357864|Miotics|miotics|mesh-ancestor
2317947|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
2317948|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317949|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317950|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2317951|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
2317952|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2317953|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2317954|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2883065|NCT05041257|Maytansine|maytansine|mesh-list
2883066|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2883067|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883068|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
2883069|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
2883070|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
2883071|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883072|NCT05035927|Psilocybin|psilocybin|mesh-list
2883073|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
2883074|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883075|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883092|NCT05034029|Metformin|metformin|mesh-list
2883093|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2317955|NCT00357864|Analgesics|analgesics|mesh-ancestor
2317956|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
2317957|NCT00357864|Protective Agents|protective agents|mesh-ancestor
2317958|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
2317959|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2317960|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317961|NCT00357942|Morphine|morphine|mesh-list
2883094|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883116|NCT05022758|Warfarin|warfarin|mesh-list
2883117|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
2883118|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
2883119|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2883120|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
2883121|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2883122|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
2883123|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2883124|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883125|NCT05013216|Poly ICLC|poly iclc|mesh-list
2317962|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2317963|NCT00357942|Narcotics|narcotics|mesh-ancestor
2317964|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2317965|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317966|NCT00357942|Analgesics|analgesics|mesh-ancestor
2317967|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
2317968|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2317969|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
2317970|NCT00357981|Ortho Evra|ortho evra|mesh-list
2883126|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
2883127|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
2883128|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883135|NCT05002816|Elotuzumab|elotuzumab|mesh-list
2317971|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2317972|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317973|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2317974|NCT00358020|Thalidomide|thalidomide|mesh-list
2317975|NCT00358020|Bortezomib|bortezomib|mesh-list
2317976|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317977|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2317978|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
2883136|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883137|NCT04979780|Heparin|heparin|mesh-list
2883138|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2883139|NCT04979780|Tinzaparin|tinzaparin|mesh-list
2883140|NCT04979780|Dalteparin|dalteparin|mesh-list
2317979|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317980|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
2317981|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2317982|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2317983|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2317984|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2317985|NCT00358020|Growth Substances|growth substances|mesh-ancestor
2317986|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
2317987|NCT00358124|Metformin|metformin|mesh-list
2317988|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
2317989|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
2317990|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2317991|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2317992|NCT00358163|Paclitaxel|paclitaxel|mesh-list
2317993|NCT00358163|Vatalanib|vatalanib|mesh-list
2317994|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2317995|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2317996|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
2317997|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
2317998|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
2317999|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318000|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2318001|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318002|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
2318003|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2318004|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2318005|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318006|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2883141|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
2883142|NCT04979780|Anticoagulants|anticoagulants|mesh-list
2883143|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2883144|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2883145|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883146|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2883147|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
2883148|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2883149|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
2883150|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318007|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318008|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2318009|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
2318010|NCT00358202|Cefepime|cefepime|mesh-list
2318011|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318012|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318013|NCT00358228|Rimonabant|rimonabant|mesh-list
2318014|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2318015|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2318016|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2318017|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318018|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318019|NCT00358228|Hormones|hormones|mesh-ancestor
2318020|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2318021|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318022|NCT00358280|Bupivacaine|bupivacaine|mesh-list
2318023|NCT00358280|Ropivacaine|ropivacaine|mesh-list
2318024|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
2318025|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
2318026|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318027|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883164|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2883165|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
2883166|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883167|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883168|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
2883169|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883170|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883171|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2883172|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2883173|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2883174|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
2883175|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
2883176|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2883177|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2883178|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2883179|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2883180|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2883181|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883182|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883183|NCT04963725|Ustekinumab|ustekinumab|mesh-list
2883184|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
2883185|NCT04957758|Varenicline|varenicline|mesh-list
2883186|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2883187|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2883188|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
2883189|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883190|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883191|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883192|NCT04949425|Adavosertib|adavosertib|mesh-list
2883193|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2883194|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883195|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2883196|NCT04944888|Eliglustat|eliglustat|mesh-list
2883197|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883198|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883199|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2883207|NCT04940039|Risperidone|risperidone|mesh-list
2883208|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2883209|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2883210|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
2883211|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883212|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883213|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883214|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2883215|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2883216|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2883217|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883218|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2883219|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
2883220|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2883221|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2883225|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
2883226|NCT04938024|Vitamins|vitamins|mesh-ancestor
2883227|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
2883228|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883229|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
2883230|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883231|NCT04938024|Protective Agents|protective agents|mesh-ancestor
2883232|NCT04936984|Abaloparatide|abaloparatide|mesh-list
2883233|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
2883234|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2883235|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883236|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2883279|NCT04929808|Emollients|emollients|mesh-list
2883280|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
2318028|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
2318029|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318030|NCT00358293|Tizanidine|tizanidine|mesh-list
2318031|NCT00358293|Analgesics|analgesics|mesh-ancestor
2318032|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
2318033|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318034|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318035|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
2318036|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2109122|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2883289|NCT04914234|Metoprolol|metoprolol|mesh-list
2883290|NCT04914234|Atenolol|atenolol|mesh-list
2883291|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2883292|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2883293|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
2883294|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
2883295|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2883296|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883297|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2883298|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2883299|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2883300|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
2883301|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883302|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883303|NCT04911062|Epinephrine|epinephrine|mesh-list
2883304|NCT04911062|Bupivacaine|bupivacaine|mesh-list
2883305|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
2883306|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
2883307|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2883308|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883309|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
2883310|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2883311|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2883312|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2883313|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
2883314|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883315|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883316|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2883317|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2883318|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
2883319|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2883320|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
2883321|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
2883322|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
2883323|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2883324|NCT04901377|Dienogest|dienogest|mesh-list
2883325|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2883326|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2883327|NCT04901377|Estradiol|estradiol|mesh-list
2883328|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2883329|NCT04901377|Estrogens|estrogens|mesh-ancestor
2883330|NCT04901377|Hormones|hormones|mesh-ancestor
2883331|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2883332|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883333|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2883334|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
2883335|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2883336|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2883337|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2883338|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2883339|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2883340|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
2883341|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2883342|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883343|NCT04896697|Pembrolizumab|pembrolizumab|mesh-list
2883344|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2883345|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318037|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2318038|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
2318039|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
2318040|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2318041|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2318042|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2318043|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
2318044|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318045|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318046|NCT00358319|Valproic Acid|valproic acid|mesh-list
2318047|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
2318048|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318049|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318050|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
2318051|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318052|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318053|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
2318054|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2318055|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318056|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2318057|NCT00358358|Fluticasone|fluticasone|mesh-list
2318058|NCT00358358|Xhance|xhance|mesh-list
2318059|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2318060|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2318061|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2318062|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2318063|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
2318064|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318065|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318066|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2318067|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
2318068|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
2883380|NCT04882072|Ustekinumab|ustekinumab|mesh-list
2883381|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
2883382|NCT04857307|Alprazolam|alprazolam|mesh-list
2883383|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2883384|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2883385|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883386|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2883387|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2883388|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883389|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
2883390|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
2883391|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883392|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883393|NCT04855526|Dronabinol|dronabinol|mesh-list
2883394|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
2883395|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883396|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883397|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2883398|NCT04855526|Analgesics|analgesics|mesh-ancestor
2883399|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
2883400|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2883401|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2883402|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2883403|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883404|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883405|NCT04855526|Hormones|hormones|mesh-ancestor
2318069|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2318070|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2318071|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2318072|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2318073|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
2318074|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883406|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2883410|NCT04842552|Hydralazine|hydralazine|mesh-list
2883411|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2883412|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
2883416|NCT04829318|Esketamine|esketamine|mesh-list
2883417|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
2883418|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883419|NCT04825652|177Lu-PSMA-617|177lu-psma-617|mesh-list
2883420|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2883421|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883425|NCT04818944|Tirofiban|tirofiban|mesh-list
2883426|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2883427|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2883428|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883429|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2883430|NCT04812951|Cyclosporine|cyclosporine|mesh-list
2883431|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2883432|NCT04812951|Cyclosporins|cyclosporins|mesh-list
2883433|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2883434|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883435|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2883436|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
2883437|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883438|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
2883439|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2883440|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
2883441|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2883442|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2883443|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2318075|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318076|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
2318077|NCT00358358|Hormones|hormones|mesh-ancestor
2318078|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2318079|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
2318080|NCT00358371|Floxacillin|floxacillin|mesh-list
2318081|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318082|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318083|NCT00358384|Betamethasone|betamethasone|mesh-list
2318084|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
2318085|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2318086|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
2318087|NCT00358384|Calcipotriene|calcipotriene|mesh-list
2318088|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2318089|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2318090|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
2318091|NCT00358384|Hormones|hormones|mesh-ancestor
2318092|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2318093|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883480|NCT04772313|Methotrexate|methotrexate|mesh-list
2883481|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2883482|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
2318094|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2318095|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
2318096|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
2318097|NCT00358410|Casopitant|casopitant|mesh-list
2318098|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
2318099|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
2318100|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318101|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318102|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2318103|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2318104|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318105|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883483|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2883484|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883485|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2883486|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
2883487|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883488|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883489|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
2883490|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2883491|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2883492|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2318106|NCT00358488|Albuterol|albuterol|mesh-list
2318107|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2318108|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2318109|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
2318110|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318111|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318112|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2318113|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
2318114|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2318115|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2318116|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2318117|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
2318118|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883493|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
2883494|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2883495|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2883496|NCT04756401|Dexamethasone|dexamethasone|mesh-list
2883497|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
2883498|NCT04756401|Daratumumab|daratumumab|mesh-list
2883499|NCT04756401|Ichthammol|ichthammol|mesh-list
2883500|NCT04756401|BB 1101|bb 1101|mesh-list
2883501|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2883502|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
2883503|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
2883504|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2883505|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883506|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2883507|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
2883508|NCT04756401|Hormones|hormones|mesh-ancestor
2883509|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2883510|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2883511|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883512|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
2883513|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2883514|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883515|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
2883516|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
2318119|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318120|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
2318121|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2318122|NCT00358553|Insulin|insulin|mesh-list
2318123|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2318124|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318125|NCT00358566|Gemcitabine|gemcitabine|mesh-list
2318126|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2318127|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
2318128|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318129|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318130|NCT00358566|Antiviral Agents|antiviral agents|mesh-ancestor
2883517|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2883518|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883519|NCT04742751|Metformin|metformin|mesh-list
2883520|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2883521|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883522|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
2883523|NCT04740307|Lenvatinib|lenvatinib|mesh-list
2883524|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2883525|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883526|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2883527|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2883528|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318131|NCT00358566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318132|NCT00358566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318133|NCT00358566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2318134|NCT00358566|Immunologic Factors|immunologic factors|mesh-ancestor
2318135|NCT00358566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318136|NCT00358618|Propofol|propofol|mesh-list
2318137|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2318138|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318139|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318140|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2318141|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
2318142|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
2318143|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
2318144|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2318145|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
2318146|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318147|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2318148|NCT00358696|Tenofovir|tenofovir|mesh-list
2318149|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
2318150|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318151|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2318152|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2318153|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318154|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318155|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2318156|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2318157|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
2318158|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2318159|NCT00358813|Casopitant|casopitant|mesh-list
2318160|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
2318161|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
2318162|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318163|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318164|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2318165|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2318166|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318167|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318168|NCT00358878|Satavaptan|satavaptan|mesh-list
2318169|NCT00358878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2318170|NCT00358878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318171|NCT00358878|Natriuretic Agents|natriuretic agents|mesh-ancestor
2318172|NCT00358878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318173|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
2318174|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318175|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2318176|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2318177|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318178|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318179|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
2318180|NCT00358969|Guanfacine|guanfacine|mesh-list
2318181|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2318182|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2318183|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2883557|NCT04707625|Aflibercept|aflibercept|mesh-list
2883558|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2883559|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2883560|NCT04707625|Growth Substances|growth substances|mesh-ancestor
2883561|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883562|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
2883563|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883564|NCT04698525|Valproic Acid|valproic acid|mesh-list
2883565|NCT04698525|Memantine|memantine|mesh-list
2883566|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2883567|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2883568|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
2883569|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883570|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883571|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883572|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2883573|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2883574|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
2883575|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2883576|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
2883577|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
2883578|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2883579|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2883580|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883581|NCT04698031|Aspirin|aspirin|mesh-list
2883582|NCT04698031|Clopidogrel|clopidogrel|mesh-list
2883583|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2883584|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2883585|NCT04698031|Analgesics|analgesics|mesh-ancestor
2883586|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
2883587|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2883588|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883589|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2883590|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2883591|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2883592|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2883593|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883594|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2883595|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2883596|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2883597|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
2883598|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2883599|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2883600|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2883601|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
2883602|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883603|NCT04696146|Complement C1s|complement c1s|mesh-list
2883604|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2883605|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2883606|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
2883607|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883608|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2883609|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2883610|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2883611|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
2883612|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
2883613|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2883614|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883615|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
2883616|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2883617|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2318184|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2318185|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
2318186|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318187|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318188|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318189|NCT00358982|Mocetinostat|mocetinostat|mesh-list
2318190|NCT00358982|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2318191|NCT00358982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318192|NCT00358982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318193|NCT00359086|Mocetinostat|mocetinostat|mesh-list
2318194|NCT00359086|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2318195|NCT00359086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318196|NCT00359086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318197|NCT00359112|Metformin|metformin|mesh-list
2318198|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2318199|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883625|NCT04673357|Ustekinumab|ustekinumab|mesh-list
2883626|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
2883632|NCT04667312|Durvalumab|durvalumab|mesh-list
2883633|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2883634|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883635|NCT04665570|Metformin|metformin|mesh-list
2883636|NCT04665570|Acarbose|acarbose|mesh-list
2883637|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2883638|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883639|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2883640|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2883641|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883642|NCT04663464|Abaloparatide|abaloparatide|mesh-list
2883643|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
2318200|NCT00359125|Mifepristone|mifepristone|mesh-list
2318201|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2318202|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
2318203|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2318204|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318205|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2318206|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2318207|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2318208|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
2883644|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2883645|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883646|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2883653|NCT04650282|Lidocaine|lidocaine|mesh-list
2883654|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
2883655|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
2883656|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2883657|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883658|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
2883659|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2883660|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2883661|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2883662|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2883663|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2883664|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109123|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2109124|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2109125|NCT02515045|Protective Agents|protective agents|mesh-ancestor
2109126|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2109127|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2109128|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2109129|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2109130|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109131|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109132|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2109133|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2109134|NCT02515045|Analgesics|analgesics|mesh-ancestor
2109135|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
2109136|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2109137|NCT02515279|Ribavirin|ribavirin|mesh-list
2109138|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2109139|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
2109140|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109141|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
2109142|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2109143|NCT02515305|Clindamycin|clindamycin|mesh-list
2109144|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
2109145|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
2109146|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2109147|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2109148|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2109149|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2109150|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109151|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883683|NCT04639466|Vaccines|vaccines|mesh-list
2883684|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
2883685|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883686|NCT04630028|Ustekinumab|ustekinumab|mesh-list
2883687|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
2883688|NCT04624945|Thromboplastin|thromboplastin|mesh-list
2883689|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
2318209|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2318210|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2318211|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
2372158|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109152|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
2883690|NCT04624945|Coagulants|coagulants|mesh-ancestor
2318212|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2318213|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
2318214|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2318215|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2318216|NCT00359151|Celecoxib|celecoxib|mesh-list
2883703|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
2883704|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
2883705|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883706|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2883707|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883708|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
2883709|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2883710|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2883711|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883712|NCT04599855|Esketamine|esketamine|mesh-list
2883713|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
2883714|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883715|NCT04596657|Vitamin D|vitamin d|mesh-list
2883716|NCT04596657|Vitamins|vitamins|mesh-ancestor
2883717|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
2883718|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883719|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2883731|NCT04550546|Nystatin|nystatin|mesh-list
2883732|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2883733|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2883734|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
2883735|NCT04550546|Ionophores|ionophores|mesh-ancestor
2883736|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2883737|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318217|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2318218|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2318219|NCT00359151|Analgesics|analgesics|mesh-ancestor
2318220|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
2318221|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318222|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318223|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2318224|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2318225|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2883745|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
2883746|NCT04540380|Rituximab|rituximab|mesh-list
2883747|NCT04540380|Fludarabine|fludarabine|mesh-list
2883748|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2883749|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
2883750|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883751|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2883752|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2883753|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
2883754|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883755|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883756|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2883757|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2883758|NCT04537715|Itraconazole|itraconazole|mesh-list
2883759|NCT04537715|Rifampin|rifampin|mesh-list
2883760|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
2883761|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2883762|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2883763|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2883764|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2883765|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883766|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2883767|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
2883768|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2883769|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883770|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2883771|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2883772|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
2883773|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2883774|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
2883775|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2883776|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2883777|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2883778|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2883779|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2883780|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2883781|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2883782|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2883783|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2883784|NCT04520607|Lorecivivint|lorecivivint|mesh-list
2318226|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2318227|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318228|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318229|NCT00359164|Bevacizumab|bevacizumab|mesh-list
2318230|NCT00359164|Verteporfin|verteporfin|mesh-list
2318231|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2883785|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2883792|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2883793|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
2883794|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883795|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2883796|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2883797|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2883798|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318232|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318233|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2318234|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2318235|NCT00359164|Growth Substances|growth substances|mesh-ancestor
2318236|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318237|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
2318238|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2318239|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
2318240|NCT00359177|Casopitant|casopitant|mesh-list
2318241|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
2318242|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
2318243|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318244|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318245|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2318246|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2883799|NCT04499131|Progesterone|progesterone|mesh-list
2883800|NCT04499131|Progestins|progestins|mesh-ancestor
2883801|NCT04499131|Hormones|hormones|mesh-ancestor
2318247|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318248|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318249|NCT00359190|Lapatinib|lapatinib|mesh-list
2318250|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318251|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2318252|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318253|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318254|NCT00359229|Zolpidem|zolpidem|mesh-list
2318255|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2318256|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2318257|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318258|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318259|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2318260|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
2318261|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
2318262|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318263|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318264|NCT00359333|Gemcitabine|gemcitabine|mesh-list
2318265|NCT00359333|Docetaxel|docetaxel|mesh-list
2318266|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2318267|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
2318268|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318269|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318270|NCT00359333|Antiviral Agents|antiviral agents|mesh-ancestor
2318271|NCT00359333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2883802|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2883803|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883804|NCT04476446|Esketamine|esketamine|mesh-list
2883805|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
2883806|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883809|NCT04471428|Docetaxel|docetaxel|mesh-list
2883810|NCT04471428|Atezolizumab|atezolizumab|mesh-list
2883811|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883812|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
2883813|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
2883814|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
2883815|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318272|NCT00359333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318273|NCT00359333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2318274|NCT00359333|Immunologic Factors|immunologic factors|mesh-ancestor
2318275|NCT00359333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318276|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
2318277|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
2318278|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
2318279|NCT00359359|Sagopilone|sagopilone|mesh-list
2318280|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318281|NCT00359385|Alendronate|alendronate|mesh-list
2318282|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2318283|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318284|NCT00359437|Satavaptan|satavaptan|mesh-list
2318285|NCT00359437|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2318286|NCT00359437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318287|NCT00359437|Natriuretic Agents|natriuretic agents|mesh-ancestor
2318288|NCT00359437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318289|NCT00359450|Taxane|taxane|mesh-list
2318290|NCT00359450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318291|NCT00359567|Palonosetron|palonosetron|mesh-list
2318292|NCT00359567|Granisetron|granisetron|mesh-list
2318293|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
2318294|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
2318295|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318296|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318297|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2318298|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2318299|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2318300|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
2318301|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318302|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318303|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
2318304|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
2318305|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318306|NCT00359658|Cyclosporine|cyclosporine|mesh-list
2318307|NCT00359658|Prednisolone|prednisolone|mesh-list
2318308|NCT00359658|Cyclosporins|cyclosporins|mesh-list
2883816|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2883817|NCT04469595|Aflibercept|aflibercept|mesh-list
2883818|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2883819|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2883820|NCT04469595|Growth Substances|growth substances|mesh-ancestor
2883821|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883822|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
2883823|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883824|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2883825|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
2883826|NCT04469595|Hormones|hormones|mesh-ancestor
2883827|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2883828|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2883829|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
2883830|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883831|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883832|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
2883833|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318309|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318310|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318311|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2318312|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
2318313|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318314|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
2318315|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318316|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
2318317|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2318318|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2318319|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2318320|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
2318321|NCT00359658|Hormones|hormones|mesh-ancestor
2318322|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2318323|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2318324|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318325|NCT00359671|Docetaxel|docetaxel|mesh-list
2318326|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318327|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
2318328|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
2318329|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
2318330|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318331|NCT00359697|Mannitol|mannitol|mesh-list
2318332|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2318333|NCT00359697|Diuretics|diuretics|mesh-ancestor
2318334|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
2318335|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318336|NCT00359723|Methylphenidate|methylphenidate|mesh-list
2318337|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2318338|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318339|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2318340|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2318341|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2318342|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318343|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
2318344|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318345|NCT00359814|Cyclosporine|cyclosporine|mesh-list
2318346|NCT00359814|Cyclosporins|cyclosporins|mesh-list
2318347|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318348|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318349|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2883834|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883835|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2883836|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2883837|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2883838|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
2883839|NCT04454424|Midazolam|midazolam|mesh-list
2883840|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2883841|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2883842|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318350|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
2318351|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318352|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
2318353|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318354|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
2318355|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2318356|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2318357|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
2318358|NCT00359840|Hematinics|hematinics|mesh-ancestor
2318359|NCT00359853|Norfloxacin|norfloxacin|mesh-list
2883843|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883844|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2883845|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2883846|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883847|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2883848|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
2883849|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
2883850|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
2883851|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
2883852|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883853|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883854|NCT04451187|Zopiclone|zopiclone|mesh-list
2883855|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2883856|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2883857|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318360|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318361|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318362|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2318363|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2318364|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318365|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318366|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318367|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2318368|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2318369|NCT00359879|Exenatide|exenatide|mesh-list
2318370|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2318371|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318372|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2318373|NCT00359879|Incretins|incretins|mesh-ancestor
2318374|NCT00359879|Hormones|hormones|mesh-ancestor
2318375|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2318376|NCT00359892|Obatoclax|obatoclax|mesh-list
2318377|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318378|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318379|NCT00359905|Tamsulosin|tamsulosin|mesh-list
2318380|NCT00359905|Silodosin|silodosin|mesh-list
2318381|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2318382|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2318383|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2318384|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
2318385|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318386|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318387|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318388|NCT00359905|Urological Agents|urological agents|mesh-ancestor
2318389|NCT00359970|Azithromycin|azithromycin|mesh-list
2883871|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
2883872|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2883873|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318390|NCT00359970|Loperamide|loperamide|mesh-list
2318391|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
2318392|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318393|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318394|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2318395|NCT00360035|Obatoclax|obatoclax|mesh-list
2318396|NCT00360035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318397|NCT00360035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318398|NCT00360048|Oxytocin|oxytocin|mesh-list
2318399|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
2883905|NCT04367090|Docetaxel|docetaxel|mesh-list
2883906|NCT04367090|Trastuzumab|trastuzumab|mesh-list
2883907|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883908|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
2883909|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
2883910|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
2883911|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883912|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2109153|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2109154|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2109155|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109156|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109157|NCT02515890|Midazolam|midazolam|mesh-list
2109158|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
2109159|NCT02515890|Ketamine|ketamine|mesh-list
2109160|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2109161|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109162|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109163|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2109164|NCT02515890|Analgesics|analgesics|mesh-ancestor
2109165|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
2109166|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109167|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2318400|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2318401|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318402|NCT00360087|Bosentan|bosentan|mesh-list
2318403|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2318404|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2318405|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318406|NCT00360178|Amlodipine|amlodipine|mesh-list
2318407|NCT00360178|Valsartan|valsartan|mesh-list
2318408|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2318409|NCT00360178|Candesartan|candesartan|mesh-list
2318410|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2883957|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
2883958|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2883959|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
2883960|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2883961|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883962|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2883963|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
2883964|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2883965|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
2883966|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883967|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2883968|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2883969|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
2883970|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
2883971|NCT04338828|Protective Agents|protective agents|mesh-ancestor
2883972|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2883973|NCT04338321|Esketamine|esketamine|mesh-list
2883974|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
2883975|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883976|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2883977|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2883978|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318411|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2318412|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2318413|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318414|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2318415|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318416|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
2318417|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2318418|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2318419|NCT00360178|Diuretics|diuretics|mesh-ancestor
2318420|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
2318421|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2318422|NCT00360191|Buspirone|buspirone|mesh-list
2318423|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2318424|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2318425|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318426|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318427|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2883979|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883980|NCT04331288|Ethanol|ethanol|mesh-list
2883981|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2883982|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2883983|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2883984|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2883985|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2883986|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2883987|NCT04312659|Infliximab|infliximab|mesh-list
2883988|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
2883989|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2883990|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2883991|NCT04299113|Vinorelbine|vinorelbine|mesh-list
2883992|NCT04299113|Mocetinostat|mocetinostat|mesh-list
2883993|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2883994|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2883995|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
2883996|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
2883997|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
2883998|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2883999|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2318428|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2318429|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
2318430|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318431|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318432|NCT00360295|Azithromycin|azithromycin|mesh-list
2318433|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318434|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318435|NCT00360386|Clopidogrel|clopidogrel|mesh-list
2318436|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2318437|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2318438|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2318439|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2318440|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
2318441|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318442|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318443|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318444|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
2318445|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2318446|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318447|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318448|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2318449|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2318450|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318451|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318452|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884000|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884013|NCT04283500|Buprenorphine|buprenorphine|mesh-list
2884014|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2884015|NCT04283500|Naloxone|naloxone|mesh-list
2884016|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2884017|NCT04283500|Narcotics|narcotics|mesh-ancestor
2318453|NCT00360425|Hematinics|hematinics|mesh-ancestor
2318454|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2318455|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2318456|NCT00360438|Rasburicase|rasburicase|mesh-list
2318457|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
2318458|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2318459|NCT00360464|Azithromycin|azithromycin|mesh-list
2318460|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318461|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318462|NCT00360594|Acamprosate|acamprosate|mesh-list
2318463|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2318464|NCT00360607|Metronidazole|metronidazole|mesh-list
2884018|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318465|NCT00360607|Amikacin|amikacin|mesh-list
2318466|NCT00360607|Ceftazidime|ceftazidime|mesh-list
2318467|NCT00360607|Sulbactam|sulbactam|mesh-list
2318468|NCT00360607|Cefoperazone|cefoperazone|mesh-list
2318469|NCT00360607|Sulperazone|sulperazone|mesh-list
2318470|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318471|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318472|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2318473|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2318474|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2318475|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318476|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318477|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2318478|NCT00360607|Renal Agents|renal agents|mesh-ancestor
2318479|NCT00360737|Antitoxins|antitoxins|mesh-list
2318480|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
2318481|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
2318482|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318483|NCT00360750|Cytarabine|cytarabine|mesh-list
2884019|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884020|NCT04283500|Analgesics|analgesics|mesh-ancestor
2884021|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
2884022|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2884023|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2884031|NCT04241549|Azacitidine|azacitidine|mesh-list
2884032|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2884033|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
2884034|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884035|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884036|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884048|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
2884049|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
2884050|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884051|NCT04225026|Protective Agents|protective agents|mesh-ancestor
2884052|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884053|NCT04217135|Hydralazine|hydralazine|mesh-list
2884054|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2318484|NCT00360750|Carboplatin|carboplatin|mesh-list
2318485|NCT00360750|Etoposide|etoposide|mesh-list
2318486|NCT00360750|Vincristine|vincristine|mesh-list
2318487|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318488|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2318489|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2318490|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2318491|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318492|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318493|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2318494|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
2318495|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
2318496|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318497|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2318498|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
2318499|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318500|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
2318501|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
2318502|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
2318503|NCT00360763|Candesartan|candesartan|mesh-list
2318504|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
2318505|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2884055|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
2318506|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2318507|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2318508|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318509|NCT00360776|Tipifarnib|tipifarnib|mesh-list
2318510|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318511|NCT00360815|Insulin|insulin|mesh-list
2318512|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2318513|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318514|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2318515|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318516|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2884061|NCT04205838|Vidarabine|vidarabine|mesh-list
2884062|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
2884063|NCT04205838|Fludarabine|fludarabine|mesh-list
2884064|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
2884065|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2318517|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318518|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318519|NCT00360867|Motesanib diphosphate|motesanib diphosphate|mesh-list
2318520|NCT00360867|Imetelstat|imetelstat|mesh-list
2318521|NCT00360867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2318522|NCT00360867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318523|NCT00360867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318524|NCT00360945|Temozolomide|temozolomide|mesh-list
2318525|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318526|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2318527|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
2318528|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318529|NCT00360984|Insulin|insulin|mesh-list
2318530|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2318531|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
2318532|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2318533|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318534|NCT00361010|Levetiracetam|levetiracetam|mesh-list
2884066|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2884067|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
2884068|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884069|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2884070|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2884071|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
2884072|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884073|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884074|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2884075|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2884076|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
2318535|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
2318536|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
2318537|NCT00361023|Losartan|losartan|mesh-list
2318538|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2318539|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2318540|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2318541|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2318542|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884077|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
2884078|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2884079|NCT04195633|Cyclosporine|cyclosporine|mesh-list
2884080|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
2884081|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
2884082|NCT04195633|Treosulfan|treosulfan|mesh-list
2884083|NCT04195633|Busulfan|busulfan|mesh-list
2884084|NCT04195633|Fludarabine|fludarabine|mesh-list
2318543|NCT00361075|Estradiol|estradiol|mesh-list
2318544|NCT00361075|Estrogens|estrogens|mesh-list
2318545|NCT00361075|Progesterone|progesterone|mesh-list
2318546|NCT00361075|Hormones|hormones|mesh-ancestor
2318547|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2318548|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318549|NCT00361075|Progestins|progestins|mesh-ancestor
2318550|NCT00361088|Bortezomib|bortezomib|mesh-list
2318551|NCT00361088|Tipifarnib|tipifarnib|mesh-list
2884085|NCT04195633|Cyclosporins|cyclosporins|mesh-list
2884086|NCT04195633|Lenograstim|lenograstim|mesh-list
2884087|NCT04195633|Sargramostim|sargramostim|mesh-list
2318552|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318553|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
2318554|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
2318555|NCT00361114|Dapsone|dapsone|mesh-list
2318556|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2318557|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
2318558|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
2318559|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2318560|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2318561|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318562|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2318563|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884088|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2884089|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
2884090|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884091|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2884092|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2884093|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
2884094|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884095|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884096|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2884097|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2884098|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884099|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
2318564|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318565|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2318566|NCT00361114|Renal Agents|renal agents|mesh-ancestor
2318567|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
2318568|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318569|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2318570|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2318571|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2318572|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
2318573|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318574|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2318575|NCT00361166|Pimavanserin|pimavanserin|mesh-list
2318576|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2318577|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2318578|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2318579|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2318580|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318581|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884100|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2884101|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
2884102|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2884103|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2884104|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2884105|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
2318582|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2318583|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2318584|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2318585|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
2318586|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318587|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318588|NCT00361244|Irinotecan|irinotecan|mesh-list
2318589|NCT00361244|Cetuximab|cetuximab|mesh-list
2318590|NCT00361244|Sunitinib|sunitinib|mesh-list
2318591|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2318592|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2884106|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318593|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318594|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318595|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318596|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2318597|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2318598|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2318599|NCT00361244|Growth Substances|growth substances|mesh-ancestor
2318600|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318601|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
2318602|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2318603|NCT00361309|Sunitinib|sunitinib|mesh-list
2318604|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318605|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2318606|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2318607|NCT00361309|Growth Substances|growth substances|mesh-ancestor
2318608|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318609|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
2318610|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2318611|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318612|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318613|NCT00361322|Clindamycin|clindamycin|mesh-list
2318614|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
2318615|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
2318616|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
2318617|NCT00361322|Salicylates|salicylates|mesh-list
2318618|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318619|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318620|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2318621|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884140|NCT04178603|Insulin|insulin|mesh-list
2884141|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2884142|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884143|NCT04170972|Insulin|insulin|mesh-list
2884144|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2884145|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318622|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318623|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
2318624|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
2318625|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
2318626|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2318627|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2318628|NCT00361322|Analgesics|analgesics|mesh-ancestor
2318629|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
2318630|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318631|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318632|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2318633|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2318634|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2318635|NCT00361348|Heparin|heparin|mesh-list
2318636|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
2318637|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2318638|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2318639|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318640|NCT00361387|Methylphenidate|methylphenidate|mesh-list
2318641|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2318642|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318643|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2318644|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2318645|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2318646|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318647|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
2318648|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318649|NCT00361413|Alefacept|alefacept|mesh-list
2318650|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
2884197|NCT04133623|Ibuprofen|ibuprofen|mesh-list
2884198|NCT04133623|Ketorolac|ketorolac|mesh-list
2884199|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2884200|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2884201|NCT04133623|Analgesics|analgesics|mesh-ancestor
2884202|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
2884203|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2884204|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884205|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2318651|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
2318652|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318653|NCT00361452|Epinephrine|epinephrine|mesh-list
2318654|NCT00361452|Albuterol|albuterol|mesh-list
2318655|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2318656|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2318657|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
2318658|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318659|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884206|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2318660|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318661|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2318662|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2318663|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
2318664|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318665|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2318666|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
2318667|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
2318668|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
2318669|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2318670|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
2318671|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2318672|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2318673|NCT00361517|Amphotericin B|amphotericin b|mesh-list
2884207|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2884208|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884209|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884210|NCT04102098|Bevacizumab|bevacizumab|mesh-list
2884211|NCT04102098|Atezolizumab|atezolizumab|mesh-list
2884212|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2884213|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884214|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2884215|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2884216|NCT04102098|Growth Substances|growth substances|mesh-ancestor
2884217|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884218|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
2884219|NCT04091217|Bevacizumab|bevacizumab|mesh-list
2884220|NCT04091217|Atezolizumab|atezolizumab|mesh-list
2884221|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2884222|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884223|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2884224|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2884225|NCT04091217|Growth Substances|growth substances|mesh-ancestor
2884226|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884227|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
2884237|NCT04064411|Abaloparatide|abaloparatide|mesh-list
2884238|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
2884239|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2884240|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884241|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2884242|NCT04057937|Apremilast|apremilast|mesh-list
2318674|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2318675|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
2318676|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
2318677|NCT00361517|Amebicides|amebicides|mesh-ancestor
2318678|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2318679|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2318680|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318681|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318682|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
2318683|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2318684|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2318685|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2318686|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2318687|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
2318688|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2318689|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318690|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2318691|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2318692|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2318693|NCT00361582|Tapentadol|tapentadol|mesh-list
2318694|NCT00361582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2318695|NCT00361582|Narcotics|narcotics|mesh-ancestor
2318696|NCT00361582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2884243|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2884244|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2884245|NCT04057937|Analgesics|analgesics|mesh-ancestor
2884246|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
2884247|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2884248|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884249|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2884250|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2884251|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2884252|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2884253|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884254|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884258|NCT04042831|Olaparib|olaparib|mesh-list
2884259|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2884260|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884261|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884262|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884263|NCT04017962|Letermovir|letermovir|mesh-list
2884264|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2884265|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884266|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884267|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884268|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
2884269|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2884270|NCT03983824|Cytarabine|cytarabine|mesh-list
2884271|NCT03983824|Etoposide|etoposide|mesh-list
2884272|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
2884273|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
2884274|NCT03983824|Peposertib|peposertib|mesh-list
2884275|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2884276|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884277|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2884278|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2884279|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884280|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884281|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2884282|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
2884283|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
2884284|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2884285|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2884286|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
2884287|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884288|NCT03983824|Analgesics|analgesics|mesh-ancestor
2884289|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
2884290|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2884291|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2884292|NCT03981744|Ustekinumab|ustekinumab|mesh-list
2884293|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
2884294|NCT03942120|Ustekinumab|ustekinumab|mesh-list
2884295|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
2884296|NCT03934684|Dexamethasone|dexamethasone|mesh-list
2884297|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
2884298|NCT03934684|Lenalidomide|lenalidomide|mesh-list
2318697|NCT00361582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318698|NCT00361582|Analgesics|analgesics|mesh-ancestor
2318699|NCT00361582|Sensory System Agents|sensory system agents|mesh-ancestor
2318700|NCT00361582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318701|NCT00361582|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2884299|NCT03934684|BB 1101|bb 1101|mesh-list
2884300|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2884301|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
2884302|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
2884303|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2884304|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884305|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2884306|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
2884307|NCT03934684|Hormones|hormones|mesh-ancestor
2884308|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2884309|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2884310|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884311|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
2884312|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318702|NCT00361582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2318703|NCT00361582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2318704|NCT00361582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318705|NCT00361582|Adrenergic Agents|adrenergic agents|mesh-ancestor
2318706|NCT00361582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2884313|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884314|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
2884315|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2884316|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2884317|NCT03934684|Growth Substances|growth substances|mesh-ancestor
2884318|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
2884319|NCT03927274|Topotecan|topotecan|mesh-list
2884320|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2884321|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2884322|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884323|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884324|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109168|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2109169|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2109170|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
2109171|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109172|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109173|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2109174|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2109175|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
2109176|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
2109177|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2109178|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2109179|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2109180|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2109181|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2109182|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2109183|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
2109184|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
2109185|NCT02516098|Scopolamine|scopolamine|mesh-list
2109186|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2318707|NCT00361621|Prednisone|prednisone|mesh-list
2318708|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
2318709|NCT00361621|Rituximab|rituximab|mesh-list
2318710|NCT00361621|Doxorubicin|doxorubicin|mesh-list
2318711|NCT00361621|Vincristine|vincristine|mesh-list
2318712|NCT00361621|Bortezomib|bortezomib|mesh-list
2318713|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2318714|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
2318715|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318716|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2318717|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2318718|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
2318719|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884362|NCT03907826|Antibodies|antibodies|mesh-list
2884363|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
2884364|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
2884365|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884366|NCT03905889|Sunitinib|sunitinib|mesh-list
2884367|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884368|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2884369|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2884370|NCT03905889|Growth Substances|growth substances|mesh-ancestor
2884371|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884372|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
2884373|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2884374|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884375|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884376|NCT03896503|Topotecan|topotecan|mesh-list
2884377|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2884378|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2884379|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884380|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884381|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318720|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318721|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2318722|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2318723|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2318724|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2884385|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
2884386|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2884387|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2884388|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2884389|NCT03847311|Analgesics|analgesics|mesh-ancestor
2884390|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
2884391|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2884392|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884393|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2884394|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2884395|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2884406|NCT03823989|Mitomycins|mitomycins|mesh-list
2884407|NCT03823989|Mitomycin|mitomycin|mesh-list
2884408|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2884409|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884410|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
2884411|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884412|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2884413|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884414|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
2884415|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2884416|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2884417|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
2884418|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
2884419|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2884420|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884421|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2318725|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2318726|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318727|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2318728|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
2318729|NCT00361621|Hormones|hormones|mesh-ancestor
2884422|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
2884423|NCT03818737|Hormones|hormones|mesh-ancestor
2884424|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2884425|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2884426|NCT03818737|Protective Agents|protective agents|mesh-ancestor
2884427|NCT03815643|Avelumab|avelumab|mesh-list
2884428|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2884429|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318730|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2318731|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2318732|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2318733|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
2318734|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
2318735|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
2318736|NCT00361686|Tramadol|tramadol|mesh-list
2318737|NCT00361686|Remifentanil|remifentanil|mesh-list
2318738|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2318739|NCT00361686|Narcotics|narcotics|mesh-ancestor
2318740|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318741|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318742|NCT00361686|Analgesics|analgesics|mesh-ancestor
2318743|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
2318744|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318745|NCT00361751|Fenofibrate|fenofibrate|mesh-list
2318746|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2318747|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
2318748|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318749|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2318750|NCT00361790|Aripiprazole|aripiprazole|mesh-list
2318751|NCT00361790|Citalopram|citalopram|mesh-list
2884458|NCT03800602|Metformin|metformin|mesh-list
2884459|NCT03800602|Nivolumab|nivolumab|mesh-list
2884460|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2884461|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884462|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2884463|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884464|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2884465|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318752|NCT00361790|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2318753|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2884475|NCT03786783|Vitamin A|vitamin a|mesh-list
2884476|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
2884477|NCT03786783|Melphalan|melphalan|mesh-list
2884478|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
2884479|NCT03786783|Thiotepa|thiotepa|mesh-list
2884480|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2884481|NCT03786783|Cisplatin|cisplatin|mesh-list
2884482|NCT03786783|Carboplatin|carboplatin|mesh-list
2884483|NCT03786783|Doxorubicin|doxorubicin|mesh-list
2884484|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2884485|NCT03786783|Etoposide|etoposide|mesh-list
2884486|NCT03786783|Vincristine|vincristine|mesh-list
2884487|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
2884488|NCT03786783|Topotecan|topotecan|mesh-list
2884489|NCT03786783|Daunorubicin|daunorubicin|mesh-list
2884490|NCT03786783|Tretinoin|tretinoin|mesh-list
2884491|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
2318754|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2318755|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318756|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318757|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
2318758|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318759|NCT00361790|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2318760|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
2318761|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2318762|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2884492|NCT03786783|Dinutuximab|dinutuximab|mesh-list
2884493|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
2884494|NCT03786783|Razoxane|razoxane|mesh-list
2884495|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
2884496|NCT03786783|Isotretinoin|isotretinoin|mesh-list
2884497|NCT03786783|Sargramostim|sargramostim|mesh-list
2884498|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2884499|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
2884500|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884501|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2884502|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2884503|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
2884504|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884505|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884506|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2884507|NCT03786783|Vitamins|vitamins|mesh-ancestor
2884508|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
2884509|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2884510|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2884511|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2884512|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884513|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2884514|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
2884515|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
2884516|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
2884517|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2884518|NCT03786783|Protective Agents|protective agents|mesh-ancestor
2884519|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
2884520|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
2884521|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2884522|NCT03782376|Ustekinumab|ustekinumab|mesh-list
2884523|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
2318763|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2318764|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318765|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
2318766|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
2318767|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2884524|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
2884525|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2884526|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2884527|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884528|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2884529|NCT03770130|Analgesics|analgesics|mesh-ancestor
2884530|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
2884531|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2884532|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2884533|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2318768|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2884534|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2884535|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
2884536|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2884537|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884542|NCT03747939|Thalidomide|thalidomide|mesh-list
2884543|NCT03747939|Apremilast|apremilast|mesh-list
2884544|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2884545|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2884546|NCT03747939|Analgesics|analgesics|mesh-ancestor
2884547|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
2884548|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2884549|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884550|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2884551|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2884552|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2884553|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2884554|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884555|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884556|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2884557|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
2884558|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
2884559|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2884560|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2884561|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2884562|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2884563|NCT03747939|Growth Substances|growth substances|mesh-ancestor
2884564|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
2884565|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318769|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2318770|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2318771|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2318772|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2318773|NCT00361803|Topotecan|topotecan|mesh-list
2318774|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2318775|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2318776|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318777|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318778|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318779|NCT00361868|Metformin|metformin|mesh-list
2318780|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
2318781|NCT00361868|Fenofibrate|fenofibrate|mesh-list
2318782|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2318783|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318784|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2318785|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
2318786|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318787|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2318788|NCT00361881|Acyclovir|acyclovir|mesh-list
2318789|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
2318790|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
2318791|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318792|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2318793|NCT00361894|Enoxaparin|enoxaparin|mesh-list
2318794|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
2318795|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2318796|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
2318797|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2318798|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
2318799|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318800|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318801|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
2318802|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2318803|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2318804|NCT00361907|Insulin|insulin|mesh-list
2318805|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2318806|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2318807|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109187|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2109188|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
2109189|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
2109190|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109191|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318808|NCT00361920|Prednisone|prednisone|mesh-list
2318809|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2318810|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
2318811|NCT00361920|Hormones|hormones|mesh-ancestor
2318812|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2318813|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884578|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
2884579|NCT03732352|Osimertinib|osimertinib|mesh-list
2884580|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2884581|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2884582|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884583|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884584|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2884585|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884586|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
2884587|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
2884588|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2884589|NCT03727971|Omalizumab|omalizumab|mesh-list
2884590|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2884591|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2884592|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
2884604|NCT03674112|Trastuzumab|trastuzumab|mesh-list
2884605|NCT03674112|Pertuzumab|pertuzumab|mesh-list
2884606|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2884607|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884608|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
2884609|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884610|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884638|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
2884639|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2884640|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2884641|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884642|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2884643|NCT03606499|Ustekinumab|ustekinumab|mesh-list
2884644|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
2884651|NCT03593018|Gemcitabine|gemcitabine|mesh-list
2884652|NCT03593018|Azacitidine|azacitidine|mesh-list
2884653|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2884654|NCT03593018|Romidepsin|romidepsin|mesh-list
2884655|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2884656|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
2884657|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884658|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884659|NCT03593018|Antiviral Agents|antiviral agents|mesh-ancestor
2884660|NCT03593018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2884661|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884662|NCT03593018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2884663|NCT03593018|Immunologic Factors|immunologic factors|mesh-ancestor
2884664|NCT03593018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884665|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2884666|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
2884667|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2109192|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2109193|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
2109194|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2109195|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
2318814|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2318815|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318816|NCT00361933|Valganciclovir|valganciclovir|mesh-list
2318817|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
2884678|NCT03563742|Tenofovir|tenofovir|mesh-list
2884679|NCT03563742|Lamivudine|lamivudine|mesh-list
2318818|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318819|NCT00361959|Fluticasone|fluticasone|mesh-list
2318820|NCT00361959|Xhance|xhance|mesh-list
2318821|NCT00361959|Bromides|bromides|mesh-list
2318822|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
2318823|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2318824|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2318825|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2318826|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
2318827|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318828|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318829|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2318830|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
2318831|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
2318832|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2318833|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
2318834|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2318835|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
2318836|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109196|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109197|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109198|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2109199|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
2109200|NCT02516150|Ethanol|ethanol|mesh-list
2109201|NCT02516150|Glucagon|glucagon|mesh-list
2109202|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2318837|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318838|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2318839|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2318840|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2318841|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
2318842|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
2318843|NCT00361985|Esomeprazole|esomeprazole|mesh-list
2318844|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2318845|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2318846|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2318847|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318848|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884680|NCT03563742|Rilpivirine|rilpivirine|mesh-list
2884681|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
2884682|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318849|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
2318850|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2318851|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318852|NCT00361998|Renal Agents|renal agents|mesh-ancestor
2318853|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318854|NCT00362037|Irbesartan|irbesartan|mesh-list
2318855|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2884683|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2884684|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2884685|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884686|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884687|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2884688|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2318856|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2318857|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2318858|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318859|NCT00362063|Hormones|hormones|mesh-list
2318860|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2318861|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318862|NCT00362089|Dronabinol|dronabinol|mesh-list
2318863|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
2318864|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318865|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2318866|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2318867|NCT00362089|Analgesics|analgesics|mesh-ancestor
2318868|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
2318869|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318870|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2318871|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2318872|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318873|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318874|NCT00362089|Hormones|hormones|mesh-ancestor
2318875|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2318876|NCT00362102|Cetuximab|cetuximab|mesh-list
2318877|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2318878|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884700|NCT03555149|Bevacizumab|bevacizumab|mesh-list
2884701|NCT03555149|Atezolizumab|atezolizumab|mesh-list
2884702|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2884703|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884704|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2884705|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2884706|NCT03555149|Growth Substances|growth substances|mesh-ancestor
2884707|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884708|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
2884709|NCT03548428|Atezolizumab|atezolizumab|mesh-list
2884710|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318879|NCT00362141|Levetiracetam|levetiracetam|mesh-list
2318880|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
2318881|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
2318882|NCT00362206|Simvastatin|simvastatin|mesh-list
2318883|NCT00362206|Pravastatin|pravastatin|mesh-list
2318884|NCT00362206|Fenofibrate|fenofibrate|mesh-list
2318885|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2318886|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2318887|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
2318888|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318889|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2318890|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2318891|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318892|NCT00362219|Morphine|morphine|mesh-list
2318893|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2318894|NCT00362219|Narcotics|narcotics|mesh-ancestor
2318895|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318896|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318897|NCT00362219|Analgesics|analgesics|mesh-ancestor
2318898|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
2318899|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318900|NCT00362245|Amikacin|amikacin|mesh-list
2318901|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2318902|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318903|NCT00362258|Irbesartan|irbesartan|mesh-list
2318904|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2318905|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2318906|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2318907|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109203|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2109204|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109205|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109206|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2109207|NCT02516150|Hormones|hormones|mesh-ancestor
2109208|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109209|NCT02516202|Estradiol|estradiol|mesh-list
2318908|NCT00362271|Aripiprazole|aripiprazole|mesh-list
2318909|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2318910|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
2318911|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2318912|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2318913|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2318914|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318915|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318916|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
2318917|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
2109210|NCT02516202|Estrogens|estrogens|mesh-ancestor
2109211|NCT02516202|Hormones|hormones|mesh-ancestor
2109212|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109213|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884738|NCT03517969|Carboplatin|carboplatin|mesh-list
2884739|NCT03517969|Docetaxel|docetaxel|mesh-list
2884740|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884741|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
2884742|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
2884743|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
2884744|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318918|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2318919|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318920|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2318921|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2318922|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
2318923|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2318924|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2318925|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2318926|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2318927|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2318928|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2318929|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2318930|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2318931|NCT00362310|Indinavir|indinavir|mesh-list
2318932|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2318933|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2884745|NCT03513952|Atezolizumab|atezolizumab|mesh-list
2884746|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2884747|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884748|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
2884749|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318934|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
2318935|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318936|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318937|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2318938|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2318939|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
2318940|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2884768|NCT03493425|Cisplatin|cisplatin|mesh-list
2318941|NCT00362323|Metformin|metformin|mesh-list
2318942|NCT00362323|Fenofibrate|fenofibrate|mesh-list
2318943|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2318944|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318945|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2318946|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
2318947|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318948|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2318949|NCT00362505|Clevudine|clevudine|mesh-list
2318950|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
2318951|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318952|NCT00362531|Prednisone|prednisone|mesh-list
2318953|NCT00362531|Tacrolimus|tacrolimus|mesh-list
2884769|NCT03493425|Carboplatin|carboplatin|mesh-list
2884770|NCT03493425|Docetaxel|docetaxel|mesh-list
2884771|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884772|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
2884773|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
2884774|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
2318954|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2318955|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
2318956|NCT00362531|Hormones|hormones|mesh-ancestor
2884775|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318957|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2318958|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318959|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2318960|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318961|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2318962|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
2318963|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2318964|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2318965|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318966|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2318967|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
2318968|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318969|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2318970|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2318971|NCT00362570|Temozolomide|temozolomide|mesh-list
2318972|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2318973|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
2318974|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318975|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2318976|NCT00362583|Fentanyl|fentanyl|mesh-list
2318977|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2318978|NCT00362583|Narcotics|narcotics|mesh-ancestor
2884779|NCT03477396|Estrogens|estrogens|mesh-list
2884780|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2884781|NCT03477396|Hormones|hormones|mesh-ancestor
2884782|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2884783|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884784|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2884785|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884786|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2318979|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2318980|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2318981|NCT00362583|Analgesics|analgesics|mesh-ancestor
2318982|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
2318983|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2318984|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2318985|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2318986|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
2318987|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
2318988|NCT00362596|Acyclovir|acyclovir|mesh-list
2318989|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
2318990|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318991|NCT00362635|Clevudine|clevudine|mesh-list
2884787|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2884788|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
2884795|NCT03466411|Ustekinumab|ustekinumab|mesh-list
2884796|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2884797|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
2884798|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
2884799|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884800|NCT03456063|Gemcitabine|gemcitabine|mesh-list
2884801|NCT03456063|Paclitaxel|paclitaxel|mesh-list
2884802|NCT03456063|Carboplatin|carboplatin|mesh-list
2318992|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
2318993|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2318994|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
2318995|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2318996|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2318997|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2318998|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2318999|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2319000|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2884803|NCT03456063|Pemetrexed|pemetrexed|mesh-list
2884804|NCT03456063|Atezolizumab|atezolizumab|mesh-list
2319001|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2884805|NCT03456063|Antibodies|antibodies|mesh-list
2884806|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2884807|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884808|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
2884809|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
2884810|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
2884811|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884812|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
2884813|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884814|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2884815|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
2884816|NCT03456063|Antiviral Agents|antiviral agents|mesh-ancestor
2884817|NCT03456063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2884818|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884819|NCT03456063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2884820|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2884821|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2884822|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
2884823|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2319002|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319003|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319004|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
2319005|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319006|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2319007|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2884824|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
2884825|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2884826|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
2884827|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884828|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884829|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
2884830|NCT03420521|Nivolumab|nivolumab|mesh-list
2884831|NCT03420521|Ipilimumab|ipilimumab|mesh-list
2884832|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2884833|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884834|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2884835|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884841|NCT03386214|Pevonedistat|pevonedistat|mesh-list
2884842|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884843|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884844|NCT03373188|Nivolumab|nivolumab|mesh-list
2884845|NCT03373188|Ipilimumab|ipilimumab|mesh-list
2884846|NCT03373188|Antibodies|antibodies|mesh-list
2884847|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2884848|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
2884849|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319008|NCT00362700|Clevudine|clevudine|mesh-list
2319009|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
2319010|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319011|NCT00362713|Ipilimumab|ipilimumab|mesh-list
2319012|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2319013|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319014|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2319015|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319016|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
2319017|NCT00362726|Ritonavir|ritonavir|mesh-list
2884850|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2884851|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884852|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2884853|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884854|NCT03369665|Cladribine|cladribine|mesh-list
2884855|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884856|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2884857|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
2884858|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884859|NCT03303339|Cytarabine|cytarabine|mesh-list
2319018|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2319019|NCT00362726|Maleic acid|maleic acid|mesh-list
2319020|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2319021|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2319022|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
2884860|NCT03303339|Decitabine|decitabine|mesh-list
2319023|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319024|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319025|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2884861|NCT03303339|Onvansertib|onvansertib|mesh-list
2884862|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2884863|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
2884864|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884865|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884866|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
2884867|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2884868|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2884869|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
2884870|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884871|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884872|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2884883|NCT03294954|Cyclophosphamide|cyclophosphamide|mesh-list
2884884|NCT03294954|Fludarabine|fludarabine|mesh-list
2884885|NCT03294954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2884886|NCT03294954|Immunologic Factors|immunologic factors|mesh-ancestor
2884887|NCT03294954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884888|NCT03294954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2884889|NCT03294954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2884890|NCT03294954|Alkylating Agents|alkylating agents|mesh-ancestor
2319026|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2319027|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
2319028|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319029|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2319030|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2319031|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2319032|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319033|NCT00362752|Norfloxacin|norfloxacin|mesh-list
2319034|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2319035|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319036|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2319037|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2319038|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319039|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319040|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319041|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2319042|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2319043|NCT00362765|Metformin|metformin|mesh-list
2319044|NCT00362765|Fenofibrate|fenofibrate|mesh-list
2319045|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2319046|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319047|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2319048|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
2319049|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319050|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2319051|NCT00362778|Insulin|insulin|mesh-list
2319052|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2319053|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319054|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
2319055|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2319056|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2319057|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2319058|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319059|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
2884891|NCT03294954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884892|NCT03294954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319060|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319061|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319062|NCT00362869|Levofloxacin|levofloxacin|mesh-list
2319063|NCT00362869|Ofloxacin|ofloxacin|mesh-list
2319064|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2319065|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2884893|NCT03294954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2884909|NCT03220178|Letrozole|letrozole|mesh-list
2884910|NCT03220178|Fulvestrant|fulvestrant|mesh-list
2884911|NCT03220178|Palbociclib|palbociclib|mesh-list
2884912|NCT03220178|Anastrozole|anastrozole|mesh-list
2884913|NCT03220178|Exemestane|exemestane|mesh-list
2884914|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884915|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2884916|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2884917|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884918|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319066|NCT00362869|Renal Agents|renal agents|mesh-ancestor
2319067|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2319068|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2319069|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2319070|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319071|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319072|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319073|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2319074|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2884919|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2884920|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
2884921|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2884922|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884923|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2884924|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2884925|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2884929|NCT03218488|Ustekinumab|ustekinumab|mesh-list
2884930|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
2884950|NCT03185819|Midazolam|midazolam|mesh-list
2884951|NCT03185819|Esketamine|esketamine|mesh-list
2884952|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2884953|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2884954|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2884955|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884956|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2884957|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2884958|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2319075|NCT00362895|Tobramycin|tobramycin|mesh-list
2319076|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
2319077|NCT00362895|Dexamethasone|dexamethasone|mesh-list
2319078|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
2884959|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2884960|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
2884961|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
2884962|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
2884963|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
2884964|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2884965|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884966|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
2884977|NCT03122301|Bupivacaine|bupivacaine|mesh-list
2884978|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
2884979|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
2884980|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2884981|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2884982|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
2884983|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2884984|NCT03085147|Olaparib|olaparib|mesh-list
2884985|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2884986|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2884987|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2884988|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2884994|NCT03038672|Nivolumab|nivolumab|mesh-list
2884995|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
2884996|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
2884997|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2884998|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2884999|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885000|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2885001|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885002|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
2885003|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319079|NCT00362895|BB 1101|bb 1101|mesh-list
2319080|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2319081|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
2319082|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
2885004|NCT03034356|Levetiracetam|levetiracetam|mesh-list
2885005|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
2885006|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
2885007|NCT03032510|Levofloxacin|levofloxacin|mesh-list
2885008|NCT03032510|Ofloxacin|ofloxacin|mesh-list
2885009|NCT03032510|Ertapenem|ertapenem|mesh-list
2885010|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2885011|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2885012|NCT03032510|Renal Agents|renal agents|mesh-ancestor
2885013|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2885014|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2885015|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2885016|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885017|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885018|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885019|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2885020|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2885021|NCT03031730|Dexamethasone|dexamethasone|mesh-list
2885022|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
2885023|NCT03031730|Lenalidomide|lenalidomide|mesh-list
2885024|NCT03031730|Ichthammol|ichthammol|mesh-list
2885025|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2885026|NCT03031730|BB 1101|bb 1101|mesh-list
2885027|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2319083|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319084|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319085|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2319086|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
2319087|NCT00362895|Hormones|hormones|mesh-ancestor
2319088|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2319089|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2885028|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
2885029|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
2885030|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2885031|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885032|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2885033|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
2885034|NCT03031730|Hormones|hormones|mesh-ancestor
2885035|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2885036|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2885037|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885038|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
2885039|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885040|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885041|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
2885042|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2885043|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2885044|NCT03031730|Growth Substances|growth substances|mesh-ancestor
2319090|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319091|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
2319092|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319093|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319094|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2319095|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319096|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2885045|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
2885046|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
2885047|NCT03029000|Lenograstim|lenograstim|mesh-list
2885048|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2885049|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
2885050|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885051|NCT03022292|Aflibercept|aflibercept|mesh-list
2885052|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2885053|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2885054|NCT03022292|Growth Substances|growth substances|mesh-ancestor
2885055|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885056|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
2885057|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885058|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
2319097|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2319098|NCT00362921|Carmustine|carmustine|mesh-list
2319099|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2319100|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2319101|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
2319102|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319103|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319104|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319105|NCT00362934|Atorvastatin|atorvastatin|mesh-list
2319106|NCT00362934|Simvastatin|simvastatin|mesh-list
2319107|NCT00362934|Fenofibrate|fenofibrate|mesh-list
2885059|NCT03012100|Vaccines|vaccines|mesh-list
2885060|NCT03012100|Sargramostim|sargramostim|mesh-list
2885061|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
2885062|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885063|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2885064|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2885065|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885066|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
2885067|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319108|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2319109|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2319110|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
2319111|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885068|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885069|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2319112|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2319113|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2319114|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319115|NCT00362947|Parnaparin|parnaparin|mesh-list
2319116|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
2319117|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2319118|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2319119|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319120|NCT00362960|Losartan|losartan|mesh-list
2885106|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
2885107|NCT02973997|Lenvatinib|lenvatinib|mesh-list
2885108|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2885109|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885110|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2885111|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885112|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885113|NCT02968602|Minocycline|minocycline|mesh-list
2885114|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2885115|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2885116|NCT02968108|Ustekinumab|ustekinumab|mesh-list
2885117|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
2885118|NCT02964273|Tolvaptan|tolvaptan|mesh-list
2885119|NCT02964273|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2885120|NCT02964273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885121|NCT02964273|Natriuretic Agents|natriuretic agents|mesh-ancestor
2319121|NCT00362960|Olmesartan|olmesartan|mesh-list
2319122|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2319123|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2319124|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2319125|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2319126|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2319127|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319128|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2319129|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2319130|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319131|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
2319132|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2319133|NCT00362986|Protective Agents|protective agents|mesh-ancestor
2319134|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319135|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
2319136|NCT00363025|Daunorubicin|daunorubicin|mesh-list
2319137|NCT00363025|Idarubicin|idarubicin|mesh-list
2885122|NCT02964273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885123|NCT02946047|Ixazomib|ixazomib|mesh-list
2885124|NCT02946047|Glycine|glycine|mesh-list
2885125|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319138|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2319139|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319140|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2319141|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2319142|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319143|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319144|NCT00363090|Prednisone|prednisone|mesh-list
2885126|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
2885127|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885128|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885129|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
2885130|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2885131|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319145|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
2319146|NCT00363090|Doxorubicin|doxorubicin|mesh-list
2319147|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2319148|NCT00363090|Vincristine|vincristine|mesh-list
2885161|NCT02893917|Olaparib|olaparib|mesh-list
2885162|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2885163|NCT02893917|Cediranib|cediranib|mesh-list
2885164|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885165|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885166|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319149|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
2319150|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2319151|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
2885167|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2885168|NCT02888743|Durvalumab|durvalumab|mesh-list
2885169|NCT02888743|Ipilimumab|ipilimumab|mesh-list
2885170|NCT02888743|Tremelimumab|tremelimumab|mesh-list
2885171|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
2885172|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2885173|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
2885174|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2885175|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885176|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
2319152|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319153|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319154|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885177|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885178|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2885179|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885180|NCT02860000|Fulvestrant|fulvestrant|mesh-list
2885181|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2885182|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885183|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2885184|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2885185|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
2885186|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2885187|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885188|NCT02849496|Atezolizumab|atezolizumab|mesh-list
2885189|NCT02849496|Olaparib|olaparib|mesh-list
2885190|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2885191|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2885192|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885193|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885194|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885195|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
2885196|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885197|NCT02832648|Selenium|selenium|mesh-list
2885198|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
2885199|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885200|NCT02832648|Protective Agents|protective agents|mesh-ancestor
2885201|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885202|NCT02832648|Trace Elements|trace elements|mesh-ancestor
2885203|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
2885204|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2885205|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885206|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885207|NCT02799602|Docetaxel|docetaxel|mesh-list
2885208|NCT02799602|Androgens|androgens|mesh-list
2885209|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885210|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
2885211|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
2885212|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
2885213|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885214|NCT02799602|Hormones|hormones|mesh-ancestor
2885215|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2885216|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885217|NCT02784704|Meropenem|meropenem|mesh-list
2885218|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2885219|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2885220|NCT02782104|Esketamine|esketamine|mesh-list
2885221|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
2885222|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2885223|NCT02765854|Dexamethasone|dexamethasone|mesh-list
2885224|NCT02765854|Lenalidomide|lenalidomide|mesh-list
2885225|NCT02765854|Ixazomib|ixazomib|mesh-list
2319155|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
2319156|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319157|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319158|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2319159|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2319160|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2319161|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2319162|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319163|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2885226|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2885227|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
2319164|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
2319165|NCT00363090|Hormones|hormones|mesh-ancestor
2319166|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2319167|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2319168|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2319169|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
2319170|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
2319171|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
2319172|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2319173|NCT00363116|Daclizumab|daclizumab|mesh-list
2319174|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2319175|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
2319176|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319177|NCT00363155|KRN 7000|krn 7000|mesh-list
2319178|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2319179|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
2319180|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319181|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319182|NCT00363259|Ribavirin|ribavirin|mesh-list
2319183|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2319184|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
2319185|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319186|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
2885228|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
2885229|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2885230|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319187|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319188|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
2319189|NCT00363285|Hormones|hormones|mesh-list
2319190|NCT00363285|Cyproterone|cyproterone|mesh-list
2319191|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2319192|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319193|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
2319194|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
2319195|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319196|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2319197|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
2319198|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2319199|NCT00363337|Aripiprazole|aripiprazole|mesh-list
2319200|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
2319201|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2319202|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2885231|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2885232|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
2885233|NCT02765854|Hormones|hormones|mesh-ancestor
2885234|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2885235|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2885236|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885237|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
2885238|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2885239|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2885240|NCT02765854|Growth Substances|growth substances|mesh-ancestor
2885241|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
2885242|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885243|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
2885244|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885245|NCT02761057|Sunitinib|sunitinib|mesh-list
2319203|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2319204|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2885246|NCT02761057|Crizotinib|crizotinib|mesh-list
2885247|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885248|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2885249|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2885250|NCT02761057|Growth Substances|growth substances|mesh-ancestor
2885251|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885252|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
2885253|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2885254|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885255|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885256|NCT02759419|Riociguat|riociguat|mesh-list
2885257|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
2885258|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885262|NCT02750540|Tenofovir|tenofovir|mesh-list
2885263|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
2885264|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2885265|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2885266|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2885267|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885268|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885269|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2885270|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2319205|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319206|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
2319207|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
2319208|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319209|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319210|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2319211|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2319212|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
2319213|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2319214|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2319215|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2319216|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2319217|NCT00363350|Rituximab|rituximab|mesh-list
2319218|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2319219|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319220|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
2319221|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319222|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319223|NCT00363376|Zonisamide|zonisamide|mesh-list
2319224|NCT00363376|Olanzapine|olanzapine|mesh-list
2319225|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
2319226|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
2319227|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319228|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319229|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2319230|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2319231|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2319232|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2319233|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2319234|NCT00363376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2319235|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2319236|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2319237|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319238|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319239|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
2319240|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
2319241|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2319242|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2319243|NCT00363389|Misoprostol|misoprostol|mesh-list
2319244|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2319245|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
2319246|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2319247|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319248|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2885294|NCT02628405|Rituximab|rituximab|mesh-list
2885295|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2885296|NCT02628405|Carboplatin|carboplatin|mesh-list
2885297|NCT02628405|Etoposide|etoposide|mesh-list
2885298|NCT02628405|Lenalidomide|lenalidomide|mesh-list
2885299|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
2885300|NCT02628405|Ifosfamide|ifosfamide|mesh-list
2885301|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
2885302|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
2885303|NCT02628405|Antibodies|antibodies|mesh-list
2885304|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
2885305|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2885306|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
2885307|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885308|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885309|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2885310|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2885311|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2885312|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2885313|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885314|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885315|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2885316|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2319249|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2885317|NCT02628405|Growth Substances|growth substances|mesh-ancestor
2885318|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
2885319|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885320|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
2885321|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
2885322|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
2885323|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
2885324|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
2885325|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
2885326|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
2885327|NCT02614066|Fludarabine|fludarabine|mesh-list
2885328|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2885329|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
2885330|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885331|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2885332|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885333|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
2885334|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885335|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885336|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2885337|NCT02595879|Cisplatin|cisplatin|mesh-list
2885338|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885339|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2885340|NCT02568553|Lenalidomide|lenalidomide|mesh-list
2885341|NCT02568553|Blinatumomab|blinatumomab|mesh-list
2885342|NCT02568553|Antibodies|antibodies|mesh-list
2885343|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
2885344|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2885345|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
2885346|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2885347|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
2885348|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885349|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885350|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2885351|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2885352|NCT02568553|Growth Substances|growth substances|mesh-ancestor
2885353|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
2885354|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2319250|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
2319251|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2319252|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2319253|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319254|NCT00363519|Incretins|incretins|mesh-ancestor
2885355|NCT02564744|Rituximab|rituximab|mesh-list
2885356|NCT02564744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2885357|NCT02564744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885358|NCT02564744|Immunologic Factors|immunologic factors|mesh-ancestor
2885359|NCT02564744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885360|NCT02564744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319255|NCT00363519|Hormones|hormones|mesh-ancestor
2319256|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2319257|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2319258|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
2319259|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319260|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319261|NCT00363532|Calcitonin|calcitonin|mesh-list
2319262|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
2319263|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2319264|NCT00363532|Katacalcin|katacalcin|mesh-list
2319265|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2319266|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319267|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2885375|NCT02520791|Antibodies|antibodies|mesh-list
2885376|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2885377|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
2885378|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885379|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2885380|NCT02511028|Hematinics|hematinics|mesh-ancestor
2885381|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2885382|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2319268|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
2319269|NCT00363571|Acetazolamide|acetazolamide|mesh-list
2319270|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
2319271|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2319272|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319273|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319274|NCT00363571|Diuretics|diuretics|mesh-ancestor
2319275|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
2319276|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319277|NCT00363584|Capecitabine|capecitabine|mesh-list
2319278|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2319279|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
2319280|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319281|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319282|NCT00363610|Pegaspargase|pegaspargase|mesh-list
2319283|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319284|NCT00363636|Galiximab|galiximab|mesh-list
2319285|NCT00363636|Rituximab|rituximab|mesh-list
2319286|NCT00363636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2319287|NCT00363636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319288|NCT00363636|Immunologic Factors|immunologic factors|mesh-ancestor
2319289|NCT00363636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319290|NCT00363636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319291|NCT00363636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2319292|NCT00363688|Penicillins|penicillins|mesh-list
2319293|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2319294|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319295|NCT00363701|Esomeprazole|esomeprazole|mesh-list
2885395|NCT02474173|Paclitaxel|paclitaxel|mesh-list
2885396|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2885397|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2885398|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885399|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
2885400|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
2885401|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
2885402|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885403|NCT02453620|Nivolumab|nivolumab|mesh-list
2885404|NCT02453620|Ipilimumab|ipilimumab|mesh-list
2885405|NCT02453620|Entinostat|entinostat|mesh-list
2885406|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2885407|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2885408|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885409|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2885410|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885411|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885412|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
2885413|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2885414|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885415|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
2885416|NCT02298959|Aflibercept|aflibercept|mesh-list
2885417|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
2885418|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2885419|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885420|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2319296|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2319297|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2319298|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2319299|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319300|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319301|NCT00363727|Ropinirole|ropinirole|mesh-list
2319302|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2319303|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2319304|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
2319305|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
2319306|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2885421|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2885422|NCT02298959|Growth Substances|growth substances|mesh-ancestor
2885423|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885424|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
2885425|NCT02207504|Crizotinib|crizotinib|mesh-list
2885426|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885427|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2885428|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885429|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885430|NCT02196961|Nivolumab|nivolumab|mesh-list
2885431|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2885432|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885433|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2885434|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319307|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319308|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319309|NCT00363753|Aspirin|aspirin|mesh-list
2319310|NCT00363753|Clopidogrel|clopidogrel|mesh-list
2319311|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2319312|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2319313|NCT00363753|Analgesics|analgesics|mesh-ancestor
2319314|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
2319315|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319316|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885478|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
2885479|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2885480|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2885481|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2885482|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2885483|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885484|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2885485|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885486|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2885487|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2885488|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2885489|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2885490|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2885491|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
2885492|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2885493|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
2885494|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2885495|NCT02118610|Analgesics|analgesics|mesh-ancestor
2885496|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
2885497|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2885498|NCT02083250|Fludarabine|fludarabine|mesh-list
2885499|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
2885500|NCT02083250|Busulfan|busulfan|mesh-list
2885501|NCT02083250|Vorinostat|vorinostat|mesh-list
2885502|NCT02083250|Clofarabine|clofarabine|mesh-list
2885503|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
2885504|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2885505|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885506|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2885507|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
2885508|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885509|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2885510|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
2319317|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2319318|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319319|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2319320|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2319321|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319322|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2885511|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885512|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
2885513|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885514|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2885515|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2885516|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319323|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2319324|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319325|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
2319326|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2319327|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2319328|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2319329|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
2319330|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319331|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
2319332|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
2319333|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
2319334|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319335|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2319336|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2319337|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319338|NCT00363844|Incretins|incretins|mesh-ancestor
2319339|NCT00363844|Hormones|hormones|mesh-ancestor
2319340|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2319341|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2319342|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
2319343|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319344|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319345|NCT00363857|Ropinirole|ropinirole|mesh-list
2319346|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2319347|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2319348|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
2319349|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
2319350|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319351|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319352|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319353|NCT00363909|Dexetimide|dexetimide|mesh-list
2319354|NCT00363909|Citalopram|citalopram|mesh-list
2319355|NCT00363909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2319356|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2319357|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2885542|NCT01966471|Maytansine|maytansine|mesh-list
2885543|NCT01966471|Docetaxel|docetaxel|mesh-list
2885544|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2885545|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
2885546|NCT01966471|Doxorubicin|doxorubicin|mesh-list
2885547|NCT01966471|Fluorouracil|fluorouracil|mesh-list
2885548|NCT01966471|Trastuzumab|trastuzumab|mesh-list
2885549|NCT01966471|Epirubicin|epirubicin|mesh-list
2885550|NCT01966471|Pertuzumab|pertuzumab|mesh-list
2885551|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2319358|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319359|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319360|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
2319361|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319362|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2319363|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
2319364|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2319365|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2319366|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2319367|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
2319368|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
2319369|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319370|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2319371|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2319372|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
2319373|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
2319374|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2319375|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2319376|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319377|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2319378|NCT00363935|Analgesics|analgesics|mesh-ancestor
2319379|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
2319380|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319381|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2319382|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2319383|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2885552|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885553|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
2885554|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
2885555|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
2885556|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885557|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2885558|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
2885559|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885560|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2885561|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885562|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
2885563|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2885564|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2885565|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2885566|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2885567|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885568|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
2885569|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2885570|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2885571|NCT01857934|Aldesleukin|aldesleukin|mesh-list
2885572|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
2319384|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
2319385|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319386|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319387|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2319388|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2319389|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319390|NCT00363948|Incretins|incretins|mesh-ancestor
2319391|NCT00363948|Hormones|hormones|mesh-ancestor
2319392|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2319393|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2319394|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
2319395|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319396|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319397|NCT00364000|Calcium|calcium|mesh-list
2885573|NCT01857934|Melphalan|melphalan|mesh-list
2885574|NCT01857934|Busulfan|busulfan|mesh-list
2885575|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
2885576|NCT01857934|Doxorubicin|doxorubicin|mesh-list
2885577|NCT01857934|Etoposide|etoposide|mesh-list
2885578|NCT01857934|Vincristine|vincristine|mesh-list
2885579|NCT01857934|Topotecan|topotecan|mesh-list
2885580|NCT01857934|Interleukin-2|interleukin-2|mesh-list
2885581|NCT01857934|Molgramostim|molgramostim|mesh-list
2885582|NCT01857934|Dinutuximab|dinutuximab|mesh-list
2885583|NCT01857934|Levetiracetam|levetiracetam|mesh-list
2885584|NCT01857934|Isotretinoin|isotretinoin|mesh-list
2885585|NCT01857934|Antibodies|antibodies|mesh-list
2885586|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
2885587|NCT01857934|Lenograstim|lenograstim|mesh-list
2885588|NCT01857934|Sargramostim|sargramostim|mesh-list
2885589|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2885590|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
2319398|NCT00364000|Sevelamer|sevelamer|mesh-list
2319399|NCT00364000|Calcium acetate|calcium acetate|mesh-list
2319400|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2319401|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319402|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
2319403|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
2319404|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319405|NCT00364026|Darusentan|darusentan|mesh-list
2319406|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2319407|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319408|NCT00364052|Valganciclovir|valganciclovir|mesh-list
2319409|NCT00364052|Ganciclovir|ganciclovir|mesh-list
2319410|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2319411|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
2319412|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319413|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2319414|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319415|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319416|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2319417|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2319418|NCT00364143|Irinotecan|irinotecan|mesh-list
2319419|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2319420|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2319421|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319422|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319423|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319424|NCT00364195|Tesmilifene|tesmilifene|mesh-list
2319425|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
2319426|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
2319427|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319428|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885591|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885592|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2885593|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885594|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
2885595|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885596|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885597|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2885598|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2885599|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2885600|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2885601|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885602|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2885603|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2885604|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
2885605|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
2885606|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
2885607|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2885608|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2319429|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319430|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2319431|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
2319432|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2319433|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319434|NCT00364247|Tapentadol|tapentadol|mesh-list
2319435|NCT00364247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2319436|NCT00364247|Narcotics|narcotics|mesh-ancestor
2319437|NCT00364247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2319438|NCT00364247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319439|NCT00364247|Analgesics|analgesics|mesh-ancestor
2319440|NCT00364247|Sensory System Agents|sensory system agents|mesh-ancestor
2885609|NCT01857934|Analgesics|analgesics|mesh-ancestor
2885610|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
2885611|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2885612|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2885613|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2885614|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
2885615|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2885616|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
2885617|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
2885618|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
2885619|NCT01841177|Milrinone|milrinone|mesh-list
2885620|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2885621|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2885622|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
2885623|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2885624|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2885625|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885626|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885627|NCT01841177|Protective Agents|protective agents|mesh-ancestor
2885628|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885629|NCT01697527|Aldesleukin|aldesleukin|mesh-list
2885630|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
2885631|NCT01697527|Fludarabine|fludarabine|mesh-list
2885632|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
2885633|NCT01697527|Interleukin-2|interleukin-2|mesh-list
2885634|NCT01697527|Vaccines|vaccines|mesh-list
2885635|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2885636|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2885637|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
2885638|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885639|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2885640|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885641|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
2319441|NCT00364247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319442|NCT00364247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2319443|NCT00364247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2319444|NCT00364247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2319445|NCT00364247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885642|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885643|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885644|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2885645|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2885646|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
2885647|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2885648|NCT01697527|Analgesics|analgesics|mesh-ancestor
2885649|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
2885650|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2885651|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2885652|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2319446|NCT00364247|Adrenergic Agents|adrenergic agents|mesh-ancestor
2319447|NCT00364247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319448|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
2885653|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
2885654|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2885655|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2885656|NCT01655225|Pemetrexed|pemetrexed|mesh-list
2885657|NCT01655225|Letrozole|letrozole|mesh-list
2885658|NCT01655225|Fulvestrant|fulvestrant|mesh-list
2885659|NCT01655225|Midazolam|midazolam|mesh-list
2885660|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885661|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2885662|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2885663|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2885664|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885665|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2885666|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2885667|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2885668|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2885669|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
2885670|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
2885671|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
2885672|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
2885673|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2885674|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885675|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885676|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2885677|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2885678|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2885679|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2885680|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2885681|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
2885682|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2885683|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2885684|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2319449|NCT00364260|Hematinics|hematinics|mesh-ancestor
2319450|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2319451|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2319452|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
2319453|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319454|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319455|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2319456|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
2319457|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2319458|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2319459|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2319460|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
2319461|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319462|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885685|NCT01591577|Temozolomide|temozolomide|mesh-list
2885686|NCT01591577|Lapatinib|lapatinib|mesh-list
2885687|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885688|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
2885689|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885690|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885691|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2885692|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885705|NCT01512888|Busulfan|busulfan|mesh-list
2885706|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
2885707|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885708|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2885709|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
2885710|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319463|NCT00364429|Lorazepam|lorazepam|mesh-list
2885711|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885712|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319464|NCT00364429|Risperidone|risperidone|mesh-list
2319465|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2319466|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
2319467|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319468|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319469|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319470|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2319471|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2319472|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2319473|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2319474|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2319475|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
2319476|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
2319477|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
2319478|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
2319479|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319480|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2319481|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2319482|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2319483|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
2319484|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
2319485|NCT00364442|Fluticasone|fluticasone|mesh-list
2319486|NCT00364442|Xhance|xhance|mesh-list
2319487|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2319488|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2319489|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2885713|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2885722|NCT01453946|Budesonide|budesonide|mesh-list
2885723|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2885724|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2885725|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
2885726|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2885727|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885728|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2885729|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
2885730|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
2885731|NCT01453946|Hormones|hormones|mesh-ancestor
2885732|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2319490|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
2319491|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319492|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319493|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2319494|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
2319495|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
2319496|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2319497|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2319498|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2319499|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2319500|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
2319501|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319502|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885733|NCT01444092|Budesonide|budesonide|mesh-list
2885734|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2319503|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
2319504|NCT00364455|Hematinics|hematinics|mesh-ancestor
2319505|NCT00364481|Omeprazole|omeprazole|mesh-list
2319506|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2319507|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2319508|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2319509|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319510|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319511|NCT00364546|Tapentadol|tapentadol|mesh-list
2319512|NCT00364546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2319513|NCT00364546|Narcotics|narcotics|mesh-ancestor
2319514|NCT00364546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2319515|NCT00364546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319516|NCT00364546|Analgesics|analgesics|mesh-ancestor
2885735|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2885736|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
2885737|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2885738|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885739|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2885740|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
2885741|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
2885742|NCT01444092|Hormones|hormones|mesh-ancestor
2885743|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2319517|NCT00364546|Sensory System Agents|sensory system agents|mesh-ancestor
2319518|NCT00364546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319519|NCT00364546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2319520|NCT00364546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2319521|NCT00364546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2319522|NCT00364546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319523|NCT00364546|Adrenergic Agents|adrenergic agents|mesh-ancestor
2319524|NCT00364546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319525|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2319526|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2319527|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2319528|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
2319529|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319530|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2319531|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2885765|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2885766|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2885767|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885768|NCT01391962|Sunitinib|sunitinib|mesh-list
2885769|NCT01391962|Cediranib|cediranib|mesh-list
2319532|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319533|NCT00364572|Etanercept|etanercept|mesh-list
2319534|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2319535|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2885770|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885771|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2885772|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2885773|NCT01391962|Growth Substances|growth substances|mesh-ancestor
2885774|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885775|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
2885776|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2885777|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885778|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885796|NCT01332968|Prednisone|prednisone|mesh-list
2319536|NCT00364572|Analgesics|analgesics|mesh-ancestor
2319537|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
2319538|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319539|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319540|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2319541|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319542|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2319543|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2319544|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
2885797|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
2885798|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2885799|NCT01332968|Rituximab|rituximab|mesh-list
2885800|NCT01332968|Doxorubicin|doxorubicin|mesh-list
2885801|NCT01332968|Vincristine|vincristine|mesh-list
2885802|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
2885803|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2885804|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
2885805|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885806|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2885807|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885808|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
2885809|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885810|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885811|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2885812|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2885813|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2885814|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2885815|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2885816|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885817|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2885818|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
2885819|NCT01332968|Hormones|hormones|mesh-ancestor
2885820|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2885821|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2885822|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2885823|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
2885824|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
2885825|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
2885826|NCT01265784|Ertapenem|ertapenem|mesh-list
2885827|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2885828|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2885829|NCT01176474|Nivolumab|nivolumab|mesh-list
2885830|NCT01176474|Ipilimumab|ipilimumab|mesh-list
2885831|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2885832|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885833|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2885834|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885850|NCT00719966|Letrozole|letrozole|mesh-list
2319552|NCT00364702|Methylphenidate|methylphenidate|mesh-list
2319553|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2319554|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319555|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2319556|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2319557|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2319558|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319559|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
2319560|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319561|NCT00364754|Tesmilifene|tesmilifene|mesh-list
2319562|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
2885851|NCT00719966|Anastrozole|anastrozole|mesh-list
2885852|NCT00719966|Exemestane|exemestane|mesh-list
2885853|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885854|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2885855|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2885856|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885857|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885858|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2885859|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
2885860|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2885861|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885862|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2885863|NCT00637832|Prednisolone|prednisolone|mesh-list
2885864|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
2885865|NCT00637832|Rituximab|rituximab|mesh-list
2885866|NCT00637832|Doxorubicin|doxorubicin|mesh-list
2885867|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2885868|NCT00637832|Vincristine|vincristine|mesh-list
2885869|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2885870|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
2885871|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885872|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2885873|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885874|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
2885875|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885876|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319563|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
2319564|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319565|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319566|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319567|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2319568|NCT00364780|XL647|xl647|mesh-list
2319569|NCT00364780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885877|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2885878|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2885879|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2885880|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2885881|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2885882|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885883|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2885884|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
2885885|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
2885886|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
2885887|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2885888|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
2885889|NCT00637832|Hormones|hormones|mesh-ancestor
2885890|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2885891|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2885892|NCT00606346|Infliximab|infliximab|mesh-list
2885893|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
2885894|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2885895|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2885896|NCT00392327|Vitamin A|vitamin a|mesh-list
2885897|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
2885898|NCT00392327|Cisplatin|cisplatin|mesh-list
2885899|NCT00392327|Carboplatin|carboplatin|mesh-list
2885900|NCT00392327|Vincristine|vincristine|mesh-list
2885901|NCT00392327|Tretinoin|tretinoin|mesh-list
2319570|NCT00364780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2885902|NCT00392327|Isotretinoin|isotretinoin|mesh-list
2885903|NCT00392327|Lenograstim|lenograstim|mesh-list
2885904|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2885905|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
2885906|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885907|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2885908|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885909|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
2885910|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885911|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885912|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2885913|NCT00392327|Vitamins|vitamins|mesh-ancestor
2885914|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
2885915|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2885916|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2885917|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
2885918|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
2885919|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
2885920|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
2885921|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
2885922|NCT00116220|Goserelin|goserelin|mesh-list
2885923|NCT00116220|Flutamide|flutamide|mesh-list
2885924|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885925|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2885926|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885927|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
2319571|NCT00364780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319572|NCT00364780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319573|NCT00364806|Metoclopramide|metoclopramide|mesh-list
2319574|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
2319575|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
2319576|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
2319577|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319578|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319579|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2319580|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2319581|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2319582|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
2319583|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2885928|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
2885929|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2885930|NCT00099086|Docetaxel|docetaxel|mesh-list
2885931|NCT00099086|Leuprolide|leuprolide|mesh-list
2885932|NCT00099086|Goserelin|goserelin|mesh-list
2885933|NCT00099086|Bicalutamide|bicalutamide|mesh-list
2885934|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885935|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
2885936|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
2885937|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
2885938|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885939|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2319584|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319585|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2319586|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2319587|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2319588|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2319589|NCT00364871|Naltrexone|naltrexone|mesh-list
2319590|NCT00364871|Bupropion|bupropion|mesh-list
2319591|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2319592|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2319593|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885940|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
2885941|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2885942|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885943|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2885944|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
2885945|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
2885946|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2885947|NCT00092222|Interferons|interferons|mesh-list
2885948|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
2885949|NCT00092222|Zidovudine|zidovudine|mesh-list
2885950|NCT00092222|Valganciclovir|valganciclovir|mesh-list
2885951|NCT00092222|Sirolimus|sirolimus|mesh-list
2885952|NCT00092222|Prednisone|prednisone|mesh-list
2885953|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
2885954|NCT00092222|Rituximab|rituximab|mesh-list
2885955|NCT00092222|Doxorubicin|doxorubicin|mesh-list
2319594|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
2319595|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2885956|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2885957|NCT00092222|Etoposide|etoposide|mesh-list
2885958|NCT00092222|Vincristine|vincristine|mesh-list
2885959|NCT00092222|Bortezomib|bortezomib|mesh-list
2885960|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2885961|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
2885962|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885963|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2885964|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885965|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
2885966|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2885967|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2885968|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2885969|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2885970|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2885971|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2885972|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2885973|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885974|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2885975|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
2885976|NCT00092222|Hormones|hormones|mesh-ancestor
2885977|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2885978|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2885979|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2885980|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
2885981|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2885982|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
2885983|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
2885984|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
2885985|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2885986|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
2885987|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
2885988|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2885989|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2885990|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2885991|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2885992|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
2885993|NCT00085202|Vincristine|vincristine|mesh-list
2319596|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2319597|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
2319598|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2319599|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2319600|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2319601|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2319602|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319603|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
2319604|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319605|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2885994|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2885995|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
2885996|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2885997|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319606|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2319607|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2885998|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2885999|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
2886000|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886001|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886002|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2886003|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2319608|NCT00364988|Pioglitazone|pioglitazone|mesh-list
2886004|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
2886005|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
2886006|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
2886018|NCT00018057|Fluoxetine|fluoxetine|mesh-list
2886019|NCT00018057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2886020|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2886021|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2886022|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886023|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2886024|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
2886025|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886026|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2886027|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
2886028|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2886029|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2886030|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2886031|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319609|NCT00364988|Losartan|losartan|mesh-list
2319610|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2319611|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319612|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2319613|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2319614|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2319615|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2319616|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319617|NCT00365001|Methotrexate|methotrexate|mesh-list
2319618|NCT00365001|Simvastatin|simvastatin|mesh-list
2319619|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2319620|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
2319621|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2319622|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319623|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2319624|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
2319625|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319626|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319627|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
2319628|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319629|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2319630|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2319631|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
2319632|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319633|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2319634|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2319635|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2319636|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2319637|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2319638|NCT00365040|Mitomycins|mitomycins|mesh-list
2319639|NCT00365040|Mitomycin|mitomycin|mesh-list
2319640|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2319641|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319642|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
2319643|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319644|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2319645|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319652|NCT00365170|Insulin|insulin|mesh-list
2319653|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2319654|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
2319655|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2319656|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319657|NCT00365183|Pemetrexed|pemetrexed|mesh-list
2319658|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
2319659|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319660|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319661|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319662|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2319663|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2886060|NCT05187507|Theobromine|theobromine|mesh-list
2886061|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2319664|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2319665|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
2319666|NCT00365222|Temozolomide|temozolomide|mesh-list
2319667|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2319668|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
2319669|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319670|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319671|NCT00365287|Cyclosporine|cyclosporine|mesh-list
2319672|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
2319673|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
2319674|NCT00365287|Fludarabine|fludarabine|mesh-list
2319675|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
2319676|NCT00365287|Cyclosporins|cyclosporins|mesh-list
2886062|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
2886063|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2886064|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886065|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2886066|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
2886067|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
2886068|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2886069|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
2319677|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2319678|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2319679|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
2319680|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319681|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319682|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2319683|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
2319684|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319685|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319686|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2886070|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
2886071|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2886072|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886073|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
2886074|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2886075|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2886076|NCT05187429|Nivolumab|nivolumab|mesh-list
2886077|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2886078|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886079|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2886080|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886081|NCT05187377|Hormones|hormones|mesh-list
2886082|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2886083|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886091|NCT05187286|Apixaban|apixaban|mesh-list
2886092|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2886093|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
2886094|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2886095|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
2886096|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886097|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886098|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
2886104|NCT05187182|Leucovorin|leucovorin|mesh-list
2886105|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
2886106|NCT05187182|Nivolumab|nivolumab|mesh-list
2886107|NCT05187182|Trastuzumab|trastuzumab|mesh-list
2886108|NCT05187182|Oxaliplatin|oxaliplatin|mesh-list
2886109|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2886110|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886111|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2886112|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886113|NCT05187182|Antidotes|antidotes|mesh-ancestor
2886114|NCT05187182|Protective Agents|protective agents|mesh-ancestor
2886115|NCT05187182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886116|NCT05187182|Vitamin B Complex|vitamin b complex|mesh-ancestor
2886117|NCT05187182|Vitamins|vitamins|mesh-ancestor
2886118|NCT05187182|Micronutrients|micronutrients|mesh-ancestor
2886122|NCT05186974|Carboplatin|carboplatin|mesh-list
2886123|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
2886124|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886125|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2886133|NCT05186675|Epinephrine|epinephrine|mesh-list
2886134|NCT05186675|Racepinephrine|racepinephrine|mesh-list
2886135|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
2886136|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2886137|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2886138|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
2886139|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2886140|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886141|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886142|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2886143|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2886144|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
2886145|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2886146|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2886147|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
2886148|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
2886149|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
2886150|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2886151|NCT05186649|Warfarin|warfarin|mesh-list
2886152|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
2886153|NCT05186623|Ustekinumab|ustekinumab|mesh-list
2886154|NCT05186623|Vedolizumab|vedolizumab|mesh-list
2886155|NCT05186623|Tofacitinib|tofacitinib|mesh-list
2886156|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
2886157|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2886158|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886159|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886160|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2886164|NCT05186558|Gemcitabine|gemcitabine|mesh-list
2886165|NCT05186558|Rituximab|rituximab|mesh-list
2886166|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
2886167|NCT05186558|Lenalidomide|lenalidomide|mesh-list
2886168|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2886169|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886170|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
2886171|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886172|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2886173|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2886174|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
2886175|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886176|NCT05186558|Antiviral Agents|antiviral agents|mesh-ancestor
2886177|NCT05186558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2886178|NCT05186558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886179|NCT05186558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2886180|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2886181|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2886182|NCT05186558|Growth Substances|growth substances|mesh-ancestor
2886183|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
2886184|NCT05186545|Fulvestrant|fulvestrant|mesh-list
2886185|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2886186|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886187|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2886188|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2319687|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2319688|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
2319689|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319690|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
2319691|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319692|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
2319693|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2319694|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2319695|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2319696|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
2319697|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2319698|NCT00365313|Celecoxib|celecoxib|mesh-list
2319699|NCT00365313|Esomeprazole|esomeprazole|mesh-list
2319700|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2319701|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2319702|NCT00365313|Analgesics|analgesics|mesh-ancestor
2319703|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
2319704|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2886189|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
2886190|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2886191|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319705|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319706|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2319707|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319708|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2319709|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2319710|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886240|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
2886241|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
2886242|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2886243|NCT05186363|Amodiaquine|amodiaquine|mesh-list
2886244|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
2886245|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2886246|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2886247|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2886248|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2886249|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886250|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886251|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2886252|NCT05186363|Renal Agents|renal agents|mesh-ancestor
2886253|NCT05186194|Vitamin D|vitamin d|mesh-list
2886254|NCT05186194|Calcium|calcium|mesh-list
2886255|NCT05186194|Vitamins|vitamins|mesh-ancestor
2886256|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
2886257|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886258|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2886259|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2886260|NCT05186129|Clopidogrel|clopidogrel|mesh-list
2886261|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2886262|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2886263|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2886264|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2886265|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
2886266|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2886267|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886268|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886269|NCT05185999|Icodextrin|icodextrin|mesh-list
2886270|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
2886271|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2886279|NCT05185869|Gemcitabine|gemcitabine|mesh-list
2109229|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2109230|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2109231|NCT02516332|Citalopram|citalopram|mesh-list
2109232|NCT02516332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2109233|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2109234|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2109235|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109236|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109237|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
2319711|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886280|NCT05185869|Paclitaxel|paclitaxel|mesh-list
2886281|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2886282|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886283|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
2886284|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
2886285|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
2886286|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886287|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2886288|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
2886289|NCT05185869|Antiviral Agents|antiviral agents|mesh-ancestor
2886290|NCT05185869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2886291|NCT05185869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886292|NCT05185869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2886293|NCT05185869|Immunologic Factors|immunologic factors|mesh-ancestor
2886294|NCT05185869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886295|NCT05185804|Enoxaparin|enoxaparin|mesh-list
2886296|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
2886297|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
2886298|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2886299|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2886300|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319712|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2319713|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2319714|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2319715|NCT00365339|Ritonavir|ritonavir|mesh-list
2886308|NCT05185583|Methylphenidate|methylphenidate|mesh-list
2886309|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2886310|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886311|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2886312|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2886313|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2886314|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319716|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2319717|NCT00365339|Tenofovir|tenofovir|mesh-list
2319718|NCT00365339|Aripiprazole|aripiprazole|mesh-list
2319719|NCT00365339|Famotidine|famotidine|mesh-list
2319720|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2319721|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2319722|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
2319723|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319724|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319725|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2886315|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
2886316|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2886317|NCT05185544|Pemetrexed|pemetrexed|mesh-list
2886318|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886319|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886320|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886321|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2886322|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2886323|NCT05185518|Insulin|insulin|mesh-list
2886324|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2886325|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886326|NCT05185505|Bevacizumab|bevacizumab|mesh-list
2886327|NCT05185505|Atezolizumab|atezolizumab|mesh-list
2886328|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2886329|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886330|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2886331|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2886332|NCT05185505|Growth Substances|growth substances|mesh-ancestor
2886333|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886334|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
2886335|NCT05185401|Propofol|propofol|mesh-list
2886336|NCT05185401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2886337|NCT05185401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2886338|NCT05185401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886339|NCT05185401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2886340|NCT05185401|Anesthetics, General|anesthetics, general|mesh-ancestor
2886341|NCT05185401|Anesthetics|anesthetics|mesh-ancestor
2886342|NCT05185284|Remdesivir|remdesivir|mesh-list
2886343|NCT05185284|Favipiravir|favipiravir|mesh-list
2886344|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
2886345|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886346|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
2886347|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2886348|NCT05185167|Propofol|propofol|mesh-list
2886349|NCT05185167|Anesthetics|anesthetics|mesh-list
2886350|NCT05185167|Desflurane|desflurane|mesh-list
2886351|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
2886352|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2886353|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2886354|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886355|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2886356|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2319726|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2319727|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
2319728|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319729|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2319730|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2319731|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2319732|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2319733|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
2319734|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2319735|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2319736|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2319737|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2319738|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319739|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
2319740|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
2319741|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319742|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2319743|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2319744|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
2319745|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2319746|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2886374|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
2886375|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2886376|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886377|NCT05184842|Decitabine|decitabine|mesh-list
2886378|NCT05184842|Venetoclax|venetoclax|mesh-list
2886379|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2886380|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
2886381|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886382|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886383|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886384|NCT05184816|Deferoxamine|deferoxamine|mesh-list
2886385|NCT05184816|Siderophores|siderophores|mesh-ancestor
2886386|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2886387|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
2886388|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
2886389|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319747|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2319748|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2319749|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2319750|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2319751|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2319752|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
2886390|NCT05184803|Docetaxel|docetaxel|mesh-list
2886391|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
2886392|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886393|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
2886394|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
2886395|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
2886396|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319753|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
2319754|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
2319755|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2319756|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
2319757|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319758|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319759|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2319760|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
2319761|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
2319762|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2319763|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
2319764|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319765|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319766|NCT00365586|Ketoprofen|ketoprofen|mesh-list
2319767|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2319768|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2319769|NCT00365586|Analgesics|analgesics|mesh-ancestor
2886404|NCT05184712|Carboplatin|carboplatin|mesh-list
2886405|NCT05184712|Pemetrexed|pemetrexed|mesh-list
2886406|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886407|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886408|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886409|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2886410|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2886411|NCT05184530|Evolocumab|evolocumab|mesh-list
2886412|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2886413|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2886414|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
2886415|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886416|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2886417|NCT05184517|Cyclosporine|cyclosporine|mesh-list
2886418|NCT05184517|Cyclosporins|cyclosporins|mesh-list
2886419|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886420|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886421|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2886422|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
2886423|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886424|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
2886425|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2886426|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
2886427|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2886428|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2886429|NCT05184465|Anesthetics|anesthetics|mesh-list
2886430|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2886431|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886432|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2886433|NCT05184374|Hormones|hormones|mesh-ancestor
2886434|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2886435|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319770|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
2319771|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319772|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319773|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2319774|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319775|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2319776|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319777|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319778|NCT00365612|Tenofovir|tenofovir|mesh-list
2319779|NCT00365612|Emtricitabine|emtricitabine|mesh-list
2319780|NCT00365612|Efavirenz|efavirenz|mesh-list
2319781|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
2319782|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319783|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2886463|NCT05184179|Olmesartan|olmesartan|mesh-list
2886464|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2886465|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2886466|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2886467|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2886468|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
2886469|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319784|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2319785|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886470|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2886471|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2886472|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886473|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2886474|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2886475|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2886476|NCT05184101|Heparin|heparin|mesh-list
2886477|NCT05184101|Calcium heparin|calcium heparin|mesh-list
2886478|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
2886479|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2886480|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2886481|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886482|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
2886483|NCT05184049|Epalrestat|epalrestat|mesh-list
2886484|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
2886485|NCT05184049|Vitamins|vitamins|mesh-ancestor
2886486|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
2886487|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886488|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886489|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886490|NCT05183997|Verapamil|verapamil|mesh-list
2886491|NCT05183997|Thrombin|thrombin|mesh-list
2886492|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2886493|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2886494|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2886495|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886496|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2886497|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886498|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
2886499|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
2886500|NCT05183997|Coagulants|coagulants|mesh-ancestor
2886501|NCT05183984|Bevacizumab|bevacizumab|mesh-list
2886502|NCT05183984|Niraparib|niraparib|mesh-list
2886503|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2886504|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886505|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2886506|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2886507|NCT05183984|Growth Substances|growth substances|mesh-ancestor
2886508|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319786|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319787|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2319788|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2319789|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2886509|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
2886510|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2886511|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886512|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886513|NCT05183880|Vitamins|vitamins|mesh-list
2886514|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
2886515|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
2886516|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886517|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
2886518|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886519|NCT05183880|Protective Agents|protective agents|mesh-ancestor
2886524|NCT05183841|Fenoterol|fenoterol|mesh-list
2886525|NCT05183841|Ipratropium|ipratropium|mesh-list
2886526|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
2886527|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
2886528|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2886529|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319790|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2886530|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2886531|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
2886532|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2886533|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
2886534|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2886535|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886536|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
2886537|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
2886538|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2886539|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2886540|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2886541|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2886542|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
2886553|NCT05183737|Propolis|propolis|mesh-list
2886554|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319791|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2319792|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2319793|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2319794|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2319795|NCT00365638|Simvastatin|simvastatin|mesh-list
2319796|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2319797|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2886555|NCT05183646|Proxigermanium|proxigermanium|mesh-list
2886556|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886557|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
2886558|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
2886559|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886560|NCT05183555|Edotreotide|edotreotide|mesh-list
2886561|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2886562|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319798|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
2319799|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319800|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2319801|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2319802|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319803|NCT00365742|Simvastatin|simvastatin|mesh-list
2319804|NCT00365742|Red yeast rice|red yeast rice|mesh-list
2319805|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2319806|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2319807|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
2886577|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
2886578|NCT05183334|Tramadol|tramadol|mesh-list
2886579|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
2886580|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2886581|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2886582|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886583|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886584|NCT05183334|Urological Agents|urological agents|mesh-ancestor
2886585|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2886586|NCT05183334|Narcotics|narcotics|mesh-ancestor
2319808|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319809|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2319810|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2319811|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319812|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
2319813|NCT00365755|Melphalan|melphalan|mesh-list
2319814|NCT00365755|Carboplatin|carboplatin|mesh-list
2319815|NCT00365755|Etoposide|etoposide|mesh-list
2319816|NCT00365755|Vincristine|vincristine|mesh-list
2319817|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2319818|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
2319819|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319820|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319821|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2319822|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
2319823|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319824|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319825|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2886587|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2886588|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886589|NCT05183334|Analgesics|analgesics|mesh-ancestor
2886590|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
2886591|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2886592|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
2886593|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2886594|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319826|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2319827|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2319828|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2319829|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319830|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
2319831|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
2319832|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
2319833|NCT00365820|Tegaserod|tegaserod|mesh-list
2319834|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2319835|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
2319836|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319837|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319838|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319839|NCT00365898|Hydromorphone|hydromorphone|mesh-list
2319840|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2319841|NCT00365898|Narcotics|narcotics|mesh-ancestor
2319842|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2319843|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319844|NCT00365898|Analgesics|analgesics|mesh-ancestor
2319845|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
2319846|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319847|NCT00365924|Teriparatide|teriparatide|mesh-list
2319848|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2319849|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886595|NCT05183204|Metformin|metformin|mesh-list
2886596|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2886597|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886598|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2886599|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886600|NCT05183178|Ticagrelor|ticagrelor|mesh-list
2886601|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2886602|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2886603|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2886604|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2886605|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2886606|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
2886607|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2886608|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886609|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886610|NCT05183139|Dexamethasone|dexamethasone|mesh-list
2886611|NCT05183139|Lenalidomide|lenalidomide|mesh-list
2319850|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2319851|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
2319852|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
2319853|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319854|NCT00365950|Warfarin|warfarin|mesh-list
2886612|NCT05183139|Pomalidomide|pomalidomide|mesh-list
2886613|NCT05183139|Ixazomib|ixazomib|mesh-list
2886614|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2886615|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
2886616|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
2886617|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2886618|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886619|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2886620|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
2886621|NCT05183139|Hormones|hormones|mesh-ancestor
2886622|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2886623|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2886624|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886625|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
2886626|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2886627|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2886628|NCT05183139|Growth Substances|growth substances|mesh-ancestor
2886629|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
2886630|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
2886631|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886632|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886633|NCT05183126|Paclitaxel|paclitaxel|mesh-list
2886634|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2886635|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2886636|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886637|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
2886638|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
2886639|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
2886640|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886641|NCT05183048|Panitumumab|panitumumab|mesh-list
2886642|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2886643|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886644|NCT05183035|Cytarabine|cytarabine|mesh-list
2886645|NCT05183035|Fludarabine|fludarabine|mesh-list
2886646|NCT05183035|Azacitidine|azacitidine|mesh-list
2886647|NCT05183035|Venetoclax|venetoclax|mesh-list
2886648|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
2886649|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886650|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2886651|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
2886652|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886653|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2886654|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
2886655|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886656|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
2886657|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2886658|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886659|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2886660|NCT05182970|Metformin|metformin|mesh-list
2319855|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
2319856|NCT00366002|Darifenacin|darifenacin|mesh-list
2319857|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2319858|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2319859|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
2319860|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319861|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319862|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319863|NCT00366002|Urological Agents|urological agents|mesh-ancestor
2886661|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2886662|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886663|NCT05182957|Lenalidomide|lenalidomide|mesh-list
2886664|NCT05182957|Azacitidine|azacitidine|mesh-list
2886665|NCT05182957|Antibodies|antibodies|mesh-list
2886666|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
2886667|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2886668|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
2886669|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886670|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2886671|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2319864|NCT00366067|Phenytoin|phenytoin|mesh-list
2319865|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
2319866|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2319867|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2886672|NCT05182957|Growth Substances|growth substances|mesh-ancestor
2886673|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
2886674|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886675|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2886676|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
2319868|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2886677|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886678|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319869|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319870|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2319871|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2319872|NCT00366093|Eszopiclone|eszopiclone|mesh-list
2319873|NCT00366093|Zopiclone|zopiclone|mesh-list
2319874|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2319875|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2319876|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319877|NCT00366119|Ramipril|ramipril|mesh-list
2319878|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2319879|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
2319880|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319881|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319882|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2319887|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
2319888|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2886701|NCT05182710|Vaccines|vaccines|mesh-list
2886702|NCT05182710|Immunologic Factors|immunologic factors|mesh-ancestor
2886703|NCT05182710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886704|NCT05182658|Empagliflozin|empagliflozin|mesh-list
2886705|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2886706|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886707|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2886708|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886709|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2886710|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
2886711|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2886712|NCT05182385|Venetoclax|venetoclax|mesh-list
2886713|NCT05182385|Blinatumomab|blinatumomab|mesh-list
2886714|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886715|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
2886716|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2886717|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886718|NCT05182151|Istradefylline|istradefylline|mesh-list
2886719|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2886720|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2886721|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2886722|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
2886723|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2886724|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886725|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886726|NCT05182138|Zinc|zinc|mesh-list
2886727|NCT05182138|Trace Elements|trace elements|mesh-ancestor
2886728|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
2886729|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886730|NCT05182112|Gemcitabine|gemcitabine|mesh-list
2886731|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886732|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2886733|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
2886734|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886735|NCT05182112|Antiviral Agents|antiviral agents|mesh-ancestor
2886736|NCT05182112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2886737|NCT05182112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886738|NCT05182112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2886739|NCT05182112|Immunologic Factors|immunologic factors|mesh-ancestor
2886740|NCT05182112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886741|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
2886742|NCT05182073|Fludarabine|fludarabine|mesh-list
2886743|NCT05182073|Daratumumab|daratumumab|mesh-list
2886744|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2886745|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2886746|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
2886747|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886748|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2886749|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2886750|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
2886751|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886752|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886753|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2886754|NCT05181969|Dextrans|dextrans|mesh-list
2886755|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
2886756|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
2886757|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
2886758|NCT05180292|Carvedilol|carvedilol|mesh-list
2319889|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319890|NCT00366262|Naproxen|naproxen|mesh-list
2319891|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2319892|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2319893|NCT00366262|Analgesics|analgesics|mesh-ancestor
2319894|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
2319895|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319896|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319897|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2319898|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319899|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
2319900|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2319901|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319902|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319903|NCT00366418|Rituximab|rituximab|mesh-list
2886759|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2886760|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2886761|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
2886762|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2886763|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886764|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886765|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2886766|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
2886767|NCT05180292|Protective Agents|protective agents|mesh-ancestor
2886768|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2886769|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2886770|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2886771|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
2886772|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2886773|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2886774|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
2886775|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2886776|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2886777|NCT05177939|Prednisolone|prednisolone|mesh-list
2886778|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
2886779|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2886780|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
2886781|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
2886782|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2886783|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
2886784|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2886785|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2886786|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
2886787|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
2886788|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2886789|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886790|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2886791|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
2886792|NCT05177939|Hormones|hormones|mesh-ancestor
2886793|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2886794|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2886795|NCT05177939|Protective Agents|protective agents|mesh-ancestor
2886796|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2886797|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886798|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
2886799|NCT05177718|Natalizumab|natalizumab|mesh-list
2886800|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
2886801|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886802|NCT05172908|Dexamethasone|dexamethasone|mesh-list
2886803|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2886804|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
2886805|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
2886806|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2886807|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886808|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2886809|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
2886810|NCT05172908|Hormones|hormones|mesh-ancestor
2886811|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2886812|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2886813|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886814|NCT05171166|Leucovorin|leucovorin|mesh-list
2886815|NCT05171166|Fluorouracil|fluorouracil|mesh-list
2886816|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
2886817|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
2886818|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
2319904|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2319905|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319906|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
2886819|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886820|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2886821|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886822|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2886823|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
2886824|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886825|NCT05171166|Antidotes|antidotes|mesh-ancestor
2886826|NCT05171166|Protective Agents|protective agents|mesh-ancestor
2886827|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
2886828|NCT05171166|Vitamins|vitamins|mesh-ancestor
2886829|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
2886830|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2886831|NCT05171166|Estrogens|estrogens|mesh-ancestor
2886832|NCT05171166|Hormones|hormones|mesh-ancestor
2886833|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2886834|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2886835|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
2886836|NCT05170711|Anesthetics|anesthetics|mesh-list
2886837|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2886838|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319907|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319908|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2319909|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
2319910|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2886848|NCT05170139|Caffeine|caffeine|mesh-list
2886849|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2886850|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886851|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2886852|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886853|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886854|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2886855|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2886856|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
2886857|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2886858|NCT05168423|Cyclophosphamide|cyclophosphamide|mesh-list
2886859|NCT05168423|Fludarabine|fludarabine|mesh-list
2886860|NCT05168423|Isotretinoin|isotretinoin|mesh-list
2886861|NCT05168423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2886862|NCT05168423|Immunologic Factors|immunologic factors|mesh-ancestor
2886863|NCT05168423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886864|NCT05168423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2886865|NCT05168423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2886866|NCT05168423|Alkylating Agents|alkylating agents|mesh-ancestor
2886867|NCT05168423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886868|NCT05168423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886869|NCT05168423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2886870|NCT05168423|Dermatologic Agents|dermatologic agents|mesh-ancestor
2886871|NCT05166291|Anesthetics|anesthetics|mesh-list
2886872|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2886873|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319911|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319912|NCT00366470|Vitamins|vitamins|mesh-ancestor
2319913|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
2319914|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2319915|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2319916|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2319917|NCT00366652|Desipramine|desipramine|mesh-list
2319918|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2886874|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
2886875|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2886876|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2886877|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
2886878|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2886895|NCT05163561|Vaccines|vaccines|mesh-list
2886896|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
2886897|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886898|NCT05163496|Psilocybin|psilocybin|mesh-list
2886899|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
2886900|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886901|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2886902|NCT05162573|177Lu-PSMA-617|177lu-psma-617|mesh-list
2886903|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2886904|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886905|NCT05162118|Nivolumab|nivolumab|mesh-list
2886906|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2886907|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886908|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2886909|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886910|NCT05159752|Afamelanotide|afamelanotide|mesh-list
2886911|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
2886912|NCT05158998|Propofol|propofol|mesh-list
2886913|NCT05158998|Sevoflurane|sevoflurane|mesh-list
2886914|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2886915|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2886916|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886917|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2886918|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
2886919|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
2886920|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2886921|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2886922|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
2886923|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2886924|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
2886925|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886926|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2886927|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2886928|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
2319919|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2319920|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2319921|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319922|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319923|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319924|NCT00366652|Analgesics|analgesics|mesh-ancestor
2319925|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
2319926|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2886929|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886930|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886931|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2886932|NCT05157971|Cytarabine|cytarabine|mesh-list
2886933|NCT05157971|Prednisone|prednisone|mesh-list
2886934|NCT05157971|Cortisone|cortisone|mesh-list
2886935|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
2886936|NCT05157971|Methotrexate|methotrexate|mesh-list
2886937|NCT05157971|Vincristine|vincristine|mesh-list
2886938|NCT05157971|Daunorubicin|daunorubicin|mesh-list
2886939|NCT05157971|Asparaginase|asparaginase|mesh-list
2886940|NCT05157971|Venetoclax|venetoclax|mesh-list
2886941|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
2886942|NCT05157971|Pegaspargase|pegaspargase|mesh-list
2886943|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2886944|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
2886945|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2886946|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2886947|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2886948|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
2886949|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886950|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886951|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2886952|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2886953|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
2886954|NCT05157971|Hormones|hormones|mesh-ancestor
2886955|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2886956|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2886957|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2886958|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
2886959|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2886960|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2886961|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
2886962|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
2886963|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886964|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2886965|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2886966|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
2886967|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2886968|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2886969|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
2319927|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
2319928|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2319929|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
2319930|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2319931|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319932|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2319933|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
2319934|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2319935|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2319936|NCT00366704|Risperidone|risperidone|mesh-list
2319937|NCT00366704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2319938|NCT00366704|Serotonin Agents|serotonin agents|mesh-ancestor
2319939|NCT00366704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319940|NCT00366704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2886970|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
2886971|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
2886972|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2886973|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2886974|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2319941|NCT00366704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319942|NCT00366704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2319943|NCT00366704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2109238|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109239|NCT02516332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2109240|NCT02516332|Antidepressive Agents|antidepressive agents|mesh-ancestor
2109241|NCT02516332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2109242|NCT02516410|Ivacaftor|ivacaftor|mesh-list
2319944|NCT00366704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2319945|NCT00366704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2319946|NCT00366704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2319947|NCT00366704|Dopamine Agents|dopamine agents|mesh-ancestor
2319948|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
2319949|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2319950|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2319951|NCT00366795|Satavaptan|satavaptan|mesh-list
2319952|NCT00366795|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2319953|NCT00366795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319954|NCT00366795|Natriuretic Agents|natriuretic agents|mesh-ancestor
2319955|NCT00366795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319956|NCT00366834|Dexamethasone|dexamethasone|mesh-list
2319957|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
2319958|NCT00366834|Ondansetron|ondansetron|mesh-list
2319959|NCT00366834|Casopitant|casopitant|mesh-list
2319960|NCT00366834|BB 1101|bb 1101|mesh-list
2319961|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2319962|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
2319963|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
2319964|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319965|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319966|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2319967|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
2319968|NCT00366834|Hormones|hormones|mesh-ancestor
2319969|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2319970|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2319971|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2319972|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
2319973|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2886990|NCT05153772|Octreotide|octreotide|mesh-list
2886991|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2886992|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2886993|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886994|NCT05152862|Bevacizumab|bevacizumab|mesh-list
2886995|NCT05152862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2886996|NCT05152862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2886997|NCT05152862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2886998|NCT05152862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2886999|NCT05152862|Growth Substances|growth substances|mesh-ancestor
2887000|NCT05152862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887001|NCT05152862|Growth Inhibitors|growth inhibitors|mesh-ancestor
2887002|NCT05151640|Nintedanib|nintedanib|mesh-list
2887003|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887004|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2887005|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887006|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887007|NCT05151484|Alendronate|alendronate|mesh-list
2887008|NCT05151484|Teriparatide|teriparatide|mesh-list
2109243|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2109244|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2109245|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109246|NCT02516592|Fluticasone|fluticasone|mesh-list
2109247|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2109248|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109249|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2109250|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
2109251|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2319974|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319975|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
2319976|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
2319977|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2319978|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
2319979|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2319980|NCT00366834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2319981|NCT00366834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2319982|NCT00366834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2319983|NCT00366834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2887009|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2887010|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887011|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2887012|NCT05151159|Antibodies|antibodies|mesh-list
2887013|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
2887014|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887036|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
2887037|NCT05150782|Curcumin|curcumin|mesh-list
2887038|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
2887039|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887040|NCT05150782|Protective Agents|protective agents|mesh-ancestor
2887041|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887042|NCT05150782|Vitamins|vitamins|mesh-ancestor
2887043|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
2887044|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2887045|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2887046|NCT05150782|Analgesics|analgesics|mesh-ancestor
2319984|NCT00366834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2319985|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2319986|NCT00366873|Calcium|calcium|mesh-list
2319987|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2319988|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2319989|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
2319990|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2319991|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2319992|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2319993|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319994|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2319995|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2319996|NCT00366938|Analgesics|analgesics|mesh-ancestor
2319997|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
2319998|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2887047|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
2887048|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2887049|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2887050|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2887051|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887052|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887053|NCT05149560|Ticagrelor|ticagrelor|mesh-list
2887054|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2887055|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2887056|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2887057|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2887058|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
2887059|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2887060|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887061|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887068|NCT05146674|Tadalafil|tadalafil|mesh-list
2887069|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
2887070|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2887071|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2887072|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887073|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887074|NCT05146674|Urological Agents|urological agents|mesh-ancestor
2887075|NCT05146635|Epirubicin|epirubicin|mesh-list
2887076|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2887077|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887078|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2887079|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2887080|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887081|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887082|NCT05145569|Paclitaxel|paclitaxel|mesh-list
2887083|NCT05145569|Carboplatin|carboplatin|mesh-list
2887084|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2887085|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887086|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
2887087|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
2887088|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
2887089|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2319999|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320000|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320001|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2320002|NCT00367068|Baclofen|baclofen|mesh-list
2320003|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2320004|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320005|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2320006|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320007|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2320008|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
2320009|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
2320010|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320011|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320012|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
2320013|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2320014|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
2320015|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
2320016|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2320017|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2320018|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320019|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2320020|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320021|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320022|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2320023|NCT00367081|Renal Agents|renal agents|mesh-ancestor
2320024|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2887112|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
2887113|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887114|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2887115|NCT05136690|Nicotine|nicotine|mesh-list
2887116|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2887117|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
2887118|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2887119|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887120|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2887121|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2887122|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
2887123|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2887124|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887125|NCT05133518|Midazolam|midazolam|mesh-list
2887126|NCT05133518|Ketamine|ketamine|mesh-list
2887127|NCT05133518|Analgesics|analgesics|mesh-ancestor
2887128|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
2887129|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2887130|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887131|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2887132|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2887133|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
2887134|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
2887135|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2887136|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2887137|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2887138|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2887139|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320025|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
2320026|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2320027|NCT00367094|Benazepril|benazepril|mesh-list
2887140|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2887141|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2887142|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2887143|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2887144|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2887145|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
2887146|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
2887155|NCT05132439|Metformin|metformin|mesh-list
2887156|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2887157|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887158|NCT05132114|Lugol's solution|lugol's solution|mesh-list
2887159|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
2887160|NCT05132114|Coagulants|coagulants|mesh-ancestor
2887173|NCT05130060|Trifluridine|trifluridine|mesh-list
2887174|NCT05130060|Vaccines|vaccines|mesh-list
2887175|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
2887176|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887177|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
2887178|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320028|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2320029|NCT00367094|Diuretics|diuretics|mesh-ancestor
2320030|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
2320031|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320032|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2320033|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2320034|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320035|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2320036|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
2320037|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887179|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
2887180|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2887181|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
2887182|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887183|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887184|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
2887185|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2887186|NCT05124899|Protective Agents|protective agents|mesh-ancestor
2887187|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887188|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
2887189|NCT05119855|Vaccines|vaccines|mesh-list
2887190|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
2887191|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320038|NCT00367120|Amoxicillin|amoxicillin|mesh-list
2320039|NCT00367120|Azithromycin|azithromycin|mesh-list
2320040|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
2320041|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
2320042|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2320043|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2320044|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320045|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2320046|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320047|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320048|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2320049|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
2320050|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320051|NCT00367185|Thalidomide|thalidomide|mesh-list
2320052|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2320053|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
2320054|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320055|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
2320056|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2320057|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320058|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2320059|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2320060|NCT00367185|Growth Substances|growth substances|mesh-ancestor
2320061|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
2320062|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320063|NCT00367211|Naproxen|naproxen|mesh-list
2320064|NCT00367211|Omeprazole|omeprazole|mesh-list
2320065|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2320066|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2320067|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2320068|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320069|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320070|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2320071|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2320072|NCT00367211|Analgesics|analgesics|mesh-ancestor
2320073|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
2320074|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320075|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320076|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320077|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2320078|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
2320079|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2320080|NCT00367250|Trastuzumab|trastuzumab|mesh-list
2320081|NCT00367250|Cetuximab|cetuximab|mesh-list
2320082|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887192|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
2887193|NCT05119140|Mesalamine|mesalamine|mesh-list
2887194|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
2887195|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2887196|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2887197|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320083|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320084|NCT00367263|Ciclesonide|ciclesonide|mesh-list
2320085|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
2887198|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320086|NCT00367263|Hormones|hormones|mesh-ancestor
2320087|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320088|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320089|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2320090|NCT00367276|Drospirenone|drospirenone|mesh-list
2320091|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2320092|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
2320093|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320094|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320095|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2887199|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887200|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2887201|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2887202|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2887203|NCT05119140|Analgesics|analgesics|mesh-ancestor
2887204|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
2887205|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2887206|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887207|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2887208|NCT05119075|Dopamine|dopamine|mesh-list
2887209|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
2320096|NCT00367276|Diuretics|diuretics|mesh-ancestor
2320097|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
2320098|NCT00367302|Buprenorphine|buprenorphine|mesh-list
2320099|NCT00367302|Methadone|methadone|mesh-list
2320100|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2320101|NCT00367302|Narcotics|narcotics|mesh-ancestor
2320102|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2320103|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320104|NCT00367302|Analgesics|analgesics|mesh-ancestor
2320105|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
2320106|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320107|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2320108|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
2320109|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
2320110|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
2320111|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2320112|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2320113|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320114|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320115|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2320116|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2320117|NCT00367315|Analgesics|analgesics|mesh-ancestor
2320118|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
2320119|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320120|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320121|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320122|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2320123|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
2320124|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2320125|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2320126|NCT00367393|Analgesics|analgesics|mesh-ancestor
2887210|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2887211|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
2887212|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
2887213|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2887214|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887215|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
2887216|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2887217|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887218|NCT05119075|Protective Agents|protective agents|mesh-ancestor
2320127|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
2320128|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320129|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320130|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320131|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2320132|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
2887244|NCT05111626|Nivolumab|nivolumab|mesh-list
2887245|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
2887246|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887247|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887248|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2887249|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887250|NCT05111262|Budesonide|budesonide|mesh-list
2887251|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
2887252|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2887253|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2887254|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
2887255|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320133|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2320134|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
2320135|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2320136|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320137|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320138|NCT00367419|Erythromycin|erythromycin|mesh-list
2320139|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
2320140|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2320141|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
2320142|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2320143|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320144|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2320145|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2320146|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320147|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320148|NCT00367445|Insulin|insulin|mesh-list
2320149|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2320150|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
2320151|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320152|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320153|NCT00367471|Paclitaxel|paclitaxel|mesh-list
2320154|NCT00367471|Carboplatin|carboplatin|mesh-list
2320155|NCT00367471|Trastuzumab|trastuzumab|mesh-list
2320156|NCT00367471|Lapatinib|lapatinib|mesh-list
2320157|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2320158|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320159|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
2320160|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
2320161|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
2320162|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320163|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2320164|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2320165|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320166|NCT00367497|Cytarabine|cytarabine|mesh-list
2320167|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
2320168|NCT00367497|Rituximab|rituximab|mesh-list
2320169|NCT00367497|Etoposide|etoposide|mesh-list
2320170|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320171|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2320172|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
2320173|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320174|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2887256|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887257|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2887258|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
2887259|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
2887260|NCT05111262|Hormones|hormones|mesh-ancestor
2887261|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2887262|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2887263|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2887264|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2887265|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
2887266|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2887267|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887268|NCT05107193|Afatinib|afatinib|mesh-list
2887269|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887270|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2887271|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887272|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887273|NCT05105282|Anesthetics|anesthetics|mesh-list
2887274|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
2320175|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2320176|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2320177|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2320178|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320179|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320180|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2320181|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
2320182|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
2320183|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320184|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2320185|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320186|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
2320187|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
2320188|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320189|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2320190|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
2320191|NCT00367497|Hormones|hormones|mesh-ancestor
2320192|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320193|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2320194|NCT00367497|Protective Agents|protective agents|mesh-ancestor
2320195|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
2320196|NCT00367536|Estrogens|estrogens|mesh-list
2320197|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2320198|NCT00367536|Hormones|hormones|mesh-ancestor
2320199|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320200|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887275|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2887276|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887277|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
2887278|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2887289|NCT05099107|Albuterol|albuterol|mesh-list
2887290|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2887291|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
2887292|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2887293|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887294|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2887295|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
2887296|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
2320201|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2320202|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2320203|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
2320204|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2320205|NCT00367562|Valsartan|valsartan|mesh-list
2320206|NCT00367562|Enalapril|enalapril|mesh-list
2320207|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2320208|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2320209|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2372159|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320210|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320211|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2320212|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
2320213|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320214|NCT00367614|Pantoprazole|pantoprazole|mesh-list
2320215|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2320216|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2320217|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2320218|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320219|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320220|NCT00367627|Albendazole|albendazole|mesh-list
2320221|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
2320222|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2320223|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320224|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
2320225|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2320226|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2320227|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
2320228|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
2320229|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
2320230|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320231|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320232|NCT00367653|Azithromycin|azithromycin|mesh-list
2320233|NCT00367653|Chloroquine|chloroquine|mesh-list
2320234|NCT00367653|Mefloquine|mefloquine|mesh-list
2320235|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2320236|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320237|NCT00367653|Amebicides|amebicides|mesh-ancestor
2320238|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2320239|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2320240|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
2320241|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2320242|NCT00367718|Bortezomib|bortezomib|mesh-list
2320243|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320244|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2887297|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2887298|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2887299|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2887300|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2887301|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
2887302|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2887303|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887321|NCT05093582|Cromakalim|cromakalim|mesh-list
2887322|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2887323|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2887324|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
2887325|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2887326|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887327|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2320245|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
2887328|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
2887329|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
2887330|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
2887331|NCT05089643|Capecitabine|capecitabine|mesh-list
2887332|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2887333|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
2887334|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320246|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320247|NCT00367822|Ropinirole|ropinirole|mesh-list
2887335|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887336|NCT05087992|Bevacizumab|bevacizumab|mesh-list
2887337|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887338|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887339|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2887340|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2887341|NCT05087992|Growth Substances|growth substances|mesh-ancestor
2887342|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887343|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
2887344|NCT05087030|Denosumab|denosumab|mesh-list
2887345|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2887346|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320248|NCT00367822|Lisuride|lisuride|mesh-list
2320249|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2320250|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2320251|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
2320252|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
2320253|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320254|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320255|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320256|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2320257|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
2320258|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
2320259|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320260|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2320261|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320262|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320263|NCT00367874|Buprenorphine|buprenorphine|mesh-list
2320264|NCT00367874|Valproic Acid|valproic acid|mesh-list
2320265|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2320266|NCT00367874|Narcotics|narcotics|mesh-ancestor
2887387|NCT05077904|Alprazolam|alprazolam|mesh-list
2320267|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2320268|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320269|NCT00367874|Analgesics|analgesics|mesh-ancestor
2320270|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
2887388|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2887389|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2887390|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887391|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2887392|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2887393|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2887394|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
2887395|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
2887396|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2887397|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887398|NCT05076617|Alprazolam|alprazolam|mesh-list
2887399|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2887400|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2887401|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887402|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2887403|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2887404|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2887405|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
2887406|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
2887407|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2887408|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887414|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
2887415|NCT05073627|Dabigatran|dabigatran|mesh-list
2887416|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
2887417|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2887418|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
2887419|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887420|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887421|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
2887422|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2887423|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2887424|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
2320271|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320272|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2320273|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
2320274|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887425|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2887426|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887427|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887428|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887429|NCT05068232|Carboplatin|carboplatin|mesh-list
2887430|NCT05068232|Etoposide|etoposide|mesh-list
2887431|NCT05068232|Durvalumab|durvalumab|mesh-list
2887432|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887433|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2887434|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2887435|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2887436|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887437|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887438|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887439|NCT05067998|Vitamins|vitamins|mesh-list
2887440|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
2887441|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887442|NCT05065190|Nintedanib|nintedanib|mesh-list
2887443|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887444|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2887445|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887446|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887447|NCT05064488|Metformin|metformin|mesh-list
2887448|NCT05064488|Digoxin|digoxin|mesh-list
2887449|NCT05064488|Sumatriptan|sumatriptan|mesh-list
2887450|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2887451|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320275|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320276|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
2320277|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320278|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
2887452|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887453|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2887454|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2887455|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
2887456|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887457|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2887458|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2887459|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320279|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2320280|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2320281|NCT00367887|Ribavirin|ribavirin|mesh-list
2320282|NCT00367887|Interferon alpha-2|interferon alpha-2|mesh-list
2320283|NCT00367887|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2320284|NCT00367887|Interferon-alpha|interferon-alpha|mesh-list
2320285|NCT00367887|Antimetabolites|antimetabolites|mesh-ancestor
2320286|NCT00367887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320287|NCT00367887|Antiviral Agents|antiviral agents|mesh-ancestor
2320288|NCT00367887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320289|NCT00367887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320290|NCT00367887|Immunologic Factors|immunologic factors|mesh-ancestor
2320291|NCT00367887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320292|NCT00367913|Clarithromycin|clarithromycin|mesh-list
2320293|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
2320294|NCT00367913|Rifampin|rifampin|mesh-list
2320295|NCT00367913|Ethambutol|ethambutol|mesh-list
2320296|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2887460|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2887461|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2887462|NCT05064488|Protective Agents|protective agents|mesh-ancestor
2887463|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2887464|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2887465|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2320297|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320298|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2320299|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887466|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
2887467|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320300|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320301|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2320302|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2320303|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2320304|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2320305|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320306|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2320307|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2320308|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
2320309|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
2320310|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2320311|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2320312|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2887505|NCT05061524|Omalizumab|omalizumab|mesh-list
2887506|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2887507|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2887508|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
2887509|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
2887510|NCT05061017|Nivolumab|nivolumab|mesh-list
2320313|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2320314|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2320315|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2320316|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2320317|NCT00367939|Amlodipine|amlodipine|mesh-list
2320318|NCT00367939|Valsartan|valsartan|mesh-list
2320319|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2320320|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2320321|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2320322|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320323|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2320324|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320325|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
2320326|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2320327|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2887511|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2887512|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
2887513|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887514|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2887515|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2887516|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
2887517|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887518|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887519|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2887520|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887521|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2887522|NCT05060627|Dexamethasone|dexamethasone|mesh-list
2887523|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2887524|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
2887525|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
2887526|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2887527|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887528|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2320328|NCT00367965|Eszopiclone|eszopiclone|mesh-list
2320329|NCT00367965|Zopiclone|zopiclone|mesh-list
2320330|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2887529|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
2887530|NCT05060627|Hormones|hormones|mesh-ancestor
2887531|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2887532|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2887533|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320331|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2320332|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320333|NCT00367978|Amlodipine|amlodipine|mesh-list
2320334|NCT00367978|Benazepril|benazepril|mesh-list
2320335|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2320336|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2320337|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2320338|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320339|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2320340|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320341|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
2320342|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2320343|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
2320344|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320345|NCT00368017|Pioglitazone|pioglitazone|mesh-list
2320346|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320347|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320348|NCT00368030|Eszopiclone|eszopiclone|mesh-list
2320349|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2320350|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2320351|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320352|NCT00368056|Eszopiclone|eszopiclone|mesh-list
2320353|NCT00368056|Zopiclone|zopiclone|mesh-list
2320354|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2320355|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2320356|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320357|NCT00368121|Dexamethasone|dexamethasone|mesh-list
2320358|NCT00368121|Cetuximab|cetuximab|mesh-list
2320359|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2887554|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2887555|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
2887556|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2887557|NCT05054140|Calcium|calcium|mesh-list
2887558|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2887559|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887560|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
2887561|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887562|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887563|NCT05051527|Silymarin|silymarin|mesh-list
2887564|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
2887565|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887566|NCT05051527|Protective Agents|protective agents|mesh-ancestor
2887567|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320360|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
2320361|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
2320362|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320363|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320364|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2320365|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
2320366|NCT00368121|Hormones|hormones|mesh-ancestor
2320367|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320368|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2320369|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320370|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2320371|NCT00368134|Vildagliptin|vildagliptin|mesh-list
2320372|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320373|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320374|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2320375|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
2320376|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320377|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887583|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
2887584|NCT05036681|Futibatinib|futibatinib|mesh-list
2887585|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887586|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887587|NCT05035836|Tamoxifen|tamoxifen|mesh-list
2887588|NCT05035836|Letrozole|letrozole|mesh-list
2887589|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887590|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2320378|NCT00368160|Eszopiclone|eszopiclone|mesh-list
2320379|NCT00368160|Zopiclone|zopiclone|mesh-list
2320380|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2320381|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2320382|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320383|NCT00368238|Aspirin|aspirin|mesh-list
2320384|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
2320385|NCT00368238|Clopidogrel|clopidogrel|mesh-list
2887591|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2887592|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887593|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887594|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2887595|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
2887596|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2887597|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887598|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2887599|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2887600|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2887601|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2320386|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2320387|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2320388|NCT00368238|Analgesics|analgesics|mesh-ancestor
2320389|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
2320390|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320391|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320392|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320393|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2320394|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2320395|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2320396|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320397|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2320398|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2320399|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320400|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
2887623|NCT05031494|Gemcitabine|gemcitabine|mesh-list
2887624|NCT05031494|Paclitaxel|paclitaxel|mesh-list
2887625|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2887626|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887627|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
2887628|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
2887629|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
2887630|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887631|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2887632|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
2887633|NCT05031494|Antiviral Agents|antiviral agents|mesh-ancestor
2887634|NCT05031494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2887635|NCT05031494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887636|NCT05031494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2887637|NCT05031494|Immunologic Factors|immunologic factors|mesh-ancestor
2887638|NCT05031494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887643|NCT05029921|Ustekinumab|ustekinumab|mesh-list
2887644|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
2887645|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2320401|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2320402|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2320403|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2320404|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
2320405|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320406|NCT00368238|Hematinics|hematinics|mesh-ancestor
2320407|NCT00368264|Infliximab|infliximab|mesh-list
2320408|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
2320409|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2320410|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2887646|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
2887647|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2887648|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
2887649|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2887650|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887651|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2887652|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2887653|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320411|NCT00368303|Paroxetine|paroxetine|mesh-list
2320412|NCT00368303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2320413|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2320414|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2320415|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320416|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320417|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
2320418|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320419|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2320420|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
2320421|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2320422|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2320423|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2320424|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320425|NCT00368329|Carboplatin|carboplatin|mesh-list
2320426|NCT00368329|Fluorouracil|fluorouracil|mesh-list
2320427|NCT00368329|Capecitabine|capecitabine|mesh-list
2320428|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2320429|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320430|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
2320431|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887679|NCT05027633|Carboplatin|carboplatin|mesh-list
2320432|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2320433|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2320434|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
2320435|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320436|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2320437|NCT00368342|Azithromycin|azithromycin|mesh-list
2320438|NCT00368342|Clarithromycin|clarithromycin|mesh-list
2320439|NCT00368342|Erythromycin|erythromycin|mesh-list
2320440|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
2320441|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2320442|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
2320443|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2320444|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320445|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2887680|NCT05027633|Docetaxel|docetaxel|mesh-list
2887681|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
2887682|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887683|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
2887684|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
2887685|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
2887686|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887687|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887701|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
2887702|NCT05014776|Ipilimumab|ipilimumab|mesh-list
2887703|NCT05014776|Tadalafil|tadalafil|mesh-list
2887704|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887705|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887706|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2887707|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887708|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
2887709|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2887710|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2887711|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887712|NCT05014776|Urological Agents|urological agents|mesh-ancestor
2887719|NCT05012943|Vaccines|vaccines|mesh-list
2887720|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
2887721|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887725|NCT05008484|Vitamin D|vitamin d|mesh-list
2320446|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320447|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320448|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2320449|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2320450|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2320451|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
2320452|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320453|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
2320454|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320455|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320456|NCT00368498|Teicoplanin|teicoplanin|mesh-list
2320457|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2320458|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320459|NCT00368589|Atorvastatin|atorvastatin|mesh-list
2887726|NCT05008484|Vitamins|vitamins|mesh-ancestor
2887727|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
2320460|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2320461|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2320462|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
2320463|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320464|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2320465|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2320466|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320467|NCT00368602|Timolol|timolol|mesh-list
2320468|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2887728|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887729|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2887748|NCT05003089|Prednisolone|prednisolone|mesh-list
2887749|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2887750|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
2887751|NCT05003089|Hormones|hormones|mesh-ancestor
2887752|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320469|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
2320470|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
2320471|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320472|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320473|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320474|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2320475|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2320476|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
2320477|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2320478|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2320479|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2320480|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
2320481|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320482|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320483|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320484|NCT00368706|Urological Agents|urological agents|mesh-ancestor
2320485|NCT00368719|Tacrolimus|tacrolimus|mesh-list
2320486|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2320487|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
2320488|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320489|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2320490|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887753|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887754|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2887755|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887756|NCT05000710|Durvalumab|durvalumab|mesh-list
2887757|NCT05000710|Tremelimumab|tremelimumab|mesh-list
2887758|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887759|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887760|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
2320491|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320492|NCT00368862|Memantine|memantine|mesh-list
2320493|NCT00368862|Citalopram|citalopram|mesh-list
2320494|NCT00368862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2320495|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2887761|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887762|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887763|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
2887764|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
2887765|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887768|NCT04993677|Carboplatin|carboplatin|mesh-list
2887769|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
2887770|NCT04993677|Pemetrexed|pemetrexed|mesh-list
2887771|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887772|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887773|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887774|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887775|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2887776|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2887777|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
2887778|NCT04989803|Fludarabine|fludarabine|mesh-list
2887779|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2887780|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
2887781|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887782|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2887783|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2887784|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
2887785|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887786|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887787|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2887793|NCT04987203|Nivolumab|nivolumab|mesh-list
2887794|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887795|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887796|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2887797|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320496|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2320497|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320498|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320499|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
2320500|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320501|NCT00368862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2320502|NCT00368862|Antidepressive Agents|antidepressive agents|mesh-ancestor
2320503|NCT00368862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2320504|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2320505|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2320506|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
2887812|NCT04967508|Ustekinumab|ustekinumab|mesh-list
2887813|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
2887814|NCT04967248|Fulvestrant|fulvestrant|mesh-list
2887815|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2887816|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887817|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2887818|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2887819|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
2320507|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2320508|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2320509|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
2320510|NCT00368901|Hematinics|hematinics|mesh-ancestor
2320511|NCT00368914|Sirolimus|sirolimus|mesh-list
2320512|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2320513|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320514|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2887820|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2887821|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320515|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320516|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
2320517|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2320518|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
2320519|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320520|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2320521|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2887829|NCT04965519|Trastuzumab|trastuzumab|mesh-list
2887830|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887831|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887834|NCT04958226|Midazolam|midazolam|mesh-list
2887835|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2887836|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2887837|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2887838|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887839|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2887840|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2887841|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2887842|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2887843|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
2887844|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
2887845|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
2887846|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
2887847|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2887848|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320522|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2320523|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
2320524|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
2320525|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2320526|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
2320527|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320528|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2320529|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320530|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
2320531|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320532|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
2320533|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2320534|NCT00369031|Protective Agents|protective agents|mesh-ancestor
2320535|NCT00369044|Prednisone|prednisone|mesh-list
2320536|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320537|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
2320538|NCT00369044|Hormones|hormones|mesh-ancestor
2320539|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320540|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320541|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2320542|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320543|NCT00369070|Paclitaxel|paclitaxel|mesh-list
2320544|NCT00369070|Bevacizumab|bevacizumab|mesh-list
2320545|NCT00369070|Carboplatin|carboplatin|mesh-list
2320546|NCT00369070|Motesanib diphosphate|motesanib diphosphate|mesh-list
2320547|NCT00369070|Imetelstat|imetelstat|mesh-list
2320548|NCT00369070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2320549|NCT00369070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320550|NCT00369070|Tubulin Modulators|tubulin modulators|mesh-ancestor
2320551|NCT00369070|Antimitotic Agents|antimitotic agents|mesh-ancestor
2320552|NCT00369070|Mitosis Modulators|mitosis modulators|mesh-ancestor
2320553|NCT00369070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320554|NCT00369070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2320555|NCT00369070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2320556|NCT00369070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2320557|NCT00369070|Growth Substances|growth substances|mesh-ancestor
2887852|NCT04952389|Budesonide|budesonide|mesh-list
2887853|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2887854|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2887855|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
2887856|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2887857|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887858|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2887859|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
2887860|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
2887861|NCT04952389|Hormones|hormones|mesh-ancestor
2887862|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2887895|NCT04943848|Iodine|iodine|mesh-list
2887896|NCT04943848|Vaccines|vaccines|mesh-list
2887897|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
2887898|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887899|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2887900|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2887901|NCT04943848|Trace Elements|trace elements|mesh-ancestor
2887902|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
2887903|NCT04943549|Bupivacaine|bupivacaine|mesh-list
2887904|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
2887905|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
2887906|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2887907|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2887908|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
2887909|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320558|NCT00369070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320559|NCT00369070|Growth Inhibitors|growth inhibitors|mesh-ancestor
2320560|NCT00369070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2320561|NCT00369070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320562|NCT00369096|Bemiparin|bemiparin|mesh-list
2320563|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
2887919|NCT04935229|Nivolumab|nivolumab|mesh-list
2320564|NCT00369148|Nateglinide|nateglinide|mesh-list
2320565|NCT00369148|Mitiglinide|mitiglinide|mesh-list
2887920|NCT04935229|Ipilimumab|ipilimumab|mesh-list
2887921|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2887922|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887923|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2887924|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887967|NCT04931667|Lorecivivint|lorecivivint|mesh-list
2887968|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2887969|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
2887970|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2887971|NCT04927975|Upadacitinib|upadacitinib|mesh-list
2887972|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2887973|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2887974|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2887975|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2887976|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2320566|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320567|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320568|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
2320569|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320570|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888005|NCT04915248|Dexamethasone|dexamethasone|mesh-list
2888006|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
2888007|NCT04915248|Bortezomib|bortezomib|mesh-list
2888008|NCT04915248|Daratumumab|daratumumab|mesh-list
2888009|NCT04915248|BB 1101|bb 1101|mesh-list
2888010|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2888011|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2888012|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
2888013|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
2888014|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2888015|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320571|NCT00369239|Risperidone|risperidone|mesh-list
2320572|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2320573|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
2320574|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2888016|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2888017|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
2888018|NCT04915248|Hormones|hormones|mesh-ancestor
2888019|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2888020|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2888021|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888022|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
2888023|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888024|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888025|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
2888034|NCT04912115|Midazolam|midazolam|mesh-list
2888035|NCT04912115|Ketamine|ketamine|mesh-list
2888036|NCT04912115|Analgesics|analgesics|mesh-ancestor
2888037|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
2888038|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2888039|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888040|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2888041|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2888042|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
2888043|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
2888044|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2888045|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2888046|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2320575|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320576|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320577|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2320578|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2320579|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2320580|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2320581|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2320582|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
2888047|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2888048|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888049|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2888050|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2888051|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2888052|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2888053|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2320583|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
2320584|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2320585|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320586|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2320587|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2320588|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
2888054|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
2888055|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
2320589|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320590|NCT00369356|Prednisone|prednisone|mesh-list
2320591|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320592|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
2320593|NCT00369356|Hormones|hormones|mesh-ancestor
2320594|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320595|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320596|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2320597|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320598|NCT00369395|Volociximab|volociximab|mesh-list
2320599|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2320600|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2320601|NCT00369395|Growth Substances|growth substances|mesh-ancestor
2320602|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320603|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
2320604|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320605|NCT00369408|Naltrexone|naltrexone|mesh-list
2320606|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2320607|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2320608|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320609|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
2320610|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320611|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2320612|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2320613|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2320614|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2320615|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320616|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320617|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320618|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
2320619|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2320620|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
2320621|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2320622|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320623|NCT00369473|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2320624|NCT00369473|Immunologic Factors|immunologic factors|mesh-ancestor
2888099|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
2888100|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
2888101|NCT04903197|Lenalidomide|lenalidomide|mesh-list
2888102|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
2888103|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888104|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2888105|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2888106|NCT04903197|Growth Substances|growth substances|mesh-ancestor
2888107|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
2888108|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888109|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2888110|NCT04902131|Menotropins|menotropins|mesh-list
2888111|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2888112|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
2888113|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2888114|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888115|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
2888116|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2888169|NCT04893291|Sirolimus|sirolimus|mesh-list
2888170|NCT04893291|Everolimus|everolimus|mesh-list
2320625|NCT00369473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320626|NCT00369538|Losartan|losartan|mesh-list
2320627|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2320628|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2320629|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2320630|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2320631|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2320632|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320633|NCT00369538|Diuretics|diuretics|mesh-ancestor
2320634|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
2320635|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888171|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888172|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2888173|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
2888174|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888175|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2888176|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2888177|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2888178|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
2888179|NCT04893109|Paclitaxel|paclitaxel|mesh-list
2888180|NCT04893109|Maytansine|maytansine|mesh-list
2888181|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2888182|NCT04893109|Trastuzumab|trastuzumab|mesh-list
2888183|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2888184|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888185|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
2888186|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
2888187|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
2888188|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888189|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2888212|NCT04889599|Docetaxel|docetaxel|mesh-list
2888213|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888214|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
2888215|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
2888216|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
2888217|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320636|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2320637|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2320638|NCT00369551|Paclitaxel|paclitaxel|mesh-list
2320639|NCT00369551|Bevacizumab|bevacizumab|mesh-list
2320640|NCT00369551|Carboplatin|carboplatin|mesh-list
2320641|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2320642|NCT00369551|Antibodies|antibodies|mesh-list
2320643|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
2320644|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2320645|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2320646|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320647|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
2320648|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
2320649|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
2320650|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320651|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2320652|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2888267|NCT04877587|Gemcitabine|gemcitabine|mesh-list
2888268|NCT04877587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888269|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2888270|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
2888271|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888272|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888273|NCT04877587|Antiviral Agents|antiviral agents|mesh-ancestor
2888274|NCT04877587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2888275|NCT04877587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888276|NCT04877587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2888277|NCT04877587|Immunologic Factors|immunologic factors|mesh-ancestor
2888278|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
2888279|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2888280|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
2888281|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320653|NCT00369551|Growth Substances|growth substances|mesh-ancestor
2888304|NCT04851613|Fulvestrant|fulvestrant|mesh-list
2888305|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2888306|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888307|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2888308|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2888309|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
2888310|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2888311|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888317|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
2888318|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
2888319|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320654|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320655|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
2320656|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
2320657|NCT00369603|Donepezil|donepezil|mesh-list
2320658|NCT00369603|Galantamine|galantamine|mesh-list
2320659|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2320660|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320661|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320662|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
2320663|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320664|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320665|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
2320666|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2320667|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
2320668|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320669|NCT00369694|Terlipressin|terlipressin|mesh-list
2320670|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2320671|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2320672|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
2320673|NCT00369733|Hematinics|hematinics|mesh-ancestor
2320674|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
2320675|NCT00369772|Hematinics|hematinics|mesh-ancestor
2320676|NCT00369798|Rolipram|rolipram|mesh-list
2320677|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
2320678|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2320679|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2320680|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2320681|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320682|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320683|NCT00369811|Fentanyl|fentanyl|mesh-list
2320684|NCT00369811|Oxycodone|oxycodone|mesh-list
2320685|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2320686|NCT00369811|Narcotics|narcotics|mesh-ancestor
2320687|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2320688|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320689|NCT00369811|Analgesics|analgesics|mesh-ancestor
2320690|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
2320691|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320692|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2320693|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2888320|NCT04842422|Imiquimod|imiquimod|mesh-list
2888321|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2888322|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
2888323|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888324|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888325|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
2888326|NCT04840641|Efavirenz|efavirenz|mesh-list
2888327|NCT04840641|Floxacillin|floxacillin|mesh-list
2888328|NCT04840641|Losartan|losartan|mesh-list
2888329|NCT04840641|Metoprolol|metoprolol|mesh-list
2888330|NCT04840641|Midazolam|midazolam|mesh-list
2888331|NCT04840641|Caffeine|caffeine|mesh-list
2888332|NCT04840641|Omeprazole|omeprazole|mesh-list
2888333|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2888334|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2888335|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2888336|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888337|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2888338|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2888339|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2888340|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2888341|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
2888342|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
2888343|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
2888344|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
2888345|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2888346|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888347|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2888348|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2888349|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2888350|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2888351|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2888352|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2888353|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2320694|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
2320695|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
2320696|NCT00369837|Clevidipine|clevidipine|mesh-list
2320697|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2320698|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2320699|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320700|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2320701|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320702|NCT00369863|Triamcinolone|triamcinolone|mesh-list
2320703|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2320704|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2320705|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2320706|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320707|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
2320708|NCT00369863|Hormones|hormones|mesh-ancestor
2320709|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320710|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888354|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888355|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2888356|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2888357|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2888358|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2888359|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
2888360|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2888361|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2888362|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
2888363|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2888364|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2888365|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2888366|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2888367|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2888368|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2888369|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2888370|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
2888371|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
2888372|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320711|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2320712|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
2320713|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320714|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888373|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2888374|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2888375|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2888376|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
2888377|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2888384|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
2888385|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
2888386|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
2888387|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2888388|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888389|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
2888390|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2888391|NCT04835805|Atezolizumab|atezolizumab|mesh-list
2888392|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888393|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
2888394|NCT04827992|Narcotics|narcotics|mesh-ancestor
2888395|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2888396|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888397|NCT04827992|Analgesics|analgesics|mesh-ancestor
2888398|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
2888399|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320715|NCT00369889|Bevacizumab|bevacizumab|mesh-list
2320716|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2320717|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2320718|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320719|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2320720|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2320721|NCT00369889|Growth Substances|growth substances|mesh-ancestor
2320722|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320723|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
2320724|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2320725|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320726|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320727|NCT00369954|Gemcitabine|gemcitabine|mesh-list
2320728|NCT00369954|Carboplatin|carboplatin|mesh-list
2320729|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320730|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2320731|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
2320732|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320733|NCT00369954|Antiviral Agents|antiviral agents|mesh-ancestor
2320734|NCT00369954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2320735|NCT00369954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320736|NCT00369954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2320737|NCT00369954|Immunologic Factors|immunologic factors|mesh-ancestor
2320738|NCT00369954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320739|NCT00369993|Fluticasone|fluticasone|mesh-list
2320740|NCT00369993|Xhance|xhance|mesh-list
2320741|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2320742|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320743|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2320744|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
2320745|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320746|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320747|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2320748|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
2888421|NCT04809285|Insulin|insulin|mesh-list
2888422|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320749|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
2320750|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2320751|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2320752|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2320753|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2320754|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
2320755|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2888423|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888424|NCT04808843|Dienogest|dienogest|mesh-list
2888425|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2888426|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
2888427|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2888428|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888429|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2888430|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2888431|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2888432|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2888433|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
2888434|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2888435|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2888436|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888439|NCT04803877|Nivolumab|nivolumab|mesh-list
2888440|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2888441|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888442|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2888443|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888444|NCT04802863|Imipenem|imipenem|mesh-list
2888445|NCT04802863|Cilastatin|cilastatin|mesh-list
2888446|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2888447|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2888448|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
2888449|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888450|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888451|NCT04802759|Trastuzumab|trastuzumab|mesh-list
2888452|NCT04802759|Pertuzumab|pertuzumab|mesh-list
2888453|NCT04802759|Everolimus|everolimus|mesh-list
2888454|NCT04802759|Palbociclib|palbociclib|mesh-list
2888455|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2888456|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888457|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2888458|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
2888459|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888460|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2888461|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888462|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888463|NCT04802746|Alprazolam|alprazolam|mesh-list
2888464|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2888465|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2888466|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888467|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2888468|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2888469|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2888470|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
2888471|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
2888472|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2888473|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888474|NCT04801043|Imipenem|imipenem|mesh-list
2888475|NCT04801043|Cilastatin|cilastatin|mesh-list
2888476|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2888477|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2888478|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
2888479|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888480|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888486|NCT04795245|Afatinib|afatinib|mesh-list
2888487|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888488|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2888489|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888490|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888491|NCT04794569|Tinzaparin|tinzaparin|mesh-list
2888492|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2888493|NCT04794569|Dalteparin|dalteparin|mesh-list
2888494|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
2888495|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2888496|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
2888497|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2888498|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
2888499|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888500|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888501|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
2888502|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2888503|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2888504|NCT04791176|Lenvatinib|lenvatinib|mesh-list
2888505|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888506|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2888507|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888508|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888509|NCT04790903|Prednisone|prednisone|mesh-list
2888510|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
2320756|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320757|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2320758|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
2320759|NCT00370019|Estradiol|estradiol|mesh-list
2320760|NCT00370019|Estrogens|estrogens|mesh-ancestor
2320761|NCT00370019|Hormones|hormones|mesh-ancestor
2320762|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320763|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320764|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2320765|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
2888511|NCT04790903|Rituximab|rituximab|mesh-list
2888512|NCT04790903|Doxorubicin|doxorubicin|mesh-list
2888513|NCT04790903|Venetoclax|venetoclax|mesh-list
2888514|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2888515|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
2888516|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888517|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2888518|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2888519|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
2888520|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888521|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888522|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2888523|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2888524|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2888525|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2888526|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2888527|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888528|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2888529|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
2888530|NCT04790903|Hormones|hormones|mesh-ancestor
2888531|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2888532|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2888533|NCT04787562|Imipenem|imipenem|mesh-list
2888534|NCT04787562|Cilastatin|cilastatin|mesh-list
2888535|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2888536|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2888537|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
2888538|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888539|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888540|NCT04786756|Bupivacaine|bupivacaine|mesh-list
2888541|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
2888542|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
2888543|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2888544|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888545|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
2320766|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2888546|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2888547|NCT04785300|Dasatinib|dasatinib|mesh-list
2888548|NCT04785300|Quercetin|quercetin|mesh-list
2888549|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888550|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2888551|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888552|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888553|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
2888554|NCT04785300|Protective Agents|protective agents|mesh-ancestor
2888555|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888556|NCT04784715|Trastuzumab|trastuzumab|mesh-list
2888557|NCT04784715|Pertuzumab|pertuzumab|mesh-list
2320767|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2320768|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2320769|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2320770|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2320771|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2888558|NCT04784715|Taxane|taxane|mesh-list
2888559|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2888560|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320772|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2320773|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320774|NCT00370045|Bivalirudin|bivalirudin|mesh-list
2320775|NCT00370045|Eptifibatide|eptifibatide|mesh-list
2320776|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
2320777|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2320778|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
2320779|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320780|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320781|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
2320782|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2320783|NCT00370097|Fluticasone|fluticasone|mesh-list
2320784|NCT00370097|Xhance|xhance|mesh-list
2888579|NCT04782791|Nivolumab|nivolumab|mesh-list
2888580|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2888581|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320785|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320786|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2320787|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
2320788|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320789|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888582|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2888583|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888587|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
2888588|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
2888589|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888590|NCT04777643|Cannabidiol|cannabidiol|mesh-list
2888591|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
2320790|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2320791|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
2320792|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
2320793|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2320794|NCT00370188|Topiramate|topiramate|mesh-list
2320795|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
2320796|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320797|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320798|NCT00370201|Colchicine|colchicine|mesh-list
2320799|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
2320800|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2320801|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
2320802|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
2320803|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
2320804|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320805|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320806|NCT00370240|Ropivacaine|ropivacaine|mesh-list
2320807|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
2320808|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
2320809|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2320810|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320811|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
2320812|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320813|NCT00370253|Terlipressin|terlipressin|mesh-list
2320814|NCT00370253|Norepinephrine|norepinephrine|mesh-list
2320815|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2320816|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2320817|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2320818|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2320819|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
2320820|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320821|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320822|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320823|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
2320824|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
2320825|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109252|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109253|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2109254|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
2109255|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
2109256|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2109257|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2109258|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2109259|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2109260|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
2109261|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109262|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109263|NCT02517021|Dexamethasone|dexamethasone|mesh-list
2109264|NCT02517021|Palonosetron|palonosetron|mesh-list
2109265|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109266|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
2109267|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
2109268|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109269|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109270|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2109271|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
2109272|NCT02517021|Hormones|hormones|mesh-ancestor
2109273|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109274|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2109275|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109276|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2109277|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2109278|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
2109279|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109280|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109281|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
2109282|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2109283|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
2109284|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2109285|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109286|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2109287|NCT02517515|Ritonavir|ritonavir|mesh-list
2109288|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2109289|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2109290|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
2109291|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888600|NCT04776018|Daratumumab|daratumumab|mesh-list
2888601|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888606|NCT04768426|Capecitabine|capecitabine|mesh-list
2888607|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2888608|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
2888609|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888610|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888611|NCT04766086|Vaccines|vaccines|mesh-list
2888612|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
2888613|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888614|NCT04762836|Cycloserine|cycloserine|mesh-list
2888615|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2888616|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2888617|NCT04762836|Renal Agents|renal agents|mesh-ancestor
2888618|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2888619|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
2888620|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2888621|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
2888622|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888623|NCT04760626|Insulin|insulin|mesh-list
2888624|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2888625|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
2888626|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2888627|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888628|NCT04759833|Prucalopride|prucalopride|mesh-list
2888629|NCT04759833|Laxatives|laxatives|mesh-ancestor
2888630|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2888631|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2888632|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2888633|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
2888634|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2888635|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888636|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888693|NCT04758949|Nivolumab|nivolumab|mesh-list
2888694|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2320826|NCT00370266|Triamcinolone|triamcinolone|mesh-list
2320827|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320828|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
2320829|NCT00370266|Hormones|hormones|mesh-ancestor
2320830|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320831|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320832|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
2320833|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320834|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320835|NCT00370318|Acetaminophen|acetaminophen|mesh-list
2320836|NCT00370318|Vaccines|vaccines|mesh-list
2320837|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2888695|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888696|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2888697|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888698|NCT04756037|Relugolix|relugolix|mesh-list
2888699|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
2109292|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109293|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2109294|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2109295|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
2109296|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2109297|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2109298|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2109299|NCT02517528|Ritonavir|ritonavir|mesh-list
2109300|NCT02517528|Ribavirin|ribavirin|mesh-list
2109301|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2109302|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2109303|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
2320838|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
2320839|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320840|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2320841|NCT00370318|Analgesics|analgesics|mesh-ancestor
2320842|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
2320843|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320844|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
2320845|NCT00370370|Triamcinolone|triamcinolone|mesh-list
2320846|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2320847|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2320848|NCT00370370|Bevacizumab|bevacizumab|mesh-list
2320849|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2320850|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2320851|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320852|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2320853|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2320854|NCT00370370|Growth Substances|growth substances|mesh-ancestor
2888700|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
2888701|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2888702|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320855|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320856|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
2888709|NCT04750395|Haloperidol|haloperidol|mesh-list
2888710|NCT04750395|Olanzapine|olanzapine|mesh-list
2888711|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
2888712|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
2888713|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
2888714|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2888715|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888716|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2888717|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2888718|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2888719|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2888720|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2888721|NCT04750395|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2888722|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2888723|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2888724|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888725|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2888726|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
2888727|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2888728|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
2888729|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2888738|NCT04743661|Antipyretics|antipyretics|mesh-list
2888739|NCT04743661|Dexamethasone|dexamethasone|mesh-list
2888740|NCT04743661|Bevacizumab|bevacizumab|mesh-list
2888741|NCT04743661|Irinotecan|irinotecan|mesh-list
2888742|NCT04743661|Temozolomide|temozolomide|mesh-list
2888743|NCT04743661|Antiemetics|antiemetics|mesh-list
2888744|NCT04743661|Emetics|emetics|mesh-list
2888745|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
2888746|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2888747|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2888748|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888749|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2888750|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2888751|NCT04743661|Growth Substances|growth substances|mesh-ancestor
2888752|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888753|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
2888754|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2888755|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
2888756|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2888757|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2888758|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
2888759|NCT04743661|Hormones|hormones|mesh-ancestor
2888760|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2888761|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2888762|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2888763|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2888764|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888765|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888766|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2888767|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
2888768|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
2888769|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2888775|NCT04740918|Trastuzumab|trastuzumab|mesh-list
2888776|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2888777|NCT04740918|Atezolizumab|atezolizumab|mesh-list
2888778|NCT04740918|Maytansine|maytansine|mesh-list
2888779|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2888780|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888781|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2888782|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
2888783|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
2888784|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
2888785|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320857|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320858|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
2320859|NCT00370370|Hormones|hormones|mesh-ancestor
2320860|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320861|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2320862|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
2320863|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320864|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320865|NCT00370383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2320866|NCT00370383|Satraplatin|satraplatin|mesh-list
2320867|NCT00370383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320868|NCT00370383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2320869|NCT00370383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320870|NCT00370383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320871|NCT00370422|Triamcinolone|triamcinolone|mesh-list
2320872|NCT00370422|Bevacizumab|bevacizumab|mesh-list
2320873|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2320874|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320875|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2320876|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2320877|NCT00370422|Growth Substances|growth substances|mesh-ancestor
2320878|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320879|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
2320880|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320881|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
2320882|NCT00370422|Hormones|hormones|mesh-ancestor
2320883|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320884|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2320885|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
2320886|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2320887|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2320888|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2320889|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2320890|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320891|NCT00370539|Triamcinolone|triamcinolone|mesh-list
2320892|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2320893|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2320894|NCT00370539|Bevacizumab|bevacizumab|mesh-list
2320895|NCT00370539|Verteporfin|verteporfin|mesh-list
2320896|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2320897|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2320898|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320899|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2320900|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2320901|NCT00370539|Growth Substances|growth substances|mesh-ancestor
2320902|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320903|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
2888814|NCT04739735|Anesthetics|anesthetics|mesh-list
2888815|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2888816|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888817|NCT04739150|Nintedanib|nintedanib|mesh-list
2888818|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888819|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2888820|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888821|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888829|NCT04735965|Meperidine|meperidine|mesh-list
2888830|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
2320904|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320905|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
2320906|NCT00370539|Hormones|hormones|mesh-ancestor
2320907|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320908|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2320909|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
2320910|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2320911|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320912|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2320913|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
2320914|NCT00370565|Insulin|insulin|mesh-list
2320915|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2320916|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320917|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320918|NCT00370591|Fluticasone|fluticasone|mesh-list
2320919|NCT00370591|Xhance|xhance|mesh-list
2320920|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2320921|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320922|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2320923|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
2320924|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320925|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320926|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2320927|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
2320928|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
2320929|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2320930|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2320931|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2320932|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2320933|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
2888831|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2888832|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2888833|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320934|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320935|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320936|NCT00370617|Metformin|metformin|mesh-list
2320937|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320938|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320939|NCT00370630|Triamcinolone|triamcinolone|mesh-list
2320940|NCT00370630|Bevacizumab|bevacizumab|mesh-list
2888834|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2888835|NCT04735965|Analgesics|analgesics|mesh-ancestor
2888836|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
2888837|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2888838|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2888839|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2888840|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2888841|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
2888842|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2888843|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888844|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2888845|NCT04735965|Narcotics|narcotics|mesh-ancestor
2888846|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2888847|NCT04734535|Thrombin|thrombin|mesh-list
2888848|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
2888849|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
2888850|NCT04734535|Coagulants|coagulants|mesh-ancestor
2888851|NCT04734379|Fasudil|fasudil|mesh-list
2888852|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2888853|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2888854|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888855|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2888856|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888857|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
2888858|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2320941|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2320942|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320943|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2320944|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2888859|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888860|NCT04734197|Cyclosporine|cyclosporine|mesh-list
2888861|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
2888862|NCT04734197|Betamethasone|betamethasone|mesh-list
2888863|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
2888864|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2888865|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
2888866|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2888867|NCT04734197|Lifitegrast|lifitegrast|mesh-list
2888868|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2888869|NCT04734197|Cyclosporins|cyclosporins|mesh-list
2888870|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2888871|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888872|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2320945|NCT00370630|Growth Substances|growth substances|mesh-ancestor
2320946|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320947|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
2320948|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320949|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
2320950|NCT00370630|Hormones|hormones|mesh-ancestor
2320951|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320952|NCT00370643|Insulin|insulin|mesh-list
2320953|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2320954|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320955|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320956|NCT00370656|Pregabalin|pregabalin|mesh-list
2320957|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2320958|NCT00370656|Amitriptyline|amitriptyline|mesh-list
2320959|NCT00370656|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2320960|NCT00370656|Analgesics|analgesics|mesh-ancestor
2320961|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
2320962|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2320963|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320964|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
2320965|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2320966|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2320967|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888873|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2888874|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
2888875|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888876|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
2888877|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2888878|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
2888879|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2888880|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2888881|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2888882|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
2888883|NCT04734197|Hormones|hormones|mesh-ancestor
2888884|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320968|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2320969|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2320970|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2320971|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2320972|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2888885|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2888886|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
2888887|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2888888|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888889|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2888890|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
2888891|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2888892|NCT04731272|Dulaglutide|dulaglutide|mesh-list
2888893|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2320973|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2320974|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2320975|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2320976|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
2320977|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
2320978|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2320979|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2320980|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2320981|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
2320982|NCT00370656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2320983|NCT00370669|Triamcinolone|triamcinolone|mesh-list
2320984|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2320985|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2320986|NCT00370669|Bevacizumab|bevacizumab|mesh-list
2320987|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2320988|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2888894|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888895|NCT04730037|Warfarin|warfarin|mesh-list
2888896|NCT04730037|Edoxaban|edoxaban|mesh-list
2888897|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
2888898|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2888899|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
2888900|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2888901|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
2888902|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888903|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888919|NCT04714190|Paclitaxel|paclitaxel|mesh-list
2888920|NCT04714190|Irinotecan|irinotecan|mesh-list
2888921|NCT04714190|Apatinib|apatinib|mesh-list
2888922|NCT04714190|Trastuzumab|trastuzumab|mesh-list
2888923|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2888924|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888925|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
2888926|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
2888927|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
2888928|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888929|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2888930|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2888931|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888932|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2888933|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2888934|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
2888935|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2888936|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2888937|NCT04704999|Chloroquine|chloroquine|mesh-list
2888938|NCT04704999|Lumefantrine|lumefantrine|mesh-list
2888939|NCT04704999|Artemether|artemether|mesh-list
2888940|NCT04704999|Tafenoquine|tafenoquine|mesh-list
2888941|NCT04704999|Amebicides|amebicides|mesh-ancestor
2888942|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2888943|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2888944|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2888945|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
2320989|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2320990|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2320991|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2320992|NCT00370669|Growth Substances|growth substances|mesh-ancestor
2320993|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2320994|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
2320995|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2320996|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
2888946|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2888947|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
2888948|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2888949|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
2888950|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888951|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
2888952|NCT04702802|Protective Agents|protective agents|mesh-ancestor
2888953|NCT04702789|Timolol|timolol|mesh-list
2888954|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2888955|NCT04702789|Dorzolamide|dorzolamide|mesh-list
2888956|NCT04702789|Latanoprost|latanoprost|mesh-list
2888957|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2888958|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2888959|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
2888960|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2888961|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2888962|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888963|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2888964|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2320997|NCT00370669|Hormones|hormones|mesh-ancestor
2320998|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2320999|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2321000|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
2321001|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321002|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321003|NCT00370721|Bevacizumab|bevacizumab|mesh-list
2321004|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2321005|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321006|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2321007|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2321008|NCT00370721|Growth Substances|growth substances|mesh-ancestor
2321009|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321010|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
2321011|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
2321012|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2321013|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2321014|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2321015|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2321016|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321017|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
2321018|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321019|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888965|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2888966|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2888967|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2888968|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2888969|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2888970|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2888971|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2888972|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
2888973|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2888974|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
2888975|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888976|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
2888977|NCT04702776|Protective Agents|protective agents|mesh-ancestor
2888978|NCT04699422|Pirinitramide|pirinitramide|mesh-list
2888979|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2888980|NCT04699422|Narcotics|narcotics|mesh-ancestor
2888981|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2888982|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2888983|NCT04699422|Analgesics|analgesics|mesh-ancestor
2888984|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
2888985|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321020|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2321021|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321022|NCT00370747|Ecabet|ecabet|mesh-list
2321023|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321024|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2321025|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2321026|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
2321027|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321028|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321029|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2321030|NCT00370747|Protective Agents|protective agents|mesh-ancestor
2321031|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321032|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321033|NCT00370760|Dexamethasone|dexamethasone|mesh-list
2321034|NCT00370760|Colchicine|colchicine|mesh-list
2321035|NCT00370760|Heparin|heparin|mesh-list
2321036|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2321037|NCT00370760|Tinzaparin|tinzaparin|mesh-list
2321038|NCT00370760|Dalteparin|dalteparin|mesh-list
2321039|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2321040|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
2321041|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
2321042|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321043|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321044|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2321045|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
2321046|NCT00370760|Hormones|hormones|mesh-ancestor
2321047|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2321048|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2321049|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321050|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
2321051|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2321052|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2321053|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321054|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
2321055|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2321056|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
2321057|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
2321058|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
2321059|NCT00370786|Bevacizumab|bevacizumab|mesh-list
2321060|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2321061|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321062|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2321063|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2321064|NCT00370786|Growth Substances|growth substances|mesh-ancestor
2321065|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321066|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
2321067|NCT00370799|Betamethasone|betamethasone|mesh-list
2321068|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
2321069|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2321070|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
2889011|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
2889012|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2889013|NCT04686773|Vaccines|vaccines|mesh-list
2889014|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
2889015|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889016|NCT04684953|Hormones|hormones|mesh-list
2889017|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2889018|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889019|NCT04683614|Norepinephrine|norepinephrine|mesh-list
2889020|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2889021|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2889022|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
2889023|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2889024|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321071|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2889025|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889026|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
2889027|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
2889028|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889029|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2889030|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2889031|NCT04674020|Erenumab|erenumab|mesh-list
2889032|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2889033|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889034|NCT04674020|Analgesics|analgesics|mesh-ancestor
2889035|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
2889036|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889037|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889038|NCT04673786|Ustekinumab|ustekinumab|mesh-list
2889039|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
2889040|NCT04672941|Bromides|bromides|mesh-list
2889041|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
2889042|NCT04672941|Olodaterol|olodaterol|mesh-list
2889043|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2889044|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
2889045|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889046|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889047|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2889048|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
2889049|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
2889050|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2889051|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
2889052|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2889053|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889054|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
2889060|NCT04667637|Edaravone|edaravone|mesh-list
2889061|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2889062|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
2889063|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889064|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2889065|NCT04667637|Protective Agents|protective agents|mesh-ancestor
2889066|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321072|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2321073|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2321074|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
2321075|NCT00370799|Hormones|hormones|mesh-ancestor
2321076|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2321077|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321078|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2321079|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
2321080|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2321081|NCT00370825|Miltefosine|miltefosine|mesh-list
2321082|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
2321083|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2889088|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
2889089|NCT04660799|Promethazine|promethazine|mesh-list
2889090|NCT04660799|Prednisone|prednisone|mesh-list
2889091|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
2889092|NCT04660799|Rituximab|rituximab|mesh-list
2889093|NCT04660799|Doxorubicin|doxorubicin|mesh-list
2889094|NCT04660799|Vincristine|vincristine|mesh-list
2889095|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2889096|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
2889097|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2889098|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
2889099|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889100|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2889101|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2889102|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
2889103|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889104|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889105|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2889106|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2889107|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2889108|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2321084|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2321085|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2321086|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321087|NCT00370851|Bevacizumab|bevacizumab|mesh-list
2321088|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2321089|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321090|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2321091|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2321092|NCT00370851|Growth Substances|growth substances|mesh-ancestor
2321093|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321094|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
2321095|NCT00370890|Gemcitabine|gemcitabine|mesh-list
2321096|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321097|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2321098|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
2321099|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321100|NCT00370890|Antiviral Agents|antiviral agents|mesh-ancestor
2889109|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2889110|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889111|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2889112|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
2889113|NCT04660799|Hormones|hormones|mesh-ancestor
2889114|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2889115|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2889116|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2889117|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
2889118|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
2889119|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
2889120|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
2889121|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889122|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2889123|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2889124|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2889125|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
2889126|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
2889127|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
2889128|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
2889129|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2889130|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
2889131|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2889132|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2889133|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
2889134|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
2889135|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
2889136|NCT04660539|Azathioprine|azathioprine|mesh-list
2889137|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2889138|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889139|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2889140|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
2889141|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2889142|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2889143|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889144|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889145|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
2889146|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2889147|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2889148|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
2889149|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889150|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2889151|NCT04659317|Oxycodone|oxycodone|mesh-list
2889152|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2889153|NCT04659317|Narcotics|narcotics|mesh-ancestor
2889154|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2889155|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889156|NCT04659317|Analgesics|analgesics|mesh-ancestor
2889157|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
2889158|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889159|NCT04659044|Rituximab|rituximab|mesh-list
2889160|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2889161|NCT04659044|Venetoclax|venetoclax|mesh-list
2889162|NCT04659044|Antibodies|antibodies|mesh-list
2889163|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
2889164|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2889165|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
2889166|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
2889167|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889168|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889169|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2889170|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
2889171|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2321101|NCT00370890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321102|NCT00370890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321103|NCT00370890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2321104|NCT00370890|Immunologic Factors|immunologic factors|mesh-ancestor
2321105|NCT00370890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321106|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
2321107|NCT00370968|Astringents|astringents|mesh-ancestor
2321108|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321109|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
2321110|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2321111|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2321112|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321113|NCT00371007|Incretins|incretins|mesh-ancestor
2321114|NCT00371007|Hormones|hormones|mesh-ancestor
2321115|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2889172|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889173|NCT04657081|Decitabine|decitabine|mesh-list
2889174|NCT04657081|Venetoclax|venetoclax|mesh-list
2889175|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2889176|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
2889177|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889178|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889179|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889180|NCT04656652|Docetaxel|docetaxel|mesh-list
2889181|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889182|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
2889183|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
2889184|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
2889185|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889186|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
2889187|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2889188|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889189|NCT04655586|Heparin|heparin|mesh-list
2889190|NCT04655586|Protein C|protein c|mesh-list
2889191|NCT04655586|Anticoagulants|anticoagulants|mesh-list
2889192|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2889193|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2889194|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889203|NCT04641312|Dulaglutide|dulaglutide|mesh-list
2889204|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2889205|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109304|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109305|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109306|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2109307|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2109308|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
2109309|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321116|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2321117|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
2321118|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889222|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
2889223|NCT04637763|Fludarabine|fludarabine|mesh-list
2889224|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2889225|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
2889226|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889227|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2889228|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2889229|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
2889230|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889231|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889232|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2889233|NCT04635423|Vaccines|vaccines|mesh-list
2889234|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
2889235|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321119|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321120|NCT00371020|Heparin|heparin|mesh-list
2321121|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2321122|NCT00371020|Tinzaparin|tinzaparin|mesh-list
2321123|NCT00371020|Dalteparin|dalteparin|mesh-list
2321124|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
2321125|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2321126|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2321127|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321128|NCT00371033|Pregabalin|pregabalin|mesh-list
2321129|NCT00371033|Analgesics|analgesics|mesh-ancestor
2321130|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
2321131|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321132|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321133|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
2321134|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2321135|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2321136|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321137|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2321138|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2321139|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2321140|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2321141|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2321142|NCT00371059|Memantine|memantine|mesh-list
2321143|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2321144|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2321145|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
2321146|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321147|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321148|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889248|NCT04627142|Irinotecan|irinotecan|mesh-list
2321149|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2321150|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2321151|NCT00371072|Mitomycins|mitomycins|mesh-list
2321152|NCT00371072|Mitomycin|mitomycin|mesh-list
2321153|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2889249|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2889250|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2889251|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889252|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889253|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889254|NCT04622319|Trastuzumab|trastuzumab|mesh-list
2889255|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2889256|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2889257|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889258|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
2889259|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
2889260|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
2889261|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889267|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
2889268|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2889269|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
2889270|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889271|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2889272|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889273|NCT04616014|Insulin|insulin|mesh-list
2889274|NCT04616014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2889275|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2889276|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889277|NCT04614363|Edetic Acid|edetic acid|mesh-list
2889278|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2889279|NCT04614363|Anticoagulants|anticoagulants|mesh-ancestor
2889280|NCT04614363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2889281|NCT04614363|Chelating Agents|chelating agents|mesh-ancestor
2889282|NCT04614363|Sequestering Agents|sequestering agents|mesh-ancestor
2889283|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889284|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2889290|NCT04611802|Vaccines|vaccines|mesh-list
2889291|NCT04611802|Immunologic Factors|immunologic factors|mesh-ancestor
2889292|NCT04611802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889293|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
2889294|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
2889295|NCT04611763|Analgesics|analgesics|mesh-ancestor
2889296|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
2889297|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889298|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889299|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2889300|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2889301|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2889302|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2889303|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2889304|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889305|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321154|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321155|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
2321156|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321157|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2321158|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321159|NCT00371098|Vaccines|vaccines|mesh-list
2321160|NCT00371098|Immunologic Factors|immunologic factors|mesh-ancestor
2321161|NCT00371098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321162|NCT00371111|Triamcinolone|triamcinolone|mesh-list
2321163|NCT00371111|Bevacizumab|bevacizumab|mesh-list
2321164|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2321165|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321166|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2321167|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2321168|NCT00371111|Growth Substances|growth substances|mesh-ancestor
2321169|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321170|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
2321171|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2321172|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
2321173|NCT00371111|Hormones|hormones|mesh-ancestor
2321174|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2321175|NCT00371124|Atropine|atropine|mesh-list
2321176|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2321177|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2321178|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2321179|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2321180|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2321181|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
2321182|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321183|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321184|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2321185|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
2321186|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
2321187|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
2321188|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2321189|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2321190|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
2321191|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321192|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321193|NCT00371306|Metformin|metformin|mesh-list
2321194|NCT00371306|Glyburide|glyburide|mesh-list
2321195|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2321196|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321197|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
2321198|NCT00371319|Tacrolimus|tacrolimus|mesh-list
2321199|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2321200|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
2321201|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889338|NCT04608786|Capecitabine|capecitabine|mesh-list
2889339|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2889340|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
2889341|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889342|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321202|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2321203|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321204|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321205|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2321206|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321207|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2321208|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
2889370|NCT04605094|Benralizumab|benralizumab|mesh-list
2889371|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2889372|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
2889373|NCT04603911|Dexamethasone|dexamethasone|mesh-list
2889374|NCT04603911|Clonidine|clonidine|mesh-list
2889375|NCT04603911|Epinephrine|epinephrine|mesh-list
2889376|NCT04603911|Bupivacaine|bupivacaine|mesh-list
2889377|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2889378|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
2321209|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2321210|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321211|NCT00371332|Minocycline|minocycline|mesh-list
2321212|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2321213|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321214|NCT00371410|Triamcinolone|triamcinolone|mesh-list
2321215|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2321216|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2321217|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2321218|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2321219|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
2321220|NCT00371410|Hormones|hormones|mesh-ancestor
2321221|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2321222|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321223|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2321224|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
2321225|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889379|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
2889380|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889381|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889382|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2889383|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
2889384|NCT04603911|Hormones|hormones|mesh-ancestor
2889385|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2889386|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2889387|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889388|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
2889389|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
2889390|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2889391|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
2889392|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2889393|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2889394|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
2889395|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2889396|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889397|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2889398|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2889399|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2889400|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
2321226|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321227|NCT00371488|Lapatinib|lapatinib|mesh-list
2889401|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
2889402|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
2889403|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2889404|NCT04603911|Analgesics|analgesics|mesh-ancestor
2889405|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2889406|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
2889407|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2889408|NCT04602221|Lamotrigine|lamotrigine|mesh-list
2889409|NCT04602221|BI 425809|bi 425809|mesh-list
2889410|NCT04602221|BI 409306|bi 409306|mesh-list
2889411|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
2889412|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2889413|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2889414|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889415|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2889416|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889417|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2889418|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2889419|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2889420|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2889421|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2889422|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2889423|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889424|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
2321228|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321229|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2321230|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321231|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321232|NCT00371501|Aspirin|aspirin|mesh-list
2321233|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2321234|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2321235|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2321236|NCT00371501|Analgesics|analgesics|mesh-ancestor
2321237|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
2321238|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321239|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321240|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2321241|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2321242|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2321243|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2321244|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889425|NCT04597268|Midazolam|midazolam|mesh-list
2889426|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
2889427|NCT04597268|Ketamine|ketamine|mesh-list
2889428|NCT04597268|Propofol|propofol|mesh-list
2889429|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2889430|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2889431|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889432|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2889433|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
2889434|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
2889435|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2889436|NCT04597268|Analgesics|analgesics|mesh-ancestor
2889437|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
2889438|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889439|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2889440|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2889441|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2889442|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
2889443|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2889444|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889445|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2889446|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2889447|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2889448|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2889449|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2889450|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2889451|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2889452|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
2889453|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
2889454|NCT04595266|Leucovorin|leucovorin|mesh-list
2889455|NCT04595266|Bevacizumab|bevacizumab|mesh-list
2889456|NCT04595266|Fluorouracil|fluorouracil|mesh-list
2889457|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
2889458|NCT04595266|Irinotecan|irinotecan|mesh-list
2889459|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2889460|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889461|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2889462|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2889463|NCT04595266|Growth Substances|growth substances|mesh-ancestor
2889464|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889465|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
2889466|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
2889467|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889468|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2889469|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2889470|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
2321245|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2321246|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2321247|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321248|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
2321249|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2321250|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2321251|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
2321252|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2321253|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2321254|NCT00371527|Ipratropium|ipratropium|mesh-list
2321255|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2321256|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
2321257|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321258|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321259|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2321260|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
2321261|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2321262|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
2321263|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321264|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321265|NCT00371553|Sunitinib|sunitinib|mesh-list
2321266|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321267|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2321268|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2321269|NCT00371553|Growth Substances|growth substances|mesh-ancestor
2889471|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2889472|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2889473|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889474|NCT04595266|Antidotes|antidotes|mesh-ancestor
2889475|NCT04595266|Protective Agents|protective agents|mesh-ancestor
2889476|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
2889477|NCT04595266|Vitamins|vitamins|mesh-ancestor
2889478|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
2889479|NCT04594798|Prednisone|prednisone|mesh-list
2889480|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
2889481|NCT04594798|Rituximab|rituximab|mesh-list
2889482|NCT04594798|Doxorubicin|doxorubicin|mesh-list
2889483|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2889484|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
2889485|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889486|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2889487|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2889488|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
2889489|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889490|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889491|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2889492|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2889493|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2889494|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2889495|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2889496|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889497|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2889498|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
2889499|NCT04594798|Hormones|hormones|mesh-ancestor
2889500|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2889501|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2889508|NCT04592536|Alprazolam|alprazolam|mesh-list
2889509|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2321270|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321271|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
2321272|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2321273|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321274|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321275|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2321276|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2321277|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2321278|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
2321279|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321280|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2321281|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2321282|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889510|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2889511|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889512|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2889513|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2889514|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2889515|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
2889516|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
2889517|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2889518|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889519|NCT04590404|Nicotine|nicotine|mesh-list
2889520|NCT04590404|Varenicline|varenicline|mesh-list
2889521|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2889522|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
2889523|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889524|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889525|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2889526|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2889527|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
2889528|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2889529|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889530|NCT04589845|Trastuzumab|trastuzumab|mesh-list
2889531|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2889532|NCT04589845|Atezolizumab|atezolizumab|mesh-list
2889533|NCT04589845|Maytansine|maytansine|mesh-list
2889534|NCT04589845|Pralsetinib|pralsetinib|mesh-list
2889535|NCT04589845|Entrectinib|entrectinib|mesh-list
2889536|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2889537|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889538|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2889539|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
2889540|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
2889541|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
2321283|NCT00371592|Acyclovir|acyclovir|mesh-list
2321284|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
2321285|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321286|NCT00371696|Acetaminophen|acetaminophen|mesh-list
2321287|NCT00371696|Diclofenac|diclofenac|mesh-list
2321288|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2321289|NCT00371696|Analgesics|analgesics|mesh-ancestor
2321290|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
2321291|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321292|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321293|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
2321294|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2889542|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889543|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2889544|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321295|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2321296|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2321297|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2321298|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321299|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321300|NCT00371735|Artesunate|artesunate|mesh-list
2321301|NCT00371735|Dapsone|dapsone|mesh-list
2321302|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
2321303|NCT00371735|Proguanil|proguanil|mesh-list
2321304|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
2321305|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2321306|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2321307|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321308|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321309|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
2889574|NCT04569032|Prednisone|prednisone|mesh-list
2889575|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
2889576|NCT04569032|Doxorubicin|doxorubicin|mesh-list
2889577|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2889578|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2889579|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
2889580|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889581|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2889582|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2889583|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
2889584|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889585|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889586|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2889587|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2889588|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2889589|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2889590|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889591|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2889592|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
2889593|NCT04569032|Hormones|hormones|mesh-ancestor
2889594|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2889595|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2889596|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2321310|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
2321311|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2321312|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
2321313|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2321314|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321315|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321316|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
2321317|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2321318|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
2321319|NCT00371813|Varenicline|varenicline|mesh-list
2321320|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2321321|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2321322|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
2321323|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321324|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321325|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321326|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2321327|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
2321328|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321329|NCT00371904|Rituximab|rituximab|mesh-list
2321330|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2321331|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321332|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
2321333|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321334|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2321335|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2321336|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2321337|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
2321338|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2321339|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321340|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2321341|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2321342|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2321343|NCT00371995|Amphotericin B|amphotericin b|mesh-list
2321344|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2889613|NCT04559581|Nintedanib|nintedanib|mesh-list
2889614|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889615|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2889616|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889617|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889618|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2889619|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2889620|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2889621|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2889622|NCT04552535|Afatinib|afatinib|mesh-list
2889623|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889624|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2889625|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889626|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889627|NCT04551352|Adalimumab|adalimumab|mesh-list
2889628|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
2889629|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2889630|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2889631|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2889632|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889659|NCT04546009|Letrozole|letrozole|mesh-list
2889660|NCT04546009|Palbociclib|palbociclib|mesh-list
2889661|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889662|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2321345|NCT00371995|Miltefosine|miltefosine|mesh-list
2321346|NCT00371995|Amebicides|amebicides|mesh-ancestor
2321347|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2321348|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2321349|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321350|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2321351|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
2321352|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321353|NCT00372008|Testosterone|testosterone|mesh-list
2889663|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2889664|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889665|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889666|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2889667|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
2889668|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2889669|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889670|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2889671|NCT04541797|Empagliflozin|empagliflozin|mesh-list
2321354|NCT00372008|Androgens|androgens|mesh-ancestor
2321355|NCT00372008|Hormones|hormones|mesh-ancestor
2321356|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2321357|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889672|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2889673|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889674|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2889675|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889676|NCT04532528|Dabigatran|dabigatran|mesh-list
2889677|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
2889678|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2889679|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
2889680|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889681|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889682|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
2889683|NCT04531553|Bupivacaine|bupivacaine|mesh-list
2889684|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
2889685|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
2889686|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2889687|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889688|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
2889689|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889690|NCT04529499|Favipiravir|favipiravir|mesh-list
2889691|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
2889692|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2889693|NCT04529265|Methylene Blue|methylene blue|mesh-list
2321365|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
2321366|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2889694|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889695|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889696|NCT04528680|Paclitaxel|paclitaxel|mesh-list
2889697|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2889698|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2889699|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889700|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
2889701|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
2889702|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
2889703|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889704|NCT04526574|Vaccines|vaccines|mesh-list
2889705|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2889706|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
2889707|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321367|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321368|NCT00372099|Calcitonin|calcitonin|mesh-list
2889715|NCT04520685|Cannabidiol|cannabidiol|mesh-list
2889716|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
2889723|NCT04518410|Gabexate|gabexate|mesh-list
2889724|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
2889725|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2321369|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
2321370|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2321371|NCT00372099|Katacalcin|katacalcin|mesh-list
2321372|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2321373|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321374|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2321375|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
2321376|NCT00372138|Thrombin|thrombin|mesh-list
2321377|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
2321378|NCT00372138|Coagulants|coagulants|mesh-ancestor
2321379|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
2321380|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
2321381|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321382|NCT00372216|Clopidogrel|clopidogrel|mesh-list
2321383|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2321384|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2321385|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2321386|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2321387|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
2321388|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321389|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321390|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321391|NCT00372229|Valganciclovir|valganciclovir|mesh-list
2321392|NCT00372229|Ganciclovir|ganciclovir|mesh-list
2321393|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2889726|NCT04518410|Antibodies|antibodies|mesh-list
2889727|NCT04518410|Camostat|camostat|mesh-list
2889728|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
2889729|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889730|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
2889731|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889732|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889733|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2321394|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
2321395|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321396|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2321397|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321398|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321399|NCT00372294|Clindamycin|clindamycin|mesh-list
2321400|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
2321401|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
2321402|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
2321403|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
2321404|NCT00372294|Dexamethasone|dexamethasone|mesh-list
2889734|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2889735|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
2889736|NCT04516057|Nabilone|nabilone|mesh-list
2889737|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
2889738|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
2889739|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889740|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889741|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2889742|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2889743|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2889744|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2889745|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2889746|NCT04515329|Cyclosporine|cyclosporine|mesh-list
2889747|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
2889748|NCT04515329|Cyclosporins|cyclosporins|mesh-list
2889749|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321405|NCT00372294|Prednisolone|prednisolone|mesh-list
2321406|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2321407|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
2321408|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
2321409|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321410|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889750|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889751|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2889752|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
2889753|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889754|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
2889755|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2889756|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
2889757|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2889758|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2889759|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2889760|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2889766|NCT04508790|Dexamethasone|dexamethasone|mesh-list
2889767|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
2889768|NCT04508790|Pomalidomide|pomalidomide|mesh-list
2889769|NCT04508790|Ichthammol|ichthammol|mesh-list
2889770|NCT04508790|BB 1101|bb 1101|mesh-list
2889771|NCT04508790|Leflunomide|leflunomide|mesh-list
2889772|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2889773|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
2889774|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
2889775|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889776|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889777|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2889778|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
2889779|NCT04508790|Hormones|hormones|mesh-ancestor
2889780|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2889781|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2889782|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889783|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
2889784|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889785|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889786|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
2889787|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2889788|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2889789|NCT04508790|Growth Substances|growth substances|mesh-ancestor
2889790|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
2889791|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
2889792|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2889793|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2889794|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2889795|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889796|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
2889797|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2889798|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2889799|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2889800|NCT04503668|Dexamethasone|dexamethasone|mesh-list
2889801|NCT04503668|Ondansetron|ondansetron|mesh-list
2889802|NCT04503668|Olanzapine|olanzapine|mesh-list
2889803|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
2889804|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
2889805|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
2889806|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2889807|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
2889808|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
2321411|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2321412|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
2889809|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889810|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889811|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2889812|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
2889813|NCT04503668|Hormones|hormones|mesh-ancestor
2889814|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2889815|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2889816|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321413|NCT00372294|Hormones|hormones|mesh-ancestor
2889817|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
2889818|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
2321414|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2321415|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2321416|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321417|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2321418|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321419|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2321420|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321421|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321422|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
2321423|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2321424|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2321425|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2321426|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
2321427|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
2321428|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2321429|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2321430|NCT00372307|Analgesics|analgesics|mesh-ancestor
2321431|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
2889819|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2889820|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
2889821|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2889822|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889823|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2889824|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2889825|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2889826|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2889827|NCT04503668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2889828|NCT04503668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2889829|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2889830|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2889831|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2889832|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
2889833|NCT04503551|Ranibizumab|ranibizumab|mesh-list
2889834|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2889835|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2889836|NCT04503551|Growth Substances|growth substances|mesh-ancestor
2889837|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889838|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
2889839|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889846|NCT04502550|Propofol|propofol|mesh-list
2889847|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2889848|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2889849|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889850|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2889851|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
2889852|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
2889853|NCT04502407|Cisplatin|cisplatin|mesh-list
2889854|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889855|NCT04494412|Zanamivir|zanamivir|mesh-list
2889856|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
2889857|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2889858|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889859|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321432|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321433|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321434|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2321435|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2321436|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
2321437|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2321438|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
2321439|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2321440|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321441|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321442|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
2321443|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2321444|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2321445|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321446|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2321447|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321448|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2321449|NCT00372437|Gemcitabine|gemcitabine|mesh-list
2321450|NCT00372437|Mocetinostat|mocetinostat|mesh-list
2321451|NCT00372437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2321452|NCT00372437|Antimetabolites|antimetabolites|mesh-ancestor
2321453|NCT00372437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321454|NCT00372437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321455|NCT00372437|Antiviral Agents|antiviral agents|mesh-ancestor
2321456|NCT00372437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321457|NCT00372437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321458|NCT00372437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2321459|NCT00372437|Immunologic Factors|immunologic factors|mesh-ancestor
2321460|NCT00372437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321461|NCT00372437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2321462|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
2321463|NCT00372476|Vinorelbine|vinorelbine|mesh-list
2889870|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2889871|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2889872|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
2889873|NCT04485013|Cetuximab|cetuximab|mesh-list
2889874|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2889875|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889876|NCT04482673|Vitamin D|vitamin d|mesh-list
2889877|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
2889878|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
2889879|NCT04482673|Vitamins|vitamins|mesh-list
2889880|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
2889881|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889882|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2889883|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2889884|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
2889885|NCT04481672|Analgesics|analgesics|mesh-ancestor
2889886|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
2889887|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2889888|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889889|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
2889890|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2889891|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2889892|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
2889893|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2889894|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2889895|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889896|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2889897|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
2889898|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2889899|NCT04470778|Famotidine|famotidine|mesh-list
2889900|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2889901|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2889902|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2889903|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
2889904|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
2889905|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2889906|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889907|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889908|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
2889909|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2889910|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889911|NCT04464798|Rituximab|rituximab|mesh-list
2889912|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
2889913|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2889914|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889915|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
2889916|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109310|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2109311|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2109312|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
2109313|NCT02517580|Vitamin K|vitamin k|mesh-list
2109314|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
2109315|NCT02517580|Vitamins|vitamins|mesh-ancestor
2889917|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2889918|NCT04461639|Factor VIII|factor viii|mesh-list
2889919|NCT04461639|Coagulants|coagulants|mesh-ancestor
2889922|NCT04458259|Axitinib|axitinib|mesh-list
2889923|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889924|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2889925|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889926|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321464|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321465|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2321466|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109316|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
2109317|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109318|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2109319|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2109320|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109321|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
2109322|NCT02517580|Coagulants|coagulants|mesh-ancestor
2109323|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2109324|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2109325|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2109326|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109327|NCT02517905|Bupivacaine|bupivacaine|mesh-list
2109328|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
2109329|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
2109330|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109331|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109332|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
2109333|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109334|NCT02517996|Lidocaine|lidocaine|mesh-list
2109335|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
2109336|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
2109337|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109338|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109339|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
2109340|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109341|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2109342|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2109343|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2109344|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2109345|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109346|NCT02518113|Dexamethasone|dexamethasone|mesh-list
2109347|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109348|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
2109349|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
2109350|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109351|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109352|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2109353|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
2109354|NCT02518113|Hormones|hormones|mesh-ancestor
2109355|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109356|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2109357|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109358|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
2889939|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
2889940|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2889941|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889942|NCT04431453|Remdesivir|remdesivir|mesh-list
2889943|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
2889944|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889945|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
2889946|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2889947|NCT04421963|Olaparib|olaparib|mesh-list
2889948|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2889949|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889950|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889951|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889952|NCT04418427|Aflibercept|aflibercept|mesh-list
2889953|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2889954|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2889955|NCT04418427|Growth Substances|growth substances|mesh-ancestor
2889956|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889957|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
2889958|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889959|NCT04412863|Interferons|interferons|mesh-list
2889960|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
2889961|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
2889962|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2889963|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889964|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
2889965|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2889966|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
2889967|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889968|NCT04412785|Cyclosporine|cyclosporine|mesh-list
2889969|NCT04412785|Cyclosporins|cyclosporins|mesh-list
2889970|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889971|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889972|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2889973|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
2889974|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889975|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
2889976|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321467|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321468|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2321469|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
2321470|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
2321471|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
2321472|NCT00372515|Gefitinib|gefitinib|mesh-list
2889977|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2889978|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2889979|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2889980|NCT04408638|Gemcitabine|gemcitabine|mesh-list
2889981|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
2889982|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
2889983|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2889984|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
2889985|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2889986|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2889987|NCT04408638|Antiviral Agents|antiviral agents|mesh-ancestor
2889988|NCT04408638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2889989|NCT04408638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2889990|NCT04408638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2889991|NCT04408638|Immunologic Factors|immunologic factors|mesh-ancestor
2889992|NCT04408638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2889993|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2321473|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321474|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2321475|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321476|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321477|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
2321478|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2321479|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321480|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
2321481|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
2321482|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2321483|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
2321484|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2321485|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2321486|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321487|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2890020|NCT04385433|Pravastatin|pravastatin|mesh-list
2890021|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2890022|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2890023|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
2890024|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890025|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2890026|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2890027|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890048|NCT04377711|Ciclesonide|ciclesonide|mesh-list
2890049|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
2890050|NCT04377711|Hormones|hormones|mesh-ancestor
2890051|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2890052|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890053|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2890054|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2890055|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
2890056|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321488|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321489|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321490|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2321491|NCT00372632|Renal Agents|renal agents|mesh-ancestor
2321492|NCT00372645|Folic Acid|folic acid|mesh-list
2321493|NCT00372645|Hematinics|hematinics|mesh-ancestor
2321494|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
2321495|NCT00372645|Vitamins|vitamins|mesh-ancestor
2321496|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
2321497|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321498|NCT00372658|Lidocaine|lidocaine|mesh-list
2321499|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
2321500|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
2321501|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2890071|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2890072|NCT04369560|Hematinics|hematinics|mesh-ancestor
2890073|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2890074|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2890075|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2890076|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2890077|NCT04356690|Etoposide|etoposide|mesh-list
2890078|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2890079|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890080|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2890081|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2890082|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890083|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890084|NCT04356209|Pravastatin|pravastatin|mesh-list
2890085|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2890086|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2890087|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
2890088|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890089|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2890090|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2890091|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890092|NCT04354025|Cytarabine|cytarabine|mesh-list
2890093|NCT04354025|Fludarabine|fludarabine|mesh-list
2890094|NCT04354025|Interleukin-2|interleukin-2|mesh-list
2890095|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890096|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2890097|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
2890098|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890099|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2890100|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
2890101|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890102|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
2890103|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2890104|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2321502|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321503|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
2321504|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890105|NCT04354025|Analgesics|analgesics|mesh-ancestor
2890106|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
2890107|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890108|NCT04353661|Azithromycin|azithromycin|mesh-list
2890109|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2890110|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2890111|NCT04352101|Citalopram|citalopram|mesh-list
2890112|NCT04352101|Bupropion|bupropion|mesh-list
2890113|NCT04352101|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2890114|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2890115|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2890116|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890117|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2890118|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
2890119|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890120|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2890121|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
2890122|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2890123|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2890124|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
2321505|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2321506|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2321507|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2890125|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2890126|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2890127|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890128|NCT04351555|Carboplatin|carboplatin|mesh-list
2890129|NCT04351555|Pemetrexed|pemetrexed|mesh-list
2890130|NCT04351555|Osimertinib|osimertinib|mesh-list
2890131|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890132|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890133|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890134|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2890135|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2890136|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2890137|NCT04350463|Nivolumab|nivolumab|mesh-list
2890138|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
2890139|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2890140|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890141|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2890142|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890143|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890144|NCT04349267|Nivolumab|nivolumab|mesh-list
2890145|NCT04349267|Cetuximab|cetuximab|mesh-list
2890146|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2890147|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890148|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2890149|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890150|NCT04347408|Antibodies|antibodies|mesh-list
2890151|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
2890152|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321508|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2321509|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321510|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
2321511|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2321512|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321513|NCT00372723|Infliximab|infliximab|mesh-list
2321514|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
2321515|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2890173|NCT04338022|Teriflunomide|teriflunomide|mesh-list
2890174|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2890175|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2890176|NCT04338022|Analgesics|analgesics|mesh-ancestor
2890177|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
2890178|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890179|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890180|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2890181|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2890182|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2890183|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
2890184|NCT04336943|Durvalumab|durvalumab|mesh-list
2890185|NCT04336943|Olaparib|olaparib|mesh-list
2890186|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2890187|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
2890188|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2321516|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2321517|NCT00372736|Docetaxel|docetaxel|mesh-list
2321518|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321519|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
2321520|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
2321521|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
2321522|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321523|NCT00372762|Furosemide|furosemide|mesh-list
2321524|NCT00372762|Bumetanide|bumetanide|mesh-list
2321525|NCT00372762|Diuretics|diuretics|mesh-ancestor
2321526|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
2321527|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321528|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2321529|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2321530|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321531|NCT00372788|Pemetrexed|pemetrexed|mesh-list
2321532|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321533|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321534|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321535|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2890189|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
2890190|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2890191|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890192|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
2890193|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890194|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890195|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890196|NCT04328727|Cyclosporine|cyclosporine|mesh-list
2890197|NCT04328727|Cyclosporins|cyclosporins|mesh-list
2890198|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2890199|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
2890200|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890201|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890202|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2890203|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
2890204|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890205|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
2890206|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2890207|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
2890208|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2890209|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2890210|NCT04325217|Nintedanib|nintedanib|mesh-list
2890211|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890212|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2890213|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890214|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890215|NCT04303858|Atezolizumab|atezolizumab|mesh-list
2890216|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890217|NCT04303117|Interleukin-12|interleukin-12|mesh-list
2890218|NCT04303117|Immunoglobulin G|immunoglobulin g|mesh-list
2890219|NCT04303117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2890220|NCT04303117|Immunologic Factors|immunologic factors|mesh-ancestor
2890221|NCT04303117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890222|NCT04303117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2890223|NCT04303117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2890224|NCT04303117|Growth Substances|growth substances|mesh-ancestor
2890225|NCT04303117|Growth Inhibitors|growth inhibitors|mesh-ancestor
2890226|NCT04303117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321536|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2321537|NCT00372801|Ibuprofen|ibuprofen|mesh-list
2321538|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2321539|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2321540|NCT00372801|Analgesics|analgesics|mesh-ancestor
2890227|NCT04302896|Tenofovir|tenofovir|mesh-list
2890228|NCT04302896|Lamivudine|lamivudine|mesh-list
2890229|NCT04302896|Emtricitabine|emtricitabine|mesh-list
2321541|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
2321542|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321543|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321544|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2321545|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2321546|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2321547|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321548|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321549|NCT00372827|Travoprost|travoprost|mesh-list
2890230|NCT04302896|Dolutegravir|dolutegravir|mesh-list
2321550|NCT00372827|Brinzolamide|brinzolamide|mesh-list
2890231|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2890232|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
2890233|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321551|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2321552|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2321553|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321554|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321555|NCT00372853|Tremelimumab|tremelimumab|mesh-list
2321556|NCT00372853|Ipilimumab|ipilimumab|mesh-list
2890234|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2890235|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2890236|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890237|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321557|NCT00372853|Sunitinib|sunitinib|mesh-list
2321558|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890238|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2890239|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2890240|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2890241|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2890242|NCT04302025|Vemurafenib|vemurafenib|mesh-list
2890243|NCT04302025|Pralsetinib|pralsetinib|mesh-list
2890244|NCT04302025|Entrectinib|entrectinib|mesh-list
2890245|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890246|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2890247|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890248|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890249|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
2890250|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2890251|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
2890252|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2890253|NCT04300920|Expectorants|expectorants|mesh-ancestor
2890254|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
2890255|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2890256|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
2890257|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321559|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2321560|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2321561|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321562|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2321563|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2321564|NCT00372853|Growth Substances|growth substances|mesh-ancestor
2321565|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321566|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
2321567|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2321568|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321569|NCT00372879|Vitamin E|vitamin e|mesh-list
2321570|NCT00372879|Vitamins|vitamins|mesh-ancestor
2321571|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
2321572|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321573|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
2321574|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321575|NCT00372879|Protective Agents|protective agents|mesh-ancestor
2321576|NCT00372892|Rituximab|rituximab|mesh-list
2321577|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2321578|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321579|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
2321580|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321581|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2321582|NCT00372944|Capecitabine|capecitabine|mesh-list
2321583|NCT00372944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2321584|NCT00372944|Antimetabolites|antimetabolites|mesh-ancestor
2321585|NCT00372944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321586|NCT00372944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321587|NCT00373048|Mefloquine|mefloquine|mesh-list
2321588|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
2321589|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2321590|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2321591|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321592|NCT00373061|Omalizumab|omalizumab|mesh-list
2890258|NCT04300920|Protective Agents|protective agents|mesh-ancestor
2890259|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890260|NCT04300920|Antidotes|antidotes|mesh-ancestor
2321593|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2321594|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2321595|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
2890261|NCT04298567|Aspirin|aspirin|mesh-list
2890262|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
2890263|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2890264|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
2890265|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2890266|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
2890267|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890268|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890269|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
2890270|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2890271|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2890272|NCT04298567|Analgesics|analgesics|mesh-ancestor
2890273|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
2890274|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890275|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890276|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2890277|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2890278|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2890279|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2890280|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2890281|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2890282|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
2890283|NCT04296942|Trastuzumab|trastuzumab|mesh-list
2890284|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2890285|NCT04296942|Maytansine|maytansine|mesh-list
2890286|NCT04296942|Entinostat|entinostat|mesh-list
2321596|NCT00373087|Entacapone|entacapone|mesh-list
2321597|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2321598|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2321599|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890287|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2890288|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890289|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2890290|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
2890291|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
2890292|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
2890293|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890294|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2890295|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890296|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
2321600|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2321601|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321602|NCT00373126|Nicotine|nicotine|mesh-list
2321603|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2321604|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
2321605|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321606|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321607|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2321608|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2321609|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
2321610|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321611|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321612|NCT00373165|Ganciclovir|ganciclovir|mesh-list
2321613|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2321614|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
2321615|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321616|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2890297|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2890298|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890299|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890300|NCT04291599|Ketorolac|ketorolac|mesh-list
2890301|NCT04291599|Morphine|morphine|mesh-list
2890302|NCT04291599|Hydromorphone|hydromorphone|mesh-list
2109359|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2109360|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
2109361|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109362|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109363|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2109364|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
2109365|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
2109366|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2109367|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
2109368|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321617|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372160|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
2890303|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2321618|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321619|NCT00373178|Metformin|metformin|mesh-list
2321620|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
2321621|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2321622|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321623|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
2321624|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321625|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2321626|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
2890304|NCT04291599|Narcotics|narcotics|mesh-ancestor
2890305|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2890306|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890307|NCT04291599|Analgesics|analgesics|mesh-ancestor
2890308|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
2890309|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890310|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2890311|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2890312|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2890313|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2890314|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2890315|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890316|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890317|NCT04287049|Azithromycin|azithromycin|mesh-list
2890318|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2890319|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2890320|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
2321627|NCT00373217|Paclitaxel|paclitaxel|mesh-list
2321628|NCT00373217|Carboplatin|carboplatin|mesh-list
2321629|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2321630|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321631|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
2321632|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
2321633|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
2321634|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321635|NCT00373282|Triamcinolone|triamcinolone|mesh-list
2321636|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2321637|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2321638|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2321639|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2321640|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
2321641|NCT00373282|Hormones|hormones|mesh-ancestor
2321642|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2321643|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321644|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2890321|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2890322|NCT04285567|Rituximab|rituximab|mesh-list
2890323|NCT04285567|Fludarabine|fludarabine|mesh-list
2890324|NCT04285567|Venetoclax|venetoclax|mesh-list
2890325|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
2890326|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2890327|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
2890328|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890329|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2890330|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2890331|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
2890332|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890333|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890334|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2890335|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2321645|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
2321646|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321647|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321648|NCT00373373|Sorafenib|sorafenib|mesh-list
2321649|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321650|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2321651|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321652|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321653|NCT00373412|Vaccines|vaccines|mesh-list
2321654|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
2321655|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321656|NCT00373451|Heparin|heparin|mesh-list
2321657|NCT00373451|Calcium heparin|calcium heparin|mesh-list
2321658|NCT00373451|Bivalirudin|bivalirudin|mesh-list
2321659|NCT00373451|Abciximab|abciximab|mesh-list
2321660|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
2321661|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2321662|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2321663|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321664|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
2321665|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2890347|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
2890348|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
2890349|NCT04269356|Antacids|antacids|mesh-ancestor
2890350|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890351|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2890358|NCT04266249|Paclitaxel|paclitaxel|mesh-list
2890359|NCT04266249|Maytansine|maytansine|mesh-list
2890360|NCT04266249|Docetaxel|docetaxel|mesh-list
2890361|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2890362|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2890363|NCT04266249|Trastuzumab|trastuzumab|mesh-list
2890364|NCT04266249|Pertuzumab|pertuzumab|mesh-list
2890365|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2890366|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2890367|NCT04266249|Antibodies|antibodies|mesh-list
2890368|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
2890369|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2890370|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
2890371|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2890372|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890373|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
2890374|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
2890375|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
2890376|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890377|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
2890378|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890379|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2890380|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2890381|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2890382|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890407|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2890408|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321666|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
2321667|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321668|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2321669|NCT00373464|Etoricoxib|etoricoxib|mesh-list
2321670|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2109369|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109370|NCT02518191|Goserelin|goserelin|mesh-list
2109371|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2109372|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109373|NCT02518464|Ticagrelor|ticagrelor|mesh-list
2321671|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2321672|NCT00373464|Analgesics|analgesics|mesh-ancestor
2890423|NCT04222504|Tenofovir|tenofovir|mesh-list
2890424|NCT04222504|Emtricitabine|emtricitabine|mesh-list
2321673|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
2321674|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321675|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321676|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2321677|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2321678|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2321679|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2321680|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321681|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321682|NCT00373503|Lofexidine|lofexidine|mesh-list
2321683|NCT00373503|Dronabinol|dronabinol|mesh-list
2321684|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
2321685|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321686|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2890425|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
2890426|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2890427|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2890428|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2890429|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890430|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890431|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2890432|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2109374|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2109375|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2109376|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2321687|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2321688|NCT00373503|Analgesics|analgesics|mesh-ancestor
2321689|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
2321690|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321691|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2321692|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2321693|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321694|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321695|NCT00373503|Hormones|hormones|mesh-ancestor
2321696|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2321697|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2321698|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2321699|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2321700|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2321701|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2321702|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
2321703|NCT00373542|Ropinirole|ropinirole|mesh-list
2321704|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2321705|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2321706|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
2321707|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
2321708|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321709|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321710|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321711|NCT00373568|Miltefosine|miltefosine|mesh-list
2321712|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
2321713|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321714|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321715|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2321716|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2321717|NCT00373581|Cocaine|cocaine|mesh-list
2321718|NCT00373581|Vigabatrin|vigabatrin|mesh-list
2321719|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
2321720|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
2321721|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2321722|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321723|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
2890498|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2890499|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
2890516|NCT04209790|Temozolomide|temozolomide|mesh-list
2890517|NCT04209790|Benzolamide|benzolamide|mesh-list
2890518|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2321724|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321725|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2321726|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2321727|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2321728|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2321729|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321730|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
2321731|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321732|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
2321733|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321734|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
2321735|NCT00373594|Rituximab|rituximab|mesh-list
2321736|NCT00373594|Fludarabine|fludarabine|mesh-list
2890519|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
2890520|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890521|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890522|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2890523|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890524|NCT04206787|Afatinib|afatinib|mesh-list
2890525|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890526|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2890527|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890528|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890529|NCT04205136|Spironolactone|spironolactone|mesh-list
2890530|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2321737|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2321738|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321739|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
2321740|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321741|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2321742|NCT00373607|Artesunate|artesunate|mesh-list
2890531|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
2890532|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2890533|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890534|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2890535|NCT04205136|Diuretics|diuretics|mesh-ancestor
2890536|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
2890537|NCT04191499|Fulvestrant|fulvestrant|mesh-list
2890538|NCT04191499|Palbociclib|palbociclib|mesh-list
2321743|NCT00373607|Piperaquine|piperaquine|mesh-list
2321744|NCT00373607|Mefloquine|mefloquine|mesh-list
2321745|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
2321746|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2890539|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2890540|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890541|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2890542|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2890543|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
2890544|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2890545|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890546|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2890547|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890548|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890598|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
2890599|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2890600|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
2890601|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
2890602|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2890603|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890604|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890605|NCT04177706|Ketamine|ketamine|mesh-list
2890606|NCT04177706|Analgesics|analgesics|mesh-ancestor
2890607|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
2890608|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890609|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890610|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2890611|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2890612|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
2890613|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
2890614|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2890615|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2890616|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2890617|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321747|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2321748|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321749|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321750|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
2321751|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
2321752|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2321753|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
2890618|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890619|NCT04173247|Mineral Oil|mineral oil|mesh-list
2890620|NCT04173247|Emollients|emollients|mesh-ancestor
2890621|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
2890622|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2890623|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2890624|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2321754|NCT00373620|Paclitaxel|paclitaxel|mesh-list
2321755|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2321756|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321757|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
2321758|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
2321759|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
2321760|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321761|NCT00373646|Thalidomide|thalidomide|mesh-list
2321762|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2321763|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
2321764|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321765|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
2321766|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2321767|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321768|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2321769|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2321770|NCT00373646|Growth Substances|growth substances|mesh-ancestor
2321771|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
2321772|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321773|NCT00373659|Ranibizumab|ranibizumab|mesh-list
2321774|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2321775|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2321776|NCT00373659|Growth Substances|growth substances|mesh-ancestor
2321777|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321778|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
2321779|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321780|NCT00373672|Modafinil|modafinil|mesh-list
2321781|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2321782|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321783|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2890625|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890626|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890627|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2890628|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2890629|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890630|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
2890631|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2890632|NCT04170738|Amphetamine|amphetamine|mesh-list
2890633|NCT04170738|Adderall|adderall|mesh-list
2890634|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
2890635|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2890636|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890637|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
2890638|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
2890639|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890640|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
2321784|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2321785|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2321786|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321787|NCT00373711|Iodine|iodine|mesh-list
2321788|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
2321789|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2321790|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2321791|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321792|NCT00373711|Trace Elements|trace elements|mesh-ancestor
2321793|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
2321794|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321795|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2321796|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321797|NCT00373776|Miltefosine|miltefosine|mesh-list
2321798|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
2321799|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321800|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321801|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2321802|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2321803|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
2321804|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2321805|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2890641|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321806|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2321807|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2321808|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321809|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
2321810|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321811|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321812|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2321813|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321814|NCT00373802|Phenylephrine|phenylephrine|mesh-list
2321815|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
2321816|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2321817|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
2321818|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
2321819|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890642|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890643|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
2890644|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2890645|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2321820|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321821|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
2321822|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2890646|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2890647|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2890648|NCT04166331|Dobutamine|dobutamine|mesh-list
2890649|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2890650|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
2890651|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
2890652|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890653|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890654|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2890655|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2890656|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2890657|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
2890658|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2890659|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890660|NCT04166331|Protective Agents|protective agents|mesh-ancestor
2321823|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
2321824|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
2321825|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2321826|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2321827|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2321828|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
2321829|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321830|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321831|NCT00373802|Protective Agents|protective agents|mesh-ancestor
2321832|NCT00373815|Everolimus|everolimus|mesh-list
2321833|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321834|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2321835|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
2321836|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321837|NCT00373893|Lidocaine|lidocaine|mesh-list
2321838|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
2321839|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
2321840|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2321841|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321842|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
2321843|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321844|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2321845|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2321846|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2321847|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2321848|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890661|NCT04166071|Naltrexone|naltrexone|mesh-list
2890662|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2890663|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2890664|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890665|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
2890666|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890671|NCT04163874|Pramlintide|pramlintide|mesh-list
2890672|NCT04163874|Pancrelipase|pancrelipase|mesh-list
2890673|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2890674|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2890675|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321849|NCT00373906|Bortezomib|bortezomib|mesh-list
2321850|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321851|NCT00373919|Erythromycin|erythromycin|mesh-list
2321852|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
2321853|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2890676|NCT04153760|Aspirin|aspirin|mesh-list
2890677|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2890678|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2890679|NCT04153760|Analgesics|analgesics|mesh-ancestor
2890680|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
2890681|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890682|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890683|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2890684|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2890685|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2890686|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2890687|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890688|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2890689|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2890690|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890691|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
2321854|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
2321855|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2321856|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321857|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2321858|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2321859|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321860|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321861|NCT00374023|Vitamin A|vitamin a|mesh-list
2321862|NCT00374023|Vitamins|vitamins|mesh-ancestor
2321863|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
2321864|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321865|NCT00374075|Valproic Acid|valproic acid|mesh-list
2321866|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
2321867|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321868|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321869|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
2321870|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321871|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321872|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
2321873|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2890708|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
2890709|NCT04140526|Osimertinib|osimertinib|mesh-list
2890710|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2890711|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890712|NCT04140526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2890713|NCT04140526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890714|NCT04140526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890715|NCT04140305|Ozanimod|ozanimod|mesh-list
2890716|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2890717|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890718|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2890719|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
2890720|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321874|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2321875|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2321876|NCT00374101|Omeprazole|omeprazole|mesh-list
2321877|NCT00374101|Pantoprazole|pantoprazole|mesh-list
2321878|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2321879|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2321880|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2321881|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321882|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321883|NCT00374166|Paroxetine|paroxetine|mesh-list
2321884|NCT00374166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2321885|NCT00374166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2321886|NCT00374166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2321887|NCT00374166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321888|NCT00374166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321889|NCT00374166|Serotonin Agents|serotonin agents|mesh-ancestor
2321890|NCT00374166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321891|NCT00374166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2321892|NCT00374166|Antidepressive Agents|antidepressive agents|mesh-ancestor
2321893|NCT00374166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2321894|NCT00374166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2321895|NCT00374166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2321896|NCT00374166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321897|NCT00374192|Eszopiclone|eszopiclone|mesh-list
2321898|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2321899|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2321900|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890721|NCT04138706|Vancomycin|vancomycin|mesh-list
2890722|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2890723|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2890724|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2890725|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
2890726|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890727|NCT04134260|Prednisone|prednisone|mesh-list
2890728|NCT04134260|Cortisone|cortisone|mesh-list
2890729|NCT04134260|Abiraterone Acetate|abiraterone acetate|mesh-list
2890730|NCT04134260|Hormones|hormones|mesh-list
2890731|NCT04134260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2890732|NCT04134260|Glucocorticoids|glucocorticoids|mesh-ancestor
2890733|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2890734|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890735|NCT04134260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2890736|NCT04134260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890737|NCT04134260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2890738|NCT04134260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890739|NCT04134260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890740|NCT04134260|Hormone Antagonists|hormone antagonists|mesh-ancestor
2890741|NCT04134260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2321901|NCT00374205|Artesunate|artesunate|mesh-list
2321902|NCT00374205|Lumefantrine|lumefantrine|mesh-list
2321903|NCT00374205|Artemether|artemether|mesh-list
2321904|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2321905|NCT00374205|Amodiaquine|amodiaquine|mesh-list
2890742|NCT04129996|Paclitaxel|paclitaxel|mesh-list
2890743|NCT04129996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2890744|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2890745|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890746|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
2321906|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
2321907|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2321908|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2321909|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2321910|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2321911|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
2321912|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
2321913|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2321914|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
2321915|NCT00374296|Mocetinostat|mocetinostat|mesh-list
2321916|NCT00374296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2321917|NCT00374296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2321918|NCT00374296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890747|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
2890748|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
2890749|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890750|NCT04129619|Ether|ether|mesh-list
2321919|NCT00374348|Aripiprazole|aripiprazole|mesh-list
2890751|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2890752|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
2321920|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
2321921|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2321922|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2321923|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2321924|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2321925|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321926|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
2321927|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
2890753|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
2890754|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2890755|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890756|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2890757|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
2890758|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2321928|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321929|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321930|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2321931|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2321932|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
2321933|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2890759|NCT04120766|Nicorandil|nicorandil|mesh-list
2890760|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2890761|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2890762|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
2890763|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
2890764|NCT04120766|Vitamins|vitamins|mesh-ancestor
2890765|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
2890766|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890767|NCT04109391|Trastuzumab|trastuzumab|mesh-list
2890768|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2890769|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890788|NCT04108156|Ranibizumab|ranibizumab|mesh-list
2890789|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2890790|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2890791|NCT04108156|Growth Substances|growth substances|mesh-ancestor
2890792|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890793|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
2890794|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890795|NCT04107038|Anesthetics|anesthetics|mesh-list
2890796|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2890797|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321934|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2321935|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2321936|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2321937|NCT00374387|NuvaRing|nuvaring|mesh-list
2321938|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2321939|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
2321940|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2321941|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321942|NCT00374426|Sertraline|sertraline|mesh-list
2321943|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
2321944|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2321945|NCT00374426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2890798|NCT04106115|Durvalumab|durvalumab|mesh-list
2890799|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2890800|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890801|NCT04105998|Oxytocin|oxytocin|mesh-list
2890802|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
2890803|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2890804|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890805|NCT04100018|Prednisone|prednisone|mesh-list
2890806|NCT04100018|Docetaxel|docetaxel|mesh-list
2890807|NCT04100018|Nivolumab|nivolumab|mesh-list
2890808|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890809|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
2890810|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
2890811|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
2890812|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890813|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2890814|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
2890815|NCT04100018|Hormones|hormones|mesh-ancestor
2890816|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2890817|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890818|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2890819|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2890820|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2890821|NCT04099888|Gemcitabine|gemcitabine|mesh-list
2890822|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890823|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2890824|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
2890825|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890826|NCT04099888|Antiviral Agents|antiviral agents|mesh-ancestor
2890827|NCT04099888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2890828|NCT04099888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890829|NCT04099888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2890830|NCT04099888|Immunologic Factors|immunologic factors|mesh-ancestor
2890831|NCT04099888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890832|NCT04095364|Paclitaxel|paclitaxel|mesh-list
2890833|NCT04095364|Carboplatin|carboplatin|mesh-list
2890834|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2890835|NCT04095364|Letrozole|letrozole|mesh-list
2890836|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2890837|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890838|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
2890839|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
2890840|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
2890841|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890842|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2890843|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2890844|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890845|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2890846|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
2890847|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2890848|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109377|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2109378|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
2109379|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109380|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109381|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109382|NCT02518971|Tamsulosin|tamsulosin|mesh-list
2109383|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2109384|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2109385|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2109386|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
2890882|NCT04088188|Gemcitabine|gemcitabine|mesh-list
2890883|NCT04088188|Cisplatin|cisplatin|mesh-list
2890884|NCT04088188|Ivosidenib|ivosidenib|mesh-list
2890885|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890886|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2890887|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
2890888|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890889|NCT04088188|Antiviral Agents|antiviral agents|mesh-ancestor
2890890|NCT04088188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2890891|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890892|NCT04088188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2890893|NCT04088188|Immunologic Factors|immunologic factors|mesh-ancestor
2890894|NCT04088188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890912|NCT04084314|Erenumab|erenumab|mesh-list
2890913|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2890914|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890915|NCT04084314|Analgesics|analgesics|mesh-ancestor
2890916|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
2890917|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890918|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890919|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
2890920|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2890921|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890922|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
2890923|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
2890924|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890925|NCT04075136|Triamcinolone|triamcinolone|mesh-list
2890926|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2890927|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2890928|NCT04075136|Ranibizumab|ranibizumab|mesh-list
2890929|NCT04075136|Verteporfin|verteporfin|mesh-list
2890930|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2890931|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2890932|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2890933|NCT04075136|Growth Substances|growth substances|mesh-ancestor
2890934|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890935|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
2890936|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890937|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2890938|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
2890939|NCT04075136|Hormones|hormones|mesh-ancestor
2890940|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2890941|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2890942|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
2890943|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890944|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890945|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2890946|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
2890947|NCT04074967|Nivolumab|nivolumab|mesh-list
2890948|NCT04074967|Ipilimumab|ipilimumab|mesh-list
2890949|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2890950|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890951|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2890952|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321946|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2321947|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2321948|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321949|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321950|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
2321951|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321952|NCT00374465|Verapamil|verapamil|mesh-list
2321953|NCT00374465|Carvedilol|carvedilol|mesh-list
2321954|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2321955|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2321956|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
2321957|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321958|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321959|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321960|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2321961|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
2321962|NCT00374465|Protective Agents|protective agents|mesh-ancestor
2321963|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2321964|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2321965|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2321966|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
2890961|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
2890962|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2890963|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890964|NCT04074174|Acetaminophen|acetaminophen|mesh-list
2890965|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
2890966|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
2890967|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2890968|NCT04074174|Analgesics|analgesics|mesh-ancestor
2890969|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
2890970|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2890971|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890972|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
2890973|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2890974|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2890975|NCT04068831|Avelumab|avelumab|mesh-list
2890976|NCT04068831|Talazoparib|talazoparib|mesh-list
2890977|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2890978|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890979|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2890980|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890981|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890982|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2890983|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
2890984|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2890985|NCT04061421|Decitabine|decitabine|mesh-list
2890986|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2890987|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
2890988|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2890989|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2890990|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2890994|NCT04054713|Acetic Acid|acetic acid|mesh-list
2890995|NCT04054713|Retinol acetate|retinol acetate|mesh-list
2890996|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2890997|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2890998|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2890999|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
2321967|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2321968|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2321969|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2321970|NCT00374478|Scopolamine|scopolamine|mesh-list
2321971|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2321972|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2321973|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
2321974|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
2321975|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2321976|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321977|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2321978|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
2321979|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2321980|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
2321981|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2321982|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2321983|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2321984|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
2321985|NCT00374621|Isosorbide|isosorbide|mesh-list
2321986|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2321987|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2321988|NCT00374621|Misoprostol|misoprostol|mesh-list
2891000|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891001|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2891002|NCT04054713|Protective Agents|protective agents|mesh-ancestor
2891003|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891004|NCT04044469|Vaccines|vaccines|mesh-list
2891005|NCT04044469|Immunologic Factors|immunologic factors|mesh-ancestor
2891006|NCT04044469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891007|NCT04040959|Niacinamide|niacinamide|mesh-list
2891008|NCT04040959|Niacin|niacin|mesh-list
2891009|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
2891010|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
2891011|NCT04040959|Vitamins|vitamins|mesh-ancestor
2891012|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
2891013|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891014|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2891015|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
2891016|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891017|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2891018|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
2891019|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
2891020|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891021|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891022|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2891023|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
2891024|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891025|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2891026|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
2891027|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2891028|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891029|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2891030|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2891031|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2891032|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
2891033|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
2321989|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2321990|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
2321991|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2321992|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2321993|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2321994|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2321995|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
2321996|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2321997|NCT00374621|Diuretics|diuretics|mesh-ancestor
2321998|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
2321999|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
2322000|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2891034|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2891035|NCT04023071|Rituximab|rituximab|mesh-list
2891036|NCT04023071|Fludarabine|fludarabine|mesh-list
2891037|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
2322001|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322002|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
2322003|NCT00374647|Sirolimus|sirolimus|mesh-list
2322004|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2322005|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322006|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2322007|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
2322008|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2322009|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322010|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322011|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322012|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
2322013|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2322014|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
2322015|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891038|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2891039|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
2891040|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891041|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2891042|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2891043|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
2322022|NCT00374686|Valganciclovir|valganciclovir|mesh-list
2322023|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
2322024|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322025|NCT00374699|Bortezomib|bortezomib|mesh-list
2322026|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322027|NCT00374764|Risperidone|risperidone|mesh-list
2322028|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2891044|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891045|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891046|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2891047|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891048|NCT04019262|Temozolomide|temozolomide|mesh-list
2891049|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2891050|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
2891051|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891052|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891053|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
2891054|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2891055|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
2891056|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
2891057|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2891058|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891059|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2891060|NCT04008628|Analgesics|analgesics|mesh-ancestor
2891061|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
2891062|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2891063|NCT04001894|Clopidogrel|clopidogrel|mesh-list
2891064|NCT04001894|Ticagrelor|ticagrelor|mesh-list
2891065|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2891066|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2891067|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2322029|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
2322030|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322031|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322032|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322033|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2322034|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2322035|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2322036|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2322037|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2322038|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
2322039|NCT00374777|Nitrazepam|nitrazepam|mesh-list
2322040|NCT00374777|Zolpidem|zolpidem|mesh-list
2322041|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2322042|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2322043|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2322044|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322045|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2322046|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
2322047|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
2322048|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322049|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322050|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
2322051|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2322052|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2322053|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2891068|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2891069|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
2891070|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2891071|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891072|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891073|NCT03997370|Carboplatin|carboplatin|mesh-list
2891074|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891086|NCT03988920|Sevelamer|sevelamer|mesh-list
2891087|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
2891088|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
2891089|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891092|NCT03982485|Paclitaxel|paclitaxel|mesh-list
2891093|NCT03982485|Apatinib|apatinib|mesh-list
2891094|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2891095|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891096|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
2891097|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
2891098|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
2891099|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891100|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2891101|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891111|NCT03975647|Tucatinib|tucatinib|mesh-list
2891112|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891113|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891114|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2891115|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322054|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
2322055|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2322056|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2322057|NCT00374855|Diuretics|diuretics|mesh-ancestor
2322058|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
2891122|NCT03969212|Baloxavir|baloxavir|mesh-list
2891123|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
2891124|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2891125|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891126|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322059|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322060|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2322061|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2322062|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322063|NCT00374881|Phenylephrine|phenylephrine|mesh-list
2322064|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
2322065|NCT00374881|Morphine|morphine|mesh-list
2322066|NCT00374881|Sorbitol|sorbitol|mesh-list
2322067|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2891127|NCT03969121|Palbociclib|palbociclib|mesh-list
2891128|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891129|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2891130|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891131|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891132|NCT03966339|Hormones|hormones|mesh-list
2891133|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2891134|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891135|NCT03965728|Methotrexate|methotrexate|mesh-list
2891136|NCT03965728|Midazolam|midazolam|mesh-list
2891137|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2891138|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
2891139|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2891140|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891141|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2891142|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
2891143|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891144|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891145|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
2891146|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891147|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2891148|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2891149|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
2891150|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2891151|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2891152|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2891153|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2891154|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2891155|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2891156|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2891157|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2891158|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2891159|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
2891160|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
2891161|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
2891162|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
2891163|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322068|NCT00374881|Narcotics|narcotics|mesh-ancestor
2322069|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2322070|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322071|NCT00374881|Analgesics|analgesics|mesh-ancestor
2322072|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
2322073|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2322074|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2891175|NCT03948022|Progesterone|progesterone|mesh-list
2891176|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
2891177|NCT03948022|Progestins|progestins|mesh-ancestor
2891178|NCT03948022|Hormones|hormones|mesh-ancestor
2891179|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2891180|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891181|NCT03946111|Naltrexone|naltrexone|mesh-list
2891182|NCT03946111|Bupropion|bupropion|mesh-list
2891183|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2891184|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2891185|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891186|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
2891187|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2891188|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2891189|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
2891190|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2891191|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2891192|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2891193|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2891194|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891195|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
2891196|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2891197|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2891198|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2891199|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891215|NCT03940586|Letermovir|letermovir|mesh-list
2891216|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2891217|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891218|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891219|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891220|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
2891221|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2891222|NCT03937596|Cycloserine|cycloserine|mesh-list
2891223|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2322075|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
2322076|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
2322077|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
2322078|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2322079|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
2322080|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
2322081|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2322082|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2322083|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2322084|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
2322085|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322086|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322087|NCT00374881|Protective Agents|protective agents|mesh-ancestor
2322088|NCT00374881|Cathartics|cathartics|mesh-ancestor
2322089|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2322090|NCT00374894|Succimer|succimer|mesh-list
2322091|NCT00374894|Antidotes|antidotes|mesh-ancestor
2322092|NCT00374894|Protective Agents|protective agents|mesh-ancestor
2322093|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322094|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
2322095|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
2891224|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2891225|NCT03937596|Renal Agents|renal agents|mesh-ancestor
2891226|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2891227|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
2891228|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2891229|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
2891230|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891231|NCT03932201|Factor VIII|factor viii|mesh-list
2891232|NCT03932201|Coagulants|coagulants|mesh-ancestor
2891240|NCT03930745|TOL-463|tol-463|mesh-list
2891241|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2891242|NCT03928158|Valsartan|valsartan|mesh-list
2891243|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2891244|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2891245|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2891246|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2891247|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891248|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2891249|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2891250|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891251|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2891252|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2891253|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2891254|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891255|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
2891256|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2891260|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2322096|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322097|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
2322098|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2322099|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322100|NCT00374985|Docetaxel|docetaxel|mesh-list
2322101|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
2322102|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322103|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
2322104|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
2322105|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
2322106|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322107|NCT00375050|Riluzole|riluzole|mesh-list
2322108|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
2322109|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2322110|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2891261|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2891262|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322111|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322112|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322113|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322114|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2322115|NCT00375050|Protective Agents|protective agents|mesh-ancestor
2891263|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2891264|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2891265|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2891266|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891267|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
2322116|NCT00375076|Enoxaparin|enoxaparin|mesh-list
2322117|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
2322118|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2322119|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2322120|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322121|NCT00375193|Amrubicin|amrubicin|mesh-list
2322122|NCT00375193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322123|NCT00375232|Montelukast|montelukast|mesh-list
2322124|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2322125|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
2322126|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2322127|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
2322128|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2322129|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322130|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2322131|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2891268|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2891269|NCT03922880|Nivolumab|nivolumab|mesh-list
2891270|NCT03922880|Ipilimumab|ipilimumab|mesh-list
2891271|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891272|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891273|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2891274|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891275|NCT03920722|Rituximab|rituximab|mesh-list
2891276|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891277|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891278|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
2322132|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322133|NCT00375245|Sirolimus|sirolimus|mesh-list
2322134|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2322135|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322136|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2891279|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891280|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2891281|NCT03916419|Paclitaxel|paclitaxel|mesh-list
2891282|NCT03916419|Carboplatin|carboplatin|mesh-list
2891283|NCT03916419|Durvalumab|durvalumab|mesh-list
2891284|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2891285|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891286|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
2891287|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
2891288|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
2891289|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891290|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2322137|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322138|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
2322139|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2322140|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
2322141|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322142|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
2322143|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2322144|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2322145|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322146|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
2322147|NCT00375258|Coagulants|coagulants|mesh-ancestor
2322148|NCT00375284|Pramipexole|pramipexole|mesh-list
2322149|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
2322150|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322151|NCT00375284|Protective Agents|protective agents|mesh-ancestor
2322152|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322153|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2322154|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2322155|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
2322156|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
2891340|NCT03902314|Lidocaine|lidocaine|mesh-list
2891341|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
2891342|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
2891343|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2891344|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891345|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
2891346|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2891347|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2891348|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2891349|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2891350|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2891351|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891352|NCT03900715|Luspatercept|luspatercept|mesh-list
2891353|NCT03900715|Hematinics|hematinics|mesh-ancestor
2891354|NCT03899467|Androgens|androgens|mesh-list
2891355|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
2322157|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322158|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
2322159|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
2322160|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2322161|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2322162|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322163|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322164|NCT00375297|Urological Agents|urological agents|mesh-ancestor
2322165|NCT00375310|Gemcitabine|gemcitabine|mesh-list
2322166|NCT00375310|Sorafenib|sorafenib|mesh-list
2322167|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2322168|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
2322169|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322170|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891356|NCT03899467|Hormones|hormones|mesh-ancestor
2891357|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2891358|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891359|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
2891360|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
2891361|NCT03898037|Metformin|metformin|mesh-list
2891362|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2891363|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891364|NCT03894501|Methadone|methadone|mesh-list
2891365|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2891366|NCT03894501|Narcotics|narcotics|mesh-ancestor
2891367|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2891368|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891369|NCT03894501|Analgesics|analgesics|mesh-ancestor
2891370|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
2891371|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2891372|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
2891373|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
2891374|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
2891375|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2891376|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
2891377|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
2891378|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2891379|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891380|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2891381|NCT03879538|Analgesics|analgesics|mesh-ancestor
2891382|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
2891383|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2891384|NCT03874325|Durvalumab|durvalumab|mesh-list
2891385|NCT03874325|Letrozole|letrozole|mesh-list
2891386|NCT03874325|Anastrozole|anastrozole|mesh-list
2322171|NCT00375310|Antiviral Agents|antiviral agents|mesh-ancestor
2322172|NCT00375310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322173|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322174|NCT00375310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2322175|NCT00375310|Immunologic Factors|immunologic factors|mesh-ancestor
2322176|NCT00375310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322177|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2322178|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
2891387|NCT03874325|Exemestane|exemestane|mesh-list
2891388|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891389|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891390|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2891391|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2891392|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891393|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891394|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2891395|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
2891396|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2891397|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891398|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2322179|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
2322180|NCT00375375|Lactulose|lactulose|mesh-list
2322181|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2322182|NCT00375388|Metformin|metformin|mesh-list
2322183|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2322184|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322185|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
2322186|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2322187|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2322188|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322189|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
2322190|NCT00375440|Coagulants|coagulants|mesh-ancestor
2322191|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
2322192|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2322193|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2322194|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322195|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
2322196|NCT00375466|Coagulants|coagulants|mesh-ancestor
2322197|NCT00375557|Valproic Acid|valproic acid|mesh-list
2322198|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2322199|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
2322200|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2322201|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2891428|NCT03860987|Prednisone|prednisone|mesh-list
2891429|NCT03860987|Goserelin|goserelin|mesh-list
2322202|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2322203|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2322204|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322205|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
2322206|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322207|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322208|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
2322209|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322210|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
2322211|NCT00375583|Albendazole|albendazole|mesh-list
2322212|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
2322213|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2322214|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322215|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
2322216|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2322217|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2322218|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
2322219|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
2322220|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
2322221|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322222|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322223|NCT00375596|Ketotifen|ketotifen|mesh-list
2322224|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2322225|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
2891430|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2891431|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
2891432|NCT03860987|Hormones|hormones|mesh-ancestor
2891433|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2891434|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891435|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2891436|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891437|NCT03859973|BI 425809|bi 425809|mesh-list
2891438|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
2891439|NCT03853317|Avelumab|avelumab|mesh-list
2891440|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891441|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891452|NCT03845517|PF-06700841|pf-06700841|mesh-list
2891453|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2891454|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891455|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891460|NCT03841565|Dexamethasone|dexamethasone|mesh-list
2891461|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
2891462|NCT03841565|Daratumumab|daratumumab|mesh-list
2891463|NCT03841565|Pomalidomide|pomalidomide|mesh-list
2891464|NCT03841565|Ichthammol|ichthammol|mesh-list
2891465|NCT03841565|BB 1101|bb 1101|mesh-list
2891466|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2891467|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
2891468|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
2891469|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2891470|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891471|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2891472|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
2322226|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
2322227|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2322228|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
2322229|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
2322230|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322231|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322232|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322233|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2322234|NCT00375622|Tamoxifen|tamoxifen|mesh-list
2322235|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2322236|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
2322237|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2322238|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322239|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2891473|NCT03841565|Hormones|hormones|mesh-ancestor
2891474|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2891475|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2891476|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891477|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
2891478|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891479|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891480|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
2891481|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2891482|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2322240|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322241|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2322242|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2891483|NCT03841565|Growth Substances|growth substances|mesh-ancestor
2891484|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
2891485|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
2891486|NCT03837860|Oxycodone|oxycodone|mesh-list
2891487|NCT03837860|Risperidone|risperidone|mesh-list
2891488|NCT03837860|Ziprasidone|ziprasidone|mesh-list
2891489|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2891490|NCT03837860|Narcotics|narcotics|mesh-ancestor
2891491|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2891492|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891493|NCT03837860|Analgesics|analgesics|mesh-ancestor
2891494|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
2891495|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2891496|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2891497|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
2891498|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2891499|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891500|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2891501|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2891502|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2891503|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2891504|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
2891505|NCT03834688|Rituximab|rituximab|mesh-list
2891506|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2891507|NCT03834688|Venetoclax|venetoclax|mesh-list
2891508|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891509|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322243|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2322244|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
2322245|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2322246|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322247|NCT00375661|Interferons|interferons|mesh-list
2322248|NCT00375661|Ribavirin|ribavirin|mesh-list
2322249|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
2322250|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
2322251|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322252|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
2891510|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
2891511|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891512|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2891513|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2891514|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
2891515|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891516|NCT03831165|Acyclovir|acyclovir|mesh-list
2891517|NCT03831165|Melatonin|melatonin|mesh-list
2891518|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
2891519|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891520|NCT03831165|Protective Agents|protective agents|mesh-ancestor
2891521|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891522|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2891523|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
2891524|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2891525|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2891526|NCT03830723|Hormones|hormones|mesh-ancestor
2891527|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2891528|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891529|NCT03829007|Durvalumab|durvalumab|mesh-list
2891530|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2891531|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891532|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891533|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
2891534|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322253|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322254|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
2322255|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322256|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
2322257|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322258|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2322259|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
2322260|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2322261|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
2322262|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2322263|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322264|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2322265|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2322266|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322267|NCT00375765|Dutasteride|dutasteride|mesh-list
2322268|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2322269|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2322270|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322271|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322272|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
2322273|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2322274|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322275|NCT00375778|Memantine|memantine|mesh-list
2322276|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2322277|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2322278|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
2322279|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322280|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322281|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322282|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2322283|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2322284|NCT00375791|Dexamethasone|dexamethasone|mesh-list
2322285|NCT00375791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2322286|NCT00375791|Antiemetics|antiemetics|mesh-ancestor
2322287|NCT00375791|Autonomic Agents|autonomic agents|mesh-ancestor
2322288|NCT00375791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2322289|NCT00375791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322290|NCT00375791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2322291|NCT00375791|Glucocorticoids|glucocorticoids|mesh-ancestor
2322292|NCT00375791|Hormones|hormones|mesh-ancestor
2322293|NCT00375791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2322294|NCT00375791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2322295|NCT00375791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322296|NCT00375843|Citalopram|citalopram|mesh-list
2322297|NCT00375843|Sertraline|sertraline|mesh-list
2322298|NCT00375843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2322299|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2891561|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2891562|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2891563|NCT03801902|Durvalumab|durvalumab|mesh-list
2891564|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
2891565|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2891566|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
2891567|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891568|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891569|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
2891570|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891571|NCT03801863|Ropivacaine|ropivacaine|mesh-list
2891572|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
2891573|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
2891574|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2891575|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891576|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
2891577|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2891578|NCT03800836|Paclitaxel|paclitaxel|mesh-list
2891579|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2891580|NCT03800836|Atezolizumab|atezolizumab|mesh-list
2891581|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2891582|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322300|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2322301|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322302|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322303|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
2322304|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322305|NCT00375843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2322306|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
2891583|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
2891584|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
2891585|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
2891586|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891587|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
2891588|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2891589|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2891590|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891591|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2891592|NCT03800641|Analgesics|analgesics|mesh-ancestor
2891593|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
2891594|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2891595|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2891596|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2891597|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2891598|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
2891599|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2891600|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891601|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
2891602|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
2891624|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
2891625|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2891626|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2891627|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2891628|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
2891629|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
2322307|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2322308|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
2322309|NCT00375869|Hematinics|hematinics|mesh-ancestor
2322310|NCT00375895|Cyclosporine|cyclosporine|mesh-list
2322311|NCT00375895|Cyclosporins|cyclosporins|mesh-list
2322312|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322313|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891654|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
2891655|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891656|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891657|NCT03772951|Clozapine|clozapine|mesh-list
2891658|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2322314|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2322315|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
2322316|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322317|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
2322318|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322319|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
2322320|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2322321|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2322322|NCT00376012|Rifampin|rifampin|mesh-list
2322323|NCT00376012|Isoniazid|isoniazid|mesh-list
2891659|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
2891660|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2891661|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891662|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891663|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2891664|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2891665|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2891666|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2891667|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
2891668|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
2891669|NCT03771612|Naproxen|naproxen|mesh-list
2891670|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2891671|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2891672|NCT03771612|Analgesics|analgesics|mesh-ancestor
2891673|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
2891674|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109387|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109388|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891675|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891676|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2891677|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2891678|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
2891679|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2891680|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891681|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891682|NCT03768570|Durvalumab|durvalumab|mesh-list
2891683|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891684|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109389|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109390|NCT02518971|Urological Agents|urological agents|mesh-ancestor
2109391|NCT02519023|Acetaminophen|acetaminophen|mesh-list
2109392|NCT02519023|Ibuprofen|ibuprofen|mesh-list
2109393|NCT02519023|Epinephrine|epinephrine|mesh-list
2109394|NCT02519023|Oxycodone|oxycodone|mesh-list
2109395|NCT02519023|Bupivacaine|bupivacaine|mesh-list
2109396|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
2109397|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
2109398|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109399|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109400|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
2322324|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
2322325|NCT00376012|Ethambutol|ethambutol|mesh-list
2322326|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2322327|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
2322328|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2322329|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322330|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
2322331|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2322332|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322333|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322334|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2322335|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2322336|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2322337|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2322338|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2322339|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2322340|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2322341|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2322342|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
2322343|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2322344|NCT00376025|Antioxidants|antioxidants|mesh-list
2322345|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322346|NCT00376025|Protective Agents|protective agents|mesh-ancestor
2322347|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891696|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
2891697|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891698|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891699|NCT03753087|Empagliflozin|empagliflozin|mesh-list
2891700|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2891701|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891702|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2891703|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891704|NCT03751124|Norethindrone|norethindrone|mesh-list
2322348|NCT00376038|Metformin|metformin|mesh-list
2322349|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2322350|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322351|NCT00376051|Citalopram|citalopram|mesh-list
2322352|NCT00376051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2322353|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2322354|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2322355|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322356|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322357|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
2322358|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322359|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2322360|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
2891705|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
2891706|NCT03751124|Estradiol|estradiol|mesh-list
2891707|NCT03751124|Relugolix|relugolix|mesh-list
2891708|NCT03751124|Estrogens|estrogens|mesh-ancestor
2891709|NCT03751124|Hormones|hormones|mesh-ancestor
2891710|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2891711|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891712|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2891713|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
2891714|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2891715|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2891716|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2891717|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2891718|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2891719|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
2891720|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
2891725|NCT03735420|Xanthohumol|xanthohumol|mesh-list
2891726|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891727|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2891728|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2891729|NCT03735420|Growth Substances|growth substances|mesh-ancestor
2891730|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891731|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
2891732|NCT03734237|Vaccines|vaccines|mesh-list
2891733|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
2891734|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891743|NCT03730337|Nivolumab|nivolumab|mesh-list
2891744|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891745|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891746|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2891747|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891748|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2891749|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
2891750|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
2891751|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891752|NCT03727776|Hormones|hormones|mesh-list
2891753|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2891754|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2891755|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
2891756|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2891757|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891758|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2891759|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891766|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2891767|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
2891768|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
2891769|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2891770|NCT03721328|Vancomycin|vancomycin|mesh-list
2891771|NCT03721328|Tobramycin|tobramycin|mesh-list
2891772|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2891773|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2891774|NCT03715933|Carboplatin|carboplatin|mesh-list
2891775|NCT03715933|Fluorouracil|fluorouracil|mesh-list
2891776|NCT03715933|Irinotecan|irinotecan|mesh-list
2891777|NCT03715933|Pemetrexed|pemetrexed|mesh-list
2891778|NCT03715933|Temozolomide|temozolomide|mesh-list
2891779|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891780|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
2891781|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891782|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2891783|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2891784|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
2891785|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891786|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2891787|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2891788|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891789|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2891790|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2891791|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2891792|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
2891793|NCT03715166|Bumetanide|bumetanide|mesh-list
2891794|NCT03715166|Diuretics|diuretics|mesh-ancestor
2891795|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
2322361|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2322362|NCT00376064|Octreotide|octreotide|mesh-list
2322363|NCT00376064|Cabergoline|cabergoline|mesh-list
2322364|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2322365|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2322366|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322367|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2322368|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2322369|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
2322370|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
2322371|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322372|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322373|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322374|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
2322375|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2322376|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2322377|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
2322378|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2322379|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2891796|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891797|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2891798|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2891799|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891800|NCT03715153|Bumetanide|bumetanide|mesh-list
2891801|NCT03715153|Diuretics|diuretics|mesh-ancestor
2891802|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
2891803|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891804|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2891805|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2891806|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891810|NCT03712228|Antibodies|antibodies|mesh-list
2891811|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2891812|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
2891813|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891814|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
2891815|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2891816|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
2891817|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2891818|NCT03711838|Expectorants|expectorants|mesh-ancestor
2891819|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
2891820|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2891821|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
2891822|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891823|NCT03711838|Protective Agents|protective agents|mesh-ancestor
2891824|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891825|NCT03711838|Antidotes|antidotes|mesh-ancestor
2891826|NCT03710824|Nintedanib|nintedanib|mesh-list
2891827|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891828|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2891829|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891830|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322380|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
2322381|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
2322382|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2322383|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322384|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2322385|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
2322386|NCT00376077|Hormones|hormones|mesh-ancestor
2322387|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2322388|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2322389|NCT00376077|Protective Agents|protective agents|mesh-ancestor
2322390|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2322391|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322392|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
2322393|NCT00376103|Temozolomide|temozolomide|mesh-list
2322394|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2322395|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
2322396|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322397|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322398|NCT00376129|Alefacept|alefacept|mesh-list
2891831|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
2891832|NCT03706898|Dolutegravir|dolutegravir|mesh-list
2322399|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
2322400|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
2322401|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322402|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
2322403|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
2322404|NCT00376155|Amodiaquine|amodiaquine|mesh-list
2322405|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
2322406|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2322407|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2322408|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322409|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2322410|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322411|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322412|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2322413|NCT00376155|Renal Agents|renal agents|mesh-ancestor
2322414|NCT00376181|Pioglitazone|pioglitazone|mesh-list
2322415|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2322416|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2322417|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322418|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2322419|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2322420|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322421|NCT00376272|Valsartan|valsartan|mesh-list
2322422|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2322423|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2322424|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2322425|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322426|NCT00376285|Fenofibrate|fenofibrate|mesh-list
2322427|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2322428|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
2322429|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322430|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2322431|NCT00376311|Calcitonin|calcitonin|mesh-list
2322432|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
2322433|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2891833|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
2891834|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
2891835|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2891836|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2891837|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2891838|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891839|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891840|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2891841|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2891842|NCT03706690|Durvalumab|durvalumab|mesh-list
2891843|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891844|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891845|NCT03701763|Apremilast|apremilast|mesh-list
2891846|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2891847|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2891848|NCT03701763|Analgesics|analgesics|mesh-ancestor
2891849|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
2322434|NCT00376311|Katacalcin|katacalcin|mesh-list
2322435|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2322436|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322437|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2322438|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
2322439|NCT00376324|Tigecycline|tigecycline|mesh-list
2322440|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2322441|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322442|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2322443|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322444|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322445|NCT00376337|Micafungin|micafungin|mesh-list
2322446|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
2322447|NCT00376337|Clotrimazole|clotrimazole|mesh-list
2322448|NCT00376337|Miconazole|miconazole|mesh-list
2322449|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322450|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2322451|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2322452|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2322453|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322454|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322455|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2322456|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
2891850|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2891851|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891852|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2891853|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2891854|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2322457|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2322458|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322459|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2322460|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2322461|NCT00376376|Levofloxacin|levofloxacin|mesh-list
2322462|NCT00376376|Ofloxacin|ofloxacin|mesh-list
2322463|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2322464|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322465|NCT00376376|Renal Agents|renal agents|mesh-ancestor
2322466|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2322467|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2322468|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2322469|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891855|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2891856|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891857|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891858|NCT03699865|Nicotine|nicotine|mesh-list
2891859|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2891860|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
2891861|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2891862|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891863|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2891864|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2891865|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
2891866|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2891867|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891871|NCT03694002|Paclitaxel|paclitaxel|mesh-list
2891872|NCT03694002|Carboplatin|carboplatin|mesh-list
2891873|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2891874|NCT03694002|Ramucirumab|ramucirumab|mesh-list
2891875|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2891876|NCT03694002|Antibodies|antibodies|mesh-list
2891877|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
2891878|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2891879|NCT03694002|Lexatumumab|lexatumumab|mesh-list
2891880|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2891881|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891882|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
2891883|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
2891884|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
2891885|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891886|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
2891887|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891888|NCT03693300|Durvalumab|durvalumab|mesh-list
2891889|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891890|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891891|NCT03691727|Tirofiban|tirofiban|mesh-list
2891892|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2891893|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2322470|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322471|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322472|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2322473|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2891894|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891895|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2891896|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
2891897|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891898|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322474|NCT00376428|Gentamicins|gentamicins|mesh-list
2322475|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2322476|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322477|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2322478|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322479|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322480|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
2322481|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322482|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2322483|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322484|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322485|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
2322486|NCT00376480|Fludarabine|fludarabine|mesh-list
2891924|NCT03653364|Baloxavir|baloxavir|mesh-list
2891925|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
2891926|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2891927|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2891928|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891929|NCT03651804|Acetaminophen|acetaminophen|mesh-list
2891930|NCT03651804|Diphosphonates|diphosphonates|mesh-list
2891931|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2891932|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2322487|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
2322488|NCT00376480|Thiotepa|thiotepa|mesh-list
2322489|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2322490|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322491|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2322492|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
2322493|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322494|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2322495|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
2891933|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2891934|NCT03651804|Analgesics|analgesics|mesh-ancestor
2891935|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
2891936|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2891937|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891938|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
2891939|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2891940|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2891941|NCT03651271|Nivolumab|nivolumab|mesh-list
2891942|NCT03651271|Ipilimumab|ipilimumab|mesh-list
2891943|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2891944|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2891945|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2891946|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2891959|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2891960|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2891961|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
2891962|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891963|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
2891964|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2891965|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2891966|NCT03647852|Prednisolone|prednisolone|mesh-list
2891967|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
2891968|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2891969|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
2891970|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2891971|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
2891972|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
2891973|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2891974|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2891975|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2891976|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
2891977|NCT03647852|Hormones|hormones|mesh-ancestor
2891978|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2891979|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2891980|NCT03647852|Protective Agents|protective agents|mesh-ancestor
2891981|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2891982|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322496|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322497|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2322498|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
2322499|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
2322500|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2322501|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2892002|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
2892003|NCT03640949|Vasopressins|vasopressins|mesh-list
2892004|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
2892005|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2892006|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
2892007|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
2892008|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2892009|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892010|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2892011|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
2892012|NCT03640949|Hormones|hormones|mesh-ancestor
2892013|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2892014|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2892015|NCT03640949|Protective Agents|protective agents|mesh-ancestor
2892016|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
2892017|NCT03640949|Coagulants|coagulants|mesh-ancestor
2892018|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2892019|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2892020|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
2892021|NCT03639948|Carboplatin|carboplatin|mesh-list
2892022|NCT03639948|Docetaxel|docetaxel|mesh-list
2892023|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
2892024|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892025|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
2892026|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
2892027|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
2322502|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
2892028|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892029|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892036|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
2892037|NCT03630211|Thiotepa|thiotepa|mesh-list
2892038|NCT03630211|Rituximab|rituximab|mesh-list
2892039|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
2892040|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
2892041|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2892042|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
2892043|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2892044|NCT03630211|Antibodies|antibodies|mesh-list
2892045|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
2892046|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2892047|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2892048|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
2892049|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892050|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2892051|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2892052|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
2892053|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892054|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892055|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2892056|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892057|NCT03629327|Aspirin|aspirin|mesh-list
2892058|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2892059|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2892060|NCT03629327|Analgesics|analgesics|mesh-ancestor
2892061|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
2892062|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2892063|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892064|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2892065|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2892066|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2892067|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2892068|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892069|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2892070|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2892071|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892072|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
2892073|NCT03623321|Pimavanserin|pimavanserin|mesh-list
2892074|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2892075|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2892076|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2322503|NCT00376480|Hormones|hormones|mesh-ancestor
2322504|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2322505|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2322506|NCT00376480|Protective Agents|protective agents|mesh-ancestor
2322507|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2322508|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
2322509|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2322510|NCT00376493|Metronidazole|metronidazole|mesh-list
2322511|NCT00376493|Doxycycline|doxycycline|mesh-list
2322512|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322513|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2322514|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2322515|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2322516|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
2322517|NCT00376519|Cyclosporine|cyclosporine|mesh-list
2322518|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
2892077|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2892078|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2892079|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322519|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
2322520|NCT00376519|Fludarabine|fludarabine|mesh-list
2322521|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
2322522|NCT00376519|Cyclosporins|cyclosporins|mesh-list
2322523|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2322524|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
2322525|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322526|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2322527|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2892080|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2892081|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2892082|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2892083|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
2892084|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2892085|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892086|NCT03616886|Paclitaxel|paclitaxel|mesh-list
2892087|NCT03616886|Carboplatin|carboplatin|mesh-list
2892088|NCT03616886|Durvalumab|durvalumab|mesh-list
2892089|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2892090|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892091|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
2892092|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
2892093|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
2892094|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892095|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892096|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
2892097|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892098|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892099|NCT03610061|Durvalumab|durvalumab|mesh-list
2892100|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892101|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322528|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
2322529|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322530|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322531|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2322532|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2322533|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
2322534|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322535|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
2322536|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322537|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
2322538|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2322539|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2322540|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2322541|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
2322542|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2322543|NCT00376584|Niacin|niacin|mesh-list
2322544|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2322545|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
2322546|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322547|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2322548|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
2322549|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
2322550|NCT00376584|Vitamins|vitamins|mesh-ancestor
2322551|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
2322552|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322553|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
2322554|NCT00376662|Hormones|hormones|mesh-list
2892148|NCT03604159|Buprenorphine|buprenorphine|mesh-list
2892149|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2892150|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2892151|NCT03604159|Narcotics|narcotics|mesh-ancestor
2892152|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2892153|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892154|NCT03604159|Analgesics|analgesics|mesh-ancestor
2892155|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
2892156|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2892157|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2892158|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
2892159|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
2322555|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2322556|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322557|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2322558|NCT00376701|Bevacizumab|bevacizumab|mesh-list
2322559|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2322560|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892160|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892161|NCT03594110|Empagliflozin|empagliflozin|mesh-list
2892162|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2892163|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892164|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2892165|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892166|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
2892167|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
2892168|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892169|NCT03592693|Vitamins|vitamins|mesh-list
2892170|NCT03592693|Ascorbic Acid|ascorbic acid|mesh-list
2892171|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
2892172|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
2892173|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892174|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2892175|NCT03592693|Antioxidants|antioxidants|mesh-ancestor
2892176|NCT03592693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892177|NCT03592693|Protective Agents|protective agents|mesh-ancestor
2892178|NCT03591380|Belimumab|belimumab|mesh-list
2892179|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2892180|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
2322561|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2322562|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2322563|NCT00376701|Growth Substances|growth substances|mesh-ancestor
2322564|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892181|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892182|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
2892183|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
2892184|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322565|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
2322566|NCT00376727|Cetuximab|cetuximab|mesh-list
2322567|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2322568|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322569|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
2322570|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2322571|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322572|NCT00376766|Levetiracetam|levetiracetam|mesh-list
2322573|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
2322574|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
2892185|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2892186|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892187|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892188|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
2892189|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
2109401|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109402|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2109403|NCT02519023|Analgesics|analgesics|mesh-ancestor
2322575|NCT00376792|Docetaxel|docetaxel|mesh-list
2322576|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322577|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
2322578|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
2892190|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
2892191|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892192|NCT03587311|Paclitaxel|paclitaxel|mesh-list
2892193|NCT03587311|Maytansine|maytansine|mesh-list
2892194|NCT03587311|Bevacizumab|bevacizumab|mesh-list
2892195|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2892196|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2892197|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
2892198|NCT03587311|Antibodies|antibodies|mesh-list
2892199|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
2322579|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
2322580|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322581|NCT00376818|Hormones|hormones|mesh-list
2322582|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2322583|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322584|NCT00376831|Fentanyl|fentanyl|mesh-list
2322585|NCT00376831|Midazolam|midazolam|mesh-list
2322586|NCT00376831|Ketamine|ketamine|mesh-list
2322587|NCT00376831|Analgesics|analgesics|mesh-ancestor
2322588|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
2322589|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2322590|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322591|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2322592|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2322593|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
2322594|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
2892200|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2892201|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
2892202|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2892203|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892204|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
2892205|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
2892206|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
2892207|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322595|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2322596|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2322597|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2322598|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322599|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322600|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2322601|NCT00376831|Narcotics|narcotics|mesh-ancestor
2322602|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2322603|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2322604|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2322605|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2322606|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2322607|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
2322608|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
2322609|NCT00376870|Pioglitazone|pioglitazone|mesh-list
2322610|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2892208|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2892209|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2892210|NCT03587311|Growth Substances|growth substances|mesh-ancestor
2892211|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892212|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
2892213|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
2892214|NCT03578172|Menotropins|menotropins|mesh-list
2322611|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322612|NCT00376883|Pamidronate|pamidronate|mesh-list
2322613|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2109404|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
2109405|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2109406|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109407|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2109408|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2109409|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109410|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109411|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2109412|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2322614|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892215|NCT03578172|Hormones|hormones|mesh-list
2892216|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2892217|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892218|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2892219|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
2892220|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2322615|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
2322616|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
2322617|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
2322618|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2322619|NCT00376987|Protective Agents|protective agents|mesh-ancestor
2322620|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322621|NCT00377000|Clindamycin|clindamycin|mesh-list
2322622|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
2892221|NCT03578081|Dexamethasone|dexamethasone|mesh-list
2892222|NCT03578081|Ondansetron|ondansetron|mesh-list
2892223|NCT03578081|Olanzapine|olanzapine|mesh-list
2892224|NCT03578081|Palonosetron|palonosetron|mesh-list
2892225|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
2892226|NCT03578081|Aprepitant|aprepitant|mesh-list
2892227|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2892228|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
2892229|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
2892230|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2892231|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892232|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2892233|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
2892234|NCT03578081|Hormones|hormones|mesh-ancestor
2892235|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2892236|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2892237|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892238|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
2892239|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
2892240|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2892241|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
2892242|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2892243|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892244|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2892245|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2892246|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2892247|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2892248|NCT03578081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2892249|NCT03578081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2892250|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2892251|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2892252|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2892253|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2892254|NCT03575052|Pimavanserin|pimavanserin|mesh-list
2892255|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2892256|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2892257|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2892258|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2892259|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2892260|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892261|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2892262|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2892263|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2892264|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
2892265|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2892266|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892267|NCT03573648|Palbociclib|palbociclib|mesh-list
2892268|NCT03573648|Avelumab|avelumab|mesh-list
2892269|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892270|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2892271|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892272|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892273|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892274|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
2892275|NCT03565445|Nivolumab|nivolumab|mesh-list
2892276|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892277|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892278|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2892279|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322623|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
2322624|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2322625|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2322626|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322627|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2322628|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322629|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322630|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
2322631|NCT00377052|Gemcitabine|gemcitabine|mesh-list
2322632|NCT00377052|Bortezomib|bortezomib|mesh-list
2322633|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2322634|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
2322635|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892280|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2892281|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892282|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892283|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892284|NCT03561259|Vorinostat|vorinostat|mesh-list
2892285|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2892286|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892287|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2892288|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892289|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892290|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2892291|NCT03557008|Metronidazole|metronidazole|mesh-list
2892292|NCT03557008|Vancomycin|vancomycin|mesh-list
2892293|NCT03557008|Neomycin|neomycin|mesh-list
2892294|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2892295|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2892296|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2892297|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2892298|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2892299|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892300|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892301|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
2892302|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
2892303|NCT03551522|Seladelpar|seladelpar|mesh-list
2892304|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2892305|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
2892306|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892307|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2892317|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
2892318|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
2892319|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
2892320|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2892321|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2892322|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2892323|NCT03539601|Analgesics|analgesics|mesh-ancestor
2892324|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
2892325|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2892326|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892327|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2892328|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
2892329|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2892330|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
2892331|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2892332|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892333|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892334|NCT03535688|Cycloserine|cycloserine|mesh-list
2892335|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2892336|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2892337|NCT03535688|Renal Agents|renal agents|mesh-ancestor
2892338|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2892339|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
2892340|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2892341|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
2322636|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322637|NCT00377052|Antiviral Agents|antiviral agents|mesh-ancestor
2892342|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892343|NCT03535350|Temozolomide|temozolomide|mesh-list
2892344|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2892345|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
2892346|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892347|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892348|NCT03533283|Atezolizumab|atezolizumab|mesh-list
2892349|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
2322638|NCT00377052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322639|NCT00377052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322640|NCT00377052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2322641|NCT00377052|Immunologic Factors|immunologic factors|mesh-ancestor
2322642|NCT00377052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322643|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
2322644|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2322645|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2892350|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892351|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892352|NCT03532451|Nivolumab|nivolumab|mesh-list
2892353|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892354|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892355|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2892356|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892357|NCT03532217|Nivolumab|nivolumab|mesh-list
2892358|NCT03532217|Ipilimumab|ipilimumab|mesh-list
2892359|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892360|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892361|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2892362|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892363|NCT03529110|Trastuzumab|trastuzumab|mesh-list
2892364|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2892365|NCT03529110|Maytansine|maytansine|mesh-list
2892366|NCT03529110|Camptothecin|camptothecin|mesh-list
2892367|NCT03529110|Immunoconjugates|immunoconjugates|mesh-list
2892368|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892369|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892370|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2892371|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
2892372|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
2892373|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
2892374|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892375|NCT03529110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2892376|NCT03529110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2892377|NCT03529110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892378|NCT03529110|Immunologic Factors|immunologic factors|mesh-ancestor
2892379|NCT03529110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892383|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
2892384|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
2892385|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892386|NCT03522844|Citalopram|citalopram|mesh-list
2892387|NCT03522844|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2892388|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2892389|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2892390|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892391|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2892392|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
2892393|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892394|NCT03522844|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2892395|NCT03522844|Antidepressive Agents|antidepressive agents|mesh-ancestor
2892396|NCT03522844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2892402|NCT03514719|Avelumab|avelumab|mesh-list
2892403|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2892404|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2322646|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
2892405|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892406|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
2892407|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892408|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
2892409|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892410|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892411|NCT03513770|Ketorolac|ketorolac|mesh-list
2892412|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2892413|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2892414|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2892415|NCT03513770|Analgesics|analgesics|mesh-ancestor
2892416|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
2892417|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2892418|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892419|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2892420|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2892421|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2892422|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892423|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892424|NCT03496623|Treprostinil|treprostinil|mesh-list
2322647|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322648|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2322649|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2322650|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892425|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2892426|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2892432|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
2892433|NCT03492112|Velpatasvir|velpatasvir|mesh-list
2892434|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
2892435|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2892436|NCT03491683|Temozolomide|temozolomide|mesh-list
2892437|NCT03491683|Cemiplimab|cemiplimab|mesh-list
2892438|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2892439|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
2892440|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892441|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892442|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892443|NCT03484520|Venetoclax|venetoclax|mesh-list
2892444|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892445|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2892446|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2892447|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2892448|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2892449|NCT03478956|Etrolizumab|etrolizumab|mesh-list
2892450|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2892451|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
2892452|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322651|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322652|NCT00377078|Lactoferrin|lactoferrin|mesh-list
2322653|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322654|NCT00377091|PENTA|penta|mesh-list
2322655|NCT00377091|Fondaparinux|fondaparinux|mesh-list
2322656|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2322657|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
2322658|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2322659|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
2322660|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322661|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322662|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
2322663|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2322664|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2322665|NCT00377104|Alvocidib|alvocidib|mesh-list
2322666|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322667|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
2322668|NCT00377104|Growth Substances|growth substances|mesh-ancestor
2322669|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892463|NCT03476642|Epinephrine|epinephrine|mesh-list
2892464|NCT03476642|Ropivacaine|ropivacaine|mesh-list
2892465|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
2892466|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
2892467|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2892468|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892469|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
2892470|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2892471|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2892472|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2892473|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
2892474|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2892475|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892476|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2892477|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2892478|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
2892479|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2892480|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
2892481|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
2892482|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
2892483|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2892484|NCT03465280|Interferons|interferons|mesh-list
2892485|NCT03465280|Acyclovir|acyclovir|mesh-list
2892486|NCT03465280|Cidofovir|cidofovir|mesh-list
2892487|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
2892488|NCT03465280|Artemisinins|artemisinins|mesh-list
2892489|NCT03465280|Artemisinin|artemisinin|mesh-list
2892490|NCT03465280|Celecoxib|celecoxib|mesh-list
2892491|NCT03465280|Bevacizumab|bevacizumab|mesh-list
2892492|NCT03465280|Methotrexate|methotrexate|mesh-list
2892493|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
2892494|NCT03465280|Isotretinoin|isotretinoin|mesh-list
2892495|NCT03465280|Cimetidine|cimetidine|mesh-list
2892496|NCT03465280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892497|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892498|NCT03465280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2892499|NCT03465280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2892500|NCT03465280|Growth Substances|growth substances|mesh-ancestor
2892501|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892502|NCT03465280|Growth Inhibitors|growth inhibitors|mesh-ancestor
2892503|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2892504|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
2892505|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2322670|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2322671|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322672|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322673|NCT00377143|Warfarin|warfarin|mesh-list
2322674|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
2322675|NCT00377182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2322676|NCT00377182|Antiviral Agents|antiviral agents|mesh-ancestor
2322677|NCT00377182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322678|NCT00377273|Fluorouracil|fluorouracil|mesh-list
2322679|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
2322680|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322681|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2322682|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322683|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2322684|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
2322685|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322686|NCT00377325|Cyclosporine|cyclosporine|mesh-list
2322687|NCT00377325|Cyclosporins|cyclosporins|mesh-list
2322688|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322689|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892506|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2892507|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
2892508|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892509|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
2892510|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892511|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2892512|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2892513|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
2892514|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2892515|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2322690|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2322691|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
2892516|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
2892517|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2892518|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2892519|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2892520|NCT03465280|Analgesics|analgesics|mesh-ancestor
2892521|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
2892522|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2892523|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2892524|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2892525|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2892526|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2322692|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322693|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
2322694|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322695|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
2322696|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2322697|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2322698|NCT00377390|Omalizumab|omalizumab|mesh-list
2322699|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2322700|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2322701|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
2322702|NCT00377442|Simvastatin|simvastatin|mesh-list
2322703|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2322704|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2322705|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
2892527|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2892528|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2892529|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
2892530|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
2892531|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2892532|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2892533|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2892534|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
2892535|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2892536|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2892537|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2892538|NCT03465280|Protective Agents|protective agents|mesh-ancestor
2892539|NCT03464136|Adalimumab|adalimumab|mesh-list
2892540|NCT03464136|Ustekinumab|ustekinumab|mesh-list
2892541|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2892542|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2892543|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
2322706|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322707|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2322708|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2322709|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322710|NCT00377468|Dronabinol|dronabinol|mesh-list
2322711|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
2322712|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322713|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2322714|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2322715|NCT00377468|Analgesics|analgesics|mesh-ancestor
2322716|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
2322717|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2322718|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2322719|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2322720|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322721|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892552|NCT03456076|Gemcitabine|gemcitabine|mesh-list
2892553|NCT03456076|Carboplatin|carboplatin|mesh-list
2892554|NCT03456076|Pemetrexed|pemetrexed|mesh-list
2892555|NCT03456076|Vinorelbine|vinorelbine|mesh-list
2892556|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892557|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2892558|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
2892559|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892560|NCT03456076|Antiviral Agents|antiviral agents|mesh-ancestor
2892561|NCT03456076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2892562|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892563|NCT03456076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2892564|NCT03456076|Immunologic Factors|immunologic factors|mesh-ancestor
2892565|NCT03456076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892566|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2892567|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2892568|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2892569|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
2892570|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
2892571|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
2892572|NCT03454035|Palbociclib|palbociclib|mesh-list
2892573|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892574|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2892575|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892576|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322722|NCT00377468|Hormones|hormones|mesh-ancestor
2322723|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2322724|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
2322725|NCT00377481|Hematinics|hematinics|mesh-ancestor
2322726|NCT00377494|Vaccines|vaccines|mesh-list
2322727|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
2892582|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2892583|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2892584|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892585|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892586|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2892587|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
2892588|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892589|NCT03435003|Dexamethasone|dexamethasone|mesh-list
2892590|NCT03435003|Fentanyl|fentanyl|mesh-list
2892591|NCT03435003|Scopolamine|scopolamine|mesh-list
2892592|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
2322728|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322729|NCT00377546|Ketorolac|ketorolac|mesh-list
2322730|NCT00377546|Nepafenac|nepafenac|mesh-list
2322731|NCT00377546|Bromfenac|bromfenac|mesh-list
2322732|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2322733|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2322734|NCT00377546|Analgesics|analgesics|mesh-ancestor
2322735|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
2322736|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2322737|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322738|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2322739|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2322740|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2322741|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322742|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892593|NCT03435003|Ondansetron|ondansetron|mesh-list
2892594|NCT03435003|Aprepitant|aprepitant|mesh-list
2892595|NCT03435003|Metoclopramide|metoclopramide|mesh-list
2892596|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
2892597|NCT03435003|Propofol|propofol|mesh-list
2892598|NCT03435003|Sevoflurane|sevoflurane|mesh-list
2892599|NCT03435003|Desflurane|desflurane|mesh-list
2892600|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2892601|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2892602|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
2892603|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
2892604|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2892605|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892606|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2892607|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
2892608|NCT03435003|Hormones|hormones|mesh-ancestor
2892609|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2892610|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2892611|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892612|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
2892613|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2892614|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2892615|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2892616|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
2892617|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2892618|NCT03435003|Analgesics|analgesics|mesh-ancestor
2892619|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
2892620|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2892621|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2892622|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2892623|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
2892624|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2892625|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892626|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2892627|NCT03435003|Narcotics|narcotics|mesh-ancestor
2322743|NCT00377559|Docetaxel|docetaxel|mesh-list
2322744|NCT00377559|Doxorubicin|doxorubicin|mesh-list
2322745|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2892628|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2892629|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2892630|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2892631|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
2892632|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
2892633|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2892634|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
2892635|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2892636|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2892637|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2892638|NCT03435003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2892639|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2892640|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2892641|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2892642|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
2892643|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
2892644|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2892645|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
2892646|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2322746|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322747|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
2322748|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
2322749|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
2322750|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322751|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2322752|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2322753|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2322754|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322755|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
2322756|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2322757|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
2322758|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322759|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
2322760|NCT00377624|Protective Agents|protective agents|mesh-ancestor
2372161|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372162|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2892647|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
2892660|NCT03427736|Ketorolac|ketorolac|mesh-list
2892661|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2892662|NCT03427736|Morphine|morphine|mesh-list
2892663|NCT03427736|Oxycodone|oxycodone|mesh-list
2892664|NCT03427736|Hydromorphone|hydromorphone|mesh-list
2892665|NCT03427736|Ketamine|ketamine|mesh-list
2892666|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2892667|NCT03427736|Narcotics|narcotics|mesh-ancestor
2892668|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2892669|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892670|NCT03427736|Analgesics|analgesics|mesh-ancestor
2892671|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
2892672|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2892673|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2892674|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2892675|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
2892676|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
2892677|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2892678|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2892679|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2892680|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892681|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2892682|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2892683|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2892684|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2892685|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2892686|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892687|NCT03421041|Dexamethasone|dexamethasone|mesh-list
2892688|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2892689|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
2892690|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
2892691|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2892692|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892693|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2892694|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
2892695|NCT03421041|Hormones|hormones|mesh-ancestor
2892696|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2892697|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2892698|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892699|NCT03410615|Durvalumab|durvalumab|mesh-list
2892700|NCT03410615|Tremelimumab|tremelimumab|mesh-list
2892701|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892702|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892703|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
2892704|NCT03410030|Gemcitabine|gemcitabine|mesh-list
2892705|NCT03410030|Paclitaxel|paclitaxel|mesh-list
2892706|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2892707|NCT03410030|Cisplatin|cisplatin|mesh-list
2892708|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2892709|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892710|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
2892711|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
2892712|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
2892713|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892714|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2892715|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
2892716|NCT03410030|Antiviral Agents|antiviral agents|mesh-ancestor
2892717|NCT03410030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2892718|NCT03410030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892719|NCT03410030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2892720|NCT03410030|Immunologic Factors|immunologic factors|mesh-ancestor
2892721|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892722|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
2892723|NCT03410030|Protective Agents|protective agents|mesh-ancestor
2892724|NCT03410030|Vitamins|vitamins|mesh-ancestor
2892725|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
2892734|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2892735|NCT03377790|Cantharidin|cantharidin|mesh-list
2892736|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892737|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892754|NCT03376477|Lenalidomide|lenalidomide|mesh-list
2892755|NCT03376477|Molgramostim|molgramostim|mesh-list
2892756|NCT03376477|Vaccines|vaccines|mesh-list
2892757|NCT03376477|Sargramostim|sargramostim|mesh-list
2892758|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2892759|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
2892760|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322761|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
2322762|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2322763|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2322764|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322765|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322766|NCT00377780|Docetaxel|docetaxel|mesh-list
2322767|NCT00377780|Doxorubicin|doxorubicin|mesh-list
2322768|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2322769|NCT00377780|Trastuzumab|trastuzumab|mesh-list
2322770|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322771|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
2322772|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
2322773|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
2322774|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322775|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2322776|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2322777|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2322778|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322779|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2322780|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2322781|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
2322782|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2892761|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2892762|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2892763|NCT03376477|Growth Substances|growth substances|mesh-ancestor
2892764|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
2892765|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892766|NCT03367871|Paclitaxel|paclitaxel|mesh-list
2892767|NCT03367871|Bevacizumab|bevacizumab|mesh-list
2892768|NCT03367871|Carboplatin|carboplatin|mesh-list
2892769|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
2892770|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2892771|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892772|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
2892773|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
2892774|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
2892775|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892776|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892777|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2892778|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2892779|NCT03367871|Growth Substances|growth substances|mesh-ancestor
2892780|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892781|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
2892782|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2892783|NCT03365882|Trastuzumab|trastuzumab|mesh-list
2892784|NCT03365882|Cetuximab|cetuximab|mesh-list
2892785|NCT03365882|Pertuzumab|pertuzumab|mesh-list
2892786|NCT03365882|Irinotecan|irinotecan|mesh-list
2892787|NCT03365882|Camptothecin|camptothecin|mesh-list
2892788|NCT03365882|Antibodies|antibodies|mesh-list
2892789|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
2892790|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2892791|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
2892792|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892793|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892794|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2892795|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2892796|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892797|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892798|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2892799|NCT03365609|Bismuth|bismuth|mesh-list
2892800|NCT03365609|Antacids|antacids|mesh-ancestor
2322783|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2322784|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322785|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322786|NCT00377793|Urological Agents|urological agents|mesh-ancestor
2322787|NCT00377806|Diclofenac|diclofenac|mesh-list
2322788|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2322789|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2322790|NCT00377806|Analgesics|analgesics|mesh-ancestor
2322791|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
2322792|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2322793|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322794|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2322795|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2892801|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892802|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2322796|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2322797|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322798|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322799|NCT00377910|Lidocaine|lidocaine|mesh-list
2322800|NCT00377910|Polidocanol|polidocanol|mesh-list
2322801|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
2322802|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
2322803|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2322804|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322805|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
2322806|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2322807|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2322808|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2322809|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2322810|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2322811|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322812|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2322813|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2322814|NCT00377923|Progesterone|progesterone|mesh-list
2322815|NCT00377923|Progestins|progestins|mesh-ancestor
2322816|NCT00377923|Hormones|hormones|mesh-ancestor
2322817|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2892811|NCT03361852|Rituximab|rituximab|mesh-list
2892812|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
2892813|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892814|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892815|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
2892816|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892817|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2892818|NCT03353675|Nivolumab|nivolumab|mesh-list
2892819|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892820|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892821|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2892822|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892823|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
2892824|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892825|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892826|NCT03341156|Thrombin|thrombin|mesh-list
2892827|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
2892828|NCT03341156|Coagulants|coagulants|mesh-ancestor
2892829|NCT03341078|Ibudilast|ibudilast|mesh-list
2892830|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2892831|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
2892832|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2892833|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892834|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2892835|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
2892836|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2892837|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892838|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892839|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2892840|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
2892841|NCT03340974|Avasopasem manganese|avasopasem manganese|mesh-list
2892842|NCT03340974|Antioxidants|antioxidants|mesh-ancestor
2892843|NCT03340974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892844|NCT03340974|Protective Agents|protective agents|mesh-ancestor
2892845|NCT03340974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892853|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2892854|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
2892855|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
2892856|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892857|NCT03326245|Methylphenidate|methylphenidate|mesh-list
2892858|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2892859|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892860|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2892861|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2892862|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2892863|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892864|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
2892865|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2892868|NCT03319316|Durvalumab|durvalumab|mesh-list
2892869|NCT03319316|Tremelimumab|tremelimumab|mesh-list
2892870|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892871|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322818|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322819|NCT00377936|Gemcitabine|gemcitabine|mesh-list
2322820|NCT00377936|Paclitaxel|paclitaxel|mesh-list
2322821|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2322822|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
2322823|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322824|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322825|NCT00377936|Antiviral Agents|antiviral agents|mesh-ancestor
2892872|NCT03317496|Gemcitabine|gemcitabine|mesh-list
2892873|NCT03317496|Cisplatin|cisplatin|mesh-list
2892874|NCT03317496|Carboplatin|carboplatin|mesh-list
2892875|NCT03317496|Pemetrexed|pemetrexed|mesh-list
2892876|NCT03317496|Avelumab|avelumab|mesh-list
2892877|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2892878|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892879|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2892880|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
2892881|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892882|NCT03317496|Antiviral Agents|antiviral agents|mesh-ancestor
2892883|NCT03317496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2892884|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892885|NCT03317496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2892886|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
2892887|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892888|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2892889|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2892890|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892891|NCT03315832|Valsartan|valsartan|mesh-list
2892892|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2892893|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2892894|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2892895|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892896|NCT03313180|Nintedanib|nintedanib|mesh-list
2892897|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322826|NCT00377936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322827|NCT00377936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322828|NCT00377936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2322829|NCT00377936|Immunologic Factors|immunologic factors|mesh-ancestor
2322830|NCT00377936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322831|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2322832|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
2322833|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
2322834|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
2322835|NCT00377975|Pioglitazone|pioglitazone|mesh-list
2322836|NCT00377975|Ephedrine|ephedrine|mesh-list
2322837|NCT00377975|Caffeine|caffeine|mesh-list
2322838|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2322839|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322840|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2322841|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2322842|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322843|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892898|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2892899|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892900|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892912|NCT03300557|Exemestane|exemestane|mesh-list
2892913|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892914|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2892915|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2892916|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892917|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892918|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2892919|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
2892920|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2892921|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892922|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2892923|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2892924|NCT03300518|Estradiol|estradiol|mesh-list
2892925|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2892926|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2892927|NCT03300518|Ganirelix|ganirelix|mesh-list
2892928|NCT03300518|Estrogens|estrogens|mesh-ancestor
2892929|NCT03300518|Hormones|hormones|mesh-ancestor
2892930|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2892931|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892932|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2892933|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
2892934|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2892935|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2892936|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
2892937|NCT03299309|Vaccines|vaccines|mesh-list
2892938|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
2892939|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892940|NCT03294109|Bupivacaine|bupivacaine|mesh-list
2892941|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
2892942|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
2892943|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2892944|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892945|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
2892946|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2892947|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
2892948|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2892949|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2892950|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
2892951|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
2892952|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2892953|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892954|NCT03290287|Bromides|bromides|mesh-list
2892955|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
2892956|NCT03289039|Fulvestrant|fulvestrant|mesh-list
2892957|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2892958|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322844|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2322845|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2322846|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
2322847|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322848|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
2322849|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
2322850|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2322851|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2322852|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
2322853|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
2892959|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2892960|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2892961|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
2892962|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2892963|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2892964|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
2892965|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2892966|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2892967|NCT03277196|Ivacaftor|ivacaftor|mesh-list
2892968|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2892969|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2892970|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892971|NCT03273413|Pravastatin|pravastatin|mesh-list
2892972|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2892973|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2892974|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
2892975|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2892976|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2892977|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2892978|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2892979|NCT03269409|Coal Tar|coal tar|mesh-list
2892980|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
2892981|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
2892982|NCT03268005|Insulin|insulin|mesh-list
2892983|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2892984|NCT03268005|Metformin|metformin|mesh-list
2892985|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
2892986|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
2892987|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2892988|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2892989|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322854|NCT00377988|Norgestimate|norgestimate|mesh-list
2322855|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
2322856|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2322857|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322858|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2322859|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2322860|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2322861|NCT00378027|PENTA|penta|mesh-list
2322862|NCT00378027|Fondaparinux|fondaparinux|mesh-list
2322863|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2322864|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
2322865|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2322866|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
2322867|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322868|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322869|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
2322870|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2893000|NCT03257618|Temozolomide|temozolomide|mesh-list
2893001|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2893002|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
2893003|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893004|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322871|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2322872|NCT00378066|Bevacizumab|bevacizumab|mesh-list
2322873|NCT00378066|Capecitabine|capecitabine|mesh-list
2322874|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
2322875|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2322876|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322877|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2322878|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2322879|NCT00378066|Growth Substances|growth substances|mesh-ancestor
2322880|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322881|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
2322882|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2322883|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
2322884|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322885|NCT00378092|Risperidone|risperidone|mesh-list
2322886|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2322887|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
2322888|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322889|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322890|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322891|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2322892|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2322893|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2322894|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2322895|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2322896|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
2322897|NCT00378118|Antibodies|antibodies|mesh-list
2322898|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
2322899|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
2322900|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
2322901|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322902|NCT00378144|Acetaminophen|acetaminophen|mesh-list
2322903|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
2322904|NCT00378144|Ephedrine|ephedrine|mesh-list
2322905|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2322906|NCT00378144|Analgesics|analgesics|mesh-ancestor
2322907|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
2322908|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2322909|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322910|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
2322911|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2322912|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
2322913|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2322914|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
2322915|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
2322916|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2322917|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2322918|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
2893012|NCT03228693|Triamcinolone|triamcinolone|mesh-list
2893013|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2893014|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
2322919|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
2322920|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322921|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322922|NCT00378183|Risperidone|risperidone|mesh-list
2322923|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2322924|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
2322925|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2322926|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322927|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322928|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2893015|NCT03228693|Hormones|hormones|mesh-ancestor
2893016|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2893017|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893018|NCT03228186|Docetaxel|docetaxel|mesh-list
2893019|NCT03228186|Pevonedistat|pevonedistat|mesh-list
2893020|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893021|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
2893022|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
2893023|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
2893024|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893025|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322929|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2322930|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2322931|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2322932|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2322933|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
2322934|NCT00378196|Ranibizumab|ranibizumab|mesh-list
2322935|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2322936|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2322937|NCT00378196|Growth Substances|growth substances|mesh-ancestor
2322938|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322939|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
2322940|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893026|NCT03226756|Nivolumab|nivolumab|mesh-list
2893027|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893028|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893029|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2893030|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893031|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2893032|NCT03220854|Antibodies|antibodies|mesh-list
2893033|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
2893034|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2322941|NCT00378287|Rabeprazole|rabeprazole|mesh-list
2322942|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2322943|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2893035|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
2893036|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893037|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893038|NCT03215511|Selitrectinib|selitrectinib|mesh-list
2893039|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893040|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893041|NCT03207867|Spartalizumab|spartalizumab|mesh-list
2893042|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2893043|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893044|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322944|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2322945|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322946|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322947|NCT00378313|Gemcitabine|gemcitabine|mesh-list
2322948|NCT00378313|Paclitaxel|paclitaxel|mesh-list
2322949|NCT00378313|Epirubicin|epirubicin|mesh-list
2322950|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2322951|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322952|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
2322953|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
2322954|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
2322955|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322956|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2322957|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
2322958|NCT00378313|Antiviral Agents|antiviral agents|mesh-ancestor
2322959|NCT00378313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2322960|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322961|NCT00378313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2322962|NCT00378313|Immunologic Factors|immunologic factors|mesh-ancestor
2322963|NCT00378313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322964|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2322965|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2322966|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2322967|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
2322968|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322969|NCT00378404|Docetaxel|docetaxel|mesh-list
2322970|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322971|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
2322972|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
2322973|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
2322974|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322975|NCT00378417|Vaccines|vaccines|mesh-list
2322976|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
2322977|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322978|NCT00378443|Prednisone|prednisone|mesh-list
2322979|NCT00378443|Losartan|losartan|mesh-list
2322980|NCT00378443|Cilazapril|cilazapril|mesh-list
2322981|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2322982|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
2322983|NCT00378443|Hormones|hormones|mesh-ancestor
2893081|NCT03187769|Olanzapine|olanzapine|mesh-list
2893082|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
2893083|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
2893084|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2893085|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893086|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2893087|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2893088|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2893089|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2893090|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2893091|NCT03187769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2893092|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2893093|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2893094|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893095|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2893096|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
2893097|NCT03182166|Golimumab|golimumab|mesh-list
2893098|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2893099|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2893100|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2893101|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
2893102|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893103|NCT03181789|Interleukin-12|interleukin-12|mesh-list
2893104|NCT03181789|Vaccines|vaccines|mesh-list
2322984|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2322985|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2322986|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2322987|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2322988|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2322989|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2322990|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2322991|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2322992|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2322993|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2322994|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
2322995|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2322996|NCT00378456|Vitamins|vitamins|mesh-list
2322997|NCT00378456|Leucovorin|leucovorin|mesh-list
2322998|NCT00378456|Folic Acid|folic acid|mesh-list
2322999|NCT00378456|Vitamin A|vitamin a|mesh-list
2323000|NCT00378456|Zinc|zinc|mesh-list
2323001|NCT00378456|Selenium|selenium|mesh-list
2893105|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
2893106|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893107|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2893108|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2893109|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2893110|NCT03181789|Growth Substances|growth substances|mesh-ancestor
2893111|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
2893112|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893113|NCT03172975|Albendazole|albendazole|mesh-list
2893114|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2893115|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
2893116|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2893117|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2893118|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
2893119|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2893120|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2893121|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
2893122|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
2893123|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
2893124|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893125|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893126|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2893127|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
2893128|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893129|NCT03172975|Antacids|antacids|mesh-ancestor
2893130|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2893131|NCT03169361|Ixazomib|ixazomib|mesh-list
2893132|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893133|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
2893134|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893135|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893136|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
2893137|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
2893138|NCT03168438|Fludarabine|fludarabine|mesh-list
2893139|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2893140|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
2893141|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893142|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2893143|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2893144|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
2893145|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893146|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893147|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2323002|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
2323003|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
2323004|NCT00378456|Antioxidants|antioxidants|mesh-list
2323005|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
2323006|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323007|NCT00378456|Trace Elements|trace elements|mesh-ancestor
2893148|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893149|NCT03155620|Olaparib|olaparib|mesh-list
2893150|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2893151|NCT03155620|Palbociclib|palbociclib|mesh-list
2893152|NCT03155620|Vemurafenib|vemurafenib|mesh-list
2893153|NCT03155620|Tipifarnib|tipifarnib|mesh-list
2893154|NCT03155620|Ensartinib|ensartinib|mesh-list
2893155|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893156|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893157|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893158|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2893159|NCT03154996|Topotecan|topotecan|mesh-list
2893160|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2893161|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2893162|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893163|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893164|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893165|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
2893166|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893167|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893168|NCT03141034|Irinotecan|irinotecan|mesh-list
2893169|NCT03141034|Ramucirumab|ramucirumab|mesh-list
2893170|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2893171|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2893172|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893173|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893174|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323008|NCT00378456|Antidotes|antidotes|mesh-ancestor
2893175|NCT03138512|Nivolumab|nivolumab|mesh-list
2893176|NCT03138512|Ipilimumab|ipilimumab|mesh-list
2893177|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893178|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893179|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2893180|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893181|NCT03132038|Nivolumab|nivolumab|mesh-list
2893182|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893183|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893184|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2893185|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893186|NCT03128021|Milnacipran|milnacipran|mesh-list
2893187|NCT03128021|Citalopram|citalopram|mesh-list
2893188|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
2893189|NCT03128021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2893190|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2893191|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2893192|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893193|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2893194|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
2893195|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893196|NCT03128021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2893197|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
2893198|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2893199|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2893200|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2893201|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2893202|NCT03128021|Analgesics|analgesics|mesh-ancestor
2893203|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
2893204|NCT03120624|Iodine|iodine|mesh-list
2893205|NCT03120624|Interferons|interferons|mesh-list
2893206|NCT03120624|Interferon-beta|interferon-beta|mesh-list
2893207|NCT03120624|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2893208|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
2893209|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893210|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
2893211|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2893212|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
2893213|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893214|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2893215|NCT03120624|Trace Elements|trace elements|mesh-ancestor
2893216|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
2893217|NCT03120624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2893218|NCT03120624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893219|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893220|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2893221|NCT03110380|Dolutegravir|dolutegravir|mesh-list
2893222|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2893223|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2893224|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2893225|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893226|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893227|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2893228|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2893229|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
2893230|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2893231|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2893232|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2323009|NCT00378456|Protective Agents|protective agents|mesh-ancestor
2323010|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
2323011|NCT00378456|Hematinics|hematinics|mesh-ancestor
2323012|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323013|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2893257|NCT03096418|Paclitaxel|paclitaxel|mesh-list
2893258|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2893259|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893260|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
2893261|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
2893262|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
2893263|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893281|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
2893282|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
2893283|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893284|NCT03078478|Insulin|insulin|mesh-list
2893285|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2893286|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
2893287|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2893288|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893289|NCT03072238|Prednisone|prednisone|mesh-list
2323014|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323015|NCT00378495|Miltefosine|miltefosine|mesh-list
2323016|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
2893290|NCT03072238|Prednisolone|prednisolone|mesh-list
2893291|NCT03072238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2893292|NCT03072238|Glucocorticoids|glucocorticoids|mesh-ancestor
2893293|NCT03072238|Hormones|hormones|mesh-ancestor
2893294|NCT03072238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2893295|NCT03072238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893296|NCT03072238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2893297|NCT03072238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893298|NCT03061539|Nivolumab|nivolumab|mesh-list
2893299|NCT03061539|Ipilimumab|ipilimumab|mesh-list
2893300|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893301|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893302|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2323017|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323018|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323019|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2323020|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2323021|NCT00378547|Acetaminophen|acetaminophen|mesh-list
2323022|NCT00378547|Dexamethasone|dexamethasone|mesh-list
2323023|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
2323024|NCT00378547|Pregabalin|pregabalin|mesh-list
2323025|NCT00378547|BB 1101|bb 1101|mesh-list
2323026|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2323027|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
2323028|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
2893303|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893304|NCT03046927|Vitamin D|vitamin d|mesh-list
2323029|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323030|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893305|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
2893306|NCT03046927|Vitamins|vitamins|mesh-ancestor
2893307|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
2893308|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893309|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2893310|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2893311|NCT03043313|Trastuzumab|trastuzumab|mesh-list
2893312|NCT03043313|Tucatinib|tucatinib|mesh-list
2893313|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893314|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893315|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2893316|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893317|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893318|NCT03040726|Palonosetron|palonosetron|mesh-list
2893319|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
2893320|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
2893321|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2893322|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893323|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2893324|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2893325|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2893326|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
2893327|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2893328|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893345|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
2893346|NCT03016377|Fludarabine|fludarabine|mesh-list
2893347|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2893348|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
2893349|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893350|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2893351|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2893352|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
2893353|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893354|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893355|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2893356|NCT03009487|Amlodipine|amlodipine|mesh-list
2893357|NCT03009487|Olmesartan|olmesartan|mesh-list
2893358|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2893359|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
2893360|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2893361|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2893362|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2893363|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2893364|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893365|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2893366|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893367|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
2893368|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2893369|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2893370|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
2893371|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2893372|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2893373|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893374|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2893375|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2893376|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
2893377|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
2893378|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2893379|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893380|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893381|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
2893382|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2893383|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2893384|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323031|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2323032|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
2323033|NCT00378547|Hormones|hormones|mesh-ancestor
2323034|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323035|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2323036|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323037|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
2323038|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323039|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323040|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2323041|NCT00378547|Analgesics|analgesics|mesh-ancestor
2323042|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
2323043|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
2323044|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
2323045|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2323046|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2323047|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2323048|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2323049|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2323050|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2323051|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2323052|NCT00378612|Sirolimus|sirolimus|mesh-list
2323053|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2323054|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323055|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2323056|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323057|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
2323058|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2323059|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
2323060|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323061|NCT00378625|Artesunate|artesunate|mesh-list
2323062|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
2323063|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2323064|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2323065|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323066|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323067|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
2323068|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
2323069|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2323070|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
2323071|NCT00378638|Bevacizumab|bevacizumab|mesh-list
2323072|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2323073|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323074|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2323075|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2323076|NCT00378638|Growth Substances|growth substances|mesh-ancestor
2323077|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323078|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
2323079|NCT00378677|Cyclosporine|cyclosporine|mesh-list
2323080|NCT00378677|Cyclosporins|cyclosporins|mesh-list
2323081|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323082|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893412|NCT02966782|Azacitidine|azacitidine|mesh-list
2893413|NCT02966782|Venetoclax|venetoclax|mesh-list
2893414|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2893415|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
2893416|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893417|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893418|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893419|NCT02961881|Blinatumomab|blinatumomab|mesh-list
2893420|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893421|NCT02954523|Dasatinib|dasatinib|mesh-list
2893422|NCT02954523|Osimertinib|osimertinib|mesh-list
2323083|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2323084|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
2323085|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323086|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
2323087|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323088|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
2323089|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2323090|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2323091|NCT00378690|Leuprolide|leuprolide|mesh-list
2323092|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2323093|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
2323094|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2323095|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323096|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2323097|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323098|NCT00378716|Leucovorin|leucovorin|mesh-list
2323099|NCT00378716|Fluorouracil|fluorouracil|mesh-list
2323100|NCT00378716|Tegafur|tegafur|mesh-list
2323101|NCT00378716|Calcium|calcium|mesh-list
2323102|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
2323103|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2323104|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323105|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
2323106|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323107|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2323108|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323109|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2323110|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
2323111|NCT00378716|Antidotes|antidotes|mesh-ancestor
2323112|NCT00378716|Protective Agents|protective agents|mesh-ancestor
2323113|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
2323114|NCT00378716|Vitamins|vitamins|mesh-ancestor
2323115|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
2323116|NCT00378729|Metformin|metformin|mesh-list
2323117|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2323118|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323119|NCT00378755|Bortezomib|bortezomib|mesh-list
2323120|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323121|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2323122|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
2323123|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893423|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893424|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2893425|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893426|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893427|NCT02951052|Rilpivirine|rilpivirine|mesh-list
2893428|NCT02951052|Cabotegravir|cabotegravir|mesh-list
2893429|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2893430|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2893431|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893432|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893433|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
2893434|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2893435|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2893436|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2893437|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2893438|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2323124|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2323125|NCT00378781|Minocycline|minocycline|mesh-list
2893439|NCT02941783|Factor VIII|factor viii|mesh-list
2893440|NCT02941783|Coagulants|coagulants|mesh-ancestor
2893441|NCT02936102|Spartalizumab|spartalizumab|mesh-list
2893442|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2893443|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893444|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893450|NCT02932410|Macitentan|macitentan|mesh-list
2893451|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2893452|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2893453|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893454|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2893455|NCT02927249|Aspirin|aspirin|mesh-list
2893456|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2893457|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2893458|NCT02927249|Analgesics|analgesics|mesh-ancestor
2893459|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
2893460|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2893461|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893462|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2893463|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2893464|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2893465|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2893466|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893467|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2893468|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2893469|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893470|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
2893471|NCT02924272|Ixazomib|ixazomib|mesh-list
2893472|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893473|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
2893474|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893475|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893500|NCT02908087|Liraglutide|liraglutide|mesh-list
2893501|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2893502|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893503|NCT02908087|Incretins|incretins|mesh-ancestor
2893504|NCT02908087|Hormones|hormones|mesh-ancestor
2893505|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2893506|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
2893507|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2323126|NCT00378781|Heparin|heparin|mesh-list
2323127|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
2323128|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2323129|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2323130|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323131|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2323132|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323133|NCT00378820|Caseins|caseins|mesh-list
2323134|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
2323135|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
2323136|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109413|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
2109414|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109415|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2109416|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2109417|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
2109418|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2109419|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
2109420|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
2109421|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
2109422|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2109423|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2109424|NCT02519023|Narcotics|narcotics|mesh-ancestor
2109425|NCT02519231|Naproxen|naproxen|mesh-list
2109426|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2893508|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893509|NCT02901483|Cisplatin|cisplatin|mesh-list
2893510|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893511|NCT02881086|Cytarabine|cytarabine|mesh-list
2893512|NCT02881086|Dexamethasone|dexamethasone|mesh-list
2893513|NCT02881086|Prednisolone|prednisolone|mesh-list
2893514|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
2893515|NCT02881086|Rituximab|rituximab|mesh-list
2893516|NCT02881086|Methotrexate|methotrexate|mesh-list
2893517|NCT02881086|Fludarabine|fludarabine|mesh-list
2893518|NCT02881086|Vincristine|vincristine|mesh-list
2893519|NCT02881086|Doxorubicin|doxorubicin|mesh-list
2893520|NCT02881086|Daunorubicin|daunorubicin|mesh-list
2893521|NCT02881086|Asparaginase|asparaginase|mesh-list
2893522|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
2893523|NCT02881086|Idarubicin|idarubicin|mesh-list
2893524|NCT02881086|Pegaspargase|pegaspargase|mesh-list
2893525|NCT02881086|Vindesine|vindesine|mesh-list
2893526|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2893527|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
2893528|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323137|NCT00378833|Niacin|niacin|mesh-list
2323138|NCT00378833|Niacinamide|niacinamide|mesh-list
2323139|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
2323140|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2323141|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
2323142|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323143|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2893529|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2893530|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2893531|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
2893532|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893533|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893534|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2893535|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2893536|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
2893537|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
2893538|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2893539|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2893540|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
2893541|NCT02881086|Hormones|hormones|mesh-ancestor
2323144|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
2323145|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
2323146|NCT00378833|Vitamins|vitamins|mesh-ancestor
2323147|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
2323148|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323149|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
2323150|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2323151|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2323152|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323153|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
2323154|NCT00378872|Coagulants|coagulants|mesh-ancestor
2323155|NCT00378911|Sunitinib|sunitinib|mesh-list
2323156|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893542|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2893543|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2893544|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893545|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2323157|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2893546|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
2893547|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2893548|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2893549|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
2893550|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
2893551|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893552|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2893553|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2893554|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
2893555|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2893556|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2893557|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
2893558|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
2893559|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
2893560|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2893561|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2893562|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2893567|NCT02874651|Apatinib|apatinib|mesh-list
2893568|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893569|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2893570|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893571|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893572|NCT02873195|Bevacizumab|bevacizumab|mesh-list
2893573|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2893574|NCT02873195|Capecitabine|capecitabine|mesh-list
2893575|NCT02873195|Atezolizumab|atezolizumab|mesh-list
2893576|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
2893577|NCT02873195|Antibodies|antibodies|mesh-list
2893578|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
2893579|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2893580|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
2893581|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893582|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2893583|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2893584|NCT02873195|Growth Substances|growth substances|mesh-ancestor
2893585|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893586|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
2893587|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
2893588|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2893589|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
2893590|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323158|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2893614|NCT02851056|Sargramostim|sargramostim|mesh-list
2893615|NCT02851056|Lenograstim|lenograstim|mesh-list
2893616|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
2893617|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893618|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2893619|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
2893620|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893621|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893622|NCT02834975|Paclitaxel|paclitaxel|mesh-list
2893623|NCT02834975|Carboplatin|carboplatin|mesh-list
2893624|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
2323159|NCT00378911|Growth Substances|growth substances|mesh-ancestor
2323160|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323161|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
2323162|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2323163|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323164|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323165|NCT00378937|Acetaminophen|acetaminophen|mesh-list
2323166|NCT00378937|Morphine|morphine|mesh-list
2323167|NCT00378937|Oxycodone|oxycodone|mesh-list
2323168|NCT00378937|Codeine|codeine|mesh-list
2323169|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
2323170|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
2323171|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2323172|NCT00378937|Narcotics|narcotics|mesh-ancestor
2323173|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109427|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2109428|NCT02519231|Analgesics|analgesics|mesh-ancestor
2109429|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
2109430|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109431|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109432|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109433|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2109434|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
2109435|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2109436|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109437|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109438|NCT02519387|Buprenorphine|buprenorphine|mesh-list
2323174|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323175|NCT00378937|Analgesics|analgesics|mesh-ancestor
2323176|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
2323177|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323178|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2323179|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
2893625|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2893626|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893627|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
2893628|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
2893629|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
2893630|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893631|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2323180|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
2323181|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
2323182|NCT00378976|Valacyclovir|valacyclovir|mesh-list
2323183|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
2323184|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323185|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
2323186|NCT00379015|Docetaxel|docetaxel|mesh-list
2323187|NCT00379015|Trastuzumab|trastuzumab|mesh-list
2323188|NCT00379015|Epirubicin|epirubicin|mesh-list
2323189|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2323190|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
2323191|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323192|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2323193|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2893638|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
2893639|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893640|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893641|NCT02818868|Apixaban|apixaban|mesh-list
2893642|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2893643|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
2893644|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2893645|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
2893646|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893647|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893648|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
2893649|NCT02809131|Levofloxacin|levofloxacin|mesh-list
2893650|NCT02809131|Ofloxacin|ofloxacin|mesh-list
2893651|NCT02809131|Clindamycin|clindamycin|mesh-list
2893652|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
2323194|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
2323195|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893653|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
2893654|NCT02809131|Cephalexin|cephalexin|mesh-list
2893655|NCT02809131|Polymyxins|polymyxins|mesh-list
2893656|NCT02809131|Bacitracin|bacitracin|mesh-list
2893657|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2893658|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2893659|NCT02809131|Renal Agents|renal agents|mesh-ancestor
2893660|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2893661|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2893662|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2893663|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893664|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893665|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893666|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2893667|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2893668|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2893669|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2893670|NCT02798471|Heparin|heparin|mesh-list
2893671|NCT02798471|Enoxaparin|enoxaparin|mesh-list
2893672|NCT02798471|Warfarin|warfarin|mesh-list
2893673|NCT02798471|Edoxaban|edoxaban|mesh-list
2893674|NCT02798471|Fondaparinux|fondaparinux|mesh-list
2893675|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
2893676|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2893677|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2893678|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893679|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2893680|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
2893681|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2893682|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
2893683|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893684|NCT02788773|Durvalumab|durvalumab|mesh-list
2893685|NCT02788773|Tremelimumab|tremelimumab|mesh-list
2893686|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893687|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893688|NCT02785952|Nivolumab|nivolumab|mesh-list
2893689|NCT02785952|Ipilimumab|ipilimumab|mesh-list
2893690|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893691|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893692|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2893693|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893694|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
2893695|NCT02784171|Pemetrexed|pemetrexed|mesh-list
2893696|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893697|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893698|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893699|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323196|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323197|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2323198|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
2323199|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
2323200|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
2323201|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2323202|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2893700|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2893701|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2893702|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2893703|NCT02758717|Nivolumab|nivolumab|mesh-list
2893704|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2893705|NCT02758717|Antibodies|antibodies|mesh-list
2893706|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
2893707|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2893708|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
2893709|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
2893710|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893711|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893712|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2893713|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893714|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2893715|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2893716|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2893717|NCT02738866|Fulvestrant|fulvestrant|mesh-list
2893718|NCT02738866|Palbociclib|palbociclib|mesh-list
2893719|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2893720|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893721|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2893722|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2893723|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
2893724|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323203|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2323204|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2323205|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323206|NCT00379028|Fluticasone|fluticasone|mesh-list
2323207|NCT00379028|Budesonide|budesonide|mesh-list
2323208|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
2323209|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2323210|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2323211|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2323212|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
2323213|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323214|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323215|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2323216|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
2323217|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
2323218|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2323219|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
2323220|NCT00379028|Hormones|hormones|mesh-ancestor
2323221|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323222|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2323223|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2323224|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2323225|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
2893725|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893726|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2893727|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893728|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893729|NCT02730429|Letrozole|letrozole|mesh-list
2893730|NCT02730429|Palbociclib|palbociclib|mesh-list
2893731|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893732|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2893733|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2893734|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893735|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893736|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2893737|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
2893738|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2893739|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323226|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323227|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323228|NCT00379041|Prednisone|prednisone|mesh-list
2323229|NCT00379041|Doxorubicin|doxorubicin|mesh-list
2323230|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2323231|NCT00379041|Bleomycin|bleomycin|mesh-list
2323232|NCT00379041|Vincristine|vincristine|mesh-list
2323233|NCT00379041|Vinblastine|vinblastine|mesh-list
2323234|NCT00379041|Procarbazine|procarbazine|mesh-list
2323235|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
2323236|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2323237|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323238|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2323239|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2323240|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323241|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893740|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2893741|NCT02730416|Paclitaxel|paclitaxel|mesh-list
2893742|NCT02730416|Carboplatin|carboplatin|mesh-list
2893743|NCT02730416|Nintedanib|nintedanib|mesh-list
2893744|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2893745|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893746|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
2893747|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
2893748|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
2893749|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893750|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2893751|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893752|NCT02723864|Veliparib|veliparib|mesh-list
2893753|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893754|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2893755|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893756|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893757|NCT02713386|Paclitaxel|paclitaxel|mesh-list
2323242|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2893758|NCT02713386|Carboplatin|carboplatin|mesh-list
2893759|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2893760|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2893761|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893762|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
2893763|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
2893764|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
2323243|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
2323244|NCT00379041|Hormones|hormones|mesh-ancestor
2323245|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323246|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323247|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2323248|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2323249|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
2323250|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
2323251|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
2323252|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
2323253|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2323254|NCT00379067|Tamsulosin|tamsulosin|mesh-list
2323255|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2323256|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2323257|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2323258|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
2323259|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323260|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323261|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323262|NCT00379067|Urological Agents|urological agents|mesh-ancestor
2893765|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893766|NCT02693821|Gabapentin|gabapentin|mesh-list
2893767|NCT02693821|Analgesics|analgesics|mesh-ancestor
2893768|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
2893769|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2893770|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893771|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
2893772|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2893773|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2893774|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2893775|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2893776|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2893777|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2893778|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2893779|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893780|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
2893786|NCT02671890|Gemcitabine|gemcitabine|mesh-list
2893787|NCT02671890|Disulfiram|disulfiram|mesh-list
2893788|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2893789|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
2893790|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893791|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893792|NCT02671890|Antiviral Agents|antiviral agents|mesh-ancestor
2893793|NCT02671890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2893794|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893795|NCT02671890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2893796|NCT02671890|Immunologic Factors|immunologic factors|mesh-ancestor
2893797|NCT02671890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893798|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2893799|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2893800|NCT02664181|Nivolumab|nivolumab|mesh-list
2893801|NCT02664181|Decitabine|decitabine|mesh-list
2893802|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
2893803|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893804|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893805|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2893806|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893807|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2893808|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
2893809|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893810|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2893811|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893812|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323263|NCT00379158|Micronutrients|micronutrients|mesh-list
2323264|NCT00379158|Trace Elements|trace elements|mesh-list
2323265|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323266|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2323267|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2323268|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2323269|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
2323270|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323271|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2323272|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2323273|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893818|NCT02633397|Riociguat|riociguat|mesh-list
2893819|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
2893820|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893821|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
2323274|NCT00379262|Fluorouracil|fluorouracil|mesh-list
2323275|NCT00379262|Capecitabine|capecitabine|mesh-list
2323276|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
2323277|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323278|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2323279|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323280|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2323281|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
2323282|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323283|NCT00379405|Ritonavir|ritonavir|mesh-list
2323284|NCT00379405|Saquinavir|saquinavir|mesh-list
2323285|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2323286|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2323287|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
2323288|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323289|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323290|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2323291|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2323292|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
2893822|NCT02633241|Propofol|propofol|mesh-list
2893823|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2893824|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2893825|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893826|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2893827|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
2893828|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
2893829|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2893830|NCT02633241|Analgesics|analgesics|mesh-ancestor
2893831|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
2893832|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2893833|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2893834|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2893835|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2893836|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
2893837|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2893838|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893839|NCT02632721|Decitabine|decitabine|mesh-list
2893840|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2893841|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
2893842|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893843|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893844|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323293|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323294|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2893863|NCT02626715|Vidarabine|vidarabine|mesh-list
2893864|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
2893865|NCT02626715|Fludarabine|fludarabine|mesh-list
2893866|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
2893867|NCT02626715|Thiotepa|thiotepa|mesh-list
2893868|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2893869|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
2893870|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893871|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893872|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2893873|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
2893874|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893875|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
2893876|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2893877|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893878|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2893879|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
2893880|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2893881|NCT02611323|Rituximab|rituximab|mesh-list
2893882|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
2893883|NCT02611323|Venetoclax|venetoclax|mesh-list
2893884|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893885|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893886|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
2893887|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893888|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2893889|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
2893890|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893891|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893892|NCT02607722|Nintedanib|nintedanib|mesh-list
2893893|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893894|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2893895|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893896|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893897|NCT02600897|Rituximab|rituximab|mesh-list
2893898|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
2893899|NCT02600897|Lenalidomide|lenalidomide|mesh-list
2893900|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893901|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893902|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
2893903|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893904|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2893905|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2893906|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2893907|NCT02600897|Growth Substances|growth substances|mesh-ancestor
2893908|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
2893909|NCT02589860|Melphalan|melphalan|mesh-list
2893910|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2893911|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
2893912|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109439|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2109440|NCT02519387|Narcotics|narcotics|mesh-ancestor
2109441|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109442|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109443|NCT02519387|Analgesics|analgesics|mesh-ancestor
2109444|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
2109445|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109446|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2109447|NCT02519595|Ketamine|ketamine|mesh-list
2109448|NCT02519595|Analgesics|analgesics|mesh-ancestor
2109449|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
2109450|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109451|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109452|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2109453|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2109454|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
2109455|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
2893913|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893914|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2323295|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2323296|NCT00379418|Abciximab|abciximab|mesh-list
2323297|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
2323298|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2893915|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2893916|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
2893917|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893918|NCT02586025|Docetaxel|docetaxel|mesh-list
2893919|NCT02586025|Trastuzumab|trastuzumab|mesh-list
2893920|NCT02586025|Pertuzumab|pertuzumab|mesh-list
2893921|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893922|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
2893923|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
2893924|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
2893925|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893926|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2893927|NCT02583789|Treprostinil|treprostinil|mesh-list
2893928|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2893929|NCT02579096|Allopurinol|allopurinol|mesh-list
2893930|NCT02579096|Febuxostat|febuxostat|mesh-list
2893931|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
2893932|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893933|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893934|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
2893935|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2893936|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2893937|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
2893938|NCT02579096|Protective Agents|protective agents|mesh-ancestor
2893939|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893940|NCT02573324|Temozolomide|temozolomide|mesh-list
2893941|NCT02573324|Immunoconjugates|immunoconjugates|mesh-list
2893942|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2893943|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
2893944|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893945|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2893946|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
2893947|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893948|NCT02568267|Entrectinib|entrectinib|mesh-list
2893949|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2893950|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2893951|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323299|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
2323300|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2323301|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2323302|NCT00379431|Prednisolone|prednisolone|mesh-list
2323303|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
2323304|NCT00379431|Rituximab|rituximab|mesh-list
2893987|NCT02562235|Riociguat|riociguat|mesh-list
2893988|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
2893989|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2893990|NCT02556606|Midazolam|midazolam|mesh-list
2893991|NCT02556606|Ketamine|ketamine|mesh-list
2893992|NCT02556606|Analgesics|analgesics|mesh-ancestor
2893993|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
2893994|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2893995|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2893996|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2893997|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2893998|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
2893999|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
2894000|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2894001|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2894002|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2894003|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2894004|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894005|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2894006|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2894007|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2894008|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2894009|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2894010|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
2894011|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
2894012|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
2894013|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2894014|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2894015|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2894016|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894017|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
2894018|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2894019|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894020|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2894021|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2894022|NCT02545283|Cytarabine|cytarabine|mesh-list
2894023|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2894024|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
2894025|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894026|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894027|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
2323305|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2323306|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
2323307|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2323308|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323309|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
2323310|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323311|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2323312|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2323313|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
2323314|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
2323315|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323316|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2323317|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
2323318|NCT00379431|Hormones|hormones|mesh-ancestor
2323319|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323320|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2323321|NCT00379431|Protective Agents|protective agents|mesh-ancestor
2323322|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2323323|NCT00379457|Dactinomycin|dactinomycin|mesh-list
2323324|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
2323325|NCT00379457|Ifosfamide|ifosfamide|mesh-list
2323326|NCT00379457|Carboplatin|carboplatin|mesh-list
2323327|NCT00379457|Doxorubicin|doxorubicin|mesh-list
2323328|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2323329|NCT00379457|Etoposide|etoposide|mesh-list
2323330|NCT00379457|Vincristine|vincristine|mesh-list
2323331|NCT00379457|Topotecan|topotecan|mesh-list
2323332|NCT00379457|Vinorelbine|vinorelbine|mesh-list
2323333|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894028|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894029|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894030|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
2894031|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894032|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
2894033|NCT02538510|Vorinostat|vorinostat|mesh-list
2894034|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2894035|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894036|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2894037|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894038|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894039|NCT02532231|Nivolumab|nivolumab|mesh-list
2894040|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2894041|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894042|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2894043|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894044|NCT02531126|Ozanimod|ozanimod|mesh-list
2323334|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
2323335|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323336|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2323337|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2323338|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
2323339|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323340|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323341|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2323342|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2323343|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2323344|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2323345|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894045|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2894046|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894047|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894048|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
2894049|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894050|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
2894051|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2894052|NCT02510300|Ledipasvir|ledipasvir|mesh-list
2894053|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2894054|NCT02510300|Velpatasvir|velpatasvir|mesh-list
2894055|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
2894056|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894057|NCT02507505|Anesthetics|anesthetics|mesh-list
2894058|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2894059|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894081|NCT02476968|Olaparib|olaparib|mesh-list
2894082|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2894083|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894084|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894085|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894088|NCT02465593|Fluorouracil|fluorouracil|mesh-list
2894089|NCT02465593|Capecitabine|capecitabine|mesh-list
2894090|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
2894091|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894092|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2894093|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894094|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894095|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
2894096|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894097|NCT02465268|Molgramostim|molgramostim|mesh-list
2894098|NCT02465268|Sargramostim|sargramostim|mesh-list
2894099|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
2894100|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894101|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323346|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2323347|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
2323348|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
2323349|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
2323350|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2323351|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2323352|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323353|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2323354|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2323355|NCT00379483|Deferasirox|deferasirox|mesh-list
2323356|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2323357|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
2323358|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
2323359|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323360|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
2323361|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2323362|NCT00379509|Lapatinib|lapatinib|mesh-list
2323363|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323364|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2323365|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323366|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323367|NCT00379522|Vasopressins|vasopressins|mesh-list
2323368|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
2323369|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
2323370|NCT00379522|Coagulants|coagulants|mesh-ancestor
2323371|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2323372|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2323373|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
2894143|NCT02448381|Hypericin|hypericin|mesh-list
2894144|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
2894145|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2323374|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323375|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
2323376|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2323377|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323378|NCT00379626|Hormones|hormones|mesh-list
2323379|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323380|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323381|NCT00379665|Cisplatin|cisplatin|mesh-list
2323382|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323383|NCT00379691|Phenylephrine|phenylephrine|mesh-list
2894146|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894147|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
2894148|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894149|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894150|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894151|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894152|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
2894153|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323384|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
2323385|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2323386|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
2323387|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
2323388|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323389|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323390|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
2323391|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2323392|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
2323393|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
2323394|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2323395|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2109456|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109457|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2109458|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2109459|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109460|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109461|NCT02519842|Dexamethasone|dexamethasone|mesh-list
2109462|NCT02519842|Ondansetron|ondansetron|mesh-list
2109463|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
2109464|NCT02519842|Aprepitant|aprepitant|mesh-list
2109465|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
2109466|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109467|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
2109468|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
2109469|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109470|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109471|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2109472|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
2109473|NCT02519842|Hormones|hormones|mesh-ancestor
2109474|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109475|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2109476|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109477|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
2109478|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
2109479|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2109480|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
2109481|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323396|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2894185|NCT02436707|Gemcitabine|gemcitabine|mesh-list
2894186|NCT02436707|Dexamethasone|dexamethasone|mesh-list
2894187|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
2894188|NCT02436707|Rituximab|rituximab|mesh-list
2894189|NCT02436707|Etoposide|etoposide|mesh-list
2894190|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894191|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
2894192|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323397|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
2323398|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323399|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323400|NCT00379691|Protective Agents|protective agents|mesh-ancestor
2323401|NCT00379717|Docetaxel|docetaxel|mesh-list
2323402|NCT00379717|Cisplatin|cisplatin|mesh-list
2323403|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323404|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
2323405|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
2323406|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
2323407|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894193|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2894194|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2894195|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
2894196|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894197|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894198|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2894199|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2894200|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
2894201|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
2894202|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2894203|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2894204|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
2894205|NCT02436707|Hormones|hormones|mesh-ancestor
2894206|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2894207|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2894208|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2894209|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2894210|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
2894211|NCT02436707|Antiviral Agents|antiviral agents|mesh-ancestor
2894212|NCT02436707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323408|NCT00379730|Prednisolone|prednisolone|mesh-list
2323409|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2323410|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
2109482|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109483|NCT02519842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2109484|NCT02519842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2109485|NCT02519842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109486|NCT02519842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2109487|NCT02519842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2109488|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2109489|NCT02520011|Cytarabine|cytarabine|mesh-list
2323411|NCT00379730|Hormones|hormones|mesh-ancestor
2323412|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323413|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323414|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2323415|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323416|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2323417|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
2323418|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2323419|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2323420|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894213|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894214|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2894215|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2894216|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2894217|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2894218|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2894219|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
2894220|NCT02424019|Hormones|hormones|mesh-ancestor
2323421|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323422|NCT00379756|Urological Agents|urological agents|mesh-ancestor
2323423|NCT00379847|Conivaptan|conivaptan|mesh-list
2323424|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2323425|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323426|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
2109490|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
2109491|NCT02520011|Alvocidib|alvocidib|mesh-list
2109492|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2109493|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
2109494|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109495|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109496|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
2109497|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2109498|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2109499|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
2109500|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109501|NCT02520011|Analgesics|analgesics|mesh-ancestor
2109502|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
2109503|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2894221|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2894222|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894223|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
2894224|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2894225|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2894226|NCT02422368|Prednisolone|prednisolone|mesh-list
2894227|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
2894228|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2894229|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
2323427|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323428|NCT00379886|Thiopental|thiopental|mesh-list
2323429|NCT00379886|Propofol|propofol|mesh-list
2323430|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2323431|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2323432|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323433|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2323434|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
2323435|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
2323436|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
2323437|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
2323438|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
2894230|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2894231|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
2894232|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
2894233|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2894234|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894235|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2894236|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
2894237|NCT02422368|Hormones|hormones|mesh-ancestor
2894238|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2894239|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2894240|NCT02422368|Protective Agents|protective agents|mesh-ancestor
2894241|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2323439|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323440|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323441|NCT00379951|Ertapenem|ertapenem|mesh-list
2323442|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2323443|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323444|NCT00379964|Caspofungin|caspofungin|mesh-list
2323445|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
2323446|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323447|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323448|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323449|NCT00379977|Vaccines|vaccines|mesh-list
2323450|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
2894242|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894243|NCT02420847|Gemcitabine|gemcitabine|mesh-list
2894244|NCT02420847|Doxorubicin|doxorubicin|mesh-list
2894245|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2894246|NCT02420847|Ixazomib|ixazomib|mesh-list
2894247|NCT02420847|Glycine|glycine|mesh-list
2894248|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2894249|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
2894250|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894251|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894252|NCT02420847|Antiviral Agents|antiviral agents|mesh-ancestor
2894253|NCT02420847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894254|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894255|NCT02420847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894256|NCT02420847|Immunologic Factors|immunologic factors|mesh-ancestor
2894257|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894258|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2894259|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2894260|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2894261|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
2894262|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
2894263|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2894264|NCT02403323|Etrolizumab|etrolizumab|mesh-list
2894265|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2894266|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
2894267|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894268|NCT02400242|Dexamethasone|dexamethasone|mesh-list
2894269|NCT02400242|Pomalidomide|pomalidomide|mesh-list
2894270|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2894271|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2894272|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
2894273|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
2894274|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2894275|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894276|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2894277|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
2894278|NCT02400242|Hormones|hormones|mesh-ancestor
2894279|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2894280|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2894281|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894282|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
2894283|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2894284|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2894285|NCT02400242|Growth Substances|growth substances|mesh-ancestor
2894286|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
2894287|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894288|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894294|NCT02393183|Selenium|selenium|mesh-list
2894295|NCT02393183|Antioxidants|antioxidants|mesh-list
2894296|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894297|NCT02393183|Protective Agents|protective agents|mesh-ancestor
2323451|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323452|NCT00379990|Prednisolone|prednisolone|mesh-list
2323453|NCT00379990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2323454|NCT00379990|Glucocorticoids|glucocorticoids|mesh-ancestor
2323455|NCT00379990|Hormones|hormones|mesh-ancestor
2323456|NCT00379990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323457|NCT00379990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323458|NCT00379990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2323459|NCT00379990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323460|NCT00380120|Warfarin|warfarin|mesh-list
2323461|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
2323462|NCT00380133|Prednisolone|prednisolone|mesh-list
2323463|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2323464|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
2323465|NCT00380133|Hormones|hormones|mesh-ancestor
2323466|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323467|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323468|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2894298|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894299|NCT02393183|Trace Elements|trace elements|mesh-ancestor
2894300|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
2894301|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
2894302|NCT02379520|Nivolumab|nivolumab|mesh-list
2894303|NCT02379520|Fludarabine|fludarabine|mesh-list
2894304|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894305|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
2894306|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894307|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2894308|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2894309|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
2894310|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894311|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894312|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2894313|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2894314|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2894315|NCT02367040|Rituximab|rituximab|mesh-list
2894316|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2894317|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894318|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
2894319|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894320|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2894324|NCT02354131|Bevacizumab|bevacizumab|mesh-list
2894325|NCT02354131|Niraparib|niraparib|mesh-list
2894326|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2894327|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894328|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2894329|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2894330|NCT02354131|Growth Substances|growth substances|mesh-ancestor
2894331|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894332|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
2894333|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2894334|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894335|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894336|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
2894337|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2894338|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
2894339|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2894340|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894341|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2894342|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2894343|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2894353|NCT02335944|Nazartinib|nazartinib|mesh-list
2894354|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894355|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
2894356|NCT02333162|Fludarabine|fludarabine|mesh-list
2894357|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
2894358|NCT02333162|Melphalan|melphalan|mesh-list
2894359|NCT02333162|Tacrolimus|tacrolimus|mesh-list
2894360|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894361|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2894362|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
2894363|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894364|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894365|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
2894366|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894367|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2894368|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894369|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2894370|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2894371|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
2894372|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2894373|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894374|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2894375|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
2894376|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2894377|NCT02318342|Warfarin|warfarin|mesh-list
2894378|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
2894379|NCT02304991|Glycerol|glycerol|mesh-list
2894380|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2894381|NCT02304991|Protective Agents|protective agents|mesh-ancestor
2894382|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894383|NCT02303821|Cytarabine|cytarabine|mesh-list
2894384|NCT02303821|Dexamethasone|dexamethasone|mesh-list
2894385|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
2894386|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
2894387|NCT02303821|Methotrexate|methotrexate|mesh-list
2894388|NCT02303821|Vincristine|vincristine|mesh-list
2894389|NCT02303821|Daunorubicin|daunorubicin|mesh-list
2894390|NCT02303821|Asparaginase|asparaginase|mesh-list
2894391|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
2894392|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
2894393|NCT02303821|Pegaspargase|pegaspargase|mesh-list
2894394|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894395|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
2894396|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894397|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2894398|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2894399|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
2894400|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894401|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894402|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2894403|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2894404|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
2894405|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
2894406|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2894407|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2894408|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
2894409|NCT02303821|Hormones|hormones|mesh-ancestor
2894410|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2894411|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2894412|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2894413|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
2894414|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2894415|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2894416|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
2894417|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
2323469|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323470|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
2323471|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
2323472|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2323473|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
2323474|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2323475|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2323476|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894418|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894419|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2894420|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2894421|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
2894422|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323477|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2323478|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323479|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323480|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2323481|NCT00380146|Renal Agents|renal agents|mesh-ancestor
2323482|NCT00380159|Lamivudine|lamivudine|mesh-list
2323483|NCT00380159|Emtricitabine|emtricitabine|mesh-list
2323484|NCT00380159|Dexelvucitabine|dexelvucitabine|mesh-list
2323485|NCT00380159|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2323486|NCT00380159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2323487|NCT00380159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109504|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2109505|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2109506|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109507|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
2109508|NCT02520011|Growth Substances|growth substances|mesh-ancestor
2109509|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2109510|NCT02520388|Methylphenidate|methylphenidate|mesh-list
2109511|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2109512|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894423|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2894424|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
2894425|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
2894426|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
2894427|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2894428|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2894429|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2894430|NCT02303821|Analgesics|analgesics|mesh-ancestor
2894431|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
2894432|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
2894433|NCT02287311|Fludarabine|fludarabine|mesh-list
2894434|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894435|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
2894436|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894437|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2894438|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2894439|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
2894440|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894441|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894442|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2894443|NCT02278120|Tamoxifen|tamoxifen|mesh-list
2894444|NCT02278120|Letrozole|letrozole|mesh-list
2894445|NCT02278120|Anastrozole|anastrozole|mesh-list
2894446|NCT02278120|Goserelin|goserelin|mesh-list
2894447|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894448|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2894449|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2894450|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894451|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894452|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2894453|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
2894454|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2894455|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894456|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2894457|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2894458|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2894459|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2894460|NCT02271919|Nicotine|nicotine|mesh-list
2894461|NCT02271919|Varenicline|varenicline|mesh-list
2894462|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2894463|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
2894464|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2894465|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894466|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2894467|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2894468|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
2894469|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2894470|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894471|NCT02263729|Losartan|losartan|mesh-list
2894472|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2894473|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2894474|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2894475|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2894476|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323488|NCT00380159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323489|NCT00380159|Antiviral Agents|antiviral agents|mesh-ancestor
2323490|NCT00380159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894481|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
2894482|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2894483|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2894484|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894485|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
2894486|NCT02261415|Coagulants|coagulants|mesh-ancestor
2323491|NCT00380159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2323492|NCT00380159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2323493|NCT00380224|Olanzapine|olanzapine|mesh-list
2323494|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
2323495|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
2894501|NCT02256696|Rifampin|rifampin|mesh-list
2894502|NCT02256696|Rifabutin|rifabutin|mesh-list
2894503|NCT02256696|Isoniazid|isoniazid|mesh-list
2894504|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
2894505|NCT02256696|Ethambutol|ethambutol|mesh-list
2894506|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2323496|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323497|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323498|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2894507|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
2894508|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2894509|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894510|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
2894511|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2894512|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894513|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894514|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2894515|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2894516|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2894517|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2894518|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2894519|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2894520|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2894521|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2894522|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
2894523|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2894524|NCT02225600|Oxytocin|oxytocin|mesh-list
2894525|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
2894526|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2894527|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894528|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
2894529|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2894530|NCT02223520|Mupirocin|mupirocin|mesh-list
2894531|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2894532|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894533|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
2894534|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
2894535|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2894536|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2894537|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894538|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894539|NCT02220309|Pramipexole|pramipexole|mesh-list
2894540|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
2894541|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894542|NCT02220309|Protective Agents|protective agents|mesh-ancestor
2894543|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894544|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2894545|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2894546|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
2894547|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
2894548|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323499|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2894572|NCT02199665|Dexamethasone|dexamethasone|mesh-list
2894573|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2894574|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
2894575|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
2894576|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2894577|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894578|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2894579|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
2894580|NCT02199665|Hormones|hormones|mesh-ancestor
2894581|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2894582|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2894583|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323500|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2323501|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2323502|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2323503|NCT00380224|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2323504|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2323505|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2323506|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323507|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323508|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
2323509|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
2323510|NCT00380263|Growth Substances|growth substances|mesh-ancestor
2323511|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323512|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
2323513|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323514|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323515|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2323516|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2323517|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
2323518|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323519|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894612|NCT02185560|Sorafenib|sorafenib|mesh-list
2894613|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894614|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2894615|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894616|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894617|NCT02178709|Leucovorin|leucovorin|mesh-list
2894618|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
2894619|NCT02178709|Irinotecan|irinotecan|mesh-list
2323520|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323521|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
2323522|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2323523|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2323524|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323525|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323526|NCT00380380|Vildagliptin|vildagliptin|mesh-list
2323527|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2894620|NCT02178709|Folfirinox|folfirinox|mesh-list
2894621|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894622|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2894623|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2894624|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894625|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894626|NCT02178709|Antidotes|antidotes|mesh-ancestor
2894627|NCT02178709|Protective Agents|protective agents|mesh-ancestor
2894628|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894629|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
2894630|NCT02178709|Vitamins|vitamins|mesh-ancestor
2894631|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
2894632|NCT02143401|Sorafenib|sorafenib|mesh-list
2894633|NCT02143401|Navitoclax|navitoclax|mesh-list
2894634|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894635|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2894636|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894637|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894638|NCT02141282|Venetoclax|venetoclax|mesh-list
2894639|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894640|NCT02126553|Lenalidomide|lenalidomide|mesh-list
2894641|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
2894642|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894643|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2894644|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2894645|NCT02126553|Growth Substances|growth substances|mesh-ancestor
2894646|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
2894647|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894648|NCT02122198|Leuprolide|leuprolide|mesh-list
2894649|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2894650|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
2894651|NCT02122198|Estradiol|estradiol|mesh-list
2894652|NCT02122198|Estrogens|estrogens|mesh-ancestor
2894653|NCT02122198|Hormones|hormones|mesh-ancestor
2894654|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2894655|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894656|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2894657|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
2894658|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2894659|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2894660|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2894661|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
2894662|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2894663|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894664|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2894665|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2894666|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2894667|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2894668|NCT02118584|Etrolizumab|etrolizumab|mesh-list
2894669|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2323528|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323529|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2323530|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
2323531|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323532|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323533|NCT00380406|Leuprolide|leuprolide|mesh-list
2323534|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2323535|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
2323536|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2323537|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323538|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2323539|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323540|NCT00380445|Vildagliptin|vildagliptin|mesh-list
2323541|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2323542|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894670|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
2894671|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894672|NCT02115997|Prednisone|prednisone|mesh-list
2894673|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
2894674|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2894675|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2894676|NCT02115997|Prednisolone|prednisolone|mesh-list
2894677|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
2894678|NCT02115997|Rituximab|rituximab|mesh-list
2894679|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2894680|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
2894681|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2894682|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894683|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
2894684|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894685|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2894686|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2894687|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
2894688|NCT02115997|Hormones|hormones|mesh-ancestor
2894689|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2894690|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2894691|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
2894692|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
2894693|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2894694|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2894695|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2894696|NCT02115997|Protective Agents|protective agents|mesh-ancestor
2894697|NCT02085148|Irinotecan|irinotecan|mesh-list
2894698|NCT02085148|Vincristine|vincristine|mesh-list
2894699|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2894700|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2894701|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894702|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894703|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894704|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2894705|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
2894706|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
2894707|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
2894708|NCT02079948|Folic Acid|folic acid|mesh-list
2894709|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
2894710|NCT02079948|Methotrexate|methotrexate|mesh-list
2894711|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2894712|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
2894713|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2894714|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894715|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2894716|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
2894717|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894718|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894719|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
2894720|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894721|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2894722|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894723|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
2894724|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2894725|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2894726|NCT02079948|Hematinics|hematinics|mesh-ancestor
2894727|NCT02079948|Vitamins|vitamins|mesh-ancestor
2894728|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
2894729|NCT02075840|Crizotinib|crizotinib|mesh-list
2894730|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894731|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2894732|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894733|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894734|NCT02060188|Nivolumab|nivolumab|mesh-list
2894735|NCT02060188|Ipilimumab|ipilimumab|mesh-list
2894736|NCT02060188|Daratumumab|daratumumab|mesh-list
2894737|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2894738|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894739|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2894740|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894741|NCT02055053|Bupivacaine|bupivacaine|mesh-list
2894742|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
2894743|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
2894744|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2894745|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894746|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
2323543|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2894747|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2894748|NCT02052778|Futibatinib|futibatinib|mesh-list
2894749|NCT02052778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894750|NCT02043678|Prednisone|prednisone|mesh-list
2894751|NCT02043678|Prednisolone|prednisolone|mesh-list
2894752|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2894753|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2894754|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
2894755|NCT02043678|Hormones|hormones|mesh-ancestor
2894756|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2894757|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894758|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2894759|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894760|NCT02034110|Trametinib|trametinib|mesh-list
2894761|NCT02034110|Dabrafenib|dabrafenib|mesh-list
2894762|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894763|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2894764|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894765|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894766|NCT02020707|Paclitaxel|paclitaxel|mesh-list
2894767|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2894768|NCT02020707|Bevacizumab|bevacizumab|mesh-list
2894769|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2894770|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
2894771|NCT02020707|Antibodies|antibodies|mesh-list
2894772|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
2894773|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2894774|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
2894775|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2894776|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894777|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
2894778|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
2894779|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
2894780|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894781|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2894782|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2894783|NCT02020707|Growth Substances|growth substances|mesh-ancestor
2894784|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894785|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
2894786|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
2894787|NCT02004275|Dexamethasone|dexamethasone|mesh-list
2894788|NCT02004275|Pomalidomide|pomalidomide|mesh-list
2894789|NCT02004275|Ixazomib|ixazomib|mesh-list
2894790|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2894791|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
2894792|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
2894793|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2894794|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894795|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2894796|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
2894797|NCT02004275|Hormones|hormones|mesh-ancestor
2894798|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2894799|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2894800|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894801|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
2894802|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2894803|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2894804|NCT02004275|Growth Substances|growth substances|mesh-ancestor
2894805|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
2894806|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
2894807|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894808|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323544|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
2323545|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323546|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323547|NCT00380484|Budesonide|budesonide|mesh-list
2323548|NCT00380484|Montelukast|montelukast|mesh-list
2323549|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2323550|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2323551|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
2323552|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323553|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894827|NCT01978938|Levofloxacin|levofloxacin|mesh-list
2894828|NCT01978938|Ofloxacin|ofloxacin|mesh-list
2894829|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2894830|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894831|NCT01978938|Renal Agents|renal agents|mesh-ancestor
2894832|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2894833|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2894834|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2894835|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894836|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894837|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894838|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2894839|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2894840|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2894841|NCT01976065|Metronidazole|metronidazole|mesh-list
2894842|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
2894843|NCT01976065|Minocycline|minocycline|mesh-list
2894844|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894845|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2894846|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2894847|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2894848|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2894849|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894850|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894851|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894852|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2894853|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2894854|NCT01932125|Bevacizumab|bevacizumab|mesh-list
2323554|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2323555|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
2323556|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
2323557|NCT00380484|Hormones|hormones|mesh-ancestor
2323558|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323559|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2323560|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
2323561|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2323562|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2323563|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323564|NCT00380523|Etoricoxib|etoricoxib|mesh-list
2323565|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2323566|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2323567|NCT00380523|Analgesics|analgesics|mesh-ancestor
2323568|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
2323569|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323570|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894855|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2109513|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2109514|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2109515|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2109516|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109517|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
2109518|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109519|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
2109520|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2109521|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109522|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2109523|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109524|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
2894856|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894857|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2894858|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2894859|NCT01932125|Growth Substances|growth substances|mesh-ancestor
2894860|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894861|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
2894862|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
2323571|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2323572|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2323573|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2323574|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2323575|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323576|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323577|NCT00380575|Conivaptan|conivaptan|mesh-list
2323578|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2323579|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323580|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
2323581|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323582|NCT00380614|Lamivudine|lamivudine|mesh-list
2323583|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2323584|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2323585|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323586|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323587|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
2323588|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323589|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2323590|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2323591|NCT00380627|Etoricoxib|etoricoxib|mesh-list
2323592|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2323593|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2323594|NCT00380627|Analgesics|analgesics|mesh-ancestor
2894863|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2894864|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
2894865|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894866|NCT01878669|Expectorants|expectorants|mesh-ancestor
2894867|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
2323595|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
2323596|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323597|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323598|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2323599|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2323600|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2323601|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2323602|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323603|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323604|NCT00380640|Trimethoprim|trimethoprim|mesh-list
2323605|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2894868|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2894869|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
2894870|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894871|NCT01878669|Protective Agents|protective agents|mesh-ancestor
2894872|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894873|NCT01878669|Antidotes|antidotes|mesh-ancestor
2894874|NCT01878617|Gemcitabine|gemcitabine|mesh-list
2894875|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
2894876|NCT01878617|Vincristine|vincristine|mesh-list
2894877|NCT01878617|Pemetrexed|pemetrexed|mesh-list
2894878|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894879|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
2894880|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894881|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2894882|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2894883|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
2894884|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894885|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894886|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2323606|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323607|NCT00380640|Renal Agents|renal agents|mesh-ancestor
2323608|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
2323609|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2323610|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2323611|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2323612|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323613|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323614|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2323615|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2323616|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2894887|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2894888|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
2323619|NCT00380679|Vaccines|vaccines|mesh-list
2323620|NCT00380679|Immunologic Factors|immunologic factors|mesh-ancestor
2323621|NCT00380679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323622|NCT00380705|Montelukast|montelukast|mesh-list
2323623|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2323624|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
2323625|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2894889|NCT01878617|Antiviral Agents|antiviral agents|mesh-ancestor
2894890|NCT01878617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894891|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894892|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2894893|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
2894894|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
2894895|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
2894896|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2894897|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2894898|NCT01854385|Sumatriptan|sumatriptan|mesh-list
2894899|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2894900|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2894901|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2894902|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
2894903|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2894904|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894905|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323626|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
2323627|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323628|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323629|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2323630|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2323631|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323632|NCT00380770|Lamivudine|lamivudine|mesh-list
2323633|NCT00380770|Stavudine|stavudine|mesh-list
2323634|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
2323635|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2323636|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2323637|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323638|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323639|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
2323640|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323641|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2323642|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2323643|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
2323644|NCT00380822|Miglitol|miglitol|mesh-list
2323645|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323646|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323647|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2323648|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894906|NCT01853826|Afatinib|afatinib|mesh-list
2894907|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894908|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2894909|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894910|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894911|NCT01844856|Ertapenem|ertapenem|mesh-list
2894912|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2894913|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2894920|NCT01817166|Vitamin D|vitamin d|mesh-list
2894921|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
2894922|NCT01817166|Vitamins|vitamins|mesh-ancestor
2894923|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
2894924|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894925|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2894926|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2894942|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
2894943|NCT01783535|Carboplatin|carboplatin|mesh-list
2894944|NCT01783535|Doxorubicin|doxorubicin|mesh-list
2894945|NCT01783535|Etoposide|etoposide|mesh-list
2894946|NCT01783535|Vincristine|vincristine|mesh-list
2894947|NCT01783535|Topotecan|topotecan|mesh-list
2894948|NCT01783535|Lenograstim|lenograstim|mesh-list
2894949|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894950|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
2894951|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323649|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2323650|NCT00380835|Amrubicin|amrubicin|mesh-list
2323651|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323652|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2894952|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2894953|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2894954|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
2894955|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2894956|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894957|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2894958|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2894959|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2894960|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2894961|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2894962|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2894963|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2894964|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
2894965|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
2894966|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
2323653|NCT00380887|Estrogens|estrogens|mesh-ancestor
2323654|NCT00380887|Hormones|hormones|mesh-ancestor
2323655|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323656|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323657|NCT00380913|Nabilone|nabilone|mesh-list
2894967|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2894968|NCT01764711|Cosyntropin|cosyntropin|mesh-list
2894969|NCT01764711|Hormones|hormones|mesh-ancestor
2894970|NCT01764711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2894971|NCT01764711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894972|NCT01726452|Leucovorin|leucovorin|mesh-list
2894973|NCT01726452|Paclitaxel|paclitaxel|mesh-list
2894974|NCT01726452|Docetaxel|docetaxel|mesh-list
2894975|NCT01726452|Carboplatin|carboplatin|mesh-list
2323658|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
2323659|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
2323660|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323661|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323662|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2323663|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2894976|NCT01726452|Fluorouracil|fluorouracil|mesh-list
2894977|NCT01726452|Capecitabine|capecitabine|mesh-list
2894978|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
2894979|NCT01726452|Epirubicin|epirubicin|mesh-list
2894980|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2894981|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2894982|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
2894983|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
2894984|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
2894985|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323664|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2894986|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
2894987|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2894988|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2894989|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
2894990|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2894991|NCT01726452|Antidotes|antidotes|mesh-ancestor
2894992|NCT01726452|Protective Agents|protective agents|mesh-ancestor
2894993|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
2894994|NCT01726452|Vitamins|vitamins|mesh-ancestor
2894995|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
2894996|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2894997|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2894998|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2894999|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895000|NCT01712789|Dexamethasone|dexamethasone|mesh-list
2895001|NCT01712789|Pomalidomide|pomalidomide|mesh-list
2895002|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2895003|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
2895004|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
2895005|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2895006|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895007|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2895008|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
2895009|NCT01712789|Hormones|hormones|mesh-ancestor
2895010|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2895011|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2895012|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895013|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
2895014|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2895015|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2895016|NCT01712789|Growth Substances|growth substances|mesh-ancestor
2895017|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
2895018|NCT01665794|Dexamethasone|dexamethasone|mesh-list
2895019|NCT01665794|Daratumumab|daratumumab|mesh-list
2895020|NCT01665794|Pomalidomide|pomalidomide|mesh-list
2895021|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2895022|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
2895023|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
2895024|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2895025|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895026|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2895027|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
2895028|NCT01665794|Hormones|hormones|mesh-ancestor
2895029|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2895030|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2895031|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895032|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
2895033|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2895034|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2895035|NCT01665794|Growth Substances|growth substances|mesh-ancestor
2895036|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
2895037|NCT01651403|Tenofovir|tenofovir|mesh-list
2895038|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
2895039|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2895040|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2895041|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2895042|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895043|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895044|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2895045|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2895046|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
2895047|NCT01560572|Prednisolone|prednisolone|mesh-list
2895048|NCT01560572|Tacrolimus|tacrolimus|mesh-list
2895049|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2895050|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
2895051|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895052|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2895053|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895054|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895055|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2895056|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
2895057|NCT01560572|Hormones|hormones|mesh-ancestor
2895058|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2895059|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2895060|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895061|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2895062|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2895063|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
2895064|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2895065|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2895078|NCT01543633|Propofol|propofol|mesh-list
2895079|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2895080|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2895081|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895082|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2895083|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
2895084|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
2895085|NCT01542736|Carboplatin|carboplatin|mesh-list
2895086|NCT01542736|Vincristine|vincristine|mesh-list
2895087|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895088|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2895089|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
2323665|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2323666|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2323667|NCT00380939|Atorvastatin|atorvastatin|mesh-list
2895090|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
2895091|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
2895092|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895095|NCT01481974|Treprostinil|treprostinil|mesh-list
2895096|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2895097|NCT01465100|Liver Extracts|liver extracts|mesh-list
2895098|NCT01465100|Hematinics|hematinics|mesh-ancestor
2895099|NCT01442649|Leucovorin|leucovorin|mesh-list
2895100|NCT01442649|Folic Acid|folic acid|mesh-list
2895101|NCT01442649|Bevacizumab|bevacizumab|mesh-list
2895102|NCT01442649|Cetuximab|cetuximab|mesh-list
2895103|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
2895104|NCT01442649|Irinotecan|irinotecan|mesh-list
2895105|NCT01442649|Fluorouracil|fluorouracil|mesh-list
2895106|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
2895107|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2895108|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895109|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2895110|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2895111|NCT01442649|Growth Substances|growth substances|mesh-ancestor
2895112|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895113|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
2895114|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2895115|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2895116|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895117|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895118|NCT01442649|Antidotes|antidotes|mesh-ancestor
2895119|NCT01442649|Protective Agents|protective agents|mesh-ancestor
2895120|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
2895121|NCT01442649|Vitamins|vitamins|mesh-ancestor
2895122|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
2895123|NCT01442649|Hematinics|hematinics|mesh-ancestor
2895124|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
2895125|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2895126|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2895127|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
2323668|NCT00380939|Pravastatin|pravastatin|mesh-list
2323669|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2323670|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2323671|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
2323672|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323673|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2323674|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2323675|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323676|NCT00380965|Nabilone|nabilone|mesh-list
2323677|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
2323678|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
2323679|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323680|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323681|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2323682|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2323683|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2323684|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2323685|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2323686|NCT00381017|Interferons|interferons|mesh-list
2323687|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
2323688|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
2323689|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2323690|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323691|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
2323692|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323693|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
2323694|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323695|NCT00381030|Carvedilol|carvedilol|mesh-list
2323696|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2323697|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2895207|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
2895208|NCT01147666|Hematinics|hematinics|mesh-ancestor
2895209|NCT01065454|Riociguat|riociguat|mesh-list
2895210|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
2895211|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895212|NCT00982111|Pemetrexed|pemetrexed|mesh-list
2895213|NCT00982111|Necitumumab|necitumumab|mesh-list
2895214|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895215|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895216|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895217|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2895218|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2895219|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2323698|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
2323699|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323700|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323701|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323702|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2323703|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
2323704|NCT00381030|Protective Agents|protective agents|mesh-ancestor
2323705|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2323706|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2323707|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2323708|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
2323709|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2323710|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2323711|NCT00381134|Losartan|losartan|mesh-list
2323712|NCT00381134|Spironolactone|spironolactone|mesh-list
2323713|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2323714|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2323715|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2323716|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2323717|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323718|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2323719|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
2323720|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2895278|NCT00781612|Paclitaxel|paclitaxel|mesh-list
2895279|NCT00781612|Maytansine|maytansine|mesh-list
2895280|NCT00781612|Docetaxel|docetaxel|mesh-list
2895281|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2895282|NCT00781612|Trastuzumab|trastuzumab|mesh-list
2895283|NCT00781612|Atezolizumab|atezolizumab|mesh-list
2895284|NCT00781612|Pertuzumab|pertuzumab|mesh-list
2895285|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2895286|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895287|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
2895288|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
2895289|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
2895290|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895291|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2895292|NCT00773695|Paclitaxel|paclitaxel|mesh-list
2895293|NCT00773695|Docetaxel|docetaxel|mesh-list
2895294|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
2895295|NCT00773695|Bevacizumab|bevacizumab|mesh-list
2895296|NCT00773695|Fluorouracil|fluorouracil|mesh-list
2895297|NCT00773695|Epirubicin|epirubicin|mesh-list
2895298|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2895299|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2895300|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895301|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
2895302|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
2895303|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
2895304|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895305|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2895306|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
2895307|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895308|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2895309|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2895310|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
2895311|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2895312|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2895313|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2895314|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2895315|NCT00773695|Growth Substances|growth substances|mesh-ancestor
2895316|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
2895317|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
2895318|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2895319|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2895320|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895321|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2895322|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
2895323|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2895324|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2895325|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2895326|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2895330|NCT00670358|Prednisone|prednisone|mesh-list
2895331|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
2895332|NCT00670358|Rituximab|rituximab|mesh-list
2895333|NCT00670358|Doxorubicin|doxorubicin|mesh-list
2895334|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2323721|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323722|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2323723|NCT00381134|Diuretics|diuretics|mesh-ancestor
2323724|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
2323725|NCT00381147|Clarithromycin|clarithromycin|mesh-list
2323726|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2323727|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323728|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2323729|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323730|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323731|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2323732|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2323733|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
2323734|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2323735|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
2323736|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323737|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2895335|NCT00670358|Vincristine|vincristine|mesh-list
2895336|NCT00670358|Lenalidomide|lenalidomide|mesh-list
2895337|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2895338|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
2895339|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895340|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2895341|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2895342|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
2895343|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895344|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895345|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2895346|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2895347|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2895348|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2895349|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2895350|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895351|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2895352|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
2895353|NCT00670358|Hormones|hormones|mesh-ancestor
2895354|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2895355|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2895356|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2895357|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
2895358|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
2895359|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
2895360|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2895361|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2895362|NCT00670358|Growth Substances|growth substances|mesh-ancestor
2895363|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
2895364|NCT00291486|Capecitabine|capecitabine|mesh-list
2895365|NCT00291486|Antibodies|antibodies|mesh-list
2895366|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2895367|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
2895368|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895369|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2895370|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
2895371|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895372|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895373|NCT00193219|Leucovorin|leucovorin|mesh-list
2895374|NCT00193219|Bevacizumab|bevacizumab|mesh-list
2895375|NCT00193219|Cetuximab|cetuximab|mesh-list
2323738|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2323739|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
2323740|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323741|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323742|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2323743|NCT00381199|Amitriptyline|amitriptyline|mesh-list
2323744|NCT00381199|Nabilone|nabilone|mesh-list
2323745|NCT00381199|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2323746|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2323747|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
2323748|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2323749|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2323750|NCT00381199|Analgesics|analgesics|mesh-ancestor
2895376|NCT00193219|Fluorouracil|fluorouracil|mesh-list
2895377|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
2895378|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2895379|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895380|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2895381|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2895382|NCT00193219|Growth Substances|growth substances|mesh-ancestor
2895383|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895384|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
2895385|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
2895386|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895387|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2895388|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2895389|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
2895390|NCT00193219|Antidotes|antidotes|mesh-ancestor
2895391|NCT00193219|Protective Agents|protective agents|mesh-ancestor
2895392|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
2895393|NCT00193219|Vitamins|vitamins|mesh-ancestor
2895394|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
2895395|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
2895396|NCT00116142|Docetaxel|docetaxel|mesh-list
2895397|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
2895398|NCT00116142|Androgens|androgens|mesh-list
2895399|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2895400|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895401|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
2895402|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
2895403|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
2895404|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895405|NCT00116142|Hormones|hormones|mesh-ancestor
2895406|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2895407|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895408|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
2895409|NCT00116142|Protective Agents|protective agents|mesh-ancestor
2895410|NCT00116142|Vitamins|vitamins|mesh-ancestor
2895411|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
2895412|NCT00116142|Estrogens|estrogens|mesh-ancestor
2895413|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2323751|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
2323752|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323753|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323754|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2323755|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2323756|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2323757|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895414|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
2323758|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
2323759|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323760|NCT00381199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2323761|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2323762|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2323763|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
2895420|NCT00070018|Prednisone|prednisone|mesh-list
2895421|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
2895422|NCT00070018|Rituximab|rituximab|mesh-list
2895423|NCT00070018|Doxorubicin|doxorubicin|mesh-list
2895424|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2895425|NCT00070018|Vincristine|vincristine|mesh-list
2895426|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2895427|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2895428|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
2323764|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
2323765|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2323766|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2323767|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2323768|NCT00381251|Estrogens|estrogens|mesh-ancestor
2323769|NCT00381251|Hormones|hormones|mesh-ancestor
2323770|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323771|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323772|NCT00381264|Nabilone|nabilone|mesh-list
2323773|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
2323774|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
2323775|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323776|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323777|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2323778|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2323779|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2323780|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2895429|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895430|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2895431|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2895432|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
2895433|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895434|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895435|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2895436|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2895437|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2323781|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2323782|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
2323783|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2323784|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323785|NCT00381342|Exenatide|exenatide|mesh-list
2323786|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2323787|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323788|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2323789|NCT00381342|Incretins|incretins|mesh-ancestor
2323790|NCT00381342|Hormones|hormones|mesh-ancestor
2323791|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323792|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
2323793|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2323794|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323795|NCT00381472|Ropinirole|ropinirole|mesh-list
2895438|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2895439|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2895440|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895441|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2323796|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2323797|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2323798|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
2323799|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
2323800|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323801|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323802|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323803|NCT00381511|Heparin|heparin|mesh-list
2323804|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2895442|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
2895443|NCT00070018|Hormones|hormones|mesh-ancestor
2895444|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2895445|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2895446|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2895447|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
2895448|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
2895449|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
2323805|NCT00381511|Tinzaparin|tinzaparin|mesh-list
2323806|NCT00381511|Dalteparin|dalteparin|mesh-list
2323807|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
2323808|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2323809|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2323810|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323811|NCT00381537|Carbamazepine|carbamazepine|mesh-list
2323812|NCT00381537|Phenobarbital|phenobarbital|mesh-list
2895483|NCT05189756|Aprepitant|aprepitant|mesh-list
2895484|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
2895485|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
2895486|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
2895487|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2895488|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895489|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2895490|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2895491|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2895492|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895493|NCT05189730|Paclitaxel|paclitaxel|mesh-list
2895494|NCT05189730|Carboplatin|carboplatin|mesh-list
2895495|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2895496|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895497|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
2895498|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
2895499|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
2895500|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895501|NCT05189717|Everolimus|everolimus|mesh-list
2895502|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323813|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
2323814|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
2323815|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2323816|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2323817|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895503|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2895504|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
2895505|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323818|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2323819|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2323820|NCT00381537|Analgesics|analgesics|mesh-ancestor
2323821|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
2323822|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323823|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2323824|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2323825|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323826|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2323827|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2323828|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2323829|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2323830|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2323831|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323832|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
2323833|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
2323834|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2323835|NCT00381589|Bromides|bromides|mesh-list
2323836|NCT00381589|Ipratropium|ipratropium|mesh-list
2895513|NCT05189535|Paclitaxel|paclitaxel|mesh-list
2895514|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
2895515|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2895516|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895517|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
2895518|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
2895519|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
2895520|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895521|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2895522|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895523|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2895524|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2895525|NCT05189535|Protective Agents|protective agents|mesh-ancestor
2895526|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895527|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
2895528|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2895529|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
2895530|NCT05189509|Plasminogen|plasminogen|mesh-list
2895531|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2895532|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2895533|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2895534|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323837|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
2323838|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2895543|NCT05189457|Docetaxel|docetaxel|mesh-list
2895544|NCT05189457|Leuprolide|leuprolide|mesh-list
2895545|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2895546|NCT05189457|Hormones|hormones|mesh-list
2895547|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2895548|NCT05189457|Relugolix|relugolix|mesh-list
2895549|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895550|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
2895551|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
2895552|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
2895553|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323839|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
2323840|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323841|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895554|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2895555|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895556|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2323842|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2323843|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
2323844|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2323845|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
2895557|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
2895558|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2895559|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2895560|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
2895561|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2895562|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
2895563|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2895564|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
2895565|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
2895566|NCT05189444|Amoxicillin|amoxicillin|mesh-list
2895567|NCT05189444|Clarithromycin|clarithromycin|mesh-list
2895568|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
2895569|NCT05189444|Esomeprazole|esomeprazole|mesh-list
2895570|NCT05189444|Bismuth|bismuth|mesh-list
2895571|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895572|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2895573|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2895574|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2895575|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2895576|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2895577|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895578|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2895579|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2895580|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2895581|NCT05189444|Antacids|antacids|mesh-ancestor
2895582|NCT05189444|Diuretics|diuretics|mesh-ancestor
2895583|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
2895584|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895585|NCT05189444|Expectorants|expectorants|mesh-ancestor
2895586|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
2895587|NCT05189223|Buprenorphine|buprenorphine|mesh-list
2895588|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2895589|NCT05189223|Narcotics|narcotics|mesh-ancestor
2895590|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2895591|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895592|NCT05189223|Analgesics|analgesics|mesh-ancestor
2895593|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
2895594|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2895595|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2895601|NCT05189184|Paclitaxel|paclitaxel|mesh-list
2895602|NCT05189184|Apatinib|apatinib|mesh-list
2895603|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2895604|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2895605|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895606|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
2895607|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
2895608|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
2895609|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895610|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2895611|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323846|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323847|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323848|NCT00381654|MP 412|mp 412|mesh-list
2323849|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323850|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2323851|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323852|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323853|NCT00381732|Tadalafil|tadalafil|mesh-list
2323854|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
2323855|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2323856|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2323857|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323858|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323859|NCT00381732|Urological Agents|urological agents|mesh-ancestor
2323860|NCT00381758|Methylphenidate|methylphenidate|mesh-list
2323861|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2323862|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323863|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2323864|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2323865|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2323866|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323867|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
2323868|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323869|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
2895627|NCT05189093|Antibodies|antibodies|mesh-list
2895628|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2895629|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
2895630|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895631|NCT05189067|Paclitaxel|paclitaxel|mesh-list
2895632|NCT05189067|Docetaxel|docetaxel|mesh-list
2895633|NCT05189067|Trastuzumab|trastuzumab|mesh-list
2895634|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2895635|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895636|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
2895637|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
2895638|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
2323870|NCT00381836|Hematinics|hematinics|mesh-ancestor
2323871|NCT00381875|Sargramostim|sargramostim|mesh-list
2323872|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
2323873|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
2323874|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323875|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2323876|NCT00381901|Trastuzumab|trastuzumab|mesh-list
2323877|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2323878|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323879|NCT00381914|Vitamin D|vitamin d|mesh-list
2323880|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
2323881|NCT00381914|Vitamins|vitamins|mesh-list
2323882|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
2895639|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895640|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2895641|NCT05189028|Gemcitabine|gemcitabine|mesh-list
2895642|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895643|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2895644|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
2895645|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895646|NCT05189028|Antiviral Agents|antiviral agents|mesh-ancestor
2895647|NCT05189028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2895648|NCT05189028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895649|NCT05189028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2895650|NCT05189028|Immunologic Factors|immunologic factors|mesh-ancestor
2895651|NCT05189028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895652|NCT05189015|Olmesartan|olmesartan|mesh-list
2895653|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2895654|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2895655|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2895656|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2323883|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323884|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2323885|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2323886|NCT00381953|Interferons|interferons|mesh-list
2323887|NCT00381953|Ribavirin|ribavirin|mesh-list
2323888|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
2323889|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
2323890|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2323891|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323892|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
2323893|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323894|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
2895657|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895658|NCT05189002|Dalteparin|dalteparin|mesh-list
2895659|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
2895660|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2895661|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2895662|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895663|NCT05188911|Prednisone|prednisone|mesh-list
2895664|NCT05188911|Androgens|androgens|mesh-list
2895665|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2895666|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
2895667|NCT05188911|Hormones|hormones|mesh-ancestor
2895668|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2895669|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895670|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2895671|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323895|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323896|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
2323897|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323898|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
2323899|NCT00382044|Hematinics|hematinics|mesh-ancestor
2323900|NCT00382057|Anastrozole|anastrozole|mesh-list
2323901|NCT00382057|Goserelin|goserelin|mesh-list
2323902|NCT00382057|Testosterone|testosterone|mesh-list
2323903|NCT00382057|Androgens|androgens|mesh-ancestor
2895678|NCT05188859|Pemetrexed|pemetrexed|mesh-list
2895679|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895680|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895681|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895682|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2895683|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2895684|NCT05188833|Paroxetine|paroxetine|mesh-list
2895685|NCT05188833|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2895686|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2895687|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2895688|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895689|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2895690|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
2895691|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323904|NCT00382057|Hormones|hormones|mesh-ancestor
2895692|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2895693|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
2895694|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2895695|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2895696|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2895697|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895700|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
2895701|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2895702|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323905|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323906|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323907|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2323908|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323909|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2323910|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2323911|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323912|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323913|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2323914|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
2323915|NCT00382083|Acetaminophen|acetaminophen|mesh-list
2323916|NCT00382083|Ibuprofen|ibuprofen|mesh-list
2323917|NCT00382083|Lidocaine|lidocaine|mesh-list
2323918|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
2323919|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
2895703|NCT05188768|Mitogens|mitogens|mesh-list
2895704|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
2895705|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895706|NCT05188742|Mirabegron|mirabegron|mesh-list
2895707|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2895708|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2895709|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2895710|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
2895711|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2323920|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2323921|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323922|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
2323923|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323924|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2323925|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2323926|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2323927|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2323928|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323929|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2323930|NCT00382083|Analgesics|analgesics|mesh-ancestor
2323931|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
2323932|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2323933|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2323934|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2895712|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895713|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895714|NCT05188742|Urological Agents|urological agents|mesh-ancestor
2323935|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2323936|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323937|NCT00382096|Metformin|metformin|mesh-list
2323938|NCT00382096|Vildagliptin|vildagliptin|mesh-list
2895725|NCT05188495|Trastuzumab|trastuzumab|mesh-list
2895726|NCT05188495|Pertuzumab|pertuzumab|mesh-list
2895727|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2323939|NCT00382096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2323940|NCT00382096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323941|NCT00382096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2895728|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895734|NCT05188339|Citric Acid|citric acid|mesh-list
2895735|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
2895736|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
2895737|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2895738|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
2895739|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
2895740|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323942|NCT00382096|Protease Inhibitors|protease inhibitors|mesh-ancestor
2323943|NCT00382096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323944|NCT00382096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323945|NCT00382135|Tadalafil|tadalafil|mesh-list
2323946|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
2323947|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2895747|NCT05188313|Paclitaxel|paclitaxel|mesh-list
2895748|NCT05188313|Carboplatin|carboplatin|mesh-list
2895749|NCT05188313|Trastuzumab|trastuzumab|mesh-list
2895750|NCT05188313|Pertuzumab|pertuzumab|mesh-list
2895751|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2895752|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895753|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
2895754|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
2895755|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
2895756|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895757|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2895758|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2895759|NCT05188170|Niclosamide|niclosamide|mesh-list
2895760|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
2895761|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2895762|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
2895763|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2895764|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2895765|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
2895766|NCT05188131|Diclofenac|diclofenac|mesh-list
2895767|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2895768|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2895769|NCT05188131|Analgesics|analgesics|mesh-ancestor
2895770|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
2895771|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2895772|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895773|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2895774|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2895775|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2895776|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895777|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895778|NCT05188118|Nivolumab|nivolumab|mesh-list
2895779|NCT05188118|Ipilimumab|ipilimumab|mesh-list
2895780|NCT05188118|Everolimus|everolimus|mesh-list
2895781|NCT05188118|Lenvatinib|lenvatinib|mesh-list
2895782|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2895783|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895784|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2895785|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895786|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2895787|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
2895788|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895789|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2895790|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323948|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2323949|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109525|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2109526|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109527|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
2109528|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895820|NCT05187715|Simvastatin|simvastatin|mesh-list
2895821|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2895822|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2895823|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
2895824|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895825|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2895826|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2895827|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895828|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
2895829|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2895830|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2895831|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
2323950|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323951|NCT00382135|Urological Agents|urological agents|mesh-ancestor
2323952|NCT00382200|Decitabine|decitabine|mesh-list
2323953|NCT00382200|Tretinoin|tretinoin|mesh-list
2323954|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2323955|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
2895843|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
2895844|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2895845|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895846|NCT05169424|Fluticasone|fluticasone|mesh-list
2895847|NCT05169424|Xhance|xhance|mesh-list
2895848|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
2895849|NCT05169424|Olodaterol|olodaterol|mesh-list
2895850|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2895851|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2323956|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109529|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
2109530|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109531|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109532|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2109533|NCT02522299|Nemiralisib|nemiralisib|mesh-list
2109534|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2109535|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109536|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895852|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
2895853|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2895854|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895855|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2895856|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
2895857|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
2895858|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2895859|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
2895860|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2895861|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
2895862|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2895863|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895864|NCT05168657|Pancrelipase|pancrelipase|mesh-list
2895865|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2895866|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
2895867|NCT05165875|Lidocaine|lidocaine|mesh-list
2895868|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
2895869|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
2895870|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2895871|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323957|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2323958|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323959|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
2323960|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
2323961|NCT00382213|Olmesartan|olmesartan|mesh-list
2323962|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2323963|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2323964|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2323965|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2895872|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
2895873|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2895874|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2895875|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2895876|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2895877|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2895878|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895879|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2323966|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323967|NCT00382239|Exenatide|exenatide|mesh-list
2323968|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2323969|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323970|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2323971|NCT00382239|Incretins|incretins|mesh-ancestor
2323972|NCT00382239|Hormones|hormones|mesh-ancestor
2323973|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2323974|NCT00382330|Ciclopirox|ciclopirox|mesh-list
2323975|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
2323976|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323977|NCT00382343|Trimethoprim|trimethoprim|mesh-list
2323978|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2323979|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
2323980|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2895892|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
2895893|NCT05165225|Docetaxel|docetaxel|mesh-list
2895894|NCT05165225|Epirubicin|epirubicin|mesh-list
2895895|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2895896|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
2895897|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895898|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2895899|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2895900|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
2895901|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895902|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895903|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2895904|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
2895905|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
2895906|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
2895907|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2895908|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2895909|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2895910|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895911|NCT05162222|Itraconazole|itraconazole|mesh-list
2895912|NCT05162222|Diltiazem|diltiazem|mesh-list
2895913|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
2895914|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2895915|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2895916|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2895917|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895918|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895919|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2895920|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
2895921|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2895922|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895923|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2895924|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2895925|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2895926|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2895927|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2895928|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
2895929|NCT05162014|Empagliflozin|empagliflozin|mesh-list
2895930|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2895931|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2895932|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895933|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895934|NCT05160896|Bevacizumab|bevacizumab|mesh-list
2895935|NCT05160896|Cetuximab|cetuximab|mesh-list
2895936|NCT05160896|Irinotecan|irinotecan|mesh-list
2895937|NCT05160896|Raltitrexed|raltitrexed|mesh-list
2895938|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2895939|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895940|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2895941|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2895942|NCT05160896|Growth Substances|growth substances|mesh-ancestor
2895943|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2895944|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
2895945|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2895946|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2895947|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895948|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895949|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2895950|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
2895951|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2895960|NCT05152004|Amoxicillin|amoxicillin|mesh-list
2895961|NCT05152004|Metronidazole|metronidazole|mesh-list
2895962|NCT05152004|Clarithromycin|clarithromycin|mesh-list
2895963|NCT05152004|Rabeprazole|rabeprazole|mesh-list
2895964|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2895965|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2895966|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2895967|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2895968|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2895969|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895970|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895971|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2895972|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2895973|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2895974|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2895975|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2895982|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
2895983|NCT05142254|Tadalafil|tadalafil|mesh-list
2895984|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
2895985|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2895986|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2323981|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2323982|NCT00382343|Renal Agents|renal agents|mesh-ancestor
2323983|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
2895987|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2895988|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2895989|NCT05142254|Urological Agents|urological agents|mesh-ancestor
2895990|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2895991|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
2895992|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2895993|NCT05124509|Vaccines|vaccines|mesh-list
2895994|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
2895995|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2323984|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2323985|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2323986|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2323987|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896015|NCT05085002|Letrozole|letrozole|mesh-list
2896016|NCT05085002|Fulvestrant|fulvestrant|mesh-list
2896017|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896018|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2896019|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2896020|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896021|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896022|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2896023|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
2896024|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2896025|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896026|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2896027|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2896028|NCT05076409|Fluconazole|fluconazole|mesh-list
2896029|NCT05076409|BI 425809|bi 425809|mesh-list
2896030|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
2896031|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2896032|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2896033|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2896034|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896035|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896036|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2896037|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
2896038|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2896039|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896040|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2896041|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2896042|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
2896043|NCT05070754|Cantharidin|cantharidin|mesh-list
2896044|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896045|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896046|NCT05060068|Ketamine|ketamine|mesh-list
2896047|NCT05060068|Esketamine|esketamine|mesh-list
2896048|NCT05060068|Analgesics|analgesics|mesh-ancestor
2896049|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
2896050|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323988|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323989|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2323990|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2323991|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2896051|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896052|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2896053|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2109537|NCT02522325|Cocaine|cocaine|mesh-list
2109538|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
2109539|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
2109540|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
2109541|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109542|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109543|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
2109544|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109545|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2109546|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2109547|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2109548|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2109549|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109550|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
2109551|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109552|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2109553|NCT02522377|Midazolam|midazolam|mesh-list
2109554|NCT02522377|Ketamine|ketamine|mesh-list
2109555|NCT02522377|Analgesics|analgesics|mesh-ancestor
2109556|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
2896054|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
2896055|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
2896056|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2896057|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2896058|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2896059|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2896060|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896061|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
2896062|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2896080|NCT05038982|Abrocitinib|abrocitinib|mesh-list
2896081|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2896082|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896083|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323992|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2323993|NCT00382356|Dutasteride|dutasteride|mesh-list
2323994|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2896100|NCT05028062|Naltrexone|naltrexone|mesh-list
2896101|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2896102|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2896103|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896104|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
2896105|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2323995|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2323996|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2323997|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2323998|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
2323999|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324000|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896127|NCT05022784|Nintedanib|nintedanib|mesh-list
2896128|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896129|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2896130|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896131|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896132|NCT05022342|Fulvestrant|fulvestrant|mesh-list
2896133|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2896134|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896135|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2896136|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2896137|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
2896138|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2896139|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896140|NCT05017545|Abatacept|abatacept|mesh-list
2896141|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2896142|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896143|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896144|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2896145|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
2896146|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896147|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2896151|NCT05008575|Fludarabine|fludarabine|mesh-list
2896152|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
2896153|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896154|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896155|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2896156|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
2896157|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896158|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2896159|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2896160|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
2896161|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2896162|NCT04999020|Ravulizumab|ravulizumab|mesh-list
2896163|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2896164|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2896165|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
2896166|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896167|NCT04988074|Cemiplimab|cemiplimab|mesh-list
2896168|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2896169|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896170|NCT04984369|Cetuximab|cetuximab|mesh-list
2896171|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2896172|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896173|NCT04978493|Ustekinumab|ustekinumab|mesh-list
2896174|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
2896177|NCT04975919|Decitabine|decitabine|mesh-list
2896178|NCT04975919|Venetoclax|venetoclax|mesh-list
2896179|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2896180|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
2896181|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896182|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896183|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896199|NCT04971473|Hormones|hormones|mesh-list
2896200|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2896201|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324001|NCT00382421|Aspirin|aspirin|mesh-list
2324002|NCT00382421|Amlodipine|amlodipine|mesh-list
2324003|NCT00382421|Bisoprolol|bisoprolol|mesh-list
2324004|NCT00382421|Molsidomine|molsidomine|mesh-list
2324005|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2324006|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2324007|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2324008|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324009|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2324010|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896208|NCT04964934|Letrozole|letrozole|mesh-list
2896209|NCT04964934|Palbociclib|palbociclib|mesh-list
2896210|NCT04964934|Anastrozole|anastrozole|mesh-list
2896211|NCT04964934|Hormones|hormones|mesh-list
2896212|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2896213|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2896214|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896215|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896216|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2896217|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2896218|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896219|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896220|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2896221|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
2896222|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2896223|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2896224|NCT04964284|Hormones|hormones|mesh-list
2324011|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
2324012|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2896225|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2896226|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896227|NCT04960202|Ritonavir|ritonavir|mesh-list
2896228|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2896229|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2896230|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
2896231|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896232|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896233|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2896234|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2896235|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
2896236|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2896237|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2896238|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2896239|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
2896240|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2896241|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2324013|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2324014|NCT00382421|Analgesics|analgesics|mesh-ancestor
2324015|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
2324016|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324017|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2896242|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896243|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2896244|NCT04946396|Analgesics|analgesics|mesh-ancestor
2896245|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
2896246|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2896247|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2896248|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2896249|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2896250|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
2896251|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2896252|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896253|NCT04944017|Ketamine|ketamine|mesh-list
2896254|NCT04944017|Analgesics|analgesics|mesh-ancestor
2896255|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
2896256|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2896257|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896258|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2896259|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2896260|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
2896261|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
2896262|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2896263|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2896264|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2896265|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324018|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2324019|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2324020|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2324021|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2324022|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2324023|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324024|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
2324025|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
2324026|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
2324027|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2324028|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2896266|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896272|NCT04934800|Cladribine|cladribine|mesh-list
2896273|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896274|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2896275|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
2896276|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109557|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109558|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109559|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2896319|NCT04933344|Daptomycin|daptomycin|mesh-list
2896320|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2896321|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2896322|NCT04930783|Nivolumab|nivolumab|mesh-list
2896323|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2896324|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896325|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2896326|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896332|NCT04925193|Dexamethasone|dexamethasone|mesh-list
2896333|NCT04925193|Daratumumab|daratumumab|mesh-list
2896334|NCT04925193|Pomalidomide|pomalidomide|mesh-list
2896335|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2896336|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
2896337|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
2896338|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2896339|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896340|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2896341|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
2896342|NCT04925193|Hormones|hormones|mesh-ancestor
2896343|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2896344|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2896345|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896346|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
2896347|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2896348|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2896349|NCT04925193|Growth Substances|growth substances|mesh-ancestor
2896350|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
2896351|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
2896352|NCT04925180|Cyproterone|cyproterone|mesh-list
2896353|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
2324029|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2324030|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
2324031|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324032|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2324033|NCT00382460|Pravastatin|pravastatin|mesh-list
2324034|NCT00382460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2324035|NCT00382460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2324036|NCT00382460|Antimetabolites|antimetabolites|mesh-ancestor
2324037|NCT00382460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324038|NCT00382460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2324039|NCT00382460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2324040|NCT00382460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324041|NCT00382499|Lidocaine|lidocaine|mesh-list
2324042|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
2324043|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
2324044|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2324045|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324046|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
2324047|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324048|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2324049|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2324050|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2324051|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2324052|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324053|NCT00382538|Mifepristone|mifepristone|mesh-list
2324054|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2324055|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
2324056|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2324057|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324058|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2324059|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2324060|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2324061|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
2324062|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2896354|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
2896355|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2896356|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896357|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896358|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2896359|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
2896360|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2896369|NCT04903509|Acetaminophen|acetaminophen|mesh-list
2896370|NCT04903509|Liraglutide|liraglutide|mesh-list
2896371|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2109560|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2109561|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
2109562|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
2109563|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109564|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2109565|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2109566|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324063|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2324064|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
2896372|NCT04903509|Analgesics|analgesics|mesh-ancestor
2896373|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
2896374|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2896375|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896376|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
2896377|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2896378|NCT04903509|Incretins|incretins|mesh-ancestor
2896379|NCT04903509|Hormones|hormones|mesh-ancestor
2109567|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109568|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2109569|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2109570|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2896380|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324065|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324066|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
2324067|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2324068|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2324069|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
2324070|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
2324071|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324072|NCT00382629|Protective Agents|protective agents|mesh-ancestor
2324073|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324074|NCT00382642|Ondansetron|ondansetron|mesh-list
2324075|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
2324076|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
2324077|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324078|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324079|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2896396|NCT04886531|Trastuzumab|trastuzumab|mesh-list
2896397|NCT04886531|Letrozole|letrozole|mesh-list
2896398|NCT04886531|Anastrozole|anastrozole|mesh-list
2896399|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2896400|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896401|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2896402|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2896403|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896404|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896405|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2896406|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
2896407|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324080|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
2324081|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
2324082|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2324083|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
2324084|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324085|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324086|NCT00382642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2324087|NCT00382642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2324088|NCT00382642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2324089|NCT00382642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2324090|NCT00382642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2324091|NCT00382668|Dasatinib|dasatinib|mesh-list
2324092|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324093|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2324094|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324095|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324096|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2324097|NCT00382694|Fludarabine|fludarabine|mesh-list
2324098|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324099|NCT00382811|Carboplatin|carboplatin|mesh-list
2324100|NCT00382811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324101|NCT00382837|Epratuzumab|epratuzumab|mesh-list
2324102|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2896408|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896409|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2896410|NCT04880278|Nabilone|nabilone|mesh-list
2896411|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
2896412|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
2896413|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2896414|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896415|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2896416|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2896417|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2896418|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2896419|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2896423|NCT04865419|Voriconazole|voriconazole|mesh-list
2896424|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
2896425|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2896426|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2896427|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2896428|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896429|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324103|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324104|NCT00382889|Beclomethasone|beclomethasone|mesh-list
2324105|NCT00382889|Albuterol|albuterol|mesh-list
2324106|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2324107|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
2324108|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324109|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324110|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2324111|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
2896430|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2896431|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
2896432|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2896433|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896434|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2896442|NCT04827953|Gemcitabine|gemcitabine|mesh-list
2896443|NCT04827953|Paclitaxel|paclitaxel|mesh-list
2896444|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2896445|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896446|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
2896447|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
2896448|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
2896449|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896450|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2896451|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
2896452|NCT04827953|Antiviral Agents|antiviral agents|mesh-ancestor
2896453|NCT04827953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2896454|NCT04827953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896455|NCT04827953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2896456|NCT04827953|Immunologic Factors|immunologic factors|mesh-ancestor
2896457|NCT04827953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896466|NCT04786067|Abatacept|abatacept|mesh-list
2896467|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2896468|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896469|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896470|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2896471|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
2896472|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896473|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2324112|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
2896482|NCT04775680|Antibodies|antibodies|mesh-list
2896483|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
2896484|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896485|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
2896486|NCT04772222|Morphine|morphine|mesh-list
2896487|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2896488|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2896489|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896490|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2896491|NCT04772222|Analgesics|analgesics|mesh-ancestor
2896492|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
2896493|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2896494|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2324113|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2324114|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2324115|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2324116|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2324117|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
2324118|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324119|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324120|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2324121|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
2324122|NCT00382889|Hormones|hormones|mesh-ancestor
2324123|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324124|NCT00382954|Bortezomib|bortezomib|mesh-list
2324125|NCT00382954|Idarubicin|idarubicin|mesh-list
2324126|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324127|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2324128|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2324129|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2896495|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2896496|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2896497|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
2896498|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2896499|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896500|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2896501|NCT04772222|Narcotics|narcotics|mesh-ancestor
2896502|NCT04760613|Cannabidiol|cannabidiol|mesh-list
2896503|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
2109571|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2109572|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2109573|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
2109574|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
2109575|NCT02522715|Prednisone|prednisone|mesh-list
2109576|NCT02522715|Cortisone|cortisone|mesh-list
2324130|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324131|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324132|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2324133|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2324134|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
2324135|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324136|NCT00382980|Antacids|antacids|mesh-ancestor
2324137|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324138|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2324139|NCT00383032|Mifepristone|mifepristone|mesh-list
2324140|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2324141|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
2324142|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2324143|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324144|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2324145|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2324146|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2324147|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
2324148|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2324149|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2324150|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
2324151|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324152|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
2324153|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2324154|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2324155|NCT00383045|Naltrexone|naltrexone|mesh-list
2324156|NCT00383045|Buprenorphine|buprenorphine|mesh-list
2324157|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2324158|NCT00383045|Narcotics|narcotics|mesh-ancestor
2324159|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2324160|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324161|NCT00383045|Analgesics|analgesics|mesh-ancestor
2324162|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
2324163|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324164|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2324165|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2324166|NCT00383136|Tirofiban|tirofiban|mesh-list
2324167|NCT00383136|Abciximab|abciximab|mesh-list
2324168|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
2324169|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2324170|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2896560|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
2896561|NCT04757363|Nivolumab|nivolumab|mesh-list
2896562|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896563|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2896564|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2896565|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324171|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2896594|NCT04738292|Fulvestrant|fulvestrant|mesh-list
2896595|NCT04738292|Onapristone|onapristone|mesh-list
2896596|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2896597|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896598|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2896599|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2896600|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
2896601|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2896602|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896603|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2896604|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
2896605|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2896606|NCT04722679|Anticoagulants|anticoagulants|mesh-list
2896607|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
2896608|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2896609|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324172|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324173|NCT00383214|Epratuzumab|epratuzumab|mesh-list
2324174|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2324175|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324176|NCT00383357|Zolpidem|zolpidem|mesh-list
2324177|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2324178|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2324179|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2324180|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324181|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2324182|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
2324183|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
2324184|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324185|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324186|NCT00383370|Aflibercept|aflibercept|mesh-list
2324187|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2324188|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2324189|NCT00383370|Growth Substances|growth substances|mesh-ancestor
2324190|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324191|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
2896617|NCT04681417|Carboplatin|carboplatin|mesh-list
2896618|NCT04681417|Etoposide|etoposide|mesh-list
2896619|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
2324192|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896620|NCT04681417|Vincristine|vincristine|mesh-list
2896621|NCT04681417|Melphalan|melphalan|mesh-list
2896622|NCT04681417|Topotecan|topotecan|mesh-list
2896623|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896624|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2896625|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2896626|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2896627|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896628|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896629|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
2896630|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
2896631|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
2896632|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2896633|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
2896634|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2896635|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2896636|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
2896637|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896638|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2896639|NCT04658849|Pioglitazone|pioglitazone|mesh-list
2324193|NCT00383396|Cyclosporine|cyclosporine|mesh-list
2324194|NCT00383396|Cyclosporins|cyclosporins|mesh-list
2324195|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324196|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324197|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2324198|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
2324199|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324200|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
2324201|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324202|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
2324203|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2324204|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2324205|NCT00383422|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2324206|NCT00383422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2324207|NCT00383422|Hormone Antagonists|hormone antagonists|mesh-ancestor
2324208|NCT00383422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324209|NCT00383422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324210|NCT00383422|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2324211|NCT00383422|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2324212|NCT00383422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2324213|NCT00383474|Bortezomib|bortezomib|mesh-list
2324214|NCT00383474|Tipifarnib|tipifarnib|mesh-list
2324215|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324216|NCT00383487|Calcitriol|calcitriol|mesh-list
2896640|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2896641|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896642|NCT04657640|Iron|iron|mesh-list
2896643|NCT04657640|Trace Elements|trace elements|mesh-list
2896644|NCT04657640|Folic Acid|folic acid|mesh-list
2896645|NCT04657640|Micronutrients|micronutrients|mesh-list
2896646|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
2896647|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896648|NCT04657640|Hematinics|hematinics|mesh-ancestor
2896649|NCT04657640|Vitamins|vitamins|mesh-ancestor
2896656|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
2896657|NCT04651088|Diuretics|diuretics|mesh-ancestor
2896658|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
2896659|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896660|NCT04651088|Expectorants|expectorants|mesh-ancestor
2896661|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
2896674|NCT04595513|Sirolimus|sirolimus|mesh-list
2896675|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2896676|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2896677|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2896678|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896679|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
2896680|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2896681|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
2896682|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896683|NCT04589832|Entrectinib|entrectinib|mesh-list
2896684|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2896685|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896686|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896694|NCT04575181|Insulin|insulin|mesh-list
2896695|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2324217|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
2324218|NCT00383487|Naproxen|naproxen|mesh-list
2324219|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
2324220|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2324221|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2324222|NCT00383487|Analgesics|analgesics|mesh-ancestor
2324223|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
2324224|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324225|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324226|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2324227|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2324228|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
2324229|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2324230|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324231|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324232|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2324233|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2896696|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
2896697|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2896698|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896699|NCT04569747|Tamoxifen|tamoxifen|mesh-list
2896700|NCT04569747|Trastuzumab|trastuzumab|mesh-list
2896701|NCT04569747|Pertuzumab|pertuzumab|mesh-list
2896702|NCT04569747|Letrozole|letrozole|mesh-list
2896703|NCT04569747|Anastrozole|anastrozole|mesh-list
2896704|NCT04569747|Leuprolide|leuprolide|mesh-list
2896705|NCT04569747|Exemestane|exemestane|mesh-list
2896706|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2896707|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896708|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2896709|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2896710|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896711|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896712|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2896713|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
2896714|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2896715|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896716|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2896717|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2896718|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2896719|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2896720|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2896721|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
2896722|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2896723|NCT04569084|Edaravone|edaravone|mesh-list
2324234|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2324235|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2324236|NCT00383487|Vitamins|vitamins|mesh-ancestor
2324237|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
2896724|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2896725|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
2896726|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896727|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2896728|NCT04569084|Protective Agents|protective agents|mesh-ancestor
2896729|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324238|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2324239|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2324240|NCT00383513|Epratuzumab|epratuzumab|mesh-list
2324241|NCT00383513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2324242|NCT00383513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324243|NCT00383526|Vaccines|vaccines|mesh-list
2324244|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
2896741|NCT04560881|Vaccines|vaccines|mesh-list
2896742|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
2896743|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896744|NCT04556773|Paclitaxel|paclitaxel|mesh-list
2896745|NCT04556773|Capecitabine|capecitabine|mesh-list
2896746|NCT04556773|Trastuzumab|trastuzumab|mesh-list
2324245|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324246|NCT00383539|Vaccines|vaccines|mesh-list
2324247|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
2324248|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324249|NCT00383578|Metformin|metformin|mesh-list
2324250|NCT00383578|Vildagliptin|vildagliptin|mesh-list
2896747|NCT04556773|Durvalumab|durvalumab|mesh-list
2896748|NCT04556773|Fulvestrant|fulvestrant|mesh-list
2896749|NCT04556773|Anastrozole|anastrozole|mesh-list
2896750|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2896751|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896752|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
2896753|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
2896754|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
2896755|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896756|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2896757|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
2896758|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2896759|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2896760|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2896761|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2896762|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
2896763|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2896764|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896765|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2896766|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2896767|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324251|NCT00383578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2324252|NCT00383578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324253|NCT00383578|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2324254|NCT00383578|Protease Inhibitors|protease inhibitors|mesh-ancestor
2324255|NCT00383578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324256|NCT00383578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324257|NCT00383591|Vaccines|vaccines|mesh-list
2324258|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
2324259|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324260|NCT00383656|Hormones|hormones|mesh-list
2324261|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324262|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324263|NCT00383682|Mexiletine|mexiletine|mesh-list
2324264|NCT00383682|Morphine|morphine|mesh-list
2324265|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2324266|NCT00383682|Narcotics|narcotics|mesh-ancestor
2324267|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2324268|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896775|NCT04544293|Molgramostim|molgramostim|mesh-list
2896776|NCT04544293|Sargramostim|sargramostim|mesh-list
2896777|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
2896778|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896779|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896780|NCT04538742|Paclitaxel|paclitaxel|mesh-list
2896781|NCT04538742|Trastuzumab|trastuzumab|mesh-list
2896782|NCT04538742|Durvalumab|durvalumab|mesh-list
2896783|NCT04538742|Pertuzumab|pertuzumab|mesh-list
2896784|NCT04538742|Tucatinib|tucatinib|mesh-list
2896785|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2896786|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896787|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
2896788|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
2896789|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
2896790|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896791|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2896792|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2896793|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896794|NCT04528082|Apremilast|apremilast|mesh-list
2896795|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2896796|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2896797|NCT04528082|Analgesics|analgesics|mesh-ancestor
2896798|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
2896799|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2896800|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896801|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2896802|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2896803|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2324269|NCT00383682|Analgesics|analgesics|mesh-ancestor
2324270|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
2324271|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324272|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2324273|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2324274|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2324275|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2324276|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324277|NCT00383695|Capecitabine|capecitabine|mesh-list
2324278|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
2324279|NCT00383695|Cetuximab|cetuximab|mesh-list
2324280|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2324281|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
2324282|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324283|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324284|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2324285|NCT00383708|Lanreotide|lanreotide|mesh-list
2324286|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324287|NCT00383799|Amiodarone|amiodarone|mesh-list
2324288|NCT00383799|Procainamide|procainamide|mesh-list
2324289|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2324290|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
2324291|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2324292|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2324293|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324294|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2324295|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2324296|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2324297|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324298|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2896804|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2896805|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896806|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896807|NCT04512066|Risperidone|risperidone|mesh-list
2896808|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2896809|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
2896810|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2896811|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896812|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896813|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2896814|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2896815|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2896816|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2896817|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2896818|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
2896819|NCT04501120|Azacitidine|azacitidine|mesh-list
2896820|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2896821|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
2896822|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896823|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896824|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896825|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
2896826|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2896827|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896828|NCT04497961|Lenalidomide|lenalidomide|mesh-list
2896829|NCT04497961|Daratumumab|daratumumab|mesh-list
2896830|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
2896831|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896832|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2896833|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2896834|NCT04497961|Growth Substances|growth substances|mesh-ancestor
2896835|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
2896836|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896837|NCT04483583|Clopidogrel|clopidogrel|mesh-list
2896838|NCT04483583|Ticagrelor|ticagrelor|mesh-list
2896839|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2896840|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2896841|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2896842|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2896843|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
2896844|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2896845|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896846|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896847|NCT04482309|Trastuzumab|trastuzumab|mesh-list
2896848|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2896849|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896850|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
2896851|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2896852|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
2896853|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2896854|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896855|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2324299|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2324300|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2324301|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2324302|NCT00383812|Bevacizumab|bevacizumab|mesh-list
2324303|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2324304|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324305|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2324306|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2324307|NCT00383812|Growth Substances|growth substances|mesh-ancestor
2324308|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324309|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
2324310|NCT00383851|Temozolomide|temozolomide|mesh-list
2324311|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2324312|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2324313|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
2324314|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324315|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324316|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
2324317|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
2324318|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324319|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2324320|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2324321|NCT00383851|Growth Substances|growth substances|mesh-ancestor
2324322|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324323|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
2324324|NCT00383864|Interferons|interferons|mesh-list
2896856|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
2896857|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2896858|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
2324325|NCT00383864|Ribavirin|ribavirin|mesh-list
2324326|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324327|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
2324328|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324329|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
2324330|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896859|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896860|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2896861|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2896862|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
2896863|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
2896864|NCT04460183|Protective Agents|protective agents|mesh-ancestor
2896871|NCT04447287|Buprenorphine|buprenorphine|mesh-list
2896872|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2896873|NCT04447287|Naloxone|naloxone|mesh-list
2896874|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2896875|NCT04447287|Narcotics|narcotics|mesh-ancestor
2896876|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2896877|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896878|NCT04447287|Analgesics|analgesics|mesh-ancestor
2896879|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
2896880|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2896881|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2324331|NCT00383877|Insulin|insulin|mesh-list
2324332|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2324333|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
2324334|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
2324335|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
2324336|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
2324337|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2324338|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324339|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
2324340|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2324341|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2324342|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324343|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2324344|NCT00383890|Analgesics|analgesics|mesh-ancestor
2324345|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
2324346|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324347|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2324348|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2324349|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2324350|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
2324351|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2896894|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
2896895|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2896896|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
2324352|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324353|NCT00383916|Pantoprazole|pantoprazole|mesh-list
2324354|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2324355|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2324356|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2324357|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324358|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896897|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2896898|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
2896899|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896900|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896901|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
2896902|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
2324359|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2324360|NCT00383929|Candesartan|candesartan|mesh-list
2324361|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
2324362|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2896903|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
2896904|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2896905|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2896906|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2896907|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896908|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896909|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2896919|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
2896920|NCT04393350|Lenvatinib|lenvatinib|mesh-list
2896921|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2896922|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2896923|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2896924|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896925|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324363|NCT00383929|Diuretics|diuretics|mesh-ancestor
2324364|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
2324365|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324366|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2324367|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2896958|NCT04336735|Vaccines|vaccines|mesh-list
2896959|NCT04336735|Immunologic Factors|immunologic factors|mesh-ancestor
2896960|NCT04336735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896970|NCT04322006|Antibodies|antibodies|mesh-list
2896971|NCT04322006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2896972|NCT04322006|Immunologic Factors|immunologic factors|mesh-ancestor
2324368|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896973|NCT04322006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896974|NCT04311502|Pyridoxine|pyridoxine|mesh-list
2896975|NCT04311502|Pyridoxal|pyridoxal|mesh-list
2896976|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
2896977|NCT04311502|Rifampin|rifampin|mesh-list
2896978|NCT04311502|Rifapentine|rifapentine|mesh-list
2896979|NCT04311502|Clofazimine|clofazimine|mesh-list
2896980|NCT04311502|Isoniazid|isoniazid|mesh-list
2896981|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
2896982|NCT04311502|Ethambutol|ethambutol|mesh-list
2896983|NCT04311502|Vitamins|vitamins|mesh-ancestor
2896984|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
2896985|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2896986|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
2896987|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2896988|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
2896989|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2896990|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2896991|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
2896992|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2896993|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2896994|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2896995|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2896996|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2896997|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2896998|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2896999|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2897000|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2897001|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2897002|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2897003|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
2897004|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2897005|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2897006|NCT04300647|Atezolizumab|atezolizumab|mesh-list
2897007|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324369|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2324370|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2324371|NCT00383994|Rituximab|rituximab|mesh-list
2324372|NCT00383994|Sargramostim|sargramostim|mesh-list
2324373|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2324374|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324375|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
2324376|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324377|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2324378|NCT00384020|Citalopram|citalopram|mesh-list
2324379|NCT00384020|Paroxetine|paroxetine|mesh-list
2324380|NCT00384020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2324381|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2324382|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2324383|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324384|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324385|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
2324386|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324387|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2324388|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
2324389|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2324390|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2324391|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2324392|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324393|NCT00384046|Testosterone|testosterone|mesh-list
2324394|NCT00384046|Androgens|androgens|mesh-ancestor
2324395|NCT00384046|Hormones|hormones|mesh-ancestor
2324396|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324397|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324398|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
2324399|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2324400|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2324401|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
2897010|NCT04283669|Crizotinib|crizotinib|mesh-list
2897011|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897012|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2897013|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897014|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324402|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324403|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324404|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2324405|NCT00384124|Imiquimod|imiquimod|mesh-list
2324406|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2324407|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
2324408|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324409|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324410|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
2324411|NCT00384137|Tacrolimus|tacrolimus|mesh-list
2324412|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2324413|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
2324414|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324415|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2324416|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324417|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324418|NCT00384150|Galiximab|galiximab|mesh-list
2897019|NCT04262154|Prednisone|prednisone|mesh-list
2897020|NCT04262154|Atezolizumab|atezolizumab|mesh-list
2897021|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2324419|NCT00384150|Rituximab|rituximab|mesh-list
2324420|NCT00384150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2324421|NCT00384150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324422|NCT00384150|Immunologic Factors|immunologic factors|mesh-ancestor
2324423|NCT00384150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324424|NCT00384150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2324425|NCT00384150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2324426|NCT00384202|Tacrolimus|tacrolimus|mesh-list
2324427|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2324428|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
2897022|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
2897023|NCT04262154|Hormones|hormones|mesh-ancestor
2897024|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2897025|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897026|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2897027|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897028|NCT04246086|Lenalidomide|lenalidomide|mesh-list
2897029|NCT04246086|Obinutuzumab|obinutuzumab|mesh-list
2897030|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
2897031|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897032|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2897033|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2897034|NCT04246086|Growth Substances|growth substances|mesh-ancestor
2897035|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
2897036|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897037|NCT04246086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897038|NCT04226950|Interferons|interferons|mesh-list
2897039|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
2897040|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
2897041|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2897042|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897043|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
2897044|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2897045|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
2897046|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324429|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324430|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2324431|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324432|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324433|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
2324434|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2324435|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324436|NCT00384280|Rifampin|rifampin|mesh-list
2324437|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2324438|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
2324439|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2324440|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324441|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
2324442|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2324443|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324444|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324445|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2324446|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2324447|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2324448|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2324449|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2324450|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2324451|NCT00384306|Prednisolone|prednisolone|mesh-list
2324452|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2324453|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
2324454|NCT00384306|Hormones|hormones|mesh-ancestor
2324455|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324456|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324457|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2324458|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324459|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
2324460|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2324461|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2324462|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2324463|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2324464|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324465|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
2324466|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324467|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324468|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2324469|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324470|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
2324471|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2324472|NCT00384410|Nabilone|nabilone|mesh-list
2324473|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
2324474|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
2324475|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324476|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324477|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2324478|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2324479|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2324480|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2324481|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2324482|NCT00384436|Citalopram|citalopram|mesh-list
2324483|NCT00384436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2324484|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2324485|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2324486|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324487|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324488|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
2324489|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897098|NCT04175964|Metformin|metformin|mesh-list
2324490|NCT00384436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2324491|NCT00384436|Antidepressive Agents|antidepressive agents|mesh-ancestor
2324492|NCT00384436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2324493|NCT00384475|Ciclesonide|ciclesonide|mesh-list
2324494|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
2324495|NCT00384475|Hormones|hormones|mesh-ancestor
2324496|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2897099|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2897100|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897112|NCT04175834|Cetirizine|cetirizine|mesh-list
2897113|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-list
2897114|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2897115|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2897116|NCT04175834|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2897117|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
2897118|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2897119|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897120|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897121|NCT04171700|Rucaparib|rucaparib|mesh-list
2897122|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2897123|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897124|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897125|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109577|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109578|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
2109579|NCT02522715|Hormones|hormones|mesh-ancestor
2109580|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109581|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109582|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2109583|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109584|NCT02522767|Mesalamine|mesalamine|mesh-list
2324497|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324498|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2324499|NCT00384527|Vancomycin|vancomycin|mesh-list
2324500|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
2324501|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2324502|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324503|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2324504|NCT00384540|Dobutamine|dobutamine|mesh-list
2324505|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2324506|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
2897134|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
2897135|NCT04157985|Nivolumab|nivolumab|mesh-list
2897136|NCT04157985|Ipilimumab|ipilimumab|mesh-list
2897137|NCT04157985|Cemiplimab|cemiplimab|mesh-list
2897138|NCT04157985|Atezolizumab|atezolizumab|mesh-list
2897139|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2897140|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897141|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897142|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897143|NCT04154956|Docetaxel|docetaxel|mesh-list
2897144|NCT04154956|Maytansine|maytansine|mesh-list
2897145|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897146|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
2897147|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
2897148|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
2897149|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897150|NCT04154956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2324507|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
2324508|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324509|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324510|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2324511|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2324512|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2324513|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
2324514|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324515|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324516|NCT00384540|Protective Agents|protective agents|mesh-ancestor
2324517|NCT00384553|Rituximab|rituximab|mesh-list
2324518|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2324519|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324520|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
2324521|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324522|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2324523|NCT00384566|Metoprolol|metoprolol|mesh-list
2324524|NCT00384566|Carvedilol|carvedilol|mesh-list
2324525|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2324526|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2324527|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
2324528|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
2324529|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324530|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324531|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2324532|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2324533|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2109585|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2109586|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2109587|NCT02522767|Analgesics|analgesics|mesh-ancestor
2109588|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
2109589|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109590|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109591|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109592|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2109593|NCT02522780|Mesalamine|mesalamine|mesh-list
2109594|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2109595|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2109596|NCT02522780|Analgesics|analgesics|mesh-ancestor
2109597|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
2109598|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109599|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109600|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109601|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2109602|NCT02523235|Ropivacaine|ropivacaine|mesh-list
2109603|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
2109604|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
2109605|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109606|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109607|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
2109608|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109609|NCT02523586|Anesthetics|anesthetics|mesh-list
2897164|NCT04137120|Aflibercept|aflibercept|mesh-list
2897165|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2897166|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2897167|NCT04137120|Growth Substances|growth substances|mesh-ancestor
2897168|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897169|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
2897170|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897171|NCT04125745|CXA-10|cxa-10|mesh-list
2897172|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2897173|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2897174|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
2897175|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2897176|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2897177|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2897178|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2897179|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897185|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
2897186|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897187|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897188|NCT04070768|Venetoclax|venetoclax|mesh-list
2897189|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
2897190|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897191|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897192|NCT04060342|Gemcitabine|gemcitabine|mesh-list
2897193|NCT04060342|Paclitaxel|paclitaxel|mesh-list
2897194|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
2897195|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2897196|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897197|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
2897198|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
2324534|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
2324535|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324536|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324537|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
2324538|NCT00384566|Protective Agents|protective agents|mesh-ancestor
2324539|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2324540|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2324541|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2324542|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
2324543|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2109610|NCT02523586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109611|NCT02523586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109612|NCT02523599|Bupivacaine|bupivacaine|mesh-list
2109613|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
2109614|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
2109615|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109616|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109617|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
2109618|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109619|NCT02524054|Furosemide|furosemide|mesh-list
2109620|NCT02524054|Diuretics|diuretics|mesh-ancestor
2109621|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
2109622|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109623|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2109624|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2109625|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324544|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2897199|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
2897200|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897201|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2897202|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
2897203|NCT04060342|Antiviral Agents|antiviral agents|mesh-ancestor
2897204|NCT04060342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2897205|NCT04060342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897206|NCT04060342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2897207|NCT04060342|Immunologic Factors|immunologic factors|mesh-ancestor
2897208|NCT04060342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897209|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897210|NCT04058366|Ivacaftor|ivacaftor|mesh-list
2897211|NCT04058366|Elexacaftor|elexacaftor|mesh-list
2897212|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2897213|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2897214|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897218|NCT04042740|Ribavirin|ribavirin|mesh-list
2897219|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
2897220|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897221|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
2897222|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2897233|NCT04039503|Tirzepatide|tirzepatide|mesh-list
2897234|NCT04039503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2897235|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897236|NCT04039503|Incretins|incretins|mesh-ancestor
2897237|NCT04039503|Hormones|hormones|mesh-ancestor
2897238|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2897239|NCT04025879|Paclitaxel|paclitaxel|mesh-list
2897240|NCT04025879|Docetaxel|docetaxel|mesh-list
2897241|NCT04025879|Carboplatin|carboplatin|mesh-list
2897242|NCT04025879|Nivolumab|nivolumab|mesh-list
2897243|NCT04025879|Pemetrexed|pemetrexed|mesh-list
2897244|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2897245|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897246|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
2897247|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
2897248|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
2897249|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897250|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897251|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2897252|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897253|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2897254|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2324545|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
2324546|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2324547|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2897258|NCT04004416|Lorazepam|lorazepam|mesh-list
2897259|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
2897260|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
2897261|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
2897262|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2897263|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897264|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2897265|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2897266|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2897267|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2897268|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2897269|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2897270|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
2897271|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
2897272|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2897273|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324548|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324549|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
2324550|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324551|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324552|NCT00384592|Esomeprazole|esomeprazole|mesh-list
2324553|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2897313|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
2897314|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
2897315|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2897316|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324554|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2324555|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2324556|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324557|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324558|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
2324559|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2324560|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2324561|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324562|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324563|NCT00384605|Hormones|hormones|mesh-ancestor
2324564|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324565|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324566|NCT00384618|Vitamin E|vitamin e|mesh-list
2324567|NCT00384618|Pravastatin|pravastatin|mesh-list
2324568|NCT00384618|Vitamins|vitamins|mesh-ancestor
2324569|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
2324570|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324571|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
2324572|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324573|NCT00384618|Protective Agents|protective agents|mesh-ancestor
2324574|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2324575|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2897317|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324576|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
2324577|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2897318|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2324578|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2324579|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324580|NCT00384631|Bevacizumab|bevacizumab|mesh-list
2324581|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2324582|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324583|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2324584|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2324585|NCT00384631|Growth Substances|growth substances|mesh-ancestor
2324586|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324587|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
2324588|NCT00384657|Iron|iron|mesh-list
2324589|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2324590|NCT00384657|Trace Elements|trace elements|mesh-ancestor
2324591|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
2324592|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324593|NCT00384657|Hematinics|hematinics|mesh-ancestor
2324594|NCT00384696|Nicotine|nicotine|mesh-list
2324595|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2324596|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
2324597|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324598|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324599|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2324600|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2324601|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
2324602|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324603|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324604|NCT00384800|Thalidomide|thalidomide|mesh-list
2324605|NCT00384800|Tegafur|tegafur|mesh-list
2324606|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2324607|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
2324608|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897415|NCT03913195|Ibalizumab|ibalizumab|mesh-list
2897416|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2897417|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2897418|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
2897419|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324609|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
2324610|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2324611|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324612|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2324613|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2324614|NCT00384800|Growth Substances|growth substances|mesh-ancestor
2324615|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
2897449|NCT03878199|Cytarabine|cytarabine|mesh-list
2897450|NCT03878199|Daunorubicin|daunorubicin|mesh-list
2897451|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2897452|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2897453|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
2897454|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897455|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897456|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
2897457|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2897458|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2897459|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
2897460|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897461|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2897462|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2897463|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2897464|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897465|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2109626|NCT02524106|Bococizumab|bococizumab|mesh-list
2109627|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2109628|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2109629|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
2109630|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109631|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2109632|NCT02524145|Isoproterenol|isoproterenol|mesh-list
2109633|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
2109634|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
2324616|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324617|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2324618|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
2324619|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324620|NCT00384826|Paclitaxel|paclitaxel|mesh-list
2324621|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2324622|NCT00384826|Carboplatin|carboplatin|mesh-list
2897485|NCT03847649|Prednisone|prednisone|mesh-list
2897486|NCT03847649|Durvalumab|durvalumab|mesh-list
2109635|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2109636|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109637|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109638|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2109639|NCT02524145|Analgesics|analgesics|mesh-ancestor
2109640|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
2109641|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109642|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2897487|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2897488|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
2897489|NCT03847649|Hormones|hormones|mesh-ancestor
2897490|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2897491|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324623|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2324624|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324625|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
2324626|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
2324627|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
2897492|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2897493|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897494|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897500|NCT03818607|Eculizumab|eculizumab|mesh-list
2897501|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2897502|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2897503|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
2897504|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897525|NCT03813121|Midazolam|midazolam|mesh-list
2897526|NCT03813121|Ketamine|ketamine|mesh-list
2324628|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324629|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2324630|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324631|NCT00384878|Leucovorin|leucovorin|mesh-list
2324632|NCT00384878|Fluorouracil|fluorouracil|mesh-list
2324633|NCT00384878|Cetuximab|cetuximab|mesh-list
2324634|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324635|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
2324636|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324637|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2324638|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2324639|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
2324640|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324641|NCT00384878|Antidotes|antidotes|mesh-ancestor
2324642|NCT00384878|Protective Agents|protective agents|mesh-ancestor
2324643|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
2324644|NCT00384878|Vitamins|vitamins|mesh-ancestor
2897527|NCT03813121|Analgesics|analgesics|mesh-ancestor
2897528|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
2897529|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2897530|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897531|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2897532|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2324645|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
2324646|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2324647|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
2324648|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2324649|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
2324650|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324651|NCT00384904|Ritonavir|ritonavir|mesh-list
2324652|NCT00384904|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2324653|NCT00384904|Tenofovir|tenofovir|mesh-list
2324654|NCT00384904|Famotidine|famotidine|mesh-list
2324655|NCT00384904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2324656|NCT00384904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2324657|NCT00384904|Protease Inhibitors|protease inhibitors|mesh-ancestor
2324658|NCT00384904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324659|NCT00384904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324660|NCT00384904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2324661|NCT00384904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2324662|NCT00384904|Antiviral Agents|antiviral agents|mesh-ancestor
2324663|NCT00384904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324664|NCT00384904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2897533|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
2897534|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
2897535|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2897536|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2897537|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2897538|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2897539|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897540|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2897541|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2897542|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2897543|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2897544|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2897545|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
2897546|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
2324665|NCT00384904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2324666|NCT00384904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2324667|NCT00384904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2324668|NCT00384904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2324669|NCT00384904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2324670|NCT00384904|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2324671|NCT00384904|Histamine Antagonists|histamine antagonists|mesh-ancestor
2324672|NCT00384904|Histamine Agents|histamine agents|mesh-ancestor
2324673|NCT00384904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324674|NCT00384904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324675|NCT00384917|Ketoconazole|ketoconazole|mesh-list
2324676|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
2324677|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324678|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2324679|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2324680|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324681|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324682|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2324683|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
2324684|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324685|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324686|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2324687|NCT00384969|Sorafenib|sorafenib|mesh-list
2324688|NCT00384969|Everolimus|everolimus|mesh-list
2324689|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324690|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2324691|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324692|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324693|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2324694|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
2324695|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324696|NCT00385021|Leucovorin|leucovorin|mesh-list
2324697|NCT00385021|Fluorouracil|fluorouracil|mesh-list
2324698|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
2324699|NCT00385021|Bevacizumab|bevacizumab|mesh-list
2324700|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
2897568|NCT03778229|Osimertinib|osimertinib|mesh-list
2897569|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897570|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2897571|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897572|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324701|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324702|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2324703|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324704|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2324705|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
2324706|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324707|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2324708|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2324709|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2324710|NCT00385021|Growth Substances|growth substances|mesh-ancestor
2324711|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
2324712|NCT00385021|Antidotes|antidotes|mesh-ancestor
2324713|NCT00385021|Protective Agents|protective agents|mesh-ancestor
2324714|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
2324715|NCT00385021|Vitamins|vitamins|mesh-ancestor
2324716|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
2324717|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
2324718|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2324719|NCT00385125|Rituximab|rituximab|mesh-list
2324720|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2324721|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2324722|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324723|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
2324724|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324725|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2324726|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2324727|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
2897588|NCT03695172|Ropivacaine|ropivacaine|mesh-list
2897589|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
2897590|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
2897591|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2897592|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897593|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
2897594|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2897631|NCT03591510|Cytarabine|cytarabine|mesh-list
2897632|NCT03591510|Fludarabine|fludarabine|mesh-list
2897633|NCT03591510|Etoposide|etoposide|mesh-list
2897634|NCT03591510|Daunorubicin|daunorubicin|mesh-list
2897635|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
2897636|NCT03591510|Idarubicin|idarubicin|mesh-list
2897637|NCT03591510|Midostaurin|midostaurin|mesh-list
2897638|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897639|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2897640|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
2897641|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897642|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2897643|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
2897644|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897645|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2897646|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2897647|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2897648|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897649|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
2897650|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2897651|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2897652|NCT03591510|Analgesics|analgesics|mesh-ancestor
2897653|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
2897654|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2897655|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2897656|NCT03580369|Omalizumab|omalizumab|mesh-list
2897657|NCT03580369|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2897658|NCT03580369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2897659|NCT03580369|Respiratory System Agents|respiratory system agents|mesh-ancestor
2897660|NCT03580356|Omalizumab|omalizumab|mesh-list
2897661|NCT03580356|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2897662|NCT03580356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2897663|NCT03580356|Respiratory System Agents|respiratory system agents|mesh-ancestor
2897664|NCT03554044|Tamoxifen|tamoxifen|mesh-list
2897665|NCT03554044|Gemcitabine|gemcitabine|mesh-list
2897666|NCT03554044|Paclitaxel|paclitaxel|mesh-list
2897667|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2897668|NCT03554044|Carboplatin|carboplatin|mesh-list
2897669|NCT03554044|Letrozole|letrozole|mesh-list
2897670|NCT03554044|Fulvestrant|fulvestrant|mesh-list
2897671|NCT03554044|Anastrozole|anastrozole|mesh-list
2897672|NCT03554044|Exemestane|exemestane|mesh-list
2897673|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2897674|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2897675|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897676|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
2897677|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
2897678|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
2897679|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897680|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2897681|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
2897682|NCT03554044|Antiviral Agents|antiviral agents|mesh-ancestor
2897683|NCT03554044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2897684|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897685|NCT03554044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2897686|NCT03554044|Immunologic Factors|immunologic factors|mesh-ancestor
2897687|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897688|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2897689|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2897690|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2897691|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
2897692|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2897693|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2897694|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2897695|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2897696|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2324728|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324729|NCT00385307|Amibegron|amibegron|mesh-list
2324730|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2897697|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2897698|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897699|NCT03552380|Nivolumab|nivolumab|mesh-list
2897700|NCT03552380|Ipilimumab|ipilimumab|mesh-list
2897701|NCT03552380|Entinostat|entinostat|mesh-list
2897702|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2324731|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2324732|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
2324733|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324734|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324735|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324736|NCT00385359|Albuterol|albuterol|mesh-list
2897703|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897704|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2897705|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897706|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2897707|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897708|NCT03547999|Nivolumab|nivolumab|mesh-list
2897709|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897710|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897711|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2897712|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897713|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
2897714|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897715|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324737|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2324738|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
2324739|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324740|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324741|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2324742|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
2324743|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
2897726|NCT03498521|Gemcitabine|gemcitabine|mesh-list
2897727|NCT03498521|Bevacizumab|bevacizumab|mesh-list
2897728|NCT03498521|Carboplatin|carboplatin|mesh-list
2897729|NCT03498521|Trastuzumab|trastuzumab|mesh-list
2897730|NCT03498521|Atezolizumab|atezolizumab|mesh-list
2897731|NCT03498521|Olaparib|olaparib|mesh-list
2897732|NCT03498521|Pertuzumab|pertuzumab|mesh-list
2897733|NCT03498521|Vemurafenib|vemurafenib|mesh-list
2897734|NCT03498521|Ivosidenib|ivosidenib|mesh-list
2897735|NCT03498521|Entrectinib|entrectinib|mesh-list
2897736|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897737|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897738|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897739|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2897740|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2897741|NCT03498521|Growth Substances|growth substances|mesh-ancestor
2897742|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897743|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
2897744|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2897745|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
2897746|NCT03498521|Antiviral Agents|antiviral agents|mesh-ancestor
2897747|NCT03498521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2897748|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897749|NCT03498521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2897750|NCT03498521|Immunologic Factors|immunologic factors|mesh-ancestor
2897751|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2897752|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2897753|NCT03491267|Tretinoin|tretinoin|mesh-list
2897754|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897755|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
2897756|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
2897757|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2324744|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2324745|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2324746|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2324747|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2324748|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
2324749|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324750|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324751|NCT00385385|KRM 1648|krm 1648|mesh-list
2324752|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2897758|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
2897759|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897760|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2897761|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
2897762|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2897763|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897764|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2897765|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2897766|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2897767|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
2324753|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
2324754|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2324755|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2897778|NCT03473756|Atezolizumab|atezolizumab|mesh-list
2897779|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897780|NCT03470675|Morphine|morphine|mesh-list
2897781|NCT03470675|Ketamine|ketamine|mesh-list
2897782|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2897783|NCT03470675|Narcotics|narcotics|mesh-ancestor
2324756|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
2324757|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2324758|NCT00385398|Temozolomide|temozolomide|mesh-list
2324759|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324760|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2324761|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324762|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324763|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2324764|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
2324765|NCT00385411|Valproic Acid|valproic acid|mesh-list
2324766|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
2324767|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324768|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897784|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2897785|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897786|NCT03470675|Analgesics|analgesics|mesh-ancestor
2324769|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
2324770|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2897787|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
2897788|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2897789|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2897790|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2897791|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
2897792|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
2897793|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2897794|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2897795|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2897796|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897797|NCT03467360|Etoposide|etoposide|mesh-list
2897798|NCT03467360|Acetazolamide|acetazolamide|mesh-list
2897799|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2897800|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897801|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2897802|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2897803|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897804|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897805|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
2897806|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2897807|NCT03467360|Diuretics|diuretics|mesh-ancestor
2897808|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
2897809|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897810|NCT03452072|Timolol|timolol|mesh-list
2897811|NCT03452072|Petrolatum|petrolatum|mesh-list
2897812|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2897813|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2897814|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
2897815|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2897816|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897817|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897818|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2897819|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2897820|NCT03452072|Emollients|emollients|mesh-ancestor
2897821|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
2897822|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2897823|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2897824|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2897825|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
2897826|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2897827|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897828|NCT03433040|Progestins|progestins|mesh-ancestor
2897829|NCT03433040|Hormones|hormones|mesh-ancestor
2897830|NCT03432065|Buspirone|buspirone|mesh-list
2897831|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2897832|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2897833|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2897834|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897835|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2897836|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2324771|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324772|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
2324773|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2324774|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2324775|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2324776|NCT00385437|Mirtazapine|mirtazapine|mesh-list
2324777|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
2324778|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2324779|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2324780|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
2324781|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
2324782|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324783|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324784|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324785|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2324786|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2324787|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2324788|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2324789|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2324790|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2324791|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
2324792|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2324793|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2324794|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
2324795|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2324796|NCT00385450|Nelfinavir|nelfinavir|mesh-list
2324797|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2324798|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2324799|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
2324800|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324801|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897837|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
2897838|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2897839|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897840|NCT03412799|Gemcitabine|gemcitabine|mesh-list
2897841|NCT03412799|Paclitaxel|paclitaxel|mesh-list
2897842|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2897843|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2897844|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897845|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
2897846|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
2897847|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
2897848|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897849|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2897850|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
2897851|NCT03412799|Antiviral Agents|antiviral agents|mesh-ancestor
2324802|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2324803|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2324804|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
2324805|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324806|NCT00385463|Montelukast|montelukast|mesh-list
2324807|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2324808|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2324809|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
2324810|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2324811|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
2897852|NCT03412799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2897853|NCT03412799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897854|NCT03412799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2897855|NCT03412799|Immunologic Factors|immunologic factors|mesh-ancestor
2897856|NCT03412799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109643|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2109644|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2109645|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
2109646|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109647|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109648|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2109649|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2109650|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2109651|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
2109652|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2109653|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2109654|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
2109655|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2109656|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
2109657|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2109658|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
2109659|NCT02524145|Protective Agents|protective agents|mesh-ancestor
2109660|NCT02524561|Estradiol|estradiol|mesh-list
2109661|NCT02524561|Progesterone|progesterone|mesh-list
2109662|NCT02524561|Estrogens|estrogens|mesh-ancestor
2109663|NCT02524561|Hormones|hormones|mesh-ancestor
2109664|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109665|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897884|NCT03405870|SMOFlipid|smoflipid|mesh-list
2897885|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2897886|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2897887|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2897888|NCT03394027|TIC10 compound|tic10 compound|mesh-list
2897889|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897890|NCT03391882|Apomorphine|apomorphine|mesh-list
2897891|NCT03391882|Emetics|emetics|mesh-ancestor
2897892|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897893|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
2897894|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2897895|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2897896|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
2897897|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
2897898|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2897899|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897900|NCT03382574|Denosumab|denosumab|mesh-list
2897901|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2897902|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897903|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
2897904|NCT03366155|Irinotecan|irinotecan|mesh-list
2897905|NCT03366155|Cetuximab|cetuximab|mesh-list
2897906|NCT03366155|Panitumumab|panitumumab|mesh-list
2897907|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897908|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2897909|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2897910|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897911|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897912|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897913|NCT03357952|Daratumumab|daratumumab|mesh-list
2897914|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897915|NCT03323463|Carboplatin|carboplatin|mesh-list
2897916|NCT03323463|Fluorouracil|fluorouracil|mesh-list
2897917|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897918|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
2897919|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324812|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324813|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324814|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2324815|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2324816|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324817|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2324818|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
2324819|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324820|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
2324821|NCT00385463|Hormones|hormones|mesh-ancestor
2324822|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
2324823|NCT00385502|Econazole|econazole|mesh-list
2897920|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2897921|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2897922|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
2109666|NCT02524561|Progestins|progestins|mesh-ancestor
2109667|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
2109668|NCT02524665|Salicylates|salicylates|mesh-list
2109669|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2109670|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2109671|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
2109672|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
2109673|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
2109674|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2109675|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2109676|NCT02524665|Analgesics|analgesics|mesh-ancestor
2109677|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
2109678|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109679|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109680|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109681|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2109682|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2109683|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109684|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109685|NCT02524769|Estrogens|estrogens|mesh-list
2109686|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2109687|NCT02524769|Hormones|hormones|mesh-ancestor
2897923|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897924|NCT03323151|Ixazomib|ixazomib|mesh-list
2897925|NCT03323151|Glycine|glycine|mesh-list
2897926|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897927|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
2897928|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897929|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897930|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
2897931|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2897932|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324824|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
2324825|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324826|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2324827|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2324828|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324829|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324830|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2324831|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
2324832|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324833|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324834|NCT00385554|UC-781|uc-781|mesh-list
2324835|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2897958|NCT03287947|Nintedanib|nintedanib|mesh-list
2897959|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897960|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2897961|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897962|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324836|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
2324837|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324838|NCT00385606|Gemcitabine|gemcitabine|mesh-list
2324839|NCT00385606|Rofecoxib|rofecoxib|mesh-list
2324840|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324841|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2324842|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
2324843|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324844|NCT00385606|Antiviral Agents|antiviral agents|mesh-ancestor
2324845|NCT00385606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324846|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324847|NCT00385606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2324848|NCT00385606|Immunologic Factors|immunologic factors|mesh-ancestor
2324849|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897963|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2897964|NCT03286556|Autoantibodies|autoantibodies|mesh-list
2897965|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2897966|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
2897967|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897968|NCT03272217|Bevacizumab|bevacizumab|mesh-list
2897969|NCT03272217|Atezolizumab|atezolizumab|mesh-list
2897970|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897971|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897972|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2897973|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2897974|NCT03272217|Growth Substances|growth substances|mesh-ancestor
2897975|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2897976|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
2897977|NCT03262935|Capecitabine|capecitabine|mesh-list
2897978|NCT03262935|Trastuzumab|trastuzumab|mesh-list
2897979|NCT03262935|Vinorelbine|vinorelbine|mesh-list
2897980|NCT03262935|Lapatinib|lapatinib|mesh-list
2897981|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2897982|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
2897983|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2897984|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897985|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897986|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2897987|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
2324850|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2324851|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2324852|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2897988|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
2897989|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
2897990|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2897991|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2897992|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
2897993|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2897994|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2897995|NCT03258281|Evolocumab|evolocumab|mesh-list
2897996|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2897997|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2897998|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
2897999|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898000|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2898001|NCT03241186|Nivolumab|nivolumab|mesh-list
2898002|NCT03241186|Ipilimumab|ipilimumab|mesh-list
2898003|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2898004|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898005|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2898006|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324853|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2324854|NCT00385606|Analgesics|analgesics|mesh-ancestor
2324855|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
2324856|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324857|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2324858|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2324859|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2324860|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
2324861|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324862|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2324863|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2324864|NCT00385645|Zidovudine|zidovudine|mesh-list
2324865|NCT00385645|Lamivudine|lamivudine|mesh-list
2324866|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2324867|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2324868|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
2324869|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898056|NCT03194542|Luspatercept|luspatercept|mesh-list
2898057|NCT03194542|Hematinics|hematinics|mesh-ancestor
2898058|NCT03178552|Gemcitabine|gemcitabine|mesh-list
2898059|NCT03178552|Bevacizumab|bevacizumab|mesh-list
2898060|NCT03178552|Carboplatin|carboplatin|mesh-list
2898061|NCT03178552|Pemetrexed|pemetrexed|mesh-list
2898062|NCT03178552|Atezolizumab|atezolizumab|mesh-list
2898063|NCT03178552|Vemurafenib|vemurafenib|mesh-list
2898064|NCT03178552|Entrectinib|entrectinib|mesh-list
2898065|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2898066|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898067|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2898068|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2898069|NCT03178552|Growth Substances|growth substances|mesh-ancestor
2898070|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898071|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
2898072|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2898073|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
2898074|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898075|NCT03178552|Antiviral Agents|antiviral agents|mesh-ancestor
2898076|NCT03178552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2898077|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898078|NCT03178552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2898079|NCT03178552|Immunologic Factors|immunologic factors|mesh-ancestor
2898080|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2898081|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2898082|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2898083|NCT03113422|Venetoclax|venetoclax|mesh-list
2898084|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324870|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324871|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2324872|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2324873|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
2324874|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324875|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2324876|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2324877|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
2324878|NCT00385658|Simvastatin|simvastatin|mesh-list
2324879|NCT00385658|Ezetimibe|ezetimibe|mesh-list
2324880|NCT00385658|Fenofibrate|fenofibrate|mesh-list
2324881|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2324882|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2324883|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
2324884|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324885|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2324886|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2324887|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898115|NCT03066622|Olanzapine|olanzapine|mesh-list
2898116|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
2898117|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
2898118|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2898119|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898120|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2898121|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2898122|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2898123|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2898124|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2898125|NCT03066622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2898126|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2898127|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2898128|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898129|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2898130|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
2898131|NCT03029598|Carboplatin|carboplatin|mesh-list
2898132|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
2898133|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898134|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2898137|NCT03020030|Leucovorin|leucovorin|mesh-list
2898138|NCT03020030|Cytarabine|cytarabine|mesh-list
2898139|NCT03020030|Dexamethasone|dexamethasone|mesh-list
2898140|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
2898141|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
2898142|NCT03020030|Doxorubicin|doxorubicin|mesh-list
2898143|NCT03020030|Methotrexate|methotrexate|mesh-list
2898144|NCT03020030|Etoposide|etoposide|mesh-list
2898145|NCT03020030|Vincristine|vincristine|mesh-list
2898146|NCT03020030|Asparaginase|asparaginase|mesh-list
2898147|NCT03020030|Dasatinib|dasatinib|mesh-list
2898148|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
2898149|NCT03020030|Pegaspargase|pegaspargase|mesh-list
2898150|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
2898151|NCT03020030|Razoxane|razoxane|mesh-list
2898152|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
2898153|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2898154|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
2898155|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898156|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2898157|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2898158|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
2898159|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898160|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898161|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2898162|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2898163|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
2898164|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
2898165|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2898166|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2324888|NCT00385710|Valproic Acid|valproic acid|mesh-list
2324889|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
2324890|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324891|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324892|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
2324893|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324894|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898167|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
2898168|NCT03020030|Hormones|hormones|mesh-ancestor
2898169|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2898170|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2898171|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2324895|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
2324896|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2324897|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2898172|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2898173|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2898174|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898175|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2898176|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
2898177|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2898178|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2898179|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
2898180|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
2898181|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2898182|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2898183|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2898184|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
2898185|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2898186|NCT03020030|Antidotes|antidotes|mesh-ancestor
2898187|NCT03020030|Protective Agents|protective agents|mesh-ancestor
2898188|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
2898189|NCT03020030|Vitamins|vitamins|mesh-ancestor
2898190|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
2898191|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
2898192|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
2898193|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
2898194|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2898195|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2898196|NCT03016312|Atezolizumab|atezolizumab|mesh-list
2898197|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324898|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2324899|NCT00385853|Temozolomide|temozolomide|mesh-list
2324900|NCT00385853|Vatalanib|vatalanib|mesh-list
2324901|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2324902|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
2324903|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324904|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324905|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2324906|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324907|NCT00385931|Valsartan|valsartan|mesh-list
2324908|NCT00385931|Simvastatin|simvastatin|mesh-list
2324909|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2324910|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2324911|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
2324912|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324913|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2324914|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2324915|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324916|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2324917|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2324918|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2324919|NCT00385957|Lamivudine|lamivudine|mesh-list
2898225|NCT02968212|Clofazimine|clofazimine|mesh-list
2898226|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2898227|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
2898228|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2109688|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109689|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109690|NCT02524847|Methoxsalen|methoxsalen|mesh-list
2324920|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2324921|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2324922|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324923|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324924|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
2324925|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324926|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2324927|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2324928|NCT00385970|Leucovorin|leucovorin|mesh-list
2324929|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
2324930|NCT00385970|Tegafur|tegafur|mesh-list
2324931|NCT00385970|Calcium|calcium|mesh-list
2898229|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2898235|NCT02932618|Factor VIII|factor viii|mesh-list
2898236|NCT02932618|Coagulants|coagulants|mesh-ancestor
2324932|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
2324933|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2324934|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324935|NCT00385970|Antidotes|antidotes|mesh-ancestor
2324936|NCT00385970|Protective Agents|protective agents|mesh-ancestor
2324937|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
2109691|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2109692|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
2109693|NCT02525133|Bupivacaine|bupivacaine|mesh-list
2109694|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
2109695|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
2109696|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109697|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109698|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
2109699|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109700|NCT02525471|RNS60|rns60|mesh-list
2109701|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2109702|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2898261|NCT02871297|Vortioxetine|vortioxetine|mesh-list
2898262|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
2898263|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2898264|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2898265|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2898266|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2898267|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898268|NCT02871297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2898269|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2898270|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2898271|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898272|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2898273|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
2898274|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2898275|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2898276|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2898277|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2898284|NCT02799212|Somatostatin|somatostatin|mesh-list
2898285|NCT02799212|Hormones|hormones|mesh-ancestor
2898286|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2898287|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898288|NCT02756897|Venetoclax|venetoclax|mesh-list
2898289|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898290|NCT02709655|Vortioxetine|vortioxetine|mesh-list
2898291|NCT02709655|Fluoxetine|fluoxetine|mesh-list
2898292|NCT02709655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2898293|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2898294|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2898295|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324938|NCT00385970|Vitamins|vitamins|mesh-ancestor
2324939|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
2324940|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2324941|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
2324942|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898296|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2898297|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
2898298|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898299|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2898300|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
2898301|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2898302|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2898303|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2898304|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898305|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2898306|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2898307|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2898308|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2898309|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2898310|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2898311|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2898318|NCT02675959|Defibrotide|defibrotide|mesh-list
2898319|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2898320|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2324943|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324944|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2324945|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
2898321|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898322|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2324946|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2324947|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
2324948|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2324949|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
2324950|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2324951|NCT00386061|Rimonabant|rimonabant|mesh-list
2324952|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2324953|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2324954|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2324955|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324956|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898330|NCT02581215|Ramucirumab|ramucirumab|mesh-list
2898331|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324957|NCT00386061|Hormones|hormones|mesh-ancestor
2324958|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2324959|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324960|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
2324961|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2324962|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
2324963|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
2324964|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324965|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2324966|NCT00386126|Hematinics|hematinics|mesh-ancestor
2324967|NCT00386178|Vitamin E|vitamin e|mesh-list
2324968|NCT00386178|Tocopherols|tocopherols|mesh-list
2324969|NCT00386178|Tocotrienols|tocotrienols|mesh-list
2324970|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
2324971|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
2324972|NCT00386178|Vitamins|vitamins|mesh-ancestor
2324973|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
2898362|NCT02553941|Azacitidine|azacitidine|mesh-list
2898363|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2898364|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
2898365|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898366|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2324974|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324975|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
2898367|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898368|NCT02549092|Levodopa|levodopa|mesh-list
2898369|NCT02549092|Carbidopa|carbidopa|mesh-list
2898370|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2898371|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2898372|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2898373|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
2898374|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2898375|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898376|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898377|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2898378|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898379|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2898380|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
2898381|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
2898389|NCT02482753|Exemestane|exemestane|mesh-list
2898390|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898391|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2898392|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2898393|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898394|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898395|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2898396|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
2898397|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2898398|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324976|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324977|NCT00386178|Protective Agents|protective agents|mesh-ancestor
2324978|NCT00386191|Clopidogrel|clopidogrel|mesh-list
2324979|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2324980|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2324981|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2898438|NCT02443077|Cytarabine|cytarabine|mesh-list
2898439|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
2898440|NCT02443077|Melphalan|melphalan|mesh-list
2898441|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
2898442|NCT02443077|Carmustine|carmustine|mesh-list
2898443|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2898444|NCT02443077|Etoposide|etoposide|mesh-list
2898445|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
2898446|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
2898447|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2898448|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
2898449|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898450|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2898451|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2898452|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
2898453|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898454|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898455|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2898456|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2898457|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2898458|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2898459|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898460|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2898461|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
2898462|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
2898463|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2898464|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
2898465|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
2898466|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
2898467|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
2898468|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
2898469|NCT02420574|Albendazole|albendazole|mesh-list
2898470|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
2898471|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2898472|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2898473|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
2898474|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2898475|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2898476|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
2898477|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
2898478|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
2898479|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898480|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898481|NCT02403193|Spartalizumab|spartalizumab|mesh-list
2898482|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2898483|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898484|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898495|NCT02358681|Ketorolac|ketorolac|mesh-list
2898496|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2898497|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2898498|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2898499|NCT02358681|Analgesics|analgesics|mesh-ancestor
2898500|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
2898501|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2324982|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2324983|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
2324984|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2324985|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324986|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324987|NCT00386230|Zidovudine|zidovudine|mesh-list
2324988|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
2324989|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2324990|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2324991|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2324992|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2324993|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
2324994|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2898502|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898503|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2898504|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2898505|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2898506|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898507|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898508|NCT02339168|Metformin|metformin|mesh-list
2898509|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2898510|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898511|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
2898512|NCT02317783|Flutemetamol|flutemetamol|mesh-list
2898513|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
2898514|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898515|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
2898516|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2898517|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2898518|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
2898519|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
2898520|NCT02269267|Protective Agents|protective agents|mesh-ancestor
2898521|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2324995|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2324996|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2324997|NCT00386269|Codeine|codeine|mesh-list
2324998|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2898550|NCT02117791|Riociguat|riociguat|mesh-list
2898551|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
2898552|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898553|NCT02101788|Tamoxifen|tamoxifen|mesh-list
2898554|NCT02101788|Paclitaxel|paclitaxel|mesh-list
2898555|NCT02101788|Doxorubicin|doxorubicin|mesh-list
2898556|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2898557|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2898558|NCT02101788|Letrozole|letrozole|mesh-list
2898559|NCT02101788|Topotecan|topotecan|mesh-list
2898560|NCT02101788|Trametinib|trametinib|mesh-list
2898561|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2898562|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2898563|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898564|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
2898565|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
2898566|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
2898567|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898568|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2898569|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2898570|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2898571|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898572|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2898573|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2898574|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2898575|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
2324999|NCT00386269|Narcotics|narcotics|mesh-ancestor
2325000|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2325001|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325002|NCT00386269|Analgesics|analgesics|mesh-ancestor
2325003|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
2325004|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325005|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
2898576|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2898577|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898578|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2898579|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2898580|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2898581|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2898582|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2325006|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
2325007|NCT00386282|Misoprostol|misoprostol|mesh-list
2325008|NCT00386282|Mifepristone|mifepristone|mesh-list
2325009|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2325010|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
2325011|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2898583|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2898584|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2898585|NCT02101788|Protective Agents|protective agents|mesh-ancestor
2898586|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2898587|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
2898588|NCT02081378|Niacinamide|niacinamide|mesh-list
2898589|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
2898590|NCT02081378|Dasatinib|dasatinib|mesh-list
2898591|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898592|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2898593|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898594|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898595|NCT02081378|Vitamin B Complex|vitamin b complex|mesh-ancestor
2325012|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325013|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2325014|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2325015|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
2325016|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2325017|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2325018|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2325019|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2325020|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
2325021|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2898596|NCT02081378|Vitamins|vitamins|mesh-ancestor
2898597|NCT02081378|Micronutrients|micronutrients|mesh-ancestor
2898598|NCT02081378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898599|NCT02015013|Plerixafor|plerixafor|mesh-list
2898600|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2898601|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2898602|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
2898603|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2898604|NCT01970410|Teriflunomide|teriflunomide|mesh-list
2898605|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2898606|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2898607|NCT01970410|Analgesics|analgesics|mesh-ancestor
2898608|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
2898609|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2898610|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898611|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2898612|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2898613|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2898614|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
2898615|NCT01963728|Insulin|insulin|mesh-list
2898616|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2898617|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
2898618|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
2898619|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
2898620|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
2898621|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2898622|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898623|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
2898624|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2898625|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2898626|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2898627|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2898628|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898629|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898630|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325022|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2325023|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
2325024|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2325025|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
2325026|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2325027|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2325028|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
2325029|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325030|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2325031|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325032|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325033|NCT00386399|Mitomycins|mitomycins|mesh-list
2325034|NCT00386399|Mitomycin|mitomycin|mesh-list
2325035|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2898644|NCT01880567|Rituximab|rituximab|mesh-list
2898645|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2898646|NCT01880567|Antibodies|antibodies|mesh-list
2898647|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
2898648|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2898649|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
2898650|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898651|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898652|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2898653|NCT01856478|Methotrexate|methotrexate|mesh-list
2898654|NCT01856478|Afatinib|afatinib|mesh-list
2898655|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2898656|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
2898657|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2898658|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898659|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2898660|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
2109703|NCT02525471|Analgesics|analgesics|mesh-ancestor
2109704|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
2109705|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2898661|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898662|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898663|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
2898664|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898665|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2898666|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2898667|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
2898668|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2898669|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2898670|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2898677|NCT01842282|Amlexanox|amlexanox|mesh-list
2898678|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2109706|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325036|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325037|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
2325038|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325039|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2325040|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325041|NCT00386412|Valganciclovir|valganciclovir|mesh-list
2325042|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
2325043|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325044|NCT00386503|Artesunate|artesunate|mesh-list
2325045|NCT00386503|Amodiaquine|amodiaquine|mesh-list
2898714|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
2898715|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
2898716|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2898717|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325046|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
2325047|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2325048|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2325049|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325050|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325051|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
2325052|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
2325053|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2325054|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
2325055|NCT00386516|Fluorouracil|fluorouracil|mesh-list
2325056|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
2325057|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325058|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2325059|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325060|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2325061|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
2325062|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325063|NCT00386529|Aspirin|aspirin|mesh-list
2325064|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2898718|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2898719|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
2898720|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2898721|NCT01622335|Analgesics|analgesics|mesh-ancestor
2898722|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
2898723|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2898726|NCT01509339|Vancomycin|vancomycin|mesh-list
2898727|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2898728|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2898729|NCT01500551|Tofacitinib|tofacitinib|mesh-list
2898730|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2898731|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898732|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898733|NCT01362374|Leucovorin|leucovorin|mesh-list
2898734|NCT01362374|Paclitaxel|paclitaxel|mesh-list
2898735|NCT01362374|Docetaxel|docetaxel|mesh-list
2898736|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
2898737|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2898738|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898739|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
2898740|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
2898741|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
2898742|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898743|NCT01362374|Antidotes|antidotes|mesh-ancestor
2898744|NCT01362374|Protective Agents|protective agents|mesh-ancestor
2898745|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898746|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
2898747|NCT01362374|Vitamins|vitamins|mesh-ancestor
2898748|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
2325065|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2325066|NCT00386529|Analgesics|analgesics|mesh-ancestor
2325067|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
2325068|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325069|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325070|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2325071|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2325072|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2325073|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2325074|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325075|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2325076|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2325077|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898774|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2898775|NCT01248247|Sorafenib|sorafenib|mesh-list
2898776|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898777|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2898778|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898779|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898780|NCT01164228|Gemcitabine|gemcitabine|mesh-list
2898781|NCT01164228|Sunitinib|sunitinib|mesh-list
2898782|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2898783|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
2898784|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898785|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898786|NCT01164228|Antiviral Agents|antiviral agents|mesh-ancestor
2898787|NCT01164228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2898788|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898789|NCT01164228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2898790|NCT01164228|Immunologic Factors|immunologic factors|mesh-ancestor
2898791|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898792|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2898793|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2898794|NCT01164228|Growth Substances|growth substances|mesh-ancestor
2898795|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
2898796|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2325078|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
2325079|NCT00386555|Docetaxel|docetaxel|mesh-list
2325080|NCT00386555|Axitinib|axitinib|mesh-list
2325081|NCT00386555|Crenolanib|crenolanib|mesh-list
2325082|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325083|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
2325084|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
2325085|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
2325086|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325087|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2325088|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325089|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2325090|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2325091|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2325092|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2325093|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325094|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
2325095|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2325096|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325097|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2325098|NCT00386646|Laxatives|laxatives|mesh-ancestor
2325099|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2325100|NCT00386659|Ritonavir|ritonavir|mesh-list
2325101|NCT00386659|Lopinavir|lopinavir|mesh-list
2325102|NCT00386659|Tenofovir|tenofovir|mesh-list
2325103|NCT00386659|Abacavir|abacavir|mesh-list
2325104|NCT00386659|Efavirenz|efavirenz|mesh-list
2325105|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
2325106|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2325107|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2325108|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
2325109|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325110|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325111|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2898809|NCT01012167|Galantamine|galantamine|mesh-list
2898810|NCT01012167|Oxytocin|oxytocin|mesh-list
2898811|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
2898812|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2898813|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898814|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2898815|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898816|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898817|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
2898818|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2898819|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2325112|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2325113|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
2325114|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325115|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2325116|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2325117|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2325118|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2325119|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2325120|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2325121|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2898820|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
2325122|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2325123|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2325124|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
2325125|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
2325126|NCT00386672|Vitamin D|vitamin d|mesh-list
2325127|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
2325128|NCT00386672|Vitamins|vitamins|mesh-list
2325129|NCT00386672|Calcium|calcium|mesh-list
2325130|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
2325131|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325132|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2325133|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2325134|NCT00386685|Trastuzumab|trastuzumab|mesh-list
2898821|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2898822|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
2325135|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2325136|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325137|NCT00386750|Lumefantrine|lumefantrine|mesh-list
2898860|NCT00924326|Vidarabine|vidarabine|mesh-list
2898861|NCT00924326|Aldesleukin|aldesleukin|mesh-list
2898862|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
2898863|NCT00924326|Fludarabine|fludarabine|mesh-list
2898864|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
2898865|NCT00924326|Interleukin-2|interleukin-2|mesh-list
2898866|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2898867|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
2898868|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898869|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2898870|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2898871|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
2898872|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898873|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898874|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2898875|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2898876|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
2898877|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
2898878|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2898879|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2898880|NCT00924326|Analgesics|analgesics|mesh-ancestor
2898881|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
2898882|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2898883|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2898884|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2325138|NCT00386750|Artemether|artemether|mesh-list
2325139|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2325140|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
2325141|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2325142|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2325143|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325144|NCT00386763|Lumefantrine|lumefantrine|mesh-list
2325145|NCT00386763|Artemether|artemether|mesh-list
2325146|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2325147|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
2325148|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2325149|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2325150|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325151|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
2325152|NCT00386802|Clotrimazole|clotrimazole|mesh-list
2325153|NCT00386802|Miconazole|miconazole|mesh-list
2325154|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325155|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2325156|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2325157|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2325158|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325159|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325160|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2325161|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
2325162|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2325163|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325164|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2325165|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2325166|NCT00386815|Pemetrexed|pemetrexed|mesh-list
2325167|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325168|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2898899|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
2898900|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2898901|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325169|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325170|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2325171|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2325172|NCT00386828|Bevacizumab|bevacizumab|mesh-list
2325173|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2325174|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325175|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2325176|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2325177|NCT00386828|Growth Substances|growth substances|mesh-ancestor
2898924|NCT00321100|Bevacizumab|bevacizumab|mesh-list
2325178|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325179|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
2898925|NCT00321100|Cetuximab|cetuximab|mesh-list
2898926|NCT00321100|Capecitabine|capecitabine|mesh-list
2325180|NCT00386841|Citalopram|citalopram|mesh-list
2325181|NCT00386841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2325182|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2325183|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2898927|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
2898928|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2898929|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898930|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2898931|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2898932|NCT00321100|Growth Substances|growth substances|mesh-ancestor
2898933|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898934|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
2898935|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2898936|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
2898937|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325184|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325185|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2325186|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
2325187|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325188|NCT00386841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2325189|NCT00386841|Antidepressive Agents|antidepressive agents|mesh-ancestor
2325190|NCT00386841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2325191|NCT00386867|Misoprostol|misoprostol|mesh-list
2325192|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2325193|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
2325194|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2325195|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325196|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2325197|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2325198|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
2325199|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
2325200|NCT00386958|Povidone|povidone|mesh-list
2325201|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
2325202|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
2325203|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2325204|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325205|NCT00386984|Octreotide|octreotide|mesh-list
2325206|NCT00386984|Somatostatin|somatostatin|mesh-list
2325207|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2325208|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2898962|NCT05191784|Bevacizumab|bevacizumab|mesh-list
2898963|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2898964|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898965|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2898966|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2898967|NCT05191784|Growth Substances|growth substances|mesh-ancestor
2898968|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325209|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325210|NCT00386984|Hormones|hormones|mesh-ancestor
2325211|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2325212|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325213|NCT00386997|Amphotericin B|amphotericin b|mesh-list
2325214|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2325215|NCT00386997|Amebicides|amebicides|mesh-ancestor
2325216|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2325217|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2325218|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325219|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2325220|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
2325221|NCT00387114|Ascorbic Acid|ascorbic acid|mesh-list
2898969|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
2898970|NCT05191706|Dexamethasone|dexamethasone|mesh-list
2898971|NCT05191706|Prednisolone|prednisolone|mesh-list
2898972|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2898973|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
2898974|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2898975|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
2898976|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2898977|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
2898978|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2898979|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
2898980|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
2898981|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2898982|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2898983|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2898984|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
2898985|NCT05191706|Hormones|hormones|mesh-ancestor
2898986|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2898987|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2898988|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898989|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2898990|NCT05191706|Protective Agents|protective agents|mesh-ancestor
2898991|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
2898992|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2898993|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2898994|NCT05191446|Ethanol|ethanol|mesh-list
2898995|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2325222|NCT00387114|Vitamins|vitamins|mesh-ancestor
2325223|NCT00387114|Micronutrients|micronutrients|mesh-ancestor
2325224|NCT00387114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325225|NCT00387114|Antioxidants|antioxidants|mesh-ancestor
2325226|NCT00387114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2898996|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2898997|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2898998|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325227|NCT00387114|Protective Agents|protective agents|mesh-ancestor
2325228|NCT00387179|Melatonin|melatonin|mesh-list
2325229|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
2325230|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325231|NCT00387179|Protective Agents|protective agents|mesh-ancestor
2325232|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325233|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2325234|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
2898999|NCT05191394|Antibodies|antibodies|mesh-list
2899000|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
2325235|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2899001|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899002|NCT05191290|Heparin|heparin|mesh-list
2899003|NCT05191290|Calcium heparin|calcium heparin|mesh-list
2899004|NCT05191290|Citric Acid|citric acid|mesh-list
2899005|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
2899006|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
2899007|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2325236|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325237|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
2325238|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325239|NCT00387322|Pemetrexed|pemetrexed|mesh-list
2325240|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2325241|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325242|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325243|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325244|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2325245|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2325246|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2325247|NCT00387374|Paclitaxel|paclitaxel|mesh-list
2325248|NCT00387374|Bevacizumab|bevacizumab|mesh-list
2325249|NCT00387374|Carboplatin|carboplatin|mesh-list
2325250|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2325251|NCT00387374|Antibodies|antibodies|mesh-list
2325252|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
2325253|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2325254|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2899008|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
2899009|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
2899010|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899011|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2899012|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2899013|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
2899014|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2899019|NCT05191225|Rituximab|rituximab|mesh-list
2899020|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2899021|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899022|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
2899023|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899024|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2899025|NCT05191004|Fulvestrant|fulvestrant|mesh-list
2899026|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2899027|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899028|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2899029|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2899030|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
2899031|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2899032|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899033|NCT05190952|Dexamethasone|dexamethasone|mesh-list
2899034|NCT05190952|Ketamine|ketamine|mesh-list
2899035|NCT05190952|Bupivacaine|bupivacaine|mesh-list
2899036|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2899037|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
2899038|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
2899039|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899040|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899041|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2899042|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
2899043|NCT05190952|Hormones|hormones|mesh-ancestor
2899044|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2899045|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2899046|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899047|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
2899048|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
2899049|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2899050|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
2899051|NCT05190952|Analgesics|analgesics|mesh-ancestor
2899052|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2899053|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2899054|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
2899055|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2899056|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2899057|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899058|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899059|NCT05190770|Triamcinolone|triamcinolone|mesh-list
2899060|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2899061|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2899062|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2899063|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2899064|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
2899065|NCT05190770|Hormones|hormones|mesh-ancestor
2899066|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2899067|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899068|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2899069|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
2899070|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899071|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899072|NCT05190705|Dexamethasone|dexamethasone|mesh-list
2899073|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
2899074|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
2899075|NCT05190705|BB 1101|bb 1101|mesh-list
2899076|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2899077|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
2899078|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
2899079|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899080|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899081|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2899082|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
2325255|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325256|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
2325257|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
2325258|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
2325259|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325260|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2325261|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2325262|NCT00387374|Growth Substances|growth substances|mesh-ancestor
2325263|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325264|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
2325265|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
2325266|NCT00387400|Everolimus|everolimus|mesh-list
2325267|NCT00387400|Temozolomide|temozolomide|mesh-list
2325268|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325269|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2325270|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
2325271|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325272|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2325273|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
2899083|NCT05190705|Hormones|hormones|mesh-ancestor
2899084|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2899085|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2899086|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899087|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
2899088|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899089|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899090|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2325274|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899110|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
2899111|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899112|NCT05190562|Astringents|astringents|mesh-ancestor
2899113|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
2899114|NCT05190471|Decitabine|decitabine|mesh-list
2899115|NCT05190471|Oblimersen|oblimersen|mesh-list
2899116|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2899117|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
2899118|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325275|NCT00387413|Niacinamide|niacinamide|mesh-list
2325276|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2325277|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2325278|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2325279|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2325280|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325281|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2325282|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325283|NCT00387413|Analgesics|analgesics|mesh-ancestor
2325284|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
2325285|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325286|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
2325287|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2325288|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
2325289|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
2325290|NCT00387413|Vitamins|vitamins|mesh-ancestor
2325291|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
2325292|NCT00387504|Fenretinide|fenretinide|mesh-list
2325293|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325294|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2325295|NCT00387504|Protective Agents|protective agents|mesh-ancestor
2325296|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325297|NCT00387530|Valganciclovir|valganciclovir|mesh-list
2325298|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2325299|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
2899119|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899120|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325300|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325301|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325302|NCT00387556|Ondansetron|ondansetron|mesh-list
2325303|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
2899132|NCT05190432|Taxifolin|taxifolin|mesh-list
2899133|NCT05190432|Ergothioneine|ergothioneine|mesh-list
2899134|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
2899135|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899136|NCT05190432|Protective Agents|protective agents|mesh-ancestor
2899137|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899138|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2899139|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2899140|NCT05190432|Analgesics|analgesics|mesh-ancestor
2899141|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
2899142|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899143|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2899144|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2899145|NCT05190341|Ibuprofen|ibuprofen|mesh-list
2899146|NCT05190341|Ketorolac|ketorolac|mesh-list
2899147|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2899148|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2899149|NCT05190341|Analgesics|analgesics|mesh-ancestor
2899150|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
2899151|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325304|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
2325305|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325306|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325307|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2325308|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
2325309|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
2325310|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2899152|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899153|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2899154|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2899155|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2899156|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325311|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
2325312|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899157|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899158|NCT05190315|Temozolomide|temozolomide|mesh-list
2899159|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
2899160|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2899161|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
2899162|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899163|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899164|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
2899165|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
2899166|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899167|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899168|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2899169|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2899170|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2899171|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2899172|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2899173|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2899174|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
2899175|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899176|NCT05190120|Ropivacaine|ropivacaine|mesh-list
2899177|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
2899178|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
2899179|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2899180|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899181|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
2899182|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899183|NCT05190094|Letrozole|letrozole|mesh-list
2899184|NCT05190094|Palbociclib|palbociclib|mesh-list
2899185|NCT05190094|Anastrozole|anastrozole|mesh-list
2899186|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2325313|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325314|NCT00387556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2325315|NCT00387556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2325316|NCT00387556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2325317|NCT00387556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2325318|NCT00387556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2325319|NCT00387569|Vaccines|vaccines|mesh-list
2325320|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
2325321|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325322|NCT00387582|Ranibizumab|ranibizumab|mesh-list
2325323|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2325324|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2325325|NCT00387582|Growth Substances|growth substances|mesh-ancestor
2325326|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325327|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
2325328|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325329|NCT00387608|Veliparib|veliparib|mesh-list
2325330|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2325331|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325332|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325333|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325334|NCT00387699|Bevacizumab|bevacizumab|mesh-list
2325335|NCT00387699|Etoposide|etoposide|mesh-list
2325336|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2325337|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899187|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899188|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2899189|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899190|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899191|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2899192|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
2899193|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2899194|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899195|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2899196|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2899197|NCT05189977|Propranolol|propranolol|mesh-list
2899198|NCT05189977|Prazosin|prazosin|mesh-list
2899199|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2325338|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2325339|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2325340|NCT00387699|Growth Substances|growth substances|mesh-ancestor
2325341|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325342|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
2325343|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2325344|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2899200|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2899201|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
2899202|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899203|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899204|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899205|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2899206|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2899207|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
2899208|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2899209|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2899210|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
2899211|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2899212|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
2899213|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2899214|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899215|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2899216|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2899217|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2899218|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
2899219|NCT05189704|Narcotics|narcotics|mesh-ancestor
2899220|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2899221|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899222|NCT05189704|Analgesics|analgesics|mesh-ancestor
2899223|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
2899224|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899225|NCT05188053|Ketorolac|ketorolac|mesh-list
2899226|NCT05188053|Epinephrine|epinephrine|mesh-list
2325345|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2325346|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325347|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325348|NCT00387738|Histamine|histamine|mesh-list
2325349|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
2325350|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
2325351|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2325352|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325353|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325354|NCT00387777|Buprenorphine|buprenorphine|mesh-list
2325355|NCT00387777|Analgesics|analgesics|mesh-list
2325356|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2325357|NCT00387777|Narcotics|narcotics|mesh-ancestor
2325358|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2899227|NCT05188053|Ropivacaine|ropivacaine|mesh-list
2899228|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
2899229|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
2899230|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2899231|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899232|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
2899233|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899234|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2109707|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109708|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2109709|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2109710|NCT02525523|Alicaforsen|alicaforsen|mesh-list
2109711|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2109712|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2109713|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
2109714|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109715|NCT02525536|Trebananib|trebananib|mesh-list
2109716|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2109717|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2109718|NCT02525536|Growth Substances|growth substances|mesh-ancestor
2899235|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2899236|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
2899237|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899238|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899239|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2899240|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2899241|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
2325359|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325360|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
2325361|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325362|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2325363|NCT00387868|Etoposide|etoposide|mesh-list
2325364|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325365|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2325366|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2325367|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2325368|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325369|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325370|NCT00387907|Trastuzumab|trastuzumab|mesh-list
2325371|NCT00387907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2325372|NCT00387907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325373|NCT00387920|Sunitinib|sunitinib|mesh-list
2899242|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2899243|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
2899244|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
2899245|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
2899246|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2899247|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2899248|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2899249|NCT05188053|Analgesics|analgesics|mesh-ancestor
2899250|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2899251|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2899252|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2899253|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899254|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
2899255|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2899256|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899264|NCT05183828|Letrozole|letrozole|mesh-list
2899265|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899266|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2899267|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2899268|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899269|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899270|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2899271|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
2899272|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2899273|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899274|NCT05180773|Bromocriptine|bromocriptine|mesh-list
2899275|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
2899276|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2899277|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
2899278|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2899279|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
2899280|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899281|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899282|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
2325374|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325375|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2325376|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2325377|NCT00387920|Growth Substances|growth substances|mesh-ancestor
2325378|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325379|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
2325380|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2899283|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2899284|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2899285|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
2899286|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2899287|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899288|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
2899289|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
2899290|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899291|NCT05180357|Benralizumab|benralizumab|mesh-list
2899292|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2899293|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
2325381|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899294|NCT05179876|Selexipag|selexipag|mesh-list
2899295|NCT05179876|Tadalafil|tadalafil|mesh-list
2899296|NCT05179876|Macitentan|macitentan|mesh-list
2899297|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
2899298|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2899299|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2899300|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899301|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899302|NCT05179876|Urological Agents|urological agents|mesh-ancestor
2899303|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2899304|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2899305|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2899306|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2899311|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
2899312|NCT05167084|Metyrapone|metyrapone|mesh-list
2899313|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2899314|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
2899315|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899316|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899317|NCT05165992|Fentanyl|fentanyl|mesh-list
2899318|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2899319|NCT05165992|Narcotics|narcotics|mesh-ancestor
2899320|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2899321|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899322|NCT05165992|Analgesics|analgesics|mesh-ancestor
2899323|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
2899324|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899325|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2899326|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2899327|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
2899328|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
2899337|NCT05154968|Mannitol|mannitol|mesh-list
2325382|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325383|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
2325384|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
2325385|NCT00387933|Vatalanib|vatalanib|mesh-list
2325386|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325387|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2325388|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325389|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325390|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
2899338|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2899339|NCT05154968|Diuretics|diuretics|mesh-ancestor
2899340|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
2899341|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899348|NCT05147415|Metoprolol|metoprolol|mesh-list
2899349|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2899350|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2899351|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
2899352|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
2899353|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899354|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899355|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2899356|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2899357|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2899358|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
2899359|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899360|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899361|NCT05147376|Curcumin|curcumin|mesh-list
2899362|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2899363|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2899364|NCT05147376|Analgesics|analgesics|mesh-ancestor
2899365|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
2899366|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899367|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899368|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2899369|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2899370|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899371|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899372|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109719|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109720|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
2109721|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109722|NCT02525549|Adapalene|adapalene|mesh-list
2109723|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2109724|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
2109725|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2899391|NCT05128773|Tamoxifen|tamoxifen|mesh-list
2899392|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2899393|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
2899394|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2899395|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899396|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2899397|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899398|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2899399|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2899400|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2899401|NCT05128344|Vigabatrin|vigabatrin|mesh-list
2899402|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
2899403|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899404|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899405|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
2899406|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899407|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899408|NCT05127876|Ephedrine|ephedrine|mesh-list
2899409|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
2899410|NCT05127876|Ondansetron|ondansetron|mesh-list
2899411|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
2899412|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
2899413|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899414|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899415|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2899416|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
2899417|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
2899418|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2899419|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
2899420|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899421|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899422|NCT05127876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2899423|NCT05127876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2899424|NCT05127876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2899425|NCT05127876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2899426|NCT05127876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2325391|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2899427|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2899428|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
2899429|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2899430|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
2899431|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2899432|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2899433|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
2899434|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
2899435|NCT05118256|Pirfenidone|pirfenidone|mesh-list
2899436|NCT05118256|Analgesics|analgesics|mesh-ancestor
2899437|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
2899438|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899439|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899440|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2899441|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2899442|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2899443|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2899444|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899461|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
2899462|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2899463|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
2899464|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2899465|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
2899466|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899467|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899468|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
2899469|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
2899470|NCT05109429|Narcotics|narcotics|mesh-ancestor
2899471|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2899472|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899473|NCT05109429|Analgesics|analgesics|mesh-ancestor
2899474|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
2899475|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899476|NCT05106335|Docetaxel|docetaxel|mesh-list
2899477|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899478|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
2899479|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
2899480|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
2899481|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899486|NCT05096845|Vaccines|vaccines|mesh-list
2899487|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
2899488|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899489|NCT05096832|Vaccines|vaccines|mesh-list
2899490|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
2899491|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899492|NCT05078866|Vaccines|vaccines|mesh-list
2899493|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
2899494|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325392|NCT00388011|Morphine|morphine|mesh-list
2325393|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2325394|NCT00388011|Narcotics|narcotics|mesh-ancestor
2325395|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2325396|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325397|NCT00388011|Analgesics|analgesics|mesh-ancestor
2325398|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
2325399|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325400|NCT00388076|Paclitaxel|paclitaxel|mesh-list
2325401|NCT00388076|Carboplatin|carboplatin|mesh-list
2325402|NCT00388076|Lapatinib|lapatinib|mesh-list
2325403|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2325404|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325405|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
2325406|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
2325407|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
2325408|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325409|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2325410|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325411|NCT00388089|Bortezomib|bortezomib|mesh-list
2325412|NCT00388089|Topotecan|topotecan|mesh-list
2325413|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325414|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2325415|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2325416|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325417|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325418|NCT00388128|Caffeine|caffeine|mesh-list
2325419|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2325420|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325421|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2325422|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325423|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325424|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2899515|NCT05060965|Nicotine|nicotine|mesh-list
2899516|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2325425|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2325426|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
2325427|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2325428|NCT00388167|Caspofungin|caspofungin|mesh-list
2325429|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
2325430|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325431|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325432|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325433|NCT00388193|Rituximab|rituximab|mesh-list
2325434|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2325435|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325436|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
2325437|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325438|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2899517|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
2899518|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899519|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899520|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2899521|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2899522|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
2325439|NCT00388219|Buprenorphine|buprenorphine|mesh-list
2325440|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2325441|NCT00388219|Narcotics|narcotics|mesh-ancestor
2325442|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2325443|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325444|NCT00388219|Analgesics|analgesics|mesh-ancestor
2325445|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
2899523|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899524|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899525|NCT05055128|Lansoprazole|lansoprazole|mesh-list
2899526|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
2899527|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2899528|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2899529|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2899530|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899531|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899537|NCT05043090|Durvalumab|durvalumab|mesh-list
2899538|NCT05043090|Sunitinib|sunitinib|mesh-list
2899539|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2899540|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899541|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2899542|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2899543|NCT05043090|Growth Substances|growth substances|mesh-ancestor
2899544|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899545|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
2899546|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2899547|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899548|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899549|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2899550|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2899551|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
2899552|NCT05042947|Hormones|hormones|mesh-ancestor
2899553|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2899554|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899555|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899556|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899575|NCT05033847|Vaccines|vaccines|mesh-list
2899576|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
2899577|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899599|NCT05019560|Sevoflurane|sevoflurane|mesh-list
2899600|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2899601|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2899602|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
2899603|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
2899604|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2899605|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899606|NCT05014919|Vortioxetine|vortioxetine|mesh-list
2899607|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
2899608|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2899609|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2899610|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2899611|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2899612|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899613|NCT05014919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2899614|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2899615|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2899616|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899617|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899618|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
2899619|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2899620|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2899621|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2899622|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2899623|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
2899624|NCT05014230|Narcotics|narcotics|mesh-ancestor
2899625|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2899626|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899627|NCT05014230|Analgesics|analgesics|mesh-ancestor
2899628|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
2899629|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899633|NCT05009862|Aspirin|aspirin|mesh-list
2899634|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
2899635|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2899636|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2899637|NCT05009862|Analgesics|analgesics|mesh-ancestor
2899638|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
2899639|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899640|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899641|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2899642|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2899643|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2899644|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2899645|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899646|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2899647|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2899648|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899649|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
2899650|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2899651|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
2899652|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2899653|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
2899654|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
2899655|NCT05007782|Pembrolizumab|pembrolizumab|mesh-list
2899656|NCT05007782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2325446|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325447|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2325448|NCT00388258|Alvimopan|alvimopan|mesh-list
2325449|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2325450|NCT00388271|Alfuzosin|alfuzosin|mesh-list
2325451|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2325452|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2325453|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2325454|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
2899657|NCT05007782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325455|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2325456|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325457|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325458|NCT00388271|Urological Agents|urological agents|mesh-ancestor
2325459|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
2325460|NCT00388336|Hematinics|hematinics|mesh-ancestor
2325461|NCT00388388|Losartan|losartan|mesh-list
2325462|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2325463|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2899679|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2899680|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2899681|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2899682|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2899683|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899684|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899685|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
2899686|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2899687|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2899688|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2899689|NCT04990323|Vidarabine|vidarabine|mesh-list
2899690|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
2899691|NCT04990323|Busulfan|busulfan|mesh-list
2899692|NCT04990323|Thiotepa|thiotepa|mesh-list
2899693|NCT04990323|Fludarabine|fludarabine|mesh-list
2899694|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
2325464|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2325465|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2325466|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2325467|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899695|NCT04990323|Clofarabine|clofarabine|mesh-list
2899696|NCT04990323|Tacrolimus|tacrolimus|mesh-list
2899697|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2899698|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
2899699|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899700|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2899701|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2899702|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
2899703|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899704|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899705|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2899706|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2899707|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
2899708|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
2899709|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2899710|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2899711|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899712|NCT04989829|Omeprazole|omeprazole|mesh-list
2899713|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2899714|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2899715|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2899716|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899717|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899718|NCT04972110|Olaparib|olaparib|mesh-list
2899719|NCT04972110|Niraparib|niraparib|mesh-list
2899720|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2325468|NCT00388388|Diuretics|diuretics|mesh-ancestor
2325469|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
2325470|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325471|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2325472|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2325473|NCT00388401|Alvimopan|alvimopan|mesh-list
2325474|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2899721|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899722|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899723|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899724|NCT04953962|Nivolumab|nivolumab|mesh-list
2899725|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899726|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2899727|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2899728|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325475|NCT00388427|Cetuximab|cetuximab|mesh-list
2325476|NCT00388427|Dasatinib|dasatinib|mesh-list
2325477|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2325478|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325479|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2325480|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325481|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325482|NCT00388479|Alvimopan|alvimopan|mesh-list
2325483|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2325484|NCT00388557|Ketoconazole|ketoconazole|mesh-list
2325485|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
2325486|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325487|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2325488|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2325489|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325490|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325491|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2325492|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
2325493|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2325494|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325495|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2325496|NCT00388635|Prednisone|prednisone|mesh-list
2325497|NCT00388635|Melphalan|melphalan|mesh-list
2325498|NCT00388635|Bortezomib|bortezomib|mesh-list
2325499|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2325500|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
2325501|NCT00388635|Hormones|hormones|mesh-ancestor
2899749|NCT04947332|Vaccines|vaccines|mesh-list
2899750|NCT04947332|Immunologic Factors|immunologic factors|mesh-ancestor
2899751|NCT04947332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899752|NCT04945720|Durvalumab|durvalumab|mesh-list
2899753|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2899754|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2899755|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899756|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
2899757|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899758|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2899759|NCT04944290|Brinzolamide|brinzolamide|mesh-list
2899760|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2899761|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2899762|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2899763|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2899764|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
2325502|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2325503|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899765|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899766|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899767|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899768|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2899769|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899770|NCT04939090|Megestrol|megestrol|mesh-list
2899771|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
2899772|NCT04939090|Olanzapine|olanzapine|mesh-list
2899773|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
2899774|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
2899775|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2899776|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899777|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2899778|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2899779|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2899780|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2899781|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2899782|NCT04939090|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2899783|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2899784|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2899785|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899786|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899787|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
2899788|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2899789|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2899790|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2899791|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
2899792|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2899793|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2899794|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2899795|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2899796|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899797|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
2899798|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2899802|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
2899803|NCT04938817|Lenvatinib|lenvatinib|mesh-list
2899804|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2899805|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899806|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2899807|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899808|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325504|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2325505|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325506|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2325507|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
2325508|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325509|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2325510|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2325511|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
2325512|NCT00388661|Melatonin|melatonin|mesh-list
2325513|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
2325514|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325515|NCT00388661|Protective Agents|protective agents|mesh-ancestor
2325516|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325517|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2325518|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
2325519|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2325520|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325521|NCT00388700|Leucovorin|leucovorin|mesh-list
2325522|NCT00388700|Bevacizumab|bevacizumab|mesh-list
2325523|NCT00388700|Fluorouracil|fluorouracil|mesh-list
2325524|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2325525|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325526|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2325527|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2325528|NCT00388700|Growth Substances|growth substances|mesh-ancestor
2325529|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325530|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
2325531|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
2325532|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325533|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2325534|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2325535|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
2325536|NCT00388700|Antidotes|antidotes|mesh-ancestor
2325537|NCT00388700|Protective Agents|protective agents|mesh-ancestor
2325538|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
2325539|NCT00388700|Vitamins|vitamins|mesh-ancestor
2325540|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
2325541|NCT00388739|Prednisolone|prednisolone|mesh-list
2325542|NCT00388739|Budesonide|budesonide|mesh-list
2325543|NCT00388739|Albuterol|albuterol|mesh-list
2325544|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2325545|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
2325546|NCT00388739|Hormones|hormones|mesh-ancestor
2325547|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2325548|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325549|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2325550|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325551|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
2325552|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325553|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2325554|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2325555|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
2325556|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
2899856|NCT04926181|Androgens|androgens|mesh-list
2899857|NCT04926181|Hormones|hormones|mesh-ancestor
2899858|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2899859|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899860|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2325557|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2899861|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2899862|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2899863|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899864|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899865|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
2899866|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2899867|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2899868|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2325558|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2325559|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2325560|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2325561|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
2325562|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2325563|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325564|NCT00388778|Doxycycline|doxycycline|mesh-list
2325565|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2325566|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325567|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
2325568|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2325569|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2325570|NCT00388856|Ascorbic Acid|ascorbic acid|mesh-list
2325571|NCT00388856|Vitamins|vitamins|mesh-ancestor
2899869|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
2899870|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2899871|NCT04924101|Cisplatin|cisplatin|mesh-list
2325572|NCT00388856|Micronutrients|micronutrients|mesh-ancestor
2325573|NCT00388856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325574|NCT00388856|Antioxidants|antioxidants|mesh-ancestor
2899872|NCT04924101|Carboplatin|carboplatin|mesh-list
2899873|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
2899874|NCT04924101|Etoposide|etoposide|mesh-list
2899875|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
2899876|NCT04924101|Lenvatinib|lenvatinib|mesh-list
2899877|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899878|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2899879|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2899880|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2899881|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2899882|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899883|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899884|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2899905|NCT04902703|Molgramostim|molgramostim|mesh-list
2325575|NCT00388856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325576|NCT00388856|Protective Agents|protective agents|mesh-ancestor
2325577|NCT00388882|Bromides|bromides|mesh-list
2325578|NCT00388882|Albuterol|albuterol|mesh-list
2325579|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
2325580|NCT00388882|Ipratropium|ipratropium|mesh-list
2899906|NCT04902703|Sargramostim|sargramostim|mesh-list
2899907|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
2899908|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899909|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325581|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2325582|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
2325583|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325584|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325585|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2325586|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
2325587|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
2325588|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2325589|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
2325590|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2325591|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325592|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
2325593|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
2325594|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2325595|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2325596|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2325597|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2325598|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
2325599|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
2325600|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325601|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2325602|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325603|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325604|NCT00388921|Vitamin A|vitamin a|mesh-list
2325605|NCT00388921|Vitamins|vitamins|mesh-ancestor
2325606|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
2325607|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325608|NCT00388960|Etoposide|etoposide|mesh-list
2325609|NCT00388960|Amrubicin|amrubicin|mesh-list
2325610|NCT00388960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325611|NCT00388960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2325612|NCT00388960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2325613|NCT00388960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2325614|NCT00388960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325615|NCT00388960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325616|NCT00388986|Glyburide|glyburide|mesh-list
2325617|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2325618|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325619|NCT00388999|Lectins|lectins|mesh-list
2325620|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
2325621|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
2325622|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325623|NCT00388999|Coagulants|coagulants|mesh-ancestor
2325624|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2325625|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2325626|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2325627|NCT00389025|Analgesics|analgesics|mesh-ancestor
2325628|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
2325629|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325630|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325631|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2325632|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2325633|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2325634|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2325635|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2325636|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
2899934|NCT04894435|Vaccines|vaccines|mesh-list
2899935|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
2899936|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325637|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
2325638|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899961|NCT04872790|Prednisone|prednisone|mesh-list
2899962|NCT04872790|Cortisone|cortisone|mesh-list
2899963|NCT04872790|Rituximab|rituximab|mesh-list
2899964|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2899965|NCT04872790|Methotrexate|methotrexate|mesh-list
2899966|NCT04872790|Dasatinib|dasatinib|mesh-list
2899967|NCT04872790|Venetoclax|venetoclax|mesh-list
2899968|NCT04872790|Antibodies|antibodies|mesh-list
2899969|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
2899970|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2899971|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
2899972|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2899973|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2899974|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2899975|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2899976|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
2899977|NCT04872790|Hormones|hormones|mesh-ancestor
2899978|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2899979|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2899980|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2899981|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
2899982|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2899983|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2899984|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
2899985|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899986|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
2899987|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2899988|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2899989|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2899990|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2899991|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2899992|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
2899993|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
2899994|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2899995|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
2899996|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2899997|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325639|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325640|NCT00389038|Amitriptyline|amitriptyline|mesh-list
2325641|NCT00389038|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2325642|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2325643|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
2325644|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2325645|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2325646|NCT00389038|Analgesics|analgesics|mesh-ancestor
2325647|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
2325648|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325649|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325650|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2325651|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2325652|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2900008|NCT04865497|Vaccines|vaccines|mesh-list
2900009|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
2900010|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900011|NCT04865042|Gabapentin|gabapentin|mesh-list
2900012|NCT04865042|Analgesics|analgesics|mesh-ancestor
2900013|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
2900014|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900015|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900016|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
2900017|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2325653|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325654|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
2325655|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2325656|NCT00389038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2900018|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2900019|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2900020|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2900021|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2900022|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2900023|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2900024|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900025|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
2900026|NCT04833855|Omalizumab|omalizumab|mesh-list
2900027|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2900028|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2900029|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2900030|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
2900031|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
2900032|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900033|NCT04823247|Interleukin-23|interleukin-23|mesh-list
2900034|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2900035|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2900036|NCT04823247|Growth Substances|growth substances|mesh-ancestor
2900037|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900038|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
2900039|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325657|NCT00389038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2325658|NCT00389038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2325659|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2325660|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2325661|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
2325662|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325663|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325664|NCT00389090|Temozolomide|temozolomide|mesh-list
2325665|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2325666|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2325667|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
2325668|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325669|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325670|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325671|NCT00389129|Aspirin|aspirin|mesh-list
2325672|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2325673|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2900040|NCT04817787|Metformin|metformin|mesh-list
2900041|NCT04817787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2900042|NCT04817787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900043|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
2900044|NCT04816162|Ketamine|ketamine|mesh-list
2900045|NCT04816162|Propofol|propofol|mesh-list
2900046|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2900047|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2900048|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900049|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2900050|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
2900051|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
2900052|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2900053|NCT04816162|Analgesics|analgesics|mesh-ancestor
2900054|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
2900055|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900056|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2900057|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2900058|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2900059|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
2900060|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2900061|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900062|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2900063|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2900064|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2900065|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
2900066|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2900067|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2900068|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
2900069|NCT04803201|Prednisone|prednisone|mesh-list
2900070|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
2900071|NCT04803201|Doxorubicin|doxorubicin|mesh-list
2900072|NCT04803201|Etoposide|etoposide|mesh-list
2900073|NCT04803201|Vincristine|vincristine|mesh-list
2900074|NCT04803201|Azacitidine|azacitidine|mesh-list
2900075|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2900076|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
2900077|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900078|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2900079|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2900080|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
2900081|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900082|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900083|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2900084|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2325674|NCT00389129|Analgesics|analgesics|mesh-ancestor
2325675|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
2325676|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325677|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325678|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2325679|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2325680|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2900085|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2900086|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2900087|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900088|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2900089|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
2900090|NCT04803201|Hormones|hormones|mesh-ancestor
2900091|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2900092|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2900093|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2900094|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
2900095|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
2325681|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2325682|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325683|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2325684|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2325685|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325686|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
2325687|NCT00389155|Gemcitabine|gemcitabine|mesh-list
2325688|NCT00389155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2325689|NCT00389155|Antimetabolites|antimetabolites|mesh-ancestor
2325690|NCT00389155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325691|NCT00389155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325692|NCT00389155|Antiviral Agents|antiviral agents|mesh-ancestor
2900096|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
2900097|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2900098|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
2900099|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
2900100|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2900101|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325693|NCT00389155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325694|NCT00389155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325695|NCT00389155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2325696|NCT00389155|Immunologic Factors|immunologic factors|mesh-ancestor
2325697|NCT00389155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325698|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
2325699|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2325700|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
2900102|NCT04790370|Heparin|heparin|mesh-list
2900103|NCT04790370|Calcium heparin|calcium heparin|mesh-list
2900104|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
2325701|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325702|NCT00389233|Protective Agents|protective agents|mesh-ancestor
2325703|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325704|NCT00389233|Vitamins|vitamins|mesh-ancestor
2325705|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
2325706|NCT00389233|Laxatives|laxatives|mesh-ancestor
2325707|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2325708|NCT00389272|Acetaminophen|acetaminophen|mesh-list
2325709|NCT00389272|Ibuprofen|ibuprofen|mesh-list
2325710|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2325711|NCT00389272|Analgesics|analgesics|mesh-ancestor
2325712|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
2325713|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325714|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325715|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
2325716|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2325717|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2325718|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2325719|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2325720|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325721|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325722|NCT00389285|Sorafenib|sorafenib|mesh-list
2325723|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325724|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2325725|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325726|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325727|NCT00389311|Nonoxynol|nonoxynol|mesh-list
2325728|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2325729|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2325730|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325731|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2325732|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
2325733|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2325734|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2325735|NCT00389376|Silymarin|silymarin|mesh-list
2325736|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
2325737|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325738|NCT00389376|Protective Agents|protective agents|mesh-ancestor
2325739|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325740|NCT00389402|Ritonavir|ritonavir|mesh-list
2325741|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2325742|NCT00389402|Saquinavir|saquinavir|mesh-list
2325743|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2325744|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2325745|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
2325746|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325747|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325748|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2325749|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2325750|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
2325751|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325752|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2325753|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2325754|NCT00389415|Vildagliptin|vildagliptin|mesh-list
2900105|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2900106|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2900107|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900108|NCT04787965|Opicapone|opicapone|mesh-list
2900109|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2900110|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900111|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900112|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2900113|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2900114|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2900115|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
2325755|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2325756|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325757|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2325758|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
2325759|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325760|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325761|NCT00389428|Cytarabine|cytarabine|mesh-list
2325762|NCT00389428|Daunorubicin|daunorubicin|mesh-list
2325763|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2325764|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
2325765|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325766|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325767|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
2900116|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2900117|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2900118|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2900119|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900120|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900121|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2900122|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2900123|NCT04770272|Paclitaxel|paclitaxel|mesh-list
2325768|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325769|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2325770|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
2325771|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325772|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2325773|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2325774|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2325775|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325776|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
2325777|NCT00389506|Fludarabine|fludarabine|mesh-list
2325778|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
2325779|NCT00389506|Immunotoxins|immunotoxins|mesh-list
2325780|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2325781|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
2325782|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325783|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2325784|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2325785|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
2325786|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900124|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
2900125|NCT04770272|Carboplatin|carboplatin|mesh-list
2900126|NCT04770272|Atezolizumab|atezolizumab|mesh-list
2900127|NCT04770272|Epirubicin|epirubicin|mesh-list
2900128|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2900129|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2900130|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900131|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
2900132|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
2900133|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
2900134|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900135|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2900136|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
2900137|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900138|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2900139|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2900140|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
2900141|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2900142|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2900143|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2900144|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2900145|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900146|NCT04748172|Antibodies|antibodies|mesh-list
2900147|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
2900148|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900149|NCT04739358|Tepotinib|tepotinib|mesh-list
2900150|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325787|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325788|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2325789|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2325790|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
2325791|NCT00389558|Amikacin|amikacin|mesh-list
2325792|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2325793|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325794|NCT00389584|Irinotecan|irinotecan|mesh-list
2325795|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2325796|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2325797|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325798|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325799|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325800|NCT00389636|Becaplermin|becaplermin|mesh-list
2900161|NCT04725188|Docetaxel|docetaxel|mesh-list
2900162|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
2900163|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900164|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
2900165|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
2900166|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
2900167|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900168|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2900169|NCT04716946|Durvalumab|durvalumab|mesh-list
2900170|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2325801|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
2325802|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2325803|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2900171|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900172|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
2900173|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900174|NCT04713358|Nalmefene|nalmefene|mesh-list
2900175|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2900176|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900177|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
2900178|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900179|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2325804|NCT00389636|Growth Substances|growth substances|mesh-ancestor
2325805|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325806|NCT00389675|Guanfacine|guanfacine|mesh-list
2325807|NCT00389675|Darusentan|darusentan|mesh-list
2325808|NCT00389675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2325809|NCT00389675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2325810|NCT00389675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2325811|NCT00389675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2325812|NCT00389675|Adrenergic Agents|adrenergic agents|mesh-ancestor
2325813|NCT00389675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2325814|NCT00389675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325815|NCT00389675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325816|NCT00389675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2325817|NCT00389688|Pemetrexed|pemetrexed|mesh-list
2325818|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900180|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2900181|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900182|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
2325819|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325820|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325821|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2325822|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2325823|NCT00389701|Dexamethasone|dexamethasone|mesh-list
2325824|NCT00389701|Bortezomib|bortezomib|mesh-list
2325825|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2325826|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
2325827|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
2900183|NCT04704219|Lenvatinib|lenvatinib|mesh-list
2900184|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2900185|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900186|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2900187|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900188|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900189|NCT04704154|Nivolumab|nivolumab|mesh-list
2900190|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2900191|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900192|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2900193|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325828|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325829|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325830|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2325831|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
2325832|NCT00389701|Hormones|hormones|mesh-ancestor
2900208|NCT04696952|Zopiclone|zopiclone|mesh-list
2900209|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2900210|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2900211|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325833|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2325834|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2325835|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325836|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2325837|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325838|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2325839|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
2325840|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2325841|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2325842|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2325843|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2325844|NCT00389766|Topotecan|topotecan|mesh-list
2325845|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2325846|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2325847|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2900212|NCT04695977|Nivolumab|nivolumab|mesh-list
2900213|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2900214|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900215|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2900216|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900217|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
2900218|NCT04676802|Narcotics|narcotics|mesh-ancestor
2900219|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2325848|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325849|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325850|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325851|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2325852|NCT00389779|Guanfacine|guanfacine|mesh-list
2325853|NCT00389779|Darusentan|darusentan|mesh-list
2325854|NCT00389779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2325855|NCT00389779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2325856|NCT00389779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2325857|NCT00389779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2325858|NCT00389779|Adrenergic Agents|adrenergic agents|mesh-ancestor
2325859|NCT00389779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2325860|NCT00389779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325861|NCT00389779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325862|NCT00389779|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2325863|NCT00389870|Cyclosporine|cyclosporine|mesh-list
2325864|NCT00389870|Irinotecan|irinotecan|mesh-list
2325865|NCT00389870|Panitumumab|panitumumab|mesh-list
2325866|NCT00389870|Cyclosporins|cyclosporins|mesh-list
2325867|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2325868|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2325869|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325870|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325871|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325872|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2325873|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
2325874|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900220|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900221|NCT04676802|Analgesics|analgesics|mesh-ancestor
2900222|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
2900223|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900229|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
2900230|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2900231|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2900232|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2900233|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900234|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2900235|NCT04668950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2900236|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2900237|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2900238|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900239|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2900240|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
2900241|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2900242|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
2900243|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2900244|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2900245|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900246|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2900266|NCT04641871|Irinotecan|irinotecan|mesh-list
2900267|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2900268|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2900269|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900270|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900271|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325875|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
2325876|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325877|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
2325878|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2325879|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2325880|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2325881|NCT00389883|Anesthetics|anesthetics|mesh-list
2325882|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2325883|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325884|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
2325885|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2325886|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2325887|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
2325888|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2325889|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325890|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325891|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
2325892|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
2325893|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325894|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
2900284|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
2900285|NCT04637594|Nivolumab|nivolumab|mesh-list
2900286|NCT04637594|Durvalumab|durvalumab|mesh-list
2900287|NCT04637594|Avelumab|avelumab|mesh-list
2900288|NCT04637594|Atezolizumab|atezolizumab|mesh-list
2900289|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2900290|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900291|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2900292|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325895|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2325896|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
2325897|NCT00389909|Doxapram|doxapram|mesh-list
2325898|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2325899|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325900|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
2325901|NCT00389922|Vinorelbine|vinorelbine|mesh-list
2325902|NCT00389922|Lapatinib|lapatinib|mesh-list
2325903|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2325904|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325905|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
2325906|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
2325907|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
2325908|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325909|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2325910|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325911|NCT00389935|Thalidomide|thalidomide|mesh-list
2325912|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2325913|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
2325914|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325915|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
2325916|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2325917|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325918|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2325919|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2325920|NCT00389935|Growth Substances|growth substances|mesh-ancestor
2325921|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
2325922|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325923|NCT00389987|Tazobactam|tazobactam|mesh-list
2325924|NCT00389987|Piperacillin|piperacillin|mesh-list
2325925|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325926|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2325927|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2325928|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2325929|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325930|NCT00390000|Pemetrexed|pemetrexed|mesh-list
2325931|NCT00390000|Vatalanib|vatalanib|mesh-list
2325932|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325933|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325934|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325935|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2325936|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2325937|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2325938|NCT00390026|Bevacizumab|bevacizumab|mesh-list
2325939|NCT00390026|Verteporfin|verteporfin|mesh-list
2325940|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2900305|NCT04631471|Ibudilast|ibudilast|mesh-list
2900306|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2900307|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
2900308|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900309|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900310|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2900311|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
2900312|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2900313|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900314|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900315|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2900316|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
2900317|NCT04624243|Risperidone|risperidone|mesh-list
2900318|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2900319|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
2900320|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2900321|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900322|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900323|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2900324|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2900325|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2900326|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2900327|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2900328|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
2900340|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2900341|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2900342|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
2900343|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2900344|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2900345|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
2325941|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325942|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2325943|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2325944|NCT00390026|Growth Substances|growth substances|mesh-ancestor
2325945|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325946|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
2325947|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2325948|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
2325949|NCT00390039|Morphine|morphine|mesh-list
2325950|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2325951|NCT00390039|Narcotics|narcotics|mesh-ancestor
2325952|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2325953|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325954|NCT00390039|Analgesics|analgesics|mesh-ancestor
2325955|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
2325956|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2325957|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
2325958|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2325959|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
2325960|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900346|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
2900347|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900348|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2900349|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900350|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900351|NCT04600336|Oxybutynin|oxybutynin|mesh-list
2900352|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
2900353|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
2900354|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900355|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900356|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2325961|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325962|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2900357|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2325963|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
2325964|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2325965|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
2325966|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325967|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2325968|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2325969|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
2325970|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
2325971|NCT00390065|Protective Agents|protective agents|mesh-ancestor
2325972|NCT00390091|Abetimus|abetimus|mesh-list
2325973|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2900358|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
2900359|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2900360|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900361|NCT04600336|Urological Agents|urological agents|mesh-ancestor
2900362|NCT04592913|Durvalumab|durvalumab|mesh-list
2900363|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2900364|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900365|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2900366|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900377|NCT04582266|Remdesivir|remdesivir|mesh-list
2900378|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
2900379|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900380|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
2900381|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2900393|NCT04563520|Coagulants|coagulants|mesh-list
2900394|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
2900395|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
2900396|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2900397|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2900398|NCT04558502|Amoxicillin|amoxicillin|mesh-list
2900399|NCT04558502|Clarithromycin|clarithromycin|mesh-list
2900400|NCT04558502|Minocycline|minocycline|mesh-list
2900401|NCT04558502|Esomeprazole|esomeprazole|mesh-list
2900402|NCT04558502|Bismuth|bismuth|mesh-list
2900403|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2900404|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2900405|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2900406|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2900407|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2900408|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900409|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900410|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2900411|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2900412|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2900413|NCT04558502|Antacids|antacids|mesh-ancestor
2900414|NCT04550455|Cladribine|cladribine|mesh-list
2900415|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900416|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2900417|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
2900418|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900419|NCT04544267|Vaccines|vaccines|mesh-list
2900420|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
2900421|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900422|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
2325974|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
2325975|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325976|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2900423|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2900424|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
2900425|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900426|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2900427|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900428|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
2900429|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2900430|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
2900431|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2900432|NCT04535882|Protective Agents|protective agents|mesh-ancestor
2325977|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
2325978|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325979|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
2325980|NCT00390156|Bevacizumab|bevacizumab|mesh-list
2900443|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2900444|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
2900445|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900446|NCT04505735|Corticosterone|corticosterone|mesh-list
2900447|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2900448|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
2900449|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900450|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2900451|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900452|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900453|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
2900454|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2900455|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900456|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2900457|NCT04489888|Paclitaxel|paclitaxel|mesh-list
2900458|NCT04489888|Carboplatin|carboplatin|mesh-list
2900459|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
2900460|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2325981|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
2325982|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2325983|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
2325984|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2325985|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2325986|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2325987|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
2325988|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2325989|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2325990|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2325991|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2325992|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2325993|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2325994|NCT00390156|Growth Substances|growth substances|mesh-ancestor
2325995|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
2325996|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2325997|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2325998|NCT00390195|Everolimus|everolimus|mesh-list
2325999|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326000|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2326001|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
2326002|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326003|NCT00390208|Dexamethasone|dexamethasone|mesh-list
2326004|NCT00390208|Ranibizumab|ranibizumab|mesh-list
2326005|NCT00390208|Verteporfin|verteporfin|mesh-list
2326006|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326007|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
2326008|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
2326009|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900461|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900462|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
2900463|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
2900464|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
2900465|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900466|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2900467|NCT04485104|Cannabidiol|cannabidiol|mesh-list
2900468|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
2900469|NCT04479267|Prednisone|prednisone|mesh-list
2900470|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
2900471|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2900472|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2900473|NCT04479267|Prednisolone|prednisolone|mesh-list
2900474|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
2900475|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
2900476|NCT04479267|Cortisone|cortisone|mesh-list
2900477|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
2900478|NCT04479267|Rituximab|rituximab|mesh-list
2900479|NCT04479267|Doxorubicin|doxorubicin|mesh-list
2900480|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2900481|NCT04479267|Antibodies|antibodies|mesh-list
2900482|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
2900483|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2900484|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
2900485|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2900486|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
2900487|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2900488|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
2900489|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900490|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2900491|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2900492|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
2900493|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900494|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900495|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2900496|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2900497|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2900498|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2900499|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2900500|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900501|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2900502|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
2900503|NCT04479267|Hormones|hormones|mesh-ancestor
2900504|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2900505|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2900506|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
2900507|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
2900508|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900509|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2900510|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2326010|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326011|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2326012|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
2326013|NCT00390208|Hormones|hormones|mesh-ancestor
2326014|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326015|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2326016|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326017|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2326018|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2326019|NCT00390208|Growth Substances|growth substances|mesh-ancestor
2326020|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
2326021|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2326022|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
2326023|NCT00390247|Thalidomide|thalidomide|mesh-list
2326024|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2326025|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
2900511|NCT04479267|Protective Agents|protective agents|mesh-ancestor
2900512|NCT04471597|Bupivacaine|bupivacaine|mesh-list
2900513|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
2900514|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
2900515|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2900516|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900517|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
2900518|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900519|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
2900520|NCT04459416|Narcotics|narcotics|mesh-ancestor
2900521|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2900522|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900523|NCT04459416|Analgesics|analgesics|mesh-ancestor
2326026|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326027|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
2326028|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2900524|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
2900525|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900526|NCT04457596|Trastuzumab|trastuzumab|mesh-list
2900527|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2900528|NCT04457596|Maytansine|maytansine|mesh-list
2900529|NCT04457596|Tucatinib|tucatinib|mesh-list
2900530|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2900531|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900532|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2900533|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
2900534|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
2900535|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
2900536|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900537|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2900538|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326029|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326030|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2326031|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2326032|NCT00390247|Growth Substances|growth substances|mesh-ancestor
2326033|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
2326034|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326035|NCT00390260|Acetaminophen|acetaminophen|mesh-list
2326036|NCT00390260|Rofecoxib|rofecoxib|mesh-list
2326037|NCT00390260|Hydrocodone|hydrocodone|mesh-list
2326038|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2326039|NCT00390260|Analgesics|analgesics|mesh-ancestor
2326040|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
2326041|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900564|NCT04449549|Paclitaxel|paclitaxel|mesh-list
2900565|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2900566|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900567|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
2900568|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
2900569|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
2900570|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900571|NCT04431778|Ethosuximide|ethosuximide|mesh-list
2900572|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
2900573|NCT04420455|Enoximone|enoximone|mesh-list
2900574|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2900575|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
2900576|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2900577|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2900578|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900579|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900580|NCT04420455|Protective Agents|protective agents|mesh-ancestor
2900581|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900582|NCT04419337|Metformin|metformin|mesh-list
2900583|NCT04419337|Pioglitazone|pioglitazone|mesh-list
2900584|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2900585|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2900586|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900587|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900588|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
2900589|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2900590|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900591|NCT04412707|Dexamethasone|dexamethasone|mesh-list
2900592|NCT04412707|Melphalan|melphalan|mesh-list
2900593|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2900594|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
2900595|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
2900596|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900597|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900598|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2900599|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
2900600|NCT04412707|Hormones|hormones|mesh-ancestor
2900601|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2900602|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2900603|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900604|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2900605|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
2900606|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900607|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2900608|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2900609|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
2900610|NCT04410991|Teriflunomide|teriflunomide|mesh-list
2900611|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2900612|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2900613|NCT04410991|Analgesics|analgesics|mesh-ancestor
2900614|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
2900615|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900616|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900617|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2900618|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2326042|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326043|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
2326044|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326045|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
2326046|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2326047|NCT00390260|Narcotics|narcotics|mesh-ancestor
2326048|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2326049|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
2326050|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2326051|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2326052|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326053|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2326054|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326055|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2326056|NCT00390273|Metformin|metformin|mesh-list
2326057|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2900619|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2900620|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
2900621|NCT04410978|Teriflunomide|teriflunomide|mesh-list
2900622|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2900623|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2900624|NCT04410978|Analgesics|analgesics|mesh-ancestor
2900625|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
2900626|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900627|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900628|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2900629|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2900630|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2900631|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
2900632|NCT04410796|Carboplatin|carboplatin|mesh-list
2900633|NCT04410796|Pemetrexed|pemetrexed|mesh-list
2900634|NCT04410796|Osimertinib|osimertinib|mesh-list
2900635|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326058|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326059|NCT00390312|Morphine|morphine|mesh-list
2326060|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2326061|NCT00390312|Narcotics|narcotics|mesh-ancestor
2326062|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2326063|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326064|NCT00390312|Analgesics|analgesics|mesh-ancestor
2326065|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
2900636|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900637|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900638|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2900639|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2900640|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2900641|NCT04394546|Anticoagulants|anticoagulants|mesh-list
2900642|NCT04390399|Leucovorin|leucovorin|mesh-list
2900643|NCT04390399|Gemcitabine|gemcitabine|mesh-list
2900644|NCT04390399|Paclitaxel|paclitaxel|mesh-list
2900645|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
2900646|NCT04390399|Fluorouracil|fluorouracil|mesh-list
2900647|NCT04390399|Irinotecan|irinotecan|mesh-list
2900648|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2900649|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326066|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326067|NCT00390390|Lansoprazole|lansoprazole|mesh-list
2326068|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
2326069|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2326070|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2326071|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2326072|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900650|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
2900651|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
2900652|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
2900653|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900654|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2900655|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
2900656|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900657|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2900658|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2900659|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
2900660|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2900661|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2900662|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
2900663|NCT04390399|Antiviral Agents|antiviral agents|mesh-ancestor
2900664|NCT04390399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2900665|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900666|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2900667|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2900668|NCT04390399|Antidotes|antidotes|mesh-ancestor
2900669|NCT04390399|Protective Agents|protective agents|mesh-ancestor
2900670|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
2900671|NCT04390399|Vitamins|vitamins|mesh-ancestor
2900672|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
2326073|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326074|NCT00390403|Acetic Acid|acetic acid|mesh-list
2326075|NCT00390403|Temozolomide|temozolomide|mesh-list
2326076|NCT00390403|Retinol acetate|retinol acetate|mesh-list
2326077|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
2326078|NCT00390403|Gossypol|gossypol|mesh-list
2326079|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2326080|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
2326081|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326082|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326083|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2326084|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326085|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2326086|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
2326087|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326088|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2326089|NCT00390403|Protective Agents|protective agents|mesh-ancestor
2326090|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2326091|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
2326092|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2326093|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2326094|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2326095|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2326096|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2326097|NCT00390520|Vildagliptin|vildagliptin|mesh-list
2326098|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2326099|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326100|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2326101|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
2326102|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326103|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326104|NCT00390598|Sennosides|sennosides|mesh-list
2326105|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2326106|NCT00390598|Laxatives|laxatives|mesh-ancestor
2326107|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2326108|NCT00390624|Mannitol|mannitol|mesh-list
2326109|NCT00390624|Ularitide|ularitide|mesh-list
2326110|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2326111|NCT00390624|Diuretics|diuretics|mesh-ancestor
2326112|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
2326113|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326114|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2326115|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
2326116|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326117|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2326118|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
2326119|NCT00390676|Carboplatin|carboplatin|mesh-list
2326120|NCT00390676|Docetaxel|docetaxel|mesh-list
2326121|NCT00390676|Capecitabine|capecitabine|mesh-list
2326122|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326123|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
2326124|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
2326125|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
2326126|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326127|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2326128|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
2326129|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
2326130|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2326131|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326132|NCT00390793|Cytarabine|cytarabine|mesh-list
2326133|NCT00390793|Dexamethasone|dexamethasone|mesh-list
2326134|NCT00390793|Prednisone|prednisone|mesh-list
2326135|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
2326136|NCT00390793|Cortisone|cortisone|mesh-list
2326137|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
2326138|NCT00390793|Doxorubicin|doxorubicin|mesh-list
2326139|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2326140|NCT00390793|Methotrexate|methotrexate|mesh-list
2900717|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
2900718|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2900719|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900720|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2900721|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
2326141|NCT00390793|Vincristine|vincristine|mesh-list
2326142|NCT00390793|Daunorubicin|daunorubicin|mesh-list
2326143|NCT00390793|Dasatinib|dasatinib|mesh-list
2326144|NCT00390793|BB 1101|bb 1101|mesh-list
2326145|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2326146|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
2326147|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326148|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2326149|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2326150|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
2326151|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326152|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326153|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2326154|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326155|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
2326156|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
2326157|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326158|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2326159|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
2326160|NCT00390793|Hormones|hormones|mesh-ancestor
2326161|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2900747|NCT04308785|Atezolizumab|atezolizumab|mesh-list
2900748|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900749|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
2900750|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2900751|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900760|NCT04297592|Doxycycline|doxycycline|mesh-list
2900761|NCT04297592|Cephalexin|cephalexin|mesh-list
2900762|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2900763|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2900764|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
2900765|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2900766|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2900767|NCT04294160|Trametinib|trametinib|mesh-list
2900768|NCT04294160|Dabrafenib|dabrafenib|mesh-list
2900769|NCT04294160|Spartalizumab|spartalizumab|mesh-list
2900770|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900771|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2900772|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900773|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326162|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2326163|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2326164|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2326165|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2900774|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2900775|NCT04270409|Dexamethasone|dexamethasone|mesh-list
2900776|NCT04270409|Lenalidomide|lenalidomide|mesh-list
2900777|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2900778|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
2900779|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
2900780|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900781|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326166|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326167|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2326168|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
2326169|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2326170|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2326171|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
2326172|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
2326173|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2326174|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2326175|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
2900782|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2900783|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
2900784|NCT04270409|Hormones|hormones|mesh-ancestor
2900785|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2900786|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2900787|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900788|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
2900789|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2900790|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2900791|NCT04270409|Growth Substances|growth substances|mesh-ancestor
2900792|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
2900793|NCT04251715|Leucovorin|leucovorin|mesh-list
2900794|NCT04251715|Dexamethasone|dexamethasone|mesh-list
2900795|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
2900796|NCT04251715|Fluorouracil|fluorouracil|mesh-list
2900797|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
2900798|NCT04251715|Irinotecan|irinotecan|mesh-list
2900799|NCT04251715|Floxuridine|floxuridine|mesh-list
2900800|NCT04251715|BB 1101|bb 1101|mesh-list
2900801|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
2900802|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2900803|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
2900804|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
2900805|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900806|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900807|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2900808|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
2900809|NCT04251715|Hormones|hormones|mesh-ancestor
2900810|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2900811|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2900812|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900813|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
2900814|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900815|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900816|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
2900817|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2900818|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2900819|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
2900820|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2900821|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2900822|NCT04251715|Antidotes|antidotes|mesh-ancestor
2900823|NCT04251715|Protective Agents|protective agents|mesh-ancestor
2900824|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
2900825|NCT04251715|Vitamins|vitamins|mesh-ancestor
2900826|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
2900827|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
2326176|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326177|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2326178|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
2326179|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
2326180|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
2900828|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2900829|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900846|NCT04234464|Budesonide|budesonide|mesh-list
2900847|NCT04234464|Albuterol|albuterol|mesh-list
2326181|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2326182|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
2326183|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
2326184|NCT00390832|Hematinics|hematinics|mesh-ancestor
2326185|NCT00390871|Fentanyl|fentanyl|mesh-list
2326186|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
2326187|NCT00390871|Propofol|propofol|mesh-list
2109726|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2109727|NCT02525549|Analgesics|analgesics|mesh-ancestor
2109728|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
2109729|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109730|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109731|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109732|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2109733|NCT02525653|Gemcitabine|gemcitabine|mesh-list
2109734|NCT02525653|Paclitaxel|paclitaxel|mesh-list
2109735|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2109736|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2109737|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900848|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2900849|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2900850|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
2900851|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900852|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900853|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2900854|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
2900855|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
2900856|NCT04234464|Hormones|hormones|mesh-ancestor
2900857|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2900858|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
2900859|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2900860|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2900861|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2900862|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2900863|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
2326188|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2326189|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2326190|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326191|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2326192|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
2326193|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
2326194|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2326195|NCT00390871|Analgesics|analgesics|mesh-ancestor
2326196|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
2326197|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326198|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2326199|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2326200|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2326201|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
2326202|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326203|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900864|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2900865|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326204|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2326205|NCT00390871|Narcotics|narcotics|mesh-ancestor
2326206|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2900877|NCT04228965|Varenicline|varenicline|mesh-list
2900878|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2900879|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2900880|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
2900881|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2900882|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900883|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900912|NCT04221945|Cisplatin|cisplatin|mesh-list
2900913|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
2900914|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900915|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2326207|NCT00390897|Interferons|interferons|mesh-list
2326208|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326209|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
2326210|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326211|NCT00390923|Selegiline|selegiline|mesh-list
2326212|NCT00390923|Nicotine|nicotine|mesh-list
2900919|NCT04211675|Irinotecan|irinotecan|mesh-list
2900920|NCT04211675|Temozolomide|temozolomide|mesh-list
2900921|NCT04211675|Dinutuximab|dinutuximab|mesh-list
2900922|NCT04211675|Sargramostim|sargramostim|mesh-list
2900923|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2900924|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2900925|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900926|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900927|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900928|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2900929|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
2900930|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
2900931|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900932|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
2900933|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2900934|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2900935|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2900936|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2900937|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900938|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900939|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326213|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2900947|NCT04198805|Vitamins|vitamins|mesh-list
2900948|NCT04198805|Vitamin E|vitamin e|mesh-list
2900949|NCT04198805|Tocopherols|tocopherols|mesh-list
2900950|NCT04198805|Tocotrienols|tocotrienols|mesh-list
2900951|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
2900952|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
2900953|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900954|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
2900955|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900956|NCT04198805|Protective Agents|protective agents|mesh-ancestor
2900957|NCT04183868|Empagliflozin|empagliflozin|mesh-list
2900958|NCT04183868|Glimepiride|glimepiride|mesh-list
2900959|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2900960|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900961|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2900962|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900963|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2900964|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2900965|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
2900970|NCT04161755|Atezolizumab|atezolizumab|mesh-list
2900971|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900972|NCT04154189|Etoposide|etoposide|mesh-list
2900973|NCT04154189|Ifosfamide|ifosfamide|mesh-list
2900974|NCT04154189|Lenvatinib|lenvatinib|mesh-list
2900975|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2900976|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900977|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2900978|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2900979|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2900980|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900981|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2900982|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
2900983|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2326214|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
2326215|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326216|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326217|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2326218|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2326219|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
2326220|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326221|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326222|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
2326223|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2326224|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2326225|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2326226|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2326227|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326228|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2326229|NCT00390923|Protective Agents|protective agents|mesh-ancestor
2326230|NCT00390975|Tegaserod|tegaserod|mesh-list
2326231|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2326232|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
2326233|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326234|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326235|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326236|NCT00391014|Amphotericin B|amphotericin b|mesh-list
2326237|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2326238|NCT00391014|Amebicides|amebicides|mesh-ancestor
2900984|NCT04143061|Vaccines|vaccines|mesh-list
2900985|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
2900986|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900987|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
2900988|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2326239|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2900989|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2900990|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2900991|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2900992|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2900993|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2900994|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2900995|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2900996|NCT04137107|Analgesics|analgesics|mesh-ancestor
2900997|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
2900998|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2900999|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
2326240|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2326241|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326242|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2326243|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
2326244|NCT00391105|Remifentanil|remifentanil|mesh-list
2326245|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2326246|NCT00391105|Narcotics|narcotics|mesh-ancestor
2326247|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2326248|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326249|NCT00391105|Analgesics|analgesics|mesh-ancestor
2326250|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
2326251|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326252|NCT00391144|Triamcinolone|triamcinolone|mesh-list
2326253|NCT00391144|Bevacizumab|bevacizumab|mesh-list
2326254|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2326255|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326256|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2326257|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2901000|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2901001|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
2901002|NCT04126733|Nivolumab|nivolumab|mesh-list
2901003|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901004|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901005|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2901006|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901007|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
2901008|NCT04123366|Olaparib|olaparib|mesh-list
2901009|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901010|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901011|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2901012|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901013|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901014|NCT04118387|Acetazolamide|acetazolamide|mesh-list
2901015|NCT04118387|Zolpidem|zolpidem|mesh-list
2901016|NCT04118387|Buspirone|buspirone|mesh-list
2901017|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2901018|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2901019|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2901020|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901021|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2901022|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
2901023|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
2901024|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2901025|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901026|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
2901027|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2901028|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901029|NCT04118387|Diuretics|diuretics|mesh-ancestor
2901030|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
2901031|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2901032|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2901033|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2901034|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2901035|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
2901036|NCT04111458|Trametinib|trametinib|mesh-list
2901037|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901038|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2901039|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901040|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901041|NCT04094688|Vitamin D|vitamin d|mesh-list
2901042|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
2901043|NCT04094688|Leucovorin|leucovorin|mesh-list
2901044|NCT04094688|Bevacizumab|bevacizumab|mesh-list
2901045|NCT04094688|Fluorouracil|fluorouracil|mesh-list
2326258|NCT00391144|Growth Substances|growth substances|mesh-ancestor
2901046|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
2901047|NCT04094688|Irinotecan|irinotecan|mesh-list
2901048|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
2901049|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901050|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901051|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2901052|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2901053|NCT04094688|Growth Substances|growth substances|mesh-ancestor
2901054|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901055|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
2901056|NCT04094688|Vitamins|vitamins|mesh-ancestor
2901057|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
2901058|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2901059|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2901060|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
2901061|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901062|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2326259|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326260|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
2326261|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326262|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
2326263|NCT00391144|Hormones|hormones|mesh-ancestor
2326264|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326265|NCT00391157|Dexamethasone|dexamethasone|mesh-list
2326266|NCT00391157|Bortezomib|bortezomib|mesh-list
2901063|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2901064|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
2901065|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2901066|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2901067|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901068|NCT04094688|Antidotes|antidotes|mesh-ancestor
2901069|NCT04094688|Protective Agents|protective agents|mesh-ancestor
2901070|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
2901071|NCT04093362|Gemcitabine|gemcitabine|mesh-list
2901072|NCT04093362|Futibatinib|futibatinib|mesh-list
2901073|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901074|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2901075|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
2901076|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901077|NCT04093362|Antiviral Agents|antiviral agents|mesh-ancestor
2901078|NCT04093362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2901079|NCT04093362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901080|NCT04093362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2901081|NCT04093362|Immunologic Factors|immunologic factors|mesh-ancestor
2901082|NCT04093362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326267|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326268|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
2326269|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
2326270|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326271|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326272|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2326273|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
2326274|NCT00391157|Hormones|hormones|mesh-ancestor
2326275|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326276|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2326277|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326278|NCT00391170|Dexamethasone|dexamethasone|mesh-list
2326279|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326280|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
2326281|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
2326282|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2901111|NCT04089514|Adalimumab|adalimumab|mesh-list
2901112|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2901113|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2326283|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326284|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2326285|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
2326286|NCT00391170|Hormones|hormones|mesh-ancestor
2326287|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326288|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2326289|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326290|NCT00391209|Insulin|insulin|mesh-list
2901119|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2901120|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
2901121|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901122|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2901123|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
2901124|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2901125|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901126|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2901127|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2901128|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2901129|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
2901132|NCT04065841|Licogliflozin|licogliflozin|mesh-list
2326291|NCT00391209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2326292|NCT00391209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2326293|NCT00391209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326294|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2326295|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326296|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2326297|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326298|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326299|NCT00391261|Metformin|metformin|mesh-list
2326300|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2326301|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326302|NCT00391313|Chloroquine|chloroquine|mesh-list
2326303|NCT00391313|Amebicides|amebicides|mesh-ancestor
2326304|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2326305|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2326306|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326307|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
2901133|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2901134|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901135|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2901136|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901140|NCT04050436|Cemiplimab|cemiplimab|mesh-list
2901141|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901142|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901143|NCT04045795|Dexamethasone|dexamethasone|mesh-list
2901144|NCT04045795|Pomalidomide|pomalidomide|mesh-list
2901145|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2901146|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2901147|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
2901148|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
2901149|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2901150|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901151|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2901152|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
2901153|NCT04045795|Hormones|hormones|mesh-ancestor
2901154|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2901155|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2901156|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901157|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
2901158|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2901159|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2901160|NCT04045795|Growth Substances|growth substances|mesh-ancestor
2901161|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
2901162|NCT04027348|Dexamethasone|dexamethasone|mesh-list
2901163|NCT04027348|Octreotide|octreotide|mesh-list
2901164|NCT04027348|Metoclopramide|metoclopramide|mesh-list
2901165|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2901166|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
2901167|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
2901168|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2901169|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901170|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2901171|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
2901172|NCT04027348|Hormones|hormones|mesh-ancestor
2901173|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2901174|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2901175|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901176|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2901177|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2901178|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
2901179|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326308|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2326309|NCT00391404|Alendronate|alendronate|mesh-list
2326310|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2326311|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326312|NCT00391417|Estradiol|estradiol|mesh-list
2326313|NCT00391417|Estrogens|estrogens|mesh-ancestor
2326314|NCT00391417|Hormones|hormones|mesh-ancestor
2326315|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326316|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326317|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
2326318|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
2326319|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2326320|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2326321|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2326322|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326323|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2326324|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2326325|NCT00391638|Interferons|interferons|mesh-list
2326326|NCT00391638|Tenofovir|tenofovir|mesh-list
2326327|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2326328|NCT00391638|Emtricitabine|emtricitabine|mesh-list
2326329|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2326330|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326331|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
2901180|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326332|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326333|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2326334|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2326335|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326336|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326337|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2326338|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2326339|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
2326340|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2326341|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326342|NCT00391651|Renal Agents|renal agents|mesh-ancestor
2326343|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2326344|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
2326345|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2326346|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326347|NCT00391885|Anesthetics|anesthetics|mesh-list
2326348|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2326349|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901184|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
2901185|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
2901186|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2901187|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
2901188|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2901189|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2901190|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2901191|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2901192|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901193|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901194|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2901195|NCT03998839|Renal Agents|renal agents|mesh-ancestor
2901196|NCT03994796|Entrectinib|entrectinib|mesh-list
2901197|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2901198|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901199|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901206|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
2901207|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901208|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901209|NCT03944941|Cetuximab|cetuximab|mesh-list
2901210|NCT03944941|Avelumab|avelumab|mesh-list
2901211|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901212|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901213|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2901214|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2326350|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
2326351|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2326352|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
2326353|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326354|NCT00391911|Expectorants|expectorants|mesh-ancestor
2901215|NCT03941730|Estradiol|estradiol|mesh-list
2901216|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2326355|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
2326356|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2326357|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
2326358|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326359|NCT00391911|Protective Agents|protective agents|mesh-ancestor
2326360|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326361|NCT00391911|Antidotes|antidotes|mesh-ancestor
2326362|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2326363|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2326364|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
2326365|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326366|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
2326367|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2326368|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326369|NCT00392002|Esomeprazole|esomeprazole|mesh-list
2326370|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2326371|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2326372|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2326373|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326374|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901217|NCT03941730|Estrogens|estrogens|mesh-ancestor
2901218|NCT03941730|Hormones|hormones|mesh-ancestor
2901219|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2901220|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901221|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2901222|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
2326375|NCT00392028|Ertapenem|ertapenem|mesh-list
2326376|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2326377|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326378|NCT00392067|Calcipotriene|calcipotriene|mesh-list
2326379|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
2326380|NCT00392080|Naproxen|naproxen|mesh-list
2326381|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2326382|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2901223|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2901224|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2901225|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
2326383|NCT00392080|Analgesics|analgesics|mesh-ancestor
2326384|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
2901226|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2901227|NCT03939767|Aflibercept|aflibercept|mesh-list
2901228|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2901229|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2901230|NCT03939767|Growth Substances|growth substances|mesh-ancestor
2901231|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901232|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
2901233|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901234|NCT03934307|Irbesartan|irbesartan|mesh-list
2901235|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2901236|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2901237|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2326385|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326386|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326387|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2901238|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326388|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2326389|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
2326390|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2326391|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326392|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326393|NCT00392093|Estrogens|estrogens|mesh-list
2326394|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2326395|NCT00392093|Hormones|hormones|mesh-ancestor
2326396|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326397|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326398|NCT00392106|Amiodarone|amiodarone|mesh-list
2326399|NCT00392106|Flecainide|flecainide|mesh-list
2326400|NCT00392106|Propafenone|propafenone|mesh-list
2326401|NCT00392106|Dofetilide|dofetilide|mesh-list
2326402|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2326403|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
2326404|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2326405|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2326406|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326407|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2326408|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2326409|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2326410|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326411|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2326412|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2326413|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2326414|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2326415|NCT00392158|Anesthetics|anesthetics|mesh-list
2901252|NCT03924635|Budesonide|budesonide|mesh-list
2901253|NCT03924635|Albuterol|albuterol|mesh-list
2901254|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
2901255|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2901256|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2901257|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2901258|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
2901259|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2901260|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901261|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2901262|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
2901263|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
2901264|NCT03924635|Hormones|hormones|mesh-ancestor
2326416|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2326417|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326418|NCT00392262|Amlodipine|amlodipine|mesh-list
2326419|NCT00392262|Valsartan|valsartan|mesh-list
2326420|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2326421|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2326422|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2326423|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901265|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2901266|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2901267|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2901268|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2901269|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
2901270|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2901271|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901272|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
2901273|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2901274|NCT03915496|Abrocitinib|abrocitinib|mesh-list
2901275|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2901276|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901277|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326424|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2326425|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326426|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
2326427|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2326428|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2326429|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
2326430|NCT00392275|Levofloxacin|levofloxacin|mesh-list
2326431|NCT00392275|Ofloxacin|ofloxacin|mesh-list
2326432|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2326433|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326434|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2326435|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2326436|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326437|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326438|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326439|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2326440|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2326441|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2326442|NCT00392275|Renal Agents|renal agents|mesh-ancestor
2326443|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
2326444|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
2326445|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326446|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
2326447|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326448|NCT00392340|Doxorubicin|doxorubicin|mesh-list
2326449|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2326450|NCT00392340|Vincristine|vincristine|mesh-list
2326451|NCT00392340|Topotecan|topotecan|mesh-list
2326452|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2326453|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326454|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2326455|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2326456|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326457|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326458|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2326459|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
2326460|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
2326461|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
2326462|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2326471|NCT00392418|Micronutrients|micronutrients|mesh-list
2326472|NCT00392418|Trace Elements|trace elements|mesh-list
2326473|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326474|NCT00392431|Amiodarone|amiodarone|mesh-list
2326475|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2326476|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
2109738|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
2109739|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
2109740|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
2109741|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109742|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2109743|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
2109744|NCT02525653|Antiviral Agents|antiviral agents|mesh-ancestor
2109745|NCT02525653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2901374|NCT03906539|Atorvastatin|atorvastatin|mesh-list
2901375|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2901376|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2901377|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
2901378|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326477|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2326478|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2326479|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326480|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2326481|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2326482|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2326483|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326484|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2326485|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2326486|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2326487|NCT00392457|Ketoconazole|ketoconazole|mesh-list
2326488|NCT00392457|Hormones|hormones|mesh-list
2326489|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326490|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326491|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
2901379|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2901380|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2901381|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901385|NCT03875235|Durvalumab|durvalumab|mesh-list
2901386|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901387|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901388|NCT03869190|Gemcitabine|gemcitabine|mesh-list
2901389|NCT03869190|Atezolizumab|atezolizumab|mesh-list
2326492|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326493|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2326494|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2326495|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326496|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326497|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2326498|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
2326499|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2901390|NCT03869190|Niraparib|niraparib|mesh-list
2901391|NCT03869190|Magrolimab|magrolimab|mesh-list
2109746|NCT02525653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109747|NCT02525653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2109748|NCT02525653|Immunologic Factors|immunologic factors|mesh-ancestor
2109749|NCT02525653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109750|NCT02525718|Dexamethasone|dexamethasone|mesh-list
2109751|NCT02525718|Epinephrine|epinephrine|mesh-list
2109752|NCT02525718|Bupivacaine|bupivacaine|mesh-list
2109753|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109754|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
2109755|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
2109756|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109757|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109758|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2901392|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901393|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2901394|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
2901395|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901396|NCT03869190|Antiviral Agents|antiviral agents|mesh-ancestor
2901397|NCT03869190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2901398|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326500|NCT00392470|Irinotecan|irinotecan|mesh-list
2326501|NCT00392470|Cetuximab|cetuximab|mesh-list
2901399|NCT03869190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2901400|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
2901401|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901402|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2901403|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901407|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
2901408|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2901409|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2901410|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2901411|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901412|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901413|NCT03845114|Insulin|insulin|mesh-list
2901414|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2901415|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2901416|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326502|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2326503|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2326504|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326505|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326506|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326507|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2326508|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
2326509|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2326510|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
2326511|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
2326512|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2326513|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326514|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2326515|NCT00392522|Analgesics|analgesics|mesh-ancestor
2326516|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
2326517|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326518|NCT00392561|Vitamin E|vitamin e|mesh-list
2326519|NCT00392561|Selenium|selenium|mesh-list
2326520|NCT00392561|Vitamins|vitamins|mesh-ancestor
2326521|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
2326522|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326523|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
2326524|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326525|NCT00392561|Protective Agents|protective agents|mesh-ancestor
2326526|NCT00392561|Trace Elements|trace elements|mesh-ancestor
2326527|NCT00392574|Prulifloxacin|prulifloxacin|mesh-list
2326528|NCT00392574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2326529|NCT00392574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326530|NCT00392574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2326531|NCT00392574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2326532|NCT00392574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326533|NCT00392574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326534|NCT00392574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326535|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
2326536|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2326537|NCT00392652|Protective Agents|protective agents|mesh-ancestor
2326538|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326539|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901452|NCT03798691|Vaccines|vaccines|mesh-list
2901453|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
2901454|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901455|NCT03789318|Acetaminophen|acetaminophen|mesh-list
2901456|NCT03789318|Fentanyl|fentanyl|mesh-list
2901457|NCT03789318|Oxycodone|oxycodone|mesh-list
2901458|NCT03789318|Hydromorphone|hydromorphone|mesh-list
2901459|NCT03789318|Bupivacaine|bupivacaine|mesh-list
2901460|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
2901461|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
2901462|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2901463|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901464|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
2901465|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2901466|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2901467|NCT03789318|Narcotics|narcotics|mesh-ancestor
2901468|NCT03789318|Analgesics|analgesics|mesh-ancestor
2901469|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2901470|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2901471|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
2901472|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2901473|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
2901474|NCT03781414|Tacrolimus|tacrolimus|mesh-list
2901475|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2901476|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
2901477|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901478|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2901479|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901480|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901481|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2901482|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2901483|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2901484|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
2901485|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901486|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901487|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
2901488|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901509|NCT03774875|Apremilast|apremilast|mesh-list
2901510|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2901511|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2901512|NCT03774875|Analgesics|analgesics|mesh-ancestor
2901513|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
2901514|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2901515|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901516|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326540|NCT00392691|Rituximab|rituximab|mesh-list
2326541|NCT00392691|Melphalan|melphalan|mesh-list
2326542|NCT00392691|Vinorelbine|vinorelbine|mesh-list
2326543|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2326544|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326545|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
2326546|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326547|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2326548|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2326549|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
2326550|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326551|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2326552|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2326553|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2326554|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
2326555|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
2326556|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
2326557|NCT00392717|Atorvastatin|atorvastatin|mesh-list
2326558|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2326559|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2326560|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
2326561|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326562|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2326563|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2326564|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326565|NCT00392756|Hormones|hormones|mesh-list
2326566|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326567|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326568|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
2326569|NCT00392886|Temozolomide|temozolomide|mesh-list
2326570|NCT00392886|Thiotepa|thiotepa|mesh-list
2326571|NCT00392886|Carboplatin|carboplatin|mesh-list
2326572|NCT00392886|Methotrexate|methotrexate|mesh-list
2326573|NCT00392886|Etoposide|etoposide|mesh-list
2326574|NCT00392886|Vincristine|vincristine|mesh-list
2326575|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2326576|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
2901517|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2901518|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2901519|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2901520|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901521|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901522|NCT03767348|Nivolumab|nivolumab|mesh-list
2901523|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901524|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326577|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326578|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2326579|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2326580|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
2326581|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901525|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2901526|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326582|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326583|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2326584|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2326585|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
2326586|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2326587|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2326588|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
2326589|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
2901544|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
2901545|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
2901546|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326590|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326591|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2326592|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2326593|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2901547|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901548|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901549|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
2901550|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
2901556|NCT03705169|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2901557|NCT03705169|Antiviral Agents|antiviral agents|mesh-ancestor
2901558|NCT03705169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2901562|NCT03691610|Vaccines|vaccines|mesh-list
2901563|NCT03691610|Immunoglobulins|immunoglobulins|mesh-list
2901564|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
2901565|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901566|NCT03673462|Vaccines|vaccines|mesh-list
2901567|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
2901568|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901569|NCT03663335|Tacrolimus|tacrolimus|mesh-list
2901570|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2901571|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
2901572|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326594|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2326595|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2326596|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
2326597|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
2326598|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
2326599|NCT00392899|Tegafur|tegafur|mesh-list
2326600|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2326601|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
2326602|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326603|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326604|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
2326605|NCT00392912|Testosterone|testosterone|mesh-list
2326606|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
2326607|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
2326608|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2326609|NCT00392912|Androgens|androgens|mesh-ancestor
2326610|NCT00392912|Hormones|hormones|mesh-ancestor
2326611|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2901573|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2901574|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901575|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901604|NCT03653507|Capecitabine|capecitabine|mesh-list
2901605|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
2901606|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2901607|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
2326612|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326613|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2326614|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326615|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
2326616|NCT00392938|Docetaxel|docetaxel|mesh-list
2326617|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
2326618|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326619|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
2901608|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901609|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326620|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
2326621|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
2326622|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326623|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
2326624|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326625|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326626|NCT00393003|Anesthetics|anesthetics|mesh-list
2326627|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2326628|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326629|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
2326630|NCT00393107|Rituximab|rituximab|mesh-list
2326631|NCT00393107|Fludarabine|fludarabine|mesh-list
2326632|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2326633|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
2326634|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326635|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2326636|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2326637|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
2326638|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326639|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326640|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2326641|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2326642|NCT00393198|Misoprostol|misoprostol|mesh-list
2326643|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
2326644|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2326645|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
2326646|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2326647|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901622|NCT03646461|Nivolumab|nivolumab|mesh-list
2901623|NCT03646461|Cetuximab|cetuximab|mesh-list
2901624|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901625|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901626|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2901627|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901628|NCT03632720|Vaccines|vaccines|mesh-list
2901629|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
2326648|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2326649|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2326650|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2326651|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2326652|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
2901630|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901631|NCT03631004|Olanzapine|olanzapine|mesh-list
2901632|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
2901633|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
2901634|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2901635|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901636|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2901637|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2901638|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2901639|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2901640|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2901641|NCT03631004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2901642|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2901643|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2901644|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901645|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2901646|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
2901647|NCT03630705|Vaccines|vaccines|mesh-list
2901648|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
2901649|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901650|NCT03615664|Gemcitabine|gemcitabine|mesh-list
2901651|NCT03615664|Dexamethasone|dexamethasone|mesh-list
2901652|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2901653|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2901654|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
2901655|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
2901656|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2901657|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901658|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2901659|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
2901660|NCT03615664|Hormones|hormones|mesh-ancestor
2901661|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2901662|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2901663|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901664|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2901665|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
2901666|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901667|NCT03615664|Antiviral Agents|antiviral agents|mesh-ancestor
2901668|NCT03615664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2901669|NCT03615664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901670|NCT03615664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2901671|NCT03615664|Immunologic Factors|immunologic factors|mesh-ancestor
2901672|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2901673|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
2901674|NCT03609216|Gemcitabine|gemcitabine|mesh-list
2901675|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901676|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2901677|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
2901678|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326653|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2326654|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2326655|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
2326656|NCT00393211|Etoricoxib|etoricoxib|mesh-list
2326657|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326658|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326659|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326660|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2901679|NCT03609216|Antiviral Agents|antiviral agents|mesh-ancestor
2901680|NCT03609216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2901681|NCT03609216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901682|NCT03609216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2901683|NCT03609216|Immunologic Factors|immunologic factors|mesh-ancestor
2901684|NCT03609216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901685|NCT03556345|Trastuzumab|trastuzumab|mesh-list
2901686|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901687|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901688|NCT03547271|Vaccines|vaccines|mesh-list
2901689|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2901690|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
2901691|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901692|NCT03537508|Vaccines|vaccines|mesh-list
2901693|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
2901694|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901695|NCT03522584|Durvalumab|durvalumab|mesh-list
2901696|NCT03522584|Ipilimumab|ipilimumab|mesh-list
2901697|NCT03522584|Tremelimumab|tremelimumab|mesh-list
2901698|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
2901699|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2901700|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
2901701|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901702|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901703|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
2901704|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901705|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2901706|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901714|NCT03513250|Scopolamine|scopolamine|mesh-list
2901715|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2901716|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2901717|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
2901718|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
2326661|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2326662|NCT00393211|Analgesics|analgesics|mesh-ancestor
2326663|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
2326664|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326665|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2326666|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2326667|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2326668|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326669|NCT00393263|Clobetasol|clobetasol|mesh-list
2326670|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
2326671|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326672|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
2326673|NCT00393263|Hormones|hormones|mesh-ancestor
2326674|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326675|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326676|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2326677|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2326678|NCT00393263|Analgesics|analgesics|mesh-ancestor
2326679|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
2326680|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2901719|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2901720|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901721|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2901722|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
2901723|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2901724|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
2901725|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2901726|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901727|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2901728|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
2901729|NCT03510884|Nicotinic Acids|nicotinic acids|mesh-list
2901730|NCT03510884|Niacin|niacin|mesh-list
2901731|NCT03510884|Niacinamide|niacinamide|mesh-list
2901732|NCT03510884|Atorvastatin|atorvastatin|mesh-list
2901733|NCT03510884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2901734|NCT03510884|Simvastatin|simvastatin|mesh-list
2901735|NCT03510884|Ezetimibe|ezetimibe|mesh-list
2901736|NCT03510884|Pravastatin|pravastatin|mesh-list
2326681|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2901737|NCT03510884|Lovastatin|lovastatin|mesh-list
2901738|NCT03510884|Cholestyramine Resin|cholestyramine resin|mesh-list
2901739|NCT03510884|Fenofibrate|fenofibrate|mesh-list
2901740|NCT03510884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2901741|NCT03510884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2901742|NCT03510884|Antimetabolites|antimetabolites|mesh-ancestor
2901743|NCT03510884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901744|NCT03510884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2901745|NCT03510884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2901746|NCT03510884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901747|NCT03510884|Vitamin B Complex|vitamin b complex|mesh-ancestor
2901748|NCT03510884|Vitamins|vitamins|mesh-ancestor
2901749|NCT03510884|Micronutrients|micronutrients|mesh-ancestor
2326682|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
2326683|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2901750|NCT03510884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901751|NCT03510884|Vasodilator Agents|vasodilator agents|mesh-ancestor
2901752|NCT03507452|BAY 2287411|bay 2287411|mesh-list
2901753|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2901754|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901763|NCT03455270|Palbociclib|palbociclib|mesh-list
2901764|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901765|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2901766|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901767|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901768|NCT03436563|Atezolizumab|atezolizumab|mesh-list
2326684|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
2326685|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2326686|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326687|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326688|NCT00393289|Calcium|calcium|mesh-list
2326689|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2326690|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326691|NCT00393315|Paclitaxel|paclitaxel|mesh-list
2901769|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901770|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2901771|NCT03406156|Venetoclax|venetoclax|mesh-list
2901772|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
2901773|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2901774|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
2901775|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901776|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901777|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901787|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
2901788|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901789|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901790|NCT03368963|Trifluridine|trifluridine|mesh-list
2901791|NCT03368963|Irinotecan|irinotecan|mesh-list
2901792|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2901793|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2901794|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901795|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901796|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901797|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
2901798|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
2901799|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2901800|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
2901801|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2901802|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2901803|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901804|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
2326692|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2326693|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326694|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
2326695|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
2326696|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
2326697|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326698|NCT00393328|Ritonavir|ritonavir|mesh-list
2326699|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2326700|NCT00393328|Aripiprazole|aripiprazole|mesh-list
2326701|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2326702|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2326703|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
2326704|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326705|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326706|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2326707|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2326708|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
2326709|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326710|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2326711|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2326712|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
2326713|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2326714|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2901805|NCT03364491|Coagulants|coagulants|mesh-ancestor
2901806|NCT03345823|Upadacitinib|upadacitinib|mesh-list
2901807|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2901808|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2901809|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901810|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326715|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2326716|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2326717|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901811|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2901812|NCT03300817|Poly ICLC|poly iclc|mesh-list
2901813|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
2901814|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
2901815|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901816|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
2901817|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901818|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901819|NCT03224767|Vemurafenib|vemurafenib|mesh-list
2901820|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901821|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2901822|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901823|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901824|NCT03198351|Teriflunomide|teriflunomide|mesh-list
2901825|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2901826|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2901827|NCT03198351|Analgesics|analgesics|mesh-ancestor
2901828|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
2901829|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2901830|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901831|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2901832|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2901833|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2326718|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
2326719|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
2326720|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326721|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2326722|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2326723|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
2326724|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2326725|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2326726|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2901834|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
2901835|NCT03176134|Tedizolid|tedizolid|mesh-list
2901836|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
2901837|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2901838|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2901839|NCT03158688|Dexamethasone|dexamethasone|mesh-list
2901840|NCT03158688|Daratumumab|daratumumab|mesh-list
2901841|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326727|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2326728|NCT00393354|Etoricoxib|etoricoxib|mesh-list
2901842|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
2326729|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326730|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326731|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326732|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2901843|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
2901844|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2901845|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901846|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2901847|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
2326733|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2326734|NCT00393354|Analgesics|analgesics|mesh-ancestor
2326735|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
2326736|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326737|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2326738|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2326739|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2326740|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901848|NCT03158688|Hormones|hormones|mesh-ancestor
2901849|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2901850|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2901851|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901852|NCT03152786|Propranolol|propranolol|mesh-list
2901853|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2901854|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2901855|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
2901856|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2901857|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901858|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901859|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2901860|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2901861|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
2901862|NCT03150693|Cytarabine|cytarabine|mesh-list
2326741|NCT00393393|Hylan|hylan|mesh-list
2326742|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
2326743|NCT00393393|Protective Agents|protective agents|mesh-ancestor
2326744|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326745|NCT00393445|Glucagon|glucagon|mesh-list
2326746|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2326747|NCT00393445|Incretins|incretins|mesh-ancestor
2326748|NCT00393445|Hormones|hormones|mesh-ancestor
2326749|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326750|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326751|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2326752|NCT00393471|Etanercept|etanercept|mesh-list
2326753|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2901863|NCT03150693|Dexamethasone|dexamethasone|mesh-list
2901864|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
2901865|NCT03150693|Rituximab|rituximab|mesh-list
2901866|NCT03150693|Doxorubicin|doxorubicin|mesh-list
2901867|NCT03150693|Methotrexate|methotrexate|mesh-list
2901868|NCT03150693|Vincristine|vincristine|mesh-list
2901869|NCT03150693|Daunorubicin|daunorubicin|mesh-list
2901870|NCT03150693|Asparaginase|asparaginase|mesh-list
2901871|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
2901872|NCT03150693|Thioguanine|thioguanine|mesh-list
2901873|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2901874|NCT03150693|Pegaspargase|pegaspargase|mesh-list
2901875|NCT03150693|Allopurinol|allopurinol|mesh-list
2901876|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2901877|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
2326754|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2326755|NCT00393471|Analgesics|analgesics|mesh-ancestor
2326756|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
2326757|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326758|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326759|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2901878|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901879|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2901880|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2901881|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
2901882|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901883|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901884|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2901885|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2901886|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
2901887|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
2901888|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2901889|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2901890|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
2901891|NCT03150693|Hormones|hormones|mesh-ancestor
2901892|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2901893|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2901894|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2901895|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2901896|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2901897|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2901898|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901899|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2901900|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
2901901|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2901902|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2901903|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
2901904|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
2901905|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2901906|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2326760|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2326761|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2326762|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2326763|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
2326764|NCT00393497|Bevacizumab|bevacizumab|mesh-list
2326765|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2326766|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326767|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2326768|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2326769|NCT00393497|Growth Substances|growth substances|mesh-ancestor
2326770|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326771|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
2326772|NCT00393562|Methylphenidate|methylphenidate|mesh-list
2326773|NCT00393562|Modafinil|modafinil|mesh-list
2326774|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2326775|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326776|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2901907|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
2901908|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2901909|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2901910|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
2901911|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
2901912|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
2901913|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
2901914|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2901915|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
2901916|NCT03150693|Protective Agents|protective agents|mesh-ancestor
2901917|NCT03138733|Daptomycin|daptomycin|mesh-list
2901918|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
2901919|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2901920|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2901921|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2901922|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2901923|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2901924|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901925|NCT03127215|Olaparib|olaparib|mesh-list
2901926|NCT03127215|Trabectedin|trabectedin|mesh-list
2901927|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2901928|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326777|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2326778|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2326779|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326780|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
2326781|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326782|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2326783|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2326784|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2326785|NCT00393614|Levetiracetam|levetiracetam|mesh-list
2326786|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
2326787|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
2326788|NCT00393679|Artesunate|artesunate|mesh-list
2326789|NCT00393679|Lumefantrine|lumefantrine|mesh-list
2326790|NCT00393679|Artemether|artemether|mesh-list
2326791|NCT00393679|Piperaquine|piperaquine|mesh-list
2326792|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2901929|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326793|NCT00393679|Amodiaquine|amodiaquine|mesh-list
2326794|NCT00393679|Artenimol|artenimol|mesh-list
2326795|NCT00393679|Dapsone|dapsone|mesh-list
2326796|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
2326797|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
2326798|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2326799|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2326800|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326801|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326802|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
2901930|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901931|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2901932|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
2901947|NCT03041688|Decitabine|decitabine|mesh-list
2901948|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2901949|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
2901950|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2901951|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901952|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2901953|NCT02983071|Fulvestrant|fulvestrant|mesh-list
2901954|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2901955|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2901956|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2901957|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2901958|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
2901959|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2901960|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901961|NCT02935595|Ketamine|ketamine|mesh-list
2901962|NCT02935595|Analgesics|analgesics|mesh-ancestor
2901963|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
2901964|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326803|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
2326804|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2326805|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
2326806|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2326807|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326808|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326809|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
2326810|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2326811|NCT00393731|Misoprostol|misoprostol|mesh-list
2326812|NCT00393731|Oxytocin|oxytocin|mesh-list
2326813|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
2326814|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2326815|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901965|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2901966|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2901967|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2901968|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
2901969|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
2901970|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2901971|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2901972|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2901973|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2901974|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326816|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2326817|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
2326818|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2326819|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2326820|NCT00393744|Amoxicillin|amoxicillin|mesh-list
2326821|NCT00393744|Pristinamycin|pristinamycin|mesh-list
2326822|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2326823|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326824|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
2326825|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
2326826|NCT00393770|Vitamins|vitamins|mesh-ancestor
2326827|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
2326828|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326829|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
2326830|NCT00393783|Trastuzumab|trastuzumab|mesh-list
2326831|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2326832|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326833|NCT00393835|Azithromycin|azithromycin|mesh-list
2326834|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2326835|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326836|NCT00393952|Fluticasone|fluticasone|mesh-list
2326837|NCT00393952|Xhance|xhance|mesh-list
2326838|NCT00393952|Formoterol Fumarate|formoterol fumarate|mesh-list
2326839|NCT00393952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326840|NCT00393952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2326841|NCT00393952|Autonomic Agents|autonomic agents|mesh-ancestor
2326842|NCT00393952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326843|NCT00393952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326844|NCT00393952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2326845|NCT00393952|Respiratory System Agents|respiratory system agents|mesh-ancestor
2901999|NCT02887248|Gemcitabine|gemcitabine|mesh-list
2326846|NCT00393952|Dermatologic Agents|dermatologic agents|mesh-ancestor
2326847|NCT00393952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2326848|NCT00393952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2326849|NCT00393952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2902000|NCT02887248|Paclitaxel|paclitaxel|mesh-list
2902001|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2902002|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902003|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
2902004|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
2902005|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
2902006|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902007|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2902008|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
2902009|NCT02887248|Antiviral Agents|antiviral agents|mesh-ancestor
2902010|NCT02887248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2902011|NCT02887248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902012|NCT02887248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2902013|NCT02887248|Immunologic Factors|immunologic factors|mesh-ancestor
2902014|NCT02887248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326850|NCT00393952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2326851|NCT00393952|Adrenergic Agents|adrenergic agents|mesh-ancestor
2326852|NCT00393952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2902049|NCT02859896|Calcitriol|calcitriol|mesh-list
2902050|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2902051|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2902052|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902053|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2902054|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2902055|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902056|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2902057|NCT02859896|Vitamins|vitamins|mesh-ancestor
2902058|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
2902059|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2902060|NCT02858310|Aldesleukin|aldesleukin|mesh-list
2902061|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
2902062|NCT02858310|Fludarabine|fludarabine|mesh-list
2902063|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2902064|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
2902065|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902066|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2902067|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2902068|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
2902069|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902070|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902071|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2902072|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2902073|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2902074|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
2902075|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2902076|NCT02849990|Prednisone|prednisone|mesh-list
2902077|NCT02849990|Cortisone|cortisone|mesh-list
2902078|NCT02849990|Indomethacin|indomethacin|mesh-list
2902079|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
2902080|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2902081|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
2902082|NCT02849990|Hormones|hormones|mesh-ancestor
2902083|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2902084|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902085|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2902086|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902087|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2902088|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902089|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902090|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
2902091|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2902092|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2326853|NCT00393952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326854|NCT00393991|Fluticasone|fluticasone|mesh-list
2326855|NCT00393991|Xhance|xhance|mesh-list
2326856|NCT00393991|Formoterol Fumarate|formoterol fumarate|mesh-list
2326857|NCT00393991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326858|NCT00393991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2326859|NCT00393991|Autonomic Agents|autonomic agents|mesh-ancestor
2326860|NCT00393991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326861|NCT00393991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326862|NCT00393991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2326863|NCT00393991|Respiratory System Agents|respiratory system agents|mesh-ancestor
2326864|NCT00393991|Dermatologic Agents|dermatologic agents|mesh-ancestor
2326865|NCT00393991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2326866|NCT00393991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2902093|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2902094|NCT02849990|Analgesics|analgesics|mesh-ancestor
2902095|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
2902096|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902097|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2902098|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
2902099|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
2902100|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2902101|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2902102|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
2902103|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2902104|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902105|NCT02818894|Lidocaine|lidocaine|mesh-list
2902106|NCT02818894|Bupivacaine|bupivacaine|mesh-list
2902107|NCT02818894|Anesthetics, Local|anesthetics, local|mesh-ancestor
2902108|NCT02818894|Anesthetics|anesthetics|mesh-ancestor
2902109|NCT02818894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2902110|NCT02818894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902111|NCT02818894|Sensory System Agents|sensory system agents|mesh-ancestor
2902112|NCT02818894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902113|NCT02818894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2902114|NCT02818894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2902115|NCT02818894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2902116|NCT02818894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2902117|NCT02818894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902118|NCT02817347|Tazobactam|tazobactam|mesh-list
2902119|NCT02817347|Piperacillin|piperacillin|mesh-list
2902120|NCT02817347|Dexamethasone|dexamethasone|mesh-list
2902121|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
2902122|NCT02817347|BB 1101|bb 1101|mesh-list
2902123|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2902124|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
2902125|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
2902126|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902127|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902128|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2902129|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
2902130|NCT02817347|Hormones|hormones|mesh-ancestor
2902131|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2902132|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2902133|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902134|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
2902135|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902136|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902137|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2902138|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2902139|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2902140|NCT02800824|Budesonide|budesonide|mesh-list
2902141|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2902142|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2902143|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
2902144|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902145|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902146|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2902147|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
2902148|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
2902149|NCT02800824|Hormones|hormones|mesh-ancestor
2902150|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2902151|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2902152|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2902153|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
2902154|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902155|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902156|NCT02782949|Curcumin|curcumin|mesh-list
2902157|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2902158|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2902159|NCT02782949|Analgesics|analgesics|mesh-ancestor
2326867|NCT00393991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2902160|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
2902161|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902162|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902163|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2902164|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2902165|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902166|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326868|NCT00393991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2326869|NCT00393991|Adrenergic Agents|adrenergic agents|mesh-ancestor
2326870|NCT00393991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326871|NCT00393991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326872|NCT00394056|Paroxetine|paroxetine|mesh-list
2326873|NCT00394056|Vestipitant|vestipitant|mesh-list
2326874|NCT00394056|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2902167|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902168|NCT02780401|Vaccines|vaccines|mesh-list
2902169|NCT02780401|Sargramostim|sargramostim|mesh-list
2902170|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
2902171|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902172|NCT02760498|Cemiplimab|cemiplimab|mesh-list
2902173|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2902174|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902175|NCT02720068|Leucovorin|leucovorin|mesh-list
2902176|NCT02720068|Fluorouracil|fluorouracil|mesh-list
2902177|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
2902178|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
2902179|NCT02720068|Irinotecan|irinotecan|mesh-list
2902180|NCT02720068|Lenvatinib|lenvatinib|mesh-list
2902181|NCT02720068|Calcium|calcium|mesh-list
2902182|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
2902183|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2902184|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902185|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
2902186|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902187|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2902188|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902189|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2902190|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
2902191|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2902192|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2902193|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2902194|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902195|NCT02720068|Antidotes|antidotes|mesh-ancestor
2902196|NCT02720068|Protective Agents|protective agents|mesh-ancestor
2902197|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
2902198|NCT02720068|Vitamins|vitamins|mesh-ancestor
2902199|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
2902200|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2902201|NCT02673151|Edetic Acid|edetic acid|mesh-list
2326875|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2326876|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2326877|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326878|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326879|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
2326880|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326881|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2326882|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
2326883|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2326884|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2326885|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2902202|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2902203|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
2902204|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
2902205|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902206|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
2902207|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2902208|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2902212|NCT02653092|Heparin|heparin|mesh-list
2902213|NCT02653092|Anticoagulants|anticoagulants|mesh-list
2902214|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2902215|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2902216|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2902217|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902218|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2902219|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2902220|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2902221|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
2902222|NCT02612311|Chlorambucil|chlorambucil|mesh-list
2902223|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2902224|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902225|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2902226|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
2902227|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902228|NCT02593175|Paclitaxel|paclitaxel|mesh-list
2902229|NCT02593175|Carboplatin|carboplatin|mesh-list
2902230|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2902231|NCT02593175|Panitumumab|panitumumab|mesh-list
2902232|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2902233|NCT02593175|Antibodies|antibodies|mesh-list
2902234|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
2902235|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2902236|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2902237|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902238|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
2902239|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
2902240|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
2902241|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326886|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326887|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2326888|NCT00394069|Montelukast|montelukast|mesh-list
2326889|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2326890|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
2326891|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2326892|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
2326893|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326894|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326895|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2326896|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2326897|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902242|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
2902243|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902248|NCT02590393|Nicotine|nicotine|mesh-list
2902249|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2902250|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
2902251|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902252|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902253|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2902254|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2902255|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
2902256|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2902257|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902258|NCT02589600|Vitamin D|vitamin d|mesh-list
2902259|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
2902260|NCT02589600|Calcium|calcium|mesh-list
2902261|NCT02589600|Vitamins|vitamins|mesh-ancestor
2902262|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
2902263|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902264|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2902265|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2902266|NCT02567578|YH12852|yh12852|mesh-list
2902267|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2902268|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2326898|NCT00394121|Fluticasone|fluticasone|mesh-list
2326899|NCT00394121|Xhance|xhance|mesh-list
2326900|NCT00394121|Formoterol Fumarate|formoterol fumarate|mesh-list
2326901|NCT00394121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326902|NCT00394121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2326903|NCT00394121|Autonomic Agents|autonomic agents|mesh-ancestor
2326904|NCT00394121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326905|NCT00394121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326906|NCT00394121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2326907|NCT00394121|Respiratory System Agents|respiratory system agents|mesh-ancestor
2326908|NCT00394121|Dermatologic Agents|dermatologic agents|mesh-ancestor
2326909|NCT00394121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2326910|NCT00394121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2326911|NCT00394121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2326912|NCT00394121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2326913|NCT00394121|Adrenergic Agents|adrenergic agents|mesh-ancestor
2326914|NCT00394121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326915|NCT00394121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326916|NCT00394147|Gemcitabine|gemcitabine|mesh-list
2326917|NCT00394147|Pemetrexed|pemetrexed|mesh-list
2326918|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2326919|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
2326920|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326921|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2326922|NCT00394147|Antiviral Agents|antiviral agents|mesh-ancestor
2326923|NCT00394147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2326924|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2326925|NCT00394147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2326926|NCT00394147|Immunologic Factors|immunologic factors|mesh-ancestor
2326927|NCT00394147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326928|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2326929|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2326930|NCT00394160|Montelukast|montelukast|mesh-list
2326931|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2326932|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
2326933|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2326934|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
2902269|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
2902270|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326935|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326936|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326937|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2326938|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2326939|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326940|NCT00394186|Solabegron|solabegron|mesh-list
2902271|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902272|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326941|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2326942|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2326943|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2326944|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
2326945|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326946|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326947|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326948|NCT00394199|Fluticasone|fluticasone|mesh-list
2326949|NCT00394199|Xhance|xhance|mesh-list
2326950|NCT00394199|Formoterol Fumarate|formoterol fumarate|mesh-list
2326951|NCT00394199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2326952|NCT00394199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2902273|NCT02523274|Resveratrol|resveratrol|mesh-list
2902274|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
2326953|NCT00394199|Autonomic Agents|autonomic agents|mesh-ancestor
2326954|NCT00394199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326955|NCT00394199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326956|NCT00394199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2326957|NCT00394199|Respiratory System Agents|respiratory system agents|mesh-ancestor
2326958|NCT00394199|Dermatologic Agents|dermatologic agents|mesh-ancestor
2326959|NCT00394199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2326960|NCT00394199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2326961|NCT00394199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2326962|NCT00394199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2326963|NCT00394199|Adrenergic Agents|adrenergic agents|mesh-ancestor
2326964|NCT00394199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326965|NCT00394199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326966|NCT00394303|Insulin|insulin|mesh-list
2326967|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2326968|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326969|NCT00394368|Fluticasone|fluticasone|mesh-list
2326970|NCT00394368|Xhance|xhance|mesh-list
2326971|NCT00394368|Beclomethasone|beclomethasone|mesh-list
2326972|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
2326973|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2326974|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2902275|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902276|NCT02523274|Protective Agents|protective agents|mesh-ancestor
2326975|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2326976|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
2326977|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2326978|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2326979|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2326980|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
2326981|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
2326982|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2326983|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2326984|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2326985|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2326986|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
2326987|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2326988|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326989|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
2326990|NCT00394368|Hormones|hormones|mesh-ancestor
2326991|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2326992|NCT00394394|Enalapril|enalapril|mesh-list
2326993|NCT00394394|Amiloride|amiloride|mesh-list
2326994|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2326995|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
2326996|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902277|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902278|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902279|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2902280|NCT02467270|Ponatinib|ponatinib|mesh-list
2902281|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902282|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2902283|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902284|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326997|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2326998|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2326999|NCT00394394|Diuretics|diuretics|mesh-ancestor
2327000|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
2327001|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327002|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2109759|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
2109760|NCT02525718|Hormones|hormones|mesh-ancestor
2109761|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109762|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2109763|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109764|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
2109765|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
2109766|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109767|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
2109768|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2902322|NCT02452554|Maytansine|maytansine|mesh-list
2902323|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
2902324|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2902325|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2902326|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902327|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
2902328|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
2902329|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
2902330|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902331|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2902351|NCT02432560|Sirolimus|sirolimus|mesh-list
2327003|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2327004|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2327005|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2327006|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2327007|NCT00394407|Insulin|insulin|mesh-list
2327008|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2327009|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2327010|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327011|NCT00394459|Anesthetics|anesthetics|mesh-list
2327012|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2327013|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327014|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
2327015|NCT00394485|Procaterol|procaterol|mesh-list
2327016|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2327017|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
2327018|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902352|NCT02432560|Everolimus|everolimus|mesh-list
2902353|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902354|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2902355|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
2902356|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327019|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902357|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2109769|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2109770|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
2109771|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109772|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109773|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2109774|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2109775|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2109776|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
2109777|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
2109778|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
2109779|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2109780|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
2109781|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2109782|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109783|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
2109784|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2109785|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902358|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2902359|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2902360|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
2327020|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2327021|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
2327022|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
2327023|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2327024|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
2327025|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327026|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327027|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
2327028|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2327029|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2327030|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2327031|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
2327032|NCT00394498|Sargramostim|sargramostim|mesh-list
2327033|NCT00394498|Lenograstim|lenograstim|mesh-list
2327034|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
2327035|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327036|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2327037|NCT00394537|Labetalol|labetalol|mesh-list
2327038|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2327039|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2327040|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
2327041|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327042|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902361|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2902362|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
2902363|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902364|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2902365|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
2902366|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2902367|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902368|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2902369|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2902370|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2902371|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
2902372|NCT02375204|Paclitaxel|paclitaxel|mesh-list
2902373|NCT02375204|Etoposide|etoposide|mesh-list
2902374|NCT02375204|Carboplatin|carboplatin|mesh-list
2902375|NCT02375204|Ifosfamide|ifosfamide|mesh-list
2902376|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
2902377|NCT02375204|Lenograstim|lenograstim|mesh-list
2902378|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2902379|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902380|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
2902381|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
2902382|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
2902383|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902384|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2902385|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2902386|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902387|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2902388|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
2902389|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902390|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2902391|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
2327043|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327044|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2327045|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
2327046|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
2327047|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902392|NCT02359175|Acetaminophen|acetaminophen|mesh-list
2902393|NCT02359175|Fentanyl|fentanyl|mesh-list
2902394|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
2902395|NCT02359175|Bupivacaine|bupivacaine|mesh-list
2902396|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
2902397|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
2902398|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2902399|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902400|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
2902401|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902402|NCT02359175|Narcotics|narcotics|mesh-ancestor
2902403|NCT02359175|Analgesics|analgesics|mesh-ancestor
2902404|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2902405|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2902406|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
2902407|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2902408|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
2902409|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
2902410|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2902411|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902412|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
2902413|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
2902414|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2902415|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2902416|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902417|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902418|NCT02335242|Urological Agents|urological agents|mesh-ancestor
2327048|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2327049|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2327050|NCT00394563|Tanezumab|tanezumab|mesh-list
2327051|NCT00394563|Analgesics|analgesics|mesh-ancestor
2327052|NCT00394563|Sensory System Agents|sensory system agents|mesh-ancestor
2327053|NCT00394563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2327054|NCT00394563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327055|NCT00394628|Temozolomide|temozolomide|mesh-list
2327056|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2327057|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
2327058|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327059|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327060|NCT00394693|Interferons|interferons|mesh-list
2327061|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
2327062|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327063|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
2327064|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327065|NCT00394745|Valsartan|valsartan|mesh-list
2327066|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2327067|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2902419|NCT02332577|Amoxicillin|amoxicillin|mesh-list
2902420|NCT02332577|Pristinamycin|pristinamycin|mesh-list
2902421|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2327068|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2327069|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327070|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
2327071|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327072|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
2902422|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2902423|NCT02323698|Caffeine|caffeine|mesh-list
2902424|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2902425|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902426|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2902427|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902428|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902429|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2902430|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2902431|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
2902432|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2902433|NCT02323659|Interferons|interferons|mesh-list
2902434|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
2902435|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
2902436|NCT02323659|Methotrexate|methotrexate|mesh-list
2902437|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2902438|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
2109786|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109787|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2109788|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2109789|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2109790|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
2109791|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2109792|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
2109793|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109794|NCT02526212|Buprenorphine|buprenorphine|mesh-list
2109795|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2109796|NCT02526212|Narcotics|narcotics|mesh-ancestor
2109797|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109798|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109799|NCT02526212|Analgesics|analgesics|mesh-ancestor
2109800|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
2109801|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2327073|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
2327074|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
2327075|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327076|NCT00394966|Rolapitant|rolapitant|mesh-list
2327077|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2327078|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327079|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327080|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327081|NCT00394992|Bevacizumab|bevacizumab|mesh-list
2327082|NCT00394992|Capecitabine|capecitabine|mesh-list
2327083|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
2327084|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2327085|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327086|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2327087|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2327088|NCT00394992|Growth Substances|growth substances|mesh-ancestor
2327089|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327090|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
2902439|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2902440|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902441|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2327091|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2327092|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
2327093|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327094|NCT00395031|Ziprasidone|ziprasidone|mesh-list
2327095|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2327096|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
2327097|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327098|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327099|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327100|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2327101|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2327102|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2327103|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2327104|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2327105|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
2327106|NCT00395070|Temozolomide|temozolomide|mesh-list
2327107|NCT00395070|Dacarbazine|dacarbazine|mesh-list
2327108|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2327109|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
2327110|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327111|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327112|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
2327113|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
2327114|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327115|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
2327116|NCT00395213|Norepinephrine|norepinephrine|mesh-list
2327117|NCT00395213|Serotonin|serotonin|mesh-list
2327118|NCT00395213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2327119|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2327120|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2327121|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
2327122|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327123|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327124|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327125|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
2327126|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
2327127|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2327128|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2327129|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2327130|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
2902442|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
2902443|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902444|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902445|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
2902446|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902447|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2902448|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327131|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2327132|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2327133|NCT00395239|Budesonide|budesonide|mesh-list
2327134|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2327135|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2327136|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
2902449|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
2902450|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2902451|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2902452|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
2902453|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2902454|NCT02318277|Durvalumab|durvalumab|mesh-list
2902455|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2902456|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902457|NCT02296801|Letrozole|letrozole|mesh-list
2902458|NCT02296801|Palbociclib|palbociclib|mesh-list
2902459|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327137|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2327138|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902460|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2902461|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2902462|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902463|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902464|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2902465|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
2902466|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2902467|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902468|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2327139|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2327140|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
2327141|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
2327142|NCT00395239|Hormones|hormones|mesh-ancestor
2327143|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2327144|NCT00395252|Gemcitabine|gemcitabine|mesh-list
2327145|NCT00395252|Cetuximab|cetuximab|mesh-list
2327146|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2327147|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
2327148|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327149|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327150|NCT00395252|Antiviral Agents|antiviral agents|mesh-ancestor
2327151|NCT00395252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327152|NCT00395252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327153|NCT00395252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327154|NCT00395252|Immunologic Factors|immunologic factors|mesh-ancestor
2327155|NCT00395252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327156|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2327157|NCT00395369|Aprotinin|aprotinin|mesh-list
2327158|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
2327159|NCT00395369|Coagulants|coagulants|mesh-ancestor
2327160|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2327161|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2327162|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
2327163|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327164|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327165|NCT00395382|Alendronate|alendronate|mesh-list
2327166|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2327167|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327168|NCT00395395|Calcitonin|calcitonin|mesh-list
2327169|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
2327170|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2327171|NCT00395395|Katacalcin|katacalcin|mesh-list
2327172|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2327173|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327174|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2327175|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
2327176|NCT00395408|Beclomethasone|beclomethasone|mesh-list
2327177|NCT00395408|Montelukast|montelukast|mesh-list
2327178|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902482|NCT02283853|Interferons|interferons|mesh-list
2902483|NCT02283853|Interferon-beta|interferon-beta|mesh-list
2902484|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
2902485|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2902486|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902487|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
2902488|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2902489|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
2902490|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2902491|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
2902492|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902493|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2327179|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327180|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
2327181|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2327182|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2327183|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
2327184|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2327185|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2327186|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2327187|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2327188|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
2327189|NCT00395408|Hormones|hormones|mesh-ancestor
2327190|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2327191|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
2327192|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327193|NCT00395434|Bevacizumab|bevacizumab|mesh-list
2327194|NCT00395434|Combretastatin|combretastatin|mesh-list
2327195|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
2327196|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2327197|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327198|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2327199|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2902522|NCT02176668|Esomeprazole|esomeprazole|mesh-list
2902523|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2327200|NCT00395434|Growth Substances|growth substances|mesh-ancestor
2327201|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327202|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
2327203|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2327204|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
2327205|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
2327206|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
2327207|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327208|NCT00395473|Ezetimibe|ezetimibe|mesh-list
2327209|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2902524|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2902525|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2902526|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327210|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2327211|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
2327212|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327213|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2327214|NCT00395499|Risperidone|risperidone|mesh-list
2327215|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2327216|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
2327217|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327218|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327219|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902527|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902528|NCT02143063|Cocaine|cocaine|mesh-list
2902529|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
2902530|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
2902531|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2902532|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902533|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
2902534|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902535|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2902536|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2902537|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2902538|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2902539|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902540|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
2902541|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2902542|NCT02073097|Acyclovir|acyclovir|mesh-list
2902543|NCT02073097|Prednisone|prednisone|mesh-list
2902544|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
2327220|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2327221|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2327222|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2327223|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2327224|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2327225|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
2327226|NCT00395551|Ranibizumab|ranibizumab|mesh-list
2327227|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2327228|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2327229|NCT00395551|Growth Substances|growth substances|mesh-ancestor
2327230|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327231|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
2327232|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327233|NCT00395603|Atorvastatin|atorvastatin|mesh-list
2327234|NCT00395603|Simvastatin|simvastatin|mesh-list
2327235|NCT00395603|Ezetimibe|ezetimibe|mesh-list
2327236|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2327237|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2327238|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
2327239|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327240|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2327241|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2327242|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327243|NCT00395655|Hydralazine|hydralazine|mesh-list
2327244|NCT00395655|Valproic Acid|valproic acid|mesh-list
2327245|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
2327246|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327247|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327248|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
2327249|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2902545|NCT02073097|Rituximab|rituximab|mesh-list
2902546|NCT02073097|Doxorubicin|doxorubicin|mesh-list
2902547|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2902548|NCT02073097|Vincristine|vincristine|mesh-list
2902549|NCT02073097|Sargramostim|sargramostim|mesh-list
2902550|NCT02073097|Lenograstim|lenograstim|mesh-list
2902551|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2902552|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
2902553|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902554|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2902555|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2902556|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
2902557|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902558|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902559|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2327250|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327251|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
2902560|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2902561|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2902562|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2902563|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2902564|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902565|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2902566|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
2902567|NCT02073097|Hormones|hormones|mesh-ancestor
2902568|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2902569|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2902570|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2327252|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2327253|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2327254|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2327255|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2327256|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
2327257|NCT00395681|Propofol|propofol|mesh-list
2327258|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2327259|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2327260|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327261|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2327262|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
2327263|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
2327264|NCT00395707|Ranibizumab|ranibizumab|mesh-list
2327265|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2327266|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2327267|NCT00395707|Growth Substances|growth substances|mesh-ancestor
2327268|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327269|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
2327270|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327271|NCT00395720|Vaccines|vaccines|mesh-list
2327272|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
2327273|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327274|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
2327275|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2327276|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2327277|NCT00395772|Vitamin K|vitamin k|mesh-list
2327278|NCT00395772|Heparin|heparin|mesh-list
2327279|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
2327280|NCT00395772|Vitamins|vitamins|mesh-ancestor
2327281|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
2327282|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327283|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
2327284|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2327285|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2327286|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327287|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2327288|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
2327289|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2327290|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
2327291|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902571|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
2902572|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
2902573|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
2902574|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2902575|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
2902576|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2902577|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
2902578|NCT02017964|Carboplatin|carboplatin|mesh-list
2902579|NCT02017964|Methotrexate|methotrexate|mesh-list
2902580|NCT02017964|Etoposide|etoposide|mesh-list
2902581|NCT02017964|Vincristine|vincristine|mesh-list
2902582|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
2327292|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2327293|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
2327294|NCT00395772|Coagulants|coagulants|mesh-ancestor
2327295|NCT00395902|Cinacalcet|cinacalcet|mesh-list
2327296|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2327297|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327298|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2327299|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
2902583|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
2902584|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2902585|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
2902586|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327300|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2327301|NCT00395915|Aripiprazole|aripiprazole|mesh-list
2902587|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2902588|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2902589|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
2902590|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902591|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902592|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2327302|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
2327303|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2327304|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2327305|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2327306|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2327307|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327308|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
2327309|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
2902593|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2902594|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
2902595|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2902596|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2902597|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
2902598|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
2902599|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902600|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2327310|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327311|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327312|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2327313|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2327314|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
2327315|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2327316|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2327317|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2902601|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2902602|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2902603|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2902604|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2902605|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
2902606|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
2902607|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
2902608|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
2902609|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2902610|NCT01956110|Hormones|hormones|mesh-ancestor
2902611|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2902612|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327318|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2327319|NCT00395941|Pioglitazone|pioglitazone|mesh-list
2327320|NCT00395941|Acitretin|acitretin|mesh-list
2327321|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2327322|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327323|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
2327324|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
2327325|NCT00396045|Lenalidomide|lenalidomide|mesh-list
2327326|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
2327327|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327328|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2327329|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2327330|NCT00396045|Growth Substances|growth substances|mesh-ancestor
2327331|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
2327332|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327333|NCT00396058|Methylphenidate|methylphenidate|mesh-list
2327334|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2327335|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327336|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2327337|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2327338|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2327339|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327340|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
2327341|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327342|NCT00396071|Vildagliptin|vildagliptin|mesh-list
2327343|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2327344|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327345|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2327346|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
2327347|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327348|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327349|NCT00396175|Finasteride|finasteride|mesh-list
2327350|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327351|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327352|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2327353|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2327354|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327355|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
2327356|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2327357|NCT00396175|Urological Agents|urological agents|mesh-ancestor
2902656|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2902657|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
2902658|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902659|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2902660|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
2902661|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2902662|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902663|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2902664|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2902665|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2109802|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2109803|NCT02526550|Vaccines|vaccines|mesh-list
2109804|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
2902666|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
2902667|NCT01335581|Tretinoin|tretinoin|mesh-list
2902668|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902669|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
2902670|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
2109805|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109806|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
2109807|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2109808|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2109809|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2109810|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
2109811|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
2902671|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
2902672|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
2902673|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902674|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2902675|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2902676|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
2902677|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2902678|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902679|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2902680|NCT00887146|Vincristine|vincristine|mesh-list
2902681|NCT00887146|Temozolomide|temozolomide|mesh-list
2902682|NCT00887146|Procarbazine|procarbazine|mesh-list
2327358|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2327359|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
2327360|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2327361|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2327362|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2327363|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2327364|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327365|NCT00396227|Pioglitazone|pioglitazone|mesh-list
2327366|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
2327367|NCT00396227|Vildagliptin|vildagliptin|mesh-list
2327368|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2902683|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2902684|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902685|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
2902686|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
2902687|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
2902688|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902689|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2902690|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
2902691|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
2902692|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
2902693|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2902694|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2327369|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2327370|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327371|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2327372|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
2327373|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327374|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327375|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2327376|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2327377|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2327378|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
2327379|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902695|NCT00882895|Prednisolone|prednisolone|mesh-list
2902696|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
2902697|NCT00882895|Tacrolimus|tacrolimus|mesh-list
2902698|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
2902699|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2327380|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2327381|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2327382|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327383|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
2327384|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2327385|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2902700|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2902701|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
2902702|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327386|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2327387|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2327388|NCT00396357|Metformin|metformin|mesh-list
2327389|NCT00396357|Vildagliptin|vildagliptin|mesh-list
2327390|NCT00396357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2327391|NCT00396357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902703|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
2902704|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327392|NCT00396357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2327393|NCT00396357|Protease Inhibitors|protease inhibitors|mesh-ancestor
2327394|NCT00396357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327395|NCT00396357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902705|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2902706|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902707|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902708|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2902709|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902710|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2902711|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
2327396|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
2327397|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2327398|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
2327399|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327400|NCT00396396|Expectorants|expectorants|mesh-ancestor
2327401|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
2327402|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2327403|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
2327404|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902712|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2902713|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2902714|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2902715|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
2902716|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
2902717|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902718|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2902719|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
2902720|NCT00882895|Hormones|hormones|mesh-ancestor
2902721|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2902722|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2902723|NCT00882895|Protective Agents|protective agents|mesh-ancestor
2902724|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2902725|NCT00877903|Remestemcel-l|remestemcel-l|mesh-list
2902726|NCT00877903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2902727|NCT00877903|Antiviral Agents|antiviral agents|mesh-ancestor
2902728|NCT00877903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2902729|NCT00867178|Vitamin A|vitamin a|mesh-list
2902730|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
2902731|NCT00867178|Thiotepa|thiotepa|mesh-list
2902732|NCT00867178|Cisplatin|cisplatin|mesh-list
2902733|NCT00867178|Carboplatin|carboplatin|mesh-list
2902734|NCT00867178|Etoposide|etoposide|mesh-list
2902735|NCT00867178|Vincristine|vincristine|mesh-list
2902736|NCT00867178|Vorinostat|vorinostat|mesh-list
2902737|NCT00867178|Tretinoin|tretinoin|mesh-list
2902738|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
2902739|NCT00867178|Isotretinoin|isotretinoin|mesh-list
2902740|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2902741|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
2902742|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902743|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2902744|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2902745|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
2902746|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902747|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902748|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2902749|NCT00867178|Vitamins|vitamins|mesh-ancestor
2902750|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
2902751|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2902752|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2902753|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2902754|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902755|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
2327405|NCT00396396|Protective Agents|protective agents|mesh-ancestor
2327406|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327407|NCT00396396|Antidotes|antidotes|mesh-ancestor
2327408|NCT00396487|Fluorouracil|fluorouracil|mesh-list
2327409|NCT00396487|Capecitabine|capecitabine|mesh-list
2902756|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
2902757|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
2902758|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2902759|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
2902760|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
2902761|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2902762|NCT00787176|Oxytocin|oxytocin|mesh-list
2902763|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
2902764|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2902765|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902766|NCT00482092|Remestemcel-l|remestemcel-l|mesh-list
2902767|NCT00482092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2902768|NCT00482092|Antiviral Agents|antiviral agents|mesh-ancestor
2902769|NCT00482092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2902770|NCT00352534|Dactinomycin|dactinomycin|mesh-list
2327410|NCT00396487|Irinotecan|irinotecan|mesh-list
2327411|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
2902771|NCT00352534|Cactinomycin|cactinomycin|mesh-list
2902772|NCT00352534|Doxorubicin|doxorubicin|mesh-list
2902773|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2902774|NCT00352534|Vincristine|vincristine|mesh-list
2902775|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2902776|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902777|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2902778|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2902779|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902780|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902781|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2902782|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
2902783|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
2902784|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
2902785|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2327412|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327413|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2327414|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327415|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327416|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
2327417|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327418|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2327419|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2327420|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327421|NCT00396500|Vitamin A|vitamin a|mesh-list
2327422|NCT00396500|Albendazole|albendazole|mesh-list
2327423|NCT00396500|Vitamins|vitamins|mesh-ancestor
2327424|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
2327425|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327426|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327427|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327428|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
2327429|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2327430|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327431|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
2327432|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2327433|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2327434|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
2327435|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
2327436|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
2327437|NCT00396513|Metformin|metformin|mesh-list
2327438|NCT00396513|Simvastatin|simvastatin|mesh-list
2327439|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2327440|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902786|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2902787|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2902788|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2902789|NCT00033293|Prednisone|prednisone|mesh-list
2902790|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
2902791|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
2902792|NCT00033293|Antibodies|antibodies|mesh-list
2902793|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
2902794|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2902795|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2902796|NCT00033293|Hormones|hormones|mesh-list
2902797|NCT00033293|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2327441|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2327442|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2327443|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
2327444|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327445|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2327446|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2327447|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327448|NCT00396526|Amoxicillin|amoxicillin|mesh-list
2327449|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2327450|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2327451|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327452|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2327453|NCT00396526|Renal Agents|renal agents|mesh-ancestor
2327454|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
2327455|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2327456|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2327457|NCT00396578|Vancomycin|vancomycin|mesh-list
2327458|NCT00396578|Gentamicins|gentamicins|mesh-list
2327459|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2327460|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327461|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2327462|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902798|NCT00033293|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2902799|NCT00033293|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
2902800|NCT00033293|beta-Endorphin|beta-endorphin|mesh-list
2902801|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2902802|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
2902803|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902804|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2327463|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327464|NCT00396604|Maleic acid|maleic acid|mesh-list
2327465|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327466|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327467|NCT00396669|Bupropion|bupropion|mesh-list
2327468|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2327469|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
2327470|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2327471|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2327472|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2327473|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2327474|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327475|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
2327476|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327477|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327478|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2327479|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2327480|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327481|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
2327482|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327483|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
2327484|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327485|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2327486|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2327487|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
2327488|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327489|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327490|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2902805|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2902806|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
2902807|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902808|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902809|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2902810|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2902811|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
2327491|NCT00396721|Sirolimus|sirolimus|mesh-list
2327492|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2327493|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2327494|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2327495|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2902812|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2902813|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2902814|NCT00033293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327496|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2327497|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327498|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
2327499|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327500|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
2902815|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
2902816|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2902817|NCT05193370|Vasopressins|vasopressins|mesh-list
2902818|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
2902819|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
2902820|NCT05193370|Giapreza|giapreza|mesh-list
2902821|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
2902822|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
2902823|NCT05193370|Coagulants|coagulants|mesh-ancestor
2902824|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2902825|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2902826|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
2902827|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902828|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2902829|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
2902830|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902831|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902832|NCT05193318|Ketamine|ketamine|mesh-list
2902833|NCT05193318|Analgesics|analgesics|mesh-ancestor
2902834|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
2902835|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902836|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902837|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2902838|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2902839|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
2902840|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
2902841|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2902842|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2902843|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2902844|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2902845|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902846|NCT05193292|Trastuzumab|trastuzumab|mesh-list
2902847|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2902848|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902851|NCT05193227|Lidocaine|lidocaine|mesh-list
2902852|NCT05193227|Bupivacaine|bupivacaine|mesh-list
2902853|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
2902854|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
2902855|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2902856|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902857|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
2902858|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902859|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2902860|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2902861|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2902862|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2902863|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902864|NCT05193214|Antibodies|antibodies|mesh-list
2902865|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2902866|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
2902867|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902868|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2902869|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902870|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902871|NCT05193071|Aspirin|aspirin|mesh-list
2902872|NCT05193071|Clopidogrel|clopidogrel|mesh-list
2902873|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2902874|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2902875|NCT05193071|Analgesics|analgesics|mesh-ancestor
2902876|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
2902877|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902878|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902879|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2902880|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2902881|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2902882|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2902883|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902884|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2902885|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2902886|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902887|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
2902888|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2902889|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2327501|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327502|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2327503|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2327504|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
2327505|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327506|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327507|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2327508|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
2327509|NCT00396734|Topiramate|topiramate|mesh-list
2327510|NCT00396734|Modafinil|modafinil|mesh-list
2327511|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
2327512|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2327513|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327514|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2327515|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2327516|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2902890|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2902891|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
2902892|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2902893|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2902894|NCT05192902|Anesthetics|anesthetics|mesh-list
2902895|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2902896|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902897|NCT05192889|Leucovorin|leucovorin|mesh-list
2327517|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2327518|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327519|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
2327520|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2327521|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2327522|NCT00396747|Prednisolone|prednisolone|mesh-list
2327523|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
2327524|NCT00396747|Methotrexate|methotrexate|mesh-list
2327525|NCT00396747|Infliximab|infliximab|mesh-list
2327526|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2327527|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
2327528|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2327529|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
2327530|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2327531|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327532|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2327533|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
2327534|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327535|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327536|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
2327537|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327538|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2327539|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327540|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
2327541|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2327542|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2327543|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2902898|NCT05192889|Cytarabine|cytarabine|mesh-list
2902899|NCT05192889|Dexamethasone|dexamethasone|mesh-list
2902900|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
2902901|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
2902902|NCT05192889|Methotrexate|methotrexate|mesh-list
2902903|NCT05192889|Etoposide|etoposide|mesh-list
2902904|NCT05192889|Vincristine|vincristine|mesh-list
2902905|NCT05192889|Asparaginase|asparaginase|mesh-list
2902906|NCT05192889|Dasatinib|dasatinib|mesh-list
2902907|NCT05192889|Venetoclax|venetoclax|mesh-list
2902908|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
2902909|NCT05192889|Pegaspargase|pegaspargase|mesh-list
2902910|NCT05192889|Blinatumomab|blinatumomab|mesh-list
2902911|NCT05192889|Navitoclax|navitoclax|mesh-list
2902912|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2902913|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
2902914|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327544|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
2327545|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
2327546|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902915|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2902916|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2902917|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
2902918|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902919|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902920|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2902921|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2327547|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2327548|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
2327549|NCT00396747|Hormones|hormones|mesh-ancestor
2327550|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2327551|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2327552|NCT00396747|Protective Agents|protective agents|mesh-ancestor
2327553|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2327554|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
2327555|NCT00396760|Aprotinin|aprotinin|mesh-list
2327556|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2327557|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2327558|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327559|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
2327560|NCT00396760|Coagulants|coagulants|mesh-ancestor
2327561|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2327562|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2902922|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
2902923|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
2902924|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902925|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2902926|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
2902927|NCT05192889|Hormones|hormones|mesh-ancestor
2902928|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2902929|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2902930|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2902931|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
2902932|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2902933|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2902934|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
2902935|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
2902936|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902937|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2902938|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2902939|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2902940|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2902941|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2902942|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
2902943|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327563|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
2327564|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327565|NCT00396786|Enoxaparin|enoxaparin|mesh-list
2327566|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
2327567|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2327568|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
2327569|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2327570|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
2327571|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327572|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327573|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
2327574|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2327575|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2327576|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
2327577|NCT00396799|Estrogens|estrogens|mesh-list
2327578|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2327579|NCT00396799|Hormones|hormones|mesh-ancestor
2327580|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2327581|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327582|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2327583|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2327584|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
2327585|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2327586|NCT00396851|Metformin|metformin|mesh-list
2327587|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2327588|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327589|NCT00396929|Paclitaxel|paclitaxel|mesh-list
2327590|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2327591|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902944|NCT05192889|Antidotes|antidotes|mesh-ancestor
2902945|NCT05192889|Protective Agents|protective agents|mesh-ancestor
2902946|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
2902947|NCT05192889|Vitamins|vitamins|mesh-ancestor
2902948|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
2902949|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
2902950|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
2327592|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
2327593|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
2902951|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
2327594|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
2327595|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327596|NCT00396968|Plerixafor|plerixafor|mesh-list
2327597|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2327598|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2902952|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2902953|NCT05192850|Metformin|metformin|mesh-list
2902954|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2902955|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902956|NCT05192798|Paclitaxel|paclitaxel|mesh-list
2902957|NCT05192798|Bevacizumab|bevacizumab|mesh-list
2902958|NCT05192798|Apatinib|apatinib|mesh-list
2902959|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2902960|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2902961|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902962|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
2902963|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
2902964|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
2902965|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902966|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2902967|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2902968|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2902969|NCT05192798|Growth Substances|growth substances|mesh-ancestor
2902970|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902971|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
2902972|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2327599|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
2327600|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327601|NCT00397059|Citalopram|citalopram|mesh-list
2327602|NCT00397059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2327603|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2327604|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2327605|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327606|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327607|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
2327608|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327609|NCT00397059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2327610|NCT00397059|Antidepressive Agents|antidepressive agents|mesh-ancestor
2327611|NCT00397059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2327612|NCT00397072|Sagopilone|sagopilone|mesh-list
2327613|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327614|NCT00397098|Amibegron|amibegron|mesh-list
2327615|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2327616|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2327617|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
2327618|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327619|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327620|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327621|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2327622|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2327623|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2327624|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2327625|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327626|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327627|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327628|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
2327629|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2327630|NCT00397241|Timolol|timolol|mesh-list
2327631|NCT00397241|Dorzolamide|dorzolamide|mesh-list
2327632|NCT00397241|Latanoprost|latanoprost|mesh-list
2327633|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
2327634|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2327635|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2327636|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
2327637|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327638|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327639|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902973|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2902974|NCT05192681|Docetaxel|docetaxel|mesh-list
2902975|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2902976|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
2902977|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
2902978|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
2902979|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327640|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2327641|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2327642|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2327643|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2902980|NCT05192629|Midazolam|midazolam|mesh-list
2902981|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
2902982|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2902983|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2902984|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2902985|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2902986|NCT05192629|Analgesics|analgesics|mesh-ancestor
2902987|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
2902988|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2902989|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2902990|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2902991|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2902992|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
2902993|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2902994|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2902995|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2902996|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2902997|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2902998|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2902999|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2903000|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
2903001|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
2903002|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
2903003|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
2327644|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2327645|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327646|NCT00397293|Topotecan|topotecan|mesh-list
2327647|NCT00397293|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2327648|NCT00397293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2327649|NCT00397293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903007|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
2903008|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2903009|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903010|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2903011|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2903012|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903013|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903014|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903015|NCT05192304|Maleic acid|maleic acid|mesh-list
2903016|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903017|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903018|NCT05192265|Artesunate|artesunate|mesh-list
2903019|NCT05192265|Lumefantrine|lumefantrine|mesh-list
2903020|NCT05192265|Artemether|artemether|mesh-list
2903021|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2327650|NCT00397293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327651|NCT00397293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327652|NCT00397319|Hormones|hormones|mesh-list
2327653|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2327654|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327655|NCT00397332|Alefacept|alefacept|mesh-list
2327656|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
2903022|NCT05192265|Pyronaridine|pyronaridine|mesh-list
2903023|NCT05192265|Antimalarials|antimalarials|mesh-list
2903024|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2903025|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2903026|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903027|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903028|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
2903029|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
2903030|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2903031|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
2903032|NCT05192213|Ascorbic Acid|ascorbic acid|mesh-list
2903033|NCT05192213|Thiamine|thiamine|mesh-list
2903034|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
2903035|NCT05192213|Vitamins|vitamins|mesh-ancestor
2903036|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
2327657|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
2327658|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327659|NCT00397358|Icodextrin|icodextrin|mesh-list
2327660|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
2903037|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903038|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2903039|NCT05192213|Antioxidants|antioxidants|mesh-ancestor
2903040|NCT05192213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903041|NCT05192213|Protective Agents|protective agents|mesh-ancestor
2903042|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
2903043|NCT05192200|Interferons|interferons|mesh-list
2903044|NCT05192200|Interferon-beta|interferon-beta|mesh-list
2903045|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903046|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
2903047|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903048|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
2903049|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903050|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2903051|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2903052|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903053|NCT05191914|Fulvestrant|fulvestrant|mesh-list
2903054|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2903055|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903056|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2903057|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2903058|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
2903059|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2903060|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903061|NCT05191888|Amoxicillin|amoxicillin|mesh-list
2903062|NCT05191888|Metronidazole|metronidazole|mesh-list
2903063|NCT05191888|Clarithromycin|clarithromycin|mesh-list
2903064|NCT05191888|Rabeprazole|rabeprazole|mesh-list
2903065|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2903066|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903067|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2903068|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2903069|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2903070|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903071|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903072|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2903073|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2327661|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2327662|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2327663|NCT00397384|Cetuximab|cetuximab|mesh-list
2327664|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2327665|NCT00397384|Antibodies|antibodies|mesh-list
2327666|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
2327667|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2327668|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
2903074|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2903075|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2903076|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2903077|NCT05191875|Doxycycline|doxycycline|mesh-list
2903078|NCT05191875|Furazolidone|furazolidone|mesh-list
2903079|NCT05191875|Bismuth|bismuth|mesh-list
2903080|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2903081|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903082|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
2903083|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2903084|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2903085|NCT05191875|Antacids|antacids|mesh-ancestor
2903086|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903087|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2903088|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2903089|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2903090|NCT05191875|Renal Agents|renal agents|mesh-ancestor
2903091|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2903092|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2903093|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903094|NCT05191862|Cilostazol|cilostazol|mesh-list
2903095|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2903096|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
2903097|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2903098|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903099|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2903100|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
2903101|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2903102|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2903103|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903104|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2903105|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
2903106|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2903107|NCT05191862|Protective Agents|protective agents|mesh-ancestor
2903108|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2903109|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2903110|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903111|NCT05191797|Atezolizumab|atezolizumab|mesh-list
2903112|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
2903113|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2903114|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
2903115|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903116|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
2903117|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903118|NCT05189483|Paclitaxel|paclitaxel|mesh-list
2903119|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2903120|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2903121|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903122|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
2903123|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
2903124|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
2903125|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903133|NCT05174858|Hemostatics|hemostatics|mesh-list
2903134|NCT05174858|Coagulants|coagulants|mesh-ancestor
2903135|NCT05173857|Paclitaxel|paclitaxel|mesh-list
2903136|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2903137|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903138|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
2903139|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
2903140|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
2903141|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903142|NCT05173324|Vaccines|vaccines|mesh-list
2903143|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
2903144|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903153|NCT05169008|Vaccines|vaccines|mesh-list
2903154|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
2903155|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903156|NCT05168527|Gemcitabine|gemcitabine|mesh-list
2903157|NCT05168527|Paclitaxel|paclitaxel|mesh-list
2903158|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2903159|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903160|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
2903161|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
2903162|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
2903163|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903164|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2903165|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
2903166|NCT05168527|Antiviral Agents|antiviral agents|mesh-ancestor
2903167|NCT05168527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903168|NCT05168527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903169|NCT05168527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2903170|NCT05168527|Immunologic Factors|immunologic factors|mesh-ancestor
2903171|NCT05168527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903172|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
2903173|NCT05166811|Analgesics|analgesics|mesh-ancestor
2903174|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
2903175|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2903176|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903177|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
2903178|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2903179|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2903180|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
2903181|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2903182|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2903183|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903184|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2903185|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
2903186|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2903187|NCT05159245|Trastuzumab|trastuzumab|mesh-list
2903188|NCT05159245|Pertuzumab|pertuzumab|mesh-list
2109812|NCT02527265|Insulin|insulin|mesh-list
2109813|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2109814|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109815|NCT02527421|Betamethasone|betamethasone|mesh-list
2109816|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109817|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
2109818|NCT02527421|Hormones|hormones|mesh-ancestor
2109819|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2903189|NCT05159245|Atezolizumab|atezolizumab|mesh-list
2903190|NCT05159245|Vemurafenib|vemurafenib|mesh-list
2903191|NCT05159245|Entrectinib|entrectinib|mesh-list
2903192|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2903193|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903194|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2903195|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903196|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903205|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2903206|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2903207|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903208|NCT05149365|Incretins|incretins|mesh-ancestor
2903209|NCT05149365|Hormones|hormones|mesh-ancestor
2903210|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2903211|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2903212|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
2903213|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903214|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903221|NCT05141708|Talazoparib|talazoparib|mesh-list
2903222|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2903223|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903224|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903225|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903226|NCT05137717|Maribavir|maribavir|mesh-list
2903227|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
2903228|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903229|NCT05133297|Tofacitinib|tofacitinib|mesh-list
2903230|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2903231|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903232|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903233|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
2327669|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327670|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327671|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2327672|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327673|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327674|NCT00397423|Sargramostim|sargramostim|mesh-list
2327675|NCT00397423|Lenograstim|lenograstim|mesh-list
2327676|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
2327677|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327678|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2327679|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
2327680|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2327681|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903234|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
2903235|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2903236|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903237|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903238|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
2903239|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2903240|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2903241|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903242|NCT05123820|Midazolam|midazolam|mesh-list
2903243|NCT05123820|Omeprazole|omeprazole|mesh-list
2903244|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2903245|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2903246|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2903247|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903248|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2903249|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2903250|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2327682|NCT00397475|Vitamins|vitamins|mesh-ancestor
2327683|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
2327684|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2327685|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
2327686|NCT00397501|Carboplatin|carboplatin|mesh-list
2327687|NCT00397501|Methotrexate|methotrexate|mesh-list
2903251|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2903252|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
2903253|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
2903254|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
2903255|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
2903256|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2903257|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903258|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2903259|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2903260|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2903261|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903262|NCT05121246|Palivizumab|palivizumab|mesh-list
2903263|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
2903264|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903265|NCT05113745|Reboxetine|reboxetine|mesh-list
2903266|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
2903267|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2903268|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2903269|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2903270|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2903271|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903272|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
2903273|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2903274|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903275|NCT05112965|Atezolizumab|atezolizumab|mesh-list
2903276|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903299|NCT05103631|Cyclophosphamide|cyclophosphamide|mesh-list
2903300|NCT05103631|Fludarabine|fludarabine|mesh-list
2903301|NCT05103631|Fludarabine phosphate|fludarabine phosphate|mesh-list
2327688|NCT00397501|Trastuzumab|trastuzumab|mesh-list
2327689|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903302|NCT05103631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2903303|NCT05103631|Immunologic Factors|immunologic factors|mesh-ancestor
2903304|NCT05103631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903305|NCT05103631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2903306|NCT05103631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2903307|NCT05103631|Alkylating Agents|alkylating agents|mesh-ancestor
2903308|NCT05103631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903309|NCT05103631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903310|NCT05103631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2903311|NCT05103631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2903312|NCT05103631|Antimetabolites|antimetabolites|mesh-ancestor
2903313|NCT05103332|Amlodipine|amlodipine|mesh-list
2903314|NCT05103332|Olmesartan|olmesartan|mesh-list
2903315|NCT05103332|Indapamide|indapamide|mesh-list
2903316|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2903317|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2903318|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2903319|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903320|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2903321|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903322|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
2903323|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2903324|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2903325|NCT05103332|Diuretics|diuretics|mesh-ancestor
2903326|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
2903327|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2903328|NCT05102149|Vildagliptin|vildagliptin|mesh-list
2903329|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2903330|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327690|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2327691|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
2327692|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2327693|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903331|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2903332|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
2903333|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903334|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903335|NCT05089734|Docetaxel|docetaxel|mesh-list
2903336|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903337|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
2903338|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
2903339|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
2903340|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903341|NCT05085574|Celecoxib|celecoxib|mesh-list
2903342|NCT05085574|Famotidine|famotidine|mesh-list
2903343|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2903344|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2327694|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2327695|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
2327696|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327697|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
2327698|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327699|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2327700|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327701|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
2327702|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2327703|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2327704|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2327705|NCT00397501|Antidotes|antidotes|mesh-ancestor
2327706|NCT00397501|Protective Agents|protective agents|mesh-ancestor
2903345|NCT05085574|Analgesics|analgesics|mesh-ancestor
2903346|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
2903347|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2903348|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903349|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2327707|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
2327708|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
2327709|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2327710|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327711|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
2327712|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
2327713|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
2903350|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2903351|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2903352|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2903353|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903354|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903355|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2903356|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2903357|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2903358|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
2903359|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
2327714|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2327715|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327716|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
2327717|NCT00397566|BMS-707035|bms-707035|mesh-list
2327718|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
2327719|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327720|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327721|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2327722|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2327723|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
2327724|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327725|NCT00397592|Hormones|hormones|mesh-list
2903360|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2903361|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
2903362|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
2903363|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2903364|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
2903365|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2903366|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2903367|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903368|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2903369|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903370|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903371|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2903372|NCT05085340|Renal Agents|renal agents|mesh-ancestor
2903373|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
2903374|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2903375|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903376|NCT05078671|Cobicistat|cobicistat|mesh-list
2903377|NCT05078671|Olaparib|olaparib|mesh-list
2903378|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2903379|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903380|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903381|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903382|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2903383|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2903384|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
2903385|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903386|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2903387|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2903388|NCT05077800|Losartan|losartan|mesh-list
2903389|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2903390|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2903391|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2903392|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2903393|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903394|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
2903395|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903396|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327726|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2327727|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327728|NCT00397657|Niacin|niacin|mesh-list
2327729|NCT00397657|Ezetimibe|ezetimibe|mesh-list
2327730|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2327731|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2327732|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
2327733|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327734|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2327735|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
2327736|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
2327737|NCT00397657|Vitamins|vitamins|mesh-ancestor
2903397|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2903398|NCT05070585|Protective Agents|protective agents|mesh-ancestor
2903399|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903400|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903401|NCT05070364|Interferons|interferons|mesh-list
2903402|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903403|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
2327738|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
2903404|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903411|NCT05059223|Reboxetine|reboxetine|mesh-list
2903412|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
2903413|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2903414|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2903415|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2903416|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2903417|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903418|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
2903419|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2903420|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327739|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327740|NCT00397709|Rifampin|rifampin|mesh-list
2327741|NCT00397709|Isoniazid|isoniazid|mesh-list
2327742|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2327743|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
2327744|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2327745|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327746|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
2327747|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2903421|NCT05057819|Empagliflozin|empagliflozin|mesh-list
2903422|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2903423|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903424|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2903425|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327748|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327749|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327750|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2327751|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2327752|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2327753|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2327754|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2327755|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2327756|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2327757|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2327758|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
2327759|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2327760|NCT00397722|Paroxetine|paroxetine|mesh-list
2327761|NCT00397722|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2327762|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2327763|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2327764|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327765|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2327766|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
2327767|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327768|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2327769|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
2327770|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2327771|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2327772|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2327773|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327774|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
2327775|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2327776|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
2327777|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327778|NCT00397735|Expectorants|expectorants|mesh-ancestor
2327779|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
2327780|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2327781|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
2327782|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327783|NCT00397735|Protective Agents|protective agents|mesh-ancestor
2327784|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327785|NCT00397735|Antidotes|antidotes|mesh-ancestor
2327786|NCT00397761|Paclitaxel|paclitaxel|mesh-list
2327787|NCT00397761|Capecitabine|capecitabine|mesh-list
2327788|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2327789|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2327790|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327791|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
2327792|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
2327793|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
2327794|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327795|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2327796|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
2327797|NCT00397787|Sunitinib|sunitinib|mesh-list
2327798|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327799|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2327800|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2327801|NCT00397787|Growth Substances|growth substances|mesh-ancestor
2327802|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327803|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
2327804|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2327805|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903468|NCT05027308|Teduglutide|teduglutide|mesh-list
2903469|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2903470|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2903471|NCT05027308|Protective Agents|protective agents|mesh-ancestor
2903472|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903473|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2903474|NCT05026736|Antibodies|antibodies|mesh-list
2903475|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
2903476|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2903477|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
2903478|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903479|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327806|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327807|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
2327808|NCT00397800|Rituximab|rituximab|mesh-list
2327809|NCT00397800|Fludarabine|fludarabine|mesh-list
2327810|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
2903505|NCT05011812|Ritonavir|ritonavir|mesh-list
2903506|NCT05011812|Midazolam|midazolam|mesh-list
2109820|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109821|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2109822|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
2109823|NCT02527434|Durvalumab|durvalumab|mesh-list
2109824|NCT02527434|Tremelimumab|tremelimumab|mesh-list
2109825|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2109826|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2109827|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109828|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
2109829|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109830|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
2109831|NCT02527512|Povidone|povidone|mesh-list
2109832|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
2109833|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
2109834|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2109835|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2109836|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
2109837|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2109838|NCT02527681|Cephalosporins|cephalosporins|mesh-list
2109839|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2109840|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2109841|NCT02528188|Tanezumab|tanezumab|mesh-list
2327811|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327812|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
2327813|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327814|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2327815|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2327816|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
2327817|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327818|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327819|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2327820|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2327821|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2903507|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2903508|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2903509|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2903510|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903511|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2903512|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2903513|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2903514|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2903515|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
2903516|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
2903517|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
2903518|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
2903519|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2903520|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903521|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2903522|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2903523|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
2903524|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903525|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2903526|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2903527|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
2903528|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903529|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2903530|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2903534|NCT05007873|Decitabine|decitabine|mesh-list
2903535|NCT05007873|Dasatinib|dasatinib|mesh-list
2903536|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2903537|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
2903538|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903539|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903540|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903541|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2903542|NCT05006573|Benralizumab|benralizumab|mesh-list
2903543|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2903544|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
2903545|NCT04980222|Prednisone|prednisone|mesh-list
2903546|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
2903547|NCT04980222|Rituximab|rituximab|mesh-list
2903548|NCT04980222|Doxorubicin|doxorubicin|mesh-list
2903549|NCT04980222|Vincristine|vincristine|mesh-list
2903550|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2903551|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
2903552|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903553|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2903554|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2903555|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
2903556|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327822|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
2327823|NCT00397826|Simvastatin|simvastatin|mesh-list
2327824|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2327825|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2327826|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
2327827|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327828|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2327829|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2327830|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327831|NCT00397917|Folic Acid|folic acid|mesh-list
2903557|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903558|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2903559|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2903560|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2903561|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2903562|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2903563|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903564|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2903565|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
2903566|NCT04980222|Hormones|hormones|mesh-ancestor
2327832|NCT00397917|Hematinics|hematinics|mesh-ancestor
2327833|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
2327834|NCT00397917|Vitamins|vitamins|mesh-ancestor
2327835|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
2327836|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327837|NCT00397956|Ertapenem|ertapenem|mesh-list
2327838|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2327839|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327840|NCT00398008|Naltrexone|naltrexone|mesh-list
2327841|NCT00398008|Buprenorphine|buprenorphine|mesh-list
2327842|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2327843|NCT00398008|Narcotics|narcotics|mesh-ancestor
2903567|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2903568|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2903569|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2903570|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
2903571|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
2903572|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
2903573|NCT04969224|Ivacaftor|ivacaftor|mesh-list
2903574|NCT04969224|Elexacaftor|elexacaftor|mesh-list
2903575|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2903576|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2903577|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903578|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2327844|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2903579|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
2903580|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2903581|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2903582|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2903583|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2903584|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903627|NCT04933149|Ketamine|ketamine|mesh-list
2903628|NCT04933149|Analgesics|analgesics|mesh-ancestor
2903629|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
2903630|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2903631|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903632|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2903633|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2903634|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
2903635|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
2903636|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2903637|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2903638|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2903639|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2903640|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903641|NCT04927312|Metronidazole|metronidazole|mesh-list
2903642|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903643|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2903644|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2903645|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2327845|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327846|NCT00398008|Analgesics|analgesics|mesh-ancestor
2327847|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
2327848|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2327849|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2327850|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2327851|NCT00398034|Testosterone|testosterone|mesh-list
2327852|NCT00398034|Androgens|androgens|mesh-ancestor
2327853|NCT00398034|Hormones|hormones|mesh-ancestor
2327854|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2327855|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327856|NCT00398099|Ertapenem|ertapenem|mesh-list
2327857|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2327858|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327859|NCT00398151|Montelukast|montelukast|mesh-list
2327860|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2327861|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
2327862|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2903690|NCT04906278|Oxytocin|oxytocin|mesh-list
2903691|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
2903692|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2903693|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327863|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
2327864|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2327865|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327866|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2327867|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2327868|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903704|NCT04893161|Belimumab|belimumab|mesh-list
2903705|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327869|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2327870|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2327871|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327872|NCT00398281|Dutasteride|dutasteride|mesh-list
2327873|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2327874|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2327875|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327876|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327877|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
2903706|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
2903707|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327878|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2327879|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327880|NCT00398294|Simvastatin|simvastatin|mesh-list
2327881|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2327882|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2327883|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
2327884|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327885|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2327886|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2327887|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327888|NCT00398307|Cisplatin|cisplatin|mesh-list
2327889|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327890|NCT00398372|Rituximab|rituximab|mesh-list
2327891|NCT00398372|Epratuzumab|epratuzumab|mesh-list
2327892|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2327893|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327894|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
2327895|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327896|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2327897|NCT00398385|Gemcitabine|gemcitabine|mesh-list
2327898|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327899|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2327900|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
2327901|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327902|NCT00398385|Antiviral Agents|antiviral agents|mesh-ancestor
2327903|NCT00398385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327904|NCT00398385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327905|NCT00398385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327906|NCT00398385|Immunologic Factors|immunologic factors|mesh-ancestor
2327907|NCT00398385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327908|NCT00398424|Cisplatin|cisplatin|mesh-list
2327909|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327910|NCT00398437|Trastuzumab|trastuzumab|mesh-list
2327911|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2327912|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327913|NCT00398450|Interferons|interferons|mesh-list
2327914|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
2327915|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
2327916|NCT00398450|Azacitidine|azacitidine|mesh-list
2327917|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327918|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
2327919|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327920|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2327921|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
2903740|NCT04887285|Anesthetics|anesthetics|mesh-list
2903741|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
2903742|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2903743|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903744|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
2903745|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2327922|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327923|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327924|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
2903754|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
2903755|NCT04880434|Fludarabine|fludarabine|mesh-list
2903756|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2903757|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
2903758|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903759|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2903760|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2903761|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
2903762|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903763|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903764|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2327925|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327926|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
2327927|NCT00398463|Tirofiban|tirofiban|mesh-list
2327928|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2327929|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2327930|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327931|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2327932|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2327933|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
2327934|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327935|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2327936|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327937|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
2327938|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327939|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
2327940|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2327941|NCT00398463|Protective Agents|protective agents|mesh-ancestor
2903770|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
2903771|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2903772|NCT04871165|Antibodies|antibodies|mesh-list
2903773|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
2903774|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903775|NCT04867928|Azacitidine|azacitidine|mesh-list
2903776|NCT04867928|Venetoclax|venetoclax|mesh-list
2903777|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2903778|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
2903779|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903780|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903781|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903782|NCT04857385|Hemostatics|hemostatics|mesh-list
2903783|NCT04857385|Coagulants|coagulants|mesh-ancestor
2903784|NCT04857138|Atezolizumab|atezolizumab|mesh-list
2903785|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903791|NCT04797780|Azacitidine|azacitidine|mesh-list
2903792|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2903793|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
2903794|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903795|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903796|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327942|NCT00398489|Tamoxifen|tamoxifen|mesh-list
2327943|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
2327944|NCT00398489|Docetaxel|docetaxel|mesh-list
2327945|NCT00398489|Trastuzumab|trastuzumab|mesh-list
2327946|NCT00398489|Epirubicin|epirubicin|mesh-list
2327947|NCT00398489|Anastrozole|anastrozole|mesh-list
2327948|NCT00398489|Goserelin|goserelin|mesh-list
2327949|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327950|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
2327951|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327952|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2327953|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2327954|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
2327955|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903800|NCT04781855|Nivolumab|nivolumab|mesh-list
2903801|NCT04781855|Ipilimumab|ipilimumab|mesh-list
2903802|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2903803|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903804|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2903805|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2327956|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327957|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2327958|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
2327959|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
2327960|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
2327961|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2327962|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2327963|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2903818|NCT04768296|Topotecan|topotecan|mesh-list
2903819|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2903820|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2903821|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903822|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903823|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903824|NCT04768101|Corticosterone|corticosterone|mesh-list
2903825|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2903826|NCT04745351|Remdesivir|remdesivir|mesh-list
2903827|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
2903828|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903829|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
2903830|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327964|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2327965|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2327966|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2327967|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
2327968|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2327969|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2327970|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2327971|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2327972|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2327973|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2327974|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2327975|NCT00398515|Sirolimus|sirolimus|mesh-list
2327976|NCT00398515|Lenalidomide|lenalidomide|mesh-list
2327977|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
2327978|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327979|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2327980|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2327981|NCT00398515|Growth Substances|growth substances|mesh-ancestor
2327982|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
2327983|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2327984|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2327985|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2327986|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2327987|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
2327988|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327989|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
2327990|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
2327991|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2327992|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
2327993|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2327994|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2327995|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2327996|NCT00398541|Losartan|losartan|mesh-list
2327997|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2327998|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2327999|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2328000|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2328001|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2328002|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328003|NCT00398541|Diuretics|diuretics|mesh-ancestor
2328004|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
2328005|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328006|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2328007|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2328008|NCT00398554|Prednisone|prednisone|mesh-list
2328009|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
2328010|NCT00398554|Doxorubicin|doxorubicin|mesh-list
2328011|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2328012|NCT00398554|Etoposide|etoposide|mesh-list
2328013|NCT00398554|Vincristine|vincristine|mesh-list
2328014|NCT00398554|Vinblastine|vinblastine|mesh-list
2328015|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2328016|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
2328017|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328018|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2328019|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2328020|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
2328021|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328022|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328023|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2328024|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2328025|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2328026|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2328027|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328028|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2328029|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
2328030|NCT00398554|Hormones|hormones|mesh-ancestor
2328031|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2328032|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2328033|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2328034|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
2328035|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
2328036|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
2328037|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
2328038|NCT00398580|Testosterone|testosterone|mesh-list
2328039|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
2328040|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
2328041|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2328042|NCT00398580|Dutasteride|dutasteride|mesh-list
2328043|NCT00398580|Androgens|androgens|mesh-ancestor
2328044|NCT00398580|Hormones|hormones|mesh-ancestor
2903859|NCT04735185|Anesthetics|anesthetics|mesh-list
2903860|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
2903861|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2903862|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903863|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
2903864|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328045|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2328046|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903865|NCT04715646|Brivaracetam|brivaracetam|mesh-list
2903866|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
2903873|NCT04666389|Atorvastatin|atorvastatin|mesh-list
2903874|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2903875|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2903876|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
2903877|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903878|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2903879|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2903880|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903881|NCT04642365|Atezolizumab|atezolizumab|mesh-list
2903882|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903883|NCT04640545|Axitinib|axitinib|mesh-list
2903884|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903885|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2903886|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903887|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903900|NCT04635631|Talazoparib|talazoparib|mesh-list
2903901|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2903902|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903903|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903904|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903905|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2903906|NCT04614168|Glycerol|glycerol|mesh-list
2903907|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903908|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2903909|NCT04614168|Protective Agents|protective agents|mesh-ancestor
2903910|NCT04607421|Leucovorin|leucovorin|mesh-list
2903911|NCT04607421|Bevacizumab|bevacizumab|mesh-list
2903912|NCT04607421|Cetuximab|cetuximab|mesh-list
2903913|NCT04607421|Fluorouracil|fluorouracil|mesh-list
2903914|NCT04607421|Capecitabine|capecitabine|mesh-list
2328047|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2328048|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328049|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
2328050|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2328051|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2328052|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328053|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328054|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
2328055|NCT00398606|Alendronate|alendronate|mesh-list
2328056|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
2328057|NCT00398606|Calcium|calcium|mesh-list
2328058|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2328059|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328060|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328061|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2328062|NCT00398606|Antacids|antacids|mesh-ancestor
2328063|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2328064|NCT00398658|Clindamycin|clindamycin|mesh-list
2328065|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
2328066|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
2328067|NCT00398658|Gentamicins|gentamicins|mesh-list
2328068|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2328069|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903915|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
2903916|NCT04607421|Irinotecan|irinotecan|mesh-list
2903917|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2903918|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903919|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2903920|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2903921|NCT04607421|Growth Substances|growth substances|mesh-ancestor
2903922|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903923|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
2903924|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
2903925|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328070|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2328071|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328072|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328073|NCT00398684|Nevirapine|nevirapine|mesh-list
2328074|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2328075|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2328076|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328077|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328078|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
2328079|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328080|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2328081|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2328082|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2328083|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2903926|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2903927|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2903928|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
2903929|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2903930|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2903931|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903932|NCT04607421|Antidotes|antidotes|mesh-ancestor
2903933|NCT04607421|Protective Agents|protective agents|mesh-ancestor
2903934|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
2903935|NCT04607421|Vitamins|vitamins|mesh-ancestor
2328084|NCT00398697|Gemcitabine|gemcitabine|mesh-list
2328085|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2328086|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
2903936|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
2903937|NCT04606381|Lazertinib|lazertinib|mesh-list
2903938|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2903939|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903940|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328087|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328088|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328089|NCT00398697|Antiviral Agents|antiviral agents|mesh-ancestor
2328090|NCT00398697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328091|NCT00398697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328092|NCT00398697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2328093|NCT00398697|Immunologic Factors|immunologic factors|mesh-ancestor
2328094|NCT00398697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328095|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
2328096|NCT00398749|Hematinics|hematinics|mesh-ancestor
2328097|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2328098|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328099|NCT00398788|Hydromorphone|hydromorphone|mesh-list
2328100|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2328101|NCT00398788|Narcotics|narcotics|mesh-ancestor
2903952|NCT04559139|Gemcitabine|gemcitabine|mesh-list
2903953|NCT04559139|Cisplatin|cisplatin|mesh-list
2903954|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903955|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2903956|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
2903957|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903958|NCT04559139|Antiviral Agents|antiviral agents|mesh-ancestor
2903959|NCT04559139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328102|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2328103|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328104|NCT00398788|Analgesics|analgesics|mesh-ancestor
2328105|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
2903960|NCT04559139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903961|NCT04559139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2903962|NCT04559139|Immunologic Factors|immunologic factors|mesh-ancestor
2903963|NCT04559139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903964|NCT04553419|Cephalexin|cephalexin|mesh-list
2903965|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2903966|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2903967|NCT04551131|Dexamethasone|dexamethasone|mesh-list
2903968|NCT04551131|Etoposide|etoposide|mesh-list
2903969|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
2903970|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2328106|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328107|NCT00398814|Sorafenib|sorafenib|mesh-list
2328108|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328109|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2328110|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328111|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328112|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
2328113|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2328114|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2328115|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328116|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2328117|NCT00398827|Analgesics|analgesics|mesh-ancestor
2328118|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
2328119|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328120|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2328121|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2328122|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2328123|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
2328124|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328125|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328126|NCT00398853|Chromium|chromium|mesh-list
2328127|NCT00398853|Picolinic acid|picolinic acid|mesh-list
2328128|NCT00398853|Trace Elements|trace elements|mesh-ancestor
2328129|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
2903971|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
2903972|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
2109842|NCT02528188|Analgesics|analgesics|mesh-ancestor
2109843|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
2109844|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2903973|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2903974|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2903975|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2903976|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
2903977|NCT04551131|Hormones|hormones|mesh-ancestor
2903978|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2903979|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2903980|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2903981|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2903982|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2903983|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2903984|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903985|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903995|NCT04532645|Olaparib|olaparib|mesh-list
2903996|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2903997|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2903998|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2903999|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904000|NCT04528108|Hemostatics|hemostatics|mesh-list
2904001|NCT04528108|Coagulants|coagulants|mesh-ancestor
2904002|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
2904003|NCT04527549|Trametinib|trametinib|mesh-list
2904004|NCT04527549|Dabrafenib|dabrafenib|mesh-list
2904005|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2904006|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
2904007|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2904008|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2904009|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904010|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904011|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904012|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2904013|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904014|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2904015|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2904016|NCT04527549|Protective Agents|protective agents|mesh-ancestor
2904017|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904018|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2904019|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
2904020|NCT04521114|Leronlimab|leronlimab|mesh-list
2904021|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2904022|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2904023|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328130|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328131|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2328132|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
2328133|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
2328134|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328135|NCT00398879|Capecitabine|capecitabine|mesh-list
2328136|NCT00398879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2328137|NCT00398879|Antimetabolites|antimetabolites|mesh-ancestor
2904024|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2904025|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2904026|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
2904027|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904028|NCT04504942|Leronlimab|leronlimab|mesh-list
2904029|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2904030|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2904031|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904032|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2904033|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2904034|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
2904035|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904036|NCT04504734|Bucillamine|bucillamine|mesh-list
2328138|NCT00398879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328139|NCT00398879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328140|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
2328141|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
2328142|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328143|NCT00398892|Protective Agents|protective agents|mesh-ancestor
2328144|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328145|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
2904037|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2904038|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2904039|NCT04504734|Analgesics|analgesics|mesh-ancestor
2904040|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
2904041|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2904042|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904043|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2904044|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2904045|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
2904046|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904047|NCT04504734|Protective Agents|protective agents|mesh-ancestor
2904048|NCT04491877|Vaccines|vaccines|mesh-list
2904049|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
2904050|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904051|NCT04490018|Vaccines|vaccines|mesh-list
2904052|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
2904053|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904054|NCT04485039|Sevelamer|sevelamer|mesh-list
2904055|NCT04485039|Calcium acetate|calcium acetate|mesh-list
2904056|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
2904057|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
2904058|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904059|NCT04482244|Cannabidiol|cannabidiol|mesh-list
2904060|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
2904061|NCT04478084|Vaccines|vaccines|mesh-list
2904062|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
2904063|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2904064|NCT04478084|Antibodies|antibodies|mesh-list
2904065|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
2904066|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904067|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
2328146|NCT00398892|Vitamins|vitamins|mesh-ancestor
2328147|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
2328148|NCT00398905|Enoxaparin|enoxaparin|mesh-list
2328149|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
2328150|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2328151|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
2328152|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2328153|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
2328154|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328155|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328156|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
2328157|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2328158|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2328159|NCT00398931|Alendronate|alendronate|mesh-list
2328160|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328161|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2328162|NCT00398957|Naltrexone|naltrexone|mesh-list
2328163|NCT00398957|Hydromorphone|hydromorphone|mesh-list
2328164|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
2904068|NCT04477837|Apixaban|apixaban|mesh-list
2904069|NCT04477837|Edoxaban|edoxaban|mesh-list
2904070|NCT04477837|Dabigatran|dabigatran|mesh-list
2904071|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2904072|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
2904073|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2904074|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
2904075|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904076|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328165|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2328166|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328167|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
2328168|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328169|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2328170|NCT00398957|Narcotics|narcotics|mesh-ancestor
2328171|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2328172|NCT00398957|Analgesics|analgesics|mesh-ancestor
2328173|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2904077|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
2904078|NCT04473807|Sotalol|sotalol|mesh-list
2904079|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2328174|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2328175|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2328176|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2328177|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328178|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328179|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328180|NCT00399022|Analgesics|analgesics|mesh-ancestor
2328181|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
2328182|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328183|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
2328184|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2328185|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
2328186|NCT00399048|Hydromorphone|hydromorphone|mesh-list
2328187|NCT00399048|Oxycodone|oxycodone|mesh-list
2328188|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2328189|NCT00399048|Narcotics|narcotics|mesh-ancestor
2328190|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2328191|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328192|NCT00399048|Analgesics|analgesics|mesh-ancestor
2328193|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
2904080|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2904081|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
2904082|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2904083|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904084|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904085|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2904086|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
2904087|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
2904088|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2904089|NCT04452344|Analgesics|analgesics|mesh-list
2904090|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904091|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
2904092|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2904105|NCT04436744|Palbociclib|palbociclib|mesh-list
2904106|NCT04436744|Anastrozole|anastrozole|mesh-list
2904107|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904108|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2904109|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904110|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904111|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2904112|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2904113|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2904114|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2904115|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
2904116|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2904117|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904118|NCT04434092|Eculizumab|eculizumab|mesh-list
2904119|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2904120|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904121|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
2904122|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904123|NCT04432584|Eculizumab|eculizumab|mesh-list
2904124|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2904125|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904126|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
2904127|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328194|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328195|NCT00399061|Cyclosporine|cyclosporine|mesh-list
2328196|NCT00399061|Cyclosporins|cyclosporins|mesh-list
2328197|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328198|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328199|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2328200|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
2904128|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
2904129|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2904130|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904131|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
2904132|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904133|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328201|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328202|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
2328203|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328204|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
2328205|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2328206|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2904134|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
2904135|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2904136|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
2904137|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
2904138|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2904139|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904140|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904141|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2904142|NCT04406649|Analgesics|analgesics|mesh-ancestor
2904143|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
2904144|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2904145|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
2328207|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
2328208|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
2328209|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2328210|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
2328211|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2328212|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2328213|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328214|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2328215|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328216|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328217|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2328218|NCT00399074|Renal Agents|renal agents|mesh-ancestor
2904146|NCT04398368|Gemcitabine|gemcitabine|mesh-list
2904147|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2904148|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
2904149|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904150|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904151|NCT04398368|Antiviral Agents|antiviral agents|mesh-ancestor
2904152|NCT04398368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904153|NCT04398368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904154|NCT04398368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904155|NCT04398368|Immunologic Factors|immunologic factors|mesh-ancestor
2904156|NCT04398368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328219|NCT00399087|Prednisone|prednisone|mesh-list
2328220|NCT00399087|Docetaxel|docetaxel|mesh-list
2328221|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328222|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
2328223|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
2328224|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
2328225|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328226|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2328227|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
2328228|NCT00399087|Hormones|hormones|mesh-ancestor
2328229|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2328230|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328231|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2328232|NCT00399126|Paclitaxel|paclitaxel|mesh-list
2328233|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2328234|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328235|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
2328236|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
2328237|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
2328238|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328239|NCT00399152|Sunitinib|sunitinib|mesh-list
2328240|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328241|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2328242|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2328243|NCT00399152|Growth Substances|growth substances|mesh-ancestor
2328244|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328245|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
2328246|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2328247|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328248|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328249|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
2328250|NCT00399165|Testosterone|testosterone|mesh-list
2328251|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
2328252|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
2328253|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2904174|NCT04388475|Temozolomide|temozolomide|mesh-list
2904175|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2904176|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
2904177|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904178|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328254|NCT00399165|Dutasteride|dutasteride|mesh-list
2328255|NCT00399165|Androgens|androgens|mesh-ancestor
2328256|NCT00399165|Hormones|hormones|mesh-ancestor
2328257|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2328258|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328259|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2328260|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328261|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
2328262|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2328263|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2328264|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328265|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328266|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
2328267|NCT00399204|Metformin|metformin|mesh-list
2328268|NCT00399204|Pioglitazone|pioglitazone|mesh-list
2328269|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2328270|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904193|NCT04357951|Cycloserine|cycloserine|mesh-list
2904194|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2904195|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904196|NCT04357951|Renal Agents|renal agents|mesh-ancestor
2904197|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2328271|NCT00399243|Sumatriptan|sumatriptan|mesh-list
2328272|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2328273|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2328274|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2328275|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
2328276|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328277|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328278|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328279|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
2904198|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
2904199|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2904200|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
2904201|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904202|NCT04347239|Leronlimab|leronlimab|mesh-list
2904203|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2904204|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2904205|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904206|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2904207|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2904208|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
2904209|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904215|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2904216|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2904217|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328280|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2328281|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
2328282|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328283|NCT00399256|Expectorants|expectorants|mesh-ancestor
2328284|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
2328285|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2328286|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
2328287|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328288|NCT00399256|Protective Agents|protective agents|mesh-ancestor
2328289|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328290|NCT00399256|Antidotes|antidotes|mesh-ancestor
2328291|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
2328292|NCT00399269|Hematinics|hematinics|mesh-ancestor
2328293|NCT00399282|Vitamin E|vitamin e|mesh-list
2328294|NCT00399282|Vitamins|vitamins|mesh-ancestor
2328295|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
2328296|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328297|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
2328298|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328299|NCT00399282|Protective Agents|protective agents|mesh-ancestor
2328300|NCT00399295|Naltrexone|naltrexone|mesh-list
2328301|NCT00399295|Hydromorphone|hydromorphone|mesh-list
2328302|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
2904285|NCT04285086|Anagrelide|anagrelide|mesh-list
2904286|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2904287|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2904288|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904289|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2328303|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2328304|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328305|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
2328306|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328307|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2328308|NCT00399295|Narcotics|narcotics|mesh-ancestor
2328309|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2328310|NCT00399295|Analgesics|analgesics|mesh-ancestor
2328311|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
2328312|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2328313|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2328314|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328315|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2328316|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
2328317|NCT00399399|Azathioprine|azathioprine|mesh-list
2328318|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2328319|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
2328320|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328321|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2328322|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2328323|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
2328324|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328325|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328326|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2904314|NCT04249401|Warfarin|warfarin|mesh-list
2904315|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
2904316|NCT04249401|Dabigatran|dabigatran|mesh-list
2904317|NCT04249401|Apixaban|apixaban|mesh-list
2904318|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
2904319|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2904320|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
2904321|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2904322|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
2904323|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904324|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904325|NCT04249167|Paclitaxel|paclitaxel|mesh-list
2904326|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2904327|NCT04249167|Atezolizumab|atezolizumab|mesh-list
2904328|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2904329|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2904330|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904331|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
2904332|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
2904333|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
2904334|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904335|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
2904336|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904337|NCT04247542|Vancomycin|vancomycin|mesh-list
2904338|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2904339|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904340|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
2904341|NCT04245423|Narcotics|narcotics|mesh-ancestor
2904342|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2904343|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904344|NCT04245423|Analgesics|analgesics|mesh-ancestor
2904345|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
2904346|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2904347|NCT04240002|Cytarabine|cytarabine|mesh-list
2904348|NCT04240002|Fludarabine|fludarabine|mesh-list
2904349|NCT04240002|Sargramostim|sargramostim|mesh-list
2904350|NCT04240002|Lenograstim|lenograstim|mesh-list
2904351|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904352|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2904353|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
2904354|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904355|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904356|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
2904357|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904358|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
2904359|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904360|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2904361|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
2904362|NCT04230265|Fludarabine|fludarabine|mesh-list
2904363|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904364|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
2904365|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904366|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2904367|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2904368|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
2904369|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904370|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904371|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2904372|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
2328327|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
2328328|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2328329|NCT00399425|Heparin|heparin|mesh-list
2328330|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2328331|NCT00399425|Tinzaparin|tinzaparin|mesh-list
2328332|NCT00399425|Dalteparin|dalteparin|mesh-list
2328333|NCT00399425|Bemiparin|bemiparin|mesh-list
2328334|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
2904373|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2904374|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
2904375|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2904376|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
2904377|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904378|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904379|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
2328335|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2328336|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2328337|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904388|NCT04198363|Amoxicillin|amoxicillin|mesh-list
2904389|NCT04198363|Clarithromycin|clarithromycin|mesh-list
2904390|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
2904391|NCT04198363|Esomeprazole|esomeprazole|mesh-list
2904392|NCT04198363|Bismuth|bismuth|mesh-list
2904393|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904394|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2904395|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904396|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2904397|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2904398|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2904399|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904400|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2904401|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2904402|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2904403|NCT04198363|Antacids|antacids|mesh-ancestor
2904404|NCT04198363|Diuretics|diuretics|mesh-ancestor
2904405|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
2904406|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904407|NCT04198363|Expectorants|expectorants|mesh-ancestor
2904408|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
2328338|NCT00399451|Polidocanol|polidocanol|mesh-list
2328339|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2328340|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2328341|NCT00399464|Alfuzosin|alfuzosin|mesh-list
2328342|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2328343|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2328344|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2328345|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
2328346|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328347|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328348|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328349|NCT00399464|Urological Agents|urological agents|mesh-ancestor
2328350|NCT00399477|Levodopa|levodopa|mesh-list
2328351|NCT00399477|Pramipexole|pramipexole|mesh-list
2328352|NCT00399477|Rasagiline|rasagiline|mesh-list
2328353|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2328354|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2904409|NCT04194203|Paclitaxel|paclitaxel|mesh-list
2904410|NCT04194203|Bevacizumab|bevacizumab|mesh-list
2904411|NCT04194203|Carboplatin|carboplatin|mesh-list
2904412|NCT04194203|Pemetrexed|pemetrexed|mesh-list
2904413|NCT04194203|Atezolizumab|atezolizumab|mesh-list
2904414|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2904415|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904416|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
2904417|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
2904418|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
2904419|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904420|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904421|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2904422|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2904423|NCT04194203|Growth Substances|growth substances|mesh-ancestor
2904424|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904425|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
2904426|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904427|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2904428|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2904447|NCT04161885|Azacitidine|azacitidine|mesh-list
2904448|NCT04161885|Venetoclax|venetoclax|mesh-list
2904449|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2904450|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
2904451|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904452|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904453|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904454|NCT04157335|Benralizumab|benralizumab|mesh-list
2904455|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2904456|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
2904466|NCT04126824|Triamcinolone|triamcinolone|mesh-list
2904467|NCT04126824|Bupivacaine|bupivacaine|mesh-list
2904468|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
2904469|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
2904470|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2904471|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904472|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
2904473|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2904474|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2904475|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
2904476|NCT04126824|Hormones|hormones|mesh-ancestor
2904477|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2904478|NCT04095689|Docetaxel|docetaxel|mesh-list
2904479|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
2904480|NCT04095689|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2904481|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904482|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
2904483|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
2904484|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
2904485|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904486|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904487|NCT04095689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328355|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
2328356|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328357|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328358|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328359|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2328360|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328361|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2328362|NCT00399477|Protective Agents|protective agents|mesh-ancestor
2328363|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
2328364|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
2328365|NCT00399633|Sumatriptan|sumatriptan|mesh-list
2328366|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2328367|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2328368|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2328369|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
2328370|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328371|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328372|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328373|NCT00399659|Tegaserod|tegaserod|mesh-list
2328374|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2904488|NCT04091386|Factor VIII|factor viii|mesh-list
2904489|NCT04091386|Coagulants|coagulants|mesh-ancestor
2904495|NCT04057469|Tulobuterol|tulobuterol|mesh-list
2328375|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
2328376|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328377|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328378|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328379|NCT00399672|Interferons|interferons|mesh-list
2328380|NCT00399672|Ribavirin|ribavirin|mesh-list
2328381|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904496|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2904497|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2904498|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
2904499|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2904500|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904501|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904502|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2904503|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
2904504|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2904505|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2904506|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
2904510|NCT04026412|Nivolumab|nivolumab|mesh-list
2904511|NCT04026412|Ipilimumab|ipilimumab|mesh-list
2904512|NCT04026412|Durvalumab|durvalumab|mesh-list
2904513|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904514|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904515|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2904516|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904517|NCT04020809|Atezolizumab|atezolizumab|mesh-list
2904518|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904519|NCT04005209|Ketamine|ketamine|mesh-list
2904520|NCT04005209|Analgesics|analgesics|mesh-ancestor
2904521|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
2904522|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2904523|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904524|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2904525|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2904526|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
2904527|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
2904528|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2904529|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2904530|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2904531|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2904532|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904533|NCT04002180|Vedolizumab|vedolizumab|mesh-list
2904534|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2904535|NCT03997123|Paclitaxel|paclitaxel|mesh-list
2904536|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2904537|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904538|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
2904539|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
2904540|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
2904541|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904551|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
2904552|NCT03961789|Narcotics|narcotics|mesh-ancestor
2904553|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2904554|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328382|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
2328383|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328384|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
2904555|NCT03961789|Analgesics|analgesics|mesh-ancestor
2904556|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
2904557|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2904558|NCT03951870|Vaccines|vaccines|mesh-list
2904559|NCT03951870|Immunologic Factors|immunologic factors|mesh-ancestor
2904560|NCT03951870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904561|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2904562|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904563|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2904564|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
2904565|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328385|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328386|NCT00399685|Efavirenz|efavirenz|mesh-list
2328387|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
2328388|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2328389|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2328390|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2328391|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328392|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328393|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
2328394|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328395|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2328396|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2328397|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2904577|NCT03912064|Ipilimumab|ipilimumab|mesh-list
2904578|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904579|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904580|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2904581|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904582|NCT03897127|Cytarabine|cytarabine|mesh-list
2904583|NCT03897127|Daunorubicin|daunorubicin|mesh-list
2328398|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2328399|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2328400|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2328401|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2328402|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2328403|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2904584|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2904585|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
2904586|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904587|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904588|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
2904589|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904590|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904591|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
2904592|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904593|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2904594|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2904595|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2904596|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904597|NCT03894540|Paclitaxel|paclitaxel|mesh-list
2904598|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
2904599|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2904600|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904601|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
2904602|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
2904603|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
2904604|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904605|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904606|NCT03878095|Olaparib|olaparib|mesh-list
2328404|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904607|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2328405|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2328406|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
2328407|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2328408|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328409|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2328410|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2328411|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2328412|NCT00399698|Risperidone|risperidone|mesh-list
2328413|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2328414|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
2328415|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328416|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328417|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328418|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2328419|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2904608|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904609|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904610|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904611|NCT03873675|Hormones|hormones|mesh-list
2904612|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
2904613|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2904614|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904615|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2904616|NCT03871348|Cemiplimab|cemiplimab|mesh-list
2904617|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904618|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904619|NCT03838367|Leronlimab|leronlimab|mesh-list
2904620|NCT03838367|Carboplatin|carboplatin|mesh-list
2904621|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
2904622|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904623|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2904624|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2904625|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904626|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2904627|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2328420|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2328421|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2328422|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2328423|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
2328424|NCT00399711|Metformin|metformin|mesh-list
2328425|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
2328426|NCT00399711|Repaglinide|repaglinide|mesh-list
2328427|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2328428|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328429|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
2328430|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2328431|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328432|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2328433|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
2904628|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
2904629|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904630|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
2904631|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328434|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328435|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328436|NCT00399750|Bevacizumab|bevacizumab|mesh-list
2328437|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
2328438|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2328439|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328440|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2328441|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2328442|NCT00399750|Growth Substances|growth substances|mesh-ancestor
2328443|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328444|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
2328445|NCT00399867|Simvastatin|simvastatin|mesh-list
2328446|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2328447|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2328448|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
2328449|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328450|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2328451|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2904649|NCT03826992|Cytarabine|cytarabine|mesh-list
2904650|NCT03826992|Daunorubicin|daunorubicin|mesh-list
2904651|NCT03826992|Venetoclax|venetoclax|mesh-list
2904652|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2904653|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
2904654|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904655|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904656|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
2904657|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904658|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904659|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
2904660|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904661|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2904662|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2904663|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2904664|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904665|NCT03816358|Gemcitabine|gemcitabine|mesh-list
2904666|NCT03816358|Nivolumab|nivolumab|mesh-list
2904667|NCT03816358|Ipilimumab|ipilimumab|mesh-list
2904668|NCT03816358|Maytansine|maytansine|mesh-list
2904669|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2904670|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
2904671|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904672|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904673|NCT03816358|Antiviral Agents|antiviral agents|mesh-ancestor
2904674|NCT03816358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904675|NCT03816358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904676|NCT03816358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904677|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
2904678|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904679|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904680|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2904681|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2904682|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
2904683|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
2904684|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
2904685|NCT03809767|Antibodies|antibodies|mesh-list
2904686|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2328452|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328453|NCT00399945|Tobramycin|tobramycin|mesh-list
2328454|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2328455|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328456|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
2328457|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328458|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
2109845|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109846|NCT02528214|Prednisone|prednisone|mesh-list
2109847|NCT02528214|Prednisolone|prednisolone|mesh-list
2109848|NCT02528214|Albuterol|albuterol|mesh-list
2109849|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2109850|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
2109851|NCT02528214|Hormones|hormones|mesh-ancestor
2109852|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109853|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109854|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2109855|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109856|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
2109857|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109858|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2109859|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2904687|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
2328459|NCT00400075|Azathioprine|azathioprine|mesh-list
2904688|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904689|NCT03778957|Bevacizumab|bevacizumab|mesh-list
2328460|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904690|NCT03778957|Durvalumab|durvalumab|mesh-list
2904691|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904692|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904693|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2904694|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2904695|NCT03778957|Growth Substances|growth substances|mesh-ancestor
2904696|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904697|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
2904698|NCT03745144|Cladribine|cladribine|mesh-list
2904699|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2904700|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2904701|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904702|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904703|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
2904704|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904705|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2904706|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
2904707|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2904708|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2904709|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2904710|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2904711|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2904712|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2904713|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2904714|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2109860|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
2109861|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
2328461|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
2328462|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328463|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2328464|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2328465|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
2328466|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328467|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328468|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2328469|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
2328470|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2328471|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
2328472|NCT00400088|Paroxetine|paroxetine|mesh-list
2328473|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
2328474|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2328475|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328476|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328477|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
2328478|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2328479|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2328480|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328481|NCT00400088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2328482|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2328483|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2328484|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328485|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
2328486|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2328487|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2328488|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2328489|NCT00400114|Irinotecan|irinotecan|mesh-list
2328490|NCT00400114|Sunitinib|sunitinib|mesh-list
2328491|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904715|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2904716|NCT03740529|Rituximab|rituximab|mesh-list
2904717|NCT03740529|Venetoclax|venetoclax|mesh-list
2904718|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904719|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904720|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
2904721|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904722|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2904731|NCT03732820|Olaparib|olaparib|mesh-list
2904732|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
2904733|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2904734|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904735|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904736|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904737|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2904738|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
2904739|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2904740|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904741|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2904742|NCT03728179|Aspirin|aspirin|mesh-list
2904743|NCT03728179|Celecoxib|celecoxib|mesh-list
2904744|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
2904745|NCT03728179|Nivolumab|nivolumab|mesh-list
2904746|NCT03728179|Ipilimumab|ipilimumab|mesh-list
2904747|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904748|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
2904749|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904750|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2904751|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2328492|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2328493|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2328494|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904752|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
2904753|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904754|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904755|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2904756|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904757|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2904758|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2904759|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2904760|NCT03728179|Analgesics|analgesics|mesh-ancestor
2904761|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
2904762|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2904763|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2904764|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2904765|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2904766|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2904767|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2904768|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904769|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
2904770|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2904771|NCT03714308|Aflibercept|aflibercept|mesh-list
2328495|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328496|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2328497|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2328498|NCT00400114|Growth Substances|growth substances|mesh-ancestor
2328499|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328500|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
2328501|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2328502|NCT00400218|Losartan|losartan|mesh-list
2328503|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2328504|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2328505|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2328506|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2328507|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2328508|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328509|NCT00400218|Diuretics|diuretics|mesh-ancestor
2328510|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
2904772|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2904773|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2904774|NCT03714308|Growth Substances|growth substances|mesh-ancestor
2904775|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904776|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
2328511|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328512|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2328513|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2328514|NCT00400231|Metformin|metformin|mesh-list
2328515|NCT00400231|Fenofibrate|fenofibrate|mesh-list
2328516|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2328517|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328518|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2328519|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
2328520|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328521|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2328522|NCT00400322|Valganciclovir|valganciclovir|mesh-list
2328523|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
2904777|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904778|NCT03639610|Dexamethasone|dexamethasone|mesh-list
2904779|NCT03639610|Melphalan|melphalan|mesh-list
2904780|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2904781|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
2904782|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
2904783|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2904784|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904785|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2904786|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
2904787|NCT03639610|Hormones|hormones|mesh-ancestor
2904788|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2904789|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2904790|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904791|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2904792|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
2904793|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904794|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2904795|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904796|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
2904804|NCT03626376|Valacyclovir|valacyclovir|mesh-list
2904805|NCT03626376|Acyclovir|acyclovir|mesh-list
2904806|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2904807|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2904808|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
2904809|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904810|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
2904811|NCT03624036|Fludarabine|fludarabine|mesh-list
2904812|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904813|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
2904814|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904815|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2904816|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2904817|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
2904818|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904819|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904820|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2904821|NCT03600805|Prednisone|prednisone|mesh-list
2904822|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2904823|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
2904824|NCT03600805|Hormones|hormones|mesh-ancestor
2904825|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2904826|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904827|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2904828|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904834|NCT03556358|Paclitaxel|paclitaxel|mesh-list
2904835|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
2904836|NCT03556358|Trastuzumab|trastuzumab|mesh-list
2328524|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328525|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
2328526|NCT00400335|Testosterone|testosterone|mesh-list
2328527|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
2328528|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
2328529|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2328530|NCT00400335|Dutasteride|dutasteride|mesh-list
2328531|NCT00400335|Androgens|androgens|mesh-ancestor
2328532|NCT00400335|Hormones|hormones|mesh-ancestor
2904837|NCT03556358|Epirubicin|epirubicin|mesh-list
2904838|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2904839|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904840|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
2904841|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
2904842|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
2904843|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904844|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904845|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
2904846|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904847|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2904848|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2904849|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
2904850|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2904851|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904852|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2904853|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2904854|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2904855|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328533|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2328534|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328535|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2904856|NCT03555578|Leuprolide|leuprolide|mesh-list
2904857|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2904858|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
2904859|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2904860|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904861|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2904862|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904863|NCT03539744|Dexamethasone|dexamethasone|mesh-list
2904864|NCT03539744|Venetoclax|venetoclax|mesh-list
2904865|NCT03539744|Pomalidomide|pomalidomide|mesh-list
2904866|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2904867|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
2904868|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
2904869|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2904870|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904871|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2904872|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
2904873|NCT03539744|Hormones|hormones|mesh-ancestor
2904874|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2904875|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2904876|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904877|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
2904878|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2904879|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2904880|NCT03539744|Growth Substances|growth substances|mesh-ancestor
2904881|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
2904882|NCT03539302|Flecainide|flecainide|mesh-list
2904883|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2904884|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2904885|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2904886|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2904887|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904888|NCT03520790|Gemcitabine|gemcitabine|mesh-list
2904889|NCT03520790|Paclitaxel|paclitaxel|mesh-list
2904890|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2904891|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904892|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
2904893|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
2904894|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
2904895|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904896|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2904897|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
2904898|NCT03520790|Antiviral Agents|antiviral agents|mesh-ancestor
2904899|NCT03520790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904900|NCT03520790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904901|NCT03520790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2328536|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328537|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
2328538|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2328539|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2328540|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904902|NCT03520790|Immunologic Factors|immunologic factors|mesh-ancestor
2328541|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328542|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
2328543|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
2904903|NCT03520790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904904|NCT03490760|Durvalumab|durvalumab|mesh-list
2904905|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904906|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904907|NCT03455504|Venetoclax|venetoclax|mesh-list
2904908|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904909|NCT03446040|Nivolumab|nivolumab|mesh-list
2904910|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904911|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904912|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2904913|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904914|NCT03436108|Bisphenol A|bisphenol a|mesh-list
2904915|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2904916|NCT03436108|Estrogens|estrogens|mesh-ancestor
2904917|NCT03436108|Hormones|hormones|mesh-ancestor
2904918|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2904919|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328544|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328545|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
2328546|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
2328547|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
2328548|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328549|NCT00400374|Celecoxib|celecoxib|mesh-list
2328550|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2328551|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328552|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2328553|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328554|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904920|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2904921|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
2904922|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904923|NCT03436108|Protective Agents|protective agents|mesh-ancestor
2904924|NCT03433248|Empagliflozin|empagliflozin|mesh-list
2904925|NCT03433248|Gliclazide|gliclazide|mesh-list
2904926|NCT03433248|Linagliptin|linagliptin|mesh-list
2904927|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2904928|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904929|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2904930|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904931|NCT03433248|Incretins|incretins|mesh-ancestor
2904932|NCT03433248|Hormones|hormones|mesh-ancestor
2904933|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2904934|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2904935|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
2904936|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2904937|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
2904938|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2904939|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2904940|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328555|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2328556|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2904941|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2904942|NCT03417999|Analgesics|analgesics|mesh-ancestor
2904943|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
2904944|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2904945|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2904946|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2904947|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2904948|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
2904949|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2904950|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904954|NCT03348670|BCG Vaccine|bcg vaccine|mesh-list
2904955|NCT03348670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2904956|NCT03348670|Immunologic Factors|immunologic factors|mesh-ancestor
2904957|NCT03348670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904958|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
2904959|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2328557|NCT00400374|Analgesics|analgesics|mesh-ancestor
2328558|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
2328559|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328560|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328561|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2328562|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2328563|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2328564|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2328565|NCT00400387|Riboflavin|riboflavin|mesh-list
2328566|NCT00400387|Thiamine|thiamine|mesh-list
2328567|NCT00400387|Pyridoxine|pyridoxine|mesh-list
2328568|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
2328569|NCT00400387|Folic Acid|folic acid|mesh-list
2328570|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
2328571|NCT00400387|Tocopherols|tocopherols|mesh-list
2328572|NCT00400387|Vitamin E|vitamin e|mesh-list
2328573|NCT00400387|Tocotrienols|tocotrienols|mesh-list
2328574|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
2328575|NCT00400387|Heparin|heparin|mesh-list
2904960|NCT03282981|Timolol|timolol|mesh-list
2904961|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2904962|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2904963|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
2904964|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2904965|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904966|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904967|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2904968|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2904969|NCT03282916|Valacyclovir|valacyclovir|mesh-list
2904970|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
2904971|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2904972|NCT03279471|Sertraline|sertraline|mesh-list
2904973|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
2904974|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2904975|NCT03279471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2904976|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2904977|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2904978|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904979|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328576|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2328577|NCT00400387|Tinzaparin|tinzaparin|mesh-list
2328578|NCT00400387|Dalteparin|dalteparin|mesh-list
2328579|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328580|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
2328581|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2904980|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
2904981|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904982|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
2904983|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2904984|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904985|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
2904986|NCT03263559|Thiotepa|thiotepa|mesh-list
2904987|NCT03263559|Fludarabine|fludarabine|mesh-list
2904988|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
2904989|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
2904990|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2904991|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
2904992|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2904993|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2904994|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2904995|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
2904996|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2904997|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2904998|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2904999|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
2905000|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905001|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2905002|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2905003|NCT03228680|Hormones|hormones|mesh-ancestor
2905004|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2905005|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905006|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
2905007|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
2905008|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2328582|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2328583|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328584|NCT00400387|Vitamins|vitamins|mesh-ancestor
2328585|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
2905009|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
2905010|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905011|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2905012|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2905019|NCT03170882|Dexamethasone|dexamethasone|mesh-list
2905020|NCT03170882|Pomalidomide|pomalidomide|mesh-list
2905021|NCT03170882|Ixazomib|ixazomib|mesh-list
2905022|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2905023|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
2905024|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
2905025|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905026|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905027|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2905028|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
2905029|NCT03170882|Hormones|hormones|mesh-ancestor
2905030|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2328586|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2328587|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
2328588|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
2328589|NCT00400387|Protective Agents|protective agents|mesh-ancestor
2328590|NCT00400387|Hematinics|hematinics|mesh-ancestor
2328591|NCT00400478|Rituximab|rituximab|mesh-list
2328592|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2328593|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328594|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
2328595|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328596|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2328597|NCT00400491|Vitamin D|vitamin d|mesh-list
2328598|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
2328599|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
2328600|NCT00400491|Vitamins|vitamins|mesh-list
2328601|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
2328602|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328603|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2905031|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2905032|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905033|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
2905034|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2905035|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2905036|NCT03170882|Growth Substances|growth substances|mesh-ancestor
2905037|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
2905038|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
2905039|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328604|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2328605|NCT00400530|Alendronate|alendronate|mesh-list
2328606|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328607|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2328608|NCT00400556|Lenograstim|lenograstim|mesh-list
2328609|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2328610|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
2328611|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328612|NCT00400582|Candesartan|candesartan|mesh-list
2328613|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2328614|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2328615|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2328616|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328617|NCT00400595|Mupirocin|mupirocin|mesh-list
2328618|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2328619|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328620|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2328621|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328622|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905040|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905041|NCT03148418|Atezolizumab|atezolizumab|mesh-list
2905042|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905054|NCT03112174|Venetoclax|venetoclax|mesh-list
2905055|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905056|NCT03082729|Apremilast|apremilast|mesh-list
2905057|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2905058|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2905059|NCT03082729|Analgesics|analgesics|mesh-ancestor
2905060|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
2905061|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905062|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905063|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2905064|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2905065|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2905066|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2905067|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905068|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905091|NCT03064126|Paclitaxel|paclitaxel|mesh-list
2905092|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2905093|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2905094|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905095|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
2905096|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
2905097|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
2905098|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905099|NCT03062826|Aspirin|aspirin|mesh-list
2905100|NCT03062826|Clopidogrel|clopidogrel|mesh-list
2905101|NCT03062826|Ticagrelor|ticagrelor|mesh-list
2905102|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2328623|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2328624|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2328625|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
2328626|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328627|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328628|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2905103|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2905104|NCT03062826|Analgesics|analgesics|mesh-ancestor
2905105|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
2905106|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905107|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905108|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2905109|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2905110|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2905111|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2905112|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905113|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2905114|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2328629|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
2905115|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905116|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
2905117|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2905118|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2905119|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2905120|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
2905121|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905122|NCT03047070|Lidocaine|lidocaine|mesh-list
2905123|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
2905124|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
2905125|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2905126|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905127|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
2905128|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905129|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2905130|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2905131|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2905132|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2905133|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905134|NCT03029611|Paclitaxel|paclitaxel|mesh-list
2905135|NCT03029611|Carboplatin|carboplatin|mesh-list
2905136|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2905137|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2905138|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905139|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
2905140|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
2905141|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
2905142|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905143|NCT03024996|Atezolizumab|atezolizumab|mesh-list
2905144|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905145|NCT03012529|Riboflavin|riboflavin|mesh-list
2905146|NCT03012529|Rifampin|rifampin|mesh-list
2905147|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2905148|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
2905149|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2905150|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2905151|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
2905152|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2905153|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905154|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905155|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2905156|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2905157|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2905158|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2905159|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2905160|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2905161|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
2905162|NCT03012529|Vitamins|vitamins|mesh-ancestor
2905163|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
2905164|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905165|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2905166|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
2905167|NCT02914977|Daunorubicin|daunorubicin|mesh-list
2905168|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2905169|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328630|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
2328631|NCT00400608|Hormones|hormones|mesh-ancestor
2905170|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2905171|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2905172|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905173|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328632|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2328633|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
2328634|NCT00400621|Acetaminophen|acetaminophen|mesh-list
2328635|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2328636|NCT00400621|Analgesics|analgesics|mesh-ancestor
2328637|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
2328638|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328639|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328640|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
2328641|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
2328642|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2328643|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328644|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2328645|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
2328646|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2328647|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328648|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328649|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328650|NCT00400725|Clobetasol|clobetasol|mesh-list
2328651|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2328652|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
2328653|NCT00400725|Hormones|hormones|mesh-ancestor
2328654|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2328655|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328656|NCT00400738|Ritonavir|ritonavir|mesh-list
2328657|NCT00400738|Lopinavir|lopinavir|mesh-list
2328658|NCT00400738|Saquinavir|saquinavir|mesh-list
2328659|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2328660|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2328661|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
2328662|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905198|NCT02891798|Dexamethasone|dexamethasone|mesh-list
2905199|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
2905200|NCT02891798|Clonidine|clonidine|mesh-list
2905201|NCT02891798|Buprenorphine|buprenorphine|mesh-list
2905202|NCT02891798|Bupivacaine|bupivacaine|mesh-list
2905203|NCT02891798|BB 1101|bb 1101|mesh-list
2905204|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2905205|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
2905206|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
2905207|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905208|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905209|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2905210|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
2905211|NCT02891798|Hormones|hormones|mesh-ancestor
2905212|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2905213|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2905214|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905215|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
2905216|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905217|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905218|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
2905219|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
2905220|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2905221|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
2905222|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2905223|NCT02891798|Narcotics|narcotics|mesh-ancestor
2905224|NCT02891798|Analgesics|analgesics|mesh-ancestor
2905225|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2905226|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2328663|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328664|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2328665|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2328666|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
2328667|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2905227|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
2905228|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2905229|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2328668|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2328669|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2328670|NCT00400777|Amlodipine|amlodipine|mesh-list
2905230|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2905231|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
2905232|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905233|NCT02870218|Nicotine|nicotine|mesh-list
2905234|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2905235|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
2905236|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905237|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905238|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2905239|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2905240|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
2905241|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905242|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905243|NCT02864992|Tepotinib|tepotinib|mesh-list
2905244|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905245|NCT02859961|Leronlimab|leronlimab|mesh-list
2905246|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
2905247|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2905248|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2905249|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905250|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2905251|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2905252|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
2905253|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2905254|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
2905255|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905268|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
2905269|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2905270|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905271|NCT02679781|Midazolam|midazolam|mesh-list
2905272|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2905273|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2905274|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2905275|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328671|NCT00400777|Valsartan|valsartan|mesh-list
2328672|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2328673|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2328674|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2328675|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2328676|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328677|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2328678|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905276|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2905277|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2905278|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2905279|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2905280|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
2905281|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
2905282|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
2905283|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
2905284|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905285|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905286|NCT02679508|Lansoprazole|lansoprazole|mesh-list
2905287|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
2905288|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2905289|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2905290|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2905291|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905292|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905293|NCT02624869|Evolocumab|evolocumab|mesh-list
2905294|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2328679|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
2328680|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2328681|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2328682|NCT00400777|Diuretics|diuretics|mesh-ancestor
2328683|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
2328684|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2328685|NCT00400790|Propofol|propofol|mesh-list
2328686|NCT00400790|Desflurane|desflurane|mesh-list
2328687|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2328688|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2328689|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328690|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2328691|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
2328692|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
2905295|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2905296|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
2905297|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905298|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2905299|NCT02614690|Calpastatin|calpastatin|mesh-list
2905300|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2905301|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
2905302|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905303|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905304|NCT02595424|Carboplatin|carboplatin|mesh-list
2905305|NCT02595424|Capecitabine|capecitabine|mesh-list
2905306|NCT02595424|Etoposide|etoposide|mesh-list
2905307|NCT02595424|Temozolomide|temozolomide|mesh-list
2905308|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905309|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2905310|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
2905311|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905312|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2905313|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2905314|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2905315|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905316|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2905317|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
2905318|NCT02569242|Paclitaxel|paclitaxel|mesh-list
2905319|NCT02569242|Docetaxel|docetaxel|mesh-list
2905320|NCT02569242|Nivolumab|nivolumab|mesh-list
2905321|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2328693|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2328694|NCT00400816|Temozolomide|temozolomide|mesh-list
2328695|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2328696|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
2328697|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328698|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328699|NCT00400855|Fluticasone|fluticasone|mesh-list
2328700|NCT00400855|Xhance|xhance|mesh-list
2328701|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2328702|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2328703|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
2328704|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328705|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328706|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2328707|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
2328708|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
2328709|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2328710|NCT00400998|Fluticasone|fluticasone|mesh-list
2328711|NCT00400998|Xhance|xhance|mesh-list
2328712|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2328713|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2328714|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
2328715|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328716|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328717|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2328718|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
2905322|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905323|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
2905324|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
2905325|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
2905326|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905327|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2905328|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2328719|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
2328720|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2328721|NCT00401011|Dexamethasone|dexamethasone|mesh-list
2328722|NCT00401011|Bortezomib|bortezomib|mesh-list
2328723|NCT00401011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2328724|NCT00401011|Antiemetics|antiemetics|mesh-ancestor
2328725|NCT00401011|Autonomic Agents|autonomic agents|mesh-ancestor
2328726|NCT00401011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328727|NCT00401011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328728|NCT00401011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2328729|NCT00401011|Glucocorticoids|glucocorticoids|mesh-ancestor
2328730|NCT00401011|Hormones|hormones|mesh-ancestor
2328731|NCT00401011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2328732|NCT00401011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2328733|NCT00401011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328734|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
2328735|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328736|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2905366|NCT02435433|Ramucirumab|ramucirumab|mesh-list
2905367|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905368|NCT02426125|Docetaxel|docetaxel|mesh-list
2905369|NCT02426125|Ramucirumab|ramucirumab|mesh-list
2905370|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905371|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
2905372|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
2905373|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
2905374|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905375|NCT02417142|Exenatide|exenatide|mesh-list
2905376|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2905377|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905378|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2905379|NCT02417142|Incretins|incretins|mesh-ancestor
2905380|NCT02417142|Hormones|hormones|mesh-ancestor
2905381|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2905382|NCT02368886|Clobetasol|clobetasol|mesh-list
2905383|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2905384|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
2905385|NCT02368886|Hormones|hormones|mesh-ancestor
2905386|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2905387|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328737|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905388|NCT02354703|Ondansetron|ondansetron|mesh-list
2905389|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
2905390|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
2905391|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905392|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905393|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2905394|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
2905395|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
2905396|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2905397|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
2905398|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905399|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905400|NCT02354703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2905401|NCT02354703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2905402|NCT02354703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2905403|NCT02354703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2905404|NCT02354703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2905405|NCT02312258|Ixazomib|ixazomib|mesh-list
2905406|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905407|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
2905408|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905409|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905410|NCT02258451|Everolimus|everolimus|mesh-list
2905411|NCT02258451|Exemestane|exemestane|mesh-list
2905412|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2905413|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905414|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2905415|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
2905416|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905417|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2328738|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328739|NCT00401115|Sirolimus|sirolimus|mesh-list
2328740|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2328741|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328742|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2328743|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328744|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
2328745|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2328746|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
2328747|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328748|NCT00401128|Gemcitabine|gemcitabine|mesh-list
2328749|NCT00401128|Irinotecan|irinotecan|mesh-list
2328750|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2328751|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
2328752|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328753|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328754|NCT00401128|Antiviral Agents|antiviral agents|mesh-ancestor
2328755|NCT00401128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328756|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328757|NCT00401128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2328758|NCT00401128|Immunologic Factors|immunologic factors|mesh-ancestor
2328759|NCT00401128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328760|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2905418|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2905419|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905420|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905421|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2905422|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
2905423|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2328761|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2328762|NCT00401167|Memantine|memantine|mesh-list
2328763|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2328764|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2328765|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
2328766|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328767|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328768|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328769|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2328770|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2328771|NCT00401180|Docetaxel|docetaxel|mesh-list
2328772|NCT00401180|Temozolomide|temozolomide|mesh-list
2328773|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328774|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
2328775|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
2328776|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
2328777|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328778|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2328779|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
2328780|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
2328781|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2328782|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2328783|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328784|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2905464|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
2905465|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328785|NCT00401206|Analgesics|analgesics|mesh-ancestor
2328786|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
2328787|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328788|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2328789|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2328790|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2328791|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
2328792|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328793|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328794|NCT00401219|Estrogens|estrogens|mesh-list
2328795|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2328796|NCT00401219|Progestins|progestins|mesh-list
2328797|NCT00401219|Hormones|hormones|mesh-ancestor
2328798|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2328799|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328800|NCT00401323|Docetaxel|docetaxel|mesh-list
2328801|NCT00401323|Fluorouracil|fluorouracil|mesh-list
2328802|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328803|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
2328804|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
2328805|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
2328806|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328807|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
2328808|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2328809|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2328810|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
2328811|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328812|NCT00401362|Naltrexone|naltrexone|mesh-list
2328813|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
2328814|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2328815|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328816|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
2328817|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328818|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2328819|NCT00401388|Allopurinol|allopurinol|mesh-list
2328820|NCT00401388|Antiemetics|antiemetics|mesh-list
2328821|NCT00401388|Loperamide|loperamide|mesh-list
2328822|NCT00401388|Antidiarrheals|antidiarrheals|mesh-list
2328823|NCT00401388|Antimetabolites|antimetabolites|mesh-ancestor
2328824|NCT00401388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328825|NCT00401388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328826|NCT00401388|Gout Suppressants|gout suppressants|mesh-ancestor
2328827|NCT00401388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2328828|NCT00401388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2328829|NCT00401388|Antioxidants|antioxidants|mesh-ancestor
2328830|NCT00401388|Protective Agents|protective agents|mesh-ancestor
2328831|NCT00401388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328832|NCT00401388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2905481|NCT01772472|Trastuzumab|trastuzumab|mesh-list
2905482|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2905483|NCT01772472|Maytansine|maytansine|mesh-list
2905484|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2905485|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905486|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2905487|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
2905488|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
2905489|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
2905490|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905491|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2905492|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2905493|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905494|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2905495|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
2905496|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905497|NCT01370512|Droxidopa|droxidopa|mesh-list
2905498|NCT01370512|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2905499|NCT01370512|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2905500|NCT01370512|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2905501|NCT01370512|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2905502|NCT01370512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905503|NCT01370512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905504|NCT01370512|Cholinergic Agents|cholinergic agents|mesh-ancestor
2905505|NCT01370512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905506|NCT01370512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905507|NCT01365195|Ketamine|ketamine|mesh-list
2905508|NCT01365195|Analgesics|analgesics|mesh-ancestor
2905509|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
2905510|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905511|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905512|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2905513|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2905514|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
2905515|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
2905516|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2905517|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2905518|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2905519|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905520|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905521|NCT00796068|Cyclosporine|cyclosporine|mesh-list
2905522|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
2905523|NCT00796068|Fludarabine|fludarabine|mesh-list
2328833|NCT00401388|Autonomic Agents|autonomic agents|mesh-ancestor
2328834|NCT00401388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905524|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
2905525|NCT00796068|Treosulfan|treosulfan|mesh-list
2905526|NCT00796068|Busulfan|busulfan|mesh-list
2905527|NCT00796068|Cyclosporins|cyclosporins|mesh-list
2905528|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905529|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2905530|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
2905531|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905532|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2905533|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
2905534|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905535|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905536|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
2905537|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2905538|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
2905539|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2905540|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2905541|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2905542|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2905543|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
2905544|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2905545|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2905546|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
2905547|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2905548|NCT00468130|Aripiprazole|aripiprazole|mesh-list
2905549|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
2905550|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2905551|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2905552|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2905553|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2905554|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905555|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
2905556|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
2905557|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905558|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328835|NCT00401427|Trastuzumab|trastuzumab|mesh-list
2328836|NCT00401427|Vinorelbine|vinorelbine|mesh-list
2328837|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2328838|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328839|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2328840|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
2328841|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
2328842|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
2328843|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328844|NCT00401440|Misoprostol|misoprostol|mesh-list
2328845|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2328846|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
2328847|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2328848|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328849|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2328850|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2328851|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
2328852|NCT00401479|Solabegron|solabegron|mesh-list
2328853|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2328854|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2328855|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2328856|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
2328857|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328858|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328859|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328860|NCT00401492|Gemcitabine|gemcitabine|mesh-list
2328861|NCT00401492|Vinorelbine|vinorelbine|mesh-list
2328862|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328863|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2328864|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
2328865|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328866|NCT00401492|Antiviral Agents|antiviral agents|mesh-ancestor
2328867|NCT00401492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328868|NCT00401492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328869|NCT00401492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2328870|NCT00401492|Immunologic Factors|immunologic factors|mesh-ancestor
2328871|NCT00401492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905559|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2905560|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2905561|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
2905562|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2905563|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2905564|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2328872|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2328873|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
2328874|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
2328875|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
2328876|NCT00401570|Gemcitabine|gemcitabine|mesh-list
2328877|NCT00401570|Volociximab|volociximab|mesh-list
2328878|NCT00401570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2328879|NCT00401570|Antimetabolites|antimetabolites|mesh-ancestor
2328880|NCT00401570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328881|NCT00401570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328882|NCT00401570|Antiviral Agents|antiviral agents|mesh-ancestor
2328883|NCT00401570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328884|NCT00401570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905565|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2328885|NCT00401570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2905566|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2905567|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2905568|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
2905569|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905570|NCT05197751|Antacids|antacids|mesh-ancestor
2905571|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905572|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2905573|NCT05197621|Vaccines|vaccines|mesh-list
2905574|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
2905575|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905584|NCT05197504|Bevacizumab|bevacizumab|mesh-list
2905585|NCT05197504|Atezolizumab|atezolizumab|mesh-list
2905586|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2905587|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905588|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2905589|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2905590|NCT05197504|Growth Substances|growth substances|mesh-ancestor
2328886|NCT00401570|Immunologic Factors|immunologic factors|mesh-ancestor
2328887|NCT00401570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328888|NCT00401570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2328889|NCT00401570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2328890|NCT00401570|Growth Substances|growth substances|mesh-ancestor
2328891|NCT00401570|Growth Inhibitors|growth inhibitors|mesh-ancestor
2328892|NCT00401596|Omalizumab|omalizumab|mesh-list
2328893|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2328894|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2328895|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
2328896|NCT00401609|Gemcitabine|gemcitabine|mesh-list
2328897|NCT00401609|Carboplatin|carboplatin|mesh-list
2328898|NCT00401609|Etoposide|etoposide|mesh-list
2328899|NCT00401609|Vinorelbine|vinorelbine|mesh-list
2328900|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328901|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2328902|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
2328903|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328904|NCT00401609|Antiviral Agents|antiviral agents|mesh-ancestor
2328905|NCT00401609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328906|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328907|NCT00401609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2328908|NCT00401609|Immunologic Factors|immunologic factors|mesh-ancestor
2328909|NCT00401609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328910|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2328911|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2328912|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2328913|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
2328914|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
2328915|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
2328916|NCT00401635|Carboplatin|carboplatin|mesh-list
2905591|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905592|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
2905593|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
2905594|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2905595|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2905596|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905597|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2905598|NCT05197439|Analgesics|analgesics|mesh-ancestor
2905599|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
2905600|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905601|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2905602|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2905603|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2905604|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
2905605|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905606|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905607|NCT05197426|Azacitidine|azacitidine|mesh-list
2905608|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2905609|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
2905610|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905611|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905612|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905613|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2905614|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2905615|NCT05197374|Estradiol|estradiol|mesh-list
2905616|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2905617|NCT05197374|Estrogens|estrogens|mesh-ancestor
2905618|NCT05197374|Hormones|hormones|mesh-ancestor
2905619|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2905620|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905621|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2905622|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
2905623|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2905624|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2905625|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
2905626|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2905627|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905628|NCT05197270|Aflibercept|aflibercept|mesh-list
2905629|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2905630|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2905631|NCT05197270|Growth Substances|growth substances|mesh-ancestor
2905632|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905633|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
2905634|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905635|NCT05197192|Venetoclax|venetoclax|mesh-list
2905636|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
2905637|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
2905638|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905639|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2905640|NCT05197101|Oxytocin|oxytocin|mesh-list
2905641|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
2905642|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2905643|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905644|NCT05197088|Tamsulosin|tamsulosin|mesh-list
2905645|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2905646|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2905647|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2905648|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
2905649|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905650|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905651|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905652|NCT05197088|Urological Agents|urological agents|mesh-ancestor
2905653|NCT05197075|Darunavir|darunavir|mesh-list
2905654|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2905655|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2905656|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
2905657|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905658|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905659|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2905660|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2905661|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
2905662|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2905663|NCT05197062|Aticaprant|aticaprant|mesh-list
2905664|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2905665|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905666|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
2905667|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905671|NCT05196945|Amoxicillin|amoxicillin|mesh-list
2905672|NCT05196945|Clarithromycin|clarithromycin|mesh-list
2328917|NCT00401635|Doxorubicin|doxorubicin|mesh-list
2328918|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2328919|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328920|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2328921|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2328922|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2328923|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328924|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328925|NCT00401648|Brivaracetam|brivaracetam|mesh-list
2328926|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
2328927|NCT00401661|Alfuzosin|alfuzosin|mesh-list
2905673|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
2905674|NCT05196945|Esomeprazole|esomeprazole|mesh-list
2905675|NCT05196945|Bismuth|bismuth|mesh-list
2905676|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905677|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2905678|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2905679|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2905680|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2905681|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2905682|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905683|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2905684|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2905685|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2905686|NCT05196945|Antacids|antacids|mesh-ancestor
2905687|NCT05196945|Diuretics|diuretics|mesh-ancestor
2905688|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
2905689|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328928|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2328929|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2328930|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2328931|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
2328932|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328933|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328934|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328935|NCT00401661|Urological Agents|urological agents|mesh-ancestor
2905690|NCT05196945|Expectorants|expectorants|mesh-ancestor
2905691|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
2905692|NCT05196932|Antibodies|antibodies|mesh-list
2905693|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
2905694|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905695|NCT05196815|Dobutamine|dobutamine|mesh-list
2328936|NCT00401674|Paclitaxel|paclitaxel|mesh-list
2328937|NCT00401674|Carboplatin|carboplatin|mesh-list
2328938|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2328939|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328940|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
2328941|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
2328942|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
2328943|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328944|NCT00401765|Docetaxel|docetaxel|mesh-list
2328945|NCT00401765|Siltuximab|siltuximab|mesh-list
2328946|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328947|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
2905696|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2905697|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
2905698|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
2905699|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905700|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905701|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2905702|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2905703|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2905704|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
2905705|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905706|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905707|NCT05196815|Protective Agents|protective agents|mesh-ancestor
2905708|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
2905709|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2905710|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905711|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2905712|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905713|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2905714|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2905715|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905716|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905717|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2905718|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2905719|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905720|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
2905721|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905722|NCT05196256|Sufentanil|sufentanil|mesh-list
2905723|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
2905724|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
2905725|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
2905726|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2905727|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328948|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
2328949|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
2905728|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
2905729|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905730|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2905731|NCT05196256|Narcotics|narcotics|mesh-ancestor
2905732|NCT05196256|Analgesics|analgesics|mesh-ancestor
2905733|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2328950|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328951|NCT00401804|Dexamethasone|dexamethasone|mesh-list
2328952|NCT00401804|Doxorubicin|doxorubicin|mesh-list
2328953|NCT00401804|Bortezomib|bortezomib|mesh-list
2328954|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2328955|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
2328956|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
2328957|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328958|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328959|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2328960|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
2328961|NCT00401804|Hormones|hormones|mesh-ancestor
2328962|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2328963|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2328964|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2328965|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2328966|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2328967|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2328968|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2328969|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328970|NCT00401856|Eplerenone|eplerenone|mesh-list
2328971|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2328972|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
2328973|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2328974|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328975|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2328976|NCT00401856|Diuretics|diuretics|mesh-ancestor
2328977|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
2328978|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2328979|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
2328980|NCT00401869|Hematinics|hematinics|mesh-ancestor
2328981|NCT00401921|Minocycline|minocycline|mesh-list
2328982|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2328983|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2328984|NCT00402012|Pioglitazone|pioglitazone|mesh-list
2328985|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2328986|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328987|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
2328988|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2328989|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2328990|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
2328991|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2328992|NCT00402077|Pramlintide|pramlintide|mesh-list
2328993|NCT00402077|Phentermine|phentermine|mesh-list
2328994|NCT00402077|Sibutramine|sibutramine|mesh-list
2109862|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2109863|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2109864|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2109865|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2109866|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
2109867|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109868|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109869|NCT02528253|Tramadol|tramadol|mesh-list
2109870|NCT02528253|Tanezumab|tanezumab|mesh-list
2109871|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2109872|NCT02528253|Narcotics|narcotics|mesh-ancestor
2905734|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2905735|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
2905736|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2905737|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2905738|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2905739|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
2905740|NCT05195996|Propranolol|propranolol|mesh-list
2905741|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2905742|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2905743|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
2905744|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2328995|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2328996|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905745|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2328997|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2328998|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
2328999|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2329000|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
2329001|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
2329002|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329003|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
2329004|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2329005|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329006|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
2329007|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2329008|NCT00402142|Vaccines|vaccines|mesh-list
2329009|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
2329010|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329011|NCT00402181|Dexamethasone|dexamethasone|mesh-list
2329012|NCT00402181|Siltuximab|siltuximab|mesh-list
2905746|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905747|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2905748|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2905749|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
2905750|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2109873|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109874|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109875|NCT02528253|Analgesics|analgesics|mesh-ancestor
2109876|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
2109877|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109878|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
2109879|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2109880|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109881|NCT02528409|Vortioxetine|vortioxetine|mesh-list
2109882|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
2109883|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2109884|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2905751|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2905752|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329013|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329014|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
2329015|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
2329016|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329017|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329018|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2329019|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
2905753|NCT05195944|Incretins|incretins|mesh-ancestor
2905754|NCT05195944|Hormones|hormones|mesh-ancestor
2905755|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2905756|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2905757|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
2905758|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905759|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905760|NCT05195918|Pirfenidone|pirfenidone|mesh-list
2905761|NCT05195918|Nintedanib|nintedanib|mesh-list
2905762|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2905763|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905764|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2905765|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905766|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905767|NCT05195918|Analgesics|analgesics|mesh-ancestor
2905768|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
2905769|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905770|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905771|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2905772|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2905773|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2905774|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2905775|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
2905776|NCT05195918|Protective Agents|protective agents|mesh-ancestor
2905777|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2905778|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2905779|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2905780|NCT05195775|Tadalafil|tadalafil|mesh-list
2905781|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
2905782|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2905783|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2905784|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109885|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2329020|NCT00402181|Hormones|hormones|mesh-ancestor
2329021|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2329022|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2329023|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905785|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905786|NCT05195775|Urological Agents|urological agents|mesh-ancestor
2905787|NCT05195645|Abatacept|abatacept|mesh-list
2905788|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2905789|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905790|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905791|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2905792|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
2905793|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905794|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2905795|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
2905796|NCT05195619|Vaccines|vaccines|mesh-list
2905797|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
2905798|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905799|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2905800|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2905801|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2905802|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
2329024|NCT00402207|Fluticasone|fluticasone|mesh-list
2329025|NCT00402207|Beclomethasone|beclomethasone|mesh-list
2329026|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329027|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2329028|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
2329029|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329030|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329031|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2329032|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
2905803|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905804|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905805|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2905806|NCT05195450|Tenofovir|tenofovir|mesh-list
2905807|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
2905808|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329033|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
2329034|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2329035|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
2329036|NCT00402207|Hormones|hormones|mesh-ancestor
2329037|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2329038|NCT00402259|Esomeprazole|esomeprazole|mesh-list
2329039|NCT00402259|Omeprazole|omeprazole|mesh-list
2329040|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2329041|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2905809|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2905810|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2905811|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905812|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905813|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2905814|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2905815|NCT05195294|Lenvatinib|lenvatinib|mesh-list
2905816|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905817|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2905818|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905819|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905832|NCT05195177|Anesthetics|anesthetics|mesh-list
2905833|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
2905834|NCT05195177|Histamine|histamine|mesh-list
2905835|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
2905836|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2905837|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2329042|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2329043|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905838|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905839|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
2905840|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905841|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
2905842|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
2905843|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905844|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905845|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
2905846|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
2905847|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2905848|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
2905849|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905850|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2905851|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2329044|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329045|NCT00402272|Everolimus|everolimus|mesh-list
2329046|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329047|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329048|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
2329049|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329050|NCT00402350|Fentanyl|fentanyl|mesh-list
2329051|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2329052|NCT00402350|Narcotics|narcotics|mesh-ancestor
2329053|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2329054|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329055|NCT00402350|Analgesics|analgesics|mesh-ancestor
2329056|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
2329057|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329058|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2329059|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2329060|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
2905852|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
2905853|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905854|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905855|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2905856|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2905857|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2905858|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
2905859|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2905860|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2905861|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905862|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
2905863|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2905864|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2905865|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905866|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2905867|NCT05195034|Analgesics|analgesics|mesh-ancestor
2905868|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
2905869|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905870|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2905871|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2905872|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2905873|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
2905874|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905875|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905876|NCT05194995|Cetuximab|cetuximab|mesh-list
2905877|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2905878|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905879|NCT05194969|Petrolatum|petrolatum|mesh-list
2905880|NCT05194969|Emollients|emollients|mesh-ancestor
2329061|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
2329062|NCT00402376|Carvedilol|carvedilol|mesh-list
2329063|NCT00402376|Perindopril|perindopril|mesh-list
2329064|NCT00402376|Pravastatin|pravastatin|mesh-list
2329065|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2329066|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2329067|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
2329068|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2329069|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329070|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329071|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2329072|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
2905881|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
2329073|NCT00402376|Protective Agents|protective agents|mesh-ancestor
2905882|NCT05194904|Ketorolac|ketorolac|mesh-list
2905883|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
2905884|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2905885|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2905886|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905887|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2905888|NCT05194904|Analgesics|analgesics|mesh-ancestor
2905889|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
2905890|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905891|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2905892|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2905893|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2905894|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
2905895|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905896|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905897|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2905898|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2905899|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2905900|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2905901|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905902|NCT05194852|Anesthetics|anesthetics|mesh-list
2905903|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
2905904|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2905905|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905906|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
2329074|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2329075|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2329076|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2329077|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
2329078|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2329079|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2329080|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2329081|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2329082|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
2329083|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2905907|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905908|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
2905909|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2905910|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905911|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2905912|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905913|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
2905914|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2905915|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2905916|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2905917|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2905918|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905919|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
2905920|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905921|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905922|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2905923|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2905924|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2905925|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2905926|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905927|NCT05194397|Niacinamide|niacinamide|mesh-list
2905928|NCT05194397|Niacin|niacin|mesh-list
2905929|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
2905930|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
2905931|NCT05194397|Vitamins|vitamins|mesh-ancestor
2905932|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
2905933|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905934|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2905935|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
2905936|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905937|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2905938|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
2329084|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2329085|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329086|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2329087|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
2329088|NCT00402415|Sirolimus|sirolimus|mesh-list
2329089|NCT00402415|Sunitinib|sunitinib|mesh-list
2329090|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2329091|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2905947|NCT05194189|Ascorbic Acid|ascorbic acid|mesh-list
2905948|NCT05194189|Vitamins|vitamins|mesh-ancestor
2905949|NCT05194189|Micronutrients|micronutrients|mesh-ancestor
2905950|NCT05194189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905951|NCT05194189|Antioxidants|antioxidants|mesh-ancestor
2905952|NCT05194189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905953|NCT05194189|Protective Agents|protective agents|mesh-ancestor
2329092|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2329093|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329094|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
2329095|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329096|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
2329097|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329098|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2329099|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2329100|NCT00402415|Growth Substances|growth substances|mesh-ancestor
2905954|NCT05194124|alpha-MSH|alpha-msh|mesh-list
2905955|NCT05194124|Hormones|hormones|mesh-ancestor
2905956|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2905957|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905958|NCT05194111|Valsartan|valsartan|mesh-list
2905959|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2905960|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2905961|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2905962|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2905963|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905964|NCT05194046|Amoxicillin|amoxicillin|mesh-list
2905965|NCT05194046|Clarithromycin|clarithromycin|mesh-list
2905966|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2905967|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2905968|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2905969|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905970|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905971|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2905972|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2905973|NCT05193994|Lamivudine|lamivudine|mesh-list
2905974|NCT05193994|Abacavir|abacavir|mesh-list
2905975|NCT05193994|Dolutegravir|dolutegravir|mesh-list
2905976|NCT05193994|Triumeq|triumeq|mesh-list
2905977|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2905978|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2905979|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2905980|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905981|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
2905982|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2905983|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2905984|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2905985|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2905986|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2905987|NCT05193968|Nitroprusside|nitroprusside|mesh-list
2905988|NCT05193968|Norepinephrine|norepinephrine|mesh-list
2905989|NCT05193968|Acetylcholine|acetylcholine|mesh-list
2905990|NCT05193968|Terbutaline|terbutaline|mesh-list
2905991|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2329101|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
2329102|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2329103|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329104|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329105|NCT00402428|Interferons|interferons|mesh-list
2329106|NCT00402428|Ribavirin|ribavirin|mesh-list
2329107|NCT00402428|Interferon-alpha|interferon-alpha|mesh-list
2329108|NCT00402428|Interferon alpha-2|interferon alpha-2|mesh-list
2329109|NCT00402428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2329110|NCT00402428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2905992|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2905993|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
2905994|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2905995|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2905996|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2905997|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
2905998|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
2905999|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2906000|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2906001|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2906002|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
2906003|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2906004|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2906005|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
2906006|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2906007|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2906008|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
2906009|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
2906010|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2906011|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2906012|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2906013|NCT05193851|Ricolinostat|ricolinostat|mesh-list
2906014|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906015|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2906016|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906017|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906018|NCT05193838|Allopurinol|allopurinol|mesh-list
2906019|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
2906020|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906021|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906022|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
2329111|NCT00402428|Antiviral Agents|antiviral agents|mesh-ancestor
2329112|NCT00402428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329113|NCT00402428|Antimetabolites|antimetabolites|mesh-ancestor
2329114|NCT00402428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329115|NCT00402428|Immunologic Factors|immunologic factors|mesh-ancestor
2329116|NCT00402428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329117|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
2329118|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2329119|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2329120|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329121|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2329122|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329123|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2329124|NCT00402454|Rifampin|rifampin|mesh-list
2906023|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2906024|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2906025|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
2906026|NCT05193838|Protective Agents|protective agents|mesh-ancestor
2906027|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906028|NCT05193747|Anesthetics|anesthetics|mesh-list
2906029|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2906030|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329125|NCT00402454|Isoniazid|isoniazid|mesh-list
2329126|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
2329127|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2329128|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
2329129|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2329130|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329131|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
2329132|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2906031|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
2906032|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
2906033|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
2906034|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906035|NCT05193604|Gemcitabine|gemcitabine|mesh-list
2906036|NCT05193604|Paclitaxel|paclitaxel|mesh-list
2906037|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2906038|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329133|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329134|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329135|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2329136|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2329137|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2329138|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2329139|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2906039|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
2906040|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
2906041|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
2906042|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906043|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2906044|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
2906045|NCT05193604|Antiviral Agents|antiviral agents|mesh-ancestor
2906046|NCT05193604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2906047|NCT05193604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906048|NCT05193604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2906049|NCT05193604|Immunologic Factors|immunologic factors|mesh-ancestor
2906050|NCT05193604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329140|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2329141|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2329142|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2329143|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
2329144|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2906068|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
2906069|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
2906070|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906074|NCT05193253|Liver Extracts|liver extracts|mesh-list
2906075|NCT05193253|Hematinics|hematinics|mesh-ancestor
2906076|NCT05190445|Paclitaxel|paclitaxel|mesh-list
2906077|NCT05190445|Ramucirumab|ramucirumab|mesh-list
2906078|NCT05190445|Tucatinib|tucatinib|mesh-list
2906079|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2906080|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906081|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
2906082|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
2906083|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
2906084|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906085|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2906086|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906087|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
2906088|NCT05188508|Temozolomide|temozolomide|mesh-list
2906089|NCT05188508|Olaparib|olaparib|mesh-list
2906090|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2906091|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906092|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2906093|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
2906094|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906095|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2906096|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329145|NCT00402467|Enoxaparin|enoxaparin|mesh-list
2329146|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
2329147|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
2329148|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2329149|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
2329150|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2329151|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
2329152|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329153|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329154|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
2906109|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2906110|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2906111|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2906112|NCT05176158|Analgesics|analgesics|mesh-ancestor
2906113|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
2906114|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2906115|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906116|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2906117|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2329155|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2329156|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2329157|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
2329158|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329159|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
2329160|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329161|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329162|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2329163|NCT00402493|Ibuprofen|ibuprofen|mesh-list
2329164|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2329165|NCT00402493|Latanoprost|latanoprost|mesh-list
2329166|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2329167|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2329168|NCT00402493|Analgesics|analgesics|mesh-ancestor
2329169|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
2329170|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329171|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329172|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2906139|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2906140|NCT05173597|Hormones|hormones|mesh-ancestor
2906141|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2906142|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906143|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
2906144|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2906145|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
2906146|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2329173|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2329174|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2329175|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329176|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329177|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2329178|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2329179|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2329180|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2906147|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906148|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2906149|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2906150|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2906151|NCT05171777|Atezolizumab|atezolizumab|mesh-list
2906152|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906153|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2906159|NCT05170464|Caffeine|caffeine|mesh-list
2906160|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2906161|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906162|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2906163|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906164|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906165|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2906166|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2906167|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
2906168|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2906169|NCT05170438|Paclitaxel|paclitaxel|mesh-list
2906170|NCT05170438|Lenvatinib|lenvatinib|mesh-list
2906171|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2906172|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906173|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
2906174|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
2906175|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
2329181|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2329182|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2329183|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
2329184|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2906176|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906177|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2906178|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906182|NCT05169866|Amiodarone|amiodarone|mesh-list
2906183|NCT05169866|Nifekalant|nifekalant|mesh-list
2906184|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2906185|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
2329185|NCT00402506|Pyridoxal|pyridoxal|mesh-list
2329186|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
2329187|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
2109886|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109887|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109888|NCT02528409|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2109889|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2109890|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2109891|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109892|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109893|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
2109894|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2109895|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2109896|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2109897|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2109898|NCT02529072|Nivolumab|nivolumab|mesh-list
2109899|NCT02529072|Vaccines|vaccines|mesh-list
2109900|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
2109901|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109902|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2109903|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109904|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2109905|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109906|NCT02529995|Osimertinib|osimertinib|mesh-list
2109907|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109908|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2109909|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109910|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109911|NCT02530125|Pidilizumab|pidilizumab|mesh-list
2109912|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2906186|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2906187|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2906188|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906189|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2906190|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2906191|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2906192|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906193|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2906194|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2906195|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2906196|NCT05168865|Letrozole|letrozole|mesh-list
2906197|NCT05168865|Estradiol|estradiol|mesh-list
2906198|NCT05168865|Progesterone|progesterone|mesh-list
2906199|NCT05168865|Estrogens|estrogens|mesh-ancestor
2329188|NCT00402506|Vitamins|vitamins|mesh-ancestor
2329189|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
2329190|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329191|NCT00402532|Everolimus|everolimus|mesh-list
2329192|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329193|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329194|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
2329195|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329196|NCT00402545|Docetaxel|docetaxel|mesh-list
2329197|NCT00402545|Fluorouracil|fluorouracil|mesh-list
2329198|NCT00402545|Cetuximab|cetuximab|mesh-list
2329199|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329200|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
2329201|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
2329202|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
2329203|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329204|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
2329205|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2329206|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329207|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
2329208|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329209|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2329210|NCT00402558|Aldesleukin|aldesleukin|mesh-list
2329211|NCT00402558|Methotrexate|methotrexate|mesh-list
2329212|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
2329213|NCT00402558|Fludarabine|fludarabine|mesh-list
2329214|NCT00402558|Busulfan|busulfan|mesh-list
2329215|NCT00402558|Interleukin-2|interleukin-2|mesh-list
2329216|NCT00402558|Tacrolimus|tacrolimus|mesh-list
2329217|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
2906200|NCT05168865|Hormones|hormones|mesh-ancestor
2906201|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2906202|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906203|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906204|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2906205|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2906206|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906207|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906208|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2906209|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
2906210|NCT05168865|Progestins|progestins|mesh-ancestor
2906211|NCT05167825|Macitentan|macitentan|mesh-list
2906212|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2906213|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2906214|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906215|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2906216|NCT05165251|Amlodipine|amlodipine|mesh-list
2906217|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
2906218|NCT05165251|Atorvastatin|atorvastatin|mesh-list
2906219|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2906220|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2906221|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
2906222|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906223|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2906224|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2906225|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906226|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2906227|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2906228|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2906229|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2329218|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2906230|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906231|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
2906232|NCT05163041|Nivolumab|nivolumab|mesh-list
2906233|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2906234|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906235|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2906236|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906248|NCT05155007|Cyclosporine|cyclosporine|mesh-list
2906249|NCT05155007|Cyclosporins|cyclosporins|mesh-list
2906250|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906251|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906252|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2906253|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
2906254|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906255|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
2906256|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2906257|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
2906258|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2906259|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2906260|NCT05154669|Nicotine|nicotine|mesh-list
2906261|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2906262|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
2906263|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2906264|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906265|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2906266|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2906267|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
2906268|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2906269|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906270|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2906271|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2906272|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2906273|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
2906274|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2906275|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906276|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2906277|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2906278|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2906279|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2906280|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2906281|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2906282|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2906283|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2906284|NCT05151146|Metformin|metformin|mesh-list
2906285|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2906286|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906287|NCT05150652|Tamoxifen|tamoxifen|mesh-list
2906288|NCT05150652|Letrozole|letrozole|mesh-list
2906289|NCT05150652|Anastrozole|anastrozole|mesh-list
2906290|NCT05150652|Exemestane|exemestane|mesh-list
2906291|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906292|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2906293|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2906294|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906295|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906296|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2906297|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
2329219|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2329220|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
2329221|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2329222|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329223|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2329224|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
2329225|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329226|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329227|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
2329228|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329229|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2329230|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329231|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
2329232|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2329233|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2329234|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
2329235|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329236|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2329237|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
2329238|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2329239|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2329240|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2906298|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2906299|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906300|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2906301|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2906302|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2906303|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2906304|NCT05149131|Leuprolide|leuprolide|mesh-list
2329241|NCT00402558|Analgesics|analgesics|mesh-ancestor
2329242|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
2329243|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329244|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2329245|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2329246|NCT00402571|Acetaminophen|acetaminophen|mesh-list
2329247|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2329248|NCT00402571|Analgesics|analgesics|mesh-ancestor
2329249|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
2329250|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329251|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329252|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
2329253|NCT00402584|Sibutramine|sibutramine|mesh-list
2329254|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
2329255|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2329256|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
2329257|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2329258|NCT00402610|Rifampin|rifampin|mesh-list
2329259|NCT00402610|Isoniazid|isoniazid|mesh-list
2906305|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2906306|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
2906307|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2906308|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906309|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2906310|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329260|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
2329261|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2329262|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
2906317|NCT05143489|Lidocaine|lidocaine|mesh-list
2906318|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
2906319|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
2906320|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2906321|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906322|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
2906323|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2906324|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2906325|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2906326|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2906327|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2906328|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906329|NCT05143073|Ethanol|ethanol|mesh-list
2906330|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2906331|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329263|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2329264|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329265|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
2329266|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2329267|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329268|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329269|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2329270|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2329271|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2329272|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2329273|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2329274|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2329275|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2906332|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2906333|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906334|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
2906335|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2906336|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906337|NCT05139875|Triamcinolone|triamcinolone|mesh-list
2906338|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2906339|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2906340|NCT05139875|Betamethasone|betamethasone|mesh-list
2906341|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
2906342|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2906343|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
2906344|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2906345|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2906346|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2906347|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
2906348|NCT05139875|Hormones|hormones|mesh-ancestor
2906349|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2906350|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906351|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2906352|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
2906353|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906354|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906355|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2906356|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
2906357|NCT05137860|Bortezomib|bortezomib|mesh-list
2906358|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906359|NCT05136898|Mitomycins|mitomycins|mesh-list
2906360|NCT05136898|Mitomycin|mitomycin|mesh-list
2906361|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2906362|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906363|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
2906364|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906365|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2906366|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906367|NCT05131997|Atorvastatin|atorvastatin|mesh-list
2906368|NCT05131997|Ezetimibe|ezetimibe|mesh-list
2906369|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2906370|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2906371|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
2906372|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329276|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2329277|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
2329278|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2329279|NCT00402623|Quercetin|quercetin|mesh-list
2329280|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
2329281|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329282|NCT00402623|Protective Agents|protective agents|mesh-ancestor
2329283|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329284|NCT00402636|Sirolimus|sirolimus|mesh-list
2329285|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2329286|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329287|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2329288|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329289|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
2329290|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329291|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
2906373|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2906374|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2906375|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906376|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2906377|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
2906378|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2906379|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
2906380|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2906381|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906382|NCT05127044|Bilirubin|bilirubin|mesh-list
2906383|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
2906384|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906385|NCT05127044|Protective Agents|protective agents|mesh-ancestor
2906386|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906387|NCT05126966|Ranibizumab|ranibizumab|mesh-list
2906388|NCT05126966|Aflibercept|aflibercept|mesh-list
2906389|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2906390|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2906391|NCT05126966|Growth Substances|growth substances|mesh-ancestor
2906392|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906393|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
2906394|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906395|NCT05123170|Lidocaine|lidocaine|mesh-list
2906396|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
2906397|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
2906398|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
2906399|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2906400|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906401|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
2906402|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329292|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329293|NCT00402662|Everolimus|everolimus|mesh-list
2329294|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
2329295|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329296|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329297|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
2329298|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329299|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2906403|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2906404|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2906405|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2906406|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2906407|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906408|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2906409|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2906410|NCT05123170|Analgesics|analgesics|mesh-ancestor
2906411|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2906412|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2906413|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2906414|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
2906415|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2906416|NCT05123131|Dexamethasone|dexamethasone|mesh-list
2906417|NCT05123131|Lenalidomide|lenalidomide|mesh-list
2906418|NCT05123131|Bortezomib|bortezomib|mesh-list
2906419|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329300|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329301|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329302|NCT00402766|Dexamethasone|dexamethasone|mesh-list
2329303|NCT00402766|Cisplatin|cisplatin|mesh-list
2329304|NCT00402766|Pemetrexed|pemetrexed|mesh-list
2329305|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
2329306|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329307|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329308|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
2329309|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
2906420|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
2906421|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
2906422|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2906423|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906424|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2906425|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
2906426|NCT05123131|Hormones|hormones|mesh-ancestor
2906427|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2906428|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2906429|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906430|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
2906431|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2906432|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2906433|NCT05123131|Growth Substances|growth substances|mesh-ancestor
2906434|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
2906435|NCT05116241|Vaccines|vaccines|mesh-list
2906436|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
2906437|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906438|NCT05112939|Rilpivirine|rilpivirine|mesh-list
2906439|NCT05112939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2906440|NCT05112939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2906441|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906442|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906443|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
2906444|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2906445|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2906446|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2906447|NCT05112601|Nivolumab|nivolumab|mesh-list
2906448|NCT05112601|Ipilimumab|ipilimumab|mesh-list
2906449|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2906450|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906451|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2906452|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906453|NCT05112536|Paclitaxel|paclitaxel|mesh-list
2906454|NCT05112536|Carboplatin|carboplatin|mesh-list
2906455|NCT05112536|Doxorubicin|doxorubicin|mesh-list
2906456|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
2906457|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2906458|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906459|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
2906460|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
2906461|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
2906462|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906463|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2906464|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2906465|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2329310|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329311|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329312|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2329313|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
2329314|NCT00402766|Hormones|hormones|mesh-ancestor
2329315|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2329316|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2329317|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329318|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329319|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2329320|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2329321|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2329322|NCT00402792|Acetaminophen|acetaminophen|mesh-list
2329323|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2329324|NCT00402792|Hydrocodone|hydrocodone|mesh-list
2329325|NCT00402792|Oxycodone|oxycodone|mesh-list
2329326|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2329327|NCT00402792|Analgesics|analgesics|mesh-ancestor
2329328|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
2329329|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329330|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329331|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
2329332|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2329333|NCT00402792|Narcotics|narcotics|mesh-ancestor
2329334|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2329335|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
2329336|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
2329337|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2906466|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906467|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2906478|NCT05109442|Atezolizumab|atezolizumab|mesh-list
2906479|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906480|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2906481|NCT05108935|Buprenorphine|buprenorphine|mesh-list
2906482|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2329338|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329339|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2329340|NCT00402909|Nateglinide|nateglinide|mesh-list
2329341|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2329342|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906483|NCT05108935|Naloxone|naloxone|mesh-list
2906484|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2906485|NCT05108935|Narcotics|narcotics|mesh-ancestor
2906486|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2906487|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906488|NCT05108935|Analgesics|analgesics|mesh-ancestor
2906489|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
2329343|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
2329344|NCT00402974|Vitamin K|vitamin k|mesh-list
2329345|NCT00402974|Vitamin MK 7|vitamin mk 7|mesh-list
2329346|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2329347|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2329348|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329349|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
2906490|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2906491|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2906492|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2906493|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2906494|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906495|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906496|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
2906497|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2906498|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2906499|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2906500|NCT05105750|Aspirin|aspirin|mesh-list
2906501|NCT05105750|Indobufen|indobufen|mesh-list
2906502|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2906503|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2906504|NCT05105750|Analgesics|analgesics|mesh-ancestor
2906505|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
2906506|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2906507|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906508|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2906509|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2906510|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2906511|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2906512|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906513|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2906514|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2906515|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906516|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
2906521|NCT05091567|Carboplatin|carboplatin|mesh-list
2906522|NCT05091567|Etoposide|etoposide|mesh-list
2906523|NCT05091567|Atezolizumab|atezolizumab|mesh-list
2906524|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906525|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2906526|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2906527|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2906528|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906529|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906530|NCT05091528|Capecitabine|capecitabine|mesh-list
2906531|NCT05091528|Trastuzumab|trastuzumab|mesh-list
2906532|NCT05091528|Tucatinib|tucatinib|mesh-list
2906533|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2906534|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
2906535|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906536|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906537|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2906538|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2329350|NCT00402974|Coagulants|coagulants|mesh-ancestor
2329351|NCT00402974|Vitamins|vitamins|mesh-ancestor
2329352|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
2329353|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329354|NCT00403000|Dutasteride|dutasteride|mesh-list
2329355|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2329356|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2329357|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906539|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906540|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
2906541|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
2906542|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906543|NCT05081089|Lumefantrine|lumefantrine|mesh-list
2906544|NCT05081089|Artemether|artemether|mesh-list
2906545|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
2906546|NCT05081089|Primaquine|primaquine|mesh-list
2906547|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
2906548|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2906549|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2906550|NCT05081089|Amodiaquine|amodiaquine|mesh-list
2906551|NCT05081089|Tafenoquine|tafenoquine|mesh-list
2906552|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
2906553|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2906554|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2906555|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2906556|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2906557|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906558|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906559|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2906560|NCT05081089|Renal Agents|renal agents|mesh-ancestor
2329358|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329359|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
2329360|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2329361|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329362|NCT00403013|Anesthetics|anesthetics|mesh-list
2329363|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2329364|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329365|NCT00403026|Bevacizumab|bevacizumab|mesh-list
2329366|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2329367|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329368|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2329369|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2329370|NCT00403026|Growth Substances|growth substances|mesh-ancestor
2329371|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329372|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
2329373|NCT00403039|Ranibizumab|ranibizumab|mesh-list
2329374|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2329375|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2329376|NCT00403039|Growth Substances|growth substances|mesh-ancestor
2329377|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329378|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
2906583|NCT05068661|Fentanyl|fentanyl|mesh-list
2906584|NCT05068661|Bupivacaine|bupivacaine|mesh-list
2906585|NCT05068661|Ropivacaine|ropivacaine|mesh-list
2906586|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2329379|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329380|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
2329381|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2329382|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
2906587|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
2906588|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
2906589|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2906590|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906591|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
2906592|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2906593|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2906594|NCT05068661|Narcotics|narcotics|mesh-ancestor
2906595|NCT05068661|Analgesics|analgesics|mesh-ancestor
2906596|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2906597|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2906598|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
2906599|NCT05065216|Kallikreins|kallikreins|mesh-list
2906600|NCT05065216|Coagulants|coagulants|mesh-ancestor
2906601|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
2906602|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
2906603|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2906604|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906605|NCT05064800|Ritonavir|ritonavir|mesh-list
2906606|NCT05064800|Dabigatran|dabigatran|mesh-list
2906607|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2906608|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2906609|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
2906610|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906611|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906612|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2906613|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2906614|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
2906615|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2906616|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2906617|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2906618|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
2906619|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2906620|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
2329383|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329384|NCT00403065|Dexamethasone|dexamethasone|mesh-list
2329385|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329386|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
2329387|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
2329388|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329389|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329390|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2906644|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
2906645|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329391|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
2329392|NCT00403065|Hormones|hormones|mesh-ancestor
2329393|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2329394|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2329395|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329396|NCT00403156|Ranibizumab|ranibizumab|mesh-list
2329397|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
2329398|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2329399|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2329400|NCT00403156|Growth Substances|growth substances|mesh-ancestor
2906646|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
2906647|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329401|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906648|NCT05062889|Leucovorin|leucovorin|mesh-list
2906649|NCT05062889|Trifluridine|trifluridine|mesh-list
2906650|NCT05062889|Fluorouracil|fluorouracil|mesh-list
2329402|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
2329403|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329404|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2329405|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906651|NCT05062889|Capecitabine|capecitabine|mesh-list
2906652|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
2906653|NCT05062889|Irinotecan|irinotecan|mesh-list
2906654|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
2906655|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
2906656|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906657|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2906658|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906659|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2906660|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
2906661|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906662|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2906663|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2906664|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906665|NCT05062889|Antidotes|antidotes|mesh-ancestor
2906666|NCT05062889|Protective Agents|protective agents|mesh-ancestor
2906667|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
2906668|NCT05062889|Vitamins|vitamins|mesh-ancestor
2906669|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
2906670|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
2906671|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329406|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329407|NCT00403169|Lenalidomide|lenalidomide|mesh-list
2906692|NCT05057806|Empagliflozin|empagliflozin|mesh-list
2906693|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2906694|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906695|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2906696|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906697|NCT05057494|Venetoclax|venetoclax|mesh-list
2906698|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
2906699|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
2906700|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906701|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2906702|NCT05050942|Octreotide|octreotide|mesh-list
2906703|NCT05050942|Lanreotide|lanreotide|mesh-list
2906704|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2906705|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2906706|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906712|NCT05048719|Dulaglutide|dulaglutide|mesh-list
2906713|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2906714|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329408|NCT00403169|Immunologic Factors|immunologic factors|mesh-ancestor
2329409|NCT00403169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329410|NCT00403169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2906715|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2906716|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2906717|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
2906718|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2906719|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906720|NCT05042505|Incretins|incretins|mesh-ancestor
2906721|NCT05042505|Hormones|hormones|mesh-ancestor
2906722|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2906723|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2906724|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
2906725|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906726|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906727|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2906728|NCT05041673|Metformin|metformin|mesh-list
2906729|NCT05041673|Liraglutide|liraglutide|mesh-list
2906730|NCT05041673|Empagliflozin|empagliflozin|mesh-list
2906731|NCT05041673|Vildagliptin|vildagliptin|mesh-list
2906732|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2906733|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906734|NCT05041673|Incretins|incretins|mesh-ancestor
2906735|NCT05041673|Hormones|hormones|mesh-ancestor
2906736|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2906737|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2906738|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906739|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2906740|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
2906741|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906758|NCT05035186|Amoxicillin|amoxicillin|mesh-list
2906759|NCT05035186|Clarithromycin|clarithromycin|mesh-list
2906760|NCT05035186|Levofloxacin|levofloxacin|mesh-list
2906761|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2906762|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2906763|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2906764|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906765|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906766|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2906767|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2906768|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2329411|NCT00403169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2329412|NCT00403169|Growth Substances|growth substances|mesh-ancestor
2906769|NCT05035186|Renal Agents|renal agents|mesh-ancestor
2906770|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2906771|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2906772|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906773|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2906774|NCT05032950|Ritonavir|ritonavir|mesh-list
2906775|NCT05032950|Midazolam|midazolam|mesh-list
2906776|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2906777|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2906778|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2906779|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329413|NCT00403169|Growth Inhibitors|growth inhibitors|mesh-ancestor
2329414|NCT00403169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329415|NCT00403182|Letrozole|letrozole|mesh-list
2329416|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329417|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2329418|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2329419|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329420|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329421|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2329422|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
2329423|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2329424|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329425|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
2329426|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
2329427|NCT00403247|Pyridoxine|pyridoxine|mesh-list
2329428|NCT00403247|Vitamins|vitamins|mesh-ancestor
2329429|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
2329430|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329431|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
2329432|NCT00403247|Hematinics|hematinics|mesh-ancestor
2329433|NCT00403286|Fluticasone|fluticasone|mesh-list
2329434|NCT00403286|Xhance|xhance|mesh-list
2329435|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
2329436|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2329437|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329438|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2329439|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
2329440|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329441|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329442|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2329443|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
2329444|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
2329445|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2329446|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2329447|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2329448|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2906780|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2906781|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2906782|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2906783|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2906784|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
2906785|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
2906786|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
2906787|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
2906788|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2906789|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906790|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2906791|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2906792|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
2329449|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
2329450|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2906793|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906794|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2906795|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2906796|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
2906797|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2906798|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2906799|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2906800|NCT05030766|Nicotine|nicotine|mesh-list
2906801|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2906802|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
2329451|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329452|NCT00403312|Nicotine|nicotine|mesh-list
2329453|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2329454|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
2329455|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329456|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329457|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2329458|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2329459|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
2329460|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2329461|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329462|NCT00403325|Ranibizumab|ranibizumab|mesh-list
2906803|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2906804|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906805|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2906806|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2906807|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
2906808|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2906809|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329463|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2329464|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2329465|NCT00403325|Growth Substances|growth substances|mesh-ancestor
2329466|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329467|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
2329468|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329469|NCT00403338|Sirolimus|sirolimus|mesh-list
2329470|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2906810|NCT05030441|Ivosidenib|ivosidenib|mesh-list
2906811|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906812|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906813|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329471|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329472|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2329473|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329474|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
2329475|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329476|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
2329477|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329478|NCT00403364|Amoxicillin|amoxicillin|mesh-list
2329479|NCT00403364|Clarithromycin|clarithromycin|mesh-list
2329480|NCT00403364|Tinidazole|tinidazole|mesh-list
2329481|NCT00403364|Pantoprazole|pantoprazole|mesh-list
2329482|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2906836|NCT05028608|Carbamazepine|carbamazepine|mesh-list
2906837|NCT05028608|Midazolam|midazolam|mesh-list
2906838|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2906839|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2906840|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2906841|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906842|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2906843|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2906844|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2906845|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2906846|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
2906847|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
2906848|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
2906849|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
2906850|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2906851|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906852|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
2906853|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
2906854|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2906855|NCT05028608|Analgesics|analgesics|mesh-ancestor
2906856|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
2329483|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329484|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2329485|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329486|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329487|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2329488|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2329489|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2329490|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2329491|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2329492|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
2329493|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2329494|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2329495|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2329496|NCT00403416|Mycophenolic Acid|mycophenolic acid|mesh-list
2329497|NCT00403416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2329498|NCT00403416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329499|NCT00403416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2329500|NCT00403416|Antitubercular Agents|antitubercular agents|mesh-ancestor
2906857|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2906858|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2906859|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2906860|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2906861|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2329501|NCT00403416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2329502|NCT00403416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329503|NCT00403416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906883|NCT05026320|Diclofenac|diclofenac|mesh-list
2906884|NCT05026320|Naproxen|naproxen|mesh-list
2906885|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2906886|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2906887|NCT05026320|Analgesics|analgesics|mesh-ancestor
2906888|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
2906889|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2906890|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906891|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2906892|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2906893|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2906894|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906895|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329504|NCT00403416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329505|NCT00403429|Capecitabine|capecitabine|mesh-list
2329506|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2329507|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
2329508|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329509|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329510|NCT00403442|Bevacizumab|bevacizumab|mesh-list
2329511|NCT00403442|Verteporfin|verteporfin|mesh-list
2329512|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2329513|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329514|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2906896|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
2906897|NCT05022927|Bevacizumab|bevacizumab|mesh-list
2906898|NCT05022927|Atezolizumab|atezolizumab|mesh-list
2906899|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2906900|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906901|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2906902|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2906903|NCT05022927|Growth Substances|growth substances|mesh-ancestor
2906904|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906905|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
2906906|NCT05013437|Acetaminophen|acetaminophen|mesh-list
2906907|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
2906908|NCT05013437|Promethazine|promethazine|mesh-list
2906909|NCT05013437|Melphalan|melphalan|mesh-list
2906910|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
2906911|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2906912|NCT05013437|Analgesics|analgesics|mesh-ancestor
2906913|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
2329515|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2329516|NCT00403442|Growth Substances|growth substances|mesh-ancestor
2329517|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329518|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
2906914|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2906915|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906916|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
2906917|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2906918|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
2906919|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906920|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906921|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2906922|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2906923|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
2906924|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2906925|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2329519|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2329520|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
2329521|NCT00403533|Atorvastatin|atorvastatin|mesh-list
2329522|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2329523|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2329524|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
2329525|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329526|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2906926|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2906927|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
2906928|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
2906929|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
2906930|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
2906931|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2906932|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2906933|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
2329527|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2329528|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329529|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
2329530|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2329531|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2329532|NCT00403559|Analgesics|analgesics|mesh-ancestor
2329533|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
2329534|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329535|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329536|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329537|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2329538|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
2329539|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329540|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
2329541|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2906934|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
2906935|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2906936|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2906937|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
2906938|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
2906939|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2906940|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2906941|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2906942|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2906943|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
2329542|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329543|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329544|NCT00403611|Praziquantel|praziquantel|mesh-list
2329545|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
2329546|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2329547|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329548|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
2329549|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329550|NCT00403637|Maleic acid|maleic acid|mesh-list
2329551|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906953|NCT05008913|Adavosertib|adavosertib|mesh-list
2906954|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906955|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906956|NCT05008276|Dextrans|dextrans|mesh-list
2906957|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
2906958|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
2906959|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
2906960|NCT05005312|Ritonavir|ritonavir|mesh-list
2906961|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2329552|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329553|NCT00403650|Iloprost|iloprost|mesh-list
2329554|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2329555|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
2329556|NCT00403663|Fentanyl|fentanyl|mesh-list
2329557|NCT00403663|Morphine|morphine|mesh-list
2329558|NCT00403663|Bupivacaine|bupivacaine|mesh-list
2329559|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
2329560|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
2329561|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2329562|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906962|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2906963|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
2906964|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906965|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906966|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2906967|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2906968|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
2906969|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2906970|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2906971|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2906972|NCT04999969|Gemcitabine|gemcitabine|mesh-list
2906973|NCT04999969|Paclitaxel|paclitaxel|mesh-list
2906974|NCT04999969|Durvalumab|durvalumab|mesh-list
2906975|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2906976|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906977|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
2906978|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
2906979|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
2906980|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2906981|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2906982|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
2906983|NCT04999969|Antiviral Agents|antiviral agents|mesh-ancestor
2906984|NCT04999969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2906985|NCT04999969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2906986|NCT04999969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2906987|NCT04999969|Immunologic Factors|immunologic factors|mesh-ancestor
2906988|NCT04999969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906989|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2906990|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
2329563|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
2329564|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329565|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2329566|NCT00403663|Narcotics|narcotics|mesh-ancestor
2329567|NCT00403663|Analgesics|analgesics|mesh-ancestor
2329568|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2329569|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2329570|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
2906991|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
2906992|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2906993|NCT04995120|Paclitaxel|paclitaxel|mesh-list
2906994|NCT04995120|Cisplatin|cisplatin|mesh-list
2906995|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2906996|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2906997|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
2906998|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
2906999|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
2907000|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907001|NCT04992312|Glucagon|glucagon|mesh-list
2907002|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2907003|NCT04992312|Hormones|hormones|mesh-ancestor
2907004|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2907005|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907012|NCT04989946|Nivolumab|nivolumab|mesh-list
2907013|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907014|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907015|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2329571|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2329572|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2329573|NCT00403728|Cyclosporine|cyclosporine|mesh-list
2329574|NCT00403728|Cyclosporins|cyclosporins|mesh-list
2329575|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329576|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907016|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907035|NCT04973150|Anesthetics|anesthetics|mesh-list
2907036|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2907037|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907038|NCT04971837|Cannabidiol|cannabidiol|mesh-list
2329577|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329578|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
2329579|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329580|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
2329581|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329582|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
2907039|NCT04971837|Sorbitol|sorbitol|mesh-list
2907040|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
2907041|NCT04971837|Cathartics|cathartics|mesh-ancestor
2907042|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2907043|NCT04971499|Dapansutrile|dapansutrile|mesh-list
2907044|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
2907045|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907046|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329583|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2329584|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2329585|NCT00403780|Pregabalin|pregabalin|mesh-list
2329586|NCT00403780|Analgesics|analgesics|mesh-ancestor
2329587|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
2907047|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2907054|NCT04964960|Paclitaxel|paclitaxel|mesh-list
2907055|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2907056|NCT04964960|Carboplatin|carboplatin|mesh-list
2907057|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
2907058|NCT04964960|Pemetrexed|pemetrexed|mesh-list
2907059|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2907060|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907061|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
2907062|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
2907063|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
2907064|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907065|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907066|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907067|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2907068|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2907069|NCT04962503|Afamelanotide|afamelanotide|mesh-list
2907070|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
2907071|NCT04959266|Itraconazole|itraconazole|mesh-list
2907072|NCT04959266|Rifampin|rifampin|mesh-list
2329588|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329589|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907073|NCT04959266|Omeprazole|omeprazole|mesh-list
2907074|NCT04959266|Adavosertib|adavosertib|mesh-list
2329590|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
2329591|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2329592|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2329593|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329594|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2329595|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2329596|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2329597|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2907075|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2907076|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2907077|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2907078|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907079|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907080|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
2907081|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2907082|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2907083|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2907084|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2907085|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
2907086|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2907087|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907088|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2907089|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2907090|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
2907091|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2907092|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
2907093|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2907094|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2907095|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2907096|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2907097|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2329598|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2329599|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
2329600|NCT00403793|Etonogestrel|etonogestrel|mesh-list
2329601|NCT00403793|Testosterone|testosterone|mesh-list
2329602|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
2329603|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
2329604|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2329605|NCT00403793|Androgens|androgens|mesh-ancestor
2329606|NCT00403793|Hormones|hormones|mesh-ancestor
2329607|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2329608|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329609|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2329610|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329611|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
2329612|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2329613|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
2329614|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2329615|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2329616|NCT00403806|Dexamethasone|dexamethasone|mesh-list
2329617|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
2329618|NCT00403806|BB 1101|bb 1101|mesh-list
2907098|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2907099|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2907100|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
2907101|NCT04959175|Sirolimus|sirolimus|mesh-list
2907102|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
2907103|NCT04959175|Fludarabine|fludarabine|mesh-list
2907104|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2907105|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
2329619|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329620|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
2329621|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
2329622|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329623|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329624|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2329625|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
2907106|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907107|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2907108|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2907109|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
2907110|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329626|NCT00403806|Hormones|hormones|mesh-ancestor
2907111|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907112|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2907113|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2907114|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2907115|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
2907116|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2907117|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329627|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2329628|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2329629|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329630|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
2907118|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907119|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
2907120|NCT04958044|Calcium|calcium|mesh-list
2907121|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2907122|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907123|NCT04954196|Amlodipine|amlodipine|mesh-list
2907124|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2907125|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2907126|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2907127|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907128|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2907129|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907130|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
2907131|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2907132|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2907133|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907134|NCT04942067|Dexamethasone|dexamethasone|mesh-list
2907135|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
2907136|NCT04942067|Lenalidomide|lenalidomide|mesh-list
2907137|NCT04942067|Daratumumab|daratumumab|mesh-list
2907138|NCT04942067|Pomalidomide|pomalidomide|mesh-list
2907139|NCT04942067|BB 1101|bb 1101|mesh-list
2907140|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2907141|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
2907142|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
2907143|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2907144|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907145|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2907146|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
2907147|NCT04942067|Hormones|hormones|mesh-ancestor
2907148|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2907149|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2907150|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907151|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
2907152|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907153|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907154|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
2907155|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2907156|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2907157|NCT04942067|Growth Substances|growth substances|mesh-ancestor
2907158|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
2329631|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329632|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329633|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2329634|NCT00403819|Laxatives|laxatives|mesh-ancestor
2329635|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2329636|NCT00403858|Lactulose|lactulose|mesh-list
2329637|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2329638|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2329639|NCT00403858|Laxatives|laxatives|mesh-ancestor
2329640|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2329641|NCT00403897|Laxatives|laxatives|mesh-ancestor
2907200|NCT04933552|Siponimod|siponimod|mesh-list
2907201|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2907202|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907203|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2907204|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
2907205|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907219|NCT04931342|Paclitaxel|paclitaxel|mesh-list
2907220|NCT04931342|Maytansine|maytansine|mesh-list
2907221|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2907222|NCT04931342|Bevacizumab|bevacizumab|mesh-list
2329642|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2329643|NCT00403910|Canrenone|canrenone|mesh-list
2329644|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2329645|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
2329646|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2329647|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329648|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2329649|NCT00403910|Diuretics|diuretics|mesh-ancestor
2329650|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
2329651|NCT00403949|Azelaic acid|azelaic acid|mesh-list
2329652|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329653|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
2329654|NCT00403962|Paroxetine|paroxetine|mesh-list
2907223|NCT04931342|Trastuzumab|trastuzumab|mesh-list
2907224|NCT04931342|Atezolizumab|atezolizumab|mesh-list
2907225|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2907226|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907227|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
2907228|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
2907229|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
2907230|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907231|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907232|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2907233|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2907234|NCT04931342|Growth Substances|growth substances|mesh-ancestor
2907235|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907236|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
2907237|NCT04929223|Bevacizumab|bevacizumab|mesh-list
2907238|NCT04929223|Cetuximab|cetuximab|mesh-list
2907239|NCT04929223|Atezolizumab|atezolizumab|mesh-list
2907240|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907241|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907242|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2329655|NCT00403962|Vestipitant|vestipitant|mesh-list
2329656|NCT00403962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2329657|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2329658|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2329659|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329660|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2329661|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
2907243|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2907244|NCT04929223|Growth Substances|growth substances|mesh-ancestor
2907245|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907246|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
2907247|NCT04925479|Niacinamide|niacinamide|mesh-list
2907248|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
2907249|NCT04925479|Vitamins|vitamins|mesh-ancestor
2907250|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
2907251|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907301|NCT04907214|Empagliflozin|empagliflozin|mesh-list
2329662|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329663|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2329664|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
2329665|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2907302|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2907303|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907304|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2907305|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907335|NCT04891809|Dexamethasone|dexamethasone|mesh-list
2907336|NCT04891809|Lenalidomide|lenalidomide|mesh-list
2907337|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2907338|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
2907339|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
2907340|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2907341|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907342|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2907343|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
2329666|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2329667|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2329668|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329669|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2907344|NCT04891809|Hormones|hormones|mesh-ancestor
2907345|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2907346|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2329670|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2329671|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2329672|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
2329673|NCT00403988|Vinorelbine|vinorelbine|mesh-list
2329674|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329675|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2907347|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907348|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
2907349|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2907350|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2907351|NCT04891809|Growth Substances|growth substances|mesh-ancestor
2907352|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
2907353|NCT04891419|Lidocaine|lidocaine|mesh-list
2907354|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
2907355|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
2907356|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2907357|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907358|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
2907359|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2907360|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2907361|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2907362|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2907363|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2907364|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907365|NCT04890106|Bimatoprost|bimatoprost|mesh-list
2907366|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2907367|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2907368|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2907379|NCT04886232|Lidocaine|lidocaine|mesh-list
2907380|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
2907381|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
2109913|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109914|NCT02530151|Clonidine|clonidine|mesh-list
2109915|NCT02530151|Morphine|morphine|mesh-list
2907382|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2907383|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907384|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
2907385|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2907386|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2907387|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2907388|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2907389|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2907390|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907391|NCT04885881|Lidocaine|lidocaine|mesh-list
2907392|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
2329676|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
2329677|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
2329678|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
2329679|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329680|NCT00404040|Lactulose|lactulose|mesh-list
2329681|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2329682|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2329683|NCT00404040|Laxatives|laxatives|mesh-ancestor
2329684|NCT00404053|Clopidogrel|clopidogrel|mesh-list
2329685|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2329686|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2329687|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2329688|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2329689|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
2329690|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2907393|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
2907394|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2907395|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907396|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
2907397|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2907398|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2907399|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2907400|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2907401|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2907402|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907403|NCT04885257|Methylphenidate|methylphenidate|mesh-list
2907404|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2907405|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907406|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2329691|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329692|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329693|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2907407|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2907408|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2907409|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907410|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
2907411|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2329694|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2329695|NCT00404157|Rituximab|rituximab|mesh-list
2329696|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2329697|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329698|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
2329699|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329700|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2329701|NCT00404183|Acetaminophen|acetaminophen|mesh-list
2329702|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2329703|NCT00404183|Hydrocodone|hydrocodone|mesh-list
2907412|NCT04884815|Prednisolone|prednisolone|mesh-list
2907413|NCT04884815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2907414|NCT04884815|Glucocorticoids|glucocorticoids|mesh-ancestor
2907415|NCT04884815|Hormones|hormones|mesh-ancestor
2907416|NCT04884815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2907417|NCT04884815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907418|NCT04884815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2907419|NCT04884815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907420|NCT04884360|Olaparib|olaparib|mesh-list
2907421|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2907422|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907423|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907424|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907425|NCT04880850|Insulin|insulin|mesh-list
2907426|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2907427|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
2907428|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
2907429|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2907430|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907431|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2907432|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
2907433|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907434|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
2907435|NCT04872595|Melphalan|melphalan|mesh-list
2907436|NCT04872595|Busulfan|busulfan|mesh-list
2907437|NCT04872595|Thiotepa|thiotepa|mesh-list
2907438|NCT04872595|Fludarabine|fludarabine|mesh-list
2907439|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2907440|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
2907441|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907442|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2907443|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2907444|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
2907445|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907446|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907447|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2907448|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2907449|NCT04871360|Laxatives|laxatives|mesh-ancestor
2907450|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2907451|NCT04867785|Dulaglutide|dulaglutide|mesh-list
2907452|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2907453|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907454|NCT04862663|Fulvestrant|fulvestrant|mesh-list
2907455|NCT04862663|Palbociclib|palbociclib|mesh-list
2907456|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2329704|NCT00404183|Oxycodone|oxycodone|mesh-list
2329705|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2329706|NCT00404183|Analgesics|analgesics|mesh-ancestor
2329707|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
2329708|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329709|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329710|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
2329711|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2329712|NCT00404183|Narcotics|narcotics|mesh-ancestor
2329713|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2329714|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
2329715|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
2907457|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907458|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2907459|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2907460|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
2907461|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2907462|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907463|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2907464|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907465|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907466|NCT04860804|Aspirin|aspirin|mesh-list
2907467|NCT04860804|Ketamine|ketamine|mesh-list
2907468|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2907469|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2907470|NCT04860804|Analgesics|analgesics|mesh-ancestor
2907471|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
2907472|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2907473|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907474|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2907475|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2907476|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2907477|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2907478|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907479|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2907480|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2907481|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907482|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
2907483|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2907484|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2907485|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
2907486|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
2907487|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2907488|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2907489|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2907490|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2329716|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2329717|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329718|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2329719|NCT00404196|Calcipotriene|calcipotriene|mesh-list
2329720|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
2329721|NCT00404222|Acetaminophen|acetaminophen|mesh-list
2907491|NCT04856904|Trifarotene|trifarotene|mesh-list
2907492|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
2907493|NCT04856488|Lugol's solution|lugol's solution|mesh-list
2907494|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2907495|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
2907496|NCT04856488|Coagulants|coagulants|mesh-ancestor
2907497|NCT04848220|APD791|apd791|mesh-list
2907498|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2907499|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2907500|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
2907501|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2907502|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907503|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907504|NCT04847557|Tirzepatide|tirzepatide|mesh-list
2907505|NCT04847557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2907506|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907507|NCT04847557|Incretins|incretins|mesh-ancestor
2907508|NCT04847557|Hormones|hormones|mesh-ancestor
2907509|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2907510|NCT04844918|Tirzepatide|tirzepatide|mesh-list
2907511|NCT04844918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2907512|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907513|NCT04844918|Incretins|incretins|mesh-ancestor
2907514|NCT04844918|Hormones|hormones|mesh-ancestor
2907515|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2907516|NCT04843761|Remdesivir|remdesivir|mesh-list
2907517|NCT04843761|Phentolamine|phentolamine|mesh-list
2907518|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
2907519|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
2907520|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907521|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
2907522|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2907523|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2907524|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2907525|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
2907526|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2907527|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907528|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2907529|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2907530|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
2907531|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2907532|NCT04843761|Protective Agents|protective agents|mesh-ancestor
2907533|NCT04823052|Sulindac|sulindac|mesh-list
2907534|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2907535|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2907536|NCT04823052|Analgesics|analgesics|mesh-ancestor
2907537|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
2907538|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329722|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2329723|NCT00404222|Hydrocodone|hydrocodone|mesh-list
2329724|NCT00404222|Oxycodone|oxycodone|mesh-list
2329725|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2329726|NCT00404222|Analgesics|analgesics|mesh-ancestor
2329727|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
2329728|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329729|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329730|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
2329731|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2329732|NCT00404222|Narcotics|narcotics|mesh-ancestor
2329733|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2329734|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
2907539|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907540|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2907541|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2907542|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907543|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2907544|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907545|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329735|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
2329736|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2329737|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329738|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2329739|NCT00404261|Fluticasone|fluticasone|mesh-list
2329740|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2329741|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2329742|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329743|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2329744|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
2329745|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329746|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329747|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2329748|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
2329749|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
2329750|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2329751|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2329752|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2329753|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2329754|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
2329755|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2329756|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329757|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
2329758|NCT00404261|Hormones|hormones|mesh-ancestor
2329759|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2329760|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
2329761|NCT00404274|Casopitant|casopitant|mesh-list
2329762|NCT00404274|Warfarin|warfarin|mesh-list
2329763|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
2329764|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
2329765|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
2329766|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329767|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329768|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2329769|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2329770|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2329771|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329772|NCT00404326|Hydralazine|hydralazine|mesh-list
2329773|NCT00404326|Valproic Acid|valproic acid|mesh-list
2329774|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
2907546|NCT04817345|Plerixafor|plerixafor|mesh-list
2907547|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2907548|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2907549|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
2907550|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2907551|NCT04810494|Lidocaine|lidocaine|mesh-list
2907552|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
2907553|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
2907554|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2907555|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907556|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
2907557|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2907558|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2907559|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2907560|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2329775|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329776|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329777|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
2329778|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2329779|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329780|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
2329781|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2907561|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2907562|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907568|NCT04809220|Dulaglutide|dulaglutide|mesh-list
2907569|NCT04809220|Biguanides|biguanides|mesh-list
2907570|NCT04809220|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2907571|NCT04809220|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
2907572|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2907573|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907574|NCT04809220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907575|NCT04809220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907576|NCT04796948|Leucovorin|leucovorin|mesh-list
2907577|NCT04796948|Fluorouracil|fluorouracil|mesh-list
2907578|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
2907579|NCT04796948|Irinotecan|irinotecan|mesh-list
2907580|NCT04796948|Calcium|calcium|mesh-list
2907581|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
2907582|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2907583|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907584|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
2907585|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907586|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2907587|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907588|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329782|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2329783|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2907589|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
2907590|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2907591|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2907592|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907593|NCT04796948|Antidotes|antidotes|mesh-ancestor
2907594|NCT04796948|Protective Agents|protective agents|mesh-ancestor
2907595|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
2907596|NCT04796948|Vitamins|vitamins|mesh-ancestor
2907597|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
2907603|NCT04792567|Siponimod|siponimod|mesh-list
2907604|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2907605|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907606|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2907607|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
2907608|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907624|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
2329784|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2329785|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
2329786|NCT00404378|Ketoconazole|ketoconazole|mesh-list
2329787|NCT00404378|Casopitant|casopitant|mesh-list
2329788|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
2329789|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2907628|NCT04774315|Omalizumab|omalizumab|mesh-list
2907629|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2907630|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2907631|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
2907632|NCT04774107|Ribavirin|ribavirin|mesh-list
2907633|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
2907634|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907635|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
2907636|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2907637|NCT04770896|Sorafenib|sorafenib|mesh-list
2907638|NCT04770896|Atezolizumab|atezolizumab|mesh-list
2907639|NCT04770896|Lenvatinib|lenvatinib|mesh-list
2907640|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907641|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2907642|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907643|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907648|NCT04763577|Bradykinin|bradykinin|mesh-list
2907649|NCT04763577|Kininogens|kininogens|mesh-list
2907650|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
2907651|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2907652|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
2907653|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907654|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907655|NCT04760288|Pralsetinib|pralsetinib|mesh-list
2907656|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329790|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2329791|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2329792|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329793|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329794|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2329795|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
2329796|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2329797|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329798|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2329799|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
2329800|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
2329801|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329802|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2329803|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2329804|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2329805|NCT00404391|Acetaminophen|acetaminophen|mesh-list
2329806|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2329807|NCT00404391|Hydrocodone|hydrocodone|mesh-list
2329808|NCT00404391|Oxycodone|oxycodone|mesh-list
2329809|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2329810|NCT00404391|Analgesics|analgesics|mesh-ancestor
2329811|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
2329812|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329813|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329814|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
2329815|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2329816|NCT00404391|Narcotics|narcotics|mesh-ancestor
2329817|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2329818|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
2329819|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
2329820|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2329821|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329822|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2329823|NCT00404404|Paclitaxel|paclitaxel|mesh-list
2329824|NCT00404404|Bevacizumab|bevacizumab|mesh-list
2329825|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2329826|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2329827|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329828|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
2329829|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
2329830|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
2329831|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329832|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2329833|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2329834|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2329835|NCT00404404|Growth Substances|growth substances|mesh-ancestor
2329836|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329837|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
2329838|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
2329839|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2329840|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2329841|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2329842|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2329843|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329844|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
2329845|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2329846|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329847|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2329848|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329849|NCT00404456|Melatonin|melatonin|mesh-list
2329850|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
2329851|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329852|NCT00404456|Protective Agents|protective agents|mesh-ancestor
2329853|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907675|NCT04750824|Afatinib|afatinib|mesh-list
2907676|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907677|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2907678|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907679|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907680|NCT04732286|Bevacizumab|bevacizumab|mesh-list
2907681|NCT04732286|Atezolizumab|atezolizumab|mesh-list
2907682|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907683|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907684|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2907685|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2907686|NCT04732286|Growth Substances|growth substances|mesh-ancestor
2907687|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329854|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2329855|NCT00404482|Cyclosporine|cyclosporine|mesh-list
2329856|NCT00404482|Cyclosporins|cyclosporins|mesh-list
2329857|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329858|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329859|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329860|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
2329861|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329862|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
2329863|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329864|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
2329865|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2329866|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2329867|NCT00404508|Hydralazine|hydralazine|mesh-list
2329868|NCT00404508|Valproic Acid|valproic acid|mesh-list
2907688|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
2907699|NCT04731233|Triamcinolone|triamcinolone|mesh-list
2907700|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2907701|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2907702|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2907703|NCT04731233|Mitogens|mitogens|mesh-list
2907704|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2907705|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
2329869|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
2329870|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329871|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329872|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
2329873|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2329874|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329875|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
2907706|NCT04731233|Hormones|hormones|mesh-ancestor
2907707|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2907708|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907709|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2907710|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
2907711|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907712|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907713|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
2329876|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2329877|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2329878|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2329879|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2329880|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
2329881|NCT00404534|Amoxicillin|amoxicillin|mesh-list
2329882|NCT00404534|Clarithromycin|clarithromycin|mesh-list
2329883|NCT00404534|Omeprazole|omeprazole|mesh-list
2329884|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2329885|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2329886|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2329887|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2329888|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2329889|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329890|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329891|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2329892|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2329893|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2329894|NCT00404573|Cariprazine|cariprazine|mesh-list
2329895|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2329896|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2329897|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2329898|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329899|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2329900|NCT00404586|Fluticasone|fluticasone|mesh-list
2329901|NCT00404586|Xhance|xhance|mesh-list
2329902|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329903|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2329904|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
2329905|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329906|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329907|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2329908|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
2329909|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
2329910|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2329911|NCT00404599|Simvastatin|simvastatin|mesh-list
2329912|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2329913|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2329914|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
2329915|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907721|NCT04729725|Cemiplimab|cemiplimab|mesh-list
2907722|NCT04729725|Antibodies|antibodies|mesh-list
2907723|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2907724|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
2907725|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907726|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907727|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329916|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2329917|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2329918|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329919|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2329920|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
2329921|NCT00404703|Bevacizumab|bevacizumab|mesh-list
2329922|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2329923|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329924|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2329925|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2329926|NCT00404703|Growth Substances|growth substances|mesh-ancestor
2329927|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329928|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
2907728|NCT04726618|Xenon|xenon|mesh-list
2907729|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2907730|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
2907731|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
2907732|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2907733|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907734|NCT04726475|Cannabidiol|cannabidiol|mesh-list
2907735|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
2907742|NCT04721613|Melatonin|melatonin|mesh-list
2907743|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
2329929|NCT00404716|Cilostazol|cilostazol|mesh-list
2329930|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2329931|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
2329932|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329933|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329934|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2329935|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
2329936|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2329937|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2329938|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329939|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2329940|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
2329941|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2329942|NCT00404716|Protective Agents|protective agents|mesh-ancestor
2329943|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2329944|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2329945|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329946|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2329947|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
2329948|NCT00404781|Aspirin|aspirin|mesh-list
2329949|NCT00404781|Cilostazol|cilostazol|mesh-list
2329950|NCT00404781|Clopidogrel|clopidogrel|mesh-list
2329951|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2329952|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2329953|NCT00404781|Analgesics|analgesics|mesh-ancestor
2907744|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907745|NCT04721613|Protective Agents|protective agents|mesh-ancestor
2907746|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907747|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2907748|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
2907749|NCT04720976|Osimertinib|osimertinib|mesh-list
2907750|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907751|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907752|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2907753|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907754|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329954|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
2329955|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2329956|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329957|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2329958|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2329959|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2329960|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2329961|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329962|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2329963|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2329964|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907759|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
2907760|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2907761|NCT04717362|Testosterone|testosterone|mesh-list
2907762|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
2907763|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
2907764|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2907765|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907766|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
2907767|NCT04717362|Hormones|hormones|mesh-ancestor
2907768|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2907769|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907770|NCT04717362|Androgens|androgens|mesh-ancestor
2907771|NCT04712643|Atezolizumab|atezolizumab|mesh-list
2907772|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907773|NCT04711837|Propofol|propofol|mesh-list
2907774|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2907775|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2907776|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907777|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2907778|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
2907779|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
2907780|NCT04707326|Lamivudine|lamivudine|mesh-list
2329965|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
2329966|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2329967|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2329968|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2329969|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
2329970|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2329971|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2329972|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
2907781|NCT04707326|Dolutegravir|dolutegravir|mesh-list
2907782|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2907783|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2907784|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907785|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907786|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
2907787|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2907788|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2907789|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2907790|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2907791|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2907792|NCT04707196|Fulvestrant|fulvestrant|mesh-list
2329973|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2329974|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
2329975|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
2329976|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2329977|NCT00404781|Protective Agents|protective agents|mesh-ancestor
2329978|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2329979|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2329980|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
2329981|NCT00404794|Prednisolone|prednisolone|mesh-list
2329982|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2329983|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
2329984|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2329985|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
2329986|NCT00404794|Tacrolimus|tacrolimus|mesh-list
2329987|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2329988|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
2329989|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2329990|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
2907793|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2907794|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2907795|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907796|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2907797|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2907798|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
2907799|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2907800|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907801|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2907802|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907803|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907804|NCT04704934|Paclitaxel|paclitaxel|mesh-list
2907805|NCT04704934|Trastuzumab|trastuzumab|mesh-list
2907806|NCT04704934|Ramucirumab|ramucirumab|mesh-list
2907807|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2907808|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907809|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
2907810|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
2907811|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
2907812|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907813|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907814|NCT04703101|Leucovorin|leucovorin|mesh-list
2907815|NCT04703101|Fluorouracil|fluorouracil|mesh-list
2907816|NCT04703101|Capecitabine|capecitabine|mesh-list
2907817|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
2907818|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
2907819|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907820|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2907821|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907822|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2907823|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
2907824|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907825|NCT04703101|Antidotes|antidotes|mesh-ancestor
2907826|NCT04703101|Protective Agents|protective agents|mesh-ancestor
2907827|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
2907828|NCT04703101|Vitamins|vitamins|mesh-ancestor
2907829|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
2329991|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2329992|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2329993|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2329994|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2329995|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2329996|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2329997|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2329998|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
2329999|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330000|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330001|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330002|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
2330003|NCT00404794|Hormones|hormones|mesh-ancestor
2330004|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330005|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2330006|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
2330007|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
2330008|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330009|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2330010|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2330011|NCT00404794|Protective Agents|protective agents|mesh-ancestor
2330012|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
2330013|NCT00404833|Prednisolone|prednisolone|mesh-list
2330014|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2330015|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
2330016|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2330017|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
2330018|NCT00404833|Chlorambucil|chlorambucil|mesh-list
2330019|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2330020|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
2330021|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2330022|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330023|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2330024|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
2330025|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330026|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330027|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330028|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330029|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330030|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
2330031|NCT00404833|Hormones|hormones|mesh-ancestor
2330032|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330033|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330034|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2330035|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
2330036|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
2907863|NCT04690023|Ropivacaine|ropivacaine|mesh-list
2907864|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
2907865|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
2907866|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109916|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2109917|NCT02530151|Narcotics|narcotics|mesh-ancestor
2109918|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2109919|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109920|NCT02530151|Analgesics|analgesics|mesh-ancestor
2109921|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
2109922|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2109923|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2109924|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
2109925|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
2109926|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2109927|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2109928|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2109929|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
2109930|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109931|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109932|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
2109933|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
2109934|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109935|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
2109936|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109937|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109938|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
2109939|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2109940|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2109941|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2109942|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
2109943|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109944|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330037|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330038|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2330039|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2330040|NCT00404833|Protective Agents|protective agents|mesh-ancestor
2330041|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2330042|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
2330043|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2330044|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
2330045|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330046|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330047|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
2330048|NCT00404937|Hormones|hormones|mesh-ancestor
2330049|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330050|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330051|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2330052|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2330053|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
2330054|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2330055|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330056|NCT00405080|Rifampin|rifampin|mesh-list
2330057|NCT00405080|Casopitant|casopitant|mesh-list
2330058|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2330059|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
2330060|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330061|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330062|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
2330063|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2330064|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330065|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330066|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2330067|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2907867|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907868|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
2907869|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2907870|NCT04686305|Carboplatin|carboplatin|mesh-list
2907871|NCT04686305|Trastuzumab|trastuzumab|mesh-list
2907872|NCT04686305|Pemetrexed|pemetrexed|mesh-list
2907873|NCT04686305|Durvalumab|durvalumab|mesh-list
2907874|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907875|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907876|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907877|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907878|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2907879|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2907880|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2907881|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907882|NCT04678895|Naltrexone|naltrexone|mesh-list
2907883|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2907884|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2907885|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907886|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
2907887|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2907888|NCT04677504|Gemcitabine|gemcitabine|mesh-list
2907889|NCT04677504|Bevacizumab|bevacizumab|mesh-list
2907890|NCT04677504|Atezolizumab|atezolizumab|mesh-list
2907891|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907892|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907893|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2907894|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2907895|NCT04677504|Growth Substances|growth substances|mesh-ancestor
2907896|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907897|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
2907898|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2907899|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
2907900|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907901|NCT04677504|Antiviral Agents|antiviral agents|mesh-ancestor
2907902|NCT04677504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2907903|NCT04677504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330068|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2330069|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2330070|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2330071|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2330072|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
2330073|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
2330074|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330075|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330076|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2907904|NCT04677504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2907905|NCT04677504|Immunologic Factors|immunologic factors|mesh-ancestor
2330077|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2330078|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330079|NCT00405119|Esomeprazole|esomeprazole|mesh-list
2330080|NCT00405119|Ranitidine|ranitidine|mesh-list
2330081|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2330082|NCT00405119|Loxtidine|loxtidine|mesh-list
2330083|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2330084|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2330085|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2330086|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330087|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330088|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2330089|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
2330090|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
2330091|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330092|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330093|NCT00405158|Acetaminophen|acetaminophen|mesh-list
2907916|NCT04667104|Tenofovir|tenofovir|mesh-list
2907917|NCT04667104|Entecavir|entecavir|mesh-list
2907918|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2907919|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
2907920|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2907921|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2907922|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2907923|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907924|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907925|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2907926|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2907927|NCT04661150|Capecitabine|capecitabine|mesh-list
2907928|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
2907929|NCT04661150|Trastuzumab|trastuzumab|mesh-list
2907930|NCT04661150|Atezolizumab|atezolizumab|mesh-list
2907931|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2907932|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
2907933|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907934|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330094|NCT00405158|Antipyretics|antipyretics|mesh-list
2330095|NCT00405158|Penicillins|penicillins|mesh-list
2330096|NCT00405158|Floxacillin|floxacillin|mesh-list
2330097|NCT00405158|Cefadroxil|cefadroxil|mesh-list
2330098|NCT00405158|Oxytocin|oxytocin|mesh-list
2330099|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
2330100|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2330101|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330102|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2330103|NCT00405158|Analgesics|analgesics|mesh-ancestor
2330104|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
2330105|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330106|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330107|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2907935|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907936|NCT04660344|Atezolizumab|atezolizumab|mesh-list
2907937|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907938|NCT04657289|Ranibizumab|ranibizumab|mesh-list
2907939|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2907940|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2907941|NCT04657289|Growth Substances|growth substances|mesh-ancestor
2907942|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330108|NCT00405171|Nevirapine|nevirapine|mesh-list
2330109|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2330110|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2330111|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330112|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330113|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
2907943|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
2907944|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907945|NCT04657003|Tirzepatide|tirzepatide|mesh-list
2907946|NCT04657003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2907947|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907948|NCT04657003|Incretins|incretins|mesh-ancestor
2907949|NCT04657003|Hormones|hormones|mesh-ancestor
2907950|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2907951|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
2330114|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330115|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2330116|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2330117|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2330118|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2330119|NCT00405210|Docetaxel|docetaxel|mesh-list
2330120|NCT00405210|Sorafenib|sorafenib|mesh-list
2330121|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330122|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
2330123|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
2330124|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
2330125|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330126|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2330127|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330128|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
2330129|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2330130|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
2330131|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330132|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330133|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2330134|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
2330135|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
2330136|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2330137|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
2330138|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330139|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330140|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
2330141|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2330142|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2330143|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330144|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330145|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
2330146|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330147|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2330148|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2330149|NCT00405262|Ketorolac|ketorolac|mesh-list
2330150|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2330151|NCT00405262|Bupivacaine|bupivacaine|mesh-list
2907952|NCT04653818|Velpatasvir|velpatasvir|mesh-list
2907953|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
2907954|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2907955|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
2907956|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907957|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2907958|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
2907959|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
2907960|NCT04647721|Protective Agents|protective agents|mesh-ancestor
2907961|NCT04646590|Vaccines|vaccines|mesh-list
2907962|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
2907963|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907964|NCT04646005|Cemiplimab|cemiplimab|mesh-list
2907965|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907966|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907967|NCT04645667|Tacrolimus|tacrolimus|mesh-list
2907968|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2907969|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
2907970|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907971|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2907972|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907973|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2907974|NCT04642469|Durvalumab|durvalumab|mesh-list
2907975|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2907976|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907989|NCT04638309|Azacitidine|azacitidine|mesh-list
2907990|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2907991|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
2907992|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330152|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
2330153|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
2330154|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2330155|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2907993|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2907994|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2907995|NCT04635254|Histamine|histamine|mesh-list
2907996|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
2907997|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
2907998|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2907999|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908000|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908001|NCT04630145|Clarithromycin|clarithromycin|mesh-list
2908002|NCT04630145|Rifampin|rifampin|mesh-list
2908003|NCT04630145|Ethambutol|ethambutol|mesh-list
2908004|NCT04630145|Rifabutin|rifabutin|mesh-list
2908005|NCT04630145|Bedaquiline|bedaquiline|mesh-list
2908006|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2908007|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908008|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2908009|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908010|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908011|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2908012|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2908013|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2908014|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
2908015|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
2908016|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2908017|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2908018|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2908019|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2908020|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2908021|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2908022|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2330156|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
2330157|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330158|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2330159|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2330160|NCT00405262|Analgesics|analgesics|mesh-ancestor
2330161|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330162|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2330163|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2330164|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330165|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330166|NCT00405301|Rifampin|rifampin|mesh-list
2330167|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
2908060|NCT04625946|Metformin|metformin|mesh-list
2908061|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2908062|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908063|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
2908064|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2908065|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2908066|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2908067|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2330168|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2330169|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
2330170|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330171|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330172|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
2330173|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2330174|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330175|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908068|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2908069|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908070|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
2908071|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2908072|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908073|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2908074|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908075|NCT04622228|Carboplatin|carboplatin|mesh-list
2908076|NCT04622228|Etoposide|etoposide|mesh-list
2908077|NCT04622228|Atezolizumab|atezolizumab|mesh-list
2908078|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908079|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2908080|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2908081|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2908082|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908083|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330176|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2330177|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2330178|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2330179|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2330180|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2330181|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2330182|NCT00405340|Rituximab|rituximab|mesh-list
2330183|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2330184|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330185|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
2330186|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330187|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2330188|NCT00405366|Sorafenib|sorafenib|mesh-list
2908084|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
2908085|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2908086|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908087|NCT04616196|Cetuximab|cetuximab|mesh-list
2908088|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2908089|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908092|NCT04613492|Durvalumab|durvalumab|mesh-list
2908093|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2908094|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908095|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
2908096|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2908097|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2908098|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908099|NCT04608344|Atorvastatin|atorvastatin|mesh-list
2908100|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2908101|NCT04608344|Pravastatin|pravastatin|mesh-list
2908102|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2908103|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2908104|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
2908105|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908106|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2908107|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2908108|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908109|NCT04606771|Osimertinib|osimertinib|mesh-list
2908110|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908111|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2908112|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908113|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908114|NCT04603807|Crizotinib|crizotinib|mesh-list
2908115|NCT04603807|Entrectinib|entrectinib|mesh-list
2908116|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908117|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2908118|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908119|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908120|NCT04594239|Lidocaine|lidocaine|mesh-list
2908121|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
2908122|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
2908123|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
2908124|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2908125|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908126|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
2908127|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908128|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2908129|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2908130|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2908131|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2908132|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908133|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2908134|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
2908135|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
2908136|NCT04594239|Protective Agents|protective agents|mesh-ancestor
2908137|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
2908138|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2908139|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2330189|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330190|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2330191|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330192|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330193|NCT00405405|Bevacizumab|bevacizumab|mesh-list
2330194|NCT00405405|Cisplatin|cisplatin|mesh-list
2330195|NCT00405405|Docetaxel|docetaxel|mesh-list
2330196|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2330197|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2330198|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330199|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2330200|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2330201|NCT00405405|Growth Substances|growth substances|mesh-ancestor
2330202|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330203|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
2330204|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
2908140|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2908141|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2908142|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2908143|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908144|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
2908145|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2908146|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908147|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2908148|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330205|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
2908155|NCT04591002|Osimertinib|osimertinib|mesh-list
2908156|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908157|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2908158|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908159|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908160|NCT04590963|Cetuximab|cetuximab|mesh-list
2330206|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
2330207|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330208|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2330209|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330210|NCT00405418|Insulin|insulin|mesh-list
2330211|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2330212|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
2330213|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
2330214|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2330215|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330216|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
2330217|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2330218|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2330219|NCT00405444|Fentanyl|fentanyl|mesh-list
2330220|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2330221|NCT00405444|Narcotics|narcotics|mesh-ancestor
2330222|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2330223|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908161|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2908162|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908163|NCT04589351|Ezetimibe|ezetimibe|mesh-list
2908164|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2908165|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2908166|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
2908167|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908168|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2908169|NCT04588246|Memantine|memantine|mesh-list
2908170|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2908171|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2330224|NCT00405444|Analgesics|analgesics|mesh-ancestor
2330225|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
2330226|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330227|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2330228|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2330229|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
2330230|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
2330231|NCT00405457|Cyclosporine|cyclosporine|mesh-list
2330232|NCT00405457|Cyclosporins|cyclosporins|mesh-list
2330233|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330234|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330235|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2330236|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
2330237|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330238|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
2330239|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330240|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
2908172|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
2908173|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2908174|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908175|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908176|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2908177|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2908178|NCT04585789|Tenofovir|tenofovir|mesh-list
2908179|NCT04585789|Entecavir|entecavir|mesh-list
2330241|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2330242|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2330243|NCT00405496|Difluprednate|difluprednate|mesh-list
2330244|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
2330245|NCT00405496|Hormones|hormones|mesh-ancestor
2330246|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330247|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330248|NCT00405535|Glycine|glycine|mesh-list
2330249|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
2330250|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330251|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330252|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330253|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2330254|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
2908180|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2330255|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
2330256|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330257|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330258|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2908181|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
2908182|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908183|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2908184|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2908185|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908186|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330259|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2330260|NCT00405574|Growth Substances|growth substances|mesh-ancestor
2330261|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908187|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2908188|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2908189|NCT04583592|Gabexate|gabexate|mesh-list
2908190|NCT04583592|Camostat|camostat|mesh-list
2908191|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
2908192|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908193|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908194|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2908195|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2908196|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
2908223|NCT04570904|Vaccines|vaccines|mesh-list
2330262|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
2330263|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330264|NCT00405613|Aspirin|aspirin|mesh-list
2330265|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2330266|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2330267|NCT00405613|Analgesics|analgesics|mesh-ancestor
2330268|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
2330269|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330270|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330271|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330272|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2330273|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2330274|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2330275|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330276|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2330277|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2330278|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330279|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
2330280|NCT00405717|Atorvastatin|atorvastatin|mesh-list
2330281|NCT00405717|Pravastatin|pravastatin|mesh-list
2330282|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2330283|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2330284|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
2330285|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330286|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2908224|NCT04570904|Immunologic Factors|immunologic factors|mesh-ancestor
2908225|NCT04570904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908226|NCT04567615|Nivolumab|nivolumab|mesh-list
2908227|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2908228|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908229|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2908230|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330287|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2330288|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330289|NCT00405730|Ketorolac|ketorolac|mesh-list
2330290|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2330291|NCT00405730|Nepafenac|nepafenac|mesh-list
2330292|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2330293|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2330294|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2330295|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2330296|NCT00405730|Analgesics|analgesics|mesh-ancestor
2330297|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
2330298|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330299|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330300|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330301|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2908242|NCT04546841|Vaccines|vaccines|mesh-list
2908243|NCT04546841|Immunologic Factors|immunologic factors|mesh-ancestor
2908244|NCT04546841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908245|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
2908246|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
2908247|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
2908248|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2908249|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2908250|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
2908251|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
2908252|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908253|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908254|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2908255|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
2908256|NCT04544436|Hormones|hormones|mesh-ancestor
2908257|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2908258|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2908259|NCT04544436|Protective Agents|protective agents|mesh-ancestor
2908260|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
2908261|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
2908262|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2908263|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908264|NCT04543409|Benralizumab|benralizumab|mesh-list
2908265|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2908266|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
2908267|NCT04540705|Nivolumab|nivolumab|mesh-list
2908268|NCT04540705|Axitinib|axitinib|mesh-list
2908269|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2908270|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908271|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2908272|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330302|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2330303|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330304|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330305|NCT00405743|Cytarabine|cytarabine|mesh-list
2330306|NCT00405743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2330307|NCT00405743|Antimetabolites|antimetabolites|mesh-ancestor
2330308|NCT00405743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330309|NCT00405743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330310|NCT00405743|Antiviral Agents|antiviral agents|mesh-ancestor
2330311|NCT00405743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908273|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2330312|NCT00405743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2330313|NCT00405743|Immunologic Factors|immunologic factors|mesh-ancestor
2908274|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908275|NCT04535544|Tenofovir|tenofovir|mesh-list
2908276|NCT04535544|Entecavir|entecavir|mesh-list
2908277|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
2908278|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908279|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2908280|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2908281|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908282|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908283|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2908284|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2330314|NCT00405743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330315|NCT00405769|Red yeast rice|red yeast rice|mesh-list
2330316|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2330317|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2330318|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2330319|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
2330320|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330321|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330322|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2330323|NCT00405808|Rimonabant|rimonabant|mesh-list
2330324|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2330325|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2330326|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2330327|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330328|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330329|NCT00405808|Hormones|hormones|mesh-ancestor
2330330|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330331|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330332|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
2330333|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2330334|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2330335|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330336|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2330337|NCT00405847|Analgesics|analgesics|mesh-ancestor
2330338|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
2330339|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330340|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2330341|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2330342|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2330343|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
2330344|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330345|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330346|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
2330347|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2330348|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330349|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2908360|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
2908361|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
2908362|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908363|NCT04529850|Protective Agents|protective agents|mesh-ancestor
2908364|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908365|NCT04524910|Aflibercept|aflibercept|mesh-list
2908366|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2908367|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2908368|NCT04524910|Growth Substances|growth substances|mesh-ancestor
2908369|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908370|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
2908371|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908372|NCT04524871|Bevacizumab|bevacizumab|mesh-list
2908373|NCT04524871|Atezolizumab|atezolizumab|mesh-list
2908374|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2908375|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908376|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2908377|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2908378|NCT04524871|Growth Substances|growth substances|mesh-ancestor
2908379|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908380|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
2908386|NCT04523961|Lidocaine|lidocaine|mesh-list
2908387|NCT04523961|Tetracaine|tetracaine|mesh-list
2908388|NCT04523961|Prilocaine|prilocaine|mesh-list
2908389|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2908390|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
2908391|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
2908392|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2908393|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908394|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
2908395|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908396|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2908397|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2908398|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2908399|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2908400|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330350|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
2330351|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330352|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330353|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330354|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330355|NCT00405925|Lamivudine|lamivudine|mesh-list
2330356|NCT00405925|Zidovudine|zidovudine|mesh-list
2330357|NCT00405925|Abacavir|abacavir|mesh-list
2330358|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2330359|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2330360|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330361|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330362|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
2330363|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330364|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2330365|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2330366|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
2330367|NCT00405951|Docetaxel|docetaxel|mesh-list
2330368|NCT00405951|Obatoclax|obatoclax|mesh-list
2330369|NCT00405951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330370|NCT00405951|Tubulin Modulators|tubulin modulators|mesh-ancestor
2908401|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2908402|NCT04505059|Anesthetics|anesthetics|mesh-list
2908403|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2908404|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908413|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
2908414|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908415|NCT04500509|Diclofenac|diclofenac|mesh-list
2908416|NCT04500509|Dinoprostone|dinoprostone|mesh-list
2908417|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2908418|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2908419|NCT04500509|Analgesics|analgesics|mesh-ancestor
2908420|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
2908421|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908422|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908423|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2908424|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2908425|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2908426|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330371|NCT00405951|Antimitotic Agents|antimitotic agents|mesh-ancestor
2330372|NCT00405951|Mitosis Modulators|mitosis modulators|mesh-ancestor
2330373|NCT00405951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330374|NCT00405951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330375|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
2330376|NCT00405977|Analgesics|analgesics|mesh-ancestor
2330377|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
2330378|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330379|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330380|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
2330381|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2908427|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908428|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
2330382|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2330383|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
2330384|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2908429|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2908430|NCT04500470|Ketoprofen|ketoprofen|mesh-list
2908431|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2908432|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2908433|NCT04500470|Analgesics|analgesics|mesh-ancestor
2908434|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
2908435|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908436|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908437|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2908438|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2908439|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2908440|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908441|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330385|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2330386|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908452|NCT04496999|Midostaurin|midostaurin|mesh-list
2908453|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908454|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2908455|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908456|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908457|NCT04472598|Navitoclax|navitoclax|mesh-list
2908458|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908467|NCT04468984|Navitoclax|navitoclax|mesh-list
2908468|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908469|NCT04461015|Insulin|insulin|mesh-list
2908470|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2908471|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2908472|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908473|NCT04458831|Dexamethasone|dexamethasone|mesh-list
2908474|NCT04458831|Pomalidomide|pomalidomide|mesh-list
2908475|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2908476|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
2908477|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
2908478|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908479|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908480|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2908481|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
2908482|NCT04458831|Hormones|hormones|mesh-ancestor
2908483|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2908484|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2908485|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908486|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
2908487|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2908488|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2908489|NCT04458831|Growth Substances|growth substances|mesh-ancestor
2908490|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
2908491|NCT04457297|Trifluridine|trifluridine|mesh-list
2908492|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
2908493|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908494|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
2908495|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908496|NCT04441073|Lidocaine|lidocaine|mesh-list
2908497|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
2908498|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
2908499|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2908500|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908501|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
2330387|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2330388|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
2330389|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2330390|NCT00406003|Paroxetine|paroxetine|mesh-list
2330391|NCT00406003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2330392|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2330393|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2330394|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330395|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330396|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
2330397|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330398|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2330399|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
2330400|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2330401|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2330402|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2330403|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330404|NCT00406042|Prednisolone|prednisolone|mesh-list
2330405|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2330406|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
2330407|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2330408|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
2330409|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2908502|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908503|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2330410|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
2330411|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330412|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
2330413|NCT00406042|Hormones|hormones|mesh-ancestor
2330414|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330415|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330416|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2330417|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330418|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
2330419|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
2330420|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330421|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2330422|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2330423|NCT00406042|Protective Agents|protective agents|mesh-ancestor
2330424|NCT00406094|Montelukast|montelukast|mesh-list
2330425|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2330426|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
2330427|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2330428|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
2330429|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330430|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908504|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2908505|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2908506|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2908507|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908508|NCT04439539|Tenofovir|tenofovir|mesh-list
2908509|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2908510|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
2908511|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908512|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2908513|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2908514|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908515|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908516|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2908517|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2908518|NCT04439201|Palbociclib|palbociclib|mesh-list
2908519|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908520|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2908521|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908522|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908523|NCT04423718|Aflibercept|aflibercept|mesh-list
2908524|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2908525|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2908526|NCT04423718|Growth Substances|growth substances|mesh-ancestor
2908527|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908528|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
2330431|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2908529|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330432|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2330433|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330434|NCT00406146|Artesunate|artesunate|mesh-list
2330435|NCT00406146|Lumefantrine|lumefantrine|mesh-list
2330436|NCT00406146|Artemether|artemether|mesh-list
2330437|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2330438|NCT00406146|Amodiaquine|amodiaquine|mesh-list
2330439|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
2908530|NCT04409665|Ketamine|ketamine|mesh-list
2908531|NCT04409665|Analgesics|analgesics|mesh-ancestor
2908532|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
2908533|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908534|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908535|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2908536|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2908537|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
2908538|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
2908539|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2908540|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2908541|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2908542|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2908543|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908544|NCT04404140|Docetaxel|docetaxel|mesh-list
2908545|NCT04404140|Atezolizumab|atezolizumab|mesh-list
2908546|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330440|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2330441|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2330442|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330443|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330444|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
2330445|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
2330446|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2330447|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
2330448|NCT00406172|Bevacizumab|bevacizumab|mesh-list
2330449|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2330450|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908547|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
2908548|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
2908549|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
2908550|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908551|NCT04401761|Aspirin|aspirin|mesh-list
2908552|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
2908553|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2908554|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2908555|NCT04401761|Analgesics|analgesics|mesh-ancestor
2908556|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
2908557|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908558|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908559|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2908560|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2908561|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2908562|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2908563|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908564|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2908565|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2908566|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908567|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
2908568|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2908569|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
2908570|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2908571|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
2908572|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
2330451|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2330452|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2330453|NCT00406172|Growth Substances|growth substances|mesh-ancestor
2330454|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330455|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
2330456|NCT00406237|Tigecycline|tigecycline|mesh-list
2330457|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330458|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330459|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2330460|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330461|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330462|NCT00406250|Bevacizumab|bevacizumab|mesh-list
2330463|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2330464|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330465|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2330466|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2330467|NCT00406250|Growth Substances|growth substances|mesh-ancestor
2330468|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330469|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
2330470|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2330471|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2330472|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330473|NCT00406302|Docetaxel|docetaxel|mesh-list
2330474|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
2330475|NCT00406302|Cetuximab|cetuximab|mesh-list
2330476|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330477|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
2330478|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
2330479|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
2330480|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330481|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2330482|NCT00406341|Difluprednate|difluprednate|mesh-list
2330483|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
2330484|NCT00406341|Hormones|hormones|mesh-ancestor
2330485|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330486|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330487|NCT00406380|Bevacizumab|bevacizumab|mesh-list
2330488|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2330489|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330490|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2330491|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2330492|NCT00406380|Growth Substances|growth substances|mesh-ancestor
2330493|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330494|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
2330495|NCT00406432|Paroxetine|paroxetine|mesh-list
2330496|NCT00406432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2330497|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2330498|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2330499|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330500|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330501|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
2330502|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330503|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2330504|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
2330505|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2330506|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2330507|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2330508|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330509|NCT00406471|Ranibizumab|ranibizumab|mesh-list
2330510|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2908594|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
2908595|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
2908596|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2330511|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2330512|NCT00406471|Growth Substances|growth substances|mesh-ancestor
2908597|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2330513|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908598|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908599|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908600|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908601|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2908602|NCT04382937|Ribavirin|ribavirin|mesh-list
2908603|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2908604|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
2908605|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908606|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
2908607|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908608|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2908609|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2908610|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
2908611|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2908612|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2908613|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908614|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908629|NCT04351698|Montelukast|montelukast|mesh-list
2908630|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2908631|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
2908632|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2908633|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
2330514|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
2330515|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330516|NCT00406497|Difluprednate|difluprednate|mesh-list
2330517|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
2330518|NCT00406497|Hormones|hormones|mesh-ancestor
2330519|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330520|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330521|NCT00406575|Methocarbamol|methocarbamol|mesh-list
2908634|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2908635|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908636|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2908637|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2908638|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908654|NCT04339036|Capecitabine|capecitabine|mesh-list
2908655|NCT04339036|Temozolomide|temozolomide|mesh-list
2908656|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2908657|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
2908658|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908659|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330522|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2330523|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330524|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2330525|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330526|NCT00406588|Levodopa|levodopa|mesh-list
2330527|NCT00406588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2330528|NCT00406588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2908660|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2908661|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
2908662|NCT04338269|Atezolizumab|atezolizumab|mesh-list
2908663|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330529|NCT00406588|Dopamine Agents|dopamine agents|mesh-ancestor
2330530|NCT00406588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330531|NCT00406588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330532|NCT00406588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330533|NCT00406601|Sorafenib|sorafenib|mesh-list
2330534|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330535|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2330536|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330537|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330538|NCT00406679|Acetaminophen|acetaminophen|mesh-list
2330539|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2330540|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2330541|NCT00406679|Analgesics|analgesics|mesh-ancestor
2330542|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
2330543|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330544|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330545|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
2330546|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2330547|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330548|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330549|NCT00406744|Bevacizumab|bevacizumab|mesh-list
2330550|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2330551|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330552|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2330553|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2330554|NCT00406744|Growth Substances|growth substances|mesh-ancestor
2330555|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330556|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
2330557|NCT00406796|Ranibizumab|ranibizumab|mesh-list
2330558|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2330559|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2330560|NCT00406796|Growth Substances|growth substances|mesh-ancestor
2330561|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330562|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
2330563|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330564|NCT00406809|Navitoclax|navitoclax|mesh-list
2330565|NCT00406809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330566|NCT00406861|Montelukast|montelukast|mesh-list
2330567|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2330568|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
2330569|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2330570|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
2330571|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330572|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330573|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2330574|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2908679|NCT04330040|Olaparib|olaparib|mesh-list
2908680|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2908681|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908682|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330575|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330576|NCT00406874|Folic Acid|folic acid|mesh-list
2330577|NCT00406874|Hematinics|hematinics|mesh-ancestor
2330578|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
2330579|NCT00406874|Vitamins|vitamins|mesh-ancestor
2330580|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
2330581|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330582|NCT00406887|Difluprednate|difluprednate|mesh-list
2330583|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
2330584|NCT00406887|Hormones|hormones|mesh-ancestor
2330585|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330586|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330587|NCT00406913|Mupirocin|mupirocin|mesh-list
2330588|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330589|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330590|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2330591|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330592|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330593|NCT00406952|Sertraline|sertraline|mesh-list
2330594|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
2330595|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2330596|NCT00406952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2330597|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2330598|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2330599|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330600|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330601|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
2330602|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330603|NCT00406978|Thalidomide|thalidomide|mesh-list
2330604|NCT00406978|Prednisone|prednisone|mesh-list
2330605|NCT00406978|Melphalan|melphalan|mesh-list
2330606|NCT00406978|Defibrotide|defibrotide|mesh-list
2330607|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330608|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
2330609|NCT00406978|Hormones|hormones|mesh-ancestor
2330610|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330611|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330612|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2330613|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330614|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2330615|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
2330616|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330617|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2330618|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2330619|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
2330620|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
2330621|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330622|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908683|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908684|NCT04321330|Atezolizumab|atezolizumab|mesh-list
2908685|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908686|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2908687|NCT04319627|Calcium|calcium|mesh-list
2908688|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2908689|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908690|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2908691|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2908692|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
2330623|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2330624|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2330625|NCT00406978|Growth Substances|growth substances|mesh-ancestor
2330626|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
2330627|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2330628|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2330629|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2330630|NCT00406991|Aspirin|aspirin|mesh-list
2330631|NCT00406991|Clopidogrel|clopidogrel|mesh-list
2330632|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2330633|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2330634|NCT00406991|Analgesics|analgesics|mesh-ancestor
2330635|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
2330636|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330637|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330638|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330639|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2330640|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2908693|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908694|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2908695|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2908696|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908697|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
2908698|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2908699|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2908700|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109945|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109946|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
2109947|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2109948|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2109949|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2109950|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
2109951|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109952|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109953|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109954|NCT02530476|Sorafenib|sorafenib|mesh-list
2109955|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109956|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2109957|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2109958|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109959|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
2109960|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2109961|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2109962|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2109963|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
2109964|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
2109965|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
2109966|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2109967|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2109968|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2109969|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
2109970|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
2109971|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
2109972|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2109973|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2109974|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2109975|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
2908701|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
2908702|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
2908703|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908716|NCT04305496|Fulvestrant|fulvestrant|mesh-list
2908717|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2908718|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908719|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2908720|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2908721|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
2908722|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2908723|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908724|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
2908725|NCT04303507|Chloroquine|chloroquine|mesh-list
2908726|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
2908727|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2908728|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2908729|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908730|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908731|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908732|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2908733|NCT04303507|Amebicides|amebicides|mesh-ancestor
2908734|NCT04294654|Vortioxetine|vortioxetine|mesh-list
2908735|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
2109976|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
2330641|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2908736|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2908737|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2908738|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2908739|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2908740|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908741|NCT04294654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2908742|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2908743|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2908744|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908745|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2908746|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
2908747|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2908748|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2330642|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330643|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2330644|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2330645|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330646|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
2330647|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2330648|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2330649|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2330650|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
2330651|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330652|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
2330653|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
2330654|NCT00407017|Ketorolac|ketorolac|mesh-list
2330655|NCT00407017|Nepafenac|nepafenac|mesh-list
2330656|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
2330657|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330658|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330659|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2330660|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2330661|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330662|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330663|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330664|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330665|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2330666|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2330667|NCT00407017|Analgesics|analgesics|mesh-ancestor
2330668|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
2330669|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908749|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2908750|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2908751|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
2908752|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2908753|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2908754|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908755|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
2908756|NCT04272606|Coagulants|coagulants|mesh-ancestor
2908787|NCT04255433|Dulaglutide|dulaglutide|mesh-list
2908788|NCT04255433|Tirzepatide|tirzepatide|mesh-list
2908789|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2908790|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908791|NCT04255433|Incretins|incretins|mesh-ancestor
2908792|NCT04255433|Hormones|hormones|mesh-ancestor
2908793|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2908794|NCT04238819|Irinotecan|irinotecan|mesh-list
2908795|NCT04238819|Temozolomide|temozolomide|mesh-list
2908796|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2908797|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2908798|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908799|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908800|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908801|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2908802|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
2908803|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2908804|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908805|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2908806|NCT04233879|Tenofovir|tenofovir|mesh-list
2908807|NCT04233879|Emtricitabine|emtricitabine|mesh-list
2908808|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2908809|NCT04233879|Islatravir|islatravir|mesh-list
2908810|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
2908811|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908812|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2908813|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2908814|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908815|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908816|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2908817|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2908818|NCT04232553|Mirikizumab|mirikizumab|mesh-list
2908819|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2908820|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2908821|NCT04232553|Analgesics|analgesics|mesh-ancestor
2908822|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
2908823|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908824|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330670|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330671|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2330672|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2330673|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2330674|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2330675|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2330676|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2330677|NCT00407056|Difluprednate|difluprednate|mesh-list
2330678|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
2330679|NCT00407056|Hormones|hormones|mesh-ancestor
2330680|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330681|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330682|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2330683|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330684|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
2330685|NCT00407082|Hormones|hormones|mesh-ancestor
2330686|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330687|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330688|NCT00407121|Bevacizumab|bevacizumab|mesh-list
2330689|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2330690|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330691|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2330692|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2330693|NCT00407121|Growth Substances|growth substances|mesh-ancestor
2330694|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330695|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
2330696|NCT00407186|Cisplatin|cisplatin|mesh-list
2330697|NCT00407186|Capecitabine|capecitabine|mesh-list
2330698|NCT00407186|Epirubicin|epirubicin|mesh-list
2330699|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330700|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2330701|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
2330702|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330703|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2330704|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2330705|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2330706|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330707|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2330708|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
2330709|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2330710|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2330711|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2330712|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2330713|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330714|NCT00407212|Maleic acid|maleic acid|mesh-list
2330715|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330716|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330717|NCT00407225|Difluprednate|difluprednate|mesh-list
2330718|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
2330719|NCT00407225|Hormones|hormones|mesh-ancestor
2330720|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330721|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330722|NCT00407251|Epothilone B|epothilone b|mesh-list
2330723|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908825|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2908826|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2908827|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2908828|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2908829|NCT04226833|Entrectinib|entrectinib|mesh-list
2908830|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2908831|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908832|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908842|NCT04214860|Azacitidine|azacitidine|mesh-list
2908843|NCT04214860|Venetoclax|venetoclax|mesh-list
2908844|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2908845|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
2330724|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
2330725|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
2330726|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
2330727|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330728|NCT00407264|Fluticasone|fluticasone|mesh-list
2330729|NCT00407264|Xhance|xhance|mesh-list
2330730|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330731|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2330732|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
2330733|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330734|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330735|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2330736|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
2330737|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
2330738|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2330739|NCT00407277|Nicotine|nicotine|mesh-list
2330740|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2330741|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
2330742|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330743|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330744|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2330745|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2330746|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
2330747|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330748|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330749|NCT00407290|Neostigmine|neostigmine|mesh-list
2330750|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2330751|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330752|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330753|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
2330754|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2908846|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908847|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908848|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908854|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2908855|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2908856|NCT04205994|Tolcapone|tolcapone|mesh-list
2908857|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2908858|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2908859|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2908860|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908861|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908862|NCT04205812|Paclitaxel|paclitaxel|mesh-list
2908863|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2908864|NCT04205812|Carboplatin|carboplatin|mesh-list
2908865|NCT04205812|Pemetrexed|pemetrexed|mesh-list
2908866|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2908867|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908868|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
2908869|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
2908870|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
2908871|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908872|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908873|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2908874|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2908875|NCT04200313|Pancrelipase|pancrelipase|mesh-list
2908876|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2330755|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330756|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2330757|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
2330758|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330759|NCT00407303|Bortezomib|bortezomib|mesh-list
2330760|NCT00407303|Obatoclax|obatoclax|mesh-list
2908877|NCT04197310|Nivolumab|nivolumab|mesh-list
2908878|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2908879|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908880|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2908881|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908882|NCT04194944|Carboplatin|carboplatin|mesh-list
2908883|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
2908884|NCT04194944|Pemetrexed|pemetrexed|mesh-list
2908885|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908886|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2908887|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2908888|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908889|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2908890|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2908891|NCT04188548|Trastuzumab|trastuzumab|mesh-list
2908892|NCT04188548|Pertuzumab|pertuzumab|mesh-list
2908893|NCT04188548|Everolimus|everolimus|mesh-list
2908894|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2908895|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2908896|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908897|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2330761|NCT00407303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330762|NCT00407303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330763|NCT00407303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330764|NCT00407342|Alefacept|alefacept|mesh-list
2330765|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
2330766|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
2330767|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330768|NCT00407394|Amoxicillin|amoxicillin|mesh-list
2330769|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330770|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330771|NCT00407407|Carboplatin|carboplatin|mesh-list
2330772|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2330773|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330774|NCT00407433|Gemcitabine|gemcitabine|mesh-list
2330775|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
2908898|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
2908899|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908900|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2908901|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330776|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2330777|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
2330778|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330779|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330780|NCT00407433|Antiviral Agents|antiviral agents|mesh-ancestor
2330781|NCT00407433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908902|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908903|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2908904|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
2908905|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2908917|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
2908918|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2908919|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2908920|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908921|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908922|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
2908923|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908924|NCT04176848|Durvalumab|durvalumab|mesh-list
2908925|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2908926|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330782|NCT00407433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330783|NCT00407433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2330784|NCT00407433|Immunologic Factors|immunologic factors|mesh-ancestor
2908931|NCT04171453|Pregabalin|pregabalin|mesh-list
2908932|NCT04171453|Analgesics|analgesics|mesh-ancestor
2908933|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
2908934|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908935|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908936|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
2908937|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2908938|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2908939|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908940|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2908941|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2908942|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2908943|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2908944|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2908945|NCT04168112|Dexamethasone|dexamethasone|mesh-list
2908946|NCT04168112|Prednisolone|prednisolone|mesh-list
2908947|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2908948|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
2908949|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2908950|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
2330785|NCT00407433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330786|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
2330787|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
2330788|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2330789|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2330790|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330791|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330792|NCT00407446|Urological Agents|urological agents|mesh-ancestor
2330793|NCT00407459|Bevacizumab|bevacizumab|mesh-list
2330794|NCT00407459|Carboplatin|carboplatin|mesh-list
2330795|NCT00407459|Pemetrexed|pemetrexed|mesh-list
2330796|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2330797|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330798|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2330799|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2330800|NCT00407459|Growth Substances|growth substances|mesh-ancestor
2908951|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2908952|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
2908953|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2908954|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
2908955|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
2908956|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908957|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908958|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2908959|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
2908960|NCT04168112|Hormones|hormones|mesh-ancestor
2908961|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2908962|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2908963|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908964|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2908965|NCT04168112|Protective Agents|protective agents|mesh-ancestor
2908966|NCT04166773|Tirzepatide|tirzepatide|mesh-list
2908967|NCT04166773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2908968|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908969|NCT04166773|Incretins|incretins|mesh-ancestor
2908970|NCT04166773|Hormones|hormones|mesh-ancestor
2908971|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2908972|NCT04166409|Carboplatin|carboplatin|mesh-list
2908973|NCT04166409|Vincristine|vincristine|mesh-list
2908974|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2908975|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2908976|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
2908977|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
2908978|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
2908979|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2908980|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
2908981|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2908982|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
2908983|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908984|NCT04165122|Valacyclovir|valacyclovir|mesh-list
2908985|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
2908986|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2908987|NCT04162210|Dexamethasone|dexamethasone|mesh-list
2908988|NCT04162210|Pomalidomide|pomalidomide|mesh-list
2908989|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2908990|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
2908991|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
2908992|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2908993|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2908994|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2908995|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
2908996|NCT04162210|Hormones|hormones|mesh-ancestor
2908997|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330801|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330802|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
2330803|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330804|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330805|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2330806|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2330807|NCT00407589|Besifloxacin|besifloxacin|mesh-list
2908998|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2908999|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909000|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
2909001|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2909002|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2909003|NCT04162210|Growth Substances|growth substances|mesh-ancestor
2909004|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
2909005|NCT04154787|Rituximab|rituximab|mesh-list
2909006|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909007|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909008|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
2909009|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909010|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2330808|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330809|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2909018|NCT04148911|Paclitaxel|paclitaxel|mesh-list
2909019|NCT04148911|Atezolizumab|atezolizumab|mesh-list
2909020|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2330810|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2330811|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2330812|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330813|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330814|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330815|NCT00407641|Heparin|heparin|mesh-list
2330816|NCT00407641|Tinzaparin|tinzaparin|mesh-list
2330817|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2330818|NCT00407641|Dalteparin|dalteparin|mesh-list
2330819|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
2330820|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2330821|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2330822|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330823|NCT00407680|Valsartan|valsartan|mesh-list
2330824|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2330825|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2330826|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2330827|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330828|NCT00407719|Bevacizumab|bevacizumab|mesh-list
2330829|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909021|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909022|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
2909023|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
2909024|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
2909025|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909026|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2909027|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
2909028|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2909029|NCT04145700|Gemcitabine|gemcitabine|mesh-list
2330830|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330831|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2330832|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2330833|NCT00407719|Growth Substances|growth substances|mesh-ancestor
2330834|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330835|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
2909030|NCT04145700|Docetaxel|docetaxel|mesh-list
2909031|NCT04145700|Ramucirumab|ramucirumab|mesh-list
2909032|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2909033|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
2909034|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909035|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909036|NCT04145700|Antiviral Agents|antiviral agents|mesh-ancestor
2909037|NCT04145700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2909038|NCT04145700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330836|NCT00407771|Tirofiban|tirofiban|mesh-list
2330837|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2330838|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2909039|NCT04145700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2909040|NCT04145700|Immunologic Factors|immunologic factors|mesh-ancestor
2909041|NCT04145700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909042|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
2909043|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
2909044|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
2909045|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
2909046|NCT04145349|Vinorelbine|vinorelbine|mesh-list
2909047|NCT04145349|Ramucirumab|ramucirumab|mesh-list
2909048|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2909049|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
2909050|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909051|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2909052|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2909053|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
2909054|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330839|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330840|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2330841|NCT00407784|Eplerenone|eplerenone|mesh-list
2330842|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2330843|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
2330844|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330845|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909055|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909056|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2330846|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2330847|NCT00407784|Diuretics|diuretics|mesh-ancestor
2330848|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
2330849|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2330850|NCT00407836|Vaccines|vaccines|mesh-list
2330851|NCT00407836|Immunologic Factors|immunologic factors|mesh-ancestor
2330852|NCT00407836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330853|NCT00407849|Triamcinolone|triamcinolone|mesh-list
2330854|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2330855|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2330856|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2330857|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330858|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
2330859|NCT00407849|Hormones|hormones|mesh-ancestor
2330860|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330861|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330862|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2330863|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
2330864|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330865|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909057|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2909058|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
2909059|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
2909060|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
2909067|NCT04139434|Azacitidine|azacitidine|mesh-list
2909068|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2909069|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
2909070|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909071|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909072|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909073|NCT04136756|Rituximab|rituximab|mesh-list
2909074|NCT04136756|Daratumumab|daratumumab|mesh-list
2909075|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909076|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909077|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
2909078|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909079|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2909102|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
2909103|NCT04130828|Trace Elements|trace elements|mesh-ancestor
2909104|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
2909105|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909106|NCT04129554|Tenofovir|tenofovir|mesh-list
2909107|NCT04129554|Entecavir|entecavir|mesh-list
2909108|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
2909109|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2909110|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2909111|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2330866|NCT00407862|Losartan|losartan|mesh-list
2909112|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909113|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909114|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2909115|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2909134|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
2909135|NCT04106219|Topotecan|topotecan|mesh-list
2909136|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2909137|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
2909138|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909139|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2909140|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2909141|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
2909142|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909143|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909144|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2909145|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2909146|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2909147|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909148|NCT04103554|Valsartan|valsartan|mesh-list
2909149|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2909150|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2909151|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2909152|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2909153|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330867|NCT00407862|Telmisartan|telmisartan|mesh-list
2330868|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2330869|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2330870|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2330871|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2330872|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330873|NCT00407927|Epinastine|epinastine|mesh-list
2330874|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2330875|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
2330876|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
2330877|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330878|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330879|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330880|NCT00408031|Cycloserine|cycloserine|mesh-list
2330881|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2330882|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330883|NCT00408031|Renal Agents|renal agents|mesh-ancestor
2330884|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2909182|NCT04090398|Paclitaxel|paclitaxel|mesh-list
2909183|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2909184|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2909185|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2909186|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909187|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
2909188|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
2909189|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
2909190|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909191|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
2909192|NCT04088890|Fludarabine|fludarabine|mesh-list
2909193|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2909194|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
2909195|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909196|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2909197|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2909198|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
2909199|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330885|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
2330886|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330887|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
2909200|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909201|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2909202|NCT04088409|Adalimumab|adalimumab|mesh-list
2909203|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2909204|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2909205|NCT04086745|Adalimumab|adalimumab|mesh-list
2909206|NCT04086745|Etanercept|etanercept|mesh-list
2909207|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
2909208|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2909209|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2909210|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2909211|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2909212|NCT04086745|Analgesics|analgesics|mesh-ancestor
2330888|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330889|NCT00408135|Telithromycin|telithromycin|mesh-list
2330890|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330891|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330892|NCT00408148|Rimonabant|rimonabant|mesh-list
2330893|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2330894|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2330895|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2330896|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2330897|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330898|NCT00408148|Hormones|hormones|mesh-ancestor
2330899|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2330900|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330901|NCT00408174|Balsalazide|balsalazide|mesh-list
2330902|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2330903|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2330904|NCT00408174|Analgesics|analgesics|mesh-ancestor
2330905|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
2330906|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330907|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330908|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2330909|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2909213|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
2909214|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2909215|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330910|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2330911|NCT00408187|Cyclosporine|cyclosporine|mesh-list
2330912|NCT00408187|Cyclosporins|cyclosporins|mesh-list
2330913|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330914|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330915|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2330916|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
2330917|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330918|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
2330919|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330920|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
2330921|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2330922|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2330923|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
2330924|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2330925|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909216|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2909217|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2909218|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
2909224|NCT04080843|Capecitabine|capecitabine|mesh-list
2909225|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
2909226|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2909227|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
2909228|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909229|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909230|NCT04075292|Rituximab|rituximab|mesh-list
2909231|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
2909232|NCT04075292|Chlorambucil|chlorambucil|mesh-list
2909233|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909234|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909235|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
2909236|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909237|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2909238|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2909239|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
2909240|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909241|NCT04073147|Venetoclax|venetoclax|mesh-list
2909242|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
2909243|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909244|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909250|NCT04054375|Prednisone|prednisone|mesh-list
2909251|NCT04054375|Prednisolone|prednisolone|mesh-list
2909252|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2909253|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
2909254|NCT04054375|Hormones|hormones|mesh-ancestor
2909255|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2909256|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909257|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2909258|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909259|NCT04052139|Naltrexone|naltrexone|mesh-list
2909260|NCT04052139|Gabapentin|gabapentin|mesh-list
2909261|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2909262|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2909263|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909264|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
2909265|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2909266|NCT04052139|Analgesics|analgesics|mesh-ancestor
2909267|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
2909268|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2909269|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2909270|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2909271|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2909272|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2909273|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2909274|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2909275|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909276|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
2330926|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2330927|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
2330928|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2330929|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330930|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330931|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330932|NCT00408226|Pemetrexed|pemetrexed|mesh-list
2330933|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330934|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330935|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330936|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2330937|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2330938|NCT00408239|Enoxaparin|enoxaparin|mesh-list
2330939|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
2330940|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2909277|NCT04032301|Ketamine|ketamine|mesh-list
2909278|NCT04032301|Analgesics|analgesics|mesh-ancestor
2909279|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
2909280|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2909281|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909282|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2909283|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2909284|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
2909285|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
2909286|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2909287|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2909288|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2909289|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2909290|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909291|NCT04012931|Rilpivirine|rilpivirine|mesh-list
2909292|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2909293|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2909294|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909295|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909296|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
2909297|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2909298|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2909299|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2909307|NCT04004611|Mirikizumab|mirikizumab|mesh-list
2909308|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2909309|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2909310|NCT04004611|Analgesics|analgesics|mesh-ancestor
2909311|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
2909312|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330941|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2330942|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330943|NCT00408252|Sunitinib|sunitinib|mesh-list
2330944|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330945|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2330946|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2330947|NCT00408252|Growth Substances|growth substances|mesh-ancestor
2909313|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909314|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2909315|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2909316|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2909317|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2909318|NCT04001829|Paclitaxel|paclitaxel|mesh-list
2909319|NCT04001829|Docetaxel|docetaxel|mesh-list
2909320|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2909321|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2909322|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909323|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
2909324|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
2909325|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
2909326|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909327|NCT03998319|Tenecteplase|tenecteplase|mesh-list
2909328|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2909329|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2909330|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909331|NCT03994627|Olaratumab|olaratumab|mesh-list
2909332|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330948|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330949|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
2330950|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2330951|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330952|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330953|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
2330954|NCT00408278|Analgesics|analgesics|mesh-ancestor
2330955|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
2330956|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2330957|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330958|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330959|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2330960|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2330961|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330962|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330963|NCT00408330|Azelaic acid|azelaic acid|mesh-list
2330964|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330965|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
2330966|NCT00408369|Pafuramidine|pafuramidine|mesh-list
2330967|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2330968|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2330969|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2330970|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2330971|NCT00408382|Atorvastatin|atorvastatin|mesh-list
2330972|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2330973|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2330974|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
2330975|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330976|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2330977|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2330978|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2330979|NCT00408447|Fludarabine|fludarabine|mesh-list
2909372|NCT03984214|Dronabinol|dronabinol|mesh-list
2909373|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
2909374|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330980|NCT00408447|Busulfan|busulfan|mesh-list
2330981|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
2330982|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2330983|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330984|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2330985|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
2330986|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2330987|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
2330988|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2330989|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2330990|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2330991|NCT00408473|Flecainide|flecainide|mesh-list
2330992|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2330993|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2909375|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2909376|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2909377|NCT03984214|Analgesics|analgesics|mesh-ancestor
2909378|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
2909379|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2909380|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2909381|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2909382|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2909383|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909384|NCT03984214|Hormones|hormones|mesh-ancestor
2909385|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2909386|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
2909387|NCT03983850|Sirolimus|sirolimus|mesh-list
2909388|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
2909389|NCT03983850|Busulfan|busulfan|mesh-list
2909390|NCT03983850|Fludarabine|fludarabine|mesh-list
2909391|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2909392|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
2909393|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909394|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2909395|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2909396|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
2909397|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909398|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909399|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2909400|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2909401|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2909402|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
2909403|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2909404|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2909405|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909406|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
2909407|NCT03976323|Cisplatin|cisplatin|mesh-list
2909408|NCT03976323|Carboplatin|carboplatin|mesh-list
2909409|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
2909410|NCT03976323|Pemetrexed|pemetrexed|mesh-list
2909411|NCT03976323|Olaparib|olaparib|mesh-list
2909412|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909413|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909414|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909415|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909416|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2909417|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2909418|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2909419|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
2909420|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
2909421|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909422|NCT03965130|Glucagon|glucagon|mesh-list
2909423|NCT03965130|Hormones|hormones|mesh-ancestor
2909424|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2909425|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909426|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2909427|NCT03958383|Nivolumab|nivolumab|mesh-list
2909428|NCT03958383|Ipilimumab|ipilimumab|mesh-list
2909429|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909430|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909431|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2909432|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909433|NCT03953079|Sunitinib|sunitinib|mesh-list
2909434|NCT03953079|Aflibercept|aflibercept|mesh-list
2909435|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909436|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2909437|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2909438|NCT03953079|Growth Substances|growth substances|mesh-ancestor
2909439|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909440|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
2909441|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2909442|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909443|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330994|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2330995|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2330996|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2330997|NCT00408525|Donepezil|donepezil|mesh-list
2330998|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2330999|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331000|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331001|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
2331002|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331003|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331004|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
2331005|NCT00408538|UC-781|uc-781|mesh-list
2331006|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
2331007|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2331008|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
2331009|NCT00408551|Leucovorin|leucovorin|mesh-list
2331010|NCT00408551|Fluorouracil|fluorouracil|mesh-list
2331011|NCT00408551|Floxuridine|floxuridine|mesh-list
2331012|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
2331013|NCT00408551|Irinotecan|irinotecan|mesh-list
2331014|NCT00408551|Calcium|calcium|mesh-list
2331015|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
2331016|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2331017|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331018|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
2331019|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331020|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2331021|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331022|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2331023|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
2331024|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2331025|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2331026|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331027|NCT00408551|Antidotes|antidotes|mesh-ancestor
2331028|NCT00408551|Protective Agents|protective agents|mesh-ancestor
2331029|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
2331030|NCT00408551|Vitamins|vitamins|mesh-ancestor
2331031|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
2331032|NCT00408655|Sirolimus|sirolimus|mesh-list
2331033|NCT00408655|Paclitaxel|paclitaxel|mesh-list
2331034|NCT00408655|Carboplatin|carboplatin|mesh-list
2331035|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2331036|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331037|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
2331038|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
2331039|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
2331040|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331041|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2331042|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331043|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2331044|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
2331045|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2331046|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
2331047|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331048|NCT00408772|Bevacizumab|bevacizumab|mesh-list
2331049|NCT00408772|Capecitabine|capecitabine|mesh-list
2331050|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
2331051|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909444|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
2909445|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2909446|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2909447|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2909448|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2909449|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909450|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
2909451|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331052|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331053|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2909452|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909453|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2909454|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2909455|NCT03944772|Carboplatin|carboplatin|mesh-list
2909456|NCT03944772|Etoposide|etoposide|mesh-list
2909457|NCT03944772|Pemetrexed|pemetrexed|mesh-list
2909458|NCT03944772|Durvalumab|durvalumab|mesh-list
2909459|NCT03944772|Gefitinib|gefitinib|mesh-list
2909460|NCT03944772|Osimertinib|osimertinib|mesh-list
2909461|NCT03944772|Necitumumab|necitumumab|mesh-list
2909462|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909463|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2909464|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2909465|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2909466|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909467|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909468|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2909469|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2909470|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909471|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2909472|NCT03944577|Evolocumab|evolocumab|mesh-list
2909473|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2909474|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2909475|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
2909476|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909477|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2909478|NCT03940703|Osimertinib|osimertinib|mesh-list
2909479|NCT03940703|Tepotinib|tepotinib|mesh-list
2909480|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909481|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2909482|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909483|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331054|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2331055|NCT00408772|Growth Substances|growth substances|mesh-ancestor
2331056|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331057|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
2331058|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2331059|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
2331060|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331061|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
2331062|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2331063|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2331064|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2331065|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2331066|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331067|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
2331068|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331069|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331070|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2331071|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331072|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
2331073|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2331074|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2331075|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2331076|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2331077|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331078|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
2331079|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331080|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331081|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2331082|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331083|NCT00408850|Pioglitazone|pioglitazone|mesh-list
2331084|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2331085|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331086|NCT00408863|Tibolone|tibolone|mesh-list
2331087|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
2331088|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
2331089|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331090|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331091|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2331092|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2331093|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909484|NCT03931291|Azacitidine|azacitidine|mesh-list
2909485|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2909486|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
2909487|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909488|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909489|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909490|NCT03926130|Mirikizumab|mirikizumab|mesh-list
2909491|NCT03926130|Ustekinumab|ustekinumab|mesh-list
2909492|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
2909493|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2909494|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2909495|NCT03926130|Analgesics|analgesics|mesh-ancestor
2909496|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
2909497|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2909498|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909499|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2909500|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2909501|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2909502|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2909506|NCT03922750|Insulin|insulin|mesh-list
2909507|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2909508|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
2909509|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2909510|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909607|NCT03914300|Nivolumab|nivolumab|mesh-list
2909608|NCT03914300|Ipilimumab|ipilimumab|mesh-list
2909609|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909610|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909611|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2909612|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909613|NCT03910673|Fosfomycin|fosfomycin|mesh-list
2909614|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2909615|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331094|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2331095|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
2331096|NCT00408863|Hormones|hormones|mesh-ancestor
2331097|NCT00408915|Lisuride|lisuride|mesh-list
2331098|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2331099|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2331100|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2331101|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
2331102|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331103|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331104|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331105|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
2331106|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
2331107|NCT00408941|Propofol|propofol|mesh-list
2331108|NCT00408941|Prilocaine|prilocaine|mesh-list
2331109|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2331110|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331111|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331112|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2331113|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
2331114|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
2331115|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
2331116|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
2331117|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331118|NCT00409019|Tenofovir|tenofovir|mesh-list
2331119|NCT00409019|Adefovir|adefovir|mesh-list
2331120|NCT00409019|Telbivudine|telbivudine|mesh-list
2331121|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
2331122|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331123|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2331124|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2331125|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331126|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331127|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2331128|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2331129|NCT00409071|Sinomenine|sinomenine|mesh-list
2331130|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2331131|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
2909645|NCT03905135|Avelumab|avelumab|mesh-list
2909646|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909647|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909653|NCT03882970|Tirzepatide|tirzepatide|mesh-list
2909654|NCT03882970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2909655|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909656|NCT03882970|Incretins|incretins|mesh-ancestor
2909657|NCT03882970|Hormones|hormones|mesh-ancestor
2909658|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331132|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2331133|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331134|NCT00409201|Reboxetine|reboxetine|mesh-list
2331135|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
2331136|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2331137|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2331138|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2909667|NCT03867734|Aztreonam|aztreonam|mesh-list
2909668|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2909669|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331139|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2331140|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331141|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
2331142|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331143|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909676|NCT03854903|Fulvestrant|fulvestrant|mesh-list
2909677|NCT03854903|Palbociclib|palbociclib|mesh-list
2909678|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2331144|NCT00409214|Talaporfin|talaporfin|mesh-list
2331145|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331146|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2331147|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
2331148|NCT00409227|Alfuzosin|alfuzosin|mesh-list
2909679|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909680|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2909681|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2909682|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
2909683|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2909684|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909685|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2909686|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909687|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909688|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
2909689|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2909690|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909691|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
2909692|NCT03829683|Vitamins|vitamins|mesh-ancestor
2909693|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
2909694|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909695|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
2909696|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909697|NCT03829683|Protective Agents|protective agents|mesh-ancestor
2909698|NCT03829410|Bevacizumab|bevacizumab|mesh-list
2909699|NCT03829410|Onvansertib|onvansertib|mesh-list
2909700|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909701|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331149|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
2331150|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2331151|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2331152|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
2331153|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331154|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331155|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331156|NCT00409227|Urological Agents|urological agents|mesh-ancestor
2331157|NCT00409253|Nicardipine|nicardipine|mesh-list
2331158|NCT00409253|Urapidil|urapidil|mesh-list
2331159|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2331160|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2331161|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2331162|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331163|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2331164|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331165|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
2331166|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2331167|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
2331168|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331169|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2331170|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2331171|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2331172|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
2331173|NCT00409305|Betahistine|betahistine|mesh-list
2331174|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
2331175|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
2331176|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
2331177|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331178|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331179|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331180|NCT00409318|Etanercept|etanercept|mesh-list
2331181|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2331182|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2331183|NCT00409318|Analgesics|analgesics|mesh-ancestor
2331184|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
2331185|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331186|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331187|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2331188|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2331189|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2331190|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2331191|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
2331192|NCT00409357|Alfuzosin|alfuzosin|mesh-list
2331193|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2331194|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2909702|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2909703|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2909704|NCT03829410|Growth Substances|growth substances|mesh-ancestor
2909705|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909706|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
2909707|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2909708|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909709|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909710|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2909711|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
2909712|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909713|NCT03818802|Niacinamide|niacinamide|mesh-list
2909714|NCT03818802|Niacin|niacin|mesh-list
2909715|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
2909716|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
2909717|NCT03818802|Vitamins|vitamins|mesh-ancestor
2909718|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
2909719|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909720|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2909721|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
2909722|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909723|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2909724|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
2909725|NCT03816345|Nivolumab|nivolumab|mesh-list
2909726|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909727|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909728|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2909729|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331195|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2331196|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
2331197|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331198|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331199|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331200|NCT00409357|Urological Agents|urological agents|mesh-ancestor
2909750|NCT03810313|Aflibercept|aflibercept|mesh-list
2909751|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2909752|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2909753|NCT03810313|Growth Substances|growth substances|mesh-ancestor
2909754|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909755|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
2909756|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909757|NCT03806335|Anesthetics|anesthetics|mesh-list
2909758|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2909759|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909760|NCT03805932|Rituximab|rituximab|mesh-list
2114043|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331201|NCT00409383|Paclitaxel|paclitaxel|mesh-list
2331202|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2331203|NCT00409383|Temozolomide|temozolomide|mesh-list
2331204|NCT00409383|Oblimersen|oblimersen|mesh-list
2331205|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2331206|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331207|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
2331208|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
2331209|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
2331210|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331211|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2331212|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
2331213|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2331214|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2909761|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
2909762|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2331215|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331216|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331217|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
2331218|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331219|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331220|NCT00409461|Sirolimus|sirolimus|mesh-list
2909763|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909764|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
2909765|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909766|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2909767|NCT03802630|Aflibercept|aflibercept|mesh-list
2909768|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2909769|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2909770|NCT03802630|Growth Substances|growth substances|mesh-ancestor
2909771|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909772|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
2909773|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331221|NCT00409461|Tacrolimus|tacrolimus|mesh-list
2331222|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2331223|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
2331224|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331225|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2331226|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331227|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909774|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
2909775|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909776|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909777|NCT03796156|Aspirin|aspirin|mesh-list
2909778|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2909779|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2909780|NCT03796156|Analgesics|analgesics|mesh-ancestor
2909781|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
2909782|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2909783|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909784|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2909785|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2331228|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2331229|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331230|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2331231|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331232|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
2331233|NCT00409526|Iloprost|iloprost|mesh-list
2331234|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2331235|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
2331236|NCT00409591|Ritonavir|ritonavir|mesh-list
2909786|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2909787|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2909788|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909789|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2909790|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2909791|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909792|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
2909793|NCT03794999|Benralizumab|benralizumab|mesh-list
2909794|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2909795|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
2909796|NCT03794427|Anesthetics|anesthetics|mesh-list
2909797|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2909798|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331237|NCT00409591|Lopinavir|lopinavir|mesh-list
2331238|NCT00409591|Zidovudine|zidovudine|mesh-list
2909799|NCT03794349|Eflornithine|eflornithine|mesh-list
2909800|NCT03794349|Irinotecan|irinotecan|mesh-list
2909801|NCT03794349|Camptothecin|camptothecin|mesh-list
2909802|NCT03794349|Temozolomide|temozolomide|mesh-list
2909803|NCT03794349|Dinutuximab|dinutuximab|mesh-list
2909804|NCT03794349|Sargramostim|sargramostim|mesh-list
2909805|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2909806|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2909807|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909808|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909809|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909810|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2909811|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
2909812|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
2331239|NCT00409591|Nevirapine|nevirapine|mesh-list
2331240|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2331241|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2331242|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
2331243|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331244|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909813|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909814|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2909815|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2909816|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2909817|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2909818|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2909819|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2331245|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2331246|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2909841|NCT03787095|Cemiplimab|cemiplimab|mesh-list
2909842|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909843|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909844|NCT03782207|Atezolizumab|atezolizumab|mesh-list
2909845|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909846|NCT03776071|Temozolomide|temozolomide|mesh-list
2909847|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2909848|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
2909849|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909850|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909851|NCT03775421|Macitentan|macitentan|mesh-list
2909852|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2909853|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2909854|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909855|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2331247|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
2331248|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331249|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2331250|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2331251|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
2331252|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2331253|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2331254|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2331255|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2331256|NCT00409630|Fluticasone|fluticasone|mesh-list
2331257|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2331258|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2331259|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
2331260|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331261|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331262|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2331263|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
2331264|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
2331265|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2331266|NCT00409643|Amlodipine|amlodipine|mesh-list
2909876|NCT03770676|Selenium|selenium|mesh-list
2909877|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
2909878|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909879|NCT03770676|Protective Agents|protective agents|mesh-ancestor
2909880|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909881|NCT03770676|Trace Elements|trace elements|mesh-ancestor
2909882|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
2909883|NCT03770455|Avelumab|avelumab|mesh-list
2331267|NCT00409643|Valsartan|valsartan|mesh-list
2331268|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2331269|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2331270|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2331271|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331272|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2331273|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331274|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
2331275|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2331276|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2909884|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909885|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909886|NCT03768063|Atezolizumab|atezolizumab|mesh-list
2909887|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909888|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
2909889|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2909890|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2909891|NCT03760458|Lamivudine|lamivudine|mesh-list
2909892|NCT03760458|Abacavir|abacavir|mesh-list
2909893|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
2909894|NCT03760458|Dolutegravir|dolutegravir|mesh-list
2909895|NCT03760458|Triumeq|triumeq|mesh-list
2909896|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2909897|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2909898|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909899|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909900|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
2909901|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2909902|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2909903|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2909904|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
2909905|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2909906|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2909907|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2331277|NCT00409656|Basiliximab|basiliximab|mesh-list
2331278|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2909908|NCT03739996|Cabotegravir|cabotegravir|mesh-list
2909909|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2909910|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909911|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909912|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
2909913|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2909914|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2909915|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2909916|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2909917|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2909935|NCT03737643|Paclitaxel|paclitaxel|mesh-list
2909936|NCT03737643|Bevacizumab|bevacizumab|mesh-list
2909937|NCT03737643|Carboplatin|carboplatin|mesh-list
2909938|NCT03737643|Durvalumab|durvalumab|mesh-list
2909939|NCT03737643|Olaparib|olaparib|mesh-list
2909940|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2331279|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
2331280|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331281|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
2331282|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2331283|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
2331284|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331285|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2331286|NCT00409721|Memantine|memantine|mesh-list
2331287|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2909941|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2909942|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909943|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
2909944|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
2909945|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
2909946|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909947|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909948|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2909949|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2909950|NCT03737643|Growth Substances|growth substances|mesh-ancestor
2909951|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909952|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
2909953|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
2909954|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2909955|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909956|NCT03735121|Atezolizumab|atezolizumab|mesh-list
2909957|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331288|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2331289|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
2331290|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331291|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331292|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331293|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2331294|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2331295|NCT00409760|Amlodipine|amlodipine|mesh-list
2331296|NCT00409760|Valsartan|valsartan|mesh-list
2331297|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2331298|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2331299|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2331300|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331301|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2331302|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331303|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
2331304|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2331305|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2331306|NCT00409851|Amlodipine|amlodipine|mesh-list
2331307|NCT00409851|Valsartan|valsartan|mesh-list
2331308|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2331309|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2331310|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2331311|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331312|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2331313|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331314|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
2331315|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2331316|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2331317|NCT00409890|Scopolamine|scopolamine|mesh-list
2331318|NCT00409890|Bromides|bromides|mesh-list
2331319|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2909975|NCT03710564|Aflibercept|aflibercept|mesh-list
2909976|NCT03710564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2909977|NCT03710564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2909978|NCT03710564|Growth Substances|growth substances|mesh-ancestor
2909979|NCT03710564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909980|NCT03710564|Growth Inhibitors|growth inhibitors|mesh-ancestor
2909981|NCT03710564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909982|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
2909983|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2909984|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909985|NCT03706365|Prednisone|prednisone|mesh-list
2909986|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
2909987|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2909988|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
2909989|NCT03706365|Hormones|hormones|mesh-ancestor
2909990|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2909991|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2909992|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2909993|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2909994|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2909995|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2909996|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2909997|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
2909998|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2331320|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
2331321|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2331322|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
2331323|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
2331324|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331325|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331326|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2331327|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
2331328|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2331329|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
2331330|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331331|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910020|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
2910021|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
2910022|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910023|NCT03689712|Protective Agents|protective agents|mesh-ancestor
2910024|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910040|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2910041|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
2910042|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910043|NCT03648892|Raclopride|raclopride|mesh-list
2910044|NCT03648892|Fallypride|fallypride|mesh-list
2910045|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2910046|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2910047|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2910048|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910049|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2910050|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2910051|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
2910052|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2910053|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910054|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2910055|NCT03637660|Penicillins|penicillins|mesh-list
2910056|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2910057|NCT03637660|Penicillin G|penicillin g|mesh-list
2910058|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
2910059|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2910060|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910061|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
2910062|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
2910063|NCT03631446|Citric Acid|citric acid|mesh-list
2910064|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
2910065|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
2910066|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2910067|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
2910068|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
2910069|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910070|NCT03631446|Cathartics|cathartics|mesh-ancestor
2910071|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2910072|NCT03631446|Antacids|antacids|mesh-ancestor
2910073|NCT03630640|Nivolumab|nivolumab|mesh-list
2910074|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2910075|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910076|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2910077|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910078|NCT03625388|Dasatinib|dasatinib|mesh-list
2910079|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910080|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2910081|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910082|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331332|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2331333|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
2331334|NCT00409903|Eprosartan|eprosartan|mesh-list
2331335|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2331336|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
2331337|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2331338|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331339|NCT00409942|Torsemide|torsemide|mesh-list
2910104|NCT03577704|Gemcitabine|gemcitabine|mesh-list
2910105|NCT03577704|Paclitaxel|paclitaxel|mesh-list
2910106|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2910107|NCT03577704|Cisplatin|cisplatin|mesh-list
2910108|NCT03577704|Carboplatin|carboplatin|mesh-list
2910109|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
2910110|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2910111|NCT03577704|Antibodies|antibodies|mesh-list
2910112|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
2910113|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2910114|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2910115|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910116|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
2910117|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
2910118|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
2910119|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331340|NCT00409942|Furosemide|furosemide|mesh-list
2331341|NCT00409942|Diuretics|diuretics|mesh-ancestor
2331342|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
2331343|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331344|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2910120|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
2910121|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910122|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2331345|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2331346|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331347|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2910123|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
2910124|NCT03577704|Antiviral Agents|antiviral agents|mesh-ancestor
2910125|NCT03577704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910126|NCT03577704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910127|NCT03577704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2910128|NCT03567057|Amantadine|amantadine|mesh-list
2910129|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2910130|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2910131|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
2910132|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910133|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
2910134|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331348|NCT00409981|Paclitaxel|paclitaxel|mesh-list
2331349|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2910135|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910136|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910137|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2910138|NCT03567057|Analgesics|analgesics|mesh-ancestor
2910139|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
2910140|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2910141|NCT03566511|Diazoxide|diazoxide|mesh-list
2910142|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2910143|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
2910144|NCT03556202|Mirikizumab|mirikizumab|mesh-list
2910145|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2910146|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2910147|NCT03556202|Analgesics|analgesics|mesh-ancestor
2910148|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
2910149|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2910150|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910151|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2910152|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2910153|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2910154|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2910155|NCT03553563|Esomeprazole|esomeprazole|mesh-list
2910156|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2910157|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2910158|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2910159|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910160|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910161|NCT03552068|Clonidine|clonidine|mesh-list
2910162|NCT03552068|Analgesics|analgesics|mesh-ancestor
2910163|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
2910164|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2910165|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910166|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2910167|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
2910168|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
2910169|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2910170|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2910171|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2910172|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
2910173|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2910174|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910175|NCT03548064|Vaccines|vaccines|mesh-list
2910176|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
2910177|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331350|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331351|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
2331352|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
2331353|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
2331354|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910178|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
2910179|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2910180|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910186|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2910187|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
2910188|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910189|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2910190|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
2910191|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2910192|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910193|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2910194|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2910195|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2910196|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
2910197|NCT03526679|Lenvatinib|lenvatinib|mesh-list
2910198|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910199|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2910200|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910201|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910202|NCT03524092|Mirikizumab|mirikizumab|mesh-list
2910203|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2910204|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2910205|NCT03524092|Analgesics|analgesics|mesh-ancestor
2910206|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
2910207|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2910208|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910209|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2910210|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2910211|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2910212|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2910213|NCT03521232|Niclosamide|niclosamide|mesh-list
2331355|NCT00409994|Sirolimus|sirolimus|mesh-list
2331356|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2331357|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331358|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2331359|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331360|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
2331361|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2331362|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
2331363|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910214|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
2910215|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2910216|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
2910217|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2910218|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910219|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
2910220|NCT03521154|Osimertinib|osimertinib|mesh-list
2910221|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910222|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2910223|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910224|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910225|NCT03519945|Mirikizumab|mirikizumab|mesh-list
2910226|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2910227|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2910228|NCT03519945|Analgesics|analgesics|mesh-ancestor
2910229|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
2910230|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2910231|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910232|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2910233|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2910234|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2910235|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2910236|NCT03511963|Bevacizumab|bevacizumab|mesh-list
2910237|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2910238|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910239|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2910240|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2910241|NCT03511963|Growth Substances|growth substances|mesh-ancestor
2910242|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910243|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
2910244|NCT03504397|Leucovorin|leucovorin|mesh-list
2910245|NCT03504397|Folic Acid|folic acid|mesh-list
2910246|NCT03504397|Fluorouracil|fluorouracil|mesh-list
2910247|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
2910248|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
2910249|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
2910250|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910251|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2910252|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910253|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2910254|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
2910255|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910256|NCT03504397|Antidotes|antidotes|mesh-ancestor
2910257|NCT03504397|Protective Agents|protective agents|mesh-ancestor
2331364|NCT00410033|Insulin|insulin|mesh-list
2331365|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2331366|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
2331367|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
2331368|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
2331369|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
2331370|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2331371|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331372|NCT00410215|Bisacodyl|bisacodyl|mesh-list
2331373|NCT00410215|Cathartics|cathartics|mesh-ancestor
2331374|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2331375|NCT00410215|Laxatives|laxatives|mesh-ancestor
2331376|NCT00410254|Midazolam|midazolam|mesh-list
2331377|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2331378|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2910258|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
2910259|NCT03504397|Vitamins|vitamins|mesh-ancestor
2331379|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331380|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331381|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2331382|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2910260|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
2910261|NCT03504397|Hematinics|hematinics|mesh-ancestor
2910262|NCT03502785|Atezolizumab|atezolizumab|mesh-list
2331383|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2331384|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2910263|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910264|NCT03502668|Decitabine|decitabine|mesh-list
2910265|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2331385|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
2331386|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
2331387|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
2331388|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
2331389|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331390|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331391|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
2331392|NCT00410306|Testosterone|testosterone|mesh-list
2331393|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
2331394|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
2331395|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2331396|NCT00410306|Androgens|androgens|mesh-ancestor
2331397|NCT00410306|Hormones|hormones|mesh-ancestor
2331398|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331399|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331400|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2331401|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331402|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
2331403|NCT00410345|Mifepristone|mifepristone|mesh-list
2331404|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2331405|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
2331406|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2331407|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331408|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2331409|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2331410|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2331411|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
2331412|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2331413|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2331414|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
2331415|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331416|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
2331417|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2331418|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2331419|NCT00410371|Lamotrigine|lamotrigine|mesh-list
2331420|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
2331421|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2331422|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2331423|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331424|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2331425|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331426|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2331427|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2910266|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
2910267|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910268|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910269|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910270|NCT03498716|Paclitaxel|paclitaxel|mesh-list
2910271|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
2910272|NCT03498716|Doxorubicin|doxorubicin|mesh-list
2910273|NCT03498716|Atezolizumab|atezolizumab|mesh-list
2910274|NCT03498716|Epirubicin|epirubicin|mesh-list
2910275|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2910276|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910277|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
2910278|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
2910279|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
2910280|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910281|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2910282|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
2910283|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910284|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2910285|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2910286|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
2910287|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2910288|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2910289|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2910290|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2910291|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331428|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331429|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2331430|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2910292|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2910293|NCT03497676|Rilpivirine|rilpivirine|mesh-list
2910294|NCT03497676|Cabotegravir|cabotegravir|mesh-list
2910295|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
2910296|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910297|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2910298|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2910299|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910300|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910301|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2910302|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2910303|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2910304|NCT03496610|Bupivacaine|bupivacaine|mesh-list
2910305|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
2910306|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
2910307|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2910308|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910309|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
2910310|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2910321|NCT03474107|Paclitaxel|paclitaxel|mesh-list
2910322|NCT03474107|Docetaxel|docetaxel|mesh-list
2910323|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2910324|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910325|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
2910326|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
2910327|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
2910328|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910329|NCT03462342|Olaparib|olaparib|mesh-list
2910330|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2910331|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910332|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910333|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910334|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2910335|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
2910336|NCT03461406|Coagulants|coagulants|mesh-ancestor
2910337|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2910338|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2910339|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910340|NCT03446456|Vasopressins|vasopressins|mesh-list
2910341|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
2910342|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
2910343|NCT03446456|Coagulants|coagulants|mesh-ancestor
2910344|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2910345|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2910346|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
2910347|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910348|NCT03424005|Gemcitabine|gemcitabine|mesh-list
2910349|NCT03424005|Paclitaxel|paclitaxel|mesh-list
2910350|NCT03424005|Bevacizumab|bevacizumab|mesh-list
2910351|NCT03424005|Carboplatin|carboplatin|mesh-list
2910352|NCT03424005|Capecitabine|capecitabine|mesh-list
2910353|NCT03424005|Atezolizumab|atezolizumab|mesh-list
2910354|NCT03424005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2910355|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910356|NCT03424005|Tubulin Modulators|tubulin modulators|mesh-ancestor
2910357|NCT03424005|Antimitotic Agents|antimitotic agents|mesh-ancestor
2910358|NCT03424005|Mitosis Modulators|mitosis modulators|mesh-ancestor
2910359|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910360|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2910361|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2331431|NCT00410449|Tocopherols|tocopherols|mesh-list
2910362|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2910363|NCT03424005|Growth Substances|growth substances|mesh-ancestor
2910364|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331432|NCT00410449|Vitamin E|vitamin e|mesh-list
2331433|NCT00410449|Tocotrienols|tocotrienols|mesh-list
2910365|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
2910366|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2910367|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
2910368|NCT03424005|Antiviral Agents|antiviral agents|mesh-ancestor
2910369|NCT03424005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910370|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910371|NCT03424005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2910372|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
2910373|NCT03422328|Macitentan|macitentan|mesh-list
2910374|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2910375|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2910376|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910377|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2910378|NCT03408574|Mecamylamine|mecamylamine|mesh-list
2910379|NCT03408574|Nicotine|nicotine|mesh-list
2910380|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2910381|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
2910382|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2910383|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910384|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2910385|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2910386|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
2910387|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2109977|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2109978|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2109979|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109980|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2109981|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109982|NCT02531113|Ozanimod|ozanimod|mesh-list
2331434|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
2331435|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
2331436|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331437|NCT00410449|Protective Agents|protective agents|mesh-ancestor
2331438|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331439|NCT00410449|Vitamins|vitamins|mesh-ancestor
2331440|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
2331441|NCT00410462|Doxorubicin|doxorubicin|mesh-list
2331442|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2331443|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2910388|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910389|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2910390|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2910391|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2910392|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2910393|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2910394|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
2910395|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910396|NCT03396692|Morphine|morphine|mesh-list
2910397|NCT03396692|Ropivacaine|ropivacaine|mesh-list
2910398|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2910399|NCT03396692|Narcotics|narcotics|mesh-ancestor
2910400|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2910401|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910402|NCT03396692|Analgesics|analgesics|mesh-ancestor
2910403|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
2910404|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2910405|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
2910406|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
2910407|NCT03395639|Heparin|heparin|mesh-list
2910408|NCT03395639|Enoxaparin|enoxaparin|mesh-list
2910409|NCT03395639|Warfarin|warfarin|mesh-list
2910410|NCT03395639|Edoxaban|edoxaban|mesh-list
2910411|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
2910412|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2910413|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2910414|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910415|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2331444|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331445|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2331446|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2331447|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331448|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910416|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
2910417|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2331449|NCT00410527|Meropenem|meropenem|mesh-list
2331450|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2331451|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331452|NCT00410540|Morphine|morphine|mesh-list
2331453|NCT00410540|Hydromorphone|hydromorphone|mesh-list
2331454|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2910418|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
2910419|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910420|NCT03388190|Leucovorin|leucovorin|mesh-list
2910421|NCT03388190|Fluorouracil|fluorouracil|mesh-list
2910422|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
2910423|NCT03388190|Nivolumab|nivolumab|mesh-list
2910424|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
2910425|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
2910426|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910427|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2910428|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910429|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2910430|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
2910431|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910432|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2910433|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2910434|NCT03388190|Antidotes|antidotes|mesh-ancestor
2910435|NCT03388190|Protective Agents|protective agents|mesh-ancestor
2910436|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
2910437|NCT03388190|Vitamins|vitamins|mesh-ancestor
2910438|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
2910439|NCT03384641|Bedaquiline|bedaquiline|mesh-list
2910440|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
2910441|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2910442|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910443|NCT03382834|Tamoxifen|tamoxifen|mesh-list
2910444|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2910445|NCT03382834|Vorinostat|vorinostat|mesh-list
2910446|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2910447|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
2910448|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2910449|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910450|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2910451|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910452|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2910453|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2910454|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2910455|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2910456|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910457|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910458|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
2910459|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910460|NCT03377491|Gemcitabine|gemcitabine|mesh-list
2910461|NCT03377491|Paclitaxel|paclitaxel|mesh-list
2910462|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2910463|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910464|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
2910465|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
2910466|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
2910467|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910468|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2910469|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
2910470|NCT03377491|Antiviral Agents|antiviral agents|mesh-ancestor
2910471|NCT03377491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910472|NCT03377491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910473|NCT03377491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2910474|NCT03377491|Immunologic Factors|immunologic factors|mesh-ancestor
2910475|NCT03377491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910476|NCT03377361|Nivolumab|nivolumab|mesh-list
2910477|NCT03377361|Ipilimumab|ipilimumab|mesh-list
2910478|NCT03377361|Trametinib|trametinib|mesh-list
2910479|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2910480|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910481|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2910482|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910483|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2331455|NCT00410540|Narcotics|narcotics|mesh-ancestor
2331456|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2910484|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910485|NCT03371017|Gemcitabine|gemcitabine|mesh-list
2910486|NCT03371017|Carboplatin|carboplatin|mesh-list
2910487|NCT03371017|Capecitabine|capecitabine|mesh-list
2331457|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331458|NCT00410540|Analgesics|analgesics|mesh-ancestor
2331459|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
2331460|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331461|NCT00410553|Gemcitabine|gemcitabine|mesh-list
2331462|NCT00410553|Halichondrin B|halichondrin b|mesh-list
2331463|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2331464|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
2331465|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331466|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331467|NCT00410553|Antiviral Agents|antiviral agents|mesh-ancestor
2331468|NCT00410553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331469|NCT00410553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910488|NCT03371017|Atezolizumab|atezolizumab|mesh-list
2910489|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910490|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2910491|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
2910492|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910493|NCT03371017|Antiviral Agents|antiviral agents|mesh-ancestor
2910494|NCT03371017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910495|NCT03371017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910496|NCT03371017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2910497|NCT03371017|Immunologic Factors|immunologic factors|mesh-ancestor
2910498|NCT03371017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910499|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
2910500|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2910501|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910502|NCT03337698|Linagliptin|linagliptin|mesh-list
2910503|NCT03337698|Gemcitabine|gemcitabine|mesh-list
2910504|NCT03337698|Bevacizumab|bevacizumab|mesh-list
2910505|NCT03337698|Carboplatin|carboplatin|mesh-list
2331470|NCT00410553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2331471|NCT00410553|Immunologic Factors|immunologic factors|mesh-ancestor
2331472|NCT00410553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331473|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
2331474|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
2331475|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
2331476|NCT00410592|Esomeprazole|esomeprazole|mesh-list
2331477|NCT00410592|Pantoprazole|pantoprazole|mesh-list
2331478|NCT00410592|Lansoprazole|lansoprazole|mesh-list
2331479|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
2331480|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2331481|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2331482|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2331483|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331484|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331485|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
2331486|NCT00410631|Melphalan|melphalan|mesh-list
2331487|NCT00410631|Ifosfamide|ifosfamide|mesh-list
2331488|NCT00410631|Dacarbazine|dacarbazine|mesh-list
2331489|NCT00410631|Carboplatin|carboplatin|mesh-list
2331490|NCT00410631|Doxorubicin|doxorubicin|mesh-list
2331491|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2331492|NCT00410631|Etoposide|etoposide|mesh-list
2331493|NCT00410631|Vincristine|vincristine|mesh-list
2331494|NCT00410631|Topotecan|topotecan|mesh-list
2331495|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
2910506|NCT03337698|Docetaxel|docetaxel|mesh-list
2910507|NCT03337698|Pemetrexed|pemetrexed|mesh-list
2910508|NCT03337698|Atezolizumab|atezolizumab|mesh-list
2910509|NCT03337698|Evolocumab|evolocumab|mesh-list
2910510|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2910511|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910512|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2910513|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2910514|NCT03337698|Growth Substances|growth substances|mesh-ancestor
2910515|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910516|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
2910517|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2910518|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
2910519|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910520|NCT03337698|Antiviral Agents|antiviral agents|mesh-ancestor
2331496|NCT00410631|Vindesine|vindesine|mesh-list
2331497|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2331498|NCT00410631|Isotretinoin|isotretinoin|mesh-list
2331499|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2331500|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
2331501|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331502|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2331503|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2910521|NCT03337698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910522|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910523|NCT03337698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2910524|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
2910525|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
2910526|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
2910527|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
2910528|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2910529|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2910530|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2910531|NCT03337698|Incretins|incretins|mesh-ancestor
2910532|NCT03337698|Hormones|hormones|mesh-ancestor
2910533|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2910534|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2910535|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
2910536|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2910537|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2910538|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2910539|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
2910540|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2910541|NCT03326193|Bevacizumab|bevacizumab|mesh-list
2910542|NCT03326193|Niraparib|niraparib|mesh-list
2910543|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2910544|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910545|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2910546|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2910547|NCT03326193|Growth Substances|growth substances|mesh-ancestor
2910548|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910549|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
2910550|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2910551|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910552|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910553|NCT03321643|Gemcitabine|gemcitabine|mesh-list
2910554|NCT03321643|Rituximab|rituximab|mesh-list
2910555|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2910556|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
2910557|NCT03321643|Atezolizumab|atezolizumab|mesh-list
2910558|NCT03321643|Antibodies|antibodies|mesh-list
2910559|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
2910560|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2910561|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
2910562|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910563|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910564|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2910565|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2910566|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
2910567|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910568|NCT03321643|Antiviral Agents|antiviral agents|mesh-ancestor
2910569|NCT03321643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910570|NCT03321643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910571|NCT03321643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2910572|NCT03310905|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2910573|NCT03310905|Immunologic Factors|immunologic factors|mesh-ancestor
2910574|NCT03310905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910575|NCT03302286|Mannitol|mannitol|mesh-list
2910576|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2910577|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2910578|NCT03302286|Diuretics|diuretics|mesh-ancestor
2331504|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
2331505|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331506|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331507|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2331508|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2331509|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2910579|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
2910580|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910584|NCT03285763|Atezolizumab|atezolizumab|mesh-list
2910585|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331510|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2331511|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331512|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2331513|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
2910589|NCT03281369|Leucovorin|leucovorin|mesh-list
2910590|NCT03281369|Linagliptin|linagliptin|mesh-list
2910591|NCT03281369|Paclitaxel|paclitaxel|mesh-list
2910592|NCT03281369|Fluorouracil|fluorouracil|mesh-list
2910593|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
2910594|NCT03281369|Atezolizumab|atezolizumab|mesh-list
2910595|NCT03281369|Ramucirumab|ramucirumab|mesh-list
2910596|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2910597|NCT03281369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2910598|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910599|NCT03281369|Tubulin Modulators|tubulin modulators|mesh-ancestor
2910600|NCT03281369|Antimitotic Agents|antimitotic agents|mesh-ancestor
2910601|NCT03281369|Mitosis Modulators|mitosis modulators|mesh-ancestor
2910602|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910603|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
2910604|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2910605|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2910606|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
2331514|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
2331515|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
2331516|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2331517|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
2331518|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2331519|NCT00410644|Hydromorphone|hydromorphone|mesh-list
2331520|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2331521|NCT00410644|Narcotics|narcotics|mesh-ancestor
2331522|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331523|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331524|NCT00410644|Analgesics|analgesics|mesh-ancestor
2331525|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
2331526|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2910607|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910608|NCT03281369|Antidotes|antidotes|mesh-ancestor
2910609|NCT03281369|Protective Agents|protective agents|mesh-ancestor
2910610|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
2910611|NCT03281369|Vitamins|vitamins|mesh-ancestor
2910612|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
2910613|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2910614|NCT03281369|Incretins|incretins|mesh-ancestor
2910615|NCT03281369|Hormones|hormones|mesh-ancestor
2910616|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2910617|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2910618|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
2910619|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910620|NCT03280563|Tamoxifen|tamoxifen|mesh-list
2910621|NCT03280563|Bevacizumab|bevacizumab|mesh-list
2910622|NCT03280563|Atezolizumab|atezolizumab|mesh-list
2910623|NCT03280563|Fulvestrant|fulvestrant|mesh-list
2910624|NCT03280563|Exemestane|exemestane|mesh-list
2910625|NCT03280563|Entinostat|entinostat|mesh-list
2910626|NCT03280563|Antibodies|antibodies|mesh-list
2910627|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2910628|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910629|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2910630|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2910631|NCT03280563|Growth Substances|growth substances|mesh-ancestor
2910632|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910633|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
2910634|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
2910635|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2910636|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
2910637|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2910638|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2910639|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2910640|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2910641|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2910642|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2910643|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2910644|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2910645|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910646|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910647|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2910648|NCT03271021|Minocycline|minocycline|mesh-list
2331527|NCT00410657|Prednisone|prednisone|mesh-list
2910649|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2910650|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331528|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
2331529|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2331530|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2331531|NCT00410657|Prednisolone|prednisolone|mesh-list
2331532|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
2331533|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
2331534|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2331535|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
2331536|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2331537|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
2331538|NCT00410657|Hormones|hormones|mesh-ancestor
2331539|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2910687|NCT03264352|Amlodipine|amlodipine|mesh-list
2910688|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2910689|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2910690|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2910691|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910692|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2910693|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910694|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
2910705|NCT03255083|Osimertinib|osimertinib|mesh-list
2910706|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910707|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2910708|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910709|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910710|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
2910711|NCT03253172|Diuretics|diuretics|mesh-ancestor
2910712|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
2910713|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910714|NCT03253172|Expectorants|expectorants|mesh-ancestor
2910715|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
2910716|NCT03232593|Atezolizumab|atezolizumab|mesh-list
2910717|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910718|NCT03227471|Ivacaftor|ivacaftor|mesh-list
2910719|NCT03227471|Elexacaftor|elexacaftor|mesh-list
2910720|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2910721|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2910722|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910723|NCT03221842|Complement C1s|complement c1s|mesh-list
2910724|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2910725|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2910726|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
2910727|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910728|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2910729|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2910730|NCT03212274|Olaparib|olaparib|mesh-list
2910731|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2910732|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910733|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910734|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910757|NCT03195478|Nivolumab|nivolumab|mesh-list
2910758|NCT03195478|Ipilimumab|ipilimumab|mesh-list
2910759|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2910760|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910761|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2910762|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910763|NCT03194321|Tacrolimus|tacrolimus|mesh-list
2910764|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2910765|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
2910766|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910767|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2910768|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910769|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331540|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331541|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2331542|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331543|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
2331544|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
2331545|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331546|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2331547|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2331548|NCT00410657|Protective Agents|protective agents|mesh-ancestor
2331549|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2331550|NCT00410696|Lenograstim|lenograstim|mesh-list
2331551|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2331552|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
2331553|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331554|NCT00410735|Pranlukast|pranlukast|mesh-list
2910775|NCT03190915|Trametinib|trametinib|mesh-list
2910776|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910777|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2910778|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910779|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910780|NCT03189693|Anesthetics|anesthetics|mesh-list
2910781|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2910782|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910783|NCT03170206|Palbociclib|palbociclib|mesh-list
2910784|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910785|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2910786|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910787|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910788|NCT03165721|Guadecitabine|guadecitabine|mesh-list
2910789|NCT03165721|Azacitidine|azacitidine|mesh-list
2910790|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910791|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2910792|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
2910793|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910794|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910795|NCT03158064|Durvalumab|durvalumab|mesh-list
2910796|NCT03158064|Tremelimumab|tremelimumab|mesh-list
2910797|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2910798|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910799|NCT03150173|Buprenorphine|buprenorphine|mesh-list
2910800|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2910801|NCT03150173|Narcotics|narcotics|mesh-ancestor
2910802|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2910803|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910804|NCT03150173|Analgesics|analgesics|mesh-ancestor
2910805|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
2910806|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2910807|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2910832|NCT03093922|Gemcitabine|gemcitabine|mesh-list
2910833|NCT03093922|Atezolizumab|atezolizumab|mesh-list
2331555|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2331556|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
2331557|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2331558|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
2331559|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331560|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331561|NCT00410748|Hydromorphone|hydromorphone|mesh-list
2331562|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2331563|NCT00410748|Narcotics|narcotics|mesh-ancestor
2331564|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331565|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331566|NCT00410748|Analgesics|analgesics|mesh-ancestor
2331567|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
2331568|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331569|NCT00410774|Gemcitabine|gemcitabine|mesh-list
2331570|NCT00410774|Bevacizumab|bevacizumab|mesh-list
2910834|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910835|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2910836|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
2910837|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910838|NCT03093922|Antiviral Agents|antiviral agents|mesh-ancestor
2910839|NCT03093922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910840|NCT03093922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910841|NCT03093922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2910842|NCT03093922|Immunologic Factors|immunologic factors|mesh-ancestor
2910843|NCT03093922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910844|NCT03085095|Leuprolide|leuprolide|mesh-list
2910845|NCT03085095|Relugolix|relugolix|mesh-list
2910846|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2910847|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
2910848|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2910849|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910850|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2910851|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910852|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
2910853|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
2910854|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2910855|NCT03074045|Drospirenone|drospirenone|mesh-list
2910856|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
2910857|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2910858|NCT03074045|Estradiol|estradiol|mesh-list
2910859|NCT03074045|Estrogens|estrogens|mesh-ancestor
2910860|NCT03074045|Hormones|hormones|mesh-ancestor
2910861|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2910862|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910863|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2910864|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
2910865|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2910866|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2910867|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2910868|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2910869|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2910870|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2910871|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
2910872|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2910873|NCT03074045|Diuretics|diuretics|mesh-ancestor
2910874|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
2910875|NCT03065062|Palbociclib|palbociclib|mesh-list
2910876|NCT03065062|Gedatolisib|gedatolisib|mesh-list
2910877|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910878|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2910879|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910880|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910881|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2910882|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2910883|NCT03057431|Diuretics|diuretics|mesh-ancestor
2910884|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
2910885|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910886|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2910887|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2910888|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910889|NCT03048422|Tenofovir|tenofovir|mesh-list
2910890|NCT03048422|Emtricitabine|emtricitabine|mesh-list
2910891|NCT03048422|Efavirenz|efavirenz|mesh-list
2910892|NCT03048422|Dolutegravir|dolutegravir|mesh-list
2910893|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2910894|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2910895|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2910896|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
2910897|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2910898|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2910899|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2910900|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910901|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910902|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2910903|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2910904|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2910905|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2910906|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2910907|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2910908|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2910909|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2910910|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2910911|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2910912|NCT03022279|Ropivacaine|ropivacaine|mesh-list
2910913|NCT03022279|Anesthetics, Local|anesthetics, local|mesh-ancestor
2910914|NCT03022279|Anesthetics|anesthetics|mesh-ancestor
2910915|NCT03022279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2910916|NCT03022279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910917|NCT03022279|Sensory System Agents|sensory system agents|mesh-ancestor
2910918|NCT03022279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2910946|NCT02984800|Anesthetics|anesthetics|mesh-list
2910947|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2910948|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2910949|NCT02977780|Temozolomide|temozolomide|mesh-list
2910950|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2910951|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
2910952|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910953|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910954|NCT02967692|Trametinib|trametinib|mesh-list
2910955|NCT02967692|Dabrafenib|dabrafenib|mesh-list
2910956|NCT02967692|Spartalizumab|spartalizumab|mesh-list
2910957|NCT02967692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2910958|NCT02967692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2910959|NCT02967692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910960|NCT02967692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910961|NCT02967692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2910962|NCT02964884|Lovastatin|lovastatin|mesh-list
2910963|NCT02964884|L 647318|l 647318|mesh-list
2910964|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
2910965|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2910966|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2910967|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
2910968|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910969|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2910970|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2910971|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910972|NCT02925650|Phenserine|phenserine|mesh-list
2331571|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2331572|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331573|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2331574|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2331575|NCT00410774|Growth Substances|growth substances|mesh-ancestor
2331576|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331577|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
2331578|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2331579|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
2331580|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331581|NCT00410774|Antiviral Agents|antiviral agents|mesh-ancestor
2331582|NCT00410774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331583|NCT00410774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910973|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2910974|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2910975|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2910976|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
2910977|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2910978|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911003|NCT02910843|Capecitabine|capecitabine|mesh-list
2911004|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2911005|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
2911006|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911007|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911008|NCT02908672|Atezolizumab|atezolizumab|mesh-list
2911009|NCT02908672|Vemurafenib|vemurafenib|mesh-list
2911010|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2911011|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911012|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
2911013|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911014|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2911015|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911016|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911017|NCT02891811|Thalidomide|thalidomide|mesh-list
2911018|NCT02891811|Dexamethasone|dexamethasone|mesh-list
2911019|NCT02891811|Lenalidomide|lenalidomide|mesh-list
2331584|NCT00410774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2331585|NCT00410774|Immunologic Factors|immunologic factors|mesh-ancestor
2331586|NCT00410787|Hydromorphone|hydromorphone|mesh-list
2331587|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2911020|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2911021|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
2911022|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
2911023|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2911024|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911025|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2911026|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
2911027|NCT02891811|Hormones|hormones|mesh-ancestor
2911028|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2911029|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2911030|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911031|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
2911032|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2911033|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2911034|NCT02891811|Growth Substances|growth substances|mesh-ancestor
2911035|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
2911036|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2911037|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
2911038|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2911039|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2911047|NCT02876510|Vidarabine|vidarabine|mesh-list
2911048|NCT02876510|Aldesleukin|aldesleukin|mesh-list
2911049|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
2911050|NCT02876510|Fludarabine|fludarabine|mesh-list
2911051|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
2911052|NCT02876510|Atezolizumab|atezolizumab|mesh-list
2911053|NCT02876510|Interleukin-2|interleukin-2|mesh-list
2911054|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2911055|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
2911056|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911057|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2911058|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2911059|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
2911060|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911061|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911062|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2911063|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2911064|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
2911065|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
2911066|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2911067|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2911068|NCT02876510|Analgesics|analgesics|mesh-ancestor
2911069|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
2911070|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2911071|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2911072|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2911073|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
2911074|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2911075|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2109983|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2109984|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2109985|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2109986|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
2109987|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109988|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
2109989|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2109990|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2109991|NCT02531321|Estradiol|estradiol|mesh-list
2109992|NCT02531321|Estrogens|estrogens|mesh-ancestor
2109993|NCT02531321|Hormones|hormones|mesh-ancestor
2109994|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2109995|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2109996|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2109997|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
2109998|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2109999|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2110000|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2110001|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2110002|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2110003|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2110004|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2110005|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
2110006|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110007|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
2110008|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2110009|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110010|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2110011|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2110012|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110013|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110014|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110015|NCT02531633|Prednisone|prednisone|mesh-list
2110016|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2110017|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2110018|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
2110019|NCT02531633|Hormones|hormones|mesh-ancestor
2110020|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2110021|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110022|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2110023|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110024|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
2911076|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
2911077|NCT02864407|Olodaterol|olodaterol|mesh-list
2911078|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2911079|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
2911080|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2911081|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911082|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2911083|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
2911084|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
2911085|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2911086|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
2911087|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2911088|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911089|NCT02839915|Leucovorin|leucovorin|mesh-list
2911090|NCT02839915|Folic Acid|folic acid|mesh-list
2911091|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
2911092|NCT02839915|Antidotes|antidotes|mesh-ancestor
2911093|NCT02839915|Protective Agents|protective agents|mesh-ancestor
2911094|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331588|NCT00410787|Narcotics|narcotics|mesh-ancestor
2331589|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331590|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331591|NCT00410787|Analgesics|analgesics|mesh-ancestor
2331592|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
2331593|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331594|NCT00410852|Insulin|insulin|mesh-list
2331595|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2331596|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2331597|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331598|NCT00410878|Hydromorphone|hydromorphone|mesh-list
2331599|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2331600|NCT00410878|Narcotics|narcotics|mesh-ancestor
2331601|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331602|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331603|NCT00410878|Analgesics|analgesics|mesh-ancestor
2331604|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
2331605|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331606|NCT00410943|Hydromorphone|hydromorphone|mesh-list
2331607|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2331608|NCT00410943|Narcotics|narcotics|mesh-ancestor
2911095|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
2911096|NCT02839915|Vitamins|vitamins|mesh-ancestor
2911097|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
2911098|NCT02839915|Hematinics|hematinics|mesh-ancestor
2911099|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
2911100|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2911101|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331609|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331610|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911108|NCT02829723|Spartalizumab|spartalizumab|mesh-list
2911109|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2911110|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911111|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911112|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
2911113|NCT02828761|Calcium|calcium|mesh-list
2911114|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2911115|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911116|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2911117|NCT02821754|Durvalumab|durvalumab|mesh-list
2911118|NCT02821754|Tremelimumab|tremelimumab|mesh-list
2911119|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2911120|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911121|NCT02815280|Minocycline|minocycline|mesh-list
2911122|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2911123|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2911124|NCT02815267|Minocycline|minocycline|mesh-list
2911125|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2911126|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2911127|NCT02813785|Docetaxel|docetaxel|mesh-list
2911128|NCT02813785|Atezolizumab|atezolizumab|mesh-list
2911129|NCT02813785|Antibodies|antibodies|mesh-list
2911130|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
2911131|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911132|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911133|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
2911134|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
2911135|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
2911136|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911137|NCT02811783|Naloxone|naloxone|mesh-list
2911138|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2911139|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911140|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
2911141|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2911142|NCT02807636|Gemcitabine|gemcitabine|mesh-list
2911143|NCT02807636|Carboplatin|carboplatin|mesh-list
2911144|NCT02807636|Atezolizumab|atezolizumab|mesh-list
2911145|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911146|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2911147|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
2331611|NCT00410943|Analgesics|analgesics|mesh-ancestor
2331612|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
2911148|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911149|NCT02807636|Antiviral Agents|antiviral agents|mesh-ancestor
2911150|NCT02807636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2911151|NCT02807636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911152|NCT02807636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2911153|NCT02807636|Immunologic Factors|immunologic factors|mesh-ancestor
2911154|NCT02807636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911155|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2911156|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911157|NCT02802228|Ifetroban|ifetroban|mesh-list
2911158|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2911159|NCT02801448|Sulforaphane|sulforaphane|mesh-list
2911160|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2911161|NCT02801448|Protective Agents|protective agents|mesh-ancestor
2911162|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911163|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911164|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
2911165|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2911166|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911167|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
2911168|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911169|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
2911170|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911171|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911172|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2911173|NCT02661022|Dexamethasone|dexamethasone|mesh-list
2911174|NCT02661022|Pomalidomide|pomalidomide|mesh-list
2911175|NCT02661022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2911176|NCT02661022|Antiemetics|antiemetics|mesh-ancestor
2911177|NCT02661022|Autonomic Agents|autonomic agents|mesh-ancestor
2911178|NCT02661022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2911179|NCT02661022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911180|NCT02661022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2911181|NCT02661022|Glucocorticoids|glucocorticoids|mesh-ancestor
2911182|NCT02661022|Hormones|hormones|mesh-ancestor
2911183|NCT02661022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2911184|NCT02661022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2911185|NCT02661022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911186|NCT02661022|Immunologic Factors|immunologic factors|mesh-ancestor
2911187|NCT02661022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2911188|NCT02661022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2911189|NCT02661022|Growth Substances|growth substances|mesh-ancestor
2911190|NCT02661022|Growth Inhibitors|growth inhibitors|mesh-ancestor
2911191|NCT02655016|Niraparib|niraparib|mesh-list
2911192|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2911193|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911194|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911195|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911196|NCT02652195|Oxytocin|oxytocin|mesh-list
2911197|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
2911198|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2911199|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911200|NCT02650401|Entrectinib|entrectinib|mesh-list
2911201|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2911202|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911203|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911204|NCT02650271|Tenofovir|tenofovir|mesh-list
2911205|NCT02650271|Entecavir|entecavir|mesh-list
2911206|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
2331613|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331614|NCT00410956|Dexamethasone|dexamethasone|mesh-list
2331615|NCT00410956|Bevacizumab|bevacizumab|mesh-list
2331616|NCT00410956|Floxuridine|floxuridine|mesh-list
2331617|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2331618|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331619|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2331620|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2331621|NCT00410956|Growth Substances|growth substances|mesh-ancestor
2331622|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331623|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
2331624|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2331625|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
2331626|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
2331627|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331628|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2331629|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
2331630|NCT00410956|Hormones|hormones|mesh-ancestor
2331631|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331632|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2331633|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2331634|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
2331635|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331636|NCT00410982|Gemcitabine|gemcitabine|mesh-list
2331637|NCT00410982|Rituximab|rituximab|mesh-list
2911207|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2911208|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2911209|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2911210|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911211|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911212|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2911213|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2911214|NCT02649855|Docetaxel|docetaxel|mesh-list
2911215|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911216|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
2331638|NCT00410982|Melphalan|melphalan|mesh-list
2331639|NCT00410982|Busulfan|busulfan|mesh-list
2331640|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2331641|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331642|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
2331643|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331644|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2331645|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2331646|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
2911217|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
2911218|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
2911219|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331647|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331648|NCT00410982|Antiviral Agents|antiviral agents|mesh-ancestor
2331649|NCT00410982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331650|NCT00410982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331651|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2331652|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2331653|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
2331654|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2331655|NCT00410995|Naproxen|naproxen|mesh-list
2911243|NCT02570984|Omalizumab|omalizumab|mesh-list
2911244|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2911245|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2911246|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
2331656|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2331657|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2331658|NCT00410995|Analgesics|analgesics|mesh-ancestor
2331659|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
2110025|NCT02531698|Vaccines|vaccines|mesh-list
2110026|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
2110027|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110028|NCT02531971|Fentanyl|fentanyl|mesh-list
2110029|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2110030|NCT02531971|Narcotics|narcotics|mesh-ancestor
2331660|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331661|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331662|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2331663|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2331664|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
2331665|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2331666|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331667|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331668|NCT00411034|Hydromorphone|hydromorphone|mesh-list
2331669|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2331670|NCT00411034|Narcotics|narcotics|mesh-ancestor
2331671|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331672|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331673|NCT00411034|Analgesics|analgesics|mesh-ancestor
2331674|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
2331675|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331676|NCT00411047|Gefitinib|gefitinib|mesh-list
2331677|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911282|NCT02562378|Doxorubicin|doxorubicin|mesh-list
2911283|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2911284|NCT02562378|Trastuzumab|trastuzumab|mesh-list
2911285|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2110031|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2911286|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911287|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2331678|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2331679|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331680|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331681|NCT00411073|Darapladib|darapladib|mesh-list
2331682|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2331683|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331684|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331685|NCT00411099|S 20098|s 20098|mesh-list
2331686|NCT00411099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2911288|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2110032|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110033|NCT02531971|Analgesics|analgesics|mesh-ancestor
2110034|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
2110035|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110036|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2110037|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2110038|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
2110039|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
2110040|NCT02532010|Cytarabine|cytarabine|mesh-list
2110041|NCT02532010|Decitabine|decitabine|mesh-list
2110042|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2110043|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
2110044|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110045|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110046|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
2110047|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110048|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2110049|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
2110050|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110051|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911289|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911290|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911291|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2911292|NCT02545868|Vaccines|vaccines|mesh-list
2911293|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
2911294|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911295|NCT02539693|Lidocaine|lidocaine|mesh-list
2911296|NCT02539693|Clonidine|clonidine|mesh-list
2911297|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
2911298|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
2911299|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2911300|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911301|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
2911302|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2911303|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2911304|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2911305|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2911306|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2911307|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911308|NCT02539693|Analgesics|analgesics|mesh-ancestor
2911309|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2911310|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
2911311|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
2911312|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2911313|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2911314|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2911315|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
2911316|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2911317|NCT02535312|Cisplatin|cisplatin|mesh-list
2911318|NCT02535312|Pemetrexed|pemetrexed|mesh-list
2911319|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911320|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911321|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911322|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2911323|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2911324|NCT02534012|Anesthetics|anesthetics|mesh-list
2911325|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2911326|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911327|NCT02505204|Clonidine|clonidine|mesh-list
2911328|NCT02505204|Analgesics|analgesics|mesh-ancestor
2911329|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
2911330|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2911331|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911332|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2911333|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
2331687|NCT00411099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331688|NCT00411099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331689|NCT00411125|Calcitonin|calcitonin|mesh-list
2331690|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
2331691|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2331692|NCT00411125|Katacalcin|katacalcin|mesh-list
2331693|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2331694|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331695|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2331696|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
2331697|NCT00411138|Paclitaxel|paclitaxel|mesh-list
2331698|NCT00411138|Carboplatin|carboplatin|mesh-list
2331699|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2331700|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331701|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
2331702|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
2331703|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
2331704|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331705|NCT00411164|Hydromorphone|hydromorphone|mesh-list
2331706|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2331707|NCT00411164|Narcotics|narcotics|mesh-ancestor
2331708|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331709|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331710|NCT00411164|Analgesics|analgesics|mesh-ancestor
2331711|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
2331712|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331713|NCT00411190|Acetaminophen|acetaminophen|mesh-list
2331714|NCT00411190|Ibuprofen|ibuprofen|mesh-list
2911334|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
2911335|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2911336|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2911337|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2911338|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
2911339|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2911340|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911341|NCT02503774|Durvalumab|durvalumab|mesh-list
2911342|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2911343|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911344|NCT02494986|Rilpivirine|rilpivirine|mesh-list
2911345|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2911346|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2911347|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911348|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911349|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
2911350|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2911351|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2911352|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2331715|NCT00411190|Atorvastatin|atorvastatin|mesh-list
2331716|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2331717|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2331718|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
2331719|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331720|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2331721|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2331722|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331723|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2331724|NCT00411190|Analgesics|analgesics|mesh-ancestor
2331725|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
2331726|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331727|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331728|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
2331729|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2331730|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2331731|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2331732|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2331733|NCT00411203|Tamoxifen|tamoxifen|mesh-list
2331734|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2331735|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
2331736|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331737|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331738|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2331739|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331740|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2331741|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2331742|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2331743|NCT00411229|Capecitabine|capecitabine|mesh-list
2331744|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
2331745|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2331746|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
2331747|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331748|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331749|NCT00411242|S 20098|s 20098|mesh-list
2331750|NCT00411242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2331751|NCT00411242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331752|NCT00411242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331753|NCT00411268|Hydromorphone|hydromorphone|mesh-list
2911357|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
2911358|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
2911359|NCT02487979|Immunotoxins|immunotoxins|mesh-list
2911360|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2911361|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
2911362|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911363|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2911364|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331754|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2331755|NCT00411268|Narcotics|narcotics|mesh-ancestor
2331756|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331757|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331758|NCT00411268|Analgesics|analgesics|mesh-ancestor
2331759|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
2911404|NCT02398773|Estradiol|estradiol|mesh-list
2911405|NCT02398773|Estrogens|estrogens|mesh-ancestor
2911406|NCT02398773|Hormones|hormones|mesh-ancestor
2911407|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2911408|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331760|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2911409|NCT02386800|Panobinostat|panobinostat|mesh-list
2911410|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911411|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2911412|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331761|NCT00411281|Cytarabine|cytarabine|mesh-list
2911413|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911414|NCT02354014|Bedaquiline|bedaquiline|mesh-list
2911415|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
2911416|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
2911417|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2911418|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331762|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2331763|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
2331764|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331765|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331766|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
2331767|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331768|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2331769|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
2331770|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331771|NCT00411307|Hydromorphone|hydromorphone|mesh-list
2331772|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2331773|NCT00411307|Narcotics|narcotics|mesh-ancestor
2911428|NCT02310867|Abatacept|abatacept|mesh-list
2911429|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2911430|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911431|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911432|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2911433|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
2911434|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911435|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2911436|NCT02303431|Edoxaban|edoxaban|mesh-list
2331774|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2331775|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331776|NCT00411307|Analgesics|analgesics|mesh-ancestor
2331777|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
2331778|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331779|NCT00411320|Dexamethasone|dexamethasone|mesh-list
2331780|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2331781|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
2331782|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
2331783|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331784|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331785|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2331786|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
2331787|NCT00411320|Hormones|hormones|mesh-ancestor
2331788|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331789|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2331790|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331791|NCT00411333|Triamcinolone|triamcinolone|mesh-list
2911437|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2911438|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
2911439|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2911440|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
2911441|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911442|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911443|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
2911444|NCT02288897|Temozolomide|temozolomide|mesh-list
2911445|NCT02288897|Dacarbazine|dacarbazine|mesh-list
2911446|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2911447|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2911448|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
2911449|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911450|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911451|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2911452|NCT02257736|Prednisone|prednisone|mesh-list
2911453|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
2911454|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2911455|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
2331792|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2911456|NCT02257736|Hormones|hormones|mesh-ancestor
2911457|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2911458|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911459|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2911460|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911461|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2911462|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911463|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911464|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
2911465|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2911466|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
2911467|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331793|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2331794|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2331795|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2331796|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
2331797|NCT00411333|Hormones|hormones|mesh-ancestor
2331798|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331799|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331800|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2331801|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
2331802|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331803|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331804|NCT00411372|Fluticasone|fluticasone|mesh-list
2331805|NCT00411372|Xhance|xhance|mesh-list
2331806|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2331807|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2331808|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2331809|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2331810|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
2331811|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331812|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331813|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2331814|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
2331815|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
2331816|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2331817|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2331818|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2331819|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2331820|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
2331821|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331822|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331823|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
2331824|NCT00411372|Hormones|hormones|mesh-ancestor
2331825|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331826|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
2331827|NCT00411385|Interferons|interferons|mesh-list
2331828|NCT00411385|Ribavirin|ribavirin|mesh-list
2331829|NCT00411385|Interferon-alpha|interferon-alpha|mesh-list
2331830|NCT00411385|Interferon alpha-2|interferon alpha-2|mesh-list
2331831|NCT00411385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2331832|NCT00411385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331833|NCT00411385|Antiviral Agents|antiviral agents|mesh-ancestor
2331834|NCT00411385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331835|NCT00411385|Antimetabolites|antimetabolites|mesh-ancestor
2331836|NCT00411385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331837|NCT00411385|Immunologic Factors|immunologic factors|mesh-ancestor
2331838|NCT00411385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331839|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2331840|NCT00411437|Oxybutynin|oxybutynin|mesh-list
2911519|NCT02179086|Temozolomide|temozolomide|mesh-list
2911520|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2911521|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
2911522|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911523|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911524|NCT02166463|Prednisone|prednisone|mesh-list
2911525|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
2911526|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2911527|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2911528|NCT02166463|Prednisolone|prednisolone|mesh-list
2911529|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
2911530|NCT02166463|Cortisone|cortisone|mesh-list
2911531|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
2911532|NCT02166463|Doxorubicin|doxorubicin|mesh-list
2911533|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2911534|NCT02166463|Etoposide|etoposide|mesh-list
2911535|NCT02166463|Vincristine|vincristine|mesh-list
2911536|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
2911537|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2331841|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2331842|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2331843|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
2331844|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331845|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331846|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331847|NCT00411437|Urological Agents|urological agents|mesh-ancestor
2331848|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
2331849|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
2331850|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331851|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
2331852|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2331853|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331854|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2331855|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
2331856|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2331857|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331858|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331859|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331860|NCT00411528|Prednisone|prednisone|mesh-list
2331861|NCT00411528|Docetaxel|docetaxel|mesh-list
2331862|NCT00411528|Epothilone B|epothilone b|mesh-list
2331863|NCT00411528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911538|NCT02166463|Bleomycin|bleomycin|mesh-list
2911539|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
2911540|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2911541|NCT02166463|Antibodies|antibodies|mesh-list
2331864|NCT00411528|Tubulin Modulators|tubulin modulators|mesh-ancestor
2331865|NCT00411528|Antimitotic Agents|antimitotic agents|mesh-ancestor
2331866|NCT00411528|Mitosis Modulators|mitosis modulators|mesh-ancestor
2331867|NCT00411528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331868|NCT00411528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2331869|NCT00411528|Glucocorticoids|glucocorticoids|mesh-ancestor
2331870|NCT00411528|Hormones|hormones|mesh-ancestor
2331871|NCT00411528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331872|NCT00411528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331873|NCT00411528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2331874|NCT00411541|Dexamethasone|dexamethasone|mesh-list
2331875|NCT00411541|Vincristine|vincristine|mesh-list
2331876|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2331877|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
2911542|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
2911543|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2331878|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
2331879|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331880|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331881|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2331882|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
2331883|NCT00411541|Hormones|hormones|mesh-ancestor
2331884|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331885|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2331886|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331887|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2331888|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
2331889|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
2331890|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
2331891|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331892|NCT00411593|Bevacizumab|bevacizumab|mesh-list
2331893|NCT00411593|Bortezomib|bortezomib|mesh-list
2331894|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2331895|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911544|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
2911545|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2911546|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
2911547|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2911548|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
2911549|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911550|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2911551|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2911552|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
2911553|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911554|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911555|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2911556|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2911557|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2911558|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2911559|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911560|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2911561|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
2911562|NCT02166463|Hormones|hormones|mesh-ancestor
2331896|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2911563|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2911564|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2911565|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2911566|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
2911567|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
2911568|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
2110052|NCT02532283|Oseltamivir|oseltamivir|mesh-list
2110053|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
2110054|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110055|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110056|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110057|NCT02532374|Nicotine|nicotine|mesh-list
2110058|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2110059|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
2110060|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110061|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911569|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
2911570|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
2911571|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2911572|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2911573|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2911574|NCT02166463|Protective Agents|protective agents|mesh-ancestor
2911575|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
2911576|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
2911577|NCT02123823|Everolimus|everolimus|mesh-list
2911578|NCT02123823|Exemestane|exemestane|mesh-list
2911579|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911580|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2911581|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
2911582|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911583|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2911584|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2911585|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911586|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911587|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2911588|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
2911589|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2911590|NCT02091960|Trastuzumab|trastuzumab|mesh-list
2911591|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2911592|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911593|NCT02022982|Palbociclib|palbociclib|mesh-list
2911594|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911595|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2911596|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911597|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911598|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2911599|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
2911600|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911601|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2911602|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
2911603|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2911604|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911605|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2911606|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2911607|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2911608|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
2331897|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2331898|NCT00411593|Growth Substances|growth substances|mesh-ancestor
2331899|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331900|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
2331901|NCT00411736|Azithromycin|azithromycin|mesh-list
2331902|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2331903|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331904|NCT00411866|Ketoconazole|ketoconazole|mesh-list
2331905|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
2331906|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331907|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2331908|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2331909|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331910|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331911|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2331912|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
2331913|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331914|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331915|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2331916|NCT00411879|Vasopressins|vasopressins|mesh-list
2331917|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
2331918|NCT00411879|Epinephrine|epinephrine|mesh-list
2911634|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
2911635|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2911636|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
2911637|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2911638|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911639|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2911640|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2911641|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2911642|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2911643|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
2911644|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911645|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2911646|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
2911647|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2911648|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911649|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2911650|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2911651|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2911652|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
2911653|NCT01898312|Mifepristone|mifepristone|mesh-list
2911654|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2911655|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
2911656|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2911657|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911658|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2911659|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2911660|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2911661|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
2110062|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2110063|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2110064|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
2110065|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110066|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110067|NCT02532647|Midazolam|midazolam|mesh-list
2110068|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2911662|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2911663|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2911664|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
2911665|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2911666|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
2911667|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2911668|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2911669|NCT01883804|Methyldopa|methyldopa|mesh-list
2331919|NCT00411879|Racepinephrine|racepinephrine|mesh-list
2331920|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
2331921|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2331922|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2331923|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
2331924|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331925|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331926|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911670|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2911671|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
2911672|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
2911673|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2911674|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911675|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2911676|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2911677|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2331927|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2331928|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2331929|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
2110069|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2110070|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2110071|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110072|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2110073|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2110074|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2110075|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2110076|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
2110077|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
2110078|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
2110079|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
2911678|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
2911679|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2911680|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911681|NCT01881048|Celecoxib|celecoxib|mesh-list
2911682|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2911683|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2911684|NCT01881048|Analgesics|analgesics|mesh-ancestor
2331930|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2331931|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2331932|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
2331933|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
2911685|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
2911686|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2911687|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911688|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2911689|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2911690|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2911691|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2911692|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911693|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331934|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
2331935|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2331936|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
2331937|NCT00411879|Coagulants|coagulants|mesh-ancestor
2331938|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2331939|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
2331940|NCT00411892|Insulin|insulin|mesh-list
2331941|NCT00411892|Pioglitazone|pioglitazone|mesh-list
2331942|NCT00411892|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2331943|NCT00411892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2331944|NCT00411892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331945|NCT00411905|Bortezomib|bortezomib|mesh-list
2331946|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331947|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2331948|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2331949|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2331950|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
2331951|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331952|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331953|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2331954|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2331955|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
2331956|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331957|NCT00411996|Ritonavir|ritonavir|mesh-list
2331958|NCT00411996|Indinavir|indinavir|mesh-list
2331959|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2331960|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2331961|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
2331962|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331963|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331964|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2331965|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2331966|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
2110080|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2331967|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2331968|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2331969|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2331970|NCT00412022|Tamoxifen|tamoxifen|mesh-list
2331971|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
2911711|NCT01838187|Vorinostat|vorinostat|mesh-list
2911712|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2911713|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911714|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2911715|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911716|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911717|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2331972|NCT00412022|Letrozole|letrozole|mesh-list
2331973|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2331974|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2331975|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2331976|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2331977|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2331978|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331979|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2331980|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
2331981|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2331982|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2331983|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2331984|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2331985|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2331986|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2331987|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
2331988|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2331989|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
2331990|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2331991|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2331992|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
2331993|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2331994|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2331995|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2331996|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2331997|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2331998|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
2331999|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332000|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332001|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2332002|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332003|NCT00412100|Oxycodone|oxycodone|mesh-list
2911744|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2911745|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2911746|NCT01771107|Doxorubicin|doxorubicin|mesh-list
2911747|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2911748|NCT01771107|Dacarbazine|dacarbazine|mesh-list
2911749|NCT01771107|Vinblastine|vinblastine|mesh-list
2911750|NCT01771107|Antibodies|antibodies|mesh-list
2911751|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
2911752|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2911753|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
2911754|NCT01771107|Imidazole|imidazole|mesh-list
2911755|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
2911756|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911757|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911758|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2911759|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2911760|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2911761|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911762|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911763|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2911764|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
2911765|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2911766|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
2911767|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
2911768|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
2911769|NCT01720147|Quercetin|quercetin|mesh-list
2911770|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
2911771|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911772|NCT01720147|Protective Agents|protective agents|mesh-ancestor
2911773|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911774|NCT01718743|Lenalidomide|lenalidomide|mesh-list
2911775|NCT01718743|Ixazomib|ixazomib|mesh-list
2911776|NCT01718743|Glycine|glycine|mesh-list
2911777|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
2911778|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911779|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2911780|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2911781|NCT01718743|Growth Substances|growth substances|mesh-ancestor
2911782|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
2911783|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911784|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911785|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
2911786|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911787|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
2911788|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2911789|NCT01694004|Benzocaine|benzocaine|mesh-list
2911790|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
2911791|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
2911792|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2911793|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911794|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
2911795|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332004|NCT00412100|Naloxone|naloxone|mesh-list
2332005|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2332006|NCT00412100|Narcotics|narcotics|mesh-ancestor
2911816|NCT01566695|Azacitidine|azacitidine|mesh-list
2911817|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2911818|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
2911819|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911820|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911821|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911832|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
2911833|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911834|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2911835|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911836|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911837|NCT01412333|Interferons|interferons|mesh-list
2911838|NCT01412333|Interferon-beta|interferon-beta|mesh-list
2911839|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
2911840|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
2911841|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911842|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
2911843|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2911844|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
2911845|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911846|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2911847|NCT01376427|Dexamethasone|dexamethasone|mesh-list
2911848|NCT01376427|Methotrexate|methotrexate|mesh-list
2911849|NCT01376427|Vincristine|vincristine|mesh-list
2911850|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2332007|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2332008|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332009|NCT00412100|Analgesics|analgesics|mesh-ancestor
2911851|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
2911852|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
2911853|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2911854|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911855|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2911856|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
2911857|NCT01376427|Hormones|hormones|mesh-ancestor
2911858|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2911859|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2911860|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911861|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2911862|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
2911863|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2911864|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2911865|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
2911866|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911867|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
2911868|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911869|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2911870|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2911871|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
2911872|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2911873|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2911874|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2911875|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
2911876|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
2911877|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
2911878|NCT01366898|Methotrexate|methotrexate|mesh-list
2911879|NCT01366898|Idarubicin|idarubicin|mesh-list
2911880|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2911881|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
2911882|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2911883|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911884|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2911885|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
2911886|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911887|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911888|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
2911889|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911890|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2911891|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2911892|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
2911893|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2911894|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2911895|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2911896|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2911897|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2911898|NCT01358201|Cytarabine|cytarabine|mesh-list
2911899|NCT01358201|Dexamethasone|dexamethasone|mesh-list
2911900|NCT01358201|Methotrexate|methotrexate|mesh-list
2911901|NCT01358201|Vincristine|vincristine|mesh-list
2911902|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2911903|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
2911904|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
2911905|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2911906|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911907|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2911908|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
2911909|NCT01358201|Hormones|hormones|mesh-ancestor
2911910|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2911911|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2911912|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911913|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2911914|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
2911915|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2911916|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2911917|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
2911918|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2911919|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
2911920|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911921|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2911922|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2911923|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
2911924|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2911925|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2911926|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2911927|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
2911928|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
2911929|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
2911930|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
2911931|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2911932|NCT01338636|Ambrisentan|ambrisentan|mesh-list
2911933|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2332010|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
2332011|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332012|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2332013|NCT00412126|Insulin|insulin|mesh-list
2332014|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2332015|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332016|NCT00412152|Oxycodone|oxycodone|mesh-list
2332017|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2332018|NCT00412152|Narcotics|narcotics|mesh-ancestor
2911950|NCT01308034|Sunitinib|sunitinib|mesh-list
2911951|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911952|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2911953|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2911954|NCT01308034|Growth Substances|growth substances|mesh-ancestor
2911955|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332019|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2911956|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
2911957|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2911958|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2911959|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332020|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332021|NCT00412152|Analgesics|analgesics|mesh-ancestor
2332022|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
2332023|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332024|NCT00412191|Lamotrigine|lamotrigine|mesh-list
2332025|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
2332026|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2332027|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2332028|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332029|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2332030|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332031|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2332032|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2332033|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2332034|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2332035|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2332036|NCT00412204|Bromides|bromides|mesh-list
2332037|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
2332038|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2911986|NCT01253161|Pasireotide|pasireotide|mesh-list
2911987|NCT01253161|Hormones|hormones|mesh-ancestor
2911988|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2911989|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911990|NCT01247324|Interferons|interferons|mesh-list
2911991|NCT01247324|Interferon-beta|interferon-beta|mesh-list
2911992|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
2911993|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
2911994|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2911995|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
2911996|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2911997|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
2911998|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2911999|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2912015|NCT01149083|Carboplatin|carboplatin|mesh-list
2912016|NCT01149083|Veliparib|veliparib|mesh-list
2912017|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912018|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2912019|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912020|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912033|NCT01093326|Ponesimod|ponesimod|mesh-list
2912034|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2912035|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912036|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2912037|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
2912038|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912039|NCT01063517|Paclitaxel|paclitaxel|mesh-list
2912040|NCT01063517|Olaparib|olaparib|mesh-list
2912041|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2912042|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912043|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
2912044|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
2912045|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
2912046|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912047|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2912048|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912064|NCT00938912|Lacosamide|lacosamide|mesh-list
2912065|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
2912066|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2912067|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2912068|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2912069|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912070|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
2110081|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110082|NCT02532855|Metformin|metformin|mesh-list
2110083|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2110084|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
2110085|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2110086|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110087|NCT02532855|Incretins|incretins|mesh-ancestor
2110088|NCT02532855|Hormones|hormones|mesh-ancestor
2110089|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2110090|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2110091|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
2332039|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
2332040|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332041|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912071|NCT00925652|Bevacizumab|bevacizumab|mesh-list
2912072|NCT00925652|Methotrexate|methotrexate|mesh-list
2912073|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2912074|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
2912075|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912076|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2912077|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2912078|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
2912079|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912080|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912081|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2912082|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2912083|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2912084|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2912085|NCT00925652|Growth Substances|growth substances|mesh-ancestor
2912086|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
2912087|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2912088|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
2912089|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2912090|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2912091|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
2912092|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
2332042|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2332043|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
2332044|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
2332045|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2332046|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
2332047|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332048|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332049|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
2332050|NCT00412321|Siltuximab|siltuximab|mesh-list
2332051|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332052|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2332053|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
2332054|NCT00412334|Ribavirin|ribavirin|mesh-list
2332055|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
2332056|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332057|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
2332058|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332059|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
2332060|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332061|NCT00412347|Insulin|insulin|mesh-list
2912093|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912094|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2912095|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2912104|NCT00885495|Ritonavir|ritonavir|mesh-list
2912105|NCT00885495|Darunavir|darunavir|mesh-list
2912106|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2912107|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2912108|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2912109|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
2912110|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912111|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912112|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2912113|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2912114|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
2912115|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912116|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2912117|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2912118|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2912119|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2912120|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
2912121|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2912122|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2912123|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
2912124|NCT00792948|Leucovorin|leucovorin|mesh-list
2332062|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2332063|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332064|NCT00412412|Trastuzumab|trastuzumab|mesh-list
2332065|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2332066|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332067|NCT00412503|Temozolomide|temozolomide|mesh-list
2332068|NCT00412503|Topotecan|topotecan|mesh-list
2332069|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2332070|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
2332071|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332072|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332073|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2332074|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2332075|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332076|NCT00412555|Oseltamivir|oseltamivir|mesh-list
2912125|NCT00792948|Folic Acid|folic acid|mesh-list
2912126|NCT00792948|Cytarabine|cytarabine|mesh-list
2912127|NCT00792948|Sirolimus|sirolimus|mesh-list
2332077|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
2332078|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332079|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332080|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332081|NCT00412581|Lenalidomide|lenalidomide|mesh-list
2912128|NCT00792948|Dexamethasone|dexamethasone|mesh-list
2912129|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
2912130|NCT00792948|Prednisone|prednisone|mesh-list
2912131|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
2912132|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2912133|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2912134|NCT00792948|Prednisolone|prednisolone|mesh-list
2912135|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
2912136|NCT00792948|Cortisone|cortisone|mesh-list
2912137|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
2912138|NCT00792948|Doxorubicin|doxorubicin|mesh-list
2912139|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2912140|NCT00792948|Methotrexate|methotrexate|mesh-list
2912141|NCT00792948|Etoposide|etoposide|mesh-list
2912142|NCT00792948|Vincristine|vincristine|mesh-list
2912143|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
2912144|NCT00792948|Dasatinib|dasatinib|mesh-list
2912145|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
2912146|NCT00792948|Tacrolimus|tacrolimus|mesh-list
2912147|NCT00792948|Lenograstim|lenograstim|mesh-list
2912148|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2912149|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
2912150|NCT00792948|BB 1101|bb 1101|mesh-list
2912151|NCT00792948|Calcium|calcium|mesh-list
2912152|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
2912153|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2912154|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
2912155|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912156|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2912157|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2912158|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
2912159|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912160|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912161|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2912162|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2912163|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
2912164|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
2912165|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110092|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110093|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110094|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2110095|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
2110096|NCT02532998|Eplerenone|eplerenone|mesh-list
2110097|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2332082|NCT00412581|Dacarbazine|dacarbazine|mesh-list
2912166|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2912167|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
2912168|NCT00792948|Hormones|hormones|mesh-ancestor
2912169|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2912170|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2332083|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
2912171|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
2912172|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912173|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2912174|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2912175|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2912176|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2912177|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2912178|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2912179|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
2912180|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2912181|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2912182|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
2912183|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
2912184|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2912185|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2912186|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2912187|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2912188|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
2912189|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912190|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2912191|NCT00792948|Antidotes|antidotes|mesh-ancestor
2912192|NCT00792948|Protective Agents|protective agents|mesh-ancestor
2912193|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
2912194|NCT00792948|Vitamins|vitamins|mesh-ancestor
2912195|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
2912196|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
2912197|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
2912198|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
2912199|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2912200|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
2912201|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2912202|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2912203|NCT00792948|Hematinics|hematinics|mesh-ancestor
2912204|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
2912205|NCT00700258|Sirolimus|sirolimus|mesh-list
2332084|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332085|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2332086|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2332087|NCT00412581|Growth Substances|growth substances|mesh-ancestor
2332088|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
2332089|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332090|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2332091|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
2332092|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332093|NCT00412594|Rituximab|rituximab|mesh-list
2912206|NCT00700258|Sunitinib|sunitinib|mesh-list
2912207|NCT00700258|Axitinib|axitinib|mesh-list
2912208|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912209|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2912210|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2912211|NCT00700258|Growth Substances|growth substances|mesh-ancestor
2912212|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912213|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
2912214|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2912215|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912216|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912217|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2332094|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2332095|NCT00412594|Cladribine|cladribine|mesh-list
2332096|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
2332097|NCT00412594|Antibodies|antibodies|mesh-list
2332098|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
2332099|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2912218|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912219|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2912220|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
2912221|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2912222|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
2912223|NCT00676715|Interferons|interferons|mesh-list
2912224|NCT00676715|Interferon-beta|interferon-beta|mesh-list
2912225|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
2912226|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912227|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
2912228|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912229|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
2912230|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912231|NCT00604617|Interferons|interferons|mesh-list
2912232|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
2912233|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912234|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
2332100|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
2912235|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912236|NCT00579826|Letrozole|letrozole|mesh-list
2912237|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912238|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2912239|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2912240|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912241|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912242|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2912243|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
2912244|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2912245|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332101|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332102|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332103|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2332104|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2332105|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2332106|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
2332107|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332108|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
2332109|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332110|NCT00412646|Etravirine|etravirine|mesh-list
2912246|NCT00562497|Remestemcel-l|remestemcel-l|mesh-list
2912247|NCT00562497|Prednisone|prednisone|mesh-list
2912248|NCT00562497|Methylprednisolone|methylprednisolone|mesh-list
2912249|NCT00562497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2912250|NCT00562497|Glucocorticoids|glucocorticoids|mesh-ancestor
2912251|NCT00562497|Hormones|hormones|mesh-ancestor
2912252|NCT00562497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2912253|NCT00562497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912254|NCT00562497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2912255|NCT00562497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912256|NCT00562497|Antiemetics|antiemetics|mesh-ancestor
2912257|NCT00562497|Autonomic Agents|autonomic agents|mesh-ancestor
2912258|NCT00562497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2912259|NCT00562497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2912260|NCT00562497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2912261|NCT00562497|Protective Agents|protective agents|mesh-ancestor
2912262|NCT00562497|Antiviral Agents|antiviral agents|mesh-ancestor
2912263|NCT00562497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912264|NCT00365157|Halichondrin B|halichondrin b|mesh-list
2912265|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
2912266|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
2912267|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
2912268|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912269|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912270|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
2912271|NCT00186888|Carboplatin|carboplatin|mesh-list
2912272|NCT00186888|Doxorubicin|doxorubicin|mesh-list
2912273|NCT00186888|Etoposide|etoposide|mesh-list
2912274|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
2912275|NCT00186888|Vincristine|vincristine|mesh-list
2912276|NCT00186888|Topotecan|topotecan|mesh-list
2332111|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2332112|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2332113|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912277|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2912278|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
2912279|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912280|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2912281|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2912282|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
2912283|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912284|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912285|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2912286|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2912287|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2912288|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2912289|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912290|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2912291|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
2912292|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
2912293|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
2332114|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332115|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
2332116|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912294|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2912301|NCT00001563|Rituximab|rituximab|mesh-list
2912302|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2912303|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332117|NCT00412698|Rimonabant|rimonabant|mesh-list
2332118|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2332119|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2912304|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
2912305|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912306|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2110098|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
2110099|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2110100|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110101|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2110102|NCT02532998|Diuretics|diuretics|mesh-ancestor
2110103|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
2110104|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2110105|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2110106|NCT02533375|Adalimumab|adalimumab|mesh-list
2110107|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2110108|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2912314|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
2912315|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2912316|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912317|NCT05200481|Carboplatin|carboplatin|mesh-list
2912318|NCT05200481|Pemetrexed|pemetrexed|mesh-list
2912319|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912320|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912321|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332120|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2332121|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332122|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332123|NCT00412698|Hormones|hormones|mesh-ancestor
2332124|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2332125|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332126|NCT00412763|Silymarin|silymarin|mesh-list
2332127|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
2332128|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332129|NCT00412763|Protective Agents|protective agents|mesh-ancestor
2332130|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332131|NCT00412789|Epothilone B|epothilone b|mesh-list
2332132|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332133|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
2332134|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
2332135|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
2912322|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2912323|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2912324|NCT05200442|Cetuximab|cetuximab|mesh-list
2912325|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2912326|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912327|NCT05200429|Ivacaftor|ivacaftor|mesh-list
2912328|NCT05200429|Elexacaftor|elexacaftor|mesh-list
2912329|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2912330|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2912331|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912332|NCT05200364|Bevacizumab|bevacizumab|mesh-list
2912333|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2912334|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912335|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2912336|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2912337|NCT05200364|Growth Substances|growth substances|mesh-ancestor
2912338|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912339|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
2912340|NCT05200312|Prednisone|prednisone|mesh-list
2332136|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332137|NCT00412802|Enoxaparin|enoxaparin|mesh-list
2332138|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
2332139|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
2332140|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2332141|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2332142|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332143|NCT00412828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
2332144|NCT00412828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2332145|NCT00412828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332146|NCT00412919|Azacitidine|azacitidine|mesh-list
2332147|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2332148|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
2332149|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332150|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332151|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332152|NCT00412997|Panobinostat|panobinostat|mesh-list
2332153|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332154|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2332155|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332156|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332157|NCT00413023|Casopitant|casopitant|mesh-list
2332158|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
2912341|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
2912342|NCT05200312|Rituximab|rituximab|mesh-list
2912343|NCT05200312|Doxorubicin|doxorubicin|mesh-list
2912344|NCT05200312|Vincristine|vincristine|mesh-list
2912345|NCT05200312|Lenalidomide|lenalidomide|mesh-list
2912346|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
2912347|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2912348|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
2912349|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912350|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2912351|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2912352|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
2912353|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912354|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912355|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2912356|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2912357|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2912358|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2912359|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2912360|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912361|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2912362|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
2912363|NCT05200312|Hormones|hormones|mesh-ancestor
2912364|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2912365|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2912366|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2912367|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
2912368|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
2912369|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
2912370|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2912371|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2912372|NCT05200312|Growth Substances|growth substances|mesh-ancestor
2912373|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
2912374|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2332159|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
2332160|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332161|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332162|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2332163|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2332164|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332165|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332166|NCT00413075|Belinostat|belinostat|mesh-list
2332167|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332168|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2332169|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912375|NCT05200299|Leucovorin|leucovorin|mesh-list
2912376|NCT05200299|Fluorouracil|fluorouracil|mesh-list
2912377|NCT05200299|Capecitabine|capecitabine|mesh-list
2912378|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
2912379|NCT05200299|Irinotecan|irinotecan|mesh-list
2912380|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
2912381|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
2912382|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912383|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2912384|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912385|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2912386|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
2912387|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912388|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2912389|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2912390|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912391|NCT05200299|Antidotes|antidotes|mesh-ancestor
2912392|NCT05200299|Protective Agents|protective agents|mesh-ancestor
2912393|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
2912394|NCT05200299|Vitamins|vitamins|mesh-ancestor
2912395|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
2912396|NCT05200286|Olorofim|olorofim|mesh-list
2912397|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
2912398|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912399|NCT05200260|Niraparib|niraparib|mesh-list
2912400|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2912401|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912402|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912403|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912404|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2912405|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
2912406|NCT05200156|Choline|choline|mesh-list
2912407|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
2912408|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2912409|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
2912410|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912411|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2912412|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2912413|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
2912414|NCT05200143|Nivolumab|nivolumab|mesh-list
2912415|NCT05200143|Ipilimumab|ipilimumab|mesh-list
2332170|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332171|NCT00413088|Bemiparin|bemiparin|mesh-list
2332172|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
2332173|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
2332174|NCT00413101|Hematinics|hematinics|mesh-ancestor
2332175|NCT00413114|Obatoclax|obatoclax|mesh-list
2332176|NCT00413114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332177|NCT00413114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332178|NCT00413127|Lidocaine|lidocaine|mesh-list
2332179|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
2332180|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
2332181|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2332182|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332183|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
2332184|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332185|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2912416|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2912417|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912418|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2912419|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912420|NCT05200052|Colchicine|colchicine|mesh-list
2912421|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
2912422|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2912423|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
2912424|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
2912425|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
2912426|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912427|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912428|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
2912429|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912430|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2912431|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912432|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912433|NCT05199818|Palonosetron|palonosetron|mesh-list
2912434|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
2912435|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
2912436|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2912437|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912438|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2912439|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2912440|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2912441|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
2912442|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2912443|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332186|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2332187|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2332188|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2332189|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332190|NCT00413179|Metformin|metformin|mesh-list
2332191|NCT00413179|Clomiphene|clomiphene|mesh-list
2332192|NCT00413179|Enclomiphene|enclomiphene|mesh-list
2332193|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
2332194|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2332195|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332196|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2332197|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
2332198|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2332199|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2332200|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
2332201|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2332202|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2332203|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2332204|NCT00413257|Nefopam|nefopam|mesh-list
2332205|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2332206|NCT00413257|Analgesics|analgesics|mesh-ancestor
2332207|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
2912447|NCT05199727|Tadalafil|tadalafil|mesh-list
2912448|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
2912449|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2332208|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2912450|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2912451|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332209|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332210|NCT00413296|Levetiracetam|levetiracetam|mesh-list
2332211|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
2912452|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912453|NCT05199727|Urological Agents|urological agents|mesh-ancestor
2912454|NCT05199714|Pramlintide|pramlintide|mesh-list
2912455|NCT05199714|Pancrelipase|pancrelipase|mesh-list
2332212|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
2332213|NCT00413322|Fluorouracil|fluorouracil|mesh-list
2332214|NCT00413322|Belinostat|belinostat|mesh-list
2332215|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
2332216|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332217|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2332218|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332219|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2332220|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
2332221|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912456|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2912457|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2912458|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912463|NCT05199597|Atropine|atropine|mesh-list
2912464|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2912465|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2912466|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2912467|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
2332222|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2332223|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912468|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2912469|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912470|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2912471|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
2912472|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
2912473|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
2912474|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2912475|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2912476|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
2912477|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2912478|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912479|NCT05199571|Ofatumumab|ofatumumab|mesh-list
2912480|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912481|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
2912482|NCT05199493|Giapreza|giapreza|mesh-list
2912483|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
2332224|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
2332225|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
2332226|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2332227|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2332228|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332229|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912484|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2912485|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2912486|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
2912487|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912488|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912489|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2912490|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
2912491|NCT05199324|Cefazolin|cefazolin|mesh-list
2912492|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
2912493|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2912494|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
2912495|NCT05199324|Trimethoprim|trimethoprim|mesh-list
2332230|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332231|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2332232|NCT00413387|Budesonide|budesonide|mesh-list
2332233|NCT00413387|Beclomethasone|beclomethasone|mesh-list
2332234|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
2332235|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2332236|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2332237|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
2332238|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332239|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912496|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
2332240|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2332241|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
2332242|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
2332243|NCT00413387|Hormones|hormones|mesh-ancestor
2332244|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2332245|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2332246|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2332247|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2332248|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
2332249|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332250|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332251|NCT00413426|Darifenacin|darifenacin|mesh-list
2332252|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2332253|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2332254|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
2332255|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332256|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332257|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332258|NCT00413426|Urological Agents|urological agents|mesh-ancestor
2332259|NCT00413439|Isavuconazole|isavuconazole|mesh-list
2332260|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
2332261|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332262|NCT00413452|Etanercept|etanercept|mesh-list
2332263|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2332264|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2332265|NCT00413452|Analgesics|analgesics|mesh-ancestor
2332266|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
2332267|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332268|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332269|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2332270|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2332271|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2332272|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2332273|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
2332274|NCT00413504|PENTA|penta|mesh-list
2332275|NCT00413504|Fondaparinux|fondaparinux|mesh-list
2332276|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2912497|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912498|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2912499|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2912500|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912501|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912502|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332277|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
2332278|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2332279|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
2332280|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332281|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332282|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
2332283|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2332284|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2332285|NCT00413608|Clopidogrel|clopidogrel|mesh-list
2332286|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2332287|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2332288|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2912503|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2912504|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2912505|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2912506|NCT05199324|Renal Agents|renal agents|mesh-ancestor
2912507|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
2912508|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2912509|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2912510|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2912511|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2912512|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2912513|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2912514|NCT05199311|Dexamethasone|dexamethasone|mesh-list
2912515|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2912516|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
2912517|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
2912518|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2912519|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912520|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2912521|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
2912522|NCT05199311|Hormones|hormones|mesh-ancestor
2332289|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2332290|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
2332291|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332292|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332293|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332294|NCT00413686|Gemcitabine|gemcitabine|mesh-list
2332295|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2332296|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
2332297|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332298|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332299|NCT00413686|Antiviral Agents|antiviral agents|mesh-ancestor
2332300|NCT00413686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332301|NCT00413686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332302|NCT00413686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2332303|NCT00413686|Immunologic Factors|immunologic factors|mesh-ancestor
2332304|NCT00413686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332305|NCT00413699|Tofacitinib|tofacitinib|mesh-list
2332306|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2332307|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332308|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332309|NCT00413712|Adenosine|adenosine|mesh-list
2332310|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
2332311|NCT00413712|Calcium|calcium|mesh-list
2332312|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2332313|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332314|NCT00413712|Analgesics|analgesics|mesh-ancestor
2332315|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
2912523|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2912524|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2912525|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912526|NCT05199285|Nivolumab|nivolumab|mesh-list
2912527|NCT05199285|Ipilimumab|ipilimumab|mesh-list
2912528|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2912529|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912530|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2912531|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912536|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2912537|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
2912538|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
2912539|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912540|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2912541|NCT05199051|Cytarabine|cytarabine|mesh-list
2912542|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
2912543|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2912544|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
2912545|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912546|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912547|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
2912548|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912549|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2912550|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
2912551|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912552|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2912553|NCT05199038|Octreotide|octreotide|mesh-list
2332316|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332317|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2332318|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
2332319|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2332320|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
2332321|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
2332322|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332323|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332324|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2332325|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2332326|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332327|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2332328|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2332329|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2332330|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2332331|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2332332|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2332333|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2912554|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2912555|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2912556|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332334|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
2332335|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332336|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332337|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332338|NCT00413764|Tibolone|tibolone|mesh-list
2332339|NCT00413764|Norethindrone|norethindrone|mesh-list
2332340|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
2332341|NCT00413764|Estradiol|estradiol|mesh-list
2332342|NCT00413764|Estrogens|estrogens|mesh-ancestor
2332343|NCT00413764|Hormones|hormones|mesh-ancestor
2332344|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2332345|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332346|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2912557|NCT05198960|Aspirin|aspirin|mesh-list
2912558|NCT05198960|Anticoagulants|anticoagulants|mesh-list
2912559|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2912560|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2912561|NCT05198960|Analgesics|analgesics|mesh-ancestor
2912562|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
2912563|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2912564|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912565|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2912566|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2912567|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2912568|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2912569|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912570|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2332347|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
2332348|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2332349|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2332350|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2332351|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2332352|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2332353|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
2332354|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
2332355|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2332356|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2332357|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332358|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2332359|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
2332360|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2332361|NCT00413790|Darifenacin|darifenacin|mesh-list
2332362|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2332363|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2332364|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
2332365|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332366|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332367|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332368|NCT00413790|Urological Agents|urological agents|mesh-ancestor
2332369|NCT00413829|Ranibizumab|ranibizumab|mesh-list
2332370|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2332371|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2332372|NCT00413829|Growth Substances|growth substances|mesh-ancestor
2332373|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912571|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2912572|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912573|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
2912574|NCT05198947|Ivermectin|ivermectin|mesh-list
2912575|NCT05198947|Permethrin|permethrin|mesh-list
2912576|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2912577|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912578|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912579|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332374|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
2332375|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332376|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
2332377|NCT00413946|Hematinics|hematinics|mesh-ancestor
2332378|NCT00414024|Tegaserod|tegaserod|mesh-list
2332379|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2332380|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
2332381|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332382|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332383|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332384|NCT00414037|Eszopiclone|eszopiclone|mesh-list
2332385|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2110109|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
2110110|NCT02533401|Rituximab|rituximab|mesh-list
2110111|NCT02533401|Fludarabine|fludarabine|mesh-list
2110112|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2110113|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
2110114|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110115|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2110116|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2110117|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
2110118|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110119|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110120|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2110121|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2110122|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2110123|NCT02533427|Norgestimate|norgestimate|mesh-list
2110124|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2110125|NCT02533427|Estradiol|estradiol|mesh-list
2110126|NCT02533427|Estrogens|estrogens|mesh-ancestor
2110127|NCT02533427|Hormones|hormones|mesh-ancestor
2110128|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2110129|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110130|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2110131|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
2110132|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2110133|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2110134|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2110135|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2110136|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2110137|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2110138|NCT02533453|Exenatide|exenatide|mesh-list
2110139|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2110140|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110141|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2110142|NCT02533453|Incretins|incretins|mesh-ancestor
2110143|NCT02533453|Hormones|hormones|mesh-ancestor
2110144|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2110145|NCT02533466|Listerine|listerine|mesh-list
2110146|NCT02533466|Fluorides|fluorides|mesh-list
2110147|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
2110148|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
2110149|NCT02533466|Protective Agents|protective agents|mesh-ancestor
2110150|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110151|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2110152|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110153|NCT02533505|Budesonide|budesonide|mesh-list
2110154|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
2110155|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2110156|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2110157|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
2110158|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110159|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332386|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2332387|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332388|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2332389|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
2332390|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332391|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
2332392|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
2332393|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2332394|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
2332395|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332396|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2332397|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2332398|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
2332399|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332400|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332401|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2332402|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2332403|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2332404|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
2332405|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2332406|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332407|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912588|NCT05198856|Thalidomide|thalidomide|mesh-list
2912589|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2912590|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
2912591|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332408|NCT00414180|Bupropion|bupropion|mesh-list
2332409|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2332410|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
2332411|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2332412|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2332413|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2332414|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2332415|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332416|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
2332417|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332418|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332419|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2912592|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
2912593|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2912594|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912595|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2912596|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2912597|NCT05198856|Growth Substances|growth substances|mesh-ancestor
2912598|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
2912599|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912600|NCT05198843|Dasatinib|dasatinib|mesh-list
2912601|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2912602|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912603|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2912604|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912605|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912606|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2912607|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2912608|NCT05198830|Cisplatin|cisplatin|mesh-list
2912609|NCT05198830|Pemetrexed|pemetrexed|mesh-list
2912610|NCT05198830|Durvalumab|durvalumab|mesh-list
2912611|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
2912612|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2912613|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
2912614|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912615|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912616|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912617|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2912618|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2912619|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2912620|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
2912621|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912622|NCT05198804|Niraparib|niraparib|mesh-list
2912623|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2912624|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912625|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912626|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912627|NCT05198791|Eplerenone|eplerenone|mesh-list
2912628|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2912629|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
2912630|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2912631|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912632|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2912633|NCT05198791|Diuretics|diuretics|mesh-ancestor
2912634|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
2912635|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2912636|NCT05198609|Apatinib|apatinib|mesh-list
2912637|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912638|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2912639|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912640|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912641|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
2912642|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2912643|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
2912644|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912645|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
2912646|NCT05198544|Protective Agents|protective agents|mesh-ancestor
2912658|NCT05198453|Vaccines|vaccines|mesh-list
2912659|NCT05198453|Immunologic Factors|immunologic factors|mesh-ancestor
2912660|NCT05198453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912665|NCT05198362|Metoprolol|metoprolol|mesh-list
2912666|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2912667|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2912668|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
2912669|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
2912670|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2912671|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912672|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2912673|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2332420|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2332421|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332422|NCT00414245|Metformin|metformin|mesh-list
2332423|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2332424|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332425|NCT00414284|Lopinavir|lopinavir|mesh-list
2332426|NCT00414284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2332427|NCT00414284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2332428|NCT00414284|Protease Inhibitors|protease inhibitors|mesh-ancestor
2332429|NCT00414284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332430|NCT00414284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332431|NCT00414284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2332432|NCT00414284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2332433|NCT00414284|Antiviral Agents|antiviral agents|mesh-ancestor
2332434|NCT00414284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332435|NCT00414284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2332436|NCT00414284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2332437|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2332438|NCT00414323|Citalopram|citalopram|mesh-list
2332439|NCT00414323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2332440|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2332441|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2332442|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332443|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332444|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
2332445|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332446|NCT00414323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2332447|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
2332448|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2912674|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2912675|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
2912676|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2912677|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912678|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
2912679|NCT05198232|TEMPO|tempo|mesh-list
2912680|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
2332449|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332450|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2332451|NCT00414323|Analgesics|analgesics|mesh-ancestor
2332452|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
2332453|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
2912681|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912682|NCT05198232|Protective Agents|protective agents|mesh-ancestor
2912683|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912684|NCT05198232|Antacids|antacids|mesh-ancestor
2912685|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2912686|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2912687|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2912688|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2912689|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912690|NCT05198141|Letrozole|letrozole|mesh-list
2912691|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912692|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2912693|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2912694|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912695|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912696|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2912697|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
2912698|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2912699|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912703|NCT05198050|Letrozole|letrozole|mesh-list
2912704|NCT05198050|Alprostadil|alprostadil|mesh-list
2912705|NCT05198050|Misoprostol|misoprostol|mesh-list
2912706|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912707|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2912708|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2912709|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912710|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912711|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2332454|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2332455|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2332456|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
2332457|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332458|NCT00414336|Antacids|antacids|mesh-ancestor
2332459|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332460|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2332461|NCT00414349|Analgesics|analgesics|mesh-list
2332462|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
2332463|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332464|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332465|NCT00414414|Prednisone|prednisone|mesh-list
2332466|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2332467|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
2332468|NCT00414414|Hormones|hormones|mesh-ancestor
2332469|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2332470|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912712|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
2912713|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2912714|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912715|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2912716|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
2912717|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2912718|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2912719|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2912720|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
2912721|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2332471|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2332472|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332473|NCT00414531|Atorvastatin|atorvastatin|mesh-list
2332474|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2332475|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2332476|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
2332477|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332478|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2332479|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2332480|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912722|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
2912723|NCT05198050|Urological Agents|urological agents|mesh-ancestor
2912724|NCT05197842|Prednisone|prednisone|mesh-list
2912725|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
2912726|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
2912727|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2912728|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
2912729|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912730|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2912731|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2912732|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
2912733|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912734|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912735|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2912736|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2912737|NCT05197842|Hormones|hormones|mesh-ancestor
2912738|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2912739|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2912740|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2912741|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2912742|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2912743|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
2912744|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332481|NCT00414648|Sirolimus|sirolimus|mesh-list
2332482|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2332483|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332484|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2332485|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332486|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
2332487|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2332488|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
2332489|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332490|NCT00414687|Iloprost|iloprost|mesh-list
2332491|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2332492|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
2332493|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
2332494|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2332495|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912745|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2912746|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2912747|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912748|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
2912749|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2912750|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
2912751|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912752|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
2912753|NCT05188898|Protective Agents|protective agents|mesh-ancestor
2332496|NCT00414921|Clonidine|clonidine|mesh-list
2332497|NCT00414921|Methylphenidate|methylphenidate|mesh-list
2332498|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2332499|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332500|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2332501|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2332502|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2332503|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332504|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
2912761|NCT05184920|Nicotine|nicotine|mesh-list
2912762|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2912763|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
2912764|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2912765|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912766|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2332505|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332506|NCT00414921|Analgesics|analgesics|mesh-ancestor
2332507|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
2332508|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332509|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2332510|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
2912767|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2912768|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
2912769|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2912770|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912771|NCT05182931|Trametinib|trametinib|mesh-list
2912772|NCT05182931|Dabrafenib|dabrafenib|mesh-list
2912773|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912774|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2912775|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912776|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912777|NCT05178225|Ubiquinone|ubiquinone|mesh-list
2912778|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
2912779|NCT05178225|Anticoagulants|anticoagulants|mesh-list
2912780|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
2912781|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912782|NCT05178225|Vitamins|vitamins|mesh-ancestor
2912783|NCT05178173|Ethanol|ethanol|mesh-list
2912784|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
2912785|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2912786|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912787|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2912788|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912789|NCT05177484|Ferric maltol|ferric maltol|mesh-list
2912790|NCT05177484|Hematinics|hematinics|mesh-ancestor
2912824|NCT05171816|Olaparib|olaparib|mesh-list
2912825|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
2332511|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
2332512|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2332513|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2332514|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2332515|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
2110160|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2110161|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
2110162|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
2110163|NCT02533505|Hormones|hormones|mesh-ancestor
2110164|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2110165|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2110166|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2110167|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2110168|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
2110169|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2912826|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2912827|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332516|NCT00414947|Vildagliptin|vildagliptin|mesh-list
2332517|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2332518|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332519|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2332520|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
2332521|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332522|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332523|NCT00415064|Dexamethasone|dexamethasone|mesh-list
2332524|NCT00415064|Lenalidomide|lenalidomide|mesh-list
2332525|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2332526|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
2332527|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
2332528|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332529|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332530|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2332531|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
2332532|NCT00415064|Hormones|hormones|mesh-ancestor
2332533|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2332534|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2332535|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332536|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
2332537|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2332538|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2912828|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912829|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912830|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2912831|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
2912832|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2912833|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912834|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2912838|NCT05166876|Brequinar|brequinar|mesh-list
2912839|NCT05166876|Dipyridamole|dipyridamole|mesh-list
2912840|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2912841|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912842|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912843|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2912844|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
2332539|NCT00415064|Growth Substances|growth substances|mesh-ancestor
2332540|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
2332541|NCT00415090|Nevirapine|nevirapine|mesh-list
2332542|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2912845|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912846|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2912847|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
2912848|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912849|NCT05162443|Adagrasib|adagrasib|mesh-list
2912850|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912859|NCT05153408|Carboplatin|carboplatin|mesh-list
2912860|NCT05153408|Pemetrexed|pemetrexed|mesh-list
2912861|NCT05153408|Osimertinib|osimertinib|mesh-list
2912862|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912863|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912864|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912865|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2912866|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2912867|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2912874|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
2332543|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2332544|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332545|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332546|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
2332547|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332548|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2332549|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2912875|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
2912876|NCT05139849|Vasopressins|vasopressins|mesh-list
2912877|NCT05139849|Arginine Vasopressin|arginine vasopressin|mesh-list
2912878|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2912879|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
2912880|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
2912881|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2912882|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912883|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2912884|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
2912885|NCT05139849|Hormones|hormones|mesh-ancestor
2912886|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2110170|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110171|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2110172|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2110173|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2110174|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110175|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
2110176|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110177|NCT02533674|Gemcitabine|gemcitabine|mesh-list
2110178|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2332550|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2332551|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2912887|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2912888|NCT05139849|Protective Agents|protective agents|mesh-ancestor
2912889|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
2912890|NCT05139849|Coagulants|coagulants|mesh-ancestor
2912891|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2912892|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2912893|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
2912894|NCT05131698|Lenvatinib|lenvatinib|mesh-list
2912895|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912896|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2912897|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2912898|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912899|NCT05127304|Bromides|bromides|mesh-list
2912900|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
2912901|NCT05127304|Olodaterol|olodaterol|mesh-list
2912902|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2912903|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
2332552|NCT00415103|Aprepitant|aprepitant|mesh-list
2332553|NCT00415103|Palonosetron|palonosetron|mesh-list
2332554|NCT00415103|Granisetron|granisetron|mesh-list
2332555|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
2332556|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
2332557|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332558|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332559|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2332560|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2332561|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332562|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332563|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2332564|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2332565|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
2332566|NCT00415116|Carboplatin|carboplatin|mesh-list
2332567|NCT00415116|Docetaxel|docetaxel|mesh-list
2332568|NCT00415116|Lenalidomide|lenalidomide|mesh-list
2912904|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2912905|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912906|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2912907|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
2912908|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
2912909|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2912910|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
2912911|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2912912|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912913|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
2912914|NCT05115513|Dronabinol|dronabinol|mesh-list
2912915|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
2110179|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
2332569|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332570|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
2332571|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
2332572|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
2332573|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332574|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
2332575|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912916|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912917|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2912918|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2912919|NCT05115513|Analgesics|analgesics|mesh-ancestor
2912920|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
2912921|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2912922|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2912923|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2912924|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2912925|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912926|NCT05115513|Hormones|hormones|mesh-ancestor
2332576|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2332577|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2332578|NCT00415116|Growth Substances|growth substances|mesh-ancestor
2332579|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
2332580|NCT00415142|Citalopram|citalopram|mesh-list
2332581|NCT00415142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2332582|NCT00415142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2332583|NCT00415142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2332584|NCT00415142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332585|NCT00415142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332586|NCT00415142|Serotonin Agents|serotonin agents|mesh-ancestor
2332587|NCT00415142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332588|NCT00415142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2332589|NCT00415142|Antidepressive Agents|antidepressive agents|mesh-ancestor
2332590|NCT00415142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2332591|NCT00415233|Hormones|hormones|mesh-list
2332592|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2332593|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332594|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2332595|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
2332596|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2332597|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
2332598|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2332599|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912927|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2912928|NCT05111002|Doxycycline|doxycycline|mesh-list
2912929|NCT05111002|Lefamulin|lefamulin|mesh-list
2912930|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2912931|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912932|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
2912933|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2912934|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2912935|NCT05110781|Atezolizumab|atezolizumab|mesh-list
2912936|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2912937|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912938|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
2912939|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912940|NCT05109416|Bupivacaine|bupivacaine|mesh-list
2912941|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
2912942|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
2912943|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2912944|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912945|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
2912946|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2912951|NCT05102721|Avelumab|avelumab|mesh-list
2912952|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2912953|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912954|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2912955|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2912956|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2912957|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2912958|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912959|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2912960|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2912961|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912962|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
2912963|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2912964|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
2912965|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2912966|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2912967|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912968|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
2912969|NCT05099276|Coagulants|coagulants|mesh-ancestor
2332600|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2332601|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2332602|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332603|NCT00415285|Docetaxel|docetaxel|mesh-list
2332604|NCT00415285|Capecitabine|capecitabine|mesh-list
2912970|NCT05094336|Docetaxel|docetaxel|mesh-list
2912971|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912972|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
2912973|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
2912974|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
2912975|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912976|NCT05090371|Ofatumumab|ofatumumab|mesh-list
2912977|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912978|NCT05087212|Plerixafor|plerixafor|mesh-list
2912979|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2912980|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2912981|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
2912982|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912983|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
2912984|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2912985|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
2912986|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2912987|NCT05081479|Expectorants|expectorants|mesh-ancestor
2912988|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
2912989|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2912990|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
2912991|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2912992|NCT05081479|Protective Agents|protective agents|mesh-ancestor
2912993|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2912994|NCT05081479|Antidotes|antidotes|mesh-ancestor
2912995|NCT05077449|Fulvestrant|fulvestrant|mesh-list
2912996|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2912997|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2912998|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2912999|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2913000|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
2913001|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2913002|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913003|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2913004|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2913005|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
2913006|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2913007|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
2913008|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913009|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
2913010|NCT05073575|Protective Agents|protective agents|mesh-ancestor
2913011|NCT05073315|Adalimumab|adalimumab|mesh-list
2913012|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2913013|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2913014|NCT05072093|Tenofovir|tenofovir|mesh-list
2913015|NCT05072093|Emtricitabine|emtricitabine|mesh-list
2913016|NCT05072093|Doxycycline|doxycycline|mesh-list
2913017|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
2913018|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913019|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2913020|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2913021|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913022|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913023|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2913024|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2913025|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2913026|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
2913027|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2913028|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2913029|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
2913030|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2913031|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2913032|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2913033|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2913034|NCT05062135|Progesterone|progesterone|mesh-list
2913035|NCT05062135|Progestins|progestins|mesh-ancestor
2913036|NCT05062135|Hormones|hormones|mesh-ancestor
2913037|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2913038|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913039|NCT05059522|Pemetrexed|pemetrexed|mesh-list
2913040|NCT05059522|Avelumab|avelumab|mesh-list
2913041|NCT05059522|Axitinib|axitinib|mesh-list
2913042|NCT05059522|Talazoparib|talazoparib|mesh-list
2913043|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913044|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913045|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332605|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332606|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
2332607|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
2332608|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
2332609|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332610|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2332611|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
2332612|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
2332613|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332614|NCT00415311|Lectins|lectins|mesh-list
2913046|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2913047|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2913048|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2913049|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2913050|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2913056|NCT05046184|Midazolam|midazolam|mesh-list
2913057|NCT05046184|Ketamine|ketamine|mesh-list
2913058|NCT05046184|Analgesics|analgesics|mesh-ancestor
2913059|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
2913060|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2913061|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913062|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2913063|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2913064|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
2913065|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
2913066|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2913067|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2913068|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2913069|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2913070|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913071|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2913072|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2913073|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2913074|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2913075|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2913076|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
2913077|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
2913094|NCT05033964|Sirolimus|sirolimus|mesh-list
2913095|NCT05033964|Rivaroxaban|rivaroxaban|mesh-list
2913096|NCT05033964|Argatroban|argatroban|mesh-list
2332615|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
2332616|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
2332617|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913097|NCT05033964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2913098|NCT05033964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913099|NCT05033964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2913100|NCT05033964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913101|NCT05033964|Antifungal Agents|antifungal agents|mesh-ancestor
2913102|NCT05033964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2913103|NCT05033964|Immunologic Factors|immunologic factors|mesh-ancestor
2913104|NCT05033964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913105|NCT05033964|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2913106|NCT05033964|Antithrombins|antithrombins|mesh-ancestor
2332618|NCT00415311|Coagulants|coagulants|mesh-ancestor
2332619|NCT00415324|Cisplatin|cisplatin|mesh-list
2332620|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332621|NCT00415350|Azithromycin|azithromycin|mesh-list
2332622|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2332623|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332624|NCT00415376|Levetiracetam|levetiracetam|mesh-list
2332625|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
2332626|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
2332627|NCT00415402|Vitamin D|vitamin d|mesh-list
2332628|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
2332629|NCT00415402|Vitamins|vitamins|mesh-ancestor
2332630|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
2332631|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332632|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2332633|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2913107|NCT05033964|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2913108|NCT05033964|Protease Inhibitors|protease inhibitors|mesh-ancestor
2913109|NCT05033964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913110|NCT05033964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913111|NCT05033964|Anticoagulants|anticoagulants|mesh-ancestor
2913112|NCT05033964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2913113|NCT05029050|Clonidine|clonidine|mesh-list
2913114|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
2913115|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2913116|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2913117|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913118|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2913119|NCT05029050|Analgesics|analgesics|mesh-ancestor
2913120|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
2913121|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2913122|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2913123|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2913124|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2913125|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
2913126|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2913127|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913128|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2913129|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
2913130|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
2332634|NCT00415584|Cinacalcet|cinacalcet|mesh-list
2332635|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2332636|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332637|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2332638|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
2332639|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2332640|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
2332641|NCT00415701|Propofol|propofol|mesh-list
2332642|NCT00415701|Etomidate|etomidate|mesh-list
2332643|NCT00415701|Cosyntropin|cosyntropin|mesh-list
2332644|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2332645|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2332646|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332647|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2332648|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
2332649|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
2332650|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2332651|NCT00415701|Hormones|hormones|mesh-ancestor
2332652|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2332653|NCT00415740|Levodopa|levodopa|mesh-list
2332654|NCT00415740|Carbidopa|carbidopa|mesh-list
2913175|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
2913176|NCT05005182|Luspatercept|luspatercept|mesh-list
2913177|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2913178|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913179|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
2913180|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913181|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913182|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2332655|NCT00415740|Entacapone|entacapone|mesh-list
2332656|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2332657|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2332658|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2332659|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
2332660|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332661|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332662|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332663|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2332664|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332665|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2332666|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2913183|NCT05005182|Hematinics|hematinics|mesh-ancestor
2913184|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
2913185|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913186|NCT04997902|Tipifarnib|tipifarnib|mesh-list
2913187|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913188|NCT04996823|Ipilimumab|ipilimumab|mesh-list
2913189|NCT04996823|Axitinib|axitinib|mesh-list
2913190|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2913191|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913192|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2913193|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913194|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2913195|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913201|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2913202|NCT04964544|Calcium|calcium|mesh-list
2913203|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2332667|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
2332668|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
2332669|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2332670|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332671|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2332672|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2332673|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332674|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
2332675|NCT00415779|Docetaxel|docetaxel|mesh-list
2332676|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332677|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
2332678|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
2332679|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
2332680|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332681|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2332682|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332683|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2332684|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2332685|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332686|NCT00415831|Levodopa|levodopa|mesh-list
2332687|NCT00415831|Carbidopa|carbidopa|mesh-list
2332688|NCT00415831|Entacapone|entacapone|mesh-list
2332689|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2332690|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2332691|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2332692|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
2332693|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110180|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110181|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110182|NCT02533674|Antiviral Agents|antiviral agents|mesh-ancestor
2110183|NCT02533674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110184|NCT02533674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110185|NCT02533674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2110186|NCT02533674|Immunologic Factors|immunologic factors|mesh-ancestor
2110187|NCT02533674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110188|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2110189|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
2110190|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110191|NCT02534129|Petrolatum|petrolatum|mesh-list
2110192|NCT02534129|Emollients|emollients|mesh-ancestor
2110193|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
2110194|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
2110195|NCT02534883|Misoprostol|misoprostol|mesh-list
2110196|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2110197|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
2110198|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2114044|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
2913204|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913205|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2913206|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2913207|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
2913208|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913209|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2913210|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2913211|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332694|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332695|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332696|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2332697|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332698|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2332699|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2332700|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
2332701|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
2332702|NCT00415844|Levodopa|levodopa|mesh-list
2332703|NCT00415844|Carbidopa|carbidopa|mesh-list
2332704|NCT00415844|Entacapone|entacapone|mesh-list
2332705|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2332706|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2913232|NCT04945148|Metformin|metformin|mesh-list
2913233|NCT04945148|Temozolomide|temozolomide|mesh-list
2913234|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2913235|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913236|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2913237|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
2913238|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913239|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913240|NCT04937816|Empagliflozin|empagliflozin|mesh-list
2913241|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2913242|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913243|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2913244|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913245|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
2913246|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913247|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
2913248|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
2913249|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
2332707|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2332708|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
2332709|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332710|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332711|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332712|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2332713|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332714|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2332715|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2332716|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
2332717|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
2332718|NCT00415883|Valsartan|valsartan|mesh-list
2332719|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2332720|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2332721|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2332722|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332723|NCT00415922|Levodopa|levodopa|mesh-list
2332724|NCT00415922|Carbidopa|carbidopa|mesh-list
2332725|NCT00415922|Entacapone|entacapone|mesh-list
2332726|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2332727|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2332728|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2332729|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
2913292|NCT04925960|Epalrestat|epalrestat|mesh-list
2913293|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913294|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913295|NCT04923594|Mazindol|mazindol|mesh-list
2913296|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2913297|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913298|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2913299|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2913300|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2913301|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913302|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
2913303|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2913304|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2913305|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
2913306|NCT04919382|Temozolomide|temozolomide|mesh-list
2913307|NCT04919382|Atezolizumab|atezolizumab|mesh-list
2913308|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2913309|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2913310|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
2913311|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913312|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913313|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
2913314|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913323|NCT04910568|Dexamethasone|dexamethasone|mesh-list
2913324|NCT04910568|Daratumumab|daratumumab|mesh-list
2913325|NCT04910568|Pomalidomide|pomalidomide|mesh-list
2913326|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2913327|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
2913328|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
2913329|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2913330|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913331|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2913332|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
2913333|NCT04910568|Hormones|hormones|mesh-ancestor
2913334|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2913335|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2913336|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913337|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
2913338|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2913339|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2913340|NCT04910568|Growth Substances|growth substances|mesh-ancestor
2913341|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
2332730|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332731|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332732|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332733|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2332734|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332735|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2332736|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2332737|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
2332738|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
2332739|NCT00415935|Methotrexate|methotrexate|mesh-list
2332740|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2332741|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
2332742|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2332743|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332744|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2332745|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
2332746|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332747|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332748|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
2332749|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913342|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
2913343|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913368|NCT04891770|Tenofovir|tenofovir|mesh-list
2913369|NCT04891770|Nivolumab|nivolumab|mesh-list
2913370|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2913371|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913372|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2913373|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913374|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
2913375|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913376|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2913377|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2913378|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913379|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2913380|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2332750|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2332751|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2332752|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
2332753|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2332754|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2332755|NCT00415961|Paclitaxel|paclitaxel|mesh-list
2332756|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2332757|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332758|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
2332759|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
2332760|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
2332761|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332762|NCT00416039|Midazolam|midazolam|mesh-list
2332763|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2332764|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2332765|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2332766|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332767|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2332768|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2332769|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2913405|NCT04878432|Azacitidine|azacitidine|mesh-list
2913406|NCT04878432|Decitabine|decitabine|mesh-list
2913407|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2332770|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2332771|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
2332772|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
2332773|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
2332774|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
2332775|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332776|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332777|NCT00416130|Vorinostat|vorinostat|mesh-list
2332778|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332779|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2332780|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332781|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332782|NCT00416143|Prednisone|prednisone|mesh-list
2913408|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
2913409|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913410|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913411|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913412|NCT04878211|Interferons|interferons|mesh-list
2913413|NCT04878211|Ofatumumab|ofatumumab|mesh-list
2913414|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
2913415|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
2913416|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913417|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
2913418|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913419|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2913420|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
2913421|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913422|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2913423|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2913424|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
2913425|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2913426|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913427|NCT04865978|Warfarin|warfarin|mesh-list
2913428|NCT04865978|Apixaban|apixaban|mesh-list
2913429|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
2913430|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2913431|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
2913432|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2913433|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
2332783|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2913434|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913435|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332784|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
2332785|NCT00416143|Hormones|hormones|mesh-ancestor
2332786|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2913436|NCT04865731|Esomeprazole|esomeprazole|mesh-list
2913437|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2913438|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2913439|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2913440|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913441|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913442|NCT04865289|Paclitaxel|paclitaxel|mesh-list
2913443|NCT04865289|Carboplatin|carboplatin|mesh-list
2913444|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
2913445|NCT04865289|Lenvatinib|lenvatinib|mesh-list
2913446|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2913447|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332787|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332788|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2332789|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332790|NCT00416169|Galantamine|galantamine|mesh-list
2913448|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
2913449|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
2913450|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
2913451|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913452|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2913453|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2913454|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913455|NCT04856293|Crizotinib|crizotinib|mesh-list
2913456|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913457|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2913458|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913459|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913460|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2913461|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2913462|NCT04827576|Docetaxel|docetaxel|mesh-list
2913463|NCT04827576|Magrolimab|magrolimab|mesh-list
2332791|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2332792|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332793|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332794|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
2332795|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332796|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332797|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2332798|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
2332799|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2332800|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
2332801|NCT00416208|Bortezomib|bortezomib|mesh-list
2332802|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332803|NCT00416221|Citalopram|citalopram|mesh-list
2913464|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913465|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
2913466|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
2913467|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
2913468|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913469|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2913470|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
2913471|NCT04809766|Fludarabine|fludarabine|mesh-list
2913472|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2913473|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
2913474|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913475|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2913476|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2913477|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
2913478|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913479|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913480|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2913481|NCT04797767|Cytarabine|cytarabine|mesh-list
2913482|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
2913483|NCT04797767|Venetoclax|venetoclax|mesh-list
2913484|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
2913485|NCT04797767|Cladribine|cladribine|mesh-list
2913486|NCT04797767|Sargramostim|sargramostim|mesh-list
2913487|NCT04797767|Lenograstim|lenograstim|mesh-list
2913488|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2913489|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
2913490|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913491|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913492|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
2913493|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913494|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2913495|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
2913496|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913497|NCT04797767|Analgesics|analgesics|mesh-ancestor
2913498|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
2913499|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2913500|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2913501|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2913502|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913503|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2913504|NCT04783233|Chitosan|chitosan|mesh-list
2913505|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
2913506|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2913507|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2913508|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
2913509|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913510|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2913511|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
2913512|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
2913513|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
2913514|NCT04783233|Coagulants|coagulants|mesh-ancestor
2913515|NCT04778410|Cytarabine|cytarabine|mesh-list
2913516|NCT04778410|Etoposide|etoposide|mesh-list
2913517|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
2913518|NCT04778410|Azacitidine|azacitidine|mesh-list
2913519|NCT04778410|Venetoclax|venetoclax|mesh-list
2913520|NCT04778410|Cc-486|cc-486|mesh-list
2913521|NCT04778410|Magrolimab|magrolimab|mesh-list
2913522|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2913523|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913524|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2913525|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2913526|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913527|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913528|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2913529|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
2913530|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
2913531|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913532|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2913533|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
2913534|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913535|NCT04778410|Analgesics|analgesics|mesh-ancestor
2913536|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
2913537|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2913538|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2913547|NCT04762069|Lomustine|lomustine|mesh-list
2913548|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2913549|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
2913550|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913551|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913552|NCT04743505|Osimertinib|osimertinib|mesh-list
2913553|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913554|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2913555|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913556|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913557|NCT04742036|Paclitaxel|paclitaxel|mesh-list
2332804|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
2332805|NCT00416221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2332806|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2332807|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2913558|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2913559|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913560|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
2913561|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
2110199|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110200|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2110201|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2913562|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
2913563|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913581|NCT04707391|Vaccines|vaccines|mesh-list
2913582|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
2913583|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913584|NCT04707183|Lidocaine|lidocaine|mesh-list
2913585|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
2913586|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
2913587|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2913588|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913589|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
2913590|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2913591|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2913592|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2913593|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2913594|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2913595|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913596|NCT04703205|Ivermectin|ivermectin|mesh-list
2913597|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2913598|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913599|NCT04700176|Dexamethasone|dexamethasone|mesh-list
2913600|NCT04700176|Daratumumab|daratumumab|mesh-list
2913601|NCT04700176|Pomalidomide|pomalidomide|mesh-list
2913602|NCT04700176|Tretinoin|tretinoin|mesh-list
2913603|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2913604|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
2913605|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
2913606|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2913607|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913608|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2913609|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
2913610|NCT04700176|Hormones|hormones|mesh-ancestor
2913611|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2913612|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2913613|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913614|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
2913615|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2913616|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2913617|NCT04700176|Growth Substances|growth substances|mesh-ancestor
2913618|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
2913619|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
2913620|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
2913621|NCT04686799|Doxycycline|doxycycline|mesh-list
2913622|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2913623|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913624|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
2913625|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2913626|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2913627|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
2913628|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913629|NCT04676334|Rucaparib|rucaparib|mesh-list
2913630|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2913631|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913632|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913633|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332808|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332809|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2332810|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
2332811|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332812|NCT00416221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2332813|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2913653|NCT04649203|Riboflavin|riboflavin|mesh-list
2913654|NCT04649203|Niacinamide|niacinamide|mesh-list
2913655|NCT04649203|Niacin|niacin|mesh-list
2913656|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
2913657|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
2913658|NCT04649203|Vitamins|vitamins|mesh-ancestor
2913659|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
2332814|NCT00416273|Bortezomib|bortezomib|mesh-list
2332815|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332816|NCT00416325|Lycopene|lycopene|mesh-list
2913660|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913661|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2913662|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
2913663|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2913664|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
2332817|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2332818|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
2332819|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332820|NCT00416325|Protective Agents|protective agents|mesh-ancestor
2332821|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332822|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2913665|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913666|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2913667|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
2913668|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
2913669|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110202|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
2110203|NCT02534935|Vaccines|vaccines|mesh-list
2110204|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
2110205|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110206|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2110207|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2110208|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2110209|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2110210|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110211|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110212|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110213|NCT02535000|Analgesics|analgesics|mesh-ancestor
2110214|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
2110215|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110216|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
2110217|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2110218|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
2110219|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
2110220|NCT02535416|Promethazine|promethazine|mesh-list
2110221|NCT02535416|Cetirizine|cetirizine|mesh-list
2913682|NCT04639414|Empagliflozin|empagliflozin|mesh-list
2913683|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2913684|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913685|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2913686|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332823|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2332824|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332825|NCT00416351|Clofarabine|clofarabine|mesh-list
2332826|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2332827|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
2332828|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332829|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332830|NCT00416377|Prednisolone|prednisolone|mesh-list
2332831|NCT00416377|Doxorubicin|doxorubicin|mesh-list
2332832|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2332833|NCT00416377|Bleomycin|bleomycin|mesh-list
2332834|NCT00416377|Vincristine|vincristine|mesh-list
2332835|NCT00416377|Dacarbazine|dacarbazine|mesh-list
2332836|NCT00416377|Vinblastine|vinblastine|mesh-list
2332837|NCT00416377|Procarbazine|procarbazine|mesh-list
2332838|NCT00416377|Chlorambucil|chlorambucil|mesh-list
2332839|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2332840|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332841|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2913690|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
2913691|NCT04624204|Etoposide|etoposide|mesh-list
2913692|NCT04624204|Olaparib|olaparib|mesh-list
2913693|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2913694|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913695|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2913696|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2913697|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2913698|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913699|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913700|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2913701|NCT04615949|Cannabidiol|cannabidiol|mesh-list
2913702|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
2913703|NCT04608903|Sulforaphane|sulforaphane|mesh-list
2913704|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2913705|NCT04608903|Protective Agents|protective agents|mesh-ancestor
2913706|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913707|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913708|NCT04572815|Interleukin-12|interleukin-12|mesh-list
2913709|NCT04572815|Ustekinumab|ustekinumab|mesh-list
2913710|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
2913711|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
2913712|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
2913713|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913714|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
2913715|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2913716|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2913717|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2913718|NCT04572815|Growth Substances|growth substances|mesh-ancestor
2913719|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
2913720|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913721|NCT04572295|Fulvestrant|fulvestrant|mesh-list
2913722|NCT04572295|Exemestane|exemestane|mesh-list
2913723|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2913724|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913725|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2913726|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2913727|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
2913728|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2913729|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913730|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2913731|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2913732|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913733|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332842|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2332843|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913745|NCT04560127|Apatinib|apatinib|mesh-list
2913746|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913747|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2913748|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913749|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913750|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2913751|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2332844|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332845|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2332846|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
2332847|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
2332848|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
2332849|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2332850|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
2913752|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913753|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
2913754|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2913755|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2913756|NCT04526132|Analgesics|analgesics|mesh-ancestor
2913757|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
2913758|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2913759|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913760|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2913761|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2913762|NCT04522973|Ethanol|ethanol|mesh-list
2913763|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2913764|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913765|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2913766|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332851|NCT00416377|Hormones|hormones|mesh-ancestor
2332852|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2332853|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332854|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2332855|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2332856|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
2332857|NCT00416390|Lycopene|lycopene|mesh-list
2913767|NCT04518345|Azacitidine|azacitidine|mesh-list
2913768|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2913769|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
2913770|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913771|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913772|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913773|NCT04515472|Hormones|hormones|mesh-list
2913774|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913775|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2913776|NCT04512079|Enoxaparin|enoxaparin|mesh-list
2913777|NCT04512079|Apixaban|apixaban|mesh-list
2332858|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2332859|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
2332860|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332861|NCT00416390|Protective Agents|protective agents|mesh-ancestor
2332862|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332863|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2332864|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2332865|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332866|NCT00416429|Interferons|interferons|mesh-list
2332867|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
2332868|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
2332869|NCT00416429|Aldesleukin|aldesleukin|mesh-list
2332870|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2332871|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
2332872|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332873|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
2332874|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913778|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
2913779|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2913780|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2913781|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913782|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2913783|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
2913784|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2913785|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
2913786|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913787|NCT04511247|Sirolimus|sirolimus|mesh-list
2913788|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2913789|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913790|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2913791|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332875|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
2332876|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332877|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2332878|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2332879|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2332880|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2332881|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2332882|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
2332883|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2332884|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2332885|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2332886|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2332887|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2332888|NCT00416468|Valsartan|valsartan|mesh-list
2332889|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2332890|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2332891|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2332892|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913792|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
2913793|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2913794|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
2913795|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913796|NCT04511234|Sirolimus|sirolimus|mesh-list
2913797|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2913798|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913799|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2913800|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913801|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
2913802|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2913803|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
2913804|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913805|NCT04494425|Paclitaxel|paclitaxel|mesh-list
2913806|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2913807|NCT04494425|Capecitabine|capecitabine|mesh-list
2913808|NCT04494425|Trastuzumab|trastuzumab|mesh-list
2913809|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2332893|NCT00416507|Gemcitabine|gemcitabine|mesh-list
2332894|NCT00416507|Fluorouracil|fluorouracil|mesh-list
2332895|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332896|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2332897|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
2332898|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332899|NCT00416507|Antiviral Agents|antiviral agents|mesh-ancestor
2332900|NCT00416507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2332901|NCT00416507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332902|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2332903|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
2332904|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332905|NCT00416533|Prednisone|prednisone|mesh-list
2332906|NCT00416533|Docetaxel|docetaxel|mesh-list
2332907|NCT00416533|Doxorubicin|doxorubicin|mesh-list
2332908|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2332909|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332910|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
2332911|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
2332912|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
2332913|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332914|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2913810|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913811|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
2913812|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
2913813|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
2913814|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332915|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2332916|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2913815|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2913816|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
2913817|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2913818|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
2913819|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2913820|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913821|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2913822|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913835|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
2913836|NCT04491617|Narcotics|narcotics|mesh-ancestor
2913837|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2913838|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913839|NCT04491617|Analgesics|analgesics|mesh-ancestor
2913840|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
2913841|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2913842|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2913843|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
2913844|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913845|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
2913846|NCT04445714|Saxagliptin|saxagliptin|mesh-list
2913847|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2913848|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913849|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2913850|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913851|NCT04445714|Incretins|incretins|mesh-ancestor
2913852|NCT04445714|Hormones|hormones|mesh-ancestor
2913853|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2913854|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2913855|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
2332917|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332918|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2332919|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
2332920|NCT00416533|Hormones|hormones|mesh-ancestor
2332921|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2332922|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332923|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2332924|NCT00416585|Isotretinoin|isotretinoin|mesh-list
2332925|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
2332926|NCT00416637|Bevacizumab|bevacizumab|mesh-list
2332927|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2332928|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332929|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2332930|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2332931|NCT00416637|Growth Substances|growth substances|mesh-ancestor
2332932|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332933|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
2332934|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2332935|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332936|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2332937|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332938|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332939|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
2332940|NCT00416676|Carboplatin|carboplatin|mesh-list
2332941|NCT00416676|Etoposide|etoposide|mesh-list
2332942|NCT00416676|Vincristine|vincristine|mesh-list
2332943|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2332944|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
2332945|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913856|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913857|NCT04437485|Norepinephrine|norepinephrine|mesh-list
2913858|NCT04437485|Bupropion|bupropion|mesh-list
2913859|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
2913860|NCT04437485|Serotonin|serotonin|mesh-list
2913861|NCT04437485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2913862|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2913863|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2913864|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2913865|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2913866|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2913867|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913868|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
2913869|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2913870|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913871|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2913872|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2332946|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2332947|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2332948|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
2913873|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913874|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2913875|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2913876|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
2332949|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332950|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332951|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2332952|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2332953|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2332954|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2332955|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332956|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
2332957|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
2332958|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
2332959|NCT00416728|Valsartan|valsartan|mesh-list
2332960|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2332961|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2332962|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2332963|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332964|NCT00416767|Leucovorin|leucovorin|mesh-list
2332965|NCT00416767|Fluorouracil|fluorouracil|mesh-list
2332966|NCT00416767|Irinotecan|irinotecan|mesh-list
2332967|NCT00416767|Calcium|calcium|mesh-list
2332968|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
2332969|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2332970|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332971|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
2332972|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332973|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2332974|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332975|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2332976|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
2332977|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2332978|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2332979|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2332980|NCT00416767|Antidotes|antidotes|mesh-ancestor
2332981|NCT00416767|Protective Agents|protective agents|mesh-ancestor
2332982|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
2332983|NCT00416767|Vitamins|vitamins|mesh-ancestor
2332984|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
2332985|NCT00416819|Leucovorin|leucovorin|mesh-list
2332986|NCT00416819|Cytarabine|cytarabine|mesh-list
2332987|NCT00416819|Rituximab|rituximab|mesh-list
2332988|NCT00416819|Methotrexate|methotrexate|mesh-list
2913877|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
2913878|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
2913879|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2913880|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2913881|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2913882|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
2913883|NCT04436224|Fentanyl|fentanyl|mesh-list
2913884|NCT04436224|Hydromorphone|hydromorphone|mesh-list
2913885|NCT04436224|Butorphanol|butorphanol|mesh-list
2913886|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2913887|NCT04436224|Narcotics|narcotics|mesh-ancestor
2913888|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2913889|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332989|NCT00416819|Etoposide|etoposide|mesh-list
2332990|NCT00416819|Temozolomide|temozolomide|mesh-list
2913890|NCT04436224|Analgesics|analgesics|mesh-ancestor
2913891|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
2913892|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2913893|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2913894|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2913895|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
2913896|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
2913897|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
2913898|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
2913899|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2913900|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
2913901|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2913902|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913903|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2332991|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
2332992|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
2332993|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2332994|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2332995|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
2332996|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2332997|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2332998|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2913904|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2913905|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2913906|NCT04433988|Protective Agents|protective agents|mesh-ancestor
2913907|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913908|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
2913909|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2913910|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
2913911|NCT04414722|Amoxicillin|amoxicillin|mesh-list
2913912|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
2913913|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
2913914|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2913915|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2913916|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913917|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2913918|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913919|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913920|NCT04410341|Vildagliptin|vildagliptin|mesh-list
2913921|NCT04410341|Citalopram|citalopram|mesh-list
2913922|NCT04410341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2913923|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2332999|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
2333000|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2333001|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2333002|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
2333003|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333004|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
2333005|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333006|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2333007|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2333008|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2333009|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2333010|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2333011|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2333012|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
2333013|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333014|NCT00416819|Antidotes|antidotes|mesh-ancestor
2333015|NCT00416819|Protective Agents|protective agents|mesh-ancestor
2333016|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
2333017|NCT00416819|Vitamins|vitamins|mesh-ancestor
2333018|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
2333019|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2333020|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
2913924|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2913925|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913926|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2913927|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
2913928|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913929|NCT04410341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2913930|NCT04410341|Antidepressive Agents|antidepressive agents|mesh-ancestor
2913931|NCT04410341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2333021|NCT00416832|Prednisone|prednisone|mesh-list
2333022|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
2333023|NCT00416832|Dacarbazine|dacarbazine|mesh-list
2913932|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2913933|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2913934|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
2913935|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913941|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
2913942|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2913943|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913944|NCT04381936|Aspirin|aspirin|mesh-list
2913945|NCT04381936|Empagliflozin|empagliflozin|mesh-list
2913946|NCT04381936|Ritonavir|ritonavir|mesh-list
2913947|NCT04381936|Lopinavir|lopinavir|mesh-list
2913948|NCT04381936|Azithromycin|azithromycin|mesh-list
2913949|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
2913950|NCT04381936|Colchicine|colchicine|mesh-list
2913951|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2913952|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2913953|NCT04381936|Antibodies|antibodies|mesh-list
2913954|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
2913955|NCT04381936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2333024|NCT00416832|Doxorubicin|doxorubicin|mesh-list
2333025|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2333026|NCT00416832|Etoposide|etoposide|mesh-list
2333027|NCT00416832|Vincristine|vincristine|mesh-list
2333028|NCT00416832|Procarbazine|procarbazine|mesh-list
2333029|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2333030|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
2333031|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333032|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2333033|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2333034|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
2333035|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333036|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333037|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2333038|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2333039|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2913956|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
2913957|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2913958|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2913959|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2913960|NCT04381936|Analgesics|analgesics|mesh-ancestor
2913961|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
2913962|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2913963|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2913964|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2913965|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2913966|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2913967|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2913968|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2913969|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2913970|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2913971|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
2913972|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2913973|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2913974|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
2913975|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2913976|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2913977|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
2913978|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2913979|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2913980|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2913981|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2913982|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
2913983|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2913984|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2913985|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2913986|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2913987|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
2913988|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
2913989|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
2333040|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2333041|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333042|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2913990|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
2913991|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2913992|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
2913993|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2913994|NCT04374019|Artesunate|artesunate|mesh-list
2913995|NCT04374019|Ivermectin|ivermectin|mesh-list
2913996|NCT04374019|Camostat|camostat|mesh-list
2913997|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
2913998|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2913999|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2914000|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2914001|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914002|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
2914003|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
2914004|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2914005|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
2914006|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
2914007|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333043|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
2333044|NCT00416832|Hormones|hormones|mesh-ancestor
2333045|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2333046|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2333047|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2333048|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
2914008|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914009|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2914010|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2914011|NCT04372927|Cisplatin|cisplatin|mesh-list
2914012|NCT04372927|Etoposide|etoposide|mesh-list
2914013|NCT04372927|Pemetrexed|pemetrexed|mesh-list
2914014|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
2914015|NCT04372927|Durvalumab|durvalumab|mesh-list
2914016|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
2914017|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
2914018|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2914019|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
2914020|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914021|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2914022|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2914023|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2914024|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914025|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914026|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2914027|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2914028|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914029|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
2914030|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914031|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
2914032|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
2914033|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
2914034|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
2914035|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
2914050|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2110222|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2110223|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2110224|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2110225|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110226|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
2110227|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
2110228|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
2110229|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110230|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
2110231|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
2333049|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
2333050|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
2333051|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2333052|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2333053|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333054|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2333055|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
2333056|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333057|NCT00416858|Fluorouracil|fluorouracil|mesh-list
2333058|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333059|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
2333060|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333061|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2333062|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2333063|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
2914051|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2914052|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2914053|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914054|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
2914055|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914056|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
2914057|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2914058|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2914059|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914060|NCT04344678|Urological Agents|urological agents|mesh-ancestor
2914066|NCT04338399|Paclitaxel|paclitaxel|mesh-list
2333064|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333065|NCT00416871|Interferons|interferons|mesh-list
2333066|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
2333067|NCT00416871|Aldesleukin|aldesleukin|mesh-list
2333068|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333069|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
2333070|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333071|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
2333072|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333073|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2333074|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2333075|NCT00416897|Dexamethasone|dexamethasone|mesh-list
2333076|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2333077|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
2333078|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
2333079|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333080|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333081|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2333082|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
2333083|NCT00416897|Hormones|hormones|mesh-ancestor
2333084|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2333085|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2333086|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333087|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
2333088|NCT00416910|Fludarabine|fludarabine|mesh-list
2333089|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
2333090|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2333091|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
2333092|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333093|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2333094|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2333095|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
2333096|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333097|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333098|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2333099|NCT00416910|Analgesics|analgesics|mesh-ancestor
2333100|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
2333101|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333102|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2333103|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2333104|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333105|NCT00416923|Rituximab|rituximab|mesh-list
2333106|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2333107|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333108|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
2333109|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333110|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2333111|NCT00416962|Oseltamivir|oseltamivir|mesh-list
2333112|NCT00416962|Amantadine|amantadine|mesh-list
2333113|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
2333114|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333115|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333116|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333117|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2333118|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2333119|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
2914067|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2914068|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914069|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
2914070|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
2914071|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
2914072|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914073|NCT04311463|Paroxetine|paroxetine|mesh-list
2914074|NCT04311463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2914075|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2914076|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2914077|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914078|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2914079|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
2914080|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914081|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2914082|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
2914083|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2914084|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2914085|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2914086|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914087|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2914088|NCT04295005|Empagliflozin|empagliflozin|mesh-list
2914089|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2914090|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914091|NCT04295005|Incretins|incretins|mesh-ancestor
2914092|NCT04295005|Hormones|hormones|mesh-ancestor
2914093|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2914094|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2914095|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
2914096|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914097|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914098|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2914099|NCT04291105|Cemiplimab|cemiplimab|mesh-list
2914100|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914101|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914126|NCT04265651|Infigratinib|infigratinib|mesh-list
2914127|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914128|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
2914129|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2333120|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333121|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333122|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2333123|NCT00416962|Analgesics|analgesics|mesh-ancestor
2333124|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
2333125|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333126|NCT00417014|Prednisolone|prednisolone|mesh-list
2914130|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
2914131|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2914132|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
2914133|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914134|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914135|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
2914143|NCT04225988|Tacrolimus|tacrolimus|mesh-list
2914144|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2914145|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
2914146|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914147|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2914148|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914149|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914159|NCT04212364|Naloxone|naloxone|mesh-list
2914160|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2914161|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914162|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
2914163|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2914164|NCT04207190|Talazoparib|talazoparib|mesh-list
2914165|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
2914166|NCT04207190|Calicheamicins|calicheamicins|mesh-list
2914167|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2914168|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914169|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914170|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914171|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914172|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2914173|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
2914174|NCT04199104|Lenvatinib|lenvatinib|mesh-list
2914175|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914176|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914177|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2914178|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914179|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914180|NCT04195750|Everolimus|everolimus|mesh-list
2914181|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914182|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2914183|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
2914184|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914185|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
2110232|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2110233|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2110234|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
2110235|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
2110236|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110237|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110238|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2110239|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
2110240|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
2110241|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2914186|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2914187|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
2914188|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2914189|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
2914190|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914191|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914192|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
2914193|NCT04179890|Afatinib|afatinib|mesh-list
2914194|NCT04179890|Mitogens|mitogens|mesh-list
2914195|NCT04179890|Mitosis Modulators|mitosis modulators|mesh-ancestor
2914196|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914197|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914198|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2914199|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914200|NCT04175509|Acetaminophen|acetaminophen|mesh-list
2914201|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2914202|NCT04175509|Analgesics|analgesics|mesh-ancestor
2914203|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
2914204|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2914205|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914206|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
2914207|NCT04170153|Niraparib|niraparib|mesh-list
2914208|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2914209|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914210|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914211|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914221|NCT04148105|Cilostazol|cilostazol|mesh-list
2914222|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2914223|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
2914224|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333127|NCT00417014|Vinblastine|vinblastine|mesh-list
2333128|NCT00417014|Procarbazine|procarbazine|mesh-list
2333129|NCT00417014|Chlorambucil|chlorambucil|mesh-list
2333130|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2333131|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
2914225|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914226|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2914227|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
2914228|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2914229|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2914230|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914231|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2914232|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
2914233|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2914234|NCT04148105|Protective Agents|protective agents|mesh-ancestor
2914235|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2914236|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2914237|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333132|NCT00417014|Hormones|hormones|mesh-ancestor
2333133|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2333134|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333135|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2333136|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333137|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2333138|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
2333139|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
2333140|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
2333141|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333142|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2333143|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
2333144|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
2333145|NCT00417053|Melphalan|melphalan|mesh-list
2333146|NCT00417053|Busulfan|busulfan|mesh-list
2333147|NCT00417053|Carboplatin|carboplatin|mesh-list
2333148|NCT00417053|Doxorubicin|doxorubicin|mesh-list
2333149|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2333150|NCT00417053|Etoposide|etoposide|mesh-list
2914238|NCT04147351|Bevacizumab|bevacizumab|mesh-list
2914239|NCT04147351|Atezolizumab|atezolizumab|mesh-list
2914240|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914241|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914242|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2914243|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2914244|NCT04147351|Growth Substances|growth substances|mesh-ancestor
2914245|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914246|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
2914247|NCT04140396|Lidocaine|lidocaine|mesh-list
2914248|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
2914249|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
2914250|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2914251|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914252|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
2914253|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2914254|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2914255|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2914256|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2914257|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2914258|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914259|NCT04135937|Bupropion|bupropion|mesh-list
2914260|NCT04135937|Nicotine|nicotine|mesh-list
2333151|NCT00417053|Vincristine|vincristine|mesh-list
2333152|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
2333153|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2333154|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
2333155|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333156|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2333157|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2333158|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
2914261|NCT04135937|Varenicline|varenicline|mesh-list
2914262|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2914263|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
2914264|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2914265|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914266|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2914267|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2914268|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
2914269|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2914270|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914271|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2914272|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
2914273|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2914274|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2914275|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2914276|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2914277|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
2914278|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2914279|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2914280|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914281|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2914282|NCT04113382|Laxatives|laxatives|mesh-ancestor
2914283|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2914289|NCT04075110|Montelukast|montelukast|mesh-list
2914290|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2914291|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
2914292|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2914293|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
2914294|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2914295|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914296|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2914297|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2914298|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914299|NCT04059003|Taxane|taxane|mesh-list
2914300|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333159|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914304|NCT04050410|Moxonidine|moxonidine|mesh-list
2914305|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2914306|NCT04046575|Paclitaxel|paclitaxel|mesh-list
2914307|NCT04046575|Carboplatin|carboplatin|mesh-list
2914308|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2914309|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914310|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
2914311|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
2914312|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
2914313|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914314|NCT04044209|Nivolumab|nivolumab|mesh-list
2914315|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914316|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333160|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333161|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2333162|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2333163|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2333164|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2333165|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333166|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2333167|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
2333168|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
2333169|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
2333170|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2333171|NCT00417066|Ganirelix|ganirelix|mesh-list
2333172|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
2333173|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2333174|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
2333175|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2333176|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333177|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2914317|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2914318|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333178|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2333179|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333180|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
2333181|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2333182|NCT00417118|Citalopram|citalopram|mesh-list
2333183|NCT00417118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2333184|NCT00417118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2333185|NCT00417118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2333186|NCT00417118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333187|NCT00417118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333188|NCT00417118|Serotonin Agents|serotonin agents|mesh-ancestor
2333189|NCT00417118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333190|NCT00417118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2333191|NCT00417118|Antidepressive Agents|antidepressive agents|mesh-ancestor
2333192|NCT00417118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2333193|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2333194|NCT00417144|Ganirelix|ganirelix|mesh-list
2333195|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
2333196|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2333197|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
2333198|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2333199|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914322|NCT03998813|Ropivacaine|ropivacaine|mesh-list
2110242|NCT02535611|Memantine|memantine|mesh-list
2110243|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2110244|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2110245|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
2110246|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110247|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110248|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110249|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2110250|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2110251|NCT02535715|Insulin|insulin|mesh-list
2110252|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2110253|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2110254|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914323|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
2914324|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
2914325|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2914326|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914327|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
2914328|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2914329|NCT03990363|Allopurinol|allopurinol|mesh-list
2914330|NCT03990363|Verinurad|verinurad|mesh-list
2914331|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
2914332|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914333|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914334|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
2914335|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2914336|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2914337|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
2914338|NCT03990363|Protective Agents|protective agents|mesh-ancestor
2914339|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914340|NCT03976375|Docetaxel|docetaxel|mesh-list
2914341|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
2914342|NCT03976375|Lenvatinib|lenvatinib|mesh-list
2914343|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914344|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
2914345|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
2914346|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
2914347|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914348|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914349|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2914350|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914351|NCT03970447|Temozolomide|temozolomide|mesh-list
2914352|NCT03970447|Lomustine|lomustine|mesh-list
2914353|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
2914354|NCT03970447|GDC-0084|gdc-0084|mesh-list
2914355|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2914356|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
2914357|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914358|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914359|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914360|NCT03969901|Relebactam|relebactam|mesh-list
2333200|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2333201|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2333202|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333203|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
2333204|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2333205|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2333206|NCT00417157|Ganirelix|ganirelix|mesh-list
2333207|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
2333208|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2333209|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333210|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2333211|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2333212|NCT00417183|Ganirelix|ganirelix|mesh-list
2333213|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
2333214|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2333215|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
2333216|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2333217|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333218|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2333219|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2914361|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2914362|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914363|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914364|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2914365|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2914366|NCT03930186|Apremilast|apremilast|mesh-list
2914367|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2914368|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2914369|NCT03930186|Analgesics|analgesics|mesh-ancestor
2914370|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
2914371|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2914372|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914373|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2914374|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2914375|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2333220|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914376|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2914377|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914378|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914379|NCT03911973|Talazoparib|talazoparib|mesh-list
2914380|NCT03911973|Gedatolisib|gedatolisib|mesh-list
2914381|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2914382|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914383|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914384|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914385|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2914386|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2914387|NCT03910972|Vaccines|vaccines|mesh-list
2914388|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
2914389|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914390|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2914391|NCT03910972|Antacids|antacids|mesh-ancestor
2333221|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
2333222|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2333223|NCT00417209|Fluorouracil|fluorouracil|mesh-list
2333224|NCT00417209|Capecitabine|capecitabine|mesh-list
2333225|NCT00417209|Antimetabolites|antimetabolites|mesh-ancestor
2333226|NCT00417209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333227|NCT00417209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2333228|NCT00417209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333229|NCT00417209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2914392|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914393|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2914394|NCT03907046|Aspirin|aspirin|mesh-list
2914395|NCT03907046|Apixaban|apixaban|mesh-list
2914396|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2914397|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2914398|NCT03907046|Analgesics|analgesics|mesh-ancestor
2914399|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
2914400|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2914401|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914402|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2914403|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2914404|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2914405|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2914406|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914407|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2914408|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2914409|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914410|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
2914411|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2914412|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
2914413|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2914414|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
2914415|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
2914431|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
2914432|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2914433|NCT03883828|Mupirocin|mupirocin|mesh-list
2914434|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2914435|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2914436|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
2333230|NCT00417209|Immunologic Factors|immunologic factors|mesh-ancestor
2333231|NCT00417209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333232|NCT00417222|Olmesartan|olmesartan|mesh-list
2333233|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2333234|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2914437|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
2914438|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2914439|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2914440|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914441|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914442|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
2914443|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914444|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914445|NCT03854227|Docetaxel|docetaxel|mesh-list
2914446|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914447|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
2914448|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
2914449|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
2914450|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914451|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
2333235|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2333236|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2333237|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333238|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
2333239|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2333240|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333241|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
2333242|NCT00417326|Sivelestat|sivelestat|mesh-list
2333243|NCT00417326|Glycine|glycine|mesh-list
2333244|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2333245|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
2333246|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333247|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333248|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
2914452|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914453|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914454|NCT03817463|Empagliflozin|empagliflozin|mesh-list
2914455|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2914456|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2914457|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914458|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2914459|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914460|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
2914461|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914462|NCT03807440|Empagliflozin|empagliflozin|mesh-list
2914463|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2914464|NCT03807440|Linagliptin|linagliptin|mesh-list
2914465|NCT03807440|Metformin|metformin|mesh-list
2914466|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2914467|NCT03807440|Glucagon|glucagon|mesh-list
2914468|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2914469|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914470|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2914471|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914472|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2914473|NCT03807440|Hormones|hormones|mesh-ancestor
2914474|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2914475|NCT03807440|Incretins|incretins|mesh-ancestor
2914476|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
2914477|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914484|NCT03787849|Anesthetics|anesthetics|mesh-list
2333249|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333250|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333251|NCT00417404|Vitamins|vitamins|mesh-list
2333252|NCT00417404|Vitamin A|vitamin a|mesh-list
2333253|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
2333254|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
2333255|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333256|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
2333257|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333258|NCT00417404|Protective Agents|protective agents|mesh-ancestor
2333259|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2333260|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333261|NCT00417430|Fulvestrant|fulvestrant|mesh-list
2333262|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2110255|NCT02535806|Cytarabine|cytarabine|mesh-list
2110256|NCT02535806|Dexamethasone|dexamethasone|mesh-list
2110257|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
2110258|NCT02535806|Methotrexate|methotrexate|mesh-list
2110259|NCT02535806|Vincristine|vincristine|mesh-list
2110260|NCT02535806|Bortezomib|bortezomib|mesh-list
2110261|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
2914485|NCT03787849|Propofol|propofol|mesh-list
2914486|NCT03787849|Sevoflurane|sevoflurane|mesh-list
2914487|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2914488|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914489|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2914490|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2914491|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
2914492|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2914493|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2914494|NCT03781440|Lidocaine|lidocaine|mesh-list
2914495|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
2914496|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
2333263|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333264|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2333265|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2333266|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
2333267|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2333268|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333269|NCT00417443|Clonidine|clonidine|mesh-list
2333270|NCT00417443|Analgesics|analgesics|mesh-ancestor
2333271|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
2333272|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333273|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333274|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2914497|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2914498|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914499|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
2914500|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2914501|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2914502|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2914503|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2914504|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2914505|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914506|NCT03777319|Prednisolone|prednisolone|mesh-list
2914507|NCT03777319|Spironolactone|spironolactone|mesh-list
2914508|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2914509|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
2914510|NCT03777319|Hormones|hormones|mesh-ancestor
2914511|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2914512|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914513|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2914514|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914515|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2914516|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
2914517|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2914518|NCT03777319|Diuretics|diuretics|mesh-ancestor
2914519|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
2914520|NCT03759288|Adalimumab|adalimumab|mesh-list
2914521|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2914522|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2914528|NCT03740100|Sirolimus|sirolimus|mesh-list
2914529|NCT03740100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2914530|NCT03740100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2914531|NCT03740100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2914532|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110262|NCT02535806|Pegaspargase|pegaspargase|mesh-list
2110263|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2110264|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
2110265|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
2110266|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110267|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110268|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2110269|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
2110270|NCT02535806|Hormones|hormones|mesh-ancestor
2914533|NCT03740100|Antifungal Agents|antifungal agents|mesh-ancestor
2914534|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2914535|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
2914536|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914537|NCT03737981|Venetoclax|venetoclax|mesh-list
2914538|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
2914539|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333275|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
2333276|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
2333277|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2333278|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2333279|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2333280|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
2333281|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333282|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333283|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2333284|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
2914540|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914549|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2914550|NCT03687814|Laxatives|laxatives|mesh-ancestor
2914551|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2333285|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914552|NCT03635983|Nivolumab|nivolumab|mesh-list
2914553|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914554|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914555|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2914556|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914557|NCT03626337|Thiamine|thiamine|mesh-list
2914558|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
2914559|NCT03626337|Vitamins|vitamins|mesh-ancestor
2914560|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
2914561|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914577|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
2914578|NCT03600649|Topotecan|topotecan|mesh-list
2914579|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2914580|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
2914581|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914582|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2914583|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2914584|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
2914585|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914586|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914587|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2914588|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2914589|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2914590|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914591|NCT03547115|Voruciclib|voruciclib|mesh-list
2914592|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914593|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2914594|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914595|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914596|NCT03515304|Evolocumab|evolocumab|mesh-list
2914597|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2914598|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2914599|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
2914600|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914601|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2914602|NCT03501368|Trametinib|trametinib|mesh-list
2914603|NCT03501368|Ceritinib|ceritinib|mesh-list
2914604|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110271|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2110272|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2110273|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110274|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2110275|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
2110276|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2110277|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2110278|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
2110279|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110280|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
2110281|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333286|NCT00417664|Midazolam|midazolam|mesh-list
2333287|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
2333288|NCT00417664|Propofol|propofol|mesh-list
2333289|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2333290|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2333291|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333292|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2333293|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
2333294|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
2333295|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2333296|NCT00417664|Analgesics|analgesics|mesh-ancestor
2333297|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
2333298|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333299|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2333300|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2333301|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2333302|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
2333303|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333304|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333305|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2333306|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2333307|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2333308|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2914605|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2914606|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914607|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914608|NCT03490513|Anastrozole|anastrozole|mesh-list
2914609|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2914610|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914611|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2914612|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2914613|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914614|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914615|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2914616|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
2914617|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2914618|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914619|NCT03481660|Aflibercept|aflibercept|mesh-list
2914620|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2914621|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2914622|NCT03481660|Growth Substances|growth substances|mesh-ancestor
2914623|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914624|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
2914625|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914626|NCT03478878|Vitamin A|vitamin a|mesh-list
2914627|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
2914628|NCT03478878|Vitamins|vitamins|mesh-ancestor
2914629|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
2914630|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914631|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
2914632|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914633|NCT03478878|Protective Agents|protective agents|mesh-ancestor
2914634|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2914635|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333309|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
2333310|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
2333311|NCT00417677|Sirolimus|sirolimus|mesh-list
2333312|NCT00417677|Sunitinib|sunitinib|mesh-list
2333313|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333314|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2333315|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2333316|NCT00417677|Growth Substances|growth substances|mesh-ancestor
2333317|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914646|NCT03471728|Linaclotide|linaclotide|mesh-list
2914647|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2914648|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
2914649|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914650|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2914651|NCT03463057|Atezolizumab|atezolizumab|mesh-list
2914652|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914653|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
2914654|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2914655|NCT03404596|Nicotine|nicotine|mesh-list
2914656|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2914657|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
2914658|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333318|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
2333319|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2333320|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333321|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333322|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2333323|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333324|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2110282|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2110283|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2110284|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
2110285|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2110286|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2110287|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
2110288|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110289|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2110290|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
2110291|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
2110292|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
2110293|NCT02535806|Analgesics|analgesics|mesh-ancestor
2110294|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
2110295|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2110296|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2110297|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
2110298|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2110299|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2110300|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110301|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
2110302|NCT02535949|Coagulants|coagulants|mesh-ancestor
2110303|NCT02536040|Fluorides|fluorides|mesh-list
2110304|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
2110305|NCT02536040|Protective Agents|protective agents|mesh-ancestor
2110306|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110307|NCT02536105|Methylphenidate|methylphenidate|mesh-list
2110308|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2110309|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110310|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2110311|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2110312|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2110313|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110314|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
2110315|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110316|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2110317|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2110318|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110319|NCT02536248|Incretins|incretins|mesh-ancestor
2110320|NCT02536248|Hormones|hormones|mesh-ancestor
2914659|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914660|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2914661|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2914662|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
2914663|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2914664|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914684|NCT03342027|Bupropion|bupropion|mesh-list
2914685|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2914686|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
2333325|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
2333326|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2914687|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2914688|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2914689|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2914690|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2914691|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914692|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
2914693|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2914694|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914695|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2914696|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2914697|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914698|NCT03321513|Bevacizumab|bevacizumab|mesh-list
2914699|NCT03321513|Aflibercept|aflibercept|mesh-list
2914700|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914701|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914702|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2914703|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2914704|NCT03321513|Growth Substances|growth substances|mesh-ancestor
2914705|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914706|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
2914707|NCT03315910|Nicotine|nicotine|mesh-list
2914708|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2914709|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
2914710|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2914711|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914712|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2914713|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2914714|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
2914715|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2914716|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914717|NCT03283761|Leucovorin|leucovorin|mesh-list
2333327|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
2333328|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
2333329|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
2333330|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2333331|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333332|NCT00417716|Bevacizumab|bevacizumab|mesh-list
2333333|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914718|NCT03283761|Paclitaxel|paclitaxel|mesh-list
2914719|NCT03283761|Fluorouracil|fluorouracil|mesh-list
2914720|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
2914721|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2914722|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914723|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
2914724|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
2914725|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
2914726|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914727|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
2914728|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2914729|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2914730|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
2914731|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914732|NCT03283761|Antidotes|antidotes|mesh-ancestor
2914733|NCT03283761|Protective Agents|protective agents|mesh-ancestor
2914734|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
2914735|NCT03283761|Vitamins|vitamins|mesh-ancestor
2914736|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
2333334|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333335|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2333336|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2333337|NCT00417716|Growth Substances|growth substances|mesh-ancestor
2333338|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333339|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
2333340|NCT00417729|Acarbose|acarbose|mesh-list
2333341|NCT00417729|Glyburide|glyburide|mesh-list
2333342|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2333343|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333344|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333345|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2333346|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333347|NCT00417768|Plasminogen|plasminogen|mesh-list
2333348|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2333349|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2333350|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2333351|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333352|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2914737|NCT03273023|Chromium|chromium|mesh-list
2914738|NCT03273023|Everolimus|everolimus|mesh-list
2914739|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914740|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2914741|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
2914742|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914743|NCT03273023|Trace Elements|trace elements|mesh-ancestor
2914744|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
2333353|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2333354|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2333355|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2333356|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333357|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
2333358|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333359|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333360|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
2333361|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333362|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2110321|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2110322|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2110323|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
2110324|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110325|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110326|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
2110327|NCT02536313|Velpatasvir|velpatasvir|mesh-list
2110328|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
2110329|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110334|NCT02536664|Rituximab|rituximab|mesh-list
2333363|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333364|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333365|NCT00417833|Bevacizumab|bevacizumab|mesh-list
2333366|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2333367|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333368|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2333369|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2333370|NCT00417833|Growth Substances|growth substances|mesh-ancestor
2333371|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333372|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
2333373|NCT00417872|Metronidazole|metronidazole|mesh-list
2333374|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
2333375|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333376|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2333377|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2333378|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2333379|NCT00417898|Aspirin|aspirin|mesh-list
2333380|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2333381|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2333382|NCT00417898|Analgesics|analgesics|mesh-ancestor
2333383|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
2333384|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333385|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333386|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2333387|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2333388|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2333389|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2333390|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333391|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2333392|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2333393|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333394|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
2333395|NCT00417911|Bortezomib|bortezomib|mesh-list
2333396|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333397|NCT00417937|Azelaic acid|azelaic acid|mesh-list
2333398|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333399|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
2333400|NCT00417950|Acarbose|acarbose|mesh-list
2333401|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2333402|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333403|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333404|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2333405|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333406|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2333407|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
2333408|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
2333409|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
2333410|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333411|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
2333412|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110335|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2110336|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110337|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
2110338|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110339|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2110340|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2110341|NCT02536794|Durvalumab|durvalumab|mesh-list
2110342|NCT02536794|Ipilimumab|ipilimumab|mesh-list
2110343|NCT02536794|Tremelimumab|tremelimumab|mesh-list
2110344|NCT02536794|Antibodies|antibodies|mesh-list
2333413|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2333414|NCT00418067|Sirolimus|sirolimus|mesh-list
2333415|NCT00418067|Paclitaxel|paclitaxel|mesh-list
2333416|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2333417|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333418|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
2333419|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
2333420|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
2333421|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333422|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2333423|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333424|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2333425|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
2333426|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2333427|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
2333428|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333429|NCT00418080|Bicalutamide|bicalutamide|mesh-list
2914796|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2914797|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2914798|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914799|NCT03199040|Durvalumab|durvalumab|mesh-list
2914800|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914801|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914802|NCT03164616|Gemcitabine|gemcitabine|mesh-list
2914803|NCT03164616|Cisplatin|cisplatin|mesh-list
2914804|NCT03164616|Carboplatin|carboplatin|mesh-list
2914805|NCT03164616|Pemetrexed|pemetrexed|mesh-list
2914806|NCT03164616|Durvalumab|durvalumab|mesh-list
2914807|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2914808|NCT03164616|Tremelimumab|tremelimumab|mesh-list
2914809|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914810|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2914811|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
2914812|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914813|NCT03164616|Antiviral Agents|antiviral agents|mesh-ancestor
2914814|NCT03164616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2914815|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914816|NCT03164616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2914817|NCT03164616|Immunologic Factors|immunologic factors|mesh-ancestor
2914818|NCT03164616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914819|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2914820|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2914821|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914822|NCT03125928|Paclitaxel|paclitaxel|mesh-list
2914823|NCT03125928|Trastuzumab|trastuzumab|mesh-list
2914824|NCT03125928|Atezolizumab|atezolizumab|mesh-list
2914825|NCT03125928|Pertuzumab|pertuzumab|mesh-list
2914826|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2914827|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914828|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
2914829|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
2914830|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
2914831|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914832|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914833|NCT03086369|Gemcitabine|gemcitabine|mesh-list
2914834|NCT03086369|Paclitaxel|paclitaxel|mesh-list
2914835|NCT03086369|Olaratumab|olaratumab|mesh-list
2914836|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2333430|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
2914837|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914838|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
2914839|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
2914840|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
2914841|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914842|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2914843|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
2914844|NCT03086369|Antiviral Agents|antiviral agents|mesh-ancestor
2914845|NCT03086369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2914846|NCT03086369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914847|NCT03086369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2914848|NCT03086369|Immunologic Factors|immunologic factors|mesh-ancestor
2914849|NCT03086369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914850|NCT03081910|Cyclophosphamide|cyclophosphamide|mesh-list
2914851|NCT03081910|Fludarabine|fludarabine|mesh-list
2914852|NCT03081910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2914853|NCT03081910|Immunologic Factors|immunologic factors|mesh-ancestor
2333431|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
2333432|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2914854|NCT03081910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914855|NCT03081910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2914856|NCT03081910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2914857|NCT03081910|Alkylating Agents|alkylating agents|mesh-ancestor
2914858|NCT03081910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914859|NCT03081910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914860|NCT03081910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2914861|NCT03081858|Paclitaxel|paclitaxel|mesh-list
2914862|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2914863|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914864|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
2914865|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
2914866|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
2914867|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914868|NCT03053362|Vortioxetine|vortioxetine|mesh-list
2914869|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
2914870|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2914871|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2914872|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2914873|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2914874|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914875|NCT03053362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2914876|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2914877|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2914878|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914879|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333433|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333434|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333435|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
2333436|NCT00418119|Hematinics|hematinics|mesh-ancestor
2333437|NCT00418132|Thalidomide|thalidomide|mesh-list
2333438|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2333439|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
2333440|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333441|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
2333442|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2333443|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333444|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2333445|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2333446|NCT00418132|Growth Substances|growth substances|mesh-ancestor
2333447|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
2333448|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333449|NCT00418171|Olanzapine|olanzapine|mesh-list
2333450|NCT00418171|Ziprasidone|ziprasidone|mesh-list
2333451|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
2333452|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
2333453|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333454|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333455|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2333456|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2333457|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2333458|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2333459|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2333460|NCT00418171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2333461|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2333462|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2914880|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
2914881|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2914882|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2914883|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2914884|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2914885|NCT03022578|Lomustine|lomustine|mesh-list
2914886|NCT03022578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2914887|NCT03022578|Alkylating Agents|alkylating agents|mesh-ancestor
2333463|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333464|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333465|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
2333466|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2333467|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2333468|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
2333469|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
2333470|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2914888|NCT03022578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914889|NCT03022578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914890|NCT02906332|Dexamethasone|dexamethasone|mesh-list
2914891|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
2914892|NCT02906332|Lenalidomide|lenalidomide|mesh-list
2914893|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2914894|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
2914895|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
2914896|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2914897|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914898|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2914899|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
2914900|NCT02906332|Hormones|hormones|mesh-ancestor
2914901|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2914902|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2914903|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914904|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914905|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
2914906|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2914907|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2914908|NCT02906332|Growth Substances|growth substances|mesh-ancestor
2914909|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
2914910|NCT02890069|Everolimus|everolimus|mesh-list
2914911|NCT02890069|Panobinostat|panobinostat|mesh-list
2914912|NCT02890069|Spartalizumab|spartalizumab|mesh-list
2914913|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914914|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2914915|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
2914916|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914917|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2914918|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914919|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914920|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2914921|NCT02810418|Paclitaxel|paclitaxel|mesh-list
2914922|NCT02810418|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2914923|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2914924|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333471|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
2333472|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333473|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333474|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2333475|NCT00418249|Protective Agents|protective agents|mesh-ancestor
2333476|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2333477|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2333478|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333479|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333480|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
2333481|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333482|NCT00418275|Plasminogen|plasminogen|mesh-list
2333483|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2333484|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2333485|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333486|NCT00418288|Glucagon|glucagon|mesh-list
2914925|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
2914926|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
2914927|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
2914928|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914929|NCT02795988|Fluorouracil|fluorouracil|mesh-list
2914930|NCT02795988|Capecitabine|capecitabine|mesh-list
2914931|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
2914932|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914933|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
2914934|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914935|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2914936|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2914937|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
2914938|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914939|NCT02786329|Lidocaine|lidocaine|mesh-list
2914940|NCT02786329|Sevoflurane|sevoflurane|mesh-list
2914941|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
2914942|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
2914943|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2914944|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914945|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
2914946|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2914947|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2914948|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2914949|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2914950|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2914951|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914952|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2914953|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2914954|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
2914955|NCT02779855|Paclitaxel|paclitaxel|mesh-list
2333487|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2333488|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2333489|NCT00418288|Hormones|hormones|mesh-ancestor
2333490|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2333491|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333492|NCT00418288|Incretins|incretins|mesh-ancestor
2333493|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2914956|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2914957|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2914958|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914959|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
2914960|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
2914961|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
2914962|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914963|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2914964|NCT02731352|Apatinib|apatinib|mesh-list
2914965|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914966|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2914967|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914968|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914969|NCT02726659|Celecoxib|celecoxib|mesh-list
2914970|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2914971|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2914972|NCT02726659|Analgesics|analgesics|mesh-ancestor
2914973|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
2914974|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2914975|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914976|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2914977|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2914978|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2914979|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2914980|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2914981|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2914982|NCT02654132|Dexamethasone|dexamethasone|mesh-list
2914983|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
2914984|NCT02654132|Pomalidomide|pomalidomide|mesh-list
2914985|NCT02654132|Elotuzumab|elotuzumab|mesh-list
2914986|NCT02654132|BB 1101|bb 1101|mesh-list
2914987|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2914988|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
2914989|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
2914990|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2914991|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914992|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2333494|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333495|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2333496|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333497|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333498|NCT00418353|Dexamethasone|dexamethasone|mesh-list
2333499|NCT00418353|Betamethasone|betamethasone|mesh-list
2333500|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
2914993|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
2333501|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2333502|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
2333503|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
2333504|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2333505|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2333506|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
2333507|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
2333508|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333509|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2914994|NCT02654132|Hormones|hormones|mesh-ancestor
2914995|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2914996|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2914997|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2914998|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
2914999|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915000|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333510|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2333511|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
2333512|NCT00418353|Hormones|hormones|mesh-ancestor
2333513|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2333514|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2333515|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333516|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2333517|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
2333518|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2333519|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2333520|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2333521|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333522|NCT00418366|Incretins|incretins|mesh-ancestor
2333523|NCT00418366|Hormones|hormones|mesh-ancestor
2333524|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2915001|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
2915002|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2915003|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2915004|NCT02654132|Growth Substances|growth substances|mesh-ancestor
2915005|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
2333525|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2333526|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
2333527|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333528|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333529|NCT00418392|Minocycline|minocycline|mesh-list
2333530|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2333531|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333532|NCT00418431|Bevacizumab|bevacizumab|mesh-list
2333533|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2333534|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333535|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2110345|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
2110346|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2110347|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
2110348|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110349|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110350|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2110351|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110352|NCT02536833|Lorecivivint|lorecivivint|mesh-list
2110353|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2110354|NCT02536846|Olanzapine|olanzapine|mesh-list
2110355|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
2110356|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
2110357|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110358|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110359|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2110360|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2110361|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2110362|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2110363|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2110364|NCT02536846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2110365|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2114045|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
2333536|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2333537|NCT00418431|Growth Substances|growth substances|mesh-ancestor
2333538|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333539|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
2333540|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2333541|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2333542|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333543|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
2333544|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
2333545|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2333546|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2333547|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333548|NCT00418496|Aldesleukin|aldesleukin|mesh-list
2333549|NCT00418496|Sorafenib|sorafenib|mesh-list
2333550|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333551|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2333552|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333553|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333554|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2333555|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2333556|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
2333557|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333558|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
2333559|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
2333560|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2333561|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
2333562|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333563|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333564|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2333565|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
2333566|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2333567|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2915006|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2915007|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
2915008|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
2915009|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2915010|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
2915011|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2915012|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2110366|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2110367|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110368|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110369|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
2110370|NCT02536976|Mirabegron|mirabegron|mesh-list
2110371|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2110372|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2110373|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2110374|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
2110375|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110376|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110377|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110378|NCT02536976|Urological Agents|urological agents|mesh-ancestor
2110379|NCT02537015|Bimatoprost|bimatoprost|mesh-list
2110380|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2110381|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
2110382|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
2110383|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2110384|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110385|NCT02537873|Cocaine|cocaine|mesh-list
2110386|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
2110387|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
2110388|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2110389|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110390|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
2110391|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110392|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2110393|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2110394|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2110395|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2110396|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110397|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
2110398|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110399|NCT02537951|Lidocaine|lidocaine|mesh-list
2110400|NCT02537951|Prilocaine|prilocaine|mesh-list
2114046|NCT02596867|Propranolol|propranolol|mesh-list
2915013|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
2915014|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915015|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915016|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
2915017|NCT02625480|Fludarabine|fludarabine|mesh-list
2915018|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915019|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
2915020|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915021|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2915022|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2915023|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
2915024|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915025|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915026|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2333568|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2333569|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
2333570|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333571|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333572|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2333573|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
2333574|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2333575|NCT00418535|Cisplatin|cisplatin|mesh-list
2333576|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333577|NCT00418548|Etanercept|etanercept|mesh-list
2915027|NCT02603432|Avelumab|avelumab|mesh-list
2915028|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2915029|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2915030|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915031|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
2915032|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915033|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
2915034|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915035|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2915036|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915037|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915038|NCT02600923|Letrozole|letrozole|mesh-list
2915039|NCT02600923|Palbociclib|palbociclib|mesh-list
2915040|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915041|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2915042|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2915043|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915044|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915045|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2915046|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
2915047|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2915048|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915049|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2915050|NCT02488759|Nivolumab|nivolumab|mesh-list
2915051|NCT02488759|Ipilimumab|ipilimumab|mesh-list
2915052|NCT02488759|Daratumumab|daratumumab|mesh-list
2110401|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2110402|NCT02537951|Capsaicin|capsaicin|mesh-list
2110403|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
2110404|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
2110405|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2110406|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110407|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
2110408|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110409|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2110410|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2110411|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2110412|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2110413|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110414|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
2110415|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
2110416|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2110417|NCT02538016|Tolvaptan|tolvaptan|mesh-list
2110418|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2110419|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110420|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
2110421|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110422|NCT02538042|Nicotine|nicotine|mesh-list
2110423|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2915053|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2915054|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915055|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2915056|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915057|NCT02484664|Celecoxib|celecoxib|mesh-list
2915058|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2915059|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2915060|NCT02484664|Analgesics|analgesics|mesh-ancestor
2915061|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
2915062|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2915063|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915064|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2915065|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2333578|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2333579|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2333580|NCT00418548|Analgesics|analgesics|mesh-ancestor
2333581|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
2333582|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333583|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333584|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2333585|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2333586|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2333587|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2333588|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
2333589|NCT00418587|Vitamin D|vitamin d|mesh-list
2333590|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
2333591|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
2333592|NCT00418587|Vitamins|vitamins|mesh-list
2333593|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
2333594|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333595|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2333596|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2333597|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2333598|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
2333599|NCT00418600|Vitamins|vitamins|mesh-ancestor
2333600|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
2333601|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333602|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2333603|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2333604|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
2333605|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2915066|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2915067|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2915068|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915069|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915070|NCT02460900|Varenicline|varenicline|mesh-list
2915071|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2915072|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2915073|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
2915074|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2915075|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915076|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915077|NCT02428647|Zinc|zinc|mesh-list
2915078|NCT02428647|Trace Elements|trace elements|mesh-ancestor
2915079|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
2333606|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333607|NCT00418678|Nabilone|nabilone|mesh-list
2333608|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
2333609|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
2333610|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333611|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333612|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2333613|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2915080|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915081|NCT02371889|Topiramate|topiramate|mesh-list
2915082|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
2915083|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2915084|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915085|NCT02362451|Vaccines|vaccines|mesh-list
2915086|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
2915087|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915088|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
2915089|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915090|NCT02272803|Dexamethasone|dexamethasone|mesh-list
2915091|NCT02272803|Lenalidomide|lenalidomide|mesh-list
2915092|NCT02272803|Elotuzumab|elotuzumab|mesh-list
2915093|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2915094|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
2333614|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2333615|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2333616|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2333617|NCT00418704|Docetaxel|docetaxel|mesh-list
2333618|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2333619|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333620|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
2333621|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
2333622|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
2333623|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333624|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2333625|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333626|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
2333627|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
2333628|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915095|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
2915096|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2915097|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915098|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2915099|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
2915100|NCT02272803|Hormones|hormones|mesh-ancestor
2915101|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2915102|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2915103|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915104|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
2915105|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2915106|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2915107|NCT02272803|Growth Substances|growth substances|mesh-ancestor
2915108|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
2915109|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
2333629|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333630|NCT00418782|Naproxen|naproxen|mesh-list
2333631|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2333632|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2333633|NCT00418782|Analgesics|analgesics|mesh-ancestor
2333634|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
2333635|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333636|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915110|NCT02257424|Trametinib|trametinib|mesh-list
2915111|NCT02257424|Dabrafenib|dabrafenib|mesh-list
2915112|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
2915113|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2915114|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2333637|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2333638|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2333639|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
2333640|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2333641|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333642|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915115|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915116|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915117|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915118|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2915119|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915120|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2333643|NCT00418847|Miglustat|miglustat|mesh-list
2333644|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333645|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333646|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2333647|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2333648|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
2333649|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333650|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2333651|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2915149|NCT02186834|Dexamethasone|dexamethasone|mesh-list
2915150|NCT02186834|Doxorubicin|doxorubicin|mesh-list
2915151|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2915152|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2915153|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
2915154|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
2915155|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2915156|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915157|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2915158|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
2333652|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333653|NCT00418860|Aspirin|aspirin|mesh-list
2333654|NCT00418860|Clopidogrel|clopidogrel|mesh-list
2333655|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2333656|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2333657|NCT00418860|Analgesics|analgesics|mesh-ancestor
2915159|NCT02186834|Hormones|hormones|mesh-ancestor
2915160|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2333658|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
2333659|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333660|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333661|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2915161|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2915162|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915163|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2915164|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2915165|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2915166|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915167|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915168|NCT02059265|Dasatinib|dasatinib|mesh-list
2915169|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915170|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2915171|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915172|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915173|NCT02053246|Nebivolol|nebivolol|mesh-list
2915174|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2915175|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
2915176|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2915177|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2915178|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2915179|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
2915180|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2915181|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915182|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915183|NCT02034422|Antioxidants|antioxidants|mesh-list
2915184|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915185|NCT02034422|Protective Agents|protective agents|mesh-ancestor
2915186|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915187|NCT02003222|Cytarabine|cytarabine|mesh-list
2915188|NCT02003222|Dexamethasone|dexamethasone|mesh-list
2915189|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
2915190|NCT02003222|Prednisone|prednisone|mesh-list
2915191|NCT02003222|Cortisone|cortisone|mesh-list
2915192|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
2915193|NCT02003222|Rituximab|rituximab|mesh-list
2915194|NCT02003222|Methotrexate|methotrexate|mesh-list
2915195|NCT02003222|Etoposide|etoposide|mesh-list
2915196|NCT02003222|Vincristine|vincristine|mesh-list
2915197|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
2915198|NCT02003222|Daunorubicin|daunorubicin|mesh-list
2915199|NCT02003222|Asparaginase|asparaginase|mesh-list
2333662|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2333663|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2333664|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2333665|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333666|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2333667|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2333668|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333669|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
2333670|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2333671|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2915200|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
2915201|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
2915202|NCT02003222|Pegaspargase|pegaspargase|mesh-list
2915203|NCT02003222|Blinatumomab|blinatumomab|mesh-list
2915204|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2915205|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
2915206|NCT02003222|Antibodies|antibodies|mesh-list
2915207|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
2915208|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2915209|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2915210|NCT02003222|BB 1101|bb 1101|mesh-list
2915211|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915212|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
2915213|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915214|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2915215|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2915216|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
2915217|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333672|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2333673|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
2333674|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333675|NCT00418873|Risperidone|risperidone|mesh-list
2333676|NCT00418873|Zotepine|zotepine|mesh-list
2333677|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2333678|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
2333679|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333680|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333681|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333682|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2333683|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2333684|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2333685|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2333686|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2333687|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
2333688|NCT00418925|Dronabinol|dronabinol|mesh-list
2915218|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915219|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2915220|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2915221|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
2915222|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
2915223|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2915224|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2915225|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
2915226|NCT02003222|Hormones|hormones|mesh-ancestor
2915227|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2915228|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2915229|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
2915230|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915231|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2915232|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
2915233|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2915234|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2915235|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
2915236|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
2915237|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2915238|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2915239|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2110424|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
2110425|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110426|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110427|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2110428|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2110429|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
2110430|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110431|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915240|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2915241|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2915242|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
2915243|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915244|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
2915245|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
2915246|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
2915247|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2915248|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
2915249|NCT01988883|Propranolol|propranolol|mesh-list
2915250|NCT01988883|Modafinil|modafinil|mesh-list
2915251|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2915252|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2915253|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
2915254|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2915255|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915256|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915257|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2915258|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2915259|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
2915260|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2915261|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2333689|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
2333690|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333691|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2333692|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2333693|NCT00418925|Analgesics|analgesics|mesh-ancestor
2333694|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
2333695|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333696|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2333697|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2333698|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333699|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333700|NCT00418925|Hormones|hormones|mesh-ancestor
2333701|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2333702|NCT00419042|Gemcitabine|gemcitabine|mesh-list
2333703|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2333704|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2333705|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
2333706|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333707|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333708|NCT00419042|Antiviral Agents|antiviral agents|mesh-ancestor
2333709|NCT00419042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333710|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333711|NCT00419042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2333712|NCT00419042|Immunologic Factors|immunologic factors|mesh-ancestor
2333713|NCT00419042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333714|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2333715|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
2333716|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2333717|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333718|NCT00419068|Vitamins|vitamins|mesh-ancestor
2333719|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
2333720|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2333721|NCT00419146|Vitamins|vitamins|mesh-list
2333722|NCT00419146|Vitamin E|vitamin e|mesh-list
2333723|NCT00419146|Tocopherols|tocopherols|mesh-list
2333724|NCT00419146|Tocotrienols|tocotrienols|mesh-list
2333725|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
2333726|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2333727|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
2333728|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333729|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
2915262|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2915263|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2915264|NCT01955499|Lenalidomide|lenalidomide|mesh-list
2110432|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
2110433|NCT02538107|Hematinics|hematinics|mesh-ancestor
2110434|NCT02538354|Riboflavin|riboflavin|mesh-list
2110435|NCT02538354|Vitamins|vitamins|mesh-ancestor
2110436|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
2110437|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110438|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
2110439|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2110440|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
2110448|NCT02538614|Idelalisib|idelalisib|mesh-list
2110449|NCT02538614|BI 836826|bi 836826|mesh-list
2110450|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110451|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110452|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110453|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2110454|NCT02538666|Nivolumab|nivolumab|mesh-list
2110455|NCT02538666|Ipilimumab|ipilimumab|mesh-list
2333730|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333731|NCT00419146|Protective Agents|protective agents|mesh-ancestor
2333732|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2333733|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2333734|NCT00419172|Rifampin|rifampin|mesh-list
2333735|NCT00419172|Deferasirox|deferasirox|mesh-list
2333736|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2333737|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
2333738|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2333739|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333740|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
2333741|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2333742|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915265|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
2915266|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915267|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2915268|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2915269|NCT01955499|Growth Substances|growth substances|mesh-ancestor
2915270|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
2915271|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915272|NCT01945775|Talazoparib|talazoparib|mesh-list
2333743|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333744|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2110456|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2110457|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110458|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2110459|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110460|NCT02538679|Epinephrine|epinephrine|mesh-list
2110461|NCT02538679|Racepinephrine|racepinephrine|mesh-list
2110462|NCT02538679|Bupivacaine|bupivacaine|mesh-list
2110463|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
2110464|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
2110465|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
2110466|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2110467|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110468|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
2110469|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110470|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2110471|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2110472|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
2110473|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110474|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110475|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2110476|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2110477|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
2110478|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2110479|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
2110480|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
2110481|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
2110482|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2110483|NCT02538965|Lenalidomide|lenalidomide|mesh-list
2110484|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
2110485|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110486|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2110487|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2110488|NCT02538965|Growth Substances|growth substances|mesh-ancestor
2110489|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
2110490|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110491|NCT02539108|Vaccines|vaccines|mesh-list
2110492|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
2110493|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110494|NCT02539225|Paclitaxel|paclitaxel|mesh-list
2333745|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2333746|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2333747|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2110495|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
2110496|NCT02539225|Ramucirumab|ramucirumab|mesh-list
2110497|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2110498|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110499|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
2110500|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
2110501|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
2110502|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110503|NCT02539342|Calcium|calcium|mesh-list
2110504|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2110505|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110506|NCT02539368|Infliximab|infliximab|mesh-list
2110507|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
2110508|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2110509|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2110510|NCT02539459|Everolimus|everolimus|mesh-list
2110511|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110512|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915273|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2915274|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915275|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915276|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915277|NCT01886859|Lenalidomide|lenalidomide|mesh-list
2915278|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
2915279|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915280|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2915281|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2915282|NCT01886859|Growth Substances|growth substances|mesh-ancestor
2915283|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
2915284|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915285|NCT01858922|Cytarabine|cytarabine|mesh-list
2915286|NCT01858922|Dexamethasone|dexamethasone|mesh-list
2915287|NCT01858922|Prednisone|prednisone|mesh-list
2915288|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
2915289|NCT01858922|Cisplatin|cisplatin|mesh-list
2915290|NCT01858922|Doxorubicin|doxorubicin|mesh-list
2915291|NCT01858922|Etoposide|etoposide|mesh-list
2915292|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
2915293|NCT01858922|Vincristine|vincristine|mesh-list
2915294|NCT01858922|Bleomycin|bleomycin|mesh-list
2333748|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2333749|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2333750|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2333751|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
2333752|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
2333753|NCT00419250|Lenalidomide|lenalidomide|mesh-list
2333754|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
2333755|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333756|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2333757|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2333758|NCT00419250|Growth Substances|growth substances|mesh-ancestor
2333759|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
2333760|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333761|NCT00419302|Insulin|insulin|mesh-list
2333762|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2333763|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333764|NCT00419367|Vorinostat|vorinostat|mesh-list
2333765|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110513|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
2110514|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110515|NCT02539511|Ketamine|ketamine|mesh-list
2110516|NCT02539511|Analgesics|analgesics|mesh-ancestor
2110517|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
2110518|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110519|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110520|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2110521|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2110522|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
2110523|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
2110524|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2110525|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2110526|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2915295|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915296|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
2915297|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915298|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2915299|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2915300|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
2915301|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915302|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915303|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2915304|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2915305|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
2915306|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
2915307|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2915308|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2915309|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
2915310|NCT01858922|Hormones|hormones|mesh-ancestor
2915311|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2915312|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2915313|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915314|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2915315|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2915316|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2915317|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2915318|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2915319|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
2915320|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
2915321|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915322|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
2333766|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2333767|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333768|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333769|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
2333770|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
2333771|NCT00419471|Citalopram|citalopram|mesh-list
2333772|NCT00419471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2333773|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2333774|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2915323|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
2915324|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
2915340|NCT01781637|Omalizumab|omalizumab|mesh-list
2915341|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2110527|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110528|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110529|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2110530|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
2110531|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110532|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
2110533|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2110534|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2110535|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110536|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
2110537|NCT02540226|Coagulants|coagulants|mesh-ancestor
2110538|NCT02540265|Meloxicam|meloxicam|mesh-list
2110539|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2110540|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2110541|NCT02540265|Analgesics|analgesics|mesh-ancestor
2110542|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
2110543|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110544|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110545|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2110546|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2915342|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2333775|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915343|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
2915344|NCT01773278|Antioxidants|antioxidants|mesh-list
2915345|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915346|NCT01773278|Protective Agents|protective agents|mesh-ancestor
2915347|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915348|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
2915349|NCT01723839|Rituximab|rituximab|mesh-list
2915350|NCT01723839|Fludarabine|fludarabine|mesh-list
2915351|NCT01723839|Lenalidomide|lenalidomide|mesh-list
2915352|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915353|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
2915354|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915355|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2915356|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2915357|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
2915358|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915359|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915360|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2915361|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2915362|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2915363|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2915364|NCT01723839|Growth Substances|growth substances|mesh-ancestor
2915365|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
2110547|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2110548|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2110549|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110550|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110551|NCT02540356|Antibodies|antibodies|mesh-list
2110552|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
2110553|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
2110554|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110555|NCT02540668|Warfarin|warfarin|mesh-list
2110556|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
2110557|NCT02540954|Aflibercept|aflibercept|mesh-list
2110558|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2110559|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2110560|NCT02540954|Growth Substances|growth substances|mesh-ancestor
2110561|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110562|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
2110563|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110564|NCT02541409|Interferons|interferons|mesh-list
2110565|NCT02541409|Ribavirin|ribavirin|mesh-list
2110566|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
2110567|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
2110568|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2110569|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
2110570|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110571|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
2110572|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110573|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
2110574|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110575|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
2110576|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110577|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
2110578|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2110579|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
2110580|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110581|NCT02541422|Expectorants|expectorants|mesh-ancestor
2110582|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
2110583|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2110584|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
2110585|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110586|NCT02541422|Protective Agents|protective agents|mesh-ancestor
2110587|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110588|NCT02541422|Antidotes|antidotes|mesh-ancestor
2110589|NCT02541565|Prednisone|prednisone|mesh-list
2110590|NCT02541565|Cortisone|cortisone|mesh-list
2110591|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
2110592|NCT02541565|Rituximab|rituximab|mesh-list
2110593|NCT02541565|Doxorubicin|doxorubicin|mesh-list
2110594|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2110595|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
2110596|NCT02541565|Vincristine|vincristine|mesh-list
2110597|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2110598|NCT02541565|Antibodies|antibodies|mesh-list
2110599|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
2915366|NCT01711541|Paclitaxel|paclitaxel|mesh-list
2915367|NCT01711541|Cisplatin|cisplatin|mesh-list
2915368|NCT01711541|Carboplatin|carboplatin|mesh-list
2915369|NCT01711541|Fluorouracil|fluorouracil|mesh-list
2915370|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2915371|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
2915372|NCT01711541|Veliparib|veliparib|mesh-list
2915373|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2915374|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915375|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
2915376|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
2915377|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
2915378|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915379|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
2915380|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2915381|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915382|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
2915383|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915384|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
2915385|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915386|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2915387|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2333776|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333777|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
2333778|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333779|NCT00419471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2333780|NCT00419471|Antidepressive Agents|antidepressive agents|mesh-ancestor
2333781|NCT00419471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2333782|NCT00419484|Pioglitazone|pioglitazone|mesh-list
2333783|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2333784|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333785|NCT00419536|Panobinostat|panobinostat|mesh-list
2333786|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333787|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2333788|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333789|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110600|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2110601|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2110602|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
2110603|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110604|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2110605|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2110606|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
2110607|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110608|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110609|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2110610|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2110611|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2110612|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2110613|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110614|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2110615|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
2110616|NCT02541565|Hormones|hormones|mesh-ancestor
2110617|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2110618|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2110619|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2110620|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
2110621|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
2110622|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
2110623|NCT02541604|Atezolizumab|atezolizumab|mesh-list
2110624|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110625|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2110626|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2110627|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2110628|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110629|NCT02541864|Amoxicillin|amoxicillin|mesh-list
2110630|NCT02541864|Metronidazole|metronidazole|mesh-list
2110631|NCT02541864|Clarithromycin|clarithromycin|mesh-list
2110632|NCT02541864|Tetracycline|tetracycline|mesh-list
2110633|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
2110634|NCT02541864|Pantoprazole|pantoprazole|mesh-list
2110635|NCT02541864|Bismuth|bismuth|mesh-list
2110636|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2110637|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110638|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2110639|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2915388|NCT01670539|Triamcinolone|triamcinolone|mesh-list
2333790|NCT00419549|Valdecoxib|valdecoxib|mesh-list
2333791|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2333792|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2333793|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333794|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333795|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2333796|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2333797|NCT00419549|Analgesics|analgesics|mesh-ancestor
2333798|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
2333799|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333800|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333801|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2333802|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2333803|NCT00419601|Fentanyl|fentanyl|mesh-list
2110640|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2110641|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110642|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110643|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2110644|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2110645|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2110646|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2110647|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2110648|NCT02541864|Antacids|antacids|mesh-ancestor
2110649|NCT02541903|Afatinib|afatinib|mesh-list
2110650|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110651|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2110652|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110653|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110654|NCT02542150|Ethanol|ethanol|mesh-list
2110655|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2110656|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110657|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2110658|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110659|NCT02542410|Cabergoline|cabergoline|mesh-list
2110660|NCT02542410|Norethindrone|norethindrone|mesh-list
2110661|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
2110662|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2110663|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2110664|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2110665|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
2110666|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2110667|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110668|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2110669|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2110670|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2110671|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2110672|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
2110673|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
2110674|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110675|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110676|NCT02542462|Vaccines|vaccines|mesh-list
2110677|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
2110678|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110679|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
2110680|NCT02542605|Erenumab|erenumab|mesh-list
2110681|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2110682|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110683|NCT02542605|Analgesics|analgesics|mesh-ancestor
2110684|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
2110685|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110686|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110687|NCT02542605|Growth Substances|growth substances|mesh-ancestor
2110688|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
2110689|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110690|NCT02542631|Insulin|insulin|mesh-list
2110691|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2110692|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2110693|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110694|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
2110695|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2110696|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110697|NCT02542943|Fluorides|fluorides|mesh-list
2110698|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
2333804|NCT00419601|Remifentanil|remifentanil|mesh-list
2915389|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2915390|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
2915391|NCT01670539|Hormones|hormones|mesh-ancestor
2915392|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2915393|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915394|NCT01622868|Lapatinib|lapatinib|mesh-list
2915395|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915396|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2915397|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915398|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915399|NCT01552434|Sirolimus|sirolimus|mesh-list
2915400|NCT01552434|Bevacizumab|bevacizumab|mesh-list
2915401|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2915402|NCT01552434|Cetuximab|cetuximab|mesh-list
2915403|NCT01552434|Valproic Acid|valproic acid|mesh-list
2915404|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
2915405|NCT01552434|Antibodies|antibodies|mesh-list
2333805|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2333806|NCT00419601|Narcotics|narcotics|mesh-ancestor
2915406|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
2110699|NCT02542943|Protective Agents|protective agents|mesh-ancestor
2110700|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110701|NCT02543346|Cetirizine|cetirizine|mesh-list
2110702|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2110703|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2110704|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2110705|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
2110706|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
2110707|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110708|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110709|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110710|NCT02543658|Neostigmine|neostigmine|mesh-list
2110711|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2110712|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110713|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110714|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
2110715|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110716|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110717|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2110718|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
2110719|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110720|NCT02543801|Ketorolac|ketorolac|mesh-list
2110721|NCT02543801|Clonidine|clonidine|mesh-list
2110722|NCT02543801|Epinephrine|epinephrine|mesh-list
2110723|NCT02543801|Bupivacaine|bupivacaine|mesh-list
2110724|NCT02543801|Ropivacaine|ropivacaine|mesh-list
2110725|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
2110726|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
2110727|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2110728|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110729|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
2110730|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110731|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2110732|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2110733|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
2110734|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110735|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110736|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2110737|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2110738|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
2110739|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2110740|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
2110741|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
2110742|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
2110743|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2110744|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2110745|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2110746|NCT02543801|Analgesics|analgesics|mesh-ancestor
2110747|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2110748|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2110749|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2110750|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110751|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2110752|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
2110753|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2110754|NCT02543918|Ixekizumab|ixekizumab|mesh-list
2915407|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2333807|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2915408|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
2915409|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915410|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2915411|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2915412|NCT01552434|Growth Substances|growth substances|mesh-ancestor
2110755|NCT02543918|Vaccines|vaccines|mesh-list
2110756|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2110757|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
2110758|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110759|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
2110760|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
2110761|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2110762|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
2110763|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110764|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2110765|NCT02544152|Lubiprostone|lubiprostone|mesh-list
2110766|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2110767|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2110768|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110769|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
2110770|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
2110771|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110772|NCT02544217|Protective Agents|protective agents|mesh-ancestor
2110773|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110774|NCT02544321|Bromocriptine|bromocriptine|mesh-list
2110775|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2110776|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2110777|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
2110778|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2110779|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110780|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
2110781|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
2110782|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110783|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110784|NCT02544451|Ivacaftor|ivacaftor|mesh-list
2110785|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2110786|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2110787|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110788|NCT02544607|Ketamine|ketamine|mesh-list
2110789|NCT02544607|Analgesics|analgesics|mesh-ancestor
2110790|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
2110791|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110792|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110793|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2110794|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2110795|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
2110796|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
2110797|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2110798|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2110799|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2110800|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110801|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110802|NCT02544763|Cannabidiol|cannabidiol|mesh-list
2110803|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
2110804|NCT02544984|Azithromycin|azithromycin|mesh-list
2110805|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2110806|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110807|NCT02545075|Ipilimumab|ipilimumab|mesh-list
2110808|NCT02545075|Dacarbazine|dacarbazine|mesh-list
2110809|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2110810|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110811|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2110812|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110813|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2110814|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
2915413|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915414|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
2915415|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
2915416|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2915417|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915418|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2915419|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
2333808|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333809|NCT00419601|Analgesics|analgesics|mesh-ancestor
2333810|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
2333811|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333812|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2333813|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2915420|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915421|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915422|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
2915423|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915424|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
2915425|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2915426|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
2915427|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2915428|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2915429|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2915430|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
2915431|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
2915432|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2915433|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2110825|NCT02545504|Leucovorin|leucovorin|mesh-list
2110826|NCT02545504|Fluorouracil|fluorouracil|mesh-list
2110827|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
2110828|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
2110829|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110830|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2110831|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110832|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2110833|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
2110834|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110835|NCT02545504|Antidotes|antidotes|mesh-ancestor
2110836|NCT02545504|Protective Agents|protective agents|mesh-ancestor
2110837|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
2110838|NCT02545504|Vitamins|vitamins|mesh-ancestor
2110839|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
2110843|NCT02545907|Thalidomide|thalidomide|mesh-list
2110844|NCT02545907|Dexamethasone|dexamethasone|mesh-list
2110845|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2110846|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
2110847|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
2110848|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110849|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110850|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2110851|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
2110852|NCT02545907|Hormones|hormones|mesh-ancestor
2110853|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2110854|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2110855|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110856|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2110857|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
2110858|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
2110859|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2110860|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110861|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2110862|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2110863|NCT02545907|Growth Substances|growth substances|mesh-ancestor
2110864|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
2110865|NCT02545933|Aspirin|aspirin|mesh-list
2110866|NCT02545933|Ticagrelor|ticagrelor|mesh-list
2110867|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2110868|NCT02545933|Vorapaxar|vorapaxar|mesh-list
2110869|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2110870|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2110871|NCT02545933|Analgesics|analgesics|mesh-ancestor
2110872|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
2110873|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110874|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110875|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2110876|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2110877|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2110878|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2110879|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110880|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2915434|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915435|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915436|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915437|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2915438|NCT01416935|Amiodarone|amiodarone|mesh-list
2333814|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
2333815|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
2333816|NCT00419653|Haloperidol|haloperidol|mesh-list
2333817|NCT00419653|Olanzapine|olanzapine|mesh-list
2333818|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
2333819|NCT00419653|Amisulpride|amisulpride|mesh-list
2333820|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
2333821|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
2333822|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333823|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333824|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2333825|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2333826|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2333827|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2333828|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2333829|NCT00419653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2333830|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2333831|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2333832|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333833|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333834|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
2333835|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2333836|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
2333837|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2333838|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2333839|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
2333840|NCT00419692|Ropinirole|ropinirole|mesh-list
2110881|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2110882|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110883|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
2110884|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2110885|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2110886|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2110887|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
2110888|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110889|NCT02546193|Misoprostol|misoprostol|mesh-list
2110890|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2110891|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
2110892|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2110893|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110894|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2110895|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2110896|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
2110897|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2110898|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2110899|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2110900|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
2110901|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110902|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2110903|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2110904|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110905|NCT02546570|Oxytocin|oxytocin|mesh-list
2110906|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
2110907|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2110908|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110909|NCT02546765|Acetaminophen|acetaminophen|mesh-list
2110910|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
2110911|NCT02546765|Propofol|propofol|mesh-list
2110912|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2110913|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2110914|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110915|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2110916|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
2110917|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
2110918|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2110919|NCT02546765|Analgesics|analgesics|mesh-ancestor
2110920|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
2110921|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110922|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2110923|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2110924|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2110925|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
2915439|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2915440|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
2915441|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2915442|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2915443|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915444|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2915445|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2915446|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2915447|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915448|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2915449|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2915450|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2915451|NCT01371981|Cytarabine|cytarabine|mesh-list
2915452|NCT01371981|Etoposide|etoposide|mesh-list
2915453|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
2915454|NCT01371981|Daunorubicin|daunorubicin|mesh-list
2915455|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
2915456|NCT01371981|Bortezomib|bortezomib|mesh-list
2915457|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
2915458|NCT01371981|Sorafenib|sorafenib|mesh-list
2915459|NCT01371981|Asparaginase|asparaginase|mesh-list
2915460|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2110926|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2110927|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110928|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
2110938|NCT02547012|Amoxicillin|amoxicillin|mesh-list
2110939|NCT02547012|Levofloxacin|levofloxacin|mesh-list
2110940|NCT02547012|Ofloxacin|ofloxacin|mesh-list
2110941|NCT02547012|Tetracycline|tetracycline|mesh-list
2110942|NCT02547012|Esomeprazole|esomeprazole|mesh-list
2110943|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2110944|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110945|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2110946|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2110947|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2110948|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110949|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110950|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2110951|NCT02547012|Renal Agents|renal agents|mesh-ancestor
2110952|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2110953|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2110954|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110955|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2110956|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2110957|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2110958|NCT02547038|Amoxicillin|amoxicillin|mesh-list
2110959|NCT02547038|Metronidazole|metronidazole|mesh-list
2110960|NCT02547038|Clarithromycin|clarithromycin|mesh-list
2110961|NCT02547038|Tetracycline|tetracycline|mesh-list
2110962|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
2110963|NCT02547038|Pantoprazole|pantoprazole|mesh-list
2110964|NCT02547038|Bismuth|bismuth|mesh-list
2110965|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2110966|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2110967|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2110968|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2110969|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2110970|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2110971|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2110972|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2110973|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2110974|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2110975|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2110976|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2110977|NCT02547038|Antacids|antacids|mesh-ancestor
2110978|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2915461|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915462|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2915463|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2915464|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915465|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915466|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2915467|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
2915468|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
2915469|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915470|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915471|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
2915472|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915473|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2915474|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2915475|NCT01371981|Analgesics|analgesics|mesh-ancestor
2915476|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
2915477|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110979|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2110980|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2110981|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
2110982|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110983|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
2110984|NCT02547454|Hematinics|hematinics|mesh-ancestor
2110985|NCT02547623|Dexamethasone|dexamethasone|mesh-list
2110986|NCT02547623|Prednisolone|prednisolone|mesh-list
2110987|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2110988|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
2110989|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
2110990|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2110991|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2110992|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2110993|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
2110994|NCT02547623|Hormones|hormones|mesh-ancestor
2110995|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2110996|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2110997|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2110998|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2110999|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
2111000|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111001|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2111002|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2111003|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
2111004|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2111005|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2111006|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
2111007|NCT02547935|Saxagliptin|saxagliptin|mesh-list
2111008|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2111009|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111010|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2111011|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111012|NCT02547935|Incretins|incretins|mesh-ancestor
2111013|NCT02547935|Hormones|hormones|mesh-ancestor
2111014|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2111015|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2111016|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
2111017|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111018|NCT02547974|Vaccines|vaccines|mesh-list
2111019|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
2111020|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111021|NCT02547987|Carboplatin|carboplatin|mesh-list
2111022|NCT02547987|Docetaxel|docetaxel|mesh-list
2111023|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111024|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
2111025|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
2111026|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
2111027|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111028|NCT02548078|Vaccines|vaccines|mesh-list
2111029|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
2111030|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111031|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2111032|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2111033|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
2111034|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2111035|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111036|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2915478|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
2915479|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
2915480|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
2915481|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
2915482|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
2915483|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
2915484|NCT01351909|Veliparib|veliparib|mesh-list
2915485|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915486|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
2915487|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915488|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2915489|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2915490|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
2915491|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915492|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915493|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2915494|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2915495|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915496|NCT01351896|Lenalidomide|lenalidomide|mesh-list
2915497|NCT01351896|Vaccines|vaccines|mesh-list
2915498|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2915499|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
2111037|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2111038|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2111039|NCT02548650|Aspirin|aspirin|mesh-list
2111040|NCT02548650|Clopidogrel|clopidogrel|mesh-list
2111041|NCT02548650|Vorapaxar|vorapaxar|mesh-list
2111042|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2111043|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2111044|NCT02548650|Analgesics|analgesics|mesh-ancestor
2111045|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
2111046|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111047|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111048|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2111049|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2111050|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2111051|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2111052|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111053|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2111054|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2111055|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111056|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
2111057|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2111058|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2111059|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2111060|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
2111061|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111062|NCT02548728|Oxytocin|oxytocin|mesh-list
2111063|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
2111064|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2111065|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111066|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
2111067|NCT02548910|Citric Acid|citric acid|mesh-list
2111068|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
2111069|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2111070|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
2111071|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
2111072|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111073|NCT02548962|Dexamethasone|dexamethasone|mesh-list
2111074|NCT02548962|Pomalidomide|pomalidomide|mesh-list
2111075|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2111076|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
2111077|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
2111078|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111079|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111080|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2111081|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
2111082|NCT02548962|Hormones|hormones|mesh-ancestor
2111083|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2111084|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2111085|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111086|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
2111087|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2111088|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2111089|NCT02548962|Growth Substances|growth substances|mesh-ancestor
2111090|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
2915500|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915501|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2915502|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2915503|NCT01351896|Growth Substances|growth substances|mesh-ancestor
2915504|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
2915505|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915506|NCT01196390|Paclitaxel|paclitaxel|mesh-list
2915507|NCT01196390|Carboplatin|carboplatin|mesh-list
2915508|NCT01196390|Trastuzumab|trastuzumab|mesh-list
2915509|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2915510|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2915511|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2915512|NCT01196390|Antibodies|antibodies|mesh-list
2915513|NCT01196390|Immunoglobulins|immunoglobulins|mesh-list
2915514|NCT01196390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2915515|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2915516|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915517|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
2915518|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
2915519|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
2915520|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915521|NCT01196390|Immunologic Factors|immunologic factors|mesh-ancestor
2333841|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2333842|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2333843|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
2333844|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
2333845|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333846|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333847|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333848|NCT00419718|Insulin|insulin|mesh-list
2333849|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2333850|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2333851|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333852|NCT00419731|Naltrexone|naltrexone|mesh-list
2111105|NCT02549196|Donepezil|donepezil|mesh-list
2111106|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
2111107|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2111108|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111109|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111110|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
2111111|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111112|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111113|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
2111114|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2111115|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2111116|NCT02549196|Urological Agents|urological agents|mesh-ancestor
2111117|NCT02549209|Paclitaxel|paclitaxel|mesh-list
2111118|NCT02549209|Carboplatin|carboplatin|mesh-list
2111119|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
2111120|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2111121|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111122|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
2111123|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
2111124|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
2111125|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111126|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2111127|NCT02549573|Apomorphine|apomorphine|mesh-list
2111128|NCT02549573|Emetics|emetics|mesh-ancestor
2111129|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111130|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
2111131|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333853|NCT00419731|Bupropion|bupropion|mesh-list
2333854|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2333855|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2333856|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333857|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
2111132|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2111133|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
2111134|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
2111135|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111136|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111137|NCT02550106|Omalizumab|omalizumab|mesh-list
2111138|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2111139|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2111140|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
2111141|NCT02550197|Vaccines|vaccines|mesh-list
2111142|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
2111143|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111144|NCT02550288|Atorvastatin|atorvastatin|mesh-list
2111145|NCT02550288|Ezetimibe|ezetimibe|mesh-list
2111146|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2111147|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2111148|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
2111149|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111150|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2111151|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2111152|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111178|NCT02550743|Capecitabine|capecitabine|mesh-list
2111179|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2111180|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
2111181|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111182|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111183|NCT02550795|Dexamethasone|dexamethasone|mesh-list
2111184|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
2111185|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2111186|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
2111187|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
2111188|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111189|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111190|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2111191|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
2111192|NCT02550795|Hormones|hormones|mesh-ancestor
2111193|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2111194|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2111195|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111196|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2111197|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2111198|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2111199|NCT02550795|Analgesics|analgesics|mesh-ancestor
2111200|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
2111201|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2111202|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2915522|NCT01196390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915523|NCT01046825|Leucovorin|leucovorin|mesh-list
2915524|NCT01046825|Folic Acid|folic acid|mesh-list
2915525|NCT01046825|Cytarabine|cytarabine|mesh-list
2111203|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2111204|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
2111205|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111206|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111207|NCT02551055|Paclitaxel|paclitaxel|mesh-list
2111208|NCT02551055|Docetaxel|docetaxel|mesh-list
2111209|NCT02551055|Serabelisib|serabelisib|mesh-list
2111210|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2111211|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111212|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
2111213|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
2111214|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
2111215|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111216|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111217|NCT02551094|Colchicine|colchicine|mesh-list
2111218|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
2111219|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2111220|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
2111221|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
2111222|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
2111223|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111224|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111225|NCT02551159|Carboplatin|carboplatin|mesh-list
2111226|NCT02551159|Fluorouracil|fluorouracil|mesh-list
2111227|NCT02551159|Cetuximab|cetuximab|mesh-list
2111228|NCT02551159|Durvalumab|durvalumab|mesh-list
2111229|NCT02551159|Tremelimumab|tremelimumab|mesh-list
2111230|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2111231|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111232|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
2111233|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111234|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2111235|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2111236|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
2111237|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111238|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2111239|NCT02551432|Paclitaxel|paclitaxel|mesh-list
2111240|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
2111241|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2111242|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111243|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
2111244|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
2111245|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
2111246|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111247|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2111248|NCT02551692|Nicotine|nicotine|mesh-list
2111249|NCT02551692|Varenicline|varenicline|mesh-list
2111250|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2111251|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
2111252|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111253|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111254|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2111255|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2111256|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
2111257|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111258|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111259|NCT02551731|Cannabidiol|cannabidiol|mesh-list
2111260|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
2111261|NCT02551744|Pantoprazole|pantoprazole|mesh-list
2111262|NCT02551744|Famotidine|famotidine|mesh-list
2111263|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2111264|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
2111265|NCT02551744|Histamine|histamine|mesh-list
2111266|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2111267|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2111268|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111269|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111270|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
2111271|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
2111272|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111273|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111274|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
2111275|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
2915526|NCT01046825|Prednisone|prednisone|mesh-list
2333858|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111276|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111277|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111278|NCT02551874|Metformin|metformin|mesh-list
2111279|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
2111280|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
2111281|NCT02551874|Saxagliptin|saxagliptin|mesh-list
2111282|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2111283|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111284|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2111285|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111286|NCT02551874|Incretins|incretins|mesh-ancestor
2111287|NCT02551874|Hormones|hormones|mesh-ancestor
2111288|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2111289|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2111290|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
2111291|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111292|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
2111293|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2111294|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111295|NCT02552147|Nicotine|nicotine|mesh-list
2111296|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2111297|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
2111298|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111299|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111300|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2111301|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2111302|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
2111303|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111304|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111305|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
2111306|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2111307|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
2111308|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111309|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2111310|NCT02552225|Amitriptyline|amitriptyline|mesh-list
2111311|NCT02552225|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2111312|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2111313|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
2111314|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2111315|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2111316|NCT02552225|Analgesics|analgesics|mesh-ancestor
2111317|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
2111318|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111319|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111320|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2111321|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2111322|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2111323|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111324|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
2111325|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111326|NCT02552225|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2111327|NCT02552225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2111328|NCT02552225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2111329|NCT02552303|Modafinil|modafinil|mesh-list
2111330|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2111331|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111332|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2111333|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2111334|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2111335|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111336|NCT02552355|Metformin|metformin|mesh-list
2111337|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2111338|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111339|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
2111340|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2111341|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111342|NCT02553629|Rocuronium|rocuronium|mesh-list
2111343|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2111344|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2111345|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2111346|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2915527|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
2915528|NCT01046825|Doxorubicin|doxorubicin|mesh-list
2915529|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2915530|NCT01046825|Rituximab|rituximab|mesh-list
2915531|NCT01046825|Rasburicase|rasburicase|mesh-list
2915532|NCT01046825|Lenograstim|lenograstim|mesh-list
2915533|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
2915534|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2915535|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
2915536|NCT01046825|Hormones|hormones|mesh-ancestor
2915537|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2915538|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915539|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2915540|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111347|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111348|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2111349|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2111350|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2111351|NCT02553772|Laxatives|laxatives|mesh-ancestor
2111352|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2111353|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
2111354|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2111355|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2111356|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2111357|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
2111358|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111359|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111360|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111361|NCT02553928|Memantine|memantine|mesh-list
2111362|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2111363|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2111364|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
2111365|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111366|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111367|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111368|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2111369|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2111370|NCT02554279|Menotropins|menotropins|mesh-list
2111371|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2111372|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
2111373|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2111374|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111375|NCT02554721|Aspirin|aspirin|mesh-list
2111376|NCT02554721|Cilostazol|cilostazol|mesh-list
2111377|NCT02554721|Clopidogrel|clopidogrel|mesh-list
2111378|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2111379|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2111380|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2111381|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2111382|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
2111383|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111384|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111385|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111386|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2111387|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2111388|NCT02554721|Analgesics|analgesics|mesh-ancestor
2111389|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
2111390|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111391|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2111392|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2111393|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2111394|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2111395|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2111396|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111397|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
2111398|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2111399|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
2111400|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2111401|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
2111402|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
2111403|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2111404|NCT02554721|Protective Agents|protective agents|mesh-ancestor
2111405|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2111406|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2915541|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2915542|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
2915543|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915544|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2915545|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2915546|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
2915547|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915548|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2915549|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2915550|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2915551|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2915552|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915553|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2915554|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2915555|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
2915556|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
2915557|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915558|NCT01046825|Antidotes|antidotes|mesh-ancestor
2915559|NCT01046825|Protective Agents|protective agents|mesh-ancestor
2915560|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
2915561|NCT01046825|Vitamins|vitamins|mesh-ancestor
2915562|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
2915563|NCT01046825|Hematinics|hematinics|mesh-ancestor
2915564|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
2915565|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
2915566|NCT01019356|Acarbose|acarbose|mesh-list
2915567|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2915568|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915569|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2915570|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915571|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915572|NCT00980538|Etravirine|etravirine|mesh-list
2333859|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2333860|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
2333861|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2333862|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2333863|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2333864|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2333865|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333866|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
2333867|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333868|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2333869|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2333870|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333871|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
2333872|NCT00419783|Ketoconazole|ketoconazole|mesh-list
2333873|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2333874|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333875|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2333876|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2333877|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333878|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333879|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333880|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915573|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2915574|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2915575|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915576|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915577|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
2915578|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915579|NCT00980460|Sirolimus|sirolimus|mesh-list
2915580|NCT00980460|Cisplatin|cisplatin|mesh-list
2915581|NCT00980460|Doxorubicin|doxorubicin|mesh-list
2915582|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2915583|NCT00980460|Fluorouracil|fluorouracil|mesh-list
2915584|NCT00980460|Irinotecan|irinotecan|mesh-list
2915585|NCT00980460|Vincristine|vincristine|mesh-list
2915586|NCT00980460|Camptothecin|camptothecin|mesh-list
2915587|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
2915588|NCT00980460|Razoxane|razoxane|mesh-list
2915589|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
2915590|NCT00980460|Liver Extracts|liver extracts|mesh-list
2915591|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915592|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2915593|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2915594|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2915595|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915596|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915597|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
2915598|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2915599|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915600|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
2915601|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915602|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2915603|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2915604|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
2915605|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
2915606|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
2915607|NCT00980460|Hematinics|hematinics|mesh-ancestor
2915608|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2915609|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915610|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
2915611|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2915612|NCT00980460|Protective Agents|protective agents|mesh-ancestor
2333881|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
2333882|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2333883|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2333884|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2333885|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
2333886|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2333887|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2333888|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
2333889|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2333890|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2333891|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333892|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333893|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2333894|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2333895|NCT00419796|Analgesics|analgesics|mesh-ancestor
2333896|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
2333897|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2333898|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333899|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2333900|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2333901|NCT00419835|Losartan|losartan|mesh-list
2333902|NCT00419835|Enalapril|enalapril|mesh-list
2333903|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2333904|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2333905|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2333906|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2333907|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333908|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2333909|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
2333910|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333911|NCT00419848|Azithromycin|azithromycin|mesh-list
2333912|NCT00419848|Doxycycline|doxycycline|mesh-list
2333913|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2333914|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333915|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
2915623|NCT00602641|Thalidomide|thalidomide|mesh-list
2915624|NCT00602641|Prednisone|prednisone|mesh-list
2915625|NCT00602641|Cortisone|cortisone|mesh-list
2915626|NCT00602641|Lenalidomide|lenalidomide|mesh-list
2915627|NCT00602641|Melphalan|melphalan|mesh-list
2915628|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
2915629|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2915630|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2915631|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
2915632|NCT00602641|Hormones|hormones|mesh-ancestor
2915633|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2915634|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915635|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2915636|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915637|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
2915638|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2915639|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2915640|NCT00602641|Growth Substances|growth substances|mesh-ancestor
2915641|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
2915642|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2915643|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
2915644|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915645|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2915646|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915647|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
2915648|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2915649|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915675|NCT00576654|Irinotecan|irinotecan|mesh-list
2915676|NCT00576654|Camptothecin|camptothecin|mesh-list
2915677|NCT00576654|Veliparib|veliparib|mesh-list
2915678|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2333916|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2333917|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2333918|NCT00419887|Vildagliptin|vildagliptin|mesh-list
2333919|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2333920|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333921|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2333922|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
2333923|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333924|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333925|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2333926|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2333927|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
2333928|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333929|NCT00419991|Tigecycline|tigecycline|mesh-list
2333930|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2333931|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333932|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2333933|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333934|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333935|NCT00420030|Abciximab|abciximab|mesh-list
2333936|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
2333937|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2333938|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
2333939|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333940|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2333941|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333942|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333943|NCT00420082|Cetirizine|cetirizine|mesh-list
2333944|NCT00420082|Fexofenadine|fexofenadine|mesh-list
2915679|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2915680|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915681|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915682|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333945|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2333946|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2333947|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2333948|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
2333949|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
2333950|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333951|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915683|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2915684|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2915685|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
2915686|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2333952|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333953|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2333954|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2333955|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
2333956|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
2333957|NCT00420355|Ritonavir|ritonavir|mesh-list
2333958|NCT00420355|Lopinavir|lopinavir|mesh-list
2333959|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2333960|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2333961|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2333962|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
2333963|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333964|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333965|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2333966|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2333967|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
2915687|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333968|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333969|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2333970|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2333971|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
2333972|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2333973|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333974|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2333975|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
2333976|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2333977|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2333978|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333979|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333980|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2333981|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2333982|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2333983|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2333984|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333985|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
2333986|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2333987|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2333988|NCT00420524|Epothilone B|epothilone b|mesh-list
2333989|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2333990|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
2333991|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
2333992|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
2915688|NCT05202730|Anesthetics|anesthetics|mesh-list
2915689|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
2915690|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2915691|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915692|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
2915693|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2915694|NCT05202665|Fluorides|fluorides|mesh-list
2915695|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
2915696|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
2915697|NCT05202665|Protective Agents|protective agents|mesh-ancestor
2915698|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915699|NCT05202561|Vaccines|vaccines|mesh-list
2915700|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
2915701|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915702|NCT05202496|Calcitriol|calcitriol|mesh-list
2915703|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2915704|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915705|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2915706|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2915707|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915708|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2915709|NCT05202496|Vitamins|vitamins|mesh-ancestor
2915710|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
2915711|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2333993|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2333994|NCT00420537|Cyclosporine|cyclosporine|mesh-list
2333995|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
2333996|NCT00420537|Everolimus|everolimus|mesh-list
2333997|NCT00420537|Cyclosporins|cyclosporins|mesh-list
2333998|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2333999|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334000|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334001|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
2334002|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334003|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
2915712|NCT05202353|Liraglutide|liraglutide|mesh-list
2915713|NCT05202353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2915714|NCT05202353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915715|NCT05202353|Incretins|incretins|mesh-ancestor
2915716|NCT05202353|Hormones|hormones|mesh-ancestor
2915717|NCT05202353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2915718|NCT05202288|Vaccines|vaccines|mesh-list
2915719|NCT05202288|Immunologic Factors|immunologic factors|mesh-ancestor
2915720|NCT05202288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915721|NCT05202275|Olanzapine|olanzapine|mesh-list
2915722|NCT05202275|Aprepitant|aprepitant|mesh-list
2915723|NCT05202275|Palonosetron|palonosetron|mesh-list
2915724|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
2915725|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
2915726|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2915727|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334004|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334005|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
2334006|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2334007|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2334008|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334009|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2334010|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2334011|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
2334012|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2334013|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
2334014|NCT00420563|Megestrol|megestrol|mesh-list
2334015|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334016|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
2334017|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334018|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2334019|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2334020|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
2334021|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334022|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334023|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2334024|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2334025|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2334026|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2334027|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
2915728|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2334028|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2334029|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2334030|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2334031|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2334032|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
2334033|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2334034|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2334035|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334036|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334037|NCT00420589|Hormones|hormones|mesh-ancestor
2915729|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2915730|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2915731|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2915732|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2915733|NCT05202275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2915734|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2915735|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2915736|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915737|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2915738|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
2915739|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2915740|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2915741|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2915742|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2915743|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2915744|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
2915745|NCT05202158|Gentamicins|gentamicins|mesh-list
2915746|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2915747|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915748|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2915749|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915750|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915751|NCT05202145|Cyclosporine|cyclosporine|mesh-list
2915752|NCT05202145|Tacrolimus|tacrolimus|mesh-list
2915753|NCT05202145|Cyclosporins|cyclosporins|mesh-list
2915754|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915755|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
2915756|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915757|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2915758|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915759|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915760|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
2915761|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915762|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
2915763|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2915764|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
2915765|NCT05202080|Narcotics|narcotics|mesh-ancestor
2915766|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2915767|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915768|NCT05202080|Analgesics|analgesics|mesh-ancestor
2915769|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
2915770|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2915771|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2334038|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2334039|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334040|NCT00420615|Epothilone B|epothilone b|mesh-list
2334041|NCT00420615|Epothilones|epothilones|mesh-list
2334042|NCT00420615|Omeprazole|omeprazole|mesh-list
2334043|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2334044|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2334045|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2334046|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334047|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334048|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915772|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2915773|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
2915774|NCT05202002|Hormones|hormones|mesh-ancestor
2915775|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2915776|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915777|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2915778|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915779|NCT05201859|Capecitabine|capecitabine|mesh-list
2915780|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2915781|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
2915782|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915783|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915784|NCT05201846|Insulin|insulin|mesh-list
2915785|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2915786|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2915787|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915788|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
2915789|NCT05201638|Calcium|calcium|mesh-list
2915790|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2915791|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915792|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2915793|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
2915794|NCT05201612|Olaparib|olaparib|mesh-list
2915795|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2915796|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915797|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2915798|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915799|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915800|NCT05201560|Fentanyl|fentanyl|mesh-list
2915801|NCT05201560|Butorphanol|butorphanol|mesh-list
2334049|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
2334050|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
2334051|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
2334052|NCT00420654|Hormones|hormones|mesh-list
2334053|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2334054|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334055|NCT00420667|Enoxaparin|enoxaparin|mesh-list
2334056|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
2334057|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2334058|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2915802|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2915803|NCT05201560|Narcotics|narcotics|mesh-ancestor
2915804|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2915805|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915806|NCT05201560|Analgesics|analgesics|mesh-ancestor
2915807|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
2915808|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2915809|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2915810|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2915811|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
2915812|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
2915813|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
2915814|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
2915815|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2915816|NCT05201547|Paclitaxel|paclitaxel|mesh-list
2915817|NCT05201547|Carboplatin|carboplatin|mesh-list
2915818|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2915819|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915820|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
2915821|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
2915822|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
2915823|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915824|NCT05201430|Capecitabine|capecitabine|mesh-list
2915825|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
2915826|NCT05201430|Irinotecan|irinotecan|mesh-list
2915827|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2915828|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
2915829|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915830|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915831|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2915832|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2915833|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915834|NCT05201352|Trifluridine|trifluridine|mesh-list
2915835|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
2915836|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915837|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
2915838|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915839|NCT05201326|Bevacizumab|bevacizumab|mesh-list
2915840|NCT05201326|Irinotecan|irinotecan|mesh-list
2915841|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2915842|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915843|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2334059|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334060|NCT00420693|Sevoflurane|sevoflurane|mesh-list
2334061|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2334062|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2334063|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
2334064|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
2334065|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2334066|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334067|NCT00420797|Phenylephrine|phenylephrine|mesh-list
2334068|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
2334069|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2334070|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
2915844|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2915845|NCT05201326|Growth Substances|growth substances|mesh-ancestor
2915846|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334071|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
2334072|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334073|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334074|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
2334075|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2915847|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
2915848|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2915849|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2915850|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915851|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915852|NCT05201313|Lidocaine|lidocaine|mesh-list
2915853|NCT05201313|Mepivacaine|mepivacaine|mesh-list
2915854|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
2915855|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
2915856|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2915857|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915858|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
2915859|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2915860|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2915861|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2915862|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2915863|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2915864|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915865|NCT05201300|Propofol|propofol|mesh-list
2915866|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2915867|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2915868|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915869|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2915870|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
2915871|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
2915872|NCT05201248|Prednisone|prednisone|mesh-list
2915873|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
2915874|NCT05201248|Rituximab|rituximab|mesh-list
2915875|NCT05201248|Doxorubicin|doxorubicin|mesh-list
2915876|NCT05201248|Vincristine|vincristine|mesh-list
2915877|NCT05201248|Lenalidomide|lenalidomide|mesh-list
2334076|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
2334077|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
2915878|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915879|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
2915880|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915881|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2915882|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2915883|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
2915884|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915885|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915886|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2915887|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2915888|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2915889|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2915890|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2915891|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915892|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2915893|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
2915894|NCT05201248|Hormones|hormones|mesh-ancestor
2915895|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2915896|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2915897|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2915898|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
2915899|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
2915900|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
2915901|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2915902|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2915903|NCT05201248|Growth Substances|growth substances|mesh-ancestor
2915904|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
2915905|NCT05201183|Fludarabine|fludarabine|mesh-list
2915906|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915908|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
2334078|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2334079|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2334080|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2334081|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
2334082|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334083|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334084|NCT00420797|Protective Agents|protective agents|mesh-ancestor
2334085|NCT00420836|Tobramycin|tobramycin|mesh-list
2334086|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2334087|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334088|NCT00420888|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2334089|NCT00420888|Immunoconjugates|immunoconjugates|mesh-list
2334090|NCT00420888|Immunologic Factors|immunologic factors|mesh-ancestor
2334091|NCT00420888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334092|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
2334093|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
2334094|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2334095|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2334096|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334097|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334098|NCT00420901|Urological Agents|urological agents|mesh-ancestor
2334099|NCT00420953|Amiodarone|amiodarone|mesh-list
2334100|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2334101|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
2334102|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2334103|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2334104|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334105|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2334106|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2334107|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2334108|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334109|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2334110|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2334111|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2334112|NCT00421018|Montelukast|montelukast|mesh-list
2334113|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2334114|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
2334115|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2334116|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
2334117|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2334118|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915909|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
2915910|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2915911|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2915912|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915913|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915914|NCT05201144|Urological Agents|urological agents|mesh-ancestor
2915915|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
2915916|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2915917|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915918|NCT05201066|Azacitidine|azacitidine|mesh-list
2915919|NCT05201066|Decitabine|decitabine|mesh-list
2915920|NCT05201066|Venetoclax|venetoclax|mesh-list
2915921|NCT05201066|Spartalizumab|spartalizumab|mesh-list
2915922|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2915923|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
2915924|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915925|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915926|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915927|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2915928|NCT05201001|Carboplatin|carboplatin|mesh-list
2915929|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915930|NCT05200988|Nivolumab|nivolumab|mesh-list
2915931|NCT05200988|Ipilimumab|ipilimumab|mesh-list
2334119|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2334120|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2334121|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334122|NCT00421044|Epothilone B|epothilone b|mesh-list
2334123|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915932|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2915933|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915934|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2915935|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915936|NCT05200884|Lidocaine|lidocaine|mesh-list
2915937|NCT05200884|Carticaine|carticaine|mesh-list
2915938|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
2915939|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
2915940|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2915941|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915942|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
2915943|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2915944|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2915945|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2915946|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2915947|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2915948|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915949|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2334124|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
2334125|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
2334126|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
2334127|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334128|NCT00421083|Tadalafil|tadalafil|mesh-list
2334129|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
2334130|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2334131|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2334132|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334133|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334134|NCT00421083|Urological Agents|urological agents|mesh-ancestor
2334135|NCT00421096|Gemcitabine|gemcitabine|mesh-list
2334136|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334137|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2915950|NCT05200793|Metformin|metformin|mesh-list
2915951|NCT05200793|Empagliflozin|empagliflozin|mesh-list
2915952|NCT05200793|Linagliptin|linagliptin|mesh-list
2915953|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2915954|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915955|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2915956|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915957|NCT05200793|Incretins|incretins|mesh-ancestor
2915958|NCT05200793|Hormones|hormones|mesh-ancestor
2915959|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2915960|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2915961|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
2334138|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
2334139|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334140|NCT00421096|Antiviral Agents|antiviral agents|mesh-ancestor
2334141|NCT00421096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334142|NCT00421096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334143|NCT00421096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334144|NCT00421096|Immunologic Factors|immunologic factors|mesh-ancestor
2334145|NCT00421096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334146|NCT00421109|Levocetirizine|levocetirizine|mesh-list
2334147|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2915962|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915963|NCT05200663|Tamoxifen|tamoxifen|mesh-list
2915964|NCT05200663|Vitamin E|vitamin e|mesh-list
2915965|NCT05200663|Vitamins|vitamins|mesh-ancestor
2915966|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
2915967|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2915968|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2915969|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
2915970|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2915971|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2915972|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2915973|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2915974|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2334148|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2334149|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
2334150|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
2334151|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334152|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334153|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334154|NCT00421122|Budesonide|budesonide|mesh-list
2334155|NCT00421122|Terbutaline|terbutaline|mesh-list
2334156|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
2334157|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2334158|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2334159|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2334160|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
2915975|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2915976|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
2915977|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915978|NCT05200663|Protective Agents|protective agents|mesh-ancestor
2915979|NCT05198531|Gemcitabine|gemcitabine|mesh-list
2915980|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334161|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334162|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334163|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2334164|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
2334165|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
2334166|NCT00421122|Hormones|hormones|mesh-ancestor
2334167|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2334168|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2334169|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2334170|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2334171|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
2334172|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334173|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334174|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
2334175|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
2334176|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2334177|NCT00421187|Amphotericin B|amphotericin b|mesh-list
2334178|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2334179|NCT00421187|Amebicides|amebicides|mesh-ancestor
2334180|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2915981|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2915982|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
2915983|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2915984|NCT05198531|Antiviral Agents|antiviral agents|mesh-ancestor
2915985|NCT05198531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2915986|NCT05198531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2915987|NCT05198531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2915988|NCT05198531|Immunologic Factors|immunologic factors|mesh-ancestor
2915989|NCT05198531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334181|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2334182|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334183|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2334184|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
2334185|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2334186|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2334187|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
2334188|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
2334189|NCT00421252|Clopidogrel|clopidogrel|mesh-list
2334190|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2334191|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2334192|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2334193|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2334194|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
2334195|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2915997|NCT05184192|Gabapentin|gabapentin|mesh-list
2915998|NCT05184192|Analgesics|analgesics|mesh-ancestor
2915999|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
2916000|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916001|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916002|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
2916003|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2334196|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334197|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334198|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
2334199|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334200|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2334201|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334202|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334203|NCT00421369|Sertraline|sertraline|mesh-list
2334204|NCT00421369|Reboxetine|reboxetine|mesh-list
2334205|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
2334206|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2334207|NCT00421369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2334208|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2334209|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2334210|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334211|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334212|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
2334213|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334214|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2334215|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
2916004|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2916005|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2916006|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2916007|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2916008|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2916009|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2916010|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916011|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
2916012|NCT05180214|Ketorolac|ketorolac|mesh-list
2916013|NCT05180214|Bupivacaine|bupivacaine|mesh-list
2916014|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
2916015|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
2916016|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2916017|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916018|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
2916019|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916020|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2916021|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2916022|NCT05180214|Analgesics|analgesics|mesh-ancestor
2916023|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2916024|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2916025|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2916026|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916027|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916028|NCT05179668|Empagliflozin|empagliflozin|mesh-list
2916029|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2916030|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916031|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2916032|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916033|NCT05171972|Ofatumumab|ofatumumab|mesh-list
2916034|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916035|NCT05170893|Ubiquinone|ubiquinone|mesh-list
2916036|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
2916037|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
2916038|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916039|NCT05170893|Vitamins|vitamins|mesh-ancestor
2334216|NCT00421395|Epratuzumab|epratuzumab|mesh-list
2334217|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2334218|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916043|NCT05159427|Glipizide|glipizide|mesh-list
2916044|NCT05159427|Rifaximin|rifaximin|mesh-list
2916045|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2916046|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2916047|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2916048|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2916049|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916050|NCT05158374|Aspirin|aspirin|mesh-list
2916051|NCT05158374|Metformin|metformin|mesh-list
2916052|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2916053|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916054|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2916055|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2916056|NCT05158374|Analgesics|analgesics|mesh-ancestor
2916057|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
2916058|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916059|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2916060|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2916061|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2916062|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2916063|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916064|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2916065|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2916066|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916067|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
2334219|NCT00421421|Dutasteride|dutasteride|mesh-list
2334220|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2334221|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2916082|NCT05147272|Gemcitabine|gemcitabine|mesh-list
2916083|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2916084|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
2916085|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916086|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916087|NCT05147272|Antiviral Agents|antiviral agents|mesh-ancestor
2916088|NCT05147272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2916089|NCT05147272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916090|NCT05147272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916091|NCT05147272|Immunologic Factors|immunologic factors|mesh-ancestor
2334222|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334223|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334224|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
2334225|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2334226|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334227|NCT00421434|Ribavirin|ribavirin|mesh-list
2334228|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2334229|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
2334230|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
2334231|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
2334232|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334233|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
2334234|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334235|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
2334236|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334237|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2334238|NCT00421447|Anastrozole|anastrozole|mesh-list
2334239|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2334240|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334241|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2334242|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2916092|NCT05147272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916093|NCT05139017|Gemcitabine|gemcitabine|mesh-list
2916094|NCT05139017|Rituximab|rituximab|mesh-list
2916095|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
2916096|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2916097|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916098|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916099|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
2916100|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916101|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2916102|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2916103|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
2916104|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916105|NCT05139017|Antiviral Agents|antiviral agents|mesh-ancestor
2916106|NCT05139017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2916107|NCT05139017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916108|NCT05139017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916109|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2916110|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
2916111|NCT05115110|Risdiplam|risdiplam|mesh-list
2916112|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2916113|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916114|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916115|NCT05108454|Micronutrients|micronutrients|mesh-list
2916116|NCT05108454|Trace Elements|trace elements|mesh-list
2916117|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916126|NCT05102162|Meropenem|meropenem|mesh-list
2916127|NCT05102162|Tazobactam|tazobactam|mesh-list
2916128|NCT05102162|Piperacillin|piperacillin|mesh-list
2916129|NCT05102162|Cefepime|cefepime|mesh-list
2916130|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2916131|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2916132|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2916133|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2916134|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916135|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916136|NCT05095961|Prednisone|prednisone|mesh-list
2916137|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2916138|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
2916139|NCT05095961|Hormones|hormones|mesh-ancestor
2916140|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2916141|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334243|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334244|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334245|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2334246|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
2334247|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2334248|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334249|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
2334250|NCT00421460|Testosterone|testosterone|mesh-list
2334251|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
2334252|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
2334253|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2334254|NCT00421460|Androgens|androgens|mesh-ancestor
2334255|NCT00421460|Hormones|hormones|mesh-ancestor
2916142|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2916143|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916144|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
2916145|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2916146|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
2916147|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2916148|NCT05074121|Expectorants|expectorants|mesh-ancestor
2916149|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
2916150|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2916151|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
2916152|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916153|NCT05074121|Protective Agents|protective agents|mesh-ancestor
2334256|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2334257|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334258|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2334259|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334260|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
2334261|NCT00421473|Atovaquone|atovaquone|mesh-list
2334262|NCT00421473|Proguanil|proguanil|mesh-list
2334263|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2334264|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334265|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
2916154|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916155|NCT05074121|Antidotes|antidotes|mesh-ancestor
2916156|NCT05069012|Morphine|morphine|mesh-list
2916157|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2916158|NCT05069012|Narcotics|narcotics|mesh-ancestor
2916159|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2916160|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916161|NCT05069012|Analgesics|analgesics|mesh-ancestor
2916162|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
2916163|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334266|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2334267|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2334268|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334269|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334270|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
2334271|NCT00421512|Bevacizumab|bevacizumab|mesh-list
2334272|NCT00421512|Sunitinib|sunitinib|mesh-list
2334273|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2334274|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916164|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
2916165|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2916166|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
2916167|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916168|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916169|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2916170|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
2916171|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2334275|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2334276|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2334277|NCT00421512|Growth Substances|growth substances|mesh-ancestor
2334278|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334279|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
2334280|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2334281|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334282|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334283|NCT00421538|Nadroparin|nadroparin|mesh-list
2334284|NCT00421538|Calcium|calcium|mesh-list
2334285|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2334286|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334287|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
2334288|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2334289|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2334290|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334291|NCT00421551|Ritonavir|ritonavir|mesh-list
2334292|NCT00421551|Darunavir|darunavir|mesh-list
2334293|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2334294|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2334295|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
2334296|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334297|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334298|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2334299|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2334300|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
2334301|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334302|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2334303|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2334304|NCT00421642|Adalimumab|adalimumab|mesh-list
2334305|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2916172|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
2916173|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916174|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2916175|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2334306|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2334307|NCT00421694|Bicalutamide|bicalutamide|mesh-list
2334308|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
2334309|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
2916176|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
2916177|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
2916178|NCT05052229|Protective Agents|protective agents|mesh-ancestor
2916184|NCT05050162|Cisplatin|cisplatin|mesh-list
2916185|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
2334310|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2916186|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334311|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334312|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334313|NCT00421720|Sufentanil|sufentanil|mesh-list
2334314|NCT00421720|Remifentanil|remifentanil|mesh-list
2334315|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2916187|NCT05049343|Ketamine|ketamine|mesh-list
2916188|NCT05049343|Analgesics|analgesics|mesh-ancestor
2916189|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
2334316|NCT00421720|Narcotics|narcotics|mesh-ancestor
2334317|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2334318|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334319|NCT00421720|Analgesics|analgesics|mesh-ancestor
2334320|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
2334321|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334322|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2334323|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2334324|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
2334325|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
2916190|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916191|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916192|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2916193|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2916194|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
2916195|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
2916196|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2916197|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2916198|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2334326|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
2334327|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2334328|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
2334329|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334330|NCT00421785|Expectorants|expectorants|mesh-ancestor
2334331|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
2334332|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2334333|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
2334334|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334335|NCT00421785|Protective Agents|protective agents|mesh-ancestor
2334336|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334337|NCT00421785|Antidotes|antidotes|mesh-ancestor
2334338|NCT00421811|Melphalan|melphalan|mesh-list
2334339|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2334340|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
2334341|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334342|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334343|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2334344|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334345|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
2334346|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334347|NCT00421824|Capecitabine|capecitabine|mesh-list
2916199|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2916200|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916201|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2916202|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2916203|NCT05041322|Buspirone|buspirone|mesh-list
2916204|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2916205|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2916206|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2916207|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916208|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2916209|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2916210|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
2916211|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2916212|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916213|NCT05040568|Vidarabine|vidarabine|mesh-list
2916214|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
2916215|NCT05040568|Fludarabine|fludarabine|mesh-list
2916216|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
2916217|NCT05040568|Cetuximab|cetuximab|mesh-list
2916218|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916219|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
2916220|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916221|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2916222|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2916223|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
2334348|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
2334349|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2334350|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
2334351|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334352|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334353|NCT00421863|Amlodipine|amlodipine|mesh-list
2334354|NCT00421863|Telmisartan|telmisartan|mesh-list
2334355|NCT00421863|Clonidine|clonidine|mesh-list
2334356|NCT00421863|Ramipril|ramipril|mesh-list
2334357|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2334358|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2334359|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2916224|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916225|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916226|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2916227|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2916228|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
2916229|NCT05040568|Antiviral Agents|antiviral agents|mesh-ancestor
2916230|NCT05040568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2916231|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916232|NCT05036278|Factor VIII|factor viii|mesh-list
2916233|NCT05036278|Coagulants|coagulants|mesh-ancestor
2334360|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334361|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2334362|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334363|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
2334364|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2334365|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2334366|NCT00421863|Analgesics|analgesics|mesh-ancestor
2334367|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
2334368|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334369|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
2334370|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
2916250|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2916251|NCT05028673|Antacids|antacids|mesh-list
2916252|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
2916253|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2916254|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
2916255|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916256|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916257|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2334371|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2334372|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2334373|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2916279|NCT05023512|Vaccines|vaccines|mesh-list
2916280|NCT05023512|Immunologic Factors|immunologic factors|mesh-ancestor
2916281|NCT05023512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916282|NCT05018273|Atezolizumab|atezolizumab|mesh-list
2916283|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916290|NCT05010122|Decitabine|decitabine|mesh-list
2916291|NCT05010122|Venetoclax|venetoclax|mesh-list
2916292|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2916293|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
2916294|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916295|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916296|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334374|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
2334375|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334376|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2334377|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
2334378|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334379|NCT00421915|Etanercept|etanercept|mesh-list
2334380|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2334381|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2334382|NCT00421915|Analgesics|analgesics|mesh-ancestor
2334383|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
2334384|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334385|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334386|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2334387|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2334388|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2334389|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334390|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
2916300|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2916301|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2916302|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916303|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916304|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2334391|NCT00421967|Ketorolac|ketorolac|mesh-list
2334392|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2334393|NCT00421967|Epinephrine|epinephrine|mesh-list
2334394|NCT00421967|Racepinephrine|racepinephrine|mesh-list
2334395|NCT00421967|Ropivacaine|ropivacaine|mesh-list
2334396|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
2334397|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
2334398|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
2334399|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2334400|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334401|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
2334402|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334403|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2334404|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2334405|NCT00421967|Analgesics|analgesics|mesh-ancestor
2334406|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2334407|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2916305|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2916306|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916307|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
2916308|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2916309|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
2916310|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2916311|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2916312|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334408|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2334409|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334410|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334411|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2334412|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2334413|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
2334414|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334415|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2334416|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2334417|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
2334418|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2334419|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
2334420|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
2334421|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
2334422|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2334423|NCT00421980|Etanercept|etanercept|mesh-list
2334424|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2334425|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2334426|NCT00421980|Analgesics|analgesics|mesh-ancestor
2334427|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
2334428|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334429|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334430|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2334431|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2334432|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2334433|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334434|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
2334435|NCT00422019|Rilotumumab|rilotumumab|mesh-list
2334436|NCT00422019|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2334437|NCT00422019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916313|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
2916314|NCT04996368|Coagulants|coagulants|mesh-ancestor
2916315|NCT04983407|Gemcitabine|gemcitabine|mesh-list
2916316|NCT04983407|Paclitaxel|paclitaxel|mesh-list
2916317|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2916318|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916319|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
2916320|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
2916321|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
2916322|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916323|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2916324|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
2916325|NCT04983407|Antiviral Agents|antiviral agents|mesh-ancestor
2916326|NCT04983407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2916327|NCT04983407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916328|NCT04983407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916329|NCT04983407|Immunologic Factors|immunologic factors|mesh-ancestor
2916330|NCT04983407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916337|NCT04956640|Cetuximab|cetuximab|mesh-list
2916338|NCT04956640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2916339|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2334438|NCT00422019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334439|NCT00422019|Immunologic Factors|immunologic factors|mesh-ancestor
2334440|NCT00422019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334441|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2334442|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
2334443|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2334444|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2334445|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2334446|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2334447|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334448|NCT00422175|Siponimod|siponimod|mesh-list
2334449|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2334450|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334451|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334452|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
2916340|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916341|NCT04956640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2916342|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916343|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916344|NCT04952779|Insulin|insulin|mesh-list
2916345|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2916346|NCT04952779|Liraglutide|liraglutide|mesh-list
2916347|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
2916348|NCT04952779|Xultophy|xultophy|mesh-list
2334453|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334454|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
2334455|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2334456|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2334457|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2334458|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
2334459|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2334460|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2334461|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2334462|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2334463|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334464|NCT00422240|Adapalene|adapalene|mesh-list
2334465|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
2334466|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2334467|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
2334468|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2334469|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2916349|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2916350|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916351|NCT04952779|Incretins|incretins|mesh-ancestor
2916352|NCT04952779|Hormones|hormones|mesh-ancestor
2916353|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2916354|NCT04941755|Famotidine|famotidine|mesh-list
2916355|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2916356|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2916357|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2916358|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
2916359|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
2916360|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2916361|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916362|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916363|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
2916364|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916365|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334470|NCT00422240|Analgesics|analgesics|mesh-ancestor
2334471|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
2334472|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334473|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334474|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2334475|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2916416|NCT04933227|Capecitabine|capecitabine|mesh-list
2916417|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
2916418|NCT04933227|Atezolizumab|atezolizumab|mesh-list
2916419|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2916420|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
2916421|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916422|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916423|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
2916424|NCT04931641|Trace Elements|trace elements|mesh-ancestor
2916425|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
2916426|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334476|NCT00422318|Benzbromarone|benzbromarone|mesh-list
2334477|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
2334478|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
2334479|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2334480|NCT00422318|Renal Agents|renal agents|mesh-ancestor
2334481|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
2334482|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
2334483|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2334484|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334485|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334486|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
2334487|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2334488|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2334489|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334490|NCT00422344|Sunitinib|sunitinib|mesh-list
2334491|NCT00422344|Everolimus|everolimus|mesh-list
2334492|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334493|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2916450|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2334494|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2334495|NCT00422344|Growth Substances|growth substances|mesh-ancestor
2334496|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334497|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
2334498|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2916451|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
2334499|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916452|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916453|NCT04878627|Cannabidiol|cannabidiol|mesh-list
2916454|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
2916455|NCT04872426|Insulin|insulin|mesh-list
2916456|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2334500|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334501|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334502|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
2334503|NCT00422396|Fenofibrate|fenofibrate|mesh-list
2334504|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2334505|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
2334506|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334507|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2334508|NCT00422435|Paclitaxel|paclitaxel|mesh-list
2334509|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2334510|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334511|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
2334512|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
2334513|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
2334514|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334515|NCT00422526|Progesterone|progesterone|mesh-list
2334516|NCT00422526|Progestins|progestins|mesh-ancestor
2334517|NCT00422526|Hormones|hormones|mesh-ancestor
2334518|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2334519|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334520|NCT00422565|Sirolimus|sirolimus|mesh-list
2334521|NCT00422565|Paclitaxel|paclitaxel|mesh-list
2334522|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2334523|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334524|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
2334525|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
2334526|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
2334527|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334528|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2334529|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2916457|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916458|NCT04856176|Paclitaxel|paclitaxel|mesh-list
2916459|NCT04856176|Carboplatin|carboplatin|mesh-list
2916460|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
2916461|NCT04856176|Pemetrexed|pemetrexed|mesh-list
2916462|NCT04856176|Molgramostim|molgramostim|mesh-list
2334530|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2334531|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
2334532|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334533|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
2334534|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334535|NCT00422578|Tadalafil|tadalafil|mesh-list
2334536|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
2334537|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2334538|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2334539|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334540|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334541|NCT00422578|Urological Agents|urological agents|mesh-ancestor
2334542|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
2334543|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2916463|NCT04856176|Sargramostim|sargramostim|mesh-list
2916464|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2916465|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916466|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
2916467|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
2916468|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
2916469|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916470|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916471|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916472|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2916473|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2916474|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
2916475|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916476|NCT04853043|Cetuximab|cetuximab|mesh-list
2916477|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916478|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916479|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
2916480|NCT04848337|Lenvatinib|lenvatinib|mesh-list
2916481|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916482|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334544|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2916483|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2916484|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916485|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916492|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
2916493|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916494|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916495|NCT04832854|Gemcitabine|gemcitabine|mesh-list
2916496|NCT04832854|Paclitaxel|paclitaxel|mesh-list
2916497|NCT04832854|Carboplatin|carboplatin|mesh-list
2916498|NCT04832854|Pemetrexed|pemetrexed|mesh-list
2916499|NCT04832854|Atezolizumab|atezolizumab|mesh-list
2916500|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2916501|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916502|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
2916503|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
2916504|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
2916505|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916506|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2916507|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
2916508|NCT04832854|Antiviral Agents|antiviral agents|mesh-ancestor
2916509|NCT04832854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2916510|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916511|NCT04832854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916512|NCT04832854|Immunologic Factors|immunologic factors|mesh-ancestor
2916513|NCT04832854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916514|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2916515|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2916516|NCT04815902|Losartan|losartan|mesh-list
2916517|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2916518|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2916519|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2916520|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2916521|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916522|NCT04804644|Memantine|memantine|mesh-list
2916523|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2916524|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2916525|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
2916526|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2916527|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916528|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916529|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2916530|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2916531|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
2916532|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2916533|NCT04800627|Pevonedistat|pevonedistat|mesh-list
2916534|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916535|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334545|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
2334546|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334547|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334548|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2916536|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334549|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
2334550|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
2334551|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2334552|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
2334553|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2916573|NCT04792073|Avelumab|avelumab|mesh-list
2916574|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916575|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916576|NCT04785820|Nivolumab|nivolumab|mesh-list
2916577|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916578|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916579|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2916580|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916581|NCT04782687|Dexamethasone|dexamethasone|mesh-list
2916582|NCT04782687|Lenalidomide|lenalidomide|mesh-list
2916583|NCT04782687|Daratumumab|daratumumab|mesh-list
2916584|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2916585|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
2916586|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
2916587|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916588|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916589|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2916590|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
2916591|NCT04782687|Hormones|hormones|mesh-ancestor
2916592|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2916593|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2916594|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916595|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
2916596|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2916597|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2916598|NCT04782687|Growth Substances|growth substances|mesh-ancestor
2916599|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
2334554|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334555|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2334556|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2334557|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2334558|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
2334559|NCT00422617|Alefacept|alefacept|mesh-list
2334560|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
2334561|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
2334562|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334563|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
2334564|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2334565|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
2334566|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334567|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
2334568|NCT00422643|Protective Agents|protective agents|mesh-ancestor
2334569|NCT00422682|Gemcitabine|gemcitabine|mesh-list
2334570|NCT00422682|Paclitaxel|paclitaxel|mesh-list
2334571|NCT00422682|Carboplatin|carboplatin|mesh-list
2334572|NCT00422682|Temozolomide|temozolomide|mesh-list
2334573|NCT00422682|Topotecan|topotecan|mesh-list
2334574|NCT00422682|Iniparib|iniparib|mesh-list
2334575|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2334576|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334577|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
2334578|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
2334579|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
2334580|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334581|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2334582|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
2334583|NCT00422682|Antiviral Agents|antiviral agents|mesh-ancestor
2334584|NCT00422682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334585|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334586|NCT00422682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916624|NCT04742673|Guanfacine|guanfacine|mesh-list
2916625|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2916626|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2916627|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2916628|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2916629|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
2916630|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2916631|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916632|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916633|NCT04740931|Aflibercept|aflibercept|mesh-list
2916634|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2916635|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2916636|NCT04740931|Growth Substances|growth substances|mesh-ancestor
2916637|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916638|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
2916639|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916640|NCT04740905|Aflibercept|aflibercept|mesh-list
2916641|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2916642|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2334587|NCT00422682|Immunologic Factors|immunologic factors|mesh-ancestor
2334588|NCT00422682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334589|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2334590|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
2334591|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2334592|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2334593|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2334594|NCT00422708|Anesthetics|anesthetics|mesh-list
2334595|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2334596|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334597|NCT00422773|Cetuximab|cetuximab|mesh-list
2334598|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916643|NCT04740905|Growth Substances|growth substances|mesh-ancestor
2916644|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916645|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
2916646|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916647|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
2916648|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916649|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
2916650|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916651|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2334599|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334600|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
2334601|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916680|NCT04734990|Azacitidine|azacitidine|mesh-list
2916681|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2916682|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
2916683|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916684|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916685|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916690|NCT04718181|Omeprazole|omeprazole|mesh-list
2916691|NCT04718181|Risdiplam|risdiplam|mesh-list
2916692|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2916693|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2916694|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2916695|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916696|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916697|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2334602|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2334603|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334604|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334605|NCT00422864|Leucovorin|leucovorin|mesh-list
2334606|NCT00422864|Fluorouracil|fluorouracil|mesh-list
2334607|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
2334608|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
2334609|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334610|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2334611|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111407|NCT02554786|Fluticasone|fluticasone|mesh-list
2111408|NCT02554786|Xhance|xhance|mesh-list
2111409|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
2111410|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2111411|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2111412|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2111413|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
2111414|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916698|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916699|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916700|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
2916701|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916702|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916703|NCT04704271|Dronabinol|dronabinol|mesh-list
2916704|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
2916705|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916706|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2916707|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2916708|NCT04704271|Analgesics|analgesics|mesh-ancestor
2111415|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916709|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
2334612|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334613|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
2334614|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334615|NCT00422864|Antidotes|antidotes|mesh-ancestor
2334616|NCT00422864|Protective Agents|protective agents|mesh-ancestor
2334617|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
2334618|NCT00422864|Vitamins|vitamins|mesh-ancestor
2916710|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916711|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2916712|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2916713|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2916714|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916715|NCT04704271|Hormones|hormones|mesh-ancestor
2916716|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2916717|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
2916718|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916719|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916720|NCT04665843|Atezolizumab|atezolizumab|mesh-list
2916721|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916722|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
2916723|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2916724|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916725|NCT04641975|Mirabegron|mirabegron|mesh-list
2916726|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2916727|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2916728|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2916729|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
2916730|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2916731|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916732|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916733|NCT04641975|Urological Agents|urological agents|mesh-ancestor
2916746|NCT04630730|Gemcitabine|gemcitabine|mesh-list
2916747|NCT04630730|Atezolizumab|atezolizumab|mesh-list
2916748|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
2916749|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916750|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2916751|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
2916752|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916753|NCT04630730|Antiviral Agents|antiviral agents|mesh-ancestor
2916754|NCT04630730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2916755|NCT04630730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916756|NCT04630730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916757|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
2916758|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916759|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2916797|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
2334619|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
2334620|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
2334621|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2334622|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334623|NCT00422994|Ropinirole|ropinirole|mesh-list
2334624|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2334625|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2334626|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
2334627|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
2334628|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334629|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334630|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334631|NCT00423007|Bromfenac|bromfenac|mesh-list
2334632|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2334633|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2334634|NCT00423007|Analgesics|analgesics|mesh-ancestor
2334635|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
2334636|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334637|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334638|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2334639|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2334640|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
2334641|NCT00423020|Hematinics|hematinics|mesh-ancestor
2334642|NCT00423059|Bevacizumab|bevacizumab|mesh-list
2916798|NCT04623944|Fludarabine|fludarabine|mesh-list
2916799|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916800|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
2916801|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916802|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2916803|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2916804|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
2916805|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916806|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916807|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2916808|NCT04604782|Regadenoson|regadenoson|mesh-list
2916809|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2916810|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2916811|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
2916812|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
2334643|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2334644|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334645|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2334646|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2334647|NCT00423059|Growth Substances|growth substances|mesh-ancestor
2334648|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334649|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
2334650|NCT00423163|Voriconazole|voriconazole|mesh-list
2334651|NCT00423163|Micafungin|micafungin|mesh-list
2334652|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
2334653|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334654|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2334655|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2334656|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334657|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334658|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2334659|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
2916813|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2916814|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916815|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916816|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
2916817|NCT04596033|Fludarabine|fludarabine|mesh-list
2916818|NCT04596033|Interleukin-2|interleukin-2|mesh-list
2916819|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916820|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
2916821|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916822|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2916823|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2334660|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2334661|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334662|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2334663|NCT00423202|Ambrisentan|ambrisentan|mesh-list
2334664|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2916824|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
2916825|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916826|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916827|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2916828|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2916829|NCT04596033|Analgesics|analgesics|mesh-ancestor
2916830|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
2916831|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916832|NCT04586023|Teriflunomide|teriflunomide|mesh-list
2916833|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2916834|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2916835|NCT04586023|Analgesics|analgesics|mesh-ancestor
2916836|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
2916837|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916838|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916839|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2916840|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2916841|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916842|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
2916843|NCT04586010|Teriflunomide|teriflunomide|mesh-list
2916844|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2916845|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2916846|NCT04586010|Analgesics|analgesics|mesh-ancestor
2916847|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
2334665|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
2334666|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2334667|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334668|NCT00423228|Donepezil|donepezil|mesh-list
2334669|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2334670|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334671|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334672|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
2334673|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334674|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334675|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
2334676|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
2334677|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2334678|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
2334679|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334680|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
2334681|NCT00423371|Protective Agents|protective agents|mesh-ancestor
2334682|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
2334683|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2334684|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334685|NCT00423397|Interferons|interferons|mesh-list
2334686|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
2334687|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
2334688|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2334689|NCT00423397|Gefitinib|gefitinib|mesh-list
2334690|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334691|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
2334692|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334693|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
2334694|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334695|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2334696|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916848|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916849|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916850|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2916851|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2334697|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334698|NCT00423475|Goserelin|goserelin|mesh-list
2334699|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2334700|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334701|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2334702|NCT00423501|Incretins|incretins|mesh-ancestor
2334703|NCT00423501|Hormones|hormones|mesh-ancestor
2334704|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2334705|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916852|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916853|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
2916854|NCT04582669|Triamcinolone|triamcinolone|mesh-list
2916855|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2916856|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2916857|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2916858|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2916859|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
2916860|NCT04582669|Hormones|hormones|mesh-ancestor
2916861|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2916862|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916863|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916864|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
2916865|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916866|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916867|NCT04578652|Metformin|metformin|mesh-list
2916868|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2916869|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334706|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
2334707|NCT00423514|Melphalan|melphalan|mesh-list
2334708|NCT00423514|Thiotepa|thiotepa|mesh-list
2916881|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
2916882|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
2916883|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916884|NCT04537806|Pregnanolone|pregnanolone|mesh-list
2916885|NCT04537806|Brexanolone|brexanolone|mesh-list
2916886|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
2916887|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2916888|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916889|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
2916890|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2916891|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916892|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
2334709|NCT00423514|Clofarabine|clofarabine|mesh-list
2334710|NCT00423514|Tacrolimus|tacrolimus|mesh-list
2334711|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
2334712|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916893|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
2916894|NCT04530565|Cytarabine|cytarabine|mesh-list
2916895|NCT04530565|Dexamethasone|dexamethasone|mesh-list
2916896|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
2916897|NCT04530565|Prednisone|prednisone|mesh-list
2916898|NCT04530565|Cortisone|cortisone|mesh-list
2916899|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
2916900|NCT04530565|Doxorubicin|doxorubicin|mesh-list
2334713|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334714|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2334715|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334716|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334717|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2916901|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2916902|NCT04530565|Methotrexate|methotrexate|mesh-list
2916903|NCT04530565|Vincristine|vincristine|mesh-list
2916904|NCT04530565|Dasatinib|dasatinib|mesh-list
2916905|NCT04530565|Blinatumomab|blinatumomab|mesh-list
2916906|NCT04530565|Ponatinib|ponatinib|mesh-list
2916907|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2916908|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
2916909|NCT04530565|Antibodies|antibodies|mesh-list
2916910|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
2916911|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2916912|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2916913|NCT04530565|BB 1101|bb 1101|mesh-list
2916914|NCT04530565|Mesna|mesna|mesh-list
2916915|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916916|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
2916917|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916918|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2916919|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2916920|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
2916921|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916922|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916923|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2916924|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2916925|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
2916926|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
2916927|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2916928|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2916929|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
2334718|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334719|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2334720|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
2334721|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2334722|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334723|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2334724|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
2334725|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2334726|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2334727|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
2916930|NCT04530565|Hormones|hormones|mesh-ancestor
2916931|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2916932|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2916933|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
2916934|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916935|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2111416|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2111417|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
2111418|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
2111419|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2111420|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2111421|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2111422|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2111423|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
2111424|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334728|NCT00423527|Levetiracetam|levetiracetam|mesh-list
2334729|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
2334730|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
2334731|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
2334732|NCT00423540|Analgesics|analgesics|mesh-ancestor
2334733|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
2334734|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334735|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334736|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
2334737|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2334738|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2334739|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
2334740|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2334741|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2334742|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334743|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2334744|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
2334745|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2334746|NCT00423696|Leucovorin|leucovorin|mesh-list
2334747|NCT00423696|Bevacizumab|bevacizumab|mesh-list
2334748|NCT00423696|Fluorouracil|fluorouracil|mesh-list
2334749|NCT00423696|Capecitabine|capecitabine|mesh-list
2334750|NCT00423696|Irinotecan|irinotecan|mesh-list
2334751|NCT00423696|Calcium|calcium|mesh-list
2334752|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
2334753|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2334754|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334755|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2334756|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2334757|NCT00423696|Growth Substances|growth substances|mesh-ancestor
2334758|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334759|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
2334760|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2334761|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
2334762|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334763|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2334764|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334765|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
2334766|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2334767|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2334768|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334769|NCT00423696|Antidotes|antidotes|mesh-ancestor
2334770|NCT00423696|Protective Agents|protective agents|mesh-ancestor
2334771|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
2334772|NCT00423696|Vitamins|vitamins|mesh-ancestor
2334773|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
2334774|NCT00423709|Fludarabine|fludarabine|mesh-list
2334775|NCT00423709|Melphalan|melphalan|mesh-list
2334776|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334777|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334778|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334779|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
2334780|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334781|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2334782|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
2334783|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2334784|NCT00423748|Ambrisentan|ambrisentan|mesh-list
2334785|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2334786|NCT00423761|Midazolam|midazolam|mesh-list
2334787|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2334788|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2334789|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2334790|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334791|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2334792|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2334793|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2334794|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2334795|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
2334796|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
2334797|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
2334798|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
2334799|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334800|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334801|NCT00423826|Cytarabine|cytarabine|mesh-list
2334802|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
2334803|NCT00423826|Fludarabine|fludarabine|mesh-list
2334804|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
2334805|NCT00423826|Busulfan|busulfan|mesh-list
2334806|NCT00423826|Tacrolimus|tacrolimus|mesh-list
2334807|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334808|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2334809|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
2334810|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334811|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334812|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
2334813|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334814|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
2334815|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334816|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2916936|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2916937|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2916938|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2916939|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
2916940|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2334817|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334818|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2334819|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2334820|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
2334821|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2334822|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
2334823|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2334824|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2334825|NCT00423865|Everolimus|everolimus|mesh-list
2334826|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334827|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334828|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
2916941|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2334829|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334830|NCT00423969|Galantamine|galantamine|mesh-list
2334831|NCT00423969|Citalopram|citalopram|mesh-list
2334832|NCT00423969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2334833|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2334834|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2334835|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334836|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334837|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
2334838|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334839|NCT00423969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2334840|NCT00423969|Antidepressive Agents|antidepressive agents|mesh-ancestor
2334841|NCT00423969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2334842|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
2334843|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334844|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
2334845|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2334846|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334847|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2916942|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
2916943|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
2916944|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2916945|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2916946|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
2916947|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2916948|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2916949|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
2916950|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
2916951|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
2916952|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2916953|NCT04530565|Protective Agents|protective agents|mesh-ancestor
2916954|NCT04501978|Remdesivir|remdesivir|mesh-list
2916955|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
2916956|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916957|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
2916958|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2916959|NCT04501614|Ponatinib|ponatinib|mesh-list
2916960|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916961|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2916962|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916963|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916964|NCT04495855|Dienogest|dienogest|mesh-list
2916965|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2916966|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
2916967|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2916968|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916969|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2916970|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2916971|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2916972|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2916973|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
2916974|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2916975|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2916976|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916977|NCT04491942|Gemcitabine|gemcitabine|mesh-list
2916978|NCT04491942|Cisplatin|cisplatin|mesh-list
2916979|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2916980|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2916981|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
2916982|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2916983|NCT04491942|Antiviral Agents|antiviral agents|mesh-ancestor
2916984|NCT04491942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2334848|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
2334849|NCT00423982|Vancomycin|vancomycin|mesh-list
2334850|NCT00423982|Rifampin|rifampin|mesh-list
2334851|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2334852|NCT00423982|Cloxacillin|cloxacillin|mesh-list
2334853|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
2916985|NCT04491942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2916986|NCT04491942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2916987|NCT04491942|Immunologic Factors|immunologic factors|mesh-ancestor
2916988|NCT04491942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2916998|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2916999|NCT04476030|Citalopram|citalopram|mesh-list
2917000|NCT04476030|Sertraline|sertraline|mesh-list
2917001|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2917002|NCT04476030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2917003|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2917004|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2917005|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917006|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2917007|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
2917008|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917009|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2334854|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2334855|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
2334856|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
2334857|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2334858|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334859|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334860|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2334861|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2334862|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2334863|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2334864|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2334865|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2334866|NCT00423995|Loratadine|loratadine|mesh-list
2334867|NCT00423995|Montelukast|montelukast|mesh-list
2334868|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2334869|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
2334870|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2334871|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
2334872|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2334873|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334874|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2334875|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2334876|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334877|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
2334878|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
2334879|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2334880|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2917010|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
2917011|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2917012|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2917013|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2917014|NCT04476030|Analgesics|analgesics|mesh-ancestor
2917015|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
2917016|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
2917017|NCT04467723|Pirfenidone|pirfenidone|mesh-list
2917018|NCT04467723|Atezolizumab|atezolizumab|mesh-list
2917019|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917020|NCT04467723|Analgesics|analgesics|mesh-ancestor
2917021|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
2917022|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2334881|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2334882|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
2334883|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
2334884|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334885|NCT00424060|Sagopilone|sagopilone|mesh-list
2334886|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334887|NCT00424086|Vaccines|vaccines|mesh-list
2334888|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
2334889|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917023|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917024|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2917025|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2917026|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2917027|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2917033|NCT04416451|Rituximab|rituximab|mesh-list
2334899|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2334900|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2334901|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334902|NCT00424151|Rituximab|rituximab|mesh-list
2334903|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2334904|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334905|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
2334906|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334907|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2334908|NCT00424164|Tamoxifen|tamoxifen|mesh-list
2334909|NCT00424164|Lapatinib|lapatinib|mesh-list
2917034|NCT04416451|Venetoclax|venetoclax|mesh-list
2917035|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917036|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917037|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
2917038|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917039|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2917040|NCT04405349|Atezolizumab|atezolizumab|mesh-list
2917041|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334910|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334911|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2334912|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
2334913|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2334914|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334915|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2334916|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917047|NCT04400838|Vaccines|vaccines|mesh-list
2917048|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
2917049|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917059|NCT04396574|Lasmiditan|lasmiditan|mesh-list
2917060|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2917061|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
2917062|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2917063|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917064|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917065|NCT04396236|Lasmiditan|lasmiditan|mesh-list
2917066|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2917067|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
2917068|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2917069|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917070|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917071|NCT04391049|Paclitaxel|paclitaxel|mesh-list
2917072|NCT04391049|Carboplatin|carboplatin|mesh-list
2917073|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2917074|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2917075|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917076|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
2917077|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
2917078|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
2917079|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917080|NCT04378933|Methamphetamine|methamphetamine|mesh-list
2917081|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2917082|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917083|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
2917084|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
2917085|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2917086|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
2334917|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2334918|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2334919|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2334920|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2334921|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334922|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
2334923|NCT00424203|Doxorubicin|doxorubicin|mesh-list
2334924|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2334925|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2334926|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
2334927|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334928|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2334929|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2917087|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2917088|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917089|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
2917090|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2917091|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2917092|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2917093|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2334930|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
2334931|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334932|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334933|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2334934|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2334935|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2334936|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2334937|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334938|NCT00424229|Lenalidomide|lenalidomide|mesh-list
2334939|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
2334940|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334941|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2334942|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2334943|NCT00424229|Growth Substances|growth substances|mesh-ancestor
2334944|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
2334945|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334946|NCT00424242|Pemetrexed|pemetrexed|mesh-list
2334947|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334948|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334949|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334950|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2334951|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2334952|NCT00424281|PENTA|penta|mesh-list
2334953|NCT00424281|Fondaparinux|fondaparinux|mesh-list
2334954|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2334955|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
2917108|NCT04368559|Fluconazole|fluconazole|mesh-list
2917109|NCT04368559|Posaconazole|posaconazole|mesh-list
2917110|NCT04368559|Rezafungin|rezafungin|mesh-list
2917111|NCT04368559|Trimethoprim|trimethoprim|mesh-list
2917112|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
2917113|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2917114|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
2917115|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917116|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2917117|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2917118|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917119|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334956|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2334957|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
2334958|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334959|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334960|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
2334961|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2334962|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2334963|NCT00424333|Insulin|insulin|mesh-list
2334964|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2334965|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2334966|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334967|NCT00424411|Insulin|insulin|mesh-list
2334968|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2334969|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2917120|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2917121|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
2917122|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2917123|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917124|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2917125|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2917126|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2917127|NCT04368559|Renal Agents|renal agents|mesh-ancestor
2917128|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
2334970|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334971|NCT00424437|Insulin|insulin|mesh-list
2917129|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2917130|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2917131|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2917132|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2917133|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2917134|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2917135|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2917136|NCT04364048|Cisplatin|cisplatin|mesh-list
2917137|NCT04364048|Carboplatin|carboplatin|mesh-list
2917138|NCT04364048|Etoposide|etoposide|mesh-list
2917139|NCT04364048|Pemetrexed|pemetrexed|mesh-list
2917140|NCT04364048|Durvalumab|durvalumab|mesh-list
2917141|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2917142|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917143|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2917144|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2917145|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2917146|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2334972|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2334973|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2334974|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334975|NCT00424580|Montelukast|montelukast|mesh-list
2334976|NCT00424580|Desloratadine|desloratadine|mesh-list
2334977|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2334978|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
2917147|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917148|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2917149|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2917150|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917151|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
2917152|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917153|NCT04353492|Ofatumumab|ofatumumab|mesh-list
2917154|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917155|NCT04344444|Azithromycin|azithromycin|mesh-list
2917156|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
2917157|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2917158|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917159|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
2917160|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2917161|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2917162|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917163|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917164|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2917165|NCT04342715|Paromomycin|paromomycin|mesh-list
2917166|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
2917167|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2334979|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2334980|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
2334981|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2334982|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2334983|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2334984|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2917168|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917169|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2917170|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2917171|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
2917172|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2917173|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
2334985|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2334986|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2334987|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
2334988|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2334989|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2334990|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2334991|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
2334992|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
2334993|NCT00424606|Docetaxel|docetaxel|mesh-list
2334994|NCT00424606|Epirubicin|epirubicin|mesh-list
2334995|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2334996|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
2334997|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
2334998|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
2334999|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335000|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2335001|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2335002|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2917190|NCT04332068|Ivermectin|ivermectin|mesh-list
2917191|NCT04332068|Permethrin|permethrin|mesh-list
2335003|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335004|NCT00424697|Lorazepam|lorazepam|mesh-list
2335005|NCT00424697|Anticonvulsants|anticonvulsants|mesh-ancestor
2335006|NCT00424697|Antiemetics|antiemetics|mesh-ancestor
2335007|NCT00424697|Autonomic Agents|autonomic agents|mesh-ancestor
2335008|NCT00424697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335009|NCT00424697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335010|NCT00424697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2335011|NCT00424697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2335012|NCT00424697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2335013|NCT00424697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2335014|NCT00424697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2335015|NCT00424697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2335016|NCT00424697|GABA Modulators|gaba modulators|mesh-ancestor
2335017|NCT00424697|GABA Agents|gaba agents|mesh-ancestor
2335018|NCT00424697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2335019|NCT00424697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335020|NCT00424710|Ranibizumab|ranibizumab|mesh-list
2335021|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2335022|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2335023|NCT00424710|Growth Substances|growth substances|mesh-ancestor
2335024|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335025|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
2335026|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335027|NCT00424723|Pemetrexed|pemetrexed|mesh-list
2335028|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335029|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335030|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335031|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2335032|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2335033|NCT00424788|Natalizumab|natalizumab|mesh-list
2335034|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
2335035|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335036|NCT00424801|Nicorandil|nicorandil|mesh-list
2917192|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2917193|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917194|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917195|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917196|NCT04324606|Acetaminophen|acetaminophen|mesh-list
2917197|NCT04324606|Vaccines|vaccines|mesh-list
2917198|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
2917199|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917200|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2917201|NCT04324606|Analgesics|analgesics|mesh-ancestor
2917202|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
2917203|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2917204|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
2917205|NCT04324463|Aspirin|aspirin|mesh-list
2917206|NCT04324463|Interferons|interferons|mesh-list
2917207|NCT04324463|Interferon-beta|interferon-beta|mesh-list
2917208|NCT04324463|Colchicine|colchicine|mesh-list
2917209|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
2917210|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917211|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
2917212|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917213|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2917214|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2917215|NCT04324463|Analgesics|analgesics|mesh-ancestor
2917216|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
2917217|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2917218|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917219|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2917220|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2917221|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2917222|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2917223|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917224|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2917225|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2917226|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917227|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
2917228|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2917229|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
2917230|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2917231|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
2917232|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
2917233|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
2917234|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
2917235|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
2917236|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
2917237|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
2917244|NCT04320940|Phenobarbital|phenobarbital|mesh-list
2917245|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
2917246|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2917247|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2917248|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917249|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2917250|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2917251|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2917252|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917253|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
2917254|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
2917255|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2917256|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2917257|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2917258|NCT04295577|Niraparib|niraparib|mesh-list
2917259|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2917260|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917261|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917262|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335037|NCT00424801|Valsartan|valsartan|mesh-list
2335038|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2335039|NCT00424801|Doxazosin|doxazosin|mesh-list
2335040|NCT00424801|Lercanidipine|lercanidipine|mesh-list
2917269|NCT04261218|Paclitaxel|paclitaxel|mesh-list
2917270|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2917271|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917272|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
2917273|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
2917274|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
2917275|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917276|NCT04251689|Mannitol|mannitol|mesh-list
2917277|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2917278|NCT04251689|Diuretics|diuretics|mesh-ancestor
2917279|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
2917280|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917281|NCT04250155|Atezolizumab|atezolizumab|mesh-list
2917282|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917283|NCT04232423|Olanzapine|olanzapine|mesh-list
2917284|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
2917285|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
2335041|NCT00424801|Pindolol|pindolol|mesh-list
2335042|NCT00424801|Moxonidine|moxonidine|mesh-list
2335043|NCT00424801|Amiloride|amiloride|mesh-list
2335044|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2335045|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2335046|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2335047|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335048|NCT00424801|Diuretics|diuretics|mesh-ancestor
2335049|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
2335050|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335051|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2335052|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2335053|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2335054|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2335055|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2335056|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
2335057|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2335058|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2335059|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2335060|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2335061|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2335062|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2335063|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
2335064|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
2335065|NCT00424801|Vitamins|vitamins|mesh-ancestor
2335066|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
2917286|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2917287|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917288|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2917289|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2917290|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2917291|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2917292|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2917293|NCT04232423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2917294|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2917295|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2917296|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917297|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2917298|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
2917299|NCT04231877|Prednisone|prednisone|mesh-list
2917300|NCT04231877|Cortisone|cortisone|mesh-list
2917301|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
2917302|NCT04231877|Rituximab|rituximab|mesh-list
2917303|NCT04231877|Doxorubicin|doxorubicin|mesh-list
2917304|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2917305|NCT04231877|Etoposide|etoposide|mesh-list
2917306|NCT04231877|Daunorubicin|daunorubicin|mesh-list
2917307|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
2917308|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2917309|NCT04231877|Antibodies|antibodies|mesh-list
2917310|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
2917311|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2917312|NCT04231877|Lenograstim|lenograstim|mesh-list
2917313|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
2917314|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917315|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
2917316|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917317|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2917318|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2917319|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
2917320|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917321|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917322|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2917323|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2917324|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2917325|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2917326|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917327|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2917328|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
2917329|NCT04231877|Hormones|hormones|mesh-ancestor
2917330|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2917331|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2917332|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2917333|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2917334|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
2917335|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
2917336|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
2917337|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
2917338|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
2917344|NCT04205409|Nivolumab|nivolumab|mesh-list
2917345|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917346|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917347|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2917348|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335067|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2335068|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2335069|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2335070|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2335071|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
2335072|NCT00424814|Ritonavir|ritonavir|mesh-list
2335073|NCT00424814|Lopinavir|lopinavir|mesh-list
2335074|NCT00424814|Lamivudine|lamivudine|mesh-list
2335075|NCT00424814|Zidovudine|zidovudine|mesh-list
2335076|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2335077|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2917349|NCT04196010|Cytarabine|cytarabine|mesh-list
2917350|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
2917351|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
2917352|NCT04196010|Cladribine|cladribine|mesh-list
2917353|NCT04196010|Sargramostim|sargramostim|mesh-list
2917354|NCT04196010|Lenograstim|lenograstim|mesh-list
2917355|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2917356|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
2917357|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917358|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917359|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
2917360|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917361|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917362|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
2917363|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917364|NCT04196010|Analgesics|analgesics|mesh-ancestor
2917365|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
2917366|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2917367|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2917368|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2917369|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917370|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2917371|NCT04190433|Carvedilol|carvedilol|mesh-list
2917372|NCT04190433|Lisinopril|lisinopril|mesh-list
2917373|NCT04190433|Spironolactone|spironolactone|mesh-list
2917374|NCT04190433|Pravastatin|pravastatin|mesh-list
2917375|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2917376|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
2917377|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2917378|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917379|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2917380|NCT04190433|Diuretics|diuretics|mesh-ancestor
2335078|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2917381|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
2917382|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2335079|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
2335080|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335081|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335082|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2335083|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2335084|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
2335085|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335086|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2335087|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2335088|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2335089|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2335090|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
2335091|NCT00424853|Gemcitabine|gemcitabine|mesh-list
2335092|NCT00424853|Cisplatin|cisplatin|mesh-list
2917383|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2917384|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
2917385|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2917386|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917387|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2917388|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
2917389|NCT04190433|Protective Agents|protective agents|mesh-ancestor
2335093|NCT00424853|Docetaxel|docetaxel|mesh-list
2335094|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335095|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2335096|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
2335097|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335098|NCT00424853|Antiviral Agents|antiviral agents|mesh-ancestor
2335099|NCT00424853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335100|NCT00424853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335101|NCT00424853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335102|NCT00424853|Immunologic Factors|immunologic factors|mesh-ancestor
2335103|NCT00424853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335104|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
2335105|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
2335106|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
2335107|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2335108|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2335109|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2917390|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2917391|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2917392|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2917393|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
2917394|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2917395|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2917396|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2917397|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2917398|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
2917399|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2917400|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2917401|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917402|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2917403|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
2917404|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2917405|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2917406|NCT04178993|Methylphenidate|methylphenidate|mesh-list
2917407|NCT04178993|Methamphetamine|methamphetamine|mesh-list
2917408|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2917409|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917410|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2917411|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2917412|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2917413|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917414|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
2917415|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2917416|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2917417|NCT04178993|Analgesics|analgesics|mesh-ancestor
2917418|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
2917419|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2917420|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
2917421|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2917422|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
2917423|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
2917424|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
2917425|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2335110|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2335111|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335112|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2335113|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335114|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
2335115|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2335116|NCT00424931|Modafinil|modafinil|mesh-list
2335117|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2335118|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335119|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2335120|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2335121|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2917443|NCT04158258|Bevacizumab|bevacizumab|mesh-list
2917444|NCT04158258|Trastuzumab|trastuzumab|mesh-list
2917445|NCT04158258|Pertuzumab|pertuzumab|mesh-list
2917446|NCT04158258|Capecitabine|capecitabine|mesh-list
2917447|NCT04158258|Atezolizumab|atezolizumab|mesh-list
2917448|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917449|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917450|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2917451|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2917452|NCT04158258|Growth Substances|growth substances|mesh-ancestor
2917453|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917454|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
2917455|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2917456|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
2917457|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917458|NCT04156828|Gemcitabine|gemcitabine|mesh-list
2917459|NCT04156828|Dexamethasone|dexamethasone|mesh-list
2917460|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
2917461|NCT04156828|Rituximab|rituximab|mesh-list
2917462|NCT04156828|Carboplatin|carboplatin|mesh-list
2917463|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2917464|NCT04156828|Antibodies|antibodies|mesh-list
2335122|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335123|NCT00424944|Vaccines|vaccines|mesh-list
2335124|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
2335125|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335126|NCT00424970|Acetazolamide|acetazolamide|mesh-list
2917465|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
2917466|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2917467|NCT04156828|Lenograstim|lenograstim|mesh-list
2917468|NCT04156828|BB 1101|bb 1101|mesh-list
2917469|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
2917470|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917471|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2917472|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
2917473|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
2917474|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2917475|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2917476|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
2335127|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
2917477|NCT04156828|Hormones|hormones|mesh-ancestor
2917478|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2917479|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2111425|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111426|NCT02554890|Valsartan|valsartan|mesh-list
2111427|NCT02554890|Enalapril|enalapril|mesh-list
2111428|NCT02554890|Enalaprilat|enalaprilat|mesh-list
2111429|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2111430|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2111431|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2111432|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2335128|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2917480|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917481|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2917482|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2917483|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
2917484|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335129|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335130|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335131|NCT00424970|Diuretics|diuretics|mesh-ancestor
2335132|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
2335133|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335134|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
2335135|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2335136|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335137|NCT00425009|Metformin|metformin|mesh-list
2335138|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2917485|NCT04156828|Antiviral Agents|antiviral agents|mesh-ancestor
2917486|NCT04156828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917487|NCT04156828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917488|NCT04156828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917489|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2917490|NCT04156828|Protease Inhibitors|protease inhibitors|mesh-ancestor
2917514|NCT04107727|Cytarabine|cytarabine|mesh-list
2917515|NCT04107727|Idarubicin|idarubicin|mesh-list
2917516|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2917517|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
2917518|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917519|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917520|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
2917521|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917522|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917523|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
2917524|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917525|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2917526|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2917527|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2917528|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917529|NCT04107077|Mitomycins|mitomycins|mesh-list
2917530|NCT04107077|Mitomycin|mitomycin|mesh-list
2917531|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917532|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2917533|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
2917534|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917535|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2917536|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917537|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
2917538|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917539|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917545|NCT04065074|FX006|fx006|mesh-list
2917546|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2917547|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
2917548|NCT04065074|Hormones|hormones|mesh-ancestor
2917549|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2917550|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917551|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917552|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
2917556|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
2917557|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917558|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
2917559|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917560|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2917561|NCT04042116|Nivolumab|nivolumab|mesh-list
2917562|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917563|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917564|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2917565|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917566|NCT04037254|Niraparib|niraparib|mesh-list
2917567|NCT04037254|Hormones|hormones|mesh-list
2917568|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2917569|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2917570|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2917571|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917572|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2917573|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917574|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917575|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917576|NCT04017390|Allantoin|allantoin|mesh-list
2917577|NCT04017390|Dermatologic Agents|dermatologic agents|mesh-ancestor
2917578|NCT04015622|Docetaxel|docetaxel|mesh-list
2917579|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917580|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
2917581|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
2917582|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
2917583|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917584|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
2917585|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
2917586|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2917587|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2917588|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917589|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917590|NCT03997097|Urological Agents|urological agents|mesh-ancestor
2917591|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
2917592|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2917593|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917594|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917595|NCT03979885|Nicotine|nicotine|mesh-list
2917596|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2917597|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
2917598|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2917599|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917600|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2917601|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2917602|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
2917603|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2917604|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917605|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
2917606|NCT03970252|Leucovorin|leucovorin|mesh-list
2917607|NCT03970252|Folic Acid|folic acid|mesh-list
2917608|NCT03970252|Fluorouracil|fluorouracil|mesh-list
2917609|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
2917610|NCT03970252|Nivolumab|nivolumab|mesh-list
2917611|NCT03970252|Irinotecan|irinotecan|mesh-list
2917612|NCT03970252|Camptothecin|camptothecin|mesh-list
2917613|NCT03970252|Calcium|calcium|mesh-list
2917614|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
2917615|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2917616|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917617|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2917618|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
2917619|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917620|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2917621|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917622|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917623|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
2917624|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917625|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2917626|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2917627|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2917628|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917629|NCT03970252|Antidotes|antidotes|mesh-ancestor
2917630|NCT03970252|Protective Agents|protective agents|mesh-ancestor
2917631|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
2917632|NCT03970252|Vitamins|vitamins|mesh-ancestor
2917633|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
2917634|NCT03970252|Hematinics|hematinics|mesh-ancestor
2917635|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2917636|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2917637|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917644|NCT03951961|Midostaurin|midostaurin|mesh-list
2335139|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335140|NCT00425035|Panitumumab|panitumumab|mesh-list
2335141|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335142|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335143|NCT00425074|Aspirin|aspirin|mesh-list
2335144|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
2335145|NCT00425074|Salicylates|salicylates|mesh-list
2335146|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917645|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917646|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2917647|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917648|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917649|NCT03949153|Nivolumab|nivolumab|mesh-list
2917650|NCT03949153|Ipilimumab|ipilimumab|mesh-list
2917651|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917652|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917653|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2917654|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917655|NCT03947216|Pimavanserin|pimavanserin|mesh-list
2917656|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2917657|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2917658|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2917659|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2917660|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2917661|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917662|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2917663|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2335147|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
2335148|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
2335149|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
2335150|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2335151|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2335152|NCT00425074|Analgesics|analgesics|mesh-ancestor
2335153|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
2917664|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2917665|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
2917666|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2917667|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917668|NCT03939520|Pirfenidone|pirfenidone|mesh-list
2917669|NCT03939520|Nintedanib|nintedanib|mesh-list
2917670|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917671|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2335154|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2917672|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917673|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917674|NCT03939520|Analgesics|analgesics|mesh-ancestor
2917675|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
2917676|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2917677|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917678|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2917679|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2917680|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2917681|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2917682|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
2917683|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2917684|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335155|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335156|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2335157|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335158|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2335159|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335160|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335161|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2335162|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2335163|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2335164|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
2335165|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
2335166|NCT00425126|Hematinics|hematinics|mesh-ancestor
2335167|NCT00425152|Leucovorin|leucovorin|mesh-list
2917725|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
2917726|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
2917727|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335168|NCT00425152|Levamisole|levamisole|mesh-list
2335169|NCT00425152|Fluorouracil|fluorouracil|mesh-list
2335170|NCT00425152|Calcium|calcium|mesh-list
2335171|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
2335172|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2335173|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335174|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
2917728|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
2917729|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2917730|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917731|NCT03906292|Niacinamide|niacinamide|mesh-list
2917732|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
2917733|NCT03906292|Dasatinib|dasatinib|mesh-list
2917734|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917735|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2917736|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917737|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917738|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
2917739|NCT03906292|Vitamins|vitamins|mesh-ancestor
2917740|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
2917741|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917742|NCT03891901|Isoniazid|isoniazid|mesh-list
2917743|NCT03891901|Rifabutin|rifabutin|mesh-list
2917744|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
2917745|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917746|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2917747|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917748|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917749|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
2917750|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2917751|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917752|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2917753|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2917754|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
2917755|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2917756|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2335175|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335176|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2335177|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335178|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335179|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
2335180|NCT00425152|Antidotes|antidotes|mesh-ancestor
2335181|NCT00425152|Protective Agents|protective agents|mesh-ancestor
2335182|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
2335183|NCT00425152|Vitamins|vitamins|mesh-ancestor
2335184|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
2335185|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2335186|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
2335187|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
2335188|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2335189|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335190|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335191|NCT00425191|Gemcitabine|gemcitabine|mesh-list
2917767|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
2917768|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917769|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917770|NCT03840200|Rucaparib|rucaparib|mesh-list
2917771|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2917772|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917773|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917774|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917775|NCT03836105|Cemiplimab|cemiplimab|mesh-list
2917776|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917777|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335192|NCT00425191|Docetaxel|docetaxel|mesh-list
2335193|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335194|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2335195|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
2335196|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335197|NCT00425191|Antiviral Agents|antiviral agents|mesh-ancestor
2335198|NCT00425191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335199|NCT00425191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335200|NCT00425191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335201|NCT00425191|Immunologic Factors|immunologic factors|mesh-ancestor
2335202|NCT00425191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335203|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
2335204|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
2335205|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
2335206|NCT00425204|Panitumumab|panitumumab|mesh-list
2335207|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335208|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335209|NCT00425217|Rituximab|rituximab|mesh-list
2335210|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335211|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335212|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
2917797|NCT03816163|Gemcitabine|gemcitabine|mesh-list
2917798|NCT03816163|Paclitaxel|paclitaxel|mesh-list
2917799|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2917800|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917801|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
2917802|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
2917803|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
2917804|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917805|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2917806|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
2917807|NCT03816163|Antiviral Agents|antiviral agents|mesh-ancestor
2917808|NCT03816163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917809|NCT03816163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917810|NCT03816163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917811|NCT03816163|Immunologic Factors|immunologic factors|mesh-ancestor
2917812|NCT03816163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917833|NCT03801876|Paclitaxel|paclitaxel|mesh-list
2917834|NCT03801876|Docetaxel|docetaxel|mesh-list
2917835|NCT03801876|Carboplatin|carboplatin|mesh-list
2917836|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2917837|NCT03801876|Fluorouracil|fluorouracil|mesh-list
2917838|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2917839|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917840|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
2917841|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
2917842|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
2917843|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917844|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
2917845|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2335213|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335214|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335215|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2335216|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2335217|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2335218|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2335219|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335220|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2335221|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335222|NCT00425230|Analgesics|analgesics|mesh-ancestor
2335223|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
2335224|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335225|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
2335226|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2335227|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
2335228|NCT00425243|Zolpidem|zolpidem|mesh-list
2335229|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2335230|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2335231|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2335232|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335233|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2335234|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
2335235|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
2335236|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2917846|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917847|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
2917848|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335237|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335238|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2335239|NCT00425347|Elotuzumab|elotuzumab|mesh-list
2335240|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335241|NCT00425360|Gemcitabine|gemcitabine|mesh-list
2335242|NCT00425360|Capecitabine|capecitabine|mesh-list
2335243|NCT00425360|Sargramostim|sargramostim|mesh-list
2917864|NCT03793010|FX006|fx006|mesh-list
2917865|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2917866|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
2917867|NCT03793010|Hormones|hormones|mesh-ancestor
2917868|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2917869|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917870|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917871|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
2917872|NCT03785678|Tenecteplase|tenecteplase|mesh-list
2917873|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2917874|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2917875|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917876|NCT03781219|Vemurafenib|vemurafenib|mesh-list
2917877|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917878|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2917879|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917880|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335244|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2335245|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
2917901|NCT03749460|Nivolumab|nivolumab|mesh-list
2917902|NCT03749460|Ipilimumab|ipilimumab|mesh-list
2917903|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917904|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917905|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2917906|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917915|NCT03728556|Antibodies|antibodies|mesh-list
2917916|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2917917|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
2917918|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917922|NCT03684980|Leucovorin|leucovorin|mesh-list
2917923|NCT03684980|Rituximab|rituximab|mesh-list
2917924|NCT03684980|Methotrexate|methotrexate|mesh-list
2917925|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917926|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917927|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
2917928|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917929|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2917930|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2917931|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
2917932|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2917933|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2917934|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
2917935|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917936|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
2917937|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917938|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2917939|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917940|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2917941|NCT03684980|Antidotes|antidotes|mesh-ancestor
2917942|NCT03684980|Protective Agents|protective agents|mesh-ancestor
2917943|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
2917944|NCT03684980|Vitamins|vitamins|mesh-ancestor
2917945|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
2917946|NCT03682068|Gemcitabine|gemcitabine|mesh-list
2917947|NCT03682068|Carboplatin|carboplatin|mesh-list
2917948|NCT03682068|Durvalumab|durvalumab|mesh-list
2917949|NCT03682068|Tremelimumab|tremelimumab|mesh-list
2917950|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917951|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2917952|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
2917953|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917954|NCT03682068|Antiviral Agents|antiviral agents|mesh-ancestor
2917955|NCT03682068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917956|NCT03682068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917957|NCT03682068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917958|NCT03682068|Immunologic Factors|immunologic factors|mesh-ancestor
2917959|NCT03682068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917960|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917961|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
2917962|NCT03644485|Tacrolimus|tacrolimus|mesh-list
2917963|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917964|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
2917965|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917966|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2917967|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917968|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917969|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2917970|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917971|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2917972|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
2917973|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2917974|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917975|NCT03642067|Nivolumab|nivolumab|mesh-list
2917976|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2917977|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917978|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2917979|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917980|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
2917981|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335246|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335247|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335248|NCT00425360|Antiviral Agents|antiviral agents|mesh-ancestor
2917982|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917983|NCT03617445|Vancomycin|vancomycin|mesh-list
2917984|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2917985|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2917986|NCT03616587|Everolimus|everolimus|mesh-list
2917987|NCT03616587|Palbociclib|palbociclib|mesh-list
2917988|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2917989|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2917990|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
2917991|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2917992|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2917993|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2917994|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2917995|NCT03606967|Gemcitabine|gemcitabine|mesh-list
2917996|NCT03606967|Poly I-C|poly i-c|mesh-list
2917997|NCT03606967|Paclitaxel|paclitaxel|mesh-list
2917998|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2917999|NCT03606967|Carboplatin|carboplatin|mesh-list
2918000|NCT03606967|Durvalumab|durvalumab|mesh-list
2918001|NCT03606967|Tremelimumab|tremelimumab|mesh-list
2918002|NCT03606967|Ipilimumab|ipilimumab|mesh-list
2918003|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2918004|NCT03606967|Vaccines|vaccines|mesh-list
2918005|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
2918006|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2918007|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
2918008|NCT03606967|Poly ICLC|poly iclc|mesh-list
2918009|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
2918010|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918011|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2918012|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918013|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
2918014|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
2918015|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
2918016|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918017|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2918018|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
2918019|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
2918020|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2918021|NCT03606967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918022|NCT03606967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2918023|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2918024|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2918025|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
2918026|NCT03606967|Laxatives|laxatives|mesh-ancestor
2918027|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2335249|NCT00425360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2918041|NCT03596905|Plecanatide|plecanatide|mesh-list
2918042|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2918043|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
2918044|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918045|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2918046|NCT03586609|Cytarabine|cytarabine|mesh-list
2918047|NCT03586609|Azacitidine|azacitidine|mesh-list
2918048|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
2918049|NCT03586609|Venetoclax|venetoclax|mesh-list
2918050|NCT03586609|Cladribine|cladribine|mesh-list
2918051|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2918052|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
2918053|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918054|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918055|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
2335250|NCT00425360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335251|NCT00425360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335252|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
2335253|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335254|NCT00425425|Fluorouracil|fluorouracil|mesh-list
2335255|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
2335256|NCT00425425|Cetuximab|cetuximab|mesh-list
2335257|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
2335258|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335259|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2335260|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335261|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335262|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
2918056|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2918057|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2918058|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
2918059|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918060|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918061|NCT03584516|Prednisone|prednisone|mesh-list
2918062|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
2918063|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2918064|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2918065|NCT03584516|Prednisolone|prednisolone|mesh-list
2918066|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
2918067|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2918068|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
2918069|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2918070|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
2918071|NCT03584516|Hormones|hormones|mesh-ancestor
2918072|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918073|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918074|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2918075|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918076|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
2918077|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
2918078|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2918079|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2918080|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2918081|NCT03584516|Protective Agents|protective agents|mesh-ancestor
2918082|NCT03579316|Olaparib|olaparib|mesh-list
2918083|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2918084|NCT03579316|Adavosertib|adavosertib|mesh-list
2335263|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335264|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335265|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
2335266|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2335267|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
2335268|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2335269|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335270|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
2335271|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
2335272|NCT00425451|Analgesics|analgesics|mesh-ancestor
2335273|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
2335274|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335275|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335276|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2335277|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2918085|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335278|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2335279|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335280|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2335281|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335282|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335283|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2335284|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2335285|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335286|NCT00425490|Incretins|incretins|mesh-ancestor
2335287|NCT00425490|Hormones|hormones|mesh-ancestor
2335288|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2335289|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2335290|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
2335291|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335292|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335293|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
2335294|NCT00425516|Docetaxel|docetaxel|mesh-list
2918086|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918087|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335295|NCT00425516|Fluorouracil|fluorouracil|mesh-list
2335296|NCT00425516|Epirubicin|epirubicin|mesh-list
2335297|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335298|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
2335299|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335300|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335301|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2335302|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
2335303|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335304|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335305|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2335306|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
2335307|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
2335308|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
2335309|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
2335310|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2335311|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2335312|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2335313|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2335314|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335315|NCT00425568|Testosterone|testosterone|mesh-list
2335316|NCT00425568|Androgens|androgens|mesh-ancestor
2335317|NCT00425568|Hormones|hormones|mesh-ancestor
2335318|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2335319|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335320|NCT00425594|Bisacodyl|bisacodyl|mesh-list
2335321|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2335322|NCT00425594|Cathartics|cathartics|mesh-ancestor
2335323|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2335324|NCT00425594|Laxatives|laxatives|mesh-ancestor
2335325|NCT00425620|Amphotericin B|amphotericin b|mesh-list
2335326|NCT00425620|Amebicides|amebicides|mesh-ancestor
2335327|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2918097|NCT03560531|Palbociclib|palbociclib|mesh-list
2918098|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918099|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2918100|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918101|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918102|NCT03529942|FX006|fx006|mesh-list
2918103|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2918104|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
2918105|NCT03529942|Hormones|hormones|mesh-ancestor
2335328|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2335329|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335330|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2335331|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
2918106|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918107|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918108|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2918109|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
2918110|NCT03505320|Leucovorin|leucovorin|mesh-list
2918111|NCT03505320|Folic Acid|folic acid|mesh-list
2918112|NCT03505320|Fluorouracil|fluorouracil|mesh-list
2918113|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
2918114|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
2918115|NCT03505320|Nivolumab|nivolumab|mesh-list
2918116|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
2918117|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
2918118|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918119|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2918120|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918121|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2918122|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
2918123|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918124|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2918125|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2918126|NCT03505320|Antidotes|antidotes|mesh-ancestor
2918127|NCT03505320|Protective Agents|protective agents|mesh-ancestor
2918128|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
2918129|NCT03505320|Vitamins|vitamins|mesh-ancestor
2918130|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
2918131|NCT03505320|Hematinics|hematinics|mesh-ancestor
2918132|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
2918133|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2918134|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2918135|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
2918136|NCT03501940|Fluorides|fluorides|mesh-list
2918137|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
2918138|NCT03501940|Protective Agents|protective agents|mesh-ancestor
2918139|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918140|NCT03473340|Pirfenidone|pirfenidone|mesh-list
2918141|NCT03473340|Analgesics|analgesics|mesh-ancestor
2918142|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
2918143|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2918144|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918145|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2918146|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2918147|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2918148|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2918149|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918150|NCT03471663|Palbociclib|palbociclib|mesh-list
2918151|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918152|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2918153|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918154|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918155|NCT03467373|Prednisone|prednisone|mesh-list
2335332|NCT00425646|Bevacizumab|bevacizumab|mesh-list
2335333|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
2335334|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335335|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335336|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2335337|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2335338|NCT00425646|Growth Substances|growth substances|mesh-ancestor
2335339|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335340|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
2335341|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2335342|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335343|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335344|NCT00425711|Acamprosate|acamprosate|mesh-list
2335345|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2335346|NCT00425724|Cyclosporine|cyclosporine|mesh-list
2335347|NCT00425724|Prednisone|prednisone|mesh-list
2335348|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
2335349|NCT00425724|Cyclosporins|cyclosporins|mesh-list
2335350|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2335351|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
2335352|NCT00425724|Hormones|hormones|mesh-ancestor
2335353|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2335354|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335355|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2335356|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918156|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
2918157|NCT03467373|Rituximab|rituximab|mesh-list
2918158|NCT03467373|Doxorubicin|doxorubicin|mesh-list
2335357|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335358|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335359|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335360|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
2335361|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
2335362|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335363|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
2335364|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335365|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2335366|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
2335367|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
2335368|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335369|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2335370|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2335371|NCT00425724|Protective Agents|protective agents|mesh-ancestor
2335372|NCT00425841|Gemcitabine|gemcitabine|mesh-list
2335373|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
2335374|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2335375|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
2335376|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335377|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335378|NCT00425841|Antiviral Agents|antiviral agents|mesh-ancestor
2335379|NCT00425841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335380|NCT00425841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335381|NCT00425841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335382|NCT00425841|Immunologic Factors|immunologic factors|mesh-ancestor
2918159|NCT03467373|Vincristine|vincristine|mesh-list
2918160|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
2918161|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2918162|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
2918163|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918164|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2918165|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2918166|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
2918167|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918168|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918169|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2918170|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2918171|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2918172|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2918173|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2918174|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918175|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2918176|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
2918177|NCT03467373|Hormones|hormones|mesh-ancestor
2918178|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918179|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2918180|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2918181|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
2918182|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
2918183|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
2918184|NCT03373760|Durvalumab|durvalumab|mesh-list
2335383|NCT00425841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335384|NCT00425906|Nicotine|nicotine|mesh-list
2335385|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2335386|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
2335387|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335388|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335389|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2335390|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2335391|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
2335392|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2335393|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335394|NCT00425932|Rituximab|rituximab|mesh-list
2918185|NCT03373760|Ipilimumab|ipilimumab|mesh-list
2918186|NCT03373760|Tremelimumab|tremelimumab|mesh-list
2918187|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
2918188|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2918189|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
2918190|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2918191|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918192|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
2918193|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335395|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335396|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335397|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
2918194|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2918195|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918196|NCT03367156|Dexamethasone|dexamethasone|mesh-list
2918197|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
2918198|NCT03367156|Ichthammol|ichthammol|mesh-list
2918199|NCT03367156|BB 1101|bb 1101|mesh-list
2918200|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2918201|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
2918202|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
2918203|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2918204|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918205|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2918206|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
2918207|NCT03367156|Hormones|hormones|mesh-ancestor
2918208|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918209|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2918210|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918211|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
2918212|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335398|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335399|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335400|NCT00425997|Amlodipine|amlodipine|mesh-list
2335401|NCT00425997|Valsartan|valsartan|mesh-list
2335402|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2335403|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2335404|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2335405|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2335406|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335407|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2335408|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335409|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
2918213|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918214|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
2918215|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
2918216|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2918217|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918218|NCT03349775|Metformin|metformin|mesh-list
2918219|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2918220|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918221|NCT03337724|Paclitaxel|paclitaxel|mesh-list
2918222|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2918223|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918224|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
2918225|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
2918226|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
2918227|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335410|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2335411|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2335412|NCT00425997|Diuretics|diuretics|mesh-ancestor
2335413|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
2335414|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2335415|NCT00426010|Caffeine|caffeine|mesh-list
2335416|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2335417|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335418|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2335419|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335420|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335421|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2335422|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2335423|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
2918239|NCT03263078|Propofol|propofol|mesh-list
2918240|NCT03263078|Sevoflurane|sevoflurane|mesh-list
2918241|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2918242|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2918243|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918244|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2918245|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
2918246|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
2918247|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2335424|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2335425|NCT00426023|Ketotifen|ketotifen|mesh-list
2335426|NCT00426023|Cyclosporine|cyclosporine|mesh-list
2335427|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2335428|NCT00426023|Cyclosporins|cyclosporins|mesh-list
2335429|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335430|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335431|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335432|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
2335433|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335434|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
2335435|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335436|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
2335437|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335438|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2335439|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2335440|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
2335441|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2918248|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2918249|NCT03256344|Atezolizumab|atezolizumab|mesh-list
2918250|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2918251|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918252|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2918253|NCT03250377|Brivaracetam|brivaracetam|mesh-list
2918254|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
2918255|NCT03216187|Pregabalin|pregabalin|mesh-list
2918256|NCT03216187|Analgesics|analgesics|mesh-ancestor
2918257|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
2918258|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335442|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
2335443|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
2335444|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2335445|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2335446|NCT00426049|Everolimus|everolimus|mesh-list
2335447|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335448|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335449|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
2335450|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335451|NCT00426101|Cyclosporine|cyclosporine|mesh-list
2335452|NCT00426101|Dexamethasone|dexamethasone|mesh-list
2335453|NCT00426101|Etoposide|etoposide|mesh-list
2335454|NCT00426101|Cyclosporins|cyclosporins|mesh-list
2335455|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2918259|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918260|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
2918261|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2918262|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2918263|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918264|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2918265|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2918266|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2335456|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
2335457|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
2335458|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335459|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335460|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2335461|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
2335462|NCT00426101|Hormones|hormones|mesh-ancestor
2335463|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2335464|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2335465|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335466|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2335467|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2335468|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2335469|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335470|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335471|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335472|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
2335473|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
2335474|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2918267|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2918268|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2918269|NCT03207815|Prednisone|prednisone|mesh-list
2335475|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
2335476|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335477|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2335478|NCT00426140|Epothilone B|epothilone b|mesh-list
2335479|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335480|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
2335481|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
2335482|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
2335483|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335484|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
2335485|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918270|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2918271|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
2918272|NCT03207815|Hormones|hormones|mesh-ancestor
2918273|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918274|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918275|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2335486|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2335487|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335488|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335489|NCT00426192|Mannitol|mannitol|mesh-list
2335490|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2335491|NCT00426192|Diuretics|diuretics|mesh-ancestor
2335492|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
2335493|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335494|NCT00426296|Ritonavir|ritonavir|mesh-list
2918276|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918301|NCT03159936|Tofacitinib|tofacitinib|mesh-list
2918302|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918303|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2918304|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918305|NCT03156816|Colchicine|colchicine|mesh-list
2918306|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
2918307|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2918308|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
2918309|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
2918310|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
2918311|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918312|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918313|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2918314|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2918315|NCT03083665|Brivaracetam|brivaracetam|mesh-list
2918316|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
2918317|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
2335495|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2335496|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2335497|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2335498|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
2335499|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918318|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2918319|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918320|NCT03074513|Bevacizumab|bevacizumab|mesh-list
2918321|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2918322|NCT03074513|Atezolizumab|atezolizumab|mesh-list
2918323|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
2918324|NCT03074513|Antibodies|antibodies|mesh-list
2335500|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335501|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2335502|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2918325|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
2918326|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2918327|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
2918328|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918329|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2918330|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2918331|NCT03074513|Growth Substances|growth substances|mesh-ancestor
2918332|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918333|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
2335503|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
2335504|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335505|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2335506|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2335507|NCT00426348|Valsartan|valsartan|mesh-list
2335508|NCT00426348|Probucol|probucol|mesh-list
2335509|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2335510|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2335511|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2335512|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335513|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2918334|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
2918335|NCT03070886|Docetaxel|docetaxel|mesh-list
2918336|NCT03070886|Leuprolide|leuprolide|mesh-list
2335514|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2335515|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
2335516|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2335517|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
2335518|NCT00426348|Protective Agents|protective agents|mesh-ancestor
2335519|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335520|NCT00426413|Pioglitazone|pioglitazone|mesh-list
2335521|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2918337|NCT03070886|Goserelin|goserelin|mesh-list
2918338|NCT03070886|Bicalutamide|bicalutamide|mesh-list
2918339|NCT03070886|Flutamide|flutamide|mesh-list
2918340|NCT03070886|Nilutamide|nilutamide|mesh-list
2918341|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918342|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
2918343|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
2918344|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
2918345|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335522|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335523|NCT00426439|Chloroquine|chloroquine|mesh-list
2335524|NCT00426439|Lumefantrine|lumefantrine|mesh-list
2335525|NCT00426439|Artemether|artemether|mesh-list
2335526|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2335527|NCT00426439|Amebicides|amebicides|mesh-ancestor
2335528|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2335529|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2335530|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335531|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
2335532|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335533|NCT00426452|Vatalanib|vatalanib|mesh-list
2335534|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2335535|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918346|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2918347|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
2918348|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2918349|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918350|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2918351|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
2918352|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
2335536|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335537|NCT00426478|Amlodipine|amlodipine|mesh-list
2335538|NCT00426478|Valsartan|valsartan|mesh-list
2335539|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2918353|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918354|NCT03026062|Durvalumab|durvalumab|mesh-list
2918355|NCT03026062|Ipilimumab|ipilimumab|mesh-list
2918356|NCT03026062|Tremelimumab|tremelimumab|mesh-list
2918357|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
2918358|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2918359|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
2918360|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2918361|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918362|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
2918363|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918364|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2918365|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918366|NCT03019640|Cytarabine|cytarabine|mesh-list
2918367|NCT03019640|Rituximab|rituximab|mesh-list
2918368|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2335540|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2335541|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2335542|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2335543|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335544|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2335545|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335546|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
2335547|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2335548|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2335549|NCT00426478|Diuretics|diuretics|mesh-ancestor
2335550|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
2335551|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2335552|NCT00426491|Misoprostol|misoprostol|mesh-list
2335553|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2335554|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
2335555|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2918369|NCT03019640|Etoposide|etoposide|mesh-list
2918370|NCT03019640|Lenalidomide|lenalidomide|mesh-list
2918371|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
2918372|NCT03019640|Melphalan|melphalan|mesh-list
2918373|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
2918374|NCT03019640|Carmustine|carmustine|mesh-list
2918375|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
2918376|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2918377|NCT03019640|Antibodies|antibodies|mesh-list
2918378|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
2918379|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2918380|NCT03019640|Lenograstim|lenograstim|mesh-list
2918381|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
2918382|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918383|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918384|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2918385|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2918386|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2918387|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2918388|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918389|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918390|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2918391|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2918392|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
2918393|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
2918394|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2918395|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2918396|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2918397|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2918398|NCT03019640|Growth Substances|growth substances|mesh-ancestor
2918399|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
2918400|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2918401|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
2918402|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2918403|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
2918404|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
2918405|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
2918406|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
2918407|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
2335556|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335557|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2335558|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2335559|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
2335560|NCT00426530|Everolimus|everolimus|mesh-list
2335561|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335562|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335563|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
2335564|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335565|NCT00426543|Rituximab|rituximab|mesh-list
2335566|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335567|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335568|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
2335569|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335570|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335571|NCT00426582|Epothilone B|epothilone b|mesh-list
2918435|NCT02991937|Tazobactam|tazobactam|mesh-list
2918436|NCT02991937|Piperacillin|piperacillin|mesh-list
2918437|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2918438|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2918439|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2918440|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2918441|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918442|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918443|NCT02980731|Venetoclax|venetoclax|mesh-list
2918444|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918445|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
2918446|NCT02968563|Idelalisib|idelalisib|mesh-list
2918447|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335572|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335573|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
2335574|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
2918448|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918449|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918450|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918451|NCT02931890|Paclitaxel|paclitaxel|mesh-list
2918452|NCT02931890|Docetaxel|docetaxel|mesh-list
2918453|NCT02931890|Carboplatin|carboplatin|mesh-list
2918454|NCT02931890|Capecitabine|capecitabine|mesh-list
2918455|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
2918456|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2918457|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918458|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
2918459|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
2918460|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
2918461|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918462|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2918463|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
2918464|NCT02915783|Everolimus|everolimus|mesh-list
2918465|NCT02915783|Lenvatinib|lenvatinib|mesh-list
2918466|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918467|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2918468|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
2918469|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918470|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2918471|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918472|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918473|NCT02913482|Risdiplam|risdiplam|mesh-list
2918474|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2918475|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335575|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
2918476|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335576|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335577|NCT00426595|Omeprazole|omeprazole|mesh-list
2335578|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2335579|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2335580|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2335581|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335582|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335583|NCT00426608|Alprazolam|alprazolam|mesh-list
2335584|NCT00426608|Metyrapone|metyrapone|mesh-list
2335585|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2335586|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2335587|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335588|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2335589|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2335590|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2335591|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
2335592|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
2335593|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2335594|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335595|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
2918501|NCT02897648|Lactams|lactams|mesh-list
2918502|NCT02897648|beta-Lactams|beta-lactams|mesh-list
2918503|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2918504|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2918511|NCT02817659|Glucagon|glucagon|mesh-list
2918512|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2918513|NCT02817659|Hormones|hormones|mesh-ancestor
2918514|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918515|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918516|NCT02811510|Dronabinol|dronabinol|mesh-list
2918517|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
2918518|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918519|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2918520|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2918521|NCT02811510|Analgesics|analgesics|mesh-ancestor
2918522|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
2918523|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2918524|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2918525|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2918526|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2918527|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918528|NCT02811510|Hormones|hormones|mesh-ancestor
2918529|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918530|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
2918531|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2918532|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2335596|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335597|NCT00426621|Diclofenac|diclofenac|mesh-list
2335598|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2335599|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2335600|NCT00426621|Analgesics|analgesics|mesh-ancestor
2335601|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
2335602|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335603|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335604|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2335605|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335606|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2918533|NCT02798523|Prednisolone|prednisolone|mesh-list
2918534|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
2918535|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
2918536|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2918537|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
2918538|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2918539|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
2918540|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
2918541|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2918542|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918543|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2335607|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335608|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335609|NCT00426647|Buprenorphine|buprenorphine|mesh-list
2335610|NCT00426647|Tramadol|tramadol|mesh-list
2335611|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2335612|NCT00426647|Narcotics|narcotics|mesh-ancestor
2335613|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2335614|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918544|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
2918545|NCT02798523|Hormones|hormones|mesh-ancestor
2918546|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918547|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2918548|NCT02798523|Protective Agents|protective agents|mesh-ancestor
2335615|NCT00426647|Analgesics|analgesics|mesh-ancestor
2335616|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
2335617|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2918549|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2918550|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918551|NCT02796261|Eflornithine|eflornithine|mesh-list
2918552|NCT02796261|Lomustine|lomustine|mesh-list
2918553|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2918554|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
2918555|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918556|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918557|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2918558|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2918559|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2918560|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2918561|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2918562|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918563|NCT02787044|Vaccines|vaccines|mesh-list
2918564|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
2918565|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918566|NCT02782468|Azacitidine|azacitidine|mesh-list
2918567|NCT02782468|Pevonedistat|pevonedistat|mesh-list
2918568|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2918569|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
2918570|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918571|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918572|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918573|NCT02781519|Dronabinol|dronabinol|mesh-list
2918574|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
2918575|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918576|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2918577|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2918578|NCT02781519|Analgesics|analgesics|mesh-ancestor
2918579|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
2918580|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335618|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2335619|NCT00426673|Brivaracetam|brivaracetam|mesh-list
2335620|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
2335621|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
2918581|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2918582|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2918583|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2918584|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918585|NCT02781519|Hormones|hormones|mesh-ancestor
2918586|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918587|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
2918588|NCT02773732|Etoposide|etoposide|mesh-list
2918589|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2918590|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918591|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2918592|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2918593|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918594|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918595|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2918596|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2918597|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2918598|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2918599|NCT02764489|Thrombin|thrombin|mesh-list
2918600|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
2918601|NCT02764489|Coagulants|coagulants|mesh-list
2918602|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
2918603|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2918604|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2918605|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918606|NCT02659241|Adavosertib|adavosertib|mesh-list
2918607|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918608|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918609|NCT02607813|Spartalizumab|spartalizumab|mesh-list
2335622|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2335623|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
2335624|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335625|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
2335626|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
2335627|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2335628|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2335629|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335630|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2335631|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335632|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2335633|NCT00426829|Bevacizumab|bevacizumab|mesh-list
2335634|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335635|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335636|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2335637|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2335638|NCT00426829|Growth Substances|growth substances|mesh-ancestor
2335639|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335640|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
2918610|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2918611|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918612|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918613|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
2918614|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918615|NCT02586675|Tamoxifen|tamoxifen|mesh-list
2918616|NCT02586675|Goserelin|goserelin|mesh-list
2918617|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2918618|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
2918619|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918620|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918621|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2918622|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918623|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2918624|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2918625|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2918626|NCT02584478|Paclitaxel|paclitaxel|mesh-list
2918627|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2918628|NCT02584478|Carboplatin|carboplatin|mesh-list
2918629|NCT02584478|Doxorubicin|doxorubicin|mesh-list
2918630|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2918631|NCT02584478|Topotecan|topotecan|mesh-list
2918632|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2918633|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918634|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
2918635|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
2918636|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
2335641|NCT00426920|Insulin|insulin|mesh-list
2335642|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2335643|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335644|NCT00426933|Vancomycin|vancomycin|mesh-list
2335645|NCT00426933|Daptomycin|daptomycin|mesh-list
2335646|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2335647|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335648|NCT00426946|Reboxetine|reboxetine|mesh-list
2335649|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
2335650|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2335651|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2335652|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2918637|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918638|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2918639|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2918640|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2918641|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918642|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2918643|NCT02582905|Choline|choline|mesh-list
2918644|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2918645|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
2918646|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2918647|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
2918648|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918649|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2918650|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2335653|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2335654|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335655|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
2335656|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2335657|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335658|NCT00426972|Estradiol|estradiol|mesh-list
2335659|NCT00426972|Estrogens|estrogens|mesh-ancestor
2335660|NCT00426972|Hormones|hormones|mesh-ancestor
2335661|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2335662|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335663|NCT00426985|Ketoprofen|ketoprofen|mesh-list
2918651|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
2918652|NCT02572843|Durvalumab|durvalumab|mesh-list
2918653|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2918654|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335664|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2335665|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2335666|NCT00426985|Analgesics|analgesics|mesh-ancestor
2335667|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
2335668|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335669|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335670|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2335671|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335672|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2335673|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335674|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335675|NCT00426998|Bevacizumab|bevacizumab|mesh-list
2335676|NCT00426998|Verteporfin|verteporfin|mesh-list
2335677|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335678|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335679|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2335680|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2335681|NCT00426998|Growth Substances|growth substances|mesh-ancestor
2335682|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335683|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
2335684|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2918685|NCT02560805|Losartan|losartan|mesh-list
2918686|NCT02560805|Atenolol|atenolol|mesh-list
2918687|NCT02560805|Nitroprusside|nitroprusside|mesh-list
2918688|NCT02560805|Phenylephrine|phenylephrine|mesh-list
2918689|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
2918690|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2918691|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2918692|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2918693|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2918694|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918695|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2918696|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
2335685|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
2335686|NCT00427076|Vancomycin|vancomycin|mesh-list
2335687|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2335688|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2335689|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335690|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2335691|NCT00427076|Renal Agents|renal agents|mesh-ancestor
2335692|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
2335693|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2335694|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2335695|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
2335696|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2335697|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
2335698|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335699|NCT00427089|Protective Agents|protective agents|mesh-ancestor
2335700|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335701|NCT00427089|Vitamins|vitamins|mesh-ancestor
2335702|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
2335703|NCT00427089|Laxatives|laxatives|mesh-ancestor
2335704|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2335705|NCT00427102|Cisplatin|cisplatin|mesh-list
2335706|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335707|NCT00427128|Fluoxetine|fluoxetine|mesh-list
2335708|NCT00427128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2335709|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2335710|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2335711|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335712|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2335713|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
2335714|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335715|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2335716|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
2335717|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2335718|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2335719|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2335720|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335721|NCT00427154|Insulin|insulin|mesh-list
2335722|NCT00427154|Metformin|metformin|mesh-list
2335723|NCT00427154|Glimepiride|glimepiride|mesh-list
2335724|NCT00427154|Rosiglitazone|rosiglitazone|mesh-list
2918697|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
2918698|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2918699|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918700|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
2918701|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2918702|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
2918703|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
2335725|NCT00427154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2335726|NCT00427154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2335727|NCT00427154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335728|NCT00427154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2335729|NCT00427154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335730|NCT00427154|Immunologic Factors|immunologic factors|mesh-ancestor
2335731|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2335732|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2335733|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
2335734|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335735|NCT00427167|Antacids|antacids|mesh-ancestor
2335736|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335737|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2335738|NCT00427206|Acetaminophen|acetaminophen|mesh-list
2335739|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2335740|NCT00427206|Analgesics|analgesics|mesh-ancestor
2335741|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
2335742|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335743|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335744|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
2335745|NCT00427232|BQ 788|bq 788|mesh-list
2335746|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2335747|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2335748|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335749|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2335750|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
2335751|NCT00427245|Goserelin|goserelin|mesh-list
2335752|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335753|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
2335754|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335755|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335756|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2335757|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
2335758|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335759|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918704|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2918705|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2918706|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2335760|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2335761|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2335762|NCT00427271|Aspirin|aspirin|mesh-list
2335763|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2335764|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2918707|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
2918708|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2918709|NCT02560805|Protective Agents|protective agents|mesh-ancestor
2918710|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
2918711|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2918712|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2918713|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2918714|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
2918715|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2335765|NCT00427271|Analgesics|analgesics|mesh-ancestor
2335766|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
2335767|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335768|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335769|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2335770|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335771|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2335772|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2335773|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335774|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2335775|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2335776|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918716|NCT02557672|Thrombin|thrombin|mesh-list
2918717|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
2918718|NCT02557672|Coagulants|coagulants|mesh-ancestor
2918719|NCT02555787|Tacrolimus|tacrolimus|mesh-list
2918720|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2918721|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
2918722|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918723|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2918724|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918725|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918726|NCT02529930|Vaccines|vaccines|mesh-list
2918727|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
2335777|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
2335778|NCT00427310|Fluorouracil|fluorouracil|mesh-list
2335779|NCT00427310|Heparin|heparin|mesh-list
2918728|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918729|NCT02504151|Cannabidiol|cannabidiol|mesh-list
2918730|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
2918731|NCT02500407|Atezolizumab|atezolizumab|mesh-list
2918732|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918733|NCT02485418|Propofol|propofol|mesh-list
2918734|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2918735|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2918736|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918737|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2918738|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
2918739|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
2918740|NCT02467582|Aspirin|aspirin|mesh-list
2918741|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2918742|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2918743|NCT02467582|Analgesics|analgesics|mesh-ancestor
2918744|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
2918745|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2918746|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918747|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2918748|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2918749|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2918750|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2918751|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918752|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2918753|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2918754|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918755|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
2335780|NCT00427310|Calcium heparin|calcium heparin|mesh-list
2335781|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
2335782|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335783|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2335784|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335785|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335786|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
2335787|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335788|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
2335789|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2335790|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2335791|NCT00427362|Adalimumab|adalimumab|mesh-list
2335792|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2335793|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335794|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
2335795|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2335796|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2335797|NCT00427388|Prednisolone|prednisolone|mesh-list
2335798|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
2335799|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2335800|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
2335801|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2335802|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
2335803|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
2335804|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335805|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335806|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2335807|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
2335808|NCT00427388|Hormones|hormones|mesh-ancestor
2335809|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2335810|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2335811|NCT00427388|Protective Agents|protective agents|mesh-ancestor
2335812|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2335813|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335814|NCT00427414|Daunorubicin|daunorubicin|mesh-list
2335815|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335816|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2335817|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335818|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2335819|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2335820|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335821|NCT00427427|Trastuzumab|trastuzumab|mesh-list
2335822|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335823|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918812|NCT02367105|Testosterone|testosterone|mesh-list
2918813|NCT02367105|Androgens|androgens|mesh-ancestor
2918814|NCT02367105|Hormones|hormones|mesh-ancestor
2918815|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918816|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918817|NCT02352948|Gemcitabine|gemcitabine|mesh-list
2918818|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2918819|NCT02352948|Durvalumab|durvalumab|mesh-list
2918820|NCT02352948|Vinorelbine|vinorelbine|mesh-list
2918821|NCT02352948|Tremelimumab|tremelimumab|mesh-list
2918822|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2918823|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2918824|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
2918825|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918826|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918827|NCT02352948|Antiviral Agents|antiviral agents|mesh-ancestor
2918828|NCT02352948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2918829|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918830|NCT02352948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2918831|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
2918832|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918833|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2918834|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335824|NCT00427440|Rilotumumab|rilotumumab|mesh-list
2918835|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2918836|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
2918837|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
2918838|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
2918848|NCT02332590|Adalimumab|adalimumab|mesh-list
2918849|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2918850|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2918851|NCT02274571|Estrogens|estrogens|mesh-list
2918852|NCT02274571|Hormones|hormones|mesh-ancestor
2918853|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918854|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918855|NCT02269670|Tamoxifen|tamoxifen|mesh-list
2918856|NCT02269670|Everolimus|everolimus|mesh-list
2918857|NCT02269670|Letrozole|letrozole|mesh-list
2918858|NCT02269670|Fulvestrant|fulvestrant|mesh-list
2335825|NCT00427440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2335826|NCT00427440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335827|NCT00427440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335828|NCT00427440|Immunologic Factors|immunologic factors|mesh-ancestor
2335829|NCT00427440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335830|NCT00427466|Pemetrexed|pemetrexed|mesh-list
2335831|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335832|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335833|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335834|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2335835|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2335836|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
2335837|NCT00427492|Antacids|antacids|mesh-ancestor
2335838|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335839|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2335840|NCT00427505|Deferasirox|deferasirox|mesh-list
2335841|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2335842|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
2335843|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
2335844|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918859|NCT02269670|Anastrozole|anastrozole|mesh-list
2918860|NCT02269670|Megestrol|megestrol|mesh-list
2918861|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
2918862|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918863|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918864|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2918865|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
2918866|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918867|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2918868|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2335845|NCT00427570|Fluorouracil|fluorouracil|mesh-list
2335846|NCT00427570|Vincristine|vincristine|mesh-list
2335847|NCT00427570|Semustine|semustine|mesh-list
2335848|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
2335849|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
2335850|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335851|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2335852|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918869|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918870|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2335853|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335854|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
2335855|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335856|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2335857|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
2335858|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
2335859|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
2335860|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2335861|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2335862|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
2335863|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
2918871|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
2918872|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918873|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2335864|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335865|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2335866|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335867|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335868|NCT00427596|Solabegron|solabegron|mesh-list
2335869|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2918874|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2918875|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2918876|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2918877|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2918878|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2918879|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2918880|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2918881|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
2918882|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2918883|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2918884|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2918885|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
2918886|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2335870|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2335871|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2335872|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
2335873|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2335874|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335875|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335876|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2335877|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2335878|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335879|NCT00427713|Capecitabine|capecitabine|mesh-list
2335880|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
2335881|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2335882|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
2335883|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335884|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335885|NCT00427856|Rituximab|rituximab|mesh-list
2335886|NCT00427856|Obatoclax|obatoclax|mesh-list
2335887|NCT00427856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2918915|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
2918916|NCT02162420|Fludarabine|fludarabine|mesh-list
2918917|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
2918918|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2918919|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335888|NCT00427856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335889|NCT00427856|Immunologic Factors|immunologic factors|mesh-ancestor
2335890|NCT00427856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335891|NCT00427856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2918920|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
2918921|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918922|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2918923|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2918924|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
2918925|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918926|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918927|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2918928|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2918929|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
2918930|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335892|NCT00427856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335893|NCT00427856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335894|NCT00427882|Alfuzosin|alfuzosin|mesh-list
2335895|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2335896|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2335897|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2335898|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
2335899|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2335900|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335901|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335902|NCT00427882|Urological Agents|urological agents|mesh-ancestor
2335903|NCT00427947|Ropivacaine|ropivacaine|mesh-list
2335904|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
2918931|NCT02135042|Gemcitabine|gemcitabine|mesh-list
2918932|NCT02135042|Paclitaxel|paclitaxel|mesh-list
2918933|NCT02135042|Cisplatin|cisplatin|mesh-list
2918934|NCT02135042|Fluorouracil|fluorouracil|mesh-list
2918935|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2918936|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2918937|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918938|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
2918939|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
2918940|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
2918941|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918942|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2918943|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
2918944|NCT02135042|Antiviral Agents|antiviral agents|mesh-ancestor
2918945|NCT02135042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2918946|NCT02135042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918947|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2918948|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
2918949|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918950|NCT02051218|Denosumab|denosumab|mesh-list
2918951|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2918952|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918953|NCT01972217|Prednisone|prednisone|mesh-list
2918954|NCT01972217|Prednisolone|prednisolone|mesh-list
2918955|NCT01972217|Olaparib|olaparib|mesh-list
2918956|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2918957|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
2918958|NCT01972217|Hormones|hormones|mesh-ancestor
2918959|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2918960|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918961|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2918962|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2918963|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2918964|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2918965|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918966|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
2918967|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
2918968|NCT01822652|Fludarabine|fludarabine|mesh-list
2918969|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
2918970|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2918971|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
2918972|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918973|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2918974|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2918975|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
2918976|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918977|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335905|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
2918978|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2918979|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2918980|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2918981|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
2918982|NCT01821690|Buspirone|buspirone|mesh-list
2918983|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2918984|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2335906|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2335907|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335908|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
2335909|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335910|NCT00428025|Diclofenac|diclofenac|mesh-list
2335911|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2335912|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2335913|NCT00428025|Analgesics|analgesics|mesh-ancestor
2335914|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
2335915|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2335916|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335917|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2918985|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2918986|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2918987|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2918988|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2918989|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
2918990|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2918991|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2918992|NCT01816165|Acipimox|acipimox|mesh-list
2918993|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2918994|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
2918995|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335918|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335919|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2335920|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335921|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335922|NCT00428064|Cyclosporine|cyclosporine|mesh-list
2335923|NCT00428064|Sirolimus|sirolimus|mesh-list
2335924|NCT00428064|Cyclosporins|cyclosporins|mesh-list
2335925|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335926|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335927|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335928|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
2335929|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335930|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
2335931|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335932|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
2335933|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335934|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2335935|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2335936|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2335937|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335938|NCT00428129|Plasminogen|plasminogen|mesh-list
2335939|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2335940|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2335941|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335942|NCT00428142|Prednisone|prednisone|mesh-list
2335943|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
2335944|NCT00428142|Rituximab|rituximab|mesh-list
2335945|NCT00428142|Vincristine|vincristine|mesh-list
2335946|NCT00428142|Bortezomib|bortezomib|mesh-list
2335947|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2335948|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
2335949|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335950|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2335951|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2335952|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
2335953|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2335954|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335955|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2335956|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2335957|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2335958|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
2335959|NCT00428142|Hormones|hormones|mesh-ancestor
2335960|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2335961|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2335962|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2335963|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
2335964|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
2335965|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
2918996|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2918997|NCT01813929|Metformin|metformin|mesh-list
2918998|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2918999|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335966|NCT00428168|Betahistine|betahistine|mesh-list
2335967|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
2335968|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
2335969|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
2335970|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2335971|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919015|NCT01693783|Ipilimumab|ipilimumab|mesh-list
2919016|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2919017|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919018|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2919019|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919026|NCT01555281|Nelfinavir|nelfinavir|mesh-list
2335972|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335973|NCT00428181|Ethanol|ethanol|mesh-list
2335974|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2335975|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335976|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2919027|NCT01555281|Dexamethasone|dexamethasone|mesh-list
2919028|NCT01555281|Lenalidomide|lenalidomide|mesh-list
2919029|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2919030|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
2919031|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
2919032|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919033|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919034|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2919035|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
2919036|NCT01555281|Hormones|hormones|mesh-ancestor
2919037|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919038|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2919039|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919040|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
2919041|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2919042|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2919043|NCT01555281|Growth Substances|growth substances|mesh-ancestor
2919044|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
2919045|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2919046|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2919047|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
2919048|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919049|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919050|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2919051|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2919052|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
2919053|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919054|NCT01502085|Dexamethasone|dexamethasone|mesh-list
2919055|NCT01502085|Vorinostat|vorinostat|mesh-list
2919056|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2919057|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
2919058|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
2919059|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919060|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919061|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2919062|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
2919063|NCT01502085|Hormones|hormones|mesh-ancestor
2919064|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2335977|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335978|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2335979|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335980|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2335981|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2335982|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919065|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2919066|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919067|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2335983|NCT00428272|Interferons|interferons|mesh-list
2335984|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
2335985|NCT00428272|Lexatumumab|lexatumumab|mesh-list
2919068|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919069|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919070|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
2919071|NCT01413100|Plerixafor|plerixafor|mesh-list
2919072|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
2335986|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2335987|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2335988|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
2335989|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2335990|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
2335991|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335992|NCT00428311|Metformin|metformin|mesh-list
2335993|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
2335994|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2335995|NCT00428311|Estradiol|estradiol|mesh-list
2919073|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
2919074|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2919075|NCT01413100|Lenograstim|lenograstim|mesh-list
2919076|NCT01413100|Sargramostim|sargramostim|mesh-list
2919077|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2919078|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
2919079|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919080|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2919081|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2335996|NCT00428311|Cyproterone|cyproterone|mesh-list
2335997|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2335998|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2335999|NCT00428311|Estrogens|estrogens|mesh-ancestor
2336000|NCT00428311|Hormones|hormones|mesh-ancestor
2336001|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336002|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2336003|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
2336004|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2336005|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2336006|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2336007|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2336008|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
2336009|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
2336010|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336011|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2919082|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
2919083|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919084|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919085|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2919086|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2919087|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2919088|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2919089|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
2919090|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2919091|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919092|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919093|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2919094|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2919095|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
2336012|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2336013|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
2919096|NCT01294020|Tacrolimus|tacrolimus|mesh-list
2919097|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2919098|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
2336014|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2336015|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2919099|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919100|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2919101|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919102|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919103|NCT01178814|Lenalidomide|lenalidomide|mesh-list
2919104|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
2919105|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919106|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2919107|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2919108|NCT01178814|Growth Substances|growth substances|mesh-ancestor
2919109|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
2919110|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919111|NCT01125176|Thalidomide|thalidomide|mesh-list
2919112|NCT01125176|Rituximab|rituximab|mesh-list
2336016|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2336017|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2336018|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336019|NCT00428428|Isoproterenol|isoproterenol|mesh-list
2336020|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2336021|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2336022|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
2336023|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336024|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336025|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336026|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2336027|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
2336028|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336029|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2336030|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
2336031|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2336032|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
2336033|NCT00428428|Protective Agents|protective agents|mesh-ancestor
2919113|NCT01125176|Lenalidomide|lenalidomide|mesh-list
2919114|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2919115|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919116|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
2919117|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919118|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2919119|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2919120|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2919121|NCT01125176|Growth Substances|growth substances|mesh-ancestor
2919122|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
2919123|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2919124|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
2919125|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2919126|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919127|NCT00882050|Exenatide|exenatide|mesh-list
2919128|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2919129|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919130|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2919131|NCT00882050|Incretins|incretins|mesh-ancestor
2336034|NCT00428454|Sirolimus|sirolimus|mesh-list
2336035|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2336036|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336037|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2336038|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336039|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
2336040|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2336041|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
2336042|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336043|NCT00428480|Methamphetamine|methamphetamine|mesh-list
2336044|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2336045|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336046|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
2336047|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
2336048|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336049|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
2336050|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336051|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336052|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
2336053|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2336054|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2919132|NCT00882050|Hormones|hormones|mesh-ancestor
2919133|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919134|NCT00790829|Nicotine|nicotine|mesh-list
2336055|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2336056|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2919135|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2919136|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
2919137|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919138|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919139|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2919140|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2919141|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
2919142|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2919143|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919144|NCT00070564|Paclitaxel|paclitaxel|mesh-list
2919145|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
2919146|NCT00070564|Doxorubicin|doxorubicin|mesh-list
2919147|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2919148|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2919149|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919150|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
2919151|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
2919152|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
2919153|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919154|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2919155|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
2919156|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919157|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2919158|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2919159|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
2919160|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2919161|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2919162|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2919163|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2919164|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336057|NCT00428519|Aprepitant|aprepitant|mesh-list
2336058|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
2336059|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
2336060|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
2336061|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336062|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336063|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2336064|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2336065|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336066|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111433|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111434|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2111435|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
2336067|NCT00428545|Bevacizumab|bevacizumab|mesh-list
2336068|NCT00428545|Bortezomib|bortezomib|mesh-list
2919165|NCT05206955|Tadalafil|tadalafil|mesh-list
2919166|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
2919167|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2919168|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2919169|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919170|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919171|NCT05206955|Urological Agents|urological agents|mesh-ancestor
2919172|NCT05206877|Insulin|insulin|mesh-list
2919173|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2919174|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2919175|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919176|NCT05206812|Durvalumab|durvalumab|mesh-list
2919177|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2919178|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919179|NCT05206747|Methamphetamine|methamphetamine|mesh-list
2919180|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2919181|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919182|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
2919183|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
2919184|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919185|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
2919186|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2919187|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919188|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
2919189|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2919190|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2919191|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2919192|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2919193|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
2919194|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2919195|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919196|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
2919197|NCT05206682|Goserelin|goserelin|mesh-list
2111436|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111437|NCT02554903|Macitentan|macitentan|mesh-list
2111438|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2111439|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2111440|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111441|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2111442|NCT02554981|Cyclosporine|cyclosporine|mesh-list
2111443|NCT02554981|Cyclosporins|cyclosporins|mesh-list
2111444|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111445|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111446|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2111447|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
2111448|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111449|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
2111450|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2111451|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
2111452|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2111453|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2111454|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2111455|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
2111456|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2111457|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
2111458|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111459|NCT02555228|Simethicone|simethicone|mesh-list
2111460|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
2114047|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2919198|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2919199|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919200|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2919201|NCT05206500|Amoxicillin|amoxicillin|mesh-list
2919202|NCT05206500|Metronidazole|metronidazole|mesh-list
2919203|NCT05206500|Clindamycin|clindamycin|mesh-list
2919204|NCT05206500|Linezolid|linezolid|mesh-list
2919205|NCT05206500|Tetracycline|tetracycline|mesh-list
2919206|NCT05206500|Penicillins|penicillins|mesh-list
2919207|NCT05206500|Ampicillin|ampicillin|mesh-list
2919208|NCT05206500|Fosfomycin|fosfomycin|mesh-list
2919209|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
2919210|NCT05206500|Cephalosporins|cephalosporins|mesh-list
2919211|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
2919212|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919213|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2919214|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2919215|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2919216|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919217|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919218|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2919219|NCT05206500|Renal Agents|renal agents|mesh-ancestor
2919220|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2919221|NCT05206448|Letrozole|letrozole|mesh-list
2919222|NCT05206448|Clomiphene|clomiphene|mesh-list
2919223|NCT05206448|Enclomiphene|enclomiphene|mesh-list
2919224|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
2919225|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919226|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919227|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2919228|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2919229|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919230|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2919231|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
2336069|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2336070|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336071|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2336072|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2919232|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919233|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919234|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2919235|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
2919236|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2919237|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2919238|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2919239|NCT05206435|Nicotine|nicotine|mesh-list
2919240|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2919241|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
2919242|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919243|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919244|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2919245|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2919246|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
2919247|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336073|NCT00428545|Growth Substances|growth substances|mesh-ancestor
2336074|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336075|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
2336076|NCT00428558|Cytarabine|cytarabine|mesh-list
2336077|NCT00428558|Daunorubicin|daunorubicin|mesh-list
2336078|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2336079|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
2336080|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336081|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336082|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
2336083|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336084|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2919248|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919249|NCT05206318|Cysteamine|cysteamine|mesh-list
2919250|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2919251|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919252|NCT05206266|Turmeric extract|turmeric extract|mesh-list
2919253|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
2919254|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919255|NCT05206266|Protective Agents|protective agents|mesh-ancestor
2919256|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919257|NCT05206175|Methamphetamine|methamphetamine|mesh-list
2919258|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2919259|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919260|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
2919261|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
2919262|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919263|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
2919264|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2919265|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919266|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
2919267|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2919268|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2919269|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2919270|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2919271|NCT05206110|Ketorolac|ketorolac|mesh-list
2919272|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2919273|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2919274|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2919275|NCT05206110|Analgesics|analgesics|mesh-ancestor
2919276|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
2919277|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919278|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919279|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2919280|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2919281|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2919282|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919283|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919284|NCT05206084|Sirolimus|sirolimus|mesh-list
2919285|NCT05206084|Everolimus|everolimus|mesh-list
2919286|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919287|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2919288|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
2919289|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919290|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2919291|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919292|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2919293|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
2919294|NCT05205837|Letrozole|letrozole|mesh-list
2919295|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919296|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2919297|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2919298|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919299|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919300|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2919301|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
2919302|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919303|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919304|NCT05205811|Zonisamide|zonisamide|mesh-list
2919305|NCT05205811|Bupropion|bupropion|mesh-list
2919306|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2336085|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
2336086|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336087|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2336088|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2336089|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2336090|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336091|NCT00428649|Selenium|selenium|mesh-list
2336092|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
2336093|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336094|NCT00428649|Protective Agents|protective agents|mesh-ancestor
2919307|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
2919308|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2919309|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2919310|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2919311|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2919312|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919313|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
2919314|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2919315|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919316|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2919317|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2919318|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919319|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
2336095|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919320|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2919321|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2919322|NCT05205720|Ropivacaine|ropivacaine|mesh-list
2919323|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
2919324|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
2336096|NCT00428649|Trace Elements|trace elements|mesh-ancestor
2336097|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
2336098|NCT00428701|Esomeprazole|esomeprazole|mesh-list
2336099|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2336100|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2336101|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2336102|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336103|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336104|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
2336105|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2336106|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
2336107|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336108|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336109|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2336110|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
2336111|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2919325|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2919326|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919327|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
2919328|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919329|NCT05205603|Mesalamine|mesalamine|mesh-list
2919330|NCT05205603|Infliximab|infliximab|mesh-list
2919331|NCT05205603|Vedolizumab|vedolizumab|mesh-list
2919332|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
2919333|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2919334|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2919335|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2919336|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2919337|NCT05205603|Analgesics|analgesics|mesh-ancestor
2919338|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
2919339|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919340|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919341|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2919342|NCT05205577|Iodine|iodine|mesh-list
2919343|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2919344|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919345|NCT05205577|Trace Elements|trace elements|mesh-ancestor
2919346|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
2919347|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919348|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2919349|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2919350|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919351|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
2919352|NCT05205499|Sirolimus|sirolimus|mesh-list
2919353|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2919354|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919355|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2919356|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919357|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
2919358|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2919359|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
2919360|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919361|NCT05205486|Cefazolin|cefazolin|mesh-list
2919362|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2919363|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919364|NCT05205473|Lidocaine|lidocaine|mesh-list
2919365|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
2919366|NCT05205473|Anesthetics|anesthetics|mesh-ancestor
2919367|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2919368|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919369|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
2919370|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919371|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2919372|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2919373|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2919374|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2919375|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919376|NCT05205447|Itraconazole|itraconazole|mesh-list
2336112|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
2919377|NCT05205447|Carbamazepine|carbamazepine|mesh-list
2919378|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
2919379|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919380|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2919381|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2919382|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919383|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919384|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2336113|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336114|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336115|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2336116|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
2336117|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
2336118|NCT00428727|Protective Agents|protective agents|mesh-ancestor
2336119|NCT00428766|Farletuzumab|farletuzumab|mesh-list
2336120|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336121|NCT00428818|Doxycycline|doxycycline|mesh-list
2336122|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2919385|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
2919386|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919387|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919388|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2919389|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
2919390|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
2919391|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2919392|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2919393|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2919394|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2919395|NCT05205447|Analgesics|analgesics|mesh-ancestor
2919396|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
2919397|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919398|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2919399|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2919400|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2919401|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2919402|NCT05205382|Nicotine|nicotine|mesh-list
2919403|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2919404|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
2336123|NCT00428818|Trimethoprim|trimethoprim|mesh-list
2336124|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
2919405|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919406|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919407|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2919408|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2919409|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
2919410|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2919411|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919412|NCT05205317|Metformin|metformin|mesh-list
2919413|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2919414|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919415|NCT05205252|Dexamethasone|dexamethasone|mesh-list
2919416|NCT05205252|Dexamethasone acetate|dexamethasone acetate|mesh-list
2919417|NCT05205252|Lenalidomide|lenalidomide|mesh-list
2919418|NCT05205252|Daratumumab|daratumumab|mesh-list
2919419|NCT05205252|Pomalidomide|pomalidomide|mesh-list
2919420|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
2919421|NCT05205252|BB 1101|bb 1101|mesh-list
2919422|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2919423|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2919424|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
2919425|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
2919426|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919427|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919428|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2336125|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2336126|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336127|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
2336128|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2919429|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
2919430|NCT05205252|Hormones|hormones|mesh-ancestor
2919431|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919432|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2919433|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336129|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2336130|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2336131|NCT00428818|Renal Agents|renal agents|mesh-ancestor
2336132|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2336133|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336134|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336135|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2336136|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2336137|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2336138|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
2336139|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2336140|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
2336141|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336142|NCT00428883|Expectorants|expectorants|mesh-ancestor
2336143|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
2336144|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2336145|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
2336146|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336147|NCT00428883|Protective Agents|protective agents|mesh-ancestor
2336148|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336149|NCT00428883|Antidotes|antidotes|mesh-ancestor
2336150|NCT00428896|Gefitinib|gefitinib|mesh-list
2336151|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336152|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2336153|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336154|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336155|NCT00428909|Acetaminophen|acetaminophen|mesh-list
2336156|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
2336157|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2336158|NCT00428909|Analgesics|analgesics|mesh-ancestor
2336159|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
2336160|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336161|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336162|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
2336163|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336164|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2336165|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336166|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336167|NCT00429065|Rituximab|rituximab|mesh-list
2336168|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2336169|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336170|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
2336171|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336172|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2336173|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2336174|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2336175|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2336176|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2336177|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919434|NCT05205252|Protease Inhibitors|protease inhibitors|mesh-ancestor
2919435|NCT05205252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919436|NCT05205252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919437|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
2919438|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2919439|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2919440|NCT05205252|Growth Substances|growth substances|mesh-ancestor
2919441|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
2919442|NCT05205200|Paclitaxel|paclitaxel|mesh-list
2919443|NCT05205200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2919444|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2919445|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919446|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
2919447|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
2919448|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
2919449|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919450|NCT05205122|Mitomycins|mitomycins|mesh-list
2919451|NCT05205122|Mitomycin|mitomycin|mesh-list
2919452|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2919453|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919454|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
2919455|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919456|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2919457|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919458|NCT05204979|Misoprostol|misoprostol|mesh-list
2919459|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2919460|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
2919461|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2919462|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336178|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
2919463|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2919464|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2919465|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
2919466|NCT05204927|Prednisone|prednisone|mesh-list
2919467|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2919468|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
2919469|NCT05204927|Hormones|hormones|mesh-ancestor
2919470|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919471|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919472|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2919473|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919474|NCT05204862|Antibodies|antibodies|mesh-list
2919475|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
2919476|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919477|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
2919478|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2919479|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919480|NCT05204667|Acetaminophen|acetaminophen|mesh-list
2919481|NCT05204667|Aspirin|aspirin|mesh-list
2919482|NCT05204667|Methocarbamol|methocarbamol|mesh-list
2919483|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2919484|NCT05204667|Analgesics|analgesics|mesh-ancestor
2919485|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
2919486|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919487|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919488|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
2919489|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2919490|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2919491|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2919492|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2919493|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2919494|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919495|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2919496|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2919497|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919498|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2919499|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2919500|NCT05204641|Rifaximin|rifaximin|mesh-list
2919501|NCT05204641|Levodopa|levodopa|mesh-list
2919502|NCT05204641|Benserazide|benserazide|mesh-list
2336179|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336180|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336181|NCT00429208|Nicotine|nicotine|mesh-list
2336182|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2336183|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
2336184|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336185|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336186|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2336187|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2336188|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
2336189|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336190|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336191|NCT00429234|Gemcitabine|gemcitabine|mesh-list
2336192|NCT00429234|Dasatinib|dasatinib|mesh-list
2919503|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2919504|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2336193|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2336194|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
2336195|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336196|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336197|NCT00429234|Antiviral Agents|antiviral agents|mesh-ancestor
2336198|NCT00429234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336199|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336200|NCT00429234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2336201|NCT00429234|Immunologic Factors|immunologic factors|mesh-ancestor
2336202|NCT00429234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336203|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2336204|NCT00429247|Trastuzumab|trastuzumab|mesh-list
2336205|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2336206|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336207|NCT00429377|Tacrolimus|tacrolimus|mesh-list
2336208|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2336209|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
2336210|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336211|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2919505|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
2336212|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336213|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336214|NCT00429442|Simvastatin|simvastatin|mesh-list
2336215|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2336216|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2336217|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
2336218|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336219|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2336220|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2336221|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336222|NCT00429468|Acetaminophen|acetaminophen|mesh-list
2336223|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2336224|NCT00429468|Hydrocodone|hydrocodone|mesh-list
2336225|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2336226|NCT00429468|Analgesics|analgesics|mesh-ancestor
2336227|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
2336228|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336229|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336230|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
2919506|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2919507|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919508|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919509|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2919510|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919511|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2919512|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919513|NCT05204628|Crizotinib|crizotinib|mesh-list
2919514|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919515|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2919516|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919517|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919518|NCT05204563|Imipenem|imipenem|mesh-list
2919519|NCT05204563|Relebactam|relebactam|mesh-list
2919520|NCT05204563|Cilastatin|cilastatin|mesh-list
2919521|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2919522|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919523|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
2919524|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919525|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919526|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2919527|NCT05204550|Heparin|heparin|mesh-list
2919528|NCT05204550|Calcium heparin|calcium heparin|mesh-list
2919529|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
2336231|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2336232|NCT00429468|Narcotics|narcotics|mesh-ancestor
2336233|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2336234|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
2336235|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
2336236|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2336237|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2336238|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2919530|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2919531|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2919532|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919533|NCT05204524|Temozolomide|temozolomide|mesh-list
2919534|NCT05204524|Epirubicin|epirubicin|mesh-list
2919535|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2919536|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
2919537|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919538|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919539|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2919540|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2919541|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2919542|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919543|NCT05204368|Meropenem|meropenem|mesh-list
2919544|NCT05204368|Imipenem|imipenem|mesh-list
2919545|NCT05204368|Cilastatin|cilastatin|mesh-list
2919546|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2919547|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919548|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
2919549|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919550|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336239|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
2336240|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2919551|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2919552|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2919553|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
2919554|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2919555|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919556|NCT05204173|Paclitaxel|paclitaxel|mesh-list
2919557|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2919558|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919559|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
2919560|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
2919561|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
2919562|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919563|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
2919564|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2919565|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919566|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2919567|NCT05204147|Antibodies|antibodies|mesh-list
2919568|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
2919569|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2919570|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
2919571|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
2919572|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919573|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919574|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
2919575|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
2919576|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919577|NCT05204134|Insulin|insulin|mesh-list
2919578|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2919579|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919580|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
2919581|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2919582|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2919583|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
2919584|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919585|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
2919586|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
2919587|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
2919588|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919589|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919590|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
2919591|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2919592|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2919593|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
2919594|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2919595|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919596|NCT05204056|Epinephrine|epinephrine|mesh-list
2919597|NCT05204056|Morphine|morphine|mesh-list
2919598|NCT05204056|Ropivacaine|ropivacaine|mesh-list
2919599|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
2919600|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2919601|NCT05204056|Narcotics|narcotics|mesh-ancestor
2919602|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2336241|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
2336242|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336243|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
2336244|NCT00429520|Protective Agents|protective agents|mesh-ancestor
2336245|NCT00429533|Dapsone|dapsone|mesh-list
2336246|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336247|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
2336248|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2919603|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919604|NCT05204056|Analgesics|analgesics|mesh-ancestor
2919605|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
2919606|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919607|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
2919608|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
2919609|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2919610|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2919611|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
2919612|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2919613|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919614|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2919615|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2919616|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
2336249|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2919617|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2919618|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
2919619|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
2919620|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
2919621|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2919622|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2919623|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2336250|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2336251|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336252|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919624|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
2919625|NCT05204056|Coagulants|coagulants|mesh-ancestor
2919626|NCT05203913|Paclitaxel|paclitaxel|mesh-list
2919627|NCT05203913|Nivolumab|nivolumab|mesh-list
2919628|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2919629|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919630|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
2919631|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
2919632|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
2919633|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919634|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2919635|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2919636|NCT05203822|Itraconazole|itraconazole|mesh-list
2919637|NCT05203822|Tepotinib|tepotinib|mesh-list
2919638|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
2919639|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919640|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2919641|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2919642|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919643|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919644|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2919645|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
2919646|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919647|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919648|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2919649|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919650|NCT05203744|Tafenoquine|tafenoquine|mesh-list
2919651|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
2919652|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2919653|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2919654|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919655|NCT05203705|Enoxaparin|enoxaparin|mesh-list
2919656|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
2919657|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2919658|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2919659|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919660|NCT05203588|Vitamin D|vitamin d|mesh-list
2919661|NCT05203588|Denosumab|denosumab|mesh-list
2919662|NCT05203588|Calcium|calcium|mesh-list
2919663|NCT05203588|Vitamins|vitamins|mesh-ancestor
2919664|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
2919665|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919666|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2919667|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2919668|NCT05203562|Letrozole|letrozole|mesh-list
2919669|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336253|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
2336254|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2336255|NCT00429559|Gemcitabine|gemcitabine|mesh-list
2336256|NCT00429559|Topotecan|topotecan|mesh-list
2336257|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2919670|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2919671|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2919672|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919673|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919674|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2919675|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
2919676|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919677|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919678|NCT05203510|Treprostinil|treprostinil|mesh-list
2919679|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2336258|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
2336259|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336260|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336261|NCT00429559|Antiviral Agents|antiviral agents|mesh-ancestor
2336262|NCT00429559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336263|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336264|NCT00429559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2919687|NCT05203432|Atropine|atropine|mesh-list
2919688|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2919689|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2919690|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2919691|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
2919692|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919693|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919694|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2919695|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
2919696|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
2919697|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
2919698|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2919699|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2919700|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
2919701|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2919702|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919703|NCT05203354|Acitretin|acitretin|mesh-list
2919704|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
2919705|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
2919706|NCT05203276|Endostar protein|endostar protein|mesh-list
2919707|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2919708|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2919709|NCT05203276|Growth Substances|growth substances|mesh-ancestor
2919710|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919711|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
2919712|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336265|NCT00429559|Immunologic Factors|immunologic factors|mesh-ancestor
2336266|NCT00429559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336267|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2336268|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2336269|NCT00429624|Acetaminophen|acetaminophen|mesh-list
2336270|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2336271|NCT00429624|Analgesics|analgesics|mesh-ancestor
2336272|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
2336273|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336274|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919713|NCT05203172|Cetuximab|cetuximab|mesh-list
2919714|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2919715|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919716|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2919717|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
2919718|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
2919719|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919720|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
2919721|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919722|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2919723|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336275|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
2336276|NCT00429676|Haloperidol|haloperidol|mesh-list
2336277|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
2336278|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
2336279|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
2336280|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336281|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336282|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2336283|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2336284|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2336285|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2336286|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2336287|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2336288|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
2336289|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336290|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336291|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2336292|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
2336293|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2336294|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
2336295|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919724|NCT05202860|Vaccines|vaccines|mesh-list
2336296|NCT00429754|Aprepitant|aprepitant|mesh-list
2336297|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
2336298|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
2336299|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336300|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336301|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2336302|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2336303|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336304|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919725|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
2919726|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919727|NCT05202821|Fluorides|fluorides|mesh-list
2919728|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
2919729|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
2919730|NCT05202821|Protective Agents|protective agents|mesh-ancestor
2919731|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919732|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
2919733|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919734|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2919735|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919736|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919737|NCT05199662|Tenecteplase|tenecteplase|mesh-list
2919738|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2919739|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2919740|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919741|NCT05199194|Tenecteplase|tenecteplase|mesh-list
2336305|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
2336306|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2336307|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
2336308|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336309|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2336310|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2336311|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
2919742|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2919743|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2919744|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919745|NCT05198388|Endorphins|endorphins|mesh-list
2919746|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2919747|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919748|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919749|NCT05198128|Calcium|calcium|mesh-list
2919750|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2919751|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919752|NCT05194293|Durvalumab|durvalumab|mesh-list
2919753|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
2919754|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2919755|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
2919756|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2919757|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919758|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
2336312|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336313|NCT00429832|Promethazine|promethazine|mesh-list
2336314|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
2336315|NCT00429832|Ondansetron|ondansetron|mesh-list
2336316|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
2336317|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
2336318|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336319|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336320|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2336321|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
2336322|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
2336323|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2336324|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
2919759|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919767|NCT05185089|Maleic acid|maleic acid|mesh-list
2919768|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336325|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336326|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919769|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919773|NCT05183412|Methamphetamine|methamphetamine|mesh-list
2919774|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2919775|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919776|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
2919777|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
2919778|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919779|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
2919780|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336327|NCT00429832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2336328|NCT00429832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2336329|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2336330|NCT00429832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2336331|NCT00429832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2336332|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2336333|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
2336334|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
2336335|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2336336|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2336337|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2336338|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
2336339|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
2336340|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
2336341|NCT00429871|Docetaxel|docetaxel|mesh-list
2336342|NCT00429871|Capecitabine|capecitabine|mesh-list
2336343|NCT00429871|Epirubicin|epirubicin|mesh-list
2919781|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919782|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
2919783|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2919784|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2919785|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2919786|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2919787|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
2919788|NCT05181527|Serotonin|serotonin|mesh-list
2919789|NCT05181527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2919790|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
2336344|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336345|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
2336346|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
2336347|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
2336348|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336349|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2336350|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
2336351|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2336352|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2336353|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2336354|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336355|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
2919791|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
2919792|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2919793|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2919794|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2919795|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919796|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919797|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2919798|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
2919799|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2919800|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2919801|NCT05180032|Denosumab|denosumab|mesh-list
2919802|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2919803|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919804|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2919805|NCT05178485|Bupivacaine|bupivacaine|mesh-list
2919806|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
2919807|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
2919808|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2919809|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336356|NCT00429897|Amiloride|amiloride|mesh-list
2336357|NCT00429897|Spironolactone|spironolactone|mesh-list
2336358|NCT00429897|Furosemide|furosemide|mesh-list
2336359|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2336360|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
2336361|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336362|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336363|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2336364|NCT00429897|Diuretics|diuretics|mesh-ancestor
2336365|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
2336366|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2336367|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2336368|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2336369|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336370|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2919810|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
2919811|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919812|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2919813|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
2919814|NCT05178485|Hormones|hormones|mesh-ancestor
2919815|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919816|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2919817|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
2919818|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
2919819|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2919820|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919821|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2919822|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2919823|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
2919824|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919825|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336371|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2336372|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2336373|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2336374|NCT00429936|Fenretinide|fenretinide|mesh-list
2336375|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336376|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2336377|NCT00429936|Protective Agents|protective agents|mesh-ancestor
2336378|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336379|NCT00429962|Ranibizumab|ranibizumab|mesh-list
2336380|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2336381|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2336382|NCT00429962|Growth Substances|growth substances|mesh-ancestor
2336383|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919826|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2919827|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2919828|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2919829|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2919830|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
2919831|NCT05171686|Torsemide|torsemide|mesh-list
2919832|NCT05171686|Furosemide|furosemide|mesh-list
2336384|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
2336385|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919833|NCT05171686|Bumetanide|bumetanide|mesh-list
2919834|NCT05171686|Diuretics|diuretics|mesh-list
2919835|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2919836|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
2919837|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919838|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2919839|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2919840|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919841|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2336386|NCT00429975|Levofloxacin|levofloxacin|mesh-list
2336387|NCT00429975|Ofloxacin|ofloxacin|mesh-list
2336388|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
2336389|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2336390|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336391|NCT00429975|Renal Agents|renal agents|mesh-ancestor
2336392|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2336393|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2336394|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2336395|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336396|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336397|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919845|NCT05169567|Fulvestrant|fulvestrant|mesh-list
2919846|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2919847|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919848|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2919849|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2919850|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
2919851|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919852|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919853|NCT05168813|Vaccines|vaccines|mesh-list
2919854|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
2919855|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919856|NCT05167370|Amifostine|amifostine|mesh-list
2919857|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2919858|NCT05167370|Protective Agents|protective agents|mesh-ancestor
2336398|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2336399|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2336400|NCT00430001|Docetaxel|docetaxel|mesh-list
2336401|NCT00430001|Trastuzumab|trastuzumab|mesh-list
2919859|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919863|NCT05156879|Aspirin|aspirin|mesh-list
2919864|NCT05156879|Drospirenone|drospirenone|mesh-list
2336402|NCT00430001|Vinorelbine|vinorelbine|mesh-list
2336403|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336404|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
2336405|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
2336406|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
2336407|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336408|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2336409|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2336410|NCT00430040|Carvedilol|carvedilol|mesh-list
2336411|NCT00430040|Lisinopril|lisinopril|mesh-list
2336412|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2336413|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2336414|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
2336415|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336416|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336417|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336418|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2336419|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
2336420|NCT00430040|Protective Agents|protective agents|mesh-ancestor
2336421|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2336422|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2336423|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2336424|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
2919865|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2919866|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2919867|NCT05156879|Estradiol|estradiol|mesh-list
2919868|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2919869|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2919870|NCT05156879|Analgesics|analgesics|mesh-ancestor
2919871|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
2919872|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919873|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919874|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2919875|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2919876|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2919877|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2919878|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919879|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2919880|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2919881|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919882|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
2919883|NCT05156879|Estrogens|estrogens|mesh-ancestor
2919884|NCT05156879|Hormones|hormones|mesh-ancestor
2336425|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2336426|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2336427|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2919885|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919886|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2919887|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
2336428|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
2336429|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336430|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2336431|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
2336432|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336433|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2336434|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919888|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2919889|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2919890|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2919891|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2919892|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2919893|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
2919894|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2336435|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336436|NCT00430079|Etanidazole|etanidazole|mesh-list
2336437|NCT00430079|Imidazole|imidazole|mesh-list
2336438|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336439|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336440|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336441|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
2336442|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2336443|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
2919895|NCT05156879|Diuretics|diuretics|mesh-ancestor
2919896|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
2919897|NCT05156710|Rituximab|rituximab|mesh-list
2919898|NCT05156710|Tacrolimus|tacrolimus|mesh-list
2919899|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
2919900|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2919901|NCT05156710|Antibodies|antibodies|mesh-list
2919902|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2919903|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
2919904|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2919905|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2919906|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919907|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
2919908|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919909|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2919910|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2919911|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2919912|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919913|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919928|NCT05147662|Factor VIII|factor viii|mesh-list
2919929|NCT05147662|Coagulants|coagulants|mesh-ancestor
2919930|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
2919931|NCT05145309|Cathartics|cathartics|mesh-ancestor
2919932|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2336444|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919948|NCT05138575|Empagliflozin|empagliflozin|mesh-list
2919949|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2919950|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919951|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2919952|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919953|NCT05136560|Dexamethasone|dexamethasone|mesh-list
2919954|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
2919955|NCT05136560|BB 1101|bb 1101|mesh-list
2919956|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2919957|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
2919958|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
2919959|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919960|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919961|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2919962|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
2919963|NCT05136560|Hormones|hormones|mesh-ancestor
2919964|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2919965|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2919966|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919967|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
2919968|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919969|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919970|NCT05132582|Trastuzumab|trastuzumab|mesh-list
2919971|NCT05132582|Pertuzumab|pertuzumab|mesh-list
2919972|NCT05132582|Tucatinib|tucatinib|mesh-list
2336445|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2336446|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2336447|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
2336448|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336449|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336450|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2336451|NCT00430118|Cytarabine|cytarabine|mesh-list
2336452|NCT00430118|Dexamethasone|dexamethasone|mesh-list
2336453|NCT00430118|Prednisone|prednisone|mesh-list
2336454|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
2336455|NCT00430118|Ifosfamide|ifosfamide|mesh-list
2336456|NCT00430118|Doxorubicin|doxorubicin|mesh-list
2336457|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2336458|NCT00430118|Methotrexate|methotrexate|mesh-list
2336459|NCT00430118|Etoposide|etoposide|mesh-list
2336460|NCT00430118|Vincristine|vincristine|mesh-list
2336461|NCT00430118|Daunorubicin|daunorubicin|mesh-list
2336462|NCT00430118|Asparaginase|asparaginase|mesh-list
2336463|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
2336464|NCT00430118|Thioguanine|thioguanine|mesh-list
2336465|NCT00430118|Vindesine|vindesine|mesh-list
2336466|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2336467|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
2336468|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336469|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2336470|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2336471|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
2336472|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336473|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336474|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2336475|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2336476|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
2336477|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
2336478|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919973|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2919974|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919975|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2919976|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919977|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336479|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2336480|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
2336481|NCT00430118|Hormones|hormones|mesh-ancestor
2336482|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336483|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2336484|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2336485|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2336486|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2336487|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336488|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2336489|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
2336490|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2919978|NCT05126264|Ibuprofen|ibuprofen|mesh-list
2919979|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2919980|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2336491|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2336492|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
2336493|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
2336494|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2336495|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2336496|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2336497|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
2336498|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336499|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
2336500|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
2336501|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
2336502|NCT00430144|Belotecan|belotecan|mesh-list
2336503|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2336504|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2336505|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336506|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336507|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336508|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
2336509|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2336510|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2336511|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336512|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336513|NCT00430170|Dipyridamole|dipyridamole|mesh-list
2336514|NCT00430170|Caffeine|caffeine|mesh-list
2336515|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2336516|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336517|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2336518|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336519|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336520|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2336521|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2336522|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
2336523|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336524|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2336525|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
2336526|NCT00430196|Tizanidine|tizanidine|mesh-list
2336527|NCT00430196|Analgesics|analgesics|mesh-ancestor
2336528|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
2336529|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336530|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336531|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
2336532|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2336533|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2919981|NCT05126264|Analgesics|analgesics|mesh-ancestor
2919982|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
2919983|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2919984|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919985|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2919986|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2919987|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2919988|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2919989|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2919990|NCT05125523|Sirolimus|sirolimus|mesh-list
2919991|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2919992|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2919993|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2919994|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2919995|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
2919996|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2919997|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
2919998|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2919999|NCT05124678|Isoniazid|isoniazid|mesh-list
2920000|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
2920001|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2920002|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920003|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2920004|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2920005|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
2920006|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920007|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2920008|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
2920009|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2920010|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
2920011|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920012|NCT05123365|Expectorants|expectorants|mesh-ancestor
2920013|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
2920014|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2920015|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
2920016|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920017|NCT05123365|Protective Agents|protective agents|mesh-ancestor
2920018|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920019|NCT05123365|Antidotes|antidotes|mesh-ancestor
2336534|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
2336535|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
2336536|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2336537|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2336538|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2336539|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
2336540|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336541|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336542|NCT00430235|Sorafenib|sorafenib|mesh-list
2336543|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336544|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2336545|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336546|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336547|NCT00430261|Sunitinib|sunitinib|mesh-list
2336548|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336549|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2336550|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2336551|NCT00430261|Growth Substances|growth substances|mesh-ancestor
2336552|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336553|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
2336554|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2336555|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336556|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336557|NCT00430365|Lenalidomide|lenalidomide|mesh-list
2336558|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
2336559|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336560|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2336561|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2336562|NCT00430365|Growth Substances|growth substances|mesh-ancestor
2336563|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
2336564|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920020|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
2920021|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920022|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920023|NCT05118776|Bevacizumab|bevacizumab|mesh-list
2920024|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920025|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920026|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2920027|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2920028|NCT05118776|Growth Substances|growth substances|mesh-ancestor
2920029|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920030|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
2920031|NCT05118724|Atezolizumab|atezolizumab|mesh-list
2920032|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920033|NCT05116189|Paclitaxel|paclitaxel|mesh-list
2920034|NCT05116189|Docetaxel|docetaxel|mesh-list
2920035|NCT05116189|Bevacizumab|bevacizumab|mesh-list
2920036|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
2920037|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2920038|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920039|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
2920040|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
2920041|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
2920042|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920043|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920044|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2920045|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2920046|NCT05116189|Growth Substances|growth substances|mesh-ancestor
2920047|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920048|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
2920049|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
2920050|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
2920051|NCT05115630|Melphalan|melphalan|mesh-list
2336565|NCT00430443|Annamycin|annamycin|mesh-list
2920052|NCT05115630|Fludarabine|fludarabine|mesh-list
2920053|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
2920054|NCT05115630|Tacrolimus|tacrolimus|mesh-list
2920055|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2920056|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
2920057|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920058|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2920059|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2920060|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
2920061|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920062|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920063|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2920064|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920065|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
2920066|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2336566|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2336567|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336568|NCT00430469|Lactoferrin|lactoferrin|mesh-list
2336569|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336570|NCT00430547|Carbimazole|carbimazole|mesh-list
2336571|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
2336572|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
2336573|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336574|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336575|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2336576|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2920067|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920068|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2920069|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2920070|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
2920071|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2920072|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920073|NCT05109728|Temozolomide|temozolomide|mesh-list
2920074|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
2920075|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2920076|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2920077|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
2920078|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920079|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920080|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
2920081|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
2920082|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2920083|NCT05106192|Triamcinolone|triamcinolone|mesh-list
2920084|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2920085|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2920086|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
2920087|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2920088|NCT05106192|Bexarotene|bexarotene|mesh-list
2920089|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2920090|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2920091|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
2920092|NCT05106192|Hormones|hormones|mesh-ancestor
2920093|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2920094|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920095|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2920096|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
2920097|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920098|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920099|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
2920100|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2920101|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920106|NCT05104554|Folic Acid|folic acid|mesh-list
2920107|NCT05104554|Micronutrients|micronutrients|mesh-list
2920108|NCT05104554|Trace Elements|trace elements|mesh-list
2920109|NCT05104554|Hematinics|hematinics|mesh-ancestor
2920110|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
2920111|NCT05104554|Vitamins|vitamins|mesh-ancestor
2920112|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336577|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
2336578|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2336579|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2920113|NCT05101564|Tamoxifen|tamoxifen|mesh-list
2920114|NCT05101564|Letrozole|letrozole|mesh-list
2920115|NCT05101564|Infigratinib|infigratinib|mesh-list
2920116|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920117|NCT05101564|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2920118|NCT05101564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2920119|NCT05101564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920120|NCT05101564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920121|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2920122|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
2920123|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2920124|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920125|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2920126|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2920127|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2920128|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2920129|NCT05098938|Acyclovir|acyclovir|mesh-list
2920130|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
2920131|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920132|NCT05092360|Gemcitabine|gemcitabine|mesh-list
2920133|NCT05092360|Paclitaxel|paclitaxel|mesh-list
2920134|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2920135|NCT05092360|Doxorubicin|doxorubicin|mesh-list
2920136|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2920137|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
2920138|NCT05092360|Topotecan|topotecan|mesh-list
2920139|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2920140|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920141|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
2920142|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
2920143|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
2920144|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920145|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920146|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
2920147|NCT05092360|Antiviral Agents|antiviral agents|mesh-ancestor
2920148|NCT05092360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920149|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920150|NCT05092360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2920151|NCT05092360|Immunologic Factors|immunologic factors|mesh-ancestor
2920152|NCT05092360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920153|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2336580|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336581|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336582|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2336583|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2336584|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336585|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
2336586|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336587|NCT00430651|Carboplatin|carboplatin|mesh-list
2336588|NCT00430651|Docetaxel|docetaxel|mesh-list
2336589|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336590|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
2336591|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
2920154|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2920155|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2920156|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920157|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2920158|NCT05083910|Misoprostol|misoprostol|mesh-list
2920159|NCT05083910|Oxytocin|oxytocin|mesh-list
2920160|NCT05083910|Carbetocin|carbetocin|mesh-list
2920161|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
2336592|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
2336593|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336594|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
2336595|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2336596|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372163|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2920162|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2920163|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920164|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2920165|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
2920166|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2920167|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2920168|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
2920169|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
2920170|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
2920171|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2920172|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2920173|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920174|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920175|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920176|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2920177|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2920178|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920179|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2920180|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336597|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
2336598|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2336599|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2336600|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336601|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336602|NCT00430742|Hormones|hormones|mesh-ancestor
2336603|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336604|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336605|NCT00430794|Spironolactone|spironolactone|mesh-list
2336606|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2336607|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
2336608|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336609|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336610|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2336611|NCT00430794|Diuretics|diuretics|mesh-ancestor
2336612|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
2336613|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
2336614|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
2920181|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
2920182|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920183|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920184|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
2920185|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920186|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920187|NCT05080959|Ropivacaine|ropivacaine|mesh-list
2920188|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
2920189|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
2920190|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2920191|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920192|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
2920193|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2920194|NCT05079841|Oxytocin|oxytocin|mesh-list
2920195|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
2920196|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2920197|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920198|NCT05079230|Azacitidine|azacitidine|mesh-list
2920199|NCT05079230|Venetoclax|venetoclax|mesh-list
2920200|NCT05079230|Magrolimab|magrolimab|mesh-list
2336615|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2336616|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2336617|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920201|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920202|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
2920203|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920204|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920205|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920206|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920207|NCT05076149|Ivacaftor|ivacaftor|mesh-list
2920208|NCT05076149|Elexacaftor|elexacaftor|mesh-list
2920209|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2920210|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2920211|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920212|NCT05073679|Naltrexone|naltrexone|mesh-list
2920213|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2920214|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2920215|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920216|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
2920217|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2920218|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2920219|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2111461|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336618|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336619|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920220|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2920221|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2920222|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920223|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
2920224|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2920225|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920226|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
2920227|NCT05068791|Psilocybin|psilocybin|mesh-list
2920228|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
2920229|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
2920230|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2920231|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2920232|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2920233|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920234|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920235|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
2920236|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2920237|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
2920238|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920239|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920242|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
2920243|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920244|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920245|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
2920246|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2920247|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
2920248|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920249|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2920250|NCT05062044|Folic Acid|folic acid|mesh-list
2920251|NCT05062044|Hematinics|hematinics|mesh-ancestor
2920252|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
2920253|NCT05062044|Vitamins|vitamins|mesh-ancestor
2920254|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
2336620|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2336621|NCT00430833|Candesartan|candesartan|mesh-list
2336622|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2336623|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2336624|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2336625|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336626|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2336627|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2336628|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336629|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
2920255|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920256|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
2920257|NCT05061420|Cetuximab|cetuximab|mesh-list
2920258|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920259|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920260|NCT05060003|Atezolizumab|atezolizumab|mesh-list
2920261|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920262|NCT05055999|Atezolizumab|atezolizumab|mesh-list
2920263|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920264|NCT05055947|Atezolizumab|atezolizumab|mesh-list
2920265|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920266|NCT05055908|Atezolizumab|atezolizumab|mesh-list
2920267|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920268|NCT05052957|Temozolomide|temozolomide|mesh-list
2920269|NCT05052957|Carmustine|carmustine|mesh-list
2920270|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2920271|NCT05052957|Lenograstim|lenograstim|mesh-list
2920272|NCT05052957|Sargramostim|sargramostim|mesh-list
2920273|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2920274|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
2920275|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920276|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2920277|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
2920278|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920279|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920280|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920281|NCT05051735|Acetaminophen|acetaminophen|mesh-list
2920282|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2920283|NCT05051735|Analgesics|analgesics|mesh-ancestor
2920284|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
2920285|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2920286|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920287|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
2920288|NCT05050981|Hormones|hormones|mesh-list
2920289|NCT05050981|Serotonin|serotonin|mesh-list
2920290|NCT05050981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2920291|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336630|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2336631|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
2336632|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2336633|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
2336634|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336635|NCT00430898|Basiliximab|basiliximab|mesh-list
2336636|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2336637|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
2336638|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920292|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920293|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2920294|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
2920295|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2920296|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920297|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2920298|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2336639|NCT00430924|Eplerenone|eplerenone|mesh-list
2336640|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2336641|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
2336642|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336643|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336644|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2336645|NCT00430924|Diuretics|diuretics|mesh-ancestor
2336646|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
2336647|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2336648|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2336649|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2336650|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336651|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336652|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2336653|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2336654|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336655|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
2336656|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2920304|NCT05050084|Leuprolide|leuprolide|mesh-list
2920305|NCT05050084|Goserelin|goserelin|mesh-list
2920306|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2920307|NCT05050084|Flutamide|flutamide|mesh-list
2920308|NCT05050084|Bicalutamide|bicalutamide|mesh-list
2920309|NCT05050084|Tryptophan|tryptophan|mesh-list
2920310|NCT05050084|Buserelin|buserelin|mesh-list
2920311|NCT05050084|Hormones|hormones|mesh-list
2920312|NCT05050084|Relugolix|relugolix|mesh-list
2920313|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2920314|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920315|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2920316|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
2920317|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2920318|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2920319|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920320|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
2920321|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
2920322|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
2920323|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2920324|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
2920325|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2920326|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2920327|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
2920328|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2111462|NCT02555228|Emollients|emollients|mesh-ancestor
2920329|NCT05049226|Vaccines|vaccines|mesh-list
2920330|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
2336657|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
2336658|NCT00431028|Triamcinolone|triamcinolone|mesh-list
2336659|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2336660|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
2336661|NCT00431028|Hormones|hormones|mesh-ancestor
2336662|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336663|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336664|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336665|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336666|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2336667|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336668|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2336669|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2336670|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336671|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2336672|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2336673|NCT00431054|Docetaxel|docetaxel|mesh-list
2336674|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336675|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
2336676|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
2336677|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
2336678|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920331|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920332|NCT05048238|Tofacitinib|tofacitinib|mesh-list
2920333|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2920334|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920335|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920336|NCT05047250|Gemcitabine|gemcitabine|mesh-list
2920337|NCT05047250|Paclitaxel|paclitaxel|mesh-list
2336679|NCT00431080|Paclitaxel|paclitaxel|mesh-list
2336680|NCT00431080|Docetaxel|docetaxel|mesh-list
2336681|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
2336682|NCT00431080|Epirubicin|epirubicin|mesh-list
2336683|NCT00431080|Fluorouracil|fluorouracil|mesh-list
2336684|NCT00431080|Mitogens|mitogens|mesh-list
2336685|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2336686|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336687|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
2336688|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
2336689|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
2336690|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336691|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2336692|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
2336693|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336694|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2336695|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2336696|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
2336697|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2336698|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2336699|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2336700|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2920338|NCT05047250|Carboplatin|carboplatin|mesh-list
2920339|NCT05047250|Pemetrexed|pemetrexed|mesh-list
2920340|NCT05047250|Atezolizumab|atezolizumab|mesh-list
2920341|NCT05047250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2920342|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920343|NCT05047250|Tubulin Modulators|tubulin modulators|mesh-ancestor
2920344|NCT05047250|Antimitotic Agents|antimitotic agents|mesh-ancestor
2920345|NCT05047250|Mitosis Modulators|mitosis modulators|mesh-ancestor
2920346|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920347|NCT05047250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920348|NCT05047250|Antimetabolites|antimetabolites|mesh-ancestor
2920349|NCT05047250|Antiviral Agents|antiviral agents|mesh-ancestor
2920350|NCT05047250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920351|NCT05047250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920352|NCT05047250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2920353|NCT05047250|Immunologic Factors|immunologic factors|mesh-ancestor
2920354|NCT05047250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920355|NCT05047250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2920356|NCT05047250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2920357|NCT05042128|Gemcitabine|gemcitabine|mesh-list
2920358|NCT05042128|Paclitaxel|paclitaxel|mesh-list
2920359|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2920360|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920361|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
2920362|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
2920363|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
2920364|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920365|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920366|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
2920367|NCT05042128|Antiviral Agents|antiviral agents|mesh-ancestor
2920368|NCT05042128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336701|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336702|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
2336703|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2336704|NCT00431093|Tibolone|tibolone|mesh-list
2336705|NCT00431093|Estradiol|estradiol|mesh-list
2336706|NCT00431093|Estrogens|estrogens|mesh-ancestor
2336707|NCT00431093|Hormones|hormones|mesh-ancestor
2336708|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336709|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920369|NCT05042128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920370|NCT05042128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2920371|NCT05042128|Immunologic Factors|immunologic factors|mesh-ancestor
2920372|NCT05042128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920389|NCT05033080|Ivacaftor|ivacaftor|mesh-list
2920390|NCT05033080|Elexacaftor|elexacaftor|mesh-list
2920391|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2920392|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2920393|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920394|NCT05033054|Dapagliflozin|dapagliflozin|mesh-list
2920395|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2920396|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920397|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2920398|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920399|NCT05032183|Leucovorin|leucovorin|mesh-list
2920400|NCT05032183|Cytarabine|cytarabine|mesh-list
2920401|NCT05032183|Dexamethasone|dexamethasone|mesh-list
2920402|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
2920403|NCT05032183|Prednisone|prednisone|mesh-list
2920404|NCT05032183|Cortisone|cortisone|mesh-list
2920405|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
2920406|NCT05032183|Rituximab|rituximab|mesh-list
2920407|NCT05032183|Methotrexate|methotrexate|mesh-list
2920408|NCT05032183|Vincristine|vincristine|mesh-list
2920409|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
2920410|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2920411|NCT05032183|Antibodies|antibodies|mesh-list
2920412|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
2920413|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2920414|NCT05032183|Lenograstim|lenograstim|mesh-list
2920415|NCT05032183|BB 1101|bb 1101|mesh-list
2920416|NCT05032183|Mesna|mesna|mesh-list
2920417|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2920418|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
2920419|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920420|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2920421|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2920422|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
2920423|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920424|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920425|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2920426|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2920427|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
2920428|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
2336710|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
2920429|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2920430|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2920431|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
2336711|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
2336712|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2336713|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2336714|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336715|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2336716|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
2336717|NCT00431106|Gemcitabine|gemcitabine|mesh-list
2336718|NCT00431106|Capecitabine|capecitabine|mesh-list
2336719|NCT00431106|Vinorelbine|vinorelbine|mesh-list
2336720|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2336721|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
2336722|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336723|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336724|NCT00431106|Antiviral Agents|antiviral agents|mesh-ancestor
2920432|NCT05032183|Hormones|hormones|mesh-ancestor
2920433|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2920434|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2920435|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
2920436|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920437|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2920438|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
2920439|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2920440|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920441|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
2920442|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
2920443|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2920444|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2920445|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2920446|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
2920447|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920448|NCT05032183|Antidotes|antidotes|mesh-ancestor
2920449|NCT05032183|Protective Agents|protective agents|mesh-ancestor
2920450|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
2920451|NCT05032183|Vitamins|vitamins|mesh-ancestor
2920452|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
2920453|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2920454|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
2920455|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
2920456|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
2920457|NCT05029999|Doxorubicin|doxorubicin|mesh-list
2920458|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2920459|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2920460|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920461|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2920462|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2920463|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920464|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336725|NCT00431106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336726|NCT00431106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336727|NCT00431106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2336728|NCT00431106|Immunologic Factors|immunologic factors|mesh-ancestor
2336729|NCT00431106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920465|NCT05029466|Psilocybin|psilocybin|mesh-list
2920466|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
2920467|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920468|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2920469|NCT05028634|Vaccines|vaccines|mesh-list
2920470|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2920471|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
2920472|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336730|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2336731|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
2336732|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
2336733|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
2336734|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
2336735|NCT00431119|Azathioprine|azathioprine|mesh-list
2920505|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
2920506|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920507|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920508|NCT05020665|Cytarabine|cytarabine|mesh-list
2920509|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920510|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
2920511|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920512|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920513|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
2920514|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920515|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2920516|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
2920517|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920518|NCT05017246|Lidocaine|lidocaine|mesh-list
2920519|NCT05017246|Morphine|morphine|mesh-list
2920520|NCT05017246|Bupivacaine|bupivacaine|mesh-list
2920521|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
2920522|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
2920523|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2920524|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920525|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
2920526|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336736|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2336737|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336738|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2336739|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
2336740|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2336741|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336742|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336743|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336744|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
2336745|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2336746|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2336747|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
2336748|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336749|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2336750|NCT00431145|Niacin|niacin|mesh-list
2920527|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2920528|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2920529|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2336751|NCT00431145|Niacinamide|niacinamide|mesh-list
2336752|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
2336753|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2336754|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
2336755|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336756|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2336757|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
2336758|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
2336759|NCT00431145|Vitamins|vitamins|mesh-ancestor
2336760|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
2336761|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336762|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
2336763|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
2920530|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2336764|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2336765|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336766|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336767|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
2336768|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2336769|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2336770|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336771|NCT00431197|Ketoconazole|ketoconazole|mesh-list
2336772|NCT00431197|Testosterone|testosterone|mesh-list
2336773|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
2336774|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336775|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2336776|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2336777|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336778|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336779|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2336780|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
2336781|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336782|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336783|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2336784|NCT00431197|Androgens|androgens|mesh-ancestor
2336785|NCT00431197|Hormones|hormones|mesh-ancestor
2336786|NCT00431236|Dexamethasone|dexamethasone|mesh-list
2920531|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920532|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2920533|NCT05017246|Narcotics|narcotics|mesh-ancestor
2920534|NCT05017246|Analgesics|analgesics|mesh-ancestor
2920535|NCT05014542|Analgesics|analgesics|mesh-list
2920536|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
2920537|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2920538|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920539|NCT05014438|Branebrutinib|branebrutinib|mesh-list
2920540|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2920541|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920542|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920543|NCT05013255|Pioglitazone|pioglitazone|mesh-list
2920544|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2336787|NCT00431236|Ondansetron|ondansetron|mesh-list
2336788|NCT00431236|Casopitant|casopitant|mesh-list
2336789|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2336790|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
2336791|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
2336792|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336793|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336794|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2336795|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
2336796|NCT00431236|Hormones|hormones|mesh-ancestor
2920545|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920546|NCT05012644|Palbociclib|palbociclib|mesh-list
2920547|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2920548|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920549|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2920550|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920551|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920552|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2920553|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2920554|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
2920555|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2920556|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920560|NCT05008224|Prednisone|prednisone|mesh-list
2920561|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
2920562|NCT05008224|Dacarbazine|dacarbazine|mesh-list
2920563|NCT05008224|Doxorubicin|doxorubicin|mesh-list
2920564|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
2920565|NCT05008224|Etoposide|etoposide|mesh-list
2920566|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
2920567|NCT05008224|Vincristine|vincristine|mesh-list
2920568|NCT05008224|Bleomycin|bleomycin|mesh-list
2920569|NCT05008224|Vinblastine|vinblastine|mesh-list
2920570|NCT05008224|Procarbazine|procarbazine|mesh-list
2920571|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2920572|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
2920573|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920574|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2336797|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336798|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2336799|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336800|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
2336801|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
2336802|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2336803|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
2336804|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336805|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336806|NCT00431236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2336807|NCT00431236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2336808|NCT00431236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2336809|NCT00431236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2336810|NCT00431236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2336811|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2336812|NCT00431249|Cilostazol|cilostazol|mesh-list
2336813|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2336814|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
2336815|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336816|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336817|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2336818|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
2336819|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2336820|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2336821|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336822|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2336823|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
2336824|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2336825|NCT00431249|Protective Agents|protective agents|mesh-ancestor
2336826|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2336827|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2336828|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336829|NCT00431262|Disulfiram|disulfiram|mesh-list
2336830|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2336831|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2336832|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920575|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2920576|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
2920577|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920578|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920579|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2920580|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2920581|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2920582|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2920583|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920584|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2920585|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
2920586|NCT05008224|Hormones|hormones|mesh-ancestor
2920587|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2920588|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2920589|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920590|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2920591|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
2920592|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
2920593|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
2920594|NCT05007106|Paclitaxel|paclitaxel|mesh-list
2920595|NCT05007106|Fluorouracil|fluorouracil|mesh-list
2920596|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
2920597|NCT05007106|Lenvatinib|lenvatinib|mesh-list
2920598|NCT05007106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2920599|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920600|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
2920601|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
2920602|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
2920603|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920604|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
2920605|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920606|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2336833|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336834|NCT00431275|Tremelimumab|tremelimumab|mesh-list
2336835|NCT00431275|Ipilimumab|ipilimumab|mesh-list
2336836|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336837|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2336838|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2336839|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336840|NCT00431340|Belinostat|belinostat|mesh-list
2336841|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336842|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2336843|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920607|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
2920608|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920609|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920610|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2920611|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920612|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
2920613|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920614|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336844|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336845|NCT00431353|Valganciclovir|valganciclovir|mesh-list
2336846|NCT00431353|Ganciclovir|ganciclovir|mesh-list
2336847|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2336848|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
2336849|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336850|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2920615|NCT05003076|Methamphetamine|methamphetamine|mesh-list
2920616|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2920617|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920618|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
2920619|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
2920620|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2920621|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
2920622|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336851|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336852|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336853|NCT00431379|Tenecteplase|tenecteplase|mesh-list
2336854|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2336855|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2336856|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336857|NCT00431392|Atropine|atropine|mesh-list
2336858|NCT00431392|Propranolol|propranolol|mesh-list
2336859|NCT00431392|Phenylephrine|phenylephrine|mesh-list
2336860|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
2336861|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2336862|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2336863|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
2336864|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
2336865|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2336866|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336867|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
2920623|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920624|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
2920625|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2920626|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2920627|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2920628|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2920629|NCT04991025|Gemcitabine|gemcitabine|mesh-list
2920630|NCT04991025|Carboplatin|carboplatin|mesh-list
2920631|NCT04991025|Pemetrexed|pemetrexed|mesh-list
2920632|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
2920633|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920634|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920635|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
2920636|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920637|NCT04991025|Antiviral Agents|antiviral agents|mesh-ancestor
2920638|NCT04991025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920639|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920640|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2920641|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
2920642|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920643|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2920644|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2920645|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2920646|NCT04989816|Trastuzumab|trastuzumab|mesh-list
2920647|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920648|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920649|NCT04988308|Adalimumab|adalimumab|mesh-list
2920650|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2920651|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2336868|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2336869|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
2336870|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
2336871|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2336872|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2336873|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2336874|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
2336875|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336876|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336877|NCT00431392|Protective Agents|protective agents|mesh-ancestor
2336878|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2336879|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2336880|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2920657|NCT04984330|Dexamethasone|dexamethasone|mesh-list
2920658|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2920659|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
2920660|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
2920661|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2920662|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920663|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2920664|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
2920665|NCT04984330|Hormones|hormones|mesh-ancestor
2920666|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2920667|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2920668|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920669|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2920670|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2920671|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2920672|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2920673|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920674|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2920675|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2920676|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920677|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
2336881|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2336882|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
2336883|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2336884|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2336885|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
2336886|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2336887|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2336888|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2336889|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
2336890|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336891|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
2336892|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
2336893|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2336894|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2336895|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336896|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336897|NCT00431418|Urological Agents|urological agents|mesh-ancestor
2336898|NCT00431431|Tibolone|tibolone|mesh-list
2336899|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
2336900|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
2336901|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336902|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920678|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2920679|NCT04971720|Valsartan|valsartan|mesh-list
2920680|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2920681|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2920682|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2920683|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2920684|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336903|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2336904|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2336905|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336906|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2336907|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
2336908|NCT00431431|Hormones|hormones|mesh-ancestor
2336909|NCT00431522|Valproic Acid|valproic acid|mesh-list
2336910|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
2336911|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336912|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336913|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
2920691|NCT04970901|Gemcitabine|gemcitabine|mesh-list
2920692|NCT04970901|Lenalidomide|lenalidomide|mesh-list
2920693|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
2920694|NCT04970901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920695|NCT04970901|Antimetabolites|antimetabolites|mesh-ancestor
2920696|NCT04970901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920697|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920698|NCT04970901|Antiviral Agents|antiviral agents|mesh-ancestor
2920699|NCT04970901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920700|NCT04970901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920701|NCT04970901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2920702|NCT04970901|Immunologic Factors|immunologic factors|mesh-ancestor
2920703|NCT04970901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920704|NCT04970901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2920705|NCT04970901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2920706|NCT04970901|Growth Substances|growth substances|mesh-ancestor
2920707|NCT04970901|Growth Inhibitors|growth inhibitors|mesh-ancestor
2920708|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920709|NCT04966481|Cetuximab|cetuximab|mesh-list
2920710|NCT04966481|Palbociclib|palbociclib|mesh-list
2920711|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920712|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920713|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2920714|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920715|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920716|NCT04956692|Paclitaxel|paclitaxel|mesh-list
2920717|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2920718|NCT04956692|Carboplatin|carboplatin|mesh-list
2920719|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
2920720|NCT04956692|Pemetrexed|pemetrexed|mesh-list
2920721|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2920722|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920723|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
2920724|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
2920725|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
2920726|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920727|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920728|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920729|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2336914|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2336915|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336916|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
2920730|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2920731|NCT04953910|Decitabine|decitabine|mesh-list
2920732|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920733|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
2920734|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920735|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920736|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920737|NCT04953897|Decitabine|decitabine|mesh-list
2920738|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920739|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
2920740|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920741|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920742|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920743|NCT04952610|Etripamil|etripamil|mesh-list
2920744|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2920745|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2920746|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920747|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2920748|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336917|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2920749|NCT04949022|Insulin|insulin|mesh-list
2336918|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2336919|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2336920|NCT00431561|Temozolomide|temozolomide|mesh-list
2336921|NCT00431561|Lomustine|lomustine|mesh-list
2336922|NCT00431561|Trabedersen|trabedersen|mesh-list
2336923|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2336924|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
2336925|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336926|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336927|NCT00431613|Gemcitabine|gemcitabine|mesh-list
2336928|NCT00431613|Carboplatin|carboplatin|mesh-list
2336929|NCT00431613|Docetaxel|docetaxel|mesh-list
2336930|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336931|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2336932|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
2336933|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336934|NCT00431613|Antiviral Agents|antiviral agents|mesh-ancestor
2336935|NCT00431613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2336936|NCT00431613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336937|NCT00431613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2336938|NCT00431613|Immunologic Factors|immunologic factors|mesh-ancestor
2920750|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2920751|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920752|NCT04948892|Anesthetics|anesthetics|mesh-list
2920753|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2920754|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920755|NCT04941287|Atezolizumab|atezolizumab|mesh-list
2920756|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
2920757|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2920758|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
2920759|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920760|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
2920761|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920764|NCT04935359|Gemcitabine|gemcitabine|mesh-list
2920765|NCT04935359|Paclitaxel|paclitaxel|mesh-list
2920766|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2920767|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336939|NCT00431613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336940|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
2336941|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
2336942|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
2336943|NCT00431665|Heparin|heparin|mesh-list
2336944|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2336945|NCT00431665|Somatostatin|somatostatin|mesh-list
2336946|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2336947|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336948|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
2336949|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2336950|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2336951|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336952|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2336953|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2336954|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2336955|NCT00431665|Hormones|hormones|mesh-ancestor
2336956|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2336957|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336958|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
2336959|NCT00431678|Levofloxacin|levofloxacin|mesh-list
2336960|NCT00431678|Ofloxacin|ofloxacin|mesh-list
2336961|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
2336962|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2336963|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2336964|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920768|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
2920769|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
2920770|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
2920771|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920772|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920773|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
2920774|NCT04935359|Antiviral Agents|antiviral agents|mesh-ancestor
2920775|NCT04935359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920776|NCT04935359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2336965|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2336966|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2336967|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920777|NCT04935359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2920778|NCT04935359|Immunologic Factors|immunologic factors|mesh-ancestor
2920779|NCT04935359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920822|NCT04929379|Fenofibrate|fenofibrate|mesh-list
2920823|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2920824|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
2920825|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920826|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2920827|NCT04928339|Bupivacaine|bupivacaine|mesh-list
2920828|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
2920829|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
2920830|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2920831|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920832|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
2920833|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2920834|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2920835|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2920836|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
2920837|NCT04920292|Oxfendazole|oxfendazole|mesh-list
2920838|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
2920839|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2920840|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2920841|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
2920842|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
2920843|NCT04917029|Bupivacaine|bupivacaine|mesh-list
2920844|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
2920845|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
2920846|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2920847|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920848|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
2920849|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2920850|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2920851|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2920852|NCT04917029|Analgesics|analgesics|mesh-ancestor
2920853|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2920854|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2920855|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2920856|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
2920857|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2920858|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920859|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2920860|NCT04915729|Tenecteplase|tenecteplase|mesh-list
2920861|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2920862|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2920863|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920872|NCT04914195|Leuprolide|leuprolide|mesh-list
2920873|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2336968|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336969|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336970|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2336971|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
2336972|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2336973|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2336974|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2336975|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2336976|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2336977|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2336978|NCT00431678|Renal Agents|renal agents|mesh-ancestor
2336979|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2336980|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2336981|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
2336982|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
2336983|NCT00431704|Carboplatin|carboplatin|mesh-list
2336984|NCT00431704|Trastuzumab|trastuzumab|mesh-list
2336985|NCT00431704|Vinorelbine|vinorelbine|mesh-list
2336986|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336987|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920874|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
2920875|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2920876|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920877|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2920878|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920879|NCT04913805|Niacinamide|niacinamide|mesh-list
2920880|NCT04913805|Niacin|niacin|mesh-list
2920881|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
2920882|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
2336988|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2336989|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
2336990|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
2336991|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
2336992|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2336993|NCT00431769|Bortezomib|bortezomib|mesh-list
2336994|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2336995|NCT00431795|Doxorubicin|doxorubicin|mesh-list
2336996|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2336997|NCT00431795|Epirubicin|epirubicin|mesh-list
2920883|NCT04913805|Vitamins|vitamins|mesh-ancestor
2336998|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2336999|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337000|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2337001|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2337002|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920884|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
2920885|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920886|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2920887|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
2920888|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920889|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2920890|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
2337003|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337004|NCT00431873|Mocetinostat|mocetinostat|mesh-list
2337005|NCT00431873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2337006|NCT00431873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920893|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2920894|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2920895|NCT04903119|Trametinib|trametinib|mesh-list
2920896|NCT04903119|Dabrafenib|dabrafenib|mesh-list
2920897|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337007|NCT00431873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337008|NCT00431990|Dexamethasone|dexamethasone|mesh-list
2337009|NCT00431990|Bortezomib|bortezomib|mesh-list
2337010|NCT00431990|Romidepsin|romidepsin|mesh-list
2337011|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2337012|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
2337013|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
2920898|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2920899|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920900|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920906|NCT04895358|Paclitaxel|paclitaxel|mesh-list
2920907|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2920908|NCT04895358|Doxorubicin|doxorubicin|mesh-list
2920909|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2920910|NCT04895358|Capecitabine|capecitabine|mesh-list
2920911|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
2920912|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2920913|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920914|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
2920915|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
2920916|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
2920917|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920918|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2920919|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2920920|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2920921|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920922|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920923|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
2920924|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920925|NCT04892875|Cisplatin|cisplatin|mesh-list
2920926|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920927|NCT04892420|Dexamethasone|dexamethasone|mesh-list
2920928|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
2920929|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
2920930|NCT04892420|Bupivacaine|bupivacaine|mesh-list
2920931|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2920932|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
2920933|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
2920934|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2920935|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920936|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2920937|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
2920938|NCT04892420|Hormones|hormones|mesh-ancestor
2920939|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2920940|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2920941|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920942|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
2920943|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
2920944|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2920945|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
2920946|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2920947|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2920948|NCT04892420|Analgesics|analgesics|mesh-ancestor
2920949|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2337014|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337015|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337016|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2337017|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
2337018|NCT00431990|Hormones|hormones|mesh-ancestor
2337019|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2337020|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2920950|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2920951|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2920952|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
2920953|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2920954|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920955|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2920956|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
2337021|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337022|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2337023|NCT00432016|Zidovudine|zidovudine|mesh-list
2337024|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
2337025|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337026|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2337027|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2337028|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337029|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
2337030|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337031|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2920957|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2920958|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2920959|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2920960|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
2920961|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2920962|NCT04891068|Azacitidine|azacitidine|mesh-list
2920963|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2920964|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
2920965|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337032|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2337033|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
2337034|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2337035|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2920966|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920967|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920978|NCT04884035|Prednisone|prednisone|mesh-list
2920979|NCT04884035|Prednisolone|prednisolone|mesh-list
2337036|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2337037|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2337038|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337039|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
2337040|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2920980|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
2920981|NCT04884035|Rituximab|rituximab|mesh-list
2920982|NCT04884035|Doxorubicin|doxorubicin|mesh-list
2920983|NCT04884035|Vincristine|vincristine|mesh-list
2920984|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2920985|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
2920986|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2920987|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2920988|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2920989|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
2920990|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2920991|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2920992|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2920993|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2920994|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2920995|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2920996|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2920997|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2920998|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2920999|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
2921000|NCT04884035|Hormones|hormones|mesh-ancestor
2921001|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2921002|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2921003|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2921004|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
2921005|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
2921006|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
2921007|NCT04876677|Beclomethasone|beclomethasone|mesh-list
2921008|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
2921009|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
2921010|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2921011|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
2921012|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337041|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337042|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2337043|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337044|NCT00432068|Octreotide|octreotide|mesh-list
2337045|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2337046|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2337047|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337048|NCT00432081|Indomethacin|indomethacin|mesh-list
2337049|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2921013|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921014|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2921015|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
2337050|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2337051|NCT00432081|Analgesics|analgesics|mesh-ancestor
2337052|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
2337053|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337054|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337055|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2337056|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337057|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
2337058|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
2337059|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2337060|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2337061|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337062|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337063|NCT00432094|Paclitaxel|paclitaxel|mesh-list
2337064|NCT00432094|Etoposide|etoposide|mesh-list
2337065|NCT00432094|Carboplatin|carboplatin|mesh-list
2337066|NCT00432094|Ifosfamide|ifosfamide|mesh-list
2337067|NCT00432094|Thiotepa|thiotepa|mesh-list
2337068|NCT00432094|Mesna|mesna|mesh-list
2337069|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2337070|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921016|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2921017|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2921018|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2921019|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
2921020|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2921021|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337071|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
2337072|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
2337073|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
2337074|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337075|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2337076|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2337077|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337078|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
2337079|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337080|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2337081|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
2337082|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2337083|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2337084|NCT00432094|Protective Agents|protective agents|mesh-ancestor
2337085|NCT00432120|Clopidogrel|clopidogrel|mesh-list
2337086|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2337087|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2337088|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2337089|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2921022|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2921023|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
2337090|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
2337091|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337092|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337093|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337094|NCT00432146|Lugol's solution|lugol's solution|mesh-list
2337095|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
2921024|NCT04876677|Hormones|hormones|mesh-ancestor
2921025|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2921026|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2921027|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2921028|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2921029|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
2921030|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
2921031|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921032|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921033|NCT04874194|Venetoclax|venetoclax|mesh-list
2921034|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
2921035|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921036|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2921037|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2921038|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921039|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921040|NCT04866602|Atovaquone|atovaquone|mesh-list
2921041|NCT04866602|Proguanil|proguanil|mesh-list
2921042|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2921043|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2921044|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
2921045|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2921046|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2921047|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921048|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921049|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
2921050|NCT04857398|Insulin|insulin|mesh-list
2921051|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2921052|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921053|NCT04854512|Metformin|metformin|mesh-list
2921054|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2921055|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921056|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
2921057|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921058|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921059|NCT04846881|BI 425809|bi 425809|mesh-list
2921060|NCT04846881|Nootropic Agents|nootropic agents|mesh-ancestor
2921061|NCT04846868|BI 425809|bi 425809|mesh-list
2921062|NCT04846868|Nootropic Agents|nootropic agents|mesh-ancestor
2921063|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2921064|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2921065|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
2921066|NCT04843579|Clarithromycin|clarithromycin|mesh-list
2921067|NCT04843579|Dexamethasone|dexamethasone|mesh-list
2921068|NCT04843579|Pomalidomide|pomalidomide|mesh-list
2921069|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2921070|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
2921071|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
2921072|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2921073|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921074|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2921075|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
2921076|NCT04843579|Hormones|hormones|mesh-ancestor
2921077|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2921078|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2337096|NCT00432146|Coagulants|coagulants|mesh-ancestor
2337097|NCT00432198|Zolpidem|zolpidem|mesh-list
2337098|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2337099|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2337100|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2337101|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337102|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2337103|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
2337104|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
2921079|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921080|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2921081|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2921082|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2921083|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921084|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921085|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2921086|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2921087|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
2337105|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2921088|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2921089|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2921090|NCT04843579|Growth Substances|growth substances|mesh-ancestor
2921091|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
2921092|NCT04840823|Enoxacin|enoxacin|mesh-list
2921093|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2921094|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2921095|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2921096|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2921097|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921098|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921099|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921100|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2921101|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2921102|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
2921103|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
2921104|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2921105|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
2921106|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111463|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
2921107|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921108|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921109|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2921110|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921111|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
2921112|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2921113|NCT04831450|Cemiplimab|cemiplimab|mesh-list
2921114|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921115|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337106|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337107|NCT00432302|Sagopilone|sagopilone|mesh-list
2337108|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337109|NCT00432315|Docetaxel|docetaxel|mesh-list
2337110|NCT00432315|Cisplatin|cisplatin|mesh-list
2337111|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337112|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
2921116|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
2921117|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
2921118|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921119|NCT04821622|Talazoparib|talazoparib|mesh-list
2921120|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2921121|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921122|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921123|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921124|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
2921125|NCT04821375|Estrogens|estrogens|mesh-list
2921126|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2921127|NCT04821375|Hormones|hormones|mesh-ancestor
2921128|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2921129|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921130|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2921131|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2921132|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
2921133|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2921134|NCT04820309|Xanomeline|xanomeline|mesh-list
2921135|NCT04820309|Trospium chloride|trospium chloride|mesh-list
2337113|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
2337114|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
2337115|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337116|NCT00432354|Atorvastatin|atorvastatin|mesh-list
2337117|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2337118|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2337119|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
2337120|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337121|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2337122|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2337123|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337124|NCT00432367|Artesunate|artesunate|mesh-list
2337125|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
2337126|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
2337127|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2337128|NCT00432367|Amodiaquine|amodiaquine|mesh-list
2337129|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
2337130|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2337131|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2337132|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337133|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337134|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
2337135|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
2337136|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2921136|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
2921137|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
2921138|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2921139|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921140|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2921141|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2921142|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
2921143|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337137|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
2337138|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2337139|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337140|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337141|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2337142|NCT00432367|Renal Agents|renal agents|mesh-ancestor
2337143|NCT00432393|Levodopa|levodopa|mesh-list
2337144|NCT00432393|Carbidopa|carbidopa|mesh-list
2337145|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2337146|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2337147|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2337148|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
2337149|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337150|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337151|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337152|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2337153|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337154|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2337155|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
2337156|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
2337157|NCT00432406|Etanercept|etanercept|mesh-list
2337158|NCT00432406|Infliximab|infliximab|mesh-list
2337159|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2337160|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2337161|NCT00432406|Analgesics|analgesics|mesh-ancestor
2337162|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
2337163|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337164|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337165|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2337166|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337167|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2337168|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2337169|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
2337170|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
2337171|NCT00432432|Infliximab|infliximab|mesh-list
2337172|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
2337173|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2337174|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337175|NCT00432510|Complement C1s|complement c1s|mesh-list
2337176|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2337177|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2337178|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
2337179|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337180|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2337181|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2337182|NCT00432549|Topiramate|topiramate|mesh-list
2337183|NCT00432549|Almotriptan|almotriptan|mesh-list
2337184|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
2921144|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921145|NCT04820309|Urological Agents|urological agents|mesh-ancestor
2921146|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2921147|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2921148|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2337185|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2337186|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337187|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2337188|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
2337189|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337190|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337191|NCT00432575|Surinabant|surinabant|mesh-list
2337192|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2337193|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2337194|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337195|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337196|NCT00432575|Hormones|hormones|mesh-ancestor
2921149|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2921150|NCT04808505|Miglustat|miglustat|mesh-list
2921151|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921152|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921153|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2921154|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2921155|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
2921156|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2921157|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2921158|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2921159|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921160|NCT04807972|Folfirinox|folfirinox|mesh-list
2921161|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921162|NCT04806919|Progesterone|progesterone|mesh-list
2921163|NCT04806919|Progestins|progestins|mesh-ancestor
2337197|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2337198|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337199|NCT00432588|Misoprostol|misoprostol|mesh-list
2337200|NCT00432588|Dinoprostone|dinoprostone|mesh-list
2337201|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2921164|NCT04806919|Hormones|hormones|mesh-ancestor
2921165|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2921166|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921167|NCT04801797|Cytarabine|cytarabine|mesh-list
2921168|NCT04801797|Azacitidine|azacitidine|mesh-list
2921169|NCT04801797|Daunorubicin|daunorubicin|mesh-list
2921170|NCT04801797|Venetoclax|venetoclax|mesh-list
2337202|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
2337203|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2921171|NCT04801797|Idarubicin|idarubicin|mesh-list
2921172|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2921173|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
2921174|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921175|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921176|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
2921177|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2921178|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2921179|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
2921180|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921181|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921182|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2921183|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2921184|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2921185|NCT04799275|Prednisone|prednisone|mesh-list
2921186|NCT04799275|Cortisone|cortisone|mesh-list
2921187|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
2921188|NCT04799275|Rituximab|rituximab|mesh-list
2921189|NCT04799275|Doxorubicin|doxorubicin|mesh-list
2921190|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2921191|NCT04799275|Vincristine|vincristine|mesh-list
2921192|NCT04799275|Azacitidine|azacitidine|mesh-list
2921193|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2921194|NCT04799275|Antibodies|antibodies|mesh-list
2921195|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
2921196|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2921197|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2921198|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
2921199|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921200|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2921201|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2921202|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
2921203|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921204|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921205|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2921206|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2921207|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2337204|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337205|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2337206|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2337207|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
2337208|NCT00432614|Citalopram|citalopram|mesh-list
2337209|NCT00432614|Amibegron|amibegron|mesh-list
2337210|NCT00432614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2337211|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2921208|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2921209|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921210|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2921211|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
2921212|NCT04799275|Hormones|hormones|mesh-ancestor
2921213|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2921214|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2921215|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2921216|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
2921217|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
2921218|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
2921219|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2921220|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
2921221|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
2921222|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921223|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921228|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
2921229|NCT04789408|Fludarabine|fludarabine|mesh-list
2921230|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2921231|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
2921232|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921233|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2921234|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2921235|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
2921236|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921237|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921238|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2921239|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
2921240|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2921241|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
2337212|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2337213|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337214|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337215|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
2337216|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337217|NCT00432614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2337218|NCT00432614|Antidepressive Agents|antidepressive agents|mesh-ancestor
2337219|NCT00432614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2337220|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2921242|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2921243|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921244|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2921245|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2921246|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2921247|NCT04785638|Bupivacaine|bupivacaine|mesh-list
2921248|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
2337221|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2337222|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
2337223|NCT00432627|Deferasirox|deferasirox|mesh-list
2337224|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2337225|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
2337226|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
2337227|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337228|NCT00432653|Rituximab|rituximab|mesh-list
2337229|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2337230|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337231|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
2337232|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921249|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
2921250|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2921251|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921252|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
2921253|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2921254|NCT04785625|Bupivacaine|bupivacaine|mesh-list
2921255|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
2921256|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
2921257|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2921258|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921259|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
2337233|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337234|NCT00432757|Ketotifen|ketotifen|mesh-list
2337235|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
2337236|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
2337237|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2337238|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
2921260|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2921264|NCT04779320|Vedolizumab|vedolizumab|mesh-list
2921265|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2921266|NCT04779307|Vedolizumab|vedolizumab|mesh-list
2921267|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2921268|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2111483|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
2337239|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
2337240|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337241|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921269|NCT04776980|Hematinics|hematinics|mesh-ancestor
2921270|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2921271|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2921272|NCT04774094|Ceftazidime|ceftazidime|mesh-list
2921273|NCT04774094|Avibactam|avibactam|mesh-list
2921274|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
2921275|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2921276|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2921277|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2921278|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921279|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921280|NCT04772079|BMS-986165|bms-986165|mesh-list
2921281|NCT04772079|Dermatologic Agents|dermatologic agents|mesh-ancestor
2921282|NCT04772079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2921283|NCT04772079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921284|NCT04772079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921285|NCT04765202|Carisoprodol|carisoprodol|mesh-list
2921286|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2921287|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921288|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2921289|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2921290|NCT04765059|Cisplatin|cisplatin|mesh-list
2921291|NCT04765059|Carboplatin|carboplatin|mesh-list
2921292|NCT04765059|Pemetrexed|pemetrexed|mesh-list
2921293|NCT04765059|Osimertinib|osimertinib|mesh-list
2921294|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921295|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921296|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921297|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2921298|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2921299|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2337242|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337243|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2337244|NCT00432796|Dalteparin|dalteparin|mesh-list
2337245|NCT00432796|Tinzaparin|tinzaparin|mesh-list
2337246|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2337247|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
2337248|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2337249|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2337250|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337251|NCT00432861|Pancrelipase|pancrelipase|mesh-list
2337252|NCT00432861|Pancreatin|pancreatin|mesh-list
2337253|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2337254|NCT00432887|Caffeine|caffeine|mesh-list
2337255|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2337256|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337257|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2337258|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337259|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337260|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2337261|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2337262|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
2337263|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337264|NCT00432978|Bosentan|bosentan|mesh-list
2337265|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2337266|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2337267|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337268|NCT00433043|Metoprolol|metoprolol|mesh-list
2337269|NCT00433043|Carvedilol|carvedilol|mesh-list
2337270|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2337271|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2337272|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2337273|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
2337274|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
2337275|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337276|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337277|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2337278|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2337279|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
2337280|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337281|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337282|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
2337283|NCT00433043|Protective Agents|protective agents|mesh-ancestor
2337284|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2337285|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2337286|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2337287|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
2337288|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2337289|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2337290|NCT00433069|Pioglitazone|pioglitazone|mesh-list
2337291|NCT00433069|Interferons|interferons|mesh-list
2337292|NCT00433069|Ribavirin|ribavirin|mesh-list
2337293|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
2337294|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
2337295|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337296|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
2337297|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337298|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
2337299|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337300|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
2337301|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337302|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2337303|NCT00433095|Trastuzumab|trastuzumab|mesh-list
2337304|NCT00433095|Vinorelbine|vinorelbine|mesh-list
2337305|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2337306|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337307|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2337308|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
2337309|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
2337310|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
2337311|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337312|NCT00433121|Olanzapine|olanzapine|mesh-list
2921356|NCT04756765|Talazoparib|talazoparib|mesh-list
2921357|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2921358|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921359|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921360|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921361|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
2921362|NCT04756063|Vitamins|vitamins|mesh-ancestor
2921363|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
2921364|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921365|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
2921366|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921367|NCT04756063|Protective Agents|protective agents|mesh-ancestor
2337313|NCT00433121|Risperidone|risperidone|mesh-list
2337314|NCT00433121|Citalopram|citalopram|mesh-list
2337315|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2337316|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
2337317|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337318|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337319|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337320|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2337321|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2337322|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2337323|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2337324|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2337325|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
2337326|NCT00433121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2337327|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2337328|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2337329|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2337330|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
2337331|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
2337332|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2921374|NCT04745832|Prednisone|prednisone|mesh-list
2921375|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
2921376|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2921377|NCT04745832|Rituximab|rituximab|mesh-list
2921378|NCT04745832|Vincristine|vincristine|mesh-list
2921379|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2921380|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
2337333|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
2337334|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2337335|NCT00433173|Anastrozole|anastrozole|mesh-list
2337336|NCT00433173|Goserelin|goserelin|mesh-list
2921381|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921382|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2921383|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2921384|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
2921385|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921386|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921387|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2921388|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921389|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2921390|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
2921391|NCT04745832|Hormones|hormones|mesh-ancestor
2921392|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2921393|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2921394|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2921395|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
2921396|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
2921397|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
2921398|NCT04742634|Decitabine|decitabine|mesh-list
2921399|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2921400|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
2921401|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921402|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337337|NCT00433173|Testosterone|testosterone|mesh-list
2337338|NCT00433173|Androgens|androgens|mesh-ancestor
2337339|NCT00433173|Hormones|hormones|mesh-ancestor
2337340|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2337341|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337342|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2337343|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337344|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2337345|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2337346|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337347|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337348|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2337349|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
2337350|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
2337351|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2337352|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337353|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2337354|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
2337355|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2337356|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337357|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337358|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337359|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
2337360|NCT00433225|Prednisolone|prednisolone|mesh-list
2337361|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2337362|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
2337363|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2337364|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
2921403|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921404|NCT04742075|Durvalumab|durvalumab|mesh-list
2921405|NCT04742075|Olaparib|olaparib|mesh-list
2921406|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2921407|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921408|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921409|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
2921410|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921411|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2921412|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921413|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921414|NCT04739813|Prednisone|prednisone|mesh-list
2921415|NCT04739813|Lenalidomide|lenalidomide|mesh-list
2921416|NCT04739813|Venetoclax|venetoclax|mesh-list
2921417|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
2921418|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2921419|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
2921420|NCT04739813|Hormones|hormones|mesh-ancestor
2921421|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2921422|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921423|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2921424|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921425|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
2921426|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2921427|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2921428|NCT04739813|Growth Substances|growth substances|mesh-ancestor
2921429|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
2921430|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2337365|NCT00433225|Ketorolac|ketorolac|mesh-list
2337366|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2337367|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
2337368|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2337369|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
2337370|NCT00433225|Hormones|hormones|mesh-ancestor
2337371|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2337372|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337373|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2337374|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337375|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
2337376|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
2337377|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337378|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2337379|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2337380|NCT00433225|Protective Agents|protective agents|mesh-ancestor
2337381|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2337382|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2337383|NCT00433225|Analgesics|analgesics|mesh-ancestor
2337384|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
2337385|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337386|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2921459|NCT04739371|Insulin|insulin|mesh-list
2921460|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2921461|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2921462|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921463|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
2921464|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921465|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921466|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
2921467|NCT04736706|Lenvatinib|lenvatinib|mesh-list
2921468|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921469|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921470|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2921471|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921472|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921473|NCT04736199|Androgens|androgens|mesh-list
2921474|NCT04736199|Hormones|hormones|mesh-ancestor
2921475|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2921476|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921477|NCT04729959|Atezolizumab|atezolizumab|mesh-list
2921478|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
2337387|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337388|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337389|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2337390|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337391|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2337392|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2921479|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2921480|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
2921481|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921482|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
2921483|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921484|NCT04729595|Tempol|tempol|mesh-list
2921485|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
2337393|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2337394|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2337395|NCT00433277|Cyclosporine|cyclosporine|mesh-list
2337396|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2337397|NCT00433277|Cyclosporins|cyclosporins|mesh-list
2337398|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337399|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337400|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2337401|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
2337402|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337403|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
2337404|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337405|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
2337406|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337407|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2337408|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2337409|NCT00433316|Ropivacaine|ropivacaine|mesh-list
2337410|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
2337411|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
2337412|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2337413|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337414|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
2337415|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337416|NCT00433342|Floxacillin|floxacillin|mesh-list
2337417|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2337418|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337419|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
2337420|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2337421|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2337422|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337423|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337424|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337425|NCT00433407|Trastuzumab|trastuzumab|mesh-list
2921486|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921487|NCT04729595|Protective Agents|protective agents|mesh-ancestor
2921488|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337426|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2337427|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337428|NCT00433420|Paclitaxel|paclitaxel|mesh-list
2337429|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
2337430|NCT00433420|Fluorouracil|fluorouracil|mesh-list
2337431|NCT00433420|Epirubicin|epirubicin|mesh-list
2337432|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2337433|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337434|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
2921489|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2921490|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921491|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2921492|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2921493|NCT04725994|Irinotecan|irinotecan|mesh-list
2921494|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2921495|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2921496|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921497|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921498|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921499|NCT04717414|Luspatercept|luspatercept|mesh-list
2921500|NCT04717414|Hematinics|hematinics|mesh-ancestor
2921501|NCT04716699|Lidocaine|lidocaine|mesh-list
2921502|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
2921503|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
2921504|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2921505|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921506|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
2921507|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2921508|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2921509|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2921510|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2337435|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
2337436|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
2337437|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337438|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2337439|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
2337440|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337441|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337442|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2337443|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
2337444|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2337445|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
2337446|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2337447|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2337448|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2337449|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2921511|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2921512|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921513|NCT04712942|Azacitidine|azacitidine|mesh-list
2921514|NCT04712942|Pevonedistat|pevonedistat|mesh-list
2921515|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2921516|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
2921517|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337450|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337451|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2337452|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2337453|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337454|NCT00433459|Prednisone|prednisone|mesh-list
2337455|NCT00433459|Prednisolone|prednisolone|mesh-list
2337456|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
2337457|NCT00433459|Dacarbazine|dacarbazine|mesh-list
2337458|NCT00433459|Vincristine|vincristine|mesh-list
2337459|NCT00433459|Procarbazine|procarbazine|mesh-list
2337460|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2337461|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2337462|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
2921518|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921519|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921520|NCT04712097|Rituximab|rituximab|mesh-list
2921521|NCT04712097|Lenalidomide|lenalidomide|mesh-list
2921522|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921523|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921524|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
2921525|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921526|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2921527|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2921528|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2921529|NCT04712097|Growth Substances|growth substances|mesh-ancestor
2921530|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
2921536|NCT04708145|Aflibercept|aflibercept|mesh-list
2921537|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2921538|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2921539|NCT04708145|Growth Substances|growth substances|mesh-ancestor
2921540|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921541|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
2921542|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337463|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337464|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337465|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2337466|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
2337467|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337468|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337469|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2337470|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2921554|NCT04700124|Gemcitabine|gemcitabine|mesh-list
2921555|NCT04700124|Cisplatin|cisplatin|mesh-list
2921556|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
2921557|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921558|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2337471|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
2337472|NCT00433459|Hormones|hormones|mesh-ancestor
2337473|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2921559|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
2921560|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921561|NCT04700124|Antiviral Agents|antiviral agents|mesh-ancestor
2921562|NCT04700124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2921563|NCT04700124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921564|NCT04700124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2921565|NCT04700124|Immunologic Factors|immunologic factors|mesh-ancestor
2921566|NCT04700124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921567|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921568|NCT04697628|Gemcitabine|gemcitabine|mesh-list
2921569|NCT04697628|Irinotecan|irinotecan|mesh-list
2921570|NCT04697628|Pemetrexed|pemetrexed|mesh-list
2921571|NCT04697628|Topotecan|topotecan|mesh-list
2921572|NCT04697628|Vinorelbine|vinorelbine|mesh-list
2921573|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
2921574|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2921575|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
2921576|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921577|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921578|NCT04697628|Antiviral Agents|antiviral agents|mesh-ancestor
2921579|NCT04697628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2921580|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921581|NCT04697628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2921582|NCT04697628|Immunologic Factors|immunologic factors|mesh-ancestor
2921583|NCT04697628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921584|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2921585|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2921586|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2921587|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2921588|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2921589|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
2921590|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
2921591|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
2921592|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921597|NCT04688177|Nicotine|nicotine|mesh-list
2921598|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
2921599|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2921600|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
2921601|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2921602|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921603|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2921604|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2921605|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
2921606|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2921607|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921608|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
2921609|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
2921610|NCT04685590|Dasatinib|dasatinib|mesh-list
2921611|NCT04685590|Quercetin|quercetin|mesh-list
2921612|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921613|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2921614|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921615|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921616|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
2921617|NCT04685590|Protective Agents|protective agents|mesh-ancestor
2921618|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921619|NCT04685135|Docetaxel|docetaxel|mesh-list
2921620|NCT04685135|Adagrasib|adagrasib|mesh-list
2921621|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921622|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
2921623|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
2921624|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
2921625|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921626|NCT04680910|Propofol|propofol|mesh-list
2921627|NCT04680910|Anesthetics|anesthetics|mesh-list
2921628|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2337474|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2337475|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2921629|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2921630|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921631|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2921632|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
2921633|NCT04672460|Talazoparib|talazoparib|mesh-list
2921634|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2921635|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921636|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921637|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921638|NCT04671810|Eculizumab|eculizumab|mesh-list
2921639|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2921640|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2921641|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
2921642|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921643|NCT04671667|Cisplatin|cisplatin|mesh-list
2337476|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
2337477|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
2337478|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
2337479|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2337480|NCT00433485|Sirolimus|sirolimus|mesh-list
2337481|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2337482|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337483|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2337484|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921644|NCT04671667|Carboplatin|carboplatin|mesh-list
2921645|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
2921646|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921647|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921648|NCT04671615|Palbociclib|palbociclib|mesh-list
2921649|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921650|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2921651|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921652|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111484|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2111485|NCT02555683|Growth Substances|growth substances|mesh-ancestor
2111486|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111487|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
2111488|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2337485|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
2337486|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2337487|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
2337488|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337489|NCT00433498|Carboplatin|carboplatin|mesh-list
2921658|NCT04668365|Prednisone|prednisone|mesh-list
2921659|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
2921660|NCT04668365|Rituximab|rituximab|mesh-list
2921661|NCT04668365|Vincristine|vincristine|mesh-list
2921662|NCT04668365|Epirubicin|epirubicin|mesh-list
2921663|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
2921664|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2921665|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
2921666|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921667|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2921668|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2921669|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
2921670|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921671|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921672|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2921673|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921674|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2921675|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
2921676|NCT04668365|Hormones|hormones|mesh-ancestor
2921677|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2921678|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2921679|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2921680|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
2921681|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
2921682|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
2111489|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
2921683|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2921684|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2921685|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2921686|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921687|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2921688|NCT04667039|Ranibizumab|ranibizumab|mesh-list
2921689|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2921690|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2921691|NCT04667039|Growth Substances|growth substances|mesh-ancestor
2921692|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921693|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
2921694|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921695|NCT04666272|Trametinib|trametinib|mesh-list
2921696|NCT04666272|Dabrafenib|dabrafenib|mesh-list
2921697|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921698|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2921699|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921700|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337490|NCT00433498|Etoposide|etoposide|mesh-list
2337491|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
2337492|NCT00433498|Pravastatin|pravastatin|mesh-list
2337493|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337494|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2337495|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2337496|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2337497|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337498|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337499|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2337500|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2337501|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
2337502|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2337503|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2337504|NCT00433576|Resveratrol|resveratrol|mesh-list
2921701|NCT04650087|Apixaban|apixaban|mesh-list
2921702|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2921703|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
2921704|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2921705|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
2921706|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921707|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921708|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
2921709|NCT04642820|Methamphetamine|methamphetamine|mesh-list
2921710|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2921711|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921712|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
2921713|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
2921714|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2921715|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
2921716|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2921717|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921718|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
2921719|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2921720|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2921721|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2921722|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2921723|NCT04641702|Atropine|atropine|mesh-list
2921724|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2921725|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2921726|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2921727|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
2921728|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2921729|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921730|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2921731|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
2921732|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
2921733|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
2921734|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2921735|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2921736|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
2921737|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2921738|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921739|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2921740|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2921741|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2921742|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921755|NCT04635735|Ipilimumab|ipilimumab|mesh-list
2921756|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921757|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921758|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2921759|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921760|NCT04634877|Paclitaxel|paclitaxel|mesh-list
2921761|NCT04634877|Docetaxel|docetaxel|mesh-list
2921762|NCT04634877|Cisplatin|cisplatin|mesh-list
2921763|NCT04634877|Carboplatin|carboplatin|mesh-list
2921764|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
2921765|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2921766|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921767|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
2921768|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
2921769|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
2921770|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921771|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921772|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
2921773|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2921774|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
2921775|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2921776|NCT04632069|Expectorants|expectorants|mesh-ancestor
2921777|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
2921778|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2921779|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
2921780|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921781|NCT04632069|Protective Agents|protective agents|mesh-ancestor
2921782|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921783|NCT04632069|Antidotes|antidotes|mesh-ancestor
2921784|NCT04629378|Amoxicillin|amoxicillin|mesh-list
2921785|NCT04629378|Meropenem|meropenem|mesh-list
2337505|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
2337506|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337507|NCT00433576|Protective Agents|protective agents|mesh-ancestor
2337508|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337509|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337510|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2337511|NCT00433589|Docetaxel|docetaxel|mesh-list
2337512|NCT00433589|Capecitabine|capecitabine|mesh-list
2337513|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337514|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
2337515|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
2337516|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
2337517|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337518|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2337519|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
2337520|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
2337521|NCT00433615|Hematinics|hematinics|mesh-ancestor
2337522|NCT00433641|Sibutramine|sibutramine|mesh-list
2337523|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
2921786|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
2921787|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
2921788|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
2921789|NCT04629378|Bedaquiline|bedaquiline|mesh-list
2921790|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2921791|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2921792|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2921793|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2921794|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111490|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2111491|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
2111492|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114048|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2921795|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921796|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
2921834|NCT04628572|Ceftazidime|ceftazidime|mesh-list
2921835|NCT04628572|Avibactam|avibactam|mesh-list
2921836|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
2921837|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2337524|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2337525|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
2337526|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2337527|NCT00433719|Efavirenz|efavirenz|mesh-list
2337528|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2337529|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2337530|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2337531|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337532|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337533|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
2337534|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337535|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2337536|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2337537|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2337538|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2337539|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2337540|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2337541|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2337542|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2337543|NCT00433732|Naproxen|naproxen|mesh-list
2337544|NCT00433732|Sumatriptan|sumatriptan|mesh-list
2337545|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2921838|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2921839|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2921840|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921841|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337546|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2337547|NCT00433732|Analgesics|analgesics|mesh-ancestor
2337548|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
2337549|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337550|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337551|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2337552|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337553|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
2337554|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2337555|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337556|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337557|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2337558|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2337559|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2337560|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
2337561|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337562|NCT00433784|Clopidogrel|clopidogrel|mesh-list
2337563|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2337564|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2337565|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2337566|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2337567|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
2337568|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337569|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337570|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337571|NCT00433823|Atorvastatin|atorvastatin|mesh-list
2337572|NCT00433823|Ezetimibe|ezetimibe|mesh-list
2337573|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2337574|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2337575|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
2337576|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337577|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2337578|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2337579|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337580|NCT00433927|Leucovorin|leucovorin|mesh-list
2337581|NCT00433927|Folic Acid|folic acid|mesh-list
2337582|NCT00433927|Bevacizumab|bevacizumab|mesh-list
2337583|NCT00433927|Cetuximab|cetuximab|mesh-list
2337584|NCT00433927|Irinotecan|irinotecan|mesh-list
2337585|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
2337586|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2337587|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337588|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2337589|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2337590|NCT00433927|Growth Substances|growth substances|mesh-ancestor
2337591|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337592|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
2337593|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2337594|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2337595|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337596|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337597|NCT00433927|Antidotes|antidotes|mesh-ancestor
2337598|NCT00433927|Protective Agents|protective agents|mesh-ancestor
2337599|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
2337600|NCT00433927|Vitamins|vitamins|mesh-ancestor
2337601|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
2337602|NCT00433927|Hematinics|hematinics|mesh-ancestor
2337603|NCT00433940|Prednisolone|prednisolone|mesh-list
2921856|NCT04619797|Carboplatin|carboplatin|mesh-list
2921857|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
2921858|NCT04619797|Pemetrexed|pemetrexed|mesh-list
2921859|NCT04619797|Atezolizumab|atezolizumab|mesh-list
2921860|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921861|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921862|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921863|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921864|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2921865|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2337604|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2337605|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
2921866|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2921867|NCT04616183|Cetuximab|cetuximab|mesh-list
2921868|NCT04616183|Antibodies|antibodies|mesh-list
2921869|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
2921870|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2921871|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
2921872|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921873|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921874|NCT04612790|Benralizumab|benralizumab|mesh-list
2921875|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2921876|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
2921877|NCT04608318|Venetoclax|venetoclax|mesh-list
2921878|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
2921879|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921880|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921881|NCT04606446|Letrozole|letrozole|mesh-list
2921882|NCT04606446|Fulvestrant|fulvestrant|mesh-list
2921883|NCT04606446|Palbociclib|palbociclib|mesh-list
2921884|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921885|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2921886|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2921887|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921888|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921889|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2921890|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
2921891|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2921892|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921893|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2921894|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2921895|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2921896|NCT04606069|Regadenoson|regadenoson|mesh-list
2921897|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2921898|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2921899|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
2921900|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
2921901|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2921902|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921903|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921904|NCT04603846|Paclitaxel|paclitaxel|mesh-list
2921905|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2921906|NCT04603846|Antibodies|antibodies|mesh-list
2921907|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2921908|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337606|NCT00433940|Hormones|hormones|mesh-ancestor
2337607|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2337608|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337609|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2337610|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337611|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
2921909|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
2921910|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
2921911|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
2921912|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921913|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
2921914|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921915|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2921916|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2921923|NCT04591353|Lidocaine|lidocaine|mesh-list
2921924|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
2921925|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
2921926|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2921927|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337612|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2337613|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337614|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2337615|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
2921928|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
2337616|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2337617|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337618|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337619|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337620|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2337621|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
2337622|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337623|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
2337624|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2337625|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
2337626|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337627|NCT00434005|Expectorants|expectorants|mesh-ancestor
2337628|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
2921929|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2921930|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2921931|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2921932|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2921933|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2921934|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921935|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
2921936|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2921937|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
2921938|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2921939|NCT04586231|Lenvatinib|lenvatinib|mesh-list
2921940|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921941|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2921942|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2921943|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2921944|NCT04581395|Rocuronium|rocuronium|mesh-list
2921945|NCT04581395|Succinylcholine|succinylcholine|mesh-list
2921946|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2921947|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2921948|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2921949|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2921950|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921951|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2337629|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2337630|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
2337631|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337632|NCT00434005|Protective Agents|protective agents|mesh-ancestor
2337633|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337634|NCT00434005|Antidotes|antidotes|mesh-ancestor
2337635|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
2337636|NCT00434031|Docetaxel|docetaxel|mesh-list
2337637|NCT00434031|Doxorubicin|doxorubicin|mesh-list
2337638|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2337639|NCT00434031|Trastuzumab|trastuzumab|mesh-list
2337640|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2337641|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
2337642|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337643|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337644|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2337645|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
2337646|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337647|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337648|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2337649|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
2337650|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
2337651|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
2337652|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2921985|NCT04578756|Cariprazine|cariprazine|mesh-list
2921986|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2921987|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2921988|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2921989|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2921990|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2921991|NCT04578106|Trastuzumab|trastuzumab|mesh-list
2921992|NCT04578106|Pertuzumab|pertuzumab|mesh-list
2921993|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2921994|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2921995|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
2921996|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2921997|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
2921998|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2921999|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922000|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922001|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
2922002|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
2922003|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2922004|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2922005|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
2922006|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922018|NCT04565236|Factor VIII|factor viii|mesh-list
2922019|NCT04565236|Coagulants|coagulants|mesh-ancestor
2922020|NCT04564755|Abrocitinib|abrocitinib|mesh-list
2337653|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2337654|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2337655|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337656|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2337657|NCT00434044|Etanercept|etanercept|mesh-list
2337658|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2337659|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2337660|NCT00434044|Analgesics|analgesics|mesh-ancestor
2337661|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
2337662|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337663|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337664|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2337665|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337666|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2922021|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2922022|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922023|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922024|NCT04553367|Meropenem|meropenem|mesh-list
2922025|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2922026|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922027|NCT04550481|Lisinopril|lisinopril|mesh-list
2337667|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2337668|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
2337669|NCT00434083|Naproxen|naproxen|mesh-list
2337670|NCT00434083|Sumatriptan|sumatriptan|mesh-list
2337671|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2337672|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2337673|NCT00434083|Analgesics|analgesics|mesh-ancestor
2337674|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
2337675|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337676|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337677|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2337678|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337679|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
2337680|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2337681|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337682|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337683|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2337684|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2337685|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2337686|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
2337687|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337688|NCT00434096|Rimonabant|rimonabant|mesh-list
2337689|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2337690|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2337691|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2337692|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337693|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337694|NCT00434096|Hormones|hormones|mesh-ancestor
2337695|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2337696|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337697|NCT00434135|Gemcitabine|gemcitabine|mesh-list
2337698|NCT00434135|Paclitaxel|paclitaxel|mesh-list
2922028|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2922029|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
2922030|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922031|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922032|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2922033|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2922034|NCT04550481|Protective Agents|protective agents|mesh-ancestor
2337699|NCT00434135|Pemetrexed|pemetrexed|mesh-list
2337700|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2337701|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337702|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
2337703|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
2337704|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
2922035|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337705|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337706|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2337707|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
2337708|NCT00434135|Antiviral Agents|antiviral agents|mesh-ancestor
2337709|NCT00434135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337710|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337711|NCT00434135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2337712|NCT00434135|Immunologic Factors|immunologic factors|mesh-ancestor
2337713|NCT00434135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337714|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2337715|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2337716|NCT00434174|Pemetrexed|pemetrexed|mesh-list
2337717|NCT00434174|Everolimus|everolimus|mesh-list
2337718|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337719|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337720|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337721|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2337722|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2337723|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2337724|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
2337725|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337726|NCT00434239|Lenalidomide|lenalidomide|mesh-list
2337727|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
2337728|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337729|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2337730|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2337731|NCT00434239|Growth Substances|growth substances|mesh-ancestor
2337732|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
2337733|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337734|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
2337735|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2337736|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337737|NCT00434382|Fentanyl|fentanyl|mesh-list
2337738|NCT00434382|Sufentanil|sufentanil|mesh-list
2337739|NCT00434382|Remifentanil|remifentanil|mesh-list
2337740|NCT00434382|Alfentanil|alfentanil|mesh-list
2922036|NCT04549376|Iodine|iodine|mesh-list
2922037|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
2922038|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
2922039|NCT04549376|Povidone|povidone|mesh-list
2922040|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2922041|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922042|NCT04549376|Trace Elements|trace elements|mesh-ancestor
2922043|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
2922044|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922045|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
2922046|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
2922054|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
2922055|NCT04546399|Leucovorin|leucovorin|mesh-list
2922056|NCT04546399|Folic Acid|folic acid|mesh-list
2922057|NCT04546399|Cytarabine|cytarabine|mesh-list
2922058|NCT04546399|Dexamethasone|dexamethasone|mesh-list
2922059|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
2922060|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
2922061|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2922062|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2922063|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2922064|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
2922065|NCT04546399|Methotrexate|methotrexate|mesh-list
2922066|NCT04546399|Nivolumab|nivolumab|mesh-list
2922067|NCT04546399|Etoposide|etoposide|mesh-list
2922068|NCT04546399|Vincristine|vincristine|mesh-list
2337741|NCT00434382|Propofol|propofol|mesh-list
2337742|NCT00434382|Sevoflurane|sevoflurane|mesh-list
2337743|NCT00434382|Desflurane|desflurane|mesh-list
2337744|NCT00434382|Isoflurane|isoflurane|mesh-list
2337745|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2337746|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2337747|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337748|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2337749|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
2337750|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
2337751|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2922069|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
2922070|NCT04546399|Asparaginase|asparaginase|mesh-list
2922071|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
2922072|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
2337752|NCT00434382|Narcotics|narcotics|mesh-ancestor
2337753|NCT00434382|Analgesics|analgesics|mesh-ancestor
2337754|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
2337755|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337756|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2337757|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2337758|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2337759|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
2337760|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2337761|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337762|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
2337763|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337764|NCT00434668|Cisplatin|cisplatin|mesh-list
2337765|NCT00434668|Docetaxel|docetaxel|mesh-list
2337766|NCT00434668|Vinorelbine|vinorelbine|mesh-list
2337767|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337768|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
2922073|NCT04546399|Pegaspargase|pegaspargase|mesh-list
2922074|NCT04546399|Thioguanine|thioguanine|mesh-list
2337769|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
2337770|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
2337771|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337772|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2337773|NCT00434681|Acetaminophen|acetaminophen|mesh-list
2922075|NCT04546399|Blinatumomab|blinatumomab|mesh-list
2922076|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2922077|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
2922078|NCT04546399|Antibodies|antibodies|mesh-list
2922079|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
2922080|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2922081|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2922082|NCT04546399|BB 1101|bb 1101|mesh-list
2922083|NCT04546399|Calcium|calcium|mesh-list
2922084|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
2922085|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
2922086|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2922087|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
2922088|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922089|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2922090|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2922091|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
2922092|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922093|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922094|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2922095|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2922096|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
2922097|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
2922098|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2922099|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2337774|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2337775|NCT00434681|Analgesics|analgesics|mesh-ancestor
2337776|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
2337777|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337778|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337779|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
2337780|NCT00434746|Fezakinumab|fezakinumab|mesh-list
2337781|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
2337782|NCT00434772|Glucagon|glucagon|mesh-list
2337783|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2337784|NCT00434772|Hormones|hormones|mesh-ancestor
2337785|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2337786|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337787|NCT00434811|Sirolimus|sirolimus|mesh-list
2337788|NCT00434811|Etanercept|etanercept|mesh-list
2337789|NCT00434811|Tacrolimus|tacrolimus|mesh-list
2337790|NCT00434811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2337791|NCT00434811|Basiliximab|basiliximab|mesh-list
2922100|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
2922101|NCT04546399|Hormones|hormones|mesh-ancestor
2922102|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2922103|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2922104|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
2922105|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922106|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2922107|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2922108|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2922109|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
2922110|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2922111|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2922112|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
2922113|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
2922114|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2922115|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2922116|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2922117|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2922118|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2922119|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2922120|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
2922121|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922122|NCT04546399|Antidotes|antidotes|mesh-ancestor
2922123|NCT04546399|Protective Agents|protective agents|mesh-ancestor
2922124|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
2922125|NCT04546399|Vitamins|vitamins|mesh-ancestor
2922126|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
2922127|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
2922128|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
2922129|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
2922130|NCT04546399|Hematinics|hematinics|mesh-ancestor
2922131|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
2922132|NCT04545151|Verapamil|verapamil|mesh-list
2922133|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2922134|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2922135|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2922136|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337792|NCT00434811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2922137|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2922138|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922139|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
2922140|NCT04537598|Morphine|morphine|mesh-list
2922141|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2922142|NCT04537598|Narcotics|narcotics|mesh-ancestor
2922143|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2922144|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922145|NCT04537598|Analgesics|analgesics|mesh-ancestor
2337793|NCT00434811|Immunologic Factors|immunologic factors|mesh-ancestor
2337794|NCT00434811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337795|NCT00434811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2337796|NCT00434811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337797|NCT00434811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337798|NCT00434811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2337799|NCT00434811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337800|NCT00434811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2337801|NCT00434811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337802|NCT00434811|Antifungal Agents|antifungal agents|mesh-ancestor
2337803|NCT00434811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2337804|NCT00434811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2337805|NCT00434811|Analgesics|analgesics|mesh-ancestor
2337806|NCT00434811|Sensory System Agents|sensory system agents|mesh-ancestor
2337807|NCT00434811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337808|NCT00434811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2337809|NCT00434811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337810|NCT00434811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2337811|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
2337812|NCT00434824|Testosterone|testosterone|mesh-list
2337813|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
2337814|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
2337815|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2337816|NCT00434824|Androgens|androgens|mesh-ancestor
2337817|NCT00434824|Hormones|hormones|mesh-ancestor
2337818|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2337819|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337820|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2337821|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337822|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
2922146|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
2922147|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2922148|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
2922149|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922150|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922151|NCT04529772|Prednisone|prednisone|mesh-list
2922152|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
2922153|NCT04529772|Rituximab|rituximab|mesh-list
2922154|NCT04529772|Doxorubicin|doxorubicin|mesh-list
2922155|NCT04529772|Vincristine|vincristine|mesh-list
2922156|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
2922157|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2922158|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
2922159|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922160|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2922161|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2922162|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
2922163|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922164|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922165|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2922166|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922167|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2922168|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2922169|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2922170|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922171|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2922172|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
2922173|NCT04529772|Hormones|hormones|mesh-ancestor
2922174|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2922175|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2922176|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2922177|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
2922178|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
2922179|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
2922180|NCT04528134|Listerine|listerine|mesh-list
2922181|NCT04528134|Fluorides|fluorides|mesh-list
2337823|NCT00434850|Gusperimus|gusperimus|mesh-list
2337824|NCT00434850|Sirolimus|sirolimus|mesh-list
2922182|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
2922183|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
2922184|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
2922185|NCT04528134|Protective Agents|protective agents|mesh-ancestor
2922186|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922187|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2922188|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337825|NCT00434850|Etanercept|etanercept|mesh-list
2337826|NCT00434850|Tacrolimus|tacrolimus|mesh-list
2337827|NCT00434850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2337828|NCT00434850|Basiliximab|basiliximab|mesh-list
2337829|NCT00434850|Daclizumab|daclizumab|mesh-list
2337830|NCT00434850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2337831|NCT00434850|Immunologic Factors|immunologic factors|mesh-ancestor
2337832|NCT00434850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337833|NCT00434850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2337834|NCT00434850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337835|NCT00434850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337836|NCT00434850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2337837|NCT00434850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337838|NCT00434850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2337839|NCT00434850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337840|NCT00434850|Antifungal Agents|antifungal agents|mesh-ancestor
2337841|NCT00434850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2337842|NCT00434850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2337843|NCT00434850|Analgesics|analgesics|mesh-ancestor
2337844|NCT00434850|Sensory System Agents|sensory system agents|mesh-ancestor
2337845|NCT00434850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337846|NCT00434850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2337847|NCT00434850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337848|NCT00434850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2337849|NCT00434850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2337850|NCT00434850|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2337851|NCT00434850|Protective Agents|protective agents|mesh-ancestor
2337852|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
2337853|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2111493|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111494|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
2111495|NCT02556203|Aspirin|aspirin|mesh-list
2337854|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2337855|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2337856|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2337857|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337858|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
2337859|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337860|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337861|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2337862|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2922197|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2922198|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
2922199|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2922200|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2922201|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2922202|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2922203|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922204|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
2922205|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922206|NCT04518046|Nivolumab|nivolumab|mesh-list
2922207|NCT04518046|Ipilimumab|ipilimumab|mesh-list
2922208|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2111496|NCT02556203|Vitamin K|vitamin k|mesh-list
2111497|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
2111498|NCT02556203|Clopidogrel|clopidogrel|mesh-list
2111499|NCT02556203|Vitamins|vitamins|mesh-ancestor
2111500|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
2111501|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111502|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2337863|NCT00434941|Capecitabine|capecitabine|mesh-list
2337864|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2337865|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
2922209|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922210|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2922211|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922212|NCT04509674|Empagliflozin|empagliflozin|mesh-list
2922213|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2922214|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922215|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2922216|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922217|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
2922218|NCT04505878|Vitamins|vitamins|mesh-ancestor
2922219|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
2922220|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922221|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
2922222|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922223|NCT04505878|Protective Agents|protective agents|mesh-ancestor
2922224|NCT04502381|Amphotericin B|amphotericin b|mesh-list
2922225|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2337866|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337867|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337868|NCT00435058|Timolol|timolol|mesh-list
2337869|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2337870|NCT00435058|Travoprost|travoprost|mesh-list
2337871|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2337872|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2337873|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
2337874|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337875|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337876|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337877|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2337878|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2922226|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
2922227|NCT04502381|Amebicides|amebicides|mesh-ancestor
2922228|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2922229|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2922230|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922231|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2922232|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
2922233|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2922234|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2922248|NCT04489732|Interferons|interferons|mesh-list
2922249|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
2922250|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922251|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
2922252|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922253|NCT04486352|Bevacizumab|bevacizumab|mesh-list
2922254|NCT04486352|Trastuzumab|trastuzumab|mesh-list
2922255|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2922256|NCT04486352|Atezolizumab|atezolizumab|mesh-list
2922257|NCT04486352|Talazoparib|talazoparib|mesh-list
2922258|NCT04486352|Maytansine|maytansine|mesh-list
2922259|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2922260|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922261|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922262|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2922263|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2922264|NCT04486352|Growth Substances|growth substances|mesh-ancestor
2922265|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922266|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
2922267|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
2922268|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2922269|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337879|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2337880|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2922270|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922271|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2922272|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
2922273|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
2922274|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
2922275|NCT04485559|Everolimus|everolimus|mesh-list
2922276|NCT04485559|Trametinib|trametinib|mesh-list
2922277|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922278|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2922279|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
2922280|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922281|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2922282|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922283|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922284|NCT04472182|Calcium|calcium|mesh-list
2922285|NCT04472182|Fluorides|fluorides|mesh-list
2922286|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
2922287|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2922288|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922289|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
2922290|NCT04472182|Protective Agents|protective agents|mesh-ancestor
2922291|NCT04467905|Etripamil|etripamil|mesh-list
2922292|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2922293|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2922294|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922295|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2922296|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922297|NCT04462965|Temozolomide|temozolomide|mesh-list
2922298|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2922299|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
2922300|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922301|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922314|NCT04430738|Leucovorin|leucovorin|mesh-list
2922315|NCT04430738|Fluorouracil|fluorouracil|mesh-list
2922316|NCT04430738|Capecitabine|capecitabine|mesh-list
2922317|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
2922318|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
2922319|NCT04430738|Trastuzumab|trastuzumab|mesh-list
2922320|NCT04430738|Tucatinib|tucatinib|mesh-list
2922321|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
2922322|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922323|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2922324|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922325|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2922326|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
2922327|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922328|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922329|NCT04430738|Antidotes|antidotes|mesh-ancestor
2922330|NCT04430738|Protective Agents|protective agents|mesh-ancestor
2922331|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
2922332|NCT04430738|Vitamins|vitamins|mesh-ancestor
2922333|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
2922334|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2922335|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922336|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
2922337|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2922338|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922339|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2922340|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2922341|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922342|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922343|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922344|NCT04423029|Nivolumab|nivolumab|mesh-list
2922345|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922346|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922347|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2922348|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922349|NCT04417257|Fenretinide|fenretinide|mesh-list
2922350|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922351|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2922352|NCT04417257|Protective Agents|protective agents|mesh-ancestor
2922353|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922354|NCT04413617|Tofacitinib|tofacitinib|mesh-list
2922355|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2922356|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922357|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922358|NCT04413123|Nivolumab|nivolumab|mesh-list
2922359|NCT04413123|Ipilimumab|ipilimumab|mesh-list
2922360|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922361|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922362|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2922363|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922364|NCT04409509|Antibodies|antibodies|mesh-list
2922365|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2922366|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
2922367|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337881|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2337882|NCT00435175|Estradiol|estradiol|mesh-list
2337883|NCT00435175|Estrogens|estrogens|mesh-ancestor
2922379|NCT04401865|Riboflavin|riboflavin|mesh-list
2922380|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
2922381|NCT04401865|Vitamins|vitamins|mesh-ancestor
2922382|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
2922383|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922384|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2922385|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
2922386|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
2922387|NCT04401150|Vitamins|vitamins|mesh-ancestor
2922388|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
2922389|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922390|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
2922391|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922392|NCT04401150|Protective Agents|protective agents|mesh-ancestor
2922402|NCT04395508|Trastuzumab|trastuzumab|mesh-list
2922403|NCT04395508|Pertuzumab|pertuzumab|mesh-list
2922404|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922405|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922406|NCT04388852|Ipilimumab|ipilimumab|mesh-list
2922407|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922408|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922409|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2922410|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922411|NCT04386811|Calcitriol|calcitriol|mesh-list
2922412|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2922413|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922414|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2922415|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2922416|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922417|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2922418|NCT04386811|Vitamins|vitamins|mesh-ancestor
2922419|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
2922420|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2922421|NCT04381143|Aspirin|aspirin|mesh-list
2922422|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2922423|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2922424|NCT04381143|Analgesics|analgesics|mesh-ancestor
2922425|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
2922426|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2922427|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922428|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2922429|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2922430|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2922431|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2922432|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922433|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2922434|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2922435|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922436|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
2922437|NCT04372108|Ustekinumab|ustekinumab|mesh-list
2922438|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
2922453|NCT04369014|Anesthetics|anesthetics|mesh-list
2922454|NCT04369014|Propofol|propofol|mesh-list
2922455|NCT04369014|Etomidate|etomidate|mesh-list
2922456|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2922457|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922458|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2922459|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2922460|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
2922461|NCT04358133|Morphine|morphine|mesh-list
2922462|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2922463|NCT04358133|Narcotics|narcotics|mesh-ancestor
2922464|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2922465|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922466|NCT04358133|Analgesics|analgesics|mesh-ancestor
2922467|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
2922468|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2922469|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
2922470|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2922471|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
2922472|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2922473|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
2922474|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922475|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922476|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
2922477|NCT04349371|Chloroquine|chloroquine|mesh-list
2922478|NCT04349371|Amebicides|amebicides|mesh-ancestor
2922479|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2922480|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2922481|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922482|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
2922483|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337884|NCT00435175|Hormones|hormones|mesh-ancestor
2337885|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2337886|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337887|NCT00435279|Eszopiclone|eszopiclone|mesh-list
2337888|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2337889|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2337890|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2337891|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2337892|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337893|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337894|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337895|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2337896|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
2337897|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2337898|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2337899|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2337900|NCT00435292|Naproxen|naproxen|mesh-list
2337901|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2337902|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2337903|NCT00435292|Analgesics|analgesics|mesh-ancestor
2337904|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
2337905|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337906|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337907|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2337908|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337909|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
2337910|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2337911|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337912|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337913|NCT00435305|Vancomycin|vancomycin|mesh-list
2337914|NCT00435305|Meropenem|meropenem|mesh-list
2337915|NCT00435305|Tazobactam|tazobactam|mesh-list
2337916|NCT00435305|Linezolid|linezolid|mesh-list
2337917|NCT00435305|Piperacillin|piperacillin|mesh-list
2337918|NCT00435305|Ceftazidime|ceftazidime|mesh-list
2337919|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2922508|NCT04334759|Cisplatin|cisplatin|mesh-list
2337920|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2337921|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337922|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2337923|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337924|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337925|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2922509|NCT04334759|Carboplatin|carboplatin|mesh-list
2922510|NCT04334759|Pemetrexed|pemetrexed|mesh-list
2922511|NCT04334759|Durvalumab|durvalumab|mesh-list
2922512|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922513|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922514|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922515|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2922516|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2922517|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922524|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
2922525|NCT04332211|Ephedrine|ephedrine|mesh-list
2922526|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2922527|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
2922528|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2922529|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922530|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2922531|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
2922532|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
2922533|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2922534|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2922535|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
2922536|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
2337926|NCT00435331|Verapamil|verapamil|mesh-list
2337927|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2337928|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2337929|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2337930|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337931|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2337932|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337933|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
2337934|NCT00435435|Disulfiram|disulfiram|mesh-list
2337935|NCT00435435|Acamprosate|acamprosate|mesh-list
2337936|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2337937|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2337938|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337939|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337940|NCT00435448|Lonidamine|lonidamine|mesh-list
2337941|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2337942|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2337943|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337944|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2337945|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
2337946|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2337947|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2337948|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2922537|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2922538|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922564|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2922565|NCT04309773|Bezafibrate|bezafibrate|mesh-list
2922566|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2922567|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2922568|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2922569|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
2922570|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922571|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2337949|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2337950|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2337951|NCT00435500|Fluorides|fluorides|mesh-list
2337952|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
2337953|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
2337954|NCT00435500|Protective Agents|protective agents|mesh-ancestor
2337955|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337956|NCT00435747|Parecoxib|parecoxib|mesh-list
2337957|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2337958|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2337959|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2337960|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337961|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2337962|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2337963|NCT00435747|Analgesics|analgesics|mesh-ancestor
2337964|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
2922613|NCT04300296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2922614|NCT04300296|Immunologic Factors|immunologic factors|mesh-ancestor
2922615|NCT04300296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922616|NCT04299867|Metronidazole|metronidazole|mesh-list
2922617|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922618|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2922619|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2922620|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2111503|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2111504|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2111505|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2111506|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
2111507|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111508|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111509|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2111510|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
2111511|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2111512|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
2111513|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111514|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
2337965|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2922629|NCT04294628|Trastuzumab|trastuzumab|mesh-list
2922630|NCT04294628|Camptothecin|camptothecin|mesh-list
2922631|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
2922632|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922633|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922634|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2922635|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2922636|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2922637|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922638|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922639|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
2922640|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922641|NCT04294459|Acetaminophen|acetaminophen|mesh-list
2922642|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
2922643|NCT04294459|Promethazine|promethazine|mesh-list
2922644|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
2922645|NCT04294459|Ranitidine|ranitidine|mesh-list
2922646|NCT04294459|Montelukast|montelukast|mesh-list
2922647|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2922648|NCT04294459|Analgesics|analgesics|mesh-ancestor
2922649|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
2922650|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2922651|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922652|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
2922653|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2922654|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
2922655|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
2922656|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2922657|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
2922658|NCT04294459|Hormones|hormones|mesh-ancestor
2922659|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2922660|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2922661|NCT04294459|Protective Agents|protective agents|mesh-ancestor
2922662|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2922663|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
2922664|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2922665|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
2922666|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2922667|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2922668|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922669|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2922670|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2922671|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2922672|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
2922673|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
2922674|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2922675|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
2922676|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
2922677|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2922678|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2922679|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
2922680|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
2922681|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2922682|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2922683|NCT04291885|Avelumab|avelumab|mesh-list
2922684|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922685|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922686|NCT04289779|Atezolizumab|atezolizumab|mesh-list
2922687|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922688|NCT04286867|Ethanol|ethanol|mesh-list
2922689|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2922690|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922691|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2922692|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922693|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
2922694|NCT04284787|Azacitidine|azacitidine|mesh-list
2337966|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337967|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2922695|NCT04284787|Venetoclax|venetoclax|mesh-list
2922696|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922697|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922698|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2922699|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
2337968|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2337969|NCT00435760|Bromides|bromides|mesh-list
2337970|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
2337971|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2337972|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
2337973|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2337974|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337975|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2337976|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
2337977|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
2337978|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2337979|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
2337980|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2337981|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2337982|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
2337983|NCT00435799|Riboflavin|riboflavin|mesh-list
2337984|NCT00435799|Dextrans|dextrans|mesh-list
2337985|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2337986|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
2337987|NCT00435799|Vitamins|vitamins|mesh-ancestor
2337988|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
2337989|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337990|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2337991|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
2337992|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
2337993|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
2337994|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
2337995|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2337996|NCT00435851|Hormones|hormones|mesh-list
2337997|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2337998|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2337999|NCT00435916|Dacetuzumab|dacetuzumab|mesh-list
2338000|NCT00435916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2338001|NCT00435916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338002|NCT00435955|Rituximab|rituximab|mesh-list
2338003|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2338004|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338005|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
2338006|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338007|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2338008|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2338009|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2338010|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
2338011|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338012|NCT00435981|Antacids|antacids|mesh-ancestor
2338013|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338014|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2338015|NCT00436033|Milnacipran|milnacipran|mesh-list
2338016|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
2922700|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922701|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922702|NCT04284657|Citric Acid|citric acid|mesh-list
2922703|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
2922704|NCT04284657|Pravastatin|pravastatin|mesh-list
2922705|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
2922706|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2922707|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
2922708|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
2922709|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922710|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2922711|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2922712|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
2922713|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2922714|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2922715|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338017|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2338018|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2338019|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2922757|NCT04263831|Aldesleukin|aldesleukin|mesh-list
2922758|NCT04263831|Interleukin-2|interleukin-2|mesh-list
2922759|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922760|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2338020|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338021|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338022|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338023|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2338024|NCT00436033|Analgesics|analgesics|mesh-ancestor
2338025|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
2338026|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338027|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
2338028|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2338029|NCT00436059|Bortezomib|bortezomib|mesh-list
2338030|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338031|NCT00436072|Irinotecan|irinotecan|mesh-list
2338032|NCT00436072|Cetuximab|cetuximab|mesh-list
2338033|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2338034|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2338035|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338036|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338037|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338038|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2338039|NCT00436124|Oseltamivir|oseltamivir|mesh-list
2338040|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
2338041|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338042|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922761|NCT04263831|Analgesics|analgesics|mesh-ancestor
2922762|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
2922763|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2922764|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922765|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2922766|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2922767|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
2922768|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922769|NCT04255381|Pancrelipase|pancrelipase|mesh-list
2922770|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2922771|NCT04241185|Gemcitabine|gemcitabine|mesh-list
2922772|NCT04241185|Fluorouracil|fluorouracil|mesh-list
2922773|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
2922774|NCT04241185|Mitomycins|mitomycins|mesh-list
2922775|NCT04241185|Mitomycin|mitomycin|mesh-list
2922776|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922777|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2922778|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
2922779|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922780|NCT04241185|Antiviral Agents|antiviral agents|mesh-ancestor
2922781|NCT04241185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922782|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922783|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2922784|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
2922785|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922786|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922787|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2922788|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
2922789|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2922790|NCT04239703|Antibodies|antibodies|mesh-list
2922791|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
2922792|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922793|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
2338043|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338044|NCT00436241|Capecitabine|capecitabine|mesh-list
2338045|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
2338046|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2338047|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
2338048|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338049|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338050|NCT00436254|Molgramostim|molgramostim|mesh-list
2922794|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
2922795|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
2922796|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2922797|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2922798|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2922799|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922800|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338051|NCT00436254|Sargramostim|sargramostim|mesh-list
2338052|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
2338053|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338054|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338055|NCT00436267|Fluorouracil|fluorouracil|mesh-list
2338056|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
2338057|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338058|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2338059|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338060|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2338061|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
2338062|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338063|NCT00436293|Docetaxel|docetaxel|mesh-list
2338064|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338065|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
2338066|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
2338067|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
2338068|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922801|NCT04223856|Gemcitabine|gemcitabine|mesh-list
2922802|NCT04223856|Carboplatin|carboplatin|mesh-list
2922803|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
2922804|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922805|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2922806|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
2922807|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922808|NCT04223856|Antiviral Agents|antiviral agents|mesh-ancestor
2922809|NCT04223856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922810|NCT04223856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922811|NCT04223856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2922812|NCT04223856|Immunologic Factors|immunologic factors|mesh-ancestor
2922813|NCT04223856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922814|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922815|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
2922816|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
2922817|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2922818|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922819|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922820|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
2922821|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2922822|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2922823|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922824|NCT04216316|Gemcitabine|gemcitabine|mesh-list
2922825|NCT04216316|Carboplatin|carboplatin|mesh-list
2922826|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
2922827|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922828|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2922829|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
2922830|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922831|NCT04216316|Antiviral Agents|antiviral agents|mesh-ancestor
2922832|NCT04216316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922833|NCT04216316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922834|NCT04216316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2922835|NCT04216316|Immunologic Factors|immunologic factors|mesh-ancestor
2922836|NCT04216316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922837|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922846|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
2922847|NCT04210115|Leucovorin|leucovorin|mesh-list
2922848|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
2922849|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
2922850|NCT04210115|Calcium|calcium|mesh-list
2922851|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
2922852|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922853|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2922854|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922855|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2922856|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922857|NCT04210115|Antidotes|antidotes|mesh-ancestor
2338069|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
2338070|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2338071|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338072|NCT00436371|Amisulpride|amisulpride|mesh-list
2338073|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2338074|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2338075|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2922858|NCT04210115|Protective Agents|protective agents|mesh-ancestor
2922859|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
2922860|NCT04210115|Vitamins|vitamins|mesh-ancestor
2922861|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
2922862|NCT04209855|Paclitaxel|paclitaxel|mesh-list
2922863|NCT04209855|Maytansine|maytansine|mesh-list
2922864|NCT04209855|Doxorubicin|doxorubicin|mesh-list
2922865|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2922866|NCT04209855|Topotecan|topotecan|mesh-list
2922867|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2922868|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922869|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
2922870|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
2922871|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
2922872|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338076|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338077|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2338078|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2338079|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
2338080|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372164|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2922873|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2922874|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2922875|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2922876|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922877|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2922878|NCT04191304|Benralizumab|benralizumab|mesh-list
2922879|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2922880|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
2922881|NCT04185311|Nivolumab|nivolumab|mesh-list
2922882|NCT04185311|Ipilimumab|ipilimumab|mesh-list
2922883|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2922884|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922885|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922886|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2922887|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922888|NCT04182334|TEMPO|tempo|mesh-list
2922889|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
2922890|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922891|NCT04182334|Protective Agents|protective agents|mesh-ancestor
2922892|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338081|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338082|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2338083|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
2338084|NCT00436423|Gemcitabine|gemcitabine|mesh-list
2338085|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2338086|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
2338087|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338088|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338089|NCT00436423|Antiviral Agents|antiviral agents|mesh-ancestor
2338090|NCT00436423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2922911|NCT04180371|Nivolumab|nivolumab|mesh-list
2922912|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922913|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922914|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2922915|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922916|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2922917|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2922918|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922930|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
2922931|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2922932|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
2922933|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2922934|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
2922935|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922936|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922937|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
2922938|NCT04172532|Peposertib|peposertib|mesh-list
2922939|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2922940|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922941|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922950|NCT04161248|Gemcitabine|gemcitabine|mesh-list
2922951|NCT04161248|Dexamethasone|dexamethasone|mesh-list
2922952|NCT04161248|Rituximab|rituximab|mesh-list
2922953|NCT04161248|Venetoclax|venetoclax|mesh-list
2922954|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2922955|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2338091|NCT00436423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338092|NCT00436423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2338093|NCT00436423|Immunologic Factors|immunologic factors|mesh-ancestor
2338094|NCT00436423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338095|NCT00436527|Metronidazole|metronidazole|mesh-list
2338096|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338097|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2338098|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2338099|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2338100|NCT00436540|Clobetasol|clobetasol|mesh-list
2338101|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2111515|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2111516|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2111517|NCT02556203|Analgesics|analgesics|mesh-ancestor
2111518|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
2111519|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2922956|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
2922957|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
2922958|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2922959|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922960|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2922961|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
2922962|NCT04161248|Hormones|hormones|mesh-ancestor
2922963|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2922964|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2922965|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2922966|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
2922967|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2922968|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2338102|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
2338103|NCT00436540|Hormones|hormones|mesh-ancestor
2338104|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338105|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338106|NCT00436579|Sorafenib|sorafenib|mesh-list
2338107|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338108|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2338109|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338110|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338111|NCT00436657|Cisplatin|cisplatin|mesh-list
2338112|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338113|NCT00436670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2338114|NCT00436670|Immunologic Factors|immunologic factors|mesh-ancestor
2922969|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
2922970|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2922971|NCT04161248|Antiviral Agents|antiviral agents|mesh-ancestor
2922972|NCT04161248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338115|NCT00436670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338116|NCT00436683|Sevelamer|sevelamer|mesh-list
2338117|NCT00436683|Chelating Agents|chelating agents|mesh-ancestor
2338118|NCT00436683|Sequestering Agents|sequestering agents|mesh-ancestor
2338119|NCT00436683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338120|NCT00436709|Paclitaxel|paclitaxel|mesh-list
2338121|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
2338122|NCT00436709|Bevacizumab|bevacizumab|mesh-list
2338123|NCT00436709|Doxorubicin|doxorubicin|mesh-list
2338124|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2338125|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2338126|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2338127|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338128|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
2338129|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
2338130|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
2338131|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338132|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2111520|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2111521|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2111522|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2111523|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2111524|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2111525|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
2111526|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2111527|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
2111528|NCT02556203|Coagulants|coagulants|mesh-ancestor
2111529|NCT02556307|Ribavirin|ribavirin|mesh-list
2111530|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2111531|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
2922973|NCT04161248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2922974|NCT04161248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2922975|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
2922976|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2922977|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
2922978|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2922979|NCT04159519|Budesonide|budesonide|mesh-list
2922980|NCT04159519|Albuterol|albuterol|mesh-list
2922981|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
2922982|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2922983|NCT04159519|Benralizumab|benralizumab|mesh-list
2922984|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2922985|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2922986|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
2922987|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2922988|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2922989|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2922990|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
2922991|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
2922992|NCT04159519|Hormones|hormones|mesh-ancestor
2922993|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2922994|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2922995|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2338133|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
2338134|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338135|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2338136|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2338137|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
2338138|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2338139|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2338140|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2338141|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2338142|NCT00436709|Growth Substances|growth substances|mesh-ancestor
2338143|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
2338144|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2338145|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2922996|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2922997|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
2922998|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2922999|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923000|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
2923001|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2923002|NCT04157348|Benralizumab|benralizumab|mesh-list
2923003|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2923004|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
2923005|NCT04155580|Decitabine|decitabine|mesh-list
2923006|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2923007|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
2923008|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923009|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338146|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2338147|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338148|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
2338149|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2338150|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
2338151|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338152|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2338153|NCT00436761|Cyclosporine|cyclosporine|mesh-list
2923010|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338154|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
2338155|NCT00436761|Melphalan|melphalan|mesh-list
2338156|NCT00436761|Busulfan|busulfan|mesh-list
2338157|NCT00436761|Cyclosporins|cyclosporins|mesh-list
2338158|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2338159|NCT00436761|Sargramostim|sargramostim|mesh-list
2338160|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338161|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338162|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923018|NCT04149145|Niraparib|niraparib|mesh-list
2338163|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
2338164|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338165|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
2338166|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338167|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
2338168|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2338169|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2338170|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2338171|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
2338172|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338173|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2338174|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2338175|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
2338176|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
2338177|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338178|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2338179|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
2338180|NCT00436761|Hormones|hormones|mesh-ancestor
2338181|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338182|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2338183|NCT00436761|Protective Agents|protective agents|mesh-ancestor
2338184|NCT00436787|PENTA|penta|mesh-list
2338185|NCT00436787|Fondaparinux|fondaparinux|mesh-list
2338186|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2338187|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
2923019|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2923020|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923021|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923022|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923023|NCT04142658|Warfarin|warfarin|mesh-list
2338188|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2338189|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
2338190|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338191|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338192|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
2923024|NCT04142658|Apixaban|apixaban|mesh-list
2923025|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
2923026|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2923027|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
2923028|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2923029|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
2923030|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923031|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923032|NCT04136548|Fentanyl|fentanyl|mesh-list
2923033|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2923034|NCT04136548|Narcotics|narcotics|mesh-ancestor
2923035|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2923036|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923037|NCT04136548|Analgesics|analgesics|mesh-ancestor
2923038|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
2923039|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923040|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2923041|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2338193|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2338194|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2338195|NCT00436800|Gemcitabine|gemcitabine|mesh-list
2338196|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
2338197|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2338198|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
2338199|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338200|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923042|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
2923043|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
2923044|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
2923045|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923046|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
2923047|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923048|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2923049|NCT04122625|Nivolumab|nivolumab|mesh-list
2923050|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923051|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923052|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2923053|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923054|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2923055|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2338201|NCT00436800|Antiviral Agents|antiviral agents|mesh-ancestor
2923056|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2923057|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2923058|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923059|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2923060|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923061|NCT04111627|Analgesics|analgesics|mesh-ancestor
2923062|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
2923063|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923064|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
2923065|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2923066|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
2338202|NCT00436800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338203|NCT00436800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338204|NCT00436800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2338205|NCT00436800|Immunologic Factors|immunologic factors|mesh-ancestor
2338206|NCT00436800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338207|NCT00436826|Interferons|interferons|mesh-list
2338208|NCT00436826|Interferon-beta|interferon-beta|mesh-list
2338209|NCT00436826|Cladribine|cladribine|mesh-list
2338210|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
2338211|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338212|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
2338213|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338214|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
2338215|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338216|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2338217|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2338218|NCT00436839|Prednisone|prednisone|mesh-list
2338219|NCT00436839|Docetaxel|docetaxel|mesh-list
2338220|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
2338221|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338222|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
2338223|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
2338224|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
2338225|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338226|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2338227|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
2338228|NCT00436839|Hormones|hormones|mesh-ancestor
2338229|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338230|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338231|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2338232|NCT00436839|Analgesics|analgesics|mesh-ancestor
2338233|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
2338234|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338235|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2338236|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2338237|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923085|NCT04102020|Azacitidine|azacitidine|mesh-list
2923086|NCT04102020|Venetoclax|venetoclax|mesh-list
2923087|NCT04102020|Cc-486|cc-486|mesh-list
2923088|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2923089|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
2923090|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923091|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338238|NCT00436930|Sargramostim|sargramostim|mesh-list
2338239|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
2338240|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923092|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923093|NCT04098393|Fludarabine|fludarabine|mesh-list
2923094|NCT04098393|Melphalan|melphalan|mesh-list
2923095|NCT04098393|Busulfan|busulfan|mesh-list
2923096|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2923097|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923098|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923099|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923100|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
2923101|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923102|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2923103|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
2923104|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2923133|NCT04087395|Lidocaine|lidocaine|mesh-list
2923134|NCT04087395|Anesthetics|anesthetics|mesh-list
2923135|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
2923136|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2923137|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923138|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
2923139|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923140|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2923141|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2923142|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2923143|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2923144|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923150|NCT04085887|Panitumumab|panitumumab|mesh-list
2923151|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923152|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923153|NCT04079712|Nivolumab|nivolumab|mesh-list
2923154|NCT04079712|Ipilimumab|ipilimumab|mesh-list
2923155|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923156|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923157|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2923158|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923159|NCT04074785|Bevacizumab|bevacizumab|mesh-list
2923160|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923161|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923162|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2923163|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2338241|NCT00436943|Bupropion|bupropion|mesh-list
2338242|NCT00436943|Nicotine|nicotine|mesh-list
2338243|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2338244|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
2923164|NCT04074785|Growth Substances|growth substances|mesh-ancestor
2923165|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923166|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
2923169|NCT04069585|Lidocaine|lidocaine|mesh-list
2923170|NCT04069585|Anesthetics|anesthetics|mesh-list
2923171|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
2923172|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2923173|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923174|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
2923175|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923176|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2923177|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2923178|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2923179|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2923180|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923181|NCT04068194|Avelumab|avelumab|mesh-list
2923182|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2923183|NCT04068194|Peposertib|peposertib|mesh-list
2923184|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923185|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923186|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
2923187|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923188|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2923189|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923190|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338245|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338246|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338247|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2338248|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2338249|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
2338250|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338251|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338252|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2338253|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
2338254|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2338255|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2338256|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2338257|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2338258|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
2338259|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2338260|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2338261|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338262|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
2338263|NCT00436995|Hematinics|hematinics|mesh-ancestor
2338264|NCT00437008|Benphothiamine|benphothiamine|mesh-list
2338265|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2338266|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
2338267|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338268|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
2338269|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
2338270|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338271|NCT00437086|Bortezomib|bortezomib|mesh-list
2338272|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338273|NCT00437112|Insulin|insulin|mesh-list
2338274|NCT00437112|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2338275|NCT00437112|Insulin Glargine|insulin glargine|mesh-list
2338276|NCT00437112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2923191|NCT04060108|Methamphetamine|methamphetamine|mesh-list
2923192|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2923193|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923194|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
2923195|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
2923196|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923197|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
2923198|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2923199|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923200|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
2923201|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2923202|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2923203|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2338277|NCT00437112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338278|NCT00437164|Insulin|insulin|mesh-list
2923204|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2923205|NCT04055753|Doxorubicin|doxorubicin|mesh-list
2923206|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2923207|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923208|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2923209|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2923210|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923211|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338279|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2338280|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2338281|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338282|NCT00437177|Apomorphine|apomorphine|mesh-list
2338283|NCT00437177|Emetics|emetics|mesh-ancestor
2338284|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338285|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
2338286|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923215|NCT04053634|Benralizumab|benralizumab|mesh-list
2923216|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2923217|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
2923218|NCT04041050|Celecoxib|celecoxib|mesh-list
2923219|NCT04041050|Navitoclax|navitoclax|mesh-list
2923220|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2923221|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2923222|NCT04041050|Analgesics|analgesics|mesh-ancestor
2923223|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
2923224|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923225|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923226|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2923227|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2923228|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2923229|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2923230|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923231|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923232|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923233|NCT04029688|Cytarabine|cytarabine|mesh-list
2923234|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
2923235|NCT04029688|Fludarabine|fludarabine|mesh-list
2923236|NCT04029688|Topotecan|topotecan|mesh-list
2923237|NCT04029688|Venetoclax|venetoclax|mesh-list
2923238|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923239|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
2923240|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923241|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2923242|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2923243|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
2338287|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2338288|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
2338289|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
2338290|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2923244|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923245|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923246|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2923247|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2923248|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
2923249|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
2923250|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2923251|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2923252|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2923253|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923254|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
2923255|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2923256|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
2923257|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
2923258|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2923259|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338291|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923269|NCT03968653|Carboplatin|carboplatin|mesh-list
2923270|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338292|NCT00437216|Clobetasol|clobetasol|mesh-list
2338293|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2338294|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
2338295|NCT00437216|Hormones|hormones|mesh-ancestor
2923277|NCT03948646|Bromides|bromides|mesh-list
2923278|NCT03948646|Anticonvulsants|anticonvulsants|mesh-ancestor
2338296|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338297|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338298|NCT00437229|Dexamethasone|dexamethasone|mesh-list
2338299|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
2338300|NCT00437229|Ondansetron|ondansetron|mesh-list
2338301|NCT00437229|Casopitant|casopitant|mesh-list
2338302|NCT00437229|BB 1101|bb 1101|mesh-list
2338303|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2923279|NCT03930953|Rituximab|rituximab|mesh-list
2923280|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
2923281|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923282|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923283|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
2923284|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923285|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2923286|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
2923287|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923288|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923289|NCT03924856|Gemcitabine|gemcitabine|mesh-list
2923290|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
2923291|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923292|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2923293|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
2923294|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923295|NCT03924856|Antiviral Agents|antiviral agents|mesh-ancestor
2923296|NCT03924856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2923297|NCT03924856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923298|NCT03924856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923299|NCT03924856|Immunologic Factors|immunologic factors|mesh-ancestor
2923300|NCT03924856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923301|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923302|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
2923303|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2923304|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
2923305|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2923306|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
2923307|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923319|NCT03911713|Ivacaftor|ivacaftor|mesh-list
2923320|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2923321|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2923322|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338304|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
2338305|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
2338306|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338307|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338308|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2338309|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
2338310|NCT00437229|Hormones|hormones|mesh-ancestor
2338311|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338312|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2338313|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338314|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
2338315|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338316|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338317|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
2338318|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
2338319|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2338320|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
2338321|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338322|NCT00437229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2338323|NCT00437229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2338324|NCT00437229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2338325|NCT00437229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2338326|NCT00437229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2338327|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2338328|NCT00437255|Betamethasone|betamethasone|mesh-list
2338329|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
2338330|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2338331|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
2338332|NCT00437255|Clobetasol|clobetasol|mesh-list
2338333|NCT00437255|Calcipotriene|calcipotriene|mesh-list
2338334|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2338335|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2923352|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
2338336|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
2338337|NCT00437255|Hormones|hormones|mesh-ancestor
2338338|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338339|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338340|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2338341|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
2338342|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
2338343|NCT00437307|Topotecan|topotecan|mesh-list
2923353|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2923354|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
2923355|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2923356|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
2923357|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923358|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923359|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
2923360|NCT03875092|Paclitaxel|paclitaxel|mesh-list
2923361|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2923362|NCT03875092|Carboplatin|carboplatin|mesh-list
2923363|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
2923364|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2923365|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923366|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
2923367|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
2338344|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2338345|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2923368|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
2923369|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923370|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923371|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
2923372|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923373|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923380|NCT03852459|Ibuprofen|ibuprofen|mesh-list
2923381|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2923382|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2923383|NCT03852459|Analgesics|analgesics|mesh-ancestor
2923384|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
2923385|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923386|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923387|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2923388|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2923389|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2923390|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923391|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923392|NCT03849768|Gefitinib|gefitinib|mesh-list
2923393|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923394|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2923395|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923396|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923397|NCT03836287|Bromides|bromides|mesh-list
2923398|NCT03836287|Anticonvulsants|anticonvulsants|mesh-ancestor
2923399|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
2923400|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923401|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923402|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
2923403|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923404|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923405|NCT03828799|Folfirinox|folfirinox|mesh-list
2338346|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338347|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338348|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338349|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2338350|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2338351|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
2338352|NCT00437333|Metformin|metformin|mesh-list
2338353|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2338354|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338355|NCT00437359|Toremifene|toremifene|mesh-list
2338356|NCT00437359|Anastrozole|anastrozole|mesh-list
2923406|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923407|NCT03824808|Lidocaine|lidocaine|mesh-list
2923408|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
2923409|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
2923410|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2923411|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923412|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
2923413|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923414|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2923415|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2923416|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2923417|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2923418|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923419|NCT03824106|Vitamin D|vitamin d|mesh-list
2923420|NCT03824106|Vitamins|vitamins|mesh-ancestor
2923421|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
2923422|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923423|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2923424|NCT03816332|Prednisone|prednisone|mesh-list
2923425|NCT03816332|Cortisone|cortisone|mesh-list
2338357|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338358|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2338359|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338360|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2923426|NCT03816332|Nivolumab|nivolumab|mesh-list
2923427|NCT03816332|Ipilimumab|ipilimumab|mesh-list
2923428|NCT03816332|Tacrolimus|tacrolimus|mesh-list
2338361|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2338362|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338363|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2923429|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2923430|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
2923431|NCT03816332|Hormones|hormones|mesh-ancestor
2923432|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2923433|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923434|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2923435|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923436|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923437|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2923438|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923439|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923440|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
2923441|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2923442|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338364|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
2338365|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338366|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338367|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2338368|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2338369|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2338370|NCT00437372|Sunitinib|sunitinib|mesh-list
2338371|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338372|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2338373|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2338374|NCT00437372|Growth Substances|growth substances|mesh-ancestor
2338375|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338376|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
2338377|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2338378|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923463|NCT03808610|Cytarabine|cytarabine|mesh-list
2923464|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
2923465|NCT03808610|Dexamethasone|dexamethasone|mesh-list
2923466|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
2923467|NCT03808610|Prednisone|prednisone|mesh-list
2923468|NCT03808610|Cortisone|cortisone|mesh-list
2338379|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338380|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
2338381|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
2338382|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2338383|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338384|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338385|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
2338386|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2338387|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2338388|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338389|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
2338390|NCT00437450|Hematinics|hematinics|mesh-ancestor
2923469|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
2923470|NCT03808610|Rituximab|rituximab|mesh-list
2923471|NCT03808610|Methotrexate|methotrexate|mesh-list
2923472|NCT03808610|Vincristine|vincristine|mesh-list
2923473|NCT03808610|Asparaginase|asparaginase|mesh-list
2923474|NCT03808610|Venetoclax|venetoclax|mesh-list
2923475|NCT03808610|Pegaspargase|pegaspargase|mesh-list
2338391|NCT00437463|Ramipril|ramipril|mesh-list
2338392|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2338393|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
2338394|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338395|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338396|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2338397|NCT00437476|Ribavirin|ribavirin|mesh-list
2338398|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2338399|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2338400|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
2338401|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338402|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
2338403|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338404|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2338405|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338406|NCT00437502|Vaccines|vaccines|mesh-list
2338407|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
2338408|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338409|NCT00437554|Glimepiride|glimepiride|mesh-list
2338410|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2338411|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2338412|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923476|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2923477|NCT03808610|Antibodies|antibodies|mesh-list
2923478|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
2923479|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2923480|NCT03808610|BB 1101|bb 1101|mesh-list
2923481|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923482|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
2923483|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923484|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2923485|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2923486|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
2923487|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923488|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923489|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2923490|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2923491|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
2338413|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2338414|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
2338415|NCT00437606|Ethanol|ethanol|mesh-list
2923492|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
2923493|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923494|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2923495|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
2923496|NCT03808610|Hormones|hormones|mesh-ancestor
2923497|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2923498|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2923499|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
2923500|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923501|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2923502|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
2923503|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2338416|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2338417|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338418|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2338419|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338420|NCT00437619|Calcipotriene|calcipotriene|mesh-list
2338421|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
2338422|NCT00437632|Caffeine|caffeine|mesh-list
2338423|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2338424|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338425|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2338426|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338427|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923504|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2923505|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
2338428|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2338429|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2338430|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
2338431|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338432|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
2338433|NCT00437671|Antibodies|antibodies|mesh-list
2338434|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
2338435|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2923506|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
2923507|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2923508|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2338436|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2338437|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
2338438|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338439|NCT00437684|Ribavirin|ribavirin|mesh-list
2338440|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2338441|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
2338442|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338443|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
2338444|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2923509|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
2923510|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2923511|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2923512|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
2923513|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
2923514|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
2923515|NCT03800134|Gemcitabine|gemcitabine|mesh-list
2923516|NCT03800134|Paclitaxel|paclitaxel|mesh-list
2923517|NCT03800134|Cisplatin|cisplatin|mesh-list
2923518|NCT03800134|Carboplatin|carboplatin|mesh-list
2923519|NCT03800134|Pemetrexed|pemetrexed|mesh-list
2923520|NCT03800134|Durvalumab|durvalumab|mesh-list
2923521|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2923522|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923523|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
2923524|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
2923525|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
2923526|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923527|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2923528|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
2923529|NCT03800134|Antiviral Agents|antiviral agents|mesh-ancestor
2923530|NCT03800134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2923531|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923532|NCT03800134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923533|NCT03800134|Immunologic Factors|immunologic factors|mesh-ancestor
2923534|NCT03800134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923535|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2923536|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2923537|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923538|NCT03797560|Pregabalin|pregabalin|mesh-list
2923539|NCT03797560|Analgesics|analgesics|mesh-ancestor
2923540|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
2923541|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923542|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923543|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
2923544|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2923545|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2923546|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923547|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2923548|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2923549|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2923550|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2923551|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2338445|NCT00437697|Dalteparin|dalteparin|mesh-list
2338446|NCT00437697|Tinzaparin|tinzaparin|mesh-list
2923593|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
2923594|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2923595|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
2923596|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2923597|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
2923598|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338447|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2338448|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
2338449|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2338450|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2338451|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338452|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
2338453|NCT00437723|Hematinics|hematinics|mesh-ancestor
2338454|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
2338455|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2338456|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2338457|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2338458|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2338459|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338460|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
2338461|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338462|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338463|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2923602|NCT03765918|Cisplatin|cisplatin|mesh-list
2923603|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
2923604|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923605|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923606|NCT03740919|Insulin|insulin|mesh-list
2923607|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2923608|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
2923609|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
2923610|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2923611|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923612|NCT03739593|Dexamethasone|dexamethasone|mesh-list
2923613|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
2923614|NCT03739593|BB 1101|bb 1101|mesh-list
2923615|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2923616|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
2923617|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
2923618|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923619|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923620|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2923621|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
2923622|NCT03739593|Hormones|hormones|mesh-ancestor
2923623|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2923624|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2923625|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923626|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
2923627|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923628|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923629|NCT03737565|Tryptophan|tryptophan|mesh-list
2923630|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2923631|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
2923632|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2923647|NCT03725059|Paclitaxel|paclitaxel|mesh-list
2923648|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
2923649|NCT03725059|Doxorubicin|doxorubicin|mesh-list
2923650|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
2923651|NCT03725059|Epirubicin|epirubicin|mesh-list
2338464|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338465|NCT00437814|Ketamine|ketamine|mesh-list
2338466|NCT00437814|Analgesics|analgesics|mesh-ancestor
2338467|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
2338468|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338469|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338470|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2338471|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2338472|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
2338473|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
2338474|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2338475|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2338476|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2338477|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338478|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923652|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2923653|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923654|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
2923655|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
2923656|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
2923657|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923658|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923659|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
2923660|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923661|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2923662|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2923663|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
2923664|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2923665|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2923666|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2923667|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2923668|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923669|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923673|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
2923674|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923675|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923676|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
2923677|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2923678|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2923679|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923680|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2923681|NCT03708315|Analgesics|analgesics|mesh-ancestor
2923682|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
2923683|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923684|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2923685|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2923686|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2923687|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
2923688|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2923689|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923690|NCT03702270|Penicillins|penicillins|mesh-list
2923691|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2923692|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338479|NCT00437853|Anastrozole|anastrozole|mesh-list
2338480|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2338481|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338482|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2338483|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2338484|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338485|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338486|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2338487|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
2338488|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338489|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338490|NCT00437892|Atorvastatin|atorvastatin|mesh-list
2338491|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2923693|NCT03700970|Bupivacaine|bupivacaine|mesh-list
2923694|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
2923695|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
2923696|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2923697|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923698|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
2923699|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923703|NCT03686345|Midostaurin|midostaurin|mesh-list
2923704|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923705|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2923706|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923707|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923708|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
2923709|NCT03684590|Narcotics|narcotics|mesh-ancestor
2923710|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2923711|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923712|NCT03684590|Analgesics|analgesics|mesh-ancestor
2923713|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
2923714|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923715|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
2923716|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923717|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923718|NCT03672643|Crizotinib|crizotinib|mesh-list
2923719|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923720|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2923721|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923722|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923723|NCT03665038|Brexanolone|brexanolone|mesh-list
2923724|NCT03665038|Neurosteroids|neurosteroids|mesh-ancestor
2923725|NCT03665038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2923726|NCT03665038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923727|NCT03665038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923728|NCT03665038|GABA Modulators|gaba modulators|mesh-ancestor
2923729|NCT03665038|GABA Agents|gaba agents|mesh-ancestor
2923730|NCT03647488|Docetaxel|docetaxel|mesh-list
2923731|NCT03647488|Spartalizumab|spartalizumab|mesh-list
2923732|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923733|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
2923734|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
2923735|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
2923736|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923737|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2923738|NCT03642132|Bevacizumab|bevacizumab|mesh-list
2338492|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2338493|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
2338494|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338495|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2338496|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2338497|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338498|NCT00437918|Acarbose|acarbose|mesh-list
2338499|NCT00437918|Nateglinide|nateglinide|mesh-list
2338500|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2338501|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338502|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923739|NCT03642132|Avelumab|avelumab|mesh-list
2923740|NCT03642132|Talazoparib|talazoparib|mesh-list
2923741|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923742|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923743|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2338503|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2338504|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338505|NCT00437957|Temozolomide|temozolomide|mesh-list
2338506|NCT00437957|Valproic Acid|valproic acid|mesh-list
2338507|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2338508|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
2338509|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338510|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338511|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
2338512|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338513|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
2338514|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338515|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338516|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
2338517|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2338518|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2338519|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2338520|NCT00437970|Metformin|metformin|mesh-list
2338521|NCT00437970|Pioglitazone|pioglitazone|mesh-list
2338522|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2338523|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923744|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2923745|NCT03642132|Growth Substances|growth substances|mesh-ancestor
2923746|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923747|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
2923748|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2923749|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923750|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923751|NCT03635164|Durvalumab|durvalumab|mesh-list
2923752|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923753|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923754|NCT03632759|Liraglutide|liraglutide|mesh-list
2923755|NCT03632759|Golimumab|golimumab|mesh-list
2923756|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2923757|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923758|NCT03632759|Incretins|incretins|mesh-ancestor
2923759|NCT03632759|Hormones|hormones|mesh-ancestor
2923760|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2923761|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2338524|NCT00437996|Clonidine|clonidine|mesh-list
2338525|NCT00437996|Sufentanil|sufentanil|mesh-list
2338526|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
2338527|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
2338528|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
2338529|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2338530|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338531|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
2338532|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338533|NCT00437996|Analgesics|analgesics|mesh-ancestor
2338534|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2338535|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
2338536|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
2923762|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2923763|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923764|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
2923765|NCT03623243|Siponimod|siponimod|mesh-list
2923766|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2923767|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923768|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923769|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
2923770|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923771|NCT03618537|Dexamethasone|dexamethasone|mesh-list
2923772|NCT03618537|Ixazomib|ixazomib|mesh-list
2923773|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2923774|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
2923775|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
2923776|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923777|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923778|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2923779|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
2923780|NCT03618537|Hormones|hormones|mesh-ancestor
2338537|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2923781|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2923782|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2923783|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923784|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
2923785|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923786|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923797|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
2923798|NCT03615105|Melphalan|melphalan|mesh-list
2923799|NCT03615105|Busulfan|busulfan|mesh-list
2923800|NCT03615105|Thiotepa|thiotepa|mesh-list
2923801|NCT03615105|Rituximab|rituximab|mesh-list
2923802|NCT03615105|Fludarabine|fludarabine|mesh-list
2923803|NCT03615105|Clofarabine|clofarabine|mesh-list
2923804|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2923805|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
2923806|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923807|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
2923808|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338538|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2338539|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2338540|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
2338541|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338542|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338543|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2338544|NCT00437996|Narcotics|narcotics|mesh-ancestor
2923809|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2923810|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2923811|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
2923812|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923813|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923814|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2923815|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923816|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2923817|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
2923818|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
2923819|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2923820|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
2923821|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2338545|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2338546|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2338547|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
2338548|NCT00438048|Pilocarpine|pilocarpine|mesh-list
2338549|NCT00438048|Miotics|miotics|mesh-ancestor
2923822|NCT03614728|Azacitidine|azacitidine|mesh-list
2923823|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
2923824|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2338550|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
2338551|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338552|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338553|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2338554|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2338555|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
2338556|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338557|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338558|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
2338559|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2338560|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2338561|NCT00438087|Prednisolone|prednisolone|mesh-list
2338562|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
2338563|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2338564|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
2338565|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2338566|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
2338567|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
2338568|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338569|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338570|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2338571|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
2923825|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
2923826|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923827|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923828|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923829|NCT03613532|Fludarabine|fludarabine|mesh-list
2923830|NCT03613532|Azacitidine|azacitidine|mesh-list
2923831|NCT03613532|Busulfan|busulfan|mesh-list
2923832|NCT03613532|Decitabine|decitabine|mesh-list
2923833|NCT03613532|Venetoclax|venetoclax|mesh-list
2923834|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338572|NCT00438087|Hormones|hormones|mesh-ancestor
2338573|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338574|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2338575|NCT00438087|Protective Agents|protective agents|mesh-ancestor
2338576|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2338577|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338578|NCT00438113|Atenolol|atenolol|mesh-list
2338579|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2338580|NCT00438113|Terazosin|terazosin|mesh-list
2338581|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2338582|NCT00438113|Diuretics|diuretics|mesh-ancestor
2338583|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
2338584|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338585|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2338586|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2338587|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338588|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2338589|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
2338590|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
2923835|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2923836|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
2923837|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923838|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923839|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
2923840|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923841|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923842|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
2923843|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2923844|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2338591|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338592|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2338593|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2338594|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2338595|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
2338596|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338597|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2338598|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2338599|NCT00438113|Urological Agents|urological agents|mesh-ancestor
2338600|NCT00438139|Dronabinol|dronabinol|mesh-list
2338601|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
2338602|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338603|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2338604|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2338605|NCT00438139|Analgesics|analgesics|mesh-ancestor
2338606|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
2338607|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338608|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2338609|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2338610|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338611|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338612|NCT00438139|Hormones|hormones|mesh-ancestor
2338613|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338614|NCT00438152|Ritonavir|ritonavir|mesh-list
2338615|NCT00438152|Lopinavir|lopinavir|mesh-list
2338616|NCT00438152|Saquinavir|saquinavir|mesh-list
2338617|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2338618|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2338619|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
2338620|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338621|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338622|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2338623|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2923845|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
2923846|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923847|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111532|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111533|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
2111534|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2111535|NCT02556333|Tenofovir|tenofovir|mesh-list
2111536|NCT02556333|Emtricitabine|emtricitabine|mesh-list
2111537|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
2111538|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2111539|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2111540|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2111541|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111542|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111543|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2111544|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2923848|NCT03595059|Paclitaxel|paclitaxel|mesh-list
2923849|NCT03595059|Docetaxel|docetaxel|mesh-list
2923850|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2338624|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
2338625|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338626|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2338627|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2923851|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923852|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
2923853|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
2923854|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
2923855|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923856|NCT03579160|Timolol|timolol|mesh-list
2923857|NCT03579160|Petrolatum|petrolatum|mesh-list
2923858|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2923859|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2923860|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
2923861|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338628|NCT00438178|Obatoclax|obatoclax|mesh-list
2338629|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338630|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338631|NCT00438217|Leuprolide|leuprolide|mesh-list
2338632|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2338633|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2338634|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2338635|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
2338636|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2338637|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338638|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2338639|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338640|NCT00438217|Hormones|hormones|mesh-ancestor
2338641|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338642|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
2338643|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2338644|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
2338645|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2338646|NCT00438230|Warfarin|warfarin|mesh-list
2338647|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
2338648|NCT00438243|Bromfenac|bromfenac|mesh-list
2338649|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2338650|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2338651|NCT00438243|Analgesics|analgesics|mesh-ancestor
2338652|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
2338653|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338654|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338655|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2338656|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2338657|NCT00438269|Metronidazole|metronidazole|mesh-list
2338658|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
2338659|NCT00438269|Meropenem|meropenem|mesh-list
2338660|NCT00438269|Cefazolin|cefazolin|mesh-list
2338661|NCT00438269|Tazobactam|tazobactam|mesh-list
2338662|NCT00438269|Piperacillin|piperacillin|mesh-list
2338663|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2338664|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338665|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2338666|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2338667|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2338668|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2338669|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2338670|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923862|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923863|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923864|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2923865|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2923866|NCT03579160|Emollients|emollients|mesh-ancestor
2923867|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
2923868|NCT03571191|Denosumab|denosumab|mesh-list
2923869|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2923870|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923871|NCT03556696|Remifentanil|remifentanil|mesh-list
2923872|NCT03556696|Propofol|propofol|mesh-list
2923873|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2923874|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2923875|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923876|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2923877|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
2923878|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
2338671|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338672|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338673|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2338674|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2338675|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2338676|NCT00438321|Anastrozole|anastrozole|mesh-list
2338677|NCT00438321|Goserelin|goserelin|mesh-list
2338678|NCT00438321|Testosterone|testosterone|mesh-list
2338679|NCT00438321|Androgens|androgens|mesh-ancestor
2338680|NCT00438321|Hormones|hormones|mesh-ancestor
2338681|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338682|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338683|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2338684|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338685|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2338686|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2338687|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338688|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338689|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2338690|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
2338691|NCT00438386|Aripiprazole|aripiprazole|mesh-list
2338692|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
2338693|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2338694|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2923879|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2923880|NCT03556696|Narcotics|narcotics|mesh-ancestor
2923881|NCT03556696|Analgesics|analgesics|mesh-ancestor
2923882|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
2923883|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923884|NCT03556332|Dexamethasone|dexamethasone|mesh-list
2923885|NCT03556332|Lenalidomide|lenalidomide|mesh-list
2923886|NCT03556332|Daratumumab|daratumumab|mesh-list
2923887|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2923888|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
2923889|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
2923890|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923891|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923892|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2338695|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2338696|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2338697|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338698|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
2338699|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
2338700|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338701|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338702|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2338703|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2338704|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
2338705|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2338706|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2338707|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2338708|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2338709|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2338710|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2338711|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338712|NCT00438568|Insulin|insulin|mesh-list
2338713|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2923893|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
2923894|NCT03556332|Hormones|hormones|mesh-ancestor
2338714|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2338715|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338716|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2338717|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
2338718|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338719|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
2338720|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2338721|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2338722|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2338723|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
2338724|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338725|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338726|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338727|NCT00438737|Leucovorin|leucovorin|mesh-list
2338728|NCT00438737|Bevacizumab|bevacizumab|mesh-list
2338729|NCT00438737|Cetuximab|cetuximab|mesh-list
2338730|NCT00438737|Fluorouracil|fluorouracil|mesh-list
2338731|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
2338732|NCT00438737|Calcium|calcium|mesh-list
2338733|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
2338734|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923895|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2923896|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2923897|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923898|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
2923899|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2923900|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2923901|NCT03556332|Growth Substances|growth substances|mesh-ancestor
2923902|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
2923903|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
2923904|NCT03531736|Fludarabine|fludarabine|mesh-list
2923905|NCT03531736|Rituximab|rituximab|mesh-list
2923906|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2923907|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
2923908|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923909|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
2923910|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923911|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2923912|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2923913|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
2923914|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923915|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923916|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2923917|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923918|NCT03527537|Insulin|insulin|mesh-list
2338735|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338736|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2338737|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2338738|NCT00438737|Growth Substances|growth substances|mesh-ancestor
2338739|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338740|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
2338741|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2338742|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
2338743|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338744|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2338745|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2338746|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
2338747|NCT00438737|Antidotes|antidotes|mesh-ancestor
2338748|NCT00438737|Protective Agents|protective agents|mesh-ancestor
2338749|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
2338750|NCT00438737|Vitamins|vitamins|mesh-ancestor
2338751|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
2338752|NCT00438776|Olanzapine|olanzapine|mesh-list
2338753|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
2338754|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
2338755|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338756|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338757|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2338758|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2923919|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2923920|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923921|NCT03520842|Methotrexate|methotrexate|mesh-list
2923922|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2923923|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
2923924|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2923925|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923926|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2923927|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
2923928|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923929|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923930|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
2923931|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923932|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2923933|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2923934|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
2923935|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2923936|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2923940|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
2923941|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2923942|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923943|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2923944|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2923945|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
2923946|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338759|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2338760|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2338761|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2338762|NCT00438776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2338763|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2338764|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2338765|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338766|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338767|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
2338768|NCT00438789|Eculizumab|eculizumab|mesh-list
2338769|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2338770|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2338771|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
2338772|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338773|NCT00438828|Dexamethasone|dexamethasone|mesh-list
2338774|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2338775|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
2338776|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
2338777|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923947|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
2923948|NCT03516981|Lenvatinib|lenvatinib|mesh-list
2923949|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2923950|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923951|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2338778|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338779|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2338780|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
2338781|NCT00438828|Hormones|hormones|mesh-ancestor
2338782|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338783|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2338784|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338785|NCT00438841|Thalidomide|thalidomide|mesh-list
2338786|NCT00438841|Dexamethasone|dexamethasone|mesh-list
2338787|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
2338788|NCT00438841|Bortezomib|bortezomib|mesh-list
2338789|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2338790|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
2338791|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338792|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2338793|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2338794|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
2338795|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338796|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338797|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2338798|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2338799|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
2338800|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
2923952|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2923953|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923954|NCT03514069|Temozolomide|temozolomide|mesh-list
2923955|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2923956|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
2923957|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2923958|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2923959|NCT03513445|Epinephrine|epinephrine|mesh-list
2338801|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338802|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2338803|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
2338804|NCT00438841|Hormones|hormones|mesh-ancestor
2338805|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338806|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2338807|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
2338808|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2338809|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338810|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2923960|NCT03513445|Morphine|morphine|mesh-list
2923961|NCT03513445|Ropivacaine|ropivacaine|mesh-list
2923962|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2923963|NCT03513445|Narcotics|narcotics|mesh-ancestor
2923964|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2923965|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2923966|NCT03513445|Analgesics|analgesics|mesh-ancestor
2923967|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
2923968|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2923969|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2923970|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2923971|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
2923972|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2923973|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338811|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2338812|NCT00438841|Growth Substances|growth substances|mesh-ancestor
2338813|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
2338814|NCT00438906|Secretin|secretin|mesh-list
2338815|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2923974|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2923975|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2923976|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
2923977|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2923978|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
2923979|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
2923980|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
2923981|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2923982|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
2923983|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
2923984|NCT03511118|Metformin|metformin|mesh-list
2923985|NCT03511118|Topiramate|topiramate|mesh-list
2923986|NCT03511118|Azithromycin|azithromycin|mesh-list
2923987|NCT03511118|Doxycycline|doxycycline|mesh-list
2923988|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
2923989|NCT03511118|Levofloxacin|levofloxacin|mesh-list
2923990|NCT03511118|Clindamycin|clindamycin|mesh-list
2923991|NCT03511118|Valganciclovir|valganciclovir|mesh-list
2923992|NCT03511118|Remdesivir|remdesivir|mesh-list
2923993|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
2923994|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2923995|NCT03511118|Verapamil|verapamil|mesh-list
2923996|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2923997|NCT03511118|Labetalol|labetalol|mesh-list
2923998|NCT03511118|Nifedipine|nifedipine|mesh-list
2923999|NCT03511118|Furosemide|furosemide|mesh-list
2924000|NCT03511118|Sumatriptan|sumatriptan|mesh-list
2924001|NCT03511118|Oxycodone|oxycodone|mesh-list
2924002|NCT03511118|Gabapentin|gabapentin|mesh-list
2924003|NCT03511118|Ondansetron|ondansetron|mesh-list
2924004|NCT03511118|Trazodone|trazodone|mesh-list
2924005|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
2924006|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
2924007|NCT03511118|Methylphenidate|methylphenidate|mesh-list
2924008|NCT03511118|Citalopram|citalopram|mesh-list
2924009|NCT03511118|Sertraline|sertraline|mesh-list
2924010|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2924011|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
2924012|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2924013|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2924014|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924015|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2924016|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2924017|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
2924018|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924019|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2924020|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2924021|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924022|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2924023|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2924024|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2924025|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2924026|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
2924027|NCT03511118|Coagulants|coagulants|mesh-ancestor
2338816|NCT00438906|Hormones|hormones|mesh-ancestor
2338817|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338818|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338819|NCT00438945|Eprosartan|eprosartan|mesh-list
2338820|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2338821|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
2338822|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2338823|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338824|NCT00438958|Lenograstim|lenograstim|mesh-list
2338825|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2338826|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
2338827|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338828|NCT00438984|Aldesleukin|aldesleukin|mesh-list
2338829|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
2338830|NCT00438984|Interleukin-2|interleukin-2|mesh-list
2338831|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2338832|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
2338833|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338834|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2924028|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2924029|NCT03511118|Narcotics|narcotics|mesh-ancestor
2924030|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2924031|NCT03511118|Analgesics|analgesics|mesh-ancestor
2924032|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
2924033|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2924034|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
2924035|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2924036|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2924037|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2924038|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2924039|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2924040|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2924041|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
2924042|NCT03511118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2924043|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2924044|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2924045|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
2924046|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2924047|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
2924048|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
2924049|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2924050|NCT03511118|Diuretics|diuretics|mesh-ancestor
2924051|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
2924052|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2924053|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2924054|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2924055|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
2924056|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
2924057|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2924058|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
2924059|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
2924060|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2924061|NCT03511118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2924062|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
2924063|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2924064|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2924065|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2924066|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2924067|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924068|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2924069|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2924070|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2924071|NCT03511118|Renal Agents|renal agents|mesh-ancestor
2924072|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2924073|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2338835|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2338836|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
2338837|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338838|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924074|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2924075|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
2924076|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2924077|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2924078|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2924079|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
2924080|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
2338839|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2338840|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2338841|NCT00438984|Analgesics|analgesics|mesh-ancestor
2338842|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
2338843|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338844|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2338845|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2338846|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
2338847|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338848|NCT00439049|Naltrexone|naltrexone|mesh-list
2338849|NCT00439049|Modafinil|modafinil|mesh-list
2338850|NCT00439049|Amphetamine|amphetamine|mesh-list
2338851|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
2338852|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2338853|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2338854|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338855|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
2924081|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2924082|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2924083|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2924084|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2924085|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2924086|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
2924087|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2924088|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2924089|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2924090|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2924091|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
2924092|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
2924093|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2924094|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2924095|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2924096|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2924097|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2924098|NCT03510468|Pyridoxine|pyridoxine|mesh-list
2924099|NCT03510468|Isoniazid|isoniazid|mesh-list
2924100|NCT03510468|Rifapentine|rifapentine|mesh-list
2924101|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
2924102|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2924103|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2924104|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2338856|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338857|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2338858|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2338859|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2924105|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2924106|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
2924107|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924108|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2924109|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
2924110|NCT03510468|Vitamins|vitamins|mesh-ancestor
2924111|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
2924112|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924113|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2924114|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
2924115|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
2924116|NCT03498014|Narcotics|narcotics|mesh-ancestor
2924117|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2924118|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924119|NCT03498014|Analgesics|analgesics|mesh-ancestor
2924120|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
2924121|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338860|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2338861|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338862|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
2338863|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
2338864|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
2338865|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338866|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
2338867|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2338868|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2338869|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2338870|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2338871|NCT00439062|Roxithromycin|roxithromycin|mesh-list
2338872|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2338873|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338874|NCT00439166|Doxycycline|doxycycline|mesh-list
2338875|NCT00439166|Rifampin|rifampin|mesh-list
2338876|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2338877|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338878|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
2338879|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2338880|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2338881|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2338882|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
2338883|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
2338884|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2338885|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338886|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338887|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2338888|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2338889|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2338890|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2338891|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2338892|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2924135|NCT03475277|Ketamine|ketamine|mesh-list
2924136|NCT03475277|Analgesics|analgesics|mesh-ancestor
2924137|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
2924138|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2924139|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924140|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2924141|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2924142|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
2924143|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
2924144|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2924145|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2924146|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2924147|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2924148|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924149|NCT03475004|Bevacizumab|bevacizumab|mesh-list
2924150|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
2924151|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924152|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338893|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2338894|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2338895|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2338896|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
2338897|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2924153|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2924154|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2924155|NCT03475004|Growth Substances|growth substances|mesh-ancestor
2924156|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924157|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
2338898|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924164|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
2924165|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924166|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2924167|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924168|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924169|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
2924170|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2924171|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924172|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2924173|NCT03447262|Ivacaftor|ivacaftor|mesh-list
2924174|NCT03447262|VX-659|vx-659|mesh-list
2924175|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2924176|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2924177|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924178|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2924179|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924180|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924181|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2924182|NCT03434730|Cyclosporine|cyclosporine|mesh-list
2338899|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338900|NCT00439192|Urological Agents|urological agents|mesh-ancestor
2338901|NCT00439283|Methotrexate|methotrexate|mesh-list
2338902|NCT00439283|Infliximab|infliximab|mesh-list
2338903|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2924183|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
2924184|NCT03434730|Lenograstim|lenograstim|mesh-list
2924185|NCT03434730|Cyclosporins|cyclosporins|mesh-list
2924186|NCT03434730|Sargramostim|sargramostim|mesh-list
2924187|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2924188|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
2924189|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924190|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924191|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924192|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2924193|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
2924194|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2924195|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
2924196|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2924197|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2924198|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2924199|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924200|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2924201|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
2924202|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2924203|NCT03429543|Empagliflozin|empagliflozin|mesh-list
2924204|NCT03429543|Linagliptin|linagliptin|mesh-list
2924205|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2924206|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924207|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2924208|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924209|NCT03429543|Incretins|incretins|mesh-ancestor
2924210|NCT03429543|Hormones|hormones|mesh-ancestor
2924211|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2924212|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2924213|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
2924214|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924215|NCT03417180|Remifentanil|remifentanil|mesh-list
2924216|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2924217|NCT03417180|Narcotics|narcotics|mesh-ancestor
2924218|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2924219|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924220|NCT03417180|Analgesics|analgesics|mesh-ancestor
2924221|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
2924222|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2924228|NCT03392246|Osimertinib|osimertinib|mesh-list
2924229|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924230|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2924231|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924232|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338904|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
2338905|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2338906|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338907|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2338908|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
2338909|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338910|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338911|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
2338912|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338913|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2338914|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2338915|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
2338916|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2338917|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2338918|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2338919|NCT00439361|Carboplatin|carboplatin|mesh-list
2338920|NCT00439361|Etoposide|etoposide|mesh-list
2338921|NCT00439361|Bortezomib|bortezomib|mesh-list
2338922|NCT00439361|Ifosfamide|ifosfamide|mesh-list
2338923|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338924|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2338925|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2338926|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2338927|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338928|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338929|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2338930|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
2338931|NCT00439400|Doxycycline|doxycycline|mesh-list
2338932|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2338933|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2338934|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
2338935|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2338936|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2338937|NCT00439426|Capecitabine|capecitabine|mesh-list
2338938|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
2338939|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2338940|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
2338941|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338942|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338943|NCT00439504|Lobeline|lobeline|mesh-list
2338944|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2338945|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
2338946|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2338947|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338948|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2924252|NCT03365791|Spartalizumab|spartalizumab|mesh-list
2924253|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2924254|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924255|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924256|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
2924257|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2924258|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2338949|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2338950|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
2338951|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338952|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338953|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
2338954|NCT00439530|Oseltamivir|oseltamivir|mesh-list
2338955|NCT00439530|Probenecid|probenecid|mesh-list
2338956|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
2338957|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2924259|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924260|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
2924261|NCT03361345|Coagulants|coagulants|mesh-ancestor
2924262|NCT03361306|Elotuzumab|elotuzumab|mesh-list
2924263|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924264|NCT03358706|Vitamin K|vitamin k|mesh-list
2924265|NCT03358706|Midazolam|midazolam|mesh-list
2924266|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
2924267|NCT03358706|Caffeine|caffeine|mesh-list
2924268|NCT03358706|Ustekinumab|ustekinumab|mesh-list
2924269|NCT03358706|Omeprazole|omeprazole|mesh-list
2924270|NCT03358706|Warfarin|warfarin|mesh-list
2924271|NCT03358706|Vitamins|vitamins|mesh-ancestor
2924272|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
2924273|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924274|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2924275|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2924276|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2924277|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2924278|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2924279|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2924280|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2924281|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
2338958|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338959|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338960|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
2338961|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
2924282|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
2924283|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
2924284|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
2924285|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2924286|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924287|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
2924288|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2924289|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2924290|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2924291|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924292|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2924293|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2924294|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2924295|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2924296|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
2924297|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
2924298|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2924299|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2924300|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
2924301|NCT03358706|Coagulants|coagulants|mesh-ancestor
2924302|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
2924303|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
2924304|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2924305|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2924319|NCT03342196|Fludarabine|fludarabine|mesh-list
2924320|NCT03342196|Melphalan|melphalan|mesh-list
2924321|NCT03342196|Thiotepa|thiotepa|mesh-list
2924322|NCT03342196|Mitogens|mitogens|mesh-list
2924323|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924324|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924325|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2924326|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
2924327|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924328|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2924329|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
2924330|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2924331|NCT03342196|Mitosis Modulators|mitosis modulators|mesh-ancestor
2924332|NCT03334617|Trastuzumab|trastuzumab|mesh-list
2924333|NCT03334617|Durvalumab|durvalumab|mesh-list
2924334|NCT03334617|Olaparib|olaparib|mesh-list
2924335|NCT03334617|Cediranib|cediranib|mesh-list
2924336|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924337|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924338|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2924339|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2338962|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2338963|NCT00439530|Renal Agents|renal agents|mesh-ancestor
2338964|NCT00439543|Iloprost|iloprost|mesh-list
2338965|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2338966|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
2338967|NCT00439699|Memantine|memantine|mesh-list
2338968|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2338969|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2338970|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
2338971|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338972|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338973|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338974|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2338975|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2338976|NCT00439712|Levocetirizine|levocetirizine|mesh-list
2338977|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2338978|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2338979|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
2338980|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
2338981|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2338982|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2338983|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338984|NCT00439751|Goserelin|goserelin|mesh-list
2338985|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2338986|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338987|NCT00439829|Cetrorelix|cetrorelix|mesh-list
2338988|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2924340|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924341|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2924342|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
2924343|NCT03331289|Exenatide|exenatide|mesh-list
2924344|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2924345|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924346|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2924347|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924348|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2924349|NCT03331289|Incretins|incretins|mesh-ancestor
2924350|NCT03331289|Hormones|hormones|mesh-ancestor
2924351|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2924354|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
2924355|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924356|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924357|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
2924358|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924359|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924360|NCT03321188|Paclitaxel|paclitaxel|mesh-list
2924361|NCT03321188|Carboplatin|carboplatin|mesh-list
2338989|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
2924362|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2924363|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924364|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
2924365|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
2924366|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
2924367|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924368|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2924369|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924370|NCT03315026|Siltuximab|siltuximab|mesh-list
2924371|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924372|NCT03311308|Metformin|metformin|mesh-list
2924373|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
2924374|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2924375|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924376|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924377|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2338990|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2338991|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2338992|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
2338993|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2338994|NCT00439855|Heparin|heparin|mesh-list
2338995|NCT00439855|Enoxaparin|enoxaparin|mesh-list
2338996|NCT00439855|Calcium heparin|calcium heparin|mesh-list
2924381|NCT03298451|Sorafenib|sorafenib|mesh-list
2924382|NCT03298451|Durvalumab|durvalumab|mesh-list
2924383|NCT03298451|Tremelimumab|tremelimumab|mesh-list
2924384|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2924385|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924386|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2924387|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924388|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924389|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924390|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
2924391|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924392|NCT03292133|Gefitinib|gefitinib|mesh-list
2924393|NCT03292133|Nazartinib|nazartinib|mesh-list
2924394|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924395|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2924396|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924397|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924398|NCT03277729|Vidarabine|vidarabine|mesh-list
2924399|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
2924400|NCT03277729|Fludarabine|fludarabine|mesh-list
2924401|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
2924402|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2924403|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
2924404|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924405|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2924406|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2924407|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
2924408|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924409|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924410|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2924411|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2924412|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
2924413|NCT03277729|Antiviral Agents|antiviral agents|mesh-ancestor
2924414|NCT03277729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2111567|NCT02556632|Curcumin|curcumin|mesh-list
2111568|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2111569|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2111570|NCT02556632|Analgesics|analgesics|mesh-ancestor
2111571|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
2111572|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111573|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111574|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2924415|NCT03270176|Avelumab|avelumab|mesh-list
2924416|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924417|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924418|NCT03267589|Durvalumab|durvalumab|mesh-list
2924419|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924420|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924432|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2924433|NCT03258554|Cetuximab|cetuximab|mesh-list
2924434|NCT03258554|Durvalumab|durvalumab|mesh-list
2924435|NCT03258554|Antibodies|antibodies|mesh-list
2924436|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
2924437|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2924438|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
2924439|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
2924440|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924441|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924442|NCT03255096|Rituximab|rituximab|mesh-list
2338997|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
2338998|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2338999|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2339000|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339001|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
2339002|NCT00439972|Ortho Evra|ortho evra|mesh-list
2339003|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2339004|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2924443|NCT03255096|Venetoclax|venetoclax|mesh-list
2924444|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924445|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924446|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
2924447|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924448|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2924452|NCT03237702|Carotenoids|carotenoids|mesh-list
2924453|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
2924454|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924455|NCT03237702|Protective Agents|protective agents|mesh-ancestor
2924456|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924457|NCT03234907|Vedolizumab|vedolizumab|mesh-list
2924458|NCT03234907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2924459|NCT03233139|Ipilimumab|ipilimumab|mesh-list
2924460|NCT03233139|Cemiplimab|cemiplimab|mesh-list
2924461|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924462|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339005|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
2339006|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2339007|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924463|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2924464|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924465|NCT03221751|Prazosin|prazosin|mesh-list
2924466|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2924467|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2924468|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2924469|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2924470|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
2924471|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2924472|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924473|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924493|NCT03191149|Osimertinib|osimertinib|mesh-list
2924494|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924495|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2924496|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924497|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924498|NCT03191084|Dronabinol|dronabinol|mesh-list
2924499|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
2924500|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924501|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2924502|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2924503|NCT03191084|Analgesics|analgesics|mesh-ancestor
2924504|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
2924505|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2924506|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2924507|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2924508|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2924509|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924510|NCT03191084|Hormones|hormones|mesh-ancestor
2924511|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2924512|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
2924513|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924514|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924515|NCT03184155|Nicardipine|nicardipine|mesh-list
2924516|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2924517|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2339008|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2339009|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2339010|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2339011|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2924518|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2924519|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924520|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2924521|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924522|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
2924523|NCT03182244|Cytarabine|cytarabine|mesh-list
2924524|NCT03182244|Fludarabine|fludarabine|mesh-list
2924525|NCT03182244|Etoposide|etoposide|mesh-list
2924526|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
2924527|NCT03182244|Sargramostim|sargramostim|mesh-list
2924528|NCT03182244|Lenograstim|lenograstim|mesh-list
2924529|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924530|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2924531|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
2924532|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924533|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2924534|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
2924535|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924536|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2924537|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2924538|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2924539|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924540|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
2924541|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2924542|NCT03182244|Analgesics|analgesics|mesh-ancestor
2339012|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339013|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339014|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339015|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2339016|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2339017|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2339018|NCT00440024|Tazarotene|tazarotene|mesh-list
2924543|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
2924544|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2924545|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2924546|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2924547|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2924548|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924549|NCT03173950|Nivolumab|nivolumab|mesh-list
2924550|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924551|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924552|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2924553|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924554|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2924555|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2924556|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924557|NCT03161912|Aflibercept|aflibercept|mesh-list
2924558|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2339019|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
2339020|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
2339021|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
2339022|NCT00440063|Hematinics|hematinics|mesh-ancestor
2924559|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2924560|NCT03161912|Growth Substances|growth substances|mesh-ancestor
2924561|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924562|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
2924563|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924564|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
2924565|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2924566|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2924567|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
2924568|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2924569|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924570|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924571|NCT03149809|Urological Agents|urological agents|mesh-ancestor
2924572|NCT03126435|Gemcitabine|gemcitabine|mesh-list
2924573|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2924574|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
2924575|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924576|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924577|NCT03126435|Antiviral Agents|antiviral agents|mesh-ancestor
2924578|NCT03126435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2924579|NCT03126435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924580|NCT03126435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2924581|NCT03126435|Immunologic Factors|immunologic factors|mesh-ancestor
2924582|NCT03126435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924583|NCT03104400|Adalimumab|adalimumab|mesh-list
2924584|NCT03104400|Upadacitinib|upadacitinib|mesh-list
2924585|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2924586|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2924587|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2924588|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2924589|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924590|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924591|NCT03104374|Upadacitinib|upadacitinib|mesh-list
2924592|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2924593|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2924594|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924595|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924596|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2924597|NCT03098654|Metformin|metformin|mesh-list
2924598|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2924599|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339023|NCT00440076|Bortezomib|bortezomib|mesh-list
2339024|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339025|NCT00440102|Ketamine|ketamine|mesh-list
2339026|NCT00440102|Etomidate|etomidate|mesh-list
2339027|NCT00440102|Analgesics|analgesics|mesh-ancestor
2339028|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
2339029|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339030|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339031|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2339032|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2339033|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
2339034|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
2339035|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2339036|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2339037|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2924600|NCT03078010|Tazobactam|tazobactam|mesh-list
2924601|NCT03078010|Piperacillin|piperacillin|mesh-list
2924602|NCT03078010|Cefepime|cefepime|mesh-list
2924603|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2924604|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2924605|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2924606|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2924607|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924608|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924609|NCT03072043|Azacitidine|azacitidine|mesh-list
2924610|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2924611|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
2339038|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339039|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339040|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2339041|NCT00440128|Docetaxel|docetaxel|mesh-list
2339042|NCT00440128|Casopitant|casopitant|mesh-list
2924612|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924613|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924614|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339043|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339044|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
2339045|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
2339046|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
2339047|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339048|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
2339049|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
2339050|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339051|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339052|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2339053|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2339054|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339055|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2924629|NCT03060772|Pioglitazone|pioglitazone|mesh-list
2924630|NCT03060772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2924631|NCT03060772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924632|NCT03049462|Ascorbic Acid|ascorbic acid|mesh-list
2924633|NCT03049462|Mirabegron|mirabegron|mesh-list
2924634|NCT03049462|Vitamins|vitamins|mesh-ancestor
2924635|NCT03049462|Micronutrients|micronutrients|mesh-ancestor
2924636|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924637|NCT03049462|Antioxidants|antioxidants|mesh-ancestor
2924638|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924639|NCT03049462|Protective Agents|protective agents|mesh-ancestor
2924640|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2924641|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2339056|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2339057|NCT00440141|Latanoprost|latanoprost|mesh-list
2339058|NCT00440141|Brinzolamide|brinzolamide|mesh-list
2339059|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2339060|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2339061|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2339062|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2924642|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2924643|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
2924644|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2924645|NCT03049462|Urological Agents|urological agents|mesh-ancestor
2924646|NCT03016013|Methotrexate|methotrexate|mesh-list
2924647|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2924648|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
2924649|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2339063|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2339064|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
2339065|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339066|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339067|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339068|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2339069|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339070|NCT00440154|Ezetimibe|ezetimibe|mesh-list
2339071|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2339072|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2339073|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
2339074|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924650|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924651|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2924652|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
2924653|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924654|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339075|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2339076|NCT00440167|Gemcitabine|gemcitabine|mesh-list
2924655|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
2924656|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924657|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2924658|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2924659|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
2924660|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2924661|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2924662|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
2924663|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
2924664|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2924665|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2924666|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2924667|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924668|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924669|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2924670|NCT03011307|Oxytocin|oxytocin|mesh-list
2924671|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
2924672|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2924673|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339077|NCT00440167|Capecitabine|capecitabine|mesh-list
2339078|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2339079|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2339080|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
2339081|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339082|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339083|NCT00440167|Antiviral Agents|antiviral agents|mesh-ancestor
2339084|NCT00440167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2924701|NCT02987257|Cyclosporine|cyclosporine|mesh-list
2924702|NCT02987257|Etanercept|etanercept|mesh-list
2924703|NCT02987257|Cyclosporins|cyclosporins|mesh-list
2924704|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924705|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924706|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2924707|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
2924708|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924709|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
2924710|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2924711|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
2924712|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2924713|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2924714|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2924715|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339085|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339086|NCT00440167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2339087|NCT00440167|Immunologic Factors|immunologic factors|mesh-ancestor
2339088|NCT00440167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339089|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2339090|NCT00440219|Prednisone|prednisone|mesh-list
2339091|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339092|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
2339093|NCT00440219|Hormones|hormones|mesh-ancestor
2339094|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2339095|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339096|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2339097|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924716|NCT02987257|Analgesics|analgesics|mesh-ancestor
2924717|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
2924718|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2924719|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2924720|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2924721|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
2924722|NCT02981069|Exenatide|exenatide|mesh-list
2924723|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2924724|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924725|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2924726|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924727|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2924728|NCT02981069|Incretins|incretins|mesh-ancestor
2924729|NCT02981069|Hormones|hormones|mesh-ancestor
2924730|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2924731|NCT02970981|Nivolumab|nivolumab|mesh-list
2111575|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2111576|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111577|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111578|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111579|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
2111580|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2111581|NCT02556775|Antibodies|antibodies|mesh-list
2111582|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
2111583|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2111584|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
2111585|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111586|NCT02556788|Trifarotene|trifarotene|mesh-list
2111587|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
2924732|NCT02970981|Ipilimumab|ipilimumab|mesh-list
2924733|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924734|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924735|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2924736|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924739|NCT02964013|Carboplatin|carboplatin|mesh-list
2924740|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
2924741|NCT02964013|Etoposide|etoposide|mesh-list
2924742|NCT02964013|Pemetrexed|pemetrexed|mesh-list
2924743|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924744|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924745|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2924746|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2339098|NCT00440245|Albuterol|albuterol|mesh-list
2339099|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2339100|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
2339101|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339102|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339103|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2111588|NCT02556918|Insulin|insulin|mesh-list
2339104|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
2924747|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2924748|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924749|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924750|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2924751|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2339105|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
2339106|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2339107|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2339108|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2339109|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2339110|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
2339111|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339112|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339113|NCT00440258|Cabergoline|cabergoline|mesh-list
2924760|NCT02933255|Nivolumab|nivolumab|mesh-list
2924761|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924762|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924763|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2924764|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924765|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
2924766|NCT02932956|Fludarabine|fludarabine|mesh-list
2924767|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
2924768|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2924769|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
2924770|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924771|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2924772|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2924773|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
2924774|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924775|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924776|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2924777|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2924778|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
2339114|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2339115|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2339116|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
2339117|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
2339118|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339119|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339120|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339121|NCT00440284|Insulin|insulin|mesh-list
2339122|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2924779|NCT02913612|Timolol|timolol|mesh-list
2924780|NCT02913612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2924781|NCT02913612|Maleic acid|maleic acid|mesh-list
2924782|NCT02913612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2924783|NCT02913612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2924784|NCT02913612|Adrenergic Agents|adrenergic agents|mesh-ancestor
2924785|NCT02913612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2924786|NCT02913612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924787|NCT02913612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924788|NCT02913612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2924789|NCT02913612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2924790|NCT02913612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924815|NCT02911935|Azithromycin|azithromycin|mesh-list
2924816|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2924817|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2924818|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
2924819|NCT02909452|Entinostat|entinostat|mesh-list
2924820|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924821|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924822|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2924823|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924824|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924825|NCT02909036|Melphalan|melphalan|mesh-list
2924826|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2924827|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
2924828|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924829|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924830|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2924831|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2924832|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
2924833|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924834|NCT02898506|Liraglutide|liraglutide|mesh-list
2924835|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2924836|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924837|NCT02898506|Incretins|incretins|mesh-ancestor
2924838|NCT02898506|Hormones|hormones|mesh-ancestor
2924839|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2111589|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2111590|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
2339123|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339124|NCT00440323|Zolpidem|zolpidem|mesh-list
2339125|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2339126|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2339127|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2339128|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339129|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2339130|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
2111591|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
2111592|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2111593|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
2111594|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2114049|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
2339131|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
2339132|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339133|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924869|NCT02880982|Vitamin D|vitamin d|mesh-list
2924870|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
2924871|NCT02880982|Vitamins|vitamins|mesh-ancestor
2924872|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
2924873|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924874|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2924875|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2924876|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
2924877|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
2924878|NCT02880293|Melphalan|melphalan|mesh-list
2924879|NCT02880293|Thiotepa|thiotepa|mesh-list
2924880|NCT02880293|Fludarabine|fludarabine|mesh-list
2924881|NCT02880293|Tacrolimus|tacrolimus|mesh-list
2924882|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2924883|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
2924884|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924885|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2924886|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2924887|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
2924888|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924889|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924890|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2924891|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2924892|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924893|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2924894|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2339134|NCT00440336|Latanoprost|latanoprost|mesh-list
2339135|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2339136|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2339137|NCT00440349|Tamoxifen|tamoxifen|mesh-list
2339138|NCT00440349|Prednisone|prednisone|mesh-list
2339139|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339140|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
2339141|NCT00440349|Hormones|hormones|mesh-ancestor
2339142|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2339143|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339144|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2339145|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339146|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2339147|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
2339148|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2339149|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2339150|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2339151|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
2339152|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2339153|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924895|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
2924896|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2924897|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2924898|NCT02861573|Dexamethasone|dexamethasone|mesh-list
2924899|NCT02861573|Prednisone|prednisone|mesh-list
2924900|NCT02861573|Carboplatin|carboplatin|mesh-list
2924901|NCT02861573|Docetaxel|docetaxel|mesh-list
2924902|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
2924903|NCT02861573|Etoposide|etoposide|mesh-list
2924904|NCT02861573|Olaparib|olaparib|mesh-list
2924905|NCT02861573|Lenvatinib|lenvatinib|mesh-list
2924906|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
2339154|NCT00440388|Rituximab|rituximab|mesh-list
2339155|NCT00440388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2339156|NCT00440388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339157|NCT00440388|Immunologic Factors|immunologic factors|mesh-ancestor
2339158|NCT00440388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339159|NCT00440388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339160|NCT00440414|Pemetrexed|pemetrexed|mesh-list
2339161|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2339162|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339163|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339164|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339165|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2924907|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2924908|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
2924909|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
2924910|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2924911|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924912|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2924913|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
2924914|NCT02861573|Hormones|hormones|mesh-ancestor
2924915|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2924916|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2924917|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924918|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
2924919|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
2924920|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
2339166|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2339167|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2339168|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2924921|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924922|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924923|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2924924|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2924925|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2924926|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924927|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2924928|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2924929|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2924930|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
2924931|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2924932|NCT02853500|Doxorubicin|doxorubicin|mesh-list
2924933|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2924934|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924935|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2924936|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2924937|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924938|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924939|NCT02842827|Tretinoin|tretinoin|mesh-list
2924940|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924941|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
2924942|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
2339169|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2924965|NCT02837029|Nivolumab|nivolumab|mesh-list
2924966|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2924967|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924968|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2924969|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924970|NCT02819635|Upadacitinib|upadacitinib|mesh-list
2924971|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2924972|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2924973|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2924974|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924975|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2924976|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
2924977|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2924978|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2924979|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
2924980|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2924981|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2924982|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
2924983|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
2924984|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2924985|NCT02740127|Dexamethasone|dexamethasone|mesh-list
2924986|NCT02740127|Clonidine|clonidine|mesh-list
2924987|NCT02740127|Epinephrine|epinephrine|mesh-list
2339170|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2339171|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2339172|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339173|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339174|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339175|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
2339176|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2339177|NCT00440440|Testosterone|testosterone|mesh-list
2339178|NCT00440440|Androgens|androgens|mesh-ancestor
2339179|NCT00440440|Hormones|hormones|mesh-ancestor
2339180|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2339181|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339182|NCT00440479|Bortezomib|bortezomib|mesh-list
2339183|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339184|NCT00440609|Ranibizumab|ranibizumab|mesh-list
2339185|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2339186|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2339187|NCT00440609|Growth Substances|growth substances|mesh-ancestor
2339188|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339189|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
2339190|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2924988|NCT02740127|Propofol|propofol|mesh-list
2924989|NCT02740127|Ropivacaine|ropivacaine|mesh-list
2924990|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2924991|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
2924992|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
2924993|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2924994|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2924995|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2924996|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
2924997|NCT02740127|Hormones|hormones|mesh-ancestor
2924998|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2924999|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2925000|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925001|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925002|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2925003|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2925004|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2925005|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
2925006|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
2925007|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
2925008|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
2925009|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2925010|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2925011|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
2925012|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2925013|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2925014|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2925015|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2925016|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
2925017|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
2925018|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
2925019|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2925020|NCT02740127|Analgesics|analgesics|mesh-ancestor
2339191|NCT00440622|Gemcitabine|gemcitabine|mesh-list
2339192|NCT00440622|Capecitabine|capecitabine|mesh-list
2339193|NCT00440622|Trastuzumab|trastuzumab|mesh-list
2339194|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2339195|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
2339196|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339197|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339198|NCT00440622|Antiviral Agents|antiviral agents|mesh-ancestor
2339199|NCT00440622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2339200|NCT00440622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339201|NCT00440622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2339202|NCT00440622|Immunologic Factors|immunologic factors|mesh-ancestor
2339203|NCT00440622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925021|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2339204|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2339205|NCT00440635|Bortezomib|bortezomib|mesh-list
2339206|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339207|NCT00440648|Sevelamer|sevelamer|mesh-list
2339208|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
2339209|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
2339210|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339211|NCT00440661|Diacetylrhein|diacetylrhein|mesh-list
2339212|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339213|NCT00440674|Paclitaxel|paclitaxel|mesh-list
2339214|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2339215|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339216|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
2339217|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
2339218|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
2339219|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925022|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
2925023|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2925024|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
2925025|NCT02737475|Nivolumab|nivolumab|mesh-list
2925026|NCT02737475|Ipilimumab|ipilimumab|mesh-list
2925027|NCT02737475|Vaccines|vaccines|mesh-list
2925028|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
2925029|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925030|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925031|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2925032|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2925033|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
2925034|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925035|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925036|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2925037|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2925038|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2925039|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
2925040|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925041|NCT02709512|Cisplatin|cisplatin|mesh-list
2925042|NCT02709512|Pemetrexed|pemetrexed|mesh-list
2339220|NCT00440687|Fluticasone|fluticasone|mesh-list
2339221|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2925043|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925044|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925045|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925046|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2925047|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2925048|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
2925049|NCT02703714|Sargramostim|sargramostim|mesh-list
2925050|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2925051|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925052|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
2925053|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925054|NCT02689440|Dasatinib|dasatinib|mesh-list
2925055|NCT02689440|Venetoclax|venetoclax|mesh-list
2339222|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2339223|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
2339224|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339225|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339226|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2339227|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
2339228|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
2339229|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2339230|NCT00440713|Aripiprazole|aripiprazole|mesh-list
2339231|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
2339232|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2339233|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2339234|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2339235|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2339236|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925056|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925057|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2925058|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925059|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925060|NCT02684006|Sunitinib|sunitinib|mesh-list
2925061|NCT02684006|Avelumab|avelumab|mesh-list
2339237|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
2925062|NCT02684006|Axitinib|axitinib|mesh-list
2925063|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925064|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2925065|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2925066|NCT02684006|Growth Substances|growth substances|mesh-ancestor
2925067|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925068|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
2925069|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2925070|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925071|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925072|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2925073|NCT02652052|Dasatinib|dasatinib|mesh-list
2925074|NCT02652052|Quercetin|quercetin|mesh-list
2925075|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925076|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2925077|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925078|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925079|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
2925080|NCT02652052|Protective Agents|protective agents|mesh-ancestor
2925081|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925082|NCT02642965|Cytarabine|cytarabine|mesh-list
2925083|NCT02642965|Fludarabine|fludarabine|mesh-list
2925084|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
2925085|NCT02642965|Daunorubicin|daunorubicin|mesh-list
2925086|NCT02642965|Lenograstim|lenograstim|mesh-list
2925087|NCT02642965|Sargramostim|sargramostim|mesh-list
2925088|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925089|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2925090|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
2925091|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925092|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925093|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
2339238|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
2339239|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339240|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339241|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2339242|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2339243|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
2339244|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2339245|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2339246|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2339247|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2339248|NCT00440739|Etoricoxib|etoricoxib|mesh-list
2339249|NCT00440739|Flavoxate|flavoxate|mesh-list
2339250|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2339251|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339252|NCT00440739|Analgesics|analgesics|mesh-ancestor
2339253|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
2339254|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339255|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925094|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925095|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2925096|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
2925097|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925098|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2925099|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2925100|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2925101|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339256|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339257|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339258|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2339259|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2339260|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339261|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339262|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
2339263|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
2339264|NCT00440739|Urological Agents|urological agents|mesh-ancestor
2339265|NCT00440765|Bortezomib|bortezomib|mesh-list
2339266|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339267|NCT00440778|Abciximab|abciximab|mesh-list
2339268|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
2339269|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2339270|NCT00440804|Ibuprofen|ibuprofen|mesh-list
2339271|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2339272|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339273|NCT00440804|Analgesics|analgesics|mesh-ancestor
2339274|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
2339275|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339276|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339277|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339278|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339279|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2339280|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339281|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339282|NCT00440843|Olanzapine|olanzapine|mesh-list
2339283|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
2339284|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
2339285|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339286|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339287|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2925107|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
2925108|NCT02638090|Vorinostat|vorinostat|mesh-list
2925109|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2925110|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925111|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2925112|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925113|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925114|NCT02632175|Adalimumab|adalimumab|mesh-list
2925115|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2925116|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2925117|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
2925118|NCT02629809|Fludarabine|fludarabine|mesh-list
2925119|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
2925120|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
2925121|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925122|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
2925123|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925124|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2925125|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2925126|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
2925127|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925128|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925129|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2925130|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2925131|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
2925132|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2925133|NCT02629159|Adalimumab|adalimumab|mesh-list
2925134|NCT02629159|Upadacitinib|upadacitinib|mesh-list
2925135|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2925136|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2925137|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2925138|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2925139|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925140|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925159|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
2925160|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2925161|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925162|NCT02611232|Liraglutide|liraglutide|mesh-list
2339288|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2925163|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2925164|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925165|NCT02611232|Incretins|incretins|mesh-ancestor
2925166|NCT02611232|Hormones|hormones|mesh-ancestor
2925167|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2925168|NCT02604433|Luspatercept|luspatercept|mesh-list
2925169|NCT02604433|Hematinics|hematinics|mesh-ancestor
2925170|NCT02598895|Carboplatin|carboplatin|mesh-list
2925171|NCT02598895|Docetaxel|docetaxel|mesh-list
2925172|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925173|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
2925174|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
2925175|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
2925176|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925182|NCT02582775|Vidarabine|vidarabine|mesh-list
2925183|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
2925184|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
2925185|NCT02582775|Busulfan|busulfan|mesh-list
2925186|NCT02582775|Fludarabine|fludarabine|mesh-list
2925187|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
2925188|NCT02582775|Tacrolimus|tacrolimus|mesh-list
2925189|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
2339289|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2339290|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2339291|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2339292|NCT00440843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2339293|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2339294|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2339295|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339296|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339297|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
2339298|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
2339299|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2339300|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
2339301|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2339302|NCT00440869|Expectorants|expectorants|mesh-ancestor
2339303|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
2339304|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2339305|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
2339306|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339307|NCT00440869|Protective Agents|protective agents|mesh-ancestor
2339308|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339309|NCT00440869|Antidotes|antidotes|mesh-ancestor
2339310|NCT00440895|Abciximab|abciximab|mesh-list
2339311|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
2339312|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2339313|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2339314|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
2925190|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2925191|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925192|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
2925193|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925194|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339315|NCT00440921|Coagulants|coagulants|mesh-ancestor
2339316|NCT00440960|Lidocaine|lidocaine|mesh-list
2339317|NCT00440960|Midazolam|midazolam|mesh-list
2339318|NCT00440960|Alfentanil|alfentanil|mesh-list
2925195|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2925196|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
2925197|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925198|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925199|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2925200|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2925201|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
2925202|NCT02582775|Antiviral Agents|antiviral agents|mesh-ancestor
2925203|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925204|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2925205|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925206|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2925207|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2339319|NCT00440960|Propofol|propofol|mesh-list
2339320|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
2925208|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
2925209|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2925210|NCT02570542|Cytarabine|cytarabine|mesh-list
2925211|NCT02570542|Plerixafor|plerixafor|mesh-list
2339321|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
2339322|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2339323|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339324|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
2339325|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339326|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2339327|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2339328|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2339329|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2339330|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339331|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2339332|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2339333|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
2339334|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2339335|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2339336|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2339337|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2339338|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
2339339|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
2339340|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339341|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2339342|NCT00440960|Narcotics|narcotics|mesh-ancestor
2339343|NCT00440960|Analgesics|analgesics|mesh-ancestor
2339344|NCT00440973|Bevacizumab|bevacizumab|mesh-list
2339345|NCT00440973|Interleukin-2|interleukin-2|mesh-list
2339346|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2339347|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339348|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2339349|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2339350|NCT00440973|Growth Substances|growth substances|mesh-ancestor
2339351|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339352|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
2339353|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339354|NCT00440973|Analgesics|analgesics|mesh-ancestor
2339355|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
2339356|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339357|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
2339358|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2339359|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339360|NCT00441051|Diclofenac|diclofenac|mesh-list
2339361|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2339362|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339363|NCT00441051|Analgesics|analgesics|mesh-ancestor
2339364|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
2339365|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339366|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339367|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339368|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339369|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2339370|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339371|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339372|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
2339373|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339374|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2339375|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339376|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339377|NCT00441181|Travoprost|travoprost|mesh-list
2339378|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2339379|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
2339380|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
2339381|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339382|NCT00441207|Protective Agents|protective agents|mesh-ancestor
2339383|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339384|NCT00441207|Vitamins|vitamins|mesh-ancestor
2339385|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
2925212|NCT02570542|Etoposide|etoposide|mesh-list
2925213|NCT02570542|Melphalan|melphalan|mesh-list
2925214|NCT02570542|Carmustine|carmustine|mesh-list
2925215|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2925216|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925217|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2925218|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2925219|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925220|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925221|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2339386|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
2339387|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
2339388|NCT00441246|Ephedrine|ephedrine|mesh-list
2339389|NCT00441246|Guaifenesin|guaifenesin|mesh-list
2339390|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2339391|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2339392|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
2339393|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339394|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339395|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2339396|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
2339397|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
2339398|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2339399|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2339400|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
2339401|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
2925222|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
2925223|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
2925224|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925225|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925226|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
2925227|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925228|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2925229|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
2925230|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2925231|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2925232|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2925266|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
2925267|NCT02550652|Prednisone|prednisone|mesh-list
2925268|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
2925269|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
2925270|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2925271|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
2925272|NCT02550652|Hormones|hormones|mesh-ancestor
2925273|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2925274|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925275|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2925276|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925277|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2925278|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2925279|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
2339402|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2925280|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2925281|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925282|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925283|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925284|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
2339403|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339404|NCT00441246|Expectorants|expectorants|mesh-ancestor
2339405|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2339406|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2339407|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
2339408|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2339409|NCT00441298|Tenofovir|tenofovir|mesh-list
2339410|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
2925285|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
2925286|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2925287|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2925288|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2925289|NCT02550652|Protective Agents|protective agents|mesh-ancestor
2925290|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2925291|NCT02537418|Durvalumab|durvalumab|mesh-list
2925292|NCT02537418|Tremelimumab|tremelimumab|mesh-list
2925293|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2925294|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925295|NCT02520154|Paclitaxel|paclitaxel|mesh-list
2925296|NCT02520154|Carboplatin|carboplatin|mesh-list
2925297|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
2925298|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2925299|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2925300|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925301|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
2925302|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
2925303|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
2925304|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925305|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2925306|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
2925307|NCT02519738|Triamcinolone|triamcinolone|mesh-list
2925308|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2925309|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2925310|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
2925311|NCT02519738|Hormones|hormones|mesh-ancestor
2925312|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2925313|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925314|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925315|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
2339411|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2339412|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2339413|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2339414|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339415|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339416|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2339417|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2339418|NCT00441415|Adapalene|adapalene|mesh-list
2339419|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2339420|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339421|NCT00441415|Analgesics|analgesics|mesh-ancestor
2339422|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
2339423|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339424|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339425|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339426|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339427|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
2339428|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
2339429|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2339430|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2339431|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
2339432|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339433|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339434|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339435|NCT00441428|Urological Agents|urological agents|mesh-ancestor
2339436|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2339437|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2339438|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339439|NCT00441519|Aspirin|aspirin|mesh-list
2339440|NCT00441519|Omeprazole|omeprazole|mesh-list
2925316|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2925317|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925318|NCT02502266|Paclitaxel|paclitaxel|mesh-list
2925319|NCT02502266|Doxorubicin|doxorubicin|mesh-list
2925320|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2925321|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2925322|NCT02502266|Topotecan|topotecan|mesh-list
2925323|NCT02502266|Olaparib|olaparib|mesh-list
2925324|NCT02502266|Cediranib|cediranib|mesh-list
2925325|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2925326|NCT02502266|Maleic acid|maleic acid|mesh-list
2925327|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2925328|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339441|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2339442|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339443|NCT00441519|Analgesics|analgesics|mesh-ancestor
2925329|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
2925330|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
2925331|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
2925332|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925333|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2925334|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2925335|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2925336|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925337|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2925338|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2339444|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
2339445|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339446|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339447|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339448|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339449|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2339450|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2339451|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339452|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2339453|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2339454|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339455|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
2339456|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2339457|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2339458|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2339459|NCT00441532|Lidocaine|lidocaine|mesh-list
2339460|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
2339461|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
2339462|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2339463|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339464|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
2339465|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339466|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2339467|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2339468|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2339469|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2339470|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339471|NCT00441597|Atorvastatin|atorvastatin|mesh-list
2339472|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2339473|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2339474|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
2339475|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339476|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2339477|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2339478|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339479|NCT00441649|Methylphenidate|methylphenidate|mesh-list
2339480|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2339481|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339482|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2339483|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2339484|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2339485|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339486|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
2339487|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339488|NCT00441662|Triamcinolone|triamcinolone|mesh-list
2339489|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339490|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
2339491|NCT00441662|Hormones|hormones|mesh-ancestor
2339492|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2339493|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339494|NCT00441740|Gemcitabine|gemcitabine|mesh-list
2339495|NCT00441740|Docetaxel|docetaxel|mesh-list
2339496|NCT00441740|Vinorelbine|vinorelbine|mesh-list
2339497|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2339498|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
2339499|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339500|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339501|NCT00441740|Antiviral Agents|antiviral agents|mesh-ancestor
2339502|NCT00441740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2339503|NCT00441740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339504|NCT00441740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2339505|NCT00441740|Immunologic Factors|immunologic factors|mesh-ancestor
2339506|NCT00441740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339507|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
2339508|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
2339509|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
2339510|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2339511|NCT00441844|Simvastatin|simvastatin|mesh-list
2339512|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2339513|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2339514|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
2339515|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339516|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2339517|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2339518|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339519|NCT00441870|Folic Acid|folic acid|mesh-list
2339520|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
2339521|NCT00441870|Hematinics|hematinics|mesh-ancestor
2339522|NCT00441870|Vitamins|vitamins|mesh-ancestor
2339523|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
2339524|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339525|NCT00441896|Ganaxolone|ganaxolone|mesh-list
2339526|NCT00441896|Neurosteroids|neurosteroids|mesh-ancestor
2339527|NCT00441896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339528|NCT00441896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339529|NCT00441896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339530|NCT00441896|GABA Modulators|gaba modulators|mesh-ancestor
2339531|NCT00441896|GABA Agents|gaba agents|mesh-ancestor
2339532|NCT00441909|UC-781|uc-781|mesh-list
2339533|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2339534|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
2339535|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2339536|NCT00441922|Docetaxel|docetaxel|mesh-list
2339537|NCT00441922|Vinorelbine|vinorelbine|mesh-list
2339538|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339539|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
2339540|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
2339541|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
2339542|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339543|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2339544|NCT00441961|Methotrexate|methotrexate|mesh-list
2339545|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2339546|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
2339547|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2339548|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339549|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2925397|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2925398|NCT02430077|Cathartics|cathartics|mesh-ancestor
2925399|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2925400|NCT02420821|Bevacizumab|bevacizumab|mesh-list
2925401|NCT02420821|Sunitinib|sunitinib|mesh-list
2925402|NCT02420821|Atezolizumab|atezolizumab|mesh-list
2925403|NCT02420821|Antibodies|antibodies|mesh-list
2925404|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2925405|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2925406|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925407|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2925408|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2925409|NCT02420821|Growth Substances|growth substances|mesh-ancestor
2925410|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925411|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
2925412|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
2925413|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2925414|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925415|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925416|NCT02412670|Gemcitabine|gemcitabine|mesh-list
2925417|NCT02412670|Cisplatin|cisplatin|mesh-list
2925418|NCT02412670|Carboplatin|carboplatin|mesh-list
2925419|NCT02412670|Doxorubicin|doxorubicin|mesh-list
2925420|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2925421|NCT02412670|Methotrexate|methotrexate|mesh-list
2925422|NCT02412670|Vinblastine|vinblastine|mesh-list
2339550|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
2339551|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339552|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339553|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
2925423|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925424|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2925425|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
2925426|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925427|NCT02412670|Antiviral Agents|antiviral agents|mesh-ancestor
2925428|NCT02412670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925429|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925430|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925431|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
2925432|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925433|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2925434|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2925435|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2925436|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2925437|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
2925438|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2339554|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339555|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2339556|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2339557|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
2339558|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339559|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2339560|NCT00442026|Gemcitabine|gemcitabine|mesh-list
2339561|NCT00442026|Docetaxel|docetaxel|mesh-list
2339562|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2339563|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
2339564|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339565|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339566|NCT00442026|Antiviral Agents|antiviral agents|mesh-ancestor
2339567|NCT00442026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2339568|NCT00442026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339569|NCT00442026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2339570|NCT00442026|Immunologic Factors|immunologic factors|mesh-ancestor
2339571|NCT00442026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339572|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
2339573|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
2339574|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
2339575|NCT00442039|Lithium Carbonate|lithium carbonate|mesh-list
2339576|NCT00442039|Antidepressive Agents|antidepressive agents|mesh-ancestor
2339577|NCT00442039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2339578|NCT00442039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339579|NCT00442039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339580|NCT00442039|Antimanic Agents|antimanic agents|mesh-ancestor
2339581|NCT00442039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2339582|NCT00442039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2339583|NCT00442039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339584|NCT00442052|Aspirin|aspirin|mesh-list
2339585|NCT00442052|Omeprazole|omeprazole|mesh-list
2339586|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2339587|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339588|NCT00442052|Analgesics|analgesics|mesh-ancestor
2339589|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
2339590|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339591|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339592|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339593|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339594|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2339595|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2339596|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339597|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2339598|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2339599|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339600|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
2339601|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2339602|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2339603|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2339604|NCT00442104|Ganaxolone|ganaxolone|mesh-list
2339605|NCT00442104|Neurosteroids|neurosteroids|mesh-ancestor
2925439|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
2925440|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2925441|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2925442|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2925443|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2925444|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
2925445|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
2925446|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
2925447|NCT02410343|Hormones|hormones|mesh-list
2925448|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2925449|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339606|NCT00442104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339607|NCT00442104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339608|NCT00442104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339609|NCT00442104|GABA Modulators|gaba modulators|mesh-ancestor
2339610|NCT00442104|GABA Agents|gaba agents|mesh-ancestor
2339611|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
2925457|NCT02376699|Gemcitabine|gemcitabine|mesh-list
2925458|NCT02376699|Paclitaxel|paclitaxel|mesh-list
2925459|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
2925460|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2925461|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925462|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
2925463|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
2925464|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
2925465|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925466|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2925467|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
2925468|NCT02376699|Antiviral Agents|antiviral agents|mesh-ancestor
2925469|NCT02376699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925470|NCT02376699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925471|NCT02376699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925472|NCT02376699|Immunologic Factors|immunologic factors|mesh-ancestor
2925473|NCT02376699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925474|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2925475|NCT02370329|Interferons|interferons|mesh-list
2925476|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
2925477|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
2925478|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2925479|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2925480|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925481|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
2339612|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2925482|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925483|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
2925484|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339613|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339614|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339615|NCT00442221|Naproxen|naproxen|mesh-list
2339616|NCT00442221|Sumatriptan|sumatriptan|mesh-list
2339617|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2339618|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339619|NCT00442221|Analgesics|analgesics|mesh-ancestor
2339620|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
2925488|NCT02352753|Denosumab|denosumab|mesh-list
2925489|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2925490|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339621|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339622|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339623|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339624|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339625|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
2339626|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2339627|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339628|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339629|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2925499|NCT02343224|Interferons|interferons|mesh-list
2925500|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
2339630|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2339631|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2339632|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
2339633|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339634|NCT00442234|Monteplase|monteplase|mesh-list
2339635|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2339636|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2339637|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339638|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2339639|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2925501|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
2925502|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2925503|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925504|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
2925505|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925506|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
2925507|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925508|NCT02339740|Vitamins|vitamins|mesh-list
2925509|NCT02339740|Vitamin A|vitamin a|mesh-list
2925510|NCT02339740|Cytarabine|cytarabine|mesh-list
2925511|NCT02339740|Dexamethasone|dexamethasone|mesh-list
2925512|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
2925513|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
2925514|NCT02339740|Idarubicin|idarubicin|mesh-list
2925515|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
2925516|NCT02339740|Tretinoin|tretinoin|mesh-list
2925517|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
2339640|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
2339641|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2339642|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2339643|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
2339644|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339645|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339646|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339647|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2339648|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2339649|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2339650|NCT00442325|Atorvastatin|atorvastatin|mesh-list
2339651|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2339652|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2339653|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
2339654|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339655|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2339656|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2339657|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339658|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
2339659|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339660|NCT00442403|Chloroquine|chloroquine|mesh-list
2339661|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2339662|NCT00442403|Amebicides|amebicides|mesh-ancestor
2339663|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2339664|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2339665|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2339666|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
2339667|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339668|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339669|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2339670|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
2339671|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2339672|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339673|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2339674|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339675|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339676|NCT00442481|Citalopram|citalopram|mesh-list
2339677|NCT00442481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2339678|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2339679|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2339680|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339681|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111595|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111596|NCT02556918|Incretins|incretins|mesh-ancestor
2111597|NCT02556918|Hormones|hormones|mesh-ancestor
2111598|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2111599|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2111600|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
2111601|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111602|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111603|NCT02557035|Dexamethasone|dexamethasone|mesh-list
2111604|NCT02557035|Palonosetron|palonosetron|mesh-list
2111605|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2111606|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
2111607|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
2111608|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111609|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111610|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2111611|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
2925518|NCT02339740|BB 1101|bb 1101|mesh-list
2925519|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
2339682|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
2339683|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339684|NCT00442481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2339685|NCT00442481|Antidepressive Agents|antidepressive agents|mesh-ancestor
2925520|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925521|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2925522|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
2925523|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
2925524|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2925525|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2925526|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
2925527|NCT02339740|Hormones|hormones|mesh-ancestor
2925528|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2925529|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2925530|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925531|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
2925532|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925533|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925534|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2925535|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
2925536|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
2925537|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925538|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925539|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
2925540|NCT02339740|Analgesics|analgesics|mesh-ancestor
2925541|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
2925542|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2339686|NCT00442481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2339687|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
2339688|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339689|NCT00442546|Pregabalin|pregabalin|mesh-list
2339690|NCT00442546|Analgesics|analgesics|mesh-ancestor
2339691|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
2339692|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339693|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339694|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
2339695|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2339696|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2339697|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339698|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2339699|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2339700|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2339701|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2339702|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2339703|NCT00442585|Ibuprofen|ibuprofen|mesh-list
2339704|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2339705|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339706|NCT00442585|Analgesics|analgesics|mesh-ancestor
2339707|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
2339708|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339709|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925543|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2925544|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2925545|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
2925546|NCT02339740|Protective Agents|protective agents|mesh-ancestor
2925547|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2925548|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
2925549|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
2925559|NCT02291445|Peppermint oil|peppermint oil|mesh-list
2925560|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
2925561|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
2925562|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2925563|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925564|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2925565|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
2925566|NCT02262026|Saracatinib|saracatinib|mesh-list
2925567|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925568|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925569|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339710|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339711|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339712|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2339713|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339714|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339715|NCT00442637|Bevacizumab|bevacizumab|mesh-list
2339716|NCT00442637|Capecitabine|capecitabine|mesh-list
2339717|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2339718|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339719|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2339720|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2339721|NCT00442637|Growth Substances|growth substances|mesh-ancestor
2339722|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339723|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
2339724|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2339725|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
2339726|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339727|NCT00442676|Celecoxib|celecoxib|mesh-list
2111612|NCT02557035|Hormones|hormones|mesh-ancestor
2111613|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2111614|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2111615|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111616|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2111617|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2111618|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
2925618|NCT02163694|Paclitaxel|paclitaxel|mesh-list
2925619|NCT02163694|Carboplatin|carboplatin|mesh-list
2925620|NCT02163694|Veliparib|veliparib|mesh-list
2925621|NCT02163694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2925622|NCT02163694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925623|NCT02163694|Tubulin Modulators|tubulin modulators|mesh-ancestor
2925624|NCT02163694|Antimitotic Agents|antimitotic agents|mesh-ancestor
2925625|NCT02163694|Mitosis Modulators|mitosis modulators|mesh-ancestor
2925626|NCT02163694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925627|NCT02163694|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2925628|NCT02163694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925629|NCT02159989|Aflibercept|aflibercept|mesh-list
2925630|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
2925631|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2925632|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2925633|NCT02159989|Growth Substances|growth substances|mesh-ancestor
2925634|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925635|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
2925636|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925637|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2925638|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925639|NCT02125461|Durvalumab|durvalumab|mesh-list
2925640|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2339728|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2339729|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339730|NCT00442676|Analgesics|analgesics|mesh-ancestor
2925641|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925642|NCT02124902|Carboplatin|carboplatin|mesh-list
2925643|NCT02124902|Docetaxel|docetaxel|mesh-list
2925644|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925645|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
2925646|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
2925647|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
2925648|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925649|NCT02113878|Cisplatin|cisplatin|mesh-list
2925650|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339731|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
2339732|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339733|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339734|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339735|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2925651|NCT02097680|Letrozole|letrozole|mesh-list
2925652|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925653|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2925654|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2925655|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925656|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925657|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2925658|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
2925659|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2925660|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925661|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2925662|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
2925663|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925664|NCT02022098|Cisplatin|cisplatin|mesh-list
2925665|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925666|NCT01995578|Azacitidine|azacitidine|mesh-list
2925667|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2925668|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
2925669|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925670|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925671|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925672|NCT01989585|Trametinib|trametinib|mesh-list
2925673|NCT01989585|Dabrafenib|dabrafenib|mesh-list
2925674|NCT01989585|Navitoclax|navitoclax|mesh-list
2925675|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925676|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2925677|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925678|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925679|NCT01986075|Amphetamine|amphetamine|mesh-list
2925680|NCT01986075|Adderall|adderall|mesh-list
2925681|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2925682|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925683|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
2925684|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
2339736|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2339737|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2339738|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339739|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925685|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2925686|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
2925687|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2925688|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925689|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
2925690|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2925691|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2925692|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2925693|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2925694|NCT01942135|Fulvestrant|fulvestrant|mesh-list
2925695|NCT01942135|Palbociclib|palbociclib|mesh-list
2925696|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2925697|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925698|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2925699|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2925700|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
2925701|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2925702|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925703|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2925704|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925705|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925706|NCT01935466|Pioglitazone|pioglitazone|mesh-list
2925707|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2925708|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925709|NCT01902290|Brodalumab|brodalumab|mesh-list
2925710|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
2925711|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2925712|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2925713|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925714|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925715|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925716|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2925717|NCT01842386|Rituximab|rituximab|mesh-list
2925718|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2925719|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925720|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
2925721|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925722|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2925723|NCT01835145|Temozolomide|temozolomide|mesh-list
2925724|NCT01835145|Dacarbazine|dacarbazine|mesh-list
2925725|NCT01835145|Imidazole|imidazole|mesh-list
2925726|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2925727|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
2925728|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925729|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925730|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339740|NCT00442741|Epothilone B|epothilone b|mesh-list
2339741|NCT00442741|Epothilones|epothilones|mesh-list
2339742|NCT00442741|Omeprazole|omeprazole|mesh-list
2339743|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2339744|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2339745|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2339746|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339747|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339748|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339749|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
2339750|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
2339751|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
2925746|NCT01799538|Albuterol|albuterol|mesh-list
2925747|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2925748|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
2925749|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2925750|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925751|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2925752|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
2925753|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
2925754|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2925755|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2925756|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2925757|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2925758|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
2339752|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
2339753|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2339754|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2925759|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2925760|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925761|NCT01759836|Atorvastatin|atorvastatin|mesh-list
2925762|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2925763|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2925764|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
2925765|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925766|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2925767|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2339755|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2339756|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
2339757|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339758|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339759|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339760|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
2339761|NCT00442793|Hematinics|hematinics|mesh-ancestor
2339762|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2339763|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
2339764|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2339765|NCT00442819|Protective Agents|protective agents|mesh-ancestor
2339766|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339767|NCT00442832|Vancomycin|vancomycin|mesh-list
2339768|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2339769|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2339770|NCT00442845|Atorvastatin|atorvastatin|mesh-list
2339771|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2339772|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2925768|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925769|NCT01758328|Fludarabine|fludarabine|mesh-list
2925770|NCT01758328|Melphalan|melphalan|mesh-list
2925771|NCT01758328|Busulfan|busulfan|mesh-list
2925772|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2925773|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925774|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925775|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925776|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
2925777|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925778|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2925779|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
2925780|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2339773|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
2339774|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339775|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2339776|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2339777|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339778|NCT00443105|Tacrolimus|tacrolimus|mesh-list
2339779|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2339780|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
2339781|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339782|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2339783|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339784|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339785|NCT00443144|Hormones|hormones|mesh-list
2339786|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2925781|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
2925782|NCT01746849|Thiotepa|thiotepa|mesh-list
2339787|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339788|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
2339789|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
2339790|NCT00443170|Midazolam|midazolam|mesh-list
2339791|NCT00443170|Caffeine|caffeine|mesh-list
2339792|NCT00443170|Omeprazole|omeprazole|mesh-list
2339793|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2339794|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2339795|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2339796|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339797|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2339798|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2339799|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2339800|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2339801|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
2339802|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
2339803|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
2339804|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
2339805|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339806|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339807|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2339808|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2925783|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925784|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
2925785|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925786|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2925787|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2925788|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
2925789|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925790|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925791|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2925792|NCT01745588|Clarithromycin|clarithromycin|mesh-list
2925793|NCT01745588|Dexamethasone|dexamethasone|mesh-list
2925794|NCT01745588|Pomalidomide|pomalidomide|mesh-list
2925795|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2925796|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
2925797|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
2925798|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2925799|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925800|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2925801|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
2925802|NCT01745588|Hormones|hormones|mesh-ancestor
2925803|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2925804|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2925805|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925806|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2925807|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925808|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2925809|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925810|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925811|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2925812|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2925813|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
2925814|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2925815|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2925816|NCT01745588|Growth Substances|growth substances|mesh-ancestor
2925817|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
2925818|NCT01701674|Aldesleukin|aldesleukin|mesh-list
2925819|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
2925820|NCT01701674|Fludarabine|fludarabine|mesh-list
2925821|NCT01701674|Ipilimumab|ipilimumab|mesh-list
2925822|NCT01701674|Interleukin-2|interleukin-2|mesh-list
2925823|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925824|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
2925825|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925826|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2925827|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2925828|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
2925829|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925830|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925831|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2925832|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2339809|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2339810|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339811|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2925833|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2925834|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2925835|NCT01701674|Analgesics|analgesics|mesh-ancestor
2925836|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
2925837|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2925838|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2925839|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2925840|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
2925841|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925842|NCT01643460|Ethanol|ethanol|mesh-list
2925843|NCT01643460|Paclitaxel|paclitaxel|mesh-list
2925844|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2925845|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2925846|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925847|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
2339812|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2339813|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2339814|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2339815|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
2339816|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2339817|NCT00443170|Analgesics|analgesics|mesh-ancestor
2339818|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
2339819|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339820|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2339821|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339822|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339823|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339824|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2339825|NCT00443222|Infliximab|infliximab|mesh-list
2339826|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
2339827|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2339828|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339829|NCT00443235|Thalidomide|thalidomide|mesh-list
2339830|NCT00443235|Prednisone|prednisone|mesh-list
2925848|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
2925849|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
2925850|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925851|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2925852|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925853|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2925854|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339831|NCT00443235|Melphalan|melphalan|mesh-list
2339832|NCT00443235|Bortezomib|bortezomib|mesh-list
2339833|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339834|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
2339835|NCT00443235|Hormones|hormones|mesh-ancestor
2339836|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2339837|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339838|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2339839|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339840|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2339841|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
2339842|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339843|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2339844|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2339845|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
2339846|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
2339847|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2339848|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2339849|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2339850|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2339851|NCT00443235|Growth Substances|growth substances|mesh-ancestor
2339852|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
2339853|NCT00443287|Cilostazol|cilostazol|mesh-list
2339854|NCT00443287|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
2339855|NCT00443287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2339856|NCT00443287|Autonomic Agents|autonomic agents|mesh-ancestor
2339857|NCT00443287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339858|NCT00443287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339859|NCT00443287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2339860|NCT00443287|Respiratory System Agents|respiratory system agents|mesh-ancestor
2339861|NCT00443287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2339862|NCT00443287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2339863|NCT00443287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339864|NCT00443287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2339865|NCT00443287|Vasodilator Agents|vasodilator agents|mesh-ancestor
2339866|NCT00443287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2339867|NCT00443287|Protective Agents|protective agents|mesh-ancestor
2925875|NCT01597388|Fulvestrant|fulvestrant|mesh-list
2925876|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2925877|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925878|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2925879|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2925880|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
2925881|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2925882|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925883|NCT01553214|Dexamethasone|dexamethasone|mesh-list
2925884|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2925885|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
2339868|NCT00443287|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2339869|NCT00443287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2339870|NCT00443287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339871|NCT00443287|Enzyme Activators|enzyme activators|mesh-ancestor
2339872|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
2339873|NCT00443339|Hematinics|hematinics|mesh-ancestor
2339874|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
2339875|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2339876|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
2339877|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339878|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339879|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2339880|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
2339881|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2339882|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2339883|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2339884|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
2925886|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
2925887|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2925888|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925889|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2925890|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
2925891|NCT01553214|Hormones|hormones|mesh-ancestor
2925892|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2925893|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2925894|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925895|NCT01528046|Metformin|metformin|mesh-list
2925896|NCT01528046|Irinotecan|irinotecan|mesh-list
2925897|NCT01528046|Camptothecin|camptothecin|mesh-list
2925898|NCT01528046|Vincristine|vincristine|mesh-list
2925899|NCT01528046|Temozolomide|temozolomide|mesh-list
2925900|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2925901|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925902|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2925903|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2925904|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925905|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925906|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925907|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2925908|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
2925909|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
2925910|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
2925911|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2925912|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
2925915|NCT01352962|Gemcitabine|gemcitabine|mesh-list
2925916|NCT01352962|Carboplatin|carboplatin|mesh-list
2925917|NCT01352962|Lenalidomide|lenalidomide|mesh-list
2925918|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925919|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2925920|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
2925921|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925922|NCT01352962|Antiviral Agents|antiviral agents|mesh-ancestor
2925923|NCT01352962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925924|NCT01352962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2925925|NCT01352962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925926|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
2925927|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925928|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2925929|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2925930|NCT01352962|Growth Substances|growth substances|mesh-ancestor
2925931|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
2925932|NCT01319565|Aldesleukin|aldesleukin|mesh-list
2925933|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
2925934|NCT01319565|Fludarabine|fludarabine|mesh-list
2925935|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2925936|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
2925937|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2925938|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2925939|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2925940|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
2925941|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2925942|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2925943|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2925944|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2925945|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2925946|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
2925947|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2925948|NCT01318486|Heparin|heparin|mesh-list
2925949|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
2925950|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2925951|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2925952|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339885|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339886|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339887|NCT00443508|Everolimus|everolimus|mesh-list
2339888|NCT00443508|Tacrolimus|tacrolimus|mesh-list
2339889|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2339890|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
2339891|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339892|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2339893|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339894|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339895|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339896|NCT00443521|Triamcinolone|triamcinolone|mesh-list
2339897|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2339898|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2339899|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2339900|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339901|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
2339902|NCT00443521|Hormones|hormones|mesh-ancestor
2339903|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2339904|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339905|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2339906|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
2339907|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339908|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339909|NCT00443573|Protein C|protein c|mesh-list
2339910|NCT00443573|Anticoagulants|anticoagulants|mesh-list
2339911|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2926000|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
2926001|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
2926002|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339912|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2111619|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111620|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111621|NCT02557100|Adalimumab|adalimumab|mesh-list
2111622|NCT02557100|Methotrexate|methotrexate|mesh-list
2111623|NCT02557100|Abatacept|abatacept|mesh-list
2111624|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2111625|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
2111626|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2111627|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111628|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2111629|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
2339913|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339914|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2339915|NCT00443612|Irbesartan|irbesartan|mesh-list
2339916|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2339917|NCT00443612|Diuretics|diuretics|mesh-ancestor
2339918|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
2339919|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339920|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2339921|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2339922|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339923|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2339924|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2339925|NCT00443690|Rolofylline|rolofylline|mesh-list
2339926|NCT00443690|Diuretics|diuretics|mesh-ancestor
2339927|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
2339928|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339929|NCT00443716|Estrogens|estrogens|mesh-list
2339930|NCT00443716|Hormones|hormones|mesh-ancestor
2339931|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2339932|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339933|NCT00443794|Aspirin|aspirin|mesh-list
2339934|NCT00443794|Atenolol|atenolol|mesh-list
2339935|NCT00443794|Ramipril|ramipril|mesh-list
2339936|NCT00443794|Simvastatin|simvastatin|mesh-list
2339937|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
2339938|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2339939|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339940|NCT00443794|Analgesics|analgesics|mesh-ancestor
2339941|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
2339942|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339943|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339944|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339945|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339946|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2339947|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2339948|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339949|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2339950|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2339951|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339952|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
2339953|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2339954|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2339955|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
2339956|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2339957|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2339958|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2339959|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
2926036|NCT01116648|Olaparib|olaparib|mesh-list
2926037|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2926038|NCT01116648|Cediranib|cediranib|mesh-list
2926039|NCT01116648|Maleic acid|maleic acid|mesh-list
2926040|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926041|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926042|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926043|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2926044|NCT01064648|Cisplatin|cisplatin|mesh-list
2926045|NCT01064648|Pemetrexed|pemetrexed|mesh-list
2339960|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2339961|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2339962|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
2339963|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
2926046|NCT01064648|Cediranib|cediranib|mesh-list
2926047|NCT01064648|Maleic acid|maleic acid|mesh-list
2339964|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2339965|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2339966|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2339967|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
2339968|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2339969|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2339970|NCT00443794|Diuretics|diuretics|mesh-ancestor
2339971|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
2339972|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2339973|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2339974|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
2339975|NCT00443937|Everolimus|everolimus|mesh-list
2339976|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2339977|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2926048|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926049|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926050|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926051|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2926052|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2926053|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2926054|NCT01064479|Cisplatin|cisplatin|mesh-list
2926055|NCT01064479|Carboplatin|carboplatin|mesh-list
2926056|NCT01064479|Docetaxel|docetaxel|mesh-list
2926057|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2926058|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926059|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
2926060|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
2926061|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
2926062|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926063|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2926064|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926078|NCT01042522|Paclitaxel|paclitaxel|mesh-list
2926079|NCT01042522|Etoposide|etoposide|mesh-list
2926080|NCT01042522|Cisplatin|cisplatin|mesh-list
2926081|NCT01042522|Carboplatin|carboplatin|mesh-list
2926082|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2926083|NCT01042522|Bleomycin|bleomycin|mesh-list
2926084|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
2339978|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
2339979|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339980|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2339981|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2339982|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
2339983|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2339984|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2339985|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2339986|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2339987|NCT00443950|Etanercept|etanercept|mesh-list
2926085|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2926086|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926087|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
2926088|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
2926089|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
2926090|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926091|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2926092|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2926093|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926094|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2339988|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2339989|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2339990|NCT00443950|Analgesics|analgesics|mesh-ancestor
2339991|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
2339992|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2339993|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2339994|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2339995|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2339996|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2339997|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2339998|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
2339999|NCT00443963|Esomeprazole|esomeprazole|mesh-list
2340000|NCT00443963|Ranitidine|ranitidine|mesh-list
2340001|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2340002|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2340003|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2340004|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340005|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340006|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2340007|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
2340008|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
2340009|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340010|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340011|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2340012|NCT00444015|Dasatinib|dasatinib|mesh-list
2340013|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340014|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2340015|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340016|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340017|NCT00444041|Bevacizumab|bevacizumab|mesh-list
2926105|NCT00958737|Leucovorin|leucovorin|mesh-list
2926106|NCT00958737|Fluorouracil|fluorouracil|mesh-list
2926107|NCT00958737|Capecitabine|capecitabine|mesh-list
2926108|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
2926109|NCT00958737|Calcium|calcium|mesh-list
2926110|NCT00958737|Levoleucovorin|levoleucovorin|mesh-list
2926111|NCT00958737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2926112|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926113|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
2926114|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926115|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2926116|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926117|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2926118|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
2926119|NCT00958737|Antidotes|antidotes|mesh-ancestor
2340018|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2340019|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340020|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2340021|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2340022|NCT00444041|Growth Substances|growth substances|mesh-ancestor
2340023|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340024|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
2340025|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
2340026|NCT00444093|Loperamide|loperamide|mesh-list
2340027|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2340028|NCT00444132|Clopidogrel|clopidogrel|mesh-list
2926120|NCT00958737|Protective Agents|protective agents|mesh-ancestor
2926121|NCT00958737|Vitamin B Complex|vitamin b complex|mesh-ancestor
2926122|NCT00958737|Vitamins|vitamins|mesh-ancestor
2926123|NCT00958737|Micronutrients|micronutrients|mesh-ancestor
2926132|NCT00826462|Triamcinolone|triamcinolone|mesh-list
2926133|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2340029|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2926134|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2926135|NCT00826462|Naproxen|naproxen|mesh-list
2926136|NCT00826462|Lidocaine|lidocaine|mesh-list
2926137|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2926138|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
2926139|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
2926140|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926141|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926142|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
2926143|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926144|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2926145|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2926146|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2926147|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2926148|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926149|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2926150|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
2926151|NCT00826462|Hormones|hormones|mesh-ancestor
2926152|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2926153|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2926154|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
2926155|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926156|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2926157|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2926158|NCT00826462|Analgesics|analgesics|mesh-ancestor
2926159|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2926160|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
2926161|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2340030|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2340031|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2926164|NCT00710970|Tamoxifen|tamoxifen|mesh-list
2926165|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2926166|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2926167|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
2926168|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2926169|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926170|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2926171|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926172|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2926173|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2926174|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2926175|NCT00685919|Carbidopa|carbidopa|mesh-list
2926176|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2926177|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2926178|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
2926179|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2926180|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926181|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926182|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2926183|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926184|NCT00574496|Gemcitabine|gemcitabine|mesh-list
2926185|NCT00574496|Cyclosporine|cyclosporine|mesh-list
2926186|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
2926187|NCT00574496|Prednisone|prednisone|mesh-list
2926188|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
2926189|NCT00574496|Melphalan|melphalan|mesh-list
2926190|NCT00574496|Ifosfamide|ifosfamide|mesh-list
2926191|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
2926192|NCT00574496|Methotrexate|methotrexate|mesh-list
2926193|NCT00574496|Fludarabine|fludarabine|mesh-list
2926194|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
2926195|NCT00574496|Vincristine|vincristine|mesh-list
2926196|NCT00574496|Vinorelbine|vinorelbine|mesh-list
2926197|NCT00574496|Procarbazine|procarbazine|mesh-list
2926198|NCT00574496|Cyclosporins|cyclosporins|mesh-list
2926199|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2926200|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
2926201|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926202|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2926203|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2926204|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
2926205|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926206|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926207|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2926208|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2926209|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
2926210|NCT00574496|Antiviral Agents|antiviral agents|mesh-ancestor
2926211|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2926212|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926213|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2926214|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
2926215|NCT00574496|Hormones|hormones|mesh-ancestor
2926216|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2926217|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2340032|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2340033|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
2340034|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340035|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340036|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340037|NCT00444171|Insulin|insulin|mesh-list
2340038|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2340039|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2340040|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340041|NCT00444184|Timolol|timolol|mesh-list
2340042|NCT00444184|Travoprost|travoprost|mesh-list
2340043|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2340044|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2926218|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2926219|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
2926220|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2926221|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
2926222|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2926223|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2926224|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2926225|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
2926226|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
2926227|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
2926228|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
2926229|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2926230|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2926231|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2926232|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
2926233|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2926234|NCT00344487|Ritonavir|ritonavir|mesh-list
2926235|NCT00344487|Lopinavir|lopinavir|mesh-list
2926236|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2926237|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2926238|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
2926239|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926240|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926241|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2926242|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2926243|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
2926244|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2926245|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2926246|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2926247|NCT00281658|Paclitaxel|paclitaxel|mesh-list
2926248|NCT00281658|Lapatinib|lapatinib|mesh-list
2926249|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2926250|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926251|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
2340045|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
2340046|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340047|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340048|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340049|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2340050|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2340051|NCT00444223|Fluorides|fluorides|mesh-list
2340052|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
2340053|NCT00444223|Protective Agents|protective agents|mesh-ancestor
2340054|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340055|NCT00444236|Esomeprazole|esomeprazole|mesh-list
2340056|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2340057|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2340058|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2340059|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340060|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340061|NCT00444249|Dipivefrin|dipivefrin|mesh-list
2340062|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2340063|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
2340064|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340065|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340066|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340067|NCT00444314|Sunitinib|sunitinib|mesh-list
2926252|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
2926253|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
2926254|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926255|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2926256|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340068|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340069|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2340070|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2340071|NCT00444314|Growth Substances|growth substances|mesh-ancestor
2340072|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340073|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
2340074|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2340075|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340076|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340077|NCT00444340|Etanercept|etanercept|mesh-list
2340078|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2340079|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2340080|NCT00444340|Analgesics|analgesics|mesh-ancestor
2340081|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
2340082|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340083|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340084|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2340085|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2340086|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2340087|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2340088|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
2340089|NCT00444379|Ritonavir|ritonavir|mesh-list
2340090|NCT00444379|Lopinavir|lopinavir|mesh-list
2340091|NCT00444379|Tenofovir|tenofovir|mesh-list
2340092|NCT00444379|Emtricitabine|emtricitabine|mesh-list
2340093|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2340094|NCT00444379|Efavirenz|efavirenz|mesh-list
2340095|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2926289|NCT05209620|Pemetrexed|pemetrexed|mesh-list
2926290|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926291|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340096|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2340097|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
2340098|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340099|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340100|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2340101|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2340102|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
2340103|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340104|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2340105|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2340106|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2340107|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2340108|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2340109|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2340110|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2340111|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2340112|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2340113|NCT00444418|Naltrexone|naltrexone|mesh-list
2340114|NCT00444418|Naloxone|naloxone|mesh-list
2340115|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2340116|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2340117|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340118|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
2926292|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926293|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2926294|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2340119|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340120|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
2340121|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2340122|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2340123|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340124|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
2340125|NCT00444470|Coagulants|coagulants|mesh-ancestor
2340126|NCT00444522|Alprazolam|alprazolam|mesh-list
2340127|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2340128|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2340129|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340130|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2340131|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2340132|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2340133|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
2340134|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
2340135|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340136|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340137|NCT00444548|Reboxetine|reboxetine|mesh-list
2926295|NCT05209555|Pilocarpine|pilocarpine|mesh-list
2926296|NCT05209555|Miotics|miotics|mesh-ancestor
2926297|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
2926298|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926299|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926300|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2926301|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2926302|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
2926303|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2926304|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926305|NCT05209529|Durvalumab|durvalumab|mesh-list
2926306|NCT05209529|Olaparib|olaparib|mesh-list
2926307|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2926308|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926309|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2926310|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926311|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926312|NCT05209490|Iodine|iodine|mesh-list
2340138|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
2340139|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2340140|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2340141|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2340142|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2340143|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340144|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
2340145|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340146|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340147|NCT00444561|Pramlintide|pramlintide|mesh-list
2340148|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2340149|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340150|NCT00444574|Methylphenidate|methylphenidate|mesh-list
2340151|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2340152|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340153|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2340154|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2340155|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2340156|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926313|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2926314|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2926315|NCT05209490|Trace Elements|trace elements|mesh-ancestor
2926316|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
2926317|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926318|NCT05209425|Vitamin D|vitamin d|mesh-list
2926319|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
2926320|NCT05209425|Vitamins|vitamins|mesh-ancestor
2926321|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
2926322|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926323|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2926324|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2926325|NCT05209412|Aspirin|aspirin|mesh-list
2926326|NCT05209412|Paclitaxel|paclitaxel|mesh-list
2340157|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
2340158|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340159|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
2340160|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
2340161|NCT00444613|Vitamins|vitamins|mesh-ancestor
2926327|NCT05209412|Clopidogrel|clopidogrel|mesh-list
2340162|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
2340163|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340164|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2340165|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
2340166|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2340167|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
2340168|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2340169|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340170|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2340171|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2340172|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340173|NCT00444652|Enoxaparin|enoxaparin|mesh-list
2340174|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
2340175|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2340176|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2340177|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340178|NCT00444665|Travoprost|travoprost|mesh-list
2340179|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2340180|NCT00444717|Pitavastatin|pitavastatin|mesh-list
2926328|NCT05209412|Ticagrelor|ticagrelor|mesh-list
2926329|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2340181|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2340182|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2340183|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2340184|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
2340185|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340186|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340187|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2340188|NCT00444756|Lidocaine|lidocaine|mesh-list
2340189|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
2340190|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
2340191|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926330|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926331|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
2926332|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
2926333|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
2926334|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926335|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2926336|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2926337|NCT05209412|Analgesics|analgesics|mesh-ancestor
2926338|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
2926339|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926340|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926341|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2926342|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2926343|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2926344|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2926345|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2340192|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340193|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
2340194|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340195|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2340196|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2340197|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2340198|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2340199|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340200|NCT00444808|Calcitonin|calcitonin|mesh-list
2340201|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
2340202|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2340203|NCT00444808|Katacalcin|katacalcin|mesh-list
2340204|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2340205|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340206|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2340207|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
2926346|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2926347|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926348|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
2926349|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2926350|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2926351|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2926352|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
2926353|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2926354|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
2926355|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2926356|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2926357|NCT05209308|Rituximab|rituximab|mesh-list
2926358|NCT05209308|Venetoclax|venetoclax|mesh-list
2926359|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2926360|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926361|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
2926362|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926363|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2926364|NCT05209295|Azacitidine|azacitidine|mesh-list
2926365|NCT05209295|Cc-486|cc-486|mesh-list
2926366|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2926367|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
2926368|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926369|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926370|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340208|NCT00444834|Carvedilol|carvedilol|mesh-list
2340209|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2340210|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2340211|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
2340212|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340213|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340214|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340215|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2340216|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
2340217|NCT00444834|Protective Agents|protective agents|mesh-ancestor
2340218|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2340219|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2340220|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2340221|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
2340222|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2926371|NCT05209256|Pemetrexed|pemetrexed|mesh-list
2926372|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926373|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926374|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926375|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2926376|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2340223|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2926391|NCT05209152|Azacitidine|azacitidine|mesh-list
2926392|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2926393|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
2926394|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926395|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926396|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926397|NCT05209074|Ivosidenib|ivosidenib|mesh-list
2926398|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926399|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926400|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926401|NCT05209035|Trazodone|trazodone|mesh-list
2926402|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2926403|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2926404|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926405|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926406|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2926407|NCT05209035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2926408|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2926409|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2926410|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926411|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2926412|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
2926413|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2926414|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
2926415|NCT05208983|Vaccines|vaccines|mesh-list
2926416|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
2926417|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926418|NCT05208944|Cemiplimab|cemiplimab|mesh-list
2926419|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2926420|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926421|NCT05208931|Mitogens|mitogens|mesh-list
2926422|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
2926423|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
2926424|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926425|NCT05208931|Growth Substances|growth substances|mesh-ancestor
2926426|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926427|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
2926428|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2926429|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926430|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926431|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2926432|NCT05208892|Analgesics|analgesics|mesh-ancestor
2926433|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
2926434|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926435|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2926436|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2926437|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2340224|NCT00444873|Lanreotide|lanreotide|mesh-list
2340225|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340226|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
2340227|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2340228|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2340229|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2340230|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2340231|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340232|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
2340233|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340234|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340235|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2340236|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340237|NCT00445016|Anesthetics|anesthetics|mesh-list
2340238|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2340239|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340240|NCT00445042|Sorafenib|sorafenib|mesh-list
2340241|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340242|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2340243|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340244|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340245|NCT00445055|Droperidol|droperidol|mesh-list
2340246|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2340247|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
2340248|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
2340249|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340250|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340251|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2340252|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2340253|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2340254|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2340255|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2926438|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
2926439|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2926440|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926441|NCT05208879|Carotenoids|carotenoids|mesh-list
2926442|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
2926443|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926444|NCT05208879|Protective Agents|protective agents|mesh-ancestor
2926445|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926446|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
2926447|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
2926448|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926449|NCT05208827|Vitamin D|vitamin d|mesh-list
2926450|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
2926451|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
2926452|NCT05208827|Vitamins|vitamins|mesh-list
2926453|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
2340256|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2340257|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2340258|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
2340259|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340260|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340261|NCT00445081|Cyclosporine|cyclosporine|mesh-list
2340262|NCT00445081|Prednisolone|prednisolone|mesh-list
2340263|NCT00445081|Cyclosporins|cyclosporins|mesh-list
2340264|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2340265|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
2340266|NCT00445081|Hormones|hormones|mesh-ancestor
2340267|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2340268|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340269|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2340270|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340271|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340272|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340273|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2340274|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
2340275|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
2340276|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340277|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
2340278|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2340279|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2340280|NCT00445094|Vancomycin|vancomycin|mesh-list
2340281|NCT00445094|Imipenem|imipenem|mesh-list
2340282|NCT00445094|Amikacin|amikacin|mesh-list
2340283|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2340284|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
2926454|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926455|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2926456|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2926457|NCT05208801|Morphine|morphine|mesh-list
2926458|NCT05208801|Bupivacaine|bupivacaine|mesh-list
2926459|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
2926460|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
2926461|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926462|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926463|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
2926464|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926465|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2926466|NCT05208801|Narcotics|narcotics|mesh-ancestor
2926467|NCT05208801|Analgesics|analgesics|mesh-ancestor
2926468|NCT05208710|Vaccines|vaccines|mesh-list
2926469|NCT05208710|Immunologic Factors|immunologic factors|mesh-ancestor
2926470|NCT05208710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926471|NCT05208619|Anesthetics|anesthetics|mesh-list
2926472|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926473|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926474|NCT05208398|Warfarin|warfarin|mesh-list
2926475|NCT05208398|Apixaban|apixaban|mesh-list
2926476|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
2926477|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2926478|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
2926479|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2926480|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
2926481|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926482|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926483|NCT05208333|Albendazole|albendazole|mesh-list
2926484|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
2340285|NCT00445094|Cilastatin|cilastatin|mesh-list
2340286|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2340287|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340288|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340289|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
2340290|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340291|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2340292|NCT00445107|Montelukast|montelukast|mesh-list
2340293|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2340294|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
2340295|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2340296|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
2926485|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2926486|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2926487|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
2926488|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2926489|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2926490|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
2926491|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
2340297|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2340298|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340299|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2926492|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
2926493|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926494|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926495|NCT05208307|Dexamethasone|dexamethasone|mesh-list
2926496|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
2926497|NCT05208307|Pomalidomide|pomalidomide|mesh-list
2926498|NCT05208307|Ichthammol|ichthammol|mesh-list
2926499|NCT05208307|BB 1101|bb 1101|mesh-list
2926500|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2926501|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
2926502|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
2340300|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2372165|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2926503|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926504|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926505|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2926506|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
2926507|NCT05208307|Hormones|hormones|mesh-ancestor
2926508|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2926509|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2926510|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926511|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
2926512|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926513|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111630|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111631|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111632|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
2111633|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111634|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2111635|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2111636|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
2111637|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2111638|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2111639|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2111640|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2111641|NCT02557646|Ribavirin|ribavirin|mesh-list
2111642|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2111643|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
2111644|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926514|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
2340301|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340302|NCT00445159|Treprostinil|treprostinil|mesh-list
2926515|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2926516|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2926517|NCT05208307|Growth Substances|growth substances|mesh-ancestor
2926518|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
2926519|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
2926520|NCT05208294|Sulpiride|sulpiride|mesh-list
2926521|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2926522|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2926523|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926524|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926525|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2926526|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2926527|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
2926528|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2926529|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926530|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2926531|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
2926532|NCT05208268|Rabeprazole|rabeprazole|mesh-list
2926533|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2926534|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2926535|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2340303|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2340304|NCT00445185|Vaccines|vaccines|mesh-list
2340305|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
2340306|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340307|NCT00445198|Navitoclax|navitoclax|mesh-list
2340308|NCT00445198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340309|NCT00445250|Calcipotriene|calcipotriene|mesh-list
2340310|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
2340311|NCT00445276|Diacetylrhein|diacetylrhein|mesh-list
2340312|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2340313|NCT00445406|Bevacizumab|bevacizumab|mesh-list
2340314|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2340315|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340316|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2340317|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2340318|NCT00445406|Growth Substances|growth substances|mesh-ancestor
2340319|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340320|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
2340321|NCT00445497|Amoxicillin|amoxicillin|mesh-list
2340322|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
2340323|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
2926536|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926537|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926538|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2926539|NCT05208190|Clozapine|clozapine|mesh-list
2926540|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2926541|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
2926542|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340324|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
2340325|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2340326|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2340327|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2926543|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926544|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926545|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2926546|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2926547|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926548|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2926549|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
2926550|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
2926561|NCT05208034|Methotrexate|methotrexate|mesh-list
2340328|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2340329|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2926562|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2926563|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
2926564|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2926565|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926566|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2926567|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
2926568|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926569|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926570|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
2926571|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926572|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2340330|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340331|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340332|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340333|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2340334|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2340335|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2340336|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
2340337|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2340338|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2340339|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340340|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340341|NCT00445523|Interferons|interferons|mesh-list
2926573|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2926574|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
2926575|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2926576|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2926577|NCT05207904|Paclitaxel|paclitaxel|mesh-list
2926578|NCT05207904|Carboplatin|carboplatin|mesh-list
2926579|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2926580|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926581|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
2926582|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
2926583|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
2926584|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926585|NCT05207774|Oxytocin|oxytocin|mesh-list
2926586|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
2926587|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2926588|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926589|NCT05207735|Capecitabine|capecitabine|mesh-list
2926590|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2926591|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
2926592|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926593|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926594|NCT05207722|Aldesleukin|aldesleukin|mesh-list
2926595|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
2926596|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
2926597|NCT05207722|Fludarabine|fludarabine|mesh-list
2926598|NCT05207722|Trastuzumab|trastuzumab|mesh-list
2926599|NCT05207722|Interleukin-2|interleukin-2|mesh-list
2926600|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2926601|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
2926602|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926603|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2926604|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2926605|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
2926606|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926607|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926608|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2926609|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2926610|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2926611|NCT05207722|Analgesics|analgesics|mesh-ancestor
2926612|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
2926613|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926614|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2926615|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2926616|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
2926617|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2926618|NCT05207709|Paclitaxel|paclitaxel|mesh-list
2926619|NCT05207709|Letrozole|letrozole|mesh-list
2340342|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
2340343|NCT00445523|Vaccines|vaccines|mesh-list
2340344|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340345|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
2340346|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340347|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
2340348|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340349|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
2340350|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
2340351|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2340352|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2340353|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340354|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2340355|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340356|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2340357|NCT00445796|Artesunate|artesunate|mesh-list
2340358|NCT00445796|Amodiaquine|amodiaquine|mesh-list
2340359|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
2340360|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2340361|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2340362|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340363|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340364|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
2340365|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
2340366|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2340367|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
2926620|NCT05207709|Palbociclib|palbociclib|mesh-list
2926621|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2926622|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926623|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
2926624|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
2926625|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
2926626|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926627|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2926628|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2926629|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926630|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2926631|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
2340368|NCT00445861|Docetaxel|docetaxel|mesh-list
2340369|NCT00445861|Cetuximab|cetuximab|mesh-list
2340370|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340371|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
2340372|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
2340373|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
2340374|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340375|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2340376|NCT00445874|Ketotifen|ketotifen|mesh-list
2340377|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
2340378|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
2340379|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2340380|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
2340381|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
2340382|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340383|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340384|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340385|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2340386|NCT00445900|Thalidomide|thalidomide|mesh-list
2340387|NCT00445900|Prednisone|prednisone|mesh-list
2340388|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
2340389|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2340390|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
2340391|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340392|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2340393|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2926632|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2926633|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926634|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2926635|NCT05207683|Antibodies|antibodies|mesh-list
2926636|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
2926637|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
2926638|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926639|NCT05207644|Letrozole|letrozole|mesh-list
2926640|NCT05207644|Misoprostol|misoprostol|mesh-list
2926641|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926642|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2926643|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2926644|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340394|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
2340395|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926645|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926646|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2926647|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
2926648|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2926649|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926650|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2926651|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
2926652|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2926653|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2926654|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2926655|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
2926656|NCT05207514|Ethanol|ethanol|mesh-list
2926657|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
2926658|NCT05207514|Docetaxel|docetaxel|mesh-list
2926659|NCT05207514|Doxorubicin|doxorubicin|mesh-list
2926660|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2340396|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340397|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2340398|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2340399|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
2340400|NCT00445900|Hormones|hormones|mesh-ancestor
2340401|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2340402|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2340403|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
2340404|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2340405|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340406|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2340407|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2926661|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
2926662|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926663|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2926664|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2926665|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
2926666|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926667|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926668|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2926669|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
2926670|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
2926671|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
2926672|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2926673|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2926674|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2926675|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926676|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2926677|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2926678|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926679|NCT05207436|Oxytocin|oxytocin|mesh-list
2926680|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
2926681|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2926682|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926683|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
2926684|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
2926685|NCT05207358|Rituximab|rituximab|mesh-list
2926686|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2926687|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
2926688|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926689|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2926690|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2926691|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
2926692|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926693|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926694|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2926695|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2926696|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2926697|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2926698|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
2926699|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2926700|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2926701|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926702|NCT05207280|Terlipressin|terlipressin|mesh-list
2926703|NCT05207280|Norepinephrine|norepinephrine|mesh-list
2926704|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2926705|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2926706|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2340408|NCT00445900|Growth Substances|growth substances|mesh-ancestor
2340409|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
2340410|NCT00445965|Antibodies|antibodies|mesh-list
2340411|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2340412|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
2340413|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340414|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
2340415|NCT00446004|Omeprazole|omeprazole|mesh-list
2340416|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2340417|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340418|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2340419|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340420|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340421|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2340422|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2340423|NCT00446017|Milrinone|milrinone|mesh-list
2340424|NCT00446017|Epinephrine|epinephrine|mesh-list
2926707|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2926708|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
2926709|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2926710|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926711|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926712|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
2926713|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
2926714|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926715|NCT05207137|Vaccines|vaccines|mesh-list
2926716|NCT05207137|Immunologic Factors|immunologic factors|mesh-ancestor
2926717|NCT05207137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926718|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
2926719|NCT05203445|Olaparib|olaparib|mesh-list
2926720|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2926721|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926722|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2926723|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926724|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926725|NCT05199753|Antibodies|antibodies|mesh-list
2926726|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
2926727|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926728|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
2340425|NCT00446017|Racepinephrine|racepinephrine|mesh-list
2340426|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
2340427|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2340428|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2340429|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
2340430|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340431|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926729|NCT05187338|Ipilimumab|ipilimumab|mesh-list
2926730|NCT05187338|Durvalumab|durvalumab|mesh-list
2926731|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2926732|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340432|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340433|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2340434|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2340435|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
2340436|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340437|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2340438|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
2340439|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
2340440|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
2340441|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2340442|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2340443|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2926733|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2926734|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926735|NCT05187208|Niraparib|niraparib|mesh-list
2926736|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2926737|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926738|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926739|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926740|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
2926741|NCT05186467|Analgesics|analgesics|mesh-ancestor
2926742|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
2926743|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926744|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926745|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
2926746|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926747|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2926748|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
2926749|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2926750|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2926751|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926752|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2926753|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
2926754|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2926762|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
2926763|NCT05185739|Lenvatinib|lenvatinib|mesh-list
2926764|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2926765|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926766|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2926767|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926768|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926769|NCT05185024|Iron|iron|mesh-list
2340444|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
2340445|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2340446|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2340447|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340448|NCT00446017|Protective Agents|protective agents|mesh-ancestor
2340449|NCT00446043|Adapalene|adapalene|mesh-list
2340450|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
2340451|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2340452|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
2340453|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2340454|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2340455|NCT00446043|Analgesics|analgesics|mesh-ancestor
2340456|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
2340457|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340458|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340459|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2340460|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2340461|NCT00446056|Ketotifen|ketotifen|mesh-list
2340462|NCT00446056|Montelukast|montelukast|mesh-list
2340463|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340464|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340465|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340466|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
2340467|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2340468|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2926770|NCT05185024|Trace Elements|trace elements|mesh-ancestor
2926771|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
2926772|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926773|NCT05184777|Estradiol|estradiol|mesh-list
2926774|NCT05184777|Progesterone|progesterone|mesh-list
2926775|NCT05184777|Estrogens|estrogens|mesh-ancestor
2926776|NCT05184777|Hormones|hormones|mesh-ancestor
2926777|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2926778|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926779|NCT05184777|Progestins|progestins|mesh-ancestor
2926780|NCT05184335|RP5063|rp5063|mesh-list
2926781|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2926782|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2926783|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926784|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926785|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2926786|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
2926787|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2926788|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926789|NCT05182892|Dopamine|dopamine|mesh-list
2926790|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
2926791|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2926792|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
2926793|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
2340469|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
2340470|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2340471|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2926794|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926795|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926796|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
2926797|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2926798|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926799|NCT05182892|Protective Agents|protective agents|mesh-ancestor
2926800|NCT05182840|Empagliflozin|empagliflozin|mesh-list
2926801|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2926802|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926803|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2926804|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926805|NCT05180097|Gemcitabine|gemcitabine|mesh-list
2926806|NCT05180097|Dexamethasone|dexamethasone|mesh-list
2926807|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
2926808|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2926809|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926810|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2926811|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
2926812|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
2926813|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926814|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926815|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2926816|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
2926817|NCT05180097|Hormones|hormones|mesh-ancestor
2926818|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2926819|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2926820|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2926821|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
2926822|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926823|NCT05180097|Antiviral Agents|antiviral agents|mesh-ancestor
2926824|NCT05180097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2926825|NCT05180097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926826|NCT05180097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2926827|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
2926828|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2926829|NCT05171673|Diclofenac|diclofenac|mesh-list
2926830|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
2926831|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2926832|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2926833|NCT05171673|Analgesics|analgesics|mesh-ancestor
2926834|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
2926835|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926836|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926837|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2926838|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2340472|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2340473|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
2340474|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
2340475|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2340476|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
2340477|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
2340478|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2340479|NCT00446069|Morphine|morphine|mesh-list
2340480|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2340481|NCT00446069|Narcotics|narcotics|mesh-ancestor
2340482|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2340483|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340484|NCT00446069|Analgesics|analgesics|mesh-ancestor
2340485|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
2340486|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340487|NCT00446082|Pasireotide|pasireotide|mesh-list
2340488|NCT00446082|Hormones|hormones|mesh-ancestor
2340489|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2340490|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340491|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
2340492|NCT00446173|Busulfan|busulfan|mesh-list
2340493|NCT00446173|Sargramostim|sargramostim|mesh-list
2340494|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2340495|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
2340496|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340497|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2340498|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2340499|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
2340500|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926839|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2926840|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926841|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926850|NCT05167487|Cisplatin|cisplatin|mesh-list
2926851|NCT05167487|Carboplatin|carboplatin|mesh-list
2926852|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926853|NCT05166239|Lenvatinib|lenvatinib|mesh-list
2926854|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926855|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2340501|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340502|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2340503|NCT00446186|Montelukast|montelukast|mesh-list
2340504|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340505|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340506|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
2340507|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2340508|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2340509|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
2340510|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2340511|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2340512|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2340513|NCT00446212|Propofol|propofol|mesh-list
2340514|NCT00446212|Desflurane|desflurane|mesh-list
2340515|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2340516|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2340517|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340518|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2340519|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
2926856|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926857|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926858|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
2926859|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2926860|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926869|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
2926870|NCT05149287|Lidocaine|lidocaine|mesh-list
2926871|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
2926872|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
2926873|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926874|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926875|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
2926876|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926877|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2926878|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2926879|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2926880|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2926881|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926882|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2926883|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2926890|NCT05122130|Melatonin|melatonin|mesh-list
2926891|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
2926892|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111645|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
2111646|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2111647|NCT02558231|Selexipag|selexipag|mesh-list
2111648|NCT02558231|Tadalafil|tadalafil|mesh-list
2926893|NCT05122130|Protective Agents|protective agents|mesh-ancestor
2926894|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926895|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926896|NCT05119166|Niacinamide|niacinamide|mesh-list
2926897|NCT05119166|Azithromycin|azithromycin|mesh-list
2926898|NCT05119166|Vitamins|vitamins|mesh-ancestor
2926899|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
2926900|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926901|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2926902|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2926903|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
2926904|NCT05112848|Vaccines|vaccines|mesh-list
2340520|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
2340521|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2340522|NCT00446225|Gemcitabine|gemcitabine|mesh-list
2340523|NCT00446225|Carboplatin|carboplatin|mesh-list
2340524|NCT00446225|Docetaxel|docetaxel|mesh-list
2340525|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2340526|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340527|NCT00446225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2340528|NCT00446225|Antimetabolites|antimetabolites|mesh-ancestor
2340529|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340530|NCT00446225|Antiviral Agents|antiviral agents|mesh-ancestor
2340531|NCT00446225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340532|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340533|NCT00446225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2926905|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
2926906|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926919|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
2926920|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2926921|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926922|NCT05096325|Insulin|insulin|mesh-list
2926923|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2926924|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926925|NCT05094128|Upadacitinib|upadacitinib|mesh-list
2926926|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2926927|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2926928|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926929|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926930|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2926931|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
2926932|NCT05087381|Niclosamide|niclosamide|mesh-list
2926933|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
2926934|NCT05087381|Bromhexine|bromhexine|mesh-list
2926935|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2926936|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926937|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2926938|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2926939|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926940|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926941|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2926942|NCT05087381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2926943|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2926944|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2926945|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2926946|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
2926947|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2926948|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
2926949|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2111649|NCT02558231|Macitentan|macitentan|mesh-list
2111650|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
2340534|NCT00446225|Immunologic Factors|immunologic factors|mesh-ancestor
2340535|NCT00446225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340536|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
2340537|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
2340538|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
2340539|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2340540|NCT00446303|Azacitidine|azacitidine|mesh-list
2340541|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2926950|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2926951|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2926952|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
2926953|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2926954|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
2926955|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2926956|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2926957|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
2926958|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
2926959|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
2926960|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2926961|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2926962|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
2926963|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
2926964|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2926965|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2926966|NCT05087381|Expectorants|expectorants|mesh-ancestor
2926967|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
2926968|NCT05086250|Ketamine|ketamine|mesh-list
2926969|NCT05086250|Analgesics|analgesics|mesh-ancestor
2926970|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
2926971|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2926972|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926973|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2926974|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2926975|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
2926976|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
2340542|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
2340543|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340544|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340545|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340546|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
2340547|NCT00446316|Antacids|antacids|mesh-list
2340548|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340549|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2340550|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340551|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340552|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2340553|NCT00446329|Cinacalcet|cinacalcet|mesh-list
2340554|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2340555|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340556|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2340557|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
2340558|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2340559|NCT00446368|Everolimus|everolimus|mesh-list
2340560|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340561|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2340562|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
2340563|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340564|NCT00446420|Fentanyl|fentanyl|mesh-list
2340565|NCT00446420|Midazolam|midazolam|mesh-list
2340566|NCT00446420|Propofol|propofol|mesh-list
2926977|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926978|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2926979|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2926980|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2926981|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2926982|NCT05082688|Vaccines|vaccines|mesh-list
2926983|NCT05082688|Immunologic Factors|immunologic factors|mesh-ancestor
2926984|NCT05082688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926985|NCT05081206|Propofol|propofol|mesh-list
2340567|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2926986|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2926987|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2926988|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2926989|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2926990|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
2926991|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
2926992|NCT05079360|Everolimus|everolimus|mesh-list
2926993|NCT05079360|Exemestane|exemestane|mesh-list
2926994|NCT05079360|Estrogens|estrogens|mesh-list
2926995|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
2926996|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
2926997|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2926998|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2926999|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
2927000|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927001|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2927002|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2927003|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927004|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927005|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2927006|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
2927007|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2927008|NCT05079360|Hormones|hormones|mesh-ancestor
2927009|NCT05077969|Celecoxib|celecoxib|mesh-list
2927010|NCT05077969|Famotidine|famotidine|mesh-list
2340568|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2340569|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340570|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2340571|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
2340572|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
2927011|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2927012|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2927013|NCT05077969|Analgesics|analgesics|mesh-ancestor
2340573|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2340574|NCT00446420|Narcotics|narcotics|mesh-ancestor
2340575|NCT00446420|Analgesics|analgesics|mesh-ancestor
2340576|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
2340577|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340578|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2340579|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2340580|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2340581|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2340582|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
2340583|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
2340584|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340585|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340586|NCT00446433|Lenalidomide|lenalidomide|mesh-list
2340587|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
2340588|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340589|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2340590|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2340591|NCT00446433|Growth Substances|growth substances|mesh-ancestor
2340592|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
2340593|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340594|NCT00446472|Becaplermin|becaplermin|mesh-list
2340595|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
2340596|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2340597|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2340598|NCT00446472|Growth Substances|growth substances|mesh-ancestor
2340599|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340600|NCT00446524|Amlodipine|amlodipine|mesh-list
2340601|NCT00446524|Valsartan|valsartan|mesh-list
2340602|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2340603|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2340604|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2927014|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
2927015|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927016|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927017|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2927018|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2927019|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2927020|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2927021|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927022|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340605|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340606|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2340607|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340608|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
2927023|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2927024|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2927025|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2927026|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
2340609|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2340610|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2340611|NCT00446537|Methylphenidate|methylphenidate|mesh-list
2340612|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2340613|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340614|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2340615|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2340616|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2927027|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
2927028|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2927029|NCT05071053|Ramucirumab|ramucirumab|mesh-list
2927030|NCT05071053|Maytansine|maytansine|mesh-list
2927031|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927032|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2927033|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
2927034|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
2927035|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
2927036|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927037|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
2927038|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927039|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927040|NCT05062577|Buprenorphine|buprenorphine|mesh-list
2927041|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2927042|NCT05062577|Naloxone|naloxone|mesh-list
2927043|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2927044|NCT05062577|Narcotics|narcotics|mesh-ancestor
2927045|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2927046|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927047|NCT05062577|Analgesics|analgesics|mesh-ancestor
2927048|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
2927049|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927050|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2927051|NCT05056727|Valsartan|valsartan|mesh-list
2927052|NCT05056727|Lisinopril|lisinopril|mesh-list
2927053|NCT05056727|Irbesartan|irbesartan|mesh-list
2927054|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2927055|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2927056|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2927057|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927058|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2340617|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340618|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
2340619|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340620|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
2340621|NCT00446576|Hematinics|hematinics|mesh-ancestor
2340622|NCT00446589|Teriparatide|teriparatide|mesh-list
2340623|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
2340624|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2340625|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340626|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2927059|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
2927060|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927061|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2927062|NCT05056727|Protective Agents|protective agents|mesh-ancestor
2927063|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927064|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
2927065|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2927066|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2927067|NCT05055050|Imiquimod|imiquimod|mesh-list
2927068|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2927069|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
2927070|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927071|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927072|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
2927078|NCT05047939|Propofol|propofol|mesh-list
2927079|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2927080|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2927081|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927082|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2927083|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
2340627|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
2340628|NCT00446602|Hematinics|hematinics|mesh-ancestor
2340629|NCT00446667|Mannitol|mannitol|mesh-list
2340630|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2340631|NCT00446667|Diuretics|diuretics|mesh-ancestor
2340632|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
2340633|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340634|NCT00446680|Mannitol|mannitol|mesh-list
2340635|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2340636|NCT00446680|Diuretics|diuretics|mesh-ancestor
2340637|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
2340638|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340639|NCT00446771|Mannitol|mannitol|mesh-list
2340640|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2340641|NCT00446771|Diuretics|diuretics|mesh-ancestor
2340642|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
2340643|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340644|NCT00446784|Methotrexate|methotrexate|mesh-list
2340645|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2340646|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
2340647|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2927084|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
2927085|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
2927086|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2927087|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2927088|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340648|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340649|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2340650|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
2340651|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340652|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340653|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
2340654|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340655|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2340656|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2340657|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
2340658|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2340659|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2340660|NCT00446810|Benphothiamine|benphothiamine|mesh-list
2340661|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2340662|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
2340663|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340664|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
2340665|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
2340666|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340667|NCT00446836|Paclitaxel|paclitaxel|mesh-list
2340668|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2340669|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2340670|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340671|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
2340672|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
2340673|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
2340674|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340675|NCT00446862|Losartan|losartan|mesh-list
2340676|NCT00446862|Enalapril|enalapril|mesh-list
2340677|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2340678|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2340679|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2340680|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2340681|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2340682|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2340683|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340684|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
2340685|NCT00446901|Selenium|selenium|mesh-list
2340686|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
2340687|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927137|NCT05022329|Vaccines|vaccines|mesh-list
2927138|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
2927139|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927140|NCT05012254|Paclitaxel|paclitaxel|mesh-list
2927141|NCT05012254|Cisplatin|cisplatin|mesh-list
2927142|NCT05012254|Carboplatin|carboplatin|mesh-list
2340688|NCT00446901|Protective Agents|protective agents|mesh-ancestor
2340689|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340690|NCT00446901|Trace Elements|trace elements|mesh-ancestor
2927143|NCT05012254|Nivolumab|nivolumab|mesh-list
2927144|NCT05012254|Pemetrexed|pemetrexed|mesh-list
2927145|NCT05012254|Ipilimumab|ipilimumab|mesh-list
2927146|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2927147|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927148|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
2927149|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
2927150|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
2927151|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927152|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2927153|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2927154|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927155|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2927156|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2927160|NCT05009069|Fluorouracil|fluorouracil|mesh-list
2927161|NCT05009069|Capecitabine|capecitabine|mesh-list
2340691|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
2340692|NCT00446940|Atorvastatin|atorvastatin|mesh-list
2340693|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2340694|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2340695|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2340696|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
2340697|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340698|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2340699|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2927162|NCT05009069|Atezolizumab|atezolizumab|mesh-list
2111651|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2111652|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2111653|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111654|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111655|NCT02558231|Urological Agents|urological agents|mesh-ancestor
2340700|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927163|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
2927164|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927165|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2927166|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927167|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2927168|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
2927169|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927170|NCT05005273|Nivolumab|nivolumab|mesh-list
2927171|NCT05005273|Ipilimumab|ipilimumab|mesh-list
2927172|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2927173|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927174|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2927175|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927176|NCT05003245|Ranibizumab|ranibizumab|mesh-list
2927177|NCT05003245|Antibodies|antibodies|mesh-list
2927178|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2927179|NCT05003245|Mitogens|mitogens|mesh-list
2927180|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
2927181|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
2927182|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927183|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
2927184|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927185|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2927186|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2927187|NCT05003245|Growth Substances|growth substances|mesh-ancestor
2927188|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
2927189|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927190|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2927191|NCT04997811|Valproic Acid|valproic acid|mesh-list
2927192|NCT04997811|Bezafibrate|bezafibrate|mesh-list
2927193|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
2927194|NCT04997811|Danazol|danazol|mesh-list
2927195|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
2927196|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927197|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927198|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
2927199|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2927200|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927201|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
2927202|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2927203|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2927204|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2927205|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2927206|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2927207|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2927208|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
2927209|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2927210|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2927211|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2927212|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2927213|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2927214|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927215|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2340701|NCT00446953|Betamethasone|betamethasone|mesh-list
2340702|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2340703|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
2340704|NCT00446953|Hormones|hormones|mesh-ancestor
2340705|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2340706|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340707|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2340708|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
2340709|NCT00446979|UC-781|uc-781|mesh-list
2927216|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
2927217|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2927218|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2927219|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
2927220|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2927221|NCT04987099|Choline|choline|mesh-list
2927222|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
2927223|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2927224|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
2927225|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927226|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2927227|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2927228|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
2927229|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2927230|NCT04973800|Simvastatin|simvastatin|mesh-list
2927231|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2340710|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2340711|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
2340712|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340713|NCT00447018|Mannitol|mannitol|mesh-list
2340714|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2340715|NCT00447018|Diuretics|diuretics|mesh-ancestor
2340716|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
2340717|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340718|NCT00447031|Triamcinolone|triamcinolone|mesh-list
2927232|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2927233|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
2927234|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927235|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2927236|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2927237|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927238|NCT04973254|Rilpivirine|rilpivirine|mesh-list
2927239|NCT04973254|Cabotegravir|cabotegravir|mesh-list
2927240|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2927241|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2927242|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927243|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927244|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
2927245|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2927246|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2927247|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2927248|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2927249|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2927250|NCT04972253|Infigratinib|infigratinib|mesh-list
2927251|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927252|NCT04947059|Gemcitabine|gemcitabine|mesh-list
2927253|NCT04947059|Epirubicin|epirubicin|mesh-list
2927254|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2927255|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
2927256|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927257|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927258|NCT04947059|Antiviral Agents|antiviral agents|mesh-ancestor
2927259|NCT04947059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2927260|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927261|NCT04947059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2927262|NCT04947059|Immunologic Factors|immunologic factors|mesh-ancestor
2927263|NCT04947059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927264|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2927265|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2927266|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2927267|NCT04941716|Venetoclax|venetoclax|mesh-list
2927268|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
2927269|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927270|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
2927271|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2927272|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111656|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2111657|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2111658|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2111659|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2111660|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
2111661|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2111662|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111663|NCT02558374|Timolol|timolol|mesh-list
2111664|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2111665|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2111666|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2111667|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2111668|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
2111669|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111670|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111671|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111672|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2111673|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2111674|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2111675|NCT02558400|Latanoprost|latanoprost|mesh-list
2111676|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2111677|NCT02558829|Insulin|insulin|mesh-list
2111678|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2111679|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2111680|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111681|NCT02558894|Durvalumab|durvalumab|mesh-list
2111682|NCT02558894|Tremelimumab|tremelimumab|mesh-list
2111683|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2111684|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2927322|NCT04921735|Cisatracurium|cisatracurium|mesh-list
2927323|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2927324|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2927325|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927326|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111685|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927335|NCT04913220|Cemiplimab|cemiplimab|mesh-list
2927336|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2927337|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927338|NCT04912427|Dexamethasone|dexamethasone|mesh-list
2927339|NCT04912427|Bortezomib|bortezomib|mesh-list
2927340|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2927341|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
2927342|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
2927343|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927344|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927345|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2927346|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
2927347|NCT04912427|Hormones|hormones|mesh-ancestor
2927348|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2927349|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2927350|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340719|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2340720|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2340721|NCT00447031|Bevacizumab|bevacizumab|mesh-list
2340722|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2340723|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2340724|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340725|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2340726|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2340727|NCT00447031|Growth Substances|growth substances|mesh-ancestor
2340728|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340729|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
2340730|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2340731|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
2340732|NCT00447031|Hormones|hormones|mesh-ancestor
2340733|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2340734|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2340735|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
2340736|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340737|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340738|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2340739|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2340740|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2340741|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
2340742|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340743|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340744|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2340745|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2340746|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
2340747|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340748|NCT00447213|Insulin|insulin|mesh-list
2340749|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2340750|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
2340751|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2340752|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340753|NCT00447239|Insulin|insulin|mesh-list
2340754|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2340755|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340756|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
2340757|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2340758|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340759|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2340760|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2340761|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340762|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340763|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340764|NCT00447356|Interferons|interferons|mesh-list
2340765|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
2340766|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340767|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
2340768|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340769|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
2340770|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340771|NCT00447369|Pregabalin|pregabalin|mesh-list
2340772|NCT00447369|Valproic Acid|valproic acid|mesh-list
2340773|NCT00447369|Analgesics|analgesics|mesh-ancestor
2340774|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
2340775|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340776|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340777|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
2340778|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2340779|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2340780|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340781|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2340782|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2340783|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2340784|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2340785|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2340786|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340787|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
2340788|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340789|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
2340790|NCT00447473|Ketoconazole|ketoconazole|mesh-list
2340791|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
2340792|NCT00447473|Analgesics|analgesics|mesh-ancestor
2340793|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
2340794|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340795|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340796|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340797|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2340798|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2340799|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340800|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340801|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
2340802|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340803|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2340804|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2340805|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2340806|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
2340807|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2340808|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2340809|NCT00447564|Buprenorphine|buprenorphine|mesh-list
2340810|NCT00447564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2340811|NCT00447564|Narcotics|narcotics|mesh-ancestor
2340812|NCT00447564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2340813|NCT00447564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340814|NCT00447564|Analgesics|analgesics|mesh-ancestor
2340815|NCT00447564|Sensory System Agents|sensory system agents|mesh-ancestor
2340816|NCT00447564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340817|NCT00447564|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2340818|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2340819|NCT00447577|Tobramycin|tobramycin|mesh-list
2340820|NCT00447577|Dexamethasone|dexamethasone|mesh-list
2340821|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2340822|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
2340823|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
2340824|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340825|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340826|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2340827|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
2340828|NCT00447577|Hormones|hormones|mesh-ancestor
2340829|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2340830|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2340831|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340832|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2340833|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340834|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2340835|NCT00447681|Fezakinumab|fezakinumab|mesh-list
2340836|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
2340837|NCT00447759|Ibuprofen|ibuprofen|mesh-list
2340838|NCT00447759|Celecoxib|celecoxib|mesh-list
2340839|NCT00447759|Diclofenac|diclofenac|mesh-list
2340840|NCT00447759|Naproxen|naproxen|mesh-list
2340841|NCT00447759|Meloxicam|meloxicam|mesh-list
2340842|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2340843|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2340844|NCT00447759|Analgesics|analgesics|mesh-ancestor
2340845|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
2340846|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340847|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340848|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2340849|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2340850|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2340851|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340852|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927371|NCT04908475|Apremilast|apremilast|mesh-list
2927372|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2927373|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2927374|NCT04908475|Analgesics|analgesics|mesh-ancestor
2927375|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
2927376|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927377|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927378|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2927379|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2927380|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2927381|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2927382|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927383|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927409|NCT04895410|Dexamethasone|dexamethasone|mesh-list
2927410|NCT04895410|Daratumumab|daratumumab|mesh-list
2927411|NCT04895410|Pomalidomide|pomalidomide|mesh-list
2927412|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2927413|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
2927414|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
2927415|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927416|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340853|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2340854|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
2927417|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2927418|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
2927419|NCT04895410|Hormones|hormones|mesh-ancestor
2927420|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2927421|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2927422|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927423|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
2340855|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
2340856|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2340857|NCT00447863|Estradiol|estradiol|mesh-list
2340858|NCT00447863|Estrogens|estrogens|mesh-ancestor
2340859|NCT00447863|Hormones|hormones|mesh-ancestor
2340860|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2340861|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340862|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2340863|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
2340864|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2340865|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2340866|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2340867|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2340868|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2340869|NCT00447915|Vitamin D|vitamin d|mesh-list
2340870|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
2340871|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
2340872|NCT00447915|Calcium|calcium|mesh-list
2340873|NCT00447915|Vitamins|vitamins|mesh-ancestor
2340874|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
2340875|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340876|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2340877|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2340878|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
2340879|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
2340880|NCT00447967|Leucovorin|leucovorin|mesh-list
2340881|NCT00447967|Fluorouracil|fluorouracil|mesh-list
2340882|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
2340883|NCT00447967|Irinotecan|irinotecan|mesh-list
2340884|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
2340885|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340886|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2340887|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340888|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2340889|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
2340890|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340891|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2340892|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2340893|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340894|NCT00447967|Antidotes|antidotes|mesh-ancestor
2340895|NCT00447967|Protective Agents|protective agents|mesh-ancestor
2340896|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
2340897|NCT00447967|Vitamins|vitamins|mesh-ancestor
2340898|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
2340899|NCT00448058|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2340900|NCT00448058|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2340901|NCT00448058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2340902|NCT00448058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2340903|NCT00448058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340904|NCT00448058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2927424|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2927425|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2927426|NCT04895410|Growth Substances|growth substances|mesh-ancestor
2927427|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
2927428|NCT04892446|Dexamethasone|dexamethasone|mesh-list
2927429|NCT04892446|Bortezomib|bortezomib|mesh-list
2927430|NCT04892446|Daratumumab|daratumumab|mesh-list
2927431|NCT04892446|Pomalidomide|pomalidomide|mesh-list
2927432|NCT04892446|Magrolimab|magrolimab|mesh-list
2927433|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2927434|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
2927435|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
2927436|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927437|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927438|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2927439|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
2927440|NCT04892446|Hormones|hormones|mesh-ancestor
2927441|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2927442|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2927443|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927444|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
2927445|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2927446|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2927447|NCT04892446|Growth Substances|growth substances|mesh-ancestor
2927448|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
2927449|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2340905|NCT00448058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927460|NCT04883281|Paclitaxel|paclitaxel|mesh-list
2927461|NCT04883281|Carboplatin|carboplatin|mesh-list
2927462|NCT04883281|Cetuximab|cetuximab|mesh-list
2927463|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2927464|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927465|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
2927466|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
2927467|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
2927468|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927469|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2927470|NCT04879368|Trifluridine|trifluridine|mesh-list
2927471|NCT04879368|Paclitaxel|paclitaxel|mesh-list
2927472|NCT04879368|Docetaxel|docetaxel|mesh-list
2927473|NCT04879368|Nivolumab|nivolumab|mesh-list
2927474|NCT04879368|Irinotecan|irinotecan|mesh-list
2927475|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2927476|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927477|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
2927478|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
2927479|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
2927480|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927481|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2340906|NCT00448058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2340907|NCT00448058|Antidepressive Agents|antidepressive agents|mesh-ancestor
2340908|NCT00448058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2340909|NCT00448097|Docetaxel|docetaxel|mesh-list
2340910|NCT00448097|Cetuximab|cetuximab|mesh-list
2340911|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340912|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
2340913|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
2927482|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2927483|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2927484|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2927485|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927486|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
2927487|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
2927488|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2927489|NCT04877990|BMS-986165|bms-986165|mesh-list
2340914|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
2340915|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340916|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2340917|NCT00448110|Diclofenac|diclofenac|mesh-list
2340918|NCT00448110|Ketorolac|ketorolac|mesh-list
2340919|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2340920|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2340921|NCT00448110|Analgesics|analgesics|mesh-ancestor
2340922|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
2340923|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2340924|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340925|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2340926|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2340927|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2340928|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340929|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340930|NCT00448149|Everolimus|everolimus|mesh-list
2340931|NCT00448149|Sorafenib|sorafenib|mesh-list
2340932|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340933|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2927490|NCT04877990|Dermatologic Agents|dermatologic agents|mesh-ancestor
2927491|NCT04877990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2927492|NCT04877990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927493|NCT04877990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927494|NCT04870112|Carboplatin|carboplatin|mesh-list
2927495|NCT04870112|Etoposide|etoposide|mesh-list
2927496|NCT04870112|Durvalumab|durvalumab|mesh-list
2927497|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340934|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
2927498|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2927499|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2927500|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2927501|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927502|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927503|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2340935|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340936|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2340937|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340938|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340939|NCT00448214|Warfarin|warfarin|mesh-list
2340940|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
2340941|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2927504|NCT04860830|BI 425809|bi 425809|mesh-list
2927505|NCT04860830|Nootropic Agents|nootropic agents|mesh-ancestor
2927506|NCT04854499|Carboplatin|carboplatin|mesh-list
2340942|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340943|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2340944|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340945|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340946|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
2340947|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
2340948|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340949|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
2340950|NCT00448266|Thiotepa|thiotepa|mesh-list
2340951|NCT00448266|Carboplatin|carboplatin|mesh-list
2340952|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2340953|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
2340954|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340955|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2340956|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2340957|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
2340958|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340959|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340960|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2340961|NCT00448292|Naluzotan|naluzotan|mesh-list
2340962|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2340963|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2340964|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
2340965|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2340966|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340967|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340968|NCT00448305|Paclitaxel|paclitaxel|mesh-list
2340969|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2340970|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2340971|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340972|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
2927507|NCT04854499|Docetaxel|docetaxel|mesh-list
2927508|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
2927509|NCT04854499|Magrolimab|magrolimab|mesh-list
2927510|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927511|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
2927512|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
2927513|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
2927514|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927515|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2927516|NCT04825275|Posaconazole|posaconazole|mesh-list
2927517|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
2340973|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
2340974|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
2340975|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340976|NCT00448383|Adalimumab|adalimumab|mesh-list
2340977|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2340978|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2340979|NCT00448396|Epothilone B|epothilone b|mesh-list
2927518|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2927519|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2927520|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2927521|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2927522|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2927523|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2927524|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927525|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927526|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2927527|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
2927528|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2927529|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340980|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340981|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
2340982|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
2340983|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
2340984|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340985|NCT00448409|Sargramostim|sargramostim|mesh-list
2340986|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
2340987|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2340988|NCT00448422|Prulifloxacin|prulifloxacin|mesh-list
2927535|NCT04808245|Atezolizumab|atezolizumab|mesh-list
2927536|NCT04808245|Imiquimod|imiquimod|mesh-list
2927537|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927538|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2927539|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
2927540|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927541|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
2927542|NCT04791553|Cenobamate|cenobamate|mesh-list
2927543|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
2927544|NCT04786964|Folic Acid|folic acid|mesh-list
2927545|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
2927546|NCT04786964|Hydroxocobalamin|hydroxocobalamin|mesh-list
2927547|NCT04786964|Dexamethasone|dexamethasone|mesh-list
2927548|NCT04786964|Carboplatin|carboplatin|mesh-list
2927549|NCT04786964|Pemetrexed|pemetrexed|mesh-list
2927550|NCT04786964|Vitamins|vitamins|mesh-ancestor
2927551|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
2340989|NCT00448422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2340990|NCT00448422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2340991|NCT00448422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2340992|NCT00448422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2340993|NCT00448422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2340994|NCT00448422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2340995|NCT00448422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2340996|NCT00448461|Heparin|heparin|mesh-list
2927552|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927553|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927554|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2927555|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
2927556|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
2927557|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927558|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2927559|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
2927560|NCT04786964|Hormones|hormones|mesh-ancestor
2927561|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2927562|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2340997|NCT00448461|Bivalirudin|bivalirudin|mesh-list
2340998|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
2340999|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2341000|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2341001|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341002|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
2341003|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2341004|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
2341005|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341006|NCT00448552|Capecitabine|capecitabine|mesh-list
2341007|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
2341008|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2341009|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
2341010|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341011|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341012|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2341013|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
2341014|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2341015|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2341016|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2341017|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2341018|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341019|NCT00448643|Cisplatin|cisplatin|mesh-list
2927563|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927564|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341020|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341021|NCT00448734|Docetaxel|docetaxel|mesh-list
2341022|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341023|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
2341024|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
2341025|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
2341026|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341027|NCT00448786|Niacinamide|niacinamide|mesh-list
2341028|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
2341029|NCT00448786|Imetelstat|imetelstat|mesh-list
2341030|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2341031|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341032|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341033|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
2341034|NCT00448786|Vitamins|vitamins|mesh-ancestor
2341035|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
2341036|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341037|NCT00448825|Topiramate|topiramate|mesh-list
2341038|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
2341039|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2341040|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341041|NCT00448838|Gemcitabine|gemcitabine|mesh-list
2341042|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
2341043|NCT00448838|Cetuximab|cetuximab|mesh-list
2341044|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2341045|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
2927565|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2927566|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2927567|NCT04786964|Hematinics|hematinics|mesh-ancestor
2927568|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
2927569|NCT04784559|Remdesivir|remdesivir|mesh-list
2927570|NCT04784559|Favipiravir|favipiravir|mesh-list
2927571|NCT04784559|Dexamethasone|dexamethasone|mesh-list
2927572|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2927573|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
2927574|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
2927575|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927576|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927577|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2927578|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
2927579|NCT04784559|Hormones|hormones|mesh-ancestor
2927580|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341046|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341047|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341048|NCT00448838|Antiviral Agents|antiviral agents|mesh-ancestor
2341049|NCT00448838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341050|NCT00448838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927581|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2927582|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927583|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
2927584|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927585|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
2927586|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2927587|NCT04776447|Carboplatin|carboplatin|mesh-list
2927588|NCT04776447|Atezolizumab|atezolizumab|mesh-list
2927589|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341051|NCT00448838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2341052|NCT00448838|Immunologic Factors|immunologic factors|mesh-ancestor
2341053|NCT00448838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341054|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2341055|NCT00448903|Bemiparin|bemiparin|mesh-list
2341056|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
2341057|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
2341058|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2341059|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341060|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
2341061|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
2341062|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2341063|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341064|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
2341065|NCT00449020|Carboplatin|carboplatin|mesh-list
2341066|NCT00449020|Docetaxel|docetaxel|mesh-list
2341067|NCT00449020|Irinotecan|irinotecan|mesh-list
2341068|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341069|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
2341070|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
2341071|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
2341072|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341073|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2341074|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2341075|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341076|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
2341077|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
2341078|NCT00449111|Losartan|losartan|mesh-list
2341079|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2341080|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2341081|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2341082|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2341083|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341084|NCT00449137|Leucovorin|leucovorin|mesh-list
2341085|NCT00449137|Fluorouracil|fluorouracil|mesh-list
2341086|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
2341087|NCT00449137|Calcium|calcium|mesh-list
2341088|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
2341089|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2341090|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341091|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
2341092|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341093|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2341094|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341095|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2341096|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
2341097|NCT00449137|Antidotes|antidotes|mesh-ancestor
2341098|NCT00449137|Protective Agents|protective agents|mesh-ancestor
2341099|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
2341100|NCT00449137|Vitamins|vitamins|mesh-ancestor
2341101|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
2341102|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
2341103|NCT00449202|Estrone|estrone|mesh-list
2341104|NCT00449202|Estrogens|estrogens|mesh-ancestor
2341105|NCT00449202|Hormones|hormones|mesh-ancestor
2341106|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341107|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341108|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2341109|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
2341110|NCT00449254|Estrone|estrone|mesh-list
2341111|NCT00449254|Estrogens|estrogens|mesh-ancestor
2341112|NCT00449254|Hormones|hormones|mesh-ancestor
2341113|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341114|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341115|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2341116|NCT00449280|Sirolimus|sirolimus|mesh-list
2341117|NCT00449280|Sorafenib|sorafenib|mesh-list
2341118|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341119|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2341120|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341121|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341122|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2341123|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341124|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2341125|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
2341126|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2341127|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
2341128|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927650|NCT04739865|Psilocybin|psilocybin|mesh-list
2927651|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
2927652|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927653|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2927654|NCT04732195|Pilocarpine|pilocarpine|mesh-list
2927655|NCT04732195|Miotics|miotics|mesh-ancestor
2927656|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
2927657|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927658|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927659|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2927660|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2927661|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
2927662|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2927663|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927664|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
2927665|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2927666|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927667|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927668|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2927669|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2927670|NCT04721015|Docetaxel|docetaxel|mesh-list
2927671|NCT04721015|Osimertinib|osimertinib|mesh-list
2927672|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927673|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
2927674|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
2341129|NCT00449319|Daunorubicin|daunorubicin|mesh-list
2341130|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2341131|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341132|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2341133|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2341134|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341135|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341136|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2341137|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
2341138|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2341139|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2341140|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2341141|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2341142|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927675|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
2927676|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927677|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2927678|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927679|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
2927680|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2927681|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2927682|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927683|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2927684|NCT04720963|Analgesics|analgesics|mesh-ancestor
2927685|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
2927686|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927687|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2927688|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2927689|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2927690|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
2927691|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2927692|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927698|NCT04699357|Atropine|atropine|mesh-list
2927699|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2927700|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2927701|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2927702|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
2927703|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927704|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927705|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2341143|NCT00449410|Atorvastatin|atorvastatin|mesh-list
2341144|NCT00449410|Ezetimibe|ezetimibe|mesh-list
2341145|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2341146|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2341147|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
2341148|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341149|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2341150|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2927706|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
2927707|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
2927708|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
2927709|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2927710|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2927711|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
2927712|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2927713|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927714|NCT04690192|Gemcitabine|gemcitabine|mesh-list
2927715|NCT04690192|Melphalan|melphalan|mesh-list
2927716|NCT04690192|Busulfan|busulfan|mesh-list
2927717|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2927718|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
2927719|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927720|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927721|NCT04690192|Antiviral Agents|antiviral agents|mesh-ancestor
2927722|NCT04690192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2927723|NCT04690192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927724|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2927725|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
2927726|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927727|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2927728|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
2927729|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2927730|NCT04673175|Tazobactam|tazobactam|mesh-list
2927731|NCT04673175|Ceftolozane|ceftolozane|mesh-list
2927732|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2927733|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2927734|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341151|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341152|NCT00449423|Acipimox|acipimox|mesh-list
2341153|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2341154|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
2341155|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341156|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2341157|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2927735|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2341158|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2341159|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
2341160|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2341161|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341162|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341163|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
2341164|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2927736|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927737|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927738|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2927739|NCT04673175|Renal Agents|renal agents|mesh-ancestor
2341165|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2341166|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2341167|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2341168|NCT00449449|Lidocaine|lidocaine|mesh-list
2341169|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
2341170|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
2341171|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2341172|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341173|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
2341174|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341175|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2341176|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2341177|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2341178|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2341179|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341180|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
2341181|NCT00449488|Hematinics|hematinics|mesh-ancestor
2341182|NCT00449501|Budesonide|budesonide|mesh-list
2341183|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
2341184|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341185|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2341186|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
2341187|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927750|NCT04661007|Lenalidomide|lenalidomide|mesh-list
2927751|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
2927752|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927753|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2927754|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2927755|NCT04661007|Growth Substances|growth substances|mesh-ancestor
2927756|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
2927757|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341188|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341189|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2341190|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
2341191|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
2341192|NCT00449501|Hormones|hormones|mesh-ancestor
2341193|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341194|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2341195|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2341196|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2341197|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
2341198|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341199|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341200|NCT00449514|Tamoxifen|tamoxifen|mesh-list
2341201|NCT00449514|Clomiphene|clomiphene|mesh-list
2341202|NCT00449514|Enclomiphene|enclomiphene|mesh-list
2341203|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
2341204|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2341205|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
2341206|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341207|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341208|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2927758|NCT04659603|Diphenhydramine|diphenhydramine|mesh-list
2927759|NCT04659603|Promethazine|promethazine|mesh-list
2927760|NCT04659603|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2927761|NCT04659603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2927762|NCT04659603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2927763|NCT04659603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927764|NCT04659603|Anesthetics, Local|anesthetics, local|mesh-ancestor
2927765|NCT04659603|Anesthetics|anesthetics|mesh-ancestor
2927766|NCT04659603|Sensory System Agents|sensory system agents|mesh-ancestor
2927767|NCT04659603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927768|NCT04659603|Antiemetics|antiemetics|mesh-ancestor
2927769|NCT04659603|Autonomic Agents|autonomic agents|mesh-ancestor
2927770|NCT04659603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2927771|NCT04659603|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2927772|NCT04659603|Histamine Antagonists|histamine antagonists|mesh-ancestor
2927773|NCT04659603|Histamine Agents|histamine agents|mesh-ancestor
2927774|NCT04659603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2927775|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927776|NCT04659603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2927777|NCT04659603|Antipruritics|antipruritics|mesh-ancestor
2927778|NCT04659603|Dermatologic Agents|dermatologic agents|mesh-ancestor
2927779|NCT04644068|Paclitaxel|paclitaxel|mesh-list
2927780|NCT04644068|Carboplatin|carboplatin|mesh-list
2927781|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2927782|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927783|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
2927784|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
2927785|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
2927786|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927787|NCT04643002|Dexamethasone|dexamethasone|mesh-list
2341209|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341210|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2341211|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2341212|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2341213|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2341214|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
2341215|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2341216|NCT00449527|Budesonide|budesonide|mesh-list
2341217|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
2341218|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341219|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2341220|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
2341221|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341222|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341223|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2341224|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
2341225|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
2341226|NCT00449527|Hormones|hormones|mesh-ancestor
2341227|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341228|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2341229|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2341230|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2341231|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
2341232|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341233|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341234|NCT00449553|Metformin|metformin|mesh-list
2341235|NCT00449553|Pioglitazone|pioglitazone|mesh-list
2341236|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2341237|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927788|NCT04643002|Pomalidomide|pomalidomide|mesh-list
2927789|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2927790|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
2927791|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
2927792|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927793|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927794|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2927795|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
2927796|NCT04643002|Hormones|hormones|mesh-ancestor
2927797|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2927798|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2927799|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927800|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
2927801|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2927802|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2927803|NCT04643002|Growth Substances|growth substances|mesh-ancestor
2927804|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
2927817|NCT04632992|Paclitaxel|paclitaxel|mesh-list
2927818|NCT04632992|Maytansine|maytansine|mesh-list
2927819|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2927820|NCT04632992|Trastuzumab|trastuzumab|mesh-list
2927821|NCT04632992|Atezolizumab|atezolizumab|mesh-list
2927822|NCT04632992|Pertuzumab|pertuzumab|mesh-list
2927823|NCT04632992|Tucatinib|tucatinib|mesh-list
2927824|NCT04632992|Pralsetinib|pralsetinib|mesh-list
2341238|NCT00449605|Metformin|metformin|mesh-list
2341239|NCT00449605|Glimepiride|glimepiride|mesh-list
2341240|NCT00449605|Rimonabant|rimonabant|mesh-list
2341241|NCT00449605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2341242|NCT00449605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341243|NCT00449605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2341244|NCT00449605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2341245|NCT00449605|Immunologic Factors|immunologic factors|mesh-ancestor
2341246|NCT00449605|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2341247|NCT00449605|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2341248|NCT00449605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2341249|NCT00449605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341250|NCT00449605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341251|NCT00449605|Hormones|hormones|mesh-ancestor
2341252|NCT00449605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341253|NCT00449618|Aspirin|aspirin|mesh-list
2341254|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2927825|NCT04632992|Entrectinib|entrectinib|mesh-list
2927826|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2927827|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927828|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
2927829|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
2927830|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
2927831|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927832|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2927833|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2927834|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927835|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
2927836|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927837|NCT04629651|Captopril|captopril|mesh-list
2927838|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2341255|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2341256|NCT00449618|Analgesics|analgesics|mesh-ancestor
2341257|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
2341258|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341259|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341260|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341261|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2341262|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2341263|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2341264|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341265|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2341266|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2341267|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341268|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
2341269|NCT00449657|Gemcitabine|gemcitabine|mesh-list
2341270|NCT00449657|Paclitaxel|paclitaxel|mesh-list
2341271|NCT00449657|Carboplatin|carboplatin|mesh-list
2341272|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2341273|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341274|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
2341275|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
2341276|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
2927839|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
2927840|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927841|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927842|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2927843|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
2927844|NCT04626024|Dasatinib|dasatinib|mesh-list
2927845|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927846|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2927847|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927848|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927865|NCT04616963|Tenofovir|tenofovir|mesh-list
2927866|NCT04616963|Emtricitabine|emtricitabine|mesh-list
2927867|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2927868|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
2927869|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2927870|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2927871|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2927872|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927873|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927874|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2927875|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2927876|NCT04607954|Durvalumab|durvalumab|mesh-list
2927877|NCT04607954|Topotecan|topotecan|mesh-list
2927878|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
2927879|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2927880|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
2927881|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2927882|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927883|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
2927884|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927885|NCT04607954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2927886|NCT04607954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2927887|NCT04607954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927888|NCT04607954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927889|NCT04603183|Paclitaxel|paclitaxel|mesh-list
2927890|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2927891|NCT04603183|Letrozole|letrozole|mesh-list
2927892|NCT04603183|Fulvestrant|fulvestrant|mesh-list
2927893|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2927894|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927895|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
2927896|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
2927897|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
2927898|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927899|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2927900|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2927901|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927902|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2927903|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
2927904|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2927905|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927906|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2927907|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2927908|NCT04594811|Nivolumab|nivolumab|mesh-list
2927909|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2927910|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927911|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2927912|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927913|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
2927914|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2927915|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927916|NCT04589208|Ketamine|ketamine|mesh-list
2341277|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341278|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2341279|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
2341280|NCT00449657|Antiviral Agents|antiviral agents|mesh-ancestor
2341281|NCT00449657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341282|NCT00449657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341283|NCT00449657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2341284|NCT00449657|Immunologic Factors|immunologic factors|mesh-ancestor
2341285|NCT00449657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341286|NCT00449683|Terazosin|terazosin|mesh-list
2341287|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2341288|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2341289|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2341290|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
2341291|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341292|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341293|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341294|NCT00449683|Urological Agents|urological agents|mesh-ancestor
2341295|NCT00449722|Mesalamine|mesalamine|mesh-list
2341296|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2341297|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2341298|NCT00449722|Analgesics|analgesics|mesh-ancestor
2341299|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
2927917|NCT04589208|Analgesics|analgesics|mesh-ancestor
2927918|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
2927919|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2927920|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927921|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2927922|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2927923|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
2927924|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
2927925|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2341300|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341301|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341302|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341303|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2927926|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2927927|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2927928|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2927929|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927930|NCT04584112|Paclitaxel|paclitaxel|mesh-list
2927931|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2927932|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
2927933|NCT04584112|Carboplatin|carboplatin|mesh-list
2927934|NCT04584112|Doxorubicin|doxorubicin|mesh-list
2927935|NCT04584112|Atezolizumab|atezolizumab|mesh-list
2927936|NCT04584112|Molgramostim|molgramostim|mesh-list
2927937|NCT04584112|Lenograstim|lenograstim|mesh-list
2927938|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2927939|NCT04584112|Sargramostim|sargramostim|mesh-list
2927940|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2927941|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927942|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
2927943|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
2927944|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
2927945|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927946|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2927947|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
2927948|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927949|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2927950|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2927951|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
2927952|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2927953|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2927954|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2927955|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2927956|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2927957|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2927958|NCT04577638|Nivolumab|nivolumab|mesh-list
2927959|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2341304|NCT00449774|Lamotrigine|lamotrigine|mesh-list
2341305|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
2927960|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341306|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2341307|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2927961|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2927962|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927981|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
2927982|NCT04561557|Fludarabine|fludarabine|mesh-list
2927983|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2927984|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
2927985|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2927986|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2927987|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2927988|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
2927989|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2927990|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2927991|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2928000|NCT04540120|Dapansutrile|dapansutrile|mesh-list
2928001|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2928002|NCT04539938|Trastuzumab|trastuzumab|mesh-list
2341308|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341309|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2341310|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341311|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2341312|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2341313|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2341314|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2341315|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2341316|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
2341317|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2341318|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341319|NCT00449813|Pantoprazole|pantoprazole|mesh-list
2341320|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2928003|NCT04539938|Tucatinib|tucatinib|mesh-list
2928004|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928005|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928006|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2928007|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928008|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928023|NCT04524611|Ustekinumab|ustekinumab|mesh-list
2928024|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2928025|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
2928026|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
2928027|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928028|NCT04513925|Durvalumab|durvalumab|mesh-list
2928029|NCT04513925|Atezolizumab|atezolizumab|mesh-list
2928030|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928031|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928032|NCT04513860|Cenobamate|cenobamate|mesh-list
2928033|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
2928034|NCT04510194|Metformin|metformin|mesh-list
2928035|NCT04510194|Ivermectin|ivermectin|mesh-list
2928036|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
2928037|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2928038|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928039|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2928040|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2928041|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2928042|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2928043|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2928044|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2111686|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
2111687|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111688|NCT02559206|Linaclotide|linaclotide|mesh-list
2111689|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2111690|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
2111691|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111692|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2111693|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
2111694|NCT02559310|Linezolid|linezolid|mesh-list
2111695|NCT02559310|Lefamulin|lefamulin|mesh-list
2111696|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2111697|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2111698|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2111699|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2111700|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111701|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111702|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111703|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2111704|NCT02559414|Aspirin|aspirin|mesh-list
2111705|NCT02559414|Clopidogrel|clopidogrel|mesh-list
2111706|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2111707|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2111708|NCT02559414|Analgesics|analgesics|mesh-ancestor
2111709|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
2111710|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111711|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341321|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2341322|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2341323|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341324|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341325|NCT00449839|Insulin|insulin|mesh-list
2341326|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2341327|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
2341328|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
2341329|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2341330|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2341331|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341332|NCT00450008|Thalidomide|thalidomide|mesh-list
2341333|NCT00450008|Docetaxel|docetaxel|mesh-list
2341334|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341335|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
2341336|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
2341337|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
2341338|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341339|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2341340|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
2341341|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341342|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
2928045|NCT04510194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2928046|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2341343|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2928047|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2928048|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111712|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2928049|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2928050|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
2928051|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2928052|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
2341344|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341345|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2341346|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2341347|NCT00450008|Growth Substances|growth substances|mesh-ancestor
2341348|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
2341349|NCT00450086|Budesonide|budesonide|mesh-list
2341350|NCT00450086|Mesalamine|mesalamine|mesh-list
2341351|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341352|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2928053|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2928054|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2928055|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928056|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2928057|NCT04503148|Propofol|propofol|mesh-list
2928058|NCT04503148|Anesthetics|anesthetics|mesh-list
2928059|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
2928060|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
2928061|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2928062|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2928063|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928064|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2928065|NCT04502706|Rituximab|rituximab|mesh-list
2928066|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928067|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928068|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
2928069|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928070|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2928071|NCT04498468|Dexamethasone|dexamethasone|mesh-list
2928072|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2928073|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
2928074|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
2928075|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928076|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928077|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2928078|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
2928079|NCT04498468|Hormones|hormones|mesh-ancestor
2928080|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2928081|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2928082|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928097|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
2928098|NCT04477200|Temozolomide|temozolomide|mesh-list
2928099|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2928100|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928101|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2928102|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
2928103|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2928104|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2928105|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928106|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928107|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2928108|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
2928109|NCT04474223|Dexamethasone|dexamethasone|mesh-list
2928110|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2928111|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
2928112|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
2341353|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
2341354|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928113|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928114|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928115|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2928116|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
2928117|NCT04474223|Hormones|hormones|mesh-ancestor
2928118|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2928119|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2928120|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928121|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
2928122|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928123|NCT04416633|Durvalumab|durvalumab|mesh-list
2928124|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928125|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928126|NCT04405102|Ozanimod|ozanimod|mesh-list
2928127|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2928128|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928129|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2928130|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
2928131|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928132|NCT04401384|Pyridoxine|pyridoxine|mesh-list
2928133|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
2928134|NCT04401384|Doxylamine|doxylamine|mesh-list
2928135|NCT04401384|Dicyclomine|dicyclomine|mesh-list
2928136|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
2928137|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
2928138|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928139|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928140|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2928141|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2928142|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
2928143|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
2928144|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2928145|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928146|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
2928147|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2928148|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2928149|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
2928150|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
2928151|NCT04401384|Vitamins|vitamins|mesh-ancestor
2928152|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
2928153|NCT04400799|Enoxaparin|enoxaparin|mesh-list
2928154|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
2928155|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2928156|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2928157|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928172|NCT04368910|Artesunate|artesunate|mesh-list
2928173|NCT04368910|Chloroquine|chloroquine|mesh-list
2928174|NCT04368910|Pyronaridine|pyronaridine|mesh-list
2928175|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
2928176|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2928177|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2928178|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2928179|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928180|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
2928181|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
2928182|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2928183|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
2928184|NCT04368910|Amebicides|amebicides|mesh-ancestor
2928185|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2928186|NCT04365985|Naltrexone|naltrexone|mesh-list
2928187|NCT04365985|Ketamine|ketamine|mesh-list
2928188|NCT04365985|Analgesics|analgesics|mesh-ancestor
2928189|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
2928190|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928191|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928192|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2928193|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2928194|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
2928195|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
2928196|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2928197|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2928198|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2928199|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2928200|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928201|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2928202|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2928203|NCT04345913|Halichondrin B|halichondrin b|mesh-list
2928204|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
2341355|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341356|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2341357|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
2341358|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
2341359|NCT00450086|Hormones|hormones|mesh-ancestor
2341360|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341361|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2341362|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2341363|NCT00450086|Analgesics|analgesics|mesh-ancestor
2341364|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
2341365|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2341366|NCT00450099|Bupivacaine|bupivacaine|mesh-list
2341367|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
2341368|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
2341369|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2341370|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341371|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
2341372|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341373|NCT00450138|Cisplatin|cisplatin|mesh-list
2341374|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341375|NCT00450164|Nadolol|nadolol|mesh-list
2341376|NCT00450164|Prazosin|prazosin|mesh-list
2928205|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
2928206|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
2928207|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928208|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341377|NCT00450164|Isosorbide|isosorbide|mesh-list
2341378|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2341379|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2928214|NCT04338061|Teriflunomide|teriflunomide|mesh-list
2928215|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2928216|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2341380|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2341381|NCT00450164|Diuretics|diuretics|mesh-ancestor
2928217|NCT04338061|Analgesics|analgesics|mesh-ancestor
2928218|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
2928219|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928220|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928221|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2928222|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2928223|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2928224|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
2928231|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2928232|NCT04329065|Paclitaxel|paclitaxel|mesh-list
2928233|NCT04329065|Trastuzumab|trastuzumab|mesh-list
2928234|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2928235|NCT04329065|Pertuzumab|pertuzumab|mesh-list
2928236|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2928237|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2928238|NCT04329065|Vaccines|vaccines|mesh-list
2928239|NCT04329065|Antibodies|antibodies|mesh-list
2928240|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
2928241|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2928242|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
2928243|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
2928244|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928245|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2928246|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928247|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
2928248|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
2928249|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
2341382|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
2341383|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341384|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
2341385|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2341386|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341387|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2341388|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2341389|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2341390|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2341391|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
2341392|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341393|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2341394|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2341395|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
2341396|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
2341397|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341398|NCT00450203|Bevacizumab|bevacizumab|mesh-list
2341399|NCT00450203|Capecitabine|capecitabine|mesh-list
2341400|NCT00450203|Epirubicin|epirubicin|mesh-list
2928250|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928251|NCT04327206|Vaccines|vaccines|mesh-list
2928252|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
2928253|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
2928254|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928255|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2928256|NCT04313881|Azacitidine|azacitidine|mesh-list
2928257|NCT04313881|Magrolimab|magrolimab|mesh-list
2928258|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2341401|NCT00450203|Lapatinib|lapatinib|mesh-list
2341402|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2341403|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341404|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2341405|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2341406|NCT00450203|Growth Substances|growth substances|mesh-ancestor
2341407|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341408|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
2341409|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2341410|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
2341411|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341412|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2341413|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2341414|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2341415|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341416|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2341417|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
2341418|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2341419|NCT00450229|Protective Agents|protective agents|mesh-ancestor
2341420|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928259|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
2928260|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928261|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928262|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928263|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928264|NCT04310020|Atezolizumab|atezolizumab|mesh-list
2928265|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2928266|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928267|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
2928268|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928269|NCT04269200|Paclitaxel|paclitaxel|mesh-list
2928270|NCT04269200|Carboplatin|carboplatin|mesh-list
2928271|NCT04269200|Durvalumab|durvalumab|mesh-list
2928272|NCT04269200|Olaparib|olaparib|mesh-list
2928273|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2928274|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2928275|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341421|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341422|NCT00450281|Antibodies|antibodies|mesh-list
2928276|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
2928277|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
2928278|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
2928279|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341423|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
2341424|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341425|NCT00450307|Antibodies|antibodies|mesh-list
2341426|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2341427|NCT00450307|Sargramostim|sargramostim|mesh-list
2341428|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
2341429|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341430|NCT00450320|Sirolimus|sirolimus|mesh-list
2928280|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928281|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
2928282|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928283|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2928284|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928285|NCT04251351|Acetaminophen|acetaminophen|mesh-list
2928286|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2928287|NCT04251351|Analgesics|analgesics|mesh-ancestor
2928288|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
2928289|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928290|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928291|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
2928292|NCT04249258|Dobutamine|dobutamine|mesh-list
2928293|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2928294|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
2928295|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
2928296|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928297|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928298|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2928299|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2928300|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2928301|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
2928302|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2928303|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928304|NCT04249258|Protective Agents|protective agents|mesh-ancestor
2928305|NCT04238546|Sirolimus|sirolimus|mesh-list
2928306|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2928307|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2928308|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2928309|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928310|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
2928311|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2928312|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
2928313|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928314|NCT04235608|Propofol|propofol|mesh-list
2341431|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2341432|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341433|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2341434|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341435|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
2341436|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2341437|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
2341438|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341439|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
2341440|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2928315|NCT04235608|Sevoflurane|sevoflurane|mesh-list
2928316|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2928317|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2928318|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928319|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2928320|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
2928321|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
2928322|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2928323|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2928324|NCT04233801|Empagliflozin|empagliflozin|mesh-list
2928325|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2928326|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928327|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2928328|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341441|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
2928329|NCT04231838|Nicotine|nicotine|mesh-list
2928330|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2928331|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
2928332|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928333|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928334|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2928335|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2928336|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
2928337|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2928338|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928339|NCT04186871|Abatacept|abatacept|mesh-list
2928340|NCT04186871|Branebrutinib|branebrutinib|mesh-list
2928341|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2928342|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928343|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928344|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2928345|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
2928346|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928347|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2928348|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2928349|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928350|NCT04176419|Acetaminophen|acetaminophen|mesh-list
2928351|NCT04176419|Celecoxib|celecoxib|mesh-list
2928352|NCT04176419|Lidocaine|lidocaine|mesh-list
2928353|NCT04176419|Ketamine|ketamine|mesh-list
2928354|NCT04176419|Gabapentin|gabapentin|mesh-list
2928355|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
2928356|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
2928357|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2928358|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928359|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
2928360|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928361|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2928362|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2928363|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2928364|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2928365|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928366|NCT04176419|Analgesics|analgesics|mesh-ancestor
2928367|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2928368|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2928369|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
2928370|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2928371|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2928372|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2928373|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2928374|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
2928375|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2928376|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2928377|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2928378|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2928379|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2928380|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928381|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
2928382|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2928383|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2928384|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2928385|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
2928386|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
2928387|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928388|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2341442|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341443|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2341444|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341445|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
2341446|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341447|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
2341448|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2341449|NCT00450398|Protective Agents|protective agents|mesh-ancestor
2341450|NCT00450515|Capecitabine|capecitabine|mesh-list
2341451|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2341452|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
2341453|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341454|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341455|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2341456|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2341457|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341458|NCT00450645|Heparin|heparin|mesh-list
2928389|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341459|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2341460|NCT00450645|Tinzaparin|tinzaparin|mesh-list
2341461|NCT00450645|Dalteparin|dalteparin|mesh-list
2341462|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
2341463|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2928390|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928391|NCT04166383|Nivolumab|nivolumab|mesh-list
2928392|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928393|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928394|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2928395|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928396|NCT04146324|Nivolumab|nivolumab|mesh-list
2928397|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928398|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928399|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2928400|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928401|NCT04141579|Evolocumab|evolocumab|mesh-list
2928402|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2928403|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2928404|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
2928405|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928406|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2928425|NCT04094519|Digoxin|digoxin|mesh-list
2928426|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2928427|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2928428|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2928429|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
2928430|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928431|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2928432|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2928433|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928434|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2928435|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2928436|NCT04094519|Protective Agents|protective agents|mesh-ancestor
2928437|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341464|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2341465|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341466|NCT00450736|Celecoxib|celecoxib|mesh-list
2341467|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2341468|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2341469|NCT00450736|Analgesics|analgesics|mesh-ancestor
2341470|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
2341471|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341472|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341473|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341474|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2341475|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2928443|NCT04083170|Vidarabine|vidarabine|mesh-list
2928444|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
2928445|NCT04083170|Thiotepa|thiotepa|mesh-list
2928446|NCT04083170|Fludarabine|fludarabine|mesh-list
2928447|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
2928448|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2928449|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
2928450|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928451|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2928452|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2928453|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
2928454|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341476|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2341477|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341478|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341479|NCT00450762|Gemcitabine|gemcitabine|mesh-list
2341480|NCT00450762|Carboplatin|carboplatin|mesh-list
2341481|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341482|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2341483|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
2341484|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341485|NCT00450762|Antiviral Agents|antiviral agents|mesh-ancestor
2341486|NCT00450762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341487|NCT00450762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341488|NCT00450762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2341489|NCT00450762|Immunologic Factors|immunologic factors|mesh-ancestor
2341490|NCT00450762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341491|NCT00450827|Bevacizumab|bevacizumab|mesh-list
2341492|NCT00450827|Antibodies|antibodies|mesh-list
2341493|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2341494|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928455|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928456|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2928457|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2928458|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
2928459|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
2928460|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2928461|NCT04080531|Vaccines|vaccines|mesh-list
2928462|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
2341495|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341496|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2341497|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2341498|NCT00450827|Growth Substances|growth substances|mesh-ancestor
2341499|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341500|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
2341501|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
2928463|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928464|NCT04064684|Budesonide|budesonide|mesh-list
2928465|NCT04064684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2928466|NCT04064684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2928467|NCT04064684|Autonomic Agents|autonomic agents|mesh-ancestor
2928468|NCT04064684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928469|NCT04064684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928470|NCT04064684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2928471|NCT04064684|Respiratory System Agents|respiratory system agents|mesh-ancestor
2928472|NCT04064684|Glucocorticoids|glucocorticoids|mesh-ancestor
2928473|NCT04064684|Hormones|hormones|mesh-ancestor
2928474|NCT04064684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2928475|NCT04064359|Antibodies|antibodies|mesh-list
2928476|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
2928477|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
2928478|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341502|NCT00450840|Simvastatin|simvastatin|mesh-list
2341503|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2341504|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2341505|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
2341506|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341507|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2341508|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2341509|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341510|NCT00450853|Granisetron|granisetron|mesh-list
2341511|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
2341512|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
2341513|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341514|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928482|NCT04045028|Rituximab|rituximab|mesh-list
2928483|NCT04045028|Atezolizumab|atezolizumab|mesh-list
2341515|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2341516|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2341517|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
2341518|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341519|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341520|NCT00450892|Docetaxel|docetaxel|mesh-list
2341521|NCT00450892|Trastuzumab|trastuzumab|mesh-list
2341522|NCT00450892|Lapatinib|lapatinib|mesh-list
2928484|NCT04045028|Daratumumab|daratumumab|mesh-list
2928485|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928486|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928487|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
2928488|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928489|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2928490|NCT03987711|Warfarin|warfarin|mesh-list
2928491|NCT03987711|Apixaban|apixaban|mesh-list
2928492|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
2928493|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2928494|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
2928495|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2928496|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
2928497|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928498|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928499|NCT03970837|Tofacitinib|tofacitinib|mesh-list
2928500|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2928501|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928502|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928503|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
2928504|NCT03938584|Vitamins|vitamins|mesh-ancestor
2928505|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
2928506|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928507|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
2928508|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928509|NCT03938584|Protective Agents|protective agents|mesh-ancestor
2928510|NCT03917381|Docetaxel|docetaxel|mesh-list
2928511|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
2341523|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341524|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
2341525|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
2341526|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
2341527|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341528|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2341529|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2341530|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341531|NCT00450944|Immunotoxins|immunotoxins|mesh-list
2341532|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
2341533|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341534|NCT00450957|Lycopene|lycopene|mesh-list
2341535|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341536|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
2341537|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341538|NCT00450957|Protective Agents|protective agents|mesh-ancestor
2341539|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341540|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2341541|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2341542|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341543|NCT00450970|Satraplatin|satraplatin|mesh-list
2341544|NCT00450970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341545|NCT00451061|Tamsulosin|tamsulosin|mesh-list
2341546|NCT00451061|Alfuzosin|alfuzosin|mesh-list
2341547|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2341548|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2928512|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928513|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
2928514|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
2928515|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
2928516|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928517|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2341549|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2341550|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
2341551|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341552|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341553|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341554|NCT00451061|Urological Agents|urological agents|mesh-ancestor
2341555|NCT00451074|Gentamicins|gentamicins|mesh-list
2341556|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2341557|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341558|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2341559|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928614|NCT03899155|Nivolumab|nivolumab|mesh-list
2928615|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928616|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928617|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2928618|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928619|NCT03850782|Bimatoprost|bimatoprost|mesh-list
2928620|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2928630|NCT03837899|Durvalumab|durvalumab|mesh-list
2928631|NCT03837899|Tremelimumab|tremelimumab|mesh-list
2928632|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2928633|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928634|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928635|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
2928636|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928637|NCT03837873|Cytarabine|cytarabine|mesh-list
2928638|NCT03837873|Dexamethasone|dexamethasone|mesh-list
2928639|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
2928640|NCT03837873|Rituximab|rituximab|mesh-list
2928641|NCT03837873|Doxorubicin|doxorubicin|mesh-list
2928642|NCT03837873|Etoposide|etoposide|mesh-list
2341560|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341561|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
2341562|NCT00451100|Neostigmine|neostigmine|mesh-list
2341563|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2341564|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341565|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341566|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
2341567|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341568|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341569|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2341570|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
2341571|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341572|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2341573|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2341574|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2341575|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2341576|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2341577|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2341578|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341579|NCT00451113|Incretins|incretins|mesh-ancestor
2341580|NCT00451113|Hormones|hormones|mesh-ancestor
2341581|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341582|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
2341583|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341584|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341585|NCT00451139|Lumefantrine|lumefantrine|mesh-list
2928643|NCT03837873|Vincristine|vincristine|mesh-list
2928644|NCT03837873|Lenalidomide|lenalidomide|mesh-list
2928645|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2341586|NCT00451139|Artemether|artemether|mesh-list
2341587|NCT00451139|Quinine|quinine|mesh-list
2341588|NCT00451139|Atovaquone|atovaquone|mesh-list
2341589|NCT00451139|Proguanil|proguanil|mesh-list
2341590|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2341591|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2928646|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
2928647|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928648|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2928649|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2928650|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
2928651|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928652|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928653|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2928654|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2928655|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
2928656|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
2928657|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928658|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2928659|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
2928660|NCT03837873|Hormones|hormones|mesh-ancestor
2928661|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2928662|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2928663|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928664|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2928665|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2928666|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2928667|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341592|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
2341593|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2341594|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2341595|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341596|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2341597|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341598|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2928668|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2928669|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2928670|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
2928671|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
2928672|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2928673|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
2928674|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
2928675|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
2928676|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2928677|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2928678|NCT03837873|Growth Substances|growth substances|mesh-ancestor
2928679|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
2928680|NCT03836209|Cytarabine|cytarabine|mesh-list
2928681|NCT03836209|Daunorubicin|daunorubicin|mesh-list
2928682|NCT03836209|Midostaurin|midostaurin|mesh-list
2928683|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2928684|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
2928685|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928686|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928687|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
2928688|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2928689|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2928690|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
2928691|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928692|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2928693|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2928694|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2928695|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928696|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2928697|NCT03820726|Nintedanib|nintedanib|mesh-list
2928698|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928699|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2928700|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928701|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928702|NCT03810495|Naltrexone|naltrexone|mesh-list
2928703|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2928704|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2928705|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928706|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
2341599|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111713|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2111714|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2111715|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2111716|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341600|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2341601|NCT00451139|Analgesics|analgesics|mesh-ancestor
2341602|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
2341603|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341604|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341605|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
2341606|NCT00451152|Hydrocortisone|hydrocortisone|mesh-list
2341607|NCT00451152|Anecortave|anecortave|mesh-list
2341608|NCT00451152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2341609|NCT00451152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2341610|NCT00451152|Growth Substances|growth substances|mesh-ancestor
2341611|NCT00451152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341612|NCT00451152|Growth Inhibitors|growth inhibitors|mesh-ancestor
2341613|NCT00451152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341614|NCT00451152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341615|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
2341616|NCT00451230|Cocaine|cocaine|mesh-list
2341617|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341618|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
2928707|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928734|NCT03775200|Psilocybin|psilocybin|mesh-list
2928735|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
2928736|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928737|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2928738|NCT03769766|Curcumin|curcumin|mesh-list
2928739|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2928740|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2341619|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
2928741|NCT03769766|Analgesics|analgesics|mesh-ancestor
2928742|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
2928743|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928744|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928745|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2928746|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2928747|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928748|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928749|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928750|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
2928751|NCT03753555|Atorvastatin|atorvastatin|mesh-list
2928752|NCT03753555|Probucol|probucol|mesh-list
2928753|NCT03753555|Calcium|calcium|mesh-list
2928754|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2928755|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111717|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2111718|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2111719|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111720|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
2928756|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2928757|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2928758|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2928759|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
2928760|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928761|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2928762|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2928763|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928764|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
2928765|NCT03753555|Protective Agents|protective agents|mesh-ancestor
2928766|NCT03734029|Gemcitabine|gemcitabine|mesh-list
2928767|NCT03734029|Paclitaxel|paclitaxel|mesh-list
2928768|NCT03734029|Camptothecin|camptothecin|mesh-list
2928769|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2928770|NCT03734029|Capecitabine|capecitabine|mesh-list
2928771|NCT03734029|Trastuzumab|trastuzumab|mesh-list
2928772|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
2928773|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2928774|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928775|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
2928776|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
2928777|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
2928778|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928779|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2928780|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
2341620|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2341621|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341622|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
2341623|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341624|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2341625|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2341626|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2341627|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2341628|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341629|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
2341630|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341631|NCT00451360|Diacetylrhein|diacetylrhein|mesh-list
2341632|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341633|NCT00451373|Vancomycin|vancomycin|mesh-list
2341634|NCT00451373|Daptomycin|daptomycin|mesh-list
2111721|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2928781|NCT03734029|Antiviral Agents|antiviral agents|mesh-ancestor
2928782|NCT03734029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2928783|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928784|NCT03734029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2928785|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
2928786|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928787|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928788|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2928789|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2928798|NCT03732677|Gemcitabine|gemcitabine|mesh-list
2928799|NCT03732677|Durvalumab|durvalumab|mesh-list
2928800|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928801|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2928802|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
2928803|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928804|NCT03732677|Antiviral Agents|antiviral agents|mesh-ancestor
2928805|NCT03732677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2928806|NCT03732677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928807|NCT03732677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2928808|NCT03732677|Immunologic Factors|immunologic factors|mesh-ancestor
2928809|NCT03732677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928810|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928811|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
2928812|NCT03716609|Citric Acid|citric acid|mesh-list
2928813|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
2928814|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
2928815|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2111722|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2111723|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2111724|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
2111725|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111726|NCT02559505|Vaccines|vaccines|mesh-list
2111727|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
2111728|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111729|NCT02559570|Linaclotide|linaclotide|mesh-list
2111730|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2111731|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
2111732|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111733|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2111734|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2111735|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
2111736|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111737|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
2111738|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928816|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
2928817|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
2928818|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928819|NCT03716609|Cathartics|cathartics|mesh-ancestor
2928820|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2928821|NCT03709355|Clarithromycin|clarithromycin|mesh-list
2928822|NCT03709355|Rifampin|rifampin|mesh-list
2928823|NCT03709355|Rifabutin|rifabutin|mesh-list
2928824|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
2928825|NCT03709355|Omeprazole|omeprazole|mesh-list
2928826|NCT03709355|Atorvastatin|atorvastatin|mesh-list
2928827|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
2928828|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2928829|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2928830|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2928831|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2928832|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
2928833|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928834|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2928835|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2928836|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928837|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2928838|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2928839|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2928840|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2928841|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2928842|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2928843|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2928844|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2928845|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2928846|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
2928847|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2928848|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928849|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2928850|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2928851|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2928852|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2928853|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
2928854|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
2928855|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2928856|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2928857|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2928858|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2928859|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2928860|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2928861|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2111739|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111740|NCT02559713|Vedolizumab|vedolizumab|mesh-list
2111741|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2111742|NCT02559817|Linaclotide|linaclotide|mesh-list
2111743|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2111744|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
2111745|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111746|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2111747|NCT02560012|Sirolimus|sirolimus|mesh-list
2111748|NCT02560012|Everolimus|everolimus|mesh-list
2111749|NCT02560012|Sorafenib|sorafenib|mesh-list
2341635|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2341636|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2928862|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2928863|NCT03709355|Estrogens|estrogens|mesh-ancestor
2928864|NCT03709355|Hormones|hormones|mesh-ancestor
2928865|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2928866|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2928867|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2928868|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
2928869|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2928870|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2928871|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
2928872|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2928873|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2928874|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2928875|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
2928876|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2928877|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928878|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2928879|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2928880|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2928881|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2928882|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341637|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
2341638|NCT00451386|Ertapenem|ertapenem|mesh-list
2341639|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2341640|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341641|NCT00451399|Metformin|metformin|mesh-list
2341642|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2341643|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341644|NCT00451412|Heparin|heparin|mesh-list
2341645|NCT00451412|Calcium heparin|calcium heparin|mesh-list
2341646|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2341647|NCT00451412|Tinzaparin|tinzaparin|mesh-list
2341648|NCT00451412|Dalteparin|dalteparin|mesh-list
2341649|NCT00451412|Certoparin|certoparin|mesh-list
2341650|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
2341651|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2341652|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2341653|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341654|NCT00451490|S 20098|s 20098|mesh-list
2341655|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2341656|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2341657|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341658|NCT00451568|Metformin|metformin|mesh-list
2341659|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2341660|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341661|NCT00451594|Dexamethasone|dexamethasone|mesh-list
2341662|NCT00451594|Prednisolone|prednisolone|mesh-list
2341663|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341664|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
2341665|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
2341666|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341667|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341668|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2341669|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
2341670|NCT00451594|Hormones|hormones|mesh-ancestor
2341671|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341672|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2341673|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341674|NCT00451620|Glyburide|glyburide|mesh-list
2341675|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2341676|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341677|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2341678|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2341679|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2341680|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2341681|NCT00451672|Bromocriptine|bromocriptine|mesh-list
2341682|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2341683|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2341684|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
2341685|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341686|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341687|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
2341688|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
2341689|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341690|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341691|NCT00451711|Amphotericin B|amphotericin b|mesh-list
2341692|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2341693|NCT00451711|Amebicides|amebicides|mesh-ancestor
2341694|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2341695|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2341696|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341697|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2341698|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
2341699|NCT00451724|Ketamine|ketamine|mesh-list
2341700|NCT00451724|Analgesics|analgesics|mesh-ancestor
2341701|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
2341702|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928883|NCT03698552|Epratuzumab|epratuzumab|mesh-list
2928884|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928885|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928886|NCT03669133|Vitamin E|vitamin e|mesh-list
2928887|NCT03669133|Vitamins|vitamins|mesh-ancestor
2928888|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
2928889|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928890|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
2928891|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928892|NCT03669133|Protective Agents|protective agents|mesh-ancestor
2928893|NCT03656718|Nivolumab|nivolumab|mesh-list
2928894|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928895|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928896|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2928897|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928898|NCT03637491|Avelumab|avelumab|mesh-list
2928899|NCT03637491|Talazoparib|talazoparib|mesh-list
2928900|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928901|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928902|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2928903|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928904|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341703|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341704|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2341705|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2341706|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
2341707|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
2341708|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2341709|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2341710|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2341711|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341712|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341713|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
2341714|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341715|NCT00451763|Bevacizumab|bevacizumab|mesh-list
2341716|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2341717|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341718|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2341719|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2341720|NCT00451763|Growth Substances|growth substances|mesh-ancestor
2341721|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341722|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
2341723|NCT00451776|Propofol|propofol|mesh-list
2928924|NCT03582618|Sorafenib|sorafenib|mesh-list
2928925|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928926|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2928927|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928928|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928934|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2928935|NCT03526848|Antibodies|antibodies|mesh-list
2928936|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
2928937|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2928938|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
2928939|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341724|NCT00451776|Etomidate|etomidate|mesh-list
2341725|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2341726|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2341727|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341728|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2928940|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928941|NCT03526250|Palbociclib|palbociclib|mesh-list
2928942|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928943|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2928944|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928945|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928954|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
2928955|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2928956|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928957|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
2928958|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2928959|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2928960|NCT03511625|Prednisolone|prednisolone|mesh-list
2928961|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
2928962|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2928963|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
2928964|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2928965|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2928966|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
2928967|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
2928968|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928969|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928970|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2928971|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
2928972|NCT03511625|Hormones|hormones|mesh-ancestor
2928973|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341729|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
2341730|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
2341731|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
2341732|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2341733|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2341734|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2341735|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
2341736|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341737|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341738|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341739|NCT00451828|Simvastatin|simvastatin|mesh-list
2341740|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2341741|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2341742|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
2341743|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341744|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2341745|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2928974|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2928975|NCT03511625|Protective Agents|protective agents|mesh-ancestor
2928976|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2928977|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928978|NCT03501381|Aldesleukin|aldesleukin|mesh-list
2928979|NCT03501381|Interleukin-2|interleukin-2|mesh-list
2928980|NCT03501381|Entinostat|entinostat|mesh-list
2928981|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2928982|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2928983|NCT03501381|Analgesics|analgesics|mesh-ancestor
2928984|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
2928985|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2928986|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928987|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2928988|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2928989|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
2928990|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2928991|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2928992|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2928993|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2928994|NCT03498391|Ketamine|ketamine|mesh-list
2928995|NCT03498391|Propofol|propofol|mesh-list
2928996|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2928997|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2928998|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2928999|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2929000|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
2929001|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
2929002|NCT03498391|Analgesics|analgesics|mesh-ancestor
2929003|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
2929004|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2929005|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2341746|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341747|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
2341748|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2341749|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929006|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2929007|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2929008|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2929009|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929010|NCT03485209|Carboplatin|carboplatin|mesh-list
2929011|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
2929012|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
2929013|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929014|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2929015|NCT03478865|Vitamin A|vitamin a|mesh-list
2929016|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
2929017|NCT03478865|Vitamins|vitamins|mesh-ancestor
2929018|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
2929019|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929020|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
2929021|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929022|NCT03478865|Protective Agents|protective agents|mesh-ancestor
2929023|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2929024|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929025|NCT03477162|Metformin|metformin|mesh-list
2929026|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2929027|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929028|NCT03461952|Nivolumab|nivolumab|mesh-list
2929029|NCT03461952|Ipilimumab|ipilimumab|mesh-list
2929030|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2929031|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929032|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2929033|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929034|NCT03420508|Ensartinib|ensartinib|mesh-list
2929035|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929036|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2929037|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929038|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929039|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2929040|NCT03390296|Avelumab|avelumab|mesh-list
2929041|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
2929042|NCT03390296|Azacitidine|azacitidine|mesh-list
2341750|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2341751|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
2341752|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2929043|NCT03390296|Venetoclax|venetoclax|mesh-list
2341753|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341754|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341755|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341756|NCT00451880|Famotidine|famotidine|mesh-list
2341757|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2929044|NCT03390296|Calicheamicins|calicheamicins|mesh-list
2929045|NCT03390296|Antibodies|antibodies|mesh-list
2929046|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
2929047|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2929048|NCT03390296|Maleic acid|maleic acid|mesh-list
2929049|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
2929050|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929051|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929052|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2929053|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
2929054|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929055|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929056|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2929057|NCT03340727|Caffeine|caffeine|mesh-list
2929058|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
2929059|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929060|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2929061|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929062|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2929063|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929064|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2929065|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2929066|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
2929067|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2929068|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2929069|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2929070|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
2929071|NCT03333486|Fludarabine|fludarabine|mesh-list
2929072|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
2929073|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2929074|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
2929075|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929076|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2929077|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2929078|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
2929079|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929080|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929081|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2929082|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2929083|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
2929084|NCT03325439|Brivaracetam|brivaracetam|mesh-list
2341758|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2341759|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2341760|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
2341761|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
2341762|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341763|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341764|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341765|NCT00451971|Leflunomide|leflunomide|mesh-list
2341766|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341767|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341768|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2341769|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
2341770|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341771|NCT00451984|Interleukin-2|interleukin-2|mesh-list
2341772|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341773|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2341774|NCT00451984|Analgesics|analgesics|mesh-ancestor
2341775|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
2341776|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341777|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341778|NCT00451997|Cytarabine|cytarabine|mesh-list
2341779|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
2341780|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2341781|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
2929085|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
2929086|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
2929087|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
2929088|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
2929089|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
2929090|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2341782|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341783|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341784|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
2341785|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341786|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2111750|NCT02560012|Sunitinib|sunitinib|mesh-list
2111751|NCT02560012|Axitinib|axitinib|mesh-list
2111752|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111753|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2111754|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
2111755|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111756|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2111757|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111758|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111759|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2111760|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2111761|NCT02560012|Growth Substances|growth substances|mesh-ancestor
2111762|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
2111763|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2111764|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2111765|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2929091|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929092|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
2929093|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929094|NCT03296813|Torsemide|torsemide|mesh-list
2929095|NCT03296813|Furosemide|furosemide|mesh-list
2929096|NCT03296813|Diuretics|diuretics|mesh-ancestor
2929097|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
2929098|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929099|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2929100|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2929101|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929102|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2341787|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
2341788|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341789|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2929108|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
2929109|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2341790|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341791|NCT00452062|Dexamethasone|dexamethasone|mesh-list
2341792|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341793|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
2341794|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
2341795|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341796|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341797|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2341798|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
2341799|NCT00452062|Hormones|hormones|mesh-ancestor
2341800|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2929110|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929111|NCT03269344|Gabapentin|gabapentin|mesh-list
2929112|NCT03269344|Analgesics|analgesics|mesh-ancestor
2929113|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
2929114|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341801|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2341802|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341803|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2341804|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341805|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2341806|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341807|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341808|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
2341809|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2341810|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341811|NCT00452192|Telmisartan|telmisartan|mesh-list
2341812|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2341813|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2341814|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2341815|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341816|NCT00452218|Sorafenib|sorafenib|mesh-list
2341817|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929115|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929116|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
2929117|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2929118|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2929119|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2929120|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2929121|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2929122|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2929123|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2929124|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929125|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
2929126|NCT03237780|Atezolizumab|atezolizumab|mesh-list
2929127|NCT03237780|Halichondrin B|halichondrin b|mesh-list
2929128|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2929129|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929130|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
2929131|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929132|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
2929133|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
2929134|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
2929135|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929146|NCT03218683|Venetoclax|venetoclax|mesh-list
2929147|NCT03218683|AZD5991|azd5991|mesh-list
2929148|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929149|NCT03215095|Durvalumab|durvalumab|mesh-list
2929150|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2929151|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929157|NCT03201458|Atezolizumab|atezolizumab|mesh-list
2929158|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2929159|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929160|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
2929161|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929162|NCT03169101|Nicotine|nicotine|mesh-list
2929163|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2929164|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
2929165|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2929166|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929167|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2929168|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2929169|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
2929170|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2929171|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929172|NCT03151811|Dexamethasone|dexamethasone|mesh-list
2929173|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
2929174|NCT03151811|Melphalan|melphalan|mesh-list
2929175|NCT03151811|Pomalidomide|pomalidomide|mesh-list
2929176|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2929177|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
2929178|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
2929179|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2929180|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929181|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2929182|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
2929183|NCT03151811|Hormones|hormones|mesh-ancestor
2929184|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2929185|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2929186|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929187|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2929188|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
2341818|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2341819|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341820|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341821|NCT00452231|Cycloserine|cycloserine|mesh-list
2341822|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2341823|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341824|NCT00452231|Renal Agents|renal agents|mesh-ancestor
2341825|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2341826|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
2341827|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2341828|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
2341829|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929189|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929190|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2929191|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2929192|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
2929193|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2929194|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2929195|NCT03151811|Growth Substances|growth substances|mesh-ancestor
2929196|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
2929197|NCT03151746|Gabapentin|gabapentin|mesh-list
2929198|NCT03151746|Analgesics|analgesics|mesh-ancestor
2929199|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
2929200|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2929201|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929202|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
2929203|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2929204|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2929205|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2929206|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2341830|NCT00452244|Gefitinib|gefitinib|mesh-list
2341831|NCT00452244|Simvastatin|simvastatin|mesh-list
2341832|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2341833|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2341834|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
2341835|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341836|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2341837|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2111766|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
2111767|NCT02560025|Cytarabine|cytarabine|mesh-list
2111768|NCT02560025|Daunorubicin|daunorubicin|mesh-list
2111769|NCT02560025|Idarubicin|idarubicin|mesh-list
2111770|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2111771|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
2111772|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111773|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111774|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
2111775|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2111776|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2111777|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
2111778|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111779|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2929207|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2929208|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2929209|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2929210|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929211|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
2341838|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341839|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111780|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2341840|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2341841|NCT00452270|Xylometazoline|xylometazoline|mesh-list
2341842|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
2341843|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2341844|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
2341845|NCT00452296|Insulin|insulin|mesh-list
2341846|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2341847|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341848|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
2341849|NCT00452322|Testosterone|testosterone|mesh-list
2341850|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
2341851|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
2341852|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2341853|NCT00452322|Androgens|androgens|mesh-ancestor
2341854|NCT00452322|Hormones|hormones|mesh-ancestor
2341855|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341856|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341857|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2341858|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341859|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
2341860|NCT00452556|Docetaxel|docetaxel|mesh-list
2341861|NCT00452556|Leuprolide|leuprolide|mesh-list
2341862|NCT00452556|Androgens|androgens|mesh-list
2341863|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341864|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
2341865|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
2341866|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
2929273|NCT03073967|Foscarnet|foscarnet|mesh-list
2929274|NCT03073967|Pritelivir|pritelivir|mesh-list
2929275|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
2341867|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341868|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2929276|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2929277|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2929278|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2929279|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929280|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929281|NCT03071406|Nivolumab|nivolumab|mesh-list
2929282|NCT03071406|Ipilimumab|ipilimumab|mesh-list
2929283|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2929284|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929285|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2341869|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
2341870|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2341871|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341872|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2341873|NCT00452556|Hormones|hormones|mesh-ancestor
2341874|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341875|NCT00452569|Thalidomide|thalidomide|mesh-list
2341876|NCT00452569|Dexamethasone|dexamethasone|mesh-list
2341877|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2341878|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
2341879|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
2341880|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341881|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929286|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929287|NCT03065335|Ketamine|ketamine|mesh-list
2929288|NCT03065335|Analgesics|analgesics|mesh-ancestor
2929289|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
2929290|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2929291|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929292|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2929293|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2929294|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
2929295|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
2929296|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2341882|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2341883|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
2341884|NCT00452569|Hormones|hormones|mesh-ancestor
2341885|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341886|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2341887|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341888|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2341889|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
2341890|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
2341891|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2341892|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341893|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2341894|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2341895|NCT00452569|Growth Substances|growth substances|mesh-ancestor
2341896|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
2341897|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
2341898|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
2341899|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2341900|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2341901|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341902|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341903|NCT00452582|Urological Agents|urological agents|mesh-ancestor
2341904|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2341905|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2341906|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2341907|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2341908|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341909|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341910|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341911|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
2929297|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2929298|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2929299|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2929300|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929301|NCT03044314|Nitric Oxide|nitric oxide|mesh-list
2929302|NCT03044314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2929303|NCT03044314|Autonomic Agents|autonomic agents|mesh-ancestor
2929304|NCT03044314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2929305|NCT03044314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929306|NCT03044314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2929307|NCT03044314|Respiratory System Agents|respiratory system agents|mesh-ancestor
2929308|NCT03044314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2929309|NCT03044314|Antioxidants|antioxidants|mesh-ancestor
2929310|NCT03044314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929311|NCT03044314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2929312|NCT03044314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2341912|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2341913|NCT00452608|Atorvastatin|atorvastatin|mesh-list
2341914|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2341915|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2341916|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
2341917|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341918|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2929313|NCT03044314|Vasodilator Agents|vasodilator agents|mesh-ancestor
2929314|NCT03044314|Gasotransmitters|gasotransmitters|mesh-ancestor
2929315|NCT03044314|Protective Agents|protective agents|mesh-ancestor
2929316|NCT03036098|Gemcitabine|gemcitabine|mesh-list
2929317|NCT03036098|Carboplatin|carboplatin|mesh-list
2929318|NCT03036098|Nivolumab|nivolumab|mesh-list
2929319|NCT03036098|Ipilimumab|ipilimumab|mesh-list
2929320|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929321|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2929322|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
2929323|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929324|NCT03036098|Antiviral Agents|antiviral agents|mesh-ancestor
2929325|NCT03036098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2929326|NCT03036098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929327|NCT03036098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2929328|NCT03036098|Immunologic Factors|immunologic factors|mesh-ancestor
2929329|NCT03036098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929330|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2341919|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2341920|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341921|NCT00452634|Irinotecan|irinotecan|mesh-list
2341922|NCT00452634|Simvastatin|simvastatin|mesh-list
2341923|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341924|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2341925|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2341926|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341927|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341928|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2341929|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2341930|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
2341931|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2341932|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2341933|NCT00452660|Deferasirox|deferasirox|mesh-list
2341934|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2341935|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
2341936|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
2341937|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341938|NCT00452725|Hormones|hormones|mesh-list
2341939|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2341940|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341941|NCT00452829|Folic Acid|folic acid|mesh-list
2341942|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
2341943|NCT00452829|Inositol|inositol|mesh-list
2341944|NCT00452829|Hematinics|hematinics|mesh-ancestor
2341945|NCT00452829|Vitamins|vitamins|mesh-ancestor
2341946|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
2341947|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341948|NCT00452855|Remifentanil|remifentanil|mesh-list
2341949|NCT00452855|Sevoflurane|sevoflurane|mesh-list
2929331|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2929332|NCT03032172|Risdiplam|risdiplam|mesh-list
2929333|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2929334|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2929335|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929336|NCT03028857|Choline|choline|mesh-list
2929337|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
2929338|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2929339|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
2929340|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929341|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2929342|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2929343|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
2341950|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
2929344|NCT02997228|Leucovorin|leucovorin|mesh-list
2929345|NCT02997228|Bevacizumab|bevacizumab|mesh-list
2929346|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2929347|NCT02997228|Fluorouracil|fluorouracil|mesh-list
2929348|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
2929349|NCT02997228|Atezolizumab|atezolizumab|mesh-list
2929350|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
2929351|NCT02997228|Antibodies|antibodies|mesh-list
2929352|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
2929353|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2929354|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
2929355|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929356|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2929357|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2929358|NCT02997228|Growth Substances|growth substances|mesh-ancestor
2929359|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929360|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
2929361|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
2929362|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
2929363|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929364|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2929365|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2929366|NCT02997228|Antidotes|antidotes|mesh-ancestor
2929367|NCT02997228|Protective Agents|protective agents|mesh-ancestor
2929368|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
2929369|NCT02997228|Vitamins|vitamins|mesh-ancestor
2929370|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
2929380|NCT02974725|Trametinib|trametinib|mesh-list
2929381|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929382|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2929383|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929384|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929385|NCT02971501|Bevacizumab|bevacizumab|mesh-list
2929386|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2929387|NCT02971501|Osimertinib|osimertinib|mesh-list
2929388|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
2929389|NCT02971501|Antibodies|antibodies|mesh-list
2929390|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
2929391|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2929392|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
2929393|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929394|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2929395|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2929396|NCT02971501|Growth Substances|growth substances|mesh-ancestor
2929397|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929398|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
2929399|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
2929400|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929401|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2929402|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929403|NCT02970448|Temozolomide|temozolomide|mesh-list
2929404|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2929405|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
2929406|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929407|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929408|NCT02966093|Lenvatinib|lenvatinib|mesh-list
2929409|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929410|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2929411|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929412|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929413|NCT02953093|Acarbose|acarbose|mesh-list
2929414|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2929415|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929416|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929417|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2929418|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929419|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
2929420|NCT02936752|Entinostat|entinostat|mesh-list
2341951|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2341952|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341953|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2341954|NCT00452855|Narcotics|narcotics|mesh-ancestor
2341955|NCT00452855|Analgesics|analgesics|mesh-ancestor
2341956|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
2341957|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2341958|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2341959|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2341960|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
2341961|NCT00452881|Gemcitabine|gemcitabine|mesh-list
2341962|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
2341963|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341964|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2341965|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
2341966|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341967|NCT00452881|Antiviral Agents|antiviral agents|mesh-ancestor
2341968|NCT00452881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2929421|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2929422|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2929423|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929424|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929425|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929426|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
2929427|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2929428|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929429|NCT02921997|Vaccines|vaccines|mesh-list
2929430|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
2929431|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341969|NCT00452881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341970|NCT00452881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2341971|NCT00452881|Immunologic Factors|immunologic factors|mesh-ancestor
2341972|NCT00452881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341973|NCT00452894|Varenicline|varenicline|mesh-list
2341974|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2341975|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2341976|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
2341977|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2341978|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341979|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2341980|NCT00452907|Artesunate|artesunate|mesh-list
2341981|NCT00452907|Lumefantrine|lumefantrine|mesh-list
2341982|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
2341983|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
2341984|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2341985|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
2341986|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2341987|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2341988|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2341989|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2341990|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
2929485|NCT02890329|Ipilimumab|ipilimumab|mesh-list
2929486|NCT02890329|Decitabine|decitabine|mesh-list
2929487|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2929488|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929489|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2929490|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929491|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2929492|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
2929493|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929494|NCT02879162|Durvalumab|durvalumab|mesh-list
2929495|NCT02879162|Tremelimumab|tremelimumab|mesh-list
2929496|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2929497|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929498|NCT02822092|Risperidone|risperidone|mesh-list
2929499|NCT02822092|Aripiprazole|aripiprazole|mesh-list
2929500|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2929501|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
2929502|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2929503|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929504|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929505|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2341991|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
2341992|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2341993|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
2341994|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2341995|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2341996|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2341997|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2341998|NCT00452907|Renal Agents|renal agents|mesh-ancestor
2341999|NCT00452920|Docetaxel|docetaxel|mesh-list
2342000|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342001|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
2342002|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
2342003|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
2342004|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342005|NCT00452972|Anesthetics|anesthetics|mesh-list
2342006|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342007|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342008|NCT00452985|Carboplatin|carboplatin|mesh-list
2342009|NCT00452985|Docetaxel|docetaxel|mesh-list
2342010|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342011|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
2342012|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
2342013|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
2342014|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342015|NCT00453050|Imiquimod|imiquimod|mesh-list
2342016|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2342017|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
2342018|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929506|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2929507|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342019|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342020|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
2342021|NCT00453076|Paclitaxel|paclitaxel|mesh-list
2342022|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2342023|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342024|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
2929508|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2929509|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2929510|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
2929511|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
2929512|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
2929513|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2929514|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2929515|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2929516|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2342025|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
2342026|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
2929539|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
2342027|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342028|NCT00453115|Gemcitabine|gemcitabine|mesh-list
2342029|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
2342030|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2342031|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
2342032|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342033|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342034|NCT00453115|Antiviral Agents|antiviral agents|mesh-ancestor
2342035|NCT00453115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342036|NCT00453115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342037|NCT00453115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2342038|NCT00453115|Immunologic Factors|immunologic factors|mesh-ancestor
2342039|NCT00453115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342040|NCT00453141|Betamethasone|betamethasone|mesh-list
2342041|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2342042|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
2342043|NCT00453141|Hormones|hormones|mesh-ancestor
2342044|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2342045|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342046|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2342047|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
2929561|NCT02717416|Hemostatics|hemostatics|mesh-list
2929562|NCT02717416|Coagulants|coagulants|mesh-ancestor
2929563|NCT02712905|Nivolumab|nivolumab|mesh-list
2929564|NCT02712905|Azacitidine|azacitidine|mesh-list
2929565|NCT02712905|Tretinoin|tretinoin|mesh-list
2929566|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2929567|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929568|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2929569|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929570|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2929571|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
2929572|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929573|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
2929574|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
2929575|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
2929576|NCT02675946|Cetuximab|cetuximab|mesh-list
2929577|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2342048|NCT00453167|Gemcitabine|gemcitabine|mesh-list
2342049|NCT00453167|Paclitaxel|paclitaxel|mesh-list
2342050|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2342051|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342052|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
2342053|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
2342054|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
2342055|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342056|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2342057|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
2342058|NCT00453167|Antiviral Agents|antiviral agents|mesh-ancestor
2342059|NCT00453167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342060|NCT00453167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342061|NCT00453167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2342062|NCT00453167|Immunologic Factors|immunologic factors|mesh-ancestor
2342063|NCT00453167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929578|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929579|NCT02660827|Insulin|insulin|mesh-list
2929580|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2929581|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111781|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2111782|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111783|NCT02560038|Gemcitabine|gemcitabine|mesh-list
2929591|NCT02639273|Nalmefene|nalmefene|mesh-list
2929592|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2929593|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929594|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
2929595|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2929596|NCT02632045|Fulvestrant|fulvestrant|mesh-list
2111784|NCT02560038|Paclitaxel|paclitaxel|mesh-list
2111785|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2111786|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111787|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
2111788|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
2111789|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
2111790|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111791|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2111792|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
2111793|NCT02560038|Antiviral Agents|antiviral agents|mesh-ancestor
2111794|NCT02560038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2111795|NCT02560038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111796|NCT02560038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2111797|NCT02560038|Immunologic Factors|immunologic factors|mesh-ancestor
2111798|NCT02560038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111799|NCT02560051|Ketoconazole|ketoconazole|mesh-list
2929597|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2929598|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342064|NCT00453232|Etoposide|etoposide|mesh-list
2342065|NCT00453232|Bleomycin|bleomycin|mesh-list
2342066|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342067|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2342068|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2342069|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2342070|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342071|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342072|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2342073|NCT00453323|Paclitaxel|paclitaxel|mesh-list
2342074|NCT00453323|Capecitabine|capecitabine|mesh-list
2342075|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2342076|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342077|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
2342078|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
2342079|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
2342080|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342081|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2342082|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
2342083|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
2342084|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
2342085|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342086|NCT00453375|Protective Agents|protective agents|mesh-ancestor
2342087|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342088|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
2929599|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2929600|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2929601|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
2929602|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2929603|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929604|NCT02631941|Budesonide|budesonide|mesh-list
2929605|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
2929606|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2929607|NCT02631941|Charcoal|charcoal|mesh-list
2929608|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2929609|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2929610|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
2929611|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2929612|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929613|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2929614|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
2929615|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
2342089|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
2342090|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342091|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342092|NCT00453414|Iloprost|iloprost|mesh-list
2342093|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2342094|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
2342095|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
2342096|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2342097|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342098|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2342099|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
2342100|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342101|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
2342102|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2342103|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2342104|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342105|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2342106|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342107|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2342108|NCT00453531|Acetylcholine|acetylcholine|mesh-list
2342109|NCT00453531|Vasodilator Agents|vasodilator agents|mesh-ancestor
2342110|NCT00453531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2342111|NCT00453531|Cholinergic Agents|cholinergic agents|mesh-ancestor
2342112|NCT00453531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342113|NCT00453531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342114|NCT00453531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342115|NCT00453609|Naltrexone|naltrexone|mesh-list
2342116|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2929616|NCT02631941|Hormones|hormones|mesh-ancestor
2929617|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2929618|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2929619|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2929620|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2929621|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
2929622|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2929623|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929624|NCT02631941|Antidotes|antidotes|mesh-ancestor
2929625|NCT02631941|Protective Agents|protective agents|mesh-ancestor
2929626|NCT02627963|Sorafenib|sorafenib|mesh-list
2929627|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929628|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2929629|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929630|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929631|NCT02627274|Trastuzumab|trastuzumab|mesh-list
2929632|NCT02627274|Cetuximab|cetuximab|mesh-list
2929633|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2929634|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929643|NCT02567422|Cisplatin|cisplatin|mesh-list
2929644|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342117|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2342118|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342119|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
2342120|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2342121|NCT00453635|Carboplatin|carboplatin|mesh-list
2342122|NCT00453635|Docetaxel|docetaxel|mesh-list
2342123|NCT00453635|Trastuzumab|trastuzumab|mesh-list
2342124|NCT00453635|Vinorelbine|vinorelbine|mesh-list
2342125|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342126|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
2342127|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
2342128|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
2342129|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342130|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2342131|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2342132|NCT00453648|Vitamin A|vitamin a|mesh-list
2342133|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
2342134|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
2342135|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342136|NCT00453648|Protective Agents|protective agents|mesh-ancestor
2342137|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342138|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2342139|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342140|NCT00453648|Vitamins|vitamins|mesh-ancestor
2342141|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
2342142|NCT00453765|Montelukast|montelukast|mesh-list
2342143|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2342144|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
2342145|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2342146|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
2342147|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2342148|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929659|NCT02520063|Everolimus|everolimus|mesh-list
2929660|NCT02520063|Letrozole|letrozole|mesh-list
2929661|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929662|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2929663|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
2342149|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2929664|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929665|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2929666|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2929667|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929668|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929669|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2929670|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
2929671|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2929685|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
2929686|NCT02496676|Analgesics|analgesics|mesh-ancestor
2929687|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
2929688|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2929689|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929690|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
2929691|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2929692|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2929693|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
2929694|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2929695|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2929696|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929697|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2929698|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
2929699|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2929700|NCT02496663|Osimertinib|osimertinib|mesh-list
2929701|NCT02496663|Necitumumab|necitumumab|mesh-list
2929702|NCT02496663|Cetuximab|cetuximab|mesh-list
2929703|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2929704|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929705|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929706|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2929707|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929708|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2929709|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
2929710|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342150|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2342151|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342152|NCT00453778|Fluticasone|fluticasone|mesh-list
2342153|NCT00453778|Xhance|xhance|mesh-list
2342154|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2342155|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2342156|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
2342157|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2342158|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342159|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2342160|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
2342161|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
2342162|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2342163|NCT00453804|Naltrexone|naltrexone|mesh-list
2342164|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2342165|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2342166|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342167|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
2342168|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2342169|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
2929713|NCT02437370|Gemcitabine|gemcitabine|mesh-list
2929714|NCT02437370|Docetaxel|docetaxel|mesh-list
2929715|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
2929716|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2929717|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
2929718|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929719|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929720|NCT02437370|Antiviral Agents|antiviral agents|mesh-ancestor
2929721|NCT02437370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342170|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
2342171|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2342172|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
2342173|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2342174|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2342175|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342176|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2342177|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342178|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342179|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2342180|NCT00453856|Renal Agents|renal agents|mesh-ancestor
2342181|NCT00453908|Alfuzosin|alfuzosin|mesh-list
2342182|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2342183|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2342184|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2342185|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
2342186|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342187|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342188|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342189|NCT00453908|Urological Agents|urological agents|mesh-ancestor
2342190|NCT00453960|Norethindrone|norethindrone|mesh-list
2342191|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
2342192|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2342193|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2342194|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2342195|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
2342196|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2342197|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929722|NCT02437370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929723|NCT02437370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2929724|NCT02437370|Immunologic Factors|immunologic factors|mesh-ancestor
2929725|NCT02437370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929726|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
2929727|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
2929728|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
2929729|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2929730|NCT02437110|Ritonavir|ritonavir|mesh-list
2929731|NCT02437110|Darunavir|darunavir|mesh-list
2929732|NCT02437110|Tenofovir|tenofovir|mesh-list
2929733|NCT02437110|Dolutegravir|dolutegravir|mesh-list
2929734|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2929735|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2929736|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
2929737|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929738|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929739|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2929740|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2929741|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
2929742|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2929743|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2929744|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2929745|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2929746|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2929747|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2929748|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2929749|NCT02425644|Teriflunomide|teriflunomide|mesh-list
2342198|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2342199|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2342200|NCT00454168|Sargramostim|sargramostim|mesh-list
2342201|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
2342202|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342203|NCT00454233|Metformin|metformin|mesh-list
2342204|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2342205|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342206|NCT00454259|Fentanyl|fentanyl|mesh-list
2342207|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2929750|NCT02425644|Ponesimod|ponesimod|mesh-list
2929751|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2929752|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2929753|NCT02425644|Analgesics|analgesics|mesh-ancestor
2929754|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
2929755|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2929756|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929757|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2342208|NCT00454259|Narcotics|narcotics|mesh-ancestor
2342209|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342210|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342211|NCT00454259|Analgesics|analgesics|mesh-ancestor
2342212|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
2342213|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2342214|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2342215|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2342216|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
2342217|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
2342218|NCT00454272|Vancomycin|vancomycin|mesh-list
2342219|NCT00454272|Teicoplanin|teicoplanin|mesh-list
2342220|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2342221|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2929758|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2929759|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2929760|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
2929761|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2929762|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342222|NCT00454285|Amoxicillin|amoxicillin|mesh-list
2342223|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2342224|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342225|NCT00454337|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2342226|NCT00454337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2342227|NCT00454337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2342228|NCT00454337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342229|NCT00454337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342230|NCT00454337|Antiviral Agents|antiviral agents|mesh-ancestor
2342231|NCT00454337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342232|NCT00454337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2342233|NCT00454337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2929763|NCT02415153|Pomalidomide|pomalidomide|mesh-list
2929764|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
2929765|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929766|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2929767|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2929768|NCT02415153|Growth Substances|growth substances|mesh-ancestor
2929769|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
2929770|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929776|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2929777|NCT02395614|Gentamicins|gentamicins|mesh-list
2929778|NCT02395614|Cefazolin|cefazolin|mesh-list
2929779|NCT02395614|Bacitracin|bacitracin|mesh-list
2929780|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
2929781|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2929782|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2929783|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
2929784|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2929785|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929786|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929787|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
2929788|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929789|NCT02379416|Paclitaxel|paclitaxel|mesh-list
2929790|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2929791|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929792|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
2342234|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2342235|NCT00454350|Vitamins|vitamins|mesh-ancestor
2342236|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
2342237|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342238|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2342239|NCT00454389|Ranibizumab|ranibizumab|mesh-list
2342240|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2342241|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2342242|NCT00454389|Growth Substances|growth substances|mesh-ancestor
2929793|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
2929794|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
2929795|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929796|NCT02345265|Olaparib|olaparib|mesh-list
2929797|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2929798|NCT02345265|Cediranib|cediranib|mesh-list
2929799|NCT02345265|Maleic acid|maleic acid|mesh-list
2929800|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929801|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929802|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929803|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2929804|NCT02340221|Fulvestrant|fulvestrant|mesh-list
2929805|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2929806|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929807|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2929808|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2929809|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
2929810|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2929811|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929812|NCT02317874|Paclitaxel|paclitaxel|mesh-list
2929813|NCT02317874|Carboplatin|carboplatin|mesh-list
2342243|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342244|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
2342245|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342246|NCT00454402|Alfuzosin|alfuzosin|mesh-list
2929814|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2929815|NCT02317874|Talazoparib|talazoparib|mesh-list
2929816|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2929817|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929818|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
2929819|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
2929820|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
2929821|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929822|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2929823|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929824|NCT02311920|Nivolumab|nivolumab|mesh-list
2929825|NCT02311920|Ipilimumab|ipilimumab|mesh-list
2929826|NCT02311920|Temozolomide|temozolomide|mesh-list
2929827|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2929828|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929829|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2929830|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929831|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2929832|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
2929863|NCT02270957|Abatacept|abatacept|mesh-list
2929864|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2929865|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929866|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929867|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2929868|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
2929869|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929870|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2929876|NCT02237508|Budesonide|budesonide|mesh-list
2929877|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
2929878|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2929879|NCT02237508|Charcoal|charcoal|mesh-list
2929880|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2929881|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2929882|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
2929883|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2929884|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929885|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2929886|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
2929887|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
2929888|NCT02237508|Hormones|hormones|mesh-ancestor
2929889|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2929890|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2929891|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2929892|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2342247|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2342248|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2342249|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2342250|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
2342251|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342252|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342253|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342254|NCT00454402|Urological Agents|urological agents|mesh-ancestor
2342255|NCT00454480|Cytarabine|cytarabine|mesh-list
2342256|NCT00454480|Fludarabine|fludarabine|mesh-list
2342257|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
2342258|NCT00454480|Azacitidine|azacitidine|mesh-list
2342259|NCT00454480|Melphalan|melphalan|mesh-list
2342260|NCT00454480|Busulfan|busulfan|mesh-list
2342261|NCT00454480|Daunorubicin|daunorubicin|mesh-list
2342262|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
2342263|NCT00454480|Clofarabine|clofarabine|mesh-list
2342264|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
2342265|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
2342266|NCT00454480|Tipifarnib|tipifarnib|mesh-list
2342267|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342268|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2342269|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
2929893|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
2929894|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2929895|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929896|NCT02237508|Antidotes|antidotes|mesh-ancestor
2929897|NCT02237508|Protective Agents|protective agents|mesh-ancestor
2929898|NCT02237183|Iloprost|iloprost|mesh-list
2929899|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2929900|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
2342270|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342271|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2342272|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
2342273|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342274|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
2342275|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342276|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342277|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2342278|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
2342279|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2342280|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2342281|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2929911|NCT02204085|Decitabine|decitabine|mesh-list
2929912|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2929913|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
2929914|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929915|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929916|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2929968|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2929969|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2929970|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929971|NCT02157883|Itraconazole|itraconazole|mesh-list
2929972|NCT02157883|Osimertinib|osimertinib|mesh-list
2929973|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
2929974|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2929975|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2342282|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2929976|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2929977|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342283|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2342284|NCT00454519|Mitomycins|mitomycins|mesh-list
2342285|NCT00454519|Mitomycin|mitomycin|mesh-list
2342286|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342287|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2929978|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2929979|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2929980|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
2929981|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2929982|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929983|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2929984|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2929985|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2342288|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
2342289|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342290|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2342291|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342292|NCT00454545|Atorvastatin|atorvastatin|mesh-list
2342293|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2342294|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2342295|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
2342296|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342297|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2342298|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2342299|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342300|NCT00454558|Riociguat|riociguat|mesh-list
2342301|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
2342302|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342303|NCT00454662|Amlodipine|amlodipine|mesh-list
2342304|NCT00454662|Olmesartan|olmesartan|mesh-list
2342305|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2342306|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2342307|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2342308|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2342309|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342310|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2342311|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342312|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
2342313|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2342314|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2342315|NCT00454701|Alefacept|alefacept|mesh-list
2342316|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
2342317|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
2342318|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342319|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
2929986|NCT02134925|Poly ICLC|poly iclc|mesh-list
2929987|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
2929988|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
2929989|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929990|NCT02133573|Progesterone|progesterone|mesh-list
2929991|NCT02133573|Progestins|progestins|mesh-ancestor
2929992|NCT02133573|Hormones|hormones|mesh-ancestor
2929993|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2929994|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2929995|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
2929996|NCT02101853|Leucovorin|leucovorin|mesh-list
2929997|NCT02101853|Folic Acid|folic acid|mesh-list
2929998|NCT02101853|Cytarabine|cytarabine|mesh-list
2929999|NCT02101853|Dexamethasone|dexamethasone|mesh-list
2930000|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
2930001|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
2930002|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2930003|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2930004|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2930005|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
2930006|NCT02101853|Methotrexate|methotrexate|mesh-list
2930007|NCT02101853|Etoposide|etoposide|mesh-list
2930008|NCT02101853|Vincristine|vincristine|mesh-list
2930009|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
2342320|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
2342321|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2342322|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2342323|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342324|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342325|NCT00454714|Urological Agents|urological agents|mesh-ancestor
2342326|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
2342327|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2342328|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2342329|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
2342330|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342331|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342332|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342333|NCT00454740|Urological Agents|urological agents|mesh-ancestor
2342339|NCT00454831|Chitosan|chitosan|mesh-list
2342340|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2930010|NCT02101853|Asparaginase|asparaginase|mesh-list
2930011|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
2930012|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
2930013|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
2930014|NCT02101853|Pegaspargase|pegaspargase|mesh-list
2930015|NCT02101853|Thioguanine|thioguanine|mesh-list
2930016|NCT02101853|Blinatumomab|blinatumomab|mesh-list
2930017|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2930018|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
2930019|NCT02101853|Antibodies|antibodies|mesh-list
2930020|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
2930021|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2930022|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2930023|NCT02101853|BB 1101|bb 1101|mesh-list
2930024|NCT02101853|Calcium|calcium|mesh-list
2930025|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
2930026|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
2930027|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2930028|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
2930029|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930030|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2930031|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2930032|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
2342341|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2342342|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
2342343|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342344|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2342345|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
2342346|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
2342347|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
2342348|NCT00454831|Coagulants|coagulants|mesh-ancestor
2930033|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930034|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930035|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2930036|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2930037|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
2930038|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
2930039|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930040|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2930041|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
2930042|NCT02101853|Hormones|hormones|mesh-ancestor
2930043|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2930044|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2930045|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
2930046|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930047|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2930048|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2342349|NCT00454883|Ziprasidone|ziprasidone|mesh-list
2342350|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2342351|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
2342352|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342353|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342354|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342355|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2342356|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2342357|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342358|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2342359|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2342360|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
2930049|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2342361|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
2930050|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
2930051|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2930052|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2930053|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
2930054|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
2930055|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2930056|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2930057|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2930058|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2930059|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2930060|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
2930061|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930062|NCT02101853|Antidotes|antidotes|mesh-ancestor
2930063|NCT02101853|Protective Agents|protective agents|mesh-ancestor
2930064|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
2930065|NCT02101853|Vitamins|vitamins|mesh-ancestor
2930066|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
2930067|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
2930068|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
2930069|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
2930070|NCT02101853|Hematinics|hematinics|mesh-ancestor
2930071|NCT02101853|Analgesics|analgesics|mesh-ancestor
2930072|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
2930073|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
2930074|NCT02054104|Celecoxib|celecoxib|mesh-list
2930075|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
2930076|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2930077|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
2930078|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930079|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2930080|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2930081|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
2930082|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930083|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930084|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2930085|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2930086|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2930087|NCT02054104|Analgesics|analgesics|mesh-ancestor
2930088|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
2930089|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2342362|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2342363|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2342364|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
2342365|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342366|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342367|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342368|NCT00454896|Urological Agents|urological agents|mesh-ancestor
2342369|NCT00454961|Lumefantrine|lumefantrine|mesh-list
2342370|NCT00454961|Artemether|artemether|mesh-list
2342371|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2342372|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
2342373|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2342374|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2342375|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342376|NCT00455026|Remifentanil|remifentanil|mesh-list
2930090|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2930091|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2930092|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2930093|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930094|NCT01954979|Abatacept|abatacept|mesh-list
2930095|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2930096|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930097|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930098|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2930099|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
2930100|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930101|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2930102|NCT01899144|Albuterol|albuterol|mesh-list
2930103|NCT01899144|Procaterol|procaterol|mesh-list
2930104|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2930105|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
2930106|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930107|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930108|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2342377|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2930109|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
2930110|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
2342378|NCT00455026|Narcotics|narcotics|mesh-ancestor
2342379|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342380|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342381|NCT00455026|Analgesics|analgesics|mesh-ancestor
2342382|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
2342383|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2342384|NCT00455039|Lapatinib|lapatinib|mesh-list
2930111|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2930112|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2930113|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2930114|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2930115|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
2930116|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930117|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930118|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
2930119|NCT01853631|Cyclophosphamide|cyclophosphamide|mesh-list
2930120|NCT01853631|Fludarabine|fludarabine|mesh-list
2930121|NCT01853631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2930122|NCT01853631|Immunologic Factors|immunologic factors|mesh-ancestor
2342385|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342386|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2342387|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342388|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342389|NCT00455091|Lamivudine|lamivudine|mesh-list
2342390|NCT00455091|Adefovir|adefovir|mesh-list
2342391|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2342392|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2342393|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2342394|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342395|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342396|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
2342397|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342398|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2342399|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2342400|NCT00455117|Parecoxib|parecoxib|mesh-list
2930123|NCT01853631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930124|NCT01853631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2930125|NCT01853631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2930126|NCT01853631|Alkylating Agents|alkylating agents|mesh-ancestor
2930127|NCT01853631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930128|NCT01853631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930129|NCT01853631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2930137|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2930138|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
2930139|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930140|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2930141|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
2930142|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930143|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930144|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2930145|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2930146|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2930147|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
2930148|NCT01724879|Dasatinib|dasatinib|mesh-list
2930149|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930150|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2930151|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342401|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2342402|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2342403|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342404|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342405|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2342406|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2342407|NCT00455117|Analgesics|analgesics|mesh-ancestor
2342408|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
2342409|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930152|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930153|NCT01631617|Doxycycline|doxycycline|mesh-list
2930154|NCT01631617|Cephalexin|cephalexin|mesh-list
2930155|NCT01631617|Trimethoprim|trimethoprim|mesh-list
2930156|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
2930157|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2930158|NCT01631617|Eusol|eusol|mesh-list
2930159|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2930160|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930161|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
2930162|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2930163|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2930164|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2930165|NCT01631617|Renal Agents|renal agents|mesh-ancestor
2930166|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2930167|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930168|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930169|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2930170|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2930171|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2930172|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
2930173|NCT01485861|Prednisone|prednisone|mesh-list
2930174|NCT01485861|Prednisolone|prednisolone|mesh-list
2930175|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2930176|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
2930177|NCT01485861|Hormones|hormones|mesh-ancestor
2930178|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2930179|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930180|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2930181|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930182|NCT01468831|Minocycline|minocycline|mesh-list
2930183|NCT01468831|Bevacizumab|bevacizumab|mesh-list
2930184|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2930185|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342410|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342411|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2342412|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2342413|NCT00455130|Mannitol|mannitol|mesh-list
2342414|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2342415|NCT00455130|Diuretics|diuretics|mesh-ancestor
2342416|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
2342417|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342418|NCT00455156|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2342419|NCT00455156|ST 1435|st 1435|mesh-list
2930186|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2930187|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2930188|NCT01468831|Growth Substances|growth substances|mesh-ancestor
2930189|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930190|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
2930191|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2930192|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930214|NCT01383109|Pyronaridine|pyronaridine|mesh-list
2342420|NCT00455156|Estradiol|estradiol|mesh-list
2930215|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
2930216|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2930217|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2930218|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342421|NCT00455156|Estrogens|estrogens|mesh-ancestor
2342422|NCT00455156|Hormones|hormones|mesh-ancestor
2342423|NCT00455156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2342424|NCT00455156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342425|NCT00455156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2342426|NCT00455156|Contraceptive Agents|contraceptive agents|mesh-ancestor
2342427|NCT00455156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2342428|NCT00455156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2342429|NCT00455156|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2342430|NCT00455156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2342431|NCT00455234|Promethazine|promethazine|mesh-list
2342432|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
2342433|NCT00455234|Haloperidol|haloperidol|mesh-list
2342434|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
2342435|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
2342436|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
2342437|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2342438|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342439|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2342440|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2342441|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2342442|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342443|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2342444|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2111800|NCT02560051|Docetaxel|docetaxel|mesh-list
2111801|NCT02560051|Doxorubicin|doxorubicin|mesh-list
2111802|NCT02560051|Estramustine|estramustine|mesh-list
2111803|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111804|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
2111805|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
2111806|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
2111807|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111808|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2111809|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2111810|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2111811|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111812|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
2111813|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342445|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
2342446|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342447|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342448|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2342449|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
2342450|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
2342451|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2342452|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
2342453|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
2342454|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2342455|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2342456|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2342457|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
2342458|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
2342459|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
2342460|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
2342461|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2111814|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2930257|NCT01059786|Rituximab|rituximab|mesh-list
2930258|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2930259|NCT01059786|Pentostatin|pentostatin|mesh-list
2930260|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2930261|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930262|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
2930263|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930264|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2930265|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2930266|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
2930267|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930268|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2930269|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342462|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2342463|NCT00455286|Prednisolone|prednisolone|mesh-list
2342464|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
2930285|NCT00822120|Prednisone|prednisone|mesh-list
2930286|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
2930287|NCT00822120|Dacarbazine|dacarbazine|mesh-list
2930288|NCT00822120|Doxorubicin|doxorubicin|mesh-list
2930289|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2930290|NCT00822120|Etoposide|etoposide|mesh-list
2930291|NCT00822120|Vincristine|vincristine|mesh-list
2930292|NCT00822120|Bleomycin|bleomycin|mesh-list
2930293|NCT00822120|Vinblastine|vinblastine|mesh-list
2930294|NCT00822120|Procarbazine|procarbazine|mesh-list
2930295|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2930296|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
2342465|NCT00455286|Methotrexate|methotrexate|mesh-list
2342466|NCT00455286|Temozolomide|temozolomide|mesh-list
2342467|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2930297|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930298|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2930299|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2930300|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
2930301|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930302|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930303|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2930304|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2930305|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2930306|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2930307|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342468|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
2342469|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2342470|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
2342471|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2342472|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342473|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2342474|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
2342475|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342476|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342477|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
2342478|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342479|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2342480|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2342481|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
2342482|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2342483|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2342484|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2342485|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
2342486|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2342487|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
2342488|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
2342489|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2342490|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2342491|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
2342492|NCT00455286|Hormones|hormones|mesh-ancestor
2342493|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2342494|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2342495|NCT00455286|Protective Agents|protective agents|mesh-ancestor
2930308|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2930309|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
2930310|NCT00822120|Hormones|hormones|mesh-ancestor
2342496|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2342497|NCT00455325|Chloroquine|chloroquine|mesh-list
2342498|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2342499|NCT00455325|Amebicides|amebicides|mesh-ancestor
2342500|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2342501|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2342502|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342503|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
2930311|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2930312|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2930313|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2930314|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
2930315|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
2930316|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
2930317|NCT00799110|Imiquimod|imiquimod|mesh-list
2930318|NCT00799110|Vaccines|vaccines|mesh-list
2930319|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
2930320|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930321|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2930322|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930323|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
2930326|NCT00697684|Clofarabine|clofarabine|mesh-list
2930327|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2930328|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2342504|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2342505|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2342506|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2342507|NCT00455325|Analgesics|analgesics|mesh-ancestor
2342508|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
2342509|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2342510|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342511|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2342512|NCT00455325|Filaricides|filaricides|mesh-ancestor
2342513|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
2342514|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
2342515|NCT00455351|Vorinostat|vorinostat|mesh-list
2342516|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342517|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2342518|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342519|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342520|NCT00455364|Voriconazole|voriconazole|mesh-list
2342521|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
2342522|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342523|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2930329|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
2930330|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930331|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930332|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
2930333|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930334|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2930335|NCT00603954|Vidarabine|vidarabine|mesh-list
2930336|NCT00603954|Fludarabine|fludarabine|mesh-list
2930337|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
2930338|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2930339|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930340|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2930341|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
2930342|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930343|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2930344|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
2930345|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930346|NCT00603954|Antiviral Agents|antiviral agents|mesh-ancestor
2930347|NCT00603954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930348|NCT00392353|Azacitidine|azacitidine|mesh-list
2930349|NCT00392353|Vorinostat|vorinostat|mesh-list
2930350|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2930351|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
2930352|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930353|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930354|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930355|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2930384|NCT00003777|Fluorouracil|fluorouracil|mesh-list
2930385|NCT00003777|Amifostine|amifostine|mesh-list
2930386|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342524|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2342525|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342526|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342527|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2342528|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
2342529|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2342530|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930387|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
2930388|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930389|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2930390|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2930391|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
2930392|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930393|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2930394|NCT00003777|Protective Agents|protective agents|mesh-ancestor
2342531|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2342532|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
2342533|NCT00455416|Selenium|selenium|mesh-list
2342534|NCT00455416|Allicin|allicin|mesh-list
2342535|NCT00455416|Resveratrol|resveratrol|mesh-list
2342536|NCT00455416|Quercetin|quercetin|mesh-list
2342537|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
2342538|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342539|NCT00455416|Protective Agents|protective agents|mesh-ancestor
2342540|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342541|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342542|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2342543|NCT00455416|Trace Elements|trace elements|mesh-ancestor
2342544|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
2342545|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342546|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2342547|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
2342548|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2342549|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2342550|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2342551|NCT00455442|Mifepristone|mifepristone|mesh-list
2342552|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2342553|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
2342554|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2930395|NCT05214599|Budesonide|budesonide|mesh-list
2930396|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2930397|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2930398|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
2930399|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930400|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930401|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2930402|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
2930403|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
2930404|NCT05214599|Hormones|hormones|mesh-ancestor
2930405|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2930406|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2342555|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342556|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2342557|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2342558|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2342559|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
2342560|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2342561|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2342562|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
2342563|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2342564|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
2342565|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2342566|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2342567|NCT00455507|Istradefylline|istradefylline|mesh-list
2342568|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2342569|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2342570|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2342571|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
2342572|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342573|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930407|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2930408|NCT05214573|Glucagon|glucagon|mesh-list
2930409|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2930410|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2930411|NCT05214573|Hormones|hormones|mesh-ancestor
2930412|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2930413|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930414|NCT05214573|Incretins|incretins|mesh-ancestor
2930415|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
2930416|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930417|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930418|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2930419|NCT05214417|Ketamine|ketamine|mesh-list
2930420|NCT05214417|Analgesics|analgesics|mesh-ancestor
2930421|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
2930422|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930423|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930424|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2930425|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2930426|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
2930427|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
2930428|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2930429|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2930430|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2930431|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930432|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930433|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
2930434|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930435|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2930436|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930437|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930438|NCT05214339|Bevacizumab|bevacizumab|mesh-list
2930439|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2930440|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930441|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2930442|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2930443|NCT05214339|Growth Substances|growth substances|mesh-ancestor
2930444|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930445|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
2930446|NCT05214287|Nitrox|nitrox|mesh-list
2930447|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2930448|NCT05214287|Protective Agents|protective agents|mesh-ancestor
2930449|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930450|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2930451|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930452|NCT05214222|Paclitaxel|paclitaxel|mesh-list
2930453|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2930454|NCT05214222|Cisplatin|cisplatin|mesh-list
2930455|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2930456|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930457|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
2930458|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
2342574|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342575|NCT00455559|Imatinib Mesylate|imatinib mesylate|mesh-list
2342576|NCT00455559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342577|NCT00455559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2342578|NCT00455559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342579|NCT00455559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342580|NCT00455572|Vinorelbine|vinorelbine|mesh-list
2342581|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342582|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2342583|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
2342584|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
2342585|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
2342586|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342587|NCT00455585|Lamivudine|lamivudine|mesh-list
2342588|NCT00455585|Nevirapine|nevirapine|mesh-list
2342589|NCT00455585|Stavudine|stavudine|mesh-list
2342590|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2342591|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2342592|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342593|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342594|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
2342595|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342596|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2342597|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2342598|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2342599|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2930459|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
2930460|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930461|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
2930462|NCT05214196|Povidone|povidone|mesh-list
2930463|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
2342600|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
2342601|NCT00455624|Androgens|androgens|mesh-list
2342602|NCT00455624|Hormones|hormones|mesh-ancestor
2342603|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2342604|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342605|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
2342606|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2342607|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2342608|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2342609|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2342610|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342611|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
2342612|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342613|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930464|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
2930465|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2930466|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930467|NCT05214183|Rituximab|rituximab|mesh-list
2930468|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
2930469|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2930470|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930471|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
2930472|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930473|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2930474|NCT05214157|Bupivacaine|bupivacaine|mesh-list
2930475|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
2930476|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
2930477|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2930478|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930479|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
2930480|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930481|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
2930482|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
2342614|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2342615|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2342616|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
2342617|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
2342618|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2342619|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2342620|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342621|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342622|NCT00455715|Urological Agents|urological agents|mesh-ancestor
2342623|NCT00455754|Esomeprazole|esomeprazole|mesh-list
2342624|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2342625|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2342626|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2342627|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342628|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342629|NCT00455806|Amoxicillin|amoxicillin|mesh-list
2342630|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
2342631|NCT00455806|Esomeprazole|esomeprazole|mesh-list
2342632|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2342633|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342634|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2930483|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930484|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2930485|NCT05214001|Almotriptan|almotriptan|mesh-list
2930486|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2930487|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
2930488|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930489|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342635|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2342636|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342637|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930490|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930491|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
2930492|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2930493|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2930494|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
2930495|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930496|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2930497|NCT05213884|Cisplatin|cisplatin|mesh-list
2930498|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930499|NCT05213832|Isoflurane|isoflurane|mesh-list
2930500|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2930501|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
2930502|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
2930503|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2930504|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930505|NCT05213728|Vaccines|vaccines|mesh-list
2930506|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
2930507|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930508|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
2930509|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2930510|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
2930511|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930512|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930513|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2930514|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
2930515|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2930516|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
2930517|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930518|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930519|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2930520|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
2342638|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342639|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2342640|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2342641|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2342642|NCT00455832|Ribavirin|ribavirin|mesh-list
2342643|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
2342644|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342645|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
2342646|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342647|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
2342648|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2342649|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
2342650|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2930521|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
2930522|NCT05213676|Protective Agents|protective agents|mesh-ancestor
2930523|NCT05213585|Ivermectin|ivermectin|mesh-list
2930524|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2930525|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930526|NCT05213507|Amikacin|amikacin|mesh-list
2342651|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342652|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2342653|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2342654|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2342655|NCT00455871|Ranibizumab|ranibizumab|mesh-list
2342656|NCT00455871|Verteporfin|verteporfin|mesh-list
2342657|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2342658|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2342659|NCT00455871|Growth Substances|growth substances|mesh-ancestor
2342660|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342661|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
2342662|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342663|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2342664|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
2342665|NCT00455897|Rituximab|rituximab|mesh-list
2342666|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2342667|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342668|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
2342669|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342670|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2342671|NCT00455910|Thalidomide|thalidomide|mesh-list
2342672|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2342673|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
2342674|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342675|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
2342676|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2930527|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2930528|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930529|NCT05213481|Tepotinib|tepotinib|mesh-list
2930530|NCT05213481|Carbamazepine|carbamazepine|mesh-list
2930531|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
2930532|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
2930533|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2930534|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2930535|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930536|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2930537|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2930538|NCT05213481|Analgesics|analgesics|mesh-ancestor
2930539|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
2930540|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930541|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2342677|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342678|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2342679|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2342680|NCT00455910|Growth Substances|growth substances|mesh-ancestor
2342681|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
2342682|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930542|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2930543|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930544|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2930545|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2930546|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930547|NCT05213312|Paclitaxel|paclitaxel|mesh-list
2930548|NCT05213312|Fluorouracil|fluorouracil|mesh-list
2930549|NCT05213312|Nivolumab|nivolumab|mesh-list
2930550|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2930551|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930552|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
2930553|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
2930554|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
2930555|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930556|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
2930557|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2930558|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2930559|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
2930560|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930561|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2930562|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2930563|NCT05213221|Lenvatinib|lenvatinib|mesh-list
2930564|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342683|NCT00455936|Gefitinib|gefitinib|mesh-list
2342684|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342685|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2342686|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342687|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342688|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2342689|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2342690|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
2342691|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342692|NCT00456027|Antacids|antacids|mesh-ancestor
2342693|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342694|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2342695|NCT00456144|Hormones|hormones|mesh-list
2342696|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2342697|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342698|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
2342699|NCT00456235|Cyclosporine|cyclosporine|mesh-list
2342700|NCT00456235|Tacrolimus|tacrolimus|mesh-list
2342701|NCT00456235|Cyclosporins|cyclosporins|mesh-list
2342702|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2930565|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2930566|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930567|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930568|NCT05213208|Propofol|propofol|mesh-list
2930569|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2930570|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2930571|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930572|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2930573|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
2930574|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
2930575|NCT05213169|Apomorphine|apomorphine|mesh-list
2930576|NCT05213169|Emetics|emetics|mesh-ancestor
2930577|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930578|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
2930579|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930580|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2930581|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
2930582|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
2930583|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930584|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930585|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2930586|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2930587|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2930588|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2930589|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930590|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2930591|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2930592|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2930593|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2930594|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
2930595|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930596|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930597|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2930598|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2930599|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
2930600|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2930601|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2930602|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
2930603|NCT05213104|Flecainide|flecainide|mesh-list
2930604|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2930605|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2930606|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2930607|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2930608|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930609|NCT05213065|Bupivacaine|bupivacaine|mesh-list
2930610|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
2930611|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
2930612|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2930613|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930614|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
2930615|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930616|NCT05212857|Leuprolide|leuprolide|mesh-list
2930617|NCT05212857|Goserelin|goserelin|mesh-list
2342703|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
2342704|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342705|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2342706|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342707|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342708|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2342709|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342710|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2342711|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
2342712|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2342713|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342714|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
2342715|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
2342716|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2342717|NCT00456248|Ribavirin|ribavirin|mesh-list
2930618|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2930619|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
2930620|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2930621|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
2930622|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2930623|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930624|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2930625|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930626|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2930627|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930628|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930629|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
2930630|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2930631|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2930632|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
2930633|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2930634|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
2930635|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2930636|NCT05212766|Vaccines|vaccines|mesh-list
2930637|NCT05212766|Immunologic Factors|immunologic factors|mesh-ancestor
2930638|NCT05212766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930639|NCT05212662|Cysteamine|cysteamine|mesh-list
2930640|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2930641|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930642|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
2930643|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2930644|NCT05212623|Vaccines|vaccines|mesh-list
2930645|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
2930646|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930647|NCT05212597|Losartan|losartan|mesh-list
2930648|NCT05212597|Amlodipine|amlodipine|mesh-list
2930649|NCT05212597|Valsartan|valsartan|mesh-list
2930650|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2930651|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2930652|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2930653|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2930654|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342718|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
2342719|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
2342720|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342721|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
2342722|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342723|NCT00456313|Fluticasone|fluticasone|mesh-list
2342724|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2342725|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2342726|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
2342727|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2342728|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342729|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2342730|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
2342731|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
2342732|NCT00456313|Hormones|hormones|mesh-ancestor
2342733|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2342734|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
2342735|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2342736|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
2342737|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2342738|NCT00456339|Amoxicillin|amoxicillin|mesh-list
2342739|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
2342740|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
2930655|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2930656|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930657|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
2930658|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2930659|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2930660|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2930661|NCT05212571|Ketamine|ketamine|mesh-list
2930662|NCT05212571|Esketamine|esketamine|mesh-list
2930663|NCT05212571|Analgesics|analgesics|mesh-ancestor
2930664|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
2111815|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2342741|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2930665|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930666|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930667|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2930668|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2930669|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
2930670|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
2930671|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342742|NCT00456339|Prednisolone|prednisolone|mesh-list
2342743|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2342744|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
2342745|NCT00456339|Hormones|hormones|mesh-ancestor
2342746|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2342747|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342748|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2342749|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342750|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2342751|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930672|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2930673|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2930674|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930675|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930676|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
2930677|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2930678|NCT05212454|Capecitabine|capecitabine|mesh-list
2930679|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2930680|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
2930681|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930682|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930683|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
2930684|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
2930685|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2930686|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2930687|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930688|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2930689|NCT05212337|Denosumab|denosumab|mesh-list
2930690|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2930691|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930692|NCT05212311|Chitosan|chitosan|mesh-list
2930693|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2930694|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2930695|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
2930696|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930697|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2930698|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
2930699|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
2930700|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
2930701|NCT05212311|Coagulants|coagulants|mesh-ancestor
2930702|NCT05212246|Imiquimod|imiquimod|mesh-list
2930703|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2930704|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
2930705|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930706|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930707|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
2930708|NCT05212025|Gemcitabine|gemcitabine|mesh-list
2930709|NCT05212025|Adavosertib|adavosertib|mesh-list
2930710|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2930711|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
2930712|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930713|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930714|NCT05212025|Antiviral Agents|antiviral agents|mesh-ancestor
2930715|NCT05212025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930716|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342752|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2342753|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930717|NCT05212025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2930718|NCT05212025|Immunologic Factors|immunologic factors|mesh-ancestor
2930719|NCT05212025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930720|NCT05212012|Methadone|methadone|mesh-list
2930721|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2930722|NCT05212012|Narcotics|narcotics|mesh-ancestor
2930723|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2930724|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930725|NCT05212012|Analgesics|analgesics|mesh-ancestor
2930726|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
2930727|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930728|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
2930729|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
2930730|NCT05211947|BI 425809|bi 425809|mesh-list
2930731|NCT05211947|Nootropic Agents|nootropic agents|mesh-ancestor
2930732|NCT05211895|Durvalumab|durvalumab|mesh-list
2930733|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2930734|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930735|NCT05211804|Ranibizumab|ranibizumab|mesh-list
2930736|NCT05211804|Aflibercept|aflibercept|mesh-list
2930737|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930738|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2930739|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2930740|NCT05211804|Growth Substances|growth substances|mesh-ancestor
2930741|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930742|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
2930743|NCT05211791|Anesthetics|anesthetics|mesh-list
2930744|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2930745|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342754|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342755|NCT00456430|Citalopram|citalopram|mesh-list
2342756|NCT00456430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2342757|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2342758|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2342759|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342760|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342761|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
2342762|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342763|NCT00456430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2342764|NCT00456430|Antidepressive Agents|antidepressive agents|mesh-ancestor
2342765|NCT00456430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2342766|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2342767|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2342768|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
2342769|NCT00456482|Hormones|hormones|mesh-ancestor
2342770|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2342771|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342772|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
2342773|NCT00456560|Paroxetine|paroxetine|mesh-list
2342774|NCT00456560|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2342775|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2342776|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2342777|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342778|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342779|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
2342780|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342781|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2342782|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
2342783|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2342784|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2342785|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2342786|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342787|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2342788|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2342789|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342790|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2342791|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2342792|NCT00456586|Istradefylline|istradefylline|mesh-list
2342793|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2930746|NCT05211635|Vitamin D|vitamin d|mesh-list
2930747|NCT05211635|Vitamins|vitamins|mesh-ancestor
2930748|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
2930749|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930750|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2930751|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
2930752|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
2930753|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2930754|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2930755|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2930756|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930757|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
2342794|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2342795|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2342796|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
2342797|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342798|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342799|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342800|NCT00456677|Minocycline|minocycline|mesh-list
2342801|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2342802|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342803|NCT00456716|Sorafenib|sorafenib|mesh-list
2342804|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342805|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2342806|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342807|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930758|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
2930759|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
2930760|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930761|NCT05211622|Protective Agents|protective agents|mesh-ancestor
2930762|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930763|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
2342808|NCT00456729|Metronidazole|metronidazole|mesh-list
2342809|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2342810|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2342811|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2342812|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2342813|NCT00456794|Istradefylline|istradefylline|mesh-list
2342814|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2342815|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2342816|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2930764|NCT05211622|Vitamins|vitamins|mesh-ancestor
2930765|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
2930766|NCT05211609|Methyldopa|methyldopa|mesh-list
2930767|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2930768|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
2930769|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
2930770|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930771|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930772|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2930773|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2930774|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2930775|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
2930776|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342817|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
2342818|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342819|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342820|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342821|NCT00456820|Bupropion|bupropion|mesh-list
2342822|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2342823|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
2342824|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2342825|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2342826|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2342827|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2342828|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342829|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
2342830|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342831|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930777|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930778|NCT05211583|Progesterone|progesterone|mesh-list
2342832|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2342833|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2342834|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342835|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2930779|NCT05211583|Progestins|progestins|mesh-ancestor
2930780|NCT05211583|Hormones|hormones|mesh-ancestor
2930781|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2930782|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930783|NCT05211570|Azacitidine|azacitidine|mesh-list
2930784|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2930785|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
2930786|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930787|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930788|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342836|NCT00456833|Everolimus|everolimus|mesh-list
2342837|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342838|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2342839|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342840|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342841|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2342842|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
2342843|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342844|NCT00456872|Lidocaine|lidocaine|mesh-list
2342845|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
2342846|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
2342847|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342848|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342849|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
2930809|NCT05211323|Gemcitabine|gemcitabine|mesh-list
2930810|NCT05211323|Bevacizumab|bevacizumab|mesh-list
2930811|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2930812|NCT05211323|Cisplatin|cisplatin|mesh-list
2930813|NCT05211323|Atezolizumab|atezolizumab|mesh-list
2930814|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
2930815|NCT05211323|Antibodies|antibodies|mesh-list
2930816|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
2930817|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2930818|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
2930819|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930820|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2930821|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2930822|NCT05211323|Growth Substances|growth substances|mesh-ancestor
2930823|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930824|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
2930825|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
2930826|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2930827|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
2930828|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930829|NCT05211323|Antiviral Agents|antiviral agents|mesh-ancestor
2930830|NCT05211323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930831|NCT05211323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930832|NCT05211323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2930833|NCT05211154|Diclofenac|diclofenac|mesh-list
2930834|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2930835|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2930836|NCT05211154|Analgesics|analgesics|mesh-ancestor
2930837|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
2930838|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930839|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930840|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2930841|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2342850|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2342851|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2342852|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2342853|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2342854|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2342855|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930842|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2930843|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930844|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930845|NCT05211050|Cromakalim|cromakalim|mesh-list
2930846|NCT05211050|Sumatriptan|sumatriptan|mesh-list
2930847|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2930848|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2930849|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2930850|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
2930851|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930852|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930853|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930854|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2930855|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2930856|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
2930857|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930858|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2930859|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
2930860|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
2930861|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
2930862|NCT05211024|Penicillins|penicillins|mesh-list
2930863|NCT05211024|Penicillin G|penicillin g|mesh-list
2930864|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2930865|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
2930866|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2342856|NCT00456898|Codeine|codeine|mesh-list
2342857|NCT00456898|Paroxetine|paroxetine|mesh-list
2342858|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2342859|NCT00456898|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2342860|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2342861|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2342862|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342863|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342864|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
2342865|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342866|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2342867|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
2342868|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2930867|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930868|NCT05211011|Fosfomycin|fosfomycin|mesh-list
2930869|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2930870|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930871|NCT05210764|Ketamine|ketamine|mesh-list
2930872|NCT05210764|Anesthetics|anesthetics|mesh-list
2930873|NCT05210764|Propofol|propofol|mesh-list
2930874|NCT05210764|Sevoflurane|sevoflurane|mesh-list
2930875|NCT05210764|Esketamine|esketamine|mesh-list
2930876|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342869|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2342870|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2342871|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342872|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2342873|NCT00456898|Narcotics|narcotics|mesh-ancestor
2342874|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342875|NCT00456898|Analgesics|analgesics|mesh-ancestor
2342876|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
2342877|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2342878|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
2342879|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
2342880|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2342881|NCT00456937|Citalopram|citalopram|mesh-list
2342882|NCT00456937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2930877|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930878|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2930879|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2930880|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
2930881|NCT05210764|Analgesics|analgesics|mesh-ancestor
2930882|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
2342883|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2342884|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2342885|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342886|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342887|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
2342888|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342889|NCT00456937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2342890|NCT00456937|Antidepressive Agents|antidepressive agents|mesh-ancestor
2342891|NCT00456937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2342892|NCT00456963|Losartan|losartan|mesh-list
2930883|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930884|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2930885|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2930886|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2930887|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930888|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930889|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2930890|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2930891|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
2930892|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2930893|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
2930894|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2930895|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
2930896|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2930897|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
2930898|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930899|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930900|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
2930901|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
2930902|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
2930903|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930904|NCT05210595|Clopidogrel|clopidogrel|mesh-list
2930905|NCT05210595|Ticagrelor|ticagrelor|mesh-list
2930906|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2930907|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2342893|NCT00456963|Enalapril|enalapril|mesh-list
2342894|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2342895|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2342896|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2342897|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2342898|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342899|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2342900|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
2342901|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342902|NCT00456976|Selegiline|selegiline|mesh-list
2342903|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
2342904|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2342905|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2930908|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2930909|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2930910|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
2930911|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930912|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930913|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930914|NCT05210582|Afamelanotide|afamelanotide|mesh-list
2930915|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
2930916|NCT05210517|Empagliflozin|empagliflozin|mesh-list
2930917|NCT05210517|Benzbromarone|benzbromarone|mesh-list
2930918|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2930919|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930920|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2930921|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930922|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
2930923|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
2930924|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2930925|NCT05210517|Renal Agents|renal agents|mesh-ancestor
2930926|NCT05210465|Dobutamine|dobutamine|mesh-list
2342906|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2342907|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2342908|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342909|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342910|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2342911|NCT00456976|Protective Agents|protective agents|mesh-ancestor
2930927|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2930928|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
2930929|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
2930930|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930931|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930932|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2930933|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2930934|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2930935|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
2930936|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930937|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930938|NCT05210465|Protective Agents|protective agents|mesh-ancestor
2930939|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2930940|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2930941|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2930942|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
2930943|NCT05210413|Spartalizumab|spartalizumab|mesh-list
2930944|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2930945|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930946|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930947|NCT05210374|Copper|copper|mesh-list
2930948|NCT05210374|Doxorubicin|doxorubicin|mesh-list
2930949|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2930950|NCT05210374|Disulfiram|disulfiram|mesh-list
2930951|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2930952|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930953|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2930954|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2930955|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930956|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930957|NCT05210374|Trace Elements|trace elements|mesh-ancestor
2930958|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
2930959|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930960|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2930961|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2930962|NCT05210192|Lidocaine|lidocaine|mesh-list
2930963|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
2930964|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
2930965|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2930966|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930967|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
2930968|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2930969|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2930970|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2930971|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2342912|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342913|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
2342914|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
2342915|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2342916|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2930972|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2930973|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930974|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
2930975|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
2930976|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930977|NCT05210166|Protective Agents|protective agents|mesh-ancestor
2930978|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930979|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2930980|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2930981|NCT05210153|Sertraline|sertraline|mesh-list
2930982|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
2930983|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2930984|NCT05210153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2930985|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2930986|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2930987|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930988|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930989|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
2930990|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930991|NCT05210140|Citalopram|citalopram|mesh-list
2930992|NCT05210140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2930993|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2930994|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2342917|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342918|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
2342919|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2342920|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342921|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342922|NCT00457067|Ranibizumab|ranibizumab|mesh-list
2342923|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2342924|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2342925|NCT00457067|Growth Substances|growth substances|mesh-ancestor
2342926|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930995|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2930996|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2930997|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
2930998|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2930999|NCT05210140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2931000|NCT05210140|Antidepressive Agents|antidepressive agents|mesh-ancestor
2931001|NCT05210140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2931002|NCT05210062|Succinylcholine|succinylcholine|mesh-list
2931003|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2931004|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2931005|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2931006|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931007|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931008|NCT05209984|Topiramate|topiramate|mesh-list
2931009|NCT05209984|Sibutramine|sibutramine|mesh-list
2931010|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
2931011|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2931012|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931013|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
2931014|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2931015|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
2931016|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2931017|NCT05209906|Fentanyl|fentanyl|mesh-list
2931018|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2931019|NCT05209906|Narcotics|narcotics|mesh-ancestor
2931020|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931021|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931022|NCT05209906|Analgesics|analgesics|mesh-ancestor
2931023|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
2931024|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931025|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2931026|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2931027|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
2931028|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
2931029|NCT05209867|Cannabidiol|cannabidiol|mesh-list
2931030|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
2931031|NCT05209841|Heparin|heparin|mesh-list
2931032|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
2931033|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2931034|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2931035|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931036|NCT05209711|Lidocaine|lidocaine|mesh-list
2931037|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
2931038|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
2931039|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931040|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931041|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
2931042|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931043|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2931044|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2931045|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2931046|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2931047|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931048|NCT05209217|Ketamine|ketamine|mesh-list
2931049|NCT05209217|Analgesics|analgesics|mesh-ancestor
2931050|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
2931051|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931052|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931053|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2931054|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2931055|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
2931056|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
2931057|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931058|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2931059|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2931060|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931061|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931062|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2342927|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
2342928|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342929|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
2342930|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2342931|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111816|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2111817|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
2111818|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2111819|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111820|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2342932|NCT00457106|Risperidone|risperidone|mesh-list
2342933|NCT00457106|Paroxetine|paroxetine|mesh-list
2342934|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2342935|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
2342936|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342937|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342938|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342939|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2342940|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2342941|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342942|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2342943|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2342944|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
2342945|NCT00457106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2342946|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2342947|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2342948|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2342949|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
2342950|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2342951|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2342952|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342953|NCT00457119|Everolimus|everolimus|mesh-list
2342954|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342955|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2342956|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
2342957|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342958|NCT00457145|Ranibizumab|ranibizumab|mesh-list
2342959|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2342960|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2342961|NCT00457145|Growth Substances|growth substances|mesh-ancestor
2931063|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
2931064|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931065|NCT05191264|Analgesics|analgesics|mesh-list
2931066|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
2931067|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931068|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931069|NCT05190627|Loratadine|loratadine|mesh-list
2931070|NCT05190627|Sirolimus|sirolimus|mesh-list
2931071|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2931072|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2931073|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2931074|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931075|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
2931076|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2931077|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
2931078|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931079|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
2931080|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
2931081|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2111821|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2111822|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
2111823|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2111824|NCT02560389|Levodopa|levodopa|mesh-list
2111825|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2111826|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2111827|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
2111828|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111829|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111830|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111831|NCT02560558|Abatacept|abatacept|mesh-list
2342962|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342963|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
2342964|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2342965|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2931082|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2931083|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2931084|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
2931085|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
2931086|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931087|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931088|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
2931089|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931090|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2931091|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931092|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931093|NCT05188820|Cortisone|cortisone|mesh-list
2931094|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2931095|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2931096|NCT05188417|Tirofiban|tirofiban|mesh-list
2931097|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2931098|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2931099|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931100|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2931101|NCT05188326|Azacitidine|azacitidine|mesh-list
2931102|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2931103|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
2931104|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931105|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931106|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931107|NCT05187039|Anesthetics|anesthetics|mesh-list
2931108|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931109|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342966|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
2342967|NCT00457223|Coagulants|coagulants|mesh-ancestor
2342968|NCT00457275|Ezetimibe|ezetimibe|mesh-list
2342969|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2342970|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2342971|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
2342972|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342973|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2342974|NCT00457340|Atorvastatin|atorvastatin|mesh-list
2342975|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2342976|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2342977|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
2342978|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342979|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2342980|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2342981|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342982|NCT00457405|Dipyridamole|dipyridamole|mesh-list
2342983|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2931110|NCT05186454|Dexamethasone|dexamethasone|mesh-list
2931111|NCT05186454|Midazolam|midazolam|mesh-list
2931112|NCT05186454|Morphine|morphine|mesh-list
2931113|NCT05186454|Bupivacaine|bupivacaine|mesh-list
2931114|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2931115|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
2931116|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
2931117|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931118|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931119|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2931120|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
2931121|NCT05186454|Hormones|hormones|mesh-ancestor
2931122|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2931123|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2931124|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931125|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
2931126|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
2931127|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2342984|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2342985|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342986|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2342987|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
2342988|NCT00457457|Tamsulosin|tamsulosin|mesh-list
2342989|NCT00457457|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2342990|NCT00457457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2931128|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
2931129|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2931130|NCT05186454|Narcotics|narcotics|mesh-ancestor
2931131|NCT05186454|Analgesics|analgesics|mesh-ancestor
2931132|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2931133|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2931134|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2931135|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2931136|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2931137|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2931138|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
2931139|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
2931140|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
2931141|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931142|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2342991|NCT00457457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2342992|NCT00457457|Adrenergic Agents|adrenergic agents|mesh-ancestor
2342993|NCT00457457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2342994|NCT00457457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931150|NCT05184348|Acitretin|acitretin|mesh-list
2931151|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
2931152|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
2931153|NCT05179772|Olanzapine|olanzapine|mesh-list
2931154|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
2931155|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
2931156|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931157|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931158|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2931159|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2931160|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2931161|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931162|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2931163|NCT05179772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2931164|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2931165|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2931166|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931167|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931168|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
2931169|NCT05176483|Nivolumab|nivolumab|mesh-list
2931170|NCT05176483|Ipilimumab|ipilimumab|mesh-list
2931171|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2931172|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931173|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2931174|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931175|NCT05176080|Fulvestrant|fulvestrant|mesh-list
2931176|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2931177|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931178|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2931179|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2931180|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
2931181|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2931182|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931183|NCT05172245|Cisplatin|cisplatin|mesh-list
2931184|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931188|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
2931189|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2931190|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
2931191|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931192|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342995|NCT00457457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2342996|NCT00457457|Urological Agents|urological agents|mesh-ancestor
2342997|NCT00457470|Rucaparib|rucaparib|mesh-list
2342998|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2342999|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931193|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2931194|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
2931195|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
2931196|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2931197|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
2931198|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931199|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343000|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343001|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343002|NCT00457483|Valsartan|valsartan|mesh-list
2343003|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2343004|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2343005|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2931200|NCT05162898|Lenvatinib|lenvatinib|mesh-list
2931201|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931202|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2931203|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931204|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931205|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2931206|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
2343006|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2343007|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343008|NCT00457483|Diuretics|diuretics|mesh-ancestor
2343009|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
2343010|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343011|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2343012|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2343013|NCT00457509|Vaccines|vaccines|mesh-list
2343014|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
2343015|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343016|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2343017|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2343018|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2343019|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
2343020|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343021|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2343022|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2343023|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343024|NCT00457678|Dexamethasone|dexamethasone|mesh-list
2343025|NCT00457678|Ranibizumab|ranibizumab|mesh-list
2343026|NCT00457678|Verteporfin|verteporfin|mesh-list
2343027|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2343028|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
2343029|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
2343030|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343031|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343032|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2343033|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
2343034|NCT00457678|Hormones|hormones|mesh-ancestor
2343035|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2343036|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2343037|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343038|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2343039|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2343040|NCT00457678|Growth Substances|growth substances|mesh-ancestor
2343041|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
2343042|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2343043|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
2343044|NCT00457717|Atropine|atropine|mesh-list
2343045|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2343046|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2343047|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2343048|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
2343049|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931207|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931208|NCT05157126|Gentamicins|gentamicins|mesh-list
2931209|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2931210|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2931211|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2931212|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931213|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931214|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
2931215|NCT05156268|Olaparib|olaparib|mesh-list
2931216|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2343050|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343051|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2343052|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
2343053|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
2343054|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
2343055|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2931217|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931218|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2931219|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931220|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931221|NCT05156060|Ketamine|ketamine|mesh-list
2931222|NCT05156060|Gabapentin|gabapentin|mesh-list
2343056|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2343057|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
2343058|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343059|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343060|NCT00457769|Donepezil|donepezil|mesh-list
2343061|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2343062|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343063|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343064|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
2343065|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343066|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343067|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
2343068|NCT00457808|Sirolimus|sirolimus|mesh-list
2343069|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2343070|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343071|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2343072|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343073|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
2343074|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2343075|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
2343076|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343077|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
2343078|NCT00457860|Immunotoxins|immunotoxins|mesh-list
2343079|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
2931223|NCT05156060|Analgesics|analgesics|mesh-ancestor
2931224|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
2931225|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931226|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931227|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2931228|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2931229|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
2931230|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
2931231|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931232|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2931233|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2931234|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931235|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931236|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
2931237|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2931238|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2931239|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2931240|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
2931241|NCT05155137|Amlodipine|amlodipine|mesh-list
2931242|NCT05155137|Valsartan|valsartan|mesh-list
2931243|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2931244|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2931245|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2931246|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2931247|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931248|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2931249|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931250|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
2931251|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2931252|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2931253|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
2931254|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2931255|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2931256|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931257|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2931258|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2343080|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931267|NCT05153525|Cisatracurium|cisatracurium|mesh-list
2931268|NCT05153525|Atracurium|atracurium|mesh-list
2931269|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2931270|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2931271|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931272|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931273|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2931274|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2931275|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2931276|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
2931277|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931278|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931279|NCT05153239|Irinotecan|irinotecan|mesh-list
2931280|NCT05153239|Topotecan|topotecan|mesh-list
2931281|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2931282|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2931283|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931284|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931285|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931286|NCT05150938|Vitamin K|vitamin k|mesh-list
2931287|NCT05150938|Heparin|heparin|mesh-list
2931288|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2931289|NCT05150938|Tinzaparin|tinzaparin|mesh-list
2931290|NCT05150938|Dalteparin|dalteparin|mesh-list
2343081|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343082|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2343083|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
2931291|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
2931292|NCT05150938|Vitamins|vitamins|mesh-ancestor
2931293|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
2931294|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931295|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
2931296|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2931297|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2931298|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931299|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2931300|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
2931301|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2931302|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
2931303|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931304|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2931305|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
2931306|NCT05150938|Coagulants|coagulants|mesh-ancestor
2931313|NCT05148078|Anesthetics|anesthetics|mesh-list
2931314|NCT05148078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931315|NCT05148078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931316|NCT05145764|Suvorexant|suvorexant|mesh-list
2931317|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2931318|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2931319|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931320|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931321|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2931322|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931323|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931324|NCT05144295|Lactulose|lactulose|mesh-list
2931325|NCT05144295|Bisacodyl|bisacodyl|mesh-list
2931326|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
2931327|NCT05144295|Lubiprostone|lubiprostone|mesh-list
2931328|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2931329|NCT05144295|Cathartics|cathartics|mesh-ancestor
2931330|NCT05144295|Laxatives|laxatives|mesh-ancestor
2931331|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2931332|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2931333|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343084|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2343085|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2343086|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2343087|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2343088|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343089|NCT00457964|Everolimus|everolimus|mesh-list
2343090|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343091|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2931334|NCT05144243|Azacitidine|azacitidine|mesh-list
2931335|NCT05144243|Venetoclax|venetoclax|mesh-list
2931336|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2931337|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
2931338|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931339|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931340|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931341|NCT05142241|Temozolomide|temozolomide|mesh-list
2931342|NCT05142241|Talazoparib|talazoparib|mesh-list
2931343|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2931344|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
2931345|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931346|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931347|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2931348|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931349|NCT05139316|Prednisolone|prednisolone|mesh-list
2931350|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2931351|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
2343092|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
2343093|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343094|NCT00458003|Phenylephrine|phenylephrine|mesh-list
2343095|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
2343096|NCT00458003|Ephedrine|ephedrine|mesh-list
2343097|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2343098|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
2343099|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
2343100|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343101|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343102|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
2343103|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2343104|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
2343105|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
2343106|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2343107|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2343108|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2343109|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
2343110|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343111|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343112|NCT00458003|Protective Agents|protective agents|mesh-ancestor
2343113|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2343114|NCT00458042|Treprostinil|treprostinil|mesh-list
2343115|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2343116|NCT00458055|Niacin|niacin|mesh-list
2931352|NCT05139316|Hormones|hormones|mesh-ancestor
2931353|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2931354|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931355|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2931356|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931357|NCT05137067|Cisplatin|cisplatin|mesh-list
2931358|NCT05137067|Docetaxel|docetaxel|mesh-list
2931359|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
2931360|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
2931361|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
2931362|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
2931363|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931364|NCT05136846|Paclitaxel|paclitaxel|mesh-list
2931365|NCT05136846|Carboplatin|carboplatin|mesh-list
2931366|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2931367|NCT05136846|Durvalumab|durvalumab|mesh-list
2931368|NCT05136846|Papaverine|papaverine|mesh-list
2931369|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
2931370|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2931371|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
2931372|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2931373|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931374|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
2931375|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
2931376|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
2931377|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343117|NCT00458055|Atorvastatin|atorvastatin|mesh-list
2343118|NCT00458055|Fenofibrate|fenofibrate|mesh-list
2343119|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2343120|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2343121|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
2343122|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343123|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2343124|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2343125|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343126|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
2343127|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
2343128|NCT00458055|Vitamins|vitamins|mesh-ancestor
2343129|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
2343130|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343131|NCT00458081|Rimonabant|rimonabant|mesh-list
2343132|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2343133|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2343134|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2343135|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343136|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343137|NCT00458081|Hormones|hormones|mesh-ancestor
2343138|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2343139|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343140|NCT00458185|Etanercept|etanercept|mesh-list
2343141|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2343142|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2343143|NCT00458185|Analgesics|analgesics|mesh-ancestor
2343144|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
2343145|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343146|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343147|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2343148|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2343149|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2343150|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2343151|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
2343152|NCT00458250|Cyclosporine|cyclosporine|mesh-list
2343153|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
2343154|NCT00458250|Busulfan|busulfan|mesh-list
2343155|NCT00458250|Methotrexate|methotrexate|mesh-list
2343156|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
2343157|NCT00458250|Cyclosporins|cyclosporins|mesh-list
2343158|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2343159|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
2343160|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343161|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2343162|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2343163|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
2343164|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343165|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343166|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2343167|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2343168|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
2343169|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2343170|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2931378|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2931379|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
2931380|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931381|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2931382|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931383|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
2931384|NCT05136846|Urological Agents|urological agents|mesh-ancestor
2931385|NCT05134857|Zonisamide|zonisamide|mesh-list
2931386|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
2931387|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2931388|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2931389|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931390|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2931391|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931392|NCT05131152|Cyclosporine|cyclosporine|mesh-list
2931393|NCT05131152|Cyclosporins|cyclosporins|mesh-list
2931394|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931395|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931396|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2343171|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
2343172|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
2931397|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
2931398|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343173|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343174|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2343175|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2343176|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
2343177|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343178|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2343179|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2343180|NCT00458263|Hormones|hormones|mesh-list
2343181|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2343182|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343183|NCT00458276|Tezosentan|tezosentan|mesh-list
2343184|NCT00458276|Vasodilator Agents|vasodilator agents|mesh-ancestor
2931399|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
2931400|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2931401|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
2931402|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2931403|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2931404|NCT05130463|Empagliflozin|empagliflozin|mesh-list
2931405|NCT05130463|Linagliptin|linagliptin|mesh-list
2931406|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2931407|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931408|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2931409|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931410|NCT05130463|Incretins|incretins|mesh-ancestor
2931411|NCT05130463|Hormones|hormones|mesh-ancestor
2931412|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2931413|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2931414|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
2931415|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111832|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2111833|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111834|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111835|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2111836|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
2111837|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111838|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2111839|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2111840|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2111841|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
2111842|NCT02560779|Sorafenib|sorafenib|mesh-list
2111843|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111844|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2931416|NCT05129358|Furosemide|furosemide|mesh-list
2931417|NCT05129358|Diuretics|diuretics|mesh-ancestor
2931418|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
2931419|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931420|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2343185|NCT00458315|Gemcitabine|gemcitabine|mesh-list
2343186|NCT00458315|Paclitaxel|paclitaxel|mesh-list
2343187|NCT00458315|Bevacizumab|bevacizumab|mesh-list
2343188|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2343189|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343190|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
2343191|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
2343192|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
2343193|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343194|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2343195|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2343196|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2343197|NCT00458315|Growth Substances|growth substances|mesh-ancestor
2343198|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343199|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
2343200|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2931421|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2931422|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931423|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
2931424|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2931425|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
2931426|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2931427|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
2931428|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931429|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931430|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
2931431|NCT05123599|Tenofovir|tenofovir|mesh-list
2931432|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
2931433|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2931434|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2931435|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2931436|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931437|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931438|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2931439|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2931440|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
2931441|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2931442|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931447|NCT05113290|Sorafenib|sorafenib|mesh-list
2931448|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931449|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2931450|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931451|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931452|NCT05112952|Lazertinib|lazertinib|mesh-list
2931453|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2931454|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931455|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931456|NCT05107778|Entecavir|entecavir|mesh-list
2931457|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
2931458|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2931463|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2931464|NCT05102409|Lifitegrast|lifitegrast|mesh-list
2931465|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2931466|NCT05102071|Metformin|metformin|mesh-list
2931467|NCT05102071|Empagliflozin|empagliflozin|mesh-list
2931468|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2931469|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931470|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2931471|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931472|NCT05100628|Doxorubicin|doxorubicin|mesh-list
2931473|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2931474|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931475|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2931476|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2931477|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931478|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931479|NCT05097768|Dexamethasone|dexamethasone|mesh-list
2931480|NCT05097768|Ibuprofen|ibuprofen|mesh-list
2931481|NCT05097768|Ketorolac|ketorolac|mesh-list
2931482|NCT05097768|Meloxicam|meloxicam|mesh-list
2931483|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2931484|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
2931485|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
2343201|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
2343202|NCT00458315|Antiviral Agents|antiviral agents|mesh-ancestor
2343203|NCT00458315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2931486|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931487|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931488|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2931489|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
2931490|NCT05097768|Hormones|hormones|mesh-ancestor
2931491|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2931492|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2931493|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931494|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2931495|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2931496|NCT05097768|Analgesics|analgesics|mesh-ancestor
2931497|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
2931498|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2931499|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2931500|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343204|NCT00458315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931501|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931502|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2931503|NCT05097716|Tolbutamide|tolbutamide|mesh-list
2931504|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2931505|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931506|NCT05096884|Metoprolol|metoprolol|mesh-list
2931507|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2931508|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2931509|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
2931510|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
2931511|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343205|NCT00458315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2343206|NCT00458315|Immunologic Factors|immunologic factors|mesh-ancestor
2343207|NCT00458328|Z 338|z 338|mesh-list
2343208|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2343209|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343210|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343211|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
2343212|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343213|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343214|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2343215|NCT00458367|Risperidone|risperidone|mesh-list
2343216|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2343217|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
2343218|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343219|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343220|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343221|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2343222|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2343223|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2343224|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2343225|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2343226|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
2343227|NCT00458419|Naloxone|naloxone|mesh-list
2343228|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2343229|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343230|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
2343231|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343232|NCT00458458|Leuprolide|leuprolide|mesh-list
2343233|NCT00458458|Norethindrone|norethindrone|mesh-list
2343234|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
2343235|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2343236|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
2931512|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931513|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2931514|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2931515|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2931516|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
2931517|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931518|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343237|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2343238|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343239|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2343240|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343241|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2343242|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2343243|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2343244|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
2343245|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2343246|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2343247|NCT00458510|Fentanyl|fentanyl|mesh-list
2343248|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2343249|NCT00458510|Narcotics|narcotics|mesh-ancestor
2931519|NCT05095857|Ketamine|ketamine|mesh-list
2931520|NCT05095857|Esketamine|esketamine|mesh-list
2931521|NCT05095857|Analgesics|analgesics|mesh-ancestor
2931522|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
2931523|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343250|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2343251|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343252|NCT00458510|Analgesics|analgesics|mesh-ancestor
2343253|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
2343254|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343255|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2343256|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2343257|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
2343258|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
2343259|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
2343260|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2931524|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931525|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2931526|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2931527|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
2931528|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
2343261|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343262|NCT00458601|Temozolomide|temozolomide|mesh-list
2343263|NCT00458601|Molgramostim|molgramostim|mesh-list
2343264|NCT00458601|Rindopepimut|rindopepimut|mesh-list
2343265|NCT00458601|Sargramostim|sargramostim|mesh-list
2343266|NCT00458601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2343267|NCT00458601|Alkylating Agents|alkylating agents|mesh-ancestor
2343268|NCT00458601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343269|NCT00458601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343270|NCT00458601|Immunologic Factors|immunologic factors|mesh-ancestor
2931529|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931530|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2931531|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2931532|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931533|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931534|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
2931535|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2343271|NCT00458601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343272|NCT00458601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2343273|NCT00458614|Lansoprazole|lansoprazole|mesh-list
2343274|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
2343275|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2343276|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2343277|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2343278|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343279|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343280|NCT00458718|Rimonabant|rimonabant|mesh-list
2343281|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2343282|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2343283|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2343284|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343285|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343286|NCT00458718|Hormones|hormones|mesh-ancestor
2931536|NCT05084638|Ofatumumab|ofatumumab|mesh-list
2931537|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931538|NCT05083845|Anesthetics|anesthetics|mesh-list
2931539|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
2931540|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931541|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931542|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
2931543|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931544|NCT05083169|Dexamethasone|dexamethasone|mesh-list
2931545|NCT05083169|Bortezomib|bortezomib|mesh-list
2343287|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2343288|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343289|NCT00458731|Bevacizumab|bevacizumab|mesh-list
2343290|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2343291|NCT00458731|Cediranib|cediranib|mesh-list
2343292|NCT00458731|Antibodies|antibodies|mesh-list
2343293|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
2343294|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2343295|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343296|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2343297|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2343298|NCT00458731|Growth Substances|growth substances|mesh-ancestor
2931546|NCT05083169|Daratumumab|daratumumab|mesh-list
2931547|NCT05083169|Pomalidomide|pomalidomide|mesh-list
2931548|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2931549|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
2931550|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
2931551|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931552|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931553|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2343299|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931554|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
2343300|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
2931555|NCT05083169|Hormones|hormones|mesh-ancestor
2931556|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2931557|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2931558|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931559|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
2931560|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2931561|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2931562|NCT05083169|Growth Substances|growth substances|mesh-ancestor
2931563|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
2931564|NCT05076877|Metformin|metformin|mesh-list
2931565|NCT05076877|Midazolam|midazolam|mesh-list
2931566|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2931567|NCT05076877|Lazertinib|lazertinib|mesh-list
2931568|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2931569|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931570|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2931571|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2931572|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931573|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2931574|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2931575|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2931576|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2931577|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
2931578|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
2931579|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
2931580|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
2931581|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931582|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931583|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2931584|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2931585|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
2931586|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2931587|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2931588|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931589|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2343301|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
2343302|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343303|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343304|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2343305|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
2343306|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2931590|NCT05076838|Diazepam|diazepam|mesh-list
2931591|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2931592|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
2111845|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111846|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111847|NCT02561078|Insulin|insulin|mesh-list
2111848|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2111849|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2111850|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111851|NCT02561130|Metformin|metformin|mesh-list
2111852|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
2111853|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
2111854|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2111855|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111856|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2931593|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
2931594|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
2931595|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931596|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931597|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2931598|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2931599|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931600|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2931601|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2931602|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2931603|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2931604|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2931605|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2931606|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
2931607|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
2931608|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
2931609|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
2931610|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931611|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931612|NCT05071664|Golimumab|golimumab|mesh-list
2931613|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2931614|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2931615|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2931616|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
2931617|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931618|NCT05070039|Antibodies|antibodies|mesh-list
2343307|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343308|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
2343309|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343310|NCT00458835|Ciclesonide|ciclesonide|mesh-list
2343311|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
2343312|NCT00458835|Hormones|hormones|mesh-ancestor
2343313|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2343314|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931619|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
2931620|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931621|NCT05063552|Bevacizumab|bevacizumab|mesh-list
2931622|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2931623|NCT05063552|Cetuximab|cetuximab|mesh-list
2931624|NCT05063552|Cisplatin|cisplatin|mesh-list
2931625|NCT05063552|Carboplatin|carboplatin|mesh-list
2931626|NCT05063552|Docetaxel|docetaxel|mesh-list
2931627|NCT05063552|Atezolizumab|atezolizumab|mesh-list
2931628|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
2931629|NCT05063552|Antibodies|antibodies|mesh-list
2931630|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
2931631|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2931632|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
2931633|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931634|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2931635|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2931636|NCT05063552|Growth Substances|growth substances|mesh-ancestor
2931637|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931638|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
2931639|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
2931640|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
2931641|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
2931642|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
2931643|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931644|NCT05060549|Cariprazine|cariprazine|mesh-list
2931645|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2931646|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2931647|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931648|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931649|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2931650|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
2931651|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2931652|NCT05058872|Estradiol|estradiol|mesh-list
2931653|NCT05058872|Estrogens|estrogens|mesh-ancestor
2931654|NCT05058872|Hormones|hormones|mesh-ancestor
2931655|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2931656|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931657|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2931658|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
2931659|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2931660|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2931661|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2931662|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2931663|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2931664|NCT05058651|Cisplatin|cisplatin|mesh-list
2931665|NCT05058651|Carboplatin|carboplatin|mesh-list
2931666|NCT05058651|Etoposide|etoposide|mesh-list
2931667|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
2931668|NCT05058651|Atezolizumab|atezolizumab|mesh-list
2931669|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
2931670|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2931671|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931672|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2931673|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2931674|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2931675|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931676|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931677|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
2931678|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931679|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
2931680|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
2931681|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
2931682|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
2931683|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
2931684|NCT05054881|Iodine|iodine|mesh-list
2931685|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2931686|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2931687|NCT05054881|Trace Elements|trace elements|mesh-ancestor
2931688|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
2931689|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343315|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2343316|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
2343317|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2343318|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343319|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2343320|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2343321|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343322|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343323|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343324|NCT00458913|Bortezomib|bortezomib|mesh-list
2343325|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343326|NCT00458978|Cediranib|cediranib|mesh-list
2343327|NCT00458978|Maleic acid|maleic acid|mesh-list
2343328|NCT00458978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343329|NCT00458978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343330|NCT00458978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343331|NCT00458978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2343332|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
2931695|NCT05050097|Lenalidomide|lenalidomide|mesh-list
2931696|NCT05050097|Pomalidomide|pomalidomide|mesh-list
2931697|NCT05050097|Daratumumab|daratumumab|mesh-list
2931698|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
2931699|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931700|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2931701|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2931702|NCT05050097|Growth Substances|growth substances|mesh-ancestor
2931703|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
2931704|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931705|NCT05048797|Carboplatin|carboplatin|mesh-list
2931706|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
2931707|NCT05048797|Trastuzumab|trastuzumab|mesh-list
2931708|NCT05048797|Pemetrexed|pemetrexed|mesh-list
2931709|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931710|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2931711|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931712|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931713|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2931714|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2931715|NCT05041907|Ivermectin|ivermectin|mesh-list
2931716|NCT05041907|Remdesivir|remdesivir|mesh-list
2931717|NCT05041907|Favipiravir|favipiravir|mesh-list
2931718|NCT05041907|Antibodies|antibodies|mesh-list
2931719|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2931720|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
2931721|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931722|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2931723|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2931724|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
2931725|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931726|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
2931727|NCT05041049|Anesthetics|anesthetics|mesh-list
2931728|NCT05041049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931729|NCT05041049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931730|NCT05038735|Fulvestrant|fulvestrant|mesh-list
2931731|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2931732|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931733|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2931734|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2931735|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
2931736|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2931737|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343333|NCT00458991|Caffeine|caffeine|mesh-list
2343334|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2343335|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343336|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2343337|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343338|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343339|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2343340|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2343341|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
2343342|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343343|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
2343344|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
2343345|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2343346|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2343347|NCT00459004|Rimonabant|rimonabant|mesh-list
2343348|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2343349|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2343350|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2343351|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343352|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343353|NCT00459004|Hormones|hormones|mesh-ancestor
2343354|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2343355|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343356|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
2343357|NCT00459173|Rimonabant|rimonabant|mesh-list
2343358|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2343359|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2343360|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2343361|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343362|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343363|NCT00459173|Hormones|hormones|mesh-ancestor
2343364|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2343365|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343366|NCT00459264|Folic Acid|folic acid|mesh-list
2343367|NCT00459264|Hematinics|hematinics|mesh-ancestor
2343368|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
2343369|NCT00459264|Vitamins|vitamins|mesh-ancestor
2343370|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
2343371|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343372|NCT00459277|Fentanyl|fentanyl|mesh-list
2343373|NCT00459277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2931786|NCT05024552|Cytarabine|cytarabine|mesh-list
2931787|NCT05024552|Daunorubicin|daunorubicin|mesh-list
2931788|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2931789|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
2931790|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931791|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931792|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
2931793|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2931794|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2931795|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
2931796|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931797|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2931798|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2931799|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2931800|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931801|NCT05020899|Nicotine|nicotine|mesh-list
2931802|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2931803|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
2931804|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931805|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343374|NCT00459277|Narcotics|narcotics|mesh-ancestor
2343375|NCT00459277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2343376|NCT00459277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343377|NCT00459277|Analgesics|analgesics|mesh-ancestor
2343378|NCT00459277|Sensory System Agents|sensory system agents|mesh-ancestor
2343379|NCT00459277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343380|NCT00459277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2343381|NCT00459277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2343382|NCT00459277|Anesthetics, General|anesthetics, general|mesh-ancestor
2343383|NCT00459277|Anesthetics|anesthetics|mesh-ancestor
2343384|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2343385|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
2343386|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343387|NCT00459407|Protective Agents|protective agents|mesh-ancestor
2343388|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343389|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2343390|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2343391|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343392|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2343393|NCT00459420|Caffeine|caffeine|mesh-list
2343394|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2343395|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343396|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2343397|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343398|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343399|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2343400|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2343401|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
2343402|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343403|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
2343404|NCT00459485|Astringents|astringents|mesh-ancestor
2343405|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343406|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
2343407|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
2343408|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2931806|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2931807|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2931808|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
2931809|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931810|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931811|NCT05020145|Vaccines|vaccines|mesh-list
2931812|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
2931813|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931814|NCT05013229|Insulin|insulin|mesh-list
2931815|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2931816|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
2931817|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
2931818|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2931819|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931823|NCT05008003|Vitamin D|vitamin d|mesh-list
2931824|NCT05008003|Vitamins|vitamins|mesh-ancestor
2931825|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
2931826|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111857|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111858|NCT02561273|Prednisone|prednisone|mesh-list
2111859|NCT02561273|Cortisone|cortisone|mesh-list
2111860|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
2111861|NCT02561273|Doxorubicin|doxorubicin|mesh-list
2111862|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2111863|NCT02561273|Etoposide|etoposide|mesh-list
2111864|NCT02561273|Vincristine|vincristine|mesh-list
2111865|NCT02561273|Lenalidomide|lenalidomide|mesh-list
2343409|NCT00459563|Vitamin D|vitamin d|mesh-list
2343410|NCT00459563|Calcitriol|calcitriol|mesh-list
2343411|NCT00459563|Vitamins|vitamins|mesh-ancestor
2343412|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
2343413|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343414|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2343415|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2343416|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2343417|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2343418|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343419|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2343420|NCT00459615|Artesunate|artesunate|mesh-list
2931827|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2931828|NCT05004662|Nicotine|nicotine|mesh-list
2931829|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2931830|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
2931831|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931832|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931833|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2931834|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2931835|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
2931836|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931837|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931838|NCT04999644|Nicotine|nicotine|mesh-list
2931839|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2931840|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
2931841|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931842|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931843|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2931844|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2931845|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
2931846|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931847|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931848|NCT04998604|Omalizumab|omalizumab|mesh-list
2931849|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2931850|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2931851|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
2931852|NCT04994717|Blinatumomab|blinatumomab|mesh-list
2931853|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931860|NCT04989699|Aflibercept|aflibercept|mesh-list
2931861|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2931862|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2931863|NCT04989699|Growth Substances|growth substances|mesh-ancestor
2931864|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931865|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
2931866|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931867|NCT04988295|Carboplatin|carboplatin|mesh-list
2931868|NCT04988295|Pemetrexed|pemetrexed|mesh-list
2111866|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
2343421|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
2931869|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
2931870|NCT04988295|Lazertinib|lazertinib|mesh-list
2931871|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343422|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2343423|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2931872|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931873|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931874|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2931875|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2931876|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2931877|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2931878|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
2343424|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343425|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343426|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
2931879|NCT04983238|Trastuzumab|trastuzumab|mesh-list
2931880|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2931881|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931882|NCT04983238|Antidotes|antidotes|mesh-ancestor
2931883|NCT04983238|Protective Agents|protective agents|mesh-ancestor
2931884|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931885|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
2931886|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931887|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
2931888|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2931889|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2931890|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
2931891|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
2931892|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2931893|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2931894|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
2931895|NCT04975308|Fulvestrant|fulvestrant|mesh-list
2931896|NCT04975308|Exemestane|exemestane|mesh-list
2931897|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2931898|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931899|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2931900|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2931901|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
2343427|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
2343428|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2343429|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
2343430|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2343431|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343432|NCT00459719|Tacrolimus|tacrolimus|mesh-list
2343433|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2343434|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
2343435|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343436|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2343437|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343438|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343439|NCT00459745|Fenofibrate|fenofibrate|mesh-list
2343440|NCT00459745|Pravastatin|pravastatin|mesh-list
2343441|NCT00459745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2343442|NCT00459745|Antimetabolites|antimetabolites|mesh-ancestor
2343443|NCT00459745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343444|NCT00459745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2343445|NCT00459745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2343446|NCT00459745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2343447|NCT00459745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343448|NCT00459771|Candesartan|candesartan|mesh-list
2343449|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2343450|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2343451|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2343452|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343453|NCT00459836|Gemcitabine|gemcitabine|mesh-list
2343454|NCT00459836|Docetaxel|docetaxel|mesh-list
2343455|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2931902|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2931903|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931904|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2931905|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2931906|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931907|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931908|NCT04975256|Adagrasib|adagrasib|mesh-list
2931909|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343456|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
2343457|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931910|NCT04973163|Midazolam|midazolam|mesh-list
2931911|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2931912|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2931913|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2343458|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343459|NCT00459836|Antiviral Agents|antiviral agents|mesh-ancestor
2343460|NCT00459836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343461|NCT00459836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343462|NCT00459836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2343463|NCT00459836|Immunologic Factors|immunologic factors|mesh-ancestor
2343464|NCT00459836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343465|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
2343466|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
2931914|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931915|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2931916|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2931917|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2931918|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2931919|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
2931920|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
2931921|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
2931922|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
2931923|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2931924|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931925|NCT04971785|Firsocostat|firsocostat|mesh-list
2931926|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931927|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931928|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
2931929|NCT04971226|Dasatinib|dasatinib|mesh-list
2931930|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931931|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2931932|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2931933|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931934|NCT04968366|Temozolomide|temozolomide|mesh-list
2931935|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2931936|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
2931937|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931938|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931939|NCT04965454|Choline|choline|mesh-list
2931940|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
2931941|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2931942|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
2931943|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931944|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2931945|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2931946|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
2931947|NCT04964700|Natalizumab|natalizumab|mesh-list
2931948|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
2931949|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931950|NCT04964128|Insulin|insulin|mesh-list
2931951|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2931952|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931958|NCT04958785|Paclitaxel|paclitaxel|mesh-list
2931959|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2931960|NCT04958785|Magrolimab|magrolimab|mesh-list
2931961|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2931962|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931963|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
2931964|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
2931965|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
2931966|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931967|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2931968|NCT04950764|Seladelpar|seladelpar|mesh-list
2931969|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2931970|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
2931971|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2931972|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2931973|NCT04948333|Niacinamide|niacinamide|mesh-list
2931974|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
2931975|NCT04948333|Vitamins|vitamins|mesh-ancestor
2931976|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
2931977|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931978|NCT04947007|Bupivacaine|bupivacaine|mesh-list
2343467|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
2343468|NCT00459901|Capecitabine|capecitabine|mesh-list
2343469|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2343470|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2343471|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
2343472|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343473|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343474|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2343475|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343476|NCT00459940|Pioglitazone|pioglitazone|mesh-list
2343477|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2343478|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343479|NCT00459992|Betahistine|betahistine|mesh-list
2343480|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
2111867|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
2111868|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2111869|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
2111870|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111871|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2111872|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2111873|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
2111874|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111875|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111876|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2343481|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
2931979|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
2931980|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
2931981|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2931982|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931983|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
2931984|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2931985|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
2931986|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2343482|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
2343483|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343484|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343485|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343486|NCT00460057|Alendronate|alendronate|mesh-list
2343487|NCT00460057|Diphosphonates|diphosphonates|mesh-list
2343488|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2343489|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343490|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
2343491|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2343492|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2343493|NCT00460083|Analgesics|analgesics|mesh-ancestor
2343494|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
2343495|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343496|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343497|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2343498|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2343499|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
2343500|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2343501|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
2343502|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2343503|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343504|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343505|NCT00460148|Ropinirole|ropinirole|mesh-list
2931987|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931988|NCT04942184|Complement Factor H|complement factor h|mesh-list
2931989|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2931990|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2931991|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
2931992|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2931995|NCT04940052|Trametinib|trametinib|mesh-list
2931996|NCT04940052|Dabrafenib|dabrafenib|mesh-list
2931997|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2931998|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2931999|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932000|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932001|NCT04939987|Acetaminophen|acetaminophen|mesh-list
2343506|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2932002|NCT04939987|Ketorolac|ketorolac|mesh-list
2932003|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2932004|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2932005|NCT04939987|Ketamine|ketamine|mesh-list
2932006|NCT04939987|Oxycodone|oxycodone|mesh-list
2932007|NCT04939987|Gabapentin|gabapentin|mesh-list
2932008|NCT04939987|Tramadol|tramadol|mesh-list
2932009|NCT04939987|Hydrocodone|hydrocodone|mesh-list
2932010|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
2932011|NCT04939987|Analgesics|analgesics|mesh-ancestor
2932012|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
2932013|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932014|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932015|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2932016|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2932017|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
2932018|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
2932019|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2932020|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2932021|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2932022|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2932023|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932024|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2932025|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
2932026|NCT04939987|Narcotics|narcotics|mesh-ancestor
2932027|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
2932028|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2932029|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2932030|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2932031|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
2932032|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2932033|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2932034|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932035|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2932036|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932037|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
2343507|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2343508|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
2343509|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
2343510|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343511|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343512|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343513|NCT00460174|Gemcitabine|gemcitabine|mesh-list
2343514|NCT00460174|Bevacizumab|bevacizumab|mesh-list
2343515|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2343516|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343517|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2343518|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2343519|NCT00460174|Growth Substances|growth substances|mesh-ancestor
2343520|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343521|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
2343522|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2343523|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
2343524|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343525|NCT00460174|Antiviral Agents|antiviral agents|mesh-ancestor
2343526|NCT00460174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343527|NCT00460174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343528|NCT00460174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2343529|NCT00460174|Immunologic Factors|immunologic factors|mesh-ancestor
2343530|NCT00460213|Valsartan|valsartan|mesh-list
2343531|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2343532|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2343533|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2343534|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343535|NCT00460226|Lamotrigine|lamotrigine|mesh-list
2343536|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
2343537|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2343538|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2343539|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343540|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2343541|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343542|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2343543|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2932038|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
2932039|NCT04938830|Palivizumab|palivizumab|mesh-list
2343544|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2343545|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2343546|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2343547|NCT00460252|Insulin|insulin|mesh-list
2343548|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2343549|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932040|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
2932041|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2932042|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2932043|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2343550|NCT00460304|Pramlintide|pramlintide|mesh-list
2343551|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2343552|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343553|NCT00460317|Paclitaxel|paclitaxel|mesh-list
2343554|NCT00460317|Carboplatin|carboplatin|mesh-list
2343555|NCT00460317|Motesanib diphosphate|motesanib diphosphate|mesh-list
2343556|NCT00460317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2343557|NCT00460317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343558|NCT00460317|Tubulin Modulators|tubulin modulators|mesh-ancestor
2343559|NCT00460317|Antimitotic Agents|antimitotic agents|mesh-ancestor
2343560|NCT00460317|Mitosis Modulators|mitosis modulators|mesh-ancestor
2343561|NCT00460317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343562|NCT00460317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2343563|NCT00460317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343564|NCT00460369|Artesunate|artesunate|mesh-list
2932044|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2932045|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932046|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
2932047|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2932048|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932049|NCT04936230|Atezolizumab|atezolizumab|mesh-list
2932050|NCT04936230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2932051|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932052|NCT04936230|Immunologic Factors|immunologic factors|mesh-ancestor
2932053|NCT04936230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932054|NCT04935177|Antibodies|antibodies|mesh-list
2932055|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
2932056|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2932057|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
2932058|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2932059|NCT04935177|Eculizumab|eculizumab|mesh-list
2932060|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
2932061|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932062|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2343565|NCT00460369|Lumefantrine|lumefantrine|mesh-list
2343566|NCT00460369|Artemether|artemether|mesh-list
2343567|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
2343568|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
2343569|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2343570|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2343571|NCT00460369|Amodiaquine|amodiaquine|mesh-list
2343572|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
2343573|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2932063|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2343574|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2343575|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2932106|NCT04923893|Dexamethasone|dexamethasone|mesh-list
2932107|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
2932108|NCT04923893|Fludarabine|fludarabine|mesh-list
2932109|NCT04923893|Lenalidomide|lenalidomide|mesh-list
2932110|NCT04923893|Bortezomib|bortezomib|mesh-list
2932111|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2932112|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
2932113|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932114|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932115|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2932116|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
2343576|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343577|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
2343578|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
2343579|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2343580|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
2343581|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2932117|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932118|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932119|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2932120|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2932121|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
2932122|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
2932123|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932124|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2932125|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
2932126|NCT04923893|Hormones|hormones|mesh-ancestor
2932127|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2932128|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2932129|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2932130|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2932131|NCT04923893|Growth Substances|growth substances|mesh-ancestor
2111877|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2111878|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2111879|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2111880|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111881|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2111882|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
2111883|NCT02561273|Hormones|hormones|mesh-ancestor
2111884|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2343582|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932132|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
2932133|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
2932134|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2932135|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
2343583|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343584|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2343585|NCT00460369|Renal Agents|renal agents|mesh-ancestor
2343586|NCT00460382|Ritonavir|ritonavir|mesh-list
2343587|NCT00460382|Darunavir|darunavir|mesh-list
2343588|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
2343589|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
2343590|NCT00460382|Etravirine|etravirine|mesh-list
2343591|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2343592|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2343593|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
2932136|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2932137|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
2932138|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932139|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932140|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
2932141|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
2932142|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
2932143|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2932144|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
2932145|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932146|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932147|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2932148|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
2932149|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932150|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932151|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2932152|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932179|NCT04918147|Acetaminophen|acetaminophen|mesh-list
2932180|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
2932181|NCT04918147|Promethazine|promethazine|mesh-list
2932182|NCT04918147|Prednisone|prednisone|mesh-list
2932183|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
2932184|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2932185|NCT04918147|Elotuzumab|elotuzumab|mesh-list
2932186|NCT04918147|Famotidine|famotidine|mesh-list
2932187|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2932188|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
2932189|NCT04918147|Hormones|hormones|mesh-ancestor
2343594|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343595|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343596|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2343597|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2343598|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
2343599|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343600|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2343601|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2343602|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2932190|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2932191|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932192|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2932193|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932194|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2932195|NCT04918147|Analgesics|analgesics|mesh-ancestor
2932196|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
2932197|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932198|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
2932199|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
2932200|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
2932201|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2932202|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2932203|NCT04918147|Protective Agents|protective agents|mesh-ancestor
2932204|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2932205|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2932206|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2932207|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
2932208|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
2932209|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2932210|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
2932211|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
2932212|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2932213|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932214|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2932215|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
2932216|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
2932217|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2932218|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2932227|NCT04914897|Paclitaxel|paclitaxel|mesh-list
2343603|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2343604|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2343605|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2343606|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2343607|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2343608|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
2343609|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2343610|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343611|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
2343612|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2343613|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2343614|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343615|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2343616|NCT00460473|Analgesics|analgesics|mesh-ancestor
2343617|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
2343618|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343619|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2343620|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2343621|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2343622|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
2343623|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343624|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343625|NCT00460486|Formaldehyde|formaldehyde|mesh-list
2343626|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
2343627|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343628|NCT00460499|Insulin|insulin|mesh-list
2343629|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2343630|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932228|NCT04914897|Carboplatin|carboplatin|mesh-list
2932229|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
2932230|NCT04914897|Pemetrexed|pemetrexed|mesh-list
2932231|NCT04914897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2932232|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932233|NCT04914897|Tubulin Modulators|tubulin modulators|mesh-ancestor
2932234|NCT04914897|Antimitotic Agents|antimitotic agents|mesh-ancestor
2343631|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2343632|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2343633|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2343634|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2343635|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343636|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2343637|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2343638|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2343639|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
2343640|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343641|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343642|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2343643|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2343644|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
2343645|NCT00460616|Cabergoline|cabergoline|mesh-list
2343646|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2343647|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2932235|NCT04914897|Mitosis Modulators|mitosis modulators|mesh-ancestor
2932236|NCT04914897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932237|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932238|NCT04914897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932239|NCT04914897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2932240|NCT04914897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2932241|NCT04909801|Adalimumab|adalimumab|mesh-list
2932242|NCT04909801|Methotrexate|methotrexate|mesh-list
2932243|NCT04909801|Abatacept|abatacept|mesh-list
2932244|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2932245|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
2932246|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2932247|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932248|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2932249|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
2932250|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932251|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932252|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
2932253|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932254|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2932255|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2932256|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
2932257|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932258|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2932259|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2932260|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2343648|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
2343649|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
2343650|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343651|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343652|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343653|NCT00460642|Cetrorelix|cetrorelix|mesh-list
2343654|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2343655|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
2343656|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2343657|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343658|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
2343659|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2343660|NCT00460681|Thymopentin|thymopentin|mesh-list
2343661|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2343662|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
2343663|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343664|NCT00460707|Ketoconazole|ketoconazole|mesh-list
2343665|NCT00460707|Casopitant|casopitant|mesh-list
2343666|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
2343667|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343668|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2343669|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2343670|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343671|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343672|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2343673|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
2343674|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2343675|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343676|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2343677|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
2343678|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
2343679|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343680|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2343681|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2343682|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343683|NCT00460733|Vitamin D|vitamin d|mesh-list
2343684|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
2932282|NCT04901715|Albuterol|albuterol|mesh-list
2932283|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2932284|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
2932285|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932286|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932287|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2932288|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
2932289|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
2932290|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2932291|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2932292|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2932293|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2932294|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
2932295|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2932296|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932302|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
2932303|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932304|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932305|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
2343685|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
2343686|NCT00460733|Calcium|calcium|mesh-list
2343687|NCT00460733|Vitamins|vitamins|mesh-ancestor
2343688|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
2343689|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343690|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2343691|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2343692|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2343693|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2343694|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343695|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
2343696|NCT00460759|Rifapentine|rifapentine|mesh-list
2343697|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2343698|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343699|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2343700|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2343701|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932306|NCT04893915|Fludarabine|fludarabine|mesh-list
2932307|NCT04893915|Interleukin-2|interleukin-2|mesh-list
2932308|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2932309|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
2932310|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932311|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932312|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2932313|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
2932314|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932315|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932316|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2932317|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2932318|NCT04893915|Analgesics|analgesics|mesh-ancestor
2932319|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
2932320|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932321|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
2932322|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932323|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932334|NCT04887831|Gemcitabine|gemcitabine|mesh-list
2932335|NCT04887831|Carboplatin|carboplatin|mesh-list
2932336|NCT04887831|Avelumab|avelumab|mesh-list
2932337|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932338|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2932339|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
2932340|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932341|NCT04887831|Antiviral Agents|antiviral agents|mesh-ancestor
2932342|NCT04887831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2932343|NCT04887831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932344|NCT04887831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2932345|NCT04887831|Immunologic Factors|immunologic factors|mesh-ancestor
2932346|NCT04887831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932347|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932348|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
2932349|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2932350|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
2932351|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932352|NCT04880707|Anesthetics|anesthetics|mesh-list
2932353|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
2932354|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2932355|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932356|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
2932357|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932358|NCT04874545|Propofol|propofol|mesh-list
2932359|NCT04874545|Sevoflurane|sevoflurane|mesh-list
2932360|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2932361|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2932362|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343702|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343703|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343704|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2343705|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
2343706|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
2343707|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
2343708|NCT00460785|Narcotics|narcotics|mesh-ancestor
2343709|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2343710|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343711|NCT00460785|Analgesics|analgesics|mesh-ancestor
2343712|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
2343713|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343714|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
2343715|NCT00460837|Cathartics|cathartics|mesh-ancestor
2932363|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2932364|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
2932365|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
2343716|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2343717|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2343718|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
2343719|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343720|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
2343721|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2343722|NCT00460876|Topotecan|topotecan|mesh-list
2343723|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2343724|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2343725|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343726|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343727|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343728|NCT00460915|Amlodipine|amlodipine|mesh-list
2343729|NCT00460915|Lacidipine|lacidipine|mesh-list
2343730|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2343731|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2343732|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2343733|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343734|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2343735|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343736|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
2343737|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
2343738|NCT00460928|Antibodies|antibodies|mesh-list
2343739|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
2932366|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2343740|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2343741|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2343742|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
2343743|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343744|NCT00460941|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2343745|NCT00460941|Incretins|incretins|mesh-ancestor
2343746|NCT00460941|Hormones|hormones|mesh-ancestor
2343747|NCT00460941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2343748|NCT00460941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932367|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2932368|NCT04864678|Vaccines|vaccines|mesh-list
2932369|NCT04864678|Immunologic Factors|immunologic factors|mesh-ancestor
2932370|NCT04864678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932371|NCT04858490|Diazepam|diazepam|mesh-list
2932372|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2932373|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
2932374|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
2932375|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
2932376|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932377|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932378|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2932379|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2932380|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2932381|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2343749|NCT00460954|Levodopa|levodopa|mesh-list
2343750|NCT00460954|Carbidopa|carbidopa|mesh-list
2343751|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2343752|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2343753|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2343754|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
2343755|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2343756|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343757|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932382|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2932383|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2932384|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2932385|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2932386|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2932387|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
2932388|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
2932389|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
2932390|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
2932391|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2932392|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343758|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2343759|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343760|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2343761|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
2343762|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
2343763|NCT00461084|Clarithromycin|clarithromycin|mesh-list
2343764|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2343765|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343766|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2343767|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343768|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343769|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2343770|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2343771|NCT00461149|Octreotide|octreotide|mesh-list
2343772|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2343773|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2343774|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343775|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2343776|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
2343777|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
2932398|NCT04853251|Ranibizumab|ranibizumab|mesh-list
2932399|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2932400|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2932401|NCT04853251|Growth Substances|growth substances|mesh-ancestor
2932402|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932403|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
2343778|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343779|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2343780|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2343781|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343782|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2343783|NCT00461344|Docetaxel|docetaxel|mesh-list
2343784|NCT00461344|Doxorubicin|doxorubicin|mesh-list
2343785|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343786|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
2343787|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
2343788|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
2343789|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343790|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2343791|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2343792|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2932404|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932405|NCT04851834|Cisplatin|cisplatin|mesh-list
2932406|NCT04851834|Carboplatin|carboplatin|mesh-list
2932407|NCT04851834|Temozolomide|temozolomide|mesh-list
2932408|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932409|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2932410|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
2932411|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932412|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
2932413|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932414|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932415|NCT04842604|Azacitidine|azacitidine|mesh-list
2932416|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2932417|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
2932418|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932419|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932420|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932421|NCT04838743|Xultophy|xultophy|mesh-list
2932422|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2932423|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932424|NCT04838743|Incretins|incretins|mesh-ancestor
2932425|NCT04838743|Hormones|hormones|mesh-ancestor
2932426|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2932427|NCT04827979|Daratumumab|daratumumab|mesh-list
2932428|NCT04827979|Abatacept|abatacept|mesh-list
2932429|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
2932430|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
2932431|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
2932432|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932433|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932434|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2932435|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932436|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2932437|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932438|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
2932439|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932440|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932441|NCT04824092|Prednisone|prednisone|mesh-list
2932442|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
2932443|NCT04824092|Rituximab|rituximab|mesh-list
2932444|NCT04824092|Doxorubicin|doxorubicin|mesh-list
2343793|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343794|NCT00461396|Interferons|interferons|mesh-list
2343795|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
2343796|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343797|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
2343798|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343799|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2343800|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
2343801|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343802|NCT00461422|Ganirelix|ganirelix|mesh-list
2343803|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
2343804|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2343805|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343806|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
2343807|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2932445|NCT04824092|Vincristine|vincristine|mesh-list
2932446|NCT04824092|Lenalidomide|lenalidomide|mesh-list
2932447|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2932448|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
2343808|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
2932449|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932450|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932451|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2932452|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
2932453|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932454|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932455|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2932456|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932457|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2932458|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2932459|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2343809|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2343810|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2343811|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343812|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343813|NCT00461565|Urological Agents|urological agents|mesh-ancestor
2343814|NCT00461578|Artesunate|artesunate|mesh-list
2343815|NCT00461578|Dapsone|dapsone|mesh-list
2343816|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
2343817|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
2343818|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2343819|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2343820|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343821|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343822|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
2932460|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932461|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2932462|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
2932463|NCT04824092|Hormones|hormones|mesh-ancestor
2932464|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2932465|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2932466|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2932467|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
2932468|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
2343823|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
2343824|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2343825|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
2343826|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2343827|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343828|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343829|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
2343830|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2343831|NCT00461617|Mitiglinide|mitiglinide|mesh-list
2343832|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2932469|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
2932470|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2932471|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2343833|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343834|NCT00461643|Metformin|metformin|mesh-list
2343835|NCT00461643|Citric Acid|citric acid|mesh-list
2343836|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
2343837|NCT00461643|Clomiphene|clomiphene|mesh-list
2343838|NCT00461643|Enclomiphene|enclomiphene|mesh-list
2343839|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
2343840|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2343841|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343842|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
2343843|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2343844|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
2343845|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
2343846|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343847|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2932472|NCT04824092|Growth Substances|growth substances|mesh-ancestor
2932473|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
2932474|NCT04822597|Lidocaine|lidocaine|mesh-list
2932475|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
2932476|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
2932477|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2932478|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932479|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
2932480|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932481|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2932482|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2343848|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
2343849|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2932483|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2932484|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2932485|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932486|NCT04822350|Avelumab|avelumab|mesh-list
2932487|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932488|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932489|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
2932490|NCT04821141|Estrogens|estrogens|mesh-list
2932491|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2932492|NCT04821141|Hormones|hormones|mesh-ancestor
2932493|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2932494|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932495|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2932496|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2932497|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
2932498|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2932499|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
2932500|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932501|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932502|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2932503|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
2932504|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932505|NCT04814355|Celecoxib|celecoxib|mesh-list
2932506|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2932507|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2932508|NCT04814355|Analgesics|analgesics|mesh-ancestor
2932509|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
2932510|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932511|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343850|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2343851|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
2343852|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2343853|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2343854|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2343855|NCT00461695|Vaccines|vaccines|mesh-list
2343856|NCT00461695|Immunologic Factors|immunologic factors|mesh-ancestor
2343857|NCT00461695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343858|NCT00461747|Thalidomide|thalidomide|mesh-list
2343859|NCT00461747|Dexamethasone|dexamethasone|mesh-list
2343860|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
2343861|NCT00461747|Bortezomib|bortezomib|mesh-list
2343862|NCT00461747|BB 1101|bb 1101|mesh-list
2343863|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2343864|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
2343865|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
2343866|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343867|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343868|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2343869|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
2343870|NCT00461747|Hormones|hormones|mesh-ancestor
2932512|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2932513|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932514|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2932515|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2932516|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932517|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932518|NCT04810546|Lactoferrin|lactoferrin|mesh-list
2932519|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2932520|NCT04804553|Apremilast|apremilast|mesh-list
2932521|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2932522|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2932523|NCT04804553|Analgesics|analgesics|mesh-ancestor
2932524|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
2932525|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932526|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932527|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2932528|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932529|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2932530|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2932531|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932532|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932533|NCT04799431|Poly I-C|poly i-c|mesh-list
2932534|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2932535|NCT04799431|Poly ICLC|poly iclc|mesh-list
2343871|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2932536|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
2932537|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
2932538|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932539|NCT04799431|Laxatives|laxatives|mesh-ancestor
2932540|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2932541|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
2932542|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2932543|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
2932544|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932545|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932546|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
2932547|NCT04798339|Hematinics|hematinics|mesh-ancestor
2932548|NCT04795531|Insulin|insulin|mesh-list
2932549|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2932550|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
2932551|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2932552|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932553|NCT04793958|Cetuximab|cetuximab|mesh-list
2932554|NCT04793958|Adagrasib|adagrasib|mesh-list
2932555|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932556|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932557|NCT04789304|Midazolam|midazolam|mesh-list
2932558|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2932559|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2932560|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2932561|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932562|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2932563|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2932564|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2932565|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2932566|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
2932567|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
2932568|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
2932569|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
2932570|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2932571|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932572|NCT04788615|Interferons|interferons|mesh-list
2932573|NCT04788615|Teriflunomide|teriflunomide|mesh-list
2932574|NCT04788615|Ofatumumab|ofatumumab|mesh-list
2932575|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
2932576|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2932577|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
2932578|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932579|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
2932580|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2932581|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
2932582|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2932583|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
2932584|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932585|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2932586|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932587|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2932588|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2932589|NCT04788615|Analgesics|analgesics|mesh-ancestor
2932590|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
2932591|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932592|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2932593|NCT04784637|Insulin|insulin|mesh-list
2932594|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2932595|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932596|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2932597|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2932598|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932599|NCT04780724|Nitrox|nitrox|mesh-list
2932600|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2932601|NCT04780724|Protective Agents|protective agents|mesh-ancestor
2932602|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932603|NCT04776252|Islatravir|islatravir|mesh-list
2932604|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
2932605|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2932606|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932607|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932608|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2932609|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2932610|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2932611|NCT04775082|Liraglutide|liraglutide|mesh-list
2932612|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2932613|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932614|NCT04775082|Incretins|incretins|mesh-ancestor
2932615|NCT04775082|Hormones|hormones|mesh-ancestor
2932616|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2932617|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
2932618|NCT04774965|Promethazine|promethazine|mesh-list
2932619|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2932620|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2932621|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2932622|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932623|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
2932624|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
2932625|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
2932626|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932627|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
2932628|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
2932629|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2932630|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2932631|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
2932632|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
2932633|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2932634|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932635|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2932636|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
2932637|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
2932638|NCT04770532|Insulin|insulin|mesh-list
2932639|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2932640|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2932641|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932642|NCT04770012|Aspirin|aspirin|mesh-list
2932643|NCT04770012|Clopidogrel|clopidogrel|mesh-list
2932644|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2932645|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2932646|NCT04770012|Analgesics|analgesics|mesh-ancestor
2932647|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
2932648|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932649|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932650|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2932651|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932652|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2932653|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2932654|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932655|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2932656|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2932657|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932658|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
2932659|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2932660|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2932661|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2932662|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
2932663|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2932664|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
2932665|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932666|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932667|NCT04762875|Plerixafor|plerixafor|mesh-list
2932668|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2932669|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2932670|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
2932671|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2932675|NCT04759586|Prednisone|prednisone|mesh-list
2932676|NCT04759586|Prednisolone|prednisolone|mesh-list
2932677|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2932678|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
2932679|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2932680|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
2932681|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
2932682|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2932683|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2932684|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2932685|NCT04759586|Cortisone|cortisone|mesh-list
2932686|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
2932687|NCT04759586|Rituximab|rituximab|mesh-list
2932688|NCT04759586|Doxorubicin|doxorubicin|mesh-list
2932689|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2932690|NCT04759586|Nivolumab|nivolumab|mesh-list
2932691|NCT04759586|Etoposide|etoposide|mesh-list
2932692|NCT04759586|Vincristine|vincristine|mesh-list
2932693|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
2932694|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2932695|NCT04759586|Antibodies|antibodies|mesh-list
2932696|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
2932697|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2932698|NCT04759586|Lenograstim|lenograstim|mesh-list
2932699|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2932700|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
2932701|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2932702|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
2932703|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932704|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932705|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2343872|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2343873|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343874|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
2343875|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343876|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343877|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2343878|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
2343879|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
2343880|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2343881|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343882|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2343883|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2343884|NCT00461747|Growth Substances|growth substances|mesh-ancestor
2343885|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
2343886|NCT00461799|Orlistat|orlistat|mesh-list
2343887|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343888|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343889|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2343890|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2343891|NCT00461825|Cyclosporine|cyclosporine|mesh-list
2343892|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
2343893|NCT00461825|Azathioprine|azathioprine|mesh-list
2343894|NCT00461825|Cyclosporins|cyclosporins|mesh-list
2343895|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343896|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343897|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2343898|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
2343899|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343900|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
2343901|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2343902|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
2343903|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2343904|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2343905|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2343906|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343907|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2343908|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
2343909|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2932706|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
2932707|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932708|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932709|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2932710|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2932711|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2932712|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2932713|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932714|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2932715|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
2932716|NCT04759586|Hormones|hormones|mesh-ancestor
2932717|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2932718|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2932719|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2932720|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2932721|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2932722|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
2932723|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
2932724|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
2932725|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
2932726|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
2932727|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932728|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2932729|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2932730|NCT04759586|Protective Agents|protective agents|mesh-ancestor
2932731|NCT04751383|Dinutuximab|dinutuximab|mesh-list
2932732|NCT04751383|Magrolimab|magrolimab|mesh-list
2932733|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932734|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2343910|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
2343911|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2343912|NCT00461890|Naltrexone|naltrexone|mesh-list
2343913|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2343914|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2343915|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343916|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
2343917|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343918|NCT00461903|Perindopril|perindopril|mesh-list
2343919|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2343920|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
2343921|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343922|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343923|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2343924|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2343925|NCT00461916|Buserelin|buserelin|mesh-list
2343926|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
2343927|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2343928|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
2343929|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2343930|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343931|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2932741|NCT04748848|Azacitidine|azacitidine|mesh-list
2932742|NCT04748848|Venetoclax|venetoclax|mesh-list
2932743|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
2932744|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2932745|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
2932746|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932747|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932748|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932749|NCT04747496|Edoxaban|edoxaban|mesh-list
2932750|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2343932|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2343933|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343934|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2343935|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
2343936|NCT00461968|Simvastatin|simvastatin|mesh-list
2343937|NCT00461968|Ezetimibe|ezetimibe|mesh-list
2343938|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2343939|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2343940|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
2343941|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343942|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2343943|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2343944|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343945|NCT00462111|Indomethacin|indomethacin|mesh-list
2343946|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2343947|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2343948|NCT00462111|Analgesics|analgesics|mesh-ancestor
2343949|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
2343950|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343951|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343952|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2343953|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2343954|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
2343955|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
2343956|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2343957|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2343958|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2343959|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932751|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
2932752|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2932753|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
2932754|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111885|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2111886|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2111887|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
2111888|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
2111889|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
2111890|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2111891|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2111892|NCT02561273|Growth Substances|growth substances|mesh-ancestor
2111893|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
2932755|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932756|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
2932757|NCT04742959|Paclitaxel|paclitaxel|mesh-list
2932758|NCT04742959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2932759|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2932760|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932761|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
2932762|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
2932763|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
2932764|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343960|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
2343961|NCT00462189|Immunotoxins|immunotoxins|mesh-list
2343962|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
2343963|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343964|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343965|NCT00462202|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
2343966|NCT00462202|Anticoagulants|anticoagulants|mesh-ancestor
2343967|NCT00462202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2343968|NCT00462202|Antimetabolites|antimetabolites|mesh-ancestor
2343969|NCT00462202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343970|NCT00462202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2932793|NCT04737187|Trifluridine|trifluridine|mesh-list
2932794|NCT04737187|Bevacizumab|bevacizumab|mesh-list
2932795|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932796|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932797|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2932798|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2932799|NCT04737187|Growth Substances|growth substances|mesh-ancestor
2343971|NCT00462202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2343972|NCT00462202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2343973|NCT00462202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2343974|NCT00462202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343975|NCT00462215|Vaccines|vaccines|mesh-list
2932800|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932801|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
2932802|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
2111894|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
2343976|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
2932803|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343977|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343978|NCT00462358|Filanesib|filanesib|mesh-list
2343979|NCT00462358|Lenograstim|lenograstim|mesh-list
2343980|NCT00462358|Sargramostim|sargramostim|mesh-list
2343981|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2343982|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
2343983|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343984|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
2343985|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
2343986|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932804|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
2932805|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2932806|NCT04733937|Caseins|caseins|mesh-list
2932807|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
2932808|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
2932809|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932810|NCT04729387|Paclitaxel|paclitaxel|mesh-list
2932811|NCT04729387|Doxorubicin|doxorubicin|mesh-list
2932812|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2932813|NCT04729387|Olaparib|olaparib|mesh-list
2932814|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2932815|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932816|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
2932817|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
2932818|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
2932819|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932820|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2932821|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2932822|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2932823|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932824|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2932825|NCT04722146|Lenalidomide|lenalidomide|mesh-list
2932826|NCT04722146|Pomalidomide|pomalidomide|mesh-list
2932827|NCT04722146|Bortezomib|bortezomib|mesh-list
2932828|NCT04722146|Daratumumab|daratumumab|mesh-list
2932829|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
2932830|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932831|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2932832|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2932833|NCT04722146|Growth Substances|growth substances|mesh-ancestor
2932834|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
2932835|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932841|NCT04706741|Prednisone|prednisone|mesh-list
2932842|NCT04706741|Prednisolone|prednisolone|mesh-list
2932843|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2932844|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
2932845|NCT04706741|Hormones|hormones|mesh-ancestor
2932846|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2932847|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932848|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2932849|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932850|NCT04702880|Carboplatin|carboplatin|mesh-list
2932851|NCT04702880|Nivolumab|nivolumab|mesh-list
2932852|NCT04702880|Etoposide|etoposide|mesh-list
2932853|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932854|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932855|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2932856|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932857|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2932858|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2932859|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2932860|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932861|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
2932862|NCT04700007|Promethazine|promethazine|mesh-list
2932863|NCT04700007|Morphine|morphine|mesh-list
2932864|NCT04700007|Capsaicin|capsaicin|mesh-list
2932865|NCT04700007|Histamine|histamine|mesh-list
2932866|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2932867|NCT04700007|Narcotics|narcotics|mesh-ancestor
2932868|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2343987|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343988|NCT00462371|Insulin|insulin|mesh-list
2932869|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932870|NCT04700007|Analgesics|analgesics|mesh-ancestor
2932871|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
2932872|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932873|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
2932874|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
2932875|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2932876|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2932877|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
2932878|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
2932879|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
2932880|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
2932881|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2932882|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2932883|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-ancestor
2932884|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
2932885|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2932886|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932887|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2932888|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
2932889|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2932890|NCT04689828|177Lu-PSMA-617|177lu-psma-617|mesh-list
2932891|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2932892|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932893|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2932894|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
2343989|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2343990|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2343991|NCT00462397|Paclitaxel|paclitaxel|mesh-list
2343992|NCT00462397|Carboplatin|carboplatin|mesh-list
2343993|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2343994|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2343995|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
2343996|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
2932895|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932896|NCT04681079|Albuterol|albuterol|mesh-list
2932897|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2932898|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
2932899|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2343997|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
2343998|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2343999|NCT00462475|Hormones|hormones|mesh-list
2344000|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2932900|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932901|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2932902|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
2932903|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
2932904|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2932905|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2932906|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2932907|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2932908|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
2932909|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2932910|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932911|NCT04680052|Rituximab|rituximab|mesh-list
2932912|NCT04680052|Lenalidomide|lenalidomide|mesh-list
2932913|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2932914|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932915|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
2932916|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932917|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932918|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2932919|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2932920|NCT04680052|Growth Substances|growth substances|mesh-ancestor
2932921|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
2932922|NCT04676646|Spironolactone|spironolactone|mesh-list
2932923|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2344001|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344002|NCT00462540|Bromides|bromides|mesh-list
2344003|NCT00462540|Albuterol|albuterol|mesh-list
2344004|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
2344005|NCT00462540|Ipratropium|ipratropium|mesh-list
2344006|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2344007|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
2344008|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932924|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
2932925|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2932926|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932927|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2932928|NCT04676646|Diuretics|diuretics|mesh-ancestor
2932929|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
2932930|NCT04672382|Morphine|morphine|mesh-list
2932931|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2932932|NCT04672382|Narcotics|narcotics|mesh-ancestor
2932933|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2932934|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932935|NCT04672382|Analgesics|analgesics|mesh-ancestor
2932936|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
2932937|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344009|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344010|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2344011|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
2344012|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2344013|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2344014|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2344015|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
2344016|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344017|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344018|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
2344019|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
2344020|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2344021|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2344022|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
2344023|NCT00462553|Gemcitabine|gemcitabine|mesh-list
2344024|NCT00462553|Sunitinib|sunitinib|mesh-list
2932943|NCT04666610|Brivaracetam|brivaracetam|mesh-list
2932944|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
2932945|NCT04663282|Insulin|insulin|mesh-list
2932946|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2932947|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932948|NCT04661358|Fenofibrate|fenofibrate|mesh-list
2932949|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2932950|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
2344025|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2344026|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
2344027|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344028|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344029|NCT00462553|Antiviral Agents|antiviral agents|mesh-ancestor
2344030|NCT00462553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344031|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344032|NCT00462553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344033|NCT00462553|Immunologic Factors|immunologic factors|mesh-ancestor
2344034|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344035|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2344036|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2344037|NCT00462553|Growth Substances|growth substances|mesh-ancestor
2932951|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932952|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2932953|NCT04658862|Gemcitabine|gemcitabine|mesh-list
2932954|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932955|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2932956|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
2932957|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932958|NCT04658862|Antiviral Agents|antiviral agents|mesh-ancestor
2932959|NCT04658862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2932960|NCT04658862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932961|NCT04658862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2932962|NCT04658862|Immunologic Factors|immunologic factors|mesh-ancestor
2932963|NCT04658862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932964|NCT04654689|Curcumin|curcumin|mesh-list
2932965|NCT04654689|Resveratrol|resveratrol|mesh-list
2932966|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2932967|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2932968|NCT04654689|Analgesics|analgesics|mesh-ancestor
2932969|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
2932970|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2932971|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932972|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2932973|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2932974|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932975|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932976|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932977|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
2932978|NCT04654689|Protective Agents|protective agents|mesh-ancestor
2932979|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2932980|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
2932981|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2932982|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
2932983|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2932984|NCT04643405|Gemcitabine|gemcitabine|mesh-list
2932985|NCT04643405|Paclitaxel|paclitaxel|mesh-list
2932986|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2932987|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2932988|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
2932989|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
2932990|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
2932991|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2932992|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2932993|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
2111895|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
2111896|NCT02561481|Sulforaphane|sulforaphane|mesh-list
2111897|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2111898|NCT02561481|Protective Agents|protective agents|mesh-ancestor
2111899|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344038|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
2344039|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2344040|NCT00462592|Budesonide|budesonide|mesh-list
2344041|NCT00462592|Montelukast|montelukast|mesh-list
2344042|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2344043|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2344044|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
2932994|NCT04643405|Antiviral Agents|antiviral agents|mesh-ancestor
2932995|NCT04643405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2932996|NCT04643405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2932997|NCT04643405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2932998|NCT04643405|Immunologic Factors|immunologic factors|mesh-ancestor
2932999|NCT04643405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933000|NCT04640623|Gemcitabine|gemcitabine|mesh-list
2933001|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2933002|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
2933003|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933004|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933005|NCT04640623|Antiviral Agents|antiviral agents|mesh-ancestor
2933006|NCT04640623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2933007|NCT04640623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933008|NCT04640623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2933009|NCT04640623|Immunologic Factors|immunologic factors|mesh-ancestor
2933010|NCT04640623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933023|NCT04639011|Norepinephrine|norepinephrine|mesh-list
2111900|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111901|NCT02561702|Mexiletine|mexiletine|mesh-list
2111902|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2111903|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2933024|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2933025|NCT04639011|Serotonin|serotonin|mesh-list
2933026|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2933027|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2344045|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344046|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344047|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2344048|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
2344049|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
2344050|NCT00462592|Hormones|hormones|mesh-ancestor
2344051|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2344052|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2933028|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2933029|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933030|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2933031|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933032|NCT04639011|Analgesics|analgesics|mesh-ancestor
2933033|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
2933034|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2933035|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
2933036|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2933037|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
2933038|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2344053|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
2344054|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2344055|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2344056|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344057|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2344058|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
2344059|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2344060|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2344061|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2344062|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2344063|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344064|NCT00462631|Paclitaxel|paclitaxel|mesh-list
2344065|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2344066|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2344067|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344068|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
2344069|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
2344070|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
2344071|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344072|NCT00462696|Docetaxel|docetaxel|mesh-list
2933039|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2933040|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
2933041|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
2933042|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
2933043|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2933044|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2344073|NCT00462696|Epirubicin|epirubicin|mesh-list
2344074|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344075|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
2344076|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
2344077|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
2344078|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344079|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2344080|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2344081|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2344082|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344083|NCT00462787|Dexamethasone|dexamethasone|mesh-list
2344084|NCT00462787|Topotecan|topotecan|mesh-list
2344085|NCT00462787|Vinorelbine|vinorelbine|mesh-list
2344086|NCT00462787|Thiotepa|thiotepa|mesh-list
2344087|NCT00462787|Clofarabine|clofarabine|mesh-list
2344088|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2344089|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
2344090|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
2344091|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344092|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344093|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2344094|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
2344095|NCT00462787|Hormones|hormones|mesh-ancestor
2344096|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2344097|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2344098|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344099|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
2344100|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2344101|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2344102|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344103|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344104|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2933045|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
2344105|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
2344106|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
2344107|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
2344108|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2344109|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
2344110|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2344111|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344112|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2344113|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
2344114|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
2344115|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2344116|NCT00462813|Protective Agents|protective agents|mesh-ancestor
2344117|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344118|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344119|NCT00462852|Gemcitabine|gemcitabine|mesh-list
2344120|NCT00462852|Dalteparin|dalteparin|mesh-list
2344121|NCT00462852|Tinzaparin|tinzaparin|mesh-list
2344122|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2344123|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2344124|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
2344125|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344126|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344127|NCT00462852|Antiviral Agents|antiviral agents|mesh-ancestor
2344128|NCT00462852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344129|NCT00462852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933083|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
2933084|NCT04626518|Lenvatinib|lenvatinib|mesh-list
2933085|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933086|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933087|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2933088|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933089|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933090|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
2933091|NCT04626479|Lenvatinib|lenvatinib|mesh-list
2933092|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933093|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933094|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2344130|NCT00462852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344131|NCT00462852|Immunologic Factors|immunologic factors|mesh-ancestor
2344132|NCT00462852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344133|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
2933095|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344134|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2344135|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2344136|NCT00462878|Vancomycin|vancomycin|mesh-list
2344137|NCT00462878|Meropenem|meropenem|mesh-list
2344138|NCT00462878|Teicoplanin|teicoplanin|mesh-list
2344139|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2344140|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344141|NCT00462956|Lapatinib|lapatinib|mesh-list
2344142|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344143|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2344144|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344145|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344146|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2344147|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344148|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2344149|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344150|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344151|NCT00463008|Methotrexate|methotrexate|mesh-list
2344152|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2344153|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
2344154|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2344155|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344156|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2344157|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
2344158|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344159|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344160|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
2344161|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344162|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2344163|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344164|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
2344165|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2344166|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2344167|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2344168|NCT00463021|Vitamins|vitamins|mesh-ancestor
2344169|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
2344170|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344171|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2933096|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933097|NCT04625803|Apatinib|apatinib|mesh-list
2933098|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933099|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2933100|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344172|NCT00463073|Bevacizumab|bevacizumab|mesh-list
2344173|NCT00463073|Cetuximab|cetuximab|mesh-list
2344174|NCT00463073|Irinotecan|irinotecan|mesh-list
2344175|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2344176|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344177|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2344178|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2344179|NCT00463073|Growth Substances|growth substances|mesh-ancestor
2344180|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344181|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
2344182|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2344183|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2344184|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344185|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344186|NCT00463086|Isoniazid|isoniazid|mesh-list
2344187|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
2344188|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2344189|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344190|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2344191|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2344192|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
2344193|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344194|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2344195|NCT00463112|Sibutramine|sibutramine|mesh-list
2344196|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
2344197|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2344198|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
2344199|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2344200|NCT00463203|Bevacizumab|bevacizumab|mesh-list
2344201|NCT00463203|Irinotecan|irinotecan|mesh-list
2344202|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2344203|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344204|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2344205|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2344206|NCT00463203|Growth Substances|growth substances|mesh-ancestor
2344207|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344208|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
2344209|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2344210|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2344211|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933101|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933102|NCT04623567|Metformin|metformin|mesh-list
2933103|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2933104|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933105|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
2933106|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2933107|NCT04620733|Seladelpar|seladelpar|mesh-list
2933108|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2933109|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
2933110|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933111|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2933112|NCT04617821|Gemcitabine|gemcitabine|mesh-list
2344212|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344213|NCT00463242|S 20098|s 20098|mesh-list
2344214|NCT00463242|Paroxetine|paroxetine|mesh-list
2344215|NCT00463242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2344216|NCT00463242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2344217|NCT00463242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2344218|NCT00463242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344219|NCT00463242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344220|NCT00463242|Serotonin Agents|serotonin agents|mesh-ancestor
2344221|NCT00463242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344222|NCT00463242|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2344223|NCT00463242|Antidepressive Agents|antidepressive agents|mesh-ancestor
2344224|NCT00463242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2344225|NCT00463242|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2933113|NCT04617821|Paclitaxel|paclitaxel|mesh-list
2933114|NCT04617821|Folfirinox|folfirinox|mesh-list
2933115|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2933116|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933117|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
2933118|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
2933119|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
2933120|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933121|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2933122|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
2933123|NCT04617821|Antiviral Agents|antiviral agents|mesh-ancestor
2933124|NCT04617821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2933125|NCT04617821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933126|NCT04617821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2933127|NCT04617821|Immunologic Factors|immunologic factors|mesh-ancestor
2933128|NCT04617821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933129|NCT04610658|Nivolumab|nivolumab|mesh-list
2933130|NCT04610658|Ipilimumab|ipilimumab|mesh-list
2344226|NCT00463242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2344227|NCT00463242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344228|NCT00463242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2344229|NCT00463242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2344230|NCT00463268|Vitamin D|vitamin d|mesh-list
2344231|NCT00463268|Alendronate|alendronate|mesh-list
2344232|NCT00463268|Calcium|calcium|mesh-list
2344233|NCT00463268|Vitamins|vitamins|mesh-ancestor
2344234|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
2344235|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933131|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933132|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933133|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2933134|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933135|NCT04607980|Ustekinumab|ustekinumab|mesh-list
2344236|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2344237|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2344238|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2933136|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
2933137|NCT04601350|Anesthetics|anesthetics|mesh-list
2933138|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2933139|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933140|NCT04594694|Bezafibrate|bezafibrate|mesh-list
2344239|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2344240|NCT00463359|Imiquimod|imiquimod|mesh-list
2344241|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2344242|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
2344243|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933141|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2933142|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
2933143|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933144|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2933151|NCT04586426|Daratumumab|daratumumab|mesh-list
2933152|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344244|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344245|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
2344246|NCT00463502|Metformin|metformin|mesh-list
2344247|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2344248|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344249|NCT00463515|Gemcitabine|gemcitabine|mesh-list
2344250|NCT00463515|Carboplatin|carboplatin|mesh-list
2344251|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344252|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2344253|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
2344254|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344255|NCT00463515|Antiviral Agents|antiviral agents|mesh-ancestor
2344256|NCT00463515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344257|NCT00463515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344258|NCT00463515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344259|NCT00463515|Immunologic Factors|immunologic factors|mesh-ancestor
2344260|NCT00463515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344261|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
2344262|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2344263|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2344264|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
2344265|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344266|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344267|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344268|NCT00463541|Urological Agents|urological agents|mesh-ancestor
2344269|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
2344270|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2344271|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
2344272|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344273|NCT00463671|Expectorants|expectorants|mesh-ancestor
2344274|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
2344275|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2344276|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
2344277|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344278|NCT00463671|Protective Agents|protective agents|mesh-ancestor
2344279|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933153|NCT04585815|Axitinib|axitinib|mesh-list
2933154|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933155|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2933156|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933157|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933158|NCT04581148|Antibodies|antibodies|mesh-list
2933159|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
2933160|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
2933161|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933162|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2933163|NCT04579367|Ezetimibe|ezetimibe|mesh-list
2933164|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2933165|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2933166|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
2933167|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933168|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2933169|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933170|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2933171|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933191|NCT04577833|Prednisone|prednisone|mesh-list
2933192|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
2933193|NCT04577833|Niraparib|niraparib|mesh-list
2933194|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2933195|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
2933196|NCT04577833|Hormones|hormones|mesh-ancestor
2933197|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933198|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933199|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2933200|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933201|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2933202|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933203|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933204|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
2933205|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2933206|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2933207|NCT04576117|Vinblastine|vinblastine|mesh-list
2933208|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2933209|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933210|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
2933211|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
2933212|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
2933213|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933214|NCT04574232|Triamcinolone|triamcinolone|mesh-list
2933215|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2933216|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2933217|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2933218|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2933219|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
2933220|NCT04574232|Hormones|hormones|mesh-ancestor
2344280|NCT00463671|Antidotes|antidotes|mesh-ancestor
2344281|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
2344282|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2344283|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
2344284|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344285|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344286|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
2344287|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344288|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2344289|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2344290|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
2344291|NCT00463736|Analgesics|analgesics|mesh-ancestor
2344292|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
2344293|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344294|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344295|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
2344296|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2344297|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2344298|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
2344299|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2344300|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2344301|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344302|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2344303|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
2344304|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2344305|NCT00463762|Sulbactam|sulbactam|mesh-list
2344306|NCT00463762|Cefoperazone|cefoperazone|mesh-list
2344307|NCT00463762|Sulperazone|sulperazone|mesh-list
2344308|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2344309|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2933221|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933222|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933223|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344310|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2344311|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344312|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344313|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2344314|NCT00463762|Renal Agents|renal agents|mesh-ancestor
2933224|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
2933225|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933226|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344315|NCT00463775|Topiramate|topiramate|mesh-list
2344316|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
2344317|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2344318|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344319|NCT00463827|Atorvastatin|atorvastatin|mesh-list
2344320|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2344321|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2344322|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
2344323|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933238|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
2933239|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2933240|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933241|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2933242|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933243|NCT04561362|Nivolumab|nivolumab|mesh-list
2344324|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2344325|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2344326|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344327|NCT00463879|Galantamine|galantamine|mesh-list
2344328|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2933244|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933245|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933246|NCT04561362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2933247|NCT04561362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344329|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344330|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344331|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
2344332|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344333|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344334|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2344335|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
2344336|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344337|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
2344338|NCT00463918|Varenicline|varenicline|mesh-list
2344339|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2344340|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2344341|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
2344342|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344343|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344344|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344345|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
2344346|NCT00463957|Tadalafil|tadalafil|mesh-list
2344347|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
2344348|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2344349|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2344350|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344351|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344352|NCT00463957|Urological Agents|urological agents|mesh-ancestor
2344353|NCT00463983|Octreotide|octreotide|mesh-list
2344354|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2344355|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2933248|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2933249|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
2933250|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933251|NCT04554888|Doxepin|doxepin|mesh-list
2933252|NCT04554888|Histamine|histamine|mesh-list
2933253|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
2933254|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
2933255|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2933256|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933257|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933258|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2933259|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2344356|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344357|NCT00464035|Calcium|calcium|mesh-list
2344358|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2344359|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344360|NCT00464061|Volinanserin|volinanserin|mesh-list
2344361|NCT00464061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2344362|NCT00464061|Serotonin Agents|serotonin agents|mesh-ancestor
2344363|NCT00464061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344364|NCT00464061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344365|NCT00464061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344366|NCT00464165|Rimonabant|rimonabant|mesh-list
2344367|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2344368|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2344369|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2344370|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344371|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344372|NCT00464165|Hormones|hormones|mesh-ancestor
2344373|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2344374|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344375|NCT00464191|Citalopram|citalopram|mesh-list
2933260|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2933261|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2933262|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
2933263|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2344376|NCT00464191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2344377|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2344378|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2344379|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344380|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344381|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
2344382|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933264|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
2933265|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
2933266|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
2933267|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
2933268|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2933269|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2933270|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
2933271|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
2933272|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2933273|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933274|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2933275|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
2933276|NCT04548999|Hormones|hormones|mesh-ancestor
2933277|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933278|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2933279|NCT04548999|Protective Agents|protective agents|mesh-ancestor
2933280|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
2933281|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
2933282|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2933283|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933284|NCT04548973|Esketamine|esketamine|mesh-list
2933285|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
2344383|NCT00464191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2344384|NCT00464191|Antidepressive Agents|antidepressive agents|mesh-ancestor
2344385|NCT00464191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2344386|NCT00464217|Idarubicin|idarubicin|mesh-list
2344387|NCT00464217|Molgramostim|molgramostim|mesh-list
2344388|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2344389|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344390|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2344391|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2933286|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2344392|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344393|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344394|NCT00464243|Volinanserin|volinanserin|mesh-list
2344395|NCT00464243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2344396|NCT00464243|Serotonin Agents|serotonin agents|mesh-ancestor
2344397|NCT00464243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344398|NCT00464243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344399|NCT00464243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344400|NCT00464256|Rimonabant|rimonabant|mesh-list
2344401|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2344402|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2344403|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2344404|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2933294|NCT04547985|Naltrexone|naltrexone|mesh-list
2933295|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2933296|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2933297|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933298|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
2933299|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2933300|NCT04544189|Fulvestrant|fulvestrant|mesh-list
2933301|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2933302|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933303|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2933304|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2933305|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
2933306|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933307|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933308|NCT04543617|Atezolizumab|atezolizumab|mesh-list
2933309|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2933310|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933311|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
2933312|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933313|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
2933314|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2933315|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933316|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2933317|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933318|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
2933319|NCT04541017|Magrolimab|magrolimab|mesh-list
2933320|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
2933321|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
2933322|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
2933323|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933324|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933325|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933326|NCT04539548|Prednisolone|prednisolone|mesh-list
2933327|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2933328|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
2933329|NCT04539548|Hormones|hormones|mesh-ancestor
2933330|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933331|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933332|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2933333|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933334|NCT04538040|Tenofovir|tenofovir|mesh-list
2933335|NCT04538040|Emtricitabine|emtricitabine|mesh-list
2933336|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2933337|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
2933338|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2933339|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2933340|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2933341|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933342|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933343|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2933344|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2933345|NCT04530305|Upadacitinib|upadacitinib|mesh-list
2933346|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2933347|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2933348|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933349|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933350|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2933351|NCT04527991|Paclitaxel|paclitaxel|mesh-list
2344405|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344406|NCT00464256|Hormones|hormones|mesh-ancestor
2344407|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2344408|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344409|NCT00464295|Capecitabine|capecitabine|mesh-list
2344410|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2344411|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
2344412|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344413|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111904|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2111905|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2111906|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111907|NCT02561806|Ustekinumab|ustekinumab|mesh-list
2111908|NCT02561806|Ixekizumab|ixekizumab|mesh-list
2111909|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
2111910|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
2111911|NCT02561832|Carboplatin|carboplatin|mesh-list
2111912|NCT02561832|Olaparib|olaparib|mesh-list
2344414|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2344415|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
2344416|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344417|NCT00464347|Triamcinolone|triamcinolone|mesh-list
2344418|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2344419|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2344420|NCT00464347|Bevacizumab|bevacizumab|mesh-list
2344421|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2344422|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2344423|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344424|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2933352|NCT04527991|Docetaxel|docetaxel|mesh-list
2933353|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2933354|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933355|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
2933356|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
2933357|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
2933358|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933359|NCT04524689|Carboplatin|carboplatin|mesh-list
2933360|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
2933361|NCT04524689|Pemetrexed|pemetrexed|mesh-list
2933362|NCT04524689|Maytansine|maytansine|mesh-list
2933363|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933364|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933365|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933366|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933367|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2933368|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2933369|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2933370|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
2933371|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
2933372|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
2933373|NCT04524455|Dexamethasone|dexamethasone|mesh-list
2933374|NCT04524455|Blinatumomab|blinatumomab|mesh-list
2933375|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2933376|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
2933377|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
2933378|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2933379|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933380|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2933381|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
2933382|NCT04524455|Hormones|hormones|mesh-ancestor
2933383|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933384|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2933385|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933386|NCT04523207|Relugolix|relugolix|mesh-list
2933387|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
2933388|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
2933389|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933390|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111913|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2933391|NCT04522804|Psilocybin|psilocybin|mesh-list
2344425|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2933392|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
2933393|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933394|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2933395|NCT04519645|Lacosamide|lacosamide|mesh-list
2933396|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
2933397|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2933398|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2933399|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2933400|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933401|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
2933402|NCT04512261|Trastuzumab|trastuzumab|mesh-list
2933403|NCT04512261|Tucatinib|tucatinib|mesh-list
2933404|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933405|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933406|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2933407|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933408|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933409|NCT04497844|Prednisone|prednisone|mesh-list
2344426|NCT00464347|Growth Substances|growth substances|mesh-ancestor
2344427|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344428|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
2344429|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2344430|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
2344431|NCT00464347|Hormones|hormones|mesh-ancestor
2344432|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2344433|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344434|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
2344435|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344436|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344437|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
2344438|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2344439|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2933410|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
2933411|NCT04497844|Niraparib|niraparib|mesh-list
2933412|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2344440|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2344441|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2344442|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344443|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
2933413|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
2933414|NCT04497844|Hormones|hormones|mesh-ancestor
2933415|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933416|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933417|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2933418|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933419|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2933420|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933421|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933422|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
2933423|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2933424|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2933425|NCT04496960|Tofacitinib|tofacitinib|mesh-list
2933426|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2933427|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933428|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933429|NCT04487080|Osimertinib|osimertinib|mesh-list
2933430|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
2933431|NCT04487080|Lazertinib|lazertinib|mesh-list
2933432|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933433|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2933434|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933435|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933436|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933437|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
2933438|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2933439|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2933440|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
2344444|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344445|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344446|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2344447|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344448|NCT00464399|Everolimus|everolimus|mesh-list
2933441|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2933442|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933443|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933444|NCT04477265|Urological Agents|urological agents|mesh-ancestor
2933445|NCT04474847|Abatacept|abatacept|mesh-list
2933446|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2933447|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933448|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933449|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2933450|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
2933451|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933452|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2933453|NCT04472429|Paclitaxel|paclitaxel|mesh-list
2933454|NCT04472429|Carboplatin|carboplatin|mesh-list
2933455|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2933456|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933457|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
2933458|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
2933459|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
2933460|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933461|NCT04468360|Pregnanolone|pregnanolone|mesh-list
2933462|NCT04468360|Brexanolone|brexanolone|mesh-list
2933463|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
2933464|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2933465|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933466|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
2933467|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2933468|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933469|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
2933470|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
2933471|NCT04464070|Aspirin|aspirin|mesh-list
2933472|NCT04464070|Niacin|niacin|mesh-list
2933473|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2933474|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2933475|NCT04464070|Analgesics|analgesics|mesh-ancestor
2933476|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
2933477|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2933478|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933479|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2933480|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2933481|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2344449|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344450|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344451|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
2344452|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344453|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
2344454|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
2344455|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2344456|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2344457|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344458|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2344459|NCT00464451|Analgesics|analgesics|mesh-ancestor
2344460|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
2344461|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344462|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2344463|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2344464|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2344465|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
2344466|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344467|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344468|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2344469|NCT00464503|Pravastatin|pravastatin|mesh-list
2344470|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2344471|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2344472|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
2344473|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344474|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2344475|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2344476|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344477|NCT00464555|Sirolimus|sirolimus|mesh-list
2344478|NCT00464555|Lisofylline|lisofylline|mesh-list
2344479|NCT00464555|Tacrolimus|tacrolimus|mesh-list
2344480|NCT00464555|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2344481|NCT00464555|Basiliximab|basiliximab|mesh-list
2344482|NCT00464555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344483|NCT00464555|Immunologic Factors|immunologic factors|mesh-ancestor
2344484|NCT00464555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344485|NCT00464555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2344486|NCT00464555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344487|NCT00464555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933482|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2933483|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344488|NCT00464555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2344489|NCT00464555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344490|NCT00464555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2344491|NCT00464555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344492|NCT00464555|Antifungal Agents|antifungal agents|mesh-ancestor
2344493|NCT00464555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2344494|NCT00464555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2344495|NCT00464555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2344496|NCT00464555|Analgesics|analgesics|mesh-ancestor
2933484|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2933485|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2933486|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933487|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
2933488|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2933489|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
2933490|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2933491|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
2933492|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
2933493|NCT04464070|Vitamins|vitamins|mesh-ancestor
2933494|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
2933495|NCT04459715|Cisplatin|cisplatin|mesh-list
2933496|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933497|NCT04458909|Gemcitabine|gemcitabine|mesh-list
2933498|NCT04458909|Cisplatin|cisplatin|mesh-list
2933499|NCT04458909|Carboplatin|carboplatin|mesh-list
2933500|NCT04458909|Nivolumab|nivolumab|mesh-list
2933501|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933502|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2933503|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
2933504|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933505|NCT04458909|Antiviral Agents|antiviral agents|mesh-ancestor
2933506|NCT04458909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2933507|NCT04458909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344497|NCT00464555|Sensory System Agents|sensory system agents|mesh-ancestor
2344498|NCT00464555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344499|NCT00464555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2344500|NCT00464555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2344501|NCT00464594|Metformin|metformin|mesh-list
2344502|NCT00464594|Acarbose|acarbose|mesh-list
2344503|NCT00464594|Gliclazide|gliclazide|mesh-list
2344504|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2933508|NCT04458909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2933509|NCT04458909|Immunologic Factors|immunologic factors|mesh-ancestor
2933510|NCT04458909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933511|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933512|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2933513|NCT04456699|Leucovorin|leucovorin|mesh-list
2933514|NCT04456699|Bevacizumab|bevacizumab|mesh-list
2933515|NCT04456699|Fluorouracil|fluorouracil|mesh-list
2933516|NCT04456699|Capecitabine|capecitabine|mesh-list
2933517|NCT04456699|Olaparib|olaparib|mesh-list
2933518|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
2933519|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933520|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933521|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2933522|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2933523|NCT04456699|Growth Substances|growth substances|mesh-ancestor
2933524|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933525|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
2933526|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
2933527|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933528|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2933529|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2933530|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
2933531|NCT04456699|Antidotes|antidotes|mesh-ancestor
2933532|NCT04456699|Protective Agents|protective agents|mesh-ancestor
2933533|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
2933534|NCT04456699|Vitamins|vitamins|mesh-ancestor
2933535|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
2933536|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2933537|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933538|NCT04456517|Ranolazine|ranolazine|mesh-list
2933539|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2933540|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2933541|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933542|NCT04447768|Venetoclax|venetoclax|mesh-list
2933543|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
2933544|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933545|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2344505|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344506|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2344507|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344508|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344509|NCT00464633|Alvocidib|alvocidib|mesh-list
2344510|NCT00464633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344511|NCT00464633|Growth Inhibitors|growth inhibitors|mesh-ancestor
2344512|NCT00464633|Growth Substances|growth substances|mesh-ancestor
2344513|NCT00464633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933558|NCT04442022|Gemcitabine|gemcitabine|mesh-list
2933559|NCT04442022|Dexamethasone|dexamethasone|mesh-list
2933560|NCT04442022|Rituximab|rituximab|mesh-list
2344514|NCT00464633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2344515|NCT00464633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344516|NCT00464633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344517|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
2344518|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2344519|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2344520|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344521|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2344522|NCT00464763|Analgesics|analgesics|mesh-ancestor
2344523|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
2344524|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344525|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2344526|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2344527|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2344528|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
2344529|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344530|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344531|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
2344532|NCT00464789|Estrogens|estrogens|mesh-list
2344533|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2344534|NCT00464789|Hormones|hormones|mesh-ancestor
2344535|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2344536|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344537|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2344538|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2344539|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
2344540|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2344541|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
2344542|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2344543|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344544|NCT00464893|Catumaxomab|catumaxomab|mesh-list
2344545|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2344546|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2344547|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
2933561|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933562|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2933563|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
2933564|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
2933565|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2933566|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933567|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2933568|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
2933569|NCT04442022|Hormones|hormones|mesh-ancestor
2344548|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344549|NCT00464919|Sorafenib|sorafenib|mesh-list
2344550|NCT00464919|Tegafur|tegafur|mesh-list
2344551|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344552|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2933570|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933571|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2933572|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933573|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
2933574|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2933575|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2933576|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
2933577|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933578|NCT04442022|Antiviral Agents|antiviral agents|mesh-ancestor
2933579|NCT04442022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2933580|NCT04442022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933581|NCT04442022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2933582|NCT04440176|Vaccines|vaccines|mesh-list
2933583|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
2933584|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933585|NCT04430452|Durvalumab|durvalumab|mesh-list
2933586|NCT04430452|Ipilimumab|ipilimumab|mesh-list
2933587|NCT04430452|Tremelimumab|tremelimumab|mesh-list
2933588|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
2933589|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2933590|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
2933591|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933592|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933593|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
2933594|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933595|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2933596|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933597|NCT04427072|Docetaxel|docetaxel|mesh-list
2933598|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933599|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
2933600|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
2933601|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
2933602|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344553|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344554|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344555|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2933617|NCT04380636|Paclitaxel|paclitaxel|mesh-list
2933618|NCT04380636|Etoposide|etoposide|mesh-list
2344556|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
2344557|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
2344558|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2344559|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
2344560|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2933619|NCT04380636|Carboplatin|carboplatin|mesh-list
2933620|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
2933621|NCT04380636|Pemetrexed|pemetrexed|mesh-list
2933622|NCT04380636|Durvalumab|durvalumab|mesh-list
2933623|NCT04380636|Olaparib|olaparib|mesh-list
2933624|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2933625|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933626|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
2933627|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
2344561|NCT00464932|Protective Agents|protective agents|mesh-ancestor
2344562|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344563|NCT00464958|Tizanidine|tizanidine|mesh-list
2344564|NCT00464958|Analgesics|analgesics|mesh-ancestor
2344565|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
2933628|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
2933629|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933630|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933631|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2933632|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2933633|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933634|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2933635|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2933636|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2933637|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2933638|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
2933639|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933654|NCT04370054|Factor VIII|factor viii|mesh-list
2933655|NCT04370054|Coagulants|coagulants|mesh-ancestor
2933656|NCT04360980|Colchicine|colchicine|mesh-list
2933657|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
2933658|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2933659|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
2933660|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
2933661|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
2933662|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933663|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933664|NCT04346654|Dexamethasone|dexamethasone|mesh-list
2933665|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2933666|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
2933667|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
2933668|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2933669|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933670|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2933671|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
2933672|NCT04346654|Hormones|hormones|mesh-ancestor
2933673|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933674|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2933675|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933676|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
2933677|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
2933678|NCT04339777|Busulfan|busulfan|mesh-list
2933679|NCT04339777|Fludarabine|fludarabine|mesh-list
2933680|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
2933681|NCT04339777|Tacrolimus|tacrolimus|mesh-list
2933682|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2933683|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
2933684|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933685|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2933686|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2933687|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
2933688|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933689|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933690|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2933691|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2344566|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344567|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344568|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
2344569|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2344570|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2344571|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
2933692|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933693|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2933694|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2933695|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
2933696|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2933697|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2933698|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933704|NCT04339738|Paclitaxel|paclitaxel|mesh-list
2933705|NCT04339738|Nivolumab|nivolumab|mesh-list
2933706|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2933707|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2933708|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933709|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
2933710|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
2933711|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
2933712|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933713|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933714|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2933724|NCT04331704|Tenofovir|tenofovir|mesh-list
2933725|NCT04331704|Emtricitabine|emtricitabine|mesh-list
2933726|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
2933727|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2933728|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2933729|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2933730|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933731|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933732|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2933733|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2933734|NCT04323436|Spartalizumab|spartalizumab|mesh-list
2344572|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
2344573|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2344574|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2344575|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2344576|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
2344577|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344578|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344579|NCT00464971|Estradiol|estradiol|mesh-list
2933735|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2933736|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933737|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933738|NCT04323046|Nivolumab|nivolumab|mesh-list
2933739|NCT04323046|Ipilimumab|ipilimumab|mesh-list
2933740|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933741|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933742|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2933743|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933744|NCT04317105|Nivolumab|nivolumab|mesh-list
2933745|NCT04317105|Ipilimumab|ipilimumab|mesh-list
2933746|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933747|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933748|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2933749|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933750|NCT04313075|Leronlimab|leronlimab|mesh-list
2933751|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2933752|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2933753|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933754|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2933755|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2933756|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
2933757|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344580|NCT00464971|Estrogens|estrogens|mesh-ancestor
2344581|NCT00464971|Hormones|hormones|mesh-ancestor
2344582|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2344583|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344584|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2344585|NCT00465036|Cathartics|cathartics|mesh-ancestor
2344586|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2344587|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
2344588|NCT00465075|Estrogens|estrogens|mesh-list
2344589|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2344590|NCT00465075|Hormones|hormones|mesh-ancestor
2344591|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2344592|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344593|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2344594|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2344595|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
2344596|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2344597|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2344598|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2344599|NCT00465192|Estradiol|estradiol|mesh-list
2344600|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2344601|NCT00465192|Estrogens|estrogens|mesh-ancestor
2344602|NCT00465192|Hormones|hormones|mesh-ancestor
2344603|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2344604|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344605|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2344606|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
2344607|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2344608|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2344609|NCT00465205|Valacyclovir|valacyclovir|mesh-list
2344610|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
2344611|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344612|NCT00465231|Fentanyl|fentanyl|mesh-list
2344613|NCT00465231|Bupivacaine|bupivacaine|mesh-list
2344614|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
2344615|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
2344616|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2344617|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344618|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
2933783|NCT04307576|Dexamethasone|dexamethasone|mesh-list
2344619|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344620|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2344621|NCT00465231|Narcotics|narcotics|mesh-ancestor
2344622|NCT00465231|Analgesics|analgesics|mesh-ancestor
2344623|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2344624|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2344625|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
2344626|NCT00465244|Levetiracetam|levetiracetam|mesh-list
2344627|NCT00465244|Lorazepam|lorazepam|mesh-list
2344628|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
2344629|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
2344630|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
2344631|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
2344632|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344633|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344634|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2344635|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2344636|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2344637|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2933784|NCT04307576|Doxorubicin|doxorubicin|mesh-list
2933785|NCT04307576|Vincristine|vincristine|mesh-list
2933786|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
2933787|NCT04307576|Blinatumomab|blinatumomab|mesh-list
2933788|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2933789|NCT04307576|Thioguanine|thioguanine|mesh-list
2933790|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2933791|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
2933792|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
2933793|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2933794|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933795|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2933796|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
2933797|NCT04307576|Hormones|hormones|mesh-ancestor
2933798|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933799|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2933800|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933801|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2933802|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2933803|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2933804|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933805|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933806|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2933807|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
2933808|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
2933809|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
2344638|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2344639|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2344640|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
2344641|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
2344642|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344643|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344644|NCT00465257|Artesunate|artesunate|mesh-list
2344645|NCT00465257|Amodiaquine|amodiaquine|mesh-list
2344646|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
2344647|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2344648|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2344649|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344650|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344651|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
2344652|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
2344653|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2344654|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
2344655|NCT00465283|Donepezil|donepezil|mesh-list
2344656|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2344657|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344658|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344659|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
2344660|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344661|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344662|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
2344663|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
2344664|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2344665|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344666|NCT00465439|Lidocaine|lidocaine|mesh-list
2344667|NCT00465439|Epinephrine|epinephrine|mesh-list
2344668|NCT00465439|Racepinephrine|racepinephrine|mesh-list
2344669|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
2344670|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
2344671|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
2344672|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2344673|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344674|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
2344675|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344676|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2344677|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2344678|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2344679|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2344680|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344681|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2344682|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2344683|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
2344684|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344685|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2344686|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2344687|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
2933810|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2344688|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2933811|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933812|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2933813|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
2933814|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
2933815|NCT04305795|Cemiplimab|cemiplimab|mesh-list
2933816|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933817|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933818|NCT04305756|Enoxaparin|enoxaparin|mesh-list
2933819|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
2933820|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2933821|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2933822|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344689|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
2344690|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
2344691|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
2344692|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2344693|NCT00465452|Dopamine|dopamine|mesh-list
2344694|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
2344695|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2344696|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
2344697|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
2344698|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344699|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344700|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
2933823|NCT04304820|Cyclosporine|cyclosporine|mesh-list
2933824|NCT04304820|Cyclosporins|cyclosporins|mesh-list
2933825|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2933826|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933827|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933828|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2933829|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
2933830|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933831|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
2933832|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344701|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344702|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344703|NCT00465452|Protective Agents|protective agents|mesh-ancestor
2933833|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
2933834|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2933835|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2344704|NCT00465517|Ganaxolone|ganaxolone|mesh-list
2344705|NCT00465517|Neurosteroids|neurosteroids|mesh-ancestor
2344706|NCT00465517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344707|NCT00465517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344708|NCT00465517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111914|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
2111915|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111916|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2933836|NCT04301934|Estradiol|estradiol|mesh-list
2933837|NCT04301934|Estrogens|estrogens|mesh-list
2933838|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2933839|NCT04301934|Hormones|hormones|mesh-ancestor
2933840|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933841|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933842|NCT04301765|Testosterone|testosterone|mesh-list
2344709|NCT00465517|GABA Modulators|gaba modulators|mesh-ancestor
2344710|NCT00465517|GABA Agents|gaba agents|mesh-ancestor
2344711|NCT00465543|Rosmarinic acid|rosmarinic acid|mesh-list
2344712|NCT00465543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2344713|NCT00465543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2344714|NCT00465543|Analgesics|analgesics|mesh-ancestor
2344715|NCT00465543|Sensory System Agents|sensory system agents|mesh-ancestor
2344716|NCT00465543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344717|NCT00465543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933843|NCT04301765|Androgens|androgens|mesh-ancestor
2933844|NCT04301765|Hormones|hormones|mesh-ancestor
2933845|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933846|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933847|NCT04301076|Prednisone|prednisone|mesh-list
2933848|NCT04301076|Cortisone|cortisone|mesh-list
2111917|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2111918|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
2111919|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111920|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111921|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2344718|NCT00465543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2344719|NCT00465543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2344720|NCT00465543|Antioxidants|antioxidants|mesh-ancestor
2344721|NCT00465543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344722|NCT00465543|Protective Agents|protective agents|mesh-ancestor
2344723|NCT00465543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2344724|NCT00465543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2344725|NCT00465543|Protease Inhibitors|protease inhibitors|mesh-ancestor
2344726|NCT00465543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344727|NCT00465608|Propranolol|propranolol|mesh-list
2344728|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2344729|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2344730|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
2344731|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344732|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344733|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344734|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2344735|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2344736|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
2344737|NCT00465621|Latanoprost|latanoprost|mesh-list
2344738|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2344739|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2344740|NCT00465673|Doxorubicin|doxorubicin|mesh-list
2344741|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2344742|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2344743|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344744|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2344745|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2344746|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344747|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933849|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
2933850|NCT04301076|Doxorubicin|doxorubicin|mesh-list
2933851|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2933852|NCT04301076|Etoposide|etoposide|mesh-list
2933853|NCT04301076|Vincristine|vincristine|mesh-list
2933854|NCT04301076|Lenalidomide|lenalidomide|mesh-list
2933855|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
2933856|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
2933857|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2933858|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
2933859|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933860|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2933861|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2933862|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
2933863|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933864|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933865|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2933866|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2933867|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2933868|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2933869|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933870|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2933871|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
2933872|NCT04301076|Hormones|hormones|mesh-ancestor
2933873|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933874|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2933875|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2933876|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
2933877|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
2933878|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
2933879|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2933880|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2933881|NCT04301076|Growth Substances|growth substances|mesh-ancestor
2933882|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
2933883|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
2933884|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
2933885|NCT04296305|Hydromorphone|hydromorphone|mesh-list
2933886|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2933887|NCT04296305|Narcotics|narcotics|mesh-ancestor
2933888|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2933889|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933890|NCT04296305|Analgesics|analgesics|mesh-ancestor
2933891|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
2933892|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344748|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2933893|NCT04278144|Nivolumab|nivolumab|mesh-list
2933894|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933895|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933896|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2933897|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933898|NCT04270747|Aflibercept|aflibercept|mesh-list
2933899|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2933900|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2933901|NCT04270747|Growth Substances|growth substances|mesh-ancestor
2933902|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933903|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
2933904|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344749|NCT00465751|Cathartics|cathartics|mesh-ancestor
2344750|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2344751|NCT00465803|Timolol|timolol|mesh-list
2344752|NCT00465803|Travoprost|travoprost|mesh-list
2344753|NCT00465803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2344754|NCT00465803|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2344755|NCT00465803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2344756|NCT00465803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2933935|NCT04263909|Sufentanil|sufentanil|mesh-list
2933936|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2933937|NCT04263909|Narcotics|narcotics|mesh-ancestor
2933938|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2933939|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933940|NCT04263909|Analgesics|analgesics|mesh-ancestor
2344757|NCT00465803|Adrenergic Agents|adrenergic agents|mesh-ancestor
2344758|NCT00465803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344759|NCT00465803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344760|NCT00465803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344761|NCT00465803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2344762|NCT00465803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2344763|NCT00465907|Paclitaxel|paclitaxel|mesh-list
2933941|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
2933942|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2933943|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2933944|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2933945|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
2933946|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
2933947|NCT04252742|Erenumab|erenumab|mesh-list
2344764|NCT00465907|Carboplatin|carboplatin|mesh-list
2344765|NCT00465907|Irinotecan|irinotecan|mesh-list
2344766|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2344767|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344768|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
2344769|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
2344770|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
2933948|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2933949|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933950|NCT04252742|Analgesics|analgesics|mesh-ancestor
2344771|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344772|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2344773|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2344774|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344775|NCT00465959|Trospium chloride|trospium chloride|mesh-list
2344776|NCT00465959|Parasympatholytics|parasympatholytics|mesh-ancestor
2344777|NCT00465959|Autonomic Agents|autonomic agents|mesh-ancestor
2344778|NCT00465959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2933951|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
2933952|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2933953|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933954|NCT04251533|Paclitaxel|paclitaxel|mesh-list
2933955|NCT04251533|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2933956|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2933957|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933958|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
2344779|NCT00465959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344780|NCT00465959|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2344781|NCT00465959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2344782|NCT00465959|Cholinergic Agents|cholinergic agents|mesh-ancestor
2344783|NCT00465959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344784|NCT00465959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344785|NCT00465959|Urological Agents|urological agents|mesh-ancestor
2933959|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
2933960|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
2933961|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933962|NCT04233840|Nivolumab|nivolumab|mesh-list
2933963|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2933964|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933965|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2933966|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933967|NCT04229290|Dolutegravir|dolutegravir|mesh-list
2933968|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2933969|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2933970|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2933971|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2933972|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2933973|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2933974|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
2933975|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2933976|NCT04223661|Dexamethasone|dexamethasone|mesh-list
2933977|NCT04223661|Lenalidomide|lenalidomide|mesh-list
2933978|NCT04223661|Daratumumab|daratumumab|mesh-list
2933979|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2933980|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
2933981|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
2933982|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2933983|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2933984|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2933985|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
2933986|NCT04223661|Hormones|hormones|mesh-ancestor
2933987|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2933988|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2933989|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2933990|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
2933991|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2933992|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2933993|NCT04223661|Growth Substances|growth substances|mesh-ancestor
2933994|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
2933995|NCT04218240|Lofexidine|lofexidine|mesh-list
2933996|NCT04218240|Pregabalin|pregabalin|mesh-list
2933997|NCT04218240|Analgesics|analgesics|mesh-ancestor
2933998|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
2933999|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2934000|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934001|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
2934002|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2934003|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2934004|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934005|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2934006|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2344786|NCT00466063|Deferasirox|deferasirox|mesh-list
2344787|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2344788|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
2344789|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
2344790|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344791|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
2344792|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
2344793|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2344794|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
2344795|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344796|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344797|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2344798|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2344799|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344800|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2344801|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344802|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344803|NCT00466102|Everolimus|everolimus|mesh-list
2344804|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344805|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344806|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
2344807|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344808|NCT00466128|Indomethacin|indomethacin|mesh-list
2344809|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2344810|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2344811|NCT00466128|Analgesics|analgesics|mesh-ancestor
2344812|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
2344813|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344814|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344815|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2344816|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2344817|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
2934007|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2934008|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2934009|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2934010|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2934011|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2934012|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2934013|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2934014|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2934015|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
2934016|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344818|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
2344819|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2344820|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2344821|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344822|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344823|NCT00466154|Aspirin|aspirin|mesh-list
2344824|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2344825|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2344826|NCT00466154|Analgesics|analgesics|mesh-ancestor
2344827|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
2344828|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344829|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344830|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2344831|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2344832|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2344833|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2344834|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934065|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
2934066|NCT04209660|Lenvatinib|lenvatinib|mesh-list
2934067|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2934068|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934069|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2934070|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934071|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934072|NCT04207931|Fluocinonide|fluocinonide|mesh-list
2344835|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2344836|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2344837|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344838|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
2344839|NCT00466180|Nevirapine|nevirapine|mesh-list
2934073|NCT04207931|Triamcinolone|triamcinolone|mesh-list
2934074|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2934075|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2934076|NCT04207931|Betamethasone|betamethasone|mesh-list
2934077|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
2934078|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2934079|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
2934080|NCT04207931|Clobetasol|clobetasol|mesh-list
2934081|NCT04207931|Minoxidil|minoxidil|mesh-list
2934082|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2934083|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2934084|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2934085|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
2934086|NCT04207931|Hormones|hormones|mesh-ancestor
2934087|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934088|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934089|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2934090|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
2934091|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934092|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934093|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2934094|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
2934095|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2934096|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
2934097|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2934098|NCT04199468|Ketamine|ketamine|mesh-list
2934099|NCT04199468|Dronabinol|dronabinol|mesh-list
2934100|NCT04199468|Analgesics|analgesics|mesh-ancestor
2934101|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
2934102|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344840|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2344841|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2344842|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934103|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934104|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2934105|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2934106|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
2934107|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
2934108|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2934109|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2934110|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2934111|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2934112|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934113|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
2934114|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2934115|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2934116|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2934117|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2934118|NCT04199468|Hormones|hormones|mesh-ancestor
2934119|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934120|NCT04195555|Ivosidenib|ivosidenib|mesh-list
2934121|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934122|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934123|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934124|NCT04191187|Fludarabine|fludarabine|mesh-list
2934125|NCT04191187|Melphalan|melphalan|mesh-list
2934126|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934127|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934128|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2934129|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
2934130|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934131|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2934132|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
2934133|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2934134|NCT04185883|Bevacizumab|bevacizumab|mesh-list
2934135|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
2934136|NCT04185883|Panitumumab|panitumumab|mesh-list
2934137|NCT04185883|Carboplatin|carboplatin|mesh-list
2934138|NCT04185883|Docetaxel|docetaxel|mesh-list
2934139|NCT04185883|Pemetrexed|pemetrexed|mesh-list
2934140|NCT04185883|Everolimus|everolimus|mesh-list
2934141|NCT04185883|Atezolizumab|atezolizumab|mesh-list
2934142|NCT04185883|Palbociclib|palbociclib|mesh-list
2934143|NCT04185883|Trametinib|trametinib|mesh-list
2934144|NCT04185883|Afatinib|afatinib|mesh-list
2934145|NCT04185883|Loperamide|loperamide|mesh-list
2934146|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2934147|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934148|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2934149|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2934150|NCT04185883|Growth Substances|growth substances|mesh-ancestor
2934151|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934152|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
2934153|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
2934154|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
2934155|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
2934156|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934157|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934158|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2934159|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2934160|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2934161|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
2934162|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2934163|NCT04185883|Antidiarrheals|antidiarrheals|mesh-ancestor
2934164|NCT04185883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2934165|NCT04181827|Dexamethasone|dexamethasone|mesh-list
2934166|NCT04181827|Bortezomib|bortezomib|mesh-list
2934167|NCT04181827|Daratumumab|daratumumab|mesh-list
2934168|NCT04181827|Pomalidomide|pomalidomide|mesh-list
2934169|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2934170|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
2934171|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
2934172|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2934173|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934174|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2934175|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
2934176|NCT04181827|Hormones|hormones|mesh-ancestor
2934177|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934178|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2934179|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934180|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
2934181|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2934182|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2934183|NCT04181827|Growth Substances|growth substances|mesh-ancestor
2934184|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
2934185|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
2934186|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2934187|NCT04181476|Protective Agents|protective agents|mesh-ancestor
2934188|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934189|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
2934219|NCT04172675|Gemcitabine|gemcitabine|mesh-list
2934220|NCT04172675|Mitomycins|mitomycins|mesh-list
2934221|NCT04172675|Mitomycin|mitomycin|mesh-list
2934222|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2934223|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
2934224|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934225|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934226|NCT04172675|Antiviral Agents|antiviral agents|mesh-ancestor
2934227|NCT04172675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2934228|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934229|NCT04172675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2934230|NCT04172675|Immunologic Factors|immunologic factors|mesh-ancestor
2934231|NCT04172675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934232|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2934233|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
2934234|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2934235|NCT04165096|Acetaminophen|acetaminophen|mesh-list
2934236|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
2934237|NCT04165096|Promethazine|promethazine|mesh-list
2934238|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
2934239|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2934240|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934241|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2934242|NCT04165096|Analgesics|analgesics|mesh-ancestor
2934243|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
2934244|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2934245|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934246|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
2934247|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2934248|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2934249|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2934250|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
2934251|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
2934252|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
2934253|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
2934254|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2934255|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2934256|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
2934257|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
2934258|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2934259|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344843|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344844|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
2344845|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344846|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2344847|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2344848|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2344849|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2344850|NCT00466219|Interferons|interferons|mesh-list
2344851|NCT00466219|Ribavirin|ribavirin|mesh-list
2344852|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
2934260|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2934261|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
2934262|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
2934263|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
2934264|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2934265|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934266|NCT04165070|Paclitaxel|paclitaxel|mesh-list
2934267|NCT04165070|Carboplatin|carboplatin|mesh-list
2934268|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
2934269|NCT04165070|Pemetrexed|pemetrexed|mesh-list
2934270|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2934271|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934272|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
2934273|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
2934274|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
2934275|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934276|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2934277|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934278|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2934279|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2934280|NCT04162015|Carboplatin|carboplatin|mesh-list
2934281|NCT04162015|Nivolumab|nivolumab|mesh-list
2934282|NCT04162015|Pemetrexed|pemetrexed|mesh-list
2934283|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934284|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2934285|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2934286|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934287|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934288|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2934289|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2934290|NCT04150887|Azacitidine|azacitidine|mesh-list
2934291|NCT04150887|Venetoclax|venetoclax|mesh-list
2934292|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2934293|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
2934294|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934295|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934296|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344853|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
2344854|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2344855|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344856|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
2344857|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344858|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
2344859|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344860|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
2344861|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344862|NCT00466232|Sorafenib|sorafenib|mesh-list
2344863|NCT00466232|Topotecan|topotecan|mesh-list
2344864|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344865|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2344866|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344867|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344868|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2344869|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2344870|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2344871|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
2344872|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344873|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2934303|NCT04133636|Dexamethasone|dexamethasone|mesh-list
2934304|NCT04133636|Lenalidomide|lenalidomide|mesh-list
2934305|NCT04133636|Bortezomib|bortezomib|mesh-list
2934306|NCT04133636|Daratumumab|daratumumab|mesh-list
2934307|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2934308|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
2934309|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
2934310|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2934311|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934312|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2934313|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
2344874|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344875|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2344876|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344877|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344878|NCT00466388|Cevimeline|cevimeline|mesh-list
2344879|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2344880|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
2934314|NCT04133636|Hormones|hormones|mesh-ancestor
2934315|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934316|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2934317|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934318|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
2934319|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2934320|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2934321|NCT04133636|Growth Substances|growth substances|mesh-ancestor
2934322|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
2934323|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
2934324|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
2934325|NCT04129723|Protective Agents|protective agents|mesh-ancestor
2934326|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934327|NCT04121455|Bevacizumab|bevacizumab|mesh-list
2934328|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
2934329|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2934330|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934331|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2934332|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2934333|NCT04121455|Growth Substances|growth substances|mesh-ancestor
2934334|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934335|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
2934336|NCT04121260|Daratumumab|daratumumab|mesh-list
2934337|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934338|NCT04111978|Letrozole|letrozole|mesh-list
2934339|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934340|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2934341|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2934342|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934343|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934344|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2344881|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2344882|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344883|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2344884|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2344885|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
2344886|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344887|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344888|NCT00466401|Simvastatin|simvastatin|mesh-list
2344889|NCT00466401|Ezetimibe|ezetimibe|mesh-list
2344890|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2344891|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2934345|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
2934346|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934347|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934348|NCT04109066|Paclitaxel|paclitaxel|mesh-list
2934349|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
2934350|NCT04109066|Nivolumab|nivolumab|mesh-list
2934351|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2934352|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934353|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
2934354|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
2934355|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
2934356|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934357|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344892|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
2934358|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
2934359|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344893|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344894|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2344895|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2344896|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344897|NCT00466466|Everolimus|everolimus|mesh-list
2934360|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2934361|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2934362|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
2934363|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2934364|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2934365|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2934366|NCT04108208|Androgens|androgens|mesh-list
2934367|NCT04108208|Hormones|hormones|mesh-ancestor
2934368|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934369|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934370|NCT04108195|Daratumumab|daratumumab|mesh-list
2934371|NCT04108195|Pomalidomide|pomalidomide|mesh-list
2934372|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934373|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
2934374|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934375|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2934376|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2344898|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344899|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344900|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
2934377|NCT04108195|Growth Substances|growth substances|mesh-ancestor
2934378|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
2934379|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
2934380|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
2934381|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2934382|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934383|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934384|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
2934385|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
2934386|NCT04093024|Nintedanib|nintedanib|mesh-list
2934387|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934388|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2934389|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934390|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344901|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344902|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2344903|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2344904|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2344905|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2344906|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2344907|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
2344908|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344909|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344910|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344911|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2344912|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2344913|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344914|NCT00466518|Incretins|incretins|mesh-ancestor
2344915|NCT00466518|Hormones|hormones|mesh-ancestor
2344916|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2344917|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2344918|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
2344919|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934424|NCT04082364|Trastuzumab|trastuzumab|mesh-list
2934425|NCT04082364|Margetuximab|margetuximab|mesh-list
2934426|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2934427|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934428|NCT04077463|Carboplatin|carboplatin|mesh-list
2934429|NCT04077463|Pemetrexed|pemetrexed|mesh-list
2934430|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
2934431|NCT04077463|Lazertinib|lazertinib|mesh-list
2934432|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934433|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934434|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934435|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2934436|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2934437|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2934438|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2934439|NCT04075396|Lazertinib|lazertinib|mesh-list
2934440|NCT04075396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2934441|NCT04075396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934442|NCT04075396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344920|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344921|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
2934456|NCT04066751|Ivacaftor|ivacaftor|mesh-list
2934457|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2934458|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2934459|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934460|NCT04065789|Dexamethasone|dexamethasone|mesh-list
2934461|NCT04065789|Lenalidomide|lenalidomide|mesh-list
2934462|NCT04065789|Daratumumab|daratumumab|mesh-list
2934463|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2934464|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
2934465|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
2934466|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2934467|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934468|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2934469|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
2934470|NCT04065789|Hormones|hormones|mesh-ancestor
2934471|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934472|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2934473|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934474|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
2934475|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2934476|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2934477|NCT04065789|Growth Substances|growth substances|mesh-ancestor
2934478|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
2934479|NCT04062448|Rituximab|rituximab|mesh-list
2934480|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2344922|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
2344923|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2344924|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2344925|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2344926|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2344927|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344928|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344929|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344930|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2344931|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2934481|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934482|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
2934483|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934484|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2934488|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
2934489|NCT04049331|Testosterone|testosterone|mesh-list
2934490|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
2934491|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
2934492|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2934493|NCT04049331|Androgens|androgens|mesh-ancestor
2934494|NCT04049331|Hormones|hormones|mesh-ancestor
2934495|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934496|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934497|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2934498|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934499|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
2934500|NCT04047953|Paclitaxel|paclitaxel|mesh-list
2934501|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2934502|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
2934503|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2934504|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934505|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
2934506|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
2934507|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
2934508|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934519|NCT04034095|Prednisolone|prednisolone|mesh-list
2934520|NCT04034095|Docetaxel|docetaxel|mesh-list
2934521|NCT04034095|Bicalutamide|bicalutamide|mesh-list
2344932|NCT00466596|Vitamins|vitamins|mesh-list
2344933|NCT00466596|Vitamin E|vitamin e|mesh-list
2344934|NCT00466596|Tocopherols|tocopherols|mesh-list
2344935|NCT00466596|Tocotrienols|tocotrienols|mesh-list
2344936|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
2344937|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
2344938|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
2344939|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344940|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
2934522|NCT04034095|Androgens|androgens|mesh-list
2934523|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344941|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344942|NCT00466596|Protective Agents|protective agents|mesh-ancestor
2344943|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2344944|NCT00466609|Fluoxetine|fluoxetine|mesh-list
2344945|NCT00466609|Clomipramine|clomipramine|mesh-list
2344946|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
2344947|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2344948|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2344949|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2344950|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2344951|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344952|NCT00466609|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2344953|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2934524|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
2934525|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
2934526|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
2934527|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934528|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2934529|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
2934530|NCT04034095|Hormones|hormones|mesh-ancestor
2934531|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934532|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934533|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2934534|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
2934535|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
2934536|NCT04031599|Hormones|hormones|mesh-list
2934537|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344954|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2344955|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344956|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344957|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
2344958|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2344959|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2344960|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2344961|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2344962|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2344963|NCT00466622|Metformin|metformin|mesh-list
2344964|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2344965|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344966|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
2344967|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2344968|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934538|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934539|NCT04030559|Niraparib|niraparib|mesh-list
2934540|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2934541|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934542|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934543|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934544|NCT04025658|Oxytocin|oxytocin|mesh-list
2934545|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
2934546|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2344969|NCT00466791|Methylphenidate|methylphenidate|mesh-list
2344970|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2344971|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344972|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2344973|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2344974|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2344975|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344976|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
2344977|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344978|NCT00466843|Prednisone|prednisone|mesh-list
2344979|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2344980|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2344981|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
2344982|NCT00466843|Hormones|hormones|mesh-ancestor
2344983|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934547|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934548|NCT04023526|Azacitidine|azacitidine|mesh-list
2934549|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2934550|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
2934551|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934552|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934553|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934554|NCT04019821|Insulin|insulin|mesh-list
2934555|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2934556|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
2934557|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
2934558|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
2934559|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2934560|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934561|NCT04016805|Venetoclax|venetoclax|mesh-list
2934562|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
2934563|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934564|NCT04006288|Aspirin|aspirin|mesh-list
2934565|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
2934566|NCT04006288|Clopidogrel|clopidogrel|mesh-list
2934567|NCT04006288|Ticagrelor|ticagrelor|mesh-list
2934568|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2934569|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2934570|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2934571|NCT04006288|Analgesics|analgesics|mesh-ancestor
2934572|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
2934573|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2934574|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934575|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2934576|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2344984|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2344985|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2344986|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344987|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
2344988|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2344989|NCT00466856|Octreotide|octreotide|mesh-list
2344990|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2934577|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2934578|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2934579|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934580|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2934581|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2934582|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934583|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
2934584|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2934585|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2934586|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2934587|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
2934588|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2934589|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2934590|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
2934591|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2934592|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
2934593|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
2934594|NCT04005690|Olaparib|olaparib|mesh-list
2934595|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2934596|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934597|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934598|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934599|NCT04005352|Aflibercept|aflibercept|mesh-list
2934600|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2934601|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2934602|NCT04005352|Growth Substances|growth substances|mesh-ancestor
2934603|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934604|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
2934605|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934606|NCT04003805|Nicotine|nicotine|mesh-list
2934607|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2934608|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
2934609|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2934610|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934611|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2934612|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2934613|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
2934614|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2934615|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934616|NCT03993132|Empagliflozin|empagliflozin|mesh-list
2934617|NCT03993132|Glucagon|glucagon|mesh-list
2344991|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2344992|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2344993|NCT00466869|Betahistine|betahistine|mesh-list
2344994|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
2344995|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
2344996|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
2344997|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2344998|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2344999|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345000|NCT00466895|Lenalidomide|lenalidomide|mesh-list
2345001|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
2345002|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345003|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345004|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345005|NCT00466895|Growth Substances|growth substances|mesh-ancestor
2345006|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345007|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345008|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2345009|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934618|NCT03993132|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2934619|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2934620|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934621|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2934622|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934623|NCT03993132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2934624|NCT03993132|Hormones|hormones|mesh-ancestor
2934625|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934626|NCT03993132|Incretins|incretins|mesh-ancestor
2345010|NCT00466999|Misoprostol|misoprostol|mesh-list
2345011|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2345012|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
2345013|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2345014|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345015|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2345016|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2345017|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
2345018|NCT00467012|Paclitaxel|paclitaxel|mesh-list
2345019|NCT00467012|Bevacizumab|bevacizumab|mesh-list
2345020|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2345021|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345022|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
2345023|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
2345024|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
2345025|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345026|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2345027|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345028|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345029|NCT00467012|Growth Substances|growth substances|mesh-ancestor
2345030|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345031|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345032|NCT00467025|Sorafenib|sorafenib|mesh-list
2345033|NCT00467025|Trebananib|trebananib|mesh-list
2934666|NCT03981614|Trifluridine|trifluridine|mesh-list
2934667|NCT03981614|Palbociclib|palbociclib|mesh-list
2934668|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934669|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2934670|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345034|NCT00467025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934671|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934672|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
2934673|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
2934674|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2934675|NCT03972488|Octreotide|octreotide|mesh-list
2934676|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2934677|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2934678|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2934679|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934680|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2934681|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934682|NCT03971734|Regadenoson|regadenoson|mesh-list
2934683|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2934684|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2934685|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
2934686|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
2934687|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2934688|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934689|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934690|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
2934691|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2934692|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934693|NCT03964090|Cytarabine|cytarabine|mesh-list
2934694|NCT03964090|Isavuconazole|isavuconazole|mesh-list
2934695|NCT03964090|Methotrexate|methotrexate|mesh-list
2934696|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2934697|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
2934698|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2934699|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934700|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2934701|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
2934702|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934703|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934704|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
2934705|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934706|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2934707|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2934708|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
2345035|NCT00467025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2345036|NCT00467025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345037|NCT00467025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345038|NCT00467025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345039|NCT00467025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345040|NCT00467025|Growth Substances|growth substances|mesh-ancestor
2345041|NCT00467025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345042|NCT00467025|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345043|NCT00467116|Gemcitabine|gemcitabine|mesh-list
2345044|NCT00467116|Cetuximab|cetuximab|mesh-list
2345045|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2345046|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
2934709|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2934710|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2934711|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
2934712|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2934713|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
2934720|NCT03943667|Gemcitabine|gemcitabine|mesh-list
2934721|NCT03943667|Paclitaxel|paclitaxel|mesh-list
2934722|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2934723|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934724|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
2111922|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2111923|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111924|NCT02561897|Warfarin|warfarin|mesh-list
2111925|NCT02561897|Edoxaban|edoxaban|mesh-list
2111926|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
2111927|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2111928|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
2111929|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2934725|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
2934726|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
2345047|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345048|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934727|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934728|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2934729|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
2934730|NCT03943667|Antiviral Agents|antiviral agents|mesh-ancestor
2934731|NCT03943667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2934732|NCT03943667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934733|NCT03943667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2934734|NCT03943667|Immunologic Factors|immunologic factors|mesh-ancestor
2934735|NCT03943667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345049|NCT00467116|Antiviral Agents|antiviral agents|mesh-ancestor
2345050|NCT00467116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345051|NCT00467116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345052|NCT00467116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345053|NCT00467116|Immunologic Factors|immunologic factors|mesh-ancestor
2345054|NCT00467116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345055|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2345056|NCT00467142|Leucovorin|leucovorin|mesh-list
2345057|NCT00467142|Bevacizumab|bevacizumab|mesh-list
2345058|NCT00467142|Fluorouracil|fluorouracil|mesh-list
2345059|NCT00467142|Irinotecan|irinotecan|mesh-list
2345060|NCT00467142|Calcium|calcium|mesh-list
2345061|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
2345062|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2345063|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345064|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345065|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345066|NCT00467142|Growth Substances|growth substances|mesh-ancestor
2345067|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345068|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345069|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2345070|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
2345071|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345072|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2345073|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2934751|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
2934752|NCT03941262|Avelumab|avelumab|mesh-list
2934753|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2934754|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934755|NCT03936933|Goserelin|goserelin|mesh-list
2934756|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2934757|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934758|NCT03936218|Goserelin|goserelin|mesh-list
2934759|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2934760|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934761|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
2934762|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934763|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2934764|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2934765|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934766|NCT03926143|Maytansine|maytansine|mesh-list
2934767|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
2934768|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2934769|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934770|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
2345074|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
2345075|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2345076|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2934771|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
2934772|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934773|NCT03923699|Anesthetics|anesthetics|mesh-list
2934774|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2934775|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934776|NCT03914742|Temozolomide|temozolomide|mesh-list
2934777|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2934778|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2934779|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
2934780|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934781|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934782|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934783|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
2934784|NCT03914625|Leucovorin|leucovorin|mesh-list
2934785|NCT03914625|Folic Acid|folic acid|mesh-list
2934786|NCT03914625|Cytarabine|cytarabine|mesh-list
2934787|NCT03914625|Dexamethasone|dexamethasone|mesh-list
2934788|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
2934789|NCT03914625|Prednisone|prednisone|mesh-list
2934790|NCT03914625|Prednisolone|prednisolone|mesh-list
2934791|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2934792|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
2934793|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2934794|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
2934795|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
2934796|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2934797|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2934798|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2345077|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345078|NCT00467142|Antidotes|antidotes|mesh-ancestor
2345079|NCT00467142|Protective Agents|protective agents|mesh-ancestor
2345080|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
2345081|NCT00467142|Vitamins|vitamins|mesh-ancestor
2345082|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
2345083|NCT00467181|Fenoldopam|fenoldopam|mesh-list
2345084|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2345085|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
2345086|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
2345087|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
2345088|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2345089|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345090|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345091|NCT00467194|Sirolimus|sirolimus|mesh-list
2345092|NCT00467194|Bevacizumab|bevacizumab|mesh-list
2934799|NCT03914625|Cortisone|cortisone|mesh-list
2934800|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
2934801|NCT03914625|Doxorubicin|doxorubicin|mesh-list
2345093|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2345094|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345095|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345096|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345097|NCT00467194|Growth Substances|growth substances|mesh-ancestor
2345098|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345099|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345100|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2345101|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345102|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2345103|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
2345104|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345105|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
2345106|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
2345107|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2345108|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2345109|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2345110|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2345111|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345112|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
2345113|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2345114|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345115|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2345116|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345117|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
2934802|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2934803|NCT03914625|Methotrexate|methotrexate|mesh-list
2934804|NCT03914625|Vincristine|vincristine|mesh-list
2345118|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2934805|NCT03914625|Asparaginase|asparaginase|mesh-list
2934806|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
2934807|NCT03914625|Pegaspargase|pegaspargase|mesh-list
2934808|NCT03914625|Thioguanine|thioguanine|mesh-list
2934809|NCT03914625|Blinatumomab|blinatumomab|mesh-list
2934810|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2934811|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
2934812|NCT03914625|Antibodies|antibodies|mesh-list
2934813|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
2934814|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2934815|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2934816|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2934817|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
2934818|NCT03914625|BB 1101|bb 1101|mesh-list
2934819|NCT03914625|Calcium|calcium|mesh-list
2934820|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
2934821|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
2934822|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2934823|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
2934824|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934825|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2934826|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2934827|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
2934828|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934829|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934830|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2345119|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345120|NCT00467376|Insulin|insulin|mesh-list
2345121|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2345122|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
2345123|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
2345124|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2345125|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345126|NCT00467402|S 20098|s 20098|mesh-list
2345127|NCT00467402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2345128|NCT00467402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2345129|NCT00467402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345130|NCT00467454|Naltrexone|naltrexone|mesh-list
2345131|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2345132|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2345133|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345134|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
2345135|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2934831|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2934832|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
2934833|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
2934834|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2934835|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2345136|NCT00467467|Alfuzosin|alfuzosin|mesh-list
2345137|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2345138|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2345139|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2345140|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
2345141|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2345142|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345143|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934836|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
2934837|NCT03914625|Hormones|hormones|mesh-ancestor
2934838|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934839|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2934840|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
2934841|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934842|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2934843|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2934844|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2934845|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2934846|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2934847|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2934848|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
2934849|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2934850|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2934851|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
2934852|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
2345144|NCT00467467|Urological Agents|urological agents|mesh-ancestor
2345145|NCT00467493|Anastrozole|anastrozole|mesh-list
2934853|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2934854|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2934855|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
2934856|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2934857|NCT03914625|Antidotes|antidotes|mesh-ancestor
2934858|NCT03914625|Protective Agents|protective agents|mesh-ancestor
2934859|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
2934860|NCT03914625|Vitamins|vitamins|mesh-ancestor
2934861|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
2934862|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2934863|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
2934864|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
2934865|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
2934866|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2934867|NCT03914625|Hematinics|hematinics|mesh-ancestor
2934879|NCT03911661|Warfarin|warfarin|mesh-list
2934880|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
2934881|NCT03908255|Vitamins|vitamins|mesh-list
2934882|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
2345146|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2345147|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345148|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2345149|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2345150|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345151|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345152|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2345153|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
2934883|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934913|NCT03902951|Leuprolide|leuprolide|mesh-list
2934914|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
2934915|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2934916|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
2934917|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2345154|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2345155|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345156|NCT00467506|Antibodies|antibodies|mesh-list
2345157|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2345158|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
2345159|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345160|NCT00467545|Telbivudine|telbivudine|mesh-list
2934918|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934919|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2934920|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345161|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
2345162|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345163|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2345164|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345165|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345166|NCT00467571|Amoxicillin|amoxicillin|mesh-list
2345167|NCT00467571|Clarithromycin|clarithromycin|mesh-list
2345168|NCT00467571|Lansoprazole|lansoprazole|mesh-list
2345169|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
2345170|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2345171|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345172|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2345173|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345174|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345175|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2345176|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2345177|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2345178|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2345179|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2934921|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2934922|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934923|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934924|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
2934925|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2934926|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2934927|NCT03901963|Lenalidomide|lenalidomide|mesh-list
2934928|NCT03901963|Daratumumab|daratumumab|mesh-list
2934929|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
2934930|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934931|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2934932|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2934933|NCT03901963|Growth Substances|growth substances|mesh-ancestor
2934934|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
2934935|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2934936|NCT03900754|Oxytocin|oxytocin|mesh-list
2934937|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
2934938|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2934939|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934940|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2934941|NCT03897244|Amoxicillin|amoxicillin|mesh-list
2934942|NCT03897244|Metronidazole|metronidazole|mesh-list
2934943|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2934944|NCT03897244|Rabeprazole|rabeprazole|mesh-list
2934945|NCT03897244|Bismuth|bismuth|mesh-list
2345180|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
2345181|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2345182|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345183|NCT00467662|Acyclovir|acyclovir|mesh-list
2345184|NCT00467662|Docosanol|docosanol|mesh-list
2345185|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
2345186|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345187|NCT00467766|Donepezil|donepezil|mesh-list
2345188|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2345189|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345190|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345191|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
2345192|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2345193|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345194|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
2345195|NCT00467883|Amphotericin B|amphotericin b|mesh-list
2345196|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2345197|NCT00467883|Amebicides|amebicides|mesh-ancestor
2345198|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2345199|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2345200|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345201|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2934946|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2934947|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2934948|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
2934949|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2934950|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2934951|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2934952|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2934953|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2934954|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934955|NCT03897244|Antacids|antacids|mesh-ancestor
2934956|NCT03896230|Ketamine|ketamine|mesh-list
2345202|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
2345203|NCT00467909|Micronutrients|micronutrients|mesh-list
2345204|NCT00467909|Trace Elements|trace elements|mesh-list
2934957|NCT03896230|Analgesics|analgesics|mesh-ancestor
2934958|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
2934959|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2934960|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934961|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2934962|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2934963|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
2934964|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
2934965|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2934966|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2934967|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2934968|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2934969|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2934970|NCT03895203|Adalimumab|adalimumab|mesh-list
2934971|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2934972|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2934973|NCT03890666|Albuterol|albuterol|mesh-list
2934974|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2934975|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
2934976|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2934977|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934978|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2934979|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
2934980|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
2934981|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2934982|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2934983|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2934984|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2934985|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
2934986|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2934987|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345205|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345206|NCT00467935|Ranibizumab|ranibizumab|mesh-list
2345207|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345208|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345209|NCT00467935|Growth Substances|growth substances|mesh-ancestor
2345210|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345211|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345212|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345213|NCT00467948|Cefazolin|cefazolin|mesh-list
2345214|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2345215|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345216|NCT00467987|Testosterone|testosterone|mesh-list
2934988|NCT03878316|Oxytocin|oxytocin|mesh-list
2934989|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
2934990|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2934991|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2934992|NCT03872947|Leucovorin|leucovorin|mesh-list
2934993|NCT03872947|Gemcitabine|gemcitabine|mesh-list
2934994|NCT03872947|Bevacizumab|bevacizumab|mesh-list
2345217|NCT00467987|Androgens|androgens|mesh-ancestor
2345218|NCT00467987|Hormones|hormones|mesh-ancestor
2345219|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2345220|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345221|NCT00468039|Metformin|metformin|mesh-list
2345222|NCT00468039|Vildagliptin|vildagliptin|mesh-list
2345223|NCT00468039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2345224|NCT00468039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345225|NCT00468039|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2345226|NCT00468039|Protease Inhibitors|protease inhibitors|mesh-ancestor
2345227|NCT00468039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345228|NCT00468039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345229|NCT00468091|Atropine|atropine|mesh-list
2345230|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2345231|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2345232|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2345233|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
2345234|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345235|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345236|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2345237|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
2345238|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
2934995|NCT03872947|Carboplatin|carboplatin|mesh-list
2934996|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
2345239|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
2345240|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2345241|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2345242|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
2345243|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2345244|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345245|NCT00468117|Etanercept|etanercept|mesh-list
2345246|NCT00468117|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2345247|NCT00468117|Basiliximab|basiliximab|mesh-list
2345248|NCT00468117|Daclizumab|daclizumab|mesh-list
2345249|NCT00468117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2345250|NCT00468117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2934997|NCT03872947|Nivolumab|nivolumab|mesh-list
2934998|NCT03872947|Irinotecan|irinotecan|mesh-list
2934999|NCT03872947|Topotecan|topotecan|mesh-list
2935000|NCT03872947|Imiquimod|imiquimod|mesh-list
2935001|NCT03872947|Ramucirumab|ramucirumab|mesh-list
2935002|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935003|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935004|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935005|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2935006|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2935007|NCT03872947|Growth Substances|growth substances|mesh-ancestor
2935008|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935009|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
2935010|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2935011|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
2935012|NCT03872947|Antiviral Agents|antiviral agents|mesh-ancestor
2935013|NCT03872947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935014|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935015|NCT03872947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935016|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
2935017|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2935018|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2935019|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2935020|NCT03872947|Antidotes|antidotes|mesh-ancestor
2935021|NCT03872947|Protective Agents|protective agents|mesh-ancestor
2935022|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
2935023|NCT03872947|Vitamins|vitamins|mesh-ancestor
2935024|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
2935025|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2935026|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
2935027|NCT03871829|Dexamethasone|dexamethasone|mesh-list
2345251|NCT00468117|Analgesics|analgesics|mesh-ancestor
2345252|NCT00468117|Sensory System Agents|sensory system agents|mesh-ancestor
2345253|NCT00468117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345254|NCT00468117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345255|NCT00468117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2345256|NCT00468117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2345257|NCT00468117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2935028|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
2935029|NCT03871829|BB 1101|bb 1101|mesh-list
2935030|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935031|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
2935032|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
2935033|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2935034|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935035|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2935036|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
2935037|NCT03871829|Hormones|hormones|mesh-ancestor
2935038|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935039|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2935040|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935041|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
2935042|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935043|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935044|NCT03869034|Leucovorin|leucovorin|mesh-list
2935045|NCT03869034|Fluorouracil|fluorouracil|mesh-list
2935046|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
2935047|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
2935048|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935049|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2935050|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935051|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935052|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
2935053|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935054|NCT03869034|Antidotes|antidotes|mesh-ancestor
2935055|NCT03869034|Protective Agents|protective agents|mesh-ancestor
2935056|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
2935057|NCT03869034|Vitamins|vitamins|mesh-ancestor
2935058|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
2935059|NCT03867357|Goserelin|goserelin|mesh-list
2935060|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2935061|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935068|NCT03859427|Dexamethasone|dexamethasone|mesh-list
2935069|NCT03859427|Lenalidomide|lenalidomide|mesh-list
2345258|NCT00468117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345259|NCT00468117|Immunologic Factors|immunologic factors|mesh-ancestor
2935070|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935071|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
2935072|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
2935073|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2935074|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935075|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2935076|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
2935077|NCT03859427|Hormones|hormones|mesh-ancestor
2935078|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935079|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2345278|NCT00468182|Interferons|interferons|mesh-list
2345279|NCT00468182|Interferon-beta|interferon-beta|mesh-list
2345280|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
2345281|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345282|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
2345283|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345284|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
2345285|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345286|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2345287|NCT00468234|Nicotine|nicotine|mesh-list
2345288|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2345289|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
2345290|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345291|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345292|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2345293|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2345294|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
2345295|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2345296|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345297|NCT00468260|Epothilone B|epothilone b|mesh-list
2345298|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345299|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
2345300|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
2345301|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
2345302|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345303|NCT00468273|Immunoglobulins|immunoglobulins|mesh-list
2345304|NCT00468273|Antibodies|antibodies|mesh-list
2345305|NCT00468273|gamma-Globulins|gamma-globulins|mesh-list
2345306|NCT00468273|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2345307|NCT00468273|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2345308|NCT00468273|Immunologic Factors|immunologic factors|mesh-ancestor
2345309|NCT00468273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345310|NCT00468351|Triamcinolone|triamcinolone|mesh-list
2345311|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2345312|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2345313|NCT00468351|Bevacizumab|bevacizumab|mesh-list
2345314|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2345315|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2345316|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345317|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345318|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345319|NCT00468351|Growth Substances|growth substances|mesh-ancestor
2345320|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345321|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345322|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2345323|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
2345324|NCT00468351|Hormones|hormones|mesh-ancestor
2345325|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935080|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935081|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
2935082|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2935083|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2935084|NCT03859427|Growth Substances|growth substances|mesh-ancestor
2935085|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345326|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345327|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
2345328|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345329|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345330|NCT00468364|Insulin|insulin|mesh-list
2345331|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2345332|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
2345333|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
2345334|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
2345335|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
2345336|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2345337|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935086|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2935087|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2935088|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2935089|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935090|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2935091|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2935092|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935093|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
2935094|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2935095|NCT03854110|Gemcitabine|gemcitabine|mesh-list
2345338|NCT00468403|Mycophenolic Acid|mycophenolic acid|mesh-list
2345339|NCT00468403|Abatacept|abatacept|mesh-list
2345340|NCT00468403|Tacrolimus|tacrolimus|mesh-list
2345341|NCT00468403|Basiliximab|basiliximab|mesh-list
2345342|NCT00468403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345343|NCT00468403|Immunologic Factors|immunologic factors|mesh-ancestor
2345344|NCT00468403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935096|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2935097|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
2935098|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935099|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935100|NCT03854110|Antiviral Agents|antiviral agents|mesh-ancestor
2935101|NCT03854110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935102|NCT03854110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935103|NCT03854110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935104|NCT03854110|Immunologic Factors|immunologic factors|mesh-ancestor
2935105|NCT03854110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935106|NCT03851081|Vincristine|vincristine|mesh-list
2935107|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2935108|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2935109|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935110|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
2935111|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
2935112|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
2935113|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935114|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935115|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2935116|NCT03847428|Bevacizumab|bevacizumab|mesh-list
2935117|NCT03847428|Durvalumab|durvalumab|mesh-list
2345345|NCT00468403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2345346|NCT00468403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935118|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935119|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935120|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2935121|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2935122|NCT03847428|Growth Substances|growth substances|mesh-ancestor
2935123|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935124|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
2935125|NCT03839823|Gemcitabine|gemcitabine|mesh-list
2935126|NCT03839823|Paclitaxel|paclitaxel|mesh-list
2935127|NCT03839823|Vinorelbine|vinorelbine|mesh-list
2935128|NCT03839823|Docetaxel|docetaxel|mesh-list
2935129|NCT03839823|Capecitabine|capecitabine|mesh-list
2935130|NCT03839823|Letrozole|letrozole|mesh-list
2935131|NCT03839823|Anastrozole|anastrozole|mesh-list
2935132|NCT03839823|Goserelin|goserelin|mesh-list
2935133|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2935134|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935135|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
2935136|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
2935137|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
2935138|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935139|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2935140|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
2935141|NCT03839823|Antiviral Agents|antiviral agents|mesh-ancestor
2935142|NCT03839823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935143|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935144|NCT03839823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935145|NCT03839823|Immunologic Factors|immunologic factors|mesh-ancestor
2935146|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935147|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2935148|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2935149|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2935150|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
2935151|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935152|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2935153|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
2935154|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935155|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935156|NCT03822468|Letrozole|letrozole|mesh-list
2935157|NCT03822468|Anastrozole|anastrozole|mesh-list
2935158|NCT03822468|Goserelin|goserelin|mesh-list
2345347|NCT00468403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345348|NCT00468403|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2345349|NCT00468403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345350|NCT00468403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2345351|NCT00468403|Antitubercular Agents|antitubercular agents|mesh-ancestor
2345352|NCT00468403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2345353|NCT00468403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345354|NCT00468403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2345355|NCT00468403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2345356|NCT00468429|Bevacizumab|bevacizumab|mesh-list
2345357|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935159|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935160|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2935161|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2935162|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935163|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935164|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2935165|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
2935166|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935167|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935168|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2935169|NCT03819465|Gemcitabine|gemcitabine|mesh-list
2935170|NCT03819465|Paclitaxel|paclitaxel|mesh-list
2935171|NCT03819465|Carboplatin|carboplatin|mesh-list
2935172|NCT03819465|Pemetrexed|pemetrexed|mesh-list
2935173|NCT03819465|Durvalumab|durvalumab|mesh-list
2935174|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2935175|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345358|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345359|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345360|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345361|NCT00468429|Growth Substances|growth substances|mesh-ancestor
2345362|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345363|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345364|NCT00468442|Sirolimus|sirolimus|mesh-list
2935176|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
2935177|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
2935178|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
2935179|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935180|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2345365|NCT00468442|Rituximab|rituximab|mesh-list
2345366|NCT00468442|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2345367|NCT00468442|Daclizumab|daclizumab|mesh-list
2345368|NCT00468442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2345369|NCT00468442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345370|NCT00468442|Immunologic Factors|immunologic factors|mesh-ancestor
2345371|NCT00468442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345372|NCT00468442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2345373|NCT00468442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2345374|NCT00468442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935181|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
2935182|NCT03819465|Antiviral Agents|antiviral agents|mesh-ancestor
2345375|NCT00468442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2345376|NCT00468442|Antifungal Agents|antifungal agents|mesh-ancestor
2345377|NCT00468442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345378|NCT00468520|Oxytocin|oxytocin|mesh-list
2345379|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
2345380|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2345381|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345382|NCT00468533|Aripiprazole|aripiprazole|mesh-list
2345383|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
2345384|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2345385|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2345386|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2345387|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2345388|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345389|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
2345390|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
2345391|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2345392|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935183|NCT03819465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935184|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935185|NCT03819465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935186|NCT03819465|Immunologic Factors|immunologic factors|mesh-ancestor
2935187|NCT03819465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935188|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2935189|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2935190|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935191|NCT03816176|Isavuconazole|isavuconazole|mesh-list
2935192|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
2935193|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345393|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2345394|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2345395|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
2345396|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2345397|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2345398|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2345399|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2345400|NCT00468689|Ketoconazole|ketoconazole|mesh-list
2345401|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
2345402|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345403|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2345404|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2345405|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345406|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345407|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2345408|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
2345409|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2345410|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345411|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2935220|NCT03809000|Leuprolide|leuprolide|mesh-list
2935221|NCT03809000|Goserelin|goserelin|mesh-list
2935222|NCT03809000|Bicalutamide|bicalutamide|mesh-list
2935223|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935224|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935225|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2935226|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
2935227|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2935228|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2935229|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935230|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
2935231|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
2935232|NCT03802799|Cannabidiol|cannabidiol|mesh-list
2935233|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
2935234|NCT03801525|Venetoclax|venetoclax|mesh-list
2935235|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935236|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
2935237|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
2935238|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935239|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
2935240|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2935241|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935242|NCT03797014|Tenofovir|tenofovir|mesh-list
2935243|NCT03797014|Emtricitabine|emtricitabine|mesh-list
2935244|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2935245|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
2935246|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935247|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2935248|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2935249|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935250|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935251|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2935252|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2345412|NCT00468715|Bicalutamide|bicalutamide|mesh-list
2345413|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
2345414|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
2345415|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2345416|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345417|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345418|NCT00468754|Insulin|insulin|mesh-list
2345419|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2345420|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345421|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2345422|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2345423|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2345424|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
2345425|NCT00468871|Hormones|hormones|mesh-ancestor
2345426|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2345427|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345428|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
2345429|NCT00468923|Candesartan|candesartan|mesh-list
2345430|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2345431|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2345432|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2345433|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
2345434|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345435|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2345436|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2345437|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345438|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2345439|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2345440|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2345441|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
2345442|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2345443|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345444|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2345445|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
2345446|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2345447|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345448|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345449|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345450|NCT00468975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2935274|NCT03787628|Cannabidiol|cannabidiol|mesh-list
2935275|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
2935276|NCT03787602|Avelumab|avelumab|mesh-list
2935277|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935278|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935279|NCT03779334|Risdiplam|risdiplam|mesh-list
2935280|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2935281|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2935282|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935283|NCT03775265|Gemcitabine|gemcitabine|mesh-list
2935284|NCT03775265|Cisplatin|cisplatin|mesh-list
2935285|NCT03775265|Fluorouracil|fluorouracil|mesh-list
2935286|NCT03775265|Atezolizumab|atezolizumab|mesh-list
2935287|NCT03775265|Mitomycins|mitomycins|mesh-list
2935288|NCT03775265|Mitomycin|mitomycin|mesh-list
2935289|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2935290|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935291|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2935292|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
2935293|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935294|NCT03775265|Antiviral Agents|antiviral agents|mesh-ancestor
2935295|NCT03775265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935296|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935297|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935298|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
2935299|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935300|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2935301|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
2935302|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2935303|NCT03768960|Daratumumab|daratumumab|mesh-list
2935304|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935305|NCT03767244|Androgens|androgens|mesh-list
2935306|NCT03767244|Hormones|hormones|mesh-ancestor
2935307|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935308|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935309|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
2935310|NCT03766126|Fludarabine|fludarabine|mesh-list
2935311|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935312|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
2935313|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935314|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2935315|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2345451|NCT00468975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2345452|NCT00468975|Autonomic Agents|autonomic agents|mesh-ancestor
2345453|NCT00468975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345454|NCT00468975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935316|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
2935317|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935318|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935319|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2935320|NCT03761095|Dacarbazine|dacarbazine|mesh-list
2935321|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2935322|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
2345455|NCT00468975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2345456|NCT00468975|Respiratory System Agents|respiratory system agents|mesh-ancestor
2345457|NCT00468975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2345458|NCT00468975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2345459|NCT00468975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2345460|NCT00468975|Adrenergic Agents|adrenergic agents|mesh-ancestor
2345461|NCT00468975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2345462|NCT00468975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345463|NCT00468988|Travoprost|travoprost|mesh-list
2935323|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935324|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935325|NCT03758781|Nivolumab|nivolumab|mesh-list
2935326|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935327|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935328|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2935329|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935330|NCT03749070|Silymarin|silymarin|mesh-list
2935331|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
2935332|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935333|NCT03749070|Protective Agents|protective agents|mesh-ancestor
2935334|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935335|NCT03748641|Prednisone|prednisone|mesh-list
2935336|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
2935337|NCT03748641|Niraparib|niraparib|mesh-list
2935338|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935339|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
2935340|NCT03748641|Hormones|hormones|mesh-ancestor
2935341|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935342|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935343|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2935344|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935345|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2935346|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935347|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935348|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
2935349|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2935350|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2935351|NCT03742895|Olaparib|olaparib|mesh-list
2935352|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2935353|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935354|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935355|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935356|NCT03742349|Spartalizumab|spartalizumab|mesh-list
2935357|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2935358|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935359|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935360|NCT03742102|Paclitaxel|paclitaxel|mesh-list
2935361|NCT03742102|Trastuzumab|trastuzumab|mesh-list
2935362|NCT03742102|Durvalumab|durvalumab|mesh-list
2935363|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2935364|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345464|NCT00468988|Latanoprost|latanoprost|mesh-list
2345465|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2345466|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2345467|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2935365|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
2935366|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
2935367|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
2935368|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935369|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935370|NCT03737994|Cisplatin|cisplatin|mesh-list
2935371|NCT03737994|Carboplatin|carboplatin|mesh-list
2935372|NCT03737994|Pemetrexed|pemetrexed|mesh-list
2935373|NCT03737994|Crizotinib|crizotinib|mesh-list
2935374|NCT03737994|Ceritinib|ceritinib|mesh-list
2935375|NCT03737994|Ensartinib|ensartinib|mesh-list
2935376|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935377|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935378|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935379|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2935380|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2935381|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2935382|NCT03737136|Bortezomib|bortezomib|mesh-list
2935383|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935384|NCT03736265|Carvedilol|carvedilol|mesh-list
2935385|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2111930|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
2111931|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935386|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2935387|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
2935388|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2935389|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935390|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935391|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2935392|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
2935393|NCT03736265|Protective Agents|protective agents|mesh-ancestor
2935394|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2935395|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2935396|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2935397|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
2935398|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2935399|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2935400|NCT03735628|Nivolumab|nivolumab|mesh-list
2935401|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935402|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935403|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2935404|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935413|NCT03729349|Golimumab|golimumab|mesh-list
2935414|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2935415|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935416|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935417|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
2935418|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935419|NCT03728881|Vaccines|vaccines|mesh-list
2935420|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
2935421|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935427|NCT03705507|Dexamethasone|dexamethasone|mesh-list
2935428|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935429|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
2935430|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
2935431|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2935432|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935433|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2935434|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
2935435|NCT03705507|Hormones|hormones|mesh-ancestor
2935436|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935437|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2935438|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935439|NCT03704584|Methylprednisolone|methylprednisolone|mesh-list
2935440|NCT03704584|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2935441|NCT03704584|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2935442|NCT03704584|Prednisolone|prednisolone|mesh-list
2935443|NCT03704584|Prednisolone acetate|prednisolone acetate|mesh-list
2935444|NCT03704584|Lidocaine|lidocaine|mesh-list
2345468|NCT00469053|Buprenorphine|buprenorphine|mesh-list
2345469|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2345470|NCT00469053|Narcotics|narcotics|mesh-ancestor
2345471|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2345472|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345473|NCT00469053|Analgesics|analgesics|mesh-ancestor
2345474|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
2345475|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345476|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2345477|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
2345478|NCT00469131|Tacrolimus|tacrolimus|mesh-list
2345479|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345480|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
2345481|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345482|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2345483|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345484|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345485|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2345486|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345487|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2935445|NCT03704584|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2935446|NCT03704584|Prednisolone phosphate|prednisolone phosphate|mesh-list
2935447|NCT03704584|Anesthetics, Local|anesthetics, local|mesh-ancestor
2935448|NCT03704584|Anesthetics|anesthetics|mesh-ancestor
2935449|NCT03704584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2935450|NCT03704584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935451|NCT03704584|Sensory System Agents|sensory system agents|mesh-ancestor
2935452|NCT03704584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2935453|NCT03704584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2935454|NCT03704584|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2935455|NCT03704584|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2935456|NCT03704584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2935457|NCT03704584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935458|NCT03704584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935459|NCT03704584|Antiemetics|antiemetics|mesh-ancestor
2345488|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
2345489|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2345490|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345491|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2345492|NCT00469183|Tretinoin|tretinoin|mesh-list
2345493|NCT00469183|Hydroquinone|hydroquinone|mesh-list
2345494|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345495|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
2345496|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
2345497|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2345498|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
2345499|NCT00469183|Hormones|hormones|mesh-ancestor
2345500|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2345501|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345502|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
2345503|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935460|NCT03704584|Autonomic Agents|autonomic agents|mesh-ancestor
2935461|NCT03704584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2935462|NCT03704584|Glucocorticoids|glucocorticoids|mesh-ancestor
2935463|NCT03704584|Hormones|hormones|mesh-ancestor
2935464|NCT03704584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935465|NCT03704584|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2935466|NCT03704584|Protective Agents|protective agents|mesh-ancestor
2935467|NCT03704584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2935468|NCT03704584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935472|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2935473|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935474|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935475|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2345504|NCT00469183|Protective Agents|protective agents|mesh-ancestor
2345505|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2935476|NCT03667716|Nivolumab|nivolumab|mesh-list
2935477|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935478|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345506|NCT00469261|Doxycycline|doxycycline|mesh-list
2345507|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2345508|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935479|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2935480|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935481|NCT03665129|Avdoralimab|avdoralimab|mesh-list
2935482|NCT03665129|Durvalumab|durvalumab|mesh-list
2935483|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2345509|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
2345510|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2345511|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2345512|NCT00469300|Acyclovir|acyclovir|mesh-list
2345513|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
2345514|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345515|NCT00469326|Atorvastatin|atorvastatin|mesh-list
2345516|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2345517|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2345518|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
2345519|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345520|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2345521|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2345522|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345523|NCT00469352|Ranibizumab|ranibizumab|mesh-list
2345524|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345525|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345526|NCT00469352|Growth Substances|growth substances|mesh-ancestor
2345527|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345528|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345529|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345530|NCT00469404|Buprenorphine|buprenorphine|mesh-list
2345531|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2345532|NCT00469404|Narcotics|narcotics|mesh-ancestor
2935484|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935485|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935486|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
2935487|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935503|NCT03659136|Everolimus|everolimus|mesh-list
2935504|NCT03659136|Exemestane|exemestane|mesh-list
2935505|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935506|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935507|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
2935508|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935509|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2935510|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2935511|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935512|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935513|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2935514|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
2935515|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935516|NCT03652064|Dexamethasone|dexamethasone|mesh-list
2935517|NCT03652064|Lenalidomide|lenalidomide|mesh-list
2935518|NCT03652064|Bortezomib|bortezomib|mesh-list
2935519|NCT03652064|Daratumumab|daratumumab|mesh-list
2935520|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935521|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
2935522|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
2935523|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2935524|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935525|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2935526|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
2935527|NCT03652064|Hormones|hormones|mesh-ancestor
2935528|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935529|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2345533|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2935530|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345534|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345535|NCT00469404|Analgesics|analgesics|mesh-ancestor
2345536|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
2345537|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345538|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2345539|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2345540|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2345541|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2345542|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
2345543|NCT00469430|Metronidazole|metronidazole|mesh-list
2345544|NCT00469430|Cefotaxime|cefotaxime|mesh-list
2935531|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
2935532|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2935533|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2935534|NCT03652064|Growth Substances|growth substances|mesh-ancestor
2935535|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
2935536|NCT03650114|Ofatumumab|ofatumumab|mesh-list
2935537|NCT03650114|Vaccines|vaccines|mesh-list
2935538|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2935539|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2935540|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
2935541|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935542|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935543|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2935544|NCT03648021|Acetaminophen|acetaminophen|mesh-list
2935545|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2345545|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345546|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2345547|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2345548|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2345549|NCT00469443|Leucovorin|leucovorin|mesh-list
2345550|NCT00469443|Bevacizumab|bevacizumab|mesh-list
2345551|NCT00469443|Fluorouracil|fluorouracil|mesh-list
2345552|NCT00469443|Capecitabine|capecitabine|mesh-list
2935546|NCT03648021|Analgesics|analgesics|mesh-ancestor
2935547|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
2935548|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2935549|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935550|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
2935551|NCT03646604|Upadacitinib|upadacitinib|mesh-list
2935552|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2935553|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2935554|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935555|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935556|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2935557|NCT03641755|Olaparib|olaparib|mesh-list
2935558|NCT03641755|Sapacitabine|sapacitabine|mesh-list
2935559|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2935560|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935561|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935562|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935563|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
2935564|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935565|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935566|NCT03617731|Dexamethasone|dexamethasone|mesh-list
2935567|NCT03617731|Lenalidomide|lenalidomide|mesh-list
2935568|NCT03617731|Bortezomib|bortezomib|mesh-list
2935569|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935570|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
2935571|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
2935572|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2935573|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935574|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2935575|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
2935576|NCT03617731|Hormones|hormones|mesh-ancestor
2935577|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935578|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2935579|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935580|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
2935581|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2935582|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2935583|NCT03617731|Growth Substances|growth substances|mesh-ancestor
2935584|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
2935585|NCT03617367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2935586|NCT03617367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2935587|NCT03617367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2935588|NCT03617367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345553|NCT00469443|Irinotecan|irinotecan|mesh-list
2345554|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2345555|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345556|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345557|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345558|NCT00469443|Growth Substances|growth substances|mesh-ancestor
2345559|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345560|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345561|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
2345562|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345563|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2345564|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345565|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
2345566|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2345567|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2345568|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345569|NCT00469443|Antidotes|antidotes|mesh-ancestor
2935589|NCT03617367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935590|NCT03617367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2935591|NCT03617367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2935592|NCT03617367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935593|NCT03617367|Cholinergic Agents|cholinergic agents|mesh-ancestor
2935594|NCT03617367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2935595|NCT03614949|Atezolizumab|atezolizumab|mesh-list
2935596|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935610|NCT03600883|Midazolam|midazolam|mesh-list
2935611|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2935612|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2935613|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2935614|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935615|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2935616|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2935617|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2935618|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2345570|NCT00469443|Protective Agents|protective agents|mesh-ancestor
2345571|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
2345572|NCT00469443|Vitamins|vitamins|mesh-ancestor
2345573|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
2935619|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
2935620|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
2935621|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
2935622|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
2935623|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2935624|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935625|NCT03599622|BMS-986165|bms-986165|mesh-list
2935626|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
2935627|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2935628|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935629|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935630|NCT03596164|Teduglutide|teduglutide|mesh-list
2935631|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2935632|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2935633|NCT03596164|Protective Agents|protective agents|mesh-ancestor
2935634|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935643|NCT03590821|Aspirin|aspirin|mesh-list
2935644|NCT03590821|Celecoxib|celecoxib|mesh-list
2345574|NCT00469469|Bevacizumab|bevacizumab|mesh-list
2935645|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2935646|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2935647|NCT03590821|Analgesics|analgesics|mesh-ancestor
2935648|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
2935649|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2935650|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935651|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935652|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2935653|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2935654|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2935655|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935656|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2935657|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2935658|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935659|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
2935660|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2935661|NCT03580044|Aztreonam|aztreonam|mesh-list
2935662|NCT03580044|Avibactam|avibactam|mesh-list
2345575|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2345576|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345577|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345578|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345579|NCT00469469|Growth Substances|growth substances|mesh-ancestor
2345580|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345581|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345582|NCT00469495|Anthelmintics|anthelmintics|mesh-list
2345583|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2345584|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345585|NCT00469547|Ethanol|ethanol|mesh-list
2345586|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
2345587|NCT00469547|Emollients|emollients|mesh-list
2345588|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2345589|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2345590|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345591|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
2345592|NCT00469560|Deferasirox|deferasirox|mesh-list
2345593|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2345594|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
2345595|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
2345596|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345597|NCT00469586|Insulin|insulin|mesh-list
2345598|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2345599|NCT00469586|Metformin|metformin|mesh-list
2345600|NCT00469586|Glimepiride|glimepiride|mesh-list
2345601|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2345602|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935663|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2935664|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935665|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2935666|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935667|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935668|NCT03578367|Niacinamide|niacinamide|mesh-list
2935669|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
2935670|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935671|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2935672|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935673|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935674|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
2935675|NCT03578367|Vitamins|vitamins|mesh-ancestor
2935676|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
2935677|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935678|NCT03576612|Valacyclovir|valacyclovir|mesh-list
2935679|NCT03576612|Acyclovir|acyclovir|mesh-list
2935680|NCT03576612|Nivolumab|nivolumab|mesh-list
2935681|NCT03576612|Temozolomide|temozolomide|mesh-list
2935682|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935683|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935684|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2935685|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935686|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2935687|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
2935688|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
2935689|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935690|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
2935691|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111932|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111933|NCT02562066|Amifampridine|amifampridine|mesh-list
2111934|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2111935|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111936|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111937|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2111938|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2345603|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2935692|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935693|NCT03557307|Benralizumab|benralizumab|mesh-list
2345604|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345605|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
2345606|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
2345607|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2345608|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2935694|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2935695|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
2935696|NCT03550391|Memantine|memantine|mesh-list
2935697|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2935698|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2935699|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
2935700|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2935701|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935702|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935703|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2935704|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2935705|NCT03543189|Nivolumab|nivolumab|mesh-list
2935706|NCT03543189|Androgens|androgens|mesh-list
2935707|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935708|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935709|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2935710|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935711|NCT03543189|Hormones|hormones|mesh-ancestor
2935712|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935713|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935714|NCT03528642|Temozolomide|temozolomide|mesh-list
2935715|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2935716|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
2935717|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935718|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935719|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2935720|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
2935721|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935722|NCT03518034|Testosterone|testosterone|mesh-list
2935723|NCT03518034|Androgens|androgens|mesh-ancestor
2935724|NCT03518034|Hormones|hormones|mesh-ancestor
2935725|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935726|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935727|NCT03505710|Trastuzumab|trastuzumab|mesh-list
2935728|NCT03505710|Camptothecin|camptothecin|mesh-list
2935729|NCT03505710|Immunoconjugates|immunoconjugates|mesh-list
2935730|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935731|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935732|NCT03505710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2935733|NCT03505710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2345609|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345610|NCT00469599|Vitamins|vitamins|mesh-ancestor
2345611|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
2345612|NCT00469651|Vaccines|vaccines|mesh-list
2345613|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
2345614|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345615|NCT00469664|Guanfacine|guanfacine|mesh-list
2345616|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2345617|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2345618|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2935734|NCT03505710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2935735|NCT03505710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935736|NCT03505710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935737|NCT03505710|Immunologic Factors|immunologic factors|mesh-ancestor
2935738|NCT03505710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935739|NCT03493932|Nivolumab|nivolumab|mesh-list
2935740|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935741|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935742|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2935743|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935744|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
2935745|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935746|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935747|NCT03482479|Naltrexone|naltrexone|mesh-list
2935748|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2935749|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2935750|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935751|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
2935752|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2935753|NCT03473743|Carboplatin|carboplatin|mesh-list
2935754|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935755|NCT03468985|Nivolumab|nivolumab|mesh-list
2935756|NCT03468985|Ipilimumab|ipilimumab|mesh-list
2935757|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935758|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935759|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2935760|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935761|NCT03464045|Empagliflozin|empagliflozin|mesh-list
2935762|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2935763|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2935764|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935765|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2935766|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935767|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
2935768|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935769|NCT03462719|Venetoclax|venetoclax|mesh-list
2935770|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
2935771|NCT03462719|Chlorambucil|chlorambucil|mesh-list
2935772|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935773|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935774|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2935775|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
2935776|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935777|NCT03455829|Osimertinib|osimertinib|mesh-list
2935778|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935779|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2935780|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935781|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935782|NCT03451851|Etanercept|etanercept|mesh-list
2935783|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2935784|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2935785|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2935786|NCT03451851|Analgesics|analgesics|mesh-ancestor
2935787|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
2935788|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2935789|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935790|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935791|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2935792|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2935793|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935794|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
2935795|NCT03446157|Cetuximab|cetuximab|mesh-list
2935796|NCT03446157|Palbociclib|palbociclib|mesh-list
2935797|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935798|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935799|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2935800|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345619|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2345620|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
2345621|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2345622|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935801|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935802|NCT03436745|Zolpidem|zolpidem|mesh-list
2935803|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2935804|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2345623|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345624|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2345625|NCT00469690|Bromfenac|bromfenac|mesh-list
2345626|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2345627|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2345628|NCT00469690|Analgesics|analgesics|mesh-ancestor
2345629|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
2345630|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345631|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345632|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2345633|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2345634|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2345635|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345636|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345637|NCT00469703|Thalidomide|thalidomide|mesh-list
2345638|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345639|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
2345640|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345641|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
2345642|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2345643|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345644|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345645|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345646|NCT00469703|Growth Substances|growth substances|mesh-ancestor
2345647|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345648|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345649|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2345650|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
2111939|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935805|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2935806|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935807|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2935808|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
2935809|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
2935810|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2935811|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935812|NCT03431350|Prednisone|prednisone|mesh-list
2935813|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
2935814|NCT03431350|Niraparib|niraparib|mesh-list
2935815|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935816|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
2935817|NCT03431350|Hormones|hormones|mesh-ancestor
2935818|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935819|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935820|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2935821|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935822|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2935823|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935824|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935825|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
2935826|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2935827|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2935828|NCT03428958|Leucovorin|leucovorin|mesh-list
2935829|NCT03428958|Bevacizumab|bevacizumab|mesh-list
2935830|NCT03428958|Cetuximab|cetuximab|mesh-list
2935831|NCT03428958|Panitumumab|panitumumab|mesh-list
2935832|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
2935833|NCT03428958|Irinotecan|irinotecan|mesh-list
2935834|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
2935835|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935836|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935837|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2935838|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2935839|NCT03428958|Growth Substances|growth substances|mesh-ancestor
2935840|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935841|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
2935842|NCT03428958|Antidotes|antidotes|mesh-ancestor
2935843|NCT03428958|Protective Agents|protective agents|mesh-ancestor
2935844|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
2935845|NCT03428958|Vitamins|vitamins|mesh-ancestor
2935846|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
2935847|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2935848|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2935849|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935850|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111943|NCT02562521|Nicotine|nicotine|mesh-list
2111944|NCT02562521|Varenicline|varenicline|mesh-list
2111945|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2111946|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
2111947|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2111948|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111949|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2935851|NCT03412565|Dexamethasone|dexamethasone|mesh-list
2935852|NCT03412565|Prednisone|prednisone|mesh-list
2345651|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
2345652|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
2345653|NCT00469755|Adapalene|adapalene|mesh-list
2345654|NCT00469755|Tazarotene|tazarotene|mesh-list
2345655|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2345656|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2345657|NCT00469755|Analgesics|analgesics|mesh-ancestor
2345658|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
2345659|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345660|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345661|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2345662|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2345663|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
2345664|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
2345665|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
2345666|NCT00469755|Vitamins|vitamins|mesh-ancestor
2345667|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
2345668|NCT00469768|Dapivirine|dapivirine|mesh-list
2345669|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2345670|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2345671|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
2345672|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345673|NCT00469781|Bromfenac|bromfenac|mesh-list
2345674|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
2345675|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2345676|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
2345677|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2345678|NCT00469781|Prednisolone|prednisolone|mesh-list
2345679|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2345680|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
2345681|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2935853|NCT03412565|Lenalidomide|lenalidomide|mesh-list
2935854|NCT03412565|Bortezomib|bortezomib|mesh-list
2935855|NCT03412565|Melphalan|melphalan|mesh-list
2935856|NCT03412565|Daratumumab|daratumumab|mesh-list
2935857|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935858|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
2935859|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
2935860|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2935861|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935862|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2935863|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
2935864|NCT03412565|Hormones|hormones|mesh-ancestor
2935865|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935866|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2935867|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935868|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
2935869|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2935870|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2935871|NCT03412565|Growth Substances|growth substances|mesh-ancestor
2935872|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
2935873|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2935874|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
2345682|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2345683|NCT00469781|Analgesics|analgesics|mesh-ancestor
2345684|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
2345685|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345686|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345687|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2345688|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2345689|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
2345690|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
2345691|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2345692|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
2345693|NCT00469781|Hormones|hormones|mesh-ancestor
2935875|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935876|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2935877|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935878|NCT03404791|Gemcitabine|gemcitabine|mesh-list
2935879|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2345694|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2345695|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2345696|NCT00469781|Protective Agents|protective agents|mesh-ancestor
2345697|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2345698|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935880|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
2935881|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935882|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935883|NCT03404791|Antiviral Agents|antiviral agents|mesh-ancestor
2935884|NCT03404791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935885|NCT03404791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935886|NCT03404791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935887|NCT03404791|Immunologic Factors|immunologic factors|mesh-ancestor
2935888|NCT03404791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935893|NCT03393611|Cytarabine|cytarabine|mesh-list
2345699|NCT00469846|Ascorbic Acid|ascorbic acid|mesh-list
2345700|NCT00469846|Vitamins|vitamins|mesh-ancestor
2345701|NCT00469846|Micronutrients|micronutrients|mesh-ancestor
2345702|NCT00469846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345703|NCT00469846|Antioxidants|antioxidants|mesh-ancestor
2345704|NCT00469846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345705|NCT00469846|Protective Agents|protective agents|mesh-ancestor
2345706|NCT00469885|Nicotine|nicotine|mesh-list
2345707|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2345708|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
2345709|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345710|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935894|NCT03393611|Fludarabine|fludarabine|mesh-list
2935895|NCT03393611|Melphalan|melphalan|mesh-list
2935896|NCT03393611|Daunorubicin|daunorubicin|mesh-list
2935897|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
2935898|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935899|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2935900|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
2935901|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935902|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345711|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2345712|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2345713|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
2345714|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2345715|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345716|NCT00469924|Caffeine|caffeine|mesh-list
2345717|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2345718|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345719|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2935903|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
2935904|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935905|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
2935906|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935907|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2935908|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
2935909|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2935910|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2935911|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2935912|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2935913|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935914|NCT03390504|Docetaxel|docetaxel|mesh-list
2935915|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
2935916|NCT03390504|Mitogens|mitogens|mesh-list
2935917|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935918|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
2935919|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
2935920|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
2935921|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935922|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2345720|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345721|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345722|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2345723|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2345724|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
2345725|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2345726|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
2345727|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
2345728|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2345729|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345730|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345731|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
2935923|NCT03384914|Vaccines|vaccines|mesh-list
2935924|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
2935925|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935926|NCT03384654|Cytarabine|cytarabine|mesh-list
2935927|NCT03384654|Prednisone|prednisone|mesh-list
2935928|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
2935929|NCT03384654|Doxorubicin|doxorubicin|mesh-list
2935930|NCT03384654|Methotrexate|methotrexate|mesh-list
2935931|NCT03384654|Vincristine|vincristine|mesh-list
2935932|NCT03384654|Asparaginase|asparaginase|mesh-list
2935933|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
2935934|NCT03384654|Daratumumab|daratumumab|mesh-list
2935935|NCT03384654|Pegaspargase|pegaspargase|mesh-list
2935936|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935937|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
2935938|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935939|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2935940|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2935941|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
2935942|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935943|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935944|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2935945|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2935946|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2935947|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2935948|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935949|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2935950|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
2935951|NCT03384654|Hormones|hormones|mesh-ancestor
2935952|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2935953|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2935954|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2345732|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2345733|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2345734|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345735|NCT00469976|Gemcitabine|gemcitabine|mesh-list
2345736|NCT00469976|Bevacizumab|bevacizumab|mesh-list
2345737|NCT00469976|Carboplatin|carboplatin|mesh-list
2345738|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935955|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
2935956|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2935957|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2345739|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345740|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345741|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345742|NCT00469976|Growth Substances|growth substances|mesh-ancestor
2345743|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345744|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345745|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2345746|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
2345747|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345748|NCT00469976|Antiviral Agents|antiviral agents|mesh-ancestor
2345749|NCT00469976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935958|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
2935959|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
2935960|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2935961|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2935962|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
2935963|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935964|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2935965|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
2935966|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
2935967|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
2935968|NCT03382561|Cisplatin|cisplatin|mesh-list
2935969|NCT03382561|Carboplatin|carboplatin|mesh-list
2935970|NCT03382561|Nivolumab|nivolumab|mesh-list
2935971|NCT03382561|Etoposide|etoposide|mesh-list
2935972|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
2935973|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
2935974|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2935975|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2935976|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2935977|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935978|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2935979|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2935980|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2935981|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935982|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
2935983|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
2935984|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
2935985|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
2935986|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
2935987|NCT03382301|Cyclosporine|cyclosporine|mesh-list
2935988|NCT03382301|Cyclosporins|cyclosporins|mesh-list
2935989|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2935990|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2935991|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2935992|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
2935993|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2935994|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
2935995|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2935996|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
2935997|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2935998|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2935999|NCT03379051|Lenalidomide|lenalidomide|mesh-list
2936000|NCT03379051|Venetoclax|venetoclax|mesh-list
2936001|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
2936002|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936003|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2936004|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2936005|NCT03379051|Growth Substances|growth substances|mesh-ancestor
2936006|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
2936007|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936008|NCT03363464|Empagliflozin|empagliflozin|mesh-list
2936009|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2936010|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2936011|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936012|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2936013|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936014|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
2936015|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936016|NCT03340506|Trametinib|trametinib|mesh-list
2936017|NCT03340506|Dabrafenib|dabrafenib|mesh-list
2936018|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936019|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2936020|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936021|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936022|NCT03331198|Venetoclax|venetoclax|mesh-list
2936023|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936024|NCT03318952|Lidocaine|lidocaine|mesh-list
2936025|NCT03318952|Carticaine|carticaine|mesh-list
2936026|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-ancestor
2936027|NCT03318952|Anesthetics|anesthetics|mesh-ancestor
2936028|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2936029|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936030|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
2936031|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936032|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2936033|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2936034|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2936035|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2936036|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936037|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
2936038|NCT03308448|Hematinics|hematinics|mesh-ancestor
2936039|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
2936040|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936041|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936042|NCT03301506|Seladelpar|seladelpar|mesh-list
2936043|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2936044|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
2936045|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936046|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2936047|NCT03301415|Valganciclovir|valganciclovir|mesh-list
2936048|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
2936049|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936050|NCT03301220|Daratumumab|daratumumab|mesh-list
2936051|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936052|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2936053|NCT03296553|Valganciclovir|valganciclovir|mesh-list
2936054|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
2936055|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936056|NCT03294460|Ethanol|ethanol|mesh-list
2936057|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2936058|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345750|NCT00469976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345751|NCT00469976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345752|NCT00469976|Immunologic Factors|immunologic factors|mesh-ancestor
2345753|NCT00470015|Aldesleukin|aldesleukin|mesh-list
2345754|NCT00470015|Interleukin-2|interleukin-2|mesh-list
2345755|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345756|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2345757|NCT00470015|Analgesics|analgesics|mesh-ancestor
2345758|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
2345759|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345760|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345761|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2936059|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2936060|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936061|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2936062|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936063|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936064|NCT03289962|Atezolizumab|atezolizumab|mesh-list
2936065|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345762|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2345763|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
2345764|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345765|NCT00470041|Lamivudine|lamivudine|mesh-list
2345766|NCT00470041|Zidovudine|zidovudine|mesh-list
2345767|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
2345768|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2345769|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2345770|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345771|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345772|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345773|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2345774|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2345775|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
2345776|NCT00470197|Cytarabine|cytarabine|mesh-list
2345777|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
2345778|NCT00470197|Alvocidib|alvocidib|mesh-list
2345779|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2345780|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
2345781|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345782|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345783|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
2345784|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345785|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345786|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
2345787|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345788|NCT00470197|Analgesics|analgesics|mesh-ancestor
2345789|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
2345790|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345791|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2345792|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2345793|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345794|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345795|NCT00470197|Growth Substances|growth substances|mesh-ancestor
2345796|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2345797|NCT00470210|Ribavirin|ribavirin|mesh-list
2345798|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2345799|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
2345800|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345801|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
2345802|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345803|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
2345804|NCT00470223|Doxorubicin|doxorubicin|mesh-list
2345805|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2345806|NCT00470223|Methotrexate|methotrexate|mesh-list
2345807|NCT00470223|Etoposide|etoposide|mesh-list
2345808|NCT00470223|Ifosfamide|ifosfamide|mesh-list
2345809|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345810|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2345811|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2936113|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2936114|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
2936115|NCT03255174|Coagulants|coagulants|mesh-ancestor
2936116|NCT03253796|Golimumab|golimumab|mesh-list
2936117|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2936118|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2936119|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345812|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2345813|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345814|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345815|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2345816|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
2345817|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2345818|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345819|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2936120|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
2936121|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936122|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
2936123|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936124|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936125|NCT03234972|Dexamethasone|dexamethasone|mesh-list
2936126|NCT03234972|Bortezomib|bortezomib|mesh-list
2936127|NCT03234972|Daratumumab|daratumumab|mesh-list
2936128|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2936129|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
2936130|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
2936131|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936132|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936133|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2936134|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
2936135|NCT03234972|Hormones|hormones|mesh-ancestor
2936136|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2936137|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2936138|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936139|NCT03233711|Nivolumab|nivolumab|mesh-list
2936140|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936141|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936142|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2345820|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
2345821|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
2345822|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2345823|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345824|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
2345825|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2345826|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2345827|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2936143|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936144|NCT03233204|Olaparib|olaparib|mesh-list
2936145|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2936146|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936147|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936148|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936149|NCT03228537|Cisplatin|cisplatin|mesh-list
2936150|NCT03228537|Pemetrexed|pemetrexed|mesh-list
2936151|NCT03228537|Atezolizumab|atezolizumab|mesh-list
2936152|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2936153|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936154|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936155|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936156|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2936157|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2936158|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
2936159|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936160|NCT03220035|Vemurafenib|vemurafenib|mesh-list
2936161|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936162|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2936163|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936164|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936165|NCT03217812|Prednisone|prednisone|mesh-list
2936166|NCT03217812|Bortezomib|bortezomib|mesh-list
2936167|NCT03217812|Melphalan|melphalan|mesh-list
2936168|NCT03217812|Daratumumab|daratumumab|mesh-list
2936169|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2936170|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
2936171|NCT03217812|Hormones|hormones|mesh-ancestor
2936172|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2936173|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936174|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2345828|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2345829|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
2345830|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2345831|NCT00470249|Gemcitabine|gemcitabine|mesh-list
2345832|NCT00470249|Carboplatin|carboplatin|mesh-list
2345833|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345834|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2345835|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
2345836|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345837|NCT00470249|Antiviral Agents|antiviral agents|mesh-ancestor
2345838|NCT00470249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345839|NCT00470249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345840|NCT00470249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345841|NCT00470249|Immunologic Factors|immunologic factors|mesh-ancestor
2345842|NCT00470249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345843|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
2345844|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2345845|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2345846|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2936175|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936176|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2936177|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
2936178|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936179|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2936180|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2936181|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
2936182|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
2936183|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936184|NCT03213652|Ensartinib|ensartinib|mesh-list
2936185|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936186|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2936187|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345847|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345848|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936188|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936189|NCT03205423|Gabapentin|gabapentin|mesh-list
2936190|NCT03205423|Analgesics|analgesics|mesh-ancestor
2936191|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
2936192|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936193|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936194|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
2936195|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2936196|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2936197|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2936198|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2936199|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2936200|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2936201|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2345849|NCT00470340|Gemcitabine|gemcitabine|mesh-list
2345850|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
2345851|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
2345852|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345853|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2345854|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
2345855|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345856|NCT00470340|Antiviral Agents|antiviral agents|mesh-ancestor
2345857|NCT00470340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345858|NCT00470340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345859|NCT00470340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345860|NCT00470340|Immunologic Factors|immunologic factors|mesh-ancestor
2345861|NCT00470340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345862|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
2345863|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
2345864|NCT00470353|Calcium|calcium|mesh-list
2345865|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2345866|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345867|NCT00470353|Vitamins|vitamins|mesh-ancestor
2345868|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
2345869|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2345870|NCT00470353|Antacids|antacids|mesh-ancestor
2345871|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936202|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936203|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
2936204|NCT03205137|Amlodipine|amlodipine|mesh-list
2936205|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2936206|NCT03205137|Telmisartan|telmisartan|mesh-list
2936207|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2345872|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2345873|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
2345874|NCT00470405|Pemetrexed|pemetrexed|mesh-list
2345875|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345876|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345877|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345878|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2345879|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2345880|NCT00470483|Paroxetine|paroxetine|mesh-list
2345881|NCT00470483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2345882|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2936208|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
2936209|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2936210|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2936211|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2936212|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936213|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2936214|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936215|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
2936216|NCT03205137|Diuretics|diuretics|mesh-ancestor
2936217|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
2936218|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2345883|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2345884|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345885|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2345886|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
2345887|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345888|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2345889|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
2345890|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2936219|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2936220|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2936221|NCT03201965|Dexamethasone|dexamethasone|mesh-list
2345891|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2345892|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2345893|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345894|NCT00470509|Adalimumab|adalimumab|mesh-list
2345895|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2345896|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2345897|NCT00470522|Folic Acid|folic acid|mesh-list
2345898|NCT00470522|Methotrexate|methotrexate|mesh-list
2345899|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2345900|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
2345901|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2345902|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345903|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2345904|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
2345905|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936222|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
2936223|NCT03201965|Bortezomib|bortezomib|mesh-list
2936224|NCT03201965|Daratumumab|daratumumab|mesh-list
2936225|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2936226|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
2936227|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936228|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2936229|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2936230|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
2936231|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936232|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936233|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2936234|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2936235|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
2936236|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
2936237|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936238|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2936239|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
2936240|NCT03201965|Hormones|hormones|mesh-ancestor
2936241|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2936242|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2345906|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345907|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
2345908|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345909|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2345910|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345911|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
2345912|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2345913|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2345914|NCT00470522|Hematinics|hematinics|mesh-ancestor
2345915|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
2345916|NCT00470522|Vitamins|vitamins|mesh-ancestor
2345917|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
2345918|NCT00470561|Aspirin|aspirin|mesh-list
2345919|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2345920|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2345921|NCT00470561|Analgesics|analgesics|mesh-ancestor
2345922|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
2345923|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345924|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345925|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2345926|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2345927|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2345928|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2345929|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345930|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2345931|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2345932|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345933|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
2936262|NCT03187379|Bupivacaine|bupivacaine|mesh-list
2936263|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
2936264|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
2936265|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2936266|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936267|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
2936268|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936269|NCT03180034|Vaccines|vaccines|mesh-list
2936270|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
2936271|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936272|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
2936273|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936274|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936275|NCT03150914|Sirolimus|sirolimus|mesh-list
2936276|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2936277|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936278|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2936279|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936280|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
2345934|NCT00470665|Sirolimus|sirolimus|mesh-list
2345935|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2345936|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2345937|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2345938|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345939|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
2345940|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2345941|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
2345942|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345943|NCT00470678|Ranibizumab|ranibizumab|mesh-list
2345944|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345945|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2936281|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2936282|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
2936283|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936284|NCT03148795|Talazoparib|talazoparib|mesh-list
2936285|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2936286|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936287|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936288|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936313|NCT03099174|Letrozole|letrozole|mesh-list
2936314|NCT03099174|Fulvestrant|fulvestrant|mesh-list
2936315|NCT03099174|Anastrozole|anastrozole|mesh-list
2345946|NCT00470678|Growth Substances|growth substances|mesh-ancestor
2936316|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936317|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2936318|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2936319|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936320|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936321|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2936322|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
2936323|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2936324|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345947|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345948|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
2345949|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345950|NCT00470704|Trastuzumab|trastuzumab|mesh-list
2345951|NCT00470704|Lapatinib|lapatinib|mesh-list
2345952|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2345953|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345954|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2936325|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2936326|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2936327|NCT03098485|Azithromycin|azithromycin|mesh-list
2936328|NCT03098485|Levofloxacin|levofloxacin|mesh-list
2936329|NCT03098485|Ofloxacin|ofloxacin|mesh-list
2936330|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
2936331|NCT03098485|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
2936332|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2936333|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936334|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2936335|NCT03098485|Renal Agents|renal agents|mesh-ancestor
2936336|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2936337|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2936338|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936339|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936340|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2345955|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345956|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345957|NCT00470743|Ibuprofen|ibuprofen|mesh-list
2345958|NCT00470743|Indomethacin|indomethacin|mesh-list
2345959|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2345960|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2345961|NCT00470743|Analgesics|analgesics|mesh-ancestor
2345962|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
2345963|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2345964|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345965|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2345966|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2936341|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2936342|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2936343|NCT03092674|Cytarabine|cytarabine|mesh-list
2936344|NCT03092674|Nivolumab|nivolumab|mesh-list
2936345|NCT03092674|Azacitidine|azacitidine|mesh-list
2936346|NCT03092674|Decitabine|decitabine|mesh-list
2936347|NCT03092674|Midostaurin|midostaurin|mesh-list
2936348|NCT03092674|Staurosporine|staurosporine|mesh-list
2936349|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936350|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936351|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2936352|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936353|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2936354|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
2936355|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
2936356|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936357|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2936358|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
2936359|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936360|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936361|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2345967|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2345968|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345969|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345970|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
2345971|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
2345972|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2345973|NCT00470821|Melatonin|melatonin|mesh-list
2345974|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
2345975|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345976|NCT00470821|Protective Agents|protective agents|mesh-ancestor
2345977|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345978|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2345979|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2345980|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
2345981|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2345982|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2345983|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345984|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345985|NCT00470873|Urological Agents|urological agents|mesh-ancestor
2345986|NCT00470886|Telmisartan|telmisartan|mesh-list
2345987|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2345988|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2345989|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2345990|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2345991|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
2345992|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2345993|NCT00470912|Protective Agents|protective agents|mesh-ancestor
2345994|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2345995|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
2345996|NCT00470977|Ranibizumab|ranibizumab|mesh-list
2936362|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
2936363|NCT03092518|Mitomycins|mitomycins|mesh-list
2936364|NCT03092518|Mitomycin|mitomycin|mesh-list
2936365|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936366|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2936367|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
2936368|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936369|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2936370|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2345997|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2345998|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2345999|NCT00470977|Growth Substances|growth substances|mesh-ancestor
2346000|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346001|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
2346002|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346003|NCT00470990|Acyline|acyline|mesh-list
2346004|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
2346005|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2936371|NCT03092518|Antidotes|antidotes|mesh-ancestor
2936372|NCT03092518|Protective Agents|protective agents|mesh-ancestor
2936373|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936374|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
2936375|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
2936376|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2936377|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936378|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
2936379|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
2936380|NCT03086486|Linezolid|linezolid|mesh-list
2936381|NCT03086486|Bedaquiline|bedaquiline|mesh-list
2936382|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2936383|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936384|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2936385|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936386|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936387|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
2936388|NCT03077243|Cisplatin|cisplatin|mesh-list
2936389|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936390|NCT03076554|Avelumab|avelumab|mesh-list
2936391|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936392|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936393|NCT03064867|Rituximab|rituximab|mesh-list
2936394|NCT03064867|Carboplatin|carboplatin|mesh-list
2936395|NCT03064867|Etoposide|etoposide|mesh-list
2936396|NCT03064867|Ifosfamide|ifosfamide|mesh-list
2936397|NCT03064867|Venetoclax|venetoclax|mesh-list
2936398|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936399|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936400|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
2936401|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936402|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2936403|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2936404|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2936405|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2936406|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936407|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936408|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2936409|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
2936410|NCT03052608|Crizotinib|crizotinib|mesh-list
2936411|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936412|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2936413|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936414|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936415|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
2936416|NCT03049449|Fludarabine|fludarabine|mesh-list
2936417|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2936418|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
2936419|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936420|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2936421|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2936422|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
2936423|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936424|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936425|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2936426|NCT03033576|Nivolumab|nivolumab|mesh-list
2936427|NCT03033576|Ipilimumab|ipilimumab|mesh-list
2936428|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936429|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936430|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2936431|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936432|NCT03015129|Durvalumab|durvalumab|mesh-list
2936433|NCT03015129|Tremelimumab|tremelimumab|mesh-list
2936434|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936435|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936436|NCT03000569|Levodopa|levodopa|mesh-list
2936437|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
2936438|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2936439|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
2936440|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2936441|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936442|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346006|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346007|NCT00471003|Telmisartan|telmisartan|mesh-list
2346008|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2346009|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2346010|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2346011|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346012|NCT00471029|Esomeprazole|esomeprazole|mesh-list
2346013|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2346014|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2346015|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2346016|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346017|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346018|NCT00471042|Buprenorphine|buprenorphine|mesh-list
2346019|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2346020|NCT00471042|Narcotics|narcotics|mesh-ancestor
2346021|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2936443|NCT02994784|Melphalan|melphalan|mesh-list
2936444|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2936445|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
2936446|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936447|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936448|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2936449|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2346022|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346023|NCT00471042|Analgesics|analgesics|mesh-ancestor
2346024|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
2346025|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346026|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2346027|NCT00471055|Capsaicin|capsaicin|mesh-list
2346028|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
2346029|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
2346030|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
2936450|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
2936451|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936452|NCT02964507|Fulvestrant|fulvestrant|mesh-list
2936453|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2936454|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936455|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2936456|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2936457|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
2936458|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2936459|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936460|NCT02964078|Aldesleukin|aldesleukin|mesh-list
2936461|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
2936462|NCT02964078|Interleukin-2|interleukin-2|mesh-list
2936463|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936464|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936465|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2936466|NCT02964078|Analgesics|analgesics|mesh-ancestor
2936467|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
2936468|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936469|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936470|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2936471|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2936472|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
2936473|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936474|NCT02955394|Fulvestrant|fulvestrant|mesh-list
2936475|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2936476|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936477|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2936478|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2936479|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
2936480|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2936481|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936482|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2936483|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
2936484|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2936485|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2936486|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346031|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346032|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346033|NCT00471094|Lansoprazole|lansoprazole|mesh-list
2346034|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
2346035|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2346036|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2346037|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2346038|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346039|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346040|NCT00471159|Docetaxel|docetaxel|mesh-list
2346041|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346042|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
2346043|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
2346044|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
2346045|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346046|NCT00471185|Acyline|acyline|mesh-list
2346047|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
2346048|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2346049|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346050|NCT00471289|Paclitaxel|paclitaxel|mesh-list
2346051|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2346052|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936487|NCT02942017|Brexanolone|brexanolone|mesh-list
2936488|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
2936489|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2936490|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936491|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936492|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
2936493|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
2936494|NCT02942004|Pregnanolone|pregnanolone|mesh-list
2936495|NCT02942004|Brexanolone|brexanolone|mesh-list
2936496|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
2936497|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2936498|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936499|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936500|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
2936501|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
2936502|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
2936503|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2936504|NCT02939573|Dapsone|dapsone|mesh-list
2936505|NCT02939573|Colchicine|colchicine|mesh-list
2936506|NCT02939573|Azathioprine|azathioprine|mesh-list
2936507|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
2936508|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2936509|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
2346053|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
2346054|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
2346055|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
2346056|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346057|NCT00471341|Celecoxib|celecoxib|mesh-list
2346058|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2346059|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2346060|NCT00471341|Analgesics|analgesics|mesh-ancestor
2346061|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
2346062|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346063|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346064|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2346065|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2346066|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2346067|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2346068|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346069|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936510|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
2936511|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
2346070|NCT00471393|Diclofenac|diclofenac|mesh-list
2346071|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2346072|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2346073|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2346074|NCT00471393|Analgesics|analgesics|mesh-ancestor
2346075|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
2936512|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936513|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936514|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
2936515|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2936516|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2936517|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
2936518|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936519|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936520|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
2936521|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2936522|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2936523|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2936524|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936525|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
2936526|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2936527|NCT02929589|Ibuprofen|ibuprofen|mesh-list
2936528|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
2936529|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2936530|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2936531|NCT02929589|Analgesics|analgesics|mesh-ancestor
2936532|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
2936533|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936534|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936535|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2936536|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2936537|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2936538|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936539|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936540|NCT02929589|Narcotics|narcotics|mesh-ancestor
2936541|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2936542|NCT02924064|Metformin|metformin|mesh-list
2936543|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2936544|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936545|NCT02921256|Leucovorin|leucovorin|mesh-list
2936546|NCT02921256|Fluorouracil|fluorouracil|mesh-list
2936547|NCT02921256|Capecitabine|capecitabine|mesh-list
2936548|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
2936549|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
2936550|NCT02921256|Veliparib|veliparib|mesh-list
2936551|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
2936552|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936553|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2936554|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936555|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2936556|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
2936557|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936558|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936559|NCT02921256|Antidotes|antidotes|mesh-ancestor
2936560|NCT02921256|Protective Agents|protective agents|mesh-ancestor
2936561|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
2346076|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936562|NCT02921256|Vitamins|vitamins|mesh-ancestor
2936563|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
2936564|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2936565|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346077|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346078|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2346079|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2346080|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2346081|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346082|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346083|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2346084|NCT00471393|Protective Agents|protective agents|mesh-ancestor
2346085|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2346086|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
2346087|NCT00471406|Verteporfin|verteporfin|mesh-list
2936590|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
2936591|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2936592|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936593|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2936594|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2936595|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936596|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936597|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936598|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
2936599|NCT02890355|Leucovorin|leucovorin|mesh-list
2936600|NCT02890355|Folic Acid|folic acid|mesh-list
2936601|NCT02890355|Fluorouracil|fluorouracil|mesh-list
2346088|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2346089|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
2346090|NCT00471419|Rimexolone|rimexolone|mesh-list
2346091|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
2346092|NCT00471419|Hormones|hormones|mesh-ancestor
2346093|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2346094|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346095|NCT00471432|Docetaxel|docetaxel|mesh-list
2936602|NCT02890355|Irinotecan|irinotecan|mesh-list
2936603|NCT02890355|Veliparib|veliparib|mesh-list
2936604|NCT02890355|Camptothecin|camptothecin|mesh-list
2936605|NCT02890355|Calcium|calcium|mesh-list
2936606|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
2936607|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2936608|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936609|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2936610|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
2936611|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936612|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2936613|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936614|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2936615|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
2936616|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2346096|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936617|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2936618|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936619|NCT02890355|Antidotes|antidotes|mesh-ancestor
2936620|NCT02890355|Protective Agents|protective agents|mesh-ancestor
2936621|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
2936622|NCT02890355|Vitamins|vitamins|mesh-ancestor
2936623|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
2936624|NCT02890355|Hematinics|hematinics|mesh-ancestor
2936625|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2936626|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2936627|NCT02878798|Topiramate|topiramate|mesh-list
2936628|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
2936629|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2936630|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936631|NCT02874742|Dexamethasone|dexamethasone|mesh-list
2936632|NCT02874742|Lenalidomide|lenalidomide|mesh-list
2936633|NCT02874742|Bortezomib|bortezomib|mesh-list
2936634|NCT02874742|Daratumumab|daratumumab|mesh-list
2936635|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2936636|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
2936637|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
2936638|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936639|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936640|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2936641|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
2936642|NCT02874742|Hormones|hormones|mesh-ancestor
2936643|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2936644|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2936645|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936646|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
2936647|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2936648|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2936649|NCT02874742|Growth Substances|growth substances|mesh-ancestor
2936650|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
2936651|NCT02864914|Empagliflozin|empagliflozin|mesh-list
2936652|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2936653|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2936654|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936655|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2936656|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936657|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
2936658|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936659|NCT02861300|Capecitabine|capecitabine|mesh-list
2936660|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2936661|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
2936662|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936663|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936664|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
2936665|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
2936666|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936667|NCT02840227|Anesthetics|anesthetics|mesh-list
2936668|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2936669|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936670|NCT02839707|Bevacizumab|bevacizumab|mesh-list
2936671|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2936672|NCT02839707|Doxorubicin|doxorubicin|mesh-list
2346097|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
2346098|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
2346099|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
2346100|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346101|NCT00471471|Sargramostim|sargramostim|mesh-list
2346102|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
2936673|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2936674|NCT02839707|Atezolizumab|atezolizumab|mesh-list
2936675|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
2936676|NCT02839707|Antibodies|antibodies|mesh-list
2936677|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
2936678|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2936679|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
2936680|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936681|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2936682|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2936683|NCT02839707|Growth Substances|growth substances|mesh-ancestor
2936684|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936685|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
2936686|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
2936687|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2936688|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2936689|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2936690|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936691|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936698|NCT02821832|Rifampin|rifampin|mesh-list
2346103|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346104|NCT00471484|Interferons|interferons|mesh-list
2346105|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
2346106|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
2346107|NCT00471484|Doxorubicin|doxorubicin|mesh-list
2346108|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2346109|NCT00471484|Fluorouracil|fluorouracil|mesh-list
2346110|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
2346111|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2346112|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346113|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2346114|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2346115|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346116|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346117|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
2346118|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2346119|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2346120|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
2346121|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346122|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
2346123|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346124|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
2346125|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
2346126|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346127|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346128|NCT00471523|Metformin|metformin|mesh-list
2346129|NCT00471523|Clomiphene|clomiphene|mesh-list
2346130|NCT00471523|Enclomiphene|enclomiphene|mesh-list
2346131|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
2346132|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2346133|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346134|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2346135|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
2346136|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2936699|NCT02821832|Isoniazid|isoniazid|mesh-list
2936700|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
2936701|NCT02821832|Ethambutol|ethambutol|mesh-list
2346137|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2346138|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
2346139|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2346140|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2346141|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2346142|NCT00471549|Simvastatin|simvastatin|mesh-list
2346143|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2346144|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2346145|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
2346146|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346147|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2346148|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2346149|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346150|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2346151|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2346152|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
2346153|NCT00471588|Pramipexole|pramipexole|mesh-list
2346154|NCT00471588|Amisulpride|amisulpride|mesh-list
2346155|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
2346156|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346157|NCT00471588|Protective Agents|protective agents|mesh-ancestor
2346158|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346159|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2346160|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2346161|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
2346162|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
2936702|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2936703|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
2936704|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2936705|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936706|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
2936707|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2346163|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346164|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2346165|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2346166|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2346167|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2346168|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2346169|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2346170|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
2346171|NCT00471627|Pancrelipase|pancrelipase|mesh-list
2346172|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2346173|NCT00471640|Dexamethasone|dexamethasone|mesh-list
2936708|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936709|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346174|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2346175|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
2346176|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
2346177|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346178|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346179|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2346180|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
2346181|NCT00471640|Hormones|hormones|mesh-ancestor
2346182|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2346183|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2346184|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346185|NCT00471653|Temozolomide|temozolomide|mesh-list
2346186|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2346187|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
2346188|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346189|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346190|NCT00471679|Ethanol|ethanol|mesh-list
2346191|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2346192|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346193|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2346194|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346195|NCT00471744|Levetiracetam|levetiracetam|mesh-list
2346196|NCT00471744|Sulthiame|sulthiame|mesh-list
2346197|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
2346198|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
2346199|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
2346200|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2346201|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346202|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
2346203|NCT00471809|Azithromycin|azithromycin|mesh-list
2346204|NCT00471809|Budesonide|budesonide|mesh-list
2346205|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2346206|NCT00471809|Montelukast|montelukast|mesh-list
2346207|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2346208|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2346209|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
2346210|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346211|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346212|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2346213|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
2346214|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
2346215|NCT00471809|Hormones|hormones|mesh-ancestor
2346216|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2346217|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2346218|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346219|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2346220|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2346221|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2346222|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
2346223|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346224|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346225|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2936710|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2936711|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2936712|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2936713|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2936714|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2936715|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2346226|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
2346227|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2936716|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2936717|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2936718|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
2936719|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2936720|NCT02820857|Bevacizumab|bevacizumab|mesh-list
2936721|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936722|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346228|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2346229|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2346230|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2346231|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
2346232|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346233|NCT00471952|Caffeine|caffeine|mesh-list
2346234|NCT00471952|Rizatriptan|rizatriptan|mesh-list
2346235|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2346236|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346237|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2346238|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936723|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2936724|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2936725|NCT02820857|Growth Substances|growth substances|mesh-ancestor
2936726|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936727|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
2936728|NCT02796391|Nicotine|nicotine|mesh-list
2936729|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2936730|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
2936731|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936732|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936733|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2936734|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2936735|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
2936736|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2936737|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936738|NCT02784210|Prednisone|prednisone|mesh-list
2936739|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
2936740|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2936741|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2936742|NCT02784210|Prednisolone|prednisolone|mesh-list
2936743|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
2346239|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346240|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2346241|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2346242|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
2936744|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2936745|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
2936746|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2936747|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
2936748|NCT02784210|Hormones|hormones|mesh-ancestor
2936749|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2936750|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936751|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2936752|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936753|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
2936754|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
2936755|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936756|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2936757|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2936758|NCT02784210|Protective Agents|protective agents|mesh-ancestor
2936759|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
2936760|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936761|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936762|NCT02775435|Paclitaxel|paclitaxel|mesh-list
2936763|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2936764|NCT02775435|Carboplatin|carboplatin|mesh-list
2936765|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
2936766|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2936767|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936768|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
2936769|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
2936770|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
2936771|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936772|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936773|NCT02769962|Olaparib|olaparib|mesh-list
2936774|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2936775|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346243|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346244|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2346245|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
2346246|NCT00471965|Leucovorin|leucovorin|mesh-list
2346247|NCT00471965|Doxorubicin|doxorubicin|mesh-list
2346248|NCT00471965|Fluorouracil|fluorouracil|mesh-list
2346249|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
2936776|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936777|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936778|NCT02767531|Orlistat|orlistat|mesh-list
2936779|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936780|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936781|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2936782|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2936783|NCT02757898|Biotin|biotin|mesh-list
2346250|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2346251|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346252|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2346253|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2346254|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346255|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346256|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
2346257|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2346258|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2346259|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
2346260|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346261|NCT00471965|Antidotes|antidotes|mesh-ancestor
2346262|NCT00471965|Protective Agents|protective agents|mesh-ancestor
2346263|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
2346264|NCT00471965|Vitamins|vitamins|mesh-ancestor
2346265|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
2346266|NCT00471991|Dienogest|dienogest|mesh-list
2346267|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2346268|NCT00471991|Estradiol|estradiol|mesh-list
2346269|NCT00471991|Estrogens|estrogens|mesh-ancestor
2346270|NCT00471991|Hormones|hormones|mesh-ancestor
2346271|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2936784|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
2936785|NCT02757898|Vitamins|vitamins|mesh-ancestor
2936786|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
2346272|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346273|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2346274|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
2346275|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2346276|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2346277|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2346278|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2346279|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2346280|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
2346281|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2346282|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346283|NCT00472004|Tibolone|tibolone|mesh-list
2936787|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936788|NCT02752035|Azacitidine|azacitidine|mesh-list
2936789|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2936790|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
2936791|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936792|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936793|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936794|NCT02741570|Cisplatin|cisplatin|mesh-list
2936795|NCT02741570|Carboplatin|carboplatin|mesh-list
2936796|NCT02741570|Fluorouracil|fluorouracil|mesh-list
2936797|NCT02741570|Nivolumab|nivolumab|mesh-list
2936798|NCT02741570|Cetuximab|cetuximab|mesh-list
2936799|NCT02741570|Ipilimumab|ipilimumab|mesh-list
2936800|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936801|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
2936802|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936803|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2936804|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2936805|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
2936806|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936807|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936808|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2936809|NCT02741323|Maraviroc|maraviroc|mesh-list
2936810|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2346284|NCT00472004|Estradiol|estradiol|mesh-list
2936811|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2346285|NCT00472004|Estrogens|estrogens|mesh-ancestor
2346286|NCT00472004|Hormones|hormones|mesh-ancestor
2346287|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2346288|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346289|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
2346290|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
2346291|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2346292|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2346293|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346294|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2346295|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
2936812|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936813|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2936814|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2936815|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
2936816|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936817|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2936818|NCT02740335|Protein C|protein c|mesh-list
2936819|NCT02740335|Protein S|protein s|mesh-list
2936820|NCT02740335|Thrombin|thrombin|mesh-list
2936821|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
2936822|NCT02740335|Coagulants|coagulants|mesh-ancestor
2936823|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
2936824|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2936825|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2936826|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936827|NCT02737306|Leronlimab|leronlimab|mesh-list
2936828|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2936829|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2936830|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936831|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2936832|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2936833|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
2346296|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2346297|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2346298|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
2346299|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2346300|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2346301|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
2346302|NCT00472134|Bupivacaine|bupivacaine|mesh-list
2346303|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
2346304|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
2346305|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2346306|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346307|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
2346308|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346309|NCT00472173|Calcium|calcium|mesh-list
2936834|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936835|NCT02728648|Oxycodone|oxycodone|mesh-list
2936836|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2936837|NCT02728648|Narcotics|narcotics|mesh-ancestor
2936838|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2936839|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936840|NCT02728648|Analgesics|analgesics|mesh-ancestor
2936841|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
2936842|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936843|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
2936844|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
2936845|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936846|NCT02684058|Carboplatin|carboplatin|mesh-list
2936847|NCT02684058|Vincristine|vincristine|mesh-list
2936848|NCT02684058|Trametinib|trametinib|mesh-list
2936849|NCT02684058|Dabrafenib|dabrafenib|mesh-list
2936850|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936851|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2936852|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
2936853|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
2936854|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
2936855|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936856|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2936857|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936858|NCT02679170|Crizotinib|crizotinib|mesh-list
2346310|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2346311|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936859|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936860|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2936861|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936862|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936863|NCT02649790|Dexamethasone|dexamethasone|mesh-list
2936864|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2936865|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
2936866|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
2936867|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936868|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936869|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2936870|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
2936871|NCT02649790|Hormones|hormones|mesh-ancestor
2936872|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2936873|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2936874|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936875|NCT02642042|Docetaxel|docetaxel|mesh-list
2936876|NCT02642042|Trametinib|trametinib|mesh-list
2936877|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936878|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
2936879|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
2936880|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
2936881|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936882|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2936883|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936884|NCT02629120|Sirolimus|sirolimus|mesh-list
2936885|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
2936886|NCT02629120|Busulfan|busulfan|mesh-list
2346319|NCT00472225|Rituximab|rituximab|mesh-list
2936887|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
2936888|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2936889|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
2936890|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936891|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2936892|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2936893|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
2936894|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936895|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936896|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2936897|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2936898|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936899|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2936900|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
2936901|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936902|NCT02614547|Brexanolone|brexanolone|mesh-list
2936903|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
2936904|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2936905|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936906|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936907|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
2936908|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
2936909|NCT02609776|Carboplatin|carboplatin|mesh-list
2936910|NCT02609776|Pemetrexed|pemetrexed|mesh-list
2936911|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
2936912|NCT02609776|Lazertinib|lazertinib|mesh-list
2936913|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2936914|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936915|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936916|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936917|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2936918|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2936919|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2936920|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936921|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
2936922|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936923|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
2936924|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936925|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2936926|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936927|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936928|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
2936929|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2936930|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936931|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2936932|NCT02599454|Atezolizumab|atezolizumab|mesh-list
2936933|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936934|NCT02595944|Nivolumab|nivolumab|mesh-list
2936935|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936936|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936937|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2936938|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936939|NCT02595931|Irinotecan|irinotecan|mesh-list
2936940|NCT02595931|Camptothecin|camptothecin|mesh-list
2936941|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2936942|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2936943|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936944|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936945|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936946|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2936947|NCT02595905|Cisplatin|cisplatin|mesh-list
2936948|NCT02595905|Veliparib|veliparib|mesh-list
2936949|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936950|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2936951|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936952|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936953|NCT02592551|Durvalumab|durvalumab|mesh-list
2936954|NCT02592551|Tremelimumab|tremelimumab|mesh-list
2936955|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2936956|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936957|NCT02592317|Pioglitazone|pioglitazone|mesh-list
2936958|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2936959|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2936960|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2936961|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
2936962|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936963|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2936964|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2346320|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2346321|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346322|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
2346323|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346324|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2346325|NCT00472329|Fludarabine|fludarabine|mesh-list
2346326|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346327|NCT00472355|Apomorphine|apomorphine|mesh-list
2346328|NCT00472355|Emetics|emetics|mesh-ancestor
2346329|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346330|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
2346331|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346332|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2346333|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
2346334|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
2346335|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346336|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346337|NCT00472368|Panobinostat|panobinostat|mesh-list
2346338|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346339|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2346340|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346341|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346342|NCT00472381|Insulin|insulin|mesh-list
2346343|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2346344|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346345|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
2346346|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2346347|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346348|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2346349|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2346350|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
2936965|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936966|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2936967|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936968|NCT02589691|Rocuronium|rocuronium|mesh-list
2936969|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2936970|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2936971|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2936972|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2936973|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2936974|NCT02584933|Ceritinib|ceritinib|mesh-list
2936975|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2936976|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2936977|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936978|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346351|NCT00472472|Paclitaxel|paclitaxel|mesh-list
2346352|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2346353|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346354|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
2346355|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
2346356|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
2346357|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346358|NCT00472550|Esomeprazole|esomeprazole|mesh-list
2346359|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2346360|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2346361|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2346362|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346363|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346369|NCT00472693|Bevacizumab|bevacizumab|mesh-list
2346370|NCT00472693|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2346371|NCT00472693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2346372|NCT00472693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346373|NCT00472693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2346374|NCT00472693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2346375|NCT00472693|Growth Substances|growth substances|mesh-ancestor
2346376|NCT00472693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346377|NCT00472693|Growth Inhibitors|growth inhibitors|mesh-ancestor
2936979|NCT02583048|Dolutegravir|dolutegravir|mesh-list
2936980|NCT02583048|Bedaquiline|bedaquiline|mesh-list
2936981|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2936982|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2936983|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2936984|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2936985|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2936986|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2936987|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
2936988|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2936989|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
2936990|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2936991|NCT02567435|Sirolimus|sirolimus|mesh-list
2936992|NCT02567435|Dactinomycin|dactinomycin|mesh-list
2936993|NCT02567435|Cactinomycin|cactinomycin|mesh-list
2936994|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
2936995|NCT02567435|Irinotecan|irinotecan|mesh-list
2936996|NCT02567435|Vincristine|vincristine|mesh-list
2936997|NCT02567435|Vinorelbine|vinorelbine|mesh-list
2936998|NCT02567435|Camptothecin|camptothecin|mesh-list
2936999|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937000|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
2937001|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937002|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937003|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2937004|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
2937005|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937006|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937007|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2937008|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2346378|NCT00472758|Sifalimumab|sifalimumab|mesh-list
2346379|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
2346380|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346381|NCT00472810|Mitomycins|mitomycins|mesh-list
2346382|NCT00472810|Mitomycin|mitomycin|mesh-list
2346383|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2346384|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346385|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
2346386|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346387|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2346388|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346389|NCT00472823|Vitamin D|vitamin d|mesh-list
2346390|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
2346391|NCT00472823|Calcium|calcium|mesh-list
2346392|NCT00472823|Vitamins|vitamins|mesh-ancestor
2346393|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
2346394|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346395|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2346396|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2937009|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2937010|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346397|NCT00472875|Glyburide|glyburide|mesh-list
2937011|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2937012|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
2937013|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
2937014|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
2937015|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2937016|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2937017|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2937018|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
2937019|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2937020|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2937021|NCT02564978|Minocycline|minocycline|mesh-list
2937022|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2937023|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2937024|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
2937025|NCT02546986|Azacitidine|azacitidine|mesh-list
2937026|NCT02546986|Cc-486|cc-486|mesh-list
2937027|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937028|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937029|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2937030|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
2937031|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937032|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937033|NCT02543983|Ketamine|ketamine|mesh-list
2937034|NCT02543983|Analgesics|analgesics|mesh-ancestor
2937035|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
2937036|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937037|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937038|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2937039|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2937040|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
2937041|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
2937042|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2937043|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2937044|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2937045|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2937046|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346398|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2346399|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346400|NCT00472901|Afamelanotide|afamelanotide|mesh-list
2346401|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
2346402|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2346403|NCT00472927|Estrogens|estrogens|mesh-ancestor
2346404|NCT00472927|Hormones|hormones|mesh-ancestor
2346405|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2346406|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346407|NCT00472953|Insulin|insulin|mesh-list
2346408|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2346409|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
2346410|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2346411|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346412|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2346413|NCT00472966|Tretinoin|tretinoin|mesh-list
2346414|NCT00472966|Glycolic acid|glycolic acid|mesh-list
2346415|NCT00472966|Hydroquinone|hydroquinone|mesh-list
2346416|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346417|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
2346418|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
2346419|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2346420|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
2346421|NCT00472966|Hormones|hormones|mesh-ancestor
2346422|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2346423|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346424|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
2346425|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346426|NCT00472966|Protective Agents|protective agents|mesh-ancestor
2346427|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2346428|NCT00473005|Capecitabine|capecitabine|mesh-list
2346429|NCT00473005|Everolimus|everolimus|mesh-list
2346430|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2346431|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
2346432|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346433|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346434|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2346435|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
2346436|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937047|NCT02539160|Ticagrelor|ticagrelor|mesh-list
2346437|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
2346438|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2346439|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2346440|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346441|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
2346442|NCT00473070|Hormones|hormones|mesh-ancestor
2346443|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2346444|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346445|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2346446|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2346447|NCT00473174|Ramipril|ramipril|mesh-list
2346448|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2346449|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
2346450|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346451|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346452|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2346453|NCT00473213|Interferons|interferons|mesh-list
2346454|NCT00473213|Interferon-beta|interferon-beta|mesh-list
2346455|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346456|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
2346457|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346458|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
2346459|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346460|NCT00473239|Vitamin D|vitamin d|mesh-list
2346461|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
2937048|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2937049|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2937050|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2937051|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2937052|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
2937053|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2937054|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937055|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937056|NCT02536300|Idelalisib|idelalisib|mesh-list
2937057|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937058|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937059|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937060|NCT02535091|Cenobamate|cenobamate|mesh-list
2937061|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
2937062|NCT02531516|Bicalutamide|bicalutamide|mesh-list
2937063|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
2346462|NCT00473239|Vitamins|vitamins|mesh-ancestor
2346463|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
2346464|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346465|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2346466|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2346467|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2346468|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2346469|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
2937064|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
2937065|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937066|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937067|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937068|NCT02519452|Daratumumab|daratumumab|mesh-list
2937069|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937070|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
2937071|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2937072|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937073|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937074|NCT02506153|Interferons|interferons|mesh-list
2937075|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
2937076|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
2937077|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
2937078|NCT02506153|Ipilimumab|ipilimumab|mesh-list
2937079|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937080|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937081|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
2937082|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2937083|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2937084|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937085|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
2937086|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937087|NCT02500797|Nivolumab|nivolumab|mesh-list
2937088|NCT02500797|Ipilimumab|ipilimumab|mesh-list
2937089|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937090|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937091|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2937092|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937093|NCT02498613|Misonidazole|misonidazole|mesh-list
2937094|NCT02498613|Olaparib|olaparib|mesh-list
2937095|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2937096|NCT02498613|Cediranib|cediranib|mesh-list
2937097|NCT02498613|Maleic acid|maleic acid|mesh-list
2937098|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937099|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937100|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937101|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2937102|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2346470|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
2346471|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2346472|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2346473|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346474|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2346475|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2346476|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346477|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937103|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2937104|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2937105|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
2937106|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2937107|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2937108|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937109|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2937110|NCT02492269|Analgesics|analgesics|mesh-ancestor
2937111|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
2937112|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937113|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2937114|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2937115|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2937116|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
2937117|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2937118|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937119|NCT02489318|Androgens|androgens|mesh-list
2937120|NCT02489318|Hormones|hormones|mesh-ancestor
2937121|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937122|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937123|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
2937124|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937125|NCT02477618|Brexanolone|brexanolone|mesh-list
2937126|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
2937127|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2937128|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937129|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937130|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
2937131|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
2937132|NCT02473497|Crizotinib|crizotinib|mesh-list
2937133|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937134|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2937135|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937136|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937176|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
2937177|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937178|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937179|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
2937180|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2937181|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2937182|NCT02444429|Prednisolone|prednisolone|mesh-list
2937183|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
2937184|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2937185|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
2346478|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346479|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2346480|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
2346481|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2346482|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346483|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2346484|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2346485|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2346486|NCT00473486|Carboplatin|carboplatin|mesh-list
2346487|NCT00473486|Pemetrexed|pemetrexed|mesh-list
2346488|NCT00473486|Sorafenib|sorafenib|mesh-list
2346489|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937186|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937187|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
2937188|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
2937189|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937190|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937191|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2937192|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
2937193|NCT02444429|Hormones|hormones|mesh-ancestor
2937194|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937195|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2937196|NCT02444429|Protective Agents|protective agents|mesh-ancestor
2937197|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937198|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937199|NCT02424851|Thalidomide|thalidomide|mesh-list
2937200|NCT02424851|Dexamethasone|dexamethasone|mesh-list
2937201|NCT02424851|Bortezomib|bortezomib|mesh-list
2937202|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2937203|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937204|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
2937205|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
2937206|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937207|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937208|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2937209|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
2937210|NCT02424851|Hormones|hormones|mesh-ancestor
2937211|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937212|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937213|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937214|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2937215|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
2937216|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937217|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937218|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
2937219|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
2937220|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2937221|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2937222|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2937223|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2937224|NCT02424851|Growth Substances|growth substances|mesh-ancestor
2937225|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
2937226|NCT02423876|Hydromorphone|hydromorphone|mesh-list
2937227|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2937228|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937229|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
2937230|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937231|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2937232|NCT02423876|Narcotics|narcotics|mesh-ancestor
2937233|NCT02423876|Analgesics|analgesics|mesh-ancestor
2937234|NCT02408549|Lacosamide|lacosamide|mesh-list
2937235|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
2937236|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2937237|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2937238|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2937239|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937240|NCT02404870|Canagliflozin|canagliflozin|mesh-list
2937241|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2937242|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937243|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2346490|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346491|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346492|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2346493|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2346494|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2346495|NCT00473551|Vidarabine|vidarabine|mesh-list
2346496|NCT00473551|Sirolimus|sirolimus|mesh-list
2346497|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
2346498|NCT00473551|Rituximab|rituximab|mesh-list
2346499|NCT00473551|Fludarabine|fludarabine|mesh-list
2346500|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
2346501|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2346502|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
2346503|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937244|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937245|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
2937246|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2937247|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
2937248|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937249|NCT02400814|Atezolizumab|atezolizumab|mesh-list
2937250|NCT02400814|Antibodies|antibodies|mesh-list
2937251|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2937252|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
2937253|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937254|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937255|NCT02368301|Dexamethasone|dexamethasone|mesh-list
2937256|NCT02368301|Lenalidomide|lenalidomide|mesh-list
2937257|NCT02368301|Elotuzumab|elotuzumab|mesh-list
2937258|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937259|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
2937260|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
2937261|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937262|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937263|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2937264|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
2937265|NCT02368301|Hormones|hormones|mesh-ancestor
2346504|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2346505|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2346506|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
2346507|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346508|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346509|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2346510|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2346511|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2346512|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
2346513|NCT00473551|Antiviral Agents|antiviral agents|mesh-ancestor
2346514|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346515|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2346516|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2346517|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
2346518|NCT00473603|Heparin|heparin|mesh-list
2346519|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
2346520|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2937266|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937267|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937268|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937269|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
2937270|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2937271|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2937272|NCT02368301|Growth Substances|growth substances|mesh-ancestor
2937273|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
2937274|NCT02365597|Metformin|metformin|mesh-list
2937275|NCT02365597|Midazolam|midazolam|mesh-list
2937276|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2937277|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937278|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2937279|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2937280|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2937281|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2937282|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2937283|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2937284|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2937285|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
2937286|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
2937287|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
2937288|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
2937289|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2937290|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937291|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
2937292|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937293|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937303|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
2937304|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937305|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937306|NCT02329847|Nivolumab|nivolumab|mesh-list
2937307|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937308|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937309|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2937310|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937311|NCT02319837|Leuprolide|leuprolide|mesh-list
2937312|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2937313|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
2937314|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2937315|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937316|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937317|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937318|NCT02316106|Daratumumab|daratumumab|mesh-list
2937319|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2937320|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937321|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
2346521|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2346522|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346523|NCT00473616|Irinotecan|irinotecan|mesh-list
2346524|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2346525|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2346526|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346527|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346528|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346529|NCT00473707|Oxytocin|oxytocin|mesh-list
2346530|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
2346531|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2346532|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346533|NCT00473720|Paclitaxel|paclitaxel|mesh-list
2346534|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2346535|NCT00473720|Satraplatin|satraplatin|mesh-list
2346536|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2346537|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937322|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937323|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
2937324|NCT02306161|Ifosfamide|ifosfamide|mesh-list
2937325|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
2937326|NCT02306161|Doxorubicin|doxorubicin|mesh-list
2937327|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2937328|NCT02306161|Etoposide|etoposide|mesh-list
2937329|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
2937330|NCT02306161|Vincristine|vincristine|mesh-list
2937331|NCT02306161|Daunorubicin|daunorubicin|mesh-list
2346538|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
2346539|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
2346540|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
2346541|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346542|NCT00473915|Fluticasone|fluticasone|mesh-list
2346543|NCT00473915|Xhance|xhance|mesh-list
2346544|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2346545|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2346546|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
2346547|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346548|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346549|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2346550|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
2346551|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
2346552|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2346553|NCT00473980|Celecoxib|celecoxib|mesh-list
2937332|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
2937333|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2937334|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937335|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
2937336|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937337|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937338|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2937339|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
2937340|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937341|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937342|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2937343|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2937344|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2937345|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2937346|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937347|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2937348|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
2937349|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
2937350|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
2937351|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
2937352|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
2937353|NCT02285504|Brexanolone|brexanolone|mesh-list
2937354|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
2937355|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2937356|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937357|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937358|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
2937359|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
2937360|NCT02277444|Golimumab|golimumab|mesh-list
2937361|NCT02277444|Methotrexate|methotrexate|mesh-list
2937362|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2937363|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
2937364|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2937365|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937366|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2937367|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
2937368|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937369|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937370|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
2937371|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937372|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2937373|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937374|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
2937375|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937376|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2937377|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2937378|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937379|NCT02257528|Nivolumab|nivolumab|mesh-list
2937380|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937381|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937382|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2937383|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937384|NCT02252172|Dexamethasone|dexamethasone|mesh-list
2937385|NCT02252172|Lenalidomide|lenalidomide|mesh-list
2937386|NCT02252172|Daratumumab|daratumumab|mesh-list
2346554|NCT00473980|Indomethacin|indomethacin|mesh-list
2937387|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2937388|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937389|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
2937390|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
2937391|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937392|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937393|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2937394|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
2937395|NCT02252172|Hormones|hormones|mesh-ancestor
2937396|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937397|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937398|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937399|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
2937400|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2937401|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2937402|NCT02252172|Growth Substances|growth substances|mesh-ancestor
2937403|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
2937404|NCT02233829|Dopamine|dopamine|mesh-list
2346555|NCT00473980|Esomeprazole|esomeprazole|mesh-list
2346556|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2346557|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2346558|NCT00473980|Analgesics|analgesics|mesh-ancestor
2346559|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
2346560|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346561|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346562|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2346563|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937405|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2937406|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
2937407|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
2937408|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937409|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937410|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
2937411|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2937412|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937413|NCT02233829|Protective Agents|protective agents|mesh-ancestor
2937414|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2937415|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2937416|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
2937417|NCT02224781|Nivolumab|nivolumab|mesh-list
2937418|NCT02224781|Ipilimumab|ipilimumab|mesh-list
2937419|NCT02224781|Trametinib|trametinib|mesh-list
2937420|NCT02224781|Dabrafenib|dabrafenib|mesh-list
2937421|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2937422|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937423|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937424|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2937425|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937426|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2937427|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937428|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2937429|NCT02224781|Protective Agents|protective agents|mesh-ancestor
2937430|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937431|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2937432|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
2937433|NCT02203526|Cytarabine|cytarabine|mesh-list
2937434|NCT02203526|Isavuconazole|isavuconazole|mesh-list
2937435|NCT02203526|Rituximab|rituximab|mesh-list
2937436|NCT02203526|Methotrexate|methotrexate|mesh-list
2937437|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937438|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937439|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
2937440|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937441|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937442|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2937443|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
2937444|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2937445|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2937446|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
2937447|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937448|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
2937449|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937450|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2937451|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937452|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2937453|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
2937454|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2937455|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
2937456|NCT02196181|Trametinib|trametinib|mesh-list
2937457|NCT02196181|Dabrafenib|dabrafenib|mesh-list
2937458|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2937459|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937460|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2937461|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937462|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937463|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2937464|NCT02196181|Protective Agents|protective agents|mesh-ancestor
2346564|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2346565|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2346566|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346567|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346568|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2346569|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2346570|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2346571|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
2346572|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
2346573|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2346574|NCT00474006|Daunorubicin|daunorubicin|mesh-list
2346575|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2346576|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346577|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2346578|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2346579|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346580|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346581|NCT00474019|Esomeprazole|esomeprazole|mesh-list
2346582|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2346583|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2346584|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2346585|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346586|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346587|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
2346588|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2346589|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2346590|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346591|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
2346592|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346593|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346594|NCT00474071|Remifentanil|remifentanil|mesh-list
2346595|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2346596|NCT00474071|Narcotics|narcotics|mesh-ancestor
2346597|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2346598|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346599|NCT00474071|Analgesics|analgesics|mesh-ancestor
2346600|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
2346601|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937465|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937466|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2937467|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
2937468|NCT02195479|Dexamethasone|dexamethasone|mesh-list
2937469|NCT02195479|Prednisone|prednisone|mesh-list
2346602|NCT00474110|Ketamine|ketamine|mesh-list
2346603|NCT00474110|Hydromorphone|hydromorphone|mesh-list
2346604|NCT00474110|Analgesics|analgesics|mesh-ancestor
2937470|NCT02195479|Melphalan|melphalan|mesh-list
2937471|NCT02195479|Bortezomib|bortezomib|mesh-list
2937472|NCT02195479|Daratumumab|daratumumab|mesh-list
2937473|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2937474|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937475|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
2937476|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
2937477|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937478|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937479|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2937480|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
2937481|NCT02195479|Hormones|hormones|mesh-ancestor
2937482|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937483|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937484|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937485|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2937486|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
2937487|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937488|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2937489|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2346605|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
2346606|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346607|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346608|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2346609|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2346610|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
2346611|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
2346612|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2346613|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2346614|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2346615|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346616|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346617|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2346618|NCT00474110|Narcotics|narcotics|mesh-ancestor
2346619|NCT00474136|Diclofenac|diclofenac|mesh-list
2937490|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
2346620|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2346621|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2346622|NCT00474136|Analgesics|analgesics|mesh-ancestor
2346623|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
2346624|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346625|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346626|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937519|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2937520|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937521|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2346627|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2346628|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2346629|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346630|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346631|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2346632|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
2346633|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
2346634|NCT00474279|Hormones|hormones|mesh-list
2346635|NCT00474279|Secretagogues|secretagogues|mesh-list
2346636|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2346637|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346638|NCT00474435|Tenofovir|tenofovir|mesh-list
2346639|NCT00474435|Emtricitabine|emtricitabine|mesh-list
2346640|NCT00474435|Efavirenz|efavirenz|mesh-list
2346641|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
2346642|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346643|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2346644|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2937522|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937523|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937524|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
2937525|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2937526|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
2937527|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2937528|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
2937529|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937530|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
2937531|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
2937532|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2937533|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2937534|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
2937535|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937536|NCT02136134|Dexamethasone|dexamethasone|mesh-list
2937537|NCT02136134|Bortezomib|bortezomib|mesh-list
2937538|NCT02136134|Daratumumab|daratumumab|mesh-list
2937539|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937540|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
2937541|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
2937542|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937543|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937544|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2937545|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
2937546|NCT02136134|Hormones|hormones|mesh-ancestor
2937547|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937548|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937549|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937550|NCT02123758|Prednisone|prednisone|mesh-list
2937551|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
2937552|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937553|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
2937554|NCT02123758|Hormones|hormones|mesh-ancestor
2937555|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937556|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937557|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937558|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937559|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2937560|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937561|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937562|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
2937563|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2937564|NCT02079740|Trametinib|trametinib|mesh-list
2937565|NCT02079740|Navitoclax|navitoclax|mesh-list
2937566|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937567|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2937568|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937569|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937570|NCT02076009|Dexamethasone|dexamethasone|mesh-list
2937571|NCT02076009|Lenalidomide|lenalidomide|mesh-list
2937572|NCT02076009|Daratumumab|daratumumab|mesh-list
2937573|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937574|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
2937575|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
2937576|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937577|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346645|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346646|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346647|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2346648|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2346649|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2346650|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2346651|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2346652|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2346653|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2346654|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2346655|NCT00474591|PENTA|penta|mesh-list
2346656|NCT00474591|Fondaparinux|fondaparinux|mesh-list
2346657|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2346658|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
2346659|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2346660|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
2346661|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346662|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346663|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
2346664|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2346665|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2346666|NCT00474669|Docetaxel|docetaxel|mesh-list
2346667|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346668|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
2346669|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
2346670|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
2346671|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346672|NCT00474695|Ranibizumab|ranibizumab|mesh-list
2346673|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2346674|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2937578|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2937579|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
2937580|NCT02076009|Hormones|hormones|mesh-ancestor
2937581|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937582|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937583|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937584|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
2937585|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2937586|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2937587|NCT02076009|Growth Substances|growth substances|mesh-ancestor
2937588|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
2937589|NCT02073968|Paclitaxel|paclitaxel|mesh-list
2937590|NCT02073968|Carboplatin|carboplatin|mesh-list
2937591|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2937592|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2346675|NCT00474695|Growth Substances|growth substances|mesh-ancestor
2346676|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346677|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
2346678|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346679|NCT00474721|Acetaminophen|acetaminophen|mesh-list
2346680|NCT00474721|Ibuprofen|ibuprofen|mesh-list
2346681|NCT00474721|Codeine|codeine|mesh-list
2346682|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2937593|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937594|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
2937595|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
2937596|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
2937597|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937598|NCT01993719|Aldesleukin|aldesleukin|mesh-list
2937599|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
2937600|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
2937601|NCT01993719|Fludarabine|fludarabine|mesh-list
2937602|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937603|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
2937604|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937605|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937606|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2937607|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
2937608|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346683|NCT00474721|Analgesics|analgesics|mesh-ancestor
2346684|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
2346685|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346686|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346687|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
2346688|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2346689|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2346690|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2346691|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2346692|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346693|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346694|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2346695|NCT00474721|Narcotics|narcotics|mesh-ancestor
2346696|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2346697|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
2346698|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
2346699|NCT00474773|Celecoxib|celecoxib|mesh-list
2346700|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2346701|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2346702|NCT00474773|Analgesics|analgesics|mesh-ancestor
2346703|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
2346704|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346705|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346706|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2346707|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2346708|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2346709|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2346710|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346711|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937609|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937610|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2937611|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937612|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2937613|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2937614|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
2937615|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2937616|NCT01974440|Prednisone|prednisone|mesh-list
2937617|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
2937618|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2937619|NCT01974440|Rituximab|rituximab|mesh-list
2937620|NCT01974440|Doxorubicin|doxorubicin|mesh-list
2937621|NCT01974440|Vincristine|vincristine|mesh-list
2937622|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937623|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
2937624|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937625|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937626|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2937627|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
2937628|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937629|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937630|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2937631|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937632|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2937633|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2937634|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2937635|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937636|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937637|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
2937638|NCT01974440|Hormones|hormones|mesh-ancestor
2937639|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937640|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937641|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2937642|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
2937643|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
2937644|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
2937645|NCT01971970|Adalimumab|adalimumab|mesh-list
2937646|NCT01971970|Infliximab|infliximab|mesh-list
2937647|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937648|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937649|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
2937650|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2937651|NCT01969409|Rituximab|rituximab|mesh-list
2937652|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2346712|NCT00474838|Metformin|metformin|mesh-list
2346713|NCT00474838|Glimepiride|glimepiride|mesh-list
2346714|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2346715|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346716|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2346717|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2346718|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
2346719|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
2346720|NCT00474890|Ephedrine|ephedrine|mesh-list
2346721|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2346722|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
2346723|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346724|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346725|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2346726|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
2937653|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937654|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
2937655|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937656|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937657|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
2937658|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2937659|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2937660|NCT01942122|Analgesics|analgesics|mesh-ancestor
2937661|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
2937662|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937663|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937664|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937665|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937666|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2937667|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937668|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937669|NCT01940094|Prednisone|prednisone|mesh-list
2937670|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
2937671|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937672|NCT01940094|Hormones|hormones|mesh-ancestor
2937673|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937674|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346727|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
2346728|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2346729|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2346730|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
2346731|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
2937675|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937676|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346732|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346733|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346734|NCT00474916|KRN 5500|krn 5500|mesh-list
2346735|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346736|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2346737|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346738|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346739|NCT00475059|Cimetidine|cimetidine|mesh-list
2346740|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2346741|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2346742|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2346743|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
2346744|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
2346745|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346746|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346747|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346748|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2346749|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2346750|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346751|NCT00475072|Ribavirin|ribavirin|mesh-list
2346752|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2346753|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
2346754|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346755|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
2346756|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346757|NCT00475098|Tinzaparin|tinzaparin|mesh-list
2346758|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2346759|NCT00475098|Dalteparin|dalteparin|mesh-list
2346760|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
2346761|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2346762|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2937680|NCT01900574|Golimumab|golimumab|mesh-list
2937681|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2937682|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937683|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937684|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
2937685|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937686|NCT01898793|Vidarabine|vidarabine|mesh-list
2937687|NCT01898793|Aldesleukin|aldesleukin|mesh-list
2937688|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
2937689|NCT01898793|Fludarabine|fludarabine|mesh-list
2937690|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
2937691|NCT01898793|Interleukin-2|interleukin-2|mesh-list
2937692|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937693|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
2937694|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937695|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2346763|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346764|NCT00475137|Lamotrigine|lamotrigine|mesh-list
2346765|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
2346766|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2346767|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2346768|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346769|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2346770|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346771|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2346772|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2346773|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2346774|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2937696|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2937697|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
2937698|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937699|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937700|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2937701|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2937702|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
2937703|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
2937704|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2937705|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2937706|NCT01898793|Analgesics|analgesics|mesh-ancestor
2937707|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
2937708|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937709|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2937710|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2346775|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2346776|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2346777|NCT00475189|Norinyl|norinyl|mesh-list
2937724|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
2937725|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937726|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
2937727|NCT01869829|Clotrimazole|clotrimazole|mesh-list
2937728|NCT01869829|Miconazole|miconazole|mesh-list
2937729|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2937730|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2937731|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2937732|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2937733|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937734|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937735|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2937736|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
2937737|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937738|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937739|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2937740|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2937741|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
2937742|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937743|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
2937744|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937745|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937746|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2937747|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
2937748|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937749|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937750|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2937751|NCT01853748|Paclitaxel|paclitaxel|mesh-list
2937752|NCT01853748|Maytansine|maytansine|mesh-list
2937753|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2937754|NCT01853748|Trastuzumab|trastuzumab|mesh-list
2937755|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2937756|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937757|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
2937758|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
2937759|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
2937760|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937761|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937762|NCT01842399|Resveratrol|resveratrol|mesh-list
2937763|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
2346778|NCT00475189|Mestranol|mestranol|mesh-list
2346779|NCT00475189|Norethindrone|norethindrone|mesh-list
2346780|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2346781|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2346782|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2346783|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
2346784|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2346785|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346786|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2346787|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2346788|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2346789|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2346790|NCT00475189|Estrogens|estrogens|mesh-ancestor
2346791|NCT00475189|Hormones|hormones|mesh-ancestor
2346792|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2346793|NCT00475293|Panitumumab|panitumumab|mesh-list
2346794|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346795|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2346796|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2346797|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2346798|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2346799|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2346800|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346801|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346802|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346803|NCT00475358|Analgesics|analgesics|mesh-ancestor
2346804|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
2346805|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346806|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
2346807|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2346808|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
2346809|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2937764|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937765|NCT01842399|Protective Agents|protective agents|mesh-ancestor
2937766|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937767|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937768|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2937769|NCT01792687|Prednisone|prednisone|mesh-list
2937770|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
2937771|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937772|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
2937773|NCT01792687|Hormones|hormones|mesh-ancestor
2937774|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937775|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937776|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937777|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937778|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2937779|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937780|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937781|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
2937782|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2937783|NCT01754779|Indapamide|indapamide|mesh-list
2937784|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
2937785|NCT01754779|Citric Acid|citric acid|mesh-list
2937786|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
2937787|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
2937788|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2937789|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
2937790|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
2937791|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937792|NCT01754779|Diuretics|diuretics|mesh-ancestor
2346810|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2346811|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2346812|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2346813|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346814|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346815|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346816|NCT00475397|Analgesics|analgesics|mesh-ancestor
2346817|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
2346818|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346819|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
2346820|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2346821|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
2346822|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2346823|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
2346824|NCT00475410|Coagulants|coagulants|mesh-ancestor
2346825|NCT00475462|Metoprolol|metoprolol|mesh-list
2937793|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
2937794|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937795|NCT01754779|Expectorants|expectorants|mesh-ancestor
2937796|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
2937797|NCT01754779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2937798|NCT01754779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2937799|NCT01754779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2937800|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
2937801|NCT01752491|Temozolomide|temozolomide|mesh-list
2937802|NCT01752491|Vitamins|vitamins|mesh-ancestor
2937803|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
2937804|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937805|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2937806|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
2937807|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937808|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937809|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
2937810|NCT01752491|Protective Agents|protective agents|mesh-ancestor
2937811|NCT01723202|Trametinib|trametinib|mesh-list
2937812|NCT01723202|Dabrafenib|dabrafenib|mesh-list
2346826|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2937813|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937814|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2937815|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937816|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937825|NCT01665144|Siponimod|siponimod|mesh-list
2937826|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2937827|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937828|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937829|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
2111950|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2111951|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
2111952|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2111953|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111954|NCT02562755|Sorafenib|sorafenib|mesh-list
2937830|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937831|NCT01615029|Dexamethasone|dexamethasone|mesh-list
2937832|NCT01615029|Lenalidomide|lenalidomide|mesh-list
2937833|NCT01615029|Daratumumab|daratumumab|mesh-list
2937834|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2937835|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937836|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
2937837|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
2937838|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2937839|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937840|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2937841|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
2937842|NCT01615029|Hormones|hormones|mesh-ancestor
2937843|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937844|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937845|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937846|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
2937847|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2937848|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2937849|NCT01615029|Growth Substances|growth substances|mesh-ancestor
2111955|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111956|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2111957|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111958|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111959|NCT02562898|Gemcitabine|gemcitabine|mesh-list
2111960|NCT02562898|Paclitaxel|paclitaxel|mesh-list
2111961|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2111962|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111963|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
2111964|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
2111965|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
2937850|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
2937851|NCT01578954|Lenalidomide|lenalidomide|mesh-list
2937852|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
2937853|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937854|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2937855|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2937856|NCT01578954|Growth Substances|growth substances|mesh-ancestor
2937857|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
2937858|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937859|NCT01517100|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2937860|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937861|NCT01495598|Pomalidomide|pomalidomide|mesh-list
2937862|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
2346827|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2346828|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
2346829|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
2346830|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346831|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346832|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2346833|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2346834|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2346835|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
2346836|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346837|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937863|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937864|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2937865|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2937866|NCT01495598|Growth Substances|growth substances|mesh-ancestor
2937867|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
2937868|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937869|NCT01419561|Zidovudine|zidovudine|mesh-list
2937870|NCT01419561|Rituximab|rituximab|mesh-list
2937871|NCT01419561|Doxorubicin|doxorubicin|mesh-list
2937872|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2937873|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2937874|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937875|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
2937876|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937877|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937878|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2937879|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2937880|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2937881|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937882|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937883|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
2937884|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2937885|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2937886|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
2937887|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2937888|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2937889|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2937890|NCT01369147|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2937891|NCT01369147|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2937892|NCT01369147|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2937893|NCT01369147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2937894|NCT01314118|Prednisone|prednisone|mesh-list
2937895|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
2937896|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937897|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
2937898|NCT01314118|Hormones|hormones|mesh-ancestor
2937899|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937900|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937901|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937902|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937903|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2937904|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937905|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937906|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
2937907|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2937908|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2937909|NCT01306045|Sunitinib|sunitinib|mesh-list
2937910|NCT01306045|Lapatinib|lapatinib|mesh-list
2937911|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937912|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2937913|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937914|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346838|NCT00475514|Frovatriptan|frovatriptan|mesh-list
2346839|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2346840|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
2346841|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346842|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346843|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346844|NCT00475527|Amoxicillin|amoxicillin|mesh-list
2346845|NCT00475527|Metronidazole|metronidazole|mesh-list
2346846|NCT00475527|Clarithromycin|clarithromycin|mesh-list
2346847|NCT00475527|Omeprazole|omeprazole|mesh-list
2346848|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2346849|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346850|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2346851|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2346852|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2346853|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2346854|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2346855|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937915|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2937916|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2937917|NCT01306045|Growth Substances|growth substances|mesh-ancestor
2111966|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2111967|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2111968|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
2111969|NCT02562898|Antiviral Agents|antiviral agents|mesh-ancestor
2111970|NCT02562898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2111971|NCT02562898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2111972|NCT02562898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2111973|NCT02562898|Immunologic Factors|immunologic factors|mesh-ancestor
2937918|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937919|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
2346856|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346857|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2346858|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2346859|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2346860|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2346861|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2346862|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2346863|NCT00475553|Etonogestrel|etonogestrel|mesh-list
2346864|NCT00475553|Desogestrel|desogestrel|mesh-list
2346865|NCT00475553|NuvaRing|nuvaring|mesh-list
2346866|NCT00475553|Estradiol|estradiol|mesh-list
2346867|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2346868|NCT00475553|Estrogens|estrogens|mesh-ancestor
2346869|NCT00475553|Hormones|hormones|mesh-ancestor
2346870|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2346871|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346872|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2346873|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
2346874|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2346875|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2346876|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2346877|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2346878|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2346879|NCT00475553|Progestins|progestins|mesh-ancestor
2346880|NCT00475566|Everolimus|everolimus|mesh-list
2346881|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346882|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2346883|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
2346884|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346885|NCT00475618|Fluorides|fluorides|mesh-list
2346886|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
2346887|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
2937929|NCT01275677|Paclitaxel|paclitaxel|mesh-list
2937930|NCT01275677|Docetaxel|docetaxel|mesh-list
2937931|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
2937932|NCT01275677|Doxorubicin|doxorubicin|mesh-list
2937933|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2937934|NCT01275677|Trastuzumab|trastuzumab|mesh-list
2937935|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2937936|NCT01275677|Daunorubicin|daunorubicin|mesh-list
2937937|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2937938|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2937939|NCT01275677|Antibodies|antibodies|mesh-list
2937940|NCT01275677|Immunoglobulins|immunoglobulins|mesh-list
2937941|NCT01275677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2937942|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2937943|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937944|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
2937945|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
2937946|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
2937947|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937948|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937949|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
2937950|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937951|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937952|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2937953|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
2937954|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2937955|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2937956|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2937957|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2937958|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937959|NCT01272037|Tamoxifen|tamoxifen|mesh-list
2346888|NCT00475618|Protective Agents|protective agents|mesh-ancestor
2346889|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346890|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2346891|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2346892|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2346893|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2346894|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346895|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346896|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346897|NCT00475696|Analgesics|analgesics|mesh-ancestor
2346898|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
2346899|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346900|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
2346901|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2346902|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
2346903|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
2346904|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2346905|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2346906|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346907|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346908|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2346909|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2346910|NCT00475800|Analgesics|analgesics|mesh-ancestor
2346911|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
2346912|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346913|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346914|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2346915|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2346916|NCT00475813|Fluticasone|fluticasone|mesh-list
2346917|NCT00475813|Xhance|xhance|mesh-list
2346918|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
2346919|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2937960|NCT01272037|Letrozole|letrozole|mesh-list
2937961|NCT01272037|Anastrozole|anastrozole|mesh-list
2937962|NCT01272037|Exemestane|exemestane|mesh-list
2937963|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937964|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937965|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2937966|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2937967|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937968|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2937969|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
2937970|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2937971|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937972|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2937973|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2937974|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2937975|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2937976|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2937977|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937978|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2937979|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2937980|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2346920|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2346921|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
2346922|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346923|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346924|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2346925|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
2937981|NCT01218555|Lenalidomide|lenalidomide|mesh-list
2937982|NCT01218555|Everolimus|everolimus|mesh-list
2937983|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
2937984|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937985|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2937986|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2937987|NCT01218555|Growth Substances|growth substances|mesh-ancestor
2937988|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
2937989|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2937990|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937991|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
2937992|NCT01176006|Busulfan|busulfan|mesh-list
2937993|NCT01176006|Fludarabine|fludarabine|mesh-list
2937994|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
2937995|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2937996|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
2937997|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2937998|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2937999|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2938000|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
2938001|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938002|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938003|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2938004|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2938005|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
2938006|NCT01161394|Pioglitazone|pioglitazone|mesh-list
2938007|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2938008|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938009|NCT01141712|Cytarabine|cytarabine|mesh-list
2938010|NCT01141712|Etoposide|etoposide|mesh-list
2938011|NCT01141712|Melphalan|melphalan|mesh-list
2938012|NCT01141712|Carmustine|carmustine|mesh-list
2938013|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2938014|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938015|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2938016|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2938017|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938018|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938019|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2938020|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
2938021|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
2938022|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938023|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2938024|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
2938025|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938026|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2938027|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
2938028|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2346926|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
2346927|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2938029|NCT01130519|Bevacizumab|bevacizumab|mesh-list
2938030|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2938031|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938032|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938033|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2938034|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2938035|NCT01130519|Growth Substances|growth substances|mesh-ancestor
2938036|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938037|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
2938038|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2938039|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938040|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938041|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
2938042|NCT01111305|Reslizumab|reslizumab|mesh-list
2938043|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2938044|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
2938045|NCT01111305|Filaricides|filaricides|mesh-ancestor
2938046|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
2938047|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
2938048|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2938049|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346928|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2346929|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2346930|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2346931|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
2346932|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346933|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346934|NCT00475826|Ezetimibe|ezetimibe|mesh-list
2346935|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2938050|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2938051|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938052|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938053|NCT01015833|Doxorubicin|doxorubicin|mesh-list
2938054|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2938055|NCT01015833|Sorafenib|sorafenib|mesh-list
2938056|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2938057|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938058|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2938059|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2938060|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938061|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938062|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2938063|NCT00977977|Cyclosporine|cyclosporine|mesh-list
2938064|NCT00977977|Rituximab|rituximab|mesh-list
2938065|NCT00977977|Cyclosporins|cyclosporins|mesh-list
2938066|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938067|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938068|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
2938069|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938070|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2938071|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938072|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938073|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2938074|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
2938075|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938076|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
2938077|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2938078|NCT00972309|Vaccines|vaccines|mesh-list
2938079|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
2938080|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938081|NCT00923013|Rituximab|rituximab|mesh-list
2938082|NCT00923013|Cladribine|cladribine|mesh-list
2938083|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938084|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938085|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
2938086|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938087|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2938088|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2938089|NCT00921856|Acetylcholine|acetylcholine|mesh-list
2938090|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
2346936|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2346937|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
2346938|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346939|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2346940|NCT00475917|Gemcitabine|gemcitabine|mesh-list
2346941|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2346942|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
2346943|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346944|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346945|NCT00475917|Antiviral Agents|antiviral agents|mesh-ancestor
2346946|NCT00475917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346947|NCT00475917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346948|NCT00475917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2346949|NCT00475917|Immunologic Factors|immunologic factors|mesh-ancestor
2346950|NCT00475917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346951|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
2938091|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2938092|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
2938093|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2938094|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938095|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938096|NCT00843882|Lenalidomide|lenalidomide|mesh-list
2938097|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
2938098|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
2938099|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938100|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2938101|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2938102|NCT00843882|Growth Substances|growth substances|mesh-ancestor
2938103|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
2938104|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938105|NCT00843882|Hematinics|hematinics|mesh-ancestor
2938106|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
2938107|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2938108|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938109|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938110|NCT00659646|Levofloxacin|levofloxacin|mesh-list
2938111|NCT00659646|Ofloxacin|ofloxacin|mesh-list
2938112|NCT00659646|Gentamicins|gentamicins|mesh-list
2938113|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2938114|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938115|NCT00659646|Renal Agents|renal agents|mesh-ancestor
2938116|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2938117|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2938118|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2938119|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938120|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938121|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938122|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2938123|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2938124|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2938125|NCT00588770|Bevacizumab|bevacizumab|mesh-list
2938126|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2938127|NCT00588770|Cisplatin|cisplatin|mesh-list
2938128|NCT00588770|Carboplatin|carboplatin|mesh-list
2938129|NCT00588770|Docetaxel|docetaxel|mesh-list
2938130|NCT00588770|Fluorouracil|fluorouracil|mesh-list
2938131|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
2938132|NCT00588770|Antibodies|antibodies|mesh-list
2938133|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
2938134|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2346952|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2346953|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2346954|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2346955|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
2346956|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
2346957|NCT00475956|Cediranib|cediranib|mesh-list
2346958|NCT00475956|Saracatinib|saracatinib|mesh-list
2346959|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2346960|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2346961|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346962|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346963|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2346964|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2346965|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2938135|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
2938136|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938137|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2938138|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2938139|NCT00588770|Growth Substances|growth substances|mesh-ancestor
2938140|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346966|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2346967|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346968|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2346969|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346970|NCT00475969|Analgesics|analgesics|mesh-ancestor
2346971|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
2346972|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346973|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
2346974|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2346975|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
2346976|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
2938141|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
2938142|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
2938143|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
2938144|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
2938145|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
2938146|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938147|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
2938148|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2938149|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2938150|NCT00567580|Leuprolide|leuprolide|mesh-list
2938151|NCT00567580|Goserelin|goserelin|mesh-list
2346977|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2346978|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2346979|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2346980|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2346981|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2346982|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2346983|NCT00476034|Analgesics|analgesics|mesh-ancestor
2346984|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
2346985|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346986|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346987|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2346988|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2346989|NCT00476073|Fluticasone|fluticasone|mesh-list
2346990|NCT00476073|Xhance|xhance|mesh-list
2346991|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
2346992|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2346993|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2346994|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
2346995|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2346996|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2346997|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2346998|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
2346999|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
2347000|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2347001|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2938152|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2938153|NCT00567580|Flutamide|flutamide|mesh-list
2938154|NCT00567580|Bicalutamide|bicalutamide|mesh-list
2938155|NCT00567580|Buserelin|buserelin|mesh-list
2938156|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2347002|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2347003|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2938157|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
2938158|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2938159|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938160|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2938161|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938162|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
2938163|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
2938164|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2938165|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
2938166|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2938167|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
2938168|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2938169|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2938170|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
2938171|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938172|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938173|NCT00477412|Cytarabine|cytarabine|mesh-list
2938174|NCT00477412|Dexamethasone|dexamethasone|mesh-list
2938175|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
2938176|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
2938177|NCT00477412|Rituximab|rituximab|mesh-list
2938178|NCT00477412|Doxorubicin|doxorubicin|mesh-list
2938179|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2938180|NCT00477412|Methotrexate|methotrexate|mesh-list
2938181|NCT00477412|Vincristine|vincristine|mesh-list
2938182|NCT00477412|Bortezomib|bortezomib|mesh-list
2938183|NCT00477412|Daunorubicin|daunorubicin|mesh-list
2938184|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2938185|NCT00477412|Antibodies|antibodies|mesh-list
2938186|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
2938187|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2938188|NCT00477412|BB 1101|bb 1101|mesh-list
2938189|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2938190|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
2938191|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938192|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2347004|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
2347005|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347006|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938193|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2938194|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
2938195|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938196|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938197|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2938198|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2938199|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
2938200|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
2938201|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938202|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2938203|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
2938204|NCT00477412|Hormones|hormones|mesh-ancestor
2938205|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2938206|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2938207|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2938208|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2938209|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2938210|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938211|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2938212|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
2938213|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2938214|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2938215|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
2938216|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
2938217|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2938218|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2938219|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
2938220|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938221|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2938222|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
2938223|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
2938224|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
2938225|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
2938226|NCT00369317|Cytarabine|cytarabine|mesh-list
2938227|NCT00369317|Etoposide|etoposide|mesh-list
2938228|NCT00369317|Daunorubicin|daunorubicin|mesh-list
2938229|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
2938230|NCT00369317|Asparaginase|asparaginase|mesh-list
2938231|NCT00369317|Thioguanine|thioguanine|mesh-list
2938232|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2938233|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938234|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2938235|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2347007|NCT00476099|Budesonide|budesonide|mesh-list
2347008|NCT00476099|Beclomethasone|beclomethasone|mesh-list
2347009|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
2347010|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2347011|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2347012|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
2347013|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347014|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347015|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2347016|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
2347017|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
2347018|NCT00476099|Hormones|hormones|mesh-ancestor
2372166|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938236|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938237|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938238|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2938239|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
2938240|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
2938241|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938242|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2938243|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
2938244|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938245|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2938246|NCT00366145|Remestemcel-l|remestemcel-l|mesh-list
2938247|NCT00366145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2938248|NCT00366145|Antiviral Agents|antiviral agents|mesh-ancestor
2938249|NCT00366145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938250|NCT00353158|Doxycycline|doxycycline|mesh-list
2938251|NCT00353158|Voriconazole|voriconazole|mesh-list
2938252|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2347019|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347020|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2347021|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2938253|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938254|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
2938255|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2938256|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2938257|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
2938258|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2938259|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2938260|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938261|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938262|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2938263|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
2938264|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2938265|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938266|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2938267|NCT00261807|Daptomycin|daptomycin|mesh-list
2938268|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2938269|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938281|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
2938282|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938283|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2938284|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938285|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938286|NCT00006436|Rituximab|rituximab|mesh-list
2938287|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938288|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347022|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2347023|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
2347024|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347025|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347026|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2347027|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
2347028|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938289|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
2938290|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938291|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2938299|NCT00001379|Interferons|interferons|mesh-list
2938300|NCT00001379|Rituximab|rituximab|mesh-list
2938301|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938302|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
2938303|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938304|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938305|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
2938306|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938307|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2347029|NCT00476138|Protective Agents|protective agents|mesh-ancestor
2347030|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347031|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2347032|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2347033|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347034|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2347035|NCT00476164|Rituximab|rituximab|mesh-list
2347036|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2347037|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347038|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
2347039|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347040|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2938314|NCT05216744|Doxycycline|doxycycline|mesh-list
2938315|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
2938316|NCT05216744|Cefixime|cefixime|mesh-list
2938317|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2938318|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347041|NCT00476190|Cytarabine|cytarabine|mesh-list
2347042|NCT00476190|Dexamethasone|dexamethasone|mesh-list
2347043|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
2347044|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2347045|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2347046|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2347047|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
2347048|NCT00476190|Doxorubicin|doxorubicin|mesh-list
2938319|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
2938320|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2938321|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2938322|NCT05216653|Capecitabine|capecitabine|mesh-list
2938323|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
2938324|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2938325|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
2938326|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938327|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938328|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
2938329|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2938330|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2938331|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2938332|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938333|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2938334|NCT05216614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2938335|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2938336|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2938337|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938338|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2938339|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
2938340|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2938341|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
2938342|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2938343|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2938344|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938345|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2938346|NCT05216575|Almitrine|almitrine|mesh-list
2938347|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
2938348|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
2938349|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
2938350|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938351|NCT05216432|Fulvestrant|fulvestrant|mesh-list
2938352|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2938353|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938354|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2347049|NCT00476190|Methotrexate|methotrexate|mesh-list
2347050|NCT00476190|Etoposide|etoposide|mesh-list
2347051|NCT00476190|Vincristine|vincristine|mesh-list
2347052|NCT00476190|Asparaginase|asparaginase|mesh-list
2347053|NCT00476190|Pegaspargase|pegaspargase|mesh-list
2347054|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2347055|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
2347056|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347057|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2347058|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2347059|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
2347060|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347061|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938355|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2347062|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2938356|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
2938357|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2938358|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938359|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
2938360|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2938361|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938362|NCT05216419|Vitamins|vitamins|mesh-ancestor
2938363|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
2938364|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2938365|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
2938366|NCT05216328|Antacids|antacids|mesh-ancestor
2938367|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938368|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2938369|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
2938370|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2938371|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2938372|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2938373|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2938374|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938375|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
2347063|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2347064|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
2347065|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
2347066|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938376|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2938377|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938378|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2938379|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938380|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
2938381|NCT05216237|Apatinib|apatinib|mesh-list
2938382|NCT05216237|Tegafur|tegafur|mesh-list
2938383|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938384|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2938385|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938386|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938387|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2938388|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
2938389|NCT05216211|Bupivacaine|bupivacaine|mesh-list
2938390|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
2938391|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
2938392|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2938393|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938394|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
2938395|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938396|NCT05216055|Dexamethasone|dexamethasone|mesh-list
2938397|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
2938398|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
2938399|NCT05216055|Bupivacaine|bupivacaine|mesh-list
2938400|NCT05216055|Ropivacaine|ropivacaine|mesh-list
2938401|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2938402|NCT05216055|BB 1101|bb 1101|mesh-list
2938403|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2938404|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
2938405|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
2938406|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938407|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938408|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2938409|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
2938410|NCT05216055|Hormones|hormones|mesh-ancestor
2938411|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2938412|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2938413|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938414|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
2938415|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
2938416|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2938417|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
2938418|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2938419|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2938420|NCT05216055|Analgesics|analgesics|mesh-ancestor
2938421|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2938422|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2938423|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2938424|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
2347067|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2938425|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2938426|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938427|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
2938428|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938429|NCT05215990|Metformin|metformin|mesh-list
2938430|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2938431|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938432|NCT05215951|Osimertinib|osimertinib|mesh-list
2938433|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938434|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2938435|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938436|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938437|NCT05215925|Cetuximab|cetuximab|mesh-list
2938438|NCT05215925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938439|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938440|NCT05215873|Misoprostol|misoprostol|mesh-list
2938441|NCT05215873|Oxytocin|oxytocin|mesh-list
2938442|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
2938443|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2938444|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938445|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2938446|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
2938447|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2938448|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2938449|NCT05215834|Remifentanil|remifentanil|mesh-list
2938450|NCT05215834|Propofol|propofol|mesh-list
2938451|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2938452|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2938453|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938454|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2938455|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
2938456|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
2938457|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2938458|NCT05215834|Narcotics|narcotics|mesh-ancestor
2938459|NCT05215834|Analgesics|analgesics|mesh-ancestor
2938460|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
2938461|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938462|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
2938463|NCT05215743|Antioxidants|antioxidants|mesh-list
2938464|NCT05215743|Deferoxamine|deferoxamine|mesh-list
2938465|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
2938466|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938467|NCT05215743|Expectorants|expectorants|mesh-ancestor
2938468|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
2938469|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2938470|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938471|NCT05215743|Protective Agents|protective agents|mesh-ancestor
2938472|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938473|NCT05215743|Siderophores|siderophores|mesh-ancestor
2938474|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2938475|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
2938476|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
2938477|NCT05215730|Copper|copper|mesh-list
2938478|NCT05215730|Trace Elements|trace elements|mesh-ancestor
2938479|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
2938480|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938481|NCT05215691|Morphine|morphine|mesh-list
2938482|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2938483|NCT05215691|Narcotics|narcotics|mesh-ancestor
2938484|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2938485|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938486|NCT05215691|Analgesics|analgesics|mesh-ancestor
2938487|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
2938488|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938489|NCT05215665|Lenvatinib|lenvatinib|mesh-list
2938490|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938491|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2938492|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347068|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
2347069|NCT00476190|Hormones|hormones|mesh-ancestor
2347070|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347071|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2347072|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2347073|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2347074|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2347075|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347076|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2347077|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
2938493|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938494|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
2938495|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938496|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938497|NCT05215548|Afatinib|afatinib|mesh-list
2938498|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938499|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2938500|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938501|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938502|NCT05215535|Liver Extracts|liver extracts|mesh-list
2938503|NCT05215535|Hematinics|hematinics|mesh-ancestor
2938510|NCT05215431|Antioxidants|antioxidants|mesh-list
2938511|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938512|NCT05215431|Protective Agents|protective agents|mesh-ancestor
2938513|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938514|NCT05215418|Topiramate|topiramate|mesh-list
2938515|NCT05215418|Phentermine|phentermine|mesh-list
2938516|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
2938517|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2938518|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938519|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2938520|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
2938521|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2938522|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
2938523|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
2938524|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938525|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
2938526|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2938527|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938528|NCT05215405|Venetoclax|venetoclax|mesh-list
2938529|NCT05215405|Navitoclax|navitoclax|mesh-list
2938530|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938531|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
2938532|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
2938533|NCT05215366|Coagulants|coagulants|mesh-ancestor
2938534|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2938535|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2938536|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
2938537|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938538|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
2938539|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938540|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938541|NCT05215327|Vaccines|vaccines|mesh-list
2938542|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
2938543|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938544|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
2938545|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2938546|NCT05215236|Narcotics|narcotics|mesh-ancestor
2938547|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2938548|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938549|NCT05215236|Analgesics|analgesics|mesh-ancestor
2938550|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
2938551|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938552|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
2938553|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2938554|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2938555|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938556|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2938557|NCT05215158|Analgesics|analgesics|mesh-ancestor
2938558|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
2938559|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938560|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2938561|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2347078|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2347079|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2347080|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
2347081|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
2347082|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2938562|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2938563|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
2347083|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2347084|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2347085|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
2938564|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2938565|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938566|NCT05215106|Durvalumab|durvalumab|mesh-list
2938567|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938568|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938569|NCT05215067|Docetaxel|docetaxel|mesh-list
2938570|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938571|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
2938572|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
2938573|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
2938574|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938575|NCT05214976|Paclitaxel|paclitaxel|mesh-list
2938576|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2938577|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938578|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
2938579|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
2938580|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
2938581|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938582|NCT05214911|Loratadine|loratadine|mesh-list
2938583|NCT05214911|Prednisolone|prednisolone|mesh-list
2938584|NCT05214911|Desloratadine|desloratadine|mesh-list
2938585|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2938586|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
2347086|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347087|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
2938587|NCT05214911|Hormones|hormones|mesh-ancestor
2938588|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2938589|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938590|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2938591|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938592|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2938593|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
2938594|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2938595|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938596|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2938597|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2938598|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
2938599|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
2938600|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
2938601|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
2938602|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2938603|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2938604|NCT05214872|Calcium|calcium|mesh-list
2938605|NCT05214872|Mitogens|mitogens|mesh-list
2938606|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2938607|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938608|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
2938609|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938610|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
2938611|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2938612|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
2938613|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938614|NCT05214807|Chitosan|chitosan|mesh-list
2938615|NCT05214807|Hylan|hylan|mesh-list
2938616|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
2938617|NCT05214807|Protective Agents|protective agents|mesh-ancestor
2938618|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938619|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2938620|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2938621|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
2938622|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938623|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2938624|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
2347088|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
2347089|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
2347090|NCT00476216|Fondaparinux|fondaparinux|mesh-list
2347091|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2347092|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
2347093|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2347094|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
2347095|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347096|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938625|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
2938626|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
2938627|NCT05214807|Coagulants|coagulants|mesh-ancestor
2938628|NCT05214664|Anesthetics|anesthetics|mesh-list
2938629|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2938630|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347097|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
2347098|NCT00476268|Beclomethasone|beclomethasone|mesh-list
2347099|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
2347100|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2347101|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
2347102|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347103|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347104|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2347105|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
2347106|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2347107|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2347108|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2347109|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
2347110|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372167|NCT00591526|Cytarabine|cytarabine|mesh-list
2938651|NCT05208047|Sunitinib|sunitinib|mesh-list
2938652|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938653|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2938654|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2938655|NCT05208047|Growth Substances|growth substances|mesh-ancestor
2938656|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938657|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
2938658|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2938659|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938660|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938661|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2938662|NCT05198934|Trifluridine|trifluridine|mesh-list
2938663|NCT05198934|Panitumumab|panitumumab|mesh-list
2938664|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938665|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938666|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
2938667|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938668|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
2938669|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938670|NCT05193591|Autoantibodies|autoantibodies|mesh-list
2938671|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
2938672|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938673|NCT05193487|Anesthetics|anesthetics|mesh-list
2938674|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2938675|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938676|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2938677|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2938678|NCT05189145|Hormones|hormones|mesh-list
2938679|NCT05189145|Estradiol|estradiol|mesh-list
2938680|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2938681|NCT05189145|Progesterone|progesterone|mesh-list
2938682|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
2938683|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2938684|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938685|NCT05189145|Estrogens|estrogens|mesh-ancestor
2347111|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347112|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2347113|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
2347114|NCT00476268|Hormones|hormones|mesh-ancestor
2347115|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347116|NCT00476346|Vitamin D|vitamin d|mesh-list
2347117|NCT00476346|Calcium|calcium|mesh-list
2347118|NCT00476346|Vitamins|vitamins|mesh-ancestor
2347119|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
2347120|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938686|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2938687|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
2938688|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2938689|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2938690|NCT05189145|Progestins|progestins|mesh-ancestor
2938691|NCT05186571|Vaccines|vaccines|mesh-list
2938692|NCT05186571|Immunologic Factors|immunologic factors|mesh-ancestor
2938693|NCT05186571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938701|NCT05183854|Vaccines|vaccines|mesh-list
2938702|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2938703|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
2938704|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938708|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2938709|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
2938710|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938711|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2938712|NCT05160922|Crizotinib|crizotinib|mesh-list
2938713|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938714|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2938715|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938716|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938725|NCT05154994|Durvalumab|durvalumab|mesh-list
2938726|NCT05154994|Ipilimumab|ipilimumab|mesh-list
2938727|NCT05154994|Tremelimumab|tremelimumab|mesh-list
2347121|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2347122|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2347123|NCT00476359|Lopinavir|lopinavir|mesh-list
2347124|NCT00476359|Saquinavir|saquinavir|mesh-list
2347125|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2347126|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2347127|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
2347128|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347129|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347130|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2347131|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2347132|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
2347133|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347134|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2347135|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2938728|NCT05154994|Belinostat|belinostat|mesh-list
2938729|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
2938730|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2938731|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
2938732|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938733|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938734|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
2347136|NCT00476424|Efavirenz|efavirenz|mesh-list
2347137|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2347138|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2347139|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938735|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938736|NCT05154994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2938737|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938738|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2938739|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938746|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2938747|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
2938748|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938749|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2938750|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
2938751|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2938752|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938753|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2938754|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2938755|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2938756|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
2938757|NCT05130788|Nicotine|nicotine|mesh-list
2938758|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2938759|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
2938760|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938761|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938762|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2938763|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2938764|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
2938765|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347140|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347141|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
2347142|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347143|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2347144|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2938766|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938767|NCT05114915|Docetaxel|docetaxel|mesh-list
2938768|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938769|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
2938770|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
2938771|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
2938772|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938773|NCT05108649|Nicotine|nicotine|mesh-list
2938774|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2938775|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
2938776|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938777|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938778|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2938779|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2938780|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
2938781|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2938782|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938783|NCT05106153|Zolpidem|zolpidem|mesh-list
2938784|NCT05106153|Suvorexant|suvorexant|mesh-list
2938785|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2938786|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2938787|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2938788|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938789|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2938790|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
2938791|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
2938792|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2938793|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938794|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2938795|NCT05105841|Venetoclax|venetoclax|mesh-list
2938796|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
2938797|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938798|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938803|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
2938804|NCT05104567|Cetuximab|cetuximab|mesh-list
2938805|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938806|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938807|NCT05096481|Temozolomide|temozolomide|mesh-list
2938808|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2938809|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
2938810|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938811|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938812|NCT05071833|Peppermint oil|peppermint oil|mesh-list
2938813|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
2938814|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
2938815|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938816|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938817|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2938818|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
2938819|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2938820|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2938821|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
2938822|NCT05064280|Lenvatinib|lenvatinib|mesh-list
2938823|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2938824|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938825|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2938826|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938827|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938828|NCT05059600|Pregnanolone|pregnanolone|mesh-list
2938829|NCT05059600|Brexanolone|brexanolone|mesh-list
2938830|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
2938831|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2938832|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938833|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
2938834|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2938835|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938836|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
2938837|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
2938849|NCT05050136|Volixibat|volixibat|mesh-list
2938850|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2938851|NCT05048849|Somatomedin B|somatomedin b|mesh-list
2938852|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2938853|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2938854|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
2938855|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938856|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938857|NCT05047640|Vaccines|vaccines|mesh-list
2938858|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
2938859|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938860|NCT05047601|Ritonavir|ritonavir|mesh-list
2938861|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2938862|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2938863|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
2938864|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938865|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938866|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2938867|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2938868|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
2938869|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938870|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2938871|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2938872|NCT05038618|Somatomedin B|somatomedin b|mesh-list
2938873|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2938874|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2938875|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
2938876|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938877|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938915|NCT05022004|Brinzolamide|brinzolamide|mesh-list
2938916|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2938917|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938918|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938919|NCT05020236|Dexamethasone|dexamethasone|mesh-list
2938920|NCT05020236|Daratumumab|daratumumab|mesh-list
2938921|NCT05020236|Pomalidomide|pomalidomide|mesh-list
2938922|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2938923|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
2938924|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
2938925|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938926|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938927|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2938928|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
2938929|NCT05020236|Hormones|hormones|mesh-ancestor
2938930|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2938931|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2938932|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938933|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
2938934|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2938935|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2938936|NCT05020236|Growth Substances|growth substances|mesh-ancestor
2938937|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
2938938|NCT05011513|Ritonavir|ritonavir|mesh-list
2938939|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2938940|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2938941|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
2938942|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938943|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938944|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2938945|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2347145|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2347146|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2347147|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2347148|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2938946|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
2938947|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938948|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2938949|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2347149|NCT00476437|Insulin|insulin|mesh-list
2347150|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2347151|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
2347152|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
2347153|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2938953|NCT05007821|Linezolid|linezolid|mesh-list
2938954|NCT05007821|Bedaquiline|bedaquiline|mesh-list
2938955|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
2938956|NCT05007821|Clofazimine|clofazimine|mesh-list
2938957|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2938958|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938959|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2938960|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938961|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938962|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
2938963|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2938964|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
2938965|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2938966|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2938967|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2938968|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2938969|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938970|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2938971|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2938972|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938973|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
2938974|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2938975|NCT04992013|Niraparib|niraparib|mesh-list
2347154|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347155|NCT00476463|Emtricitabine|emtricitabine|mesh-list
2347156|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
2347157|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347158|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2347159|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2347160|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347161|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347162|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2347163|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2347164|NCT00476515|Rituximab|rituximab|mesh-list
2347165|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2347166|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347167|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
2347168|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347169|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2347170|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
2347171|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2347172|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347175|NCT00476606|Ritonavir|ritonavir|mesh-list
2347176|NCT00476606|Nelfinavir|nelfinavir|mesh-list
2347177|NCT00476606|Indinavir|indinavir|mesh-list
2347178|NCT00476606|Saquinavir|saquinavir|mesh-list
2347179|NCT00476606|Lamivudine|lamivudine|mesh-list
2347180|NCT00476606|Zidovudine|zidovudine|mesh-list
2347181|NCT00476606|Nevirapine|nevirapine|mesh-list
2347182|NCT00476606|Stavudine|stavudine|mesh-list
2347183|NCT00476606|Didanosine|didanosine|mesh-list
2347184|NCT00476606|Efavirenz|efavirenz|mesh-list
2347185|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2347186|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2938976|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2938977|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2938978|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938979|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938980|NCT04988035|Remdesivir|remdesivir|mesh-list
2938981|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
2938982|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938983|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
2347187|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
2347188|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347189|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938984|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2938985|NCT04979442|Trabectedin|trabectedin|mesh-list
2938986|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2938987|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
2938988|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938989|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2938990|NCT04967443|Prazosin|prazosin|mesh-list
2938991|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2938992|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2938993|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2938994|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2938995|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
2938996|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2938997|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2938998|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2938999|NCT04967079|Trametinib|trametinib|mesh-list
2939000|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939001|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2939002|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939003|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939004|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
2939005|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2939006|NCT04964193|Cyproterone|cyproterone|mesh-list
2939007|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
2939008|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2939009|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2347190|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2347191|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2939010|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2939011|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
2939012|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2347192|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
2347193|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347194|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2347195|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2347196|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2347197|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2347198|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
2347199|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2347200|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2347201|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2347202|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2347203|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2347204|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
2347205|NCT00476619|Hematinics|hematinics|mesh-ancestor
2347206|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2939013|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939014|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2939015|NCT04964193|Estrogens|estrogens|mesh-ancestor
2939016|NCT04964193|Hormones|hormones|mesh-ancestor
2939017|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2939018|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
2347207|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2347208|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2347209|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
2347210|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347211|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2347212|NCT00476853|Nevirapine|nevirapine|mesh-list
2347213|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2347214|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2347215|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347216|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347217|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
2347218|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347219|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2347220|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2347221|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2347222|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2347223|NCT00476918|Triamcinolone|triamcinolone|mesh-list
2347224|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2347225|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2347226|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2939019|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
2939020|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939021|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2939022|NCT04958876|Naltrexone|naltrexone|mesh-list
2939023|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2939024|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2939025|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939026|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
2939027|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2939028|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2939029|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2939030|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939031|NCT04951388|Somatomedin B|somatomedin b|mesh-list
2939032|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2939033|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2939034|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
2939035|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939036|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939037|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
2939038|NCT04949256|Leucovorin|leucovorin|mesh-list
2939039|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
2939040|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
2939041|NCT04949256|Lenvatinib|lenvatinib|mesh-list
2939042|NCT04949256|Calcium|calcium|mesh-list
2939043|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
2939044|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939045|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2939046|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939047|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2939048|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939049|NCT04949256|Antidotes|antidotes|mesh-ancestor
2939050|NCT04949256|Protective Agents|protective agents|mesh-ancestor
2939051|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
2939052|NCT04949256|Vitamins|vitamins|mesh-ancestor
2939053|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
2939054|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2939055|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939056|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939057|NCT04946006|Oxytocin|oxytocin|mesh-list
2939058|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
2939059|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2939060|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939061|NCT04940065|Ofatumumab|ofatumumab|mesh-list
2939062|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111974|NCT02562898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111975|NCT02562924|Prednisone|prednisone|mesh-list
2111976|NCT02562924|Budesonide|budesonide|mesh-list
2347227|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2347228|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
2347229|NCT00476918|Hormones|hormones|mesh-ancestor
2111977|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2939105|NCT04926285|Venetoclax|venetoclax|mesh-list
2939106|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
2939107|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939108|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2939109|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2939110|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939111|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347230|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347231|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347232|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2347233|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
2347234|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347235|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347236|NCT00476983|Ritonavir|ritonavir|mesh-list
2347237|NCT00476983|Saquinavir|saquinavir|mesh-list
2347238|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2347239|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2347240|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2347241|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
2347242|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939120|NCT04912063|Azacitidine|azacitidine|mesh-list
2939121|NCT04912063|Venetoclax|venetoclax|mesh-list
2939122|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2939123|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
2939124|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939125|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939126|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939127|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
2347243|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347244|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2347245|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2347246|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
2347247|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347248|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2347249|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2347250|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2347251|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2347252|NCT00477035|Gemcitabine|gemcitabine|mesh-list
2347253|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
2347254|NCT00477035|Melphalan|melphalan|mesh-list
2347255|NCT00477035|Carmustine|carmustine|mesh-list
2347256|NCT00477035|Etoposide|etoposide|mesh-list
2347257|NCT00477035|Vinorelbine|vinorelbine|mesh-list
2347258|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2347259|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
2347260|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347261|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2347262|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2347263|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
2347264|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939128|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
2939129|NCT04904588|Melphalan|melphalan|mesh-list
2939130|NCT04904588|Busulfan|busulfan|mesh-list
2347265|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347266|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2347267|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2347268|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
2347269|NCT00477035|Antiviral Agents|antiviral agents|mesh-ancestor
2347270|NCT00477035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2939131|NCT04904588|Fludarabine|fludarabine|mesh-list
2939132|NCT04904588|Tacrolimus|tacrolimus|mesh-list
2939133|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2939134|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
2939135|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939136|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2939137|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2939138|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
2347271|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347272|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2347273|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2347274|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2347275|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
2939139|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939140|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939141|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2939142|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2939143|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939144|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2939145|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2939146|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
2939147|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2939148|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2939149|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
2939150|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2939151|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2939152|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
2939153|NCT04896320|Tucatinib|tucatinib|mesh-list
2939154|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939155|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2939156|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939157|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939163|NCT04895436|Venetoclax|venetoclax|mesh-list
2939164|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
2939165|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939166|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939177|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
2939178|NCT04881240|Fludarabine|fludarabine|mesh-list
2939179|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2939180|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
2939181|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939182|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2939183|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2939184|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
2939185|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939186|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347276|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
2347277|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
2347278|NCT00477048|Saquinavir|saquinavir|mesh-list
2347279|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2347280|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2347281|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
2347282|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347283|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347284|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2939187|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2939188|NCT04869943|Exemestane|exemestane|mesh-list
2347285|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2347286|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
2347287|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347288|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2347289|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2347290|NCT00477061|Morphine|morphine|mesh-list
2347291|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2347292|NCT00477061|Narcotics|narcotics|mesh-ancestor
2347293|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2347294|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347295|NCT00477061|Analgesics|analgesics|mesh-ancestor
2347296|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
2347297|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347298|NCT00477126|Ritonavir|ritonavir|mesh-list
2347299|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2347300|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2347301|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
2347302|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347303|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347304|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2347305|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2347306|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
2347307|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347308|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2347309|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2347310|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
2347311|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2347312|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347313|NCT00477282|Topotecan|topotecan|mesh-list
2347314|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2347315|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2939189|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939190|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2939191|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2347316|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347317|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347318|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347319|NCT00477347|Anesthetics|anesthetics|mesh-list
2347320|NCT00477347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2347321|NCT00477347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347322|NCT00477373|Valproic Acid|valproic acid|mesh-list
2347323|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
2347324|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347325|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347326|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
2939192|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939193|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347327|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347328|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347329|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
2347330|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2347331|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2347332|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2939194|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2939195|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
2939196|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2939197|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939198|NCT04865796|Lactoferrin|lactoferrin|mesh-list
2939199|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2939205|NCT04858269|Paclitaxel|paclitaxel|mesh-list
2939206|NCT04858269|Carboplatin|carboplatin|mesh-list
2939207|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
2939208|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2939209|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939210|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
2939211|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
2939212|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
2939213|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939214|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939215|NCT04844528|Niacinamide|niacinamide|mesh-list
2939216|NCT04844528|Niacin|niacin|mesh-list
2939217|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
2939218|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
2939219|NCT04844528|Vitamins|vitamins|mesh-ancestor
2939220|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
2939221|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939222|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2939223|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
2939224|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939225|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2939226|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
2939227|NCT04840589|Nivolumab|nivolumab|mesh-list
2939228|NCT04840589|Ipilimumab|ipilimumab|mesh-list
2939229|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939230|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939231|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2939232|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939233|NCT04818086|Buprenorphine|buprenorphine|mesh-list
2939234|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2939235|NCT04818086|Lemborexant|lemborexant|mesh-list
2939236|NCT04818086|Naloxone|naloxone|mesh-list
2939237|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2939238|NCT04818086|Narcotics|narcotics|mesh-ancestor
2939239|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2939240|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939241|NCT04818086|Analgesics|analgesics|mesh-ancestor
2939242|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
2939243|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2939244|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2939245|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2939246|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2939247|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939248|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2939249|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2939250|NCT04816643|Vaccines|vaccines|mesh-list
2939251|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
2939252|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939253|NCT04813991|Ibuprofen|ibuprofen|mesh-list
2939254|NCT04813991|Oxycodone|oxycodone|mesh-list
2939255|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2939256|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2939257|NCT04813991|Analgesics|analgesics|mesh-ancestor
2939258|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
2939259|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2939260|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347386|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
2347387|NCT00477503|Gallium citrate|gallium citrate|mesh-list
2347388|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
2347389|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
2347390|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347391|NCT00477503|Antidotes|antidotes|mesh-ancestor
2939261|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2939262|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2939263|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2939264|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939265|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939266|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2939267|NCT04813991|Narcotics|narcotics|mesh-ancestor
2939268|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2939269|NCT04811118|Docetaxel|docetaxel|mesh-list
2939270|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939271|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
2939272|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
2939273|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
2939274|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939275|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
2939276|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939277|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939278|NCT04793685|Prazosin|prazosin|mesh-list
2939279|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2939280|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2939281|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2939282|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2939283|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
2939284|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2939285|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939286|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939287|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2939288|NCT04785287|Nivolumab|nivolumab|mesh-list
2939289|NCT04785287|Antibodies|antibodies|mesh-list
2939290|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
2939291|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2939292|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
2939293|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939294|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939295|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2939296|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939297|NCT04757636|Aflibercept|aflibercept|mesh-list
2939298|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2939299|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2347392|NCT00477503|Protective Agents|protective agents|mesh-ancestor
2347393|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347394|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2347395|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2939300|NCT04757636|Growth Substances|growth substances|mesh-ancestor
2347396|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
2347397|NCT00477516|Calcium|calcium|mesh-list
2347398|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2347399|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347400|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2347401|NCT00477529|Docetaxel|docetaxel|mesh-list
2347402|NCT00477529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347403|NCT00477529|Tubulin Modulators|tubulin modulators|mesh-ancestor
2347404|NCT00477529|Antimitotic Agents|antimitotic agents|mesh-ancestor
2347405|NCT00477529|Mitosis Modulators|mitosis modulators|mesh-ancestor
2347406|NCT00477529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347407|NCT00477542|Clofarabine|clofarabine|mesh-list
2347408|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2347409|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
2347410|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347411|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347412|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2347413|NCT00477581|Exenatide|exenatide|mesh-list
2347414|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2347415|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347416|NCT00477581|Incretins|incretins|mesh-ancestor
2347417|NCT00477581|Hormones|hormones|mesh-ancestor
2347418|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347419|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2939301|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939302|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
2939303|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939304|NCT04757610|Ranibizumab|ranibizumab|mesh-list
2939305|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2939306|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2939307|NCT04757610|Growth Substances|growth substances|mesh-ancestor
2939308|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939309|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
2939310|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939317|NCT04739800|Paclitaxel|paclitaxel|mesh-list
2939318|NCT04739800|Doxorubicin|doxorubicin|mesh-list
2939319|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2939320|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2939321|NCT04739800|Durvalumab|durvalumab|mesh-list
2939322|NCT04739800|Topotecan|topotecan|mesh-list
2939323|NCT04739800|Olaparib|olaparib|mesh-list
2939324|NCT04739800|Cediranib|cediranib|mesh-list
2939325|NCT04739800|Maleic acid|maleic acid|mesh-list
2939326|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
2939327|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2939328|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
2939329|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2939330|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939331|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
2939332|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
2939333|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
2939334|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939335|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2939336|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2939337|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2939338|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939339|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939340|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
2939341|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939342|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2939343|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2939344|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2939345|NCT04733534|Dasatinib|dasatinib|mesh-list
2939346|NCT04733534|Quercetin|quercetin|mesh-list
2939347|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939348|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2939349|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939350|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939351|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
2939352|NCT04733534|Protective Agents|protective agents|mesh-ancestor
2347420|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
2347421|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347422|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347423|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2347424|NCT00477711|Capecitabine|capecitabine|mesh-list
2347425|NCT00477711|Cetuximab|cetuximab|mesh-list
2347426|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347427|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2347428|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
2347429|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347430|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2347431|NCT00477737|Propofol|propofol|mesh-list
2347432|NCT00477737|Sevoflurane|sevoflurane|mesh-list
2347433|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2347434|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2347435|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347436|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2347437|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
2347438|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
2347439|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2347440|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2347441|NCT00477763|Cyclosporine|cyclosporine|mesh-list
2347442|NCT00477763|Cyclosporins|cyclosporins|mesh-list
2347443|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347444|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347445|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2347446|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
2347447|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347448|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
2347449|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347450|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
2347451|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2347452|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2347453|NCT00477776|Metoclopramide|metoclopramide|mesh-list
2347454|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
2347455|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
2347456|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347457|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347458|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2347459|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2347460|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2347461|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
2347462|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347463|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347464|NCT00477789|Allopurinol|allopurinol|mesh-list
2347465|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
2347466|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347467|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347468|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
2347469|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2939353|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939354|NCT04718961|Volixibat|volixibat|mesh-list
2939355|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2347470|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2347471|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
2347472|NCT00477789|Protective Agents|protective agents|mesh-ancestor
2347473|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347474|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
2347475|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2347476|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2347477|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2347478|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2347479|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347480|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
2347481|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347482|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347483|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2347484|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347485|NCT00477815|Rituximab|rituximab|mesh-list
2939356|NCT04711252|Palbociclib|palbociclib|mesh-list
2939357|NCT04711252|Anastrozole|anastrozole|mesh-list
2939358|NCT04711252|Hormones|hormones|mesh-list
2939359|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2347486|NCT00477815|Melphalan|melphalan|mesh-list
2347487|NCT00477815|Sargramostim|sargramostim|mesh-list
2347488|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2939360|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2939361|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939362|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939363|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2939364|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939365|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939366|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2939367|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2939368|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2347489|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2347490|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347491|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
2347492|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347493|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2347494|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2347495|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
2347496|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347497|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2347498|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2347499|NCT00477854|Chromium|chromium|mesh-list
2347500|NCT00477854|Picolinic acid|picolinic acid|mesh-list
2347501|NCT00477854|Trace Elements|trace elements|mesh-ancestor
2347502|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
2347503|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347504|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2347505|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
2939369|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2939370|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
2939371|NCT04708470|Entinostat|entinostat|mesh-list
2939372|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939373|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2939374|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939375|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939376|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
2939377|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2347506|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
2347507|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347508|NCT00477880|Cetuximab|cetuximab|mesh-list
2347509|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2347510|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347511|NCT00477893|Adalimumab|adalimumab|mesh-list
2347512|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2347513|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2347514|NCT00477945|Clofarabine|clofarabine|mesh-list
2347515|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2347516|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
2347517|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347518|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347519|NCT00477984|Ethanol|ethanol|mesh-list
2347520|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2347521|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347522|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2347523|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347524|NCT00477997|Hormones|hormones|mesh-list
2347525|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347526|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347527|NCT00478049|Docetaxel|docetaxel|mesh-list
2939378|NCT04703036|Glycine|glycine|mesh-list
2939379|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
2939380|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2939381|NCT04703036|Expectorants|expectorants|mesh-ancestor
2939382|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
2939383|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2939384|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
2939385|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939386|NCT04703036|Protective Agents|protective agents|mesh-ancestor
2347528|NCT00478049|Gefitinib|gefitinib|mesh-list
2347529|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347530|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
2347531|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
2347532|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
2347533|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347534|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2347535|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939387|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939388|NCT04703036|Antidotes|antidotes|mesh-ancestor
2939389|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
2939390|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2939391|NCT04695652|Somatomedin B|somatomedin b|mesh-list
2939392|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2939393|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2939394|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
2939395|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939396|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939397|NCT04669665|Ketamine|ketamine|mesh-list
2347536|NCT00478075|Bortezomib|bortezomib|mesh-list
2347537|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
2347538|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347539|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2347540|NCT00478075|Analgesics|analgesics|mesh-ancestor
2347541|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
2347542|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347543|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347544|NCT00478101|Fentanyl|fentanyl|mesh-list
2347545|NCT00478101|Oxycodone|oxycodone|mesh-list
2347546|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2347547|NCT00478101|Narcotics|narcotics|mesh-ancestor
2939398|NCT04669665|Analgesics|analgesics|mesh-ancestor
2939399|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
2939400|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2939401|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939402|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2939403|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2939404|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
2939405|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
2939406|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2939407|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2939408|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2939409|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2939410|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939411|NCT04662710|Leucovorin|leucovorin|mesh-list
2939412|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
2939413|NCT04662710|Capecitabine|capecitabine|mesh-list
2939414|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
2939415|NCT04662710|Lenvatinib|lenvatinib|mesh-list
2939416|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
2939417|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939418|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939419|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2939420|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
2347548|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2347549|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347550|NCT00478101|Analgesics|analgesics|mesh-ancestor
2347551|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
2347552|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347553|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2347554|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2347555|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
2347556|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
2347557|NCT00478114|Sorafenib|sorafenib|mesh-list
2347558|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347559|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2347560|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347561|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347562|NCT00478179|Bupivacaine|bupivacaine|mesh-list
2347563|NCT00478179|Anesthetics, Local|anesthetics, local|mesh-ancestor
2347564|NCT00478179|Anesthetics|anesthetics|mesh-ancestor
2347565|NCT00478179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2939421|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939422|NCT04662710|Antidotes|antidotes|mesh-ancestor
2939423|NCT04662710|Protective Agents|protective agents|mesh-ancestor
2939424|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939425|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
2347566|NCT00478179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347567|NCT00478179|Sensory System Agents|sensory system agents|mesh-ancestor
2347568|NCT00478179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2939426|NCT04662710|Vitamins|vitamins|mesh-ancestor
2939427|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
2939428|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2939429|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939430|NCT04650581|Fulvestrant|fulvestrant|mesh-list
2939431|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2939432|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939433|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2939434|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2939435|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
2939436|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2939437|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939438|NCT04647084|Lidocaine|lidocaine|mesh-list
2939439|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
2939440|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
2939441|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2939442|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939443|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
2939444|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2939445|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2939446|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2939447|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2939448|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2939449|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939462|NCT04632927|Ustekinumab|ustekinumab|mesh-list
2939463|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
2939464|NCT04628767|Gemcitabine|gemcitabine|mesh-list
2939465|NCT04628767|Cisplatin|cisplatin|mesh-list
2111978|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
2111979|NCT02562924|Hormones|hormones|mesh-ancestor
2111980|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2111981|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111982|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2111983|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2111984|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2111985|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
2111986|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2939466|NCT04628767|Doxorubicin|doxorubicin|mesh-list
2939467|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2939468|NCT04628767|Methotrexate|methotrexate|mesh-list
2939469|NCT04628767|Durvalumab|durvalumab|mesh-list
2939470|NCT04628767|Vinblastine|vinblastine|mesh-list
2939471|NCT04628767|Lenograstim|lenograstim|mesh-list
2939472|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
2939473|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2939474|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
2939475|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939476|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2939477|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
2939478|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939479|NCT04628767|Antiviral Agents|antiviral agents|mesh-ancestor
2939480|NCT04628767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2939481|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939482|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2939483|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
2939484|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939485|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2939486|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2939487|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2939488|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2939489|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
2939490|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2939491|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
2939492|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2939493|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2939494|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2939495|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2939496|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2347569|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
2347570|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2347571|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347572|NCT00478374|Doxorubicin|doxorubicin|mesh-list
2347573|NCT00478374|Sorafenib|sorafenib|mesh-list
2347574|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2347575|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939497|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2939498|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
2939499|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
2939500|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
2939501|NCT04620798|Antibodies|antibodies|mesh-list
2939502|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
2939503|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939504|NCT04609046|Rituximab|rituximab|mesh-list
2939505|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2939506|NCT04609046|Nivolumab|nivolumab|mesh-list
2939507|NCT04609046|Methotrexate|methotrexate|mesh-list
2939508|NCT04609046|Lenalidomide|lenalidomide|mesh-list
2939509|NCT04609046|Antibodies|antibodies|mesh-list
2347576|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2347577|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2347578|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347579|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347580|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2939510|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
2939511|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2939512|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
2939513|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939514|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939515|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2939516|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2939517|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
2939518|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2939519|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2939520|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
2939521|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939522|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
2939523|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939524|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2939525|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2939526|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2939527|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2939528|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2347581|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
2347582|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2347583|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
2347584|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347585|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2347586|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2347587|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
2347588|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939529|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2939530|NCT04609046|Growth Substances|growth substances|mesh-ancestor
2939531|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
2939532|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
2939533|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
2939534|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939535|NCT04603898|Protective Agents|protective agents|mesh-ancestor
2939536|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939537|NCT04603898|Vitamins|vitamins|mesh-ancestor
2939538|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
2939539|NCT04598477|Prednisone|prednisone|mesh-list
2939540|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2939541|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
2939542|NCT04598477|Hormones|hormones|mesh-ancestor
2939543|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2939544|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939545|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2939546|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939547|NCT04598451|Prednisone|prednisone|mesh-list
2939548|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2939549|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
2939550|NCT04598451|Hormones|hormones|mesh-ancestor
2939551|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2939552|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939553|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2939554|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939555|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2939556|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939557|NCT04583956|Remdesivir|remdesivir|mesh-list
2939558|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
2939559|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939560|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
2939561|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2939562|NCT04582383|Doxycycline|doxycycline|mesh-list
2939563|NCT04582383|Spironolactone|spironolactone|mesh-list
2939564|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2939565|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2939566|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
2939567|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2939568|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2347589|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347590|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2347591|NCT00478465|Valganciclovir|valganciclovir|mesh-list
2347592|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
2347593|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347594|NCT00478504|Letrozole|letrozole|mesh-list
2347595|NCT00478504|Clomiphene|clomiphene|mesh-list
2347596|NCT00478504|Enclomiphene|enclomiphene|mesh-list
2347597|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
2347598|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347599|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347600|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2347601|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2347602|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939569|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2939570|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
2939571|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2939572|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939573|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2939574|NCT04582383|Diuretics|diuretics|mesh-ancestor
2939575|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
2347603|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2347604|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
2347605|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347606|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347607|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2347608|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
2347609|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2347610|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2347611|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2347612|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
2347613|NCT00478517|Hematinics|hematinics|mesh-ancestor
2347614|NCT00478543|Furosemide|furosemide|mesh-list
2347615|NCT00478543|Diuretics|diuretics|mesh-ancestor
2347616|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
2347617|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347618|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2347619|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2347620|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347621|NCT00478595|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2347622|NCT00478595|Rimonabant|rimonabant|mesh-list
2347623|NCT00478595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2347624|NCT00478595|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2347625|NCT00478595|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2347626|NCT00478595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347627|NCT00478595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347628|NCT00478595|Hormones|hormones|mesh-ancestor
2347629|NCT00478595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347630|NCT00478595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347631|NCT00478621|Vaccines|vaccines|mesh-list
2347632|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
2347633|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347634|NCT00478634|Irinotecan|irinotecan|mesh-list
2347635|NCT00478634|Cetuximab|cetuximab|mesh-list
2347636|NCT00478634|Everolimus|everolimus|mesh-list
2347637|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2347638|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2347639|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347640|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347641|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347642|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2347643|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2347644|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
2347645|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347646|NCT00478660|Adalimumab|adalimumab|mesh-list
2347647|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2347648|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2347649|NCT00478699|Gemcitabine|gemcitabine|mesh-list
2347650|NCT00478699|Cisplatin|cisplatin|mesh-list
2347651|NCT00478699|Docetaxel|docetaxel|mesh-list
2347652|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347653|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2347654|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
2347655|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347656|NCT00478699|Antiviral Agents|antiviral agents|mesh-ancestor
2347657|NCT00478699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347658|NCT00478699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347659|NCT00478699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2347660|NCT00478699|Immunologic Factors|immunologic factors|mesh-ancestor
2347661|NCT00478699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939595|NCT04576078|Nefopam|nefopam|mesh-list
2939596|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2939597|NCT04576078|Analgesics|analgesics|mesh-ancestor
2939598|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
2939599|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2939600|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347662|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
2347663|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
2347664|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
2347665|NCT00478764|Triamcinolone|triamcinolone|mesh-list
2939612|NCT04557449|Letrozole|letrozole|mesh-list
2939613|NCT04557449|Fulvestrant|fulvestrant|mesh-list
2939614|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939615|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2939616|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2939617|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347666|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2347667|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
2347668|NCT00478764|Hormones|hormones|mesh-ancestor
2347669|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347670|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347671|NCT00478816|Vaccines|vaccines|mesh-list
2347672|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
2939618|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939619|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2347673|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347674|NCT00478855|Piperacillin|piperacillin|mesh-list
2347675|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2347676|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2347677|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347678|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2347679|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347680|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347681|NCT00478907|Ketamine|ketamine|mesh-list
2347682|NCT00478907|Thiopental|thiopental|mesh-list
2347683|NCT00478907|Propofol|propofol|mesh-list
2347684|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2347685|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2347686|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347687|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2347688|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
2347689|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
2347690|NCT00478907|Analgesics|analgesics|mesh-ancestor
2347691|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
2347692|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347693|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2347694|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2347695|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2347696|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347697|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347698|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
2347699|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
2347700|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
2347701|NCT00478946|Leucovorin|leucovorin|mesh-list
2347702|NCT00478946|Antidotes|antidotes|mesh-ancestor
2347703|NCT00478946|Protective Agents|protective agents|mesh-ancestor
2347704|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347705|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
2347706|NCT00478946|Vitamins|vitamins|mesh-ancestor
2347707|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
2347708|NCT00478959|Lenalidomide|lenalidomide|mesh-list
2347709|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
2347710|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347711|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2347712|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2347713|NCT00478959|Growth Substances|growth substances|mesh-ancestor
2347714|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
2347715|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347716|NCT00478972|Rimonabant|rimonabant|mesh-list
2347717|NCT00478972|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2347718|NCT00478972|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2347719|NCT00478972|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2347720|NCT00478972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347721|NCT00478972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347722|NCT00478972|Hormones|hormones|mesh-ancestor
2347723|NCT00478972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347724|NCT00478972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347725|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
2347726|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347727|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2347728|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347729|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939620|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
2939621|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2939622|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939623|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2939624|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2939625|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
2939626|NCT04548752|Olaparib|olaparib|mesh-list
2939627|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2939628|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939629|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939630|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939631|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939632|NCT04530409|Dexamethasone|dexamethasone|mesh-list
2939633|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
2939634|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2939635|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
2939636|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
2347730|NCT00478998|Tamsulosin|tamsulosin|mesh-list
2939637|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2939638|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939639|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2939640|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
2939641|NCT04530409|Hormones|hormones|mesh-ancestor
2939642|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2939643|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2939644|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939645|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2939646|NCT04530409|Protective Agents|protective agents|mesh-ancestor
2939647|NCT04521231|Blinatumomab|blinatumomab|mesh-list
2939648|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939649|NCT04520217|Imipramine|imipramine|mesh-list
2939650|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2939651|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
2939652|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2939653|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2939654|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2939655|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2939656|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939657|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
2939658|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2939659|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939660|NCT04514484|Nivolumab|nivolumab|mesh-list
2939661|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939662|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939663|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2939664|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347731|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2347732|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2347733|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2347734|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
2347735|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347736|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347737|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347738|NCT00478998|Urological Agents|urological agents|mesh-ancestor
2347739|NCT00479076|Aflibercept|aflibercept|mesh-list
2347740|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2347741|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2347742|NCT00479076|Growth Substances|growth substances|mesh-ancestor
2347743|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347744|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
2347745|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347746|NCT00479128|Gemcitabine|gemcitabine|mesh-list
2347747|NCT00479128|Doxorubicin|doxorubicin|mesh-list
2939665|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
2939666|NCT04505774|Empagliflozin|empagliflozin|mesh-list
2939667|NCT04505774|Canagliflozin|canagliflozin|mesh-list
2939668|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
2939669|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2939670|NCT04505774|Heparin|heparin|mesh-list
2939671|NCT04505774|Calcium heparin|calcium heparin|mesh-list
2939672|NCT04505774|Enoxaparin|enoxaparin|mesh-list
2939673|NCT04505774|Dalteparin|dalteparin|mesh-list
2939674|NCT04505774|Tinzaparin|tinzaparin|mesh-list
2939675|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2347748|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2347749|NCT00479128|Bortezomib|bortezomib|mesh-list
2347750|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2347751|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
2347752|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347753|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347754|NCT00479128|Antiviral Agents|antiviral agents|mesh-ancestor
2347755|NCT00479128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347756|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347757|NCT00479128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2347758|NCT00479128|Immunologic Factors|immunologic factors|mesh-ancestor
2347759|NCT00479128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347760|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2347761|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2347762|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2347763|NCT00479193|Bacitracin|bacitracin|mesh-list
2347764|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2939676|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
2939677|NCT04505774|Clopidogrel|clopidogrel|mesh-list
2939678|NCT04505774|Ticagrelor|ticagrelor|mesh-list
2347765|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347766|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2347767|NCT00479206|Artesunate|artesunate|mesh-list
2347768|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
2347769|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2347770|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2939679|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2939680|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2939681|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2939682|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2939683|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
2939684|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2939685|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939686|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939687|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
2939688|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2939689|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2939690|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2939691|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2939692|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2939693|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2939694|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2939695|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939696|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2939697|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939698|NCT04504812|Analgesics|analgesics|mesh-ancestor
2939699|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
2939700|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2939701|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
2939702|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2939703|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
2939704|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
2939705|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2939706|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2939707|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939708|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
2939709|NCT04489108|Coagulants|coagulants|mesh-ancestor
2939710|NCT04480554|Naltrexone|naltrexone|mesh-list
2939711|NCT04480554|Buprenorphine|buprenorphine|mesh-list
2939712|NCT04480554|Methadone|methadone|mesh-list
2939713|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2939714|NCT04480554|Naloxone|naloxone|mesh-list
2939715|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2939716|NCT04480554|Narcotics|narcotics|mesh-ancestor
2347771|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347772|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347773|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
2347774|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
2347775|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2347776|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
2347777|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2347778|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
2347779|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347780|NCT00479362|Aspirin|aspirin|mesh-list
2347781|NCT00479362|Warfarin|warfarin|mesh-list
2939717|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2939718|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939719|NCT04480554|Analgesics|analgesics|mesh-ancestor
2939720|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
2939721|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2939722|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2939723|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2939724|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
2939725|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
2939726|NCT04471675|Docetaxel|docetaxel|mesh-list
2939727|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939728|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
2939729|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
2939730|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
2939731|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939732|NCT04460560|Terlipressin|terlipressin|mesh-list
2939733|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2939734|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2939735|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
2347782|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2347783|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2939736|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
2939737|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2939738|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939739|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939740|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2939741|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
2939742|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2939743|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
2939744|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2939745|NCT04453839|Protective Agents|protective agents|mesh-ancestor
2939746|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347784|NCT00479362|Analgesics|analgesics|mesh-ancestor
2347785|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
2347786|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347787|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347788|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2347789|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2347790|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2347791|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2347792|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347793|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2347794|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2347795|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347796|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
2347797|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
2347798|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
2347799|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
2347800|NCT00479479|Vitamins|vitamins|mesh-ancestor
2347801|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
2347802|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347803|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
2347804|NCT00479479|Hematinics|hematinics|mesh-ancestor
2347805|NCT00479609|Testosterone|testosterone|mesh-list
2347806|NCT00479609|Androgens|androgens|mesh-ancestor
2347807|NCT00479609|Hormones|hormones|mesh-ancestor
2347808|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347809|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347810|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
2347811|NCT00479661|Propofol|propofol|mesh-list
2347812|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2347813|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2939759|NCT04439513|Hemostatics|hemostatics|mesh-list
2939760|NCT04439513|Coagulants|coagulants|mesh-ancestor
2939761|NCT04431375|Tenofovir|tenofovir|mesh-list
2939762|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
2939763|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2939764|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2939765|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2939766|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939767|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939768|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2939769|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2939770|NCT04428151|Paclitaxel|paclitaxel|mesh-list
2939771|NCT04428151|Docetaxel|docetaxel|mesh-list
2939772|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
2939773|NCT04428151|Capecitabine|capecitabine|mesh-list
2939774|NCT04428151|Cetuximab|cetuximab|mesh-list
2347814|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347815|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2347816|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
2347817|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
2347818|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2347819|NCT00479661|Analgesics|analgesics|mesh-ancestor
2939775|NCT04428151|Lenvatinib|lenvatinib|mesh-list
2939776|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2939777|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939778|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
2939779|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
2939780|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
2939781|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939782|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939783|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2939784|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
2347820|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
2347821|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347822|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2347823|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2347824|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2347825|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
2347826|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347827|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347828|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2347829|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2347830|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2347831|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2347832|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347833|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347834|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347835|NCT00479726|Analgesics|analgesics|mesh-ancestor
2347836|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
2347837|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347838|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
2347839|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2347840|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
2347841|NCT00479739|Fluticasone|fluticasone|mesh-list
2347842|NCT00479739|Xhance|xhance|mesh-list
2347843|NCT00479739|Budesonide|budesonide|mesh-list
2347844|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
2939785|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2939786|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939787|NCT04426825|Bevacizumab|bevacizumab|mesh-list
2939788|NCT04426825|Atezolizumab|atezolizumab|mesh-list
2939789|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939790|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939791|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2939792|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2939793|NCT04426825|Growth Substances|growth substances|mesh-ancestor
2939794|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939795|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
2939796|NCT04410913|Psilocybin|psilocybin|mesh-list
2939797|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
2939798|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939799|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2939800|NCT04402788|Atezolizumab|atezolizumab|mesh-list
2939801|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2939802|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939803|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
2939804|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939805|NCT04401748|Azacitidine|azacitidine|mesh-list
2939806|NCT04401748|Venetoclax|venetoclax|mesh-list
2939807|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2939808|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
2939809|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939810|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939811|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939812|NCT04396860|Nivolumab|nivolumab|mesh-list
2939813|NCT04396860|Ipilimumab|ipilimumab|mesh-list
2939814|NCT04396860|Temozolomide|temozolomide|mesh-list
2939815|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939816|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939817|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2939818|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347845|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2347846|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2347847|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2347848|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
2347849|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347850|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347851|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2347852|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
2347853|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
2939819|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2939820|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
2939821|NCT04394858|Temozolomide|temozolomide|mesh-list
2939822|NCT04394858|Olaparib|olaparib|mesh-list
2939823|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2939824|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2939825|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
2939826|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347854|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2347855|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
2347856|NCT00479739|Hormones|hormones|mesh-ancestor
2347857|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347858|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2347859|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2347860|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2347861|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
2347862|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347863|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939827|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939828|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939829|NCT04382664|Nivolumab|nivolumab|mesh-list
2939830|NCT04382664|Ipilimumab|ipilimumab|mesh-list
2939831|NCT04382664|Sargramostim|sargramostim|mesh-list
2939832|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939833|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939834|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2939835|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939836|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
2939837|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939852|NCT04369664|Atorvastatin|atorvastatin|mesh-list
2939853|NCT04369664|Ezetimibe|ezetimibe|mesh-list
2939854|NCT04369664|Evolocumab|evolocumab|mesh-list
2939855|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2939856|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2939857|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
2939858|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939859|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2939860|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2939861|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939862|NCT04345367|Abrocitinib|abrocitinib|mesh-list
2939863|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2939864|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939865|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939866|NCT04340843|Decitabine|decitabine|mesh-list
2939867|NCT04340843|Azacitidine|azacitidine|mesh-list
2939868|NCT04340843|Belinostat|belinostat|mesh-list
2939869|NCT04340843|Guadecitabine|guadecitabine|mesh-list
2939870|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2939871|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
2939872|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939873|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939874|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939875|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2939881|NCT04334941|Atezolizumab|atezolizumab|mesh-list
2939882|NCT04334941|Talazoparib|talazoparib|mesh-list
2939883|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2939884|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939885|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
2939886|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939887|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2939888|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939889|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939890|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
2939891|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
2939892|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2939893|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2939894|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939895|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2939896|NCT04315038|Anesthetics|anesthetics|mesh-list
2939897|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2939898|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939899|NCT04311411|Liraglutide|liraglutide|mesh-list
2939900|NCT04311411|Tirzepatide|tirzepatide|mesh-list
2939901|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2939902|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939903|NCT04311411|Incretins|incretins|mesh-ancestor
2939904|NCT04311411|Hormones|hormones|mesh-ancestor
2939905|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347864|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
2347865|NCT00479752|Cetuximab|cetuximab|mesh-list
2939931|NCT04304144|Dexamethasone|dexamethasone|mesh-list
2939932|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
2939933|NCT04304144|Bortezomib|bortezomib|mesh-list
2939934|NCT04304144|Daratumumab|daratumumab|mesh-list
2939935|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2939936|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
2939937|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347866|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347867|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2347868|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
2347869|NCT00479778|Estrogens|estrogens|mesh-list
2347870|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2347871|NCT00479778|Hormones|hormones|mesh-ancestor
2347872|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347873|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347874|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2347875|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2347876|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
2347877|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2939938|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2939939|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2939940|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
2939941|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939942|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939943|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2939944|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2939945|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
2939946|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
2347878|NCT00479817|Paclitaxel|paclitaxel|mesh-list
2347879|NCT00479817|Trebananib|trebananib|mesh-list
2347880|NCT00479817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2347881|NCT00479817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347882|NCT00479817|Tubulin Modulators|tubulin modulators|mesh-ancestor
2347883|NCT00479817|Antimitotic Agents|antimitotic agents|mesh-ancestor
2347884|NCT00479817|Mitosis Modulators|mitosis modulators|mesh-ancestor
2347885|NCT00479817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347886|NCT00479817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2347887|NCT00479817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2347888|NCT00479817|Growth Substances|growth substances|mesh-ancestor
2347889|NCT00479817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347890|NCT00479817|Growth Inhibitors|growth inhibitors|mesh-ancestor
2347891|NCT00479895|HBOC 201|hboc 201|mesh-list
2347892|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
2347893|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
2347894|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
2347895|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347896|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
2347897|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2347898|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2347899|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347900|NCT00479908|Urological Agents|urological agents|mesh-ancestor
2347901|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
2347902|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939947|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2939948|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2939949|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
2939950|NCT04304144|Hormones|hormones|mesh-ancestor
2939951|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2939952|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2939953|NCT04269902|Venetoclax|venetoclax|mesh-list
2939954|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
2939955|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939956|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939957|NCT04267848|Gemcitabine|gemcitabine|mesh-list
2939958|NCT04267848|Paclitaxel|paclitaxel|mesh-list
2347903|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2347904|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2347905|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347906|NCT00479986|Pioglitazone|pioglitazone|mesh-list
2347907|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2347908|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347909|NCT00480064|Cytarabine|cytarabine|mesh-list
2347910|NCT00480064|Lomustine|lomustine|mesh-list
2347911|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2939959|NCT04267848|Cisplatin|cisplatin|mesh-list
2939960|NCT04267848|Carboplatin|carboplatin|mesh-list
2939961|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
2939962|NCT04267848|Pemetrexed|pemetrexed|mesh-list
2347912|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
2347913|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347914|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347915|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
2347916|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347917|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2347918|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
2347919|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347920|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2347921|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
2347922|NCT00480090|Cytarabine|cytarabine|mesh-list
2347923|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2347924|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
2347925|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347926|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347927|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
2347928|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2347929|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2347930|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
2347931|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347932|NCT00480103|Mineral Oil|mineral oil|mesh-list
2347933|NCT00480103|Emollients|emollients|mesh-ancestor
2347934|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
2347935|NCT00480116|Vaccines|vaccines|mesh-list
2347936|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
2347937|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347938|NCT00480142|Oxycodone|oxycodone|mesh-list
2347939|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2347940|NCT00480142|Narcotics|narcotics|mesh-ancestor
2347941|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2347942|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939963|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2939964|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2939965|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939966|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
2939967|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
2939968|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
2939969|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939970|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2939971|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
2347943|NCT00480142|Analgesics|analgesics|mesh-ancestor
2347944|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
2347945|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347946|NCT00480181|Nabilone|nabilone|mesh-list
2347947|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
2939972|NCT04267848|Antiviral Agents|antiviral agents|mesh-ancestor
2939973|NCT04267848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2939974|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939975|NCT04267848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2939976|NCT04267848|Immunologic Factors|immunologic factors|mesh-ancestor
2939977|NCT04267848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939978|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939979|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2939980|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2939981|NCT04256629|Allopurinol|allopurinol|mesh-list
2939982|NCT04256629|Verinurad|verinurad|mesh-list
2939983|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
2939984|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939985|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939986|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
2939987|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2939988|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2939989|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
2939990|NCT04256629|Protective Agents|protective agents|mesh-ancestor
2939991|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2939992|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
2939993|NCT04246177|Lenvatinib|lenvatinib|mesh-list
2939994|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2939995|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2939996|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2939997|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2939998|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2939999|NCT04236414|Olaparib|olaparib|mesh-list
2940000|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2940001|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940002|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940003|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940004|NCT04231084|Epoprostenol|epoprostenol|mesh-list
2940005|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
2940006|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
2347948|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
2347949|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347950|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347951|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2347952|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2347953|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2347954|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2347955|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2347956|NCT00480194|Xylometazoline|xylometazoline|mesh-list
2347957|NCT00480194|Bromides|bromides|mesh-list
2347958|NCT00480194|Ipratropium|ipratropium|mesh-list
2347959|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
2347960|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2347961|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
2347962|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347963|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347964|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2347965|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
2940007|NCT04231084|Tezosentan|tezosentan|mesh-list
2940008|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2940009|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
2347966|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2940010|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2347967|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
2940011|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940012|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2940013|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
2940014|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2940015|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
2940016|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940017|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2940018|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2940019|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
2940020|NCT04231084|Protective Agents|protective agents|mesh-ancestor
2940021|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2940022|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2940023|NCT04224545|Colchicine|colchicine|mesh-list
2940024|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
2940025|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2940026|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
2940027|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
2940028|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
2940029|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940030|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347968|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2347969|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347970|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
2347971|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2347972|NCT00480207|Folic Acid|folic acid|mesh-list
2347973|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
2347974|NCT00480207|Hematinics|hematinics|mesh-ancestor
2347975|NCT00480207|Vitamins|vitamins|mesh-ancestor
2347976|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
2347977|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347978|NCT00480246|Perphenazine|perphenazine|mesh-list
2347979|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2347980|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2347981|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2347982|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347983|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2347984|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2347985|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
2347986|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2940071|NCT04214262|Atezolizumab|atezolizumab|mesh-list
2940072|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2940073|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940074|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
2940075|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940076|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
2940077|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940078|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940079|NCT04206319|Listerine|listerine|mesh-list
2940080|NCT04206319|Fluorides|fluorides|mesh-list
2940081|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
2940082|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
2940083|NCT04206319|Protective Agents|protective agents|mesh-ancestor
2940084|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940085|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2940086|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2940087|NCT04186494|Liraglutide|liraglutide|mesh-list
2940088|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2940089|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940090|NCT04186494|Incretins|incretins|mesh-ancestor
2940091|NCT04186494|Hormones|hormones|mesh-ancestor
2940092|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2940093|NCT04181060|Bevacizumab|bevacizumab|mesh-list
2940094|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2940095|NCT04181060|Osimertinib|osimertinib|mesh-list
2940096|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
2347987|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2347988|NCT00480272|Prednisone|prednisone|mesh-list
2347989|NCT00480272|Adalimumab|adalimumab|mesh-list
2347990|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2347991|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
2347992|NCT00480272|Hormones|hormones|mesh-ancestor
2940097|NCT04181060|Antibodies|antibodies|mesh-list
2940098|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
2940099|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2940100|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
2940101|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940102|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2940103|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2940104|NCT04181060|Growth Substances|growth substances|mesh-ancestor
2940105|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940106|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
2940107|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
2940108|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940109|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2940110|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940111|NCT04180995|Axitinib|axitinib|mesh-list
2940112|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940113|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2940114|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940115|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940116|NCT04175912|Paclitaxel|paclitaxel|mesh-list
2940117|NCT04175912|Carboplatin|carboplatin|mesh-list
2940118|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2940119|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2940120|NCT04175912|Pevonedistat|pevonedistat|mesh-list
2940121|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2940122|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347993|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2347994|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2347995|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2347996|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2347997|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2347998|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
2347999|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2348000|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2348001|NCT00480298|Prednisolone|prednisolone|mesh-list
2348002|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
2348003|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2940123|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
2940124|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
2940125|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
2940126|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940127|NCT04165772|Capecitabine|capecitabine|mesh-list
2940128|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2348004|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
2348005|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2348006|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
2348007|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
2348008|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2348009|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348010|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2348011|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
2348012|NCT00480298|Hormones|hormones|mesh-ancestor
2348013|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348014|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2348015|NCT00480298|Protective Agents|protective agents|mesh-ancestor
2348016|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2348017|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348018|NCT00480363|Dexamethasone|dexamethasone|mesh-list
2348019|NCT00480363|Lenalidomide|lenalidomide|mesh-list
2348020|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2348021|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
2348022|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
2348023|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2348024|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348025|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2348026|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
2348027|NCT00480363|Hormones|hormones|mesh-ancestor
2348028|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348029|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2940129|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
2940130|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940131|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940132|NCT04164082|Gemcitabine|gemcitabine|mesh-list
2940133|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
2940134|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2940135|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
2940136|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940137|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940138|NCT04164082|Antiviral Agents|antiviral agents|mesh-ancestor
2940139|NCT04164082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2940140|NCT04164082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940141|NCT04164082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2940142|NCT04164082|Immunologic Factors|immunologic factors|mesh-ancestor
2940143|NCT04164082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940144|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2348030|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348031|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
2348032|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2348033|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2348034|NCT00480363|Growth Substances|growth substances|mesh-ancestor
2348035|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
2348036|NCT00480376|Gentamicins|gentamicins|mesh-list
2940145|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2940146|NCT04163952|Panitumumab|panitumumab|mesh-list
2940147|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2940148|NCT04163952|Antibodies|antibodies|mesh-list
2940149|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
2940150|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2940151|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
2940152|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940153|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940154|NCT04145115|Nivolumab|nivolumab|mesh-list
2940155|NCT04145115|Ipilimumab|ipilimumab|mesh-list
2940156|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940157|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940158|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2940159|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940160|NCT04112199|Terlipressin|terlipressin|mesh-list
2940161|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2940162|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2348037|NCT00480376|Ofloxacin|ofloxacin|mesh-list
2940191|NCT04091867|Cetuximab|cetuximab|mesh-list
2940192|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940193|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940194|NCT04090567|Olaparib|olaparib|mesh-list
2940195|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2940196|NCT04090567|Cediranib|cediranib|mesh-list
2940197|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940198|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940199|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940200|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2940206|NCT04083963|Paclitaxel|paclitaxel|mesh-list
2940207|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
2940208|NCT04083963|Carboplatin|carboplatin|mesh-list
2940209|NCT04083963|Doxorubicin|doxorubicin|mesh-list
2940210|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2940211|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940212|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
2940213|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
2940214|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
2940215|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940216|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2940217|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
2940218|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940219|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2940220|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2348038|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2348039|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348040|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2348041|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348042|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348043|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2348044|NCT00480376|Renal Agents|renal agents|mesh-ancestor
2348045|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2940221|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
2940222|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2940223|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2940224|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2940225|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2940226|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940227|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2348046|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2348047|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348048|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2348049|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2348050|NCT00480389|Sorafenib|sorafenib|mesh-list
2348051|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348052|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2348053|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348054|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348055|NCT00480402|Progesterone|progesterone|mesh-list
2348056|NCT00480402|Progestins|progestins|mesh-ancestor
2348057|NCT00480402|Hormones|hormones|mesh-ancestor
2348058|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348059|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111987|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2111988|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
2111989|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
2111990|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2111991|NCT02563067|Growth Substances|growth substances|mesh-ancestor
2940228|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
2940229|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2940230|NCT04071236|Avelumab|avelumab|mesh-list
2940231|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2940232|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2940233|NCT04071236|Peposertib|peposertib|mesh-list
2940234|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940235|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940236|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
2940237|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940238|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2348060|NCT00480454|Vaccines|vaccines|mesh-list
2348061|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
2348062|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348063|NCT00480558|Vaccines|vaccines|mesh-list
2348064|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
2348065|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348066|NCT00480571|Perphenazine|perphenazine|mesh-list
2348067|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
2348068|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
2348069|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348070|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348071|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940239|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940240|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940241|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2940242|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348072|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2348073|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2348074|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2348075|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2348076|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2348077|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
2348078|NCT00480584|Gemcitabine|gemcitabine|mesh-list
2348079|NCT00480584|Capecitabine|capecitabine|mesh-list
2348080|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2348081|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2348082|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
2348083|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348084|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940246|NCT04028063|Doxorubicin|doxorubicin|mesh-list
2940247|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2940248|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940249|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2940250|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2940251|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940252|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940253|NCT04014075|Trastuzumab|trastuzumab|mesh-list
2940254|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940255|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940256|NCT04003285|Pregnanolone|pregnanolone|mesh-list
2940257|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
2940258|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2940259|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940260|NCT03984448|Prednisone|prednisone|mesh-list
2940261|NCT03984448|Cortisone|cortisone|mesh-list
2940262|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
2111992|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111993|NCT02563093|Vaccines|vaccines|mesh-list
2111994|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
2111995|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2111996|NCT02563496|Chloroquine|chloroquine|mesh-list
2111997|NCT02563496|Tafenoquine|tafenoquine|mesh-list
2111998|NCT02563496|Amebicides|amebicides|mesh-ancestor
2111999|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2940263|NCT03984448|Rituximab|rituximab|mesh-list
2348085|NCT00480584|Antiviral Agents|antiviral agents|mesh-ancestor
2348086|NCT00480584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348087|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348088|NCT00480584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2348089|NCT00480584|Immunologic Factors|immunologic factors|mesh-ancestor
2348090|NCT00480584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348091|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2348092|NCT00480597|Gemcitabine|gemcitabine|mesh-list
2348093|NCT00480597|Capecitabine|capecitabine|mesh-list
2348094|NCT00480597|Vinorelbine|vinorelbine|mesh-list
2348095|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348096|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2348097|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
2348098|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348099|NCT00480597|Antiviral Agents|antiviral agents|mesh-ancestor
2348100|NCT00480597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2940264|NCT03984448|Doxorubicin|doxorubicin|mesh-list
2940265|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2940266|NCT03984448|Etoposide|etoposide|mesh-list
2940267|NCT03984448|Vincristine|vincristine|mesh-list
2940268|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
2940269|NCT03984448|Venetoclax|venetoclax|mesh-list
2940270|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
2940271|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2940272|NCT03984448|Antibodies|antibodies|mesh-list
2940273|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
2940274|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2940275|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2348101|NCT00480597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348102|NCT00480597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2348103|NCT00480597|Immunologic Factors|immunologic factors|mesh-ancestor
2348104|NCT00480597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348105|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2348106|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
2348107|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
2348108|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
2348109|NCT00480610|Tacrolimus|tacrolimus|mesh-list
2348110|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2348111|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
2348112|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940276|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
2940277|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940278|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2940279|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2940280|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
2940281|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940282|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940283|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2940284|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2940285|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2940286|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2940287|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940288|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2940289|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
2940290|NCT03984448|Hormones|hormones|mesh-ancestor
2940291|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2940292|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2940293|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2940294|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
2940295|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
2940296|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
2940297|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
2940298|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
2940299|NCT03965689|Paclitaxel|paclitaxel|mesh-list
2940300|NCT03965689|Carboplatin|carboplatin|mesh-list
2940301|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2940302|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2940303|NCT03965689|Pevonedistat|pevonedistat|mesh-list
2940304|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2940305|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940306|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
2940307|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
2940308|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
2348113|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2348114|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372168|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2940309|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940310|NCT03952585|Cisplatin|cisplatin|mesh-list
2940311|NCT03952585|Nivolumab|nivolumab|mesh-list
2940312|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348115|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348116|NCT00480623|Satraplatin|satraplatin|mesh-list
2348117|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348118|NCT00480649|Fluticasone|fluticasone|mesh-list
2348119|NCT00480649|Xhance|xhance|mesh-list
2348120|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2348121|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2348122|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2348123|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
2348124|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2940313|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940314|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2940315|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940331|NCT03936270|Letrozole|letrozole|mesh-list
2940332|NCT03936270|Palbociclib|palbociclib|mesh-list
2940333|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940334|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2940335|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2940336|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940337|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940338|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2940339|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
2940340|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2940341|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940342|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2940343|NCT03932162|Insulin|insulin|mesh-list
2940344|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2940345|NCT03932162|Mitogens|mitogens|mesh-list
2940346|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2940347|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940348|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
2940349|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940350|NCT03925532|Denosumab|denosumab|mesh-list
2940351|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2940352|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940353|NCT03914612|Paclitaxel|paclitaxel|mesh-list
2348125|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348126|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2348127|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
2348128|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
2348129|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2348130|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2348131|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2348132|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2348133|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
2348134|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348135|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348136|NCT00480662|Alendronate|alendronate|mesh-list
2348137|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2348138|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348139|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2348140|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
2348141|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2940354|NCT03914612|Carboplatin|carboplatin|mesh-list
2940355|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
2348142|NCT00480675|Prednisolone|prednisolone|mesh-list
2940356|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2940357|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2348143|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
2348144|NCT00480675|Bupivacaine|bupivacaine|mesh-list
2348145|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2348146|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
2348147|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
2348148|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
2348149|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2348150|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940358|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940359|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
2940360|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
2940361|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
2940362|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940363|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940364|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2940365|NCT03907488|Nivolumab|nivolumab|mesh-list
2940366|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2940367|NCT03907488|Doxorubicin|doxorubicin|mesh-list
2940368|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2940369|NCT03907488|Dacarbazine|dacarbazine|mesh-list
2348151|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
2348152|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2348153|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2348154|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
2348155|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
2940370|NCT03907488|Vinblastine|vinblastine|mesh-list
2940371|NCT03907488|Antibodies|antibodies|mesh-list
2940372|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
2940373|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2940374|NCT03907488|Lenograstim|lenograstim|mesh-list
2940375|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
2940376|NCT03907488|Imidazole|imidazole|mesh-list
2940377|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
2940378|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940379|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940380|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2940381|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2940382|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2940383|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348156|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2348157|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
2348158|NCT00480675|Hormones|hormones|mesh-ancestor
2348159|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348160|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2348161|NCT00480675|Protective Agents|protective agents|mesh-ancestor
2348162|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2348163|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348164|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
2348165|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
2348166|NCT00480805|Losartan|losartan|mesh-list
2348167|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2348168|NCT00480805|Ramipril|ramipril|mesh-list
2348169|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2348170|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2940384|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940385|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2940386|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2940387|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2940388|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
2940389|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2940390|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
2940391|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
2940392|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
2940393|NCT03906071|Docetaxel|docetaxel|mesh-list
2940394|NCT03906071|Nivolumab|nivolumab|mesh-list
2940395|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940396|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
2940397|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
2348171|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2348172|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2348173|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940398|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
2940399|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940400|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940401|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2348174|NCT00480805|Diuretics|diuretics|mesh-ancestor
2348175|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
2348176|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348177|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2348178|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2348179|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2348180|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
2348181|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348182|NCT00480831|Paclitaxel|paclitaxel|mesh-list
2348183|NCT00480831|Bevacizumab|bevacizumab|mesh-list
2348184|NCT00480831|Carboplatin|carboplatin|mesh-list
2348185|NCT00480831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2348186|NCT00480831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348187|NCT00480831|Tubulin Modulators|tubulin modulators|mesh-ancestor
2348188|NCT00480831|Antimitotic Agents|antimitotic agents|mesh-ancestor
2348189|NCT00480831|Mitosis Modulators|mitosis modulators|mesh-ancestor
2348190|NCT00480831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940410|NCT03866382|Nivolumab|nivolumab|mesh-list
2940411|NCT03866382|Ipilimumab|ipilimumab|mesh-list
2940412|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940413|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940414|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2940415|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940416|NCT03840837|Rivastigmine|rivastigmine|mesh-list
2940417|NCT03840837|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2940418|NCT03840837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940419|NCT03840837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940420|NCT03840837|Cholinergic Agents|cholinergic agents|mesh-ancestor
2940421|NCT03840837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2940422|NCT03840837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940423|NCT03840837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2940424|NCT03840837|Protective Agents|protective agents|mesh-ancestor
2940451|NCT03793179|Carboplatin|carboplatin|mesh-list
2940452|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
2348191|NCT00480831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2348192|NCT00480831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2348193|NCT00480831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2348194|NCT00480831|Growth Substances|growth substances|mesh-ancestor
2348195|NCT00480831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940453|NCT03793179|Pemetrexed|pemetrexed|mesh-list
2940454|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940455|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2348196|NCT00480831|Growth Inhibitors|growth inhibitors|mesh-ancestor
2348197|NCT00480844|Risperidone|risperidone|mesh-list
2348198|NCT00480844|Sertindole|sertindole|mesh-list
2348199|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2348200|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
2348201|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348202|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348203|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348204|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2348205|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2940456|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940457|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940458|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2940459|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2348206|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2348207|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2348208|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2348209|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
2348210|NCT00480870|Donepezil|donepezil|mesh-list
2348211|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2348212|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348213|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348214|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
2348215|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348216|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348217|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
2940466|NCT03790111|Gemcitabine|gemcitabine|mesh-list
2940467|NCT03790111|Cisplatin|cisplatin|mesh-list
2940468|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940469|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2940470|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
2940471|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940472|NCT03790111|Antiviral Agents|antiviral agents|mesh-ancestor
2940473|NCT03790111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348218|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2348219|NCT00480883|Allopurinol|allopurinol|mesh-list
2348220|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
2348221|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348222|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348223|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
2348224|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2348225|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2348226|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
2348227|NCT00480883|Protective Agents|protective agents|mesh-ancestor
2348228|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348229|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2348230|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2348231|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348232|NCT00480896|Tacrolimus|tacrolimus|mesh-list
2348233|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2348234|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
2348235|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348236|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2348237|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348238|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348239|NCT00480935|Sunitinib|sunitinib|mesh-list
2348240|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348241|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2348242|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2348243|NCT00480935|Growth Substances|growth substances|mesh-ancestor
2348244|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348245|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
2940474|NCT03790111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940475|NCT03790111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2940476|NCT03790111|Immunologic Factors|immunologic factors|mesh-ancestor
2940477|NCT03790111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348246|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2348247|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348248|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940478|NCT03789240|Rituximab|rituximab|mesh-list
2940479|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940480|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940481|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
2940482|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940483|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2940484|NCT03786081|Bevacizumab|bevacizumab|mesh-list
2940485|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
2940486|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
2940487|NCT03786081|Carboplatin|carboplatin|mesh-list
2940488|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940489|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940490|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2940491|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2940492|NCT03786081|Growth Substances|growth substances|mesh-ancestor
2940493|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940494|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
2940495|NCT03771586|Ketamine|ketamine|mesh-list
2940496|NCT03771586|Analgesics|analgesics|mesh-ancestor
2940497|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
2940498|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2940499|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940500|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2940501|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2940502|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
2940503|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
2940504|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2940505|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2940506|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2940507|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2940508|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940509|NCT03769181|Cemiplimab|cemiplimab|mesh-list
2940510|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940511|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940512|NCT03767582|Nivolumab|nivolumab|mesh-list
2348249|NCT00481013|Valproic Acid|valproic acid|mesh-list
2348250|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
2348251|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348252|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348253|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
2348254|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348255|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348256|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
2348257|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2348258|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2348259|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2348260|NCT00481091|Navitoclax|navitoclax|mesh-list
2348261|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348262|NCT00481143|Deferasirox|deferasirox|mesh-list
2940513|NCT03767582|Vaccines|vaccines|mesh-list
2940514|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
2940515|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348263|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2348264|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
2348265|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
2348266|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348267|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
2348268|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2348269|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2348270|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
2348271|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348272|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348273|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2940516|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940517|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940518|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2940519|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940520|NCT03743662|Bevacizumab|bevacizumab|mesh-list
2940521|NCT03743662|Nivolumab|nivolumab|mesh-list
2940522|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940523|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940524|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2940525|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2940526|NCT03743662|Growth Substances|growth substances|mesh-ancestor
2940527|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940528|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
2940529|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2940530|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940531|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2940532|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2940533|NCT03739814|Blinatumomab|blinatumomab|mesh-list
2940534|NCT03739814|Antibodies|antibodies|mesh-list
2940535|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
2940536|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2940537|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
2940538|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2940539|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
2940540|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940541|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940542|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2940543|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2940552|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
2940553|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940554|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940555|NCT03711058|Nivolumab|nivolumab|mesh-list
2940556|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940557|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940558|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2940559|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940560|NCT03706885|Efavirenz|efavirenz|mesh-list
2940561|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2940562|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2940563|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940564|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940565|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
2940566|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2940567|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2940568|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2940569|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2940570|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2940571|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2940572|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2940576|NCT03671330|Letrozole|letrozole|mesh-list
2940577|NCT03671330|Goserelin|goserelin|mesh-list
2940578|NCT03671330|Anastrozole|anastrozole|mesh-list
2940579|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940580|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2940581|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2940582|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940583|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940584|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2940585|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
2940586|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2940587|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940588|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2940589|NCT03660826|Durvalumab|durvalumab|mesh-list
2940590|NCT03660826|Olaparib|olaparib|mesh-list
2940591|NCT03660826|Cediranib|cediranib|mesh-list
2940592|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2940593|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
2940594|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2940595|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
2940596|NCT03660826|Maleic acid|maleic acid|mesh-list
2940597|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940598|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940599|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
2348274|NCT00481182|Ritonavir|ritonavir|mesh-list
2348275|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
2348276|NCT00481182|Methadone|methadone|mesh-list
2348277|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2348278|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2348279|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
2348280|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348281|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348282|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2348283|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2348284|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
2348285|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348286|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2348287|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2348288|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2348289|NCT00481182|Narcotics|narcotics|mesh-ancestor
2348290|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2348291|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348292|NCT00481182|Analgesics|analgesics|mesh-ancestor
2348293|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
2348294|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2348295|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
2940600|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940601|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940602|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348296|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
2348297|NCT00481273|Azacitidine|azacitidine|mesh-list
2348298|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2348299|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
2348300|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348301|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348302|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348303|NCT00481312|Midazolam|midazolam|mesh-list
2348304|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
2348305|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2348306|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2348307|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348308|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2348309|NCT00481312|Analgesics|analgesics|mesh-ancestor
2348310|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
2348311|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2348312|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2348313|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2348314|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2940603|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2940604|NCT03643744|Celecoxib|celecoxib|mesh-list
2940605|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2940606|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2940607|NCT03643744|Analgesics|analgesics|mesh-ancestor
2940608|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
2348315|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
2348316|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348317|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348318|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2348319|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2348320|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2348321|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2348322|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2348323|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
2348324|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
2348325|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
2348326|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
2348327|NCT00481325|Citalopram|citalopram|mesh-list
2348328|NCT00481325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2348329|NCT00481325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2348330|NCT00481325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2348331|NCT00481325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940609|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2940610|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940611|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2940612|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2940613|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2940614|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2348332|NCT00481325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348333|NCT00481325|Serotonin Agents|serotonin agents|mesh-ancestor
2348334|NCT00481325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348335|NCT00481325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2348336|NCT00481325|Antidepressive Agents|antidepressive agents|mesh-ancestor
2348337|NCT00481325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2348338|NCT00481364|Atorvastatin|atorvastatin|mesh-list
2348339|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2348340|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2348341|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
2348342|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348343|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2940615|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940616|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940617|NCT03604991|Paclitaxel|paclitaxel|mesh-list
2940618|NCT03604991|Carboplatin|carboplatin|mesh-list
2940619|NCT03604991|Nivolumab|nivolumab|mesh-list
2940620|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2940621|NCT03604991|Ipilimumab|ipilimumab|mesh-list
2940622|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2940623|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940624|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
2940625|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
2940626|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
2940627|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940628|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940629|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2348344|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2348345|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348346|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
2348347|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2348348|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348349|NCT00481442|Phenylephrine|phenylephrine|mesh-list
2348350|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
2348351|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2348352|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
2348353|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
2348354|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2348355|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348356|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
2348357|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2940636|NCT03595124|Nivolumab|nivolumab|mesh-list
2940637|NCT03595124|Axitinib|axitinib|mesh-list
2940638|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940639|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940640|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2940641|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940642|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2940643|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940644|NCT03583333|Linezolid|linezolid|mesh-list
2940645|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2940646|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2940647|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2940648|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940649|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940650|NCT03568422|Paclitaxel|paclitaxel|mesh-list
2940651|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2940652|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940653|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
2940654|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
2940655|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
2940656|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940657|NCT03560960|Pramlintide|pramlintide|mesh-list
2940658|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2940659|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940660|NCT03518606|Durvalumab|durvalumab|mesh-list
2940661|NCT03518606|Vinorelbine|vinorelbine|mesh-list
2940662|NCT03518606|Tremelimumab|tremelimumab|mesh-list
2348358|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
2372169|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
2940663|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940664|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940665|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2940666|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
2940667|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
2940668|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
2348359|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
2348360|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2348361|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2348362|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2348363|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
2348364|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348365|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348366|NCT00481442|Protective Agents|protective agents|mesh-ancestor
2348367|NCT00481455|Temozolomide|temozolomide|mesh-list
2348368|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
2348369|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2348370|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
2348371|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348372|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348373|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
2348374|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
2348375|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
2348376|NCT00481481|Tacrolimus|tacrolimus|mesh-list
2348377|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2348378|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
2348379|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348380|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2348381|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348382|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348383|NCT00481533|Oxytocin|oxytocin|mesh-list
2348384|NCT00481533|Ergonovine|ergonovine|mesh-list
2348385|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
2348386|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2348387|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348388|NCT00481572|Terlipressin|terlipressin|mesh-list
2940669|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940670|NCT03504423|Leucovorin|leucovorin|mesh-list
2940671|NCT03504423|Folic Acid|folic acid|mesh-list
2940672|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
2940673|NCT03504423|Irinotecan|irinotecan|mesh-list
2940674|NCT03504423|Folfirinox|folfirinox|mesh-list
2940675|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
2940676|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940677|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2940678|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2940679|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348389|NCT00481572|Vasopressins|vasopressins|mesh-list
2348390|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
2348391|NCT00481572|Norepinephrine|norepinephrine|mesh-list
2348392|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2348393|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2348394|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
2348395|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348396|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348397|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348398|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
2348399|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
2348400|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2348401|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2348402|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
2348403|NCT00481572|Coagulants|coagulants|mesh-ancestor
2348404|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2348405|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
2348406|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2348407|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
2348408|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
2348409|NCT00481624|Hematinics|hematinics|mesh-ancestor
2348410|NCT00481663|Metformin|metformin|mesh-list
2348411|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2348412|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2348413|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348414|NCT00481663|Incretins|incretins|mesh-ancestor
2348415|NCT00481663|Hormones|hormones|mesh-ancestor
2348416|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348417|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2348418|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
2940680|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940681|NCT03504423|Antidotes|antidotes|mesh-ancestor
2348419|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348420|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348421|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
2348422|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2940682|NCT03504423|Protective Agents|protective agents|mesh-ancestor
2940683|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940684|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
2940685|NCT03504423|Vitamins|vitamins|mesh-ancestor
2940686|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
2940687|NCT03504423|Hematinics|hematinics|mesh-ancestor
2940688|NCT03424525|Trimethoprim|trimethoprim|mesh-list
2940689|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2940690|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2940691|NCT03424525|Renal Agents|renal agents|mesh-ancestor
2940692|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
2940693|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2940694|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2940695|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2940696|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940697|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940698|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2940699|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2940700|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2940701|NCT03404960|Nivolumab|nivolumab|mesh-list
2940702|NCT03404960|Ipilimumab|ipilimumab|mesh-list
2940703|NCT03404960|Niraparib|niraparib|mesh-list
2940704|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940705|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940706|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2940707|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940708|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2940709|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940710|NCT03385655|Carboplatin|carboplatin|mesh-list
2940711|NCT03385655|Durvalumab|durvalumab|mesh-list
2940712|NCT03385655|Tremelimumab|tremelimumab|mesh-list
2940713|NCT03385655|Adavosertib|adavosertib|mesh-list
2940714|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940715|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940716|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940717|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940718|NCT03352765|Rituximab|rituximab|mesh-list
2940719|NCT03352765|Melphalan|melphalan|mesh-list
2940720|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2940721|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940722|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940723|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
2940724|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940725|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2940726|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2940727|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
2940728|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940729|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2940730|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2940731|NCT03300544|Leucovorin|leucovorin|mesh-list
2940732|NCT03300544|Fluorouracil|fluorouracil|mesh-list
2940733|NCT03300544|Capecitabine|capecitabine|mesh-list
2940734|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
2940735|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2940736|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
2940737|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940738|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2940739|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940740|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2940741|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
2940742|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348423|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348424|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2348425|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2348426|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348427|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348428|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348429|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2348430|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2348431|NCT00481702|Metronidazole|metronidazole|mesh-list
2940743|NCT03300544|Antidotes|antidotes|mesh-ancestor
2940744|NCT03300544|Protective Agents|protective agents|mesh-ancestor
2348432|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
2348433|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348434|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2348435|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2348436|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2348437|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2348438|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2940745|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
2940746|NCT03300544|Vitamins|vitamins|mesh-ancestor
2940747|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
2940748|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940749|NCT03284853|Latanoprost|latanoprost|mesh-list
2940750|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2940751|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2940752|NCT03269669|Prednisone|prednisone|mesh-list
2940753|NCT03269669|Cortisone|cortisone|mesh-list
2940754|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
2940755|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2940756|NCT03269669|Doxorubicin|doxorubicin|mesh-list
2940757|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2940758|NCT03269669|Vincristine|vincristine|mesh-list
2940759|NCT03269669|Lenalidomide|lenalidomide|mesh-list
2940760|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
2940761|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2940762|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
2940763|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940764|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2940765|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2940766|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
2940767|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940768|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940769|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2940770|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2940771|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2940772|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2940773|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940774|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2940775|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
2940776|NCT03269669|Hormones|hormones|mesh-ancestor
2940777|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348439|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2348440|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
2348441|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348442|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940778|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2940779|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2940780|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
2940781|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
2940782|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
2940783|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2348443|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348444|NCT00481728|Urological Agents|urological agents|mesh-ancestor
2348445|NCT00481741|Hemostatics|hemostatics|mesh-list
2348446|NCT00481741|Coagulants|coagulants|mesh-ancestor
2348447|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
2348448|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
2940784|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2940785|NCT03269669|Growth Substances|growth substances|mesh-ancestor
2940786|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
2940787|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940788|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
2940789|NCT03267277|Antidotes|antidotes|mesh-ancestor
2940790|NCT03267277|Protective Agents|protective agents|mesh-ancestor
2940791|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940792|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
2940793|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940794|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
2940795|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2940796|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2940797|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
2940798|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
2940799|NCT03206463|Dronabinol|dronabinol|mesh-list
2940800|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
2940801|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940802|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2940803|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2940804|NCT03206463|Analgesics|analgesics|mesh-ancestor
2940805|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
2940806|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2940807|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2940808|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2940809|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2940810|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940811|NCT03206463|Hormones|hormones|mesh-ancestor
2940812|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2940813|NCT03199885|Paclitaxel|paclitaxel|mesh-list
2940814|NCT03199885|Docetaxel|docetaxel|mesh-list
2940815|NCT03199885|Trastuzumab|trastuzumab|mesh-list
2940816|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2940817|NCT03199885|Atezolizumab|atezolizumab|mesh-list
2940818|NCT03199885|Pertuzumab|pertuzumab|mesh-list
2940819|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2940820|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2940821|NCT03199885|Antibodies|antibodies|mesh-list
2940822|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
2940823|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2940824|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2940825|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940826|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
2940827|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
2940828|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
2940829|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940830|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
2940831|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940832|NCT03166761|Dexamethasone|dexamethasone|mesh-list
2940833|NCT03166761|Triamcinolone|triamcinolone|mesh-list
2940834|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2940835|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2940836|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2940837|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2940838|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
2940839|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
2940840|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2940841|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940842|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2940843|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
2940844|NCT03166761|Hormones|hormones|mesh-ancestor
2348449|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2348450|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2348451|NCT00481819|Prednisolone|prednisolone|mesh-list
2348452|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
2348453|NCT00481819|Tacrolimus|tacrolimus|mesh-list
2348454|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2348455|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
2348456|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2348457|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
2348458|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348459|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2348460|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348461|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348462|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2348463|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348464|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2348465|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
2940845|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2940846|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2940847|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940848|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2940849|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
2940850|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940851|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940852|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
2348466|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2348467|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348468|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2348469|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
2940853|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
2940854|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2940855|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
2940856|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940857|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2940858|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2940859|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
2940860|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940861|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940862|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2940863|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2348470|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
2348471|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2348472|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2348473|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
2348474|NCT00481819|Hormones|hormones|mesh-ancestor
2348475|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348476|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2348477|NCT00481819|Protective Agents|protective agents|mesh-ancestor
2940864|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
2940865|NCT03148457|Apixaban|apixaban|mesh-list
2940866|NCT03148457|Edoxaban|edoxaban|mesh-list
2940867|NCT03148457|Dabigatran|dabigatran|mesh-list
2940868|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2348478|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2348479|NCT00481884|Petrolatum|petrolatum|mesh-list
2348480|NCT00481884|Emollients|emollients|mesh-ancestor
2348481|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
2348482|NCT00481923|Rimonabant|rimonabant|mesh-list
2348483|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2348484|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2348485|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2348486|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348487|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348488|NCT00481923|Hormones|hormones|mesh-ancestor
2348489|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348490|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348491|NCT00481962|Tigecycline|tigecycline|mesh-list
2348492|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2348493|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2940869|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
2940870|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2940871|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
2348494|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2348495|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348496|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348497|NCT00481975|Rimonabant|rimonabant|mesh-list
2348498|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2348499|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2348500|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2348501|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348502|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348503|NCT00481975|Hormones|hormones|mesh-ancestor
2348504|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348505|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348506|NCT00482027|Vaccines|vaccines|mesh-list
2348507|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
2348508|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348509|NCT00482066|Abatacept|abatacept|mesh-list
2348510|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2348511|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348512|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348513|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2348514|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
2348515|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348516|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2348517|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2940872|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940873|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940874|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
2940875|NCT03109288|Pioglitazone|pioglitazone|mesh-list
2940876|NCT03109288|Clemastine|clemastine|mesh-list
2940877|NCT03109288|Pirfenidone|pirfenidone|mesh-list
2940878|NCT03109288|Dantrolene|dantrolene|mesh-list
2940879|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2940880|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940881|NCT03109288|Analgesics|analgesics|mesh-ancestor
2940882|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
2940883|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2940884|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2940885|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2940886|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2940887|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2940888|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940889|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2940890|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2940891|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
2940892|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
2940893|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2940894|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
2940895|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
2940896|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2940897|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940898|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2940899|NCT03072147|Teriparatide|teriparatide|mesh-list
2940900|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2940901|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940902|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2940903|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
2940904|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2940905|NCT03016533|Lamivudine|lamivudine|mesh-list
2940906|NCT03016533|Dolutegravir|dolutegravir|mesh-list
2940907|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2940908|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2940909|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940910|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940911|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
2348518|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2348519|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348520|NCT00482079|Incretins|incretins|mesh-ancestor
2348521|NCT00482079|Hormones|hormones|mesh-ancestor
2348522|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348523|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2348524|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
2348525|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348526|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348531|NCT00482157|Vitamin D|vitamin d|mesh-list
2348532|NCT00482157|Calcitriol|calcitriol|mesh-list
2348533|NCT00482157|Vitamins|vitamins|mesh-ancestor
2348534|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
2348535|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348536|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2348537|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2348538|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2348539|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2348540|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940912|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2940913|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2940914|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2940915|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2940916|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2940917|NCT03011814|Lenalidomide|lenalidomide|mesh-list
2940918|NCT03011814|Durvalumab|durvalumab|mesh-list
2940919|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
2940920|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2940921|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
2940922|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
2940923|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940924|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2940925|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2940926|NCT03011814|Growth Substances|growth substances|mesh-ancestor
2940927|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
2940928|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940929|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940930|NCT03000439|Tofacitinib|tofacitinib|mesh-list
2940931|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2940932|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940933|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940934|NCT02979873|Sirolimus|sirolimus|mesh-list
2940935|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2940936|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2940937|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2348541|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2348542|NCT00482183|Pioglitazone|pioglitazone|mesh-list
2348543|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2348544|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348545|NCT00482209|Misoprostol|misoprostol|mesh-list
2348546|NCT00482209|Mifepristone|mifepristone|mesh-list
2940938|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940939|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
2940940|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2940941|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
2940942|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940943|NCT02962414|Everolimus|everolimus|mesh-list
2940944|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348547|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2348548|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
2348549|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2348550|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348551|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2348552|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2348553|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
2348554|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2348555|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2348556|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2348557|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2348558|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
2348559|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2348560|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2348561|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
2348562|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348563|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
2348564|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2348565|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2348566|NCT00482222|Leucovorin|leucovorin|mesh-list
2348567|NCT00482222|Fluorouracil|fluorouracil|mesh-list
2348568|NCT00482222|Capecitabine|capecitabine|mesh-list
2348569|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
2348570|NCT00482222|Cetuximab|cetuximab|mesh-list
2348571|NCT00482222|Calcium|calcium|mesh-list
2348572|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
2348573|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2348574|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348575|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
2348576|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348577|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2348578|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348579|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2348580|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
2348581|NCT00482222|Antidotes|antidotes|mesh-ancestor
2348582|NCT00482222|Protective Agents|protective agents|mesh-ancestor
2348583|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
2348584|NCT00482222|Vitamins|vitamins|mesh-ancestor
2348585|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
2348586|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2348587|NCT00482248|Omalizumab|omalizumab|mesh-list
2348588|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2348589|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2348590|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
2348591|NCT00482261|Aspirin|aspirin|mesh-list
2348592|NCT00482261|Dexamethasone|dexamethasone|mesh-list
2940945|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2940946|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
2940947|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940948|NCT02947165|Spartalizumab|spartalizumab|mesh-list
2940949|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2348593|NCT00482261|Lenalidomide|lenalidomide|mesh-list
2348594|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2348595|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
2348596|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
2348597|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2348598|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348599|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2348600|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
2348601|NCT00482261|Hormones|hormones|mesh-ancestor
2348602|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348603|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2348604|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348605|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2348606|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2348607|NCT00482261|Analgesics|analgesics|mesh-ancestor
2348608|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
2348609|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2348610|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2348611|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2348612|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940950|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940951|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940952|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2940953|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940954|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940955|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
2940956|NCT02912559|Leucovorin|leucovorin|mesh-list
2348613|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2348614|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2348615|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348616|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
2348617|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
2348618|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2348619|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2348620|NCT00482261|Growth Substances|growth substances|mesh-ancestor
2348621|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
2348622|NCT00482313|Methylphenidate|methylphenidate|mesh-list
2348623|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2348624|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348625|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2348626|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2348627|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2348628|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348629|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
2940957|NCT02912559|Folic Acid|folic acid|mesh-list
2940958|NCT02912559|Fluorouracil|fluorouracil|mesh-list
2940959|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
2940960|NCT02912559|Atezolizumab|atezolizumab|mesh-list
2940961|NCT02912559|Calcium|calcium|mesh-list
2940962|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2940963|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
2940964|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2940965|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940966|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2940967|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
2940968|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940969|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2940970|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940971|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2940972|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
2940973|NCT02912559|Antidotes|antidotes|mesh-ancestor
2940974|NCT02912559|Protective Agents|protective agents|mesh-ancestor
2348630|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348631|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
2348632|NCT00482378|Pamidronate|pamidronate|mesh-list
2348633|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2348634|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348635|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
2348636|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2348637|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
2348638|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
2348639|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2348640|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348641|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2348642|NCT00482456|Analgesics|analgesics|mesh-ancestor
2348643|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
2348644|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2348645|NCT00482495|Bevacizumab|bevacizumab|mesh-list
2348646|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2348647|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348648|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2348649|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2348650|NCT00482495|Growth Substances|growth substances|mesh-ancestor
2348651|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348652|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
2348653|NCT00482508|Omalizumab|omalizumab|mesh-list
2348654|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2348655|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2348656|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
2940975|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
2940976|NCT02912559|Vitamins|vitamins|mesh-ancestor
2940977|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
2940978|NCT02912559|Hematinics|hematinics|mesh-ancestor
2940979|NCT02905318|Palbociclib|palbociclib|mesh-list
2940980|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940981|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2940982|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2940983|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2940984|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
2940985|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940986|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2940987|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
2940988|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2940989|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2940990|NCT02846545|Golimumab|golimumab|mesh-list
2348657|NCT00482521|Pomalidomide|pomalidomide|mesh-list
2348658|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
2348659|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348660|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2348661|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2348662|NCT00482521|Growth Substances|growth substances|mesh-ancestor
2348663|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
2348664|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348665|NCT00482573|Epinephrine|epinephrine|mesh-list
2348666|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2348667|NCT00482573|Anesthetics|anesthetics|mesh-list
2348668|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2348669|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940991|NCT02846545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2940992|NCT02846545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2940993|NCT02846545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2940994|NCT02846545|Immunologic Factors|immunologic factors|mesh-ancestor
2940995|NCT02846545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2940996|NCT02834013|Nivolumab|nivolumab|mesh-list
2940997|NCT02834013|Ipilimumab|ipilimumab|mesh-list
2940998|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2940999|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941000|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2941001|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941002|NCT02767804|Crizotinib|crizotinib|mesh-list
2941003|NCT02767804|Ensartinib|ensartinib|mesh-list
2941004|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941005|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2941006|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941007|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941008|NCT02721069|Diazepam|diazepam|mesh-list
2941009|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2941010|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
2941011|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
2941012|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
2941013|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941014|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941015|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2941016|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2941017|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2941018|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2941019|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2941020|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2941021|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2941022|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2941023|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2941024|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
2941025|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
2941026|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
2941027|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
2941028|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941029|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941030|NCT02719613|Dexamethasone|dexamethasone|mesh-list
2941031|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
2941032|NCT02719613|Nivolumab|nivolumab|mesh-list
2941033|NCT02719613|Lenalidomide|lenalidomide|mesh-list
2941034|NCT02719613|Bortezomib|bortezomib|mesh-list
2941035|NCT02719613|Pomalidomide|pomalidomide|mesh-list
2941036|NCT02719613|Elotuzumab|elotuzumab|mesh-list
2941037|NCT02719613|BB 1101|bb 1101|mesh-list
2941038|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2941039|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
2941040|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
2348670|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2348671|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2348672|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
2348673|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348674|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348675|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2348676|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2348677|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
2348678|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2348679|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2348680|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
2348681|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
2941041|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941042|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941043|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2941044|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
2941045|NCT02719613|Hormones|hormones|mesh-ancestor
2941046|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941047|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2941048|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941049|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
2941050|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941051|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348682|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
2348683|NCT00482690|Nicotine|nicotine|mesh-list
2348684|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2348685|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
2348686|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2348687|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348688|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2348689|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2348690|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
2348691|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348692|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348693|NCT00482716|Iron|iron|mesh-list
2348694|NCT00482716|Dextrans|dextrans|mesh-list
2348695|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
2348696|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2348697|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
2348698|NCT00482716|Trace Elements|trace elements|mesh-ancestor
2348699|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
2348700|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348701|NCT00482716|Hematinics|hematinics|mesh-ancestor
2348702|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
2348703|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
2348704|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
2941052|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2941053|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2941054|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
2941055|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2941056|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2941057|NCT02719613|Growth Substances|growth substances|mesh-ancestor
2941058|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
2941059|NCT02717507|Carvedilol|carvedilol|mesh-list
2941060|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2348705|NCT00482755|Sunitinib|sunitinib|mesh-list
2348706|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348707|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2348708|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2348709|NCT00482755|Growth Substances|growth substances|mesh-ancestor
2348710|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348711|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
2348712|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2941061|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2941062|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
2941063|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941064|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941065|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941066|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2941067|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
2941068|NCT02717507|Protective Agents|protective agents|mesh-ancestor
2941069|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2941070|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2348713|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348714|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941071|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2941072|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
2941073|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2941074|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2941075|NCT02677038|Olaparib|olaparib|mesh-list
2941076|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2941077|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941078|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941079|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941080|NCT02658981|Nivolumab|nivolumab|mesh-list
2941081|NCT02658981|Antibodies|antibodies|mesh-list
2941082|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2941083|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
2941084|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941085|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2941086|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941087|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2941088|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941089|NCT02608268|Decitabine|decitabine|mesh-list
2941090|NCT02608268|Spartalizumab|spartalizumab|mesh-list
2941091|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2941092|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
2941093|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941094|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941095|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941096|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2941097|NCT02575794|Masoprocol|masoprocol|mesh-list
2348715|NCT00482807|Docetaxel|docetaxel|mesh-list
2348716|NCT00482807|Goserelin|goserelin|mesh-list
2348717|NCT00482807|Bicalutamide|bicalutamide|mesh-list
2348718|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348719|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
2348720|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
2348721|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
2941098|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
2941099|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941100|NCT02575794|Protective Agents|protective agents|mesh-ancestor
2941101|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941102|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2941103|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941104|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2941105|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2941106|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2941107|NCT02575794|Analgesics|analgesics|mesh-ancestor
2941108|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
2941109|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941110|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2941111|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2941114|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2941115|NCT02465060|Nivolumab|nivolumab|mesh-list
2941116|NCT02465060|Trastuzumab|trastuzumab|mesh-list
2941117|NCT02465060|Pertuzumab|pertuzumab|mesh-list
2941118|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2348722|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348723|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2348724|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
2348725|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
2348726|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348727|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941119|NCT02465060|Sunitinib|sunitinib|mesh-list
2941120|NCT02465060|Dasatinib|dasatinib|mesh-list
2941121|NCT02465060|Palbociclib|palbociclib|mesh-list
2941122|NCT02465060|Trametinib|trametinib|mesh-list
2941123|NCT02465060|Afatinib|afatinib|mesh-list
2941124|NCT02465060|Osimertinib|osimertinib|mesh-list
2941125|NCT02465060|Dabrafenib|dabrafenib|mesh-list
2941126|NCT02465060|Crizotinib|crizotinib|mesh-list
2941127|NCT02465060|Maytansine|maytansine|mesh-list
2941128|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2941129|NCT02465060|GSK2636771|gsk2636771|mesh-list
2941130|NCT02465060|Antibodies|antibodies|mesh-list
2941131|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
2941132|NCT02465060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2941133|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
2941134|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
2941135|NCT02465060|Adavosertib|adavosertib|mesh-list
2941136|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
2941137|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941138|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941139|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2941140|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941141|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2941142|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2941143|NCT02465060|Growth Substances|growth substances|mesh-ancestor
2941144|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
2941145|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2941146|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941147|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2941148|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
2941149|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
2941150|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
2941151|NCT02452268|Spartalizumab|spartalizumab|mesh-list
2941152|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2941153|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941154|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941155|NCT02435212|Deferasirox|deferasirox|mesh-list
2941156|NCT02435212|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2941157|NCT02435212|Chelating Agents|chelating agents|mesh-ancestor
2941158|NCT02435212|Sequestering Agents|sequestering agents|mesh-ancestor
2941159|NCT02435212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941160|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
2941161|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941162|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2941163|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348752|NCT00482846|Melphalan|melphalan|mesh-list
2348753|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2348754|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
2941164|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941165|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
2941166|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941167|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941168|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2941169|NCT02389465|Celecoxib|celecoxib|mesh-list
2941170|NCT02389465|Dexetimide|dexetimide|mesh-list
2941171|NCT02389465|Citalopram|citalopram|mesh-list
2941172|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2941173|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2941174|NCT02389465|Analgesics|analgesics|mesh-ancestor
2941175|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
2941176|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941177|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941178|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2941179|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2941180|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2941181|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2941182|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348755|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348756|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348757|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2348758|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2348759|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
2348760|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348761|NCT00482963|Efavirenz|efavirenz|mesh-list
2348762|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
2348763|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2348764|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2348765|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348766|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348767|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
2941183|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941184|NCT02389465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2941185|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2941186|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2941187|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941188|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
2941189|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2941190|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
2941191|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2348768|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348769|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2348770|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2348771|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2348772|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2348773|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2348774|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2348775|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2348776|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
2348777|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2348778|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348779|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2348780|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2348781|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2348782|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
2348783|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941192|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2941193|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2941194|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
2941195|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
2941196|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2941197|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2941198|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
2941199|NCT02367456|Azacitidine|azacitidine|mesh-list
2941200|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2941201|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
2941202|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941203|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941204|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941205|NCT02339571|Nivolumab|nivolumab|mesh-list
2941206|NCT02339571|Ipilimumab|ipilimumab|mesh-list
2941207|NCT02339571|Sargramostim|sargramostim|mesh-list
2941208|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2941209|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941210|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2941211|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941212|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
2941213|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941214|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
2941215|NCT02335060|Dronabinol|dronabinol|mesh-list
2941216|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2941217|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
2941218|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2941219|NCT02335060|Expectorants|expectorants|mesh-ancestor
2941220|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
2941221|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2941222|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
2941223|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941224|NCT02335060|Protective Agents|protective agents|mesh-ancestor
2941225|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941226|NCT02335060|Antidotes|antidotes|mesh-ancestor
2941227|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
2941228|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2941229|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2941230|NCT02335060|Analgesics|analgesics|mesh-ancestor
2941231|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
2941232|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941233|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2941234|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2941235|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941236|NCT02335060|Hormones|hormones|mesh-ancestor
2941237|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941238|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
2941239|NCT02299414|Nifedipine|nifedipine|mesh-list
2941240|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2941241|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2941242|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941243|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2941244|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941245|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
2941246|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
2941247|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2941248|NCT02297438|Letrozole|letrozole|mesh-list
2941249|NCT02297438|Palbociclib|palbociclib|mesh-list
2941250|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941251|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2941252|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2941253|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941254|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941255|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2941256|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
2941257|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941258|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348784|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348785|NCT00482989|Sifalimumab|sifalimumab|mesh-list
2348786|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
2348787|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348788|NCT00483028|Donepezil|donepezil|mesh-list
2348789|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2348790|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348791|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348792|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
2348793|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348794|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348795|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
2348796|NCT00483054|Efavirenz|efavirenz|mesh-list
2348797|NCT00483054|Nevirapine|nevirapine|mesh-list
2348798|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2941259|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2941260|NCT02297412|Minocycline|minocycline|mesh-list
2941261|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2941262|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2941263|NCT02292758|Bevacizumab|bevacizumab|mesh-list
2941264|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2941265|NCT02292758|Cetuximab|cetuximab|mesh-list
2941266|NCT02292758|Irinotecan|irinotecan|mesh-list
2941267|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
2941268|NCT02292758|Antibodies|antibodies|mesh-list
2941269|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
2941270|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2941271|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
2941272|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941273|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2941274|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2941275|NCT02292758|Growth Substances|growth substances|mesh-ancestor
2941276|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941277|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
2941278|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
2941279|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2941280|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2941281|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941282|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941283|NCT02288247|Prednisolone|prednisolone|mesh-list
2941284|NCT02288247|Docetaxel|docetaxel|mesh-list
2941285|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941286|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
2348799|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2348800|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348801|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348802|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
2348803|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348804|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2348805|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2941287|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
2941288|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
2941289|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941290|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2941291|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
2941292|NCT02288247|Hormones|hormones|mesh-ancestor
2941293|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348806|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2348807|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2348808|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2941294|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941295|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2941296|NCT02250326|Paclitaxel|paclitaxel|mesh-list
2941297|NCT02250326|Azacitidine|azacitidine|mesh-list
2941298|NCT02250326|Cc-486|cc-486|mesh-list
2941299|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2941300|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941301|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
2941302|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
2941303|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
2941304|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941305|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2941306|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
2941307|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941308|NCT02230189|Methacholine Chloride|methacholine chloride|mesh-list
2941309|NCT02230189|Miotics|miotics|mesh-ancestor
2941310|NCT02230189|Autonomic Agents|autonomic agents|mesh-ancestor
2941311|NCT02230189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941312|NCT02230189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941313|NCT02230189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2941314|NCT02230189|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2941315|NCT02230189|Respiratory System Agents|respiratory system agents|mesh-ancestor
2941316|NCT02230189|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2941317|NCT02230189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2348809|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2348810|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2348811|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2348812|NCT00483067|Cytarabine|cytarabine|mesh-list
2348813|NCT00483067|Cladribine|cladribine|mesh-list
2348814|NCT00483067|Lenograstim|lenograstim|mesh-list
2348815|NCT00483067|Sargramostim|sargramostim|mesh-list
2348816|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2348817|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
2348818|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348819|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2348820|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
2348821|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348822|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348823|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
2348824|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348825|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2941318|NCT02230189|Cholinergic Agents|cholinergic agents|mesh-ancestor
2348826|NCT00483093|Cisplatin|cisplatin|mesh-list
2348827|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348828|NCT00483106|Methylphenidate|methylphenidate|mesh-list
2348829|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2348830|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348831|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2348832|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2348833|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2348834|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348835|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
2348836|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2348837|NCT00483132|Interferons|interferons|mesh-list
2348838|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
2348839|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
2348840|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348841|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
2348842|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348843|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
2348844|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348845|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2348846|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2348847|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2348848|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
2348849|NCT00483158|Finafloxacin|finafloxacin|mesh-list
2348850|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2348851|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2941319|NCT02230189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941320|NCT02230189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348852|NCT00483158|Renal Agents|renal agents|mesh-ancestor
2348853|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2348854|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2348855|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2348856|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348857|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348858|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348859|NCT00483210|Fenofibrate|fenofibrate|mesh-list
2348860|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2348861|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
2348862|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348863|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2348864|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
2348865|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2348866|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2348867|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348868|NCT00483275|Vitamins|vitamins|mesh-ancestor
2348869|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
2348870|NCT00483301|Sorafenib|sorafenib|mesh-list
2348871|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2348872|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348873|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2348874|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348875|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348876|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
2348877|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2348878|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
2348879|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348880|NCT00483314|Expectorants|expectorants|mesh-ancestor
2348881|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
2348882|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2348883|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
2348884|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348885|NCT00483314|Protective Agents|protective agents|mesh-ancestor
2348886|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348887|NCT00483314|Antidotes|antidotes|mesh-ancestor
2348888|NCT00483366|Gemcitabine|gemcitabine|mesh-list
2348889|NCT00483366|Capecitabine|capecitabine|mesh-list
2941349|NCT02152995|Iodine|iodine|mesh-list
2941350|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
2941351|NCT02152995|Trametinib|trametinib|mesh-list
2941352|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2941353|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2941354|NCT02152995|Trace Elements|trace elements|mesh-ancestor
2941355|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
2941356|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941357|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941358|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2941359|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941360|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941361|NCT02102113|Dronabinol|dronabinol|mesh-list
2941362|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
2941363|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348890|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
2348891|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2348892|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
2348893|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348894|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348895|NCT00483366|Antiviral Agents|antiviral agents|mesh-ancestor
2348896|NCT00483366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2348897|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112000|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2112001|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112002|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
2112003|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2112004|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
2112005|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2112006|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112007|NCT02563561|Apaziquone|apaziquone|mesh-list
2112008|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112009|NCT02563834|Insulin|insulin|mesh-list
2941364|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2941365|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2941366|NCT02102113|Analgesics|analgesics|mesh-ancestor
2941367|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
2348898|NCT00483366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2348899|NCT00483366|Immunologic Factors|immunologic factors|mesh-ancestor
2348900|NCT00483366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348901|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2348902|NCT00483392|Metformin|metformin|mesh-list
2348903|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
2348904|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2348905|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348906|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2348907|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348908|NCT00483470|Vaccines|vaccines|mesh-list
2348909|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
2348910|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348911|NCT00483600|PENTA|penta|mesh-list
2348912|NCT00483600|Fondaparinux|fondaparinux|mesh-list
2348913|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2348914|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
2348915|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2348916|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
2348917|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941368|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941369|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2941370|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2941371|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941372|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941373|NCT02102113|Hormones|hormones|mesh-ancestor
2941374|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941375|NCT01996449|Amlodipine|amlodipine|mesh-list
2941376|NCT01996449|Eplerenone|eplerenone|mesh-list
2941377|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2941378|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2941379|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2941380|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348918|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112010|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2348919|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
2348920|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2941381|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2941382|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941383|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
2941384|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2941385|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
2941386|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941387|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2941388|NCT01996449|Diuretics|diuretics|mesh-ancestor
2941389|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
2941390|NCT01951469|Pemetrexed|pemetrexed|mesh-list
2941391|NCT01951469|Gefitinib|gefitinib|mesh-list
2941392|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941393|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941394|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941395|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2941396|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2941397|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2941398|NCT01922076|Adavosertib|adavosertib|mesh-list
2941399|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941400|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941401|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2941402|NCT01896999|Nivolumab|nivolumab|mesh-list
2941403|NCT01896999|Ipilimumab|ipilimumab|mesh-list
2941404|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2941405|NCT01896999|Antibodies|antibodies|mesh-list
2941406|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
2941407|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2941408|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
2941409|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
2941410|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941411|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941412|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2941413|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941414|NCT01864018|Dexamethasone|dexamethasone|mesh-list
2941415|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
2941416|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
2941417|NCT01864018|Ixazomib|ixazomib|mesh-list
2941418|NCT01864018|Ichthammol|ichthammol|mesh-list
2941419|NCT01864018|BB 1101|bb 1101|mesh-list
2941420|NCT01864018|Glycine|glycine|mesh-list
2941421|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2941422|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
2941423|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941424|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2348921|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2348922|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
2348923|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
2348924|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2348925|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2348926|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941425|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2941426|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
2941427|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941428|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941429|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2941430|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2941431|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
2941432|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
2941433|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941434|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2941435|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
2941436|NCT01864018|Hormones|hormones|mesh-ancestor
2348927|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348928|NCT00483626|Urological Agents|urological agents|mesh-ancestor
2348929|NCT00483730|Actovegin|actovegin|mesh-list
2348930|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2348931|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941437|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941438|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2941439|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
2941440|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941441|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
2941442|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
2348932|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2348933|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2348934|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
2348935|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348936|NCT00483730|Protective Agents|protective agents|mesh-ancestor
2348937|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2348938|NCT00483743|Budesonide|budesonide|mesh-list
2348939|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2348940|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2348941|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
2348942|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2348943|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348944|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2348945|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
2348946|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
2348947|NCT00483743|Hormones|hormones|mesh-ancestor
2348948|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2348949|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
2348950|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2348951|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348952|NCT00483782|Paclitaxel|paclitaxel|mesh-list
2348953|NCT00483782|Bevacizumab|bevacizumab|mesh-list
2348954|NCT00483782|Carboplatin|carboplatin|mesh-list
2348955|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2348956|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348957|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
2348958|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
2348959|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
2348960|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348961|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2348962|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2348963|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2348964|NCT00483782|Growth Substances|growth substances|mesh-ancestor
2348965|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348966|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
2348967|NCT00483795|Citric Acid|citric acid|mesh-list
2348968|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
2348969|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
2348970|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2348971|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
2348972|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
2941443|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941444|NCT01856270|Amitriptyline|amitriptyline|mesh-list
2941445|NCT01856270|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2941446|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2941447|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
2941448|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2941449|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2941450|NCT01856270|Analgesics|analgesics|mesh-ancestor
2941451|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
2941452|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941453|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941454|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2941455|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2941456|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2941457|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941458|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
2941459|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941460|NCT01856270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2941461|NCT01856270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2941462|NCT01856270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2941463|NCT01810913|Cisplatin|cisplatin|mesh-list
2941464|NCT01810913|Docetaxel|docetaxel|mesh-list
2941465|NCT01810913|Cetuximab|cetuximab|mesh-list
2941466|NCT01810913|Atezolizumab|atezolizumab|mesh-list
2941467|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2941468|NCT01810913|Antibodies|antibodies|mesh-list
2941469|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
2941470|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2941471|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
2941472|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941473|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941474|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
2941475|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
2941476|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
2941477|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941478|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2941479|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2941480|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941481|NCT01741103|Incretins|incretins|mesh-ancestor
2348973|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348974|NCT00483834|Bevacizumab|bevacizumab|mesh-list
2348975|NCT00483834|Capecitabine|capecitabine|mesh-list
2348976|NCT00483834|Irinotecan|irinotecan|mesh-list
2348977|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2348978|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348979|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2348980|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2348981|NCT00483834|Growth Substances|growth substances|mesh-ancestor
2348982|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2348983|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
2348984|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2348985|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
2348986|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941482|NCT01741103|Hormones|hormones|mesh-ancestor
2941483|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941484|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2941485|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
2941486|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941487|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941488|NCT01712620|Spironolactone|spironolactone|mesh-list
2348987|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2348988|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2348989|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348990|NCT00483860|Topotecan|topotecan|mesh-list
2348991|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2348992|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2348993|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2348994|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2348995|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2348996|NCT00483886|Prucalopride|prucalopride|mesh-list
2348997|NCT00483886|Laxatives|laxatives|mesh-ancestor
2348998|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2348999|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2349000|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2349001|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
2349002|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349003|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349004|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349005|NCT00483964|Olanzapine|olanzapine|mesh-list
2349006|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
2941489|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2941490|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
2941491|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941492|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941493|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2941494|NCT01712620|Diuretics|diuretics|mesh-ancestor
2941495|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
2941496|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
2941497|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
2941498|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941499|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2941500|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941501|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2941502|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
2941503|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941504|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2941505|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941506|NCT01503515|Fluconazole|fluconazole|mesh-list
2941507|NCT01503515|Voriconazole|voriconazole|mesh-list
2941508|NCT01503515|Caspofungin|caspofungin|mesh-list
2941509|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
2941510|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2941511|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2941512|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2941513|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941514|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941515|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2941516|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
2941517|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941518|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941519|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2941520|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2941521|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2941522|NCT01491893|Vaccines|vaccines|mesh-list
2941523|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
2941524|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941525|NCT01306019|Busulfan|busulfan|mesh-list
2941526|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
2941527|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941528|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2941529|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
2941530|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941531|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2941532|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941533|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2941534|NCT01180374|Dronabinol|dronabinol|mesh-list
2941535|NCT01180374|Cannabidiol|cannabidiol|mesh-list
2941536|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
2941537|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
2941538|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941539|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2941540|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2941541|NCT01180374|Analgesics|analgesics|mesh-ancestor
2349007|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
2349008|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349009|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349010|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2349011|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2349012|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2349013|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349014|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349015|NCT00483964|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2349016|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349017|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349018|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349019|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349020|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
2349021|NCT00483977|Oxycodone|oxycodone|mesh-list
2349022|NCT00483977|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2349023|NCT00483977|Narcotics|narcotics|mesh-ancestor
2349024|NCT00483977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349025|NCT00483977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349026|NCT00483977|Analgesics|analgesics|mesh-ancestor
2941542|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
2941543|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941544|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2941545|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2941546|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941547|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941548|NCT01180374|Hormones|hormones|mesh-ancestor
2941549|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941550|NCT01174121|Aldesleukin|aldesleukin|mesh-list
2941551|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
2941552|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
2941553|NCT01174121|Fludarabine|fludarabine|mesh-list
2941554|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2941555|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
2941556|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941557|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2941558|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2941559|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
2941560|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941561|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941562|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2941563|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2941564|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2941565|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2941566|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
2941567|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2941568|NCT01101438|Metformin|metformin|mesh-list
2941569|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2941570|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941571|NCT00720785|Bortezomib|bortezomib|mesh-list
2941572|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941573|NCT00700596|Salvinorin A|salvinorin a|mesh-list
2941574|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
2941575|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941576|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2941577|NCT00687882|Anticoagulants|anticoagulants|mesh-list
2941578|NCT00565851|Gemcitabine|gemcitabine|mesh-list
2941579|NCT00565851|Paclitaxel|paclitaxel|mesh-list
2941580|NCT00565851|Docetaxel|docetaxel|mesh-list
2941581|NCT00565851|Bevacizumab|bevacizumab|mesh-list
2941582|NCT00565851|Carboplatin|carboplatin|mesh-list
2941583|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2941584|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2941585|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
2941586|NCT00565851|Antibodies|antibodies|mesh-list
2941587|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
2349027|NCT00483977|Sensory System Agents|sensory system agents|mesh-ancestor
2349028|NCT00483977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349029|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2349030|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
2349031|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
2349032|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349033|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349034|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
2349035|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349036|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2349037|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
2941588|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2941589|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
2941590|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2941591|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941592|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
2941593|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
2941594|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
2941595|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941596|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2941597|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2941598|NCT00565851|Growth Substances|growth substances|mesh-ancestor
2941599|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941600|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
2941601|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
2941602|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2941603|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
2941604|NCT00565851|Antiviral Agents|antiviral agents|mesh-ancestor
2941605|NCT00565851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2941606|NCT00565851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941607|NCT00565851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2941608|NCT00357565|Cyclosporine|cyclosporine|mesh-list
2941609|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
2941610|NCT00357565|Fludarabine|fludarabine|mesh-list
2941611|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
2941612|NCT00357565|Melphalan|melphalan|mesh-list
2941613|NCT00357565|Busulfan|busulfan|mesh-list
2941614|NCT00357565|Cyclosporins|cyclosporins|mesh-list
2941615|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941616|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2941617|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
2941618|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941619|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2941620|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
2941621|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941622|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941623|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
2941624|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2941625|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
2941626|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2941627|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2941628|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2941629|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2941630|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
2941631|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2941632|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2941633|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
2941634|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2941635|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
2941636|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2941637|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
2941638|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349038|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2349039|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2349040|NCT00484003|Analgesics|analgesics|mesh-ancestor
2349041|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
2349042|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349043|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349044|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2349045|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349046|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
2349047|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2349048|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
2349049|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2349050|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349051|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349052|NCT00484055|Gentamicins|gentamicins|mesh-list
2349053|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2349054|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349055|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2349056|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349057|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349058|NCT00484068|Enalapril|enalapril|mesh-list
2349059|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2349060|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
2349061|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349062|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349063|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2349064|NCT00484107|Estrogens|estrogens|mesh-list
2349065|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2349066|NCT00484107|Hormones|hormones|mesh-ancestor
2349067|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2349068|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349069|NCT00484120|Diclofenac|diclofenac|mesh-list
2349070|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2349071|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2349072|NCT00484120|Analgesics|analgesics|mesh-ancestor
2349073|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
2349074|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349075|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349076|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2349077|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349078|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2349079|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349080|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349081|NCT00484133|Dobutamine|dobutamine|mesh-list
2349082|NCT00484133|Dopamine|dopamine|mesh-list
2349083|NCT00484133|Enoximone|enoximone|mesh-list
2941639|NCT00245960|Etanercept|etanercept|mesh-list
2941640|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2941641|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2941642|NCT00245960|Analgesics|analgesics|mesh-ancestor
2941643|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
2941644|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941645|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941646|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2349084|NCT00484133|Norepinephrine|norepinephrine|mesh-list
2349085|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
2349086|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
2349087|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2349088|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
2349089|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
2349090|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349091|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349092|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2349093|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2349094|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2349095|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
2349096|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349097|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941647|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2941648|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2941649|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2941650|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
2941651|NCT00136903|Cyclosporine|cyclosporine|mesh-list
2941652|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
2941653|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
2349098|NCT00484133|Protective Agents|protective agents|mesh-ancestor
2349099|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
2349100|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2349101|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2349102|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2349103|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2349104|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349105|NCT00484237|Etanercept|etanercept|mesh-list
2941654|NCT00136903|Prednisone|prednisone|mesh-list
2941655|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
2941656|NCT00136903|Tacrolimus|tacrolimus|mesh-list
2941657|NCT00136903|Cyclosporins|cyclosporins|mesh-list
2941658|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2941659|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
2941660|NCT00136903|Hormones|hormones|mesh-ancestor
2941661|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941662|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941663|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2941664|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941665|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2941666|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
2941667|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2941668|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941669|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941670|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
2941671|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2941672|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
2941673|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2941674|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2941675|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2941676|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
2941677|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2941678|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
2941679|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
2941680|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941681|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2941682|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2941683|NCT00136903|Protective Agents|protective agents|mesh-ancestor
2941684|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
2941685|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2941686|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941687|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941688|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941689|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2941690|NCT00065676|Quercetin|quercetin|mesh-list
2941691|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
2941692|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941693|NCT00065676|Protective Agents|protective agents|mesh-ancestor
2941694|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941695|NCT00061568|Sirolimus|sirolimus|mesh-list
2941696|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
2941697|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2941698|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2941699|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2941700|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941701|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
2941702|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2941703|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
2941704|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941705|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2941706|NCT00001481|Estradiol|estradiol|mesh-list
2941707|NCT00001481|Progesterone|progesterone|mesh-list
2941708|NCT00001481|Estrogens|estrogens|mesh-ancestor
2941709|NCT00001481|Hormones|hormones|mesh-ancestor
2941710|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941711|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941712|NCT00001481|Progestins|progestins|mesh-ancestor
2941713|NCT00001337|Rituximab|rituximab|mesh-list
2941714|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2941715|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941716|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
2941717|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941718|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349106|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2349107|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2349108|NCT00484237|Analgesics|analgesics|mesh-ancestor
2349109|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
2349110|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349111|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349112|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2349113|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349114|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2349115|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2349116|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
2349117|NCT00484250|Metronidazole|metronidazole|mesh-list
2349118|NCT00484250|Doxycycline|doxycycline|mesh-list
2349119|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349120|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2349121|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2349122|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2349123|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
2349124|NCT00484328|Ribavirin|ribavirin|mesh-list
2349125|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
2349126|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349127|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
2349128|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349129|NCT00484341|Doxorubicin|doxorubicin|mesh-list
2349130|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2349131|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349132|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2349133|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2349134|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349135|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349136|NCT00484432|Doxorubicin|doxorubicin|mesh-list
2349137|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2349138|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349139|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2349140|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2349141|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349142|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349143|NCT00484471|Valproic Acid|valproic acid|mesh-list
2349144|NCT00484471|Aripiprazole|aripiprazole|mesh-list
2349145|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
2349146|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349147|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2349148|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2349149|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349150|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941719|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2941720|NCT05218915|Dulaglutide|dulaglutide|mesh-list
2941721|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2941722|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941723|NCT05218889|Gemcitabine|gemcitabine|mesh-list
2941724|NCT05218889|Paclitaxel|paclitaxel|mesh-list
2941725|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2941726|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2941727|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941728|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
2941729|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
2941730|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
2941731|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941732|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2941733|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
2941734|NCT05218889|Antiviral Agents|antiviral agents|mesh-ancestor
2941735|NCT05218889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2941736|NCT05218889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941737|NCT05218889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2941738|NCT05218889|Immunologic Factors|immunologic factors|mesh-ancestor
2941739|NCT05218889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941740|NCT05218733|Fentanyl|fentanyl|mesh-list
2941741|NCT05218733|Morphine|morphine|mesh-list
2941742|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
2941743|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2941744|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941745|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2941746|NCT05218733|Narcotics|narcotics|mesh-ancestor
2941747|NCT05218733|Analgesics|analgesics|mesh-ancestor
2941748|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
2941749|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941750|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2941751|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2349151|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
2349152|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
2941752|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
2941753|NCT05218668|Fasudil|fasudil|mesh-list
2941754|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2941755|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2941756|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941757|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2941758|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941759|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
2941760|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2941761|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941762|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2941763|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941764|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941765|NCT05218616|Sunitinib|sunitinib|mesh-list
2941766|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941767|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2941768|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2941769|NCT05218616|Growth Substances|growth substances|mesh-ancestor
2941770|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941771|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
2941772|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2941773|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941774|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941775|NCT05218603|Bortezomib|bortezomib|mesh-list
2941776|NCT05218603|Daratumumab|daratumumab|mesh-list
2941777|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941778|NCT05218577|Selenium|selenium|mesh-list
2941779|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
2941780|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941781|NCT05218577|Protective Agents|protective agents|mesh-ancestor
2941782|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941783|NCT05218577|Trace Elements|trace elements|mesh-ancestor
2941784|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
2941785|NCT05218499|Doxorubicin|doxorubicin|mesh-list
2941786|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2941787|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941788|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2941789|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2941790|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941791|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941792|NCT05218486|Isotretinoin|isotretinoin|mesh-list
2941793|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
2941794|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
2941795|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2941796|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2941797|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941798|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2941799|NCT05218161|Analgesics|analgesics|mesh-ancestor
2941800|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
2941801|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941802|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2941803|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2941804|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2941805|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
2941806|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941807|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941808|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
2941809|NCT05218148|Trastuzumab|trastuzumab|mesh-list
2941810|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941811|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2941812|NCT05217836|Hepcidins|hepcidins|mesh-list
2941813|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349153|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349154|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349155|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2349156|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2349157|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
2349158|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2349159|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2349160|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2941814|NCT05217758|Mifepristone|mifepristone|mesh-list
2941815|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2941816|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
2941817|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2941818|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941819|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2349161|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2349162|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
2349163|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349164|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
2349165|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
2349166|NCT00484484|Ketamine|ketamine|mesh-list
2349167|NCT00484484|Analgesics|analgesics|mesh-ancestor
2349168|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
2349169|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349170|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349171|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2349172|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2349173|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
2349174|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
2349175|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349176|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2349177|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2349178|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349179|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349180|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
2349181|NCT00484510|Vitamins|vitamins|mesh-ancestor
2349182|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
2349183|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349184|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
2349185|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349186|NCT00484510|Protective Agents|protective agents|mesh-ancestor
2349187|NCT00484575|Propofol|propofol|mesh-list
2349188|NCT00484575|Sevoflurane|sevoflurane|mesh-list
2349189|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2349190|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349191|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349192|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2349193|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
2349194|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
2349195|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2349196|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2349197|NCT00484601|Doxorubicin|doxorubicin|mesh-list
2349198|NCT00484601|Ifosfamide|ifosfamide|mesh-list
2349199|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2349200|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349201|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2349202|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2349203|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349204|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941820|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2941821|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2941822|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
2941823|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2941824|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2941825|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
2941826|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941827|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
2941828|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2941829|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2941830|NCT05217706|Ketamine|ketamine|mesh-list
2941831|NCT05217706|Analgesics|analgesics|mesh-ancestor
2941832|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
2941833|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941834|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941835|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2941836|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2941837|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
2941838|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
2941839|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2941840|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2941841|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2349205|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2349206|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
2349207|NCT00484640|Warfarin|warfarin|mesh-list
2349208|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
2349209|NCT00484692|Bupropion|bupropion|mesh-list
2941842|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941843|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941844|NCT05217680|Bevacizumab|bevacizumab|mesh-list
2941845|NCT05217680|Ranibizumab|ranibizumab|mesh-list
2941846|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2941847|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941848|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2941849|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2941850|NCT05217680|Growth Substances|growth substances|mesh-ancestor
2941851|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941852|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
2941853|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
2941854|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2941855|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941856|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2941857|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941858|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2941859|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2941860|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
2941861|NCT05217589|Hormones|hormones|mesh-ancestor
2941862|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941863|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941864|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941865|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941866|NCT05217498|Istradefylline|istradefylline|mesh-list
2941867|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2941868|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2941869|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2941870|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
2941871|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941872|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349210|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2349211|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
2349212|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349213|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2941873|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941874|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
2941875|NCT05217446|Cetuximab|cetuximab|mesh-list
2941876|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2941877|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349214|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349215|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349216|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349217|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
2941878|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
2941879|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2941880|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2941881|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2941882|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2941883|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941884|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
2941885|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2941886|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941887|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2941888|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941889|NCT05217342|Diuretics|diuretics|mesh-list
2941890|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
2941891|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941892|NCT05217238|Remifentanil|remifentanil|mesh-list
2941893|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2941894|NCT05217238|Narcotics|narcotics|mesh-ancestor
2941895|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2941896|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941897|NCT05217238|Analgesics|analgesics|mesh-ancestor
2941898|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
2941899|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941900|NCT05217160|Morphine|morphine|mesh-list
2941901|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2941902|NCT05217160|Narcotics|narcotics|mesh-ancestor
2941903|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2941904|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941905|NCT05217160|Analgesics|analgesics|mesh-ancestor
2941906|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
2941907|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941908|NCT05217069|Leucovorin|leucovorin|mesh-list
2941909|NCT05217069|Folic Acid|folic acid|mesh-list
2941910|NCT05217069|Irinotecan|irinotecan|mesh-list
2941911|NCT05217069|Cetuximab|cetuximab|mesh-list
2941912|NCT05217069|Avelumab|avelumab|mesh-list
2941913|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
2349218|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349219|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349220|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2349221|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2349222|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941914|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2941915|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2941916|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941917|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941918|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941919|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2941920|NCT05217069|Antidotes|antidotes|mesh-ancestor
2941921|NCT05217069|Protective Agents|protective agents|mesh-ancestor
2941922|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349223|NCT00484731|Bupivacaine|bupivacaine|mesh-list
2349224|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
2349225|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
2349226|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349227|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349228|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
2349229|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349230|NCT00484744|Acetaminophen|acetaminophen|mesh-list
2349231|NCT00484744|Ibuprofen|ibuprofen|mesh-list
2349232|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2349233|NCT00484744|Analgesics|analgesics|mesh-ancestor
2941923|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
2941924|NCT05217069|Vitamins|vitamins|mesh-ancestor
2941925|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
2941926|NCT05217069|Hematinics|hematinics|mesh-ancestor
2941927|NCT05216952|Misoprostol|misoprostol|mesh-list
2941928|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
2941929|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2941930|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
2941931|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2941932|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941933|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2941934|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2941935|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
2941936|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2941937|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
2941938|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2941939|NCT05216822|Racecadotril|racecadotril|mesh-list
2941940|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
2941941|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2941942|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
2349234|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
2349235|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349236|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349237|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
2349238|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2349239|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2349240|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349241|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2349242|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349243|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349244|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2349245|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
2349246|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349247|NCT00484809|Etanercept|etanercept|mesh-list
2349248|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2349249|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2349250|NCT00484809|Analgesics|analgesics|mesh-ancestor
2349251|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
2349252|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349253|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349254|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2941943|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941944|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941945|NCT05216770|Bupivacaine|bupivacaine|mesh-list
2941946|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
2941947|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
2941948|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2941949|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941950|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
2941951|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941952|NCT05215470|Nivolumab|nivolumab|mesh-list
2941953|NCT05215470|Ipilimumab|ipilimumab|mesh-list
2349255|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349256|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2349257|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2349258|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
2349259|NCT00484822|Heparin|heparin|mesh-list
2349260|NCT00484822|Calcium heparin|calcium heparin|mesh-list
2349261|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
2349262|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2349263|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2349264|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349265|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2349266|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
2349267|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2349268|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2941954|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2941955|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941956|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2941957|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941958|NCT05211336|Prednisone|prednisone|mesh-list
2941959|NCT05211336|Nivolumab|nivolumab|mesh-list
2941960|NCT05211336|Lenalidomide|lenalidomide|mesh-list
2941961|NCT05211336|Venetoclax|venetoclax|mesh-list
2941962|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
2941963|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2941964|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
2941965|NCT05211336|Hormones|hormones|mesh-ancestor
2941966|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941967|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941968|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2941969|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941970|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2941971|NCT05211336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2941972|NCT05211336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2941973|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
2941974|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2941975|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2941976|NCT05211336|Growth Substances|growth substances|mesh-ancestor
2941977|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
2941978|NCT05195242|Dexamethasone|dexamethasone|mesh-list
2941979|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2941980|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
2941981|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
2941982|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941983|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2941984|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2941985|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
2941986|NCT05195242|Hormones|hormones|mesh-ancestor
2941987|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2941988|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2941989|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2941990|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
2941991|NCT05193565|Sirolimus|sirolimus|mesh-list
2941992|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2941993|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349269|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349270|NCT00484926|Aspirin|aspirin|mesh-list
2349271|NCT00484926|Clopidogrel|clopidogrel|mesh-list
2349272|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2941994|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2941995|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
2941996|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2941997|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349273|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2349274|NCT00484926|Analgesics|analgesics|mesh-ancestor
2349275|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
2349276|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2941998|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2941999|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349277|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349278|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2349279|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349280|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2349281|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2349282|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349283|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2349284|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2349285|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349286|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
2349287|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2349288|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2349289|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2349290|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
2349291|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349292|NCT00484991|Verapamil|verapamil|mesh-list
2349293|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2349294|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2349295|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349296|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942000|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
2942001|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2942002|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
2942003|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942004|NCT05192460|Vaccines|vaccines|mesh-list
2942005|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
2942006|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942007|NCT05186779|Progestins|progestins|mesh-list
2942008|NCT05186779|Hormones|hormones|mesh-ancestor
2942009|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2942010|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942011|NCT05185973|Micronutrients|micronutrients|mesh-list
2942012|NCT05185973|Trace Elements|trace elements|mesh-list
2942013|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942014|NCT05185947|Paclitaxel|paclitaxel|mesh-list
2942015|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2942016|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942017|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
2942018|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
2942019|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
2942020|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942021|NCT05178888|Palbociclib|palbociclib|mesh-list
2942022|NCT05178888|Adagrasib|adagrasib|mesh-list
2942023|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942024|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2942025|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942026|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942027|NCT05178550|Heparin|heparin|mesh-list
2942028|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
2942029|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2942030|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2942031|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942032|NCT05177133|Capecitabine|capecitabine|mesh-list
2942033|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
2942034|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2942035|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
2942036|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942037|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942038|NCT05176964|Capecitabine|capecitabine|mesh-list
2942039|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
2942040|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2942041|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
2942042|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942043|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942044|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2942045|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2942046|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2942047|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
2942048|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942049|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2942050|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2942051|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942052|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
2942053|NCT05175781|Ketamine|ketamine|mesh-list
2942054|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2942055|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2942056|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942057|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2942058|NCT05175781|Analgesics|analgesics|mesh-ancestor
2942059|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
2942060|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942061|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2942062|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2942063|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2942064|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
2942065|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942066|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942067|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2942068|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2942069|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
2942070|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
2942071|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2942072|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2942073|NCT05175768|Niacinamide|niacinamide|mesh-list
2942074|NCT05175768|Niacin|niacin|mesh-list
2942075|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
2942076|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
2942077|NCT05175768|Vitamins|vitamins|mesh-ancestor
2942078|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
2942079|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942080|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2942081|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
2942082|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942083|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2349297|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2349298|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349299|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
2349300|NCT00485004|Sirolimus|sirolimus|mesh-list
2349301|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2349302|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349303|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2349304|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349305|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
2349306|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2349307|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
2349308|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349309|NCT00485030|Sirolimus|sirolimus|mesh-list
2349310|NCT00485030|Everolimus|everolimus|mesh-list
2349311|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349312|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2349313|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
2349314|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349315|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2349316|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349317|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2349318|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
2349319|NCT00485056|Pioglitazone|pioglitazone|mesh-list
2349320|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2349321|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349322|NCT00485108|Prednisolone|prednisolone|mesh-list
2349323|NCT00485108|Ketorolac|ketorolac|mesh-list
2349324|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
2349325|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2942084|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
2942085|NCT05171647|Gemcitabine|gemcitabine|mesh-list
2942086|NCT05171647|Rituximab|rituximab|mesh-list
2942087|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
2942088|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942089|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942090|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
2942091|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942092|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2942093|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2942094|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
2942095|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942096|NCT05171647|Antiviral Agents|antiviral agents|mesh-ancestor
2942097|NCT05171647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349326|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
2349327|NCT00485108|Hormones|hormones|mesh-ancestor
2349328|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2942098|NCT05171647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942099|NCT05171647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2942100|NCT05170685|Nivolumab|nivolumab|mesh-list
2942101|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942102|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942103|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2942104|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942105|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2942106|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
2942107|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942108|NCT05170204|Durvalumab|durvalumab|mesh-list
2942109|NCT05170204|Pralsetinib|pralsetinib|mesh-list
2942110|NCT05170204|Entrectinib|entrectinib|mesh-list
2942111|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942112|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942113|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2942114|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942115|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942116|NCT05161754|Hemostatics|hemostatics|mesh-list
2942117|NCT05161754|Coagulants|coagulants|mesh-ancestor
2942118|NCT05160428|Vaccines|vaccines|mesh-list
2942119|NCT05160428|Immunologic Factors|immunologic factors|mesh-ancestor
2942120|NCT05160428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942121|NCT05155709|Azacitidine|azacitidine|mesh-list
2942122|NCT05155709|Venetoclax|venetoclax|mesh-list
2942123|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2942124|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
2942125|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942126|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942127|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942128|NCT05155033|Aldesleukin|aldesleukin|mesh-list
2942129|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
2942130|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942131|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349329|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349330|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2349331|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942132|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2942133|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2942134|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
2942135|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349332|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349333|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2349334|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2349335|NCT00485108|Analgesics|analgesics|mesh-ancestor
2349336|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
2349337|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349338|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2349339|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349340|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349341|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2942136|NCT05148234|Decitabine|decitabine|mesh-list
2942137|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2942138|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
2942139|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942140|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942141|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942142|NCT05146232|Anesthetics|anesthetics|mesh-list
2942143|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2942144|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942145|NCT05141305|Aspirin|aspirin|mesh-list
2942146|NCT05141305|Clopidogrel|clopidogrel|mesh-list
2942147|NCT05141305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2942148|NCT05141305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2942149|NCT05141305|Analgesics|analgesics|mesh-ancestor
2942150|NCT05141305|Sensory System Agents|sensory system agents|mesh-ancestor
2942151|NCT05141305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349342|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2349343|NCT00485121|Ezetimibe|ezetimibe|mesh-list
2349344|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2349345|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2349346|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
2349347|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942152|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942153|NCT05141305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2349348|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2349349|NCT00485160|Ibuprofen|ibuprofen|mesh-list
2349350|NCT00485160|Indomethacin|indomethacin|mesh-list
2349351|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2942154|NCT05141305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2942155|NCT05141305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2942156|NCT05141305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2942157|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942158|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2942159|NCT05141305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2349352|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2349353|NCT00485160|Analgesics|analgesics|mesh-ancestor
2349354|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
2349355|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349356|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349357|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2349358|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349359|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2349360|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349361|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349362|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
2349363|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
2349364|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2349365|NCT00485238|Acetazolamide|acetazolamide|mesh-list
2349366|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
2349367|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2349368|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349369|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349370|NCT00485238|Diuretics|diuretics|mesh-ancestor
2349371|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
2349372|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349373|NCT00485342|Interferons|interferons|mesh-list
2349374|NCT00485342|Ribavirin|ribavirin|mesh-list
2349375|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
2942160|NCT05141305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942161|NCT05141305|Antipyretics|antipyretics|mesh-ancestor
2942162|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2942163|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2942164|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2942165|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
2942166|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942167|NCT05125016|Cemiplimab|cemiplimab|mesh-list
2942168|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942169|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942170|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2942171|NCT05114746|177Lu-PSMA-617|177lu-psma-617|mesh-list
2942172|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2942173|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942174|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
2942175|NCT05114590|Lixisenatide|lixisenatide|mesh-list
2942176|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2349376|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
2349377|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2349378|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942177|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942178|NCT05114486|Pilocarpine|pilocarpine|mesh-list
2942179|NCT05114486|Miotics|miotics|mesh-ancestor
2942180|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
2942181|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942182|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942183|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2942184|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2942185|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
2942186|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942187|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942188|NCT05113251|Paclitaxel|paclitaxel|mesh-list
2942189|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
2942190|NCT05113251|Doxorubicin|doxorubicin|mesh-list
2942191|NCT05113251|Trastuzumab|trastuzumab|mesh-list
2942192|NCT05113251|Pertuzumab|pertuzumab|mesh-list
2942193|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2942194|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942195|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
2942196|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
2942197|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
2942198|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349379|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
2942199|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2942200|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
2942201|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942202|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2942203|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2942204|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
2942205|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2942206|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2349380|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349381|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
2349382|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349383|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
2349384|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349385|NCT00485368|Perindopril|perindopril|mesh-list
2349386|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2349387|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
2349388|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349389|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349390|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2349391|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2349392|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2349393|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349394|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349395|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349396|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
2349397|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349398|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349399|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2349400|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2349401|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349402|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349403|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349404|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
2349405|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349406|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349407|NCT00485498|Olanzapine|olanzapine|mesh-list
2349408|NCT00485498|Risperidone|risperidone|mesh-list
2349409|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2349410|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
2349411|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349412|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349413|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349414|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2349415|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2349416|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349417|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349418|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2349419|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
2349420|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
2942207|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2942208|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2942209|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942210|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942211|NCT05104723|Tofacitinib|tofacitinib|mesh-list
2349421|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
2349422|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349423|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2349424|NCT00485498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2349425|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349426|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349427|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
2349428|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349429|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
2349430|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349431|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349432|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2349433|NCT00485550|Methylphenidate|methylphenidate|mesh-list
2349434|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2349435|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2349436|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349437|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2942212|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2942213|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942214|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942215|NCT05103605|Osimertinib|osimertinib|mesh-list
2942216|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942217|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2942218|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942219|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942220|NCT05096169|Citric Acid|citric acid|mesh-list
2942221|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
2942222|NCT05096169|Clomiphene|clomiphene|mesh-list
2942223|NCT05096169|Enclomiphene|enclomiphene|mesh-list
2942224|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
2942225|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
2942226|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2942227|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
2942228|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
2942229|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942230|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2349438|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349439|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349440|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349441|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
2942231|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
2942232|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2942233|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942234|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2942235|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
2942236|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2942237|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2942238|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2942239|NCT05089708|Trifarotene|trifarotene|mesh-list
2942240|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
2942241|NCT05078879|Empagliflozin|empagliflozin|mesh-list
2942242|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2942243|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942244|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2942245|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942246|NCT05072184|Anesthetics|anesthetics|mesh-list
2942247|NCT05072184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2942248|NCT05072184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942249|NCT05066308|Cannabidiol|cannabidiol|mesh-list
2942250|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
2942251|NCT05065294|Psilocybin|psilocybin|mesh-list
2942252|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
2942253|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
2942254|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942255|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2942256|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2942257|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
2942258|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942259|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942260|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2942261|NCT05063201|Cariprazine|cariprazine|mesh-list
2942262|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2942263|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2942264|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2942265|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942266|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2942267|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2942268|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2942269|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
2942270|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2942271|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2942272|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942273|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
2942274|NCT05053867|Coagulants|coagulants|mesh-ancestor
2942275|NCT05052970|Dexamethasone|dexamethasone|mesh-list
2942276|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
2942277|NCT05052970|Bortezomib|bortezomib|mesh-list
2942278|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
2942279|NCT05052970|BB 1101|bb 1101|mesh-list
2942280|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2942281|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
2942282|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
2942283|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942284|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349442|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349443|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2349444|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
2349445|NCT00485563|Folic Acid|folic acid|mesh-list
2349446|NCT00485563|Vitamin B Complex|vitamin b complex|mesh-list
2349447|NCT00485563|Interferons|interferons|mesh-list
2349448|NCT00485563|Interferon-alpha|interferon-alpha|mesh-list
2349449|NCT00485563|Interleukin-2|interleukin-2|mesh-list
2349450|NCT00485563|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2349451|NCT00485563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349452|NCT00485563|Antiviral Agents|antiviral agents|mesh-ancestor
2349453|NCT00485563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349454|NCT00485563|Immunologic Factors|immunologic factors|mesh-ancestor
2349455|NCT00485563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349456|NCT00485563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2349457|NCT00485563|Analgesics|analgesics|mesh-ancestor
2349458|NCT00485563|Sensory System Agents|sensory system agents|mesh-ancestor
2349459|NCT00485563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349460|NCT00485563|Hematinics|hematinics|mesh-ancestor
2349461|NCT00485563|Vitamins|vitamins|mesh-ancestor
2349462|NCT00485563|Micronutrients|micronutrients|mesh-ancestor
2349463|NCT00485563|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2349464|NCT00485576|Eculizumab|eculizumab|mesh-list
2349465|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2349466|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2349467|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
2349468|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349469|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2349470|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2349471|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2942285|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2942286|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
2942287|NCT05052970|Hormones|hormones|mesh-ancestor
2942288|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2942289|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2942290|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942291|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
2942292|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942293|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942294|NCT05052970|Analgesics|analgesics|mesh-ancestor
2942295|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
2942296|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2942297|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2942298|NCT05050916|Vitamin D|vitamin d|mesh-list
2942299|NCT05050916|Vitamins|vitamins|mesh-ancestor
2942300|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
2942301|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942302|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2942303|NCT05039177|Cetuximab|cetuximab|mesh-list
2942304|NCT05039177|Palbociclib|palbociclib|mesh-list
2942305|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942306|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942307|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2942308|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942309|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349472|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349473|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349474|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
2349475|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349476|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349477|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
2349478|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2349479|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349480|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2349481|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2349482|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349483|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349484|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349485|NCT00485680|Olanzapine|olanzapine|mesh-list
2349486|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
2349487|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
2349488|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
2349489|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349490|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349491|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2349492|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2942310|NCT05035407|Aldesleukin|aldesleukin|mesh-list
2942311|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
2942312|NCT05035407|Fludarabine|fludarabine|mesh-list
2942313|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2942314|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
2942315|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942316|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2942317|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2942318|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
2942319|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942320|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942321|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2942322|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2942323|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2349493|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2349494|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349495|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349496|NCT00485680|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2349497|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349498|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349499|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349500|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349501|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
2349502|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
2942324|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
2942325|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2942326|NCT05034367|Mannitol|mannitol|mesh-list
2942327|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2942328|NCT05034367|Diuretics|diuretics|mesh-ancestor
2942329|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
2942330|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942331|NCT05029973|Bevacizumab|bevacizumab|mesh-list
2942332|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942333|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942334|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2942335|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2942336|NCT05029973|Growth Substances|growth substances|mesh-ancestor
2942337|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942338|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
2942339|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
2942340|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2942341|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2942342|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2942343|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349503|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349504|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
2349505|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
2942344|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942345|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
2942346|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942347|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942348|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2942349|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942350|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
2942351|NCT05027945|Sirolimus|sirolimus|mesh-list
2942352|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
2942353|NCT05027945|Busulfan|busulfan|mesh-list
2942354|NCT05027945|Fludarabine|fludarabine|mesh-list
2942355|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2942356|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
2942357|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942358|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2942359|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2942360|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
2942361|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942362|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942363|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2349506|NCT00485706|Calcium|calcium|mesh-list
2349507|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2349508|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349509|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2349510|NCT00485771|Lamotrigine|lamotrigine|mesh-list
2349511|NCT00485771|Olanzapine|olanzapine|mesh-list
2942364|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2942365|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2942366|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
2942367|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2942368|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2942369|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942370|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
2942371|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2942372|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942373|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349512|NCT00485771|Fluoxetine|fluoxetine|mesh-list
2349513|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
2349514|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
2349515|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349516|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349517|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2349518|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2349519|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2349520|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349521|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349522|NCT00485771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2349523|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349524|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349525|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349526|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349527|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
2349528|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2349529|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
2349530|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2349531|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2349532|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349533|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
2349534|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2349535|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2349536|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2349537|NCT00485797|Methylphenidate|methylphenidate|mesh-list
2942374|NCT05024032|Tirzepatide|tirzepatide|mesh-list
2942375|NCT05024032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2942376|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942377|NCT05024032|Incretins|incretins|mesh-ancestor
2942378|NCT05024032|Hormones|hormones|mesh-ancestor
2942379|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2942380|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2942381|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2942382|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
2942383|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942384|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942385|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942386|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2942387|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2942388|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942389|NCT05008783|Capecitabine|capecitabine|mesh-list
2942390|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
2942391|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2942392|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
2942393|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942394|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942395|NCT05005728|Carboplatin|carboplatin|mesh-list
2942396|NCT05005728|Olaparib|olaparib|mesh-list
2942397|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942398|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2942399|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942400|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942401|NCT04994977|Carboplatin|carboplatin|mesh-list
2942402|NCT04994977|Melphalan|melphalan|mesh-list
2942403|NCT04994977|Topotecan|topotecan|mesh-list
2942404|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942405|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2942406|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
2942407|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942408|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2942409|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2942410|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
2942411|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942412|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2942413|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2349538|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2349539|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942414|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942415|NCT04992065|Evolocumab|evolocumab|mesh-list
2942416|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2942417|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2942418|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
2942419|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942420|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2942421|NCT04986579|Trastuzumab|trastuzumab|mesh-list
2942422|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942423|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942424|NCT04984044|Vitamin D|vitamin d|mesh-list
2942425|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
2942426|NCT04984044|Vitamins|vitamins|mesh-ancestor
2942427|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
2942428|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942429|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2942430|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2349540|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2349541|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349542|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349543|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349544|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
2349545|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942431|NCT04977986|Cannabidiol|cannabidiol|mesh-list
2942432|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
2942433|NCT04969250|Vaccines|vaccines|mesh-list
2942434|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
2942435|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942436|NCT04967664|Capsaicin|capsaicin|mesh-list
2942437|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
2942438|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
2942439|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
2942440|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942441|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942442|NCT04959981|Osimertinib|osimertinib|mesh-list
2942443|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942444|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2942445|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942446|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942447|NCT04951492|Olaparib|olaparib|mesh-list
2942448|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2942449|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942450|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942451|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942452|NCT04933617|Prednisone|prednisone|mesh-list
2942453|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
2942454|NCT04933617|Rituximab|rituximab|mesh-list
2942455|NCT04933617|Doxorubicin|doxorubicin|mesh-list
2942456|NCT04933617|Etoposide|etoposide|mesh-list
2942457|NCT04933617|Vincristine|vincristine|mesh-list
2942458|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2942459|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
2942460|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942461|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2942462|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2942463|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
2942464|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349546|NCT00485810|Olanzapine|olanzapine|mesh-list
2349547|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
2349548|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
2349549|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349550|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349551|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2349552|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2942465|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942466|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2349553|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2349554|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349555|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349556|NCT00485810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2349557|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349558|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2942467|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942468|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2942469|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2942470|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2942471|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942472|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2942473|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
2942474|NCT04933617|Hormones|hormones|mesh-ancestor
2942475|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2942476|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2942477|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2942478|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
2942479|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
2942480|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
2942481|NCT04933539|Dexamethasone|dexamethasone|mesh-list
2942482|NCT04933539|Daratumumab|daratumumab|mesh-list
2942483|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2942484|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
2942485|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
2942486|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942487|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942488|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2942489|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
2942490|NCT04933539|Hormones|hormones|mesh-ancestor
2942491|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2942492|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2942493|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942494|NCT04930315|Apatinib|apatinib|mesh-list
2349559|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942495|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942496|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2942497|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942498|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942499|NCT04921007|Bupivacaine|bupivacaine|mesh-list
2942500|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
2942501|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
2942502|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2942503|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942504|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
2942505|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942506|NCT04920994|Bupivacaine|bupivacaine|mesh-list
2942507|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
2942508|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
2942509|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2942510|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942511|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
2942512|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942513|NCT04919226|Leucovorin|leucovorin|mesh-list
2942514|NCT04919226|Folic Acid|folic acid|mesh-list
2942515|NCT04919226|Fluorouracil|fluorouracil|mesh-list
2942516|NCT04919226|Capecitabine|capecitabine|mesh-list
2942517|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
2942518|NCT04919226|Everolimus|everolimus|mesh-list
2942519|NCT04919226|Temozolomide|temozolomide|mesh-list
2942520|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2942521|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
2942522|NCT04919226|Edotreotide|edotreotide|mesh-list
2349560|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349561|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
2349562|NCT00485823|Olanzapine|olanzapine|mesh-list
2349563|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
2349564|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
2942523|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
2942524|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942525|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2942526|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942527|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2942528|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
2942529|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942530|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2942531|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
2942532|NCT04919226|Antidotes|antidotes|mesh-ancestor
2942533|NCT04919226|Protective Agents|protective agents|mesh-ancestor
2942534|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
2942535|NCT04919226|Vitamins|vitamins|mesh-ancestor
2942536|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
2349565|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942537|NCT04919226|Hematinics|hematinics|mesh-ancestor
2942538|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2942539|NCT04915183|Atorvastatin|atorvastatin|mesh-list
2942540|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2942541|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2942542|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
2942543|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942544|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2942545|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2942546|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942547|NCT04909515|Isotretinoin|isotretinoin|mesh-list
2942548|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
2942549|NCT04908605|Melatonin|melatonin|mesh-list
2942550|NCT04908605|Mirtazapine|mirtazapine|mesh-list
2942551|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
2942552|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942553|NCT04908605|Protective Agents|protective agents|mesh-ancestor
2942554|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942555|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2942556|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
2942557|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2942558|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2942559|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
2942560|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
2942561|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942562|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2942563|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2942564|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2942565|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2942566|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2942567|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
2942568|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2942569|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2942570|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
2349566|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349567|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2349568|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2349569|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2349570|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349571|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349572|NCT00485823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2349573|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349574|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349575|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349576|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349577|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
2349578|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2349579|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2942571|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2942572|NCT04908579|Ketamine|ketamine|mesh-list
2942573|NCT04908579|Bupivacaine|bupivacaine|mesh-list
2942574|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
2942575|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
2942576|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2942577|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942578|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
2942579|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942580|NCT04908579|Analgesics|analgesics|mesh-ancestor
2942581|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2942582|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2942583|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
2942584|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2942585|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2942586|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942587|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942588|NCT04908202|BMS-986165|bms-986165|mesh-list
2942589|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
2942590|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2349580|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349581|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349582|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349583|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
2349584|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349585|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349586|NCT00485862|Sertraline|sertraline|mesh-list
2942591|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349587|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2349588|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
2349589|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349590|NCT00485862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2349591|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349592|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349593|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349594|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349595|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
2349596|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349597|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2349598|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
2942592|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942593|NCT04908189|Apremilast|apremilast|mesh-list
2942594|NCT04908189|BMS-986165|bms-986165|mesh-list
2942595|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2942596|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2942597|NCT04908189|Analgesics|analgesics|mesh-ancestor
2942598|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
2942599|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942600|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942601|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2942602|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2942603|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2942604|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2942605|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942606|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349599|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2349600|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2349601|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349602|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349603|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349604|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
2942607|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
2942608|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2942609|NCT04903210|Niacinamide|niacinamide|mesh-list
2942610|NCT04903210|Niacin|niacin|mesh-list
2942611|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
2942612|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
2942613|NCT04903210|Vitamins|vitamins|mesh-ancestor
2942614|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
2942615|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349605|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349606|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349607|NCT00485888|Citalopram|citalopram|mesh-list
2349608|NCT00485888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2349609|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349610|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349611|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349612|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349613|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
2349614|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349615|NCT00485888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2942616|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2942617|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
2942618|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942619|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2942620|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
2942621|NCT04900116|Bupivacaine|bupivacaine|mesh-list
2942622|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
2942623|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
2942624|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2942625|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942626|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
2942627|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942628|NCT04896658|Dexamethasone|dexamethasone|mesh-list
2942629|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
2942630|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2942631|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
2942632|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942633|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2942634|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2942635|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
2942636|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942637|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942638|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2942639|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2942640|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
2942641|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
2349616|NCT00485888|Antidepressive Agents|antidepressive agents|mesh-ancestor
2349617|NCT00485888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349618|NCT00485901|Haloperidol|haloperidol|mesh-list
2349619|NCT00485901|Olanzapine|olanzapine|mesh-list
2349620|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
2349621|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
2349622|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
2349623|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349624|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349625|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2349626|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2349627|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2942642|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942643|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2942644|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
2942645|NCT04896658|Hormones|hormones|mesh-ancestor
2942646|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2942647|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2942648|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
2942649|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2942650|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
2942651|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942652|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942653|NCT04895709|Nivolumab|nivolumab|mesh-list
2942654|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942655|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942656|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2942657|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942658|NCT04890093|Vincristine|vincristine|mesh-list
2942659|NCT04890093|Temozolomide|temozolomide|mesh-list
2942660|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2942661|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942662|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
2942663|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
2942664|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
2942665|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942666|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2942667|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
2942668|NCT04887506|Prednisone|prednisone|mesh-list
2942669|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
2942670|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2942671|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
2942672|NCT04887506|Hormones|hormones|mesh-ancestor
2942673|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2942674|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942675|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2942676|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942677|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2942678|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942679|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942680|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
2942681|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2942682|NCT04882085|Ceftazidime|ceftazidime|mesh-list
2942683|NCT04882085|Avibactam|avibactam|mesh-list
2942684|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
2942685|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2942686|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2942687|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2942688|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349628|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349629|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349630|NCT00485901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2349631|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349632|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349633|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942689|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942690|NCT04858425|Niclosamide|niclosamide|mesh-list
2942691|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
2942692|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2942693|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
2349634|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349635|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
2349636|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2349637|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
2349638|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2349639|NCT00485940|Prucalopride|prucalopride|mesh-list
2349640|NCT00485940|Laxatives|laxatives|mesh-ancestor
2349641|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2942694|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2942695|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2942696|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
2942697|NCT04858334|Olaparib|olaparib|mesh-list
2942698|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2942699|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942700|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942701|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349642|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2349643|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2349644|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
2349645|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349646|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349647|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349648|NCT00485979|Docetaxel|docetaxel|mesh-list
2349649|NCT00485979|Trastuzumab|trastuzumab|mesh-list
2349650|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349651|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
2349652|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
2942702|NCT04857034|BMS-986165|bms-986165|mesh-list
2942703|NCT04857034|Dermatologic Agents|dermatologic agents|mesh-ancestor
2942704|NCT04857034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2942705|NCT04857034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942706|NCT04857034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942707|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2942708|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2942709|NCT04826393|Cemiplimab|cemiplimab|mesh-list
2942710|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942711|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942712|NCT04818632|Everolimus|everolimus|mesh-list
2942713|NCT04818632|Palbociclib|palbociclib|mesh-list
2942714|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942715|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2942716|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
2942717|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942718|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2942719|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942720|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942721|NCT04813926|Riociguat|riociguat|mesh-list
2942722|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
2942723|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942724|NCT04812548|Azacitidine|azacitidine|mesh-list
2942725|NCT04812548|Venetoclax|venetoclax|mesh-list
2942726|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2942727|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
2942728|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942729|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942730|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942731|NCT04810078|Nivolumab|nivolumab|mesh-list
2942732|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942733|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942734|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2942735|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942736|NCT04802837|Vancomycin|vancomycin|mesh-list
2942737|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2942738|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2942739|NCT04779138|Vaccines|vaccines|mesh-list
2942740|NCT04779138|Immunologic Factors|immunologic factors|mesh-ancestor
2942741|NCT04779138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942742|NCT04769401|Progesterone|progesterone|mesh-list
2942743|NCT04769401|Progestins|progestins|mesh-ancestor
2942744|NCT04769401|Hormones|hormones|mesh-ancestor
2942745|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2942746|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942747|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
2942748|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2942749|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2942750|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2942751|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2942752|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2942753|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942754|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
2942755|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942756|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942757|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2942758|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942759|NCT04762680|Vaccines|vaccines|mesh-list
2942760|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
2942761|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942762|NCT04751370|Nivolumab|nivolumab|mesh-list
2349653|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
2349654|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349655|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2349656|NCT00486005|Olanzapine|olanzapine|mesh-list
2349657|NCT00486005|Nizatidine|nizatidine|mesh-list
2349658|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
2942763|NCT04751370|Ipilimumab|ipilimumab|mesh-list
2942764|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942765|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942766|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2942767|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942768|NCT04750226|Levodopa|levodopa|mesh-list
2942769|NCT04750226|Carbidopa|carbidopa|mesh-list
2942770|NCT04750226|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2942771|NCT04750226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2942772|NCT04750226|Dopamine Agents|dopamine agents|mesh-ancestor
2942773|NCT04750226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942774|NCT04750226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942775|NCT04750226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942776|NCT04750226|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2942777|NCT04750226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942778|NCT04742023|Insulin|insulin|mesh-list
2942779|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2942780|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942781|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
2942782|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2942783|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2349659|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
2349660|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349661|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349662|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2349663|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2349664|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2349665|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349666|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349667|NCT00486005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2942784|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942785|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
2942786|NCT04733157|Coagulants|coagulants|mesh-ancestor
2942787|NCT04727424|Budesonide|budesonide|mesh-list
2942788|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
2942789|NCT04727424|Maleic acid|maleic acid|mesh-list
2942790|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2942791|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2942792|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
2942793|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942794|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942795|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2942796|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
2942797|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
2942798|NCT04727424|Hormones|hormones|mesh-ancestor
2942799|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2942800|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349668|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349669|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349670|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349671|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349672|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
2349673|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2349674|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2349675|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
2349676|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
2349677|NCT00486083|Methylphenidate|methylphenidate|mesh-list
2349678|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2942801|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942802|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2942803|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2942804|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2942805|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2942806|NCT04727424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2942807|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2942808|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2942809|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942810|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
2942811|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2349679|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2349680|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349681|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2349682|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349683|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349684|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349685|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
2349686|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349687|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2349688|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
2942812|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
2942813|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2942814|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2942815|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2942816|NCT04724252|Gabapentin|gabapentin|mesh-list
2942817|NCT04724252|Analgesics|analgesics|mesh-ancestor
2942818|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
2942819|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942820|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942821|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
2349689|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2349690|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2349691|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2349692|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349693|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349694|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
2349695|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349696|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349697|NCT00486174|Methylene Blue|methylene blue|mesh-list
2349698|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942822|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2942823|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2942824|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2942825|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2942826|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2942827|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2942828|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942829|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942830|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
2942831|NCT04720781|Esomeprazole|esomeprazole|mesh-list
2942832|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2942833|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2942834|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2349699|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349700|NCT00486187|Metformin|metformin|mesh-list
2349701|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
2349702|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2349703|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349704|NCT00486200|Valacyclovir|valacyclovir|mesh-list
2349705|NCT00486200|Antiviral Agents|antiviral agents|mesh-ancestor
2349706|NCT00486200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349707|NCT00486213|Pyridoxine|pyridoxine|mesh-list
2349708|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
2349709|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
2349710|NCT00486213|Vitamins|vitamins|mesh-ancestor
2349711|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
2942835|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942836|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942837|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2942838|NCT04720157|177Lu-PSMA-617|177lu-psma-617|mesh-list
2942839|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2942840|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942841|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
2942842|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2942843|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2942844|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
2942845|NCT04719208|Listerine|listerine|mesh-list
2942846|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2942847|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2349712|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349713|NCT00486317|Calcitonin|calcitonin|mesh-list
2349714|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
2942848|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2942849|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
2942850|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
2942851|NCT04718116|Tramadol|tramadol|mesh-list
2942852|NCT04718116|Tapentadol|tapentadol|mesh-list
2942853|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2942854|NCT04718116|Narcotics|narcotics|mesh-ancestor
2942855|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2942856|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942857|NCT04718116|Analgesics|analgesics|mesh-ancestor
2942858|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
2942859|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942860|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2942861|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2942862|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2942863|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942864|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
2942865|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942866|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
2942867|NCT04717375|Cetuximab|cetuximab|mesh-list
2942868|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942869|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942870|NCT04707872|Antibodies|antibodies|mesh-list
2942871|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
2942872|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942873|NCT04706715|Cemiplimab|cemiplimab|mesh-list
2942874|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942875|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942876|NCT04701190|Norepinephrine|norepinephrine|mesh-list
2942877|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349715|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2349716|NCT00486317|Katacalcin|katacalcin|mesh-list
2349717|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2349718|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349719|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2349720|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
2349721|NCT00486343|Zileuton|zileuton|mesh-list
2349722|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2349723|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2349724|NCT00486343|Analgesics|analgesics|mesh-ancestor
2349725|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
2349726|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349727|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349728|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2349729|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349730|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2349731|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349732|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349733|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2349734|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
2349735|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2349736|NCT00486356|Carboplatin|carboplatin|mesh-list
2349737|NCT00486356|Capecitabine|capecitabine|mesh-list
2349738|NCT00486356|Epirubicin|epirubicin|mesh-list
2942878|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2942879|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2942880|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
2942881|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942882|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942883|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
2349739|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349740|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2349741|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
2349742|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349743|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2349744|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2942884|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
2112011|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112012|NCT02563860|Lovastatin|lovastatin|mesh-list
2112013|NCT02563860|L 647318|l 647318|mesh-list
2112014|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
2112015|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2112016|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2112017|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
2112018|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112019|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2112020|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2942885|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942886|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2942887|NCT04700423|Ivermectin|ivermectin|mesh-list
2942888|NCT04700423|Albendazole|albendazole|mesh-list
2942889|NCT04700423|Moxidectin|moxidectin|mesh-list
2942890|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2942891|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2942892|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
2942893|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
2942894|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2942895|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2942896|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
2942897|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
2942898|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
2942899|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942900|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942901|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
2942902|NCT04699604|Levocetirizine|levocetirizine|mesh-list
2942903|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2942904|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2942905|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
2942906|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
2942907|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942908|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942909|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942910|NCT04671082|Tolperisone|tolperisone|mesh-list
2942911|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2942912|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942913|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2942914|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942915|NCT04666454|Adenosine|adenosine|mesh-list
2942916|NCT04666454|Dipyridamole|dipyridamole|mesh-list
2942917|NCT04666454|Apixaban|apixaban|mesh-list
2942918|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2942919|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
2942920|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2942921|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
2942922|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942923|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942924|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
2942925|NCT04666454|Analgesics|analgesics|mesh-ancestor
2942926|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
2942927|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2942928|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942929|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2942930|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
2942931|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2942932|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
2942933|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
2942934|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2942935|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2942936|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2942937|NCT04660760|Trifluridine|trifluridine|mesh-list
2942938|NCT04660760|Paclitaxel|paclitaxel|mesh-list
2942939|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2942940|NCT04660760|Ramucirumab|ramucirumab|mesh-list
2942941|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2942942|NCT04660760|Antibodies|antibodies|mesh-list
2942943|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
2349745|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2349746|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349747|NCT00486369|Calcitonin|calcitonin|mesh-list
2349748|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
2349749|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2349750|NCT00486369|Katacalcin|katacalcin|mesh-list
2349751|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2349752|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942944|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2942945|NCT04660760|Lexatumumab|lexatumumab|mesh-list
2942946|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2942947|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942948|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
2942949|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
2942950|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
2942951|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942952|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
2942953|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2942954|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
2942955|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
2942956|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2942957|NCT04639843|Doxorubicin|doxorubicin|mesh-list
2942958|NCT04639843|Romidepsin|romidepsin|mesh-list
2942959|NCT04639843|Azacitidine|azacitidine|mesh-list
2942960|NCT04639843|Cc-486|cc-486|mesh-list
2942961|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2942962|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942963|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2942964|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2942965|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942966|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942967|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2942968|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
2942969|NCT04639219|Trastuzumab|trastuzumab|mesh-list
2942970|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942971|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2942972|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
2942973|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2942974|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2942975|NCT04623775|Paclitaxel|paclitaxel|mesh-list
2942976|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2942977|NCT04623775|Carboplatin|carboplatin|mesh-list
2942978|NCT04623775|Nivolumab|nivolumab|mesh-list
2942979|NCT04623775|Pemetrexed|pemetrexed|mesh-list
2942980|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2942981|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349753|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2349754|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
2349755|NCT00486421|Prednisone|prednisone|mesh-list
2349756|NCT00486421|Rituximab|rituximab|mesh-list
2349757|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2349758|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349759|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
2349760|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349761|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349762|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2349763|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
2349764|NCT00486421|Hormones|hormones|mesh-ancestor
2942982|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
2942983|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
2942984|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
2942985|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942986|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2942987|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2942988|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942989|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2942990|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2942991|NCT04613518|BMS-986165|bms-986165|mesh-list
2942992|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
2942993|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2942994|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2942995|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2942996|NCT04606316|Nivolumab|nivolumab|mesh-list
2942997|NCT04606316|Ipilimumab|ipilimumab|mesh-list
2942998|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2349765|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2942999|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943000|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2943001|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943002|NCT04601883|Colchicine|colchicine|mesh-list
2943003|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
2943004|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2943005|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
2349766|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2349767|NCT00486460|Gemcitabine|gemcitabine|mesh-list
2349768|NCT00486460|Curcumin|curcumin|mesh-list
2349769|NCT00486460|Celecoxib|celecoxib|mesh-list
2349770|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2349771|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
2943006|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
2943007|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
2943008|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943009|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943010|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
2943011|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2943012|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943013|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2943014|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943015|NCT04593927|Siponimod|siponimod|mesh-list
2943016|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2943017|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943018|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2943019|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
2943020|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943021|NCT04579640|Vitamin D|vitamin d|mesh-list
2943022|NCT04579640|Vitamins|vitamins|mesh-ancestor
2943023|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
2943024|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943025|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2943026|NCT04579380|Trastuzumab|trastuzumab|mesh-list
2943027|NCT04579380|Fulvestrant|fulvestrant|mesh-list
2943028|NCT04579380|Tucatinib|tucatinib|mesh-list
2349772|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349773|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349774|NCT00486460|Antiviral Agents|antiviral agents|mesh-ancestor
2349775|NCT00486460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349776|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349777|NCT00486460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2349778|NCT00486460|Immunologic Factors|immunologic factors|mesh-ancestor
2349779|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349780|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2349781|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2349782|NCT00486460|Analgesics|analgesics|mesh-ancestor
2349783|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
2349784|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349785|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2349786|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349787|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2943029|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943030|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943031|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2943032|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2943033|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2943034|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
2943035|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2943036|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943037|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2943038|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943039|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943040|NCT04579224|Gemcitabine|gemcitabine|mesh-list
2943041|NCT04579224|Paclitaxel|paclitaxel|mesh-list
2943042|NCT04579224|Docetaxel|docetaxel|mesh-list
2943043|NCT04579224|Halichondrin B|halichondrin b|mesh-list
2349788|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2349789|NCT00486486|Timolol|timolol|mesh-list
2349790|NCT00486486|Bimatoprost|bimatoprost|mesh-list
2349791|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2349792|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2349793|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
2349794|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349795|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349796|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349797|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2349798|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2349799|NCT00486512|Aspirin|aspirin|mesh-list
2349800|NCT00486512|Calcium, Dietary|calcium, dietary|mesh-list
2349801|NCT00486512|Calcitriol|calcitriol|mesh-list
2349802|NCT00486512|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
2349803|NCT00486512|Calcium Carbonate|calcium carbonate|mesh-list
2349804|NCT00486512|Calcium|calcium|mesh-list
2349805|NCT00486512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2349806|NCT00486512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349807|NCT00486512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2349808|NCT00486512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2349809|NCT00486512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2349810|NCT00486512|Analgesics|analgesics|mesh-ancestor
2349811|NCT00486512|Sensory System Agents|sensory system agents|mesh-ancestor
2349812|NCT00486512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349813|NCT00486512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2349814|NCT00486512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349815|NCT00486512|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2349816|NCT00486512|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2349817|NCT00486512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349818|NCT00486512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2349819|NCT00486512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2349820|NCT00486512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349821|NCT00486512|Antipyretics|antipyretics|mesh-ancestor
2349822|NCT00486512|Antacids|antacids|mesh-ancestor
2349823|NCT00486512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2349824|NCT00486512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2349825|NCT00486512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349826|NCT00486512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2349827|NCT00486512|Vitamins|vitamins|mesh-ancestor
2349828|NCT00486512|Micronutrients|micronutrients|mesh-ancestor
2349829|NCT00486564|Nifurtimox|nifurtimox|mesh-list
2349830|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2349831|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2349832|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2349833|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349834|NCT00486668|Paclitaxel|paclitaxel|mesh-list
2349835|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
2349836|NCT00486668|Doxorubicin|doxorubicin|mesh-list
2349837|NCT00486668|Trastuzumab|trastuzumab|mesh-list
2349838|NCT00486668|Lapatinib|lapatinib|mesh-list
2349839|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2349840|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349841|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
2349842|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
2349843|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
2349844|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349845|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2349846|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
2349847|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349848|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349849|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2943044|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2943045|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2943046|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943047|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
2943048|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
2943049|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
2943050|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943051|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2943052|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
2943053|NCT04579224|Antiviral Agents|antiviral agents|mesh-ancestor
2943054|NCT04579224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943055|NCT04579224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943056|NCT04579224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2349850|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
2349851|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2349852|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2349853|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2349854|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2349855|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349856|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2349857|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2349858|NCT00486694|Artesunate|artesunate|mesh-list
2349859|NCT00486694|Chloroquine|chloroquine|mesh-list
2943057|NCT04579224|Immunologic Factors|immunologic factors|mesh-ancestor
2943058|NCT04579224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943059|NCT04573777|Evolocumab|evolocumab|mesh-list
2943060|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2943061|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2943062|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
2943063|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943064|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2943065|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
2943066|NCT04566133|Trametinib|trametinib|mesh-list
2943067|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
2943068|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2943069|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2943070|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943071|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943072|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943073|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2943074|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943075|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2943076|NCT04564898|Trifluridine|trifluridine|mesh-list
2943077|NCT04564898|Bevacizumab|bevacizumab|mesh-list
2943078|NCT04564898|Capecitabine|capecitabine|mesh-list
2943079|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943080|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943081|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2943082|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2943083|NCT04564898|Growth Substances|growth substances|mesh-ancestor
2943084|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943085|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
2943086|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2943087|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
2349860|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
2349861|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
2349862|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2349863|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
2349864|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2349865|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2349866|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349867|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349868|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
2349869|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
2349870|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2349871|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
2349872|NCT00486694|Amebicides|amebicides|mesh-ancestor
2349873|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349874|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2349875|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943088|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943089|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
2943090|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943091|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
2943092|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2943093|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
2943094|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2943095|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943096|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2943097|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943098|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943099|NCT04560166|Irinotecan|irinotecan|mesh-list
2943100|NCT04560166|Temozolomide|temozolomide|mesh-list
2943101|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2943102|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2943103|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943104|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943105|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943106|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2943107|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
2943108|NCT04559646|Hemostatics|hemostatics|mesh-list
2943109|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2943110|NCT04559646|Coagulants|coagulants|mesh-ancestor
2943111|NCT04546126|Dexamethasone|dexamethasone|mesh-list
2943112|NCT04546126|Cosyntropin|cosyntropin|mesh-list
2943113|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2943114|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
2349876|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943115|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
2943116|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349877|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2349878|NCT00486694|Renal Agents|renal agents|mesh-ancestor
2349879|NCT00486772|Calcium|calcium|mesh-list
2943117|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943118|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2943119|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
2943120|NCT04546126|Hormones|hormones|mesh-ancestor
2943121|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2943122|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2943123|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943124|NCT04538352|Insulin|insulin|mesh-list
2943125|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2943126|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
2943127|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2943128|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943129|NCT04531176|Liraglutide|liraglutide|mesh-list
2943130|NCT04531176|Topiramate|topiramate|mesh-list
2943131|NCT04531176|Orlistat|orlistat|mesh-list
2943132|NCT04531176|Phentermine|phentermine|mesh-list
2943133|NCT04531176|Naltrexone|naltrexone|mesh-list
2943134|NCT04531176|Bupropion|bupropion|mesh-list
2943135|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2943136|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2943137|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943138|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
2943139|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943140|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2943141|NCT04531176|Incretins|incretins|mesh-ancestor
2943142|NCT04531176|Hormones|hormones|mesh-ancestor
2943143|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2349880|NCT00486772|Sevelamer|sevelamer|mesh-list
2349881|NCT00486772|Calcium acetate|calcium acetate|mesh-list
2349882|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2943144|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2943145|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
2943146|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2943147|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2943148|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2943149|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2943150|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943151|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
2943152|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2943153|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2943154|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2943155|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943156|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
2943157|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2943158|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2943159|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2943160|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
2943161|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
2943162|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
2943163|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
2349883|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349884|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
2349885|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
2349886|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349887|NCT00486785|Alfuzosin|alfuzosin|mesh-list
2349888|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2349889|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2349890|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2349891|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
2349892|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349893|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349894|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349895|NCT00486785|Urological Agents|urological agents|mesh-ancestor
2943164|NCT04519619|Aflibercept|aflibercept|mesh-list
2943165|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2943166|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2943167|NCT04519619|Growth Substances|growth substances|mesh-ancestor
2943168|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943169|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
2943170|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2349896|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2943171|NCT04499924|Paclitaxel|paclitaxel|mesh-list
2943172|NCT04499924|Trastuzumab|trastuzumab|mesh-list
2349897|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
2349898|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349899|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2943173|NCT04499924|Ramucirumab|ramucirumab|mesh-list
2943174|NCT04499924|Tucatinib|tucatinib|mesh-list
2943175|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2943176|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943177|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
2943178|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
2943179|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
2943180|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943181|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943182|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2943183|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943184|NCT04498117|Paclitaxel|paclitaxel|mesh-list
2943185|NCT04498117|Carboplatin|carboplatin|mesh-list
2943186|NCT04498117|Oregovomab|oregovomab|mesh-list
2943187|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2943188|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943189|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
2943190|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
2943191|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
2943192|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943193|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943194|NCT04496362|Heparin|heparin|mesh-list
2943195|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
2943196|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2943197|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2943198|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943199|NCT04487925|Hormones|hormones|mesh-list
2943200|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2943201|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2943202|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943203|NCT04465266|Tolperisone|tolperisone|mesh-list
2943204|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2943205|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943206|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2943207|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943208|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
2943209|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943210|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943211|NCT04444921|Paclitaxel|paclitaxel|mesh-list
2349900|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2349901|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349902|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943212|NCT04444921|Carboplatin|carboplatin|mesh-list
2943213|NCT04444921|Nivolumab|nivolumab|mesh-list
2943214|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2943215|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2943216|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943217|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
2943218|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
2943219|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
2943220|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943221|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943222|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2943223|NCT04443348|Paclitaxel|paclitaxel|mesh-list
2943224|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
2943225|NCT04443348|Carboplatin|carboplatin|mesh-list
2943226|NCT04443348|Doxorubicin|doxorubicin|mesh-list
2943227|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
2943228|NCT04443348|Capecitabine|capecitabine|mesh-list
2943229|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2943230|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943231|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
2943232|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
2943233|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
2943234|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943235|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2943236|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
2943237|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943238|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2943239|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2943240|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
2943241|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2943242|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2943243|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2943244|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2943245|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943246|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943247|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2943248|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
2943249|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
2943250|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2943251|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2943252|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
2943253|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2943254|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943255|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943256|NCT04437108|Urological Agents|urological agents|mesh-ancestor
2943257|NCT04434300|Daptomycin|daptomycin|mesh-list
2943258|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2943259|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943260|NCT04433767|Nicotine|nicotine|mesh-list
2943261|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2943262|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
2943263|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943264|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943265|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2943266|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2943267|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
2943268|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2943269|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943270|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
2943271|NCT04423588|Lansoprazole|lansoprazole|mesh-list
2943272|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2943273|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2943274|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2943275|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943276|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943277|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
2943278|NCT04407377|Tolperisone|tolperisone|mesh-list
2943279|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2349903|NCT00486876|Tofisopam|tofisopam|mesh-list
2349904|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
2349905|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2349906|NCT00486980|Peramivir|peramivir|mesh-list
2349907|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
2349908|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2349909|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349910|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349911|NCT00487032|Fluticasone|fluticasone|mesh-list
2349912|NCT00487032|Xhance|xhance|mesh-list
2349913|NCT00487032|Prazosin|prazosin|mesh-list
2349914|NCT00487032|Phenylephrine|phenylephrine|mesh-list
2349915|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
2349916|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2943280|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
2943281|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2943282|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2943283|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943284|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2943285|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943286|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2943287|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2943288|NCT04404283|Rituximab|rituximab|mesh-list
2943289|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2943290|NCT04404283|Lenalidomide|lenalidomide|mesh-list
2943291|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943292|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943293|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
2943294|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943295|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2349917|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2349918|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
2349919|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349920|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349921|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2349922|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
2349923|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
2349924|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2943296|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2349925|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2349926|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2349927|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2349928|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2349929|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
2349930|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349931|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112021|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112022|NCT02564029|Lorazepam|lorazepam|mesh-list
2112023|NCT02564029|PF-06372865|pf-06372865|mesh-list
2112024|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
2112025|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
2112026|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
2112027|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112028|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112029|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2112030|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2112031|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2112032|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2349932|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2349933|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2349934|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
2349935|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
2349936|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2349937|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2349938|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
2943297|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2943298|NCT04404283|Growth Substances|growth substances|mesh-ancestor
2943299|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
2943300|NCT04394117|Losartan|losartan|mesh-list
2943301|NCT04394117|Valsartan|valsartan|mesh-list
2943302|NCT04394117|Telmisartan|telmisartan|mesh-list
2943303|NCT04394117|Candesartan|candesartan|mesh-list
2943304|NCT04394117|Olmesartan|olmesartan|mesh-list
2943305|NCT04394117|Irbesartan|irbesartan|mesh-list
2943306|NCT04394117|Eprosartan|eprosartan|mesh-list
2943307|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2943308|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2943309|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2943310|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943311|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2943312|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
2943313|NCT04388163|Gentian Violet|gentian violet|mesh-list
2943314|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2943315|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943316|NCT04379596|Fluorouracil|fluorouracil|mesh-list
2943317|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
2943318|NCT04379596|Capecitabine|capecitabine|mesh-list
2943319|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
2943320|NCT04379596|Trastuzumab|trastuzumab|mesh-list
2943321|NCT04379596|Durvalumab|durvalumab|mesh-list
2943322|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943323|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
2349939|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2349940|NCT00487032|Protective Agents|protective agents|mesh-ancestor
2349941|NCT00487110|Acetaminophen|acetaminophen|mesh-list
2349942|NCT00487110|Tropisetron|tropisetron|mesh-list
2349943|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2349944|NCT00487110|Analgesics|analgesics|mesh-ancestor
2349945|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
2349946|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349947|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349948|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
2349949|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
2943324|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943325|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2943326|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2943327|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
2943328|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943329|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943330|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2943331|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
2943332|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
2943333|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943334|NCT04370795|Sirolimus|sirolimus|mesh-list
2943335|NCT04370795|Busulfan|busulfan|mesh-list
2112033|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2943336|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2943337|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943338|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2943339|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943340|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
2943341|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2943342|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
2943343|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943344|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
2943345|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943346|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2943347|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2943348|NCT04354012|Gentian Violet|gentian violet|mesh-list
2943349|NCT04354012|Methylene Blue|methylene blue|mesh-list
2943350|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943351|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943352|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2943353|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943354|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
2943355|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943356|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943357|NCT04339751|Vorinostat|vorinostat|mesh-list
2943358|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943359|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2943360|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943361|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943362|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
2943363|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
2943364|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2943365|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2943366|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943367|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943368|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943369|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2943370|NCT04315948|Interferons|interferons|mesh-list
2943371|NCT04315948|Ritonavir|ritonavir|mesh-list
2943372|NCT04315948|Lopinavir|lopinavir|mesh-list
2943373|NCT04315948|Interferon-beta|interferon-beta|mesh-list
2943374|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
2943375|NCT04315948|Remdesivir|remdesivir|mesh-list
2943376|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
2943377|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943378|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
2943379|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943380|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2943381|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2943382|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
2943383|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943384|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943385|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2943386|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2943387|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2943388|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2943389|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
2349950|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
2349951|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2349952|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2349953|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2349954|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
2349955|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349956|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349957|NCT00487123|Valsartan|valsartan|mesh-list
2349958|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2349959|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2349960|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2943390|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2943391|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2943392|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2943393|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
2943394|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943395|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2943396|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
2943397|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
2943398|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
2943399|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2943400|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2349961|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2349962|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349963|NCT00487123|Diuretics|diuretics|mesh-ancestor
2349964|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
2349965|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349966|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2349967|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2349968|NCT00487136|Warfarin|warfarin|mesh-list
2349969|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2943401|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943402|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943403|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943404|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2943405|NCT04310007|Gemcitabine|gemcitabine|mesh-list
2943406|NCT04310007|Paclitaxel|paclitaxel|mesh-list
2943407|NCT04310007|Docetaxel|docetaxel|mesh-list
2943408|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2349970|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
2349971|NCT00487136|Fenofibrate|fenofibrate|mesh-list
2349972|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2943409|NCT04310007|Nivolumab|nivolumab|mesh-list
2943410|NCT04310007|Ramucirumab|ramucirumab|mesh-list
2943411|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2349973|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2349974|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
2349975|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349976|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2349977|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2349978|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943412|NCT04310007|Antibodies|antibodies|mesh-list
2943413|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
2943414|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2943415|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2943416|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943417|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
2349979|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
2349980|NCT00487175|Tramadol|tramadol|mesh-list
2349981|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2349982|NCT00487175|Narcotics|narcotics|mesh-ancestor
2349983|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2349984|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349985|NCT00487175|Analgesics|analgesics|mesh-ancestor
2349986|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
2349987|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2349988|NCT00487227|Caffeine|caffeine|mesh-list
2349989|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2349990|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2349991|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2349992|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2349993|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2349994|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2349995|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2349996|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
2349997|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2349998|NCT00487253|Miltefosine|miltefosine|mesh-list
2349999|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2350000|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
2350001|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350002|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350003|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2943418|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
2943419|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
2350004|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2350005|NCT00487422|Prucalopride|prucalopride|mesh-list
2350006|NCT00487422|Laxatives|laxatives|mesh-ancestor
2350007|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2350008|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2350009|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2350010|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
2350011|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350012|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350013|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350014|NCT00487448|Cytarabine|cytarabine|mesh-list
2350015|NCT00487448|Fludarabine|fludarabine|mesh-list
2350016|NCT00487448|Idarubicin|idarubicin|mesh-list
2350017|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943420|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943421|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
2350018|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350019|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
2350020|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943422|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943423|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2943424|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
2943425|NCT04310007|Antiviral Agents|antiviral agents|mesh-ancestor
2943426|NCT04310007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350021|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350022|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
2350023|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350024|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
2350025|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350026|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2350027|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2350028|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2350029|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350030|NCT00487591|Simvastatin|simvastatin|mesh-list
2943427|NCT04310007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943428|NCT04310007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2943429|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2943430|NCT04307797|Exenatide|exenatide|mesh-list
2943431|NCT04307797|Glucagon|glucagon|mesh-list
2943432|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2943433|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2943434|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943435|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2943436|NCT04307797|Incretins|incretins|mesh-ancestor
2943437|NCT04307797|Hormones|hormones|mesh-ancestor
2943438|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2943439|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2943440|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2350031|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2350032|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2350033|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
2350034|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350035|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2350036|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2350037|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350038|NCT00487682|Valacyclovir|valacyclovir|mesh-list
2350039|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
2350040|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350041|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
2350042|NCT00487734|Testosterone|testosterone|mesh-list
2350043|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
2350044|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
2943441|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2943442|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
2350045|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2350046|NCT00487734|Androgens|androgens|mesh-ancestor
2350047|NCT00487734|Hormones|hormones|mesh-ancestor
2350048|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2350049|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350050|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2350051|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350052|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
2350053|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
2350054|NCT00487773|Budesonide|budesonide|mesh-list
2350055|NCT00487773|Albuterol|albuterol|mesh-list
2350056|NCT00487773|Montelukast|montelukast|mesh-list
2350057|NCT00487773|Vitamins|vitamins|mesh-ancestor
2350058|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
2350059|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350060|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350061|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2350062|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
2350063|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350064|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2350065|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
2350066|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
2350067|NCT00487773|Hormones|hormones|mesh-ancestor
2350068|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2350069|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2350070|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
2943443|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
2943444|NCT04297150|Apixaban|apixaban|mesh-list
2943445|NCT04297150|Edoxaban|edoxaban|mesh-list
2943446|NCT04297150|Dabigatran|dabigatran|mesh-list
2943447|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2943448|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
2943449|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2943450|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
2943451|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943452|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943453|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
2943454|NCT04284774|Tipifarnib|tipifarnib|mesh-list
2943455|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943456|NCT04276259|Naltrexone|naltrexone|mesh-list
2943457|NCT04276259|Buprenorphine|buprenorphine|mesh-list
2943458|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2943459|NCT04276259|Narcotics|narcotics|mesh-ancestor
2943460|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2943461|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943462|NCT04276259|Analgesics|analgesics|mesh-ancestor
2943463|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
2943464|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943465|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2943466|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2943467|NCT04267939|Niraparib|niraparib|mesh-list
2943468|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2943469|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943470|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943471|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943472|NCT04266301|Azacitidine|azacitidine|mesh-list
2350071|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2350072|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2350073|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350074|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
2350075|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2350076|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2350077|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2350078|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2943473|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2943474|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
2943475|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943476|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943477|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943478|NCT04249362|Durvalumab|durvalumab|mesh-list
2943479|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943480|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943481|NCT04249323|Prednisone|prednisone|mesh-list
2943482|NCT04249323|Cortisone|cortisone|mesh-list
2943483|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2943484|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
2943485|NCT04249323|Hormones|hormones|mesh-ancestor
2943486|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2943487|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943488|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2943489|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943490|NCT04246047|Dexamethasone|dexamethasone|mesh-list
2943491|NCT04246047|Bortezomib|bortezomib|mesh-list
2350079|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
2350080|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350081|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2350082|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2350083|NCT00487786|Docetaxel|docetaxel|mesh-list
2350084|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350085|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
2350086|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
2350087|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
2350088|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350089|NCT00487799|Ularitide|ularitide|mesh-list
2350090|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2943492|NCT04246047|Daratumumab|daratumumab|mesh-list
2943493|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2943494|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
2943495|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
2943496|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943497|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943498|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2943499|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
2350091|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
2350092|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350093|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943500|NCT04246047|Hormones|hormones|mesh-ancestor
2943501|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2943502|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2943503|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943504|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2943505|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2943506|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2943507|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943508|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943509|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2943510|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
2943511|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2943512|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943513|NCT04218357|Probenecid|probenecid|mesh-list
2943514|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
2943515|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
2943516|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2943517|NCT04218357|Renal Agents|renal agents|mesh-ancestor
2943518|NCT04216290|Gemcitabine|gemcitabine|mesh-list
2943519|NCT04216290|Cisplatin|cisplatin|mesh-list
2350094|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2350095|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
2350096|NCT00487799|Diuretics|diuretics|mesh-ancestor
2350097|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
2350098|NCT00487812|Dobutamine|dobutamine|mesh-list
2350099|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2350100|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
2350101|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
2350102|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350103|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350104|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2350105|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2350106|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2350107|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
2350108|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350109|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350110|NCT00487812|Protective Agents|protective agents|mesh-ancestor
2350111|NCT00487994|Atorvastatin|atorvastatin|mesh-list
2350112|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2350113|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2350114|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
2350115|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350116|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2350117|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2350118|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350119|NCT00488072|Mirtazapine|mirtazapine|mesh-list
2350120|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
2350121|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2350122|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2350123|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
2350124|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
2350125|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350126|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350127|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350128|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2350129|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2350130|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2350131|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2350132|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2350133|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2350134|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
2350135|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2350136|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2350137|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
2350138|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2350139|NCT00488137|Prucalopride|prucalopride|mesh-list
2350140|NCT00488137|Laxatives|laxatives|mesh-ancestor
2943520|NCT04216290|Carboplatin|carboplatin|mesh-list
2943521|NCT04216290|Doxorubicin|doxorubicin|mesh-list
2943522|NCT04216290|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2943523|NCT04216290|Fluorouracil|fluorouracil|mesh-list
2943524|NCT04216290|Methotrexate|methotrexate|mesh-list
2943525|NCT04216290|Durvalumab|durvalumab|mesh-list
2350141|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2350142|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2350143|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2350144|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
2943526|NCT04216290|Mitomycins|mitomycins|mesh-list
2943527|NCT04216290|Mitomycin|mitomycin|mesh-list
2943528|NCT04216290|Vinblastine|vinblastine|mesh-list
2943529|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
2943530|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2943531|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
2943532|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943533|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2943534|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
2943535|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943536|NCT04216290|Antiviral Agents|antiviral agents|mesh-ancestor
2943537|NCT04216290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943538|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943539|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2943540|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
2943541|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943542|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2350145|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350146|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350147|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943543|NCT04216290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2943544|NCT04216290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2943545|NCT04216290|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2943546|NCT04216290|Abortifacient Agents|abortifacient agents|mesh-ancestor
2943547|NCT04216290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2943548|NCT04216290|Dermatologic Agents|dermatologic agents|mesh-ancestor
2943549|NCT04216290|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2943550|NCT04216290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2943551|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2943552|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2350148|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2943553|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
2943554|NCT04216290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2943555|NCT04216290|Tubulin Modulators|tubulin modulators|mesh-ancestor
2943556|NCT04216290|Antimitotic Agents|antimitotic agents|mesh-ancestor
2943557|NCT04216290|Mitosis Modulators|mitosis modulators|mesh-ancestor
2943558|NCT04190056|Tamoxifen|tamoxifen|mesh-list
2943559|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
2943560|NCT04190056|Vorinostat|vorinostat|mesh-list
2943561|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943562|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943563|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2943564|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
2943565|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2943566|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943567|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2943568|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2943569|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2943570|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2943571|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2943572|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943573|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943574|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
2943575|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943576|NCT04150029|Azacitidine|azacitidine|mesh-list
2350149|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2350150|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2350151|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2350152|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350153|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
2350154|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350155|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350156|NCT00488176|Cetirizine|cetirizine|mesh-list
2350157|NCT00488176|Montelukast|montelukast|mesh-list
2350158|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2350159|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
2350160|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2350161|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
2350162|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2350163|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350164|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2350165|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2350166|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350167|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2350168|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2350169|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2350170|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
2350171|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
2350172|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350173|NCT00488189|Tazobactam|tazobactam|mesh-list
2350174|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2350175|NCT00488189|Piperacillin|piperacillin|mesh-list
2350176|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2350177|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350178|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2350179|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350180|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943577|NCT04150029|Venetoclax|venetoclax|mesh-list
2943578|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2943579|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
2943580|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943581|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943582|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943583|NCT04149574|Nivolumab|nivolumab|mesh-list
2943584|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
2943585|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2350181|NCT00488215|Prucalopride|prucalopride|mesh-list
2350182|NCT00488215|Laxatives|laxatives|mesh-ancestor
2350183|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2350184|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2350185|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2350186|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
2350187|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350188|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350189|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350190|NCT00488267|Ketoprofen|ketoprofen|mesh-list
2943586|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943587|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2943588|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943589|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2943590|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
2943591|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943592|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
2943593|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
2943594|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2943595|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
2943596|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2943597|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943598|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2943599|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2943600|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2943601|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2943602|NCT04140266|Tenofovir|tenofovir|mesh-list
2943603|NCT04140266|Emtricitabine|emtricitabine|mesh-list
2943604|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2943605|NCT04140266|Dapivirine|dapivirine|mesh-list
2943606|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
2943607|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943608|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2943609|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2943610|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943611|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943612|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2943613|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2943614|NCT04136366|Methotrexate|methotrexate|mesh-list
2943615|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2943616|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
2943617|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2943618|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943619|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2943620|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
2350191|NCT00488267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2350192|NCT00488267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2350193|NCT00488267|Analgesics|analgesics|mesh-ancestor
2350194|NCT00488267|Sensory System Agents|sensory system agents|mesh-ancestor
2350195|NCT00488267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350196|NCT00488267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350197|NCT00488267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350198|NCT00488267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2350199|NCT00488267|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2350200|NCT00488267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350201|NCT00488267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943621|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943622|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943623|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
2943624|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943625|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2943626|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2943627|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
2943628|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2943629|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2943630|NCT04132388|Adalimumab|adalimumab|mesh-list
2943631|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350202|NCT00488306|Tigecycline|tigecycline|mesh-list
2350203|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2350204|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350205|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2350206|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350207|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350208|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2350209|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
2350210|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350211|NCT00488384|Acitretin|acitretin|mesh-list
2350212|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
2350213|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
2350214|NCT00488436|Cyclosporine|cyclosporine|mesh-list
2350215|NCT00488436|Cyclosporins|cyclosporins|mesh-list
2350216|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2350217|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350218|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350219|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350220|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
2350221|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350222|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
2350223|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350224|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
2350225|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2350226|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2350227|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
2943632|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2943633|NCT04129502|Carboplatin|carboplatin|mesh-list
2943634|NCT04129502|Pemetrexed|pemetrexed|mesh-list
2943635|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350228|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2350229|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350230|NCT00488540|Acetaminophen|acetaminophen|mesh-list
2350231|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2350232|NCT00488540|Analgesics|analgesics|mesh-ancestor
2943636|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943637|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943638|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2943639|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2943640|NCT04112641|Niacinamide|niacinamide|mesh-list
2943641|NCT04112641|Niacin|niacin|mesh-list
2943642|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
2943643|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
2943644|NCT04112641|Vitamins|vitamins|mesh-ancestor
2943645|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
2943646|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943647|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2943648|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
2943649|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943650|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2943651|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
2943652|NCT04108962|Benralizumab|benralizumab|mesh-list
2943653|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2943654|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
2943655|NCT04092283|Paclitaxel|paclitaxel|mesh-list
2943656|NCT04092283|Etoposide|etoposide|mesh-list
2943657|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
2943658|NCT04092283|Cisplatin|cisplatin|mesh-list
2943659|NCT04092283|Carboplatin|carboplatin|mesh-list
2943660|NCT04092283|Pemetrexed|pemetrexed|mesh-list
2943661|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2943662|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
2943663|NCT04092283|Durvalumab|durvalumab|mesh-list
2943664|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
2943665|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2943666|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
2943667|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2943668|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943669|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
2943670|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
2943671|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
2943672|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943673|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2943674|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2943675|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943676|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2943677|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2943678|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943679|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
2943680|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943681|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
2943682|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
2943683|NCT04091126|Dexamethasone|dexamethasone|mesh-list
2350233|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
2350234|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350235|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350236|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
2350237|NCT00488566|Lamotrigine|lamotrigine|mesh-list
2350238|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
2350239|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2350240|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2350241|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350242|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2350243|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350244|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2350245|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2943684|NCT04091126|Lenalidomide|lenalidomide|mesh-list
2943685|NCT04091126|Bortezomib|bortezomib|mesh-list
2943686|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2943687|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
2943688|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
2943689|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943690|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943691|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2943692|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
2943693|NCT04091126|Hormones|hormones|mesh-ancestor
2943694|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2943695|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2943696|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943697|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
2943698|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2943699|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2943700|NCT04091126|Growth Substances|growth substances|mesh-ancestor
2943701|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
2943702|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
2943703|NCT04090684|Celecoxib|celecoxib|mesh-list
2943704|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2943705|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2943706|NCT04090684|Analgesics|analgesics|mesh-ancestor
2943707|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
2943708|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943709|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943710|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350246|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2350247|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2350248|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2350249|NCT00488605|Leucovorin|leucovorin|mesh-list
2350250|NCT00488605|Prednisone|prednisone|mesh-list
2350251|NCT00488605|Methotrexate|methotrexate|mesh-list
2350252|NCT00488605|Vinblastine|vinblastine|mesh-list
2350253|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
2943711|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2350254|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350255|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
2350256|NCT00488605|Hormones|hormones|mesh-ancestor
2350257|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2350258|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350259|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2350260|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350261|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2350262|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
2350263|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2350264|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350265|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
2350266|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943712|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2943713|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2943714|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943715|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943716|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2943717|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943718|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2943719|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2943720|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112034|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2112035|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
2112036|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
2112037|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112038|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112039|NCT02564198|Ramucirumab|ramucirumab|mesh-list
2112040|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112041|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2112042|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
2112043|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2943721|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2943722|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2943723|NCT04086485|Olaparib|olaparib|mesh-list
2943724|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2943725|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943726|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943727|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943728|NCT04085458|Factor VIII|factor viii|mesh-list
2943729|NCT04085458|Coagulants|coagulants|mesh-ancestor
2943730|NCT04054752|Vaccines|vaccines|mesh-list
2943731|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
2943732|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943733|NCT04051619|Oxytocin|oxytocin|mesh-list
2943734|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
2350267|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
2350268|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350269|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2350270|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350271|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
2350272|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2350273|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2350274|NCT00488605|Antidotes|antidotes|mesh-ancestor
2350275|NCT00488605|Protective Agents|protective agents|mesh-ancestor
2350276|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
2350277|NCT00488605|Vitamins|vitamins|mesh-ancestor
2350278|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
2350279|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2350280|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
2350281|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
2350282|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
2350283|NCT00488670|Citalopram|citalopram|mesh-list
2350284|NCT00488670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2350285|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2350286|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2350287|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350288|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350289|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
2350290|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350291|NCT00488670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2350292|NCT00488670|Antidepressive Agents|antidepressive agents|mesh-ancestor
2350293|NCT00488670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2112044|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943735|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2943736|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943737|NCT04045301|Omalizumab|omalizumab|mesh-list
2943738|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2943739|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2943740|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2943741|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
2943742|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
2943743|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943744|NCT04039607|Nivolumab|nivolumab|mesh-list
2943745|NCT04039607|Ipilimumab|ipilimumab|mesh-list
2943746|NCT04039607|Sorafenib|sorafenib|mesh-list
2943747|NCT04039607|Lenvatinib|lenvatinib|mesh-list
2943748|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943749|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943750|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2943751|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943752|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2943753|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943754|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
2943755|NCT04033107|Metformin|metformin|mesh-list
2943756|NCT04033107|Vitamins|vitamins|mesh-ancestor
2943757|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
2943758|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943759|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2943760|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
2943761|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943762|NCT04033107|Protective Agents|protective agents|mesh-ancestor
2943763|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
2943764|NCT04024761|Fludarabine|fludarabine|mesh-list
2943765|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2943766|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
2943767|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943768|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2943769|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2943770|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
2943771|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943772|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943773|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2943774|NCT04006457|Vaccines|vaccines|mesh-list
2943775|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
2943776|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943777|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
2943778|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2943779|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2943780|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2943781|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2943782|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2943783|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943784|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
2350294|NCT00488709|Cytarabine|cytarabine|mesh-list
2350295|NCT00488709|Fludarabine|fludarabine|mesh-list
2350296|NCT00488709|Topotecan|topotecan|mesh-list
2350297|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350298|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350299|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
2350300|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350301|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350302|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
2350303|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350304|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
2350305|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350306|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2350307|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2943785|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2943786|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943787|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2943788|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943789|NCT03986424|Memantine|memantine|mesh-list
2943790|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2943791|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2943792|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
2943793|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2943794|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943795|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943796|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2350308|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350309|NCT00488722|Goserelin|goserelin|mesh-list
2350310|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2350311|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350312|NCT00488761|Tigecycline|tigecycline|mesh-list
2350313|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2350314|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350315|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2350316|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943797|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2943798|NCT03986034|Venetoclax|venetoclax|mesh-list
2943799|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943800|NCT03950245|Glucagon|glucagon|mesh-list
2943801|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2943802|NCT03950245|Incretins|incretins|mesh-ancestor
2943803|NCT03950245|Hormones|hormones|mesh-ancestor
2943804|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2943805|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943806|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2943807|NCT03941860|Lenalidomide|lenalidomide|mesh-list
2943808|NCT03941860|Ixazomib|ixazomib|mesh-list
2943809|NCT03941860|Glycine|glycine|mesh-list
2943810|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
2943811|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943812|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2943813|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2943814|NCT03941860|Growth Substances|growth substances|mesh-ancestor
2943815|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
2943816|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943817|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943818|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
2943819|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943820|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
2943821|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2943822|NCT03939104|Artesunate|artesunate|mesh-list
2943823|NCT03939104|Lumefantrine|lumefantrine|mesh-list
2943824|NCT03939104|Artemether|artemether|mesh-list
2350317|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350318|NCT00488787|Ketamine|ketamine|mesh-list
2350319|NCT00488787|Analgesics|analgesics|mesh-ancestor
2350320|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
2350321|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350322|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350323|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2350324|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2350325|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
2350326|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
2350327|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2943825|NCT03939104|Piperaquine|piperaquine|mesh-list
2943826|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2943827|NCT03939104|Amodiaquine|amodiaquine|mesh-list
2943828|NCT03939104|Mefloquine|mefloquine|mesh-list
2943829|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
2943830|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2943831|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2943832|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943833|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943834|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
2943835|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
2943836|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2943837|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
2943838|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2350328|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2350329|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2350330|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350331|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350332|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2350333|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
2350334|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350335|NCT00488813|Cephalosporins|cephalosporins|mesh-list
2350336|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2350337|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350338|NCT00488839|Baclofen|baclofen|mesh-list
2350339|NCT00488839|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2350340|NCT00488839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943839|NCT03922945|Topiramate|topiramate|mesh-list
2943840|NCT03922945|Phentermine|phentermine|mesh-list
2943841|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
2350341|NCT00488839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2350342|NCT00488839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943842|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2943843|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943844|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2943845|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
2943846|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2943847|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
2943848|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
2943849|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943850|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
2943851|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2943852|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943853|NCT03913091|Bupivacaine|bupivacaine|mesh-list
2943854|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
2943855|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
2350343|NCT00488839|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2350344|NCT00488839|GABA Agonists|gaba agonists|mesh-ancestor
2350345|NCT00488839|GABA Agents|gaba agents|mesh-ancestor
2350346|NCT00488839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350347|NCT00488839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943856|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2943857|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943858|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
2943859|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943860|NCT03906136|Adalimumab|adalimumab|mesh-list
2943861|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2943862|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2943863|NCT03893955|Paclitaxel|paclitaxel|mesh-list
2943864|NCT03893955|Carboplatin|carboplatin|mesh-list
2943865|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2943866|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943867|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
2350348|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2350349|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
2350350|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2350351|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2350352|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350353|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2350354|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2350355|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2350356|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
2350357|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350358|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350359|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2943868|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
2943869|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
2943870|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943871|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2943872|NCT03889249|Tenecteplase|tenecteplase|mesh-list
2943873|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2943874|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2943875|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943876|NCT03879629|Carvedilol|carvedilol|mesh-list
2943877|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2943878|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2943879|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
2943880|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2943881|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943882|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350360|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2943883|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2943884|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
2943885|NCT03879629|Protective Agents|protective agents|mesh-ancestor
2943886|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2943887|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2943888|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2943889|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
2943890|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2943891|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2943892|NCT03871257|Carboplatin|carboplatin|mesh-list
2943893|NCT03871257|Vincristine|vincristine|mesh-list
2943894|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943895|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2943896|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
2943897|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
2943898|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
2943899|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943900|NCT03858322|Paclitaxel|paclitaxel|mesh-list
2943901|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
2943902|NCT03858322|Carboplatin|carboplatin|mesh-list
2943903|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2943904|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943905|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
2943906|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
2943907|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
2943908|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943909|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2943910|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
2943911|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943912|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2943913|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2943914|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
2943915|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2943916|NCT03845166|Atezolizumab|atezolizumab|mesh-list
2943917|NCT03845166|Avelumab|avelumab|mesh-list
2943918|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943919|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943920|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
2943921|NCT03822637|Albuterol|albuterol|mesh-list
2943922|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2943923|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2943924|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
2943925|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943926|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943927|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2943928|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
2943929|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
2943930|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2943931|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2943932|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2943933|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2943934|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
2943935|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2943936|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943937|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
2943938|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943939|NCT03822637|Expectorants|expectorants|mesh-ancestor
2943940|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2943941|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
2943942|NCT03822637|Protective Agents|protective agents|mesh-ancestor
2943943|NCT03822637|Antidotes|antidotes|mesh-ancestor
2943944|NCT03811015|Cisplatin|cisplatin|mesh-list
2943945|NCT03811015|Nivolumab|nivolumab|mesh-list
2943946|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943947|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943948|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2943949|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943950|NCT03811002|Cisplatin|cisplatin|mesh-list
2943951|NCT03811002|Carboplatin|carboplatin|mesh-list
2943952|NCT03811002|Etoposide|etoposide|mesh-list
2943953|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
2943954|NCT03811002|Atezolizumab|atezolizumab|mesh-list
2943955|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
2943956|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2943957|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943958|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2943959|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2943960|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2943961|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2943962|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943963|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
2943964|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943965|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
2350361|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
2350362|NCT00488969|Morphine|morphine|mesh-list
2350363|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2350364|NCT00488969|Narcotics|narcotics|mesh-ancestor
2943966|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
2943967|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
2943968|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
2943969|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
2350365|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2350366|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350367|NCT00488969|Analgesics|analgesics|mesh-ancestor
2350368|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
2350369|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350370|NCT00488995|Tremelimumab|tremelimumab|mesh-list
2350371|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350372|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2350373|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2350374|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2350375|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2350376|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350377|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350378|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350379|NCT00489073|Analgesics|analgesics|mesh-ancestor
2350380|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
2350381|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350382|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
2943970|NCT03802591|Capecitabine|capecitabine|mesh-list
2943971|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
2943972|NCT03802591|Antibodies|antibodies|mesh-list
2943973|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2943974|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
2943975|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943976|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2943977|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
2943978|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943979|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943980|NCT03802565|Tolperisone|tolperisone|mesh-list
2943981|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2943982|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2943983|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2943984|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2943985|NCT03793166|Nivolumab|nivolumab|mesh-list
2943986|NCT03793166|Ipilimumab|ipilimumab|mesh-list
2943987|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2943988|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943989|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2943990|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350383|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2350384|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
2350385|NCT00489099|Vaccines|vaccines|mesh-list
2350386|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
2350387|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350388|NCT00489138|Ertapenem|ertapenem|mesh-list
2350389|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2350390|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2943991|NCT03763422|Temozolomide|temozolomide|mesh-list
2943992|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2943993|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
2943994|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2943995|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2943996|NCT03752307|Prednisone|prednisone|mesh-list
2943997|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
2943998|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
2943999|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944000|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
2944001|NCT03752307|Hormones|hormones|mesh-ancestor
2944002|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944003|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944004|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2944005|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944006|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
2944007|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
2944008|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944009|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2944010|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2944011|NCT03752307|Protective Agents|protective agents|mesh-ancestor
2944012|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2944013|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2944014|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
2944015|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2944016|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944017|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
2944018|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
2944019|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
2944020|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2944021|NCT03740334|Dexamethasone|dexamethasone|mesh-list
2944022|NCT03740334|Everolimus|everolimus|mesh-list
2944023|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944024|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
2350391|NCT00489151|Lamivudine|lamivudine|mesh-list
2350392|NCT00489151|Adefovir|adefovir|mesh-list
2350393|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2350394|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2350395|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2350396|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350397|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350398|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
2944025|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
2944026|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944027|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944028|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2944029|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
2944030|NCT03740334|Hormones|hormones|mesh-ancestor
2944031|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944032|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2944033|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944034|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350399|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350400|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2350401|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2350402|NCT00489164|Sirolimus|sirolimus|mesh-list
2350403|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2350404|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350405|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2350406|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350407|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
2350408|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944035|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
2944036|NCT03734653|Testosterone|testosterone|mesh-list
2944037|NCT03734653|Androgens|androgens|mesh-ancestor
2944038|NCT03734653|Hormones|hormones|mesh-ancestor
2944039|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944040|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944041|NCT03733067|Abatacept|abatacept|mesh-list
2944042|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2944043|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944044|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112045|NCT02564211|Incretins|incretins|mesh-ancestor
2112046|NCT02564211|Hormones|hormones|mesh-ancestor
2112047|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112048|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2112049|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
2112050|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112051|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112052|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2350409|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
2350410|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350411|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
2350412|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2350413|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350414|NCT00489203|Beclomethasone|beclomethasone|mesh-list
2350415|NCT00489203|Methotrexate|methotrexate|mesh-list
2350416|NCT00489203|Tacrolimus|tacrolimus|mesh-list
2350417|NCT00489203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2350418|NCT00489203|Abortifacient Agents|abortifacient agents|mesh-ancestor
2350419|NCT00489203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2350420|NCT00489203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350421|NCT00489203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350422|NCT00489203|Antimetabolites|antimetabolites|mesh-ancestor
2350423|NCT00489203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350424|NCT00489203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350425|NCT00489203|Dermatologic Agents|dermatologic agents|mesh-ancestor
2350426|NCT00489203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350427|NCT00489203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2350428|NCT00489203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350429|NCT00489203|Immunologic Factors|immunologic factors|mesh-ancestor
2944045|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944046|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
2944047|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944048|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944049|NCT03725202|Upadacitinib|upadacitinib|mesh-list
2944050|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2944051|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2350430|NCT00489203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2350431|NCT00489203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2944052|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944053|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944054|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944055|NCT03725007|Upadacitinib|upadacitinib|mesh-list
2944056|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2944057|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2944058|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944059|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944060|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944061|NCT03718767|Nivolumab|nivolumab|mesh-list
2944062|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944063|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944064|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2944065|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944066|NCT03701308|Cytarabine|cytarabine|mesh-list
2944067|NCT03701308|Daunorubicin|daunorubicin|mesh-list
2944068|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2944069|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
2944070|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944071|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944072|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
2944073|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2944074|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944075|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
2944076|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944077|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2944078|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2944079|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2944080|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944081|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
2944082|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944083|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944084|NCT03692325|Nivolumab|nivolumab|mesh-list
2944085|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944086|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944087|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2944088|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944089|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
2944090|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944091|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944092|NCT03646123|Doxorubicin|doxorubicin|mesh-list
2944093|NCT03646123|Nivolumab|nivolumab|mesh-list
2944094|NCT03646123|Dacarbazine|dacarbazine|mesh-list
2944095|NCT03646123|Vinblastine|vinblastine|mesh-list
2944096|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2944097|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2944098|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944099|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2350432|NCT00489203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2350433|NCT00489203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350434|NCT00489203|Glucocorticoids|glucocorticoids|mesh-ancestor
2350435|NCT00489203|Hormones|hormones|mesh-ancestor
2350436|NCT00489203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2350437|NCT00489203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2350438|NCT00489203|Respiratory System Agents|respiratory system agents|mesh-ancestor
2350439|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
2350440|NCT00489229|Ramipril|ramipril|mesh-list
2350441|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2944100|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2944101|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944102|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944103|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944104|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2944105|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2944106|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
2944107|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2944108|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
2350442|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350443|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2350444|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
2350445|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350446|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350447|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2350460|NCT00489346|Fluticasone|fluticasone|mesh-list
2350461|NCT00489346|Xhance|xhance|mesh-list
2350462|NCT00489346|Montelukast|montelukast|mesh-list
2350463|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350464|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2350465|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
2350466|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944109|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
2944110|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
2350467|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350468|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2350469|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
2350470|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
2350471|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2350472|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350473|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2350474|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
2350475|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2350476|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2350477|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2350478|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
2350479|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2350480|NCT00489372|Protective Agents|protective agents|mesh-ancestor
2350481|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350482|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350483|NCT00489385|Ribavirin|ribavirin|mesh-list
2350484|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
2350485|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350486|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
2350487|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350488|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2944111|NCT03637556|Deferasirox|deferasirox|mesh-list
2944112|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2944113|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
2944114|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
2944115|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350489|NCT00489398|Epinastine|epinastine|mesh-list
2350490|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2350491|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2350492|NCT00489398|Analgesics|analgesics|mesh-ancestor
2350493|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
2350494|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350495|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350496|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350497|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2350498|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2350499|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2350500|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2350501|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
2350502|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
2350503|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350504|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350505|NCT00489437|Heparin|heparin|mesh-list
2350506|NCT00489437|Antibodies|antibodies|mesh-list
2350507|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
2350508|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944116|NCT03627897|Bupivacaine|bupivacaine|mesh-list
2944117|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
2944118|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
2944119|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2944120|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944121|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
2944122|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944123|NCT03604978|Nivolumab|nivolumab|mesh-list
2944124|NCT03604978|Ipilimumab|ipilimumab|mesh-list
2944125|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944126|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944127|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2350509|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
2350510|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2350511|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2350512|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350513|NCT00489528|Hormones|hormones|mesh-list
2350514|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2350515|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350516|NCT00489593|Olanzapine|olanzapine|mesh-list
2350517|NCT00489593|Fluoxetine|fluoxetine|mesh-list
2350518|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
2350519|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
2350520|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944128|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944129|NCT03603184|Paclitaxel|paclitaxel|mesh-list
2944130|NCT03603184|Carboplatin|carboplatin|mesh-list
2944131|NCT03603184|Atezolizumab|atezolizumab|mesh-list
2944132|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2944133|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944134|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
2944135|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
2944136|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
2944137|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944138|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
2944139|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
2944140|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2944141|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944142|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944143|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
2350521|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350522|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2350523|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2944144|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
2944145|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
2944146|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944147|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2944148|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944149|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944150|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
2944151|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944152|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944153|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2944154|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
2944155|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
2944156|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2944157|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944158|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350524|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2350525|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2350526|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2350527|NCT00489593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2350528|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2944159|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
2944160|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
2944161|NCT03502031|Losartan|losartan|mesh-list
2944162|NCT03502031|Valsartan|valsartan|mesh-list
2944163|NCT03502031|Enalapril|enalapril|mesh-list
2944164|NCT03502031|Enalaprilat|enalaprilat|mesh-list
2944165|NCT03502031|Lisinopril|lisinopril|mesh-list
2944166|NCT03502031|Perindopril|perindopril|mesh-list
2944167|NCT03502031|Spironolactone|spironolactone|mesh-list
2944168|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2944169|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2350529|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2350530|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350531|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350532|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
2350533|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2350534|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
2350535|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2350536|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2350537|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350538|NCT00489645|Pramlintide|pramlintide|mesh-list
2350539|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
2350540|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2944170|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2944171|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944172|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2944173|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2944174|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
2944175|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944176|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944177|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2944178|NCT03502031|Diuretics|diuretics|mesh-ancestor
2944179|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
2944180|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2944181|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
2944182|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944183|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2112067|NCT02564471|Doxycycline|doxycycline|mesh-list
2112068|NCT02564471|Chloroquine|chloroquine|mesh-list
2112069|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2112070|NCT02564471|Atovaquone|atovaquone|mesh-list
2112071|NCT02564471|Proguanil|proguanil|mesh-list
2112072|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2112073|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112074|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
2112075|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2944184|NCT03502031|Protective Agents|protective agents|mesh-ancestor
2944185|NCT03452111|ST 1435|st 1435|mesh-list
2944186|NCT03452111|Testosterone|testosterone|mesh-list
2944187|NCT03452111|Androgens|androgens|mesh-ancestor
2944188|NCT03452111|Hormones|hormones|mesh-ancestor
2944189|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2350541|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350542|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
2350543|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2350544|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
2350545|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350546|NCT00489658|Eflornithine|eflornithine|mesh-list
2350547|NCT00489658|Nifurtimox|nifurtimox|mesh-list
2350548|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350549|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2350550|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2350551|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2944190|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944191|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2944192|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
2944193|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2944194|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2944195|NCT03441555|Venetoclax|venetoclax|mesh-list
2944196|NCT03441555|Alvocidib|alvocidib|mesh-list
2944197|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944198|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
2944199|NCT03441555|Growth Substances|growth substances|mesh-ancestor
2944200|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944201|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2944202|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944203|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944204|NCT03439293|Dexamethasone|dexamethasone|mesh-list
2944205|NCT03439293|Daratumumab|daratumumab|mesh-list
2944206|NCT03439293|Ixazomib|ixazomib|mesh-list
2944207|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944208|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
2944209|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
2944210|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944211|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350552|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350553|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2350554|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350555|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350556|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2350557|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944212|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2944213|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
2944214|NCT03439293|Hormones|hormones|mesh-ancestor
2944215|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944216|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2112076|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2112077|NCT02564471|Amebicides|amebicides|mesh-ancestor
2944217|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944218|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
2944219|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944220|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944221|NCT03438526|Melatonin|melatonin|mesh-list
2944222|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
2944223|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944224|NCT03438526|Protective Agents|protective agents|mesh-ancestor
2944225|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944226|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2944227|NCT03416179|Cytarabine|cytarabine|mesh-list
2944228|NCT03416179|Azacitidine|azacitidine|mesh-list
2944229|NCT03416179|Daunorubicin|daunorubicin|mesh-list
2944230|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2944231|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
2944232|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944233|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944234|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
2944235|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2944236|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944237|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
2944238|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944239|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944240|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2944241|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2944242|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2944243|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
2944244|NCT03409198|Doxorubicin|doxorubicin|mesh-list
2944245|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2944246|NCT03409198|Nivolumab|nivolumab|mesh-list
2944247|NCT03409198|Ipilimumab|ipilimumab|mesh-list
2944248|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944249|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
2944250|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944251|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944252|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2944253|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
2944254|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944255|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944256|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2944257|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2944258|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2112078|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2112079|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2112080|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2112081|NCT02564471|Analgesics|analgesics|mesh-ancestor
2350558|NCT00489723|Tamsulosin|tamsulosin|mesh-list
2350559|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2350560|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2350561|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2350562|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
2350563|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350564|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350565|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350566|NCT00489723|Urological Agents|urological agents|mesh-ancestor
2350567|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2350568|NCT00489775|Paroxetine|paroxetine|mesh-list
2350569|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2350570|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2944259|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2944260|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944261|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944262|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2944263|NCT03395197|Talazoparib|talazoparib|mesh-list
2944264|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2944265|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944266|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944267|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944268|NCT03395184|PF-06700841|pf-06700841|mesh-list
2944269|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2944270|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944271|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944272|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
2944273|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
2944274|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2944275|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2944276|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2944277|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944278|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350571|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2350572|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350573|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350574|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350575|NCT00489775|Analgesics|analgesics|mesh-ancestor
2350576|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
2350577|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350578|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
2350579|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2350580|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
2350581|NCT00489775|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2350582|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
2350583|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2350584|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2944279|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944280|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
2944281|NCT03353922|Tolperisone|tolperisone|mesh-list
2944282|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2944283|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
2944284|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2944285|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2944286|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944287|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2944288|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350585|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2350586|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350587|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
2350588|NCT00489840|Anecortave|anecortave|mesh-list
2350589|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2350590|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2944289|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2944290|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2944291|NCT03346239|Citalopram|citalopram|mesh-list
2944292|NCT03346239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2944293|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2944294|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2944295|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944296|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2944297|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
2944298|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944299|NCT03346239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2944300|NCT03346239|Antidepressive Agents|antidepressive agents|mesh-ancestor
2944301|NCT03346239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2944302|NCT03314181|Dexamethasone|dexamethasone|mesh-list
2944303|NCT03314181|Bortezomib|bortezomib|mesh-list
2944304|NCT03314181|Venetoclax|venetoclax|mesh-list
2944305|NCT03314181|Daratumumab|daratumumab|mesh-list
2350591|NCT00489840|Growth Substances|growth substances|mesh-ancestor
2350592|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350593|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
2350594|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350595|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350596|NCT00489892|Modafinil|modafinil|mesh-list
2944306|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944307|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
2944308|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
2944309|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944310|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944311|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2944312|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
2944313|NCT03314181|Hormones|hormones|mesh-ancestor
2944314|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944315|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2944316|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944317|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
2944318|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944319|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944320|NCT03290794|Aflibercept|aflibercept|mesh-list
2944321|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2944322|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2944323|NCT03290794|Growth Substances|growth substances|mesh-ancestor
2944324|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944325|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
2944326|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944327|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
2944328|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944329|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944330|NCT03259074|Adalimumab|adalimumab|mesh-list
2944331|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944332|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944333|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
2944334|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944335|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944336|NCT03236857|Venetoclax|venetoclax|mesh-list
2944337|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944338|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
2944339|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
2944340|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944341|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350597|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2350598|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350599|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2350600|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2350601|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2350602|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350603|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
2350604|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2350605|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350606|NCT00489944|Tamoxifen|tamoxifen|mesh-list
2350607|NCT00489944|Sunitinib|sunitinib|mesh-list
2350608|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350609|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350610|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2350611|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2350612|NCT00489944|Growth Substances|growth substances|mesh-ancestor
2350613|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350614|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
2350615|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2350616|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350617|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2350618|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
2350619|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2350620|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2350621|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2944342|NCT03188705|Aspirin|aspirin|mesh-list
2944343|NCT03188705|Clopidogrel|clopidogrel|mesh-list
2944344|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2944345|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2944346|NCT03188705|Analgesics|analgesics|mesh-ancestor
2944347|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
2944348|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944349|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944350|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944351|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944352|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2944353|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2944354|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944355|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2944356|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2944357|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944358|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
2944359|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2944360|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2944361|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2944362|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
2944363|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2944364|NCT03186456|Aspirin|aspirin|mesh-list
2944365|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2944366|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2944367|NCT03186456|Analgesics|analgesics|mesh-ancestor
2944368|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
2944369|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944370|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944371|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944372|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944373|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2944374|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2944375|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350622|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2350623|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2350624|NCT00489983|Gemcitabine|gemcitabine|mesh-list
2350625|NCT00489983|Pemetrexed|pemetrexed|mesh-list
2350626|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350627|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
2350628|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350629|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350630|NCT00489983|Antiviral Agents|antiviral agents|mesh-ancestor
2350631|NCT00489983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2944376|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2944377|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2944378|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944379|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
2944380|NCT03184935|Decitabine|decitabine|mesh-list
2944381|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2944382|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
2944383|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944384|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944385|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944386|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
2944387|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944388|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944389|NCT03173456|Acetaminophen|acetaminophen|mesh-list
2944390|NCT03173456|Ibuprofen|ibuprofen|mesh-list
2944391|NCT03173456|Oxycodone|oxycodone|mesh-list
2944392|NCT03173456|Hydrocodone|hydrocodone|mesh-list
2944393|NCT03173456|Codeine|codeine|mesh-list
2944394|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2944395|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2350632|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350633|NCT00489983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350634|NCT00489983|Immunologic Factors|immunologic factors|mesh-ancestor
2350635|NCT00489983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350636|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2350637|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2350638|NCT00489996|Gemcitabine|gemcitabine|mesh-list
2350639|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350640|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350641|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
2350642|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350643|NCT00489996|Antiviral Agents|antiviral agents|mesh-ancestor
2350644|NCT00489996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350645|NCT00489996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350646|NCT00489996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350647|NCT00489996|Immunologic Factors|immunologic factors|mesh-ancestor
2350648|NCT00489996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350649|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
2350650|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2944396|NCT03173456|Analgesics|analgesics|mesh-ancestor
2944397|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
2944398|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944399|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944400|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944401|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944402|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2944403|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944404|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944405|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2944406|NCT03173456|Narcotics|narcotics|mesh-ancestor
2944407|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2944408|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
2944409|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
2944410|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
2944411|NCT03167437|Vorinostat|vorinostat|mesh-list
2944412|NCT03167437|Ustekinumab|ustekinumab|mesh-list
2944413|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944414|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2944415|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944416|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350651|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
2350652|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2350653|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944417|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
2944418|NCT03161678|Clopidogrel|clopidogrel|mesh-list
2944419|NCT03161678|Ticagrelor|ticagrelor|mesh-list
2944420|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2944421|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2944422|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2944423|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2944424|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
2944425|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2944426|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944427|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944428|NCT03149003|Bevacizumab|bevacizumab|mesh-list
2944429|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944430|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944431|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2944432|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2944433|NCT03149003|Growth Substances|growth substances|mesh-ancestor
2944434|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944435|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
2944436|NCT03136055|Paclitaxel|paclitaxel|mesh-list
2944437|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
2944438|NCT03136055|Irinotecan|irinotecan|mesh-list
2944439|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2944440|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944441|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
2944442|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
2944443|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
2944444|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944445|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944446|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2944447|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2944448|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944449|NCT03101566|Gemcitabine|gemcitabine|mesh-list
2944450|NCT03101566|Nivolumab|nivolumab|mesh-list
2944451|NCT03101566|Ipilimumab|ipilimumab|mesh-list
2944452|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944453|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2944454|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
2944455|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944456|NCT03101566|Antiviral Agents|antiviral agents|mesh-ancestor
2944457|NCT03101566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2944458|NCT03101566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944459|NCT03101566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944460|NCT03101566|Immunologic Factors|immunologic factors|mesh-ancestor
2944461|NCT03101566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944462|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944463|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2944464|NCT03041701|Dasatinib|dasatinib|mesh-list
2944465|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944466|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2944467|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944468|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944469|NCT03020199|Betamethasone|betamethasone|mesh-list
2350654|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2350655|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2944470|NCT03020199|Calcipotriene|calcipotriene|mesh-list
2944471|NCT03020199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2944472|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944473|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
2944474|NCT03020199|Hormones|hormones|mesh-ancestor
2944475|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944476|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944477|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2944478|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
2944479|NCT03020199|Immunologic Factors|immunologic factors|mesh-ancestor
2944480|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
2944481|NCT03006068|Upadacitinib|upadacitinib|mesh-list
2944482|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2944483|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2944484|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944485|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944486|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944487|NCT03003520|Prednisone|prednisone|mesh-list
2350656|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2350657|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
2350658|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
2350659|NCT00490113|Vitamins|vitamins|mesh-ancestor
2350660|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
2350661|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350662|NCT00490178|Metformin|metformin|mesh-list
2350663|NCT00490178|Fenofibrate|fenofibrate|mesh-list
2350664|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2350665|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944488|NCT03003520|Prednisolone|prednisolone|mesh-list
2944489|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
2944490|NCT03003520|Rituximab|rituximab|mesh-list
2944491|NCT03003520|Doxorubicin|doxorubicin|mesh-list
2944492|NCT03003520|Vincristine|vincristine|mesh-list
2944493|NCT03003520|Lenalidomide|lenalidomide|mesh-list
2944494|NCT03003520|Durvalumab|durvalumab|mesh-list
2944495|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350666|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2350667|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
2350668|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350669|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2350670|NCT00490204|Cetirizine|cetirizine|mesh-list
2944496|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
2944497|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944498|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944499|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2944500|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
2944501|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944502|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944503|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2944504|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944505|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2944506|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2944507|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2944508|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350671|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2350672|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2350673|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2350674|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
2350675|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
2350676|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350677|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350678|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350679|NCT00490243|Budesonide|budesonide|mesh-list
2944509|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944510|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
2944511|NCT03003520|Hormones|hormones|mesh-ancestor
2944512|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944513|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2944514|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2944515|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
2944516|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
2944517|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
2944518|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2944519|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2944520|NCT03003520|Growth Substances|growth substances|mesh-ancestor
2944521|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
2350680|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
2350681|NCT00490243|Montelukast|montelukast|mesh-list
2350682|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350683|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2350684|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
2350685|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350686|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350687|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2350688|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
2350689|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
2350690|NCT00490243|Hormones|hormones|mesh-ancestor
2350691|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2350692|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2350693|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2350694|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2350695|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
2350696|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2944522|NCT02992015|Gemcitabine|gemcitabine|mesh-list
2944523|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350697|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350698|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2350699|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
2350700|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2350701|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2350702|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2350703|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2350704|NCT00490308|Estradiol|estradiol|mesh-list
2350705|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2350706|NCT00490308|Estrogens|estrogens|mesh-ancestor
2350707|NCT00490308|Hormones|hormones|mesh-ancestor
2944524|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
2944525|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944526|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944527|NCT02992015|Antiviral Agents|antiviral agents|mesh-ancestor
2944528|NCT02992015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2944529|NCT02992015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944530|NCT02992015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944531|NCT02992015|Immunologic Factors|immunologic factors|mesh-ancestor
2944532|NCT02992015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944533|NCT02991495|Vaccines|vaccines|mesh-list
2944534|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
2944535|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944536|NCT02966756|Venetoclax|venetoclax|mesh-list
2944537|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944538|NCT02963493|Dexamethasone|dexamethasone|mesh-list
2944539|NCT02963493|Melphalan|melphalan|mesh-list
2944540|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944541|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
2944542|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
2944543|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944544|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944545|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2944546|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
2944547|NCT02963493|Hormones|hormones|mesh-ancestor
2944548|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944549|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2944550|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944551|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2944552|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
2944553|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944554|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2944555|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944556|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
2944557|NCT02928406|Atezolizumab|atezolizumab|mesh-list
2944558|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944559|NCT02918370|Aripiprazole|aripiprazole|mesh-list
2944560|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
2944561|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2350708|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2350709|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350710|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2350711|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
2350712|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2350713|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2350714|NCT00490360|Gemcitabine|gemcitabine|mesh-list
2944562|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2944563|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2944564|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2944565|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944566|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
2944567|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
2944568|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2944569|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944570|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2944571|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2944572|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
2944573|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2944574|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2944575|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2944576|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2944577|NCT02891824|Bevacizumab|bevacizumab|mesh-list
2944578|NCT02891824|Atezolizumab|atezolizumab|mesh-list
2944579|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944580|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944581|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2944582|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2350715|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350716|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350717|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
2350718|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350719|NCT00490360|Antiviral Agents|antiviral agents|mesh-ancestor
2350720|NCT00490360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350721|NCT00490360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944583|NCT02891824|Growth Substances|growth substances|mesh-ancestor
2944584|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944585|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
2944586|NCT02862457|Paclitaxel|paclitaxel|mesh-list
2944587|NCT02862457|Cisplatin|cisplatin|mesh-list
2944588|NCT02862457|Carboplatin|carboplatin|mesh-list
2944589|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
2944590|NCT02862457|Pemetrexed|pemetrexed|mesh-list
2944591|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2944592|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944593|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
2944594|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
2944595|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
2944596|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944597|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944598|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944599|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2944600|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2944601|NCT02845323|Nivolumab|nivolumab|mesh-list
2944602|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944603|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944604|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2944605|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944606|NCT02790515|Sirolimus|sirolimus|mesh-list
2944607|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
2944608|NCT02790515|Melphalan|melphalan|mesh-list
2944609|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
2944610|NCT02790515|Thiotepa|thiotepa|mesh-list
2944611|NCT02790515|Rituximab|rituximab|mesh-list
2944612|NCT02790515|Fludarabine|fludarabine|mesh-list
2944613|NCT02790515|Blinatumomab|blinatumomab|mesh-list
2944614|NCT02790515|Tacrolimus|tacrolimus|mesh-list
2944615|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
2944616|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2944617|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944618|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
2944619|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944620|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944621|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2350722|NCT00490360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350723|NCT00490360|Immunologic Factors|immunologic factors|mesh-ancestor
2350724|NCT00490360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350725|NCT00490373|Pemetrexed|pemetrexed|mesh-list
2350726|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350727|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944622|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
2944623|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944624|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944625|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2944626|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944627|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2944628|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944629|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2944630|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2944631|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2944632|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
2944633|NCT02733042|Rituximab|rituximab|mesh-list
2944634|NCT02733042|Durvalumab|durvalumab|mesh-list
2944635|NCT02733042|Lenalidomide|lenalidomide|mesh-list
2944636|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2944637|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944638|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944639|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
2944640|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944641|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944642|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2944643|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2944644|NCT02733042|Growth Substances|growth substances|mesh-ancestor
2944645|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
2944646|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2944647|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
2944648|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944649|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
2944650|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
2944651|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2944652|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
2350728|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350729|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2350730|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2350731|NCT00490399|Gemcitabine|gemcitabine|mesh-list
2350732|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350733|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350734|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
2350735|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350736|NCT00490399|Antiviral Agents|antiviral agents|mesh-ancestor
2350737|NCT00490399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350738|NCT00490399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350739|NCT00490399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350740|NCT00490399|Immunologic Factors|immunologic factors|mesh-ancestor
2350741|NCT00490399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350742|NCT00490412|Vitamin D|vitamin d|mesh-list
2350743|NCT00490412|Vitamins|vitamins|mesh-ancestor
2944653|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944654|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
2944655|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2944656|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944657|NCT02663518|Rituximab|rituximab|mesh-list
2944658|NCT02663518|Nivolumab|nivolumab|mesh-list
2944659|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
2944660|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944661|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944662|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
2350744|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
2350745|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350746|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2350747|NCT00490464|Nicardipine|nicardipine|mesh-list
2350748|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2350749|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2350750|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2350751|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350752|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2350753|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350754|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
2350755|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
2350756|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350757|NCT00490633|Ethanol|ethanol|mesh-list
2350758|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
2350759|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2350760|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350761|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2350762|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350763|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
2350764|NCT00490659|Gemcitabine|gemcitabine|mesh-list
2350765|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350766|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350767|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
2350768|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350769|NCT00490659|Antiviral Agents|antiviral agents|mesh-ancestor
2350770|NCT00490659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350771|NCT00490659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350772|NCT00490659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350773|NCT00490659|Immunologic Factors|immunologic factors|mesh-ancestor
2350774|NCT00490659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350775|NCT00490685|Sorafenib|sorafenib|mesh-list
2350776|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350777|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2350778|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350779|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350780|NCT00490711|Gemcitabine|gemcitabine|mesh-list
2350781|NCT00490711|Paclitaxel|paclitaxel|mesh-list
2350782|NCT00490711|Carboplatin|carboplatin|mesh-list
2350783|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2350784|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350785|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
2350786|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
2944663|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944664|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944665|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2944666|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944667|NCT02663271|Bevacizumab|bevacizumab|mesh-list
2944668|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944669|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944670|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2944671|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2944672|NCT02663271|Growth Substances|growth substances|mesh-ancestor
2944673|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944674|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
2944675|NCT02661971|Leucovorin|leucovorin|mesh-list
2944676|NCT02661971|Docetaxel|docetaxel|mesh-list
2944677|NCT02661971|Fluorouracil|fluorouracil|mesh-list
2944678|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
2944679|NCT02661971|Ramucirumab|ramucirumab|mesh-list
2944680|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944681|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
2944682|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
2944683|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
2944684|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944685|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
2944686|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2944687|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944688|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
2944689|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944690|NCT02661971|Antidotes|antidotes|mesh-ancestor
2944691|NCT02661971|Protective Agents|protective agents|mesh-ancestor
2944692|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
2944693|NCT02661971|Vitamins|vitamins|mesh-ancestor
2944694|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
2944695|NCT02640664|Ranibizumab|ranibizumab|mesh-list
2350787|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
2350788|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350789|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350790|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
2350791|NCT00490711|Antiviral Agents|antiviral agents|mesh-ancestor
2350792|NCT00490711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2944696|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2944697|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2944698|NCT02640664|Growth Substances|growth substances|mesh-ancestor
2350793|NCT00490711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350794|NCT00490711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350795|NCT00490711|Immunologic Factors|immunologic factors|mesh-ancestor
2350796|NCT00490711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350797|NCT00490737|Daptomycin|daptomycin|mesh-list
2350798|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2350799|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350800|NCT00490789|Sirolimus|sirolimus|mesh-list
2350801|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2350802|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350803|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2944699|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944700|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
2944701|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944702|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
2944703|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
2944704|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
2944705|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944706|NCT02588105|Leucovorin|leucovorin|mesh-list
2944707|NCT02588105|Folic Acid|folic acid|mesh-list
2944708|NCT02588105|Fluorouracil|fluorouracil|mesh-list
2944709|NCT02588105|Irinotecan|irinotecan|mesh-list
2944710|NCT02588105|Olaparib|olaparib|mesh-list
2944711|NCT02588105|AZD0156|azd0156|mesh-list
2944712|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
2944713|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
2944714|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944715|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2944716|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944717|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944718|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
2350804|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350805|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
2350806|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350807|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
2350808|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350809|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
2350810|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2350811|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2350812|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2350813|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350814|NCT00490854|Insulin|insulin|mesh-list
2350815|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2350816|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
2350817|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
2350818|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
2350819|NCT00490854|Protamines|protamines|mesh-list
2350820|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2350821|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350822|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
2350823|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350824|NCT00490854|Coagulants|coagulants|mesh-ancestor
2350825|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
2350826|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
2350827|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944719|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944720|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2944721|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2944722|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944723|NCT02588105|Antidotes|antidotes|mesh-ancestor
2944724|NCT02588105|Protective Agents|protective agents|mesh-ancestor
2944725|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
2944726|NCT02588105|Vitamins|vitamins|mesh-ancestor
2350828|NCT00490867|Protective Agents|protective agents|mesh-ancestor
2350829|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350830|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
2350831|NCT00490867|Vitamins|vitamins|mesh-ancestor
2350832|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
2350833|NCT00490880|Gemcitabine|gemcitabine|mesh-list
2350834|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944727|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
2944728|NCT02588105|Hematinics|hematinics|mesh-ancestor
2944729|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2944730|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2944731|NCT02575144|Clarithromycin|clarithromycin|mesh-list
2944732|NCT02575144|Dexamethasone|dexamethasone|mesh-list
2944733|NCT02575144|Lenalidomide|lenalidomide|mesh-list
2944734|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944735|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
2350835|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350836|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
2350837|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944736|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
2944737|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944738|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944739|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2944740|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
2944741|NCT02575144|Hormones|hormones|mesh-ancestor
2944742|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944743|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2944744|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944745|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
2944746|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2944747|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2944748|NCT02575144|Growth Substances|growth substances|mesh-ancestor
2944749|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
2944750|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2944751|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2944752|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2944753|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944754|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350838|NCT00490880|Antiviral Agents|antiviral agents|mesh-ancestor
2350839|NCT00490880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350840|NCT00490880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350841|NCT00490880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350842|NCT00490880|Immunologic Factors|immunologic factors|mesh-ancestor
2944755|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2944756|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2944757|NCT02574286|Vitamin D|vitamin d|mesh-list
2944758|NCT02574286|Vitamins|vitamins|mesh-ancestor
2944759|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
2944760|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944761|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2944762|NCT02542956|Bupivacaine|bupivacaine|mesh-list
2350843|NCT00490880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350844|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
2350845|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2350846|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350847|NCT00490906|Interferons|interferons|mesh-list
2350848|NCT00490906|Interferon-beta|interferon-beta|mesh-list
2350849|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
2350850|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
2350851|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
2350852|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
2350853|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350854|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
2350855|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350856|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
2350857|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350858|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2944763|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
2944764|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
2944765|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2944766|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944767|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
2944768|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944769|NCT02471144|Etanercept|etanercept|mesh-list
2944770|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2944771|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2944772|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2944773|NCT02471144|Analgesics|analgesics|mesh-ancestor
2944774|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
2944775|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944776|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944777|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944778|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2350859|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350860|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2350861|NCT00490958|Telmisartan|telmisartan|mesh-list
2350862|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2350863|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2350864|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2944779|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2944780|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944781|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
2944782|NCT02466971|Cisplatin|cisplatin|mesh-list
2944783|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944784|NCT02440464|Fludarabine|fludarabine|mesh-list
2944785|NCT02440464|Bortezomib|bortezomib|mesh-list
2944786|NCT02440464|Melphalan|melphalan|mesh-list
2944787|NCT02440464|Ixazomib|ixazomib|mesh-list
2944788|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944789|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944790|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944791|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
2944792|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944793|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2944794|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
2944795|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2944796|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
2944797|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944798|NCT02428985|Riociguat|riociguat|mesh-list
2944799|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
2944800|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944801|NCT02366728|Temozolomide|temozolomide|mesh-list
2944802|NCT02366728|Basiliximab|basiliximab|mesh-list
2944803|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
2944804|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944805|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2944806|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
2944807|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944808|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944809|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350865|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944810|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
2944811|NCT02344355|Temozolomide|temozolomide|mesh-list
2350866|NCT00490997|Ketamine|ketamine|mesh-list
2350867|NCT00490997|Propofol|propofol|mesh-list
2350868|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2350869|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2350870|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350871|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2350872|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
2350873|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
2350874|NCT00490997|Analgesics|analgesics|mesh-ancestor
2350875|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
2350876|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350877|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2350878|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2350879|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2350880|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350881|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944812|NCT02344355|Vitamins|vitamins|mesh-ancestor
2944813|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
2944814|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944815|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2944816|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
2944817|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944818|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350882|NCT00491049|Levofloxacin|levofloxacin|mesh-list
2350883|NCT00491049|Ofloxacin|ofloxacin|mesh-list
2350884|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2350885|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2350886|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2350887|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350888|NCT00491049|Renal Agents|renal agents|mesh-ancestor
2350889|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2350890|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2350891|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2350892|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350893|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350894|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350895|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2350896|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2350897|NCT00491114|Gemcitabine|gemcitabine|mesh-list
2350898|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350899|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
2350900|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350901|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350902|NCT00491114|Antiviral Agents|antiviral agents|mesh-ancestor
2350903|NCT00491114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350904|NCT00491114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944819|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
2944820|NCT02344355|Protective Agents|protective agents|mesh-ancestor
2944821|NCT02332850|Dexamethasone|dexamethasone|mesh-list
2944822|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944823|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
2350905|NCT00491114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350906|NCT00491114|Immunologic Factors|immunologic factors|mesh-ancestor
2350907|NCT00491114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350908|NCT00491127|Gemcitabine|gemcitabine|mesh-list
2350909|NCT00491127|Dexamethasone|dexamethasone|mesh-list
2350910|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2350911|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350912|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
2350913|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
2350914|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350915|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350916|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2350917|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
2944824|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
2944825|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944826|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350918|NCT00491127|Hormones|hormones|mesh-ancestor
2350919|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2350920|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2350921|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2350922|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
2944827|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2944828|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
2350923|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350924|NCT00491127|Antiviral Agents|antiviral agents|mesh-ancestor
2350925|NCT00491127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350926|NCT00491127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350927|NCT00491127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2350928|NCT00491127|Immunologic Factors|immunologic factors|mesh-ancestor
2350929|NCT00491166|Bromfenac|bromfenac|mesh-list
2350930|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2350931|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2350932|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2350933|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2350934|NCT00491166|Analgesics|analgesics|mesh-ancestor
2350935|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
2350936|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350937|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944829|NCT02332850|Hormones|hormones|mesh-ancestor
2944830|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944831|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2944832|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944833|NCT02313870|Clobetasol|clobetasol|mesh-list
2944834|NCT02313870|Methotrexate|methotrexate|mesh-list
2944835|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2944836|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
2944837|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2944838|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944839|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2944840|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
2944841|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944842|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944843|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
2350938|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350939|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2350940|NCT00491192|Diclofenac|diclofenac|mesh-list
2350941|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2350942|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2350943|NCT00491192|Analgesics|analgesics|mesh-ancestor
2350944|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
2350945|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350946|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350947|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2350948|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2350949|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2350950|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350951|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350952|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2350953|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2350954|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2350955|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2350956|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350957|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350958|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2350959|NCT00491348|Analgesics|analgesics|mesh-ancestor
2350960|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
2350961|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2350962|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
2350963|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2350964|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
2350965|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
2350966|NCT00491413|Hematinics|hematinics|mesh-ancestor
2350967|NCT00491426|Metronidazole|metronidazole|mesh-list
2350968|NCT00491426|Tazobactam|tazobactam|mesh-list
2350969|NCT00491426|Piperacillin|piperacillin|mesh-list
2350970|NCT00491426|Amphotericin B|amphotericin b|mesh-list
2350971|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2350972|NCT00491426|Acyclovir|acyclovir|mesh-list
2350973|NCT00491426|Ampicillin|ampicillin|mesh-list
2350974|NCT00491426|Caspofungin|caspofungin|mesh-list
2350975|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2350976|NCT00491426|Anidulafungin|anidulafungin|mesh-list
2350977|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2350978|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2350979|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2350980|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2350981|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2350982|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2350983|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350984|NCT00491426|Amebicides|amebicides|mesh-ancestor
2350985|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
2350986|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
2350987|NCT00491478|Sertraline|sertraline|mesh-list
2350988|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
2350989|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2350990|NCT00491478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2350991|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2350992|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2350993|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2350994|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2350995|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
2350996|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944844|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944845|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2944846|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944847|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
2944848|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2944849|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2944850|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2944851|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
2944852|NCT02313870|Hormones|hormones|mesh-ancestor
2944853|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944854|NCT02310321|Cytarabine|cytarabine|mesh-list
2944855|NCT02310321|Idarubicin|idarubicin|mesh-list
2944856|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2944857|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
2944858|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944859|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944860|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
2944861|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2944862|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944863|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
2944864|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944865|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2944866|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2944867|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2944868|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944869|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2944870|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2944871|NCT02243709|Mifepristone|mifepristone|mesh-list
2944872|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2944873|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
2944874|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2944875|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944876|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2944877|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2944878|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2944879|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
2944880|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2944881|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2944882|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
2944883|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944884|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
2944885|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2944886|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2944887|NCT02236806|Ramipril|ramipril|mesh-list
2944888|NCT02236806|Bisoprolol|bisoprolol|mesh-list
2944889|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2944890|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
2944891|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944892|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944893|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2350997|NCT00491517|Sirolimus|sirolimus|mesh-list
2350998|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2350999|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351000|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2351001|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351002|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
2351003|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2351004|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
2351005|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351006|NCT00491582|Hormones|hormones|mesh-list
2944894|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
2944895|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
2944896|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944897|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351007|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351008|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351009|NCT00491634|Treosulfan|treosulfan|mesh-list
2351010|NCT00491634|Busulfan|busulfan|mesh-list
2351011|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2351012|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
2351013|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351014|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351015|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2351016|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
2351017|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351018|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2351019|NCT00491712|Triamcinolone|triamcinolone|mesh-list
2351020|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2351021|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
2944898|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2944899|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2944900|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2944901|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
2944902|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2944903|NCT02236572|Everolimus|everolimus|mesh-list
2944904|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944905|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944906|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
2944907|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944908|NCT02220452|Anesthetics|anesthetics|mesh-list
2944909|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2944910|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944911|NCT02194738|Gemcitabine|gemcitabine|mesh-list
2944912|NCT02194738|Paclitaxel|paclitaxel|mesh-list
2944913|NCT02194738|Cisplatin|cisplatin|mesh-list
2944914|NCT02194738|Carboplatin|carboplatin|mesh-list
2944915|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
2944916|NCT02194738|Nivolumab|nivolumab|mesh-list
2944917|NCT02194738|Pemetrexed|pemetrexed|mesh-list
2944918|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2944919|NCT02194738|Crizotinib|crizotinib|mesh-list
2944920|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2944921|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944922|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
2944923|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
2944924|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
2944925|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944926|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2944927|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
2944928|NCT02194738|Antiviral Agents|antiviral agents|mesh-ancestor
2944929|NCT02194738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2944930|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944931|NCT02194738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2944932|NCT02194738|Immunologic Factors|immunologic factors|mesh-ancestor
2944933|NCT02194738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944934|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944935|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2944936|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2944937|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2944938|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2944939|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2944940|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944941|NCT02099058|Nivolumab|nivolumab|mesh-list
2944942|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2944943|NCT02099058|Osimertinib|osimertinib|mesh-list
2944944|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2944945|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944946|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944947|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2944948|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944949|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2944950|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351022|NCT00491712|Hormones|hormones|mesh-ancestor
2351023|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2944951|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
2351024|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351025|NCT00491725|Metformin|metformin|mesh-list
2351026|NCT00491725|Repaglinide|repaglinide|mesh-list
2351027|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2351028|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351029|NCT00491790|Montelukast|montelukast|mesh-list
2351030|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2351031|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
2351032|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2351033|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
2351034|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351035|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351036|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2351037|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2351038|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351039|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
2351040|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
2351041|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2351042|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2351043|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351044|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351045|NCT00491803|Urological Agents|urological agents|mesh-ancestor
2351046|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2351047|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351048|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2351049|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351050|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351051|NCT00491855|Paclitaxel|paclitaxel|mesh-list
2351052|NCT00491855|Bevacizumab|bevacizumab|mesh-list
2351053|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
2351054|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2351055|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351056|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
2351057|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
2351058|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
2944952|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944953|NCT02083354|Trametinib|trametinib|mesh-list
2944954|NCT02083354|Dabrafenib|dabrafenib|mesh-list
2944955|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944956|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2944957|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2944958|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944959|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
2944960|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2944961|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
2944962|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
2944963|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
2944964|NCT02065635|Propofol|propofol|mesh-list
2944965|NCT02065635|Sevoflurane|sevoflurane|mesh-list
2944966|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2944967|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2944968|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944969|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2944970|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
2944971|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
2944972|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2944973|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2351059|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351060|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2351061|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2351062|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2351063|NCT00491855|Growth Substances|growth substances|mesh-ancestor
2944974|NCT02061514|Propofol|propofol|mesh-list
2944975|NCT02061514|Desflurane|desflurane|mesh-list
2944976|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2944977|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2944978|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944979|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2944980|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
2944981|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
2944982|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2944983|NCT02000882|Capecitabine|capecitabine|mesh-list
2944984|NCT02000882|Trastuzumab|trastuzumab|mesh-list
2944985|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2944986|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
2944987|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2944988|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944989|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2944990|NCT01937468|Interleukin-2|interleukin-2|mesh-list
2944991|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2944992|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2944993|NCT01937468|Analgesics|analgesics|mesh-ancestor
2944994|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
2944995|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2944996|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2944997|NCT01775813|Metformin|metformin|mesh-list
2944998|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2944999|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2945000|NCT01694069|Tazobactam|tazobactam|mesh-list
2945001|NCT01694069|Piperacillin|piperacillin|mesh-list
2945002|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2945003|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2945004|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2945005|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2945006|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2945007|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2945008|NCT01446016|Paclitaxel|paclitaxel|mesh-list
2945009|NCT01446016|Docetaxel|docetaxel|mesh-list
2945010|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2945011|NCT01446016|Taxane|taxane|mesh-list
2945012|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2945013|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2945014|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
2945015|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
2945016|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
2945017|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2945018|NCT01434602|Everolimus|everolimus|mesh-list
2945019|NCT01434602|Sorafenib|sorafenib|mesh-list
2945020|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2945021|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2945022|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
2945023|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2945024|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2945025|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351064|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351065|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
2351066|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
2351067|NCT00491868|Hematinics|hematinics|mesh-ancestor
2351068|NCT00491907|Folic Acid|folic acid|mesh-list
2351069|NCT00491907|Hematinics|hematinics|mesh-ancestor
2351070|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
2351071|NCT00491907|Vitamins|vitamins|mesh-ancestor
2351072|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
2351073|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2945026|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2945027|NCT01399918|Bevacizumab|bevacizumab|mesh-list
2945028|NCT01399918|Everolimus|everolimus|mesh-list
2945029|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2945030|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2945031|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2945032|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2945033|NCT01399918|Growth Substances|growth substances|mesh-ancestor
2945034|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2945035|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
2945036|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2945037|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
2945038|NCT01078454|Dexamethasone|dexamethasone|mesh-list
2945039|NCT01078454|Bortezomib|bortezomib|mesh-list
2945040|NCT01078454|Melphalan|melphalan|mesh-list
2945041|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2945042|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
2945043|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
2945044|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2945045|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2945046|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2945047|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
2945048|NCT01078454|Hormones|hormones|mesh-ancestor
2945049|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2945050|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2351074|NCT00491920|Vitamin D|vitamin d|mesh-list
2351075|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
2351076|NCT00491920|Vitamins|vitamins|mesh-ancestor
2945051|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2945052|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2945053|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
2945054|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2945055|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2945056|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2945057|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
2945058|NCT00967785|Plerixafor|plerixafor|mesh-list
2945059|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2945060|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2945061|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
2945062|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2945063|NCT00472654|Vitamin D|vitamin d|mesh-list
2945064|NCT00472654|Vitamins|vitamins|mesh-ancestor
2351077|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
2351078|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351079|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2945065|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
2945066|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2945067|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2945068|NCT00458536|Molgramostim|molgramostim|mesh-list
2945069|NCT00458536|Sargramostim|sargramostim|mesh-list
2945070|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
2945071|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2945072|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2945073|NCT00112840|Bevacizumab|bevacizumab|mesh-list
2945074|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2945075|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2945076|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2945077|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2945078|NCT00112840|Growth Substances|growth substances|mesh-ancestor
2945079|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2945080|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
2351080|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2351081|NCT00491946|Dactinomycin|dactinomycin|mesh-list
2351082|NCT00491946|Vincristine|vincristine|mesh-list
2351083|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2351084|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351085|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
2351086|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
2351087|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
2351088|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351089|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2351090|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351091|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2351092|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2351093|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351094|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2351095|NCT00491985|Vaccines|vaccines|mesh-list
2351096|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
2351097|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351098|NCT00491998|Entacapone|entacapone|mesh-list
2351099|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2351100|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2351101|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2351102|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351103|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351104|NCT00492037|Conivaptan|conivaptan|mesh-list
2351105|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2351106|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351107|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
2351108|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351109|NCT00492050|Valacyclovir|valacyclovir|mesh-list
2351110|NCT00492050|Rituximab|rituximab|mesh-list
2351111|NCT00492050|Bortezomib|bortezomib|mesh-list
2351112|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2351113|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351114|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
2351115|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351116|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2351117|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
2351118|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351119|NCT00492102|Montelukast|montelukast|mesh-list
2351120|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2351121|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
2351122|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2351123|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
2351124|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351125|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351126|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2351127|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2351128|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351129|NCT00492128|Losartan|losartan|mesh-list
2351130|NCT00492128|Amlodipine|amlodipine|mesh-list
2351131|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2351132|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2351133|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2351134|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2351135|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351136|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2351137|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351138|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
2351139|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2351140|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2351141|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2351142|NCT00492128|Diuretics|diuretics|mesh-ancestor
2351143|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
2351144|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2351145|NCT00492141|Temozolomide|temozolomide|mesh-list
2351146|NCT00492141|Camptothecin|camptothecin|mesh-list
2351147|NCT00492141|Rubitecan|rubitecan|mesh-list
2351148|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2351149|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
2351150|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351151|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351152|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2351153|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2351154|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2351155|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351156|NCT00492167|Antibodies|antibodies|mesh-list
2351157|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2351158|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
2351159|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351160|NCT00492219|Cimetidine|cimetidine|mesh-list
2351161|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2351162|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2351163|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2351164|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
2351165|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
2351166|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351167|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351168|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351169|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2351170|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2351171|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351172|NCT00492245|Mitomycins|mitomycins|mesh-list
2351173|NCT00492245|Mitomycin|mitomycin|mesh-list
2351174|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2351175|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351176|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
2351177|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351178|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2351179|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351180|NCT00492258|Sorafenib|sorafenib|mesh-list
2351181|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351182|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2351183|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351184|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351185|NCT00492388|Ketamine|ketamine|mesh-list
2351186|NCT00492388|Analgesics|analgesics|mesh-ancestor
2351187|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
2351188|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351189|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351190|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2351191|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2351192|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
2351193|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
2351194|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2351195|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2351196|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2351197|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351198|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351199|NCT00492414|Paroxetine|paroxetine|mesh-list
2351200|NCT00492414|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2351201|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2351202|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2351203|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351204|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351205|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
2351206|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351207|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2351208|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
2351209|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2351210|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2351211|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2351212|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351213|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
2351214|NCT00492427|Hematinics|hematinics|mesh-ancestor
2351215|NCT00492466|Interferons|interferons|mesh-list
2351216|NCT00492466|Interferon-beta|interferon-beta|mesh-list
2351217|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
2351218|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
2351219|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351220|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
2351221|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351222|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2351223|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
2351224|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
2351225|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351226|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351227|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2351228|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
2351229|NCT00492466|Hormones|hormones|mesh-ancestor
2351230|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351231|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2351232|NCT00492466|Protective Agents|protective agents|mesh-ancestor
2351233|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
2351234|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2351235|NCT00492479|Kinetin|kinetin|mesh-list
2351236|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2351237|NCT00492479|Growth Substances|growth substances|mesh-ancestor
2351238|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351239|NCT00492505|Tamoxifen|tamoxifen|mesh-list
2351240|NCT00492505|Sorafenib|sorafenib|mesh-list
2351241|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351242|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351243|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2351244|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351245|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2351246|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
2351247|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351248|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351249|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2351250|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2351251|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2351252|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2351253|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
2351254|NCT00492518|Theophylline|theophylline|mesh-list
2351255|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2351256|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
2351257|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351258|NCT00492518|Expectorants|expectorants|mesh-ancestor
2351259|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
2351260|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2351261|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
2351262|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351263|NCT00492518|Protective Agents|protective agents|mesh-ancestor
2351264|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351265|NCT00492518|Antidotes|antidotes|mesh-ancestor
2351266|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2351267|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
2351268|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351269|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2351270|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2351271|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351272|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
2351273|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2351274|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2351275|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
2351276|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351277|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2351278|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
2351279|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2351280|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2351281|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351282|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351283|NCT00492635|Urological Agents|urological agents|mesh-ancestor
2351284|NCT00492661|Tacrolimus|tacrolimus|mesh-list
2351285|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2351286|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
2351287|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351288|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2351289|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351290|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351291|NCT00492687|Tamoxifen|tamoxifen|mesh-list
2351292|NCT00492687|Carboplatin|carboplatin|mesh-list
2351293|NCT00492687|Temozolomide|temozolomide|mesh-list
2351294|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351295|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351296|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2351297|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
2351298|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2351299|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
2351300|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351301|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351302|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2351303|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2351304|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2351305|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2351306|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
2351307|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2351308|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351309|NCT00492739|Vaccines|vaccines|mesh-list
2351310|NCT00492739|Immunologic Factors|immunologic factors|mesh-ancestor
2351311|NCT00492739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351312|NCT00492765|Interferons|interferons|mesh-list
2351313|NCT00492765|Interferon-beta|interferon-beta|mesh-list
2351314|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
2351315|NCT00492765|Simvastatin|simvastatin|mesh-list
2351316|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351317|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
2351318|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351319|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2351320|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2351321|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
2351322|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351323|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2351324|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2351325|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351326|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
2351327|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351328|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2351329|NCT00492778|Cisplatin|cisplatin|mesh-list
2351330|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351331|NCT00492830|Antibodies|antibodies|mesh-list
2351332|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2351333|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
2351334|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351335|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
2351336|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2351337|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351338|NCT00492934|Menotropins|menotropins|mesh-list
2351339|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2351340|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
2351341|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2351342|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351343|NCT00492986|Sorafenib|sorafenib|mesh-list
2351344|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351345|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2351346|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351347|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351348|NCT00492999|Leucovorin|leucovorin|mesh-list
2351349|NCT00492999|Dexamethasone|dexamethasone|mesh-list
2351350|NCT00492999|Fluorouracil|fluorouracil|mesh-list
2351351|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
2351352|NCT00492999|Irinotecan|irinotecan|mesh-list
2351353|NCT00492999|Floxuridine|floxuridine|mesh-list
2351354|NCT00492999|Calcium|calcium|mesh-list
2351355|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
2351356|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2351357|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
2351358|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
2351359|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351360|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351361|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2351362|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
2351363|NCT00492999|Hormones|hormones|mesh-ancestor
2351364|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351365|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2351366|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351367|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2351368|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
2351369|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351370|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2351371|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2351372|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
2351373|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2351374|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2351375|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351376|NCT00492999|Antidotes|antidotes|mesh-ancestor
2351377|NCT00492999|Protective Agents|protective agents|mesh-ancestor
2351378|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
2351379|NCT00492999|Vitamins|vitamins|mesh-ancestor
2351380|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
2351381|NCT00493077|Interferons|interferons|mesh-list
2351382|NCT00493077|Interferon-beta|interferon-beta|mesh-list
2351383|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
2351384|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351385|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
2351386|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351387|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
2351388|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351389|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2351390|NCT00493116|Interferons|interferons|mesh-list
2351391|NCT00493116|Interferon-beta|interferon-beta|mesh-list
2351392|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
2351393|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
2351394|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351395|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
2351396|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351397|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2351398|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
2351399|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
2351400|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351401|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351402|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2351403|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
2351404|NCT00493116|Hormones|hormones|mesh-ancestor
2351405|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351406|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2351407|NCT00493116|Protective Agents|protective agents|mesh-ancestor
2351408|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
2351409|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2351410|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
2351411|NCT00493129|Interleukin-2|interleukin-2|mesh-list
2351412|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351413|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2351414|NCT00493129|Analgesics|analgesics|mesh-ancestor
2351415|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
2351416|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351417|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351418|NCT00493194|Cyclosporine|cyclosporine|mesh-list
2351419|NCT00493194|Sirolimus|sirolimus|mesh-list
2351420|NCT00493194|Cyclosporins|cyclosporins|mesh-list
2351421|NCT00493194|Daclizumab|daclizumab|mesh-list
2351422|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351423|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351424|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2351425|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
2351426|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351427|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
2351428|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351429|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
2351430|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2351431|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2351432|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2351433|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2351434|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351435|NCT00493233|Olanzapine|olanzapine|mesh-list
2351436|NCT00493233|Risperidone|risperidone|mesh-list
2351437|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2351438|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
2351439|NCT00493233|Clozapine|clozapine|mesh-list
2351440|NCT00493233|Perphenazine|perphenazine|mesh-list
2351441|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2351442|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
2351443|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351444|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351445|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351446|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2351447|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2351448|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2351449|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2351450|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
2351451|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
2351452|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
2351453|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351454|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2351455|NCT00493233|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2351456|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2351457|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2351458|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
2351459|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
2351460|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
2351461|NCT00493298|Natalizumab|natalizumab|mesh-list
2351462|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
2351463|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351464|NCT00493324|Alefacept|alefacept|mesh-list
2351465|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2351466|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
2351467|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351468|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
2351469|NCT00493363|Artesunate|artesunate|mesh-list
2351470|NCT00493363|Mefloquine|mefloquine|mesh-list
2351471|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
2351472|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2351473|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2351474|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351475|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351476|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
2351477|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
2351478|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2351479|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
2351480|NCT00493389|Hormones|hormones|mesh-list
2351481|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2351482|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351483|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351484|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
2351485|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2351486|NCT00493402|Estrogens|estrogens|mesh-ancestor
2351487|NCT00493402|Hormones|hormones|mesh-ancestor
2351488|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351489|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351490|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2351491|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351492|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
2351493|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
2351494|NCT00493428|Baclofen|baclofen|mesh-list
2351495|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2351496|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351497|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2351498|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351499|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2351500|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
2351501|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
2351502|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351503|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351504|NCT00493480|Propranolol|propranolol|mesh-list
2351505|NCT00493480|Carvedilol|carvedilol|mesh-list
2351506|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2351507|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2351508|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
2351509|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351510|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351511|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351512|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2351513|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2351514|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
2351515|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
2351516|NCT00493480|Protective Agents|protective agents|mesh-ancestor
2351517|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2351518|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2351519|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2351520|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2351521|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2351522|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
2351523|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2351524|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351525|NCT00493545|Poly ICLC|poly iclc|mesh-list
2351526|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
2351527|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
2351528|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351529|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
2351530|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2351531|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
2351532|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351533|NCT00493610|Expectorants|expectorants|mesh-ancestor
2351534|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
2351535|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2351536|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
2351537|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351538|NCT00493610|Protective Agents|protective agents|mesh-ancestor
2351539|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351540|NCT00493610|Antidotes|antidotes|mesh-ancestor
2351541|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
2351542|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2351543|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351544|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
2351545|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2351546|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
2351547|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351548|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
2351549|NCT00493662|Protective Agents|protective agents|mesh-ancestor
2351550|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
2351551|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2351552|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
2351553|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351554|NCT00493727|Expectorants|expectorants|mesh-ancestor
2351555|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
2351556|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2351557|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
2351558|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351559|NCT00493727|Protective Agents|protective agents|mesh-ancestor
2351560|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351561|NCT00493727|Antidotes|antidotes|mesh-ancestor
2351562|NCT00493766|Panobinostat|panobinostat|mesh-list
2351563|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351564|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2351565|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351566|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351567|NCT00493831|Nicotine|nicotine|mesh-list
2351568|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2351569|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
2351570|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351571|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351572|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2351573|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2351574|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
2351575|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351576|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351577|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
2351578|NCT00493857|Antibodies|antibodies|mesh-list
2351579|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2351580|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
2351581|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351582|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2351583|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351584|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
2351585|NCT00493870|Docetaxel|docetaxel|mesh-list
2351586|NCT00493870|Doxorubicin|doxorubicin|mesh-list
2351587|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2351588|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
2351589|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351590|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2351591|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2351592|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
2351593|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351594|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351595|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2351596|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
2351597|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
2351598|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
2351599|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2351600|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2351601|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2351602|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351603|NCT00493896|Enoxaparin|enoxaparin|mesh-list
2351604|NCT00493896|PENTA|penta|mesh-list
2351605|NCT00493896|Fondaparinux|fondaparinux|mesh-list
2351606|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
2351607|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2351608|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2351609|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351610|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2351611|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
2351612|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2351613|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
2351614|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351615|NCT00493961|Hormones|hormones|mesh-list
2351616|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351617|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351618|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
2351619|NCT00493987|Testosterone|testosterone|mesh-list
2351620|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
2351621|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
2351622|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2351623|NCT00493987|Dutasteride|dutasteride|mesh-list
2351624|NCT00493987|Androgens|androgens|mesh-ancestor
2351625|NCT00493987|Hormones|hormones|mesh-ancestor
2351626|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351627|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351628|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2351629|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351630|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
2351631|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2351632|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2351633|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351634|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351635|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
2351636|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
2351637|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
2351638|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2351639|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2351640|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351641|NCT00494104|Vitamin D|vitamin d|mesh-list
2351642|NCT00494104|Vitamins|vitamins|mesh-ancestor
2351643|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
2351644|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351645|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2351646|NCT00494156|Aspirin|aspirin|mesh-list
2351647|NCT00494156|Heparin|heparin|mesh-list
2351648|NCT00494156|Clopidogrel|clopidogrel|mesh-list
2351649|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2351650|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2351651|NCT00494156|Analgesics|analgesics|mesh-ancestor
2351652|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
2351653|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351654|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351655|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2351656|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2351657|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2351658|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2351659|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351660|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2351661|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2351662|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351663|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
2351664|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2351665|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2351666|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2351667|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
2351668|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351669|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
2351670|NCT00494182|Paclitaxel|paclitaxel|mesh-list
2351671|NCT00494182|Carboplatin|carboplatin|mesh-list
2351672|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2351673|NCT00494182|Sorafenib|sorafenib|mesh-list
2351674|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2351675|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351676|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
2351677|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
2351678|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
2351679|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351680|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2351681|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351682|NCT00494208|Testosterone|testosterone|mesh-list
2351683|NCT00494208|Androgens|androgens|mesh-ancestor
2351684|NCT00494208|Hormones|hormones|mesh-ancestor
2351685|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351686|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351687|NCT00494247|Antibodies|antibodies|mesh-list
2351688|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
2351689|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351690|NCT00494312|Pioglitazone|pioglitazone|mesh-list
2351691|NCT00494312|Glyburide|glyburide|mesh-list
2351692|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2351693|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351694|NCT00494338|Docetaxel|docetaxel|mesh-list
2351695|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351696|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
2351697|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
2351698|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
2112082|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
2112083|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112084|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112085|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2112086|NCT02564471|Filaricides|filaricides|mesh-ancestor
2112087|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
2112088|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
2112089|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351699|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351700|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2351701|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2351702|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2351703|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2351704|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351705|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351706|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351707|NCT00494377|Analgesics|analgesics|mesh-ancestor
2112090|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112091|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
2112092|NCT02564497|Abatacept|abatacept|mesh-list
2112093|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2112094|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112095|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112096|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2112097|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
2351708|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
2351709|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351710|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
2351711|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2351712|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
2351713|NCT00494429|Morphine|morphine|mesh-list
2351714|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2351715|NCT00494429|Narcotics|narcotics|mesh-ancestor
2351716|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2351717|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351718|NCT00494429|Analgesics|analgesics|mesh-ancestor
2351719|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
2351720|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351721|NCT00494468|Zolpidem|zolpidem|mesh-list
2351722|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2351723|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2351724|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2351725|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351726|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2351727|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
2351728|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
2351729|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351730|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351731|NCT00494533|Treprostinil|treprostinil|mesh-list
2351732|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2351733|NCT00494559|Pioglitazone|pioglitazone|mesh-list
2351734|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2351735|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351736|NCT00494572|Montelukast|montelukast|mesh-list
2351737|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2351738|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
2351739|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2351740|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
2351741|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351742|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351743|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2351744|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2351745|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351746|NCT00494598|Sufentanil|sufentanil|mesh-list
2351747|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2351748|NCT00494598|Narcotics|narcotics|mesh-ancestor
2351749|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2351750|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351751|NCT00494598|Analgesics|analgesics|mesh-ancestor
2351752|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
2351753|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351754|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2351755|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2351756|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
2351757|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
2351758|NCT00494611|Cetuximab|cetuximab|mesh-list
2351759|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2351760|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351761|NCT00494624|Prednisolone|prednisolone|mesh-list
2351762|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2351763|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
2351764|NCT00494624|Hormones|hormones|mesh-ancestor
2351765|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351766|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351767|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2351768|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351769|NCT00494663|Ketoconazole|ketoconazole|mesh-list
2351770|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
2351771|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351772|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2351773|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2351774|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351775|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351776|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2351777|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
2351778|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351779|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351780|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2351781|NCT00494715|Valsartan|valsartan|mesh-list
2351782|NCT00494715|Benazepril|benazepril|mesh-list
2351783|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2351784|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2351785|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2351786|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351787|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2351788|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
2351789|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351790|NCT00494728|Nicotine|nicotine|mesh-list
2351791|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2351792|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
2351793|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351794|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351795|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2351796|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2351797|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
2351798|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351799|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351800|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
2351801|NCT00494741|Azathioprine|azathioprine|mesh-list
2351802|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2351803|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351804|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2351805|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
2351806|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2351807|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351808|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351809|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351810|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
2351811|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2351812|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2351813|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
2351814|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351815|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2351816|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
2351817|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2351818|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2351819|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351820|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2351821|NCT00494832|Analgesics|analgesics|mesh-ancestor
2351822|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
2351823|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351824|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2351825|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2351826|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2351827|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
2351828|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351829|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351830|NCT00494884|Vildagliptin|vildagliptin|mesh-list
2351831|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2351832|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351833|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2351834|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
2351835|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351836|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351837|NCT00494897|Cytarabine|cytarabine|mesh-list
2351838|NCT00494897|Prednisone|prednisone|mesh-list
2351839|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
2351840|NCT00494897|Methotrexate|methotrexate|mesh-list
2351841|NCT00494897|Vincristine|vincristine|mesh-list
2351842|NCT00494897|Daunorubicin|daunorubicin|mesh-list
2351843|NCT00494897|Asparaginase|asparaginase|mesh-list
2351844|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
2351845|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2351846|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
2351847|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351848|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2351849|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2351850|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
2351851|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351852|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351853|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2351854|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2351855|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
2351856|NCT00494897|Hormones|hormones|mesh-ancestor
2351857|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2351858|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2351859|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2351860|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
2351861|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2351862|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2351863|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
2351864|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
2351865|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351866|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2351867|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2351868|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
2351869|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351870|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2351871|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
2351872|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
2351873|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
2351874|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2351875|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2351876|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2351877|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2351878|NCT00494988|Insulin|insulin|mesh-list
2351879|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2351880|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
2351881|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
2351882|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
2351883|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
2351884|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2351885|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351886|NCT00495027|Vaccines|vaccines|mesh-list
2351887|NCT00495027|Immunologic Factors|immunologic factors|mesh-ancestor
2351888|NCT00495027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351889|NCT00495066|Ipilimumab|ipilimumab|mesh-list
2351890|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2351891|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351892|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2351893|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351894|NCT00495092|Biperiden|biperiden|mesh-list
2351895|NCT00495092|Caffeine|caffeine|mesh-list
2351896|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2351897|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351898|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2351899|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351900|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351901|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2351902|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2351903|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
2351904|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351905|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2351906|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2351907|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
2351908|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
2351909|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351910|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2351911|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2351912|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
2351913|NCT00495118|Risperidone|risperidone|mesh-list
2351914|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2351915|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
2351916|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351917|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351918|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351919|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2351920|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2351921|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2351922|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2351923|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2351924|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
2351925|NCT00495183|Biperiden|biperiden|mesh-list
2351926|NCT00495183|Caffeine|caffeine|mesh-list
2351927|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2351928|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351929|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2351930|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351931|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351932|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2351933|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2351934|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
2351935|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2351936|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2351937|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2351938|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
2351939|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
2351940|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2351941|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2351942|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2351943|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
2351944|NCT00495287|Cytarabine|cytarabine|mesh-list
2351945|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2351946|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
2351947|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351948|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2351949|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
2351950|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351951|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2351952|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
2351953|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2351954|NCT00495313|Metronidazole|metronidazole|mesh-list
2351955|NCT00495313|Doxycycline|doxycycline|mesh-list
2351956|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351957|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2351958|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2351959|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2351960|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
2351961|NCT00495326|Efavirenz|efavirenz|mesh-list
2351962|NCT00495326|Nevirapine|nevirapine|mesh-list
2351963|NCT00495326|Rifampin|rifampin|mesh-list
2351964|NCT00495326|Isoniazid|isoniazid|mesh-list
2351965|NCT00495326|Ethambutol|ethambutol|mesh-list
2351966|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2351967|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2351968|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2351969|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2351970|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
2351971|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351972|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2351973|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2351974|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2351975|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2351976|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2351977|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2351978|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2351979|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2351980|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2351981|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
2351982|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2351983|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
2351984|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2351985|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2351986|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2351987|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2351988|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2351989|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
2351990|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2351991|NCT00495339|Levofloxacin|levofloxacin|mesh-list
2351992|NCT00495339|Ofloxacin|ofloxacin|mesh-list
2351993|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2351994|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2351995|NCT00495339|Renal Agents|renal agents|mesh-ancestor
2351996|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2351997|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2351998|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2351999|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352000|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352001|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352002|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2352003|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2352004|NCT00495352|Bupropion|bupropion|mesh-list
2352005|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2352006|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
2352007|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2352008|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2352009|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2352010|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2352011|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352012|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
2352013|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352014|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352015|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2352016|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2352017|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352018|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
2352019|NCT00495365|Hematinics|hematinics|mesh-ancestor
2352020|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
2352021|NCT00495378|Hematinics|hematinics|mesh-ancestor
2352022|NCT00495508|Lumefantrine|lumefantrine|mesh-list
2352023|NCT00495508|Artemether|artemether|mesh-list
2352024|NCT00495508|Quinine|quinine|mesh-list
2352025|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2352026|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
2352027|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2352028|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2352029|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352030|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2352031|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352032|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2352033|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352034|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2352035|NCT00495508|Analgesics|analgesics|mesh-ancestor
2352036|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
2352037|NCT00495547|Azacitidine|azacitidine|mesh-list
2352038|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
2352039|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2352040|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
2352041|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352042|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352043|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352044|NCT00495547|Hematinics|hematinics|mesh-ancestor
2352045|NCT00495560|Misoprostol|misoprostol|mesh-list
2352046|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2352047|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
2352048|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2352049|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352050|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2352051|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2352052|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
2112098|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112099|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2112100|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
2112101|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2112102|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
2112103|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2112104|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
2352053|NCT00495573|Acyclovir|acyclovir|mesh-list
2352054|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
2352055|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352056|NCT00495651|Isoniazid|isoniazid|mesh-list
2352057|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2352058|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
2352059|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2352060|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352061|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2352062|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2352063|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
2352064|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352065|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2352066|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
2352067|NCT00495729|Simvastatin|simvastatin|mesh-list
2352068|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2352069|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2352070|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
2352071|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352072|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2352073|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2352074|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352075|NCT00495781|Iron|iron|mesh-list
2352076|NCT00495781|Trace Elements|trace elements|mesh-ancestor
2352077|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
2352078|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352079|NCT00495846|Octreotide|octreotide|mesh-list
2352080|NCT00495846|Lanreotide|lanreotide|mesh-list
2352081|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2352082|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2352083|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352084|NCT00495872|Lenalidomide|lenalidomide|mesh-list
2352085|NCT00495872|Sunitinib|sunitinib|mesh-list
2352086|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2352087|NCT00495872|Sorafenib|sorafenib|mesh-list
2352088|NCT00495872|Dasatinib|dasatinib|mesh-list
2352089|NCT00495872|Lapatinib|lapatinib|mesh-list
2352090|NCT00495872|Valproic Acid|valproic acid|mesh-list
2352091|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
2352092|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352093|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2352094|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2352095|NCT00495872|Growth Substances|growth substances|mesh-ancestor
2352096|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
2352097|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352098|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2352099|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352100|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352101|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
2352102|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
2352103|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352104|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
2352105|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2352106|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2352107|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2352108|NCT00495885|Volinanserin|volinanserin|mesh-list
2352109|NCT00495885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2352110|NCT00495885|Serotonin Agents|serotonin agents|mesh-ancestor
2352111|NCT00495885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352112|NCT00495885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352113|NCT00495885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352114|NCT00495898|Sirolimus|sirolimus|mesh-list
2352115|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2352116|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352117|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2352118|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352119|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
2352120|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352121|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
2352122|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352123|NCT00496002|Adefovir|adefovir|mesh-list
2352124|NCT00496002|Clevudine|clevudine|mesh-list
2352125|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
2352126|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352127|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2352128|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2352129|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352130|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352131|NCT00496028|Paclitaxel|paclitaxel|mesh-list
2352132|NCT00496028|Carboplatin|carboplatin|mesh-list
2352133|NCT00496028|Saracatinib|saracatinib|mesh-list
2352134|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2352135|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352136|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
2352137|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
2352138|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
2352139|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352140|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352141|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2352142|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
2352143|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352144|NCT00496158|Adefovir|adefovir|mesh-list
2352145|NCT00496158|Clevudine|clevudine|mesh-list
2352146|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
2352147|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352148|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2352149|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2352150|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352151|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352152|NCT00496184|Nifedipine|nifedipine|mesh-list
2352153|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2352154|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2352155|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352156|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2352157|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352158|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
2352159|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
2352160|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2352161|NCT00496223|Sunitinib|sunitinib|mesh-list
2352162|NCT00496223|Dacarbazine|dacarbazine|mesh-list
2352163|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352164|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2352165|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2352166|NCT00496223|Growth Substances|growth substances|mesh-ancestor
2352167|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352168|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
2352169|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2352170|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352171|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352172|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2352173|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
2352174|NCT00496275|Gemcitabine|gemcitabine|mesh-list
2352175|NCT00496275|Cisplatin|cisplatin|mesh-list
2352176|NCT00496275|Vinorelbine|vinorelbine|mesh-list
2352177|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352178|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2352179|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
2352180|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352181|NCT00496275|Antiviral Agents|antiviral agents|mesh-ancestor
2352182|NCT00496275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352183|NCT00496275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352184|NCT00496275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352185|NCT00496275|Immunologic Factors|immunologic factors|mesh-ancestor
2352186|NCT00496275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352187|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2352188|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
2352189|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
2352190|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
2352191|NCT00496301|Gemcitabine|gemcitabine|mesh-list
2352192|NCT00496301|Capecitabine|capecitabine|mesh-list
2352193|NCT00496301|Sorafenib|sorafenib|mesh-list
2352194|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2352195|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
2352196|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352197|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352198|NCT00496301|Antiviral Agents|antiviral agents|mesh-ancestor
2352199|NCT00496301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352200|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352201|NCT00496301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352202|NCT00496301|Immunologic Factors|immunologic factors|mesh-ancestor
2352203|NCT00496301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352204|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2352205|NCT00496392|Fentanyl|fentanyl|mesh-list
2352206|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2352207|NCT00496392|Narcotics|narcotics|mesh-ancestor
2352208|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2352209|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352210|NCT00496392|Analgesics|analgesics|mesh-ancestor
2352211|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
2352212|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352213|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2352214|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2352215|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
2352216|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
2352217|NCT00496405|Bevacizumab|bevacizumab|mesh-list
2352218|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2352219|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352220|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2352221|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2352222|NCT00496405|Growth Substances|growth substances|mesh-ancestor
2352223|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352224|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
2352229|NCT00496444|Azacitidine|azacitidine|mesh-list
2352230|NCT00496444|Valproic Acid|valproic acid|mesh-list
2352231|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2352232|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
2352233|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352234|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352235|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352236|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
2352237|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
2352238|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352239|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352240|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
2352241|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2352242|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2352243|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2352244|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
2352245|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352246|NCT00496600|Everolimus|everolimus|mesh-list
2352247|NCT00496600|Epothilone B|epothilone b|mesh-list
2352248|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352249|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352250|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
2352251|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352252|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
2352253|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
2352254|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
2352255|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352256|NCT00496652|Zalutumumab|zalutumumab|mesh-list
2352257|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2352258|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352259|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
2352260|NCT00496665|Methotrexate|methotrexate|mesh-list
2352261|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352262|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
2352263|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352264|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2352265|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2352266|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
2352267|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352268|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352269|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2352270|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2352271|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
2352272|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2352273|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2352274|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
2352275|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
2352276|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352277|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2352278|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2352279|NCT00496704|Gemcitabine|gemcitabine|mesh-list
2352280|NCT00496704|Capecitabine|capecitabine|mesh-list
2352281|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
2352282|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2352283|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
2352284|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352285|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352286|NCT00496704|Antiviral Agents|antiviral agents|mesh-ancestor
2352287|NCT00496704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352288|NCT00496704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352289|NCT00496704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352290|NCT00496704|Immunologic Factors|immunologic factors|mesh-ancestor
2352291|NCT00496704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352292|NCT00496795|Docetaxel|docetaxel|mesh-list
2352293|NCT00496795|Epirubicin|epirubicin|mesh-list
2352294|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352295|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
2352296|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
2352297|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
2352298|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352299|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2352300|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2352301|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2352302|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352303|NCT00497003|Metoprolol|metoprolol|mesh-list
2352304|NCT00497003|Carvedilol|carvedilol|mesh-list
2352305|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2352306|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2352307|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
2352308|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
2352309|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352310|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352311|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2352312|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2352313|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2352314|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
2352315|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352316|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352317|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
2352318|NCT00497003|Protective Agents|protective agents|mesh-ancestor
2352319|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2352320|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2352321|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2352322|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
2352323|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2352324|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2352325|NCT00497016|Atorvastatin|atorvastatin|mesh-list
2352326|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2352327|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2352328|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
2352329|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352330|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2352331|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2352332|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352333|NCT00497029|Fluorides|fluorides|mesh-list
2352334|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
2352335|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
2352336|NCT00497029|Protective Agents|protective agents|mesh-ancestor
2352337|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352338|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
2352339|NCT00497107|Leucovorin|leucovorin|mesh-list
2352340|NCT00497107|Calcium|calcium|mesh-list
2352341|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
2352342|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2352343|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352344|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2352345|NCT00497107|Antidotes|antidotes|mesh-ancestor
2352346|NCT00497107|Protective Agents|protective agents|mesh-ancestor
2352347|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
2352348|NCT00497107|Vitamins|vitamins|mesh-ancestor
2352349|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
2352350|NCT00497120|Acetazolamide|acetazolamide|mesh-list
2352351|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
2352352|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2352353|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352354|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352355|NCT00497120|Diuretics|diuretics|mesh-ancestor
2352356|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
2352357|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352358|NCT00497172|Sirolimus|sirolimus|mesh-list
2352359|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2352360|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352361|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2352362|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352363|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
2352364|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352365|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
2352366|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352367|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2352368|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352369|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2352370|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352371|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352372|NCT00497237|Fluticasone|fluticasone|mesh-list
2352373|NCT00497237|Beclomethasone|beclomethasone|mesh-list
2352374|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
2352375|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2352376|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2352377|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2352378|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
2352379|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352380|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352381|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2352382|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
2352383|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
2352384|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2352385|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2352386|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2352387|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2352388|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
2352389|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352390|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352391|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
2352392|NCT00497237|Hormones|hormones|mesh-ancestor
2352393|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2352394|NCT00497250|Gefitinib|gefitinib|mesh-list
2352395|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352396|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2352397|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352398|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352399|NCT00497315|Pemetrexed|pemetrexed|mesh-list
2352400|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352401|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352402|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352403|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2352404|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2352405|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
2352406|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2352407|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
2352408|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352409|NCT00497328|Expectorants|expectorants|mesh-ancestor
2352410|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
2352411|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2352412|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
2352413|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352414|NCT00497328|Protective Agents|protective agents|mesh-ancestor
2352415|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352416|NCT00497328|Antidotes|antidotes|mesh-ancestor
2352417|NCT00497341|Cefuroxime|cefuroxime|mesh-list
2352418|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
2352419|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2352420|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352421|NCT00497354|Anesthetics|anesthetics|mesh-list
2352422|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
2352423|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2352424|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352425|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
2352426|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352427|NCT00497458|Testosterone|testosterone|mesh-list
2352428|NCT00497458|Androgens|androgens|mesh-ancestor
2352429|NCT00497458|Hormones|hormones|mesh-ancestor
2352430|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2352431|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352432|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
2352433|NCT00497471|Dapsone|dapsone|mesh-list
2352434|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
2352435|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2352436|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2352437|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352438|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2352439|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352440|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352441|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
2352442|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2352443|NCT00497497|Bevacizumab|bevacizumab|mesh-list
2352444|NCT00497497|Cetuximab|cetuximab|mesh-list
2352445|NCT00497497|Irinotecan|irinotecan|mesh-list
2352446|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2352447|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352448|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2352449|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2352450|NCT00497497|Growth Substances|growth substances|mesh-ancestor
2352451|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352452|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
2352453|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2352454|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2352455|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352456|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352457|NCT00497523|Beclomethasone|beclomethasone|mesh-list
2352458|NCT00497523|Albuterol|albuterol|mesh-list
2352459|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2352460|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
2352461|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352462|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352463|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2352464|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
2352465|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
2352466|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2352467|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2352468|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2352469|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2352470|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
2352471|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352472|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352473|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2352474|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
2352475|NCT00497523|Hormones|hormones|mesh-ancestor
2352476|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2352477|NCT00497536|Insulin|insulin|mesh-list
2352478|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2352479|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
2352480|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
2352481|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2352482|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2352483|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352484|NCT00497562|Tramadol|tramadol|mesh-list
2352485|NCT00497562|Amitriptyline|amitriptyline|mesh-list
2352486|NCT00497562|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2352487|NCT00497562|Fluoxetine|fluoxetine|mesh-list
2352488|NCT00497562|Hormones|hormones|mesh-list
2352489|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2352490|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352491|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2352492|NCT00497562|Narcotics|narcotics|mesh-ancestor
2352493|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2352494|NCT00497562|Analgesics|analgesics|mesh-ancestor
2352495|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
2352496|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352497|NCT00497562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2352498|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2352499|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2352500|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352501|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352502|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
2352503|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2352504|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
2352505|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2352506|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2352507|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2352508|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352509|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2352510|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2352511|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2352512|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
2352513|NCT00497562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2352514|NCT00497562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2352515|NCT00497601|Amphotericin B|amphotericin b|mesh-list
2352516|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2352517|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2352518|NCT00497601|Amebicides|amebicides|mesh-ancestor
2352519|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2352520|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2352521|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352522|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2352523|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
2352524|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2352525|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2352526|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2352527|NCT00497614|Adalimumab|adalimumab|mesh-list
2352528|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2352529|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2352530|NCT00497744|Cefepime|cefepime|mesh-list
2352531|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2352532|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352533|NCT00497809|Lenograstim|lenograstim|mesh-list
2352534|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2352535|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
2352536|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352537|NCT00497900|Vitamin D|vitamin d|mesh-list
2352538|NCT00497900|Vitamins|vitamins|mesh-ancestor
2352539|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
2352540|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352541|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2352542|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
2352543|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2352544|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2352545|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2352546|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2352547|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352548|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
2352549|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352550|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352551|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2352552|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352553|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
2352554|NCT00497939|Urological Agents|urological agents|mesh-ancestor
2352555|NCT00498004|Risperidone|risperidone|mesh-list
2352556|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2352557|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2352558|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
2352559|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352560|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352561|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352562|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2352563|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2352564|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2352565|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2352566|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2352567|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
2352568|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
2352569|NCT00498108|Rotigotine|rotigotine|mesh-list
2352570|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
2352571|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
2352572|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352573|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352574|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352575|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
2352576|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2352577|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352578|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352579|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2352580|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2352581|NCT00498134|Analgesics|analgesics|mesh-ancestor
2352582|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
2352583|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352584|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352585|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2352586|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2352587|NCT00498212|1018 oligonucleotide|1018 oligonucleotide|mesh-list
2352588|NCT00498212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2352589|NCT00498212|Immunologic Factors|immunologic factors|mesh-ancestor
2352590|NCT00498212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352591|NCT00498225|Gemcitabine|gemcitabine|mesh-list
2352592|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2352593|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
2352594|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352595|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352596|NCT00498225|Antiviral Agents|antiviral agents|mesh-ancestor
2352597|NCT00498225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352598|NCT00498225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352599|NCT00498225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352600|NCT00498225|Immunologic Factors|immunologic factors|mesh-ancestor
2352601|NCT00498225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352602|NCT00498251|Albuterol|albuterol|mesh-list
2352603|NCT00498251|Ipratropium|ipratropium|mesh-list
2352604|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2352605|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
2352606|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352607|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352608|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2352609|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
2352610|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
2352611|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2352612|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2352613|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2352614|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2352615|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
2352616|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352617|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352618|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2352619|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
2352620|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
2352621|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
2352622|NCT00498316|Melphalan|melphalan|mesh-list
2352623|NCT00498316|Busulfan|busulfan|mesh-list
2352624|NCT00498316|Rituximab|rituximab|mesh-list
2352625|NCT00498316|Fludarabine|fludarabine|mesh-list
2352626|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
2352627|NCT00498316|Clofarabine|clofarabine|mesh-list
2352628|NCT00498316|Tacrolimus|tacrolimus|mesh-list
2352629|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
2352630|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2352631|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352632|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
2352633|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352634|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2352635|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2352636|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
2352637|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352638|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352639|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2352640|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2352641|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2352642|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
2352643|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352644|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2352645|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352646|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2352647|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2352648|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
2352649|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2352650|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
2352651|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2352652|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
2352653|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352654|NCT00498342|Expectorants|expectorants|mesh-ancestor
2352655|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
2352656|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2352657|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
2352658|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352659|NCT00498342|Protective Agents|protective agents|mesh-ancestor
2352660|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352661|NCT00498342|Antidotes|antidotes|mesh-ancestor
2352662|NCT00498537|Spironolactone|spironolactone|mesh-list
2352663|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2352664|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
2352665|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2352666|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352667|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2352668|NCT00498537|Diuretics|diuretics|mesh-ancestor
2352669|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
2352670|NCT00498589|Methotrexate|methotrexate|mesh-list
2352671|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2352672|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
2352673|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2352674|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352675|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2352676|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
2352677|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352678|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352679|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
2352680|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352681|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2352682|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352683|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
2352684|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2352685|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2352686|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
2352687|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2352688|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
2352689|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2352690|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2352691|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352692|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352693|NCT00498680|Urological Agents|urological agents|mesh-ancestor
2352694|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
2352695|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2352696|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
2352697|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2352698|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352699|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2352700|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2352701|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2352702|NCT00498836|Sorafenib|sorafenib|mesh-list
2352703|NCT00498836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352704|NCT00498836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2352705|NCT00498836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352706|NCT00498836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352707|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2352708|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2352709|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2352710|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
2352711|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352712|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352713|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352714|NCT00498888|Urological Agents|urological agents|mesh-ancestor
2352715|NCT00498901|Letrozole|letrozole|mesh-list
2352716|NCT00498901|Leuprolide|leuprolide|mesh-list
2352717|NCT00498901|Goserelin|goserelin|mesh-list
2352718|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352719|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2352720|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2352721|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352722|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352723|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2352724|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
2352725|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2352726|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352727|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2352728|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
2352729|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2352730|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2352731|NCT00498953|Carboplatin|carboplatin|mesh-list
2352732|NCT00498953|Docetaxel|docetaxel|mesh-list
2352733|NCT00498953|Fluorouracil|fluorouracil|mesh-list
2352734|NCT00498953|Lapatinib|lapatinib|mesh-list
2352735|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2352736|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352737|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
2352738|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
2352739|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
2352740|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352741|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
2352742|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2352743|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352744|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
2352745|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352746|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2352747|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352748|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2352749|NCT00498979|Interferons|interferons|mesh-list
2352750|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
2352751|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
2352752|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
2352753|NCT00498979|Dacarbazine|dacarbazine|mesh-list
2352754|NCT00498979|Vinblastine|vinblastine|mesh-list
2352755|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352756|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
2352757|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352758|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
2352759|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352760|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2352761|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
2352762|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352763|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2352764|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
2352765|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
2352766|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
2352767|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2352768|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2352769|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
2352770|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2352771|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
2352772|NCT00498992|Vitamin E|vitamin e|mesh-list
2352773|NCT00498992|Lidocaine|lidocaine|mesh-list
2352774|NCT00498992|Vitamins|vitamins|mesh-ancestor
2352775|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
2352776|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352777|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
2352778|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
2352779|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2352780|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
2352781|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352782|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2352783|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2352784|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2352785|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2352786|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352787|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
2352788|NCT00498992|Protective Agents|protective agents|mesh-ancestor
2352789|NCT00499005|Carbetocin|carbetocin|mesh-list
2352790|NCT00499005|Oxytocin|oxytocin|mesh-list
2352791|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
2352792|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2352793|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352794|NCT00499018|Cytarabine|cytarabine|mesh-list
2352795|NCT00499018|Prednisone|prednisone|mesh-list
2352796|NCT00499018|Rituximab|rituximab|mesh-list
2352797|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
2352798|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
2352799|NCT00499018|Vincristine|vincristine|mesh-list
2352800|NCT00499018|Doxorubicin|doxorubicin|mesh-list
2352801|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2352802|NCT00499018|Lenograstim|lenograstim|mesh-list
2352803|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2352804|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352805|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
2352806|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352807|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2352808|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2352809|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
2352810|NCT00499018|Hormones|hormones|mesh-ancestor
2352811|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2352812|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2352813|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2352814|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
2352815|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352816|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
2352817|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352818|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352819|NCT00499018|Analgesics|analgesics|mesh-ancestor
2352820|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
2352821|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352822|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2352823|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2352824|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352825|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2352826|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
2352827|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2352828|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2352829|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2352830|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
2352831|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
2352832|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
2352833|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2352834|NCT00499135|Alovudine|alovudine|mesh-list
2352835|NCT00499135|Sunitinib|sunitinib|mesh-list
2352836|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352837|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2352838|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2352839|NCT00499135|Growth Substances|growth substances|mesh-ancestor
2352840|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352841|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
2352842|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2352843|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352844|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352845|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
2352846|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352847|NCT00499265|Gemcitabine|gemcitabine|mesh-list
2352848|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
2352849|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
2352850|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2352851|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
2352852|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352853|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352854|NCT00499265|Antiviral Agents|antiviral agents|mesh-ancestor
2352855|NCT00499265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352856|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352857|NCT00499265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352858|NCT00499265|Immunologic Factors|immunologic factors|mesh-ancestor
2352859|NCT00499265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352860|NCT00499291|Paclitaxel|paclitaxel|mesh-list
2112105|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112106|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112107|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
2112108|NCT02564900|Camptothecin|camptothecin|mesh-list
2112109|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
2112110|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2112111|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112112|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2112113|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2112114|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112115|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352861|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2352862|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2352863|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352864|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
2352865|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
2352866|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
2352867|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352868|NCT00499525|Paclitaxel|paclitaxel|mesh-list
2352869|NCT00499525|Sorafenib|sorafenib|mesh-list
2352870|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2352871|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352872|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
2352873|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
2352874|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
2352875|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352876|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2352877|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352878|NCT00499577|Vaccines|vaccines|mesh-list
2352879|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2352880|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
2352881|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352882|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
2352883|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2352884|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352885|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2352886|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2352887|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352888|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352889|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352890|NCT00499668|Ondansetron|ondansetron|mesh-list
2352891|NCT00499668|Aprepitant|aprepitant|mesh-list
2352892|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
2352893|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
2352894|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352895|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352896|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2352897|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
2352898|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
2352899|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2352900|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
2352901|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352902|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352903|NCT00499668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2352904|NCT00499668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2352905|NCT00499668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2352906|NCT00499668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2352907|NCT00499668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2352908|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2352909|NCT00499707|Metformin|metformin|mesh-list
2352910|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
2352911|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2352912|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352913|NCT00499720|Aztreonam|aztreonam|mesh-list
2352914|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2352915|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352916|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
2352917|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352918|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
2352919|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352920|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2352921|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2352922|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
2352923|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352924|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352925|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2352926|NCT00499811|Vorinostat|vorinostat|mesh-list
2352927|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352928|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2352929|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352930|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352931|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2352932|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
2352933|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2352934|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2352935|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
2352936|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352937|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352938|NCT00499850|Leucovorin|leucovorin|mesh-list
2352939|NCT00499850|Fluorouracil|fluorouracil|mesh-list
2352940|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
2352941|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
2352942|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352943|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2352944|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352945|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2352946|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
2352947|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352948|NCT00499850|Antidotes|antidotes|mesh-ancestor
2352949|NCT00499850|Protective Agents|protective agents|mesh-ancestor
2352950|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
2352951|NCT00499850|Vitamins|vitamins|mesh-ancestor
2352952|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
2352953|NCT00499876|Mefloquine|mefloquine|mesh-list
2352954|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
2352955|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2352956|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2352957|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2352958|NCT00499993|Lanreotide|lanreotide|mesh-list
2352959|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352960|NCT00500006|Dasatinib|dasatinib|mesh-list
2352961|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352962|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2352963|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352964|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352965|NCT00500058|Rituximab|rituximab|mesh-list
2352966|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2352967|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352968|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
2352969|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352970|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2352971|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2352972|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
2352973|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2352974|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2352975|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
2352976|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352977|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352978|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
2352979|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2352980|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2352981|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2352982|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352983|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
2352984|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
2352985|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2352986|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
2352987|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2352988|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2352989|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2352990|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
2352991|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2352992|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
2352993|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2352994|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2352995|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2352996|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
2352997|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
2352998|NCT00500253|Protective Agents|protective agents|mesh-ancestor
2352999|NCT00500253|Miotics|miotics|mesh-ancestor
2353000|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2353001|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2353002|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2353003|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2353004|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
2353005|NCT00500279|Celecoxib|celecoxib|mesh-list
2353006|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2353007|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2353008|NCT00500279|Analgesics|analgesics|mesh-ancestor
2353009|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
2353010|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353011|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353012|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2353013|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353014|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2353015|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2353016|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353017|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353018|NCT00500344|Ranibizumab|ranibizumab|mesh-list
2353019|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2353020|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2353021|NCT00500344|Growth Substances|growth substances|mesh-ancestor
2353022|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353023|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
2353024|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353025|NCT00500409|Vitamin D|vitamin d|mesh-list
2353026|NCT00500409|Vitamins|vitamins|mesh-ancestor
2353027|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
2353028|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353029|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2353030|NCT00500422|Gemcitabine|gemcitabine|mesh-list
2353031|NCT00500422|Doxorubicin|doxorubicin|mesh-list
2353032|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2353033|NCT00500422|Bortezomib|bortezomib|mesh-list
2353034|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2353035|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
2353036|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353037|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353038|NCT00500422|Antiviral Agents|antiviral agents|mesh-ancestor
2353039|NCT00500422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353040|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353041|NCT00500422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2353042|NCT00500422|Immunologic Factors|immunologic factors|mesh-ancestor
2353043|NCT00500422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353044|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2353045|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2353046|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2353047|NCT00500552|Perhexiline|perhexiline|mesh-list
2353048|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2353049|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2353050|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353051|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2353052|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353053|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
2353054|NCT00500565|Bupivacaine|bupivacaine|mesh-list
2353055|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
2353056|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
2353057|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2353058|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353059|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
2353060|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353061|NCT00500604|Valsartan|valsartan|mesh-list
2353062|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2353063|NCT00500604|Irbesartan|irbesartan|mesh-list
2353064|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2353065|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2353066|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2353067|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353068|NCT00500604|Diuretics|diuretics|mesh-ancestor
2353069|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
2353070|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353071|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2353072|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2353073|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
2353074|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2353075|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353076|NCT00500721|Desipramine|desipramine|mesh-list
2353077|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2353078|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
2353079|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2353080|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353081|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353082|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2353083|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2353084|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2353085|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
2353086|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2353087|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353088|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
2353089|NCT00500864|Analgesics|analgesics|mesh-ancestor
2353090|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
2353091|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353092|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353093|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
2353094|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2353095|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2353096|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
2353097|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2353098|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2353099|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353100|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2353101|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
2353102|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2353103|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
2353104|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2353105|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353106|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
2353107|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2353108|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353109|NCT00501098|Caspofungin|caspofungin|mesh-list
2353110|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
2353111|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353112|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353113|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353114|NCT00501111|Donepezil|donepezil|mesh-list
2353115|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2353116|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353117|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353118|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
2353119|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2353120|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353121|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
2353122|NCT00501124|Clevudine|clevudine|mesh-list
2353123|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
2353124|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353125|NCT00501137|Vaccines|vaccines|mesh-list
2353126|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
2353127|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353128|NCT00501150|Linezolid|linezolid|mesh-list
2353129|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2353130|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353131|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2353132|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353133|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353134|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
2353135|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2353136|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353137|NCT00501241|ATI 7505|ati 7505|mesh-list
2353138|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2353139|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2353140|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
2353141|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2353142|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353143|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353144|NCT00501254|Aspirin|aspirin|mesh-list
2353145|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
2353146|NCT00501254|Salicylates|salicylates|mesh-list
2353147|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353148|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
2353149|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
2353150|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
2353151|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2353152|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2353153|NCT00501254|Analgesics|analgesics|mesh-ancestor
2353154|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
2353155|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353156|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353157|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2353158|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353159|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2353160|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353161|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353162|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2353163|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2353164|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2353165|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
2353166|NCT00501267|Oxybutynin|oxybutynin|mesh-list
2353167|NCT00501267|Solabegron|solabegron|mesh-list
2353168|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
2353169|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
2112116|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
2112117|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112118|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
2112119|NCT02564926|Glimepiride|glimepiride|mesh-list
2112120|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2112121|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112122|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2112123|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112124|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2112125|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2112126|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
2112127|NCT02564952|Cannabidiol|cannabidiol|mesh-list
2112128|NCT02564952|Clobazam|clobazam|mesh-list
2112129|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
2112130|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2112131|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2353170|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353171|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353172|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2353173|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2353174|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
2353175|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2353176|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353177|NCT00501267|Urological Agents|urological agents|mesh-ancestor
2353178|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2353179|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2353180|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2353181|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
2353182|NCT00501384|Satavaptan|satavaptan|mesh-list
2353183|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2353184|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353185|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
2353186|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353187|NCT00501397|Ketoconazole|ketoconazole|mesh-list
2353188|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
2353189|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353190|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2353191|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2353192|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353193|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353194|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2353195|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
2353196|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2353197|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353198|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2353199|NCT00501410|Leucovorin|leucovorin|mesh-list
2353200|NCT00501410|Fluorouracil|fluorouracil|mesh-list
2353201|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
2353202|NCT00501410|Cetuximab|cetuximab|mesh-list
2353203|NCT00501410|Dasatinib|dasatinib|mesh-list
2353204|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
2353205|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353206|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2353207|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353208|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2353209|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
2353210|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353211|NCT00501410|Antidotes|antidotes|mesh-ancestor
2353212|NCT00501410|Protective Agents|protective agents|mesh-ancestor
2353213|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
2353214|NCT00501410|Vitamins|vitamins|mesh-ancestor
2353215|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
2353216|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2353217|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2353218|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353219|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
2353220|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2353221|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353222|NCT00501514|Hormones|hormones|mesh-list
2353223|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2353224|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353225|NCT00501566|Satavaptan|satavaptan|mesh-list
2353226|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2353227|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353228|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
2353229|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353230|NCT00501579|Prednisolone|prednisolone|mesh-list
2353231|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2353232|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
2353233|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2353234|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
2353235|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2353236|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
2353237|NCT00501579|Difluprednate|difluprednate|mesh-list
2353238|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2353239|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
2353240|NCT00501579|Hormones|hormones|mesh-ancestor
2353241|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2353242|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353243|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2353244|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353245|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
2353246|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
2353247|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353248|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2353249|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2353250|NCT00501579|Protective Agents|protective agents|mesh-ancestor
2353251|NCT00501605|Cediranib|cediranib|mesh-list
2353252|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353253|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2353254|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353255|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353256|NCT00501618|Clozapine|clozapine|mesh-list
2353257|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2353258|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
2353259|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2353260|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353261|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353262|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2353263|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2353264|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2353265|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2353266|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
2353267|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
2353268|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2353269|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2353270|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353271|NCT00501657|Incretins|incretins|mesh-ancestor
2353272|NCT00501657|Hormones|hormones|mesh-ancestor
2353273|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2353274|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2353275|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
2353276|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353277|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353278|NCT00501696|Naltrexone|naltrexone|mesh-list
2353279|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2353280|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2353281|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353282|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
2353283|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353284|NCT00501709|Abatacept|abatacept|mesh-list
2353285|NCT00501709|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2353286|NCT00501709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2353287|NCT00501709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353288|NCT00501709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353289|NCT00501709|Immunologic Factors|immunologic factors|mesh-ancestor
2353290|NCT00501709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353291|NCT00501709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353292|NCT00501722|Satavaptan|satavaptan|mesh-list
2353293|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2353294|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353295|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
2353296|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353297|NCT00501748|Rituximab|rituximab|mesh-list
2353298|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2353299|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353300|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
2353301|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353302|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353303|NCT00501787|Metformin|metformin|mesh-list
2353304|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2353305|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353359|NCT00501839|Clomiphene|clomiphene|mesh-list
2353360|NCT00501839|Enclomiphene|enclomiphene|mesh-list
2353361|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
2353362|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2353363|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
2353364|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2353365|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353366|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2353367|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
2353368|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2353369|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2353370|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2353371|NCT00501878|Phenylephrine|phenylephrine|mesh-list
2353372|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
2353373|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2353374|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
2353375|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
2353376|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353377|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353378|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
2353379|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2353380|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
2353381|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
2353382|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2353383|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2353384|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2353385|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
2353386|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2353387|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353388|NCT00501878|Protective Agents|protective agents|mesh-ancestor
2353389|NCT00501904|Metformin|metformin|mesh-list
2353390|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2353391|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353392|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
2353393|NCT00501917|Hematinics|hematinics|mesh-ancestor
2353394|NCT00501982|Poractant alfa|poractant alfa|mesh-list
2353395|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2353396|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
2353397|NCT00502034|Interferons|interferons|mesh-list
2353398|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
2353399|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
2353400|NCT00502034|Interleukin-2|interleukin-2|mesh-list
2353401|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353402|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
2353403|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353404|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
2353405|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353406|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2353407|NCT00502034|Analgesics|analgesics|mesh-ancestor
2353408|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
2353409|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353410|NCT00502060|Cediranib|cediranib|mesh-list
2353411|NCT00502060|Gefitinib|gefitinib|mesh-list
2353412|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353413|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2353414|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353415|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353416|NCT00502073|Cyclosporine|cyclosporine|mesh-list
2353417|NCT00502073|Cyclosporins|cyclosporins|mesh-list
2353418|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353419|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353420|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2353421|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
2353422|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353423|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
2353424|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353425|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
2353426|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353427|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2353428|NCT00502099|Interferons|interferons|mesh-list
2353429|NCT00502099|Ribavirin|ribavirin|mesh-list
2353430|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
2353431|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
2353432|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2353433|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2353434|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353435|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
2353436|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353437|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
2353438|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353439|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
2353440|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353441|NCT00502112|Lenalidomide|lenalidomide|mesh-list
2353442|NCT00502112|Lintuzumab|lintuzumab|mesh-list
2353443|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
2353444|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353445|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2353446|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2353447|NCT00502112|Growth Substances|growth substances|mesh-ancestor
2353448|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
2353449|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353450|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2353451|NCT00502138|Pramlintide|pramlintide|mesh-list
2353452|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
2353453|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2353454|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353455|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
2353456|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2353457|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
2353458|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353459|NCT00502164|Cediranib|cediranib|mesh-list
2353460|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353461|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2353462|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353463|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353464|NCT00502190|Silicon|silicon|mesh-list
2353465|NCT00502190|Trace Elements|trace elements|mesh-ancestor
2353466|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
2353467|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353468|NCT00502229|Metformin|metformin|mesh-list
2353469|NCT00502229|Clomiphene|clomiphene|mesh-list
2353470|NCT00502229|Enclomiphene|enclomiphene|mesh-list
2353471|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
2353472|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2353473|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353474|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2353475|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
2353476|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2353477|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2353478|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
2353479|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2353480|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2353481|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2353482|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2353483|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
2353484|NCT00502268|Vitamins|vitamins|mesh-ancestor
2353485|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
2353486|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353487|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2353488|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2353489|NCT00502294|Visilizumab|visilizumab|mesh-list
2353490|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
2353491|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353492|NCT00502385|Cediranib|cediranib|mesh-list
2353493|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353494|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2353495|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353496|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353497|NCT00502411|Doxorubicin|doxorubicin|mesh-list
2353498|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2353499|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2353500|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353501|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2353502|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2353503|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353504|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353505|NCT00502437|Granisetron|granisetron|mesh-list
2353506|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
2353507|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
2353508|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353509|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353510|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2353511|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2353512|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
2353513|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2353514|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353515|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
2353516|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2353517|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353518|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
2353519|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
2353520|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2353521|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2353522|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353523|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2353524|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2353525|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
2353526|NCT00502541|Hormones|hormones|mesh-ancestor
2353527|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2353528|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353529|NCT00502567|Leucovorin|leucovorin|mesh-list
2353530|NCT00502567|Docetaxel|docetaxel|mesh-list
2353531|NCT00502567|Fluorouracil|fluorouracil|mesh-list
2353532|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
2353533|NCT00502567|Irinotecan|irinotecan|mesh-list
2353534|NCT00502567|Pemetrexed|pemetrexed|mesh-list
2353535|NCT00502567|Cetuximab|cetuximab|mesh-list
2353536|NCT00502567|Cediranib|cediranib|mesh-list
2353537|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353538|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
2353539|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
2353540|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
2353541|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353542|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
2353543|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2353544|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2353545|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
2353546|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353547|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2353548|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2353549|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353550|NCT00502567|Antidotes|antidotes|mesh-ancestor
2353551|NCT00502567|Protective Agents|protective agents|mesh-ancestor
2353552|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
2353553|NCT00502567|Vitamins|vitamins|mesh-ancestor
2353554|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
2353555|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2353556|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2353557|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2353558|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2353559|NCT00502658|Vitamins|vitamins|mesh-list
2353560|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
2353561|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353562|NCT00502684|Etodolac|etodolac|mesh-list
2353563|NCT00502684|Propranolol|propranolol|mesh-list
2353564|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2353565|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2353566|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
2353567|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2353568|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353569|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353570|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2353571|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2353572|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
2353573|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2353574|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2353575|NCT00502684|Analgesics|analgesics|mesh-ancestor
2353576|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
2353577|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353578|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2353579|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353580|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2353581|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2353582|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353583|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
2353584|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2353585|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353586|NCT00502762|Topotecan|topotecan|mesh-list
2353587|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2353588|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2112132|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2112133|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112134|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2112135|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2112136|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
2112137|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
2112138|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112139|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112140|NCT02565108|Cannabidiol|cannabidiol|mesh-list
2112141|NCT02565108|Clobazam|clobazam|mesh-list
2112142|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
2112143|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2112144|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2112145|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2112146|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112147|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2112148|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2112149|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
2112150|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
2112151|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112152|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112153|NCT02565147|Heparin|heparin|mesh-list
2112154|NCT02565147|Bivalirudin|bivalirudin|mesh-list
2112155|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
2112156|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2353589|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353590|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353591|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353592|NCT00502788|Ribavirin|ribavirin|mesh-list
2353593|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2353594|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
2353595|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353596|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
2353597|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353598|NCT00502879|Etanercept|etanercept|mesh-list
2353599|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2353600|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2353601|NCT00502879|Analgesics|analgesics|mesh-ancestor
2353602|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
2353603|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353604|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353605|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2353606|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353607|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2353608|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2353609|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
2353610|NCT00502892|Carboplatin|carboplatin|mesh-list
2353611|NCT00502892|Topotecan|topotecan|mesh-list
2353612|NCT00502892|Ifosfamide|ifosfamide|mesh-list
2353613|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353614|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2353615|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2353616|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353617|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353618|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2353619|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
2353620|NCT00502970|Interferons|interferons|mesh-list
2353621|NCT00502970|Ribavirin|ribavirin|mesh-list
2353622|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
2353623|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353624|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
2353625|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353626|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
2353627|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353628|NCT00502970|Hematinics|hematinics|mesh-ancestor
2353629|NCT00503035|Celecoxib|celecoxib|mesh-list
2353630|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2353631|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2353632|NCT00503035|Analgesics|analgesics|mesh-ancestor
2353633|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
2353634|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353635|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353636|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2353637|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353638|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2353639|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2353640|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353641|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353642|NCT00503126|Bivalirudin|bivalirudin|mesh-list
2353643|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
2353644|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2353645|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
2353646|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353647|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353648|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
2353649|NCT00503152|Valsartan|valsartan|mesh-list
2353650|NCT00503152|Benazepril|benazepril|mesh-list
2353651|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2353652|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2353653|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2353654|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353655|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2353656|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
2353657|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353658|NCT00503204|Cediranib|cediranib|mesh-list
2353659|NCT00503204|Lomustine|lomustine|mesh-list
2112157|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2112158|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112159|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
2112160|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2112161|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
2112162|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112163|NCT02565186|Lasmiditan|lasmiditan|mesh-list
2112164|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2112165|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
2112166|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112167|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112168|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112169|NCT02565381|Nicotine|nicotine|mesh-list
2112170|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2112171|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
2112172|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353660|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353661|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2353662|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353663|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353664|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2353665|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
2353666|NCT00503243|Mesalamine|mesalamine|mesh-list
2353667|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2353668|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2353669|NCT00503243|Analgesics|analgesics|mesh-ancestor
2353670|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
2353671|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353672|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353673|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2353674|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353675|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
2353676|NCT00503321|Tegafur|tegafur|mesh-list
2353677|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2353678|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
2353679|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353680|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353681|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2353682|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
2353683|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353684|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2353685|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
2353686|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353687|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
2353688|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2353689|NCT00503321|Protective Agents|protective agents|mesh-ancestor
2353690|NCT00503347|Bavituximab|bavituximab|mesh-list
2353691|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2353692|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353693|NCT00503386|Palonosetron|palonosetron|mesh-list
2353694|NCT00503386|Granisetron|granisetron|mesh-list
2353695|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
2353696|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
2353697|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353698|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353699|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2353700|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2353701|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2353702|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
2353703|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2353704|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353705|NCT00503412|Cediranib|cediranib|mesh-list
2353706|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353707|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2353708|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353709|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353710|NCT00503451|Panobinostat|panobinostat|mesh-list
2353711|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353712|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2353713|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353714|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353715|NCT00503477|Cediranib|cediranib|mesh-list
2353716|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353717|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2353718|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353719|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353720|NCT00503490|Levofloxacin|levofloxacin|mesh-list
2353721|NCT00503490|Ofloxacin|ofloxacin|mesh-list
2353722|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2353723|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353724|NCT00503490|Renal Agents|renal agents|mesh-ancestor
2353725|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2353726|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2353727|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2353728|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353729|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353730|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353731|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2353732|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2353733|NCT00503503|Etanercept|etanercept|mesh-list
2353734|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2353735|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2353736|NCT00503503|Analgesics|analgesics|mesh-ancestor
2353737|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
2353738|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353739|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353740|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2353741|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353742|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2353743|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2353744|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
2353745|NCT00503516|Megestrol|megestrol|mesh-list
2353746|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
2353747|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2353748|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2353749|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2353750|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
2353751|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2353752|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353753|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2353754|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2353755|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2353756|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353757|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
2353758|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2353759|NCT00503542|Metronidazole|metronidazole|mesh-list
2353760|NCT00503542|Clindamycin|clindamycin|mesh-list
2353761|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
2353762|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
2353763|NCT00503542|Fluconazole|fluconazole|mesh-list
2353764|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353765|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2353766|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2353767|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2353768|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2353769|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353770|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353771|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
2353772|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2353773|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2353774|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2353775|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
2353776|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2353777|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353778|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2353779|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2353780|NCT00503568|Vaccines|vaccines|mesh-list
2353781|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
2353782|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353783|NCT00503594|Cytarabine|cytarabine|mesh-list
2353784|NCT00503594|Methotrexate|methotrexate|mesh-list
2353785|NCT00503594|Vincristine|vincristine|mesh-list
2353786|NCT00503594|Temozolomide|temozolomide|mesh-list
2353787|NCT00503594|Procarbazine|procarbazine|mesh-list
2353788|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2353789|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
2353790|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2353791|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353792|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2353793|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
2353794|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353795|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353796|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
2353797|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353798|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2353799|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2353800|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
2353801|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353802|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2353803|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
2353804|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353805|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2353806|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
2353807|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
2353808|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
2353809|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2353810|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
2353811|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2353812|NCT00503607|Laxatives|laxatives|mesh-ancestor
2353813|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2353814|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
2353815|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2353816|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2353817|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2353818|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2353819|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353820|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
2353821|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2353822|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353823|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2353824|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353825|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
2353826|NCT00503659|Miotics|miotics|mesh-ancestor
2353827|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
2353828|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353829|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353830|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2353831|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2353832|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
2353833|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2353834|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2353835|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
2353836|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2353837|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353838|NCT00503763|Simvastatin|simvastatin|mesh-list
2353839|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2353840|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2353841|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
2353842|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353843|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2353844|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2353845|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353846|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2353847|NCT00503815|Laxatives|laxatives|mesh-ancestor
2353848|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2353849|NCT00503828|Naproxen|naproxen|mesh-list
2353850|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2353851|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2353852|NCT00503828|Analgesics|analgesics|mesh-ancestor
2353853|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
2353854|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353855|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353856|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2353857|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353858|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
2353859|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2353860|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353861|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353862|NCT00503932|Capecitabine|capecitabine|mesh-list
2353863|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2353864|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
2353865|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353866|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353867|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2353868|NCT00503971|Vorinostat|vorinostat|mesh-list
2353869|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353870|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2353871|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353872|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353873|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2353874|NCT00504062|Fluticasone|fluticasone|mesh-list
2353875|NCT00504062|Budesonide|budesonide|mesh-list
2353876|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2353877|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2353878|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
2353879|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353880|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353881|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2353882|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
2353883|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
2353884|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2353885|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
2353886|NCT00504062|Hormones|hormones|mesh-ancestor
2353887|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2353888|NCT00504101|Bortezomib|bortezomib|mesh-list
2353889|NCT00504101|Melphalan|melphalan|mesh-list
2353890|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
2353891|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353892|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2353893|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
2353894|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353895|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2353896|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2353897|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
2353898|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353899|NCT00504127|Naproxen|naproxen|mesh-list
2353900|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
2353901|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2353902|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2353903|NCT00504127|Analgesics|analgesics|mesh-ancestor
2353904|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
2353905|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353906|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353907|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2353908|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353909|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
2353910|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2353911|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353912|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353913|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2353914|NCT00504140|Interferons|interferons|mesh-list
2353915|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
2353916|NCT00504140|Etoposide|etoposide|mesh-list
2353917|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2353918|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353919|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2353920|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2353921|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353922|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353923|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
2353924|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353925|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
2353926|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353927|NCT00504192|Gemcitabine|gemcitabine|mesh-list
2353928|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
2353929|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2353930|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
2353931|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353932|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353933|NCT00504192|Antiviral Agents|antiviral agents|mesh-ancestor
2353934|NCT00504192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353935|NCT00504192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353936|NCT00504192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2353937|NCT00504192|Immunologic Factors|immunologic factors|mesh-ancestor
2353938|NCT00504192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353939|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
2353940|NCT00504244|Azathioprine|azathioprine|mesh-list
2353941|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
2353942|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353943|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2353944|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353945|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2353946|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
2353947|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353948|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353949|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2353950|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2353951|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
2353952|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2353953|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2353954|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353955|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2353956|NCT00504283|Morphine|morphine|mesh-list
2353957|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2353958|NCT00504283|Narcotics|narcotics|mesh-ancestor
2353959|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2353960|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353961|NCT00504283|Analgesics|analgesics|mesh-ancestor
2353962|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
2353963|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2353964|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2353965|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2353966|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2353967|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2353968|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2353969|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353970|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353971|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2353972|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2353973|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353974|NCT00504400|Ranibizumab|ranibizumab|mesh-list
2353975|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2353976|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2353977|NCT00504400|Growth Substances|growth substances|mesh-ancestor
2353978|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353979|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
2353980|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2353981|NCT00504413|Digoxin|digoxin|mesh-list
2353982|NCT00504413|Midazolam|midazolam|mesh-list
2353983|NCT00504413|Methadone|methadone|mesh-list
2353984|NCT00504413|Bupropion|bupropion|mesh-list
2353985|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2353986|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2353987|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2353988|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2353989|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2353990|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2353991|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2353992|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2353993|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
2353994|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
2353995|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
2353996|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
2353997|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2353998|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2353999|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2354000|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
2354001|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2354002|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2354003|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2354004|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
2354005|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2354006|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2354007|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354008|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2354009|NCT00504413|Narcotics|narcotics|mesh-ancestor
2354010|NCT00504413|Analgesics|analgesics|mesh-ancestor
2354011|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
2354012|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354013|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
2354014|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
2354015|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2354016|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2354017|NCT00504413|Protective Agents|protective agents|mesh-ancestor
2354018|NCT00504439|Simvastatin|simvastatin|mesh-list
2354019|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2354020|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2354021|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
2354022|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354023|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2354024|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2354025|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354026|NCT00504465|Dinoprostone|dinoprostone|mesh-list
2354027|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
2354028|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2354029|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354030|NCT00504491|Rituximab|rituximab|mesh-list
2354031|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
2354032|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2354033|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354034|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
2354035|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354036|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2354037|NCT00504543|Everolimus|everolimus|mesh-list
2354038|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2354039|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
2354040|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354041|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354042|NCT00504634|Bortezomib|bortezomib|mesh-list
2354043|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354044|NCT00504673|Insulin|insulin|mesh-list
2354045|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2354046|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
2354047|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
2354048|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
2354049|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
2354050|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
2354051|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2354052|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354053|NCT00504712|Testosterone|testosterone|mesh-list
2354054|NCT00504712|Androgens|androgens|mesh-ancestor
2354055|NCT00504712|Hormones|hormones|mesh-ancestor
2354056|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2354057|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354058|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
2354059|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354060|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2354061|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2354062|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2354063|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2354064|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
2354065|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2354066|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354067|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2354068|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2354069|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2354070|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2354071|NCT00504855|Calpastatin|calpastatin|mesh-list
2354072|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2354073|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
2354074|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354075|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354076|NCT00504933|Cetirizine|cetirizine|mesh-list
2354077|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2354078|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2354079|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2354080|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
2354081|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
2354082|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354083|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354084|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354085|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
2354086|NCT00504946|Prednisone|prednisone|mesh-list
2354087|NCT00504946|Budesonide|budesonide|mesh-list
2354088|NCT00504946|Montelukast|montelukast|mesh-list
2354089|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2354090|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
2354091|NCT00504946|Hormones|hormones|mesh-ancestor
2354092|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2354093|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354094|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2354095|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354096|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2354097|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
2354098|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2354099|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
2354100|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2354101|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2354102|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354103|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2354104|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
2354105|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354106|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2354107|NCT00504946|Vitamins|vitamins|mesh-ancestor
2354108|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
2354109|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2354110|NCT00504959|Ranibizumab|ranibizumab|mesh-list
2354111|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2354112|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2354113|NCT00504959|Growth Substances|growth substances|mesh-ancestor
2354114|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354115|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
2354116|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354117|NCT00505037|Sevelamer|sevelamer|mesh-list
2354118|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
2354119|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
2354120|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354121|NCT00505063|Vaccines|vaccines|mesh-list
2354122|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2354123|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
2354124|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354125|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2354126|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
2354127|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354128|NCT00505102|Everolimus|everolimus|mesh-list
2354129|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354130|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2354131|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
2354132|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354133|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2354134|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2354135|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2354136|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
2354137|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354138|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2354139|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2354140|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354141|NCT00505167|Memantine|memantine|mesh-list
2354142|NCT00505167|Donepezil|donepezil|mesh-list
2354143|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2354144|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354145|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354146|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
2354147|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354148|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354149|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
2354150|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2354151|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2354152|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
2354153|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2354154|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2354155|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2354156|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
2354157|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354158|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
2354159|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2354160|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2354161|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2354162|NCT00505336|Eplerenone|eplerenone|mesh-list
2354163|NCT00505336|Atorvastatin|atorvastatin|mesh-list
2354164|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2354165|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2354166|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
2354167|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354168|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2354169|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2354170|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354171|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2354172|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
2354173|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2354174|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354175|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2354176|NCT00505336|Diuretics|diuretics|mesh-ancestor
2354177|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
2354178|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2354179|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
2354180|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
2354181|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354182|NCT00505427|Protective Agents|protective agents|mesh-ancestor
2354183|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354184|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
2354185|NCT00505427|Vitamins|vitamins|mesh-ancestor
2354186|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
2354187|NCT00505492|Paclitaxel|paclitaxel|mesh-list
2354188|NCT00505492|Cisplatin|cisplatin|mesh-list
2354189|NCT00505492|Carboplatin|carboplatin|mesh-list
2354190|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2354191|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354192|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
2354193|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
2354194|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
2354195|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354196|NCT00505505|Insulin|insulin|mesh-list
2354197|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2354198|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2354199|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354200|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
2354201|NCT00505531|Tramadol|tramadol|mesh-list
2354202|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2354203|NCT00505531|Narcotics|narcotics|mesh-ancestor
2354204|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2354205|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354206|NCT00505531|Analgesics|analgesics|mesh-ancestor
2354207|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
2354208|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354209|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2354210|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2354211|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
2354212|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
2354213|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
2354214|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
2354215|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2354216|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2354217|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
2354218|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
2354219|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354220|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354221|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2354222|NCT00505700|Cytarabine|cytarabine|mesh-list
2354223|NCT00505700|Bortezomib|bortezomib|mesh-list
2354224|NCT00505700|Idarubicin|idarubicin|mesh-list
2354225|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2354226|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
2354227|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354228|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354229|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
2354230|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2354231|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2354232|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
2354233|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354234|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2354235|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2354236|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2354237|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354238|NCT00505739|Mifepristone|mifepristone|mesh-list
2354239|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2354240|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
2354241|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2354242|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354243|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2354244|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2354245|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2354246|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
2354247|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2354248|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2354249|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
2354250|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2354251|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
2354252|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2354253|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2354254|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2354255|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
2354256|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354257|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
2354258|NCT00505804|Haloperidol|haloperidol|mesh-list
2354259|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
2354260|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2354261|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2354262|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354263|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2354264|NCT00505804|Analgesics|analgesics|mesh-ancestor
2354265|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
2354266|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354267|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2354268|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2354269|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2354270|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
2354271|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354272|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354273|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
2354274|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
2354275|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2354276|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2354277|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2354278|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2354279|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2354280|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
2354281|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2354282|NCT00505817|Leuprolide|leuprolide|mesh-list
2354283|NCT00505817|Cetrorelix|cetrorelix|mesh-list
2354284|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2354285|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
2354286|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2354287|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354288|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2354289|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354290|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
2354291|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2354292|NCT00505843|Levodopa|levodopa|mesh-list
2354293|NCT00505843|Carbidopa|carbidopa|mesh-list
2354294|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2354295|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2354296|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
2354297|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354298|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354299|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354300|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2354301|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354302|NCT00505882|Pramlintide|pramlintide|mesh-list
2354303|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2354304|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354305|NCT00505947|Infliximab|infliximab|mesh-list
2354306|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
2354307|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2354308|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2354309|NCT00506051|Pemetrexed|pemetrexed|mesh-list
2354310|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354311|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354312|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354313|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2354314|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2354315|NCT00506168|Capecitabine|capecitabine|mesh-list
2354316|NCT00506168|Irinotecan|irinotecan|mesh-list
2354317|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2354318|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
2354319|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354320|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354321|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2354322|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2354323|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354324|NCT00506194|Gliclazide|gliclazide|mesh-list
2354325|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2354326|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354327|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
2354328|NCT00506207|Irinotecan|irinotecan|mesh-list
2354329|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354330|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2354331|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2354332|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354333|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354334|NCT00506246|Propofol|propofol|mesh-list
2354335|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2354336|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2354337|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354338|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2354339|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
2354340|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
2354341|NCT00506259|Melatonin|melatonin|mesh-list
2354342|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
2354343|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354344|NCT00506259|Protective Agents|protective agents|mesh-ancestor
2354345|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354346|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2354347|NCT00506272|Insulin|insulin|mesh-list
2354348|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2354349|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354350|NCT00506298|Diflunisal|diflunisal|mesh-list
2354351|NCT00506298|Bezafibrate|bezafibrate|mesh-list
2354352|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2354353|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
2354354|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354355|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2354356|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2354357|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2354358|NCT00506298|Analgesics|analgesics|mesh-ancestor
2354359|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
2354360|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354361|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354362|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2354363|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2354364|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2354365|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354366|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2354367|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
2354368|NCT00506311|Coagulants|coagulants|mesh-ancestor
2354369|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
2354370|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2354371|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
2354372|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2354373|NCT00506506|Expectorants|expectorants|mesh-ancestor
2354374|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
2354375|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2354376|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
2354377|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354378|NCT00506506|Protective Agents|protective agents|mesh-ancestor
2354379|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354380|NCT00506506|Antidotes|antidotes|mesh-ancestor
2354381|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2354382|NCT00506532|Calfactant|calfactant|mesh-list
2354383|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
2354384|NCT00506545|Rolapitant|rolapitant|mesh-list
2354385|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2354386|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354387|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354388|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354389|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
2354390|NCT00506571|Irinotecan|irinotecan|mesh-list
2354391|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354392|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2354393|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2354394|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354395|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354396|NCT00506623|Capecitabine|capecitabine|mesh-list
2354397|NCT00506623|Irinotecan|irinotecan|mesh-list
2354398|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2354399|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
2354400|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354401|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354402|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2354403|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2354404|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354405|NCT00506701|Tadalafil|tadalafil|mesh-list
2354406|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
2354407|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2354408|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2354409|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354410|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354411|NCT00506701|Urological Agents|urological agents|mesh-ancestor
2354412|NCT00506727|Amphetamine|amphetamine|mesh-list
2354413|NCT00506727|Adderall|adderall|mesh-list
2354414|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2354415|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2354416|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2354417|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2354418|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354419|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
2354420|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354421|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354422|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2354423|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
2354424|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
2354425|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354426|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
2354427|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2354428|NCT00506844|Capecitabine|capecitabine|mesh-list
2354429|NCT00506844|Irinotecan|irinotecan|mesh-list
2354430|NCT00506844|Cetuximab|cetuximab|mesh-list
2354431|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2354432|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
2354433|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354434|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354435|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2354436|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2354437|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354438|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2354439|NCT00506935|Vigabatrin|vigabatrin|mesh-list
2354440|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
2354441|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354442|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354443|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
2354444|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354445|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354446|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2354447|NCT00506961|Simvastatin|simvastatin|mesh-list
2354448|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2354449|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2354450|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
2354451|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354452|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2354453|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2354454|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354455|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
2354456|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2354457|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2354458|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
2354459|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
2354460|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2354461|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354462|NCT00507000|Vitamin D|vitamin d|mesh-list
2354463|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
2354464|NCT00507000|Vitamins|vitamins|mesh-ancestor
2354465|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
2354466|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354467|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2354468|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2354469|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
2354470|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2354471|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
2354472|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2354473|NCT00507052|Expectorants|expectorants|mesh-ancestor
2354474|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
2354475|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2354476|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
2354477|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354478|NCT00507052|Protective Agents|protective agents|mesh-ancestor
2354479|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354480|NCT00507052|Antidotes|antidotes|mesh-ancestor
2354481|NCT00507065|Amphetamine|amphetamine|mesh-list
2354482|NCT00507065|Adderall|adderall|mesh-list
2354483|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2354484|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354485|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
2354486|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
2354487|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354488|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
2354489|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354490|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354491|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
2354492|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2354493|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2354494|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2354495|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2354496|NCT00507091|Leucovorin|leucovorin|mesh-list
2354497|NCT00507091|Fluorouracil|fluorouracil|mesh-list
2354498|NCT00507091|Irinotecan|irinotecan|mesh-list
2354499|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
2354500|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354501|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2354502|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354503|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2354504|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
2354505|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354506|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2354507|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2354508|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354509|NCT00507091|Antidotes|antidotes|mesh-ancestor
2354510|NCT00507091|Protective Agents|protective agents|mesh-ancestor
2354511|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
2354512|NCT00507091|Vitamins|vitamins|mesh-ancestor
2354513|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
2354514|NCT00507117|Eszopiclone|eszopiclone|mesh-list
2354515|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2354516|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2354517|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354518|NCT00507143|Irinotecan|irinotecan|mesh-list
2354519|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2354520|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2354521|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354522|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354523|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354524|NCT00507195|Midazolam|midazolam|mesh-list
2354525|NCT00507195|Propofol|propofol|mesh-list
2354526|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2354527|NCT00507195|Sevoflurane|sevoflurane|mesh-list
2354528|NCT00507195|Desflurane|desflurane|mesh-list
2354529|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2354530|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354531|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2354532|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
2354533|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
2354534|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2354535|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2354536|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2354537|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2354538|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
2354539|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
2354540|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354541|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354542|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2354543|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2354544|NCT00507221|Albendazole|albendazole|mesh-list
2354545|NCT00507221|Praziquantel|praziquantel|mesh-list
2354546|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
2354547|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2354548|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2354549|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
2354550|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2354551|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2354552|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
2354553|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
2354554|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
2354555|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354556|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354557|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
2354558|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2354559|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
2354560|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354561|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354562|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2354563|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
2354564|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2354565|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2354566|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2354567|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
2354568|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354569|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354570|NCT00507247|Daptomycin|daptomycin|mesh-list
2354571|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2354572|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2354573|NCT00507286|Alprostadil|alprostadil|mesh-list
2354574|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2354575|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
2354576|NCT00507286|Urological Agents|urological agents|mesh-ancestor
2354577|NCT00507403|Infliximab|infliximab|mesh-list
2354578|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
2354579|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2354580|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2354581|NCT00507494|Pioglitazone|pioglitazone|mesh-list
2354582|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2354583|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354584|NCT00507585|Leucovorin|leucovorin|mesh-list
2354585|NCT00507585|Bevacizumab|bevacizumab|mesh-list
2354586|NCT00507585|Fluorouracil|fluorouracil|mesh-list
2354587|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
2354588|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2354589|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354590|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2354591|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2354592|NCT00507585|Growth Substances|growth substances|mesh-ancestor
2354593|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354594|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
2354595|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
2354596|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354597|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2354598|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2354599|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
2354600|NCT00507585|Antidotes|antidotes|mesh-ancestor
2354601|NCT00507585|Protective Agents|protective agents|mesh-ancestor
2354602|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
2354603|NCT00507585|Vitamins|vitamins|mesh-ancestor
2354604|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
2354605|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
2354606|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2354607|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2354608|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2354609|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2354610|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2354611|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354612|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
2354613|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354614|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354615|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2354616|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354617|NCT00507663|Atenolol|atenolol|mesh-list
2354618|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2354619|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2354620|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
2354621|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
2354622|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354623|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354624|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2354625|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2354626|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2354627|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
2354628|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354629|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354630|NCT00507793|Cyclosporine|cyclosporine|mesh-list
2354631|NCT00507793|Sirolimus|sirolimus|mesh-list
2354632|NCT00507793|Cyclosporins|cyclosporins|mesh-list
2354633|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354634|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354635|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2354636|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
2354637|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354638|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
2354639|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2354640|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
2354641|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2354642|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2354643|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2354644|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2354645|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354646|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
2354647|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2354648|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2354649|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2354650|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
2354651|NCT00507832|Tacrolimus|tacrolimus|mesh-list
2354652|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2354653|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2354654|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2354655|NCT00507832|Analgesics|analgesics|mesh-ancestor
2354656|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
2354657|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354658|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354659|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2354660|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
2354661|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2354662|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
2354663|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2354664|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354665|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354666|NCT00507845|Felodipine|felodipine|mesh-list
2354667|NCT00507845|Ramipril|ramipril|mesh-list
2354668|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2354669|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
2354670|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354671|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354672|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2354673|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2354674|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2354675|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2354676|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2354677|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354678|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
2354679|NCT00507858|Dexamethasone|dexamethasone|mesh-list
2354680|NCT00507858|Pemetrexed|pemetrexed|mesh-list
2354681|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2354682|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
2354683|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
2354684|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354685|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354686|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2354687|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
2354688|NCT00507858|Hormones|hormones|mesh-ancestor
2354689|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2354690|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2354691|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354692|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354693|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354694|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2354695|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2354696|NCT00507936|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2354697|NCT00507936|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2354698|NCT00507936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2354699|NCT00507936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2354700|NCT00507936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354701|NCT00507936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354702|NCT00507936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354703|NCT00507936|Analgesics|analgesics|mesh-ancestor
2354704|NCT00507936|Sensory System Agents|sensory system agents|mesh-ancestor
2354705|NCT00507936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354706|NCT00507936|Antidepressive Agents|antidepressive agents|mesh-ancestor
2354707|NCT00507936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2354708|NCT00507936|Dopamine Agents|dopamine agents|mesh-ancestor
2354709|NCT00507949|Megestrol|megestrol|mesh-list
2354710|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
2354711|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2354712|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2354713|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2354714|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
2354715|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2354716|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354717|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2354718|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2354719|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2354720|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354721|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
2354722|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2354723|NCT00507962|Cisplatin|cisplatin|mesh-list
2354724|NCT00507962|Doxorubicin|doxorubicin|mesh-list
2354725|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2354726|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354727|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2354728|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2354729|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2354730|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354731|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354732|NCT00507975|Nicotine|nicotine|mesh-list
2354733|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2354734|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
2354735|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354736|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354737|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2354738|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2354739|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
2354740|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354741|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354742|NCT00508040|Interferons|interferons|mesh-list
2354743|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
2354744|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
2354745|NCT00508040|Prednisone|prednisone|mesh-list
2354746|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2354747|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
2354748|NCT00508040|Hormones|hormones|mesh-ancestor
2354749|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2354750|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354751|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2354752|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354753|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
2354754|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2354755|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
2354756|NCT00508066|Bupivacaine|bupivacaine|mesh-list
2354757|NCT00508066|Anesthetics, Local|anesthetics, local|mesh-ancestor
2354758|NCT00508066|Anesthetics|anesthetics|mesh-ancestor
2354759|NCT00508066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2354760|NCT00508066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354761|NCT00508066|Sensory System Agents|sensory system agents|mesh-ancestor
2354762|NCT00508066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354763|NCT00508092|Anesthetics|anesthetics|mesh-list
2354764|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
2354765|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2354766|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354767|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
2354768|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354769|NCT00508209|Bortezomib|bortezomib|mesh-list
2354770|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354771|NCT00508222|Lopinavir|lopinavir|mesh-list
2354772|NCT00508222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2354773|NCT00508222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2354774|NCT00508222|Protease Inhibitors|protease inhibitors|mesh-ancestor
2354775|NCT00508222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354776|NCT00508222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354777|NCT00508222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2354778|NCT00508222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2354779|NCT00508222|Antiviral Agents|antiviral agents|mesh-ancestor
2354780|NCT00508222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2354781|NCT00508222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2354782|NCT00508222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2354783|NCT00508287|Exenatide|exenatide|mesh-list
2354784|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2354785|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354786|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2354787|NCT00508287|Incretins|incretins|mesh-ancestor
2354788|NCT00508287|Hormones|hormones|mesh-ancestor
2354789|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2354790|NCT00508326|Paclitaxel|paclitaxel|mesh-list
2354791|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2354792|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354793|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
2354794|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
2354795|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
2354796|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354797|NCT00508365|Carvedilol|carvedilol|mesh-list
2354798|NCT00508365|Lisinopril|lisinopril|mesh-list
2354799|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2354800|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2354801|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
2354802|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354803|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354804|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354805|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2354806|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
2354807|NCT00508365|Protective Agents|protective agents|mesh-ancestor
2354808|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2354809|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2354810|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2354811|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
2354812|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2354813|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2354814|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2354815|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
2354816|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354817|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2354818|NCT00508456|Temozolomide|temozolomide|mesh-list
2354819|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2354820|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
2354821|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354822|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354823|NCT00508495|Acetaminophen|acetaminophen|mesh-list
2354824|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2354825|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2354826|NCT00508495|Analgesics|analgesics|mesh-ancestor
2354827|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
2354828|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354829|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354830|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
2354831|NCT00508625|Paclitaxel|paclitaxel|mesh-list
2354832|NCT00508625|Bevacizumab|bevacizumab|mesh-list
2354833|NCT00508625|Carboplatin|carboplatin|mesh-list
2354834|NCT00508625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2354835|NCT00508625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354836|NCT00508625|Tubulin Modulators|tubulin modulators|mesh-ancestor
2354837|NCT00508625|Antimitotic Agents|antimitotic agents|mesh-ancestor
2354838|NCT00508625|Mitosis Modulators|mitosis modulators|mesh-ancestor
2354839|NCT00508625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354840|NCT00508625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2354841|NCT00508625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2354842|NCT00508625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2354843|NCT00508625|Growth Substances|growth substances|mesh-ancestor
2354844|NCT00508625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354845|NCT00508625|Growth Inhibitors|growth inhibitors|mesh-ancestor
2354846|NCT00508664|Docetaxel|docetaxel|mesh-list
2354847|NCT00508664|Fluorouracil|fluorouracil|mesh-list
2354848|NCT00508664|Cetuximab|cetuximab|mesh-list
2354849|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354850|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
2354851|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
2354852|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
2354853|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354854|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
2354855|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2354856|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2354857|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
2354858|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354859|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2354860|NCT00508690|Metronidazole|metronidazole|mesh-list
2354861|NCT00508690|Kanamycin|kanamycin|mesh-list
2354862|NCT00508690|Cefmetazole|cefmetazole|mesh-list
2354863|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2354864|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2354865|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2354866|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2354867|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2354868|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354869|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354870|NCT00508859|Sertraline|sertraline|mesh-list
2354871|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
2354872|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2354873|NCT00508859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2354874|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2354875|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2354876|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354877|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354878|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
2354879|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354880|NCT00508885|Niacinamide|niacinamide|mesh-list
2354881|NCT00508885|Niacin|niacin|mesh-list
2354882|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
2354883|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
2354884|NCT00508885|Vitamins|vitamins|mesh-ancestor
2354885|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
2354886|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112173|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112174|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2112175|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2112176|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
2112177|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112178|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112179|NCT02565511|CNP520|cnp520|mesh-list
2112180|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112181|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112182|NCT02565628|PF-06669571|pf-06669571|mesh-list
2112183|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
2112184|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
2112185|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112186|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354887|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2354888|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
2354889|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354890|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2354891|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
2354892|NCT00508898|Calcitriol|calcitriol|mesh-list
2354893|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2354894|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354895|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2354896|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2354897|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354898|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2354899|NCT00508898|Vitamins|vitamins|mesh-ancestor
2354900|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
2354901|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2354902|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
2354903|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
2354904|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2354905|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354906|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2354907|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
2354908|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2354909|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2354910|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112187|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112188|NCT02565810|Adalimumab|adalimumab|mesh-list
2112189|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2112190|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2112191|NCT02565901|Sirolimus|sirolimus|mesh-list
2354911|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
2354912|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2354913|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
2354914|NCT00508976|Lidocaine|lidocaine|mesh-list
2354915|NCT00508976|Bupivacaine|bupivacaine|mesh-list
2354916|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
2354917|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
2354918|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2354919|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354920|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
2354921|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2354922|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2354923|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2354924|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2354925|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2354926|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354927|NCT00508989|Niacin|niacin|mesh-list
2354928|NCT00508989|Acetylcholine|acetylcholine|mesh-list
2354929|NCT00508989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2354930|NCT00508989|Antimetabolites|antimetabolites|mesh-ancestor
2354931|NCT00508989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354932|NCT00508989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2354933|NCT00508989|Vasodilator Agents|vasodilator agents|mesh-ancestor
2354934|NCT00508989|Vitamin B Complex|vitamin b complex|mesh-ancestor
2354935|NCT00508989|Vitamins|vitamins|mesh-ancestor
2354936|NCT00508989|Micronutrients|micronutrients|mesh-ancestor
2354937|NCT00508989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354938|NCT00508989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2354939|NCT00508989|Cholinergic Agents|cholinergic agents|mesh-ancestor
2354940|NCT00508989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2354941|NCT00509015|Artesunate|artesunate|mesh-list
2354942|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
2354943|NCT00509015|Primaquine|primaquine|mesh-list
2354944|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
2354945|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2354946|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
2354947|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2354948|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2354949|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2354950|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354951|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
2354952|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
2354953|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2354954|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
2354955|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2354956|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354957|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354958|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2354959|NCT00509015|Renal Agents|renal agents|mesh-ancestor
2354960|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2354961|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2354962|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
2354963|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354964|NCT00509158|Antacids|antacids|mesh-ancestor
2354965|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354966|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2354967|NCT00509184|Rituximab|rituximab|mesh-list
2354968|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2354969|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354970|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
2354971|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354972|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2354973|NCT00509327|Bisacodyl|bisacodyl|mesh-list
2354974|NCT00509327|Cathartics|cathartics|mesh-ancestor
2354975|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2354976|NCT00509327|Laxatives|laxatives|mesh-ancestor
2354977|NCT00509353|Irinotecan|irinotecan|mesh-list
2354978|NCT00509353|Vincristine|vincristine|mesh-list
2354979|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2354980|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2354981|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2354982|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2354983|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2354984|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354985|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2354986|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
2354987|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
2354988|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
2354989|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2354990|NCT00509379|Rituximab|rituximab|mesh-list
2354991|NCT00509379|Bortezomib|bortezomib|mesh-list
2354992|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2354993|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2354994|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
2354995|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2354996|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2354997|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
2354998|NCT00509405|Diuretics|diuretics|mesh-ancestor
2354999|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
2355000|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355001|NCT00509405|Expectorants|expectorants|mesh-ancestor
2355002|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
2355003|NCT00509431|Sirolimus|sirolimus|mesh-list
2355004|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2355005|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355006|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2355007|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355008|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355009|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2355010|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355011|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2355012|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
2355013|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2355014|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
2355015|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355016|NCT00509470|Amlodipine|amlodipine|mesh-list
2355017|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2355018|NCT00509470|Telmisartan|telmisartan|mesh-list
2355019|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2355020|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2355021|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2355022|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355023|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2355024|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355025|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
2355026|NCT00509470|Diuretics|diuretics|mesh-ancestor
2355027|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
2355028|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2355029|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2355030|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2355031|NCT00509561|Capecitabine|capecitabine|mesh-list
2355032|NCT00509561|Cetuximab|cetuximab|mesh-list
2355033|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355034|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2355035|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
2355036|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355037|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2355038|NCT00509613|Sirolimus|sirolimus|mesh-list
2355039|NCT00509613|Sorafenib|sorafenib|mesh-list
2355040|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355041|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2355042|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355043|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355044|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2355045|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355046|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2355047|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
2355048|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2355049|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
2355050|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355051|NCT00509639|Metronidazole|metronidazole|mesh-list
2355052|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355053|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2355054|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2355055|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2355056|NCT00509678|Rituximab|rituximab|mesh-list
2355057|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2355058|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355059|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
2355060|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355061|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2355062|NCT00509743|Diclofenac|diclofenac|mesh-list
2355063|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2355064|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2355065|NCT00509743|Analgesics|analgesics|mesh-ancestor
2355066|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
2355067|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355068|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355069|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2355070|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2355071|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2355072|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355073|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355074|NCT00509834|Lactoferrin|lactoferrin|mesh-list
2355075|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355076|NCT00509847|Lactoferrin|lactoferrin|mesh-list
2355077|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355078|NCT00509860|Irinotecan|irinotecan|mesh-list
2355079|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2355080|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2355081|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355082|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355083|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355084|NCT00509938|Lactoferrin|lactoferrin|mesh-list
2355085|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355086|NCT00509964|Irinotecan|irinotecan|mesh-list
2355087|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2355088|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2355089|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355090|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355091|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355092|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
2355093|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2355094|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2355095|NCT00509990|Analgesics|analgesics|mesh-ancestor
2355096|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
2355097|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355098|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355099|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2355100|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2355101|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
2355102|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2355103|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
2355104|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2355105|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355106|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355107|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
2355108|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2355109|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2355110|NCT00510003|Analgesics|analgesics|mesh-ancestor
2355111|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
2355112|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355113|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355114|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2355115|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2355116|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
2355117|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2355118|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
2355119|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2355120|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355121|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355122|NCT00510016|Clonidine|clonidine|mesh-list
2355123|NCT00510016|Analgesics|analgesics|mesh-ancestor
2355124|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
2355125|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355126|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355127|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2355128|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
2355129|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
2355130|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2355131|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2355132|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2355133|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
2355134|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355135|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355136|NCT00510081|Calcium|calcium|mesh-list
2355137|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2355138|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355139|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
2355140|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355141|NCT00510159|Artesunate|artesunate|mesh-list
2355142|NCT00510159|Sulfalene|sulfalene|mesh-list
2355143|NCT00510159|Praziquantel|praziquantel|mesh-list
2355144|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
2355145|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2355146|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2355147|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355148|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355149|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
2355150|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
2355151|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2355152|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
2355153|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2355154|NCT00510159|Renal Agents|renal agents|mesh-ancestor
2355155|NCT00510172|Epoprostenol|epoprostenol|mesh-list
2355156|NCT00510172|Tezosentan|tezosentan|mesh-list
2355157|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2355158|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2355159|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
2355160|NCT00510211|Olanzapine|olanzapine|mesh-list
2355161|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
2355162|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
2355163|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355164|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355165|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2355166|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2355167|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2355168|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2355169|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2355170|NCT00510211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2355171|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2355172|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2355173|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355174|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355175|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
2355176|NCT00510250|Sorafenib|sorafenib|mesh-list
2355177|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355178|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2355179|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355180|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355181|NCT00510263|Valacyclovir|valacyclovir|mesh-list
2355182|NCT00510263|Prednisolone|prednisolone|mesh-list
2355183|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2355184|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
2355185|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2355186|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
2355187|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2355188|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
2355189|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2355190|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
2355191|NCT00510263|Hormones|hormones|mesh-ancestor
2355192|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2355193|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355194|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2355195|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355196|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
2355197|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
2355198|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355199|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2355200|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2355201|NCT00510263|Protective Agents|protective agents|mesh-ancestor
2355202|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
2355203|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355204|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
2355205|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355206|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2355207|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355208|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355209|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
2355210|NCT00510367|Doxorubicin|doxorubicin|mesh-list
2355211|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2355212|NCT00510367|Fluorouracil|fluorouracil|mesh-list
2355213|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2355214|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
2355215|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355216|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2355217|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2355218|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
2355219|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355220|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355221|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2355222|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2355223|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2355224|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2355225|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355226|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
2355227|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2355228|NCT00510393|Everolimus|everolimus|mesh-list
2355229|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355230|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2355231|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
2355232|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355233|NCT00510406|Tamsulosin|tamsulosin|mesh-list
2355234|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
2355235|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2355236|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2355237|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2355238|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
2355239|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355240|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355241|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355242|NCT00510406|Urological Agents|urological agents|mesh-ancestor
2355243|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2355244|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2355245|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
2355246|NCT00510419|Sumatriptan|sumatriptan|mesh-list
2355247|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2355248|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2355249|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2355250|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
2355251|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355252|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355253|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355254|NCT00510445|Imetelstat|imetelstat|mesh-list
2355255|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
2355256|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355257|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355258|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2355259|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
2355260|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2355261|NCT00510471|Antibodies|antibodies|mesh-list
2355262|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2355263|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
2355264|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355265|NCT00510536|Acetaminophen|acetaminophen|mesh-list
2355266|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2355267|NCT00510536|Analgesics|analgesics|mesh-ancestor
2355268|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
2355269|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355270|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355271|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
2355272|NCT00510588|Metformin|metformin|mesh-list
2355273|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2355274|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355275|NCT00510614|Tinidazole|tinidazole|mesh-list
2355276|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
2355277|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355278|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2355279|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355280|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2355281|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2355282|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2355283|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
2355284|NCT00510627|Irinotecan|irinotecan|mesh-list
2355285|NCT00510627|Cetuximab|cetuximab|mesh-list
2355286|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355287|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2355288|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2355289|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355290|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355291|NCT00510627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2355292|NCT00510640|Sunitinib|sunitinib|mesh-list
2355293|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355294|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2355295|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2355296|NCT00510640|Growth Substances|growth substances|mesh-ancestor
2355297|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355298|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
2355299|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2355300|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355301|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355302|NCT00510666|Tramadol|tramadol|mesh-list
2355303|NCT00510666|Butorphanol|butorphanol|mesh-list
2355304|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2355305|NCT00510666|Narcotics|narcotics|mesh-ancestor
2355306|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2355307|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355308|NCT00510666|Analgesics|analgesics|mesh-ancestor
2355309|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
2355310|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355311|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
2355312|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
2355313|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2355314|NCT00510705|Metformin|metformin|mesh-list
2355315|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2355316|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355317|NCT00510913|Tacrolimus|tacrolimus|mesh-list
2355318|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2355319|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
2355320|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355321|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2355322|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355323|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355324|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
2355325|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355326|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2355327|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355328|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355329|NCT00510939|Bortezomib|bortezomib|mesh-list
2355330|NCT00510939|Tipifarnib|tipifarnib|mesh-list
2355331|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355332|NCT00510965|Ranibizumab|ranibizumab|mesh-list
2355333|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2355334|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2355335|NCT00510965|Growth Substances|growth substances|mesh-ancestor
2355336|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355337|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
2355338|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355339|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2355340|NCT00511017|Vitamins|vitamins|mesh-ancestor
2355341|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
2355342|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355343|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2355344|NCT00511043|Vatalanib|vatalanib|mesh-list
2355345|NCT00511043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2355346|NCT00511043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355347|NCT00511043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355348|NCT00511069|Bortezomib|bortezomib|mesh-list
2355349|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355350|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2355351|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
2355352|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355353|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2355354|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355355|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355356|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
2355357|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355358|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
2355359|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2355360|NCT00511212|Antibodies|antibodies|mesh-list
2355361|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
2355362|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2355363|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
2355364|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355365|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
2355366|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2355367|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355368|NCT00511225|Vitamins|vitamins|mesh-ancestor
2355369|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
2355370|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2355371|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2355372|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
2355373|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2355374|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2355375|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2355376|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2355377|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355378|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
2355379|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355380|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2355381|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355382|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355383|NCT00511316|Montelukast|montelukast|mesh-list
2355384|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2355385|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
2355386|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2355387|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
2355388|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2355389|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355390|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2355391|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2355392|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355393|NCT00511446|Docetaxel|docetaxel|mesh-list
2355394|NCT00511446|Capecitabine|capecitabine|mesh-list
2355395|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
2355396|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355397|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
2355398|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
2355399|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
2355400|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355401|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2355402|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
2355403|NCT00511459|Paclitaxel|paclitaxel|mesh-list
2355404|NCT00511459|Bevacizumab|bevacizumab|mesh-list
2355405|NCT00511459|Trebananib|trebananib|mesh-list
2355406|NCT00511459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2355407|NCT00511459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355408|NCT00511459|Tubulin Modulators|tubulin modulators|mesh-ancestor
2355409|NCT00511459|Antimitotic Agents|antimitotic agents|mesh-ancestor
2355410|NCT00511459|Mitosis Modulators|mitosis modulators|mesh-ancestor
2355411|NCT00511459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355412|NCT00511459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2355413|NCT00511459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2355414|NCT00511459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2355415|NCT00511459|Growth Substances|growth substances|mesh-ancestor
2355416|NCT00511459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355417|NCT00511459|Growth Inhibitors|growth inhibitors|mesh-ancestor
2355418|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
2355419|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
2355420|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2355421|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2355422|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355423|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355424|NCT00511498|Urological Agents|urological agents|mesh-ancestor
2355425|NCT00511576|Docetaxel|docetaxel|mesh-list
2355426|NCT00511576|Mocetinostat|mocetinostat|mesh-list
2355427|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355428|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
2355429|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
2355430|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
2355431|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355432|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2355433|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355434|NCT00511602|Insulin|insulin|mesh-list
2355435|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2355436|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355437|NCT00511628|Risperidone|risperidone|mesh-list
2355438|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2355439|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
2355440|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355441|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355442|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355443|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2355444|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2355445|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2355446|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2355447|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2355448|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
2355449|NCT00511654|Midazolam|midazolam|mesh-list
2355450|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2355451|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2355452|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2355453|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355454|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2355455|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2355456|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2355457|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2355458|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
2355459|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
2355460|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
2355461|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
2355462|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355463|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355464|NCT00511719|Insulin|insulin|mesh-list
2355465|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2355466|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2355467|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355468|NCT00511732|Insulin|insulin|mesh-list
2355469|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2355470|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355471|NCT00511771|Tegaserod|tegaserod|mesh-list
2355472|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2355473|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
2355474|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355475|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355476|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355477|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
2355478|NCT00511823|Granisetron|granisetron|mesh-list
2355479|NCT00511823|Casopitant|casopitant|mesh-list
2355480|NCT00511823|Dolasetron|dolasetron|mesh-list
2355481|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2355482|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355483|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
2355484|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
2355485|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355486|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2355487|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2355488|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
2355489|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355490|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355491|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2355492|NCT00511849|Paclitaxel|paclitaxel|mesh-list
2355493|NCT00511849|Carboplatin|carboplatin|mesh-list
2355494|NCT00511849|Sunitinib|sunitinib|mesh-list
2355495|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2355496|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355497|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
2355498|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
2355499|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
2355500|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355501|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2355502|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2355503|NCT00511849|Growth Substances|growth substances|mesh-ancestor
2355504|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355505|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
2355506|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2355507|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355508|NCT00511940|Acamprosate|acamprosate|mesh-list
2355509|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2355510|NCT00511953|Gabapentin|gabapentin|mesh-list
2355511|NCT00511953|Analgesics|analgesics|mesh-ancestor
2355512|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
2355513|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355514|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355515|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
2355516|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2355517|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2355518|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2355519|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2355520|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2355521|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2355522|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355523|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355524|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
2355525|NCT00511966|Rabeprazole|rabeprazole|mesh-list
2355526|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2355527|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2355528|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2355529|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355530|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355531|NCT00511979|Insulin|insulin|mesh-list
2355532|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2355533|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2355534|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355535|NCT00512044|Anesthetics|anesthetics|mesh-list
2355536|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2355537|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355538|NCT00512057|Allopurinol|allopurinol|mesh-list
2355539|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
2355540|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355541|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355542|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
2355543|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2355544|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2355545|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
2355546|NCT00512057|Protective Agents|protective agents|mesh-ancestor
2355547|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355548|NCT00512070|Olanzapine|olanzapine|mesh-list
2355549|NCT00512070|Melatonin|melatonin|mesh-list
2355550|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
2355551|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355552|NCT00512070|Protective Agents|protective agents|mesh-ancestor
2355553|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355554|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2355555|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
2355556|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
2355557|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355558|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2355559|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2355560|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2355561|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2355562|NCT00512070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2355563|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2355564|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2355565|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355566|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
2355567|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
2355568|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2355569|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
2355570|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355571|NCT00512265|Expectorants|expectorants|mesh-ancestor
2355572|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
2355573|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2355574|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
2355575|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355576|NCT00512265|Protective Agents|protective agents|mesh-ancestor
2355577|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355578|NCT00512265|Antidotes|antidotes|mesh-ancestor
2355579|NCT00512291|Olanzapine|olanzapine|mesh-list
2355580|NCT00512291|Fluoxetine|fluoxetine|mesh-list
2355581|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
2355582|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
2355583|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355584|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355585|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2355586|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2355587|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2355588|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2355589|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2355590|NCT00512291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2355591|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2355592|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2355593|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355594|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355595|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
2355596|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2355597|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
2355598|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2355599|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2355600|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355601|NCT00512317|Ganaxolone|ganaxolone|mesh-list
2355602|NCT00512317|Neurosteroids|neurosteroids|mesh-ancestor
2355603|NCT00512317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355604|NCT00512317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355605|NCT00512317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355606|NCT00512317|GABA Modulators|gaba modulators|mesh-ancestor
2355607|NCT00512317|GABA Agents|gaba agents|mesh-ancestor
2355608|NCT00512395|Fentanyl|fentanyl|mesh-list
2355609|NCT00512395|Ropivacaine|ropivacaine|mesh-list
2355610|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2355611|NCT00512395|Narcotics|narcotics|mesh-ancestor
2355612|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2355613|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355614|NCT00512395|Analgesics|analgesics|mesh-ancestor
2355615|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
2355616|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355617|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2355618|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2355619|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
2355620|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
2355621|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
2355622|NCT00512408|Testosterone|testosterone|mesh-list
2355623|NCT00512408|Androgens|androgens|mesh-ancestor
2355624|NCT00512408|Hormones|hormones|mesh-ancestor
2355625|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2355626|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355627|NCT00512473|Hormones|hormones|mesh-list
2355628|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2355629|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355630|NCT00512486|Benralizumab|benralizumab|mesh-list
2355631|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2355632|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
2112192|NCT02565901|Carboplatin|carboplatin|mesh-list
2112193|NCT02565901|Docetaxel|docetaxel|mesh-list
2112194|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112195|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
2112196|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
2112197|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
2112198|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112199|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2112200|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355633|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
2355634|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2355635|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355636|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2355637|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2355638|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2355639|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2355640|NCT00512668|Sirolimus|sirolimus|mesh-list
2355641|NCT00512668|Leuprolide|leuprolide|mesh-list
2355642|NCT00512668|Goserelin|goserelin|mesh-list
2355643|NCT00512668|Flutamide|flutamide|mesh-list
2355644|NCT00512668|Bicalutamide|bicalutamide|mesh-list
2355645|NCT00512668|Nilutamide|nilutamide|mesh-list
2355646|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2355647|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
2355648|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2355649|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355650|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2355651|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355652|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2355653|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355654|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2355655|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
2355656|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2355657|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
2355658|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
2355659|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
2355660|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2355661|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
2355662|NCT00512681|Irinotecan|irinotecan|mesh-list
2355663|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355664|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2355665|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2355666|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355667|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355668|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
2355669|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
2355670|NCT00512811|Furosemide|furosemide|mesh-list
2355671|NCT00512811|Diuretics|diuretics|mesh-ancestor
2355672|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
2355673|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355674|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2355675|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2355676|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355677|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
2355678|NCT00512824|Calcium|calcium|mesh-list
2355679|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2355680|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355681|NCT00512824|Antacids|antacids|mesh-ancestor
2355682|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355683|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2355684|NCT00512850|Folic Acid|folic acid|mesh-list
2355685|NCT00512850|Hematinics|hematinics|mesh-ancestor
2355686|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
2355687|NCT00512850|Vitamins|vitamins|mesh-ancestor
2355688|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
2355689|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355690|NCT00512863|Adalimumab|adalimumab|mesh-list
2355691|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2355692|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2355693|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
2355694|NCT00512928|Vitamin K|vitamin k|mesh-list
2355695|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
2355696|NCT00512928|Vitamin MK 7|vitamin mk 7|mesh-list
2355697|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2355698|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2355699|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355700|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
2355701|NCT00512928|Coagulants|coagulants|mesh-ancestor
2355702|NCT00512928|Vitamins|vitamins|mesh-ancestor
2355703|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
2355704|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355705|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
2355706|NCT00512980|Gemcitabine|gemcitabine|mesh-list
2355707|NCT00512980|Prednisone|prednisone|mesh-list
2355708|NCT00512980|Doxorubicin|doxorubicin|mesh-list
2355709|NCT00512980|Vinblastine|vinblastine|mesh-list
2355710|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2355711|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
2355712|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355713|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355714|NCT00512980|Antiviral Agents|antiviral agents|mesh-ancestor
2355715|NCT00512980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355716|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355717|NCT00512980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2355718|NCT00512980|Immunologic Factors|immunologic factors|mesh-ancestor
2355719|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355720|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2355721|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2355722|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2355723|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2355724|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
2355725|NCT00512980|Hormones|hormones|mesh-ancestor
2355726|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2355727|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2355728|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2355729|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
2355730|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
2355731|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
2355732|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
2355733|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2355734|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355735|NCT00513032|Methylene Blue|methylene blue|mesh-list
2355736|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355737|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355738|NCT00513058|Vinorelbine|vinorelbine|mesh-list
2355739|NCT00513058|Lapatinib|lapatinib|mesh-list
2355740|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2355741|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355742|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
2355743|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
2355744|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
2355745|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355746|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2355747|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355748|NCT00513110|Caffeine|caffeine|mesh-list
2355749|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2355750|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355751|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2355752|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355753|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355754|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2355755|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2355756|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
2355757|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355758|NCT00513149|Clopidogrel|clopidogrel|mesh-list
2355759|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2355760|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2355761|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2355762|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2355763|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
2355764|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355765|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355766|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355767|NCT00513162|Etoposide|etoposide|mesh-list
2355768|NCT00513162|Valproic Acid|valproic acid|mesh-list
2355769|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2355770|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355771|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2355772|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2355773|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355774|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355775|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
2355776|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
2355777|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355778|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355779|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
2355780|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2355781|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2355782|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2355783|NCT00513188|Leucovorin|leucovorin|mesh-list
2355784|NCT00513188|Cytarabine|cytarabine|mesh-list
2355785|NCT00513188|Prednisone|prednisone|mesh-list
2355786|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
2355787|NCT00513188|Doxorubicin|doxorubicin|mesh-list
2355788|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2355789|NCT00513188|Methotrexate|methotrexate|mesh-list
2355790|NCT00513188|Vincristine|vincristine|mesh-list
2355791|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
2355792|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
2355793|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2355794|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
2355795|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355796|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2355797|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2355798|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
2355799|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355800|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355801|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2355802|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2355803|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2355804|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2355805|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355806|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2355807|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
2355808|NCT00513188|Hormones|hormones|mesh-ancestor
2355809|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2355810|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2355811|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2355812|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
2355813|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2355814|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2355815|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
2355816|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
2355817|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2355818|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2355819|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
2355820|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355821|NCT00513188|Antidotes|antidotes|mesh-ancestor
2355822|NCT00513188|Protective Agents|protective agents|mesh-ancestor
2355823|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
2355824|NCT00513188|Vitamins|vitamins|mesh-ancestor
2355825|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
2355826|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2355827|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
2355828|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
2355829|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
2355830|NCT00513201|Insulin|insulin|mesh-list
2355831|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2355832|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2355833|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355834|NCT00513253|Lapatinib|lapatinib|mesh-list
2355835|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355836|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2355837|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355838|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355839|NCT00513266|Leucovorin|leucovorin|mesh-list
2355840|NCT00513266|Bevacizumab|bevacizumab|mesh-list
2355841|NCT00513266|Cetuximab|cetuximab|mesh-list
2355842|NCT00513266|Fluorouracil|fluorouracil|mesh-list
2355843|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
2355844|NCT00513266|Irinotecan|irinotecan|mesh-list
2355845|NCT00513266|Calcium|calcium|mesh-list
2355846|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
2355847|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2355848|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355849|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2355850|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2355851|NCT00513266|Growth Substances|growth substances|mesh-ancestor
2355852|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355853|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
2355854|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2355855|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
2355856|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355857|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2355858|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2355859|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
2355860|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2355861|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2355862|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355863|NCT00513266|Antidotes|antidotes|mesh-ancestor
2355864|NCT00513266|Protective Agents|protective agents|mesh-ancestor
2355865|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
2355866|NCT00513266|Vitamins|vitamins|mesh-ancestor
2355867|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
2355868|NCT00513383|Paclitaxel|paclitaxel|mesh-list
2355869|NCT00513383|Docetaxel|docetaxel|mesh-list
2355870|NCT00513383|Carboplatin|carboplatin|mesh-list
2355871|NCT00513383|Fluorouracil|fluorouracil|mesh-list
2355872|NCT00513383|Panitumumab|panitumumab|mesh-list
2355873|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2355874|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355875|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
2355876|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
2355877|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
2355878|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355879|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
2355880|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2355881|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2355882|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
2355883|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355884|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2355885|NCT00513396|Isoniazid|isoniazid|mesh-list
2355886|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
2355887|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2355888|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355889|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2355890|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2355891|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
2355892|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355893|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2355894|NCT00513487|Fluticasone|fluticasone|mesh-list
2355895|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
2355896|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2355897|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2355898|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
2355899|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355900|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355901|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2355902|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
2355903|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
2355904|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2355905|NCT00513487|Miotics|miotics|mesh-ancestor
2355906|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2355907|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2355908|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2355909|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2355910|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
2355911|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355912|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355913|NCT00513513|Ritonavir|ritonavir|mesh-list
2355914|NCT00513513|Darunavir|darunavir|mesh-list
2355915|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2355916|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2355917|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
2355918|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355919|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355920|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2355921|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2355922|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
2355923|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355924|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2355925|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2355926|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2355927|NCT00513539|Trioxsalen|trioxsalen|mesh-list
2355928|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355929|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
2112201|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2112202|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
2112203|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2112204|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
2112205|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355930|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2355931|NCT00513552|Clarithromycin|clarithromycin|mesh-list
2355932|NCT00513552|Rifabutin|rifabutin|mesh-list
2355933|NCT00513552|Clofazimine|clofazimine|mesh-list
2355934|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2355935|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2355936|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2355937|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2355938|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355939|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2355940|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2112206|NCT02565914|Ivacaftor|ivacaftor|mesh-list
2112207|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2112208|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2112209|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112210|NCT02566005|Misoprostol|misoprostol|mesh-list
2112211|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2355941|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2355942|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
2355943|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2355944|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
2355945|NCT00513578|Sargramostim|sargramostim|mesh-list
2355946|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
2355947|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
2355948|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355949|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2355950|NCT00513630|Metformin|metformin|mesh-list
2355951|NCT00513630|Glipizide|glipizide|mesh-list
2355952|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2355953|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355954|NCT00513643|Insulin|insulin|mesh-list
2355955|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2355956|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
2355957|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2355958|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355959|NCT00513656|Oxycodone|oxycodone|mesh-list
2355960|NCT00513656|Naloxone|naloxone|mesh-list
2355961|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2355962|NCT00513656|Narcotics|narcotics|mesh-ancestor
2355963|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2355964|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355965|NCT00513656|Analgesics|analgesics|mesh-ancestor
2355966|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
2355967|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355968|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2355969|NCT00513786|Paclitaxel|paclitaxel|mesh-list
2355970|NCT00513786|Bevacizumab|bevacizumab|mesh-list
2355971|NCT00513786|Carboplatin|carboplatin|mesh-list
2355972|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2355973|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2355974|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
2355975|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
2355976|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
2355977|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2355978|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2355979|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2355980|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2355981|NCT00513786|Growth Substances|growth substances|mesh-ancestor
2355982|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355983|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
2355984|NCT00513864|Morphine|morphine|mesh-list
2355985|NCT00513864|Codeine|codeine|mesh-list
2355986|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
2355987|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2355988|NCT00513864|Narcotics|narcotics|mesh-ancestor
2355989|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2355990|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2355991|NCT00513864|Analgesics|analgesics|mesh-ancestor
2355992|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
2355993|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2355994|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
2355995|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
2355996|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2355997|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2355998|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2355999|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356000|NCT00513877|Bortezomib|bortezomib|mesh-list
2356001|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356002|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
2356003|NCT00513929|Astringents|astringents|mesh-ancestor
2356004|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356005|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
2356006|NCT00513955|Prednisolone|prednisolone|mesh-list
2356007|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
2356008|NCT00513955|Doxorubicin|doxorubicin|mesh-list
2356009|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2356010|NCT00513955|Vincristine|vincristine|mesh-list
2356011|NCT00513955|Bortezomib|bortezomib|mesh-list
2356012|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356013|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
2356014|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356015|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2356016|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2356017|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
2356018|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356019|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356020|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2356021|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2356022|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2356023|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2356024|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356025|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2356026|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
2356027|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
2356028|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
2356029|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2356030|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
2356031|NCT00513955|Hormones|hormones|mesh-ancestor
2356032|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2356033|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2356034|NCT00513968|Adefovir|adefovir|mesh-list
2356035|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
2356036|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356037|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2356038|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2356039|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356040|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356041|NCT00513981|Leucovorin|leucovorin|mesh-list
2356042|NCT00513981|Methotrexate|methotrexate|mesh-list
2356043|NCT00513981|Calcium|calcium|mesh-list
2356044|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
2356045|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2356046|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356047|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2356048|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
2356049|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2356050|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2356051|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
2356052|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356053|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356054|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
2356055|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356056|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2356057|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356058|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
2356059|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2356060|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2356061|NCT00513981|Antidotes|antidotes|mesh-ancestor
2356062|NCT00513981|Protective Agents|protective agents|mesh-ancestor
2356063|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
2356064|NCT00513981|Vitamins|vitamins|mesh-ancestor
2356065|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
2356066|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
2356067|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
2356068|NCT00514072|Vaccines|vaccines|mesh-list
2356069|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
2356070|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
2356071|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356072|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2356073|NCT00514111|Interferons|interferons|mesh-list
2356074|NCT00514111|Ribavirin|ribavirin|mesh-list
2356075|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356076|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
2356077|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356078|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
2356079|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356080|NCT00514163|Gemcitabine|gemcitabine|mesh-list
2356081|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2356082|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
2356083|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356084|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356085|NCT00514163|Antiviral Agents|antiviral agents|mesh-ancestor
2356086|NCT00514163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356087|NCT00514163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356088|NCT00514163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356089|NCT00514163|Immunologic Factors|immunologic factors|mesh-ancestor
2356090|NCT00514163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356091|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
2356092|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2356093|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356094|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2356095|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2356096|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2356097|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356098|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
2356099|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356100|NCT00514228|Sunitinib|sunitinib|mesh-list
2356101|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356102|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2356103|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2356104|NCT00514228|Growth Substances|growth substances|mesh-ancestor
2356105|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356106|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
2356107|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2356108|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356109|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356110|NCT00514267|Prednisone|prednisone|mesh-list
2356111|NCT00514267|Docetaxel|docetaxel|mesh-list
2356112|NCT00514267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356113|NCT00514267|Tubulin Modulators|tubulin modulators|mesh-ancestor
2356114|NCT00514267|Antimitotic Agents|antimitotic agents|mesh-ancestor
2356115|NCT00514267|Mitosis Modulators|mitosis modulators|mesh-ancestor
2356116|NCT00514267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356117|NCT00514267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2356118|NCT00514267|Glucocorticoids|glucocorticoids|mesh-ancestor
2356119|NCT00514267|Hormones|hormones|mesh-ancestor
2356120|NCT00514267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2356121|NCT00514267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356122|NCT00514267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2356123|NCT00514293|Carboplatin|carboplatin|mesh-list
2356124|NCT00514293|Docetaxel|docetaxel|mesh-list
2356125|NCT00514293|Capecitabine|capecitabine|mesh-list
2356126|NCT00514293|Tretinoin|tretinoin|mesh-list
2356127|NCT00514293|Bexarotene|bexarotene|mesh-list
2356128|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356129|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
2356130|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
2356131|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
2356132|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356133|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2356134|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
2356135|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
2356136|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
2356137|NCT00514371|Bortezomib|bortezomib|mesh-list
2356138|NCT00514371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356139|NCT00514397|Temozolomide|temozolomide|mesh-list
2356140|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
2356141|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2356142|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
2356143|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356144|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356145|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2356146|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
2356147|NCT00514410|Folic Acid|folic acid|mesh-list
2356148|NCT00514410|Hematinics|hematinics|mesh-ancestor
2356149|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
2356150|NCT00514410|Vitamins|vitamins|mesh-ancestor
2356151|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
2356152|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356153|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2356154|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
2356155|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356156|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
2356157|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356158|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2356159|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356160|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356161|NCT00514527|Oritavancin|oritavancin|mesh-list
2356162|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2356163|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356164|NCT00514605|Antibodies|antibodies|mesh-list
2356165|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
2356166|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
2356167|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356168|NCT00514618|Misoprostol|misoprostol|mesh-list
2356169|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2356170|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
2356171|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2356172|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356173|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2356174|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2356175|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
2356176|NCT00514657|Mitogens|mitogens|mesh-list
2356177|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
2356178|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356179|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
2356180|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2356181|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356182|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
2356183|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
2356184|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2356185|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2356186|NCT00514748|Analgesics|analgesics|mesh-ancestor
2356187|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
2356188|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2356189|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356190|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2356191|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2356192|NCT00514761|Capecitabine|capecitabine|mesh-list
2356193|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2356194|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
2356195|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356196|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356197|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2356198|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2356199|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2356200|NCT00514891|Vitamin A|vitamin a|mesh-list
2356201|NCT00514891|Vitamins|vitamins|mesh-ancestor
2356202|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
2356203|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356204|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
2356205|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356206|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2356207|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356208|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356209|NCT00514982|Adalimumab|adalimumab|mesh-list
2356210|NCT00514982|Mesalamine|mesalamine|mesh-list
2356211|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
2356212|NCT00514982|Infliximab|infliximab|mesh-list
2356213|NCT00514982|Tacrolimus|tacrolimus|mesh-list
2356214|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356215|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
2356216|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356217|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2356218|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356219|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356220|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2356221|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2356222|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
2356223|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2356224|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
2356225|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2356226|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356227|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2356228|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2356229|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2356230|NCT00514982|Analgesics|analgesics|mesh-ancestor
2356231|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
2356232|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2356233|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
2356234|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2356235|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2356236|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
2356237|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
2356238|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2356239|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356240|NCT00515138|Rituximab|rituximab|mesh-list
2356241|NCT00515138|Carboplatin|carboplatin|mesh-list
2356242|NCT00515138|Etoposide|etoposide|mesh-list
2356243|NCT00515138|Bortezomib|bortezomib|mesh-list
2356244|NCT00515138|Ifosfamide|ifosfamide|mesh-list
2356245|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2356246|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356247|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
2356248|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356249|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2356250|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2356251|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2356252|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2356253|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356254|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356255|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2356256|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
2356257|NCT00515151|Ethanol|ethanol|mesh-list
2356258|NCT00515151|Octenidine|octenidine|mesh-list
2356259|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2356260|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356261|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2356262|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356263|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
2356264|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356265|NCT00515229|Amitriptyline|amitriptyline|mesh-list
2356266|NCT00515229|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2356267|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2356268|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
2356269|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2356270|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2356271|NCT00515229|Analgesics|analgesics|mesh-ancestor
2356272|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
2356273|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2356274|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356275|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2356276|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2356277|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2356278|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356279|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
2356280|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356281|NCT00515229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2356282|NCT00515229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2356283|NCT00515229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2356284|NCT00515255|Minocycline|minocycline|mesh-list
2356285|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2356286|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356287|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
2356288|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2356289|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2356290|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356291|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356292|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
2356293|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2356294|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
2356295|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2356296|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356297|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2356298|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
2356299|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2356300|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
2356301|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356302|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356303|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2356304|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
2356305|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
2356306|NCT00515281|Protective Agents|protective agents|mesh-ancestor
2356307|NCT00515320|Fluoxetine|fluoxetine|mesh-list
2356308|NCT00515320|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2356309|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2356310|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2356311|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356312|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356313|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
2356314|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356315|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2356316|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
2356317|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2356318|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2356319|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2356320|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356321|NCT00515359|Propofol|propofol|mesh-list
2356322|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2356323|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2356324|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356325|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2356326|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
2356327|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
2356328|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
2356329|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2356330|NCT00515450|Antibodies|antibodies|mesh-list
2356331|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
2356332|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2356333|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
2356334|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356335|NCT00515489|Risperidone|risperidone|mesh-list
2356336|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2356337|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
2356338|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356339|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356340|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356341|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2356342|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2356343|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2356344|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2356345|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2356346|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
2356347|NCT00515554|Rituximab|rituximab|mesh-list
2356348|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2356349|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356350|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
2356351|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356352|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2356353|NCT00515593|Hormones|hormones|mesh-list
2356354|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
2356355|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2356356|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356357|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2356358|NCT00515684|Bevacizumab|bevacizumab|mesh-list
2356359|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2356360|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356361|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2356362|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2356363|NCT00515684|Growth Substances|growth substances|mesh-ancestor
2356364|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356365|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
2356366|NCT00515736|Vitamins|vitamins|mesh-list
2356367|NCT00515736|Vitamin E|vitamin e|mesh-list
2356368|NCT00515736|Thiamine|thiamine|mesh-list
2356369|NCT00515736|Zinc|zinc|mesh-list
2356370|NCT00515736|Selenium|selenium|mesh-list
2356371|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
2356372|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356373|NCT00515736|Trace Elements|trace elements|mesh-ancestor
2356374|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
2356375|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356376|NCT00515736|Protective Agents|protective agents|mesh-ancestor
2356377|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
2356378|NCT00515788|Cytarabine|cytarabine|mesh-list
2356379|NCT00515788|Temozolomide|temozolomide|mesh-list
2356380|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2356381|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
2356382|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356383|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356384|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
2356385|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356386|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356387|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
2356388|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356389|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2356390|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
2356391|NCT00515801|Glyburide|glyburide|mesh-list
2356392|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2356393|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356394|NCT00515866|Gemcitabine|gemcitabine|mesh-list
2356395|NCT00515866|Olaparib|olaparib|mesh-list
2356396|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2356397|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2356398|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
2356399|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356400|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356401|NCT00515866|Antiviral Agents|antiviral agents|mesh-ancestor
2356402|NCT00515866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356403|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356404|NCT00515866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356405|NCT00515866|Immunologic Factors|immunologic factors|mesh-ancestor
2356406|NCT00515866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356407|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
2356408|NCT00515892|Antibodies|antibodies|mesh-list
2356409|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
2356410|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2356411|NCT00515892|Immunotoxins|immunotoxins|mesh-list
2356412|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
2356413|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356414|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356415|NCT00515905|Propofol|propofol|mesh-list
2356416|NCT00515905|Sevoflurane|sevoflurane|mesh-list
2356417|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2356418|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2356419|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356420|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2356421|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
2356422|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
2356423|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2356424|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2356425|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
2356426|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2356427|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2356428|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2356429|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2356430|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356431|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
2356432|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356433|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356434|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2356435|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2356436|NCT00515957|Antibodies|antibodies|mesh-list
2356437|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
2356438|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356439|NCT00516009|Dexamethasone|dexamethasone|mesh-list
2356440|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2356441|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
2356442|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
2356443|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2356444|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356445|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2356446|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
2356447|NCT00516009|Hormones|hormones|mesh-ancestor
2356448|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2356449|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2356450|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356451|NCT00516100|Pemetrexed|pemetrexed|mesh-list
2356452|NCT00516100|Bortezomib|bortezomib|mesh-list
2356453|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356454|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356455|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356456|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2356457|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2356458|NCT00516113|Paroxetine|paroxetine|mesh-list
2356459|NCT00516113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2356460|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2356461|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2356462|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356463|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356464|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
2356465|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356466|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2356467|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
2356468|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2356469|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2356470|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2356471|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356472|NCT00516152|Methotrexate|methotrexate|mesh-list
2356473|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
2356474|NCT00516152|Fludarabine|fludarabine|mesh-list
2356475|NCT00516152|Busulfan|busulfan|mesh-list
2356476|NCT00516152|Tacrolimus|tacrolimus|mesh-list
2356477|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2356478|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
2356479|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2356480|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356481|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2356482|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
2356483|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356484|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356485|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
2356486|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356487|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2356488|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356489|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
2356490|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2356491|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2356492|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2356493|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
2356494|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2356495|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2356496|NCT00516191|Doxorubicin|doxorubicin|mesh-list
2356497|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2356498|NCT00516191|Bortezomib|bortezomib|mesh-list
2356499|NCT00516191|Melphalan|melphalan|mesh-list
2356500|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2356501|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356502|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2356503|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2356504|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356505|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356506|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2356507|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
2356508|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2356509|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356510|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
2356511|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356512|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2356513|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
2356514|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356515|NCT00516243|Protective Agents|protective agents|mesh-ancestor
2356516|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356517|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2356518|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2356519|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356520|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2356521|NCT00516282|Temozolomide|temozolomide|mesh-list
2356522|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2356523|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
2356524|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356525|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356526|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
2356527|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2356528|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356529|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
2356530|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
2356531|NCT00516399|Natamycin|natamycin|mesh-list
2356532|NCT00516399|Povidone|povidone|mesh-list
2356533|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2356534|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2356535|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
2356536|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
2356537|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2356538|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356539|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2356540|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
2356541|NCT00516412|Everolimus|everolimus|mesh-list
2356542|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356543|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356544|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
2356545|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356546|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
2356547|NCT00516425|Doxorubicin|doxorubicin|mesh-list
2356548|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2356549|NCT00516425|Epirubicin|epirubicin|mesh-list
2356550|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356551|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
2356552|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356553|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2356554|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2356555|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
2356556|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356557|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356558|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2356559|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2356560|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2356561|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2356562|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356563|NCT00516438|Topotecan|topotecan|mesh-list
2356564|NCT00516438|Olaparib|olaparib|mesh-list
2356565|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2356566|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2356567|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2356568|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356569|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356570|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356571|NCT00516464|Ranibizumab|ranibizumab|mesh-list
2356572|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2356573|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2356574|NCT00516464|Growth Substances|growth substances|mesh-ancestor
2356575|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356576|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
2356577|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356578|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2356579|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
2356580|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2356581|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
2356582|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2356583|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356584|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2356585|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2356586|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356587|NCT00516542|Letrozole|letrozole|mesh-list
2356588|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356589|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2356590|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2356591|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356592|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356593|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2356594|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
2356595|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2356596|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356597|NCT00516607|Temozolomide|temozolomide|mesh-list
2356598|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2356599|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
2356600|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356601|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356602|NCT00516672|Lapatinib|lapatinib|mesh-list
2356603|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356604|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2356605|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356606|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356607|NCT00516711|Sevoflurane|sevoflurane|mesh-list
2356608|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2356609|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2356610|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
2356611|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
2356612|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2356613|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356614|NCT00516750|Doxorubicin|doxorubicin|mesh-list
2356615|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2356616|NCT00516750|Methotrexate|methotrexate|mesh-list
2356617|NCT00516750|Vinblastine|vinblastine|mesh-list
2356618|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356619|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2356620|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2356621|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2356622|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356623|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356624|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2356625|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
2356626|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2356627|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356628|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2356629|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
2356630|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
2356631|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2356632|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356633|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
2356634|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2356635|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2356636|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2356637|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
2356638|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
2356639|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
2356640|NCT00516802|Olaparib|olaparib|mesh-list
2356641|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2356642|NCT00516802|Dacarbazine|dacarbazine|mesh-list
2356643|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356644|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356645|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356646|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2356647|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
2356648|NCT00516828|Cytarabine|cytarabine|mesh-list
2356649|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2356650|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
2356651|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356652|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356653|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
2356654|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356655|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356656|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
2356657|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356658|NCT00516841|Volociximab|volociximab|mesh-list
2356659|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2356660|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2356661|NCT00516841|Growth Substances|growth substances|mesh-ancestor
2356662|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356663|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
2356664|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356665|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
2356666|NCT00516854|Clidinium|clidinium|mesh-list
2356667|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2356668|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2356669|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2356670|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356671|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2356672|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2356673|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2356674|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
2356675|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
2356676|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356677|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356678|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
2356679|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
2356680|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2356681|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
2356682|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2356683|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356684|NCT00516945|Lamivudine|lamivudine|mesh-list
2356685|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2356686|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2356687|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356688|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356689|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
2356690|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356691|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2356692|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2356693|NCT00516958|Levofloxacin|levofloxacin|mesh-list
2356694|NCT00516958|Ofloxacin|ofloxacin|mesh-list
2356695|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2356696|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2356697|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356698|NCT00516958|Renal Agents|renal agents|mesh-ancestor
2356699|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2356700|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2356701|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2356702|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356703|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356704|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356705|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2356706|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2356707|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
2356708|NCT00516971|Esomeprazole|esomeprazole|mesh-list
2356709|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2356710|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2356711|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2356712|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356713|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356714|NCT00517049|Rituximab|rituximab|mesh-list
2356715|NCT00517049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2356716|NCT00517049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356717|NCT00517049|Immunologic Factors|immunologic factors|mesh-ancestor
2356718|NCT00517049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356719|NCT00517049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2356720|NCT00517062|Hormones|hormones|mesh-list
2356721|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2356722|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356723|NCT00517114|Rabeprazole|rabeprazole|mesh-list
2356724|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2356725|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2356726|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2356727|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356728|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356729|NCT00517153|Miglustat|miglustat|mesh-list
2356730|NCT00517153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356731|NCT00517153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356732|NCT00517153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2356733|NCT00517153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2356734|NCT00517153|Antiviral Agents|antiviral agents|mesh-ancestor
2356735|NCT00517153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356736|NCT00517153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2356737|NCT00517153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2356738|NCT00517153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356739|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2356740|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
2356741|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2356742|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2356743|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356744|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356745|NCT00517179|Urological Agents|urological agents|mesh-ancestor
2356746|NCT00517218|Oblimersen|oblimersen|mesh-list
2356747|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356748|NCT00517257|Atorvastatin|atorvastatin|mesh-list
2356749|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2356750|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2356751|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
2356752|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356753|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2356754|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2356755|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356756|NCT00517270|Rabeprazole|rabeprazole|mesh-list
2356757|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2356758|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2356759|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2356760|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356761|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356762|NCT00517283|Exenatide|exenatide|mesh-list
2356763|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2356764|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356765|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2356766|NCT00517283|Incretins|incretins|mesh-ancestor
2356767|NCT00517283|Hormones|hormones|mesh-ancestor
2356768|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2356769|NCT00517309|Vaccines|vaccines|mesh-list
2356770|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
2356771|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356772|NCT00517322|Ramipril|ramipril|mesh-list
2356773|NCT00517322|Irbesartan|irbesartan|mesh-list
2356774|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2356775|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
2356776|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356777|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356778|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2356779|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2356780|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2356781|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2356782|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
2356783|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2356784|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2356785|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2356786|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2356787|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356788|NCT00517426|Acetazolamide|acetazolamide|mesh-list
2356789|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
2356790|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2356791|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356792|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356793|NCT00517426|Diuretics|diuretics|mesh-ancestor
2356794|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
2356795|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356796|NCT00517439|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2356797|NCT00517439|Interferon-alpha|interferon-alpha|mesh-list
2356798|NCT00517439|Antiviral Agents|antiviral agents|mesh-ancestor
2356799|NCT00517439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356800|NCT00517439|Immunologic Factors|immunologic factors|mesh-ancestor
2356801|NCT00517439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356802|NCT00517491|Lanreotide|lanreotide|mesh-list
2356803|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356804|NCT00517504|Methylphenidate|methylphenidate|mesh-list
2356805|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2356806|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356807|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2356808|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2356809|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2356810|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356811|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
2356812|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356813|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
2356814|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
2356815|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
2356816|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356817|NCT00517582|Icatibant|icatibant|mesh-list
2356818|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2356819|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2356820|NCT00517582|Analgesics|analgesics|mesh-ancestor
2356821|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
2356822|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2356823|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356824|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2356825|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2356826|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
2356827|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
2356828|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356829|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2356830|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356831|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
2356832|NCT00517621|Paclitaxel|paclitaxel|mesh-list
2356833|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2356834|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356835|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
2356836|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
2356837|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
2356838|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356839|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
2356840|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356841|NCT00517725|Carvedilol|carvedilol|mesh-list
2356842|NCT00517725|Nebivolol|nebivolol|mesh-list
2356843|NCT00517725|Bisoprolol|bisoprolol|mesh-list
2356844|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2356845|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2356846|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
2356847|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356848|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356849|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356850|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2356851|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
2356852|NCT00517725|Protective Agents|protective agents|mesh-ancestor
2356853|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2356854|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2356855|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2356856|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
2356857|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2356858|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2356859|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2356860|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2356861|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2356862|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
2356863|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
2356864|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2356865|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2356866|NCT00517764|Citalopram|citalopram|mesh-list
2356867|NCT00517764|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2356868|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2356869|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2356870|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356871|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356872|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
2356873|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356874|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2356875|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
2356876|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2356877|NCT00517803|Micronutrients|micronutrients|mesh-list
2356878|NCT00517803|Trace Elements|trace elements|mesh-list
2356879|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356880|NCT00517946|Cetirizine|cetirizine|mesh-list
2356881|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
2356882|NCT00517946|Ephedrine|ephedrine|mesh-list
2356883|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2356884|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2356885|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2356886|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
2356887|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
2356888|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356889|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356890|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356891|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2356892|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
2356893|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2356894|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2356895|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
2356896|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
2356897|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2356898|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2356899|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
2356900|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
2356901|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2356902|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2356903|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2356904|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2356905|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356906|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356907|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356908|NCT00517985|Analgesics|analgesics|mesh-ancestor
2356909|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
2356910|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2356911|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
2356912|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2356913|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
2356914|NCT00518102|Becaplermin|becaplermin|mesh-list
2356915|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
2356916|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2356917|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2356918|NCT00518102|Growth Substances|growth substances|mesh-ancestor
2356919|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356920|NCT00518141|Aspirin|aspirin|mesh-list
2356921|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
2356922|NCT00518141|Salicylates|salicylates|mesh-list
2356923|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356924|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
2356925|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
2356926|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
2356927|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2356928|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2356929|NCT00518141|Analgesics|analgesics|mesh-ancestor
2356930|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
2356931|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2356932|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356933|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2356934|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2356935|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2356936|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356937|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356938|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2356939|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2356940|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2356941|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
2356942|NCT00518193|Cetuximab|cetuximab|mesh-list
2356943|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2356944|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356945|NCT00518232|Methylphenidate|methylphenidate|mesh-list
2356946|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2356947|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356948|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2356949|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2356950|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2356951|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356952|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
2356953|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2356954|NCT00518245|Enoxaparin|enoxaparin|mesh-list
2356955|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
2356956|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2356957|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2356958|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356959|NCT00518271|Sirolimus|sirolimus|mesh-list
2356960|NCT00518271|Tacrolimus|tacrolimus|mesh-list
2356961|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356962|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
2356963|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356964|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2356965|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356966|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356967|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2356968|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356969|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2356970|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2356971|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
2356972|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
2356973|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2356974|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2356975|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2356976|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
2356977|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356978|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2356979|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2356980|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356981|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356982|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2356983|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2356984|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
2356985|NCT00518375|Cyclosporine|cyclosporine|mesh-list
2356986|NCT00518375|Sirolimus|sirolimus|mesh-list
2356987|NCT00518375|Cyclosporins|cyclosporins|mesh-list
2356988|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2356989|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2356990|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2356991|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
2356992|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2356993|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
2356994|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2356995|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
2356996|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2356997|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2356998|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2356999|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2357000|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357001|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
2357002|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2357003|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357004|NCT00518466|Topiramate|topiramate|mesh-list
2357005|NCT00518466|Phentermine|phentermine|mesh-list
2357006|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
2357007|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2357008|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357009|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2357010|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
2357011|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2357012|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
2357013|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
2357014|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357015|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
2357016|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357017|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357018|NCT00518479|Amlodipine|amlodipine|mesh-list
2357019|NCT00518479|Valsartan|valsartan|mesh-list
2357020|NCT00518479|Moxonidine|moxonidine|mesh-list
2357021|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
2357022|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2357023|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2357024|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2357025|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357026|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2357027|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357028|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
2357029|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2357030|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2357031|NCT00518479|Diuretics|diuretics|mesh-ancestor
2357032|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
2357033|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2357034|NCT00518570|Levetiracetam|levetiracetam|mesh-list
2357035|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
2357036|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
2357037|NCT00518583|Paclitaxel|paclitaxel|mesh-list
2357038|NCT00518583|Doxorubicin|doxorubicin|mesh-list
2357039|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2357040|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2357041|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357042|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
2357043|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
2357044|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
2357045|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357046|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2357047|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2357048|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2357049|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357050|NCT00518635|Insulin|insulin|mesh-list
2357051|NCT00518635|Hormones|hormones|mesh-list
2357052|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2357053|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357054|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2357055|NCT00518895|Dacarbazine|dacarbazine|mesh-list
2357056|NCT00518895|Oblimersen|oblimersen|mesh-list
2357057|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2357058|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
2357059|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357060|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357061|NCT00518908|Sevoflurane|sevoflurane|mesh-list
2357062|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2357063|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2357064|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
2357065|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
2357066|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357067|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357068|NCT00518947|Verapamil|verapamil|mesh-list
2357069|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
2357070|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
2357071|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2357072|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357073|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357074|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
2357075|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2357076|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357077|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357078|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2357079|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2357080|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2357081|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2357082|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
2357083|NCT00519012|Sertraline|sertraline|mesh-list
2357084|NCT00519012|Paroxetine|paroxetine|mesh-list
2357085|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
2357086|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2357087|NCT00519012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2357088|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2357089|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2357090|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357091|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357092|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
2357093|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357094|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2357095|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2357096|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2357097|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357098|NCT00519051|Fluoxetine|fluoxetine|mesh-list
2357099|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
2357100|NCT00519051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2357101|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2357102|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2357103|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357104|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357105|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
2357106|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357107|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2357108|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2357109|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2357110|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2357111|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357112|NCT00519116|Sirolimus|sirolimus|mesh-list
2357113|NCT00519116|Tacrolimus|tacrolimus|mesh-list
2357114|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2357115|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
2357116|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357117|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2357118|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357119|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357120|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2357121|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2357122|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2357123|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357124|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
2357125|NCT00519142|Mitiglinide|mitiglinide|mesh-list
2357126|NCT00519142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2357127|NCT00519142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357128|NCT00519181|Valproic Acid|valproic acid|mesh-list
2357129|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
2357130|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357131|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357132|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
2357133|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357134|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357135|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
2357136|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2357137|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357138|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2357139|NCT00519207|Lidocaine|lidocaine|mesh-list
2357140|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
2357141|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
2357142|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357143|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357144|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
2357145|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357146|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2357147|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2357148|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2357149|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2357150|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357151|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2357152|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
2357153|NCT00519246|Narcotics|narcotics|mesh-ancestor
2357154|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357155|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357156|NCT00519246|Analgesics|analgesics|mesh-ancestor
2357157|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
2357158|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357159|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2357160|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2357161|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2357162|NCT00519259|Lobeline|lobeline|mesh-list
2357163|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2357164|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
2357165|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357166|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357167|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2357168|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2357169|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
2357170|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357171|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357172|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
2357173|NCT00519298|Donepezil|donepezil|mesh-list
2357174|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2357175|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357176|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357177|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
2357178|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357179|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357180|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
2357181|NCT00519324|Everolimus|everolimus|mesh-list
2357182|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357183|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2357184|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
2357185|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357186|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
2357187|NCT00519337|Vitamins|vitamins|mesh-ancestor
2357188|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
2357189|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357190|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
2357191|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357192|NCT00519337|Protective Agents|protective agents|mesh-ancestor
2357193|NCT00519363|Atorvastatin|atorvastatin|mesh-list
2357194|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2357195|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2357196|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
2357197|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357198|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2357199|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2357200|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357201|NCT00519467|Artesunate|artesunate|mesh-list
2357202|NCT00519467|Dapsone|dapsone|mesh-list
2357203|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
2357204|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
2357205|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2357206|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2357207|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2357208|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357209|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
2357210|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
2357211|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2357212|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
2357213|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2357214|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357215|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357216|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
2357217|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2357218|NCT00519480|Metformin|metformin|mesh-list
2357219|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2357220|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357221|NCT00519519|Omeprazole|omeprazole|mesh-list
2357222|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2357223|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2357224|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2357225|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357226|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357227|NCT00519675|Alitretinoin|alitretinoin|mesh-list
2357228|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357229|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
2357230|NCT00519688|Thalidomide|thalidomide|mesh-list
2357231|NCT00519688|Tegafur|tegafur|mesh-list
2357232|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2357233|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
2357234|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357235|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
2357236|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2357237|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2357238|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2357239|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2357240|NCT00519688|Growth Substances|growth substances|mesh-ancestor
2357241|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
2357242|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357243|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2357244|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
2357245|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357246|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
2357247|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357248|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
2357249|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357250|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357251|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2357252|NCT00519753|Timolol|timolol|mesh-list
2357253|NCT00519753|Travoprost|travoprost|mesh-list
2357254|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2357255|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2357256|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2357257|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2357258|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
2357259|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357260|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357261|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357262|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2357263|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2357264|NCT00519805|Dalteparin|dalteparin|mesh-list
2357265|NCT00519805|Tinzaparin|tinzaparin|mesh-list
2357266|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2357267|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
2357268|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2357269|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2357270|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357271|NCT00519857|Tibolone|tibolone|mesh-list
2357272|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
2357273|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
2357274|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2357275|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357276|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2357277|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2357278|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357279|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2357280|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
2357281|NCT00519857|Hormones|hormones|mesh-ancestor
2357282|NCT00519870|Losartan|losartan|mesh-list
2357283|NCT00519870|Nifedipine|nifedipine|mesh-list
2357284|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2357285|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2357286|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2357287|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2357288|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357289|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2357290|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2357291|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2357292|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357293|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
2357294|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
2357295|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2357296|NCT00519909|Calcium|calcium|mesh-list
2357297|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2357298|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357299|NCT00519987|Ketamine|ketamine|mesh-list
2357300|NCT00519987|Analgesics|analgesics|mesh-ancestor
2357301|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
2357302|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357303|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357304|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2357305|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2357306|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
2357307|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
2357308|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357309|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2357310|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2357311|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357312|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357313|NCT00520000|Carboplatin|carboplatin|mesh-list
2357314|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2357315|NCT00520000|Paclitaxel|paclitaxel|mesh-list
2357316|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357317|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2357318|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
2357319|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
2357320|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
2357321|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357322|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
2357323|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
2357324|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2357325|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357326|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357327|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
2357328|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2357329|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357330|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357331|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
2357332|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2357333|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357334|NCT00520091|Celecoxib|celecoxib|mesh-list
2112212|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
2112213|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2112214|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112215|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2112216|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2112217|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
2112218|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
2112219|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
2112220|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2112221|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
2112222|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112223|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112224|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2112225|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
2112226|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
2112227|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2112228|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
2357335|NCT00520091|Irinotecan|irinotecan|mesh-list
2357336|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357337|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2357338|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2357339|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357340|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357341|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2357342|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2357343|NCT00520091|Analgesics|analgesics|mesh-ancestor
2357344|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
2357345|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357346|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357347|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2357348|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2357349|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2357350|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2357351|NCT00520104|Ketamine|ketamine|mesh-list
2357352|NCT00520104|Analgesics|analgesics|mesh-ancestor
2357353|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
2357354|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357355|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357356|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2357357|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2357358|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
2357359|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
2112229|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112230|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112231|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2112232|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2112233|NCT02566369|Trifarotene|trifarotene|mesh-list
2112234|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
2112235|NCT02566889|Infliximab|infliximab|mesh-list
2112236|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
2112237|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2112238|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2112239|NCT02566902|Albuterol|albuterol|mesh-list
2112240|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2112241|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
2112242|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112243|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357360|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357361|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2357362|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2112244|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2357363|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357364|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357365|NCT00520169|Ketamine|ketamine|mesh-list
2357366|NCT00520169|Analgesics|analgesics|mesh-ancestor
2357367|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
2357368|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357369|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357370|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2357371|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2357372|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
2357373|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
2357374|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357375|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2357376|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2357377|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357378|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357379|NCT00520247|Folic Acid|folic acid|mesh-list
2357380|NCT00520247|Enalapril|enalapril|mesh-list
2357381|NCT00520247|Hematinics|hematinics|mesh-ancestor
2357382|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
2357383|NCT00520247|Vitamins|vitamins|mesh-ancestor
2357384|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
2357385|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357386|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2357387|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
2357388|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357389|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357390|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2357391|NCT00520260|Ketorolac|ketorolac|mesh-list
2357392|NCT00520260|Bromfenac|bromfenac|mesh-list
2357393|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2357394|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2357395|NCT00520260|Analgesics|analgesics|mesh-ancestor
2357396|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
2357397|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357398|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357399|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2357400|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2357401|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2357402|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357403|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357404|NCT00520325|Lectins|lectins|mesh-list
2357405|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
2357406|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
2357407|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357408|NCT00520325|Coagulants|coagulants|mesh-ancestor
2357409|NCT00520338|Celecoxib|celecoxib|mesh-list
2357410|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2357411|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2357412|NCT00520338|Analgesics|analgesics|mesh-ancestor
2357413|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
2357414|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357415|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357416|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2357417|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2357418|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2357419|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2357420|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357421|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357422|NCT00520442|Ibuprofen|ibuprofen|mesh-list
2357423|NCT00520442|Codeine|codeine|mesh-list
2357424|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2357425|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2357426|NCT00520442|Analgesics|analgesics|mesh-ancestor
2357427|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
2357428|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112245|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
2112246|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
2112247|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2112248|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2112249|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2112250|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2112251|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
2112252|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112253|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112254|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
2112255|NCT02566993|Doxorubicin|doxorubicin|mesh-list
2112256|NCT02566993|Vincristine|vincristine|mesh-list
2112257|NCT02566993|Topotecan|topotecan|mesh-list
2112258|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2112259|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
2112260|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112261|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2112262|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2112263|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
2357429|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357430|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2357431|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2357432|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2357433|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357434|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357435|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2357436|NCT00520442|Narcotics|narcotics|mesh-ancestor
2357437|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357438|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
2357439|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
2357440|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
2357441|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2357442|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
2357443|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2357444|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357445|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2357446|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2357447|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2357448|NCT00520507|Olanzapine|olanzapine|mesh-list
2357449|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
2357450|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
2357451|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357452|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357453|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2357454|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2357455|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2357456|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357457|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2357458|NCT00520507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2357459|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2357460|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2357461|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357462|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357463|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
2357464|NCT00520585|Atorvastatin|atorvastatin|mesh-list
2357465|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2357466|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2357467|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
2357468|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357469|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2357470|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2357471|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357472|NCT00520650|Aripiprazole|aripiprazole|mesh-list
2357473|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
2357474|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2357475|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2357476|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2357477|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357478|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357479|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
2357480|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
2357481|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357482|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357483|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2357484|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2357485|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
2357486|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2357487|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2357488|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2357489|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2357490|NCT00520754|Levocetirizine|levocetirizine|mesh-list
2357491|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2357492|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2357493|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
2357494|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
2357495|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357496|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357497|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357498|NCT00520806|Methocarbamol|methocarbamol|mesh-list
2357499|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2357500|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357501|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2357502|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357503|NCT00520819|Antioxidants|antioxidants|mesh-list
2357504|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112264|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112265|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112266|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2112267|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2112268|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2112269|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2112270|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112271|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2357505|NCT00520819|Protective Agents|protective agents|mesh-ancestor
2357506|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357507|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
2357508|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2357509|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2357510|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
2357511|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2357512|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2357513|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2357514|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357515|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357516|NCT00520923|Olanzapine|olanzapine|mesh-list
2357517|NCT00520923|Antiemetics|antiemetics|mesh-ancestor
2357518|NCT00520923|Autonomic Agents|autonomic agents|mesh-ancestor
2357519|NCT00520923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357520|NCT00520923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357521|NCT00520923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2357522|NCT00520923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2357523|NCT00520923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2357524|NCT00520923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357525|NCT00520923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2357526|NCT00520923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2357527|NCT00520923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2357528|NCT00520923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2357529|NCT00520923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357530|NCT00520923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357531|NCT00520923|Serotonin Agents|serotonin agents|mesh-ancestor
2357532|NCT00520949|Amoxicillin|amoxicillin|mesh-list
2357533|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2357534|NCT00520949|Furazolidone|furazolidone|mesh-list
2357535|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
2357536|NCT00520949|Esomeprazole|esomeprazole|mesh-list
2357537|NCT00520949|Bismuth|bismuth|mesh-list
2357538|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2357539|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2357540|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2357541|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2357542|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2357543|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357544|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357545|NCT00520949|Antacids|antacids|mesh-ancestor
2357546|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2357547|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2357548|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2357549|NCT00520949|Renal Agents|renal agents|mesh-ancestor
2357550|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2357551|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2357552|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2357553|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2357554|NCT00521040|Levocetirizine|levocetirizine|mesh-list
2357555|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2357556|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2357557|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
2357558|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
2357559|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357560|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357561|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357562|NCT00521092|Sunitinib|sunitinib|mesh-list
2357563|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357564|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2357565|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2357566|NCT00521092|Growth Substances|growth substances|mesh-ancestor
2357567|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357568|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
2357569|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2357570|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357571|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357572|NCT00521131|Levocetirizine|levocetirizine|mesh-list
2357573|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2357574|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2357575|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
2357576|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
2357577|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357578|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357579|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357580|NCT00521157|Naltrexone|naltrexone|mesh-list
2357581|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2357582|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2357583|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357584|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
2357585|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357586|NCT00521170|Levocetirizine|levocetirizine|mesh-list
2357587|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2357588|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2357589|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
2357590|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
2357591|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357592|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357593|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357594|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
2357595|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
2357596|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357597|NCT00521222|Fluticasone|fluticasone|mesh-list
2357598|NCT00521222|Xhance|xhance|mesh-list
2357599|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2357600|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2357601|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2357602|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2357603|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
2357604|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357605|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357606|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2357607|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
2357608|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
2357609|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2357610|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2357611|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2357612|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2357613|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
2357614|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357615|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357616|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
2357617|NCT00521222|Hormones|hormones|mesh-ancestor
2357618|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2357619|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
2357620|NCT00521248|Morphine|morphine|mesh-list
2357621|NCT00521248|Buprenorphine|buprenorphine|mesh-list
2357622|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2357623|NCT00521248|Narcotics|narcotics|mesh-ancestor
2357624|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357625|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357626|NCT00521248|Analgesics|analgesics|mesh-ancestor
2357627|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
2357628|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357629|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2357630|NCT00521261|Antibodies|antibodies|mesh-list
2357631|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2357632|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
2357633|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357634|NCT00521274|Docetaxel|docetaxel|mesh-list
2357635|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357636|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
2357637|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
2357638|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
2357639|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357640|NCT00521300|Octreotide|octreotide|mesh-list
2357641|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2357642|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2357643|NCT00521300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357644|NCT00521430|Cyclosporine|cyclosporine|mesh-list
2357645|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
2357646|NCT00521430|Methotrexate|methotrexate|mesh-list
2357647|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
2112272|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
2112273|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
2112274|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
2112275|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2112276|NCT02567552|Progesterone|progesterone|mesh-list
2112277|NCT02567552|Progestins|progestins|mesh-ancestor
2112278|NCT02567552|Hormones|hormones|mesh-ancestor
2112279|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112280|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112281|NCT02567656|Tenalisib|tenalisib|mesh-list
2112282|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
2112283|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112284|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112285|NCT02567708|Nemiralisib|nemiralisib|mesh-list
2112286|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2112287|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114050|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357648|NCT00521430|Fludarabine|fludarabine|mesh-list
2357649|NCT00521430|Busulfan|busulfan|mesh-list
2357650|NCT00521430|Cyclosporins|cyclosporins|mesh-list
2357651|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2357652|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2357653|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
2357654|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2357655|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357656|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2357657|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
2357658|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357659|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357660|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
2357661|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357662|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2357663|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2357664|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
2357665|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2357666|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2357667|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
2357668|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2357669|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2357670|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2357671|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
2357672|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
2357673|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357674|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2357675|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
2357676|NCT00521430|Hormones|hormones|mesh-ancestor
2357677|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2357678|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2357679|NCT00521430|Protective Agents|protective agents|mesh-ancestor
2357680|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
2357681|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2357682|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2357683|NCT00521482|Thalidomide|thalidomide|mesh-list
2357684|NCT00521482|Temozolomide|temozolomide|mesh-list
2357685|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2357686|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
2357687|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357688|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357689|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2357690|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
2357691|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357692|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
2357693|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2357694|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2357695|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2357696|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2357697|NCT00521482|Growth Substances|growth substances|mesh-ancestor
2357698|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
2357699|NCT00521521|Docetaxel|docetaxel|mesh-list
2357700|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357701|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
2357702|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
2357703|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
2357704|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357705|NCT00521612|Sevoflurane|sevoflurane|mesh-list
2357706|NCT00521612|Isoflurane|isoflurane|mesh-list
2357707|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2357708|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2357709|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
2357710|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
2357711|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357712|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357713|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
2357714|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2357715|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357716|NCT00521703|Lidocaine|lidocaine|mesh-list
2357717|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
2357718|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
2357719|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357720|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357721|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
2357722|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357723|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2357724|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2357725|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2357726|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2357727|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357728|NCT00521742|Pioglitazone|pioglitazone|mesh-list
2357729|NCT00521742|Glyburide|glyburide|mesh-list
2357730|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2357731|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357732|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2357733|NCT00521781|Leuprolide|leuprolide|mesh-list
2357734|NCT00521781|Bicalutamide|bicalutamide|mesh-list
2357735|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
2357736|NCT00521781|Androgens|androgens|mesh-list
2357737|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357738|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2357739|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
2357740|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2357741|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357742|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2357743|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
2357744|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2357745|NCT00521781|Hormones|hormones|mesh-ancestor
2357746|NCT00521820|Pioglitazone|pioglitazone|mesh-list
2112288|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112289|NCT02567968|Caffeine|caffeine|mesh-list
2112290|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
2112291|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112292|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2112293|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357747|NCT00521820|Glyburide|glyburide|mesh-list
2357748|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2112294|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2112295|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112296|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2112297|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2112298|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
2357749|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357762|NCT00521859|Vidarabine|vidarabine|mesh-list
2357763|NCT00521859|Fludarabine|fludarabine|mesh-list
2357764|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
2357765|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357766|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2357767|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
2357768|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357769|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2357770|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
2357771|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357772|NCT00521859|Antiviral Agents|antiviral agents|mesh-ancestor
2357773|NCT00521859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2357774|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
2357775|NCT00521950|Azathioprine|azathioprine|mesh-list
2357776|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
2357777|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357778|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2357779|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357780|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2357781|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
2357782|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357783|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2357784|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357785|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2357786|NCT00521963|Infliximab|infliximab|mesh-list
2357787|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
2357788|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2357789|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2357790|NCT00522015|Rivastigmine|rivastigmine|mesh-list
2357791|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2357792|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357793|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357794|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
2357795|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357796|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357797|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2357798|NCT00522015|Protective Agents|protective agents|mesh-ancestor
2357799|NCT00522132|Artesunate|artesunate|mesh-list
2357800|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
2357801|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2357802|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2357803|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2357804|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357805|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
2357806|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
2357807|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2357808|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
2357809|NCT00522145|XL647|xl647|mesh-list
2357810|NCT00522145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357811|NCT00522145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2357812|NCT00522145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357813|NCT00522145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357814|NCT00522158|Atorvastatin|atorvastatin|mesh-list
2357815|NCT00522158|Simvastatin|simvastatin|mesh-list
2357816|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2357817|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2357818|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
2357819|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357820|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2357821|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2357822|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357823|NCT00522184|Etanercept|etanercept|mesh-list
2357824|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2357825|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2357826|NCT00522184|Analgesics|analgesics|mesh-ancestor
2357827|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
2357828|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357829|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357830|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2357831|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2357832|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2357833|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2357834|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
2357835|NCT00522210|Insulin|insulin|mesh-list
2357836|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
2357837|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2357838|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357839|NCT00522249|Interferons|interferons|mesh-list
2357840|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2357841|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
2357842|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2357843|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2357844|NCT00522249|Sunitinib|sunitinib|mesh-list
2357845|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357846|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
2357847|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2357848|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2357849|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357850|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357851|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2357852|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2357853|NCT00522249|Growth Substances|growth substances|mesh-ancestor
2357854|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357855|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
2357856|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
2357857|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
2357858|NCT00522444|Analgesics|analgesics|mesh-ancestor
2357859|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
2357860|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357861|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357862|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
2357863|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357864|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2357865|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
2357866|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2357867|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2357868|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357869|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2357870|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
2357871|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2357872|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
2357873|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2357874|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357875|NCT00522509|Floxuridine|floxuridine|mesh-list
2357876|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2357877|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
2357878|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357879|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357880|NCT00522587|Remifentanil|remifentanil|mesh-list
2357881|NCT00522587|Sevoflurane|sevoflurane|mesh-list
2357882|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2357883|NCT00522587|Narcotics|narcotics|mesh-ancestor
2357884|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357885|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357886|NCT00522587|Analgesics|analgesics|mesh-ancestor
2357887|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
2357888|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357889|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2357890|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2357891|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
2357892|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
2357893|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
2357894|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
2357895|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357896|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
2357897|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2357898|NCT00522665|Irinotecan|irinotecan|mesh-list
2357899|NCT00522665|Cetuximab|cetuximab|mesh-list
2357900|NCT00522665|Everolimus|everolimus|mesh-list
2357901|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2357902|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2357903|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357904|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357905|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357906|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2357907|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2357908|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
2357909|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357910|NCT00522743|Hormones|hormones|mesh-list
2357911|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2357912|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357913|NCT00522782|Budesonide|budesonide|mesh-list
2357914|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
2357915|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2357916|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2357917|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
2357918|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357919|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357920|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2357921|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
2357922|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
2357923|NCT00522782|Hormones|hormones|mesh-ancestor
2357924|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2357925|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2357926|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
2357927|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357928|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357929|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2357930|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
2357931|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
2357932|NCT00522782|Protective Agents|protective agents|mesh-ancestor
2357933|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2357934|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
2357935|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2357936|NCT00522821|Antibodies|antibodies|mesh-list
2357937|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
2357938|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2357939|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2357940|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
2357941|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357942|NCT00522834|Paclitaxel|paclitaxel|mesh-list
2357943|NCT00522834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2357944|NCT00522834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357945|NCT00522834|Tubulin Modulators|tubulin modulators|mesh-ancestor
2357946|NCT00522834|Antimitotic Agents|antimitotic agents|mesh-ancestor
2357947|NCT00522834|Mitosis Modulators|mitosis modulators|mesh-ancestor
2357948|NCT00522834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357949|NCT00522886|Cetuximab|cetuximab|mesh-list
2357950|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2357951|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357952|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2357953|NCT00522938|Tosedostat|tosedostat|mesh-list
2357954|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357955|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2357956|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357957|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357958|NCT00523042|Insulin|insulin|mesh-list
2357959|NCT00523042|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2357960|NCT00523042|Insulin Aspart|insulin aspart|mesh-list
2357961|NCT00523042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2357962|NCT00523042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357963|NCT00523055|Lidocaine|lidocaine|mesh-list
2357964|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
2357965|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
2357966|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2357967|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357968|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
2357969|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357970|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2357971|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2357972|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2357973|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2357974|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357975|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2357976|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2357977|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2357978|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
2357979|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2357980|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357981|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357982|NCT00523068|Urological Agents|urological agents|mesh-ancestor
2357983|NCT00523120|Diclofenac|diclofenac|mesh-list
2357984|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2357985|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2357986|NCT00523120|Analgesics|analgesics|mesh-ancestor
2357987|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
2112299|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112300|NCT02568046|Leucovorin|leucovorin|mesh-list
2112301|NCT02568046|Fluorouracil|fluorouracil|mesh-list
2112302|NCT02568046|Irinotecan|irinotecan|mesh-list
2112303|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
2112304|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112305|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2112306|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2357988|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2357989|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357990|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2357991|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2357992|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2357993|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2357994|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2357995|NCT00523133|Naltrexone|naltrexone|mesh-list
2357996|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2357997|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2357998|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2357999|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
2358000|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358001|NCT00523159|Sargramostim|sargramostim|mesh-list
2358002|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
2358003|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358004|NCT00523185|Diazepam|diazepam|mesh-list
2358005|NCT00523185|Lorazepam|lorazepam|mesh-list
2358006|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
2358007|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
2358008|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
2358009|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112307|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358010|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358011|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2358012|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2358013|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2358014|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2358015|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2358016|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2358017|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
2358018|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
2358019|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358020|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358021|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2358022|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2358023|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2358024|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2358025|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
2358026|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
2358027|NCT00523250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2358028|NCT00523250|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2358029|NCT00523263|Heparin|heparin|mesh-list
2358030|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
2358031|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2358032|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2358033|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358034|NCT00523289|Bupivacaine|bupivacaine|mesh-list
2358035|NCT00523289|Ropivacaine|ropivacaine|mesh-list
2358036|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
2358037|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
2358038|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2358039|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358040|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
2358041|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358042|NCT00523354|Infliximab|infliximab|mesh-list
2358043|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
2358044|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2358045|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358046|NCT00523380|Doxorubicin|doxorubicin|mesh-list
2358047|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2358048|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2358049|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358050|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2358051|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2358052|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358053|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358054|NCT00523393|Insulin|insulin|mesh-list
2358055|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2358056|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2358057|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358058|NCT00523406|Triamcinolone|triamcinolone|mesh-list
2358059|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2358060|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
2358061|NCT00523406|Hormones|hormones|mesh-ancestor
2112308|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
2112309|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112310|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2112311|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2112312|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112313|NCT02568046|Antidotes|antidotes|mesh-ancestor
2112314|NCT02568046|Protective Agents|protective agents|mesh-ancestor
2112315|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
2112316|NCT02568046|Vitamins|vitamins|mesh-ancestor
2112317|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
2358062|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2358063|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358064|NCT00523432|Sirolimus|sirolimus|mesh-list
2358065|NCT00523432|Topotecan|topotecan|mesh-list
2358066|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2358067|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2112318|NCT02568397|Dabigatran|dabigatran|mesh-list
2112319|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
2112320|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2112321|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
2112322|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112323|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112324|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
2112325|NCT02568644|Ketoprofen|ketoprofen|mesh-list
2358068|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358069|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358070|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358071|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2358072|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358073|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2358074|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
2358075|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358076|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
2358077|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358078|NCT00523445|Varenicline|varenicline|mesh-list
2358079|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2358080|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2358081|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
2358082|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112326|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2112327|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2112328|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2112329|NCT02568644|Analgesics|analgesics|mesh-ancestor
2112330|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
2112331|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112332|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112333|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2112334|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2112335|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112336|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112337|NCT02568683|Vincristine|vincristine|mesh-list
2358083|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358084|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358085|NCT00523458|Efavirenz|efavirenz|mesh-list
2358086|NCT00523458|Nevirapine|nevirapine|mesh-list
2358087|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2358088|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2358089|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112338|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2112339|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112340|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
2112341|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
2112342|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
2112343|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358090|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358091|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
2358092|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358093|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2358094|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2358095|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2358096|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2358097|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2358098|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2358099|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2358100|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2358101|NCT00523666|Galantamine|galantamine|mesh-list
2358102|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2358103|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358104|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358105|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
2358106|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358107|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358108|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2358109|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
2358110|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358111|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
2358112|NCT00523692|Etanercept|etanercept|mesh-list
2358113|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2358114|NCT00523692|Methotrexate|methotrexate|mesh-list
2358115|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2358116|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
2358117|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2358118|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358119|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2358120|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
2358121|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358122|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358123|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
2358124|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358125|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2358126|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358127|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
2358128|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358129|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2358130|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2358131|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2358132|NCT00523692|Analgesics|analgesics|mesh-ancestor
2358133|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
2358134|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358135|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2358136|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2358137|NCT00523757|Spironolactone|spironolactone|mesh-list
2358138|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2358139|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
2358140|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2358141|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358142|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2358143|NCT00523757|Diuretics|diuretics|mesh-ancestor
2358144|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
2358145|NCT00523887|Fentanyl|fentanyl|mesh-list
2358146|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2358147|NCT00523887|Narcotics|narcotics|mesh-ancestor
2358148|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2358149|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358150|NCT00523887|Analgesics|analgesics|mesh-ancestor
2358151|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
2358152|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358153|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2358154|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2358155|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
2358156|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
2358157|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
2358158|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2358159|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358160|NCT00523926|Bedaquiline|bedaquiline|mesh-list
2358161|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
2358162|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2358163|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358164|NCT00523952|Tacrolimus|tacrolimus|mesh-list
2358165|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358166|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
2358167|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358168|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2358169|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358170|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358171|NCT00523965|Amphotericin B|amphotericin b|mesh-list
2358172|NCT00523965|Paromomycin|paromomycin|mesh-list
2358173|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2358174|NCT00523965|Miltefosine|miltefosine|mesh-list
2358175|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
2358176|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
2358177|NCT00523965|Amebicides|amebicides|mesh-ancestor
2358178|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2358179|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2358180|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358181|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2358182|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
2358183|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358184|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2358185|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2358186|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
2358187|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
2358188|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358189|NCT00524069|Gemcitabine|gemcitabine|mesh-list
2358190|NCT00524069|Bevacizumab|bevacizumab|mesh-list
2358191|NCT00524069|Capecitabine|capecitabine|mesh-list
2358192|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2358193|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358194|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2358195|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2358196|NCT00524069|Growth Substances|growth substances|mesh-ancestor
2358197|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358198|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
2358199|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2358200|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
2358201|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358202|NCT00524069|Antiviral Agents|antiviral agents|mesh-ancestor
2358203|NCT00524069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358204|NCT00524069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358205|NCT00524069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358206|NCT00524069|Immunologic Factors|immunologic factors|mesh-ancestor
2358207|NCT00524095|Fluticasone|fluticasone|mesh-list
2358208|NCT00524095|Xhance|xhance|mesh-list
2358209|NCT00524095|Azithromycin|azithromycin|mesh-list
2358210|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2358211|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2358212|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
2358213|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358214|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358215|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2358216|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
2358217|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
2358218|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2358219|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2358220|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358221|NCT00524160|Fentanyl|fentanyl|mesh-list
2358222|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2358223|NCT00524160|Narcotics|narcotics|mesh-ancestor
2358224|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2358225|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358226|NCT00524160|Analgesics|analgesics|mesh-ancestor
2358227|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
2358228|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358229|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2358230|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2358231|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
2358232|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
2358233|NCT00524186|Leucovorin|leucovorin|mesh-list
2358234|NCT00524186|Fluorouracil|fluorouracil|mesh-list
2358235|NCT00524186|Irinotecan|irinotecan|mesh-list
2358236|NCT00524186|Sunitinib|sunitinib|mesh-list
2358237|NCT00524186|Calcium|calcium|mesh-list
2358238|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
2112344|NCT02568852|Anesthetics|anesthetics|mesh-list
2112345|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2112346|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112347|NCT02569437|Fluticasone|fluticasone|mesh-list
2112348|NCT02569437|Doxycycline|doxycycline|mesh-list
2112349|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
2112350|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2112351|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2112352|NCT02569437|Prednisolone|prednisolone|mesh-list
2358239|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2358240|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358241|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
2358242|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358243|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2358244|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358245|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358246|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
2358247|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2358248|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2358249|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358250|NCT00524186|Antidotes|antidotes|mesh-ancestor
2358251|NCT00524186|Protective Agents|protective agents|mesh-ancestor
2358252|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
2358253|NCT00524186|Vitamins|vitamins|mesh-ancestor
2358254|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
2358255|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2358256|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2112353|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
2358257|NCT00524186|Growth Substances|growth substances|mesh-ancestor
2358258|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
2358259|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2358260|NCT00524199|Mesna|mesna|mesh-list
2358261|NCT00524199|Protective Agents|protective agents|mesh-ancestor
2358262|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358263|NCT00524251|Esomeprazole|esomeprazole|mesh-list
2358264|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2358265|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2358266|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2358267|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358268|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358269|NCT00524277|Molgramostim|molgramostim|mesh-list
2358270|NCT00524277|Vaccines|vaccines|mesh-list
2358271|NCT00524277|Sargramostim|sargramostim|mesh-list
2358272|NCT00524277|Immunologic Factors|immunologic factors|mesh-ancestor
2358273|NCT00524277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358274|NCT00524277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358275|NCT00524381|Etanercept|etanercept|mesh-list
2358276|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2358277|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2358278|NCT00524381|Analgesics|analgesics|mesh-ancestor
2358279|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
2358280|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358281|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358282|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2358283|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358284|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2358285|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358286|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
2358287|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
2358288|NCT00524407|Hematinics|hematinics|mesh-ancestor
2358289|NCT00524433|Tezosentan|tezosentan|mesh-list
2358290|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
2358291|NCT00524498|Cisplatin|cisplatin|mesh-list
2358292|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358293|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
2358294|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358295|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2358296|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2358297|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358298|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358299|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
2358300|NCT00524615|Spironolactone|spironolactone|mesh-list
2358301|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2358302|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
2358303|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2358304|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358305|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2358306|NCT00524615|Diuretics|diuretics|mesh-ancestor
2358307|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
2358308|NCT00524667|Fludarabine|fludarabine|mesh-list
2358309|NCT00524667|Valproic Acid|valproic acid|mesh-list
2358310|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358311|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358312|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358313|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
2358314|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358315|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
2358316|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358317|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
2358318|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2358319|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2358320|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2358321|NCT00524693|Montelukast|montelukast|mesh-list
2358322|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2358323|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
2358324|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2358325|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
2358326|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2358327|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358328|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2358329|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2358330|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358331|NCT00524706|Leucovorin|leucovorin|mesh-list
2358332|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
2358333|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358334|NCT00524706|Antidotes|antidotes|mesh-ancestor
2358335|NCT00524706|Protective Agents|protective agents|mesh-ancestor
2358336|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358337|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
2358338|NCT00524706|Vitamins|vitamins|mesh-ancestor
2358339|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
2358340|NCT00524810|Docetaxel|docetaxel|mesh-list
2358341|NCT00524810|Doxorubicin|doxorubicin|mesh-list
2358342|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2358343|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358344|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
2358345|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
2358346|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
2358347|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358348|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2358349|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2358350|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2358351|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358352|NCT00524836|Levocetirizine|levocetirizine|mesh-list
2358353|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2358354|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2358355|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
2358356|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
2358357|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358358|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358359|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358360|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
2358361|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2358362|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358363|NCT00524875|Bevacizumab|bevacizumab|mesh-list
2358364|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2358365|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358366|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2358367|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2358368|NCT00524875|Growth Substances|growth substances|mesh-ancestor
2358369|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358370|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
2358371|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
2358372|NCT00524901|Hematinics|hematinics|mesh-ancestor
2358373|NCT00524914|Apomorphine|apomorphine|mesh-list
2358374|NCT00524914|Emetics|emetics|mesh-ancestor
2358375|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358376|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
2358377|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358378|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2358379|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
2358380|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
2358381|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358382|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358383|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
2358384|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2358385|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
2358386|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
2358387|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2358388|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358389|NCT00524966|Hemostatics|hemostatics|mesh-list
2358390|NCT00524966|Coagulants|coagulants|mesh-ancestor
2358391|NCT00525005|Docetaxel|docetaxel|mesh-list
2358392|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
2358393|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358394|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
2358395|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
2358396|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
2358397|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358398|NCT00525096|Celecoxib|celecoxib|mesh-list
2358399|NCT00525096|Exemestane|exemestane|mesh-list
2358400|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2358401|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2358402|NCT00525096|Analgesics|analgesics|mesh-ancestor
2358403|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
2358404|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358405|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358406|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2358407|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358408|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2358409|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2358410|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358411|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358412|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358413|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2358414|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2358415|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2358416|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
2358417|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2358418|NCT00525200|Docetaxel|docetaxel|mesh-list
2358419|NCT00525200|Cisplatin|cisplatin|mesh-list
2358420|NCT00525200|Fluorouracil|fluorouracil|mesh-list
2358421|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358422|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
2358423|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
2358424|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
2358425|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358426|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
2358427|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2358428|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358429|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
2358430|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358431|NCT00525239|Ritonavir|ritonavir|mesh-list
2358432|NCT00525239|Lopinavir|lopinavir|mesh-list
2358433|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2358434|NCT00525239|Efavirenz|efavirenz|mesh-list
2358435|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2358436|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2358437|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
2358438|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358439|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358440|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2358441|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2358442|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
2358443|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358444|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2358445|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2358446|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2358447|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2358448|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2358449|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2358450|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2358451|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2358452|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2358453|NCT00525252|Baclofen|baclofen|mesh-list
2358454|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2112354|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2112355|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
2112356|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2112357|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
2112358|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
2112359|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112360|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112361|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2112362|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
2112363|NCT02569437|Hormones|hormones|mesh-ancestor
2112364|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112365|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2112366|NCT02569437|Protective Agents|protective agents|mesh-ancestor
2358455|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358456|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2358457|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358458|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2358459|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
2358460|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
2358461|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358462|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358463|NCT00525278|Levocetirizine|levocetirizine|mesh-list
2358464|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2358465|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2358466|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
2358467|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
2358468|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358469|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358470|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358471|NCT00525330|Metformin|metformin|mesh-list
2358472|NCT00525330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2358473|NCT00525330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358474|NCT00525382|Levocetirizine|levocetirizine|mesh-list
2358475|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2358476|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2358477|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
2358478|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
2358479|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358480|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358481|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358482|NCT00525408|Docetaxel|docetaxel|mesh-list
2358483|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358484|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
2358485|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
2358486|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
2358487|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358488|NCT00525447|Dexamethasone|dexamethasone|mesh-list
2358489|NCT00525447|Lenalidomide|lenalidomide|mesh-list
2358490|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
2358491|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2358492|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
2358493|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
2358494|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358495|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358496|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2358497|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
2358498|NCT00525447|Hormones|hormones|mesh-ancestor
2358499|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2358500|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2358501|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358502|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
2358503|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2358504|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2358505|NCT00525447|Growth Substances|growth substances|mesh-ancestor
2358506|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
2358507|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2358508|NCT00525473|Azathioprine|azathioprine|mesh-list
2358509|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
2358510|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358511|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2358512|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358513|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358514|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
2358515|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358516|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358517|NCT00525486|Nifedipine|nifedipine|mesh-list
2358518|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2358519|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2358520|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358521|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2358522|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358523|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
2358524|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
2358525|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2358526|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
2358527|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2358528|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
2358529|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358530|NCT00525551|Expectorants|expectorants|mesh-ancestor
2358531|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
2358532|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2358533|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
2358534|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358535|NCT00525551|Protective Agents|protective agents|mesh-ancestor
2358536|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358537|NCT00525551|Antidotes|antidotes|mesh-ancestor
2358538|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2358539|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2358540|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
2358541|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358542|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358543|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2358544|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
2358545|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2358546|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2358547|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2112367|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2112368|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112369|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2112370|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112371|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
2112372|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2112373|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2112374|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2112375|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2112376|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
2112377|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
2112378|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2112379|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
2112380|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
2112381|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2112382|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112383|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2112384|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112385|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112386|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
2112387|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2112388|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112389|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2112390|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112391|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112392|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
2112393|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2112394|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2112395|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112396|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
2358548|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
2358549|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358550|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358551|NCT00525577|Probucol|probucol|mesh-list
2358552|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2358553|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2358554|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
2358555|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358556|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2358557|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
2358558|NCT00525577|Protective Agents|protective agents|mesh-ancestor
2358559|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358560|NCT00525616|Rituximab|rituximab|mesh-list
2358561|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2358562|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358563|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
2358564|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358565|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358566|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
2358567|NCT00525642|Docetaxel|docetaxel|mesh-list
2358568|NCT00525642|Doxorubicin|doxorubicin|mesh-list
2358569|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2358570|NCT00525642|Epirubicin|epirubicin|mesh-list
2358571|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358572|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
2358573|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358574|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358575|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2358576|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
2358577|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358578|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358579|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2358580|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
2358581|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
2358582|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
2358583|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2358584|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2358585|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2358586|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358587|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2358588|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
2358589|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358590|NCT00525668|Protective Agents|protective agents|mesh-ancestor
2358591|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358592|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2358593|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2358594|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358595|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2358596|NCT00525681|Cyclosporine|cyclosporine|mesh-list
2358597|NCT00525681|Tacrolimus|tacrolimus|mesh-list
2358598|NCT00525681|Cyclosporins|cyclosporins|mesh-list
2358599|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358600|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
2358601|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358602|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2358603|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358604|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358605|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
2358606|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358607|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
2358608|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358609|NCT00525694|Cocaine|cocaine|mesh-list
2358610|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
2358611|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
2358612|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2358613|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358614|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
2358615|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358616|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2358617|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2358618|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2358619|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2358620|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358621|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
2358622|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358623|NCT00525707|Tezosentan|tezosentan|mesh-list
2358624|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
2358625|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
2358626|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
2358627|NCT00525759|Docetaxel|docetaxel|mesh-list
2358628|NCT00525759|Fluorouracil|fluorouracil|mesh-list
2358629|NCT00525759|Epirubicin|epirubicin|mesh-list
2358630|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358631|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
2358632|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358633|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358634|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2358635|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
2358636|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358637|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358638|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2358639|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
2358640|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
2358641|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
2358642|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
2358643|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2358644|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2358645|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2358646|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2358647|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358648|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2358649|NCT00525772|Ciclesonide|ciclesonide|mesh-list
2358650|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
2358651|NCT00525772|Hormones|hormones|mesh-ancestor
2358652|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2358653|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358654|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2358655|NCT00525889|Sirolimus|sirolimus|mesh-list
2358656|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2358657|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358658|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2358659|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358660|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
2358661|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358662|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
2358663|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358664|NCT00525928|Varenicline|varenicline|mesh-list
2358665|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2358666|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2358667|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
2358668|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358669|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112397|NCT02569658|Coagulants|coagulants|mesh-ancestor
2112398|NCT02569710|Simeprevir|simeprevir|mesh-list
2112399|NCT02569710|Odalasvir|odalasvir|mesh-list
2112400|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
2112401|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112402|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
2112403|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112404|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112405|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
2112406|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112407|NCT02569801|Fulvestrant|fulvestrant|mesh-list
2112408|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2112409|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112410|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2112411|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2112412|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
2112413|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112414|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112415|NCT02569996|Rituximab|rituximab|mesh-list
2112416|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2112417|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112418|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
2358670|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358671|NCT00525941|Indiplon|indiplon|mesh-list
2358672|NCT00525941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2358673|NCT00525941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2358674|NCT00525941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358675|NCT00525941|GABA Modulators|gaba modulators|mesh-ancestor
2358676|NCT00525941|GABA Agents|gaba agents|mesh-ancestor
2358677|NCT00525941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358678|NCT00525941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358679|NCT00525967|Acetaminophen|acetaminophen|mesh-list
2358680|NCT00525967|Methadone|methadone|mesh-list
2358681|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2358682|NCT00525967|Analgesics|analgesics|mesh-ancestor
2358683|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
2358684|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358685|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358686|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
2358687|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2358688|NCT00525967|Narcotics|narcotics|mesh-ancestor
2358689|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2358690|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
2358691|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
2358692|NCT00525993|Etoricoxib|etoricoxib|mesh-list
2358693|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2358694|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2358695|NCT00525993|Analgesics|analgesics|mesh-ancestor
2358696|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
2358697|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358698|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358699|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2358700|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358701|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2358702|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2358703|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358704|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358705|NCT00526006|Esomeprazole|esomeprazole|mesh-list
2358706|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2358707|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2358708|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2358709|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358710|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358711|NCT00526175|Cytarabine|cytarabine|mesh-list
2358712|NCT00526175|Prednisone|prednisone|mesh-list
2358713|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
2358714|NCT00526175|Methotrexate|methotrexate|mesh-list
2358715|NCT00526175|Vincristine|vincristine|mesh-list
2358716|NCT00526175|Daunorubicin|daunorubicin|mesh-list
2358717|NCT00526175|Asparaginase|asparaginase|mesh-list
2358718|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
2358719|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358720|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
2358721|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358722|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358723|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2358724|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
2358725|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358726|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358727|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2358728|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2358729|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
2358730|NCT00526175|Hormones|hormones|mesh-ancestor
2358731|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2358732|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2358733|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2358734|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
2358735|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2358736|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2358737|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
2358738|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
2358739|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358740|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2358741|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2358742|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2358743|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
2358744|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
2358745|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
2358746|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
2358747|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358748|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2358749|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2358750|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2358751|NCT00526214|Celecoxib|celecoxib|mesh-list
2358752|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2358753|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2358754|NCT00526214|Analgesics|analgesics|mesh-ancestor
2358755|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
2358756|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358757|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358758|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2358759|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358760|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2358761|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2358762|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358763|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358764|NCT00526305|Cytarabine|cytarabine|mesh-list
2358765|NCT00526305|Dexamethasone|dexamethasone|mesh-list
2358766|NCT00526305|Prednisone|prednisone|mesh-list
2358767|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
2358768|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
2358769|NCT00526305|Vincristine|vincristine|mesh-list
2358770|NCT00526305|Daunorubicin|daunorubicin|mesh-list
2358771|NCT00526305|Asparaginase|asparaginase|mesh-list
2358772|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
2358773|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
2358774|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358775|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
2358776|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358777|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358778|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2358779|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
2358780|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358781|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358782|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2358783|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2358784|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
2358785|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
2358786|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358787|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2358788|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
2358789|NCT00526305|Hormones|hormones|mesh-ancestor
2358790|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2358791|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2358792|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2358793|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
2358794|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
2358795|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
2358796|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2358797|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
2358798|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
2358799|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358800|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2358801|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2358802|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2358803|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358804|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2358805|NCT00526305|Analgesics|analgesics|mesh-ancestor
2358806|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
2358807|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
2358808|NCT00526318|Melphalan|melphalan|mesh-list
2358809|NCT00526318|Ifosfamide|ifosfamide|mesh-list
2358810|NCT00526318|Dacarbazine|dacarbazine|mesh-list
2358811|NCT00526318|Carboplatin|carboplatin|mesh-list
2358812|NCT00526318|Doxorubicin|doxorubicin|mesh-list
2358813|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2358814|NCT00526318|Etoposide|etoposide|mesh-list
2358815|NCT00526318|Vincristine|vincristine|mesh-list
2358816|NCT00526318|Topotecan|topotecan|mesh-list
2358817|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
2358818|NCT00526318|Vindesine|vindesine|mesh-list
2358819|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2358820|NCT00526318|Isotretinoin|isotretinoin|mesh-list
2358821|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358822|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
2358823|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358824|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358825|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2358826|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
2358827|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358828|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358829|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2358830|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2358831|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2358832|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2358833|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358834|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2358835|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
2358836|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
2358837|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
2358838|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2358839|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
2358840|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2358841|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
2358842|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
2358843|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2358844|NCT00526396|Cisplatin|cisplatin|mesh-list
2358845|NCT00526396|Etoposide|etoposide|mesh-list
2358846|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
2358847|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358848|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2358849|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2358850|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2358851|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358852|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358853|NCT00526409|Cytarabine|cytarabine|mesh-list
2358854|NCT00526409|Prednisolone|prednisolone|mesh-list
2358855|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
2358856|NCT00526409|Methotrexate|methotrexate|mesh-list
2358857|NCT00526409|Vincristine|vincristine|mesh-list
2358858|NCT00526409|Daunorubicin|daunorubicin|mesh-list
2358859|NCT00526409|Asparaginase|asparaginase|mesh-list
2358860|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358861|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
2358862|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358863|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2358864|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2358865|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
2358866|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358867|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358868|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2358869|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2358870|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
2358871|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2358872|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2358873|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
2358874|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
2358875|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358876|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2358877|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2358878|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2358879|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
2358880|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
2358881|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
2358882|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2358883|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
2358884|NCT00526409|Hormones|hormones|mesh-ancestor
2358885|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2358886|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2358887|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
2358888|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358889|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2358890|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2358891|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2358892|NCT00526448|Ribavirin|ribavirin|mesh-list
2358893|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2358894|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
2358895|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358896|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
2358897|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358898|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
2358899|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2358900|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358901|NCT00526617|Temozolomide|temozolomide|mesh-list
2358902|NCT00526617|Veliparib|veliparib|mesh-list
2358903|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2358904|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
2358905|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358906|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358907|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2358908|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358909|NCT00526643|Gemcitabine|gemcitabine|mesh-list
2358910|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358911|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2358912|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
2358913|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358914|NCT00526643|Antiviral Agents|antiviral agents|mesh-ancestor
2358915|NCT00526643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2358916|NCT00526643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2358917|NCT00526643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358918|NCT00526643|Immunologic Factors|immunologic factors|mesh-ancestor
2358919|NCT00526643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358920|NCT00526695|Sevoflurane|sevoflurane|mesh-list
2358921|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2358922|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2358923|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
2358924|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
2358925|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2358926|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358927|NCT00526734|Melphalan|melphalan|mesh-list
2358928|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
2358929|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358930|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2358931|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
2358932|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358933|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2358934|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2358935|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2358936|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
2358937|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2358938|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2358939|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358940|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2358941|NCT00526760|Analgesics|analgesics|mesh-ancestor
2358942|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
2358943|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358944|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2358945|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2358946|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2358947|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
2358948|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358949|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358950|NCT00526877|Risperidone|risperidone|mesh-list
2358951|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2358952|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
2358953|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358954|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358955|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358956|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2358957|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2358958|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2358959|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2358960|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2358961|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
2358962|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
2358963|NCT00526929|Hematinics|hematinics|mesh-ancestor
2358964|NCT00527020|Nicotine|nicotine|mesh-list
2358965|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2358966|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
2358967|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2358968|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358969|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2358970|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2358971|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
2358972|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358973|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358974|NCT00527033|Mirabegron|mirabegron|mesh-list
2358975|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2358976|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2358977|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2358978|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
2358979|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358980|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358981|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358982|NCT00527033|Urological Agents|urological agents|mesh-ancestor
2358983|NCT00527059|Simendan|simendan|mesh-list
2358984|NCT00527059|Spironolactone|spironolactone|mesh-list
2358985|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2358986|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2358987|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
2358988|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2358989|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2358990|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2358991|NCT00527059|Diuretics|diuretics|mesh-ancestor
2358992|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
2358993|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2358994|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
2358995|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2358996|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2358997|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2358998|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
2358999|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2359000|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2359001|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359002|NCT00527059|Protective Agents|protective agents|mesh-ancestor
2359003|NCT00527085|Cinacalcet|cinacalcet|mesh-list
2359004|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2359005|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359006|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2359007|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
2359008|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2359009|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
2359010|NCT00527137|Hematinics|hematinics|mesh-ancestor
2359011|NCT00527150|Varenicline|varenicline|mesh-list
2359012|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2359013|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2359014|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
2359015|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359016|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359017|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359018|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
2359019|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2359020|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2359021|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2359022|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2359023|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359024|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
2359025|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359026|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359027|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2359028|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359029|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
2359030|NCT00527215|Hematinics|hematinics|mesh-ancestor
2359031|NCT00527228|Deflazacort|deflazacort|mesh-list
2359032|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2359033|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2359034|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
2359035|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359036|NCT00527267|Cinacalcet|cinacalcet|mesh-list
2359037|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2359038|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359039|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2359040|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
2359041|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2359042|NCT00527449|Carboplatin|carboplatin|mesh-list
2359043|NCT00527449|Docetaxel|docetaxel|mesh-list
2359044|NCT00527449|Epirubicin|epirubicin|mesh-list
2359045|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359046|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
2359047|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
2359048|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
2359049|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359050|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2359051|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2359052|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2359053|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359054|NCT00527501|Travoprost|travoprost|mesh-list
2359055|NCT00527501|Brinzolamide|brinzolamide|mesh-list
2359056|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2359057|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2359058|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359059|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359060|NCT00527540|Interferons|interferons|mesh-list
2359061|NCT00527540|Ribavirin|ribavirin|mesh-list
2359062|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
2359063|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
2359064|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2359065|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359066|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
2359067|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359068|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
2359069|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359070|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
2359071|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359072|NCT00527657|Thalidomide|thalidomide|mesh-list
2359073|NCT00527657|Temozolomide|temozolomide|mesh-list
2359074|NCT00527657|Lomustine|lomustine|mesh-list
2359075|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2359076|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
2359077|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359078|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359079|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2359080|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
2359081|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359082|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
2359083|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2359084|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359085|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2359086|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2359087|NCT00527657|Growth Substances|growth substances|mesh-ancestor
2359088|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
2359089|NCT00527683|Vigabatrin|vigabatrin|mesh-list
2359090|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
2359091|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359092|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359093|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
2359094|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359095|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359096|NCT00527761|Cisplatin|cisplatin|mesh-list
2359097|NCT00527761|Docetaxel|docetaxel|mesh-list
2359098|NCT00527761|Temozolomide|temozolomide|mesh-list
2359099|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359100|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
2359101|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
2359102|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
2359103|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359104|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2359105|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
2359106|NCT00527800|Lumefantrine|lumefantrine|mesh-list
2359107|NCT00527800|Artemether|artemether|mesh-list
2359108|NCT00527800|Piperaquine|piperaquine|mesh-list
2359109|NCT00527800|Trimethoprim|trimethoprim|mesh-list
2359110|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2359111|NCT00527800|Artenimol|artenimol|mesh-list
2359112|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2359113|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
2359114|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
2359115|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2359116|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2359117|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359118|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2359119|NCT00527800|Renal Agents|renal agents|mesh-ancestor
2359120|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2359121|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359122|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359123|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2359124|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2359125|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2359126|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2359127|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
2359128|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359129|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
2359130|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
2359131|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2359132|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2359133|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359134|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359135|NCT00527995|Urological Agents|urological agents|mesh-ancestor
2359136|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
2359137|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2359138|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
2359139|NCT00528008|Povidone|povidone|mesh-list
2359140|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2359141|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359142|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
2359143|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
2359144|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
2359145|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
2359146|NCT00528060|Ritonavir|ritonavir|mesh-list
2359147|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2359148|NCT00528060|Tenofovir|tenofovir|mesh-list
2359149|NCT00528060|Emtricitabine|emtricitabine|mesh-list
2359150|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2359151|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2359152|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
2359153|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359154|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359155|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2359156|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2359157|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
2359158|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359159|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2359160|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2359161|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2359162|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2359163|NCT00528073|Rifaximin|rifaximin|mesh-list
2359164|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2359165|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359166|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2359167|NCT00528151|Curcumin|curcumin|mesh-list
2359168|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2359169|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2359170|NCT00528151|Analgesics|analgesics|mesh-ancestor
2359171|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
2359172|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359173|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359174|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2359175|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2359176|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359177|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359178|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359179|NCT00528177|Morphine|morphine|mesh-list
2359180|NCT00528177|Oxycodone|oxycodone|mesh-list
2359181|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2359182|NCT00528177|Narcotics|narcotics|mesh-ancestor
2359183|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2359184|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359185|NCT00528177|Analgesics|analgesics|mesh-ancestor
2359186|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
2359187|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359188|NCT00528216|Capsaicin|capsaicin|mesh-list
2359189|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
2359190|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
2359191|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
2359192|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359193|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359194|NCT00528255|Misoprostol|misoprostol|mesh-list
2359195|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2359196|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
2359197|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2359198|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359199|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2359200|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2359201|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
2359202|NCT00528281|Pemetrexed|pemetrexed|mesh-list
2359203|NCT00528281|Lapatinib|lapatinib|mesh-list
2359204|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359205|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359206|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359207|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2359208|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2359209|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2359210|NCT00528333|Cytarabine|cytarabine|mesh-list
2359211|NCT00528333|Lintuzumab|lintuzumab|mesh-list
2359212|NCT00528333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2359213|NCT00528333|Antimetabolites|antimetabolites|mesh-ancestor
2359214|NCT00528333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359215|NCT00528333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359216|NCT00528333|Antiviral Agents|antiviral agents|mesh-ancestor
2359217|NCT00528333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359218|NCT00528333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2359219|NCT00528333|Immunologic Factors|immunologic factors|mesh-ancestor
2359220|NCT00528333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359221|NCT00528333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2359222|NCT00528359|Olanzapine|olanzapine|mesh-list
2359223|NCT00528359|Risperidone|risperidone|mesh-list
2359224|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2359225|NCT00528359|Aripiprazole|aripiprazole|mesh-list
2359226|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2359227|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
2359228|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359229|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359230|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359231|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2359232|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2359233|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2359234|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2359235|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2359236|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
2359237|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
2359238|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
2359239|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359240|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2359241|NCT00528359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2359242|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2359243|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2359244|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
2359245|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
2359246|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2359247|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2359248|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2359249|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2359250|NCT00528385|Spironolactone|spironolactone|mesh-list
2359251|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2359252|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
2359253|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2359254|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359255|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2359256|NCT00528385|Diuretics|diuretics|mesh-ancestor
2359257|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
2359258|NCT00528502|Lidocaine|lidocaine|mesh-list
2359259|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
2359260|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
2359261|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2359262|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359263|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
2359264|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359265|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2359266|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2359267|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2359268|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2359269|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359270|NCT00528515|Propofol|propofol|mesh-list
2359271|NCT00528515|Desflurane|desflurane|mesh-list
2359272|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2359273|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2359274|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359275|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2359276|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
2359277|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
2359278|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2359279|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
2359280|NCT00528593|Hematinics|hematinics|mesh-ancestor
2359281|NCT00528619|Carboplatin|carboplatin|mesh-list
2359282|NCT00528619|Pemetrexed|pemetrexed|mesh-list
2359283|NCT00528619|Sunitinib|sunitinib|mesh-list
2359284|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359285|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359286|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359287|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2359288|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2359289|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2359290|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2359291|NCT00528619|Growth Substances|growth substances|mesh-ancestor
2359292|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359293|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
2359294|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2359295|NCT00528658|Acetaminophen|acetaminophen|mesh-list
2359296|NCT00528658|Ibuprofen|ibuprofen|mesh-list
2359297|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2359298|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2359299|NCT00528658|Analgesics|analgesics|mesh-ancestor
2359300|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
2359301|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359302|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359303|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2359304|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2359305|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2359306|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359307|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359308|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
2359309|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
2359310|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
2359311|NCT00528697|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2359312|NCT00528697|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2359313|NCT00528697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2359314|NCT00528697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2359315|NCT00528697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359316|NCT00528697|Adrenergic Agents|adrenergic agents|mesh-ancestor
2359317|NCT00528697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359318|NCT00528697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359319|NCT00528723|Albuterol|albuterol|mesh-list
2359320|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2359321|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
2359322|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359323|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359324|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2359325|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
2359326|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
2359327|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2359328|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2359329|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2359330|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2359331|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
2359332|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359333|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359334|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
2359335|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2359336|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359337|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
2359338|NCT00528827|Nicardipine|nicardipine|mesh-list
2359339|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2359340|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2359341|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2359342|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359343|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2359344|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359345|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
2359346|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
2359347|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2359348|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2359349|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
2359350|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359351|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2359352|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2359353|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359354|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359355|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
2359356|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2359357|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359358|NCT00528983|Azacitidine|azacitidine|mesh-list
2359359|NCT00528983|Cc-486|cc-486|mesh-list
2359360|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2359361|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
2359362|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359363|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359364|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359365|NCT00529022|Carboplatin|carboplatin|mesh-list
2359366|NCT00529022|Azacitidine|azacitidine|mesh-list
2359367|NCT00529022|Valproic Acid|valproic acid|mesh-list
2359368|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359369|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2359370|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
2359371|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359372|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359373|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
2359374|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
2359375|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359376|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359377|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
2359378|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2359379|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2359380|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2359381|NCT00529113|Gemcitabine|gemcitabine|mesh-list
2359382|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2359383|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
2359384|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359385|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359386|NCT00529113|Antiviral Agents|antiviral agents|mesh-ancestor
2359387|NCT00529113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359388|NCT00529113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359389|NCT00529113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2359390|NCT00529113|Immunologic Factors|immunologic factors|mesh-ancestor
2359391|NCT00529113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359392|NCT00529178|Pravastatin|pravastatin|mesh-list
2359393|NCT00529178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2359394|NCT00529178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2359395|NCT00529178|Antimetabolites|antimetabolites|mesh-ancestor
2359396|NCT00529178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359397|NCT00529178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2359398|NCT00529178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2359399|NCT00529178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359400|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
2359401|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2359402|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359403|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2359404|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
2359405|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2359406|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359407|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359408|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359409|NCT00529295|Misoprostol|misoprostol|mesh-list
2359410|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2359411|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
2359412|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2359413|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359414|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2359415|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2359416|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
2359417|NCT00529360|Clofarabine|clofarabine|mesh-list
2359418|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2359419|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
2359420|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359421|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359422|NCT00529425|Ropivacaine|ropivacaine|mesh-list
2359423|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
2359424|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
2359425|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2359426|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359427|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
2359428|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359429|NCT00529503|Rituximab|rituximab|mesh-list
2359430|NCT00529503|Dacetuzumab|dacetuzumab|mesh-list
2359431|NCT00529503|Carboplatin|carboplatin|mesh-list
2359432|NCT00529503|Etoposide|etoposide|mesh-list
2359433|NCT00529503|Ifosfamide|ifosfamide|mesh-list
2359434|NCT00529503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2359435|NCT00529503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359436|NCT00529503|Immunologic Factors|immunologic factors|mesh-ancestor
2359437|NCT00529503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359438|NCT00529503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2359439|NCT00529503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2359440|NCT00529503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2359441|NCT00529503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2359442|NCT00529503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359443|NCT00529503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359444|NCT00529503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2359445|NCT00529503|Alkylating Agents|alkylating agents|mesh-ancestor
2359446|NCT00529594|Etoricoxib|etoricoxib|mesh-list
2359447|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2359448|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2359449|NCT00529594|Analgesics|analgesics|mesh-ancestor
2359450|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
2359451|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359452|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359453|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2359454|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2359455|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2359456|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2359457|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359458|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359459|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
2359460|NCT00529620|Piperaquine|piperaquine|mesh-list
2359461|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
2359462|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2359463|NCT00529620|Amodiaquine|amodiaquine|mesh-list
2359464|NCT00529620|Artenimol|artenimol|mesh-list
2359465|NCT00529620|Sulfalene|sulfalene|mesh-list
2359466|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
2359467|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2359468|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2359469|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359470|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2359471|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359472|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359473|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2359474|NCT00529620|Renal Agents|renal agents|mesh-ancestor
2359475|NCT00529646|APD791|apd791|mesh-list
2359476|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2359477|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2359478|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
2359479|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359480|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359481|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359482|NCT00529750|Atenolol|atenolol|mesh-list
2359483|NCT00529750|Irbesartan|irbesartan|mesh-list
2359484|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2359485|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2359486|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
2359487|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
2359488|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359489|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359490|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2359491|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2359492|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2359493|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
2359494|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359495|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359496|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2359497|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2359498|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
2359499|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2359500|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2359501|NCT00529867|Lumefantrine|lumefantrine|mesh-list
2359502|NCT00529867|Artemether|artemether|mesh-list
2359503|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2359504|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
2359505|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2359506|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2359507|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359508|NCT00529880|Cytarabine|cytarabine|mesh-list
2359509|NCT00529880|Fludarabine|fludarabine|mesh-list
2359510|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359511|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2359512|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
2359513|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359514|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2359515|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
2359516|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359517|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
2359518|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359519|NCT00530101|Doxorubicin|doxorubicin|mesh-list
2359520|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2359521|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359522|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2359523|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2359524|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359525|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359526|NCT00530127|Deferiprone|deferiprone|mesh-list
2359527|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2359528|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
2359529|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
2359530|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359531|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2359532|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
2359533|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359534|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2359535|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
2359536|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359537|NCT00530387|Ibuprofen|ibuprofen|mesh-list
2359538|NCT00530387|Diclofenac|diclofenac|mesh-list
2359539|NCT00530387|Ketoprofen|ketoprofen|mesh-list
2359540|NCT00530387|Piroxicam|piroxicam|mesh-list
2359541|NCT00530387|Salicylates|salicylates|mesh-list
2359542|NCT00530387|Etofenamate|etofenamate|mesh-list
2359543|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
2359544|NCT00530387|Homosalate|homosalate|mesh-list
2359545|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
2359546|NCT00530387|Benzophenone|benzophenone|mesh-list
2359547|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2359548|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2359549|NCT00530387|Analgesics|analgesics|mesh-ancestor
2359550|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
2359551|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359552|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359553|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2359554|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2359555|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2359556|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359557|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359558|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2359559|NCT00530387|Protective Agents|protective agents|mesh-ancestor
2359560|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
2359561|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2359562|NCT00530400|Cefuroxime|cefuroxime|mesh-list
2359563|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
2359564|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2359565|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359566|NCT00530413|Phenobarbital|phenobarbital|mesh-list
2359567|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
2359568|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2359569|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2359570|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359571|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2359572|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2359573|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359574|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359575|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
2359576|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
2359577|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2359578|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2359579|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2359580|NCT00530478|Donepezil|donepezil|mesh-list
2359581|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2359582|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359583|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359584|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
2359585|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359586|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359587|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
2359588|NCT00530517|Sumatriptan|sumatriptan|mesh-list
2359589|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2359590|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2359591|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2359592|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
2359593|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359594|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359595|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359596|NCT00530556|Zolpidem|zolpidem|mesh-list
2359597|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2359598|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2359599|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2359600|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359601|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2359602|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
2359603|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
2359604|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359605|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359606|NCT00530582|Progesterone|progesterone|mesh-list
2359607|NCT00530582|Progestins|progestins|mesh-ancestor
2359608|NCT00530582|Hormones|hormones|mesh-ancestor
2359609|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2359610|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359611|NCT00530595|Losartan|losartan|mesh-list
2359612|NCT00530595|Valsartan|valsartan|mesh-list
2359613|NCT00530595|Candesartan|candesartan|mesh-list
2359614|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2359615|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2359616|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2359617|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359618|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2359619|NCT00530868|Bevacizumab|bevacizumab|mesh-list
2359620|NCT00530868|Letrozole|letrozole|mesh-list
2359621|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2359622|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359623|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2359624|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2359625|NCT00530868|Growth Substances|growth substances|mesh-ancestor
2359626|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359627|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
2359628|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2359629|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2359630|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359631|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359632|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2359633|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
2359634|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2359635|NCT00530907|Bevacizumab|bevacizumab|mesh-list
2359636|NCT00530907|Valproic Acid|valproic acid|mesh-list
2359637|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2359638|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359639|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2359640|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2359641|NCT00530907|Growth Substances|growth substances|mesh-ancestor
2359642|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359643|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
2359644|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
2359645|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359646|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359647|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
2359648|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359649|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
2359650|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2359651|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2359652|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2359653|NCT00530972|Ribavirin|ribavirin|mesh-list
2359654|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2359655|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
2359656|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359657|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
2359658|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359659|NCT00531024|Bevacizumab|bevacizumab|mesh-list
2359660|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2359661|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359662|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2359663|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2359664|NCT00531024|Growth Substances|growth substances|mesh-ancestor
2359665|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359666|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
2359667|NCT00531063|Everolimus|everolimus|mesh-list
2359668|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359669|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2359670|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
2359671|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359672|NCT00531076|Bevacizumab|bevacizumab|mesh-list
2359673|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2359674|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359675|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2359676|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2359677|NCT00531076|Growth Substances|growth substances|mesh-ancestor
2359678|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359679|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
2359680|NCT00531089|Rituximab|rituximab|mesh-list
2359681|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2359682|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359683|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
2359684|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359685|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2359686|NCT00531115|Cetuximab|cetuximab|mesh-list
2359687|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2359688|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359689|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
2359690|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2359691|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
2359692|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359693|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2359694|NCT00531167|Lamivudine|lamivudine|mesh-list
2359695|NCT00531167|Adefovir|adefovir|mesh-list
2359696|NCT00531167|Entecavir|entecavir|mesh-list
2359697|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2359698|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2359699|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359700|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359701|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
2359702|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359703|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2359704|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2359705|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
2359706|NCT00531193|SCH 442416|sch 442416|mesh-list
2359707|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2359708|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2359709|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2359710|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
2359711|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359712|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359713|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359714|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
2359715|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359716|NCT00531271|Docetaxel|docetaxel|mesh-list
2359717|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359718|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
2359719|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
2359720|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
2359721|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359722|NCT00531310|Fludarabine|fludarabine|mesh-list
2359723|NCT00531310|Busulfan|busulfan|mesh-list
2359724|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359725|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359726|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2359727|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
2359728|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359729|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
2359730|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2359731|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2359732|NCT00531323|Etravirine|etravirine|mesh-list
2359733|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2359734|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2359735|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359736|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359737|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
2359738|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359739|NCT00531336|Bevacizumab|bevacizumab|mesh-list
2359740|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2359741|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359742|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2359743|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2359744|NCT00531336|Growth Substances|growth substances|mesh-ancestor
2359745|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359746|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
2359747|NCT00531349|Propofol|propofol|mesh-list
2359748|NCT00531349|Sevoflurane|sevoflurane|mesh-list
2359749|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
2359750|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2359751|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359752|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2359753|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2359754|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
2359755|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2359756|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2359757|NCT00531362|Aspirin|aspirin|mesh-list
2359758|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2359759|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2359760|NCT00531362|Analgesics|analgesics|mesh-ancestor
2359761|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
2359762|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359763|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359764|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2359765|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2359766|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2359767|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2359768|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359769|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2359770|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2359771|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359772|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
2359773|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
2359774|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359775|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359776|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359777|NCT00531440|Everolimus|everolimus|mesh-list
2359778|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359779|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2359780|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
2359781|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359782|NCT00531466|Tolperisone|tolperisone|mesh-list
2359783|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2359784|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359785|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2359786|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359787|NCT00531544|Sunitinib|sunitinib|mesh-list
2359788|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359789|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2359790|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2359791|NCT00531544|Growth Substances|growth substances|mesh-ancestor
2359792|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359793|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
2359794|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2359795|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359796|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359797|NCT00531557|Ritonavir|ritonavir|mesh-list
2359798|NCT00531557|Darunavir|darunavir|mesh-list
2359799|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2359800|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2359801|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
2359802|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359803|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359804|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2359805|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2359806|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
2359807|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359808|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2359809|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2359810|NCT00531596|Selegiline|selegiline|mesh-list
2359811|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
2359812|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2359813|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2359814|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2359815|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2359816|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359817|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359818|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2359819|NCT00531596|Protective Agents|protective agents|mesh-ancestor
2359820|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359821|NCT00531622|Citalopram|citalopram|mesh-list
2359822|NCT00531622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2359823|NCT00531622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2359824|NCT00531622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2359825|NCT00531622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359826|NCT00531622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359827|NCT00531622|Serotonin Agents|serotonin agents|mesh-ancestor
2359828|NCT00531622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359829|NCT00531622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2359830|NCT00531622|Antidepressive Agents|antidepressive agents|mesh-ancestor
2359831|NCT00531622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2359832|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
2359833|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2359834|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359835|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2359836|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
2359837|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2359838|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359839|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359840|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359841|NCT00531674|Tocopherols|tocopherols|mesh-list
2359842|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
2359843|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359844|NCT00531674|Protective Agents|protective agents|mesh-ancestor
2359845|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359846|NCT00531674|Vitamins|vitamins|mesh-ancestor
2359847|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
2359848|NCT00531687|Gemcitabine|gemcitabine|mesh-list
2359849|NCT00531687|Paclitaxel|paclitaxel|mesh-list
2359850|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2359851|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359852|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
2359853|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
2359854|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
2359855|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359856|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2359857|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
2359858|NCT00531687|Antiviral Agents|antiviral agents|mesh-ancestor
2359859|NCT00531687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359860|NCT00531687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359861|NCT00531687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2359862|NCT00531687|Immunologic Factors|immunologic factors|mesh-ancestor
2359863|NCT00531687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359864|NCT00531791|Prednisone|prednisone|mesh-list
2359865|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2359866|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
2359867|NCT00531791|Hormones|hormones|mesh-ancestor
2359868|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2359869|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359870|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2359871|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359872|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
2359873|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
2359874|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359875|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
2359876|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359877|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359878|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2359879|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2359880|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2359881|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2359882|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359883|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2359884|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359885|NCT00531895|Analgesics|analgesics|mesh-ancestor
2359886|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
2359887|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359888|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
2359889|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2359890|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
2359891|NCT00531908|Furosemide|furosemide|mesh-list
2359892|NCT00531908|Diuretics|diuretics|mesh-ancestor
2359893|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
2359894|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359895|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2359896|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2359897|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359898|NCT00531973|Doxorubicin|doxorubicin|mesh-list
2359899|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2359900|NCT00531973|Epirubicin|epirubicin|mesh-list
2359901|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2359902|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359903|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2359904|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2359905|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359906|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359907|NCT00531986|Lopinavir|lopinavir|mesh-list
2359908|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2359909|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2359910|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
2359911|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359912|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359913|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2359914|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2359915|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
2359916|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359917|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2359918|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2359919|NCT00531999|Ritonavir|ritonavir|mesh-list
2359920|NCT00531999|Lopinavir|lopinavir|mesh-list
2359921|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
2359922|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2359923|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2359924|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
2359925|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359926|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112419|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112420|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2112421|NCT02570022|Bupivacaine|bupivacaine|mesh-list
2112422|NCT02570022|Ropivacaine|ropivacaine|mesh-list
2112423|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
2112424|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
2112425|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2112426|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112427|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
2112428|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112429|NCT02570074|Fosfomycin|fosfomycin|mesh-list
2112430|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2112431|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112432|NCT02570139|Protective Agents|protective agents|mesh-list
2112433|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112434|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2112435|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2112436|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
2112437|NCT02570711|Gemcitabine|gemcitabine|mesh-list
2112438|NCT02570711|Paclitaxel|paclitaxel|mesh-list
2359927|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2359928|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2359929|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
2359930|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359931|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2359932|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2359933|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2359934|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2359935|NCT00532025|Sorafenib|sorafenib|mesh-list
2359936|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359937|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2359938|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359939|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359940|NCT00532038|Ketoprofen|ketoprofen|mesh-list
2359941|NCT00532038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2359942|NCT00532038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2359943|NCT00532038|Analgesics|analgesics|mesh-ancestor
2359944|NCT00532038|Sensory System Agents|sensory system agents|mesh-ancestor
2359945|NCT00532038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2359946|NCT00532038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359947|NCT00532038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2359948|NCT00532038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2359949|NCT00532038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2359950|NCT00532038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359951|NCT00532038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359952|NCT00532090|R04929097|r04929097|mesh-list
2359953|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359954|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359955|NCT00532116|Selegiline|selegiline|mesh-list
2359956|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
2359957|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2359958|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2359959|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2359960|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2359961|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359962|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359963|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2359964|NCT00532116|Protective Agents|protective agents|mesh-ancestor
2359965|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359966|NCT00532142|Triamcinolone|triamcinolone|mesh-list
2359967|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2359968|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
2359969|NCT00532142|Hormones|hormones|mesh-ancestor
2359970|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2359971|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2359972|NCT00532168|Ritonavir|ritonavir|mesh-list
2359973|NCT00532168|Lopinavir|lopinavir|mesh-list
2359974|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2359975|NCT00532168|Tenofovir|tenofovir|mesh-list
2359976|NCT00532168|Emtricitabine|emtricitabine|mesh-list
2359977|NCT00532168|Efavirenz|efavirenz|mesh-list
2359978|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2359979|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2359980|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
2359981|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2359982|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2359983|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2359984|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2359985|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
2359986|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2359987|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2359988|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2359989|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2359990|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2359991|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2359992|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2359993|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2359994|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2359995|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2359996|NCT00532194|Cediranib|cediranib|mesh-list
2359997|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2359998|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2359999|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360000|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360001|NCT00532207|Teriparatide|teriparatide|mesh-list
2360002|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2360003|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360004|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2360005|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
2360006|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2360007|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360008|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2360009|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2360010|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
2360011|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2360012|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360013|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2360014|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2360015|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2360016|NCT00532272|Letrozole|letrozole|mesh-list
2360017|NCT00532272|Goserelin|goserelin|mesh-list
2360018|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360019|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2360020|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2360021|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360022|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360023|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2360024|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
2360025|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2360026|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360027|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2360028|NCT00532285|Gemcitabine|gemcitabine|mesh-list
2360029|NCT00532285|Paclitaxel|paclitaxel|mesh-list
2360030|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2360031|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2360032|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360033|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
2360034|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
2360035|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
2360036|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360037|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2360038|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
2360039|NCT00532285|Antiviral Agents|antiviral agents|mesh-ancestor
2360040|NCT00532285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360041|NCT00532285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360042|NCT00532285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2360043|NCT00532285|Immunologic Factors|immunologic factors|mesh-ancestor
2360044|NCT00532285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360045|NCT00532311|Atorvastatin|atorvastatin|mesh-list
2360046|NCT00532311|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2360047|NCT00532311|Simvastatin|simvastatin|mesh-list
2360048|NCT00532311|Pravastatin|pravastatin|mesh-list
2360049|NCT00532311|Lovastatin|lovastatin|mesh-list
2360050|NCT00532311|L 647318|l 647318|mesh-list
2360051|NCT00532311|Dihydromevinolin|dihydromevinolin|mesh-list
2360052|NCT00532311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2360053|NCT00532311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2360054|NCT00532311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2360055|NCT00532311|Antimetabolites|antimetabolites|mesh-ancestor
2360056|NCT00532311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360057|NCT00532311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2360058|NCT00532311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360059|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
2360060|NCT00532324|Mupirocin|mupirocin|mesh-list
2360061|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2360062|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360063|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
2360064|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2360065|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2360066|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360067|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360068|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
2360069|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2360070|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
2360071|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360072|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360073|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2360074|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
2360075|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
2360076|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2360077|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
2360078|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360079|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360080|NCT00532389|Panobinostat|panobinostat|mesh-list
2360081|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360082|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2360083|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360084|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360085|NCT00532415|Triamcinolone|triamcinolone|mesh-list
2360086|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2360087|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2360088|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2360089|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2360090|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
2360091|NCT00532415|Hormones|hormones|mesh-ancestor
2360092|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2360093|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360094|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2360095|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
2360096|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360097|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360098|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2360099|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2360100|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
2360101|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2360102|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360103|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2360104|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2360105|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2360106|NCT00532454|Tamoxifen|tamoxifen|mesh-list
2360107|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2360108|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
2360109|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2360110|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360111|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2360112|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360113|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2360114|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2360115|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2360116|NCT00532519|Citalopram|citalopram|mesh-list
2360117|NCT00532519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2360118|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2360119|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2360120|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360121|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360122|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
2360123|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360124|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2360125|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
2360126|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2360127|NCT00532532|Tolperisone|tolperisone|mesh-list
2360128|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2360129|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360130|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2360131|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360132|NCT00532545|Teriparatide|teriparatide|mesh-list
2360133|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2360134|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360135|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2360136|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
2360137|NCT00532571|Vitamins|vitamins|mesh-ancestor
2360138|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
2360139|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360140|NCT00532584|Beclomethasone|beclomethasone|mesh-list
2360141|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2360142|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
2360143|NCT00532584|Hormones|hormones|mesh-ancestor
2360144|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2360145|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360146|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2360147|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
2360148|NCT00532623|Gemcitabine|gemcitabine|mesh-list
2360149|NCT00532623|Vinorelbine|vinorelbine|mesh-list
2360150|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2360151|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
2360152|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360153|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360154|NCT00532623|Antiviral Agents|antiviral agents|mesh-ancestor
2360155|NCT00532623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360156|NCT00532623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360157|NCT00532623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2360158|NCT00532623|Immunologic Factors|immunologic factors|mesh-ancestor
2360159|NCT00532623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360160|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2360161|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
2360162|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
2360163|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
2360164|NCT00532662|Ketamine|ketamine|mesh-list
2360165|NCT00532662|Analgesics|analgesics|mesh-ancestor
2360166|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
2360167|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360168|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360169|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2360170|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2360171|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
2360172|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
2360173|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2360174|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2360175|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2360176|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360177|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360178|NCT00532675|Lenalidomide|lenalidomide|mesh-list
2360179|NCT00532675|Panobinostat|panobinostat|mesh-list
2360180|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
2360181|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360182|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2360183|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2360184|NCT00532675|Growth Substances|growth substances|mesh-ancestor
2360185|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
2360186|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360187|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2360188|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360189|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360190|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
2360191|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2360192|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
2360193|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360194|NCT00532688|Expectorants|expectorants|mesh-ancestor
2360195|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
2360196|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2360197|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
2360198|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360199|NCT00532688|Protective Agents|protective agents|mesh-ancestor
2360200|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360201|NCT00532688|Antidotes|antidotes|mesh-ancestor
2360202|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2360203|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
2360204|NCT00532701|Ribavirin|ribavirin|mesh-list
2360205|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
2360206|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360207|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
2360208|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360209|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
2360210|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360211|NCT00532714|Capecitabine|capecitabine|mesh-list
2360212|NCT00532714|Irinotecan|irinotecan|mesh-list
2360213|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2360214|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
2360215|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360216|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360217|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2360218|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2360219|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360220|NCT00532727|Carboplatin|carboplatin|mesh-list
2360221|NCT00532727|Docetaxel|docetaxel|mesh-list
2360222|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360223|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
2360224|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
2360225|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
2360226|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360227|NCT00532818|Hydralazine|hydralazine|mesh-list
2360228|NCT00532818|Valproic Acid|valproic acid|mesh-list
2360229|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
2360230|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360231|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360232|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
2360233|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360234|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360235|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
2360236|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2360237|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2360238|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2360239|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2360240|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
2360241|NCT00532857|Gemcitabine|gemcitabine|mesh-list
2360242|NCT00532857|Paclitaxel|paclitaxel|mesh-list
2360243|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2360244|NCT00532857|Trastuzumab|trastuzumab|mesh-list
2360245|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2360246|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360247|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
2360248|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
2360249|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
2360250|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360251|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2360252|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
2360253|NCT00532857|Antiviral Agents|antiviral agents|mesh-ancestor
2360254|NCT00532857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360255|NCT00532857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360256|NCT00532857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2360257|NCT00532857|Immunologic Factors|immunologic factors|mesh-ancestor
2360258|NCT00532857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360259|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2360260|NCT00532909|Bevacizumab|bevacizumab|mesh-list
2360261|NCT00532909|Capecitabine|capecitabine|mesh-list
2360262|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
2360263|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2360264|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360265|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2360266|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2360267|NCT00532909|Growth Substances|growth substances|mesh-ancestor
2360268|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360269|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
2360270|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2360271|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
2360272|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360273|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2360274|NCT00532961|Tobramycin|tobramycin|mesh-list
2360275|NCT00532961|Dexamethasone|dexamethasone|mesh-list
2360276|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2360277|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
2360278|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
2360279|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360280|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360281|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2360282|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
2360283|NCT00532961|Hormones|hormones|mesh-ancestor
2360284|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2360285|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2360286|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360287|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2360288|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360289|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2360290|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2360291|NCT00533026|Warfarin|warfarin|mesh-list
2360292|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
2360293|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2360294|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2360295|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2360296|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360297|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360298|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360299|NCT00533026|Analgesics|analgesics|mesh-ancestor
2360300|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
2360301|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360302|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
2360303|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2360304|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
2360305|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
2360306|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2360307|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360308|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360309|NCT00533065|Donepezil|donepezil|mesh-list
2360310|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2360311|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360312|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360313|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
2360314|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360315|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360316|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
2360317|NCT00533091|Sifalimumab|sifalimumab|mesh-list
2360318|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
2360319|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360320|NCT00533169|Tretinoin|tretinoin|mesh-list
2360321|NCT00533169|Isotretinoin|isotretinoin|mesh-list
2360322|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360323|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
2360324|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
2360325|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
2360326|NCT00533195|Methoxsalen|methoxsalen|mesh-list
2360327|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2360328|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
2360329|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2360330|NCT00533247|Celecoxib|celecoxib|mesh-list
2360331|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2360332|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2360333|NCT00533247|Analgesics|analgesics|mesh-ancestor
2360334|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
2360335|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360336|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360337|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2360338|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2360339|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2360340|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2360341|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360342|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360343|NCT00533299|Hydralazine|hydralazine|mesh-list
2360344|NCT00533299|Valproic Acid|valproic acid|mesh-list
2360345|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
2360346|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360347|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360348|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
2360349|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360350|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360351|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
2360352|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2360353|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2360354|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2360355|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2360356|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
2360357|NCT00533312|Niacin|niacin|mesh-list
2360358|NCT00533312|Niacinamide|niacinamide|mesh-list
2360359|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
2360360|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2360361|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
2360362|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360363|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2360364|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
2360365|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
2360366|NCT00533312|Vitamins|vitamins|mesh-ancestor
2360367|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
2360368|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360369|NCT00533390|Efavirenz|efavirenz|mesh-list
2360370|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2360371|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2360372|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360373|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360374|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
2360375|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360376|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2360377|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2360378|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2360379|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2360380|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2360381|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2360382|NCT00533416|ON 01910|on 01910|mesh-list
2360383|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360384|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2360385|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360386|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360387|NCT00533455|Gabapentin|gabapentin|mesh-list
2360388|NCT00533455|Analgesics|analgesics|mesh-ancestor
2360389|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
2360390|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360391|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360392|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
2360393|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2360394|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2360395|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2360396|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2360397|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2360398|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2360399|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360400|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360401|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
2360402|NCT00533468|Lidocaine|lidocaine|mesh-list
2360403|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
2360404|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
2360405|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2360406|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360407|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
2360408|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360409|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2360410|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2360411|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2360412|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2360413|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360414|NCT00533520|Ranibizumab|ranibizumab|mesh-list
2360415|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2360416|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2360417|NCT00533520|Growth Substances|growth substances|mesh-ancestor
2360418|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360419|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
2360420|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360421|NCT00533533|Docetaxel|docetaxel|mesh-list
2360422|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
2360423|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360424|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
2360425|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
2360426|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
2360427|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360428|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2360429|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360430|NCT00533585|Paclitaxel|paclitaxel|mesh-list
2360431|NCT00533585|Bevacizumab|bevacizumab|mesh-list
2360432|NCT00533585|Carboplatin|carboplatin|mesh-list
2360433|NCT00533585|Sorafenib|sorafenib|mesh-list
2360434|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2360435|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360436|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
2360437|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
2360438|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
2360439|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360440|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2360441|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2360442|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2360443|NCT00533585|Growth Substances|growth substances|mesh-ancestor
2360444|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360445|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
2360446|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2360447|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360448|NCT00533611|Niacin|niacin|mesh-list
2360449|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360450|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360451|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2360452|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
2360453|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2360454|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
2360455|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
2360456|NCT00533611|Vitamins|vitamins|mesh-ancestor
2360457|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
2360458|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
2360459|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2360460|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360461|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2360462|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
2360463|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2360464|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360465|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360466|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360467|NCT00533637|Cetirizine|cetirizine|mesh-list
2360468|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2360469|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2360470|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2360471|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
2360472|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
2360473|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360474|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360475|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360476|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
2360477|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2360478|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2360479|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
2360480|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360481|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360482|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360483|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
2360484|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
2360485|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360486|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
2360487|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2360488|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
2360489|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2360490|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2360491|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
2360492|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360493|NCT00533741|Antacids|antacids|mesh-ancestor
2360494|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360495|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2360496|NCT00533858|Losartan|losartan|mesh-list
2360497|NCT00533858|Lacidipine|lacidipine|mesh-list
2360498|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2360499|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2360500|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2360501|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2360502|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360503|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2360504|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2360505|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2360506|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360507|NCT00533923|Cyclosporine|cyclosporine|mesh-list
2360508|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
2360509|NCT00533923|Fludarabine|fludarabine|mesh-list
2360510|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
2360511|NCT00533923|Cyclosporins|cyclosporins|mesh-list
2360512|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2360513|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
2360514|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360515|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2360516|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2360517|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
2360518|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360519|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360520|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2360521|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360522|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
2360523|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360524|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
2360525|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2360526|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2360527|NCT00533936|Paclitaxel|paclitaxel|mesh-list
2360528|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
2360529|NCT00533936|Doxorubicin|doxorubicin|mesh-list
2360530|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2360531|NCT00533936|Fluorouracil|fluorouracil|mesh-list
2360532|NCT00533936|Trastuzumab|trastuzumab|mesh-list
2360533|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2360534|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360535|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
2360536|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
2360537|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
2360538|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360539|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2360540|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
2360541|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360542|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2360543|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2360544|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
2360545|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2360546|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2360547|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2360548|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2112439|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
2112440|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2112441|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112442|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
2112443|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
2112444|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
2112445|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112446|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2112447|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
2112448|NCT02570711|Antiviral Agents|antiviral agents|mesh-ancestor
2360549|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360550|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
2360551|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2360552|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2360553|NCT00533962|Anecortave|anecortave|mesh-list
2360554|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2360555|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2360556|NCT00533962|Growth Substances|growth substances|mesh-ancestor
2360557|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360558|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
2360559|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360560|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
2360561|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2360562|NCT00534014|Ascorbic Acid|ascorbic acid|mesh-list
2360563|NCT00534014|Vitamins|vitamins|mesh-ancestor
2360564|NCT00534014|Micronutrients|micronutrients|mesh-ancestor
2360565|NCT00534014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360566|NCT00534014|Antioxidants|antioxidants|mesh-ancestor
2360567|NCT00534014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360568|NCT00534014|Protective Agents|protective agents|mesh-ancestor
2360569|NCT00534027|Conatumumab|conatumumab|mesh-list
2360570|NCT00534027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2360571|NCT00534027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360572|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2360573|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
2360574|NCT00534144|Hematinics|hematinics|mesh-ancestor
2360575|NCT00534183|Haloperidol|haloperidol|mesh-list
2360576|NCT00534183|Olanzapine|olanzapine|mesh-list
2360577|NCT00534183|Risperidone|risperidone|mesh-list
2360578|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
2360579|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2360580|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
2360581|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360582|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360583|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360584|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2360585|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2360586|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2360587|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2360588|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2360589|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
2360590|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
2360591|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
2360592|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360593|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2360594|NCT00534183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2360595|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2360596|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2360597|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2360598|NCT00534261|Interferons|interferons|mesh-list
2360599|NCT00534261|Interferon-beta|interferon-beta|mesh-list
2360600|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
2360601|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360602|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
2360603|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360604|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
2360605|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360606|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2360607|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
2360608|NCT00534287|Meropenem|meropenem|mesh-list
2360609|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2360610|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2360611|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360612|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2360613|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2360614|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360615|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360616|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360617|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2360618|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
2360619|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2360620|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360621|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2360622|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2360623|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2360624|NCT00534378|Midazolam|midazolam|mesh-list
2360625|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2360626|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2360627|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2360628|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360629|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2360630|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2360631|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2360632|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2360633|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
2360634|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
2360635|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
2360636|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
2360637|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360638|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360639|NCT00534391|Polymyxins|polymyxins|mesh-list
2360640|NCT00534391|Neomycin|neomycin|mesh-list
2360641|NCT00534391|Polymyxin B|polymyxin b|mesh-list
2360642|NCT00534391|Gramicidin|gramicidin|mesh-list
2360643|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
2360644|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2360645|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2360646|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2360647|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360648|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2360649|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360650|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360651|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2360652|NCT00534430|Cyclosporine|cyclosporine|mesh-list
2360653|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
2360654|NCT00534430|Etoposide|etoposide|mesh-list
2360655|NCT00534430|Busulfan|busulfan|mesh-list
2360656|NCT00534430|Cyclosporins|cyclosporins|mesh-list
2360657|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2360658|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360659|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2360660|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2360661|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360662|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360663|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2360664|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
2360665|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360666|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
2360667|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360668|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
2360669|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2360670|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2360671|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2360672|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2360673|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
2360674|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2360675|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
2360676|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2360677|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2360678|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
2360679|NCT00534456|Hematinics|hematinics|mesh-ancestor
2360680|NCT00534469|Cytarabine|cytarabine|mesh-list
2360681|NCT00534469|Aldesleukin|aldesleukin|mesh-list
2360682|NCT00534469|Etoposide|etoposide|mesh-list
2360683|NCT00534469|Idarubicin|idarubicin|mesh-list
2360684|NCT00534469|Busulfan|busulfan|mesh-list
2360685|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2360686|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360687|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2360688|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2360689|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360690|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360691|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
2360692|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360693|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2360694|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
2360695|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
2360696|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360697|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2360698|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
2360699|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2360700|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2360701|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2360702|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2360703|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2360704|NCT00534508|Tacrolimus|tacrolimus|mesh-list
2360705|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2360706|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
2360707|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360708|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2360709|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360710|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360711|NCT00534573|Amisulpride|amisulpride|mesh-list
2360712|NCT00534573|Moclobemide|moclobemide|mesh-list
2360713|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2360714|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2360715|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2360716|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360717|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2360718|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2360719|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
2360720|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360721|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360722|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2360723|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
2360724|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2360725|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360726|NCT00534586|Ketamine|ketamine|mesh-list
2360727|NCT00534586|Remifentanil|remifentanil|mesh-list
2360728|NCT00534586|Propofol|propofol|mesh-list
2360729|NCT00534586|Sevoflurane|sevoflurane|mesh-list
2360730|NCT00534586|Esketamine|esketamine|mesh-list
2360731|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2360732|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2360733|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360734|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2360735|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
2360736|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
2360737|NCT00534586|Analgesics|analgesics|mesh-ancestor
2360738|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
2360739|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360740|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2360741|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2360742|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2360743|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360744|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360745|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2360746|NCT00534586|Narcotics|narcotics|mesh-ancestor
2360747|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2360748|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2360749|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
2360750|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2360751|NCT00534625|Zileuton|zileuton|mesh-list
2360752|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
2360753|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2360754|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2360755|NCT00534625|Analgesics|analgesics|mesh-ancestor
2360756|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
2360757|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360758|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360759|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2360760|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2360761|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2360762|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360763|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360764|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2360765|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
2360766|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2360767|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360768|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
2360769|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2360770|NCT00534651|Acetaminophen|acetaminophen|mesh-list
2360771|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2360772|NCT00534651|Analgesics|analgesics|mesh-ancestor
2360773|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
2360774|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360775|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360776|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
2360777|NCT00534677|Octreotide|octreotide|mesh-list
2360778|NCT00534677|Terlipressin|terlipressin|mesh-list
2360779|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2360780|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2360781|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360782|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2360783|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2360784|NCT00534729|Carboplatin|carboplatin|mesh-list
2360785|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360786|NCT00534807|Rifampin|rifampin|mesh-list
2360787|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2360788|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
2360789|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2360790|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360791|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
2360792|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2360793|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360794|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360795|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2360796|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2360797|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2360798|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2360799|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2360800|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2360801|NCT00534846|Toremifene|toremifene|mesh-list
2360802|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2360803|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360804|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2360805|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2360806|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
2360807|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2360808|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360809|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2360810|NCT00534898|Fenretinide|fenretinide|mesh-list
2360811|NCT00534898|Bexarotene|bexarotene|mesh-list
2360812|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360813|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2360814|NCT00534898|Protective Agents|protective agents|mesh-ancestor
2360815|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360816|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2360817|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2360818|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2360819|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
2360820|NCT00535119|Paclitaxel|paclitaxel|mesh-list
2360821|NCT00535119|Carboplatin|carboplatin|mesh-list
2360822|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2360823|NCT00535119|Veliparib|veliparib|mesh-list
2360824|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2360825|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360826|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
2360827|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
2360828|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
2360829|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360830|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2360831|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360832|NCT00535158|Vitamin D|vitamin d|mesh-list
2360833|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
2360834|NCT00535158|Vitamins|vitamins|mesh-ancestor
2360835|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
2360836|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360837|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2360838|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2360839|NCT00535340|Amibegron|amibegron|mesh-list
2360840|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2360841|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2360842|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
2360843|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360844|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360845|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360846|NCT00535353|Irinotecan|irinotecan|mesh-list
2360847|NCT00535353|Olaparib|olaparib|mesh-list
2360848|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2360849|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2360850|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360851|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360852|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360853|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2360854|NCT00535366|Fluticasone|fluticasone|mesh-list
2360855|NCT00535366|Ciclesonide|ciclesonide|mesh-list
2360856|NCT00535366|Tiotropium Bromide|tiotropium bromide|mesh-list
2360857|NCT00535366|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2360858|NCT00535366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2360859|NCT00535366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2360860|NCT00535366|Autonomic Agents|autonomic agents|mesh-ancestor
2360861|NCT00535366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360862|NCT00535366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360863|NCT00535366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2360864|NCT00535366|Respiratory System Agents|respiratory system agents|mesh-ancestor
2360865|NCT00535366|Dermatologic Agents|dermatologic agents|mesh-ancestor
2360866|NCT00535366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2360867|NCT00535366|Parasympatholytics|parasympatholytics|mesh-ancestor
2360868|NCT00535366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2360869|NCT00535366|Cholinergic Agents|cholinergic agents|mesh-ancestor
2360870|NCT00535366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2360871|NCT00535366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360872|NCT00535366|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2360873|NCT00535366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2360874|NCT00535366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2360875|NCT00535366|Adrenergic Agents|adrenergic agents|mesh-ancestor
2360876|NCT00535366|Glucocorticoids|glucocorticoids|mesh-ancestor
2360877|NCT00535366|Hormones|hormones|mesh-ancestor
2360878|NCT00535366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2360879|NCT00535379|Sunitinib|sunitinib|mesh-list
2360880|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360881|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2360882|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2360883|NCT00535379|Growth Substances|growth substances|mesh-ancestor
2360884|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360885|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
2360886|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2360887|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360888|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360889|NCT00535418|Letrozole|letrozole|mesh-list
2360890|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360891|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2360892|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2360893|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360894|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360895|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2360896|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
2360897|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2360898|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360899|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
2360900|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
2360901|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360902|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2360903|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360904|NCT00535509|Cisplatin|cisplatin|mesh-list
2360905|NCT00535509|Docetaxel|docetaxel|mesh-list
2360906|NCT00535509|Trastuzumab|trastuzumab|mesh-list
2360907|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360908|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
2360909|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
2360910|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
2360911|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360912|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2360913|NCT00535574|Bexarotene|bexarotene|mesh-list
2360914|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360915|NCT00535665|Vaccines|vaccines|mesh-list
2360916|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
2360917|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360918|NCT00535691|Tacrolimus|tacrolimus|mesh-list
2360919|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2360920|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
2360921|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360922|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2360923|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360924|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360925|NCT00535808|Nitroprusside|nitroprusside|mesh-list
2360926|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
2360927|NCT00535808|Sevoflurane|sevoflurane|mesh-list
2360928|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2360929|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2360930|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
2360931|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
2360932|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2360933|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360934|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
2360935|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2360936|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2360937|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360938|NCT00535860|Teriparatide|teriparatide|mesh-list
2360939|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2360940|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360941|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2360942|NCT00535951|Panobinostat|panobinostat|mesh-list
2360943|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2360944|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2360945|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360946|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360947|NCT00536003|Progesterone|progesterone|mesh-list
2360948|NCT00536003|Progestins|progestins|mesh-ancestor
2360949|NCT00536003|Hormones|hormones|mesh-ancestor
2360950|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2360951|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360952|NCT00536042|Minocycline|minocycline|mesh-list
2360953|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2360954|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2360955|NCT00536068|Acetaminophen|acetaminophen|mesh-list
2360956|NCT00536068|Aspirin|aspirin|mesh-list
2360957|NCT00536068|Diclofenac|diclofenac|mesh-list
2360958|NCT00536068|Naproxen|naproxen|mesh-list
2360959|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2360960|NCT00536068|Analgesics|analgesics|mesh-ancestor
2360961|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
2360962|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2360963|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360964|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
2360965|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2360966|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2360967|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2360968|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2360969|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2360970|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360971|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
2360972|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2360973|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2360974|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2360975|NCT00536211|Metformin|metformin|mesh-list
2360976|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2360977|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360978|NCT00536237|Niacin|niacin|mesh-list
2360979|NCT00536237|Niacinamide|niacinamide|mesh-list
2360980|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
2360981|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2360982|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360983|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2360984|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
2360985|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2360986|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
2360987|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
2360988|NCT00536237|Vitamins|vitamins|mesh-ancestor
2360989|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
2360990|NCT00536276|Vitamin D|vitamin d|mesh-list
2360991|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
2360992|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
2360993|NCT00536276|Vitamins|vitamins|mesh-list
2360994|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
2360995|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2360996|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2360997|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2360998|NCT00536393|Doxorubicin|doxorubicin|mesh-list
2360999|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2361000|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2361001|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361002|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2361003|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2361004|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361005|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361006|NCT00536419|Methylphenidate|methylphenidate|mesh-list
2361007|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2361008|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361009|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2361010|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2361011|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2361012|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361013|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
2361014|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361015|NCT00536614|Cetuximab|cetuximab|mesh-list
2361016|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2361017|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361018|NCT00536640|Gemcitabine|gemcitabine|mesh-list
2361019|NCT00536640|Bevacizumab|bevacizumab|mesh-list
2361020|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2361021|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2361022|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361023|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2361024|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2361025|NCT00536640|Growth Substances|growth substances|mesh-ancestor
2361026|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361027|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
2361028|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2361029|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
2361030|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361031|NCT00536640|Antiviral Agents|antiviral agents|mesh-ancestor
2361032|NCT00536640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361033|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361034|NCT00536640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2361035|NCT00536640|Immunologic Factors|immunologic factors|mesh-ancestor
2361036|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2361037|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
2361038|NCT00536653|Vitamin D|vitamin d|mesh-list
2361039|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
2361040|NCT00536653|Vitamins|vitamins|mesh-list
2361041|NCT00536653|Goserelin|goserelin|mesh-list
2361042|NCT00536653|Bicalutamide|bicalutamide|mesh-list
2361043|NCT00536653|Calcium|calcium|mesh-list
2361044|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2361045|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
2361046|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361047|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2361048|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2361049|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2361050|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361051|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
2361052|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
2361053|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2361054|NCT00536653|Hormones|hormones|mesh-ancestor
2361055|NCT00536692|Mecamylamine|mecamylamine|mesh-list
2361056|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2361057|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2361058|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
2361059|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2361060|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361061|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2361062|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2361063|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
2361064|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361065|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361066|NCT00536705|Montelukast|montelukast|mesh-list
2361067|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2361068|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
2361069|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2361070|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
2361071|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2361072|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361073|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2361074|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2361075|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361076|NCT00536770|Calcitriol|calcitriol|mesh-list
2361077|NCT00536770|Gemcitabine|gemcitabine|mesh-list
2361078|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2361079|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2361080|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
2361081|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361082|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361083|NCT00536770|Antiviral Agents|antiviral agents|mesh-ancestor
2361084|NCT00536770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361085|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361086|NCT00536770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2361087|NCT00536770|Immunologic Factors|immunologic factors|mesh-ancestor
2361088|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361089|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2361090|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2361091|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2361092|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2361093|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2361094|NCT00536770|Vitamins|vitamins|mesh-ancestor
2361095|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
2361096|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2361097|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2361098|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
2361099|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2361100|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2361101|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2361102|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2361103|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361104|NCT00536848|Metronidazole|metronidazole|mesh-list
2361105|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361106|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2361107|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2361108|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2361109|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2361110|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361111|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2361112|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361113|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361114|NCT00536887|Atorvastatin|atorvastatin|mesh-list
2361115|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2361116|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2361117|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
2361118|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361119|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2361120|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2361121|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361122|NCT00537043|Carvedilol|carvedilol|mesh-list
2361123|NCT00537043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2361124|NCT00537043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2361125|NCT00537043|Adrenergic Agents|adrenergic agents|mesh-ancestor
2361126|NCT00537043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361127|NCT00537043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361128|NCT00537043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361129|NCT00537043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2361130|NCT00537043|Antioxidants|antioxidants|mesh-ancestor
2361131|NCT00537043|Protective Agents|protective agents|mesh-ancestor
2361132|NCT00537043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2361133|NCT00537043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2361134|NCT00537043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2361135|NCT00537043|Vasodilator Agents|vasodilator agents|mesh-ancestor
2361136|NCT00537043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2361137|NCT00537043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2361138|NCT00537121|Leucovorin|leucovorin|mesh-list
2361139|NCT00537121|Fluorouracil|fluorouracil|mesh-list
2361140|NCT00537121|Irinotecan|irinotecan|mesh-list
2361141|NCT00537121|Vorinostat|vorinostat|mesh-list
2361142|NCT00537121|Calcium|calcium|mesh-list
2361143|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
2361144|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2361145|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361146|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
2361147|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361148|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2361149|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361150|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2361151|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
2361152|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2361153|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2361154|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361155|NCT00537121|Antidotes|antidotes|mesh-ancestor
2361156|NCT00537121|Protective Agents|protective agents|mesh-ancestor
2361157|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
2361158|NCT00537121|Vitamins|vitamins|mesh-ancestor
2361159|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
2361160|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2361161|NCT00537173|Paclitaxel|paclitaxel|mesh-list
2361162|NCT00537173|Bevacizumab|bevacizumab|mesh-list
2361163|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2361164|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361165|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
2361166|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
2361167|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
2361168|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361169|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2361170|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2361171|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2361172|NCT00537173|Growth Substances|growth substances|mesh-ancestor
2361173|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361174|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
2361175|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
2361176|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2361177|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361178|NCT00537355|Histamine|histamine|mesh-list
2361179|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
2361180|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
2361181|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361182|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361183|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361184|NCT00537420|Sibutramine|sibutramine|mesh-list
2361185|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
2361186|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2361187|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
2361188|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2361189|NCT00537472|Bupivacaine|bupivacaine|mesh-list
2361190|NCT00537472|Anesthetics|anesthetics|mesh-list
2361191|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
2361192|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2361193|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361194|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
2361195|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2361196|NCT00537524|Vaccines|vaccines|mesh-list
2361197|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
2361198|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361199|NCT00537537|Telbivudine|telbivudine|mesh-list
2361200|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
2361201|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361202|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2361203|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361204|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361205|NCT00537550|Methotrexate|methotrexate|mesh-list
2361206|NCT00537550|Vincristine|vincristine|mesh-list
2361207|NCT00537550|Asparaginase|asparaginase|mesh-list
2361208|NCT00537550|Daunorubicin|daunorubicin|mesh-list
2361209|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2361210|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
2361211|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2361212|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361213|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2361214|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
2361215|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361216|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361217|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
2361218|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361219|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2361220|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2361221|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
2361222|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2361223|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2361224|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2112449|NCT02570711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112450|NCT02570711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112451|NCT02570711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2112452|NCT02570711|Immunologic Factors|immunologic factors|mesh-ancestor
2112453|NCT02570711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112454|NCT02571049|Sumatriptan|sumatriptan|mesh-list
2112455|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2112456|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2361225|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
2361226|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
2361227|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
2361228|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2361229|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2361230|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2361231|NCT00537563|Telithromycin|telithromycin|mesh-list
2361232|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2361233|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361234|NCT00537602|Miglustat|miglustat|mesh-list
2361235|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361236|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361237|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2361238|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2361239|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
2361240|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361241|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2361242|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2361243|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361244|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2361245|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2361246|NCT00537732|Omeprazole|omeprazole|mesh-list
2361247|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2361248|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2361249|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2361250|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361251|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361252|NCT00537836|Estradiol|estradiol|mesh-list
2361253|NCT00537836|Estrogens|estrogens|mesh-ancestor
2361254|NCT00537836|Hormones|hormones|mesh-ancestor
2361255|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2361256|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361257|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
2361258|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2361259|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361260|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2361261|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
2361262|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2361263|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361264|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361265|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361266|NCT00537888|Fluconazole|fluconazole|mesh-list
2361267|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
2361268|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361269|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2361270|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2361271|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361272|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361273|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2361274|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
2361275|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2361276|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361277|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2361278|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2361279|NCT00537901|Bevacizumab|bevacizumab|mesh-list
2361280|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2361281|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361282|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2361283|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2361284|NCT00537901|Growth Substances|growth substances|mesh-ancestor
2361285|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361286|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
2361287|NCT00537953|Miltefosine|miltefosine|mesh-list
2361288|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2361289|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
2361290|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361291|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361292|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2361293|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2361294|NCT00537966|Ritonavir|ritonavir|mesh-list
2361295|NCT00537966|Darunavir|darunavir|mesh-list
2361296|NCT00537966|Tenofovir|tenofovir|mesh-list
2361297|NCT00537966|Lamivudine|lamivudine|mesh-list
2112457|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2112458|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
2112459|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112460|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112461|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112462|NCT02571153|Ketamine|ketamine|mesh-list
2112463|NCT02571153|Analgesics|analgesics|mesh-ancestor
2112464|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
2112465|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112466|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112467|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2361298|NCT00537966|Emtricitabine|emtricitabine|mesh-list
2361299|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
2361300|NCT00537966|Abacavir|abacavir|mesh-list
2361301|NCT00537966|Dolutegravir|dolutegravir|mesh-list
2361302|NCT00537966|Cobicistat|cobicistat|mesh-list
2361303|NCT00537966|Rilpivirine|rilpivirine|mesh-list
2361304|NCT00537966|Elvitegravir|elvitegravir|mesh-list
2361305|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2361306|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2361307|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
2361308|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361309|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361310|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2361311|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2361312|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
2361313|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361314|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2361315|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2361316|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2361317|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2361318|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2361319|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2361320|NCT00538005|Bevacizumab|bevacizumab|mesh-list
2361321|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
2361322|NCT00538005|Sorafenib|sorafenib|mesh-list
2361323|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2361324|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361325|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2361326|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2361327|NCT00538005|Growth Substances|growth substances|mesh-ancestor
2361328|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361329|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
2361330|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2361331|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361332|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361333|NCT00538018|Telithromycin|telithromycin|mesh-list
2361334|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2361335|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361336|NCT00538031|Celecoxib|celecoxib|mesh-list
2361337|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
2361338|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2361339|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
2361340|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361341|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2361342|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2361343|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
2361344|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361345|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361346|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2361347|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2361348|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2361349|NCT00538031|Analgesics|analgesics|mesh-ancestor
2361350|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
2361351|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2361352|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2361353|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2361354|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2361355|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361356|NCT00538044|Simvastatin|simvastatin|mesh-list
2361357|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2361358|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2361359|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
2361360|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361361|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2361362|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2361363|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361364|NCT00538070|Glycine|glycine|mesh-list
2361365|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
2361366|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361367|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361368|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361369|NCT00538096|Blinatumomab|blinatumomab|mesh-list
2361370|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361371|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
2361372|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361373|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2361374|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361375|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361376|NCT00538148|Telithromycin|telithromycin|mesh-list
2361377|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2361378|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361379|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
2361380|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2361381|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361382|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2361383|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361384|NCT00538187|Bortezomib|bortezomib|mesh-list
2361385|NCT00538187|Obatoclax|obatoclax|mesh-list
2361386|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361387|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361388|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361389|NCT00538239|Sirolimus|sirolimus|mesh-list
2361390|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2361391|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361392|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2361393|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361394|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
2361395|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2361396|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
2361397|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361398|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
2361399|NCT00538265|Tacrolimus|tacrolimus|mesh-list
2361400|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
2361401|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2361402|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
2361403|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361404|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2361405|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361406|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361407|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2361408|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361409|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2361410|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
2361411|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2361412|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361413|NCT00538317|Tirofiban|tirofiban|mesh-list
2361414|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2361415|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2361416|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361417|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2361418|NCT00538330|Tamoxifen|tamoxifen|mesh-list
2361419|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2361420|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
2361421|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2361422|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361423|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2361424|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361425|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2361426|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2361427|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2361428|NCT00538382|Artesunate|artesunate|mesh-list
2361429|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
2361430|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2361431|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2361432|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361433|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361434|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
2361435|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
2361436|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2361437|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
2361438|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
2361439|NCT00538395|Doxorubicin|doxorubicin|mesh-list
2361440|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2361441|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2361442|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
2361443|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361444|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2361445|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2361446|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
2361447|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361448|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361449|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2361450|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2361451|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2361452|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2361453|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361454|NCT00538421|Propofol|propofol|mesh-list
2361455|NCT00538421|Sevoflurane|sevoflurane|mesh-list
2361456|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2361457|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2361458|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361459|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2361460|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
2361461|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
2361462|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2112468|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2112469|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
2112470|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
2112471|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2112472|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2112473|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2112474|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361463|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2361464|NCT00538486|Metformin|metformin|mesh-list
2361465|NCT00538486|Amlodipine|amlodipine|mesh-list
2361466|NCT00538486|Telmisartan|telmisartan|mesh-list
2361467|NCT00538486|Candesartan|candesartan|mesh-list
2361468|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
2112475|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112476|NCT02571439|Ropivacaine|ropivacaine|mesh-list
2112477|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
2112478|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
2112479|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2361469|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2361470|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361471|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2361472|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2361473|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2361474|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361475|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2361476|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
2361477|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2361478|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2361479|NCT00538499|Fentanyl|fentanyl|mesh-list
2361480|NCT00538499|Bupivacaine|bupivacaine|mesh-list
2361481|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
2361482|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
2361483|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2361484|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361485|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
2361486|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2361487|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2361488|NCT00538499|Narcotics|narcotics|mesh-ancestor
2361489|NCT00538499|Analgesics|analgesics|mesh-ancestor
2361490|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2361491|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2361492|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
2361493|NCT00538525|Docetaxel|docetaxel|mesh-list
2361494|NCT00538525|Doxorubicin|doxorubicin|mesh-list
2361495|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361496|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
2361497|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
2361498|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
2361499|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361500|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2361501|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2361502|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2361503|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361504|NCT00538538|Ranibizumab|ranibizumab|mesh-list
2361505|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2361506|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2361507|NCT00538538|Growth Substances|growth substances|mesh-ancestor
2361508|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361509|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
2361510|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361511|NCT00538564|Tadalafil|tadalafil|mesh-list
2361512|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
2361513|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2361514|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2361515|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361516|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361517|NCT00538564|Urological Agents|urological agents|mesh-ancestor
2361518|NCT00538603|Paclitaxel|paclitaxel|mesh-list
2361519|NCT00538603|Carboplatin|carboplatin|mesh-list
2361520|NCT00538603|Doxorubicin|doxorubicin|mesh-list
2361521|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2361522|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2361523|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361524|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
2361525|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
2361526|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
2361527|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361528|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2361529|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2361530|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2361531|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361532|NCT00538655|Modafinil|modafinil|mesh-list
2361533|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2361534|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361535|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2361536|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2361537|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2361538|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361539|NCT00538694|Daptomycin|daptomycin|mesh-list
2361540|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2361541|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361542|NCT00538720|Vitamin D|vitamin d|mesh-list
2361543|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
2361544|NCT00538720|Vitamins|vitamins|mesh-ancestor
2361545|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
2361546|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361547|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2361548|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2361549|NCT00538811|Interferons|interferons|mesh-list
2361550|NCT00538811|Ribavirin|ribavirin|mesh-list
2361551|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
2361552|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
2361553|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
2361554|NCT00538811|Amantadine|amantadine|mesh-list
2361555|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361556|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
2361557|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361558|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
2361559|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361560|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
2361561|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361562|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2361563|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2361564|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
2361565|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361566|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2361567|NCT00538811|Analgesics|analgesics|mesh-ancestor
2361568|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
2361569|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2361570|NCT00538876|Decitabine|decitabine|mesh-list
2361571|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2361572|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
2361573|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361574|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361575|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361576|NCT00538889|Citalopram|citalopram|mesh-list
2361577|NCT00538889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2361578|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2361579|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2361580|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361581|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361582|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
2361583|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361584|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2361585|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
2361586|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2361587|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
2361588|NCT00538954|Antacids|antacids|mesh-ancestor
2361589|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361590|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2361591|NCT00538967|Doxycycline|doxycycline|mesh-list
2361592|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2361593|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361594|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
2361595|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2361596|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2361597|NCT00539071|Risperidone|risperidone|mesh-list
2361598|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2361599|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
2361600|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361601|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361602|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361603|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2361604|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2361605|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2361606|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2361607|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2361608|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
2361609|NCT00539123|Buprenorphine|buprenorphine|mesh-list
2361610|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2361611|NCT00539123|Narcotics|narcotics|mesh-ancestor
2361612|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2361613|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361614|NCT00539123|Analgesics|analgesics|mesh-ancestor
2361615|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
2361616|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2361617|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2361618|NCT00539149|Amoxicillin|amoxicillin|mesh-list
2361619|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2361620|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361621|NCT00539331|Paclitaxel|paclitaxel|mesh-list
2361622|NCT00539331|Carboplatin|carboplatin|mesh-list
2361623|NCT00539331|Cediranib|cediranib|mesh-list
2361624|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2361625|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361626|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
2361627|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
2361628|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
2361629|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361630|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2361631|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361632|NCT00539396|Insulin|insulin|mesh-list
2361633|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2361634|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361635|NCT00539409|Insulin|insulin|mesh-list
2361636|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
2361637|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2361638|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2361639|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361640|NCT00539435|Insulin|insulin|mesh-list
2361641|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
2361642|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2361643|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361644|NCT00539448|Insulin|insulin|mesh-list
2361645|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2361646|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
2361647|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
2361648|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2361649|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361650|NCT00539565|Prednisolone|prednisolone|mesh-list
2361651|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2361652|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
2361653|NCT00539565|Hormones|hormones|mesh-ancestor
2361654|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2361655|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361656|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2361657|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361658|NCT00539630|Docetaxel|docetaxel|mesh-list
2361659|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361660|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
2361661|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
2361662|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
2361663|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361664|NCT00539669|Docetaxel|docetaxel|mesh-list
2361665|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361666|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
2361667|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
2361668|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
2361669|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361670|NCT00539721|Ondansetron|ondansetron|mesh-list
2361671|NCT00539721|Rolapitant|rolapitant|mesh-list
2361672|NCT00539721|Antiemetics|antiemetics|mesh-ancestor
2361673|NCT00539721|Autonomic Agents|autonomic agents|mesh-ancestor
2361674|NCT00539721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2361675|NCT00539721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361676|NCT00539721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2361677|NCT00539721|Antipruritics|antipruritics|mesh-ancestor
2361678|NCT00539721|Dermatologic Agents|dermatologic agents|mesh-ancestor
2361679|NCT00539721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2361680|NCT00539721|Serotonin Agents|serotonin agents|mesh-ancestor
2361681|NCT00539721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361682|NCT00539721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361683|NCT00539721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2361684|NCT00539721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2361685|NCT00539721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2361686|NCT00539721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2361687|NCT00539721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2361688|NCT00539721|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2361689|NCT00539773|Interferons|interferons|mesh-list
2361690|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361691|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
2361692|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361693|NCT00539786|Rabeprazole|rabeprazole|mesh-list
2361694|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2361695|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2361696|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2361697|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361698|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361699|NCT00539799|Prednisolone|prednisolone|mesh-list
2361700|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2361701|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
2361702|NCT00539799|Hormones|hormones|mesh-ancestor
2361703|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2361704|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361705|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2361706|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361707|NCT00539877|Irinotecan|irinotecan|mesh-list
2361708|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2361709|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2361710|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361711|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361712|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361713|NCT00539890|Insulin|insulin|mesh-list
2361714|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2361715|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361716|NCT00539968|Docetaxel|docetaxel|mesh-list
2361717|NCT00539968|Lonafarnib|lonafarnib|mesh-list
2361718|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361719|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
2361720|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
2361721|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
2361722|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361723|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361724|NCT00540072|Daptomycin|daptomycin|mesh-list
2361725|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2361726|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361727|NCT00540085|Rocuronium|rocuronium|mesh-list
2361728|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2361729|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2361730|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2361731|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2361732|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361733|NCT00540098|Paroxetine|paroxetine|mesh-list
2361734|NCT00540098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2361735|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2361736|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2361737|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361738|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361739|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
2361740|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361741|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2361742|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
2361743|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2361744|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2361745|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2361746|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361747|NCT00540137|Ritonavir|ritonavir|mesh-list
2361748|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2361749|NCT00540137|Nevirapine|nevirapine|mesh-list
2361750|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2361751|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2361752|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
2361753|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361754|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361755|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2361756|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2361757|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
2361758|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361759|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2361760|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2361761|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2361762|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2361763|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2361764|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2361765|NCT00540202|Lumefantrine|lumefantrine|mesh-list
2361766|NCT00540202|Artemether|artemether|mesh-list
2361767|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2361768|NCT00540202|Quinine|quinine|mesh-list
2361769|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
2361770|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2361771|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2361772|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361773|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2361774|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361775|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2361776|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2361777|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2361778|NCT00540202|Analgesics|analgesics|mesh-ancestor
2361779|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
2361780|NCT00540241|Pemetrexed|pemetrexed|mesh-list
2361781|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361782|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361783|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361784|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2361785|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2361786|NCT00540280|Gemcitabine|gemcitabine|mesh-list
2361787|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361788|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2361789|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
2361790|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361791|NCT00540280|Antiviral Agents|antiviral agents|mesh-ancestor
2361792|NCT00540280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361793|NCT00540280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361794|NCT00540280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2361795|NCT00540280|Immunologic Factors|immunologic factors|mesh-ancestor
2361796|NCT00540280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361797|NCT00540345|Interferons|interferons|mesh-list
2361798|NCT00540345|Ribavirin|ribavirin|mesh-list
2361799|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
2361800|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
2361801|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2361802|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361803|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
2361804|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361805|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
2361806|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361807|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
2361808|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361809|NCT00540358|Gemcitabine|gemcitabine|mesh-list
2361810|NCT00540358|Carboplatin|carboplatin|mesh-list
2361811|NCT00540358|Iniparib|iniparib|mesh-list
2361812|NCT00540358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361813|NCT00540358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2361814|NCT00540358|Antimetabolites|antimetabolites|mesh-ancestor
2361815|NCT00540358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361816|NCT00540358|Antiviral Agents|antiviral agents|mesh-ancestor
2361817|NCT00540358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361818|NCT00540358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361819|NCT00540358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2361820|NCT00540358|Immunologic Factors|immunologic factors|mesh-ancestor
2361821|NCT00540358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361822|NCT00540358|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2361823|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
2361824|NCT00540384|Hematinics|hematinics|mesh-ancestor
2361825|NCT00540410|Artesunate|artesunate|mesh-list
2361826|NCT00540410|Lumefantrine|lumefantrine|mesh-list
2361827|NCT00540410|Amodiaquine|amodiaquine|mesh-list
2361828|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2361829|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
2361830|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2361831|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2361832|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361833|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361834|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
2112480|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112481|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
2112482|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112483|NCT02571634|Fentanyl|fentanyl|mesh-list
2112484|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2112485|NCT02571634|Narcotics|narcotics|mesh-ancestor
2112486|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2112487|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361835|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
2361836|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2361837|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
2361838|NCT00540501|Oseltamivir|oseltamivir|mesh-list
2361839|NCT00540501|Zanamivir|zanamivir|mesh-list
2361840|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
2361841|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361842|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361843|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361844|NCT00540527|Plasminogen|plasminogen|mesh-list
2361845|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2361846|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2361847|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2361848|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361849|NCT00540605|Tenofovir|tenofovir|mesh-list
2361850|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
2361851|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361852|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2361853|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2361854|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361855|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361856|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2361857|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2361858|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
2361859|NCT00540696|Hematinics|hematinics|mesh-ancestor
2361860|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
2361861|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2361862|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361863|NCT00540748|Oxytocin|oxytocin|mesh-list
2361864|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
2361865|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2361866|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361867|NCT00540787|Quinidine|quinidine|mesh-list
2361868|NCT00540787|Amiodarone|amiodarone|mesh-list
2361869|NCT00540787|Sotalol|sotalol|mesh-list
2361870|NCT00540787|Flecainide|flecainide|mesh-list
2361871|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2361872|NCT00540787|Propafenone|propafenone|mesh-list
2361873|NCT00540787|Dofetilide|dofetilide|mesh-list
2361874|NCT00540787|Cifenline|cifenline|mesh-list
2361875|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
2361876|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2361877|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361878|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
2361879|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2361880|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2361881|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361882|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2361883|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2361884|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2361885|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361886|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2361887|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2361888|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2361889|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2361890|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2361891|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
2361892|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361893|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
2361894|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
2361895|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2361896|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2361897|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2361898|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
2361899|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2361900|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2361901|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361902|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2361903|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2361904|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
2361905|NCT00540800|Docetaxel|docetaxel|mesh-list
2361906|NCT00540800|Capecitabine|capecitabine|mesh-list
2361907|NCT00540800|Epirubicin|epirubicin|mesh-list
2361908|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361909|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
2361910|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
2361911|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
2361912|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361913|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2361914|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
2361915|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2361916|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2361917|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2361918|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361919|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2361920|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2361921|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2361922|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2361923|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361924|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
2361925|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361926|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361927|NCT00540839|Fluticasone|fluticasone|mesh-list
2361928|NCT00540839|Xhance|xhance|mesh-list
2361929|NCT00540839|Montelukast|montelukast|mesh-list
2361930|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2361931|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2361932|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
2361933|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2361934|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361935|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2361936|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
2361937|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
2361938|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2361939|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2361940|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
2361941|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2361942|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2361943|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2361944|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361945|NCT00540891|Alfuzosin|alfuzosin|mesh-list
2361946|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2361947|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2361948|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2361949|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
2361950|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2361951|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361952|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361953|NCT00540891|Urological Agents|urological agents|mesh-ancestor
2361954|NCT00540930|Ranibizumab|ranibizumab|mesh-list
2361955|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2361956|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2361957|NCT00540930|Growth Substances|growth substances|mesh-ancestor
2361958|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361959|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
2361960|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361961|NCT00540943|Irinotecan|irinotecan|mesh-list
2361962|NCT00540943|Cetuximab|cetuximab|mesh-list
2361963|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2361964|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2361965|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361966|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361967|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361968|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2361969|NCT00540956|Cytarabine|cytarabine|mesh-list
2361970|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2361971|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
2361972|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361973|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361974|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
2361975|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361976|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2361977|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
2361978|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361979|NCT00541008|Sunitinib|sunitinib|mesh-list
2361980|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112488|NCT02571634|Analgesics|analgesics|mesh-ancestor
2112489|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
2112490|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112491|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2112492|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2112493|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
2112494|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
2112495|NCT02571777|Fluticasone|fluticasone|mesh-list
2112496|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2112497|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2361981|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2361982|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2361983|NCT00541008|Growth Substances|growth substances|mesh-ancestor
2361984|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2361985|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
2361986|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2361987|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361988|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361989|NCT00541021|Gemcitabine|gemcitabine|mesh-list
2361990|NCT00541021|Sorafenib|sorafenib|mesh-list
2361991|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2361992|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
2361993|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2361994|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2361995|NCT00541021|Antiviral Agents|antiviral agents|mesh-ancestor
2361996|NCT00541021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2361997|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2361998|NCT00541021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2361999|NCT00541021|Immunologic Factors|immunologic factors|mesh-ancestor
2362000|NCT00541021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362001|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2362002|NCT00541047|Leuprolide|leuprolide|mesh-list
2362003|NCT00541047|Goserelin|goserelin|mesh-list
2362004|NCT00541047|Bicalutamide|bicalutamide|mesh-list
2362005|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2362006|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
2362007|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2362008|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362009|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2362010|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362011|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
2362012|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
2362013|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2362014|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
2362015|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
2362016|NCT00541073|Pemetrexed|pemetrexed|mesh-list
2362017|NCT00541073|Vitamins|vitamins|mesh-ancestor
2362018|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
2362019|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362020|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362021|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362022|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362023|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2362024|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2362025|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
2362026|NCT00541073|Hematinics|hematinics|mesh-ancestor
2362027|NCT00541086|Tamoxifen|tamoxifen|mesh-list
2362028|NCT00541086|Letrozole|letrozole|mesh-list
2362029|NCT00541086|Anastrozole|anastrozole|mesh-list
2362030|NCT00541086|Exemestane|exemestane|mesh-list
2362031|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362032|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362033|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2362034|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2362035|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362036|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2362037|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
2362038|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2362039|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362040|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2362041|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2362042|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2362043|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2362044|NCT00541112|Leucovorin|leucovorin|mesh-list
2362045|NCT00541112|Fluorouracil|fluorouracil|mesh-list
2362046|NCT00541112|Capecitabine|capecitabine|mesh-list
2362047|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
2362048|NCT00541112|Cetuximab|cetuximab|mesh-list
2362049|NCT00541112|Calcium|calcium|mesh-list
2362050|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
2362051|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2362052|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362053|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
2362054|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362055|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2362056|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362057|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362058|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
2362059|NCT00541112|Antidotes|antidotes|mesh-ancestor
2362060|NCT00541112|Protective Agents|protective agents|mesh-ancestor
2362061|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
2362062|NCT00541112|Vitamins|vitamins|mesh-ancestor
2362063|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
2362064|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2362065|NCT00541125|Leucovorin|leucovorin|mesh-list
2362066|NCT00541125|Bevacizumab|bevacizumab|mesh-list
2362067|NCT00541125|Fluorouracil|fluorouracil|mesh-list
2362068|NCT00541125|Irinotecan|irinotecan|mesh-list
2362069|NCT00541125|Calcium|calcium|mesh-list
2362070|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
2362071|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2362072|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362073|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2362074|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2362075|NCT00541125|Growth Substances|growth substances|mesh-ancestor
2362076|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362077|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
2362078|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2362079|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
2362080|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362081|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2362082|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362083|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
2362084|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2362085|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2362086|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362087|NCT00541125|Antidotes|antidotes|mesh-ancestor
2362088|NCT00541125|Protective Agents|protective agents|mesh-ancestor
2362089|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
2112498|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2112499|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
2112500|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112501|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112502|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2362090|NCT00541125|Vitamins|vitamins|mesh-ancestor
2362091|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
2362092|NCT00541138|Tamoxifen|tamoxifen|mesh-list
2362093|NCT00541138|Carboplatin|carboplatin|mesh-list
2112503|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
2112504|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
2112505|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2112506|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2112507|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2112508|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2112509|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
2112510|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112511|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112512|NCT02571972|Timolol|timolol|mesh-list
2112513|NCT02571972|Dorzolamide|dorzolamide|mesh-list
2362094|NCT00541138|Topotecan|topotecan|mesh-list
2362095|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362096|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362097|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2362098|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2362099|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362100|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2362101|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
2362102|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2362103|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362104|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2362105|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2362106|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2362107|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2362108|NCT00541164|Ubiquinone|ubiquinone|mesh-list
2362109|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
2362110|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
2362111|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362112|NCT00541164|Vitamins|vitamins|mesh-ancestor
2362113|NCT00541177|Atropine|atropine|mesh-list
2362114|NCT00541177|Tropicamide|tropicamide|mesh-list
2362115|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2362116|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2362117|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2362118|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
2362119|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362120|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112514|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2112515|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2112516|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
2112517|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112518|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112519|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112520|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2112521|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2112522|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2112523|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112524|NCT02572167|Nivolumab|nivolumab|mesh-list
2112525|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2112526|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2112527|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112528|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2112529|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112530|NCT02572609|Ambroxol|ambroxol|mesh-list
2112531|NCT02572609|Expectorants|expectorants|mesh-ancestor
2112532|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
2112533|NCT02572752|Nintedanib|nintedanib|mesh-list
2112534|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112535|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2112536|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112537|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112538|NCT02573012|Prednisone|prednisone|mesh-list
2112539|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2112540|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
2112541|NCT02573012|Hormones|hormones|mesh-ancestor
2112542|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112543|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112544|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2112545|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112546|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
2362121|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2362122|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
2362123|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
2362124|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
2362125|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2362126|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2362127|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
2362128|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2362129|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362130|NCT00541216|Ephedrine|ephedrine|mesh-list
2362131|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2362132|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362133|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
2362134|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
2362135|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362136|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2362137|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
2362138|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2362139|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362140|NCT00541281|Prednisone|prednisone|mesh-list
2362141|NCT00541281|Docetaxel|docetaxel|mesh-list
2362142|NCT00541281|Estramustine|estramustine|mesh-list
2362143|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362144|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
2362145|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
2362146|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
2362147|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362148|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2362149|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
2362150|NCT00541281|Hormones|hormones|mesh-ancestor
2362151|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2362152|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362153|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2362154|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2362155|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
2362156|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
2362157|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2362158|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
2362159|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2362160|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
2362161|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362162|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362163|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
2362164|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
2362165|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2362166|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
2362167|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362168|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362169|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2362170|NCT00541359|Bortezomib|bortezomib|mesh-list
2362171|NCT00541359|Topotecan|topotecan|mesh-list
2362172|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362173|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2362174|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2362175|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362176|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362177|NCT00541372|Insulin|insulin|mesh-list
2362178|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2362179|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362180|NCT00541411|Dactinomycin|dactinomycin|mesh-list
2362181|NCT00541411|Vincristine|vincristine|mesh-list
2362182|NCT00541411|Ifosfamide|ifosfamide|mesh-list
2362183|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2362184|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362185|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
2362186|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
2362187|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
2362188|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362189|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2362190|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
2362191|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2362192|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2362193|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2362194|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2362195|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362196|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2362197|NCT00541463|Nelfinavir|nelfinavir|mesh-list
2362198|NCT00541463|Indinavir|indinavir|mesh-list
2362199|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362200|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2362201|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2362202|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
2362203|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362204|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2362205|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2362206|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
2362207|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2362208|NCT00541489|Naproxen|naproxen|mesh-list
2362209|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
2362210|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2362211|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2362212|NCT00541489|Analgesics|analgesics|mesh-ancestor
2362213|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
2362214|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362215|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362216|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2362217|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2362218|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
2362219|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2362220|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362221|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362222|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2362223|NCT00541515|Insulin|insulin|mesh-list
2362224|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2362225|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362226|NCT00541554|Aripiprazole|aripiprazole|mesh-list
2362227|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
2362228|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2362229|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2362230|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2362231|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2362232|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362233|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
2362234|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
2362235|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2362236|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362237|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2362238|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2362239|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
2362240|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2362241|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2362242|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2362243|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2362244|NCT00541567|Ibipinabant|ibipinabant|mesh-list
2362245|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2362246|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2362247|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2362248|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362249|NCT00541567|Hormones|hormones|mesh-ancestor
2362250|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2362251|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362252|NCT00541684|Atenolol|atenolol|mesh-list
2362253|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
2362254|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2362255|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362256|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362257|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
2362258|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362259|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2362260|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2362261|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
2362262|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2362263|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2362264|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2362265|NCT00541697|Atorvastatin|atorvastatin|mesh-list
2362266|NCT00541697|Simvastatin|simvastatin|mesh-list
2362267|NCT00541697|Ezetimibe|ezetimibe|mesh-list
2362268|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2362269|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2362270|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
2362271|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362272|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2362273|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2362274|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362275|NCT00541710|Genistein|genistein|mesh-list
2362276|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2362277|NCT00541710|Protective Agents|protective agents|mesh-ancestor
2362278|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362279|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112547|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2112548|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
2112549|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362280|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2362281|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362282|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362283|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
2362284|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2362285|NCT00541710|Estrogens|estrogens|mesh-ancestor
2362286|NCT00541710|Hormones|hormones|mesh-ancestor
2362287|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2362288|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2362289|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2362290|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362291|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362292|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2362293|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2362294|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362295|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
2362296|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2362297|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
2362298|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
2362299|NCT00541814|Cyclosporine|cyclosporine|mesh-list
2362300|NCT00541814|Cyclosporins|cyclosporins|mesh-list
2362301|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362302|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362303|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362304|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
2362305|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362306|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
2362307|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2362308|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
2362309|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2362310|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2362311|NCT00541840|Sorafenib|sorafenib|mesh-list
2362312|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362313|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2362314|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112550|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112551|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2112552|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
2112553|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
2112554|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2112555|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
2112556|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112557|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112558|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2112559|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
2112560|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112561|NCT02573233|Fluticasone|fluticasone|mesh-list
2112562|NCT02573233|Xhance|xhance|mesh-list
2112563|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
2112564|NCT02573233|Budesonide|budesonide|mesh-list
2362315|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362316|NCT00541853|Candesartan|candesartan|mesh-list
2362317|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
2362318|NCT00541853|Cilnidipine|cilnidipine|mesh-list
2362319|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2362320|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2362321|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2362322|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362323|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2362324|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2362325|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2362326|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362327|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2362328|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2362329|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362330|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362331|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2362332|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2362333|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362334|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
2362335|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2362336|NCT00541918|Propofol|propofol|mesh-list
2362337|NCT00541918|Sevoflurane|sevoflurane|mesh-list
2362338|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2362339|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2362340|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362341|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2362342|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
2362343|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
2362344|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2362345|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2362346|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
2362347|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2362348|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2362349|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
2362350|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2362351|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362352|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362353|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
2362354|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
2362355|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362356|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
2362357|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2362358|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
2362359|NCT00542074|Ethanol|ethanol|mesh-list
2362360|NCT00542074|Emollients|emollients|mesh-list
2362361|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
2362362|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2362363|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2362364|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2362365|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362366|NCT00542087|Diclofenac|diclofenac|mesh-list
2362367|NCT00542087|Etoricoxib|etoricoxib|mesh-list
2362368|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2362369|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2362370|NCT00542087|Analgesics|analgesics|mesh-ancestor
2362371|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
2362372|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362373|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362374|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2362375|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2362376|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2362377|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362378|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362379|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2362380|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2362381|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
2362382|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2362383|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
2362384|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2362385|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362386|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2362387|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2362388|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362389|NCT00542139|Betamethasone|betamethasone|mesh-list
2362390|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2362391|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
2362392|NCT00542139|Hormones|hormones|mesh-ancestor
2362393|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2362394|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362395|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2362396|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
2362397|NCT00542152|Cyclosporine|cyclosporine|mesh-list
2362398|NCT00542152|Infliximab|infliximab|mesh-list
2362399|NCT00542152|Cyclosporins|cyclosporins|mesh-list
2362400|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362401|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362402|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362403|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
2362404|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362405|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
2362406|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2362407|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
2362408|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2362409|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2362410|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2362411|NCT00542165|Alfuzosin|alfuzosin|mesh-list
2362412|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2362413|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2362414|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2362415|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
2362416|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2362417|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362418|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362419|NCT00542165|Urological Agents|urological agents|mesh-ancestor
2362420|NCT00542243|Finasteride|finasteride|mesh-list
2362421|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2362422|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2362423|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362424|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362425|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
2362426|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2362427|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362428|NCT00542243|Urological Agents|urological agents|mesh-ancestor
2362429|NCT00542295|Mebeverine|mebeverine|mesh-list
2362430|NCT00542295|Alverine|alverine|mesh-list
2362431|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
2362432|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
2362433|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362434|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362435|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
2362436|NCT00542347|Esomeprazole|esomeprazole|mesh-list
2362437|NCT00542347|Omeprazole|omeprazole|mesh-list
2362438|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2362439|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2362440|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2362441|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362442|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362443|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
2362444|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2362445|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362446|NCT00542412|Riluzole|riluzole|mesh-list
2362447|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
2362448|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2362449|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2362450|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2362451|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362452|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362453|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2362454|NCT00542412|Protective Agents|protective agents|mesh-ancestor
2362455|NCT00542451|Paclitaxel|paclitaxel|mesh-list
2362456|NCT00542451|Trastuzumab|trastuzumab|mesh-list
2362457|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2362458|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362459|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
2362460|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
2362461|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
2362462|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362463|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2362464|NCT00542555|Naproxen|naproxen|mesh-list
2112565|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
2112566|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2112567|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2112568|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2112569|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
2112570|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112571|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112572|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2112573|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
2112574|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
2112575|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2112576|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
2112577|NCT02573233|Hormones|hormones|mesh-ancestor
2112578|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112579|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2112580|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2112581|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2112582|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
2112583|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112584|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112585|NCT02573311|Tamsulosin|tamsulosin|mesh-list
2112586|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2112587|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2112588|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2112589|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
2112590|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112591|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112592|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112593|NCT02573311|Urological Agents|urological agents|mesh-ancestor
2112594|NCT02573493|Paclitaxel|paclitaxel|mesh-list
2112595|NCT02573493|Cisplatin|cisplatin|mesh-list
2112596|NCT02573493|Cetuximab|cetuximab|mesh-list
2112597|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2112598|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112599|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
2112600|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
2112601|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
2112602|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112603|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2112604|NCT02573857|Artefenomel|artefenomel|mesh-list
2112605|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
2112606|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2112607|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2112608|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112609|NCT02573870|Fluticasone|fluticasone|mesh-list
2112610|NCT02573870|Xhance|xhance|mesh-list
2112611|NCT02573870|Albuterol|albuterol|mesh-list
2112612|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2112613|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2362465|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
2362466|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2362467|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2362468|NCT00542555|Analgesics|analgesics|mesh-ancestor
2362469|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
2362470|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362471|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362472|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2362473|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2362474|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
2362475|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2362476|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112614|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
2112615|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112616|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112617|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2112618|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
2112619|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
2112620|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2112621|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
2112622|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2112623|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2112624|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2362477|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362478|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2362479|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
2362480|NCT00542568|Hematinics|hematinics|mesh-ancestor
2362481|NCT00542607|Levocetirizine|levocetirizine|mesh-list
2362482|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2362483|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2362484|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
2112625|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2112626|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
2112627|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112628|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112629|NCT02573883|Clobetasol|clobetasol|mesh-list
2112630|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2112631|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
2112632|NCT02573883|Hormones|hormones|mesh-ancestor
2112633|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112634|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112635|NCT02574078|Gemcitabine|gemcitabine|mesh-list
2112636|NCT02574078|Paclitaxel|paclitaxel|mesh-list
2112637|NCT02574078|Docetaxel|docetaxel|mesh-list
2112638|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2112639|NCT02574078|Bevacizumab|bevacizumab|mesh-list
2112640|NCT02574078|Carboplatin|carboplatin|mesh-list
2112641|NCT02574078|Nivolumab|nivolumab|mesh-list
2112642|NCT02574078|Pemetrexed|pemetrexed|mesh-list
2112643|NCT02574078|Crizotinib|crizotinib|mesh-list
2112644|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2112645|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112646|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
2112647|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
2112648|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
2112649|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112650|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2112651|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2112652|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2112653|NCT02574078|Growth Substances|growth substances|mesh-ancestor
2112654|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112655|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
2112656|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2112657|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
2112658|NCT02574078|Antiviral Agents|antiviral agents|mesh-ancestor
2112659|NCT02574078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112660|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112661|NCT02574078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2112662|NCT02574078|Immunologic Factors|immunologic factors|mesh-ancestor
2112663|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2112664|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2112665|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2112666|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2112667|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2112668|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2112669|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362485|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
2362486|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2362487|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362488|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362489|NCT00542633|Insulin|insulin|mesh-list
2362490|NCT00542633|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2362491|NCT00542633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2362492|NCT00542633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362493|NCT00542711|Curcumin|curcumin|mesh-list
2362494|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2362495|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2362496|NCT00542711|Analgesics|analgesics|mesh-ancestor
2362497|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
2362498|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362499|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362500|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2362501|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2112687|NCT02574520|Bupivacaine|bupivacaine|mesh-list
2112688|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2112689|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
2112690|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
2112691|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2112692|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112693|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
2112694|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112695|NCT02574598|Docetaxel|docetaxel|mesh-list
2112696|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
2112697|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112698|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
2362502|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362503|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362504|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362505|NCT00542724|Insulin|insulin|mesh-list
2362506|NCT00542724|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2362507|NCT00542724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2362508|NCT00542724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362509|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
2362510|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2362511|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362512|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2362513|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
2362514|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2362515|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2362516|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112699|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
2112700|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
2112701|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112702|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2112703|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2112704|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
2112705|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112706|NCT02574832|Lidocaine|lidocaine|mesh-list
2112707|NCT02574832|Fentanyl|fentanyl|mesh-list
2112708|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
2112709|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
2112710|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2112711|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112712|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
2112713|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112714|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2112715|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2362517|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362518|NCT00542802|Carbamazepine|carbamazepine|mesh-list
2362519|NCT00542802|Levetiracetam|levetiracetam|mesh-list
2362520|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
2362521|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
2362522|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
2362523|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2362524|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2362525|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362526|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2362527|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2362528|NCT00542802|Analgesics|analgesics|mesh-ancestor
2362529|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
2362530|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362531|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2362532|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2362533|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362534|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2362535|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2362536|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
2362537|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2362538|NCT00542893|Dacarbazine|dacarbazine|mesh-list
2362539|NCT00542893|Oblimersen|oblimersen|mesh-list
2362540|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2362541|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
2362542|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362543|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362544|NCT00542984|Teriparatide|teriparatide|mesh-list
2362545|NCT00542984|Calcitonin|calcitonin|mesh-list
2362546|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
2362547|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2362548|NCT00542984|Katacalcin|katacalcin|mesh-list
2362549|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2362550|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362551|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2362552|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
2362553|NCT00543023|Teriparatide|teriparatide|mesh-list
2362554|NCT00543023|Calcitonin|calcitonin|mesh-list
2362555|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
2362556|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2362557|NCT00543023|Katacalcin|katacalcin|mesh-list
2362558|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2362559|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362560|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2362561|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
2362562|NCT00543049|Sunitinib|sunitinib|mesh-list
2362563|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362564|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2362565|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2362566|NCT00543049|Growth Substances|growth substances|mesh-ancestor
2362567|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362568|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
2362569|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2362570|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362571|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362572|NCT00543075|Oblimersen|oblimersen|mesh-list
2362573|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362574|NCT00543114|Rituximab|rituximab|mesh-list
2362575|NCT00543114|Fludarabine|fludarabine|mesh-list
2362576|NCT00543114|Lenalidomide|lenalidomide|mesh-list
2362577|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2362578|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362579|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
2362580|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112716|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2112717|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2112718|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112719|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2112720|NCT02574832|Narcotics|narcotics|mesh-ancestor
2112721|NCT02574832|Analgesics|analgesics|mesh-ancestor
2112722|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2112723|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2112724|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
2112725|NCT02574845|Metformin|metformin|mesh-list
2112726|NCT02574845|Furosemide|furosemide|mesh-list
2112727|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2112728|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2112729|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112730|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2112731|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2362581|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2362582|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2362583|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2362584|NCT00543114|Growth Substances|growth substances|mesh-ancestor
2362585|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
2362586|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2362587|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2362588|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
2362589|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362590|NCT00543179|Lanreotide|lanreotide|mesh-list
2362591|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362592|NCT00543205|Oblimersen|oblimersen|mesh-list
2362593|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362594|NCT00543218|Teriparatide|teriparatide|mesh-list
2362595|NCT00543218|Calcitonin|calcitonin|mesh-list
2362596|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
2362597|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2362598|NCT00543218|Katacalcin|katacalcin|mesh-list
2362599|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2362600|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362601|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2362602|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
2362603|NCT00543231|Oblimersen|oblimersen|mesh-list
2362604|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362605|NCT00543244|Interferons|interferons|mesh-list
2362606|NCT00543244|Ribavirin|ribavirin|mesh-list
2362607|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
2362608|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2362609|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362610|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
2362611|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2362612|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
2362613|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362614|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
2362615|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112732|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
2112733|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112734|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2112735|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2112736|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112737|NCT02574845|Diuretics|diuretics|mesh-ancestor
2112738|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
2112739|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2112740|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2362616|NCT00543335|Sorafenib|sorafenib|mesh-list
2362617|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362618|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2362619|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362620|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362621|NCT00543361|Metformin|metformin|mesh-list
2362622|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2362623|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362628|NCT00543413|Enalapril|enalapril|mesh-list
2362629|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2362630|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
2362631|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362632|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362633|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2362634|NCT00543504|Bevacizumab|bevacizumab|mesh-list
2112741|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
2112742|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2112743|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112744|NCT02575833|Erenumab|erenumab|mesh-list
2112745|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2112746|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112747|NCT02575833|Analgesics|analgesics|mesh-ancestor
2112748|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
2362635|NCT00543504|Trastuzumab|trastuzumab|mesh-list
2362636|NCT00543504|Cetuximab|cetuximab|mesh-list
2362637|NCT00543504|Sunitinib|sunitinib|mesh-list
2362638|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2362639|NCT00543504|Sorafenib|sorafenib|mesh-list
2362640|NCT00543504|Lapatinib|lapatinib|mesh-list
2362641|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2362642|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362643|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2362644|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2362645|NCT00543504|Growth Substances|growth substances|mesh-ancestor
2362646|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362647|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
2362648|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2362649|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362650|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362651|NCT00543582|Azacitidine|azacitidine|mesh-list
2362652|NCT00543582|Mocetinostat|mocetinostat|mesh-list
2362653|NCT00543582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2362654|NCT00543582|Antimetabolites|antimetabolites|mesh-ancestor
2362655|NCT00543582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362656|NCT00543582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362657|NCT00543582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362658|NCT00543582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2362659|NCT00543608|Vancomycin|vancomycin|mesh-list
2362660|NCT00543608|Iclaprim|iclaprim|mesh-list
2362661|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2362662|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112749|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112750|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112751|NCT02576067|Methotrexate|methotrexate|mesh-list
2112752|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2112753|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
2112754|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2112755|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112756|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2112757|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
2112758|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112759|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112760|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
2112761|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112762|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2112763|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2112764|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
2112765|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2112766|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2112767|NCT02576145|Daclizumab|daclizumab|mesh-list
2112768|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362663|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2362664|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362665|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362666|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2362667|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2362668|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2362669|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
2362670|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2362671|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362672|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2362673|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2362674|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2362675|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362676|NCT00543634|Estrogens|estrogens|mesh-ancestor
2362677|NCT00543634|Hormones|hormones|mesh-ancestor
2362678|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2362679|NCT00543647|Fenofibrate|fenofibrate|mesh-list
2112769|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
2112770|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112771|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
2112772|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2112773|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2112774|NCT02576249|Prednisolone|prednisolone|mesh-list
2112775|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
2112776|NCT02576249|Ropivacaine|ropivacaine|mesh-list
2112777|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2112778|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
2112779|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
2112780|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
2112781|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2112782|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112783|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
2112784|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112785|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2112786|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
2112787|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
2112788|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2112789|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
2112790|NCT02576249|Hormones|hormones|mesh-ancestor
2112791|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112792|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2112793|NCT02576249|Protective Agents|protective agents|mesh-ancestor
2112794|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2112795|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112796|NCT02576509|Nivolumab|nivolumab|mesh-list
2112797|NCT02576509|Sorafenib|sorafenib|mesh-list
2112798|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2112799|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112800|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2112801|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362680|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2362681|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
2362682|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362683|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2362684|NCT00543686|Fluticasone|fluticasone|mesh-list
2362685|NCT00543686|Montelukast|montelukast|mesh-list
2362686|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2362687|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2362688|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
2362689|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362690|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362691|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2362692|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
2362693|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
2362694|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2362695|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2362696|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
2362697|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2362698|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2362699|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2362700|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362701|NCT00543829|Tamoxifen|tamoxifen|mesh-list
2362702|NCT00543829|Docetaxel|docetaxel|mesh-list
2362703|NCT00543829|Doxorubicin|doxorubicin|mesh-list
2362704|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2362705|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362706|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
2362707|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
2362708|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
2362709|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362710|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2362711|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2362712|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2362713|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362714|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2362715|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
2362716|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112802|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2112803|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112804|NCT02576639|CNP520|cnp520|mesh-list
2112805|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112806|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112807|NCT02576652|Tetracycline|tetracycline|mesh-list
2112808|NCT02576652|Demeclocycline|demeclocycline|mesh-list
2112809|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2112810|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112811|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2112812|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112813|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112814|NCT02576678|Apremilast|apremilast|mesh-list
2112815|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2112816|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2112817|NCT02576678|Analgesics|analgesics|mesh-ancestor
2112818|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
2112819|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112820|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362717|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362718|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2362719|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2362720|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2112821|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2112822|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2112823|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2112824|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2112825|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112826|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112827|NCT02576938|Triamcinolone|triamcinolone|mesh-list
2112828|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2112829|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
2112830|NCT02576938|Hormones|hormones|mesh-ancestor
2112831|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112832|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112833|NCT02576977|Dexamethasone|dexamethasone|mesh-list
2112834|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
2112835|NCT02576977|Pomalidomide|pomalidomide|mesh-list
2112836|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2112837|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
2112838|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
2112839|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112840|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112841|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2112842|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
2112843|NCT02576977|Hormones|hormones|mesh-ancestor
2112844|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112845|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2112846|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112847|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2112848|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
2112849|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2112850|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2112851|NCT02576977|Growth Substances|growth substances|mesh-ancestor
2112852|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
2112853|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
2112854|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2112855|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112856|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2112857|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
2112858|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2112859|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112860|NCT02577003|Incretins|incretins|mesh-ancestor
2112861|NCT02577003|Hormones|hormones|mesh-ancestor
2112862|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112863|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2112864|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
2112865|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112866|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112867|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2112868|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2112869|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
2112870|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2112871|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112872|NCT02577016|Incretins|incretins|mesh-ancestor
2112873|NCT02577016|Hormones|hormones|mesh-ancestor
2112874|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112875|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2112876|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
2112877|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112878|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112879|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2112880|NCT02577029|Interferons|interferons|mesh-list
2112881|NCT02577029|Tenofovir|tenofovir|mesh-list
2112882|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
2112883|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
2112884|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2112885|NCT02577029|Entecavir|entecavir|mesh-list
2112886|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
2112887|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2112888|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362721|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2362722|NCT00543842|Bevacizumab|bevacizumab|mesh-list
2362723|NCT00543842|Capecitabine|capecitabine|mesh-list
2362724|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2362725|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2362726|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362727|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2362728|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2362729|NCT00543842|Growth Substances|growth substances|mesh-ancestor
2362730|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362731|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
2362732|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2362733|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
2362734|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112889|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
2112890|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112891|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2112892|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2112893|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112894|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112895|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2112896|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2112897|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
2112898|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112899|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
2112900|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112901|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
2112902|NCT02577042|Atorvastatin|atorvastatin|mesh-list
2112903|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2112904|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2112905|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
2112906|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112907|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2112908|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2112909|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112910|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2112911|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2112912|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
2112913|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112914|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2112915|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2112916|NCT02577107|Ranibizumab|ranibizumab|mesh-list
2112917|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2112918|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2112919|NCT02577107|Growth Substances|growth substances|mesh-ancestor
2362735|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2362736|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362737|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
2362738|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2362739|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
2362740|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2362741|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362742|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2362743|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
2362744|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2362745|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
2362746|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362747|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2362748|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2362749|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
2362750|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
2362751|NCT00543933|Protective Agents|protective agents|mesh-ancestor
2362752|NCT00543959|Pioglitazone|pioglitazone|mesh-list
2362753|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2362754|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362755|NCT00544011|Bevacizumab|bevacizumab|mesh-list
2362756|NCT00544011|Fluorouracil|fluorouracil|mesh-list
2362757|NCT00544011|Capecitabine|capecitabine|mesh-list
2362758|NCT00544011|Irinotecan|irinotecan|mesh-list
2362759|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2362760|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362761|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2112920|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112921|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
2112922|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112923|NCT02577315|Metformin|metformin|mesh-list
2112924|NCT02577315|Empagliflozin|empagliflozin|mesh-list
2112925|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2112926|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112927|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2112928|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112929|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
2112930|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2112931|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
2112932|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
2112933|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2362762|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2362763|NCT00544011|Growth Substances|growth substances|mesh-ancestor
2362764|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362765|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
2362766|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
2362767|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362768|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2362769|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2112934|NCT02577601|Estradiol|estradiol|mesh-list
2112935|NCT02577601|Estrogens|estrogens|mesh-ancestor
2112936|NCT02577601|Hormones|hormones|mesh-ancestor
2112937|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112938|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112939|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2112940|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
2112941|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2112942|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2112943|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2112944|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2112945|NCT02577718|Ethanol|ethanol|mesh-list
2112946|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
2112947|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2112948|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2112949|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2112950|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112951|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
2112952|NCT02577991|Triamcinolone|triamcinolone|mesh-list
2112953|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2112954|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112955|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
2112956|NCT02577991|Hormones|hormones|mesh-ancestor
2112957|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2112958|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
2112959|NCT02578186|Promethazine|promethazine|mesh-list
2112960|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2112961|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2112962|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2112963|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112964|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
2112965|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
2112966|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
2112967|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112968|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
2112969|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
2112970|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2112971|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2112972|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
2112973|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
2112974|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2112975|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112976|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2112977|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
2112978|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
2112979|NCT02578316|Lenvatinib|lenvatinib|mesh-list
2112980|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112981|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2112982|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2112983|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2112984|NCT02578680|Folic Acid|folic acid|mesh-list
2112985|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
2112986|NCT02578680|Hydroxocobalamin|hydroxocobalamin|mesh-list
2112987|NCT02578680|Dexamethasone|dexamethasone|mesh-list
2112988|NCT02578680|Carboplatin|carboplatin|mesh-list
2112989|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
2112990|NCT02578680|Pemetrexed|pemetrexed|mesh-list
2112991|NCT02578680|Vitamins|vitamins|mesh-ancestor
2112992|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
2112993|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2112994|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2112995|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2112996|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
2112997|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
2112998|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2112999|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2113000|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
2113001|NCT02578680|Hormones|hormones|mesh-ancestor
2113002|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2113003|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2113004|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2113005|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113006|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113007|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2113008|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2113009|NCT02578680|Hematinics|hematinics|mesh-ancestor
2113010|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
2113011|NCT02578706|Aspirin|aspirin|mesh-list
2113012|NCT02578706|Clopidogrel|clopidogrel|mesh-list
2113013|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2113014|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2113015|NCT02578706|Analgesics|analgesics|mesh-ancestor
2113016|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
2113017|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113018|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113019|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2113020|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2113021|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2113022|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2113023|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113024|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2113025|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2113026|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113027|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
2362770|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
2362771|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2362772|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2362773|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362774|NCT00544037|Interferons|interferons|mesh-list
2362775|NCT00544037|Interferon-beta|interferon-beta|mesh-list
2362776|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
2362777|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362778|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
2362779|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2362780|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
2362781|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362782|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2362783|NCT00544050|Levetiracetam|levetiracetam|mesh-list
2362784|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
2362785|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
2113028|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2113029|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2113030|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2113031|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
2113032|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2113033|NCT02578732|Leucovorin|leucovorin|mesh-list
2113034|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
2113035|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113036|NCT02578732|Antidotes|antidotes|mesh-ancestor
2113037|NCT02578732|Protective Agents|protective agents|mesh-ancestor
2113038|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113039|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
2113040|NCT02578732|Vitamins|vitamins|mesh-ancestor
2113041|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
2113042|NCT02578862|Propofol|propofol|mesh-list
2113043|NCT02578862|Sevoflurane|sevoflurane|mesh-list
2113044|NCT02578862|Isoflurane|isoflurane|mesh-list
2113045|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2113046|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2113047|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113048|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2113049|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
2113050|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
2113051|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2113052|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2113053|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
2113054|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2113055|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2113056|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113057|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
2113058|NCT02578901|Coagulants|coagulants|mesh-ancestor
2113059|NCT02579057|Furosemide|furosemide|mesh-list
2113060|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2113061|NCT02579057|Diuretics|diuretics|mesh-ancestor
2113062|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
2113063|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113064|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2113065|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2113066|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113067|NCT02579343|Dexetimide|dexetimide|mesh-list
2113068|NCT02579343|Citalopram|citalopram|mesh-list
2113069|NCT02579343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2113070|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2113071|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2113072|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113073|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2113074|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
2113075|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113076|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2113077|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
2113078|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2113079|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2113080|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2362786|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
2362787|NCT00544063|Irinotecan|irinotecan|mesh-list
2362788|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362789|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2362790|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2362791|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362792|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362793|NCT00544115|Cyclosporine|cyclosporine|mesh-list
2362794|NCT00544115|Sirolimus|sirolimus|mesh-list
2362795|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
2362796|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
2113081|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
2113082|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
2113083|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113084|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2113085|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2113086|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
2113087|NCT02579382|Vesatolimod|vesatolimod|mesh-list
2113088|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
2113089|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113090|NCT02579421|Progesterone|progesterone|mesh-list
2113091|NCT02579421|Progestins|progestins|mesh-ancestor
2113092|NCT02579421|Hormones|hormones|mesh-ancestor
2113093|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2113094|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113095|NCT02579603|Pirfenidone|pirfenidone|mesh-list
2113096|NCT02579603|Nintedanib|nintedanib|mesh-list
2113097|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113098|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2113099|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113100|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113101|NCT02579603|Analgesics|analgesics|mesh-ancestor
2113102|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
2113103|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113104|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113105|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2113106|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2113107|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2113108|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2113109|NCT02579616|Lenvatinib|lenvatinib|mesh-list
2113110|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113111|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2113112|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113113|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113114|NCT02579629|Ropivacaine|ropivacaine|mesh-list
2113115|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
2113116|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
2113117|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2113118|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113119|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
2113120|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113121|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
2113122|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2113123|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
2113124|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113125|NCT02579772|Expectorants|expectorants|mesh-ancestor
2113126|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
2113127|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2113128|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
2113129|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113130|NCT02579772|Protective Agents|protective agents|mesh-ancestor
2113131|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113132|NCT02579772|Antidotes|antidotes|mesh-ancestor
2113133|NCT02579811|Axitinib|axitinib|mesh-list
2362797|NCT00544115|Melphalan|melphalan|mesh-list
2113134|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113135|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2113136|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113137|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113138|NCT02579863|Dexamethasone|dexamethasone|mesh-list
2113139|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
2113140|NCT02579863|Lenalidomide|lenalidomide|mesh-list
2113141|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2113142|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
2362798|NCT00544115|Busulfan|busulfan|mesh-list
2362799|NCT00544115|Methotrexate|methotrexate|mesh-list
2362800|NCT00544115|Fludarabine|fludarabine|mesh-list
2362801|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
2362802|NCT00544115|Etoposide|etoposide|mesh-list
2362803|NCT00544115|Tacrolimus|tacrolimus|mesh-list
2362804|NCT00544115|Cyclosporins|cyclosporins|mesh-list
2362805|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362806|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
2362807|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362808|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2362809|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2362810|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
2113143|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
2113144|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113145|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113146|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2113147|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
2113148|NCT02579863|Hormones|hormones|mesh-ancestor
2113149|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2113150|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2113151|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113152|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2113153|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
2113154|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2113155|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2113156|NCT02579863|Growth Substances|growth substances|mesh-ancestor
2113157|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
2113158|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
2113159|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113160|NCT02579928|Midazolam|midazolam|mesh-list
2113161|NCT02579928|Ketamine|ketamine|mesh-list
2113162|NCT02579928|Analgesics|analgesics|mesh-ancestor
2113163|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
2113164|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113165|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113166|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2113167|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2113168|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
2113169|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
2113170|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2113171|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2113172|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2113173|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2113174|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113175|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2113176|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2113177|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2113178|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2113179|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2113180|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
2113181|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
2113182|NCT02580058|Doxorubicin|doxorubicin|mesh-list
2113183|NCT02580058|Avelumab|avelumab|mesh-list
2113184|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2362811|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362812|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362813|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2362814|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2362815|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
2362816|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2362817|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2362818|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
2362819|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
2362820|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362821|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2362822|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2362823|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2362824|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2362825|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2362826|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2362827|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
2362828|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113185|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113186|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2113187|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2113188|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113189|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113190|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2113191|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
2113192|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2113193|NCT02580591|Empagliflozin|empagliflozin|mesh-list
2113194|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2113195|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113196|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2113197|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113198|NCT02580877|Insulin|insulin|mesh-list
2113199|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2113200|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
2113201|NCT02580877|Methamphetamine|methamphetamine|mesh-list
2113202|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2113203|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113204|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2113205|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
2113206|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
2113207|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113208|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
2113209|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2113210|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113211|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
2113212|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2113213|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2113214|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2113215|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2113216|NCT02581111|Naloxone|naloxone|mesh-list
2113217|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2113218|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113219|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
2113220|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113221|NCT02581137|Metformin|metformin|mesh-list
2113222|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2113223|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113224|NCT02581163|Ritonavir|ritonavir|mesh-list
2113225|NCT02581163|Ribavirin|ribavirin|mesh-list
2113226|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2113227|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2113228|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
2113229|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113230|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113231|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2113232|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2113233|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
2113234|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113235|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2113236|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2113237|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
2113238|NCT02581189|Ritonavir|ritonavir|mesh-list
2113239|NCT02581189|Ribavirin|ribavirin|mesh-list
2113240|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2113241|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2113242|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
2113243|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113244|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113245|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2113246|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2113247|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
2113248|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113249|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2113250|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2113251|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
2113252|NCT02581202|Ritonavir|ritonavir|mesh-list
2113253|NCT02581202|Lopinavir|lopinavir|mesh-list
2113254|NCT02581202|Lamivudine|lamivudine|mesh-list
2113255|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2113256|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2113257|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
2113258|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113259|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113260|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2113261|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2113262|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
2113263|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113264|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2113265|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2113266|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2113267|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2113268|NCT02581345|Adalimumab|adalimumab|mesh-list
2113269|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2113270|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2113271|NCT02581839|Dexamethasone|dexamethasone|mesh-list
2113272|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
2113273|NCT02581839|Ondansetron|ondansetron|mesh-list
2113274|NCT02581839|BB 1101|bb 1101|mesh-list
2113275|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2113276|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
2113277|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
2113278|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113279|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113280|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2113281|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
2113282|NCT02581839|Hormones|hormones|mesh-ancestor
2113283|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2113284|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2113285|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113286|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
2113287|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113288|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113289|NCT02581839|Antipruritics|antipruritics|mesh-ancestor
2113290|NCT02581839|Dermatologic Agents|dermatologic agents|mesh-ancestor
2113291|NCT02581839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2113292|NCT02581839|Serotonin Agents|serotonin agents|mesh-ancestor
2113293|NCT02581839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2113294|NCT02581839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2113295|NCT02581839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2113296|NCT02581839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2113297|NCT02581839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2113298|NCT02581839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2113299|NCT02581891|Aflibercept|aflibercept|mesh-list
2113300|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2113301|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2113302|NCT02581891|Growth Substances|growth substances|mesh-ancestor
2113303|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113304|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
2113305|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113306|NCT02581995|Aflibercept|aflibercept|mesh-list
2113307|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2113308|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2113309|NCT02581995|Growth Substances|growth substances|mesh-ancestor
2113310|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113311|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
2113312|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113313|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
2113314|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
2113315|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2113316|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2113317|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113318|NCT02582515|Cycloserine|cycloserine|mesh-list
2113319|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2113320|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113321|NCT02582515|Renal Agents|renal agents|mesh-ancestor
2113322|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2113323|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
2113324|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2113325|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
2113326|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113327|NCT02582632|Ritonavir|ritonavir|mesh-list
2113328|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2113329|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2113330|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
2113331|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113332|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113333|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2113334|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2113335|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
2113336|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113337|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2113338|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2113339|NCT02582671|Ritonavir|ritonavir|mesh-list
2113340|NCT02582671|Ribavirin|ribavirin|mesh-list
2113341|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2113342|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2113343|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
2113344|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113345|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113346|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2113347|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2113348|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
2113349|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113350|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2113351|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2113352|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
2113353|NCT02582684|Lamivudine|lamivudine|mesh-list
2113354|NCT02582684|Dolutegravir|dolutegravir|mesh-list
2113355|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2113356|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2113357|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113358|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113359|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
2113360|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113361|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2113362|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2113363|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2113364|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2113365|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
2113366|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2113367|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113368|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2113369|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113370|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
2113371|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2113372|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113373|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2113374|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113375|NCT02582866|Lacosamide|lacosamide|mesh-list
2113376|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
2113377|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2113378|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2113379|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2113380|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113381|NCT02582970|Bevacizumab|bevacizumab|mesh-list
2113382|NCT02582970|Fluorouracil|fluorouracil|mesh-list
2113383|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
2113384|NCT02582970|Irinotecan|irinotecan|mesh-list
2113385|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2113386|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113387|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2113388|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2113389|NCT02582970|Growth Substances|growth substances|mesh-ancestor
2113390|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113391|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
2113392|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
2113393|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113394|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2113395|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2113396|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
2113397|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2113398|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2113399|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113400|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
2113401|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2113402|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2113403|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113404|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2113405|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2113406|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
2113407|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113420|NCT02583399|Ibuprofen|ibuprofen|mesh-list
2113421|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2113422|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2113423|NCT02583399|Analgesics|analgesics|mesh-ancestor
2113424|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
2113425|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113426|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113427|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2113428|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2113429|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2362829|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2362830|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2362831|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
2362832|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2362833|NCT00544128|Ritonavir|ritonavir|mesh-list
2113430|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113431|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113432|NCT02583477|Gemcitabine|gemcitabine|mesh-list
2113433|NCT02583477|Paclitaxel|paclitaxel|mesh-list
2113434|NCT02583477|Durvalumab|durvalumab|mesh-list
2113435|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2113436|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2113437|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113438|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
2113439|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
2113440|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
2113441|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113442|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2113443|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
2113444|NCT02583477|Antiviral Agents|antiviral agents|mesh-ancestor
2113445|NCT02583477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113446|NCT02583477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113447|NCT02583477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2113448|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
2113449|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113450|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2113451|NCT02584257|Albuterol|albuterol|mesh-list
2113452|NCT02584257|Procaterol|procaterol|mesh-list
2113453|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
2113454|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2113455|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
2113456|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113457|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113458|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2113459|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
2113460|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
2113461|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2113462|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2113463|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2113464|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2113465|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
2113466|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2113467|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113468|NCT02584257|Miotics|miotics|mesh-ancestor
2113469|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2113470|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2113471|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2113472|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2113473|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
2113474|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
2113475|NCT02584452|Dexamethasone|dexamethasone|mesh-list
2113476|NCT02584452|Fentanyl|fentanyl|mesh-list
2113477|NCT02584452|Bupivacaine|bupivacaine|mesh-list
2113478|NCT02584452|Ropivacaine|ropivacaine|mesh-list
2113479|NCT02584452|Mepivacaine|mepivacaine|mesh-list
2113480|NCT02584452|Propofol|propofol|mesh-list
2113481|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2113482|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
2113483|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
2113484|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113485|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113486|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2113487|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
2113488|NCT02584452|Hormones|hormones|mesh-ancestor
2113489|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2113490|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2113491|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113492|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
2113493|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
2113494|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2113495|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
2113496|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2113497|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2113498|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
2113499|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2113500|NCT02584452|Narcotics|narcotics|mesh-ancestor
2113501|NCT02584452|Analgesics|analgesics|mesh-ancestor
2113502|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2113503|NCT02584504|Atorvastatin|atorvastatin|mesh-list
2113504|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2113505|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2113506|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
2113507|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113508|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2113509|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2113510|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113511|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
2113512|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
2113513|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113514|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
2113515|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2113516|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
2113517|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2113518|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
2113519|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113520|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113521|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
2113522|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
2113523|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2113524|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2113525|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2113526|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2113527|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113528|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
2113529|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2113530|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113531|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2113532|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113533|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
2362834|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2362835|NCT00544128|Tenofovir|tenofovir|mesh-list
2362836|NCT00544128|Lamivudine|lamivudine|mesh-list
2362837|NCT00544128|Emtricitabine|emtricitabine|mesh-list
2362838|NCT00544128|Abacavir|abacavir|mesh-list
2362839|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2362840|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2362841|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
2362842|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362843|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362844|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2362845|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2362846|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
2362847|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2362848|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2362849|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2113534|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2113535|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2113536|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113537|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
2113538|NCT02584725|Coagulants|coagulants|mesh-ancestor
2113539|NCT02584855|Ixekizumab|ixekizumab|mesh-list
2113540|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
2113541|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2113542|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
2113543|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
2113544|NCT02584959|Complement C1s|complement c1s|mesh-list
2113545|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2113546|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2113547|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
2113548|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113549|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2113550|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2113551|NCT02585713|Dalteparin|dalteparin|mesh-list
2113552|NCT02585713|Tinzaparin|tinzaparin|mesh-list
2113553|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2113554|NCT02585713|Apixaban|apixaban|mesh-list
2113555|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2113556|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
2113557|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2113558|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
2113559|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113560|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113561|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
2113562|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2113563|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2113564|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2113565|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113566|NCT02585843|Spironolactone|spironolactone|mesh-list
2113567|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2113568|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
2113569|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2113570|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113571|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2113572|NCT02585843|Diuretics|diuretics|mesh-ancestor
2113573|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
2113574|NCT02585895|Evolocumab|evolocumab|mesh-list
2113575|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2113576|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2113577|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
2113578|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113579|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2113580|NCT02585960|Factor VIII|factor viii|mesh-list
2113581|NCT02585960|BAX 855|bax 855|mesh-list
2113582|NCT02585960|Coagulants|coagulants|mesh-ancestor
2113583|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
2113584|NCT02585999|Ortho Evra|ortho evra|mesh-list
2113585|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2113586|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113587|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2113597|NCT02586155|Atorvastatin|atorvastatin|mesh-list
2113598|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2113599|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2113600|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2113601|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
2113602|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113603|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2113604|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2113605|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113606|NCT02586207|Cisplatin|cisplatin|mesh-list
2113607|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
2113608|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113609|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2113621|NCT02586727|Aflibercept|aflibercept|mesh-list
2113622|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2113623|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2113624|NCT02586727|Growth Substances|growth substances|mesh-ancestor
2113625|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113626|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
2113627|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113628|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2113629|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
2113630|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113633|NCT02587065|Interferons|interferons|mesh-list
2113634|NCT02587065|Interferon-beta|interferon-beta|mesh-list
2113635|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
2113636|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113637|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
2113638|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113639|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
2113640|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113641|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2113642|NCT02587117|Prednisolone|prednisolone|mesh-list
2113643|NCT02587117|Lycopene|lycopene|mesh-list
2113644|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2113645|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
2113646|NCT02587117|Hormones|hormones|mesh-ancestor
2113647|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2113648|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113649|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2113650|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113651|NCT02587117|Protective Agents|protective agents|mesh-ancestor
2113652|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
2113653|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113654|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2113655|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2113656|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
2113657|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
2113658|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
2113659|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2113660|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113661|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
2113662|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113663|NCT02587351|Metoprolol|metoprolol|mesh-list
2113664|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2113665|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2113666|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
2362850|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2362851|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2113667|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
2113668|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113669|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113670|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2113671|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2113672|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2113673|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
2113674|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2113675|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113676|NCT02587520|Vaccines|vaccines|mesh-list
2113677|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
2113678|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113679|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
2113680|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2113681|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113682|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2113683|NCT02588261|Gefitinib|gefitinib|mesh-list
2113684|NCT02588261|Naquotinib|naquotinib|mesh-list
2113685|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113686|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2113687|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113688|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113689|NCT02588339|Sirolimus|sirolimus|mesh-list
2113690|NCT02588339|Panobinostat|panobinostat|mesh-list
2113691|NCT02588339|Tacrolimus|tacrolimus|mesh-list
2113692|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2113693|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
2113694|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113695|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2113696|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113697|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113698|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2113699|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113700|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2113701|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113702|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
2113703|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2113704|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2113705|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
2113706|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113707|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
2113708|NCT02588612|Fludarabine|fludarabine|mesh-list
2113709|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2113710|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
2113711|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113712|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2113713|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2113714|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
2113715|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113716|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113717|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2113718|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
2113719|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2113720|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
2113721|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113722|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
2113723|NCT02588872|Protective Agents|protective agents|mesh-ancestor
2113724|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
2113725|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2113726|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2113727|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113728|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
2113729|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
2113730|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2113731|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
2113732|NCT02589626|Empagliflozin|empagliflozin|mesh-list
2113733|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2113734|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113735|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2113736|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113737|NCT02589639|Empagliflozin|empagliflozin|mesh-list
2113738|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2362852|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
2362853|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362854|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
2362855|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362856|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2362857|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
2362858|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2362859|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2362860|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362861|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2362862|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362863|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2362864|NCT00544193|Gemcitabine|gemcitabine|mesh-list
2362865|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2362866|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
2362867|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362868|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362869|NCT00544193|Antiviral Agents|antiviral agents|mesh-ancestor
2362870|NCT00544193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2362871|NCT00544193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362872|NCT00544193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362873|NCT00544193|Immunologic Factors|immunologic factors|mesh-ancestor
2362874|NCT00544193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362875|NCT00544219|Prednisone|prednisone|mesh-list
2362876|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
2362877|NCT00544219|Rituximab|rituximab|mesh-list
2362878|NCT00544219|Doxorubicin|doxorubicin|mesh-list
2362879|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2362880|NCT00544219|Vincristine|vincristine|mesh-list
2362881|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362882|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
2362883|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362884|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2362885|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2362886|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
2362887|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362888|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362889|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2362890|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2362891|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2362892|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2362893|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2362894|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362895|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2362896|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
2362897|NCT00544219|Hormones|hormones|mesh-ancestor
2362898|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2362899|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2362900|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2362901|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
2362902|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
2362903|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
2362904|NCT00544232|Paclitaxel|paclitaxel|mesh-list
2362905|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2362906|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
2362907|NCT00544232|Methotrexate|methotrexate|mesh-list
2362908|NCT00544232|Epirubicin|epirubicin|mesh-list
2362909|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
2362910|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2362911|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362912|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
2362913|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
2362914|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
2362915|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362916|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362917|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
2362918|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362919|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2362920|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2362921|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
2362922|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2362923|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2362924|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
2362925|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2362926|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2362927|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
2362928|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
2362929|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362930|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2362931|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2362932|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2362933|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2362934|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2362935|NCT00544232|Hematinics|hematinics|mesh-ancestor
2362936|NCT00544284|Bortezomib|bortezomib|mesh-list
2362937|NCT00544284|Temozolomide|temozolomide|mesh-list
2362938|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362939|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2362940|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
2362941|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362942|NCT00544349|Leucovorin|leucovorin|mesh-list
2362943|NCT00544349|Fluorouracil|fluorouracil|mesh-list
2362944|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
2362945|NCT00544349|Cetuximab|cetuximab|mesh-list
2362946|NCT00544349|Calcium|calcium|mesh-list
2362947|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
2362948|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2362949|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362950|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
2362951|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362952|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2362953|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362954|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362955|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
2362956|NCT00544349|Antidotes|antidotes|mesh-ancestor
2362957|NCT00544349|Protective Agents|protective agents|mesh-ancestor
2362958|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
2362959|NCT00544349|Vitamins|vitamins|mesh-ancestor
2362960|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
2362961|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2362962|NCT00544362|Fluorouracil|fluorouracil|mesh-list
2362963|NCT00544362|Cetuximab|cetuximab|mesh-list
2362964|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362965|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
2362966|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362967|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2362968|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362969|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
2362970|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362971|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2362972|NCT00544388|Levocetirizine|levocetirizine|mesh-list
2362973|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2362974|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2362975|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
2362976|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
2362977|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2362978|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362979|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362980|NCT00544414|Leucovorin|leucovorin|mesh-list
2362981|NCT00544414|Gemcitabine|gemcitabine|mesh-list
2362982|NCT00544414|Docetaxel|docetaxel|mesh-list
2362983|NCT00544414|Fluorouracil|fluorouracil|mesh-list
2362984|NCT00544414|Calcium|calcium|mesh-list
2362985|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
2362986|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2362987|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2362988|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
2362989|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2362990|NCT00544414|Antiviral Agents|antiviral agents|mesh-ancestor
2362991|NCT00544414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2362992|NCT00544414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2362993|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2362994|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
2362995|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2362996|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
2362997|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
2362998|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
2362999|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2363000|NCT00544414|Antidotes|antidotes|mesh-ancestor
2363001|NCT00544414|Protective Agents|protective agents|mesh-ancestor
2363002|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
2363003|NCT00544414|Vitamins|vitamins|mesh-ancestor
2363004|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
2363005|NCT00544466|Fludarabine|fludarabine|mesh-list
2363006|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
2363007|NCT00544466|Melphalan|melphalan|mesh-list
2363008|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363009|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2363010|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
2363011|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363012|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2363013|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
2363014|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363015|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2363016|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
2363017|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2363018|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
2363019|NCT00544505|Fluorouracil|fluorouracil|mesh-list
2363020|NCT00544505|Epirubicin|epirubicin|mesh-list
2363021|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2363022|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
2363023|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363024|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2363025|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2363026|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
2363027|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363028|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363029|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2363030|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
2363031|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2363032|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2363033|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2363034|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2363035|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363036|NCT00544518|Metformin|metformin|mesh-list
2363037|NCT00544518|Benfluorex|benfluorex|mesh-list
2363038|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2363039|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363040|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2363041|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
2363042|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363043|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2363044|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
2363045|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2363046|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
2363047|NCT00544570|Melphalan|melphalan|mesh-list
2363048|NCT00544570|Carmustine|carmustine|mesh-list
2363049|NCT00544570|Etoposide|etoposide|mesh-list
2363050|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2363051|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
2363052|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363053|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2363054|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2363055|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
2363056|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363057|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363058|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2363059|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2363060|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2363061|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2363062|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363063|NCT00544596|Acetic Acid|acetic acid|mesh-list
2363064|NCT00544596|Etoposide|etoposide|mesh-list
2363065|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
2363066|NCT00544596|Retinol acetate|retinol acetate|mesh-list
2363067|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
2363068|NCT00544596|Gossypol|gossypol|mesh-list
2363069|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363070|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2363071|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2363072|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2363073|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363074|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363075|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2363076|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363077|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2363078|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
2363079|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363080|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2363081|NCT00544596|Protective Agents|protective agents|mesh-ancestor
2363082|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2363083|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
2363084|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2363085|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2363086|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2363087|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2363088|NCT00544609|Sorafenib|sorafenib|mesh-list
2363089|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363090|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2363091|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363092|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363093|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
2363094|NCT00544687|Nortriptyline|nortriptyline|mesh-list
2363095|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2363096|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
2363097|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2363098|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2363099|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
2363100|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2363101|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2363102|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2363103|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2363104|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363105|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
2363106|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363107|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363108|NCT00544700|Bevacizumab|bevacizumab|mesh-list
2363109|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2363110|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363111|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2363112|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2363113|NCT00544700|Growth Substances|growth substances|mesh-ancestor
2363114|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363115|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
2363116|NCT00544791|Melatonin|melatonin|mesh-list
2363117|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
2363118|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363119|NCT00544791|Protective Agents|protective agents|mesh-ancestor
2363120|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363121|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2363122|NCT00544804|Lapatinib|lapatinib|mesh-list
2363123|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363124|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2363125|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363126|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363127|NCT00544830|Leuprolide|leuprolide|mesh-list
2363128|NCT00544830|Goserelin|goserelin|mesh-list
2363129|NCT00544830|Bicalutamide|bicalutamide|mesh-list
2363130|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2363131|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
2363132|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2363133|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363134|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2363135|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363136|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
2363137|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
2363138|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2363139|NCT00544960|Docetaxel|docetaxel|mesh-list
2363140|NCT00544960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363141|NCT00544960|Tubulin Modulators|tubulin modulators|mesh-ancestor
2363142|NCT00544960|Antimitotic Agents|antimitotic agents|mesh-ancestor
2363143|NCT00544960|Mitosis Modulators|mitosis modulators|mesh-ancestor
2363144|NCT00544960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363145|NCT00544986|Anastrozole|anastrozole|mesh-list
2363146|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2363147|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363148|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2363149|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2363150|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363151|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363152|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2363153|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
2363154|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2363155|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363156|NCT00544999|Cytarabine|cytarabine|mesh-list
2363157|NCT00544999|Everolimus|everolimus|mesh-list
2363158|NCT00544999|Daunorubicin|daunorubicin|mesh-list
2363159|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2363160|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
2363161|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363162|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363163|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
2363164|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363165|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2363166|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
2363167|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363168|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2363169|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2363170|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2363171|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363172|NCT00545012|Levetiracetam|levetiracetam|mesh-list
2363173|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
2363174|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
2363175|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
2363176|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2363177|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363178|NCT00545129|Tanezumab|tanezumab|mesh-list
2363179|NCT00545129|Analgesics|analgesics|mesh-ancestor
2363180|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
2363181|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363182|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363183|NCT00545142|Valproic Acid|valproic acid|mesh-list
2363184|NCT00545142|Aripiprazole|aripiprazole|mesh-list
2363185|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
2363186|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2363187|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2363188|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2363189|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2363190|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363191|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
2363192|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
2363193|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363194|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363195|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2363196|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2363197|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
2363198|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2363199|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2363200|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2363201|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2363202|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
2363203|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363204|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
2363205|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
2363206|NCT00545194|Dinoprostone|dinoprostone|mesh-list
2363207|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
2363208|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2363209|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363210|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
2363211|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2363212|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363213|NCT00545246|Docetaxel|docetaxel|mesh-list
2363214|NCT00545246|Aflibercept|aflibercept|mesh-list
2363215|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363216|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
2363217|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
2363218|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
2363219|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363220|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2363221|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2363222|NCT00545246|Growth Substances|growth substances|mesh-ancestor
2363223|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363224|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
2363225|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
2363226|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2363227|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2363228|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2363229|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
2363230|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363231|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363232|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363233|NCT00545324|Fluticasone|fluticasone|mesh-list
2363234|NCT00545324|Montelukast|montelukast|mesh-list
2363235|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2363236|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2363237|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
2363238|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363239|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363240|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2363241|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
2363242|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
2363243|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2363244|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363245|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2363246|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
2363247|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2363248|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2363249|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2363250|NCT00545389|Mesalamine|mesalamine|mesh-list
2363251|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2363252|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2363253|NCT00545389|Analgesics|analgesics|mesh-ancestor
2363254|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
2363255|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363256|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363257|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2363258|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2363259|NCT00545467|Aripiprazole|aripiprazole|mesh-list
2363260|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
2363261|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2363262|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2363263|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2363264|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2363265|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363266|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
2363267|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
2363268|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363269|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363270|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2363271|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2363272|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
2363273|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2363274|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2363275|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2363276|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2363277|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
2363278|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2363279|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363280|NCT00545493|Tacrolimus|tacrolimus|mesh-list
2363281|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
2363282|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2363283|NCT00545493|Antibodies|antibodies|mesh-list
2363284|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2363285|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
2363286|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363287|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2363288|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363289|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363290|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
2363291|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
2363292|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363293|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2363294|NCT00545558|Tenofovir|tenofovir|mesh-list
2363295|NCT00545558|Emtricitabine|emtricitabine|mesh-list
2363296|NCT00545558|Efavirenz|efavirenz|mesh-list
2363297|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2363298|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
2363299|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363300|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2363301|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2363302|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363303|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363304|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2363305|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2363306|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2363307|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2363308|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2363309|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2363310|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2363311|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2363312|NCT00545675|Valproic Acid|valproic acid|mesh-list
2363313|NCT00545675|Aripiprazole|aripiprazole|mesh-list
2363314|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
2363315|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2363316|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2363317|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2363318|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2363319|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363320|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
2363321|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
2363322|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363323|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363324|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2363325|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2363326|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
2363327|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2363328|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2363329|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2363330|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2363331|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
2363332|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363333|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
2363334|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
2363335|NCT00545831|Taurolidine|taurolidine|mesh-list
2363336|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363337|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2363338|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363339|NCT00545857|Pioglitazone|pioglitazone|mesh-list
2363340|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2363341|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363342|NCT00545870|Bevacizumab|bevacizumab|mesh-list
2363343|NCT00545870|Ranibizumab|ranibizumab|mesh-list
2363344|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2363345|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363346|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2363347|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2363348|NCT00545870|Growth Substances|growth substances|mesh-ancestor
2363349|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363350|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
2363351|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
2363352|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2363353|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363354|NCT00545935|Artesunate|artesunate|mesh-list
2363355|NCT00545935|Amodiaquine|amodiaquine|mesh-list
2363356|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
2363357|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2363358|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2363359|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363360|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363361|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
2363362|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
2363363|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2363364|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
2363365|NCT00545961|Amoxicillin|amoxicillin|mesh-list
2363366|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
2363367|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
2363368|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2363369|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2363370|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363371|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2363372|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363373|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363374|NCT00546039|Genistein|genistein|mesh-list
2363375|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2363376|NCT00546039|Protective Agents|protective agents|mesh-ancestor
2363377|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363378|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363379|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2363380|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363381|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363382|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
2363383|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2363384|NCT00546039|Estrogens|estrogens|mesh-ancestor
2363385|NCT00546039|Hormones|hormones|mesh-ancestor
2363386|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2363387|NCT00546065|Esomeprazole|esomeprazole|mesh-list
2363388|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2363389|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2363390|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2363391|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363392|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363393|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
2363394|NCT00546130|Cisplatin|cisplatin|mesh-list
2363395|NCT00546130|Irinotecan|irinotecan|mesh-list
2363396|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363397|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2363398|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2363399|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363400|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363401|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2363402|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
2363403|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363404|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2363405|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
2363406|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363407|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
2363408|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2363409|NCT00546130|Protective Agents|protective agents|mesh-ancestor
2363410|NCT00546143|Omalizumab|omalizumab|mesh-list
2363411|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2363412|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2363413|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2363414|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
2363415|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
2363416|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363417|NCT00546169|Thrombin|thrombin|mesh-list
2363418|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
2363419|NCT00546169|Coagulants|coagulants|mesh-ancestor
2363420|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
2363421|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2363422|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
2363423|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363424|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363425|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2363426|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
2363427|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
2363428|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2363429|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
2363430|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363431|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363432|NCT00546286|Timolol|timolol|mesh-list
2363433|NCT00546286|Dorzolamide|dorzolamide|mesh-list
2363434|NCT00546286|Maleic acid|maleic acid|mesh-list
2363435|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2363436|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2363437|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
2363438|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363439|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363440|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363441|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2363442|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2363443|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363444|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2363445|NCT00546325|Rimonabant|rimonabant|mesh-list
2363446|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2363447|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2363448|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2363449|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363450|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363451|NCT00546325|Hormones|hormones|mesh-ancestor
2363452|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2363453|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363454|NCT00546403|Modafinil|modafinil|mesh-list
2363455|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2363456|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363457|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2363458|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2363459|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2363460|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363461|NCT00546442|Metformin|metformin|mesh-list
2363462|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2363463|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363464|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2363465|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2363466|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2363467|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2363468|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363469|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363470|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363471|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2363472|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
2363473|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2363474|NCT00546507|Celecoxib|celecoxib|mesh-list
2363475|NCT00546507|Diclofenac|diclofenac|mesh-list
2363476|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2363477|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2363478|NCT00546507|Analgesics|analgesics|mesh-ancestor
2363479|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
2363480|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363481|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363482|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2363483|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2363484|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2363485|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2363486|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363487|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363488|NCT00546520|Ciclesonide|ciclesonide|mesh-list
2363489|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
2363490|NCT00546520|Hormones|hormones|mesh-ancestor
2363491|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2363492|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363493|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2363494|NCT00546533|Etanercept|etanercept|mesh-list
2363495|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2363496|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2363497|NCT00546533|Analgesics|analgesics|mesh-ancestor
2363498|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
2363499|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363500|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363501|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2363502|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2363503|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2363504|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2363505|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
2363506|NCT00546546|Methotrexate|methotrexate|mesh-list
2363507|NCT00546546|Azathioprine|azathioprine|mesh-list
2363508|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2363509|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2363510|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
2363511|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2363512|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363513|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2363514|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
2363515|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363516|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363517|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
2363518|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363519|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2363520|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
2363521|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2363522|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2363523|NCT00546559|Simvastatin|simvastatin|mesh-list
2363524|NCT00546559|Pravastatin|pravastatin|mesh-list
2363525|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2363526|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2363527|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
2363528|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363529|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2363530|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2363531|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363532|NCT00546650|Sumatriptan|sumatriptan|mesh-list
2363533|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2363534|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2363535|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2363536|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
2363537|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363538|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363539|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363540|NCT00546676|Telithromycin|telithromycin|mesh-list
2363541|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2363542|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363543|NCT00546741|Metformin|metformin|mesh-list
2363544|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
2363545|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2363546|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363547|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2363548|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363549|NCT00546780|Bortezomib|bortezomib|mesh-list
2363550|NCT00546780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363551|NCT00546793|Veltuzumab|veltuzumab|mesh-list
2363552|NCT00546793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363553|NCT00546832|Celecoxib|celecoxib|mesh-list
2363554|NCT00546832|Diclofenac|diclofenac|mesh-list
2363555|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2363556|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2363557|NCT00546832|Analgesics|analgesics|mesh-ancestor
2363558|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
2363559|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363560|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363561|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2363562|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2363563|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2363564|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2363565|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363566|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363567|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2363568|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2363569|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2363570|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2363571|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363572|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363573|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363574|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2363575|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
2363576|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2363577|NCT00546936|Ranibizumab|ranibizumab|mesh-list
2363578|NCT00546936|Verteporfin|verteporfin|mesh-list
2363579|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2363580|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2363581|NCT00546936|Growth Substances|growth substances|mesh-ancestor
2363582|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363583|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
2363584|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363585|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2363586|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
2363587|NCT00547001|Estradiol|estradiol|mesh-list
2363588|NCT00547001|Estrogens|estrogens|mesh-ancestor
2363589|NCT00547001|Hormones|hormones|mesh-ancestor
2363590|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2363591|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363592|NCT00547053|Amiloride|amiloride|mesh-list
2363593|NCT00547053|Diuretics|diuretics|mesh-ancestor
2363594|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
2363595|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363596|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2363597|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2363598|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2363599|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363600|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2363601|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2363602|NCT00547066|Veltuzumab|veltuzumab|mesh-list
2363603|NCT00547066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363604|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
2363605|NCT00547092|Tadalafil|tadalafil|mesh-list
2363606|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
2363607|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2363608|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2363609|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363610|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363611|NCT00547092|Urological Agents|urological agents|mesh-ancestor
2363612|NCT00547131|Temozolomide|temozolomide|mesh-list
2363613|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2363614|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
2363615|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363616|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363617|NCT00547144|Gemcitabine|gemcitabine|mesh-list
2363618|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2363619|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
2363620|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363621|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363622|NCT00547144|Antiviral Agents|antiviral agents|mesh-ancestor
2363623|NCT00547144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363624|NCT00547144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363625|NCT00547144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2363626|NCT00547144|Immunologic Factors|immunologic factors|mesh-ancestor
2363627|NCT00547144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363628|NCT00547170|Doxycycline|doxycycline|mesh-list
2363629|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2363630|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363631|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
2363632|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2363633|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2363634|NCT00547183|Tadalafil|tadalafil|mesh-list
2363635|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
2363636|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2363637|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2363638|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363639|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363640|NCT00547183|Urological Agents|urological agents|mesh-ancestor
2363641|NCT00547196|Cyclosporine|cyclosporine|mesh-list
2363642|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
2363643|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
2363644|NCT00547196|Melphalan|melphalan|mesh-list
2363645|NCT00547196|Busulfan|busulfan|mesh-list
2363646|NCT00547196|Fludarabine|fludarabine|mesh-list
2363647|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
2363648|NCT00547196|Cyclosporins|cyclosporins|mesh-list
2363649|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2363650|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
2363651|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363652|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2363653|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2363654|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
2363655|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363656|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363657|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2363658|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2363659|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
2363660|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363661|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
2363662|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363663|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
2363664|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2363665|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2363666|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2363667|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
2363668|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2363669|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
2363670|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2363671|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
2363672|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
2363673|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2363674|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363675|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2363676|NCT00547209|Analgesics|analgesics|mesh-ancestor
2363677|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
2363678|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363679|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
2363680|NCT00547287|Tadalafil|tadalafil|mesh-list
2363681|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
2363682|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2363683|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2363684|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363685|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363686|NCT00547287|Urological Agents|urological agents|mesh-ancestor
2363687|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
2363688|NCT00547352|Tadalafil|tadalafil|mesh-list
2363689|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
2363690|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2363691|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2363692|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363693|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363694|NCT00547352|Urological Agents|urological agents|mesh-ancestor
2363695|NCT00547417|Tadalafil|tadalafil|mesh-list
2363696|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
2363697|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2363698|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2363699|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363700|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363701|NCT00547417|Urological Agents|urological agents|mesh-ancestor
2363702|NCT00547443|Paclitaxel|paclitaxel|mesh-list
2363703|NCT00547443|Carboplatin|carboplatin|mesh-list
2363704|NCT00547443|Sorafenib|sorafenib|mesh-list
2363705|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2363706|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363707|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
2363708|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
2363709|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
2363710|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363711|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2363712|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363713|NCT00547495|Tadalafil|tadalafil|mesh-list
2363714|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
2363715|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2363716|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2363717|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363718|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363719|NCT00547495|Urological Agents|urological agents|mesh-ancestor
2363720|NCT00547508|Tadalafil|tadalafil|mesh-list
2363721|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
2363722|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2363723|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2363724|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363725|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363726|NCT00547508|Urological Agents|urological agents|mesh-ancestor
2363727|NCT00547547|Selenium|selenium|mesh-list
2363728|NCT00547547|Capecitabine|capecitabine|mesh-list
2363729|NCT00547547|Irinotecan|irinotecan|mesh-list
2363730|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2363731|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
2363732|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363733|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363734|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2363735|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2363736|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363737|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
2363738|NCT00547547|Protective Agents|protective agents|mesh-ancestor
2363739|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363740|NCT00547547|Trace Elements|trace elements|mesh-ancestor
2363741|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
2363742|NCT00547573|Tadalafil|tadalafil|mesh-list
2363743|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
2363744|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2363745|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2363746|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363747|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363748|NCT00547573|Urological Agents|urological agents|mesh-ancestor
2363749|NCT00547599|Tadalafil|tadalafil|mesh-list
2363750|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
2363751|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2363752|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2363753|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363754|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363755|NCT00547599|Urological Agents|urological agents|mesh-ancestor
2363756|NCT00547612|Substance P|substance p|mesh-list
2363757|NCT00547612|Neurokinin A|neurokinin a|mesh-list
2363758|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363759|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363760|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363761|NCT00547625|Tadalafil|tadalafil|mesh-list
2363762|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
2363763|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2363764|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2363765|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363766|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363767|NCT00547625|Urological Agents|urological agents|mesh-ancestor
2363768|NCT00547651|Topotecan|topotecan|mesh-list
2363769|NCT00547651|Amrubicin|amrubicin|mesh-list
2363770|NCT00547651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2363771|NCT00547651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2363772|NCT00547651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363773|NCT00547651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363774|NCT00547651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363775|NCT00547664|Morphine|morphine|mesh-list
2363776|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2363777|NCT00547664|Narcotics|narcotics|mesh-ancestor
2363778|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2363779|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363780|NCT00547664|Analgesics|analgesics|mesh-ancestor
2363781|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
2363782|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363783|NCT00547768|Fexofenadine|fexofenadine|mesh-list
2363784|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2363785|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2363786|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2363787|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
2363788|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
2363789|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363790|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363791|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363792|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
2363793|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2363794|NCT00547885|Narcotics|narcotics|mesh-ancestor
2363795|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2363796|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363797|NCT00547885|Analgesics|analgesics|mesh-ancestor
2363798|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
2363799|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363800|NCT00547989|Bupivacaine|bupivacaine|mesh-list
2363801|NCT00547989|Ropivacaine|ropivacaine|mesh-list
2363802|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
2363803|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
2363804|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2363805|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363806|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
2363807|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363808|NCT00548002|Levofloxacin|levofloxacin|mesh-list
2363809|NCT00548002|Ofloxacin|ofloxacin|mesh-list
2363810|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
2363811|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2363812|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363813|NCT00548002|Renal Agents|renal agents|mesh-ancestor
2363814|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2363815|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2363816|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2363817|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363818|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363819|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363820|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2363821|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2363822|NCT00548067|Amlodipine|amlodipine|mesh-list
2363823|NCT00548067|Valsartan|valsartan|mesh-list
2363824|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2363825|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2363826|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2363827|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2363828|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363829|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2363830|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363831|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
2363832|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2363833|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2363834|NCT00548067|Diuretics|diuretics|mesh-ancestor
2363835|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
2363836|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2363837|NCT00548080|Caspofungin|caspofungin|mesh-list
2363838|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
2363839|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363840|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363841|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363842|NCT00548288|Pamidronate|pamidronate|mesh-list
2363843|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2363844|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363845|NCT00548301|Cyclosporine|cyclosporine|mesh-list
2363846|NCT00548301|Cyclosporins|cyclosporins|mesh-list
2363847|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363848|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363849|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2363850|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
2363851|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363852|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
2363853|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2363854|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
2363855|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2363856|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2363857|NCT00548379|Vitamin D|vitamin d|mesh-list
2363858|NCT00548379|Vitamins|vitamins|mesh-ancestor
2363859|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
2363860|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363861|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2363862|NCT00548483|Dexamethasone|dexamethasone|mesh-list
2363863|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2363864|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
2363865|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
2363866|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363867|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363868|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2363869|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
2363870|NCT00548483|Hormones|hormones|mesh-ancestor
2363871|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2363872|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2363873|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363874|NCT00548509|Vitamin K|vitamin k|mesh-list
2363875|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
2363876|NCT00548509|Menatetrenone|menatetrenone|mesh-list
2363877|NCT00548509|Vitamins|vitamins|mesh-ancestor
2363878|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
2363879|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363880|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2363881|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2363882|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363883|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
2363884|NCT00548509|Coagulants|coagulants|mesh-ancestor
2363885|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
2363886|NCT00548561|Razoxane|razoxane|mesh-list
2363887|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363888|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2363889|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2363890|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2363891|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363892|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363893|NCT00548561|Protective Agents|protective agents|mesh-ancestor
2363894|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363895|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
2363896|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
2363897|NCT00548574|Mesalamine|mesalamine|mesh-list
2363898|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2363899|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2363900|NCT00548574|Analgesics|analgesics|mesh-ancestor
2363901|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
2363902|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363903|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363904|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2363905|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2363906|NCT00548678|Aspirin|aspirin|mesh-list
2363907|NCT00548678|Diclofenac|diclofenac|mesh-list
2363908|NCT00548678|Ketorolac|ketorolac|mesh-list
2363909|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2363910|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2363911|NCT00548678|Analgesics|analgesics|mesh-ancestor
2363912|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
2363913|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363914|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363915|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2363916|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2363917|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2363918|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2363919|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363920|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2363921|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2363922|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363923|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
2363924|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
2363925|NCT00548704|Razoxane|razoxane|mesh-list
2363926|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363927|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2363928|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2363929|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2363930|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363931|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363932|NCT00548704|Protective Agents|protective agents|mesh-ancestor
2363933|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363934|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
2363935|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
2363936|NCT00548821|Cisplatin|cisplatin|mesh-list
2363937|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363938|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
2363939|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2363940|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
2363941|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363942|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2363943|NCT00548899|Sorafenib|sorafenib|mesh-list
2363944|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363945|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2363946|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363947|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363956|NCT00548938|Temozolomide|temozolomide|mesh-list
2363957|NCT00548938|Carmustine|carmustine|mesh-list
2363958|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2363959|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
2363960|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363961|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2363962|NCT00548964|Ketamine|ketamine|mesh-list
2363963|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
2363964|NCT00548964|Analgesics|analgesics|mesh-ancestor
2363965|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
2363966|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2363967|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363968|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2363969|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2363970|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
2363971|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
2363972|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2363973|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2363974|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2363975|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2363976|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363977|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
2363978|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2363979|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363980|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
2363981|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2363982|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
2363983|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2363984|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2363985|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363986|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2363987|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363988|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2363989|NCT00549107|Simendan|simendan|mesh-list
2363990|NCT00549107|Milrinone|milrinone|mesh-list
2363991|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2363992|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
2363993|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2363994|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2363995|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2363996|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2363997|NCT00549107|Protective Agents|protective agents|mesh-ancestor
2363998|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2363999|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2364000|NCT00549120|Propranolol|propranolol|mesh-list
2364001|NCT00549120|Albuterol|albuterol|mesh-list
2364002|NCT00549120|Ipratropium|ipratropium|mesh-list
2364003|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2364004|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2364005|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
2364006|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2364007|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364008|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364009|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2364010|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2364011|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
2364012|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2364013|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
2364014|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364015|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2364016|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
2364017|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
2364018|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2364019|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2364020|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2364021|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2364022|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2364023|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
2364024|NCT00549133|Irbesartan|irbesartan|mesh-list
2364025|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2364026|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2364027|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2364028|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364029|NCT00549146|Fluticasone|fluticasone|mesh-list
2364030|NCT00549146|Xhance|xhance|mesh-list
2364031|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2364032|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2364033|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2364034|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2364035|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
2364036|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364037|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364038|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2364039|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
2364040|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
2364041|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2364042|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2364043|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2364044|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2364045|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
2364046|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2364047|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364048|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
2364049|NCT00549146|Hormones|hormones|mesh-ancestor
2364050|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2364051|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
2364052|NCT00549289|Cyclosporine|cyclosporine|mesh-list
2364053|NCT00549289|Cyclosporins|cyclosporins|mesh-list
2364054|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364055|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364056|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364057|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
2364058|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364059|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
2364060|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364061|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
2364062|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2364063|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2364064|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
2364065|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2364066|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2364067|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364068|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
2364069|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2364070|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364071|NCT00549419|Dobutamine|dobutamine|mesh-list
2364072|NCT00549419|Norepinephrine|norepinephrine|mesh-list
2364073|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2364074|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2364075|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
2364076|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2364077|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364078|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364079|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
2364080|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
2364081|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364082|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2364083|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2113739|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113740|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2113741|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113742|NCT02589665|Mirikizumab|mirikizumab|mesh-list
2113743|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2113744|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2113745|NCT02589665|Analgesics|analgesics|mesh-ancestor
2113746|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
2113747|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113748|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113749|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2113750|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2113751|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2113752|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2113753|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2113754|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2113755|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113756|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
2113757|NCT02589977|Regadenoson|regadenoson|mesh-list
2113758|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2113759|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2113760|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
2113761|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
2113762|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2113763|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113764|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364084|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2364085|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2364086|NCT00549419|Protective Agents|protective agents|mesh-ancestor
2364087|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
2364088|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2364089|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2364090|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2364091|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2364092|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364093|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
2364094|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2364095|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364096|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2364097|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364098|NCT00549510|Lisinopril|lisinopril|mesh-list
2364099|NCT00549510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2364100|NCT00549510|Protease Inhibitors|protease inhibitors|mesh-ancestor
2364101|NCT00549510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364102|NCT00549510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364103|NCT00549510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2364104|NCT00549510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2364105|NCT00549510|Protective Agents|protective agents|mesh-ancestor
2364106|NCT00549510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364107|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
2364108|NCT00549536|Calcium|calcium|mesh-list
2364109|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2364110|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364111|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2364112|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
2364113|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2364114|NCT00549588|Protective Agents|protective agents|mesh-ancestor
2364115|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364116|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
2364117|NCT00549614|Acipimox|acipimox|mesh-list
2364118|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2364119|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
2364120|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364121|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2364122|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
2364123|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2364124|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2364125|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2364126|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2364127|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2364128|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364129|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2364130|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2364131|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2364132|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2364133|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
2364134|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2364135|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364136|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2364137|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2364138|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
2364139|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2364140|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2364141|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
2364142|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2364143|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
2364144|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2364145|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2364146|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2364147|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2364148|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2364149|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364150|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2364151|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2364152|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364153|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364154|NCT00549679|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
2364155|NCT00549679|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2364156|NCT00549679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2364157|NCT00549679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364158|NCT00549679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364159|NCT00549744|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
2364160|NCT00549744|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2364161|NCT00549744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2364162|NCT00549744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364163|NCT00549744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364164|NCT00549848|Cytarabine|cytarabine|mesh-list
2364165|NCT00549848|Dexamethasone|dexamethasone|mesh-list
2364166|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
2364167|NCT00549848|Prednisone|prednisone|mesh-list
2364168|NCT00549848|Prednisolone|prednisolone|mesh-list
2364169|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
2364170|NCT00549848|Doxorubicin|doxorubicin|mesh-list
2364171|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2364172|NCT00549848|Methotrexate|methotrexate|mesh-list
2364173|NCT00549848|Etoposide|etoposide|mesh-list
2364174|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
2364175|NCT00549848|Vincristine|vincristine|mesh-list
2364176|NCT00549848|Daunorubicin|daunorubicin|mesh-list
2364177|NCT00549848|Asparaginase|asparaginase|mesh-list
2364178|NCT00549848|Dasatinib|dasatinib|mesh-list
2364179|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
2364180|NCT00549848|Clofarabine|clofarabine|mesh-list
2364181|NCT00549848|Thioguanine|thioguanine|mesh-list
2364182|NCT00549848|Pegaspargase|pegaspargase|mesh-list
2364183|NCT00549848|BB 1101|bb 1101|mesh-list
2364184|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364185|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
2364186|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364187|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2364188|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2364189|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
2364190|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364191|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364192|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2364193|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2364194|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
2364195|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
2364196|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364197|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2364198|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
2364199|NCT00549848|Hormones|hormones|mesh-ancestor
2364200|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2364201|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2364202|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
2364203|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364204|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2364205|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2364206|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2364207|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2364208|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
2364209|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2364210|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2364211|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
2364212|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
2364213|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2364214|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2364215|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2364216|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
2364217|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364218|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
2364219|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
2364220|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
2364221|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2364222|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
2364223|NCT00549874|Glyburide|glyburide|mesh-list
2364224|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364225|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364226|NCT00549887|Insulin|insulin|mesh-list
2364227|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2364228|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364229|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364230|NCT00549926|Atorvastatin|atorvastatin|mesh-list
2364231|NCT00549926|Pravastatin|pravastatin|mesh-list
2364232|NCT00549926|Pitavastatin|pitavastatin|mesh-list
2364233|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2364234|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2364235|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
2364236|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364237|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2364238|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2364239|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364240|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
2364241|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2364242|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2364243|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364244|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2364245|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364246|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2364247|NCT00549978|Cilostazol|cilostazol|mesh-list
2364248|NCT00549978|Probucol|probucol|mesh-list
2364249|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2364250|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
2364251|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364252|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364253|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2364254|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
2364255|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2364256|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2364257|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364258|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2364259|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
2364260|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2364261|NCT00549978|Protective Agents|protective agents|mesh-ancestor
2364262|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2364263|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2364264|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364265|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2364266|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2364267|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
2364268|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2364269|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
2364270|NCT00550004|Gemcitabine|gemcitabine|mesh-list
2364271|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2364272|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
2364273|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364274|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364275|NCT00550004|Antiviral Agents|antiviral agents|mesh-ancestor
2364276|NCT00550004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113765|NCT02590003|Paclitaxel|paclitaxel|mesh-list
2113766|NCT02590003|Carboplatin|carboplatin|mesh-list
2113767|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2113768|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113769|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
2113770|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
2113771|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
2113772|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364277|NCT00550004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364278|NCT00550004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364279|NCT00550004|Immunologic Factors|immunologic factors|mesh-ancestor
2364280|NCT00550004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364281|NCT00550095|Valsartan|valsartan|mesh-list
2364282|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2364283|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2364284|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2364285|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364286|NCT00550108|Ethanol|ethanol|mesh-list
2364287|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2364288|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364289|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2364290|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364291|NCT00550121|Ascorbic Acid|ascorbic acid|mesh-list
2364292|NCT00550121|Vitamins|vitamins|mesh-ancestor
2364293|NCT00550121|Micronutrients|micronutrients|mesh-ancestor
2364294|NCT00550121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364295|NCT00550121|Antioxidants|antioxidants|mesh-ancestor
2364296|NCT00550121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364297|NCT00550121|Protective Agents|protective agents|mesh-ancestor
2364298|NCT00550160|Artesunate|artesunate|mesh-list
2364299|NCT00550160|Amodiaquine|amodiaquine|mesh-list
2364300|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
2364301|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2364302|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2364303|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364304|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364305|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
2364306|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
2364307|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2364308|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
2364309|NCT00550199|Gemcitabine|gemcitabine|mesh-list
2364310|NCT00550199|Panobinostat|panobinostat|mesh-list
2364311|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2364312|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
2364313|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364314|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364315|NCT00550199|Antiviral Agents|antiviral agents|mesh-ancestor
2364316|NCT00550199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364317|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364318|NCT00550199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364319|NCT00550199|Immunologic Factors|immunologic factors|mesh-ancestor
2364320|NCT00550199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364321|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2364322|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
2364323|NCT00550303|Estrogens|estrogens|mesh-list
2364324|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2364325|NCT00550303|Hormones|hormones|mesh-ancestor
2364326|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2364327|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364328|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2364329|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2364330|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
2364331|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2364332|NCT00550329|Glipizide|glipizide|mesh-list
2364333|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364334|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364335|NCT00550342|Rituximab|rituximab|mesh-list
2364336|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2364337|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364338|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
2364339|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364340|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2364341|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
2364342|NCT00550433|Estrogens|estrogens|mesh-list
2364343|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2364344|NCT00550433|Hormones|hormones|mesh-ancestor
2364345|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2364346|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364347|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2364348|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2364349|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
2364350|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2364351|NCT00550485|Citalopram|citalopram|mesh-list
2364352|NCT00550485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2364353|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2364354|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2364355|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364356|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2364357|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
2364358|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364359|NCT00550485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2364360|NCT00550485|Antidepressive Agents|antidepressive agents|mesh-ancestor
2364361|NCT00550485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2364362|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
2364363|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2364364|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364365|NCT00550563|Vitamins|vitamins|mesh-ancestor
2364366|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
2364367|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2364368|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2364369|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2364370|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364371|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
2364372|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2364373|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364374|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
2364375|NCT00550784|Paclitaxel|paclitaxel|mesh-list
2364376|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
2364377|NCT00550784|Melphalan|melphalan|mesh-list
2364378|NCT00550784|Topotecan|topotecan|mesh-list
2364379|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2364380|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364381|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
2364382|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
2364383|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
2364384|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364385|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364386|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
2364387|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364388|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2364389|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2364390|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
2364391|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2364392|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2364393|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2364394|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364395|NCT00550810|Sunitinib|sunitinib|mesh-list
2364396|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364397|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2364398|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2364399|NCT00550810|Growth Substances|growth substances|mesh-ancestor
2364400|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364401|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
2364402|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2364403|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364404|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364405|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
2364406|NCT00550901|Razoxane|razoxane|mesh-list
2364407|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364408|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2364409|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2364410|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2364411|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364412|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364413|NCT00550901|Protective Agents|protective agents|mesh-ancestor
2364414|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364415|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
2364416|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
2364417|NCT00550927|Bevacizumab|bevacizumab|mesh-list
2364418|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2364419|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364420|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2364421|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2364422|NCT00550927|Growth Substances|growth substances|mesh-ancestor
2364423|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364424|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
2364425|NCT00550992|Leucovorin|leucovorin|mesh-list
2364426|NCT00550992|Cytarabine|cytarabine|mesh-list
2364427|NCT00550992|Cyclosporine|cyclosporine|mesh-list
2364428|NCT00550992|Prednisone|prednisone|mesh-list
2364429|NCT00550992|Prednisolone|prednisolone|mesh-list
2364430|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
2364431|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2364432|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2364433|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2364434|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
2364435|NCT00550992|Melphalan|melphalan|mesh-list
2364436|NCT00550992|Busulfan|busulfan|mesh-list
2113773|NCT02590432|Linaclotide|linaclotide|mesh-list
2113774|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2113775|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
2113776|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113777|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2113778|NCT02590588|Idelalisib|idelalisib|mesh-list
2113779|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113780|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113781|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113782|NCT02591238|Melatonin|melatonin|mesh-list
2113783|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
2113784|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113785|NCT02591238|Protective Agents|protective agents|mesh-ancestor
2113786|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113787|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2113788|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
2113789|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2113790|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113791|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364437|NCT00550992|Methotrexate|methotrexate|mesh-list
2364438|NCT00550992|Etoposide|etoposide|mesh-list
2364439|NCT00550992|Vincristine|vincristine|mesh-list
2364440|NCT00550992|Daunorubicin|daunorubicin|mesh-list
2364441|NCT00550992|Asparaginase|asparaginase|mesh-list
2364442|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
2364443|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
2364444|NCT00550992|Thioguanine|thioguanine|mesh-list
2364445|NCT00550992|Pegaspargase|pegaspargase|mesh-list
2364446|NCT00550992|Cyclosporins|cyclosporins|mesh-list
2364447|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2364448|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
2364449|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364450|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
2364451|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364452|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2364453|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2364454|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
2364455|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364456|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364457|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2364458|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2364459|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
2364460|NCT00550992|Hormones|hormones|mesh-ancestor
2364461|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2364462|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2364463|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2364464|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
2364465|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2364466|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2364467|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
2364468|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
2364469|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364470|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2364471|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2364472|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2364473|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2364474|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2364475|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
2364476|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364477|NCT00550992|Antidotes|antidotes|mesh-ancestor
2364478|NCT00550992|Protective Agents|protective agents|mesh-ancestor
2364479|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
2364480|NCT00550992|Vitamins|vitamins|mesh-ancestor
2364481|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
2364482|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
2364483|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
2364484|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
2364485|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
2364486|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2364487|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364488|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2364489|NCT00550992|Analgesics|analgesics|mesh-ancestor
2364490|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
2364491|NCT00551005|Celecoxib|celecoxib|mesh-list
2364492|NCT00551005|Etoposide|etoposide|mesh-list
2364493|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2364494|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364495|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2364496|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2364497|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364498|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364499|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2364500|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2364501|NCT00551005|Analgesics|analgesics|mesh-ancestor
2364502|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
2364503|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364504|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364505|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2364506|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2364507|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2364508|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2364509|NCT00551018|Tenofovir|tenofovir|mesh-list
2364510|NCT00551018|Emtricitabine|emtricitabine|mesh-list
2364511|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
2364512|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364513|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2364514|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2364515|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364516|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364517|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2364518|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2364519|NCT00551044|Bicalutamide|bicalutamide|mesh-list
2364520|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
2364521|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
2364522|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2364523|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364524|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364525|NCT00551096|Gemcitabine|gemcitabine|mesh-list
2364526|NCT00551096|Capecitabine|capecitabine|mesh-list
2364527|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2364528|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
2364529|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364530|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364531|NCT00551096|Antiviral Agents|antiviral agents|mesh-ancestor
2364532|NCT00551096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364533|NCT00551096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364534|NCT00551096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364535|NCT00551096|Immunologic Factors|immunologic factors|mesh-ancestor
2364536|NCT00551096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364537|NCT00551109|SA 4503|sa 4503|mesh-list
2364538|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
2364539|NCT00551122|Gemcitabine|gemcitabine|mesh-list
2364540|NCT00551122|Paclitaxel|paclitaxel|mesh-list
2364541|NCT00551122|Ifosfamide|ifosfamide|mesh-list
2364542|NCT00551122|Lenograstim|lenograstim|mesh-list
2364543|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2364544|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364545|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
2364546|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
2364547|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
2364548|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364549|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2364550|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
2364551|NCT00551122|Antiviral Agents|antiviral agents|mesh-ancestor
2364552|NCT00551122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364553|NCT00551122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364554|NCT00551122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364555|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
2364556|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364557|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2364558|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2364559|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
2364560|NCT00551239|Rituximab|rituximab|mesh-list
2364561|NCT00551239|Fludarabine|fludarabine|mesh-list
2364562|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
2364563|NCT00551239|Pixantrone|pixantrone|mesh-list
2364564|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2364565|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364566|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
2364567|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364568|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2364569|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2364570|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
2364571|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364572|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364573|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2364574|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2364575|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364576|NCT00551252|Gemcitabine|gemcitabine|mesh-list
2364577|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
2364578|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2364579|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
2364580|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364581|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364582|NCT00551252|Antiviral Agents|antiviral agents|mesh-ancestor
2364583|NCT00551252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364584|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364585|NCT00551252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364586|NCT00551252|Immunologic Factors|immunologic factors|mesh-ancestor
2364587|NCT00551252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364588|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2364589|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
2364590|NCT00551265|Oregovomab|oregovomab|mesh-list
2364591|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2364592|NCT00551265|Antibodies|antibodies|mesh-list
2364593|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
2364594|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2364595|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364596|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
2364597|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364598|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2364599|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2364600|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
2364601|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364602|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364603|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2364604|NCT00551317|Darapladib|darapladib|mesh-list
2113792|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113793|NCT02592434|Tofacitinib|tofacitinib|mesh-list
2113794|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2113795|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113796|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113797|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2113798|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
2113799|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113800|NCT02592629|Triamcinolone|triamcinolone|mesh-list
2113801|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2113802|NCT02592629|Lidocaine|lidocaine|mesh-list
2113803|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
2113804|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
2113805|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
2113806|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2113807|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113808|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
2113809|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113810|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2113811|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2113812|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2113813|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2113814|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113815|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2113816|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
2113817|NCT02592629|Hormones|hormones|mesh-ancestor
2113818|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2113819|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2113820|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
2113821|NCT02592798|Abatacept|abatacept|mesh-list
2113822|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2364605|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2364606|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364607|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364608|NCT00551343|Exenatide|exenatide|mesh-list
2364609|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364610|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364611|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2364612|NCT00551343|Incretins|incretins|mesh-ancestor
2364613|NCT00551343|Hormones|hormones|mesh-ancestor
2364614|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2364615|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
2364616|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364617|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364618|NCT00551382|Montelukast|montelukast|mesh-list
2364619|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2364620|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
2364621|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2364622|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
2364623|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2364624|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364625|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2364626|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2364627|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364628|NCT00551447|Simvastatin|simvastatin|mesh-list
2364629|NCT00551447|Ezetimibe|ezetimibe|mesh-list
2364630|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2364631|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2364632|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
2364633|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364634|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2364635|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2364636|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364637|NCT00551512|Cisplatin|cisplatin|mesh-list
2364638|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364639|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
2364640|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364641|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364642|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
2364643|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364644|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364645|NCT00551577|Carboplatin|carboplatin|mesh-list
2364646|NCT00551577|Docetaxel|docetaxel|mesh-list
2364647|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364648|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
2364649|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
2364650|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
2364651|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364652|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2364653|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364654|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364655|NCT00551590|Incretins|incretins|mesh-ancestor
2364656|NCT00551590|Hormones|hormones|mesh-ancestor
2364657|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2364658|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2364659|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
2364660|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364661|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364662|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
2364663|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2364664|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
2364665|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2364666|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364667|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2364668|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2364669|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2364670|NCT00551733|Paclitaxel|paclitaxel|mesh-list
2364671|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2364672|NCT00551733|Carboplatin|carboplatin|mesh-list
2364673|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2364674|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2364675|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364676|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
2364677|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
2364678|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
2364679|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364680|NCT00551824|Mitomycins|mitomycins|mesh-list
2364681|NCT00551824|Mitomycin|mitomycin|mesh-list
2364682|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2364683|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364684|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
2364685|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364686|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2364687|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364688|NCT00551850|MP 412|mp 412|mesh-list
2364689|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364690|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2364691|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364692|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364693|NCT00551876|Simvastatin|simvastatin|mesh-list
2364694|NCT00551876|Ezetimibe|ezetimibe|mesh-list
2364695|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2364696|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2364697|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
2364698|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364699|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2364700|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2364701|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364702|NCT00551889|Celecoxib|celecoxib|mesh-list
2364703|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
2364704|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364705|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
2364706|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364707|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2364708|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2364709|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
2364710|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364711|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364712|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2364713|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2364714|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2364715|NCT00551889|Analgesics|analgesics|mesh-ancestor
2364716|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
2364717|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364718|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2364719|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2364720|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2364721|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364722|NCT00551928|Prednisone|prednisone|mesh-list
2364723|NCT00551928|Lenalidomide|lenalidomide|mesh-list
2364724|NCT00551928|Melphalan|melphalan|mesh-list
2364725|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2364726|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
2364727|NCT00551928|Hormones|hormones|mesh-ancestor
2364728|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2364729|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364730|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2364731|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364732|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
2364733|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2364734|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2364735|NCT00551928|Growth Substances|growth substances|mesh-ancestor
2364736|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
2364737|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2364738|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
2364739|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364740|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2364741|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364742|NCT00551954|Acarbose|acarbose|mesh-list
2364743|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2364744|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364745|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364746|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364747|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364748|NCT00552097|Simvastatin|simvastatin|mesh-list
2364749|NCT00552097|Ezetimibe|ezetimibe|mesh-list
2364750|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2364751|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2364752|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
2364753|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364754|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2364755|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2364756|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364757|NCT00552149|Cetuximab|cetuximab|mesh-list
2364758|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2364759|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364760|NCT00552201|Tacrolimus|tacrolimus|mesh-list
2364761|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364762|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
2364763|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364764|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2364765|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364766|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364767|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
2364768|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364769|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364770|NCT00552266|Methylphenidate|methylphenidate|mesh-list
2364771|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2364772|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364773|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2364774|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2364775|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2364776|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364777|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
2364778|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2364779|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
2364780|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364781|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364782|NCT00552461|Rituximab|rituximab|mesh-list
2364783|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2364784|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364785|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
2364786|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364787|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2364788|NCT00552500|Valproic Acid|valproic acid|mesh-list
2364789|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
2364790|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364791|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364792|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
2364793|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2364794|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364795|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
2364796|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2364797|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2364798|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2364799|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
2364800|NCT00552630|Penicillamine|penicillamine|mesh-list
2364801|NCT00552630|Antidotes|antidotes|mesh-ancestor
2364802|NCT00552630|Protective Agents|protective agents|mesh-ancestor
2364803|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364804|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
2364805|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
2364806|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364807|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2364808|NCT00552656|Sirolimus|sirolimus|mesh-list
2364809|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2364810|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364811|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2364812|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364813|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
2364814|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364815|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
2364816|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364817|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2364818|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2364819|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2364820|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2364821|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364822|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2364823|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364824|NCT00552682|Analgesics|analgesics|mesh-ancestor
2364825|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
2364826|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364827|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
2364828|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2364829|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
2364830|NCT00552708|Lisinopril|lisinopril|mesh-list
2364831|NCT00552708|Carvedilol|carvedilol|mesh-list
2364832|NCT00552708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2364833|NCT00552708|Protease Inhibitors|protease inhibitors|mesh-ancestor
2364834|NCT00552708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364835|NCT00552708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364836|NCT00552708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2364837|NCT00552708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2364838|NCT00552708|Protective Agents|protective agents|mesh-ancestor
2364839|NCT00552708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364840|NCT00552708|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2364841|NCT00552708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2364842|NCT00552708|Adrenergic Agents|adrenergic agents|mesh-ancestor
2364843|NCT00552708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2364844|NCT00552708|Antioxidants|antioxidants|mesh-ancestor
2364845|NCT00552708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2364846|NCT00552708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2364847|NCT00552708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2364848|NCT00552708|Vasodilator Agents|vasodilator agents|mesh-ancestor
2364849|NCT00552708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2364850|NCT00552708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2364851|NCT00552734|Insulin|insulin|mesh-list
2364852|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2364853|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364854|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364855|NCT00552747|Fenofibrate|fenofibrate|mesh-list
2364856|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2364857|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
2364858|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364859|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2364860|NCT00552799|Penicillins|penicillins|mesh-list
2364861|NCT00552799|Penicillin V|penicillin v|mesh-list
2364862|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2364863|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364864|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
2364865|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2364866|NCT00552864|Ropivacaine|ropivacaine|mesh-list
2364867|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
2364868|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
2364869|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
2364870|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2364871|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364872|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
2364873|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364874|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
2364875|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364876|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364877|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
2364878|NCT00553072|Analgesics|analgesics|mesh-ancestor
2364879|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
2364880|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364881|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364882|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
2364883|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2364884|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2364885|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
2364886|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2364887|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2364888|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364889|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2364890|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
2364891|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2364892|NCT00553124|Vitamin E|vitamin e|mesh-list
2364893|NCT00553124|Selenium|selenium|mesh-list
2364894|NCT00553124|Vitamins|vitamins|mesh-ancestor
2364895|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
2364896|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364897|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
2364898|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364899|NCT00553124|Protective Agents|protective agents|mesh-ancestor
2364900|NCT00553124|Trace Elements|trace elements|mesh-ancestor
2364901|NCT00553137|Fluconazole|fluconazole|mesh-list
2364902|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
2364903|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364904|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2364905|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2364906|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364907|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364908|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2364909|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
2364910|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2364911|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364912|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2364913|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2364914|NCT00553189|Topotecan|topotecan|mesh-list
2364915|NCT00553189|Veliparib|veliparib|mesh-list
2364916|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2364917|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2364918|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364919|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364920|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364921|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2364922|NCT00553293|Hormones|hormones|mesh-list
2364923|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2364924|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2364925|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364926|NCT00553306|Aldesleukin|aldesleukin|mesh-list
2364927|NCT00553306|Cyclophosphamide|cyclophosphamide|mesh-list
2364928|NCT00553306|Interleukin-2|interleukin-2|mesh-list
2364929|NCT00553306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2364930|NCT00553306|Immunologic Factors|immunologic factors|mesh-ancestor
2364931|NCT00553306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364932|NCT00553306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2364933|NCT00553306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2364934|NCT00553306|Alkylating Agents|alkylating agents|mesh-ancestor
2364935|NCT00553306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364936|NCT00553306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364937|NCT00553306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2364938|NCT00553306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2364939|NCT00553306|Analgesics|analgesics|mesh-ancestor
2364940|NCT00553306|Sensory System Agents|sensory system agents|mesh-ancestor
2364941|NCT00553306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364942|NCT00553306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2364943|NCT00553306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2364944|NCT00553306|Antiviral Agents|antiviral agents|mesh-ancestor
2364945|NCT00553306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364946|NCT00553345|Vitamin E|vitamin e|mesh-list
2364947|NCT00553345|Selenium|selenium|mesh-list
2364948|NCT00553345|Vitamins|vitamins|mesh-ancestor
2364949|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
2364950|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364951|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
2364952|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364953|NCT00553345|Protective Agents|protective agents|mesh-ancestor
2364954|NCT00553345|Trace Elements|trace elements|mesh-ancestor
2364955|NCT00553423|Lactulose|lactulose|mesh-list
2364956|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2364957|NCT00553449|Rabeprazole|rabeprazole|mesh-list
2364958|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2364959|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2364960|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2364961|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2364962|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364963|NCT00553488|Insulin|insulin|mesh-list
2364964|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2364965|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
2364966|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2364967|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364968|NCT00553553|Morphine|morphine|mesh-list
2364969|NCT00553553|Remifentanil|remifentanil|mesh-list
2364970|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2364971|NCT00553553|Narcotics|narcotics|mesh-ancestor
2364972|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2364973|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364974|NCT00553553|Analgesics|analgesics|mesh-ancestor
2364975|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
2364976|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364977|NCT00553618|Aldesleukin|aldesleukin|mesh-list
2364978|NCT00553618|Dacarbazine|dacarbazine|mesh-list
2364979|NCT00553618|Interleukin-2|interleukin-2|mesh-list
2364980|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2364981|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
2364982|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364983|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2364984|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2364985|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2364986|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
2364987|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2364988|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2364989|NCT00553618|Analgesics|analgesics|mesh-ancestor
2364990|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
2364991|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2364992|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2364993|NCT00553657|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2364994|NCT00553657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2364995|NCT00553657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2364996|NCT00553657|Cholinergic Agents|cholinergic agents|mesh-ancestor
2364997|NCT00553657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2364998|NCT00553657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2364999|NCT00553657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365000|NCT00553657|Urological Agents|urological agents|mesh-ancestor
2365001|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
2365002|NCT00553683|Poly ICLC|poly iclc|mesh-list
2365003|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365004|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
2365005|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365006|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365007|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2365008|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
2365009|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365010|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365011|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2365012|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
2365013|NCT00553709|Nicotine|nicotine|mesh-list
2365014|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2365015|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
2365016|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365017|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365018|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2365019|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2365020|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
2365021|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365022|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365023|NCT00553722|Eplerenone|eplerenone|mesh-list
2365024|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2365025|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
2365026|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365027|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365028|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2365029|NCT00553722|Diuretics|diuretics|mesh-ancestor
2365030|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
2365031|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2365032|NCT00553748|Alovudine|alovudine|mesh-list
2365033|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
2365034|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365035|NCT00553800|Bevacizumab|bevacizumab|mesh-list
2365036|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2365037|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2365038|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365039|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2365040|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2365041|NCT00553800|Growth Substances|growth substances|mesh-ancestor
2365042|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365043|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
2365044|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2365045|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365046|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365047|NCT00553878|Dutasteride|dutasteride|mesh-list
2365048|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2365049|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2365050|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365051|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365052|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
2365053|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365054|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365055|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
2365056|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365057|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
2365058|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2365059|NCT00553930|Interferons|interferons|mesh-list
2365060|NCT00553930|Ribavirin|ribavirin|mesh-list
2365061|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
2365062|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
2365063|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2365064|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365065|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
2365066|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365067|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
2365068|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365069|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
2365070|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365071|NCT00553943|Cytarabine|cytarabine|mesh-list
2365072|NCT00553943|Rituximab|rituximab|mesh-list
2365073|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2365074|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365075|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
2365076|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365077|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365078|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2365079|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
2365080|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365081|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
2365082|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365083|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365084|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2365085|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2365086|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2365087|NCT00553995|Analgesics|analgesics|mesh-ancestor
2365088|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
2365089|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365090|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365091|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365092|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365093|NCT00554086|Bicalutamide|bicalutamide|mesh-list
2365094|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
2365095|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
2365096|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365097|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365098|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365099|NCT00554125|Sirolimus|sirolimus|mesh-list
2365100|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2365101|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365102|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2365103|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365104|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
2365105|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365106|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
2365107|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365108|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2365109|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2365110|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2365111|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
2365112|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365113|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2365114|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2365115|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365116|NCT00554164|Prednisone|prednisone|mesh-list
2365117|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
2365118|NCT00554164|Doxorubicin|doxorubicin|mesh-list
2365119|NCT00554164|Vincristine|vincristine|mesh-list
2365120|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365121|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
2365122|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113823|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113824|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113825|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2113826|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
2113827|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113828|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2113829|NCT02592876|Rituximab|rituximab|mesh-list
2113830|NCT02592876|Carboplatin|carboplatin|mesh-list
2113831|NCT02592876|Etoposide|etoposide|mesh-list
2113832|NCT02592876|Ifosfamide|ifosfamide|mesh-list
2113833|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2113834|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365123|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365124|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2365125|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
2365126|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365127|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365128|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2365129|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2365130|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2365131|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2365132|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365133|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365134|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
2365135|NCT00554164|Hormones|hormones|mesh-ancestor
2365136|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365137|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2113835|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
2365138|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2365139|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
2365140|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
2365141|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
2365142|NCT00554177|Mifepristone|mifepristone|mesh-list
2365143|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2365144|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
2365145|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2365146|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365147|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2365148|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2365149|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2365150|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
2365151|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2365152|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2365153|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
2365154|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365155|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
2365156|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2365157|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2365158|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
2365159|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365160|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2365161|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2365162|NCT00554203|Analgesics|analgesics|mesh-ancestor
2365163|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
2365164|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365165|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365166|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365167|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365168|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2365169|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
2365170|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
2365171|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
2365172|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365173|NCT00554242|Protective Agents|protective agents|mesh-ancestor
2365174|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365175|NCT00554242|Vitamins|vitamins|mesh-ancestor
2365176|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
2365177|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2365178|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365179|NCT00554346|Etoricoxib|etoricoxib|mesh-list
2365180|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2365181|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2365182|NCT00554346|Analgesics|analgesics|mesh-ancestor
2365183|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
2365184|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365185|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365186|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365187|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365188|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2365189|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2365190|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365191|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365192|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
2365193|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2365194|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2365195|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
2365196|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365197|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2365198|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2365199|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365200|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365201|NCT00554424|Lidocaine|lidocaine|mesh-list
2365202|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
2365203|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
2365204|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2365205|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365206|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
2365207|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365208|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2365209|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2365210|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2365211|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2365212|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365213|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
2365214|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2365215|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365216|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2365217|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365218|NCT00554476|Triamcinolone|triamcinolone|mesh-list
2365219|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2365220|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2365221|NCT00554476|Indomethacin|indomethacin|mesh-list
2365222|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2365223|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365224|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
2365225|NCT00554476|Hormones|hormones|mesh-ancestor
2365226|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365227|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365228|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365229|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
2365230|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365231|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365232|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2365233|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2365234|NCT00554476|Analgesics|analgesics|mesh-ancestor
2365235|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
2365236|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365237|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365238|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
2365239|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
2365240|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2365241|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2365242|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2365243|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2365244|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
2365245|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365246|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365247|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
2365248|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365249|NCT00554528|Meloxicam|meloxicam|mesh-list
2365250|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2365251|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2365252|NCT00554528|Analgesics|analgesics|mesh-ancestor
2365253|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
2365254|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365255|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365256|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365257|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365258|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2365259|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2365260|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365261|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365262|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2365263|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2365264|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2365265|NCT00554632|Norgestimate|norgestimate|mesh-list
2365266|NCT00554632|Norelgestromin|norelgestromin|mesh-list
2365267|NCT00554632|Ortho Evra|ortho evra|mesh-list
2365268|NCT00554632|Estradiol|estradiol|mesh-list
2365269|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2365270|NCT00554632|Estrogens|estrogens|mesh-ancestor
2365271|NCT00554632|Hormones|hormones|mesh-ancestor
2365272|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365273|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365274|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2365275|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
2365276|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2365277|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2365278|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2365279|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2365280|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2365281|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2365282|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
2365283|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2365284|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2365285|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2365286|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2365287|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365288|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
2365289|NCT00554710|Budesonide|budesonide|mesh-list
2365290|NCT00554710|Azathioprine|azathioprine|mesh-list
2365291|NCT00554710|Infliximab|infliximab|mesh-list
2365292|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365293|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
2365294|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
2365295|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365296|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365297|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2365298|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
2365299|NCT00554710|Hormones|hormones|mesh-ancestor
2365300|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365301|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2365302|NCT00554710|Protective Agents|protective agents|mesh-ancestor
2365303|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365304|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2365305|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2365306|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
2365307|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
2365308|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365309|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
2365310|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365311|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2365312|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365313|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
2365314|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2365315|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365316|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2365317|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365318|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365319|NCT00554827|Vitamins|vitamins|mesh-list
2365320|NCT00554827|Folic Acid|folic acid|mesh-list
2365321|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
2365322|NCT00554827|Hydroxocobalamin|hydroxocobalamin|mesh-list
2365323|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
2365324|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
2365325|NCT00554827|Aminopterin|aminopterin|mesh-list
2365326|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
2365327|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365328|NCT00554827|Hematinics|hematinics|mesh-ancestor
2365329|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2365330|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365331|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365332|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365333|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
2365334|NCT00554918|Prednisolone|prednisolone|mesh-list
2365335|NCT00554918|Docetaxel|docetaxel|mesh-list
2365336|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365337|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
2365338|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
2365339|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
2365340|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365341|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365342|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
2365343|NCT00554918|Hormones|hormones|mesh-ancestor
2365344|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365345|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365346|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2365347|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2365348|NCT00555022|Bromides|bromides|mesh-list
2365349|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
2365350|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2365351|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
2365352|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365353|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365354|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2365355|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
2365356|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
2365357|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2365358|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
2365359|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365360|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365361|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
2365362|NCT00555035|Dolutegravir|dolutegravir|mesh-list
2365363|NCT00555035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2365364|NCT00555035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2365365|NCT00555035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365366|NCT00555035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365367|NCT00555035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2365368|NCT00555035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2365369|NCT00555035|Antiviral Agents|antiviral agents|mesh-ancestor
2365370|NCT00555035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365371|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
2365372|NCT00555087|Testosterone|testosterone|mesh-list
2365373|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
2365374|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
2365375|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2365376|NCT00555087|Androgens|androgens|mesh-ancestor
2365377|NCT00555087|Hormones|hormones|mesh-ancestor
2365378|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365379|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365380|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2365381|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365382|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
2365383|NCT00555100|Dexamethasone|dexamethasone|mesh-list
2365384|NCT00555100|Lenalidomide|lenalidomide|mesh-list
2365385|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365386|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
2365387|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
2365388|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365389|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365390|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2365391|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
2365392|NCT00555100|Hormones|hormones|mesh-ancestor
2365393|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365394|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2365395|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365396|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
2365397|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2365398|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2365399|NCT00555100|Growth Substances|growth substances|mesh-ancestor
2365400|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
2365401|NCT00555139|Alprazolam|alprazolam|mesh-list
2365402|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2365403|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2365404|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365405|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2365406|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2365407|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2365408|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
2365409|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
2365410|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365411|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365412|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2365413|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2365414|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2365415|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
2365416|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365417|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2365418|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2365419|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365420|NCT00555256|Sirolimus|sirolimus|mesh-list
2365421|NCT00555256|Sunitinib|sunitinib|mesh-list
2365422|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365423|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2365424|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2365425|NCT00555256|Growth Substances|growth substances|mesh-ancestor
2365426|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365427|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
2365428|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2365429|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365430|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365431|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2365432|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365433|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2365434|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
2365435|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365436|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
2365437|NCT00555334|Lamivudine|lamivudine|mesh-list
2365438|NCT00555334|Entecavir|entecavir|mesh-list
2365439|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2365440|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2365441|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365442|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365443|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
2365444|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365445|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2365446|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2365447|NCT00555347|Modafinil|modafinil|mesh-list
2365448|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2365449|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365450|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2365451|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2365452|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2365453|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365454|NCT00555373|Sirolimus|sirolimus|mesh-list
2365455|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2365456|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365457|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2365458|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365459|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
2365460|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365461|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
2365462|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365463|NCT00555386|Selenium|selenium|mesh-list
2365464|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
2365465|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365466|NCT00555386|Protective Agents|protective agents|mesh-ancestor
2365467|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365468|NCT00555386|Trace Elements|trace elements|mesh-ancestor
2365469|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
2365470|NCT00555399|Temozolomide|temozolomide|mesh-list
2365471|NCT00555399|Vorinostat|vorinostat|mesh-list
2365472|NCT00555399|Isotretinoin|isotretinoin|mesh-list
2365473|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2365474|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
2365475|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365476|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365477|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2365478|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365479|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
2365480|NCT00555412|Loxapine|loxapine|mesh-list
2365481|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2365482|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2365483|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2365484|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365485|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2365486|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2365487|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
2365488|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365489|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365490|NCT00555542|Rituximab|rituximab|mesh-list
2365491|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2365492|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365493|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
2365494|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365495|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365496|NCT00555555|Factor VIII|factor viii|mesh-list
2365497|NCT00555555|Coagulants|coagulants|mesh-ancestor
2365498|NCT00555594|Bevacizumab|bevacizumab|mesh-list
2365499|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2365500|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365501|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2365502|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2365503|NCT00555594|Growth Substances|growth substances|mesh-ancestor
2365504|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365505|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
2365506|NCT00555607|Prednisolone|prednisolone|mesh-list
2365507|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365508|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
2365509|NCT00555607|Hormones|hormones|mesh-ancestor
2365510|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365511|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365512|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2365513|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365514|NCT00555776|Gabapentin|gabapentin|mesh-list
2365515|NCT00555776|Analgesics|analgesics|mesh-ancestor
2365516|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
2365517|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365518|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365519|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
2365520|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2365521|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2365522|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2365523|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2365524|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2365525|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2365526|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365527|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365528|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
2365529|NCT00555789|Tacrolimus|tacrolimus|mesh-list
2365530|NCT00555789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365531|NCT00555789|Immunologic Factors|immunologic factors|mesh-ancestor
2365532|NCT00555789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365533|NCT00555789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2365534|NCT00555789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365535|NCT00555789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365536|NCT00555854|Benzocaine|benzocaine|mesh-list
2365537|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
2365538|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
2365539|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2365540|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365541|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
2365542|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365543|NCT00555867|Anastrozole|anastrozole|mesh-list
2365544|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2365545|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365546|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2365547|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2365548|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365549|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365550|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2365551|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
2365552|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365553|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365554|NCT00555984|Remifentanil|remifentanil|mesh-list
2365555|NCT00555984|Propofol|propofol|mesh-list
2365556|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
2365557|NCT00555984|Sevoflurane|sevoflurane|mesh-list
2365558|NCT00555984|Anesthetics|anesthetics|mesh-list
2365559|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2365560|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2365561|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365562|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
2365563|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2365564|NCT00555984|Narcotics|narcotics|mesh-ancestor
2365565|NCT00555984|Analgesics|analgesics|mesh-ancestor
2365566|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
2365567|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365568|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2365569|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2365570|NCT00556023|Gemcitabine|gemcitabine|mesh-list
2365571|NCT00556023|Tremelimumab|tremelimumab|mesh-list
2365572|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2365573|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
2365574|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365575|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365576|NCT00556023|Antiviral Agents|antiviral agents|mesh-ancestor
2365577|NCT00556023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365578|NCT00556023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365579|NCT00556023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365580|NCT00556023|Immunologic Factors|immunologic factors|mesh-ancestor
2365581|NCT00556023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365582|NCT00556062|Vaccines|vaccines|mesh-list
2365583|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
2365584|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365585|NCT00556088|Paclitaxel|paclitaxel|mesh-list
2365586|NCT00556088|Bevacizumab|bevacizumab|mesh-list
2365587|NCT00556088|Carboplatin|carboplatin|mesh-list
2365588|NCT00556088|Panobinostat|panobinostat|mesh-list
2365589|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2365590|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365591|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
2365592|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
2365593|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
2365594|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365595|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2365596|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2365597|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2365598|NCT00556088|Growth Substances|growth substances|mesh-ancestor
2365599|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365600|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
2365601|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2365602|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365603|NCT00556127|Cytarabine|cytarabine|mesh-list
2365604|NCT00556127|Dexamethasone|dexamethasone|mesh-list
2365605|NCT00556127|Prednisone|prednisone|mesh-list
2365606|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
2365607|NCT00556127|Melphalan|melphalan|mesh-list
2365608|NCT00556127|Carmustine|carmustine|mesh-list
2365609|NCT00556127|Rituximab|rituximab|mesh-list
2365610|NCT00556127|Etoposide|etoposide|mesh-list
2365611|NCT00556127|Vincristine|vincristine|mesh-list
2365612|NCT00556127|Epirubicin|epirubicin|mesh-list
2365613|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
2365614|NCT00556127|Sargramostim|sargramostim|mesh-list
2365615|NCT00556127|Lenograstim|lenograstim|mesh-list
2365616|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365617|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
2365618|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365619|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365620|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2365621|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
2365622|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365623|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365624|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2365625|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365626|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
2365627|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
2365628|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365629|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2365630|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
2365631|NCT00556127|Hormones|hormones|mesh-ancestor
2365632|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365633|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2365634|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2365635|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2365636|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2365637|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2365638|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365639|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2365640|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
2365641|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
2365642|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365643|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
2365644|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
2365645|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
2365646|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2365647|NCT00556127|Analgesics|analgesics|mesh-ancestor
2365648|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
2365649|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2365650|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
2365651|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365652|NCT00556192|Rituximab|rituximab|mesh-list
2365653|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2365654|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365655|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
2365656|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365657|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365658|NCT00556205|Bevacizumab|bevacizumab|mesh-list
2365659|NCT00556205|Sunitinib|sunitinib|mesh-list
2365660|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2365661|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365662|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2365663|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2365664|NCT00556205|Growth Substances|growth substances|mesh-ancestor
2365665|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365666|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
2365667|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2365668|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365669|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365670|NCT00556257|Cyclosporine|cyclosporine|mesh-list
2365671|NCT00556257|Cyclosporins|cyclosporins|mesh-list
2365672|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365673|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365674|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365675|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
2365676|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365677|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
2365678|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365679|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
2365680|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365681|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2365682|NCT00556270|Fentanyl|fentanyl|mesh-list
2365683|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2365684|NCT00556270|Narcotics|narcotics|mesh-ancestor
2365685|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2365686|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365687|NCT00556270|Analgesics|analgesics|mesh-ancestor
2365688|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
2365689|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365690|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2365691|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2365692|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
2365693|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
2365694|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2365695|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2365696|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365697|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2365698|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2365699|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2365700|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365701|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
2365702|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365703|NCT00556348|Bevacizumab|bevacizumab|mesh-list
2365704|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2365705|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365706|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2365707|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2365708|NCT00556348|Growth Substances|growth substances|mesh-ancestor
2365709|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365710|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
2365711|NCT00556361|Ketamine|ketamine|mesh-list
2365712|NCT00556361|Analgesics|analgesics|mesh-ancestor
2365713|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
2365714|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365715|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365716|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2365717|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2365718|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
2365719|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
2365720|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2365721|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2365722|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2365723|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365724|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365725|NCT00556387|Ketamine|ketamine|mesh-list
2365726|NCT00556387|Analgesics|analgesics|mesh-ancestor
2365727|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
2365728|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365729|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365730|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2365731|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2365732|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
2365733|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
2365734|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2365735|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2365736|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2365737|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365738|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365739|NCT00556413|Leucovorin|leucovorin|mesh-list
2365740|NCT00556413|Fluorouracil|fluorouracil|mesh-list
2365741|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
2365742|NCT00556413|Irinotecan|irinotecan|mesh-list
2365743|NCT00556413|Cetuximab|cetuximab|mesh-list
2365744|NCT00556413|Calcium|calcium|mesh-list
2365745|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
2365746|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2365747|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365748|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
2365749|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365750|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2365751|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365752|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365753|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
2365754|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2365755|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2365756|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365757|NCT00556413|Antidotes|antidotes|mesh-ancestor
2365758|NCT00556413|Protective Agents|protective agents|mesh-ancestor
2365759|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
2365760|NCT00556413|Vitamins|vitamins|mesh-ancestor
2365761|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
2365762|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2365763|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
2365764|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2365765|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
2365766|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365767|NCT00556465|Expectorants|expectorants|mesh-ancestor
2365768|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
2365769|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2365770|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
2365771|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365772|NCT00556465|Protective Agents|protective agents|mesh-ancestor
2365773|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365774|NCT00556465|Antidotes|antidotes|mesh-ancestor
2365775|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2365776|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
2365777|NCT00556608|Hylan|hylan|mesh-list
2365778|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2365779|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
2365780|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365781|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
2365782|NCT00556608|Protective Agents|protective agents|mesh-ancestor
2365783|NCT00556621|Gemcitabine|gemcitabine|mesh-list
2365784|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365785|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2365786|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
2365787|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365788|NCT00556621|Antiviral Agents|antiviral agents|mesh-ancestor
2365789|NCT00556621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365790|NCT00556621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365791|NCT00556621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365792|NCT00556621|Immunologic Factors|immunologic factors|mesh-ancestor
2365793|NCT00556621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365794|NCT00556634|Efavirenz|efavirenz|mesh-list
2365795|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2365796|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2365797|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365798|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365799|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
2365800|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365801|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2365802|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2365803|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2365804|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2365805|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2365806|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2365807|NCT00556699|Rituximab|rituximab|mesh-list
2365808|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2365809|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365810|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
2365811|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365812|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365813|NCT00556920|Carvedilol|carvedilol|mesh-list
2365814|NCT00556920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2365815|NCT00556920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2365816|NCT00556920|Adrenergic Agents|adrenergic agents|mesh-ancestor
2365817|NCT00556920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365818|NCT00556920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365819|NCT00556920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365820|NCT00556920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2365821|NCT00556920|Antioxidants|antioxidants|mesh-ancestor
2365822|NCT00556920|Protective Agents|protective agents|mesh-ancestor
2365823|NCT00556920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2365824|NCT00556920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2365825|NCT00556920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2365826|NCT00556920|Vasodilator Agents|vasodilator agents|mesh-ancestor
2365827|NCT00556920|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2365828|NCT00556920|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2365829|NCT00556959|Clonidine|clonidine|mesh-list
2365830|NCT00556959|Analgesics|analgesics|mesh-ancestor
2365831|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
2365832|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365833|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365834|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2365835|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
2365836|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
2365837|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2365838|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2365839|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2365840|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
2365841|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365842|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365843|NCT00557011|Amphetamine|amphetamine|mesh-list
2365844|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2365845|NCT00557011|Adderall|adderall|mesh-list
2365846|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2365847|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365848|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
2365849|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
2365850|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365851|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
2365852|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365853|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365854|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
2365855|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2365856|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2365857|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2365858|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2365859|NCT00557102|Leucovorin|leucovorin|mesh-list
2365860|NCT00557102|Fluorouracil|fluorouracil|mesh-list
2365861|NCT00557102|Irinotecan|irinotecan|mesh-list
2365862|NCT00557102|Cetuximab|cetuximab|mesh-list
2365863|NCT00557102|Calcium|calcium|mesh-list
2365864|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
2365865|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2365866|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365867|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
2365868|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365869|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2365870|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365871|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2365872|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
2365873|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2365874|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2365875|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365876|NCT00557102|Antidotes|antidotes|mesh-ancestor
2365877|NCT00557102|Protective Agents|protective agents|mesh-ancestor
2365878|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
2365879|NCT00557102|Vitamins|vitamins|mesh-ancestor
2365880|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
2365881|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2365882|NCT00557128|Lisinopril|lisinopril|mesh-list
2365883|NCT00557128|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2365884|NCT00557128|Protease Inhibitors|protease inhibitors|mesh-ancestor
2365885|NCT00557128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365886|NCT00557128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365887|NCT00557128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2365888|NCT00557128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2365889|NCT00557128|Protective Agents|protective agents|mesh-ancestor
2365890|NCT00557128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365891|NCT00557180|Beclomethasone|beclomethasone|mesh-list
2365892|NCT00557180|Bromides|bromides|mesh-list
2365893|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
2365894|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2365895|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2365896|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
2365897|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365898|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365899|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2365900|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
2365901|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
2365902|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2365903|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
2365904|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365905|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365906|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2365907|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2365908|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2365909|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
2365910|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
2365911|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365912|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
2365913|NCT00557180|Hormones|hormones|mesh-ancestor
2365914|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2365915|NCT00557206|Docetaxel|docetaxel|mesh-list
2365916|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
2365917|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365918|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
2365919|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
2365920|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
2365921|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365922|NCT00557219|Fenoldopam|fenoldopam|mesh-list
2365923|NCT00557219|Ketanserin|ketanserin|mesh-list
2365924|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2365925|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
2365926|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
2365927|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
2365928|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365929|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365930|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365931|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2365932|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2365933|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
2365934|NCT00557232|Bevacizumab|bevacizumab|mesh-list
2365935|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2365936|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365937|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2365938|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2365939|NCT00557232|Growth Substances|growth substances|mesh-ancestor
2365940|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365941|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
2365942|NCT00557401|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
2365943|NCT00557401|Baclofen|baclofen|mesh-list
2365944|NCT00557401|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2365945|NCT00557401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365946|NCT00557401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2365947|NCT00557401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365948|NCT00557401|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2365949|NCT00557401|GABA Agonists|gaba agonists|mesh-ancestor
2365950|NCT00557401|GABA Agents|gaba agents|mesh-ancestor
2365951|NCT00557401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365952|NCT00557401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365953|NCT00557427|Fluoxetine|fluoxetine|mesh-list
2365954|NCT00557427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2365955|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2365956|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2365957|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365958|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365959|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
2365960|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365961|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2365962|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
2365963|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2365964|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2365965|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2365966|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365967|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2365968|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2365969|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2365970|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
2365971|NCT00557544|Ketoprofen|ketoprofen|mesh-list
2365972|NCT00557544|Metoclopramide|metoclopramide|mesh-list
2365973|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
2365974|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
2365975|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365976|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365977|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2365978|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2365979|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2365980|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
2113836|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113837|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2113838|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2113839|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2113840|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2113841|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113842|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365981|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2365982|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2365983|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2365984|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2365985|NCT00557544|Analgesics|analgesics|mesh-ancestor
2365986|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
2365987|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2365988|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2365989|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2365990|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2365991|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
2365992|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2365993|NCT00557700|Bromides|bromides|mesh-list
2365994|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
2365995|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2365996|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
2365997|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2365998|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2365999|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2366000|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
2366001|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
2366002|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2366003|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
2366004|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366005|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366006|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
2366007|NCT00557713|Bevacizumab|bevacizumab|mesh-list
2366008|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2366009|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366010|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2366011|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2366012|NCT00557713|Growth Substances|growth substances|mesh-ancestor
2366013|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366014|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
2366015|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
2366016|NCT00557739|Nortriptyline|nortriptyline|mesh-list
2366017|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2366018|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
2366019|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2366020|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2366021|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
2366022|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2366023|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2366024|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2366025|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2366026|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366027|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
2366028|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366029|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366030|NCT00557791|Ranibizumab|ranibizumab|mesh-list
2366031|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2366032|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2366033|NCT00557791|Growth Substances|growth substances|mesh-ancestor
2366034|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366035|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
2366036|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366037|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
2366038|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2366039|NCT00557817|Hematinics|hematinics|mesh-ancestor
2366040|NCT00557843|Bupivacaine|bupivacaine|mesh-list
2366041|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
2366042|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
2366043|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2366044|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366045|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
2366046|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366047|NCT00557921|Aspirin|aspirin|mesh-list
2366048|NCT00557921|Omeprazole|omeprazole|mesh-list
2366049|NCT00557921|Clopidogrel|clopidogrel|mesh-list
2366050|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2366051|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2366052|NCT00557921|Analgesics|analgesics|mesh-ancestor
2366053|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
2366054|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366055|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366056|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2366057|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2366058|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2366059|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2366060|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366061|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2366062|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2366063|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366064|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
2366065|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2366066|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2366067|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2366068|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
2366069|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366070|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2366071|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2366072|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2366073|NCT00557934|Dobutamine|dobutamine|mesh-list
2366074|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2366075|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
2366076|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
2366077|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366078|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366079|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2366080|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2366081|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2366082|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
2366083|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366084|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366085|NCT00557934|Protective Agents|protective agents|mesh-ancestor
2366086|NCT00557960|Amphetamine|amphetamine|mesh-list
2366087|NCT00557960|Adderall|adderall|mesh-list
2366088|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2366089|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2366090|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2366091|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2366092|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366093|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
2366094|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366095|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366096|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2366097|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
2366098|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
2366099|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366100|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
2366101|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2366102|NCT00557973|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
2366103|NCT00557973|Baclofen|baclofen|mesh-list
2366104|NCT00557973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2366105|NCT00557973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366106|NCT00557973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2366107|NCT00557973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366108|NCT00557973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2366109|NCT00557973|GABA Agonists|gaba agonists|mesh-ancestor
2366110|NCT00557973|GABA Agents|gaba agents|mesh-ancestor
2366111|NCT00557973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366112|NCT00557973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366113|NCT00558038|Lactulose|lactulose|mesh-list
2366114|NCT00558038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2366115|NCT00558051|Vaccines|vaccines|mesh-list
2366116|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
2366117|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366118|NCT00558077|Metformin|metformin|mesh-list
2366119|NCT00558077|Clomiphene|clomiphene|mesh-list
2366120|NCT00558077|Enclomiphene|enclomiphene|mesh-list
2366121|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
2366122|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2366123|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366124|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2366125|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
2366126|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2366127|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2366128|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
2366129|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2366130|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2366131|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2366132|NCT00558090|Morphine|morphine|mesh-list
2366133|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2366134|NCT00558090|Narcotics|narcotics|mesh-ancestor
2366135|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2366136|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366137|NCT00558090|Analgesics|analgesics|mesh-ancestor
2366138|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
2366139|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366140|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
2366141|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2366142|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
2366143|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366144|NCT00558142|Expectorants|expectorants|mesh-ancestor
2366145|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
2366146|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2366147|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
2366148|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366149|NCT00558142|Protective Agents|protective agents|mesh-ancestor
2366150|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366151|NCT00558142|Antidotes|antidotes|mesh-ancestor
2366152|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
2366153|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2366154|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2366155|NCT00558181|Prednisolone|prednisolone|mesh-list
2366156|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
2366157|NCT00558181|Rituximab|rituximab|mesh-list
2366158|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2366159|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
2366160|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2366161|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366162|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
2366163|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366164|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2366165|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2366166|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
2366167|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
2366168|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366169|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2366170|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
2366171|NCT00558181|Hormones|hormones|mesh-ancestor
2366172|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2366173|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2366174|NCT00558181|Protective Agents|protective agents|mesh-ancestor
2366175|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2366176|NCT00558207|Gemcitabine|gemcitabine|mesh-list
2366177|NCT00558207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2366178|NCT00558207|Antimetabolites|antimetabolites|mesh-ancestor
2366179|NCT00558207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366180|NCT00558207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366181|NCT00558207|Antiviral Agents|antiviral agents|mesh-ancestor
2366182|NCT00558207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366183|NCT00558207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366184|NCT00558207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2366185|NCT00558207|Immunologic Factors|immunologic factors|mesh-ancestor
2366186|NCT00558207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366187|NCT00558298|Risperidone|risperidone|mesh-list
2366188|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2366189|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
2366190|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366191|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366192|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366193|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2366194|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2366195|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2366196|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2366197|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2366198|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
2366199|NCT00558337|Levodopa|levodopa|mesh-list
2366200|NCT00558337|Carbidopa|carbidopa|mesh-list
2366201|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2366202|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2366203|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2366204|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
2366205|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366206|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366207|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366208|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2366209|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366210|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2366211|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
2366212|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
2366213|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2366214|NCT00558376|Laxatives|laxatives|mesh-ancestor
2366215|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2366216|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
2366217|NCT00558454|Hematinics|hematinics|mesh-ancestor
2366218|NCT00558480|Vitamins|vitamins|mesh-list
2366219|NCT00558480|Vitamin A|vitamin a|mesh-list
2366220|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
2366221|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
2366222|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366223|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
2366224|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366225|NCT00558480|Protective Agents|protective agents|mesh-ancestor
2366226|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2366227|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366228|NCT00558493|Clevudine|clevudine|mesh-list
2366229|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
2366230|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366231|NCT00558506|Abatacept|abatacept|mesh-list
2366232|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2366233|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366234|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366235|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2366236|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
2366237|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366238|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2366239|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
2366240|NCT00558623|Calcium|calcium|mesh-list
2366241|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2366242|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366243|NCT00558623|Antacids|antacids|mesh-ancestor
2366244|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366245|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2366246|NCT00558662|Monensin|monensin|mesh-list
2366247|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
2366248|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366249|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2366250|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2366251|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
2366252|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
2366253|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
2366254|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366255|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366256|NCT00558662|Ionophores|ionophores|mesh-ancestor
2366257|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2366258|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
2366259|NCT00558818|Clevudine|clevudine|mesh-list
2366260|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
2366261|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366262|NCT00558883|Acarbose|acarbose|mesh-list
2366263|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2366264|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366265|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366266|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2366267|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366268|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
2366269|NCT00558961|Chlorambucil|chlorambucil|mesh-list
2366270|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366271|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2366272|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366273|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366274|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2366275|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
2366276|NCT00559026|Dacarbazine|dacarbazine|mesh-list
2366277|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2366278|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
2366279|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366280|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366281|NCT00559052|Pancrelipase|pancrelipase|mesh-list
2366282|NCT00559052|Pancreatin|pancreatin|mesh-list
2366283|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2366284|NCT00559091|Ribavirin|ribavirin|mesh-list
2366285|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
2366286|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366287|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
2366288|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366289|NCT00559169|Verapamil|verapamil|mesh-list
2366290|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2366291|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2366292|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2366293|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366294|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2366295|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366296|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
2366297|NCT00559182|Omeprazole|omeprazole|mesh-list
2366298|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2366299|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2366300|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2366301|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366302|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366303|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
2366304|NCT00559195|Hematinics|hematinics|mesh-ancestor
2366305|NCT00559247|Asunaprevir|asunaprevir|mesh-list
2366306|NCT00559247|Protease Inhibitors|protease inhibitors|mesh-ancestor
2366307|NCT00559247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366308|NCT00559247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366309|NCT00559286|Telmisartan|telmisartan|mesh-list
2366310|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2366311|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2366312|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2366313|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366314|NCT00559312|Fluticasone|fluticasone|mesh-list
2366315|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2366316|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2366317|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2366318|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2366319|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
2366320|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366321|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366322|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2366323|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
2366324|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
2366325|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2366326|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2366327|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2366328|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2366329|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
2366330|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366331|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366332|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
2366333|NCT00559312|Hormones|hormones|mesh-ancestor
2366334|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2366335|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
2366336|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2366337|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
2366338|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366339|NCT00559351|Fluorouracil|fluorouracil|mesh-list
2366340|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366341|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
2366342|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366343|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2366344|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2366345|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
2366346|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366347|NCT00559429|Docetaxel|docetaxel|mesh-list
2366348|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
2366349|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366350|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
2366351|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
2366352|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
2366353|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366354|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2366355|NCT00559429|Analgesics|analgesics|mesh-ancestor
2366356|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
2366357|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366358|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366359|NCT00559455|Leucovorin|leucovorin|mesh-list
2366360|NCT00559455|Fluorouracil|fluorouracil|mesh-list
2366361|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
2366362|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
2366363|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366364|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2366365|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366366|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2366367|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
2366368|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366369|NCT00559455|Antidotes|antidotes|mesh-ancestor
2366370|NCT00559455|Protective Agents|protective agents|mesh-ancestor
2366371|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
2366372|NCT00559455|Vitamins|vitamins|mesh-ancestor
2366373|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
2366374|NCT00559481|Ketoconazole|ketoconazole|mesh-list
2366375|NCT00559481|Dexamethasone|dexamethasone|mesh-list
2366376|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
2366377|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2366378|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2366379|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2366380|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2366381|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
2366382|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
2366383|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366384|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366385|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2366386|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
2366387|NCT00559481|Hormones|hormones|mesh-ancestor
2366388|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2366389|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2366390|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366391|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
2366392|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366393|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2366394|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2366395|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366396|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366397|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2366398|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
2366399|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2366400|NCT00559494|Minocycline|minocycline|mesh-list
2366401|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2366402|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366403|NCT00559546|Montelukast|montelukast|mesh-list
2366404|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2366405|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
2366406|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2366407|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
2366408|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2366409|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366410|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2366411|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2366412|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366413|NCT00559676|Leucovorin|leucovorin|mesh-list
2366414|NCT00559676|Fluorouracil|fluorouracil|mesh-list
2366415|NCT00559676|Capecitabine|capecitabine|mesh-list
2366416|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
2366417|NCT00559676|Irinotecan|irinotecan|mesh-list
2366418|NCT00559676|Calcium|calcium|mesh-list
2366419|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
2366420|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2366421|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366422|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
2366423|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366424|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2366425|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366426|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2366427|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
2366428|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2366429|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2366430|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366431|NCT00559676|Antidotes|antidotes|mesh-ancestor
2366432|NCT00559676|Protective Agents|protective agents|mesh-ancestor
2366433|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
2366434|NCT00559676|Vitamins|vitamins|mesh-ancestor
2366435|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
2366436|NCT00559689|Budesonide|budesonide|mesh-list
2366437|NCT00559689|Beclomethasone|beclomethasone|mesh-list
2366438|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2366439|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2366440|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
2366441|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366442|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366443|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2366444|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
2366445|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
2366446|NCT00559689|Hormones|hormones|mesh-ancestor
2366447|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2366448|NCT00559702|Natalizumab|natalizumab|mesh-list
2366449|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
2366450|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366451|NCT00559715|Bevacizumab|bevacizumab|mesh-list
2366452|NCT00559715|Ranibizumab|ranibizumab|mesh-list
2366453|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2366454|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366455|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2366456|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2366457|NCT00559715|Growth Substances|growth substances|mesh-ancestor
2366458|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366459|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
2366460|NCT00559741|Leucovorin|leucovorin|mesh-list
2366461|NCT00559741|Fluorouracil|fluorouracil|mesh-list
2366462|NCT00559741|Irinotecan|irinotecan|mesh-list
2366463|NCT00559741|Cetuximab|cetuximab|mesh-list
2366464|NCT00559741|Calcium|calcium|mesh-list
2366465|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
2366466|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2366467|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366468|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
2366469|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366470|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2366471|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366472|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2366473|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
2366474|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2366475|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2366476|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366477|NCT00559741|Antidotes|antidotes|mesh-ancestor
2366478|NCT00559741|Protective Agents|protective agents|mesh-ancestor
2366479|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
2366480|NCT00559741|Vitamins|vitamins|mesh-ancestor
2366481|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
2366482|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2366483|NCT00559858|Pyridoxine|pyridoxine|mesh-list
2366484|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
2366485|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
2366486|NCT00559858|Vitamins|vitamins|mesh-ancestor
2366487|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
2366488|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366489|NCT00559975|Vaccines|vaccines|mesh-list
2366490|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
2366491|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366492|NCT00560079|Allopurinol|allopurinol|mesh-list
2366493|NCT00560079|Dipyridamole|dipyridamole|mesh-list
2366494|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
2366495|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366496|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366497|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
2366498|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2366499|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2366500|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
2366501|NCT00560079|Protective Agents|protective agents|mesh-ancestor
2366502|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366503|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2366504|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2366505|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
2366506|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
2366507|NCT00560092|Analgesics|analgesics|mesh-ancestor
2366508|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
2366509|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366510|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366511|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
2366512|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2366513|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2366514|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
2366515|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2366516|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2366517|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366518|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2366519|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
2366520|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2366521|NCT00560118|Fotemustine|fotemustine|mesh-list
2366522|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366523|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2366524|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
2366525|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366526|NCT00560170|Simvastatin|simvastatin|mesh-list
2366527|NCT00560170|Ezetimibe|ezetimibe|mesh-list
2366528|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2366529|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2366530|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2366531|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
2366532|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366533|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2366534|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2366535|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366536|NCT00560183|Morphine|morphine|mesh-list
2366537|NCT00560183|Oxycodone|oxycodone|mesh-list
2366538|NCT00560183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2366539|NCT00560183|Narcotics|narcotics|mesh-ancestor
2366540|NCT00560183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2366541|NCT00560183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366542|NCT00560183|Analgesics|analgesics|mesh-ancestor
2366543|NCT00560183|Sensory System Agents|sensory system agents|mesh-ancestor
2366544|NCT00560183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366545|NCT00560209|Landiolol|landiolol|mesh-list
2366546|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2366547|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2366548|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
2366549|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366550|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366551|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366552|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2366553|NCT00560222|Lactoferrin|lactoferrin|mesh-list
2366554|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366555|NCT00560274|Ribavirin|ribavirin|mesh-list
2366556|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2366557|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
2366558|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366559|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
2366560|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366561|NCT00560300|Vitamin D|vitamin d|mesh-list
2366562|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
2366563|NCT00560300|Calcitriol|calcitriol|mesh-list
2366564|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2366565|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
2366566|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
2366567|NCT00560300|Calcium|calcium|mesh-list
2366568|NCT00560300|Sevelamer|sevelamer|mesh-list
2366569|NCT00560300|Vitamins|vitamins|mesh-ancestor
2366570|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
2366571|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366572|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2366573|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2366574|NCT00560300|Antacids|antacids|mesh-ancestor
2366575|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366576|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2366577|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2366578|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2366579|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2366580|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
2366581|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
2366582|NCT00560326|Tacrolimus|tacrolimus|mesh-list
2366583|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2366584|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
2366585|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366586|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2366587|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366588|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366589|NCT00560378|Tacrolimus|tacrolimus|mesh-list
2366590|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2366591|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
2366592|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366593|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2366594|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366595|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366596|NCT00560430|Telmisartan|telmisartan|mesh-list
2366597|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2366598|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2366599|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2366600|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366601|NCT00560443|Ketorolac|ketorolac|mesh-list
2366602|NCT00560443|Tramadol|tramadol|mesh-list
2366603|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2366604|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2366605|NCT00560443|Analgesics|analgesics|mesh-ancestor
2366606|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
2366607|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366608|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366609|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2366610|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2366611|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2366612|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366613|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366614|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2366615|NCT00560443|Narcotics|narcotics|mesh-ancestor
2366616|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2366617|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2366618|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2366619|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2366620|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366621|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
2366622|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
2366623|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366624|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2366625|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2366626|NCT00560495|Growth Substances|growth substances|mesh-ancestor
2366627|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366628|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
2366629|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366630|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
2366631|NCT00560547|Hematinics|hematinics|mesh-ancestor
2366632|NCT00560586|Budesonide|budesonide|mesh-list
2366633|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2366634|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2366635|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
2366636|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366637|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366638|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2366639|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
2366640|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
2366641|NCT00560586|Hormones|hormones|mesh-ancestor
2366642|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2366643|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
2366644|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2366645|NCT00560599|Mupirocin|mupirocin|mesh-list
2366646|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2366647|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366648|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
2366649|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
2366650|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2366651|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2366652|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366653|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366654|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2366655|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2366656|NCT00560690|Metformin|metformin|mesh-list
2366657|NCT00560690|Interferons|interferons|mesh-list
2366658|NCT00560690|Ribavirin|ribavirin|mesh-list
2366659|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2366660|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366661|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366662|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
2366663|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366664|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
2366665|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366666|NCT00560820|Deferasirox|deferasirox|mesh-list
2366667|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2366668|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
2366669|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
2366670|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366671|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2366672|NCT00560924|Estradiol|estradiol|mesh-list
2366673|NCT00560924|Estrogens|estrogens|mesh-ancestor
2366674|NCT00560924|Hormones|hormones|mesh-ancestor
2366675|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2366676|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366677|NCT00560963|Everolimus|everolimus|mesh-list
2366678|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366679|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2366680|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
2366681|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366682|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2366683|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
2366684|NCT00560976|Hematinics|hematinics|mesh-ancestor
2366685|NCT00561028|Antibodies|antibodies|mesh-list
2366686|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
2366687|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366688|NCT00561054|Cetuximab|cetuximab|mesh-list
2366689|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2366690|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366691|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
2366692|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2366693|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2366694|NCT00561067|Prednisolone|prednisolone|mesh-list
2366695|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
2366696|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
2366697|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2366698|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
2366699|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2366700|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
2366701|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
2366702|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366703|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366704|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2366705|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
2366706|NCT00561067|Hormones|hormones|mesh-ancestor
2366707|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2366708|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2366709|NCT00561067|Protective Agents|protective agents|mesh-ancestor
2366710|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2366711|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366712|NCT00561067|Hematinics|hematinics|mesh-ancestor
2366713|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2366714|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
2366715|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2366716|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366717|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366718|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2366719|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2366720|NCT00561093|Protective Agents|protective agents|mesh-ancestor
2366721|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366722|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
2366723|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2366724|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
2366725|NCT00561106|Valacyclovir|valacyclovir|mesh-list
2366726|NCT00561106|Prednisone|prednisone|mesh-list
2366727|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2366728|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
2366729|NCT00561106|Hormones|hormones|mesh-ancestor
2366730|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2366731|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366732|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2366733|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366734|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
2366735|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366736|NCT00561119|Gemcitabine|gemcitabine|mesh-list
2366737|NCT00561119|Paclitaxel|paclitaxel|mesh-list
2366738|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2366739|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366740|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
2366741|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
2366742|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
2366743|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366744|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2113843|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2113844|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
2113845|NCT02593097|Metformin|metformin|mesh-list
2113846|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2113847|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113848|NCT02593305|Methamphetamine|methamphetamine|mesh-list
2113849|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2113850|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113851|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
2113852|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
2113853|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113854|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
2113855|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2113856|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113857|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
2113858|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2113859|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2366745|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
2366746|NCT00561119|Antiviral Agents|antiviral agents|mesh-ancestor
2366747|NCT00561119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366748|NCT00561119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366749|NCT00561119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2366750|NCT00561119|Immunologic Factors|immunologic factors|mesh-ancestor
2366751|NCT00561119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366752|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
2366753|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
2366754|NCT00561132|Antacids|antacids|mesh-ancestor
2366755|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366756|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2366757|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2366758|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366759|NCT00561184|Vaccines|vaccines|mesh-list
2366760|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
2366761|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366762|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
2366763|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2366764|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366765|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2366766|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
2366767|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2366768|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366769|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2366770|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2366771|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2366772|NCT00561223|Iloprost|iloprost|mesh-list
2366773|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2366774|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
2366775|NCT00561288|Acetaminophen|acetaminophen|mesh-list
2366776|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2366777|NCT00561288|Analgesics|analgesics|mesh-ancestor
2366778|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
2366779|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366780|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366781|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
2366782|NCT00561327|Losartan|losartan|mesh-list
2366783|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2366784|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2366785|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2366786|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2366787|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366788|NCT00561379|Rituximab|rituximab|mesh-list
2366789|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2366790|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366791|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
2366792|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366793|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2366794|NCT00561496|Tenofovir|tenofovir|mesh-list
2366795|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
2366796|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366797|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2366798|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2366799|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366800|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366801|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2366802|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2366803|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
2366804|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2366805|NCT00561522|Capecitabine|capecitabine|mesh-list
2366806|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2366807|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
2366808|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366809|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366810|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2366811|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
2366812|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2366813|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2366814|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2366815|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2366816|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366817|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
2366818|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2366819|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366820|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2366821|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
2366822|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2366823|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
2366824|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2366825|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366826|NCT00561704|Losartan|losartan|mesh-list
2366827|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2366828|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2366829|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2366830|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2366831|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366832|NCT00561717|Cetirizine|cetirizine|mesh-list
2366833|NCT00561717|Loratadine|loratadine|mesh-list
2366834|NCT00561717|Azelastine|azelastine|mesh-list
2366835|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2366836|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2366837|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2366838|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
2366839|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
2366840|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366841|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366842|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366843|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
2366844|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
2366845|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2366846|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
2366847|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366848|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2366849|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
2366850|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2366851|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366852|NCT00561743|Dexamethasone|dexamethasone|mesh-list
2366853|NCT00561743|Doxorubicin|doxorubicin|mesh-list
2366854|NCT00561743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2366855|NCT00561743|Bortezomib|bortezomib|mesh-list
2366856|NCT00561743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2366857|NCT00561743|Antiemetics|antiemetics|mesh-ancestor
2366858|NCT00561743|Autonomic Agents|autonomic agents|mesh-ancestor
2366859|NCT00561743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366860|NCT00561743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366861|NCT00561743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2366862|NCT00561743|Glucocorticoids|glucocorticoids|mesh-ancestor
2366863|NCT00561743|Hormones|hormones|mesh-ancestor
2366864|NCT00561743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2366865|NCT00561743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2366866|NCT00561743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366867|NCT00561743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2366868|NCT00561743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2366869|NCT00561743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2366870|NCT00561743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366871|NCT00561743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366872|NCT00561756|Vaccines|vaccines|mesh-list
2366873|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
2366874|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366875|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
2366876|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2366877|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
2366878|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2366879|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366880|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2366881|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
2366882|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2366883|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2366884|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2366885|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
2366886|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366887|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366888|NCT00561899|Piperaquine|piperaquine|mesh-list
2366889|NCT00561899|Amodiaquine|amodiaquine|mesh-list
2366890|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
2366891|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2366892|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2366893|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2366894|NCT00561964|Irbesartan|irbesartan|mesh-list
2366895|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2366896|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2366897|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2366898|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366899|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
2366900|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2366901|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366902|NCT00562055|Reboxetine|reboxetine|mesh-list
2366903|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2366904|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2366905|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2366906|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2366907|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366908|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
2366909|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366910|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366911|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
2366912|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2366913|NCT00562068|Prednisolone|prednisolone|mesh-list
2366914|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
2366915|NCT00562068|Doxorubicin|doxorubicin|mesh-list
2366916|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2366917|NCT00562068|Vincristine|vincristine|mesh-list
2366918|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
2366919|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2366920|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
2366921|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366922|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2366923|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2366924|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
2366925|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366926|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366927|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2366928|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2366929|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2366930|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2366931|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366932|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2366933|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
2366934|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
2366935|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
2366936|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2366937|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
2366938|NCT00562068|Hormones|hormones|mesh-ancestor
2366939|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2366940|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2366941|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2366942|NCT00562133|Insulin|insulin|mesh-list
2366943|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2366944|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
2366945|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2366946|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366947|NCT00562172|Metformin|metformin|mesh-list
2366948|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
2366949|NCT00562172|Glimepiride|glimepiride|mesh-list
2366950|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2366951|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366952|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2366953|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2366954|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
2366955|NCT00562185|Carboplatin|carboplatin|mesh-list
2366956|NCT00562185|Doxorubicin|doxorubicin|mesh-list
2366957|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2366958|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2366959|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2366960|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2366961|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2366962|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366963|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366964|NCT00562198|Carbidopa|carbidopa|mesh-list
2366965|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2366966|NCT00562198|Entacapone|entacapone|mesh-list
2366967|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2366968|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2366969|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
2366970|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2366971|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366972|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366973|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2366974|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366975|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2366976|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
2366977|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
2366978|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2366979|NCT00562224|Abexinostat|abexinostat|mesh-list
2366980|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2366981|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2366982|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366983|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
2366984|NCT00562250|Glimepiride|glimepiride|mesh-list
2366985|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2366986|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2366987|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2366988|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2366989|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2366990|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2366991|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
2366992|NCT00562289|Aspirin|aspirin|mesh-list
2366993|NCT00562289|Dipyridamole|dipyridamole|mesh-list
2366994|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
2366995|NCT00562289|Apixaban|apixaban|mesh-list
2366996|NCT00562289|Dabigatran|dabigatran|mesh-list
2366997|NCT00562289|Antivitamins K|antivitamins k|mesh-list
2366998|NCT00562289|Clopidogrel|clopidogrel|mesh-list
2366999|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2367000|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2367001|NCT00562289|Analgesics|analgesics|mesh-ancestor
2367002|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
2367003|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367004|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367005|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2367006|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2367007|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2367008|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2367009|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367010|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2367011|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2367012|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367013|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
2367014|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2367015|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2367016|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2367017|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
2367018|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367019|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2367020|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
2367021|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2367022|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
2367023|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
2367024|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2367025|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
2367026|NCT00562406|Ranibizumab|ranibizumab|mesh-list
2367027|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2367028|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2367029|NCT00562406|Growth Substances|growth substances|mesh-ancestor
2367030|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367031|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
2367032|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367033|NCT00562419|Irinotecan|irinotecan|mesh-list
2367034|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2367035|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2367036|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367037|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367038|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367039|NCT00562458|Anastrozole|anastrozole|mesh-list
2367040|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2367041|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367042|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2367043|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2367044|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367045|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367046|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2367047|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
2367048|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2367049|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367054|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
2367055|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2367056|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2367057|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
2367058|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367059|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2367060|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2367061|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367062|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367063|NCT00562523|Sorafenib|sorafenib|mesh-list
2367064|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367065|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2367066|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367067|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367068|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
2367069|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2367070|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
2367071|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367072|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2367073|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2367074|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
2367075|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367076|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367077|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2367078|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2367079|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
2367080|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367081|NCT00562705|Hormones|hormones|mesh-list
2367082|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2367083|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367084|NCT00562770|Valacyclovir|valacyclovir|mesh-list
2367085|NCT00562770|Valganciclovir|valganciclovir|mesh-list
2367086|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
2367087|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367088|NCT00562809|Irbesartan|irbesartan|mesh-list
2367089|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2367090|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2367091|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2367092|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367093|NCT00562835|Thiamine|thiamine|mesh-list
2367094|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
2367095|NCT00562835|Vitamins|vitamins|mesh-ancestor
2367096|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
2367097|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367098|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2367099|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
2367100|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
2367101|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367102|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2367103|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
2367104|NCT00562835|Hormones|hormones|mesh-ancestor
2367105|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2367106|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2367107|NCT00562835|Protective Agents|protective agents|mesh-ancestor
2367108|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
2367109|NCT00562887|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2367110|NCT00562887|Immunologic Factors|immunologic factors|mesh-ancestor
2367111|NCT00562887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367112|NCT00562913|Sorafenib|sorafenib|mesh-list
2367113|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367114|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2367115|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367116|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367117|NCT00562939|Vaccines|vaccines|mesh-list
2367118|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2367119|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
2367120|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367121|NCT00562952|Telmisartan|telmisartan|mesh-list
2367122|NCT00562952|Bisoprolol|bisoprolol|mesh-list
2367123|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2367124|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2367125|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2367126|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367127|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
2367128|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
2367129|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367130|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367131|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2367132|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2367133|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2367134|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
2367135|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367136|NCT00563017|Risperidone|risperidone|mesh-list
2367137|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2367138|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
2367139|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367140|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367141|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367142|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2367143|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2367144|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2367145|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2367146|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2367147|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
2367148|NCT00563056|Fluticasone|fluticasone|mesh-list
2367149|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
2367150|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2367151|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
2367152|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367153|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367154|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2367155|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
2367156|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2367157|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2367158|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2367159|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
2367160|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367161|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367162|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2367163|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
2367164|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2367165|NCT00563069|Midazolam|midazolam|mesh-list
2367166|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2367167|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2367168|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2367169|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367170|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2367171|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2367172|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2367173|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2367174|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
2367175|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
2367176|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
2367177|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
2367178|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367179|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367180|NCT00563095|Interferons|interferons|mesh-list
2367181|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367182|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
2367183|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367184|NCT00563108|Basiliximab|basiliximab|mesh-list
2367185|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2367186|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
2367187|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367188|NCT00563147|Sirolimus|sirolimus|mesh-list
2367189|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2367190|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367191|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2367192|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367193|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
2367194|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2367195|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
2367196|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367197|NCT00563160|Gemcitabine|gemcitabine|mesh-list
2367198|NCT00563160|Carboplatin|carboplatin|mesh-list
2367199|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367200|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2367201|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
2367202|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367203|NCT00563160|Antiviral Agents|antiviral agents|mesh-ancestor
2367204|NCT00563160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367205|NCT00563160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367206|NCT00563160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2367207|NCT00563160|Immunologic Factors|immunologic factors|mesh-ancestor
2367208|NCT00563160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367209|NCT00563212|Interferons|interferons|mesh-list
2367210|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
2367211|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367212|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
2367213|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367214|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
2367215|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2367216|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367217|NCT00563238|Metoprolol|metoprolol|mesh-list
2367218|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2367219|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2367220|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
2367221|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
2367222|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367223|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367224|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2367225|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2367226|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2367227|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
2367228|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367229|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367230|NCT00563251|Azithromycin|azithromycin|mesh-list
2367231|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2367232|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367233|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
2367234|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2367235|NCT00563342|Ethanol|ethanol|mesh-list
2367236|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2367237|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367238|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2367239|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367240|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
2367241|NCT00563355|Hematinics|hematinics|mesh-ancestor
2367242|NCT00563394|Ofloxacin|ofloxacin|mesh-list
2367243|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2367244|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367245|NCT00563394|Renal Agents|renal agents|mesh-ancestor
2367246|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2367247|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2367248|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2367249|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367250|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367251|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367252|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2367253|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2367254|NCT00563433|Ofloxacin|ofloxacin|mesh-list
2367255|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2367256|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367257|NCT00563433|Renal Agents|renal agents|mesh-ancestor
2367258|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2367259|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2367260|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2367261|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367262|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367263|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367264|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2367265|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2367266|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
2367267|NCT00563446|Hematinics|hematinics|mesh-ancestor
2367268|NCT00563459|Topiramate|topiramate|mesh-list
2367269|NCT00563459|Levetiracetam|levetiracetam|mesh-list
2367270|NCT00563459|Anticonvulsants|anticonvulsants|mesh-ancestor
2367271|NCT00563459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2367272|NCT00563459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367273|NCT00563459|Nootropic Agents|nootropic agents|mesh-ancestor
2367274|NCT00563472|Desogestrel|desogestrel|mesh-list
2367275|NCT00563472|Progesterone|progesterone|mesh-list
2367276|NCT00563472|Progestins|progestins|mesh-ancestor
2367277|NCT00563472|Hormones|hormones|mesh-ancestor
2367278|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2367279|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367280|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2367281|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2475608|NCT01085097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2475609|NCT01085097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475610|NCT01085097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2475611|NCT01085097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475612|NCT01085097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2475613|NCT01085097|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2475614|NCT01085097|Antitubercular Agents|antitubercular agents|mesh-ancestor
2475615|NCT01085097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2475616|NCT01085097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475617|NCT01085097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475618|NCT01085097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475619|NCT01085149|Simvastatin|simvastatin|mesh-list
2475620|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2475621|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2475622|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
2475623|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475624|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2475625|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2475626|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367282|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2367283|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
2367284|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2367285|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2367286|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2367287|NCT00563485|Doxazosin|doxazosin|mesh-list
2367288|NCT00563485|Terazosin|terazosin|mesh-list
2367289|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2367290|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2367291|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2367292|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2475627|NCT01085383|Aripiprazole|aripiprazole|mesh-list
2475628|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
2475629|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2475630|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2475631|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2367293|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
2475632|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475633|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475634|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
2475635|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
2475636|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475637|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475638|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2475639|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2475640|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
2475641|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2475642|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2475643|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2475644|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2475645|NCT01085422|Temozolomide|temozolomide|mesh-list
2475646|NCT01085422|Veliparib|veliparib|mesh-list
2475647|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2475648|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
2475649|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475650|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475651|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2113860|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2113861|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2113862|NCT02593396|Bupropion|bupropion|mesh-list
2113863|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2113864|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
2113865|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2113866|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2113867|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2113868|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2367294|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367295|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367296|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367297|NCT00563485|Urological Agents|urological agents|mesh-ancestor
2367298|NCT00563524|Fezakinumab|fezakinumab|mesh-list
2367299|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
2367300|NCT00563563|Naltrexone|naltrexone|mesh-list
2367301|NCT00563563|Bupropion|bupropion|mesh-list
2367302|NCT00563563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2367303|NCT00563563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2367304|NCT00563563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367305|NCT00563563|Sensory System Agents|sensory system agents|mesh-ancestor
2367306|NCT00563563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367307|NCT00563563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2367308|NCT00563563|Antidepressive Agents|antidepressive agents|mesh-ancestor
2367309|NCT00563563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2367310|NCT00563563|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2367311|NCT00563563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2367312|NCT00563563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2367313|NCT00563563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367314|NCT00563563|Dopamine Agents|dopamine agents|mesh-ancestor
2367315|NCT00563563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367316|NCT00563563|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2367317|NCT00563563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2367318|NCT00563563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367319|NCT00563589|Cyclosporine|cyclosporine|mesh-list
2367320|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
2367321|NCT00563589|Methotrexate|methotrexate|mesh-list
2367322|NCT00563589|Cyclosporins|cyclosporins|mesh-list
2367323|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2367324|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
2367325|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2367326|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367327|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2367328|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
2367329|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367330|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367331|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
2367332|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367333|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2367334|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2367335|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
2367336|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2367337|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2367338|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
2367339|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367340|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2367341|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2367342|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2367343|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
2367344|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2367345|NCT00563615|Tegaserod|tegaserod|mesh-list
2367346|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2367347|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
2367348|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367349|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367350|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367351|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2367352|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
2367353|NCT00563654|Alfuzosin|alfuzosin|mesh-list
2367354|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2367355|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2367356|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2475652|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475653|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
2475654|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
2475655|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2475656|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
2475657|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2475658|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475659|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2475660|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2475661|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2475662|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2475663|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475664|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
2475665|NCT01085487|Coagulants|coagulants|mesh-ancestor
2367357|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
2367358|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367359|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367360|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367361|NCT00563654|Urological Agents|urological agents|mesh-ancestor
2367362|NCT00563758|Tegaserod|tegaserod|mesh-list
2367363|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2367364|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
2367365|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367366|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367367|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367368|NCT00563771|Rasburicase|rasburicase|mesh-list
2367369|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
2367370|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2367371|NCT00563823|Vatalanib|vatalanib|mesh-list
2367372|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2367373|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367374|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367375|NCT00563836|Catumaxomab|catumaxomab|mesh-list
2367376|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2367377|NCT00563849|Leflunomide|leflunomide|mesh-list
2367378|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367379|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367380|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2367381|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
2367382|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367383|NCT00563862|Fluorouracil|fluorouracil|mesh-list
2367384|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367385|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
2367386|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367387|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2367388|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2367389|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
2367390|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367391|NCT00563875|Aspirin|aspirin|mesh-list
2367392|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2367393|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2367394|NCT00563875|Analgesics|analgesics|mesh-ancestor
2367395|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
2367396|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367397|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367398|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2475666|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
2475667|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475668|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
2475669|NCT01085552|Hematinics|hematinics|mesh-ancestor
2475670|NCT01085617|Cytarabine|cytarabine|mesh-list
2475671|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
2475672|NCT01085617|Melphalan|melphalan|mesh-list
2475673|NCT01085617|Rituximab|rituximab|mesh-list
2475674|NCT01085617|Methotrexate|methotrexate|mesh-list
2475675|NCT01085617|Fludarabine|fludarabine|mesh-list
2475676|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
2475677|NCT01085617|Etoposide|etoposide|mesh-list
2475678|NCT01085617|Vincristine|vincristine|mesh-list
2475679|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
2475680|NCT01085617|Daunorubicin|daunorubicin|mesh-list
2475681|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
2475682|NCT01085617|Pegaspargase|pegaspargase|mesh-list
2475683|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2475684|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
2475685|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475686|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2475687|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2475688|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
2367399|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2367400|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2367401|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2367402|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367403|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2367404|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2367405|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367406|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
2367407|NCT00563914|Amodiaquine|amodiaquine|mesh-list
2367408|NCT00563914|Ferroquine|ferroquine|mesh-list
2367409|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
2367410|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2367411|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2367412|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367413|NCT00563927|Fluorouracil|fluorouracil|mesh-list
2367414|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367415|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
2367416|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367417|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2367418|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2367419|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
2367420|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367421|NCT00563953|Doxorubicin|doxorubicin|mesh-list
2367422|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2367423|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367424|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2367425|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2367426|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367427|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367428|NCT00563992|Valproic Acid|valproic acid|mesh-list
2367429|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2367430|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367431|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367432|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
2367433|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2367434|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2367435|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367436|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
2367437|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
2367438|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367439|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2367440|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
2367441|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2367442|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
2367443|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2367444|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367445|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2367446|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2367447|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2367448|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367449|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2367450|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2367451|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2367452|NCT00564057|Candesartan|candesartan|mesh-list
2367453|NCT00564057|Lercanidipine|lercanidipine|mesh-list
2367454|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2367455|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2367456|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2367457|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367458|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2367459|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2367460|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2367461|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367462|NCT00564148|Bevacizumab|bevacizumab|mesh-list
2367463|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2367464|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367465|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2367466|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2367467|NCT00564148|Growth Substances|growth substances|mesh-ancestor
2367468|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367469|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
2367470|NCT00564174|Aspirin|aspirin|mesh-list
2367471|NCT00564174|Heparin|heparin|mesh-list
2367472|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2367473|NCT00564174|Tinzaparin|tinzaparin|mesh-list
2367474|NCT00564174|Dalteparin|dalteparin|mesh-list
2367475|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2367476|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2367477|NCT00564174|Analgesics|analgesics|mesh-ancestor
2367478|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
2367479|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367480|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367481|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2367482|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2367483|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2367484|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2367485|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367486|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2367487|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2367488|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367489|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
2367490|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
2367491|NCT00564187|Irbesartan|irbesartan|mesh-list
2367492|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2367493|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2367494|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2367495|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367496|NCT00564200|Dexamethasone|dexamethasone|mesh-list
2367497|NCT00564200|Fludarabine|fludarabine|mesh-list
2367498|NCT00564200|Bortezomib|bortezomib|mesh-list
2367499|NCT00564200|Melphalan|melphalan|mesh-list
2367500|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2367501|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
2367502|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
2367503|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367504|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367505|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2367506|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
2367507|NCT00564200|Hormones|hormones|mesh-ancestor
2367508|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2367509|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2367510|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367511|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367512|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2367513|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
2367514|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2367515|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
2367516|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2367517|NCT00564213|Mitomycins|mitomycins|mesh-list
2367518|NCT00564213|Mitomycin|mitomycin|mesh-list
2367519|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2367520|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475689|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475690|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475691|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2475692|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2367521|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
2367522|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367523|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2367524|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367525|NCT00564226|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2367526|NCT00564226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2367527|NCT00564226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2367528|NCT00564226|Cholinergic Agents|cholinergic agents|mesh-ancestor
2367529|NCT00564226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367530|NCT00564226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367531|NCT00564226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367532|NCT00564226|Urological Agents|urological agents|mesh-ancestor
2367533|NCT00564252|Finasteride|finasteride|mesh-list
2367534|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2367535|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2367536|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367537|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367538|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
2367539|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2367540|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367541|NCT00564252|Urological Agents|urological agents|mesh-ancestor
2367542|NCT00564330|Esomeprazole|esomeprazole|mesh-list
2367543|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2367544|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2367545|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2367546|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367547|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367548|NCT00564408|Carbachol|carbachol|mesh-list
2367549|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2367550|NCT00564408|Miotics|miotics|mesh-ancestor
2367551|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
2367552|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367553|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367554|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2367555|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
2367556|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367557|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367558|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2367559|NCT00564408|Analgesics|analgesics|mesh-ancestor
2367560|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
2367561|NCT00564408|Protective Agents|protective agents|mesh-ancestor
2367562|NCT00564421|Epinastine|epinastine|mesh-list
2367563|NCT00564421|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2367564|NCT00564421|Histamine Antagonists|histamine antagonists|mesh-ancestor
2367565|NCT00564421|Histamine Agents|histamine agents|mesh-ancestor
2367566|NCT00564421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367567|NCT00564421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367568|NCT00564421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367569|NCT00564460|Finasteride|finasteride|mesh-list
2367570|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2367571|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2367572|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367573|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367574|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
2367575|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2367576|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367577|NCT00564460|Urological Agents|urological agents|mesh-ancestor
2367578|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
2367579|NCT00564512|Rituximab|rituximab|mesh-list
2367580|NCT00564512|Fludarabine|fludarabine|mesh-list
2367581|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
2367582|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2367583|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
2367584|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367585|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2367586|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2367587|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
2367588|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367589|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367590|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2367591|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2367592|NCT00564525|Amitriptyline|amitriptyline|mesh-list
2367593|NCT00564525|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2475693|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2475694|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
2475695|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2475696|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2475697|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
2475698|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
2475699|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475700|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2475701|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2475702|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2475703|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2475704|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2475705|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
2475706|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475707|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
2475708|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
2475709|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
2475710|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2475711|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2475712|NCT01085656|Combretastatin|combretastatin|mesh-list
2475713|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2475714|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475715|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
2475716|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
2475717|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
2475718|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475719|NCT01085695|Rabeprazole|rabeprazole|mesh-list
2475720|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2475721|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2475722|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2475723|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475724|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475725|NCT01085708|Rabeprazole|rabeprazole|mesh-list
2475726|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2475727|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2475728|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2475729|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475730|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475731|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
2475732|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
2475733|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
2475734|NCT01085721|Ephedrine|ephedrine|mesh-list
2367594|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2367595|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
2367596|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2367597|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2367598|NCT00564525|Analgesics|analgesics|mesh-ancestor
2367599|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
2367600|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367601|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367602|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2367603|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2367604|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2367605|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367606|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
2367607|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367608|NCT00564525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2367609|NCT00564525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2367610|NCT00564525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2367611|NCT00564538|Tacrolimus|tacrolimus|mesh-list
2367612|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
2367613|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2367614|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2367615|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
2367616|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475735|NCT01085721|Guaifenesin|guaifenesin|mesh-list
2475736|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2475737|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
2475738|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2475739|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
2475740|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475741|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475742|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2475743|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
2475744|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
2475745|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2367617|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2367618|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367619|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367620|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
2367621|NCT00564551|Calcium|calcium|mesh-list
2367622|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2367623|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367624|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2367625|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2367626|NCT00564564|Clomipramine|clomipramine|mesh-list
2367627|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
2367628|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2367629|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2367630|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2367631|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2367632|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475746|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2475747|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
2475748|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
2475749|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475750|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475751|NCT01085721|Expectorants|expectorants|mesh-ancestor
2475752|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2475753|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2475754|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
2475755|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2475756|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2475757|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
2475758|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
2475759|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
2367633|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2367634|NCT00564564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2367635|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2367636|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2367637|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367638|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367639|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
2367640|NCT00564590|Melatonin|melatonin|mesh-list
2367641|NCT00564590|Omeprazole|omeprazole|mesh-list
2367642|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
2367643|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367644|NCT00564590|Protective Agents|protective agents|mesh-ancestor
2475760|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
2475761|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2475762|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2475763|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475764|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2475765|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475766|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475767|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
2475768|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
2475769|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2475770|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
2367645|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367646|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2367647|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2367648|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2367649|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2367650|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367651|NCT00564603|Dexamethasone|dexamethasone|mesh-list
2367652|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
2367653|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2367654|NCT00564603|BB 1101|bb 1101|mesh-list
2367655|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2367656|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
2367657|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
2367658|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367659|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367660|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2367661|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
2367662|NCT00564603|Hormones|hormones|mesh-ancestor
2367663|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2367664|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2367665|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367666|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
2367667|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367668|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367669|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
2367670|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2367671|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
2367672|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367673|NCT00564642|Expectorants|expectorants|mesh-ancestor
2367674|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
2367675|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2367676|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
2367677|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367678|NCT00564642|Protective Agents|protective agents|mesh-ancestor
2475771|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
2475772|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475773|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475774|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475775|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
2367679|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367680|NCT00564642|Antidotes|antidotes|mesh-ancestor
2367681|NCT00564655|Epinephrine|epinephrine|mesh-list
2367682|NCT00564655|Racepinephrine|racepinephrine|mesh-list
2367683|NCT00564655|Bupivacaine|bupivacaine|mesh-list
2367684|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
2367685|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
2367686|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
2367687|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2367688|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367689|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
2367690|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367691|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2367692|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2367693|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
2367694|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367695|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367696|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2367697|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2367698|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
2367699|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2367700|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
2367701|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
2367702|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
2367703|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2367704|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
2367705|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
2367706|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2367707|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367708|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
2367709|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2367710|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2367711|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2367712|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2367713|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367714|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
2367715|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367716|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367717|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2367718|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367719|NCT00564720|Gemcitabine|gemcitabine|mesh-list
2475776|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
2475777|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2475778|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2475779|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2475780|NCT01085877|Estradiol|estradiol|mesh-list
2475781|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2475782|NCT01085877|Estrogens|estrogens|mesh-ancestor
2475783|NCT01085877|Hormones|hormones|mesh-ancestor
2475784|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2475785|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475786|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2475787|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
2475788|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2475789|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2475790|NCT01085981|Niacin|niacin|mesh-list
2475791|NCT01085981|Niacinamide|niacinamide|mesh-list
2475792|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
2475793|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2475794|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
2475795|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475796|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2367720|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
2367721|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2367722|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2367723|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
2367724|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367725|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367726|NCT00564720|Antiviral Agents|antiviral agents|mesh-ancestor
2367727|NCT00564720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367728|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367729|NCT00564720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2367730|NCT00564720|Immunologic Factors|immunologic factors|mesh-ancestor
2367731|NCT00564720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367732|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2367733|NCT00564772|Ritonavir|ritonavir|mesh-list
2367734|NCT00564772|Lopinavir|lopinavir|mesh-list
2367735|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
2367736|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2367737|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2367738|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
2367739|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367740|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367741|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2367742|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2367743|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
2367744|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367745|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2367746|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2367747|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2367748|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2367749|NCT00564824|Caffeine|caffeine|mesh-list
2367750|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2367751|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367752|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2367753|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367754|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367755|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2367756|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2367757|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
2367758|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367759|NCT00564941|Deferasirox|deferasirox|mesh-list
2367760|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2367761|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
2367762|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
2475797|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
2475798|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
2475799|NCT01085981|Vitamins|vitamins|mesh-ancestor
2475800|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
2475801|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475802|NCT01086020|Atorvastatin|atorvastatin|mesh-list
2475803|NCT01086020|Ezetimibe|ezetimibe|mesh-list
2475804|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2475805|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2475806|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
2475807|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475808|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2475809|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2475810|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475811|NCT01086046|Heparin|heparin|mesh-list
2475812|NCT01086046|Enoxaparin|enoxaparin|mesh-list
2475813|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2475814|NCT01086046|Tinzaparin|tinzaparin|mesh-list
2475815|NCT01086046|Dalteparin|dalteparin|mesh-list
2367763|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367764|NCT00564993|Dobutamine|dobutamine|mesh-list
2367765|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2367766|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
2367767|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
2475816|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
2475817|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2475818|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2475819|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475820|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2475821|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
2475822|NCT01086085|Adefovir|adefovir|mesh-list
2475823|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
2475824|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475825|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
2475826|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475827|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2475828|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2475829|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475830|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475831|NCT01086254|Gemcitabine|gemcitabine|mesh-list
2475832|NCT01086254|Iniparib|iniparib|mesh-list
2475833|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475834|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2475835|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
2475836|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475837|NCT01086254|Antiviral Agents|antiviral agents|mesh-ancestor
2475838|NCT01086254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475839|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475840|NCT01086254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2475841|NCT01086254|Immunologic Factors|immunologic factors|mesh-ancestor
2475842|NCT01086254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475843|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2475844|NCT01086267|Cetuximab|cetuximab|mesh-list
2475845|NCT01086267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2475846|NCT01086267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475847|NCT01086332|Gemcitabine|gemcitabine|mesh-list
2475848|NCT01086332|Nelfinavir|nelfinavir|mesh-list
2475849|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2475850|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
2475851|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475852|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475853|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
2475854|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475855|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475856|NCT01086332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2475857|NCT01086332|Immunologic Factors|immunologic factors|mesh-ancestor
2367768|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367769|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367770|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2367771|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2367772|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2367773|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
2367774|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367775|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367776|NCT00564993|Protective Agents|protective agents|mesh-ancestor
2367777|NCT00565006|Anacetrapib|anacetrapib|mesh-list
2367778|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2367779|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2367780|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
2367781|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367782|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2367783|NCT00565019|Triamcinolone|triamcinolone|mesh-list
2475858|NCT01086332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475859|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2367784|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2367785|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2367786|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2475860|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2475861|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
2475862|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2475863|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2475864|NCT01086345|Bevacizumab|bevacizumab|mesh-list
2475865|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2475866|NCT01086345|Irinotecan|irinotecan|mesh-list
2475867|NCT01086345|Camptothecin|camptothecin|mesh-list
2475868|NCT01086345|Antibodies|antibodies|mesh-list
2475869|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
2475870|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2475871|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475872|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2475873|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2475874|NCT01086345|Growth Substances|growth substances|mesh-ancestor
2475875|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367787|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2367788|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
2367789|NCT00565019|Hormones|hormones|mesh-ancestor
2367790|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2367791|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367792|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2367793|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
2367794|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367795|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367796|NCT00565097|Lanreotide|lanreotide|mesh-list
2367797|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367798|NCT00565123|Levofloxacin|levofloxacin|mesh-list
2367799|NCT00565123|Ofloxacin|ofloxacin|mesh-list
2367800|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2367801|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2367802|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2367803|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367804|NCT00565123|Renal Agents|renal agents|mesh-ancestor
2367805|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2367806|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2367807|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2367808|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367809|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367810|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367811|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2367812|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2367813|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
2367814|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2367815|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367816|NCT00565175|Famotidine|famotidine|mesh-list
2367817|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2367818|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2367819|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2367820|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
2367821|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
2367822|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367823|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367824|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367825|NCT00565188|Adenosine|adenosine|mesh-list
2367826|NCT00565188|Analgesics|analgesics|mesh-ancestor
2367827|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
2367828|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367829|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367830|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2367831|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
2475876|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
2475877|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
2475878|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2475879|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2475880|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475881|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475882|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2475883|NCT01086527|Montelukast|montelukast|mesh-list
2475884|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2475885|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
2475886|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2367832|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2367833|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
2367834|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
2367835|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367836|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367837|NCT00565214|Vitamins|vitamins|mesh-list
2367838|NCT00565214|Vitamin E|vitamin e|mesh-list
2367839|NCT00565214|Selenium|selenium|mesh-list
2367840|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
2367841|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367842|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
2367843|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367844|NCT00565214|Protective Agents|protective agents|mesh-ancestor
2367845|NCT00565214|Trace Elements|trace elements|mesh-ancestor
2367846|NCT00565227|Docetaxel|docetaxel|mesh-list
2367847|NCT00565227|Vorinostat|vorinostat|mesh-list
2367848|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367849|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
2367850|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
2367851|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
2367852|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367853|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2367854|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367855|NCT00565240|Letrozole|letrozole|mesh-list
2367856|NCT00565240|NuvaRing|nuvaring|mesh-list
2367857|NCT00565240|Desogestrel|desogestrel|mesh-list
2367858|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367859|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2367860|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2367861|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367862|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367863|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2367864|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
2367865|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2367866|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367867|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2367868|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
2367869|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2367870|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2367871|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2367872|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2367873|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2367874|NCT00565240|Progestins|progestins|mesh-ancestor
2367875|NCT00565240|Hormones|hormones|mesh-ancestor
2475887|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
2475888|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2475889|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367876|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
2367877|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2367878|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
2367879|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367880|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367881|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2475890|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2475891|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2475892|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475893|NCT01086553|Budesonide|budesonide|mesh-list
2475894|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2475895|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2475896|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
2475897|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475898|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475899|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2475900|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
2475901|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
2475902|NCT01086553|Hormones|hormones|mesh-ancestor
2475903|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2475904|NCT01086579|Paclitaxel|paclitaxel|mesh-list
2475905|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2475906|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2475907|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475908|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
2475909|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
2475910|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
2367882|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
2367883|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2367884|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
2367885|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367886|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475911|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475912|NCT01086631|Rituximab|rituximab|mesh-list
2475913|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2475914|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475915|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
2475916|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475917|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2475918|NCT01086748|Risperidone|risperidone|mesh-list
2475919|NCT01086748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2475920|NCT01086748|Serotonin Agents|serotonin agents|mesh-ancestor
2475921|NCT01086748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475922|NCT01086748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475923|NCT01086748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475924|NCT01086748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2475925|NCT01086748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2475926|NCT01086748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475927|NCT01086748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2475928|NCT01086748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2367887|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2367888|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
2367889|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
2367890|NCT00565253|Protective Agents|protective agents|mesh-ancestor
2367891|NCT00565292|Anacetrapib|anacetrapib|mesh-list
2367892|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2367893|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2367894|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
2367895|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367896|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2367897|NCT00565318|Benphothiamine|benphothiamine|mesh-list
2367898|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2475929|NCT01086748|Dopamine Agents|dopamine agents|mesh-ancestor
2475930|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2475931|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
2475932|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2475933|NCT01086826|Cisplatin|cisplatin|mesh-list
2475934|NCT01086826|Docetaxel|docetaxel|mesh-list
2475935|NCT01086826|Fluorouracil|fluorouracil|mesh-list
2367899|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
2475936|NCT01086826|Cetuximab|cetuximab|mesh-list
2475937|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475938|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
2475939|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
2475940|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
2475941|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475942|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
2475943|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2475944|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2475945|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
2113869|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113870|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
2113871|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2113872|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113873|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2113874|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2113875|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367900|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367901|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
2367902|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
2367903|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367904|NCT00565331|Rituximab|rituximab|mesh-list
2367905|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2367906|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367907|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
2367908|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367909|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2367910|NCT00565383|Fentanyl|fentanyl|mesh-list
2367911|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2367912|NCT00565383|Narcotics|narcotics|mesh-ancestor
2367913|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2367914|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367915|NCT00565383|Analgesics|analgesics|mesh-ancestor
2475946|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475947|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2475948|NCT01086878|Trimethoprim|trimethoprim|mesh-list
2475949|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2475950|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
2475951|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2475952|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475953|NCT01086878|Renal Agents|renal agents|mesh-ancestor
2475954|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
2475955|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2475956|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2475957|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2475958|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475959|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475960|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2475961|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2475962|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2367916|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
2367917|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367918|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2367919|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2367920|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
2367921|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
2367922|NCT00565396|Losartan|losartan|mesh-list
2367923|NCT00565396|Fosinopril|fosinopril|mesh-list
2367924|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2367925|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2367926|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2367927|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2367928|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367929|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2367930|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
2367931|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367932|NCT00565422|Citalopram|citalopram|mesh-list
2367933|NCT00565422|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2367934|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2367935|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2367936|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367937|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367938|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
2367939|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367940|NCT00565422|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2367941|NCT00565422|Antidepressive Agents|antidepressive agents|mesh-ancestor
2367942|NCT00565422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2367943|NCT00565461|Vaccines|vaccines|mesh-list
2367944|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
2367945|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367946|NCT00565487|Capecitabine|capecitabine|mesh-list
2367947|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2367948|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2475963|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2475964|NCT01086956|Sufentanil|sufentanil|mesh-list
2475965|NCT01086956|Ropivacaine|ropivacaine|mesh-list
2475966|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
2475967|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
2475968|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475969|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475970|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
2475971|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475972|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2475973|NCT01086956|Narcotics|narcotics|mesh-ancestor
2475974|NCT01086956|Analgesics|analgesics|mesh-ancestor
2475975|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2475976|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2475977|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
2475978|NCT01086982|Octreotide|octreotide|mesh-list
2475979|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2475980|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2475981|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475982|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
2475983|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2475984|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475985|NCT01087099|Albendazole|albendazole|mesh-list
2367949|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
2367950|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367951|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367952|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2367953|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367954|NCT00565500|Ibuprofen|ibuprofen|mesh-list
2367955|NCT00565500|Celecoxib|celecoxib|mesh-list
2475986|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
2475987|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2475988|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475989|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
2475990|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2475991|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2475992|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
2475993|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
2475994|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
2475995|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475996|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475997|NCT01087138|Calcium|calcium|mesh-list
2475998|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2475999|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476000|NCT01087151|Rituximab|rituximab|mesh-list
2476001|NCT01087151|Navitoclax|navitoclax|mesh-list
2476002|NCT01087151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2367956|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2367957|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2367958|NCT00565500|Analgesics|analgesics|mesh-ancestor
2367959|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
2367960|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367961|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367962|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2367963|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2367964|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2367965|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367966|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367967|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2367968|NCT00565539|Interferons|interferons|mesh-list
2367969|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367970|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
2367971|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367972|NCT00565591|Albuterol|albuterol|mesh-list
2367973|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2367974|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
2367975|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2367976|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2367977|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2367978|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
2367979|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
2367980|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2367981|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2367982|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2367983|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2367984|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
2367985|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2367986|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367987|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
2367988|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2367989|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2367990|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2367991|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2476003|NCT01087151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476004|NCT01087151|Immunologic Factors|immunologic factors|mesh-ancestor
2476005|NCT01087151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476006|NCT01087151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2476007|NCT01087190|Isoniazid|isoniazid|mesh-list
2476008|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
2476009|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2476010|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476011|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2367992|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2367993|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2367994|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2367995|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2367996|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2367997|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
2367998|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2367999|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368000|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2368001|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2368002|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2368003|NCT00565656|Bevacizumab|bevacizumab|mesh-list
2368004|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2368005|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368006|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2368007|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2368008|NCT00565656|Growth Substances|growth substances|mesh-ancestor
2368009|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368010|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
2368011|NCT00565682|Etoricoxib|etoricoxib|mesh-list
2368012|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2368013|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2368014|NCT00565682|Analgesics|analgesics|mesh-ancestor
2368015|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
2368016|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368017|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368018|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368019|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368020|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2368021|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2368022|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368023|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368024|NCT00565708|Aspirin|aspirin|mesh-list
2368025|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2368026|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2368027|NCT00565708|Analgesics|analgesics|mesh-ancestor
2368028|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
2368029|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368030|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113876|NCT02593539|Nemiralisib|nemiralisib|mesh-list
2113877|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2113878|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113879|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113880|NCT02593773|Interferons|interferons|mesh-list
2113881|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
2113882|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113883|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
2113884|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113885|NCT02593903|Trimethoprim|trimethoprim|mesh-list
2113886|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2113887|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
2476012|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2476013|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
2476014|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476015|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2476016|NCT01087203|Tanezumab|tanezumab|mesh-list
2476017|NCT01087203|Analgesics|analgesics|mesh-ancestor
2476018|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
2476019|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476020|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476021|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
2368031|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368032|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368033|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2368034|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2368035|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368036|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2368037|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2368038|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368039|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
2368040|NCT00565955|Montelukast|montelukast|mesh-list
2368041|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2368042|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
2368043|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2476022|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2476023|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
2476024|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
2476025|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2476026|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476027|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2476028|NCT01087229|Analgesics|analgesics|mesh-ancestor
2476029|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
2476030|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476031|NCT01087359|Melatonin|melatonin|mesh-list
2476032|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
2476033|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476034|NCT01087359|Protective Agents|protective agents|mesh-ancestor
2476035|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368044|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
2368045|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2368046|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368047|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2368048|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2368049|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368050|NCT00565968|Sorafenib|sorafenib|mesh-list
2368051|NCT00565968|Melphalan|melphalan|mesh-list
2368052|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368053|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2368054|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368055|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476036|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2476037|NCT01087398|Cyclosporine|cyclosporine|mesh-list
2476038|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
2476039|NCT01087398|Busulfan|busulfan|mesh-list
2476040|NCT01087398|Methotrexate|methotrexate|mesh-list
2476041|NCT01087398|Fludarabine|fludarabine|mesh-list
2476042|NCT01087398|Cyclosporins|cyclosporins|mesh-list
2476043|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
2476044|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476045|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
2476046|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476047|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2476048|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2476049|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
2476050|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476051|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476052|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2368056|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2368057|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
2368058|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2368059|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2368060|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
2368061|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368062|NCT00565981|Fludarabine|fludarabine|mesh-list
2476053|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2476054|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
2476055|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2368063|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
2368064|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
2368065|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368066|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2368067|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
2476056|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2476057|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
2476058|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
2476059|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476060|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2476061|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2476062|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
2476063|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476064|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2476065|NCT01087437|Calcium|calcium|mesh-list
2476066|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2476067|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476068|NCT01087476|Doxycycline|doxycycline|mesh-list
2476069|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2476070|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476071|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
2476072|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2476073|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2476074|NCT01087554|Sirolimus|sirolimus|mesh-list
2476075|NCT01087554|Everolimus|everolimus|mesh-list
2476076|NCT01087554|Vorinostat|vorinostat|mesh-list
2476077|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476078|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476079|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
2476080|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476081|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2476082|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476083|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2476084|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
2476085|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2476086|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476087|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476088|NCT01087567|Insulin|insulin|mesh-list
2476089|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2476090|NCT01087567|Metformin|metformin|mesh-list
2476091|NCT01087567|Pioglitazone|pioglitazone|mesh-list
2476092|NCT01087567|Glimepiride|glimepiride|mesh-list
2476093|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2476094|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476095|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2476096|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476097|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
2368068|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368069|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2368070|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
2368071|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368072|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2368073|NCT00566046|Levetiracetam|levetiracetam|mesh-list
2368074|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
2368075|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
2368076|NCT00566124|Insulin|insulin|mesh-list
2368077|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2368078|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
2368079|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
2368080|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
2368081|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
2368082|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
2368083|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2368084|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368085|NCT00566202|Citalopram|citalopram|mesh-list
2368086|NCT00566202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2476098|NCT01087580|Prednisone|prednisone|mesh-list
2476099|NCT01087580|Docetaxel|docetaxel|mesh-list
2476100|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476101|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
2476102|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
2476103|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
2368087|NCT00566202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2368088|NCT00566202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2368089|NCT00566202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368090|NCT00566202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368091|NCT00566202|Serotonin Agents|serotonin agents|mesh-ancestor
2368092|NCT00566202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368093|NCT00566202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2368094|NCT00566202|Antidepressive Agents|antidepressive agents|mesh-ancestor
2368095|NCT00566202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2368096|NCT00566241|Mecasermin|mecasermin|mesh-list
2368097|NCT00566241|Growth Substances|growth substances|mesh-ancestor
2368098|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368099|NCT00566267|Simvastatin|simvastatin|mesh-list
2476104|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476105|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2476106|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
2476107|NCT01087580|Hormones|hormones|mesh-ancestor
2476108|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2476109|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476110|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2476111|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2476112|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2476113|NCT01087593|Estradiol|estradiol|mesh-list
2476114|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2476115|NCT01087593|Estrogens|estrogens|mesh-ancestor
2368100|NCT00566267|Ezetimibe|ezetimibe|mesh-list
2476116|NCT01087593|Hormones|hormones|mesh-ancestor
2368101|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2368102|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2368103|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
2368104|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368105|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2368106|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2476117|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2476118|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476119|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2476120|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
2476121|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2476122|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2476126|NCT01087632|Folic Acid|folic acid|mesh-list
2476127|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
2476128|NCT01087632|Policosanol|policosanol|mesh-list
2476129|NCT01087632|Red yeast rice|red yeast rice|mesh-list
2476130|NCT01087632|Hematinics|hematinics|mesh-ancestor
2476131|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
2476132|NCT01087632|Vitamins|vitamins|mesh-ancestor
2476133|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
2476134|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476135|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2476136|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2368107|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368108|NCT00566332|Fludarabine|fludarabine|mesh-list
2368109|NCT00566332|Chlorambucil|chlorambucil|mesh-list
2368110|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368111|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368112|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2368113|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
2368114|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2368115|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2476137|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2476138|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
2476139|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476140|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476141|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2476142|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2368116|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2368117|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2368118|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368119|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
2368120|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368121|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368122|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2368123|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2368124|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
2368125|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368126|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
2368127|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2368128|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368129|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
2368130|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2368131|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368132|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
2476143|NCT01087658|Calcium|calcium|mesh-list
2476144|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2476145|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476146|NCT01087710|Vitamins|vitamins|mesh-list
2476147|NCT01087710|Antioxidants|antioxidants|mesh-list
2476148|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
2476149|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368133|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368134|NCT00566553|Protective Agents|protective agents|mesh-ancestor
2368135|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368136|NCT00566592|Ethanol|ethanol|mesh-list
2368137|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2368138|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2368139|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2368140|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368141|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
2368142|NCT00566618|Dasatinib|dasatinib|mesh-list
2368143|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368144|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2368145|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368146|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368147|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2368148|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368149|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
2368150|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2368151|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
2368152|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2368153|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368154|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2368155|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2476150|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476151|NCT01087710|Protective Agents|protective agents|mesh-ancestor
2476152|NCT01087749|Losartan|losartan|mesh-list
2476153|NCT01087749|Propranolol|propranolol|mesh-list
2476154|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2476155|NCT01087749|Eprosartan|eprosartan|mesh-list
2476156|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2476157|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2476158|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2476159|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2476160|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476161|NCT01087749|Diuretics|diuretics|mesh-ancestor
2476162|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
2476163|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476164|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2476165|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2476166|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2476167|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2476168|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
2476169|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2476170|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
2476171|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
2476172|NCT01087840|Tenofovir|tenofovir|mesh-list
2368156|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2368157|NCT00566683|Meperidine|meperidine|mesh-list
2368158|NCT00566683|Diazepam|diazepam|mesh-list
2368159|NCT00566683|Alfentanil|alfentanil|mesh-list
2368160|NCT00566683|Propofol|propofol|mesh-list
2368161|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2368162|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2368163|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368164|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2476173|NCT01087840|Emtricitabine|emtricitabine|mesh-list
2476174|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
2476175|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
2476176|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476177|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2476178|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2476179|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476180|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476181|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2476182|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2476183|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2368165|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
2368166|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
2368167|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2368168|NCT00566683|Narcotics|narcotics|mesh-ancestor
2368169|NCT00566683|Analgesics|analgesics|mesh-ancestor
2368170|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
2368171|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368172|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2368173|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
2368174|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
2368175|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
2368176|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2368177|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2368178|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2368179|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2368180|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2368181|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2368182|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
2368183|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
2368184|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368185|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368186|NCT00566761|Triamcinolone|triamcinolone|mesh-list
2368187|NCT00566761|Bevacizumab|bevacizumab|mesh-list
2368188|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2476184|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2476185|NCT01087866|Metformin|metformin|mesh-list
2476186|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2476187|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476188|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2476189|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2476190|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2476191|NCT01087879|Etonogestrel|etonogestrel|mesh-list
2476192|NCT01087879|Desogestrel|desogestrel|mesh-list
2476193|NCT01087879|NuvaRing|nuvaring|mesh-list
2476194|NCT01087879|Norelgestromin|norelgestromin|mesh-list
2476195|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
2476196|NCT01087879|Estradiol|estradiol|mesh-list
2368189|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368190|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2368191|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2368192|NCT00566761|Growth Substances|growth substances|mesh-ancestor
2368193|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476197|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2476198|NCT01087879|Estrogens|estrogens|mesh-ancestor
2476199|NCT01087879|Hormones|hormones|mesh-ancestor
2368194|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
2368195|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368196|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
2368197|NCT00566761|Hormones|hormones|mesh-ancestor
2368198|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2368199|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2368200|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368201|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2368202|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368203|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368204|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
2476200|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2476201|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476202|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2476203|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2476204|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2476205|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2476206|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2476207|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2476208|NCT01087879|Progestins|progestins|mesh-ancestor
2476209|NCT01087983|Metformin|metformin|mesh-list
2476210|NCT01087983|Sirolimus|sirolimus|mesh-list
2476211|NCT01087983|Lapatinib|lapatinib|mesh-list
2476212|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2476213|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476214|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2476215|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476216|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2476217|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476218|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
2476219|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476220|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
2476221|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2476222|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476223|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476224|NCT01088009|Lamivudine|lamivudine|mesh-list
2476225|NCT01088009|Adefovir|adefovir|mesh-list
2476226|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2476227|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2476228|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368205|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2368206|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
2368207|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368208|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2368209|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2368210|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2368211|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368212|NCT00566891|Tirofiban|tirofiban|mesh-list
2368213|NCT00566891|Clopidogrel|clopidogrel|mesh-list
2368214|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2368215|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2368216|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2368217|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2368218|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
2368219|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368220|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368221|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368222|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2368223|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2368224|NCT00566904|Aspirin|aspirin|mesh-list
2368225|NCT00566904|Lidocaine|lidocaine|mesh-list
2368226|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
2368227|NCT00566904|Anesthetics|anesthetics|mesh-list
2368228|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2368229|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368230|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
2368231|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368232|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2368233|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2368234|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2368235|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2368236|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368237|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2368238|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2368239|NCT00566904|Analgesics|analgesics|mesh-ancestor
2368240|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368241|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368242|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2368243|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2368244|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2368245|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2368246|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368247|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
2368248|NCT00567034|Naltrexone|naltrexone|mesh-list
2368249|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2476229|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476230|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
2476231|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476232|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2476233|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2476234|NCT01088022|Dexamethasone|dexamethasone|mesh-list
2476235|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
2476236|NCT01088022|Aprepitant|aprepitant|mesh-list
2476237|NCT01088022|Palonosetron|palonosetron|mesh-list
2368250|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2368251|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368252|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
2368253|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368254|NCT00567047|Vildagliptin|vildagliptin|mesh-list
2368255|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2368256|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368257|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2368258|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
2368259|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368260|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368261|NCT00567060|Piracetam|piracetam|mesh-list
2368262|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2368263|NCT00567060|Protective Agents|protective agents|mesh-ancestor
2368264|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368265|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
2368266|NCT00567099|Aripiprazole|aripiprazole|mesh-list
2368267|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
2368268|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2368269|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2368270|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2368271|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2368272|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368273|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
2368274|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
2368275|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368276|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368277|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2476238|NCT01088022|BB 1101|bb 1101|mesh-list
2476239|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2476240|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
2476241|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
2476242|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476243|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368278|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2368279|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
2368280|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2368281|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2368282|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2476244|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2476245|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
2476246|NCT01088022|Hormones|hormones|mesh-ancestor
2476247|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2476248|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2476249|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476250|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
2476251|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476252|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476253|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2476254|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2476255|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2476256|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2476257|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
2476258|NCT01088035|Carboplatin|carboplatin|mesh-list
2476259|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476260|NCT01088165|Adalimumab|adalimumab|mesh-list
2476261|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2476262|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2476263|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
2476264|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2476265|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
2476266|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2476267|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476268|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2476269|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2476270|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2476271|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
2368283|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2368284|NCT00567177|Cyclosporine|cyclosporine|mesh-list
2368285|NCT00567177|Cyclosporins|cyclosporins|mesh-list
2368286|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368287|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368288|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2368289|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
2368290|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368291|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
2368292|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2368293|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
2368294|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368295|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2368296|NCT00567216|Nadolol|nadolol|mesh-list
2368297|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2368298|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2368299|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
2368300|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368301|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368302|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368303|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2368304|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2368305|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
2368306|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
2368307|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368308|NCT00567372|Bevacizumab|bevacizumab|mesh-list
2476272|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2476273|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
2476274|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476275|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
2476276|NCT01088191|Protective Agents|protective agents|mesh-ancestor
2476277|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
2476278|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2476279|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2476280|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476281|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
2476282|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2476283|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368309|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2368310|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368311|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2368312|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2368313|NCT00567372|Growth Substances|growth substances|mesh-ancestor
2368314|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368315|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
2368316|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2368317|NCT00567411|Apraclonidine|apraclonidine|mesh-list
2368318|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2368319|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2368320|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2368321|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2368322|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
2368323|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2476284|NCT01088256|Etoricoxib|etoricoxib|mesh-list
2476285|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2476286|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2476287|NCT01088256|Analgesics|analgesics|mesh-ancestor
2476288|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
2476289|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476290|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368324|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368325|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368326|NCT00567450|Ropivacaine|ropivacaine|mesh-list
2368327|NCT00567450|Mepivacaine|mepivacaine|mesh-list
2368328|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
2368329|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
2368330|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2476291|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2476292|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368331|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476293|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2476294|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2476295|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476296|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476297|NCT01088282|Dipivefrin|dipivefrin|mesh-list
2476298|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2476299|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
2476300|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2476301|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476302|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476303|NCT01088347|Mapatumumab|mapatumumab|mesh-list
2368332|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
2368333|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368334|NCT00567463|Fluticasone|fluticasone|mesh-list
2368335|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368336|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2368337|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
2368338|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368339|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368340|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2368341|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
2368342|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
2476304|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476305|NCT01088373|Lenalidomide|lenalidomide|mesh-list
2476306|NCT01088373|Azacitidine|azacitidine|mesh-list
2476307|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
2476308|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476309|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2476310|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2476311|NCT01088373|Growth Substances|growth substances|mesh-ancestor
2476312|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
2476313|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476314|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2476315|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
2476316|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476317|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476318|NCT01088451|Insulin|insulin|mesh-list
2476319|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2476320|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476321|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2368343|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2368344|NCT00567528|Ibuprofen|ibuprofen|mesh-list
2368345|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2368346|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2368347|NCT00567528|Analgesics|analgesics|mesh-ancestor
2368348|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
2368349|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368350|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368351|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368352|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368353|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2368354|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368355|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368356|NCT00567554|Paclitaxel|paclitaxel|mesh-list
2368357|NCT00567554|Docetaxel|docetaxel|mesh-list
2476322|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2476323|NCT01088477|Estradiol|estradiol|mesh-list
2476324|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2476325|NCT01088477|Estrogens|estrogens|mesh-ancestor
2476326|NCT01088477|Hormones|hormones|mesh-ancestor
2476327|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2476328|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476329|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2476330|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
2368358|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2476331|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2476332|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2476333|NCT01088516|Ritonavir|ritonavir|mesh-list
2476334|NCT01088516|Lopinavir|lopinavir|mesh-list
2476335|NCT01088516|Zidovudine|zidovudine|mesh-list
2476336|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2476337|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2476338|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
2476339|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476340|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476341|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2476342|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2476343|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
2476344|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476345|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2476346|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2476347|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
2476348|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2476349|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2368359|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
2368360|NCT00567554|Bevacizumab|bevacizumab|mesh-list
2368361|NCT00567554|Trastuzumab|trastuzumab|mesh-list
2368362|NCT00567554|Everolimus|everolimus|mesh-list
2368363|NCT00567554|Epirubicin|epirubicin|mesh-list
2368364|NCT00567554|Lapatinib|lapatinib|mesh-list
2368365|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2368366|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368367|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
2368368|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
2368369|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
2368370|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368371|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2368372|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
2476350|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
2476351|NCT01088555|Antidotes|antidotes|mesh-ancestor
2476352|NCT01088555|Protective Agents|protective agents|mesh-ancestor
2368373|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368374|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368375|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2368376|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
2368377|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2368378|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2476353|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476354|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
2476355|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476356|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
2476357|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2476358|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476359|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
2476360|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
2368379|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2368380|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2368381|NCT00567554|Growth Substances|growth substances|mesh-ancestor
2368382|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
2368383|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2368384|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2368385|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2368386|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476361|NCT01088594|Pioglitazone|pioglitazone|mesh-list
2476362|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
2476363|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2476364|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476365|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2476366|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2476367|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2476368|NCT01088620|Pemetrexed|pemetrexed|mesh-list
2476369|NCT01088620|Panitumumab|panitumumab|mesh-list
2476370|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476371|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476372|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476373|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2476374|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2476375|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2476376|NCT01088659|Tenofovir|tenofovir|mesh-list
2368387|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2368388|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
2476377|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2476378|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
2476379|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476380|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2476381|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2476382|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476383|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476384|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2476385|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2476386|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
2476387|NCT01088724|Rituximab|rituximab|mesh-list
2476388|NCT01088724|Doxorubicin|doxorubicin|mesh-list
2476389|NCT01088724|Fludarabine|fludarabine|mesh-list
2476390|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476391|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
2476392|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476393|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2476394|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2476395|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
2476396|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476397|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476398|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2476399|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2476400|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2476401|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2476402|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2368389|NCT00567606|Calcium|calcium|mesh-list
2368390|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2368391|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368392|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2368393|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2368394|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368395|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2368396|NCT00567658|Esomeprazole|esomeprazole|mesh-list
2368397|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2368398|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2368399|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2368400|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368401|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368402|NCT00567697|Ranibizumab|ranibizumab|mesh-list
2368403|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2368404|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2368405|NCT00567697|Growth Substances|growth substances|mesh-ancestor
2476403|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476404|NCT01088737|Imiquimod|imiquimod|mesh-list
2476405|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2476406|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
2476407|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476408|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476409|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
2476410|NCT01088750|Prednisolone|prednisolone|mesh-list
2476411|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
2476412|NCT01088750|Vinblastine|vinblastine|mesh-list
2476413|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476414|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
2476415|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476416|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2476417|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2476418|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
2476419|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476420|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476421|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2476422|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2476423|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
2476424|NCT01088750|Hormones|hormones|mesh-ancestor
2476425|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2476426|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2476427|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2476428|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
2368406|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368407|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
2368408|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368409|NCT00567710|Risperidone|risperidone|mesh-list
2368410|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2368411|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
2368412|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368413|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368414|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368415|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2368416|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2368417|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2476429|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
2476430|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
2368418|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2368419|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2368420|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
2368421|NCT00567762|Tacrolimus|tacrolimus|mesh-list
2368422|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2368423|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
2368424|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368425|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2368426|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368427|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368428|NCT00567775|Insulin|insulin|mesh-list
2368429|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2368430|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2368431|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368432|NCT00567788|Bimatoprost|bimatoprost|mesh-list
2368433|NCT00567788|Latanoprost|latanoprost|mesh-list
2368434|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2368435|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2368436|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2368437|NCT00567814|Oxazepam|oxazepam|mesh-list
2368438|NCT00567814|Metyrapone|metyrapone|mesh-list
2368439|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
2368440|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476431|NCT01088763|Dexamethasone|dexamethasone|mesh-list
2476432|NCT01088763|R04929097|r04929097|mesh-list
2476433|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368441|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368442|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2368443|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2368444|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368445|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2368446|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2368447|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2368448|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
2368449|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
2368450|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368451|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2368452|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
2368453|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2368454|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2476434|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
2476435|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
2476436|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476437|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476438|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2476439|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
2476440|NCT01088763|Hormones|hormones|mesh-ancestor
2476441|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2476442|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2476443|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476444|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476445|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476446|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
2476447|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476448|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
2476449|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476450|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2476451|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2476452|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
2476453|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368455|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2368456|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2476454|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476455|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2476456|NCT01088802|Carboplatin|carboplatin|mesh-list
2476457|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476458|NCT01088815|Gemcitabine|gemcitabine|mesh-list
2476459|NCT01088815|Paclitaxel|paclitaxel|mesh-list
2476460|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2476461|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476462|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
2476463|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
2476464|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
2476465|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476466|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2476467|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
2476468|NCT01088815|Antiviral Agents|antiviral agents|mesh-ancestor
2476469|NCT01088815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476470|NCT01088815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476471|NCT01088815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476472|NCT01088815|Immunologic Factors|immunologic factors|mesh-ancestor
2476473|NCT01088815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476474|NCT01088893|Everolimus|everolimus|mesh-list
2476475|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476476|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476477|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
2476478|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476479|NCT01088906|Pemetrexed|pemetrexed|mesh-list
2476480|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476481|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476482|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476483|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2476484|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2476485|NCT01088919|Pioglitazone|pioglitazone|mesh-list
2476486|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
2476487|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2476488|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476489|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2476490|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476491|NCT01088932|SRX246|srx246|mesh-list
2476492|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2476493|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476494|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
2476495|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476496|NCT01088958|Micronutrients|micronutrients|mesh-list
2476497|NCT01088958|Trace Elements|trace elements|mesh-list
2476498|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476499|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
2476500|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2476501|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2476502|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2476503|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2476504|NCT01089088|Gemcitabine|gemcitabine|mesh-list
2476505|NCT01089088|Sunitinib|sunitinib|mesh-list
2368457|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368458|NCT00567918|Tacrolimus|tacrolimus|mesh-list
2368459|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2368460|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
2368461|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368462|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2368463|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368464|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368465|NCT00567931|Tryptophan|tryptophan|mesh-list
2368466|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2368467|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
2368468|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2368469|NCT00567957|Remifentanil|remifentanil|mesh-list
2368470|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2368471|NCT00567957|Narcotics|narcotics|mesh-ancestor
2368472|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2368473|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368474|NCT00567957|Analgesics|analgesics|mesh-ancestor
2368475|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
2368476|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476506|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368477|NCT00567983|Cyclosporine|cyclosporine|mesh-list
2476507|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2476508|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
2476509|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476510|NCT01089088|Antiviral Agents|antiviral agents|mesh-ancestor
2476511|NCT01089088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476512|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476513|NCT01089088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476514|NCT01089088|Immunologic Factors|immunologic factors|mesh-ancestor
2476515|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476516|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2476517|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2476518|NCT01089088|Growth Substances|growth substances|mesh-ancestor
2476519|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
2368478|NCT00567983|Cyclosporins|cyclosporins|mesh-list
2368479|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368480|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368481|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2368482|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
2368483|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368484|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
2368485|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2368486|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
2368487|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368488|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2368489|NCT00568048|Bevacizumab|bevacizumab|mesh-list
2368490|NCT00568048|Temozolomide|temozolomide|mesh-list
2368491|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2368492|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368493|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2368494|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2368495|NCT00568048|Growth Substances|growth substances|mesh-ancestor
2368496|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368497|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
2368498|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2476520|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2476521|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
2476522|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2368499|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
2368500|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368501|NCT00568074|Repaglinide|repaglinide|mesh-list
2368502|NCT00568074|Acarbose|acarbose|mesh-list
2368503|NCT00568074|Gliquidone|gliquidone|mesh-list
2368504|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2368505|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368506|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2476523|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2476524|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476525|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
2476526|NCT01089140|Coagulants|coagulants|mesh-ancestor
2476527|NCT01089166|Metformin|metformin|mesh-list
2476528|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2476529|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476530|NCT01089179|Metformin|metformin|mesh-list
2476531|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2368507|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368508|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368509|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
2368510|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2368511|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
2368512|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2368513|NCT00568113|Expectorants|expectorants|mesh-ancestor
2368514|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
2368515|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2368516|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
2368517|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368518|NCT00568113|Protective Agents|protective agents|mesh-ancestor
2368519|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368520|NCT00568113|Antidotes|antidotes|mesh-ancestor
2368521|NCT00568152|Aspirin|aspirin|mesh-list
2368522|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2368523|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2368524|NCT00568152|Analgesics|analgesics|mesh-ancestor
2368525|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
2368526|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368527|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476532|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476533|NCT01089192|Metformin|metformin|mesh-list
2476534|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2476535|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476536|NCT01089205|Metformin|metformin|mesh-list
2476537|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2476538|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476539|NCT01089218|Amoxicillin|amoxicillin|mesh-list
2476540|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
2476541|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
2476542|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2476543|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2476544|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476545|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2476546|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476547|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476548|NCT01089309|Spironolactone|spironolactone|mesh-list
2476549|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2476550|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
2476551|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2476552|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476553|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2476554|NCT01089309|Diuretics|diuretics|mesh-ancestor
2476555|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
2476556|NCT01089348|Metronidazole|metronidazole|mesh-list
2476557|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476558|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2476559|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2476560|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2476561|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
2476562|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2476563|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
2476564|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476565|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476566|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2476567|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
2476568|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2476569|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
2476570|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476571|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2476572|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2476573|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
2476574|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
2476575|NCT01089439|Protective Agents|protective agents|mesh-ancestor
2476576|NCT01089452|Amlodipine|amlodipine|mesh-list
2476577|NCT01089452|Olmesartan|olmesartan|mesh-list
2476578|NCT01089452|Perindopril|perindopril|mesh-list
2476579|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2476580|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2476581|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2476582|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476583|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2476584|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476585|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
2476586|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2476587|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2476588|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2476589|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
2476590|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476591|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
2476592|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2476593|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2476594|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2476595|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2476596|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476597|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2476598|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476599|NCT01089621|Analgesics|analgesics|mesh-ancestor
2476600|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
2476601|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476602|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
2476603|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2476604|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
2476605|NCT01089660|Vaccines|vaccines|mesh-list
2476606|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
2476607|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476608|NCT01089790|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2476609|NCT01089790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2476610|NCT01089790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476611|NCT01089790|Incretins|incretins|mesh-ancestor
2476612|NCT01089790|Hormones|hormones|mesh-ancestor
2476613|NCT01089790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2476614|NCT01089790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2476615|NCT01089790|Protease Inhibitors|protease inhibitors|mesh-ancestor
2476616|NCT01089790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476617|NCT01089790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476618|NCT01089855|Carbamazepine|carbamazepine|mesh-list
2476619|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
2476620|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
2476621|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2476622|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2476623|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476624|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2476625|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2476626|NCT01089855|Analgesics|analgesics|mesh-ancestor
2476627|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
2476628|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476629|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2476630|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2476631|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476632|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2476633|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2368528|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368529|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368530|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2368531|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2368532|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368533|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2368534|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2368535|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368536|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
2368537|NCT00568217|Acetaminophen|acetaminophen|mesh-list
2368538|NCT00568217|Ibuprofen|ibuprofen|mesh-list
2368539|NCT00568217|Diclofenac|diclofenac|mesh-list
2368540|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2476634|NCT01089933|Anesthetics|anesthetics|mesh-list
2476635|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
2476636|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2476637|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476638|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
2476639|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476640|NCT01089959|Esomeprazole|esomeprazole|mesh-list
2476641|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2476642|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2476643|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2476644|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476645|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476646|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2476647|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2476648|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2476649|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2476650|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476651|NCT01090037|Epoprostenol|epoprostenol|mesh-list
2476652|NCT01090037|Beraprost|beraprost|mesh-list
2476653|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2476654|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
2476655|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2476656|NCT01090089|Dexamethasone|dexamethasone|mesh-list
2476657|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
2476658|NCT01090089|Lenalidomide|lenalidomide|mesh-list
2476659|NCT01090089|BB 1101|bb 1101|mesh-list
2476660|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2476661|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
2476662|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
2476663|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476664|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476665|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2476666|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
2476667|NCT01090089|Hormones|hormones|mesh-ancestor
2476668|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2368541|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2368542|NCT00568217|Analgesics|analgesics|mesh-ancestor
2368543|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
2368544|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368545|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368546|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368547|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368548|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2368549|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368550|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368551|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
2368552|NCT00568295|Acetaminophen|acetaminophen|mesh-list
2368553|NCT00568295|Rofecoxib|rofecoxib|mesh-list
2368554|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2368555|NCT00568295|Analgesics|analgesics|mesh-ancestor
2368556|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
2368557|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368558|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368559|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
2368560|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2368561|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2368562|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368563|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368564|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2368565|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368566|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368567|NCT00568347|Fluticasone|fluticasone|mesh-list
2368568|NCT00568347|Xhance|xhance|mesh-list
2368569|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2368570|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2368571|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368572|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2368573|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
2368574|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368575|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368576|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2368577|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
2368578|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
2368579|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2368580|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2368581|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2368582|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2368583|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
2476669|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2476670|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476671|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
2476672|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476673|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476674|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
2476675|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2476676|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2476677|NCT01090089|Growth Substances|growth substances|mesh-ancestor
2476678|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
2476679|NCT01090128|Paclitaxel|paclitaxel|mesh-list
2476680|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
2476681|NCT01090128|Doxorubicin|doxorubicin|mesh-list
2476682|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2476683|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2476684|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476685|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
2476686|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
2476687|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
2368584|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368585|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368586|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
2368587|NCT00568347|Hormones|hormones|mesh-ancestor
2368588|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2368589|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
2368590|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
2368591|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2368592|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2368593|NCT00568412|Analgesics|analgesics|mesh-ancestor
2368594|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
2368595|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368596|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476688|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476689|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476690|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
2476691|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476692|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2476693|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2476694|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
2476695|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2476696|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2476697|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2476698|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2476699|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368597|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368598|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368599|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
2368600|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2368601|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
2368602|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2368603|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368604|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368605|NCT00568477|Rituximab|rituximab|mesh-list
2368606|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2368607|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368608|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
2368609|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368610|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368611|NCT00568503|Bromides|bromides|mesh-list
2368612|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
2368613|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2476705|NCT01090167|Clofarabine|clofarabine|mesh-list
2476706|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2476707|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
2476708|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476709|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476710|NCT01090206|Vitamin D|vitamin d|mesh-list
2476711|NCT01090206|Calcium|calcium|mesh-list
2476712|NCT01090206|Vitamins|vitamins|mesh-ancestor
2476713|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
2476714|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476715|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2476716|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2476717|NCT01090466|Gemcitabine|gemcitabine|mesh-list
2476718|NCT01090466|Sirolimus|sirolimus|mesh-list
2476719|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476720|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2476721|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
2476722|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476723|NCT01090466|Antiviral Agents|antiviral agents|mesh-ancestor
2476724|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476725|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476726|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476727|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
2476728|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476729|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2476730|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2476731|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
2476732|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
2476733|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476734|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
2476735|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368614|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
2368615|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368616|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368617|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2368618|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
2476736|NCT01090596|Naproxen|naproxen|mesh-list
2476737|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2476738|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2476739|NCT01090596|Analgesics|analgesics|mesh-ancestor
2476740|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
2476741|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476742|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476743|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2476744|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2476745|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
2476746|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2476747|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476748|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476749|NCT01090648|Etravirine|etravirine|mesh-list
2476750|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2476751|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2476752|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476753|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476754|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
2476755|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476756|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
2476757|NCT01090661|Mipomersen|mipomersen|mesh-list
2476758|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2476759|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2476760|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476761|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2476762|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2476763|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476764|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476765|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476766|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2476767|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
2476768|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2476769|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476770|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2476771|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2476772|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2476773|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2476774|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2476775|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
2368619|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
2368620|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2368621|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
2368622|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368623|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368624|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
2368625|NCT00568529|Capecitabine|capecitabine|mesh-list
2368626|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
2368627|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2368628|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
2368629|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368630|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368631|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
2368632|NCT00568542|Hematinics|hematinics|mesh-ancestor
2368633|NCT00568568|Hormones|hormones|mesh-list
2368634|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2368635|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368636|NCT00568672|Olanzapine|olanzapine|mesh-list
2368637|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
2368638|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
2368639|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368640|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368641|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2368642|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2368643|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2368644|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2368645|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2476776|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2476777|NCT01090700|Simeprevir|simeprevir|mesh-list
2476778|NCT01090700|Dexetimide|dexetimide|mesh-list
2476779|NCT01090700|Citalopram|citalopram|mesh-list
2476780|NCT01090700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2476781|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2368646|NCT00568672|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2368647|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2368648|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2368649|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368650|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368651|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
2368652|NCT00568711|Doxycycline|doxycycline|mesh-list
2368653|NCT00568711|Rifampin|rifampin|mesh-list
2368654|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2368655|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2368656|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
2368657|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2368658|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2368659|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2368660|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
2368661|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
2368662|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2476782|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2476783|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476784|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2476785|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
2476786|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476787|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2476788|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
2476789|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2476790|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2476791|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2476792|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
2476793|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
2476794|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476795|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2476796|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2476797|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
2476798|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
2476799|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2368663|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368664|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368665|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2476800|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
2476801|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476802|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2476803|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2476804|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476805|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2476806|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2476807|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2476808|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476809|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
2476810|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2476811|NCT01090778|Hormones|hormones|mesh-list
2476812|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2476813|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476814|NCT01090830|Paclitaxel|paclitaxel|mesh-list
2476815|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2476816|NCT01090830|Bevacizumab|bevacizumab|mesh-list
2476817|NCT01090830|Carboplatin|carboplatin|mesh-list
2476818|NCT01090830|Belinostat|belinostat|mesh-list
2476819|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2476820|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476821|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
2476822|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
2476823|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
2476824|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476825|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2476826|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2476827|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2476828|NCT01090830|Growth Substances|growth substances|mesh-ancestor
2476829|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476830|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
2476831|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2368666|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2368667|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2368668|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2368669|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2368670|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2368671|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
2368672|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2368673|NCT00568750|Dasatinib|dasatinib|mesh-list
2368674|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476832|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368675|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2368676|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368677|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368678|NCT00568763|Sargramostim|sargramostim|mesh-list
2368679|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
2476833|NCT01090882|Bupivacaine|bupivacaine|mesh-list
2476834|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
2476835|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
2476836|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2476837|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476838|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
2476839|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476840|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
2476841|NCT01090895|Vitamins|vitamins|mesh-ancestor
2368680|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368681|NCT00568789|Zolpidem|zolpidem|mesh-list
2368682|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2368683|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2368684|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2368685|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368686|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2368687|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
2368688|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
2368689|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368690|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368691|NCT00568815|Rituximab|rituximab|mesh-list
2368692|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2368693|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368694|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
2368695|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368696|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368697|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2368698|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368699|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2368700|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368701|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368702|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
2476842|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
2476843|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476844|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
2476845|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476846|NCT01090895|Protective Agents|protective agents|mesh-ancestor
2476847|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2476848|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476849|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
2476850|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
2476851|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2476852|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2476853|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476854|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476855|NCT01091012|Urological Agents|urological agents|mesh-ancestor
2476856|NCT01091051|Ustekinumab|ustekinumab|mesh-list
2368703|NCT00568880|Bortezomib|bortezomib|mesh-list
2368704|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368705|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
2368706|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2368707|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2368708|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2368709|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368710|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368711|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368712|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
2368713|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2368714|NCT00568971|Docetaxel|docetaxel|mesh-list
2368715|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368716|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
2368717|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
2368718|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
2368719|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368720|NCT00568984|Metformin|metformin|mesh-list
2368721|NCT00568984|Repaglinide|repaglinide|mesh-list
2368722|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2368723|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476857|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
2476858|NCT01091077|Naringenin|naringenin|mesh-list
2476859|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2476860|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2476861|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2476862|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
2476863|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2476864|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476865|NCT01091207|Sorafenib|sorafenib|mesh-list
2476866|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476867|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2476868|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476869|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476870|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
2368739|NCT00569088|Mannitol|mannitol|mesh-list
2368740|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2368741|NCT00569088|Diuretics|diuretics|mesh-ancestor
2368742|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
2368743|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368744|NCT00569101|Tacrolimus|tacrolimus|mesh-list
2368745|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2368746|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
2368747|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368748|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2368749|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368750|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368751|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2368752|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2368753|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476871|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476872|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
2476873|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476874|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2476875|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
2476876|NCT01091324|Silymarin|silymarin|mesh-list
2476877|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
2476878|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
2476879|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2476880|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2476881|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2476882|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476883|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476884|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
2476885|NCT01091324|Protective Agents|protective agents|mesh-ancestor
2476886|NCT01091337|Albuterol|albuterol|mesh-list
2476887|NCT01091337|Procaterol|procaterol|mesh-list
2476888|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2476889|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
2476890|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476891|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476892|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2476893|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
2476894|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
2476895|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2476896|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2476897|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2476898|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2476899|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
2476900|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2476901|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476902|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
2368754|NCT00569296|Aldesleukin|aldesleukin|mesh-list
2476903|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2476904|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476905|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2476906|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476907|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476908|NCT01091415|Calcium|calcium|mesh-list
2476909|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2476910|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476911|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
2476912|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2476913|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476914|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2476915|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2476916|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476917|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476918|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476919|NCT01091571|Dipyridamole|dipyridamole|mesh-list
2476920|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2476921|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476922|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476923|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2476924|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
2476925|NCT01091649|Ritonavir|ritonavir|mesh-list
2476926|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2476927|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2476928|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
2476929|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2476930|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476931|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2476932|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2476933|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
2476934|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2476935|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2476936|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2476937|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
2476938|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2476939|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2476940|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
2476941|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2476942|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2476943|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2476944|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2476945|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476946|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
2476947|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2476948|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476949|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2476950|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476951|NCT01091753|Amlodipine|amlodipine|mesh-list
2476952|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2476953|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2476954|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2476955|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476956|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2476957|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476958|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
2476959|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2476960|NCT01091792|Bevacizumab|bevacizumab|mesh-list
2476961|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2476962|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2476963|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2476964|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2476965|NCT01091792|Growth Substances|growth substances|mesh-ancestor
2476966|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476967|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
2476968|NCT01091818|Midazolam|midazolam|mesh-list
2476969|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
2476970|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2476971|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2476972|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476973|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2476974|NCT01091818|Analgesics|analgesics|mesh-ancestor
2476975|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
2476976|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2476977|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2476978|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2476979|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2476980|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
2476981|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2476982|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2476983|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2476984|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2476985|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2476986|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2476987|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2476988|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
2476989|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
2476990|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
2476991|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
2476992|NCT01091831|Dexamethasone|dexamethasone|mesh-list
2476993|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
2476994|NCT01091831|Melphalan|melphalan|mesh-list
2476995|NCT01091831|Lenalidomide|lenalidomide|mesh-list
2476996|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2476997|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
2476998|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2476999|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2477000|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2477001|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
2477002|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477003|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477004|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2477005|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2477006|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
2477007|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
2477008|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368755|NCT00569296|Sargramostim|sargramostim|mesh-list
2368756|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
2368757|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368758|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368759|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2368760|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2368761|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
2477009|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2477010|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
2477011|NCT01091831|Hormones|hormones|mesh-ancestor
2477012|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477013|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2477014|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2477015|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2477016|NCT01091831|Growth Substances|growth substances|mesh-ancestor
2477017|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
2477018|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
2477019|NCT01091870|Citric Acid|citric acid|mesh-list
2477020|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
2477021|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
2477022|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2477023|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
2477024|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
2477025|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477026|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
2477027|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2477028|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2477029|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477030|NCT01091870|Urological Agents|urological agents|mesh-ancestor
2477031|NCT01091896|Bevacizumab|bevacizumab|mesh-list
2477032|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2477033|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477034|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2477035|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2477036|NCT01091896|Growth Substances|growth substances|mesh-ancestor
2477037|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477038|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
2477039|NCT01092039|Lactoferrin|lactoferrin|mesh-list
2368762|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2368763|NCT00569335|Bevacizumab|bevacizumab|mesh-list
2368764|NCT00569335|Irinotecan|irinotecan|mesh-list
2477040|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2477041|NCT01092065|Levodopa|levodopa|mesh-list
2477042|NCT01092065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2113888|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2113889|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2113890|NCT02593903|Renal Agents|renal agents|mesh-ancestor
2113891|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
2477043|NCT01092065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2477044|NCT01092065|Dopamine Agents|dopamine agents|mesh-ancestor
2477045|NCT01092065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477046|NCT01092065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477047|NCT01092065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477048|NCT01092091|BCT-100|bct-100|mesh-list
2477049|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477050|NCT01092104|Cenicriviroc|cenicriviroc|mesh-list
2477051|NCT01092104|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2477052|NCT01092104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477053|NCT01092104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2477054|NCT01092104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2477055|NCT01092104|Antiviral Agents|antiviral agents|mesh-ancestor
2477056|NCT01092104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2477057|NCT01092130|Vitamin D|vitamin d|mesh-list
2477058|NCT01092130|Vitamins|vitamins|mesh-ancestor
2477059|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
2477060|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477061|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2477062|NCT01092143|Fluticasone|fluticasone|mesh-list
2368765|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2368766|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368767|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2368768|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2368769|NCT00569335|Growth Substances|growth substances|mesh-ancestor
2368770|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368771|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
2368772|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2368773|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2368774|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368775|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368776|NCT00569387|Vaccines|vaccines|mesh-list
2368777|NCT00569387|Immunologic Factors|immunologic factors|mesh-ancestor
2368778|NCT00569387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368779|NCT00569400|Insulin|insulin|mesh-list
2368780|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2368781|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2368782|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477063|NCT01092143|Xhance|xhance|mesh-list
2477064|NCT01092143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2477065|NCT01092143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2477066|NCT01092143|Autonomic Agents|autonomic agents|mesh-ancestor
2477067|NCT01092143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477068|NCT01092143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477069|NCT01092143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2477070|NCT01092143|Respiratory System Agents|respiratory system agents|mesh-ancestor
2477071|NCT01092143|Dermatologic Agents|dermatologic agents|mesh-ancestor
2477072|NCT01092143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2477073|NCT01092221|Allopurinol|allopurinol|mesh-list
2477074|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
2477075|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477076|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477077|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
2477078|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368783|NCT00569452|Insulin|insulin|mesh-list
2368784|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2368785|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2368786|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477079|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2477080|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
2477081|NCT01092221|Protective Agents|protective agents|mesh-ancestor
2477082|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477083|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
2477084|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2477085|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2477086|NCT01092351|Renal Agents|renal agents|mesh-ancestor
2477087|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2477088|NCT01092455|Heparin|heparin|mesh-list
2477089|NCT01092455|Calcium heparin|calcium heparin|mesh-list
2477090|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
2477091|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2477092|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2113892|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2368787|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
2368788|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2368789|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
2368790|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2368791|NCT00569465|Expectorants|expectorants|mesh-ancestor
2368792|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
2368793|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2368794|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
2368795|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477093|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477094|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
2368796|NCT00569465|Protective Agents|protective agents|mesh-ancestor
2368797|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368798|NCT00569465|Antidotes|antidotes|mesh-ancestor
2477095|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477096|NCT01092520|Gabapentin|gabapentin|mesh-list
2477097|NCT01092520|Analgesics|analgesics|mesh-ancestor
2477098|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
2477099|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477100|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368799|NCT00569621|Moxaverine|moxaverine|mesh-list
2368800|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
2368801|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
2368802|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368803|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368804|NCT00569699|Bevacizumab|bevacizumab|mesh-list
2368805|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2368806|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368807|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2368808|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2368809|NCT00569699|Growth Substances|growth substances|mesh-ancestor
2368810|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368811|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
2368812|NCT00569712|Budesonide|budesonide|mesh-list
2368813|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
2368814|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368815|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2368816|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
2368817|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368818|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368819|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2368820|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
2368821|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
2368822|NCT00569712|Hormones|hormones|mesh-ancestor
2368823|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2368824|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2368825|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2368826|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2368827|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
2368828|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368829|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368830|NCT00569751|Paclitaxel|paclitaxel|mesh-list
2477101|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
2477102|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2477103|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2477104|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2477105|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2477106|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2477107|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2477108|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477109|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477110|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
2477111|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
2477112|NCT01092533|Prednisolone|prednisolone|mesh-list
2477113|NCT01092533|Prednisone|prednisone|mesh-list
2477114|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2477115|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477116|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2477117|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
2477118|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2477119|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2477120|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477121|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477122|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368831|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2368832|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368833|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
2477123|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
2477124|NCT01092533|Hormones|hormones|mesh-ancestor
2477125|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477126|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477127|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2477128|NCT01092572|Simvastatin|simvastatin|mesh-list
2477129|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2477130|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2477131|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
2477132|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477133|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2477134|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2477135|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477136|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
2477137|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2368834|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
2368835|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
2368836|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368837|NCT00569790|Bevacizumab|bevacizumab|mesh-list
2368838|NCT00569790|Irinotecan|irinotecan|mesh-list
2368839|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2368840|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368841|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2368842|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2368843|NCT00569790|Growth Substances|growth substances|mesh-ancestor
2368844|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477138|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2477139|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
2477140|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477141|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477142|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477143|NCT01092624|Urological Agents|urological agents|mesh-ancestor
2477144|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
2477145|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477146|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2477147|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477148|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477149|NCT01092806|Tacrolimus|tacrolimus|mesh-list
2477150|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477151|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
2477152|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477153|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2368845|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
2368846|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2368847|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2368848|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368849|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368850|NCT00569816|Sevoflurane|sevoflurane|mesh-list
2368851|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2368852|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2477154|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477155|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477156|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
2477157|NCT01092858|Testosterone|testosterone|mesh-list
2477158|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
2477159|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
2477160|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2477161|NCT01092858|Androgens|androgens|mesh-ancestor
2477162|NCT01092858|Hormones|hormones|mesh-ancestor
2477163|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477164|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477165|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2477166|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477167|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
2477168|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
2477169|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
2477170|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477171|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
2477172|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477173|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368853|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
2368854|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
2368855|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2368856|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368857|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
2477174|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2477175|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
2477176|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477177|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477178|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2477179|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2477180|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2477181|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
2477182|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2477183|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2477184|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477185|NCT01092975|Phenylephrine|phenylephrine|mesh-list
2477186|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
2477187|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2477188|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
2477189|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
2477190|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477191|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477192|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
2477193|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2477194|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
2477195|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
2477196|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2477197|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2477198|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2477199|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
2477200|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477201|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477202|NCT01092975|Protective Agents|protective agents|mesh-ancestor
2477203|NCT01093040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2477204|NCT01093040|Immunologic Factors|immunologic factors|mesh-ancestor
2477205|NCT01093040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477206|NCT01093092|Calcitriol|calcitriol|mesh-list
2477207|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
2477208|NCT01093092|Gemcitabine|gemcitabine|mesh-list
2477209|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477210|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2368858|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
2368859|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2368860|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2368861|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2368862|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2368863|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368864|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368865|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368866|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2368867|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2368868|NCT00569920|Dexamethasone|dexamethasone|mesh-list
2368869|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
2368870|NCT00569920|BB 1101|bb 1101|mesh-list
2368871|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2368872|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
2368873|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
2368874|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368875|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368876|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2368877|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
2368878|NCT00569920|Hormones|hormones|mesh-ancestor
2368879|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2368880|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2368881|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368882|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
2368883|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368884|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368885|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
2368886|NCT00569985|Carmustine|carmustine|mesh-list
2368887|NCT00569985|Etoposide|etoposide|mesh-list
2477211|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
2477212|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477213|NCT01093092|Antiviral Agents|antiviral agents|mesh-ancestor
2477214|NCT01093092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2477215|NCT01093092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477216|NCT01093092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477217|NCT01093092|Immunologic Factors|immunologic factors|mesh-ancestor
2477218|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477219|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2477220|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2477221|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2477222|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2477223|NCT01093092|Vitamins|vitamins|mesh-ancestor
2477224|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
2477225|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2477226|NCT01093157|Hormones|hormones|mesh-list
2477227|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2477228|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477229|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477230|NCT01093196|Dexamethasone|dexamethasone|mesh-list
2477231|NCT01093196|Prednisone|prednisone|mesh-list
2477232|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
2477233|NCT01093196|Melphalan|melphalan|mesh-list
2477234|NCT01093196|Lenalidomide|lenalidomide|mesh-list
2477235|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477236|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
2477237|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477238|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2477239|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2477240|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
2477241|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477242|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477243|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2477244|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2477245|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
2477246|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
2477247|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477248|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2477249|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
2477250|NCT01093196|Hormones|hormones|mesh-ancestor
2477251|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477252|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2477253|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2477254|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2477255|NCT01093196|Growth Substances|growth substances|mesh-ancestor
2477256|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
2477257|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
2477258|NCT01093235|Bevacizumab|bevacizumab|mesh-list
2477259|NCT01093235|Docetaxel|docetaxel|mesh-list
2368888|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
2368889|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2368890|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
2368891|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368892|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2368893|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2368894|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
2368895|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368896|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368897|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2368898|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2368899|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2477260|NCT01093235|Fluorouracil|fluorouracil|mesh-list
2477261|NCT01093235|Epirubicin|epirubicin|mesh-list
2477262|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477263|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
2477264|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477265|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2477266|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2477267|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
2477268|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477269|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477270|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2477271|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2477272|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2477273|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2477274|NCT01093235|Growth Substances|growth substances|mesh-ancestor
2477275|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
2477276|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
2477277|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
2477278|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
2477279|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
2477280|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2477281|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2477282|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2477283|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2368900|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2368901|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368902|NCT00570050|Insulin|insulin|mesh-list
2368903|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2368904|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2368905|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368906|NCT00570180|Bortezomib|bortezomib|mesh-list
2368907|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368908|NCT00570193|Ranibizumab|ranibizumab|mesh-list
2368909|NCT00570193|Verteporfin|verteporfin|mesh-list
2368910|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2368911|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2368912|NCT00570193|Growth Substances|growth substances|mesh-ancestor
2368913|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477284|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477285|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
2477286|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
2477287|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2477288|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
2477289|NCT01093274|Cathartics|cathartics|mesh-ancestor
2477290|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2477291|NCT01093300|Paclitaxel|paclitaxel|mesh-list
2477292|NCT01093300|Everolimus|everolimus|mesh-list
2477293|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2477294|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477295|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
2477296|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
2477297|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
2477298|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477299|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477300|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
2477301|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477308|NCT01093365|Varenicline|varenicline|mesh-list
2477309|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2477310|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2477311|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
2477312|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477313|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368914|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
2368915|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368916|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2368917|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
2368918|NCT00570219|Valproic Acid|valproic acid|mesh-list
2368919|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
2368920|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368921|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368922|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
2368923|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368924|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368925|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
2368926|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2368927|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2368928|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2368929|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
2368930|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2368931|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
2368932|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368933|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368934|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2477314|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477315|NCT01093612|Copper|copper|mesh-list
2477316|NCT01093612|Trastuzumab|trastuzumab|mesh-list
2477317|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2477318|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477319|NCT01093612|Trace Elements|trace elements|mesh-ancestor
2368935|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
2368936|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2368937|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
2368938|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368939|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368940|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2368941|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
2368942|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
2368943|NCT00570245|Protective Agents|protective agents|mesh-ancestor
2368944|NCT00570284|Panobinostat|panobinostat|mesh-list
2368945|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368946|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2368947|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368948|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368949|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2477320|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
2477321|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477322|NCT01093638|Insulin|insulin|mesh-list
2477323|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2477324|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477325|NCT01093768|Vasopressins|vasopressins|mesh-list
2477326|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
2477327|NCT01093768|Oxytocin|oxytocin|mesh-list
2477328|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
2477329|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2477330|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477331|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
2477332|NCT01093768|Coagulants|coagulants|mesh-ancestor
2477333|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2477334|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2477335|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
2477336|NCT01093807|Enalapril|enalapril|mesh-list
2477337|NCT01093807|Enalaprilat|enalaprilat|mesh-list
2477338|NCT01093807|Lercanidipine|lercanidipine|mesh-list
2477339|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2477340|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
2477341|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477342|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477343|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2477344|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2477345|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2477346|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2477347|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477348|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
2477349|NCT01093820|Hematinics|hematinics|mesh-ancestor
2477350|NCT01093937|Varenicline|varenicline|mesh-list
2477351|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2477352|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2477353|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
2368950|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368951|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2368952|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2368953|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2368954|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
2368955|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2368956|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
2368957|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
2368958|NCT00570440|Estradiol|estradiol|mesh-list
2368959|NCT00570440|Estrogens|estrogens|mesh-ancestor
2368960|NCT00570440|Hormones|hormones|mesh-ancestor
2368961|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477354|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477355|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477356|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477357|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2477358|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2477359|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477360|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2477361|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2477362|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2477363|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477364|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
2477365|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477366|NCT01094015|Lidocaine|lidocaine|mesh-list
2368962|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477367|NCT01094015|Prilocaine|prilocaine|mesh-list
2368963|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2368964|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2368965|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2368966|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2368967|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2368968|NCT00570479|Anecortave|anecortave|mesh-list
2368969|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2368970|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2368971|NCT00570479|Growth Substances|growth substances|mesh-ancestor
2368972|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368973|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
2368974|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2368975|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
2368976|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2368977|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
2368978|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2368979|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368980|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2368981|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
2368982|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
2368983|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2368984|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
2368985|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2368986|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477368|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2477369|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
2477370|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
2477371|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2477372|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368987|NCT00570622|Pioglitazone|pioglitazone|mesh-list
2368988|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2368989|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368990|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
2368991|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2368992|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
2368993|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2368994|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
2368995|NCT00570648|Protective Agents|protective agents|mesh-ancestor
2477373|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
2477374|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477375|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2368996|NCT00570726|Ranibizumab|ranibizumab|mesh-list
2368997|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2368998|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2368999|NCT00570726|Growth Substances|growth substances|mesh-ancestor
2369000|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369001|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
2369002|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369003|NCT00570752|Atorvastatin|atorvastatin|mesh-list
2369004|NCT00570752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2369005|NCT00570752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2369006|NCT00570752|Antimetabolites|antimetabolites|mesh-ancestor
2369007|NCT00570752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369008|NCT00570752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2369009|NCT00570752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2369010|NCT00570752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369011|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2369012|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2369013|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
2369014|NCT00570830|Hormones|hormones|mesh-ancestor
2369015|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2369016|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369017|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
2369018|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2369019|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2369020|NCT00570856|Folic Acid|folic acid|mesh-list
2369021|NCT00570856|Hematinics|hematinics|mesh-ancestor
2369022|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
2477376|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2477377|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2477378|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2477379|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477380|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2477381|NCT01094028|Oxytocin|oxytocin|mesh-list
2369023|NCT00570856|Vitamins|vitamins|mesh-ancestor
2369024|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
2369025|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369026|NCT00570882|Sunitinib|sunitinib|mesh-list
2369027|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369028|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2369029|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2477382|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
2477383|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2477384|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477385|NCT01094158|Cholic Acids|cholic acids|mesh-list
2477386|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2477387|NCT01094210|Fluorides|fluorides|mesh-list
2369030|NCT00570882|Growth Substances|growth substances|mesh-ancestor
2369031|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369032|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
2369033|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2369034|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369035|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369036|NCT00570895|Ascorbic Acid|ascorbic acid|mesh-list
2369037|NCT00570895|Vitamins|vitamins|mesh-ancestor
2477388|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
2477389|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
2477390|NCT01094210|Protective Agents|protective agents|mesh-ancestor
2477391|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477392|NCT01094249|Valproic Acid|valproic acid|mesh-list
2477393|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2477394|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2477395|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2477396|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2477397|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477398|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2477399|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2477400|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2477401|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
2477402|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477403|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477404|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2369038|NCT00570895|Micronutrients|micronutrients|mesh-ancestor
2369039|NCT00570895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369040|NCT00570895|Antioxidants|antioxidants|mesh-ancestor
2369041|NCT00570895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369042|NCT00570895|Protective Agents|protective agents|mesh-ancestor
2369043|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
2369044|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
2369045|NCT00570934|Calcium|calcium|mesh-list
2369046|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2369047|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369048|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2369049|NCT00570934|Vitamins|vitamins|mesh-ancestor
2477405|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2477406|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
2477407|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
2369050|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
2369051|NCT00570986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2369052|NCT00570986|Immunologic Factors|immunologic factors|mesh-ancestor
2369053|NCT00570986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369054|NCT00570999|Mitogens|mitogens|mesh-list
2369055|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
2369056|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369057|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
2369058|NCT00571116|Disulfiram|disulfiram|mesh-list
2369059|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369060|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2369061|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2369062|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369063|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369064|NCT00571129|Mitomycins|mitomycins|mesh-list
2369065|NCT00571129|Mitomycin|mitomycin|mesh-list
2369066|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2369067|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369068|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
2369069|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369070|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2369071|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477408|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477409|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
2369072|NCT00571142|Bevacizumab|bevacizumab|mesh-list
2477410|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
2477411|NCT01094262|Oxycodone|oxycodone|mesh-list
2477412|NCT01094262|Analgesics|analgesics|mesh-list
2477413|NCT01094262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2477414|NCT01094262|Narcotics|narcotics|mesh-ancestor
2477415|NCT01094262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2477416|NCT01094262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477417|NCT01094262|Sensory System Agents|sensory system agents|mesh-ancestor
2477418|NCT01094262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477419|NCT01094275|Omeprazole|omeprazole|mesh-list
2477420|NCT01094275|Clopidogrel|clopidogrel|mesh-list
2477421|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2477422|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2477423|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2477424|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2477425|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
2477426|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477427|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477428|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477429|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2477430|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2369073|NCT00571142|Temazepam|temazepam|mesh-list
2369074|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2369075|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369076|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2369077|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2369078|NCT00571142|Growth Substances|growth substances|mesh-ancestor
2369079|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369080|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
2369081|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2369082|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2369083|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2369084|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2477431|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2477432|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477433|NCT01094340|Thalidomide|thalidomide|mesh-list
2477434|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477435|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
2477436|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477437|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
2477438|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2477439|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2477440|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2477441|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2477442|NCT01094340|Growth Substances|growth substances|mesh-ancestor
2477443|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
2477444|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477445|NCT01094444|Vitamin K|vitamin k|mesh-list
2477446|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
2477447|NCT01094444|Vitamins|vitamins|mesh-ancestor
2477448|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
2477449|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477450|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2477451|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2477452|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477453|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
2477454|NCT01094444|Coagulants|coagulants|mesh-ancestor
2477455|NCT01094457|Aspirin|aspirin|mesh-list
2477456|NCT01094457|Cilostazol|cilostazol|mesh-list
2477457|NCT01094457|Clopidogrel|clopidogrel|mesh-list
2477458|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2477459|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2477460|NCT01094457|Analgesics|analgesics|mesh-ancestor
2477461|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
2477462|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477463|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477464|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2477465|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2477466|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2477467|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2477468|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477469|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2477470|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2477471|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477472|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
2369085|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2369086|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
2369087|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
2369088|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369089|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369090|NCT00571155|Levetiracetam|levetiracetam|mesh-list
2369091|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
2369092|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
2369093|NCT00571246|Topiramate|topiramate|mesh-list
2369094|NCT00571246|Lamotrigine|lamotrigine|mesh-list
2369095|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
2369096|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2477473|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2477474|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2477475|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2477476|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
2477477|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477478|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2477479|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
2477480|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2477481|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
2477482|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
2477483|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2477484|NCT01094457|Protective Agents|protective agents|mesh-ancestor
2477485|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2477486|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2477487|NCT01094535|Secretin|secretin|mesh-list
2477488|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2477489|NCT01094535|Hormones|hormones|mesh-ancestor
2477490|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477491|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477492|NCT01094600|Secretin|secretin|mesh-list
2477493|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2477494|NCT01094600|Hormones|hormones|mesh-ancestor
2477495|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477496|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477497|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
2477498|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
2477499|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477500|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2477501|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477502|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477503|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
2477504|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477505|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2369097|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369098|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2369099|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2369100|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369101|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2477506|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477507|NCT01094626|Secretin|secretin|mesh-list
2477508|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2477509|NCT01094626|Hormones|hormones|mesh-ancestor
2477510|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477511|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477512|NCT01094769|Moxonidine|moxonidine|mesh-list
2477513|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2477514|NCT01094821|ATI 7505|ati 7505|mesh-list
2477515|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2477516|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2477517|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
2477518|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477519|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477520|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477521|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
2477522|NCT01094912|Narcotics|narcotics|mesh-ancestor
2477523|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2477524|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477525|NCT01094912|Analgesics|analgesics|mesh-ancestor
2477526|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
2477527|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477528|NCT01094925|Gabapentin|gabapentin|mesh-list
2369102|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2477529|NCT01094925|Analgesics|analgesics|mesh-ancestor
2477530|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
2477531|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477532|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477533|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
2477534|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2369103|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2369104|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2369105|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2369106|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2369107|NCT00571285|Vitamin D|vitamin d|mesh-list
2369108|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
2369109|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
2369110|NCT00571285|Vitamins|vitamins|mesh-list
2477535|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2477536|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2477537|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2477538|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2477539|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2477540|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477541|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477542|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
2477543|NCT01094964|Interferons|interferons|mesh-list
2477544|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
2477545|NCT01094964|Epirubicin|epirubicin|mesh-list
2477546|NCT01094964|Mitomycins|mitomycins|mesh-list
2477547|NCT01094964|Mitomycin|mitomycin|mesh-list
2477548|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369111|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
2369112|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369113|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2369114|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2369115|NCT00571298|Gemcitabine|gemcitabine|mesh-list
2369116|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
2369117|NCT00571298|Amifostine|amifostine|mesh-list
2369118|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369119|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2369120|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
2369121|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369122|NCT00571298|Antiviral Agents|antiviral agents|mesh-ancestor
2477549|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
2477550|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2477551|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
2477552|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477553|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2477554|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2477555|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2477556|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369123|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369124|NCT00571298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369125|NCT00571298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2369126|NCT00571298|Immunologic Factors|immunologic factors|mesh-ancestor
2369127|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369128|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2369129|NCT00571298|Protective Agents|protective agents|mesh-ancestor
2369130|NCT00571298|Antidotes|antidotes|mesh-ancestor
2369131|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
2477557|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477558|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
2477559|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2477560|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
2477561|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2477562|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2477563|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477564|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
2477565|NCT01094977|Coagulants|coagulants|mesh-ancestor
2477566|NCT01094990|Dexamethasone|dexamethasone|mesh-list
2477567|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2477568|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
2477569|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
2477570|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477571|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477572|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2477573|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
2477574|NCT01094990|Hormones|hormones|mesh-ancestor
2483657|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369132|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
2369133|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2477575|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477576|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2477577|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477578|NCT01095016|Fenoterol|fenoterol|mesh-list
2369134|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
2369135|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
2369136|NCT00571337|Infliximab|infliximab|mesh-list
2369137|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
2369138|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2369139|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2369140|NCT00571506|Pioglitazone|pioglitazone|mesh-list
2369141|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
2369142|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2369143|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369144|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2369145|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2369146|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
2477579|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2477580|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
2477581|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477582|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477583|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2477584|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
2477585|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
2477586|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
2477587|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2477588|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2477589|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2477590|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2477591|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
2477592|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477593|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477594|NCT01095133|Amiloride|amiloride|mesh-list
2477595|NCT01095133|Diuretics|diuretics|mesh-ancestor
2369147|NCT00571636|Fentanyl|fentanyl|mesh-list
2369148|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2369149|NCT00571636|Narcotics|narcotics|mesh-ancestor
2369150|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2369151|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369152|NCT00571636|Analgesics|analgesics|mesh-ancestor
2369153|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
2369154|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369155|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2369156|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2369157|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
2369158|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
2369159|NCT00571675|Prednisone|prednisone|mesh-list
2369160|NCT00571675|Docetaxel|docetaxel|mesh-list
2369161|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369162|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
2369163|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
2369164|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
2477596|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
2477597|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477598|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2477599|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2477600|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2477601|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477602|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2477603|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2477604|NCT01095172|Prednisolone|prednisolone|mesh-list
2477605|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2477606|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
2477607|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2477608|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
2477609|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
2477610|NCT01095172|Rituximab|rituximab|mesh-list
2477611|NCT01095172|Tacrolimus|tacrolimus|mesh-list
2477612|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2477613|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
2477614|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2477615|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477616|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
2477617|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477618|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2369165|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369166|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2369167|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
2369168|NCT00571675|Hormones|hormones|mesh-ancestor
2369169|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2369170|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369171|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2369172|NCT00571714|Ribavirin|ribavirin|mesh-list
2477619|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477620|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2477621|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477622|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477623|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2477624|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
2477625|NCT01095172|Hormones|hormones|mesh-ancestor
2477626|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477627|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2477628|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
2477629|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
2477630|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477631|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2477632|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2369173|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2369174|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
2369175|NCT00571714|Betaine|betaine|mesh-list
2369176|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
2369177|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369178|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
2369179|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369180|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
2369181|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369182|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2369183|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
2369184|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2369185|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2369186|NCT00571727|Mecasermin|mecasermin|mesh-list
2369187|NCT00571727|Growth Substances|growth substances|mesh-ancestor
2369188|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369189|NCT00571740|Leucovorin|leucovorin|mesh-list
2369190|NCT00571740|Bevacizumab|bevacizumab|mesh-list
2369191|NCT00571740|Cetuximab|cetuximab|mesh-list
2369192|NCT00571740|Fluorouracil|fluorouracil|mesh-list
2477633|NCT01095172|Protective Agents|protective agents|mesh-ancestor
2477634|NCT01095185|Simvastatin|simvastatin|mesh-list
2477635|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2477636|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2477637|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
2477638|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477639|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2477640|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2369193|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
2369194|NCT00571740|Calcium|calcium|mesh-list
2369195|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
2369196|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2369197|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369198|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2369199|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2369200|NCT00571740|Growth Substances|growth substances|mesh-ancestor
2369201|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369202|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
2369203|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2369204|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
2369205|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369206|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2477641|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477642|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
2477643|NCT01095211|Vitamins|vitamins|mesh-ancestor
2477644|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
2477645|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477646|NCT01095302|Docetaxel|docetaxel|mesh-list
2477647|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477648|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
2477649|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
2477650|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
2477651|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477652|NCT01095445|Ribavirin|ribavirin|mesh-list
2369207|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477653|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2477654|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
2477655|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477656|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
2477657|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2477658|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2477659|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
2369208|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
2369209|NCT00571740|Antidotes|antidotes|mesh-ancestor
2369210|NCT00571740|Protective Agents|protective agents|mesh-ancestor
2369211|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
2369212|NCT00571740|Vitamins|vitamins|mesh-ancestor
2369213|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
2369214|NCT00571753|Isoniazid|isoniazid|mesh-list
2369215|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
2369216|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2369217|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369218|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2369219|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2369220|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
2369221|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477660|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477661|NCT01095484|Rotigotine|rotigotine|mesh-list
2477662|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
2477663|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
2477664|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477665|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477666|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477667|NCT01095575|Morphine|morphine|mesh-list
2477668|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2477669|NCT01095575|Narcotics|narcotics|mesh-ancestor
2477670|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2477671|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477672|NCT01095575|Analgesics|analgesics|mesh-ancestor
2477673|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
2477674|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477675|NCT01095640|Adapalene|adapalene|mesh-list
2477676|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2477677|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2477678|NCT01095640|Analgesics|analgesics|mesh-ancestor
2477679|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
2477680|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477681|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477682|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2477683|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2477684|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
2477685|NCT01095679|Baclofen|baclofen|mesh-list
2477686|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2477687|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477688|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2477689|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477690|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2477691|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
2477692|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
2477693|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477694|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477695|NCT01095731|Acetic Acid|acetic acid|mesh-list
2477696|NCT01095731|Retinol acetate|retinol acetate|mesh-list
2477697|NCT01095731|Glycine|glycine|mesh-list
2477698|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
2477699|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477700|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369222|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2369223|NCT00571805|Varenicline|varenicline|mesh-list
2369224|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2369225|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2369226|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
2369227|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369228|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369229|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369230|NCT00571870|Cetrorelix|cetrorelix|mesh-list
2369231|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2369232|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
2477701|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477702|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2477703|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369233|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2369234|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477704|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2477705|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
2477706|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2477707|NCT01095731|Protective Agents|protective agents|mesh-ancestor
2477708|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477709|NCT01095809|Triamcinolone|triamcinolone|mesh-list
2477710|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2477711|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2477712|NCT01095809|Bevacizumab|bevacizumab|mesh-list
2477713|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2477714|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2477715|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477716|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2477717|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2477718|NCT01095809|Growth Substances|growth substances|mesh-ancestor
2477719|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477720|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
2477721|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2477722|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
2477723|NCT01095809|Hormones|hormones|mesh-ancestor
2477724|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477725|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477726|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
2477727|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477728|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477729|NCT01095822|Valsartan|valsartan|mesh-list
2477730|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2477731|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2477732|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2477733|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477734|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
2477735|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2477736|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2477737|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477738|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
2477739|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477740|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477741|NCT01095926|Doxorubicin|doxorubicin|mesh-list
2477742|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2477743|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477744|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2477745|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2477746|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477747|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477748|NCT01095939|Benazepril|benazepril|mesh-list
2477749|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2477750|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
2477751|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477752|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477753|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2477754|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2477755|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2477756|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477757|NCT01095991|Incretins|incretins|mesh-ancestor
2477758|NCT01095991|Hormones|hormones|mesh-ancestor
2477759|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477760|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2477761|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
2477762|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477763|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477764|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
2477765|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
2477766|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2477767|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477768|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477769|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
2477770|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2477771|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2477772|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477773|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2477774|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477775|NCT01096121|Enalapril|enalapril|mesh-list
2369235|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
2369236|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2369237|NCT00571935|Insulin|insulin|mesh-list
2369238|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2369239|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
2477776|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2477777|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
2477778|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477779|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477780|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2477781|NCT01096199|Cisplatin|cisplatin|mesh-list
2477782|NCT01096199|Everolimus|everolimus|mesh-list
2477783|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477784|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477785|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
2477786|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477787|NCT01096212|Sevoflurane|sevoflurane|mesh-list
2477788|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2477789|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2477790|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
2477791|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
2477792|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2477793|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477794|NCT01096225|Vaccines|vaccines|mesh-list
2477795|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
2477796|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477797|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2477798|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2477799|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477800|NCT01096277|Incretins|incretins|mesh-ancestor
2477801|NCT01096277|Hormones|hormones|mesh-ancestor
2477802|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477803|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2477804|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
2477805|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477806|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477807|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
2477808|NCT01096329|Testosterone|testosterone|mesh-list
2477809|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
2477810|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
2477811|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2477812|NCT01096329|Androgens|androgens|mesh-ancestor
2477813|NCT01096329|Hormones|hormones|mesh-ancestor
2477814|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477815|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477816|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2477817|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477818|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
2477819|NCT01096355|R04929097|r04929097|mesh-list
2477820|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477821|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369240|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2369241|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369242|NCT00572013|Rituximab|rituximab|mesh-list
2369243|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2369244|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369245|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
2369246|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369247|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2369248|NCT00572026|Methylphenidate|methylphenidate|mesh-list
2369249|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2369250|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369251|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2477822|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
2477823|NCT01096368|Cisplatin|cisplatin|mesh-list
2477824|NCT01096368|Carboplatin|carboplatin|mesh-list
2477825|NCT01096368|Etoposide|etoposide|mesh-list
2477826|NCT01096368|Vincristine|vincristine|mesh-list
2477827|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
2477828|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
2477829|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477830|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
2477831|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477832|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2369252|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2477833|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2477834|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
2477835|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477836|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477837|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2477838|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2477839|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2477840|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2477841|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477842|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
2477843|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
2477844|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
2477845|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
2477846|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
2369253|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2369254|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369255|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
2369256|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369257|NCT00572065|Cytarabine|cytarabine|mesh-list
2369258|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
2477847|NCT01096420|Topiramate|topiramate|mesh-list
2477848|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
2477849|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2477850|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477851|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
2477852|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2477853|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
2477854|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2477855|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477856|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2477857|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2477858|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2477859|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
2477860|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2477861|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
2477862|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2477863|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477864|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2477865|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2477866|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2477867|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
2477868|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2477869|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2369259|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2369260|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
2369261|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369262|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369263|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
2477870|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2477871|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2477872|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2477873|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477874|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477875|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477876|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2477877|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
2477878|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2477879|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477880|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2477881|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2477882|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2477883|NCT01096654|Epinephrine|epinephrine|mesh-list
2477884|NCT01096654|Racepinephrine|racepinephrine|mesh-list
2477885|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
2369264|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369265|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2369266|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
2369267|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369268|NCT00572078|Sorafenib|sorafenib|mesh-list
2369269|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369270|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2369271|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369272|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369273|NCT00572169|Thalidomide|thalidomide|mesh-list
2369274|NCT00572169|Dexamethasone|dexamethasone|mesh-list
2369275|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
2369276|NCT00572169|Cisplatin|cisplatin|mesh-list
2369277|NCT00572169|Doxorubicin|doxorubicin|mesh-list
2369278|NCT00572169|Etoposide|etoposide|mesh-list
2369279|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2369280|NCT00572169|Bortezomib|bortezomib|mesh-list
2369281|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2369282|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
2369283|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369284|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2369285|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2369286|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
2369287|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369288|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369289|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2369290|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2477886|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2477887|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2477888|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
2477889|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477890|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477891|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477892|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2477893|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2477894|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
2477895|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477896|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2477897|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
2477898|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
2477899|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
2477900|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2477901|NCT01096693|Substance P|substance p|mesh-list
2477902|NCT01096693|Neurokinin A|neurokinin a|mesh-list
2477903|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477904|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369291|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
2369292|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
2369293|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369294|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2369295|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
2369296|NCT00572169|Hormones|hormones|mesh-ancestor
2369297|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2369298|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2369299|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2369300|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2369301|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2477905|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477906|NCT01096706|Aspirin|aspirin|mesh-list
2477907|NCT01096706|Fluconazole|fluconazole|mesh-list
2477908|NCT01096706|Substance P|substance p|mesh-list
2477909|NCT01096706|Neurokinin A|neurokinin a|mesh-list
2477910|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2477911|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2477912|NCT01096706|Analgesics|analgesics|mesh-ancestor
2477913|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
2477914|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477915|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477916|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2477917|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2477918|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2477919|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2369302|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369303|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2369304|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
2369305|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2369306|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369307|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2369308|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2369309|NCT00572169|Growth Substances|growth substances|mesh-ancestor
2369310|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
2369311|NCT00572208|Gabapentin|gabapentin|mesh-list
2369312|NCT00572208|Analgesics|analgesics|mesh-ancestor
2369313|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
2369314|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369315|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477920|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477921|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2477922|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2477923|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477924|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
2477925|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
2477926|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2477927|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2477928|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2477929|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2477930|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
2477931|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2477932|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2477933|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2477934|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477935|NCT01096745|Gemcitabine|gemcitabine|mesh-list
2477936|NCT01096745|Cisplatin|cisplatin|mesh-list
2477937|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477938|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2477939|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
2369316|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
2369317|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2369318|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2369319|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2369320|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2369321|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2477940|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477941|NCT01096745|Antiviral Agents|antiviral agents|mesh-ancestor
2477942|NCT01096745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2477943|NCT01096745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477944|NCT01096745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477945|NCT01096745|Immunologic Factors|immunologic factors|mesh-ancestor
2477946|NCT01096745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477947|NCT01096797|Sevoflurane|sevoflurane|mesh-list
2477948|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2477949|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2477950|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
2477951|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
2477952|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2477953|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477954|NCT01096862|Peficitinib|peficitinib|mesh-list
2477955|NCT01096862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477956|NCT01096862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477957|NCT01096862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2477958|NCT01096862|Immunologic Factors|immunologic factors|mesh-ancestor
2477959|NCT01096862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477960|NCT01096927|Amoxicillin|amoxicillin|mesh-list
2477961|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
2477962|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
2477963|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2477964|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2477965|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369322|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2369323|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369324|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369325|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
2477966|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477967|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2477968|NCT01096940|Simvastatin|simvastatin|mesh-list
2477969|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2477970|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2477971|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
2477972|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369326|NCT00572299|Alendronate|alendronate|mesh-list
2369327|NCT00572299|Prednisone|prednisone|mesh-list
2369328|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2369329|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
2369330|NCT00572299|Hormones|hormones|mesh-ancestor
2369331|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2369332|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369333|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2369334|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477973|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2369335|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2477974|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2477975|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2477976|NCT01096966|Bupivacaine|bupivacaine|mesh-list
2477977|NCT01096966|Anesthetics, Local|anesthetics, local|mesh-ancestor
2477978|NCT01096966|Anesthetics|anesthetics|mesh-ancestor
2477979|NCT01096966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2369336|NCT00572312|Atorvastatin|atorvastatin|mesh-list
2369337|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2369338|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2369339|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
2369340|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477980|NCT01096966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477981|NCT01096966|Sensory System Agents|sensory system agents|mesh-ancestor
2477982|NCT01096966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477983|NCT01097018|Capecitabine|capecitabine|mesh-list
2477984|NCT01097018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2477985|NCT01097018|Antimetabolites|antimetabolites|mesh-ancestor
2477986|NCT01097018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477987|NCT01097018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2477988|NCT01097148|Atracurium|atracurium|mesh-list
2477989|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2477990|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2477991|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2369341|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2369342|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2369343|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369344|NCT00572364|Olaparib|olaparib|mesh-list
2369345|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2369346|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369347|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369348|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369349|NCT00572390|Estrogens|estrogens|mesh-list
2477992|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2477993|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2477994|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2477995|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2477996|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
2477997|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2477998|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2477999|NCT01097213|Ethanol|ethanol|mesh-list
2478000|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2478001|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478002|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2478003|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478004|NCT01097252|Cisplatin|cisplatin|mesh-list
2478005|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478006|NCT01097265|Capecitabine|capecitabine|mesh-list
2369350|NCT00572390|Hormones|hormones|mesh-ancestor
2369351|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2369352|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369353|NCT00572559|Vancomycin|vancomycin|mesh-list
2369354|NCT00572559|Linezolid|linezolid|mesh-list
2369355|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2369356|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369357|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2369358|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369359|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369360|NCT00572637|Delanzomib|delanzomib|mesh-list
2478007|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
2478008|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2478009|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
2369361|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
2369362|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
2369363|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369364|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369365|NCT00572650|Vildagliptin|vildagliptin|mesh-list
2369366|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2369367|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369368|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2369369|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
2369370|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369371|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478010|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478011|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478012|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
2478013|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2478014|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478015|NCT01097278|Vitamins|vitamins|mesh-ancestor
2478016|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
2478017|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2478018|NCT01097317|Carboplatin|carboplatin|mesh-list
2478019|NCT01097317|Vinorelbine|vinorelbine|mesh-list
2478020|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478021|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2478022|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
2478023|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
2478024|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
2478025|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478026|NCT01097382|Zolpidem|zolpidem|mesh-list
2478027|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2478028|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2478029|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2478030|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478031|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2478032|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
2478033|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
2478034|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478035|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478036|NCT01097512|Gemcitabine|gemcitabine|mesh-list
2369372|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
2369373|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2369374|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
2369375|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478037|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2478038|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
2478039|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478040|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478041|NCT01097512|Antiviral Agents|antiviral agents|mesh-ancestor
2478042|NCT01097512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478043|NCT01097512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478044|NCT01097512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2478045|NCT01097512|Immunologic Factors|immunologic factors|mesh-ancestor
2478046|NCT01097512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478047|NCT01097551|Phenylephrine|phenylephrine|mesh-list
2478048|NCT01097551|Acetylcholine|acetylcholine|mesh-list
2478049|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
2478050|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
2478051|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2478052|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
2478053|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478054|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478055|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478056|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2478057|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
2478058|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
2478059|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478060|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
2478061|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2478062|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
2478063|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
2478064|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2478065|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2478066|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2478067|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
2478068|NCT01097551|Protective Agents|protective agents|mesh-ancestor
2478069|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
2478070|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2478071|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478072|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2478073|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478074|NCT01097811|Erythromycin|erythromycin|mesh-list
2478075|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
2478076|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2478077|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
2478078|NCT01097811|Neomycin|neomycin|mesh-list
2478079|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2478080|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369376|NCT00572663|Expectorants|expectorants|mesh-ancestor
2478081|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2478082|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2478083|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478084|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369377|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
2369378|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2369379|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
2369380|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369381|NCT00572663|Protective Agents|protective agents|mesh-ancestor
2369382|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369383|NCT00572663|Antidotes|antidotes|mesh-ancestor
2369384|NCT00572689|Exenatide|exenatide|mesh-list
2369385|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2369386|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478085|NCT01097902|Ibuprofen|ibuprofen|mesh-list
2478086|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2478087|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2478088|NCT01097902|Analgesics|analgesics|mesh-ancestor
2478089|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
2478090|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478091|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478092|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2478093|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2478094|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2478095|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478096|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478097|NCT01097941|Vaccines|vaccines|mesh-list
2478098|NCT01097941|Immunoglobulins|immunoglobulins|mesh-list
2478099|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
2478100|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478101|NCT01097980|Trazodone|trazodone|mesh-list
2478102|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2478103|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2478104|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2478105|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478106|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2369387|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2369388|NCT00572689|Incretins|incretins|mesh-ancestor
2369389|NCT00572689|Hormones|hormones|mesh-ancestor
2369390|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2369391|NCT00572741|Ascorbic Acid|ascorbic acid|mesh-list
2369392|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
2369393|NCT00572741|Vitamins|vitamins|mesh-ancestor
2369394|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
2369395|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369396|NCT00572741|Antioxidants|antioxidants|mesh-ancestor
2369397|NCT00572741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369398|NCT00572741|Protective Agents|protective agents|mesh-ancestor
2369399|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
2369400|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2369401|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369402|NCT00572819|Misoprostol|misoprostol|mesh-list
2478107|NCT01097980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2478108|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2478109|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2478110|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478111|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478112|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
2478113|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2478114|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
2478115|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
2478116|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2478117|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2478118|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2478119|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2478120|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478121|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
2478122|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478123|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478124|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2113893|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2369403|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2369404|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
2369405|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2478125|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478126|NCT01098084|Decitabine|decitabine|mesh-list
2478127|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2478128|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
2478129|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478130|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478131|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478132|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
2478133|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2478134|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
2478135|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478136|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2478137|NCT01098344|Gemcitabine|gemcitabine|mesh-list
2478138|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2478139|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
2369406|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369407|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2369408|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2369409|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
2369410|NCT00572884|Permethrin|permethrin|mesh-list
2369411|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478140|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478141|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478142|NCT01098344|Antiviral Agents|antiviral agents|mesh-ancestor
2478143|NCT01098344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478144|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369412|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369413|NCT00573001|Ritonavir|ritonavir|mesh-list
2369414|NCT00573001|Lopinavir|lopinavir|mesh-list
2369415|NCT00573001|Tenofovir|tenofovir|mesh-list
2369416|NCT00573001|Zidovudine|zidovudine|mesh-list
2369417|NCT00573001|Emtricitabine|emtricitabine|mesh-list
2369418|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2369419|NCT00573001|Nevirapine|nevirapine|mesh-list
2369420|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2369421|NCT00573001|Efavirenz|efavirenz|mesh-list
2369422|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2369423|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2369424|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
2478145|NCT01098344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2478146|NCT01098344|Immunologic Factors|immunologic factors|mesh-ancestor
2478147|NCT01098344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478148|NCT01098357|Becaplermin|becaplermin|mesh-list
2478149|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
2478150|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2478151|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2478152|NCT01098357|Growth Substances|growth substances|mesh-ancestor
2369425|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369426|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369427|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2369428|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2369429|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
2369430|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369431|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2369432|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2369433|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2369434|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2369435|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
2369436|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2369437|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2369438|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2369439|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2369440|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2369441|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2369442|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2369443|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
2369444|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
2369445|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369446|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2369447|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369448|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369449|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2478153|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478154|NCT01098383|Acetylcholine|acetylcholine|mesh-list
2478155|NCT01098383|Donepezil|donepezil|mesh-list
2478156|NCT01098383|Choline|choline|mesh-list
2478157|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2478158|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478159|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478160|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
2478161|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478162|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478163|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
2478164|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
2478165|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2478166|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
2478167|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2478168|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2478169|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
2478170|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2478171|NCT01098435|ALKS-33|alks-33|mesh-list
2478172|NCT01098435|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2478173|NCT01098435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478174|NCT01098435|Sensory System Agents|sensory system agents|mesh-ancestor
2478175|NCT01098435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478176|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2478177|NCT01098448|Amoxicillin|amoxicillin|mesh-list
2478178|NCT01098448|Metronidazole|metronidazole|mesh-list
2478179|NCT01098448|Tetracycline|tetracycline|mesh-list
2478180|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478181|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2478182|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2478183|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2478184|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478185|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478186|NCT01098513|Dolutegravir|dolutegravir|mesh-list
2478187|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2478188|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2369450|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
2369451|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369452|NCT00573404|Sunitinib|sunitinib|mesh-list
2478189|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478190|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478191|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2478192|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2478193|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
2478194|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478195|NCT01098526|Efavirenz|efavirenz|mesh-list
2478196|NCT01098526|Dolutegravir|dolutegravir|mesh-list
2478197|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2478198|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2478199|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478200|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478201|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
2478202|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478203|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2478204|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2478205|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2478206|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2478207|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2478208|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2478209|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2478210|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2478211|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2478212|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2478213|NCT01098656|Lenalidomide|lenalidomide|mesh-list
2478214|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
2478215|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478216|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2478217|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2478218|NCT01098656|Growth Substances|growth substances|mesh-ancestor
2478219|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
2478220|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478221|NCT01098760|Sorafenib|sorafenib|mesh-list
2478222|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478223|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2478224|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478225|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478226|NCT01098890|Plasminogen|plasminogen|mesh-list
2369453|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
2478227|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2478228|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2478229|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2478230|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478231|NCT01098955|Varenicline|varenicline|mesh-list
2369454|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369455|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2369456|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2369457|NCT00573404|Growth Substances|growth substances|mesh-ancestor
2369458|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369459|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
2369460|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2369461|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478232|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2478233|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2478234|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
2478235|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478236|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478237|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478238|NCT01098994|Vitamin E|vitamin e|mesh-list
2478239|NCT01098994|Tocopherols|tocopherols|mesh-list
2478240|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
2478241|NCT01098994|Vitamins|vitamins|mesh-ancestor
2478242|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
2478243|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478244|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
2478245|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478246|NCT01098994|Protective Agents|protective agents|mesh-ancestor
2478247|NCT01099059|Amantadine|amantadine|mesh-list
2478248|NCT01099059|Methylphenidate|methylphenidate|mesh-list
2478249|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2478250|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478251|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2478252|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2478253|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2478254|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478255|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
2478256|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478257|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2478258|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2478259|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
2478260|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478261|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2478262|NCT01099059|Analgesics|analgesics|mesh-ancestor
2478263|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
2478264|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478265|NCT01099072|Methylphenidate|methylphenidate|mesh-list
2478266|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2478267|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478268|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2478269|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2478270|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2478271|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478272|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
2478273|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478274|NCT01099085|Simvastatin|simvastatin|mesh-list
2478275|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2478276|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2478277|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
2478278|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478279|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2478280|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2478281|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478282|NCT01099137|Vildagliptin|vildagliptin|mesh-list
2478283|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2478284|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478285|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2478286|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
2478287|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478288|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478289|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
2478290|NCT01099150|Procyanidin|procyanidin|mesh-list
2478291|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
2483658|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369462|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369463|NCT00573417|Modafinil|modafinil|mesh-list
2369464|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2369465|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369466|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2369467|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2369468|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2369469|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369470|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
2369471|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2369472|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
2369473|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369474|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369475|NCT00573547|Fluoxetine|fluoxetine|mesh-list
2369476|NCT00573547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2369477|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2369478|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2369479|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478292|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478293|NCT01099150|Protective Agents|protective agents|mesh-ancestor
2478294|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478295|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2478296|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2478297|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478298|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2478299|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478300|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478301|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478302|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2478303|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
2478304|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
2369480|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369481|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
2369482|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369483|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2369484|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
2369485|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2369486|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2369487|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2369488|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369489|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
2369490|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
2478305|NCT01099436|Docetaxel|docetaxel|mesh-list
2478306|NCT01099436|Doxorubicin|doxorubicin|mesh-list
2478307|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2478308|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2478309|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
2478310|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478311|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2478312|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2478313|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
2478314|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478315|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478316|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2369491|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2369492|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2369493|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2478317|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
2478318|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
2478319|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
2478320|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2478321|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2478322|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2478323|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478324|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2478325|NCT01099462|Ibuprofen|ibuprofen|mesh-list
2478326|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2478327|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2478328|NCT01099462|Analgesics|analgesics|mesh-ancestor
2478329|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
2478330|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478331|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369494|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369495|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
2369496|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
2369497|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
2369498|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369499|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
2369500|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
2369501|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2369502|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2369503|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
2369504|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
2478332|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2478333|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2478334|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2478335|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478336|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478337|NCT01099527|Capecitabine|capecitabine|mesh-list
2478338|NCT01099527|Everolimus|everolimus|mesh-list
2369505|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369506|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369507|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2369508|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2369509|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2369510|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2369511|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2369512|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
2369513|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2369514|NCT00573638|Latanoprost|latanoprost|mesh-list
2369515|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2369516|NCT00573664|Gabapentin|gabapentin|mesh-list
2369517|NCT00573664|Analgesics|analgesics|mesh-ancestor
2369518|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
2369519|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369520|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369521|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
2369522|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2369523|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2369524|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2369525|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2369526|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2369527|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2369528|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369529|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369530|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
2369531|NCT00573690|Carboplatin|carboplatin|mesh-list
2369532|NCT00573690|Etoposide|etoposide|mesh-list
2369533|NCT00573690|Pemetrexed|pemetrexed|mesh-list
2369534|NCT00573690|Sorafenib|sorafenib|mesh-list
2478339|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2478340|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
2478341|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478342|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478343|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2478344|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
2478345|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478346|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2478347|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2478348|NCT01099592|Citalopram|citalopram|mesh-list
2478349|NCT01099592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2478350|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2478351|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2478352|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478353|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478354|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
2478355|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478356|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2478357|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
2478358|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2478359|NCT01099605|Bupivacaine|bupivacaine|mesh-list
2478360|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
2478361|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
2478362|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2369535|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369536|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2369537|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2478363|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478364|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
2478365|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478366|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2478367|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2478368|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
2478369|NCT01099748|Methadone|methadone|mesh-list
2478370|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2478371|NCT01099748|Narcotics|narcotics|mesh-ancestor
2478372|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2478373|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478374|NCT01099748|Analgesics|analgesics|mesh-ancestor
2478375|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
2478376|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478377|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
2478378|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
2478379|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
2478380|NCT01099839|Miglitol|miglitol|mesh-list
2369538|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2369539|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369540|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369541|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2369542|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2369543|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2369544|NCT00573742|Candesartan|candesartan|mesh-list
2369545|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2369546|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2478381|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2478382|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478383|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2478384|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478385|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478386|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2478387|NCT01100021|Doxazosin|doxazosin|mesh-list
2478388|NCT01100021|Tamsulosin|tamsulosin|mesh-list
2478389|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2478390|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2478391|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2478392|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
2478393|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478394|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478395|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478396|NCT01100021|Urological Agents|urological agents|mesh-ancestor
2478397|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2478398|NCT01100060|Azithromycin|azithromycin|mesh-list
2478399|NCT01100060|Chloroquine|chloroquine|mesh-list
2478400|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2478401|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2478402|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478403|NCT01100060|Amebicides|amebicides|mesh-ancestor
2478404|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2478405|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2478406|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
2478407|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2478408|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2478409|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2478410|NCT01100060|Analgesics|analgesics|mesh-ancestor
2478411|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
2478412|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369547|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2369548|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369549|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2369550|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
2369551|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369552|NCT00573885|Protective Agents|protective agents|mesh-ancestor
2369553|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369554|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2369555|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2369556|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369557|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2369558|NCT00573924|Lansoprazole|lansoprazole|mesh-list
2369559|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
2369560|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2369561|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2478413|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478414|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2478415|NCT01100060|Filaricides|filaricides|mesh-ancestor
2478416|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
2478417|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
2478418|NCT01100125|Insulin|insulin|mesh-list
2478419|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2478420|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2478421|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
2478422|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2478423|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478424|NCT01100125|Incretins|incretins|mesh-ancestor
2478425|NCT01100125|Hormones|hormones|mesh-ancestor
2478426|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2369562|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2369563|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369564|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369565|NCT00573950|Cilostazol|cilostazol|mesh-list
2369566|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2369567|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
2369568|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369569|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369570|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2369571|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
2369572|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2369573|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2369574|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369575|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2369576|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
2369577|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2369578|NCT00573950|Protective Agents|protective agents|mesh-ancestor
2369579|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2369580|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2369581|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369582|NCT00573963|Ropivacaine|ropivacaine|mesh-list
2369583|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
2369584|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
2369585|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2369586|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369587|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
2369588|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369589|NCT00574015|Acetaminophen|acetaminophen|mesh-list
2369590|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2369591|NCT00574015|Hydrocodone|hydrocodone|mesh-list
2113894|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2113895|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113896|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113897|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2113898|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2113899|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2113900|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2113901|NCT02594111|Colchicine|colchicine|mesh-list
2113902|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
2478427|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2478428|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
2478429|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478430|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478431|NCT01100164|Eszopiclone|eszopiclone|mesh-list
2478432|NCT01100164|Zopiclone|zopiclone|mesh-list
2478433|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2478434|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2478435|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478436|NCT01100177|Sunitinib|sunitinib|mesh-list
2478437|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478438|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2478439|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2478440|NCT01100177|Growth Substances|growth substances|mesh-ancestor
2478441|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478442|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
2478443|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2478444|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478445|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478446|NCT01100203|Eplerenone|eplerenone|mesh-list
2369592|NCT00574015|Bupivacaine|bupivacaine|mesh-list
2478447|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2478448|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
2478449|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2478450|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369593|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
2369594|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
2369595|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2369596|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369597|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
2369598|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369599|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2369600|NCT00574015|Analgesics|analgesics|mesh-ancestor
2369601|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
2369602|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2369603|NCT00574015|Narcotics|narcotics|mesh-ancestor
2369604|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
2369605|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
2478451|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2478452|NCT01100203|Diuretics|diuretics|mesh-ancestor
2478453|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
2478454|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2478455|NCT01100216|Nicotine|nicotine|mesh-list
2478456|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2478457|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
2478458|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478459|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478460|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2478461|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2478462|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
2478463|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478464|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478465|NCT01100294|Vaccines|vaccines|mesh-list
2478466|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
2478467|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478468|NCT01100333|Hormones|hormones|mesh-list
2478469|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2478470|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2478471|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478472|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2478473|NCT01100346|Hormones|hormones|mesh-ancestor
2478474|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2478475|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478476|NCT01100359|Carboplatin|carboplatin|mesh-list
2478477|NCT01100359|Doxorubicin|doxorubicin|mesh-list
2478478|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2478479|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478480|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2478481|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2478482|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2478483|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478484|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478485|NCT01100372|Gemcitabine|gemcitabine|mesh-list
2478486|NCT01100372|Doxorubicin|doxorubicin|mesh-list
2478487|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2478488|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2478489|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
2478490|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478491|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478492|NCT01100372|Antiviral Agents|antiviral agents|mesh-ancestor
2478493|NCT01100372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478494|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369606|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2369607|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2369608|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2369609|NCT00574041|Interferons|interferons|mesh-list
2369610|NCT00574041|Interferon-beta|interferon-beta|mesh-list
2369611|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
2369612|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369613|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
2369614|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369615|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
2369616|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369617|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2369618|NCT00574093|Ranibizumab|ranibizumab|mesh-list
2369619|NCT00574093|Verteporfin|verteporfin|mesh-list
2369620|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2369621|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2369622|NCT00574093|Growth Substances|growth substances|mesh-ancestor
2369623|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369624|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
2369625|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478495|NCT01100372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2478496|NCT01100372|Immunologic Factors|immunologic factors|mesh-ancestor
2478497|NCT01100372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369626|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2369627|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
2369628|NCT00574353|Misonidazole|misonidazole|mesh-list
2369629|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478498|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2478499|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2478500|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2478501|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
2478502|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2478503|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478504|NCT01100736|Bosentan|bosentan|mesh-list
2478505|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
2478506|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2478507|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2478508|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478509|NCT01100775|Galantamine|galantamine|mesh-list
2478510|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2478511|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478512|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369630|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2369631|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2369632|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369633|NCT00574366|Everolimus|everolimus|mesh-list
2369634|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2369635|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369636|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2478513|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
2478514|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478515|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478516|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2478517|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
2478518|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478519|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
2478520|NCT01100801|Cisplatin|cisplatin|mesh-list
2478521|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
2478522|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478523|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
2478524|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2478525|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369637|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
2369638|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369639|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2369640|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369641|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369642|NCT00574470|Infliximab|infliximab|mesh-list
2369643|NCT00574470|Daclizumab|daclizumab|mesh-list
2369644|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
2369645|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2369646|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2369647|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2369648|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
2113903|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2113904|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
2113905|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
2113906|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
2113907|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113908|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113909|NCT02594163|Rituximab|rituximab|mesh-list
2113910|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2113911|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2113912|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2113913|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113914|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
2113915|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113916|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2369649|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369650|NCT00574483|Quinacrine|quinacrine|mesh-list
2478526|NCT01101009|Amlodipine|amlodipine|mesh-list
2478527|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2478528|NCT01101009|Olmesartan|olmesartan|mesh-list
2478529|NCT01101009|Perindopril|perindopril|mesh-list
2478530|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2478531|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2478532|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2478533|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369651|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
2369652|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2369653|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
2369654|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2369655|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369656|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
2369657|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2478534|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2478535|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478536|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
2478537|NCT01101009|Diuretics|diuretics|mesh-ancestor
2478538|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
2478539|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2478540|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2478541|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2478542|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2478543|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
2478544|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478545|NCT01101113|Cinacalcet|cinacalcet|mesh-list
2478546|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2478547|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478548|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2478549|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
2478550|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2478551|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2478552|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2478553|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2478554|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2478555|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478556|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478557|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478558|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
2478559|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2478560|NCT01101204|Metformin|metformin|mesh-list
2478561|NCT01101204|Simvastatin|simvastatin|mesh-list
2478562|NCT01101204|Fenofibrate|fenofibrate|mesh-list
2478563|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2478564|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478565|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2478566|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2478567|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
2478568|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478569|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2478570|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2478571|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478572|NCT01101269|Lisinopril|lisinopril|mesh-list
2478573|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2478574|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
2478575|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478576|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478577|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2478578|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2369658|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
2369659|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369660|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369661|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369662|NCT00574509|Tositumomab I-131|tositumomab i-131|mesh-list
2369663|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369664|NCT00574600|Vaccines|vaccines|mesh-list
2369665|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
2369666|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369667|NCT00574639|Alprazolam|alprazolam|mesh-list
2369668|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2369669|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2369670|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369671|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2478579|NCT01101269|Protective Agents|protective agents|mesh-ancestor
2478580|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478581|NCT01101386|Voriconazole|voriconazole|mesh-list
2478582|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
2478583|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478584|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2478585|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2478586|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478587|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478588|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2478589|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
2478590|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2478591|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478592|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2478593|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
2478594|NCT01101412|Ethanol|ethanol|mesh-list
2478595|NCT01101412|Trimethoprim|trimethoprim|mesh-list
2478596|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
2478597|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2478598|NCT01101412|Edetic Acid|edetic acid|mesh-list
2478599|NCT01101412|Calcium|calcium|mesh-list
2478600|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
2478601|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2478602|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478603|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2478604|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2478605|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478606|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2478607|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2478608|NCT01101412|Renal Agents|renal agents|mesh-ancestor
2478609|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
2478610|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2478611|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2478612|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2478613|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478614|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369672|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2369673|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2369674|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
2369675|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
2369676|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369677|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369678|NCT00574652|Aldesleukin|aldesleukin|mesh-list
2369679|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369680|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2369681|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2369682|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
2369683|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369684|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2369685|NCT00574730|Rituximab|rituximab|mesh-list
2369686|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2369687|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369688|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
2369689|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369690|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2369691|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
2369692|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369693|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
2369694|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2369695|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369696|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2369697|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
2369698|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2369699|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369700|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369701|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478615|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2478616|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2478617|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2478618|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2478619|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
2478620|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2478621|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
2478622|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
2478623|NCT01101412|Antidotes|antidotes|mesh-ancestor
2478624|NCT01101412|Protective Agents|protective agents|mesh-ancestor
2478625|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2478629|NCT01101451|Cisplatin|cisplatin|mesh-list
2478630|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478631|NCT01101529|Aprepitant|aprepitant|mesh-list
2478632|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
2478633|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
2478634|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478635|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478636|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2478637|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2478638|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478639|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478640|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2478641|NCT01101568|Simvastatin|simvastatin|mesh-list
2478642|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2478643|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2478644|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
2369702|NCT00574756|Ranolazine|ranolazine|mesh-list
2369703|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2369704|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2478645|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478646|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2478647|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2478648|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478649|NCT01101581|Epratuzumab|epratuzumab|mesh-list
2478650|NCT01101581|Veltuzumab|veltuzumab|mesh-list
2478651|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
2369705|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369706|NCT00574769|Bevacizumab|bevacizumab|mesh-list
2369707|NCT00574769|Docetaxel|docetaxel|mesh-list
2369708|NCT00574769|Everolimus|everolimus|mesh-list
2369709|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2369710|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478652|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2478653|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478654|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
2478655|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
2478656|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478657|NCT01101594|Doxorubicin|doxorubicin|mesh-list
2478658|NCT01101594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2478659|NCT01101594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478660|NCT01101594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2478661|NCT01101594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2478662|NCT01101594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478663|NCT01101594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478664|NCT01101620|Simendan|simendan|mesh-list
2478665|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2478666|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
2478667|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2478668|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2478669|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478670|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478671|NCT01101620|Protective Agents|protective agents|mesh-ancestor
2478672|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478673|NCT01101646|Rabeprazole|rabeprazole|mesh-list
2478674|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2369711|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2369712|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2369713|NCT00574769|Growth Substances|growth substances|mesh-ancestor
2369714|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369715|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
2369716|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
2369717|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
2369718|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
2369719|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369720|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2369721|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
2369722|NCT00574925|Esomeprazole|esomeprazole|mesh-list
2369723|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2369724|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2478675|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2478676|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2478677|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478678|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478679|NCT01101659|Ketamine|ketamine|mesh-list
2478680|NCT01101659|Analgesics|analgesics|mesh-ancestor
2478681|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
2478682|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478683|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478684|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2478685|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2478686|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
2478687|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
2478688|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2478689|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2478690|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2478691|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478692|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478693|NCT01101685|Citalopram|citalopram|mesh-list
2478694|NCT01101685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2478695|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2478696|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2478697|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478698|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478699|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
2478700|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478701|NCT01101685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2478702|NCT01101685|Antidepressive Agents|antidepressive agents|mesh-ancestor
2478703|NCT01101685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2478704|NCT01101698|Vitamin D|vitamin d|mesh-list
2478705|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
2478706|NCT01101698|Vitamins|vitamins|mesh-list
2478707|NCT01101698|Vitamin K|vitamin k|mesh-list
2478708|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
2478709|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
2478710|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478711|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2478712|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2478713|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2478714|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2478715|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478716|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
2478717|NCT01101698|Coagulants|coagulants|mesh-ancestor
2478718|NCT01101776|Interferons|interferons|mesh-list
2478719|NCT01101776|Interferon-beta|interferon-beta|mesh-list
2478720|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
2478721|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478722|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
2478723|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478724|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
2478725|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478726|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2478727|NCT01101789|Triclosan|triclosan|mesh-list
2478728|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2478729|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478730|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2478731|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2478732|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
2478733|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478734|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2478735|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
2478736|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2478737|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478738|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2478739|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
2478740|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2478741|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478742|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478743|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478744|NCT01101815|Naltrexone|naltrexone|mesh-list
2478745|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2478746|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2478747|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478748|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
2478749|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478750|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
2478751|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2478752|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2478753|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
2478754|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478755|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2478756|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2478757|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478758|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478759|NCT01101919|Tofacitinib|tofacitinib|mesh-list
2478760|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2478761|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478762|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478763|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2478764|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2478765|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
2369725|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2369726|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369727|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369728|NCT00574964|Temozolomide|temozolomide|mesh-list
2369729|NCT00574964|Carmustine|carmustine|mesh-list
2369730|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2369731|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
2369732|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369733|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369734|NCT00575068|Galiximab|galiximab|mesh-list
2478766|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2478767|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
2478768|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478769|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
2478770|NCT01101984|Protective Agents|protective agents|mesh-ancestor
2478771|NCT01102101|Remifentanil|remifentanil|mesh-list
2478772|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2478773|NCT01102101|Narcotics|narcotics|mesh-ancestor
2478774|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2478775|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478776|NCT01102101|Analgesics|analgesics|mesh-ancestor
2478777|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
2478778|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478779|NCT01102114|Vaccines|vaccines|mesh-list
2478780|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
2478781|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478782|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
2478783|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2478784|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2478785|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478786|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
2478787|NCT01102244|Hormones|hormones|mesh-ancestor
2478788|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2478789|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478790|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2478791|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2478792|NCT01102335|Telbivudine|telbivudine|mesh-list
2478793|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
2478794|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478795|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2478796|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478797|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478798|NCT01102439|Aspirin|aspirin|mesh-list
2478799|NCT01102439|Clopidogrel|clopidogrel|mesh-list
2478800|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2478801|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2478802|NCT01102439|Analgesics|analgesics|mesh-ancestor
2478803|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
2478804|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478805|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478806|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2478807|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2478808|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2478809|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2478810|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478811|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2478812|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2478813|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478814|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
2478815|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2478816|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2478817|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2478818|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
2478819|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478820|NCT01102465|Losartan|losartan|mesh-list
2478821|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2478822|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2478823|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2478824|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2369735|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2369736|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369737|NCT00575224|Interferons|interferons|mesh-list
2369738|NCT00575224|Ribavirin|ribavirin|mesh-list
2369739|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369740|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
2369741|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369742|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
2369743|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369744|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2369745|NCT00575302|Hormones|hormones|mesh-ancestor
2369746|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2478825|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2478826|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478827|NCT01102465|Diuretics|diuretics|mesh-ancestor
2478828|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
2478829|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478830|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2478831|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2478832|NCT01102478|Losartan|losartan|mesh-list
2478833|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2478834|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2478835|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2478836|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2478837|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2478838|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478839|NCT01102478|Diuretics|diuretics|mesh-ancestor
2478840|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
2478841|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478842|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2478843|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2478844|NCT01102595|Bevacizumab|bevacizumab|mesh-list
2478845|NCT01102595|Temozolomide|temozolomide|mesh-list
2478846|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2478847|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478848|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2478849|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2478850|NCT01102595|Growth Substances|growth substances|mesh-ancestor
2478851|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478852|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
2478853|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2478854|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
2478855|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478856|NCT01102608|Ifosfamide|ifosfamide|mesh-list
2478857|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2369747|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369748|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2369749|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2369750|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
2369751|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369752|NCT00575354|Sevoflurane|sevoflurane|mesh-list
2369753|NCT00575354|Isoflurane|isoflurane|mesh-list
2369754|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2369755|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2369756|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
2369757|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
2369758|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2369759|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369760|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
2478858|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
2478859|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478860|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478861|NCT01102660|Naproxen|naproxen|mesh-list
2478862|NCT01102660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2369761|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2369762|NCT00575406|Prednisolone|prednisolone|mesh-list
2369763|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
2478863|NCT01102660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2478864|NCT01102660|Analgesics|analgesics|mesh-ancestor
2478865|NCT01102660|Sensory System Agents|sensory system agents|mesh-ancestor
2478866|NCT01102660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478867|NCT01102660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478868|NCT01102660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2478869|NCT01102660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2478870|NCT01102660|Gout Suppressants|gout suppressants|mesh-ancestor
2478871|NCT01102660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2478872|NCT01102660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478873|NCT01102660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478874|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
2478875|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478876|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478877|NCT01102686|Leucovorin|leucovorin|mesh-list
2478878|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
2478879|NCT01102686|Antidotes|antidotes|mesh-ancestor
2478880|NCT01102686|Protective Agents|protective agents|mesh-ancestor
2478881|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478882|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
2478883|NCT01102686|Vitamins|vitamins|mesh-ancestor
2478884|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
2478885|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
2478886|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2478887|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2478888|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2478889|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2478890|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478891|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478892|NCT01102699|Lenograstim|lenograstim|mesh-list
2478893|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2478894|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
2478895|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478896|NCT01102946|Ranibizumab|ranibizumab|mesh-list
2478897|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2478898|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2478899|NCT01102946|Growth Substances|growth substances|mesh-ancestor
2478900|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478901|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
2478902|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478903|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2478904|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
2478905|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478906|NCT01103050|Cetirizine|cetirizine|mesh-list
2478907|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2478908|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2478909|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2478910|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
2478911|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
2478912|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478913|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478914|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478915|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
2478916|NCT01103115|Vitamin D|vitamin d|mesh-list
2478917|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
2478918|NCT01103115|Calcium|calcium|mesh-list
2478919|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2478920|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478921|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2478922|NCT01103115|Vitamins|vitamins|mesh-ancestor
2478923|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
2478924|NCT01103115|Antacids|antacids|mesh-ancestor
2369764|NCT00575406|Rituximab|rituximab|mesh-list
2369765|NCT00575406|Doxorubicin|doxorubicin|mesh-list
2369766|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2369767|NCT00575406|Vincristine|vincristine|mesh-list
2369768|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2369769|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
2369770|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369771|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2478925|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478926|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2478927|NCT01103154|Nadolol|nadolol|mesh-list
2478928|NCT01103154|Carvedilol|carvedilol|mesh-list
2478929|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2478930|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2478931|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
2478932|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2478933|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478934|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478935|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2478936|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
2478937|NCT01103154|Protective Agents|protective agents|mesh-ancestor
2478938|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2478939|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2478940|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2478941|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
2478942|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2478943|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2478944|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2478945|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
2478946|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
2478947|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369772|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2369773|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
2369774|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369775|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369776|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2369777|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2369778|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2478948|NCT01103193|Remifentanil|remifentanil|mesh-list
2478949|NCT01103193|Sevoflurane|sevoflurane|mesh-list
2478950|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2478951|NCT01103193|Narcotics|narcotics|mesh-ancestor
2478952|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2478953|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478954|NCT01103193|Analgesics|analgesics|mesh-ancestor
2478955|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
2478956|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2478957|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2478958|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2478959|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
2478960|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
2478961|NCT01103206|Cinacalcet|cinacalcet|mesh-list
2369779|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2369780|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2369781|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369782|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2369783|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
2369784|NCT00575406|Hormones|hormones|mesh-ancestor
2369785|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2369786|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2369787|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2369788|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
2369789|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
2369790|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
2369791|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
2369792|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2369793|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
2369794|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369795|NCT00575419|Expectorants|expectorants|mesh-ancestor
2478962|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2478963|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478964|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2478965|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
2478966|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2478967|NCT01103336|Nicorandil|nicorandil|mesh-list
2478968|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2478969|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2478970|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
2478971|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
2478972|NCT01103336|Vitamins|vitamins|mesh-ancestor
2478973|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
2478974|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478975|NCT01103349|Montelukast|montelukast|mesh-list
2478976|NCT01103349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2478977|NCT01103349|Respiratory System Agents|respiratory system agents|mesh-ancestor
2478978|NCT01103349|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2369796|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
2369797|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2369798|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
2369799|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369800|NCT00575419|Protective Agents|protective agents|mesh-ancestor
2369801|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369802|NCT00575419|Antidotes|antidotes|mesh-ancestor
2369803|NCT00575523|Atropine|atropine|mesh-list
2369804|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2369805|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2369806|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2369807|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
2478979|NCT01103349|Hormone Antagonists|hormone antagonists|mesh-ancestor
2478980|NCT01103349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2478981|NCT01103349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478982|NCT01103349|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2478983|NCT01103349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2369808|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369809|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369810|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2369811|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
2369812|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
2369813|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
2369814|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2369815|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2369816|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
2369817|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369818|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369819|NCT00575549|Dobutamine|dobutamine|mesh-list
2369820|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2369821|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
2369822|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
2369823|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369824|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369825|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2369826|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2369827|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2369828|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
2369829|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369830|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369831|NCT00575549|Protective Agents|protective agents|mesh-ancestor
2369832|NCT00575601|Simvastatin|simvastatin|mesh-list
2369833|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2369834|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2369835|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
2369836|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369837|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2369838|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2369839|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369840|NCT00575614|Prucalopride|prucalopride|mesh-list
2369841|NCT00575614|Laxatives|laxatives|mesh-ancestor
2369842|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2369843|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2369844|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2478984|NCT01103349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478985|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2478986|NCT01103375|Isotretinoin|isotretinoin|mesh-list
2478987|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369845|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
2369846|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369847|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369848|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369849|NCT00575627|Interferons|interferons|mesh-list
2369850|NCT00575627|Ribavirin|ribavirin|mesh-list
2369851|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
2369852|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
2369853|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2369854|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369855|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
2369856|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2369857|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
2478988|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2478989|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2478990|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2478991|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
2478992|NCT01103388|Rituximab|rituximab|mesh-list
2478993|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2478994|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2478995|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
2478996|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2478997|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2478998|NCT01103401|Tobramycin|tobramycin|mesh-list
2478999|NCT01103401|Dexamethasone|dexamethasone|mesh-list
2479000|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
2479001|NCT01103401|Ketorolac|ketorolac|mesh-list
2479002|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2479003|NCT01103401|BB 1101|bb 1101|mesh-list
2479004|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2479005|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
2479006|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
2479007|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479008|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479009|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2479010|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
2479011|NCT01103401|Hormones|hormones|mesh-ancestor
2479012|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2479013|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2369858|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369859|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
2369860|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369861|NCT00575640|Hydralazine|hydralazine|mesh-list
2369862|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2369863|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
2369864|NCT00575718|Nicotine|nicotine|mesh-list
2369865|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2369866|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
2369867|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369868|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369869|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2479014|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479015|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
2479016|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479017|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479018|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2479019|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2479020|NCT01103401|Analgesics|analgesics|mesh-ancestor
2479021|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
2479022|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2479023|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2479024|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2479025|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479026|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
2479027|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2479028|NCT01103518|Estradiol|estradiol|mesh-list
2479029|NCT01103518|Cyproterone|cyproterone|mesh-list
2479030|NCT01103518|Estrogens|estrogens|mesh-ancestor
2479031|NCT01103518|Hormones|hormones|mesh-ancestor
2479032|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2479033|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479034|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2479035|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
2479036|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2479037|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2479038|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2479039|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2479040|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
2479041|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
2479042|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479043|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2479044|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
2369870|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2369871|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
2369872|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369873|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369874|NCT00575796|Vinblastine|vinblastine|mesh-list
2369875|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2369876|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479045|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479046|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
2479047|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479048|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479049|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2479050|NCT01103609|Warfarin|warfarin|mesh-list
2479051|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
2479052|NCT01103622|Digoxin|digoxin|mesh-list
2479053|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2479054|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2479055|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479056|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479057|NCT01103622|Protective Agents|protective agents|mesh-ancestor
2479058|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479059|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2479060|NCT01103635|Ipilimumab|ipilimumab|mesh-list
2479061|NCT01103635|Tremelimumab|tremelimumab|mesh-list
2479062|NCT01103635|Antibodies|antibodies|mesh-list
2479063|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
2479064|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2479065|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
2479066|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479067|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479068|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2479069|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479070|NCT01103648|Simvastatin|simvastatin|mesh-list
2479071|NCT01103648|Ezetimibe|ezetimibe|mesh-list
2479072|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
2479073|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2479074|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2479075|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
2479076|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479077|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2479078|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479079|NCT01103739|Simvastatin|simvastatin|mesh-list
2479080|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2479081|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2479082|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
2479083|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479084|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2479085|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2479086|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479087|NCT01103791|Docetaxel|docetaxel|mesh-list
2479088|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479089|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
2479090|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
2479091|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
2479092|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479093|NCT01103817|Vitamin D|vitamin d|mesh-list
2479094|NCT01103817|Vitamins|vitamins|mesh-ancestor
2479095|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
2479096|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479097|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2479098|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
2369877|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
2369878|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
2369879|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
2369880|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369881|NCT00575835|Vitamin D|vitamin d|mesh-list
2479099|NCT01103830|Lumefantrine|lumefantrine|mesh-list
2479100|NCT01103830|Artemether|artemether|mesh-list
2479101|NCT01103830|Piperaquine|piperaquine|mesh-list
2479102|NCT01103830|Artenimol|artenimol|mesh-list
2479103|NCT01103830|Artemisinins|artemisinins|mesh-list
2479104|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2479105|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2479106|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2479107|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479108|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2479109|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2479110|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479111|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479112|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479113|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2479114|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
2479115|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2479116|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479117|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2479118|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2479119|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2479120|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
2479121|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2479122|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2479123|NCT01103843|Clopidogrel|clopidogrel|mesh-list
2479124|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2479125|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2479126|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2479127|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2479128|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2479129|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
2479130|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479131|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479132|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479133|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
2479134|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2479135|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2369882|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
2369883|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
2369884|NCT00575835|Vitamins|vitamins|mesh-list
2369885|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
2369886|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369887|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2369888|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2369889|NCT00575848|Glycine|glycine|mesh-list
2369890|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
2369891|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369892|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369893|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369894|NCT00575861|Zileuton|zileuton|mesh-list
2369895|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2369896|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2369897|NCT00575861|Analgesics|analgesics|mesh-ancestor
2369898|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
2369899|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369900|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369901|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2369902|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2369903|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2369904|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369905|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369906|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2369907|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
2479136|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479137|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
2479138|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
2479139|NCT01104259|Vinorelbine|vinorelbine|mesh-list
2479140|NCT01104259|Veliparib|veliparib|mesh-list
2479141|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479142|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2369908|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2369909|NCT00575874|Pioglitazone|pioglitazone|mesh-list
2369910|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2369911|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369912|NCT00575913|Alfuzosin|alfuzosin|mesh-list
2369913|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2369914|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2369915|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2369916|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
2369917|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369918|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479143|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
2479144|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
2479145|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
2479146|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479147|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2479148|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479149|NCT01104298|Doxorubicin|doxorubicin|mesh-list
2479150|NCT01104298|Trabectedin|trabectedin|mesh-list
2479151|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2479152|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369919|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479153|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2479154|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2479155|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479156|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479157|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2479158|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
2369920|NCT00575913|Urological Agents|urological agents|mesh-ancestor
2369921|NCT00575952|Paclitaxel|paclitaxel|mesh-list
2369922|NCT00575952|Doxorubicin|doxorubicin|mesh-list
2369923|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2369924|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2369925|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369926|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
2369927|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
2369928|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
2369929|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369930|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2369931|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2369932|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2369933|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2369934|NCT00575978|Hydralazine|hydralazine|mesh-list
2369935|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2369936|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
2369937|NCT00576017|Fentanyl|fentanyl|mesh-list
2369938|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2369939|NCT00576017|Narcotics|narcotics|mesh-ancestor
2369940|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2369941|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479159|NCT01104337|Acetaminophen|acetaminophen|mesh-list
2479160|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2479161|NCT01104337|Analgesics|analgesics|mesh-ancestor
2479162|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
2479163|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479164|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479165|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
2479166|NCT01104350|Gemcitabine|gemcitabine|mesh-list
2479167|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2479168|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
2479169|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479170|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479171|NCT01104350|Antiviral Agents|antiviral agents|mesh-ancestor
2479172|NCT01104350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479173|NCT01104350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479174|NCT01104350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2369942|NCT00576017|Analgesics|analgesics|mesh-ancestor
2369943|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
2369944|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369945|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2369946|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2369947|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
2369948|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
2369949|NCT00576069|Fluticasone|fluticasone|mesh-list
2369950|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
2369951|NCT00576069|Prednisone|prednisone|mesh-list
2369952|NCT00576069|Budesonide|budesonide|mesh-list
2369953|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
2369954|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2369955|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2369956|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2369957|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2369958|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
2479175|NCT01104350|Immunologic Factors|immunologic factors|mesh-ancestor
2479176|NCT01104350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479177|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
2479178|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2479179|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2479180|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479181|NCT01104519|Niacin|niacin|mesh-list
2479182|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
2479183|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2479184|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
2479185|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479186|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2479187|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
2369959|NCT00576069|Hormones|hormones|mesh-ancestor
2479188|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
2479189|NCT01104519|Vitamins|vitamins|mesh-ancestor
2479190|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
2479191|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479192|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2479193|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
2479194|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2479195|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479196|NCT01104532|Incretins|incretins|mesh-ancestor
2479197|NCT01104532|Hormones|hormones|mesh-ancestor
2479198|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2479199|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2479200|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
2479201|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479202|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479203|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2479204|NCT01104571|Trastuzumab|trastuzumab|mesh-list
2479205|NCT01104571|Lapatinib|lapatinib|mesh-list
2479206|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2479207|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479208|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2479209|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479210|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479211|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
2479212|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
2479213|NCT01104649|Riluzole|riluzole|mesh-list
2479214|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
2479215|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2479216|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2479217|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479218|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479219|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479220|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2479221|NCT01104649|Protective Agents|protective agents|mesh-ancestor
2479222|NCT01104844|Acetaminophen|acetaminophen|mesh-list
2479223|NCT01104844|Ibuprofen|ibuprofen|mesh-list
2479224|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2479225|NCT01104844|Analgesics|analgesics|mesh-ancestor
2479226|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
2479227|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479228|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479229|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
2479230|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2479231|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2479232|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2479233|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2479234|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479235|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479236|NCT01104883|Iodine|iodine|mesh-list
2479237|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2479238|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479239|NCT01104883|Trace Elements|trace elements|mesh-ancestor
2479240|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
2479241|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479242|NCT01104896|Nicotine|nicotine|mesh-list
2479243|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2479244|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
2479245|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479246|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479247|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2479248|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2479249|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
2479250|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479251|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479252|NCT01104922|Cetuximab|cetuximab|mesh-list
2369960|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2369961|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369962|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2479253|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2479254|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479255|NCT01104935|Trastuzumab|trastuzumab|mesh-list
2479256|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2479257|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479258|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2479259|NCT01104987|Alendronate|alendronate|mesh-list
2479260|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2479261|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369963|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369964|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2369965|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
2369966|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369967|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2369968|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
2479262|NCT01105013|Clotrimazole|clotrimazole|mesh-list
2479263|NCT01105013|Miconazole|miconazole|mesh-list
2479264|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2479265|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479266|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
2479267|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2479268|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2479269|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479270|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479271|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2479272|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
2479273|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2479274|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479275|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2479276|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2479277|NCT01105208|Cephalexin|cephalexin|mesh-list
2479278|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2479279|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479280|NCT01105234|Vitamin D|vitamin d|mesh-list
2479281|NCT01105234|Calcipotriene|calcipotriene|mesh-list
2479282|NCT01105234|Vitamins|vitamins|mesh-ancestor
2479283|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
2479284|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479285|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2479286|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
2479287|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
2479288|NCT01105273|Fludarabine|fludarabine|mesh-list
2479289|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2479290|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2479291|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
2479292|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479293|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2479294|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2479295|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
2479296|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479297|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479298|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2479299|NCT01105286|Vitamin D|vitamin d|mesh-list
2479300|NCT01105286|Calcipotriene|calcipotriene|mesh-list
2479301|NCT01105286|Vitamins|vitamins|mesh-ancestor
2479302|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
2479303|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479304|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2479305|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
2479306|NCT01105299|Anastrozole|anastrozole|mesh-list
2479307|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2479308|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479309|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2479310|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2479311|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479312|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479313|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2479314|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
2479315|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2479316|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479317|NCT01105338|Lycopene|lycopene|mesh-list
2479318|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2369969|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
2369970|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2479319|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
2479320|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479321|NCT01105338|Protective Agents|protective agents|mesh-ancestor
2479322|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479323|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2479324|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2479325|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479326|NCT01105351|Folic Acid|folic acid|mesh-list
2479327|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
2479328|NCT01105351|Hematinics|hematinics|mesh-ancestor
2479329|NCT01105351|Vitamins|vitamins|mesh-ancestor
2479330|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
2479331|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479332|NCT01105390|Pemetrexed|pemetrexed|mesh-list
2479333|NCT01105390|Rilotumumab|rilotumumab|mesh-list
2479334|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2479335|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479336|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479337|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479338|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2369971|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2369972|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2369973|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2369974|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
2369975|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2369976|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369977|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
2369978|NCT00576173|Acetaminophen|acetaminophen|mesh-list
2369979|NCT00576173|Tramadol|tramadol|mesh-list
2369980|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2369981|NCT00576173|Analgesics|analgesics|mesh-ancestor
2369982|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
2369983|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2369984|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2369985|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
2369986|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2369987|NCT00576173|Narcotics|narcotics|mesh-ancestor
2369988|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2369989|NCT00576225|Paclitaxel|paclitaxel|mesh-list
2369990|NCT00576225|Carboplatin|carboplatin|mesh-list
2369991|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2369992|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2369993|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2369994|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
2369995|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
2369996|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
2369997|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2369998|NCT00576238|Betamethasone|betamethasone|mesh-list
2369999|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
2370000|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2370001|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
2370002|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2370003|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2370004|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
2370005|NCT00576238|Hormones|hormones|mesh-ancestor
2370006|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2370007|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370008|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2370009|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
2370010|NCT00576329|Ketorolac|ketorolac|mesh-list
2479339|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2479340|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2479341|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
2479342|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479343|NCT01105481|Amisulpride|amisulpride|mesh-list
2479344|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2479345|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2479346|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2479347|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479348|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2370011|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2370012|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2370013|NCT00576329|Analgesics|analgesics|mesh-ancestor
2370014|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
2370015|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370016|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370017|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2370018|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2370019|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2370020|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479349|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2479350|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
2479351|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479352|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479353|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2479354|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
2479355|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
2479356|NCT01105494|Hematinics|hematinics|mesh-ancestor
2479357|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2479358|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2479359|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
2479360|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479361|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2479362|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479363|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2479364|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479365|NCT01105611|Ritonavir|ritonavir|mesh-list
2479366|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2479367|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
2479368|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2479369|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2479370|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
2479371|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479372|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479373|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2479374|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2479375|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
2479376|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479377|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2479378|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2479379|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2479380|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2479381|NCT01105624|Azithromycin|azithromycin|mesh-list
2479382|NCT01105624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2479383|NCT01105624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2479384|NCT01105624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2479385|NCT01105624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479386|NCT01105793|Danazol|danazol|mesh-list
2370021|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370022|NCT00576342|Timolol|timolol|mesh-list
2370023|NCT00576342|Dorzolamide|dorzolamide|mesh-list
2370024|NCT00576342|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2370025|NCT00576342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2370026|NCT00576342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2370027|NCT00576342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2370028|NCT00576342|Adrenergic Agents|adrenergic agents|mesh-ancestor
2370029|NCT00576342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2370030|NCT00576342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370031|NCT00576342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370032|NCT00576342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2479387|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2479388|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
2479389|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2479390|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479391|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
2479392|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2370033|NCT00576342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2370034|NCT00576342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2370035|NCT00576342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370036|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
2370037|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2370038|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370039|NCT00576394|Insulin|insulin|mesh-list
2370040|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2370041|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2370042|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370043|NCT00576433|Rituximab|rituximab|mesh-list
2370044|NCT00576433|Methotrexate|methotrexate|mesh-list
2370045|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2370046|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370047|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
2370048|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370049|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2479393|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479394|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
2479395|NCT01105832|Teriparatide|teriparatide|mesh-list
2479396|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2479397|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479398|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2479399|NCT01105871|Naloxone|naloxone|mesh-list
2479400|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2479401|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479402|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
2479403|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479404|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2479405|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
2479406|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2479407|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
2479408|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
2479409|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
2479410|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2479411|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479412|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
2479413|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479414|NCT01106053|Pramipexole|pramipexole|mesh-list
2479415|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
2479416|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479417|NCT01106053|Protective Agents|protective agents|mesh-ancestor
2479418|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479419|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2479420|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2479421|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
2479422|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
2479423|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479424|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
2479425|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479426|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2479427|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
2479428|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2479429|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2479430|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479431|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479432|NCT01106118|Urological Agents|urological agents|mesh-ancestor
2479433|NCT01106131|Pioglitazone|pioglitazone|mesh-list
2479434|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2479435|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479436|NCT01106235|Aldesleukin|aldesleukin|mesh-list
2479437|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
2479438|NCT01106235|Interleukin-2|interleukin-2|mesh-list
2479439|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2479440|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
2479441|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479442|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2479443|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2479444|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
2479445|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479446|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479447|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2479448|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2479449|NCT01106235|Analgesics|analgesics|mesh-ancestor
2479450|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
2479451|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479452|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2479453|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2479454|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
2479455|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479456|NCT01106495|Simvastatin|simvastatin|mesh-list
2479457|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2479458|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2479459|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
2479460|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479461|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2479462|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2479463|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479464|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
2479465|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2479466|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2479467|NCT01106547|Prednisolone|prednisolone|mesh-list
2479468|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
2479469|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2479470|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
2479471|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2479472|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
2370050|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2370051|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
2370052|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2370053|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2370054|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
2370055|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370056|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
2370057|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479473|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
2479474|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479475|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479476|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2479477|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
2479478|NCT01106547|Hormones|hormones|mesh-ancestor
2479479|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2479480|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2479481|NCT01106547|Protective Agents|protective agents|mesh-ancestor
2479482|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2479483|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479484|NCT01106716|Lidocaine|lidocaine|mesh-list
2479485|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
2479486|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
2479487|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2479488|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479489|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
2479490|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479491|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2479492|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2479493|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2479494|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2479495|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479496|NCT01106807|Adapalene|adapalene|mesh-list
2479497|NCT01106807|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
2479498|NCT01106807|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2479499|NCT01106807|Dermatologic Agents|dermatologic agents|mesh-ancestor
2479500|NCT01106807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2479501|NCT01106807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2479502|NCT01106807|Analgesics|analgesics|mesh-ancestor
2479503|NCT01106807|Sensory System Agents|sensory system agents|mesh-ancestor
2479504|NCT01106807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479505|NCT01106807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479506|NCT01106807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2479507|NCT01106807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2479508|NCT01106872|Gemcitabine|gemcitabine|mesh-list
2479509|NCT01106872|Bevacizumab|bevacizumab|mesh-list
2479510|NCT01106872|Docetaxel|docetaxel|mesh-list
2479511|NCT01106872|Valproic Acid|valproic acid|mesh-list
2479512|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2479513|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479514|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2479515|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2479516|NCT01106872|Growth Substances|growth substances|mesh-ancestor
2479517|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479518|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
2479519|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2479520|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
2479521|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370058|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2370059|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2370060|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2370061|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2370062|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2370063|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
2370064|NCT00576459|Hormones|hormones|mesh-ancestor
2370065|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2370066|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370067|NCT00576511|Prucalopride|prucalopride|mesh-list
2370068|NCT00576511|Laxatives|laxatives|mesh-ancestor
2370069|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2370070|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2370071|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2370072|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
2370073|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479522|NCT01106872|Antiviral Agents|antiviral agents|mesh-ancestor
2479523|NCT01106872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479524|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479525|NCT01106872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2479526|NCT01106872|Immunologic Factors|immunologic factors|mesh-ancestor
2479527|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
2479528|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
2479529|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
2479530|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
2479531|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
2479532|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479533|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
2479534|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2479535|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2479536|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2479537|NCT01106989|Lidocaine|lidocaine|mesh-list
2479538|NCT01106989|Tetracaine|tetracaine|mesh-list
2479539|NCT01106989|Anesthetics, Local|anesthetics, local|mesh-ancestor
2479540|NCT01106989|Anesthetics|anesthetics|mesh-ancestor
2479541|NCT01106989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2479542|NCT01106989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479543|NCT01106989|Sensory System Agents|sensory system agents|mesh-ancestor
2479544|NCT01106989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479545|NCT01106989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2479546|NCT01106989|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2479547|NCT01106989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2479548|NCT01106989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2479549|NCT01106989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479550|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
2479551|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2479552|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479553|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2479554|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2479555|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479556|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479557|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479558|NCT01107067|Testosterone|testosterone|mesh-list
2370074|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370075|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370076|NCT00576537|Vaccines|vaccines|mesh-list
2370077|NCT00576537|Immunologic Factors|immunologic factors|mesh-ancestor
2370078|NCT00576537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370079|NCT00576550|Betamethasone|betamethasone|mesh-list
2370080|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
2370081|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2370082|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
2370083|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2479559|NCT01107067|Androgens|androgens|mesh-ancestor
2479560|NCT01107067|Hormones|hormones|mesh-ancestor
2479561|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2370084|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2370085|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
2370086|NCT00576550|Hormones|hormones|mesh-ancestor
2370087|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2370088|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370089|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2479562|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479563|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
2479564|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2479565|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
2479566|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2479567|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479568|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2479569|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
2479570|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2479571|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
2479572|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2479573|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479574|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2479575|NCT01107145|Artesunate|artesunate|mesh-list
2479576|NCT01107145|Chloroquine|chloroquine|mesh-list
2479577|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2479578|NCT01107145|Lumefantrine|lumefantrine|mesh-list
2479579|NCT01107145|Artemether|artemether|mesh-list
2479580|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2479581|NCT01107145|Mefloquine|mefloquine|mesh-list
2479582|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
2479583|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2479584|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2479585|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479586|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479587|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
2479588|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
2479589|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2479590|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
2479591|NCT01107145|Amebicides|amebicides|mesh-ancestor
2479592|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2479593|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2479594|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2479595|NCT01107145|Analgesics|analgesics|mesh-ancestor
2479596|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
2479597|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479598|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479599|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2479600|NCT01107145|Filaricides|filaricides|mesh-ancestor
2479601|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
2479602|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2479603|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2479604|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479605|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
2479606|NCT01107236|Naproxen|naproxen|mesh-list
2479607|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2479608|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2479609|NCT01107236|Analgesics|analgesics|mesh-ancestor
2479610|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
2479611|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479612|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479613|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2479614|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2479615|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
2479616|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2479617|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479618|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479619|NCT01107431|Chromium|chromium|mesh-list
2479620|NCT01107431|Trace Elements|trace elements|mesh-ancestor
2479621|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
2479622|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479623|NCT01107496|Viloxazine|viloxazine|mesh-list
2479624|NCT01107496|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2479625|NCT01107496|Antidepressive Agents|antidepressive agents|mesh-ancestor
2479626|NCT01107496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2479627|NCT01107496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2479628|NCT01107496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2113917|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2113918|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
2113919|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113920|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2113921|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2113922|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
2370090|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
2370091|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
2370092|NCT00576602|Hematinics|hematinics|mesh-ancestor
2370093|NCT00576615|Propofol|propofol|mesh-list
2370094|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2370095|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370096|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370097|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2479629|NCT01107496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2479630|NCT01107496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479631|NCT01107496|Adrenergic Agents|adrenergic agents|mesh-ancestor
2479632|NCT01107496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479633|NCT01107496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479634|NCT01107509|Everolimus|everolimus|mesh-list
2479635|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479636|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2479637|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
2479638|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479639|NCT01107522|Temozolomide|temozolomide|mesh-list
2479640|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2479641|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
2479642|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370098|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
2370099|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
2479643|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479644|NCT01107574|Gabapentin|gabapentin|mesh-list
2479645|NCT01107574|Analgesics|analgesics|mesh-ancestor
2479646|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
2479647|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479648|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479649|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
2479650|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2479651|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2479652|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2479653|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2479654|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2479655|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2479656|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479657|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479658|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
2479659|NCT01107639|Docetaxel|docetaxel|mesh-list
2479660|NCT01107639|Cetuximab|cetuximab|mesh-list
2479661|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479662|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
2479663|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
2113929|NCT02595398|Triamcinolone|triamcinolone|mesh-list
2113930|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2113931|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2113932|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2113933|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2113934|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
2113935|NCT02595398|Hormones|hormones|mesh-ancestor
2113936|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2113937|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113938|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2113939|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
2113940|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479664|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
2479665|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479666|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2113941|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113942|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2113943|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113944|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2113945|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113946|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113947|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2113948|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2113949|NCT02595684|Tadalafil|tadalafil|mesh-list
2113950|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
2113951|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2113952|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2113953|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2113954|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113955|NCT02595684|Urological Agents|urological agents|mesh-ancestor
2113956|NCT02595723|Megestrol|megestrol|mesh-list
2479667|NCT01107717|Metformin|metformin|mesh-list
2479668|NCT01107717|Pioglitazone|pioglitazone|mesh-list
2479669|NCT01107717|Exenatide|exenatide|mesh-list
2479670|NCT01107717|Glyburide|glyburide|mesh-list
2479671|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2479672|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479673|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2479674|NCT01107717|Incretins|incretins|mesh-ancestor
2479675|NCT01107717|Hormones|hormones|mesh-ancestor
2479676|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2479677|NCT01107756|Lenograstim|lenograstim|mesh-list
2479678|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2479679|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
2479680|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479681|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
2479682|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
2479683|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2479684|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2479685|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370110|NCT00576667|Rimonabant|rimonabant|mesh-list
2479686|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479687|NCT01107782|Urological Agents|urological agents|mesh-ancestor
2479688|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
2479689|NCT01107808|Vitamin D|vitamin d|mesh-list
2479690|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
2479691|NCT01107808|Metformin|metformin|mesh-list
2479692|NCT01107808|Calcium|calcium|mesh-list
2479693|NCT01107808|Vitamins|vitamins|mesh-ancestor
2479694|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
2479695|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479696|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2479697|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2479698|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2479699|NCT01107938|Esomeprazole|esomeprazole|mesh-list
2479700|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2479701|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2479702|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2479703|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479704|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479705|NCT01107951|Dexamethasone|dexamethasone|mesh-list
2479706|NCT01107951|Rituximab|rituximab|mesh-list
2479707|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2479708|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
2479709|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
2479710|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479711|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479712|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2479713|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
2479714|NCT01107951|Hormones|hormones|mesh-ancestor
2479715|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2479716|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2479717|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479718|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2479719|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
2479720|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2479721|NCT01108029|Memantine|memantine|mesh-list
2479722|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2479723|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2479724|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
2479725|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479726|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479727|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479728|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2479729|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2479730|NCT01108042|Docetaxel|docetaxel|mesh-list
2479731|NCT01108042|Fluorouracil|fluorouracil|mesh-list
2479732|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479733|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
2479734|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
2479735|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
2479736|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479737|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
2479738|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2479739|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2479740|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
2479741|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479742|NCT01108055|Paclitaxel|paclitaxel|mesh-list
2479743|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2479744|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370111|NCT00576667|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2370112|NCT00576667|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2113957|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
2479745|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
2479746|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
2479747|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
2479748|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479749|NCT01108107|Capecitabine|capecitabine|mesh-list
2479750|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
2479751|NCT01108107|Panitumumab|panitumumab|mesh-list
2479752|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2479753|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
2479754|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479755|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479756|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2479757|NCT01108133|Dexamethasone|dexamethasone|mesh-list
2479758|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2479759|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
2479760|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
2479761|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479762|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479763|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2479764|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
2479765|NCT01108133|Hormones|hormones|mesh-ancestor
2479766|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2479767|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2479768|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479769|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
2479770|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2479771|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2479772|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2479773|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2479774|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
2479775|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2479776|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
2479777|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2479778|NCT01108289|Oxytocin|oxytocin|mesh-list
2479779|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
2370113|NCT00576667|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2370114|NCT00576667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2370115|NCT00576667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370116|NCT00576667|Hormones|hormones|mesh-ancestor
2370117|NCT00576667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2370118|NCT00576667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370119|NCT00576706|Misoprostol|misoprostol|mesh-list
2370120|NCT00576706|Rebamipide|rebamipide|mesh-list
2370121|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2370122|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
2370123|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2370124|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370125|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2370126|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2370127|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
2370128|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
2370129|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370130|NCT00576706|Protective Agents|protective agents|mesh-ancestor
2370131|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370132|NCT00576784|Pioglitazone|pioglitazone|mesh-list
2370133|NCT00576784|Glimepiride|glimepiride|mesh-list
2370134|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2370135|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370136|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2370137|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2370138|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
2370139|NCT00576810|Picosulfate sodium|picosulfate sodium|mesh-list
2479780|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2479781|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479782|NCT01108302|Oxytocin|oxytocin|mesh-list
2479783|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
2479784|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2479785|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479786|NCT01108393|S 20098|s 20098|mesh-list
2479787|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2479788|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2479789|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479790|NCT01108562|Lidocaine|lidocaine|mesh-list
2479791|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
2113958|NCT02595723|Phenytoin|phenytoin|mesh-list
2479792|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
2479793|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2479794|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479795|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
2479796|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479797|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2479798|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2479799|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2479800|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2479801|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479802|NCT01108588|Aspirin|aspirin|mesh-list
2479803|NCT01108588|Clopidogrel|clopidogrel|mesh-list
2479804|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2479805|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2479806|NCT01108588|Analgesics|analgesics|mesh-ancestor
2479807|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
2479808|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479809|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479810|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2479811|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2479812|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2479813|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2479814|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370140|NCT00576810|Cathartics|cathartics|mesh-ancestor
2370141|NCT00576810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2370142|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
2370143|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2370144|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370145|NCT00576914|Endostatins|endostatins|mesh-list
2370146|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2370147|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2370148|NCT00576914|Growth Substances|growth substances|mesh-ancestor
2370149|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370150|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
2479815|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2479816|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2479817|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479818|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
2479819|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2479820|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2479821|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2479822|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
2479823|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479824|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
2479825|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2479826|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479827|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2479828|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2479829|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479830|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479831|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479832|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2479833|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2479834|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
2479835|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2479836|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
2479837|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479838|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479839|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2479840|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
2479841|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2479842|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2479843|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2479844|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
2479845|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479846|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479847|NCT01108744|Mannitol|mannitol|mesh-list
2479848|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2479849|NCT01108744|Diuretics|diuretics|mesh-ancestor
2479850|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
2113959|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2113960|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2113961|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2113962|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
2479851|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479852|NCT01108783|Desloratadine|desloratadine|mesh-list
2479853|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2479854|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
2479855|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479856|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479857|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479858|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2479859|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2479860|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
2370151|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370152|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
2370153|NCT00576979|Etoposide|etoposide|mesh-list
2370154|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
2370155|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2479861|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
2479862|NCT01108848|Complement C1s|complement c1s|mesh-list
2479863|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2479864|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2479865|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
2479866|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479867|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2479868|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2370156|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
2370157|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370158|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2370159|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2370160|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
2370161|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370162|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370163|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2370164|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2370165|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2370166|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2370167|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370168|NCT00577018|Prucalopride|prucalopride|mesh-list
2370169|NCT00577018|Laxatives|laxatives|mesh-ancestor
2370170|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2370171|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2370172|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2370173|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
2370174|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2370175|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479869|NCT01108874|Metaraminol|metaraminol|mesh-list
2479870|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
2479871|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
2479872|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479873|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479874|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2479875|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2479876|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2479877|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2479878|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
2479879|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479880|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479881|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
2479882|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
2479883|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2479884|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2479885|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479886|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370176|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370177|NCT00577057|Fluorouracil|fluorouracil|mesh-list
2370178|NCT00577057|Capecitabine|capecitabine|mesh-list
2370179|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370180|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
2370181|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370182|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2370183|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2370184|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
2370185|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370186|NCT00577109|Leucovorin|leucovorin|mesh-list
2370187|NCT00577109|Bevacizumab|bevacizumab|mesh-list
2370188|NCT00577109|Cetuximab|cetuximab|mesh-list
2370189|NCT00577109|Irinotecan|irinotecan|mesh-list
2370190|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2370191|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370192|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2370193|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2479887|NCT01108900|Urological Agents|urological agents|mesh-ancestor
2479888|NCT01108926|Tenofovir|tenofovir|mesh-list
2479889|NCT01108926|Emtricitabine|emtricitabine|mesh-list
2479890|NCT01108926|Efavirenz|efavirenz|mesh-list
2479891|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2113963|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2113964|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113965|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2113966|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2113967|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2113968|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113969|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
2113970|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2113971|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
2370194|NCT00577109|Growth Substances|growth substances|mesh-ancestor
2479892|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
2479893|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479894|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2479895|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2479896|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479897|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479898|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2479899|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2479900|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2479901|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2479902|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2479903|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2479904|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2479905|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2479906|NCT01108939|Antimalarials|antimalarials|mesh-list
2479907|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2479908|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2479909|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479910|NCT01109030|Pioglitazone|pioglitazone|mesh-list
2479911|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
2479912|NCT01109030|Dexetimide|dexetimide|mesh-list
2479913|NCT01109030|Citalopram|citalopram|mesh-list
2479914|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2479915|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479916|NCT01109030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2479917|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2479918|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2479919|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479920|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479921|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
2479922|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2479923|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
2479924|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2479925|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2479926|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2479927|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
2479928|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
2479929|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370195|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370196|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
2370197|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2370198|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2370199|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479930|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2479931|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2479932|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
2479933|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2479934|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2479935|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2479936|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2479937|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2479938|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
2479939|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
2370200|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370201|NCT00577109|Antidotes|antidotes|mesh-ancestor
2370202|NCT00577109|Protective Agents|protective agents|mesh-ancestor
2479940|NCT01109043|Bisoprolol|bisoprolol|mesh-list
2479941|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2479942|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
2479943|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
2479944|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479945|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479946|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2479947|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2479948|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2479949|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
2479950|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479951|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479952|NCT01109121|Allopurinol|allopurinol|mesh-list
2370203|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
2370204|NCT00577109|Vitamins|vitamins|mesh-ancestor
2370205|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
2370206|NCT00577148|Rimonabant|rimonabant|mesh-list
2370207|NCT00577148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2370208|NCT00577148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2370209|NCT00577148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2370210|NCT00577148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479953|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
2479954|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479955|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479956|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
2479957|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2479958|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2479959|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
2479960|NCT01109121|Protective Agents|protective agents|mesh-ancestor
2479961|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479962|NCT01109134|Tirofiban|tirofiban|mesh-list
2479963|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2479964|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2479965|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479966|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2479967|NCT01109160|Azithromycin|azithromycin|mesh-list
2370211|NCT00577148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370212|NCT00577148|Hormones|hormones|mesh-ancestor
2370213|NCT00577148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2370214|NCT00577148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370215|NCT00577161|Vidarabine|vidarabine|mesh-list
2370216|NCT00577161|Rituximab|rituximab|mesh-list
2370217|NCT00577161|Fludarabine|fludarabine|mesh-list
2479968|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2479969|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2479970|NCT01109212|Bindarit|bindarit|mesh-list
2479971|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2479972|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2479973|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2479974|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479975|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2479976|NCT01109264|Chlorambucil|chlorambucil|mesh-list
2479977|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2370218|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
2370219|NCT00577161|Pixantrone|pixantrone|mesh-list
2370220|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2370221|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370222|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
2479978|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
2479979|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2479980|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2479981|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2479982|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2479983|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2479984|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2479985|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2479986|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2479987|NCT01109485|Analgesics|analgesics|mesh-ancestor
2479988|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
2479989|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2479990|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2479991|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2479992|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2479993|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2370223|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370224|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2370225|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2370226|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
2370227|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370228|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2479994|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2479995|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2479996|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
2479997|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
2479998|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2479999|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480000|NCT01109498|Cyclosporine|cyclosporine|mesh-list
2480001|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
2480002|NCT01109498|Cyclosporins|cyclosporins|mesh-list
2480003|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480004|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480005|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2480006|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
2480007|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480008|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
2480009|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480010|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
2480011|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2480012|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2480013|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2480014|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480015|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2480016|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
2480017|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2480018|NCT01109511|Oxycodone|oxycodone|mesh-list
2480019|NCT01109511|Naloxone|naloxone|mesh-list
2480020|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2480021|NCT01109511|Narcotics|narcotics|mesh-ancestor
2480022|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370229|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
2370230|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370231|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2370232|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2370233|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370234|NCT00577200|Midazolam|midazolam|mesh-list
2370235|NCT00577200|Sufentanil|sufentanil|mesh-list
2370236|NCT00577200|Propofol|propofol|mesh-list
2370237|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2480023|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480024|NCT01109511|Analgesics|analgesics|mesh-ancestor
2480025|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
2480026|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480027|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2480028|NCT01109615|Gemcitabine|gemcitabine|mesh-list
2480029|NCT01109615|Pemetrexed|pemetrexed|mesh-list
2480030|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2480031|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
2480032|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480033|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480034|NCT01109615|Antiviral Agents|antiviral agents|mesh-ancestor
2480035|NCT01109615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480036|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480037|NCT01109615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2480038|NCT01109615|Immunologic Factors|immunologic factors|mesh-ancestor
2480039|NCT01109615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480040|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2480041|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2480042|NCT01109654|Cetrorelix|cetrorelix|mesh-list
2480043|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2480044|NCT01109654|Hormones|hormones|mesh-ancestor
2480045|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2480046|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480047|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2480048|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
2480049|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2480050|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
2480051|NCT01109693|Mirtazapine|mirtazapine|mesh-list
2480052|NCT01109693|Sertraline|sertraline|mesh-list
2480053|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
2370238|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370239|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370240|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2370241|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
2370242|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
2370243|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2370244|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2370245|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2370246|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2480054|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2480055|NCT01109693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2480056|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2480057|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2480058|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480059|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480060|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
2480061|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480062|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2480063|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
2480064|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
2480065|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2480066|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2480067|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480068|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2480069|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2480070|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2480071|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
2480072|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2480073|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2480074|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2480075|NCT01109758|Fenofibrate|fenofibrate|mesh-list
2480076|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2480077|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
2480078|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480079|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2480080|NCT01109784|Clopidogrel|clopidogrel|mesh-list
2480081|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2370247|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
2370248|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
2370249|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2370250|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370251|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2480082|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2480083|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2480084|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2480085|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2480086|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
2480087|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480088|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480089|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370252|NCT00577200|Narcotics|narcotics|mesh-ancestor
2370253|NCT00577200|Analgesics|analgesics|mesh-ancestor
2370254|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
2370255|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370256|NCT00577278|Sirolimus|sirolimus|mesh-list
2370257|NCT00577278|Rituximab|rituximab|mesh-list
2370258|NCT00577278|Fludarabine|fludarabine|mesh-list
2370259|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
2370260|NCT00577278|Melphalan|melphalan|mesh-list
2370261|NCT00577278|Tacrolimus|tacrolimus|mesh-list
2370262|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2370263|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2370264|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370265|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
2370266|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480090|NCT01109823|Levofloxacin|levofloxacin|mesh-list
2480091|NCT01109823|Ofloxacin|ofloxacin|mesh-list
2480092|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2480093|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480094|NCT01109823|Renal Agents|renal agents|mesh-ancestor
2480095|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2480096|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2370267|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2370268|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2370269|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
2370270|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370271|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2370272|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2370273|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480097|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2480098|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480099|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480100|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480101|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2480102|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2480103|NCT01109888|Cetrorelix|cetrorelix|mesh-list
2480104|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2480105|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
2480106|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2480107|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480108|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
2480109|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2480110|NCT01109927|Insulin|insulin|mesh-list
2480111|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2480112|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480113|NCT01110031|Ofatumumab|ofatumumab|mesh-list
2480114|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480115|NCT01110226|Cisplatin|cisplatin|mesh-list
2480116|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
2480117|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370274|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2370275|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370276|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2370277|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
2370278|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2370279|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
2370280|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2370281|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
2370282|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
2370283|NCT00577369|Desflurane|desflurane|mesh-list
2370284|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2370285|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
2370286|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
2370287|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370288|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370289|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
2370290|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2370291|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2370292|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370293|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2370294|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480118|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480119|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480120|NCT01110291|Docetaxel|docetaxel|mesh-list
2480121|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480122|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
2480123|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
2480124|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
2480125|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370295|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2370296|NCT00577668|Thalidomide|thalidomide|mesh-list
2370297|NCT00577668|Dexamethasone|dexamethasone|mesh-list
2370298|NCT00577668|Melphalan|melphalan|mesh-list
2370299|NCT00577668|Bortezomib|bortezomib|mesh-list
2370300|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2370301|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
2370302|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
2370303|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370304|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480126|NCT01110304|Analgesics|analgesics|mesh-list
2480127|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
2480128|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480129|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480130|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2480131|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2480132|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2370305|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2370306|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
2370307|NCT00577668|Hormones|hormones|mesh-ancestor
2480133|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370308|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2370309|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2370310|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370311|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2370312|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
2370313|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370314|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2370315|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2370316|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
2370317|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
2370318|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2370319|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370320|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2370321|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2370322|NCT00577668|Growth Substances|growth substances|mesh-ancestor
2370323|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
2370324|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2480134|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480135|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2480136|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2480137|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2480138|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
2480139|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480140|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480141|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2480142|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2480143|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
2480144|NCT01110473|Azacitidine|azacitidine|mesh-list
2480145|NCT01110473|Ilorasertib|ilorasertib|mesh-list
2480146|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2480147|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
2480148|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480149|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480150|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480151|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2480152|NCT01110486|Carboplatin|carboplatin|mesh-list
2480153|NCT01110486|Docetaxel|docetaxel|mesh-list
2480154|NCT01110486|Ilorasertib|ilorasertib|mesh-list
2480155|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480156|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
2480157|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
2480158|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
2480159|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480160|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2480161|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480162|NCT01110551|Vaccines|vaccines|mesh-list
2480163|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
2480164|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370325|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
2370326|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370327|NCT00577694|Clofarabine|clofarabine|mesh-list
2370328|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
2370329|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2370330|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
2370331|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370332|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370333|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2370334|NCT00577798|Doxorubicin|doxorubicin|mesh-list
2370335|NCT00577798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2370336|NCT00577798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2370337|NCT00577798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370338|NCT00577798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2370339|NCT00577798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2370340|NCT00577798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370341|NCT00577798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370342|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
2370343|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
2370344|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2480165|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2480166|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
2480167|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2480168|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2480169|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480170|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480171|NCT01110590|Urological Agents|urological agents|mesh-ancestor
2480172|NCT01110603|Paclitaxel|paclitaxel|mesh-list
2480173|NCT01110603|Carboplatin|carboplatin|mesh-list
2480174|NCT01110603|Doxorubicin|doxorubicin|mesh-list
2480175|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2370345|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2370346|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370347|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2370348|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370349|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2370350|NCT00577850|Alendronate|alendronate|mesh-list
2370351|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
2370352|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2370353|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370354|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2370355|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2370356|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370357|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2370358|NCT00577967|Gabapentin|gabapentin|mesh-list
2370359|NCT00577967|Analgesics|analgesics|mesh-ancestor
2370360|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
2370361|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370362|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370363|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
2370364|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2370365|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2370366|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370367|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2370368|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2370369|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2370370|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2370371|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370372|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
2370373|NCT00577980|Testosterone|testosterone|mesh-list
2370374|NCT00577980|Androgens|androgens|mesh-ancestor
2370375|NCT00577980|Hormones|hormones|mesh-ancestor
2370376|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2480176|NCT01110603|Niraparib|niraparib|mesh-list
2480177|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2480178|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480179|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
2480180|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
2480181|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
2370377|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370378|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
2370379|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2370380|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2370381|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2370382|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2370383|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370384|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
2370385|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2370386|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370387|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2370388|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370389|NCT00578149|Paclitaxel|paclitaxel|mesh-list
2370390|NCT00578149|Bevacizumab|bevacizumab|mesh-list
2370391|NCT00578149|Carboplatin|carboplatin|mesh-list
2370392|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2370393|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370394|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
2370395|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
2370396|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
2370397|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370398|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2370399|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2370400|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2370401|NCT00578149|Growth Substances|growth substances|mesh-ancestor
2370402|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370403|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
2370404|NCT00578201|Cetuximab|cetuximab|mesh-list
2370405|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2480182|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480183|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2480184|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2480185|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2480186|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480187|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2480188|NCT01110616|Lorazepam|lorazepam|mesh-list
2480189|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
2480190|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
2480191|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
2480192|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480193|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480194|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2480195|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2480196|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480197|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2480198|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2480199|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2480200|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
2480201|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
2480202|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480203|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480204|NCT01110642|Lovastatin|lovastatin|mesh-list
2480205|NCT01110642|L 647318|l 647318|mesh-list
2480206|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
2480207|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2480208|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2480209|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
2480210|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480211|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2480212|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2480213|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480214|NCT01110746|Insulin|insulin|mesh-list
2480215|NCT01110746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2480216|NCT01110746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2480217|NCT01110746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480218|NCT01110785|Panitumumab|panitumumab|mesh-list
2480219|NCT01110785|Simvastatin|simvastatin|mesh-list
2480220|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2480221|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2480222|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
2480223|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480224|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2480225|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2480226|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370406|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370407|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
2370408|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
2370409|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2370410|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
2370411|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370412|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2370413|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2370414|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
2370415|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370416|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370417|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2370418|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2370419|NCT00578370|Cyclosporine|cyclosporine|mesh-list
2370420|NCT00578370|Betamethasone|betamethasone|mesh-list
2370421|NCT00578370|Calcipotriene|calcipotriene|mesh-list
2370422|NCT00578370|Cyclosporins|cyclosporins|mesh-list
2370423|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370424|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370425|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2370426|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
2370427|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370428|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
2370429|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370430|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
2370431|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2370432|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2370433|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2480227|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2480228|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480229|NCT01110824|Carvedilol|carvedilol|mesh-list
2480230|NCT01110824|Enalapril|enalapril|mesh-list
2480231|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2480232|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2480233|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
2480234|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480235|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480236|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480237|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2480238|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
2480239|NCT01110824|Protective Agents|protective agents|mesh-ancestor
2480240|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2480241|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2480242|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2480243|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
2480244|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2480245|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2480246|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2370434|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
2370435|NCT00578370|Hormones|hormones|mesh-ancestor
2370436|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2370437|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2370438|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
2370439|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
2370440|NCT00578435|Busulfan|busulfan|mesh-list
2370441|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2370442|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
2370443|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370444|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2370445|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2370446|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
2370447|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370448|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370449|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2370450|NCT00578474|Ofloxacin|ofloxacin|mesh-list
2370451|NCT00578474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2370452|NCT00578474|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2370453|NCT00578474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370454|NCT00578474|Renal Agents|renal agents|mesh-ancestor
2370455|NCT00578474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2370456|NCT00578474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2370457|NCT00578474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2480247|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
2480248|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480249|NCT01110889|S 20098|s 20098|mesh-list
2480250|NCT01110889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2480251|NCT01110889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480252|NCT01110889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480253|NCT01110902|S 20098|s 20098|mesh-list
2480254|NCT01110902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2480255|NCT01110902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480256|NCT01110902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480257|NCT01110941|Leucovorin|leucovorin|mesh-list
2480258|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
2480259|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480260|NCT01110941|Antidotes|antidotes|mesh-ancestor
2480261|NCT01110941|Protective Agents|protective agents|mesh-ancestor
2480262|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480263|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
2480264|NCT01110941|Vitamins|vitamins|mesh-ancestor
2480265|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
2480266|NCT01111019|Hormones|hormones|mesh-list
2480267|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2480268|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480269|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2480270|NCT01111084|Hormones|hormones|mesh-ancestor
2480271|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2480272|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480273|NCT01111188|Bortezomib|bortezomib|mesh-list
2480274|NCT01111188|Palbociclib|palbociclib|mesh-list
2480275|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480276|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2480277|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480278|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480279|NCT01111227|Propofol|propofol|mesh-list
2480280|NCT01111227|Isoflurane|isoflurane|mesh-list
2480281|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2480282|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480283|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480284|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2480285|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
2480286|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
2480287|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2480288|NCT01111253|Amoxicillin|amoxicillin|mesh-list
2480289|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
2480290|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
2480291|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2480292|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2480293|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480294|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2480295|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480296|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480297|NCT01111383|Tobramycin|tobramycin|mesh-list
2480298|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2480299|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480300|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
2480301|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2480302|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
2480303|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480304|NCT01111422|Expectorants|expectorants|mesh-ancestor
2480305|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
2480306|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2480307|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
2480308|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480309|NCT01111422|Protective Agents|protective agents|mesh-ancestor
2480310|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480311|NCT01111422|Antidotes|antidotes|mesh-ancestor
2480312|NCT01111448|Sirolimus|sirolimus|mesh-list
2480313|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2480314|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480315|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2480316|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480317|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
2480318|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2480319|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
2480320|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480321|NCT01111513|Analgesics|analgesics|mesh-list
2480322|NCT01111513|Ropivacaine|ropivacaine|mesh-list
2370458|NCT00578474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370459|NCT00578474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370460|NCT00578474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370461|NCT00578474|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2370462|NCT00578474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2370463|NCT00578526|Sunitinib|sunitinib|mesh-list
2370464|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370465|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2370466|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2370467|NCT00578526|Growth Substances|growth substances|mesh-ancestor
2370468|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370469|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
2370470|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2370471|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370472|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370473|NCT00578591|Rituximab|rituximab|mesh-list
2370474|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2370475|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370476|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
2370477|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370478|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2370479|NCT00578721|Aspirin|aspirin|mesh-list
2370480|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2370481|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2370482|NCT00578721|Analgesics|analgesics|mesh-ancestor
2370483|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
2370484|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370485|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370486|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2370487|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2370488|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2370489|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2480323|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
2480324|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
2370490|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370491|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2370492|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2370493|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480325|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480326|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480327|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
2480328|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480361|NCT01111591|Celecoxib|celecoxib|mesh-list
2480362|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
2480363|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2480364|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2480365|NCT01111591|Analgesics|analgesics|mesh-ancestor
2480366|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
2480367|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480368|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480369|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2480370|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2480371|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2480372|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480373|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480374|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
2370494|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
2370495|NCT00578760|Aspirin|aspirin|mesh-list
2370496|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2370497|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2370498|NCT00578760|Analgesics|analgesics|mesh-ancestor
2370499|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
2370500|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370501|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370502|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2370503|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2480375|NCT01111630|Hematinics|hematinics|mesh-ancestor
2480376|NCT01111656|Interferons|interferons|mesh-list
2480377|NCT01111656|Interferon-beta|interferon-beta|mesh-list
2480378|NCT01111656|Atorvastatin|atorvastatin|mesh-list
2480379|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
2480380|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370504|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2370505|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2370506|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370507|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2370508|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2370509|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370510|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
2370511|NCT00578773|Moxifloxacin|moxifloxacin|mesh-list
2370512|NCT00578773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2370513|NCT00578773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2370514|NCT00578773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370515|NCT00578773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2370516|NCT00578773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2480381|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
2480382|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370517|NCT00578773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370518|NCT00578773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370519|NCT00578773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370520|NCT00578825|Ritonavir|ritonavir|mesh-list
2370521|NCT00578825|Lopinavir|lopinavir|mesh-list
2370522|NCT00578825|Ribavirin|ribavirin|mesh-list
2370523|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2370524|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2370525|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
2370526|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370527|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370528|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2370529|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2370530|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
2480383|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2480384|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2480385|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
2480386|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480387|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2480388|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2480389|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480390|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
2480391|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480392|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2480393|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
2480394|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2480395|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2480396|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480397|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
2480398|NCT01111669|Coagulants|coagulants|mesh-ancestor
2480399|NCT01111682|Mannitol|mannitol|mesh-list
2480400|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2480401|NCT01111682|Diuretics|diuretics|mesh-ancestor
2480402|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
2480403|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480404|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
2480405|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2480406|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480407|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
2480408|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480409|NCT01111734|Expectorants|expectorants|mesh-ancestor
2480410|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
2480411|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2480412|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
2480413|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480414|NCT01111734|Protective Agents|protective agents|mesh-ancestor
2480415|NCT01111734|Antidotes|antidotes|mesh-ancestor
2480416|NCT01111747|Mitogens|mitogens|mesh-list
2480417|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
2480418|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480419|NCT01111773|Lidocaine|lidocaine|mesh-list
2480420|NCT01111773|Tetracaine|tetracaine|mesh-list
2480421|NCT01111773|Anesthetics, Local|anesthetics, local|mesh-ancestor
2480422|NCT01111773|Anesthetics|anesthetics|mesh-ancestor
2480423|NCT01111773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2113972|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2113973|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2370531|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370532|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2370533|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2370534|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
2370535|NCT00579020|Moxifloxacin|moxifloxacin|mesh-list
2370536|NCT00579020|Dexamethasone|dexamethasone|mesh-list
2370537|NCT00579020|Dexamethasone acetate|dexamethasone acetate|mesh-list
2480424|NCT01111773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480425|NCT01111773|Sensory System Agents|sensory system agents|mesh-ancestor
2480426|NCT01111773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480427|NCT01111773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2480428|NCT01111773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2480429|NCT01111773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2480430|NCT01111773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2480431|NCT01111773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480432|NCT01111864|Micronutrients|micronutrients|mesh-list
2480433|NCT01111864|Trace Elements|trace elements|mesh-list
2480434|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370538|NCT00579020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2370539|NCT00579020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2370540|NCT00579020|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2370541|NCT00579020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2370542|NCT00579020|BB 1101|bb 1101|mesh-list
2370543|NCT00579020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2370544|NCT00579020|Antiemetics|antiemetics|mesh-ancestor
2480435|NCT01111890|Timolol|timolol|mesh-list
2480436|NCT01111890|Dorzolamide|dorzolamide|mesh-list
2480437|NCT01111890|Brinzolamide|brinzolamide|mesh-list
2480438|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2480439|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2480440|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
2480441|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480442|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480443|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480444|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2480445|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2480446|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2480447|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370545|NCT00579020|Autonomic Agents|autonomic agents|mesh-ancestor
2370546|NCT00579020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370547|NCT00579020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370548|NCT00579020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2370549|NCT00579020|Glucocorticoids|glucocorticoids|mesh-ancestor
2370550|NCT00579020|Hormones|hormones|mesh-ancestor
2370551|NCT00579020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2370552|NCT00579020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2370553|NCT00579020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370554|NCT00579020|Protease Inhibitors|protease inhibitors|mesh-ancestor
2370555|NCT00579020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370556|NCT00579020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370557|NCT00579020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2370558|NCT00579020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370559|NCT00579020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2370560|NCT00579020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2370561|NCT00579020|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2370562|NCT00579020|Contraceptive Agents|contraceptive agents|mesh-ancestor
2370563|NCT00579020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2370564|NCT00579020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2370565|NCT00579020|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2480448|NCT01111903|Lenalidomide|lenalidomide|mesh-list
2480449|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
2480450|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480451|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2480452|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2480453|NCT01111903|Growth Substances|growth substances|mesh-ancestor
2480454|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
2480455|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370566|NCT00579020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2370567|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
2370568|NCT00579046|Hematinics|hematinics|mesh-ancestor
2370569|NCT00579085|Ketamine|ketamine|mesh-list
2370570|NCT00579085|Analgesics|analgesics|mesh-ancestor
2370571|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
2370572|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370573|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370574|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2370575|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2370576|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
2370577|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
2370578|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370579|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2370580|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2480456|NCT01111942|Cisplatin|cisplatin|mesh-list
2370581|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480457|NCT01111942|Carboplatin|carboplatin|mesh-list
2480458|NCT01111942|Docetaxel|docetaxel|mesh-list
2480459|NCT01111942|Fluorouracil|fluorouracil|mesh-list
2480460|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480461|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
2480462|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
2480463|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
2480464|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480465|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
2370582|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370583|NCT00579189|Moxifloxacin|moxifloxacin|mesh-list
2370584|NCT00579189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2370585|NCT00579189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2370586|NCT00579189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370587|NCT00579189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2370588|NCT00579189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2370589|NCT00579189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370590|NCT00579189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370591|NCT00579189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480466|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2480467|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2480468|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
2480469|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480470|NCT01111955|Metformin|metformin|mesh-list
2480471|NCT01111955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2480472|NCT01111955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480473|NCT01111968|Vaccines|vaccines|mesh-list
2480474|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
2480475|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480476|NCT01111981|Clobetasol|clobetasol|mesh-list
2480477|NCT01111981|Emollients|emollients|mesh-list
2480478|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2480479|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
2480480|NCT01111981|Hormones|hormones|mesh-ancestor
2480481|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2480482|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480483|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
2480484|NCT01111994|Clindamycin|clindamycin|mesh-list
2480485|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
2480486|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
2480487|NCT01111994|Tretinoin|tretinoin|mesh-list
2480488|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2480489|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480490|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2480491|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480492|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480493|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480494|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
2480495|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
2480496|NCT01112072|Riboflavin|riboflavin|mesh-list
2480497|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
2480498|NCT01112072|Vitamins|vitamins|mesh-ancestor
2480499|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
2480500|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480501|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2480502|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
2480503|NCT01112085|Ranibizumab|ranibizumab|mesh-list
2480504|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2480505|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2480506|NCT01112085|Growth Substances|growth substances|mesh-ancestor
2480507|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480508|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
2480509|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480510|NCT01112137|Clopidogrel|clopidogrel|mesh-list
2480511|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2480512|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2480513|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2480514|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2480515|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
2480516|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480517|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480518|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480519|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
2480520|NCT01112215|Azathioprine|azathioprine|mesh-list
2480521|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2370592|NCT00579475|Mifepristone|mifepristone|mesh-list
2480522|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480523|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2480524|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
2480525|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2480526|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480527|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480528|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480529|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
2370593|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2370594|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
2370595|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2370596|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370597|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2370598|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2370599|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2370600|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
2370601|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2370602|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2370603|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
2370604|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2370605|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
2370606|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2370607|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2370608|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
2480530|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2480531|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2480532|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
2480533|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480534|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2480537|NCT01112449|Selenium|selenium|mesh-list
2480538|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
2480539|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480540|NCT01112449|Protective Agents|protective agents|mesh-ancestor
2480541|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480542|NCT01112449|Trace Elements|trace elements|mesh-ancestor
2480543|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
2480544|NCT01112462|Acetaminophen|acetaminophen|mesh-list
2480545|NCT01112462|Phenylephrine|phenylephrine|mesh-list
2480546|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
2480547|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2480548|NCT01112462|Analgesics|analgesics|mesh-ancestor
2480549|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
2480550|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480551|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480552|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
2480553|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2480554|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
2480555|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
2480556|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
2480557|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2480558|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
2480559|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
2480560|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2480561|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2480562|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2480563|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
2480564|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480565|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480566|NCT01112462|Protective Agents|protective agents|mesh-ancestor
2480567|NCT01112540|Morphine|morphine|mesh-list
2370609|NCT00579592|Rituximab|rituximab|mesh-list
2370610|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
2370611|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2370612|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370613|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
2370614|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370615|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2370616|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2370617|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2480568|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2480569|NCT01112540|Narcotics|narcotics|mesh-ancestor
2480570|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370618|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
2370619|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2370620|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370621|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370622|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370623|NCT00579644|Minocycline|minocycline|mesh-list
2370624|NCT00579644|Methotrexate|methotrexate|mesh-list
2370625|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2480571|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480572|NCT01112540|Analgesics|analgesics|mesh-ancestor
2480573|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
2480574|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480575|NCT01112644|Oxycodone|oxycodone|mesh-list
2480576|NCT01112644|Naloxone|naloxone|mesh-list
2480577|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2480578|NCT01112644|Narcotics|narcotics|mesh-ancestor
2480579|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480580|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480581|NCT01112644|Analgesics|analgesics|mesh-ancestor
2480582|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
2480583|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480584|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2480585|NCT01112722|Histamine|histamine|mesh-list
2480586|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
2480587|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
2480588|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480589|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480590|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480591|NCT01112748|Lidocaine|lidocaine|mesh-list
2480592|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
2480593|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
2480594|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480595|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480596|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
2480597|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480598|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2480599|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2480600|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2480601|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2480602|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480603|NCT01112787|Tazarotene|tazarotene|mesh-list
2480604|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
2480605|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
2480606|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
2480607|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
2480608|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2480609|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480610|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480611|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
2480612|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2480613|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480614|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480615|NCT01112826|Capecitabine|capecitabine|mesh-list
2480616|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2480617|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
2480618|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480619|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480620|NCT01112852|Terlipressin|terlipressin|mesh-list
2480621|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2480622|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2480623|NCT01112852|Somatostatin|somatostatin|mesh-list
2480624|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480625|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480626|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2480627|NCT01112852|Hormones|hormones|mesh-ancestor
2370626|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
2370627|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2370628|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370629|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2370630|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
2370631|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370632|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370633|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
2370634|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480628|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2480629|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480630|NCT01112878|Clonidine|clonidine|mesh-list
2480631|NCT01112878|Gabapentin|gabapentin|mesh-list
2480632|NCT01112878|Analgesics|analgesics|mesh-ancestor
2480633|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
2480634|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370635|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2370636|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2370637|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
2370638|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2370639|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2370640|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2370641|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370642|NCT00579956|Meropenem|meropenem|mesh-list
2370643|NCT00579956|Ceftazidime|ceftazidime|mesh-list
2370644|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2480635|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480636|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
2480637|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2480638|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2480639|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480640|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2480641|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2480642|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2480643|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480644|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480645|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
2480646|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2480647|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
2480648|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
2480649|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2480650|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2480651|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2480652|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
2480653|NCT01112891|Vitamin D|vitamin d|mesh-list
2480654|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
2480655|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
2480656|NCT01112891|Vitamins|vitamins|mesh-list
2480657|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
2480658|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480659|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2480660|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2480661|NCT01113047|Amlodipine|amlodipine|mesh-list
2480662|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2480663|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2480664|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2480665|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480666|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2480667|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480668|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
2370645|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370646|NCT00579969|Timolol|timolol|mesh-list
2370647|NCT00579969|Latanoprost|latanoprost|mesh-list
2370648|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2370649|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2370650|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
2370651|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480669|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
2480670|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2480671|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480672|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2480673|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480674|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480675|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
2480676|NCT01113138|Analgesics|analgesics|mesh-ancestor
2480677|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
2480678|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480679|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480680|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
2480681|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480682|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2480683|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
2480684|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2480685|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2370652|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370653|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370654|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2370655|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2480686|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480687|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2480688|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
2480689|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2480690|NCT01113164|Ondansetron|ondansetron|mesh-list
2480691|NCT01113164|Sertraline|sertraline|mesh-list
2480692|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
2480693|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
2480694|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480695|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480696|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2480697|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
2480698|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
2480699|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2480700|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
2480701|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480702|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480703|NCT01113164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2480704|NCT01113164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2370656|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2370657|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2370658|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
2370659|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2370660|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
2370661|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370662|NCT00579995|Expectorants|expectorants|mesh-ancestor
2370663|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
2370664|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2370665|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
2370666|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370667|NCT00579995|Protective Agents|protective agents|mesh-ancestor
2370668|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370669|NCT00579995|Antidotes|antidotes|mesh-ancestor
2370670|NCT00580060|Molgramostim|molgramostim|mesh-list
2370671|NCT00580060|Sargramostim|sargramostim|mesh-list
2370672|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
2370673|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370674|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370675|NCT00580112|Dexamethasone|dexamethasone|mesh-list
2370676|NCT00580112|Trabectedin|trabectedin|mesh-list
2370677|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2370678|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
2370679|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
2370680|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370681|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370682|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2480705|NCT01113164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480706|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2480707|NCT01113164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2480708|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
2480709|NCT01113164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2480710|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2480711|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2480712|NCT01113229|Misoprostol|misoprostol|mesh-list
2480713|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2480714|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
2480715|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2480716|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480717|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2480718|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2480719|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
2480720|NCT01113281|Vaccines|vaccines|mesh-list
2480721|NCT01113281|Immunoglobulins|immunoglobulins|mesh-list
2480722|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
2480723|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480724|NCT01113372|Clopidogrel|clopidogrel|mesh-list
2480725|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2480726|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2480727|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2480728|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2370683|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
2370684|NCT00580112|Hormones|hormones|mesh-ancestor
2480729|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
2480730|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480731|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480732|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480733|NCT01113424|Nicotine|nicotine|mesh-list
2480734|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2480735|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
2480736|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480737|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480738|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2480739|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2480740|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
2480741|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480742|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480743|NCT01113437|Omalizumab|omalizumab|mesh-list
2480744|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2480745|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2480746|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
2480747|NCT01113476|Gemcitabine|gemcitabine|mesh-list
2480748|NCT01113476|Paclitaxel|paclitaxel|mesh-list
2480749|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2480750|NCT01113476|Bevacizumab|bevacizumab|mesh-list
2480751|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2480752|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480753|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
2480754|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
2480755|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
2480756|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480757|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2480758|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2480759|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2480760|NCT01113476|Growth Substances|growth substances|mesh-ancestor
2480761|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480762|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
2480763|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2480764|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
2370685|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2370686|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2370687|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370688|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2370689|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
2370690|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370691|NCT00580125|Aripiprazole|aripiprazole|mesh-list
2370692|NCT00580125|Antidepressive Agents|antidepressive agents|mesh-ancestor
2370693|NCT00580125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2370694|NCT00580125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2480765|NCT01113476|Antiviral Agents|antiviral agents|mesh-ancestor
2480766|NCT01113476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480767|NCT01113476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480768|NCT01113476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2480769|NCT01113476|Immunologic Factors|immunologic factors|mesh-ancestor
2480770|NCT01113489|Beclomethasone|beclomethasone|mesh-list
2480771|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2370695|NCT00580125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2370696|NCT00580125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370697|NCT00580125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370698|NCT00580125|Dopamine Agonists|dopamine agonists|mesh-ancestor
2370699|NCT00580125|Dopamine Agents|dopamine agents|mesh-ancestor
2370700|NCT00580125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2370701|NCT00580125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370702|NCT00580125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2370703|NCT00580125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2370704|NCT00580125|Serotonin Agents|serotonin agents|mesh-ancestor
2370705|NCT00580125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2370706|NCT00580125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2370707|NCT00580125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2370708|NCT00580125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2370709|NCT00580190|Alprazolam|alprazolam|mesh-list
2480772|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
2480773|NCT01113489|Hormones|hormones|mesh-ancestor
2480774|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2480775|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480776|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2480777|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
2480778|NCT01113515|Esmolol|esmolol|mesh-list
2480779|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2480780|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2480781|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2480782|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
2480783|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480784|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480785|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480786|NCT01113528|Aspirin|aspirin|mesh-list
2480787|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2480788|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2480789|NCT01113528|Analgesics|analgesics|mesh-ancestor
2480790|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
2480791|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480792|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480793|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2480794|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2480795|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2480796|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2480797|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480798|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2480799|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2370710|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2370711|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370712|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370713|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2370714|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2370715|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2370716|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
2370717|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
2370718|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2370719|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370720|NCT00580216|Biotin|biotin|mesh-list
2370721|NCT00580216|Warfarin|warfarin|mesh-list
2370722|NCT00580216|Idraparinux|idraparinux|mesh-list
2370723|NCT00580216|Idrabiotaparinux|idrabiotaparinux|mesh-list
2370724|NCT00580216|Anticoagulants|anticoagulants|mesh-ancestor
2370725|NCT00580216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2370726|NCT00580216|Antithrombins|antithrombins|mesh-ancestor
2370727|NCT00580216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2370728|NCT00580216|Protease Inhibitors|protease inhibitors|mesh-ancestor
2370729|NCT00580216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370730|NCT00580216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370731|NCT00580216|Vitamin B Complex|vitamin b complex|mesh-ancestor
2370732|NCT00580216|Vitamins|vitamins|mesh-ancestor
2370733|NCT00580216|Micronutrients|micronutrients|mesh-ancestor
2370734|NCT00580216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370735|NCT00580242|Lenalidomide|lenalidomide|mesh-list
2370736|NCT00580242|Bortezomib|bortezomib|mesh-list
2370737|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
2370738|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370739|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2370740|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2370741|NCT00580242|Growth Substances|growth substances|mesh-ancestor
2370742|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
2370743|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370744|NCT00580320|Bortezomib|bortezomib|mesh-list
2370745|NCT00580320|Dacarbazine|dacarbazine|mesh-list
2370746|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370747|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2370748|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
2370749|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370750|NCT00580359|Capecitabine|capecitabine|mesh-list
2370751|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2370752|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
2370753|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370754|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370755|NCT00580424|Norethindrone|norethindrone|mesh-list
2370756|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
2370757|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2370758|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2370759|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2370760|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
2370761|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2480800|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480801|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
2480802|NCT01113593|Formoterol Fumarate|formoterol fumarate|mesh-list
2480803|NCT01113593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2480804|NCT01113593|Autonomic Agents|autonomic agents|mesh-ancestor
2480805|NCT01113593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480806|NCT01113593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480807|NCT01113593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2480808|NCT01113593|Respiratory System Agents|respiratory system agents|mesh-ancestor
2480809|NCT01113593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2113974|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2113975|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113976|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2113977|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2113978|NCT02595749|Oxytocin|oxytocin|mesh-list
2113979|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
2113980|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2113981|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2113982|NCT02596022|Ketamine|ketamine|mesh-list
2113983|NCT02596022|Analgesics|analgesics|mesh-ancestor
2113984|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
2113985|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113986|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370762|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370763|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2370764|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2370765|NCT00580437|Dobutamine|dobutamine|mesh-list
2370766|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2480810|NCT01113593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2480811|NCT01113593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2480812|NCT01113593|Adrenergic Agents|adrenergic agents|mesh-ancestor
2480813|NCT01113593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480814|NCT01113593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480815|NCT01113671|Vitamin E|vitamin e|mesh-list
2480816|NCT01113671|Tocopherols|tocopherols|mesh-list
2480817|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
2480818|NCT01113671|Vitamins|vitamins|mesh-ancestor
2480819|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
2370767|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
2370768|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
2370769|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370770|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370771|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2370772|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2370773|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2370774|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
2370775|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480820|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480821|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
2480822|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480823|NCT01113671|Protective Agents|protective agents|mesh-ancestor
2480824|NCT01113762|Cimetidine|cimetidine|mesh-list
2480825|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2480826|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2480827|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2480828|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
2480829|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
2480830|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480831|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480832|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480833|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2480834|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2480835|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480836|NCT01113957|Doxorubicin|doxorubicin|mesh-list
2480837|NCT01113957|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2480838|NCT01113957|Temozolomide|temozolomide|mesh-list
2480839|NCT01113957|Veliparib|veliparib|mesh-list
2480840|NCT01113957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2480841|NCT01113957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480842|NCT01113957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2480843|NCT01113957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2480844|NCT01113957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480845|NCT01113957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480846|NCT01113957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2480847|NCT01113957|Alkylating Agents|alkylating agents|mesh-ancestor
2480848|NCT01113957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2480849|NCT01114048|Thalidomide|thalidomide|mesh-list
2480850|NCT01114048|Dexamethasone|dexamethasone|mesh-list
2480851|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
2480852|NCT01114048|Bortezomib|bortezomib|mesh-list
2480853|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2480854|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
2480855|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480856|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2480857|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2480858|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
2480859|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480860|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480861|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2480862|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2480863|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
2480864|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
2480865|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480866|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2480867|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
2480868|NCT01114048|Hormones|hormones|mesh-ancestor
2480869|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2480870|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2480871|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
2480872|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2480873|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480874|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2480875|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2480876|NCT01114048|Growth Substances|growth substances|mesh-ancestor
2480877|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
2480878|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
2480879|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480880|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2480881|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480882|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480883|NCT01114100|Sertraline|sertraline|mesh-list
2480884|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
2480885|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2480886|NCT01114100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2480887|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2480888|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2480889|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480890|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480891|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
2370776|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370777|NCT00580437|Protective Agents|protective agents|mesh-ancestor
2370778|NCT00580450|Thymalfasin|thymalfasin|mesh-list
2370779|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2370780|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
2370781|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370782|NCT00580489|Fentanyl|fentanyl|mesh-list
2370783|NCT00580489|Morphine|morphine|mesh-list
2370784|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2370785|NCT00580489|Narcotics|narcotics|mesh-ancestor
2370786|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370787|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370788|NCT00580489|Analgesics|analgesics|mesh-ancestor
2370789|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
2370790|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370791|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2370792|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2370793|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
2370794|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
2370795|NCT00580619|Methyldopa|methyldopa|mesh-list
2370796|NCT00580619|Trimethaphan|trimethaphan|mesh-list
2370797|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
2370798|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370799|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2370800|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
2370801|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
2480892|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480893|NCT01114191|Ketoconazole|ketoconazole|mesh-list
2480894|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
2480895|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370802|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2113987|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2113988|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2113989|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
2113990|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
2113991|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2113992|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2113993|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2113994|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2113995|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2113996|NCT02596035|Nivolumab|nivolumab|mesh-list
2370803|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370804|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2370805|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2370806|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2370807|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
2370808|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2370809|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2370810|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2370811|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2480896|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2480897|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2480898|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480899|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480900|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2480901|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
2480902|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2480903|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480904|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2480905|NCT01114282|Bortezomib|bortezomib|mesh-list
2480906|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480907|NCT01114308|Buprenorphine|buprenorphine|mesh-list
2480908|NCT01114308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2480909|NCT01114308|Narcotics|narcotics|mesh-ancestor
2480910|NCT01114308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480911|NCT01114308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480912|NCT01114308|Analgesics|analgesics|mesh-ancestor
2480913|NCT01114308|Sensory System Agents|sensory system agents|mesh-ancestor
2480914|NCT01114308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480915|NCT01114308|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2480916|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
2480917|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2480918|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2480919|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2480920|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
2480921|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480922|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2480923|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2480924|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370812|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2370813|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
2370814|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
2370815|NCT00580814|Methylphenidate|methylphenidate|mesh-list
2370816|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2370817|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370818|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2370819|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2370820|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2370821|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370822|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
2480925|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480926|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2480927|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2480928|NCT01114490|Anacetrapib|anacetrapib|mesh-list
2480929|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2480930|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2480931|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
2480932|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480933|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2480934|NCT01114542|Insulin|insulin|mesh-list
2480935|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2480936|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
2480937|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2480938|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480939|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
2480940|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2370823|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2370824|NCT00580827|Disulfiram|disulfiram|mesh-list
2370825|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2370826|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2370827|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370828|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370829|NCT00580905|Adenosine|adenosine|mesh-list
2370830|NCT00580905|Nitroprusside|nitroprusside|mesh-list
2480941|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480942|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2480943|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480944|NCT01114698|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2480945|NCT01114698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2480946|NCT01114698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2480947|NCT01114698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2480948|NCT01114698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480949|NCT01114698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480950|NCT01114698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480951|NCT01114698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2480952|NCT01114698|Antidepressive Agents|antidepressive agents|mesh-ancestor
2480953|NCT01114698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2480954|NCT01114750|Dextrans|dextrans|mesh-list
2480955|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
2480956|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
2480957|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
2480958|NCT01114841|Tazarotene|tazarotene|mesh-list
2480959|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
2480960|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
2480961|NCT01114854|Topiramate|topiramate|mesh-list
2370831|NCT00580905|Analgesics|analgesics|mesh-ancestor
2370832|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
2370833|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370834|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370835|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2480962|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
2480963|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2480964|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480965|NCT01114958|Cisplatin|cisplatin|mesh-list
2480966|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480967|NCT01115036|Panobinostat|panobinostat|mesh-list
2480968|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2480969|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2480970|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2480971|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480972|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
2480973|NCT01115049|Hexetidine|hexetidine|mesh-list
2480974|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2480975|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2480976|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
2480977|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
2480978|NCT01115062|Lidocaine|lidocaine|mesh-list
2480979|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
2480980|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
2370836|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
2370837|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2370838|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
2370839|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
2370840|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2480981|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480982|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480983|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
2480984|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2480985|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2480986|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2480987|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2480988|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2480989|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480990|NCT01115127|Inositol|inositol|mesh-list
2480991|NCT01115127|Melatonin|melatonin|mesh-list
2480992|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
2480993|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2480994|NCT01115127|Protective Agents|protective agents|mesh-ancestor
2370841|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370842|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2370843|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2370844|NCT00580931|Niacinamide|niacinamide|mesh-list
2370845|NCT00580931|Niacin|niacin|mesh-list
2370846|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
2370847|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
2370848|NCT00580931|Vitamins|vitamins|mesh-ancestor
2370849|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
2370850|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480995|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2480996|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2480997|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
2370851|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2370852|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
2370853|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370854|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2370855|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
2370856|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
2370857|NCT00581009|Sertraline|sertraline|mesh-list
2370858|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
2370859|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2370860|NCT00581009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2370861|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2370862|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2370863|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370864|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2370865|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
2370866|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370867|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370868|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
2370869|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2370870|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370871|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2480998|NCT01115127|Vitamins|vitamins|mesh-ancestor
2480999|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
2481000|NCT01115140|Folic Acid|folic acid|mesh-list
2481001|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
2481002|NCT01115140|Metformin|metformin|mesh-list
2481003|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2481004|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370872|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
2370873|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370874|NCT00581139|Midazolam|midazolam|mesh-list
2370875|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
2370876|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370877|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370878|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2370879|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2370880|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2370881|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2481005|NCT01115140|Hematinics|hematinics|mesh-ancestor
2481006|NCT01115140|Vitamins|vitamins|mesh-ancestor
2481007|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
2481008|NCT01115179|Propofol|propofol|mesh-list
2481009|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2481010|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2481011|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481012|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481013|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2481014|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
2481015|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
2481016|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2370882|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2370883|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2370884|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
2370885|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
2370886|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
2370887|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2370888|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370889|NCT00581165|Etanercept|etanercept|mesh-list
2370890|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2370891|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2370892|NCT00581165|Analgesics|analgesics|mesh-ancestor
2370893|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
2481017|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2481018|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2370894|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370895|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370896|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2370897|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2370898|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2370899|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2370900|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
2370901|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2370902|NCT00581217|Laxatives|laxatives|mesh-ancestor
2370903|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2370904|NCT00581425|Interferons|interferons|mesh-list
2370905|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
2370906|NCT00581425|Imiquimod|imiquimod|mesh-list
2370907|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481019|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
2481020|NCT01115322|Tazarotene|tazarotene|mesh-list
2481021|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
2481022|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
2481023|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
2481024|NCT01115322|Vitamins|vitamins|mesh-ancestor
2481025|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
2481026|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481027|NCT01115426|Losartan|losartan|mesh-list
2481028|NCT01115426|Ramipril|ramipril|mesh-list
2481029|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2481030|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2481031|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2481032|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2481033|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481034|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2481035|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
2481036|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481037|NCT01115439|Artesunate|artesunate|mesh-list
2481038|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
2481039|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
2481040|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2481041|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
2481042|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2481043|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2481044|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2481045|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481046|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
2481047|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
2481048|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2481049|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
2481050|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2481051|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481052|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481053|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2481054|NCT01115439|Renal Agents|renal agents|mesh-ancestor
2481055|NCT01115478|Vitamin A|vitamin a|mesh-list
2481056|NCT01115478|Vitamins|vitamins|mesh-ancestor
2481057|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
2481058|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481059|NCT01115504|Thiamine|thiamine|mesh-list
2481060|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
2481061|NCT01115504|Vitamins|vitamins|mesh-ancestor
2481062|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
2481063|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481064|NCT01115543|Calcitriol|calcitriol|mesh-list
2481065|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
2481066|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2481067|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2481068|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481069|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2481070|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2370908|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
2370909|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2370910|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
2481071|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481072|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2481073|NCT01115543|Vitamins|vitamins|mesh-ancestor
2481074|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
2481075|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2481076|NCT01115712|Pioglitazone|pioglitazone|mesh-list
2481077|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2481078|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481079|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2481080|NCT01115725|Hormones|hormones|mesh-ancestor
2370911|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481081|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2481082|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481083|NCT01115842|Vitamin D|vitamin d|mesh-list
2481084|NCT01115842|Vitamins|vitamins|mesh-ancestor
2370912|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2370913|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
2370914|NCT00581477|Methyldopa|methyldopa|mesh-list
2370915|NCT00581477|Levodopa|levodopa|mesh-list
2370916|NCT00581477|Carbidopa|carbidopa|mesh-list
2370917|NCT00581477|Droxidopa|droxidopa|mesh-list
2370918|NCT00581477|Metoclopramide|metoclopramide|mesh-list
2370919|NCT00581477|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2370920|NCT00581477|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
2370921|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2370922|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2370923|NCT00581477|Dopamine Agents|dopamine agents|mesh-ancestor
2370924|NCT00581477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2370925|NCT00581477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370926|NCT00581477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370927|NCT00581477|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2370928|NCT00581477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2370929|NCT00581477|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2481085|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
2481086|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481087|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2481088|NCT01115894|Naltrexone|naltrexone|mesh-list
2481089|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2481090|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2481091|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481092|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
2481093|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481094|NCT01115946|Enalapril|enalapril|mesh-list
2481095|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2481096|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
2481097|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481098|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481099|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2481100|NCT01115959|Valproic Acid|valproic acid|mesh-list
2481101|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
2481102|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481103|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481104|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
2481105|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481106|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481107|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
2481108|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2481109|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481110|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2481111|NCT01115972|Valsartan|valsartan|mesh-list
2481112|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2481113|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2481114|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2481115|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481116|NCT01115985|Atorvastatin|atorvastatin|mesh-list
2481117|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2481118|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2481119|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
2481120|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481121|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2481122|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2370930|NCT00581477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2370931|NCT00581477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2370932|NCT00581477|Adrenergic Agents|adrenergic agents|mesh-ancestor
2370933|NCT00581477|Antiemetics|antiemetics|mesh-ancestor
2370934|NCT00581477|Autonomic Agents|autonomic agents|mesh-ancestor
2370935|NCT00581477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370936|NCT00581477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2370937|NCT00581477|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2370938|NCT00581477|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2370939|NCT00581477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2370940|NCT00581477|Sympatholytics|sympatholytics|mesh-ancestor
2370941|NCT00581477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2370942|NCT00581477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2370943|NCT00581477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2370944|NCT00581607|Bosentan|bosentan|mesh-list
2370945|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2370946|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2370947|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370948|NCT00581685|Celecoxib|celecoxib|mesh-list
2370949|NCT00581685|Pregabalin|pregabalin|mesh-list
2370950|NCT00581685|Analgesics|analgesics|mesh-ancestor
2370951|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
2370952|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2370953|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370954|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
2370955|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2370956|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2370957|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370958|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2370959|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2370960|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2370961|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370962|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2481123|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481124|NCT01116050|Misoprostol|misoprostol|mesh-list
2481125|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2481126|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
2481127|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2481128|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481129|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2481130|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2481131|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
2481132|NCT01116063|Iloprost|iloprost|mesh-list
2481133|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2481134|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
2481135|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
2481136|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481137|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481138|NCT01116128|Prednisone|prednisone|mesh-list
2481139|NCT01116128|Melphalan|melphalan|mesh-list
2481140|NCT01116128|Dasatinib|dasatinib|mesh-list
2481141|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2481142|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
2481143|NCT01116128|Hormones|hormones|mesh-ancestor
2481144|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2481145|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481146|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2481147|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481148|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2481149|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
2481150|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481151|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2481152|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2481153|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
2481154|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2481155|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481156|NCT01116141|Folic Acid|folic acid|mesh-list
2481157|NCT01116141|Methotrexate|methotrexate|mesh-list
2481158|NCT01116141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2481159|NCT01116141|Abortifacient Agents|abortifacient agents|mesh-ancestor
2481160|NCT01116141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2481161|NCT01116141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481162|NCT01116141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2481163|NCT01116141|Antimetabolites|antimetabolites|mesh-ancestor
2481164|NCT01116141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481165|NCT01116141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481166|NCT01116141|Dermatologic Agents|dermatologic agents|mesh-ancestor
2481167|NCT01116141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481168|NCT01116141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2481169|NCT01116141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2481170|NCT01116141|Immunologic Factors|immunologic factors|mesh-ancestor
2481171|NCT01116141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2481172|NCT01116141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2481173|NCT01116141|Hematinics|hematinics|mesh-ancestor
2481174|NCT01116141|Vitamin B Complex|vitamin b complex|mesh-ancestor
2481175|NCT01116141|Vitamins|vitamins|mesh-ancestor
2481176|NCT01116141|Micronutrients|micronutrients|mesh-ancestor
2481177|NCT01116154|Lenalidomide|lenalidomide|mesh-list
2481178|NCT01116154|Vorinostat|vorinostat|mesh-list
2113997|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2113998|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2113999|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2481179|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
2481180|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481181|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2481182|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2481183|NCT01116154|Growth Substances|growth substances|mesh-ancestor
2481184|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
2481185|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481186|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2481187|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481188|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481189|NCT01116167|Letrozole|letrozole|mesh-list
2481190|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481191|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2481192|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2481193|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481194|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481195|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2481196|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
2481197|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2481198|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481199|NCT01116180|Candesartan|candesartan|mesh-list
2481200|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
2481201|NCT01116180|Giapreza|giapreza|mesh-list
2481202|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2481203|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
2481204|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2370963|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2370964|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2370965|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2370966|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2481205|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2481206|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481207|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2481208|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2481209|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
2481210|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481211|NCT01116193|Dexamethasone|dexamethasone|mesh-list
2481212|NCT01116193|Lenalidomide|lenalidomide|mesh-list
2481213|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2481214|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
2481215|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
2481216|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481217|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481218|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2481219|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
2481220|NCT01116193|Hormones|hormones|mesh-ancestor
2481221|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2481222|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2481223|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481224|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
2481225|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2481226|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2481227|NCT01116193|Growth Substances|growth substances|mesh-ancestor
2481228|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
2481229|NCT01116206|Prucalopride|prucalopride|mesh-list
2481230|NCT01116206|Laxatives|laxatives|mesh-ancestor
2481231|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2481232|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2481233|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2481234|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
2481235|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481236|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481237|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481238|NCT01116219|Bevacizumab|bevacizumab|mesh-list
2481239|NCT01116219|Pemetrexed|pemetrexed|mesh-list
2481240|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2481241|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2481242|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481243|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2481244|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2481245|NCT01116219|Growth Substances|growth substances|mesh-ancestor
2481246|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481247|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
2481248|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481249|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481250|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2481251|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2481252|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2481253|NCT01116271|Irinotecan|irinotecan|mesh-list
2481254|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2481255|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2370967|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2370968|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2370969|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481256|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481257|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481258|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481259|NCT01116310|Glycine|glycine|mesh-list
2481260|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
2481261|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481262|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481263|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481264|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2481265|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481266|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2481267|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481268|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481269|NCT01116388|Caseins|caseins|mesh-list
2481270|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
2481271|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
2481272|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481273|NCT01116531|Pregabalin|pregabalin|mesh-list
2481274|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2481275|NCT01116531|Tramadol|tramadol|mesh-list
2481276|NCT01116531|Analgesics|analgesics|mesh-ancestor
2481277|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
2481278|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481279|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481280|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
2481281|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2481282|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2481283|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481284|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2481285|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2481286|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2481287|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481288|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2481289|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2481290|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2481291|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481292|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
2481293|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
2481294|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2481295|NCT01116531|Narcotics|narcotics|mesh-ancestor
2481296|NCT01116583|Gabapentin|gabapentin|mesh-list
2481297|NCT01116583|Analgesics|analgesics|mesh-ancestor
2481298|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
2481299|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481300|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481301|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
2481302|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2481303|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2481304|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481305|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2481306|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2481307|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2481308|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481309|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481310|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
2481311|NCT01116596|Acetaminophen|acetaminophen|mesh-list
2481312|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2481313|NCT01116596|Analgesics|analgesics|mesh-ancestor
2481314|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
2481315|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481316|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481317|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
2481318|NCT01116609|Epinephrine|epinephrine|mesh-list
2481319|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2481320|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2481321|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
2481322|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481323|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481324|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481325|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2481326|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2481327|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
2481328|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481329|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2481330|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
2481331|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
2481332|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
2370970|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2370971|NCT00581789|Sunitinib|sunitinib|mesh-list
2370972|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370973|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2370974|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481333|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2481334|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2481335|NCT01116622|Bexarotene|bexarotene|mesh-list
2481336|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481337|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2481338|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481339|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481340|NCT01116635|Doxorubicin|doxorubicin|mesh-list
2481341|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2481342|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481343|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2481344|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2481345|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481346|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481347|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
2481348|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2481349|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481350|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481351|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2481352|NCT01116700|Analgesics|analgesics|mesh-ancestor
2481353|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
2481354|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481355|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2481356|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2481357|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2481358|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
2481359|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481360|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481361|NCT01116713|Dexamethasone|dexamethasone|mesh-list
2481362|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2370975|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370976|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2370977|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2370978|NCT00581789|Growth Substances|growth substances|mesh-ancestor
2370979|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370980|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
2370981|NCT00582582|Vitamin D|vitamin d|mesh-list
2370982|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2370983|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2370984|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
2481363|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
2481364|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
2481365|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481366|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481367|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2481368|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
2481369|NCT01116713|Hormones|hormones|mesh-ancestor
2481370|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2481371|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2481372|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481373|NCT01116791|Cisplatin|cisplatin|mesh-list
2481374|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481375|NCT01116817|Ritonavir|ritonavir|mesh-list
2481376|NCT01116817|Lopinavir|lopinavir|mesh-list
2481377|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2114000|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114001|NCT02596451|Diclofenac|diclofenac|mesh-list
2114002|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2114003|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2114004|NCT02596451|Analgesics|analgesics|mesh-ancestor
2114005|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
2114006|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114007|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114008|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2114009|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2114010|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2114011|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114012|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114013|NCT02596620|Amoxicillin|amoxicillin|mesh-list
2114014|NCT02596620|Metronidazole|metronidazole|mesh-list
2114015|NCT02596620|Levofloxacin|levofloxacin|mesh-list
2114016|NCT02596620|Esomeprazole|esomeprazole|mesh-list
2114017|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2114018|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114019|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2114020|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2114021|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2114022|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2370985|NCT00582582|Docetaxel|docetaxel|mesh-list
2481378|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2481379|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
2481380|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481381|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481382|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2481383|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2481384|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
2481385|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2481386|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2481387|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2481388|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
2481389|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2481390|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2370986|NCT00582582|Vitamins|vitamins|mesh-ancestor
2370987|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
2370988|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2370989|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2370990|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
2370991|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
2370992|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
2370993|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2370994|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2370995|NCT00582634|Docetaxel|docetaxel|mesh-list
2370996|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481391|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481392|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2481393|NCT01117038|Amlodipine|amlodipine|mesh-list
2481394|NCT01117038|Enalapril|enalapril|mesh-list
2481395|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2481396|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2481397|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2481398|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481399|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2481400|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481401|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
2481402|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2481403|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
2481404|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481405|NCT01117116|Fluticasone|fluticasone|mesh-list
2370997|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
2370998|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
2370999|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
2371000|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371001|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
2481406|NCT01117116|Xhance|xhance|mesh-list
2481407|NCT01117116|Budesonide|budesonide|mesh-list
2481408|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
2481409|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2481410|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2481411|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2371002|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2371003|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371004|NCT00582985|Antibodies|antibodies|mesh-list
2371005|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
2371006|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371007|NCT00583063|Sirolimus|sirolimus|mesh-list
2371008|NCT00583063|Sunitinib|sunitinib|mesh-list
2371009|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481412|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
2481413|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481414|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481415|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2481416|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
2481417|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
2481418|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2481419|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
2481420|NCT01117116|Hormones|hormones|mesh-ancestor
2481421|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2481422|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2481423|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2481424|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2481425|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
2481426|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481427|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481428|NCT01117129|Rituximab|rituximab|mesh-list
2481429|NCT01117129|Methotrexate|methotrexate|mesh-list
2481430|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2481431|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371010|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2371011|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2371012|NCT00583063|Growth Substances|growth substances|mesh-ancestor
2371013|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371014|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
2371015|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2371016|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371017|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481432|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
2481433|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481434|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2481435|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2481436|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
2481437|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2371018|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2371019|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2371020|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2371021|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
2371022|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2371023|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
2371024|NCT00583180|Capsaicin|capsaicin|mesh-list
2371025|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
2371026|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
2371027|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
2371028|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371029|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371030|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2371031|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2371032|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2371033|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2371034|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371035|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371036|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371037|NCT00583193|Analgesics|analgesics|mesh-ancestor
2371038|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
2371039|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371040|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
2371041|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2371042|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
2371043|NCT00583258|Alfuzosin|alfuzosin|mesh-list
2371044|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2371045|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2371046|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2371047|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
2371048|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481438|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2481439|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
2481440|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481441|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
2481442|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481443|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2481444|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2481445|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2481446|NCT01117220|Ziprasidone|ziprasidone|mesh-list
2481447|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2481448|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
2481449|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481450|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481451|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481452|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2481453|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2481454|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481455|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2481456|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2481457|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
2481458|NCT01117298|Tadalafil|tadalafil|mesh-list
2481459|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
2481460|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2481461|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2481462|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481463|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481464|NCT01117298|Urological Agents|urological agents|mesh-ancestor
2481465|NCT01117376|Erythromycin|erythromycin|mesh-list
2481466|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
2481467|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2371049|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371050|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371051|NCT00583258|Urological Agents|urological agents|mesh-ancestor
2481468|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
2481469|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
2481470|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2481471|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2481472|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2481473|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2481474|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481475|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481476|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2481477|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481478|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
2481479|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481480|NCT01117441|Cytarabine|cytarabine|mesh-list
2481481|NCT01117441|Dexamethasone|dexamethasone|mesh-list
2481482|NCT01117441|Prednisone|prednisone|mesh-list
2481483|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
2481484|NCT01117441|Ifosfamide|ifosfamide|mesh-list
2481485|NCT01117441|Doxorubicin|doxorubicin|mesh-list
2481486|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2481487|NCT01117441|Methotrexate|methotrexate|mesh-list
2371052|NCT00583271|Triamcinolone|triamcinolone|mesh-list
2371053|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2371054|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
2371055|NCT00583271|Hormones|hormones|mesh-ancestor
2371056|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371057|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371058|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
2371059|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2371060|NCT00583349|Paclitaxel|paclitaxel|mesh-list
2371061|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2371062|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371063|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
2371064|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
2371065|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
2481488|NCT01117441|Fludarabine|fludarabine|mesh-list
2481489|NCT01117441|Etoposide|etoposide|mesh-list
2371066|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371067|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
2371068|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
2481490|NCT01117441|Vincristine|vincristine|mesh-list
2481491|NCT01117441|Daunorubicin|daunorubicin|mesh-list
2481492|NCT01117441|Asparaginase|asparaginase|mesh-list
2481493|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
2481494|NCT01117441|Thioguanine|thioguanine|mesh-list
2481495|NCT01117441|Pegaspargase|pegaspargase|mesh-list
2481496|NCT01117441|Vindesine|vindesine|mesh-list
2481497|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2481498|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
2481499|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481500|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2481501|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2371069|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2371070|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
2371071|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371072|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2371073|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2371074|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2371075|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2371076|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371077|NCT00583518|Hormones|hormones|mesh-list
2371078|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
2371079|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371080|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371081|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2371082|NCT00583609|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2481502|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
2481503|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481504|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481505|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2481506|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2481507|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
2481508|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
2481509|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481510|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2481511|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
2481512|NCT01117441|Hormones|hormones|mesh-ancestor
2481513|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2481514|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2371083|NCT00583609|Laxatives|laxatives|mesh-ancestor
2371084|NCT00583609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2371085|NCT00583674|Cisplatin|cisplatin|mesh-list
2371086|NCT00583674|Capecitabine|capecitabine|mesh-list
2371087|NCT00583674|Trebananib|trebananib|mesh-list
2371088|NCT00583674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371089|NCT00583674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2371090|NCT00583674|Antimetabolites|antimetabolites|mesh-ancestor
2371091|NCT00583674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371092|NCT00583674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2371093|NCT00583674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2371094|NCT00583674|Growth Substances|growth substances|mesh-ancestor
2371095|NCT00583674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371096|NCT00583674|Growth Inhibitors|growth inhibitors|mesh-ancestor
2371097|NCT00583778|Ipratropium|ipratropium|mesh-list
2371098|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2371099|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
2371100|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371101|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371102|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2371103|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
2371104|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2371105|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
2481515|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2481516|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2481517|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2481518|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481519|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2481520|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
2481521|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2481522|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2481523|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
2481524|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
2481525|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2481526|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2481527|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2481528|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
2371106|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371107|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481529|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2481530|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
2481531|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
2481532|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
2481533|NCT01117584|Metformin|metformin|mesh-list
2481534|NCT01117584|Ipragliflozin|ipragliflozin|mesh-list
2481535|NCT01117584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2481536|NCT01117584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481537|NCT01117584|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2481538|NCT01117584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481539|NCT01117610|Ropivacaine|ropivacaine|mesh-list
2481540|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
2481541|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
2481542|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481543|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481544|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
2481545|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481546|NCT01117636|Aspirin|aspirin|mesh-list
2481547|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2481548|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2481549|NCT01117636|Analgesics|analgesics|mesh-ancestor
2481550|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
2481551|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481552|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481553|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2481554|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2481555|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2481556|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2481557|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481558|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2481559|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2481560|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481561|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
2481562|NCT01117662|Rituximab|rituximab|mesh-list
2371108|NCT00583830|Paclitaxel|paclitaxel|mesh-list
2371109|NCT00583830|Carboplatin|carboplatin|mesh-list
2371110|NCT00583830|Mapatumumab|mapatumumab|mesh-list
2371111|NCT00583830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2371112|NCT00583830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2371113|NCT00583830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371114|NCT00583830|Tubulin Modulators|tubulin modulators|mesh-ancestor
2371115|NCT00583830|Antimitotic Agents|antimitotic agents|mesh-ancestor
2371116|NCT00583830|Mitosis Modulators|mitosis modulators|mesh-ancestor
2371117|NCT00583830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371118|NCT00583830|Immunologic Factors|immunologic factors|mesh-ancestor
2371119|NCT00583830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371120|NCT00583869|Pregabalin|pregabalin|mesh-list
2371121|NCT00583869|Analgesics|analgesics|mesh-ancestor
2371122|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
2371123|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371124|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371125|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
2371126|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2371127|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2371128|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371129|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2371130|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2371131|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2371132|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2371133|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2371134|NCT00583986|Albuterol|albuterol|mesh-list
2371135|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2371136|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
2371137|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371138|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371139|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2371140|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
2371141|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
2371142|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2371143|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2371144|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2371145|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2371146|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
2371147|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481563|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2481564|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481565|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
2481566|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481567|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2481568|NCT01118039|Sunitinib|sunitinib|mesh-list
2481569|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481570|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2481571|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2481572|NCT01118039|Growth Substances|growth substances|mesh-ancestor
2481573|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481574|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
2481575|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2481576|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481577|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481578|NCT01118065|Everolimus|everolimus|mesh-list
2481579|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481580|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2481581|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
2481582|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481583|NCT01118234|Rituximab|rituximab|mesh-list
2481584|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2481585|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481586|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
2481587|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481588|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2481589|NCT01118260|Anesthetics|anesthetics|mesh-list
2481590|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481591|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481592|NCT01118286|Nifedipine|nifedipine|mesh-list
2481593|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2481594|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2481595|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481596|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2481597|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481598|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
2481599|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
2481600|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2481601|NCT01118403|Ampicillin|ampicillin|mesh-list
2481602|NCT01118403|Sulbactam|sulbactam|mesh-list
2481603|NCT01118403|Sultamicillin|sultamicillin|mesh-list
2481604|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2481605|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2481606|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2481607|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481608|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481609|NCT01118429|Oxybutynin|oxybutynin|mesh-list
2481610|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
2481611|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
2481612|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481613|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481614|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2481615|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2481616|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
2481617|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481618|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481619|NCT01118429|Urological Agents|urological agents|mesh-ancestor
2481620|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
2481621|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
2481622|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
2481623|NCT01118559|Darexaban|darexaban|mesh-list
2481624|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2481625|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
2481626|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2481627|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
2481628|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481629|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481630|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
2481631|NCT01118572|Celecoxib|celecoxib|mesh-list
2481632|NCT01118572|Etodolac|etodolac|mesh-list
2481633|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2481634|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2481635|NCT01118572|Analgesics|analgesics|mesh-ancestor
2481636|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
2481637|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481638|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371148|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371149|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
2371150|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2371151|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2481639|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2481640|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2481641|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2481642|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2481643|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481644|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481645|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
2481646|NCT01118598|Niacin|niacin|mesh-list
2481647|NCT01118598|Niacinamide|niacinamide|mesh-list
2481648|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
2481649|NCT01118598|Vitamins|vitamins|mesh-ancestor
2481650|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
2481651|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481652|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2481653|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
2481654|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481655|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2481656|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
2481657|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2481658|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2481659|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481660|NCT01118702|Methylphenidate|methylphenidate|mesh-list
2481661|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2481662|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481663|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2481664|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2481665|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2481666|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481667|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
2481668|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481669|NCT01118793|Clopidogrel|clopidogrel|mesh-list
2481670|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2481671|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2481672|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2481673|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2481674|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
2481675|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481676|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481677|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481678|NCT01118871|Ritonavir|ritonavir|mesh-list
2481679|NCT01118871|Darunavir|darunavir|mesh-list
2481680|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2481681|NCT01118871|Etravirine|etravirine|mesh-list
2481682|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2481683|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2481684|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
2481685|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481686|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481687|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2481688|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2481689|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
2481690|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2481691|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2481692|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2481693|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2371152|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
2371153|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371154|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371155|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371156|NCT00584090|Urological Agents|urological agents|mesh-ancestor
2371157|NCT00584155|Ofloxacin|ofloxacin|mesh-list
2371158|NCT00584155|Levofloxacin|levofloxacin|mesh-list
2371159|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2371160|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2371161|NCT00584155|Renal Agents|renal agents|mesh-ancestor
2371162|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2371163|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2371164|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2371165|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371166|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371167|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371168|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2371169|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2371170|NCT00584168|Dexamethasone|dexamethasone|mesh-list
2371171|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2371172|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
2371173|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
2371174|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371175|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371176|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2371177|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
2371178|NCT00584168|Hormones|hormones|mesh-ancestor
2371179|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371180|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2371181|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371182|NCT00584298|Octreotide|octreotide|mesh-list
2371183|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2371184|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2371185|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371186|NCT00584376|Pregabalin|pregabalin|mesh-list
2371187|NCT00584376|Analgesics|analgesics|mesh-ancestor
2481694|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2481695|NCT01118884|Promethazine|promethazine|mesh-list
2481696|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
2481697|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
2481698|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
2481699|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2481700|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
2481701|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
2481702|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481703|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481704|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481705|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2481706|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2481707|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2481708|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481709|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
2481710|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
2481711|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
2481712|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481713|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
2371188|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
2371189|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371190|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371191|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
2371192|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2371193|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2371194|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371195|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2371196|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2371197|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2371198|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2371199|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2371200|NCT00584389|Rimonabant|rimonabant|mesh-list
2371201|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2371202|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2481714|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
2481715|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2481716|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
2481717|NCT01118923|Antacids|antacids|mesh-ancestor
2481718|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481719|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2481720|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
2481721|NCT01118936|Antacids|antacids|mesh-ancestor
2481722|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481723|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2481724|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2481725|NCT01119014|Aripiprazole|aripiprazole|mesh-list
2481726|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
2481727|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2481728|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2481729|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2371203|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2481730|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481731|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481732|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
2481733|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
2481734|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481735|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481736|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2481737|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2481738|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
2481739|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2371204|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371205|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371206|NCT00584389|Hormones|hormones|mesh-ancestor
2371207|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371208|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481740|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2481741|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2481742|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2481743|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
2481744|NCT01119066|Melphalan|melphalan|mesh-list
2481745|NCT01119066|Busulfan|busulfan|mesh-list
2481746|NCT01119066|Thiotepa|thiotepa|mesh-list
2481747|NCT01119066|Fludarabine|fludarabine|mesh-list
2481748|NCT01119066|Clofarabine|clofarabine|mesh-list
2481749|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2481750|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
2481751|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481752|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2481753|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2481754|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
2481755|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481756|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481757|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2481758|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2481759|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
2481760|NCT01119079|Anesthetics|anesthetics|mesh-list
2481761|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481762|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481763|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
2481764|NCT01119144|Calcium|calcium|mesh-list
2481765|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2481766|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481767|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2481768|NCT01119157|Vaccines|vaccines|mesh-list
2481769|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
2481770|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371209|NCT00584493|Tremelimumab|tremelimumab|mesh-list
2371210|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371211|NCT00584532|Genistein|genistein|mesh-list
2371212|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2371213|NCT00584532|Protective Agents|protective agents|mesh-ancestor
2371214|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371215|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371216|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2371217|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371218|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371219|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
2371220|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2371221|NCT00584532|Estrogens|estrogens|mesh-ancestor
2371222|NCT00584532|Hormones|hormones|mesh-ancestor
2371223|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371224|NCT00584571|Dexetimide|dexetimide|mesh-list
2371225|NCT00584571|Citalopram|citalopram|mesh-list
2371226|NCT00584571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2371227|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2371228|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2371229|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371230|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371231|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
2481771|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
2481772|NCT01119196|Icodextrin|icodextrin|mesh-list
2481773|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2481774|NCT01119209|Ropivacaine|ropivacaine|mesh-list
2481775|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
2481776|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
2481777|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481778|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481779|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
2481780|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481781|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
2481782|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2481783|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2481784|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481785|NCT01119430|Fluoxetine|fluoxetine|mesh-list
2481786|NCT01119430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2481787|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2481788|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2481789|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481790|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481791|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
2481792|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481793|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2481794|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
2481795|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2481796|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2481797|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2481798|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481799|NCT01119482|Vaccines|vaccines|mesh-list
2481800|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
2481801|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481802|NCT01119521|Isoniazid|isoniazid|mesh-list
2481803|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
2481804|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2481805|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2481806|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2481807|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2481808|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
2481809|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481810|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2481811|NCT01119534|Camphor|camphor|mesh-list
2481812|NCT01119534|Eucalyptol|eucalyptol|mesh-list
2481813|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
2481814|NCT01119534|Menthol|menthol|mesh-list
2481815|NCT01119534|Guaifenesin|guaifenesin|mesh-list
2481816|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2481817|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
2481818|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
2481819|NCT01119534|Expectorants|expectorants|mesh-ancestor
2481820|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
2371232|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371233|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2371234|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
2371235|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2371236|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2371237|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2371238|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
2371239|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
2371240|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371241|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2371242|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2371243|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
2481821|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2481822|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2481823|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
2481824|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481825|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481826|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481827|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
2481828|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2481829|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
2481830|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
2481831|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481832|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
2481833|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2481834|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2481835|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2481836|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
2481837|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
2371244|NCT00584610|Copper|copper|mesh-list
2371245|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
2371246|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2371247|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
2371248|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2371249|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371250|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2371251|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2481838|NCT01119534|Protective Agents|protective agents|mesh-ancestor
2481839|NCT01119599|Temozolomide|temozolomide|mesh-list
2481840|NCT01119599|R04929097|r04929097|mesh-list
2481841|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2481842|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
2481843|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481844|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481845|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481846|NCT01119638|Risperidone|risperidone|mesh-list
2481847|NCT01119638|Citalopram|citalopram|mesh-list
2481848|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2481849|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
2481850|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2481851|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481852|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481853|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2371252|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2371253|NCT00584610|Trace Elements|trace elements|mesh-ancestor
2371254|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
2371255|NCT00584636|Budesonide|budesonide|mesh-list
2371256|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2371257|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2371258|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
2481854|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2481855|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481856|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2481857|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2481858|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
2481859|NCT01119638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2481860|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2481861|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2481862|NCT01119638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2481863|NCT01119638|Antidepressive Agents|antidepressive agents|mesh-ancestor
2481864|NCT01119651|Tazarotene|tazarotene|mesh-list
2481865|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
2481866|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
2481867|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
2481868|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2481869|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
2481870|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481871|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481872|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
2481873|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2481874|NCT01119742|Butenafine|butenafine|mesh-list
2481875|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
2481876|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2481877|NCT01119885|Fentanyl|fentanyl|mesh-list
2481878|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2371259|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371260|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371261|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2371262|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
2371263|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
2371264|NCT00584636|Hormones|hormones|mesh-ancestor
2371265|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2481879|NCT01119885|Narcotics|narcotics|mesh-ancestor
2481880|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2481881|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481882|NCT01119885|Analgesics|analgesics|mesh-ancestor
2481883|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
2481884|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481885|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2481886|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2481887|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
2481888|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
2481889|NCT01120015|Diacetylrhein|diacetylrhein|mesh-list
2481890|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2481891|NCT01120106|Simendan|simendan|mesh-list
2481892|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2481893|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
2481894|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2481895|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2481896|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481897|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481898|NCT01120106|Protective Agents|protective agents|mesh-ancestor
2481899|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481900|NCT01120119|Calcitriol|calcitriol|mesh-list
2481901|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2481902|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481903|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2371266|NCT00584662|Phenylephrine|phenylephrine|mesh-list
2371267|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
2371268|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2371269|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2371270|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
2371271|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371272|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114023|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2114024|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114025|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114026|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2114027|NCT02596620|Renal Agents|renal agents|mesh-ancestor
2114028|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2114029|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2114030|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114031|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2114032|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2114033|NCT02596711|Nicotine|nicotine|mesh-list
2114034|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
2114035|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2114036|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
2114037|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114038|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114039|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2114040|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2371273|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481904|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2481905|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481906|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2481907|NCT01120119|Vitamins|vitamins|mesh-ancestor
2481908|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
2481909|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2481910|NCT01120158|Paclitaxel|paclitaxel|mesh-list
2481911|NCT01120158|Bevacizumab|bevacizumab|mesh-list
2481912|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2481913|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481914|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
2481915|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
2481916|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
2371274|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
2371275|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
2371276|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371277|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
2371278|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2371279|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
2371280|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2371281|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
2371282|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2371283|NCT00584662|Protective Agents|protective agents|mesh-ancestor
2371284|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2481917|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481918|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2481919|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2481920|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2481921|NCT01120158|Growth Substances|growth substances|mesh-ancestor
2481922|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481923|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
2481924|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
2481925|NCT01120171|Doxorubicin|doxorubicin|mesh-list
2481926|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2481927|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2481928|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
2481929|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481930|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2481931|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2481932|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
2481933|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481934|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481935|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2481936|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2481937|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2481938|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2481939|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481940|NCT01120314|Otamixaban|otamixaban|mesh-list
2481941|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2371285|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
2371286|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2371287|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2481942|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
2481943|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2481944|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
2481945|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481946|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481947|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
2481948|NCT01120327|Amlodipine|amlodipine|mesh-list
2481949|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2481950|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2481951|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2481952|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481953|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2481954|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481955|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
2481956|NCT01120340|Mesalamine|mesalamine|mesh-list
2481957|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2481958|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2481959|NCT01120340|Analgesics|analgesics|mesh-ancestor
2481960|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
2481961|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2481962|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481963|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2481964|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2481965|NCT01120366|Methotrexate|methotrexate|mesh-list
2481966|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2481967|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
2481968|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2481969|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481970|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2481971|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
2481972|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481973|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481974|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
2481975|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481976|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2481977|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2481978|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
2481979|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2481980|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2481981|NCT01120418|Besifloxacin|besifloxacin|mesh-list
2481982|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2481983|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2481984|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2481985|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2481986|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2481987|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2481988|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2481989|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2481990|NCT01120444|Insulin|insulin|mesh-list
2481991|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2481992|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481993|NCT01120470|Prednisone|prednisone|mesh-list
2481994|NCT01120470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2481995|NCT01120470|Glucocorticoids|glucocorticoids|mesh-ancestor
2481996|NCT01120470|Hormones|hormones|mesh-ancestor
2481997|NCT01120470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2481998|NCT01120470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2481999|NCT01120470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2482000|NCT01120470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482001|NCT01120561|Trastuzumab|trastuzumab|mesh-list
2371288|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2371289|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2371290|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371291|NCT00584779|Gabapentin|gabapentin|mesh-list
2371292|NCT00584779|Analgesics|analgesics|mesh-ancestor
2371293|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
2371294|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371295|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371296|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
2371297|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2371298|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2371299|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2371300|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2371301|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2371302|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2371303|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371304|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371305|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
2371306|NCT00584974|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2371307|NCT00584974|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2371308|NCT00584974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2371309|NCT00584974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2371310|NCT00584974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371311|NCT00584974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371312|NCT00584974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371313|NCT00584974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2371314|NCT00584974|Antidepressive Agents|antidepressive agents|mesh-ancestor
2371315|NCT00584974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2371316|NCT00585000|Tremelimumab|tremelimumab|mesh-list
2371317|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371318|NCT00585091|Phenylephrine|phenylephrine|mesh-list
2371319|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
2371320|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2371321|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
2371322|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
2371323|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371324|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371325|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
2371326|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2371327|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
2482002|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2482003|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2482004|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371328|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
2371329|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2371330|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2371331|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2371332|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
2371333|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371334|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371335|NCT00585091|Protective Agents|protective agents|mesh-ancestor
2371336|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2482005|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
2482006|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
2482007|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
2482008|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482009|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2482010|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2482011|NCT01120665|Estradiol|estradiol|mesh-list
2482012|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2482013|NCT01120665|Hormones|hormones|mesh-ancestor
2482014|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2482015|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482016|NCT01120665|Estrogens|estrogens|mesh-ancestor
2482017|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2482018|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
2482019|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2482020|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2482021|NCT01120769|Acetaminophen|acetaminophen|mesh-list
2482022|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2482023|NCT01120769|Analgesics|analgesics|mesh-ancestor
2482024|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
2482025|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371337|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2371338|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2371339|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
2371340|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371341|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2371342|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2371343|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482026|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482027|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
2482028|NCT01120795|Interferons|interferons|mesh-list
2482029|NCT01120795|Ribavirin|ribavirin|mesh-list
2482030|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2482031|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
2482032|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482033|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
2482034|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482035|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
2482036|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482037|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
2482038|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482039|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
2482040|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482041|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2482042|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482043|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482044|NCT01120912|Insulin|insulin|mesh-list
2482045|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2482046|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482047|NCT01121016|Montelukast|montelukast|mesh-list
2482048|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2482049|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
2482050|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2482051|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
2482052|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2482053|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482054|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2482055|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2482056|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482057|NCT01121042|Ondansetron|ondansetron|mesh-list
2482058|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
2482059|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
2482060|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482061|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482062|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2482063|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
2482064|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
2482065|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2482066|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
2482067|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482068|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482069|NCT01121042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2482070|NCT01121042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2482071|NCT01121042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2482072|NCT01121042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2482073|NCT01121042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2482074|NCT01121055|Lorazepam|lorazepam|mesh-list
2482075|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
2482076|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
2482077|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
2482078|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482079|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482080|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2482081|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2482082|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2482083|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2482084|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2482085|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2482086|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
2482087|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
2482088|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482089|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482090|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2482091|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2482092|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
2482093|NCT01121133|Rifampin|rifampin|mesh-list
2371344|NCT00585156|Celecoxib|celecoxib|mesh-list
2371345|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2371346|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2371347|NCT00585156|Analgesics|analgesics|mesh-ancestor
2371348|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
2371349|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371350|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371351|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2371352|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2371353|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2371354|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2371355|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371356|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371357|NCT00585260|Mannitol|mannitol|mesh-list
2371358|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2371359|NCT00585260|Diuretics|diuretics|mesh-ancestor
2371360|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
2371361|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371362|NCT00585442|Vitamin D|vitamin d|mesh-list
2371363|NCT00585442|Calcitriol|calcitriol|mesh-list
2371364|NCT00585442|Vitamins|vitamins|mesh-ancestor
2371365|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
2371366|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371367|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2371368|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2371369|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2371370|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2371371|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371372|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2371373|NCT00585455|Sertraline|sertraline|mesh-list
2371374|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
2371375|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2371376|NCT00585455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2371377|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2371378|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2371379|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371380|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371381|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
2371382|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371383|NCT00585507|Fulvestrant|fulvestrant|mesh-list
2371384|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2371385|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371386|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2371387|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2371388|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
2371389|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371390|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371391|NCT00585520|Progesterone|progesterone|mesh-list
2371392|NCT00585520|Progestins|progestins|mesh-ancestor
2371393|NCT00585520|Hormones|hormones|mesh-ancestor
2371394|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371395|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371396|NCT00585559|Acetaminophen|acetaminophen|mesh-list
2371397|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
2371398|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2371399|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2371400|NCT00585559|Analgesics|analgesics|mesh-ancestor
2371401|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
2371402|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371403|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371404|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
2482094|NCT01121133|Navitoclax|navitoclax|mesh-list
2482095|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2482096|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
2482097|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2482098|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482099|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
2482100|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2482101|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482102|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482103|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2482104|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2482105|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2482106|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2482107|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2482108|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2482109|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482110|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
2482111|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2482112|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482113|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2482114|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482115|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
2482116|NCT01121237|Hematinics|hematinics|mesh-ancestor
2371405|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
2371406|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2371407|NCT00585559|Expectorants|expectorants|mesh-ancestor
2371408|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
2371409|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2371410|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
2371411|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482117|NCT01121276|Insulin|insulin|mesh-list
2482118|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2482119|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
2482120|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
2482121|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2482122|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2482123|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482124|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
2482125|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2482126|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482127|NCT01121354|Cefazolin|cefazolin|mesh-list
2482128|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2482129|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482130|NCT01121458|Clevidipine|clevidipine|mesh-list
2482131|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2482132|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2482133|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482134|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2482135|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482136|NCT01121497|Physostigmine|physostigmine|mesh-list
2482137|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2482138|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482139|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482140|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
2482141|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482142|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482143|NCT01121497|Miotics|miotics|mesh-ancestor
2482144|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
2482145|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371412|NCT00585559|Protective Agents|protective agents|mesh-ancestor
2371413|NCT00585559|Antidotes|antidotes|mesh-ancestor
2371414|NCT00585741|Alovudine|alovudine|mesh-list
2371415|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
2371416|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2371417|NCT00585754|Guanfacine|guanfacine|mesh-list
2371418|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2371419|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2371420|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2371421|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2371422|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
2371423|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371424|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371425|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482146|NCT01121588|Crizotinib|crizotinib|mesh-list
2482147|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482148|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2482149|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482150|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482151|NCT01121705|Interferons|interferons|mesh-list
2482152|NCT01121705|Ribavirin|ribavirin|mesh-list
2482153|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
2482154|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
2482155|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2482156|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482157|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
2482158|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2371426|NCT00585793|Lopinavir|lopinavir|mesh-list
2482159|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
2482160|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482161|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
2482162|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482163|NCT01121731|Interferons|interferons|mesh-list
2482164|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
2482165|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482166|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
2482167|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482168|NCT01121744|Sirolimus|sirolimus|mesh-list
2482169|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2482170|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482171|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2371427|NCT00585793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2371428|NCT00585793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2371429|NCT00585793|Protease Inhibitors|protease inhibitors|mesh-ancestor
2371430|NCT00585793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371431|NCT00585793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371432|NCT00585793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2371433|NCT00585793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2371434|NCT00585793|Antiviral Agents|antiviral agents|mesh-ancestor
2371435|NCT00585793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2371436|NCT00585793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2371437|NCT00585793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2371438|NCT00585871|Metoprolol|metoprolol|mesh-list
2371439|NCT00585871|Clonidine|clonidine|mesh-list
2371440|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2371441|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2371442|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
2371443|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
2371444|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371445|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371446|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2371447|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2371448|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2371449|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
2371450|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371451|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371452|NCT00585871|Analgesics|analgesics|mesh-ancestor
2371453|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
2371454|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2371455|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2371456|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2371457|NCT00586092|Bevacizumab|bevacizumab|mesh-list
2482172|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482173|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
2482174|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2482175|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
2482176|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482177|NCT01121770|PENTA|penta|mesh-list
2482178|NCT01121770|Fondaparinux|fondaparinux|mesh-list
2482179|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2371458|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2371459|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371460|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2371461|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2371462|NCT00586092|Growth Substances|growth substances|mesh-ancestor
2371463|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371464|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
2371465|NCT00586118|Propofol|propofol|mesh-list
2371466|NCT00586118|Sevoflurane|sevoflurane|mesh-list
2371467|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2371468|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2371469|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371470|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2371471|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
2371472|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
2371473|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2371474|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2371475|NCT00586131|Citric Acid|citric acid|mesh-list
2371476|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
2371477|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
2371478|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2371479|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
2371480|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
2482180|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
2482181|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2482182|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
2482183|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482184|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482185|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
2482186|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2482187|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2482188|NCT01121796|Vitamin D|vitamin d|mesh-list
2482189|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
2482190|NCT01121796|Vitamins|vitamins|mesh-list
2482191|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
2482192|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482193|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2482194|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2482195|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
2482196|NCT01121809|Etravirine|etravirine|mesh-list
2482197|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2482198|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2482199|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
2482200|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482201|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2482202|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2482203|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482204|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482205|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2482206|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2482207|NCT01121822|Vaccines|vaccines|mesh-list
2482208|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
2482209|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482210|NCT01121835|Insulin|insulin|mesh-list
2482211|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2482212|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
2482213|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
2482214|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2482215|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482216|NCT01121848|Leucovorin|leucovorin|mesh-list
2482217|NCT01121848|Fluorouracil|fluorouracil|mesh-list
2482218|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
2482219|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
2482220|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482221|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2482222|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482223|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2482224|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
2482225|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482226|NCT01121848|Antidotes|antidotes|mesh-ancestor
2482227|NCT01121848|Protective Agents|protective agents|mesh-ancestor
2482228|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
2482229|NCT01121848|Vitamins|vitamins|mesh-ancestor
2482230|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
2482231|NCT01122004|Pregabalin|pregabalin|mesh-list
2482232|NCT01122004|Analgesics|analgesics|mesh-ancestor
2482233|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
2482234|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482235|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482236|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
2482237|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2482238|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2482239|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482240|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2482241|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2482242|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2482243|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2482244|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2482245|NCT01122056|Interferons|interferons|mesh-list
2482246|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
2482247|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482248|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
2482249|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482250|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2482251|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
2482252|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482253|NCT01122121|Leuprolide|leuprolide|mesh-list
2482254|NCT01122121|Flutamide|flutamide|mesh-list
2371481|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371482|NCT00586274|Fludarabine|fludarabine|mesh-list
2371483|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
2482255|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2482256|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
2371484|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371485|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2482257|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2482258|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482259|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2482260|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482261|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
2482262|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
2482263|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2482264|NCT01122134|Artesunate|artesunate|mesh-list
2482265|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
2482266|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2482267|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2482268|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482269|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482270|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
2482271|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
2482272|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2482273|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
2482274|NCT01122199|Everolimus|everolimus|mesh-list
2482275|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482276|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2482277|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
2482278|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482279|NCT01122251|Valsartan|valsartan|mesh-list
2482280|NCT01122251|Lercanidipine|lercanidipine|mesh-list
2482281|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2482282|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2482283|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2482284|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482285|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2482286|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2482287|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2482288|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482289|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
2482290|NCT01122342|Testosterone|testosterone|mesh-list
2482291|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
2482292|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
2482293|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2482294|NCT01122342|Androgens|androgens|mesh-ancestor
2482295|NCT01122342|Hormones|hormones|mesh-ancestor
2482296|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2482297|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482298|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2371486|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
2371487|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
2371488|NCT00586365|Naproxen|naproxen|mesh-list
2371489|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2371490|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2371491|NCT00586365|Analgesics|analgesics|mesh-ancestor
2371492|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
2371493|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371494|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371495|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2371496|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2371497|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
2371498|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2371499|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371500|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482299|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482300|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
2482301|NCT01122368|Micafungin|micafungin|mesh-list
2371501|NCT00586391|Ipilimumab|ipilimumab|mesh-list
2371502|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2371503|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371504|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2482302|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
2482303|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482304|NCT01122407|Trimethaphan|trimethaphan|mesh-list
2482305|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
2482306|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482307|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2482308|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2482309|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2482310|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
2482311|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482312|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482313|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2482314|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2482315|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
2482316|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482317|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
2482318|NCT01122472|Lenalidomide|lenalidomide|mesh-list
2482319|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
2482320|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482321|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2482322|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2482323|NCT01122472|Growth Substances|growth substances|mesh-ancestor
2482324|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
2482325|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482326|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
2482327|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2482328|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2482329|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
2482330|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482331|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482332|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482333|NCT01122563|Urological Agents|urological agents|mesh-ancestor
2482334|NCT01122602|Aspirin|aspirin|mesh-list
2482335|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2482336|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2482337|NCT01122602|Analgesics|analgesics|mesh-ancestor
2482338|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
2482339|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482340|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482341|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2482342|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2482343|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2482344|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2371505|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371506|NCT00586430|Lorazepam|lorazepam|mesh-list
2371507|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
2371508|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
2371509|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
2371510|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371511|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371512|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2371513|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2371514|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2371515|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2371516|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2371517|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2371518|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
2371519|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
2371520|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371521|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371522|NCT00586443|Bevacizumab|bevacizumab|mesh-list
2482345|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482346|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2482347|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2482348|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482349|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
2482350|NCT01122615|Sirolimus|sirolimus|mesh-list
2482351|NCT01122615|Sunitinib|sunitinib|mesh-list
2482352|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482353|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2482354|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2482355|NCT01122615|Growth Substances|growth substances|mesh-ancestor
2482356|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482357|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
2482358|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2482359|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482360|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482361|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2482362|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482363|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2482364|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
2482365|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2482366|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
2482367|NCT01122641|Vildagliptin|vildagliptin|mesh-list
2482368|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2482369|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482370|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2482371|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
2482372|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482373|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482374|NCT01122667|Anacetrapib|anacetrapib|mesh-list
2482375|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2482376|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2482377|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
2482378|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482379|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2482380|NCT01122771|Amphotericin B|amphotericin b|mesh-list
2482381|NCT01122771|Paromomycin|paromomycin|mesh-list
2482382|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2482383|NCT01122771|Miltefosine|miltefosine|mesh-list
2482384|NCT01122771|Amebicides|amebicides|mesh-ancestor
2482385|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2482386|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2482387|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482388|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2482389|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
2482390|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482391|NCT01122784|Vaccines|vaccines|mesh-list
2482392|NCT01122784|Immunologic Factors|immunologic factors|mesh-ancestor
2482393|NCT01122784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482394|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2482395|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2482396|NCT01122940|Phenytoin|phenytoin|mesh-list
2482397|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
2482398|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2482399|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2482400|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2482401|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482402|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2482403|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2482404|NCT01122953|Phenytoin|phenytoin|mesh-list
2482405|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
2482406|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2482407|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2482408|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2482409|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482410|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2482411|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2482412|NCT01122966|Bevacizumab|bevacizumab|mesh-list
2482413|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2482414|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482415|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2482416|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2482417|NCT01122966|Growth Substances|growth substances|mesh-ancestor
2482418|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482419|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
2482420|NCT01122979|Insulin|insulin|mesh-list
2482421|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2482422|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
2482423|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
2482424|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
2482425|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
2482426|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
2482427|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2482428|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482429|NCT01123031|Esomeprazole|esomeprazole|mesh-list
2482430|NCT01123031|Lansoprazole|lansoprazole|mesh-list
2482431|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
2482432|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2482433|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2482434|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2482435|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482436|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482437|NCT01123057|Riboflavin|riboflavin|mesh-list
2482438|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
2482439|NCT01123057|Vitamins|vitamins|mesh-ancestor
2371523|NCT00586443|Panitumumab|panitumumab|mesh-list
2371524|NCT00586443|Everolimus|everolimus|mesh-list
2371525|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2371526|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371527|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2371528|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2371529|NCT00586443|Growth Substances|growth substances|mesh-ancestor
2371530|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371531|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
2371532|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2371533|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
2371534|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
2371535|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2371536|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
2371537|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371538|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2371539|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2371540|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
2371541|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371542|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371543|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2482440|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
2482441|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482442|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2482443|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
2482444|NCT01123265|Methotrexate|methotrexate|mesh-list
2482445|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2482446|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
2482447|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2482448|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482449|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2482450|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
2482451|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482452|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482453|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
2482454|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482455|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2482456|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2482457|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
2482458|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2482459|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2482460|NCT01123278|Testosterone|testosterone|mesh-list
2482461|NCT01123278|Androgens|androgens|mesh-ancestor
2482462|NCT01123278|Hormones|hormones|mesh-ancestor
2482463|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2482464|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482465|NCT01123317|Oxytocin|oxytocin|mesh-list
2482466|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
2482467|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2482468|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482469|NCT01123408|Haloperidol|haloperidol|mesh-list
2482470|NCT01123408|Olanzapine|olanzapine|mesh-list
2482471|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
2482472|NCT01123408|Clozapine|clozapine|mesh-list
2482473|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
2482474|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
2482475|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482476|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482477|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2482478|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2482479|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2482480|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2482481|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2482482|NCT01123408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2482483|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2482484|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2482485|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482486|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482487|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
2371544|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
2371545|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
2371546|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2371547|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2371548|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371549|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371550|NCT00586794|Urological Agents|urological agents|mesh-ancestor
2371551|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
2371552|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371553|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371554|NCT00586911|Betaine|betaine|mesh-list
2371555|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2371556|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
2371557|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2371558|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
2371559|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371560|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2371561|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
2482488|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2482489|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
2482490|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2482491|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2482492|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
2482493|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
2482494|NCT01123473|Fluorouracil|fluorouracil|mesh-list
2482495|NCT01123473|Capecitabine|capecitabine|mesh-list
2482496|NCT01123473|Epirubicin|epirubicin|mesh-list
2482497|NCT01123473|Lapatinib|lapatinib|mesh-list
2482498|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482499|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
2482500|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482501|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2482502|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2482503|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
2482504|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482505|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2482506|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2482507|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2482508|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482509|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2482510|NCT01123486|Hydromorphone|hydromorphone|mesh-list
2482511|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2482512|NCT01123486|Narcotics|narcotics|mesh-ancestor
2482513|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2482514|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482515|NCT01123486|Analgesics|analgesics|mesh-ancestor
2482516|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
2482517|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482518|NCT01123525|Adenosine|adenosine|mesh-list
2482519|NCT01123525|Analgesics|analgesics|mesh-ancestor
2482520|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
2482521|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482522|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482523|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2371562|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371563|NCT00586976|Ropivacaine|ropivacaine|mesh-list
2371564|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
2371565|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
2371566|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2371567|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371568|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
2371569|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371570|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
2371571|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371572|NCT00587119|Budesonide|budesonide|mesh-list
2371573|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2371574|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2371575|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
2371576|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371577|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371578|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2371579|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
2371580|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
2371581|NCT00587119|Hormones|hormones|mesh-ancestor
2371582|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371583|NCT00587145|Docetaxel|docetaxel|mesh-list
2371584|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371585|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
2371586|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
2371587|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
2371588|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371589|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2371590|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2371591|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
2371592|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371593|NCT00587249|Antacids|antacids|mesh-ancestor
2482524|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
2482525|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2482526|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
2482527|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
2482528|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482529|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482530|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
2482531|NCT01123538|Progesterone|progesterone|mesh-list
2482532|NCT01123538|Progestins|progestins|mesh-ancestor
2482533|NCT01123538|Hormones|hormones|mesh-ancestor
2482534|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2482535|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482536|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
2482537|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
2482538|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2482539|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2482540|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2482541|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
2482542|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2482543|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2482544|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2482545|NCT01123551|Morphine|morphine|mesh-list
2371594|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371595|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2371596|NCT00587327|Atosiban|atosiban|mesh-list
2371597|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
2371598|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371599|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371600|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
2371601|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2371602|NCT00587379|Atorvastatin|atorvastatin|mesh-list
2482546|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2482547|NCT01123551|Narcotics|narcotics|mesh-ancestor
2482548|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2482549|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482550|NCT01123551|Analgesics|analgesics|mesh-ancestor
2482551|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
2482552|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482553|NCT01123564|Ranibizumab|ranibizumab|mesh-list
2482554|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2482555|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2482556|NCT01123564|Growth Substances|growth substances|mesh-ancestor
2482557|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482558|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
2482559|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482583|NCT01123811|Cetuximab|cetuximab|mesh-list
2482584|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2482585|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482586|NCT01123824|Clopidogrel|clopidogrel|mesh-list
2482587|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2371603|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2482588|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2482589|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2482590|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2482591|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
2482592|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482593|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482594|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482595|NCT01123876|Veliparib|veliparib|mesh-list
2371604|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2371605|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
2371606|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371607|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2371608|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2371609|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371610|NCT00587444|Heparin|heparin|mesh-list
2371611|NCT00587444|Calcium heparin|calcium heparin|mesh-list
2371612|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
2371613|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2371614|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2371615|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371616|NCT00587470|Candesartan|candesartan|mesh-list
2371617|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
2371618|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2371619|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2371620|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2371621|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371622|NCT00587496|Aspirin|aspirin|mesh-list
2371623|NCT00587496|Valacyclovir|valacyclovir|mesh-list
2371624|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2371625|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2371626|NCT00587496|Analgesics|analgesics|mesh-ancestor
2482596|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2482597|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482598|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482599|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482600|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2482601|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2482602|NCT01123915|Protective Agents|protective agents|mesh-ancestor
2482603|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482604|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2482605|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
2482606|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482607|NCT01123967|Nicotine|nicotine|mesh-list
2482608|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2482609|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
2482610|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482611|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482612|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2482613|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2482614|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
2482615|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482616|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482617|NCT01124032|Methylphenidate|methylphenidate|mesh-list
2482618|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2482619|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482620|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2482621|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2482622|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2482623|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482624|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
2482625|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482626|NCT01124058|Heparin|heparin|mesh-list
2482627|NCT01124058|Calcium heparin|calcium heparin|mesh-list
2371627|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
2371628|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371629|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371630|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2371631|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2371632|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2371633|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2371634|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371635|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2371636|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2371637|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371638|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
2482628|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2482629|NCT01124058|Tinzaparin|tinzaparin|mesh-list
2482630|NCT01124058|Dalteparin|dalteparin|mesh-list
2482631|NCT01124058|Warfarin|warfarin|mesh-list
2482632|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
2482633|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2482634|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2482635|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482636|NCT01124227|Icodextrin|icodextrin|mesh-list
2482637|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
2482638|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2482639|NCT01124240|Temozolomide|temozolomide|mesh-list
2482640|NCT01124240|Procarbazine|procarbazine|mesh-list
2482641|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2482642|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
2482643|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482644|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482645|NCT01124253|Endostatins|endostatins|mesh-list
2482646|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2482647|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2482648|NCT01124253|Growth Substances|growth substances|mesh-ancestor
2482649|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482650|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
2482651|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482652|NCT01124318|Lactulose|lactulose|mesh-list
2482653|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2482654|NCT01124383|Lidocaine|lidocaine|mesh-list
2482655|NCT01124383|Ephedrine|ephedrine|mesh-list
2482656|NCT01124383|Midazolam|midazolam|mesh-list
2482657|NCT01124383|Sufentanil|sufentanil|mesh-list
2482658|NCT01124383|Dsuvia|dsuvia|mesh-list
2482659|NCT01124383|Anesthetics|anesthetics|mesh-list
2482660|NCT01124383|Propofol|propofol|mesh-list
2482661|NCT01124383|Sevoflurane|sevoflurane|mesh-list
2482662|NCT01124383|Rocuronium|rocuronium|mesh-list
2482663|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
2482664|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2482665|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482666|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
2482667|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371639|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
2371640|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2371641|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
2371642|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2371643|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371644|NCT00587665|Ketamine|ketamine|mesh-list
2371645|NCT00587665|Analgesics|analgesics|mesh-ancestor
2371646|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
2371647|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371648|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371649|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2371650|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2371651|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
2371652|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
2482668|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2482669|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2482670|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2482671|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2482672|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482673|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2482674|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2482675|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
2482676|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2482677|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2482678|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2482679|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2482680|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
2482681|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
2482682|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482683|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2482684|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2371653|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2371654|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2482685|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2482686|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2482687|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2482688|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2482689|NCT01124383|Narcotics|narcotics|mesh-ancestor
2482690|NCT01124383|Analgesics|analgesics|mesh-ancestor
2482691|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2482692|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
2482693|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
2482694|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2482695|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
2482696|NCT01124435|Celecoxib|celecoxib|mesh-list
2482697|NCT01124435|Carboplatin|carboplatin|mesh-list
2482698|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371655|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2371656|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371657|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371658|NCT00587717|Simvastatin|simvastatin|mesh-list
2371659|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2482699|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2482700|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2482701|NCT01124435|Analgesics|analgesics|mesh-ancestor
2371660|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2371661|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
2371662|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371663|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2371664|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2371665|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371666|NCT00587873|Leucovorin|leucovorin|mesh-list
2371667|NCT00587873|Methotrexate|methotrexate|mesh-list
2371668|NCT00587873|Thioguanine|thioguanine|mesh-list
2371669|NCT00587873|Calcium|calcium|mesh-list
2371670|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
2482702|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
2482703|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482704|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482705|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2371671|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2371672|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371673|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2371674|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
2371675|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2482706|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2482707|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2482708|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2482709|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482710|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482711|NCT01124487|Insulin|insulin|mesh-list
2371676|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2371677|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
2371678|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371679|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371680|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
2371681|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482712|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2482713|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482714|NCT01124500|Methylphenidate|methylphenidate|mesh-list
2482715|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2482716|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482717|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2482718|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2482719|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2482720|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482721|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
2482722|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482723|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
2482724|NCT01124526|Rituximab|rituximab|mesh-list
2482725|NCT01124526|Fludarabine|fludarabine|mesh-list
2482726|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2482727|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
2482728|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482729|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2482730|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2482731|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
2482732|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482733|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482734|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2482735|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2482736|NCT01124539|Camptothecin|camptothecin|mesh-list
2482737|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
2482738|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2482739|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482740|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2482741|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2482742|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482743|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482744|NCT01124552|Botulinum Toxins|botulinum toxins|mesh-list
2482745|NCT01124552|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2482746|NCT01124552|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2482747|NCT01124552|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2482748|NCT01124552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2482749|NCT01124552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482750|NCT01124552|Cholinergic Agents|cholinergic agents|mesh-ancestor
2482751|NCT01124552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482752|NCT01124552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482753|NCT01124552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2482754|NCT01124552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482755|NCT01124630|Leucovorin|leucovorin|mesh-list
2482756|NCT01124630|Fluorouracil|fluorouracil|mesh-list
2482757|NCT01124630|Irinotecan|irinotecan|mesh-list
2482758|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
2482759|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482760|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2371682|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2371683|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2371684|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
2371685|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2371686|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2371687|NCT00587873|Antidotes|antidotes|mesh-ancestor
2371688|NCT00587873|Protective Agents|protective agents|mesh-ancestor
2371689|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
2371690|NCT00587873|Vitamins|vitamins|mesh-ancestor
2371691|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
2371692|NCT00588003|Anastrozole|anastrozole|mesh-list
2482761|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482762|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2482763|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
2482764|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482765|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2482766|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2482767|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482768|NCT01124630|Antidotes|antidotes|mesh-ancestor
2482769|NCT01124630|Protective Agents|protective agents|mesh-ancestor
2482770|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
2482771|NCT01124630|Vitamins|vitamins|mesh-ancestor
2482772|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
2482773|NCT01124656|Pioglitazone|pioglitazone|mesh-list
2482774|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2482775|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2482776|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482777|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2482778|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2482779|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482780|NCT01124695|Tamoxifen|tamoxifen|mesh-list
2482781|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2482782|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
2482783|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371693|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2371694|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371695|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2371696|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2371697|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371698|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371699|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2371700|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
2371701|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371702|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371703|NCT00588016|Itraconazole|itraconazole|mesh-list
2371704|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
2482784|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482785|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2482786|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482787|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2482788|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2482789|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2482790|NCT01124760|Ketoconazole|ketoconazole|mesh-list
2482791|NCT01124760|Diltiazem|diltiazem|mesh-list
2482792|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
2482793|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482794|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2482795|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2371705|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2371706|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2371707|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2371708|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371709|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371710|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2371711|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
2371712|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2482796|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482797|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482798|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2482799|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
2482800|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371713|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371714|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2371715|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
2371716|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2371717|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2371718|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371719|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
2371720|NCT00588133|Coagulants|coagulants|mesh-ancestor
2371721|NCT00588172|Metformin|metformin|mesh-list
2371722|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2371723|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371724|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
2371725|NCT00588185|Testosterone|testosterone|mesh-list
2371726|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
2371727|NCT00588185|Androgens|androgens|mesh-ancestor
2482801|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482802|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2482803|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2482804|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2482805|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2482806|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2482807|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
2482808|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
2482809|NCT01124799|Simeprevir|simeprevir|mesh-list
2482810|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2371728|NCT00588185|Hormones|hormones|mesh-ancestor
2371729|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371730|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371731|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
2371732|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371733|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
2371734|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2371735|NCT00588302|Moexipril|moexipril|mesh-list
2482811|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482812|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2371736|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2371737|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
2371738|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371739|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371740|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2371741|NCT00588523|Temozolomide|temozolomide|mesh-list
2371742|NCT00588523|Busulfan|busulfan|mesh-list
2371743|NCT00588523|Thiotepa|thiotepa|mesh-list
2371744|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2371745|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
2371746|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371747|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482813|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2482814|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482815|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482816|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482817|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2482818|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2482819|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
2482820|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
2482821|NCT01124877|Ziprasidone|ziprasidone|mesh-list
2482822|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2482823|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
2482824|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482825|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482826|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482827|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2482828|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2482829|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2371748|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2371749|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
2371750|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371751|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2482830|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2482831|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2482832|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
2482833|NCT01125020|Gemcitabine|gemcitabine|mesh-list
2482834|NCT01125020|Doxorubicin|doxorubicin|mesh-list
2482835|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
2482836|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482837|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2482838|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
2482839|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482840|NCT01125020|Antiviral Agents|antiviral agents|mesh-ancestor
2482841|NCT01125020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482842|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482843|NCT01125020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2482844|NCT01125020|Immunologic Factors|immunologic factors|mesh-ancestor
2482845|NCT01125020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482846|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2482847|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2482848|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2482849|NCT01125033|Vitamins|vitamins|mesh-list
2482850|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
2482851|NCT01125033|Vitamin E|vitamin e|mesh-list
2482852|NCT01125033|Tocopherols|tocopherols|mesh-list
2482853|NCT01125033|Tocotrienols|tocotrienols|mesh-list
2371752|NCT00588835|Dexamethasone|dexamethasone|mesh-list
2371753|NCT00588835|Ondansetron|ondansetron|mesh-list
2371754|NCT00588835|Aprepitant|aprepitant|mesh-list
2371755|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2371756|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
2371757|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
2371758|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371759|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371760|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2371761|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
2371762|NCT00588835|Hormones|hormones|mesh-ancestor
2371763|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371764|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2371765|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371766|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
2371767|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
2371768|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2371769|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
2371770|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371771|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371772|NCT00588835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2371773|NCT00588835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2482854|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
2482855|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
2482856|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482857|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
2482858|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482859|NCT01125033|Protective Agents|protective agents|mesh-ancestor
2482860|NCT01125059|Methadone|methadone|mesh-list
2482861|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2482862|NCT01125059|Narcotics|narcotics|mesh-ancestor
2482863|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2482864|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482865|NCT01125059|Analgesics|analgesics|mesh-ancestor
2482866|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
2482867|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482868|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
2482869|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
2482870|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
2482871|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2482872|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482873|NCT01125150|Metformin|metformin|mesh-list
2482874|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2482875|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482876|NCT01125215|Capsaicin|capsaicin|mesh-list
2482877|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
2482878|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
2482879|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
2482880|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482881|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482882|NCT01125254|Amlodipine|amlodipine|mesh-list
2482883|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2482884|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2482885|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2482886|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482887|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2482888|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482889|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
2482890|NCT01125371|Ethanol|ethanol|mesh-list
2482891|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2371774|NCT00588835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2371775|NCT00588835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2371776|NCT00588835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2371777|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2371778|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
2371779|NCT00588913|Aldesleukin|aldesleukin|mesh-list
2371780|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371781|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2371782|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2371783|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
2371784|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482892|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482893|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2482894|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482895|NCT01125410|Clindamycin|clindamycin|mesh-list
2482896|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
2482897|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
2482898|NCT01125410|Dequalinium|dequalinium|mesh-list
2482899|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2482900|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482901|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2482902|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482903|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482904|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2482905|NCT01125423|Milnacipran|milnacipran|mesh-list
2482906|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
2482907|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2482908|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2482909|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2482910|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482911|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482912|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482913|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2482914|NCT01125423|Analgesics|analgesics|mesh-ancestor
2482915|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
2482916|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2482917|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
2482918|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2482919|NCT01125436|Vitamin D|vitamin d|mesh-list
2482920|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
2371785|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2371786|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371787|NCT00588926|Remifentanil|remifentanil|mesh-list
2371788|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2371789|NCT00588926|Narcotics|narcotics|mesh-ancestor
2371790|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2371791|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482921|NCT01125436|Vitamins|vitamins|mesh-ancestor
2482922|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
2482923|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482924|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2482925|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2482926|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
2482927|NCT01125449|Vitamins|vitamins|mesh-ancestor
2482928|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
2482929|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482930|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
2482931|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482932|NCT01125449|Protective Agents|protective agents|mesh-ancestor
2482933|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2482934|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
2482935|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2482936|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
2482937|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2371792|NCT00588926|Analgesics|analgesics|mesh-ancestor
2371793|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
2371794|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371795|NCT00589082|Daunorubicin|daunorubicin|mesh-list
2371796|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2371797|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371798|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2371799|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2371800|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371801|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371802|NCT00589134|Ganirelix|ganirelix|mesh-list
2371803|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
2482938|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482939|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2482940|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2371804|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2371805|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371806|NCT00589186|Celecoxib|celecoxib|mesh-list
2371807|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2371808|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2371809|NCT00589186|Analgesics|analgesics|mesh-ancestor
2371810|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
2371811|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371812|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371813|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2371814|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2371815|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2482941|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2482942|NCT01125527|Vaccines|vaccines|mesh-list
2482943|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
2482944|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482945|NCT01125553|Insulin|insulin|mesh-list
2482946|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
2482947|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2482948|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482949|NCT01125657|Darexaban|darexaban|mesh-list
2482950|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2482951|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
2482952|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2482953|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
2482954|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482955|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482956|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
2482957|NCT01125670|Darexaban|darexaban|mesh-list
2482958|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2482959|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
2482960|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2482961|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
2482962|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482963|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482964|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
2482965|NCT01125683|Donepezil|donepezil|mesh-list
2482966|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2482967|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482968|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482969|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
2482970|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2482971|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2482972|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
2371816|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2371817|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371818|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482973|NCT01125696|Ritonavir|ritonavir|mesh-list
2482974|NCT01125696|Lopinavir|lopinavir|mesh-list
2482975|NCT01125696|Tenofovir|tenofovir|mesh-list
2482976|NCT01125696|Lamivudine|lamivudine|mesh-list
2482977|NCT01125696|Zidovudine|zidovudine|mesh-list
2482978|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2482979|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2482980|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
2482981|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2482982|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2482983|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2482984|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2482985|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
2482986|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2482987|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2482988|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2482989|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2482990|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2482991|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
2482992|NCT01125761|Clemastine|clemastine|mesh-list
2482993|NCT01125761|Dexamethasone|dexamethasone|mesh-list
2482994|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
2482995|NCT01125761|BB 1101|bb 1101|mesh-list
2482996|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2482997|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
2482998|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
2482999|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483000|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483001|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2483002|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
2483003|NCT01125761|Hormones|hormones|mesh-ancestor
2483004|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2483005|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2483006|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483007|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
2483008|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483009|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483010|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
2483011|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
2483012|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2483013|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
2483014|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
2483015|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483016|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2483017|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2483018|NCT01125787|Ofatumumab|ofatumumab|mesh-list
2483019|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2483020|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2483021|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
2483022|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483023|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483024|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
2483025|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483026|NCT01125891|Gemcitabine|gemcitabine|mesh-list
2483027|NCT01125891|ON 01910|on 01910|mesh-list
2483028|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2483029|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
2483030|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371819|NCT00589238|Paclitaxel|paclitaxel|mesh-list
2371820|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
2371821|NCT00589238|Carboplatin|carboplatin|mesh-list
2371822|NCT00589238|Doxorubicin|doxorubicin|mesh-list
2371823|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2371824|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2371825|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371826|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
2371827|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
2371828|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
2371829|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371830|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2371831|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
2371832|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371833|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2483031|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483032|NCT01125891|Antiviral Agents|antiviral agents|mesh-ancestor
2483033|NCT01125891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483034|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483035|NCT01125891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2483036|NCT01125891|Immunologic Factors|immunologic factors|mesh-ancestor
2483037|NCT01125891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483038|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2483039|NCT01125904|Crizotinib|crizotinib|mesh-list
2483040|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483041|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2483042|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483043|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483044|NCT01125943|Bevacizumab|bevacizumab|mesh-list
2483045|NCT01125943|Nitroprusside|nitroprusside|mesh-list
2483046|NCT01125943|Acetylcholine|acetylcholine|mesh-list
2483047|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2483048|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483049|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2483050|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2483051|NCT01125943|Growth Substances|growth substances|mesh-ancestor
2483052|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483053|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
2483054|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2483055|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
2483056|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2483057|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483058|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2483059|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
2483060|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483061|NCT01125982|Propofol|propofol|mesh-list
2483062|NCT01125982|Desflurane|desflurane|mesh-list
2483063|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2483064|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2483065|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483066|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2483067|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
2483068|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
2483069|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2483070|NCT01126008|Docetaxel|docetaxel|mesh-list
2483071|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483072|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
2483073|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
2483074|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
2483075|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483076|NCT01126073|Niacin|niacin|mesh-list
2483077|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2483078|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
2483079|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483080|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2483081|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
2483082|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
2483083|NCT01126073|Vitamins|vitamins|mesh-ancestor
2483084|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
2371834|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2371835|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
2371836|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2371837|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2371838|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2371839|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2371840|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371841|NCT00589251|Penicillins|penicillins|mesh-list
2371842|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2371843|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2371844|NCT00589264|Copper|copper|mesh-list
2371845|NCT00589264|Trace Elements|trace elements|mesh-ancestor
2371846|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
2371847|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371848|NCT00589316|Iodine|iodine|mesh-list
2483085|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483086|NCT01126086|Otamixaban|otamixaban|mesh-list
2483087|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2483088|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
2483089|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2483090|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
2483091|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483092|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483093|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
2371849|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
2371850|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
2371851|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
2371852|NCT00589316|Fludarabine|fludarabine|mesh-list
2371853|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
2371854|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2371855|NCT00589316|Tacrolimus|tacrolimus|mesh-list
2371856|NCT00589316|Antibodies|antibodies|mesh-list
2371857|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
2483094|NCT01126112|Panitumumab|panitumumab|mesh-list
2483095|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2483096|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483097|NCT01126138|Docetaxel|docetaxel|mesh-list
2483098|NCT01126138|Capecitabine|capecitabine|mesh-list
2483099|NCT01126138|Vinorelbine|vinorelbine|mesh-list
2483100|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483101|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
2483102|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
2483103|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
2483104|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483105|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2483106|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
2483107|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2483108|NCT01126177|Interferons|interferons|mesh-list
2483109|NCT01126177|Interferon-beta|interferon-beta|mesh-list
2483110|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
2483111|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483112|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
2483113|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483114|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
2483115|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483116|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2483117|NCT01126190|Docetaxel|docetaxel|mesh-list
2483118|NCT01126190|Doxorubicin|doxorubicin|mesh-list
2483119|NCT01126190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483120|NCT01126190|Tubulin Modulators|tubulin modulators|mesh-ancestor
2483121|NCT01126190|Antimitotic Agents|antimitotic agents|mesh-ancestor
2483122|NCT01126190|Mitosis Modulators|mitosis modulators|mesh-ancestor
2483123|NCT01126190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483124|NCT01126190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2483125|NCT01126190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2483126|NCT01126190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2483127|NCT01126190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483128|NCT01126216|Paclitaxel|paclitaxel|mesh-list
2483129|NCT01126216|Cisplatin|cisplatin|mesh-list
2483130|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2483131|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483132|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
2483133|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
2483134|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
2483135|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483136|NCT01126229|Resveratrol|resveratrol|mesh-list
2483137|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
2483138|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483139|NCT01126229|Protective Agents|protective agents|mesh-ancestor
2483140|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483141|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483142|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2483143|NCT01126255|Clobetasol|clobetasol|mesh-list
2483144|NCT01126255|Progesterone|progesterone|mesh-list
2483145|NCT01126255|Progestins|progestins|mesh-ancestor
2483146|NCT01126255|Hormones|hormones|mesh-ancestor
2483147|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2483148|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483149|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2483150|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
2483151|NCT01126294|Melatonin|melatonin|mesh-list
2483152|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
2483153|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371858|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2371859|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2371860|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
2371861|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371862|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2371863|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2371864|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
2483154|NCT01126294|Protective Agents|protective agents|mesh-ancestor
2483155|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483156|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2483157|NCT01126307|Verapamil|verapamil|mesh-list
2483158|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2483159|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2483160|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2483161|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483162|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2483163|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483164|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
2483165|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2483166|NCT01126450|Cetuximab|cetuximab|mesh-list
2483167|NCT01126450|Lenalidomide|lenalidomide|mesh-list
2483168|NCT01126450|Antibodies|antibodies|mesh-list
2483169|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
2483170|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2483171|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
2483172|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483173|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483174|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2483175|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2483176|NCT01126450|Growth Substances|growth substances|mesh-ancestor
2483177|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
2483178|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
2483179|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483180|NCT01126528|Vitamin D|vitamin d|mesh-list
2483181|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
2483182|NCT01126528|Vitamins|vitamins|mesh-ancestor
2371865|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371866|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371867|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2371868|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2371869|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
2371870|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2371871|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371872|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2371873|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2371874|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
2371875|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2371876|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2371877|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2371878|NCT00589316|Trace Elements|trace elements|mesh-ancestor
2371879|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
2371880|NCT00589381|Fenretinide|fenretinide|mesh-list
2371881|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371882|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2371883|NCT00589381|Protective Agents|protective agents|mesh-ancestor
2371884|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371885|NCT00589394|Vaccines|vaccines|mesh-list
2371886|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2371887|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
2483183|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
2483184|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483185|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2483186|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2483187|NCT01126606|Glycerol|glycerol|mesh-list
2483188|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2483189|NCT01126606|Protective Agents|protective agents|mesh-ancestor
2483190|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483191|NCT01126645|Sorafenib|sorafenib|mesh-list
2483192|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483193|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2483194|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483195|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483196|NCT01126684|Atorvastatin|atorvastatin|mesh-list
2483197|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2483198|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2483199|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
2483200|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483201|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2483202|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2483203|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483204|NCT01126697|Ubiquinone|ubiquinone|mesh-list
2483205|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
2483206|NCT01126697|Lisinopril|lisinopril|mesh-list
2483659|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2371888|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483207|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2483208|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
2483209|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483210|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483211|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2483212|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2483213|NCT01126697|Protective Agents|protective agents|mesh-ancestor
2483214|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483215|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
2483216|NCT01126697|Vitamins|vitamins|mesh-ancestor
2483217|NCT01126736|Pemetrexed|pemetrexed|mesh-list
2483218|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483219|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483220|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483221|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2483222|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2483223|NCT01126749|Gemcitabine|gemcitabine|mesh-list
2483224|NCT01126749|Cisplatin|cisplatin|mesh-list
2483225|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483226|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2483227|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
2483228|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483229|NCT01126749|Antiviral Agents|antiviral agents|mesh-ancestor
2483230|NCT01126749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483231|NCT01126749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483232|NCT01126749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2483233|NCT01126749|Immunologic Factors|immunologic factors|mesh-ancestor
2483234|NCT01126749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483235|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
2483236|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483237|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2483238|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483239|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483240|NCT01126866|Bevacizumab|bevacizumab|mesh-list
2483241|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2483242|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483243|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2483244|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2483245|NCT01126866|Growth Substances|growth substances|mesh-ancestor
2483246|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483247|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
2483248|NCT01126970|Orlistat|orlistat|mesh-list
2483249|NCT01126970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483250|NCT01126970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483251|NCT01126970|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2483252|NCT01126970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2483253|NCT01127009|Cytarabine|cytarabine|mesh-list
2483254|NCT01127009|Etoposide|etoposide|mesh-list
2483255|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
2371889|NCT00589420|Docetaxel|docetaxel|mesh-list
2371890|NCT00589420|Sorafenib|sorafenib|mesh-list
2371891|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371892|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
2371893|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
2371894|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
2371895|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371896|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2371897|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371898|NCT00589485|Cobalt|cobalt|mesh-list
2371899|NCT00589485|Trace Elements|trace elements|mesh-ancestor
2483256|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
2483257|NCT01127009|Bortezomib|bortezomib|mesh-list
2483258|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
2483259|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2483260|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483261|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2483262|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2371900|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
2371901|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371902|NCT00589732|Valsartan|valsartan|mesh-list
2371903|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2371904|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2371905|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2371906|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371907|NCT00589823|Fentanyl|fentanyl|mesh-list
2371908|NCT00589823|Morphine|morphine|mesh-list
2371909|NCT00589823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2371910|NCT00589823|Narcotics|narcotics|mesh-ancestor
2371911|NCT00589823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2371912|NCT00589823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371913|NCT00589823|Analgesics|analgesics|mesh-ancestor
2371914|NCT00589823|Sensory System Agents|sensory system agents|mesh-ancestor
2371915|NCT00589823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371916|NCT00589823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2371917|NCT00589823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2371918|NCT00589823|Anesthetics, General|anesthetics, general|mesh-ancestor
2371919|NCT00589823|Anesthetics|anesthetics|mesh-ancestor
2371920|NCT00589862|Clopidogrel|clopidogrel|mesh-list
2371921|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2371922|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2371923|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2371924|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2371925|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
2371926|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371927|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371928|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371929|NCT00589875|Valacyclovir|valacyclovir|mesh-list
2371930|NCT00589875|Antiviral Agents|antiviral agents|mesh-ancestor
2371931|NCT00589875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2371932|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
2371933|NCT00589901|Capecitabine|capecitabine|mesh-list
2371934|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2371935|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
2371936|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371937|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2483263|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483264|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483265|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2483266|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
2483267|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
2483268|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483269|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2483270|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
2483271|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483272|NCT01127009|Analgesics|analgesics|mesh-ancestor
2483273|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
2483274|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483275|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
2483276|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
2483277|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
2483278|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
2483279|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
2483280|NCT01127022|Choline|choline|mesh-list
2483281|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
2371938|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2371939|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
2371940|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371941|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2371942|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2371943|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2371944|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
2371945|NCT00589927|Cilostazol|cilostazol|mesh-list
2371946|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2371947|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
2483282|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2483283|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
2371948|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371949|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371950|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2371951|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
2371952|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2371953|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2371954|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371955|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2483284|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483285|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2483286|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2483287|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
2483288|NCT01127100|Fentanyl|fentanyl|mesh-list
2483289|NCT01127100|Gabapentin|gabapentin|mesh-list
2371956|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
2371957|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2371958|NCT00589927|Protective Agents|protective agents|mesh-ancestor
2371959|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2371960|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2371961|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483290|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2483291|NCT01127100|Narcotics|narcotics|mesh-ancestor
2483292|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2483293|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483294|NCT01127100|Analgesics|analgesics|mesh-ancestor
2483295|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
2483296|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483297|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2483298|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2483299|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
2483300|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
2483301|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
2483302|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2483303|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2483304|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2483305|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2483306|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2483307|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483308|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483309|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
2483310|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
2483311|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2483312|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483313|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483314|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483315|NCT01127204|Lamivudine|lamivudine|mesh-list
2483316|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2483317|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2483318|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483319|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483320|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
2483321|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483322|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2483323|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2483324|NCT01127217|Losartan|losartan|mesh-list
2483325|NCT01127217|Amlodipine|amlodipine|mesh-list
2483326|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2371962|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
2371963|NCT00589953|Hematinics|hematinics|mesh-ancestor
2371964|NCT00589992|Ibutilide|ibutilide|mesh-list
2371965|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2371966|NCT00590070|Adenosine|adenosine|mesh-list
2371967|NCT00590070|Nitroprusside|nitroprusside|mesh-list
2371968|NCT00590070|Analgesics|analgesics|mesh-ancestor
2371969|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
2371970|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2371971|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371972|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2371973|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
2371974|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2483327|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2483328|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2483329|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483330|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2483331|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483332|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
2483333|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2483334|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2483335|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2483336|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
2483337|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2371975|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
2371976|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
2371977|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371978|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371979|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2371980|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2371981|NCT00590122|Levodopa|levodopa|mesh-list
2371982|NCT00590122|Carbidopa|carbidopa|mesh-list
2371983|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2371984|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2371985|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2371986|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
2371987|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2371988|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2371989|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2371990|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2371991|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2371992|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2371993|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
2371994|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
2371995|NCT00590174|Aspirin|aspirin|mesh-list
2371996|NCT00590174|Clopidogrel|clopidogrel|mesh-list
2371997|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2371998|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2371999|NCT00590174|Analgesics|analgesics|mesh-ancestor
2372000|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
2372001|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372002|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372003|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2372004|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2372005|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2372006|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2372007|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372008|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2372009|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2372010|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483338|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483339|NCT01127282|Vitamins|vitamins|mesh-list
2483340|NCT01127282|Vitamin A|vitamin a|mesh-list
2483341|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
2483342|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483343|NCT01127295|Tamoxifen|tamoxifen|mesh-list
2483344|NCT01127295|Letrozole|letrozole|mesh-list
2483345|NCT01127295|Anastrozole|anastrozole|mesh-list
2483346|NCT01127295|Exemestane|exemestane|mesh-list
2483347|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483348|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2483349|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2483350|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483351|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483352|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2483353|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
2483354|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2483355|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483356|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2483357|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2483358|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2483359|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2483360|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
2483361|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2483362|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483363|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2483364|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483365|NCT01127360|Bevacizumab|bevacizumab|mesh-list
2483366|NCT01127360|Ranibizumab|ranibizumab|mesh-list
2483367|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2483368|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483369|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2483370|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2483371|NCT01127360|Growth Substances|growth substances|mesh-ancestor
2483372|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372011|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
2372012|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2372013|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2372014|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2372015|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
2372016|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372017|NCT00590187|Sapacitabine|sapacitabine|mesh-list
2372018|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372019|NCT00590213|Bicalutamide|bicalutamide|mesh-list
2372020|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
2372021|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
2483373|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
2483374|NCT01127386|Lenalidomide|lenalidomide|mesh-list
2483375|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
2483376|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483377|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2483378|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2483379|NCT01127386|Growth Substances|growth substances|mesh-ancestor
2483380|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
2483381|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483382|NCT01127451|Denileukin diftitox|denileukin diftitox|mesh-list
2483383|NCT01127451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483384|NCT01127464|Poly ICLC|poly iclc|mesh-list
2483385|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
2483386|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
2483387|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483388|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2483389|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
2483390|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
2483391|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2483392|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2483393|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2483394|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2483395|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483396|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483397|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483398|NCT01127490|Analgesics|analgesics|mesh-ancestor
2483399|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
2483400|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483401|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
2483402|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2483403|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
2483404|NCT01127529|Protein C|protein c|mesh-list
2372022|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2372023|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372024|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372025|NCT00590278|Raltitrexed|raltitrexed|mesh-list
2372026|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2372027|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
2372028|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372029|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372030|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2372031|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372032|NCT00590343|Vatalanib|vatalanib|mesh-list
2372033|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2372034|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372035|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372036|NCT00590408|Ubiquinone|ubiquinone|mesh-list
2372037|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
2372038|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
2372039|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372040|NCT00590408|Vitamins|vitamins|mesh-ancestor
2372041|NCT00590447|Rituximab|rituximab|mesh-list
2372042|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2372043|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483405|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
2483406|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2483407|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2483408|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483409|NCT01127542|Lenalidomide|lenalidomide|mesh-list
2483410|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
2483411|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483412|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2483413|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2483414|NCT01127542|Growth Substances|growth substances|mesh-ancestor
2483415|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
2483416|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483417|NCT01127555|Leucovorin|leucovorin|mesh-list
2483418|NCT01127555|Fluorouracil|fluorouracil|mesh-list
2483419|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
2483420|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
2483421|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483422|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2483423|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372044|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
2372045|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483424|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2483425|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
2483426|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483427|NCT01127555|Antidotes|antidotes|mesh-ancestor
2483428|NCT01127555|Protective Agents|protective agents|mesh-ancestor
2483429|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
2483430|NCT01127555|Vitamins|vitamins|mesh-ancestor
2483431|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
2483432|NCT01127568|Propranolol|propranolol|mesh-list
2483433|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2483434|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2483435|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
2483436|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483437|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483438|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483439|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2483440|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2483441|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
2483442|NCT01127594|Temozolomide|temozolomide|mesh-list
2483443|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2483444|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
2483445|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483446|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483447|NCT01127620|Cetirizine|cetirizine|mesh-list
2483448|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2483449|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2483450|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2483451|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
2483452|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
2483453|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483454|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483455|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483456|NCT01127672|Betamethasone|betamethasone|mesh-list
2483457|NCT01127672|Lidocaine|lidocaine|mesh-list
2483458|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2483459|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
2483460|NCT01127672|Hormones|hormones|mesh-ancestor
2483461|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2483462|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483463|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2483464|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
2483465|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
2483466|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
2483467|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2483468|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
2483469|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483470|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2483471|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2483472|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2483473|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2483474|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483475|NCT01127724|Vitamins|vitamins|mesh-list
2483476|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
2483477|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
2483478|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
2483479|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
2483480|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483481|NCT01127724|Hematinics|hematinics|mesh-ancestor
2483482|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2483483|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2483484|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483485|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2483486|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
2483487|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483488|NCT01127841|Rituximab|rituximab|mesh-list
2483489|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2483490|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2483491|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483492|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
2483493|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483494|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2483495|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2483496|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
2372046|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2483497|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483498|NCT01127880|Clindamycin|clindamycin|mesh-list
2483499|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
2483500|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
2483501|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2483502|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483503|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2483504|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483505|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372047|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
2372048|NCT00590603|Bortezomib|bortezomib|mesh-list
2372049|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
2372050|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372051|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
2372052|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372053|NCT00590603|Protective Agents|protective agents|mesh-ancestor
2483506|NCT01127906|Oxycodone|oxycodone|mesh-list
2483507|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2483508|NCT01127906|Narcotics|narcotics|mesh-ancestor
2483509|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2483510|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483511|NCT01127906|Analgesics|analgesics|mesh-ancestor
2483512|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
2483513|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483514|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2483515|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
2372054|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372055|NCT00590603|Vitamins|vitamins|mesh-ancestor
2372056|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
2372057|NCT00590629|Niacin|niacin|mesh-list
2372058|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
2372059|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2372060|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
2372061|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372062|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2372063|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
2372064|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
2372065|NCT00590629|Vitamins|vitamins|mesh-ancestor
2372066|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
2372067|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372068|NCT00590694|Ranibizumab|ranibizumab|mesh-list
2372069|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2372070|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2372071|NCT00590694|Growth Substances|growth substances|mesh-ancestor
2483516|NCT01127984|Coagulants|coagulants|mesh-ancestor
2483517|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
2483518|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2483519|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
2483520|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483521|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483522|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
2483523|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483524|NCT01128101|Spironolactone|spironolactone|mesh-list
2483525|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2483526|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
2483527|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2483528|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483529|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2483530|NCT01128101|Diuretics|diuretics|mesh-ancestor
2483531|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
2483532|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2483533|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2483534|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
2483535|NCT01128257|Alendronate|alendronate|mesh-list
2372072|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372073|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
2372074|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372075|NCT00590785|Tamoxifen|tamoxifen|mesh-list
2372076|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
2372077|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
2372078|NCT00590785|Doxorubicin|doxorubicin|mesh-list
2483536|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
2483537|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2483538|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483539|NCT01128322|Niacin|niacin|mesh-list
2483540|NCT01128322|Amlodipine|amlodipine|mesh-list
2372079|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2372080|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
2483541|NCT01128322|Telmisartan|telmisartan|mesh-list
2372081|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372082|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2372083|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2372084|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
2372085|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372086|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483542|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2483543|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2483544|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2483545|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483546|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2483547|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372087|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2372088|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2372089|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2372090|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2372091|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483548|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
2483549|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2483550|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2483551|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2483552|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
2483553|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2483554|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
2483555|NCT01128322|Vitamins|vitamins|mesh-ancestor
2483556|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
2483557|NCT01128335|Tacrolimus|tacrolimus|mesh-list
2483558|NCT01128335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2483559|NCT01128335|Immunologic Factors|immunologic factors|mesh-ancestor
2483560|NCT01128335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372092|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2372093|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
2372094|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2372095|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2372096|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2372097|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2372098|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2372099|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2372100|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372101|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2372102|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2372103|NCT00590837|Lomustine|lomustine|mesh-list
2483561|NCT01128335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2483562|NCT01128335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483563|NCT01128335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483564|NCT01128530|Linezolid|linezolid|mesh-list
2483565|NCT01128530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2483566|NCT01128530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483567|NCT01128530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2483568|NCT01128530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483569|NCT01128530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483570|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
2483571|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2483572|NCT01128699|Bevacizumab|bevacizumab|mesh-list
2372104|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2372105|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
2372106|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372107|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372108|NCT00590915|Asparaginase|asparaginase|mesh-list
2372109|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372110|NCT00590928|Esomeprazole|esomeprazole|mesh-list
2372111|NCT00590928|Ranitidine|ranitidine|mesh-list
2483573|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2483574|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483575|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2483576|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2483577|NCT01128699|Growth Substances|growth substances|mesh-ancestor
2483578|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483579|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
2483580|NCT01128712|Pregabalin|pregabalin|mesh-list
2483581|NCT01128712|Analgesics|analgesics|mesh-ancestor
2372112|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2483582|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
2483583|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483584|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483585|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
2483586|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2483587|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2483588|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483589|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2483590|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2483591|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2483592|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2483593|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2483594|NCT01128985|Canagliflozin|canagliflozin|mesh-list
2483595|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2483596|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483597|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2483598|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483599|NCT01128998|Sorafenib|sorafenib|mesh-list
2483600|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483601|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2483602|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483603|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483604|NCT01129063|Clopidogrel|clopidogrel|mesh-list
2483605|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2483606|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2483607|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2483608|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2483609|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
2483610|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483611|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483612|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483613|NCT01129089|Micronutrients|micronutrients|mesh-list
2483614|NCT01129089|Trace Elements|trace elements|mesh-list
2483615|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483616|NCT01129154|Panitumumab|panitumumab|mesh-list
2483617|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2483618|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483619|NCT01129180|Bortezomib|bortezomib|mesh-list
2483620|NCT01129180|Azacitidine|azacitidine|mesh-list
2483621|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483622|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2483623|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
2483624|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483625|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483626|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
2483627|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483628|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483629|NCT01129271|Clopidogrel|clopidogrel|mesh-list
2483630|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2483631|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2483632|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2483633|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2483634|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
2483635|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483636|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483637|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483638|NCT01129310|Capecitabine|capecitabine|mesh-list
2483639|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
2483640|NCT01129310|Irinotecan|irinotecan|mesh-list
2483641|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2483642|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
2483643|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483644|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483645|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2372113|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2372114|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2372115|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2372116|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372117|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372118|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2372119|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
2483668|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483669|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483670|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2483671|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2483672|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2483673|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483674|NCT01129388|Omeprazole|omeprazole|mesh-list
2483675|NCT01129388|Clopidogrel|clopidogrel|mesh-list
2483676|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2483677|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2483678|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2483679|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2483680|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
2483681|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483682|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483683|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483684|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2483685|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2483686|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2483687|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483688|NCT01129414|Omeprazole|omeprazole|mesh-list
2483689|NCT01129414|Clopidogrel|clopidogrel|mesh-list
2483690|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2483691|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2483692|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2483693|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2483694|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
2483695|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483696|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483697|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483698|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2483699|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2483700|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2483701|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483702|NCT01129427|Pantoprazole|pantoprazole|mesh-list
2483703|NCT01129427|Clopidogrel|clopidogrel|mesh-list
2483704|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2483705|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2483706|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2483707|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2483708|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
2483709|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483710|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483711|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483712|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2483713|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2483714|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2483715|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483716|NCT01129479|Galantamine|galantamine|mesh-list
2483717|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2483718|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483719|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483720|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
2483721|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483722|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483723|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2483724|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
2483725|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483726|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
2483727|NCT01129518|Vaccines|vaccines|mesh-list
2483728|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
2483729|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483730|NCT01129570|Silybin|silybin|mesh-list
2483731|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2372170|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372171|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372172|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
2372173|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372174|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2372175|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
2483732|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483733|NCT01129570|Protective Agents|protective agents|mesh-ancestor
2483734|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483735|NCT01129596|Donepezil|donepezil|mesh-list
2483736|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2483737|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483738|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372176|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372177|NCT00591604|Vitamin D|vitamin d|mesh-list
2372178|NCT00591604|Vitamins|vitamins|mesh-ancestor
2372179|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
2372180|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372181|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2372182|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2372183|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2372184|NCT00591617|Narcotics|narcotics|mesh-ancestor
2372185|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2372186|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372187|NCT00591617|Analgesics|analgesics|mesh-ancestor
2372188|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
2372189|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372190|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2372191|NCT00591643|Epinephrine|epinephrine|mesh-list
2372192|NCT00591643|Racepinephrine|racepinephrine|mesh-list
2483739|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
2483740|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483741|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483742|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
2483743|NCT01129648|Allopurinol|allopurinol|mesh-list
2483744|NCT01129648|Antimetabolites|antimetabolites|mesh-ancestor
2483745|NCT01129648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483746|NCT01129648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483747|NCT01129648|Gout Suppressants|gout suppressants|mesh-ancestor
2483748|NCT01129648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2483749|NCT01129648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2483750|NCT01129648|Antioxidants|antioxidants|mesh-ancestor
2483751|NCT01129648|Protective Agents|protective agents|mesh-ancestor
2483752|NCT01129648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483753|NCT01129674|Olanzapine|olanzapine|mesh-list
2372193|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
2372194|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2372195|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2372196|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
2372197|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372198|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372199|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372200|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2483754|NCT01129674|Risperidone|risperidone|mesh-list
2483755|NCT01129674|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2483756|NCT01129674|Aripiprazole|aripiprazole|mesh-list
2483757|NCT01129674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2483758|NCT01129674|Serotonin Agents|serotonin agents|mesh-ancestor
2483759|NCT01129674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483760|NCT01129674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483761|NCT01129674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483762|NCT01129674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2483763|NCT01129674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2483764|NCT01129674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2483765|NCT01129674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2483766|NCT01129674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2483767|NCT01129674|Dopamine Agents|dopamine agents|mesh-ancestor
2483768|NCT01129674|Antiemetics|antiemetics|mesh-ancestor
2483769|NCT01129674|Autonomic Agents|autonomic agents|mesh-ancestor
2483770|NCT01129674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483771|NCT01129674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2483772|NCT01129674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2483773|NCT01129674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2483774|NCT01129674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2483775|NCT01129674|Antidepressive Agents|antidepressive agents|mesh-ancestor
2483776|NCT01129674|Dopamine Agonists|dopamine agonists|mesh-ancestor
2483777|NCT01129674|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2483778|NCT01129674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2483779|NCT01129674|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2372201|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2372202|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
2372203|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483780|NCT01129674|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2483781|NCT01129713|Esomeprazole|esomeprazole|mesh-list
2483782|NCT01129713|Omeprazole|omeprazole|mesh-list
2372204|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2483783|NCT01129713|Lansoprazole|lansoprazole|mesh-list
2483784|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2483785|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2483786|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2483787|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483788|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483789|NCT01129739|Cyclosporine|cyclosporine|mesh-list
2483790|NCT01129739|Cyclosporins|cyclosporins|mesh-list
2483791|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372205|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
2372206|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
2372207|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
2372208|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2114051|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114052|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114053|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2114054|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2114055|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
2114056|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
2114057|NCT02596945|Hematinics|hematinics|mesh-ancestor
2114058|NCT02596958|Bevacizumab|bevacizumab|mesh-list
2114059|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2114060|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483792|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483793|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2483794|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
2483795|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483796|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
2483797|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483798|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
2483799|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2483800|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2483801|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2483802|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2483803|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
2483804|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483805|NCT01129856|Dexamethasone|dexamethasone|mesh-list
2483806|NCT01129856|Citric Acid|citric acid|mesh-list
2483807|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
2483808|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2483809|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2483810|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2483811|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2483812|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
2483813|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
2483814|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483815|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483816|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2483817|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
2483818|NCT01129856|Hormones|hormones|mesh-ancestor
2483819|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2114061|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2114062|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2114063|NCT02596958|Growth Substances|growth substances|mesh-ancestor
2114064|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114065|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
2114066|NCT02596971|Prednisone|prednisone|mesh-list
2114067|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
2114068|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2114069|NCT02596971|Rituximab|rituximab|mesh-list
2114070|NCT02596971|Doxorubicin|doxorubicin|mesh-list
2114071|NCT02596971|Vincristine|vincristine|mesh-list
2114072|NCT02596971|Atezolizumab|atezolizumab|mesh-list
2114073|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
2114074|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2114075|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
2114076|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114077|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2114078|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2114079|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
2114080|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114081|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114082|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2114083|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2483820|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2483821|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372209|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
2372210|NCT00591708|Citric Acid|citric acid|mesh-list
2372211|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
2372212|NCT00591708|Calcium|calcium|mesh-list
2372213|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
2372214|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2372215|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372216|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2372217|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
2372218|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2372219|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
2372220|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
2372221|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372222|NCT00591916|Thrombin|thrombin|mesh-list
2372223|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
2372224|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
2372225|NCT00591916|Coagulants|coagulants|mesh-ancestor
2372226|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2372227|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
2372228|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372229|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
2372230|NCT00591916|Protective Agents|protective agents|mesh-ancestor
2372231|NCT00591994|Piribedil|piribedil|mesh-list
2372232|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2372233|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2372234|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
2372235|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
2483822|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
2483823|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2483824|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
2483825|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
2483826|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483827|NCT01129934|Promethazine|promethazine|mesh-list
2483828|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
2483829|NCT01129934|Morphine|morphine|mesh-list
2483830|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2483831|NCT01129934|Narcotics|narcotics|mesh-ancestor
2483832|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2483833|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483834|NCT01129934|Analgesics|analgesics|mesh-ancestor
2483835|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
2483836|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483837|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
2483838|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
2483839|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2483840|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
2483841|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
2483842|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372236|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372237|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372238|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483843|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483844|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2483845|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2372239|NCT00592111|Prednisone|prednisone|mesh-list
2372240|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
2372241|NCT00592111|Etoposide|etoposide|mesh-list
2483846|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2483847|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
2483848|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
2483849|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
2483850|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
2483851|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2483852|NCT01130025|Tinzaparin|tinzaparin|mesh-list
2483853|NCT01130025|Warfarin|warfarin|mesh-list
2483854|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
2483855|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2483856|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2483857|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483858|NCT01130077|Poly ICLC|poly iclc|mesh-list
2483859|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
2483860|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
2483861|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483862|NCT01130142|Gemcitabine|gemcitabine|mesh-list
2483863|NCT01130142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2483864|NCT01130142|Antimetabolites|antimetabolites|mesh-ancestor
2483865|NCT01130142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372242|NCT00592111|Vincristine|vincristine|mesh-list
2483866|NCT01130142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483867|NCT01130142|Antiviral Agents|antiviral agents|mesh-ancestor
2483868|NCT01130142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483869|NCT01130142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483870|NCT01130142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2483871|NCT01130142|Immunologic Factors|immunologic factors|mesh-ancestor
2483872|NCT01130142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483873|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
2483874|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2372243|NCT00592111|Doxorubicin|doxorubicin|mesh-list
2372244|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2372245|NCT00592111|Bleomycin|bleomycin|mesh-list
2372246|NCT00592111|Vinblastine|vinblastine|mesh-list
2372247|NCT00592111|Procarbazine|procarbazine|mesh-list
2372248|NCT00592111|Mitogens|mitogens|mesh-list
2372249|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2483875|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483876|NCT01130181|Vitamins|vitamins|mesh-ancestor
2483877|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
2483878|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2483879|NCT01130194|Procarbazine|procarbazine|mesh-list
2483880|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483881|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
2483882|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2483883|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483884|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483885|NCT01130259|Iniparib|iniparib|mesh-list
2483886|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2483887|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483888|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483889|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483890|NCT01130298|Testosterone|testosterone|mesh-list
2483891|NCT01130298|Androgens|androgens|mesh-ancestor
2483892|NCT01130298|Hormones|hormones|mesh-ancestor
2483893|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2483894|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483895|NCT01130311|Vitamin D|vitamin d|mesh-list
2483896|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
2483897|NCT01130311|Vitamins|vitamins|mesh-ancestor
2483898|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
2483899|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483900|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2483901|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2483902|NCT01130324|Telavancin|telavancin|mesh-list
2483903|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2483904|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483905|NCT01130376|Aldesleukin|aldesleukin|mesh-list
2483906|NCT01130376|Interleukin-2|interleukin-2|mesh-list
2483907|NCT01130376|Hormones|hormones|mesh-list
2483908|NCT01130376|Sargramostim|sargramostim|mesh-list
2483909|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2483910|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483911|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483912|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2483913|NCT01130376|Analgesics|analgesics|mesh-ancestor
2483914|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
2483915|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483916|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
2483917|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2483918|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2483919|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
2483920|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483921|NCT01130467|Methylphenidate|methylphenidate|mesh-list
2483922|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2483923|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2483924|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483925|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2483926|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2483927|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2483928|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483929|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
2483930|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2483931|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2483932|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
2483933|NCT01130506|Cytarabine|cytarabine|mesh-list
2483934|NCT01130506|Decitabine|decitabine|mesh-list
2483935|NCT01130506|Vorinostat|vorinostat|mesh-list
2372250|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
2372251|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483936|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2483937|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
2483938|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483939|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483940|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
2483941|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483942|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2483943|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
2483944|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483945|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483946|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2483959|NCT01130636|Oseltamivir|oseltamivir|mesh-list
2483960|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
2483961|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2483962|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483963|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483964|NCT01130662|Decitabine|decitabine|mesh-list
2483965|NCT01130662|Midostaurin|midostaurin|mesh-list
2483966|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2483967|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
2483968|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483969|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483970|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483971|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2483972|NCT01130688|Zileuton|zileuton|mesh-list
2483973|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2483974|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2483975|NCT01130688|Analgesics|analgesics|mesh-ancestor
2483976|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
2483977|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2483978|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2483979|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2483980|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2483981|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2483982|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483983|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483984|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2483985|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
2483986|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2483987|NCT01130701|Capecitabine|capecitabine|mesh-list
2483988|NCT01130701|Panitumumab|panitumumab|mesh-list
2483989|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2483990|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
2483991|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483992|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483993|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2483994|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2483995|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2483996|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2483997|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2483998|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2483999|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2484000|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484001|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2484002|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484003|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484004|NCT01130805|Capecitabine|capecitabine|mesh-list
2372252|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2372253|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2484005|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
2484006|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2484007|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
2484008|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484009|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484010|NCT01130909|Ketamine|ketamine|mesh-list
2484011|NCT01130909|Analgesics|analgesics|mesh-ancestor
2484012|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
2484013|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484014|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484015|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2484016|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2484017|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
2484018|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
2484019|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2484020|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2484021|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2484022|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484023|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484024|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
2484025|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2484026|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2484027|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484028|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2484029|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2484030|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484031|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484032|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484033|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2484034|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
2484035|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2484036|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484037|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2484038|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2484039|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2484040|NCT01131000|Ibuprofen|ibuprofen|mesh-list
2484041|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2484042|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2484043|NCT01131000|Analgesics|analgesics|mesh-ancestor
2484044|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
2484045|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484046|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484047|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2484048|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2484049|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2484050|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484051|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484052|NCT01131026|Amoxicillin|amoxicillin|mesh-list
2372254|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
2372255|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372256|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372257|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2372258|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2372259|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
2484053|NCT01131026|Levofloxacin|levofloxacin|mesh-list
2484054|NCT01131026|Ofloxacin|ofloxacin|mesh-list
2484055|NCT01131026|Lansoprazole|lansoprazole|mesh-list
2484056|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
2484057|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2484058|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484059|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2484060|NCT01131026|Renal Agents|renal agents|mesh-ancestor
2484061|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2484062|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2484063|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484064|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484065|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484066|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2484067|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2484068|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2484069|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2372260|NCT00592111|Hormones|hormones|mesh-ancestor
2372261|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2484070|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2484071|NCT01131039|Gemcitabine|gemcitabine|mesh-list
2484072|NCT01131039|Bevacizumab|bevacizumab|mesh-list
2484073|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2484074|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484075|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2484076|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2484077|NCT01131039|Growth Substances|growth substances|mesh-ancestor
2484078|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484079|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
2484080|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2484081|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
2484082|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484083|NCT01131039|Antiviral Agents|antiviral agents|mesh-ancestor
2484084|NCT01131039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484085|NCT01131039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484086|NCT01131039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2484087|NCT01131039|Immunologic Factors|immunologic factors|mesh-ancestor
2484088|NCT01131195|Paclitaxel|paclitaxel|mesh-list
2484089|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
2484090|NCT01131195|Bevacizumab|bevacizumab|mesh-list
2484091|NCT01131195|Capecitabine|capecitabine|mesh-list
2484092|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2484093|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484094|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
2484095|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
2484096|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
2484097|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484098|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2484099|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
2484100|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484101|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2484102|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2484103|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
2372262|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2372263|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2372264|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2372265|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2372266|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372267|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
2372268|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
2372269|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
2372270|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2372271|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
2372272|NCT00592137|Calcium|calcium|mesh-list
2372273|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2372274|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372275|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2372276|NCT00592150|Fenoldopam|fenoldopam|mesh-list
2372277|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2372278|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
2372279|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
2372280|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
2372281|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372282|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372283|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372284|NCT00592215|Misoprostol|misoprostol|mesh-list
2372285|NCT00592215|Mifepristone|mifepristone|mesh-list
2372286|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2372287|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
2372288|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2372289|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484104|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2484105|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2484106|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2484107|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2484108|NCT01131195|Growth Substances|growth substances|mesh-ancestor
2484109|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
2484110|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2484111|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
2484112|NCT01131234|Cediranib|cediranib|mesh-list
2484113|NCT01131234|R04929097|r04929097|mesh-list
2484114|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484115|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484116|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484117|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2484118|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2484119|NCT01131247|Ofatumumab|ofatumumab|mesh-list
2484120|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2484121|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2484122|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
2484123|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484124|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484125|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
2484126|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484127|NCT01131273|Buprenorphine|buprenorphine|mesh-list
2484128|NCT01131273|Methadone|methadone|mesh-list
2484129|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2484130|NCT01131273|Naloxone|naloxone|mesh-list
2484131|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2484132|NCT01131273|Narcotics|narcotics|mesh-ancestor
2372290|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2372291|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2372292|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
2372293|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2372294|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2372295|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2372296|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2372297|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
2372298|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2372299|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2372300|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
2372301|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2372302|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
2372303|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2372304|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2372305|NCT00592241|Insulin|insulin|mesh-list
2372306|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2372307|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2372308|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372309|NCT00592280|Pancrelipase|pancrelipase|mesh-list
2372310|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2372311|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
2372312|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2372313|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
2372314|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372315|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2372316|NCT00592332|Alprazolam|alprazolam|mesh-list
2372317|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2372318|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2372319|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372320|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2372321|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2372322|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2372323|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
2372324|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
2372325|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372326|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372327|NCT00592410|Insulin|insulin|mesh-list
2372328|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2372329|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2372330|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372331|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
2372332|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2372333|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372334|NCT00592566|Dexamethasone|dexamethasone|mesh-list
2372335|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2372336|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2372337|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
2372338|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
2372339|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372340|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372341|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2372342|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
2372343|NCT00592566|Hormones|hormones|mesh-ancestor
2372344|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2372345|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2372346|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484133|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2484134|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484135|NCT01131273|Analgesics|analgesics|mesh-ancestor
2484136|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
2484137|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484138|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2484139|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
2484140|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
2484141|NCT01131364|Doxorubicin|doxorubicin|mesh-list
2484142|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2484143|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484144|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2484145|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2484146|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372347|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
2372348|NCT00592566|Coagulants|coagulants|mesh-ancestor
2372349|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2372350|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
2372351|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
2372352|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372353|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
2372354|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
2372355|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
2372356|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372357|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
2372358|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2372359|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
2372360|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372361|NCT00592618|Expectorants|expectorants|mesh-ancestor
2372362|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
2372363|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2372364|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
2484147|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484148|NCT01131377|Acetazolamide|acetazolamide|mesh-list
2484149|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
2484150|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2484151|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484152|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484153|NCT01131377|Diuretics|diuretics|mesh-ancestor
2484154|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
2484155|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484156|NCT01131429|Cisplatin|cisplatin|mesh-list
2484157|NCT01131429|Docetaxel|docetaxel|mesh-list
2484158|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2484159|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484160|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
2484161|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
2484162|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
2484163|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484164|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2484165|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484166|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
2484167|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2484168|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
2484169|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484170|NCT01131468|Expectorants|expectorants|mesh-ancestor
2484171|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
2484172|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2484173|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
2484174|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484175|NCT01131468|Protective Agents|protective agents|mesh-ancestor
2484176|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484177|NCT01131468|Antidotes|antidotes|mesh-ancestor
2484178|NCT01131546|Amlodipine|amlodipine|mesh-list
2484179|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2484180|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2484181|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2484182|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484183|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2484184|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484185|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
2484186|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2484187|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2484188|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484189|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2484190|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2484191|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372365|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372366|NCT00592618|Protective Agents|protective agents|mesh-ancestor
2372367|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372368|NCT00592618|Antidotes|antidotes|mesh-ancestor
2372369|NCT00592670|Fluoxetine|fluoxetine|mesh-list
2372370|NCT00592670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2372371|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2372372|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372373|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372374|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372375|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
2372376|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372377|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2372378|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
2372379|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2372380|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2372381|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2372382|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372383|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
2372384|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
2372385|NCT00592917|Calcium|calcium|mesh-list
2372386|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2372387|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372388|NCT00592917|Vitamins|vitamins|mesh-ancestor
2484192|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484193|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
2484194|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484195|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
2484196|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2484197|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
2484198|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484199|NCT01131572|Expectorants|expectorants|mesh-ancestor
2484200|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
2484201|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2484202|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
2484203|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484204|NCT01131572|Protective Agents|protective agents|mesh-ancestor
2372389|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
2372390|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2372391|NCT00592917|Antacids|antacids|mesh-ancestor
2372392|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372393|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2372394|NCT00592930|Olanzapine|olanzapine|mesh-list
2372395|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
2372396|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
2372397|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372398|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372399|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2372400|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2372401|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2372402|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2372403|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2372404|NCT00592930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2372405|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2372406|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372407|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372408|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372409|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
2372410|NCT00592969|Metformin|metformin|mesh-list
2372411|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
2484205|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484206|NCT01131572|Antidotes|antidotes|mesh-ancestor
2484207|NCT01131689|Sorafenib|sorafenib|mesh-list
2484208|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484209|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2484210|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484211|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484212|NCT01131702|Ranitidine|ranitidine|mesh-list
2484213|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2484214|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2484215|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2484216|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2484217|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
2484218|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
2484219|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484220|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484221|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484222|NCT01131728|Naproxen|naproxen|mesh-list
2484223|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
2484224|NCT01131728|Ephedrine|ephedrine|mesh-list
2484225|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2484226|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2484227|NCT01131728|Analgesics|analgesics|mesh-ancestor
2484228|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
2484229|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484230|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484231|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2484232|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2484233|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
2484234|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2484235|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484236|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484237|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2484238|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
2484239|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2484240|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
2484241|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
2484242|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2484243|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2484244|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
2484245|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
2484246|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484247|NCT01131741|Epinephrine|epinephrine|mesh-list
2484248|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2484249|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2484250|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
2484251|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484252|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484253|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484254|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2484255|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2484256|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
2484257|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484258|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2484259|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
2484260|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
2484261|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
2484262|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2484263|NCT01131754|Heparin|heparin|mesh-list
2484264|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
2484265|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2484266|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2484267|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484268|NCT01131767|Naproxen|naproxen|mesh-list
2484269|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
2484270|NCT01131767|Ephedrine|ephedrine|mesh-list
2484271|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2484272|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2484273|NCT01131767|Analgesics|analgesics|mesh-ancestor
2484274|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
2484275|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484276|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484277|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2484278|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2484279|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
2484280|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2372412|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
2372413|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2372414|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372415|NCT00593008|Gemcitabine|gemcitabine|mesh-list
2372416|NCT00593008|Sirolimus|sirolimus|mesh-list
2372417|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2372418|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
2372419|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372420|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372421|NCT00593008|Antiviral Agents|antiviral agents|mesh-ancestor
2372422|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372423|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372424|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2372425|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
2372426|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484281|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372427|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2372428|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2372429|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
2372430|NCT00593060|Sirolimus|sirolimus|mesh-list
2372431|NCT00593060|Cetuximab|cetuximab|mesh-list
2484282|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484283|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2484284|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
2372432|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2372433|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372434|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2372435|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372436|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2372437|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
2372438|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2372439|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
2372440|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372441|NCT00593099|Bupropion|bupropion|mesh-list
2372442|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2372443|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
2372444|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2372445|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2372446|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2372447|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372448|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372449|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
2372450|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372451|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372452|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2372453|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2372454|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372455|NCT00593125|Levetiracetam|levetiracetam|mesh-list
2372456|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
2372457|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
2372458|NCT00593138|Methylphenidate|methylphenidate|mesh-list
2372459|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
2372460|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2372461|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372462|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2372463|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2372464|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372465|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372466|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
2372467|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372468|NCT00593151|Interferons|interferons|mesh-list
2372469|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
2372470|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
2372471|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2484285|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2484286|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
2484287|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
2484288|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2484289|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2484290|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
2484291|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
2484292|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484293|NCT01131780|Ibuprofen|ibuprofen|mesh-list
2372472|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372473|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
2372474|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372475|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
2372476|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372477|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
2372478|NCT00593164|Analgesics|analgesics|mesh-ancestor
2372479|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
2372480|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372481|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372482|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
2372483|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2372484|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2372485|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
2372486|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2372487|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372488|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372489|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2372490|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
2372491|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2372492|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
2372493|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2372494|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372495|NCT00593255|Insulin|insulin|mesh-list
2372496|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2372497|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
2484294|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
2484295|NCT01131780|Ephedrine|ephedrine|mesh-list
2484296|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2484297|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2484298|NCT01131780|Analgesics|analgesics|mesh-ancestor
2484299|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
2484300|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484301|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484302|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2484303|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2484304|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2484305|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484306|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484307|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2484308|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
2484309|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2484310|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
2372498|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
2372499|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
2372500|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
2372501|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2372502|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372503|NCT00593294|Drospirenone|drospirenone|mesh-list
2372504|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2372505|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372506|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2372507|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
2372508|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2372509|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2372510|NCT00593294|Diuretics|diuretics|mesh-ancestor
2372511|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
2372512|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2484311|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
2484312|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2484313|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2484314|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
2484315|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
2484316|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484317|NCT01131806|Fluticasone|fluticasone|mesh-list
2484318|NCT01131806|Xhance|xhance|mesh-list
2484319|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2484320|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2484321|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2484322|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2484323|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
2484324|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484325|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484326|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2484327|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
2484328|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
2484329|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2484330|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2484331|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2484332|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2372513|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2372514|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2372515|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
2372516|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2372517|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2372518|NCT00593294|Estrogens|estrogens|mesh-ancestor
2372519|NCT00593294|Hormones|hormones|mesh-ancestor
2372520|NCT00593463|Cycloserine|cycloserine|mesh-list
2372521|NCT00593463|Verapamil|verapamil|mesh-list
2372522|NCT00593463|Diltiazem|diltiazem|mesh-list
2372523|NCT00593463|Isradipine|isradipine|mesh-list
2484333|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
2372524|NCT00593463|Nifedipine|nifedipine|mesh-list
2484334|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372525|NCT00593463|Gabapentin|gabapentin|mesh-list
2372526|NCT00593463|Naloxone|naloxone|mesh-list
2372527|NCT00593463|Analgesics|analgesics|mesh-ancestor
2484335|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484336|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
2484337|NCT01131806|Hormones|hormones|mesh-ancestor
2372528|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
2372529|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372530|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372531|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
2372532|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2372533|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2372534|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2372535|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2484338|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2484339|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
2484340|NCT01131845|Treprostinil|treprostinil|mesh-list
2484341|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2484342|NCT01131897|Levetiracetam|levetiracetam|mesh-list
2484343|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
2484344|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
2484345|NCT01131910|Vaccines|vaccines|mesh-list
2484346|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
2484347|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484348|NCT01131923|Amlodipine|amlodipine|mesh-list
2484349|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2372536|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2372537|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2484350|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2484351|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2484352|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484353|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2484354|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484355|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
2372538|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372539|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372540|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
2372541|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2372542|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2372543|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2484356|NCT01131936|Amlodipine|amlodipine|mesh-list
2484357|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2484358|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2484359|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2484360|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484361|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2484362|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484363|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
2484364|NCT01131949|Lamotrigine|lamotrigine|mesh-list
2484365|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
2484366|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2484367|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2484368|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484369|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2484370|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484371|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2484372|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2484373|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2484374|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2484375|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2484376|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
2484377|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2484378|NCT01131975|Lamotrigine|lamotrigine|mesh-list
2484379|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
2484380|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2484381|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2484382|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484383|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2484384|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484385|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2484386|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2372544|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2372545|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
2484387|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2484388|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2372546|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
2372547|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2372548|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2372549|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372550|NCT00593463|Renal Agents|renal agents|mesh-ancestor
2372551|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2372552|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
2372553|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2372554|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
2372555|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2372556|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2372557|NCT00593502|Oseltamivir|oseltamivir|mesh-list
2484389|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2484390|NCT01131988|Tacrolimus|tacrolimus|mesh-list
2484391|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2484392|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
2484393|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484394|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2484395|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484396|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484397|NCT01132027|Tacrolimus|tacrolimus|mesh-list
2484398|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2484399|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
2484400|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484401|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2484402|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484403|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484404|NCT01132040|Primidone|primidone|mesh-list
2372558|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
2372559|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372560|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372561|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372562|NCT00593567|Levofloxacin|levofloxacin|mesh-list
2372563|NCT00593567|Ofloxacin|ofloxacin|mesh-list
2372564|NCT00593567|Gentamicins|gentamicins|mesh-list
2372565|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2372566|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372567|NCT00593567|Renal Agents|renal agents|mesh-ancestor
2372568|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2372569|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2372570|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2372571|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372572|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372573|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372574|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2372575|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2484405|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
2484406|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
2484407|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
2484408|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484409|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484410|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484411|NCT01132157|Propofol|propofol|mesh-list
2372576|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2372577|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
2372578|NCT00593580|Alendronate|alendronate|mesh-list
2372579|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2372580|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372581|NCT00593580|Vitamins|vitamins|mesh-ancestor
2372582|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
2372583|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2372584|NCT00593619|Iron|iron|mesh-list
2372585|NCT00593619|Dextrans|dextrans|mesh-list
2372586|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2372587|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
2372588|NCT00593619|Trace Elements|trace elements|mesh-ancestor
2372589|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
2372590|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484412|NCT01132157|Desflurane|desflurane|mesh-list
2484413|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2484414|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2484415|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484416|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2372591|NCT00593619|Hematinics|hematinics|mesh-ancestor
2372592|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
2372593|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
2372594|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
2372595|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
2372596|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2372597|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372598|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372599|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2372600|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2372601|NCT00593658|Protective Agents|protective agents|mesh-ancestor
2372602|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372603|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
2372604|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2372605|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
2372606|NCT00593697|Docetaxel|docetaxel|mesh-list
2372607|NCT00593697|Trastuzumab|trastuzumab|mesh-list
2372608|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372609|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
2372610|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
2372611|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
2372612|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372613|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2372614|NCT00593710|Losartan|losartan|mesh-list
2372615|NCT00593710|Atenolol|atenolol|mesh-list
2372616|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2372617|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2372618|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2372619|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2372620|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372621|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
2484417|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
2484418|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
2484419|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2484420|NCT01132170|Valproic Acid|valproic acid|mesh-list
2484421|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
2484422|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484423|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484424|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
2484425|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484426|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484427|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
2484428|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2484429|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2484430|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2484431|NCT01132183|Valproic Acid|valproic acid|mesh-list
2484432|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
2484433|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484434|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484435|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
2484436|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484437|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484438|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
2484439|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2484440|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2484441|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2484442|NCT01132196|Valproic Acid|valproic acid|mesh-list
2484443|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
2484444|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484445|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484446|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
2484447|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484448|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484449|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
2484450|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2484451|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2484452|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2484453|NCT01132222|Ibuprofen|ibuprofen|mesh-list
2484454|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
2484455|NCT01132222|Ephedrine|ephedrine|mesh-list
2484456|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2484457|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2484458|NCT01132222|Analgesics|analgesics|mesh-ancestor
2484459|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
2484460|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484461|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484462|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2484463|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2484464|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2484465|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484466|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484467|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2484468|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
2372622|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
2372623|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372624|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372625|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2372626|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2372627|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2372628|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
2372629|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372630|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
2372631|NCT00593801|Hematinics|hematinics|mesh-ancestor
2372632|NCT00593853|Methylphenidate|methylphenidate|mesh-list
2372633|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2372634|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372635|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2372636|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2372637|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372638|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372639|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
2372640|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372641|NCT00593879|Mecamylamine|mecamylamine|mesh-list
2372642|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2484469|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2484470|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
2484471|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
2484472|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2484473|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2484474|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
2484475|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
2484476|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484477|NCT01132235|Etanercept|etanercept|mesh-list
2484478|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2484479|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2484480|NCT01132235|Analgesics|analgesics|mesh-ancestor
2484481|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
2484482|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484483|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372643|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2372644|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
2372645|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372646|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372647|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2372648|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2372649|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
2372650|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372651|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114084|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2114085|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2114086|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2114087|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114088|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2114089|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
2114090|NCT02596971|Hormones|hormones|mesh-ancestor
2114091|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2484484|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2484485|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2484486|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2484487|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2484488|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
2484489|NCT01132248|Mefloquine|mefloquine|mesh-list
2484490|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
2484491|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2484492|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2484493|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484494|NCT01132352|Levetiracetam|levetiracetam|mesh-list
2422903|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484495|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
2484496|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
2484497|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
2484498|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
2484499|NCT01132404|Leuprolide|leuprolide|mesh-list
2372658|NCT00593996|Vitamin D|vitamin d|mesh-list
2372659|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
2372660|NCT00593996|Vitamins|vitamins|mesh-ancestor
2372661|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
2372662|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372663|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2372664|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2372665|NCT00594087|Eszopiclone|eszopiclone|mesh-list
2372666|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2372667|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2372668|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372669|NCT00594126|Imetelstat|imetelstat|mesh-list
2372670|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
2372671|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372672|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372673|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2372674|NCT00594191|Simvastatin|simvastatin|mesh-list
2372675|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2484500|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2484501|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
2484502|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2484503|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484504|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2484505|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484506|NCT01132417|Tigecycline|tigecycline|mesh-list
2484507|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2484508|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484509|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2484510|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484511|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484512|NCT01132443|Clindamycin|clindamycin|mesh-list
2484513|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
2484514|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
2484515|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2484516|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2484517|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484518|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2484519|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484520|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484521|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
2484522|NCT01132521|Urinastatin|urinastatin|mesh-list
2484523|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
2484524|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2484525|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
2484526|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484527|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484528|NCT01132573|Clofarabine|clofarabine|mesh-list
2484529|NCT01132573|Entinostat|entinostat|mesh-list
2484530|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2484531|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2484532|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
2484533|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484534|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484535|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484536|NCT01132586|Cytarabine|cytarabine|mesh-list
2484537|NCT01132586|Lenalidomide|lenalidomide|mesh-list
2484538|NCT01132586|Idarubicin|idarubicin|mesh-list
2484539|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2484540|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
2484541|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484542|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484543|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
2484544|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484545|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2484546|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
2484547|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484548|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2484549|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2484550|NCT01132586|Growth Substances|growth substances|mesh-ancestor
2484551|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
2484552|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2484553|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2484554|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2484555|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484556|NCT01132599|Choline|choline|mesh-list
2484557|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
2484558|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2484559|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
2484560|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484561|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2484562|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2484563|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
2484564|NCT01132638|Esomeprazole|esomeprazole|mesh-list
2372676|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2372677|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
2372678|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372679|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2372680|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2372681|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372682|NCT00594217|Progesterone|progesterone|mesh-list
2372683|NCT00594217|Progestins|progestins|mesh-ancestor
2372684|NCT00594217|Hormones|hormones|mesh-ancestor
2372685|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2372686|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372687|NCT00594269|Risperidone|risperidone|mesh-list
2372688|NCT00594269|Citalopram|citalopram|mesh-list
2372689|NCT00594269|Sertraline|sertraline|mesh-list
2372690|NCT00594269|Paroxetine|paroxetine|mesh-list
2372691|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2372692|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
2372693|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372694|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372695|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372696|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2484565|NCT01132638|Pantoprazole|pantoprazole|mesh-list
2484566|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2484567|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2484568|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2484569|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484570|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484571|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
2484572|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2484573|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2484574|NCT01132677|Prednisolone|prednisolone|mesh-list
2484575|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
2484576|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2484577|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
2484578|NCT01132677|Hylan|hylan|mesh-list
2484579|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2484580|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
2484581|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
2484582|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484583|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484584|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2484585|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
2484586|NCT01132677|Hormones|hormones|mesh-ancestor
2484587|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2484588|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2484589|NCT01132677|Protective Agents|protective agents|mesh-ancestor
2484590|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2372697|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2372698|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2372699|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2372700|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2484591|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484592|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
2484593|NCT01132703|Glyburide|glyburide|mesh-list
2484594|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2484595|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484596|NCT01132716|Valacyclovir|valacyclovir|mesh-list
2484597|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
2484598|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484599|NCT01132729|Valacyclovir|valacyclovir|mesh-list
2484600|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
2484601|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372701|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
2484602|NCT01132768|Atenolol|atenolol|mesh-list
2484603|NCT01132768|Olmesartan|olmesartan|mesh-list
2484604|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2372702|NCT00594269|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2372703|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2372704|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372705|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2372706|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
2372707|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2372708|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2372709|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372710|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
2484605|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2484606|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2484607|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2484608|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484609|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2484610|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
2484611|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
2484612|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484613|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484614|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2484615|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2484616|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2484617|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
2484618|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484619|NCT01132781|Theophylline|theophylline|mesh-list
2484620|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2484621|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
2484622|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484623|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484624|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2484625|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
2484626|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2484627|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484628|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484629|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
2484630|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2484631|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2484632|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
2484633|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372711|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2372712|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372713|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372714|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2372715|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372716|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2372717|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2372718|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
2372719|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372720|NCT00594373|Tenofovir|tenofovir|mesh-list
2372721|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
2372722|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372723|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2484634|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
2484635|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2484636|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2484637|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484638|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2484639|NCT01132794|Analgesics|analgesics|mesh-ancestor
2484640|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
2484641|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484642|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2484643|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2484644|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2484645|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
2484646|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484647|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484648|NCT01132911|Bortezomib|bortezomib|mesh-list
2484649|NCT01132911|Vorinostat|vorinostat|mesh-list
2372724|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2372725|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422904|NCT00819468|Teduglutide|teduglutide|mesh-list
2484650|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484651|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2484652|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484653|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484654|NCT01132989|Lenalidomide|lenalidomide|mesh-list
2484655|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
2484656|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484657|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2484658|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2484659|NCT01132989|Growth Substances|growth substances|mesh-ancestor
2484660|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
2484661|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484662|NCT01133080|Minocycline|minocycline|mesh-list
2484663|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2484664|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484665|NCT01133119|Bupivacaine|bupivacaine|mesh-list
2484666|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
2484667|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
2484668|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2484669|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484670|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
2484671|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484672|NCT01133210|Maraviroc|maraviroc|mesh-list
2484673|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2484674|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2484675|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484676|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2484677|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2484678|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
2484679|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484680|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2484681|NCT01133223|Plasminogen|plasminogen|mesh-list
2484682|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2484683|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2484684|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2484685|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484686|NCT01133301|Naltrexone|naltrexone|mesh-list
2484687|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2484688|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2484689|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484690|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
2114092|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2114093|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2372726|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372727|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2372728|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2372729|NCT00594542|Lidocaine|lidocaine|mesh-list
2372730|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
2372731|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
2372732|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2372733|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372734|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
2484691|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484692|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
2484693|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2484694|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2484695|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2484696|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484697|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
2484698|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484699|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484700|NCT01133366|Warfarin|warfarin|mesh-list
2484701|NCT01133366|Mipomersen|mipomersen|mesh-list
2484702|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
2484703|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2484704|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2484705|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
2484706|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484707|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2484708|NCT01133431|Glimepiride|glimepiride|mesh-list
2484709|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2484710|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2484711|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484712|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2484713|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
2484714|NCT01133444|Finasteride|finasteride|mesh-list
2484715|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2484716|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2484717|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484718|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484719|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
2484720|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2484721|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484722|NCT01133444|Urological Agents|urological agents|mesh-ancestor
2484723|NCT01133457|Finasteride|finasteride|mesh-list
2484724|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2484725|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2484726|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484727|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484728|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
2484729|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2484730|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484731|NCT01133457|Urological Agents|urological agents|mesh-ancestor
2484732|NCT01133470|Fexofenadine|fexofenadine|mesh-list
2484733|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
2372735|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372736|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2372737|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2372738|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2372739|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372740|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372741|NCT00594555|Cytarabine|cytarabine|mesh-list
2372742|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
2372743|NCT00594555|Cladribine|cladribine|mesh-list
2372744|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2372745|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
2372746|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372747|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372748|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
2372749|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372750|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2372751|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
2484734|NCT01133470|Ephedrine|ephedrine|mesh-list
2484735|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2484736|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
2484737|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484738|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484739|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2484740|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
2484741|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
2484742|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2484743|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2484744|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
2484745|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
2484746|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484747|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484748|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2484749|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2484750|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2484751|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
2484752|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
2484753|NCT01133483|Fexofenadine|fexofenadine|mesh-list
2484754|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
2484755|NCT01133483|Ephedrine|ephedrine|mesh-list
2484756|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2484757|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
2484758|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484759|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484760|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2484761|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
2484762|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
2484763|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2484764|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2484765|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
2484766|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
2484767|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484768|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372752|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372753|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2372754|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372755|NCT00594633|Donepezil|donepezil|mesh-list
2372756|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2372757|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372758|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372759|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
2484769|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2484770|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2484771|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2484772|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
2484773|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
2484774|NCT01133496|Alendronate|alendronate|mesh-list
2484775|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2484776|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484777|NCT01133509|Vaccines|vaccines|mesh-list
2484778|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
2484779|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372760|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372761|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372762|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
2372763|NCT00594737|Memantine|memantine|mesh-list
2372764|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2372765|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2372766|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
2372767|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372768|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372769|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372770|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2372771|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2372772|NCT00594867|Aspirin|aspirin|mesh-list
2372773|NCT00594867|Acetaminophen|acetaminophen|mesh-list
2372774|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2372775|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2372776|NCT00594867|Analgesics|analgesics|mesh-ancestor
2372777|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
2372778|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372779|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372780|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2372781|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2372782|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2372783|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2372784|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372785|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2372786|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2372787|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372788|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
2372789|NCT00594984|Irinotecan|irinotecan|mesh-list
2372790|NCT00594984|Cetuximab|cetuximab|mesh-list
2372791|NCT00594984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2372792|NCT00594984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2372793|NCT00594984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372794|NCT00594984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372795|NCT00594984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372796|NCT00594984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2372797|NCT00595049|Bosentan|bosentan|mesh-list
2484780|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
2484781|NCT01133548|Testosterone|testosterone|mesh-list
2484782|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
2484783|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
2484784|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2484785|NCT01133548|Androgens|androgens|mesh-ancestor
2484786|NCT01133548|Hormones|hormones|mesh-ancestor
2484787|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2484788|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484789|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2484790|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484791|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
2484792|NCT01133600|Vancomycin|vancomycin|mesh-list
2484793|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2484794|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484795|NCT01133743|Thalidomide|thalidomide|mesh-list
2484796|NCT01133743|Dexamethasone|dexamethasone|mesh-list
2484797|NCT01133743|Lenalidomide|lenalidomide|mesh-list
2484798|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2372798|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2372799|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2372800|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372801|NCT00595140|Octreotide|octreotide|mesh-list
2372802|NCT00595140|Dopamine|dopamine|mesh-list
2484799|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
2484800|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
2484801|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484802|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484803|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2484804|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
2484805|NCT01133743|Hormones|hormones|mesh-ancestor
2484806|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2484807|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2372803|NCT00595140|Cabergoline|cabergoline|mesh-list
2372804|NCT00595140|Somatostatin|somatostatin|mesh-list
2372805|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
2372806|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2484808|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484809|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
2484810|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2484811|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2484812|NCT01133743|Growth Substances|growth substances|mesh-ancestor
2484813|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
2484814|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2484815|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
2484816|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2484817|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484818|NCT01133795|Midodrine|midodrine|mesh-list
2484819|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
2484820|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
2484821|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484822|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484823|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2484824|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2484825|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2484826|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2484827|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
2484828|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484829|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484830|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
2484831|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
2484832|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2484833|NCT01133873|Narcotics|narcotics|mesh-ancestor
2484834|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2484835|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484836|NCT01133873|Analgesics|analgesics|mesh-ancestor
2484837|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
2484838|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484839|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
2484840|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
2484841|NCT01133886|Decitabine|decitabine|mesh-list
2484842|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2484843|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
2484844|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484845|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484846|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484847|NCT01133912|Gemcitabine|gemcitabine|mesh-list
2484848|NCT01133912|Paclitaxel|paclitaxel|mesh-list
2484849|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2484850|NCT01133912|Lapatinib|lapatinib|mesh-list
2484851|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2484852|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484853|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
2484854|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
2484855|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
2484856|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484857|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2484858|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
2484859|NCT01133912|Antiviral Agents|antiviral agents|mesh-ancestor
2484860|NCT01133912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484861|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484862|NCT01133912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2484863|NCT01133912|Immunologic Factors|immunologic factors|mesh-ancestor
2484864|NCT01133912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484865|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2484866|NCT01133925|Sirolimus|sirolimus|mesh-list
2484867|NCT01133925|Paclitaxel|paclitaxel|mesh-list
2484868|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2484869|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484870|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
2484871|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
2484872|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
2484873|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484874|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2484875|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2484876|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2484877|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
2484878|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2484879|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
2484880|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484881|NCT01133990|Leucovorin|leucovorin|mesh-list
2484882|NCT01133990|Bevacizumab|bevacizumab|mesh-list
2484883|NCT01133990|Fluorouracil|fluorouracil|mesh-list
2484884|NCT01133990|Irinotecan|irinotecan|mesh-list
2484885|NCT01133990|Calcium|calcium|mesh-list
2484886|NCT01133990|Levoleucovorin|levoleucovorin|mesh-list
2484887|NCT01133990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2484888|NCT01133990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484889|NCT01133990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2484890|NCT01133990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2484891|NCT01133990|Growth Substances|growth substances|mesh-ancestor
2484892|NCT01133990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484893|NCT01133990|Growth Inhibitors|growth inhibitors|mesh-ancestor
2484894|NCT01133990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2484895|NCT01133990|Antimetabolites|antimetabolites|mesh-ancestor
2484896|NCT01133990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484897|NCT01133990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2484898|NCT01133990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2484899|NCT01133990|Immunologic Factors|immunologic factors|mesh-ancestor
2484900|NCT01133990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2484901|NCT01133990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2484902|NCT01133990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484903|NCT01133990|Antidotes|antidotes|mesh-ancestor
2484904|NCT01133990|Protective Agents|protective agents|mesh-ancestor
2484905|NCT01133990|Vitamin B Complex|vitamin b complex|mesh-ancestor
2484906|NCT01133990|Vitamins|vitamins|mesh-ancestor
2484907|NCT01133990|Micronutrients|micronutrients|mesh-ancestor
2484908|NCT01134185|Prucalopride|prucalopride|mesh-list
2484909|NCT01134185|Laxatives|laxatives|mesh-ancestor
2484910|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2484911|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2484912|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2484913|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
2484914|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2484915|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484916|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484917|NCT01134224|Insulin|insulin|mesh-list
2484918|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2484919|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
2484920|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
2484921|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2484922|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
2484923|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2484924|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
2484925|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2484926|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484927|NCT01134250|Paclitaxel|paclitaxel|mesh-list
2484928|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2484929|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484930|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
2484931|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
2484932|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
2484933|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484934|NCT01134289|Bupivacaine|bupivacaine|mesh-list
2484935|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
2484936|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
2484937|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
2484938|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2484939|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484940|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
2484941|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372807|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2372808|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372809|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2372810|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
2372811|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
2372812|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372813|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372814|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
2372815|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372816|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372817|NCT00595140|Protective Agents|protective agents|mesh-ancestor
2372818|NCT00595140|Hormones|hormones|mesh-ancestor
2372819|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2372820|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2372821|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2372822|NCT00595322|Bevacizumab|bevacizumab|mesh-list
2372823|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2372824|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372825|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2372826|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2372827|NCT00595322|Growth Substances|growth substances|mesh-ancestor
2372828|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372829|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
2372830|NCT00595374|Insulin|insulin|mesh-list
2372831|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2372832|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
2372833|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
2372834|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
2372835|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
2484942|NCT01134341|Vitamins|vitamins|mesh-list
2484943|NCT01134341|Folic Acid|folic acid|mesh-list
2484944|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
2484945|NCT01134341|Hydroxocobalamin|hydroxocobalamin|mesh-list
2484946|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
2484947|NCT01134341|Bexarotene|bexarotene|mesh-list
2484948|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
2484949|NCT01134341|Aminopterin|aminopterin|mesh-list
2484950|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
2484951|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484952|NCT01134341|Hematinics|hematinics|mesh-ancestor
2484953|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2484954|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2484955|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2484956|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484957|NCT01134406|Hylan|hylan|mesh-list
2484958|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
2484959|NCT01134406|Protective Agents|protective agents|mesh-ancestor
2484960|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484961|NCT01134432|Prednisolone|prednisolone|mesh-list
2484962|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2484963|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
2484964|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2484965|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
2484966|NCT01134432|Rituximab|rituximab|mesh-list
2484967|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2484968|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
2484969|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2484970|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484971|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
2484972|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372836|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
2372837|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2372838|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372839|NCT00595426|Warfarin|warfarin|mesh-list
2372840|NCT00595426|Anticoagulants|anticoagulants|mesh-ancestor
2372841|NCT00595543|Diclofenac|diclofenac|mesh-list
2372842|NCT00595543|Ketorolac|ketorolac|mesh-list
2372843|NCT00595543|Bromfenac|bromfenac|mesh-list
2372844|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2372845|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2372846|NCT00595543|Analgesics|analgesics|mesh-ancestor
2372847|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
2372848|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484973|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2484974|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2484975|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
2372849|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484976|NCT01134432|Hormones|hormones|mesh-ancestor
2484977|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2484978|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2484979|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
2484980|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
2484981|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484982|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2484983|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2484984|NCT01134432|Protective Agents|protective agents|mesh-ancestor
2484985|NCT01134484|Thalidomide|thalidomide|mesh-list
2484986|NCT01134484|Dexamethasone|dexamethasone|mesh-list
2484987|NCT01134484|Bortezomib|bortezomib|mesh-list
2484988|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2484989|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
2484990|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
2484991|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2484992|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2484993|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2484994|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
2484995|NCT01134484|Hormones|hormones|mesh-ancestor
2484996|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2484997|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2484998|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2484999|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2485000|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
2485001|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
2485002|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2485003|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485004|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2485005|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2485006|NCT01134484|Growth Substances|growth substances|mesh-ancestor
2485007|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
2485008|NCT01134523|Paclitaxel|paclitaxel|mesh-list
2485009|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2485010|NCT01134523|Epirubicin|epirubicin|mesh-list
2485011|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2485012|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485013|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
2485014|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
2485015|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
2485016|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485017|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2485018|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2485019|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2485020|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485021|NCT01134536|Tapentadol|tapentadol|mesh-list
2372850|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2372851|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2485022|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2485023|NCT01134536|Narcotics|narcotics|mesh-ancestor
2485024|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2485025|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485026|NCT01134536|Analgesics|analgesics|mesh-ancestor
2485027|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
2485028|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485029|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2485030|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2485031|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2485032|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485033|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
2485034|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485035|NCT01134666|Cetuximab|cetuximab|mesh-list
2485036|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2485037|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485038|NCT01134692|Norfloxacin|norfloxacin|mesh-list
2485039|NCT01134692|Propranolol|propranolol|mesh-list
2485040|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2485041|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2485042|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
2485043|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485044|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485045|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485046|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2485047|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2485048|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
2372852|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2372853|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485049|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2372854|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372855|NCT00595569|Insulin|insulin|mesh-list
2372856|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2372857|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372858|NCT00595699|Citalopram|citalopram|mesh-list
2372859|NCT00595699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2372860|NCT00595699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2372861|NCT00595699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372862|NCT00595699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372863|NCT00595699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372864|NCT00595699|Serotonin Agents|serotonin agents|mesh-ancestor
2372865|NCT00595699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372866|NCT00595699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2372867|NCT00595699|Antidepressive Agents|antidepressive agents|mesh-ancestor
2372868|NCT00595699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2372869|NCT00595933|Muramidase|muramidase|mesh-list
2372870|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372871|NCT00595972|Endostar protein|endostar protein|mesh-list
2372872|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2372873|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2372874|NCT00595972|Growth Substances|growth substances|mesh-ancestor
2372875|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372876|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
2372877|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372878|NCT00595985|Sorafenib|sorafenib|mesh-list
2372879|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372880|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2372881|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372882|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372883|NCT00596037|Hormones|hormones|mesh-list
2372884|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2372885|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372886|NCT00596050|Lidocaine|lidocaine|mesh-list
2372887|NCT00596050|Fentanyl|fentanyl|mesh-list
2372888|NCT00596050|Midazolam|midazolam|mesh-list
2372889|NCT00596050|Ketamine|ketamine|mesh-list
2485050|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485051|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2485052|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2485053|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485054|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485055|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2485056|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2485057|NCT01134718|Simeprevir|simeprevir|mesh-list
2485058|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
2485059|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485060|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
2485061|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485062|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485063|NCT01134848|Morphine|morphine|mesh-list
2485064|NCT01134848|Secretin|secretin|mesh-list
2485065|NCT01134848|Neostigmine|neostigmine|mesh-list
2485066|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2485067|NCT01134848|Narcotics|narcotics|mesh-ancestor
2485068|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2485069|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485070|NCT01134848|Analgesics|analgesics|mesh-ancestor
2485071|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
2485072|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372890|NCT00596050|Etomidate|etomidate|mesh-list
2372891|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
2372892|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
2372893|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2372894|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372895|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
2372896|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372897|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2372898|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2372899|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2485073|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2485074|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485075|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485076|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
2485077|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485078|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2372900|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2372901|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372902|NCT00596050|Analgesics|analgesics|mesh-ancestor
2372903|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2372904|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2372905|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
2372906|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2372907|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2485079|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
2485080|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2485081|NCT01134848|Hormones|hormones|mesh-ancestor
2485082|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2485083|NCT01134861|Cisplatin|cisplatin|mesh-list
2485084|NCT01134861|Etoposide|etoposide|mesh-list
2485085|NCT01134861|Vinblastine|vinblastine|mesh-list
2485086|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485087|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2485088|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2485089|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2485090|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485091|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485092|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
2485093|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
2485094|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
2485095|NCT01134926|Misoprostol|misoprostol|mesh-list
2485096|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2485097|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
2485098|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2485099|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485100|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2485101|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2485102|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
2485103|NCT01134965|Digoxin|digoxin|mesh-list
2485104|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2485105|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2485106|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485107|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485108|NCT01134965|Protective Agents|protective agents|mesh-ancestor
2485109|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485110|NCT01134991|Minocycline|minocycline|mesh-list
2485111|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2485112|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485113|NCT01135056|Sorafenib|sorafenib|mesh-list
2485114|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485115|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2485116|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485117|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485118|NCT01135199|Pomalidomide|pomalidomide|mesh-list
2485119|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
2485120|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485121|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2485122|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2485123|NCT01135199|Growth Substances|growth substances|mesh-ancestor
2485124|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
2485125|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485126|NCT01135212|Candesartan|candesartan|mesh-list
2372908|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372909|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2372910|NCT00596050|Narcotics|narcotics|mesh-ancestor
2372911|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2372912|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2372913|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2372914|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2372915|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2372916|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
2372917|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
2485127|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
2485128|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2485129|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2485130|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2485131|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485132|NCT01135290|Petrolatum|petrolatum|mesh-list
2485133|NCT01135290|Emollients|emollients|mesh-ancestor
2372918|NCT00596063|Insulin|insulin|mesh-list
2372919|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2485134|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
2485135|NCT01135433|Metformin|metformin|mesh-list
2372920|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485136|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
2485137|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2485138|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485139|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2485140|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485141|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
2485142|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2485143|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485144|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2485145|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485146|NCT01135472|Esomeprazole|esomeprazole|mesh-list
2485147|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2485148|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2485149|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2485150|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485151|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485152|NCT01135550|Dexamethasone|dexamethasone|mesh-list
2485153|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
2485154|NCT01135550|BB 1101|bb 1101|mesh-list
2485155|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2485156|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
2485157|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
2485158|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485159|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485160|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2485161|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
2372921|NCT00596115|Pramipexole|pramipexole|mesh-list
2372922|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
2372923|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372924|NCT00596115|Protective Agents|protective agents|mesh-ancestor
2372925|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372926|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2372927|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2372928|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
2372929|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
2372930|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485162|NCT01135550|Hormones|hormones|mesh-ancestor
2485163|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2485164|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2485165|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485166|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
2485167|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485168|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485169|NCT01135563|Sirolimus|sirolimus|mesh-list
2485170|NCT01135563|Vinblastine|vinblastine|mesh-list
2485171|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2372931|NCT00596128|Insulin|insulin|mesh-list
2372932|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2372933|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372934|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2372935|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
2372936|NCT00596154|Busulfan|busulfan|mesh-list
2485172|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485173|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2485174|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485175|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
2485176|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2485177|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
2485178|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485179|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2372937|NCT00596154|Thiotepa|thiotepa|mesh-list
2372938|NCT00596154|Rituximab|rituximab|mesh-list
2372939|NCT00596154|Methotrexate|methotrexate|mesh-list
2372940|NCT00596154|Vincristine|vincristine|mesh-list
2372941|NCT00596154|Procarbazine|procarbazine|mesh-list
2372942|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2372943|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
2372944|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372945|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2485180|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
2485181|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
2372946|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2372947|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
2372948|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485182|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
2485183|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485184|NCT01135589|Micafungin|micafungin|mesh-list
2485185|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
2372949|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372950|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2372951|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2372952|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2372953|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
2372954|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2372955|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2372956|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
2372957|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
2372958|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485186|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485187|NCT01135602|Topiramate|topiramate|mesh-list
2485188|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
2485189|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2485190|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485191|NCT01135615|Calcium|calcium|mesh-list
2485192|NCT01135615|Sevelamer|sevelamer|mesh-list
2485193|NCT01135615|Calcium acetate|calcium acetate|mesh-list
2485194|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2485195|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485196|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
2485197|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
2485198|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485199|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
2485200|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2485201|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485202|NCT01135641|Cyclosporine|cyclosporine|mesh-list
2485203|NCT01135641|Rituximab|rituximab|mesh-list
2485204|NCT01135641|Cyclosporins|cyclosporins|mesh-list
2485205|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2485206|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485207|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
2485208|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485209|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2485210|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485211|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485212|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2485213|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
2485214|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485215|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
2485216|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2485217|NCT01135667|Clopidogrel|clopidogrel|mesh-list
2485218|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2485219|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2485220|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2485221|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2485222|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2485223|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
2485224|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485225|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485226|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485227|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
2485228|NCT01135680|Glycerol|glycerol|mesh-list
2485229|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2485230|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485231|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2485232|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2485233|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485234|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485235|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372959|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2372960|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2372961|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2372962|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
2372963|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
2372964|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
2372965|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2372966|NCT00596206|Leflunomide|leflunomide|mesh-list
2485236|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485237|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2485238|NCT01135680|Protective Agents|protective agents|mesh-ancestor
2485239|NCT01135758|Ketamine|ketamine|mesh-list
2372967|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485240|NCT01135758|Analgesics|analgesics|mesh-ancestor
2485241|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
2485242|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485243|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485244|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2485245|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2485246|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
2485247|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
2485248|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2485249|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2485250|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2485251|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485252|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485253|NCT01135771|Insulin|insulin|mesh-list
2485254|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2485255|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485256|NCT01135927|Insulin|insulin|mesh-list
2485257|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2485258|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
2485259|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2485260|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485261|NCT01135953|Cycloserine|cycloserine|mesh-list
2485262|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2485263|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485264|NCT01135953|Renal Agents|renal agents|mesh-ancestor
2485265|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2485266|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
2485267|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2485268|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
2485269|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485270|NCT01136005|Provitamins|provitamins|mesh-list
2485271|NCT01136005|Vitamins|vitamins|mesh-ancestor
2485272|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
2485273|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485274|NCT01136031|Paclitaxel|paclitaxel|mesh-list
2485275|NCT01136031|Irinotecan|irinotecan|mesh-list
2485276|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2485277|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485278|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
2485279|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
2485280|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
2485281|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485282|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2485283|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2485284|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485285|NCT01136213|Fluoxetine|fluoxetine|mesh-list
2485286|NCT01136213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2485287|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2485288|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2485289|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485290|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485291|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
2485292|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485293|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2485294|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
2485295|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2485296|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2485297|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2485298|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485299|NCT01136252|Adalimumab|adalimumab|mesh-list
2485300|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2485301|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2485302|NCT01136278|Clonidine|clonidine|mesh-list
2485303|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2485304|NCT01136278|Analgesics|analgesics|mesh-ancestor
2485305|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
2485306|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485307|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485308|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2485309|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
2485310|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
2485311|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2485312|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2485313|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2372968|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372969|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2372970|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
2372971|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372972|NCT00596219|Celecoxib|celecoxib|mesh-list
2372973|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2372974|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2372975|NCT00596219|Analgesics|analgesics|mesh-ancestor
2372976|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
2372977|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2372978|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372979|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2372980|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2372981|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2372982|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2372983|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2372984|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2372985|NCT00596297|Bevacizumab|bevacizumab|mesh-list
2372986|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2372987|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372988|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2372989|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2372990|NCT00596297|Growth Substances|growth substances|mesh-ancestor
2485314|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
2485315|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485316|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485317|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
2485318|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2485319|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
2485320|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2485321|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2485322|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2485323|NCT01136317|Omeprazole|omeprazole|mesh-list
2485324|NCT01136317|Rabeprazole|rabeprazole|mesh-list
2485325|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2485326|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2485327|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2485328|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485329|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485330|NCT01136395|Rituximab|rituximab|mesh-list
2485331|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2485332|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485333|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
2485334|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485335|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2485336|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
2485337|NCT01136421|Bromides|bromides|mesh-list
2485338|NCT01136421|Ipratropium|ipratropium|mesh-list
2485339|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
2485340|NCT01136421|Analgesics|analgesics|mesh-ancestor
2485341|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
2485342|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485343|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485344|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
2485345|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2485346|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2485347|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2485348|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2485349|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485350|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2485351|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
2485352|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2485353|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2485354|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
2485355|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2485356|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
2485357|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2485358|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
2485359|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485360|NCT01136499|Panobinostat|panobinostat|mesh-list
2485361|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485362|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2485363|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485364|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485365|NCT01136525|Valacyclovir|valacyclovir|mesh-list
2485366|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
2485367|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485368|NCT01136538|Valacyclovir|valacyclovir|mesh-list
2485369|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
2485370|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485371|NCT01136551|Huperzine A|huperzine a|mesh-list
2372991|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372992|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
2372993|NCT00596336|Imiquimod|imiquimod|mesh-list
2372994|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2372995|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
2372996|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2372997|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2372998|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
2485372|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2485373|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485374|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485375|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
2485376|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2372999|NCT00596375|Lidocaine|lidocaine|mesh-list
2373000|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
2373001|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
2373002|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2373003|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373004|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
2373005|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373006|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2373007|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2373008|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2373009|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2373010|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373011|NCT00596414|Midazolam|midazolam|mesh-list
2373012|NCT00596414|Meperidine|meperidine|mesh-list
2373013|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2373014|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2485377|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485378|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2485379|NCT01136551|Protective Agents|protective agents|mesh-ancestor
2485380|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
2485381|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2485382|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2485383|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485384|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
2485385|NCT01136590|Coagulants|coagulants|mesh-ancestor
2485386|NCT01136642|Nicotine|nicotine|mesh-list
2485387|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2485388|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
2373015|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2373016|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373017|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2373018|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2373019|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2485389|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485390|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485391|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2485392|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2485393|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
2485394|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485395|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485396|NCT01136759|Tenofovir|tenofovir|mesh-list
2485397|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
2485398|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485399|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2485400|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2485401|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485402|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485403|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2485404|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2485405|NCT01136850|Azithromycin|azithromycin|mesh-list
2485406|NCT01136850|Chloroquine|chloroquine|mesh-list
2485407|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
2485408|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
2485409|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2485410|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2485411|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485412|NCT01136850|Amebicides|amebicides|mesh-ancestor
2485413|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2485414|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2485415|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
2485416|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2485417|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2485418|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485419|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485420|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2485421|NCT01136850|Renal Agents|renal agents|mesh-ancestor
2485422|NCT01136863|Felodipine|felodipine|mesh-list
2485423|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2485424|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2485425|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2485426|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2373020|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2373021|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
2373022|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
2485427|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485428|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2485429|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373023|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
2373024|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
2373025|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373026|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373027|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2373028|NCT00596414|Narcotics|narcotics|mesh-ancestor
2373029|NCT00596414|Analgesics|analgesics|mesh-ancestor
2373030|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
2373031|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373032|NCT00596479|Lenograstim|lenograstim|mesh-list
2485430|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
2485431|NCT01136941|Zileuton|zileuton|mesh-list
2485432|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2485433|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2485434|NCT01136941|Analgesics|analgesics|mesh-ancestor
2485435|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
2485436|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485437|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485438|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2485439|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2373033|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2373034|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
2373035|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373036|NCT00596531|Acamprosate|acamprosate|mesh-list
2373037|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2373038|NCT00596557|Everolimus|everolimus|mesh-list
2373039|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373040|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2373041|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
2373042|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373043|NCT00596596|Prucalopride|prucalopride|mesh-list
2373044|NCT00596596|Laxatives|laxatives|mesh-ancestor
2373045|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2373046|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2373047|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2373048|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
2373049|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373050|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373051|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373052|NCT00596609|Morphine|morphine|mesh-list
2373053|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2373054|NCT00596609|Narcotics|narcotics|mesh-ancestor
2373055|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2373056|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373057|NCT00596609|Analgesics|analgesics|mesh-ancestor
2373058|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
2373059|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373060|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2373061|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373062|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2373063|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373064|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373065|NCT00596804|Veltuzumab|veltuzumab|mesh-list
2373066|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373067|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2373068|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2373069|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2373070|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2373071|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485440|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2485441|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485442|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373072|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373073|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373074|NCT00596986|Analgesics|analgesics|mesh-ancestor
2485443|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2485444|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
2485445|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2485446|NCT01136967|Lenvatinib|lenvatinib|mesh-list
2485447|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485448|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2485449|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485450|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485451|NCT01137019|Everolimus|everolimus|mesh-list
2485452|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485453|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2485454|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
2485455|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485456|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
2485457|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2485458|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2485459|NCT01137084|Prednisolone|prednisolone|mesh-list
2485460|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
2485461|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2485462|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
2485463|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2485464|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
2485465|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
2485466|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485467|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485468|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2485469|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
2485470|NCT01137084|Hormones|hormones|mesh-ancestor
2485471|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2485472|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2485473|NCT01137084|Protective Agents|protective agents|mesh-ancestor
2485474|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2485475|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485476|NCT01137253|Trimethaphan|trimethaphan|mesh-list
2485477|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
2485478|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2485479|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2485480|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2485481|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
2485482|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485483|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485484|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2485485|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2485486|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
2485487|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485488|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485489|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
2485490|NCT01137383|Interferons|interferons|mesh-list
2485491|NCT01137383|Ribavirin|ribavirin|mesh-list
2485492|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
2373075|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
2373076|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485493|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
2485494|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2485495|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485496|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
2485497|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485498|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
2485499|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485500|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
2485501|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485502|NCT01137526|Donepezil|donepezil|mesh-list
2485503|NCT01137526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2485504|NCT01137526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373077|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
2373078|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2373079|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
2373080|NCT00597064|Prednisone|prednisone|mesh-list
2373081|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2373082|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
2373083|NCT00597064|Hormones|hormones|mesh-ancestor
2373084|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2373085|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373086|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2373087|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373088|NCT00597181|Mitomycins|mitomycins|mesh-list
2373089|NCT00597181|Mitomycin|mitomycin|mesh-list
2373090|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2373091|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373092|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
2373093|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373094|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2485505|NCT01137526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485506|NCT01137526|Cholinergic Agents|cholinergic agents|mesh-ancestor
2485507|NCT01137526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373095|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373096|NCT00597233|Insulin|insulin|mesh-list
2373097|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2373098|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
2373099|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
2485508|NCT01137526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485509|NCT01137526|Nootropic Agents|nootropic agents|mesh-ancestor
2485510|NCT01137591|Acetaminophen|acetaminophen|mesh-list
2373100|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
2373101|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
2373102|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2373103|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373104|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2373105|NCT00597259|Entecavir|entecavir|mesh-list
2373106|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
2373107|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373108|NCT00597389|Propranolol|propranolol|mesh-list
2373109|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2373110|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2373111|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
2373112|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373113|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373114|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373115|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2373116|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2485511|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
2485512|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2485513|NCT01137591|Analgesics|analgesics|mesh-ancestor
2485514|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
2485515|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485516|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485517|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
2485518|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
2485519|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485520|NCT01137591|Expectorants|expectorants|mesh-ancestor
2485521|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
2485522|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2485523|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
2485524|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373117|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
2373118|NCT00597415|Celecoxib|celecoxib|mesh-list
2373119|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2373120|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2373121|NCT00597415|Analgesics|analgesics|mesh-ancestor
2373122|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
2373123|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373124|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373125|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2373126|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2373127|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2373128|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2485525|NCT01137591|Protective Agents|protective agents|mesh-ancestor
2485526|NCT01137656|Acetylcholine|acetylcholine|mesh-list
2485527|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
2485528|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2373129|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485529|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
2485530|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485531|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485532|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485533|NCT01137695|Pramlintide|pramlintide|mesh-list
2485534|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
2485535|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2373130|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373131|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2373132|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373133|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2373134|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485536|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485537|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
2485538|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2485539|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
2485540|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485541|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
2485542|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2485543|NCT01137708|Tofacitinib|tofacitinib|mesh-list
2485544|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2485545|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
2485546|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2485547|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485548|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2485549|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2485550|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2485551|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2485552|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485553|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373135|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373136|NCT00597623|Adalimumab|adalimumab|mesh-list
2373137|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2373138|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2373139|NCT00597662|Icodextrin|icodextrin|mesh-list
2485554|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2485555|NCT01137708|Estrogens|estrogens|mesh-ancestor
2485556|NCT01137708|Hormones|hormones|mesh-ancestor
2485557|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2485558|NCT01137903|Amoxicillin|amoxicillin|mesh-list
2373140|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
2373141|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2373142|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
2373143|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2373144|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373145|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
2373146|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
2373147|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2373148|NCT00598013|Pioglitazone|pioglitazone|mesh-list
2373149|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2373150|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373151|NCT00598052|Citalopram|citalopram|mesh-list
2485559|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
2485560|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
2485561|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
2485562|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2485563|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2485564|NCT01137903|Trimethoprim|trimethoprim|mesh-list
2485565|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
2485566|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2485567|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485568|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2485569|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2485570|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485571|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485572|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485573|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2485574|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2485575|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2485576|NCT01137903|Renal Agents|renal agents|mesh-ancestor
2373152|NCT00598052|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2373153|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2373154|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2485577|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
2485578|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2485579|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2485580|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2485581|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2485582|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2485583|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2485584|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
2485585|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485586|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2485587|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485588|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485589|NCT01137942|Metronidazole|metronidazole|mesh-list
2485590|NCT01137942|Clarithromycin|clarithromycin|mesh-list
2485591|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2485592|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373155|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373156|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373157|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
2373158|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373159|NCT00598052|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2373160|NCT00598052|Antidepressive Agents|antidepressive agents|mesh-ancestor
2373161|NCT00598052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2373162|NCT00598091|Gemcitabine|gemcitabine|mesh-list
2373163|NCT00598091|Dasatinib|dasatinib|mesh-list
2373164|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2373165|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
2485593|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2485594|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2485595|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2485596|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2485597|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485598|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485599|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2485600|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2485601|NCT01137955|Rifaximin|rifaximin|mesh-list
2485602|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2485603|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485604|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2485605|NCT01137968|Bevacizumab|bevacizumab|mesh-list
2485606|NCT01137968|Imetelstat|imetelstat|mesh-list
2485607|NCT01137968|Motesanib diphosphate|motesanib diphosphate|mesh-list
2485608|NCT01137968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2485609|NCT01137968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485610|NCT01137968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2485611|NCT01137968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2485612|NCT01137968|Growth Substances|growth substances|mesh-ancestor
2373166|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373167|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373168|NCT00598091|Antiviral Agents|antiviral agents|mesh-ancestor
2373169|NCT00598091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485613|NCT01137968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485614|NCT01137968|Growth Inhibitors|growth inhibitors|mesh-ancestor
2485615|NCT01137968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485616|NCT01137968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485617|NCT01137968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2485618|NCT01137981|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2485619|NCT01137981|Antiviral Agents|antiviral agents|mesh-ancestor
2485620|NCT01137981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485621|NCT01137994|Paclitaxel|paclitaxel|mesh-list
2485622|NCT01137994|Vinorelbine|vinorelbine|mesh-list
2485623|NCT01137994|Docetaxel|docetaxel|mesh-list
2485624|NCT01137994|Trastuzumab|trastuzumab|mesh-list
2485625|NCT01137994|Lapatinib|lapatinib|mesh-list
2485626|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2485627|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485628|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
2485629|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
2485630|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
2485631|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485632|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2485633|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2485634|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373170|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485635|NCT01138072|Atorvastatin|atorvastatin|mesh-list
2485636|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2485637|NCT01138072|Simvastatin|simvastatin|mesh-list
2485638|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2485639|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2485640|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
2485641|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485642|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2485643|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2485644|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485645|NCT01138085|Trametinib|trametinib|mesh-list
2485646|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485647|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2485648|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485649|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485650|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
2485651|NCT01138137|Paclitaxel|paclitaxel|mesh-list
2485652|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2485653|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2485654|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485655|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
2485656|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
2485657|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
2485658|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485659|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
2485660|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485661|NCT01138137|Expectorants|expectorants|mesh-ancestor
2485662|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
2485663|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2485664|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
2485665|NCT01138137|Protective Agents|protective agents|mesh-ancestor
2485666|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485667|NCT01138137|Antidotes|antidotes|mesh-ancestor
2485668|NCT01138163|Docetaxel|docetaxel|mesh-list
2485669|NCT01138163|Bavituximab|bavituximab|mesh-list
2485670|NCT01138163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485671|NCT01138163|Tubulin Modulators|tubulin modulators|mesh-ancestor
2485672|NCT01138163|Antimitotic Agents|antimitotic agents|mesh-ancestor
2485673|NCT01138163|Mitosis Modulators|mitosis modulators|mesh-ancestor
2485674|NCT01138163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485675|NCT01138163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2485676|NCT01138215|Vaccines|vaccines|mesh-list
2485677|NCT01138215|Immunologic Factors|immunologic factors|mesh-ancestor
2373171|NCT00598091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2373172|NCT00598091|Immunologic Factors|immunologic factors|mesh-ancestor
2373173|NCT00598091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373174|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2373175|NCT00598156|Bevacizumab|bevacizumab|mesh-list
2373176|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2373177|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2373178|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373179|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2373180|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2373181|NCT00598156|Growth Substances|growth substances|mesh-ancestor
2373182|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373183|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
2373184|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2373185|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373186|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373187|NCT00598169|Dexamethasone|dexamethasone|mesh-list
2373188|NCT00598169|Rituximab|rituximab|mesh-list
2373189|NCT00598169|Carboplatin|carboplatin|mesh-list
2373190|NCT00598169|Etoposide|etoposide|mesh-list
2373191|NCT00598169|Bortezomib|bortezomib|mesh-list
2373192|NCT00598169|Ifosfamide|ifosfamide|mesh-list
2373193|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2373194|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
2373195|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
2373196|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373197|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373198|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2373199|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
2373200|NCT00598169|Hormones|hormones|mesh-ancestor
2373201|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2373202|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2373203|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373204|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2373205|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
2373206|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2485678|NCT01138215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485679|NCT01138384|Lapatinib|lapatinib|mesh-list
2485680|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485681|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2485682|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485683|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485684|NCT01138397|Vaccines|vaccines|mesh-list
2485685|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
2485686|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485687|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2485688|NCT01138423|Moxonidine|moxonidine|mesh-list
2485689|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2485690|NCT01138423|Diuretics|diuretics|mesh-ancestor
2373207|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2373208|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2373209|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2373210|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373211|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373212|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2373213|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
2373214|NCT00598195|Ketamine|ketamine|mesh-list
2373215|NCT00598195|Analgesics|analgesics|mesh-ancestor
2373216|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
2373217|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373218|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373219|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2373220|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2373221|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
2373222|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
2373223|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2373224|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2373225|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2373226|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485691|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
2485692|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485693|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2485694|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2485695|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485696|NCT01138449|Vitamin A|vitamin a|mesh-list
2485697|NCT01138449|Vitamins|vitamins|mesh-ancestor
2485698|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
2485699|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485700|NCT01138488|Insulin|insulin|mesh-list
2485701|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
2485702|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2485703|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485704|NCT01138553|Mifepristone|mifepristone|mesh-list
2485705|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2485706|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
2485707|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2485708|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485709|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2485710|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2485711|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2485712|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
2485713|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2485714|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2485715|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
2485716|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2485717|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
2485718|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2485719|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2485720|NCT01138605|Ritonavir|ritonavir|mesh-list
2485721|NCT01138605|Darunavir|darunavir|mesh-list
2485722|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2485723|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2485724|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
2485725|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485726|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485727|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2485728|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2485729|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
2485730|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485731|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2485732|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2485733|NCT01138683|Diuretics|diuretics|mesh-list
2485734|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
2485735|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485736|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
2485737|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
2373227|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373228|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2373229|NCT00598208|Hormones|hormones|mesh-ancestor
2373230|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2373231|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373232|NCT00598234|Celecoxib|celecoxib|mesh-list
2373233|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2373234|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2373235|NCT00598234|Analgesics|analgesics|mesh-ancestor
2373236|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
2373237|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373238|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373239|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2485738|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485739|NCT01138774|Protective Agents|protective agents|mesh-ancestor
2485740|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485741|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
2485742|NCT01138774|Vitamins|vitamins|mesh-ancestor
2485743|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
2485744|NCT01138839|Dexamethasone|dexamethasone|mesh-list
2485745|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2485746|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
2485747|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
2485748|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485749|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485750|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2485751|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
2485752|NCT01138839|Hormones|hormones|mesh-ancestor
2485753|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2485754|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2485755|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485756|NCT01138852|Ampicillin|ampicillin|mesh-list
2485757|NCT01138852|Cefuroxime|cefuroxime|mesh-list
2485758|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
2485759|NCT01138852|Sulbactam|sulbactam|mesh-list
2485760|NCT01138852|Sultamicillin|sultamicillin|mesh-list
2485761|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2485762|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485763|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2485764|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485765|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485766|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
2485767|NCT01138904|Irinotecan|irinotecan|mesh-list
2485768|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485769|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2485770|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2485771|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485772|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485773|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
2485774|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2485775|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
2485776|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485777|NCT01138956|Expectorants|expectorants|mesh-ancestor
2485778|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
2485779|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2485780|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
2485781|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373240|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2373241|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2373242|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2485782|NCT01138956|Protective Agents|protective agents|mesh-ancestor
2485783|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485784|NCT01138956|Antidotes|antidotes|mesh-ancestor
2485785|NCT01139138|Irinotecan|irinotecan|mesh-list
2485786|NCT01139138|Everolimus|everolimus|mesh-list
2485787|NCT01139138|Panitumumab|panitumumab|mesh-list
2485788|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2485789|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2485790|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485791|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485792|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485793|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2485794|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
2485795|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485796|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2485797|NCT01139151|Cytarabine|cytarabine|mesh-list
2485798|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2485799|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
2485800|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485801|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485802|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
2485803|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485804|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2485805|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
2485806|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485807|NCT01139203|Lamivudine|lamivudine|mesh-list
2485808|NCT01139203|Adefovir|adefovir|mesh-list
2485809|NCT01139203|Entecavir|entecavir|mesh-list
2485810|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2485811|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2485812|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485813|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485814|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
2485815|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485816|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2485817|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2485818|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2485819|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
2485820|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2485821|NCT01139437|Vaccines|vaccines|mesh-list
2485822|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
2485823|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485824|NCT01139463|Haloperidol|haloperidol|mesh-list
2485825|NCT01139463|Olanzapine|olanzapine|mesh-list
2485826|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
2485827|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
2485828|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
2485829|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485830|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485831|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2485832|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2485833|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2485834|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2485835|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2485836|NCT01139463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2485837|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2373243|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373244|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373245|NCT00598247|Paclitaxel|paclitaxel|mesh-list
2373246|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2373247|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2373248|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373249|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
2373250|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
2373251|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
2373252|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373253|NCT00598312|Leuprolide|leuprolide|mesh-list
2373254|NCT00598312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2373255|NCT00598312|Fertility Agents|fertility agents|mesh-ancestor
2485838|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2485839|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485840|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485841|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
2485842|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2485843|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
2485844|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2373256|NCT00598312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2373257|NCT00598312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373258|NCT00598312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2373259|NCT00598312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373260|NCT00598338|Prucalopride|prucalopride|mesh-list
2373261|NCT00598338|Laxatives|laxatives|mesh-ancestor
2373262|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2373263|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2373264|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2485845|NCT01139645|Esomeprazole|esomeprazole|mesh-list
2485846|NCT01139645|Rabeprazole|rabeprazole|mesh-list
2485847|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2485848|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2485849|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2485850|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485851|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373265|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
2373266|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373267|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373268|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373269|NCT00598377|Cosyntropin|cosyntropin|mesh-list
2373270|NCT00598377|Hormones|hormones|mesh-ancestor
2373271|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2373272|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373273|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
2373274|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
2373275|NCT00598403|Cefditoren|cefditoren|mesh-list
2373276|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2373277|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373278|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2373279|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2373280|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373281|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373282|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373283|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2485852|NCT01139671|Remifentanil|remifentanil|mesh-list
2485853|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2485854|NCT01139671|Narcotics|narcotics|mesh-ancestor
2485855|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2485856|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485857|NCT01139671|Analgesics|analgesics|mesh-ancestor
2485858|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
2485859|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485860|NCT01139723|Bevacizumab|bevacizumab|mesh-list
2485861|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2485862|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485863|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2485864|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2485865|NCT01139723|Growth Substances|growth substances|mesh-ancestor
2485866|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485867|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
2485868|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
2485869|NCT01139749|Ciclopirox|ciclopirox|mesh-list
2485870|NCT01139749|Salicylates|salicylates|mesh-list
2485871|NCT01139749|Isotretinoin|isotretinoin|mesh-list
2485872|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
2485873|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485874|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
2485875|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
2485876|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2485877|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2485878|NCT01139749|Analgesics|analgesics|mesh-ancestor
2485879|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
2485880|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485881|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485882|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2485883|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2485884|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2485885|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485886|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485887|NCT01139840|Vitamin D|vitamin d|mesh-list
2485888|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
2485889|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
2485890|NCT01139840|Vitamins|vitamins|mesh-list
2485891|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
2485892|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485893|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2373284|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2373285|NCT00598429|Alprostadil|alprostadil|mesh-list
2373286|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2373287|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
2373288|NCT00598429|Urological Agents|urological agents|mesh-ancestor
2373289|NCT00598533|Sirolimus|sirolimus|mesh-list
2373290|NCT00598533|Probucol|probucol|mesh-list
2373291|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2373292|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485894|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2485895|NCT01139905|Ritonavir|ritonavir|mesh-list
2485896|NCT01139905|Lopinavir|lopinavir|mesh-list
2485897|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2485898|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2485899|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
2485900|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485901|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485902|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2485903|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2485904|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
2485905|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485906|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2485907|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2485908|NCT01140009|Vaccines|vaccines|mesh-list
2485909|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
2485910|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485911|NCT01140035|Insulin|insulin|mesh-list
2485912|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2485913|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485914|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
2485915|NCT01140074|Astringents|astringents|mesh-ancestor
2373293|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2373294|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373295|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
2373296|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2373297|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
2485916|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485917|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
2485918|NCT01140100|Thiopental|thiopental|mesh-list
2373298|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373299|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2373300|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2373301|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
2373302|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373303|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2373304|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
2373305|NCT00598533|Protective Agents|protective agents|mesh-ancestor
2373306|NCT00598572|Deferoxamine|deferoxamine|mesh-list
2373307|NCT00598572|Siderophores|siderophores|mesh-ancestor
2373308|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2373309|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
2373310|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
2373311|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373312|NCT00598611|Loratadine|loratadine|mesh-list
2373313|NCT00598611|Desloratadine|desloratadine|mesh-list
2373314|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2373315|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
2373316|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373317|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373318|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373319|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2373320|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2373321|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
2373322|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
2373323|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
2373324|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
2373325|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2373326|NCT00598624|Treosulfan|treosulfan|mesh-list
2485919|NCT01140100|Propofol|propofol|mesh-list
2485920|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2485921|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2485922|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485923|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2485924|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
2485925|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
2485926|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
2485927|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
2485928|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
2485929|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485930|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485931|NCT01140126|UB-421|ub-421|mesh-list
2485932|NCT01140126|Antibodies|antibodies|mesh-list
2485933|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
2485934|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485935|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2485936|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
2485937|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485938|NCT01140217|Norethindrone|norethindrone|mesh-list
2485939|NCT01140217|Norethindrone Acetate|norethindrone acetate|mesh-list
2485940|NCT01140217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2485941|NCT01140217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2485942|NCT01140217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2485943|NCT01140217|Contraceptive Agents|contraceptive agents|mesh-ancestor
2485944|NCT01140217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2485945|NCT01140217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114094|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
2114095|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
2114096|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
2114097|NCT02597049|Metformin|metformin|mesh-list
2114098|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
2114099|NCT02597049|Empagliflozin|empagliflozin|mesh-list
2114100|NCT02597049|Canagliflozin|canagliflozin|mesh-list
2114101|NCT02597049|Dulaglutide|dulaglutide|mesh-list
2114102|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2114103|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2485946|NCT01140217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2485947|NCT01140217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2485948|NCT01140308|Ubiquinone|ubiquinone|mesh-list
2485949|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
2485950|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
2485951|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485952|NCT01140308|Vitamins|vitamins|mesh-ancestor
2485953|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
2485954|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2485955|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
2485956|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485957|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2485958|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2485959|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
2485960|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485961|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2485962|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2373327|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2373328|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
2373329|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373330|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373331|NCT00598637|Everolimus|everolimus|mesh-list
2373332|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373333|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2373334|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
2373335|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373336|NCT00598676|Sirolimus|sirolimus|mesh-list
2373337|NCT00598676|Everolimus|everolimus|mesh-list
2373338|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373339|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2373340|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
2373341|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373342|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2373343|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373344|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2373345|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
2373346|NCT00598715|Sirolimus|sirolimus|mesh-list
2373347|NCT00598715|Paclitaxel|paclitaxel|mesh-list
2373348|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2373349|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373350|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
2373351|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
2373352|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
2373353|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373354|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2373355|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373356|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2373357|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
2373358|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2373359|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
2373360|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373361|NCT00598793|Insulin|insulin|mesh-list
2373362|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2373363|NCT00598793|Metformin|metformin|mesh-list
2373364|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
2373365|NCT00598793|Pioglitazone|pioglitazone|mesh-list
2373366|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
2485963|NCT01140399|Dopamine|dopamine|mesh-list
2114104|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485964|NCT01140399|Furosemide|furosemide|mesh-list
2485965|NCT01140399|Diuretics|diuretics|mesh-ancestor
2485966|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
2373367|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
2373368|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2373369|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373370|NCT00598858|Prednisone|prednisone|mesh-list
2373371|NCT00598858|Cortisone|cortisone|mesh-list
2373372|NCT00598858|Docetaxel|docetaxel|mesh-list
2373373|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373374|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
2373375|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
2373376|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
2373377|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373378|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2373379|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
2373380|NCT00598858|Hormones|hormones|mesh-ancestor
2373381|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2373382|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373383|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2373384|NCT00598897|Clarithromycin|clarithromycin|mesh-list
2373385|NCT00598897|Rifabutin|rifabutin|mesh-list
2373386|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2373387|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373388|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2373389|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373390|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373391|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2373392|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2373393|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2485967|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2485968|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2485969|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2485970|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485971|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2485972|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
2485973|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
2485974|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2485975|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
2485976|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2485977|NCT01140399|Protective Agents|protective agents|mesh-ancestor
2485978|NCT01140412|Ritonavir|ritonavir|mesh-list
2485979|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
2485980|NCT01140412|Maraviroc|maraviroc|mesh-list
2485981|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2485982|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2485983|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
2485984|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2485985|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2485986|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2373394|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
2373395|NCT00598923|Topiramate|topiramate|mesh-list
2373396|NCT00598923|Phenytoin|phenytoin|mesh-list
2373397|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
2373398|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2485987|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2485988|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
2485989|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485990|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2485991|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2485992|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2485993|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2485994|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2485995|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
2485996|NCT01140425|PF 232798|pf 232798|mesh-list
2485997|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2485998|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2485999|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2486000|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2486001|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486002|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486003|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486004|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2486005|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2486006|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2486007|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
2486008|NCT01140438|Metformin|metformin|mesh-list
2486009|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2486010|NCT01140438|Repaglinide|repaglinide|mesh-list
2486011|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
2486012|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
2486013|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
2486014|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2486015|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373399|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373400|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2373401|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2373402|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2373403|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373404|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2373405|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2373406|NCT00598962|Azithromycin|azithromycin|mesh-list
2373407|NCT00598962|Rifampin|rifampin|mesh-list
2373408|NCT00598962|Rifabutin|rifabutin|mesh-list
2373409|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2373410|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373411|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2373412|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
2373413|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
2373414|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2373415|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373416|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373417|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2373418|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2373419|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2373420|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2373421|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2373422|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2373423|NCT00599079|Azithromycin|azithromycin|mesh-list
2373424|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2373425|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373426|NCT00599222|Ranibizumab|ranibizumab|mesh-list
2373427|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2373428|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2373429|NCT00599222|Growth Substances|growth substances|mesh-ancestor
2373430|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373431|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
2373432|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373433|NCT00599235|Hydralazine|hydralazine|mesh-list
2373434|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
2373435|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
2373436|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2373437|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2373438|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373439|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373440|NCT00599235|Urological Agents|urological agents|mesh-ancestor
2373441|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2373442|NCT00599274|Interferons|interferons|mesh-list
2373443|NCT00599274|Interferon-beta|interferon-beta|mesh-list
2373444|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
2373445|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373446|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
2373447|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373448|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
2373449|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373450|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2373451|NCT00599287|Haloperidol|haloperidol|mesh-list
2373452|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
2373453|NCT00599287|Methylphenidate|methylphenidate|mesh-list
2373454|NCT00599287|Rivastigmine|rivastigmine|mesh-list
2486016|NCT01140438|Incretins|incretins|mesh-ancestor
2486017|NCT01140438|Hormones|hormones|mesh-ancestor
2486018|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2486019|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2486020|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
2486021|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486022|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486023|NCT01140516|Trimethoprim|trimethoprim|mesh-list
2373455|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2373456|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373457|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2373458|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2486024|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2486025|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486026|NCT01140516|Renal Agents|renal agents|mesh-ancestor
2486027|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
2486028|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2486029|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2486030|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2486031|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486032|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486033|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2486034|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2486035|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2486036|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
2486037|NCT01140529|Haloperidol|haloperidol|mesh-list
2486038|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
2486039|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2486040|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2486041|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486042|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2486043|NCT01140529|Analgesics|analgesics|mesh-ancestor
2486044|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
2486045|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486046|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2486047|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2486048|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2486049|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
2486050|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486051|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486052|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
2486053|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
2486054|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2486055|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2486056|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2373459|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2373460|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373461|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
2373462|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373463|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
2373464|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
2373465|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373466|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2373467|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2373468|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2373469|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2373470|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2373471|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2373472|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2373473|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2373474|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373475|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
2373476|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2373477|NCT00599287|Protective Agents|protective agents|mesh-ancestor
2373478|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
2373479|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2373480|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
2373481|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373482|NCT00599534|Montelukast|montelukast|mesh-list
2373483|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2373484|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
2486057|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2486058|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2486059|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
2486060|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2486061|NCT01140581|Dronedarone|dronedarone|mesh-list
2486062|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2373485|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2373486|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
2373487|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2373488|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373489|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2373490|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2373491|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373492|NCT00599560|Vasopressins|vasopressins|mesh-list
2486063|NCT01140620|Ketamine|ketamine|mesh-list
2486064|NCT01140620|Risperidone|risperidone|mesh-list
2373493|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
2373494|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
2373495|NCT00599560|Coagulants|coagulants|mesh-ancestor
2373496|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2373497|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2373498|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
2373499|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373500|NCT00599573|Ondansetron|ondansetron|mesh-list
2373501|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
2373502|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
2373503|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373504|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373505|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2373506|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
2373507|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
2373508|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2373509|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
2373510|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373511|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373512|NCT00599573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2486065|NCT01140620|Analgesics|analgesics|mesh-ancestor
2486066|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
2486067|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486068|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486069|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2486070|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2486071|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
2486072|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
2486073|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2486074|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2486075|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2486076|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486077|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486078|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2486079|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
2486080|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2486081|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2486082|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2486083|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2486084|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
2486085|NCT01140737|Axitinib|axitinib|mesh-list
2486086|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373513|NCT00599573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2373514|NCT00599573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2373515|NCT00599573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2373516|NCT00599573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2373517|NCT00599625|Pravastatin|pravastatin|mesh-list
2486087|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2486088|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486089|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486090|NCT01140828|Rabeprazole|rabeprazole|mesh-list
2486091|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2486092|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2486093|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2486094|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486095|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486096|NCT01140893|Exenatide|exenatide|mesh-list
2486097|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2486098|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486099|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2486100|NCT01140893|Incretins|incretins|mesh-ancestor
2486101|NCT01140893|Hormones|hormones|mesh-ancestor
2486102|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2486103|NCT01140932|Prednisolone|prednisolone|mesh-list
2486104|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2486105|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
2486106|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2486107|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
2486108|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2486109|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
2486110|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2486111|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
2486112|NCT01140932|Hormones|hormones|mesh-ancestor
2486113|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2486114|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373518|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2486115|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2373519|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2373520|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
2373521|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486116|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486117|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
2486118|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
2486119|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486120|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2486121|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2486122|NCT01140932|Protective Agents|protective agents|mesh-ancestor
2486123|NCT01140971|Misoprostol|misoprostol|mesh-list
2486124|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2486125|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
2486126|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2486127|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486128|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2486129|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2486130|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
2486131|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
2486132|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2373522|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2373523|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2373524|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373525|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2373526|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
2373527|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
2373528|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2373529|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
2373530|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373531|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
2373532|NCT00599716|Protective Agents|protective agents|mesh-ancestor
2373533|NCT00599807|Vitamin D|vitamin d|mesh-list
2373534|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
2373535|NCT00599807|Vitamins|vitamins|mesh-ancestor
2373536|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
2373537|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373538|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2373539|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2373540|NCT00599820|Bevacizumab|bevacizumab|mesh-list
2373541|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2373542|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373543|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2373544|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2373545|NCT00599820|Growth Substances|growth substances|mesh-ancestor
2486133|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2486134|NCT01140984|Prednisolone|prednisolone|mesh-list
2486135|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
2486136|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2486137|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
2486138|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2486139|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
2486140|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
2373546|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373547|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
2373548|NCT00599833|Cetuximab|cetuximab|mesh-list
2373549|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2373550|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373551|NCT00599885|Valsartan|valsartan|mesh-list
2486141|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486142|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486143|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2486144|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
2486145|NCT01140984|Hormones|hormones|mesh-ancestor
2486146|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2486147|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2486148|NCT01140984|Protective Agents|protective agents|mesh-ancestor
2486149|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2486150|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486151|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2486152|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2486153|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
2486154|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486155|NCT01141036|Midazolam|midazolam|mesh-list
2486156|NCT01141036|Propofol|propofol|mesh-list
2486157|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2486158|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2373552|NCT00599885|Telmisartan|telmisartan|mesh-list
2373553|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2373554|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2373555|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2373556|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486159|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486160|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2486161|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
2486162|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
2486163|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2486164|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2486165|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2486166|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2486167|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
2486168|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
2486169|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373557|NCT00599898|Nifedipine|nifedipine|mesh-list
2373558|NCT00599898|Atosiban|atosiban|mesh-list
2373559|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2373560|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2373561|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373562|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2373563|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373564|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
2373565|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
2373566|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2373567|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
2373568|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2373569|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2373570|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2373571|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2373572|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2373573|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373574|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373575|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373576|NCT00599911|Analgesics|analgesics|mesh-ancestor
2373577|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
2373578|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373579|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
2373580|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2373581|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
2373582|NCT00599937|Tretinoin|tretinoin|mesh-list
2373583|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373584|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
2373585|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
2373586|NCT00599950|Mitomycins|mitomycins|mesh-list
2373587|NCT00599950|Mitomycin|mitomycin|mesh-list
2373588|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2373589|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373590|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
2373591|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373592|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2373593|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373594|NCT00600041|Pantoprazole|pantoprazole|mesh-list
2486170|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486171|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
2486172|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2486173|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2486174|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486175|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
2486176|NCT01141127|Coagulants|coagulants|mesh-ancestor
2486177|NCT01141153|Aspirin|aspirin|mesh-list
2486178|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
2486179|NCT01141153|Clopidogrel|clopidogrel|mesh-list
2486180|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2486181|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2486182|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2486183|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2486184|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
2486185|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486186|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486187|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486188|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2486189|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2486190|NCT01141153|Analgesics|analgesics|mesh-ancestor
2486191|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
2486192|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486193|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2373595|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2373596|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2373597|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2373598|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373599|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486194|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2486195|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2486196|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2486197|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2486198|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486199|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
2486200|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
2486201|NCT01141192|Vitamin D|vitamin d|mesh-list
2486202|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
2486203|NCT01141192|Vitamins|vitamins|mesh-ancestor
2486204|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
2486205|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486206|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2486207|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2486208|NCT01141244|Sirolimus|sirolimus|mesh-list
2486209|NCT01141244|Irinotecan|irinotecan|mesh-list
2486210|NCT01141244|Temozolomide|temozolomide|mesh-list
2486211|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2486212|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2486213|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486214|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486215|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486216|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2486217|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
2486218|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2486219|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486220|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2486221|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
2486222|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2486223|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
2486224|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486225|NCT01141296|Fenofibrate|fenofibrate|mesh-list
2486226|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2486227|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
2486228|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486229|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2486230|NCT01141309|Everolimus|everolimus|mesh-list
2486231|NCT01141309|Sorafenib|sorafenib|mesh-list
2486232|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486233|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2486234|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
2486235|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486236|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2486237|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486238|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486239|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2486240|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2486241|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2486242|NCT01141439|Fluticasone|fluticasone|mesh-list
2486243|NCT01141439|Xhance|xhance|mesh-list
2486244|NCT01141439|Beclomethasone|beclomethasone|mesh-list
2486245|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2486246|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2486247|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
2486248|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486249|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486250|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2486251|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
2373600|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
2373601|NCT00600054|Antibodies|antibodies|mesh-list
2373602|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2486252|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
2486253|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2486254|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
2486255|NCT01141439|Hormones|hormones|mesh-ancestor
2486256|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2486257|NCT01141452|Fluticasone|fluticasone|mesh-list
2486258|NCT01141452|Xhance|xhance|mesh-list
2486259|NCT01141452|Beclomethasone|beclomethasone|mesh-list
2486260|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2486261|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2486262|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
2486263|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486264|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486265|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2486266|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
2486267|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
2486268|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2486269|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
2373603|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
2373604|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373605|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2373606|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373607|NCT00600093|Amantadine|amantadine|mesh-list
2373608|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2373609|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2486270|NCT01141452|Hormones|hormones|mesh-ancestor
2486271|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2486272|NCT01141465|Fluticasone|fluticasone|mesh-list
2486273|NCT01141465|Xhance|xhance|mesh-list
2486274|NCT01141465|Budesonide|budesonide|mesh-list
2486275|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
2486276|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2486277|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2486278|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2486279|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2486280|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2486281|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
2486282|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486283|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486284|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2486285|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
2486286|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
2486287|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2486288|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
2486289|NCT01141465|Hormones|hormones|mesh-ancestor
2486290|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2486291|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2486292|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2486293|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2486294|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
2486295|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486296|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486297|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
2486298|NCT01141543|Plerixafor|plerixafor|mesh-list
2486299|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2486300|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2486301|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
2486302|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486303|NCT01141556|Selenium|selenium|mesh-list
2486304|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
2486305|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486306|NCT01141556|Protective Agents|protective agents|mesh-ancestor
2486307|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486308|NCT01141556|Trace Elements|trace elements|mesh-ancestor
2486309|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
2486310|NCT01141855|Varenicline|varenicline|mesh-list
2486311|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2486312|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2486313|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
2373610|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
2373611|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373612|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
2373613|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373614|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373615|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373616|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2373617|NCT00600093|Analgesics|analgesics|mesh-ancestor
2373618|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
2373619|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373620|NCT00600145|Mirtazapine|mirtazapine|mesh-list
2486314|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486315|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486316|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486317|NCT01141881|Bevacizumab|bevacizumab|mesh-list
2486318|NCT01141881|Plasminogen|plasminogen|mesh-list
2486319|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2486320|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2486321|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486322|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2486323|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2486324|NCT01141881|Growth Substances|growth substances|mesh-ancestor
2486325|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486326|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
2486327|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2486328|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2373621|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
2373622|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2373623|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2373624|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
2373625|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
2373626|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373627|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373628|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373629|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2486329|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486330|NCT01141894|Phenylephrine|phenylephrine|mesh-list
2486331|NCT01141894|Dobutamine|dobutamine|mesh-list
2486332|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
2486333|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2486334|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2486335|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
2486336|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
2486337|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486338|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486339|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
2486340|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2486341|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
2486342|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
2486343|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2486344|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2486345|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2486346|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
2486347|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486348|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373630|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2373631|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2373632|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2373633|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2486349|NCT01141894|Protective Agents|protective agents|mesh-ancestor
2486350|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2486351|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2486352|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
2486353|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
2486354|NCT01141972|Vitamin D|vitamin d|mesh-list
2486355|NCT01141972|Vitamins|vitamins|mesh-ancestor
2486356|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
2486357|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486358|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2486359|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
2486360|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
2486361|NCT01141998|Calcium|calcium|mesh-list
2486362|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2486363|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486364|NCT01141998|Vitamins|vitamins|mesh-ancestor
2486365|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
2486366|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2486367|NCT01142011|Belimumab|belimumab|mesh-list
2486368|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2486369|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
2486370|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486371|NCT01142245|Esomeprazole|esomeprazole|mesh-list
2486372|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2486373|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2486374|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2486375|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486376|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486377|NCT01142258|Trazodone|trazodone|mesh-list
2486378|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2486379|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2373634|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2486380|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2486381|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486382|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2486383|NCT01142258|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2486384|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2486385|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2486386|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486387|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486388|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
2486389|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2486390|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
2486391|NCT01142284|Cilostazol|cilostazol|mesh-list
2486392|NCT01142284|Probucol|probucol|mesh-list
2373635|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
2373636|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2373637|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2373638|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
2373639|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2373640|NCT00600158|Lidocaine|lidocaine|mesh-list
2373641|NCT00600158|Hydromorphone|hydromorphone|mesh-list
2373642|NCT00600158|Bupivacaine|bupivacaine|mesh-list
2373643|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
2373644|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
2373645|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2373646|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373647|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
2373648|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373649|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2373650|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2373651|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2373652|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2373653|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373654|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2486393|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2486394|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
2486395|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486396|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486397|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2486398|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
2486399|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2486400|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2486401|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486402|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2486403|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
2486404|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2486405|NCT01142284|Protective Agents|protective agents|mesh-ancestor
2486406|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2373655|NCT00600158|Narcotics|narcotics|mesh-ancestor
2373656|NCT00600158|Analgesics|analgesics|mesh-ancestor
2373657|NCT00600210|Bevacizumab|bevacizumab|mesh-list
2373658|NCT00600210|Carboplatin|carboplatin|mesh-list
2373659|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2373660|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373661|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2373662|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2486407|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2486408|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486409|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2486410|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2486411|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
2486412|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2486413|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
2486414|NCT01142401|Bortezomib|bortezomib|mesh-list
2486415|NCT01142401|Fulvestrant|fulvestrant|mesh-list
2486416|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486417|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2486418|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2486419|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2373663|NCT00600210|Growth Substances|growth substances|mesh-ancestor
2373664|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373665|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
2373666|NCT00600249|Docetaxel|docetaxel|mesh-list
2373667|NCT00600249|Cetuximab|cetuximab|mesh-list
2373668|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373669|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
2373670|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
2373671|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
2373672|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373673|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2373674|NCT00600262|Bevacizumab|bevacizumab|mesh-list
2373675|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2373676|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373677|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2373678|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2373679|NCT00600262|Growth Substances|growth substances|mesh-ancestor
2373680|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373681|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
2373682|NCT00600288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2373683|NCT00600288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2373684|NCT00600301|Triamcinolone|triamcinolone|mesh-list
2373685|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2373686|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2373687|NCT00600301|Bevacizumab|bevacizumab|mesh-list
2373688|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2373689|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2373690|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373691|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2373692|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2373693|NCT00600301|Growth Substances|growth substances|mesh-ancestor
2373694|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486420|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
2486421|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2486422|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486423|NCT01142414|Fluorouracil|fluorouracil|mesh-list
2486424|NCT01142414|Panitumumab|panitumumab|mesh-list
2486425|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486426|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
2486427|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486428|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2486429|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2486430|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
2486431|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486432|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2486433|NCT01142453|Interferons|interferons|mesh-list
2114105|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114106|NCT02597062|Dexamethasone|dexamethasone|mesh-list
2114107|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
2486434|NCT01142453|Interferon-beta|interferon-beta|mesh-list
2486435|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
2486436|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486437|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
2486438|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486439|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
2486440|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486441|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2486442|NCT01142492|Interferons|interferons|mesh-list
2486443|NCT01142492|Interferon-beta|interferon-beta|mesh-list
2486444|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
2486445|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486446|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
2486447|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486448|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
2486449|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486450|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2486451|NCT01142505|Mannitol|mannitol|mesh-list
2486452|NCT01142505|Montelukast|montelukast|mesh-list
2486453|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2486454|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
2486455|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2486456|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
2486457|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2486458|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486459|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2486460|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2486461|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486462|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2486463|NCT01142505|Diuretics|diuretics|mesh-ancestor
2486464|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
2486465|NCT01142518|Interferons|interferons|mesh-list
2486466|NCT01142518|Interferon-beta|interferon-beta|mesh-list
2486467|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
2486468|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486469|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
2486470|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486471|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
2486472|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486473|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2486474|NCT01142557|Interferons|interferons|mesh-list
2486475|NCT01142557|Interferon-beta|interferon-beta|mesh-list
2486476|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
2486477|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486478|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
2373695|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
2373696|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2373697|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
2373698|NCT00600301|Hormones|hormones|mesh-ancestor
2373699|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2373700|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2373701|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
2373702|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373703|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373704|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
2373705|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
2373706|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2373707|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2373708|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373709|NCT00600405|Ibuprofen|ibuprofen|mesh-list
2373710|NCT00600405|Oxycodone|oxycodone|mesh-list
2373711|NCT00600405|Tamsulosin|tamsulosin|mesh-list
2373712|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2373713|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2486479|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486480|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
2486481|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486482|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2486483|NCT01142622|Ropivacaine|ropivacaine|mesh-list
2486484|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
2486485|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
2486486|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2486487|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486488|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
2373714|NCT00600405|Analgesics|analgesics|mesh-ancestor
2373715|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
2373716|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486489|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486490|NCT01142635|Bromides|bromides|mesh-list
2486491|NCT01142635|Rocuronium|rocuronium|mesh-list
2486492|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
2486493|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2486494|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2486495|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2486496|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486497|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373717|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373718|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2373719|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2373720|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2373721|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373722|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373723|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2373724|NCT00600405|Narcotics|narcotics|mesh-ancestor
2373725|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2373726|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2373727|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2373728|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2373729|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
2486498|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
2486499|NCT01142648|Neostigmine|neostigmine|mesh-list
2486500|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2373730|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373731|NCT00600405|Urological Agents|urological agents|mesh-ancestor
2373732|NCT00600483|Gentamicins|gentamicins|mesh-list
2486501|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486502|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486503|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
2486504|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486505|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486506|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2486507|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
2486508|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486509|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2486510|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2486511|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2486512|NCT01142700|Ribavirin|ribavirin|mesh-list
2486513|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2486514|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
2486515|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486516|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
2486517|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486518|NCT01142778|Bevacizumab|bevacizumab|mesh-list
2486519|NCT01142778|Trastuzumab|trastuzumab|mesh-list
2373733|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2373734|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373735|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2486520|NCT01142778|Docetaxel|docetaxel|mesh-list
2486521|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2486522|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486523|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2486524|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2486525|NCT01142778|Growth Substances|growth substances|mesh-ancestor
2486526|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486527|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
2486528|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
2486529|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
2486530|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
2486531|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486532|NCT01142843|Propolis|propolis|mesh-list
2486533|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486534|NCT01142869|Cetuximab|cetuximab|mesh-list
2373736|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373737|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486535|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2486536|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486537|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
2373758|NCT00600509|Levetiracetam|levetiracetam|mesh-list
2373759|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
2373760|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
2373761|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
2373762|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
2373763|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373764|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2373765|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373766|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373767|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
2486538|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2486539|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2486540|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486541|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
2486542|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
2486543|NCT01143025|Ropivacaine|ropivacaine|mesh-list
2486544|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
2486545|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
2486546|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2486547|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486548|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
2486549|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373768|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2373769|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373770|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2373771|NCT00600535|Hormones|hormones|mesh-ancestor
2373772|NCT00600548|Miltefosine|miltefosine|mesh-list
2373773|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2373774|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
2373775|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373776|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373777|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2373778|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2373779|NCT00600587|Gemcitabine|gemcitabine|mesh-list
2373780|NCT00600587|Carboplatin|carboplatin|mesh-list
2373781|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2373782|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373783|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2373784|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
2373785|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373786|NCT00600587|Antiviral Agents|antiviral agents|mesh-ancestor
2373787|NCT00600587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373788|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373789|NCT00600587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2373790|NCT00600587|Immunologic Factors|immunologic factors|mesh-ancestor
2373791|NCT00600587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373792|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2373793|NCT00600600|Tigecycline|tigecycline|mesh-list
2486550|NCT01143064|Progesterone|progesterone|mesh-list
2486551|NCT01143064|Progestins|progestins|mesh-ancestor
2486552|NCT01143064|Hormones|hormones|mesh-ancestor
2486553|NCT01143064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2486554|NCT01143064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486555|NCT01143129|Dexamethasone|dexamethasone|mesh-list
2486556|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2486557|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
2486558|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
2486559|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486560|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486561|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2486562|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
2486563|NCT01143129|Hormones|hormones|mesh-ancestor
2486564|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2486565|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2486566|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486567|NCT01143246|Terlipressin|terlipressin|mesh-list
2486568|NCT01143246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2486569|NCT01143246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2486570|NCT01143545|Celecoxib|celecoxib|mesh-list
2486571|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
2486572|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2486573|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
2486574|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486575|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2486576|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2486577|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
2486578|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486579|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486580|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2486581|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2486582|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2486583|NCT01143545|Analgesics|analgesics|mesh-ancestor
2486584|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
2486585|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486586|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2486587|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2486588|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2486589|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486590|NCT01143584|Dopamine|dopamine|mesh-list
2486591|NCT01143584|Cabergoline|cabergoline|mesh-list
2486592|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
2486593|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2486594|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
2373794|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2373795|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486595|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
2486596|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486597|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486598|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
2486599|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486600|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486601|NCT01143584|Protective Agents|protective agents|mesh-ancestor
2486602|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2486603|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2486604|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2486605|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
2486606|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486613|NCT01143805|Tofacitinib|tofacitinib|mesh-list
2373796|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2373797|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373798|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373799|NCT00600626|Insulin|insulin|mesh-list
2373800|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2486614|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2486615|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486616|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486617|NCT01143831|Vitamins|vitamins|mesh-list
2486618|NCT01143831|Vitamin K|vitamin k|mesh-list
2486619|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
2486620|NCT01143831|Menatetrenone|menatetrenone|mesh-list
2486621|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
2486622|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486623|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2486624|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2486625|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486626|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
2486627|NCT01143831|Coagulants|coagulants|mesh-ancestor
2486628|NCT01143857|Varenicline|varenicline|mesh-list
2486629|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2486630|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2486631|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
2486632|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486633|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486634|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486635|NCT01143948|Insulin|insulin|mesh-list
2486636|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2486637|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2486638|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486639|NCT01143974|Pemetrexed|pemetrexed|mesh-list
2486640|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373801|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
2373802|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
2373803|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2373804|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
2373805|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
2373806|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
2373807|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
2373808|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2373809|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373810|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2373811|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2373812|NCT00600639|Prednisolone|prednisolone|mesh-list
2373813|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2373814|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
2373815|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2373816|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
2373817|NCT00600639|Albuterol|albuterol|mesh-list
2373818|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2373819|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
2486641|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486642|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486643|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2486644|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2486645|NCT01143987|Cinacalcet|cinacalcet|mesh-list
2486646|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2486647|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486648|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2486649|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
2486650|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2486651|NCT01144000|Daptomycin|daptomycin|mesh-list
2486652|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2486653|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486654|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
2486655|NCT01144065|Testosterone|testosterone|mesh-list
2486656|NCT01144065|Androgens|androgens|mesh-ancestor
2486657|NCT01144065|Hormones|hormones|mesh-ancestor
2486658|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2486659|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486660|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2486661|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
2486662|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2486663|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486664|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373820|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373821|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
2373822|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2373823|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
2373824|NCT00600639|Hormones|hormones|mesh-ancestor
2373825|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2373826|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373827|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2373828|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373829|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
2373830|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
2373831|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373832|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2373833|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2486665|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2486666|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2486667|NCT01144091|Protective Agents|protective agents|mesh-ancestor
2486668|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486669|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
2486670|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2486671|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
2486672|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
2486673|NCT01144117|Hematinics|hematinics|mesh-ancestor
2486674|NCT01144156|Adalimumab|adalimumab|mesh-list
2486675|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2486676|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2486677|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
2486678|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
2486679|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2486680|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2486681|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486682|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486683|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486684|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2486685|NCT01144195|Panitumumab|panitumumab|mesh-list
2373834|NCT00600639|Protective Agents|protective agents|mesh-ancestor
2373835|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2373836|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2373837|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
2373838|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
2373839|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2373840|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2373841|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2373842|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2373843|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
2373844|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373845|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486686|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2486687|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486688|NCT01144260|Bafetinib|bafetinib|mesh-list
2486689|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2486690|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486691|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486692|NCT01144312|Fentanyl|fentanyl|mesh-list
2486693|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2486694|NCT01144312|Narcotics|narcotics|mesh-ancestor
2486695|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2486696|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486697|NCT01144312|Analgesics|analgesics|mesh-ancestor
2486698|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
2486699|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486700|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2486701|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2373846|NCT00600691|Finasteride|finasteride|mesh-list
2373847|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2373848|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2373849|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373850|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373851|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
2373852|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2373853|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373854|NCT00600691|Urological Agents|urological agents|mesh-ancestor
2373855|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2373856|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373857|NCT00600769|Clarithromycin|clarithromycin|mesh-list
2373858|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2373859|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373860|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2373861|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373862|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373863|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2373864|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2373865|NCT00600847|Loratadine|loratadine|mesh-list
2373866|NCT00600847|Desloratadine|desloratadine|mesh-list
2373867|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2373868|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
2373869|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373870|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373871|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373872|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2373873|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2373874|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
2373875|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
2373876|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
2373877|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
2373878|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2373879|NCT00600873|Pramipexole|pramipexole|mesh-list
2373880|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
2373881|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486702|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
2486703|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
2486704|NCT01144390|Methadone|methadone|mesh-list
2486705|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2486706|NCT01144390|Narcotics|narcotics|mesh-ancestor
2486707|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2486708|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486709|NCT01144390|Analgesics|analgesics|mesh-ancestor
2486710|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
2486711|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486712|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
2373882|NCT00600873|Protective Agents|protective agents|mesh-ancestor
2486713|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
2486714|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
2486715|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2486716|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
2486717|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486718|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
2486719|NCT01144533|Protective Agents|protective agents|mesh-ancestor
2486720|NCT01144650|Dapsone|dapsone|mesh-list
2486721|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486722|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
2486723|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2486724|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2486725|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2486726|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486727|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486728|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
2486729|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2486730|NCT01144676|Dapivirine|dapivirine|mesh-list
2486731|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2486732|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2486733|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
2486734|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486735|NCT01144702|Artesunate|artesunate|mesh-list
2486736|NCT01144702|Mefloquine|mefloquine|mesh-list
2486737|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
2486738|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2486739|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2486740|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486741|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486742|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
2486743|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
2486744|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2486745|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
2486746|NCT01144728|Metformin|metformin|mesh-list
2486747|NCT01144728|Glimepiride|glimepiride|mesh-list
2486748|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2486749|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486750|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2486751|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2486752|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
2486753|NCT01144754|Rituximab|rituximab|mesh-list
2486754|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2486755|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486756|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
2486757|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373883|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373884|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2486758|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2486759|NCT01144832|Ebastine|ebastine|mesh-list
2486760|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2486761|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
2486762|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
2486763|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486764|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486765|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486766|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
2486767|NCT01144910|Miotics|miotics|mesh-ancestor
2486768|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
2486769|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486770|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486771|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2486772|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2486773|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
2486774|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2486775|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2486776|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
2486777|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486778|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486779|NCT01144923|Gabapentin|gabapentin|mesh-list
2486780|NCT01144923|Nortriptyline|nortriptyline|mesh-list
2486781|NCT01144923|Analgesics|analgesics|mesh-ancestor
2486782|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
2486783|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486784|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486785|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
2486786|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2486787|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2486788|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2486789|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2486790|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2486791|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2486792|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486793|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486794|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
2486795|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2486796|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
2486797|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2486798|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2486799|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2373885|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2373886|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
2373887|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
2373888|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373889|NCT00600912|SMOFlipid|smoflipid|mesh-list
2373890|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2486800|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
2486801|NCT01144988|Bevacizumab|bevacizumab|mesh-list
2373891|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2373892|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2373893|NCT00600964|Obatoclax|obatoclax|mesh-list
2373894|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373895|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373896|NCT00600977|Doxorubicin|doxorubicin|mesh-list
2373897|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2373898|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2373899|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373900|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2373901|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2373902|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373903|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486802|NCT01144988|Irinotecan|irinotecan|mesh-list
2486803|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2486804|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486805|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2486806|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2486807|NCT01144988|Growth Substances|growth substances|mesh-ancestor
2486808|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486809|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
2486810|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2486811|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2486812|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486813|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486814|NCT01145079|Sirolimus|sirolimus|mesh-list
2486815|NCT01145079|Everolimus|everolimus|mesh-list
2486816|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486817|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2486818|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
2486819|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373904|NCT00600990|Vestipitant|vestipitant|mesh-list
2373905|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2373906|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373907|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373908|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373909|NCT00601003|Nifurtimox|nifurtimox|mesh-list
2373910|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
2373911|NCT00601003|Topotecan|topotecan|mesh-list
2373912|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2373913|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
2373914|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373915|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2373916|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2373917|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
2373918|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373919|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373920|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2373921|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2373922|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2373923|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373924|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2373925|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2373926|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2373927|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373928|NCT00601016|Imiquimod|imiquimod|mesh-list
2373929|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2373930|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
2373931|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373932|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373933|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
2373934|NCT00601042|Lobeline|lobeline|mesh-list
2373935|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2373936|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
2373937|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373938|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373939|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2373940|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2373941|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
2373942|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486820|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2486821|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486822|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2486823|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
2486824|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2486825|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2486826|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
2486827|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486828|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
2486829|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2486830|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486831|NCT01145326|Lidocaine|lidocaine|mesh-list
2486832|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
2486833|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
2486834|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2486835|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486836|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
2486837|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486838|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2486839|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2486840|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2486841|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2486842|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486843|NCT01145365|Anesthetics|anesthetics|mesh-list
2486844|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2486845|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486846|NCT01145404|Capecitabine|capecitabine|mesh-list
2486847|NCT01145404|Lapatinib|lapatinib|mesh-list
2486848|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2486849|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
2486850|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486851|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486852|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2486853|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486854|NCT01145430|Doxorubicin|doxorubicin|mesh-list
2486855|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2486856|NCT01145430|Veliparib|veliparib|mesh-list
2486857|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2486858|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486859|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2486860|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2486861|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486862|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486863|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2486864|NCT01145456|Gemcitabine|gemcitabine|mesh-list
2486865|NCT01145456|R04929097|r04929097|mesh-list
2486866|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2486867|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
2486868|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486869|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373943|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373944|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
2373945|NCT00601159|Gemcitabine|gemcitabine|mesh-list
2373946|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373947|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2373948|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
2373949|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373950|NCT00601159|Antiviral Agents|antiviral agents|mesh-ancestor
2486870|NCT01145456|Antiviral Agents|antiviral agents|mesh-ancestor
2486871|NCT01145456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486872|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486873|NCT01145456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2486874|NCT01145456|Immunologic Factors|immunologic factors|mesh-ancestor
2486875|NCT01145456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486876|NCT01145534|Glyburide|glyburide|mesh-list
2373951|NCT00601159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2373952|NCT00601159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2373953|NCT00601159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2486877|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2486878|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486879|NCT01145573|Calcium|calcium|mesh-list
2486880|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2373954|NCT00601159|Immunologic Factors|immunologic factors|mesh-ancestor
2373955|NCT00601159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373956|NCT00601198|Leucovorin|leucovorin|mesh-list
2373957|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
2373958|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
2373959|NCT00601198|Amifostine|amifostine|mesh-list
2373960|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373961|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486881|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486882|NCT01145612|Losartan|losartan|mesh-list
2486883|NCT01145612|Atenolol|atenolol|mesh-list
2486884|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2486885|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2486886|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2486887|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2486888|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486889|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
2486890|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
2373962|NCT00601198|Antidotes|antidotes|mesh-ancestor
2373963|NCT00601198|Protective Agents|protective agents|mesh-ancestor
2373964|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
2373965|NCT00601198|Vitamins|vitamins|mesh-ancestor
2373966|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
2373967|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2373968|NCT00601211|Pilocarpine|pilocarpine|mesh-list
2373969|NCT00601211|Miotics|miotics|mesh-ancestor
2373970|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
2373971|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2373972|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373973|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2486891|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2486892|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486893|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2486894|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2486895|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2486896|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
2486897|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486898|NCT01145677|Topiramate|topiramate|mesh-list
2486899|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
2486900|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2486901|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486902|NCT01145703|Vitamin D|vitamin d|mesh-list
2486903|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
2486904|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
2486905|NCT01145703|Vitamins|vitamins|mesh-list
2486906|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
2486907|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486908|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2373974|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2373975|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
2373976|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2373977|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373978|NCT00601276|Leuprolide|leuprolide|mesh-list
2373979|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
2373980|NCT00601276|Cyproterone|cyproterone|mesh-list
2373981|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2373982|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
2373983|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2373984|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2373985|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2373986|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373987|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
2373988|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
2373989|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2373990|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2373991|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
2373992|NCT00601289|Temozolomide|temozolomide|mesh-list
2373993|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2373994|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
2373995|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2373996|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2373997|NCT00601302|Amlodipine|amlodipine|mesh-list
2373998|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2373999|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2374000|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2374001|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374002|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2374003|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486909|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2486910|NCT01145807|Terbinafine|terbinafine|mesh-list
2486911|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
2486912|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486913|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486914|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486915|NCT01145846|Cytarabine|cytarabine|mesh-list
2486916|NCT01145846|Daunorubicin|daunorubicin|mesh-list
2486917|NCT01145846|Idarubicin|idarubicin|mesh-list
2486918|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2486919|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
2486920|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486921|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486922|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
2486923|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2486924|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2486925|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
2486926|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486927|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2486928|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2486929|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2486930|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486931|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
2486932|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2486933|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
2486934|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2486935|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
2486936|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486937|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486938|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
2486939|NCT01145950|Etanercept|etanercept|mesh-list
2486940|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2486941|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2486942|NCT01145950|Analgesics|analgesics|mesh-ancestor
2486943|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
2486944|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374004|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
2374005|NCT00601315|Clarithromycin|clarithromycin|mesh-list
2374006|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2374007|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374008|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2374009|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374010|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486945|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486946|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2486947|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2486948|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2486949|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2486950|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
2374011|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2374012|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2374013|NCT00601328|Calcitriol|calcitriol|mesh-list
2374014|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2374015|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374016|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2374017|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2374018|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374019|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2374020|NCT00601328|Vitamins|vitamins|mesh-ancestor
2374021|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
2374022|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2374023|NCT00601432|Levofloxacin|levofloxacin|mesh-list
2486951|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
2486952|NCT01145976|Fludarabine|fludarabine|mesh-list
2374024|NCT00601432|Ofloxacin|ofloxacin|mesh-list
2374025|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2374026|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374027|NCT00601432|Renal Agents|renal agents|mesh-ancestor
2374028|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2486953|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
2486954|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2486955|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2486956|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
2486957|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486958|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2486959|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2486960|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
2486961|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486962|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2486963|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2486964|NCT01146002|Guanfacine|guanfacine|mesh-list
2486965|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2374029|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2374030|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2374031|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374032|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374033|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374034|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2374035|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2374036|NCT00601510|Capecitabine|capecitabine|mesh-list
2374037|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
2374038|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374039|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2374040|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
2374041|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374042|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2374043|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374044|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
2374045|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
2374046|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2374047|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374048|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486966|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2486967|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2486968|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2486969|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
2486970|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486971|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486972|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486973|NCT01146028|Tizanidine|tizanidine|mesh-list
2486974|NCT01146028|Analgesics|analgesics|mesh-ancestor
2486975|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
2486976|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374049|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
2374050|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2374051|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2374052|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374053|NCT00601562|Zidovudine|zidovudine|mesh-list
2486977|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486978|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
2486979|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2486980|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2486981|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
2486982|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
2486983|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2486984|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2486985|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2486986|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
2486987|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486988|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486989|NCT01146041|Rivastigmine|rivastigmine|mesh-list
2486990|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2486991|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486992|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2486993|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
2486994|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2486995|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2486996|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2486997|NCT01146041|Protective Agents|protective agents|mesh-ancestor
2374054|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
2374055|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374056|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2374057|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2374058|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374059|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
2374060|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374061|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2374062|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2374063|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
2374064|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
2374065|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2374066|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2486998|NCT01146067|Rivastigmine|rivastigmine|mesh-list
2486999|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2487000|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487001|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487002|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
2487003|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487004|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487005|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2487006|NCT01146067|Protective Agents|protective agents|mesh-ancestor
2487007|NCT01146093|Pravastatin|pravastatin|mesh-list
2487008|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2487009|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2487010|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
2487011|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487012|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2487013|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2487014|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487015|NCT01146106|Pravastatin|pravastatin|mesh-list
2487016|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2487017|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2487018|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
2487019|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487020|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2487021|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2487022|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487023|NCT01146145|Morphine|morphine|mesh-list
2487024|NCT01146145|Ketamine|ketamine|mesh-list
2487025|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2487026|NCT01146145|Narcotics|narcotics|mesh-ancestor
2487027|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2487028|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487029|NCT01146145|Analgesics|analgesics|mesh-ancestor
2487030|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
2487031|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487032|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2374067|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374068|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
2374069|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2374070|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2374071|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374072|NCT00601588|Sertraline|sertraline|mesh-list
2487033|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2487034|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
2487035|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
2487036|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2487037|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2487038|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487039|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487040|NCT01146301|Clopidogrel|clopidogrel|mesh-list
2487041|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2487042|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2487043|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2487044|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2487045|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
2487046|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374073|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
2374074|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2374075|NCT00601588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2374076|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2374077|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2374078|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374079|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374080|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
2374081|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374082|NCT00601614|Temozolomide|temozolomide|mesh-list
2374083|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2487047|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487048|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487049|NCT01146431|Anesthetics|anesthetics|mesh-list
2487050|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2487051|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487052|NCT01146483|Pantoprazole|pantoprazole|mesh-list
2487053|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2487054|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2487055|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2487056|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
2487057|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487058|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2487059|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2487060|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487061|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2487062|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2487063|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2487064|NCT01146509|Donepezil|donepezil|mesh-list
2487065|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2487066|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487067|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487068|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
2487069|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487070|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487071|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
2487072|NCT01146535|Interferons|interferons|mesh-list
2487073|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
2374084|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
2374085|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374086|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374087|NCT00601666|Zolpidem|zolpidem|mesh-list
2374088|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2374089|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2374090|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2374091|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374092|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2374093|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
2374094|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
2374095|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374096|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374097|NCT00601692|Docetaxel|docetaxel|mesh-list
2374098|NCT00601692|Irinotecan|irinotecan|mesh-list
2374099|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374100|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
2487074|NCT01146535|Oseltamivir|oseltamivir|mesh-list
2487075|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487076|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
2487077|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487078|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
2487079|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487080|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487081|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487082|NCT01146548|Fluoxetine|fluoxetine|mesh-list
2487083|NCT01146548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2487084|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2487085|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2487086|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487087|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487088|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
2487089|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487090|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2487091|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
2487092|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2487093|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2487094|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2487095|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487096|NCT01146626|Vitamin D|vitamin d|mesh-list
2487097|NCT01146626|Ribavirin|ribavirin|mesh-list
2487098|NCT01146626|Vitamins|vitamins|mesh-ancestor
2487099|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
2487100|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487101|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2487102|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
2487103|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487104|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
2487105|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487106|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
2487107|NCT01146678|Lixisenatide|lixisenatide|mesh-list
2487108|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2487109|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487110|NCT01146925|Deferiprone|deferiprone|mesh-list
2487111|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2374101|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
2374102|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
2374103|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374104|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2487112|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
2487113|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
2487114|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487115|NCT01146977|Cytarabine|cytarabine|mesh-list
2487116|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2487117|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
2487118|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487119|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487120|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
2487121|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487122|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2487123|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
2487124|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487125|NCT01147016|Paclitaxel|paclitaxel|mesh-list
2487126|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
2487127|NCT01147016|Doxorubicin|doxorubicin|mesh-list
2487128|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2487129|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2487130|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487131|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
2487132|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
2487133|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
2487134|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487135|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2374105|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2374106|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374107|NCT00601874|Pilocarpine|pilocarpine|mesh-list
2374108|NCT00601874|Miotics|miotics|mesh-ancestor
2374109|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
2374110|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374111|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374112|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2374113|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2374114|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
2374115|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374116|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374117|NCT00601887|Meloxicam|meloxicam|mesh-list
2374118|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2374119|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2487136|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
2487137|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487138|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2487139|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2487140|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
2487141|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2487142|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2374120|NCT00601887|Analgesics|analgesics|mesh-ancestor
2374121|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
2374122|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487143|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2487144|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2487145|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487146|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
2487147|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2487148|NCT01147029|Growth Substances|growth substances|mesh-ancestor
2487149|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487150|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
2487151|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374123|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374124|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2374125|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2374126|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2374127|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2374128|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374129|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374130|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2374131|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374132|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2374133|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374134|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374135|NCT00601978|Levodopa|levodopa|mesh-list
2374136|NCT00601978|Carbidopa|carbidopa|mesh-list
2374137|NCT00601978|Entacapone|entacapone|mesh-list
2374138|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2374139|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2374140|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2487152|NCT01147133|Clopidogrel|clopidogrel|mesh-list
2487153|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2487154|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2487155|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2487156|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2487157|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
2487158|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487159|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487160|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487161|NCT01147146|Fentanyl|fentanyl|mesh-list
2487162|NCT01147146|Midazolam|midazolam|mesh-list
2487163|NCT01147146|Bupivacaine|bupivacaine|mesh-list
2487164|NCT01147146|Propofol|propofol|mesh-list
2487165|NCT01147146|Atracurium|atracurium|mesh-list
2487166|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
2487167|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
2487168|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2487169|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487170|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
2487171|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487172|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2487173|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2374141|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
2374142|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374143|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374144|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374145|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2374146|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374147|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2374148|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2374149|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
2374150|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
2374151|NCT00601991|Aflibercept|aflibercept|mesh-list
2374152|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
2374153|NCT00601991|Growth Substances|growth substances|mesh-ancestor
2374154|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374155|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2374156|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2374157|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
2374158|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487174|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
2487175|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2487176|NCT01147146|Narcotics|narcotics|mesh-ancestor
2487177|NCT01147146|Analgesics|analgesics|mesh-ancestor
2487178|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2487179|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2487180|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2487181|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2487182|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
2487183|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
2487184|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487185|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487186|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2487187|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2487188|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2487189|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2487190|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2487191|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
2487192|NCT01147224|Ciclesonide|ciclesonide|mesh-list
2487193|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
2487194|NCT01147224|Hormones|hormones|mesh-ancestor
2487195|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2487196|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374159|NCT00602004|Losartan|losartan|mesh-list
2374160|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2374161|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2374162|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2374163|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2422905|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2487197|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2487198|NCT01147276|Vildagliptin|vildagliptin|mesh-list
2487199|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2487200|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487201|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2487202|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
2487203|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487204|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487205|NCT01147289|Meloxicam|meloxicam|mesh-list
2374164|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374165|NCT00602017|Amlodipine|amlodipine|mesh-list
2374166|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2487206|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2487207|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2487208|NCT01147289|Analgesics|analgesics|mesh-ancestor
2487209|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
2487210|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487211|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487212|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2487213|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2487214|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2487215|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2487216|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487217|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487218|NCT01147354|Selenium|selenium|mesh-list
2487219|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
2487220|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487221|NCT01147354|Protective Agents|protective agents|mesh-ancestor
2487222|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487223|NCT01147354|Trace Elements|trace elements|mesh-ancestor
2487224|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
2487225|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
2487226|NCT01147432|Capsaicin|capsaicin|mesh-list
2487227|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
2487228|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
2487229|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
2487230|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487231|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487232|NCT01147510|Montelukast|montelukast|mesh-list
2374167|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2374168|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2374169|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374170|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2374171|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487233|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2487234|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
2487235|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2487236|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
2487237|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2487238|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487239|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2487240|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2487241|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487242|NCT01147523|Vitamin E|vitamin e|mesh-list
2487243|NCT01147523|Spironolactone|spironolactone|mesh-list
2487244|NCT01147523|Vitamins|vitamins|mesh-ancestor
2487245|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
2487246|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487247|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
2487248|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487249|NCT01147523|Protective Agents|protective agents|mesh-ancestor
2487250|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2374172|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
2374173|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2374174|NCT00602030|Entinostat|entinostat|mesh-list
2374175|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374176|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2374177|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374178|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374179|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2374180|NCT00602056|Vaccines|vaccines|mesh-list
2374181|NCT00602056|Immunologic Factors|immunologic factors|mesh-ancestor
2374182|NCT00602056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374183|NCT00602082|Capecitabine|capecitabine|mesh-list
2374184|NCT00602082|Streptozocin|streptozocin|mesh-list
2487251|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
2487252|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2487253|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2487254|NCT01147523|Diuretics|diuretics|mesh-ancestor
2487255|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
2487256|NCT01147588|Esomeprazole|esomeprazole|mesh-list
2487257|NCT01147588|Omeprazole|omeprazole|mesh-list
2487258|NCT01147588|Lansoprazole|lansoprazole|mesh-list
2487259|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
2487260|NCT01147588|Clopidogrel|clopidogrel|mesh-list
2487261|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2487262|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2487263|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2487264|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2487265|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
2487266|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487267|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487268|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487269|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2487270|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2487271|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2487272|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487275|NCT01147692|Simvastatin|simvastatin|mesh-list
2487276|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
2487277|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2487278|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2487279|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
2487280|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487281|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2487282|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2487283|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487284|NCT01147692|Incretins|incretins|mesh-ancestor
2487285|NCT01147692|Hormones|hormones|mesh-ancestor
2487286|NCT01147692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2487287|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487288|NCT01147705|Allopurinol|allopurinol|mesh-list
2487289|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
2487290|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487291|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487292|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
2487293|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2487294|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2487295|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
2487296|NCT01147705|Protective Agents|protective agents|mesh-ancestor
2487297|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487298|NCT01147718|Digoxin|digoxin|mesh-list
2487299|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
2487300|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2487301|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2487302|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487303|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487304|NCT01147718|Protective Agents|protective agents|mesh-ancestor
2487305|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487306|NCT01147718|Incretins|incretins|mesh-ancestor
2487307|NCT01147718|Hormones|hormones|mesh-ancestor
2487308|NCT01147718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2487309|NCT01147731|Warfarin|warfarin|mesh-list
2487310|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
2487311|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
2487312|NCT01147731|Incretins|incretins|mesh-ancestor
2487313|NCT01147731|Hormones|hormones|mesh-ancestor
2487314|NCT01147731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2487315|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487316|NCT01147757|Remifentanil|remifentanil|mesh-list
2374185|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374186|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2374187|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
2374188|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374189|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2374190|NCT00602095|Misoprostol|misoprostol|mesh-list
2374191|NCT00602095|Dinoprostone|dinoprostone|mesh-list
2374192|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2487317|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2374193|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
2487318|NCT01147757|Narcotics|narcotics|mesh-ancestor
2374194|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2374195|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374196|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2374197|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2374198|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
2374199|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
2374200|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
2374201|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374202|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2487319|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2487320|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487321|NCT01147757|Analgesics|analgesics|mesh-ancestor
2487322|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
2487323|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487324|NCT01147770|Progesterone|progesterone|mesh-list
2374203|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374204|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2374205|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
2374206|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487325|NCT01147770|Progestins|progestins|mesh-ancestor
2487326|NCT01147770|Hormones|hormones|mesh-ancestor
2487327|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2487328|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487329|NCT01148004|Ritonavir|ritonavir|mesh-list
2487330|NCT01148004|Lopinavir|lopinavir|mesh-list
2487331|NCT01148004|Fenofibrate|fenofibrate|mesh-list
2487332|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2487333|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2487334|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
2487335|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487336|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487337|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2487338|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2487339|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
2487340|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487341|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2487342|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2487343|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2487344|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
2487345|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2487346|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2487347|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487348|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
2487349|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
2487350|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2487351|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2487352|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487353|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487354|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487355|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2487356|NCT01148147|Adenosine|adenosine|mesh-list
2487357|NCT01148147|Analgesics|analgesics|mesh-ancestor
2487358|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
2487359|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374207|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2374208|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374209|NCT00602173|Cilostazol|cilostazol|mesh-list
2374210|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2374211|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
2374212|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374213|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374214|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2374215|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
2374216|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2374217|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2374218|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374219|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2374220|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
2374221|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2374222|NCT00602173|Protective Agents|protective agents|mesh-ancestor
2374223|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2374224|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2487360|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487361|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2374225|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374226|NCT00602186|Prazosin|prazosin|mesh-list
2374227|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2374228|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2374229|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2374230|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2374231|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
2374232|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374233|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374234|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374235|NCT00602251|Terbinafine|terbinafine|mesh-list
2374236|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
2374237|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374238|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374239|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487362|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
2487363|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2487364|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
2487365|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
2487366|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487367|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487368|NCT01148160|Voriconazole|voriconazole|mesh-list
2487369|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
2487370|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487371|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2487372|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2487373|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487374|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487375|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2487376|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
2487377|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2487378|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487379|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2487380|NCT01148173|Ifosfamide|ifosfamide|mesh-list
2487381|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2487382|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
2487383|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487384|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487385|NCT01148264|Olanzapine|olanzapine|mesh-list
2487386|NCT01148264|Metoclopramide|metoclopramide|mesh-list
2487387|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
2487388|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
2487389|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487390|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487391|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2487392|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2487393|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2487394|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2487395|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2487396|NCT01148264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2487397|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2487398|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2487399|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487400|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487401|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
2487402|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2487403|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2487404|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
2487405|NCT01148277|Fentanyl|fentanyl|mesh-list
2487406|NCT01148277|Midazolam|midazolam|mesh-list
2487407|NCT01148277|Propofol|propofol|mesh-list
2487408|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2487409|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2487410|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487411|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2487412|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
2487413|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
2487414|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2487415|NCT01148277|Narcotics|narcotics|mesh-ancestor
2487416|NCT01148277|Analgesics|analgesics|mesh-ancestor
2487417|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
2487418|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374240|NCT00602303|Torsemide|torsemide|mesh-list
2374241|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2487419|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2487420|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2487421|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2487422|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2487423|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
2487424|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
2487425|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487426|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487427|NCT01148303|Etoricoxib|etoricoxib|mesh-list
2487428|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2374242|NCT00602303|Diuretics|diuretics|mesh-ancestor
2374243|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
2374244|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374245|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2374246|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2374247|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374248|NCT00602316|Chelating Agents|chelating agents|mesh-list
2374249|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
2374250|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374251|NCT00602329|Leucovorin|leucovorin|mesh-list
2374252|NCT00602329|Bevacizumab|bevacizumab|mesh-list
2374253|NCT00602329|Fluorouracil|fluorouracil|mesh-list
2374254|NCT00602329|Oxaliplatin|oxaliplatin|mesh-list
2374255|NCT00602329|Calcium|calcium|mesh-list
2374256|NCT00602329|Levoleucovorin|levoleucovorin|mesh-list
2374257|NCT00602329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2374258|NCT00602329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374259|NCT00602329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2487429|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2487430|NCT01148303|Analgesics|analgesics|mesh-ancestor
2487431|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
2487432|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487433|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487434|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2487435|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2487436|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2487437|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2487438|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487439|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487440|NCT01148316|Fluoxetine|fluoxetine|mesh-list
2487441|NCT01148316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2487442|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2487443|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2487444|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487445|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487446|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
2487447|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487448|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2487449|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
2487450|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2487451|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2487452|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2487453|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487454|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2487455|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
2487456|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487457|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2487458|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
2487459|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487460|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487461|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2487462|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2487463|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2487464|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
2487465|NCT01148446|Prednisone|prednisone|mesh-list
2487466|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
2487467|NCT01148446|Rituximab|rituximab|mesh-list
2487468|NCT01148446|Doxorubicin|doxorubicin|mesh-list
2487469|NCT01148446|Vincristine|vincristine|mesh-list
2487470|NCT01148446|Epirubicin|epirubicin|mesh-list
2487471|NCT01148446|Vinblastine|vinblastine|mesh-list
2487472|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2487473|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
2487474|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487475|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2487476|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2487477|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
2487478|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487479|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487480|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2487481|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2487482|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2487483|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2487484|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2487485|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487486|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2487487|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
2374260|NCT00602329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2374261|NCT00602329|Growth Substances|growth substances|mesh-ancestor
2374262|NCT00602329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374263|NCT00602329|Growth Inhibitors|growth inhibitors|mesh-ancestor
2374264|NCT00602329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2374265|NCT00602329|Antimetabolites|antimetabolites|mesh-ancestor
2374266|NCT00602329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374267|NCT00602329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2374268|NCT00602329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2374269|NCT00602329|Immunologic Factors|immunologic factors|mesh-ancestor
2374270|NCT00602329|Antidotes|antidotes|mesh-ancestor
2374271|NCT00602329|Protective Agents|protective agents|mesh-ancestor
2374272|NCT00602329|Vitamin B Complex|vitamin b complex|mesh-ancestor
2374273|NCT00602329|Vitamins|vitamins|mesh-ancestor
2374274|NCT00602329|Micronutrients|micronutrients|mesh-ancestor
2374275|NCT00602342|Terbinafine|terbinafine|mesh-list
2374276|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
2374277|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374278|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374279|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374280|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
2374281|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
2374282|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2374283|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374284|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374285|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
2374286|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2487488|NCT01148446|Hormones|hormones|mesh-ancestor
2487489|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2487490|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2487491|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2487492|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
2487493|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
2487494|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
2487495|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2487496|NCT01148472|Citalopram|citalopram|mesh-list
2487497|NCT01148472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2487498|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2487499|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2487500|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487501|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487502|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
2487503|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487504|NCT01148472|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2487505|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
2487506|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2487507|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487508|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2487509|NCT01148472|Analgesics|analgesics|mesh-ancestor
2487510|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
2487511|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
2487512|NCT01148576|Vitamin E|vitamin e|mesh-list
2487513|NCT01148576|Entecavir|entecavir|mesh-list
2487514|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
2487515|NCT01148576|Vitamins|vitamins|mesh-ancestor
2487516|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
2487517|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487518|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
2487519|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487520|NCT01148576|Protective Agents|protective agents|mesh-ancestor
2487521|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
2487522|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374287|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2374288|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374289|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
2374290|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
2374291|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2374292|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374293|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374294|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
2374295|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2374296|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2374297|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374298|NCT00602407|Cilostazol|cilostazol|mesh-list
2374299|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2374300|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
2374301|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374302|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374303|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2487523|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2487524|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
2487525|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2487526|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2487527|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
2487528|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2487529|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2487530|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
2487531|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2487532|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2487533|NCT01148615|Docetaxel|docetaxel|mesh-list
2487534|NCT01148615|Aflibercept|aflibercept|mesh-list
2487535|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487536|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
2487537|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
2487538|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
2487539|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487540|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2487541|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2487542|NCT01148615|Growth Substances|growth substances|mesh-ancestor
2487543|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487544|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
2487545|NCT01148628|Everolimus|everolimus|mesh-list
2487546|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487547|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2487548|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
2487549|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487550|NCT01148667|Caseins|caseins|mesh-list
2487551|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
2487552|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
2487553|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487554|NCT01148849|Margetuximab|margetuximab|mesh-list
2374304|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
2374305|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2374306|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2374307|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374308|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2374309|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
2374310|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2374311|NCT00602407|Protective Agents|protective agents|mesh-ancestor
2374312|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2374313|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2487555|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487556|NCT01148901|Infliximab|infliximab|mesh-list
2487557|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
2487558|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2487559|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2487560|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2487561|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2487562|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
2487563|NCT01148992|Lofexidine|lofexidine|mesh-list
2374314|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374315|NCT00602498|Clarithromycin|clarithromycin|mesh-list
2374316|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2374317|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374318|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2374319|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487564|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2487565|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2487566|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487567|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
2487568|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487569|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2487570|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2487571|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2487572|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
2487573|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487574|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487575|NCT01149005|Insulin|insulin|mesh-list
2487576|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2487577|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
2487578|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
2487579|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
2487580|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2487581|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487582|NCT01149018|Dronabinol|dronabinol|mesh-list
2487583|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
2487584|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487585|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2487586|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2487587|NCT01149018|Analgesics|analgesics|mesh-ancestor
2487588|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
2487589|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487590|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2487591|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2487592|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487593|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487594|NCT01149018|Hormones|hormones|mesh-ancestor
2487595|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2374320|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374321|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2374322|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2374323|NCT00602511|Thalidomide|thalidomide|mesh-list
2374324|NCT00602511|Bortezomib|bortezomib|mesh-list
2374325|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374326|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2374327|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
2374328|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487602|NCT01149109|Temozolomide|temozolomide|mesh-list
2487603|NCT01149109|Lomustine|lomustine|mesh-list
2487604|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2487605|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
2374329|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
2374330|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2374331|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374332|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2374333|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2374334|NCT00602511|Growth Substances|growth substances|mesh-ancestor
2487606|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487607|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487608|NCT01149122|Gemcitabine|gemcitabine|mesh-list
2487609|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
2487610|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2487611|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2487612|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
2487613|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487614|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487615|NCT01149122|Antiviral Agents|antiviral agents|mesh-ancestor
2487616|NCT01149122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487617|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487618|NCT01149122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2487619|NCT01149122|Immunologic Factors|immunologic factors|mesh-ancestor
2487620|NCT01149122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487621|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2487622|NCT01149174|Mitomycins|mitomycins|mesh-list
2487623|NCT01149174|Mitomycin|mitomycin|mesh-list
2487624|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2487625|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487626|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
2487627|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487628|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2487629|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487630|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
2487631|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2487632|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2487633|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374335|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
2374336|NCT00602524|Pilocarpine|pilocarpine|mesh-list
2374337|NCT00602524|Miotics|miotics|mesh-ancestor
2374338|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
2374339|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374340|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487634|NCT01149278|Benzocaine|benzocaine|mesh-list
2487635|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
2487636|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
2487637|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2487638|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487639|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
2487640|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487641|NCT01149304|Enoxaparin|enoxaparin|mesh-list
2374341|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2374342|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2374343|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
2374344|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374345|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374346|NCT00602550|Zidovudine|zidovudine|mesh-list
2374347|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
2374348|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374349|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2374350|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2374351|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374352|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
2374353|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374354|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2374355|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2374356|NCT00602576|Temozolomide|temozolomide|mesh-list
2374357|NCT00602576|Sorafenib|sorafenib|mesh-list
2374358|NCT00602576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2374359|NCT00602576|Alkylating Agents|alkylating agents|mesh-ancestor
2374360|NCT00602576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374361|NCT00602576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374362|NCT00602576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2374363|NCT00602576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374364|NCT00602589|Levofloxacin|levofloxacin|mesh-list
2374365|NCT00602589|Ofloxacin|ofloxacin|mesh-list
2374366|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2374367|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374368|NCT00602589|Renal Agents|renal agents|mesh-ancestor
2374369|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2374370|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2374371|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2374372|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374373|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487642|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
2487643|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2487644|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
2487645|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2487646|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2487647|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487648|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2487649|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487650|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2487651|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2487652|NCT01149304|Protective Agents|protective agents|mesh-ancestor
2487653|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487654|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
2487655|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2487656|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
2487657|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2487658|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2487659|NCT01149330|Adapalene|adapalene|mesh-list
2374374|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487660|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2487661|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2487662|NCT01149330|Analgesics|analgesics|mesh-ancestor
2487663|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
2487664|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487665|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487666|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2487667|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2487668|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
2487669|NCT01149356|Exemestane|exemestane|mesh-list
2487670|NCT01149356|Goserelin|goserelin|mesh-list
2487671|NCT01149356|R04929097|r04929097|mesh-list
2487672|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487673|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2487674|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2487675|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487676|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487677|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2487678|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
2487679|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2487680|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487681|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2487682|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
2487683|NCT01149395|Lansoprazole|lansoprazole|mesh-list
2487684|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2487685|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2487686|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2487687|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487688|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487689|NCT01149408|Decitabine|decitabine|mesh-list
2487690|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2487691|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
2487692|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487693|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487694|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487695|NCT01149499|Valacyclovir|valacyclovir|mesh-list
2487696|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
2487697|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487698|NCT01149564|Ibuprofen|ibuprofen|mesh-list
2487699|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2487700|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2487701|NCT01149564|Analgesics|analgesics|mesh-ancestor
2487702|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
2487703|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487704|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487705|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2487706|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2487707|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2487708|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487709|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487710|NCT01149577|Olanzapine|olanzapine|mesh-list
2487711|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
2374375|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2374376|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2374377|NCT00602602|Gemcitabine|gemcitabine|mesh-list
2374378|NCT00602602|Bevacizumab|bevacizumab|mesh-list
2374379|NCT00602602|Fluorouracil|fluorouracil|mesh-list
2374380|NCT00602602|Oxaliplatin|oxaliplatin|mesh-list
2374381|NCT00602602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2374382|NCT00602602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374383|NCT00602602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2374384|NCT00602602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2374385|NCT00602602|Growth Substances|growth substances|mesh-ancestor
2374386|NCT00602602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374387|NCT00602602|Growth Inhibitors|growth inhibitors|mesh-ancestor
2374388|NCT00602602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2374389|NCT00602602|Antimetabolites|antimetabolites|mesh-ancestor
2374390|NCT00602602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374391|NCT00602602|Antiviral Agents|antiviral agents|mesh-ancestor
2487712|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
2487713|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487714|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487715|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2487716|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2487717|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2487718|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2487719|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2487720|NCT01149577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2487721|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2487722|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2487723|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487724|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374392|NCT00602602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374393|NCT00602602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487725|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
2487726|NCT01149629|Droxidopa|droxidopa|mesh-list
2487727|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2487728|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2487729|NCT01149668|Abexinostat|abexinostat|mesh-list
2487730|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2487731|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487732|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487733|NCT01149746|Tamsulosin|tamsulosin|mesh-list
2487734|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2487735|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2487736|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2487737|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
2487738|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487739|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487740|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487741|NCT01149746|Urological Agents|urological agents|mesh-ancestor
2487742|NCT01149798|Cisplatin|cisplatin|mesh-list
2487743|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2487744|NCT01149798|Paclitaxel|paclitaxel|mesh-list
2487745|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487746|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2487747|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
2487748|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
2487749|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
2487750|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487751|NCT01149824|Salvinorin A|salvinorin a|mesh-list
2487752|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
2487753|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487754|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2487755|NCT01149850|Bevacizumab|bevacizumab|mesh-list
2487756|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2487757|NCT01149850|Temozolomide|temozolomide|mesh-list
2487758|NCT01149850|Antibodies|antibodies|mesh-list
2487759|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
2487760|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2487761|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487762|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2487763|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2487764|NCT01149850|Growth Substances|growth substances|mesh-ancestor
2487765|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487766|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
2487767|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
2487768|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2487769|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
2487770|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487771|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
2487772|NCT01149902|Docetaxel|docetaxel|mesh-list
2487773|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2487774|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
2487775|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487776|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2487777|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2487778|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
2487779|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487780|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487781|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2487782|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
2487783|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
2487784|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
2487785|NCT01149941|Ibuprofen|ibuprofen|mesh-list
2487786|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2487787|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2374394|NCT00602602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2374395|NCT00602602|Immunologic Factors|immunologic factors|mesh-ancestor
2374396|NCT00602615|Torsemide|torsemide|mesh-list
2487788|NCT01149941|Analgesics|analgesics|mesh-ancestor
2487789|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
2374397|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2374398|NCT00602615|Diuretics|diuretics|mesh-ancestor
2374399|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
2374400|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374401|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2374402|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2374403|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374404|NCT00602680|Donepezil|donepezil|mesh-list
2374405|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2374406|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374407|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374408|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
2374409|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374410|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374411|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
2374412|NCT00602693|Sirolimus|sirolimus|mesh-list
2374413|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
2374414|NCT00602693|Fludarabine|fludarabine|mesh-list
2374415|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
2374416|NCT00602693|Allopurinol|allopurinol|mesh-list
2374417|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2374418|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
2374419|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487790|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487791|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487792|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2487793|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2487794|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2487795|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487796|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487797|NCT01149954|Ibuprofen|ibuprofen|mesh-list
2487798|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2487799|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2487800|NCT01149954|Analgesics|analgesics|mesh-ancestor
2487801|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
2374420|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2374421|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2374422|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
2487802|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487803|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487804|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2487805|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2487806|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2487807|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487808|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487809|NCT01149967|Dexetimide|dexetimide|mesh-list
2487810|NCT01149967|Citalopram|citalopram|mesh-list
2487811|NCT01149967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2487812|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2487813|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2487814|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487815|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487816|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
2487817|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487818|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2487819|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
2487820|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2487821|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2487822|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2487823|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
2487824|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
2487825|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487826|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2487827|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2487828|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
2487829|NCT01149980|Dexetimide|dexetimide|mesh-list
2487830|NCT01149980|Citalopram|citalopram|mesh-list
2487831|NCT01149980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2487832|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2487833|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2487834|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487835|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487836|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
2487837|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487838|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2487839|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
2487840|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2487841|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2487842|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2487843|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
2487844|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
2487845|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487846|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2487847|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2487848|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
2487849|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
2487850|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
2487851|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2487852|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
2487853|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487854|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2487855|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2487856|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487857|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2487858|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
2487859|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2487860|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487861|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487862|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487863|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
2487864|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487865|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
2487866|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
2487867|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
2487868|NCT01150162|Omeprazole|omeprazole|mesh-list
2487869|NCT01150162|Rebamipide|rebamipide|mesh-list
2487870|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2487871|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2487872|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2487873|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487874|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487875|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
2487876|NCT01150162|Protective Agents|protective agents|mesh-ancestor
2487877|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487878|NCT01150201|Losartan|losartan|mesh-list
2487879|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2487880|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2487881|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2487882|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2487883|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487884|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2487885|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2487886|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2487887|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487888|NCT01150318|Iodine|iodine|mesh-list
2487889|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2487890|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487891|NCT01150318|Trace Elements|trace elements|mesh-ancestor
2487892|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
2487893|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487894|NCT01150331|Levetiracetam|levetiracetam|mesh-list
2487895|NCT01150331|Clonazepam|clonazepam|mesh-list
2487896|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
2487897|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
2487898|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
2487899|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
2487900|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487901|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487902|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487903|NCT01150344|Artemether|artemether|mesh-list
2487904|NCT01150344|Atovaquone|atovaquone|mesh-list
2487905|NCT01150344|Proguanil|proguanil|mesh-list
2487906|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2487907|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
2487908|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2487909|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2487910|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487911|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374423|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374424|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374425|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2374426|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2374427|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
2374428|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2374429|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374430|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2374431|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
2374432|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374433|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
2374434|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2374435|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
2374436|NCT00602693|Protective Agents|protective agents|mesh-ancestor
2374437|NCT00602706|Melphalan|melphalan|mesh-list
2374438|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
2374439|NCT00602706|Sargramostim|sargramostim|mesh-list
2374440|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2374441|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
2374442|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487912|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487913|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
2487914|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2487915|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2487916|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2487917|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2487918|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487919|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2487920|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2487921|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2487922|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
2487923|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2487924|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487925|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2487926|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2487927|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
2487928|NCT01150617|Insulin|insulin|mesh-list
2487929|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2487930|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
2487931|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2487932|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
2487933|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487934|NCT01150630|Gemcitabine|gemcitabine|mesh-list
2487935|NCT01150630|Capecitabine|capecitabine|mesh-list
2487936|NCT01150630|Epirubicin|epirubicin|mesh-list
2487937|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2487938|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2487939|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
2487940|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487941|NCT01150630|Antiviral Agents|antiviral agents|mesh-ancestor
2487942|NCT01150630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487943|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487944|NCT01150630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2487945|NCT01150630|Immunologic Factors|immunologic factors|mesh-ancestor
2487946|NCT01150630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487947|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2487948|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2487949|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2487950|NCT01150695|Vaccines|vaccines|mesh-list
2487951|NCT01150695|Immunologic Factors|immunologic factors|mesh-ancestor
2487952|NCT01150695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487953|NCT01150747|Azithromycin|azithromycin|mesh-list
2487954|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
2487955|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2487956|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2487957|NCT01150786|Selenium|selenium|mesh-list
2487958|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
2487959|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487960|NCT01150786|Protective Agents|protective agents|mesh-ancestor
2487961|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487962|NCT01150786|Trace Elements|trace elements|mesh-ancestor
2487963|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
2487964|NCT01150877|Vitamin D|vitamin d|mesh-list
2487965|NCT01150877|Vitamins|vitamins|mesh-ancestor
2374443|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374444|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2487966|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
2487967|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487968|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2487974|NCT01150955|Resveratrol|resveratrol|mesh-list
2487975|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
2487976|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2487977|NCT01150955|Protective Agents|protective agents|mesh-ancestor
2487978|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487979|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2487980|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2487981|NCT01151072|Insulin|insulin|mesh-list
2487982|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2487983|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487984|NCT01151176|Insulin|insulin|mesh-list
2487985|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2487986|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2487987|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487988|NCT01151241|Anesthetics|anesthetics|mesh-list
2487989|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
2487990|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2487991|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2487992|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
2487993|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2487994|NCT01151254|Propofol|propofol|mesh-list
2487995|NCT01151254|Sevoflurane|sevoflurane|mesh-list
2487996|NCT01151254|Isoflurane|isoflurane|mesh-list
2487997|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2487998|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2487999|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488000|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2488001|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
2488002|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
2488003|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2488004|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2488005|NCT01151267|Anesthetics|anesthetics|mesh-list
2488006|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488007|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488008|NCT01151306|Simvastatin|simvastatin|mesh-list
2488009|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2488010|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2488011|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
2488012|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488013|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2488014|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2488015|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488016|NCT01151384|Docetaxel|docetaxel|mesh-list
2488017|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488018|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
2488019|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
2488020|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
2488021|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488022|NCT01151397|Vitamin D|vitamin d|mesh-list
2488023|NCT01151397|Ribavirin|ribavirin|mesh-list
2488024|NCT01151397|Vitamins|vitamins|mesh-ancestor
2488025|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
2488026|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488027|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2488028|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
2488029|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374445|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2374446|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
2374447|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374448|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2374449|NCT00602706|Analgesics|analgesics|mesh-ancestor
2374450|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
2488030|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
2488031|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488032|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2374451|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374452|NCT00602719|Zolpidem|zolpidem|mesh-list
2374453|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2374454|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2488033|NCT01151592|Hematinics|hematinics|mesh-ancestor
2374455|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2374456|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374457|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2374458|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
2374459|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
2374460|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374461|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374462|NCT00602745|Fluorouracil|fluorouracil|mesh-list
2374463|NCT00602745|Antimetabolites|antimetabolites|mesh-ancestor
2374464|NCT00602745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374465|NCT00602745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2488034|NCT01151605|Insulin|insulin|mesh-list
2488035|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2488036|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2488037|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488038|NCT01151670|Pioglitazone|pioglitazone|mesh-list
2488039|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2488040|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488041|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
2488042|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
2488043|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
2488044|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2488045|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
2488046|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
2488047|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2488048|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488049|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488050|NCT01151722|Bevacizumab|bevacizumab|mesh-list
2488051|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2488052|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488053|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2488054|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2488055|NCT01151722|Growth Substances|growth substances|mesh-ancestor
2488056|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488057|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
2488058|NCT01151735|Complement C1s|complement c1s|mesh-list
2488059|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
2488060|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488061|NCT01151787|Amitriptyline|amitriptyline|mesh-list
2488062|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
2488063|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2488064|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
2488065|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2488066|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2488067|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488068|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2488069|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488070|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2488071|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488072|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2488073|NCT01151787|Analgesics|analgesics|mesh-ancestor
2488074|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
2488075|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2488076|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2488077|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2488078|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488079|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
2488080|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2488081|NCT01151800|Benzocaine|benzocaine|mesh-list
2488082|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
2488083|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
2488084|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488085|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488086|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
2488087|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488088|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
2488089|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2488090|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488091|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488092|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2488093|NCT01151865|Analgesics|analgesics|mesh-ancestor
2488094|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
2488095|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488096|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2488097|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2488098|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2488099|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
2488100|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2488101|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488102|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2488103|NCT01151878|Cathartics|cathartics|mesh-ancestor
2374466|NCT00602745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374467|NCT00602745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2374468|NCT00602745|Immunologic Factors|immunologic factors|mesh-ancestor
2374469|NCT00602745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374470|NCT00602849|Sertraline|sertraline|mesh-list
2374471|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
2374472|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2374473|NCT00602849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2374474|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2374475|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2374476|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374477|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374478|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
2374479|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488104|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2488105|NCT01151943|Anesthetics|anesthetics|mesh-list
2488106|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
2488107|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488108|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488109|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
2488110|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488111|NCT01152047|Oxytocin|oxytocin|mesh-list
2488112|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
2488113|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2488114|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488115|NCT01152203|Bevacizumab|bevacizumab|mesh-list
2488116|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2488117|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2488118|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488119|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2488120|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2488121|NCT01152203|Growth Substances|growth substances|mesh-ancestor
2488122|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488123|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
2488124|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2488125|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
2488126|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488127|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
2488128|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2488129|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488130|NCT01152346|Azacitidine|azacitidine|mesh-list
2488131|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2488132|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
2488133|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488134|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488135|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488136|NCT01152372|Insulin|insulin|mesh-list
2488137|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2488138|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488139|NCT01152476|Remifentanil|remifentanil|mesh-list
2488140|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2488141|NCT01152476|Narcotics|narcotics|mesh-ancestor
2488142|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488143|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488144|NCT01152476|Analgesics|analgesics|mesh-ancestor
2488145|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
2374480|NCT00602862|Bevacizumab|bevacizumab|mesh-list
2374481|NCT00602862|Sorafenib|sorafenib|mesh-list
2374482|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2374483|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374484|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2374485|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2374486|NCT00602862|Growth Substances|growth substances|mesh-ancestor
2374487|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374488|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
2374489|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2488146|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488147|NCT01152541|Riboflavin|riboflavin|mesh-list
2488148|NCT01152541|Dextrans|dextrans|mesh-list
2488149|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2488150|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
2488151|NCT01152541|Vitamins|vitamins|mesh-ancestor
2488152|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
2488153|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488154|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2488155|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
2488156|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
2488157|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
2374490|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374491|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374492|NCT00602901|Naproxen|naproxen|mesh-list
2374493|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2374494|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2374495|NCT00602901|Analgesics|analgesics|mesh-ancestor
2374496|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
2374497|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374498|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374499|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2374500|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2374501|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
2374502|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2374503|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374504|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374505|NCT00603031|Glucagon|glucagon|mesh-list
2374506|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
2374507|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2488158|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
2488159|NCT01152593|Mupirocin|mupirocin|mesh-list
2488160|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2488161|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488162|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2488163|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488164|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488165|NCT01152606|Trastuzumab|trastuzumab|mesh-list
2488166|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2488167|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488168|NCT01152710|Capecitabine|capecitabine|mesh-list
2488169|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2114108|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2114109|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
2114110|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114111|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2114112|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2114113|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
2114114|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488170|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
2488171|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488172|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488173|NCT01152723|Nicotine|nicotine|mesh-list
2488174|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2488175|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
2488176|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488177|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488178|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2488179|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2488180|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
2488181|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2488182|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488183|NCT01152736|Nicotine|nicotine|mesh-list
2488184|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2488185|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
2488186|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488187|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488188|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2488189|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2488190|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
2488191|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2488192|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488193|NCT01152749|Nicotine|nicotine|mesh-list
2488194|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2488195|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
2488196|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488197|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374508|NCT00603031|Hormones|hormones|mesh-ancestor
2374509|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2374510|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374511|NCT00603031|Incretins|incretins|mesh-ancestor
2488198|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2488199|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2488200|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
2488201|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2488202|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488203|NCT01152801|Everolimus|everolimus|mesh-list
2374512|NCT00603083|Ketorolac|ketorolac|mesh-list
2374513|NCT00603083|Ropivacaine|ropivacaine|mesh-list
2374514|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
2488204|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488205|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2488206|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
2488207|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488208|NCT01152827|Everolimus|everolimus|mesh-list
2488209|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488210|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2488211|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
2488212|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488213|NCT01152840|Everolimus|everolimus|mesh-list
2488214|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374515|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
2374516|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2374517|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374518|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
2374519|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374520|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2374521|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2374522|NCT00603083|Analgesics|analgesics|mesh-ancestor
2374523|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2374524|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2374525|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2374526|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374527|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488215|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2488216|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
2488217|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488218|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2488219|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2488220|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488221|NCT01152931|Vitamins|vitamins|mesh-list
2488222|NCT01152931|Vitamin E|vitamin e|mesh-list
2488223|NCT01152931|Tocopherols|tocopherols|mesh-list
2488224|NCT01152931|Tocotrienols|tocotrienols|mesh-list
2488225|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
2488226|NCT01152931|Vitamin A|vitamin a|mesh-list
2488227|NCT01152931|Zinc|zinc|mesh-list
2488228|NCT01152931|Selenium|selenium|mesh-list
2488229|NCT01152931|Artesunate|artesunate|mesh-list
2488230|NCT01152931|Lumefantrine|lumefantrine|mesh-list
2488231|NCT01152931|Artemether|artemether|mesh-list
2488232|NCT01152931|Amodiaquine|amodiaquine|mesh-list
2488233|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
2488234|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
2488235|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488236|NCT01152931|Trace Elements|trace elements|mesh-ancestor
2488237|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
2488238|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488239|NCT01152931|Protective Agents|protective agents|mesh-ancestor
2488240|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
2488241|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2488242|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2488243|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374528|NCT00603109|Rimonabant|rimonabant|mesh-list
2374529|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2488244|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488245|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
2488246|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
2488247|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2488248|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
2488249|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2488250|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
2488251|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2488252|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488253|NCT01153165|Citalopram|citalopram|mesh-list
2488254|NCT01153165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2488255|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2488256|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2488257|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488258|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2488259|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
2488260|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488261|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2374530|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2374531|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2374532|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374533|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374534|NCT00603109|Hormones|hormones|mesh-ancestor
2374535|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2374536|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374537|NCT00603135|Levetiracetam|levetiracetam|mesh-list
2374538|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
2374539|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
2374540|NCT00603317|Amoxicillin|amoxicillin|mesh-list
2374541|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
2374542|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
2374543|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2374544|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2374545|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374546|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374547|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374548|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2374549|NCT00603343|Propiverine|propiverine|mesh-list
2374550|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
2374551|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
2374552|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374553|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374554|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2374555|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2374556|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
2488262|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
2488263|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2488264|NCT01153191|Gentamicins|gentamicins|mesh-list
2488265|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2488266|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488267|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2488268|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488269|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488270|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
2488271|NCT01153204|Citric Acid|citric acid|mesh-list
2488272|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
2488273|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
2488274|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2488275|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
2488276|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
2488277|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488278|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
2488279|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2488280|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2488281|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374557|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374558|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374559|NCT00603343|Urological Agents|urological agents|mesh-ancestor
2374560|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2374561|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374562|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2374563|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374564|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374565|NCT00603434|Methylphenidate|methylphenidate|mesh-list
2374566|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2374567|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374568|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2488282|NCT01153204|Urological Agents|urological agents|mesh-ancestor
2488283|NCT01153217|Tenofovir|tenofovir|mesh-list
2488284|NCT01153217|Abacavir|abacavir|mesh-list
2488285|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
2488286|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488287|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2488288|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2488289|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488290|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488291|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2488292|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2488293|NCT01153243|Vitamin D|vitamin d|mesh-list
2488294|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
2488295|NCT01153243|Vitamins|vitamins|mesh-ancestor
2488296|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
2488297|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488298|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2488299|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2488300|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
2488301|NCT01153256|Analgesics|analgesics|mesh-ancestor
2488302|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
2488303|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488304|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488305|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
2374569|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2374570|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2374571|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374572|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
2374573|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374574|NCT00603577|Xaliproden|xaliproden|mesh-list
2374575|NCT00603577|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2374576|NCT00603577|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2488306|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488307|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2488308|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
2488309|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2488310|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2488311|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488312|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2374577|NCT00603577|Serotonin Agents|serotonin agents|mesh-ancestor
2374578|NCT00603577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374579|NCT00603577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374580|NCT00603577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488313|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
2488314|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2488315|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2488316|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2488317|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2488318|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
2488319|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488320|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2488321|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2488322|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488323|NCT01153373|Ethanol|ethanol|mesh-list
2374585|NCT00603759|Celecoxib|celecoxib|mesh-list
2374586|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2374587|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2374588|NCT00603759|Analgesics|analgesics|mesh-ancestor
2374589|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
2374590|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374591|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374592|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2374593|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2374594|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2374595|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2374596|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374597|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374598|NCT00603772|Tretinoin|tretinoin|mesh-list
2374599|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488324|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2488325|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488326|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488327|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488328|NCT01153386|Treprostinil|treprostinil|mesh-list
2488329|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2488330|NCT01153542|Ivacaftor|ivacaftor|mesh-list
2488331|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2488332|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2488333|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488334|NCT01153568|Vitamin D|vitamin d|mesh-list
2488335|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
2488336|NCT01153568|Vitamins|vitamins|mesh-ancestor
2488337|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
2488338|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488339|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2488340|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2488341|NCT01153659|Esomeprazole|esomeprazole|mesh-list
2488342|NCT01153659|Rabeprazole|rabeprazole|mesh-list
2374600|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
2374601|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
2374602|NCT00603785|Omalizumab|omalizumab|mesh-list
2374603|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2374604|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2488343|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2488344|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2488345|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2488346|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374605|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
2374606|NCT00603824|PENTA|penta|mesh-list
2374607|NCT00603824|Lepirudin|lepirudin|mesh-list
2374608|NCT00603824|Fondaparinux|fondaparinux|mesh-list
2374609|NCT00603824|Argatroban|argatroban|mesh-list
2374610|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2374611|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
2374612|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2374613|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
2374614|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374615|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374616|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
2374617|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2374618|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2374619|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2488347|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488348|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
2488349|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488350|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2488351|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374626|NCT00604006|Spironolactone|spironolactone|mesh-list
2374627|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2374628|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
2374629|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2374630|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374631|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2374632|NCT00604006|Diuretics|diuretics|mesh-ancestor
2374633|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
2488352|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488353|NCT01153802|Dopamine|dopamine|mesh-list
2488354|NCT01153802|Norepinephrine|norepinephrine|mesh-list
2488355|NCT01153802|Serotonin|serotonin|mesh-list
2488356|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
2488357|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2488358|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2488359|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
2488360|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488361|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488362|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
2488363|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
2488364|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488365|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2488366|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2488367|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
2488368|NCT01153802|Protective Agents|protective agents|mesh-ancestor
2488369|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2488370|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
2374634|NCT00604032|Tretinoin|tretinoin|mesh-list
2374635|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374636|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
2488371|NCT01153828|Mupirocin|mupirocin|mesh-list
2488372|NCT01153828|Retapamulin|retapamulin|mesh-list
2374637|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
2374638|NCT00604058|Vaccines|vaccines|mesh-list
2374639|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
2374640|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374641|NCT00604084|Ivermectin|ivermectin|mesh-list
2374642|NCT00604084|Permethrin|permethrin|mesh-list
2374643|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2374644|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374645|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374646|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374647|NCT00604253|Insulin|insulin|mesh-list
2488373|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
2488374|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2488375|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488376|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2488377|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488378|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488379|NCT01153854|Racecadotril|racecadotril|mesh-list
2488380|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
2488381|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2488382|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
2488383|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488384|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488385|NCT01153880|Mupirocin|mupirocin|mesh-list
2488386|NCT01153880|Retapamulin|retapamulin|mesh-list
2488387|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2488388|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488389|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2488390|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488391|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488392|NCT01153919|Interferons|interferons|mesh-list
2488393|NCT01153919|Ribavirin|ribavirin|mesh-list
2488394|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
2488395|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
2488396|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2488397|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488398|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
2488399|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488400|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
2488401|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488402|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
2488403|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488404|NCT01154114|Darapladib|darapladib|mesh-list
2488405|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2488406|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488407|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488408|NCT01154348|Metformin|metformin|mesh-list
2488409|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2488410|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488411|NCT01154361|Cortisone|cortisone|mesh-list
2488412|NCT01154361|Icatibant|icatibant|mesh-list
2488413|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2488414|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2488415|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2488416|NCT01154361|Analgesics|analgesics|mesh-ancestor
2488417|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
2488418|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488419|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488420|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2488421|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
2488422|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
2488423|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488424|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2488425|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2488426|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
2488427|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
2488428|NCT01154387|Tacrolimus|tacrolimus|mesh-list
2488429|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
2488430|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2488431|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2488432|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
2488433|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488434|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2488435|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488436|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374648|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2374649|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
2374650|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
2374651|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
2374652|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
2374653|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2374654|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374655|NCT00604344|Insulin|insulin|mesh-list
2374656|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2374657|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
2374658|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
2374659|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
2374660|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
2374661|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2374662|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374663|NCT00604357|Sirolimus|sirolimus|mesh-list
2374664|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2374665|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374666|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2488437|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2488438|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488439|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2488440|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
2488441|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2488442|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488443|NCT01154400|Caseins|caseins|mesh-list
2488444|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
2488445|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
2488446|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488447|NCT01154426|Gemcitabine|gemcitabine|mesh-list
2488448|NCT01154426|Veliparib|veliparib|mesh-list
2488449|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2488450|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
2488451|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488452|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488453|NCT01154426|Antiviral Agents|antiviral agents|mesh-ancestor
2488454|NCT01154426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488455|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488456|NCT01154426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2374667|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374668|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
2374669|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2374670|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
2374671|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374672|NCT00604396|Insulin|insulin|mesh-list
2374673|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2374674|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
2374675|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
2374676|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
2374677|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
2374678|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2374679|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374680|NCT00604409|Capecitabine|capecitabine|mesh-list
2488457|NCT01154426|Immunologic Factors|immunologic factors|mesh-ancestor
2488458|NCT01154426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374681|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2374682|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
2374683|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374684|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374685|NCT00604435|Docetaxel|docetaxel|mesh-list
2374686|NCT00604435|Epirubicin|epirubicin|mesh-list
2374687|NCT00604435|Endostatins|endostatins|mesh-list
2374688|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374689|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
2374690|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
2488459|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2488460|NCT01154439|Cytarabine|cytarabine|mesh-list
2488461|NCT01154439|Etoposide|etoposide|mesh-list
2488462|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
2488463|NCT01154439|Idarubicin|idarubicin|mesh-list
2488464|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
2488465|NCT01154439|Everolimus|everolimus|mesh-list
2488466|NCT01154439|Ifosfamide|ifosfamide|mesh-list
2374691|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
2374692|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374693|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2374694|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2374695|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2374696|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374697|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2488467|NCT01154439|Carboplatin|carboplatin|mesh-list
2374698|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2374699|NCT00604435|Growth Substances|growth substances|mesh-ancestor
2374700|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374701|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
2374702|NCT00604578|Pioglitazone|pioglitazone|mesh-list
2374703|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2374704|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374705|NCT00604591|Tolcapone|tolcapone|mesh-list
2374706|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2374707|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2374708|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2374709|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374710|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488468|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2488469|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488470|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2488471|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2488472|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488473|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488474|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2488475|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
2488476|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
2488477|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488478|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2488479|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
2488480|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488481|NCT01154439|Analgesics|analgesics|mesh-ancestor
2488482|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
2374716|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
2374717|NCT00604630|Hematinics|hematinics|mesh-ancestor
2374718|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
2374719|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2374720|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374721|NCT00604682|Apremilast|apremilast|mesh-list
2374722|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2374723|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2374724|NCT00604682|Analgesics|analgesics|mesh-ancestor
2374725|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
2374726|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374727|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374728|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2374729|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2374730|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2374731|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2374732|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374733|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374734|NCT00604864|Infliximab|infliximab|mesh-list
2374735|NCT00604864|Antibodies|antibodies|mesh-list
2374736|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2374737|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
2374738|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374739|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
2374740|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2374741|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2374742|NCT00604942|Domperidone|domperidone|mesh-list
2374743|NCT00604942|Esomeprazole|esomeprazole|mesh-list
2374744|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2374745|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2374746|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2374747|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374748|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374749|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
2374750|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
2374751|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374752|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374753|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2374754|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
2374755|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374756|NCT00604955|Paromomycin|paromomycin|mesh-list
2374757|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2374758|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488483|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488484|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2488485|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2488486|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
2488487|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
2488488|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2488489|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488490|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
2488491|NCT01154491|Hematinics|hematinics|mesh-ancestor
2488492|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
2488493|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2488494|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2488495|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
2488496|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488497|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488498|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2488499|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
2488500|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2488501|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
2488502|NCT01154504|Protective Agents|protective agents|mesh-ancestor
2374759|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2374760|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2374761|NCT00605020|Insulin|insulin|mesh-list
2374762|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2374763|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
2374764|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
2374765|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2374766|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
2374767|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
2374768|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2374769|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374770|NCT00605098|Ritonavir|ritonavir|mesh-list
2374771|NCT00605098|Lopinavir|lopinavir|mesh-list
2374772|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2374773|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2374774|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
2374775|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374776|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374777|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2374778|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2374779|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
2374780|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374781|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2374782|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2374783|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
2374784|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
2374785|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2374786|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374787|NCT00605137|Insulin|insulin|mesh-list
2374788|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2374789|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
2374790|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
2374791|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
2374792|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
2374793|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2374794|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374795|NCT00605215|Interferons|interferons|mesh-list
2374796|NCT00605215|Interferon beta-1a|interferon beta-1a|mesh-list
2374797|NCT00605215|Interferon-beta|interferon-beta|mesh-list
2374798|NCT00605215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374799|NCT00605215|Antiviral Agents|antiviral agents|mesh-ancestor
2374800|NCT00605215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488503|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
2488504|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2488505|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488506|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
2488507|NCT01154569|Azithromycin|azithromycin|mesh-list
2488508|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2488509|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488510|NCT01154647|Citalopram|citalopram|mesh-list
2488511|NCT01154647|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2488512|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2488513|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2488514|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374801|NCT00605215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2374802|NCT00605215|Immunologic Factors|immunologic factors|mesh-ancestor
2374803|NCT00605215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488515|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374804|NCT00605371|Lamotrigine|lamotrigine|mesh-list
2374805|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
2374806|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2374807|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2374808|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374809|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2374810|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488516|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
2488517|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488518|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2488519|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
2488520|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2488521|NCT01154738|Lidocaine|lidocaine|mesh-list
2488522|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
2488523|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
2488524|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488525|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488526|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
2374811|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2374812|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2374813|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2374814|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2374815|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2374816|NCT00605397|Trastuzumab|trastuzumab|mesh-list
2374817|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2374818|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374819|NCT00605410|Bromides|bromides|mesh-list
2374820|NCT00605410|Ipratropium|ipratropium|mesh-list
2374821|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
2488527|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488528|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2488529|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2488530|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2488531|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2488532|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488533|NCT01154764|Ketoconazole|ketoconazole|mesh-list
2488534|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
2488535|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488536|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2488537|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2488538|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488539|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488540|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2488541|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
2488542|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2488543|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488544|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2488545|NCT01154790|Naproxen|naproxen|mesh-list
2488546|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2488547|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2488548|NCT01154790|Analgesics|analgesics|mesh-ancestor
2488549|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
2488550|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488551|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488552|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2488553|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2488554|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
2488555|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2488556|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488557|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488558|NCT01154803|Micronutrients|micronutrients|mesh-list
2488559|NCT01154803|Trace Elements|trace elements|mesh-list
2488560|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488561|NCT01154829|Aripiprazole|aripiprazole|mesh-list
2488562|NCT01154829|Amisulpride|amisulpride|mesh-list
2488563|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
2488564|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2488565|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2488566|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2488567|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488568|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488569|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
2488570|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
2374822|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2374823|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
2488571|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2488572|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488573|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2374824|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374825|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374826|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2374827|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
2374828|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2374829|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
2374830|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374831|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374832|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
2374833|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
2374834|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
2374835|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2374836|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2488574|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2488575|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
2488576|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2488577|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2488578|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2488579|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2488580|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2488581|NCT01154881|Insulin|insulin|mesh-list
2488582|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2488583|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488584|NCT01154907|Praziquantel|praziquantel|mesh-list
2488585|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
2114115|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114116|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2114117|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2114118|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
2114119|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
2114120|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114121|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2114122|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
2488586|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2488587|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488588|NCT01154920|Paclitaxel|paclitaxel|mesh-list
2374837|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374838|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374839|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374840|NCT00605683|Cabergoline|cabergoline|mesh-list
2374841|NCT00605683|Pramipexole|pramipexole|mesh-list
2374842|NCT00605683|Ropinirole|ropinirole|mesh-list
2374843|NCT00605683|Bromocriptine|bromocriptine|mesh-list
2374844|NCT00605683|Lisuride|lisuride|mesh-list
2374845|NCT00605683|Apomorphine|apomorphine|mesh-list
2374846|NCT00605683|Pergolide|pergolide|mesh-list
2374847|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2374848|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2374849|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
2374850|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
2374851|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374852|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374853|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374854|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
2374855|NCT00605683|Protective Agents|protective agents|mesh-ancestor
2374856|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
2374857|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2374858|NCT00605683|Emetics|emetics|mesh-ancestor
2374859|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
2374860|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374861|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2374862|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2374863|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
2374864|NCT00605774|Epinephrine|epinephrine|mesh-list
2374865|NCT00605774|Racepinephrine|racepinephrine|mesh-list
2374866|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
2374867|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2488589|NCT01154920|Docetaxel|docetaxel|mesh-list
2488590|NCT01154920|Cisplatin|cisplatin|mesh-list
2488591|NCT01154920|Carboplatin|carboplatin|mesh-list
2114123|NCT02597062|Hormones|hormones|mesh-ancestor
2488592|NCT01154920|Fluorouracil|fluorouracil|mesh-list
2488593|NCT01154920|Cetuximab|cetuximab|mesh-list
2374868|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2374869|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
2374870|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374871|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374872|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374873|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2488594|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2488595|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488596|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
2488597|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
2488598|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
2488599|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488600|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
2488601|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2488602|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2488603|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
2488604|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488605|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2488606|NCT01154933|Exenatide|exenatide|mesh-list
2488607|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2374874|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2374875|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
2374876|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488608|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488609|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2488610|NCT01154933|Incretins|incretins|mesh-ancestor
2488611|NCT01154933|Hormones|hormones|mesh-ancestor
2488612|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2488613|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
2488614|NCT01154959|Rifampin|rifampin|mesh-list
2488615|NCT01154959|Isoniazid|isoniazid|mesh-list
2488616|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
2488617|NCT01154959|Ethambutol|ethambutol|mesh-list
2488618|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2488619|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488620|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2488621|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2488622|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488623|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488624|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488625|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2488626|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
2488627|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
2488628|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2488629|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2488630|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2488631|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2488632|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2488633|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2488634|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2488635|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2488636|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2488637|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
2488638|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2488639|NCT01155037|Vaccines|vaccines|mesh-list
2488640|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
2488641|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488642|NCT01155089|Anastrozole|anastrozole|mesh-list
2488643|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2488644|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488645|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2488646|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2488647|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488648|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488649|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2488650|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
2488651|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2488652|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488653|NCT01155102|Anastrozole|anastrozole|mesh-list
2488654|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2488655|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488656|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2488657|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2374877|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2374878|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
2374879|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
2374880|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
2488658|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488659|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488660|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2488661|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
2488662|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2488663|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488664|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
2488665|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2488666|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
2488667|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488668|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488669|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2488670|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
2488671|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2488672|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
2488673|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488674|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2488675|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2488676|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
2488677|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
2488678|NCT01155115|Protective Agents|protective agents|mesh-ancestor
2488679|NCT01155206|Glucagon|glucagon|mesh-list
2488680|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2488681|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2488682|NCT01155206|Hormones|hormones|mesh-ancestor
2488683|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2488684|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488685|NCT01155206|Incretins|incretins|mesh-ancestor
2488686|NCT01155232|Teriparatide|teriparatide|mesh-list
2488687|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
2488688|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488689|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2488690|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2488691|NCT01155245|Teriparatide|teriparatide|mesh-list
2374881|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2374882|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
2374883|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
2374884|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374885|NCT00605787|Protective Agents|protective agents|mesh-ancestor
2488692|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2488693|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488694|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2488695|NCT01155258|Sirolimus|sirolimus|mesh-list
2488696|NCT01155258|Vinorelbine|vinorelbine|mesh-list
2488697|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2488698|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488699|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2488700|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488701|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
2488702|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2488703|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
2488704|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488705|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2488706|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
2488707|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
2488708|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
2488709|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488710|NCT01155440|Lidocaine|lidocaine|mesh-list
2488711|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
2488712|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
2488713|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488714|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488715|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
2488716|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488717|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2488718|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2488719|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2488720|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2488721|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488722|NCT01155453|Trametinib|trametinib|mesh-list
2488723|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488724|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2488725|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488726|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488727|NCT01155505|Lenalidomide|lenalidomide|mesh-list
2488728|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
2488729|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488730|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2488731|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2488732|NCT01155505|Growth Substances|growth substances|mesh-ancestor
2488733|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
2488734|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488735|NCT01155635|Carvedilol|carvedilol|mesh-list
2488736|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2488737|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2488738|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
2488739|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2488740|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488741|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488742|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2374886|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374887|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2374888|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2374889|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2374890|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
2488743|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
2488744|NCT01155635|Protective Agents|protective agents|mesh-ancestor
2488745|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2488746|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2488747|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2488748|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
2488749|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2488750|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2488751|NCT01155700|Omalizumab|omalizumab|mesh-list
2488752|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2488753|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2488754|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
2488755|NCT01155765|Clopidogrel|clopidogrel|mesh-list
2488756|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2488757|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2488758|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2488759|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2374891|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374892|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374893|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2374894|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
2374895|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2374896|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2374897|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2374898|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
2374899|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374900|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374901|NCT00605930|Niacinamide|niacinamide|mesh-list
2374902|NCT00605930|Niacin|niacin|mesh-list
2374903|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
2374904|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
2374905|NCT00605930|Vitamins|vitamins|mesh-ancestor
2374906|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
2374907|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374908|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2374909|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
2374910|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374911|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2374912|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
2374913|NCT00605995|Simvastatin|simvastatin|mesh-list
2374914|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2374915|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2374916|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
2374917|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374918|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2374919|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2374920|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374921|NCT00606060|Factor VIII|factor viii|mesh-list
2488760|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2488761|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
2488762|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374922|NCT00606060|Coagulants|coagulants|mesh-ancestor
2374923|NCT00606099|Adefovir|adefovir|mesh-list
2374924|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2488763|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488764|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488765|NCT01155791|Prednisone|prednisone|mesh-list
2488766|NCT01155791|Docetaxel|docetaxel|mesh-list
2488767|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488768|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
2488769|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
2488770|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
2488771|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488772|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2488773|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
2488774|NCT01155791|Hormones|hormones|mesh-ancestor
2488775|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2488776|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488777|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2488778|NCT01155895|Amlodipine|amlodipine|mesh-list
2488779|NCT01155895|Benazepril|benazepril|mesh-list
2488780|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2488781|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2488782|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2488783|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488784|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2488785|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488786|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
2488787|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2488788|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
2488789|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488790|NCT01155908|Amlodipine|amlodipine|mesh-list
2488791|NCT01155908|Benazepril|benazepril|mesh-list
2488792|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2488793|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2374925|NCT00606099|Telbivudine|telbivudine|mesh-list
2374926|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
2374927|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374928|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2374929|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2374930|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374931|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374932|NCT00606125|Sorafenib|sorafenib|mesh-list
2374933|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374934|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2374935|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2374936|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374937|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
2374938|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2488794|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2488795|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488796|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2488797|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488798|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
2488799|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2488800|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
2488801|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488802|NCT01155921|Risperidone|risperidone|mesh-list
2488803|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2488804|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
2488805|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2488806|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488807|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488808|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2488809|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2488810|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488811|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2488812|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2488813|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
2488814|NCT01155934|Risperidone|risperidone|mesh-list
2488815|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2374939|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
2488816|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
2488817|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2488818|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488819|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488820|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2488821|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2488822|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488823|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2488824|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2488825|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
2488826|NCT01155947|Anastrozole|anastrozole|mesh-list
2488827|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2488828|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488829|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2488830|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2488831|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488832|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488833|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2488834|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
2488835|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2488836|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488837|NCT01155960|Anastrozole|anastrozole|mesh-list
2488838|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2488839|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488840|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2374940|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374941|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374942|NCT00606203|Milnacipran|milnacipran|mesh-list
2374943|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
2374944|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2374945|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2374946|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2374947|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374948|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2374949|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488841|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2488842|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488843|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488844|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2488845|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
2488846|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2488847|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488848|NCT01155986|Lidocaine|lidocaine|mesh-list
2488849|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
2488850|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
2488851|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488852|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488853|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
2488854|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488855|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2488856|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2488857|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2488858|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2488859|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488860|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
2488861|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2488862|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488863|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2488864|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
2488865|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2488866|NCT01156220|Furosemide|furosemide|mesh-list
2488867|NCT01156220|Diuretics|diuretics|mesh-ancestor
2488868|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
2374950|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2374951|NCT00606203|Analgesics|analgesics|mesh-ancestor
2374952|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
2374953|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374954|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
2374955|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2374956|NCT00606242|Fluticasone|fluticasone|mesh-list
2374957|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2374958|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2374959|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
2374960|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374961|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374962|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2374963|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
2374964|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
2374965|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2488869|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488870|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2488871|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2374966|NCT00606268|Micafungin|micafungin|mesh-list
2374967|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
2374968|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374969|NCT00606333|Sirolimus|sirolimus|mesh-list
2374970|NCT00606333|Paclitaxel|paclitaxel|mesh-list
2374971|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2374972|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2374973|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374974|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
2374975|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
2374976|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
2374977|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2374978|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2488872|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488873|NCT01156233|Anesthetics|anesthetics|mesh-list
2488874|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488875|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488876|NCT01156246|Metformin|metformin|mesh-list
2488877|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
2488878|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2488879|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488880|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2488881|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488882|NCT01156350|Fludarabine|fludarabine|mesh-list
2488883|NCT01156350|Busulfan|busulfan|mesh-list
2488884|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488885|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488886|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2488887|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
2488888|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488889|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
2488890|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2488891|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2488892|NCT01156389|Ritonavir|ritonavir|mesh-list
2488893|NCT01156389|Artesunate|artesunate|mesh-list
2488894|NCT01156389|Pyronaridine|pyronaridine|mesh-list
2488895|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2488896|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2488897|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
2488898|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488899|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488900|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2488901|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2488902|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
2488903|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488904|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2488905|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2488906|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
2488907|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2488908|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2488909|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488910|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
2488911|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2488912|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
2488913|NCT01156415|S 20098|s 20098|mesh-list
2488914|NCT01156415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2374979|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2374980|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2374981|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
2374982|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2374983|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
2374984|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374985|NCT00606411|Topiramate|topiramate|mesh-list
2374986|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
2374987|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2488915|NCT01156415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2488916|NCT01156415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488917|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
2488918|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2488919|NCT01156545|Afatinib|afatinib|mesh-list
2488920|NCT01156545|Simvastatin|simvastatin|mesh-list
2488921|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2488922|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2488923|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
2488924|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488925|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2488926|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2488927|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488928|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488929|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2488930|NCT01156584|Flucytosine|flucytosine|mesh-list
2488931|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
2488932|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488933|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
2488934|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488935|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
2488936|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
2488937|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2488938|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2488939|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2488940|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2488941|NCT01156636|Urological Agents|urological agents|mesh-ancestor
2488942|NCT01156649|Acetaminophen|acetaminophen|mesh-list
2488943|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2488944|NCT01156649|Analgesics|analgesics|mesh-ancestor
2488945|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
2488946|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2488947|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488948|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
2488949|NCT01156688|Misoprostol|misoprostol|mesh-list
2374988|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374989|NCT00606437|Fludarabine|fludarabine|mesh-list
2374990|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2374991|NCT00606450|Thalidomide|thalidomide|mesh-list
2374992|NCT00606450|Apremilast|apremilast|mesh-list
2374993|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2374994|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2374995|NCT00606450|Analgesics|analgesics|mesh-ancestor
2374996|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
2374997|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2374998|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2374999|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2375000|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2375001|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2375002|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2375003|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375004|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375005|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375006|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
2375007|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
2375008|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2488950|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2488951|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
2488952|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2488953|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488954|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2488955|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2488956|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
2488957|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2488958|NCT01156740|Amoxicillin|amoxicillin|mesh-list
2488959|NCT01156740|Penicillins|penicillins|mesh-list
2488960|NCT01156740|beta-Lactams|beta-lactams|mesh-list
2488961|NCT01156740|Penicillin G|penicillin g|mesh-list
2488962|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2488963|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
2488964|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488965|NCT01156753|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
2488966|NCT01156753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2488967|NCT01156753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2488968|NCT01156779|Exenatide|exenatide|mesh-list
2375009|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2488969|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2488970|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375010|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2375011|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2375012|NCT00606450|Growth Substances|growth substances|mesh-ancestor
2375013|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
2375014|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375015|NCT00606515|Paclitaxel|paclitaxel|mesh-list
2375016|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2375017|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2375018|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375019|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
2375020|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
2375021|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
2375022|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375023|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2375024|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
2375025|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2488971|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2488972|NCT01156779|Incretins|incretins|mesh-ancestor
2488973|NCT01156779|Hormones|hormones|mesh-ancestor
2488974|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2488975|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
2488976|NCT01156857|Progestins|progestins|mesh-list
2488977|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2488978|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
2488979|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2488980|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2488981|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2488982|NCT01156857|Hormones|hormones|mesh-ancestor
2488983|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2488984|NCT01156883|Cytarabine|cytarabine|mesh-list
2488985|NCT01156883|Dexamethasone|dexamethasone|mesh-list
2488986|NCT01156883|Prednisone|prednisone|mesh-list
2488987|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
2488988|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
2488989|NCT01156883|Ifosfamide|ifosfamide|mesh-list
2488990|NCT01156883|Doxorubicin|doxorubicin|mesh-list
2488991|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2488992|NCT01156883|Methotrexate|methotrexate|mesh-list
2488993|NCT01156883|Vincristine|vincristine|mesh-list
2488994|NCT01156883|Daunorubicin|daunorubicin|mesh-list
2488995|NCT01156883|Asparaginase|asparaginase|mesh-list
2488996|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
2488997|NCT01156883|Thioguanine|thioguanine|mesh-list
2488998|NCT01156883|Vindesine|vindesine|mesh-list
2488999|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2489000|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
2489001|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489002|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2489003|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2375026|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2375027|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2489004|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
2489005|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489006|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489007|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2489008|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2489009|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
2489010|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
2489011|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489012|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2489013|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
2489014|NCT01156883|Hormones|hormones|mesh-ancestor
2489015|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2489016|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2489017|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2489018|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2489019|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2489020|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489021|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2489022|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
2489023|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2489024|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2375028|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489025|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
2489026|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
2375029|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375030|NCT00606697|Vofopitant|vofopitant|mesh-list
2375031|NCT00606697|Vestipitant|vestipitant|mesh-list
2375032|NCT00606697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2375033|NCT00606697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375034|NCT00606697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489027|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2489028|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2489029|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
2489030|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2489031|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2489032|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
2489033|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
2489034|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
2375035|NCT00606697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375036|NCT00606697|Antiemetics|antiemetics|mesh-ancestor
2375037|NCT00606697|Autonomic Agents|autonomic agents|mesh-ancestor
2375038|NCT00606697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375039|NCT00606697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2375040|NCT00606775|Carvedilol|carvedilol|mesh-list
2375041|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2375042|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2375043|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
2375044|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489035|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2489036|NCT01156883|Protective Agents|protective agents|mesh-ancestor
2489037|NCT01156909|Rituximab|rituximab|mesh-list
2489038|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2489039|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489040|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
2489041|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489042|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2489043|NCT01156922|Rituximab|rituximab|mesh-list
2489044|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2489045|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489046|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
2489047|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489048|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2489049|NCT01156948|Misoprostol|misoprostol|mesh-list
2489050|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2489051|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
2489052|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2489053|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489054|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2489055|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2489056|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
2489057|NCT01156961|Paclitaxel|paclitaxel|mesh-list
2489058|NCT01156961|Bevacizumab|bevacizumab|mesh-list
2489059|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2489060|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489061|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
2489062|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
2489063|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
2489064|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489065|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2489066|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2489067|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2489068|NCT01156961|Growth Substances|growth substances|mesh-ancestor
2489069|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489070|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
2375045|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375046|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375047|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2375048|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
2375049|NCT00606775|Protective Agents|protective agents|mesh-ancestor
2375050|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2375051|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2489071|NCT01157000|Canagliflozin|canagliflozin|mesh-list
2489072|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2489073|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489074|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2489075|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489076|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2375052|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2489077|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2489078|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489079|NCT01157026|Tamoxifen|tamoxifen|mesh-list
2489080|NCT01157026|Tocotrienols|tocotrienols|mesh-list
2489081|NCT01157026|Vitamin E|vitamin e|mesh-list
2489082|NCT01157026|Tocopherols|tocopherols|mesh-list
2489083|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2489084|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
2375053|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
2375054|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2375055|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2375056|NCT00606814|Docetaxel|docetaxel|mesh-list
2375057|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375058|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
2375059|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
2375060|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
2375061|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375062|NCT00606866|Sorafenib|sorafenib|mesh-list
2489085|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2489086|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489087|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2489088|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489089|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2489090|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2489091|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2489092|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
2489093|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489094|NCT01157026|Protective Agents|protective agents|mesh-ancestor
2489095|NCT01157026|Vitamins|vitamins|mesh-ancestor
2489096|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
2489097|NCT01157052|Capecitabine|capecitabine|mesh-list
2489098|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
2489099|NCT01157052|Calcium|calcium|mesh-list
2489100|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2489101|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489102|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2489103|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
2489104|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489105|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489106|NCT01157247|Fentanyl|fentanyl|mesh-list
2489107|NCT01157247|Anesthetics|anesthetics|mesh-list
2489108|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
2489109|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2489110|NCT01157247|Narcotics|narcotics|mesh-ancestor
2489111|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489112|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489113|NCT01157247|Analgesics|analgesics|mesh-ancestor
2489114|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
2489115|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375063|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375064|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2375065|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375066|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375067|NCT00606957|Vitamin D|vitamin d|mesh-list
2375068|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
2375069|NCT00606957|Vitamins|vitamins|mesh-ancestor
2375070|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
2375071|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375072|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2375073|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2375074|NCT00606983|Tamsulosin|tamsulosin|mesh-list
2375075|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2375076|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2375077|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2375078|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
2489116|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2489117|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2489118|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
2489119|NCT01157312|Citric Acid|citric acid|mesh-list
2489120|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
2489121|NCT01157312|Clomiphene|clomiphene|mesh-list
2489122|NCT01157312|Enclomiphene|enclomiphene|mesh-list
2375079|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489123|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
2489124|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
2489125|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2489126|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
2489127|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
2489128|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489129|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2489130|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
2489131|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2489132|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489133|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2489134|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
2489135|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2489136|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2489137|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2489138|NCT01157455|Aspirin|aspirin|mesh-list
2489139|NCT01157455|Everolimus|everolimus|mesh-list
2489140|NCT01157455|Heparin|heparin|mesh-list
2489141|NCT01157455|Bivalirudin|bivalirudin|mesh-list
2489142|NCT01157455|Clopidogrel|clopidogrel|mesh-list
2489143|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2489144|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2489145|NCT01157455|Analgesics|analgesics|mesh-ancestor
2489146|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
2489147|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489148|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489149|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2489150|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2375080|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375081|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375082|NCT00606983|Urological Agents|urological agents|mesh-ancestor
2375083|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2375084|NCT00607035|Olmesartan|olmesartan|mesh-list
2375085|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2375086|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2375087|NCT00607035|Diuretics|diuretics|mesh-ancestor
2375088|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
2375089|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375090|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2375091|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2375092|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489151|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2489152|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2489153|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489154|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2489155|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2489156|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489157|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
2489158|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489159|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2489160|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
2489161|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2489162|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2489163|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2489164|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
2489165|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489166|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
2375093|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2375094|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2375095|NCT00607074|Albendazole|albendazole|mesh-list
2375096|NCT00607074|Anthelmintics|anthelmintics|mesh-list
2375097|NCT00607074|Secnidazole|secnidazole|mesh-list
2375098|NCT00607074|Metronidazole|metronidazole|mesh-list
2375099|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2375100|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2375101|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
2489167|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
2489168|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2489169|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
2489170|NCT01157481|Nifedipine|nifedipine|mesh-list
2489171|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2489172|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2489173|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489174|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2489175|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489176|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
2489177|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
2489178|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2375102|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2375103|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2375104|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
2375105|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
2375106|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
2375107|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375108|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375109|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2375110|NCT00607152|Allopurinol|allopurinol|mesh-list
2375111|NCT00607152|Rasburicase|rasburicase|mesh-list
2375112|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
2375113|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375114|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375115|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
2375116|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2375117|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2375118|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
2375119|NCT00607152|Protective Agents|protective agents|mesh-ancestor
2489179|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2489180|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2489181|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2489182|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489183|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489184|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2489185|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2375120|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375121|NCT00607178|Vaccines|vaccines|mesh-list
2375122|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
2375123|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375124|NCT00607217|Vaccines|vaccines|mesh-list
2375125|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
2375126|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375127|NCT00607256|Reboxetine|reboxetine|mesh-list
2375128|NCT00607256|Antidepressive Agents|antidepressive agents|mesh-ancestor
2375129|NCT00607256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2375130|NCT00607256|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2375131|NCT00607256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2375132|NCT00607256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2375133|NCT00607256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375134|NCT00607256|Adrenergic Agents|adrenergic agents|mesh-ancestor
2375135|NCT00607256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489186|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489187|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
2489188|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489189|NCT01157546|Lidocaine|lidocaine|mesh-list
2489190|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
2489191|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
2489192|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489193|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489194|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
2489195|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489196|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2489197|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2489198|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2489199|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2489200|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489201|NCT01157559|Ziprasidone|ziprasidone|mesh-list
2489202|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2489203|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
2489204|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489205|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489206|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489207|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2489208|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2489209|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489210|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2489211|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2489212|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
2489213|NCT01157572|Metoprolol|metoprolol|mesh-list
2489214|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2489215|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2489216|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
2489217|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
2489218|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375136|NCT00607256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375137|NCT00607282|Udenafil|udenafil|mesh-list
2375138|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2375139|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2375140|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375141|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375142|NCT00607438|Paclitaxel|paclitaxel|mesh-list
2375143|NCT00607438|Sorafenib|sorafenib|mesh-list
2375144|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2375145|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2375146|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489219|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489220|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2489221|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2489222|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2489223|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
2489224|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489225|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489226|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2489227|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2489228|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2489229|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489230|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489231|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2489232|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2489233|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2489234|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
2489235|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489236|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489237|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2489238|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2489239|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
2489240|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
2489241|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2489242|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
2375147|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
2375148|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
2375149|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
2375150|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375151|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2375152|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375153|NCT00607503|Terbutaline|terbutaline|mesh-list
2375154|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2375155|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
2375156|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375157|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375158|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2375159|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
2375160|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
2375161|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
2375162|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2375163|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2375164|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2375165|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2375166|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
2375167|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375168|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375169|NCT00607542|Baclofen|baclofen|mesh-list
2375170|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2375171|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375172|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2375173|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489243|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2489244|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489245|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2489246|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2489247|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2489248|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
2489249|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2489250|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2489251|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2489252|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2489253|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375174|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2375175|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
2375176|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
2375177|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489254|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489255|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489256|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2489257|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2489258|NCT01157858|Everolimus|everolimus|mesh-list
2489259|NCT01157858|Octreotide|octreotide|mesh-list
2489260|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375178|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375179|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2375180|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2375181|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2375182|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2375183|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375184|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
2375185|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375186|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375187|NCT00607581|Dexamethasone|dexamethasone|mesh-list
2489261|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2489262|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
2489263|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489264|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2489265|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2489266|NCT01157936|Allopurinol|allopurinol|mesh-list
2489267|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
2489268|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489269|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489270|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
2375188|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
2375189|NCT00607581|Lenalidomide|lenalidomide|mesh-list
2375190|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375191|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
2375192|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489271|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2489272|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2489273|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
2489274|NCT01157936|Protective Agents|protective agents|mesh-ancestor
2489275|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489276|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
2489277|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
2489278|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489279|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375193|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2375194|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2375195|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
2375196|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375197|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375198|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2375199|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2375200|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
2375201|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
2489280|NCT01157975|Pioglitazone|pioglitazone|mesh-list
2489281|NCT01157975|Prednisone|prednisone|mesh-list
2489282|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2489283|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
2489284|NCT01157975|Hormones|hormones|mesh-ancestor
2489285|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2489286|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489287|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2489288|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489289|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2489290|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2489291|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
2489292|NCT01158014|Coagulants|coagulants|mesh-ancestor
2489293|NCT01158105|Bortezomib|bortezomib|mesh-list
2375202|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375203|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2375204|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
2375205|NCT00607581|Hormones|hormones|mesh-ancestor
2375206|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2489294|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489295|NCT01158144|Paclitaxel|paclitaxel|mesh-list
2489296|NCT01158144|Carboplatin|carboplatin|mesh-list
2489297|NCT01158144|Endostar protein|endostar protein|mesh-list
2489298|NCT01158144|Endostatins|endostatins|mesh-list
2489299|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2489300|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489301|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
2489302|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
2489303|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
2489304|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489305|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2489306|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2489307|NCT01158144|Growth Substances|growth substances|mesh-ancestor
2375207|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2375208|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2375209|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2375210|NCT00607581|Growth Substances|growth substances|mesh-ancestor
2375211|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
2375212|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2375213|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2375214|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
2375215|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375216|NCT00607685|Fluorouracil|fluorouracil|mesh-list
2489308|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489309|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
2375217|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
2375218|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
2375219|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375220|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2375221|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375222|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375223|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
2375224|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375225|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2375226|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
2489310|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2489311|NCT01158170|Gefitinib|gefitinib|mesh-list
2489312|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489313|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2489314|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489315|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489316|NCT01158183|Interferons|interferons|mesh-list
2489317|NCT01158183|Interferon-beta|interferon-beta|mesh-list
2489318|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
2489319|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489320|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
2489321|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2489322|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
2489323|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489324|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2489325|NCT01158248|Panitumumab|panitumumab|mesh-list
2489326|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489327|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2489328|NCT01158274|Capecitabine|capecitabine|mesh-list
2489329|NCT01158274|R04929097|r04929097|mesh-list
2489330|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2489331|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
2489332|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489333|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489334|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489335|NCT01158287|Sorafenib|sorafenib|mesh-list
2489336|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489337|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2489338|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489339|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489340|NCT01158365|Glycerol|glycerol|mesh-list
2489341|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2489342|NCT01158365|Protective Agents|protective agents|mesh-ancestor
2489343|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489344|NCT01158417|Resveratrol|resveratrol|mesh-list
2489345|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
2489346|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489347|NCT01158417|Protective Agents|protective agents|mesh-ancestor
2489348|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489349|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375227|NCT00607685|Protective Agents|protective agents|mesh-ancestor
2375228|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
2375229|NCT00607711|Ifosfamide|ifosfamide|mesh-list
2375230|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2375231|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
2375232|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375233|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375234|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
2375235|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2375236|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375237|NCT00607750|Mecamylamine|mecamylamine|mesh-list
2375238|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2375239|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2375240|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
2375241|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375242|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375243|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2489350|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2489351|NCT01158560|Vitamin D|vitamin d|mesh-list
2489352|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
2489353|NCT01158560|Vitamins|vitamins|mesh-ancestor
2489354|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
2489355|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489356|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2489357|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2489358|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
2489359|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
2489360|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
2489361|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489362|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489363|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
2489364|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489365|NCT01158612|Hormones|hormones|mesh-list
2489366|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2489367|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489368|NCT01158729|Antithrombins|antithrombins|mesh-list
2489369|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
2489370|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2489371|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
2489372|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489373|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489374|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
2489375|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
2489376|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2489377|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2489378|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2489379|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2489380|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489381|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489382|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489383|NCT01158846|Bivalirudin|bivalirudin|mesh-list
2489384|NCT01158846|Abciximab|abciximab|mesh-list
2489385|NCT01158846|Clopidogrel|clopidogrel|mesh-list
2489386|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2489387|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2489388|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2489389|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2489390|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2489391|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
2489392|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489393|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375244|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2375245|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
2375246|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375247|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375248|NCT00607763|Micafungin|micafungin|mesh-list
2375249|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
2375250|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2375251|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
2375252|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2375253|NCT00607932|Protective Agents|protective agents|mesh-ancestor
2375254|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375255|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375256|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
2375257|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2375258|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375259|NCT00607958|Ritonavir|ritonavir|mesh-list
2489394|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489395|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
2489396|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2489397|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
2489398|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489399|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
2489400|NCT01158859|Pregabalin|pregabalin|mesh-list
2489401|NCT01158859|Analgesics|analgesics|mesh-ancestor
2489402|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
2489403|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489404|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489405|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
2489406|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2489407|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2489408|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489409|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2489410|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2489411|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2489412|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489413|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2489414|NCT01158937|Meropenem|meropenem|mesh-list
2489415|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2489416|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2489417|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
2489418|NCT01159080|Tacrolimus|tacrolimus|mesh-list
2489419|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2489420|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
2489421|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489422|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2489423|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489424|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489425|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2489426|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489427|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2489428|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
2489429|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2489430|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2489431|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
2489432|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2489433|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2489434|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
2489435|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2489436|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2489437|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2489438|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489439|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489440|NCT01159145|Omeprazole|omeprazole|mesh-list
2489441|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2489442|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2489443|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2489444|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489445|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489446|NCT01159158|Nateglinide|nateglinide|mesh-list
2489447|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2489448|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489449|NCT01159210|Thrombin|thrombin|mesh-list
2489450|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
2489451|NCT01159210|Coagulants|coagulants|mesh-ancestor
2489452|NCT01159236|Paclitaxel|paclitaxel|mesh-list
2489453|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
2489454|NCT01159236|Bevacizumab|bevacizumab|mesh-list
2489455|NCT01159236|Doxorubicin|doxorubicin|mesh-list
2489456|NCT01159236|Fluorouracil|fluorouracil|mesh-list
2489457|NCT01159236|Epirubicin|epirubicin|mesh-list
2489458|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2489459|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489460|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
2489461|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
2489462|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
2489463|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489464|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2489465|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
2489466|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489467|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2489468|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2489469|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
2489470|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2489471|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2489472|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2375260|NCT00607958|Tipranavir|tipranavir|mesh-list
2375261|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2375262|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2375263|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
2375264|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375265|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375266|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2375267|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2375268|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
2375269|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2375270|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2375271|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2375272|NCT00607971|Renzapride|renzapride|mesh-list
2375273|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2375274|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
2375275|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375276|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375277|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375278|NCT00607984|Melphalan|melphalan|mesh-list
2375279|NCT00607984|Thiotepa|thiotepa|mesh-list
2375280|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2489473|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2489474|NCT01159236|Growth Substances|growth substances|mesh-ancestor
2489475|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
2489476|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2489477|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2489478|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2489479|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489480|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
2489481|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2489482|NCT01159249|Vildagliptin|vildagliptin|mesh-list
2489483|NCT01159249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2489484|NCT01159249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489485|NCT01159249|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2489486|NCT01159249|Protease Inhibitors|protease inhibitors|mesh-ancestor
2489487|NCT01159249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489488|NCT01159249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489489|NCT01159275|Lopinavir|lopinavir|mesh-list
2489490|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2489491|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2489492|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
2489493|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489494|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489495|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2489496|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2489497|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
2489498|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2489499|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2489500|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2489501|NCT01159301|Sorafenib|sorafenib|mesh-list
2489502|NCT01159301|Entinostat|entinostat|mesh-list
2489503|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2489504|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489505|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2489506|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489507|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489508|NCT01159327|Sorafenib|sorafenib|mesh-list
2489509|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489510|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2489511|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489512|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489513|NCT01159353|Insulin|insulin|mesh-list
2489514|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2489515|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
2489516|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
2489517|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2489518|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489519|NCT01159379|Ertapenem|ertapenem|mesh-list
2489520|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2489521|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2489522|NCT01159418|Paclitaxel|paclitaxel|mesh-list
2489523|NCT01159418|Carboplatin|carboplatin|mesh-list
2489524|NCT01159418|Panobinostat|panobinostat|mesh-list
2489525|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2375281|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
2375282|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375283|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375284|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2375285|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375286|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
2375287|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375288|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
2375289|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
2375290|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2489526|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489527|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
2489528|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
2489529|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
2489530|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489531|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2489532|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489533|NCT01159457|Vaccines|vaccines|mesh-list
2489534|NCT01159457|Immunologic Factors|immunologic factors|mesh-ancestor
2375291|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375292|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375293|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
2375294|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2375295|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2375296|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375297|NCT00608101|Dexamethasone|dexamethasone|mesh-list
2375298|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
2375299|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2375300|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
2375301|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
2375302|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375303|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375304|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2375305|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
2489535|NCT01159457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489536|NCT01159548|Promethazine|promethazine|mesh-list
2489537|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
2489538|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
2489539|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
2489540|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2489541|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
2489542|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
2489543|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489544|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489545|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489546|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2489547|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2489548|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2489549|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489550|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
2489551|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
2489552|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
2489553|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489554|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
2489555|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
2489556|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2489557|NCT01159587|Factor VIII|factor viii|mesh-list
2489558|NCT01159587|Coagulants|coagulants|mesh-ancestor
2489559|NCT01159639|Clopidogrel|clopidogrel|mesh-list
2489560|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2489561|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2489562|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2489563|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2489564|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
2489565|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489566|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489567|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489568|NCT01159652|Zaleplon|zaleplon|mesh-list
2489569|NCT01159652|Zolpidem|zolpidem|mesh-list
2489570|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2489571|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2489572|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489573|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489574|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2375306|NCT00608101|Hormones|hormones|mesh-ancestor
2489575|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
2375307|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2375308|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2375309|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375310|NCT00608179|Glimepiride|glimepiride|mesh-list
2375311|NCT00608179|Glyburide|glyburide|mesh-list
2375312|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2375313|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2375314|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375315|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375316|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
2375317|NCT00608218|Ciclesonide|ciclesonide|mesh-list
2375318|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
2375319|NCT00608218|Hormones|hormones|mesh-ancestor
2375320|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2375321|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375322|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2489576|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
2489577|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489578|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489579|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
2489580|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
2489581|NCT01159821|Paroxetine|paroxetine|mesh-list
2489582|NCT01159821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2489583|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2489584|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2375323|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
2375324|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2375325|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2375326|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489585|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489586|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489587|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
2489588|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489589|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2489590|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
2489591|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2489592|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2489593|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2489594|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489595|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2489596|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2375327|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2375328|NCT00608231|Analgesics|analgesics|mesh-ancestor
2375329|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
2375330|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375331|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2375332|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2375333|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2375334|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
2375335|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375336|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375337|NCT00608335|Micafungin|micafungin|mesh-list
2375338|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
2375339|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2375340|NCT00608361|Dasatinib|dasatinib|mesh-list
2375341|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375342|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2375343|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375344|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375345|NCT00608374|Fludarabine|fludarabine|mesh-list
2375346|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
2375347|NCT00608374|Chlorambucil|chlorambucil|mesh-list
2375348|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375349|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2375350|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
2375351|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375352|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375353|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
2375354|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375355|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2375356|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
2375357|NCT00608595|Celecoxib|celecoxib|mesh-list
2375358|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2375359|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2375360|NCT00608595|Analgesics|analgesics|mesh-ancestor
2375361|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
2375362|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375363|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375364|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2375365|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2375366|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2375367|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2375368|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375369|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375370|NCT00608673|Betamethasone|betamethasone|mesh-list
2375371|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
2375372|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2375373|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
2375374|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
2375375|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2375376|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2375377|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
2375378|NCT00608673|Hormones|hormones|mesh-ancestor
2375379|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2375380|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375381|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2375382|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
2375383|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2375384|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2375385|NCT00608673|Analgesics|analgesics|mesh-ancestor
2375386|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
2375387|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375388|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2375389|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
2375390|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375391|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
2375392|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2375393|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375394|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375395|NCT00608699|Niacin|niacin|mesh-list
2375396|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2375397|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
2375398|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375399|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2489597|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489598|NCT01159847|Incretins|incretins|mesh-ancestor
2489599|NCT01159847|Hormones|hormones|mesh-ancestor
2375400|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
2375401|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
2375402|NCT00608699|Vitamins|vitamins|mesh-ancestor
2375403|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
2375404|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375405|NCT00608712|Esomeprazole|esomeprazole|mesh-list
2375406|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2375407|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2375408|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2375409|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375410|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375411|NCT00608725|Propranolol|propranolol|mesh-list
2375412|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2375413|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2375414|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
2375415|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375416|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375417|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375418|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2489600|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2489601|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2489602|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
2489603|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489604|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489605|NCT01160029|Nateglinide|nateglinide|mesh-list
2489606|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2489607|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489608|NCT01160042|Metformin|metformin|mesh-list
2489609|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2489610|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489611|NCT01160068|Metformin|metformin|mesh-list
2489612|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2489613|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489614|NCT01160107|Prednisone|prednisone|mesh-list
2489615|NCT01160107|Melphalan|melphalan|mesh-list
2489616|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2489617|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
2489618|NCT01160107|Hormones|hormones|mesh-ancestor
2375419|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2375420|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
2375421|NCT00608790|Albuterol|albuterol|mesh-list
2375422|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2375423|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
2375424|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375425|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375426|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2375427|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
2375428|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
2375429|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2375430|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2375431|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2375432|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2375433|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
2375434|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375435|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375436|NCT00608803|Doxorubicin|doxorubicin|mesh-list
2375437|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2375438|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375439|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2375440|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2375441|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375442|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375443|NCT00608816|Epinephrine|epinephrine|mesh-list
2375444|NCT00608816|Racepinephrine|racepinephrine|mesh-list
2375445|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
2375446|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2375447|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2375448|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
2375449|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375450|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375451|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375452|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2375453|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2375454|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
2375455|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375456|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2375457|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
2375458|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
2375459|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
2375460|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2375461|NCT00608946|Copper|copper|mesh-list
2375462|NCT00608946|Trace Elements|trace elements|mesh-ancestor
2375463|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
2375464|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375465|NCT00608972|Bevacizumab|bevacizumab|mesh-list
2375466|NCT00608972|Carboplatin|carboplatin|mesh-list
2375467|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2375468|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375469|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2375470|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2375471|NCT00608972|Growth Substances|growth substances|mesh-ancestor
2375472|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375473|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
2375474|NCT00609011|Temozolomide|temozolomide|mesh-list
2375475|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2375476|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
2375477|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375478|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375479|NCT00609063|Atorvastatin|atorvastatin|mesh-list
2375480|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2375481|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2375482|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
2375483|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375484|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2375485|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2668473|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2489619|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2489620|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489621|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2489622|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489623|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2489624|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
2489625|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489626|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2489627|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2489628|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
2489629|NCT01160172|Vaccines|vaccines|mesh-list
2489630|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
2489631|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489632|NCT01160185|Paclitaxel|paclitaxel|mesh-list
2489633|NCT01160185|Topotecan|topotecan|mesh-list
2489634|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2489635|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489636|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
2489637|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
2489638|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
2489639|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489640|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2489641|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2489642|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489643|NCT01160276|Cyclosporine|cyclosporine|mesh-list
2489644|NCT01160276|Colchicine|colchicine|mesh-list
2489645|NCT01160276|Tacrolimus|tacrolimus|mesh-list
2489646|NCT01160276|Cyclosporins|cyclosporins|mesh-list
2489647|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2489648|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
2489649|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489650|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2375486|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375487|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
2375488|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
2375489|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2375490|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2375491|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
2375492|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375493|NCT00609154|Glucagon|glucagon|mesh-list
2375494|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2375495|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2375496|NCT00609154|Hormones|hormones|mesh-ancestor
2489651|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489652|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489653|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
2489654|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2489655|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
2489656|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2489657|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
2489658|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
2489659|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
2489660|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
2489661|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489662|NCT01160302|Curcumin|curcumin|mesh-list
2489663|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2489664|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2489665|NCT01160302|Analgesics|analgesics|mesh-ancestor
2489666|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
2489667|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489668|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489669|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2489670|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2489671|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489672|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489673|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489674|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2489675|NCT01160315|Norethindrone|norethindrone|mesh-list
2184805|NCT00002832|Cyclosporine|cyclosporine|mesh-list
2184806|NCT00002832|Decitabine|decitabine|mesh-list
2184807|NCT00002832|Cyclosporins|cyclosporins|mesh-list
2184808|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
2184809|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184810|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184811|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184812|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2489676|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
2489677|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
2489678|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2375497|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2375498|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489679|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
2489680|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2489681|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489682|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2489683|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2489684|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489685|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2489686|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2489687|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2489688|NCT01160328|Leuprolide|leuprolide|mesh-list
2489689|NCT01160328|Testosterone|testosterone|mesh-list
2489690|NCT01160328|Androgens|androgens|mesh-ancestor
2489691|NCT01160328|Hormones|hormones|mesh-ancestor
2489692|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2489693|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489694|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2489695|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489696|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2489697|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
2489698|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2489699|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
2489700|NCT01160341|Testosterone|testosterone|mesh-list
2489701|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
2489702|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
2489703|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2375499|NCT00609154|Incretins|incretins|mesh-ancestor
2375500|NCT00609180|Antioxidants|antioxidants|mesh-list
2375501|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375502|NCT00609180|Protective Agents|protective agents|mesh-ancestor
2375503|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375504|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2375505|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
2375506|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2375507|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2375508|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2375509|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2375510|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375511|NCT00609284|Carboplatin|carboplatin|mesh-list
2375512|NCT00609284|Cetuximab|cetuximab|mesh-list
2375513|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375514|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2375515|NCT00609323|Lidocaine|lidocaine|mesh-list
2375516|NCT00609323|Tetracaine|tetracaine|mesh-list
2489704|NCT01160341|Androgens|androgens|mesh-ancestor
2489705|NCT01160341|Hormones|hormones|mesh-ancestor
2489706|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2375517|NCT00609323|Anesthetics, Local|anesthetics, local|mesh-ancestor
2375518|NCT00609323|Anesthetics|anesthetics|mesh-ancestor
2375519|NCT00609323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2375520|NCT00609323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375521|NCT00609323|Sensory System Agents|sensory system agents|mesh-ancestor
2375522|NCT00609323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375523|NCT00609323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2375524|NCT00609323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2375525|NCT00609323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2489707|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489708|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2489709|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489710|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
2489711|NCT01160419|Leucovorin|leucovorin|mesh-list
2489712|NCT01160419|Folic Acid|folic acid|mesh-list
2489713|NCT01160419|Docetaxel|docetaxel|mesh-list
2375526|NCT00609323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2375527|NCT00609323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375528|NCT00609375|Cefepime|cefepime|mesh-list
2375529|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2375530|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2375531|NCT00609388|Tacrolimus|tacrolimus|mesh-list
2489714|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
2375532|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2489715|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
2375533|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
2375534|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375535|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2375536|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375537|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375538|NCT00609401|Sorafenib|sorafenib|mesh-list
2375539|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375540|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2375541|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375542|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375543|NCT00609531|Citalopram|citalopram|mesh-list
2375544|NCT00609531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2375545|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2375546|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2375547|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375548|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375549|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
2375550|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375551|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2375552|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
2375553|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2375554|NCT00609544|Rilonacept|rilonacept|mesh-list
2375555|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2375556|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2489716|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489717|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
2489718|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
2489719|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
2489720|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489721|NCT01160419|Antidotes|antidotes|mesh-ancestor
2489722|NCT01160419|Protective Agents|protective agents|mesh-ancestor
2489723|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489724|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
2489725|NCT01160419|Vitamins|vitamins|mesh-ancestor
2489726|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
2489727|NCT01160419|Hematinics|hematinics|mesh-ancestor
2489728|NCT01160432|Methadone|methadone|mesh-list
2489729|NCT01160432|Naloxone|naloxone|mesh-list
2489730|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2489731|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489732|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
2489733|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489734|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2489735|NCT01160432|Narcotics|narcotics|mesh-ancestor
2489736|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489737|NCT01160432|Analgesics|analgesics|mesh-ancestor
2489738|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
2489739|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
2489740|NCT01160588|Sertraline|sertraline|mesh-list
2489741|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
2489742|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2489743|NCT01160588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2489744|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2489745|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2489746|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375557|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2375558|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2375559|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2375560|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375561|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375562|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375563|NCT00609557|Analgesics|analgesics|mesh-ancestor
2375564|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
2375565|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375566|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
2375567|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2375568|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
2375569|NCT00609570|Calcium|calcium|mesh-list
2375570|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2375571|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375572|NCT00609596|Dutasteride|dutasteride|mesh-list
2375573|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2489747|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489748|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
2489749|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489750|NCT01160601|Paclitaxel|paclitaxel|mesh-list
2489751|NCT01160601|Carboplatin|carboplatin|mesh-list
2489752|NCT01160601|Bavituximab|bavituximab|mesh-list
2489753|NCT01160601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2489754|NCT01160601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489755|NCT01160601|Tubulin Modulators|tubulin modulators|mesh-ancestor
2489756|NCT01160601|Antimitotic Agents|antimitotic agents|mesh-ancestor
2489757|NCT01160601|Mitosis Modulators|mitosis modulators|mesh-ancestor
2489758|NCT01160601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489759|NCT01160601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2489760|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
2489761|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2489762|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
2375574|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2375575|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375576|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375577|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
2375578|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2375579|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375580|NCT00609752|Prednisolone|prednisolone|mesh-list
2375581|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2375582|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
2375583|NCT00609752|Hormones|hormones|mesh-ancestor
2375584|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2375585|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375586|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2375587|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489763|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2489764|NCT01160627|Expectorants|expectorants|mesh-ancestor
2489765|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
2489766|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2489767|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
2489768|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489769|NCT01160627|Protective Agents|protective agents|mesh-ancestor
2489770|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489771|NCT01160627|Antidotes|antidotes|mesh-ancestor
2489772|NCT01160666|Belimumab|belimumab|mesh-list
2489773|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2489774|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
2489775|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489776|NCT01160705|Docetaxel|docetaxel|mesh-list
2489777|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489778|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
2489779|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
2489780|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
2489781|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489782|NCT01160718|Fulvestrant|fulvestrant|mesh-list
2489783|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2489784|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489785|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2489786|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2489787|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
2489788|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2489789|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375588|NCT00609791|Paclitaxel|paclitaxel|mesh-list
2375589|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2375590|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2375591|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375592|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
2375593|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
2375594|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
2375595|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375596|NCT00609817|Dexamethasone|dexamethasone|mesh-list
2375597|NCT00609817|Bortezomib|bortezomib|mesh-list
2375598|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2375599|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
2375600|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
2375601|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375602|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375603|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2375604|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
2375605|NCT00609817|Hormones|hormones|mesh-ancestor
2489790|NCT01160731|Etoposide|etoposide|mesh-list
2489791|NCT01160731|Panobinostat|panobinostat|mesh-list
2489792|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
2489793|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489794|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2489795|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2489796|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2489797|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489798|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489799|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2375606|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2375607|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2375608|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375609|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
2375610|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375611|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
2375612|NCT00609856|Pioglitazone|pioglitazone|mesh-list
2375613|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2375614|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375615|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
2375616|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2375617|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375618|NCT00609934|Sorafenib|sorafenib|mesh-list
2375619|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375620|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2375621|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489800|NCT01160900|Bivalirudin|bivalirudin|mesh-list
2489801|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2489802|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2489803|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
2489804|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2489805|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
2489806|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375622|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375623|NCT00609960|Midazolam|midazolam|mesh-list
2375624|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2375625|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2375626|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2375627|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375628|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2375629|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2375630|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2375631|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2375632|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
2375633|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
2375634|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
2375635|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
2375636|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375637|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375638|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2375639|NCT00609999|Dasatinib|dasatinib|mesh-list
2375640|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489807|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489808|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
2489809|NCT01160926|Cediranib|cediranib|mesh-list
2489810|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489811|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2489812|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489813|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489814|NCT01160952|Itraconazole|itraconazole|mesh-list
2489815|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
2489816|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2489817|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2489818|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2489819|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489820|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489821|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2489822|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
2489823|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2489824|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489825|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2489826|NCT01160965|Ropivacaine|ropivacaine|mesh-list
2489827|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
2489828|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
2489829|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
2489830|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2375641|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2489831|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489832|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
2489833|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489834|NCT01160978|Simvastatin|simvastatin|mesh-list
2489835|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2489836|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2489837|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
2489838|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375642|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375643|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375644|NCT00610038|Glyburide|glyburide|mesh-list
2375645|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2375646|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375647|NCT00610051|Alprostadil|alprostadil|mesh-list
2375648|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2375649|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
2375650|NCT00610051|Urological Agents|urological agents|mesh-ancestor
2375651|NCT00610077|Letrozole|letrozole|mesh-list
2375652|NCT00610077|Clomiphene|clomiphene|mesh-list
2375653|NCT00610077|Enclomiphene|enclomiphene|mesh-list
2489839|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2489840|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2489841|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489842|NCT01160991|Olanzapine|olanzapine|mesh-list
2489843|NCT01160991|Amisulpride|amisulpride|mesh-list
2489844|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
2489845|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
2489846|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489847|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489848|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2489849|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2489850|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2489851|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489852|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2489853|NCT01160991|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2489854|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2489855|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2489856|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489857|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489858|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
2489859|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2489860|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
2489861|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2489862|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
2489863|NCT01161017|Topiramate|topiramate|mesh-list
2489864|NCT01161017|Amitriptyline|amitriptyline|mesh-list
2489865|NCT01161017|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2489866|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
2489867|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2489868|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489869|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2489870|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
2489871|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2489872|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2489873|NCT01161017|Analgesics|analgesics|mesh-ancestor
2489874|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
2489875|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489876|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2489877|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2489878|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2489879|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489880|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
2489881|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489882|NCT01161017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2489883|NCT01161017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2489884|NCT01161017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489885|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
2489886|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2489887|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2489888|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489889|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489890|NCT01161108|Melatonin|melatonin|mesh-list
2489891|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
2489892|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375654|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
2375655|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375656|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375657|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2375658|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2375659|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375660|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2375661|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
2375662|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2375663|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375664|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2375665|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
2375666|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2375667|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2375668|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2375669|NCT00610103|Apomorphine|apomorphine|mesh-list
2375670|NCT00610103|Emetics|emetics|mesh-ancestor
2375671|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375672|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
2375673|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375674|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2375675|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
2375676|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
2375677|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375678|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375679|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
2375680|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
2375681|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2375682|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2375683|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2375684|NCT00610142|Analgesics|analgesics|mesh-ancestor
2375685|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
2375686|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375687|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375688|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2375689|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
2375690|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375691|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
2375692|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2375693|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375694|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489893|NCT01161108|Protective Agents|protective agents|mesh-ancestor
2489894|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489895|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489896|NCT01161134|Meloxicam|meloxicam|mesh-list
2489897|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2489898|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2489899|NCT01161134|Analgesics|analgesics|mesh-ancestor
2489900|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
2489901|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489902|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489903|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2489904|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2489905|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2489906|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2489907|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489908|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489909|NCT01161147|Meloxicam|meloxicam|mesh-list
2489910|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2489911|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2489912|NCT01161147|Analgesics|analgesics|mesh-ancestor
2489913|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
2489914|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489915|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489916|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2489917|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2489918|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2489919|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2489920|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489921|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489922|NCT01161186|Gemcitabine|gemcitabine|mesh-list
2489923|NCT01161186|Paclitaxel|paclitaxel|mesh-list
2489924|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2489925|NCT01161186|Capecitabine|capecitabine|mesh-list
2489926|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2489927|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489928|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
2489929|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
2489930|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
2489931|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489932|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2489933|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
2489934|NCT01161186|Antiviral Agents|antiviral agents|mesh-ancestor
2489935|NCT01161186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2489936|NCT01161186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489937|NCT01161186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2489938|NCT01161186|Immunologic Factors|immunologic factors|mesh-ancestor
2489939|NCT01161186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489940|NCT01161277|Haloperidol|haloperidol|mesh-list
2375695|NCT00610246|Sorafenib|sorafenib|mesh-list
2375696|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375697|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2375698|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375699|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375700|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
2375701|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2375702|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2375703|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2375704|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
2375705|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
2375706|NCT00610350|Simendan|simendan|mesh-list
2375707|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2375708|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
2375709|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2375710|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2375711|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375712|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489941|NCT01161277|Aripiprazole|aripiprazole|mesh-list
2489942|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
2489943|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
2489944|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2489945|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2489946|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2489947|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2489948|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489949|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
2489950|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
2489951|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2489952|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375713|NCT00610350|Protective Agents|protective agents|mesh-ancestor
2114124|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2114125|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2114126|NCT02597101|Metformin|metformin|mesh-list
2114127|NCT02597101|Saxagliptin|saxagliptin|mesh-list
2114128|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2114129|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114130|NCT02597101|Incretins|incretins|mesh-ancestor
2114131|NCT02597101|Hormones|hormones|mesh-ancestor
2114132|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2114133|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2114134|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
2114135|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114136|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114137|NCT02597478|Fentanyl|fentanyl|mesh-list
2114138|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2114139|NCT02597478|Narcotics|narcotics|mesh-ancestor
2114140|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2114141|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114142|NCT02597478|Analgesics|analgesics|mesh-ancestor
2114143|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
2114144|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114145|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2114146|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2114147|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
2114148|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
2489953|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2489954|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2489955|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
2489956|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2489957|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2489958|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2489959|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2489960|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
2489961|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
2489962|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2489963|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2489964|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2489965|NCT01161316|Cetuximab|cetuximab|mesh-list
2489966|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2489967|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489968|NCT01161368|Vinorelbine|vinorelbine|mesh-list
2489969|NCT01161368|Lapatinib|lapatinib|mesh-list
2489970|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2489971|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489972|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
2489973|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
2489974|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
2489975|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489976|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2489977|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489981|NCT01161459|Prednisone|prednisone|mesh-list
2489982|NCT01161459|Tacrolimus|tacrolimus|mesh-list
2489983|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2489984|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
2489985|NCT01161459|Hormones|hormones|mesh-ancestor
2489986|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2489987|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2489988|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2489989|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2489990|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375714|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375715|NCT00610454|Levetiracetam|levetiracetam|mesh-list
2375716|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
2375717|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
2375718|NCT00610493|Sirolimus|sirolimus|mesh-list
2375719|NCT00610493|Bevacizumab|bevacizumab|mesh-list
2375720|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2375721|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375722|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2375723|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2375724|NCT00610493|Growth Substances|growth substances|mesh-ancestor
2375725|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375726|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
2375727|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2375728|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2375729|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2375730|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
2375731|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375732|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
2375733|NCT00610506|Dexetimide|dexetimide|mesh-list
2489991|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
2489992|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2489993|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2489994|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2489995|NCT01161550|Cytarabine|cytarabine|mesh-list
2489996|NCT01161550|Tretinoin|tretinoin|mesh-list
2489997|NCT01161550|Cladribine|cladribine|mesh-list
2489998|NCT01161550|Midostaurin|midostaurin|mesh-list
2489999|NCT01161550|Lenograstim|lenograstim|mesh-list
2375734|NCT00610506|Citalopram|citalopram|mesh-list
2375735|NCT00610506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2375736|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2375737|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2375738|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375739|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490000|NCT01161550|Sargramostim|sargramostim|mesh-list
2490001|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2490002|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
2490003|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490004|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2490005|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
2490006|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375740|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
2375741|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375742|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2375743|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
2375744|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2375745|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2375746|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2375747|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
2375748|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
2375749|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375750|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2375751|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2375752|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
2375753|NCT00610545|Atorvastatin|atorvastatin|mesh-list
2375754|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2375755|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2375756|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
2375757|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375758|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2375759|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2375760|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375761|NCT00610571|Temozolomide|temozolomide|mesh-list
2375762|NCT00610571|Topotecan|topotecan|mesh-list
2490007|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490008|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
2490009|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490010|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375763|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2375764|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
2375765|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490011|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
2490012|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
2490013|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2490014|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490015|NCT01161654|Naratriptan|naratriptan|mesh-list
2490016|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2490017|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2490018|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2490019|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
2490020|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490021|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490022|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490023|NCT01161667|Naratriptan|naratriptan|mesh-list
2490024|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2490025|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2490026|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2490027|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
2490028|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490029|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490030|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490031|NCT01161836|Iniparib|iniparib|mesh-list
2490032|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2490033|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490034|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490035|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490036|NCT01161888|Imiquimod|imiquimod|mesh-list
2490037|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2375766|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490038|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
2490039|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490040|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490041|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
2490042|NCT01161927|Nizatidine|nizatidine|mesh-list
2490043|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2490044|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2490045|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2490046|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
2490047|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
2490048|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490049|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490050|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490051|NCT01161940|Nizatidine|nizatidine|mesh-list
2490052|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2490053|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2490054|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2490055|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
2490056|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
2490057|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490058|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490059|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490060|NCT01161966|Zonisamide|zonisamide|mesh-list
2490061|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
2490062|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2490063|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2490064|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490065|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2490066|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490067|NCT01161979|Zonisamide|zonisamide|mesh-list
2490068|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
2490069|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2490070|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2490071|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490072|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2490073|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490074|NCT01162031|Bortezomib|bortezomib|mesh-list
2490075|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490076|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
2490077|NCT01162109|Astringents|astringents|mesh-ancestor
2375767|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2375768|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2375769|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375770|NCT00610584|Cetirizine|cetirizine|mesh-list
2375771|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2375772|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2375773|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2375774|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
2375775|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
2375776|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375777|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375778|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375779|NCT00610610|Paroxetine|paroxetine|mesh-list
2375780|NCT00610610|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2375781|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2375782|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2375783|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375784|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375785|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
2490078|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490079|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
2490080|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2490081|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
2490082|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2490083|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2490084|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2490085|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490086|NCT01162603|Latanoprost|latanoprost|mesh-list
2490087|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2490088|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2490089|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
2490090|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2490091|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2490092|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
2490093|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490094|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490095|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490096|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
2490097|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
2490098|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490099|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
2490100|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2490101|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
2490102|NCT01162746|Dexamethasone|dexamethasone|mesh-list
2490103|NCT01162746|Ranibizumab|ranibizumab|mesh-list
2375786|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375787|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2375788|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
2375789|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2375790|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2375791|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2375792|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375793|NCT00610623|Azithromycin|azithromycin|mesh-list
2375794|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2375795|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2375796|NCT00610792|Doxorubicin|doxorubicin|mesh-list
2375797|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2375798|NCT00610792|Bortezomib|bortezomib|mesh-list
2375799|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2375800|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375801|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2375802|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2375803|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375804|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375805|NCT00610818|Mitogens|mitogens|mesh-list
2375806|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
2375807|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375808|NCT00610870|Atorvastatin|atorvastatin|mesh-list
2375809|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2375810|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2375811|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
2375812|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375813|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2375814|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2375815|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375816|NCT00610909|Paroxetine|paroxetine|mesh-list
2375817|NCT00610909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2375818|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2375819|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2375820|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375821|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375822|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
2375823|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375824|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2375825|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
2375826|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2375827|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2375828|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2490104|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2490105|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
2490106|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
2490107|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490108|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490109|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2490110|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
2490111|NCT01162746|Hormones|hormones|mesh-ancestor
2490112|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2490113|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2490114|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490115|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2490116|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2490117|NCT01162746|Growth Substances|growth substances|mesh-ancestor
2490118|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
2490119|NCT01162824|Adenosine|adenosine|mesh-list
2490120|NCT01162824|Acetylcholine|acetylcholine|mesh-list
2490121|NCT01162824|Analgesics|analgesics|mesh-ancestor
2490122|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
2490123|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490124|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490125|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2490126|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
2490127|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2490128|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
2490129|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
2490130|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490131|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490132|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2490133|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
2375829|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375830|NCT00610948|Leucovorin|leucovorin|mesh-list
2375831|NCT00610948|Fluorouracil|fluorouracil|mesh-list
2375832|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
2375833|NCT00610948|Everolimus|everolimus|mesh-list
2375834|NCT00610948|Panitumumab|panitumumab|mesh-list
2375835|NCT00610948|Calcium|calcium|mesh-list
2375836|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
2375837|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2375838|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375839|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
2375840|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375841|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2375842|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375843|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375844|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
2375845|NCT00610948|Antidotes|antidotes|mesh-ancestor
2375846|NCT00610948|Protective Agents|protective agents|mesh-ancestor
2375847|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
2375848|NCT00610948|Vitamins|vitamins|mesh-ancestor
2375849|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
2375850|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2375851|NCT00611000|Folic Acid|folic acid|mesh-list
2375852|NCT00611000|Hematinics|hematinics|mesh-ancestor
2375853|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
2375854|NCT00611000|Vitamins|vitamins|mesh-ancestor
2375855|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
2375856|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375857|NCT00611039|Ritonavir|ritonavir|mesh-list
2375858|NCT00611039|Darunavir|darunavir|mesh-list
2375859|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2375860|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2375861|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
2375862|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375863|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375864|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2375865|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2375866|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
2375867|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490134|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2490135|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
2490136|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490137|NCT01162902|Candesartan|candesartan|mesh-list
2490138|NCT01162902|Diltiazem|diltiazem|mesh-list
2490139|NCT01162902|Bisoprolol|bisoprolol|mesh-list
2490140|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2490141|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2490142|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2490143|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490144|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2490145|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2490146|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2490147|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490148|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
2490149|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
2490150|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
2490151|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490152|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2490153|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2490154|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2490155|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
2490156|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490157|NCT01162941|Prednisolone|prednisolone|mesh-list
2490158|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2490159|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
2490160|NCT01162941|Hormones|hormones|mesh-ancestor
2490161|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2490162|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490163|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2490164|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375868|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2375869|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2375870|NCT00611143|Atorvastatin|atorvastatin|mesh-list
2375871|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2375872|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2375873|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
2490165|NCT01162967|Posaconazole|posaconazole|mesh-list
2490166|NCT01162967|Benzonidazole|benzonidazole|mesh-list
2490167|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
2490168|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490169|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2490170|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2375874|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375875|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2375876|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2375877|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375878|NCT00611169|Tirofiban|tirofiban|mesh-list
2375879|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2375880|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2375881|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375882|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2375883|NCT00611195|Remifentanil|remifentanil|mesh-list
2375884|NCT00611195|Propofol|propofol|mesh-list
2375885|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2490171|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2490172|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2490173|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2490174|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490175|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490176|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2490177|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
2375886|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2375887|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375888|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2375889|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
2490178|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2490179|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490180|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2490181|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
2490182|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
2490183|NCT01163201|Fludarabine|fludarabine|mesh-list
2490184|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2490185|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
2490186|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490187|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2490188|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2490189|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
2375890|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
2375891|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2375892|NCT00611195|Narcotics|narcotics|mesh-ancestor
2375893|NCT00611195|Analgesics|analgesics|mesh-ancestor
2375894|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
2375895|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2375896|NCT00611286|Sirolimus|sirolimus|mesh-list
2375897|NCT00611286|Paclitaxel|paclitaxel|mesh-list
2375898|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2375899|NCT00611286|Everolimus|everolimus|mesh-list
2375900|NCT00611286|Clopidogrel|clopidogrel|mesh-list
2375901|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
2375902|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2375903|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375904|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
2375905|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
2375906|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
2375907|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375908|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375909|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
2375910|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490190|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490191|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490192|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2490193|NCT01163357|Sirolimus|sirolimus|mesh-list
2490194|NCT01163357|Fludarabine|fludarabine|mesh-list
2490195|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
2490196|NCT01163357|Bortezomib|bortezomib|mesh-list
2490197|NCT01163357|Melphalan|melphalan|mesh-list
2490198|NCT01163357|Tacrolimus|tacrolimus|mesh-list
2490199|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490200|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2490201|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
2490202|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375911|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2490203|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2490204|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
2490205|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490206|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2490207|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490208|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2490209|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490210|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2490211|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
2490212|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2490213|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
2490214|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2490215|NCT01163383|Iodine|iodine|mesh-list
2490216|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
2490217|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2490218|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2490219|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2375912|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2375913|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2375914|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
2375915|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375916|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2375917|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2375918|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2375919|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
2375920|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2375921|NCT00611416|Caffeine|caffeine|mesh-list
2375922|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2375923|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375924|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2375925|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375926|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375927|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2375928|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2375929|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
2375930|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375931|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
2375932|NCT00611416|Protective Agents|protective agents|mesh-ancestor
2375933|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2375934|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2375935|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375936|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2375937|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
2375938|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2375939|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375940|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2490220|NCT01163383|Trace Elements|trace elements|mesh-ancestor
2490221|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
2490222|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490223|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490224|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490225|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490226|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2490227|NCT01163396|Leucovorin|leucovorin|mesh-list
2490228|NCT01163396|Bevacizumab|bevacizumab|mesh-list
2490229|NCT01163396|Fluorouracil|fluorouracil|mesh-list
2490230|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
2490231|NCT01163396|Irinotecan|irinotecan|mesh-list
2490232|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2490233|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490234|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2490235|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2375941|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
2375942|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2375943|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2375944|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375945|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375946|NCT00611507|Fluorouracil|fluorouracil|mesh-list
2490236|NCT01163396|Growth Substances|growth substances|mesh-ancestor
2490237|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490238|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
2490239|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
2490240|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490241|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2490242|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2490243|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
2375947|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
2375948|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
2375949|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375950|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2490244|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2490245|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2490246|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490247|NCT01163396|Antidotes|antidotes|mesh-ancestor
2490248|NCT01163396|Protective Agents|protective agents|mesh-ancestor
2490249|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
2490250|NCT01163396|Vitamins|vitamins|mesh-ancestor
2490251|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
2375951|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375952|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2375953|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
2375954|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375955|NCT00611572|Flumazenil|flumazenil|mesh-list
2375956|NCT00611572|Antidotes|antidotes|mesh-ancestor
2375957|NCT00611572|Protective Agents|protective agents|mesh-ancestor
2375958|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375959|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
2375960|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
2375961|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375962|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375963|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2375964|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
2375965|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375966|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2375967|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
2375968|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375969|NCT00611650|Protective Agents|protective agents|mesh-ancestor
2375970|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375971|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2375972|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2375973|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375974|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2490252|NCT01163435|Clarithromycin|clarithromycin|mesh-list
2490253|NCT01163435|Levofloxacin|levofloxacin|mesh-list
2490254|NCT01163435|Ofloxacin|ofloxacin|mesh-list
2490255|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2490256|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490257|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2375975|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2490258|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490259|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490260|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2490261|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2490262|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2490263|NCT01163435|Renal Agents|renal agents|mesh-ancestor
2490264|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2490265|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2490266|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490267|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2490268|NCT01163500|Ubiquinone|ubiquinone|mesh-list
2490269|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
2490270|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
2490271|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490272|NCT01163500|Vitamins|vitamins|mesh-ancestor
2490273|NCT01163630|Esomeprazole|esomeprazole|mesh-list
2490274|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2490275|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2490276|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2490277|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490278|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490279|NCT01163734|Ranolazine|ranolazine|mesh-list
2490280|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2490281|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2490282|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490283|NCT01163799|Alefacept|alefacept|mesh-list
2490284|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
2490285|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
2490286|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490287|NCT01163825|Mitogens|mitogens|mesh-list
2490288|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
2490289|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490290|NCT01163903|Doxorubicin|doxorubicin|mesh-list
2375976|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
2375977|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375978|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2375979|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2375980|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2375981|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2375982|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375983|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2375984|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2375985|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2375986|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
2375987|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2375988|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
2375989|NCT00611689|Vatalanib|vatalanib|mesh-list
2375990|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2375991|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2375992|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375993|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2375994|NCT00611728|Irinotecan|irinotecan|mesh-list
2490291|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2490292|NCT01163903|Pantoprazole|pantoprazole|mesh-list
2490293|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2490294|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490295|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2490296|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2490297|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375995|NCT00611728|Sunitinib|sunitinib|mesh-list
2375996|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2375997|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2375998|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2375999|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376000|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376001|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2376002|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2490298|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490299|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2490300|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2490301|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2490302|NCT01163929|Paclitaxel|paclitaxel|mesh-list
2490303|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2490304|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490305|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
2376003|NCT00611728|Growth Substances|growth substances|mesh-ancestor
2376004|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376005|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
2376006|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2376007|NCT00611741|Furosemide|furosemide|mesh-list
2376008|NCT00611741|Diuretics|diuretics|mesh-ancestor
2376009|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
2376010|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376011|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2376012|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2376013|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490306|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
2490307|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
2490308|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490309|NCT01163994|Doxycycline|doxycycline|mesh-list
2490310|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
2490311|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2490312|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490313|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
2490314|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2490315|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2490316|NCT01164046|Vitamin K|vitamin k|mesh-list
2490317|NCT01164046|Heparin|heparin|mesh-list
2490318|NCT01164046|Enoxaparin|enoxaparin|mesh-list
2490319|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2490320|NCT01164046|Tinzaparin|tinzaparin|mesh-list
2490321|NCT01164046|Dalteparin|dalteparin|mesh-list
2490322|NCT01164046|Nadroparin|nadroparin|mesh-list
2490323|NCT01164046|Reviparin|reviparin|mesh-list
2490324|NCT01164046|Warfarin|warfarin|mesh-list
2490325|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
2490326|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
2490327|NCT01164046|Bemiparin|bemiparin|mesh-list
2490328|NCT01164046|Certoparin|certoparin|mesh-list
2490329|NCT01164046|Vitamins|vitamins|mesh-ancestor
2376014|NCT00611754|Fluorouracil|fluorouracil|mesh-list
2376015|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
2376016|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
2376017|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376018|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2376019|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376020|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2490330|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
2490331|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490332|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
2490333|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2490334|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2490335|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490336|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2490337|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
2490338|NCT01164046|Coagulants|coagulants|mesh-ancestor
2490339|NCT01164059|Haloperidol|haloperidol|mesh-list
2490340|NCT01164059|Olanzapine|olanzapine|mesh-list
2490341|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2490342|NCT01164059|Aripiprazole|aripiprazole|mesh-list
2490343|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
2490344|NCT01164059|Flupenthixol|flupenthixol|mesh-list
2490345|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
2490346|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
2490347|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
2490348|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490349|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490350|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2490351|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2490352|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2490353|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2490354|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2490355|NCT01164059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2376021|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
2376022|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376023|NCT00611793|Bevacizumab|bevacizumab|mesh-list
2376024|NCT00611793|Vatalanib|vatalanib|mesh-list
2376025|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2376026|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376027|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2376028|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2376029|NCT00611793|Growth Substances|growth substances|mesh-ancestor
2376030|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376031|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
2376032|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2376033|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376034|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376035|NCT00611819|Interferons|interferons|mesh-list
2376036|NCT00611819|Ribavirin|ribavirin|mesh-list
2376037|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2376038|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
2376039|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376040|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
2376041|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376042|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
2376043|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376044|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
2376045|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376046|NCT00611845|Aprotinin|aprotinin|mesh-list
2376047|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
2376048|NCT00611845|Coagulants|coagulants|mesh-ancestor
2376049|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2376050|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2376051|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
2376052|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376053|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376054|NCT00611871|Propranolol|propranolol|mesh-list
2376055|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2376056|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2376057|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
2376058|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2376059|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376060|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376061|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2376062|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2490356|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2668474|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2490357|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2490358|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490359|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490360|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
2490361|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
2490362|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
2490363|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
2490364|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2490365|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2490366|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2490367|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2490368|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2490369|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2490370|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2490371|NCT01164085|Ketorolac|ketorolac|mesh-list
2490372|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2490373|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2490374|NCT01164085|Analgesics|analgesics|mesh-ancestor
2490375|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
2490376|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376063|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
2376064|NCT00611910|Sirolimus|sirolimus|mesh-list
2376065|NCT00611910|Paclitaxel|paclitaxel|mesh-list
2376066|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2376067|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376068|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
2376069|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
2490377|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490378|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2376070|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
2376071|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376072|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2376073|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376074|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2376075|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
2376076|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376077|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
2376078|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376079|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2376080|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2376081|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2376082|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2376083|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376084|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
2376085|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2376086|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376087|NCT00611962|Paclitaxel|paclitaxel|mesh-list
2376088|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
2376089|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2376090|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376091|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
2376092|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
2376093|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
2376094|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490379|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2490380|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2490381|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490382|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490383|NCT01164176|Everolimus|everolimus|mesh-list
2376095|NCT00612079|Sertindole|sertindole|mesh-list
2376096|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2376097|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2376098|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2376099|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376100|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2376101|NCT00612118|Azelastine|azelastine|mesh-list
2376102|NCT00612118|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
2376103|NCT00612118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2376104|NCT00612118|Autonomic Agents|autonomic agents|mesh-ancestor
2376105|NCT00612118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376106|NCT00612118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376107|NCT00612118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2490384|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490385|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2490386|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
2490387|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490388|NCT01164189|Bevacizumab|bevacizumab|mesh-list
2490389|NCT01164189|Temozolomide|temozolomide|mesh-list
2490390|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2490391|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490392|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2490393|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2490394|NCT01164189|Growth Substances|growth substances|mesh-ancestor
2490395|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490396|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
2490397|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2490398|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
2490399|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490400|NCT01164202|Sunitinib|sunitinib|mesh-list
2490401|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490402|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2490403|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2490404|NCT01164202|Growth Substances|growth substances|mesh-ancestor
2490405|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490406|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
2490407|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2490408|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490409|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490410|NCT01164215|Leucovorin|leucovorin|mesh-list
2490411|NCT01164215|Fluorouracil|fluorouracil|mesh-list
2490412|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
2490413|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
2490414|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376108|NCT00612118|Respiratory System Agents|respiratory system agents|mesh-ancestor
2376109|NCT00612118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2376110|NCT00612118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376111|NCT00612118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376112|NCT00612118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2376113|NCT00612118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2376114|NCT00612118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2490415|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
2490416|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490417|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2490418|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490419|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2490420|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
2490421|NCT01164215|Antidotes|antidotes|mesh-ancestor
2490422|NCT01164215|Protective Agents|protective agents|mesh-ancestor
2490423|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
2490424|NCT01164215|Vitamins|vitamins|mesh-ancestor
2490425|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
2490426|NCT01164267|Everolimus|everolimus|mesh-list
2490427|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490428|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2490429|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
2490430|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490431|NCT01164306|Nicotine|nicotine|mesh-list
2490432|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2490433|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
2376115|NCT00612118|Histamine Antagonists|histamine antagonists|mesh-ancestor
2376116|NCT00612118|Histamine Agents|histamine agents|mesh-ancestor
2376117|NCT00612118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2376118|NCT00612118|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2376119|NCT00612118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2376120|NCT00612144|Metformin|metformin|mesh-list
2376121|NCT00612144|Glimepiride|glimepiride|mesh-list
2376122|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2376123|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376124|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2376125|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376126|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
2376127|NCT00612157|Eszopiclone|eszopiclone|mesh-list
2376128|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2376129|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2376130|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376131|NCT00612170|Reboxetine|reboxetine|mesh-list
2376132|NCT00612170|Antidepressive Agents|antidepressive agents|mesh-ancestor
2490434|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490435|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490436|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2490437|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2490438|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
2376133|NCT00612170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2376134|NCT00612170|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2376135|NCT00612170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2376136|NCT00612170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2376137|NCT00612170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376138|NCT00612170|Adrenergic Agents|adrenergic agents|mesh-ancestor
2376139|NCT00612170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2376140|NCT00612170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376141|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2376142|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376143|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
2376144|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376145|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376146|NCT00612261|Triamcinolone|triamcinolone|mesh-list
2490439|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490440|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490441|NCT01164345|Plerixafor|plerixafor|mesh-list
2490442|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2490443|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2490444|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
2490445|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490446|NCT01164488|Ritonavir|ritonavir|mesh-list
2490447|NCT01164488|Ketoconazole|ketoconazole|mesh-list
2490448|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2490449|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2490450|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
2490451|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490452|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490453|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2490454|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2490455|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
2490456|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490457|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2490458|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2490459|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
2490460|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2490461|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2490462|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
2490463|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2490464|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490465|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2490466|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2490467|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2490468|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
2490469|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490470|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2490471|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2490472|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490473|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
2490474|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2490475|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2490476|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
2490477|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490478|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2490479|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2490480|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490481|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490482|NCT01164709|Nelfinavir|nelfinavir|mesh-list
2376147|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2376148|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2376149|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2376150|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2376151|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
2376152|NCT00612261|Hormones|hormones|mesh-ancestor
2490483|NCT01164709|Bortezomib|bortezomib|mesh-list
2490484|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490485|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2490486|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2490487|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
2490488|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376153|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2490489|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490490|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2490491|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2376154|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376155|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376156|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
2376157|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376158|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376159|NCT00612274|Sirolimus|sirolimus|mesh-list
2376160|NCT00612274|Methotrexate|methotrexate|mesh-list
2376161|NCT00612274|Tacrolimus|tacrolimus|mesh-list
2376162|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2376163|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
2376164|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2490492|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
2490493|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490494|NCT01164761|Ramipril|ramipril|mesh-list
2490495|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2490496|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
2490497|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490498|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490499|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2490500|NCT01164774|Ramipril|ramipril|mesh-list
2490501|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2490502|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
2490503|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490504|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490505|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2490506|NCT01164787|Trandolapril|trandolapril|mesh-list
2490507|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2490508|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
2490509|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490510|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490511|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2490512|NCT01164800|Trandolapril|trandolapril|mesh-list
2490513|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2376165|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376166|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2376167|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
2376168|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376169|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376170|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
2376171|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376172|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2376173|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376174|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
2376175|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2490514|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
2490515|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490516|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490517|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2490518|NCT01164813|Nabumetone|nabumetone|mesh-list
2490519|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2490520|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2490521|NCT01164813|Analgesics|analgesics|mesh-ancestor
2490522|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
2490523|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490524|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490525|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2376176|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2376177|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2376178|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2376179|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376180|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2376181|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
2376182|NCT00612287|Buprenorphine|buprenorphine|mesh-list
2490526|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2490527|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2490528|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2490529|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490530|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490531|NCT01164826|Nabumetone|nabumetone|mesh-list
2490532|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2490533|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2490534|NCT01164826|Analgesics|analgesics|mesh-ancestor
2490535|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
2490536|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490537|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490538|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2490539|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2490540|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2490541|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2490542|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376183|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2376184|NCT00612287|Narcotics|narcotics|mesh-ancestor
2376185|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2376186|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376187|NCT00612287|Analgesics|analgesics|mesh-ancestor
2376188|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
2376189|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376190|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2376191|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
2376192|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2490543|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490544|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2490545|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
2490546|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490547|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2490548|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490554|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2490555|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2490556|NCT01165060|Bezafibrate|bezafibrate|mesh-list
2490557|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2490558|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
2490559|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490560|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2490561|NCT01165125|Ketoconazole|ketoconazole|mesh-list
2490562|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
2490563|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490564|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2490565|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2490566|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376193|NCT00612469|Listerine|listerine|mesh-list
2376194|NCT00612469|Vancomycin|vancomycin|mesh-list
2376195|NCT00612469|Fluorides|fluorides|mesh-list
2376196|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
2376197|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
2376198|NCT00612469|Protective Agents|protective agents|mesh-ancestor
2376199|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376200|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2376201|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376202|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
2376203|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
2376204|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2376205|NCT00612495|Fluorouracil|fluorouracil|mesh-list
2376206|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
2490567|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490568|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2490569|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
2490570|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2490571|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490572|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2490573|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2490574|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
2490575|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2490576|NCT01165255|Bupropion|bupropion|mesh-list
2490577|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
2490578|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2490579|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2490580|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2376207|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
2376208|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490581|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2490582|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2490583|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490584|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
2490585|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490586|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490587|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2490588|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2490589|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490590|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
2490591|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2490592|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490593|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2490594|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490595|NCT01165294|Ketamine|ketamine|mesh-list
2490596|NCT01165294|Analgesics|analgesics|mesh-ancestor
2490597|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
2490598|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490599|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490600|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2490601|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2490602|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
2490603|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
2490604|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2490605|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2490606|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2490607|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490608|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490609|NCT01165372|Artesunate|artesunate|mesh-list
2490610|NCT01165372|Piperaquine|piperaquine|mesh-list
2490611|NCT01165372|Artenimol|artenimol|mesh-list
2490612|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
2490613|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2490614|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2490615|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490616|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490617|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
2376209|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2376210|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376211|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376212|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
2376213|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376214|NCT00612521|Adenosine|adenosine|mesh-list
2376215|NCT00612521|Analgesics|analgesics|mesh-ancestor
2376216|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
2376217|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376218|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376219|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2376220|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
2376221|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2376222|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
2376223|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
2376224|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2376225|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376226|NCT00612547|Artesunate|artesunate|mesh-list
2376227|NCT00612547|Amodiaquine|amodiaquine|mesh-list
2376228|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
2376229|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2376230|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2376231|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376232|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376233|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
2376234|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
2376235|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2376236|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
2376237|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
2490618|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
2490619|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2490620|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
2490621|NCT01165385|Cisplatin|cisplatin|mesh-list
2490622|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490623|NCT01165476|Treprostinil|treprostinil|mesh-list
2490624|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2490625|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
2490626|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2490627|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2490628|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490629|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2490630|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2490631|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
2490632|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490633|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490634|NCT01165580|Valganciclovir|valganciclovir|mesh-list
2490635|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
2490636|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490637|NCT01165632|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
2490638|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490639|NCT01165632|Dopamine Agents|dopamine agents|mesh-ancestor
2490640|NCT01165632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490641|NCT01165632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490642|NCT01165645|Ritonavir|ritonavir|mesh-list
2490643|NCT01165645|Lopinavir|lopinavir|mesh-list
2490644|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2490645|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2490646|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
2490647|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490648|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490649|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2490650|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2490651|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
2490652|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376238|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
2376239|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2376240|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490653|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2490654|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2490655|NCT01165814|Naproxen|naproxen|mesh-list
2376241|NCT00612612|Rituximab|rituximab|mesh-list
2376242|NCT00612612|Fludarabine|fludarabine|mesh-list
2376243|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
2376244|NCT00612612|Obatoclax|obatoclax|mesh-list
2376245|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2376246|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376247|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
2376248|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376249|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2376250|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2376251|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
2490656|NCT01165814|Tramadol|tramadol|mesh-list
2490657|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2490658|NCT01165814|Narcotics|narcotics|mesh-ancestor
2490659|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2490660|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490661|NCT01165814|Analgesics|analgesics|mesh-ancestor
2490662|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
2490663|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490664|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2490665|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2490666|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2490667|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2490668|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
2490669|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2490670|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490671|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490672|NCT01165866|Ondansetron|ondansetron|mesh-list
2490673|NCT01165866|Metoclopramide|metoclopramide|mesh-list
2490674|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
2490675|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
2490676|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490677|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490678|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2490679|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
2376252|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376253|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376254|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490680|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
2490681|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2490682|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
2490683|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490684|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490685|NCT01165866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2376255|NCT00612625|Glucagon|glucagon|mesh-list
2376256|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2376257|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2376258|NCT00612625|Hormones|hormones|mesh-ancestor
2376259|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2490686|NCT01165866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2490687|NCT01165866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2490688|NCT01165866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2490689|NCT01165866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2490690|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2490691|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2490692|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
2490693|NCT01165905|Gemcitabine|gemcitabine|mesh-list
2490694|NCT01165905|ON 01910|on 01910|mesh-list
2490695|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2376260|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376261|NCT00612625|Incretins|incretins|mesh-ancestor
2376262|NCT00612638|Irinotecan|irinotecan|mesh-list
2376263|NCT00612638|Temozolomide|temozolomide|mesh-list
2376264|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2376265|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2376266|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2376267|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376268|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376269|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376270|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376271|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
2376272|NCT00612651|Temozolomide|temozolomide|mesh-list
2376273|NCT00612651|Lonafarnib|lonafarnib|mesh-list
2376274|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376275|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
2376276|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376277|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376278|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376279|NCT00612742|Testosterone|testosterone|mesh-list
2376280|NCT00612742|Androgens|androgens|mesh-ancestor
2490696|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
2490697|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490698|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490699|NCT01165905|Antiviral Agents|antiviral agents|mesh-ancestor
2490700|NCT01165905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490701|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490702|NCT01165905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2490703|NCT01165905|Immunologic Factors|immunologic factors|mesh-ancestor
2490704|NCT01165905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490705|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2490706|NCT01165931|Riociguat|riociguat|mesh-list
2490707|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
2490708|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490709|NCT01165944|Pramlintide|pramlintide|mesh-list
2490710|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2490711|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490712|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2490713|NCT01165970|Laxatives|laxatives|mesh-ancestor
2490714|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2490715|NCT01166035|Lenalidomide|lenalidomide|mesh-list
2490716|NCT01166035|Cetuximab|cetuximab|mesh-list
2490717|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
2490718|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490719|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2376281|NCT00612742|Hormones|hormones|mesh-ancestor
2376282|NCT00612742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2376283|NCT00612742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490720|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2490721|NCT01166035|Growth Substances|growth substances|mesh-ancestor
2490722|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
2376284|NCT00612755|Ribavirin|ribavirin|mesh-list
2376285|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2376286|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
2376287|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376288|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
2376289|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376290|NCT00612794|Exenatide|exenatide|mesh-list
2376291|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2376292|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376293|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2376294|NCT00612794|Incretins|incretins|mesh-ancestor
2490723|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490724|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2490725|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2490726|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2490727|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2490728|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2490729|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490730|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490731|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490732|NCT01166048|Analgesics|analgesics|mesh-ancestor
2490733|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
2490734|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490735|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
2490736|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2490737|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
2490738|NCT01166087|Fluoxetine|fluoxetine|mesh-list
2490739|NCT01166087|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2490740|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2490741|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2490742|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490743|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490744|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
2490745|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490746|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2490747|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
2490748|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2490749|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2490750|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2490751|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490752|NCT01166100|Fluoxetine|fluoxetine|mesh-list
2490753|NCT01166100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2490754|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2490755|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2490756|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490757|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490758|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
2490759|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490760|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2490761|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
2490762|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2490763|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2490764|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2490765|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490766|NCT01166113|Prednisone|prednisone|mesh-list
2490767|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
2490768|NCT01166113|Pomalidomide|pomalidomide|mesh-list
2376295|NCT00612794|Hormones|hormones|mesh-ancestor
2376296|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2376297|NCT00612820|Fluticasone|fluticasone|mesh-list
2376298|NCT00612820|Xhance|xhance|mesh-list
2376299|NCT00612820|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
2376300|NCT00612820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2376301|NCT00612820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2376302|NCT00612820|Autonomic Agents|autonomic agents|mesh-ancestor
2376303|NCT00612820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376304|NCT00612820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376305|NCT00612820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2490769|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2490770|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
2490771|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490772|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2490773|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376306|NCT00612820|Respiratory System Agents|respiratory system agents|mesh-ancestor
2376307|NCT00612820|Dermatologic Agents|dermatologic agents|mesh-ancestor
2376308|NCT00612820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2376309|NCT00612820|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2376310|NCT00612820|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2376311|NCT00612820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422906|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2490774|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
2490775|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490776|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490777|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2490778|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2490779|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
2490780|NCT01166113|Hormones|hormones|mesh-ancestor
2490781|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2490782|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2490783|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2376312|NCT00612820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376313|NCT00612859|Levetiracetam|levetiracetam|mesh-list
2376314|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
2376315|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
2376316|NCT00612898|Lamivudine|lamivudine|mesh-list
2376317|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2376318|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2376319|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490784|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2490785|NCT01166113|Growth Substances|growth substances|mesh-ancestor
2490786|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
2490787|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
2490788|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2490789|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490790|NCT01166165|Vitamins|vitamins|mesh-ancestor
2490791|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
2490792|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2490793|NCT01166412|Levonorgestrel|levonorgestrel|mesh-list
2490794|NCT01166412|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2490795|NCT01166412|Contraceptive Agents|contraceptive agents|mesh-ancestor
2490796|NCT01166412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2490797|NCT01166412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490798|NCT01166412|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2490799|NCT01166412|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2490800|NCT01166412|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2490801|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
2490802|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
2490803|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2490804|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490805|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490806|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
2490807|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2490808|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2490809|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490810|NCT01166451|Iron|iron|mesh-list
2490811|NCT01166451|Trace Elements|trace elements|mesh-ancestor
2490812|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
2490813|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490814|NCT01166477|Ritonavir|ritonavir|mesh-list
2490815|NCT01166477|Lopinavir|lopinavir|mesh-list
2376320|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376321|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
2376322|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376323|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2490816|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2490817|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2490818|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
2490819|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490820|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490821|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2490822|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2490823|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
2490824|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490825|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2490826|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2490827|NCT01166542|Paclitaxel|paclitaxel|mesh-list
2490828|NCT01166542|Carboplatin|carboplatin|mesh-list
2490829|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2490830|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490831|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
2490832|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
2490833|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
2490834|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490835|NCT01166594|Bevacizumab|bevacizumab|mesh-list
2490836|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2490837|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490838|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2490839|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2490840|NCT01166594|Growth Substances|growth substances|mesh-ancestor
2490841|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490842|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
2490843|NCT01166633|Atorvastatin|atorvastatin|mesh-list
2490844|NCT01166633|Pitavastatin|pitavastatin|mesh-list
2490845|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2490846|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2490847|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
2490848|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490849|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2490850|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2490851|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490852|NCT01166685|Everolimus|everolimus|mesh-list
2376324|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2376325|NCT00612950|Glucagon|glucagon|mesh-list
2376326|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
2376327|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2376328|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2376329|NCT00612950|Hormones|hormones|mesh-ancestor
2376330|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2376331|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376332|NCT00612950|Incretins|incretins|mesh-ancestor
2376333|NCT00612989|Temozolomide|temozolomide|mesh-list
2490853|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490854|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2490855|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
2490856|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490857|NCT01166711|Chromium|chromium|mesh-list
2490858|NCT01166711|Paclitaxel|paclitaxel|mesh-list
2490859|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2490860|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2490861|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490862|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
2490863|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
2490864|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
2490865|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490866|NCT01166711|Trace Elements|trace elements|mesh-ancestor
2490867|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
2490868|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490869|NCT01166789|Lubiprostone|lubiprostone|mesh-list
2490870|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2490871|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2376334|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2376335|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376336|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
2376337|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376338|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376339|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376340|NCT00613002|Testosterone|testosterone|mesh-list
2376341|NCT00613002|Androgens|androgens|mesh-ancestor
2376342|NCT00613002|Hormones|hormones|mesh-ancestor
2376343|NCT00613002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2376344|NCT00613002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376345|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
2376346|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
2376347|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376348|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2376349|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376350|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376351|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
2376352|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2376353|NCT00613067|Citalopram|citalopram|mesh-list
2376354|NCT00613067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2376355|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2376356|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2376357|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376358|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2376359|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
2376360|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376361|NCT00613067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2376362|NCT00613067|Antidepressive Agents|antidepressive agents|mesh-ancestor
2376363|NCT00613067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2490872|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490873|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
2490874|NCT01166815|Astringents|astringents|mesh-ancestor
2490875|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490876|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
2490877|NCT01166932|Amoxicillin|amoxicillin|mesh-list
2490878|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
2490879|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
2490880|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
2490881|NCT01166932|Oxacillin|oxacillin|mesh-list
2490882|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2490883|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2490884|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490885|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490886|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2490887|NCT01167010|Budesonide|budesonide|mesh-list
2490888|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
2490889|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2490890|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2490891|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
2490892|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490893|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490894|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2490895|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
2490896|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
2490897|NCT01167010|Hormones|hormones|mesh-ancestor
2490898|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2490899|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2490900|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2490901|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2490902|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
2490903|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490904|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490905|NCT01167049|Capecitabine|capecitabine|mesh-list
2490906|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2490907|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
2490908|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490909|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490910|NCT01167062|Tamsulosin|tamsulosin|mesh-list
2490911|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2490912|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2490913|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2490914|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
2490915|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490916|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490917|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490918|NCT01167062|Urological Agents|urological agents|mesh-ancestor
2376364|NCT00613093|Temozolomide|temozolomide|mesh-list
2376365|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2376366|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376367|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
2376368|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376369|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376370|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376371|NCT00613132|Everolimus|everolimus|mesh-list
2376372|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
2376373|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
2376374|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376375|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376376|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
2376377|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376378|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2376379|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376380|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376381|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
2376382|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2376383|NCT00613145|Capecitabine|capecitabine|mesh-list
2376384|NCT00613145|Sorafenib|sorafenib|mesh-list
2376385|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2376386|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
2376387|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376388|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376389|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2376390|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376391|NCT00613223|Etoposide|etoposide|mesh-list
2376392|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
2376393|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2376394|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376395|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2490919|NCT01167101|Pantoprazole|pantoprazole|mesh-list
2490920|NCT01167101|Rebamipide|rebamipide|mesh-list
2490921|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2490922|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2490923|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2490924|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490925|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490926|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
2376396|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2376397|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376398|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376399|NCT00613249|Dapivirine|dapivirine|mesh-list
2376400|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2376401|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2376402|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
2376403|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376404|NCT00613288|Testosterone|testosterone|mesh-list
2376405|NCT00613288|Androgens|androgens|mesh-ancestor
2376406|NCT00613288|Hormones|hormones|mesh-ancestor
2376407|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2376408|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376409|NCT00613392|Antioxidants|antioxidants|mesh-list
2376410|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376411|NCT00613392|Protective Agents|protective agents|mesh-ancestor
2376412|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376413|NCT00613457|Cytarabine|cytarabine|mesh-list
2376414|NCT00613457|Dexamethasone|dexamethasone|mesh-list
2376415|NCT00613457|Prednisone|prednisone|mesh-list
2376416|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
2376417|NCT00613457|Ifosfamide|ifosfamide|mesh-list
2376418|NCT00613457|Doxorubicin|doxorubicin|mesh-list
2376419|NCT00613457|Methotrexate|methotrexate|mesh-list
2376420|NCT00613457|Etoposide|etoposide|mesh-list
2376421|NCT00613457|Vincristine|vincristine|mesh-list
2376422|NCT00613457|Daunorubicin|daunorubicin|mesh-list
2376423|NCT00613457|Asparaginase|asparaginase|mesh-list
2376424|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
2376425|NCT00613457|Thioguanine|thioguanine|mesh-list
2376426|NCT00613457|Vindesine|vindesine|mesh-list
2376427|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376428|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
2376429|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376430|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2376431|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376432|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
2376433|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376434|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376435|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2376436|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2376437|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
2376438|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
2376439|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376440|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2376441|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
2376442|NCT00613457|Hormones|hormones|mesh-ancestor
2376443|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2376444|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2376445|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2376446|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2376447|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2376448|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376449|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2376450|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
2376451|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2376452|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2376453|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
2376454|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
2376455|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2376456|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2376457|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2376458|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
2376459|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376460|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
2376461|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
2490927|NCT01167101|Protective Agents|protective agents|mesh-ancestor
2490928|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490929|NCT01167127|Oxycodone|oxycodone|mesh-list
2490930|NCT01167127|Naloxone|naloxone|mesh-list
2490931|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2490932|NCT01167127|Narcotics|narcotics|mesh-ancestor
2490933|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2490934|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490935|NCT01167127|Analgesics|analgesics|mesh-ancestor
2490936|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
2490937|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490938|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2490939|NCT01167166|ON 01910|on 01910|mesh-list
2490940|NCT01167166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490941|NCT01167166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2490942|NCT01167166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490943|NCT01167166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490944|NCT01167231|Acarbose|acarbose|mesh-list
2490945|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2490946|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490947|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376462|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
2376463|NCT00613470|Citalopram|citalopram|mesh-list
2376464|NCT00613470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2376465|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2376466|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2376467|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376468|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2376469|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
2376470|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376471|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2376472|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
2490948|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2490949|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490950|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
2490951|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
2490952|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
2490953|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2490954|NCT01167465|Protective Agents|protective agents|mesh-ancestor
2490955|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490956|NCT01167478|Caffeine|caffeine|mesh-list
2490957|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2490958|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490959|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2490960|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2490961|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490962|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2490963|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2490964|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
2490965|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2490966|NCT01167530|Everolimus|everolimus|mesh-list
2490967|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490968|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2490969|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
2490970|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490971|NCT01167699|Oxycodone|oxycodone|mesh-list
2490972|NCT01167699|Naloxone|naloxone|mesh-list
2490973|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2490974|NCT01167699|Narcotics|narcotics|mesh-ancestor
2490975|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2490976|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490977|NCT01167699|Analgesics|analgesics|mesh-ancestor
2376473|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2376474|NCT00613496|Irbesartan|irbesartan|mesh-list
2376475|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2376476|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2376477|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2376478|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376479|NCT00613561|Fludarabine|fludarabine|mesh-list
2376480|NCT00613561|Busulfan|busulfan|mesh-list
2376481|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2376482|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376483|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2490978|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
2490979|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2490980|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2490981|NCT01167725|Leucovorin|leucovorin|mesh-list
2490982|NCT01167725|Bevacizumab|bevacizumab|mesh-list
2490983|NCT01167725|Cetuximab|cetuximab|mesh-list
2490984|NCT01167725|Fluorouracil|fluorouracil|mesh-list
2376484|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376485|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
2490985|NCT01167725|Capecitabine|capecitabine|mesh-list
2490986|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
2490987|NCT01167725|Irinotecan|irinotecan|mesh-list
2490988|NCT01167725|Mitomycins|mitomycins|mesh-list
2490989|NCT01167725|Mitomycin|mitomycin|mesh-list
2376486|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376487|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
2376488|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376489|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2376490|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2376491|NCT00613600|Cathartics|cathartics|mesh-ancestor
2376492|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2376493|NCT00613613|Fenofibrate|fenofibrate|mesh-list
2376494|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2376495|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
2376496|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376497|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2376498|NCT00613665|Vaccines|vaccines|mesh-list
2376499|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
2490990|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
2490991|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2490992|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2490993|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2490994|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2490995|NCT01167725|Growth Substances|growth substances|mesh-ancestor
2490996|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2490997|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
2490998|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
2490999|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491000|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2491001|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2491002|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
2491003|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2491004|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2491005|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491006|NCT01167725|Antidotes|antidotes|mesh-ancestor
2491007|NCT01167725|Protective Agents|protective agents|mesh-ancestor
2491008|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
2491009|NCT01167725|Vitamins|vitamins|mesh-ancestor
2491010|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
2491011|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2491012|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
2376500|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376501|NCT00613717|Vitamin D|vitamin d|mesh-list
2376502|NCT00613717|Vitamins|vitamins|mesh-list
2376503|NCT00613717|Folic Acid|folic acid|mesh-list
2376504|NCT00613717|Vitamin A|vitamin a|mesh-list
2376505|NCT00613717|Iron|iron|mesh-list
2376506|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
2376507|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
2376508|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
2376509|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376510|NCT00613717|Trace Elements|trace elements|mesh-ancestor
2376511|NCT00613717|Hematinics|hematinics|mesh-ancestor
2376512|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
2376513|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376514|NCT00613717|Protective Agents|protective agents|mesh-ancestor
2376515|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2376516|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376517|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2376518|NCT00613743|Morphine|morphine|mesh-list
2376519|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2376520|NCT00613743|Narcotics|narcotics|mesh-ancestor
2376521|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2376522|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376523|NCT00613743|Analgesics|analgesics|mesh-ancestor
2376524|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
2376525|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376526|NCT00613769|Metronidazole|metronidazole|mesh-list
2376527|NCT00613769|Trimethoprim|trimethoprim|mesh-list
2376528|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
2376529|NCT00613769|Cefuroxime|cefuroxime|mesh-list
2376530|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
2491013|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2491014|NCT01167738|Metformin|metformin|mesh-list
2491015|NCT01167738|Gemcitabine|gemcitabine|mesh-list
2376531|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2376532|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376533|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2376534|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2376535|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2376536|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2376537|NCT00613769|Renal Agents|renal agents|mesh-ancestor
2376538|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
2376539|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2376540|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376541|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376542|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2376543|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2376544|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2376545|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
2376546|NCT00613782|Testosterone|testosterone|mesh-list
2376547|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
2376548|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
2376549|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2376550|NCT00613782|Androgens|androgens|mesh-ancestor
2376551|NCT00613782|Hormones|hormones|mesh-ancestor
2376552|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2376553|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376554|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2376555|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376556|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
2491016|NCT01167738|Capecitabine|capecitabine|mesh-list
2491017|NCT01167738|Epirubicin|epirubicin|mesh-list
2491018|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491019|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2491020|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
2491021|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491022|NCT01167738|Antiviral Agents|antiviral agents|mesh-ancestor
2491023|NCT01167738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376557|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
2376558|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2376559|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
2376560|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376561|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376562|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2376563|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
2376564|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2376565|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
2376566|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376567|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2376568|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2376569|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
2376570|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
2376571|NCT00613808|Protective Agents|protective agents|mesh-ancestor
2376572|NCT00613847|Trastuzumab|trastuzumab|mesh-list
2376573|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
2376574|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2376575|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376576|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376577|NCT00613964|Diuretics|diuretics|mesh-list
2376578|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
2376579|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
2376580|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376581|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2376582|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376583|NCT00614029|Sumatriptan|sumatriptan|mesh-list
2491024|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491025|NCT01167738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2491026|NCT01167738|Immunologic Factors|immunologic factors|mesh-ancestor
2491027|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491028|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2491029|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2491030|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2491031|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2491032|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
2491033|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2491034|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2491035|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491036|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
2491037|NCT01167764|Coagulants|coagulants|mesh-ancestor
2376584|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2376585|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2376586|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2376587|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
2376588|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2376589|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376590|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376591|NCT00614159|Ketamine|ketamine|mesh-list
2376592|NCT00614159|Propofol|propofol|mesh-list
2376593|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2376594|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2376595|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376596|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2376597|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
2376598|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
2376599|NCT00614159|Analgesics|analgesics|mesh-ancestor
2376600|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
2376601|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376602|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2491038|NCT01167803|Desflurane|desflurane|mesh-list
2491039|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2491040|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
2491041|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
2491042|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491043|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491044|NCT01167816|Azacitidine|azacitidine|mesh-list
2491045|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2491046|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
2491047|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491048|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491049|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491050|NCT01167894|Simvastatin|simvastatin|mesh-list
2491051|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2376603|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2376604|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2376605|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2376606|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376607|NCT00614328|Naltrexone|naltrexone|mesh-list
2376608|NCT00614328|Baclofen|baclofen|mesh-list
2376609|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2376610|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2376611|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376612|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
2376613|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376614|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2376615|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2376616|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2491052|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2491053|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
2491054|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491055|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2491056|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2491057|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491058|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
2491059|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
2491060|NCT01167920|Diuretics|diuretics|mesh-list
2491061|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2491062|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2491063|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491064|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
2491065|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
2491066|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491067|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491068|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2491069|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2491070|NCT01167933|Simvastatin|simvastatin|mesh-list
2491071|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2491072|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2491073|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
2491074|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491075|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2491076|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2376617|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
2376618|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
2376619|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2376620|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491077|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491078|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
2491079|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2491080|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2491081|NCT01167946|Prednisolone|prednisolone|mesh-list
2491082|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
2491083|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2491084|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
2491085|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2491086|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
2491087|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
2376621|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2376622|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
2376623|NCT00614471|Entecavir|entecavir|mesh-list
2376624|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
2376625|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376626|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
2376627|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376628|NCT00614536|Rabeprazole|rabeprazole|mesh-list
2376629|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2376630|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2376631|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2376632|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376633|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376634|NCT00614588|Anesthetics|anesthetics|mesh-list
2376635|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2376636|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376637|NCT00614601|Vaccines|vaccines|mesh-list
2376638|NCT00614601|Immunologic Factors|immunologic factors|mesh-ancestor
2376639|NCT00614601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376640|NCT00614653|Bevacizumab|bevacizumab|mesh-list
2376641|NCT00614653|Capecitabine|capecitabine|mesh-list
2376642|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2376643|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2376644|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376645|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2376646|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2376647|NCT00614653|Growth Substances|growth substances|mesh-ancestor
2376648|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376649|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
2491088|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491089|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491090|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2491091|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
2491092|NCT01167946|Hormones|hormones|mesh-ancestor
2491093|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2491094|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2491095|NCT01167946|Protective Agents|protective agents|mesh-ancestor
2491096|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2491097|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491098|NCT01168011|ON 01910|on 01910|mesh-list
2491099|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491100|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2491101|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491102|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491103|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2491104|NCT01168063|Amoxicillin|amoxicillin|mesh-list
2491105|NCT01168063|Metronidazole|metronidazole|mesh-list
2491106|NCT01168063|Clarithromycin|clarithromycin|mesh-list
2491107|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2491108|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491109|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
2491110|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2491111|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2491112|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2491113|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491114|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491115|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2668475|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
2376650|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2376651|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
2376652|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376653|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2376654|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376655|NCT00614666|Nikkomycin|nikkomycin|mesh-list
2376656|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
2376657|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376658|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376659|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376660|NCT00614679|Tigecycline|tigecycline|mesh-list
2376661|NCT00614679|Heparin|heparin|mesh-list
2376662|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
2376663|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2376664|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2376665|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376666|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2376667|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376668|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2376669|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376670|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
2376671|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2376672|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
2491116|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2491117|NCT01168310|Fluticasone|fluticasone|mesh-list
2491118|NCT01168310|Xhance|xhance|mesh-list
2491119|NCT01168310|Formoterol Fumarate|formoterol fumarate|mesh-list
2491120|NCT01168310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2491121|NCT01168310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2491122|NCT01168310|Autonomic Agents|autonomic agents|mesh-ancestor
2491123|NCT01168310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491124|NCT01168310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491125|NCT01168310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2491126|NCT01168310|Respiratory System Agents|respiratory system agents|mesh-ancestor
2491127|NCT01168310|Dermatologic Agents|dermatologic agents|mesh-ancestor
2491128|NCT01168310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2491129|NCT01168310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2491130|NCT01168310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2491131|NCT01168310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2491132|NCT01168310|Adrenergic Agents|adrenergic agents|mesh-ancestor
2491133|NCT01168310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491134|NCT01168310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491135|NCT01168336|Betahistine|betahistine|mesh-list
2491136|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
2491137|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
2376673|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376674|NCT00614757|Expectorants|expectorants|mesh-ancestor
2376675|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
2376676|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2376677|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
2376678|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491138|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
2491139|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491140|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491141|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491142|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2491143|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2491144|NCT01168440|Sunitinib|sunitinib|mesh-list
2491145|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491146|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2491147|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2491148|NCT01168440|Growth Substances|growth substances|mesh-ancestor
2491149|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491150|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
2491151|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2491152|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491153|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491154|NCT01168492|Ketamine|ketamine|mesh-list
2491155|NCT01168492|Analgesics|analgesics|mesh-ancestor
2491156|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
2491157|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491158|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491159|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2491160|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2491161|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
2491162|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
2376679|NCT00614757|Protective Agents|protective agents|mesh-ancestor
2376680|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491163|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491164|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2491165|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2491166|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491167|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491168|NCT01168505|Teferrol|teferrol|mesh-list
2491169|NCT01168505|Hematinics|hematinics|mesh-ancestor
2491170|NCT01168531|Dexamethasone|dexamethasone|mesh-list
2491171|NCT01168531|Pregabalin|pregabalin|mesh-list
2491172|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2491173|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
2491174|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
2491175|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491176|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491177|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2491178|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
2491179|NCT01168531|Hormones|hormones|mesh-ancestor
2491180|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2491181|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2491182|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491183|NCT01168531|Analgesics|analgesics|mesh-ancestor
2491184|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
2491185|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
2491186|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2491187|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2491188|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491189|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2491190|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2491191|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2491192|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491193|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2491194|NCT01168544|Vitamin D|vitamin d|mesh-list
2376681|NCT00614757|Antidotes|antidotes|mesh-ancestor
2376682|NCT00614809|Gefitinib|gefitinib|mesh-list
2376683|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376684|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2376685|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376686|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376687|NCT00614835|Gemcitabine|gemcitabine|mesh-list
2491195|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
2491196|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
2491197|NCT01168544|Vitamins|vitamins|mesh-list
2491198|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
2491199|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491200|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2491201|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2376688|NCT00614835|Docetaxel|docetaxel|mesh-list
2376689|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2376690|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
2376691|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376692|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376693|NCT00614835|Antiviral Agents|antiviral agents|mesh-ancestor
2376694|NCT00614835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376695|NCT00614835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376696|NCT00614835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376697|NCT00614835|Immunologic Factors|immunologic factors|mesh-ancestor
2376698|NCT00614835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376699|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
2376700|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
2376701|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
2376702|NCT00614965|Irinotecan|irinotecan|mesh-list
2376703|NCT00614965|Pemetrexed|pemetrexed|mesh-list
2376704|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376705|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2376706|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2376707|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376708|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376709|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2376710|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2376711|NCT00614978|Temozolomide|temozolomide|mesh-list
2376712|NCT00614978|Lapatinib|lapatinib|mesh-list
2376713|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376714|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
2376715|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376716|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376717|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2491202|NCT01168713|Levofloxacin|levofloxacin|mesh-list
2491203|NCT01168713|Ofloxacin|ofloxacin|mesh-list
2491204|NCT01168713|Solithromycin|solithromycin|mesh-list
2491205|NCT01168713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2491206|NCT01168713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491207|NCT01168713|Renal Agents|renal agents|mesh-ancestor
2491208|NCT01168713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2491209|NCT01168713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2491210|NCT01168713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2491211|NCT01168713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376718|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376719|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
2376720|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2376721|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2376722|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376723|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2376724|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2376725|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
2376726|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376727|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
2491212|NCT01168713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491213|NCT01168713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491214|NCT01168713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2491215|NCT01168713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2491216|NCT01168739|Quercetin|quercetin|mesh-list
2491217|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
2491218|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491219|NCT01168739|Protective Agents|protective agents|mesh-ancestor
2491220|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491221|NCT01168791|Doxorubicin|doxorubicin|mesh-list
2491222|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2376728|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2376729|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2376730|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376731|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
2376732|NCT00615147|Coagulants|coagulants|mesh-ancestor
2376733|NCT00615160|Dacarbazine|dacarbazine|mesh-list
2376734|NCT00615160|Vatalanib|vatalanib|mesh-list
2491223|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
2491224|NCT01168791|Ifosfamide|ifosfamide|mesh-list
2491225|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2491226|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491227|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2491228|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2491229|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491230|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491231|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2491232|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
2491233|NCT01168804|Dexamethasone|dexamethasone|mesh-list
2376735|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376736|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
2376737|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376738|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376739|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2376740|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376741|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
2376742|NCT00615173|Azathioprine|azathioprine|mesh-list
2376743|NCT00615173|Tacrolimus|tacrolimus|mesh-list
2376744|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376745|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
2376746|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376747|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2376748|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376749|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
2376750|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376751|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376752|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2376753|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2376754|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376755|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
2376756|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2376757|NCT00615186|Temozolomide|temozolomide|mesh-list
2376758|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376759|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
2376760|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491234|NCT01168804|Bortezomib|bortezomib|mesh-list
2376761|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376762|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
2376763|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
2491235|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2491236|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2491237|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
2491238|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
2491239|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491240|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491241|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2491242|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
2491243|NCT01168804|Hormones|hormones|mesh-ancestor
2491244|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2491245|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2491246|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491247|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2491248|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
2491249|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491250|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2491251|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
2491252|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2491253|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2376764|NCT00615212|Midazolam|midazolam|mesh-list
2376765|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2376766|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2376767|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2376768|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376769|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2376770|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2376771|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2376772|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2376773|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
2376774|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
2376775|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
2376776|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
2376777|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2376778|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376779|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2376780|NCT00615212|Analgesics|analgesics|mesh-ancestor
2376781|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
2376782|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376783|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2376784|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2376785|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2376786|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2376787|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2376788|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376789|NCT00615251|Progesterone|progesterone|mesh-list
2376790|NCT00615251|Progestins|progestins|mesh-ancestor
2376791|NCT00615251|Hormones|hormones|mesh-ancestor
2376792|NCT00615251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2376793|NCT00615251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376794|NCT00615303|Simethicone|simethicone|mesh-list
2376795|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
2376796|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376797|NCT00615303|Emollients|emollients|mesh-ancestor
2376798|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
2376799|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
2376800|NCT00615368|Hematinics|hematinics|mesh-ancestor
2376801|NCT00615381|Insulin|insulin|mesh-list
2376802|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2376803|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2376804|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376805|NCT00615446|Gemcitabine|gemcitabine|mesh-list
2376806|NCT00615446|Sunitinib|sunitinib|mesh-list
2376807|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2376808|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
2376809|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376810|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376811|NCT00615446|Antiviral Agents|antiviral agents|mesh-ancestor
2376812|NCT00615446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376813|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376814|NCT00615446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376815|NCT00615446|Immunologic Factors|immunologic factors|mesh-ancestor
2376816|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376817|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2114149|NCT02597543|Regadenoson|regadenoson|mesh-list
2114150|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2114151|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2114152|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
2114153|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
2114154|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2114155|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114156|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114157|NCT02597855|Aflibercept|aflibercept|mesh-list
2114158|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2114159|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2114160|NCT02597855|Growth Substances|growth substances|mesh-ancestor
2114161|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114162|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
2491254|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491255|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491256|NCT01168817|Urological Agents|urological agents|mesh-ancestor
2491257|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
2491258|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2491259|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491260|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2491261|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2491262|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491263|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491264|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491265|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2491266|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2491267|NCT01169012|Clofarabine|clofarabine|mesh-list
2491268|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2491269|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
2491270|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491271|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491272|NCT01169025|Fentanyl|fentanyl|mesh-list
2491273|NCT01169025|Ketamine|ketamine|mesh-list
2491274|NCT01169025|Analgesics|analgesics|mesh-ancestor
2491275|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
2491276|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491277|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491278|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2491279|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2491280|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
2491281|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
2491282|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491283|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2491284|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2491285|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491286|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491287|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2491288|NCT01169025|Narcotics|narcotics|mesh-ancestor
2376818|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2376819|NCT00615446|Growth Substances|growth substances|mesh-ancestor
2376820|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
2376821|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2376822|NCT00615524|Exemestane|exemestane|mesh-list
2376823|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376824|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2376825|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2376826|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376827|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376828|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2376829|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
2491289|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2491290|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2491291|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2491292|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491293|NCT01169090|Incretins|incretins|mesh-ancestor
2491294|NCT01169090|Hormones|hormones|mesh-ancestor
2491295|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2491296|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2491297|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
2491298|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491299|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491300|NCT01169142|Vitamin D|vitamin d|mesh-list
2376830|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2376831|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376832|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
2376833|NCT00615602|Docetaxel|docetaxel|mesh-list
2376834|NCT00615602|Trastuzumab|trastuzumab|mesh-list
2376835|NCT00615602|Epirubicin|epirubicin|mesh-list
2376836|NCT00615602|Fluorouracil|fluorouracil|mesh-list
2376837|NCT00615602|Mitogens|mitogens|mesh-list
2376838|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376839|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
2376840|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376841|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2376842|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376843|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
2376844|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376845|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376846|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2376847|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
2376848|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
2376849|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
2491301|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
2491302|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
2491303|NCT01169142|Vitamins|vitamins|mesh-list
2491304|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
2491305|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491306|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2491307|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2491308|NCT01169298|Lenalidomide|lenalidomide|mesh-list
2491309|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
2491310|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491311|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2491312|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2491313|NCT01169298|Growth Substances|growth substances|mesh-ancestor
2491314|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
2491315|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491316|NCT01169389|Bupivacaine|bupivacaine|mesh-list
2491317|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
2491318|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
2491319|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491320|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491321|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
2491322|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491323|NCT01169402|Fluconazole|fluconazole|mesh-list
2491324|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
2491325|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491326|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2491327|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2491328|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491329|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491330|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2491331|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
2376850|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2376851|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2376852|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2376853|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2376854|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376855|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
2376856|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2376857|NCT00615615|Levetiracetam|levetiracetam|mesh-list
2376858|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
2376859|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
2376860|NCT00615667|Tacrolimus|tacrolimus|mesh-list
2376861|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2376862|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
2491332|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2491333|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491334|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2491335|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2491336|NCT01169415|Dexamethasone|dexamethasone|mesh-list
2491337|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
2491338|NCT01169415|BB 1101|bb 1101|mesh-list
2491339|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2491340|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
2491341|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
2668476|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376863|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376864|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2376865|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376866|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376867|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2376868|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2376869|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2376870|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376871|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376872|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
2376873|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376874|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2376875|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2376876|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2376877|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376878|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2376879|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376880|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376881|NCT00615797|Penicillins|penicillins|mesh-list
2376882|NCT00615797|Penicillin V|penicillin v|mesh-list
2376883|NCT00615797|Haloperidol|haloperidol|mesh-list
2376884|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
2376885|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
2376886|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2376887|NCT00615797|Antibodies|antibodies|mesh-list
2376888|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
2376889|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2376890|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
2376891|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376892|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
2376893|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
2376894|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376895|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2376896|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2376897|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2376898|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2376899|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2376900|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2376901|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
2376902|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2376903|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376904|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2376905|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2376906|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376907|NCT00615810|Efavirenz|efavirenz|mesh-list
2376908|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2376909|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2376910|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2376911|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376912|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376913|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
2376914|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376915|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2376916|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2376917|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2376918|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2376919|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2376920|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2376921|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2491342|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491343|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491344|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2491345|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
2376922|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2376923|NCT00615823|Atorvastatin|atorvastatin|mesh-list
2376924|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2376925|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2376926|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
2376927|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376928|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2376929|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2376930|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376931|NCT00615875|Naproxen|naproxen|mesh-list
2491346|NCT01169415|Hormones|hormones|mesh-ancestor
2491347|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2491348|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2491349|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491350|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
2491351|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491352|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491353|NCT01169506|Silicon|silicon|mesh-list
2491354|NCT01169506|Trace Elements|trace elements|mesh-ancestor
2491355|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
2491356|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491357|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
2491358|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2491359|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491360|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491361|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2491362|NCT01169571|Analgesics|analgesics|mesh-ancestor
2491363|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
2376932|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2376933|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2376934|NCT00615875|Analgesics|analgesics|mesh-ancestor
2376935|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
2376936|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376937|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376938|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2376939|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2376940|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
2376941|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2376942|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376943|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376944|NCT00616005|Irinotecan|irinotecan|mesh-list
2376945|NCT00616005|Temozolomide|temozolomide|mesh-list
2376946|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2376947|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2376948|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376949|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491364|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491365|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2491366|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2491367|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2491368|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
2491369|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491370|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491371|NCT01169584|Molgramostim|molgramostim|mesh-list
2491372|NCT01169584|Sargramostim|sargramostim|mesh-list
2491373|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
2491374|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491375|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491376|NCT01169597|Prednisone|prednisone|mesh-list
2491377|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2491378|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
2491379|NCT01169597|Hormones|hormones|mesh-ancestor
2491380|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2491381|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114163|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114164|NCT02597907|Aprepitant|aprepitant|mesh-list
2114165|NCT02597907|Palonosetron|palonosetron|mesh-list
2114166|NCT02597907|Ramosetron|ramosetron|mesh-list
2114167|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
2114168|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
2114169|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2376950|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376951|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2376952|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
2376953|NCT00616031|Paclitaxel|paclitaxel|mesh-list
2376954|NCT00616031|Carboplatin|carboplatin|mesh-list
2376955|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
2376956|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2376957|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376958|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
2376959|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
2376960|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
2114170|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114171|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2114172|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2491382|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2491383|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491384|NCT01169688|Phenylephrine|phenylephrine|mesh-list
2491385|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
2491386|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
2491387|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2491388|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
2491389|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
2491390|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491391|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491392|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
2491393|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2491394|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
2491395|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
2491396|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2491397|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2491398|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2491399|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
2491400|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491401|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491402|NCT01169688|Protective Agents|protective agents|mesh-ancestor
2491403|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
2491404|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2491405|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2491406|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
2491407|NCT01169740|Bilirubin|bilirubin|mesh-list
2491408|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
2491409|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491410|NCT01169740|Protective Agents|protective agents|mesh-ancestor
2491411|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491412|NCT01169792|Tamoxifen|tamoxifen|mesh-list
2491413|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2491414|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
2491415|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2491416|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491417|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2491418|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491419|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2491420|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2491421|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2491422|NCT01169805|Ondansetron|ondansetron|mesh-list
2491423|NCT01169805|Palonosetron|palonosetron|mesh-list
2491424|NCT01169805|Ramosetron|ramosetron|mesh-list
2491425|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
2491426|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
2491427|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491428|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491429|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2491430|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
2491431|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
2491432|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2491433|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
2491434|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491435|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491436|NCT01169805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2491437|NCT01169805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2491438|NCT01169805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491439|NCT01169805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2491440|NCT01169805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2491441|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2491442|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
2491443|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2491444|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491445|NCT01169857|Bortezomib|bortezomib|mesh-list
2491446|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
2491447|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491448|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
2491449|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491450|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491451|NCT01169870|Paclitaxel|paclitaxel|mesh-list
2491452|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2376961|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376962|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
2376963|NCT00616044|Anesthetics|anesthetics|mesh-list
2422907|NCT00819468|Protective Agents|protective agents|mesh-ancestor
2376964|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2376965|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376966|NCT00616070|Difluprednate|difluprednate|mesh-list
2376967|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
2376968|NCT00616070|Hormones|hormones|mesh-ancestor
2376969|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2376970|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376971|NCT00616148|Cenobamate|cenobamate|mesh-list
2376972|NCT00616148|Anticonvulsants|anticonvulsants|mesh-ancestor
2376973|NCT00616187|Interferons|interferons|mesh-list
2376974|NCT00616187|Interferon-beta|interferon-beta|mesh-list
2376975|NCT00616187|Atorvastatin|atorvastatin|mesh-list
2376976|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2376977|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
2376978|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376979|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2376980|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2376981|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
2376982|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2376983|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2376984|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2376985|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2376986|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
2376987|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376988|NCT00616213|Lenograstim|lenograstim|mesh-list
2376989|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2376990|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
2376991|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2376992|NCT00616330|Clindamycin|clindamycin|mesh-list
2376993|NCT00616330|Clindamycin palmitate|clindamycin palmitate|mesh-list
2376994|NCT00616330|Clindamycin phosphate|clindamycin phosphate|mesh-list
2376995|NCT00616330|Butoconazole|butoconazole|mesh-list
2376996|NCT00616330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2376997|NCT00616330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2376998|NCT00616330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2376999|NCT00616330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377000|NCT00616330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377001|NCT00616330|Antifungal Agents|antifungal agents|mesh-ancestor
2377002|NCT00616382|Indomethacin|indomethacin|mesh-list
2377003|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
2377004|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2377005|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2377006|NCT00616382|Analgesics|analgesics|mesh-ancestor
2377007|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
2377008|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377009|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377010|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2377011|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2491453|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491454|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
2491455|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
2491456|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
2491457|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491458|NCT01169909|Ranibizumab|ranibizumab|mesh-list
2491459|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2491460|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2491461|NCT01169909|Growth Substances|growth substances|mesh-ancestor
2377012|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
2377013|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
2377014|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2491462|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491463|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
2491464|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491465|NCT01169922|Ethanol|ethanol|mesh-list
2491466|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2491467|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491468|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491469|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491470|NCT01169935|Dextrans|dextrans|mesh-list
2491471|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
2491472|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
2491473|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
2491474|NCT01170052|Sirolimus|sirolimus|mesh-list
2491475|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2491476|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2491477|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
2491478|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491479|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491480|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2491481|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491482|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2491483|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
2491484|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2377015|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2377016|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377017|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377018|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2377019|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2377020|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2377021|NCT00616382|Protective Agents|protective agents|mesh-ancestor
2377022|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
2377023|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2377024|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
2377025|NCT00616408|Octreotide|octreotide|mesh-list
2491485|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
2491486|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491487|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
2377026|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2377027|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2377028|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377029|NCT00616460|Bivalirudin|bivalirudin|mesh-list
2377030|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
2491488|NCT01170078|Hematinics|hematinics|mesh-ancestor
2491489|NCT01170104|Sorafenib|sorafenib|mesh-list
2491490|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491491|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2491492|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491493|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491494|NCT01170130|Lidocaine|lidocaine|mesh-list
2491495|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
2491496|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
2491497|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491498|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491499|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
2491500|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491501|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2491502|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2491503|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2377031|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2377032|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
2377033|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377034|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377035|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
2377036|NCT00616499|Gefitinib|gefitinib|mesh-list
2377037|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377038|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2377039|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377040|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491504|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2491505|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491506|NCT01170143|Trastuzumab|trastuzumab|mesh-list
2491507|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2491508|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491509|NCT01170169|Omeprazole|omeprazole|mesh-list
2491510|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2491511|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2491512|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2491513|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491514|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491515|NCT01170182|Omeprazole|omeprazole|mesh-list
2491516|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2491517|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2491518|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2491519|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491520|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491521|NCT01170260|Ethanol|ethanol|mesh-list
2491522|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2491523|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491524|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2377041|NCT00616538|Fluticasone|fluticasone|mesh-list
2491525|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491526|NCT01170325|Valproic Acid|valproic acid|mesh-list
2491527|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
2377042|NCT00616538|Xhance|xhance|mesh-list
2377043|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2377044|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2491528|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491529|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491530|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
2491531|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491532|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377045|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
2377046|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377047|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377048|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2377049|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
2377050|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
2377051|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2377052|NCT00616551|Octreotide|octreotide|mesh-list
2377053|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2377054|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2377055|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377056|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
2377057|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
2377058|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2377059|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2377060|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377061|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377062|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2377063|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2491533|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
2491534|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2491535|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491536|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2491537|NCT01170338|Varenicline|varenicline|mesh-list
2491538|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2491539|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2491540|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
2491541|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491542|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491543|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491544|NCT01170351|Cyclosporine|cyclosporine|mesh-list
2491545|NCT01170351|Cyclosporins|cyclosporins|mesh-list
2491546|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491547|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491548|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2491549|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
2491550|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491551|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
2491552|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491553|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
2491554|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2491555|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2491556|NCT01170429|Procaterol|procaterol|mesh-list
2491557|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2491558|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
2491559|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491560|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377064|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
2377065|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2377066|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377067|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377068|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2377069|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377070|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2377071|NCT00616720|Interferons|interferons|mesh-list
2377072|NCT00616720|Aldesleukin|aldesleukin|mesh-list
2377073|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
2377074|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377075|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
2377076|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377077|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2377078|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2377079|NCT00616746|Ethanol|ethanol|mesh-list
2377080|NCT00616746|Nicotine|nicotine|mesh-list
2491561|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2491562|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
2491563|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
2491564|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2491565|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2491566|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2491567|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
2491568|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491569|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491570|NCT01170442|Vitamin D|vitamin d|mesh-list
2491571|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
2491572|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
2491573|NCT01170442|Vitamins|vitamins|mesh-list
2491574|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
2491575|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491576|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2491577|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2491578|NCT01170468|Vitamin D|vitamin d|mesh-list
2491579|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
2491580|NCT01170468|Vitamins|vitamins|mesh-ancestor
2491581|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
2491582|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491583|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2491584|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2491585|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
2491586|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
2491587|NCT01170494|Vitamin D|vitamin d|mesh-list
2491588|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2491589|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491590|NCT01170494|Vitamins|vitamins|mesh-ancestor
2491591|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
2491592|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2491593|NCT01170507|Vitamin D|vitamin d|mesh-list
2491594|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
2491595|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
2491596|NCT01170507|Vitamins|vitamins|mesh-list
2491597|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
2491598|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491599|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2491600|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2491601|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2491602|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2491603|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2491604|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
2491605|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491606|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2491607|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2491608|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491609|NCT01170637|Ibuprofen|ibuprofen|mesh-list
2491610|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
2491611|NCT01170637|Ephedrine|ephedrine|mesh-list
2491612|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2491613|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2491614|NCT01170637|Analgesics|analgesics|mesh-ancestor
2491615|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
2491616|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377081|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2377082|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
2377083|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377084|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377085|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2377086|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2377087|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
2377088|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377089|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377090|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2377091|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491617|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491618|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2491619|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2491620|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2491621|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491622|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491623|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2491624|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
2377092|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2377093|NCT00616785|Etoposide|etoposide|mesh-list
2377094|NCT00616785|Irinotecan|irinotecan|mesh-list
2491625|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2491626|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
2491627|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
2491628|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2491629|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2491630|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
2491631|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
2491632|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491633|NCT01170650|Doxorubicin|doxorubicin|mesh-list
2491634|NCT01170650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2491635|NCT01170650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2491636|NCT01170650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491637|NCT01170650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2491638|NCT01170650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2491639|NCT01170650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491640|NCT01170650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491648|NCT01170767|Bevacizumab|bevacizumab|mesh-list
2377095|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377096|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2377097|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2377098|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2377099|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377100|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377101|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2377102|NCT00616798|Antipsychotic Agents|antipsychotic agents|mesh-list
2377103|NCT00616798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2377104|NCT00616798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2377105|NCT00616798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377106|NCT00616798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2377107|NCT00616811|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2377108|NCT00616811|Vildagliptin|vildagliptin|mesh-list
2377109|NCT00616811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2377110|NCT00616811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377111|NCT00616811|Incretins|incretins|mesh-ancestor
2377112|NCT00616811|Hormones|hormones|mesh-ancestor
2377113|NCT00616811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2377114|NCT00616811|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2377115|NCT00616811|Protease Inhibitors|protease inhibitors|mesh-ancestor
2377116|NCT00616811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377117|NCT00616811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377118|NCT00616850|Lidocaine|lidocaine|mesh-list
2377119|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
2377120|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
2377121|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491649|NCT01170767|Ranibizumab|ranibizumab|mesh-list
2491650|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2491651|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491652|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2491653|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2491654|NCT01170767|Growth Substances|growth substances|mesh-ancestor
2491655|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491656|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
2377122|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377123|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
2377124|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377125|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2377126|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2377127|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2377128|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377129|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377130|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
2377131|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
2377132|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2377133|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2377134|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377135|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377136|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2377137|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2377138|NCT00616876|Lactulose|lactulose|mesh-list
2377139|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2377140|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2377141|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
2377142|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2377143|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2377144|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2377145|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2377146|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377147|NCT00616915|Bupropion|bupropion|mesh-list
2377148|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2377149|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
2377150|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2377151|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2491657|NCT01170780|Dexamethasone|dexamethasone|mesh-list
2491658|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2491659|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
2491660|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
2491661|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491662|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491663|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2491664|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
2491665|NCT01170780|Hormones|hormones|mesh-ancestor
2491666|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2491667|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2491668|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491669|NCT01170806|Orlistat|orlistat|mesh-list
2491670|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491671|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491672|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2491673|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2491674|NCT01170819|Dinoprostone|dinoprostone|mesh-list
2491675|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
2491676|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2491677|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491678|NCT01170845|Sivelestat|sivelestat|mesh-list
2491679|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2491680|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
2491681|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491682|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491683|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2491684|NCT01170858|Icodextrin|icodextrin|mesh-list
2491685|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
2491686|NCT01170871|Pemetrexed|pemetrexed|mesh-list
2377152|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2377153|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377154|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491687|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491688|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491689|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491690|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2491691|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2491692|NCT01171092|Bortezomib|bortezomib|mesh-list
2491693|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491694|NCT01171170|Paclitaxel|paclitaxel|mesh-list
2491695|NCT01171170|Bevacizumab|bevacizumab|mesh-list
2491696|NCT01171170|Carboplatin|carboplatin|mesh-list
2491697|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2491698|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
2491699|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2491700|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491701|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
2491702|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
2377155|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
2377156|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377157|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377158|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2377159|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2377160|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491703|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
2491704|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491705|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2491706|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2491707|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2491708|NCT01171170|Growth Substances|growth substances|mesh-ancestor
2491709|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491710|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
2491711|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
2377161|NCT00616993|Difluprednate|difluprednate|mesh-list
2377162|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
2377163|NCT00616993|Hormones|hormones|mesh-ancestor
2377164|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2377165|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377166|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2377167|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2377168|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2377169|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377170|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491712|NCT01171209|Interferons|interferons|mesh-list
2491713|NCT01171209|Interferon-beta|interferon-beta|mesh-list
2491714|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
2491715|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
2491716|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491717|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
2491718|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491719|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
2491720|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491721|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2491722|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2491723|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2491724|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491725|NCT01171313|Carbidopa|carbidopa|mesh-list
2491726|NCT01171313|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2491727|NCT01171313|Levodopa|levodopa|mesh-list
2491728|NCT01171313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2491729|NCT01171313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2491730|NCT01171313|Dopamine Agents|dopamine agents|mesh-ancestor
2491731|NCT01171313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491732|NCT01171313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491733|NCT01171313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491734|NCT01171313|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2491735|NCT01171313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491736|NCT01171313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2491737|NCT01171313|Immunologic Factors|immunologic factors|mesh-ancestor
2491738|NCT01171313|Dopamine Agonists|dopamine agonists|mesh-ancestor
2491739|NCT01171326|Minocycline|minocycline|mesh-list
2491740|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2491741|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491742|NCT01171365|Ciclesonide|ciclesonide|mesh-list
2491743|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
2491744|NCT01171365|Hormones|hormones|mesh-ancestor
2491745|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2491746|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491747|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2491748|NCT01171378|Ofatumumab|ofatumumab|mesh-list
2491749|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491750|NCT01171456|Metformin|metformin|mesh-list
2377171|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377172|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377173|NCT00617045|Analgesics|analgesics|mesh-ancestor
2377174|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
2377175|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377176|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
2377177|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2377178|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
2377179|NCT00617253|Sunitinib|sunitinib|mesh-list
2377180|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377181|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2377182|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2377183|NCT00617253|Growth Substances|growth substances|mesh-ancestor
2377184|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377185|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
2377186|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2491751|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2377187|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491752|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491753|NCT01171469|Imiquimod|imiquimod|mesh-list
2491754|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2491755|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
2491756|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491757|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491758|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
2491759|NCT01171482|Fluorouracil|fluorouracil|mesh-list
2491760|NCT01171482|Sorafenib|sorafenib|mesh-list
2491761|NCT01171482|Mitomycins|mitomycins|mesh-list
2491762|NCT01171482|Mitomycin|mitomycin|mesh-list
2491763|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
2491764|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491765|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2491766|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491767|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2491768|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
2491769|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491770|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2491771|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491772|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2491773|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
2491774|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2491775|NCT01171547|Daptomycin|daptomycin|mesh-list
2491776|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2491777|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491778|NCT01171651|Sorafenib|sorafenib|mesh-list
2491779|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491780|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2491781|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491782|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491783|NCT01171755|Gemcitabine|gemcitabine|mesh-list
2491784|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2491785|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
2491786|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377188|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377189|NCT00617370|Paclitaxel|paclitaxel|mesh-list
2377190|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
2377191|NCT00617370|Epirubicin|epirubicin|mesh-list
2377192|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2491787|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491788|NCT01171755|Antiviral Agents|antiviral agents|mesh-ancestor
2491789|NCT01171755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491790|NCT01171755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491791|NCT01171755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2491792|NCT01171755|Immunologic Factors|immunologic factors|mesh-ancestor
2491793|NCT01171755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491794|NCT01171781|Cisplatin|cisplatin|mesh-list
2491795|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491796|NCT01171807|Dexamethasone|dexamethasone|mesh-list
2491797|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2491798|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2491799|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
2491800|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
2491801|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491802|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491803|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2491804|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
2491805|NCT01171807|Hormones|hormones|mesh-ancestor
2491806|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2491807|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2491808|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491809|NCT01171833|Sevoflurane|sevoflurane|mesh-list
2491810|NCT01171833|Desflurane|desflurane|mesh-list
2491811|NCT01171833|Isoflurane|isoflurane|mesh-list
2377193|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377194|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
2377195|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
2377196|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
2377197|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377198|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2377199|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
2377200|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491812|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2491813|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2491814|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
2377201|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2377202|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2377203|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
2377204|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2377205|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2377206|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2377207|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2491815|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
2491816|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491817|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491818|NCT01171859|Doxycycline|doxycycline|mesh-list
2491819|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
2491820|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2491821|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491822|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
2377208|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377209|NCT00617448|Anesthetics|anesthetics|mesh-list
2377210|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2377211|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377212|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
2377213|NCT00617474|Hematinics|hematinics|mesh-ancestor
2377214|NCT00617500|Hormones|hormones|mesh-list
2377215|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2377216|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377217|NCT00617513|Prucalopride|prucalopride|mesh-list
2377218|NCT00617513|Laxatives|laxatives|mesh-ancestor
2377219|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2377220|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2377221|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2377222|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
2377223|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377224|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377225|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377226|NCT00617565|Insulin|insulin|mesh-list
2377227|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2377228|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
2377229|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
2377230|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2377231|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377232|NCT00617643|Nevirapine|nevirapine|mesh-list
2491823|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2491824|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2491825|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
2491826|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2491827|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2491828|NCT01171885|Ropivacaine|ropivacaine|mesh-list
2491829|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
2491830|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
2377233|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2377234|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2377235|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377236|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377237|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
2377238|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377239|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2377240|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2377241|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2377242|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2377243|NCT00617656|Gemcitabine|gemcitabine|mesh-list
2377244|NCT00617656|Cisplatin|cisplatin|mesh-list
2377245|NCT00617656|Docetaxel|docetaxel|mesh-list
2377246|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377247|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2377248|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
2377249|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377250|NCT00617656|Antiviral Agents|antiviral agents|mesh-ancestor
2377251|NCT00617656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377252|NCT00617656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377253|NCT00617656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2377254|NCT00617656|Immunologic Factors|immunologic factors|mesh-ancestor
2377255|NCT00617656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377256|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
2491831|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491832|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491833|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
2491834|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377257|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
2377258|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
2377259|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
2377260|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2491835|NCT01171911|Nicardipine|nicardipine|mesh-list
2491836|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
2491837|NCT01171911|Esmolol|esmolol|mesh-list
2491838|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2491839|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491840|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2491841|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2491842|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2491843|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
2491844|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491845|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491846|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2491847|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2491848|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
2491849|NCT01171937|Risperidone|risperidone|mesh-list
2491850|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2491851|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
2491852|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491853|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491854|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491855|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2491856|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2491857|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491858|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2491859|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2491860|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
2491861|NCT01172002|Azathioprine|azathioprine|mesh-list
2491862|NCT01172002|Leflunomide|leflunomide|mesh-list
2377261|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2377262|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
2377263|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377264|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377265|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377266|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
2377267|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2377268|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2377269|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
2377270|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377271|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377272|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377273|NCT00617760|Vaccines|vaccines|mesh-list
2377274|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2377275|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
2377276|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377277|NCT00617799|Aldesleukin|aldesleukin|mesh-list
2377278|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377279|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2377280|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2377281|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
2377282|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377283|NCT00617877|Losartan|losartan|mesh-list
2377284|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2377285|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2377286|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2377287|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2377288|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2377289|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377290|NCT00617877|Diuretics|diuretics|mesh-ancestor
2377291|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
2377292|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377293|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2377294|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377295|NCT00617955|Aprotinin|aprotinin|mesh-list
2377296|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377297|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
2377298|NCT00617955|Coagulants|coagulants|mesh-ancestor
2377299|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2377300|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2377301|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
2377302|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377303|NCT00617968|Docetaxel|docetaxel|mesh-list
2377304|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377305|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
2377306|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
2377307|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
2377308|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377309|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
2491863|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
2491864|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491865|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2491866|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491867|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2491868|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
2491869|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491870|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2491871|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491872|NCT01172028|Docetaxel|docetaxel|mesh-list
2491873|NCT01172028|Pemetrexed|pemetrexed|mesh-list
2491874|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491875|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
2491876|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
2491877|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
2491878|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491879|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491880|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2491881|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2491882|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2491883|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2491884|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491885|NCT01172171|Melatonin|melatonin|mesh-list
2491886|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
2491887|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491888|NCT01172171|Protective Agents|protective agents|mesh-ancestor
2491889|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491890|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491891|NCT01172223|Paclitaxel|paclitaxel|mesh-list
2491892|NCT01172223|Doxorubicin|doxorubicin|mesh-list
2491893|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2491894|NCT01172223|Lapatinib|lapatinib|mesh-list
2491895|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2491896|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491897|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
2491898|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
2491899|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
2491900|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491901|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2491902|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2491903|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2491904|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491905|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2491906|NCT01172236|Lactoferrin|lactoferrin|mesh-list
2491907|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491908|NCT01172392|Interferons|interferons|mesh-list
2491909|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
2491910|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
2491911|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2491912|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491913|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
2491914|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491915|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
2491916|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491917|NCT01172405|Ibuprofen|ibuprofen|mesh-list
2491918|NCT01172405|Caffeine|caffeine|mesh-list
2491919|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2491920|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2491921|NCT01172405|Analgesics|analgesics|mesh-ancestor
2491922|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
2491923|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491924|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491925|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2491926|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2491927|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2491928|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491929|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491930|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2377310|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
2491931|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2491932|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2491933|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2377311|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2377312|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2377313|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377314|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377315|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2377316|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2377317|NCT00618059|Pilocarpine|pilocarpine|mesh-list
2377318|NCT00618059|Miotics|miotics|mesh-ancestor
2377319|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
2377320|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377321|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377322|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2377323|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2377324|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
2377325|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377326|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377327|NCT00618098|Thrombin|thrombin|mesh-list
2377328|NCT00618098|Hemostatics|hemostatics|mesh-ancestor
2377329|NCT00618098|Coagulants|coagulants|mesh-ancestor
2377330|NCT00618111|Granisetron|granisetron|mesh-list
2377331|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
2377332|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
2377333|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377334|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377335|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2377336|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2377337|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
2377338|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377339|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377340|NCT00618124|Capecitabine|capecitabine|mesh-list
2377341|NCT00618124|Sunitinib|sunitinib|mesh-list
2377342|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2377343|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
2377344|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377345|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377346|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2377347|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2377348|NCT00618124|Growth Substances|growth substances|mesh-ancestor
2377349|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377350|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
2377351|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2377352|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377353|NCT00618163|Meloxicam|meloxicam|mesh-list
2377354|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2377355|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2377356|NCT00618163|Analgesics|analgesics|mesh-ancestor
2377357|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
2377358|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377359|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377360|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2377361|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2377362|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2377363|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2377364|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377365|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377366|NCT00618176|Lamivudine|lamivudine|mesh-list
2377367|NCT00618176|Zidovudine|zidovudine|mesh-list
2377368|NCT00618176|Nevirapine|nevirapine|mesh-list
2377369|NCT00618176|Stavudine|stavudine|mesh-list
2377370|NCT00618176|Didanosine|didanosine|mesh-list
2377371|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2377372|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2377373|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377374|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377375|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
2377376|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377377|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2377378|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2377379|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
2377380|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2377381|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2377382|NCT00618202|Balsalazide|balsalazide|mesh-list
2491934|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
2491935|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491936|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2491937|NCT01172431|Indapamide|indapamide|mesh-list
2491938|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2491939|NCT01172431|Diuretics|diuretics|mesh-ancestor
2491940|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
2491941|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491942|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2491943|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2491944|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491945|NCT01172444|Mesalamine|mesalamine|mesh-list
2491946|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2377383|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2377384|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2377385|NCT00618202|Analgesics|analgesics|mesh-ancestor
2377386|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
2377387|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377388|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377389|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2377390|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2377391|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2377392|NCT00618228|Balsalazide|balsalazide|mesh-list
2377393|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2377394|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2377395|NCT00618228|Analgesics|analgesics|mesh-ancestor
2377396|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
2377397|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377398|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377399|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2377400|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2377401|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2377402|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
2377403|NCT00618241|Lamotrigine|lamotrigine|mesh-list
2377404|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2377405|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2377406|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
2377407|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377408|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2377409|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2377410|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491947|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2491948|NCT01172444|Analgesics|analgesics|mesh-ancestor
2491949|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
2491950|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491951|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491952|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2491953|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2491954|NCT01172470|Gemcitabine|gemcitabine|mesh-list
2491955|NCT01172470|Carboplatin|carboplatin|mesh-list
2491956|NCT01172470|Pemetrexed|pemetrexed|mesh-list
2491957|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491958|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2491959|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
2491960|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491961|NCT01172470|Antiviral Agents|antiviral agents|mesh-ancestor
2491962|NCT01172470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2491963|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491964|NCT01172470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2491965|NCT01172470|Immunologic Factors|immunologic factors|mesh-ancestor
2377411|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377412|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
2377413|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2377414|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377415|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2377416|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377417|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2491966|NCT01172470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491967|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2491968|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2491969|NCT01172496|Treprostinil|treprostinil|mesh-list
2491970|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2491971|NCT01172509|Baclofen|baclofen|mesh-list
2491972|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2491973|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377418|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2377419|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2377420|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2377421|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2377422|NCT00618254|Granisetron|granisetron|mesh-list
2377423|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
2377424|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
2377425|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491974|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2491975|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2491976|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2377426|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377427|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2377428|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2377429|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
2377430|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377431|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491977|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
2491978|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
2491979|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491980|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491981|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
2491982|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2491983|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2491984|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491985|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491986|NCT01172626|Valproic Acid|valproic acid|mesh-list
2491987|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
2491988|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2491989|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2491990|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
2491991|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2491992|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2491993|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
2491994|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2491995|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2491996|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2377432|NCT00618280|Nicotine|nicotine|mesh-list
2377433|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2377434|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
2377435|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377436|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377437|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2377438|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2377439|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
2377440|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377441|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377442|NCT00618345|Everolimus|everolimus|mesh-list
2377443|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377444|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2377445|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
2377446|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377447|NCT00618358|Thrombin|thrombin|mesh-list
2377448|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
2377449|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
2377450|NCT00618358|Coagulants|coagulants|mesh-ancestor
2377451|NCT00618384|Sorafenib|sorafenib|mesh-list
2377452|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377453|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2377454|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114173|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2114174|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114175|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2114176|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2114177|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
2114178|NCT02597933|Nintedanib|nintedanib|mesh-list
2114179|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114180|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2114181|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114182|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114183|NCT02597946|Paclitaxel|paclitaxel|mesh-list
2114184|NCT02597946|Afatinib|afatinib|mesh-list
2114185|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2377455|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377456|NCT00618397|Ketamine|ketamine|mesh-list
2377457|NCT00618397|Analgesics|analgesics|mesh-ancestor
2377458|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
2377459|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377460|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377461|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2377462|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2377463|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
2377464|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
2377465|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2377466|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2377467|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2377468|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377469|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377470|NCT00618423|Ketamine|ketamine|mesh-list
2377471|NCT00618423|Analgesics|analgesics|mesh-ancestor
2491997|NCT01172652|Ziprasidone|ziprasidone|mesh-list
2491998|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2491999|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
2492000|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492001|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492002|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492003|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2492004|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2492005|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2492006|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2492007|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2492008|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
2492009|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
2492010|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2492011|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
2492012|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492013|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492014|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2492015|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
2492016|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2492017|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
2492018|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492019|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492020|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2492021|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
2377472|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
2377473|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377474|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377475|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2377476|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2377477|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
2377478|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
2377479|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2377480|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2492022|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
2492023|NCT01172691|Protective Agents|protective agents|mesh-ancestor
2492024|NCT01172717|Panitumumab|panitumumab|mesh-list
2492025|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2492026|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492027|NCT01172756|Riociguat|riociguat|mesh-list
2492028|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
2492029|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492030|NCT01172769|Sirolimus|sirolimus|mesh-list
2492031|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
2492032|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2492033|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492034|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2492035|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492036|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
2492037|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2492038|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
2492039|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492040|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492041|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492042|NCT01172782|Hydromorphone|hydromorphone|mesh-list
2492043|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2492044|NCT01172782|Narcotics|narcotics|mesh-ancestor
2492045|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2492046|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492047|NCT01172782|Analgesics|analgesics|mesh-ancestor
2492048|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
2492049|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492050|NCT01172912|Dexamethasone|dexamethasone|mesh-list
2492051|NCT01172912|Carboplatin|carboplatin|mesh-list
2492052|NCT01172912|Etoposide|etoposide|mesh-list
2492053|NCT01172912|Ifosfamide|ifosfamide|mesh-list
2492054|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492055|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2492056|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
2492057|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
2492058|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492059|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492060|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2492061|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
2492062|NCT01172912|Hormones|hormones|mesh-ancestor
2492063|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2492064|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2492065|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2492066|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2492067|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2492068|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492069|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492070|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2492071|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
2492072|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
2492073|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2492074|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
2492075|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377481|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2377482|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377483|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377484|NCT00618501|Leucovorin|leucovorin|mesh-list
2377485|NCT00618501|Cytarabine|cytarabine|mesh-list
2377486|NCT00618501|Prednisolone|prednisolone|mesh-list
2377487|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
2377488|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2377489|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2377490|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2377491|NCT00618501|Methotrexate|methotrexate|mesh-list
2492076|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492077|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2492078|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
2492079|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
2492080|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2492081|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
2492082|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377492|NCT00618501|Etoposide|etoposide|mesh-list
2492083|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492084|NCT01172964|Flucytosine|flucytosine|mesh-list
2492085|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
2492086|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492087|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
2492088|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492089|NCT01173003|Misoprostol|misoprostol|mesh-list
2492090|NCT01173003|Mifepristone|mifepristone|mesh-list
2492091|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2492092|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
2492093|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2492094|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492095|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2492096|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2492097|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
2492098|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2492099|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2114186|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114187|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
2114188|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
2114189|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
2114190|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114191|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2114192|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114193|NCT02598193|Pirfenidone|pirfenidone|mesh-list
2114194|NCT02598193|Nintedanib|nintedanib|mesh-list
2114195|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114196|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2492100|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2492101|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2492102|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
2492103|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2492104|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2492105|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
2492106|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2492107|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
2492108|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2492109|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2492110|NCT01173068|Ertapenem|ertapenem|mesh-list
2492111|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2492112|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492113|NCT01173081|Teriparatide|teriparatide|mesh-list
2492114|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2492115|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492116|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2492117|NCT01173107|Colchicine|colchicine|mesh-list
2492118|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
2492119|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2377493|NCT00618501|Vincristine|vincristine|mesh-list
2377494|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
2377495|NCT00618501|Daunorubicin|daunorubicin|mesh-list
2377496|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
2377497|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377498|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2377499|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
2377500|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2492120|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
2492121|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
2492122|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
2492123|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492124|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492125|NCT01173172|Boron|boron|mesh-list
2492126|NCT01173172|Trace Elements|trace elements|mesh-ancestor
2377501|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2377502|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
2377503|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377504|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377505|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
2377506|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377507|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2377508|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2377509|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
2377510|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2377511|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2377512|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2377513|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2377514|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2377515|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
2377516|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377517|NCT00618501|Antidotes|antidotes|mesh-ancestor
2377518|NCT00618501|Protective Agents|protective agents|mesh-ancestor
2377519|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
2377520|NCT00618501|Vitamins|vitamins|mesh-ancestor
2377521|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
2377522|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
2377523|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
2377524|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
2377525|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2377526|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
2377527|NCT00618501|Hormones|hormones|mesh-ancestor
2492127|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
2492128|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492129|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2492130|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
2492131|NCT01173263|Propofol|propofol|mesh-list
2492132|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2492133|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2492134|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492135|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2492136|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
2492137|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
2492138|NCT01173315|Vitamins|vitamins|mesh-list
2377528|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2377529|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2377530|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2377531|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2377532|NCT00618527|Interferons|interferons|mesh-list
2377533|NCT00618527|Interferon-beta|interferon-beta|mesh-list
2377534|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
2377535|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
2377536|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377537|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
2377538|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377539|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2377540|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2377541|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
2377542|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2377543|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492139|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
2492140|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492141|NCT01173497|Irinotecan|irinotecan|mesh-list
2377544|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377545|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
2377546|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377547|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2377548|NCT00618579|Warfarin|warfarin|mesh-list
2377549|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
2377550|NCT00618631|Carfentanil|carfentanil|mesh-list
2377551|NCT00618631|Nicotine|nicotine|mesh-list
2377552|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2377553|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
2377554|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377555|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377556|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2377557|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2377558|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
2377559|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377560|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377561|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2377562|NCT00618631|Narcotics|narcotics|mesh-ancestor
2377563|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2377564|NCT00618631|Analgesics|analgesics|mesh-ancestor
2377565|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
2377566|NCT00618644|Ranibizumab|ranibizumab|mesh-list
2377567|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2377568|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2114197|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114198|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114199|NCT02598193|Analgesics|analgesics|mesh-ancestor
2114200|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
2114201|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114202|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114203|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2114204|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2114205|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2114206|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2114207|NCT02598583|Ravulizumab|ravulizumab|mesh-list
2114208|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2377569|NCT00618644|Growth Substances|growth substances|mesh-ancestor
2377570|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492142|NCT01173497|Iniparib|iniparib|mesh-list
2492143|NCT01173497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2492144|NCT01173497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2492145|NCT01173497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492146|NCT01173497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492147|NCT01173497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492148|NCT01173497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2492149|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
2492150|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2377571|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
2377572|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377573|NCT00618657|Paclitaxel|paclitaxel|mesh-list
2492151|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2492152|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2492153|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2492154|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
2377574|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2377575|NCT00618657|Bevacizumab|bevacizumab|mesh-list
2377576|NCT00618657|Carboplatin|carboplatin|mesh-list
2377577|NCT00618657|Trastuzumab|trastuzumab|mesh-list
2377578|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2377579|NCT00618657|Antibodies|antibodies|mesh-list
2377580|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
2377581|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2377582|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2377583|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377584|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
2377585|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
2377586|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
2377587|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377588|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2377589|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2377590|NCT00618657|Growth Substances|growth substances|mesh-ancestor
2492155|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492156|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2492157|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2492158|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492159|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492160|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2492161|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2492162|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
2492163|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2492164|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492165|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2492166|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2492167|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492168|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492169|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492170|NCT01173549|Canagliflozin|canagliflozin|mesh-list
2492171|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2492172|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492173|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2492174|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377591|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377592|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
2377593|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
2377594|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2377595|NCT00618696|Antibodies|antibodies|mesh-list
2377596|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
2377597|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2377598|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
2377599|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377600|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377601|NCT00618852|Furosemide|furosemide|mesh-list
2377602|NCT00618852|Diuretics|diuretics|mesh-ancestor
2377603|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
2377604|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492175|NCT01173562|Mebendazole|mebendazole|mesh-list
2492176|NCT01173562|Piperazine|piperazine|mesh-list
2492177|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
2492178|NCT01173562|DMP 777|dmp 777|mesh-list
2492179|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
2492180|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
2492181|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2492182|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492183|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
2492184|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
2492185|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
2492186|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492187|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492188|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492189|NCT01173627|Fentanyl|fentanyl|mesh-list
2492190|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2492191|NCT01173627|Narcotics|narcotics|mesh-ancestor
2492192|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2492193|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492194|NCT01173627|Analgesics|analgesics|mesh-ancestor
2492195|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
2492196|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492197|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2492198|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2492199|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
2492200|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
2492201|NCT01173640|Midazolam|midazolam|mesh-list
2492202|NCT01173640|Resveratrol|resveratrol|mesh-list
2492203|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2492204|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2492205|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2377605|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2377606|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377607|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377608|NCT00618969|Busulfan|busulfan|mesh-list
2377609|NCT00618969|Melphalan|melphalan|mesh-list
2377610|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
2377611|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377612|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2377613|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
2377614|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377615|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2377616|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377617|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2377618|NCT00619021|Gemcitabine|gemcitabine|mesh-list
2377619|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2377620|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
2377621|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377622|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492206|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492207|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2492208|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2492209|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2492210|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2492211|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
2492212|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
2492213|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
2492214|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
2492215|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492216|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492217|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
2492218|NCT01173640|Protective Agents|protective agents|mesh-ancestor
2492219|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492220|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2492221|NCT01173809|Amiodarone|amiodarone|mesh-list
2492222|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2492223|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
2492224|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2492225|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2492226|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492227|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2492228|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2492229|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2492230|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492231|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2492232|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2492233|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2492234|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
2492235|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492236|NCT01173926|Insulin|insulin|mesh-list
2492237|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2492238|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
2492239|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
2492240|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2492241|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2492242|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492243|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2492244|NCT01173939|Pravastatin|pravastatin|mesh-list
2492245|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2492246|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2492247|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
2492248|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492249|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2492250|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2377623|NCT00619021|Antiviral Agents|antiviral agents|mesh-ancestor
2377624|NCT00619021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377625|NCT00619021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377626|NCT00619021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2377627|NCT00619021|Immunologic Factors|immunologic factors|mesh-ancestor
2377628|NCT00619021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377629|NCT00619034|Diclofenac|diclofenac|mesh-list
2377630|NCT00619034|Dorzolamide|dorzolamide|mesh-list
2492251|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492252|NCT01173978|Prednisolone|prednisolone|mesh-list
2492253|NCT01173978|Hormones|hormones|mesh-list
2492254|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2492255|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492256|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2492257|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
2492258|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2492259|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377631|NCT00619034|Latanoprost|latanoprost|mesh-list
2377632|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2377633|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2377634|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2377635|NCT00619034|Analgesics|analgesics|mesh-ancestor
2377636|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
2377637|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377638|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377639|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2377640|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2377641|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2377642|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377643|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377644|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2377645|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2377646|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2377647|NCT00619203|Acetaminophen|acetaminophen|mesh-list
2377648|NCT00619203|Glycerol|glycerol|mesh-list
2377649|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2377650|NCT00619203|Analgesics|analgesics|mesh-ancestor
2377651|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
2492260|NCT01174017|Iodine|iodine|mesh-list
2492261|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
2492262|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2492263|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492264|NCT01174017|Trace Elements|trace elements|mesh-ancestor
2492265|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
2492266|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492267|NCT01174056|Pioglitazone|pioglitazone|mesh-list
2492268|NCT01174056|Zileuton|zileuton|mesh-list
2492269|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
2492270|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2492271|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492272|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2492273|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2492274|NCT01174056|Analgesics|analgesics|mesh-ancestor
2492275|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
2492276|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492277|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2492278|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2492279|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2492280|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492281|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492282|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2492283|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
2377652|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377653|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377654|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
2377655|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2377656|NCT00619203|Protective Agents|protective agents|mesh-ancestor
2377657|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
2377658|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2377659|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377660|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2377661|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
2377662|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2377663|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377664|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377665|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377666|NCT00619268|Interferons|interferons|mesh-list
2377667|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
2377668|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
2377669|NCT00619268|Sirolimus|sirolimus|mesh-list
2377670|NCT00619268|Bevacizumab|bevacizumab|mesh-list
2377671|NCT00619268|Sunitinib|sunitinib|mesh-list
2377672|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2377673|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377674|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2377675|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2377676|NCT00619268|Growth Substances|growth substances|mesh-ancestor
2377677|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377678|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
2377679|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
2377680|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377681|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
2377682|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2377683|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377684|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377685|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2377686|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2492284|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2492285|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492286|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
2492287|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2377687|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
2377688|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2377689|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2377690|NCT00619333|Hormones|hormones|mesh-ancestor
2377691|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2377692|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377693|NCT00619346|Pafuramidine|pafuramidine|mesh-list
2377694|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2377695|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2377696|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2377697|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377698|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
2377699|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
2492306|NCT01174199|Sirolimus|sirolimus|mesh-list
2377700|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377701|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2377702|NCT00619398|Tacrolimus|tacrolimus|mesh-list
2377703|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2377704|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
2377705|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377706|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2492307|NCT01174199|Vorinostat|vorinostat|mesh-list
2492308|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2492309|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492310|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2492311|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492312|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
2492313|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2492314|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
2492315|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492316|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2492317|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492318|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492319|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2492320|NCT01174212|Vancomycin|vancomycin|mesh-list
2492321|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2492322|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492323|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
2492324|NCT01174290|Haloperidol|haloperidol|mesh-list
2492325|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
2492326|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
2492327|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
2492328|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492329|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492330|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2492331|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2492332|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2492333|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2492334|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2492335|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2492336|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
2492337|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492338|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492339|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2492340|NCT01174303|Insulin|insulin|mesh-list
2492341|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2492342|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
2492343|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
2492344|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2492345|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
2492346|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2492347|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2492348|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492349|NCT01174394|Fluoxetine|fluoxetine|mesh-list
2492350|NCT01174394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2492351|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2492352|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2492353|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492354|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492355|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
2492356|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492357|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2492358|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
2377707|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377708|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377709|NCT00619424|Pemetrexed|pemetrexed|mesh-list
2492359|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2492360|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2492361|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2492362|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492363|NCT01174420|Mitomycins|mitomycins|mesh-list
2492364|NCT01174420|Mitomycin|mitomycin|mesh-list
2492365|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2492366|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492367|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
2492368|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492369|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2492370|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492371|NCT01174472|Paclitaxel|paclitaxel|mesh-list
2492372|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2492373|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492374|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
2492375|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
2492376|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
2492377|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492378|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2492379|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2492380|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2492381|NCT01174524|Gestodene|gestodene|mesh-list
2492382|NCT01174524|Femovan|femovan|mesh-list
2492383|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
2492384|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
2492385|NCT01174524|Estradiol|estradiol|mesh-list
2492386|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2492387|NCT01174524|Estrogens|estrogens|mesh-ancestor
2377710|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2377711|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377712|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377713|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377714|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2377715|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2377716|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2377717|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
2377718|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2377719|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377720|NCT00619541|Fluorouracil|fluorouracil|mesh-list
2377721|NCT00619541|Sorafenib|sorafenib|mesh-list
2377722|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
2492388|NCT01174524|Hormones|hormones|mesh-ancestor
2492389|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2492390|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492391|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2492392|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2492393|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2492394|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2492395|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2492396|NCT01174524|Progestins|progestins|mesh-ancestor
2377723|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377724|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2377725|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377726|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2377727|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
2377728|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377729|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2377730|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377731|NCT00619671|Rituximab|rituximab|mesh-list
2377732|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2377733|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377734|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
2377735|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377736|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2377737|NCT00619697|Insulin|insulin|mesh-list
2377738|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2377739|NCT00619697|Metformin|metformin|mesh-list
2377740|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
2377741|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
2492397|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2492398|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2492399|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492400|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2492401|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492402|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492403|NCT01174693|Clopidogrel|clopidogrel|mesh-list
2492404|NCT01174693|Triflusal|triflusal|mesh-list
2492405|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2492406|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2492407|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2492408|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2492409|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
2492410|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492411|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492412|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492413|NCT01174732|Albuterol|albuterol|mesh-list
2492414|NCT01174732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2492415|NCT01174732|Autonomic Agents|autonomic agents|mesh-ancestor
2492416|NCT01174732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492417|NCT01174732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377742|NCT00619697|Glimepiride|glimepiride|mesh-list
2377743|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
2377744|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2377745|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2377746|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377747|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2377748|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2377749|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
2377750|NCT00619710|Meropenem|meropenem|mesh-list
2377751|NCT00619710|Imipenem|imipenem|mesh-list
2377752|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
2377753|NCT00619710|Cilastatin|cilastatin|mesh-list
2377754|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2377755|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377756|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
2377757|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377758|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377759|NCT00619840|Methylphenidate|methylphenidate|mesh-list
2492418|NCT01174732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2492419|NCT01174732|Respiratory System Agents|respiratory system agents|mesh-ancestor
2377760|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2377761|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377762|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2377763|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2377764|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377765|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377766|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
2377767|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492420|NCT01174732|Tocolytic Agents|tocolytic agents|mesh-ancestor
2492421|NCT01174732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2492422|NCT01174732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2492423|NCT01174732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2492424|NCT01174732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2492425|NCT01174732|Adrenergic Agents|adrenergic agents|mesh-ancestor
2492426|NCT01174732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492427|NCT01174732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492428|NCT01174810|Exenatide|exenatide|mesh-list
2492429|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2492430|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492431|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2492432|NCT01174810|Incretins|incretins|mesh-ancestor
2492433|NCT01174810|Hormones|hormones|mesh-ancestor
2492434|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2492435|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2492436|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
2492437|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492438|NCT01174888|Cytarabine|cytarabine|mesh-list
2492439|NCT01174888|Etoposide|etoposide|mesh-list
2492440|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
2492441|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
2492442|NCT01174888|Bortezomib|bortezomib|mesh-list
2492443|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
2492444|NCT01174888|Midostaurin|midostaurin|mesh-list
2492445|NCT01174888|Staurosporine|staurosporine|mesh-list
2492446|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2492447|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492448|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2492449|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2492450|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492451|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492452|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2492453|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
2492454|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
2377768|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2377769|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
2377770|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377771|NCT00619931|APD791|apd791|mesh-list
2377772|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2377773|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2377774|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
2377775|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377776|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377777|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377778|NCT00619944|Ritonavir|ritonavir|mesh-list
2377779|NCT00619944|Lopinavir|lopinavir|mesh-list
2492455|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492456|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2492457|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
2492458|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492459|NCT01174888|Analgesics|analgesics|mesh-ancestor
2492460|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
2492461|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492462|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
2492463|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
2492464|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
2492465|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
2492466|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
2492467|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2492468|NCT01174914|Tenofovir|tenofovir|mesh-list
2492469|NCT01174914|Lamivudine|lamivudine|mesh-list
2492470|NCT01174914|Emtricitabine|emtricitabine|mesh-list
2492471|NCT01174914|Efavirenz|efavirenz|mesh-list
2492472|NCT01174914|Lopinavir|lopinavir|mesh-list
2492473|NCT01174914|Nevirapine|nevirapine|mesh-list
2492474|NCT01174914|Stavudine|stavudine|mesh-list
2492475|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
2492476|NCT01174914|Naltrexone|naltrexone|mesh-list
2377780|NCT00619944|Lumefantrine|lumefantrine|mesh-list
2492477|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
2492478|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377781|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2377782|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2377783|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2377784|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
2377785|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377786|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377787|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2377788|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2377789|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
2377790|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377791|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2377792|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2377793|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
2377794|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2377795|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2492479|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2492480|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2492481|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492482|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492483|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2492484|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2377796|NCT00619996|Docetaxel|docetaxel|mesh-list
2377797|NCT00619996|Sorafenib|sorafenib|mesh-list
2377798|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377799|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
2377800|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
2377801|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
2377802|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377803|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2377804|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492485|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2492486|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2492487|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492488|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
2492489|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492490|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2492491|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2492492|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2492493|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2492494|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2492495|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2492496|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2492497|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2492498|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
2492499|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2492500|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
2492501|NCT01174927|Heroin|heroin|mesh-list
2492502|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2377805|NCT00620100|Docetaxel|docetaxel|mesh-list
2377806|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377807|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
2377808|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
2377809|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
2377810|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377811|NCT00620165|Levetiracetam|levetiracetam|mesh-list
2377812|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
2377813|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
2377814|NCT00620178|Losartan|losartan|mesh-list
2377815|NCT00620178|Candesartan|candesartan|mesh-list
2377816|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
2377817|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2377818|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2377819|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2377820|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2377821|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377822|NCT00620204|Atorvastatin|atorvastatin|mesh-list
2377823|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2377824|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2377825|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
2377826|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377827|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2377828|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2377829|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377830|NCT00620256|Timolol|timolol|mesh-list
2492503|NCT01174927|Narcotics|narcotics|mesh-ancestor
2492504|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2492505|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492506|NCT01174927|Analgesics|analgesics|mesh-ancestor
2492507|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
2492508|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492509|NCT01174953|Finasteride|finasteride|mesh-list
2492510|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2492511|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2492512|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492513|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492514|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
2492515|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2492516|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492517|NCT01174953|Urological Agents|urological agents|mesh-ancestor
2492518|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
2492519|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2492520|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492521|NCT01175096|Everolimus|everolimus|mesh-list
2492522|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377831|NCT00620256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2377832|NCT00620256|Latanoprost|latanoprost|mesh-list
2377833|NCT00620256|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2377834|NCT00620256|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2377835|NCT00620256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2377836|NCT00620256|Adrenergic Agents|adrenergic agents|mesh-ancestor
2377837|NCT00620256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377838|NCT00620256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377839|NCT00620256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377840|NCT00620256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2377841|NCT00620256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2377842|NCT00620269|Irinotecan|irinotecan|mesh-list
2377843|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2377844|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377845|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2377846|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2377847|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377848|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377849|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2377850|NCT00620295|Gemcitabine|gemcitabine|mesh-list
2377851|NCT00620295|Bortezomib|bortezomib|mesh-list
2377852|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2377853|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
2377854|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377855|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377856|NCT00620295|Antiviral Agents|antiviral agents|mesh-ancestor
2492523|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2492524|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
2492525|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492526|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
2492527|NCT01175109|Panobinostat|panobinostat|mesh-list
2492528|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492529|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2492530|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492531|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492532|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2492533|NCT01175161|Copper|copper|mesh-list
2492534|NCT01175161|Trace Elements|trace elements|mesh-ancestor
2492535|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
2492536|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492537|NCT01175200|Lansoprazole|lansoprazole|mesh-list
2492538|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
2492539|NCT01175200|Clopidogrel|clopidogrel|mesh-list
2492540|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2492541|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2492542|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2492543|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2492544|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2492545|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
2492546|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492547|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377857|NCT00620295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377858|NCT00620295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377859|NCT00620295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2492548|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492549|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2492550|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2492551|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2492552|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492553|NCT01175291|Leucovorin|leucovorin|mesh-list
2492554|NCT01175291|Bevacizumab|bevacizumab|mesh-list
2492555|NCT01175291|Fluorouracil|fluorouracil|mesh-list
2492556|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
2492557|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
2492558|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2492559|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492560|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2492561|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2492562|NCT01175291|Growth Substances|growth substances|mesh-ancestor
2492563|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492564|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
2492565|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
2492566|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492567|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2492568|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2492569|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
2492570|NCT01175291|Antidotes|antidotes|mesh-ancestor
2492571|NCT01175291|Protective Agents|protective agents|mesh-ancestor
2492572|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
2492573|NCT01175291|Vitamins|vitamins|mesh-ancestor
2492574|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
2492575|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2492576|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2492577|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2492578|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2492579|NCT01175460|Nedaplatin|nedaplatin|mesh-list
2492580|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492581|NCT01175486|Pioglitazone|pioglitazone|mesh-list
2492582|NCT01175486|Acarbose|acarbose|mesh-list
2492583|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2492584|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492585|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2492586|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492587|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492588|NCT01175512|Naltrexone|naltrexone|mesh-list
2492589|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2492590|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2492591|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492592|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
2492593|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492594|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
2492595|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
2492596|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
2492597|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492598|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2377860|NCT00620295|Immunologic Factors|immunologic factors|mesh-ancestor
2377861|NCT00620295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377862|NCT00620347|Sunitinib|sunitinib|mesh-list
2377863|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377864|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2377865|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2377866|NCT00620347|Growth Substances|growth substances|mesh-ancestor
2377867|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377868|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
2377869|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2377870|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492599|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2492600|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
2492601|NCT01175538|Lactulose|lactulose|mesh-list
2492602|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2492603|NCT01175577|Carotenoids|carotenoids|mesh-list
2492604|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
2492605|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492606|NCT01175577|Protective Agents|protective agents|mesh-ancestor
2492607|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492608|NCT01175733|Panitumumab|panitumumab|mesh-list
2492609|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2492610|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492611|NCT01175746|Nicardipine|nicardipine|mesh-list
2492612|NCT01175746|Remifentanil|remifentanil|mesh-list
2492613|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2377871|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377872|NCT00620438|Efavirenz|efavirenz|mesh-list
2377873|NCT00620438|Nevirapine|nevirapine|mesh-list
2377874|NCT00620438|Rifampin|rifampin|mesh-list
2377875|NCT00620438|Lumefantrine|lumefantrine|mesh-list
2377876|NCT00620438|Artemether|artemether|mesh-list
2377877|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2377878|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2377879|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2377880|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377881|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377882|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
2377883|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377884|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2377885|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2377886|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2377887|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2377888|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2377889|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2377890|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2377891|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2377892|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2377893|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
2377894|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2377895|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
2492614|NCT01175746|Narcotics|narcotics|mesh-ancestor
2492615|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2492616|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492617|NCT01175746|Analgesics|analgesics|mesh-ancestor
2492618|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
2492619|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492620|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2492621|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2492622|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2492623|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492624|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2492625|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
2492626|NCT01175772|Celecoxib|celecoxib|mesh-list
2492627|NCT01175772|Methotrexate|methotrexate|mesh-list
2492628|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
2492629|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2492630|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
2492631|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2377896|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2377897|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2377898|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2377899|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
2377900|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2377901|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2377902|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
2377903|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
2377904|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
2492632|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492633|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2492634|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
2492635|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492636|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492637|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
2492638|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492639|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2492640|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2492641|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
2492642|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2492643|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2492644|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2492645|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2492646|NCT01175772|Analgesics|analgesics|mesh-ancestor
2492647|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
2492648|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492649|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2492650|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2492651|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2492652|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2492653|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
2492654|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2492655|NCT01175785|Cyclosporine|cyclosporine|mesh-list
2492656|NCT01175785|Mycophenolic Acid|mycophenolic acid|mesh-list
2492657|NCT01175785|Cyclophosphamide|cyclophosphamide|mesh-list
2492658|NCT01175785|Fludarabine|fludarabine|mesh-list
2492659|NCT01175785|Fludarabine phosphate|fludarabine phosphate|mesh-list
2492660|NCT01175785|Cyclosporins|cyclosporins|mesh-list
2492661|NCT01175785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2492662|NCT01175785|Immunologic Factors|immunologic factors|mesh-ancestor
2492663|NCT01175785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492664|NCT01175785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2492665|NCT01175785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2492666|NCT01175785|Alkylating Agents|alkylating agents|mesh-ancestor
2492667|NCT01175785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492668|NCT01175785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492669|NCT01175785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2377905|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2377906|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377907|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
2377908|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377909|NCT00620490|Ropivacaine|ropivacaine|mesh-list
2377910|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
2492670|NCT01175785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2492671|NCT01175785|Antimetabolites|antimetabolites|mesh-ancestor
2492672|NCT01175785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492673|NCT01175785|Antifungal Agents|antifungal agents|mesh-ancestor
2492674|NCT01175785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492675|NCT01175785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2492676|NCT01175785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2492677|NCT01175785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2492678|NCT01175785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2492679|NCT01175785|Antitubercular Agents|antitubercular agents|mesh-ancestor
2377911|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
2377912|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2377913|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377914|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
2377915|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377916|NCT00620581|Paroxetine|paroxetine|mesh-list
2377917|NCT00620581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2377918|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2377919|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377920|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377921|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377922|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
2377923|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377924|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2377925|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
2377926|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2492680|NCT01175785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2492681|NCT01175954|Lacosamide|lacosamide|mesh-list
2492682|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
2492683|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2492684|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2492685|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2492686|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492687|NCT01176175|Progesterone|progesterone|mesh-list
2492688|NCT01176175|Progestins|progestins|mesh-ancestor
2492689|NCT01176175|Hormones|hormones|mesh-ancestor
2492690|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2492691|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492692|NCT01176318|Erdosteine|erdosteine|mesh-list
2492693|NCT01176318|Expectorants|expectorants|mesh-ancestor
2492694|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
2492695|NCT01176344|Vitamin D|vitamin d|mesh-list
2492696|NCT01176344|Vitamins|vitamins|mesh-ancestor
2492697|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
2492698|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492699|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2492700|NCT01176409|Valacyclovir|valacyclovir|mesh-list
2492701|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
2492702|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2377927|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2492703|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
2492704|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
2492705|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2492706|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
2492707|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492708|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
2492709|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492710|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492711|NCT01176669|Apatinib|apatinib|mesh-list
2492712|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492713|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2492714|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492715|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492716|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2492717|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
2492718|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492719|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492720|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2492721|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492722|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
2492723|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2492724|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
2492725|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492726|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492727|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2492728|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
2492729|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2492730|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2492731|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2492732|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
2377928|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2377929|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377930|NCT00620594|Dactolisib|dactolisib|mesh-list
2377931|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2377932|NCT00620620|Zaleplon|zaleplon|mesh-list
2377933|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
2377934|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2114209|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2114210|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
2114211|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114212|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
2114213|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2114214|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114215|NCT02599194|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2114216|NCT02599194|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2377935|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2377936|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377937|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
2377938|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
2377939|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377940|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377941|NCT00620646|Aspirin|aspirin|mesh-list
2377942|NCT00620646|Cilostazol|cilostazol|mesh-list
2377943|NCT00620646|Clopidogrel|clopidogrel|mesh-list
2377944|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2377945|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2377946|NCT00620646|Analgesics|analgesics|mesh-ancestor
2377947|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
2377948|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377949|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377950|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2377951|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2377952|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2377953|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2377954|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377955|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2377956|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2492733|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492734|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492735|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2492736|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
2492737|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492738|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492739|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2492740|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492741|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
2377957|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2377958|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
2377959|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2377960|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2377961|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2377962|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
2377963|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377964|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2377965|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
2492742|NCT01176799|Doxorubicin|doxorubicin|mesh-list
2492743|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2492744|NCT01176799|Sunitinib|sunitinib|mesh-list
2492745|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2492746|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
2492747|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492748|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2492749|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2377966|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2377967|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
2377968|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
2377969|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2492750|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
2492751|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492752|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492753|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2492754|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2492755|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2492756|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2492757|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492758|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2492759|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2492760|NCT01176799|Growth Substances|growth substances|mesh-ancestor
2492761|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
2377970|NCT00620646|Protective Agents|protective agents|mesh-ancestor
2377971|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2377972|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2377973|NCT00620724|Nifedipine|nifedipine|mesh-list
2377974|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2377975|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377976|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377977|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2492762|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2492763|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
2492764|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2492765|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2492766|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2492767|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
2492768|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492769|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492770|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492771|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
2492772|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
2492773|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2492774|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
2492775|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492776|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492777|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2492778|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
2492779|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
2492780|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2492781|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
2492782|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492783|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492784|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2492785|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2492786|NCT01177176|Bupropion|bupropion|mesh-list
2492787|NCT01177176|Nicotine|nicotine|mesh-list
2492788|NCT01177176|Varenicline|varenicline|mesh-list
2492789|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2492790|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
2492791|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492792|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492793|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2492794|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2492795|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
2492796|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492797|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492798|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2492799|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
2492800|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2492801|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2492802|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2377978|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377979|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
2377980|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
2377981|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2377982|NCT00620789|Dexetimide|dexetimide|mesh-list
2377983|NCT00620789|Citalopram|citalopram|mesh-list
2377984|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
2377985|NCT00620789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2377986|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2377987|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2377988|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2377989|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2377990|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
2377991|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2377992|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2377993|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2377994|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2377995|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2377996|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
2377997|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
2377998|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2377999|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2378000|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2378001|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
2378002|NCT00620802|Clopidogrel|clopidogrel|mesh-list
2378003|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2378004|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2378005|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2378006|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2378007|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
2378008|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378009|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492803|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2492804|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
2492805|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2492806|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2492807|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492808|NCT01177306|Guanfacine|guanfacine|mesh-list
2492809|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2492810|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2492811|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2492812|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2492813|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
2492814|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492815|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492816|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492817|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
2492818|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2492819|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2492820|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2492821|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2492822|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492823|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
2492824|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492825|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492826|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2492827|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492828|NCT01177371|Cyclosporine|cyclosporine|mesh-list
2492829|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
2492830|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2492831|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2492832|NCT01177371|Prednisolone|prednisolone|mesh-list
2492833|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
2492834|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
2492835|NCT01177371|Busulfan|busulfan|mesh-list
2492836|NCT01177371|Methotrexate|methotrexate|mesh-list
2378010|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378011|NCT00620867|Ibuprofen|ibuprofen|mesh-list
2378012|NCT00620867|Celecoxib|celecoxib|mesh-list
2378013|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2378014|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2378015|NCT00620867|Analgesics|analgesics|mesh-ancestor
2378016|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
2492837|NCT01177371|Cyclosporins|cyclosporins|mesh-list
2492838|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2492839|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
2492840|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2492841|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
2492842|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492843|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2378017|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378018|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378019|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2378020|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2378021|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2378022|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492844|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2492845|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
2492846|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492847|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492848|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2378023|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378024|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2378025|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
2378026|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2378027|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2378028|NCT00620919|Secretin|secretin|mesh-list
2378029|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2378030|NCT00620919|Hormones|hormones|mesh-ancestor
2378031|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2378032|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378033|NCT00620971|Gemcitabine|gemcitabine|mesh-list
2378034|NCT00620971|Bevacizumab|bevacizumab|mesh-list
2378035|NCT00620971|Cisplatin|cisplatin|mesh-list
2492849|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2492850|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
2492851|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2492852|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2492853|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
2492854|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
2492855|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492856|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2492857|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2492858|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
2492859|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492860|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2492861|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2492862|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
2492863|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
2492864|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492865|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2492866|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
2492867|NCT01177371|Hormones|hormones|mesh-ancestor
2492868|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2492869|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2492870|NCT01177371|Protective Agents|protective agents|mesh-ancestor
2492871|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2378036|NCT00620971|Docetaxel|docetaxel|mesh-list
2378037|NCT00620971|Vinorelbine|vinorelbine|mesh-list
2378038|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2378039|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378040|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2378041|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2378042|NCT00620971|Growth Substances|growth substances|mesh-ancestor
2378043|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378044|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
2378045|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2378046|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
2378047|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378048|NCT00620971|Antiviral Agents|antiviral agents|mesh-ancestor
2492872|NCT01177423|Anesthetics|anesthetics|mesh-list
2492873|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2492874|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492875|NCT01177501|Topotecan|topotecan|mesh-list
2492876|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2492877|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2492878|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492879|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492880|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492881|NCT01177514|Gabapentin|gabapentin|mesh-list
2492882|NCT01177514|Analgesics|analgesics|mesh-ancestor
2492883|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
2492884|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492885|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492886|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
2492887|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2492888|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2492889|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2492890|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2492891|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2492892|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2492893|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492894|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492895|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
2492896|NCT01177540|Decitabine|decitabine|mesh-list
2492897|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2492898|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
2492899|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492900|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492901|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492902|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
2492903|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2492904|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2492905|NCT01177566|Analgesics|analgesics|mesh-ancestor
2492906|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
2492907|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492908|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492909|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2492910|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2378049|NCT00620971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378050|NCT00620971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378051|NCT00620971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2378052|NCT00620971|Immunologic Factors|immunologic factors|mesh-ancestor
2378053|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
2378054|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
2378055|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
2378056|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2378057|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
2378058|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
2378059|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
2378060|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378061|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378062|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
2378063|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378064|NCT00621036|Methotrexate|methotrexate|mesh-list
2378065|NCT00621036|Thiotepa|thiotepa|mesh-list
2378066|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
2492911|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
2492912|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2492913|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
2378067|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2378068|NCT00621036|Antibodies|antibodies|mesh-list
2378069|NCT00621036|Sargramostim|sargramostim|mesh-list
2492914|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2492915|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492916|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492917|NCT01177579|Copper|copper|mesh-list
2492918|NCT01177579|Trace Elements|trace elements|mesh-ancestor
2492919|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
2378070|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2378071|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2378072|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
2378073|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2378074|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378075|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2378076|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
2492920|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492921|NCT01177683|Doxorubicin|doxorubicin|mesh-list
2492922|NCT01177683|Bortezomib|bortezomib|mesh-list
2378077|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378078|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378079|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
2378080|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378081|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2378082|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2378083|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
2378084|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2378085|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2378086|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2378087|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
2378088|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2378089|NCT00621101|Sirolimus|sirolimus|mesh-list
2378090|NCT00621101|Ezetimibe|ezetimibe|mesh-list
2492923|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2492924|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2492925|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2492926|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2492927|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2492928|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492929|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492930|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2492931|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
2492932|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
2492933|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
2492934|NCT01177852|Promethazine|promethazine|mesh-list
2492935|NCT01177852|Brompheniramine|brompheniramine|mesh-list
2492936|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
2492937|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
2492938|NCT01177852|Ephedrine|ephedrine|mesh-list
2492939|NCT01177852|Dipropizine|dipropizine|mesh-list
2492940|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492941|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2492942|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2492943|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2492944|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492945|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
2492946|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
2492947|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
2492948|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492949|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
2492950|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
2492951|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2492952|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2492953|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
2492954|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
2492955|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2492956|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2492957|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
2492958|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
2492959|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2492960|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2492961|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
2492962|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
2492963|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2492964|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2492965|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
2492966|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
2492967|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
2492968|NCT01177904|Progesterone|progesterone|mesh-list
2492969|NCT01177904|Progestins|progestins|mesh-ancestor
2492970|NCT01177904|Hormones|hormones|mesh-ancestor
2492971|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2492972|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492973|NCT01178021|Chloroquine|chloroquine|mesh-list
2492974|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2492975|NCT01178021|Primaquine|primaquine|mesh-list
2492976|NCT01178021|Amebicides|amebicides|mesh-ancestor
2492977|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2492978|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2492979|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2492980|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
2492981|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2492982|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2378091|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2378092|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378093|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2378094|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378095|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
2378096|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2378097|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
2378098|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378099|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2378100|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2378101|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
2378102|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378103|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2378104|NCT00621166|Ritonavir|ritonavir|mesh-list
2378105|NCT00621166|Lopinavir|lopinavir|mesh-list
2378106|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2378107|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2378108|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
2378109|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378110|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378111|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2378112|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2378113|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
2378114|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378115|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2378116|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2378117|NCT00621218|Tretinoin|tretinoin|mesh-list
2378118|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378119|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
2378120|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
2378121|NCT00621283|Secretin|secretin|mesh-list
2378122|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2378123|NCT00621283|Hormones|hormones|mesh-ancestor
2378124|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2378125|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378126|NCT00621361|Etoposide|etoposide|mesh-list
2378127|NCT00621361|Cediranib|cediranib|mesh-list
2378128|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378129|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2378130|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2378131|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2378132|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378133|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492983|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2492984|NCT01178021|Analgesics|analgesics|mesh-ancestor
2492985|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
2492986|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2492987|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2492988|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2492989|NCT01178021|Filaricides|filaricides|mesh-ancestor
2492990|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
2492991|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
2492992|NCT01178034|Warfarin|warfarin|mesh-list
2492993|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
2492994|NCT01178047|Rasagiline|rasagiline|mesh-list
2492995|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2492996|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2492997|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2492998|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2492999|NCT01178047|Protective Agents|protective agents|mesh-ancestor
2493000|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493001|NCT01178112|Carboplatin|carboplatin|mesh-list
2493002|NCT01178112|Trientine|trientine|mesh-list
2493003|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493004|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
2493005|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
2493006|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493007|NCT01178151|Everolimus|everolimus|mesh-list
2493008|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493009|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2493010|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
2493011|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493012|NCT01178203|Naproxen|naproxen|mesh-list
2493013|NCT01178203|Tramadol|tramadol|mesh-list
2493014|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2493015|NCT01178203|Narcotics|narcotics|mesh-ancestor
2493016|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378134|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2378135|NCT00621387|Ofloxacin|ofloxacin|mesh-list
2378136|NCT00621387|Roxithromycin|roxithromycin|mesh-list
2378137|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2378138|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493017|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493018|NCT01178203|Analgesics|analgesics|mesh-ancestor
2493019|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
2493020|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493021|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2493022|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2493023|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2493024|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2493025|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
2493026|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2493027|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493028|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493029|NCT01178320|Niacin|niacin|mesh-list
2493030|NCT01178320|Niacinamide|niacinamide|mesh-list
2493031|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
2493032|NCT01178320|Simvastatin|simvastatin|mesh-list
2493033|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2493034|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2378139|NCT00621387|Renal Agents|renal agents|mesh-ancestor
2378140|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2378141|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2378142|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2378143|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378144|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378145|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378146|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2378147|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2378148|NCT00621400|Dexamethasone|dexamethasone|mesh-list
2378149|NCT00621400|Lenalidomide|lenalidomide|mesh-list
2378150|NCT00621400|Melphalan|melphalan|mesh-list
2378151|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2378152|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
2378153|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
2378154|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378155|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378156|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2378157|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
2378158|NCT00621400|Hormones|hormones|mesh-ancestor
2378159|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2378160|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2378161|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378162|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
2378163|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2378164|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2378165|NCT00621400|Growth Substances|growth substances|mesh-ancestor
2378166|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
2378167|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2378168|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
2493035|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
2493036|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493037|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2493038|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2493039|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493040|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
2493041|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
2493042|NCT01178320|Vitamins|vitamins|mesh-ancestor
2493043|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
2493044|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493045|NCT01178372|Lactulose|lactulose|mesh-list
2493046|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2493047|NCT01178450|Cinacalcet|cinacalcet|mesh-list
2493048|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2378169|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378170|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2378171|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2378172|NCT00621452|Aldesleukin|aldesleukin|mesh-list
2378173|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
2378174|NCT00621452|Interleukin-2|interleukin-2|mesh-list
2378175|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2378176|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
2378177|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378178|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2378179|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2493049|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493050|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2493051|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
2493052|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2493053|NCT01178645|Cytarabine|cytarabine|mesh-list
2493054|NCT01178645|Etoposide|etoposide|mesh-list
2493055|NCT01178645|Melphalan|melphalan|mesh-list
2493056|NCT01178645|Busulfan|busulfan|mesh-list
2493057|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2493058|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493059|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2493060|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2493061|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493062|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493063|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2378180|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
2378181|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378182|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378183|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2378184|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2378185|NCT00621452|Analgesics|analgesics|mesh-ancestor
2378186|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
2378187|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493064|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
2493065|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
2493066|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493067|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2493068|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
2493069|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493070|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2378188|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2378189|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2378190|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
2493071|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
2493072|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2493073|NCT01178658|Cytarabine|cytarabine|mesh-list
2493074|NCT01178658|Etoposide|etoposide|mesh-list
2493075|NCT01178658|Melphalan|melphalan|mesh-list
2493076|NCT01178658|Busulfan|busulfan|mesh-list
2493077|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2493078|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493079|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2493080|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2493081|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493082|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493083|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2493084|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
2493085|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
2493086|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493087|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2493088|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
2493089|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493090|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2493091|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
2493092|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2493093|NCT01178697|Triamcinolone|triamcinolone|mesh-list
2493094|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2493095|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2493096|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2493097|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2493098|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
2493099|NCT01178697|Hormones|hormones|mesh-ancestor
2378191|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378192|NCT00621478|Diazepam|diazepam|mesh-list
2378193|NCT00621478|Lorazepam|lorazepam|mesh-list
2378194|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
2378195|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
2378196|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
2378197|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378198|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378199|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2378200|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2378201|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2493100|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2378202|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2378203|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2378204|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2378205|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
2378206|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
2378207|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378208|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378209|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2378210|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2378211|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2378212|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2378213|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
2378214|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
2493101|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493102|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2493103|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
2493104|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493105|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493106|NCT01178710|Simvastatin|simvastatin|mesh-list
2493107|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2493108|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2493109|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
2378215|NCT00621491|Warfarin|warfarin|mesh-list
2378216|NCT00621491|Anticoagulants|anticoagulants|mesh-list
2378217|NCT00621556|Secretin|secretin|mesh-list
2378218|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2378219|NCT00621556|Hormones|hormones|mesh-ancestor
2378220|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2378221|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378222|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2378223|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
2378224|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2493110|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493111|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2493112|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2493113|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493114|NCT01178788|Progesterone|progesterone|mesh-list
2493115|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2493116|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2493117|NCT01178788|Progestins|progestins|mesh-ancestor
2493118|NCT01178788|Hormones|hormones|mesh-ancestor
2493119|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2493120|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493121|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2493122|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
2493123|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
2493124|NCT01178931|Progesterone|progesterone|mesh-list
2493125|NCT01178931|Progestins|progestins|mesh-ancestor
2493126|NCT01178931|Hormones|hormones|mesh-ancestor
2493127|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2493128|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493129|NCT01178996|Ribavirin|ribavirin|mesh-list
2493130|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2493131|NCT01178996|Thymalfasin|thymalfasin|mesh-list
2493132|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
2493133|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493134|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
2493135|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493136|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2493137|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
2493138|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493139|NCT01179009|Clonidine|clonidine|mesh-list
2493140|NCT01179009|Scopolamine|scopolamine|mesh-list
2493141|NCT01179009|Ketamine|ketamine|mesh-list
2493142|NCT01179009|Lorazepam|lorazepam|mesh-list
2493143|NCT01179009|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2493144|NCT01179009|Analgesics|analgesics|mesh-ancestor
2493145|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
2493146|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493147|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493148|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2493149|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2493150|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
2493151|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
2378225|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2378226|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2493152|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378227|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2493153|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2493154|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2493155|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493156|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493157|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2493158|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
2493159|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
2493160|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2493161|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2493162|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2493163|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
2493164|NCT01179009|Anticonvulsants|anticonvulsants|mesh-ancestor
2493165|NCT01179009|Antiemetics|antiemetics|mesh-ancestor
2493166|NCT01179009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2493167|NCT01179009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2493168|NCT01179009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2493169|NCT01179009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2493170|NCT01179009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2493171|NCT01179009|GABA Modulators|gaba modulators|mesh-ancestor
2493172|NCT01179009|GABA Agents|gaba agents|mesh-ancestor
2493173|NCT01179009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2493174|NCT01179009|Mydriatics|mydriatics|mesh-ancestor
2493175|NCT01179009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2493176|NCT01179009|Cholinergic Agents|cholinergic agents|mesh-ancestor
2493177|NCT01179009|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2493178|NCT01179009|Parasympatholytics|parasympatholytics|mesh-ancestor
2378228|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378229|NCT00621673|Factor VIII|factor viii|mesh-list
2378230|NCT00621673|Coagulants|coagulants|mesh-ancestor
2378231|NCT00621699|Ezetimibe|ezetimibe|mesh-list
2378232|NCT00621699|Tacrolimus|tacrolimus|mesh-list
2378233|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2378234|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
2378235|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378236|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2378237|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378238|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493179|NCT01179100|Lidocaine|lidocaine|mesh-list
2493180|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
2493181|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
2493182|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2493183|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493184|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
2493185|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493186|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2493187|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2493188|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2493189|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2493190|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493191|NCT01179152|Budesonide|budesonide|mesh-list
2493192|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
2493193|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2493194|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2493195|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
2493196|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493197|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493198|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2493199|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
2493200|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
2493201|NCT01179152|Hormones|hormones|mesh-ancestor
2493202|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2493203|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2493204|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2493205|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2493206|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
2493207|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493208|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493209|NCT01179230|Dipyridamole|dipyridamole|mesh-list
2493210|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2493211|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493212|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493213|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2493214|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
2493215|NCT01179256|Curcumin|curcumin|mesh-list
2493216|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2493217|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2493218|NCT01179256|Analgesics|analgesics|mesh-ancestor
2493219|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
2493220|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493221|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493222|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2378239|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2378240|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2378241|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
2378242|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2378243|NCT00621725|Cediranib|cediranib|mesh-list
2378244|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378245|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2378246|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378247|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378248|NCT00621790|Fenoldopam|fenoldopam|mesh-list
2378249|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2378250|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
2378251|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
2493223|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2493224|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493225|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493226|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493227|NCT01179269|Paclitaxel|paclitaxel|mesh-list
2493228|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2493229|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493230|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
2493231|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
2493232|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
2493233|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493234|NCT01179308|Anesthetics|anesthetics|mesh-list
2493235|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2493236|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493237|NCT01179412|Iodine|iodine|mesh-list
2493238|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
2493239|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
2493240|NCT01179412|Povidone|povidone|mesh-list
2493241|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2493242|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493243|NCT01179412|Trace Elements|trace elements|mesh-ancestor
2493244|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
2493245|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493246|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
2493247|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
2493248|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
2493249|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2493250|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2493251|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493252|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2493253|NCT01179438|Analgesics|analgesics|mesh-ancestor
2493254|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
2493255|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493256|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2493257|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2493258|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2493259|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
2493260|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493261|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493262|NCT01179464|Simvastatin|simvastatin|mesh-list
2493263|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2493264|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2493265|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
2493266|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493267|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2493268|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2493269|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493270|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
2493271|NCT01179503|Vitamin D|vitamin d|mesh-list
2493272|NCT01179503|Calcium|calcium|mesh-list
2493273|NCT01179503|Vitamins|vitamins|mesh-ancestor
2493274|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
2493275|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493276|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2493277|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2493278|NCT01179529|Omalizumab|omalizumab|mesh-list
2493279|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2493280|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2493281|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
2493282|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2493283|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
2493284|NCT01179594|Entecavir|entecavir|mesh-list
2493285|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
2493286|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493287|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
2493288|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493289|NCT01179620|Certoparin|certoparin|mesh-list
2493290|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
2493291|NCT01179646|Pantoprazole|pantoprazole|mesh-list
2493292|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2493293|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2493294|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2493295|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493296|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493297|NCT01179659|Pantoprazole|pantoprazole|mesh-list
2493298|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2493299|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2493300|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2493301|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493302|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493303|NCT01179724|Pantoprazole|pantoprazole|mesh-list
2493304|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2493305|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2493306|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2493307|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493308|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493309|NCT01179776|Iloprost|iloprost|mesh-list
2493310|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2493311|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
2493312|NCT01179828|Oxycodone|oxycodone|mesh-list
2493313|NCT01179828|Clobazam|clobazam|mesh-list
2493314|NCT01179828|Imipramine|imipramine|mesh-list
2493315|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2493316|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2493317|NCT01179828|Narcotics|narcotics|mesh-ancestor
2493318|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2493319|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493320|NCT01179828|Analgesics|analgesics|mesh-ancestor
2493321|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
2493322|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493323|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2493324|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2493325|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
2493326|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493327|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493328|NCT01179828|Urological Agents|urological agents|mesh-ancestor
2378252|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
2378253|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378254|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378255|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378256|NCT00621816|Nitroprusside|nitroprusside|mesh-list
2378257|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2378258|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
2378259|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2378260|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378261|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
2378262|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2378263|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378264|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2378265|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378266|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
2378267|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2378268|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378269|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
2493329|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2493330|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
2493331|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2493332|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2493333|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2493334|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2493335|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
2493336|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
2493337|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2493338|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2493339|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2493340|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
2493341|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
2493342|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
2493343|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2493344|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2493345|NCT01179971|Analgesics|analgesics|mesh-ancestor
2493346|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
2493347|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493348|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493349|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2493350|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2493351|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2493352|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
2493353|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493354|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2493355|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
2493356|NCT01180062|Latanoprost|latanoprost|mesh-list
2493357|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2378270|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
2378271|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
2378272|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378273|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378274|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
2378275|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493358|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2493359|NCT01180075|Ritonavir|ritonavir|mesh-list
2493360|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2493361|NCT01180075|Tenofovir|tenofovir|mesh-list
2493362|NCT01180075|Emtricitabine|emtricitabine|mesh-list
2493363|NCT01180075|Efavirenz|efavirenz|mesh-list
2493364|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2493365|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2493366|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
2493367|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493368|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493369|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2493370|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2493371|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
2493372|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493373|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2493374|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2493375|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2493376|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2493377|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2493378|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2493379|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2493380|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2493381|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2493382|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
2493383|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493384|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
2493385|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2493386|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493387|NCT01180179|Lansoprazole|lansoprazole|mesh-list
2493388|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
2493389|NCT01180179|Famotidine|famotidine|mesh-list
2493390|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2493391|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2493392|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2493393|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493394|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493395|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2493396|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
2493397|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
2493398|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493399|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493400|NCT01180205|Amlodipine|amlodipine|mesh-list
2493401|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2493402|NCT01180205|Telmisartan|telmisartan|mesh-list
2493403|NCT01180205|Olmesartan|olmesartan|mesh-list
2493404|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2493405|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2493406|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2378276|NCT00621998|Olanzapine|olanzapine|mesh-list
2378277|NCT00621998|Risperidone|risperidone|mesh-list
2378278|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2378279|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
2378280|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378281|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378282|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378283|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2378284|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2378285|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378286|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2378287|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2493407|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2493408|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493409|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2493410|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493411|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
2493412|NCT01180205|Diuretics|diuretics|mesh-ancestor
2493413|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
2493414|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2493415|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2493416|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2493417|NCT01180231|Moxonidine|moxonidine|mesh-list
2493418|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2493419|NCT01180322|Cytarabine|cytarabine|mesh-list
2493420|NCT01180322|Etoposide|etoposide|mesh-list
2493421|NCT01180322|Idarubicin|idarubicin|mesh-list
2378288|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
2378289|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
2378290|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
2493422|NCT01180322|Azacitidine|azacitidine|mesh-list
2493423|NCT01180322|Lenograstim|lenograstim|mesh-list
2493424|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2493425|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493426|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2493427|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2378291|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378292|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2378293|NCT00621998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2378294|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2378295|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2378296|NCT00622011|Risperidone|risperidone|mesh-list
2378297|NCT00622011|Zotepine|zotepine|mesh-list
2378298|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2378299|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
2378300|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378301|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378302|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378303|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2378304|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2378305|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2493428|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493429|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493430|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2493431|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
2493432|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
2493433|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493434|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2493435|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
2493436|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493437|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2493438|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2493439|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
2493440|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2493441|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2493442|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2493443|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2493444|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493445|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
2493446|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493447|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493448|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2493449|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378306|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2378307|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2378308|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
2378309|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
2378310|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2378311|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2378312|NCT00622063|Beta-lapachone|beta-lapachone|mesh-list
2378313|NCT00622063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378314|NCT00622063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2378315|NCT00622063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2493466|NCT01180413|Losartan|losartan|mesh-list
2493467|NCT01180413|Amlodipine|amlodipine|mesh-list
2493468|NCT01180413|Ramipril|ramipril|mesh-list
2493469|NCT01180413|Lercanidipine|lercanidipine|mesh-list
2493470|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2493471|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2493472|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2493473|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493474|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2493475|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493476|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
2493477|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2493478|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2493479|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2493480|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2493481|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
2493482|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493483|NCT01180426|Tosedostat|tosedostat|mesh-list
2493484|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493485|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493486|NCT01180569|Lenalidomide|lenalidomide|mesh-list
2493487|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
2493488|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493489|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2493490|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2493491|NCT01180569|Growth Substances|growth substances|mesh-ancestor
2493492|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
2493493|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493494|NCT01180621|Vaccines|vaccines|mesh-list
2493495|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
2493496|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493497|NCT01180634|Levofloxacin|levofloxacin|mesh-list
2493498|NCT01180634|Ofloxacin|ofloxacin|mesh-list
2493499|NCT01180634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2493500|NCT01180634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493501|NCT01180634|Renal Agents|renal agents|mesh-ancestor
2493502|NCT01180634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2493503|NCT01180634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2493504|NCT01180634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2493505|NCT01180634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493506|NCT01180634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378316|NCT00622063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378317|NCT00622063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378318|NCT00622063|Antiviral Agents|antiviral agents|mesh-ancestor
2493507|NCT01180634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493508|NCT01180634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2493509|NCT01180634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2493510|NCT01180725|Psyllium|psyllium|mesh-list
2378319|NCT00622115|Enoxaparin|enoxaparin|mesh-list
2378320|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
2378321|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2378322|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2378323|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378324|NCT00622141|Saquinavir|saquinavir|mesh-list
2378325|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2378326|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2378327|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
2378328|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378329|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378330|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2378331|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2493511|NCT01180725|Cathartics|cathartics|mesh-ancestor
2493512|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2493513|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2493514|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2493515|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493516|NCT01180816|Temozolomide|temozolomide|mesh-list
2493517|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2493518|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
2493519|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493520|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493521|NCT01180933|Folic Acid|folic acid|mesh-list
2493522|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
2493523|NCT01180933|Hematinics|hematinics|mesh-ancestor
2493524|NCT01180933|Vitamins|vitamins|mesh-ancestor
2493525|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
2493526|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378332|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
2378333|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378334|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2378335|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2378336|NCT00622206|Ritonavir|ritonavir|mesh-list
2378337|NCT00622206|Saquinavir|saquinavir|mesh-list
2378338|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2378339|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2493527|NCT01180946|Vitamin D|vitamin d|mesh-list
2493528|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
2493529|NCT01180946|Vitamins|vitamins|mesh-ancestor
2493530|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
2493531|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493532|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2493533|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2493534|NCT01180959|Bevacizumab|bevacizumab|mesh-list
2493535|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2493536|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2493537|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493538|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2493539|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2493540|NCT01180959|Growth Substances|growth substances|mesh-ancestor
2493541|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493542|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
2493543|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2378340|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
2378341|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378342|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378343|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2378344|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2378345|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
2378346|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378347|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2378348|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2378349|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2378350|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
2493544|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493545|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493546|NCT01181063|Budesonide|budesonide|mesh-list
2493547|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
2493548|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2493549|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2493550|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
2378351|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2378352|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2378353|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2378354|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378355|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378356|NCT00622258|Everolimus|everolimus|mesh-list
2378357|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378358|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2378359|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
2378360|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378361|NCT00622349|Gemcitabine|gemcitabine|mesh-list
2378362|NCT00622349|Cisplatin|cisplatin|mesh-list
2378363|NCT00622349|Docetaxel|docetaxel|mesh-list
2378364|NCT00622349|Ifosfamide|ifosfamide|mesh-list
2378365|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
2378366|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378367|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2378368|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
2378369|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493551|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493552|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493553|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2493554|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
2493555|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
2493556|NCT01181063|Hormones|hormones|mesh-ancestor
2493557|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2493558|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2493559|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2493560|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2493561|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
2493562|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493563|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493564|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
2493565|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2493566|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
2493567|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493568|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493569|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
2493570|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493571|NCT01181154|Rituximab|rituximab|mesh-list
2493572|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2493573|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493574|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
2493575|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493576|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2493577|NCT01181193|Vitamin D|vitamin d|mesh-list
2493578|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
2493579|NCT01181193|Temozolomide|temozolomide|mesh-list
2493580|NCT01181193|Vitamins|vitamins|mesh-ancestor
2493581|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
2493582|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493583|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2493584|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2493585|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
2493586|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493587|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378370|NCT00622349|Antiviral Agents|antiviral agents|mesh-ancestor
2378371|NCT00622349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378372|NCT00622349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378373|NCT00622349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2378374|NCT00622349|Immunologic Factors|immunologic factors|mesh-ancestor
2378375|NCT00622349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378376|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
2378377|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
2378378|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
2378379|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2378380|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
2378381|NCT00622375|Mesalamine|mesalamine|mesh-list
2378382|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2378383|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2378384|NCT00622375|Analgesics|analgesics|mesh-ancestor
2378385|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
2378386|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378387|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378388|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2493588|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2493589|NCT01181232|Zolpidem|zolpidem|mesh-list
2493590|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2493591|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2378389|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2378390|NCT00622414|Aflibercept|aflibercept|mesh-list
2493592|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2493593|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493594|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2493595|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
2493596|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
2493597|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493598|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493599|NCT01181310|Scopolamine|scopolamine|mesh-list
2493600|NCT01181310|Donepezil|donepezil|mesh-list
2493601|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2493602|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2493603|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493604|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493605|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
2493606|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493607|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493608|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
2493609|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2493610|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
2493611|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
2493612|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493613|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2493614|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
2493615|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2493616|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2493617|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
2493618|NCT01181388|Tirofiban|tirofiban|mesh-list
2493619|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2493620|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2493621|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493622|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2493623|NCT01181401|Cisplatin|cisplatin|mesh-list
2493624|NCT01181401|Docetaxel|docetaxel|mesh-list
2493625|NCT01181401|Cetuximab|cetuximab|mesh-list
2493626|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493627|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
2378391|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
2378392|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2378393|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2378394|NCT00622414|Growth Substances|growth substances|mesh-ancestor
2378395|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378396|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
2493628|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
2493629|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
2493630|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493631|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2493632|NCT01181414|Amiodarone|amiodarone|mesh-list
2493633|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2493634|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2493635|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
2493636|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2493637|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2493638|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493639|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2493640|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2493641|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2493642|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493643|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2493644|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2493645|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2493646|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2493647|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
2493648|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493649|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493650|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
2493651|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493652|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493653|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2493654|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2493655|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2493656|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
2493657|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493658|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493659|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493660|NCT01181505|Urological Agents|urological agents|mesh-ancestor
2493661|NCT01181544|Heparin|heparin|mesh-list
2493662|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
2493663|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2493664|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2493665|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493666|NCT01181570|Adalimumab|adalimumab|mesh-list
2493667|NCT01181570|Mannitol|mannitol|mesh-list
2493668|NCT01181570|Citric Acid|citric acid|mesh-list
2493669|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
2493670|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
2493671|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2493672|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
2493673|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
2493674|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493675|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2493676|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2493677|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2493678|NCT01181570|Diuretics|diuretics|mesh-ancestor
2493679|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
2493680|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493681|NCT01181622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2493682|NCT01181765|Infliximab|infliximab|mesh-list
2493683|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
2493684|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2493685|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2493686|NCT01181882|Aspirin|aspirin|mesh-list
2378397|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378398|NCT00622479|Sorafenib|sorafenib|mesh-list
2378399|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378400|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2378401|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378402|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378403|NCT00622570|Pentobarbital|pentobarbital|mesh-list
2378404|NCT00622570|Thiopental|thiopental|mesh-list
2378405|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
2378406|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2378407|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378408|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378409|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2378410|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
2493687|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2493688|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2493689|NCT01181882|Analgesics|analgesics|mesh-ancestor
2493690|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
2493691|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493692|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493693|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2493694|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2378411|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
2378412|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
2378413|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
2378414|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378415|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493695|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2493696|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2493697|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493698|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2493699|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2493700|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493701|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
2493702|NCT01181934|Nicotine|nicotine|mesh-list
2493703|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2493704|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
2493705|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493706|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493707|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2493708|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2493709|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
2493710|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493711|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493712|NCT01181960|Risperidone|risperidone|mesh-list
2493713|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2493714|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
2378416|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2378417|NCT00622622|Gemcitabine|gemcitabine|mesh-list
2493715|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2493716|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
2493717|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493718|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493719|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493720|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2378418|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2378419|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
2493721|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2493722|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2493723|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2493724|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
2493725|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2493726|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2493727|NCT01181999|Rituximab|rituximab|mesh-list
2493728|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2493729|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493730|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
2493731|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493732|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2493733|NCT01182077|Midazolam|midazolam|mesh-list
2493734|NCT01182077|Peficitinib|peficitinib|mesh-list
2493735|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2493736|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2493737|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2493738|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493739|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2493740|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2493741|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2493742|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2493743|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
2493744|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
2493745|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
2493746|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
2493747|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493748|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493749|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493750|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2493751|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
2493752|NCT01182129|Nicotine|nicotine|mesh-list
2493753|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2493754|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
2493755|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493756|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493757|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2493758|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2493759|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
2493760|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493761|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493762|NCT01182142|Capecitabine|capecitabine|mesh-list
2493763|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2493764|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
2493765|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493766|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493767|NCT01182168|Gemcitabine|gemcitabine|mesh-list
2493768|NCT01182168|Everolimus|everolimus|mesh-list
2493769|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493770|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2493771|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
2493772|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493773|NCT01182168|Antiviral Agents|antiviral agents|mesh-ancestor
2493774|NCT01182168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493775|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378420|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378421|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378422|NCT00622622|Antiviral Agents|antiviral agents|mesh-ancestor
2378423|NCT00622622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378424|NCT00622622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378425|NCT00622622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2378426|NCT00622622|Immunologic Factors|immunologic factors|mesh-ancestor
2378427|NCT00622622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378428|NCT00622648|Enoxaparin|enoxaparin|mesh-list
2378429|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
2378430|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2493776|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2493777|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
2493778|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493779|NCT01182246|Genistein|genistein|mesh-list
2493780|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2493781|NCT01182246|Protective Agents|protective agents|mesh-ancestor
2493782|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378431|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2378432|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378433|NCT00622674|Cetuximab|cetuximab|mesh-list
2378434|NCT00622674|Bortezomib|bortezomib|mesh-list
2378435|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2378436|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378437|NCT00622687|Iloprost|iloprost|mesh-list
2378438|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2378439|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
2378440|NCT00622752|Nicotine|nicotine|mesh-list
2378441|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2378442|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
2378443|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378444|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378445|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2378446|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2493783|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493784|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2378447|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
2378448|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378449|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378450|NCT00622817|Epinephrine|epinephrine|mesh-list
2378451|NCT00622817|Xylometazoline|xylometazoline|mesh-list
2378452|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2378453|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2378454|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
2378455|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378456|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378457|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378458|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2378459|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2378460|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
2378461|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378462|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2378463|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
2378464|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
2493785|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493786|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493787|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
2493788|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2493789|NCT01182246|Estrogens|estrogens|mesh-ancestor
2493790|NCT01182246|Hormones|hormones|mesh-ancestor
2493791|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2493792|NCT01182272|Sorafenib|sorafenib|mesh-list
2493793|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493794|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2493795|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493796|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493797|NCT01182597|Pantoprazole|pantoprazole|mesh-list
2493798|NCT01182597|Lansoprazole|lansoprazole|mesh-list
2493799|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
2493800|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2493801|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2493802|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2493803|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493804|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493805|NCT01182636|Adapalene|adapalene|mesh-list
2493806|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2493807|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2493808|NCT01182636|Analgesics|analgesics|mesh-ancestor
2493809|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
2493810|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493811|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378465|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
2378466|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2493812|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2493813|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2493814|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
2493815|NCT01182662|Cyclosporine|cyclosporine|mesh-list
2493816|NCT01182662|Cyclosporins|cyclosporins|mesh-list
2493817|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493818|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493819|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2493820|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
2493821|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493822|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
2493823|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493824|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
2493825|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2493826|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2493827|NCT01182766|Topiramate|topiramate|mesh-list
2493828|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
2493829|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2493830|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493831|NCT01182792|Ascorbic Acid|ascorbic acid|mesh-list
2493832|NCT01182792|Vitamins|vitamins|mesh-ancestor
2493833|NCT01182792|Micronutrients|micronutrients|mesh-ancestor
2493834|NCT01182792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493835|NCT01182792|Antioxidants|antioxidants|mesh-ancestor
2493836|NCT01182792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493837|NCT01182792|Protective Agents|protective agents|mesh-ancestor
2493838|NCT01182883|Sirolimus|sirolimus|mesh-list
2493839|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2493840|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493841|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2493842|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378467|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
2378468|NCT00622830|Darapladib|darapladib|mesh-list
2378469|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2378470|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378471|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378472|NCT00622843|Vaccines|vaccines|mesh-list
2378473|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2378474|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
2378475|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378476|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
2378477|NCT00622934|Hematinics|hematinics|mesh-ancestor
2378478|NCT00623064|Gemcitabine|gemcitabine|mesh-list
2378479|NCT00623064|Lapatinib|lapatinib|mesh-list
2378480|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378481|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2378482|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
2378483|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493843|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
2493844|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2493845|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
2493846|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493847|NCT01182974|Acetaminophen|acetaminophen|mesh-list
2378484|NCT00623064|Antiviral Agents|antiviral agents|mesh-ancestor
2378485|NCT00623064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378486|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378487|NCT00623064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2378488|NCT00623064|Immunologic Factors|immunologic factors|mesh-ancestor
2378489|NCT00623064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378490|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2378491|NCT00623077|Etoposide|etoposide|mesh-list
2378492|NCT00623077|Melphalan|melphalan|mesh-list
2378493|NCT00623077|Busulfan|busulfan|mesh-list
2378494|NCT00623077|Ifosfamide|ifosfamide|mesh-list
2378495|NCT00623077|Thiotepa|thiotepa|mesh-list
2378496|NCT00623077|Sargramostim|sargramostim|mesh-list
2378497|NCT00623077|Mesna|mesna|mesh-list
2378498|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2378499|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378500|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2378501|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2378502|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378503|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378504|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
2378505|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378506|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2378507|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
2378508|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2378509|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2378510|NCT00623077|Protective Agents|protective agents|mesh-ancestor
2493848|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2493849|NCT01182974|Analgesics|analgesics|mesh-ancestor
2493850|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
2493851|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493852|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493853|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
2493854|NCT01183247|Sirolimus|sirolimus|mesh-list
2493855|NCT01183247|Prednisone|prednisone|mesh-list
2493856|NCT01183247|Everolimus|everolimus|mesh-list
2493857|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2493858|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
2493859|NCT01183247|Hormones|hormones|mesh-ancestor
2493860|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2493861|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493862|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2493863|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493864|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2493865|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
2493866|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2493867|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493868|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2493869|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
2493870|NCT01183364|Docetaxel|docetaxel|mesh-list
2493871|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493872|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
2493873|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
2493874|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
2493875|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493876|NCT01183442|Vitamin D|vitamin d|mesh-list
2493877|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
2493878|NCT01183442|Vitamins|vitamins|mesh-list
2493879|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
2493880|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493881|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2493882|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2493883|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2493884|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
2493885|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2493886|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2493887|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493888|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493889|NCT01183494|Irinotecan|irinotecan|mesh-list
2493890|NCT01183494|Bevacizumab|bevacizumab|mesh-list
2493891|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2493892|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2493893|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493894|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493895|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493896|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2493897|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2493898|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2493899|NCT01183494|Growth Substances|growth substances|mesh-ancestor
2493900|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493901|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
2493902|NCT01183572|Iron|iron|mesh-list
2493903|NCT01183572|Folic Acid|folic acid|mesh-list
2493904|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
2493905|NCT01183572|Trace Elements|trace elements|mesh-ancestor
2493906|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
2493907|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493908|NCT01183572|Hematinics|hematinics|mesh-ancestor
2493909|NCT01183572|Vitamins|vitamins|mesh-ancestor
2493910|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2493911|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2493912|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2493913|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
2493914|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493915|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2493916|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2114217|NCT02599194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114218|NCT02599402|Nivolumab|nivolumab|mesh-list
2114219|NCT02599402|Ipilimumab|ipilimumab|mesh-list
2114220|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2114221|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114222|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2114223|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114224|NCT02599649|Nivolumab|nivolumab|mesh-list
2114225|NCT02599649|Azacitidine|azacitidine|mesh-list
2114226|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2493917|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493918|NCT01183611|Vaccines|vaccines|mesh-list
2493919|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
2493920|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493921|NCT01183624|Analgesics|analgesics|mesh-list
2493922|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
2493923|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2493924|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493925|NCT01183663|Leucovorin|leucovorin|mesh-list
2493926|NCT01183663|Sirolimus|sirolimus|mesh-list
2493927|NCT01183663|Bevacizumab|bevacizumab|mesh-list
2493928|NCT01183663|Lenalidomide|lenalidomide|mesh-list
2378511|NCT00623116|Testosterone|testosterone|mesh-list
2378512|NCT00623116|Estrogens|estrogens|mesh-list
2378513|NCT00623116|Androgens|androgens|mesh-ancestor
2378514|NCT00623116|Hormones|hormones|mesh-ancestor
2378515|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2378516|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493929|NCT01183663|Fluorouracil|fluorouracil|mesh-list
2493930|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
2493931|NCT01183663|Sorafenib|sorafenib|mesh-list
2493932|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2493933|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493934|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2493935|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2493936|NCT01183663|Growth Substances|growth substances|mesh-ancestor
2493937|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493938|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
2493939|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
2493940|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493941|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2493942|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2493943|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
2493944|NCT01183663|Antidotes|antidotes|mesh-ancestor
2493945|NCT01183663|Protective Agents|protective agents|mesh-ancestor
2493946|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
2493947|NCT01183663|Vitamins|vitamins|mesh-ancestor
2493948|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
2493949|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2493950|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493951|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2493952|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2493953|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2493954|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
2493955|NCT01183676|Valproic Acid|valproic acid|mesh-list
2493956|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
2493957|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493958|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493959|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
2493960|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493961|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493962|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
2493963|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2493964|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378517|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
2378518|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
2378519|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2493965|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2493966|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2493967|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
2493968|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493969|NCT01183767|Protective Agents|protective agents|mesh-ancestor
2493970|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493971|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2493972|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2378520|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
2378521|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2378522|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2378523|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378524|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2378525|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378526|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378527|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2378528|NCT00623155|Renal Agents|renal agents|mesh-ancestor
2378529|NCT00623168|Ribavirin|ribavirin|mesh-list
2378530|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
2493973|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493974|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2493975|NCT01183806|Rivastigmine|rivastigmine|mesh-list
2493976|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2493977|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2493978|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493979|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
2493980|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2493981|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493982|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2493983|NCT01183806|Protective Agents|protective agents|mesh-ancestor
2493984|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
2493985|NCT01183910|Calcium|calcium|mesh-list
2493986|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2493987|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493988|NCT01183910|Antacids|antacids|mesh-ancestor
2493989|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2493990|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2493991|NCT01183949|Bortezomib|bortezomib|mesh-list
2493992|NCT01183949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2493993|NCT01183962|Vitamin D|vitamin d|mesh-list
2493994|NCT01183962|Vitamins|vitamins|mesh-ancestor
2493995|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
2493996|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2493997|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2493998|NCT01184144|Pioglitazone|pioglitazone|mesh-list
2493999|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2494000|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494001|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
2494002|NCT01184196|Povidone|povidone|mesh-list
2494003|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
2494004|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
2494005|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2494006|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494007|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
2494008|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
2494009|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2494010|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2494011|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494012|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494013|NCT01184287|Ranpirnase|ranpirnase|mesh-list
2494014|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494015|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2494016|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378531|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378532|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
2378533|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378534|NCT00623207|Atropine|atropine|mesh-list
2378535|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2378536|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2378537|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2378538|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
2378539|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378540|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378541|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2378542|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
2378543|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
2494017|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494018|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2494019|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2494020|NCT01184378|Caseins|caseins|mesh-list
2494021|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
2494022|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
2494023|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494024|NCT01184391|Valproic Acid|valproic acid|mesh-list
2494025|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
2494026|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494027|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494028|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
2494029|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494030|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494031|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
2494032|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2494033|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494034|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2494035|NCT01184404|Bosentan|bosentan|mesh-list
2494036|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2378544|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
2494037|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2494038|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378545|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2378546|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2494039|NCT01184443|Olanzapine|olanzapine|mesh-list
2494040|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
2494041|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
2494042|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494043|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494044|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2494045|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2494046|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2494047|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494048|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2494049|NCT01184443|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2494050|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2494051|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2494052|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494053|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494054|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
2494055|NCT01184482|Cetuximab|cetuximab|mesh-list
2494056|NCT01184482|Lapatinib|lapatinib|mesh-list
2494057|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2494058|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494059|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2494060|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494061|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378547|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
2378548|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378549|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378550|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
2378551|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2378552|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
2378553|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
2378554|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378555|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378556|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2378557|NCT00623220|Analgesics|analgesics|mesh-ancestor
2378558|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
2378559|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378560|NCT00623285|Pregabalin|pregabalin|mesh-list
2378561|NCT00623285|Analgesics|analgesics|mesh-ancestor
2378562|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
2378563|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378564|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378565|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
2378566|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2378567|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2378568|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494062|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
2494063|NCT01184495|Hematinics|hematinics|mesh-ancestor
2494064|NCT01184560|Orlistat|orlistat|mesh-list
2494065|NCT01184560|Sibutramine|sibutramine|mesh-list
2494066|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494067|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494068|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2494069|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2494070|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
2494071|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2494072|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
2494073|NCT01184638|Propofol|propofol|mesh-list
2494074|NCT01184638|Sevoflurane|sevoflurane|mesh-list
2494075|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2494076|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494077|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494078|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2494079|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
2494080|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
2494081|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2494082|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2494083|NCT01184664|Nicotine|nicotine|mesh-list
2494084|NCT01184664|Varenicline|varenicline|mesh-list
2494085|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2494086|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
2494087|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494088|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494089|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2494090|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2378569|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2378570|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2378571|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2378572|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378573|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2378574|NCT00623376|Dronabinol|dronabinol|mesh-list
2378575|NCT00623376|Nabilone|nabilone|mesh-list
2378576|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
2378577|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
2378578|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378579|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378580|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2378581|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2378582|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2378583|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378584|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2378585|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
2378586|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2378587|NCT00623376|Analgesics|analgesics|mesh-ancestor
2378588|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
2378589|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2378590|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2378591|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378592|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378593|NCT00623376|Hormones|hormones|mesh-ancestor
2378594|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2378595|NCT00623402|Interferons|interferons|mesh-list
2378596|NCT00623402|Sorafenib|sorafenib|mesh-list
2378597|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378598|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
2494091|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
2494092|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494093|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494094|NCT01184716|Vitamin D|vitamin d|mesh-list
2494095|NCT01184716|Vitamins|vitamins|mesh-ancestor
2494096|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
2494097|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494098|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2494099|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
2494100|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
2494101|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
2494102|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494103|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494104|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
2494105|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494106|NCT01184820|Factor VIII|factor viii|mesh-list
2494107|NCT01184820|Coagulants|coagulants|mesh-ancestor
2378599|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378600|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2378601|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378602|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378603|NCT00623415|Flupirtine|flupirtine|mesh-list
2378604|NCT00623415|Analgesics|analgesics|mesh-ancestor
2378605|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
2378606|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378607|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378608|NCT00623558|Docetaxel|docetaxel|mesh-list
2378609|NCT00623558|Cetuximab|cetuximab|mesh-list
2378610|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378611|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
2494108|NCT01184833|Interferons|interferons|mesh-list
2494109|NCT01184833|Interferon-beta|interferon-beta|mesh-list
2494110|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
2494111|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494112|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
2494113|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494114|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
2494115|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494116|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2494117|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
2494118|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
2494119|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2494120|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
2378612|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
2378613|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
2494121|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2494122|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2494123|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494124|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2494125|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494126|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494127|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2494128|NCT01184911|Renal Agents|renal agents|mesh-ancestor
2494129|NCT01185015|Nicorandil|nicorandil|mesh-list
2494130|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2494131|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2494132|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
2494133|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
2494134|NCT01185015|Vitamins|vitamins|mesh-ancestor
2494135|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
2494136|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494137|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
2494138|NCT01185067|Resveratrol|resveratrol|mesh-list
2494139|NCT01185067|Antioxidants|antioxidants|mesh-list
2494140|NCT01185067|Quercetin|quercetin|mesh-list
2494141|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494142|NCT01185067|Protective Agents|protective agents|mesh-ancestor
2494143|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494144|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494145|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2494146|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2494147|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494148|NCT01185119|Glucagon|glucagon|mesh-list
2494149|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2494150|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2494151|NCT01185119|Hormones|hormones|mesh-ancestor
2494152|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2494153|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494154|NCT01185119|Incretins|incretins|mesh-ancestor
2494155|NCT01185158|Gefitinib|gefitinib|mesh-list
2378614|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378615|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2378616|NCT00623688|Imidacloprid|imidacloprid|mesh-list
2378617|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
2378618|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378619|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378620|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494156|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494157|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2494158|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494159|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494160|NCT01185184|Tofacitinib|tofacitinib|mesh-list
2494161|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2494162|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494163|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494164|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
2494165|NCT01185197|Prednisolone|prednisolone|mesh-list
2494166|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2494167|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494168|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2494169|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
2494170|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2494171|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494172|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494173|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494174|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2494175|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
2494176|NCT01185197|Hormones|hormones|mesh-ancestor
2494177|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2494178|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494179|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2494180|NCT01185223|Valganciclovir|valganciclovir|mesh-list
2494181|NCT01185223|Ganciclovir|ganciclovir|mesh-list
2494182|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2494183|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
2494184|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378621|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
2378622|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2378623|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2378624|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2378625|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2378626|NCT00623857|Vitamins|vitamins|mesh-list
2494185|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2494186|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494187|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494188|NCT01185236|Atorvastatin|atorvastatin|mesh-list
2494189|NCT01185236|Simvastatin|simvastatin|mesh-list
2494190|NCT01185236|Ezetimibe|ezetimibe|mesh-list
2494191|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2494192|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2494193|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
2494194|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494195|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2494196|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2494197|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494198|NCT01185262|Rituximab|rituximab|mesh-list
2494199|NCT01185262|Lenalidomide|lenalidomide|mesh-list
2494200|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2494201|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494202|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
2378627|NCT00623857|Zinc|zinc|mesh-list
2378628|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
2378629|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378630|NCT00623857|Trace Elements|trace elements|mesh-ancestor
2378631|NCT00623987|Warfarin|warfarin|mesh-list
2378632|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
2378633|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2378634|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2378635|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2378636|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378637|NCT00624026|Memantine|memantine|mesh-list
2378638|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2378639|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2378640|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
2378641|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378642|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378643|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378644|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2378645|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2378646|NCT00624039|Pilocarpine|pilocarpine|mesh-list
2378647|NCT00624039|Miotics|miotics|mesh-ancestor
2378648|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
2378649|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378650|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378651|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2378652|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2378653|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
2378654|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378655|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378656|NCT00624078|Antivenins|antivenins|mesh-list
2378657|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
2378658|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378659|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2378660|NCT00624130|Dacuronium|dacuronium|mesh-list
2378661|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2378662|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494203|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494204|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2494205|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2494206|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2494207|NCT01185262|Growth Substances|growth substances|mesh-ancestor
2494208|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
2494209|NCT01185405|Voriconazole|voriconazole|mesh-list
2494210|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
2494211|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494212|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2494213|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2494214|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494215|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494216|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2494217|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
2494218|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2494219|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494220|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2494221|NCT01185418|Haloperidol|haloperidol|mesh-list
2494222|NCT01185418|Risperidone|risperidone|mesh-list
2494223|NCT01185418|Aripiprazole|aripiprazole|mesh-list
2114227|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114228|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2114229|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114230|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2114231|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
2114232|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114233|NCT02600325|Grazoprevir|grazoprevir|mesh-list
2114234|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
2114235|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114236|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
2114237|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2114238|NCT02600351|Ledipasvir|ledipasvir|mesh-list
2114239|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
2494224|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
2494225|NCT01185418|Amisulpride|amisulpride|mesh-list
2494226|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2494227|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
2494228|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494229|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494230|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494231|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2494232|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2494233|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494234|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2494235|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2494236|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
2494237|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
2494238|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
2494239|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2494240|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2494241|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2494242|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2494243|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
2378663|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2378664|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2378665|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2378666|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378667|NCT00624143|Voriconazole|voriconazole|mesh-list
2494244|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
2494245|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494246|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2494247|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2494248|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2494249|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
2494250|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2494251|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
2494252|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494253|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
2494254|NCT01185444|Protective Agents|protective agents|mesh-ancestor
2494255|NCT01185470|Morphine|morphine|mesh-list
2494256|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2494257|NCT01185470|Narcotics|narcotics|mesh-ancestor
2378668|NCT00624143|Amphotericin B|amphotericin b|mesh-list
2378669|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2494258|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494259|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494260|NCT01185470|Analgesics|analgesics|mesh-ancestor
2494261|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
2494262|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494263|NCT01185535|Anesthetics|anesthetics|mesh-list
2494264|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494265|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494266|NCT01185574|Vitamin D|vitamin d|mesh-list
2494267|NCT01185574|Vitamins|vitamins|mesh-ancestor
2378670|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
2378671|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378672|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2378673|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2378674|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378675|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378676|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2378677|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
2494268|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
2114240|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114241|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
2494269|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494270|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2494271|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
2494272|NCT01185678|Desogestrel|desogestrel|mesh-list
2494273|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
2494274|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2494275|NCT01185678|Progestins|progestins|mesh-list
2494276|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2494277|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494278|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2494279|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2494280|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2494281|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2494282|NCT01185678|Hormones|hormones|mesh-ancestor
2494283|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2494284|NCT01185743|Olanzapine|olanzapine|mesh-list
2494285|NCT01185743|Ziprasidone|ziprasidone|mesh-list
2494286|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
2378678|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2378679|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378680|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2378681|NCT00624143|Amebicides|amebicides|mesh-ancestor
2378682|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2378683|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2378684|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2378685|NCT00624182|Gemcitabine|gemcitabine|mesh-list
2378686|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2378687|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
2378688|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494287|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
2494288|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494289|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494290|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2494291|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2494292|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2494293|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494294|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2494295|NCT01185743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2494296|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2494297|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2494298|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494299|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494300|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
2494301|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2494302|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2378689|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378690|NCT00624182|Antiviral Agents|antiviral agents|mesh-ancestor
2378691|NCT00624182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494303|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
2494304|NCT01185769|Tocotrienols|tocotrienols|mesh-list
2494305|NCT01185769|Vitamin E|vitamin e|mesh-list
2494306|NCT01185769|Tocopherols|tocopherols|mesh-list
2494307|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
2494308|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494309|NCT01185769|Protective Agents|protective agents|mesh-ancestor
2494310|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494311|NCT01185769|Vitamins|vitamins|mesh-ancestor
2494312|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
2494313|NCT01185808|Vitamin D|vitamin d|mesh-list
2378692|NCT00624182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378693|NCT00624182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2378694|NCT00624182|Immunologic Factors|immunologic factors|mesh-ancestor
2378695|NCT00624182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378696|NCT00624208|Droperidol|droperidol|mesh-list
2378697|NCT00624208|Ondansetron|ondansetron|mesh-list
2378698|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
2378699|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
2378700|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378701|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378702|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2378703|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
2378704|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
2378705|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2494314|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
2378706|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
2494315|NCT01185808|Vitamins|vitamins|mesh-list
2494316|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
2494317|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494318|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2494319|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2494320|NCT01185847|Gemcitabine|gemcitabine|mesh-list
2378707|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378708|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378709|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2378710|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2378711|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378712|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2378713|NCT00624208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2378714|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2378715|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2378716|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2378717|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
2378718|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
2378719|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
2378720|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2378721|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2378722|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378723|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378724|NCT00624273|Urological Agents|urological agents|mesh-ancestor
2494321|NCT01185847|Pemetrexed|pemetrexed|mesh-list
2494322|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494323|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2494324|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
2494325|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494326|NCT01185847|Antiviral Agents|antiviral agents|mesh-ancestor
2494327|NCT01185847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494328|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494329|NCT01185847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2494330|NCT01185847|Immunologic Factors|immunologic factors|mesh-ancestor
2494331|NCT01185847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494332|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2494333|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2494334|NCT01185860|Ritonavir|ritonavir|mesh-list
2494335|NCT01185860|Ribavirin|ribavirin|mesh-list
2494336|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2494337|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2494338|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2494339|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
2378725|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
2378726|NCT00624312|Hematinics|hematinics|mesh-ancestor
2378727|NCT00624325|Interferons|interferons|mesh-list
2378728|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
2378729|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
2378730|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378731|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
2378732|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378733|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
2378734|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378735|NCT00624351|Epratuzumab|epratuzumab|mesh-list
2378736|NCT00624351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2378737|NCT00624351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378738|NCT00624364|Metformin|metformin|mesh-list
2378739|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
2378740|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
2378741|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2378742|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378743|NCT00624429|Budesonide|budesonide|mesh-list
2378744|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2378745|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2378746|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
2378747|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378748|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378749|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2378750|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
2378751|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
2378752|NCT00624429|Hormones|hormones|mesh-ancestor
2378753|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2378754|NCT00624455|Gabapentin|gabapentin|mesh-list
2378755|NCT00624455|Analgesics|analgesics|mesh-ancestor
2378756|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
2378757|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378758|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378759|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
2378760|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2378761|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2378762|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378763|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2378764|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2378765|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2378766|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378767|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378768|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
2378769|NCT00624481|Teriparatide|teriparatide|mesh-list
2378770|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2378771|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378772|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2378773|NCT00624546|Lansoprazole|lansoprazole|mesh-list
2378774|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
2378775|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2378776|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2378777|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2378778|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378779|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378780|NCT00624663|Rivastigmine|rivastigmine|mesh-list
2378781|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2378782|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378783|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378784|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
2378785|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378786|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378787|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2378788|NCT00624663|Protective Agents|protective agents|mesh-ancestor
2378789|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
2378790|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
2378791|NCT00624676|Salicylates|salicylates|mesh-list
2378792|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2378793|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
2378794|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378795|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
2378796|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
2378797|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2378798|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2378799|NCT00624676|Analgesics|analgesics|mesh-ancestor
2378800|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
2378801|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378802|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378803|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2378804|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2378805|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2378806|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378807|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378808|NCT00624702|Maleic acid|maleic acid|mesh-list
2378809|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378810|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378811|NCT00624741|Pergolide|pergolide|mesh-list
2378812|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
2378813|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
2378814|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494340|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494341|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494342|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2494343|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2494344|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
2494345|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494346|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2494347|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2494348|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
2494349|NCT01185873|Ritonavir|ritonavir|mesh-list
2378815|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378816|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378817|NCT00624754|Budesonide|budesonide|mesh-list
2378818|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
2378819|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2378820|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2378821|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
2378822|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378823|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378824|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2494350|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2494351|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2494352|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
2494353|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494354|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494355|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2494356|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2378825|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
2378826|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
2378827|NCT00624754|Hormones|hormones|mesh-ancestor
2378828|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2378829|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2378830|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2494357|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
2494358|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494359|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2494360|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2494361|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
2494362|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
2494363|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2494364|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2494365|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494366|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494367|NCT01185925|Urological Agents|urological agents|mesh-ancestor
2494368|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2494369|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2494370|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2494371|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
2494372|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494373|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2494374|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2494375|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494376|NCT01185951|Polidocanol|polidocanol|mesh-list
2494377|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2494378|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2494379|NCT01185977|Fluoxetine|fluoxetine|mesh-list
2494380|NCT01185977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2494381|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2494382|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2494383|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494384|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494385|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
2494386|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378831|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2378832|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
2378833|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378834|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378835|NCT00624767|Insulin|insulin|mesh-list
2378836|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2378837|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
2378838|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2378839|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378840|NCT00624858|Naltrexone|naltrexone|mesh-list
2378841|NCT00624858|Bupropion|bupropion|mesh-list
2378842|NCT00624858|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2378843|NCT00624858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2378844|NCT00624858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378845|NCT00624858|Sensory System Agents|sensory system agents|mesh-ancestor
2378846|NCT00624858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378847|NCT00624858|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2378848|NCT00624858|Antidepressive Agents|antidepressive agents|mesh-ancestor
2378849|NCT00624858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2378850|NCT00624858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2494387|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2494388|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
2494389|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2494390|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2494391|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2494392|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494396|NCT01186029|Aprepitant|aprepitant|mesh-list
2494397|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
2494398|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
2494399|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494400|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494401|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2494402|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2494403|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494404|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494405|NCT01186094|Sirolimus|sirolimus|mesh-list
2494406|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2494407|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494408|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2494409|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494410|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
2494411|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2494412|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
2494413|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494414|NCT01186120|Umirolimus|umirolimus|mesh-list
2494415|NCT01186120|Everolimus|everolimus|mesh-list
2494416|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494417|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2494418|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
2494419|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494420|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2494421|NCT01186146|Aspirin|aspirin|mesh-list
2494422|NCT01186146|Clopidogrel|clopidogrel|mesh-list
2494423|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2494424|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2494425|NCT01186146|Analgesics|analgesics|mesh-ancestor
2494426|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
2494427|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494428|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494429|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2494430|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2494431|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2494432|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2494433|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494434|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2494435|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2494436|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494437|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
2494438|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2494439|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2494440|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2494441|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
2494442|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494443|NCT01186159|Parecoxib|parecoxib|mesh-list
2494444|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2494445|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2494446|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494447|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378851|NCT00624858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2378852|NCT00624858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2378853|NCT00624858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378854|NCT00624858|Dopamine Agents|dopamine agents|mesh-ancestor
2378855|NCT00624858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378856|NCT00624858|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2378857|NCT00624858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2378858|NCT00624858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378859|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
2494448|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2494449|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2494450|NCT01186159|Analgesics|analgesics|mesh-ancestor
2494451|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
2494452|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494453|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494454|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2494455|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2494456|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2494457|NCT01186172|Ethanol|ethanol|mesh-list
2494458|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378860|NCT00624871|Ibuprofen|ibuprofen|mesh-list
2378861|NCT00624871|Vitamins|vitamins|mesh-ancestor
2378862|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
2494459|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2494460|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494461|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494462|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
2494463|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2494464|NCT01186224|Plerixafor|plerixafor|mesh-list
2494465|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2494466|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2494467|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
2494468|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494469|NCT01186289|Atorvastatin|atorvastatin|mesh-list
2494470|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2494471|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2494472|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
2494473|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494474|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2378863|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378864|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2378865|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2378866|NCT00624871|Analgesics|analgesics|mesh-ancestor
2378867|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
2378868|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378869|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2378870|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2378871|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2378872|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378873|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378874|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
2378875|NCT00624871|Protective Agents|protective agents|mesh-ancestor
2378876|NCT00624936|Bortezomib|bortezomib|mesh-list
2378877|NCT00624936|Azacitidine|azacitidine|mesh-list
2378878|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378879|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2378880|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
2378881|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378882|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378883|NCT00625014|Haloperidol|haloperidol|mesh-list
2494475|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2494476|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494477|NCT01186445|Morphine|morphine|mesh-list
2494478|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2494479|NCT01186445|Narcotics|narcotics|mesh-ancestor
2494480|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494481|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494482|NCT01186445|Analgesics|analgesics|mesh-ancestor
2378884|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
2378885|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
2378886|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
2378887|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378888|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378889|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2494483|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
2494484|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494485|NCT01186471|Nicotine|nicotine|mesh-list
2494486|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2494487|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
2494488|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494489|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494490|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2494491|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2494492|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
2494493|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494494|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494495|NCT01186497|Rabeprazole|rabeprazole|mesh-list
2494496|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2494497|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2494498|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2494499|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494500|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494501|NCT01186549|Lidocaine|lidocaine|mesh-list
2494502|NCT01186549|Ephedrine|ephedrine|mesh-list
2494503|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
2494504|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
2494505|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
2494506|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494507|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378890|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2378891|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2378892|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378893|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2378894|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2378895|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
2378896|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378897|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378898|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2378899|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
2378900|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
2378901|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2378902|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2378903|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378904|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378905|NCT00625079|Urological Agents|urological agents|mesh-ancestor
2378906|NCT00625092|Leucovorin|leucovorin|mesh-list
2378907|NCT00625092|Fluorouracil|fluorouracil|mesh-list
2378908|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
2378909|NCT00625092|Calcium|calcium|mesh-list
2378910|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
2378911|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2378912|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378913|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
2378914|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378915|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2378916|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378917|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2378918|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
2378919|NCT00625092|Antidotes|antidotes|mesh-ancestor
2378920|NCT00625092|Protective Agents|protective agents|mesh-ancestor
2378921|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
2378922|NCT00625092|Vitamins|vitamins|mesh-ancestor
2378923|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
2378924|NCT00625170|Haloperidol|haloperidol|mesh-list
2378925|NCT00625170|Olanzapine|olanzapine|mesh-list
2378926|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
2494508|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
2494509|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494510|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2494511|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2494512|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2494513|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2494514|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494515|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2494516|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
2494517|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
2494518|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2494519|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
2494520|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494521|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2494522|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2494523|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
2494524|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
2494525|NCT01186588|Canagliflozin|canagliflozin|mesh-list
2494526|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2494527|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494528|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2494529|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378927|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
2378928|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
2378929|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378930|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378931|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2378932|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2378933|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2378934|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2378935|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2378936|NCT00625170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2378937|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2378938|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2378939|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378940|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2378941|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
2378942|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2378943|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
2378944|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2378945|NCT00625196|Fluticasone|fluticasone|mesh-list
2378946|NCT00625196|Xhance|xhance|mesh-list
2378947|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2378948|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2378949|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
2378950|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2378951|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2378952|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2378953|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
2378954|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
2378955|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2378956|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
2378957|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
2378958|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2378959|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2378960|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2378961|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
2378962|NCT00625209|Protein C|protein c|mesh-list
2378963|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2378964|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
2378965|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2378966|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2378967|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378968|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378969|NCT00625248|Anticoagulants|anticoagulants|mesh-list
2378970|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2378971|NCT00625274|Esomeprazole|esomeprazole|mesh-list
2378972|NCT00625274|Pantoprazole|pantoprazole|mesh-list
2378973|NCT00625274|Lansoprazole|lansoprazole|mesh-list
2378974|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
2378975|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2378976|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2494556|NCT01186653|Fluticasone|fluticasone|mesh-list
2494557|NCT01186653|Budesonide|budesonide|mesh-list
2494558|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
2494559|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2494560|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2494561|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2378977|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2378978|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378979|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378980|NCT00625326|Calcipotriene|calcipotriene|mesh-list
2378981|NCT00625326|Dermatologic Agents|dermatologic agents|mesh-ancestor
2494562|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2494563|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
2494564|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494565|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494566|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2378982|NCT00625339|Lamivudine|lamivudine|mesh-list
2378983|NCT00625339|Entecavir|entecavir|mesh-list
2494567|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
2494568|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
2494569|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2494570|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
2494571|NCT01186653|Hormones|hormones|mesh-ancestor
2494572|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2494573|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2494574|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2494575|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2494576|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
2494577|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494578|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494579|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
2494580|NCT01186731|Docetaxel|docetaxel|mesh-list
2494581|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494582|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
2494583|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
2494584|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
2494585|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494586|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
2114242|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2114243|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114244|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2114245|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2114246|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114247|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114248|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114249|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2114250|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2114251|NCT02600611|Vancomycin|vancomycin|mesh-list
2114252|NCT02600611|Iclaprim|iclaprim|mesh-list
2114253|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2114254|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378984|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2378985|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2378986|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2378987|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378988|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
2378989|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378990|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2494587|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2494588|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2494589|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
2494590|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2494591|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2494592|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494593|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
2494594|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494595|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494596|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2494597|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
2494598|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
2494599|NCT01186835|Protective Agents|protective agents|mesh-ancestor
2494600|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2494601|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494602|NCT01186861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2494603|NCT01186861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494604|NCT01186861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2494605|NCT01186861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494606|NCT01186861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494607|NCT01186887|Celecoxib|celecoxib|mesh-list
2494608|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2494609|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2494610|NCT01186887|Analgesics|analgesics|mesh-ancestor
2494611|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
2494612|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494613|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494614|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2494615|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2378991|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2378992|NCT00625352|Gemcitabine|gemcitabine|mesh-list
2378993|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2378994|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
2494616|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2494617|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2494618|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494619|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494620|NCT01186991|Paclitaxel|paclitaxel|mesh-list
2494621|NCT01186991|Bevacizumab|bevacizumab|mesh-list
2494622|NCT01186991|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2494623|NCT01186991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2494624|NCT01186991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494625|NCT01186991|Tubulin Modulators|tubulin modulators|mesh-ancestor
2494626|NCT01186991|Antimitotic Agents|antimitotic agents|mesh-ancestor
2494627|NCT01186991|Mitosis Modulators|mitosis modulators|mesh-ancestor
2494628|NCT01186991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494629|NCT01186991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2494630|NCT01186991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2494631|NCT01186991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2494632|NCT01186991|Growth Substances|growth substances|mesh-ancestor
2494633|NCT01186991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494634|NCT01186991|Growth Inhibitors|growth inhibitors|mesh-ancestor
2494635|NCT01186991|Immunologic Factors|immunologic factors|mesh-ancestor
2494636|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
2494637|NCT01187108|Acetazolamide|acetazolamide|mesh-list
2494638|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2494639|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
2494640|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494641|NCT01187108|Expectorants|expectorants|mesh-ancestor
2494642|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
2494643|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2494644|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
2494645|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494646|NCT01187108|Protective Agents|protective agents|mesh-ancestor
2494647|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494648|NCT01187108|Antidotes|antidotes|mesh-ancestor
2494649|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
2494650|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2494651|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494652|NCT01187108|Diuretics|diuretics|mesh-ancestor
2494653|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
2494654|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
2494655|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2494656|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494657|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2494658|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494659|NCT01187199|Sirolimus|sirolimus|mesh-list
2494660|NCT01187199|Paclitaxel|paclitaxel|mesh-list
2494661|NCT01187199|Bevacizumab|bevacizumab|mesh-list
2494662|NCT01187199|Carboplatin|carboplatin|mesh-list
2494663|NCT01187199|Sorafenib|sorafenib|mesh-list
2494664|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2494665|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494666|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
2494667|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
2494668|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
2494669|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494670|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2378995|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2378996|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2378997|NCT00625352|Antiviral Agents|antiviral agents|mesh-ancestor
2378998|NCT00625352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2378999|NCT00625352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379000|NCT00625352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379001|NCT00625352|Immunologic Factors|immunologic factors|mesh-ancestor
2494671|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2494672|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2494673|NCT01187199|Growth Substances|growth substances|mesh-ancestor
2494674|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494675|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
2494676|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2494677|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494678|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2494679|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494680|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2494681|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
2494682|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2494683|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
2494684|NCT01187212|Cisplatin|cisplatin|mesh-list
2379002|NCT00625352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379003|NCT00625378|Sorafenib|sorafenib|mesh-list
2379004|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379005|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2379006|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379007|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379008|NCT00625430|Vidarabine|vidarabine|mesh-list
2379009|NCT00625430|Fludarabine|fludarabine|mesh-list
2379010|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
2379011|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379012|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2379013|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
2379014|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379015|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379016|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
2379017|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379018|NCT00625430|Antiviral Agents|antiviral agents|mesh-ancestor
2379019|NCT00625430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2379020|NCT00625456|Molgramostim|molgramostim|mesh-list
2379021|NCT00625456|Sargramostim|sargramostim|mesh-list
2379022|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
2379023|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379024|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494685|NCT01187212|Capecitabine|capecitabine|mesh-list
2494686|NCT01187212|Sorafenib|sorafenib|mesh-list
2494687|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494688|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2494689|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
2379025|NCT00625469|Bosentan|bosentan|mesh-list
2379026|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2379027|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2379028|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379029|NCT00625495|Esomeprazole|esomeprazole|mesh-list
2379030|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2379031|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2379032|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2379033|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379034|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379035|NCT00625547|Levodopa|levodopa|mesh-list
2379036|NCT00625547|Cabergoline|cabergoline|mesh-list
2379037|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2379038|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2379039|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
2379040|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379041|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379042|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379043|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
2379044|NCT00625560|Lamivudine|lamivudine|mesh-list
2379045|NCT00625560|Entecavir|entecavir|mesh-list
2494690|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494691|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2494692|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494693|NCT01187238|Cisplatin|cisplatin|mesh-list
2494694|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494695|NCT01187264|Methotrexate|methotrexate|mesh-list
2494696|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2494697|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
2494698|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2494699|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494700|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2494701|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
2494702|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494703|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494704|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
2494705|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494706|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2494707|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2494708|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
2494709|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2494710|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2494711|NCT01187303|Ofatumumab|ofatumumab|mesh-list
2494712|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494713|NCT01187459|Vitamin D|vitamin d|mesh-list
2494714|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
2379046|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2494715|NCT01187459|Vitamins|vitamins|mesh-list
2494716|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
2494717|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494718|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2494719|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2494720|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
2379047|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2379048|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379049|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379050|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
2379051|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2379052|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2379053|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2379054|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2379055|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494721|NCT01187485|Testosterone|testosterone|mesh-list
2494722|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
2494723|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
2494724|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2494725|NCT01187485|Androgens|androgens|mesh-ancestor
2494726|NCT01187485|Hormones|hormones|mesh-ancestor
2494727|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2494728|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494729|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2494730|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494731|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
2494732|NCT01187537|Bupivacaine|bupivacaine|mesh-list
2494733|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
2379056|NCT00625651|Bevacizumab|bevacizumab|mesh-list
2379057|NCT00625651|Conatumumab|conatumumab|mesh-list
2379058|NCT00625651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2379059|NCT00625651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379060|NCT00625651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2379061|NCT00625651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2379062|NCT00625651|Growth Substances|growth substances|mesh-ancestor
2379063|NCT00625651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379064|NCT00625651|Growth Inhibitors|growth inhibitors|mesh-ancestor
2379065|NCT00625664|Gemcitabine|gemcitabine|mesh-list
2379066|NCT00625664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379067|NCT00625664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2379068|NCT00625664|Antimetabolites|antimetabolites|mesh-ancestor
2494734|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
2494735|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494736|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494737|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
2494738|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494739|NCT01187589|Albuterol|albuterol|mesh-list
2494740|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2494741|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
2494742|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494743|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494744|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2494745|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
2494746|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
2494747|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2494748|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2494749|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2494750|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2494751|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
2494752|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494753|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494754|NCT01187615|Cisplatin|cisplatin|mesh-list
2494755|NCT01187615|Pemetrexed|pemetrexed|mesh-list
2494756|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494757|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494758|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494759|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2379069|NCT00625664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379070|NCT00625664|Antiviral Agents|antiviral agents|mesh-ancestor
2379071|NCT00625664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2379072|NCT00625664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379073|NCT00625664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379074|NCT00625664|Immunologic Factors|immunologic factors|mesh-ancestor
2379075|NCT00625664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379076|NCT00625677|Vaccines|vaccines|mesh-list
2379077|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
2494760|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2494761|NCT01187719|Phenytoin|phenytoin|mesh-list
2494762|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
2494763|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2494764|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2494765|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2379078|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379079|NCT00625781|Insulin|insulin|mesh-list
2379080|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2379081|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
2379082|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2379083|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379084|NCT00625794|Nicotine|nicotine|mesh-list
2379085|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2379086|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
2379087|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379088|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379089|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2379090|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2379091|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
2379092|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379093|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379094|NCT00625833|Reboxetine|reboxetine|mesh-list
2494766|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494767|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2494768|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2494769|NCT01187810|Cytarabine|cytarabine|mesh-list
2494770|NCT01187810|Methotrexate|methotrexate|mesh-list
2494771|NCT01187810|Fenretinide|fenretinide|mesh-list
2494772|NCT01187810|Retinamide|retinamide|mesh-list
2494773|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2494774|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
2494775|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2494776|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494777|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2494778|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
2494779|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494780|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494781|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
2494782|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494783|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2379095|NCT00625833|Antidepressive Agents|antidepressive agents|mesh-ancestor
2379096|NCT00625833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2379097|NCT00625833|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2379098|NCT00625833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2379099|NCT00625833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2379100|NCT00625833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379101|NCT00625833|Adrenergic Agents|adrenergic agents|mesh-ancestor
2379102|NCT00625833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379103|NCT00625833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379104|NCT00625859|Bupropion|bupropion|mesh-list
2379105|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2379106|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
2379107|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2379108|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2379109|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2379110|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2379111|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379112|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
2379113|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379114|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379115|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2494784|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2494785|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
2494786|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2494787|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2494788|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
2494789|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494790|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2494791|NCT01187810|Protective Agents|protective agents|mesh-ancestor
2494792|NCT01187849|Metformin|metformin|mesh-list
2494793|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2494794|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494795|NCT01187862|Efavirenz|efavirenz|mesh-list
2494796|NCT01187862|Losartan|losartan|mesh-list
2494797|NCT01187862|Metoprolol|metoprolol|mesh-list
2494798|NCT01187862|Midazolam|midazolam|mesh-list
2494799|NCT01187862|Caffeine|caffeine|mesh-list
2494800|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
2494801|NCT01187862|Omeprazole|omeprazole|mesh-list
2494802|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2494803|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2494804|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494805|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494806|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2494807|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2494808|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2494809|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2494810|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
2494811|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
2494812|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
2494813|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
2494814|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494815|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494816|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2494817|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2494818|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2494819|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2494820|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2494821|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2494822|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2379116|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2379117|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379118|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
2379119|NCT00625898|Bevacizumab|bevacizumab|mesh-list
2379120|NCT00625898|Carboplatin|carboplatin|mesh-list
2379121|NCT00625898|Docetaxel|docetaxel|mesh-list
2379122|NCT00625898|Fluorouracil|fluorouracil|mesh-list
2379123|NCT00625898|Trastuzumab|trastuzumab|mesh-list
2379124|NCT00625898|Epirubicin|epirubicin|mesh-list
2379125|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379126|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
2379127|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379128|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2379129|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2379130|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
2379131|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379132|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379133|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2379134|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2379135|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2379136|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2379137|NCT00625898|Growth Substances|growth substances|mesh-ancestor
2379138|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
2379139|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
2379140|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
2379141|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
2379142|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
2494823|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494824|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2494825|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2494826|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2494827|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2494828|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
2494829|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2494830|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2494831|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
2494832|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494833|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2494834|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2494835|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2494836|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2494837|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2494838|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2494839|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
2494840|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
2494841|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379143|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2379144|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2494842|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2494843|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2379145|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2379146|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2379147|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379148|NCT00625911|Morphine|morphine|mesh-list
2379149|NCT00625911|Ketamine|ketamine|mesh-list
2379150|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2379151|NCT00625911|Narcotics|narcotics|mesh-ancestor
2494844|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2494845|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
2494846|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2494847|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2494848|NCT01187888|Rasagiline|rasagiline|mesh-list
2379152|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2379153|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379154|NCT00625911|Analgesics|analgesics|mesh-ancestor
2379155|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
2379156|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379157|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2379158|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2494849|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2494850|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494851|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494852|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2494853|NCT01187888|Protective Agents|protective agents|mesh-ancestor
2494854|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494855|NCT01187992|Atorvastatin|atorvastatin|mesh-list
2494856|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2494857|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2494858|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
2494859|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494860|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2494861|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2494862|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494863|NCT01188005|Vitamins|vitamins|mesh-list
2494864|NCT01188005|Vitamin E|vitamin e|mesh-list
2494865|NCT01188005|Vitamin A|vitamin a|mesh-list
2494866|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
2494867|NCT01188005|Allopurinol|allopurinol|mesh-list
2494868|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2494869|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
2494870|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494871|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
2494872|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494873|NCT01188005|Protective Agents|protective agents|mesh-ancestor
2494874|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
2494875|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2494876|NCT01188005|Expectorants|expectorants|mesh-ancestor
2494877|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
2494878|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2494879|NCT01188005|Antidotes|antidotes|mesh-ancestor
2494880|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
2494881|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494882|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
2494883|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2494884|NCT01188031|Alprazolam|alprazolam|mesh-list
2494885|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2494886|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494887|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494888|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2494889|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2494890|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2494891|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
2494892|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
2494893|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494894|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379159|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
2379160|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
2379161|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2379162|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2379163|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379164|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379165|NCT00625937|Docetaxel|docetaxel|mesh-list
2379166|NCT00625937|Tegafur|tegafur|mesh-list
2379167|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379168|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
2494895|NCT01188057|Alprazolam|alprazolam|mesh-list
2494896|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2494897|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494898|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379169|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
2379170|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
2379171|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379172|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2379173|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
2379174|NCT00626015|Temozolomide|temozolomide|mesh-list
2379175|NCT00626015|Daclizumab|daclizumab|mesh-list
2379176|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2379177|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
2379178|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379179|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379180|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379181|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
2379182|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379183|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2379184|NCT00626080|Insulin|insulin|mesh-list
2379185|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2379186|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
2379187|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
2379188|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
2379189|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
2379190|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2379191|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379192|NCT00626106|Fulvestrant|fulvestrant|mesh-list
2379193|NCT00626106|Exemestane|exemestane|mesh-list
2379194|NCT00626106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2114255|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2114256|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114257|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114258|NCT02600715|Morphine|morphine|mesh-list
2114259|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2114260|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2114261|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2114262|NCT02600715|Narcotics|narcotics|mesh-ancestor
2494899|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2494900|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2494901|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2494902|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
2494903|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
2494904|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494905|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494906|NCT01188096|Poly ICLC|poly iclc|mesh-list
2494907|NCT01188096|Interferon Inducers|interferon inducers|mesh-ancestor
2494908|NCT01188096|Immunologic Factors|immunologic factors|mesh-ancestor
2494909|NCT01188096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379195|NCT00626106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2379196|NCT00626106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379197|NCT00626106|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2379198|NCT00626106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2379199|NCT00626106|Hormone Antagonists|hormone antagonists|mesh-ancestor
2379200|NCT00626106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2379201|NCT00626106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379202|NCT00626106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2379203|NCT00626106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2379204|NCT00626106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379205|NCT00626106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494910|NCT01188148|Memantine|memantine|mesh-list
2494911|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2494912|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2494913|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
2494914|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494915|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379206|NCT00626106|Immunologic Factors|immunologic factors|mesh-ancestor
2379207|NCT00626158|Gemcitabine|gemcitabine|mesh-list
2379208|NCT00626158|Capecitabine|capecitabine|mesh-list
2379209|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2379210|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
2379211|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379212|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379213|NCT00626158|Antiviral Agents|antiviral agents|mesh-ancestor
2379214|NCT00626158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2379215|NCT00626158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379216|NCT00626158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2494916|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494917|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2494918|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2494919|NCT01188174|Clofarabine|clofarabine|mesh-list
2494920|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2494921|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
2379217|NCT00626158|Immunologic Factors|immunologic factors|mesh-ancestor
2379218|NCT00626158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379219|NCT00626223|Folic Acid|folic acid|mesh-list
2379220|NCT00626223|Hematinics|hematinics|mesh-ancestor
2379221|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
2379222|NCT00626223|Vitamins|vitamins|mesh-ancestor
2379223|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
2379224|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379225|NCT00626262|Esomeprazole|esomeprazole|mesh-list
2379226|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2379227|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2379228|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2379229|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379230|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379231|NCT00626288|Mesalamine|mesalamine|mesh-list
2379232|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2379233|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2379234|NCT00626288|Analgesics|analgesics|mesh-ancestor
2379235|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
2379236|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379237|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379238|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2379239|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2379240|NCT00626483|Basiliximab|basiliximab|mesh-list
2379241|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379242|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
2379243|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494922|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494923|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494924|NCT01188187|Dexamethasone|dexamethasone|mesh-list
2494925|NCT01188187|Prednisone|prednisone|mesh-list
2494926|NCT01188187|Docetaxel|docetaxel|mesh-list
2494927|NCT01188187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2494928|NCT01188187|Antiemetics|antiemetics|mesh-ancestor
2494929|NCT01188187|Autonomic Agents|autonomic agents|mesh-ancestor
2494930|NCT01188187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494931|NCT01188187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494932|NCT01188187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2494933|NCT01188187|Glucocorticoids|glucocorticoids|mesh-ancestor
2494934|NCT01188187|Hormones|hormones|mesh-ancestor
2494935|NCT01188187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2379244|NCT00626509|Sunitinib|sunitinib|mesh-list
2379245|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379246|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2494936|NCT01188187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2494937|NCT01188187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494938|NCT01188187|Tubulin Modulators|tubulin modulators|mesh-ancestor
2379247|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2379248|NCT00626509|Growth Substances|growth substances|mesh-ancestor
2379249|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379250|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
2379251|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2379252|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379253|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379254|NCT00626535|Esomeprazole|esomeprazole|mesh-list
2379255|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2379256|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2379257|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2379258|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379259|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379260|NCT00626600|Oxycodone|oxycodone|mesh-list
2379261|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2494939|NCT01188187|Antimitotic Agents|antimitotic agents|mesh-ancestor
2494940|NCT01188187|Mitosis Modulators|mitosis modulators|mesh-ancestor
2494941|NCT01188187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494942|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
2494943|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2494944|NCT01188265|Valproic Acid|valproic acid|mesh-list
2494945|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
2494946|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
2379262|NCT00626600|Narcotics|narcotics|mesh-ancestor
2494947|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
2494948|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2494949|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2494950|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2494951|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494952|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494953|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
2494954|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494955|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
2494956|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
2494957|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2494958|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2494959|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2494960|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
2494961|NCT01188278|Dasatinib|dasatinib|mesh-list
2494962|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494963|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2494964|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494965|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494966|NCT01188304|Aspirin|aspirin|mesh-list
2494967|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2494968|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2494969|NCT01188304|Analgesics|analgesics|mesh-ancestor
2494970|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
2494971|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494972|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494973|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2494974|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2494975|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2494976|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2494977|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494978|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2494979|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2379263|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2379264|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379265|NCT00626600|Analgesics|analgesics|mesh-ancestor
2379266|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
2379267|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379268|NCT00626613|Risperidone|risperidone|mesh-list
2379269|NCT00626613|Galantamine|galantamine|mesh-list
2379270|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2379271|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
2379272|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379273|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379274|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379275|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2379276|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2379277|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2379278|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2379279|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2379280|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
2379281|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2379282|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379283|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
2379284|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2379285|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
2379286|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379287|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
2379288|NCT00626665|Tadalafil|tadalafil|mesh-list
2379289|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
2379290|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2379291|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2379292|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379293|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379294|NCT00626665|Urological Agents|urological agents|mesh-ancestor
2379295|NCT00626678|Prednisone|prednisone|mesh-list
2379296|NCT00626678|Azathioprine|azathioprine|mesh-list
2379297|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2379298|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
2379299|NCT00626678|Hormones|hormones|mesh-ancestor
2379300|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2379301|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379302|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2379303|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114263|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2114264|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114265|NCT02600715|Analgesics|analgesics|mesh-ancestor
2114266|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
2114267|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114268|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2114269|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2114270|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2114271|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114272|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
2114273|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2114274|NCT02600767|Lumefantrine|lumefantrine|mesh-list
2114275|NCT02600767|Artemether|artemether|mesh-list
2114276|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2494980|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494981|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
2494982|NCT01188317|Ibuprofen|ibuprofen|mesh-list
2494983|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2494984|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2494985|NCT01188317|Analgesics|analgesics|mesh-ancestor
2494986|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
2494987|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2494988|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2494989|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2494990|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2494991|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2494992|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2494993|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2494994|NCT01188408|Docetaxel|docetaxel|mesh-list
2494995|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2494996|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
2494997|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
2494998|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
2494999|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495000|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2495001|NCT01188707|Belinostat|belinostat|mesh-list
2495002|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495003|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2495004|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495005|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495006|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2495007|NCT01188733|Octreotide|octreotide|mesh-list
2495008|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2495009|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2495010|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495011|NCT01188759|Voriconazole|voriconazole|mesh-list
2495012|NCT01188759|Anidulafungin|anidulafungin|mesh-list
2495013|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
2495014|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495015|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2379304|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
2379305|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379306|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2495016|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2495017|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495018|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495019|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2495020|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
2495021|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2495022|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495023|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2495024|NCT01188824|Cilostazol|cilostazol|mesh-list
2379307|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379308|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
2379309|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2379310|NCT00626704|Doxorubicin|doxorubicin|mesh-list
2379311|NCT00626704|Conatumumab|conatumumab|mesh-list
2379312|NCT00626704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2379313|NCT00626704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379314|NCT00626704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2379315|NCT00626704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2379316|NCT00626704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379317|NCT00626704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495025|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2495026|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
2495027|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495028|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495029|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2495030|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
2495031|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2495032|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2495033|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495034|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2495035|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
2495036|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2495037|NCT01188824|Protective Agents|protective agents|mesh-ancestor
2495038|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2495039|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2495040|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495041|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2495042|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2495043|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495044|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2495045|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495046|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
2495047|NCT01188889|Everolimus|everolimus|mesh-list
2495048|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495049|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2495050|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495051|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495052|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2495053|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
2495054|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495055|NCT01188954|Doxycycline|doxycycline|mesh-list
2495056|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2495057|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495058|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
2495059|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2495060|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2495061|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
2495062|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
2495063|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
2495064|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2495065|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2495066|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495067|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495068|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495069|NCT01189019|Ranibizumab|ranibizumab|mesh-list
2495070|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2495071|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2495072|NCT01189019|Growth Substances|growth substances|mesh-ancestor
2495073|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495074|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
2495075|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379318|NCT00626704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2379319|NCT00626717|Riboflavin|riboflavin|mesh-list
2379320|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
2379321|NCT00626717|Vitamins|vitamins|mesh-ancestor
2379322|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
2379323|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379324|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2379325|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
2379326|NCT00626769|Genistein|genistein|mesh-list
2379327|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2379328|NCT00626769|Protective Agents|protective agents|mesh-ancestor
2379329|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379330|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379331|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2379332|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379333|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379334|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
2379335|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2379336|NCT00626769|Estrogens|estrogens|mesh-ancestor
2379337|NCT00626769|Hormones|hormones|mesh-ancestor
2379338|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2379339|NCT00626834|Vigabatrin|vigabatrin|mesh-list
2379340|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
2379341|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379342|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379343|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
2379344|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379345|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379346|NCT00626977|Clonidine|clonidine|mesh-list
2379347|NCT00626977|Ropivacaine|ropivacaine|mesh-list
2379348|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
2379349|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
2379350|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2379351|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379352|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
2379353|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379354|NCT00626977|Analgesics|analgesics|mesh-ancestor
2379355|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2495076|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
2495077|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
2495078|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
2495079|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2495080|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2379356|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
2379357|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
2379358|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2379359|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2379360|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2379361|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
2379362|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379363|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379364|NCT00626990|Temozolomide|temozolomide|mesh-list
2379365|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2379366|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
2379367|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379368|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495081|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495082|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379369|NCT00627003|Cabergoline|cabergoline|mesh-list
2379370|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2379371|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2379372|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
2379373|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
2379374|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379375|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379376|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379377|NCT00627081|Remifentanil|remifentanil|mesh-list
2379378|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2495083|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495084|NCT01189214|Memantine|memantine|mesh-list
2495085|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2495086|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2495087|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
2495088|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495089|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495090|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495091|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2495092|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2495093|NCT01189253|Doxorubicin|doxorubicin|mesh-list
2495094|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2495095|NCT01189253|Trabectedin|trabectedin|mesh-list
2495096|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2114277|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
2114278|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2114279|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2114280|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114281|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2114282|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2114283|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2495097|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495098|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2495099|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2495100|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495101|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379379|NCT00627081|Narcotics|narcotics|mesh-ancestor
2379380|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2379381|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379382|NCT00627081|Analgesics|analgesics|mesh-ancestor
2495102|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2495103|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
2495104|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2495105|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
2495106|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2495107|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2495108|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2495109|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2379383|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
2379384|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379385|NCT00627133|Levetiracetam|levetiracetam|mesh-list
2379386|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
2379387|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
2379388|NCT00627250|Amantadine|amantadine|mesh-list
2379389|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2379390|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2379391|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
2379392|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2379393|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
2379394|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495110|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495111|NCT01189396|Albuterol|albuterol|mesh-list
2495112|NCT01189396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2379395|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379396|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379397|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2379398|NCT00627250|Analgesics|analgesics|mesh-ancestor
2379399|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
2379400|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379401|NCT00627354|Prednisone|prednisone|mesh-list
2379402|NCT00627354|Etoposide|etoposide|mesh-list
2379403|NCT00627354|Vinorelbine|vinorelbine|mesh-list
2379404|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
2379405|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2379406|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
2379407|NCT00627354|Hormones|hormones|mesh-ancestor
2379408|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2379409|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379410|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2379411|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379412|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2379413|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2379414|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2379415|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379416|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379417|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
2379418|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
2379419|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
2379420|NCT00627354|Analgesics|analgesics|mesh-ancestor
2495113|NCT01189396|Autonomic Agents|autonomic agents|mesh-ancestor
2495114|NCT01189396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495115|NCT01189396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495116|NCT01189396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2495117|NCT01189396|Respiratory System Agents|respiratory system agents|mesh-ancestor
2495118|NCT01189396|Tocolytic Agents|tocolytic agents|mesh-ancestor
2495119|NCT01189396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2495120|NCT01189396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2495121|NCT01189396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2495122|NCT01189396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2495123|NCT01189396|Adrenergic Agents|adrenergic agents|mesh-ancestor
2495124|NCT01189396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379421|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
2379422|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379423|NCT00627432|Gemcitabine|gemcitabine|mesh-list
2379424|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
2379425|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2379426|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
2495125|NCT01189396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495126|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
2495127|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
2495128|NCT01189448|Spiramycin|spiramycin|mesh-list
2379427|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379428|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379429|NCT00627432|Antiviral Agents|antiviral agents|mesh-ancestor
2379430|NCT00627432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2379431|NCT00627432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379432|NCT00627432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379433|NCT00627432|Immunologic Factors|immunologic factors|mesh-ancestor
2379434|NCT00627432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379435|NCT00627471|Insulin|insulin|mesh-list
2379436|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2379437|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
2379438|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2495129|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
2495130|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2495131|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2495132|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495133|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2495134|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495135|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495136|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2495137|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
2495138|NCT01189526|Ranibizumab|ranibizumab|mesh-list
2495139|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2495140|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2495141|NCT01189526|Growth Substances|growth substances|mesh-ancestor
2495142|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495143|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
2495144|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379439|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379440|NCT00627536|Mitogens|mitogens|mesh-list
2379441|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
2379442|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379443|NCT00627575|Lamotrigine|lamotrigine|mesh-list
2379444|NCT00627575|Phenytoin|phenytoin|mesh-list
2379445|NCT00627575|Atorvastatin|atorvastatin|mesh-list
2379446|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2379447|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2379448|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
2379449|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379450|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2379451|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2379452|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379453|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
2379454|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2379455|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2379456|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2379457|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379458|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2379459|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2379460|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2495145|NCT01189643|Bevacizumab|bevacizumab|mesh-list
2495146|NCT01189643|Irinotecan|irinotecan|mesh-list
2495147|NCT01189643|Temozolomide|temozolomide|mesh-list
2495148|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2495149|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495150|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2495151|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2495152|NCT01189643|Growth Substances|growth substances|mesh-ancestor
2495153|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495154|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
2495155|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2495156|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2495157|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495158|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495159|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2495160|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
2495161|NCT01189656|Vaccines|vaccines|mesh-list
2495162|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
2495163|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495164|NCT01189695|Ritonavir|ritonavir|mesh-list
2495165|NCT01189695|Lopinavir|lopinavir|mesh-list
2495166|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2495167|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2495168|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
2495169|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495170|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495171|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2495172|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2495173|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
2495174|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495175|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2495176|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2495177|NCT01189721|Propofol|propofol|mesh-list
2495178|NCT01189721|Sevoflurane|sevoflurane|mesh-list
2495179|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2495180|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2495181|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495182|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2495183|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
2495184|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
2495185|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2495186|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2495187|NCT01189773|Ibuprofen|ibuprofen|mesh-list
2495188|NCT01189773|Codeine|codeine|mesh-list
2495189|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2495190|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2495191|NCT01189773|Analgesics|analgesics|mesh-ancestor
2495192|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
2495193|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495194|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495195|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2495196|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2495197|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2495198|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495199|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495200|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2495201|NCT01189773|Narcotics|narcotics|mesh-ancestor
2495202|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2495203|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
2495204|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
2495205|NCT01189864|Diclofenac|diclofenac|mesh-list
2495206|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
2495207|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2495208|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
2495209|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2495210|NCT01189864|Prednisolone|prednisolone|mesh-list
2495211|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2495212|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
2495213|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2495214|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2495215|NCT01189864|Analgesics|analgesics|mesh-ancestor
2495216|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
2495217|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495218|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495219|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2495220|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2495221|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2495222|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495223|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379461|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2379462|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2379463|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2379464|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2379465|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2495224|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
2495225|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
2379466|NCT00627653|Fenofibrate|fenofibrate|mesh-list
2379467|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2379468|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
2379469|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379470|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2379471|NCT00627666|Leucovorin|leucovorin|mesh-list
2379472|NCT00627666|Methotrexate|methotrexate|mesh-list
2379473|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
2379474|NCT00627666|Fludarabine|fludarabine|mesh-list
2379475|NCT00627666|Busulfan|busulfan|mesh-list
2379476|NCT00627666|Calcium|calcium|mesh-list
2379477|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2379478|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
2379479|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2379480|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379481|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2379482|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
2379483|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2379484|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2379485|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
2379486|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379487|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379488|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
2379489|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379490|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2379491|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379492|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
2379493|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2379494|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2379495|NCT00627666|Antidotes|antidotes|mesh-ancestor
2379496|NCT00627666|Protective Agents|protective agents|mesh-ancestor
2379497|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
2379498|NCT00627666|Vitamins|vitamins|mesh-ancestor
2495226|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2495227|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
2495228|NCT01189864|Hormones|hormones|mesh-ancestor
2495229|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2495230|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2495231|NCT01189864|Protective Agents|protective agents|mesh-ancestor
2495232|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2495233|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495234|NCT01189929|Gemcitabine|gemcitabine|mesh-list
2495235|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2495236|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2495237|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
2495238|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495239|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495240|NCT01189929|Antiviral Agents|antiviral agents|mesh-ancestor
2495241|NCT01189929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495242|NCT01189929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495243|NCT01189929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2495244|NCT01189929|Immunologic Factors|immunologic factors|mesh-ancestor
2495245|NCT01189929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495246|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
2495247|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
2495248|NCT01190137|Vitamin D|vitamin d|mesh-list
2495249|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2495250|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495251|NCT01190137|Vitamins|vitamins|mesh-ancestor
2495252|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
2495253|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2495254|NCT01190163|Oxytocin|oxytocin|mesh-list
2495255|NCT01190163|Dinoprostone|dinoprostone|mesh-list
2495256|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
2495257|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2495258|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495259|NCT01190241|Everolimus|everolimus|mesh-list
2495260|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2495261|NCT01190241|Sorafenib|sorafenib|mesh-list
2495262|NCT01190241|Sunitinib|sunitinib|mesh-list
2495263|NCT01190241|Lapatinib|lapatinib|mesh-list
2495264|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495265|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2495266|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
2495267|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495268|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2495269|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495270|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495271|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2495272|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2495273|NCT01190241|Growth Substances|growth substances|mesh-ancestor
2495274|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
2495275|NCT01190293|Efavirenz|efavirenz|mesh-list
2495276|NCT01190293|Maraviroc|maraviroc|mesh-list
2495277|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2495278|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2495279|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379499|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
2379500|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
2495280|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495281|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
2495282|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2379501|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2379502|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2379503|NCT00627692|Prucalopride|prucalopride|mesh-list
2379504|NCT00627692|Laxatives|laxatives|mesh-ancestor
2379505|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2379506|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2379507|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2379508|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
2379509|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379510|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379511|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379512|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
2379513|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2379514|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2379515|NCT00627731|Prednisolone|prednisolone|mesh-list
2379516|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
2379517|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2495283|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2495284|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2495285|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2495286|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2495287|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2495288|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2495289|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2495290|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2495291|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2495292|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2495293|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2495294|NCT01190345|Bevacizumab|bevacizumab|mesh-list
2495295|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2495296|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495297|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2495298|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2495299|NCT01190345|Growth Substances|growth substances|mesh-ancestor
2495300|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495301|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
2495302|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
2495303|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2495304|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495305|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
2495306|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495307|NCT01190358|Protective Agents|protective agents|mesh-ancestor
2495308|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495309|NCT01190371|Artesunate|artesunate|mesh-list
2495310|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
2495311|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2495312|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2114284|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
2114285|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114286|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
2114287|NCT02600871|Povidone|povidone|mesh-list
2114288|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
2114289|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
2114290|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2114291|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495313|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495314|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495315|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
2495316|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
2495317|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2495318|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
2495319|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
2495320|NCT01190384|Antioxidants|antioxidants|mesh-list
2495321|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495322|NCT01190384|Protective Agents|protective agents|mesh-ancestor
2495323|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495324|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2495325|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495326|NCT01190462|Cetuximab|cetuximab|mesh-list
2495327|NCT01190462|Simvastatin|simvastatin|mesh-list
2379518|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
2495328|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2495329|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495330|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2495331|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2495332|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
2495333|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495334|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2379519|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2379520|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
2379521|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
2379522|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379523|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379524|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2379525|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
2379526|NCT00627731|Hormones|hormones|mesh-ancestor
2379527|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2379528|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2379529|NCT00627731|Protective Agents|protective agents|mesh-ancestor
2379530|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2379531|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495335|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2495336|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495337|NCT01190553|Amantadine|amantadine|mesh-list
2495338|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2495339|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2495340|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
2495341|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495342|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
2495343|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495344|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495345|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495346|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2495347|NCT01190553|Analgesics|analgesics|mesh-ancestor
2495348|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
2495349|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495350|NCT01190670|Tacrolimus|tacrolimus|mesh-list
2495351|NCT01190670|Peficitinib|peficitinib|mesh-list
2495352|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2495353|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
2495354|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495355|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2495356|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495357|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495358|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
2379532|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2379533|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2379534|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379535|NCT00627744|Incretins|incretins|mesh-ancestor
2379536|NCT00627744|Hormones|hormones|mesh-ancestor
2379537|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2379538|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2379539|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
2379540|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379541|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379542|NCT00627796|Lanreotide|lanreotide|mesh-list
2379543|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379544|NCT00627809|Streptokinase|streptokinase|mesh-list
2379545|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2495359|NCT01190683|Vitamin D|vitamin d|mesh-list
2495360|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
2495361|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
2495362|NCT01190683|Vitamins|vitamins|mesh-list
2495363|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
2495364|NCT01190683|Calcium|calcium|mesh-list
2495365|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
2495366|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495367|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2495368|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2495369|NCT01190683|Antacids|antacids|mesh-ancestor
2495370|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495371|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2495372|NCT01190722|Diclofenac|diclofenac|mesh-list
2495373|NCT01190722|Etoricoxib|etoricoxib|mesh-list
2379546|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2379547|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379548|NCT00627835|Cisplatin|cisplatin|mesh-list
2379549|NCT00627835|Sorafenib|sorafenib|mesh-list
2379550|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379551|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2379552|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379553|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379554|NCT00627848|Rivastigmine|rivastigmine|mesh-list
2379555|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2379556|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379557|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379558|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
2379559|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379560|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379561|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2379562|NCT00627848|Protective Agents|protective agents|mesh-ancestor
2379563|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2379564|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
2379565|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2379566|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379567|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379568|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2495374|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2495375|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2495376|NCT01190722|Analgesics|analgesics|mesh-ancestor
2495377|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
2495378|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495379|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495380|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2495381|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2495382|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2495383|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495384|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495385|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2495386|NCT01190735|Caffeine|caffeine|mesh-list
2495387|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2495388|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495389|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2495390|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495391|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495392|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2495393|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2495394|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
2495395|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379569|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2379570|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2379571|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379572|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2379573|NCT00627900|Sirolimus|sirolimus|mesh-list
2495396|NCT01190748|Galantamine|galantamine|mesh-list
2495397|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2495398|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495399|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495400|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
2495401|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495402|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495403|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2495404|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
2495405|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495406|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
2495407|NCT01190761|Galantamine|galantamine|mesh-list
2495408|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2495409|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495410|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495411|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
2495412|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495413|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495414|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2495415|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
2495416|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495417|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
2495418|NCT01190787|Prednisone|prednisone|mesh-list
2495419|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
2495420|NCT01190787|Melphalan|melphalan|mesh-list
2495421|NCT01190787|Bortezomib|bortezomib|mesh-list
2495422|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2495423|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
2495424|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495425|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2495426|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2495427|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
2495428|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495429|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495430|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2495431|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2495432|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
2495433|NCT01190787|Hormones|hormones|mesh-ancestor
2379574|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2379575|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2379576|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2379577|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379578|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
2379579|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379580|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
2379581|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379582|NCT00627913|Anesthetics|anesthetics|mesh-list
2379583|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2379584|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379585|NCT00627952|Amlodipine|amlodipine|mesh-list
2379586|NCT00627952|Manidipine|manidipine|mesh-list
2379587|NCT00627952|Delapril|delapril|mesh-list
2379588|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2495434|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2495435|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2495436|NCT01190852|Fluticasone|fluticasone|mesh-list
2495437|NCT01190852|Azelastine|azelastine|mesh-list
2495438|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2495439|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2495440|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
2495441|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495442|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495443|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2495444|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
2495445|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
2495446|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2495447|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2495448|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495449|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495450|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2495451|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2495452|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
2495453|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
2495454|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495455|NCT01190982|Paclitaxel|paclitaxel|mesh-list
2495456|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2495457|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495458|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
2495459|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
2495460|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
2495461|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495462|NCT01191021|Propofol|propofol|mesh-list
2495463|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
2495464|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2495465|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495466|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2495467|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2495468|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
2495469|NCT01191034|Imiquimod|imiquimod|mesh-list
2495470|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2495471|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
2379589|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2379590|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2379591|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379592|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2379593|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379594|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
2379595|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2379596|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
2379597|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379598|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
2379599|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379600|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
2379601|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2379602|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2379603|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379604|NCT00627965|Urological Agents|urological agents|mesh-ancestor
2379605|NCT00627991|Valsartan|valsartan|mesh-list
2379606|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2379607|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2379608|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2379609|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379610|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
2379611|NCT00628043|Hematinics|hematinics|mesh-ancestor
2379612|NCT00628056|Perhexiline|perhexiline|mesh-list
2379613|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2379614|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2379615|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379616|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2495472|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495473|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495474|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
2495475|NCT01191060|Lenalidomide|lenalidomide|mesh-list
2495476|NCT01191060|Bortezomib|bortezomib|mesh-list
2495477|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
2495478|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495479|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2495480|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2495481|NCT01191060|Growth Substances|growth substances|mesh-ancestor
2495482|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
2495483|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495484|NCT01191203|Copper|copper|mesh-list
2495485|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2495486|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
2495487|NCT01191203|Trace Elements|trace elements|mesh-ancestor
2495488|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
2495489|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495490|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2495491|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2495492|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2379617|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379618|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
2379619|NCT00628121|Cetrorelix|cetrorelix|mesh-list
2495493|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
2495494|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2495495|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2495496|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2495497|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2495498|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2495499|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379620|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2379621|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
2379622|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2379623|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379624|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
2379625|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2379626|NCT00628160|Terlipressin|terlipressin|mesh-list
2379627|NCT00628160|Dopamine|dopamine|mesh-list
2379628|NCT00628160|Norepinephrine|norepinephrine|mesh-list
2495500|NCT01191216|Docetaxel|docetaxel|mesh-list
2495501|NCT01191216|Tryptophan|tryptophan|mesh-list
2495502|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495503|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
2495504|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
2495505|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
2495506|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495507|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2495508|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
2495509|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2379629|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
2379630|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2379631|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2379632|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422908|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379633|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379634|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379635|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
2379636|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
2379637|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379638|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2379639|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2379640|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2379641|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
2379642|NCT00628160|Protective Agents|protective agents|mesh-ancestor
2379643|NCT00628225|Bupropion|bupropion|mesh-list
2379644|NCT00628225|Nicotine|nicotine|mesh-list
2379645|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2379646|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
2379647|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379648|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379649|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2379650|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2379651|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
2379652|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379653|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379654|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2379655|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
2379656|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2379657|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2379658|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2379659|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2379660|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
2379661|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2379662|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2379663|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379664|NCT00628238|Rituximab|rituximab|mesh-list
2495510|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
2495511|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2495512|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
2495513|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495514|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495515|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2495516|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
2495517|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2495518|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2495519|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2495520|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
2495521|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495522|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495523|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
2495524|NCT01191450|Amiloride|amiloride|mesh-list
2495525|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2495526|NCT01191450|Diuretics|diuretics|mesh-ancestor
2379665|NCT00628238|Lenalidomide|lenalidomide|mesh-list
2379666|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2379667|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379668|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
2379669|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379670|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2379671|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2379672|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2379673|NCT00628238|Growth Substances|growth substances|mesh-ancestor
2379674|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
2379675|NCT00628290|Cannabidiol|cannabidiol|mesh-list
2495527|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
2495528|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495529|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2495530|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2495531|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495532|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2495533|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2495534|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2495535|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2495536|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
2495537|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2495538|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2495539|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495540|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
2495541|NCT01191554|Coagulants|coagulants|mesh-ancestor
2495542|NCT01191593|Ropivacaine|ropivacaine|mesh-list
2495543|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
2495544|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
2495545|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2495546|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495547|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
2495548|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495549|NCT01191645|Remifentanil|remifentanil|mesh-list
2495550|NCT01191645|Metoclopramide|metoclopramide|mesh-list
2495551|NCT01191645|Naloxone|naloxone|mesh-list
2495552|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2495553|NCT01191645|Narcotics|narcotics|mesh-ancestor
2495554|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2495555|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495556|NCT01191645|Analgesics|analgesics|mesh-ancestor
2495557|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
2495558|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495559|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2495560|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
2495561|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
2495562|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2495563|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2495564|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2495565|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
2495566|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495567|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495568|NCT01191684|Vaccines|vaccines|mesh-list
2495569|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
2495570|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495571|NCT01191697|Bevacizumab|bevacizumab|mesh-list
2495572|NCT01191697|Trastuzumab|trastuzumab|mesh-list
2495573|NCT01191697|Capecitabine|capecitabine|mesh-list
2495574|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
2495575|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2495576|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495577|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2495578|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2495579|NCT01191697|Growth Substances|growth substances|mesh-ancestor
2495580|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495581|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
2495582|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2495583|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
2495584|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495585|NCT01191710|Progesterone|progesterone|mesh-list
2495586|NCT01191710|Progestins|progestins|mesh-ancestor
2495587|NCT01191710|Hormones|hormones|mesh-ancestor
2495588|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2495589|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495590|NCT01191892|Gemcitabine|gemcitabine|mesh-list
2495591|NCT01191892|Carboplatin|carboplatin|mesh-list
2495592|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495593|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2495594|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
2495595|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495596|NCT01191892|Antiviral Agents|antiviral agents|mesh-ancestor
2495597|NCT01191892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495598|NCT01191892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495599|NCT01191892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2495600|NCT01191892|Immunologic Factors|immunologic factors|mesh-ancestor
2495601|NCT01191892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379676|NCT00628290|Amisulpride|amisulpride|mesh-list
2379677|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
2379678|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2379679|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2379680|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2379681|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379682|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2379683|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2379684|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
2379685|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379686|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379687|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2379688|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
2495602|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
2495603|NCT01191918|Donepezil|donepezil|mesh-list
2495604|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2495605|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495606|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495607|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
2495608|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495609|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495610|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
2495611|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
2495612|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2495613|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
2495614|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2495615|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2495616|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
2495617|NCT01191957|Busulfan|busulfan|mesh-list
2495618|NCT01191957|Fludarabine|fludarabine|mesh-list
2495619|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379689|NCT00628316|Caffeine|caffeine|mesh-list
2379690|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2379691|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379692|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2379693|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379694|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379695|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2379696|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2379697|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
2379698|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379699|NCT00628342|Esomeprazole|esomeprazole|mesh-list
2379700|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2379701|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2379702|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2379703|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379704|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379705|NCT00628459|Micronutrients|micronutrients|mesh-list
2379706|NCT00628459|Trace Elements|trace elements|mesh-list
2495620|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
2495621|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495622|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2495623|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2495624|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
2495625|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495626|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495627|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2495628|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
2495629|NCT01191983|Hematinics|hematinics|mesh-ancestor
2495630|NCT01192035|Ritonavir|ritonavir|mesh-list
2495631|NCT01192035|Lopinavir|lopinavir|mesh-list
2495632|NCT01192035|Nevirapine|nevirapine|mesh-list
2495633|NCT01192035|Efavirenz|efavirenz|mesh-list
2495634|NCT01192035|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2495635|NCT01192035|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2495636|NCT01192035|Protease Inhibitors|protease inhibitors|mesh-ancestor
2495637|NCT01192035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495638|NCT01192035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495639|NCT01192035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2495640|NCT01192035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2495641|NCT01192035|Antiviral Agents|antiviral agents|mesh-ancestor
2495642|NCT01192035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495643|NCT01192035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2495644|NCT01192035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2495645|NCT01192035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2495646|NCT01192035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2495647|NCT01192035|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2495648|NCT01192035|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2495649|NCT01192035|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2495650|NCT01192035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2495651|NCT01192035|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2495652|NCT01192087|Cetuximab|cetuximab|mesh-list
2495653|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2495654|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495655|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
2495656|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
2495657|NCT01192113|Vitamins|vitamins|mesh-ancestor
2495658|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
2495659|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495660|NCT01192165|Paclitaxel|paclitaxel|mesh-list
2495661|NCT01192165|Docetaxel|docetaxel|mesh-list
2379707|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379708|NCT00628550|Vasopressins|vasopressins|mesh-list
2379709|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
2379710|NCT00628550|Epinephrine|epinephrine|mesh-list
2379711|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2379712|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2495662|NCT01192165|Carboplatin|carboplatin|mesh-list
2495663|NCT01192165|Pemetrexed|pemetrexed|mesh-list
2495664|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2495665|NCT01192165|Trametinib|trametinib|mesh-list
2495666|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2495667|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495668|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
2495669|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
2495670|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
2495671|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495672|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495673|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2495674|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2495675|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2495676|NCT01192230|Docetaxel|docetaxel|mesh-list
2495677|NCT01192230|Endostatins|endostatins|mesh-list
2495678|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495679|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
2495680|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
2495681|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
2495682|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495683|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2495684|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2495685|NCT01192230|Growth Substances|growth substances|mesh-ancestor
2495686|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379713|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
2379714|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379715|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379716|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495687|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
2495688|NCT01192243|Carboplatin|carboplatin|mesh-list
2495689|NCT01192243|Pemetrexed|pemetrexed|mesh-list
2495690|NCT01192243|Gefitinib|gefitinib|mesh-list
2495691|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495692|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495693|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495694|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2495695|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2495696|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2495697|NCT01192308|Tamoxifen|tamoxifen|mesh-list
2495698|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2495699|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
2495700|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2495701|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495702|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2495703|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495704|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2495705|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2495706|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2495707|NCT01192490|Lidocaine|lidocaine|mesh-list
2495708|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
2495709|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
2495710|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2495711|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495712|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
2495713|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495714|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2495715|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2495716|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2495717|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2495718|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495719|NCT01192503|Rasagiline|rasagiline|mesh-list
2495720|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2495721|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495722|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495723|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2495724|NCT01192503|Protective Agents|protective agents|mesh-ancestor
2495725|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495726|NCT01192529|Phentermine|phentermine|mesh-list
2495727|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2495728|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495729|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
2495730|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2495731|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
2495732|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
2495733|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495734|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
2495735|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495736|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495737|NCT01192555|Cyclophosphamide|cyclophosphamide|mesh-list
2495738|NCT01192555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2495739|NCT01192555|Immunologic Factors|immunologic factors|mesh-ancestor
2495740|NCT01192555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495741|NCT01192555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2495742|NCT01192555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2495743|NCT01192555|Alkylating Agents|alkylating agents|mesh-ancestor
2495744|NCT01192555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495745|NCT01192555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379717|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2379718|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2495746|NCT01192555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2495758|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2379719|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
2379720|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379721|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2379722|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
2379723|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
2379724|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
2379725|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2379726|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
2495759|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
2495760|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
2495761|NCT01192724|Aspirin|aspirin|mesh-list
2495762|NCT01192724|Cilostazol|cilostazol|mesh-list
2495763|NCT01192724|Clopidogrel|clopidogrel|mesh-list
2495764|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2114304|NCT02601027|Acetaminophen|acetaminophen|mesh-list
2114305|NCT02601027|Oxycodone|oxycodone|mesh-list
2114306|NCT02601027|Hydromorphone|hydromorphone|mesh-list
2114307|NCT02601027|Ondansetron|ondansetron|mesh-list
2114308|NCT02601027|Bupivacaine|bupivacaine|mesh-list
2114309|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
2114310|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
2114311|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2114312|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114313|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
2114314|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114315|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2114316|NCT02601027|Narcotics|narcotics|mesh-ancestor
2114317|NCT02601027|Analgesics|analgesics|mesh-ancestor
2114318|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
2114319|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
2114320|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2114321|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
2379727|NCT00628550|Coagulants|coagulants|mesh-ancestor
2495765|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2495766|NCT01192724|Analgesics|analgesics|mesh-ancestor
2495767|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
2495768|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495769|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495770|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2495771|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2495772|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2495773|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2495774|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495775|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2495776|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2495777|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495778|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
2495779|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2495780|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2495781|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2379728|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2379729|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
2379730|NCT00628576|Heparin|heparin|mesh-list
2379731|NCT00628576|Calcium heparin|calcium heparin|mesh-list
2379732|NCT00628576|Tinzaparin|tinzaparin|mesh-list
2379733|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2379734|NCT00628576|Dalteparin|dalteparin|mesh-list
2379735|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
2379736|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2379737|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2379738|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379739|NCT00628667|Esomeprazole|esomeprazole|mesh-list
2379740|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2379741|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2379742|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2495782|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
2495783|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495784|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2495785|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
2495786|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2495787|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
2495788|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
2495789|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2495790|NCT01192724|Protective Agents|protective agents|mesh-ancestor
2495791|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2495792|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2379743|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379744|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379745|NCT00628680|Heparin|heparin|mesh-list
2379746|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
2379747|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2379748|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2379749|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379750|NCT00628706|Dronabinol|dronabinol|mesh-list
2379751|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
2379752|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379753|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2379754|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2495793|NCT01192763|R04929097|r04929097|mesh-list
2495794|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495795|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495796|NCT01192789|Amoxicillin|amoxicillin|mesh-list
2495797|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2495798|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495799|NCT01192802|Albendazole|albendazole|mesh-list
2495800|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
2495801|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2495802|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495803|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
2495804|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2495805|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2495806|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
2495807|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
2495808|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
2495809|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495810|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495811|NCT01192854|Adefovir|adefovir|mesh-list
2379755|NCT00628706|Analgesics|analgesics|mesh-ancestor
2379756|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
2495812|NCT01192854|Clevudine|clevudine|mesh-list
2379757|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379758|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2379759|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2379760|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379761|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379762|NCT00628706|Hormones|hormones|mesh-ancestor
2379763|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2379764|NCT00628719|Amphotericin B|amphotericin b|mesh-list
2379765|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2379766|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
2379767|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
2379768|NCT00628719|Amebicides|amebicides|mesh-ancestor
2379769|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2379770|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2379771|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2379772|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2379773|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
2379774|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2379775|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2379776|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
2495813|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
2495814|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495815|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2495816|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2495817|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495818|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495819|NCT01192880|Antipsychotic Agents|antipsychotic agents|mesh-list
2495820|NCT01192880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2495821|NCT01192880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2495822|NCT01192880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495823|NCT01192880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2495824|NCT01192971|Apatinib|apatinib|mesh-list
2495825|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495826|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2495827|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495828|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495829|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
2495830|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495831|NCT01193140|Temozolomide|temozolomide|mesh-list
2379777|NCT00628732|Topotecan|topotecan|mesh-list
2379778|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379779|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
2379780|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379781|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2379782|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2379783|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
2379784|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379785|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379786|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2379787|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2379788|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2379789|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379790|NCT00628810|Leucovorin|leucovorin|mesh-list
2379791|NCT00628810|Bevacizumab|bevacizumab|mesh-list
2379792|NCT00628810|Fluorouracil|fluorouracil|mesh-list
2379793|NCT00628810|Irinotecan|irinotecan|mesh-list
2495832|NCT01193140|Veliparib|veliparib|mesh-list
2495833|NCT01193140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2495834|NCT01193140|Alkylating Agents|alkylating agents|mesh-ancestor
2495835|NCT01193140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495836|NCT01193140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495837|NCT01193140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2495838|NCT01193140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495839|NCT01193166|Olanzapine|olanzapine|mesh-list
2495840|NCT01193166|Risperidone|risperidone|mesh-list
2495841|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2495842|NCT01193166|Aripiprazole|aripiprazole|mesh-list
2495843|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2495844|NCT01193166|Perphenazine|perphenazine|mesh-list
2379794|NCT00628810|Calcium|calcium|mesh-list
2379795|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
2379796|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2379797|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379798|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2495845|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2495846|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
2495847|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495848|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495849|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495850|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2495851|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2495852|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2379799|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2379800|NCT00628810|Growth Substances|growth substances|mesh-ancestor
2379801|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379802|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
2379803|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2379804|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
2379805|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379806|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2379807|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379808|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
2379809|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2379810|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2379811|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379812|NCT00628810|Antidotes|antidotes|mesh-ancestor
2379813|NCT00628810|Protective Agents|protective agents|mesh-ancestor
2379814|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
2379815|NCT00628810|Vitamins|vitamins|mesh-ancestor
2379816|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
2379817|NCT00628914|Dexetimide|dexetimide|mesh-list
2379818|NCT00628914|Eszopiclone|eszopiclone|mesh-list
2379819|NCT00628914|Citalopram|citalopram|mesh-list
2379820|NCT00628914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2379821|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2379822|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2379823|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379824|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379825|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
2379826|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379827|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2379828|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
2379829|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2379830|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2379831|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2379832|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
2379833|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
2379834|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379835|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2379836|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2379837|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
2379838|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2379839|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2379840|NCT00628953|Esomeprazole|esomeprazole|mesh-list
2379841|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2379842|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2379843|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2379844|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379845|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379846|NCT00629031|Paromomycin|paromomycin|mesh-list
2379847|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2379848|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2379849|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2379850|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2379851|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
2495853|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2495854|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2495855|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
2495856|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
2495857|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
2495858|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495859|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2495860|NCT01193166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2495861|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2495862|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2495863|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
2495864|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
2495865|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2495866|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2495867|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2379852|NCT00629135|Metronidazole|metronidazole|mesh-list
2379853|NCT00629135|Tazobactam|tazobactam|mesh-list
2379854|NCT00629135|Piperacillin|piperacillin|mesh-list
2379855|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2379856|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2379857|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2379858|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2379859|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2379860|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379861|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379862|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379863|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2379864|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2379865|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2379866|NCT00629148|Capecitabine|capecitabine|mesh-list
2379867|NCT00629148|Vinorelbine|vinorelbine|mesh-list
2379868|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2379869|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
2379870|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379871|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379872|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2379873|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
2379874|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
2379875|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
2379876|NCT00629187|Temozolomide|temozolomide|mesh-list
2379877|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2379878|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
2379879|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379880|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379881|NCT00629200|Interferons|interferons|mesh-list
2379882|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
2379883|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
2379884|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
2379885|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379886|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
2379887|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2379888|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
2379889|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379890|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2379891|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2379892|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
2379893|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2379894|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
2379895|NCT00629213|Acarbose|acarbose|mesh-list
2379896|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2379897|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379898|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379899|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2379900|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379901|NCT00629226|Cetuximab|cetuximab|mesh-list
2379902|NCT00629226|Bortezomib|bortezomib|mesh-list
2495868|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2495869|NCT01193192|Vitamins|vitamins|mesh-list
2495870|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
2495871|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495872|NCT01193270|Vitamin E|vitamin e|mesh-list
2495873|NCT01193270|Vitamins|vitamins|mesh-ancestor
2495874|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
2495875|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495876|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
2495877|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495878|NCT01193270|Protective Agents|protective agents|mesh-ancestor
2495879|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2495880|NCT01193296|Vildagliptin|vildagliptin|mesh-list
2495881|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2495882|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495883|NCT01193296|Incretins|incretins|mesh-ancestor
2495884|NCT01193296|Hormones|hormones|mesh-ancestor
2495885|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2495886|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2495887|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
2495888|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495889|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495890|NCT01193361|Interferons|interferons|mesh-list
2379903|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379904|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2495891|NCT01193361|Ribavirin|ribavirin|mesh-list
2379905|NCT00629252|Risperidone|risperidone|mesh-list
2379906|NCT00629252|Sertindole|sertindole|mesh-list
2379907|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2379908|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
2379909|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2379910|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379911|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379912|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2379913|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2379914|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2114322|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
2114323|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2114324|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
2114325|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2114326|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114327|NCT02601027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2114328|NCT02601027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2114329|NCT02601027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2114330|NCT02601027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2114331|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2114332|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
2114333|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
2114334|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2114335|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
2114336|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114337|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
2114338|NCT02601170|Protective Agents|protective agents|mesh-ancestor
2114339|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
2114340|NCT02601313|Fludarabine|fludarabine|mesh-list
2114341|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2114342|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
2114343|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114344|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2114345|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2114346|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
2495892|NCT01193361|Interferon-alpha|interferon-alpha|mesh-list
2495893|NCT01193361|Interferon alpha-2|interferon alpha-2|mesh-list
2379915|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2379916|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2379917|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
2379918|NCT00629278|Tamoxifen|tamoxifen|mesh-list
2379919|NCT00629278|Docetaxel|docetaxel|mesh-list
2379920|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
2379921|NCT00629278|Doxorubicin|doxorubicin|mesh-list
2379922|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2379923|NCT00629278|Fluorouracil|fluorouracil|mesh-list
2379924|NCT00629278|Trastuzumab|trastuzumab|mesh-list
2379925|NCT00629278|Epirubicin|epirubicin|mesh-list
2379926|NCT00629278|Hormones|hormones|mesh-list
2379927|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2379928|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379929|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
2379930|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
2114347|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114348|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114349|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2114350|NCT02601573|Ribavirin|ribavirin|mesh-list
2114351|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
2114352|NCT02601573|Grazoprevir|grazoprevir|mesh-list
2114353|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
2495894|NCT01193361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2495895|NCT01193361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495896|NCT01193361|Antiviral Agents|antiviral agents|mesh-ancestor
2495897|NCT01193361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495898|NCT01193361|Antimetabolites|antimetabolites|mesh-ancestor
2495899|NCT01193361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495900|NCT01193361|Immunologic Factors|immunologic factors|mesh-ancestor
2495901|NCT01193361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495902|NCT01193387|Insulin|insulin|mesh-list
2495903|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2495904|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
2495905|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2495906|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495907|NCT01193400|Cytarabine|cytarabine|mesh-list
2495908|NCT01193400|Clofarabine|clofarabine|mesh-list
2495909|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2495910|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
2379931|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
2379932|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379933|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2379934|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
2379935|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379936|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2379937|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2379938|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
2379939|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2379940|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2379941|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2379942|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2379943|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379944|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
2379945|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2379946|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2379947|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2379948|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2379949|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
2379950|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2379951|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2379952|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2379953|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2379954|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2379955|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
2379956|NCT00629304|Antithrombins|antithrombins|mesh-list
2379957|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2379958|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
2379959|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379960|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495911|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495912|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495913|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
2379961|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
2379962|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2379963|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2379964|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2379965|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
2379966|NCT00629343|Temozolomide|temozolomide|mesh-list
2379967|NCT00629343|Azacitidine|azacitidine|mesh-list
2379968|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2379969|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
2379970|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379971|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379972|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2379973|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
2379974|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379975|NCT00629382|Polymyxins|polymyxins|mesh-list
2379976|NCT00629382|Polymyxin B|polymyxin b|mesh-list
2379977|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2379978|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2379979|NCT00629447|Tinzaparin|tinzaparin|mesh-list
2379980|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
2379981|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2379982|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2379983|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2379984|NCT00629473|Dexamethasone|dexamethasone|mesh-list
2379985|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
2379986|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2379987|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
2379988|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
2379989|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2379990|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2379991|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2379992|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
2379993|NCT00629473|Hormones|hormones|mesh-ancestor
2379994|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2379995|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2379996|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2379997|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
2379998|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2379999|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380000|NCT00629512|Esomeprazole|esomeprazole|mesh-list
2380001|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2495914|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495915|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2380002|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2380003|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2380004|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380005|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380006|NCT00629551|Paroxetine|paroxetine|mesh-list
2495916|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
2495917|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495918|NCT01193452|Leucovorin|leucovorin|mesh-list
2495919|NCT01193452|Fluorouracil|fluorouracil|mesh-list
2495920|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
2495921|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
2495922|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495923|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2380007|NCT00629551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2380008|NCT00629551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2380009|NCT00629551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2380010|NCT00629551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380011|NCT00629551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380012|NCT00629551|Serotonin Agents|serotonin agents|mesh-ancestor
2380013|NCT00629551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380014|NCT00629551|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2380015|NCT00629551|Antidepressive Agents|antidepressive agents|mesh-ancestor
2380016|NCT00629551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2380017|NCT00629551|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2380018|NCT00629551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2380019|NCT00629551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380020|NCT00629564|Esomeprazole|esomeprazole|mesh-list
2495924|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495925|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2495926|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
2495927|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495928|NCT01193452|Antidotes|antidotes|mesh-ancestor
2495929|NCT01193452|Protective Agents|protective agents|mesh-ancestor
2495930|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
2495931|NCT01193452|Vitamins|vitamins|mesh-ancestor
2495932|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
2495933|NCT01193465|Anesthetics|anesthetics|mesh-list
2495934|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380021|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2380022|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2380023|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2380024|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380025|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380026|NCT00629590|Azithromycin|azithromycin|mesh-list
2380027|NCT00629590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2495935|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495936|NCT01193478|Ledipasvir|ledipasvir|mesh-list
2495937|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
2495938|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495939|NCT01193491|Geldanamycin|geldanamycin|mesh-list
2495940|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2495941|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495942|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
2495943|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2495944|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2495945|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495946|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2495947|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
2495948|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2495949|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
2495950|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2495951|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
2495952|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2495953|NCT01193504|Prednisolone|prednisolone|mesh-list
2495954|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2495955|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
2495956|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2495957|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
2495958|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
2495959|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495960|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495961|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2495962|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
2495963|NCT01193504|Hormones|hormones|mesh-ancestor
2495964|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2495965|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2495966|NCT01193504|Protective Agents|protective agents|mesh-ancestor
2495967|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2495968|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495969|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2495970|NCT01193595|Bevacizumab|bevacizumab|mesh-list
2380028|NCT00629590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380029|NCT00629616|Fulvestrant|fulvestrant|mesh-list
2380030|NCT00629616|Anastrozole|anastrozole|mesh-list
2380031|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2380032|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380033|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2380034|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2380035|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
2380036|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2380037|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380038|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2380039|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2380040|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380041|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380042|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
2380043|NCT00629642|Oxybutynin|oxybutynin|mesh-list
2380044|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2380045|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2380046|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
2380047|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380048|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380049|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380050|NCT00629642|Urological Agents|urological agents|mesh-ancestor
2380051|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
2380052|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
2380053|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380054|NCT00629681|Pregabalin|pregabalin|mesh-list
2380055|NCT00629681|Analgesics|analgesics|mesh-ancestor
2380056|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
2380057|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380058|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380059|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
2380060|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2380061|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2380062|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380063|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2380064|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2380065|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2380066|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380067|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2380068|NCT00629720|Alfuzosin|alfuzosin|mesh-list
2422909|NCT00819520|Ivermectin|ivermectin|mesh-list
2495971|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2495972|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2495973|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2495974|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2495975|NCT01193595|Growth Substances|growth substances|mesh-ancestor
2495976|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495977|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
2495978|NCT01193621|Haloperidol|haloperidol|mesh-list
2495979|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
2495980|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
2495981|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
2495982|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2495983|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495984|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2495985|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2495986|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2495987|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2495988|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2495989|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2495990|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
2495991|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2495992|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2495993|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2495994|NCT01193816|Loxapine|loxapine|mesh-list
2495995|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2495996|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2495997|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2495998|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2495999|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2496000|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2496001|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
2496002|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2496003|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496004|NCT01193855|Dutasteride|dutasteride|mesh-list
2496005|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2496006|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2496007|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496008|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496009|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
2496010|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2496011|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496012|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2496013|NCT01193881|R04929097|r04929097|mesh-list
2496014|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380069|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2380070|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2380071|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2380072|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
2380073|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380074|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380075|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380076|NCT00629720|Urological Agents|urological agents|mesh-ancestor
2380077|NCT00629811|Mitogens|mitogens|mesh-list
2380078|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
2380079|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496015|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2496016|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496017|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496018|NCT01194037|Interferons|interferons|mesh-list
2496019|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
2496020|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
2496021|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2496022|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380080|NCT00629824|Interferons|interferons|mesh-list
2380081|NCT00629824|Ribavirin|ribavirin|mesh-list
2380082|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
2380083|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2380084|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380085|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
2380086|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380087|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
2380088|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380089|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
2380090|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380091|NCT00629837|Factor VIII|factor viii|mesh-list
2380092|NCT00629837|Coagulants|coagulants|mesh-ancestor
2380093|NCT00629863|Fluorouracil|fluorouracil|mesh-list
2380094|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380095|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
2380096|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380097|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2380098|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2496023|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
2496024|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496025|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
2496026|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496027|NCT01194115|Metronidazole|metronidazole|mesh-list
2496028|NCT01194115|Cephalexin|cephalexin|mesh-list
2496029|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496030|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2496031|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2496032|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2496033|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
2496034|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
2496035|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2496036|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2496037|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496038|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496039|NCT01194232|Urological Agents|urological agents|mesh-ancestor
2380099|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
2380100|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496040|NCT01194284|Mifamurtide|mifamurtide|mesh-list
2380101|NCT00629889|Pregabalin|pregabalin|mesh-list
2496041|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2496042|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
2496043|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380102|NCT00629889|Levetiracetam|levetiracetam|mesh-list
2380103|NCT00629889|Analgesics|analgesics|mesh-ancestor
2380104|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
2380105|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380106|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380107|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
2380108|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2380109|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2380110|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380111|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2380112|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2380113|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2380114|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380115|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2380116|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
2380117|NCT00629928|Esomeprazole|esomeprazole|mesh-list
2380118|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2380119|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2380120|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2380121|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380122|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380123|NCT00629941|Azithromycin|azithromycin|mesh-list
2380124|NCT00629941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2380125|NCT00629941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380126|NCT00629967|Interferons|interferons|mesh-list
2380127|NCT00629967|Ribavirin|ribavirin|mesh-list
2380128|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
2380129|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
2380130|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2380131|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380132|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
2380133|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380134|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
2496044|NCT01194336|Huperzine A|huperzine a|mesh-list
2496045|NCT01194336|Donepezil|donepezil|mesh-list
2496046|NCT01194336|Galantamine|galantamine|mesh-list
2496047|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2496048|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496049|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496050|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
2496051|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380135|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380136|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
2380137|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380138|NCT00629980|Azithromycin|azithromycin|mesh-list
2380139|NCT00629980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2380140|NCT00629980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380141|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
2380142|NCT00630019|Levofloxacin|levofloxacin|mesh-list
2496052|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496053|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
2496054|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2496055|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
2496056|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496057|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2496058|NCT01194336|Protective Agents|protective agents|mesh-ancestor
2496059|NCT01194622|Fluticasone|fluticasone|mesh-list
2496060|NCT01194622|Xhance|xhance|mesh-list
2496061|NCT01194622|Azelastine|azelastine|mesh-list
2496062|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2496063|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2496064|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
2496065|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496066|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496067|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2496068|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
2496069|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
2496070|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2496071|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2496072|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380143|NCT00630019|Ofloxacin|ofloxacin|mesh-list
2380144|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2496073|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496074|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2496075|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2496076|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
2496077|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
2496078|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2496079|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2496080|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2496081|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
2496082|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496083|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496084|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2496085|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
2496086|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
2496087|NCT01194700|Hormones|hormones|mesh-ancestor
2496088|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2496089|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
2496090|NCT01194778|Vitamins|vitamins|mesh-list
2496091|NCT01194778|Vitamin K|vitamin k|mesh-list
2496092|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
2496093|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
2496094|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
2496095|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496096|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2496097|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2496098|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496099|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
2496100|NCT01194778|Coagulants|coagulants|mesh-ancestor
2496101|NCT01194791|Dexamethasone|dexamethasone|mesh-list
2496102|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
2496103|NCT01194791|Lenalidomide|lenalidomide|mesh-list
2496104|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2496105|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
2496106|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496107|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2496108|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2496109|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
2496110|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496111|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496112|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2496113|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2496114|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
2496115|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
2496116|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496117|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2496118|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
2496119|NCT01194791|Hormones|hormones|mesh-ancestor
2380145|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2380146|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2380147|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2380148|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380149|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2380150|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2380151|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380152|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380153|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380154|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2380155|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
2380156|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2380157|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380158|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2380159|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2380160|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2380161|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2380162|NCT00630019|Renal Agents|renal agents|mesh-ancestor
2380163|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2380164|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2380165|NCT00630045|Capecitabine|capecitabine|mesh-list
2380166|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
2380167|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2496120|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2496121|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2496122|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2496123|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2496124|NCT01194791|Growth Substances|growth substances|mesh-ancestor
2496125|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
2496126|NCT01194843|Ropivacaine|ropivacaine|mesh-list
2496127|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
2496128|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
2496129|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2496130|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496131|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
2496132|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496133|NCT01194882|Insulin|insulin|mesh-list
2496134|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2496135|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2496136|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496137|NCT01194934|Lenograstim|lenograstim|mesh-list
2496138|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2496139|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
2496140|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496141|NCT01194960|Docetaxel|docetaxel|mesh-list
2496142|NCT01194960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496143|NCT01194960|Tubulin Modulators|tubulin modulators|mesh-ancestor
2496144|NCT01194960|Antimitotic Agents|antimitotic agents|mesh-ancestor
2496145|NCT01194960|Mitosis Modulators|mitosis modulators|mesh-ancestor
2496146|NCT01194960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496147|NCT01195181|Ribavirin|ribavirin|mesh-list
2496148|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
2496149|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496150|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
2496151|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496152|NCT01195246|Vaccines|vaccines|mesh-list
2380168|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
2380169|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380170|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380171|NCT00630084|Interferons|interferons|mesh-list
2380172|NCT00630084|Ribavirin|ribavirin|mesh-list
2380173|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
2380174|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
2380175|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2380176|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380177|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
2380178|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380179|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
2380180|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380181|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
2380182|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380183|NCT00630097|Modafinil|modafinil|mesh-list
2380184|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2380185|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380186|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2380187|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2380188|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2380189|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380190|NCT00630110|Docetaxel|docetaxel|mesh-list
2496153|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
2496154|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496155|NCT01195259|Metformin|metformin|mesh-list
2496156|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
2496157|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2496158|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496159|NCT01195298|Bevacizumab|bevacizumab|mesh-list
2380191|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380192|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
2380193|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
2380194|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
2380195|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380196|NCT00630149|Pemetrexed|pemetrexed|mesh-list
2380197|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380198|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380199|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380200|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2380201|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2380202|NCT00630175|Zolpidem|zolpidem|mesh-list
2380203|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2380204|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2380205|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2496160|NCT01195298|Capecitabine|capecitabine|mesh-list
2496161|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2496162|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380206|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496163|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2496164|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2496165|NCT01195298|Growth Substances|growth substances|mesh-ancestor
2496166|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496167|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
2380207|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2380208|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
2380209|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
2380210|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380211|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380212|NCT00630201|Buprenorphine|buprenorphine|mesh-list
2380213|NCT00630201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2380214|NCT00630201|Narcotics|narcotics|mesh-ancestor
2380215|NCT00630201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380216|NCT00630201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380217|NCT00630201|Analgesics|analgesics|mesh-ancestor
2380218|NCT00630201|Sensory System Agents|sensory system agents|mesh-ancestor
2380219|NCT00630201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380220|NCT00630201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2380221|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
2380222|NCT00630214|Vitamin D|vitamin d|mesh-list
2380223|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
2380224|NCT00630214|Vitamins|vitamins|mesh-list
2380225|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
2380226|NCT00630214|Calcium|calcium|mesh-list
2380227|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
2380228|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380229|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2380230|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2380231|NCT00630214|Antacids|antacids|mesh-ancestor
2380232|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380233|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2496168|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2496169|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
2496170|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496171|NCT01195324|Canagliflozin|canagliflozin|mesh-list
2496172|NCT01195324|Warfarin|warfarin|mesh-list
2496173|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
2496174|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2496175|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496176|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2496177|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380234|NCT00630357|Levetiracetam|levetiracetam|mesh-list
2380235|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
2380236|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
2496178|NCT01195376|Dactolisib|dactolisib|mesh-list
2496179|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496180|NCT01195428|Simvastatin|simvastatin|mesh-list
2496181|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2496182|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2496183|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
2496184|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496185|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2496186|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2496187|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496188|NCT01195454|Insulin|insulin|mesh-list
2380237|NCT00630370|ATI 7505|ati 7505|mesh-list
2380238|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2380239|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2380240|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
2380241|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380242|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380243|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380244|NCT00630383|Histamine|histamine|mesh-list
2380245|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
2380246|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
2380247|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380248|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380249|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380250|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2380251|NCT00630435|Estrogens|estrogens|mesh-ancestor
2380252|NCT00630435|Hormones|hormones|mesh-ancestor
2496189|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2496190|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
2496191|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2496192|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496193|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2496194|NCT01195571|Vaccines|vaccines|mesh-list
2496195|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
2496196|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496197|NCT01195649|Sorafenib|sorafenib|mesh-list
2496198|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496199|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2496200|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496201|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496202|NCT01195714|Ofatumumab|ofatumumab|mesh-list
2496203|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496204|NCT01195727|Apixaban|apixaban|mesh-list
2496205|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2496206|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
2496207|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2496208|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
2380253|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2380254|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380255|NCT00630474|Xylometazoline|xylometazoline|mesh-list
2380256|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
2380257|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2380258|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
2380259|NCT00630500|Memantine|memantine|mesh-list
2380260|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2496209|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496210|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496211|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
2496212|NCT01195766|Ofatumumab|ofatumumab|mesh-list
2496213|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496214|NCT01195805|Amiloride|amiloride|mesh-list
2496215|NCT01195805|Spironolactone|spironolactone|mesh-list
2496216|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2496217|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
2496218|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2496219|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496220|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2496221|NCT01195805|Diuretics|diuretics|mesh-ancestor
2496222|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
2496223|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2496224|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2496225|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2496226|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496227|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2496228|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2496229|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2496230|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496231|NCT01196013|Clofarabine|clofarabine|mesh-list
2496232|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2496233|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
2496234|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496235|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496236|NCT01196065|Memantine|memantine|mesh-list
2496237|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2496238|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2496239|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
2380261|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2380262|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
2380263|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380264|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380265|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380266|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2380267|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2380268|NCT00630513|Ampicillin|ampicillin|mesh-list
2380269|NCT00630513|Ertapenem|ertapenem|mesh-list
2380270|NCT00630513|Sulbactam|sulbactam|mesh-list
2380271|NCT00630513|Sultamicillin|sultamicillin|mesh-list
2380272|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2380273|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380274|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2380275|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380276|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380277|NCT00630552|Conatumumab|conatumumab|mesh-list
2422910|NCT00819520|Malathion|malathion|mesh-list
2496240|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2496241|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496242|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496243|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2496244|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2496245|NCT01196169|Vancomycin|vancomycin|mesh-list
2496246|NCT01196169|Daptomycin|daptomycin|mesh-list
2496247|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2496248|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496249|NCT01196195|Lopinavir|lopinavir|mesh-list
2496250|NCT01196195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2496251|NCT01196195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2380278|NCT00630552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2380279|NCT00630552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380280|NCT00630565|Dexamethasone|dexamethasone|mesh-list
2380281|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
2380282|NCT00630565|Busulfan|busulfan|mesh-list
2380283|NCT00630565|Etoposide|etoposide|mesh-list
2380284|NCT00630565|Sargramostim|sargramostim|mesh-list
2380285|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2380286|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
2380287|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380288|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2380289|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2380290|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
2380291|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380292|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380293|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2380294|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2380295|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
2380296|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
2380297|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380298|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2380299|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
2380300|NCT00630565|Hormones|hormones|mesh-ancestor
2380301|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2380302|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2380303|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2380304|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2380305|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2380306|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380307|NCT00630630|Levetiracetam|levetiracetam|mesh-list
2380308|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
2496252|NCT01196195|Protease Inhibitors|protease inhibitors|mesh-ancestor
2496253|NCT01196195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496254|NCT01196195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496255|NCT01196195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2496256|NCT01196195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2496257|NCT01196195|Antiviral Agents|antiviral agents|mesh-ancestor
2496258|NCT01196195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496259|NCT01196195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2380309|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
2380310|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
2380311|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
2380312|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380313|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2380314|NCT00630656|Talactoferrin alfa|talactoferrin alfa|mesh-list
2380315|NCT00630656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380316|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
2380317|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2380318|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380319|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2380320|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2380321|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2380322|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380323|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
2380324|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380325|NCT00630695|Lanreotide|lanreotide|mesh-list
2380326|NCT00630695|Somatostatin|somatostatin|mesh-list
2380327|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380328|NCT00630695|Hormones|hormones|mesh-ancestor
2380329|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2380330|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380331|NCT00630708|Losartan|losartan|mesh-list
2380332|NCT00630708|Benazepril|benazepril|mesh-list
2380333|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2496260|NCT01196195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2496261|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2496262|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2496263|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496264|NCT01196234|Paclitaxel|paclitaxel|mesh-list
2496265|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2496266|NCT01196234|Carboplatin|carboplatin|mesh-list
2496267|NCT01196234|Gefitinib|gefitinib|mesh-list
2496268|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2496269|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496270|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
2496271|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
2496272|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
2496273|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496274|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2496275|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496276|NCT01196260|Capecitabine|capecitabine|mesh-list
2496277|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
2496278|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2496279|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
2496280|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496281|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496282|NCT01196455|Capecitabine|capecitabine|mesh-list
2496283|NCT01196455|Mitomycins|mitomycins|mesh-list
2496284|NCT01196455|Mitomycin|mitomycin|mesh-list
2496285|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2496286|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
2496287|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496288|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496289|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2496290|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
2496291|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2496292|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496293|NCT01196481|Carvedilol|carvedilol|mesh-list
2496294|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2496295|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2496296|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
2496297|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2496298|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496299|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496300|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2496301|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
2496302|NCT01196481|Protective Agents|protective agents|mesh-ancestor
2496303|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2496304|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2496305|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2496306|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
2496307|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2380334|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2380335|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2380336|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2380337|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422911|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2496308|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2496309|NCT01196507|Carvedilol|carvedilol|mesh-list
2496310|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2496311|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2496312|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
2496313|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2496314|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496315|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496316|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2496317|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
2496318|NCT01196507|Protective Agents|protective agents|mesh-ancestor
2496319|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2496320|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2496321|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2496322|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
2496323|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2496324|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2496325|NCT01196546|Metformin|metformin|mesh-list
2496326|NCT01196546|Vildagliptin|vildagliptin|mesh-list
2496327|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2496328|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496329|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2496330|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
2496331|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496332|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496333|NCT01196559|Gemcitabine|gemcitabine|mesh-list
2496334|NCT01196559|Vinorelbine|vinorelbine|mesh-list
2496335|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2496336|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
2496337|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496338|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496339|NCT01196559|Antiviral Agents|antiviral agents|mesh-ancestor
2496340|NCT01196559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496341|NCT01196559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496342|NCT01196559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2496343|NCT01196559|Immunologic Factors|immunologic factors|mesh-ancestor
2496344|NCT01196559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496345|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2496346|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
2496347|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
2496348|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
2496349|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
2496350|NCT01196715|Hematinics|hematinics|mesh-ancestor
2496351|NCT01196754|Sevoflurane|sevoflurane|mesh-list
2496352|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2496353|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2496354|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
2496355|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
2380338|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2380339|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
2380340|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380341|NCT00630799|Leuprolide|leuprolide|mesh-list
2380342|NCT00630799|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2380343|NCT00630799|Fertility Agents|fertility agents|mesh-ancestor
2380344|NCT00630799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2380345|NCT00630799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380346|NCT00630799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2380347|NCT00630799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380348|NCT00630851|Donepezil|donepezil|mesh-list
2380349|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2380350|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380351|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380352|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
2380353|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380354|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380355|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
2380356|NCT00630890|Capecitabine|capecitabine|mesh-list
2380357|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2380358|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
2380359|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380360|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380361|NCT00630903|Methoxsalen|methoxsalen|mesh-list
2380362|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2380363|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
2380364|NCT00630929|Ibuprofen|ibuprofen|mesh-list
2380365|NCT00630929|Celecoxib|celecoxib|mesh-list
2380366|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2380367|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2380368|NCT00630929|Analgesics|analgesics|mesh-ancestor
2380369|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
2380370|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380371|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380372|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2380373|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2380374|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2380375|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380376|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380377|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2380378|NCT00630942|Minocycline|minocycline|mesh-list
2380379|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2380380|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380381|NCT00630968|Levetiracetam|levetiracetam|mesh-list
2496356|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2496357|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496358|NCT01196767|Ropivacaine|ropivacaine|mesh-list
2380382|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
2380383|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
2380384|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2380385|NCT00630981|Citalopram|citalopram|mesh-list
2380386|NCT00630981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2380387|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2380388|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2380389|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380390|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380391|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
2380392|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380393|NCT00630981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2380394|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
2380395|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2380396|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2380397|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2380398|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380399|NCT00631033|Metformin|metformin|mesh-list
2380400|NCT00631033|Diazoxide|diazoxide|mesh-list
2496359|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
2496360|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
2496361|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2496362|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496363|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
2496364|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380401|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2380402|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380403|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2380404|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
2380405|NCT00631085|Tocopherols|tocopherols|mesh-list
2380406|NCT00631085|Vitamin E|vitamin e|mesh-list
2380407|NCT00631085|Tocotrienols|tocotrienols|mesh-list
2380408|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
2496365|NCT01197001|Losartan|losartan|mesh-list
2496366|NCT01197001|Amlodipine|amlodipine|mesh-list
2496367|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2496368|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2496369|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2496370|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380409|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
2380410|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
2496371|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2496372|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496373|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
2496374|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2496375|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2496376|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2496377|NCT01197014|Losartan|losartan|mesh-list
2496378|NCT01197014|Amlodipine|amlodipine|mesh-list
2496379|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2496380|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2496381|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2496382|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496383|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2496384|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496385|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
2496386|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2496387|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2496388|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2496389|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
2496390|NCT01197040|Prednisone|prednisone|mesh-list
2496391|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2184813|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
2184814|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184815|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
2184816|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184817|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2184818|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184819|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
2184820|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184821|NCT00002833|Cytarabine|cytarabine|mesh-list
2184822|NCT00002833|Cyclosporine|cyclosporine|mesh-list
2184823|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
2184824|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2184825|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2184826|NCT00002833|Prednisolone|prednisolone|mesh-list
2496392|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
2496393|NCT01197040|Hormones|hormones|mesh-ancestor
2496394|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2496395|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496396|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2496397|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496398|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2496399|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2496400|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
2496401|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2380411|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380412|NCT00631085|Protective Agents|protective agents|mesh-ancestor
2380413|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380414|NCT00631085|Vitamins|vitamins|mesh-ancestor
2380415|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
2380416|NCT00631111|Aspirin|aspirin|mesh-list
2380417|NCT00631111|Ascorbic Acid|ascorbic acid|mesh-list
2380418|NCT00631111|Ibuprofen|ibuprofen|mesh-list
2380419|NCT00631111|Vitamins|vitamins|mesh-ancestor
2380420|NCT00631111|Micronutrients|micronutrients|mesh-ancestor
2380421|NCT00631111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380422|NCT00631111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2496402|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496403|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380423|NCT00631111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2380424|NCT00631111|Analgesics|analgesics|mesh-ancestor
2380425|NCT00631111|Sensory System Agents|sensory system agents|mesh-ancestor
2380426|NCT00631111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380427|NCT00631111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2380428|NCT00631111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2380429|NCT00631111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2380430|NCT00631111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2380431|NCT00631111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380432|NCT00631111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2380433|NCT00631111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2380434|NCT00631111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380435|NCT00631111|Antipyretics|antipyretics|mesh-ancestor
2380436|NCT00631111|Antioxidants|antioxidants|mesh-ancestor
2380437|NCT00631111|Protective Agents|protective agents|mesh-ancestor
2380438|NCT00631124|Drospirenone|drospirenone|mesh-list
2380439|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2380440|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2380441|NCT00631124|Estradiol|estradiol|mesh-list
2380442|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2380443|NCT00631124|Estrogens|estrogens|mesh-ancestor
2380444|NCT00631124|Hormones|hormones|mesh-ancestor
2380445|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2380446|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380447|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2380448|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
2380449|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2380450|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2380451|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2380452|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
2496404|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496405|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
2496406|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2496407|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
2496408|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496409|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2496410|NCT01197144|Adalimumab|adalimumab|mesh-list
2496411|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2496412|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2496413|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
2496414|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2496415|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496416|NCT01197170|Bevacizumab|bevacizumab|mesh-list
2496417|NCT01197170|Everolimus|everolimus|mesh-list
2496418|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2496419|NCT01197170|Sorafenib|sorafenib|mesh-list
2496420|NCT01197170|Anastrozole|anastrozole|mesh-list
2496421|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2496422|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496423|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2496424|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2496425|NCT01197170|Growth Substances|growth substances|mesh-ancestor
2496426|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496427|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
2496428|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2496429|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
2496430|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2496431|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496432|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496433|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2496434|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2496435|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2496436|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2496437|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
2496438|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2496439|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
2496440|NCT01197235|Hematinics|hematinics|mesh-ancestor
2496441|NCT01197261|Oxycodone|oxycodone|mesh-list
2496442|NCT01197261|Naloxone|naloxone|mesh-list
2496443|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2496444|NCT01197261|Narcotics|narcotics|mesh-ancestor
2496445|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2496446|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496447|NCT01197261|Analgesics|analgesics|mesh-ancestor
2496448|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
2496449|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496450|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2496451|NCT01197469|Tadalafil|tadalafil|mesh-list
2496452|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
2496453|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2496454|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2496455|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496456|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496457|NCT01197469|Urological Agents|urological agents|mesh-ancestor
2496458|NCT01197664|Fluorouracil|fluorouracil|mesh-list
2496459|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
2496460|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496461|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2496462|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496463|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2496464|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
2496465|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496466|NCT01197781|Verapamil|verapamil|mesh-list
2496467|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2496468|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2496469|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2496470|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496471|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2496472|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496473|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
2496474|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2496475|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
2496476|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2496477|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2496478|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2496479|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380453|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2380454|NCT00631124|Diuretics|diuretics|mesh-ancestor
2380455|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
2380456|NCT00631150|Levetiracetam|levetiracetam|mesh-list
2380457|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
2380458|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
2380459|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
2380460|NCT00631202|Hematinics|hematinics|mesh-ancestor
2380461|NCT00631228|Everolimus|everolimus|mesh-list
2380462|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380463|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2380464|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
2380465|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496480|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496481|NCT01198054|Lenalidomide|lenalidomide|mesh-list
2496482|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
2496483|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496484|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2496485|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2496486|NCT01198054|Growth Substances|growth substances|mesh-ancestor
2380466|NCT00631501|Doxycycline|doxycycline|mesh-list
2380467|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2496487|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
2496488|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496489|NCT01198067|Pomalidomide|pomalidomide|mesh-list
2496490|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
2496491|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496492|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2496493|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2496494|NCT01198067|Growth Substances|growth substances|mesh-ancestor
2496495|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
2496496|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496497|NCT01198106|Cinnarizine|cinnarizine|mesh-list
2496498|NCT01198106|Scopolamine|scopolamine|mesh-list
2496499|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2496500|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2496501|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
2496502|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
2496503|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496504|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496505|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2496506|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
2496507|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2496508|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
2496509|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2496510|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496511|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2496512|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
2496513|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2496514|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2496515|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2496516|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2496517|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
2496518|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
2496519|NCT01198184|Sirolimus|sirolimus|mesh-list
2496520|NCT01198184|R04929097|r04929097|mesh-list
2496521|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2380468|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380469|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
2380470|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2380471|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2114354|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114355|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
2114356|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114357|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2114358|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
2114359|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114360|NCT02601833|Fluorides|fluorides|mesh-list
2114361|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
2114362|NCT02601833|Protective Agents|protective agents|mesh-ancestor
2114363|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114364|NCT02601976|Ribavirin|ribavirin|mesh-list
2114365|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2114366|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
2114367|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114368|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
2496522|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496523|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2496524|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496525|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
2496526|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2496527|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
2380472|NCT00631514|Acetaminophen|acetaminophen|mesh-list
2380473|NCT00631514|Ibuprofen|ibuprofen|mesh-list
2380474|NCT00631514|Piroxicam|piroxicam|mesh-list
2380475|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2380476|NCT00631514|Analgesics|analgesics|mesh-ancestor
2380477|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
2380478|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380479|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380480|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
2380481|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2380482|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2380483|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2380484|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2380485|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496528|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380486|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380487|NCT00631527|Sunitinib|sunitinib|mesh-list
2496529|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496530|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496531|NCT01198210|Dexamethasone|dexamethasone|mesh-list
2496532|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
2496533|NCT01198210|Ketamine|ketamine|mesh-list
2496534|NCT01198210|BB 1101|bb 1101|mesh-list
2496535|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2496536|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
2496537|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
2496538|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380488|NCT00631527|Leuprolide|leuprolide|mesh-list
2380489|NCT00631527|Goserelin|goserelin|mesh-list
2380490|NCT00631527|Bicalutamide|bicalutamide|mesh-list
2380491|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380492|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2380493|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2380494|NCT00631527|Growth Substances|growth substances|mesh-ancestor
2380495|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380496|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
2380497|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2380498|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380499|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380500|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2380501|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
2380502|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2380503|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2380504|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
2380505|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
2380506|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2380507|NCT00631579|Rasburicase|rasburicase|mesh-list
2380508|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
2380509|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2380510|NCT00631592|Dolutegravir|dolutegravir|mesh-list
2380511|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2380512|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2380513|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380514|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380515|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2380516|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2380517|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
2380518|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380519|NCT00631618|Sunitinib|sunitinib|mesh-list
2380520|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380521|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2380522|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2380523|NCT00631618|Growth Substances|growth substances|mesh-ancestor
2380524|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380525|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
2380526|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2380527|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380528|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380529|NCT00631631|Mifamurtide|mifamurtide|mesh-list
2380530|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2380531|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
2380532|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380533|NCT00631722|Haloperidol|haloperidol|mesh-list
2380534|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
2496539|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496540|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2496541|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
2496542|NCT01198210|Hormones|hormones|mesh-ancestor
2496543|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2496544|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2496545|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496546|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
2496547|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496548|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496549|NCT01198210|Analgesics|analgesics|mesh-ancestor
2496550|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
2496551|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2496552|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2496553|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
2496554|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
2380535|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
2380536|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
2496555|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2496556|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2496557|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2496558|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2496559|NCT01198223|Nystatin|nystatin|mesh-list
2496560|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2496561|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496562|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
2496563|NCT01198223|Ionophores|ionophores|mesh-ancestor
2496564|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2496565|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496566|NCT01198236|Itraconazole|itraconazole|mesh-list
2496567|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
2496568|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496569|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2496570|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2496571|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380537|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380538|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380539|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2496572|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496573|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2496574|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
2496575|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2496576|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496577|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2496578|NCT01198249|Losartan|losartan|mesh-list
2496579|NCT01198249|Amlodipine|amlodipine|mesh-list
2496580|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2496581|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2496582|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2496583|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2380540|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2380541|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2380542|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380543|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2380544|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2380545|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
2380546|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380547|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380548|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2380549|NCT00631813|Prucalopride|prucalopride|mesh-list
2380550|NCT00631813|Laxatives|laxatives|mesh-ancestor
2380551|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2380552|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2380553|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2380554|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
2380555|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380556|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380557|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380558|NCT00631943|Pregabalin|pregabalin|mesh-list
2380559|NCT00631943|Analgesics|analgesics|mesh-ancestor
2380560|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
2380561|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380562|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380563|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
2380564|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2380565|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2380566|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380567|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2380568|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2380569|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2380570|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380571|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2380572|NCT00631995|Vaccines|vaccines|mesh-list
2380573|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
2380574|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380575|NCT00632073|Maleic acid|maleic acid|mesh-list
2380576|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380577|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380578|NCT00632086|Aspirin|aspirin|mesh-list
2380579|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2380580|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2380581|NCT00632086|Analgesics|analgesics|mesh-ancestor
2496584|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496585|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2496586|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496587|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
2496588|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2496589|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2496590|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2496591|NCT01198249|Diuretics|diuretics|mesh-ancestor
2496592|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
2496593|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2496594|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2496595|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
2496596|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380582|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
2380583|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380584|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496597|NCT01198340|Ropivacaine|ropivacaine|mesh-list
2496598|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
2496599|NCT01198340|Anesthetics|anesthetics|mesh-list
2496600|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2496601|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496602|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
2496603|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496604|NCT01198353|Ziprasidone|ziprasidone|mesh-list
2496605|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2496606|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
2496607|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380585|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2380586|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2380587|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2380588|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2380589|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496608|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496609|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496610|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2496611|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2496612|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2496613|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2496614|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2496615|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
2496616|NCT01198379|Aspirin|aspirin|mesh-list
2496617|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2496618|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2496619|NCT01198379|Analgesics|analgesics|mesh-ancestor
2496620|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
2496621|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496622|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496623|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2496624|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2496625|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2496626|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2496627|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496628|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2496629|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2496630|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496631|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
2496632|NCT01198392|Cisplatin|cisplatin|mesh-list
2496633|NCT01198392|Tegafur|tegafur|mesh-list
2496634|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496635|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2380590|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2380591|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2380592|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380593|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
2380594|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
2380595|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2380596|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2380597|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380598|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2380599|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380600|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2496636|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
2496637|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380601|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
2380602|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380603|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2380604|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380605|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380606|NCT00632268|Leucovorin|leucovorin|mesh-list
2380607|NCT00632268|Everolimus|everolimus|mesh-list
2380608|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380609|NCT00632268|Antidotes|antidotes|mesh-ancestor
2380610|NCT00632268|Protective Agents|protective agents|mesh-ancestor
2380611|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380612|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
2380613|NCT00632268|Vitamins|vitamins|mesh-ancestor
2380614|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
2380615|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2380616|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
2380617|NCT00632333|Fluorouracil|fluorouracil|mesh-list
2380618|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380619|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
2496638|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2496639|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2496640|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496641|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
2496642|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2380620|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380621|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2380622|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2380623|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
2380624|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380625|NCT00632385|Eletriptan|eletriptan|mesh-list
2380626|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2380627|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
2380628|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380629|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380630|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380631|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
2380632|NCT00632476|Vitamins|vitamins|mesh-ancestor
2496643|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496644|NCT01198496|Losartan|losartan|mesh-list
2496645|NCT01198496|Amlodipine|amlodipine|mesh-list
2496646|NCT01198496|Valsartan|valsartan|mesh-list
2496647|NCT01198496|Telmisartan|telmisartan|mesh-list
2496648|NCT01198496|Candesartan|candesartan|mesh-list
2496649|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
2380633|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
2380634|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380635|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
2380636|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380637|NCT00632476|Protective Agents|protective agents|mesh-ancestor
2380638|NCT00632554|Prednisolone|prednisolone|mesh-list
2380639|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2380640|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
2496650|NCT01198496|Olmesartan|olmesartan|mesh-list
2496651|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2496652|NCT01198496|Spironolactone|spironolactone|mesh-list
2496653|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2496654|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2496655|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2380641|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2380642|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
2380643|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2380644|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
2380645|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2380646|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
2496656|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496657|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2496658|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496659|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
2496660|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2496661|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2496662|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2496663|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2496664|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
2668477|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2380647|NCT00632554|Hormones|hormones|mesh-ancestor
2496665|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2496666|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2496667|NCT01198496|Diuretics|diuretics|mesh-ancestor
2496668|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
2496669|NCT01198522|Gemcitabine|gemcitabine|mesh-list
2496670|NCT01198522|Antibodies|antibodies|mesh-list
2496671|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2496672|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
2496673|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496674|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2496675|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
2496676|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496677|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496678|NCT01198522|Antiviral Agents|antiviral agents|mesh-ancestor
2496679|NCT01198522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496680|NCT01198522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496681|NCT01198522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2496682|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2496683|NCT01198535|Cetuximab|cetuximab|mesh-list
2496684|NCT01198535|Antibodies|antibodies|mesh-list
2496685|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
2496686|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2380648|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2380649|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380650|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2496687|NCT01198535|R04929097|r04929097|mesh-list
2496688|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
2496689|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496690|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496691|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496692|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496693|NCT01198626|Moxifloxacin|moxifloxacin|mesh-list
2496694|NCT01198626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2496695|NCT01198626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496696|NCT01198626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2496697|NCT01198626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2496698|NCT01198626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496699|NCT01198626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496700|NCT01198626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496701|NCT01198639|Remifentanil|remifentanil|mesh-list
2496702|NCT01198639|Propofol|propofol|mesh-list
2496703|NCT01198639|Anesthetics|anesthetics|mesh-list
2496704|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2496705|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2496706|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496707|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2496708|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
2496709|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2496710|NCT01198639|Narcotics|narcotics|mesh-ancestor
2496711|NCT01198639|Analgesics|analgesics|mesh-ancestor
2496712|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
2496713|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496714|NCT01198665|Prednisolone|prednisolone|mesh-list
2496715|NCT01198665|Doxorubicin|doxorubicin|mesh-list
2496716|NCT01198665|Vincristine|vincristine|mesh-list
2496717|NCT01198665|Everolimus|everolimus|mesh-list
2496718|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2380651|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380652|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
2380653|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
2380654|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380655|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2380656|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2380657|NCT00632554|Protective Agents|protective agents|mesh-ancestor
2380658|NCT00632580|Ropivacaine|ropivacaine|mesh-list
2380659|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
2496719|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496720|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2496721|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2496722|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496723|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496724|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2496725|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
2496726|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
2496727|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
2496728|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2496729|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
2496730|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496731|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2496732|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
2496733|NCT01198665|Hormones|hormones|mesh-ancestor
2496734|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2496735|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2496736|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2496737|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
2496738|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2496739|NCT01198821|Gemcitabine|gemcitabine|mesh-list
2496740|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2496741|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
2496742|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496743|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496744|NCT01198821|Antiviral Agents|antiviral agents|mesh-ancestor
2496745|NCT01198821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496746|NCT01198821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496747|NCT01198821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2496748|NCT01198821|Immunologic Factors|immunologic factors|mesh-ancestor
2496749|NCT01198821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496750|NCT01198834|Etodolac|etodolac|mesh-list
2496751|NCT01198834|Lidocaine|lidocaine|mesh-list
2496752|NCT01198834|Anesthetics, Local|anesthetics, local|mesh-ancestor
2496753|NCT01198834|Anesthetics|anesthetics|mesh-ancestor
2496754|NCT01198834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2496755|NCT01198834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496756|NCT01198834|Sensory System Agents|sensory system agents|mesh-ancestor
2496757|NCT01198834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496758|NCT01198834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2380660|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
2380661|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380662|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380663|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
2380664|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380665|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
2380666|NCT00632606|Metoclopramide|metoclopramide|mesh-list
2380667|NCT00632606|Analgesics|analgesics|mesh-ancestor
2380668|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
2380669|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380670|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380671|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
2380672|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380673|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2380674|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
2380675|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2380676|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2380677|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380678|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2380679|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
2380680|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2380681|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
2380682|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
2380683|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2380684|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2380685|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2380686|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
2380687|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380688|NCT00632645|Olanzapine|olanzapine|mesh-list
2380689|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
2380690|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
2380691|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
2380692|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
2380693|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380694|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380695|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2380696|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2380697|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2380698|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380699|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2380700|NCT00632645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2380701|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2380702|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2380703|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380704|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380705|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
2380706|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2380707|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
2380708|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2380709|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
2380710|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
2380711|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2380712|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380713|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380714|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2380715|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2380716|NCT00632697|Protective Agents|protective agents|mesh-ancestor
2380717|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380718|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
2380719|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2380720|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
2380721|NCT00632723|Gefitinib|gefitinib|mesh-list
2380722|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496759|NCT01198834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2496760|NCT01198834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2496761|NCT01198834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2496762|NCT01198834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496763|NCT01198834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2496764|NCT01198834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2496765|NCT01198834|Analgesics|analgesics|mesh-ancestor
2496766|NCT01198834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2496767|NCT01198834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2496768|NCT01198834|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2496769|NCT01198834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2496770|NCT01198834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496771|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
2496772|NCT01198860|Tenofovir|tenofovir|mesh-list
2496773|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
2496774|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496775|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2496776|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2496777|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496778|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496779|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2496780|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2496781|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
2496782|NCT01198860|Protective Agents|protective agents|mesh-ancestor
2496783|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496784|NCT01198860|Vitamins|vitamins|mesh-ancestor
2496785|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
2496786|NCT01198912|Doxycycline|doxycycline|mesh-list
2496787|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2496788|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496789|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
2496790|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2496791|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2496792|NCT01198925|Piperacillin|piperacillin|mesh-list
2496793|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2496794|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496795|NCT01198938|Melatonin|melatonin|mesh-list
2496796|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
2496797|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496798|NCT01198938|Protective Agents|protective agents|mesh-ancestor
2496799|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496800|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2496801|NCT01199029|Prednisone|prednisone|mesh-list
2496802|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2496803|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
2496804|NCT01199029|Hormones|hormones|mesh-ancestor
2496805|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2496806|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496807|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2496808|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496809|NCT01199081|Dronedarone|dronedarone|mesh-list
2380723|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2380724|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380725|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380726|NCT00632762|Amantadine|amantadine|mesh-list
2496810|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2380727|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2496811|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
2496812|NCT01199159|Pyridoxal|pyridoxal|mesh-list
2496813|NCT01199159|Pyridoxine|pyridoxine|mesh-list
2496814|NCT01199159|Misoprostol|misoprostol|mesh-list
2496815|NCT01199159|Vitamins|vitamins|mesh-ancestor
2496816|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
2380728|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2380729|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
2380730|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380731|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
2380732|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380733|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380734|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380735|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2380736|NCT00632762|Analgesics|analgesics|mesh-ancestor
2380737|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
2380738|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380739|NCT00632840|Atorvastatin|atorvastatin|mesh-list
2496817|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496818|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2496819|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
2496820|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2496821|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2496822|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2496823|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
2496824|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
2496825|NCT01199224|Veliparib|veliparib|mesh-list
2496826|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2496827|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496828|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496829|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380740|NCT00632840|Fenofibrate|fenofibrate|mesh-list
2380741|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2380742|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2380743|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
2380744|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380745|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2380746|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2380747|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380748|NCT00632853|Carboplatin|carboplatin|mesh-list
2380749|NCT00632853|Etoposide|etoposide|mesh-list
2380750|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496830|NCT01199276|Sevoflurane|sevoflurane|mesh-list
2496831|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2114369|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114370|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
2114371|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114372|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114373|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
2114374|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114375|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2114376|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2114377|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2114378|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2114379|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
2114380|NCT02603120|Tenofovir|tenofovir|mesh-list
2114381|NCT02603120|Emtricitabine|emtricitabine|mesh-list
2114382|NCT02603120|Lamivudine|lamivudine|mesh-list
2114383|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2114384|NCT02603120|Triumeq|triumeq|mesh-list
2114385|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
2114386|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114387|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2114388|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2114389|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114390|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114391|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2114392|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2114393|NCT02603393|Fluticasone|fluticasone|mesh-list
2114394|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
2114395|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2114396|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2114397|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2114398|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
2114399|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114400|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496832|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2496833|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
2496834|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
2496835|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2496836|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496839|NCT01199328|Aspirin|aspirin|mesh-list
2496840|NCT01199328|Esomeprazole|esomeprazole|mesh-list
2496841|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2496842|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2496843|NCT01199328|Analgesics|analgesics|mesh-ancestor
2496844|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
2496845|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496846|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496847|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2496848|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2496849|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2496850|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2496851|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380751|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2380752|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2380753|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2380754|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380755|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380756|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
2380757|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
2380758|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2380759|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2380760|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380761|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380762|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380763|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2380764|NCT00633035|Esomeprazole|esomeprazole|mesh-list
2380765|NCT00633035|Famotidine|famotidine|mesh-list
2380766|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2380767|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2380768|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2380769|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380770|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380771|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2496852|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2496853|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2496854|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496855|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
2496856|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2496857|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2496858|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2496859|NCT01199341|Warfarin|warfarin|mesh-list
2496860|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
2496861|NCT01199367|Letrozole|letrozole|mesh-list
2496862|NCT01199367|Lapatinib|lapatinib|mesh-list
2496863|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496864|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2496865|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2496866|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380772|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
2380773|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
2380774|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380775|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380776|NCT00633269|Olaparib|olaparib|mesh-list
2380777|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2380778|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380779|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380780|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380781|NCT00633282|Pioglitazone|pioglitazone|mesh-list
2380782|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2380783|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2380784|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380785|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2496867|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496868|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2496869|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
2496870|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2496871|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496872|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2496873|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
2380786|NCT00633347|Cetrorelix|cetrorelix|mesh-list
2380787|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2380788|NCT00633347|Hormones|hormones|mesh-ancestor
2380789|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2380790|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380791|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2380792|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
2380793|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2380794|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
2380795|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
2380796|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2380797|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
2380798|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2380799|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2380800|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380801|NCT00633373|Cyclosporine|cyclosporine|mesh-list
2380802|NCT00633373|Cyclosporins|cyclosporins|mesh-list
2380803|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380804|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380805|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2380806|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
2380807|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380808|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
2380809|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380810|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
2380811|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2380812|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2380813|NCT00633386|Celecoxib|celecoxib|mesh-list
2496874|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
2496875|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
2496876|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380814|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2380815|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2380816|NCT00633386|Analgesics|analgesics|mesh-ancestor
2380817|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
2380818|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380819|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380820|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2380821|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2380822|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2380823|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2380824|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380825|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496877|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496878|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
2496879|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496880|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
2380826|NCT00633412|Esomeprazole|esomeprazole|mesh-list
2380827|NCT00633412|Ranitidine|ranitidine|mesh-list
2380828|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2380829|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2380830|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2380831|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2496881|NCT01199432|Fluorouracil|fluorouracil|mesh-list
2496882|NCT01199432|Epirubicin|epirubicin|mesh-list
2496883|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2496884|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
2496885|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496886|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2496887|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2496888|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
2496889|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496890|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496891|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2496892|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
2496893|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2496894|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2496895|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2496896|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2496897|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496898|NCT01199445|Vitamin A|vitamin a|mesh-list
2496899|NCT01199445|Vitamins|vitamins|mesh-ancestor
2496900|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
2496901|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496902|NCT01199458|Alfentanil|alfentanil|mesh-list
2496903|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2496904|NCT01199458|Narcotics|narcotics|mesh-ancestor
2496905|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380832|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380833|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380834|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2380835|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
2380836|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
2380837|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380838|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380839|NCT00633425|Glimepiride|glimepiride|mesh-list
2380840|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2496906|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496907|NCT01199458|Analgesics|analgesics|mesh-ancestor
2496908|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
2496909|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496910|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2496911|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
2496912|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
2496913|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2496914|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
2496915|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2496916|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
2496917|NCT01199523|Mirabegron|mirabegron|mesh-list
2496918|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2496919|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496920|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2496921|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2496922|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496923|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496924|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496925|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496926|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2380841|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2380842|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496927|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2496928|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2496929|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
2496930|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2496931|NCT01199523|Urological Agents|urological agents|mesh-ancestor
2496932|NCT01199562|Valganciclovir|valganciclovir|mesh-list
2496933|NCT01199562|Ganciclovir|ganciclovir|mesh-list
2496934|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2496935|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
2496936|NCT01199562|Foscarnet|foscarnet|mesh-list
2496937|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2496938|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496939|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2496940|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496941|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496942|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2496943|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
2496944|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496945|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2496946|NCT01199757|Fluticasone|fluticasone|mesh-list
2496947|NCT01199757|Xhance|xhance|mesh-list
2496948|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
2496949|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2380843|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2380844|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
2380845|NCT00633438|Celecoxib|celecoxib|mesh-list
2380846|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2380847|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2380848|NCT00633438|Analgesics|analgesics|mesh-ancestor
2380849|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
2496950|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2496951|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
2496952|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496953|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380850|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380851|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380852|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2380853|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2380854|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2496954|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2496955|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
2496956|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
2496957|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2496958|NCT01199783|Vancomycin|vancomycin|mesh-list
2496959|NCT01199783|Daptomycin|daptomycin|mesh-list
2496960|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2496961|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496962|NCT01199835|Calcium|calcium|mesh-list
2496963|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2496964|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496965|NCT01199900|Prednisone|prednisone|mesh-list
2496966|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2496967|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
2496968|NCT01199900|Hormones|hormones|mesh-ancestor
2496969|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2496970|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496971|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2496972|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496973|NCT01200004|Lenalidomide|lenalidomide|mesh-list
2496974|NCT01200004|Azacitidine|azacitidine|mesh-list
2496975|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
2496976|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2496977|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2496978|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2496979|NCT01200004|Growth Substances|growth substances|mesh-ancestor
2496980|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
2496981|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2496982|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2496983|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
2496984|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496985|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496986|NCT01200056|Atorvastatin|atorvastatin|mesh-list
2496987|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2496988|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2496989|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
2496990|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2496991|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2496992|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2496993|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2496994|NCT01200108|Budesonide|budesonide|mesh-list
2380855|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2380856|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380857|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380858|NCT00633490|Apatinib|apatinib|mesh-list
2380859|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380860|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2380861|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380862|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380863|NCT00633542|Interferons|interferons|mesh-list
2380864|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
2380865|NCT00633542|Thalidomide|thalidomide|mesh-list
2380866|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380867|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
2380868|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2496995|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2496996|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2496997|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
2496998|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2496999|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380869|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
2380870|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380871|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497000|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2497001|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
2497002|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
2497003|NCT01200108|Hormones|hormones|mesh-ancestor
2497004|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2497005|NCT01200121|Bevacizumab|bevacizumab|mesh-list
2497006|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2497007|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497008|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2497009|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2497010|NCT01200121|Growth Substances|growth substances|mesh-ancestor
2497011|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497012|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
2380872|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
2380873|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2380874|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2380875|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2380876|NCT00633542|Growth Substances|growth substances|mesh-ancestor
2380877|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
2497013|NCT01200186|Progestins|progestins|mesh-list
2497014|NCT01200186|Hormones|hormones|mesh-ancestor
2497015|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2497016|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497017|NCT01200212|Bevacizumab|bevacizumab|mesh-list
2497018|NCT01200212|Taxane|taxane|mesh-list
2380878|NCT00633568|Cisplatin|cisplatin|mesh-list
2380879|NCT00633568|Docetaxel|docetaxel|mesh-list
2380880|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380881|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
2380882|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
2380883|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
2380884|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380885|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
2380886|NCT00633581|Vitamins|vitamins|mesh-ancestor
2380887|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
2380888|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380889|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
2380890|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380891|NCT00633581|Protective Agents|protective agents|mesh-ancestor
2380892|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2380893|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2380894|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
2497019|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2497020|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497021|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2497022|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2497023|NCT01200212|Growth Substances|growth substances|mesh-ancestor
2497024|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497025|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
2497026|NCT01200251|Bimatoprost|bimatoprost|mesh-list
2497027|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2497028|NCT01200264|Apremilast|apremilast|mesh-list
2497029|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2497030|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2497031|NCT01200264|Analgesics|analgesics|mesh-ancestor
2497032|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
2497033|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497034|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497035|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2497036|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2497037|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2497038|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2497039|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497040|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497041|NCT01200472|Apremilast|apremilast|mesh-list
2497042|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2497043|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2497044|NCT01200472|Analgesics|analgesics|mesh-ancestor
2497045|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
2497046|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497047|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497048|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2497049|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2497050|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2497051|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2497052|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497053|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497054|NCT01200537|Norinyl|norinyl|mesh-list
2497055|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
2497056|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
2497057|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2497058|NCT01200537|Estradiol|estradiol|mesh-list
2497059|NCT01200537|Estrogens|estrogens|mesh-ancestor
2497060|NCT01200537|Hormones|hormones|mesh-ancestor
2497061|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2497062|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497063|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2497064|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2380895|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
2497065|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2497066|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2497067|NCT01200641|Gabapentin|gabapentin|mesh-list
2497068|NCT01200641|Melatonin|melatonin|mesh-list
2497069|NCT01200641|Analgesics|analgesics|mesh-ancestor
2497070|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
2497071|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497072|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497073|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
2497074|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2497075|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2497076|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2497077|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2497078|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2497079|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2497080|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2497081|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497082|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
2497083|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
2497084|NCT01200641|Protective Agents|protective agents|mesh-ancestor
2497085|NCT01200654|Linezolid|linezolid|mesh-list
2497086|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2380896|NCT00633672|Esomeprazole|esomeprazole|mesh-list
2380897|NCT00633672|Ranitidine|ranitidine|mesh-list
2380898|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2380899|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2380900|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2380901|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2380902|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380903|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380904|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2380905|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
2380906|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
2380907|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380908|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380909|NCT00633685|Fluoxetine|fluoxetine|mesh-list
2380910|NCT00633685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2380911|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2380912|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2380913|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380914|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380915|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
2380916|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380917|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2497087|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497088|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2497089|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497090|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380918|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
2380919|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2380920|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2380921|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2380922|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380923|NCT00633698|Niacin|niacin|mesh-list
2380924|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
2380925|NCT00633698|Niacinamide|niacinamide|mesh-list
2380926|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2380927|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
2380928|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497091|NCT01200693|Sirolimus|sirolimus|mesh-list
2497092|NCT01200693|Everolimus|everolimus|mesh-list
2497093|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497094|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497095|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
2497096|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497097|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2497098|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497099|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2497100|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
2497101|NCT01200706|Amoxicillin|amoxicillin|mesh-list
2497102|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2380929|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2380930|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
2380931|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
2380932|NCT00633698|Vitamins|vitamins|mesh-ancestor
2497103|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497104|NCT01200732|Tadalafil|tadalafil|mesh-list
2497105|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
2497106|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2497107|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2497108|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497109|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497110|NCT01200732|Urological Agents|urological agents|mesh-ancestor
2497111|NCT01200745|Capsaicin|capsaicin|mesh-list
2497112|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
2497113|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
2497114|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
2497115|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497116|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497117|NCT01200784|Niacinamide|niacinamide|mesh-list
2497118|NCT01200784|Niacin|niacin|mesh-list
2497119|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
2497120|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
2497121|NCT01200784|Vitamins|vitamins|mesh-ancestor
2497122|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
2497123|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497124|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2497125|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
2497126|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497127|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2497128|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
2380933|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
2380934|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380935|NCT00633763|Fallypride|fallypride|mesh-list
2380936|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2497129|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2497130|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
2497131|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2497132|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2497133|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2380937|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2380938|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
2380939|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380940|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380941|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380942|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
2380943|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2380944|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
2380945|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2380946|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380947|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2380948|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
2380949|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2380950|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2380951|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2380952|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
2380953|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380954|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380955|NCT00633802|Risperidone|risperidone|mesh-list
2380956|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2380957|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
2380958|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2380959|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380960|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380961|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2380962|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2380963|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380964|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2380965|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2380966|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
2380967|NCT00633958|Alovudine|alovudine|mesh-list
2380968|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
2380969|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380970|NCT00633997|Vildagliptin|vildagliptin|mesh-list
2380971|NCT00633997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2497134|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2497135|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497136|NCT01200914|Heparin|heparin|mesh-list
2497137|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
2497138|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2497139|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2497140|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497141|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
2497142|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
2497143|NCT01201005|Hematinics|hematinics|mesh-ancestor
2497144|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
2497145|NCT01201005|Vitamins|vitamins|mesh-ancestor
2497146|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
2497147|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497148|NCT01201044|Gemcitabine|gemcitabine|mesh-list
2497149|NCT01201044|Nedaplatin|nedaplatin|mesh-list
2497150|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2497151|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
2497152|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497153|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2380972|NCT00633997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380973|NCT00633997|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2380974|NCT00633997|Protease Inhibitors|protease inhibitors|mesh-ancestor
2380975|NCT00633997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2380976|NCT00633997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380977|NCT00634062|Lamotrigine|lamotrigine|mesh-list
2380978|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
2380979|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2380980|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2380981|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380982|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2380983|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2380984|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2380985|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2380986|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2380987|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2380988|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2380989|NCT00634140|Ezetimibe|ezetimibe|mesh-list
2497154|NCT01201044|Antiviral Agents|antiviral agents|mesh-ancestor
2497155|NCT01201044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497156|NCT01201044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497157|NCT01201044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497158|NCT01201044|Immunologic Factors|immunologic factors|mesh-ancestor
2497159|NCT01201044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497160|NCT01201070|Antithrombins|antithrombins|mesh-list
2497161|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
2497162|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2497163|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
2497164|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497165|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497166|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
2497167|NCT01201122|Mesalamine|mesalamine|mesh-list
2497168|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2497169|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2497170|NCT01201122|Analgesics|analgesics|mesh-ancestor
2497171|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
2497172|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497173|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497174|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2497175|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2380990|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2380991|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2380992|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
2497176|NCT01201161|Ranibizumab|ranibizumab|mesh-list
2497177|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2497178|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2497179|NCT01201161|Growth Substances|growth substances|mesh-ancestor
2497180|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497181|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
2497182|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497183|NCT01201213|Anesthetics|anesthetics|mesh-list
2497184|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
2497185|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2497186|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497187|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
2497188|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497189|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
2497190|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2497191|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2497192|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
2497193|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497194|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2497195|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2497196|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497197|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497198|NCT01201278|Insulin|insulin|mesh-list
2497199|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2497200|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
2497201|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2497202|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497203|NCT01201499|Morphine|morphine|mesh-list
2497204|NCT01201499|Remifentanil|remifentanil|mesh-list
2497205|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2497206|NCT01201499|Narcotics|narcotics|mesh-ancestor
2497207|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2497208|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497209|NCT01201499|Analgesics|analgesics|mesh-ancestor
2497210|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
2497211|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497212|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2497213|NCT01201551|Latanoprost|latanoprost|mesh-list
2497214|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2497215|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2497216|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2497217|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2497218|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2497219|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2497220|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
2497221|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2497222|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497223|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497224|NCT01201577|Azithromycin|azithromycin|mesh-list
2380993|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2380994|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2380995|NCT00634192|Tobramycin|tobramycin|mesh-list
2380996|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2380997|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2380998|NCT00634205|Doxorubicin|doxorubicin|mesh-list
2380999|NCT00634205|Valproic Acid|valproic acid|mesh-list
2497225|NCT01201577|Sulfalene|sulfalene|mesh-list
2497226|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2497227|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497228|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2497229|NCT01201577|Renal Agents|renal agents|mesh-ancestor
2497230|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
2497231|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2497232|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2497233|NCT01201642|Prednisolone|prednisolone|mesh-list
2497234|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2497235|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
2497236|NCT01201642|Hormones|hormones|mesh-ancestor
2497237|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2497238|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497239|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2497240|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381000|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2381001|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381002|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2381003|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2381004|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381005|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381006|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
2381007|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
2381008|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381009|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381010|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
2381011|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2381012|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2381013|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2381014|NCT00634231|Valacyclovir|valacyclovir|mesh-list
2381015|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
2381016|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497241|NCT01201694|Curcumin|curcumin|mesh-list
2497242|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2497243|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2497244|NCT01201694|Analgesics|analgesics|mesh-ancestor
2497245|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
2497246|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497247|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381017|NCT00634309|Candesartan|candesartan|mesh-list
2114401|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2114402|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
2114403|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
2114404|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2114405|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
2381018|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2381019|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2381020|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2381021|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381022|NCT00634348|Aripiprazole|aripiprazole|mesh-list
2381023|NCT00634348|Ziprasidone|ziprasidone|mesh-list
2381024|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
2381025|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2381026|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2381027|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2381028|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2381029|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497248|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2497249|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2497250|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381030|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
2381031|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
2381032|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381033|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497251|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497252|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497253|NCT01201902|Vaccines|vaccines|mesh-list
2497254|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
2497255|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497256|NCT01201928|Insulin|insulin|mesh-list
2497257|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2497258|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497259|NCT01202032|Bevacizumab|bevacizumab|mesh-list
2497260|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2497261|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497262|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2497263|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2497264|NCT01202032|Growth Substances|growth substances|mesh-ancestor
2497265|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497266|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
2497267|NCT01202058|Sirolimus|sirolimus|mesh-list
2497268|NCT01202058|Everolimus|everolimus|mesh-list
2497269|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497270|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497271|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
2497272|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497273|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2497274|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497275|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2497276|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
2497277|NCT01202084|Fluticasone|fluticasone|mesh-list
2497278|NCT01202084|Xhance|xhance|mesh-list
2497279|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
2497280|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2497281|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2497282|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
2497283|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497284|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497285|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2497286|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
2497287|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
2497288|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2497289|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2497290|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2497291|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2497292|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
2497293|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2497294|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497295|NCT01202097|Fluticasone|fluticasone|mesh-list
2497296|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2497297|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2497298|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2497299|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2497300|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
2497301|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497302|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497303|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2497304|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
2497305|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
2497306|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2497307|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2497308|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2497309|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2497310|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
2381034|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2381035|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2381036|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
2381037|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2381038|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2497311|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2497312|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497313|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
2497314|NCT01202097|Hormones|hormones|mesh-ancestor
2497315|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2497316|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
2497317|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
2497318|NCT01202149|Emollients|emollients|mesh-list
2381039|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2381040|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2381041|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2497319|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2497320|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2497321|NCT01202149|Analgesics|analgesics|mesh-ancestor
2497322|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
2497323|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497324|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497325|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2497326|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2497327|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
2497328|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497329|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
2497330|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2497331|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497332|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497333|NCT01202240|Ketoconazole|ketoconazole|mesh-list
2497334|NCT01202240|Tofacitinib|tofacitinib|mesh-list
2381042|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2381043|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2381044|NCT00634400|Candesartan|candesartan|mesh-list
2381045|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2497335|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
2497336|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497337|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2497338|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2497339|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497340|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497341|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2497342|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
2497343|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2497344|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497345|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2497346|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2497347|NCT01202331|Azithromycin|azithromycin|mesh-list
2497348|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2497349|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497350|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
2497351|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2497352|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497353|NCT01202422|Pregabalin|pregabalin|mesh-list
2497354|NCT01202422|Analgesics|analgesics|mesh-ancestor
2497355|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
2497356|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497357|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497358|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
2497359|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2497360|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2497361|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668478|NCT02142595|Midazolam|midazolam|mesh-list
2497362|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2497363|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2497364|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2497365|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2497366|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2497367|NCT01202435|Pregabalin|pregabalin|mesh-list
2497368|NCT01202435|Analgesics|analgesics|mesh-ancestor
2497369|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
2497370|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497371|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497372|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
2497373|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2497374|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2497375|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497376|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2497377|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2497378|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2497379|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2497380|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2497381|NCT01202474|Insulin|insulin|mesh-list
2497382|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2497383|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
2497384|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
2497385|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2497386|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497387|NCT01202487|Lidocaine|lidocaine|mesh-list
2497388|NCT01202487|Epinephrine|epinephrine|mesh-list
2497389|NCT01202487|Tetracaine|tetracaine|mesh-list
2497390|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
2497391|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
2497392|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2497393|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114406|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2114407|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
2114408|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2114409|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114410|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2114411|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2114412|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2114413|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
2114414|NCT02603419|Avelumab|avelumab|mesh-list
2114415|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2184827|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
2497394|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
2497395|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497396|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2497397|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2497398|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2497399|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2497400|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497401|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2497402|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2497403|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
2497404|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2497405|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2497406|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2497407|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
2381046|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2381047|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2381048|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381049|NCT00634413|Budesonide|budesonide|mesh-list
2381050|NCT00634413|Theophylline|theophylline|mesh-list
2381051|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2381052|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2381053|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
2381054|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2381055|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381056|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2381057|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
2381058|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
2381059|NCT00634413|Hormones|hormones|mesh-ancestor
2381060|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2381061|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2497408|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2497409|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
2497410|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
2497411|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
2497412|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2497413|NCT01202513|Bimatoprost|bimatoprost|mesh-list
2497414|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2497415|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2497416|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2497417|NCT01202552|Vaccines|vaccines|mesh-list
2497418|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
2497419|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497420|NCT01202734|Methylphenidate|methylphenidate|mesh-list
2497421|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2497422|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497423|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2497424|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2497425|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2497426|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497427|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
2497428|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2497429|NCT01202799|Diclofenac|diclofenac|mesh-list
2497430|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2497431|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2381062|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381063|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381064|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
2381065|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2381066|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2381067|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
2497432|NCT01202799|Analgesics|analgesics|mesh-ancestor
2497433|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
2497434|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497435|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497436|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2497437|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2497438|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2497439|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497440|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497441|NCT01202825|Simeprevir|simeprevir|mesh-list
2497442|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
2497443|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497444|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
2497445|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497446|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497447|NCT01202890|Bevacizumab|bevacizumab|mesh-list
2497448|NCT01202890|Lenalidomide|lenalidomide|mesh-list
2497449|NCT01202890|Doxorubicin|doxorubicin|mesh-list
2497450|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2497451|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2497452|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497453|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2497454|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2497455|NCT01202890|Growth Substances|growth substances|mesh-ancestor
2497456|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497457|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
2497458|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2497459|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2497460|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2497461|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381068|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381069|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2381070|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2381071|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2381072|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2381073|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381074|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
2381075|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381076|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381077|NCT00634491|Acetazolamide|acetazolamide|mesh-list
2381078|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
2381079|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2381080|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381081|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381082|NCT00634491|Diuretics|diuretics|mesh-ancestor
2381083|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
2497462|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497463|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
2497464|NCT01203020|Vidarabine|vidarabine|mesh-list
2497465|NCT01203020|Fludarabine|fludarabine|mesh-list
2497466|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
2497467|NCT01203020|Busulfan|busulfan|mesh-list
2497468|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497469|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2497470|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
2497471|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497472|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497473|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
2497474|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497475|NCT01203020|Antiviral Agents|antiviral agents|mesh-ancestor
2497476|NCT01203020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497477|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
2497478|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2497479|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2497480|NCT01203111|Insulin|insulin|mesh-list
2497481|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2497482|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
2497483|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
2497484|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2381084|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381085|NCT00634517|Albuterol|albuterol|mesh-list
2381086|NCT00634517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2381087|NCT00634517|Autonomic Agents|autonomic agents|mesh-ancestor
2381088|NCT00634517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2381089|NCT00634517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381090|NCT00634517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2381091|NCT00634517|Respiratory System Agents|respiratory system agents|mesh-ancestor
2497485|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497486|NCT01203202|Clomipramine|clomipramine|mesh-list
2497487|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2497488|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
2497489|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2497490|NCT01203202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2497491|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2497492|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2497493|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497494|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2497495|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
2497496|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497497|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
2497498|NCT01203228|Busulfan|busulfan|mesh-list
2497499|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
2497500|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497501|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
2497502|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497503|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2497504|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2497505|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
2497506|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497507|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497508|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2497509|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2497510|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
2497511|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2497512|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2497513|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2497514|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
2497515|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497516|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2497517|NCT01203267|Paclitaxel|paclitaxel|mesh-list
2497518|NCT01203267|Carboplatin|carboplatin|mesh-list
2497519|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2497520|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497521|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
2497522|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
2497523|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
2497524|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497525|NCT01203306|Bevacizumab|bevacizumab|mesh-list
2497526|NCT01203306|Capecitabine|capecitabine|mesh-list
2381092|NCT00634517|Tocolytic Agents|tocolytic agents|mesh-ancestor
2381093|NCT00634517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2497527|NCT01203306|Octreotide|octreotide|mesh-list
2497528|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2497529|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497530|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2497531|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2497532|NCT01203306|Growth Substances|growth substances|mesh-ancestor
2497533|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497534|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
2497535|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2497536|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
2497537|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497538|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2497539|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2497540|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2497541|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
2497542|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497543|NCT01203358|Beractant|beractant|mesh-list
2497544|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2497545|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
2497546|NCT01203371|Naftopidil|naftopidil|mesh-list
2497547|NCT01203371|Tamsulosin|tamsulosin|mesh-list
2497548|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2497549|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2497550|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2497551|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
2497552|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2497553|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497554|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497555|NCT01203371|Urological Agents|urological agents|mesh-ancestor
2381094|NCT00634517|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2381095|NCT00634517|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2381096|NCT00634517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2381097|NCT00634517|Adrenergic Agents|adrenergic agents|mesh-ancestor
2381098|NCT00634517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381099|NCT00634517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381100|NCT00634556|Levodopa|levodopa|mesh-list
2381101|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
2381102|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2381103|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2381104|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
2381105|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381106|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381107|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381108|NCT00634595|Paclitaxel|paclitaxel|mesh-list
2381109|NCT00634595|Cisplatin|cisplatin|mesh-list
2381110|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2381111|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381112|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
2497556|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2497557|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2497558|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2497559|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2497560|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2497561|NCT01203384|Flurbiprofen|flurbiprofen|mesh-list
2497562|NCT01203384|Analgesics|analgesics|mesh-ancestor
2497563|NCT01203384|Sensory System Agents|sensory system agents|mesh-ancestor
2497564|NCT01203384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497565|NCT01203384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497566|NCT01203384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2497567|NCT01203384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2497568|NCT01203384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2497569|NCT01203384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2497570|NCT01203384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2497571|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497572|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497573|NCT01203488|Vitamin A|vitamin a|mesh-list
2497574|NCT01203488|Vitamins|vitamins|mesh-ancestor
2497575|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
2497576|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497577|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
2497578|NCT01203514|Hematinics|hematinics|mesh-ancestor
2497579|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2381113|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
2381114|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
2381115|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381116|NCT00634634|Sorafenib|sorafenib|mesh-list
2381117|NCT00634634|Letrozole|letrozole|mesh-list
2381118|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381119|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2497580|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2497581|NCT01203592|Albuterol|albuterol|mesh-list
2497582|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2497583|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
2497584|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497585|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497586|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2497587|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
2497588|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
2497589|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2497590|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2497591|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2497592|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2497593|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
2497594|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2497595|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497596|NCT01203618|Farletuzumab|farletuzumab|mesh-list
2497597|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497598|NCT01203696|Amlodipine|amlodipine|mesh-list
2497599|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2497600|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2497601|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2497602|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497603|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2497604|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497605|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
2497606|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
2497607|NCT01203709|Tacrolimus|tacrolimus|mesh-list
2497608|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497609|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
2497610|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497611|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2497612|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497613|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497614|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2497615|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497616|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2497617|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
2497618|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2497619|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497620|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
2497621|NCT01203722|Sirolimus|sirolimus|mesh-list
2497622|NCT01203722|Fludarabine|fludarabine|mesh-list
2497623|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
2497624|NCT01203722|Tacrolimus|tacrolimus|mesh-list
2497625|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497626|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497627|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497628|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
2497629|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497630|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2497631|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497632|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2497633|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2497634|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
2497635|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2497636|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2497637|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2497638|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
2497639|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2497640|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497641|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
2497642|NCT01203735|Valproic Acid|valproic acid|mesh-list
2497643|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
2497644|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497645|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497646|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
2497647|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381120|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381121|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381122|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2381123|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2381124|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2381125|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
2381126|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2497648|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497649|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
2497650|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2497651|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2497652|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2497653|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2497654|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2497655|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2497656|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
2497657|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497658|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2381127|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381128|NCT00634686|Vitamin D|vitamin d|mesh-list
2381129|NCT00634686|Calcium|calcium|mesh-list
2381130|NCT00634686|Vitamins|vitamins|mesh-ancestor
2381131|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
2381132|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381133|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2381134|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2381135|NCT00634712|Candesartan|candesartan|mesh-list
2381136|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2381137|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2381138|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2381139|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381140|NCT00634725|Gemcitabine|gemcitabine|mesh-list
2381141|NCT00634725|Capecitabine|capecitabine|mesh-list
2381142|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2381143|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2381144|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
2381145|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381146|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381147|NCT00634725|Antiviral Agents|antiviral agents|mesh-ancestor
2381148|NCT00634725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381149|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381150|NCT00634725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2381151|NCT00634725|Immunologic Factors|immunologic factors|mesh-ancestor
2381152|NCT00634725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381153|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2381154|NCT00634790|Alprazolam|alprazolam|mesh-list
2381155|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2381156|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2381157|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381158|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2381159|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2381160|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2381161|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
2381162|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
2381163|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381164|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497659|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2497660|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497661|NCT01204086|Fluoxetine|fluoxetine|mesh-list
2497662|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2497663|NCT01204086|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2497664|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2497665|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2497666|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381165|NCT00634829|Albuterol|albuterol|mesh-list
2381166|NCT00634829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2381167|NCT00634829|Autonomic Agents|autonomic agents|mesh-ancestor
2381168|NCT00634829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2381169|NCT00634829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381170|NCT00634829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2381171|NCT00634829|Respiratory System Agents|respiratory system agents|mesh-ancestor
2381172|NCT00634829|Tocolytic Agents|tocolytic agents|mesh-ancestor
2381173|NCT00634829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2381174|NCT00634829|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2497667|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2497668|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
2497669|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497670|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2497671|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
2497672|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2497673|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2497674|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2497675|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497676|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2497677|NCT01204099|Docetaxel|docetaxel|mesh-list
2497678|NCT01204099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497679|NCT01204099|Tubulin Modulators|tubulin modulators|mesh-ancestor
2497680|NCT01204099|Antimitotic Agents|antimitotic agents|mesh-ancestor
2497681|NCT01204099|Mitosis Modulators|mitosis modulators|mesh-ancestor
2497682|NCT01204099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497683|NCT01204112|Rifampin|rifampin|mesh-list
2497684|NCT01204112|Tofacitinib|tofacitinib|mesh-list
2497685|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2497686|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
2497687|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2497688|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497689|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
2497690|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2497691|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497692|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497693|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2497694|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2497695|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2497696|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2497697|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2497698|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2497699|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2497700|NCT01204125|Paclitaxel|paclitaxel|mesh-list
2497701|NCT01204125|Iniparib|iniparib|mesh-list
2497702|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2497703|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497704|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
2497705|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
2497706|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
2497707|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497708|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2497709|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497710|NCT01204138|Apremilast|apremilast|mesh-list
2497711|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2497712|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2497713|NCT01204138|Analgesics|analgesics|mesh-ancestor
2497714|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
2497715|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497716|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497717|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2497718|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2497719|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2497720|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2497721|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497722|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497723|NCT01204164|Dexamethasone|dexamethasone|mesh-list
2497724|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2497725|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
2497726|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
2497727|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497728|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497729|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2497730|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
2497731|NCT01204164|Hormones|hormones|mesh-ancestor
2497732|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2497733|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2497734|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497735|NCT01204177|Sorafenib|sorafenib|mesh-list
2497736|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381175|NCT00634829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2381176|NCT00634829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2381177|NCT00634829|Adrenergic Agents|adrenergic agents|mesh-ancestor
2381178|NCT00634829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381179|NCT00634829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381180|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
2381181|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2381182|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381183|NCT00634894|Letrozole|letrozole|mesh-list
2381184|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381185|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2381186|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2381187|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381188|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381189|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2381190|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
2381191|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2497737|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2497738|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497739|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497740|NCT01204190|Gestodene|gestodene|mesh-list
2497741|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2497742|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2497743|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2497744|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
2381192|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381193|NCT00634959|Maraviroc|maraviroc|mesh-list
2381194|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2381195|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2381196|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381197|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2381198|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2381199|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
2381200|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381201|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2381202|NCT00634985|Eletriptan|eletriptan|mesh-list
2381203|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2381204|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
2381205|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381206|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381207|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497745|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2497746|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497747|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2497748|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2497749|NCT01204190|Progestins|progestins|mesh-ancestor
2497750|NCT01204190|Hormones|hormones|mesh-ancestor
2497751|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2497752|NCT01204216|Biotin|biotin|mesh-list
2497753|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
2497754|NCT01204216|Vitamins|vitamins|mesh-ancestor
2381208|NCT00634998|Ascorbic Acid|ascorbic acid|mesh-list
2381209|NCT00634998|Vitamins|vitamins|mesh-ancestor
2381210|NCT00634998|Micronutrients|micronutrients|mesh-ancestor
2381211|NCT00634998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381212|NCT00634998|Antioxidants|antioxidants|mesh-ancestor
2381213|NCT00634998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381214|NCT00634998|Protective Agents|protective agents|mesh-ancestor
2497755|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
2497756|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497757|NCT01204242|Lidocaine|lidocaine|mesh-list
2497758|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
2497759|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
2497760|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2497761|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497762|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
2497763|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497764|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2497765|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2497766|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2497767|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2497768|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497769|NCT01204268|Sevoflurane|sevoflurane|mesh-list
2497770|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2497771|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2381215|NCT00635037|Bupivacaine|bupivacaine|mesh-list
2381216|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
2381217|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
2381218|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2381219|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381220|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
2381221|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2381222|NCT00635076|Alprazolam|alprazolam|mesh-list
2381223|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2381224|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2381225|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381226|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2497772|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
2497773|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
2497774|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2497775|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497776|NCT01204307|Cisplatin|cisplatin|mesh-list
2381227|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2381228|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2381229|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
2381230|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
2381231|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381232|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381233|NCT00635193|Doxorubicin|doxorubicin|mesh-list
2381234|NCT00635193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2381235|NCT00635193|Volociximab|volociximab|mesh-list
2381236|NCT00635193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2381237|NCT00635193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2381238|NCT00635193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381239|NCT00635193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2381240|NCT00635193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2381241|NCT00635193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381242|NCT00635193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381243|NCT00635193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2381244|NCT00635193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2381245|NCT00635193|Growth Substances|growth substances|mesh-ancestor
2381246|NCT00635193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381247|NCT00635193|Growth Inhibitors|growth inhibitors|mesh-ancestor
2381248|NCT00635193|Immunologic Factors|immunologic factors|mesh-ancestor
2381249|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2381250|NCT00635258|Ganirelix|ganirelix|mesh-list
2381251|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2381252|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497777|NCT01204307|Docetaxel|docetaxel|mesh-list
2497778|NCT01204307|Pemetrexed|pemetrexed|mesh-list
2497779|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497780|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
2497781|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
2497782|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
2497783|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497784|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497785|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2497786|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2497787|NCT01204320|Paclitaxel|paclitaxel|mesh-list
2497788|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2497789|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2497790|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497791|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
2497792|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
2497793|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
2497794|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497795|NCT01204333|Heparin|heparin|mesh-list
2497796|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
2497797|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2497798|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2497799|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497800|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
2497801|NCT01204372|Gemcitabine|gemcitabine|mesh-list
2497802|NCT01204372|Trastuzumab|trastuzumab|mesh-list
2497803|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2497804|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2497805|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
2497806|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381253|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
2381254|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2381255|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
2497807|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497808|NCT01204372|Antiviral Agents|antiviral agents|mesh-ancestor
2497809|NCT01204372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381256|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2381257|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2381258|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2381259|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381260|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
2381261|NCT00635284|Sirolimus|sirolimus|mesh-list
2381262|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2381263|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381264|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2381265|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381266|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
2381267|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2381268|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
2381269|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381270|NCT00635310|Liver Extracts|liver extracts|mesh-list
2381271|NCT00635310|Hematinics|hematinics|mesh-ancestor
2381272|NCT00635323|Capecitabine|capecitabine|mesh-list
2381273|NCT00635323|Irinotecan|irinotecan|mesh-list
2381274|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2381275|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
2381276|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497810|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497811|NCT01204372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497812|NCT01204372|Immunologic Factors|immunologic factors|mesh-ancestor
2497813|NCT01204372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497814|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2497815|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2497816|NCT01204411|Artesunate|artesunate|mesh-list
2497817|NCT01204411|Amodiaquine|amodiaquine|mesh-list
2497818|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
2497819|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2497820|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2497821|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497822|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497823|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
2497824|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
2497825|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2497826|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
2497827|NCT01204437|Paclitaxel|paclitaxel|mesh-list
2497828|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
2497829|NCT01204437|Capecitabine|capecitabine|mesh-list
2497830|NCT01204437|Methotrexate|methotrexate|mesh-list
2497831|NCT01204437|Epirubicin|epirubicin|mesh-list
2497832|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2497833|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497834|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
2497835|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
2497836|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
2497837|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497838|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497839|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
2497840|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497841|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2497842|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2497843|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
2497844|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2497845|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2497846|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
2497847|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2497848|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
2497849|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2497850|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
2497851|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381277|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381278|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2381279|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2381280|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381281|NCT00635401|Varenicline|varenicline|mesh-list
2381282|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2381283|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2381284|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
2381285|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2497852|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2497853|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2497854|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2497855|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2497856|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2497857|NCT01204450|Sirolimus|sirolimus|mesh-list
2497858|NCT01204450|Valproic Acid|valproic acid|mesh-list
2497859|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2497860|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381286|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381287|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381288|NCT00635414|Esomeprazole|esomeprazole|mesh-list
2381289|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2381290|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2381291|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2381292|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381293|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381294|NCT00635505|Albuterol|albuterol|mesh-list
2381295|NCT00635505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2381296|NCT00635505|Autonomic Agents|autonomic agents|mesh-ancestor
2381297|NCT00635505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2381298|NCT00635505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381299|NCT00635505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2381300|NCT00635505|Respiratory System Agents|respiratory system agents|mesh-ancestor
2381301|NCT00635505|Tocolytic Agents|tocolytic agents|mesh-ancestor
2381302|NCT00635505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2381303|NCT00635505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2381304|NCT00635505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2381305|NCT00635505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2381306|NCT00635505|Adrenergic Agents|adrenergic agents|mesh-ancestor
2381307|NCT00635505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381308|NCT00635505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381309|NCT00635531|Alprazolam|alprazolam|mesh-list
2381310|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2381311|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2381312|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381313|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2381314|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2381315|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2381316|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
2497861|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2497862|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497863|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
2497864|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497865|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
2497866|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497867|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
2497868|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497869|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497870|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
2497871|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2497872|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
2497873|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2497874|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2497875|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2497876|NCT01204476|Everolimus|everolimus|mesh-list
2497877|NCT01204476|Octreotide|octreotide|mesh-list
2497878|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2497879|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497880|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497881|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
2497882|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497883|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2497884|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2497885|NCT01204580|Metformin|metformin|mesh-list
2497886|NCT01204580|Glimepiride|glimepiride|mesh-list
2497887|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2497888|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497889|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2497890|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497891|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
2497892|NCT01204593|Insulin|insulin|mesh-list
2497893|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2497894|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
2497895|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
2497896|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2497897|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497898|NCT01204684|Vaccines|vaccines|mesh-list
2497899|NCT01204684|Poly ICLC|poly iclc|mesh-list
2381317|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
2497900|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
2497901|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497902|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
2497903|NCT01204723|Aprepitant|aprepitant|mesh-list
2497904|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
2497905|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
2497906|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
2497907|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2497908|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497909|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2497910|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2497911|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2497912|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497913|NCT01204749|Paclitaxel|paclitaxel|mesh-list
2497914|NCT01204749|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2497915|NCT01204749|Trebananib|trebananib|mesh-list
2497916|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
2497917|NCT01204749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2497918|NCT01204749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497919|NCT01204749|Tubulin Modulators|tubulin modulators|mesh-ancestor
2497920|NCT01204749|Antimitotic Agents|antimitotic agents|mesh-ancestor
2497921|NCT01204749|Mitosis Modulators|mitosis modulators|mesh-ancestor
2497922|NCT01204749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497923|NCT01204749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2497924|NCT01204749|Growth Substances|growth substances|mesh-ancestor
2497925|NCT01204749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497926|NCT01204749|Growth Inhibitors|growth inhibitors|mesh-ancestor
2497927|NCT01204762|Entecavir|entecavir|mesh-list
2497928|NCT01204762|Antiviral Agents|antiviral agents|mesh-ancestor
2497929|NCT01204762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497930|NCT01204801|Doxorubicin|doxorubicin|mesh-list
2497931|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2497932|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2497933|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497934|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2497935|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2497936|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497937|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497938|NCT01204840|Hormones|hormones|mesh-list
2497939|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2497940|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497941|NCT01204996|Gemcitabine|gemcitabine|mesh-list
2497942|NCT01204996|Paclitaxel|paclitaxel|mesh-list
2381318|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381319|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381320|NCT00635557|Carboplatin|carboplatin|mesh-list
2381321|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381322|NCT00635713|Fulvestrant|fulvestrant|mesh-list
2381323|NCT00635713|Anastrozole|anastrozole|mesh-list
2381324|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2381325|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381326|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2381327|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2381328|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
2381329|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2381330|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381331|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2381332|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2381333|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381334|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381335|NCT00635726|Gemcitabine|gemcitabine|mesh-list
2497943|NCT01204996|Docetaxel|docetaxel|mesh-list
2497944|NCT01204996|Carboplatin|carboplatin|mesh-list
2497945|NCT01204996|Doxorubicin|doxorubicin|mesh-list
2497946|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2497947|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2497948|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497949|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
2497950|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
2497951|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
2497952|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497953|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2497954|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
2497955|NCT01204996|Antiviral Agents|antiviral agents|mesh-ancestor
2497956|NCT01204996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2497957|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497958|NCT01204996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497959|NCT01204996|Immunologic Factors|immunologic factors|mesh-ancestor
2497960|NCT01204996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497961|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2497962|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2497963|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2497964|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2497965|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2497966|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497967|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
2497968|NCT01205022|Leucovorin|leucovorin|mesh-list
2497969|NCT01205022|Bevacizumab|bevacizumab|mesh-list
2497970|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2497971|NCT01205022|Fluorouracil|fluorouracil|mesh-list
2497972|NCT01205022|Irinotecan|irinotecan|mesh-list
2497973|NCT01205022|Camptothecin|camptothecin|mesh-list
2497974|NCT01205022|Antibodies|antibodies|mesh-list
2497975|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
2497976|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2497977|NCT01205022|Calcium|calcium|mesh-list
2497978|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
2497979|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2497980|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2497981|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2497982|NCT01205022|Growth Substances|growth substances|mesh-ancestor
2497983|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2497984|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
2497985|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
2497986|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2497987|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2497988|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
2381336|NCT00635726|Cisplatin|cisplatin|mesh-list
2381337|NCT00635726|Doxorubicin|doxorubicin|mesh-list
2381338|NCT00635726|Methotrexate|methotrexate|mesh-list
2381339|NCT00635726|Vinblastine|vinblastine|mesh-list
2497989|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2497990|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2497991|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2497992|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2497993|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2497994|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2497995|NCT01205022|Antidotes|antidotes|mesh-ancestor
2497996|NCT01205022|Protective Agents|protective agents|mesh-ancestor
2497997|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
2497998|NCT01205022|Vitamins|vitamins|mesh-ancestor
2497999|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
2498000|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2498001|NCT01205048|Lidocaine|lidocaine|mesh-list
2498002|NCT01205048|Anesthetics, Local|anesthetics, local|mesh-ancestor
2498003|NCT01205048|Anesthetics|anesthetics|mesh-ancestor
2498004|NCT01205048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2498005|NCT01205048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498006|NCT01205048|Sensory System Agents|sensory system agents|mesh-ancestor
2498007|NCT01205048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498008|NCT01205048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2498009|NCT01205048|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2498010|NCT01205048|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2498011|NCT01205048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2498012|NCT01205048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381340|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381341|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2381342|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
2381343|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381344|NCT00635726|Antiviral Agents|antiviral agents|mesh-ancestor
2381345|NCT00635726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381346|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381347|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2381348|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
2381349|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381350|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2381351|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2381352|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2381353|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2498013|NCT01205061|Lidocaine|lidocaine|mesh-list
2498014|NCT01205061|Anesthetics, Local|anesthetics, local|mesh-ancestor
2498015|NCT01205061|Anesthetics|anesthetics|mesh-ancestor
2381354|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
2381355|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2381356|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
2381357|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2381358|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2381359|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2381360|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2381361|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
2381362|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
2498016|NCT01205061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2498017|NCT01205061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498018|NCT01205061|Sensory System Agents|sensory system agents|mesh-ancestor
2498019|NCT01205061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498020|NCT01205061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2498021|NCT01205061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2498022|NCT01205061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2498023|NCT01205061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2498024|NCT01205061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498025|NCT01205074|Ethanol|ethanol|mesh-list
2498026|NCT01205074|Propranolol|propranolol|mesh-list
2498027|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2498028|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2498029|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
2498030|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2498031|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498032|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498033|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2498034|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2498035|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
2498036|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2498037|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498038|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2498039|NCT01205087|Omeprazole|omeprazole|mesh-list
2498040|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2498041|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2498042|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2381363|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
2381364|NCT00635791|Sorafenib|sorafenib|mesh-list
2381365|NCT00635791|Vorinostat|vorinostat|mesh-list
2381366|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381367|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2381368|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381369|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381370|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2381371|NCT00635856|Gefitinib|gefitinib|mesh-list
2381372|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498043|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498044|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498045|NCT01205139|Simeprevir|simeprevir|mesh-list
2498046|NCT01205139|Rilpivirine|rilpivirine|mesh-list
2498047|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
2498048|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498049|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
2498050|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498051|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498052|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2498053|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2498054|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2498055|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2498056|NCT01205178|Chloroquine|chloroquine|mesh-list
2498057|NCT01205178|Primaquine|primaquine|mesh-list
2498058|NCT01205178|Tafenoquine|tafenoquine|mesh-list
2498059|NCT01205178|Amebicides|amebicides|mesh-ancestor
2498060|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2498061|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2498062|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498063|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
2498064|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2498065|NCT01205204|Clonidine|clonidine|mesh-list
2498066|NCT01205204|Fentanyl|fentanyl|mesh-list
2498067|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2498068|NCT01205204|Narcotics|narcotics|mesh-ancestor
2498069|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2381373|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2498070|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498071|NCT01205204|Analgesics|analgesics|mesh-ancestor
2498072|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
2498073|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498074|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2498075|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2498076|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
2498077|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
2498078|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2498079|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
2498080|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
2498081|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2498082|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2498083|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2498084|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
2498085|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2498086|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498087|NCT01205217|Paclitaxel|paclitaxel|mesh-list
2498088|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
2498089|NCT01205217|Trastuzumab|trastuzumab|mesh-list
2498090|NCT01205217|Epirubicin|epirubicin|mesh-list
2498091|NCT01205217|Lapatinib|lapatinib|mesh-list
2498092|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2498093|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498094|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
2498095|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
2498096|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
2498097|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498098|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2498099|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
2498100|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498101|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2114416|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2114417|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114418|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
2498102|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2498103|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
2498104|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2381374|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381375|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381376|NCT00635921|Ziprasidone|ziprasidone|mesh-list
2381377|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2381378|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
2381379|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381380|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381381|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381382|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2498105|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2498106|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2498107|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2498108|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2498109|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498110|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2498111|NCT01205243|Abacavir|abacavir|mesh-list
2498112|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2498113|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2498114|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498115|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498116|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
2498117|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498118|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2498119|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2498120|NCT01205256|Methadone|methadone|mesh-list
2498121|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2498122|NCT01205256|Narcotics|narcotics|mesh-ancestor
2498123|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2498124|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498125|NCT01205256|Analgesics|analgesics|mesh-ancestor
2498126|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
2498127|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498128|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
2498129|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
2498130|NCT01205282|Pioglitazone|pioglitazone|mesh-list
2498131|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2498132|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498133|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
2381383|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2381384|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2381385|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2381386|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2381387|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
2381388|NCT00635960|Hormones|hormones|mesh-list
2381389|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2381390|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498134|NCT01205321|Bombesin|bombesin|mesh-list
2498135|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2498136|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498137|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498138|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2498139|NCT01205347|Simvastatin|simvastatin|mesh-list
2498140|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2498141|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2498142|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
2498143|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498144|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2498145|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2498146|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498147|NCT01205360|Fentanyl|fentanyl|mesh-list
2498148|NCT01205360|Bupivacaine|bupivacaine|mesh-list
2498149|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
2498150|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
2498151|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2498152|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498153|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
2498154|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498155|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2381391|NCT00635973|Gefitinib|gefitinib|mesh-list
2381392|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381393|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2381394|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381395|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381396|NCT00635986|Fentanyl|fentanyl|mesh-list
2381397|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2381398|NCT00635986|Narcotics|narcotics|mesh-ancestor
2381399|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2381400|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381401|NCT00635986|Analgesics|analgesics|mesh-ancestor
2381402|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
2381403|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2381404|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2381405|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2381406|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
2498156|NCT01205360|Narcotics|narcotics|mesh-ancestor
2498157|NCT01205360|Analgesics|analgesics|mesh-ancestor
2498158|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2498159|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2498160|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
2498161|NCT01205464|Doxycycline|doxycycline|mesh-list
2498162|NCT01205464|Tetracycline|tetracycline|mesh-list
2498163|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2498164|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498165|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
2498166|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2498167|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2498168|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2498169|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498170|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498171|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2498172|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2498173|NCT01205516|Morphine|morphine|mesh-list
2498174|NCT01205516|Methadone|methadone|mesh-list
2498175|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2498176|NCT01205516|Narcotics|narcotics|mesh-ancestor
2498177|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2498178|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498179|NCT01205516|Analgesics|analgesics|mesh-ancestor
2381407|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
2381408|NCT00636038|Beta Carotene|beta carotene|mesh-list
2381409|NCT00636038|Carotenoids|carotenoids|mesh-list
2381410|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
2381411|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498180|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
2498181|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498182|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
2498183|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
2498184|NCT01205672|Metformin|metformin|mesh-list
2498185|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2498186|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498187|NCT01205711|Leucovorin|leucovorin|mesh-list
2498188|NCT01205711|Fluorouracil|fluorouracil|mesh-list
2498189|NCT01205711|Irinotecan|irinotecan|mesh-list
2498190|NCT01205711|Calcium|calcium|mesh-list
2498191|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
2498192|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2498193|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498194|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
2498195|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498196|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2498197|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498198|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2498199|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
2498200|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2498201|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2498202|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498203|NCT01205711|Antidotes|antidotes|mesh-ancestor
2498204|NCT01205711|Protective Agents|protective agents|mesh-ancestor
2498205|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
2498206|NCT01205711|Vitamins|vitamins|mesh-ancestor
2498207|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
2498208|NCT01205724|Factor VIII|factor viii|mesh-list
2498209|NCT01205724|Coagulants|coagulants|mesh-ancestor
2498210|NCT01205737|Rituximab|rituximab|mesh-list
2498211|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2498212|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498213|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
2498214|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498215|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2498216|NCT01205750|Insulin|insulin|mesh-list
2498217|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2498218|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2498219|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498220|NCT01205880|Calcitriol|calcitriol|mesh-list
2498221|NCT01205880|Clobetasol|clobetasol|mesh-list
2498222|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2498223|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498224|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2498225|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2498226|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498227|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2498228|NCT01205880|Vitamins|vitamins|mesh-ancestor
2498229|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
2498230|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2498231|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2498232|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
2498233|NCT01205880|Hormones|hormones|mesh-ancestor
2498234|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498235|NCT01205932|Enoxaparin|enoxaparin|mesh-list
2498236|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
2498237|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2498238|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
2498239|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2498240|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
2498241|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498242|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498243|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
2498244|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2498245|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2498246|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
2498247|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2498248|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2498249|NCT01205958|Analgesics|analgesics|mesh-ancestor
2498250|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
2498251|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498252|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498253|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2498254|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2498255|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
2498256|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2498257|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
2498258|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2668479|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
2498259|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2498260|NCT01205984|Prednisolone|prednisolone|mesh-list
2498261|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
2498262|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2498263|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
2498264|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2498265|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
2498266|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
2498267|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498268|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498269|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2498270|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
2498271|NCT01205984|Hormones|hormones|mesh-ancestor
2381412|NCT00636038|Protective Agents|protective agents|mesh-ancestor
2381413|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381414|NCT00636038|Provitamins|provitamins|mesh-ancestor
2381415|NCT00636038|Vitamins|vitamins|mesh-ancestor
2381416|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
2381417|NCT00636064|Parecoxib|parecoxib|mesh-list
2381418|NCT00636064|Valdecoxib|valdecoxib|mesh-list
2381419|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2381420|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2381421|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381422|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381423|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2381424|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2381425|NCT00636064|Analgesics|analgesics|mesh-ancestor
2381426|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
2381427|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2381428|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381429|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2381430|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2381431|NCT00636116|Antivenins|antivenins|mesh-list
2381432|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
2381433|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381434|NCT00636142|Infliximab|infliximab|mesh-list
2381435|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
2381436|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2381437|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2498272|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498273|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2498274|NCT01205984|Protective Agents|protective agents|mesh-ancestor
2498275|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2381438|NCT00636246|Sertraline|sertraline|mesh-list
2381439|NCT00636246|Reboxetine|reboxetine|mesh-list
2498276|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498277|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2498278|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381440|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
2381441|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2381442|NCT00636246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2381443|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2381444|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2381445|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381446|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381447|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
2381448|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381449|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2381450|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
2381451|NCT00636259|Bicalutamide|bicalutamide|mesh-list
2381452|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
2381453|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
2498279|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2498280|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498281|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498282|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
2498283|NCT01205997|Fentanyl|fentanyl|mesh-list
2498284|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2498285|NCT01205997|Narcotics|narcotics|mesh-ancestor
2498286|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2498287|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498288|NCT01205997|Analgesics|analgesics|mesh-ancestor
2498289|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
2498290|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498291|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2381454|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498292|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2498293|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
2498294|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
2498295|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2498296|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
2381455|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381456|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498297|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2498298|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2498299|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498300|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2498301|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
2498302|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2498303|NCT01206010|Varenicline|varenicline|mesh-list
2498304|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2498305|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2498306|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
2498307|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2498308|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498309|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498310|NCT01206036|Sirolimus|sirolimus|mesh-list
2498311|NCT01206036|Docetaxel|docetaxel|mesh-list
2498312|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498313|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
2498314|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
2498315|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
2381457|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2381458|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
2381459|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381460|NCT00636298|Bevacizumab|bevacizumab|mesh-list
2381461|NCT00636298|Cetuximab|cetuximab|mesh-list
2381462|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2381463|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381464|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2381465|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2381466|NCT00636298|Growth Substances|growth substances|mesh-ancestor
2381467|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381468|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
2381469|NCT00636311|Gemcitabine|gemcitabine|mesh-list
2498316|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498317|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2498318|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498319|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2498320|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
2498321|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2498322|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
2498323|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498324|NCT01206049|Gemcitabine|gemcitabine|mesh-list
2381470|NCT00636311|Bortezomib|bortezomib|mesh-list
2381471|NCT00636311|Vinorelbine|vinorelbine|mesh-list
2381472|NCT00636311|Ifosfamide|ifosfamide|mesh-list
2381473|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2381474|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
2381475|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381476|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381477|NCT00636311|Antiviral Agents|antiviral agents|mesh-ancestor
2498325|NCT01206049|Bevacizumab|bevacizumab|mesh-list
2498326|NCT01206049|Panitumumab|panitumumab|mesh-list
2498327|NCT01206049|Capecitabine|capecitabine|mesh-list
2498328|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
2498329|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2498330|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498331|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2498332|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2498333|NCT01206049|Growth Substances|growth substances|mesh-ancestor
2498334|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498335|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
2498336|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2498337|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
2498338|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498339|NCT01206049|Antiviral Agents|antiviral agents|mesh-ancestor
2498340|NCT01206049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498341|NCT01206049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498342|NCT01206049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2498343|NCT01206049|Immunologic Factors|immunologic factors|mesh-ancestor
2498344|NCT01206075|Plerixafor|plerixafor|mesh-list
2498345|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2381478|NCT00636311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381479|NCT00636311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498346|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2498347|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
2498348|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498349|NCT01206153|Metformin|metformin|mesh-list
2498350|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2498351|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498352|NCT01206205|Lenalidomide|lenalidomide|mesh-list
2498353|NCT01206205|Bortezomib|bortezomib|mesh-list
2498354|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
2498355|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498356|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2498357|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2498358|NCT01206205|Growth Substances|growth substances|mesh-ancestor
2498359|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
2498360|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498361|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
2498362|NCT01206270|Castor Oil|castor oil|mesh-list
2498363|NCT01206270|Testosterone|testosterone|mesh-list
2381480|NCT00636311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2381481|NCT00636311|Immunologic Factors|immunologic factors|mesh-ancestor
2381482|NCT00636311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381483|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2381484|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
2381485|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
2381486|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
2381487|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2381488|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
2381489|NCT00636415|Morphine|morphine|mesh-list
2381490|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2381491|NCT00636415|Narcotics|narcotics|mesh-ancestor
2381492|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2498364|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
2498365|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
2498366|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2498367|NCT01206270|Androgens|androgens|mesh-ancestor
2498368|NCT01206270|Hormones|hormones|mesh-ancestor
2498369|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2381493|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381494|NCT00636415|Analgesics|analgesics|mesh-ancestor
2498370|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498371|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2498372|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498373|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
2498374|NCT01206270|Cathartics|cathartics|mesh-ancestor
2498375|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2498376|NCT01206348|Minocycline|minocycline|mesh-list
2498377|NCT01206348|Clindamycin|clindamycin|mesh-list
2498378|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
2498379|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
2498380|NCT01206348|Tretinoin|tretinoin|mesh-list
2498381|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2498382|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2498383|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498384|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2498385|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498386|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498387|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
2498388|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498389|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
2498390|NCT01206530|Leucovorin|leucovorin|mesh-list
2498391|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
2498392|NCT01206530|Bevacizumab|bevacizumab|mesh-list
2498393|NCT01206530|Fluorouracil|fluorouracil|mesh-list
2498394|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
2498395|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2498396|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498397|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2498398|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2498399|NCT01206530|Growth Substances|growth substances|mesh-ancestor
2498400|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498401|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
2498402|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
2498403|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498404|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2498405|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2498406|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
2498407|NCT01206530|Antidotes|antidotes|mesh-ancestor
2498408|NCT01206530|Protective Agents|protective agents|mesh-ancestor
2498409|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
2498410|NCT01206530|Vitamins|vitamins|mesh-ancestor
2498411|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
2498412|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
2498413|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2498414|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2498415|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498416|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498417|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2498418|NCT01206569|Tacrolimus|tacrolimus|mesh-list
2498419|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2498420|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
2498421|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498422|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2498423|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498424|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498425|NCT01206647|Metformin|metformin|mesh-list
2498426|NCT01206647|Saxagliptin|saxagliptin|mesh-list
2498427|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2498428|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498429|NCT01206647|Incretins|incretins|mesh-ancestor
2498430|NCT01206647|Hormones|hormones|mesh-ancestor
2498431|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498432|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2498433|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
2498434|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498435|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498436|NCT01206803|Ganirelix|ganirelix|mesh-list
2498437|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
2498438|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498439|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498440|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
2498441|NCT01206881|Docetaxel|docetaxel|mesh-list
2498442|NCT01206881|Doxorubicin|doxorubicin|mesh-list
2498443|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2498444|NCT01206881|Trastuzumab|trastuzumab|mesh-list
2498445|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2498446|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
2498447|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498448|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2498449|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2498450|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
2498451|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498452|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498453|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2498454|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
2498455|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
2498456|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
2498457|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2498458|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2498459|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2498460|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498461|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2498462|NCT01206907|Oxymorphone|oxymorphone|mesh-list
2498463|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2498464|NCT01206907|Narcotics|narcotics|mesh-ancestor
2498465|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2498466|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498467|NCT01206907|Analgesics|analgesics|mesh-ancestor
2498468|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
2498469|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498470|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2498471|NCT01206946|Betamethasone|betamethasone|mesh-list
2498472|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2498473|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
2498474|NCT01206946|Hormones|hormones|mesh-ancestor
2498475|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498476|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498477|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2498478|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
2498479|NCT01206972|Enoxaparin|enoxaparin|mesh-list
2498480|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
2498481|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2498482|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
2498483|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2381495|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
2381496|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2381497|NCT00636428|Midazolam|midazolam|mesh-list
2381498|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2498484|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
2498485|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498486|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498487|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
2498488|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2498489|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2498490|NCT01206998|Progesterone|progesterone|mesh-list
2498491|NCT01206998|Progestins|progestins|mesh-ancestor
2498492|NCT01206998|Hormones|hormones|mesh-ancestor
2498493|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498494|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498495|NCT01207011|Docetaxel|docetaxel|mesh-list
2498496|NCT01207011|Amrubicin|amrubicin|mesh-list
2498497|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498498|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
2498499|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
2381499|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2381500|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2381501|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381502|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2498500|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
2498501|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498502|NCT01207115|Naproxen|naproxen|mesh-list
2498503|NCT01207115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2498504|NCT01207115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2498505|NCT01207115|Analgesics|analgesics|mesh-ancestor
2498506|NCT01207115|Sensory System Agents|sensory system agents|mesh-ancestor
2498507|NCT01207115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498508|NCT01207115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498509|NCT01207115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2498510|NCT01207115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2498511|NCT01207115|Gout Suppressants|gout suppressants|mesh-ancestor
2498512|NCT01207115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2498513|NCT01207115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498514|NCT01207115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498515|NCT01207128|Voriconazole|voriconazole|mesh-list
2498516|NCT01207128|Micafungin|micafungin|mesh-list
2498517|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
2498518|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498519|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2498520|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2498521|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498522|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498523|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2498524|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
2498525|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498526|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498527|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2498528|NCT01207206|Ketamine|ketamine|mesh-list
2498529|NCT01207206|Analgesics|analgesics|mesh-ancestor
2498530|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
2498531|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498532|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498533|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2498534|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2498535|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
2498536|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
2498537|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2498538|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2498539|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2498540|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2498541|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498542|NCT01207245|Tobramycin|tobramycin|mesh-list
2498543|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2498544|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498545|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
2498546|NCT01207297|Tacrolimus|tacrolimus|mesh-list
2498547|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2498548|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
2498549|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114419|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381503|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2381504|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2381505|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2381506|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
2381507|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
2381508|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
2381509|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
2381510|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2498550|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2498551|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2498552|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
2498553|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498554|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498555|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2498556|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2498557|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498558|NCT01207310|Nicotine|nicotine|mesh-list
2498559|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2498560|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
2498561|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498562|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498563|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2498564|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2498565|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
2498566|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2498567|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498568|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2498569|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2498570|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2498571|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2498572|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498573|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
2498574|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381511|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381512|NCT00636480|Chlorhexidine|chlorhexidine|mesh-list
2381513|NCT00636480|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2381514|NCT00636480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2381515|NCT00636480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381516|NCT00636480|Disinfectants|disinfectants|mesh-ancestor
2381517|NCT00636480|Dermatologic Agents|dermatologic agents|mesh-ancestor
2381518|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2381519|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2381520|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
2498575|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498576|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
2498577|NCT01207739|Doxycycline|doxycycline|mesh-list
2498578|NCT01207739|Clarithromycin|clarithromycin|mesh-list
2498579|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
2498580|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2498581|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2498582|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498583|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498584|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498585|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2498586|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2498587|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2498588|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2498589|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2498590|NCT01207921|Lenalidomide|lenalidomide|mesh-list
2498591|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
2498592|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498593|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2498594|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2498595|NCT01207921|Growth Substances|growth substances|mesh-ancestor
2498596|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
2498597|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498598|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2498599|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
2498600|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2498601|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2498602|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381521|NCT00636493|Hormones|hormones|mesh-ancestor
2381522|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498603|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498604|NCT01207947|Urological Agents|urological agents|mesh-ancestor
2498605|NCT01208012|Liraglutide|liraglutide|mesh-list
2498606|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2498607|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498608|NCT01208012|Incretins|incretins|mesh-ancestor
2498609|NCT01208012|Hormones|hormones|mesh-ancestor
2498610|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498611|NCT01208090|Ponesimod|ponesimod|mesh-list
2498612|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2498613|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381523|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381524|NCT00636519|Antitoxins|antitoxins|mesh-list
2381525|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
2381526|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
2381527|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381528|NCT00636545|Oblimersen|oblimersen|mesh-list
2381529|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381530|NCT00636584|Nitroprusside|nitroprusside|mesh-list
2381531|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2381532|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
2381533|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2381534|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381535|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
2381536|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2498614|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2498615|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
2498616|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498617|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
2498618|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498619|NCT01208285|Ivacaftor|ivacaftor|mesh-list
2498620|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2498621|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2498622|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498623|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
2498624|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2498625|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
2498626|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
2498627|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498628|NCT01208441|Letrozole|letrozole|mesh-list
2498629|NCT01208441|R04929097|r04929097|mesh-list
2498630|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498631|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2498632|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2498633|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498634|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498635|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2498636|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
2498637|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498638|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381537|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381538|NCT00636766|Metformin|metformin|mesh-list
2381539|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
2381540|NCT00636766|Rimonabant|rimonabant|mesh-list
2381541|NCT00636766|Atorvastatin|atorvastatin|mesh-list
2381542|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2381543|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381544|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2381545|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2381546|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
2381547|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381548|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2381549|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2381550|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381551|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2381552|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2381553|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2381554|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381555|NCT00636766|Hormones|hormones|mesh-ancestor
2498639|NCT01208454|Vitamin A|vitamin a|mesh-list
2498640|NCT01208454|Vorinostat|vorinostat|mesh-list
2498641|NCT01208454|Tretinoin|tretinoin|mesh-list
2498642|NCT01208454|Isotretinoin|isotretinoin|mesh-list
2498643|NCT01208454|Vitamins|vitamins|mesh-ancestor
2498644|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
2498645|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498646|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498647|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2498648|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381556|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2381557|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2381558|NCT00636831|Cefazolin|cefazolin|mesh-list
2381559|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381560|NCT00636870|Fexofenadine|fexofenadine|mesh-list
2381561|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2381562|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2381563|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2381564|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
2381565|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
2381566|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381567|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381568|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381569|NCT00636883|Gemcitabine|gemcitabine|mesh-list
2381570|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
2381571|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2381572|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
2381573|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381574|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381575|NCT00636883|Antiviral Agents|antiviral agents|mesh-ancestor
2381576|NCT00636883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381577|NCT00636883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381578|NCT00636883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2381579|NCT00636883|Immunologic Factors|immunologic factors|mesh-ancestor
2381580|NCT00636883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381581|NCT00636896|Olanzapine|olanzapine|mesh-list
2381582|NCT00636896|Modafinil|modafinil|mesh-list
2381583|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
2381584|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
2381585|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2381586|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381587|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2381588|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2381589|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2381590|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2381591|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2381592|NCT00636896|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2381593|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2381594|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2381595|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381596|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381597|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
2381598|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2381599|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2381600|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2381601|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2381602|NCT00636909|Cyclosporine|cyclosporine|mesh-list
2381603|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
2381604|NCT00636909|Methotrexate|methotrexate|mesh-list
2381605|NCT00636909|Fludarabine|fludarabine|mesh-list
2381606|NCT00636909|Cyclosporins|cyclosporins|mesh-list
2381607|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2381608|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
2381609|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498649|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498650|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
2498651|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
2498652|NCT01208480|Carboplatin|carboplatin|mesh-list
2498653|NCT01208480|Docetaxel|docetaxel|mesh-list
2498654|NCT01208480|Bevacizumab|bevacizumab|mesh-list
2498655|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498656|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
2498657|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
2498658|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
2498659|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498660|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2381610|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2381611|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2381612|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
2498661|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2381613|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381614|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381615|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2381616|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2381617|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
2381618|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2381619|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2381620|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
2381621|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
2381622|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381623|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2381624|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2381625|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
2381626|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498662|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2498663|NCT01208480|Growth Substances|growth substances|mesh-ancestor
2498664|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498665|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
2498666|NCT01208649|Exenatide|exenatide|mesh-list
2498667|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2498668|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498669|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2498670|NCT01208649|Incretins|incretins|mesh-ancestor
2498671|NCT01208649|Hormones|hormones|mesh-ancestor
2498672|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2381627|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2381628|NCT00636922|Everolimus|everolimus|mesh-list
2381629|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381630|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2381631|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
2381632|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381633|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2381634|NCT00636935|Clindamycin|clindamycin|mesh-list
2498673|NCT01208662|Dexamethasone|dexamethasone|mesh-list
2498674|NCT01208662|Lenalidomide|lenalidomide|mesh-list
2498675|NCT01208662|Bortezomib|bortezomib|mesh-list
2498676|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2498677|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
2498678|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
2498679|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498680|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498681|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2498682|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
2498683|NCT01208662|Hormones|hormones|mesh-ancestor
2498684|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498685|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2498686|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498687|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
2498688|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2498689|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2498690|NCT01208662|Growth Substances|growth substances|mesh-ancestor
2498691|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
2498692|NCT01208701|Atorvastatin|atorvastatin|mesh-list
2381635|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
2381636|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
2381637|NCT00636935|Dapsone|dapsone|mesh-list
2498693|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2498694|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2498695|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
2498696|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498697|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2498698|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2498699|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498700|NCT01208740|Metformin|metformin|mesh-list
2498701|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2498702|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498703|NCT01208766|Dexamethasone|dexamethasone|mesh-list
2498704|NCT01208766|Prednisone|prednisone|mesh-list
2498705|NCT01208766|Lenalidomide|lenalidomide|mesh-list
2498706|NCT01208766|Bortezomib|bortezomib|mesh-list
2498707|NCT01208766|Melphalan|melphalan|mesh-list
2498708|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2498709|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
2498710|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
2498711|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498712|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498713|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2498714|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
2381638|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2381639|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2498715|NCT01208766|Hormones|hormones|mesh-ancestor
2498716|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498717|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2498718|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498719|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
2498720|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2498721|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2498722|NCT01208766|Growth Substances|growth substances|mesh-ancestor
2498723|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
2498724|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2498725|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
2498726|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498727|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2498728|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2498729|NCT01208818|Dexamethasone|dexamethasone|mesh-list
2498730|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
2498731|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
2498732|NCT01208818|Bortezomib|bortezomib|mesh-list
2498733|NCT01208818|BB 1101|bb 1101|mesh-list
2498734|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2498735|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
2498736|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498737|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2498738|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2498739|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
2498740|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498741|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498742|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2498743|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2498744|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
2498745|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
2498746|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498747|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2498748|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
2498749|NCT01208818|Hormones|hormones|mesh-ancestor
2498750|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498751|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2498752|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
2498753|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498754|NCT01208935|Nicotine|nicotine|mesh-list
2498755|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2498756|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
2498757|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498758|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498759|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2498760|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2498761|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
2498762|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2498763|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498764|NCT01209026|Fluticasone|fluticasone|mesh-list
2498765|NCT01209026|Xhance|xhance|mesh-list
2498766|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
2498767|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2498768|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2498769|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2498770|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
2381640|NCT00636935|Primaquine|primaquine|mesh-list
2381641|NCT00636935|Trimethoprim|trimethoprim|mesh-list
2381642|NCT00636935|Atovaquone|atovaquone|mesh-list
2381643|NCT00636935|Pentamidine|pentamidine|mesh-list
2381644|NCT00636935|Prednisone|prednisone|mesh-list
2381645|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2381646|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
2498771|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498772|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498773|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2498774|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
2498775|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
2498776|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2498777|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2498778|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498779|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2498780|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2381647|NCT00636935|Hormones|hormones|mesh-ancestor
2381648|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2381649|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498781|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498782|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381650|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2381651|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498783|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498784|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2498785|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
2498786|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2498787|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2498788|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2498789|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2498790|NCT01209065|Ritonavir|ritonavir|mesh-list
2498791|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
2498792|NCT01209065|Dolutegravir|dolutegravir|mesh-list
2498793|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2498794|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2498795|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
2498796|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381652|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381653|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
2381654|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2381655|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381656|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381657|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
2498797|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498798|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2498799|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2498800|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
2498801|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498802|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2498803|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2498804|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2498805|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2498806|NCT01209130|Rituximab|rituximab|mesh-list
2498807|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2498808|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498809|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
2498810|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498811|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2498812|NCT01209208|Budesonide|budesonide|mesh-list
2498813|NCT01209208|Mesalamine|mesalamine|mesh-list
2498814|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2498815|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2498816|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
2498817|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498818|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381658|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2381659|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2381660|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2381661|NCT00636935|Renal Agents|renal agents|mesh-ancestor
2498819|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2498820|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
2498821|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
2498822|NCT01209208|Hormones|hormones|mesh-ancestor
2498823|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2114426|NCT02603809|Lisinopril|lisinopril|mesh-list
2114427|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2114428|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
2114429|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114430|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114431|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2114432|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2114433|NCT02603809|Protective Agents|protective agents|mesh-ancestor
2114434|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114435|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
2114436|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2498824|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2381662|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2381663|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2381664|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2381665|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2381666|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
2381667|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
2381668|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2381669|NCT00636974|Anesthetics|anesthetics|mesh-list
2381670|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2381671|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381672|NCT00637026|Gefitinib|gefitinib|mesh-list
2381673|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381674|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2381675|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381676|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381677|NCT00637052|Filanesib|filanesib|mesh-list
2498825|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2498826|NCT01209208|Analgesics|analgesics|mesh-ancestor
2498827|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
2498828|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2498829|NCT01209351|Teduglutide|teduglutide|mesh-list
2498830|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2498831|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2498832|NCT01209351|Protective Agents|protective agents|mesh-ancestor
2498833|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498834|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
2498835|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2498836|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2498837|NCT01209364|Prednisolone|prednisolone|mesh-list
2498838|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
2498839|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2498840|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
2498841|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2498842|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
2498843|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
2498844|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498845|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498846|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2498847|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
2498848|NCT01209364|Hormones|hormones|mesh-ancestor
2381678|NCT00637052|Antimitotic Agents|antimitotic agents|mesh-ancestor
2381679|NCT00637052|Mitosis Modulators|mitosis modulators|mesh-ancestor
2381680|NCT00637052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381681|NCT00637052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381682|NCT00637065|Bosentan|bosentan|mesh-list
2381683|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2381684|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2381685|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381686|NCT00637078|Amlodipine|amlodipine|mesh-list
2381687|NCT00637078|Spironolactone|spironolactone|mesh-list
2381688|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2381689|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2381690|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2381691|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381692|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2381693|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381694|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
2381695|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2381696|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
2381697|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2381698|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2381699|NCT00637078|Diuretics|diuretics|mesh-ancestor
2381700|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
2381701|NCT00637091|Irinotecan|irinotecan|mesh-list
2381702|NCT00637091|Cetuximab|cetuximab|mesh-list
2381703|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2381704|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2381705|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381706|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381707|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381708|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2498849|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498850|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2381709|NCT00637104|Chromium|chromium|mesh-list
2381710|NCT00637104|Trace Elements|trace elements|mesh-ancestor
2381711|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
2381712|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381713|NCT00637117|Interferons|interferons|mesh-list
2381714|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
2381715|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381716|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
2381717|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381718|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
2381719|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498851|NCT01209364|Protective Agents|protective agents|mesh-ancestor
2498852|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2498853|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2498854|NCT01209403|Insulin|insulin|mesh-list
2498855|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
2498856|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2498857|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498858|NCT01209416|Acipimox|acipimox|mesh-list
2498859|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2498860|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
2498861|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498862|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2498863|NCT01209429|Hormones|hormones|mesh-list
2498864|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498865|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498866|NCT01209455|Acetaminophen|acetaminophen|mesh-list
2498867|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
2498868|NCT01209455|Ranitidine|ranitidine|mesh-list
2498869|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2498870|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2498871|NCT01209455|Analgesics|analgesics|mesh-ancestor
2498872|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
2498873|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498874|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498875|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
2498876|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2498877|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2498878|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2498879|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
2498880|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
2498881|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2498882|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498883|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
2498884|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
2498885|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2498886|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2498887|NCT01209533|Iloprost|iloprost|mesh-list
2498888|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2498889|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
2498890|NCT01209650|Afatinib|afatinib|mesh-list
2498891|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381720|NCT00637130|Travoprost|travoprost|mesh-list
2381721|NCT00637130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2381722|NCT00637130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2381723|NCT00637130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2381724|NCT00637143|Cyclosporine|cyclosporine|mesh-list
2381725|NCT00637143|Tacrolimus|tacrolimus|mesh-list
2381726|NCT00637143|Cyclosporins|cyclosporins|mesh-list
2381727|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2381728|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
2381729|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381730|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2381731|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381732|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381733|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
2381734|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381735|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
2381736|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2381737|NCT00637182|Anastrozole|anastrozole|mesh-list
2381738|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2381739|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381740|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2381741|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2381742|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381743|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498892|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2498893|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2498894|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498895|NCT01209715|Fluticasone|fluticasone|mesh-list
2498896|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2498897|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2498898|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2498899|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2498900|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
2498901|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498902|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498903|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2498904|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
2498905|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
2498906|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2498907|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2498908|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2498909|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2498910|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
2498911|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2498912|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498913|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
2498914|NCT01209715|Hormones|hormones|mesh-ancestor
2498915|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2498916|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
2498917|NCT01209728|Ethanol|ethanol|mesh-list
2498918|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2498919|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498920|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2498921|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498922|NCT01209806|Simethicone|simethicone|mesh-list
2498923|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
2498924|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2498925|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
2498926|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
2498927|NCT01209806|TEMPO|tempo|mesh-list
2498928|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
2498929|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498930|NCT01209806|Emollients|emollients|mesh-ancestor
2498931|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
2498932|NCT01209806|Antacids|antacids|mesh-ancestor
2498933|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2498934|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2498935|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
2498936|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498937|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
2381744|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2381745|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
2381746|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2381747|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498938|NCT01209806|Protective Agents|protective agents|mesh-ancestor
2498939|NCT01209845|Ketamine|ketamine|mesh-list
2498940|NCT01209845|Analgesics|analgesics|mesh-ancestor
2498941|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
2381748|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
2381749|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
2381750|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2381751|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2381752|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2381753|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381754|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2381755|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2381756|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
2381757|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2381758|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2381759|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
2381760|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381761|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381762|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381763|NCT00637325|Trastuzumab|trastuzumab|mesh-list
2381764|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2381765|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381766|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
2381767|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2498942|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2498943|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498944|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2498945|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2498946|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
2498947|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
2498948|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2498949|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2498950|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2498951|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2498952|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498953|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2498954|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2498955|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2498956|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
2498957|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2498958|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498959|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2498960|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2498961|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2498962|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2498963|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2498964|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2381768|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381769|NCT00637403|Megestrol|megestrol|mesh-list
2381770|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
2381771|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2381772|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2381773|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2381774|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
2381775|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2381776|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381777|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2381778|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2381779|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2381780|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381781|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
2498965|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2498966|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2498967|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
2498968|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2498969|NCT01209871|Antibodies|antibodies|mesh-list
2498970|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
2498971|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498972|NCT01209988|Tamsulosin|tamsulosin|mesh-list
2498973|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2498974|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2498975|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2498976|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
2498977|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2498978|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2498979|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498980|NCT01209988|Urological Agents|urological agents|mesh-ancestor
2498981|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
2498982|NCT01210014|Astringents|astringents|mesh-ancestor
2498983|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498984|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
2498985|NCT01210040|Folic Acid|folic acid|mesh-list
2498986|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
2498987|NCT01210040|Hematinics|hematinics|mesh-ancestor
2498988|NCT01210040|Vitamins|vitamins|mesh-ancestor
2498989|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
2498990|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498991|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2498992|NCT01210066|Fentanyl|fentanyl|mesh-list
2498993|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
2498994|NCT01210066|Narcotics|narcotics|mesh-ancestor
2498995|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2381782|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2381783|NCT00637442|Galantamine|galantamine|mesh-list
2381784|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2381785|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422912|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2498996|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2498997|NCT01210066|Analgesics|analgesics|mesh-ancestor
2498998|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
2498999|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499000|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2499001|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2499002|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
2499003|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
2499004|NCT01210287|Lamivudine|lamivudine|mesh-list
2499005|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2381786|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381787|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
2381788|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381789|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381790|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2381791|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
2381792|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2381793|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
2381794|NCT00637455|Fexofenadine|fexofenadine|mesh-list
2381795|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2381796|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2381797|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2381798|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
2499006|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2499007|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499008|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499009|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
2499010|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499011|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2499012|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2499013|NCT01210339|Esomeprazole|esomeprazole|mesh-list
2499014|NCT01210339|Clopidogrel|clopidogrel|mesh-list
2499015|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2499016|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2499017|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2499018|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2499019|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
2499020|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2499021|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499022|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499023|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2499024|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2499025|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2499026|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499027|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
2499028|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
2499029|NCT01210391|Caseins|caseins|mesh-list
2499030|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
2499031|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
2499032|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381799|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
2381800|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381801|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381802|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381803|NCT00637468|Aspirin|aspirin|mesh-list
2381804|NCT00637468|Heparin|heparin|mesh-list
2381805|NCT00637468|Acetazolamide|acetazolamide|mesh-list
2381806|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2381807|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
2381808|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2381809|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2381810|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381811|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2499033|NCT01210430|Vitamins|vitamins|mesh-list
2499034|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
2499035|NCT01210430|Losartan|losartan|mesh-list
2499036|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
2499037|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499038|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2499039|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2499040|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2499041|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2381812|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2381813|NCT00637468|Analgesics|analgesics|mesh-ancestor
2499042|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381814|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
2381815|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2381816|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381817|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2381818|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2381819|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2381820|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2499043|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
2499044|NCT01210430|Protective Agents|protective agents|mesh-ancestor
2499045|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
2499046|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2499047|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
2499048|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499049|NCT01210456|Expectorants|expectorants|mesh-ancestor
2499050|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
2499051|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2499052|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
2499053|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499054|NCT01210456|Protective Agents|protective agents|mesh-ancestor
2499055|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499056|NCT01210456|Antidotes|antidotes|mesh-ancestor
2499057|NCT01210482|Sirolimus|sirolimus|mesh-list
2499058|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2499059|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499060|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2499061|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499062|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
2499063|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2499064|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
2499065|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499066|NCT01210521|Vitamin D|vitamin d|mesh-list
2499067|NCT01210521|Vitamins|vitamins|mesh-ancestor
2499068|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
2499069|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499070|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2499071|NCT01210599|Pamidronate|pamidronate|mesh-list
2499072|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2499073|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499074|NCT01210625|Psyllium|psyllium|mesh-list
2499075|NCT01210625|Cathartics|cathartics|mesh-ancestor
2499076|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2499077|NCT01210638|Oxymorphone|oxymorphone|mesh-list
2499078|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2499079|NCT01210638|Narcotics|narcotics|mesh-ancestor
2499080|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2499081|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499082|NCT01210638|Analgesics|analgesics|mesh-ancestor
2499083|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
2499084|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499085|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2499086|NCT01210677|Prednisone|prednisone|mesh-list
2499087|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2499088|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
2499089|NCT01210677|Hormones|hormones|mesh-ancestor
2499090|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2499091|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499092|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2499093|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499094|NCT01210742|Hylan|hylan|mesh-list
2499095|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
2499096|NCT01210742|Protective Agents|protective agents|mesh-ancestor
2499097|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499098|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
2499099|NCT01210755|Dabigatran|dabigatran|mesh-list
2499100|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2499101|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
2499102|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2499103|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
2499104|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499105|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499106|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
2381821|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381822|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
2381823|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
2381824|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2381825|NCT00637468|Diuretics|diuretics|mesh-ancestor
2499107|NCT01210911|Metformin|metformin|mesh-list
2499108|NCT01210911|Gemcitabine|gemcitabine|mesh-list
2499109|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2381826|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
2381827|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2499110|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2499111|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
2499112|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499113|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499114|NCT01210911|Antiviral Agents|antiviral agents|mesh-ancestor
2499115|NCT01210911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499116|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499117|NCT01210911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2499118|NCT01210911|Immunologic Factors|immunologic factors|mesh-ancestor
2499119|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499120|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2499121|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2499122|NCT01210976|Simendan|simendan|mesh-list
2499123|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2499124|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
2499125|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2499126|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2499127|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499128|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381828|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
2381829|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381830|NCT00637481|Atorvastatin|atorvastatin|mesh-list
2499129|NCT01210976|Protective Agents|protective agents|mesh-ancestor
2499130|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499131|NCT01211002|Endostatins|endostatins|mesh-list
2499132|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499133|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2499134|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2499135|NCT01211002|Growth Substances|growth substances|mesh-ancestor
2499136|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499137|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
2499138|NCT01211080|Propranolol|propranolol|mesh-list
2499139|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2381831|NCT00637481|Calcium|calcium|mesh-list
2381832|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2381833|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381834|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2381835|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2381836|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
2381837|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381838|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2381839|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2381840|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381841|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
2381842|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2381843|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2381844|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2381845|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2381846|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381847|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
2381848|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381849|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381850|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2381851|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2381852|NCT00637559|Esomeprazole|esomeprazole|mesh-list
2381853|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2499140|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2499141|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
2499142|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2499143|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499144|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499145|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2499146|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2381854|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2381855|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2381856|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381857|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381858|NCT00637585|Fexofenadine|fexofenadine|mesh-list
2381859|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2381860|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2381861|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2499147|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
2499148|NCT01211158|Ketamine|ketamine|mesh-list
2499149|NCT01211158|Propofol|propofol|mesh-list
2499150|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2499151|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2499152|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499153|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2499154|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
2499155|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
2499156|NCT01211158|Analgesics|analgesics|mesh-ancestor
2499157|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
2499158|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499159|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2381862|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
2381863|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
2381864|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381865|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381866|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381867|NCT00637611|Fexofenadine|fexofenadine|mesh-list
2381868|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2381869|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2381870|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2381871|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
2381872|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
2381873|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381874|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381875|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381876|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
2381877|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2381878|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
2381879|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381880|NCT00637624|Expectorants|expectorants|mesh-ancestor
2381881|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
2381882|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2381883|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
2381884|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381885|NCT00637624|Protective Agents|protective agents|mesh-ancestor
2381886|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381887|NCT00637624|Antidotes|antidotes|mesh-ancestor
2381888|NCT00637637|Ritonavir|ritonavir|mesh-list
2381889|NCT00637637|Indinavir|indinavir|mesh-list
2381890|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2381891|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2381892|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
2381893|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381894|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381895|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2381896|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2381897|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
2381898|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381899|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2381900|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2381901|NCT00637663|Lamivudine|lamivudine|mesh-list
2499160|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2499161|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2499162|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2499163|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499164|NCT01211171|Telmisartan|telmisartan|mesh-list
2499165|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2499166|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2499167|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2499168|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499169|NCT01211210|Fluorouracil|fluorouracil|mesh-list
2499170|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
2499171|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
2499172|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499173|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2499174|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499175|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2499176|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
2499177|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499178|NCT01211223|Amoxicillin|amoxicillin|mesh-list
2499179|NCT01211223|Metronidazole|metronidazole|mesh-list
2499180|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2381902|NCT00637663|Entecavir|entecavir|mesh-list
2499181|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499182|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2381903|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2381904|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2381905|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381906|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381907|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
2381908|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2381909|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2381910|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2381911|NCT00637715|Alfuzosin|alfuzosin|mesh-list
2381912|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2381913|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2381914|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2381915|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
2381916|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381917|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381918|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499183|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2499184|NCT01211275|Cisplatin|cisplatin|mesh-list
2499185|NCT01211275|Pemetrexed|pemetrexed|mesh-list
2499186|NCT01211275|Axitinib|axitinib|mesh-list
2499187|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499188|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499189|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499190|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2499191|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2499192|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2499193|NCT01211314|Enalapril|enalapril|mesh-list
2499194|NCT01211314|Lercanidipine|lercanidipine|mesh-list
2499195|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2499196|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
2499197|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499198|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499199|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2499200|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2499201|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2499202|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2499203|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499204|NCT01211327|Cyclosporine|cyclosporine|mesh-list
2499205|NCT01211327|Dexamethasone|dexamethasone|mesh-list
2499206|NCT01211327|Cyclosporins|cyclosporins|mesh-list
2499207|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2499208|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
2499209|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
2499210|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499211|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499212|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2499213|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
2499214|NCT01211327|Hormones|hormones|mesh-ancestor
2499215|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2499216|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2499217|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499218|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499219|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499220|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2499221|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
2499222|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
2499223|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499224|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
2499225|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2499226|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2499227|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2499228|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
2499229|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499230|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2499231|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
2499232|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2499233|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499234|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2499235|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2499236|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2499237|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
2499238|NCT01211457|Decitabine|decitabine|mesh-list
2499239|NCT01211457|Venetoclax|venetoclax|mesh-list
2381919|NCT00637715|Urological Agents|urological agents|mesh-ancestor
2381920|NCT00637767|Melphalan|melphalan|mesh-list
2381921|NCT00637767|Antibodies|antibodies|mesh-list
2381922|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2381923|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
2381924|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381925|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2381926|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
2381927|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381928|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381929|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2381930|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2381931|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
2381932|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2381933|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2381934|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
2381935|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2381936|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381937|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381938|NCT00637819|Leflunomide|leflunomide|mesh-list
2381939|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381940|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381941|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2381942|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
2381943|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499240|NCT01211457|Sapacitabine|sapacitabine|mesh-list
2499241|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2499242|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
2499243|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499244|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499245|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499246|NCT01211470|Daptomycin|daptomycin|mesh-list
2499247|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2499248|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499249|NCT01211496|Methamphetamine|methamphetamine|mesh-list
2499250|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2499251|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499252|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
2499253|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
2499254|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499255|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
2381973|NCT00637845|Esomeprazole|esomeprazole|mesh-list
2381974|NCT00637845|Lansoprazole|lansoprazole|mesh-list
2499256|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668480|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2499257|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499258|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
2499259|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2499260|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2499261|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2499262|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2499263|NCT01211509|Montelukast|montelukast|mesh-list
2381975|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
2381976|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2381977|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2381978|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2381979|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2381980|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381981|NCT00637858|Lycopene|lycopene|mesh-list
2381982|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2381983|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
2381984|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2381985|NCT00637858|Protective Agents|protective agents|mesh-ancestor
2381986|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381987|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2381988|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2381989|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381990|NCT00637871|Tamoxifen|tamoxifen|mesh-list
2381991|NCT00637871|Bicalutamide|bicalutamide|mesh-list
2381992|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2381993|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
2381994|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2381995|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2381996|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2381997|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2381998|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2381999|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2382000|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2382001|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
2382002|NCT00637884|Fexofenadine|fexofenadine|mesh-list
2382003|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2382004|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2382005|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2382006|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
2382007|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
2382008|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382009|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382010|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382011|NCT00637897|Paclitaxel|paclitaxel|mesh-list
2382012|NCT00637897|Docetaxel|docetaxel|mesh-list
2382013|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2382014|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2382015|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382016|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
2382017|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
2382018|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
2382019|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382020|NCT00637910|Docetaxel|docetaxel|mesh-list
2382021|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2382022|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382023|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
2382024|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
2382025|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
2382026|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382027|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2382028|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382029|NCT00637949|Rofecoxib|rofecoxib|mesh-list
2382030|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
2382031|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2382032|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2382033|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382034|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382035|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2382036|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2382037|NCT00637949|Analgesics|analgesics|mesh-ancestor
2499264|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2499265|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
2499266|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2382038|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
2382039|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382040|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382041|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2499267|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
2499268|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2499269|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499270|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2499271|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2499272|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499273|NCT01211561|Selenium|selenium|mesh-list
2499274|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
2499275|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499276|NCT01211561|Protective Agents|protective agents|mesh-ancestor
2499277|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499278|NCT01211561|Trace Elements|trace elements|mesh-ancestor
2499279|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
2499280|NCT01211691|Antibodies|antibodies|mesh-list
2499281|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2499282|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
2499283|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499284|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2499285|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2499286|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2499287|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2499288|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499289|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2499290|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2499291|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2382042|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2382043|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
2382044|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2382045|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
2382046|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382047|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2382048|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382049|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
2382050|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382051|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
2382052|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2382053|NCT00637962|Protective Agents|protective agents|mesh-ancestor
2382054|NCT00637975|Pregabalin|pregabalin|mesh-list
2382055|NCT00637975|Oxycodone|oxycodone|mesh-list
2382056|NCT00637975|Analgesics|analgesics|mesh-ancestor
2382057|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
2499292|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
2499293|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2499294|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499295|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2499296|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2499297|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
2499298|NCT01211795|Ketoprofen|ketoprofen|mesh-list
2499299|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2499300|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2499301|NCT01211795|Analgesics|analgesics|mesh-ancestor
2499302|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
2499303|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499304|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499305|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2499306|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2499307|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2499308|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499309|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499310|NCT01211808|Diltiazem|diltiazem|mesh-list
2499311|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2499312|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2499313|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2499314|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499315|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2499316|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499317|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
2499318|NCT01211821|Metoprolol|metoprolol|mesh-list
2499319|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2499320|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2499321|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
2499322|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
2499323|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499324|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499325|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2499326|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2499327|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2382058|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382059|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382060|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
2382061|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2382062|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2382063|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382064|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2382065|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2382066|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2382067|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2382068|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2382069|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2382070|NCT00637975|Narcotics|narcotics|mesh-ancestor
2382071|NCT00637988|Aspirin|aspirin|mesh-list
2382072|NCT00637988|Rofecoxib|rofecoxib|mesh-list
2382073|NCT00637988|Esomeprazole|esomeprazole|mesh-list
2499328|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
2499329|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2499330|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499331|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
2382074|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2382075|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2382076|NCT00637988|Analgesics|analgesics|mesh-ancestor
2382077|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
2382078|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382079|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382080|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382081|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2499332|NCT01211847|Diazoxide|diazoxide|mesh-list
2499333|NCT01211847|Choline|choline|mesh-list
2499334|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
2499335|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2499336|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
2382082|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2382083|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2382084|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382085|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2382086|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2382087|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382088|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
2382089|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2382090|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2382091|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2382092|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2382093|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
2382094|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2382095|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2499337|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499338|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2499339|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2499340|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
2499341|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2499342|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
2499343|NCT01211860|Diazoxide|diazoxide|mesh-list
2499344|NCT01211860|Choline|choline|mesh-list
2499345|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
2499346|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2499347|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
2499348|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499349|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2499350|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2499351|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
2499352|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2499353|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
2499354|NCT01211912|Acetaminophen|acetaminophen|mesh-list
2499355|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2499356|NCT01211912|Analgesics|analgesics|mesh-ancestor
2499357|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
2499358|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499359|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499360|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
2499361|NCT01211925|Aspirin|aspirin|mesh-list
2499362|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2499363|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2499364|NCT01211925|Analgesics|analgesics|mesh-ancestor
2499365|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
2499366|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499367|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499368|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2499369|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2499370|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2499371|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2499372|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382096|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2382097|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2382098|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382099|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
2382100|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382101|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382102|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2382103|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382104|NCT00638079|Megestrol|megestrol|mesh-list
2382105|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
2382106|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2382107|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2382108|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2382109|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
2382110|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2382111|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382112|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2382113|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2499373|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2499374|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2382114|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2382115|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382116|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
2382117|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2382118|NCT00638118|Fexofenadine|fexofenadine|mesh-list
2382119|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2382120|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2382121|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2382122|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
2382123|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
2382124|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382125|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382126|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382127|NCT00638131|Bosentan|bosentan|mesh-list
2382128|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2382129|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2382130|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382131|NCT00638209|Insulin|insulin|mesh-list
2382132|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2382133|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2382134|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382135|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
2382136|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2499375|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499376|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
2499377|NCT01211938|Cetuximab|cetuximab|mesh-list
2499378|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2499379|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499380|NCT01212133|Liraglutide|liraglutide|mesh-list
2499381|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2499382|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499383|NCT01212133|Incretins|incretins|mesh-ancestor
2499384|NCT01212133|Hormones|hormones|mesh-ancestor
2499385|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2499386|NCT01212250|Carvedilol|carvedilol|mesh-list
2499387|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2499388|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2499389|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
2499390|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382137|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2382138|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382139|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
2382140|NCT00638300|Calcium|calcium|mesh-list
2382141|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2382142|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382143|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2499391|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499392|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499393|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2499394|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
2499395|NCT01212250|Protective Agents|protective agents|mesh-ancestor
2499396|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2499397|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2499398|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2499399|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
2499400|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2499401|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2499402|NCT01212315|Triclosan|triclosan|mesh-list
2499403|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2499404|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382144|NCT00638326|Clopidogrel|clopidogrel|mesh-list
2382145|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2382146|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2382147|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2382148|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2382149|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
2382150|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382151|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382152|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382153|NCT00638391|Anastrozole|anastrozole|mesh-list
2382154|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2382155|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382156|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2382157|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2382158|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382159|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382160|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2499405|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2499406|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2499407|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
2499408|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382161|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
2382162|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2382163|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382164|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2382165|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2382166|NCT00638482|Diuretics|diuretics|mesh-ancestor
2382167|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
2382168|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382169|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2382170|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2382171|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382172|NCT00638534|Telithromycin|telithromycin|mesh-list
2382173|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2382174|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382175|NCT00638560|Vitamins|vitamins|mesh-list
2382176|NCT00638560|Ascorbic Acid|ascorbic acid|mesh-list
2382177|NCT00638560|Vitamin E|vitamin e|mesh-list
2382178|NCT00638560|Antioxidants|antioxidants|mesh-list
2382179|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
2382180|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382181|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382182|NCT00638560|Protective Agents|protective agents|mesh-ancestor
2382183|NCT00638612|Valacyclovir|valacyclovir|mesh-list
2382184|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
2499409|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2499410|NCT01212367|Interferons|interferons|mesh-list
2499411|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
2499412|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
2499413|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2499414|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499415|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
2499416|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499417|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
2499418|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499419|NCT01212406|Vitamin D|vitamin d|mesh-list
2499420|NCT01212406|Vitamins|vitamins|mesh-ancestor
2499421|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
2499422|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499423|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2499424|NCT01212432|Daptomycin|daptomycin|mesh-list
2499425|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2499426|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499427|NCT01212523|Propofol|propofol|mesh-list
2499428|NCT01212523|Isoflurane|isoflurane|mesh-list
2499429|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2499430|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2499431|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499432|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2499433|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
2499434|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
2499435|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2499436|NCT01212653|Golimumab|golimumab|mesh-list
2499437|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2499438|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2499439|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2499440|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
2499441|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499442|NCT01212666|Ropivacaine|ropivacaine|mesh-list
2499443|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
2499444|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
2499445|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2499446|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499447|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
2382185|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382186|NCT00638638|Abciximab|abciximab|mesh-list
2382187|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
2382188|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2382189|NCT00638677|Sorbitol|sorbitol|mesh-list
2382190|NCT00638677|Cathartics|cathartics|mesh-ancestor
2382191|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2382192|NCT00638729|Clonidine|clonidine|mesh-list
2382193|NCT00638729|Midazolam|midazolam|mesh-list
2382194|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2382195|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2382196|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2382197|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382198|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2382199|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2382200|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2382201|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2382202|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
2382203|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
2382204|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
2382205|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
2382206|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382207|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382208|NCT00638729|Analgesics|analgesics|mesh-ancestor
2382209|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
2382210|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499448|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499449|NCT01212679|Mitogens|mitogens|mesh-list
2499450|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
2499451|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499452|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
2499453|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2499454|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
2499455|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499456|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
2499457|NCT01212809|Protective Agents|protective agents|mesh-ancestor
2499458|NCT01212822|Leucovorin|leucovorin|mesh-list
2499459|NCT01212822|Bevacizumab|bevacizumab|mesh-list
2499460|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2499461|NCT01212822|Fluorouracil|fluorouracil|mesh-list
2499462|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
2499463|NCT01212822|Antibodies|antibodies|mesh-list
2382211|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2382212|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
2499464|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
2499465|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2499466|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
2499467|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499468|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2499469|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2499470|NCT01212822|Growth Substances|growth substances|mesh-ancestor
2499471|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499472|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
2499473|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
2499474|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
2499475|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499476|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2499477|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2499478|NCT01212822|Antidotes|antidotes|mesh-ancestor
2499479|NCT01212822|Protective Agents|protective agents|mesh-ancestor
2499480|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
2499481|NCT01212822|Vitamins|vitamins|mesh-ancestor
2499482|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
2499483|NCT01212887|Aldesleukin|aldesleukin|mesh-list
2499484|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
2499485|NCT01212887|Fludarabine|fludarabine|mesh-list
2499486|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
2499487|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2499488|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
2499489|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499490|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2499491|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2499492|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
2499493|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499494|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499495|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2499496|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2499497|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
2499498|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2499499|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2499500|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
2499501|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499502|NCT01212913|Insulin|insulin|mesh-list
2499503|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2499504|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
2499505|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
2499506|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
2499507|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2499508|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2499509|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499510|NCT01212965|Selenium|selenium|mesh-list
2499511|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
2499512|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499513|NCT01212965|Protective Agents|protective agents|mesh-ancestor
2499514|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499515|NCT01212965|Trace Elements|trace elements|mesh-ancestor
2499516|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
2499517|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
2499518|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2499519|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
2499520|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499521|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2499522|NCT01213095|Rituximab|rituximab|mesh-list
2382213|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
2382214|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2382215|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2382216|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2382217|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
2382218|NCT00638742|Latanoprost|latanoprost|mesh-list
2382219|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2499523|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2499524|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499525|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
2499526|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499527|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2382220|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2382221|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
2382222|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2382223|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2382224|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382225|NCT00638807|Celecoxib|celecoxib|mesh-list
2382226|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2382227|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2499528|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2499529|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
2499530|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2499531|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2499532|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2499533|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2499534|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499535|NCT01213147|Clomiphene|clomiphene|mesh-list
2499536|NCT01213147|Enclomiphene|enclomiphene|mesh-list
2499537|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
2499538|NCT01213147|Buserelin|buserelin|mesh-list
2499539|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2499540|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
2499541|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2499542|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499543|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2499544|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
2499545|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2499546|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2499547|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2499548|NCT01213238|Bevacizumab|bevacizumab|mesh-list
2499549|NCT01213238|Capecitabine|capecitabine|mesh-list
2499550|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
2499551|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2499552|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499553|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2499554|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2499555|NCT01213238|Growth Substances|growth substances|mesh-ancestor
2499556|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499557|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
2499558|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2499559|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
2499560|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499561|NCT01213355|Scopolamine|scopolamine|mesh-list
2499562|NCT01213355|Donepezil|donepezil|mesh-list
2499563|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2499564|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2382228|NCT00638807|Analgesics|analgesics|mesh-ancestor
2382229|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
2382230|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382231|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382232|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382233|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2382234|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2382235|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2382236|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382237|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382238|NCT00638833|Memantine|memantine|mesh-list
2382239|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2382240|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2382241|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
2382242|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382243|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382244|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382245|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2499565|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499566|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499567|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
2499568|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2499569|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499570|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
2382246|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2382247|NCT00638859|Telithromycin|telithromycin|mesh-list
2382248|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2382249|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382250|NCT00638898|Melphalan|melphalan|mesh-list
2382251|NCT00638898|Busulfan|busulfan|mesh-list
2382252|NCT00638898|Topotecan|topotecan|mesh-list
2382253|NCT00638898|Lenograstim|lenograstim|mesh-list
2382254|NCT00638898|Sargramostim|sargramostim|mesh-list
2382255|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2382256|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
2382257|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382258|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2382259|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
2382260|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499571|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2382261|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382262|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2382263|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2382264|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2382265|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2382266|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382267|NCT00638976|Eptifibatide|eptifibatide|mesh-list
2382268|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2382269|NCT00639015|Phenylephrine|phenylephrine|mesh-list
2382270|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
2382271|NCT00639015|Norepinephrine|norepinephrine|mesh-list
2382272|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2382273|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
2382274|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
2382275|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382276|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382277|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
2382278|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2382279|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
2382280|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
2382281|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2382282|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2499572|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
2499573|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
2499574|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499575|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2499576|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
2499577|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2499578|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2499579|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
2499580|NCT01213368|Dronedarone|dronedarone|mesh-list
2499581|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2499582|NCT01213381|Gemcitabine|gemcitabine|mesh-list
2499583|NCT01213381|Carboplatin|carboplatin|mesh-list
2499584|NCT01213381|Iniparib|iniparib|mesh-list
2499585|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499586|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2499587|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
2499588|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499589|NCT01213381|Antiviral Agents|antiviral agents|mesh-ancestor
2499590|NCT01213381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499591|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499592|NCT01213381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2499593|NCT01213381|Immunologic Factors|immunologic factors|mesh-ancestor
2499594|NCT01213381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499595|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2499596|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
2499597|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2382283|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2382284|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
2382285|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382286|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382287|NCT00639015|Protective Agents|protective agents|mesh-ancestor
2382288|NCT00639119|Ropinirole|ropinirole|mesh-list
2382289|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2382290|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2382291|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
2382292|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
2382293|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2499598|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499599|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2499600|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
2499601|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2499602|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382294|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382295|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382296|NCT00639249|SA 4503|sa 4503|mesh-list
2382297|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
2382298|NCT00639262|Temozolomide|temozolomide|mesh-list
2382299|NCT00639262|Sorafenib|sorafenib|mesh-list
2382300|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2382301|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
2382302|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382303|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382304|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2499603|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499604|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499605|NCT01213407|Temozolomide|temozolomide|mesh-list
2499606|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2499607|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
2499608|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499609|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499610|NCT01213433|Artesunate|artesunate|mesh-list
2382305|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382306|NCT00639327|Irinotecan|irinotecan|mesh-list
2382307|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2382308|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2382309|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382310|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382311|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382312|NCT00639366|Trastuzumab|trastuzumab|mesh-list
2382313|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2382314|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382315|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
2382316|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2499611|NCT01213433|Amodiaquine|amodiaquine|mesh-list
2499612|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
2499613|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2499614|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2499615|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499616|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499617|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
2499618|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
2499619|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2499620|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
2499621|NCT01213498|Atorvastatin|atorvastatin|mesh-list
2499622|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2499623|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2499624|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
2499625|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499626|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2499627|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2499628|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499629|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
2499630|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2499631|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2499632|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499633|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
2499634|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
2499635|NCT01213563|Insulin|insulin|mesh-list
2499636|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2499637|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
2499638|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
2382317|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382318|NCT00639483|Celecoxib|celecoxib|mesh-list
2382319|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2382320|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2382321|NCT00639483|Analgesics|analgesics|mesh-ancestor
2382322|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
2382323|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382324|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382325|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382326|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2382327|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2382328|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2382329|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499639|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2499640|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499641|NCT01213667|Ranibizumab|ranibizumab|mesh-list
2499642|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2499643|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2499644|NCT01213667|Growth Substances|growth substances|mesh-ancestor
2499645|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499646|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
2499647|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499648|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
2499649|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2499650|NCT01213680|Hematinics|hematinics|mesh-ancestor
2499651|NCT01213693|Fluticasone|fluticasone|mesh-list
2499652|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2499653|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2499654|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2499655|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
2499656|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499657|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499658|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2499659|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
2499660|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
2499661|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2499662|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2499663|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2499664|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2499665|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
2499666|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2499667|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499668|NCT01213719|Betaine|betaine|mesh-list
2499669|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2499670|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
2499671|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2499672|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
2499673|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499674|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2499675|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2499676|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499677|NCT01213849|Fluticasone|fluticasone|mesh-list
2499678|NCT01213849|Xhance|xhance|mesh-list
2499679|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2499680|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2499681|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
2499682|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2499683|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499684|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2499685|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
2499686|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
2499687|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2499688|NCT01213888|Trientine|trientine|mesh-list
2382330|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382331|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
2382332|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2382333|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
2382334|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382335|NCT00639496|Expectorants|expectorants|mesh-ancestor
2382336|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
2382337|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2382338|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
2382339|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499689|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
2499690|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
2499691|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499692|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
2499693|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2499694|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499695|NCT01213979|Iron|iron|mesh-list
2499696|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2499697|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
2499698|NCT01213979|Trace Elements|trace elements|mesh-ancestor
2499699|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
2499700|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499701|NCT01213979|Hematinics|hematinics|mesh-ancestor
2499702|NCT01213992|Iron|iron|mesh-list
2499703|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2499704|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
2499705|NCT01213992|Trace Elements|trace elements|mesh-ancestor
2499706|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
2499707|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499708|NCT01213992|Hematinics|hematinics|mesh-ancestor
2499709|NCT01214122|Warfarin|warfarin|mesh-list
2499710|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
2499711|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
2499712|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2499713|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499714|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499715|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2499716|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2499717|NCT01214226|Protective Agents|protective agents|mesh-ancestor
2499718|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499719|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
2382340|NCT00639496|Protective Agents|protective agents|mesh-ancestor
2499720|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2499721|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
2499722|NCT01214291|Toremifene|toremifene|mesh-list
2499723|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2499724|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499725|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2499726|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2499727|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
2499728|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2499729|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499730|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2499731|NCT01214343|Sorafenib|sorafenib|mesh-list
2499732|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499733|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2499734|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499735|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499736|NCT01214382|Sertraline|sertraline|mesh-list
2499737|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
2499738|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2499739|NCT01214382|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2499740|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2499741|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2499742|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499743|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2499744|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
2499745|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499746|NCT01214408|Pantoprazole|pantoprazole|mesh-list
2499747|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2499748|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2382341|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382342|NCT00639496|Antidotes|antidotes|mesh-ancestor
2382343|NCT00639522|Paclitaxel|paclitaxel|mesh-list
2382344|NCT00639522|Capecitabine|capecitabine|mesh-list
2382345|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2382346|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382347|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
2382348|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
2382349|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
2382350|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382351|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2382352|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
2382353|NCT00639574|Nefopam|nefopam|mesh-list
2382354|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2382355|NCT00639574|Analgesics|analgesics|mesh-ancestor
2382356|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
2382357|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382358|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382359|NCT00639587|Cetirizine|cetirizine|mesh-list
2499749|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2499750|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499751|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499752|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
2499753|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2499754|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2499755|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
2499756|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499757|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2499758|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2499759|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499760|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499761|NCT01214746|Atorvastatin|atorvastatin|mesh-list
2499762|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2499763|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2499764|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
2499765|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499766|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2499767|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2499768|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499769|NCT01214772|Heparin|heparin|mesh-list
2499770|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
2499771|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2499772|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2499773|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499774|NCT01214889|Vaccines|vaccines|mesh-list
2499775|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
2382360|NCT00639587|Ketotifen|ketotifen|mesh-list
2382361|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2499776|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499777|NCT01214928|Vitamin D|vitamin d|mesh-list
2499778|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
2499779|NCT01214928|Vitamins|vitamins|mesh-ancestor
2499780|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
2499781|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499782|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2499783|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2499784|NCT01214941|Itraconazole|itraconazole|mesh-list
2499785|NCT01214941|Ticlopidine|ticlopidine|mesh-list
2499786|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
2499787|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499788|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2499789|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2382362|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2382363|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2382364|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
2382365|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
2382366|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382367|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382368|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382369|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
2382370|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
2499790|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499791|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499792|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2499793|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
2499794|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2499795|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499796|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2499797|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2499798|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2499799|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2499800|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2499801|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2499802|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2499803|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
2499804|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2499805|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2499806|NCT01214993|Dolutegravir|dolutegravir|mesh-list
2499807|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2499808|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2499809|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499810|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499811|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2499812|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2499813|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
2499814|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2499815|NCT01215019|Mannitol|mannitol|mesh-list
2499816|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2499817|NCT01215019|Diuretics|diuretics|mesh-ancestor
2499818|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
2499819|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499820|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
2499821|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2499822|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2499823|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499824|NCT01215136|Paclitaxel|paclitaxel|mesh-list
2499825|NCT01215136|Everolimus|everolimus|mesh-list
2499826|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2499827|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499828|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
2499829|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
2382371|NCT00639691|Omalizumab|omalizumab|mesh-list
2382372|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2382373|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2382374|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
2382375|NCT00639743|Tenecteplase|tenecteplase|mesh-list
2382376|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2382377|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2382378|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382379|NCT00639756|Allopurinol|allopurinol|mesh-list
2382380|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
2382381|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499830|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
2499831|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499832|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2499833|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
2499834|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499835|NCT01215149|Vaccines|vaccines|mesh-list
2499836|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
2382382|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382383|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
2382384|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2382385|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2382386|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
2382387|NCT00639756|Protective Agents|protective agents|mesh-ancestor
2382388|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382389|NCT00639873|Doxycycline|doxycycline|mesh-list
2382390|NCT00639873|Artesunate|artesunate|mesh-list
2382391|NCT00639873|Quinine|quinine|mesh-list
2382392|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2382393|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382394|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
2382395|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2382396|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2382397|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382398|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
2382399|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
2382400|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2382401|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
2382402|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2382403|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382404|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2382405|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382406|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2382407|NCT00639873|Analgesics|analgesics|mesh-ancestor
2382408|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
2382409|NCT00639925|Gemcitabine|gemcitabine|mesh-list
2382410|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2382411|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
2499837|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499838|NCT01215214|Midazolam|midazolam|mesh-list
2499839|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2499840|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2499841|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2499842|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499843|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2499844|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2499845|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2499846|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2499847|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
2499848|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
2382412|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382413|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382414|NCT00639925|Antiviral Agents|antiviral agents|mesh-ancestor
2382415|NCT00639925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382416|NCT00639925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382417|NCT00639925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2382418|NCT00639925|Immunologic Factors|immunologic factors|mesh-ancestor
2382419|NCT00639925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382420|NCT00639938|Nevirapine|nevirapine|mesh-list
2382421|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
2382422|NCT00639938|Antibodies|antibodies|mesh-list
2382423|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
2382424|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2382425|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2382426|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
2382427|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382428|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2382429|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2382430|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382431|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382432|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
2382433|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382434|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2382435|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2382436|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2382437|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2382438|NCT00640003|Baclofen|baclofen|mesh-list
2499849|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
2499850|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
2499851|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2499852|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499853|NCT01215266|Sorafenib|sorafenib|mesh-list
2499854|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499855|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2499856|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499857|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499858|NCT01215331|Insulin|insulin|mesh-list
2499859|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2499860|NCT01215331|Metformin|metformin|mesh-list
2499861|NCT01215331|Glyburide|glyburide|mesh-list
2499862|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2499863|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499864|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2499865|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
2499866|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2499867|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2499868|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499869|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499870|NCT01215409|Urological Agents|urological agents|mesh-ancestor
2499871|NCT01215539|Panitumumab|panitumumab|mesh-list
2499872|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2499873|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499874|NCT01215565|Sunitinib|sunitinib|mesh-list
2499875|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499876|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2499877|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2382439|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2382440|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382441|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2382442|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382443|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2382444|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
2382445|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
2382446|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382447|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382448|NCT00640029|Meloxicam|meloxicam|mesh-list
2382449|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2382450|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2382451|NCT00640029|Analgesics|analgesics|mesh-ancestor
2382452|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
2382453|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382454|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382455|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382456|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2499878|NCT01215565|Growth Substances|growth substances|mesh-ancestor
2499879|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499880|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
2499881|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2499882|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499883|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499884|NCT01215578|Sunitinib|sunitinib|mesh-list
2499885|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499886|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2499887|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2499888|NCT01215578|Growth Substances|growth substances|mesh-ancestor
2499889|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499890|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
2499891|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2499892|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499893|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499894|NCT01215669|Vaccines|vaccines|mesh-list
2499895|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
2499896|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499897|NCT01215682|Vitamin D|vitamin d|mesh-list
2499898|NCT01215682|Vitamins|vitamins|mesh-ancestor
2499899|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
2499900|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499901|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2499902|NCT01215708|Tamsulosin|tamsulosin|mesh-list
2499903|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2499904|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2499905|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2499906|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
2499907|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2499908|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499909|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499910|NCT01215708|Urological Agents|urological agents|mesh-ancestor
2382457|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2382458|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2382459|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382460|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382461|NCT00640081|Leucovorin|leucovorin|mesh-list
2499911|NCT01215799|Bafetinib|bafetinib|mesh-list
2499912|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2499913|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499914|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499915|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
2499916|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2499917|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2499918|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499919|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2499920|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499921|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2499922|NCT01216007|Propofol|propofol|mesh-list
2499923|NCT01216007|Sevoflurane|sevoflurane|mesh-list
2499924|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2499925|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2499926|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499927|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2499928|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
2499929|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
2499930|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2499931|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2499932|NCT01216020|Cisplatin|cisplatin|mesh-list
2382462|NCT00640081|Fluorouracil|fluorouracil|mesh-list
2382463|NCT00640081|Capecitabine|capecitabine|mesh-list
2382464|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
2382465|NCT00640081|Cetuximab|cetuximab|mesh-list
2499933|NCT01216020|Cetuximab|cetuximab|mesh-list
2499934|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499935|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2499936|NCT01216046|Ivacaftor|ivacaftor|mesh-list
2499937|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2499938|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2499939|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499940|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
2499941|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499942|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2499943|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499944|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499945|NCT01216111|Paclitaxel|paclitaxel|mesh-list
2499946|NCT01216111|Docetaxel|docetaxel|mesh-list
2499947|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
2499948|NCT01216111|Fluorouracil|fluorouracil|mesh-list
2499949|NCT01216111|Epirubicin|epirubicin|mesh-list
2499950|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2499951|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499952|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
2499953|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
2499954|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
2499955|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382466|NCT00640081|Calcium|calcium|mesh-list
2382467|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
2382468|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2382469|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382470|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
2382471|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382472|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2382473|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382474|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2382475|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
2382476|NCT00640081|Antidotes|antidotes|mesh-ancestor
2382477|NCT00640081|Protective Agents|protective agents|mesh-ancestor
2382478|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
2382479|NCT00640081|Vitamins|vitamins|mesh-ancestor
2382480|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
2382481|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2382482|NCT00640094|Melatonin|melatonin|mesh-list
2382483|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
2422913|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2499956|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2499957|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
2499958|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2499959|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2499960|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2499961|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
2499962|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2499963|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
2499964|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2499965|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2499966|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2499967|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2499968|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499969|NCT01216124|Docetaxel|docetaxel|mesh-list
2499970|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
2499971|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499972|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
2499973|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
2499974|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
2499975|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499976|NCT01216267|Lansoprazole|lansoprazole|mesh-list
2499977|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
2499978|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2499979|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2499980|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2499981|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499982|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499983|NCT01216293|Esomeprazole|esomeprazole|mesh-list
2499984|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
2499985|NCT01216293|Lansoprazole|lansoprazole|mesh-list
2499986|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2499987|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2499988|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2499989|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2499990|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499991|NCT01216345|Gemcitabine|gemcitabine|mesh-list
2499992|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
2499993|NCT01216345|Cetuximab|cetuximab|mesh-list
2499994|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2499995|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
2499996|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2499997|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2499998|NCT01216345|Antiviral Agents|antiviral agents|mesh-ancestor
2499999|NCT01216345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500000|NCT01216345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500001|NCT01216345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2500002|NCT01216345|Immunologic Factors|immunologic factors|mesh-ancestor
2500003|NCT01216345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500004|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2500005|NCT01216371|Sunitinib|sunitinib|mesh-list
2500006|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500007|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2500008|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2500009|NCT01216371|Growth Substances|growth substances|mesh-ancestor
2500010|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500011|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
2500012|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2500013|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500014|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500015|NCT01216436|Vaccines|vaccines|mesh-list
2500016|NCT01216436|Immunologic Factors|immunologic factors|mesh-ancestor
2500017|NCT01216436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500018|NCT01216449|Citalopram|citalopram|mesh-list
2500019|NCT01216449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2500020|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2500021|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2382484|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382485|NCT00640094|Protective Agents|protective agents|mesh-ancestor
2382486|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382487|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2500022|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500023|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2500024|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
2500025|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382488|NCT00640159|Selegiline|selegiline|mesh-list
2382489|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
2382490|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2382491|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2382492|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2382493|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2382494|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382495|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382496|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2382497|NCT00640159|Protective Agents|protective agents|mesh-ancestor
2382498|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382499|NCT00640198|Memantine|memantine|mesh-list
2382500|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2382501|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2382502|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
2500026|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2500027|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
2500028|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2500029|NCT01216488|Lidocaine|lidocaine|mesh-list
2500030|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
2500031|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
2500032|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2500033|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500034|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
2500035|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500036|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2500037|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2500038|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2500039|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2500040|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500041|NCT01216579|Mannitol|mannitol|mesh-list
2500042|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2500043|NCT01216579|Diuretics|diuretics|mesh-ancestor
2500044|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
2382503|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382504|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382505|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382506|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2382507|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2382508|NCT00640237|Calcifediol|calcifediol|mesh-list
2382509|NCT00640237|Vitamins|vitamins|mesh-ancestor
2382510|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
2500045|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500046|NCT01216605|Oxytocin|oxytocin|mesh-list
2500047|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
2500048|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2500049|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500050|NCT01216644|Leucovorin|leucovorin|mesh-list
2500051|NCT01216644|Docetaxel|docetaxel|mesh-list
2500052|NCT01216644|Fluorouracil|fluorouracil|mesh-list
2500053|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
2500054|NCT01216644|Epirubicin|epirubicin|mesh-list
2500055|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500056|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
2500057|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
2500058|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
2500059|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500060|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
2500061|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2500062|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2500063|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
2500064|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500065|NCT01216644|Antidotes|antidotes|mesh-ancestor
2500066|NCT01216644|Protective Agents|protective agents|mesh-ancestor
2500067|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
2500068|NCT01216644|Vitamins|vitamins|mesh-ancestor
2500069|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
2500070|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2500071|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2500072|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2500073|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500074|NCT01216657|Sunitinib|sunitinib|mesh-list
2500075|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500076|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2382511|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500077|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2500078|NCT01216657|Growth Substances|growth substances|mesh-ancestor
2500079|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500080|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
2500081|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2500082|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500083|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500084|NCT01216696|Ipilimumab|ipilimumab|mesh-list
2500085|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2500086|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500087|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2500088|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500089|NCT01216709|Iron|iron|mesh-list
2500090|NCT01216709|Trace Elements|trace elements|mesh-ancestor
2500091|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
2500092|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500093|NCT01216787|R04929097|r04929097|mesh-list
2500094|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500095|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500096|NCT01216826|Everolimus|everolimus|mesh-list
2500097|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500098|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2500099|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
2500100|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500101|NCT01216839|Everolimus|everolimus|mesh-list
2500102|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500103|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2500104|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
2500105|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500106|NCT01216852|Losartan|losartan|mesh-list
2500107|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2500108|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2500109|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2500110|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2500111|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500112|NCT01216878|Losartan|losartan|mesh-list
2382512|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2382513|NCT00640263|Ritonavir|ritonavir|mesh-list
2382514|NCT00640263|Lopinavir|lopinavir|mesh-list
2382515|NCT00640263|Lamivudine|lamivudine|mesh-list
2382516|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2382517|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2382518|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
2382519|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382520|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382521|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2382522|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2382523|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
2500113|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2500114|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2500115|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2500116|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2500117|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500118|NCT01216904|Nicotine|nicotine|mesh-list
2500119|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2500120|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
2500121|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500122|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500123|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2500124|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2500125|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
2500126|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2500127|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500128|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
2382524|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382525|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2382526|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2422914|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500129|NCT01216956|Niacin|niacin|mesh-list
2500130|NCT01216956|Niacinamide|niacinamide|mesh-list
2500131|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
2500132|NCT01216956|Vitamins|vitamins|mesh-ancestor
2500133|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
2500134|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500135|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2500136|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
2500137|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500138|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2500139|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
2500140|NCT01217034|Sorafenib|sorafenib|mesh-list
2500141|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
2500142|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500143|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2500144|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500145|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500146|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2500147|NCT01217034|Estrogens|estrogens|mesh-ancestor
2500148|NCT01217034|Hormones|hormones|mesh-ancestor
2500149|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500150|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500151|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2500152|NCT01217086|Infliximab|infliximab|mesh-list
2500153|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
2500154|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2500155|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2500156|NCT01217099|Azithromycin|azithromycin|mesh-list
2382527|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2382528|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2382529|NCT00640276|Pitavastatin|pitavastatin|mesh-list
2382530|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2382531|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2382532|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2382533|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
2382534|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382535|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382536|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2382537|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2382538|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2382539|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2382540|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382541|NCT00640432|Celecoxib|celecoxib|mesh-list
2382542|NCT00640432|Diclofenac|diclofenac|mesh-list
2382543|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2382544|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2382545|NCT00640432|Analgesics|analgesics|mesh-ancestor
2382546|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
2382547|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500157|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
2500158|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2500159|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2500160|NCT01217099|Prednisolone|prednisolone|mesh-list
2500161|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
2500162|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2500163|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
2500164|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2500165|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
2500166|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
2500167|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500168|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500169|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2500170|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
2500171|NCT01217099|Hormones|hormones|mesh-ancestor
2500172|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500173|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2500174|NCT01217099|Protective Agents|protective agents|mesh-ancestor
2500175|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2500176|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500177|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2500178|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500179|NCT01217125|Sirolimus|sirolimus|mesh-list
2500180|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2500181|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500182|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2500183|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500184|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
2500185|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2500186|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
2382548|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382549|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2500187|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500188|NCT01217138|Epinephrine|epinephrine|mesh-list
2500189|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2382550|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2382551|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2382552|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2382553|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382554|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382555|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
2382556|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
2382557|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2382558|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2382559|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382560|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382561|NCT00640458|Urological Agents|urological agents|mesh-ancestor
2382562|NCT00640471|Cetuximab|cetuximab|mesh-list
2382563|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2382564|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500190|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2500191|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
2382565|NCT00640484|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2382566|NCT00640484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2382567|NCT00640484|Autonomic Agents|autonomic agents|mesh-ancestor
2500192|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2500193|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500194|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500195|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2500196|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2500197|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
2382568|NCT00640484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382569|NCT00640484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382570|NCT00640484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2382571|NCT00640484|Respiratory System Agents|respiratory system agents|mesh-ancestor
2382572|NCT00640484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2500198|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500199|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2500200|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
2500201|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
2500202|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
2500203|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2500204|NCT01217177|Everolimus|everolimus|mesh-list
2500205|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500206|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2500207|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
2500208|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500209|NCT01217203|Lenalidomide|lenalidomide|mesh-list
2500210|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
2500211|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500212|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2500213|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2500214|NCT01217203|Growth Substances|growth substances|mesh-ancestor
2500215|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
2114437|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114438|NCT02603926|Pregnanolone|pregnanolone|mesh-list
2114439|NCT02603926|Brexanolone|brexanolone|mesh-list
2114440|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
2114441|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2114442|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114443|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
2114444|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2114445|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500216|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500217|NCT01217294|Morphine|morphine|mesh-list
2500218|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2500219|NCT01217294|Narcotics|narcotics|mesh-ancestor
2500220|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2500221|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500222|NCT01217294|Analgesics|analgesics|mesh-ancestor
2500223|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
2500224|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500225|NCT01217359|Interferons|interferons|mesh-list
2500226|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
2500227|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
2500228|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500229|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
2500230|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500231|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
2500232|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382573|NCT00640484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2382574|NCT00640484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2382575|NCT00640484|Adrenergic Agents|adrenergic agents|mesh-ancestor
2382576|NCT00640484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382577|NCT00640484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382578|NCT00640549|Atorvastatin|atorvastatin|mesh-list
2382579|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2382580|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2382581|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
2382582|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382583|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2382584|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2382585|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382586|NCT00640575|Triamcinolone|triamcinolone|mesh-list
2382587|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2382588|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2382589|NCT00640575|Lidocaine|lidocaine|mesh-list
2382590|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2382591|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
2382592|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
2382593|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2382594|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382595|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
2382596|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382597|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2382598|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2382599|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2382600|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2382601|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382602|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382603|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
2382604|NCT00640575|Hormones|hormones|mesh-ancestor
2382605|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2382606|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2382607|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
2382608|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382609|NCT00640588|Adefovir|adefovir|mesh-list
2382610|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2382611|NCT00640588|Telbivudine|telbivudine|mesh-list
2382612|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
2382613|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382614|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2382615|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2382616|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382617|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382618|NCT00640627|Celecoxib|celecoxib|mesh-list
2382619|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2382620|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2382621|NCT00640627|Analgesics|analgesics|mesh-ancestor
2382622|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
2382623|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382624|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382625|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382626|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2382627|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2500233|NCT01217398|Bevacizumab|bevacizumab|mesh-list
2500234|NCT01217398|Temozolomide|temozolomide|mesh-list
2500235|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2500236|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500237|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2500238|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2500239|NCT01217398|Growth Substances|growth substances|mesh-ancestor
2500240|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500241|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
2500242|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2500243|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
2500244|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500245|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2500246|NCT01217450|Cetuximab|cetuximab|mesh-list
2500247|NCT01217450|Antibodies|antibodies|mesh-list
2500248|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
2500249|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2382628|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2382629|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382630|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382631|NCT00640640|Bevacizumab|bevacizumab|mesh-list
2382632|NCT00640640|Ranibizumab|ranibizumab|mesh-list
2382633|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2382634|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382635|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2382636|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2500250|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
2500251|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500252|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500253|NCT01217580|Ropivacaine|ropivacaine|mesh-list
2500254|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
2500255|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
2500256|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2500257|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382637|NCT00640640|Growth Substances|growth substances|mesh-ancestor
2382638|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382639|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
2382640|NCT00640679|Clopidogrel|clopidogrel|mesh-list
2382641|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2382642|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2382643|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2382644|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2382645|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
2382646|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382647|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382648|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382649|NCT00640705|Diclofenac|diclofenac|mesh-list
2382650|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2382651|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2382652|NCT00640705|Analgesics|analgesics|mesh-ancestor
2382653|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
2382654|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382655|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382656|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382657|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2382658|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2382659|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382660|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382661|NCT00640744|Atorvastatin|atorvastatin|mesh-list
2382662|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2382663|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2382664|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
2382665|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382666|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2382667|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2382668|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382669|NCT00640796|Aldesleukin|aldesleukin|mesh-list
2382670|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
2382671|NCT00640796|Fludarabine|fludarabine|mesh-list
2382672|NCT00640796|Interleukin-2|interleukin-2|mesh-list
2382673|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2382674|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
2382675|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382676|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2382677|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2382678|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
2382679|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382680|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500258|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
2500259|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500260|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2382681|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2500261|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500262|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2500263|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500264|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500265|NCT01217632|Entecavir|entecavir|mesh-list
2500266|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
2500267|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500268|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
2500269|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2500270|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500271|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500272|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2500273|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2500274|NCT01217697|Prednisone|prednisone|mesh-list
2500275|NCT01217697|Prednisolone|prednisolone|mesh-list
2500276|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
2500277|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2500278|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
2500279|NCT01217697|Hormones|hormones|mesh-ancestor
2382682|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2382683|NCT00640796|Analgesics|analgesics|mesh-ancestor
2382684|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
2382685|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382686|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2382687|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2382688|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
2382689|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382690|NCT00640809|Ibuprofen|ibuprofen|mesh-list
2382691|NCT00640809|Celecoxib|celecoxib|mesh-list
2382692|NCT00640809|Omeprazole|omeprazole|mesh-list
2382693|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2500280|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500281|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500282|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2500283|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500284|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2500285|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500286|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500287|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
2500288|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2382694|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2382695|NCT00640809|Analgesics|analgesics|mesh-ancestor
2382696|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
2382697|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382698|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382699|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382700|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2382701|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2500289|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
2500290|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2500291|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
2500292|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500293|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2500294|NCT01217879|Telmisartan|telmisartan|mesh-list
2500295|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2500296|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2500297|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2500298|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500299|NCT01217931|Bevacizumab|bevacizumab|mesh-list
2500300|NCT01217931|Everolimus|everolimus|mesh-list
2500301|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2382702|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382703|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382704|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2382705|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2382706|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2382707|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2382708|NCT00640861|Vaccines|vaccines|mesh-list
2382709|NCT00640861|Sargramostim|sargramostim|mesh-list
2382710|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
2500302|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500303|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2500304|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2500305|NCT01217931|Growth Substances|growth substances|mesh-ancestor
2500306|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500307|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
2500308|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2500309|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
2500310|NCT01217970|Ibudilast|ibudilast|mesh-list
2500311|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2500312|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
2500313|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500314|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500315|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2382711|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
2500316|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
2500317|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2500318|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500319|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500320|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2500321|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
2500322|NCT01218022|Losartan|losartan|mesh-list
2500323|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2500324|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2500325|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2500326|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2500327|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500328|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
2500329|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2500330|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500331|NCT01218217|Rifampin|rifampin|mesh-list
2500332|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2500333|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
2500334|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2500335|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382712|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382713|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2382714|NCT00640887|Ritonavir|ritonavir|mesh-list
2382715|NCT00640887|Lopinavir|lopinavir|mesh-list
2382716|NCT00640887|Nevirapine|nevirapine|mesh-list
2382717|NCT00640887|Efavirenz|efavirenz|mesh-list
2382718|NCT00640887|Rifabutin|rifabutin|mesh-list
2382719|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2382720|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2382721|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
2382722|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382723|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382724|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2382725|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2382726|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
2382727|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382728|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2382729|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2382730|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2382731|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2382732|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2382733|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2382734|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2382735|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2382736|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2382737|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2382738|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2382739|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
2382740|NCT00640939|Diclofenac|diclofenac|mesh-list
2382741|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2500336|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
2500337|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2500338|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500339|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500340|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2500341|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2500342|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2500343|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2500344|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2500345|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2500346|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
2500347|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2500348|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2500349|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2500350|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
2500351|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500352|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2500353|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2500354|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500355|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2500356|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2500357|NCT01218386|Estradiol|estradiol|mesh-list
2382742|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2382743|NCT00640939|Analgesics|analgesics|mesh-ancestor
2382744|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
2382745|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382746|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382747|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382748|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2382749|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2382750|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382751|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382752|NCT00640952|Acamprosate|acamprosate|mesh-list
2382753|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2382754|NCT00640991|Insulin|insulin|mesh-list
2500358|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2500359|NCT01218386|Estrogens|estrogens|mesh-ancestor
2500360|NCT01218386|Hormones|hormones|mesh-ancestor
2382755|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
2382756|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
2382757|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2382758|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382759|NCT00641004|Esomeprazole|esomeprazole|mesh-list
2382760|NCT00641004|Rebamipide|rebamipide|mesh-list
2382761|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2382762|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2382763|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2382764|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382765|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500361|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500362|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500363|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2500364|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
2500365|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2500366|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2500367|NCT01218425|Levodopa|levodopa|mesh-list
2500368|NCT01218425|Carbidopa|carbidopa|mesh-list
2500369|NCT01218425|Domperidone|domperidone|mesh-list
2500370|NCT01218425|Methylphenidate|methylphenidate|mesh-list
2500371|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2500372|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500373|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2500374|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2500375|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2500376|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500377|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
2500378|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2500379|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2500380|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2500381|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2500382|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500383|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
2500384|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
2382766|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
2382767|NCT00641004|Protective Agents|protective agents|mesh-ancestor
2382768|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382769|NCT00641030|Melphalan|melphalan|mesh-list
2382770|NCT00641030|Clofarabine|clofarabine|mesh-list
2500385|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500386|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2500387|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2500388|NCT01218451|Vaccines|vaccines|mesh-list
2500389|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
2500390|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500391|NCT01218529|Lapatinib|lapatinib|mesh-list
2500392|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500393|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2500394|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500395|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382771|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2382772|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
2500406|NCT01218568|Rifaximin|rifaximin|mesh-list
2500407|NCT01218568|Lactulose|lactulose|mesh-list
2500408|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2500409|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500410|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2500411|NCT01218581|Letrozole|letrozole|mesh-list
2500412|NCT01218581|Goserelin|goserelin|mesh-list
2500413|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500414|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2500415|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2500416|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500417|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500418|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2500419|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
2500420|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500421|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500422|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2500423|NCT01218607|Bosentan|bosentan|mesh-list
2500424|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2500425|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2500426|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500427|NCT01218620|Tolbutamide|tolbutamide|mesh-list
2500428|NCT01218620|Rifampin|rifampin|mesh-list
2500429|NCT01218620|Ketoconazole|ketoconazole|mesh-list
2500430|NCT01218620|Midazolam|midazolam|mesh-list
2500431|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
2382773|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382774|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382775|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2382776|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2382777|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
2382778|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382779|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2382780|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
2382781|NCT00641082|Adefovir|adefovir|mesh-list
2382782|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2382783|NCT00641082|Clevudine|clevudine|mesh-list
2382784|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
2382785|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382786|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2382787|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2382788|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500432|NCT01218620|Omeprazole|omeprazole|mesh-list
2500433|NCT01218620|R04929097|r04929097|mesh-list
2500434|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2500435|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2500436|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2500437|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500438|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2500439|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2382789|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382790|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
2382791|NCT00641095|Rituximab|rituximab|mesh-list
2382792|NCT00641095|Fludarabine|fludarabine|mesh-list
2500440|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2500441|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2500442|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
2500443|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
2500444|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
2500445|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
2500446|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2500447|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500448|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2382793|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2382794|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
2382795|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382796|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2382797|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2382798|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
2500449|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2500450|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2500451|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500452|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2500453|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
2382799|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500454|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2500455|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500456|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
2500457|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2500458|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2500459|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2500460|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2500461|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2500462|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2500463|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2500464|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
2500465|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2500466|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2500467|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2500468|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
2500469|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500470|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2500471|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
2500472|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
2382800|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382801|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2382802|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2382803|NCT00641160|Vinorelbine|vinorelbine|mesh-list
2382804|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2382805|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382806|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
2500473|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2500474|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2500475|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2500476|NCT01218698|Losartan|losartan|mesh-list
2500477|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2500478|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2500479|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2500480|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2382807|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
2382808|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
2382809|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382810|NCT00641173|Paroxetine|paroxetine|mesh-list
2382811|NCT00641173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2382812|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2382813|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2382814|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382815|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382816|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
2500481|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500482|NCT01218711|Losartan|losartan|mesh-list
2500483|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2500484|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2500485|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2500486|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2500487|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2500488|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500489|NCT01218711|Diuretics|diuretics|mesh-ancestor
2500490|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
2500491|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500492|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2500493|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2382817|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382818|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2382819|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
2382820|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2382821|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2382822|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2382823|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382824|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
2382825|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2382826|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2382827|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
2382828|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
2500494|NCT01218724|Losartan|losartan|mesh-list
2500495|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2500496|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2500497|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2500498|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2500499|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2500500|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500501|NCT01218724|Diuretics|diuretics|mesh-ancestor
2500502|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
2500503|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500504|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2500505|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2500506|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
2500507|NCT01218737|Prednisolone|prednisolone|mesh-list
2500508|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2500509|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
2500510|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2500511|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
2500512|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2500513|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
2500514|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2500515|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
2500516|NCT01218737|Hormones|hormones|mesh-ancestor
2382829|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2382830|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382831|NCT00641212|Budesonide|budesonide|mesh-list
2382832|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382833|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2382834|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
2382835|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382836|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382837|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2382838|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
2500517|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500518|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500519|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2500520|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500521|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
2500522|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
2500523|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500524|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2500525|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2500526|NCT01218737|Protective Agents|protective agents|mesh-ancestor
2500527|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2500528|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500529|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2500530|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2500531|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2500532|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2500533|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382839|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
2382840|NCT00641212|Hormones|hormones|mesh-ancestor
2382841|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2382842|NCT00641264|Omeprazole|omeprazole|mesh-list
2382843|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2500534|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500535|NCT01218750|Bevacizumab|bevacizumab|mesh-list
2500536|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2500537|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500538|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2500539|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2500540|NCT01218750|Growth Substances|growth substances|mesh-ancestor
2500541|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500542|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
2500543|NCT01218893|Chloroquine|chloroquine|mesh-list
2500544|NCT01218893|Proguanil|proguanil|mesh-list
2500545|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2500546|NCT01218893|Vaccines|vaccines|mesh-list
2500547|NCT01218893|Amebicides|amebicides|mesh-ancestor
2500548|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2500549|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2500550|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382844|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2382845|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2500551|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
2382846|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382847|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382848|NCT00641329|Clonidine|clonidine|mesh-list
2382849|NCT00641329|Analgesics|analgesics|mesh-ancestor
2382850|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
2500552|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2500553|NCT01218893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500554|NCT01218893|Immunologic Factors|immunologic factors|mesh-ancestor
2500555|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
2500556|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500557|NCT01219010|Siltuximab|siltuximab|mesh-list
2500558|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500559|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
2500560|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500561|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
2500562|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2500563|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2500564|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500565|NCT01219023|Urological Agents|urological agents|mesh-ancestor
2500566|NCT01219036|Budesonide|budesonide|mesh-list
2500567|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2500568|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2500569|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
2500570|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500571|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500572|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2500573|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
2500574|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
2500575|NCT01219036|Hormones|hormones|mesh-ancestor
2500576|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500577|NCT01219062|Morphine|morphine|mesh-list
2500578|NCT01219062|Bupivacaine|bupivacaine|mesh-list
2500579|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
2500580|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
2500581|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2500582|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382851|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382852|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382853|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2382854|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
2382855|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
2382856|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2382857|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2382858|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2382859|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
2382860|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2382861|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382862|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
2382863|NCT00641381|Carmustine|carmustine|mesh-list
2382864|NCT00641381|Etoposide|etoposide|mesh-list
2382865|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2382866|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
2500583|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
2500584|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500585|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2500586|NCT01219062|Narcotics|narcotics|mesh-ancestor
2500587|NCT01219062|Analgesics|analgesics|mesh-ancestor
2500588|NCT01219088|Morphine|morphine|mesh-list
2500589|NCT01219088|Bupivacaine|bupivacaine|mesh-list
2500590|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
2500591|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
2500592|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2500593|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500594|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
2500595|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500596|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2500597|NCT01219088|Narcotics|narcotics|mesh-ancestor
2500598|NCT01219088|Analgesics|analgesics|mesh-ancestor
2500599|NCT01219101|Citric Acid|citric acid|mesh-list
2500600|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
2500601|NCT01219101|Clomiphene|clomiphene|mesh-list
2500602|NCT01219101|Enclomiphene|enclomiphene|mesh-list
2500603|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
2500604|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
2382867|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500605|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2500606|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
2500607|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
2500608|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500609|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2500610|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
2500611|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500612|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500613|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2500614|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
2500615|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2500616|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2500617|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2500618|NCT01219153|Letrozole|letrozole|mesh-list
2500619|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
2500620|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2500621|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500622|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2500623|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2500624|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500625|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500626|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2500627|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
2500628|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500629|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382868|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2382869|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2382870|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
2382871|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382872|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382873|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2382874|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2382875|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2382876|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2382877|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382878|NCT00641407|Insulin|insulin|mesh-list
2382879|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2382880|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
2382881|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2382882|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382883|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
2382884|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2382885|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2382886|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382887|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2382888|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2382889|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
2382890|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2382891|NCT00641446|Budesonide|budesonide|mesh-list
2500630|NCT01219153|Hormones|hormones|mesh-ancestor
2500631|NCT01219205|Bevacizumab|bevacizumab|mesh-list
2500632|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2500633|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500634|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2500635|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2500636|NCT01219205|Growth Substances|growth substances|mesh-ancestor
2500637|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500638|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
2500639|NCT01219244|Resveratrol|resveratrol|mesh-list
2500640|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
2500641|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500642|NCT01219244|Protective Agents|protective agents|mesh-ancestor
2500643|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500644|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382892|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382893|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2382894|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
2382895|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382896|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382897|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2382898|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
2382899|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
2382900|NCT00641446|Hormones|hormones|mesh-ancestor
2382901|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2382902|NCT00641472|Budesonide|budesonide|mesh-list
2382903|NCT00641472|Montelukast|montelukast|mesh-list
2382904|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382905|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2500645|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2500646|NCT01219257|Adalimumab|adalimumab|mesh-list
2500647|NCT01219257|Etanercept|etanercept|mesh-list
2500648|NCT01219257|Golimumab|golimumab|mesh-list
2500649|NCT01219257|Infliximab|infliximab|mesh-list
2500650|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2500651|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2500652|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2500653|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2500654|NCT01219257|Analgesics|analgesics|mesh-ancestor
2500655|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
2500656|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500657|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500658|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2500659|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2500660|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
2500661|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
2500662|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2500663|NCT01219348|Vaccines|vaccines|mesh-list
2500664|NCT01219348|Immunologic Factors|immunologic factors|mesh-ancestor
2500665|NCT01219348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500666|NCT01219400|Vildagliptin|vildagliptin|mesh-list
2500667|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2500668|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500669|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2500670|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
2500671|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500672|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500673|NCT01219413|Perindopril|perindopril|mesh-list
2500674|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2500675|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
2500676|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500677|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500678|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2500679|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2500680|NCT01219556|Olmesartan|olmesartan|mesh-list
2500681|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2500682|NCT01219556|Diuretics|diuretics|mesh-ancestor
2500683|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
2500684|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500685|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2500686|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2500687|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500688|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2500689|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2500690|NCT01219569|Propofol|propofol|mesh-list
2382906|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
2382907|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382908|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382909|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2382910|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
2500691|NCT01219569|Sevoflurane|sevoflurane|mesh-list
2500692|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2500693|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2500694|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500695|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2500696|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
2500697|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
2500698|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2500699|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2500700|NCT01219582|Metformin|metformin|mesh-list
2500701|NCT01219582|Acarbose|acarbose|mesh-list
2382911|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
2382912|NCT00641472|Hormones|hormones|mesh-ancestor
2382913|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2382914|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2382915|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
2382916|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2382917|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2382918|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382919|NCT00641537|Cladribine|cladribine|mesh-list
2382920|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382921|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2382922|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
2382923|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382924|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
2382925|NCT00641589|Hematinics|hematinics|mesh-ancestor
2382926|NCT00641602|Esomeprazole|esomeprazole|mesh-list
2382927|NCT00641602|Lansoprazole|lansoprazole|mesh-list
2382928|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
2382929|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2382930|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2382931|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2382932|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382933|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382934|NCT00641654|Interferons|interferons|mesh-list
2382935|NCT00641654|Ribavirin|ribavirin|mesh-list
2382936|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
2382937|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
2382938|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2382939|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2382940|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
2382941|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2382942|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
2382943|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382944|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
2382945|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382946|NCT00641680|Fluticasone|fluticasone|mesh-list
2382947|NCT00641680|Xhance|xhance|mesh-list
2382948|NCT00641680|Budesonide|budesonide|mesh-list
2382949|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382950|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2382951|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
2382952|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382953|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382954|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2382955|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
2382956|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
2382957|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2382958|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
2382959|NCT00641680|Hormones|hormones|mesh-ancestor
2382960|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500702|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2500703|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500704|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2382961|NCT00641693|Budesonide|budesonide|mesh-list
2382962|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2382963|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2382964|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
2382965|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2382966|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382967|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2382968|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
2382969|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
2382970|NCT00641693|Hormones|hormones|mesh-ancestor
2382971|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2382972|NCT00641732|Enoxaparin|enoxaparin|mesh-list
2382973|NCT00641732|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
2382974|NCT00641732|Anticoagulants|anticoagulants|mesh-ancestor
2382975|NCT00641732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2382976|NCT00641732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2382977|NCT00641732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382978|NCT00641732|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2382979|NCT00641732|Antithrombins|antithrombins|mesh-ancestor
2382980|NCT00641732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2382981|NCT00641732|Protease Inhibitors|protease inhibitors|mesh-ancestor
2382982|NCT00641732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382983|NCT00641758|Pycnogenols|pycnogenols|mesh-list
2382984|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2382985|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
2382986|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382987|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
2382988|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2382989|NCT00641758|Protective Agents|protective agents|mesh-ancestor
2382990|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2382991|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
2382992|NCT00641771|Alendronate|alendronate|mesh-list
2500705|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500706|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500707|NCT01219686|Pindolol|pindolol|mesh-list
2500708|NCT01219686|Dexetimide|dexetimide|mesh-list
2500709|NCT01219686|Citalopram|citalopram|mesh-list
2500710|NCT01219686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2500711|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2500712|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2500713|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500714|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2500715|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
2500716|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500717|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2500718|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
2500719|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2500720|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2500721|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2500722|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
2500723|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
2500724|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500725|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2500726|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2500727|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
2500728|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2500729|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2500730|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
2500731|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2500732|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2500733|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
2500734|NCT01219699|Fulvestrant|fulvestrant|mesh-list
2500735|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2500736|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500737|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2500738|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2500739|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
2500740|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500741|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500742|NCT01219712|Simendan|simendan|mesh-list
2500743|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2500744|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
2500745|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2500746|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2500747|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2382993|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2382994|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2382995|NCT00641771|Vitamins|vitamins|mesh-ancestor
2382996|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
2382997|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2382998|NCT00641810|Caffeine|caffeine|mesh-list
2382999|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2383000|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383001|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2383002|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383003|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383004|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2383005|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2383006|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
2383007|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383008|NCT00641914|Budesonide|budesonide|mesh-list
2383009|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383010|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2383011|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
2383012|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383013|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383014|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2383015|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
2383016|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
2383017|NCT00641914|Hormones|hormones|mesh-ancestor
2500748|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500749|NCT01219712|Protective Agents|protective agents|mesh-ancestor
2500750|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500751|NCT01219751|Sunitinib|sunitinib|mesh-list
2500752|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500753|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2383018|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2383019|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
2383020|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2383021|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
2383022|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383023|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383024|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383025|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
2383026|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2383027|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383028|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383029|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2383030|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2383031|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2500754|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2500755|NCT01219751|Growth Substances|growth substances|mesh-ancestor
2500756|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500757|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
2500758|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2500759|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500760|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500761|NCT01219764|Amoxicillin|amoxicillin|mesh-list
2500762|NCT01219764|Metronidazole|metronidazole|mesh-list
2500763|NCT01219764|Clarithromycin|clarithromycin|mesh-list
2500764|NCT01219764|Rabeprazole|rabeprazole|mesh-list
2500765|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2500766|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500767|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2500768|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2500769|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2500770|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500771|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500772|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2500773|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2500774|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2500775|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2500776|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2500777|NCT01219816|Epratuzumab|epratuzumab|mesh-list
2500778|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2500779|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500780|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
2500781|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2500782|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
2500783|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500784|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2500785|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2500786|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
2500787|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500788|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500789|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2500790|NCT01219920|Leucovorin|leucovorin|mesh-list
2500791|NCT01219920|Irinotecan|irinotecan|mesh-list
2500792|NCT01219920|Antidotes|antidotes|mesh-ancestor
2500793|NCT01219920|Protective Agents|protective agents|mesh-ancestor
2500794|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500795|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
2500796|NCT01219920|Vitamins|vitamins|mesh-ancestor
2500797|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
2500798|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500799|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500800|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2500801|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2500802|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500803|NCT01220063|Irinotecan|irinotecan|mesh-list
2500804|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2500805|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2500806|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500807|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500808|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500809|NCT01220076|Tamoxifen|tamoxifen|mesh-list
2383032|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2500810|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2500811|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
2668481|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2500812|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500813|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500814|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2383033|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2383034|NCT00641979|Budesonide|budesonide|mesh-list
2383035|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383036|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2383037|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
2383038|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383039|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383040|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2383041|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
2383042|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
2383043|NCT00641979|Hormones|hormones|mesh-ancestor
2383044|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2383045|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
2383046|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2383047|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2383048|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2383049|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383050|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
2383051|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2500815|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500816|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2500817|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2500818|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2500819|NCT01220102|Adapalene|adapalene|mesh-list
2500820|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2500821|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
2500822|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2500823|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2500824|NCT01220102|Analgesics|analgesics|mesh-ancestor
2500825|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
2500826|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500827|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383052|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383053|NCT00642096|Metoprolol|metoprolol|mesh-list
2383054|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2383055|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2500828|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2500829|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2500830|NCT01220154|Paclitaxel|paclitaxel|mesh-list
2500831|NCT01220154|Bevacizumab|bevacizumab|mesh-list
2500832|NCT01220154|Carboplatin|carboplatin|mesh-list
2500833|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2500834|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500835|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
2500836|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
2500837|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
2500838|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500839|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2383056|NCT00642096|Diuretics|diuretics|mesh-ancestor
2383057|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
2383058|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383059|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2383060|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2383061|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383062|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2383063|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
2383064|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
2383065|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383066|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2383067|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2383068|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2383069|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
2383070|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383071|NCT00642122|Budesonide|budesonide|mesh-list
2383072|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383073|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2383074|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
2383075|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383076|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383077|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2500840|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2500841|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2500842|NCT01220154|Growth Substances|growth substances|mesh-ancestor
2500843|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500844|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
2500845|NCT01220219|Pregabalin|pregabalin|mesh-list
2500846|NCT01220219|Analgesics|analgesics|mesh-ancestor
2500847|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
2500848|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500849|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500850|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
2500851|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2500852|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2500853|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500854|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2500855|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2383078|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
2383079|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
2383080|NCT00642122|Hormones|hormones|mesh-ancestor
2383081|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2114446|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
2114447|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
2114448|NCT02603952|Oseltamivir|oseltamivir|mesh-list
2500856|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2500857|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2500858|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2500859|NCT01220232|Lamivudine|lamivudine|mesh-list
2500860|NCT01220232|Abacavir|abacavir|mesh-list
2500861|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
2500862|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2500863|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2500864|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500865|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500866|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
2500867|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500868|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2500869|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2383082|NCT00642135|Phenylephrine|phenylephrine|mesh-list
2383083|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
2383084|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2383085|NCT00642135|Tropicamide|tropicamide|mesh-list
2383086|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2383087|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
2383088|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
2383089|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383090|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383091|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
2383092|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2383093|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
2383094|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
2383095|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2383096|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2383097|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2383098|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
2383099|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383100|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383101|NCT00642135|Protective Agents|protective agents|mesh-ancestor
2383102|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2383103|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2383104|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2383105|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
2383106|NCT00642148|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2383107|NCT00642148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2383108|NCT00642148|Autonomic Agents|autonomic agents|mesh-ancestor
2114449|NCT02603952|MEDI8852|medi8852|mesh-list
2114450|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
2114451|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114452|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114453|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114454|NCT02604173|Budesonide|budesonide|mesh-list
2114455|NCT02604173|Acetazolamide|acetazolamide|mesh-list
2114456|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2114457|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2114458|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
2114459|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114460|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500870|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
2500871|NCT01220245|Heparin|heparin|mesh-list
2500872|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
2500873|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2500874|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2500875|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500876|NCT01220258|Azithromycin|azithromycin|mesh-list
2500877|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2500878|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2500879|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2500880|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500881|NCT01220271|Temozolomide|temozolomide|mesh-list
2500882|NCT01220271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2500883|NCT01220271|Alkylating Agents|alkylating agents|mesh-ancestor
2500884|NCT01220271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500885|NCT01220271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500886|NCT01220284|Vinorelbine|vinorelbine|mesh-list
2383109|NCT00642148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383110|NCT00642148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383111|NCT00642148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2383112|NCT00642148|Respiratory System Agents|respiratory system agents|mesh-ancestor
2383113|NCT00642148|Glucocorticoids|glucocorticoids|mesh-ancestor
2383114|NCT00642148|Hormones|hormones|mesh-ancestor
2383115|NCT00642148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2383116|NCT00642148|Sympathomimetics|sympathomimetics|mesh-ancestor
2383117|NCT00642161|Budesonide|budesonide|mesh-list
2383118|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383119|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2383120|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
2383121|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383122|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383123|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2383124|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
2383125|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
2383126|NCT00642161|Hormones|hormones|mesh-ancestor
2383127|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2383128|NCT00642187|Budesonide|budesonide|mesh-list
2383129|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383130|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2383131|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
2383132|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383133|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383134|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2383135|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
2383136|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
2383137|NCT00642187|Hormones|hormones|mesh-ancestor
2383138|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2383139|NCT00642226|Triamcinolone|triamcinolone|mesh-list
2383140|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383141|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
2383142|NCT00642226|Hormones|hormones|mesh-ancestor
2383143|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2383144|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383145|NCT00642252|Fluorides|fluorides|mesh-list
2383146|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
2383147|NCT00642252|Protective Agents|protective agents|mesh-ancestor
2383148|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383149|NCT00642291|Emtricitabine|emtricitabine|mesh-list
2383150|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
2500887|NCT01220284|Satraplatin|satraplatin|mesh-list
2500888|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2500889|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500890|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
2500891|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
2500892|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
2500893|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500894|NCT01220362|Fentanyl|fentanyl|mesh-list
2500895|NCT01220362|Bupivacaine|bupivacaine|mesh-list
2500896|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
2500897|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
2500898|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2500899|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500900|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
2500901|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500902|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2500903|NCT01220362|Narcotics|narcotics|mesh-ancestor
2500904|NCT01220362|Analgesics|analgesics|mesh-ancestor
2500905|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2500906|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2500907|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
2500908|NCT01220375|Plerixafor|plerixafor|mesh-list
2500909|NCT01220375|Vinorelbine|vinorelbine|mesh-list
2500910|NCT01220375|Lenograstim|lenograstim|mesh-list
2500911|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2500912|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
2500913|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500914|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2500915|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500916|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
2500917|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
2500918|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
2500919|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500920|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2500921|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2383151|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383152|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2383153|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2383154|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383155|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383156|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2383157|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2383158|NCT00642330|Ibuprofen|ibuprofen|mesh-list
2383159|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2383160|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2383161|NCT00642330|Analgesics|analgesics|mesh-ancestor
2383162|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
2500922|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
2500923|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500924|NCT01220440|Methylphenidate|methylphenidate|mesh-list
2500925|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
2500926|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2500927|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500928|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2500929|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2500930|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2500931|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500932|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
2500933|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2500934|NCT01220518|Infliximab|infliximab|mesh-list
2500935|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
2500936|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2500937|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2500938|NCT01220531|Cyclosporine|cyclosporine|mesh-list
2500939|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
2500940|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
2500941|NCT01220531|Prednisolone|prednisolone|mesh-list
2500942|NCT01220531|Tacrolimus|tacrolimus|mesh-list
2500943|NCT01220531|Cyclosporins|cyclosporins|mesh-list
2500944|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2500945|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
2500946|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2500947|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
2500948|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500949|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2500950|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2500951|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500952|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
2500953|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500954|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
2500955|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2500956|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2500957|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500958|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2500959|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
2500960|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2500961|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2500962|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
2500963|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
2383163|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383164|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500964|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2500965|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2500966|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
2500967|NCT01220531|Hormones|hormones|mesh-ancestor
2500968|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2500969|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2500970|NCT01220531|Protective Agents|protective agents|mesh-ancestor
2500971|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2500972|NCT01220570|Sirolimus|sirolimus|mesh-list
2500973|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2500974|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2500975|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500976|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2500977|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383165|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383166|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2383167|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2383168|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383169|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383170|NCT00642395|Bortezomib|bortezomib|mesh-list
2500978|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
2500979|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2500980|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
2500981|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500982|NCT01220583|Cisplatin|cisplatin|mesh-list
2500983|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500984|NCT01220596|Interferons|interferons|mesh-list
2500985|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2500986|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
2500987|NCT01220596|Entecavir|entecavir|mesh-list
2500988|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2500989|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
2500990|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2500991|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
2500992|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2500993|NCT01220622|Nimodipine|nimodipine|mesh-list
2500994|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2500995|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2500996|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2500997|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2500998|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2500999|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501000|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
2501001|NCT01220648|Interferons|interferons|mesh-list
2501002|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
2501003|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501004|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
2501005|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501006|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
2501007|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383171|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383172|NCT00642408|Micronutrients|micronutrients|mesh-list
2383173|NCT00642408|Trace Elements|trace elements|mesh-list
2383174|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383175|NCT00642421|Octreotide|octreotide|mesh-list
2383176|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2383177|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2383178|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383179|NCT00642434|Metoprolol|metoprolol|mesh-list
2383180|NCT00642434|Carvedilol|carvedilol|mesh-list
2383181|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2383182|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2383183|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
2383184|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
2383185|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383186|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501008|NCT01220661|Cefotetan|cefotetan|mesh-list
2501009|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2501010|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501011|NCT01220791|Progesterone|progesterone|mesh-list
2501012|NCT01220791|Progestins|progestins|mesh-ancestor
2501013|NCT01220791|Hormones|hormones|mesh-ancestor
2501014|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2501015|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501016|NCT01220843|Sevelamer|sevelamer|mesh-list
2501017|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
2383187|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2501018|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
2501019|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501020|NCT01220947|Ritonavir|ritonavir|mesh-list
2501021|NCT01220947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2501022|NCT01220947|Lactams|lactams|mesh-list
2501023|NCT01220947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2501024|NCT01220947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2383188|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2383189|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2383190|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
2383191|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383192|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383193|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
2383194|NCT00642434|Protective Agents|protective agents|mesh-ancestor
2383195|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2383196|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2383197|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2501025|NCT01220947|Protease Inhibitors|protease inhibitors|mesh-ancestor
2501026|NCT01220947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501027|NCT01220947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501028|NCT01220947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2501029|NCT01220947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2501030|NCT01220947|Antiviral Agents|antiviral agents|mesh-ancestor
2501031|NCT01220947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501032|NCT01220947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2501033|NCT01220947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2501034|NCT01220947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2501035|NCT01221025|Parecoxib|parecoxib|mesh-list
2501036|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2501037|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2501038|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501039|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501040|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2501041|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2501042|NCT01221025|Analgesics|analgesics|mesh-ancestor
2501043|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
2501044|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383198|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
2383199|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2383200|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2383201|NCT00642499|Dronabinol|dronabinol|mesh-list
2383202|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
2383203|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383204|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383205|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2501045|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501046|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2501047|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2501048|NCT01221077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2501049|NCT01221077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501050|NCT01221077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2501051|NCT01221077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501052|NCT01221077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501053|NCT01221103|Dexamethasone|dexamethasone|mesh-list
2501054|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2501055|NCT01221103|Ofatumumab|ofatumumab|mesh-list
2501056|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2501057|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2501058|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
2501059|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
2501060|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501061|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501062|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2501063|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
2501064|NCT01221103|Hormones|hormones|mesh-ancestor
2501065|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2501066|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2501067|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501068|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2383206|NCT00642499|Analgesics|analgesics|mesh-ancestor
2383207|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
2383208|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383209|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2383210|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2383211|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501069|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
2383212|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383213|NCT00642499|Hormones|hormones|mesh-ancestor
2501070|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501071|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
2501072|NCT01221116|Simendan|simendan|mesh-list
2501073|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2501074|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
2501075|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2501076|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2501077|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501078|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501079|NCT01221116|Protective Agents|protective agents|mesh-ancestor
2501080|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501081|NCT01221129|Zinc|zinc|mesh-list
2501082|NCT01221129|Trace Elements|trace elements|mesh-ancestor
2501083|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
2501084|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383214|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2383215|NCT00642512|Dronabinol|dronabinol|mesh-list
2383216|NCT00642512|Ondansetron|ondansetron|mesh-list
2383217|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
2383218|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
2383219|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383220|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383221|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2383222|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
2383223|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
2383224|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2501085|NCT01221337|Heparin|heparin|mesh-list
2501086|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
2501087|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2501088|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2501089|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501090|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
2501091|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501092|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2501093|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501094|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501095|NCT01221402|Niacin|niacin|mesh-list
2501096|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2501097|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
2501098|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501099|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2501100|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
2501101|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
2501102|NCT01221402|Vitamins|vitamins|mesh-ancestor
2501103|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
2501104|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501105|NCT01221558|Lycopene|lycopene|mesh-list
2501106|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2501107|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
2501108|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501109|NCT01221558|Protective Agents|protective agents|mesh-ancestor
2501110|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501111|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2501112|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2501113|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501114|NCT01221636|Abatacept|abatacept|mesh-list
2501115|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2501116|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501117|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501118|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2501119|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
2501120|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501121|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2501122|NCT01221675|Antibodies|antibodies|mesh-list
2501123|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
2501124|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501125|NCT01221740|Milnacipran|milnacipran|mesh-list
2501126|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
2501127|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2501128|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2501129|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2383225|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
2501130|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383226|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383227|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501131|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501132|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501133|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2501134|NCT01221740|Analgesics|analgesics|mesh-ancestor
2501135|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
2383228|NCT00642512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2383229|NCT00642512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2383230|NCT00642512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383231|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383232|NCT00642512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2383233|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
2383234|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2383235|NCT00642512|Analgesics|analgesics|mesh-ancestor
2383236|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
2383237|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2383238|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2383239|NCT00642512|Hormones|hormones|mesh-ancestor
2383240|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2383241|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
2383242|NCT00642551|Vitamin K|vitamin k|mesh-list
2383243|NCT00642551|Vitamin MK 7|vitamin mk 7|mesh-list
2383244|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2383245|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2383246|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383247|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
2501136|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501137|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
2501138|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2501139|NCT01221792|Carvedilol|carvedilol|mesh-list
2501140|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2501141|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2501142|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
2501143|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501144|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501145|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501146|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2501147|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
2501148|NCT01221792|Protective Agents|protective agents|mesh-ancestor
2501149|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2501150|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2501151|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2501152|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
2501153|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2501154|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2501155|NCT01221831|Dienogest|dienogest|mesh-list
2501156|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2501157|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2501158|NCT01221831|Estradiol|estradiol|mesh-list
2501159|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2501160|NCT01221831|Estrogens|estrogens|mesh-ancestor
2501161|NCT01221831|Hormones|hormones|mesh-ancestor
2501162|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2501163|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501164|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2501165|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
2501166|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2501167|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2501168|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2501169|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2501170|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2501171|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
2501172|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2501173|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501174|NCT01221883|Diazepam|diazepam|mesh-list
2501175|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2501176|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
2501177|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
2501178|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
2501179|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501180|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501181|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2501182|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2501183|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2501184|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2501185|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2501186|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2501187|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2501188|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2501189|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2501190|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
2383248|NCT00642551|Coagulants|coagulants|mesh-ancestor
2383249|NCT00642551|Vitamins|vitamins|mesh-ancestor
2383250|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
2383251|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383252|NCT00642577|Leucovorin|leucovorin|mesh-list
2383253|NCT00642577|Bevacizumab|bevacizumab|mesh-list
2383254|NCT00642577|Fluorouracil|fluorouracil|mesh-list
2383255|NCT00642577|Irinotecan|irinotecan|mesh-list
2383256|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2383257|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501191|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
2501192|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
2501193|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
2501194|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501195|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501196|NCT01221896|Choline|choline|mesh-list
2501197|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
2501198|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2501199|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
2501200|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501201|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2501202|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2501203|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
2501204|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
2501205|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2501206|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2501207|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501208|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
2501209|NCT01221909|Coagulants|coagulants|mesh-ancestor
2501210|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2501211|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
2501212|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2501213|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2501214|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501215|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501216|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501217|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
2501218|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383258|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2383259|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2383260|NCT00642577|Growth Substances|growth substances|mesh-ancestor
2501219|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
2501220|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501221|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2501222|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501223|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501224|NCT01222026|Vitamin D|vitamin d|mesh-list
2501225|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
2501226|NCT01222026|Vitamins|vitamins|mesh-ancestor
2501227|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
2501228|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501229|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2501230|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
2383261|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383262|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
2383263|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
2383264|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383265|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2383266|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2383267|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
2383268|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2383269|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2383270|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383271|NCT00642577|Antidotes|antidotes|mesh-ancestor
2383272|NCT00642577|Protective Agents|protective agents|mesh-ancestor
2501231|NCT01222052|Docetaxel|docetaxel|mesh-list
2383273|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
2501232|NCT01222052|Fluorouracil|fluorouracil|mesh-list
2501233|NCT01222052|Epirubicin|epirubicin|mesh-list
2383274|NCT00642577|Vitamins|vitamins|mesh-ancestor
2383275|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
2383276|NCT00642655|Rituximab|rituximab|mesh-list
2383277|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2383278|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383279|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
2383280|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383281|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2383282|NCT00642681|Insulin|insulin|mesh-list
2501234|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2501235|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
2501236|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501237|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2501238|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2383283|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2383284|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383285|NCT00642733|Gemcitabine|gemcitabine|mesh-list
2383286|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2383287|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2383288|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
2383289|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383290|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383291|NCT00642733|Antiviral Agents|antiviral agents|mesh-ancestor
2383292|NCT00642733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383293|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383294|NCT00642733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2383295|NCT00642733|Immunologic Factors|immunologic factors|mesh-ancestor
2383296|NCT00642733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383297|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2383298|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2383299|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2383300|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383301|NCT00642798|Incretins|incretins|mesh-ancestor
2383302|NCT00642798|Hormones|hormones|mesh-ancestor
2383303|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2383304|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2383305|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
2383306|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383307|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383308|NCT00642824|Bevacizumab|bevacizumab|mesh-list
2383309|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2383310|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383311|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2501239|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
2501240|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501241|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501242|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2501243|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
2501244|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
2501245|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
2501246|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
2501247|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2501248|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2501249|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2501250|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2383312|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2383313|NCT00642824|Growth Substances|growth substances|mesh-ancestor
2383314|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501251|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501252|NCT01222169|Propofol|propofol|mesh-list
2501253|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2501254|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2501255|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501256|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2501257|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
2501258|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
2501259|NCT01222182|Atorvastatin|atorvastatin|mesh-list
2501260|NCT01222182|Simvastatin|simvastatin|mesh-list
2501261|NCT01222182|Pravastatin|pravastatin|mesh-list
2501262|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2501263|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2501264|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
2501265|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383315|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
2383316|NCT00642837|Acetaminophen|acetaminophen|mesh-list
2383317|NCT00642837|Tramadol|tramadol|mesh-list
2383318|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2383319|NCT00642837|Analgesics|analgesics|mesh-ancestor
2383320|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
2383321|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383322|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383323|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
2383324|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2383325|NCT00642837|Narcotics|narcotics|mesh-ancestor
2383326|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383327|NCT00642863|Vitamin D|vitamin d|mesh-list
2383328|NCT00642863|Vitamins|vitamins|mesh-list
2383329|NCT00642863|Vitamin A|vitamin a|mesh-list
2383330|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
2383331|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
2383332|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383333|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
2383334|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383335|NCT00642863|Protective Agents|protective agents|mesh-ancestor
2383336|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2383337|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383338|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2383339|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
2501266|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2501267|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2501268|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501269|NCT01222221|Temozolomide|temozolomide|mesh-list
2501270|NCT01222221|Sargramostim|sargramostim|mesh-list
2501271|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2501272|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
2501273|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501274|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501275|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
2501276|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501277|NCT01222312|Docetaxel|docetaxel|mesh-list
2501278|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
2501279|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501280|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
2501281|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
2501282|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
2501283|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501284|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
2501285|NCT01222442|AZD-3199|azd-3199|mesh-list
2501286|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2501287|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501288|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2501289|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2501290|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501291|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501292|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501293|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501294|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2501295|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2501296|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2501297|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
2501298|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501299|NCT01222468|Nabilone|nabilone|mesh-list
2501300|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
2501301|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
2501302|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501303|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501304|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2501305|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2501306|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2383340|NCT00642915|Glimepiride|glimepiride|mesh-list
2383341|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2383342|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383343|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2383344|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2383345|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
2383346|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
2383347|NCT00642967|Hematinics|hematinics|mesh-ancestor
2383348|NCT00642980|Clindamycin|clindamycin|mesh-list
2383349|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
2383350|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
2383351|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383352|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383353|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2501307|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2501308|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2501309|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
2501310|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2501311|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2501312|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
2501313|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501314|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501315|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2501316|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2501317|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
2501318|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501319|NCT01222650|Silodosin|silodosin|mesh-list
2501320|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2383354|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383355|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383356|NCT00643071|Tacrolimus|tacrolimus|mesh-list
2383357|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2383358|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
2383359|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383360|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2383361|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383362|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383363|NCT00643136|Pregabalin|pregabalin|mesh-list
2383364|NCT00643136|Analgesics|analgesics|mesh-ancestor
2383365|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
2383366|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383367|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383368|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
2383369|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2383370|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2383371|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383372|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2383373|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2383374|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2383375|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383376|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383377|NCT00643149|Amoxicillin|amoxicillin|mesh-list
2383378|NCT00643149|Azithromycin|azithromycin|mesh-list
2383379|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383380|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383381|NCT00643227|Azithromycin|azithromycin|mesh-list
2383382|NCT00643227|Clarithromycin|clarithromycin|mesh-list
2383383|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383384|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383385|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2383386|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501321|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2501322|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2501323|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
2501324|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501325|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501326|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501327|NCT01222650|Urological Agents|urological agents|mesh-ancestor
2501328|NCT01222676|Gemcitabine|gemcitabine|mesh-list
2501329|NCT01222676|Sorafenib|sorafenib|mesh-list
2501330|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2501331|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501332|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2501333|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
2501334|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501335|NCT01222676|Antiviral Agents|antiviral agents|mesh-ancestor
2501336|NCT01222676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501337|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501338|NCT01222676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2501339|NCT01222676|Immunologic Factors|immunologic factors|mesh-ancestor
2501340|NCT01222676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501341|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2501342|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2501343|NCT01222702|Vancomycin|vancomycin|mesh-list
2501344|NCT01222702|Oxazolidinones|oxazolidinones|mesh-list
2501345|NCT01222702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2501346|NCT01222702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501347|NCT01222702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2501348|NCT01222702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501349|NCT01222702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501358|NCT01222780|Vincristine|vincristine|mesh-list
2383387|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383388|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2383389|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2383390|NCT00643240|Antibodies|antibodies|mesh-list
2383391|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2383392|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
2383393|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383394|NCT00643292|Amoxicillin|amoxicillin|mesh-list
2383395|NCT00643292|Azithromycin|azithromycin|mesh-list
2383396|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
2383397|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
2383398|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2383399|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383400|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383401|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2383402|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383403|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383404|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
2383405|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2383406|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
2383407|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
2383408|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383409|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383410|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2383411|NCT00643357|Analgesics|analgesics|mesh-ancestor
2383412|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
2383413|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383414|NCT00643383|Acetaminophen|acetaminophen|mesh-list
2383415|NCT00643383|Tramadol|tramadol|mesh-list
2383416|NCT00643383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2383417|NCT00643383|Analgesics|analgesics|mesh-ancestor
2383418|NCT00643383|Sensory System Agents|sensory system agents|mesh-ancestor
2501359|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2501360|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501361|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
2501362|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
2501363|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
2383419|NCT00643383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383420|NCT00643383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383421|NCT00643383|Antipyretics|antipyretics|mesh-ancestor
2383422|NCT00643383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2383423|NCT00643383|Narcotics|narcotics|mesh-ancestor
2383424|NCT00643383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383425|NCT00643409|Azithromycin|azithromycin|mesh-list
2501364|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501365|NCT01222819|Lenograstim|lenograstim|mesh-list
2501366|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2501367|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
2501368|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501369|NCT01222897|Valacyclovir|valacyclovir|mesh-list
2501370|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
2501371|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501372|NCT01222910|Valacyclovir|valacyclovir|mesh-list
2501373|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
2501374|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501375|NCT01222923|Risperidone|risperidone|mesh-list
2501376|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2383426|NCT00643409|Levofloxacin|levofloxacin|mesh-list
2383427|NCT00643409|Ofloxacin|ofloxacin|mesh-list
2383428|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2501377|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
2501378|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501379|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383429|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383430|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2501380|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501381|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2501382|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2501383|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2501384|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2501385|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2501386|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
2501387|NCT01222936|Panobinostat|panobinostat|mesh-list
2501388|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501389|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2501390|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501391|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501392|NCT01222975|Risperidone|risperidone|mesh-list
2501393|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2501394|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
2501395|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501396|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501397|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501398|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2501399|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2501400|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2501401|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383431|NCT00643409|Renal Agents|renal agents|mesh-ancestor
2383432|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2383433|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2383434|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383435|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383436|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383437|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2383438|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2383439|NCT00643500|Levetiracetam|levetiracetam|mesh-list
2383440|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
2383441|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
2383442|NCT00643539|Azithromycin|azithromycin|mesh-list
2383443|NCT00643539|Amoxicillin|amoxicillin|mesh-list
2383444|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2501402|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2501403|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
2501404|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2501405|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
2501406|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2501407|NCT01223053|Ketoprofen|ketoprofen|mesh-list
2383445|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383446|NCT00643643|Maraviroc|maraviroc|mesh-list
2383447|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2383448|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2383449|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383450|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2383451|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2383452|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
2501408|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2501409|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2501410|NCT01223053|Analgesics|analgesics|mesh-ancestor
2501411|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
2501412|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501413|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501414|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2501415|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2501416|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2501417|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501418|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501419|NCT01223131|Insulin|insulin|mesh-list
2501420|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2501421|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
2501422|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
2501423|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
2501424|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
2501425|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2501426|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501427|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
2501428|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2501429|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
2501430|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501431|NCT01223326|Expectorants|expectorants|mesh-ancestor
2501432|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
2501433|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2501434|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
2383453|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383454|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2383455|NCT00643734|Azithromycin|azithromycin|mesh-list
2383456|NCT00643734|Levofloxacin|levofloxacin|mesh-list
2501435|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501436|NCT01223326|Protective Agents|protective agents|mesh-ancestor
2501437|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501438|NCT01223326|Antidotes|antidotes|mesh-ancestor
2501439|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
2501440|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2501441|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501442|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2501443|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501444|NCT01223443|Paclitaxel|paclitaxel|mesh-list
2501445|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2501446|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501447|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
2501448|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
2383457|NCT00643734|Ofloxacin|ofloxacin|mesh-list
2383458|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383459|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383460|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2383461|NCT00643734|Renal Agents|renal agents|mesh-ancestor
2383462|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2383463|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2383464|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383465|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383466|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383467|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2383468|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2383469|NCT00643799|Celecoxib|celecoxib|mesh-list
2501449|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
2501450|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501451|NCT01223534|Isoniazid|isoniazid|mesh-list
2501452|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
2501453|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2501454|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501455|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2501456|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2501457|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
2501458|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501459|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2501460|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
2501461|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2501462|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501463|NCT01223612|Ranibizumab|ranibizumab|mesh-list
2501464|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2501465|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2501466|NCT01223612|Growth Substances|growth substances|mesh-ancestor
2501467|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383470|NCT00643799|Naproxen|naproxen|mesh-list
2383471|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2383472|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2383473|NCT00643799|Analgesics|analgesics|mesh-ancestor
2383474|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
2383475|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383476|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383477|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383478|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2383479|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2383480|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2383481|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383482|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383483|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
2383484|NCT00643825|Temozolomide|temozolomide|mesh-list
2501468|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
2501469|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501470|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2501471|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2501472|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2501473|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
2501474|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501475|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2501476|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2501477|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501478|NCT01223690|Clarithromycin|clarithromycin|mesh-list
2501479|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2501480|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501481|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2501482|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501483|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501484|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2501485|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2501486|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
2501487|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
2501488|NCT01223729|Vitamins|vitamins|mesh-ancestor
2501489|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
2501490|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501491|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
2501492|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
2501493|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
2501494|NCT01223742|Vitamins|vitamins|mesh-ancestor
2501495|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
2501496|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501497|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
2501498|NCT01223755|Sirolimus|sirolimus|mesh-list
2501499|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2501500|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501501|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2501502|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501503|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
2501504|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2501505|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
2501506|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501507|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
2501508|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
2501509|NCT01223768|Vitamins|vitamins|mesh-ancestor
2501510|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
2501511|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501512|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
2501513|NCT01223820|Capsaicin|capsaicin|mesh-list
2501514|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
2501515|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
2501516|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
2501517|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501518|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383485|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2383486|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
2383487|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383488|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383489|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
2383490|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383491|NCT00644020|Fluorouracil|fluorouracil|mesh-list
2383492|NCT00644020|Mitomycins|mitomycins|mesh-list
2383493|NCT00644020|Mitomycin|mitomycin|mesh-list
2383494|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
2383495|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383496|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2383497|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383498|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2383499|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
2383500|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383501|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2501519|NCT01224028|Tacrolimus|tacrolimus|mesh-list
2501520|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2501521|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
2501522|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501523|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2501524|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501525|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501526|NCT01224041|Tacrolimus|tacrolimus|mesh-list
2501527|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2501528|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
2501529|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501530|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2501531|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501532|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501533|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2501534|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
2501535|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2501536|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2383502|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
2383503|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2383504|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383505|NCT00644033|Frovatriptan|frovatriptan|mesh-list
2383506|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2383507|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
2383508|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383509|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383510|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383511|NCT00644085|Aspirin|aspirin|mesh-list
2383512|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2501537|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2501538|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2501539|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501540|NCT01224093|Rituximab|rituximab|mesh-list
2501541|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2501542|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501543|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
2501544|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501545|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2501546|NCT01224197|Simeprevir|simeprevir|mesh-list
2501547|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
2501548|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501549|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
2501550|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501551|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501552|NCT01224262|Vaccines|vaccines|mesh-list
2501553|NCT01224262|Immunologic Factors|immunologic factors|mesh-ancestor
2501554|NCT01224262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501555|NCT01224301|Vaccines|vaccines|mesh-list
2501556|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
2501557|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501558|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
2501559|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2501560|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
2501561|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
2501562|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501563|NCT01224353|Protective Agents|protective agents|mesh-ancestor
2501564|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501565|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
2501566|NCT01224353|Vitamins|vitamins|mesh-ancestor
2501567|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
2501568|NCT01224366|Vildagliptin|vildagliptin|mesh-list
2501569|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2383513|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2383514|NCT00644085|Analgesics|analgesics|mesh-ancestor
2383515|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
2383516|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383517|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383518|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383519|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2501570|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501571|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2501572|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
2501573|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501574|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501575|NCT01224392|Capecitabine|capecitabine|mesh-list
2501576|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2501577|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
2501578|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501579|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501580|NCT01224405|Docetaxel|docetaxel|mesh-list
2501581|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501582|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
2501583|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
2501584|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
2501585|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501586|NCT01224418|Tacrolimus|tacrolimus|mesh-list
2383520|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2383521|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2383522|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383523|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2501587|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2501588|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
2501589|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383524|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2383525|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383526|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
2383527|NCT00644111|Hydromorphone|hydromorphone|mesh-list
2383528|NCT00644111|Bupivacaine|bupivacaine|mesh-list
2383529|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
2383530|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
2383531|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383532|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383533|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
2383534|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383535|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2383536|NCT00644111|Narcotics|narcotics|mesh-ancestor
2383537|NCT00644111|Analgesics|analgesics|mesh-ancestor
2383538|NCT00644124|Aflibercept|aflibercept|mesh-list
2383539|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2383540|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2383541|NCT00644124|Growth Substances|growth substances|mesh-ancestor
2383542|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383543|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
2383544|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383545|NCT00644137|Pregabalin|pregabalin|mesh-list
2501590|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2501591|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501592|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501593|NCT01224457|Phenobarbital|phenobarbital|mesh-list
2501594|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
2501595|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2501596|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2501597|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501598|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2501599|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2501600|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501601|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501602|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
2501603|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
2501604|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2383546|NCT00644137|Analgesics|analgesics|mesh-ancestor
2383547|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
2383548|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383549|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383550|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
2501605|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2501606|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2501607|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
2501608|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2501609|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2501610|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383551|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2383552|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2383553|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383554|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2383555|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2501611|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2501612|NCT01224470|Analgesics|analgesics|mesh-ancestor
2501613|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
2501614|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501615|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2501616|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2501617|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2501618|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
2501619|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383556|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2383557|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383558|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2501620|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501621|NCT01224509|Mifepristone|mifepristone|mesh-list
2501622|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2501623|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
2501624|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2501625|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501626|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2383559|NCT00644176|Azithromycin|azithromycin|mesh-list
2383560|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2501627|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2501628|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2501629|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
2501630|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2501631|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2501632|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
2501633|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2501634|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
2501635|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2501636|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2501637|NCT01224535|Micronutrients|micronutrients|mesh-list
2501638|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501639|NCT01224613|Vaccines|vaccines|mesh-list
2501640|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
2501641|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383561|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383562|NCT00644215|Mitomycins|mitomycins|mesh-list
2383563|NCT00644215|Mitomycin|mitomycin|mesh-list
2383564|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2383565|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383566|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
2383567|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383568|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2383569|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383570|NCT00644293|Azithromycin|azithromycin|mesh-list
2383571|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383572|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383573|NCT00644306|Thalidomide|thalidomide|mesh-list
2383574|NCT00644306|Prednisone|prednisone|mesh-list
2383575|NCT00644306|Melphalan|melphalan|mesh-list
2383576|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383577|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
2383578|NCT00644306|Hormones|hormones|mesh-ancestor
2383579|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2383580|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383581|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2383582|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383583|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2383584|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
2383585|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383586|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2383587|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2383588|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
2383589|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
2383590|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383591|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383592|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2383593|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2383594|NCT00644306|Growth Substances|growth substances|mesh-ancestor
2383595|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
2383596|NCT00644319|Ibuprofen|ibuprofen|mesh-list
2383597|NCT00644319|Morphine|morphine|mesh-list
2383598|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2383599|NCT00644319|Narcotics|narcotics|mesh-ancestor
2383600|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383601|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383602|NCT00644319|Analgesics|analgesics|mesh-ancestor
2383603|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
2383604|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383605|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2383606|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2383607|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383608|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2383609|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2383610|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383611|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383612|NCT00644371|Rituximab|rituximab|mesh-list
2383613|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2383614|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383615|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
2383616|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383617|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2383618|NCT00644384|Acitretin|acitretin|mesh-list
2383619|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
2383620|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
2501642|NCT01224652|Paclitaxel|paclitaxel|mesh-list
2383621|NCT00644449|Azithromycin|azithromycin|mesh-list
2383622|NCT00644449|Levofloxacin|levofloxacin|mesh-list
2383623|NCT00644449|Ofloxacin|ofloxacin|mesh-list
2383624|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383625|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383626|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2383627|NCT00644449|Renal Agents|renal agents|mesh-ancestor
2383628|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2383629|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2383630|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383631|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383632|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383633|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2383634|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2383635|NCT00644475|Candesartan|candesartan|mesh-list
2383636|NCT00644475|Imidapril|imidapril|mesh-list
2383637|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2383638|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2383639|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2501643|NCT01224652|Irinotecan|irinotecan|mesh-list
2501644|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2501645|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501646|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
2501647|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
2501648|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
2383640|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501649|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501650|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2501651|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2501652|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501653|NCT01224717|Teriparatide|teriparatide|mesh-list
2501654|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2501655|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501656|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2501657|NCT01224756|Tinoridine|tinoridine|mesh-list
2501658|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2501659|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2501660|NCT01224756|Analgesics|analgesics|mesh-ancestor
2501661|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
2501662|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501663|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501664|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2501665|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2501666|NCT01224769|Rituximab|rituximab|mesh-list
2501667|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2501668|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2501669|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501670|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
2501671|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501672|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2501673|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2501674|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
2114461|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2114462|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
2114463|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
2114464|NCT02604173|Hormones|hormones|mesh-ancestor
2114465|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2114466|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
2114467|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2114468|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114469|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114470|NCT02604173|Diuretics|diuretics|mesh-ancestor
2114471|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
2114472|NCT02604199|Tenofovir|tenofovir|mesh-list
2114473|NCT02604199|Entecavir|entecavir|mesh-list
2114474|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
2114475|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2114476|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
2114477|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114478|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2114479|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2501675|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501676|NCT01224795|Peramivir|peramivir|mesh-list
2501677|NCT01224795|Antiviral Agents|antiviral agents|mesh-ancestor
2501678|NCT01224795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501679|NCT01224795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501680|NCT01224795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501681|NCT01224847|Lidocaine|lidocaine|mesh-list
2501682|NCT01224847|Cocaine|cocaine|mesh-list
2501683|NCT01224847|Tetracaine|tetracaine|mesh-list
2501684|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
2501685|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
2501686|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2501687|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501688|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
2501689|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501690|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2501691|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2501692|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2501693|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2501694|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501695|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2501696|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2501697|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2501698|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
2501699|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501700|NCT01224860|Losartan|losartan|mesh-list
2501701|NCT01224860|Telmisartan|telmisartan|mesh-list
2501702|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2501703|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2501704|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2501705|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2501706|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501707|NCT01224951|Beclomethasone|beclomethasone|mesh-list
2501708|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2501709|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
2501710|NCT01224951|Hormones|hormones|mesh-ancestor
2501711|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2501712|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501713|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2501714|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
2501715|NCT01224964|Montelukast|montelukast|mesh-list
2501716|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2501717|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
2501718|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2501719|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
2501720|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2501721|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501722|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2501723|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2501724|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501725|NCT01224977|Azithromycin|azithromycin|mesh-list
2501726|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2501727|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501728|NCT01225081|Pioglitazone|pioglitazone|mesh-list
2383641|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2383642|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
2383643|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383644|NCT00644540|Vaccines|vaccines|mesh-list
2383645|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
2383646|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383647|NCT00644553|Amoxicillin|amoxicillin|mesh-list
2383648|NCT00644553|Clarithromycin|clarithromycin|mesh-list
2501729|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
2501730|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2501731|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501732|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2501733|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501734|NCT01225094|Curcumin|curcumin|mesh-list
2501735|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2501736|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2501737|NCT01225094|Analgesics|analgesics|mesh-ancestor
2501738|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
2501739|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501740|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501741|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383649|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
2383650|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2383651|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383652|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383653|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2383654|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383655|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383656|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2383657|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2383658|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2383659|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
2383660|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
2383661|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2383662|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2383663|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383664|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383665|NCT00644605|Urological Agents|urological agents|mesh-ancestor
2383666|NCT00644618|Gemcitabine|gemcitabine|mesh-list
2383667|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2383668|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
2501742|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2501743|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501744|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501745|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501746|NCT01225198|Vitamins|vitamins|mesh-list
2501747|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
2501748|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501749|NCT01225224|Peficitinib|peficitinib|mesh-list
2383669|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383670|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383671|NCT00644618|Antiviral Agents|antiviral agents|mesh-ancestor
2383672|NCT00644618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383673|NCT00644618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383674|NCT00644618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2383675|NCT00644618|Immunologic Factors|immunologic factors|mesh-ancestor
2383676|NCT00644618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501750|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501751|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501752|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2501753|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
2501754|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501755|NCT01225237|Ramosetron|ramosetron|mesh-list
2501756|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
2501757|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
2501758|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501759|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501760|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2501761|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2501762|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
2501763|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501764|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501765|NCT01225302|Paclitaxel|paclitaxel|mesh-list
2501766|NCT01225302|Carboplatin|carboplatin|mesh-list
2501767|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2501768|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501769|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
2501770|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
2383677|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
2501771|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
2501772|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501773|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2501774|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2501775|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2501776|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501777|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501778|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2501779|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2501780|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501781|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
2501782|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501783|NCT01225380|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2501784|NCT01225380|Interferon-alpha|interferon-alpha|mesh-list
2501785|NCT01225380|Ribavirin|ribavirin|mesh-list
2501786|NCT01225380|Antiviral Agents|antiviral agents|mesh-ancestor
2383678|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
2383679|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2383680|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2383681|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383682|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383683|NCT00644631|Urological Agents|urological agents|mesh-ancestor
2383684|NCT00644670|Atorvastatin|atorvastatin|mesh-list
2383685|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2383686|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2383687|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
2383688|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383689|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2383690|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2383691|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383692|NCT00644696|Cefixime|cefixime|mesh-list
2383693|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
2383694|NCT00644696|Irinotecan|irinotecan|mesh-list
2383695|NCT00644696|Bortezomib|bortezomib|mesh-list
2383696|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2383697|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2383698|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383699|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383700|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383701|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383702|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383703|NCT00644709|Atorvastatin|atorvastatin|mesh-list
2383704|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2383705|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2383706|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
2383707|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383708|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2383709|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2383710|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383711|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
2383712|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
2383713|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
2383714|NCT00644735|Esomeprazole|esomeprazole|mesh-list
2383715|NCT00644735|Lansoprazole|lansoprazole|mesh-list
2383716|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
2383717|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2383718|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2383719|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2383720|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383721|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383722|NCT00644748|Gabapentin|gabapentin|mesh-list
2383723|NCT00644748|Analgesics|analgesics|mesh-ancestor
2383724|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
2383725|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383726|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383727|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
2383728|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2383729|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2501787|NCT01225380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501788|NCT01225380|Immunologic Factors|immunologic factors|mesh-ancestor
2501789|NCT01225380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501790|NCT01225380|Antimetabolites|antimetabolites|mesh-ancestor
2501791|NCT01225380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501792|NCT01225393|Adalimumab|adalimumab|mesh-list
2383730|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383731|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383732|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2383733|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2383734|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383735|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383736|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
2383737|NCT00644761|Adefovir|adefovir|mesh-list
2383738|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2383739|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
2383740|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383741|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2383742|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2383743|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383744|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383745|NCT00644774|Azithromycin|azithromycin|mesh-list
2383746|NCT00644774|Cefdinir|cefdinir|mesh-list
2501793|NCT01225393|Methotrexate|methotrexate|mesh-list
2383747|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383748|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383749|NCT00644800|Ziprasidone|ziprasidone|mesh-list
2383750|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2383751|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
2383752|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383753|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383754|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383755|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2383756|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2383757|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383758|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383759|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2383760|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
2383761|NCT00644891|Amoxicillin|amoxicillin|mesh-list
2383762|NCT00644891|Cefdinir|cefdinir|mesh-list
2383763|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383764|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383765|NCT00644904|Vitamin D|vitamin d|mesh-list
2383766|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
2383767|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
2383768|NCT00644904|Vitamins|vitamins|mesh-list
2383769|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
2383770|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383771|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2383772|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2383773|NCT00644943|Amoxicillin|amoxicillin|mesh-list
2383774|NCT00644943|Cefdinir|cefdinir|mesh-list
2383775|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383776|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383777|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
2383778|NCT00644956|Tadalafil|tadalafil|mesh-list
2383779|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
2383780|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2383781|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2501794|NCT01225393|Leflunomide|leflunomide|mesh-list
2501795|NCT01225393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2501796|NCT01225393|Abortifacient Agents|abortifacient agents|mesh-ancestor
2501797|NCT01225393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2501798|NCT01225393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501799|NCT01225393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2501800|NCT01225393|Antimetabolites|antimetabolites|mesh-ancestor
2501801|NCT01225393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383782|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383783|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383784|NCT00644956|Urological Agents|urological agents|mesh-ancestor
2383785|NCT00644982|Sertraline|sertraline|mesh-list
2501802|NCT01225393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501803|NCT01225393|Dermatologic Agents|dermatologic agents|mesh-ancestor
2501804|NCT01225393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501805|NCT01225393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2501806|NCT01225393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2501807|NCT01225393|Immunologic Factors|immunologic factors|mesh-ancestor
2501808|NCT01225393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2383786|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2383787|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
2383788|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383789|NCT00644982|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2383790|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2383791|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2383792|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383793|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383794|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
2383795|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383796|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2383797|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2383798|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
2383799|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
2383800|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2383801|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2383802|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501809|NCT01225393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2501810|NCT01225393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383803|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501811|NCT01225406|Tenofovir|tenofovir|mesh-list
2501812|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
2501813|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501814|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2501815|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2501816|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501817|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501818|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2501819|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2501820|NCT01225419|Plerixafor|plerixafor|mesh-list
2501821|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2501822|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2501823|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
2383804|NCT00645034|Urological Agents|urological agents|mesh-ancestor
2383805|NCT00645060|Antibodies|antibodies|mesh-list
2383806|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2383807|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
2383808|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383809|NCT00645073|Levofloxacin|levofloxacin|mesh-list
2501824|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501825|NCT01225445|Ramipril|ramipril|mesh-list
2501826|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2501827|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
2501828|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501829|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501830|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2501831|NCT01225484|Ropivacaine|ropivacaine|mesh-list
2501832|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
2501833|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
2501834|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2501835|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501836|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
2501837|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501838|NCT01225523|Paclitaxel|paclitaxel|mesh-list
2501839|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2383810|NCT00645073|Ofloxacin|ofloxacin|mesh-list
2383811|NCT00645073|Cefdinir|cefdinir|mesh-list
2383812|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2383813|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383814|NCT00645073|Renal Agents|renal agents|mesh-ancestor
2383815|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2501840|NCT01225523|Cisplatin|cisplatin|mesh-list
2501841|NCT01225523|Fluorouracil|fluorouracil|mesh-list
2501842|NCT01225523|Capecitabine|capecitabine|mesh-list
2501843|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2501844|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501845|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
2501846|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
2501847|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
2501848|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501849|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
2383816|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2383817|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2383818|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383819|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383820|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383821|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2383822|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2383823|NCT00645086|Clarithromycin|clarithromycin|mesh-list
2383824|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383825|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383826|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2383827|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383828|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501850|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2501851|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2501852|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
2501853|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501854|NCT01225640|Oxazolidinones|oxazolidinones|mesh-list
2501855|NCT01225640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501856|NCT01225640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2501857|NCT01225640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501858|NCT01225640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501859|NCT01225653|Latanoprost|latanoprost|mesh-list
2501860|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2501861|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2501862|NCT01225705|Ritonavir|ritonavir|mesh-list
2501863|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2501864|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
2501865|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2501866|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2501867|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
2501868|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501869|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501870|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2501871|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2501872|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
2501873|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501874|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2501875|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2501876|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2383829|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2383830|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2383831|NCT00645112|Azithromycin|azithromycin|mesh-list
2383832|NCT00645112|Cefdinir|cefdinir|mesh-list
2383833|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383834|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383835|NCT00645125|Amoxicillin|amoxicillin|mesh-list
2383836|NCT00645125|Cefdinir|cefdinir|mesh-list
2383837|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383838|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383839|NCT00645138|Anesthetics|anesthetics|mesh-list
2383840|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383841|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383842|NCT00645151|Atorvastatin|atorvastatin|mesh-list
2383843|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2383844|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2383845|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
2383846|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383847|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2383848|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2383849|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383850|NCT00645177|Paclitaxel|paclitaxel|mesh-list
2383851|NCT00645177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2383852|NCT00645177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383853|NCT00645177|Tubulin Modulators|tubulin modulators|mesh-ancestor
2383854|NCT00645177|Antimitotic Agents|antimitotic agents|mesh-ancestor
2383855|NCT00645177|Mitosis Modulators|mitosis modulators|mesh-ancestor
2383856|NCT00645177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383857|NCT00645190|Galantamine|galantamine|mesh-list
2383858|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2383859|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383860|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383861|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
2383862|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383863|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383864|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2383865|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
2383866|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383867|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
2383868|NCT00645203|Cefdinir|cefdinir|mesh-list
2383869|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2383870|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383871|NCT00645229|Ziprasidone|ziprasidone|mesh-list
2383872|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2383873|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
2383874|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383875|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383876|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383877|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2383878|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2383879|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383880|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383881|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2383882|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
2501877|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2501878|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
2501879|NCT01225744|Irinotecan|irinotecan|mesh-list
2501880|NCT01225744|Cetuximab|cetuximab|mesh-list
2501881|NCT01225744|Tegafur|tegafur|mesh-list
2383883|NCT00645242|Fluconazole|fluconazole|mesh-list
2383884|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
2501882|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383885|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383886|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2383887|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2383888|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383889|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383890|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2383891|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
2383892|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2383893|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383894|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2383895|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2383896|NCT00645255|Sibutramine|sibutramine|mesh-list
2383897|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
2383898|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383899|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
2383900|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2383901|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
2383902|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
2383903|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2383904|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2383905|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383906|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383907|NCT00645268|Urological Agents|urological agents|mesh-ancestor
2383908|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2383909|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2383910|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2383911|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
2383912|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383913|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383914|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383915|NCT00645281|Urological Agents|urological agents|mesh-ancestor
2383916|NCT00645294|Adefovir|adefovir|mesh-list
2383917|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2383918|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
2383919|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383920|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2383921|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2383922|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383923|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383924|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2383925|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2383926|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2383927|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383928|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383929|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383930|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2383931|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2383932|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
2383933|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383934|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383935|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2383936|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2383937|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
2383938|NCT00645320|Ziprasidone|ziprasidone|mesh-list
2501883|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2501884|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2501885|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501886|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501887|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2501888|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2501889|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
2501890|NCT01225874|Cytarabine|cytarabine|mesh-list
2501891|NCT01225874|Dexamethasone|dexamethasone|mesh-list
2501892|NCT01225874|Prednisone|prednisone|mesh-list
2501893|NCT01225874|Methotrexate|methotrexate|mesh-list
2501894|NCT01225874|Vincristine|vincristine|mesh-list
2501895|NCT01225874|Daunorubicin|daunorubicin|mesh-list
2501896|NCT01225874|Asparaginase|asparaginase|mesh-list
2501897|NCT01225874|Pegaspargase|pegaspargase|mesh-list
2501898|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2501899|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
2501900|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
2501901|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501902|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383939|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2383940|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
2383941|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383942|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383943|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383944|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2383945|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2383946|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383947|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2501903|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2501904|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
2501905|NCT01225874|Hormones|hormones|mesh-ancestor
2501906|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2501907|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2501908|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501909|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2501910|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
2501911|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2501912|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2501913|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
2501914|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501915|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
2501916|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501917|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2501918|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2501919|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
2501920|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2501921|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2501922|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
2501923|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501924|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2501925|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
2501926|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
2501927|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
2501928|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2501929|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2501930|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2501931|NCT01225913|Fluticasone|fluticasone|mesh-list
2501932|NCT01225913|Xhance|xhance|mesh-list
2501933|NCT01225913|Budesonide|budesonide|mesh-list
2501934|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
2501935|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2501936|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2501937|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2501938|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2383948|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2383949|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
2383950|NCT00645372|Risperidone|risperidone|mesh-list
2383951|NCT00645372|Ziprasidone|ziprasidone|mesh-list
2383952|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2383953|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
2383954|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2383955|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383956|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383957|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2383958|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2383959|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383960|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383961|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2383962|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
2383963|NCT00645398|Pregabalin|pregabalin|mesh-list
2383964|NCT00645398|Analgesics|analgesics|mesh-ancestor
2383965|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
2501939|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2501940|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
2501941|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501942|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501943|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2501944|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
2501945|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
2501946|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2501947|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
2383966|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2383967|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2383968|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
2501948|NCT01225913|Hormones|hormones|mesh-ancestor
2501949|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2501950|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2501951|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2501952|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2501953|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
2501954|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2501955|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501956|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
2501957|NCT01226017|Oxytocin|oxytocin|mesh-list
2501958|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
2501959|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2501960|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501961|NCT01226056|Everolimus|everolimus|mesh-list
2501962|NCT01226056|Sorafenib|sorafenib|mesh-list
2501963|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2501964|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2501965|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
2501966|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501967|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2501968|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2501969|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501970|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
2501971|NCT01226069|Glycerol|glycerol|mesh-list
2501972|NCT01226069|Analgesics|analgesics|mesh-ancestor
2501973|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
2501974|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501975|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501976|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
2501977|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2501978|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2501979|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
2501980|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2501981|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2383969|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2383970|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2383971|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383972|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2383973|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2501982|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2501983|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2501984|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
2501985|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2501986|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2501987|NCT01226069|Protective Agents|protective agents|mesh-ancestor
2501988|NCT01226186|Morphine|morphine|mesh-list
2501989|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2501990|NCT01226186|Narcotics|narcotics|mesh-ancestor
2501991|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2501992|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2501993|NCT01226186|Analgesics|analgesics|mesh-ancestor
2501994|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
2501995|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2501996|NCT01226212|Sulfalene|sulfalene|mesh-list
2501997|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2501998|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2383974|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2383975|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2383976|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2383977|NCT00645424|Atorvastatin|atorvastatin|mesh-list
2383978|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2383979|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2383980|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
2383981|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383982|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2383983|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2383984|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383985|NCT00645437|Levofloxacin|levofloxacin|mesh-list
2383986|NCT00645437|Ofloxacin|ofloxacin|mesh-list
2383987|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2383988|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2383989|NCT00645437|Renal Agents|renal agents|mesh-ancestor
2501999|NCT01226212|Renal Agents|renal agents|mesh-ancestor
2502000|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
2502001|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2383990|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2502002|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2502003|NCT01226303|Tretinoin|tretinoin|mesh-list
2502004|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502005|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
2502006|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
2383991|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2383992|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2383993|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2383994|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2383995|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2383996|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2383997|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2383998|NCT00645502|Risperidone|risperidone|mesh-list
2383999|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2384000|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
2384001|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384002|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384003|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384004|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2384005|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2384006|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384007|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2384008|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2384009|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
2384010|NCT00645515|Risperidone|risperidone|mesh-list
2502007|NCT01226355|Sirolimus|sirolimus|mesh-list
2502008|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2502009|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502010|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2502011|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384011|NCT00645515|Ziprasidone|ziprasidone|mesh-list
2384012|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2384013|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
2384014|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384015|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384016|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384017|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2384018|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2384019|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384020|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2384021|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2384022|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
2384023|NCT00645554|Galantamine|galantamine|mesh-list
2502012|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
2502013|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2502014|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
2502015|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502016|NCT01226446|Vitamin D|vitamin d|mesh-list
2502017|NCT01226446|Vitamins|vitamins|mesh-ancestor
2502018|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
2502019|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502020|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2502021|NCT01226563|Calcium|calcium|mesh-list
2502022|NCT01226563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2502023|NCT01226563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502024|NCT01226602|Ticagrelor|ticagrelor|mesh-list
2502025|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2502026|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2502027|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2502028|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2502029|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
2502030|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502031|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502032|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502033|NCT01226667|Pregabalin|pregabalin|mesh-list
2502034|NCT01226667|Analgesics|analgesics|mesh-ancestor
2502035|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
2502036|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502037|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502038|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
2384024|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2384025|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384026|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502039|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2384027|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
2384028|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384029|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384030|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2384031|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
2502040|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2502041|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502042|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2502043|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2502044|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2384032|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384033|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
2384034|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
2384035|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2384036|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2384037|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384038|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384039|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2384040|NCT00645580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2384041|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2384042|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2384043|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384044|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384045|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
2384046|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2384047|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
2384048|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2384049|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2384050|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384051|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2384052|NCT00645606|Rituximab|rituximab|mesh-list
2384053|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2384054|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384055|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
2384056|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384057|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384058|NCT00645632|Doxorubicin|doxorubicin|mesh-list
2384059|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2384060|NCT00645632|Methotrexate|methotrexate|mesh-list
2384061|NCT00645632|Ifosfamide|ifosfamide|mesh-list
2384062|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384063|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2384064|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2384065|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2384066|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384067|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384068|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2384069|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
2384070|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2384071|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384072|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2384073|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
2384074|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
2384075|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2384076|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2502045|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2502046|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2502047|NCT01226680|Tofacitinib|tofacitinib|mesh-list
2502048|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2502049|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502050|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502051|NCT01226771|Ribavirin|ribavirin|mesh-list
2502052|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
2502053|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502054|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
2502055|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502056|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2384077|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
2384078|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384079|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2384080|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2384081|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
2384082|NCT00645658|Testosterone|testosterone|mesh-list
2384083|NCT00645658|Androgens|androgens|mesh-ancestor
2384084|NCT00645658|Hormones|hormones|mesh-ancestor
2384085|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384086|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384087|NCT00645723|Colistin|colistin|mesh-list
2384088|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2384089|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2384090|NCT00645801|Lubiprostone|lubiprostone|mesh-list
2502057|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2502058|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2502059|NCT01226849|Rituximab|rituximab|mesh-list
2502060|NCT01226849|Carboplatin|carboplatin|mesh-list
2502061|NCT01226849|Etoposide|etoposide|mesh-list
2502062|NCT01226849|Bortezomib|bortezomib|mesh-list
2502063|NCT01226849|Ifosfamide|ifosfamide|mesh-list
2502064|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2502065|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502066|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
2502067|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502068|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502069|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2502070|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2502071|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2502072|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502073|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384091|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2384092|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2384093|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384094|NCT00645814|Adalimumab|adalimumab|mesh-list
2384095|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384096|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384097|NCT00645866|Docetaxel|docetaxel|mesh-list
2502074|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2502075|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
2502076|NCT01226901|Niraparib|niraparib|mesh-list
2502077|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2502078|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502079|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502080|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502081|NCT01226966|Liraglutide|liraglutide|mesh-list
2502082|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2502083|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502084|NCT01226966|Incretins|incretins|mesh-ancestor
2502085|NCT01226966|Hormones|hormones|mesh-ancestor
2502086|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2502087|NCT01226992|Vancomycin|vancomycin|mesh-list
2502088|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2502089|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502090|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
2502091|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
2502092|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502093|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2502094|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502095|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502096|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
2502097|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2502098|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2502099|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502100|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502101|NCT01227148|Insulin|insulin|mesh-list
2502102|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2502103|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502104|NCT01227174|Propofol|propofol|mesh-list
2502105|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2502106|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2502107|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502108|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2502109|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
2502110|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
2502111|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
2384098|NCT00645866|Capecitabine|capecitabine|mesh-list
2384099|NCT00645866|Epirubicin|epirubicin|mesh-list
2384100|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384101|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
2384102|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
2384103|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
2502112|NCT01227187|Protein C|protein c|mesh-list
2502113|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502114|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
2502115|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2502116|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2502117|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502118|NCT01227200|Tramadol|tramadol|mesh-list
2502119|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2502120|NCT01227200|Narcotics|narcotics|mesh-ancestor
2502121|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2502122|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502123|NCT01227200|Analgesics|analgesics|mesh-ancestor
2502124|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
2502125|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502126|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
2502127|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2502128|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2502129|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
2502130|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502131|NCT01227356|Interferons|interferons|mesh-list
2502132|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
2502133|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502134|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
2502135|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502136|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2502137|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502138|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502139|NCT01227408|Paclitaxel|paclitaxel|mesh-list
2502140|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
2502141|NCT01227408|Doxorubicin|doxorubicin|mesh-list
2502142|NCT01227408|Capecitabine|capecitabine|mesh-list
2502143|NCT01227408|Methotrexate|methotrexate|mesh-list
2502144|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2502145|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2502146|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502147|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
2502148|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
2502149|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
2502150|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502151|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2502152|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
2502153|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502154|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502155|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2502156|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
2502157|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2502158|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2384104|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384105|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2384106|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
2384107|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2384108|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2502159|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2502160|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2502161|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502162|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2502163|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
2502164|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2502165|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
2502166|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2502167|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
2384109|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2384110|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384111|NCT00645879|Citric Acid|citric acid|mesh-list
2384112|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
2502168|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2502169|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2502170|NCT01227460|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2502171|NCT01227460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2502172|NCT01227460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502173|NCT01227460|Incretins|incretins|mesh-ancestor
2502174|NCT01227460|Hormones|hormones|mesh-ancestor
2502175|NCT01227460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2502176|NCT01227460|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2502177|NCT01227460|Protease Inhibitors|protease inhibitors|mesh-ancestor
2502178|NCT01227460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502179|NCT01227460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502180|NCT01227590|Ritonavir|ritonavir|mesh-list
2502181|NCT01227590|Lopinavir|lopinavir|mesh-list
2502182|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2502183|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2502184|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
2502185|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502186|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502187|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2502188|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2502189|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
2502190|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502191|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2502192|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2502193|NCT01227603|Candesartan|candesartan|mesh-list
2384113|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
2384114|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2384115|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
2384116|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
2502194|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
2502195|NCT01227603|Nifedipine|nifedipine|mesh-list
2502196|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2502197|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2502198|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2502199|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502200|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2502201|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2502202|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2502203|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502204|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
2502205|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
2384117|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384118|NCT00645892|Adalimumab|adalimumab|mesh-list
2384119|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384120|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384121|NCT00645905|Adalimumab|adalimumab|mesh-list
2384122|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384123|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384124|NCT00645918|Clopidogrel|clopidogrel|mesh-list
2384125|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2384126|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2384127|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2384128|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2384129|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
2384130|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384131|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384132|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384133|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2384134|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384135|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384136|NCT00646009|Fluticasone|fluticasone|mesh-list
2384137|NCT00646009|Budesonide|budesonide|mesh-list
2384138|NCT00646009|Albuterol|albuterol|mesh-list
2384139|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
2384140|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2384141|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2384142|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384143|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2502206|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2502207|NCT01227720|Nicotine|nicotine|mesh-list
2502208|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2502209|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
2502210|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502211|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502212|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2502213|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2502214|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
2502215|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502216|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502217|NCT01227759|Tyrothricin|tyrothricin|mesh-list
2502218|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2502219|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502220|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2502221|NCT01227798|Interferons|interferons|mesh-list
2384144|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
2384145|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384146|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384147|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2384148|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
2502222|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
2502223|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502224|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
2502225|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502226|NCT01227811|Darifenacin|darifenacin|mesh-list
2502227|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
2502228|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
2502229|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2502230|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502231|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502232|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502233|NCT01227811|Urological Agents|urological agents|mesh-ancestor
2384149|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
2384150|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2384151|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
2384152|NCT00646009|Hormones|hormones|mesh-ancestor
2384153|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384154|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2384155|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2384156|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2502234|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
2502235|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2502236|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502237|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2502238|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
2502239|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2502240|NCT01227876|Prednisolone|prednisolone|mesh-list
2502241|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
2502242|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2502243|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
2502244|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2502245|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
2502246|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
2502247|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502248|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502249|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2502250|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
2502251|NCT01227876|Hormones|hormones|mesh-ancestor
2502252|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2502253|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2502254|NCT01227876|Protective Agents|protective agents|mesh-ancestor
2502255|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2502256|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502257|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
2502258|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2502259|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2502260|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502261|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
2502262|NCT01227915|Hormones|hormones|mesh-ancestor
2502263|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2502264|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502265|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2502266|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2502267|NCT01227941|Doxorubicin|doxorubicin|mesh-list
2502268|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2502269|NCT01227941|Niraparib|niraparib|mesh-list
2502270|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2502271|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502272|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2502273|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2502274|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384157|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
2384158|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384159|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384160|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
2384161|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2384162|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
2384163|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
2384164|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2502275|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384165|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384166|NCT00646035|Vitamins|vitamins|mesh-ancestor
2384167|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
2384168|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2384169|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2384170|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
2384171|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
2384172|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384173|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384174|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2502276|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2502277|NCT01228045|Trastuzumab|trastuzumab|mesh-list
2502278|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502279|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2502280|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
2502281|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2502282|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
2502283|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2502284|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2502285|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502286|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
2502287|NCT01228136|Coagulants|coagulants|mesh-ancestor
2502288|NCT01228214|Aspirin|aspirin|mesh-list
2502289|NCT01228214|Amiloride|amiloride|mesh-list
2502290|NCT01228214|Clopidogrel|clopidogrel|mesh-list
2502291|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2502292|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2502293|NCT01228214|Analgesics|analgesics|mesh-ancestor
2502294|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
2502295|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502296|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502297|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2502298|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502299|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2502300|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2502301|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502302|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2502303|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2502304|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502305|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
2502306|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2502307|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2502308|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2502309|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
2502310|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502311|NCT01228214|Diuretics|diuretics|mesh-ancestor
2502312|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
2502313|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2502314|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2502315|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2502316|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2502317|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2502318|NCT01228227|Atorvastatin|atorvastatin|mesh-list
2502319|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2502320|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2502321|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2502322|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
2502323|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502324|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2502325|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2502326|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502327|NCT01228240|Metformin|metformin|mesh-list
2502328|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2502329|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502330|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2502331|NCT01228279|Icodextrin|icodextrin|mesh-list
2502332|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
2502333|NCT01228292|Heparin|heparin|mesh-list
2502334|NCT01228292|Calcium heparin|calcium heparin|mesh-list
2502335|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
2502336|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2502337|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2502338|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384175|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2502339|NCT01228305|Acetaminophen|acetaminophen|mesh-list
2502340|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2502341|NCT01228305|Analgesics|analgesics|mesh-ancestor
2502342|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
2502343|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502344|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502345|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
2502346|NCT01228331|Cytarabine|cytarabine|mesh-list
2502347|NCT01228331|Dexamethasone|dexamethasone|mesh-list
2502348|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
2502349|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
2502350|NCT01228331|Doxorubicin|doxorubicin|mesh-list
2502351|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2502352|NCT01228331|Methotrexate|methotrexate|mesh-list
2502353|NCT01228331|Etoposide|etoposide|mesh-list
2502354|NCT01228331|Vincristine|vincristine|mesh-list
2502355|NCT01228331|Daunorubicin|daunorubicin|mesh-list
2502356|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
2502357|NCT01228331|Clofarabine|clofarabine|mesh-list
2502358|NCT01228331|Thioguanine|thioguanine|mesh-list
2502359|NCT01228331|Pegaspargase|pegaspargase|mesh-list
2502360|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
2502361|NCT01228331|Amsacrine|amsacrine|mesh-list
2502362|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2502363|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
2502364|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502365|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502366|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2502367|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
2502368|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502369|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502370|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2502371|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2502372|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
2502373|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
2384176|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
2384177|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384178|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384179|NCT00646087|Ketamine|ketamine|mesh-list
2384180|NCT00646087|Analgesics|analgesics|mesh-ancestor
2384181|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
2384182|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384183|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384184|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2384185|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2384186|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
2384187|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
2384188|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384189|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2384190|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2384191|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384192|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384193|NCT00646126|Artesunate|artesunate|mesh-list
2384194|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
2384195|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
2384196|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
2384197|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2384198|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2384199|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2384200|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384201|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
2502374|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502375|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2502376|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
2502377|NCT01228331|Hormones|hormones|mesh-ancestor
2502378|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2502379|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2502380|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2502381|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2502382|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2502383|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502384|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2502385|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
2502386|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2502387|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2384202|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
2502388|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
2502389|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
2502390|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2502391|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2502392|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2502393|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
2502394|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502395|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
2502396|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
2502397|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
2502398|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2502399|NCT01228331|Protective Agents|protective agents|mesh-ancestor
2502400|NCT01228344|Lumefantrine|lumefantrine|mesh-list
2384203|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2384204|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
2384205|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2384206|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502401|NCT01228344|Artemether|artemether|mesh-list
2502402|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2502403|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
2502404|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2502405|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2502406|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502407|NCT01228357|Milnacipran|milnacipran|mesh-list
2502408|NCT01228357|Mirtazapine|mirtazapine|mesh-list
2502409|NCT01228357|Sertraline|sertraline|mesh-list
2502410|NCT01228357|Fluoxetine|fluoxetine|mesh-list
2502411|NCT01228357|Paroxetine|paroxetine|mesh-list
2502412|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2502413|NCT01228357|Nortriptyline|nortriptyline|mesh-list
2502414|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
2502415|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2502416|NCT01228357|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2502417|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2502418|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2502419|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502420|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502421|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
2502422|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502423|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2502424|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2502425|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2502426|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502427|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2502428|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2502429|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
2384207|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384208|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2384209|NCT00646126|Renal Agents|renal agents|mesh-ancestor
2502430|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
2502431|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2502432|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2502433|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2502434|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2502435|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2502436|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2502437|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
2502438|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2502439|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2502440|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2502441|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2502442|NCT01228357|Analgesics|analgesics|mesh-ancestor
2502443|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
2502444|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502445|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2502446|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2502447|NCT01228370|Silodosin|silodosin|mesh-list
2502448|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2502449|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2502450|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2502451|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
2502452|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502453|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502454|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384210|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
2384211|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502455|NCT01228370|Urological Agents|urological agents|mesh-ancestor
2502456|NCT01228383|Vaccines|vaccines|mesh-list
2502457|NCT01228383|Antibodies|antibodies|mesh-list
2502458|NCT01228383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2502459|NCT01228383|Immunoglobulins|immunoglobulins|mesh-list
2502460|NCT01228383|gamma-Globulins|gamma-globulins|mesh-list
2384212|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384213|NCT00646152|Poly ICLC|poly iclc|mesh-list
2384214|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
2384215|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
2384216|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502461|NCT01228383|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2502462|NCT01228383|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2502463|NCT01228383|Immunologic Factors|immunologic factors|mesh-ancestor
2502464|NCT01228383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502465|NCT01228409|Acitretin|acitretin|mesh-list
2502466|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
2502467|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
2502468|NCT01228422|Interferons|interferons|mesh-list
2502469|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
2502470|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
2502471|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502472|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
2502473|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502474|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
2502475|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384217|NCT00646178|Adalimumab|adalimumab|mesh-list
2384218|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384219|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384220|NCT00646191|Adalimumab|adalimumab|mesh-list
2384221|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2502476|NCT01228552|Ketoprofen|ketoprofen|mesh-list
2502477|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2502478|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2502479|NCT01228552|Analgesics|analgesics|mesh-ancestor
2502480|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
2502481|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502482|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502483|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2502484|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502485|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2502486|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502487|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502488|NCT01228565|Cetuximab|cetuximab|mesh-list
2502489|NCT01228565|OTD70DERM|otd70derm|mesh-list
2502490|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2502491|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502492|NCT01228565|Protective Agents|protective agents|mesh-ancestor
2502493|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502494|NCT01228604|Methylphenidate|methylphenidate|mesh-list
2502495|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2502496|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502497|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2384222|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384223|NCT00646204|Memantine|memantine|mesh-list
2384224|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2384225|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2384226|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
2384227|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384228|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384229|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384230|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2384231|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2384232|NCT00646230|Fenretinide|fenretinide|mesh-list
2502498|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2502499|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2502500|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502501|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
2502502|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502503|NCT01228617|Nicotine|nicotine|mesh-list
2502504|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2502505|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
2502506|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502507|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384233|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502508|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2502509|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2502510|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
2502511|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502512|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502513|NCT01228630|Loratadine|loratadine|mesh-list
2502514|NCT01228630|Fexofenadine|fexofenadine|mesh-list
2502515|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
2502516|NCT01228630|Ephedrine|ephedrine|mesh-list
2502517|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2502518|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
2502519|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502520|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502521|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2502522|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
2502523|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
2502524|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2502525|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2502526|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
2502527|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
2502528|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502529|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502530|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
2502531|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
2502532|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2384234|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2384235|NCT00646230|Protective Agents|protective agents|mesh-ancestor
2384236|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384237|NCT00646321|Budesonide|budesonide|mesh-list
2384238|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
2384239|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2384240|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384241|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2384242|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
2384243|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384244|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384245|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2384246|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
2384247|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
2384248|NCT00646321|Hormones|hormones|mesh-ancestor
2384249|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384250|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2384251|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2384252|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2384253|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
2384254|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384255|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384256|NCT00646386|Adalimumab|adalimumab|mesh-list
2384257|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384258|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384259|NCT00646425|Basiliximab|basiliximab|mesh-list
2384260|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2384261|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
2384262|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384263|NCT00646503|Telbivudine|telbivudine|mesh-list
2384264|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
2384265|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2384266|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2384267|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384268|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384269|NCT00646516|Budesonide|budesonide|mesh-list
2384270|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
2384271|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2384272|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384273|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2384274|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
2384275|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384276|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384277|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2384278|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
2384279|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
2384280|NCT00646516|Hormones|hormones|mesh-ancestor
2384281|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384282|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2384283|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2384284|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2502533|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2502534|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2502535|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
2502536|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
2502537|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
2502538|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
2502539|NCT01228656|Salicylates|salicylates|mesh-list
2502540|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2502541|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
2502542|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2502543|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502544|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
2502545|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
2502546|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2502547|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2502548|NCT01228656|Analgesics|analgesics|mesh-ancestor
2502549|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
2502550|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384285|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
2384286|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384287|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384288|NCT00646529|Budesonide|budesonide|mesh-list
2384289|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
2384290|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2384291|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384292|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2384293|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
2384294|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502551|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502552|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502553|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2502554|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502555|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502556|NCT01228682|Tolvaptan|tolvaptan|mesh-list
2502557|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2502558|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502559|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
2502560|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502561|NCT01228994|Baclofen|baclofen|mesh-list
2502562|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2502563|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502564|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2502565|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502566|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2502567|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
2502568|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
2502569|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502570|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502571|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
2502572|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
2502573|NCT01229046|Ticarcillin|ticarcillin|mesh-list
2502574|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
2502575|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2502576|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502577|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502578|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502579|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2502580|NCT01229072|Heparin|heparin|mesh-list
2502581|NCT01229072|Calcium heparin|calcium heparin|mesh-list
2502582|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
2502583|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2502584|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2384295|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384296|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2384297|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
2384298|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
2384299|NCT00646529|Hormones|hormones|mesh-ancestor
2384300|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384301|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2384302|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2384303|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2384304|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
2384305|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384306|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502585|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502586|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
2502587|NCT01229085|Salicylates|salicylates|mesh-list
2502588|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502589|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
2502590|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
2502591|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
2502592|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2502593|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2502594|NCT01229085|Analgesics|analgesics|mesh-ancestor
2502595|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
2502596|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502597|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502598|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2502599|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502600|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2502601|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502602|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384307|NCT00646542|Vildagliptin|vildagliptin|mesh-list
2384308|NCT00646542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2384309|NCT00646542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384310|NCT00646542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2384311|NCT00646542|Protease Inhibitors|protease inhibitors|mesh-ancestor
2384312|NCT00646542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384313|NCT00646542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384314|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2384315|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2384316|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384317|NCT00646594|Fluticasone|fluticasone|mesh-list
2384318|NCT00646594|Budesonide|budesonide|mesh-list
2384319|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
2384320|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2384321|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2384322|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2384323|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384324|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2384325|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
2384326|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384327|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384328|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2384329|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
2502603|NCT01229189|Vitamin D|vitamin d|mesh-list
2502604|NCT01229189|Vitamins|vitamins|mesh-ancestor
2502605|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
2502606|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502607|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2502608|NCT01229202|Bevacizumab|bevacizumab|mesh-list
2502609|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2502610|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502611|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2384330|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
2384331|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2384332|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
2384333|NCT00646594|Hormones|hormones|mesh-ancestor
2384334|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384335|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2384336|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2384337|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2384338|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
2384339|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384340|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384341|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
2384342|NCT00646607|Leucovorin|leucovorin|mesh-list
2384343|NCT00646607|Fluorouracil|fluorouracil|mesh-list
2384344|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
2384345|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
2384346|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
2384347|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384348|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2384349|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384350|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2384351|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
2502612|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2502613|NCT01229202|Growth Substances|growth substances|mesh-ancestor
2502614|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502615|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
2502616|NCT01229241|Anesthetics|anesthetics|mesh-list
2502617|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
2502618|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2502619|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384352|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384353|NCT00646607|Antidotes|antidotes|mesh-ancestor
2384354|NCT00646607|Protective Agents|protective agents|mesh-ancestor
2384355|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
2384356|NCT00646607|Vitamins|vitamins|mesh-ancestor
2384357|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
2384358|NCT00646620|Fluticasone|fluticasone|mesh-list
2384359|NCT00646620|Budesonide|budesonide|mesh-list
2384360|NCT00646620|Albuterol|albuterol|mesh-list
2384361|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
2384362|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2384363|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2384364|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2384365|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384366|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2384367|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
2384368|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384369|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384370|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2384371|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
2384372|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
2384373|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2384374|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
2384375|NCT00646620|Hormones|hormones|mesh-ancestor
2384376|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384377|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2384378|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2384379|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2502620|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
2502621|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502622|NCT01229280|Darifenacin|darifenacin|mesh-list
2502623|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
2502624|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
2502625|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2502626|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502627|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502628|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502629|NCT01229280|Urological Agents|urological agents|mesh-ancestor
2502630|NCT01229319|Imiquimod|imiquimod|mesh-list
2502631|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2502632|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
2502633|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502634|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502635|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
2502636|NCT01229332|Carbidopa|carbidopa|mesh-list
2502637|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2502638|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2502639|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
2502640|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502641|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502642|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502643|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2502644|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502645|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
2502646|NCT01229579|Astringents|astringents|mesh-ancestor
2502647|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502648|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
2502649|NCT01229592|Ethanol|ethanol|mesh-list
2502650|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2502651|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502652|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2502653|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502654|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
2502655|NCT01229605|Docetaxel|docetaxel|mesh-list
2502656|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2502657|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
2502658|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502659|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502660|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2502661|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
2384380|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
2384381|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384382|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384383|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
2384384|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2384385|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
2384386|NCT00646659|Carboplatin|carboplatin|mesh-list
2502662|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502663|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502664|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2384387|NCT00646659|Docetaxel|docetaxel|mesh-list
2384388|NCT00646659|Fluorouracil|fluorouracil|mesh-list
2384389|NCT00646659|Cetuximab|cetuximab|mesh-list
2384390|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384391|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
2384392|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
2384393|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
2384394|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384395|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
2384396|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2384397|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2384398|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
2384399|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384400|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2384401|NCT00646711|Valproic Acid|valproic acid|mesh-list
2384402|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
2502665|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
2502666|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
2502667|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
2502668|NCT01229644|Crenolanib|crenolanib|mesh-list
2502669|NCT01229644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502670|NCT01229761|Trimethoprim|trimethoprim|mesh-list
2502671|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2502672|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
2502673|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2502674|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502675|NCT01229761|Renal Agents|renal agents|mesh-ancestor
2502676|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
2502677|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2502678|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2502679|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2502680|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502681|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502682|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2502683|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2502684|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2502685|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2502686|NCT01229774|Diclofenac|diclofenac|mesh-list
2502687|NCT01229774|Etoricoxib|etoricoxib|mesh-list
2502688|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2502689|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2502690|NCT01229774|Analgesics|analgesics|mesh-ancestor
2384403|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384404|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384405|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
2384406|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384407|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384408|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
2384409|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2502691|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
2502692|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502693|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384410|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384411|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2384412|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
2384413|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2384414|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384415|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2384416|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
2384417|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2384418|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2384419|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384420|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502694|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384421|NCT00646750|Rituximab|rituximab|mesh-list
2502695|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502696|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2502697|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502698|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502699|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2502700|NCT01229813|Bevacizumab|bevacizumab|mesh-list
2502701|NCT01229813|Capecitabine|capecitabine|mesh-list
2502702|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2502703|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2502704|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502705|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2502706|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2502707|NCT01229813|Growth Substances|growth substances|mesh-ancestor
2502708|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384422|NCT00646750|Melphalan|melphalan|mesh-list
2384423|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2384424|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384425|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
2384426|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384427|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384428|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2502709|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
2502710|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2502711|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
2502712|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502713|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2502714|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502715|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
2502716|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
2502717|NCT01229878|Vitamin D|vitamin d|mesh-list
2502718|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
2502719|NCT01229878|Vitamins|vitamins|mesh-ancestor
2502720|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
2502721|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502722|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2502723|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2384429|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
2384430|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384431|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2384432|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2384433|NCT00646802|Progesterone|progesterone|mesh-list
2384434|NCT00646802|Progestins|progestins|mesh-ancestor
2384435|NCT00646802|Hormones|hormones|mesh-ancestor
2384436|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384437|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384438|NCT00646815|Hormones|hormones|mesh-list
2502724|NCT01229930|Paclitaxel|paclitaxel|mesh-list
2502725|NCT01229930|Carboplatin|carboplatin|mesh-list
2502726|NCT01229930|Cediranib|cediranib|mesh-list
2502727|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2502728|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502729|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
2502730|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
2502731|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
2502732|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502733|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502734|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2502735|NCT01229982|Latanoprost|latanoprost|mesh-list
2502736|NCT01229982|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2502737|NCT01229982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2384439|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384440|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384441|NCT00646841|Doxazosin|doxazosin|mesh-list
2384442|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2384443|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2384444|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2384445|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2384446|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
2384447|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502738|NCT01230034|Ramipril|ramipril|mesh-list
2502739|NCT01230034|Imidapril|imidapril|mesh-list
2502740|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2502741|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
2502742|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502743|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502744|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2384448|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384449|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384450|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
2384451|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
2384452|NCT00646854|Doxorubicin|doxorubicin|mesh-list
2384453|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2384454|NCT00646854|Vincristine|vincristine|mesh-list
2384455|NCT00646854|Lenograstim|lenograstim|mesh-list
2384456|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2384457|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
2384458|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384459|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384460|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2384461|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
2384462|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384463|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384464|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2384465|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2384466|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2384467|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2384468|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2384469|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2384470|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384471|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2384472|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
2384473|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
2384474|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
2384475|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2384476|NCT00646880|Propiverine|propiverine|mesh-list
2384477|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2384478|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2384479|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
2384480|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384481|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384482|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384483|NCT00646880|Urological Agents|urological agents|mesh-ancestor
2384484|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
2384485|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
2384486|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384487|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
2384488|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2384489|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384490|NCT00646932|Vitamins|vitamins|mesh-ancestor
2384491|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
2384492|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2384493|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
2384494|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2114480|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114481|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114482|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2114483|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2114484|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
2114485|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2114486|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114487|NCT02604212|Tenofovir|tenofovir|mesh-list
2114488|NCT02604212|Entecavir|entecavir|mesh-list
2114489|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
2502753|NCT01230359|Pyridoxine|pyridoxine|mesh-list
2502754|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
2502755|NCT01230359|Vitamins|vitamins|mesh-ancestor
2502756|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
2502757|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502758|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
2384495|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
2384496|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
2384497|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2502759|NCT01230411|Ibuprofen|ibuprofen|mesh-list
2384498|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384499|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2384500|NCT00646945|Analgesics|analgesics|mesh-ancestor
2384501|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
2384502|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384503|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2384504|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
2384505|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2384506|NCT00647023|Metformin|metformin|mesh-list
2384507|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2384508|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384509|NCT00647049|Cytarabine|cytarabine|mesh-list
2384510|NCT00647049|Rituximab|rituximab|mesh-list
2384511|NCT00647049|Methotrexate|methotrexate|mesh-list
2384512|NCT00647049|Thiotepa|thiotepa|mesh-list
2384513|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2384514|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384515|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
2384516|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384517|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384518|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2384519|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
2384520|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2384521|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2384522|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
2384523|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502760|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2502761|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2502762|NCT01230411|Analgesics|analgesics|mesh-ancestor
2502763|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
2502764|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502765|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384524|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
2384525|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384526|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2384527|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2384528|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2384529|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
2384530|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2384531|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2384532|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
2384533|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2384534|NCT00647101|Latanoprost|latanoprost|mesh-list
2384535|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2384536|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2384537|NCT00647127|Fentanyl|fentanyl|mesh-list
2384538|NCT00647127|Buprenorphine|buprenorphine|mesh-list
2384539|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2502766|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2502767|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502768|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2502769|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502770|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502771|NCT01230463|Ketorolac|ketorolac|mesh-list
2502772|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2502773|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2502774|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2502775|NCT01230463|Analgesics|analgesics|mesh-ancestor
2502776|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
2502777|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502778|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502779|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2502780|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502781|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2502782|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502783|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502784|NCT01230476|Cetuximab|cetuximab|mesh-list
2502785|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2502786|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502787|NCT01230541|Udenafil|udenafil|mesh-list
2502788|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2502789|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2502790|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502791|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384540|NCT00647127|Narcotics|narcotics|mesh-ancestor
2502792|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2502793|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2502794|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
2502795|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
2502796|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502797|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502798|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502799|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2502800|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2502801|NCT01230697|Sorafenib|sorafenib|mesh-list
2384541|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384542|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384543|NCT00647127|Analgesics|analgesics|mesh-ancestor
2384544|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
2384545|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384546|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2384547|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2384548|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
2384549|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
2384550|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2384551|NCT00647140|Levodopa|levodopa|mesh-list
2384552|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
2384553|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384554|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384555|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384556|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2384557|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2422915|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422916|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
2422917|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422918|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422919|NCT00819546|Everolimus|everolimus|mesh-list
2502802|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502803|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2502804|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502805|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502806|NCT01230723|Everolimus|everolimus|mesh-list
2502807|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422920|NCT00819546|Midostaurin|midostaurin|mesh-list
2422921|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422922|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2422923|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
2422924|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422925|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2422926|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422927|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422928|NCT00819572|Antibodies|antibodies|mesh-list
2422929|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
2502808|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2502809|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
2502810|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502811|NCT01230736|Timolol|timolol|mesh-list
2502812|NCT01230736|Travoprost|travoprost|mesh-list
2502813|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2502814|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2502815|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2502816|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2502817|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
2502818|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502819|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502820|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502821|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2502822|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2502823|NCT01230775|Anagrelide|anagrelide|mesh-list
2502824|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2502825|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2502826|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502827|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2502828|NCT01230957|Vaccines|vaccines|mesh-list
2502829|NCT01230957|Immunologic Factors|immunologic factors|mesh-ancestor
2502830|NCT01230957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502831|NCT01230983|Leucovorin|leucovorin|mesh-list
2502832|NCT01230983|Cytarabine|cytarabine|mesh-list
2502833|NCT01230983|Prednisone|prednisone|mesh-list
2502834|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
2502835|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2384558|NCT00647166|Azathioprine|azathioprine|mesh-list
2384559|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
2384560|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384561|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2384562|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384563|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2384564|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
2384565|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384566|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384567|NCT00647192|Eplerenone|eplerenone|mesh-list
2384568|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2384569|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
2384570|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384571|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384572|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2384573|NCT00647192|Diuretics|diuretics|mesh-ancestor
2384574|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
2384575|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2384576|NCT00647218|Paclitaxel|paclitaxel|mesh-list
2384577|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2384578|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384579|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
2384580|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
2384581|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
2384582|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384583|NCT00647231|Ketoprofen|ketoprofen|mesh-list
2384584|NCT00647231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2502836|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2502837|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2502838|NCT01230983|Doxorubicin|doxorubicin|mesh-list
2502839|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2502840|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
2502841|NCT01230983|Methotrexate|methotrexate|mesh-list
2502842|NCT01230983|Vincristine|vincristine|mesh-list
2502843|NCT01230983|Asparaginase|asparaginase|mesh-list
2502844|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
2502845|NCT01230983|Razoxane|razoxane|mesh-list
2502846|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
2502847|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2502848|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502849|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2502850|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2502851|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384585|NCT00647231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2384586|NCT00647231|Analgesics|analgesics|mesh-ancestor
2384587|NCT00647231|Sensory System Agents|sensory system agents|mesh-ancestor
2384588|NCT00647231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384589|NCT00647231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384590|NCT00647231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384591|NCT00647231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384592|NCT00647231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2384593|NCT00647231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384594|NCT00647231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384595|NCT00647244|Tenofovir|tenofovir|mesh-list
2384596|NCT00647244|Abacavir|abacavir|mesh-list
2384597|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
2384598|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2384599|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2384600|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2384601|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384602|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384603|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2384604|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2502852|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502853|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502854|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384605|NCT00647257|Losartan|losartan|mesh-list
2384606|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2384607|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2384608|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2384609|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2422930|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
2502855|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
2502856|NCT01230983|Hormones|hormones|mesh-ancestor
2502857|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2502858|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2502859|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2502860|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
2502861|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2502862|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2502863|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
2502864|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
2502865|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2502866|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2502867|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
2502868|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502869|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2502870|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
2502871|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502872|NCT01230983|Antidotes|antidotes|mesh-ancestor
2502873|NCT01230983|Protective Agents|protective agents|mesh-ancestor
2502874|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
2502875|NCT01230983|Vitamins|vitamins|mesh-ancestor
2502876|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
2502877|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2502878|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
2502879|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
2502880|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
2502881|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2502882|NCT01230996|Cisplatin|cisplatin|mesh-list
2502883|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502884|NCT01231074|Metformin|metformin|mesh-list
2502885|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2502886|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502887|NCT01231113|Artesunate|artesunate|mesh-list
2502888|NCT01231113|Piperaquine|piperaquine|mesh-list
2502889|NCT01231113|Amodiaquine|amodiaquine|mesh-list
2502890|NCT01231113|Artenimol|artenimol|mesh-list
2502891|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
2502892|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2502893|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2502894|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502895|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384610|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384611|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
2502896|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
2502897|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
2502898|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2502899|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
2502900|NCT01231126|Misoprostol|misoprostol|mesh-list
2502901|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2502902|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
2502903|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2502904|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502905|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2502906|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2502907|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
2502908|NCT01231139|Acetaminophen|acetaminophen|mesh-list
2502909|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2502910|NCT01231139|Analgesics|analgesics|mesh-ancestor
2502911|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
2384612|NCT00647465|Vaccines|vaccines|mesh-list
2384613|NCT00647465|Immunologic Factors|immunologic factors|mesh-ancestor
2384614|NCT00647465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384615|NCT00647491|Adalimumab|adalimumab|mesh-list
2384616|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384617|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384618|NCT00647530|Fluorouracil|fluorouracil|mesh-list
2384619|NCT00647530|Capecitabine|capecitabine|mesh-list
2384620|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
2384621|NCT00647530|Panitumumab|panitumumab|mesh-list
2384622|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
2384623|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502912|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502913|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502914|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
2502915|NCT01231165|Aspirin|aspirin|mesh-list
2502916|NCT01231165|Amiloride|amiloride|mesh-list
2502917|NCT01231165|Clopidogrel|clopidogrel|mesh-list
2502918|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2502919|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2384624|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2502920|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2502921|NCT01231165|Analgesics|analgesics|mesh-ancestor
2502922|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
2502923|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502924|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502925|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2502926|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502927|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2502928|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2502929|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502930|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2502931|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2502932|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502933|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
2502934|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2502935|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2502936|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2502937|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
2502938|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2502939|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2502940|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2502941|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
2502942|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2502943|NCT01231165|Diuretics|diuretics|mesh-ancestor
2502944|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
2502945|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2502946|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2502947|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2502948|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2502949|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2502950|NCT01231191|Acetaminophen|acetaminophen|mesh-list
2502951|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2502952|NCT01231191|Analgesics|analgesics|mesh-ancestor
2502953|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
2502954|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502955|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502956|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
2502957|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2502958|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2502959|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2384625|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384626|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2384627|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
2384628|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384629|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2384630|NCT00647543|Atorvastatin|atorvastatin|mesh-list
2384631|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2384632|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2384633|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
2384634|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384635|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2384636|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2384637|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384638|NCT00647608|Propranolol|propranolol|mesh-list
2384639|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2502960|NCT01231347|Gemcitabine|gemcitabine|mesh-list
2502961|NCT01231347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2502962|NCT01231347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2502963|NCT01231347|Antimetabolites|antimetabolites|mesh-ancestor
2502964|NCT01231347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502965|NCT01231347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2502966|NCT01231347|Antiviral Agents|antiviral agents|mesh-ancestor
2502967|NCT01231347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502968|NCT01231347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502969|NCT01231347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2502970|NCT01231347|Immunologic Factors|immunologic factors|mesh-ancestor
2502971|NCT01231347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502972|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
2502973|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2502974|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2502975|NCT01231490|Naproxen|naproxen|mesh-list
2502976|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2502977|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2502978|NCT01231490|Analgesics|analgesics|mesh-ancestor
2502979|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
2502980|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2502981|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384640|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2384641|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
2502982|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2502983|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2502984|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
2502985|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2502986|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502987|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502988|NCT01231529|Dolutegravir|dolutegravir|mesh-list
2502989|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2502990|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2502991|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2502992|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2502993|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2502994|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2502995|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
2502996|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2502997|NCT01231542|Rifampin|rifampin|mesh-list
2502998|NCT01231542|Rifabutin|rifabutin|mesh-list
2502999|NCT01231542|Dolutegravir|dolutegravir|mesh-list
2503000|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2503001|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
2503002|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2503003|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503004|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
2503005|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2503006|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503007|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503008|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2503009|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2503010|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2503011|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2503012|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2503013|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2503014|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2503015|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2503016|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2503017|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2503018|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
2503019|NCT01231594|Trametinib|trametinib|mesh-list
2503020|NCT01231594|Dabrafenib|dabrafenib|mesh-list
2503021|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
2384642|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384643|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384644|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384645|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2384646|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2384647|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
2384648|NCT00647621|Phenytoin|phenytoin|mesh-list
2384649|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
2384650|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2384651|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2384652|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2384653|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503022|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2503023|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503024|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503025|NCT01231685|Ritonavir|ritonavir|mesh-list
2503026|NCT01231685|Lopinavir|lopinavir|mesh-list
2503027|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2503028|NCT01231685|Darunavir|darunavir|mesh-list
2503029|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2503030|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
2503031|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
2503032|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2503033|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503034|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503035|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2503036|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2503037|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
2503038|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503039|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2503040|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2503041|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2503042|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2503043|NCT01231698|Esmolol|esmolol|mesh-list
2503044|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2503045|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2503046|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2503047|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
2503048|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503049|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503050|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503051|NCT01231711|Ethanol|ethanol|mesh-list
2503052|NCT01231711|Povidone-Iodine|povidone-iodine|mesh-list
2503053|NCT01231711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2503054|NCT01231711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503055|NCT01231711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503056|NCT01231711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503057|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
2503058|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2384654|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2384655|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2384656|NCT00647634|Alprazolam|alprazolam|mesh-list
2384657|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2384658|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384659|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384660|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2384661|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2384662|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2384663|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
2384664|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
2384665|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384666|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503059|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503060|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2503061|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2503062|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503063|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503064|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503065|NCT01231802|Leucovorin|leucovorin|mesh-list
2503066|NCT01231802|Fluorouracil|fluorouracil|mesh-list
2503067|NCT01231802|Capecitabine|capecitabine|mesh-list
2503068|NCT01231802|Eniluracil|eniluracil|mesh-list
2503069|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
2503070|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503071|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2503072|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503073|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2503074|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
2503075|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503076|NCT01231802|Antidotes|antidotes|mesh-ancestor
2503077|NCT01231802|Protective Agents|protective agents|mesh-ancestor
2503078|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
2503079|NCT01231802|Vitamins|vitamins|mesh-ancestor
2503080|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
2384667|NCT00647647|Terbinafine|terbinafine|mesh-list
2384668|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
2384669|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503081|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503082|NCT01231828|Lactulose|lactulose|mesh-list
2503083|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2503084|NCT01231854|Cyclosporine|cyclosporine|mesh-list
2503085|NCT01231854|Alitretinoin|alitretinoin|mesh-list
2503086|NCT01231854|Cyclosporins|cyclosporins|mesh-list
2503087|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503088|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384670|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384671|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384672|NCT00647660|Nadolol|nadolol|mesh-list
2384673|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
2384674|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2384675|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2384676|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
2384677|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384678|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384679|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384680|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2503089|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2503090|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
2503091|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503092|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
2503093|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2384681|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2384682|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
2384683|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
2384684|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384685|NCT00647660|Diuretics|diuretics|mesh-ancestor
2384686|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
2384687|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2384688|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2384689|NCT00647673|Verapamil|verapamil|mesh-list
2384690|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2384691|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2384692|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2384693|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384694|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2384695|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384696|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
2384697|NCT00647686|Fentanyl|fentanyl|mesh-list
2384698|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2384699|NCT00647686|Narcotics|narcotics|mesh-ancestor
2384700|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503094|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
2503095|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2503096|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2503097|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503098|NCT01231880|Piperaquine|piperaquine|mesh-list
2503099|NCT01231880|Artenimol|artenimol|mesh-list
2503100|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
2503101|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2503102|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2503103|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503104|NCT01231997|Udenafil|udenafil|mesh-list
2503105|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2503106|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2503107|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503108|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384701|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384702|NCT00647686|Analgesics|analgesics|mesh-ancestor
2384703|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
2503109|NCT01232010|Mirodenafil|mirodenafil|mesh-list
2503110|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2503111|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2503112|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503113|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503114|NCT01232023|Indobufen|indobufen|mesh-list
2503115|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2503116|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2503117|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503118|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503119|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2503120|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2384704|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384705|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2384706|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2384707|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
2384708|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
2384709|NCT00647712|Valproic Acid|valproic acid|mesh-list
2384710|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
2384711|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384712|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384713|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
2384714|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384715|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384716|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
2384717|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2384718|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384719|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2384720|NCT00647738|Baclofen|baclofen|mesh-list
2384721|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2384722|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384723|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2384724|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384725|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2384726|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
2503121|NCT01232023|Analgesics|analgesics|mesh-ancestor
2503122|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
2503123|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503124|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503125|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2503126|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2503127|NCT01232036|Metformin|metformin|mesh-list
2503128|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2503129|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503130|NCT01232075|Letrozole|letrozole|mesh-list
2503131|NCT01232075|Citric Acid|citric acid|mesh-list
2503132|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
2503133|NCT01232075|Clomiphene|clomiphene|mesh-list
2503134|NCT01232075|Enclomiphene|enclomiphene|mesh-list
2503135|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
2503136|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
2503137|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2503138|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
2503139|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
2503140|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503141|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503142|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2503143|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2503144|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503145|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2503146|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
2503147|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503148|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503149|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2503150|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
2503151|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2503152|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2503153|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2503154|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2503155|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503156|NCT01232244|Glucagon|glucagon|mesh-list
2503157|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2503158|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2503159|NCT01232244|Hormones|hormones|mesh-ancestor
2503160|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503161|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503162|NCT01232244|Incretins|incretins|mesh-ancestor
2503163|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
2503164|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2503165|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
2503166|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503167|NCT01232257|Expectorants|expectorants|mesh-ancestor
2503168|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
2503169|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2503170|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
2384727|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
2384728|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384729|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384730|NCT00647751|Lamotrigine|lamotrigine|mesh-list
2384731|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
2384732|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2384733|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2384734|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384735|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2384736|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384737|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2384738|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2384739|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384740|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2384741|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2384742|NCT00647777|Olanzapine|olanzapine|mesh-list
2384743|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
2384744|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
2384745|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384746|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384747|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2384748|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2503171|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503172|NCT01232257|Protective Agents|protective agents|mesh-ancestor
2503173|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503174|NCT01232257|Antidotes|antidotes|mesh-ancestor
2384749|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2384750|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384751|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2384752|NCT00647777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2384753|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2384754|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2384755|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384756|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384757|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
2384758|NCT00647816|Propranolol|propranolol|mesh-list
2384759|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2384760|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2384761|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
2384762|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384763|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384764|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384765|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2384766|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2384767|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
2384768|NCT00647829|Valdecoxib|valdecoxib|mesh-list
2384769|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2384770|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2384771|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384772|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384773|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2384774|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2503175|NCT01232270|Propofol|propofol|mesh-list
2503176|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2503177|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503178|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503179|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2503180|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
2503181|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
2503182|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
2503183|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503184|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2503185|NCT01232400|Esmolol|esmolol|mesh-list
2503186|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2503187|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2384775|NCT00647829|Analgesics|analgesics|mesh-ancestor
2384776|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
2384777|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503188|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2503189|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
2503190|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503191|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503192|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503193|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
2503194|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
2503195|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2503196|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503197|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2503198|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2503199|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503200|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503201|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503202|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503203|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2503204|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2503205|NCT01232439|Aticaprant|aticaprant|mesh-list
2503206|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503207|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
2503208|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384778|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384779|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384780|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384781|NCT00647842|Fentanyl|fentanyl|mesh-list
2384782|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2384783|NCT00647842|Narcotics|narcotics|mesh-ancestor
2384784|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384785|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384786|NCT00647842|Analgesics|analgesics|mesh-ancestor
2384787|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
2503209|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2503210|NCT01232595|Vancomycin|vancomycin|mesh-list
2503211|NCT01232595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2503212|NCT01232595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503213|NCT01232647|Vitamins|vitamins|mesh-list
2503214|NCT01232647|Vitamin K|vitamin k|mesh-list
2503215|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
2503216|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
2503217|NCT01232647|Menatetrenone|menatetrenone|mesh-list
2503218|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
2503219|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503220|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2503221|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2503222|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503223|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
2503224|NCT01232647|Coagulants|coagulants|mesh-ancestor
2503225|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
2503226|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
2503227|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2503228|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2503229|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503230|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503231|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503232|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2503233|NCT01232777|Bevacizumab|bevacizumab|mesh-list
2503234|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2503235|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503236|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2503237|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2503238|NCT01232777|Growth Substances|growth substances|mesh-ancestor
2503239|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503240|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
2503241|NCT01232803|Tenofovir|tenofovir|mesh-list
2503242|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
2503243|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503244|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2503245|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2503246|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503247|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503248|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2503249|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2503250|NCT01233167|Clopidogrel|clopidogrel|mesh-list
2503251|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2503252|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2503253|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2503254|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2503255|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
2503256|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503257|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384788|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384789|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2384790|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2384791|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
2384792|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
2384793|NCT00647868|Testosterone|testosterone|mesh-list
2384794|NCT00647868|Androgens|androgens|mesh-ancestor
2384795|NCT00647868|Hormones|hormones|mesh-ancestor
2384796|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384797|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384798|NCT00647881|Paroxetine|paroxetine|mesh-list
2384799|NCT00647881|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2384800|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2384801|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2503258|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503259|NCT01233206|Metformin|metformin|mesh-list
2503260|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2503261|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503262|NCT01233219|Morphine|morphine|mesh-list
2503263|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2503264|NCT01233219|Narcotics|narcotics|mesh-ancestor
2503265|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503266|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503267|NCT01233219|Analgesics|analgesics|mesh-ancestor
2503268|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
2503269|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503270|NCT01233245|Interferons|interferons|mesh-list
2503271|NCT01233245|Interferon-beta|interferon-beta|mesh-list
2503272|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
2503273|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503274|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
2503275|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503276|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
2503277|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503278|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2503279|NCT01233297|Azithromycin|azithromycin|mesh-list
2503280|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2503281|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503282|NCT01233362|Vaccines|vaccines|mesh-list
2503283|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
2503284|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503285|NCT01233453|Umirolimus|umirolimus|mesh-list
2503286|NCT01233453|Everolimus|everolimus|mesh-list
2503287|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503288|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2503289|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
2503290|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503291|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2503292|NCT01233492|Mannitol|mannitol|mesh-list
2503293|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2503294|NCT01233492|Diuretics|diuretics|mesh-ancestor
2503295|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
2503296|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503297|NCT01233505|Capecitabine|capecitabine|mesh-list
2503298|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
2503299|NCT01233505|Veliparib|veliparib|mesh-list
2503300|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2503301|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
2503302|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503303|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503304|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2503305|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503306|NCT01233570|Tacrolimus|tacrolimus|mesh-list
2503307|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2503308|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
2503309|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503310|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2384802|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384803|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384804|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
2384805|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384806|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2384807|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
2384808|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2384809|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2384810|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2384811|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384812|NCT00647894|Alprazolam|alprazolam|mesh-list
2384813|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2503311|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503312|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503313|NCT01233583|Adalimumab|adalimumab|mesh-list
2503314|NCT01233583|Etanercept|etanercept|mesh-list
2503315|NCT01233583|Infliximab|infliximab|mesh-list
2503316|NCT01233583|Acitretin|acitretin|mesh-list
2503317|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2503318|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2503319|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2503320|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2503321|NCT01233583|Analgesics|analgesics|mesh-ancestor
2503322|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
2503323|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503324|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384814|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384815|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384816|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2384817|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2384818|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2384819|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
2384820|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
2384821|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384822|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384823|NCT00647907|Voriconazole|voriconazole|mesh-list
2384824|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
2384825|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503325|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2503326|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2503327|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
2503328|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
2503329|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
2384826|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2384827|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2384828|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384829|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384830|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2384831|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
2384832|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384833|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384834|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2384835|NCT00647920|Adalimumab|adalimumab|mesh-list
2384836|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384837|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384838|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2384839|NCT00647933|Lynestrenol|lynestrenol|mesh-list
2384840|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2384841|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2384842|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2384843|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
2503330|NCT01233622|Vildagliptin|vildagliptin|mesh-list
2503331|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2503332|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503333|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2503334|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
2503335|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503336|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503337|NCT01233635|Losartan|losartan|mesh-list
2503338|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2503339|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2503340|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2503341|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2503342|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503343|NCT01233752|Morphine|morphine|mesh-list
2503344|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2503345|NCT01233752|Narcotics|narcotics|mesh-ancestor
2503346|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503347|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503348|NCT01233752|Analgesics|analgesics|mesh-ancestor
2503349|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
2503350|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503351|NCT01233791|Diazepam|diazepam|mesh-list
2503352|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2503353|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
2503354|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
2503355|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
2503356|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503357|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503358|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2503359|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2503360|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503361|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2503362|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2503363|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2503364|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2503365|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2503366|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2503367|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
2503368|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
2384844|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2384845|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384846|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2384847|NCT00647933|Estrogens|estrogens|mesh-ancestor
2384848|NCT00647933|Hormones|hormones|mesh-ancestor
2422931|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503369|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
2503370|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
2503371|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503372|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503373|NCT01233843|Carboplatin|carboplatin|mesh-list
2503374|NCT01233843|Fluorouracil|fluorouracil|mesh-list
2503375|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384849|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384850|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2384851|NCT00647946|Tenofovir|tenofovir|mesh-list
2384852|NCT00647946|Abacavir|abacavir|mesh-list
2384853|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
2384854|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2384855|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2503376|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
2503377|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503378|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2384856|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2384857|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384858|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384859|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2384860|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2384861|NCT00647959|Doxycycline|doxycycline|mesh-list
2384862|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2384863|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2384864|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
2384865|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2384866|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2384867|NCT00647972|Olanzapine|olanzapine|mesh-list
2384868|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
2384869|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
2384870|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384871|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384872|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2503379|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2503380|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
2503381|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503382|NCT01233895|Bortezomib|bortezomib|mesh-list
2503383|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503384|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
2503385|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
2503386|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2503387|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
2503388|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
2503389|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503390|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503391|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503392|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
2503393|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
2503394|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2503395|NCT01233947|Fulvestrant|fulvestrant|mesh-list
2503396|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2503397|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503398|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2503399|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2503400|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
2503401|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503402|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503407|NCT01234025|Prednisone|prednisone|mesh-list
2503408|NCT01234025|Docetaxel|docetaxel|mesh-list
2503409|NCT01234025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503410|NCT01234025|Tubulin Modulators|tubulin modulators|mesh-ancestor
2503411|NCT01234025|Antimitotic Agents|antimitotic agents|mesh-ancestor
2503412|NCT01234025|Mitosis Modulators|mitosis modulators|mesh-ancestor
2503413|NCT01234025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503414|NCT01234025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2503415|NCT01234025|Glucocorticoids|glucocorticoids|mesh-ancestor
2503416|NCT01234025|Hormones|hormones|mesh-ancestor
2503417|NCT01234025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384873|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2384874|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2384875|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384876|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2384877|NCT00647972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2384878|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2384879|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2503418|NCT01234025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384880|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384881|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384882|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
2384883|NCT00647985|Fexofenadine|fexofenadine|mesh-list
2384884|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2384885|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2384886|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2384887|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
2384888|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
2384889|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384890|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503419|NCT01234025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2503420|NCT01234038|Paclitaxel|paclitaxel|mesh-list
2503421|NCT01234038|Carboplatin|carboplatin|mesh-list
2503422|NCT01234038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2503423|NCT01234038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503424|NCT01234038|Tubulin Modulators|tubulin modulators|mesh-ancestor
2503425|NCT01234038|Antimitotic Agents|antimitotic agents|mesh-ancestor
2503426|NCT01234038|Mitosis Modulators|mitosis modulators|mesh-ancestor
2503427|NCT01234038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503428|NCT01234051|Docetaxel|docetaxel|mesh-list
2503429|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
2503430|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503431|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
2503432|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
2503433|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
2503434|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503435|NCT01234116|Tenofovir|tenofovir|mesh-list
2503436|NCT01234116|Emtricitabine|emtricitabine|mesh-list
2503437|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2503438|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
2503439|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503440|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2503441|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2384891|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384892|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2384893|NCT00648011|Quinapril|quinapril|mesh-list
2384894|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2384895|NCT00648011|Diuretics|diuretics|mesh-ancestor
2384896|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
2384897|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384898|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2384899|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422932|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
2503442|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503443|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503444|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2503445|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2503446|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
2503447|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2503448|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503449|NCT01234142|Varenicline|varenicline|mesh-list
2503450|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2503451|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2503452|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
2503453|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503454|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503455|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503456|NCT01234194|Remifentanil|remifentanil|mesh-list
2503457|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2503458|NCT01234194|Narcotics|narcotics|mesh-ancestor
2503459|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503460|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503461|NCT01234194|Analgesics|analgesics|mesh-ancestor
2503462|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
2503463|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503464|NCT01234272|Morphine|morphine|mesh-list
2503465|NCT01234272|Ropivacaine|ropivacaine|mesh-list
2503466|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2503467|NCT01234272|Narcotics|narcotics|mesh-ancestor
2503468|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503469|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503470|NCT01234272|Analgesics|analgesics|mesh-ancestor
2503471|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
2503472|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503473|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
2503474|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
2503475|NCT01234285|Heparin|heparin|mesh-list
2503476|NCT01234285|Calcium heparin|calcium heparin|mesh-list
2503477|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
2503478|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2503479|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2503480|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503481|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2503482|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2503483|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503484|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2503485|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2503486|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2503487|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384900|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384901|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2384902|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
2384903|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384904|NCT00648024|Anagrelide|anagrelide|mesh-list
2384905|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2384906|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2384907|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384908|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2384909|NCT00648050|Verapamil|verapamil|mesh-list
2384910|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2384911|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2384912|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2384913|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384914|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2384915|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384916|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
2384917|NCT00648063|Letrozole|letrozole|mesh-list
2384918|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384919|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2384920|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2384921|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384922|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384923|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2384924|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
2384925|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384926|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503488|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
2503489|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503490|NCT01234324|Cisplatin|cisplatin|mesh-list
2503491|NCT01234324|Capecitabine|capecitabine|mesh-list
2503492|NCT01234324|Epirubicin|epirubicin|mesh-list
2503493|NCT01234324|Panitumumab|panitumumab|mesh-list
2503494|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503495|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2503496|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
2503497|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503498|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2503499|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2503500|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2503501|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503502|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2384927|NCT00648076|Valproic Acid|valproic acid|mesh-list
2384928|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
2384929|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384930|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384931|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
2384932|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384933|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384934|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
2384935|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2503503|NCT01234454|Olanzapine|olanzapine|mesh-list
2503504|NCT01234454|Risperidone|risperidone|mesh-list
2503505|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2503506|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
2503507|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503508|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503509|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384936|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2384937|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2384938|NCT00648128|Clarithromycin|clarithromycin|mesh-list
2384939|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2384940|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2384941|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2384942|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384943|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384944|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2384945|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2384946|NCT00648141|Celecoxib|celecoxib|mesh-list
2384947|NCT00648141|Diclofenac|diclofenac|mesh-list
2503510|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2503511|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2503512|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503513|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2503514|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2503515|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
2503516|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
2503517|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
2503518|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503519|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2503520|NCT01234454|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2503521|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2503522|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2503523|NCT01234506|Vitamin D|vitamin d|mesh-list
2503524|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
2503525|NCT01234506|Vitamins|vitamins|mesh-ancestor
2503526|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
2503527|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503528|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2503529|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
2503530|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2503531|NCT01234506|Estrogens|estrogens|mesh-ancestor
2503532|NCT01234506|Hormones|hormones|mesh-ancestor
2384948|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2384949|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2384950|NCT00648141|Analgesics|analgesics|mesh-ancestor
2384951|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
2384952|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2384953|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384954|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2384955|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2384956|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2384957|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2384958|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384959|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384960|NCT00648154|Letrozole|letrozole|mesh-list
2384961|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2384962|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2384963|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2384964|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384965|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384966|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2384967|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
2384968|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2384969|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384970|NCT00648180|Doxycycline|doxycycline|mesh-list
2503533|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503534|NCT01234519|Doxorubicin|doxorubicin|mesh-list
2503535|NCT01234519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2503536|NCT01234519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503537|NCT01234519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2503538|NCT01234519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2503539|NCT01234519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503540|NCT01234519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503541|NCT01234532|Anastrozole|anastrozole|mesh-list
2503542|NCT01234532|Entinostat|entinostat|mesh-list
2503543|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2503544|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503545|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2503546|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2503547|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384971|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2503548|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503549|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2503550|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
2503551|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503552|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503553|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2503554|NCT01234597|Insulin|insulin|mesh-list
2503555|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2503556|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
2503557|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
2503558|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2503559|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503560|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2503561|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2503562|NCT01234701|Liver Extracts|liver extracts|mesh-list
2503563|NCT01234701|Hematinics|hematinics|mesh-ancestor
2503564|NCT01234740|Bafetinib|bafetinib|mesh-list
2503565|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2503566|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503567|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503568|NCT01234779|Olanzapine|olanzapine|mesh-list
2503569|NCT01234779|Antiemetics|antiemetics|mesh-ancestor
2503570|NCT01234779|Autonomic Agents|autonomic agents|mesh-ancestor
2503571|NCT01234779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503572|NCT01234779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503573|NCT01234779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2503574|NCT01234779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2384972|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2384973|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
2384974|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2384975|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2384976|NCT00648193|Paroxetine|paroxetine|mesh-list
2384977|NCT00648193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2384978|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2384979|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2384980|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384981|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2384982|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
2503575|NCT01234779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2503576|NCT01234779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503577|NCT01234779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2503578|NCT01234779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2503579|NCT01234779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2503580|NCT01234779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2503581|NCT01234779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503582|NCT01234779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503583|NCT01234779|Serotonin Agents|serotonin agents|mesh-ancestor
2384983|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2384984|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2384985|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
2384986|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2384987|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2384988|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2384989|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2384990|NCT00648219|Olmesartan|olmesartan|mesh-list
2384991|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2384992|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2384993|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2384994|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2384995|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2384996|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2384997|NCT00648258|Naproxen|naproxen|mesh-list
2384998|NCT00648258|Valdecoxib|valdecoxib|mesh-list
2384999|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2385000|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2385001|NCT00648258|Analgesics|analgesics|mesh-ancestor
2385002|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
2503584|NCT01234792|Nicotine|nicotine|mesh-list
2503585|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2503586|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
2503587|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503588|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503589|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2503590|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2503591|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
2503592|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503593|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503594|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
2503595|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2385003|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385004|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385005|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2385006|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2385007|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
2385008|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2385009|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385010|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385011|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2385012|NCT00648271|Metoprolol|metoprolol|mesh-list
2385013|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2385014|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385015|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
2385016|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
2385017|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385018|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385019|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2385020|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2385021|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2385022|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
2385023|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385024|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385025|NCT00648297|Nadolol|nadolol|mesh-list
2385026|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
2385027|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2385028|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2503596|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
2503597|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2503598|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503599|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2503600|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2503601|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2503602|NCT01234857|Sirolimus|sirolimus|mesh-list
2503603|NCT01234857|Exemestane|exemestane|mesh-list
2503604|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2503605|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503606|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2503607|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2503608|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503609|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503610|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2503611|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
2503612|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503613|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503614|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2503615|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503616|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2503617|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
2503618|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2503619|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
2503620|NCT01234896|Nicotine|nicotine|mesh-list
2503621|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2503622|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
2503623|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503624|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503625|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2503626|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2503627|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
2503628|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503629|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503630|NCT01234935|Gemcitabine|gemcitabine|mesh-list
2503631|NCT01234935|Dasatinib|dasatinib|mesh-list
2503632|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2503633|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
2503634|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503635|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503636|NCT01234935|Antiviral Agents|antiviral agents|mesh-ancestor
2503637|NCT01234935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503638|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385029|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
2385030|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385031|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385032|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385033|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2385034|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385035|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
2385036|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
2385037|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385038|NCT00648297|Diuretics|diuretics|mesh-ancestor
2385039|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
2385040|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2385041|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385042|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2385043|NCT00648310|Estrogens|estrogens|mesh-list
2385044|NCT00648310|Hormones|hormones|mesh-ancestor
2503639|NCT01234935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2503640|NCT01234935|Immunologic Factors|immunologic factors|mesh-ancestor
2503641|NCT01234935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503642|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2503643|NCT01234974|Everolimus|everolimus|mesh-list
2503644|NCT01234974|Pasireotide|pasireotide|mesh-list
2503645|NCT01234974|Somatostatin|somatostatin|mesh-list
2503646|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503647|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2503648|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
2503649|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503650|NCT01234974|Hormones|hormones|mesh-ancestor
2503651|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503652|NCT01235013|Maraviroc|maraviroc|mesh-list
2503653|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2503654|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2503655|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503656|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2503657|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2503658|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
2385045|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2385046|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385047|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2385048|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2503659|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503660|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2503661|NCT01235039|Insulin|insulin|mesh-list
2385049|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
2385050|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385051|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385052|NCT00648310|Urological Agents|urological agents|mesh-ancestor
2385053|NCT00648323|Doxazosin|doxazosin|mesh-list
2385054|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385055|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2385056|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2385057|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2385058|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
2385059|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385060|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385061|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385062|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
2385063|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
2385064|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385065|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2385066|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503662|NCT01235039|Insulin Lispro|insulin lispro|mesh-list
2503663|NCT01235039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2503664|NCT01235039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2503665|NCT01235039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503666|NCT01235117|Azacitidine|azacitidine|mesh-list
2503667|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2503668|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
2385067|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2385068|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
2385069|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385070|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2385071|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385072|NCT00648349|Rabeprazole|rabeprazole|mesh-list
2503669|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503670|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2385073|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2385074|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385075|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2385076|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385077|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385078|NCT00648362|Glimepiride|glimepiride|mesh-list
2385079|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2385080|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2385081|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385082|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2385083|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
2385084|NCT00648388|Cilostazol|cilostazol|mesh-list
2385085|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2385086|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
2385087|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385088|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385089|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2385090|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
2385091|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2385092|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2385093|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385094|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2385095|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
2385096|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2385097|NCT00648388|Protective Agents|protective agents|mesh-ancestor
2385098|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2385099|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2385100|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385101|NCT00648401|Verapamil|verapamil|mesh-list
2385102|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2385103|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2385104|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385105|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385106|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2385107|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385108|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
2385109|NCT00648414|Fentanyl|fentanyl|mesh-list
2503671|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503672|NCT01235143|Sevoflurane|sevoflurane|mesh-list
2503673|NCT01235143|Desflurane|desflurane|mesh-list
2503674|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2503675|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2503676|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
2503677|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
2503678|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2385110|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2385111|NCT00648414|Narcotics|narcotics|mesh-ancestor
2503679|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503680|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
2503681|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2503682|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2503683|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503684|NCT01235260|Becaplermin|becaplermin|mesh-list
2503685|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
2503686|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2385112|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2385113|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385114|NCT00648414|Analgesics|analgesics|mesh-ancestor
2385115|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
2385116|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385117|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2385118|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2385119|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
2385120|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
2385121|NCT00648427|Paroxetine|paroxetine|mesh-list
2385122|NCT00648427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2385123|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2385124|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385125|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385126|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385127|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
2503687|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2385128|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385129|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2385130|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
2385131|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2385132|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2385133|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2385134|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385135|NCT00648440|Midodrine|midodrine|mesh-list
2385136|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
2385137|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
2385138|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385139|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385140|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2385141|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2385142|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2385143|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2385144|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
2385145|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385146|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385147|NCT00648453|Clopidogrel|clopidogrel|mesh-list
2385148|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2385149|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2385150|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2385151|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2385152|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
2385153|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503688|NCT01235260|Growth Substances|growth substances|mesh-ancestor
2503689|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503690|NCT01235273|Hormones|hormones|mesh-list
2503691|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503692|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503693|NCT01235325|Vitamin K|vitamin k|mesh-list
2503694|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
2503695|NCT01235325|Vitamins|vitamins|mesh-ancestor
2503696|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
2503697|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503698|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2503699|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2503700|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503701|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
2503702|NCT01235325|Coagulants|coagulants|mesh-ancestor
2503703|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
2503704|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2503705|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503706|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503707|NCT01235455|Interferons|interferons|mesh-list
2503708|NCT01235455|Interferon-beta|interferon-beta|mesh-list
2503709|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
2503710|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503711|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
2503712|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503713|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
2503714|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503715|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2503716|NCT01235637|Sufentanil|sufentanil|mesh-list
2503717|NCT01235637|Alfentanil|alfentanil|mesh-list
2503718|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2503719|NCT01235637|Narcotics|narcotics|mesh-ancestor
2503720|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503721|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503722|NCT01235637|Analgesics|analgesics|mesh-ancestor
2503723|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
2503724|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503725|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2503726|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2503727|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
2503728|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
2503729|NCT01235754|Methyltestosterone|methyltestosterone|mesh-list
2503730|NCT01235754|Testosterone|testosterone|mesh-list
2503731|NCT01235754|Testosterone undecanoate|testosterone undecanoate|mesh-list
2503732|NCT01235754|Testosterone enanthate|testosterone enanthate|mesh-list
2503733|NCT01235754|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2503734|NCT01235754|Androgens|androgens|mesh-ancestor
2503735|NCT01235754|Hormones|hormones|mesh-ancestor
2503736|NCT01235754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503737|NCT01235754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503738|NCT01235754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2503739|NCT01235754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503740|NCT01235754|Anabolic Agents|anabolic agents|mesh-ancestor
2503741|NCT01235819|Insulin|insulin|mesh-list
2503742|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2503743|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2503744|NCT01235819|Exenatide|exenatide|mesh-list
2503745|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2503746|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2503747|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385154|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385155|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385156|NCT00648466|Sumatriptan|sumatriptan|mesh-list
2385157|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2385158|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2385159|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2385160|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
2385161|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385162|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385163|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385164|NCT00648492|Metformin|metformin|mesh-list
2385165|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2385166|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385167|NCT00648505|Metformin|metformin|mesh-list
2385168|NCT00648505|Glipizide|glipizide|mesh-list
2385169|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2385170|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385171|NCT00648518|Metformin|metformin|mesh-list
2385172|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2385173|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385174|NCT00648531|Balsalazide|balsalazide|mesh-list
2503748|NCT01235819|Incretins|incretins|mesh-ancestor
2503749|NCT01235819|Hormones|hormones|mesh-ancestor
2503750|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503751|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
2503752|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503753|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503754|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2503755|NCT01236040|Vaccines|vaccines|mesh-list
2503756|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
2503757|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503758|NCT01236144|Plerixafor|plerixafor|mesh-list
2503759|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2503760|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2503761|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
2503762|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503763|NCT01236430|Atorvastatin|atorvastatin|mesh-list
2503764|NCT01236430|Ezetimibe|ezetimibe|mesh-list
2503765|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2503766|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2503767|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
2503768|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503769|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2503770|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2503771|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503772|NCT01236482|Oxytocin|oxytocin|mesh-list
2503773|NCT01236482|Ergonovine|ergonovine|mesh-list
2503774|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
2503775|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2503776|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503777|NCT01236495|Morphine|morphine|mesh-list
2503778|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2503779|NCT01236495|Narcotics|narcotics|mesh-ancestor
2503780|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503781|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503782|NCT01236495|Analgesics|analgesics|mesh-ancestor
2503783|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
2503784|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503785|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2503786|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2503787|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503788|NCT01236586|Dexamethasone|dexamethasone|mesh-list
2503789|NCT01236586|R04929097|r04929097|mesh-list
2503790|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2503791|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
2503792|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
2503793|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503794|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503795|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2503796|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
2503797|NCT01236586|Hormones|hormones|mesh-ancestor
2503798|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503799|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2503800|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503801|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503802|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503803|NCT01236612|Chloroquine|chloroquine|mesh-list
2503804|NCT01236612|Proguanil|proguanil|mesh-list
2503805|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2503806|NCT01236612|Vaccines|vaccines|mesh-list
2503807|NCT01236612|Amebicides|amebicides|mesh-ancestor
2503808|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2503809|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2503810|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503811|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
2503812|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2503813|NCT01236612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503814|NCT01236612|Immunologic Factors|immunologic factors|mesh-ancestor
2503815|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
2503816|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503817|NCT01236638|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2503818|NCT01236638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2503819|NCT01236638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503820|NCT01236638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503821|NCT01236651|Drotaverin|drotaverin|mesh-list
2385175|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2385176|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2385177|NCT00648531|Analgesics|analgesics|mesh-ancestor
2385178|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
2385179|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385180|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385181|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2385182|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2385183|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385184|NCT00648544|Pravastatin|pravastatin|mesh-list
2385185|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2385186|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2385187|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
2385188|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385189|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2385190|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2385191|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385192|NCT00648570|Dexetimide|dexetimide|mesh-list
2503822|NCT01236651|Meperidine|meperidine|mesh-list
2503823|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2503824|NCT01236651|Narcotics|narcotics|mesh-ancestor
2503825|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503826|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503827|NCT01236651|Analgesics|analgesics|mesh-ancestor
2503828|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
2503829|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503830|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2503831|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
2503832|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
2503833|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
2503834|NCT01236716|Gemcitabine|gemcitabine|mesh-list
2503835|NCT01236716|Paclitaxel|paclitaxel|mesh-list
2503836|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2503837|NCT01236716|Carboplatin|carboplatin|mesh-list
2503838|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2503839|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503840|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
2503841|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
2503842|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
2503843|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503844|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2503845|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
2503846|NCT01236716|Antiviral Agents|antiviral agents|mesh-ancestor
2503847|NCT01236716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503848|NCT01236716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503849|NCT01236716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2503850|NCT01236716|Immunologic Factors|immunologic factors|mesh-ancestor
2503851|NCT01236716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503852|NCT01236859|Gabapentin|gabapentin|mesh-list
2503853|NCT01236859|Analgesics|analgesics|mesh-ancestor
2503854|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
2503855|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503856|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385193|NCT00648570|Citalopram|citalopram|mesh-list
2385194|NCT00648570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2385195|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2385196|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385197|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385198|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385199|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
2385200|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385201|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2385202|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
2385203|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2385204|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2385205|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2385206|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
2385207|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
2385208|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385209|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2503857|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
2503858|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2503859|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2503860|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2503861|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2503862|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2503863|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2503864|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503865|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503866|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
2503867|NCT01236911|Calcium|calcium|mesh-list
2503868|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2503869|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503870|NCT01236950|Listerine|listerine|mesh-list
2503871|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2503872|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503873|NCT01236963|Listerine|listerine|mesh-list
2503874|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2503875|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503876|NCT01236989|Liver Extracts|liver extracts|mesh-list
2503877|NCT01236989|Hematinics|hematinics|mesh-ancestor
2503878|NCT01237028|Calcitriol|calcitriol|mesh-list
2503879|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2503880|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503881|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2503882|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2503883|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503884|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2503885|NCT01237028|Vitamins|vitamins|mesh-ancestor
2503886|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
2503887|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2503888|NCT01237067|Carboplatin|carboplatin|mesh-list
2503889|NCT01237067|Olaparib|olaparib|mesh-list
2503890|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503891|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2503892|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503893|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503894|NCT01237119|Liraglutide|liraglutide|mesh-list
2503895|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2503896|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503897|NCT01237119|Incretins|incretins|mesh-ancestor
2503898|NCT01237119|Hormones|hormones|mesh-ancestor
2503899|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503900|NCT01237249|Dexamethasone|dexamethasone|mesh-list
2503901|NCT01237249|Prednisone|prednisone|mesh-list
2503902|NCT01237249|Melphalan|melphalan|mesh-list
2503903|NCT01237249|Lenalidomide|lenalidomide|mesh-list
2503904|NCT01237249|Bortezomib|bortezomib|mesh-list
2503905|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2385210|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2503906|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
2503907|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
2385211|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
2385212|NCT00648583|Ondansetron|ondansetron|mesh-list
2385213|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
2385214|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
2503908|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2503909|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503910|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2503911|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
2503912|NCT01237249|Hormones|hormones|mesh-ancestor
2503913|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503914|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2503915|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503916|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2503917|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
2503918|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503919|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2503920|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2503921|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
2385215|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385216|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385217|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385218|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
2385219|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
2503922|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2503923|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2503924|NCT01237249|Growth Substances|growth substances|mesh-ancestor
2503925|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
2503926|NCT01237262|Adalimumab|adalimumab|mesh-list
2503927|NCT01237262|Etanercept|etanercept|mesh-list
2503928|NCT01237262|Infliximab|infliximab|mesh-list
2503929|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2503930|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2503931|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2503932|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2503933|NCT01237262|Analgesics|analgesics|mesh-ancestor
2503934|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
2503935|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385220|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2385221|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
2385222|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385223|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385224|NCT00648583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2503936|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503937|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2503938|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2503939|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
2503940|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
2503941|NCT01237275|Sertraline|sertraline|mesh-list
2503942|NCT01237275|Fluoxetine|fluoxetine|mesh-list
2503943|NCT01237275|Paroxetine|paroxetine|mesh-list
2503944|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
2503945|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2503946|NCT01237275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2503947|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2503948|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2503949|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503950|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2503951|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
2503952|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503953|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2503954|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2503955|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2503956|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503957|NCT01237444|Ritonavir|ritonavir|mesh-list
2503958|NCT01237444|Lopinavir|lopinavir|mesh-list
2503959|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2503960|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2503961|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
2503962|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2503963|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503964|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2503965|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2503966|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
2503967|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385225|NCT00648583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2385226|NCT00648583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2385227|NCT00648583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2385228|NCT00648583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2385229|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
2385230|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
2385231|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2385232|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2385233|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385234|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385235|NCT00648596|Urological Agents|urological agents|mesh-ancestor
2385236|NCT00648622|Carvedilol|carvedilol|mesh-list
2385237|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2385238|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2385239|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
2385240|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385241|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385242|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385243|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385244|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
2385245|NCT00648622|Protective Agents|protective agents|mesh-ancestor
2385246|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2385247|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385248|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2385249|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
2385250|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2385251|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2385252|NCT00648661|Dexetimide|dexetimide|mesh-list
2385253|NCT00648661|Citalopram|citalopram|mesh-list
2385254|NCT00648661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2385255|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2385256|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385257|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385258|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385259|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
2385260|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385261|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2385262|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
2385263|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2385264|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2385265|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2385266|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
2385267|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
2385268|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385269|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2385270|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2385271|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
2385272|NCT00648713|Terbinafine|terbinafine|mesh-list
2385273|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
2385274|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503968|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2503969|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2503970|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2503971|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2503972|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2503973|NCT01237483|Cetuximab|cetuximab|mesh-list
2503974|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2503975|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2503976|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2503977|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
2503978|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503979|NCT01237522|Metformin|metformin|mesh-list
2503980|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2503981|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503982|NCT01237535|Progesterone|progesterone|mesh-list
2503983|NCT01237535|Estrogens|estrogens|mesh-list
2503984|NCT01237535|Progestins|progestins|mesh-ancestor
2503985|NCT01237535|Hormones|hormones|mesh-ancestor
2385275|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385276|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385277|NCT00648726|Azithromycin|azithromycin|mesh-list
2385278|NCT00648726|Erythromycin|erythromycin|mesh-list
2385279|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
2503986|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2503987|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503988|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2503989|NCT01237730|Cefuroxime|cefuroxime|mesh-list
2503990|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
2503991|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2503992|NCT01237769|Vitamin D|vitamin d|mesh-list
2503993|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
2503994|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
2503995|NCT01237769|Vitamins|vitamins|mesh-list
2503996|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
2503997|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2503998|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2503999|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2504000|NCT01237782|Propolis|propolis|mesh-list
2504001|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2504002|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504003|NCT01237808|Cytarabine|cytarabine|mesh-list
2504004|NCT01237808|Etoposide|etoposide|mesh-list
2504005|NCT01237808|Tretinoin|tretinoin|mesh-list
2504006|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2504007|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504008|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2504009|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2504010|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504011|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504012|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2504013|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
2504014|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
2504015|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504016|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504017|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
2504018|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504019|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
2504020|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
2504021|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
2504022|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
2504023|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2504024|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
2504025|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
2504026|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504027|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504028|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504029|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
2385280|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2385281|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
2385282|NCT00648726|Cefuroxime|cefuroxime|mesh-list
2385283|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
2385284|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2385285|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385286|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385287|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2385288|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385289|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504030|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
2504031|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2504032|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
2504033|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2504034|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2504035|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2504036|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2504037|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504038|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
2504039|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504040|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504041|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2504042|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504043|NCT01238029|Capecitabine|capecitabine|mesh-list
2504044|NCT01238029|Vinorelbine|vinorelbine|mesh-list
2504045|NCT01238029|Lapatinib|lapatinib|mesh-list
2504046|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2504047|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
2504048|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504049|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2385290|NCT00648765|Anagrelide|anagrelide|mesh-list
2504050|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2504051|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
2504052|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
2504053|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
2385291|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2385292|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2385293|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385294|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2385295|NCT00648778|Loxapine|loxapine|mesh-list
2385296|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2385297|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2385298|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2385299|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385300|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2385301|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2504054|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2504055|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504056|NCT01238055|Docetaxel|docetaxel|mesh-list
2504057|NCT01238055|Sunitinib|sunitinib|mesh-list
2504058|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504059|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
2504060|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
2504061|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
2504062|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504063|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2504064|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2504065|NCT01238055|Growth Substances|growth substances|mesh-ancestor
2504066|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504067|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
2504068|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2504069|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504070|NCT01238094|Simvastatin|simvastatin|mesh-list
2504071|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2504072|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2504073|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
2504074|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504075|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2504076|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2504077|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504078|NCT01238133|Paclitaxel|paclitaxel|mesh-list
2504079|NCT01238133|Carboplatin|carboplatin|mesh-list
2504080|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2504081|NCT01238133|R04929097|r04929097|mesh-list
2504082|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2504083|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504084|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
2504085|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
2504086|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
2504087|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504088|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504089|NCT01238146|Rituximab|rituximab|mesh-list
2504090|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2385302|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
2385303|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385304|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385305|NCT00648791|Finasteride|finasteride|mesh-list
2385306|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2385307|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2385308|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504091|NCT01238146|Obatoclax|obatoclax|mesh-list
2504092|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2504093|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504094|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
2504095|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504096|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2504097|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2504098|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
2504099|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504100|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504101|NCT01238185|Aspirin|aspirin|mesh-list
2504102|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2504103|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2504104|NCT01238185|Analgesics|analgesics|mesh-ancestor
2504105|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
2504106|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504107|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504108|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2504109|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2504110|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2385309|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385310|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
2385311|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2385312|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504111|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2504112|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504113|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2504114|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2504115|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504116|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
2504117|NCT01238224|Tadalafil|tadalafil|mesh-list
2504118|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
2504119|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2504120|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2504121|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504122|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504123|NCT01238224|Urological Agents|urological agents|mesh-ancestor
2504124|NCT01238237|Cetuximab|cetuximab|mesh-list
2504125|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2504126|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504127|NCT01238276|Cefazolin|cefazolin|mesh-list
2504128|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2504129|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504130|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
2504131|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2504132|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504133|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
2504134|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504135|NCT01238367|Factor VIII|factor viii|mesh-list
2504136|NCT01238367|Coagulants|coagulants|mesh-ancestor
2504137|NCT01238393|Ranibizumab|ranibizumab|mesh-list
2504138|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2504139|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2504140|NCT01238393|Growth Substances|growth substances|mesh-ancestor
2504141|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504142|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
2504143|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504144|NCT01238406|Pancrelipase|pancrelipase|mesh-list
2504145|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2504146|NCT01238523|Calpastatin|calpastatin|mesh-list
2504147|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2385313|NCT00648791|Urological Agents|urological agents|mesh-ancestor
2385314|NCT00648804|Ondansetron|ondansetron|mesh-list
2385315|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
2385316|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
2385317|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385318|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385319|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385320|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
2385321|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
2385322|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2385323|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
2385324|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385325|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385326|NCT00648804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2385327|NCT00648804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2385328|NCT00648804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2385329|NCT00648804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2385330|NCT00648804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2385331|NCT00648817|Tenofovir|tenofovir|mesh-list
2385332|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
2385333|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385334|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2385335|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2385336|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385337|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385338|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2385339|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2385340|NCT00648830|Clarithromycin|clarithromycin|mesh-list
2385341|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2385342|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385343|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2385344|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385345|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385346|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2385347|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2385348|NCT00648843|Oxybutynin|oxybutynin|mesh-list
2385349|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
2385350|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
2385351|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385352|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385353|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2385354|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2385355|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
2385356|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385357|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504148|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
2504149|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504150|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504151|NCT01238562|Lenograstim|lenograstim|mesh-list
2504152|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2504153|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
2504154|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504155|NCT01238627|Nicotine|nicotine|mesh-list
2504156|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2504157|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
2504158|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504159|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504160|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2504161|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2504162|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
2504163|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504164|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504165|NCT01238692|Rituximab|rituximab|mesh-list
2504166|NCT01238692|Panobinostat|panobinostat|mesh-list
2504167|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2504168|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504169|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
2504170|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504171|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2504172|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2504173|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504174|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504175|NCT01238705|Metoprolol|metoprolol|mesh-list
2504176|NCT01238705|Felodipine|felodipine|mesh-list
2504177|NCT01238705|Irbesartan|irbesartan|mesh-list
2504178|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2504179|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2504180|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
2504181|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
2504182|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504183|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504184|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2504185|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2504186|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2504187|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
2504188|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504189|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504190|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2504191|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2504192|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2504193|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2504194|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2504195|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
2504196|NCT01238718|Lidocaine|lidocaine|mesh-list
2504197|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
2504198|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
2504199|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2504200|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504201|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
2504202|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504203|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2504204|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2504205|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2504206|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2504207|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504208|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
2504209|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504210|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
2504211|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504212|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2385358|NCT00648843|Urological Agents|urological agents|mesh-ancestor
2385359|NCT00648856|Sertraline|sertraline|mesh-list
2385360|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
2385361|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2385362|NCT00648856|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2385363|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2385364|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385365|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385366|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385367|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
2385368|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385369|NCT00648869|Metformin|metformin|mesh-list
2385370|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2385371|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385372|NCT00648921|Olanzapine|olanzapine|mesh-list
2385373|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
2385374|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
2385375|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385376|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385377|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385378|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2385379|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2385380|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2385381|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2385382|NCT00648921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2385383|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2385384|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385385|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385386|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385387|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
2385388|NCT00648934|Topiramate|topiramate|mesh-list
2385389|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
2385390|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2385391|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385392|NCT00648947|Clopidogrel|clopidogrel|mesh-list
2385393|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2385394|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2504213|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2504214|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
2504215|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504216|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504217|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2504218|NCT01238796|Telavancin|telavancin|mesh-list
2504219|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2504220|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504221|NCT01238926|Vitamins|vitamins|mesh-list
2504222|NCT01238926|Folic Acid|folic acid|mesh-list
2504223|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
2504224|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
2504225|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
2504226|NCT01238926|Pyridoxal|pyridoxal|mesh-list
2504227|NCT01238926|Pyridoxine|pyridoxine|mesh-list
2504228|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
2504229|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
2504230|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504231|NCT01238926|Hematinics|hematinics|mesh-ancestor
2504232|NCT01238952|Carboplatin|carboplatin|mesh-list
2504233|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504234|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
2504235|NCT01238965|Leucovorin|leucovorin|mesh-list
2504236|NCT01238965|Fluorouracil|fluorouracil|mesh-list
2504237|NCT01238965|Panobinostat|panobinostat|mesh-list
2504238|NCT01238965|Calcium|calcium|mesh-list
2504239|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
2504240|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2504241|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2504242|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504243|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2504244|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
2504245|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385395|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2385396|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2385397|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
2504246|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2504247|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504248|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504249|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
2504250|NCT01238965|Antidotes|antidotes|mesh-ancestor
2504251|NCT01238965|Protective Agents|protective agents|mesh-ancestor
2504252|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
2504253|NCT01238965|Vitamins|vitamins|mesh-ancestor
2504254|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
2385398|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385399|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385400|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385401|NCT00648960|Clarithromycin|clarithromycin|mesh-list
2385402|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2385403|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385404|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2385405|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385406|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385407|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2385408|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2385409|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
2385410|NCT00648973|Promethazine|promethazine|mesh-list
2385411|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
2385412|NCT00648973|Ephedrine|ephedrine|mesh-list
2385413|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2385414|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2504255|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504256|NCT01238978|Vildagliptin|vildagliptin|mesh-list
2504257|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2504258|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504259|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2504260|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
2504261|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504262|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504263|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2504264|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2504265|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2504266|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
2504267|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504268|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2504269|NCT01239017|Fasinumab|fasinumab|mesh-list
2504270|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2504271|NCT01239017|Analgesics|analgesics|mesh-ancestor
2504272|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
2504273|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504274|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504275|NCT01239030|Methylphenidate|methylphenidate|mesh-list
2504276|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2504277|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504278|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2504279|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2504280|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2504281|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504282|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
2385415|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2385416|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385417|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
2385418|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
2385419|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
2385420|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385421|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
2385422|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
2385423|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385424|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2385425|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
2385426|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
2385427|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385428|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385429|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2385430|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
2385431|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
2385432|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2385433|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2385434|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
2385435|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
2385436|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2385437|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2385438|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
2385439|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
2385440|NCT00648986|Tazarotene|tazarotene|mesh-list
2504283|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504284|NCT01239173|Propranolol|propranolol|mesh-list
2504285|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2504286|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2504287|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
2504288|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504289|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504290|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504291|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2504292|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2504293|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
2504294|NCT01239368|Sirolimus|sirolimus|mesh-list
2504295|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2504296|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504297|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2504298|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504299|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
2504300|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504301|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
2504302|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385441|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
2385442|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
2385443|NCT00648999|Ritonavir|ritonavir|mesh-list
2385444|NCT00648999|Lopinavir|lopinavir|mesh-list
2385445|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2504303|NCT01239459|Teriflunomide|teriflunomide|mesh-list
2504304|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
2504305|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2504306|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2504307|NCT01239459|Analgesics|analgesics|mesh-ancestor
2504308|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
2504309|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504310|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504311|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2504312|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2504313|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504314|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
2504315|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2504316|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2504317|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
2504318|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504319|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2504320|NCT01239485|Irinotecan|irinotecan|mesh-list
2504321|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2504322|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2504323|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504324|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504325|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504326|NCT01239498|Lidocaine|lidocaine|mesh-list
2504327|NCT01239498|Epinephrine|epinephrine|mesh-list
2504328|NCT01239498|Racepinephrine|racepinephrine|mesh-list
2504329|NCT01239498|Anesthetics|anesthetics|mesh-list
2504330|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
2504331|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
2504332|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2504333|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504334|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
2504335|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504336|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2504337|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2504338|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2504339|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2504340|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504341|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2504342|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2504343|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
2504344|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504345|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2504346|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2504347|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
2385446|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2504348|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2504349|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
2504350|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
2504351|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
2504352|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2504353|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
2504354|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2385447|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
2385448|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385449|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504355|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504356|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
2385450|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2385451|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2385452|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
2385453|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385454|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2385455|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2385456|NCT00649012|Pioglitazone|pioglitazone|mesh-list
2385457|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2385458|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385459|NCT00649025|Fluticasone|fluticasone|mesh-list
2385460|NCT00649025|Xhance|xhance|mesh-list
2385461|NCT00649025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2385462|NCT00649025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2385463|NCT00649025|Autonomic Agents|autonomic agents|mesh-ancestor
2385464|NCT00649025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385465|NCT00649025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385466|NCT00649025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2385467|NCT00649025|Respiratory System Agents|respiratory system agents|mesh-ancestor
2385468|NCT00649025|Dermatologic Agents|dermatologic agents|mesh-ancestor
2385469|NCT00649025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2385470|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2385471|NCT00649038|Benazepril|benazepril|mesh-list
2385472|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385473|NCT00649038|Diuretics|diuretics|mesh-ancestor
2385474|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
2385475|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385476|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2385477|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385478|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385479|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2385480|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
2385481|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385482|NCT00649051|Metolazone|metolazone|mesh-list
2385483|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385484|NCT00649051|Diuretics|diuretics|mesh-ancestor
2385485|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
2385486|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385487|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2385488|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385489|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385490|NCT00649064|Ziprasidone|ziprasidone|mesh-list
2385491|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2385492|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
2385493|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385494|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385495|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385496|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2385497|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2385498|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2385499|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2385500|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2385501|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
2385502|NCT00649077|Meloxicam|meloxicam|mesh-list
2385503|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2385504|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2385505|NCT00649077|Analgesics|analgesics|mesh-ancestor
2385506|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
2385507|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385508|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385509|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2385510|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2385511|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2385512|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2504357|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2504358|NCT01239563|Basiliximab|basiliximab|mesh-list
2504359|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
2504360|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504361|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504362|NCT01239719|Clemastine|clemastine|mesh-list
2504363|NCT01239719|Dexamethasone|dexamethasone|mesh-list
2504364|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
2504365|NCT01239719|BB 1101|bb 1101|mesh-list
2504366|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2504367|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
2504368|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
2504369|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504370|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504371|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2504372|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
2504373|NCT01239719|Hormones|hormones|mesh-ancestor
2504374|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2385513|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385514|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385515|NCT00649090|Exemestane|exemestane|mesh-list
2385516|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504375|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2504376|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504377|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
2504378|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504379|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504380|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
2504381|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
2504382|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2504383|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
2504384|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
2504385|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504386|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2504387|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
2504388|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2385517|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2385518|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2385519|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385520|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385521|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2385522|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
2504389|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
2504390|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504391|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
2504392|NCT01239810|Protective Agents|protective agents|mesh-ancestor
2504393|NCT01239849|Atorvastatin|atorvastatin|mesh-list
2504394|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2504395|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2504396|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
2504397|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504398|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2504399|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2504400|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504401|NCT01239875|Vaccines|vaccines|mesh-list
2504402|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2504403|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
2114490|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2114491|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
2114492|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114493|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2184828|NCT00002833|Fludarabine|fludarabine|mesh-list
2385523|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2385524|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385525|NCT00649103|Quinapril|quinapril|mesh-list
2385526|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2385527|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
2385528|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504404|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504405|NCT01239888|Tibolone|tibolone|mesh-list
2504406|NCT01239888|Oxytocin|oxytocin|mesh-list
2504407|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
2504408|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2504409|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504410|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
2504411|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
2504412|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2504413|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2504414|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2504415|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504416|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2504417|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
2504418|NCT01239888|Hormones|hormones|mesh-ancestor
2504419|NCT01239940|Paclitaxel|paclitaxel|mesh-list
2504420|NCT01239940|Everolimus|everolimus|mesh-list
2504421|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2504422|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504423|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
2504424|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
2504425|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
2504426|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385529|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385530|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385531|NCT00649116|Metoprolol|metoprolol|mesh-list
2385532|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2385533|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2504427|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504428|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
2504429|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504430|NCT01239953|Paclitaxel|paclitaxel|mesh-list
2504431|NCT01239953|Everolimus|everolimus|mesh-list
2504432|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2504433|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504434|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
2504435|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
2504436|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
2504437|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504438|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504439|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
2504440|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504441|NCT01240096|Mirtazapine|mirtazapine|mesh-list
2504442|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
2504443|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2504444|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2504445|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
2504446|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
2504447|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504448|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504449|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504450|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2504451|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2504452|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2504453|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2504454|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2504455|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2504456|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
2504457|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2504458|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2504459|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
2504460|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2504461|NCT01240109|Remifentanil|remifentanil|mesh-list
2504462|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2504463|NCT01240109|Narcotics|narcotics|mesh-ancestor
2504464|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2385534|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
2385535|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
2385536|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385537|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504465|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504466|NCT01240109|Analgesics|analgesics|mesh-ancestor
2504467|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
2504468|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504469|NCT01240148|Lidocaine|lidocaine|mesh-list
2504470|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
2504471|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
2504472|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2504473|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504474|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
2504475|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504476|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2504477|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2504478|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2504479|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2504480|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504481|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2504482|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504483|NCT01240213|Vitamin D|vitamin d|mesh-list
2504484|NCT01240213|Vitamins|vitamins|mesh-ancestor
2504485|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
2504486|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385538|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2385539|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2385540|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2385541|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
2385542|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504487|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2504488|NCT01240226|Ketoconazole|ketoconazole|mesh-list
2504489|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
2504490|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504491|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2504492|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2504493|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504494|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504495|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2504496|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
2504497|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2504498|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504499|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2504500|NCT01240252|Insulin|insulin|mesh-list
2504501|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2504502|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2504503|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504504|NCT01240265|Vitamin D|vitamin d|mesh-list
2504505|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
2504506|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
2504507|NCT01240265|Vitamins|vitamins|mesh-list
2385543|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385544|NCT00649129|Oxybutynin|oxybutynin|mesh-list
2385545|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
2385546|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
2385547|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504508|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
2504509|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504510|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2385548|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385549|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2385550|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2385551|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
2385552|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385553|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385554|NCT00649129|Urological Agents|urological agents|mesh-ancestor
2385555|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
2385556|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2385557|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385558|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2385559|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2385560|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385561|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504511|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2504512|NCT01240408|Lenvatinib|lenvatinib|mesh-list
2504513|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504514|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2504515|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504516|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504517|NCT01240512|Vitamin D|vitamin d|mesh-list
2504518|NCT01240512|Cholecalciferol|cholecalciferol|mesh-list
2504519|NCT01240512|Vitamins|vitamins|mesh-ancestor
2504520|NCT01240512|Micronutrients|micronutrients|mesh-ancestor
2504521|NCT01240512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504522|NCT01240512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2504523|NCT01240512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2504524|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
2504525|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2385562|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2385563|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2504526|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
2504527|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504528|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2504529|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2504530|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
2504531|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504532|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504533|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2504534|NCT01240629|Doxorubicin|doxorubicin|mesh-list
2504535|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2504536|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2504537|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504538|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2504539|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2504540|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504541|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504542|NCT01240642|Vadimezan|vadimezan|mesh-list
2504543|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504544|NCT01240655|Paclitaxel|paclitaxel|mesh-list
2504545|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2504546|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504547|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
2504548|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
2504549|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
2504550|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504551|NCT01240759|Metformin|metformin|mesh-list
2504552|NCT01240759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2504553|NCT01240759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504554|NCT01240824|Aminophylline|aminophylline|mesh-list
2504555|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2504556|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
2504557|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504558|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504559|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2504560|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
2504561|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2504562|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2504563|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504564|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504565|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2504566|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2504567|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
2504568|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504569|NCT01240824|Protective Agents|protective agents|mesh-ancestor
2504570|NCT01240850|Prednisone|prednisone|mesh-list
2385564|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2385565|NCT00649168|Bromocriptine|bromocriptine|mesh-list
2385566|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2385567|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2385568|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
2385569|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2385570|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385571|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
2385572|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
2385573|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385574|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385575|NCT00649181|Metolazone|metolazone|mesh-list
2385576|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385577|NCT00649181|Diuretics|diuretics|mesh-ancestor
2385578|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
2385579|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385580|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2385581|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385582|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385583|NCT00649194|Rabeprazole|rabeprazole|mesh-list
2385584|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2385585|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385586|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2504571|NCT01240850|Methotrexate|methotrexate|mesh-list
2504572|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2504573|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
2385587|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504574|NCT01240850|Hormones|hormones|mesh-ancestor
2504575|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2504576|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504577|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2385588|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385589|NCT00649207|Veliparib|veliparib|mesh-list
2385590|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2504578|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504579|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2504580|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
2504581|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2504582|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2504583|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
2504584|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504585|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
2504586|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504587|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2504588|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504589|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
2504590|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2504591|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2504592|NCT01240889|Fluticasone|fluticasone|mesh-list
2504593|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2504594|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2504595|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
2504596|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504597|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504598|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2385591|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385592|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385593|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2385594|NCT00649233|Metoprolol|metoprolol|mesh-list
2385595|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2385596|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385597|NCT00649233|Diuretics|diuretics|mesh-ancestor
2385598|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
2385599|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385600|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2385601|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385602|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385603|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2385604|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
2385605|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
2385606|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385607|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2504599|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
2504600|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
2504601|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2504602|NCT01240928|Exemestane|exemestane|mesh-list
2504603|NCT01240928|Goserelin|goserelin|mesh-list
2504604|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504605|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2504606|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2385608|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2385609|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2385610|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
2385611|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385612|NCT00649259|Oxybutynin|oxybutynin|mesh-list
2385613|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
2385614|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
2385615|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385616|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385617|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2385618|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2385619|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
2385620|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385621|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385622|NCT00649259|Urological Agents|urological agents|mesh-ancestor
2385623|NCT00649272|Oxybutynin|oxybutynin|mesh-list
2385624|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
2385625|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
2385626|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504607|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668482|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504608|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504609|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2504610|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
2504611|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2504612|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504613|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2504614|NCT01240941|Exemestane|exemestane|mesh-list
2504615|NCT01240941|Goserelin|goserelin|mesh-list
2385627|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385628|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2385629|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2385630|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
2385631|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385632|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504616|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504617|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2504618|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2504619|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504620|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504621|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2504622|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
2504623|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2504624|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504625|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2504626|NCT01241006|Dexamethasone|dexamethasone|mesh-list
2504627|NCT01241006|Prednisone|prednisone|mesh-list
2504628|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
2504629|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2504630|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
2504631|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
2504632|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504633|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504634|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2504635|NCT01241006|Hormones|hormones|mesh-ancestor
2504636|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2504637|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2504638|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504639|NCT01241019|Topiramate|topiramate|mesh-list
2504640|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
2504641|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2504642|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504643|NCT01241032|Udenafil|udenafil|mesh-list
2504644|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2504645|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2504646|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504647|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504648|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
2504649|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
2504650|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2385633|NCT00649272|Urological Agents|urological agents|mesh-ancestor
2385634|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
2385635|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2385636|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385637|NCT00649285|Renal Agents|renal agents|mesh-ancestor
2385638|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2385639|NCT00649311|Losartan|losartan|mesh-list
2385640|NCT00649311|Eplerenone|eplerenone|mesh-list
2385641|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2385642|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385643|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2385644|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2385645|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385646|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2385647|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
2385648|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2385649|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385650|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2385651|NCT00649311|Diuretics|diuretics|mesh-ancestor
2385652|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
2385653|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2385654|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385655|NCT00649324|Diuretics|diuretics|mesh-ancestor
2504651|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504652|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2504653|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
2504654|NCT01241097|Simvastatin|simvastatin|mesh-list
2504655|NCT01241097|Ezetimibe|ezetimibe|mesh-list
2504656|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2504657|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2504658|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
2504659|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504660|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2504661|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2504662|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504663|NCT01241110|Ofloxacin|ofloxacin|mesh-list
2504664|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2504665|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504666|NCT01241110|Renal Agents|renal agents|mesh-ancestor
2504667|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2504668|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2504669|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2504670|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504671|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504672|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504673|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2504674|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2504675|NCT01241162|Decitabine|decitabine|mesh-list
2504676|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2504677|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
2504678|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504679|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504680|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504681|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
2504682|NCT01241175|Analgesics|analgesics|mesh-ancestor
2504683|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
2504684|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504685|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504686|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
2504687|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2504688|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2385656|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
2385657|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385658|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2385659|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385660|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385661|NCT00649350|Metformin|metformin|mesh-list
2385662|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2385663|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385664|NCT00649363|Ondansetron|ondansetron|mesh-list
2385665|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
2385666|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
2385667|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504689|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
2504690|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2504691|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2504692|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504693|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2504694|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
2504695|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2504696|NCT01241214|Cetirizine|cetirizine|mesh-list
2504697|NCT01241214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2504698|NCT01241214|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2504699|NCT01241214|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2504700|NCT01241214|Histamine Antagonists|histamine antagonists|mesh-ancestor
2504701|NCT01241214|Histamine Agents|histamine agents|mesh-ancestor
2504702|NCT01241214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504703|NCT01241214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504704|NCT01241214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504705|NCT01241383|Bosentan|bosentan|mesh-list
2504706|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2504707|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2504708|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504709|NCT01241409|Rabeprazole|rabeprazole|mesh-list
2504710|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2504711|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385668|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385669|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385670|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
2385671|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
2385672|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2385673|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
2385674|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385675|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385676|NCT00649363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2385677|NCT00649363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2385678|NCT00649363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2385679|NCT00649363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2504712|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2504713|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504714|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504715|NCT01241422|Montelukast|montelukast|mesh-list
2504716|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2504717|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
2504718|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2504719|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
2504720|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2504721|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504722|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2504723|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2504724|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504725|NCT01241487|Amlodipine|amlodipine|mesh-list
2504726|NCT01241487|Valsartan|valsartan|mesh-list
2504727|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2504728|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2504729|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2504730|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504731|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2385680|NCT00649363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2385681|NCT00649376|Fexofenadine|fexofenadine|mesh-list
2385682|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2385683|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2385684|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2385685|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
2385686|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
2385687|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385688|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385689|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385690|NCT00649402|Amlodipine|amlodipine|mesh-list
2385691|NCT00649402|Benazepril|benazepril|mesh-list
2385692|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385693|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2385694|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385695|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504732|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504733|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
2504734|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2504735|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2504736|NCT01241500|ON 01910|on 01910|mesh-list
2504737|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504738|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2504739|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504740|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504741|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
2504742|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504743|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
2504744|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504745|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2504746|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2504747|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
2504748|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504749|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504750|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2504751|NCT01241708|Bortezomib|bortezomib|mesh-list
2504752|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504753|NCT01241734|Lenalidomide|lenalidomide|mesh-list
2504754|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
2504755|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385696|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2385697|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385698|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
2385699|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2385700|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
2385701|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385702|NCT00649415|Valdecoxib|valdecoxib|mesh-list
2385703|NCT00649415|Piroxicam|piroxicam|mesh-list
2385704|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2385705|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2385706|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385707|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385708|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2385709|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2385710|NCT00649415|Analgesics|analgesics|mesh-ancestor
2385711|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
2385712|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385713|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385714|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2385715|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2385716|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2504756|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2504757|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2504758|NCT01241734|Growth Substances|growth substances|mesh-ancestor
2504759|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
2504760|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504761|NCT01241773|Efavirenz|efavirenz|mesh-list
2504762|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
2504763|NCT01241773|Simeprevir|simeprevir|mesh-list
2504764|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2504765|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2504766|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504767|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504768|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
2504769|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504770|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2504771|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2504772|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2504773|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2504774|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2504775|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2504776|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2504777|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2504778|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2504779|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2504780|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
2504781|NCT01241786|Lenalidomide|lenalidomide|mesh-list
2504782|NCT01241786|Azacitidine|azacitidine|mesh-list
2504783|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
2504784|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504785|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2504786|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2504787|NCT01241786|Growth Substances|growth substances|mesh-ancestor
2504788|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
2504789|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504790|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2504791|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
2504792|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504793|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385717|NCT00649441|Quinapril|quinapril|mesh-list
2385718|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385719|NCT00649441|Diuretics|diuretics|mesh-ancestor
2385720|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
2385721|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385722|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2385723|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385724|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385725|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2385726|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
2385727|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385728|NCT00649454|Metformin|metformin|mesh-list
2504794|NCT01242046|Caffeine|caffeine|mesh-list
2504795|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2385729|NCT00649454|Glipizide|glipizide|mesh-list
2504796|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504797|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2504798|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504799|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385730|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2385731|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385732|NCT00649467|Topiramate|topiramate|mesh-list
2385733|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
2385734|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2504800|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2504801|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2504802|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
2504803|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504804|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
2504805|NCT01242072|Ifosfamide|ifosfamide|mesh-list
2504806|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2504807|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
2504808|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504809|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504810|NCT01242098|Fluticasone|fluticasone|mesh-list
2504811|NCT01242098|Beclomethasone|beclomethasone|mesh-list
2504812|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
2504813|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2504814|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2504815|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2504816|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
2504817|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504818|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504819|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2504820|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
2385735|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385736|NCT00649480|Balsalazide|balsalazide|mesh-list
2385737|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2385738|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2385739|NCT00649480|Analgesics|analgesics|mesh-ancestor
2385740|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
2385741|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385742|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385743|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2385744|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2385745|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385746|NCT00649493|Rabeprazole|rabeprazole|mesh-list
2385747|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2385748|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385749|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2504821|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
2504822|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2504823|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2504824|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2504825|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2504826|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
2504827|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504828|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504829|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
2504830|NCT01242098|Hormones|hormones|mesh-ancestor
2504831|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2504832|NCT01242202|Acarbose|acarbose|mesh-list
2504833|NCT01242202|Voglibose|voglibose|mesh-list
2504834|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
2504835|NCT01242202|Miglitol|miglitol|mesh-list
2504836|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
2504837|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504838|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504839|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2504840|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504841|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2504842|NCT01242215|Glimepiride|glimepiride|mesh-list
2504843|NCT01242215|Gliclazide|gliclazide|mesh-list
2504844|NCT01242215|Glyburide|glyburide|mesh-list
2504845|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
2504846|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2504847|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2504848|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385750|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504849|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504850|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
2504851|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2504852|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504853|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2385751|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385752|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
2385753|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2385754|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385755|NCT00649506|Renal Agents|renal agents|mesh-ancestor
2385756|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2385757|NCT00649519|Amlodipine|amlodipine|mesh-list
2385758|NCT00649519|Benazepril|benazepril|mesh-list
2385759|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2504854|NCT01242228|Vildagliptin|vildagliptin|mesh-list
2504855|NCT01242228|Saxagliptin|saxagliptin|mesh-list
2504856|NCT01242228|Alogliptin|alogliptin|mesh-list
2504857|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
2504858|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2504859|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2504860|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504861|NCT01242228|Incretins|incretins|mesh-ancestor
2504862|NCT01242228|Hormones|hormones|mesh-ancestor
2504863|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2504864|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
2504865|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504866|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504867|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2504868|NCT01242267|Thalidomide|thalidomide|mesh-list
2504869|NCT01242267|Bortezomib|bortezomib|mesh-list
2504870|NCT01242267|Melphalan|melphalan|mesh-list
2504871|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504872|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2504873|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
2504874|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504875|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2504876|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504877|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
2504878|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504879|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
2504880|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2504881|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504882|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2504883|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2504884|NCT01242267|Growth Substances|growth substances|mesh-ancestor
2504885|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
2504886|NCT01242306|Acetylcholine|acetylcholine|mesh-list
2504887|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
2504888|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2504889|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
2504890|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385760|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2385761|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2504891|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504892|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504893|NCT01242332|Pregabalin|pregabalin|mesh-list
2504894|NCT01242332|Analgesics|analgesics|mesh-ancestor
2504895|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
2504896|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2504897|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504898|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
2504899|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2504900|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2504901|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504902|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2504903|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2504904|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2504905|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2504906|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2504907|NCT01242384|Silicon|silicon|mesh-list
2385762|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385763|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2385764|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385765|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
2385766|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2504908|NCT01242384|Trace Elements|trace elements|mesh-ancestor
2504909|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
2504910|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504911|NCT01242410|Silicon|silicon|mesh-list
2504912|NCT01242410|Trace Elements|trace elements|mesh-ancestor
2504913|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
2504914|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504915|NCT01242449|Trastuzumab|trastuzumab|mesh-list
2504916|NCT01242449|Vinorelbine|vinorelbine|mesh-list
2504917|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2504918|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504919|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2504920|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
2504921|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
2504922|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
2504923|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504924|NCT01242566|Temozolomide|temozolomide|mesh-list
2504925|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2504926|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
2504927|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504928|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504929|NCT01242579|Maraviroc|maraviroc|mesh-list
2504930|NCT01242579|Dapivirine|dapivirine|mesh-list
2504931|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2504932|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2504933|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385767|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
2385768|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385769|NCT00649532|Ondansetron|ondansetron|mesh-list
2385770|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
2385771|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
2385772|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385773|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385774|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385775|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
2385776|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
2385777|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2385778|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
2385779|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385780|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385781|NCT00649532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2504934|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2504935|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2504936|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
2504937|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504938|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2504939|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
2504940|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2504941|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504942|NCT01242605|Gemcitabine|gemcitabine|mesh-list
2504943|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504944|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2504945|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
2504946|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504947|NCT01242605|Antiviral Agents|antiviral agents|mesh-ancestor
2504948|NCT01242605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504949|NCT01242605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504950|NCT01242605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504951|NCT01242605|Immunologic Factors|immunologic factors|mesh-ancestor
2504952|NCT01242605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504953|NCT01242631|Everolimus|everolimus|mesh-list
2504954|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504955|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2504956|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
2504957|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504958|NCT01242774|Panobinostat|panobinostat|mesh-list
2504959|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2504960|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2504961|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504962|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504963|NCT01242787|Entecavir|entecavir|mesh-list
2504964|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
2504965|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2504966|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
2504967|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
2504968|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2385782|NCT00649532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2504969|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504970|NCT01242904|Icodextrin|icodextrin|mesh-list
2504971|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
2504972|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2504973|NCT01242930|Niacinamide|niacinamide|mesh-list
2504974|NCT01242930|Lenalidomide|lenalidomide|mesh-list
2504975|NCT01242930|Imetelstat|imetelstat|mesh-list
2504976|NCT01242930|Motesanib diphosphate|motesanib diphosphate|mesh-list
2504977|NCT01242930|Immunologic Factors|immunologic factors|mesh-ancestor
2504978|NCT01242930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385783|NCT00649532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2385784|NCT00649532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2385785|NCT00649532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2385786|NCT00649545|Adalimumab|adalimumab|mesh-list
2385787|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2385788|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2385789|NCT00649558|Pioglitazone|pioglitazone|mesh-list
2385790|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2385791|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385792|NCT00649571|Doxycycline|doxycycline|mesh-list
2385793|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2385794|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385795|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
2385796|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2385797|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2385798|NCT00649584|Gemcitabine|gemcitabine|mesh-list
2385799|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2385800|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2385801|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
2385802|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385803|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2385804|NCT00649584|Antiviral Agents|antiviral agents|mesh-ancestor
2385805|NCT00649584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385806|NCT00649584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385807|NCT00649584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2385808|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
2504979|NCT01242930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2504980|NCT01242930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2504981|NCT01242930|Growth Substances|growth substances|mesh-ancestor
2504982|NCT01242930|Growth Inhibitors|growth inhibitors|mesh-ancestor
2504983|NCT01242930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2385809|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385810|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2385811|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2385812|NCT00649597|Benazepril|benazepril|mesh-list
2385813|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385814|NCT00649597|Diuretics|diuretics|mesh-ancestor
2385815|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
2385816|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385817|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2385818|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385819|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385820|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2385821|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
2385822|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385823|NCT00649610|Diclofenac|diclofenac|mesh-list
2385824|NCT00649610|Valdecoxib|valdecoxib|mesh-list
2385825|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2385826|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2385827|NCT00649610|Analgesics|analgesics|mesh-ancestor
2385828|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
2385829|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385830|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385831|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2385832|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2385833|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2385834|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385835|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385836|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2385837|NCT00649623|Olmesartan|olmesartan|mesh-list
2385838|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2385839|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385840|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2385841|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2385842|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504984|NCT01242930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2504985|NCT01242930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2504986|NCT01242930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2504987|NCT01242930|Vitamin B Complex|vitamin b complex|mesh-ancestor
2504988|NCT01242930|Vitamins|vitamins|mesh-ancestor
2504989|NCT01242930|Micronutrients|micronutrients|mesh-ancestor
2504990|NCT01243060|Zolpidem|zolpidem|mesh-list
2504991|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2504992|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2504993|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2504994|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2504995|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2504996|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
2504997|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
2504998|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2504999|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505000|NCT01243073|Imetelstat|imetelstat|mesh-list
2505001|NCT01243073|Motesanib diphosphate|motesanib diphosphate|mesh-list
2505002|NCT01243073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505003|NCT01243073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505004|NCT01243073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2505005|NCT01243086|Dexamethasone|dexamethasone|mesh-list
2505006|NCT01243086|Ranibizumab|ranibizumab|mesh-list
2505007|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505008|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
2505009|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
2505010|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385843|NCT00649636|Fluoxetine|fluoxetine|mesh-list
2385844|NCT00649636|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2385845|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2385846|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385847|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385848|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385849|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
2385850|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385851|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2385852|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
2385853|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2385854|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2505011|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505012|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2505013|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
2505014|NCT01243086|Hormones|hormones|mesh-ancestor
2505015|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2505016|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2505017|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505018|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2505019|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2505020|NCT01243086|Growth Substances|growth substances|mesh-ancestor
2505021|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
2505022|NCT01243190|Ofatumumab|ofatumumab|mesh-list
2505023|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505024|NCT01243203|Varenicline|varenicline|mesh-list
2505025|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2505026|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2505027|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
2505028|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505029|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505030|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505031|NCT01243281|Entecavir|entecavir|mesh-list
2505032|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
2505033|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505034|NCT01243346|Crenolanib|crenolanib|mesh-list
2505035|NCT01243346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505036|NCT01243359|Bevacizumab|bevacizumab|mesh-list
2505037|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2505038|NCT01243359|Sunitinib|sunitinib|mesh-list
2505039|NCT01243359|Antibodies|antibodies|mesh-list
2505040|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
2505041|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2505042|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2385855|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2385856|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385857|NCT00649649|Quinapril|quinapril|mesh-list
2385858|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2385859|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
2505043|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2505044|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2505045|NCT01243359|Growth Substances|growth substances|mesh-ancestor
2505046|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505047|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
2505048|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
2505049|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2505050|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505051|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505052|NCT01243385|Metformin|metformin|mesh-list
2505053|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2505054|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505055|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
2505056|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2505057|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505058|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2505059|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2505060|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505061|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505062|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505063|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2505064|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2505065|NCT01243476|Lenalidomide|lenalidomide|mesh-list
2505066|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
2505067|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505068|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2505069|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2505070|NCT01243476|Growth Substances|growth substances|mesh-ancestor
2505071|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
2505072|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505073|NCT01243528|Vitamin D|vitamin d|mesh-list
2505074|NCT01243528|Vitamins|vitamins|mesh-ancestor
2505075|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
2505076|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505077|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2505078|NCT01243632|Gemcitabine|gemcitabine|mesh-list
2505079|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2505080|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
2505081|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505082|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505083|NCT01243632|Antiviral Agents|antiviral agents|mesh-ancestor
2505084|NCT01243632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505085|NCT01243632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505086|NCT01243632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2505087|NCT01243632|Immunologic Factors|immunologic factors|mesh-ancestor
2505088|NCT01243632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505089|NCT01243658|Oxytocin|oxytocin|mesh-list
2505090|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
2505091|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2505092|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505093|NCT01243697|Desogestrel|desogestrel|mesh-list
2505094|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2385860|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422933|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2505095|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2505096|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2505097|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
2505098|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2505099|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505100|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2505101|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2505102|NCT01243697|Progestins|progestins|mesh-ancestor
2505103|NCT01243697|Hormones|hormones|mesh-ancestor
2505104|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2505105|NCT01243710|Taurolidine|taurolidine|mesh-list
2505106|NCT01243710|Heparin|heparin|mesh-list
2505107|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
2505108|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2505109|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2505110|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505111|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505112|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2505113|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505114|NCT01243736|Metoclopramide|metoclopramide|mesh-list
2505115|NCT01243736|Simethicone|simethicone|mesh-list
2505116|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
2505117|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
2385861|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385862|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385863|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
2385864|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2385865|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385866|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2385867|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2385868|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385869|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385870|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505118|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505119|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505120|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2505121|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2505122|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2505123|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
2505124|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385871|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2385872|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2385873|NCT00649675|Meloxicam|meloxicam|mesh-list
2385874|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2385875|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2385876|NCT00649675|Analgesics|analgesics|mesh-ancestor
2385877|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
2385878|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385879|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385880|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2385881|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2385882|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2385883|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2385884|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2385885|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385886|NCT00649688|Metoprolol|metoprolol|mesh-list
2385887|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2385888|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2385889|NCT00649688|Diuretics|diuretics|mesh-ancestor
2385890|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
2385891|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385892|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2385893|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385894|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385895|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2385896|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
2385897|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
2385898|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385899|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2385900|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2385901|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2385902|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
2385903|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385904|NCT00649714|Zonisamide|zonisamide|mesh-list
2385905|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
2505125|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505126|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
2505127|NCT01243736|Emollients|emollients|mesh-ancestor
2505128|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
2505129|NCT01243788|Fluticasone|fluticasone|mesh-list
2505130|NCT01243788|Xhance|xhance|mesh-list
2505131|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2505132|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505133|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2505134|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
2505135|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505136|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505137|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2385906|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2385907|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385908|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385909|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2385910|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385911|NCT00649727|Oxybutynin|oxybutynin|mesh-list
2385912|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
2505138|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
2505139|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
2505140|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2505141|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2505142|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2505143|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2505144|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
2505145|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505146|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505147|NCT01243801|Ketamine|ketamine|mesh-list
2505148|NCT01243801|Analgesics|analgesics|mesh-ancestor
2505149|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
2505150|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385913|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
2385914|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385915|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385916|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2385917|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2385918|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
2385919|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385920|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385921|NCT00649727|Urological Agents|urological agents|mesh-ancestor
2385922|NCT00649740|Topiramate|topiramate|mesh-list
2385923|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
2385924|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2385925|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385926|NCT00649779|Albuterol|albuterol|mesh-list
2505151|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505152|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2505153|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2505154|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
2505155|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
2505156|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2505157|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2505158|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2505159|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505160|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505161|NCT01243827|Carvedilol|carvedilol|mesh-list
2505162|NCT01243827|Bisoprolol|bisoprolol|mesh-list
2505163|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2505164|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2505165|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
2505166|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385927|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2385928|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
2385929|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385930|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385931|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2385932|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
2385933|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
2385934|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2385935|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2385936|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2385937|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2385938|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
2385939|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385940|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385941|NCT00649805|Verapamil|verapamil|mesh-list
2385942|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2385943|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2385944|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2385945|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385946|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2385947|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385948|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
2385949|NCT00649818|Lorazepam|lorazepam|mesh-list
2385950|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
2385951|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
2385952|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
2385953|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2385954|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385955|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2385956|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2385957|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2385958|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2505167|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505168|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505169|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2505170|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
2505171|NCT01243827|Protective Agents|protective agents|mesh-ancestor
2505172|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2505173|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2505174|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2505175|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
2505176|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2505177|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2505178|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
2505179|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
2505180|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505181|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2505182|NCT01243970|Phenylephrine|phenylephrine|mesh-list
2505183|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
2505184|NCT01243970|Ephedrine|ephedrine|mesh-list
2505185|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2505186|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
2505187|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
2505188|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505189|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505190|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
2505191|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2505192|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
2505193|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
2505194|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2505195|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2505196|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2505197|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
2385959|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2385960|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2385961|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
2385962|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
2385963|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385964|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385965|NCT00649831|Amoxicillin|amoxicillin|mesh-list
2385966|NCT00649831|Azithromycin|azithromycin|mesh-list
2385967|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2385968|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385969|NCT00649844|Ziprasidone|ziprasidone|mesh-list
2385970|NCT00649844|Clozapine|clozapine|mesh-list
2385971|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2385972|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
2385973|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385974|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385975|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385976|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2385977|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2385978|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2385979|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2385980|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2505198|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505199|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505200|NCT01243970|Protective Agents|protective agents|mesh-ancestor
2505201|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2505202|NCT01243996|Ibuprofen|ibuprofen|mesh-list
2505203|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2505204|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2505205|NCT01243996|Analgesics|analgesics|mesh-ancestor
2505206|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
2505207|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505208|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505209|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505210|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2505211|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2505212|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505213|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505214|NCT01244009|Niraparib|niraparib|mesh-list
2505215|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2505216|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505217|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505218|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505219|NCT01244100|Aspirin|aspirin|mesh-list
2505220|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2505221|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2505222|NCT01244100|Analgesics|analgesics|mesh-ancestor
2505223|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
2505224|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505225|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505226|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505227|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2505228|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2505229|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2505230|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505231|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2505232|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2505233|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505234|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
2505235|NCT01244113|Propofol|propofol|mesh-list
2505236|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2505237|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2505238|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505239|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2505240|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
2385981|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
2385982|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
2385983|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
2385984|NCT00649857|Cetirizine|cetirizine|mesh-list
2385985|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2385986|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2385987|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2385988|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
2385989|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
2385990|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2385991|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2385992|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385993|NCT00649870|Valacyclovir|valacyclovir|mesh-list
2505241|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
2505242|NCT01244178|Insulin|insulin|mesh-list
2505243|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2385994|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
2385995|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2385996|NCT00649883|Vaccines|vaccines|mesh-list
2385997|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
2385998|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2385999|NCT00649896|Estradiol|estradiol|mesh-list
2386000|NCT00649896|Estrogens|estrogens|mesh-ancestor
2386001|NCT00649896|Hormones|hormones|mesh-ancestor
2386002|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386003|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386004|NCT00649922|Adalimumab|adalimumab|mesh-list
2386005|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386006|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2386007|NCT00649935|Azithromycin|azithromycin|mesh-list
2386008|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2386009|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386010|NCT00649948|Metformin|metformin|mesh-list
2386011|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2386012|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386013|NCT00649974|Valacyclovir|valacyclovir|mesh-list
2386014|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
2386015|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386016|NCT00649987|Albuterol|albuterol|mesh-list
2386017|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2386018|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
2386019|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386020|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386021|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2386022|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
2505244|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2505245|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505246|NCT01244204|Vitamin D|vitamin d|mesh-list
2505247|NCT01244204|Vitamins|vitamins|mesh-ancestor
2505248|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
2505249|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386023|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
2386024|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2386025|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2386026|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2505250|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2386027|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2386028|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
2386029|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386030|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505251|NCT01244217|Fexofenadine|fexofenadine|mesh-list
2505252|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2505253|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2505254|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2505255|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
2505256|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
2505257|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505258|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505259|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505260|NCT01244230|Fexofenadine|fexofenadine|mesh-list
2505261|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2505262|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2505263|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2505264|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
2505265|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
2505266|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505267|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505268|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505269|NCT01244256|Gentamicins|gentamicins|mesh-list
2505270|NCT01244256|Clotrimazole|clotrimazole|mesh-list
2505271|NCT01244256|Miconazole|miconazole|mesh-list
2505272|NCT01244256|Beclomethasone|beclomethasone|mesh-list
2505273|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2505274|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505275|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2505276|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505277|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505278|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505279|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
2505280|NCT01244256|Hormones|hormones|mesh-ancestor
2505281|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2505282|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505283|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2505284|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
2505285|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2505286|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
2505287|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2505288|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2505289|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2505290|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
2505291|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2505292|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2505293|NCT01244269|Methylphenidate|methylphenidate|mesh-list
2505294|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2505295|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505296|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2505297|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2505298|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2505299|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505300|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
2505301|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505302|NCT01244334|Prednisolone|prednisolone|mesh-list
2505303|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2505304|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
2505305|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2505306|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
2505307|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2505308|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
2505309|NCT01244334|Difluprednate|difluprednate|mesh-list
2505310|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505311|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
2505312|NCT01244334|Hormones|hormones|mesh-ancestor
2505313|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2505314|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505315|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2505316|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505317|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
2505318|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
2505319|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505320|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2505321|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2505322|NCT01244334|Protective Agents|protective agents|mesh-ancestor
2505323|NCT01244347|Folic Acid|folic acid|mesh-list
2505324|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
2505325|NCT01244347|Hematinics|hematinics|mesh-ancestor
2505326|NCT01244347|Vitamins|vitamins|mesh-ancestor
2505327|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
2505328|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505329|NCT01244360|Resveratrol|resveratrol|mesh-list
2505330|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
2505331|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505332|NCT01244360|Protective Agents|protective agents|mesh-ancestor
2505333|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505334|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386031|NCT00650000|Modafinil|modafinil|mesh-list
2386032|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2386033|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386034|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2386035|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2386036|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2386037|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386038|NCT00650013|Midodrine|midodrine|mesh-list
2386039|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
2386040|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
2386041|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386042|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386043|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2386044|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2386045|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2505335|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2505336|NCT01244399|Inositol|inositol|mesh-list
2505337|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
2505338|NCT01244399|Vitamins|vitamins|mesh-ancestor
2505339|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
2505340|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505341|NCT01244581|Amoxicillin|amoxicillin|mesh-list
2505342|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
2505343|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
2505344|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2505345|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2505346|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505347|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2505348|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386046|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2386047|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
2386048|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386049|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386050|NCT00650026|Adalimumab|adalimumab|mesh-list
2386051|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386052|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2386053|NCT00650039|Valdecoxib|valdecoxib|mesh-list
2386054|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2386055|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2386056|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386057|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386058|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2386059|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2386060|NCT00650039|Analgesics|analgesics|mesh-ancestor
2386061|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
2386062|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386063|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386064|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386065|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2386066|NCT00650052|Zonisamide|zonisamide|mesh-list
2386067|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
2386068|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2505349|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505350|NCT01244659|Tacrolimus|tacrolimus|mesh-list
2505351|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2505352|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
2505353|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505354|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2505355|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505356|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505357|NCT01244698|Clindamycin|clindamycin|mesh-list
2505358|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
2505359|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
2505360|NCT01244698|Cefazolin|cefazolin|mesh-list
2505361|NCT01244698|Cefadroxil|cefadroxil|mesh-list
2505362|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2505363|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505364|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2505365|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505366|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505367|NCT01244789|Paclitaxel|paclitaxel|mesh-list
2505368|NCT01244789|Carboplatin|carboplatin|mesh-list
2505369|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2505370|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505371|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
2505372|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
2386069|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2386070|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386071|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2386072|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386073|NCT00650065|Cetirizine|cetirizine|mesh-list
2386074|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2386075|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2386076|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2386077|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
2386078|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
2386079|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386080|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386081|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386082|NCT00650117|Fentanyl|fentanyl|mesh-list
2386083|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2386084|NCT00650117|Narcotics|narcotics|mesh-ancestor
2386085|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2386086|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386087|NCT00650117|Analgesics|analgesics|mesh-ancestor
2386088|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
2386089|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386090|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2386091|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2386092|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
2386093|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
2386094|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2386095|NCT00650143|Lenograstim|lenograstim|mesh-list
2386096|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2386097|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386098|NCT00650143|Incretins|incretins|mesh-ancestor
2386099|NCT00650143|Hormones|hormones|mesh-ancestor
2386100|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386101|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2386102|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
2386103|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386104|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386105|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2386106|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
2386107|NCT00650156|Adalimumab|adalimumab|mesh-list
2386108|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505373|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
2505374|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505375|NCT01244880|Ketamine|ketamine|mesh-list
2505376|NCT01244880|Analgesics|analgesics|mesh-ancestor
2505377|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
2505378|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505379|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505380|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2505381|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2505382|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
2505383|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
2505384|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2505385|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2505386|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2505387|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505388|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505389|NCT01244932|Bupivacaine|bupivacaine|mesh-list
2505390|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
2505391|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
2505392|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2505393|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505394|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
2505395|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386109|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2386110|NCT00650169|Clopidogrel|clopidogrel|mesh-list
2386111|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2386112|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2386113|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2386114|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2386115|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
2386116|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386117|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386118|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386119|NCT00650182|Fentanyl|fentanyl|mesh-list
2386120|NCT00650182|Naltrexone|naltrexone|mesh-list
2386121|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2386122|NCT00650182|Narcotics|narcotics|mesh-ancestor
2386123|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2386124|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386125|NCT00650182|Analgesics|analgesics|mesh-ancestor
2505396|NCT01244958|Rituximab|rituximab|mesh-list
2505397|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2505398|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505399|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
2505400|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386126|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
2386127|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386128|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2386129|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2386130|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
2386131|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
2386132|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2386133|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2386134|NCT00650195|Metolazone|metolazone|mesh-list
2386135|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2505401|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2505402|NCT01244971|Acarbose|acarbose|mesh-list
2505403|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2505404|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505405|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505406|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2505407|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505408|NCT01245166|Metformin|metformin|mesh-list
2505409|NCT01245166|Acarbose|acarbose|mesh-list
2505410|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2505411|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505412|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2505413|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386136|NCT00650195|Diuretics|diuretics|mesh-ancestor
2386137|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
2386138|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386139|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2386140|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2386141|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386142|NCT00650208|Lamotrigine|lamotrigine|mesh-list
2386143|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
2386144|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2505414|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505415|NCT01245179|Panobinostat|panobinostat|mesh-list
2505416|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505417|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2505418|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505419|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505420|NCT01245205|Lapatinib|lapatinib|mesh-list
2505421|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505422|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2505423|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505424|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505425|NCT01245244|Morphine|morphine|mesh-list
2505426|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2505427|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2505428|NCT01245244|Narcotics|narcotics|mesh-ancestor
2505429|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2386145|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2386146|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386147|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2386148|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386149|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2386150|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2386151|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2386152|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2386153|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2386154|NCT00650221|Pravastatin|pravastatin|mesh-list
2386155|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2386156|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2386157|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
2386158|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386159|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386160|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2505430|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505431|NCT01245244|Analgesics|analgesics|mesh-ancestor
2505432|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
2505433|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505434|NCT01245361|Infliximab|infliximab|mesh-list
2505435|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
2505436|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2505437|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2505438|NCT01245452|Methotrexate|methotrexate|mesh-list
2505439|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2505440|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
2505441|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2505442|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505443|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2505444|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
2505445|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505446|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505447|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
2505448|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505449|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2505450|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2505451|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
2505452|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2505453|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2505454|NCT01245530|Donepezil|donepezil|mesh-list
2505455|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2505456|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505457|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505458|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
2505459|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505460|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505461|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
2505462|NCT01245543|Docetaxel|docetaxel|mesh-list
2505463|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505464|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
2505465|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
2505466|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
2505467|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505468|NCT01245556|Ipilimumab|ipilimumab|mesh-list
2505469|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2505470|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505471|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2505472|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505473|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2505474|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2505475|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
2505476|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505477|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505478|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2505479|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
2505480|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
2505481|NCT01245569|Hormones|hormones|mesh-ancestor
2505482|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2505483|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
2505484|NCT01245582|Capecitabine|capecitabine|mesh-list
2505485|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
2505486|NCT01245582|Sorafenib|sorafenib|mesh-list
2505487|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2505488|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
2505489|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505490|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505491|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2505492|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505493|NCT01245660|Lapatinib|lapatinib|mesh-list
2505494|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505495|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2505496|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505497|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505498|NCT01245725|Tirofiban|tirofiban|mesh-list
2505499|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2505500|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2505501|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505502|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2505503|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2505504|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2505505|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2505506|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
2505507|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505508|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2505509|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2505510|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505511|NCT01245816|Eflornithine|eflornithine|mesh-list
2505512|NCT01245816|Sulindac|sulindac|mesh-list
2505513|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505514|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2505515|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2505516|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2505517|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505518|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2505519|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505520|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505521|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2505522|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2505523|NCT01245816|Analgesics|analgesics|mesh-ancestor
2505524|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
2505525|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505526|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505527|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505528|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2505529|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2505530|NCT01245855|Alprostadil|alprostadil|mesh-list
2505531|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2505532|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
2505533|NCT01245855|Urological Agents|urological agents|mesh-ancestor
2505534|NCT01245868|Lidocaine|lidocaine|mesh-list
2386161|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386162|NCT00650234|Metformin|metformin|mesh-list
2386163|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2386164|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386165|NCT00650247|Sumatriptan|sumatriptan|mesh-list
2386166|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2386167|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2386168|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2386169|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
2386170|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386171|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386172|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386173|NCT00650273|Azithromycin|azithromycin|mesh-list
2386174|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2386175|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386176|NCT00650286|Modafinil|modafinil|mesh-list
2386177|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2386178|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386179|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2386180|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2386181|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2386182|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386183|NCT00650299|Alprazolam|alprazolam|mesh-list
2505535|NCT01245868|Bupivacaine|bupivacaine|mesh-list
2505536|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
2505537|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
2505538|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2505539|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505540|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
2505541|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505542|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2505543|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2505544|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2505545|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2505546|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505547|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
2505548|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2505549|NCT01245881|Protective Agents|protective agents|mesh-ancestor
2505550|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505551|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
2505552|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2505553|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2505554|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2505555|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
2505556|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505557|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2505558|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2505559|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505560|NCT01245946|Doxycycline|doxycycline|mesh-list
2505561|NCT01245946|Adapalene|adapalene|mesh-list
2505562|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2505563|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505564|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
2505565|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2505566|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2505567|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2505568|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2505569|NCT01245946|Analgesics|analgesics|mesh-ancestor
2505570|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
2505571|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505572|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505573|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505574|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2505575|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
2505576|NCT01245959|Cisplatin|cisplatin|mesh-list
2505577|NCT01245959|Docetaxel|docetaxel|mesh-list
2505578|NCT01245959|Fluorouracil|fluorouracil|mesh-list
2505579|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505580|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
2505581|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
2505582|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
2505583|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505584|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
2386184|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2386185|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2386186|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386187|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2386188|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2386189|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2386190|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
2386191|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
2386192|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386193|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386194|NCT00650312|Metformin|metformin|mesh-list
2386195|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2386196|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386197|NCT00650325|Sertraline|sertraline|mesh-list
2386198|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
2386199|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2386200|NCT00650325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2386201|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2505585|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2505586|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2505587|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
2505588|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505589|NCT01245998|Dalteparin|dalteparin|mesh-list
2505590|NCT01245998|Tinzaparin|tinzaparin|mesh-list
2505591|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2505592|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
2505593|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2505594|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2386202|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2386203|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386204|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386205|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
2386206|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386207|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2386208|NCT00650338|Latanoprost|latanoprost|mesh-list
2386209|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2386210|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
2386211|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2505595|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505596|NCT01246037|Bisoprolol|bisoprolol|mesh-list
2505597|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2505598|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
2505599|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
2505600|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505601|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505602|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2505603|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2505604|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2505605|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
2505606|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505607|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505608|NCT01246089|Ranibizumab|ranibizumab|mesh-list
2386212|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386213|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2386214|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2386215|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386216|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386217|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2386218|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2386219|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2386220|NCT00650364|Midodrine|midodrine|mesh-list
2386221|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
2386222|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
2386223|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386224|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386225|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2386226|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2386227|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2386228|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2386229|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
2386230|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386231|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386232|NCT00650377|Finasteride|finasteride|mesh-list
2386233|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2386234|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2386235|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386236|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505609|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2505610|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2505611|NCT01246089|Growth Substances|growth substances|mesh-ancestor
2505612|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505613|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
2505614|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505615|NCT01246180|Diclofenac|diclofenac|mesh-list
2505616|NCT01246180|Amiloride|amiloride|mesh-list
2505617|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2505618|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2505619|NCT01246180|Analgesics|analgesics|mesh-ancestor
2505620|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
2505621|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505622|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505623|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386237|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
2386238|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386239|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386240|NCT00650377|Urological Agents|urological agents|mesh-ancestor
2386241|NCT00650390|Adalimumab|adalimumab|mesh-list
2386242|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386243|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2386244|NCT00650403|Paroxetine|paroxetine|mesh-list
2422934|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
2386245|NCT00650403|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2386246|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2386247|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2386248|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386249|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386250|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
2386251|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505624|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2505625|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2505626|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505627|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505628|NCT01246180|Diuretics|diuretics|mesh-ancestor
2505629|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
2505630|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2505631|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2505632|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2505633|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2505634|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2505635|NCT01246232|Amisulpride|amisulpride|mesh-list
2505636|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2505637|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2505638|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2505639|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505640|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2505641|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2505642|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
2505643|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505644|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505645|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2505646|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
2505647|NCT01246284|Triamcinolone|triamcinolone|mesh-list
2505648|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2505649|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2505650|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2505651|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505652|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
2505653|NCT01246284|Hormones|hormones|mesh-ancestor
2505654|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2505655|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505656|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2505657|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
2505658|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505659|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505660|NCT01246310|Inositol|inositol|mesh-list
2505661|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
2505662|NCT01246310|Vitamins|vitamins|mesh-ancestor
2505663|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
2505664|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505665|NCT01246323|Fentanyl|fentanyl|mesh-list
2505666|NCT01246323|Morphine|morphine|mesh-list
2386252|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2386253|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
2386254|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2386255|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2386256|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2505667|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
2505668|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2505669|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505670|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2505671|NCT01246323|Narcotics|narcotics|mesh-ancestor
2505672|NCT01246323|Analgesics|analgesics|mesh-ancestor
2505673|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
2505674|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505675|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2505676|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2505677|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
2505678|NCT01246362|Etoricoxib|etoricoxib|mesh-list
2505679|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2386257|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386258|NCT00650416|Carvedilol|carvedilol|mesh-list
2386259|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2386260|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2386261|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
2386262|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386263|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386264|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386265|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2386266|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
2386267|NCT00650416|Protective Agents|protective agents|mesh-ancestor
2386268|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2386269|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2386270|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2386271|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
2386272|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2386273|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2386274|NCT00650429|Ziprasidone|ziprasidone|mesh-list
2386275|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2505680|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2505681|NCT01246362|Analgesics|analgesics|mesh-ancestor
2505682|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
2505683|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505684|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505685|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505686|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2505687|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2505688|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2505689|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505690|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505691|NCT01246440|Catumaxomab|catumaxomab|mesh-list
2505692|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2505693|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2505694|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2505695|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2505696|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505697|NCT01246557|Dexamethasone|dexamethasone|mesh-list
2505698|NCT01246557|Lenalidomide|lenalidomide|mesh-list
2505699|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505700|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
2505701|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
2505702|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505703|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505704|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2505705|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
2505706|NCT01246557|Hormones|hormones|mesh-ancestor
2505707|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2505708|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2505709|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505710|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
2505711|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2505712|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2505713|NCT01246557|Growth Substances|growth substances|mesh-ancestor
2505714|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
2505715|NCT01246622|Cytarabine|cytarabine|mesh-list
2505716|NCT01246622|Lenalidomide|lenalidomide|mesh-list
2505717|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2386276|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
2386277|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386278|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386279|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386280|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2386281|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2386282|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2386283|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2386284|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2386285|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
2386286|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2386287|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2386288|NCT00650442|Estradiol|estradiol|mesh-list
2386289|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2386290|NCT00650442|Estrogens|estrogens|mesh-ancestor
2386291|NCT00650442|Hormones|hormones|mesh-ancestor
2386292|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386293|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386294|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2386295|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
2386296|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2386297|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2505718|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
2505719|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505720|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505721|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
2505722|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505723|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2505724|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
2505725|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505726|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2505727|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2505728|NCT01246622|Growth Substances|growth substances|mesh-ancestor
2505729|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
2505730|NCT01246752|Cytarabine|cytarabine|mesh-list
2505731|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2505732|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
2505733|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505734|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505735|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
2505736|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505737|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2505738|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
2505739|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505740|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
2505741|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2505742|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2505743|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
2505744|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505745|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2505746|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2505747|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505748|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505749|NCT01246817|Sirolimus|sirolimus|mesh-list
2505750|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2505751|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505752|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2505753|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505754|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
2505755|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2505756|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
2505757|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505758|NCT01246921|Fluticasone|fluticasone|mesh-list
2505759|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505760|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2386298|NCT00650455|Naproxen|naproxen|mesh-list
2386299|NCT00650455|Valdecoxib|valdecoxib|mesh-list
2386300|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2386301|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2386302|NCT00650455|Analgesics|analgesics|mesh-ancestor
2386303|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
2386304|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386305|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386306|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386307|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2386308|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
2386309|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2386310|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386311|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386312|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2386313|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
2386314|NCT00650468|Prednisone|prednisone|mesh-list
2386315|NCT00650468|Tacrolimus|tacrolimus|mesh-list
2386316|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386317|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
2386318|NCT00650468|Hormones|hormones|mesh-ancestor
2386319|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386320|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386321|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2386322|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2386323|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2386324|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
2386325|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2386326|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386327|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386328|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2386329|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2505761|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
2505762|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505763|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505764|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2505765|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
2505766|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
2505767|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2505768|NCT01247077|Selenium|selenium|mesh-list
2505769|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
2505770|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505771|NCT01247077|Protective Agents|protective agents|mesh-ancestor
2505772|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505773|NCT01247077|Trace Elements|trace elements|mesh-ancestor
2505774|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
2505775|NCT01247311|Vitamin D|vitamin d|mesh-list
2505776|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
2505777|NCT01247311|Vitamins|vitamins|mesh-list
2505778|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
2505779|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505780|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2505781|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2505782|NCT01247337|Gemcitabine|gemcitabine|mesh-list
2505783|NCT01247337|Capecitabine|capecitabine|mesh-list
2505784|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
2505785|NCT01247337|Cetuximab|cetuximab|mesh-list
2505786|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2386330|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
2386331|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2386332|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386333|NCT00650481|Oxybutynin|oxybutynin|mesh-list
2386334|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
2386335|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
2386336|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386337|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505787|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
2505788|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505789|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505790|NCT01247337|Antiviral Agents|antiviral agents|mesh-ancestor
2505791|NCT01247337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505792|NCT01247337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505793|NCT01247337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2386338|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2386339|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2386340|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
2386341|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386342|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505794|NCT01247337|Immunologic Factors|immunologic factors|mesh-ancestor
2505795|NCT01247337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505796|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2505797|NCT01247493|Cytarabine|cytarabine|mesh-list
2505798|NCT01247493|Fludarabine|fludarabine|mesh-list
2505799|NCT01247493|Idarubicin|idarubicin|mesh-list
2505800|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505801|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2505802|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
2505803|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386343|NCT00650481|Urological Agents|urological agents|mesh-ancestor
2386344|NCT00650494|Valacyclovir|valacyclovir|mesh-list
2386345|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
2386346|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386347|NCT00650520|Bromocriptine|bromocriptine|mesh-list
2386348|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2386349|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2386350|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
2386351|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386352|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386353|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
2386354|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
2386355|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386356|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386357|NCT00650533|Glimepiride|glimepiride|mesh-list
2386358|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2386359|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2386360|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386361|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2386362|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
2505804|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2505805|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
2505806|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386363|NCT00650598|Diclofenac|diclofenac|mesh-list
2386364|NCT00650598|Valdecoxib|valdecoxib|mesh-list
2386365|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2386366|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2386367|NCT00650598|Analgesics|analgesics|mesh-ancestor
2386368|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
2386369|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386370|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386371|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386372|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2386373|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2505807|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
2505808|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505809|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2505810|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2505811|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2505812|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505813|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
2505814|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
2505815|NCT01247558|Vitamins|vitamins|mesh-ancestor
2505816|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
2505817|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505818|NCT01247688|Fludarabine|fludarabine|mesh-list
2505819|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
2505820|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505821|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505822|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2505823|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
2505824|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505825|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2505826|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2505827|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
2505828|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2505829|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
2505830|NCT01247701|Busulfan|busulfan|mesh-list
2505831|NCT01247701|Fludarabine|fludarabine|mesh-list
2505832|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2505833|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
2505834|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505835|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2505836|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2505837|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
2505838|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505839|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505840|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2505841|NCT01247714|Phentermine|phentermine|mesh-list
2505842|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2505843|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505844|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
2505845|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2505846|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
2505847|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
2505848|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505849|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
2505850|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505851|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505852|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
2505853|NCT01247805|Citric Acid|citric acid|mesh-list
2505854|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
2505855|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
2505856|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2505857|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
2505858|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
2505859|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505860|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
2505861|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2505862|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2386374|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386375|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386376|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2386377|NCT00650611|Ziprasidone|ziprasidone|mesh-list
2386378|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2505863|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505864|NCT01247805|Urological Agents|urological agents|mesh-ancestor
2386379|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
2386380|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505865|NCT01247857|Ropivacaine|ropivacaine|mesh-list
2505866|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
2505867|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
2505868|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2505869|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505870|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
2505871|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505872|NCT01247870|Metformin|metformin|mesh-list
2505873|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2505874|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505875|NCT01247909|Gentamicins|gentamicins|mesh-list
2505876|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
2505877|NCT01247909|Penicillins|penicillins|mesh-list
2505878|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2505879|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505880|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2505881|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505882|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505883|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2505884|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2505885|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505886|NCT01247961|Dexamethasone|dexamethasone|mesh-list
2505887|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
2505888|NCT01247961|BB 1101|bb 1101|mesh-list
2505889|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2505890|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
2505891|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
2505892|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505893|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386381|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386382|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386383|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2386384|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2386385|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2505894|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2505895|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
2505896|NCT01247961|Hormones|hormones|mesh-ancestor
2505897|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2505898|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2505899|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505900|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
2505901|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2505902|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505903|NCT01248078|Cephalexin|cephalexin|mesh-list
2505904|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2505905|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2505906|NCT01248091|Nitroprusside|nitroprusside|mesh-list
2505907|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2505908|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
2505909|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2505910|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505911|NCT01248117|Ranibizumab|ranibizumab|mesh-list
2505912|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2505913|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2386386|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2386387|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2505914|NCT01248117|Growth Substances|growth substances|mesh-ancestor
2505915|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505916|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
2505917|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505918|NCT01248195|Olanzapine|olanzapine|mesh-list
2505919|NCT01248195|Clozapine|clozapine|mesh-list
2505920|NCT01248195|Amisulpride|amisulpride|mesh-list
2505921|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
2505922|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
2505923|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505924|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505925|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2386388|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
2386389|NCT00650624|Valdecoxib|valdecoxib|mesh-list
2386390|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2386391|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2505926|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2505927|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2505928|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2505929|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2505930|NCT01248195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2505931|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2505932|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2505933|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505934|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505935|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
2505936|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2505937|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
2505938|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
2505939|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2505940|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
2505941|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2505942|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
2505943|NCT01248234|Propofol|propofol|mesh-list
2505944|NCT01248234|Etomidate|etomidate|mesh-list
2505945|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2505946|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2505947|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505948|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2505949|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
2505950|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
2505957|NCT01248260|Folic Acid|folic acid|mesh-list
2505958|NCT01248260|Hematinics|hematinics|mesh-ancestor
2505959|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
2505960|NCT01248260|Vitamins|vitamins|mesh-ancestor
2505961|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
2505962|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505963|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
2505964|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
2505965|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505966|NCT01248299|Cisplatin|cisplatin|mesh-list
2386392|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386393|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386394|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2386395|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2386396|NCT00650624|Analgesics|analgesics|mesh-ancestor
2386397|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
2386398|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386399|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386400|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386401|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2386402|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
2386403|NCT00650637|Lamivudine|lamivudine|mesh-list
2386404|NCT00650637|Zidovudine|zidovudine|mesh-list
2386405|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2386406|NCT00650637|Nelfinavir|nelfinavir|mesh-list
2386407|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
2386408|NCT00650637|Loperamide|loperamide|mesh-list
2386409|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
2386410|NCT00650637|Calcium|calcium|mesh-list
2386411|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2386412|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386413|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2386414|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2386415|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2505967|NCT01248299|Docetaxel|docetaxel|mesh-list
2505968|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
2505969|NCT01248299|Fluorouracil|fluorouracil|mesh-list
2505970|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2505971|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
2505972|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
2505973|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
2505974|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2505975|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
2505976|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2505977|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2505978|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
2505979|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505980|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2505981|NCT01248338|Metoprolol|metoprolol|mesh-list
2505982|NCT01248338|Nebivolol|nebivolol|mesh-list
2505983|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2505984|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2505985|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
2505986|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
2505987|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2505988|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2505989|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2505990|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2505991|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2505992|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
2505993|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2505994|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386416|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386417|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386418|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
2386419|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386420|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2386421|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2386422|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
2505995|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
2505996|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2505997|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2505998|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2505999|NCT01248403|Paclitaxel|paclitaxel|mesh-list
2506000|NCT01248403|Everolimus|everolimus|mesh-list
2506001|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2506002|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506003|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
2506004|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
2506005|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
2506006|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506007|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2506008|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
2506009|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506010|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
2506011|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2506012|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506013|NCT01248442|Vitamins|vitamins|mesh-ancestor
2506014|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
2506015|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2506016|NCT01248481|Acarbose|acarbose|mesh-list
2506017|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2506018|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506019|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506020|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2506021|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506022|NCT01248494|Letrozole|letrozole|mesh-list
2506023|NCT01248494|Dactolisib|dactolisib|mesh-list
2506024|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506025|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2506026|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2506027|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506028|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506029|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2506030|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
2506031|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2506032|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506033|NCT01248611|Fentanyl|fentanyl|mesh-list
2506034|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2506035|NCT01248611|Narcotics|narcotics|mesh-ancestor
2506036|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2506037|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506038|NCT01248611|Analgesics|analgesics|mesh-ancestor
2506039|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
2506040|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506041|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2506042|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2506043|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
2386423|NCT00650637|Antacids|antacids|mesh-ancestor
2386424|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2386425|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2506044|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
2506045|NCT01248819|Ropivacaine|ropivacaine|mesh-list
2506046|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
2506047|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
2506048|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2506049|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506050|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
2506051|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506052|NCT01248858|Trametinib|trametinib|mesh-list
2506053|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506054|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2506055|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506056|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506057|NCT01248871|Sufentanil|sufentanil|mesh-list
2506058|NCT01248871|Remifentanil|remifentanil|mesh-list
2506059|NCT01248871|Dsuvia|dsuvia|mesh-list
2506060|NCT01248871|Propofol|propofol|mesh-list
2506061|NCT01248871|Sevoflurane|sevoflurane|mesh-list
2506062|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2506063|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2506064|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114494|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2114495|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114496|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114497|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2114498|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2114499|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
2114500|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2114501|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114502|NCT02604342|Docetaxel|docetaxel|mesh-list
2114503|NCT02604342|Pemetrexed|pemetrexed|mesh-list
2114504|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114505|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
2114506|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
2506065|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2506066|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
2506067|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
2506068|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2506069|NCT01248871|Narcotics|narcotics|mesh-ancestor
2386426|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2386427|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
2386428|NCT00650663|Simvastatin|simvastatin|mesh-list
2386429|NCT00650663|Ezetimibe|ezetimibe|mesh-list
2386430|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2386431|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2386432|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
2386433|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386434|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386435|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2386436|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386437|NCT00650689|Atorvastatin|atorvastatin|mesh-list
2506070|NCT01248871|Analgesics|analgesics|mesh-ancestor
2506071|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
2506072|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506073|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2506074|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2506075|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2506076|NCT01248923|Dexamethasone|dexamethasone|mesh-list
2506077|NCT01248923|Bortezomib|bortezomib|mesh-list
2506078|NCT01248923|Filanesib|filanesib|mesh-list
2506079|NCT01248923|Lenograstim|lenograstim|mesh-list
2506080|NCT01248923|Sargramostim|sargramostim|mesh-list
2506081|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
2506082|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2506083|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
2506084|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
2506085|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506086|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386438|NCT00650689|Ezetimibe|ezetimibe|mesh-list
2386439|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2386440|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2386441|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
2386442|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386443|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386444|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2506087|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2506088|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
2506089|NCT01248923|Hormones|hormones|mesh-ancestor
2506090|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2114507|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
2386445|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386446|NCT00650702|Latanoprost|latanoprost|mesh-list
2386447|NCT00650702|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2386448|NCT00650702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2386449|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2386450|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2386451|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
2386452|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386453|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2386454|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2386455|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2386456|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2386457|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386458|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2386459|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2386460|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2386461|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
2386462|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386463|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386464|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2386465|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2386466|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
2386467|NCT00650819|Simvastatin|simvastatin|mesh-list
2386468|NCT00650819|Ezetimibe|ezetimibe|mesh-list
2386469|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2386470|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2506091|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2506092|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506093|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2506094|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
2506095|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
2506096|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506097|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506098|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
2506099|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
2506100|NCT01248975|Montelukast|montelukast|mesh-list
2506101|NCT01248975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2506102|NCT01248975|Respiratory System Agents|respiratory system agents|mesh-ancestor
2506103|NCT01248975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2506104|NCT01248975|Hormone Antagonists|hormone antagonists|mesh-ancestor
2506105|NCT01248975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2506106|NCT01248975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506107|NCT01248975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2506108|NCT01248975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2506109|NCT01248975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506110|NCT01249001|Aprepitant|aprepitant|mesh-list
2506111|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
2506112|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
2506113|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
2506114|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506115|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506116|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2506117|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2506118|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506119|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506120|NCT01249339|Lobeline|lobeline|mesh-list
2506121|NCT01249339|Nicotine|nicotine|mesh-list
2506122|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2506123|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
2506124|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506125|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506126|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2506127|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2506128|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
2506129|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506130|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506131|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
2506132|NCT01249352|Fluorouracil|fluorouracil|mesh-list
2506133|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
2506134|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506135|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
2506136|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506137|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2506138|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2386471|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
2386472|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386473|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386474|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2386475|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386476|NCT00650832|Darunavir|darunavir|mesh-list
2386477|NCT00650832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2386478|NCT00650832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2386479|NCT00650832|Protease Inhibitors|protease inhibitors|mesh-ancestor
2386480|NCT00650832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386481|NCT00650832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386482|NCT00650832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2386483|NCT00650832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2386484|NCT00650832|Antiviral Agents|antiviral agents|mesh-ancestor
2386485|NCT00650832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386486|NCT00650871|Casopitant|casopitant|mesh-list
2386487|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
2506139|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
2506140|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506141|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2506142|NCT01249430|Cytarabine|cytarabine|mesh-list
2506143|NCT01249430|Etoposide|etoposide|mesh-list
2506144|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
2506145|NCT01249430|Azacitidine|azacitidine|mesh-list
2506146|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
2506147|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2506148|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506149|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2506150|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2506151|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506152|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506153|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2506154|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
2506155|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
2506156|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506157|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2506158|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
2506159|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506160|NCT01249430|Analgesics|analgesics|mesh-ancestor
2506161|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
2506162|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506163|NCT01249443|Paclitaxel|paclitaxel|mesh-list
2506164|NCT01249443|Carboplatin|carboplatin|mesh-list
2506165|NCT01249443|Vorinostat|vorinostat|mesh-list
2506166|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2506167|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506168|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
2506169|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
2506170|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
2506171|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386488|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
2386489|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386490|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386491|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2386492|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2386493|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386494|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386495|NCT00650897|Citalopram|citalopram|mesh-list
2386496|NCT00650897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2386497|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2386498|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2506172|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2506173|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506174|NCT01249521|Bevacizumab|bevacizumab|mesh-list
2506175|NCT01249521|Trebananib|trebananib|mesh-list
2506176|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2506177|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506178|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2506179|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2506180|NCT01249521|Growth Substances|growth substances|mesh-ancestor
2506181|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506182|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
2506183|NCT01249547|Axitinib|axitinib|mesh-list
2506184|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506185|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2506186|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506187|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506188|NCT01249638|Bevacizumab|bevacizumab|mesh-list
2506189|NCT01249638|Capecitabine|capecitabine|mesh-list
2506190|NCT01249638|Irinotecan|irinotecan|mesh-list
2506191|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2506192|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506193|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2506194|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2506195|NCT01249638|Growth Substances|growth substances|mesh-ancestor
2506196|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506197|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
2506198|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2506199|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
2506200|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506201|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2506202|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2506203|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506204|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
2386499|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386500|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386501|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
2386502|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386503|NCT00650897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2386504|NCT00650897|Antidepressive Agents|antidepressive agents|mesh-ancestor
2386505|NCT00650897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2386506|NCT00650910|Lapatinib|lapatinib|mesh-list
2386507|NCT00650910|Digoxin|digoxin|mesh-list
2386508|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2386509|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2386510|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386511|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386512|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2386513|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2386514|NCT00650910|Protective Agents|protective agents|mesh-ancestor
2386515|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386516|NCT00650923|Temozolomide|temozolomide|mesh-list
2386517|NCT00650923|Aflibercept|aflibercept|mesh-list
2386518|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
2386519|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2386520|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
2386521|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386522|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2386523|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2386524|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2386525|NCT00650923|Growth Substances|growth substances|mesh-ancestor
2386526|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506205|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2506206|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506207|NCT01249690|Thalidomide|thalidomide|mesh-list
2506208|NCT01249690|Dexamethasone|dexamethasone|mesh-list
2506209|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
2506210|NCT01249690|Bortezomib|bortezomib|mesh-list
2506211|NCT01249690|Pirarubicin|pirarubicin|mesh-list
2506212|NCT01249690|Doxorubicin|doxorubicin|mesh-list
2506213|NCT01249690|BB 1101|bb 1101|mesh-list
2506214|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2506215|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
2386527|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
2386528|NCT00650949|Carboplatin|carboplatin|mesh-list
2386529|NCT00650949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2386530|NCT00651014|Ezetimibe|ezetimibe|mesh-list
2386531|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2386532|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2386533|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
2386534|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386535|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386536|NCT00651066|Ritonavir|ritonavir|mesh-list
2386537|NCT00651066|Lopinavir|lopinavir|mesh-list
2386538|NCT00651066|Rifabutin|rifabutin|mesh-list
2506216|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
2506217|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506218|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506219|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2386539|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2506220|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
2506221|NCT01249690|Hormones|hormones|mesh-ancestor
2506222|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2506223|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2506224|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506225|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
2506226|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506227|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506228|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2506229|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
2506230|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
2506231|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2506232|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506233|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2506234|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2506235|NCT01249690|Growth Substances|growth substances|mesh-ancestor
2506236|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
2506237|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2506238|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2506239|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2386540|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2386541|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
2386542|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386543|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386544|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2386545|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2386546|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
2386547|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386548|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2386549|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2386550|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2386551|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2386552|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
2386553|NCT00651105|Vildagliptin|vildagliptin|mesh-list
2386554|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2386555|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386556|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2386557|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
2386558|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386559|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386560|NCT00651131|Daptomycin|daptomycin|mesh-list
2386561|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2386562|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386563|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2386564|NCT00651144|Ezetimibe|ezetimibe|mesh-list
2386565|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2386566|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2506240|NCT01249820|Anidulafungin|anidulafungin|mesh-list
2506241|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
2506242|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506243|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
2506244|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2506245|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2506246|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506247|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
2506248|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
2506249|NCT01249937|Triamcinolone|triamcinolone|mesh-list
2506250|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2506251|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2506252|NCT01249937|Ranibizumab|ranibizumab|mesh-list
2386567|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
2386568|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386569|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386570|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2386571|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386572|NCT00651209|Tenofovir|tenofovir|mesh-list
2386573|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
2386574|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386575|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2386576|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2386577|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386578|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386579|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2386580|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2386581|NCT00651235|Losartan|losartan|mesh-list
2386582|NCT00651235|Propranolol|propranolol|mesh-list
2386583|NCT00651235|Atenolol|atenolol|mesh-list
2506253|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2386584|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2386585|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2386586|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2386587|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2386588|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386589|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2386590|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2506254|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2506255|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2506256|NCT01249937|Growth Substances|growth substances|mesh-ancestor
2506257|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506258|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
2506259|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506260|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2506261|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
2506262|NCT01249937|Hormones|hormones|mesh-ancestor
2506263|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2506264|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2506265|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
2506266|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506267|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506268|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2506269|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2506270|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2506271|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2506272|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2506273|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
2506274|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506275|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506276|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506277|NCT01250249|Vaccines|vaccines|mesh-list
2506278|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
2506279|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
2506280|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506281|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2506282|NCT01250340|Aspirin|aspirin|mesh-list
2506283|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2506284|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2506285|NCT01250340|Analgesics|analgesics|mesh-ancestor
2506286|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
2506287|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506288|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506289|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2506290|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2506291|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2506292|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2386591|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
2386592|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386593|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386594|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
2386595|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
2386596|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
2386597|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386598|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2386599|NCT00651274|Ezetimibe|ezetimibe|mesh-list
2386600|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2386601|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2386602|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
2386603|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386604|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386605|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2386606|NCT00651287|Quinapril|quinapril|mesh-list
2386607|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2386608|NCT00651287|Diuretics|diuretics|mesh-ancestor
2386609|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
2386610|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386611|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2386612|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2386613|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386614|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2386615|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
2386616|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506293|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506294|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2506295|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2506296|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506297|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
2506298|NCT01250366|Ribavirin|ribavirin|mesh-list
2506299|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
2506300|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506301|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
2506302|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506303|NCT01250405|Cinacalcet|cinacalcet|mesh-list
2506304|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2506305|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506306|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2506307|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
2506308|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2506309|NCT01250457|Timolol|timolol|mesh-list
2506310|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2506311|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2506312|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
2506313|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506314|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506315|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506316|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2506317|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2506318|NCT01250470|Sargramostim|sargramostim|mesh-list
2506319|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
2506320|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506321|NCT01250496|Aminophylline|aminophylline|mesh-list
2506322|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2506323|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
2506324|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506325|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506326|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2506327|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
2506328|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2506329|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2506330|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506331|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506332|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2506333|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2506334|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
2506335|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386617|NCT00651300|Parecoxib|parecoxib|mesh-list
2386618|NCT00651300|Valdecoxib|valdecoxib|mesh-list
2386619|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2386620|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2386621|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386622|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386623|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2386624|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2386625|NCT00651300|Analgesics|analgesics|mesh-ancestor
2386626|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
2386627|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386628|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386629|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386630|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2386631|NCT00651326|Docetaxel|docetaxel|mesh-list
2386632|NCT00651326|Leuprolide|leuprolide|mesh-list
2386633|NCT00651326|Goserelin|goserelin|mesh-list
2386634|NCT00651326|Bicalutamide|bicalutamide|mesh-list
2386635|NCT00651326|Flutamide|flutamide|mesh-list
2386636|NCT00651326|Buserelin|buserelin|mesh-list
2386637|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506336|NCT01250496|Protective Agents|protective agents|mesh-ancestor
2506337|NCT01250535|Warfarin|warfarin|mesh-list
2506338|NCT01250535|Lovastatin|lovastatin|mesh-list
2506339|NCT01250535|L 647318|l 647318|mesh-list
2506340|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
2506341|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
2506342|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2506343|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2506344|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
2506345|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506346|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386638|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
2506347|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2506348|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506349|NCT01250548|Apremilast|apremilast|mesh-list
2506350|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2386639|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
2386640|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
2386641|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386642|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2386643|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
2386644|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2386645|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386646|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2386647|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
2386648|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
2386649|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386650|NCT00651352|Nicotine|nicotine|mesh-list
2386651|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2386652|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
2386653|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386654|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506351|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2506352|NCT01250548|Analgesics|analgesics|mesh-ancestor
2506353|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
2506354|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506355|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506356|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2506357|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2506358|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2506359|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2506360|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506361|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506362|NCT01250561|Valacyclovir|valacyclovir|mesh-list
2506363|NCT01250561|Gabapentin|gabapentin|mesh-list
2506364|NCT01250561|Analgesics|analgesics|mesh-ancestor
2506365|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
2506366|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386655|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2386656|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2386657|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
2386658|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386659|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386660|NCT00651378|Atorvastatin|atorvastatin|mesh-list
2386661|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2386662|NCT00651378|Ezetimibe|ezetimibe|mesh-list
2386663|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2386664|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2386665|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
2386666|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386667|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386668|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2386669|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386670|NCT00651391|Simvastatin|simvastatin|mesh-list
2386671|NCT00651391|Ezetimibe|ezetimibe|mesh-list
2386672|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2386673|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2386674|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
2386675|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386676|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386677|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2386678|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386679|NCT00651404|Ezetimibe|ezetimibe|mesh-list
2386680|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2386681|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2386682|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
2386683|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506367|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506368|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
2506369|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2506370|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2506371|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2506372|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2506373|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2506374|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2506375|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506376|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386684|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386685|NCT00651443|Galiximab|galiximab|mesh-list
2386686|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2506377|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
2506378|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
2506379|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506380|NCT01250652|Cetirizine|cetirizine|mesh-list
2506381|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
2506382|NCT01250652|Levocetirizine|levocetirizine|mesh-list
2506383|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2506384|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2506385|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
2506386|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
2506387|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506388|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506389|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506390|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2506391|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
2506392|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
2506393|NCT01250743|Vitamins|vitamins|mesh-list
2506394|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
2506395|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
2506396|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506397|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
2506398|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506399|NCT01250743|Protective Agents|protective agents|mesh-ancestor
2506400|NCT01250808|Dexamethasone|dexamethasone|mesh-list
2506401|NCT01250808|Bortezomib|bortezomib|mesh-list
2506402|NCT01250808|Melphalan|melphalan|mesh-list
2506403|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2506404|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
2506405|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
2506406|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506407|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506408|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2506409|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
2506410|NCT01250808|Hormones|hormones|mesh-ancestor
2506411|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2506412|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2506413|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506414|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2506415|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
2506416|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506417|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2506418|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2506419|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
2506420|NCT01250821|Menotropins|menotropins|mesh-list
2506421|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2506422|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
2506423|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2506424|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506425|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2506426|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
2506427|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2506428|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2506429|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2506430|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2506431|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506432|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2506433|NCT01250951|Deferasirox|deferasirox|mesh-list
2506434|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2506435|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
2506436|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
2506437|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506438|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
2506439|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2386687|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2386688|NCT00651456|Bevacizumab|bevacizumab|mesh-list
2386689|NCT00651456|Cisplatin|cisplatin|mesh-list
2386690|NCT00651456|Pemetrexed|pemetrexed|mesh-list
2386691|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2386692|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2386693|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2506440|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
2506441|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386694|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2386695|NCT00651456|Growth Substances|growth substances|mesh-ancestor
2386696|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386697|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
2386698|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386699|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386700|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2386701|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2386702|NCT00651547|Budesonide|budesonide|mesh-list
2386703|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
2386704|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386705|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2506442|NCT01251029|Expectorants|expectorants|mesh-ancestor
2506443|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
2506444|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2506445|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
2506446|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506447|NCT01251029|Protective Agents|protective agents|mesh-ancestor
2506448|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506449|NCT01251029|Antidotes|antidotes|mesh-ancestor
2506450|NCT01251107|Prednisone|prednisone|mesh-list
2506451|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
2506452|NCT01251107|Dacarbazine|dacarbazine|mesh-list
2506453|NCT01251107|Doxorubicin|doxorubicin|mesh-list
2506454|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2506455|NCT01251107|Etoposide|etoposide|mesh-list
2506456|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
2506457|NCT01251107|Vincristine|vincristine|mesh-list
2506458|NCT01251107|Bleomycin|bleomycin|mesh-list
2386706|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
2386707|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386708|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386709|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2386710|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
2386711|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
2386712|NCT00651547|Hormones|hormones|mesh-ancestor
2386713|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386714|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2386715|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2386716|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2386717|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
2386718|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386719|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386720|NCT00651560|Simvastatin|simvastatin|mesh-list
2386721|NCT00651560|Ezetimibe|ezetimibe|mesh-list
2386722|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2386723|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2386724|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
2386725|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386726|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386727|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2386728|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386729|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
2386730|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
2386731|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2386732|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2506459|NCT01251107|Vinblastine|vinblastine|mesh-list
2506460|NCT01251107|Procarbazine|procarbazine|mesh-list
2506461|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2506462|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
2506463|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506464|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2506465|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2506466|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
2506467|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506468|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506469|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2506470|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2506471|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2506472|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2506473|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506474|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2506475|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
2506476|NCT01251107|Hormones|hormones|mesh-ancestor
2386733|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2506477|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386734|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386735|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2386736|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2386737|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386738|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386739|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2386740|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2386741|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2386742|NCT00651599|Drospirenone|drospirenone|mesh-list
2386743|NCT00651599|Estradiol|estradiol|mesh-list
2386744|NCT00651599|Estrogens|estrogens|mesh-ancestor
2386745|NCT00651599|Hormones|hormones|mesh-ancestor
2386746|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386747|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386748|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2386749|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
2386750|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2386751|NCT00651599|Diuretics|diuretics|mesh-ancestor
2386752|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
2386753|NCT00651612|Timolol|timolol|mesh-list
2386754|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2506478|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2506479|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2506480|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
2506481|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
2506482|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
2506483|NCT01251133|Vaccines|vaccines|mesh-list
2506484|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
2506485|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386755|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2386756|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2386757|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2386758|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2386759|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
2386760|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386761|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386762|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386763|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2386764|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2386765|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2386766|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2386767|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2386768|NCT00651651|Budesonide|budesonide|mesh-list
2386769|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
2386770|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386771|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2386772|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
2386773|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386774|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386775|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2386776|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
2386777|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
2506486|NCT01251172|Melphalan|melphalan|mesh-list
2506487|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
2506488|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2506489|NCT01251172|R04929097|r04929097|mesh-list
2506490|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2506491|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
2386778|NCT00651651|Hormones|hormones|mesh-ancestor
2386779|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386780|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2506492|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506493|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506494|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2506495|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2506496|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
2386781|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2386782|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2386783|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
2386784|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386785|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386786|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
2386787|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2386788|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2506497|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506498|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506499|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
2506500|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2506501|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2506502|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2506503|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2506504|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506505|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
2506506|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506507|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506508|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2506509|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506510|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2506511|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2506512|NCT01251263|Estradiol|estradiol|mesh-list
2506513|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2506514|NCT01251263|Estrogens|estrogens|mesh-ancestor
2506515|NCT01251263|Hormones|hormones|mesh-ancestor
2506516|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2506517|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506518|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2506519|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
2506520|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2506521|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2506522|NCT01251328|Anesthetics|anesthetics|mesh-list
2506523|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2506524|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506525|NCT01251458|Sirolimus|sirolimus|mesh-list
2506526|NCT01251458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2506527|NCT01251458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506528|NCT01251458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2506529|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506530|NCT01251458|Antifungal Agents|antifungal agents|mesh-ancestor
2506531|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2506532|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
2506533|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506534|NCT01251471|Citalopram|citalopram|mesh-list
2506535|NCT01251471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2506536|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2506537|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2506538|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386789|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2386790|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2386791|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386792|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
2386793|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386794|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386795|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2386796|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386797|NCT00651703|Imiquimod|imiquimod|mesh-list
2386798|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2386799|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
2506539|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506540|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
2506541|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506542|NCT01251471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2506543|NCT01251471|Antidepressive Agents|antidepressive agents|mesh-ancestor
2506544|NCT01251471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2506545|NCT01251484|Nintedanib|nintedanib|mesh-list
2506546|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506547|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2506548|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506549|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506550|NCT01251627|Decitabine|decitabine|mesh-list
2506551|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2506552|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
2506553|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506554|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506555|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506556|NCT01251640|Gemcitabine|gemcitabine|mesh-list
2506557|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2506558|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
2506559|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506560|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506561|NCT01251640|Antiviral Agents|antiviral agents|mesh-ancestor
2506562|NCT01251640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506563|NCT01251640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506564|NCT01251640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2506565|NCT01251640|Immunologic Factors|immunologic factors|mesh-ancestor
2506566|NCT01251640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506567|NCT01251718|Donepezil|donepezil|mesh-list
2506568|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2506569|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506570|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506571|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
2386800|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386801|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2386802|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
2386803|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
2386804|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2386805|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2386806|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2386807|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2386808|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386809|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
2506572|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506573|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506574|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
2506575|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2506576|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506577|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2506578|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506579|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506580|NCT01251809|Pegaspargase|pegaspargase|mesh-list
2506581|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506582|NCT01251822|Prucalopride|prucalopride|mesh-list
2386810|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386811|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386812|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2386813|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386814|NCT00651768|Budesonide|budesonide|mesh-list
2386815|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
2386816|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2386817|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386818|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2386819|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
2386820|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386821|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386822|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2386823|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
2386824|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
2506583|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2506584|NCT01251822|Laxatives|laxatives|mesh-ancestor
2506585|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2506586|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2506587|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2506588|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
2506589|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506590|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506591|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506592|NCT01251835|Rifampin|rifampin|mesh-list
2506593|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
2506594|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2506595|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
2506596|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2506597|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506598|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
2386825|NCT00651768|Hormones|hormones|mesh-ancestor
2386826|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386827|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2386828|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2386829|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2386830|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
2386831|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386832|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506599|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2506600|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506601|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506602|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2506603|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2506604|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2506605|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2506606|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2506607|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2506608|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2506609|NCT01251848|Ritonavir|ritonavir|mesh-list
2506610|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
2506611|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2506612|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2506613|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
2506614|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506615|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386833|NCT00651781|Bortezomib|bortezomib|mesh-list
2386834|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2386835|NCT00651807|Etonogestrel|etonogestrel|mesh-list
2386836|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2506616|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2506617|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2506618|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
2506619|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506620|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2506621|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2506622|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2506623|NCT01251874|Alovudine|alovudine|mesh-list
2506624|NCT01251874|Carboplatin|carboplatin|mesh-list
2506625|NCT01251874|Veliparib|veliparib|mesh-list
2506626|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506627|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2506628|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506629|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506630|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
2506631|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506632|NCT01251926|Bevacizumab|bevacizumab|mesh-list
2506633|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2506634|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506635|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2506636|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2506637|NCT01251926|Growth Substances|growth substances|mesh-ancestor
2506638|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506639|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
2506640|NCT01251991|Psyllium|psyllium|mesh-list
2506641|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
2506642|NCT01251991|Cathartics|cathartics|mesh-ancestor
2386837|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
2386838|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2386839|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386840|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2506643|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2506644|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
2506645|NCT01252056|Cilostazol|cilostazol|mesh-list
2506646|NCT01252056|Probucol|probucol|mesh-list
2506647|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2506648|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
2506649|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506650|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506651|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2386841|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2386842|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2386843|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2386844|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386845|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2386846|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
2386847|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2386848|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2386849|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2386850|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2386851|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2506652|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
2386852|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2386853|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2386854|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2386855|NCT00651859|Bimatoprost|bimatoprost|mesh-list
2386856|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2386857|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2386858|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2386859|NCT00651885|Treprostinil|treprostinil|mesh-list
2386860|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2386861|NCT00651911|Rasburicase|rasburicase|mesh-list
2506653|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2506654|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2506655|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506656|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2506657|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
2506658|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2506659|NCT01252056|Protective Agents|protective agents|mesh-ancestor
2506660|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2506661|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2506662|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506663|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2506664|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2386862|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
2386863|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2386864|NCT00651963|Ezetimibe|ezetimibe|mesh-list
2386865|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2386866|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2386867|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
2386868|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386869|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386870|NCT00651976|Letrozole|letrozole|mesh-list
2386871|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2386872|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2386873|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2386874|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386875|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386876|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2386877|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
2386878|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386879|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386880|NCT00652002|Budesonide|budesonide|mesh-list
2386881|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
2386882|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2386883|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2386884|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
2386885|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2386886|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386887|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2386888|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
2386889|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
2386890|NCT00652002|Hormones|hormones|mesh-ancestor
2386891|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2386892|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2386893|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2386894|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2386895|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
2386896|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386897|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386898|NCT00652041|Thalidomide|thalidomide|mesh-list
2386899|NCT00652041|Bortezomib|bortezomib|mesh-list
2386900|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2386901|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2386902|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
2386903|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386904|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
2386905|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2506665|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
2506666|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2506667|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
2506668|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
2506669|NCT01252069|Progestins|progestins|mesh-list
2506670|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2506671|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
2506672|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2506673|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386906|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386907|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2386908|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2386909|NCT00652041|Growth Substances|growth substances|mesh-ancestor
2386910|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
2386911|NCT00652106|Timolol|timolol|mesh-list
2386912|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2386913|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2386914|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2386915|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2386916|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2386917|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
2386918|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2386919|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386920|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386921|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2386922|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2386923|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2386924|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2386925|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2386926|NCT00652119|Paclitaxel|paclitaxel|mesh-list
2386927|NCT00652119|Bevacizumab|bevacizumab|mesh-list
2386928|NCT00652119|Carboplatin|carboplatin|mesh-list
2386929|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2386930|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2386931|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
2386932|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
2386933|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
2386934|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386935|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2386936|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2386937|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2386938|NCT00652119|Growth Substances|growth substances|mesh-ancestor
2386939|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386940|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
2386941|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
2386942|NCT00652132|Antidotes|antidotes|mesh-ancestor
2386943|NCT00652132|Protective Agents|protective agents|mesh-ancestor
2386944|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506674|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2506675|NCT01252069|Hormones|hormones|mesh-ancestor
2506676|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2506677|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2506678|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
2506679|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2506680|NCT01252160|Capsaicin|capsaicin|mesh-list
2506681|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
2506682|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
2506683|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
2386945|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
2386946|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386947|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
2386948|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2386949|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386950|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
2386951|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
2386952|NCT00652171|Lamotrigine|lamotrigine|mesh-list
2386953|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
2386954|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2386955|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2386956|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386957|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2386958|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386959|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2386960|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2386961|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2386962|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2386963|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2386964|NCT00652184|Valacyclovir|valacyclovir|mesh-list
2386965|NCT00652184|Sorivudine|sorivudine|mesh-list
2386966|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
2386967|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2386968|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386969|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386970|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2386971|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
2386972|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2386973|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2386974|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386975|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386976|NCT00652262|Urological Agents|urological agents|mesh-ancestor
2386977|NCT00652288|Insulin|insulin|mesh-list
2506684|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506685|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506686|NCT01252225|Lidocaine|lidocaine|mesh-list
2506687|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
2506688|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
2506689|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2506690|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506691|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
2386978|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2386979|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
2386980|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
2386981|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
2386982|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2386983|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
2386984|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
2386985|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2386986|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2386987|NCT00652301|Simvastatin|simvastatin|mesh-list
2506692|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506693|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2506694|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2506695|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2506696|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2506697|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506698|NCT01252342|Oxytocin|oxytocin|mesh-list
2506699|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
2506700|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2506701|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506702|NCT01252420|Enoxaparin|enoxaparin|mesh-list
2506703|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
2506704|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2506705|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2506706|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506707|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
2506708|NCT01252524|Psyllium|psyllium|mesh-list
2506709|NCT01252524|Calcium|calcium|mesh-list
2386988|NCT00652301|Ezetimibe|ezetimibe|mesh-list
2386989|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2386990|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2386991|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
2386992|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2386993|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2386994|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2386995|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2386996|NCT00652379|Octreotide|octreotide|mesh-list
2386997|NCT00652379|Lanreotide|lanreotide|mesh-list
2386998|NCT00652379|Somatostatin|somatostatin|mesh-list
2386999|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2387000|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2387001|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2387002|NCT00652379|Hormones|hormones|mesh-ancestor
2387003|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2387004|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387005|NCT00652392|Budesonide|budesonide|mesh-list
2387006|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
2387007|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2387008|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2387009|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
2387010|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387011|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387012|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2506710|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2506711|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506712|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
2506713|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2506714|NCT01252524|Cathartics|cathartics|mesh-ancestor
2506715|NCT01252628|Cetuximab|cetuximab|mesh-list
2387013|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
2387014|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
2387015|NCT00652392|Hormones|hormones|mesh-ancestor
2387016|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2387017|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2387018|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2387019|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2387020|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
2387021|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387022|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387023|NCT00652431|Niacin|niacin|mesh-list
2506716|NCT01252628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2506717|NCT01252628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506718|NCT01252680|Vaccines|vaccines|mesh-list
2506719|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
2506720|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506721|NCT01252693|Goserelin|goserelin|mesh-list
2506722|NCT01252693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2387024|NCT00652431|Niacinamide|niacinamide|mesh-list
2387025|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
2387026|NCT00652431|Simvastatin|simvastatin|mesh-list
2387027|NCT00652431|Ezetimibe|ezetimibe|mesh-list
2387028|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2387029|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387030|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387031|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
2506723|NCT01252693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506724|NCT01252719|Vancomycin|vancomycin|mesh-list
2506725|NCT01252719|Oritavancin|oritavancin|mesh-list
2506726|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2506727|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506728|NCT01252758|Albuterol|albuterol|mesh-list
2506729|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2506730|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
2506731|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506732|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506733|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2506734|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
2387032|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387033|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387034|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387035|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387036|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
2387037|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
2387038|NCT00652431|Vitamins|vitamins|mesh-ancestor
2387039|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
2387040|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387041|NCT00652444|Simvastatin|simvastatin|mesh-list
2387042|NCT00652444|Ezetimibe|ezetimibe|mesh-list
2387043|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387044|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387045|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
2387046|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387047|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387048|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387049|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387050|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2387051|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2387052|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2387053|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2387054|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2506735|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
2506736|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2506737|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2506738|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2506739|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2506740|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
2114508|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114509|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114510|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2114511|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2114514|NCT02604550|Naproxen|naproxen|mesh-list
2184829|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
2387055|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2387056|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2506741|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506742|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506747|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2506748|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2506749|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506750|NCT01253382|Ecallantide|ecallantide|mesh-list
2506751|NCT01253382|Analgesics|analgesics|mesh-ancestor
2506752|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
2506753|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506754|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506755|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2506756|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2506757|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2506758|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2506759|NCT01253473|Budesonide|budesonide|mesh-list
2506760|NCT01253473|Albuterol|albuterol|mesh-list
2506761|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
2506762|NCT01253473|Ipratropium|ipratropium|mesh-list
2506763|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2387057|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
2387058|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387059|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387060|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387061|NCT00652496|Bimatoprost|bimatoprost|mesh-list
2387062|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2506764|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2506765|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
2506766|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387063|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2387064|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2387065|NCT00652574|Dasatinib|dasatinib|mesh-list
2506767|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506768|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2506769|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
2387066|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2387067|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2387068|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387069|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387070|NCT00652600|Propranolol|propranolol|mesh-list
2387071|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2387072|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2387073|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
2387074|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387075|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387076|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387077|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2387078|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2387079|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
2387080|NCT00652639|Clonazepam|clonazepam|mesh-list
2387081|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
2387082|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
2387083|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
2387084|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387085|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387086|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387087|NCT00652652|Furosemide|furosemide|mesh-list
2387088|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2387089|NCT00652652|Diuretics|diuretics|mesh-ancestor
2387090|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
2387091|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506770|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
2506771|NCT01253473|Hormones|hormones|mesh-ancestor
2506772|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2506773|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2506774|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2506775|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2506776|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
2506777|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506778|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506779|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
2506780|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2387092|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2387093|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2387094|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387095|NCT00652665|Leflunomide|leflunomide|mesh-list
2387096|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506781|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2506782|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
2506783|NCT01253603|Fluticasone|fluticasone|mesh-list
2506784|NCT01253603|Xhance|xhance|mesh-list
2506785|NCT01253603|Indoleacetic Acids|indoleacetic acids|mesh-list
2506786|NCT01253603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2506787|NCT01253603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2387097|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387098|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2387099|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
2387100|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387101|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
2387102|NCT00652691|Carboplatin|carboplatin|mesh-list
2387103|NCT00652691|Topotecan|topotecan|mesh-list
2387104|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2387105|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
2387106|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387107|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2387108|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2387109|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
2387110|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387111|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2387112|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2387113|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2387114|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2387115|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387116|NCT00652704|Doxycycline|doxycycline|mesh-list
2387117|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2387118|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506788|NCT01253603|Autonomic Agents|autonomic agents|mesh-ancestor
2506789|NCT01253603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506790|NCT01253603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506791|NCT01253603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2506792|NCT01253603|Respiratory System Agents|respiratory system agents|mesh-ancestor
2506793|NCT01253603|Dermatologic Agents|dermatologic agents|mesh-ancestor
2506794|NCT01253603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2506795|NCT01253603|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2506796|NCT01253603|Growth Substances|growth substances|mesh-ancestor
2387119|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
2387120|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2387121|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2387122|NCT00652717|Simvastatin|simvastatin|mesh-list
2387123|NCT00652717|Ezetimibe|ezetimibe|mesh-list
2387124|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2506797|NCT01253681|Paclitaxel|paclitaxel|mesh-list
2506798|NCT01253681|Carboplatin|carboplatin|mesh-list
2506799|NCT01253681|Trebananib|trebananib|mesh-list
2506800|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2506801|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506802|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
2506803|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
2506804|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
2506805|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506806|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2506807|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2506808|NCT01253681|Growth Substances|growth substances|mesh-ancestor
2506809|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506810|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
2506811|NCT01253694|Ranibizumab|ranibizumab|mesh-list
2506812|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2506813|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2506814|NCT01253694|Growth Substances|growth substances|mesh-ancestor
2506815|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506816|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
2506817|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506818|NCT01253928|Pioglitazone|pioglitazone|mesh-list
2387125|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387126|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
2387127|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506819|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2506820|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506821|NCT01254006|Thiamine|thiamine|mesh-list
2506822|NCT01254006|Vitamins|vitamins|mesh-ancestor
2506823|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
2506824|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506825|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
2506826|NCT01254071|Tamsulosin|tamsulosin|mesh-list
2506827|NCT01254071|Dutasteride|dutasteride|mesh-list
2506828|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2506829|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2506830|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2506831|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
2506832|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506833|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506834|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506835|NCT01254071|Urological Agents|urological agents|mesh-ancestor
2506836|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2506837|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2506838|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506839|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
2387128|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387129|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387130|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387131|NCT00652730|Buspirone|buspirone|mesh-list
2387132|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2387133|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2506840|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2506841|NCT01254123|Exenatide|exenatide|mesh-list
2506842|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2506843|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506844|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2506845|NCT01254123|Incretins|incretins|mesh-ancestor
2506846|NCT01254123|Hormones|hormones|mesh-ancestor
2387134|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387135|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387136|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2387137|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2387138|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
2387139|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387140|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387141|NCT00652782|Rolofylline|rolofylline|mesh-list
2387142|NCT00652782|Diuretics|diuretics|mesh-ancestor
2387143|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
2387144|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387145|NCT00652795|Doxycycline|doxycycline|mesh-list
2387146|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2506847|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2506848|NCT01254136|Trastuzumab|trastuzumab|mesh-list
2506849|NCT01254136|Vinorelbine|vinorelbine|mesh-list
2506850|NCT01254136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2506851|NCT01254136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506852|NCT01254136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2506853|NCT01254136|Tubulin Modulators|tubulin modulators|mesh-ancestor
2387147|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2387148|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
2387149|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2387150|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2387151|NCT00652808|Naproxen|naproxen|mesh-list
2387152|NCT00652808|Valdecoxib|valdecoxib|mesh-list
2387153|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2387154|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2387155|NCT00652808|Analgesics|analgesics|mesh-ancestor
2387156|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
2387157|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387158|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387159|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2387160|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2387161|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
2387162|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2387163|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387164|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506854|NCT01254136|Antimitotic Agents|antimitotic agents|mesh-ancestor
2506855|NCT01254136|Mitosis Modulators|mitosis modulators|mesh-ancestor
2506856|NCT01254136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506857|NCT01254175|Vaccines|vaccines|mesh-list
2387165|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2387166|NCT00652821|Tramadol|tramadol|mesh-list
2387167|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2387168|NCT00652821|Narcotics|narcotics|mesh-ancestor
2387169|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387170|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506858|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
2506859|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506860|NCT01254370|Travoprost|travoprost|mesh-list
2506861|NCT01254370|Latanoprost|latanoprost|mesh-list
2506862|NCT01254370|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2506863|NCT01254370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2506864|NCT01254370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2506865|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
2506866|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
2506867|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2506868|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2506869|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506870|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506871|NCT01254383|Urological Agents|urological agents|mesh-ancestor
2506872|NCT01254461|Pravastatin|pravastatin|mesh-list
2506873|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2506874|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2506875|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
2506876|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506877|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2506878|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2506879|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387171|NCT00652821|Analgesics|analgesics|mesh-ancestor
2387172|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
2387173|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387174|NCT00652847|Ezetimibe|ezetimibe|mesh-list
2387175|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387176|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387177|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
2387178|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387179|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387180|NCT00652860|Doxorubicin|doxorubicin|mesh-list
2387181|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2387182|NCT00652860|Ifosfamide|ifosfamide|mesh-list
2387183|NCT00652860|Molgramostim|molgramostim|mesh-list
2387184|NCT00652860|Mitomycins|mitomycins|mesh-list
2387185|NCT00652860|Mitomycin|mitomycin|mesh-list
2387186|NCT00652860|Sargramostim|sargramostim|mesh-list
2387187|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2387188|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2387189|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2387190|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2506880|NCT00701207|Nicotine|nicotine|mesh-list
2506881|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2506882|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
2506883|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506884|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506885|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2506886|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2506887|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
2387191|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387192|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387193|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2387194|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
2387195|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
2387196|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387197|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2387198|NCT00652873|Cabergoline|cabergoline|mesh-list
2387199|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2387200|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2387201|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
2387202|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
2387203|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387204|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387205|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387206|NCT00652886|Oxandrolone|oxandrolone|mesh-list
2387207|NCT00652886|Androgens|androgens|mesh-ancestor
2387208|NCT00652886|Hormones|hormones|mesh-ancestor
2387209|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2387210|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387211|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
2387212|NCT00652912|Clonazepam|clonazepam|mesh-list
2387213|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
2387214|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
2387215|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
2387216|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387217|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387218|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387219|NCT00652925|Celecoxib|celecoxib|mesh-list
2387220|NCT00652925|Naproxen|naproxen|mesh-list
2387221|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2387222|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2387223|NCT00652925|Analgesics|analgesics|mesh-ancestor
2387224|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
2387225|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387226|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387227|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2387228|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2387229|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2387230|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2387231|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387232|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387233|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
2387234|NCT00653003|Leflunomide|leflunomide|mesh-list
2387235|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387236|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387237|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2387238|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
2387239|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387240|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2387241|NCT00653016|Norelgestromin|norelgestromin|mesh-list
2387242|NCT00653016|Estradiol|estradiol|mesh-list
2387243|NCT00653016|Estrogens|estrogens|mesh-ancestor
2387244|NCT00653016|Hormones|hormones|mesh-ancestor
2387245|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2387246|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387247|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2387248|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
2387249|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2387250|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2387251|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2387252|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2387253|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2387254|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
2387255|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387256|NCT00653055|Cabergoline|cabergoline|mesh-list
2387257|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2387258|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2387259|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
2506888|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506889|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506890|NCT01254513|Prednisone|prednisone|mesh-list
2506891|NCT01254513|Docetaxel|docetaxel|mesh-list
2506892|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506893|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
2506894|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
2506895|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
2506896|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506897|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2506898|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
2506899|NCT01254513|Hormones|hormones|mesh-ancestor
2506900|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2506901|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506902|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2506903|NCT01254526|Paclitaxel|paclitaxel|mesh-list
2506904|NCT01254526|Bevacizumab|bevacizumab|mesh-list
2506905|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2506906|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506907|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
2506908|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
2506909|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
2506910|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506911|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2506912|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2506913|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2506914|NCT01254526|Growth Substances|growth substances|mesh-ancestor
2387260|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
2387261|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387262|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387263|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387264|NCT00653120|Propranolol|propranolol|mesh-list
2387265|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2387266|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2387267|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
2387268|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387269|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387270|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387271|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2387272|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2387273|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
2387274|NCT00653172|Streptogramin A|streptogramin a|mesh-list
2387275|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2387276|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2387277|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
2387278|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2387279|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2387280|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
2387281|NCT00653250|Celecoxib|celecoxib|mesh-list
2387282|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2387283|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2387284|NCT00653250|Analgesics|analgesics|mesh-ancestor
2387285|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
2387286|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387287|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387288|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2387289|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2387290|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2387291|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2387292|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506915|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506916|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
2506917|NCT01254578|Lenalidomide|lenalidomide|mesh-list
2506918|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
2506919|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506920|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2506921|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2506922|NCT01254578|Growth Substances|growth substances|mesh-ancestor
2506923|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
2506924|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506925|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2506926|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2506927|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506928|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2506929|NCT01254617|Cetuximab|cetuximab|mesh-list
2506930|NCT01254617|Lenalidomide|lenalidomide|mesh-list
2506931|NCT01254617|Antibodies|antibodies|mesh-list
2506932|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
2506933|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2506934|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
2387293|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387294|NCT00653276|Cyclosporine|cyclosporine|mesh-list
2387295|NCT00653276|Ezetimibe|ezetimibe|mesh-list
2387296|NCT00653276|Cyclosporins|cyclosporins|mesh-list
2387297|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387298|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387299|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2387300|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
2387301|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387302|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
2506935|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506936|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506937|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2506938|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2506939|NCT01254617|Growth Substances|growth substances|mesh-ancestor
2506940|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
2506941|NCT00660673|Levodopa|levodopa|mesh-list
2506942|NCT00660673|Carbidopa|carbidopa|mesh-list
2506943|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2506944|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2506945|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2387303|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506946|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
2387304|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
2387305|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2387306|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2387307|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387308|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387309|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
2387310|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387311|NCT00653302|Metformin|metformin|mesh-list
2387312|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
2387313|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2506947|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2506948|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2506949|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506950|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2506951|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506952|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2506953|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
2506954|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
2506955|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2506956|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
2506957|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506958|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2506959|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2506960|NCT01254799|Doxycycline|doxycycline|mesh-list
2506961|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2506962|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2506963|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
2506964|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2506965|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2506966|NCT01254825|Ropivacaine|ropivacaine|mesh-list
2506967|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
2506968|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
2506969|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2506970|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506971|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
2387314|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387315|NCT00653315|Tramadol|tramadol|mesh-list
2506972|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2506973|NCT01254864|Prednisone|prednisone|mesh-list
2506974|NCT01254864|Sunitinib|sunitinib|mesh-list
2506975|NCT01254864|Dasatinib|dasatinib|mesh-list
2387316|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2387317|NCT00653315|Narcotics|narcotics|mesh-ancestor
2387318|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387319|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387320|NCT00653315|Analgesics|analgesics|mesh-ancestor
2387321|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
2387322|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387323|NCT00653341|Insulin|insulin|mesh-list
2387324|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2387325|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
2387326|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
2387327|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
2387328|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
2387329|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2387330|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387331|NCT00653354|Valdecoxib|valdecoxib|mesh-list
2506976|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
2506977|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2506978|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
2506979|NCT01254864|Hormones|hormones|mesh-ancestor
2506980|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2506981|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2506982|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2506983|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506984|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2506985|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2506986|NCT01254864|Growth Substances|growth substances|mesh-ancestor
2506987|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
2506988|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2506989|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506990|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184830|NCT00002833|Idarubicin|idarubicin|mesh-list
2387332|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2387333|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2387334|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2506991|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2506992|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
2506993|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2506994|NCT00660218|Paclitaxel|paclitaxel|mesh-list
2506995|NCT00660218|Cetuximab|cetuximab|mesh-list
2506996|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
2506997|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2506998|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2506999|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
2507000|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
2507001|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
2507002|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507003|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2507004|NCT01254929|Frovatriptan|frovatriptan|mesh-list
2507005|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2507006|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
2507007|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387335|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387336|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2387337|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2387338|NCT00653354|Analgesics|analgesics|mesh-ancestor
2387339|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
2387340|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387341|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387342|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507008|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507009|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507010|NCT01254994|Entecavir|entecavir|mesh-list
2507011|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
2507012|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507013|NCT01255046|Donepezil|donepezil|mesh-list
2507014|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2507015|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507016|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387343|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2387344|NCT00653380|Doxycycline|doxycycline|mesh-list
2387345|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2387346|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2387347|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
2387348|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2387349|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2387350|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
2387351|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
2507017|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
2507018|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507019|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507020|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
2507021|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
2507022|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2507023|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
2507024|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387352|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2387353|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2387354|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387355|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387356|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2387357|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2387358|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387359|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387360|NCT00653406|Risperidone|risperidone|mesh-list
2387361|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2387362|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
2387363|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507025|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507026|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2507027|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
2507028|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2507029|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
2507030|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507031|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507032|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2507033|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
2507034|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
2507035|NCT01255215|Protective Agents|protective agents|mesh-ancestor
2507036|NCT01255358|Dexamethasone|dexamethasone|mesh-list
2507037|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
2507038|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2507039|NCT01255358|BB 1101|bb 1101|mesh-list
2507040|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507041|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
2507042|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
2387364|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387365|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387366|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2387367|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2387368|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387369|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2387370|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2387371|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
2387372|NCT00653419|Buspirone|buspirone|mesh-list
2387373|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2387374|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2387375|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387376|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387377|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2387378|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2387379|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
2387380|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387381|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387382|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2507043|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507044|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507045|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2507046|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
2507047|NCT01255358|Hormones|hormones|mesh-ancestor
2387383|NCT00653445|Ezetimibe|ezetimibe|mesh-list
2387384|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387385|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387386|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
2387387|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387388|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387389|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387390|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387391|NCT00653458|Ondansetron|ondansetron|mesh-list
2387392|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
2507048|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2507049|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2507050|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507051|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
2507052|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507053|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507054|NCT01255371|Lopinavir|lopinavir|mesh-list
2507055|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2507056|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2507057|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2507058|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
2507059|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507060|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507061|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2507062|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2507063|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
2507064|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507065|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2507066|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2507067|NCT01255410|Vaccines|vaccines|mesh-list
2387393|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
2387394|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387395|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387396|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2387397|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
2387398|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
2387399|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2387400|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
2387401|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387402|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387403|NCT00653458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2387404|NCT00653458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2387405|NCT00653458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387406|NCT00653458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2387407|NCT00653458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2387408|NCT00653510|Insulin|insulin|mesh-list
2507068|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
2507069|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507070|NCT01255475|Amlodipine|amlodipine|mesh-list
2507071|NCT01255475|Hydralazine|hydralazine|mesh-list
2507072|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2387409|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2387410|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2387411|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387412|NCT00653549|Torsemide|torsemide|mesh-list
2387413|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2387414|NCT00653549|Diuretics|diuretics|mesh-ancestor
2387415|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
2387416|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387417|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2387418|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2387419|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387420|NCT00653562|Zolpidem|zolpidem|mesh-list
2387421|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2387422|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2387423|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387424|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387425|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2387426|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
2387427|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
2387428|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387429|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387430|NCT00653588|Atorvastatin|atorvastatin|mesh-list
2387431|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2387432|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387433|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387434|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
2387435|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387436|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387437|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387438|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387439|NCT00653614|Drospirenone|drospirenone|mesh-list
2387440|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2387441|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
2387442|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2387443|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387444|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2387445|NCT00653614|Diuretics|diuretics|mesh-ancestor
2387446|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
2387447|NCT00653744|Atorvastatin|atorvastatin|mesh-list
2387448|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2387449|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387450|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387451|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
2387452|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387453|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387454|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387455|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387456|NCT00653757|Leuprolide|leuprolide|mesh-list
2387457|NCT00653757|Goserelin|goserelin|mesh-list
2387458|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2387459|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
2387460|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2387461|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387462|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2387463|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2387464|NCT00653796|Atorvastatin|atorvastatin|mesh-list
2387465|NCT00653796|Ezetimibe|ezetimibe|mesh-list
2387466|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387467|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387468|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
2387469|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387470|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387471|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387472|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387473|NCT00653822|Alefacept|alefacept|mesh-list
2387474|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
2387475|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
2387476|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387477|NCT00653835|Simvastatin|simvastatin|mesh-list
2507073|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2507074|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2507075|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507076|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2507077|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507078|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
2507079|NCT01255527|Bortezomib|bortezomib|mesh-list
2507080|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507081|NCT01255579|Fluticasone|fluticasone|mesh-list
2507082|NCT01255579|Beclomethasone|beclomethasone|mesh-list
2507083|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
2507084|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2507085|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2507086|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507087|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2507088|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
2507089|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507090|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507091|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2387478|NCT00653835|Ezetimibe|ezetimibe|mesh-list
2387479|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387480|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387481|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
2387482|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507092|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
2507093|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
2507094|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2507095|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2507096|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2507097|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2507098|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
2507099|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507100|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507101|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
2507102|NCT01255579|Hormones|hormones|mesh-ancestor
2507103|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2387483|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387484|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387485|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387486|NCT00653848|Docetaxel|docetaxel|mesh-list
2387487|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507104|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
2507105|NCT01255644|Valganciclovir|valganciclovir|mesh-list
2507106|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
2507107|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507108|NCT01255709|Epinephrine|epinephrine|mesh-list
2507109|NCT01255709|Racepinephrine|racepinephrine|mesh-list
2507110|NCT01255709|Epinephryl borate|epinephryl borate|mesh-list
2507111|NCT01255709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2507112|NCT01255709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2507113|NCT01255709|Adrenergic Agents|adrenergic agents|mesh-ancestor
2507114|NCT01255709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507115|NCT01255709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507116|NCT01255709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507117|NCT01255709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2507118|NCT01255709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2507119|NCT01255709|Autonomic Agents|autonomic agents|mesh-ancestor
2507120|NCT01255709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507121|NCT01255709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2507122|NCT01255709|Respiratory System Agents|respiratory system agents|mesh-ancestor
2507123|NCT01255709|Mydriatics|mydriatics|mesh-ancestor
2507124|NCT01255709|Sympathomimetics|sympathomimetics|mesh-ancestor
2507125|NCT01255709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2507126|NCT01255774|Ranibizumab|ranibizumab|mesh-list
2507127|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2507128|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2507129|NCT01255774|Growth Substances|growth substances|mesh-ancestor
2507130|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507131|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
2507132|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507133|NCT01255800|Cetuximab|cetuximab|mesh-list
2507134|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2507135|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507136|NCT01255852|Atorvastatin|atorvastatin|mesh-list
2387488|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
2507137|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2507138|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2507139|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
2507140|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507141|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2507142|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2507143|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507144|NCT01255878|Gabapentin|gabapentin|mesh-list
2507145|NCT01255878|Analgesics|analgesics|mesh-ancestor
2387489|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
2387490|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
2387491|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387492|NCT00653874|Bilirubin|bilirubin|mesh-list
2387493|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
2387494|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387495|NCT00653874|Protective Agents|protective agents|mesh-ancestor
2387496|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387497|NCT00653913|Ezetimibe|ezetimibe|mesh-list
2387498|NCT00653913|Pitavastatin|pitavastatin|mesh-list
2387499|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387500|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387501|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
2387502|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387503|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387504|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387505|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387506|NCT00653926|Epinephrine|epinephrine|mesh-list
2387507|NCT00653926|Ropivacaine|ropivacaine|mesh-list
2387508|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
2387509|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
2387510|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387511|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387512|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
2387513|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387514|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2387515|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2387516|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
2387517|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387518|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387519|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2387520|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2387521|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
2387522|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2387523|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
2387524|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
2387525|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
2387526|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2387527|NCT00653952|Paclitaxel|paclitaxel|mesh-list
2387528|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2387529|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2387530|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
2387531|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
2387532|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
2387533|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387534|NCT00653965|Atorvastatin|atorvastatin|mesh-list
2387535|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2387536|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387537|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387538|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
2387539|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387540|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387541|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387542|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387543|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
2387544|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
2387545|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2387546|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2387547|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387548|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387549|NCT00654017|Urological Agents|urological agents|mesh-ancestor
2387550|NCT00654043|Torsemide|torsemide|mesh-list
2387551|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2387552|NCT00654043|Diuretics|diuretics|mesh-ancestor
2387553|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
2507146|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
2507147|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507148|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507149|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
2507150|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2507151|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2507152|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2507153|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2507154|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2507155|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2507156|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507157|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507158|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
2507159|NCT01255891|Androgens|androgens|mesh-list
2507160|NCT01255891|Hormones|hormones|mesh-ancestor
2507161|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2507162|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507163|NCT01255956|Sirolimus|sirolimus|mesh-list
2507164|NCT01255956|Paclitaxel|paclitaxel|mesh-list
2507165|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2507166|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507167|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
2507168|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
2507169|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
2507170|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507171|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2507172|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507173|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2507174|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
2507175|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2507176|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
2507177|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507178|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
2507179|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2507180|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2507181|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2507182|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2507183|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507184|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
2507185|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507186|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507187|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2507188|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507189|NCT01256151|Alprazolam|alprazolam|mesh-list
2387554|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387555|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2387556|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2387557|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387558|NCT00654056|Insulin|insulin|mesh-list
2387559|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2387560|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2387561|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387562|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
2387563|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
2387564|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2387565|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2387566|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387567|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387568|NCT00654082|Urological Agents|urological agents|mesh-ancestor
2507190|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2507191|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2507192|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507193|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2507194|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2507195|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2507196|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
2507197|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
2507198|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507199|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507200|NCT01256268|Paclitaxel|paclitaxel|mesh-list
2507201|NCT01256268|Carboplatin|carboplatin|mesh-list
2507202|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2507203|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507204|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
2387569|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
2387570|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
2387571|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2387572|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2387573|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2387574|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2507205|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
2507206|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
2507207|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507208|NCT01256359|Docetaxel|docetaxel|mesh-list
2507209|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507210|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
2507211|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
2507212|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
2507213|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507214|NCT01256489|Infliximab|infliximab|mesh-list
2507215|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
2507216|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2507217|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2507218|NCT01256541|Lactulose|lactulose|mesh-list
2507219|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2387575|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387576|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387577|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2387578|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2387579|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2507220|NCT01256580|Dexamethasone|dexamethasone|mesh-list
2507221|NCT01256580|Bevacizumab|bevacizumab|mesh-list
2507222|NCT01256580|Verteporfin|verteporfin|mesh-list
2507223|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2507224|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507225|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2507226|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2507227|NCT01256580|Growth Substances|growth substances|mesh-ancestor
2507228|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507229|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
2507230|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507231|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
2507232|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
2507233|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507234|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2507235|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
2507236|NCT01256580|Hormones|hormones|mesh-ancestor
2507237|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2507238|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2507239|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2507240|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
2507241|NCT01256619|Desogestrel|desogestrel|mesh-list
2507242|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2507243|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2507244|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2507245|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
2507246|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2507247|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507248|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2507249|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2507250|NCT01256619|Progestins|progestins|mesh-ancestor
2507251|NCT01256619|Hormones|hormones|mesh-ancestor
2507252|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2507253|NCT01256632|Ranibizumab|ranibizumab|mesh-list
2507254|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2507255|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2507256|NCT01256632|Growth Substances|growth substances|mesh-ancestor
2507257|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507258|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
2507259|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507260|NCT01256762|Paclitaxel|paclitaxel|mesh-list
2507261|NCT01256762|Bevacizumab|bevacizumab|mesh-list
2507262|NCT01256762|Imetelstat|imetelstat|mesh-list
2507263|NCT01256762|Motesanib diphosphate|motesanib diphosphate|mesh-list
2507264|NCT01256762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2507265|NCT01256762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507266|NCT01256762|Tubulin Modulators|tubulin modulators|mesh-ancestor
2507267|NCT01256762|Antimitotic Agents|antimitotic agents|mesh-ancestor
2507268|NCT01256762|Mitosis Modulators|mitosis modulators|mesh-ancestor
2507269|NCT01256762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507270|NCT01256762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2507271|NCT01256762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2507272|NCT01256762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2507273|NCT01256762|Growth Substances|growth substances|mesh-ancestor
2507274|NCT01256762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507275|NCT01256762|Growth Inhibitors|growth inhibitors|mesh-ancestor
2507276|NCT01256762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507277|NCT01256762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2507278|NCT01256775|Aspirin|aspirin|mesh-list
2387580|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
2387581|NCT00654108|Protective Agents|protective agents|mesh-ancestor
2387582|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387583|NCT00654108|Vitamins|vitamins|mesh-ancestor
2387584|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
2387585|NCT00654121|Insulin|insulin|mesh-list
2387586|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2387587|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2387588|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387589|NCT00654160|Leucovorin|leucovorin|mesh-list
2387590|NCT00654160|Fluorouracil|fluorouracil|mesh-list
2387591|NCT00654160|Irinotecan|irinotecan|mesh-list
2387592|NCT00654160|Calcium|calcium|mesh-list
2507279|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
2507280|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2507281|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2507282|NCT01256775|Analgesics|analgesics|mesh-ancestor
2507283|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
2507284|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507285|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507286|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2387593|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
2387594|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2387595|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387596|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
2387597|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387598|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2387599|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2387600|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2387601|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
2387602|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2387603|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2387604|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387605|NCT00654160|Antidotes|antidotes|mesh-ancestor
2387606|NCT00654160|Protective Agents|protective agents|mesh-ancestor
2387607|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
2387608|NCT00654160|Vitamins|vitamins|mesh-ancestor
2387609|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
2387610|NCT00654173|Atorvastatin|atorvastatin|mesh-list
2507287|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2507288|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2507289|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2507290|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507291|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2507292|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2507293|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
2507294|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387611|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2387612|NCT00654173|Simvastatin|simvastatin|mesh-list
2387613|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387614|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387615|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
2387616|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387617|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387618|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387619|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387620|NCT00654225|Atorvastatin|atorvastatin|mesh-list
2387621|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2387622|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387623|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387624|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
2387625|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387626|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387627|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387628|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387629|NCT00654277|Ondansetron|ondansetron|mesh-list
2387630|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
2507295|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2387631|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
2387632|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387633|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387634|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2387635|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
2387636|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
2387637|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2387638|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
2387639|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387640|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387641|NCT00654277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2387642|NCT00654277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2387643|NCT00654277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387644|NCT00654277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2387645|NCT00654277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2387646|NCT00654290|Propranolol|propranolol|mesh-list
2387647|NCT00654290|Amiodarone|amiodarone|mesh-list
2387648|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2387649|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2387650|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
2387651|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387652|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507296|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
2507297|NCT01256801|Interleukin-2|interleukin-2|mesh-list
2507298|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507299|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2507300|NCT01256801|Analgesics|analgesics|mesh-ancestor
2507301|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
2507302|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507303|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507304|NCT01256866|Midazolam|midazolam|mesh-list
2507305|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
2507306|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2507307|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2507308|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507309|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2507310|NCT01256866|Analgesics|analgesics|mesh-ancestor
2507311|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
2507312|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507313|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2507314|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2507315|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2507316|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
2507317|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507318|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507319|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2507320|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2507321|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2507322|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2507323|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2507324|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
2507325|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
2507326|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
2507327|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
2507328|NCT01256905|Modafinil|modafinil|mesh-list
2507329|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2507330|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507331|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2507332|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2507333|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2507334|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507335|NCT01257009|Atorvastatin|atorvastatin|mesh-list
2507336|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2507337|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2507338|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
2507339|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507340|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2507341|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2507342|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507343|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
2507344|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2507345|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507346|NCT01257048|Budesonide|budesonide|mesh-list
2387653|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507347|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
2507348|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507349|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2507350|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
2507351|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507352|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507353|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2507354|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
2387654|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2387655|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2387656|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
2387657|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2387658|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2387659|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2387660|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2387661|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2387662|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387663|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2387664|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2387665|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2387666|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2387667|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387668|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387669|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
2387670|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387671|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387672|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2507355|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
2507356|NCT01257048|Hormones|hormones|mesh-ancestor
2507357|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2507358|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2507359|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2507360|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2507361|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
2507362|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507363|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507364|NCT01257074|Acyclovir|acyclovir|mesh-list
2507365|NCT01257074|Penciclovir|penciclovir|mesh-list
2507366|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
2507367|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507368|NCT01257126|Diclofenac|diclofenac|mesh-list
2507369|NCT01257126|Nimesulide|nimesulide|mesh-list
2507370|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2507371|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2507372|NCT01257126|Analgesics|analgesics|mesh-ancestor
2507373|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
2507374|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507375|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507376|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507377|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2507378|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2507379|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507380|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507381|NCT01257139|Docetaxel|docetaxel|mesh-list
2507382|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507383|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
2507384|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
2507385|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
2507386|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507387|NCT01257165|Ethanol|ethanol|mesh-list
2507388|NCT01257165|Zopiclone|zopiclone|mesh-list
2507389|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2507390|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507391|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2507392|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507393|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2507394|NCT01257243|Potassium iodate|potassium iodate|mesh-list
2507395|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
2507396|NCT01257243|Guaifenesin|guaifenesin|mesh-list
2507397|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2507398|NCT01257243|Expectorants|expectorants|mesh-ancestor
2507399|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
2507400|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2507401|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2507402|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
2507403|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507404|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507405|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507406|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
2387673|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387674|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2387675|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387676|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387677|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
2387678|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387679|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387680|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387681|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387682|NCT00654407|Atorvastatin|atorvastatin|mesh-list
2387683|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2387684|NCT00654407|Simvastatin|simvastatin|mesh-list
2387685|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387686|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387687|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
2387688|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387689|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387690|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387691|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387692|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2387693|NCT00654446|Simvastatin|simvastatin|mesh-list
2507407|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2507408|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
2507409|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
2507410|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507411|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
2507412|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2507413|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
2507414|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507415|NCT01257334|Empagliflozin|empagliflozin|mesh-list
2507416|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2507417|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507418|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2507419|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507420|NCT01257360|Panitumumab|panitumumab|mesh-list
2507421|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2507422|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507423|NCT01257373|Cobalt|cobalt|mesh-list
2507424|NCT01257373|Chromium|chromium|mesh-list
2507425|NCT01257373|Sirolimus|sirolimus|mesh-list
2507426|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2507427|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507428|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2507429|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507430|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
2507431|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2507432|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
2507433|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507434|NCT01257373|Trace Elements|trace elements|mesh-ancestor
2507435|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
2507436|NCT01257386|Mesalamine|mesalamine|mesh-list
2507437|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2507438|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2507439|NCT01257386|Analgesics|analgesics|mesh-ancestor
2114515|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2114516|NCT02604550|Ropivacaine|ropivacaine|mesh-list
2114517|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
2114518|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
2114519|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2114520|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114521|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
2114522|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114523|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2114524|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2114525|NCT02604550|Analgesics|analgesics|mesh-ancestor
2387694|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387695|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387696|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
2387697|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507440|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
2507441|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507442|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387698|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387699|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2507443|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507444|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2507445|NCT01257399|Mesalamine|mesalamine|mesh-list
2507446|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2507447|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2507448|NCT01257399|Analgesics|analgesics|mesh-ancestor
2507449|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
2507450|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507451|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507452|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507453|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2507454|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
2507455|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2507456|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507457|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2387700|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387701|NCT00654459|Policosanol|policosanol|mesh-list
2387702|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387703|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387704|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
2387705|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387706|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387707|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2387708|NCT00654485|Atorvastatin|atorvastatin|mesh-list
2387709|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2507458|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507459|NCT01257451|Vildagliptin|vildagliptin|mesh-list
2507460|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2507461|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507462|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2507463|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
2507464|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507465|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507466|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2507467|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2507468|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2507469|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507470|NCT01257464|Incretins|incretins|mesh-ancestor
2507471|NCT01257464|Hormones|hormones|mesh-ancestor
2507472|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2507473|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
2507474|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507475|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507476|NCT01257490|Bupropion|bupropion|mesh-list
2507477|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2507478|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
2507479|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2507480|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2507481|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2507482|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2507483|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507484|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
2507485|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507486|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507487|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2507488|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2507489|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507490|NCT01257516|Pregabalin|pregabalin|mesh-list
2507491|NCT01257516|Analgesics|analgesics|mesh-ancestor
2387710|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387711|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387712|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
2387713|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387714|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2507492|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
2507493|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507494|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387715|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387716|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387717|NCT00654524|Vitamin D|vitamin d|mesh-list
2387718|NCT00654524|Goserelin|goserelin|mesh-list
2387719|NCT00654524|Hormones|hormones|mesh-list
2387720|NCT00654524|Vitamins|vitamins|mesh-ancestor
2387721|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
2387722|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387723|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2387724|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2387725|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2387726|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2387727|NCT00654537|Atorvastatin|atorvastatin|mesh-list
2387728|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2387729|NCT00654537|Simvastatin|simvastatin|mesh-list
2387730|NCT00654537|Pravastatin|pravastatin|mesh-list
2507495|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
2507496|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2507497|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2507498|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507499|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2507500|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2507501|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2507502|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2507503|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2507504|NCT01257529|Pregabalin|pregabalin|mesh-list
2507505|NCT01257529|Analgesics|analgesics|mesh-ancestor
2507506|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
2387731|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387732|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387733|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
2387734|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387735|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387736|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387737|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387738|NCT00654576|Olanzapine|olanzapine|mesh-list
2387739|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
2507507|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507508|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507509|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
2507510|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2507511|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2387740|NCT00654576|Risperidone|risperidone|mesh-list
2387741|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2387742|NCT00654576|Clozapine|clozapine|mesh-list
2387743|NCT00654576|Sulpiride|sulpiride|mesh-list
2387744|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2387745|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
2387746|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387747|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507512|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507513|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2507514|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2507515|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2507516|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2507517|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2507518|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2387748|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387749|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2387750|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2387751|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387752|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2507519|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507520|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2507521|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507522|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507523|NCT01257607|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2507524|NCT01257607|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2507525|NCT01257672|Ondansetron|ondansetron|mesh-list
2507526|NCT01257672|Domperidone|domperidone|mesh-list
2507527|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
2507528|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
2507529|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387753|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2387754|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
2387755|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
2387756|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
2387757|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387758|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2387759|NCT00654576|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2387760|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2507530|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507531|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2507532|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
2507533|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
2507534|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2507535|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
2507536|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507537|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507538|NCT01257672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2507539|NCT01257672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2507540|NCT01257672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2507541|NCT01257672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2507542|NCT01257672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2507543|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2507544|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
2507545|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
2507546|NCT00077285|Ifosfamide|ifosfamide|mesh-list
2507547|NCT00077285|Carboplatin|carboplatin|mesh-list
2507548|NCT00077285|Doxorubicin|doxorubicin|mesh-list
2507549|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2507550|NCT00077285|Etoposide|etoposide|mesh-list
2507551|NCT00077285|Irinotecan|irinotecan|mesh-list
2507552|NCT00077285|Vincristine|vincristine|mesh-list
2507553|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
2507554|NCT00077285|Razoxane|razoxane|mesh-list
2507555|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2507556|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
2507557|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507558|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2507559|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2507560|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
2507561|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387761|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2387762|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
2387763|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
2387764|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
2387765|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2387766|NCT00654589|Deferasirox|deferasirox|mesh-list
2387767|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2387768|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
2507562|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507563|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2507564|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2507565|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2507566|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2507567|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507568|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2507569|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2507570|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
2507571|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
2507572|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
2507573|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2507574|NCT00077285|Protective Agents|protective agents|mesh-ancestor
2507575|NCT01257815|Ranibizumab|ranibizumab|mesh-list
2507576|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2507577|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2387769|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
2387770|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387771|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2387772|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387773|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387774|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
2387775|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387776|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387777|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2387778|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387779|NCT00654667|Resveratrol|resveratrol|mesh-list
2387780|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
2387781|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387782|NCT00654667|Protective Agents|protective agents|mesh-ancestor
2387783|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387784|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387785|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2387786|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2387787|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
2387788|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2387789|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2387790|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387791|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387792|NCT00654680|Urological Agents|urological agents|mesh-ancestor
2387793|NCT00654706|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2387794|NCT00654706|Sertindole|sertindole|mesh-list
2387795|NCT00654706|Antidepressive Agents|antidepressive agents|mesh-ancestor
2387796|NCT00654706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2387797|NCT00654706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2387798|NCT00654706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2387799|NCT00654706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387800|NCT00654706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387801|NCT00654758|Paclitaxel|paclitaxel|mesh-list
2507578|NCT01257815|Growth Substances|growth substances|mesh-ancestor
2507579|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387802|NCT00654758|Carboplatin|carboplatin|mesh-list
2387803|NCT00654758|Volociximab|volociximab|mesh-list
2387804|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2387805|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2387806|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507580|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
2507581|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507582|NCT01257828|Riluzole|riluzole|mesh-list
2507583|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
2507584|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2507585|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2507586|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507587|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507588|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507589|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2507590|NCT01257828|Protective Agents|protective agents|mesh-ancestor
2507591|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
2507592|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
2507593|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2507594|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507595|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507596|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
2507597|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2507598|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2507599|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114526|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2114527|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2114528|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
2114529|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2114530|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114531|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114532|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2114533|NCT02604550|Narcotics|narcotics|mesh-ancestor
2114534|NCT02604589|Hydromorphone|hydromorphone|mesh-list
2114535|NCT02604589|Bupivacaine|bupivacaine|mesh-list
2114536|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
2114537|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
2114538|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2114539|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114540|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
2114541|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114542|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2114543|NCT02604589|Narcotics|narcotics|mesh-ancestor
2114544|NCT02604589|Analgesics|analgesics|mesh-ancestor
2114545|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
2114546|NCT02604810|Antibodies|antibodies|mesh-list
2114547|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
2114548|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2114549|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2114550|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
2114551|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
2114552|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114553|NCT02605122|Amoxicillin|amoxicillin|mesh-list
2114554|NCT02605122|Azithromycin|azithromycin|mesh-list
2114555|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
2387807|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
2387808|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
2387809|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
2387810|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387811|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2387812|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2387813|NCT00654758|Growth Substances|growth substances|mesh-ancestor
2387814|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387815|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
2387816|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
2387817|NCT00654888|Mitomycins|mitomycins|mesh-list
2387818|NCT00654888|Mitomycin|mitomycin|mesh-list
2387819|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2387820|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2387821|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
2387822|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387823|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2387824|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387825|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2387826|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
2387827|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2387828|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2387829|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387830|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507600|NCT01257893|Aspirin|aspirin|mesh-list
2507601|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2507602|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2507603|NCT01257893|Analgesics|analgesics|mesh-ancestor
2507604|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
2507605|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507606|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507607|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507608|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2507609|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2507610|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2507611|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507612|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2507613|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2507614|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507615|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
2507616|NCT01257906|Tretinoin|tretinoin|mesh-list
2507617|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507618|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
2507619|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
2507620|NCT01257919|Azelaic acid|azelaic acid|mesh-list
2507621|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507622|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
2507623|NCT01257958|Vitamin D|vitamin d|mesh-list
2507624|NCT01257958|Vitamins|vitamins|mesh-ancestor
2507625|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
2507626|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507627|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2507628|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
2507629|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2507630|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2507631|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507632|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
2507633|NCT01258010|Coagulants|coagulants|mesh-ancestor
2507634|NCT01258036|Hormones|hormones|mesh-list
2507635|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2507636|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507637|NCT01258192|Paclitaxel|paclitaxel|mesh-list
2507638|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2507639|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2507640|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507641|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
2507642|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
2507643|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
2507644|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507645|NCT01258296|Fentanyl|fentanyl|mesh-list
2507646|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2507647|NCT01258296|Narcotics|narcotics|mesh-ancestor
2507648|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2507649|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507650|NCT01258296|Analgesics|analgesics|mesh-ancestor
2507651|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
2507652|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507653|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2507654|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2507655|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
2507656|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
2507657|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2507658|NCT01258309|Ketorolac|ketorolac|mesh-list
2507659|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2507660|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2507661|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2507662|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2507663|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2507664|NCT01258309|Analgesics|analgesics|mesh-ancestor
2507665|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
2507666|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507667|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507668|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507669|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2507670|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2507671|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507672|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507673|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2507674|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2507675|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2507676|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
2507677|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
2507678|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507679|NCT01258322|Pioglitazone|pioglitazone|mesh-list
2507680|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2507681|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507682|NCT01258439|Ritonavir|ritonavir|mesh-list
2507683|NCT01258439|Darunavir|darunavir|mesh-list
2507684|NCT01258439|Tenofovir|tenofovir|mesh-list
2507685|NCT01258439|Emtricitabine|emtricitabine|mesh-list
2507686|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
2507687|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2507688|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2507689|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2507690|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
2507691|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387831|NCT00654914|Urological Agents|urological agents|mesh-ancestor
2387832|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
2387833|NCT00655018|Tocopherols|tocopherols|mesh-list
2387834|NCT00655018|Vitamin E|vitamin e|mesh-list
2387835|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
2387836|NCT00655018|Vitamins|vitamins|mesh-ancestor
2387837|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
2387838|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387839|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
2387840|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507692|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507693|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2507694|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2507695|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
2507696|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507697|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2507698|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2507699|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2387841|NCT00655018|Protective Agents|protective agents|mesh-ancestor
2387842|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
2387843|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2387844|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387845|NCT00655109|Fluticasone|fluticasone|mesh-list
2387846|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2387847|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
2387848|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2387849|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2387850|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
2387851|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114556|NCT02605122|Erythromycin|erythromycin|mesh-list
2114557|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
2114558|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2114559|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
2114560|NCT02605122|Ampicillin|ampicillin|mesh-list
2387852|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387853|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2507700|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2387854|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
2387855|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
2387856|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2507701|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2507702|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2507703|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
2507704|NCT01258491|Niacin|niacin|mesh-list
2507705|NCT01258491|Niacinamide|niacinamide|mesh-list
2507706|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
2507707|NCT01258491|Vitamins|vitamins|mesh-ancestor
2507708|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
2507709|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507710|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2507711|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
2387857|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2387858|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2387859|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2507712|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507713|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2507714|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
2507715|NCT01258530|Oseltamivir|oseltamivir|mesh-list
2507716|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
2507717|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507718|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507719|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507720|NCT01258569|Alvimopan|alvimopan|mesh-list
2507721|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2507722|NCT01258634|Leucovorin|leucovorin|mesh-list
2507723|NCT01258634|Doxorubicin|doxorubicin|mesh-list
2507724|NCT01258634|Etoposide|etoposide|mesh-list
2507725|NCT01258634|Ifosfamide|ifosfamide|mesh-list
2507726|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
2507727|NCT01258634|Razoxane|razoxane|mesh-list
2507728|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507729|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2507730|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2507731|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2507732|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507733|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507734|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2387860|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2387861|NCT00655109|Analgesics|analgesics|mesh-ancestor
2387862|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
2387863|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2387864|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2387865|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2387866|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
2387867|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
2387868|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387869|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387870|NCT00655122|Dalteparin|dalteparin|mesh-list
2387871|NCT00655122|Tinzaparin|tinzaparin|mesh-list
2507735|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507736|NCT01258634|Antidotes|antidotes|mesh-ancestor
2507737|NCT01258634|Protective Agents|protective agents|mesh-ancestor
2507738|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
2507739|NCT01258634|Vitamins|vitamins|mesh-ancestor
2507740|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
2387872|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2387873|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
2387874|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2387875|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2387876|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387877|NCT00655135|Vedolizumab|vedolizumab|mesh-list
2387878|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2387879|NCT00655148|Vaccines|vaccines|mesh-list
2387880|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
2387881|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387882|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
2387883|NCT00655174|Sertraline|sertraline|mesh-list
2387884|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
2387885|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2387886|NCT00655174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2387887|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2387888|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2387889|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507741|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2507742|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
2387890|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387891|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
2387892|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387893|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2387894|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2387895|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2507743|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2507744|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
2507745|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
2507746|NCT01258686|Silymarin|silymarin|mesh-list
2507747|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
2507748|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507749|NCT01258686|Protective Agents|protective agents|mesh-ancestor
2507750|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507751|NCT01258712|Methotrexate|methotrexate|mesh-list
2507752|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2507753|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
2507754|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2507755|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507756|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2507757|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
2507758|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507759|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507760|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
2507761|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507762|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2507763|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2507764|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
2507765|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2507766|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2507767|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2507768|NCT01258764|Lisinopril|lisinopril|mesh-list
2507769|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2507770|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2507771|NCT01258764|Diuretics|diuretics|mesh-ancestor
2507772|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
2507773|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507774|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2507775|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2507776|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507777|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
2507778|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507779|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2507780|NCT01258764|Protective Agents|protective agents|mesh-ancestor
2507781|NCT01258777|Golimumab|golimumab|mesh-list
2507782|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2507783|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2507784|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507785|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2507786|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
2507787|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507788|NCT01258868|Celecoxib|celecoxib|mesh-list
2507789|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2507790|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2507791|NCT01258868|Analgesics|analgesics|mesh-ancestor
2507792|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
2507793|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507794|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507795|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507796|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2507797|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2507798|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2507799|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387896|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2387897|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2507800|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507801|NCT01258907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2507802|NCT01258907|Immunologic Factors|immunologic factors|mesh-ancestor
2507803|NCT01258907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507804|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2507805|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2507806|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2507807|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387898|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2387899|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387900|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2387901|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
2387902|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2387903|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387904|NCT00655252|Everolimus|everolimus|mesh-list
2387905|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507808|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507809|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2507810|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2507811|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2507812|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
2507813|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507814|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507815|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2507816|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2507817|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
2507818|NCT01258933|Ofatumumab|ofatumumab|mesh-list
2507819|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507820|NCT01258959|Anesthetics|anesthetics|mesh-list
2507821|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
2507822|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387906|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2387907|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
2387908|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387909|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2387910|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387911|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387912|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
2387913|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387914|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387915|NCT00655330|Valsartan|valsartan|mesh-list
2387916|NCT00655330|Probucol|probucol|mesh-list
2387917|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2387918|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2387919|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2387920|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387921|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2387922|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2387923|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
2387924|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2387925|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
2387926|NCT00655330|Protective Agents|protective agents|mesh-ancestor
2387927|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387928|NCT00655408|Iron|iron|mesh-list
2387929|NCT00655408|Trace Elements|trace elements|mesh-ancestor
2387930|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
2387931|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387932|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
2387933|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
2387934|NCT00655421|Coagulants|coagulants|mesh-ancestor
2507823|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507824|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
2507825|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507826|NCT01259050|Copper|copper|mesh-list
2507827|NCT01259050|Trace Elements|trace elements|mesh-ancestor
2507828|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
2507829|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507830|NCT01259141|Azithromycin|azithromycin|mesh-list
2507831|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
2507832|NCT01259141|Cephalosporins|cephalosporins|mesh-list
2507833|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2507834|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507835|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2507836|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2507837|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507838|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507839|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507840|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
2507841|NCT01259193|Sorafenib|sorafenib|mesh-list
2507842|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507843|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2507844|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507845|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507846|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2507847|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507848|NCT01259219|Rifabutin|rifabutin|mesh-list
2507849|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2507850|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507851|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2507852|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
2507853|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2507854|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
2507855|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507856|NCT01259336|Itraconazole|itraconazole|mesh-list
2507857|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
2507858|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507859|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2507860|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2507861|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507862|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507863|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2507864|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
2507865|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2507866|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507867|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2507868|NCT01259362|Cocaine|cocaine|mesh-list
2507869|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
2507870|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
2507871|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2507872|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507873|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
2507874|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507875|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2507876|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2507877|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2507878|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2507879|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507880|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
2507881|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507882|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
2507883|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507884|NCT01259453|Vaccines|vaccines|mesh-list
2507885|NCT01259453|Immunologic Factors|immunologic factors|mesh-ancestor
2507886|NCT01259453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507887|NCT01259479|Satraplatin|satraplatin|mesh-list
2507888|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507889|NCT01259531|Silodosin|silodosin|mesh-list
2507890|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2507891|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2507892|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2507893|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
2507894|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507895|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507896|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507897|NCT01259531|Urological Agents|urological agents|mesh-ancestor
2507898|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
2507899|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2507900|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2507901|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2507902|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2507903|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507904|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
2507905|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507906|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507907|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2507908|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507909|NCT01259648|Remifentanil|remifentanil|mesh-list
2507910|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2507911|NCT01259648|Narcotics|narcotics|mesh-ancestor
2507912|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2507913|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507914|NCT01259648|Analgesics|analgesics|mesh-ancestor
2507915|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
2507916|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507917|NCT01259817|Aspirin|aspirin|mesh-list
2507918|NCT01259817|Interferons|interferons|mesh-list
2507919|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
2507920|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
2507921|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2507922|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507923|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
2507924|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507925|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2507926|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2507927|NCT01259817|Analgesics|analgesics|mesh-ancestor
2507928|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
2507929|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507930|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507931|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507932|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2507933|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2507934|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2507935|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507936|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2507937|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2507938|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507939|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
2507940|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
2507941|NCT01259830|Etoricoxib|etoricoxib|mesh-list
2507942|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2387935|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
2387936|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387937|NCT00655512|Clobetasol|clobetasol|mesh-list
2387938|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
2387939|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2387940|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
2387941|NCT00655512|Hormones|hormones|mesh-ancestor
2387942|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2387943|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507943|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2507944|NCT01259830|Analgesics|analgesics|mesh-ancestor
2507945|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
2507946|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507947|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507948|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2507949|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2507950|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2507951|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2507952|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2507953|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507954|NCT01259934|Interferons|interferons|mesh-list
2507955|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
2507956|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
2507957|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507958|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
2507959|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507960|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
2507961|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507962|NCT01259973|Haloperidol|haloperidol|mesh-list
2507963|NCT01259973|Risperidone|risperidone|mesh-list
2507964|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
2507965|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2507966|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
2507967|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2507968|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507969|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507970|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2507971|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2507972|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2387944|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2387945|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2387946|NCT00655512|Analgesics|analgesics|mesh-ancestor
2387947|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
2387948|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387949|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2507973|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2507974|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2507975|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
2507976|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
2507977|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
2507978|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2507979|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2507980|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2507981|NCT01260012|Praziquantel|praziquantel|mesh-list
2507982|NCT01260012|Antioxidants|antioxidants|mesh-list
2507983|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2507984|NCT01260012|Protective Agents|protective agents|mesh-ancestor
2507985|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507986|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
2507987|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2507988|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2507989|NCT01260025|Endostatins|endostatins|mesh-list
2507990|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2507991|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2507992|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2507993|NCT01260025|Growth Substances|growth substances|mesh-ancestor
2507994|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2507995|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
2507996|NCT01260103|Temozolomide|temozolomide|mesh-list
2507997|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2507998|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
2507999|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508000|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508001|NCT01260129|Silodosin|silodosin|mesh-list
2508002|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2508003|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2508004|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2508005|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
2508006|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508007|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508008|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508009|NCT01260129|Urological Agents|urological agents|mesh-ancestor
2508010|NCT01260233|Nicotine|nicotine|mesh-list
2508011|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2387950|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
2387951|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2387952|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
2387953|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2387954|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387955|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387956|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
2387957|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2387958|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
2387959|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2387960|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2387961|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387962|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387963|NCT00655590|Urological Agents|urological agents|mesh-ancestor
2387964|NCT00655603|Pancrelipase|pancrelipase|mesh-list
2387965|NCT00655603|Hormones|hormones|mesh-list
2387966|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2387967|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387968|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2387969|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2387970|NCT00655616|Montelukast|montelukast|mesh-list
2387971|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2387972|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
2387973|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2387974|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387975|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2387976|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
2508012|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
2508013|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508014|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508015|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2508016|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2508017|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
2508018|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508019|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508020|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2508021|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2508022|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508023|NCT01260246|Incretins|incretins|mesh-ancestor
2508024|NCT01260246|Hormones|hormones|mesh-ancestor
2508025|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2508026|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2508027|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
2508028|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508029|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508030|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2508031|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
2508032|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2387977|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2387978|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2387979|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2387980|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
2387981|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2387982|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387983|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2387984|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
2387985|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2508033|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2508034|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508035|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508036|NCT01260285|Urological Agents|urological agents|mesh-ancestor
2508037|NCT01260376|Acipimox|acipimox|mesh-list
2508038|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2508039|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
2508040|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508041|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2508042|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
2508043|NCT01260415|Panitumumab|panitumumab|mesh-list
2508044|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508045|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2508046|NCT01260506|Bevacizumab|bevacizumab|mesh-list
2508047|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2508048|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508049|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2508050|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2508051|NCT01260506|Growth Substances|growth substances|mesh-ancestor
2508052|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508053|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
2508054|NCT01260519|Heparin|heparin|mesh-list
2508055|NCT01260519|Calcium heparin|calcium heparin|mesh-list
2508056|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
2508057|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2508058|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2508059|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508060|NCT01260558|Sirolimus|sirolimus|mesh-list
2508061|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2508062|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508063|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2508064|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508065|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
2508066|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2508067|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
2387986|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2387987|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2387988|NCT00655655|Everolimus|everolimus|mesh-list
2387989|NCT00655655|Vatalanib|vatalanib|mesh-list
2387990|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2387991|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2387992|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
2387993|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2387994|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2387995|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2387996|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2387997|NCT00655681|Pamidronate|pamidronate|mesh-list
2387998|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2387999|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388000|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
2388001|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
2508068|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508069|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2508070|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
2508071|NCT01260610|Tenofovir|tenofovir|mesh-list
2508072|NCT01260610|Telbivudine|telbivudine|mesh-list
2508073|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
2508074|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508075|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2508076|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2508077|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508078|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508079|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2508080|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2508081|NCT01260623|Prednisone|prednisone|mesh-list
2388002|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
2388003|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388004|NCT00655785|Gemcitabine|gemcitabine|mesh-list
2388005|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2508082|NCT01260623|Prednisolone|prednisolone|mesh-list
2508083|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2508084|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
2508085|NCT01260623|Hormones|hormones|mesh-ancestor
2508086|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2508087|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508088|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2508089|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508090|NCT01260675|Buprenorphine|buprenorphine|mesh-list
2508091|NCT01260675|Naloxone|naloxone|mesh-list
2508092|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2508093|NCT01260675|Narcotics|narcotics|mesh-ancestor
2508094|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2508095|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508096|NCT01260675|Analgesics|analgesics|mesh-ancestor
2508097|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
2388006|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
2388007|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388008|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388009|NCT00655785|Antiviral Agents|antiviral agents|mesh-ancestor
2388010|NCT00655785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388011|NCT00655785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388012|NCT00655785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2508098|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508099|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2508100|NCT01260714|Etoposide|etoposide|mesh-list
2508101|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
2508102|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
2508103|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
2508104|NCT01260714|Azacitidine|azacitidine|mesh-list
2508105|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2508106|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508107|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2508108|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2508109|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508110|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508111|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2508112|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
2508113|NCT01260714|Analgesics|analgesics|mesh-ancestor
2508114|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
2508115|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508116|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508117|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
2508118|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
2508119|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
2508120|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
2508121|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
2508122|NCT01260727|Vaccines|vaccines|mesh-list
2508123|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
2508124|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508125|NCT01260753|Fluticasone|fluticasone|mesh-list
2508126|NCT01260753|Xhance|xhance|mesh-list
2508127|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2508128|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2508129|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
2508130|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508131|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508132|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2508133|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
2508134|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
2508135|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2508136|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
2508137|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2508138|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2508139|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508140|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
2508141|NCT01260818|Coagulants|coagulants|mesh-ancestor
2508142|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2508143|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
2508144|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508145|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
2508146|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2508147|NCT01260857|Diuretics|diuretics|mesh-ancestor
2508148|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
2508149|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508150|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2508151|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2508152|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508153|NCT01260870|Paclitaxel|paclitaxel|mesh-list
2508154|NCT01260870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2508155|NCT01260870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508156|NCT01260870|Tubulin Modulators|tubulin modulators|mesh-ancestor
2508157|NCT01260870|Antimitotic Agents|antimitotic agents|mesh-ancestor
2508158|NCT01260870|Mitosis Modulators|mitosis modulators|mesh-ancestor
2508159|NCT01260870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508160|NCT01260974|Caspofungin|caspofungin|mesh-list
2508161|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
2508162|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508163|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508164|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388013|NCT00655785|Immunologic Factors|immunologic factors|mesh-ancestor
2388014|NCT00655785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388015|NCT00655798|Antioxidants|antioxidants|mesh-list
2388016|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388017|NCT00655798|Protective Agents|protective agents|mesh-ancestor
2388018|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388019|NCT00655824|Ofatumumab|ofatumumab|mesh-list
2388020|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388021|NCT00655837|Gemcitabine|gemcitabine|mesh-list
2388022|NCT00655837|Rituximab|rituximab|mesh-list
2388023|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
2388024|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2388025|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508165|NCT01261065|Carvedilol|carvedilol|mesh-list
2508166|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2508167|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2508168|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
2508169|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508170|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508171|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508172|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2508173|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
2508174|NCT01261065|Protective Agents|protective agents|mesh-ancestor
2508175|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2508176|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2508177|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2508178|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
2114561|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
2114562|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
2114563|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2114564|NCT02605122|Solithromycin|solithromycin|mesh-list
2114565|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
2388026|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
2388027|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388028|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2388029|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2388030|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
2388031|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388032|NCT00655837|Antiviral Agents|antiviral agents|mesh-ancestor
2388033|NCT00655837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388034|NCT00655837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388035|NCT00655837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2388036|NCT00655915|Betamethasone|betamethasone|mesh-list
2388037|NCT00655915|Lidocaine|lidocaine|mesh-list
2388038|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
2388039|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
2388040|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2388041|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388042|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
2388043|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114566|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2508179|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2508180|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2508181|NCT01261078|Epinephrine|epinephrine|mesh-list
2508182|NCT01261078|Racepinephrine|racepinephrine|mesh-list
2508183|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
2508184|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2508185|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2508186|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
2508187|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508188|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508189|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508190|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2508191|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2508192|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
2508193|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508194|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2508195|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
2508196|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
2388044|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2388045|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2508197|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
2508198|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2508199|NCT01261117|Ibuprofen|ibuprofen|mesh-list
2508200|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2508201|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2508202|NCT01261117|Analgesics|analgesics|mesh-ancestor
2508203|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
2508204|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508205|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508206|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2508207|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2508208|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2508209|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508210|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508211|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2508212|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2508213|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
2508214|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508215|NCT01261130|Antacids|antacids|mesh-ancestor
2508216|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508217|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2508218|NCT01261156|Diltiazem|diltiazem|mesh-list
2508219|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2508220|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2388046|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2388047|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2388048|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388049|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2388050|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
2388051|NCT00655915|Hormones|hormones|mesh-ancestor
2388052|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388053|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2388054|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
2388055|NCT00655967|Acamprosate|acamprosate|mesh-list
2388056|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2388057|NCT00655993|Simvastatin|simvastatin|mesh-list
2388058|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2388059|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2388060|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
2508221|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2508222|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508223|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2508224|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508225|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
2508226|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
2508227|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2508228|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508229|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2508230|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
2508231|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2508232|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508233|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508234|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388061|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388062|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2388063|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2388064|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388065|NCT00656006|Ribavirin|ribavirin|mesh-list
2388066|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
2388067|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388068|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
2388069|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388070|NCT00656032|Cinacalcet|cinacalcet|mesh-list
2388071|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2388072|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388073|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2388074|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
2388075|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388076|NCT00656110|Ethanol|ethanol|mesh-list
2388077|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
2388078|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2388079|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2388080|NCT00656110|Prednisolone|prednisolone|mesh-list
2388081|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
2388082|NCT00656110|Lidocaine|lidocaine|mesh-list
2388083|NCT00656110|Bupivacaine|bupivacaine|mesh-list
2388084|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2388085|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
2388086|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
2388087|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
2388088|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2388089|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388090|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
2388091|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388092|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2388093|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2388094|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2388095|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2388096|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388097|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2388098|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
2388099|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
2388100|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2388101|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
2388102|NCT00656110|Hormones|hormones|mesh-ancestor
2388103|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388104|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2388105|NCT00656110|Protective Agents|protective agents|mesh-ancestor
2388106|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2388107|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388108|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2508235|NCT01261234|Cilostazol|cilostazol|mesh-list
2508236|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2508237|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
2508238|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508239|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508240|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2508241|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
2508242|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2508243|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2508244|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508245|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2508246|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
2508247|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2508248|NCT01261234|Protective Agents|protective agents|mesh-ancestor
2508249|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2508250|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2508251|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508252|NCT01261286|Verapamil|verapamil|mesh-list
2508253|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2508254|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2508255|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2508256|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508257|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2388109|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388110|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
2508258|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508259|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
2508260|NCT01261299|Carboplatin|carboplatin|mesh-list
2508261|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508262|NCT01261312|Guadecitabine|guadecitabine|mesh-list
2508263|NCT01261312|Azacitidine|azacitidine|mesh-list
2508264|NCT01261312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508265|NCT01261312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2508266|NCT01261312|Antimetabolites|antimetabolites|mesh-ancestor
2508267|NCT01261312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508268|NCT01261312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508269|NCT01261416|Levetiracetam|levetiracetam|mesh-list
2508270|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
2508271|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
2508272|NCT01261481|Tolvaptan|tolvaptan|mesh-list
2508273|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2508274|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508275|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
2508276|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508277|NCT01261546|Dexamethasone|dexamethasone|mesh-list
2508278|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2508279|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
2508280|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
2508281|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508282|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508283|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2508284|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
2508285|NCT01261546|Hormones|hormones|mesh-ancestor
2508286|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2508287|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2508288|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508289|NCT01261637|Ropivacaine|ropivacaine|mesh-list
2508290|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
2508291|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
2388111|NCT00656123|Molgramostim|molgramostim|mesh-list
2388112|NCT00656123|Sargramostim|sargramostim|mesh-list
2388113|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
2388114|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388115|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2508292|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2508293|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508294|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
2508295|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508296|NCT01261689|Sufentanil|sufentanil|mesh-list
2508297|NCT01261689|Dsuvia|dsuvia|mesh-list
2508298|NCT01261689|Ropivacaine|ropivacaine|mesh-list
2508299|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
2508300|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
2508301|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2508302|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508303|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
2508304|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508305|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2508306|NCT01261689|Narcotics|narcotics|mesh-ancestor
2508307|NCT01261689|Analgesics|analgesics|mesh-ancestor
2508308|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2508309|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2508310|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
2508311|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
2508312|NCT01261702|Analgesics|analgesics|mesh-ancestor
2508313|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
2508314|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508315|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508316|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
2508317|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2508318|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2508319|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
2508320|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2508321|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2508322|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508323|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2508324|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
2388116|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2508325|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2508337|NCT01261741|Memantine|memantine|mesh-list
2508338|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2508339|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2508340|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
2508341|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508342|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508343|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508344|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2508345|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2508346|NCT01261832|Cilostazol|cilostazol|mesh-list
2508347|NCT01261832|Clopidogrel|clopidogrel|mesh-list
2508348|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2508349|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2508350|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2508351|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2508352|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
2508353|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508354|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508355|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508356|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2508357|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
2508358|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508359|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2508360|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
2508361|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2508362|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2508363|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
2508364|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2508365|NCT01261832|Protective Agents|protective agents|mesh-ancestor
2508366|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2388117|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2388118|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
2388119|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388120|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388121|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2388122|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2388123|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
2508367|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2508368|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508369|NCT01261897|Ropivacaine|ropivacaine|mesh-list
2508370|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
2508371|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
2508372|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2508373|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508374|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
2508375|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508376|NCT01261923|Alitretinoin|alitretinoin|mesh-list
2508377|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508378|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
2508379|NCT01262001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2508380|NCT01262001|Immunologic Factors|immunologic factors|mesh-ancestor
2508381|NCT01262001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508382|NCT01262183|Panitumumab|panitumumab|mesh-list
2508383|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2508384|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508385|NCT01262261|Buprenorphine|buprenorphine|mesh-list
2508386|NCT01262261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2508387|NCT01262261|Narcotics|narcotics|mesh-ancestor
2508388|NCT01262261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2508389|NCT01262261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508390|NCT01262261|Analgesics|analgesics|mesh-ancestor
2508391|NCT01262261|Sensory System Agents|sensory system agents|mesh-ancestor
2508392|NCT01262261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508393|NCT01262261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2508394|NCT01262274|Anastrozole|anastrozole|mesh-list
2508395|NCT01262274|Tegafur|tegafur|mesh-list
2508396|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2508397|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508398|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2508399|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2508400|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508401|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508402|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2508403|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
2508404|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2508405|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508406|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2508407|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
2508408|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
2508409|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2508410|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2508411|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
2388124|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2388125|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2508412|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508413|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508414|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508415|NCT01262391|Urological Agents|urological agents|mesh-ancestor
2508416|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
2508417|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2508418|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
2508419|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508420|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
2508421|NCT01262417|Protective Agents|protective agents|mesh-ancestor
2508422|NCT01262469|Capecitabine|capecitabine|mesh-list
2508423|NCT01262469|Lapatinib|lapatinib|mesh-list
2508424|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2508425|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
2508426|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508427|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508428|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2508429|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508430|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
2508431|NCT01262482|Sorafenib|sorafenib|mesh-list
2508432|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508433|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2508434|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508435|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508436|NCT01262586|Glimepiride|glimepiride|mesh-list
2508437|NCT01262586|Vildagliptin|vildagliptin|mesh-list
2508438|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2508439|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2508440|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508441|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2508442|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
2508443|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2508444|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
2508445|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508446|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508447|NCT01262612|Cediranib|cediranib|mesh-list
2508448|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388126|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388127|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388128|NCT00656188|Urological Agents|urological agents|mesh-ancestor
2388129|NCT00656214|Lycopene|lycopene|mesh-list
2388130|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2388131|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
2388132|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388133|NCT00656214|Protective Agents|protective agents|mesh-ancestor
2388134|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388135|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2508449|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2508450|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508451|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388136|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2388137|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388138|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2388139|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2508452|NCT01262729|Xenon|xenon|mesh-list
2508453|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2508454|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
2508455|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
2508456|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2508457|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508458|NCT01262742|Carbetocin|carbetocin|mesh-list
2508459|NCT01262742|Oxytocin|oxytocin|mesh-list
2508460|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
2508461|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2508462|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508463|NCT01262859|Bevacizumab|bevacizumab|mesh-list
2508464|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2508465|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508466|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2508467|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2508468|NCT01262859|Growth Substances|growth substances|mesh-ancestor
2508469|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508470|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
2508471|NCT01262924|Vaccines|vaccines|mesh-list
2508472|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
2508473|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508474|NCT01262963|Dabrafenib|dabrafenib|mesh-list
2508475|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508476|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2388140|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
2388141|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2388142|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388143|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2388144|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
2388145|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2388146|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388147|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388148|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388149|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
2388150|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
2388151|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2388152|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2388153|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388154|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2388155|NCT00656331|Amlodipine|amlodipine|mesh-list
2388156|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2388157|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2508477|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508478|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508479|NCT01263002|Adefovir|adefovir|mesh-list
2508480|NCT01263002|Clevudine|clevudine|mesh-list
2508481|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
2508482|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508483|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2508484|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2508485|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508486|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508487|NCT01263080|Folic Acid|folic acid|mesh-list
2508488|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
2508489|NCT01263080|Mirtazapine|mirtazapine|mesh-list
2508490|NCT01263080|Vitamins|vitamins|mesh-ancestor
2508491|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
2508492|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508493|NCT01263080|Hematinics|hematinics|mesh-ancestor
2508494|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
2508495|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2508496|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2508497|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
2388158|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2388159|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388160|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2388161|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388162|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
2388163|NCT00656357|Cocaine|cocaine|mesh-list
2388164|NCT00656357|Anesthetics, Local|anesthetics, local|mesh-ancestor
2388165|NCT00656357|Anesthetics|anesthetics|mesh-ancestor
2508498|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
2508499|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508500|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508501|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2508502|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2508503|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2508504|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2508505|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2508506|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2508507|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
2508508|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2508509|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2508510|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
2508511|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2508512|NCT01263145|Paclitaxel|paclitaxel|mesh-list
2508513|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2508514|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508515|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
2508516|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
2508517|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
2508518|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508519|NCT01263158|Oxytocin|oxytocin|mesh-list
2508520|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
2508521|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2508522|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508523|NCT01263171|Leucovorin|leucovorin|mesh-list
2508524|NCT01263171|Fluorouracil|fluorouracil|mesh-list
2508525|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
2508526|NCT01263171|Calcium|calcium|mesh-list
2508527|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
2508528|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2508529|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508530|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
2508531|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508532|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2508533|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508534|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2508535|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
2508536|NCT01263171|Antidotes|antidotes|mesh-ancestor
2508537|NCT01263171|Protective Agents|protective agents|mesh-ancestor
2508538|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
2508539|NCT01263171|Vitamins|vitamins|mesh-ancestor
2508540|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
2508541|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2508542|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
2508543|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508544|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
2388166|NCT00656357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2388167|NCT00656357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388168|NCT00656357|Sensory System Agents|sensory system agents|mesh-ancestor
2388169|NCT00656357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388170|NCT00656357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2388171|NCT00656357|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2388172|NCT00656357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2388173|NCT00656357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2388174|NCT00656357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388175|NCT00656357|Dopamine Agents|dopamine agents|mesh-ancestor
2388176|NCT00656357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388177|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2388178|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
2388179|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388180|NCT00656422|Insulin|insulin|mesh-list
2388181|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2388182|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
2388183|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2508545|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2508546|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508547|NCT01263288|Vitamins|vitamins|mesh-ancestor
2508548|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
2508549|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2508550|NCT01263353|Everolimus|everolimus|mesh-list
2508551|NCT01263353|Pasireotide|pasireotide|mesh-list
2508552|NCT01263353|Somatostatin|somatostatin|mesh-list
2508553|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508554|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2508555|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
2508556|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508557|NCT01263353|Hormones|hormones|mesh-ancestor
2508558|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2508559|NCT01263366|Norepinephrine|norepinephrine|mesh-list
2508560|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2508561|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2508562|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
2508563|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508564|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508565|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508566|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
2508567|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
2508568|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508569|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2508570|NCT01263418|Ofatumumab|ofatumumab|mesh-list
2508571|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508572|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2508573|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2508574|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508575|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2508576|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2508577|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2508578|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508579|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
2508580|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508581|NCT01263574|Ethanol|ethanol|mesh-list
2508582|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2508583|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508584|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2508585|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508586|NCT01263652|Dipyrone|dipyrone|mesh-list
2508587|NCT01263652|Diclofenac|diclofenac|mesh-list
2508588|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
2508589|NCT01263652|Tramadol|tramadol|mesh-list
2508590|NCT01263652|Orphenadrine|orphenadrine|mesh-list
2508591|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2508592|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2508593|NCT01263652|Analgesics|analgesics|mesh-ancestor
2508594|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
2508595|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508596|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508597|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2508598|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2508599|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2508600|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508601|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508602|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2388184|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388185|NCT00656435|Bevacizumab|bevacizumab|mesh-list
2388186|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2388187|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388188|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2508603|NCT01263652|Narcotics|narcotics|mesh-ancestor
2508604|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2508605|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
2508606|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2508607|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2508608|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2508609|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2508610|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
2508611|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
2508612|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2508613|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2508614|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
2508615|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508616|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
2508617|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2508618|NCT01263769|Axitinib|axitinib|mesh-list
2508619|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508620|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2508621|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508622|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508623|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
2508624|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2508625|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508626|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2508627|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2508628|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508629|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508630|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508631|NCT01263834|Bevacizumab|bevacizumab|mesh-list
2508632|NCT01263834|Mitomycins|mitomycins|mesh-list
2388189|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2388190|NCT00656435|Growth Substances|growth substances|mesh-ancestor
2388191|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388192|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
2388193|NCT00656526|Lidocaine|lidocaine|mesh-list
2388194|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
2388195|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
2388196|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2388197|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508633|NCT01263834|Mitomycin|mitomycin|mesh-list
2508634|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2508635|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508636|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2508637|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2508638|NCT01263834|Growth Substances|growth substances|mesh-ancestor
2508639|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508640|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
2508641|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2508642|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
2508643|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508644|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2508645|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508646|NCT01263860|Ribavirin|ribavirin|mesh-list
2508647|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2508648|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
2508649|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
2508650|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508651|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
2508652|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508653|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
2508654|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508655|NCT01263951|Everolimus|everolimus|mesh-list
2508656|NCT01263951|Sorafenib|sorafenib|mesh-list
2508657|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388198|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
2388199|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388200|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2388201|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2388202|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2388203|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2388204|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508658|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2508659|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
2508660|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508661|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2508662|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508663|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508664|NCT01264094|Clevudine|clevudine|mesh-list
2508665|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
2508666|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508667|NCT01264133|Adefovir|adefovir|mesh-list
2508668|NCT01264133|Clevudine|clevudine|mesh-list
2508669|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
2508670|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508671|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2508672|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2508673|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508674|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508675|NCT01264211|Diacetylrhein|diacetylrhein|mesh-list
2508676|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2508677|NCT01264237|Etoricoxib|etoricoxib|mesh-list
2508678|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2508679|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2508680|NCT01264237|Analgesics|analgesics|mesh-ancestor
2508681|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
2508682|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508683|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508684|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2508685|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2508686|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2388205|NCT00656539|Azithromycin|azithromycin|mesh-list
2388206|NCT00656539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2388207|NCT00656539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388208|NCT00656552|Citalopram|citalopram|mesh-list
2508687|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2508688|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508689|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508690|NCT01264289|Finasteride|finasteride|mesh-list
2508691|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2508692|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2508693|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508694|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508695|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
2508696|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2508697|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508698|NCT01264289|Urological Agents|urological agents|mesh-ancestor
2508699|NCT01264302|Finasteride|finasteride|mesh-list
2508700|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2508701|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2508702|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508703|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508704|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
2508705|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2508706|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508707|NCT01264302|Urological Agents|urological agents|mesh-ancestor
2508708|NCT01264315|Lenalidomide|lenalidomide|mesh-list
2508709|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
2508710|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508711|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2508712|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2508713|NCT01264315|Growth Substances|growth substances|mesh-ancestor
2508714|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
2508715|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508716|NCT01264328|Paclitaxel|paclitaxel|mesh-list
2508717|NCT01264328|Panitumumab|panitumumab|mesh-list
2508718|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2508719|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508720|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
2508721|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
2508722|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
2508723|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508724|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2508725|NCT01264341|Sirolimus|sirolimus|mesh-list
2508726|NCT01264341|Bevacizumab|bevacizumab|mesh-list
2508727|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2508728|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508729|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2508730|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2508731|NCT01264341|Growth Substances|growth substances|mesh-ancestor
2508732|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508733|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
2508734|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2508735|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508736|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2508737|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
2508738|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2508739|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
2508740|NCT01264354|Adefovir|adefovir|mesh-list
2508741|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2508742|NCT01264354|Clevudine|clevudine|mesh-list
2508743|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
2508744|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508745|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2508746|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2508747|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508748|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508749|NCT01264367|Interferons|interferons|mesh-list
2508750|NCT01264367|Clevudine|clevudine|mesh-list
2508751|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508752|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
2508753|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508754|NCT01264432|Veliparib|veliparib|mesh-list
2508755|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2388209|NCT00656552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2388210|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2388211|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2388212|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388213|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388214|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
2388215|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388216|NCT00656552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2388217|NCT00656552|Antidepressive Agents|antidepressive agents|mesh-ancestor
2508756|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508757|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508758|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508759|NCT01264445|Vaccines|vaccines|mesh-list
2508760|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
2508761|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508762|NCT01264484|Imidacloprid|imidacloprid|mesh-list
2508763|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
2508764|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508765|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508766|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508767|NCT01264497|Tesamorelin|tesamorelin|mesh-list
2508768|NCT01264497|Growth Substances|growth substances|mesh-ancestor
2508769|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508770|NCT01264536|Lactoferrin|lactoferrin|mesh-list
2508771|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508772|NCT01264575|Epinephrine|epinephrine|mesh-list
2508773|NCT01264575|Racepinephrine|racepinephrine|mesh-list
2508774|NCT01264575|Bupivacaine|bupivacaine|mesh-list
2508775|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
2508776|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
2508777|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
2508778|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2508779|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508780|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
2508781|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508782|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2508783|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2508784|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
2508785|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508786|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508787|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2508788|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2508789|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
2508790|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2508791|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
2508792|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
2508793|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
2508794|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2508795|NCT01264588|Calcium|calcium|mesh-list
2508796|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2508797|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508798|NCT01264640|Aspirin|aspirin|mesh-list
2508799|NCT01264640|Clopidogrel|clopidogrel|mesh-list
2508800|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2388218|NCT00656552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2388219|NCT00656591|Methotrexate|methotrexate|mesh-list
2388220|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2388221|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
2388222|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2388223|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388224|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2388225|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
2388226|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388227|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388228|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
2388229|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388230|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2388231|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2388232|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
2388233|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2388234|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2388235|NCT00656643|Sirolimus|sirolimus|mesh-list
2388236|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2508801|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2508802|NCT01264640|Analgesics|analgesics|mesh-ancestor
2508803|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
2508804|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508805|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508806|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2508807|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2508808|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2508809|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2508810|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508811|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2508812|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2508813|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508814|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
2508815|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2508816|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2508817|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2508818|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
2508819|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508820|NCT01264653|Epinephrine|epinephrine|mesh-list
2508821|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2508822|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2508823|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
2508824|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2508825|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508826|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508827|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2508828|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2508829|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
2508830|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508831|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2508832|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
2508833|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
2508834|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
2508835|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2508836|NCT01264692|Amlodipine|amlodipine|mesh-list
2508837|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2508838|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2508839|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2508840|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508841|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2508842|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508843|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
2508844|NCT01264731|Imiquimod|imiquimod|mesh-list
2508845|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2508846|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
2508847|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508848|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508849|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
2508850|NCT01264783|RNS60|rns60|mesh-list
2508851|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2508852|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2508853|NCT01264783|Analgesics|analgesics|mesh-ancestor
2508854|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
2508855|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508856|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508857|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2508858|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2508859|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2508860|NCT01264822|Rabeprazole|rabeprazole|mesh-list
2508861|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2508862|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2508863|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2508864|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508865|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508866|NCT01264874|Vitamin D|vitamin d|mesh-list
2508867|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
2508868|NCT01264874|Vitamins|vitamins|mesh-ancestor
2508869|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
2508870|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508871|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2508872|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2508873|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2508874|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
2508875|NCT01265004|Coagulants|coagulants|mesh-ancestor
2508876|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
2508877|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2508878|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2388237|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508879|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2508880|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2508881|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2508882|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2508883|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
2508884|NCT01265017|Estradiol|estradiol|mesh-list
2508885|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2508886|NCT01265017|Hormones|hormones|mesh-ancestor
2508887|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2508888|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508889|NCT01265017|Estrogens|estrogens|mesh-ancestor
2508890|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2508891|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
2508892|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2508893|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2508894|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2508895|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2508896|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2508897|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2508898|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2508899|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2388238|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2388239|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388240|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
2388241|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2388242|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
2388243|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388244|NCT00656695|Cyclosporine|cyclosporine|mesh-list
2388245|NCT00656695|Cyclosporins|cyclosporins|mesh-list
2388246|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
2388247|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388248|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
2388249|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388250|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388251|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2388252|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
2388253|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388254|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2388255|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2388256|NCT00656747|Amoxicillin|amoxicillin|mesh-list
2388257|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
2508900|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508901|NCT01265030|Sirolimus|sirolimus|mesh-list
2508902|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2508903|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508904|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2508905|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508906|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
2508907|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2508908|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
2508909|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508910|NCT01265108|Iron|iron|mesh-list
2508911|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2508912|NCT01265108|Trace Elements|trace elements|mesh-ancestor
2508913|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
2508914|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508915|NCT01265108|Hematinics|hematinics|mesh-ancestor
2508916|NCT01265147|Nedaplatin|nedaplatin|mesh-list
2508917|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508918|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
2508919|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
2508920|NCT01265173|Cefotaxime|cefotaxime|mesh-list
2508921|NCT01265173|Cefoxitin|cefoxitin|mesh-list
2508922|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2508923|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508924|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2508925|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2508926|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508927|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508928|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508929|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2508930|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2508931|NCT01265199|Cytarabine|cytarabine|mesh-list
2508932|NCT01265199|Daunorubicin|daunorubicin|mesh-list
2508933|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2508934|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
2388258|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
2388259|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
2388260|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2388261|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2388262|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2388263|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388264|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2388265|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2388266|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508935|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508936|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508937|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
2508938|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508939|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2508940|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
2508941|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508942|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2508943|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2508944|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2508945|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508946|NCT01265342|Beclomethasone|beclomethasone|mesh-list
2508947|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2508948|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
2508949|NCT01265342|Hormones|hormones|mesh-ancestor
2508950|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388267|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388268|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388269|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2388270|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
2388271|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2388272|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388273|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2388274|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2388275|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2388276|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2388277|NCT00656773|Sufentanil|sufentanil|mesh-list
2508951|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508952|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2508953|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
2508954|NCT01265433|Molgramostim|molgramostim|mesh-list
2508955|NCT01265433|Sargramostim|sargramostim|mesh-list
2388278|NCT00656773|Morphine|morphine|mesh-list
2388279|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2388280|NCT00656773|Narcotics|narcotics|mesh-ancestor
2388281|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2388282|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388283|NCT00656773|Analgesics|analgesics|mesh-ancestor
2388284|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
2388285|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388286|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2508956|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
2508957|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508958|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508959|NCT01265576|Etodolac|etodolac|mesh-list
2508960|NCT01265576|Sorafenib|sorafenib|mesh-list
2508961|NCT01265576|Propranolol|propranolol|mesh-list
2508962|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508963|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2508964|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508965|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2508966|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2508967|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2508968|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
2508969|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388287|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2388288|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
2388289|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
2388290|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
2388291|NCT00656786|Vitamin K|vitamin k|mesh-list
2388292|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2388293|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2388294|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388295|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
2388296|NCT00656786|Coagulants|coagulants|mesh-ancestor
2388297|NCT00656786|Vitamins|vitamins|mesh-ancestor
2388298|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
2388299|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388300|NCT00656812|Rituximab|rituximab|mesh-list
2388301|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2388302|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388303|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
2508970|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508971|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2508972|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2508973|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
2508974|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2508975|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2388304|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388305|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2508976|NCT01265576|Analgesics|analgesics|mesh-ancestor
2508977|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
2508978|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2508979|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2508980|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2508981|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2508982|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2508983|NCT01265589|Vitamin A|vitamin a|mesh-list
2508984|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2508985|NCT01265589|Vitamins|vitamins|mesh-ancestor
2508986|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
2508987|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508988|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
2508989|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
2508990|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2508991|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2508992|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2508993|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2508994|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2508995|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388306|NCT00656864|Pioglitazone|pioglitazone|mesh-list
2388307|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2388308|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388309|NCT00656929|Vitamin D|vitamin d|mesh-list
2388310|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
2388311|NCT00656929|Vitamins|vitamins|mesh-ancestor
2388312|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
2388313|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2508996|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2508997|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
2508998|NCT01265680|Hematinics|hematinics|mesh-ancestor
2508999|NCT01265810|Calcium|calcium|mesh-list
2509000|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2509001|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509002|NCT01265849|Indomethacin|indomethacin|mesh-list
2509003|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
2509004|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2509005|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
2509006|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509007|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509008|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2509009|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
2509010|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509011|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509012|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2509013|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2509014|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2509015|NCT01265849|Analgesics|analgesics|mesh-ancestor
2509016|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
2509017|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509018|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509019|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
2509020|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
2509021|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2388314|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2388315|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2388316|NCT00657007|Belimumab|belimumab|mesh-list
2388317|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2509022|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2509023|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388318|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
2388319|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114567|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114568|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2114569|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2114570|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114571|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184831|NCT00002833|Cladribine|cladribine|mesh-list
2388320|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2509024|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
2509025|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2509026|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
2388321|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
2388322|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2388323|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2388324|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388325|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509027|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509028|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509029|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2509030|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
2509031|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2509032|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
2509033|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509034|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509035|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2509036|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
2509037|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
2509038|NCT01265888|Protective Agents|protective agents|mesh-ancestor
2509039|NCT01265901|Cyclophosphamide|cyclophosphamide|mesh-list
2388326|NCT00657033|Urological Agents|urological agents|mesh-ancestor
2388327|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
2388328|NCT00657059|Prednisone|prednisone|mesh-list
2388329|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
2388330|NCT00657059|Irbesartan|irbesartan|mesh-list
2388331|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2388332|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
2388333|NCT00657059|Hormones|hormones|mesh-ancestor
2388334|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388335|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388336|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2388337|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388338|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2388339|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2388340|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
2509040|NCT01265901|Sunitinib|sunitinib|mesh-list
2509041|NCT01265901|Molgramostim|molgramostim|mesh-list
2509042|NCT01265901|Sargramostim|sargramostim|mesh-list
2509043|NCT01265901|Immunologic Factors|immunologic factors|mesh-ancestor
2509044|NCT01265901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509045|NCT01265901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2509046|NCT01265901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509047|NCT01265901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2509048|NCT01265901|Alkylating Agents|alkylating agents|mesh-ancestor
2509049|NCT01265901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509050|NCT01265901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509051|NCT01265901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2509052|NCT01265901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2509053|NCT01265901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2509054|NCT01265901|Growth Substances|growth substances|mesh-ancestor
2509055|NCT01265901|Growth Inhibitors|growth inhibitors|mesh-ancestor
2509056|NCT01265901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2509057|NCT01265901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509058|NCT01265927|Trastuzumab|trastuzumab|mesh-list
2509059|NCT01265927|Imetelstat|imetelstat|mesh-list
2509060|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2509061|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509062|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509063|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509064|NCT01265940|Vinblastine|vinblastine|mesh-list
2509065|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2509066|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509067|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
2509068|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
2509069|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
2509070|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509071|NCT01266005|Entecavir|entecavir|mesh-list
2509072|NCT01266005|Clevudine|clevudine|mesh-list
2509073|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
2509074|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509075|NCT01266031|Bevacizumab|bevacizumab|mesh-list
2509076|NCT01266031|Vorinostat|vorinostat|mesh-list
2509077|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2509078|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509079|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2509080|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2509081|NCT01266031|Growth Substances|growth substances|mesh-ancestor
2509082|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509083|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
2509084|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2509085|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509086|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509087|NCT01266057|Sirolimus|sirolimus|mesh-list
2509088|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
2509089|NCT01266057|Vorinostat|vorinostat|mesh-list
2509090|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2509091|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509092|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2509093|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509094|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
2509095|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2509096|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
2388341|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2388342|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388343|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388344|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509097|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509098|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
2509099|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2509100|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2509101|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509102|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509103|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509104|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2509105|NCT01266174|Eltoprazine|eltoprazine|mesh-list
2509106|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2509107|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
2509108|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388345|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
2388346|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
2388347|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388348|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2388349|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2388350|NCT00657059|Protective Agents|protective agents|mesh-ancestor
2388351|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2388352|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2388353|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2388354|NCT00657137|Capecitabine|capecitabine|mesh-list
2388355|NCT00657137|Lapatinib|lapatinib|mesh-list
2388356|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2509109|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509110|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509111|NCT01266187|Leucovorin|leucovorin|mesh-list
2509112|NCT01266187|Cetuximab|cetuximab|mesh-list
2509113|NCT01266187|Fluorouracil|fluorouracil|mesh-list
2509114|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
2509115|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2509116|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509117|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
2509118|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509119|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2509120|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2509121|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
2509122|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509123|NCT01266187|Antidotes|antidotes|mesh-ancestor
2509124|NCT01266187|Protective Agents|protective agents|mesh-ancestor
2509125|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
2509126|NCT01266187|Vitamins|vitamins|mesh-ancestor
2509127|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
2509128|NCT01266213|Fulvestrant|fulvestrant|mesh-list
2509129|NCT01266213|Anastrozole|anastrozole|mesh-list
2509130|NCT01266213|Goserelin|goserelin|mesh-list
2509131|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2388357|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
2509132|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509133|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2509134|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2509135|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
2509136|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2509137|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509138|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2509139|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2509140|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509141|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509142|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
2509143|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2509144|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2509145|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509146|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2509147|NCT01266252|Analgesics|analgesics|mesh-ancestor
2509148|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
2509149|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509150|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2509151|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2509152|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2509153|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
2509154|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509155|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509156|NCT01266434|Simvastatin|simvastatin|mesh-list
2509157|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2509158|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2509159|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
2509160|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509161|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2509162|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2509163|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509164|NCT01266486|Metformin|metformin|mesh-list
2509165|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2509166|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509167|NCT01266499|Colistin|colistin|mesh-list
2509168|NCT01266499|Polymyxins|polymyxins|mesh-list
2509169|NCT01266499|Gentamicins|gentamicins|mesh-list
2509170|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2509171|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509172|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2509173|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509174|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509175|NCT01266512|Docetaxel|docetaxel|mesh-list
2509176|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509177|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
2509178|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
2388358|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388359|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388360|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2388361|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388362|NCT00657163|Fluoxetine|fluoxetine|mesh-list
2388363|NCT00657163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2388364|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2388365|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2509179|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
2509180|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509181|NCT01266525|Donepezil|donepezil|mesh-list
2509182|NCT01266525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2509183|NCT01266525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509184|NCT01266525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509185|NCT01266525|Cholinergic Agents|cholinergic agents|mesh-ancestor
2509186|NCT01266525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509187|NCT01266525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509188|NCT01266525|Nootropic Agents|nootropic agents|mesh-ancestor
2509189|NCT01266655|Baclofen|baclofen|mesh-list
2509190|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2509191|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509192|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2509193|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388366|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388367|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2114572|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2114573|NCT02605174|Lasmiditan|lasmiditan|mesh-list
2114574|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2388368|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
2388369|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388370|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2388371|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
2388372|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2388373|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2388374|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2388375|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388376|NCT00657189|Sifalimumab|sifalimumab|mesh-list
2388377|NCT00657189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2388378|NCT00657189|Immunologic Factors|immunologic factors|mesh-ancestor
2509194|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2509195|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
2509196|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
2509197|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509198|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509199|NCT01266681|Amiodarone|amiodarone|mesh-list
2509200|NCT01266681|Dronedarone|dronedarone|mesh-list
2509201|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2509202|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
2509203|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2509204|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2509205|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509206|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2509207|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2388379|NCT00657189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388380|NCT00657202|Ranibizumab|ranibizumab|mesh-list
2388381|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2388382|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2388383|NCT00657202|Growth Substances|growth substances|mesh-ancestor
2388384|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388385|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
2388386|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388387|NCT00657228|Heparin|heparin|mesh-list
2388388|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
2388389|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2388390|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2388391|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388392|NCT00657241|Valsartan|valsartan|mesh-list
2388393|NCT00657241|Carvedilol|carvedilol|mesh-list
2388394|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2388395|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2388396|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2388397|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388398|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2388399|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2388400|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
2388401|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388402|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388403|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
2388404|NCT00657241|Protective Agents|protective agents|mesh-ancestor
2388405|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2388406|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2388407|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2388408|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
2388409|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2388410|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2388411|NCT00657254|Sorafenib|sorafenib|mesh-list
2388412|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388413|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2388414|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388415|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388416|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
2388417|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2388418|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
2388419|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
2509208|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2509209|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509210|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2509211|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2509212|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2509213|NCT01266694|Colchicine|colchicine|mesh-list
2509214|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
2509215|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509216|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
2509217|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
2509218|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
2509219|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509220|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509221|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
2509222|NCT01266707|Vaccines|vaccines|mesh-list
2509223|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
2509224|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509225|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2509226|NCT01266707|Growth Substances|growth substances|mesh-ancestor
2509227|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
2509228|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509229|NCT01266720|Gemcitabine|gemcitabine|mesh-list
2509230|NCT01266720|Immunologic Factors|immunologic factors|mesh-ancestor
2509231|NCT01266720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509232|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2509233|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
2509234|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509235|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509236|NCT01266720|Antiviral Agents|antiviral agents|mesh-ancestor
2509237|NCT01266720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509238|NCT01266720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509239|NCT01266720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2509240|NCT01266759|NuvaRing|nuvaring|mesh-list
2509241|NCT01266759|Norethindrone|norethindrone|mesh-list
2509242|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
2509243|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2509244|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
2388420|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2388421|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2388422|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388423|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
2388424|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2509245|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2509246|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509247|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2509248|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2388425|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2388426|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388427|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
2388428|NCT00657384|Coagulants|coagulants|mesh-ancestor
2388429|NCT00657397|Methadone|methadone|mesh-list
2388430|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2388431|NCT00657397|Narcotics|narcotics|mesh-ancestor
2388432|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2388433|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388434|NCT00657397|Analgesics|analgesics|mesh-ancestor
2388435|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
2388436|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388437|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
2388438|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
2388439|NCT00657410|Dexamethasone|dexamethasone|mesh-list
2388440|NCT00657410|Prednisone|prednisone|mesh-list
2388441|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2388442|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
2388443|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
2388444|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509249|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2509250|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2509251|NCT01266772|Budesonide|budesonide|mesh-list
2509252|NCT01266772|Montelukast|montelukast|mesh-list
2509253|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509254|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2509255|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
2509256|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509257|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509258|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2509259|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
2509260|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
2388445|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509261|NCT01266772|Hormones|hormones|mesh-ancestor
2509262|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2509263|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2509264|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
2509265|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2509266|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2509267|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509268|NCT01266785|Infliximab|infliximab|mesh-list
2509269|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2509270|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2509271|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509272|NCT01266811|Dexamethasone|dexamethasone|mesh-list
2509273|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
2509274|NCT01266811|Bortezomib|bortezomib|mesh-list
2509275|NCT01266811|Siltuximab|siltuximab|mesh-list
2509276|NCT01266811|BB 1101|bb 1101|mesh-list
2388446|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2388447|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
2388448|NCT00657410|Hormones|hormones|mesh-ancestor
2388449|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388450|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2388451|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388452|NCT00657423|Cisplatin|cisplatin|mesh-list
2388453|NCT00657423|Docetaxel|docetaxel|mesh-list
2388454|NCT00657423|Endostar protein|endostar protein|mesh-list
2388455|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388456|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
2388457|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
2388458|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
2388459|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388460|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2388461|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2388462|NCT00657423|Growth Substances|growth substances|mesh-ancestor
2388463|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388464|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
2388465|NCT00657449|Valdecoxib|valdecoxib|mesh-list
2388466|NCT00657449|Rofecoxib|rofecoxib|mesh-list
2388467|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2388468|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2388469|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388470|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388471|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2388472|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2388473|NCT00657449|Analgesics|analgesics|mesh-ancestor
2388474|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
2388475|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509277|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509278|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
2509279|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
2509280|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509281|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509282|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2509283|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
2509284|NCT01266811|Hormones|hormones|mesh-ancestor
2509285|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2509286|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2509287|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509288|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
2509289|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509290|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509291|NCT01266837|Everolimus|everolimus|mesh-list
2509292|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509293|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2509294|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
2509295|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509296|NCT01266928|Ascorbic Acid|ascorbic acid|mesh-list
2509297|NCT01266928|Vitamins|vitamins|mesh-ancestor
2509298|NCT01266928|Micronutrients|micronutrients|mesh-ancestor
2509299|NCT01266928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509300|NCT01266928|Antioxidants|antioxidants|mesh-ancestor
2509301|NCT01266928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509302|NCT01266928|Protective Agents|protective agents|mesh-ancestor
2509303|NCT01267058|Vaccines|vaccines|mesh-list
2509304|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
2509305|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509306|NCT01267084|Ketoconazole|ketoconazole|mesh-list
2509307|NCT01267084|Dexamethasone|dexamethasone|mesh-list
2509308|NCT01267084|Trabectedin|trabectedin|mesh-list
2509309|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509310|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
2509311|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
2509312|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509313|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509314|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2509315|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
2509316|NCT01267084|Hormones|hormones|mesh-ancestor
2509317|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2509318|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2509319|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509320|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
2509321|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509322|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2509323|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2509324|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509325|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509326|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2509327|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
2509328|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2509329|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2509330|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
2509331|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
2509332|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2509333|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
2388476|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388477|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2388478|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2388479|NCT00657475|Heparin|heparin|mesh-list
2388480|NCT00657475|Calcium heparin|calcium heparin|mesh-list
2388481|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
2388482|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2509334|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509335|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
2509336|NCT01267214|Protective Agents|protective agents|mesh-ancestor
2388483|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2388484|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388485|NCT00657488|Thalidomide|thalidomide|mesh-list
2388486|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2388487|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
2388488|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388489|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
2388490|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2388491|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388492|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2388493|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2509337|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
2509338|NCT01267305|PENTA|penta|mesh-list
2509339|NCT01267305|Nadroparin|nadroparin|mesh-list
2509340|NCT01267305|Fondaparinux|fondaparinux|mesh-list
2509341|NCT01267305|Calcium|calcium|mesh-list
2509342|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2509343|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388494|NCT00657488|Growth Substances|growth substances|mesh-ancestor
2388495|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
2388496|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388497|NCT00657501|Testosterone|testosterone|mesh-list
2388498|NCT00657501|Androgens|androgens|mesh-ancestor
2388499|NCT00657501|Hormones|hormones|mesh-ancestor
2388500|NCT00657501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388501|NCT00657501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388502|NCT00657514|Ranolazine|ranolazine|mesh-list
2388503|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2388504|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2509344|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2509345|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2509346|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
2509347|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2509348|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
2509349|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509350|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509351|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
2509352|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2509353|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2422935|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388505|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388506|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2388507|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2509354|NCT01267344|Gemcitabine|gemcitabine|mesh-list
2509355|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
2509356|NCT01267344|Cetuximab|cetuximab|mesh-list
2509357|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2509358|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
2509359|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509360|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509361|NCT01267344|Antiviral Agents|antiviral agents|mesh-ancestor
2509362|NCT01267344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509363|NCT01267344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509364|NCT01267344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2509365|NCT01267344|Immunologic Factors|immunologic factors|mesh-ancestor
2509366|NCT01267344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509367|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2509368|NCT01267383|Sertraline|sertraline|mesh-list
2509369|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
2509370|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2509371|NCT01267383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2509372|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2509373|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2388508|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2388509|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
2388510|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388511|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2388512|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2388513|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388514|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2388515|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2388516|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388517|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
2388518|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2388519|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2388520|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2509374|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509375|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509376|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
2509377|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509378|NCT01267396|Sertraline|sertraline|mesh-list
2509379|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
2509380|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2509381|NCT01267396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2509382|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2509383|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2509384|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509385|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509386|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
2388521|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
2388522|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2388523|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2388524|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388525|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388526|NCT00657644|Urological Agents|urological agents|mesh-ancestor
2388527|NCT00657748|Triacetin|triacetin|mesh-list
2388528|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
2388529|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
2388530|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2388531|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388532|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388533|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
2388534|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2388535|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2388536|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388537|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
2388538|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388539|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
2388540|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2388541|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2388542|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388543|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2388544|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2509387|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509388|NCT01267448|Metformin|metformin|mesh-list
2509389|NCT01267448|Saxagliptin|saxagliptin|mesh-list
2509390|NCT01267448|Glipizide|glipizide|mesh-list
2509391|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2509392|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509393|NCT01267448|Incretins|incretins|mesh-ancestor
2509394|NCT01267448|Hormones|hormones|mesh-ancestor
2509395|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2509396|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2509397|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
2509398|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509399|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509400|NCT01267487|Heparin|heparin|mesh-list
2509401|NCT01267487|Calcium heparin|calcium heparin|mesh-list
2509402|NCT01267487|Protamines|protamines|mesh-list
2509403|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
2509404|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2388545|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
2388546|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388547|NCT00657774|Prednisone|prednisone|mesh-list
2388548|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2388549|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
2388550|NCT00657774|Hormones|hormones|mesh-ancestor
2388551|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388552|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388553|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2388554|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388555|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2388556|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
2388557|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2388558|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2388559|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388560|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388561|NCT00657839|Urological Agents|urological agents|mesh-ancestor
2388562|NCT00657852|Pamidronate|pamidronate|mesh-list
2388563|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2388564|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388565|NCT00657865|Ramipril|ramipril|mesh-list
2388566|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2388567|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
2388568|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388569|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388570|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2388571|NCT00657878|Gemcitabine|gemcitabine|mesh-list
2388572|NCT00657878|Paclitaxel|paclitaxel|mesh-list
2388573|NCT00657878|Carboplatin|carboplatin|mesh-list
2388574|NCT00657878|Doxorubicin|doxorubicin|mesh-list
2388575|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2388576|NCT00657878|Topotecan|topotecan|mesh-list
2388577|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2388578|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388579|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
2388580|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
2388581|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
2388582|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388583|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2388584|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
2388585|NCT00657878|Antiviral Agents|antiviral agents|mesh-ancestor
2388586|NCT00657878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388587|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388588|NCT00657878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2388589|NCT00657878|Immunologic Factors|immunologic factors|mesh-ancestor
2388590|NCT00657878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388591|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2388592|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2388593|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2388594|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2388595|NCT00657891|Omalizumab|omalizumab|mesh-list
2509405|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2509406|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509407|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
2509408|NCT01267487|Coagulants|coagulants|mesh-ancestor
2509409|NCT01267578|Vaccines|vaccines|mesh-list
2509410|NCT01267578|Immunologic Factors|immunologic factors|mesh-ancestor
2509411|NCT01267578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509412|NCT01267604|Inositol|inositol|mesh-list
2509413|NCT01267604|Melatonin|melatonin|mesh-list
2509414|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
2509415|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509416|NCT01267604|Protective Agents|protective agents|mesh-ancestor
2509417|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509418|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2509419|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
2509420|NCT01267604|Vitamins|vitamins|mesh-ancestor
2509421|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
2509422|NCT01267643|Alefacept|alefacept|mesh-list
2509423|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
2509424|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
2509425|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509426|NCT01267669|Somatostatin|somatostatin|mesh-list
2509427|NCT01267669|Hormones|hormones|mesh-ancestor
2509428|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2509429|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509430|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
2509431|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509432|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2509433|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509434|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509435|NCT01267734|Everolimus|everolimus|mesh-list
2509436|NCT01267734|Clopidogrel|clopidogrel|mesh-list
2509437|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509438|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2509439|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
2509440|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509441|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2509442|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2509443|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2509444|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2388596|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2388597|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2388598|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
2388599|NCT00657904|Bicalutamide|bicalutamide|mesh-list
2388600|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
2388601|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
2388602|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388603|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388604|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388605|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
2388606|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2388607|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388608|NCT00657943|Insulin|insulin|mesh-list
2388609|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2388610|NCT00657943|Metformin|metformin|mesh-list
2388611|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
2388612|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
2388613|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2509445|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
2509446|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509447|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509448|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
2509449|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2509450|NCT01267812|Rituximab|rituximab|mesh-list
2509451|NCT01267812|Bortezomib|bortezomib|mesh-list
2509452|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2388614|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
2388615|NCT00657943|Protamines|protamines|mesh-list
2388616|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2388617|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388618|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
2388619|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509453|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509454|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
2388620|NCT00657943|Coagulants|coagulants|mesh-ancestor
2388621|NCT00657982|Everolimus|everolimus|mesh-list
2388622|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388623|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2388624|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
2388625|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388626|NCT00657995|Pancrelipase|pancrelipase|mesh-list
2388627|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2388628|NCT00658008|Paroxetine|paroxetine|mesh-list
2509455|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388629|NCT00658008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2388630|NCT00658008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2388631|NCT00658008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2388632|NCT00658008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388633|NCT00658008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388634|NCT00658008|Serotonin Agents|serotonin agents|mesh-ancestor
2388635|NCT00658008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388636|NCT00658008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2388637|NCT00658008|Antidepressive Agents|antidepressive agents|mesh-ancestor
2388638|NCT00658008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2388639|NCT00658008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2388640|NCT00658008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2388641|NCT00658008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388642|NCT00658047|Methotrexate|methotrexate|mesh-list
2388643|NCT00658047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2388644|NCT00658047|Abortifacient Agents|abortifacient agents|mesh-ancestor
2388645|NCT00658047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2509456|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509457|NCT01267903|Vaccines|vaccines|mesh-list
2509458|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
2509459|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509460|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2509461|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2509462|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509463|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2509464|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509465|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509466|NCT01268033|Rituximab|rituximab|mesh-list
2509467|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2509468|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509469|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
2509470|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509471|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509472|NCT01268163|Docetaxel|docetaxel|mesh-list
2509473|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509474|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
2509475|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
2509476|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
2509477|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388646|NCT00658047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388647|NCT00658047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2388648|NCT00658047|Antimetabolites|antimetabolites|mesh-ancestor
2388649|NCT00658047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509478|NCT01268176|Vitamin D|vitamin d|mesh-list
2509479|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
2509480|NCT01268176|Vitamins|vitamins|mesh-ancestor
2509481|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
2509482|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509483|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2509484|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2509485|NCT01268202|Pravastatin|pravastatin|mesh-list
2509486|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2509487|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2388650|NCT00658047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388651|NCT00658047|Dermatologic Agents|dermatologic agents|mesh-ancestor
2388652|NCT00658047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388653|NCT00658047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2388654|NCT00658047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2388655|NCT00658047|Immunologic Factors|immunologic factors|mesh-ancestor
2388656|NCT00658047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2388657|NCT00658047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2388658|NCT00658099|Insulin|insulin|mesh-list
2509488|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
2509489|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509490|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2509491|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2509492|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509493|NCT01268215|Budesonide|budesonide|mesh-list
2509494|NCT01268215|Calfactant|calfactant|mesh-list
2509495|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509496|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2509497|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
2509498|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509499|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509500|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2509501|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
2509502|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
2509503|NCT01268215|Hormones|hormones|mesh-ancestor
2509504|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2509505|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2509506|NCT01268371|Everolimus|everolimus|mesh-list
2509507|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509508|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2509509|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
2509510|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509511|NCT01268384|Gemcitabine|gemcitabine|mesh-list
2509512|NCT01268384|Capecitabine|capecitabine|mesh-list
2509513|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2509514|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
2509515|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509516|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509517|NCT01268384|Antiviral Agents|antiviral agents|mesh-ancestor
2509518|NCT01268384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509519|NCT01268384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509520|NCT01268384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2509521|NCT01268384|Immunologic Factors|immunologic factors|mesh-ancestor
2509522|NCT01268384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509523|NCT01268579|Ribavirin|ribavirin|mesh-list
2509524|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
2509525|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509526|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
2509527|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509528|NCT01268631|Pregabalin|pregabalin|mesh-list
2509529|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2509530|NCT01268631|Analgesics|analgesics|mesh-ancestor
2509531|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
2509532|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509533|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509534|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
2509535|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2509536|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2509537|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509538|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2388659|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2388660|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
2388661|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
2388662|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
2388663|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
2388664|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2388665|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388666|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2388667|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
2388668|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2388669|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2388670|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388671|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388672|NCT00658177|Urological Agents|urological agents|mesh-ancestor
2388673|NCT00658255|Budesonide|budesonide|mesh-list
2509539|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2509540|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2509541|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2509542|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2509543|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2509544|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2509545|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509546|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
2509547|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
2509548|NCT01268670|Ibuprofen|ibuprofen|mesh-list
2509549|NCT01268670|Oxycodone|oxycodone|mesh-list
2509550|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2509551|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2509552|NCT01268670|Analgesics|analgesics|mesh-ancestor
2509553|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
2509554|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509555|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509556|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509557|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509558|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2509559|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509560|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509561|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2509562|NCT01268670|Narcotics|narcotics|mesh-ancestor
2509563|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2509564|NCT01268709|Doxepin|doxepin|mesh-list
2509565|NCT01268709|Nortriptyline|nortriptyline|mesh-list
2509566|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2509567|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
2509568|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2509569|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2509570|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2509571|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2509572|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509573|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
2509574|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509575|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509576|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2509577|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2509578|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2509579|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
2509580|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
2509581|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2509582|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
2509583|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2388674|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
2388675|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2388676|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2388677|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
2388678|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388679|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388680|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2388681|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
2388682|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
2388683|NCT00658255|Hormones|hormones|mesh-ancestor
2388684|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388685|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2509584|NCT01268761|Cetrorelix|cetrorelix|mesh-list
2509585|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2509586|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
2509587|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2509588|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509589|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
2509590|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2509591|NCT01268839|Efavirenz|efavirenz|mesh-list
2509592|NCT01268839|Rilpivirine|rilpivirine|mesh-list
2509593|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2509594|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2509595|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509596|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509597|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
2509598|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509599|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2509600|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2509601|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2509602|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2509603|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2509604|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2509605|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2509606|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2509607|NCT01268904|Valproic Acid|valproic acid|mesh-list
2509608|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
2509609|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509610|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509611|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
2388686|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2388687|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2388688|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
2388689|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388690|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388691|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
2509612|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509613|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509614|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
2509615|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2509616|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2509617|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2509618|NCT01268917|Aspirin|aspirin|mesh-list
2509619|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2388692|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2388693|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388694|NCT00658372|Paroxetine|paroxetine|mesh-list
2388695|NCT00658372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2388696|NCT00658372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2388697|NCT00658372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2388698|NCT00658372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388699|NCT00658372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388700|NCT00658372|Serotonin Agents|serotonin agents|mesh-ancestor
2509620|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2509621|NCT01268917|Analgesics|analgesics|mesh-ancestor
2509622|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
2509623|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509624|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509625|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509626|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509627|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2509628|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2509629|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509630|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2509631|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2509632|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509633|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
2509634|NCT01268930|Hemostatics|hemostatics|mesh-list
2509635|NCT01268930|Coagulants|coagulants|mesh-ancestor
2509636|NCT01268995|Cyclosporine|cyclosporine|mesh-list
2509637|NCT01268995|Tacrolimus|tacrolimus|mesh-list
2509638|NCT01268995|Cyclosporins|cyclosporins|mesh-list
2509639|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2388701|NCT00658372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388702|NCT00658372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2388703|NCT00658372|Antidepressive Agents|antidepressive agents|mesh-ancestor
2388704|NCT00658372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2388705|NCT00658372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2388706|NCT00658372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2388707|NCT00658372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388708|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2388709|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2388710|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2388711|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
2388712|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388713|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2388714|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2388715|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388716|NCT00658580|Etoposide|etoposide|mesh-list
2509640|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
2509641|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509642|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2509643|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509644|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509645|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
2509646|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509647|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
2509648|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509649|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
2509650|NCT01269021|Prednisone|prednisone|mesh-list
2509651|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509652|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
2509653|NCT01269021|Hormones|hormones|mesh-ancestor
2388717|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
2388718|NCT00658580|Epirubicin|epirubicin|mesh-list
2388719|NCT00658580|Ifosfamide|ifosfamide|mesh-list
2388720|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388721|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2388722|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2388723|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2388724|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509654|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2509655|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509656|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2509657|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509658|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2509659|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2509660|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
2509661|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2509662|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509663|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509664|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509665|NCT01269099|Fentanyl|fentanyl|mesh-list
2509666|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2509667|NCT01269099|Narcotics|narcotics|mesh-ancestor
2509668|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2509669|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509670|NCT01269099|Analgesics|analgesics|mesh-ancestor
2509671|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
2509672|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509673|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2509674|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2509675|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
2509676|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
2509677|NCT01269112|Citric Acid|citric acid|mesh-list
2509678|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
2509679|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
2509680|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2509681|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
2509682|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
2509683|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509684|NCT01269138|Thrombin|thrombin|mesh-list
2509685|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
2509686|NCT01269138|Coagulants|coagulants|mesh-ancestor
2509687|NCT01269151|Ranibizumab|ranibizumab|mesh-list
2509688|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2509689|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2509690|NCT01269151|Growth Substances|growth substances|mesh-ancestor
2509691|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509692|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
2509693|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509694|NCT01269190|Proflavine|proflavine|mesh-list
2509695|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2509696|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509697|NCT01269203|Curcumin|curcumin|mesh-list
2388725|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388726|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2388727|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2388728|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
2388729|NCT00658593|Gemcitabine|gemcitabine|mesh-list
2388730|NCT00658593|Capecitabine|capecitabine|mesh-list
2388731|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2388732|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
2388733|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388734|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388735|NCT00658593|Antiviral Agents|antiviral agents|mesh-ancestor
2388736|NCT00658593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388737|NCT00658593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388738|NCT00658593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2388739|NCT00658593|Immunologic Factors|immunologic factors|mesh-ancestor
2388740|NCT00658593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388741|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2388742|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
2388743|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2509698|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2509699|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2509700|NCT01269203|Analgesics|analgesics|mesh-ancestor
2509701|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
2509702|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509703|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509704|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509705|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509706|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509707|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509708|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509709|NCT01269216|Leucovorin|leucovorin|mesh-list
2509710|NCT01269216|Irinotecan|irinotecan|mesh-list
2509711|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2509712|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2509713|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509714|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509715|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509716|NCT01269216|Antidotes|antidotes|mesh-ancestor
2509717|NCT01269216|Protective Agents|protective agents|mesh-ancestor
2509718|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509719|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
2509720|NCT01269216|Vitamins|vitamins|mesh-ancestor
2509721|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
2509722|NCT01269242|Bindarit|bindarit|mesh-list
2509723|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509724|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2509725|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509726|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509727|NCT01269255|Cisplatin|cisplatin|mesh-list
2388744|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2388745|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2388746|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2388747|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388748|NCT00658762|Paroxetine|paroxetine|mesh-list
2388749|NCT00658762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2388750|NCT00658762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2388751|NCT00658762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2388752|NCT00658762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388753|NCT00658762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388754|NCT00658762|Serotonin Agents|serotonin agents|mesh-ancestor
2388755|NCT00658762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388756|NCT00658762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2509728|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509729|NCT01269281|Sumatriptan|sumatriptan|mesh-list
2509730|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2509731|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2509732|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2509733|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
2388757|NCT00658762|Antidepressive Agents|antidepressive agents|mesh-ancestor
2388758|NCT00658762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2388759|NCT00658762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2388760|NCT00658762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2388761|NCT00658762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388762|NCT00658840|Capecitabine|capecitabine|mesh-list
2388763|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2388764|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
2509734|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509735|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509736|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509737|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
2509738|NCT01269294|Simeprevir|simeprevir|mesh-list
2509739|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2509740|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2509741|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509742|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2509743|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2509744|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509745|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509746|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509747|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2509748|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
2509749|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2509750|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509751|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2509752|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2509753|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2509754|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
2509755|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
2509756|NCT01269307|Ketamine|ketamine|mesh-list
2509757|NCT01269307|Propofol|propofol|mesh-list
2509758|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2509759|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2509760|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509761|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2509762|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
2509763|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
2509764|NCT01269307|Analgesics|analgesics|mesh-ancestor
2509765|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
2509766|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509767|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2509768|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2509769|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2509770|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509771|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509772|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
2509773|NCT01269333|Omeprazole|omeprazole|mesh-list
2509774|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2509775|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2509776|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2509777|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509778|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509779|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2509780|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2388765|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388766|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388767|NCT00658892|Antibodies|antibodies|mesh-list
2509781|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2509782|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509783|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2509784|NCT01269333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2509785|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2509786|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2509787|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509788|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
2509789|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2509790|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
2509791|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2509792|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2388768|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
2388769|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388770|NCT00658918|Ciclesonide|ciclesonide|mesh-list
2509793|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2509794|NCT01269411|R04929097|r04929097|mesh-list
2509795|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509796|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388771|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
2388772|NCT00658918|Hormones|hormones|mesh-ancestor
2388773|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388774|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388775|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2388776|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2388777|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2388778|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2509804|NCT01269437|Budesonide|budesonide|mesh-list
2509805|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509806|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2509807|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
2509808|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509809|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509810|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2509811|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
2509812|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
2509813|NCT01269437|Hormones|hormones|mesh-ancestor
2509814|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2509815|NCT01269450|Progesterone|progesterone|mesh-list
2509816|NCT01269450|Progestins|progestins|mesh-ancestor
2509817|NCT01269450|Hormones|hormones|mesh-ancestor
2509818|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2509819|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509820|NCT01269463|Methylphenidate|methylphenidate|mesh-list
2509821|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2509822|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509823|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2509824|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2509825|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2509826|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509827|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
2509828|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509829|NCT01269476|Fluorides|fluorides|mesh-list
2509830|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
2509831|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
2509832|NCT01269476|Protective Agents|protective agents|mesh-ancestor
2509833|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509834|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2509835|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509836|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509837|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
2509838|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509839|NCT01269515|Etoricoxib|etoricoxib|mesh-list
2509840|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2509841|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2509842|NCT01269515|Analgesics|analgesics|mesh-ancestor
2509843|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
2388779|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2388780|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388781|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388782|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388783|NCT00658931|Analgesics|analgesics|mesh-ancestor
2388784|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
2509844|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509845|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509846|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509847|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509848|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2509849|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2509850|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509851|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509852|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
2509853|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
2509854|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2509855|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
2509856|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509857|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509858|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2509859|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
2509860|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2509861|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
2509862|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509863|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509864|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2509865|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
2509866|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
2509867|NCT01269528|Protective Agents|protective agents|mesh-ancestor
2509868|NCT01269528|Miotics|miotics|mesh-ancestor
2509869|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2509870|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2509871|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2509872|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2509873|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
2509874|NCT01269541|Rifampin|rifampin|mesh-list
2509875|NCT01269541|Mupirocin|mupirocin|mesh-list
2509876|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2509877|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
2509878|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2509879|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509880|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
2509881|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2509882|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509883|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509884|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2509885|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2509886|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2509887|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2388785|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388786|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
2388787|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2388788|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
2388789|NCT00658957|Gentamicins|gentamicins|mesh-list
2388790|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2388791|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388792|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2388793|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388794|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388795|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
2388796|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388797|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388798|NCT00659022|Bevacizumab|bevacizumab|mesh-list
2388799|NCT00659022|Capecitabine|capecitabine|mesh-list
2509888|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2509889|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2509890|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2509891|NCT01269606|Insulin|insulin|mesh-list
2509892|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2509893|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
2509894|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
2509895|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2509896|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2509897|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509898|NCT01269658|Azithromycin|azithromycin|mesh-list
2509899|NCT01269658|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2509900|NCT01269658|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2509901|NCT01269658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2509902|NCT01269658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509903|NCT01269671|Peppermint oil|peppermint oil|mesh-list
2509904|NCT01269671|Melatonin|melatonin|mesh-list
2509905|NCT01269671|Simethicone|simethicone|mesh-list
2509906|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
2509907|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509908|NCT01269671|Protective Agents|protective agents|mesh-ancestor
2509909|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509910|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2509911|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
2509912|NCT01269671|Emollients|emollients|mesh-ancestor
2509913|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
2509914|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
2509915|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
2509916|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509917|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2509918|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
2509919|NCT01269684|Everolimus|everolimus|mesh-list
2509920|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509921|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2509922|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
2509923|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509924|NCT01269788|Fluoxetine|fluoxetine|mesh-list
2509925|NCT01269788|Omeprazole|omeprazole|mesh-list
2509926|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2509927|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2388800|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
2388801|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2388802|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388803|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2388804|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2388805|NCT00659022|Growth Substances|growth substances|mesh-ancestor
2388806|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388807|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
2388808|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2388809|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
2388810|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509928|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2509929|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509930|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509931|NCT01269788|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2509932|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2509933|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2509934|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2509935|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
2509936|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388811|NCT00659048|Ciclesonide|ciclesonide|mesh-list
2388812|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
2509937|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2509938|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
2509939|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2388813|NCT00659048|Hormones|hormones|mesh-ancestor
2388814|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388815|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388816|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2388817|NCT00659074|Ondansetron|ondansetron|mesh-list
2388818|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
2388819|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
2388820|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388821|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388822|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2388823|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
2388824|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
2388825|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2388826|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
2388827|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388828|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388829|NCT00659074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2388830|NCT00659074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2388831|NCT00659074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2388832|NCT00659074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2509940|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2509941|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2509942|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
2509943|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2509944|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2509945|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509946|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2509947|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2509948|NCT01269827|Protective Agents|protective agents|mesh-ancestor
2509949|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509950|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
2509951|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2509952|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
2509953|NCT01269853|Bevacizumab|bevacizumab|mesh-list
2509954|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2509955|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2509956|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2509957|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2509958|NCT01269853|Growth Substances|growth substances|mesh-ancestor
2509959|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509960|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
2509961|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2509962|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2509963|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2509964|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2509965|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509966|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388833|NCT00659074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2388834|NCT00659100|Gabapentin|gabapentin|mesh-list
2388835|NCT00659100|Analgesics|analgesics|mesh-ancestor
2388836|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
2388837|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388838|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388839|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
2388840|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2388841|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2388842|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2388843|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2388844|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2509967|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509968|NCT01269866|Analgesics|analgesics|mesh-ancestor
2509969|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
2509970|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2509971|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
2509972|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2509973|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
2509974|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2509975|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2509976|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509977|NCT01269996|Metformin|metformin|mesh-list
2509978|NCT01269996|Gliclazide|gliclazide|mesh-list
2509979|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2509980|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509981|NCT01270035|Adalimumab|adalimumab|mesh-list
2509982|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509983|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509984|NCT01270074|Azithromycin|azithromycin|mesh-list
2509985|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2509986|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2509987|NCT01270087|Adalimumab|adalimumab|mesh-list
2509988|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2509989|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2509990|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
2509991|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
2388845|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2388846|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388847|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388848|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
2388849|NCT00659113|Tegafur|tegafur|mesh-list
2388850|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388851|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2388852|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
2388853|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388854|NCT00659178|Doxorubicin|doxorubicin|mesh-list
2388855|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2388856|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2388857|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388858|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2509992|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2509993|NCT01270152|Protective Agents|protective agents|mesh-ancestor
2509994|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2509995|NCT01270152|Vitamins|vitamins|mesh-ancestor
2509996|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
2509997|NCT01270165|Telbivudine|telbivudine|mesh-list
2509998|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
2509999|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510000|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2510001|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510002|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510003|NCT01270178|Entecavir|entecavir|mesh-list
2510004|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
2510005|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510006|NCT01270191|Exenatide|exenatide|mesh-list
2510007|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
2510008|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2510009|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510010|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2510011|NCT01270191|Incretins|incretins|mesh-ancestor
2388859|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2388860|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388861|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388862|NCT00659191|Cabotegravir|cabotegravir|mesh-list
2388863|NCT00659191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2388864|NCT00659191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2388865|NCT00659191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510012|NCT01270191|Hormones|hormones|mesh-ancestor
2510013|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2510014|NCT01270308|Lansoprazole|lansoprazole|mesh-list
2510015|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
2510016|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2510017|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2510018|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2510019|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510020|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510021|NCT01270347|Levofloxacin|levofloxacin|mesh-list
2510022|NCT01270347|Ofloxacin|ofloxacin|mesh-list
2510023|NCT01270347|Tobramycin|tobramycin|mesh-list
2510024|NCT01270347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2388866|NCT00659191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388867|NCT00659191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2388868|NCT00659191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2388869|NCT00659191|Antiviral Agents|antiviral agents|mesh-ancestor
2388870|NCT00659191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510025|NCT01270347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2510026|NCT01270347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510027|NCT01270347|Renal Agents|renal agents|mesh-ancestor
2510028|NCT01270347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2510029|NCT01270347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2388871|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
2388872|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
2388873|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2388874|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2510030|NCT01270347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2510031|NCT01270347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510032|NCT01270347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510033|NCT01270347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510034|NCT01270347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2510035|NCT01270347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2510036|NCT01270373|Docetaxel|docetaxel|mesh-list
2510037|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510038|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
2510039|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
2510040|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
2510041|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510042|NCT01270386|Apatinib|apatinib|mesh-list
2510043|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510044|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2510045|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510046|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510047|NCT01270412|Mitogens|mitogens|mesh-list
2510048|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
2114575|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
2114576|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2114577|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510049|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
2510050|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510051|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2510052|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
2510053|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510054|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
2388875|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388876|NCT00659321|Nicotine|nicotine|mesh-list
2388877|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2388878|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
2388879|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388880|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388881|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2388882|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2388883|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
2388884|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388885|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388886|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
2388887|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2388888|NCT00659386|Antibodies|antibodies|mesh-list
2388889|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
2388890|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2388891|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
2510055|NCT01270412|Protective Agents|protective agents|mesh-ancestor
2510056|NCT01270438|Leucovorin|leucovorin|mesh-list
2510057|NCT01270438|Bevacizumab|bevacizumab|mesh-list
2388892|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388893|NCT00659399|PENTA|penta|mesh-list
2388894|NCT00659399|Fondaparinux|fondaparinux|mesh-list
2388895|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2388896|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
2388897|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2388898|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
2388899|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388900|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388901|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
2510058|NCT01270438|Fluorouracil|fluorouracil|mesh-list
2114578|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114579|NCT02605187|Acetaminophen|acetaminophen|mesh-list
2114580|NCT02605187|Ibuprofen|ibuprofen|mesh-list
2114581|NCT02605187|Morphine|morphine|mesh-list
2114582|NCT02605187|Gabapentin|gabapentin|mesh-list
2114583|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2114584|NCT02605187|Narcotics|narcotics|mesh-ancestor
2114585|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2114586|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114587|NCT02605187|Analgesics|analgesics|mesh-ancestor
2114588|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
2114589|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114590|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2388902|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2388903|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2388904|NCT00659412|Methotrexate|methotrexate|mesh-list
2388905|NCT00659412|Alefacept|alefacept|mesh-list
2388906|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2388907|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
2388908|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2388909|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388910|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2388911|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
2510059|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
2510060|NCT01270438|Calcium|calcium|mesh-list
2510061|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
2510062|NCT01270438|R04929097|r04929097|mesh-list
2510063|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2510064|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510065|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2510066|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2510067|NCT01270438|Growth Substances|growth substances|mesh-ancestor
2510068|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510069|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
2510070|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2510071|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
2510072|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510073|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2510074|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2510075|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
2510076|NCT01270438|Antidotes|antidotes|mesh-ancestor
2510077|NCT01270438|Protective Agents|protective agents|mesh-ancestor
2510078|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
2510079|NCT01270438|Vitamins|vitamins|mesh-ancestor
2510080|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
2510081|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510082|NCT01270451|Insulin|insulin|mesh-list
2510083|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2388912|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388913|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388914|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
2388915|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388916|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2388917|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2388918|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
2388919|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2388920|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2388921|NCT00659451|Losartan|losartan|mesh-list
2388922|NCT00659451|Amlodipine|amlodipine|mesh-list
2388923|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2388924|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2388925|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2388926|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388927|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2388928|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388929|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
2388930|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2388931|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2388932|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2388933|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
2388934|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2388935|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510084|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510085|NCT01270490|Interferons|interferons|mesh-list
2510086|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
2510087|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510088|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
2510089|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510090|NCT01270672|Carvedilol|carvedilol|mesh-list
2510091|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2510092|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2510093|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2510094|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
2510095|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510096|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510097|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510098|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2510099|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
2388936|NCT00659503|Ciclesonide|ciclesonide|mesh-list
2510100|NCT01270672|Protective Agents|protective agents|mesh-ancestor
2388937|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
2388938|NCT00659503|Hormones|hormones|mesh-ancestor
2388939|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388940|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388941|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2388942|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2388943|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2388944|NCT00659568|Metformin|metformin|mesh-list
2388945|NCT00659568|Sirolimus|sirolimus|mesh-list
2388946|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2388947|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388948|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2510101|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2510102|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2510103|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2510104|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
2510105|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2510106|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2510107|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
2510108|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2510109|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
2510110|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2510111|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2510112|NCT01270724|Gemcitabine|gemcitabine|mesh-list
2510113|NCT01270724|Paclitaxel|paclitaxel|mesh-list
2510114|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
2510115|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2510116|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510117|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
2510118|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
2510119|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
2510120|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510121|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2510122|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
2510123|NCT01270724|Antiviral Agents|antiviral agents|mesh-ancestor
2510124|NCT01270724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510125|NCT01270724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510126|NCT01270724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2510127|NCT01270724|Immunologic Factors|immunologic factors|mesh-ancestor
2510128|NCT01270724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510129|NCT01270737|Daidzein|daidzein|mesh-list
2510130|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
2510131|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2510132|NCT01270737|Estrogens|estrogens|mesh-ancestor
2510133|NCT01270737|Hormones|hormones|mesh-ancestor
2510134|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2510135|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510136|NCT01270750|Bosentan|bosentan|mesh-list
2510137|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2510138|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2510139|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510140|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
2510141|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2510142|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2510143|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510144|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
2510145|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
2510146|NCT01270789|Liraglutide|liraglutide|mesh-list
2510147|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2510148|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510149|NCT01270789|Incretins|incretins|mesh-ancestor
2510150|NCT01270789|Hormones|hormones|mesh-ancestor
2510151|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2510152|NCT01270815|Pregabalin|pregabalin|mesh-list
2510153|NCT01270815|Analgesics|analgesics|mesh-ancestor
2510154|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
2510155|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510156|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510157|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
2510158|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2510159|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2510160|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510161|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2388949|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2388950|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2388951|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2388952|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
2388953|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2388954|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
2388955|NCT00659594|Ciclesonide|ciclesonide|mesh-list
2388956|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
2388957|NCT00659594|Hormones|hormones|mesh-ancestor
2388958|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388959|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388960|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2388961|NCT00659659|Benralizumab|benralizumab|mesh-list
2388962|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2388963|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
2388964|NCT00659685|Ondansetron|ondansetron|mesh-list
2388965|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
2510162|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2510163|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2510164|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2510165|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2510166|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
2510167|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2510168|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2510169|NCT01270932|Dexamethasone|dexamethasone|mesh-list
2510170|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
2510171|NCT01270932|Lenalidomide|lenalidomide|mesh-list
2510172|NCT01270932|BB 1101|bb 1101|mesh-list
2510173|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2510174|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
2510175|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
2510176|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510177|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510178|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2510179|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
2510180|NCT01270932|Hormones|hormones|mesh-ancestor
2388966|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
2388967|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2388968|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388969|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2388970|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
2510181|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2510182|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2510183|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510184|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
2510185|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510186|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510187|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
2510188|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2510189|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2510190|NCT01270932|Growth Substances|growth substances|mesh-ancestor
2510191|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
2510192|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
2510193|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510194|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2510195|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510196|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510197|NCT01270997|Etanercept|etanercept|mesh-list
2510198|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2510199|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2510200|NCT01270997|Analgesics|analgesics|mesh-ancestor
2510201|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
2510202|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510203|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510204|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2510205|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2510206|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2510207|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2510208|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
2510209|NCT01271023|Insulin|insulin|mesh-list
2388971|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
2388972|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2388973|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
2388974|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2388975|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388976|NCT00659685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2510210|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2510211|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510212|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
2510213|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2510214|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
2510215|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510216|NCT01271088|Expectorants|expectorants|mesh-ancestor
2510217|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
2510218|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2510219|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
2510220|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510221|NCT01271088|Protective Agents|protective agents|mesh-ancestor
2510222|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510223|NCT01271088|Antidotes|antidotes|mesh-ancestor
2510224|NCT01271114|Terlipressin|terlipressin|mesh-list
2510225|NCT01271114|Norepinephrine|norepinephrine|mesh-list
2510226|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2510227|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2510228|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
2510229|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510230|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510231|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510232|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
2510233|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
2388977|NCT00659685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2388978|NCT00659685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2388979|NCT00659685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2388980|NCT00659685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2388981|NCT00659698|Pancrelipase|pancrelipase|mesh-list
2388982|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2388983|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2388984|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2388985|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388986|NCT00659711|Incretins|incretins|mesh-ancestor
2388987|NCT00659711|Hormones|hormones|mesh-ancestor
2388988|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2388989|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2388990|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
2388991|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2388992|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2388993|NCT00659750|Ciclesonide|ciclesonide|mesh-list
2388994|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
2388995|NCT00659750|Hormones|hormones|mesh-ancestor
2510234|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510235|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2510236|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2510237|NCT01271140|Insulin|insulin|mesh-list
2510238|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2510239|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510240|NCT01271153|Dobutamine|dobutamine|mesh-list
2510241|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2510242|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
2510243|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
2510244|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510245|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510246|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2510247|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2510248|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2510249|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
2510250|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510251|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510252|NCT01271153|Protective Agents|protective agents|mesh-ancestor
2510253|NCT01271166|Leucovorin|leucovorin|mesh-list
2510254|NCT01271166|Bevacizumab|bevacizumab|mesh-list
2510255|NCT01271166|Fluorouracil|fluorouracil|mesh-list
2510256|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
2510257|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
2510258|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2510259|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510260|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2510261|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2510262|NCT01271166|Growth Substances|growth substances|mesh-ancestor
2510263|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510264|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
2510265|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
2388996|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2510266|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510267|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2510268|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2510269|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
2510270|NCT01271166|Antidotes|antidotes|mesh-ancestor
2510271|NCT01271166|Protective Agents|protective agents|mesh-ancestor
2510272|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
2510273|NCT01271166|Vitamins|vitamins|mesh-ancestor
2510274|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
2510275|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2510276|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510277|NCT01271179|Insulin|insulin|mesh-list
2510278|NCT01271179|Allopurinol|allopurinol|mesh-list
2510279|NCT01271179|Adenosine|adenosine|mesh-list
2510280|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2510281|NCT01271179|Analgesics|analgesics|mesh-ancestor
2510282|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
2510283|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510284|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510285|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2510286|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
2510287|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2510288|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
2510289|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
2510290|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510291|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510292|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
2510293|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510294|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
2510295|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2510296|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2510297|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
2510298|NCT01271179|Protective Agents|protective agents|mesh-ancestor
2510299|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2510300|NCT01271231|Azithromycin|azithromycin|mesh-list
2510301|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2510302|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510303|NCT01271257|Misoprostol|misoprostol|mesh-list
2510304|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2510305|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
2510306|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2510307|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510308|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2510309|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2510310|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
2510311|NCT01271283|Lenalidomide|lenalidomide|mesh-list
2510312|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
2510313|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510314|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2510315|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2510316|NCT01271283|Growth Substances|growth substances|mesh-ancestor
2510317|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
2510318|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510319|NCT01271348|Etoricoxib|etoricoxib|mesh-list
2510320|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2510321|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2510322|NCT01271348|Analgesics|analgesics|mesh-ancestor
2510323|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
2510324|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510325|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510326|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2388997|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2388998|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2388999|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2389000|NCT00659776|Hematinics|hematinics|mesh-ancestor
2389001|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2389002|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2389003|NCT00659841|Ciclesonide|ciclesonide|mesh-list
2389004|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
2389005|NCT00659841|Hormones|hormones|mesh-ancestor
2389006|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2510327|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2510328|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2510329|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2510330|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510331|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510332|NCT01271361|Sirolimus|sirolimus|mesh-list
2510333|NCT01271361|Umirolimus|umirolimus|mesh-list
2510334|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2510335|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2510336|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
2510337|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510338|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2510339|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510340|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2510341|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510342|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
2389007|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389008|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2389009|NCT00659919|Trazodone|trazodone|mesh-list
2389010|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2389011|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2389012|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2389013|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389014|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2389015|NCT00659919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2389016|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2389017|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2389018|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389019|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389020|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
2389021|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2389022|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
2389023|NCT00659958|Zonisamide|zonisamide|mesh-list
2389024|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
2389025|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2389026|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2389027|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389028|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2389029|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389030|NCT00659997|Albendazole|albendazole|mesh-list
2389031|NCT00659997|Levamisole|levamisole|mesh-list
2389032|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
2389033|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2389034|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389035|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
2389036|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2389037|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2389038|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
2389039|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
2389040|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
2389041|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389042|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389043|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2389044|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
2389045|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389046|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
2389047|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2389048|NCT00660036|Etoposide|etoposide|mesh-list
2389049|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
2389050|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
2389051|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2389052|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389053|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2510343|NCT01271374|Losartan|losartan|mesh-list
2510344|NCT01271374|Amlodipine|amlodipine|mesh-list
2510345|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2510346|NCT01271374|Olmesartan|olmesartan|mesh-list
2510347|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
2510348|NCT01271374|Spironolactone|spironolactone|mesh-list
2510349|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2510350|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2510351|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2510352|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510353|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2510354|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510355|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
2510356|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2510357|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2510358|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2510359|NCT01271374|Diuretics|diuretics|mesh-ancestor
2510360|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
2510361|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2389054|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2389055|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389056|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389057|NCT00660036|Analgesics|analgesics|mesh-ancestor
2389058|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
2389059|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389060|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389061|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2389062|NCT00660062|Dexetimide|dexetimide|mesh-list
2389063|NCT00660062|Citalopram|citalopram|mesh-list
2389064|NCT00660062|Nortriptyline|nortriptyline|mesh-list
2389065|NCT00660062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2389066|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2389067|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2389068|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389069|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389070|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
2389071|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389072|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2389073|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
2389074|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2389075|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2389076|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2389077|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
2389078|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
2389079|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389080|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2389081|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2389082|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
2389083|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2389084|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2389085|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
2389086|NCT00660140|Gemcitabine|gemcitabine|mesh-list
2389087|NCT00660140|Carboplatin|carboplatin|mesh-list
2389088|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389089|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2389090|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
2389091|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389092|NCT00660140|Antiviral Agents|antiviral agents|mesh-ancestor
2389093|NCT00660140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389094|NCT00660140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389095|NCT00660140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2389096|NCT00660140|Immunologic Factors|immunologic factors|mesh-ancestor
2389097|NCT00660140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389098|NCT00660231|Gemcitabine|gemcitabine|mesh-list
2389099|NCT00660231|Bexarotene|bexarotene|mesh-list
2389100|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2389101|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
2389102|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389103|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389104|NCT00660231|Antiviral Agents|antiviral agents|mesh-ancestor
2389105|NCT00660231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389106|NCT00660231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389107|NCT00660231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2389108|NCT00660231|Immunologic Factors|immunologic factors|mesh-ancestor
2389109|NCT00660231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389110|NCT00660244|Anastrozole|anastrozole|mesh-list
2389111|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2389112|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389113|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2389114|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2389115|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389116|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389117|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2389118|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
2389119|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2389120|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389121|NCT00660257|Vaccines|vaccines|mesh-list
2389122|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
2389123|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389124|NCT00660270|Gemcitabine|gemcitabine|mesh-list
2389125|NCT00660270|Interferons|interferons|mesh-list
2389126|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
2389127|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2510362|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2510363|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
2389128|NCT00660270|Fluorouracil|fluorouracil|mesh-list
2389129|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389130|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2389131|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
2389132|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389133|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
2389134|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389135|NCT00660270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389136|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2389137|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
2389138|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389139|NCT00660283|Temozolomide|temozolomide|mesh-list
2510364|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2510365|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2510366|NCT01271439|Cetuximab|cetuximab|mesh-list
2510367|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2510368|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510369|NCT01271478|Telmisartan|telmisartan|mesh-list
2510370|NCT01271478|Captopril|captopril|mesh-list
2510371|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2510372|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2510373|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2510374|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510375|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2510376|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
2510377|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510378|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
2510379|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
2510380|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
2510381|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2510382|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510383|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2510384|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
2510385|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
2510386|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510387|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510388|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2510389|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
2510390|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2510391|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2510392|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2510393|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
2510394|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510395|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510396|NCT01271569|Fospropofol|fospropofol|mesh-list
2510397|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2510398|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2510399|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510400|NCT01271582|Leucovorin|leucovorin|mesh-list
2510401|NCT01271582|Irinotecan|irinotecan|mesh-list
2389140|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2389141|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
2389142|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389143|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389144|NCT00660335|Secretin|secretin|mesh-list
2389145|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2389146|NCT00660335|Hormones|hormones|mesh-ancestor
2389147|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2389148|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389149|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
2389150|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
2389151|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
2389152|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2389153|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389154|NCT00660426|Gemcitabine|gemcitabine|mesh-list
2389155|NCT00660426|Capecitabine|capecitabine|mesh-list
2389156|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
2389157|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2389158|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
2422936|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510402|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2510403|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2510404|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510405|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510406|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510407|NCT01271582|Antidotes|antidotes|mesh-ancestor
2510408|NCT01271582|Protective Agents|protective agents|mesh-ancestor
2510409|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510410|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
2510411|NCT01271582|Vitamins|vitamins|mesh-ancestor
2510412|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
2510413|NCT01271660|Pregabalin|pregabalin|mesh-list
2510414|NCT01271660|Analgesics|analgesics|mesh-ancestor
2389159|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389160|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389161|NCT00660426|Antiviral Agents|antiviral agents|mesh-ancestor
2389162|NCT00660426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389163|NCT00660426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389164|NCT00660426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2389165|NCT00660426|Immunologic Factors|immunologic factors|mesh-ancestor
2389166|NCT00660426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510415|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
2510416|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510417|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510418|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
2510419|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2510420|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2510421|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510422|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2510423|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2510424|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2510425|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2510426|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2510427|NCT01271790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2510428|NCT01271790|Interferon-alpha|interferon-alpha|mesh-list
2510429|NCT01271790|Ribavirin|ribavirin|mesh-list
2510430|NCT01271790|Antiviral Agents|antiviral agents|mesh-ancestor
2510431|NCT01271790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510432|NCT01271790|Immunologic Factors|immunologic factors|mesh-ancestor
2510433|NCT01271790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510434|NCT01271790|Antimetabolites|antimetabolites|mesh-ancestor
2510435|NCT01271790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510436|NCT01271881|Heparin|heparin|mesh-list
2510437|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
2510438|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2389167|NCT00660582|Leucovorin|leucovorin|mesh-list
2389168|NCT00660582|Folic Acid|folic acid|mesh-list
2389169|NCT00660582|Fluorouracil|fluorouracil|mesh-list
2389170|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
2389171|NCT00660582|Cetuximab|cetuximab|mesh-list
2389172|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
2389173|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
2389174|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389175|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2389176|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510439|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2510440|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510441|NCT01271894|Efavirenz|efavirenz|mesh-list
2510442|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2510443|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2510444|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510445|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510446|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
2510447|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510448|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2510449|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2510450|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2389177|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2389178|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
2389179|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389180|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2389181|NCT00660582|Antidotes|antidotes|mesh-ancestor
2510451|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2510452|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2510453|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2510454|NCT01271920|Trastuzumab|trastuzumab|mesh-list
2389182|NCT00660582|Protective Agents|protective agents|mesh-ancestor
2389183|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
2389184|NCT00660582|Vitamins|vitamins|mesh-ancestor
2510455|NCT01271920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2510456|NCT01271920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510457|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
2510458|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2510459|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389185|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
2389186|NCT00660582|Hematinics|hematinics|mesh-ancestor
2389187|NCT00660621|Bevacizumab|bevacizumab|mesh-list
2389188|NCT00660621|Temozolomide|temozolomide|mesh-list
2510477|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2510478|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2510479|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2510480|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2510481|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2510482|NCT01272089|Analgesics|analgesics|mesh-ancestor
2510483|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
2510484|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510485|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510486|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2510487|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2510488|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2510489|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2389189|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2389190|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389191|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2389192|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2389193|NCT00660621|Growth Substances|growth substances|mesh-ancestor
2389194|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389195|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
2389196|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2389197|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
2389198|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389199|NCT00660647|Adalimumab|adalimumab|mesh-list
2389200|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2389201|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2389202|NCT00660725|Gemcitabine|gemcitabine|mesh-list
2389203|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
2389204|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2389205|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
2389206|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389207|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389208|NCT00660725|Antiviral Agents|antiviral agents|mesh-ancestor
2389209|NCT00660725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389210|NCT00660725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389211|NCT00660725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2510490|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2510491|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
2510492|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
2510493|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510494|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510495|NCT01272128|Interferons|interferons|mesh-list
2389212|NCT00660725|Immunologic Factors|immunologic factors|mesh-ancestor
2389213|NCT00660725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389214|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2389215|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2389216|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2389217|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2389218|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389219|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389220|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389221|NCT00660751|Analgesics|analgesics|mesh-ancestor
2389222|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
2389223|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389224|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
2389225|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2389226|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
2389227|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2389228|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2389229|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2389230|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
2389231|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389232|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2389233|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2389234|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389235|NCT00660803|Fulvestrant|fulvestrant|mesh-list
2389236|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2389237|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389238|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2389239|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2389240|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
2389241|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2389242|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389243|NCT00660842|Paclitaxel|paclitaxel|mesh-list
2389244|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2389245|NCT00660842|Carboplatin|carboplatin|mesh-list
2389246|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2389247|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389248|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
2389249|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
2389250|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
2389251|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389252|NCT00660855|Parecoxib|parecoxib|mesh-list
2510496|NCT01272128|Interferon-beta|interferon-beta|mesh-list
2510497|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
2510498|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510499|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
2510500|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510501|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
2510502|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510503|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2510504|NCT01272258|Leronlimab|leronlimab|mesh-list
2510505|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2510506|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2389253|NCT00660855|Valdecoxib|valdecoxib|mesh-list
2389254|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2389255|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2389256|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389257|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389258|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2389259|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2389260|NCT00660855|Analgesics|analgesics|mesh-ancestor
2389261|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
2389262|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389263|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389264|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2389265|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2389266|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
2389267|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2389268|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389269|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389270|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2389271|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2389272|NCT00660868|Protective Agents|protective agents|mesh-ancestor
2389273|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389274|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
2389275|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2389276|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
2510507|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389277|NCT00660881|Epratuzumab|epratuzumab|mesh-list
2389278|NCT00660881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2389279|NCT00660881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389280|NCT00660894|Leucovorin|leucovorin|mesh-list
2389281|NCT00660894|Tegafur|tegafur|mesh-list
2389282|NCT00660894|Calcium|calcium|mesh-list
2389283|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
2389284|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2389285|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510508|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2510509|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2510510|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
2510511|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510512|NCT01272310|Interferons|interferons|mesh-list
2510513|NCT01272310|Ribavirin|ribavirin|mesh-list
2510514|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
2510515|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
2510516|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2510517|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
2510518|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510519|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
2510520|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510521|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
2510522|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389286|NCT00660894|Antidotes|antidotes|mesh-ancestor
2389287|NCT00660894|Protective Agents|protective agents|mesh-ancestor
2389288|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
2389289|NCT00660894|Vitamins|vitamins|mesh-ancestor
2510523|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
2510524|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510525|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
2510526|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2510527|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2510528|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510529|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2510530|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
2510531|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2510532|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2510533|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2510534|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2510535|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510536|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
2510537|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510538|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510539|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2510540|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510541|NCT01272531|Valproic Acid|valproic acid|mesh-list
2510542|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
2510543|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
2510544|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510545|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510546|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
2510547|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510548|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510549|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
2510550|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2510551|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2510552|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2510553|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
2510554|NCT01272557|Doxorubicin|doxorubicin|mesh-list
2510555|NCT01272557|Sorafenib|sorafenib|mesh-list
2510556|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2510557|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510558|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2510559|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2510560|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510561|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510562|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2510563|NCT01272609|Timolol|timolol|mesh-list
2510564|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2510565|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2510566|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
2510567|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510568|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510569|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389290|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
2389291|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2389292|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
2389293|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389294|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389295|NCT00660920|Ponatinib|ponatinib|mesh-list
2389296|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389297|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2389298|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389299|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510570|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2510571|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2510572|NCT01272778|Lorazepam|lorazepam|mesh-list
2510573|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
2510574|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
2510575|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
2510576|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510577|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510578|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2510579|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2510580|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2510581|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2389300|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2389301|NCT00660933|Hematinics|hematinics|mesh-ancestor
2389302|NCT00660972|Tenofovir|tenofovir|mesh-list
2389303|NCT00660972|Emtricitabine|emtricitabine|mesh-list
2389304|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
2389305|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2389306|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
2389307|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389308|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2389309|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2389310|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389311|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389312|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2389313|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2389314|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2389315|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2389316|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2389317|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
2510582|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2510583|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2510584|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
2510585|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
2510586|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510587|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510588|NCT01272791|Gemcitabine|gemcitabine|mesh-list
2510589|NCT01272791|Bavituximab|bavituximab|mesh-list
2510590|NCT01272791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2510591|NCT01272791|Antimetabolites|antimetabolites|mesh-ancestor
2510592|NCT01272791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510593|NCT01272791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510594|NCT01272791|Antiviral Agents|antiviral agents|mesh-ancestor
2510595|NCT01272791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510596|NCT01272791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510597|NCT01272791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2510598|NCT01272791|Immunologic Factors|immunologic factors|mesh-ancestor
2510599|NCT01272791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510600|NCT01272791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2510601|NCT01272856|Abatacept|abatacept|mesh-list
2510602|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2510603|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510604|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510605|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2510606|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
2510607|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510608|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2510609|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
2510610|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
2510611|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510612|NCT01273051|Capecitabine|capecitabine|mesh-list
2510613|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2510614|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
2510615|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510616|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510617|NCT01273090|Imetelstat|imetelstat|mesh-list
2510618|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
2510619|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389318|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2389319|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2389320|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510620|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510621|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2510622|NCT01273233|Vaccines|vaccines|mesh-list
2510623|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
2510624|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510625|NCT01273246|Vaccines|vaccines|mesh-list
2510626|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
2510627|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510628|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2510629|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2510630|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
2510631|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510632|NCT01273298|Bisoprolol|bisoprolol|mesh-list
2510633|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2510634|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
2510635|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
2510636|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510637|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510638|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2510639|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2510640|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2510641|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
2510642|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510643|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510644|NCT01273402|Antibodies|antibodies|mesh-list
2510645|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
2510646|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2510647|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
2510648|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510649|NCT01273441|Amoxicillin|amoxicillin|mesh-list
2510650|NCT01273441|Metronidazole|metronidazole|mesh-list
2510651|NCT01273441|Clarithromycin|clarithromycin|mesh-list
2510652|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2510653|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510654|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2510655|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2510656|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2510657|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510658|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510659|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2510660|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2510661|NCT01273454|Hydromorphone|hydromorphone|mesh-list
2510662|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2510663|NCT01273454|Narcotics|narcotics|mesh-ancestor
2510664|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2510665|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510666|NCT01273454|Analgesics|analgesics|mesh-ancestor
2510667|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
2389321|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389322|NCT00660998|Urological Agents|urological agents|mesh-ancestor
2389323|NCT00661063|Clonidine|clonidine|mesh-list
2389324|NCT00661063|Ketamine|ketamine|mesh-list
2389325|NCT00661063|Analgesics|analgesics|mesh-ancestor
2510668|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510669|NCT01273493|Dexamethasone|dexamethasone|mesh-list
2510670|NCT01273493|Trabectedin|trabectedin|mesh-list
2510671|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2510672|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
2510673|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
2510674|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510675|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510676|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2510677|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
2510678|NCT01273493|Hormones|hormones|mesh-ancestor
2510679|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2510680|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2510681|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510682|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2510683|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
2510684|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510685|NCT01273506|Tapentadol|tapentadol|mesh-list
2510686|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2510687|NCT01273506|Narcotics|narcotics|mesh-ancestor
2510688|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2510689|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510690|NCT01273506|Analgesics|analgesics|mesh-ancestor
2510691|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
2510692|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510693|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2510694|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2510695|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2510696|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389326|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
2389327|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389328|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389329|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2389330|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2389331|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
2389332|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
2389333|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2389334|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2389335|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2389336|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389337|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389338|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2389339|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
2389340|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
2389341|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2389342|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2389343|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2389344|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
2389345|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2510697|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
2510698|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510699|NCT01273532|Tapentadol|tapentadol|mesh-list
2510700|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2510701|NCT01273532|Narcotics|narcotics|mesh-ancestor
2510702|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2510703|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389346|NCT00661076|Adefovir|adefovir|mesh-list
2389347|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2389348|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
2389349|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389350|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2389351|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2389352|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389353|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389354|NCT00661102|Capecitabine|capecitabine|mesh-list
2389355|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2389356|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
2389357|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389358|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389359|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2389360|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
2389361|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2389362|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2389363|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389364|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389365|NCT00661115|Urological Agents|urological agents|mesh-ancestor
2389366|NCT00661154|Bevacizumab|bevacizumab|mesh-list
2389367|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2389368|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389369|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2389370|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2389371|NCT00661154|Growth Substances|growth substances|mesh-ancestor
2389372|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389373|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
2389374|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2389375|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389376|NCT00661180|Sorafenib|sorafenib|mesh-list
2389377|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510704|NCT01273532|Analgesics|analgesics|mesh-ancestor
2510705|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
2510706|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510707|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2389378|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2389379|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389380|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389381|NCT00661206|Clopidogrel|clopidogrel|mesh-list
2389382|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2389383|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2389384|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2389385|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2389386|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
2389387|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510708|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2510709|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2510710|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510711|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
2510712|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389388|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389389|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389390|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2389391|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
2389392|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2389393|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2389394|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389395|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389396|NCT00661219|Urological Agents|urological agents|mesh-ancestor
2510713|NCT01273558|Canagliflozin|canagliflozin|mesh-list
2510714|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2510715|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510716|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2510717|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510718|NCT01273571|Metformin|metformin|mesh-list
2510719|NCT01273571|Canagliflozin|canagliflozin|mesh-list
2510720|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2510721|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510722|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2510723|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510724|NCT01273584|Metformin|metformin|mesh-list
2510725|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2510726|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510727|NCT01273610|Trastuzumab|trastuzumab|mesh-list
2510728|NCT01273610|Lapatinib|lapatinib|mesh-list
2510729|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2510730|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510731|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2510732|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510733|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510734|NCT01273662|Axitinib|axitinib|mesh-list
2510735|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510736|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2510737|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510738|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510739|NCT01273727|Dexamethasone|dexamethasone|mesh-list
2510740|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
2510741|NCT01273727|BB 1101|bb 1101|mesh-list
2510742|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2510743|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
2510744|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
2510745|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389397|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2389398|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
2389399|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2389400|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2389401|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389402|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389403|NCT00661297|Urological Agents|urological agents|mesh-ancestor
2389404|NCT00661336|Melphalan|melphalan|mesh-list
2389405|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
2389406|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2389407|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
2510746|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510747|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2510748|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
2510749|NCT01273727|Hormones|hormones|mesh-ancestor
2510750|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2510751|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2510752|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510753|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
2510754|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510755|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510756|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
2510757|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510758|NCT01273831|Cisatracurium|cisatracurium|mesh-list
2510759|NCT01273831|Atracurium|atracurium|mesh-list
2510760|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2510761|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2510762|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510763|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510764|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2510765|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2510766|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2510767|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
2510768|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389408|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389409|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389410|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2389411|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2389412|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
2389413|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389414|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
2389415|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2389416|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389417|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2389418|NCT00661336|Protective Agents|protective agents|mesh-ancestor
2389419|NCT00661349|Ritonavir|ritonavir|mesh-list
2389420|NCT00661349|Lopinavir|lopinavir|mesh-list
2389421|NCT00661349|Nevirapine|nevirapine|mesh-list
2389422|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2389423|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2389424|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
2389425|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389426|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389427|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2389428|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2389429|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
2389430|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389431|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2389432|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2510769|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510770|NCT01273844|Bortezomib|bortezomib|mesh-list
2510771|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510772|NCT01273948|Interferons|interferons|mesh-list
2510773|NCT01273948|Bavituximab|bavituximab|mesh-list
2510774|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510775|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
2510776|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510777|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2510778|NCT01273974|Vaccines|vaccines|mesh-list
2510779|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
2510780|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510781|NCT01274000|Ramosetron|ramosetron|mesh-list
2510782|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
2510783|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
2510784|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510785|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510786|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2510787|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2510788|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
2510789|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510790|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510791|NCT01274026|Verapamil|verapamil|mesh-list
2389433|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2389434|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2389435|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2389436|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2389437|NCT00661375|Sorafenib|sorafenib|mesh-list
2389438|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389439|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2510792|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2510793|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2510794|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2510795|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510796|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2510797|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510798|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
2510799|NCT01274039|Acetazolamide|acetazolamide|mesh-list
2510800|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
2389440|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389441|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389442|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
2389443|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
2389444|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510801|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2510802|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510803|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510804|NCT01274039|Diuretics|diuretics|mesh-ancestor
2510805|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
2510806|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510807|NCT01274104|Vitamin D|vitamin d|mesh-list
2510808|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
2510809|NCT01274104|Vitamins|vitamins|mesh-ancestor
2510810|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
2510811|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510812|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2510813|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2510814|NCT01274130|Metformin|metformin|mesh-list
2510815|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2510816|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510817|NCT01274195|Busulfan|busulfan|mesh-list
2510818|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
2510819|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510820|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2510821|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
2510822|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510823|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2510824|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510825|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2510826|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2510827|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2510828|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510829|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2510830|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2510831|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2510832|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510833|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
2510834|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510835|NCT01274247|Benzocaine|benzocaine|mesh-list
2510836|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
2510837|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
2510838|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2389445|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2389446|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
2389447|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2389448|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2389449|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389450|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389451|NCT00661596|Urological Agents|urological agents|mesh-ancestor
2389452|NCT00661635|Valdecoxib|valdecoxib|mesh-list
2389453|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2389454|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2389455|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389456|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389457|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2389458|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2389459|NCT00661635|Analgesics|analgesics|mesh-ancestor
2510839|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510840|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
2510841|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510842|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
2510843|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2510844|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2510845|NCT01274260|Prednisolone|prednisolone|mesh-list
2510846|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
2510847|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2510848|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
2510849|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2510850|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
2510851|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
2510852|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510853|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510854|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2510855|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
2510856|NCT01274260|Hormones|hormones|mesh-ancestor
2510857|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2510858|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2510859|NCT01274260|Protective Agents|protective agents|mesh-ancestor
2510860|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2510861|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510862|NCT01274273|Interferons|interferons|mesh-list
2510863|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
2510864|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
2510865|NCT01274273|Aldesleukin|aldesleukin|mesh-list
2510866|NCT01274273|Bevacizumab|bevacizumab|mesh-list
2510867|NCT01274273|Interleukin-2|interleukin-2|mesh-list
2510868|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2510869|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510870|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2510871|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2510872|NCT01274273|Growth Substances|growth substances|mesh-ancestor
2510873|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510874|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
2510875|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
2510876|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510877|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
2510878|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2510879|NCT01274273|Analgesics|analgesics|mesh-ancestor
2510880|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
2510881|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510882|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2510883|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2510884|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2510885|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2510886|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
2510887|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510888|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510889|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2510890|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
2510891|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
2510892|NCT01274325|Hormones|hormones|mesh-ancestor
2510893|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2510894|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
2510895|NCT01274403|Thalidomide|thalidomide|mesh-list
2510896|NCT01274403|Prednisone|prednisone|mesh-list
2389460|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
2389461|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389462|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389463|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2389464|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2389465|NCT00661648|Pancrelipase|pancrelipase|mesh-list
2389466|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2389467|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2389468|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
2389469|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2389470|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2389471|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510897|NCT01274403|Melphalan|melphalan|mesh-list
2510898|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2510899|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
2510900|NCT01274403|Hormones|hormones|mesh-ancestor
2510901|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2510902|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510903|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2510904|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510905|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2389472|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389473|NCT00661700|Urological Agents|urological agents|mesh-ancestor
2510906|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
2389474|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2389475|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2389476|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
2389477|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389478|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389479|NCT00661765|Varenicline|varenicline|mesh-list
2389480|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2389481|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2389482|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
2510907|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510908|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2510909|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2510910|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
2510911|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
2510912|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2510913|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510914|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2389483|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389484|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389485|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389486|NCT00661856|Genistein|genistein|mesh-list
2389487|NCT00661856|Daidzein|daidzein|mesh-list
2389488|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2389489|NCT00661856|Protective Agents|protective agents|mesh-ancestor
2389490|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389491|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389492|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2389493|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389494|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510915|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2510916|NCT01274403|Growth Substances|growth substances|mesh-ancestor
2510917|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
2510918|NCT01274481|Iloprost|iloprost|mesh-list
2510919|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2510920|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
2510921|NCT01274624|Leucovorin|leucovorin|mesh-list
2510922|NCT01274624|Bevacizumab|bevacizumab|mesh-list
2510923|NCT01274624|Fluorouracil|fluorouracil|mesh-list
2510924|NCT01274624|Irinotecan|irinotecan|mesh-list
2510925|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2510926|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510927|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2510928|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2510929|NCT01274624|Growth Substances|growth substances|mesh-ancestor
2510930|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510931|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
2510932|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
2510933|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510934|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2510935|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2510936|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
2510937|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2510938|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2510939|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510940|NCT01274624|Antidotes|antidotes|mesh-ancestor
2510941|NCT01274624|Protective Agents|protective agents|mesh-ancestor
2510942|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
2510943|NCT01274624|Vitamins|vitamins|mesh-ancestor
2510944|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
2510945|NCT01274780|Ritonavir|ritonavir|mesh-list
2510946|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2510947|NCT01274780|Darunavir|darunavir|mesh-list
2510948|NCT01274780|Tenofovir|tenofovir|mesh-list
2510949|NCT01274780|Emtricitabine|emtricitabine|mesh-list
2510950|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2510951|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2389495|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
2389496|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2389497|NCT00661856|Estrogens|estrogens|mesh-ancestor
2389498|NCT00661856|Hormones|hormones|mesh-ancestor
2389499|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2389500|NCT00661973|Budesonide|budesonide|mesh-list
2389501|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2389502|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2389503|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
2510952|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
2510953|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2510954|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510955|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2510956|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2510957|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
2510958|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2510959|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2510960|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2510961|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2510962|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2510963|NCT01274793|Mosapride|mosapride|mesh-list
2510964|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2510965|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2389504|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389505|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389506|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2389507|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
2389508|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
2389509|NCT00661973|Hormones|hormones|mesh-ancestor
2389510|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2389511|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
2510966|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2510967|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
2510968|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2510969|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510970|NCT01274988|Methadone|methadone|mesh-list
2510971|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2510972|NCT01274988|Narcotics|narcotics|mesh-ancestor
2510973|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2510974|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510975|NCT01274988|Analgesics|analgesics|mesh-ancestor
2510976|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
2510977|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510978|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
2510979|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
2510980|NCT01275014|Dexamethasone|dexamethasone|mesh-list
2510981|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2510982|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
2510983|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
2510984|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2510985|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2510986|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2510987|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
2510988|NCT01275014|Hormones|hormones|mesh-ancestor
2510989|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2510990|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2510991|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2510992|NCT01275105|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2510993|NCT01275105|Phenylephrine|phenylephrine|mesh-list
2510994|NCT01275105|Oxymetazoline|oxymetazoline|mesh-list
2510995|NCT01275105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2510996|NCT01275105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2510997|NCT01275105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2510998|NCT01275105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2510999|NCT01275105|Adrenergic Agents|adrenergic agents|mesh-ancestor
2511000|NCT01275105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511001|NCT01275105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511002|NCT01275105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511003|NCT01275105|Sympathomimetics|sympathomimetics|mesh-ancestor
2511004|NCT01275105|Autonomic Agents|autonomic agents|mesh-ancestor
2511005|NCT01275105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511006|NCT01275105|Nasal Decongestants|nasal decongestants|mesh-ancestor
2511007|NCT01275105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2511008|NCT01275105|Respiratory System Agents|respiratory system agents|mesh-ancestor
2511009|NCT01275105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2511010|NCT01275105|Mydriatics|mydriatics|mesh-ancestor
2511011|NCT01275105|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2511012|NCT01275105|Protective Agents|protective agents|mesh-ancestor
2511013|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
2511014|NCT01275183|Cisplatin|cisplatin|mesh-list
2511015|NCT01275183|Docetaxel|docetaxel|mesh-list
2511016|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511017|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
2511018|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
2511019|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
2668483|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2511020|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511021|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2511022|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2511023|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
2511024|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511025|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2511026|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2511027|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511028|NCT01275248|Ondansetron|ondansetron|mesh-list
2511029|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
2511030|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
2511031|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511032|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511033|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2511034|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
2511035|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
2511036|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2511037|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
2389512|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2389513|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389514|NCT00662220|Ribavirin|ribavirin|mesh-list
2389515|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2389516|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
2389517|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
2389518|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389519|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
2389520|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389521|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
2389522|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389523|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
2389524|NCT00662233|Ifosfamide|ifosfamide|mesh-list
2389525|NCT00662233|Doxorubicin|doxorubicin|mesh-list
2389526|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2389527|NCT00662233|Etoposide|etoposide|mesh-list
2389528|NCT00662233|Vincristine|vincristine|mesh-list
2389529|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2389530|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
2389531|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389532|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2389533|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2389534|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
2389535|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389536|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389537|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2389538|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2389539|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2389540|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2389541|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389542|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2389543|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
2389544|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
2389545|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
2389546|NCT00662272|Vaccines|vaccines|mesh-list
2389547|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
2389548|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389549|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
2389550|NCT00662337|Promethazine|promethazine|mesh-list
2389551|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2389552|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2389553|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511038|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511039|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511040|NCT01275248|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2511041|NCT01275248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2511042|NCT01275248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511043|NCT01275248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2511044|NCT01275248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2511045|NCT01275274|Tretinoin|tretinoin|mesh-list
2511046|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511047|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
2511048|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
2511049|NCT01275287|Eculizumab|eculizumab|mesh-list
2511050|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2511051|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2511052|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
2511053|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511054|NCT01275352|Eplerenone|eplerenone|mesh-list
2511055|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
2511056|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
2511057|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511058|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511059|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2511060|NCT01275352|Diuretics|diuretics|mesh-ancestor
2511061|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
2511062|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2511063|NCT01275443|Rilpivirine|rilpivirine|mesh-list
2389554|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389555|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
2389556|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
2389557|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
2389558|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389559|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
2389560|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
2389561|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2389562|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2389563|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
2389564|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
2389565|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389566|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389567|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2389568|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
2511064|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2511065|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2511066|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511067|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511068|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
2511069|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511070|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2511071|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2511072|NCT01275508|Adalimumab|adalimumab|mesh-list
2511073|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2511074|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2511075|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2511076|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2511077|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511078|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511079|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2511080|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2511081|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511082|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
2511083|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511084|NCT01275547|Midazolam|midazolam|mesh-list
2511085|NCT01275547|Morphine|morphine|mesh-list
2511086|NCT01275547|Ketamine|ketamine|mesh-list
2511087|NCT01275547|Esketamine|esketamine|mesh-list
2511088|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2511089|NCT01275547|Narcotics|narcotics|mesh-ancestor
2511090|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511091|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511092|NCT01275547|Analgesics|analgesics|mesh-ancestor
2511093|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
2511094|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511095|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2511096|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2511097|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
2511098|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
2511099|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2511100|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2511101|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511102|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511103|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2511104|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2511105|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2511106|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2511107|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2511108|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
2389569|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
2389570|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2389571|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
2389572|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2389573|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2389574|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511109|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
2511110|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
2511111|NCT01275560|Metronidazole|metronidazole|mesh-list
2389575|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389576|NCT00662441|Urological Agents|urological agents|mesh-ancestor
2389577|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2389578|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2389579|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
2389580|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2389581|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2389582|NCT00662454|Estradiol|estradiol|mesh-list
2389583|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2389584|NCT00662454|Estrogens|estrogens|mesh-ancestor
2389585|NCT00662454|Hormones|hormones|mesh-ancestor
2511112|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511113|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2511114|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2511115|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2511116|NCT01275599|Buprenorphine|buprenorphine|mesh-list
2511117|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2511118|NCT01275599|Naloxone|naloxone|mesh-list
2511119|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2511120|NCT01275599|Narcotics|narcotics|mesh-ancestor
2511121|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2389586|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2389587|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389588|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2389589|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
2389590|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2389591|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2389592|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2389593|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2389594|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2389595|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2389596|NCT00662467|Aspirin|aspirin|mesh-list
2389597|NCT00662467|Warfarin|warfarin|mesh-list
2389598|NCT00662467|Clopidogrel|clopidogrel|mesh-list
2389599|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2389600|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2389601|NCT00662467|Analgesics|analgesics|mesh-ancestor
2389602|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
2389603|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389604|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389605|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2389606|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2389607|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2389608|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2389609|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389610|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2389611|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2389612|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389613|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
2389614|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2511122|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511123|NCT01275599|Analgesics|analgesics|mesh-ancestor
2511124|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
2511125|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511126|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2511127|NCT01275638|Prednisolone|prednisolone|mesh-list
2511128|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2389615|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2389616|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2389617|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
2389618|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389619|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
2389620|NCT00662506|Deoxyglucose|deoxyglucose|mesh-list
2389621|NCT00662506|Temozolomide|temozolomide|mesh-list
2389622|NCT00662506|Cediranib|cediranib|mesh-list
2389623|NCT00662506|Maleic acid|maleic acid|mesh-list
2389624|NCT00662506|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2511129|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
2511130|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2511131|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
2389625|NCT00662506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2389626|NCT00662506|Alkylating Agents|alkylating agents|mesh-ancestor
2511132|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2511133|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
2511134|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2511135|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
2511136|NCT01275638|Hormones|hormones|mesh-ancestor
2511137|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511138|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511139|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2389627|NCT00662506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389628|NCT00662506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389629|NCT00662506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389630|NCT00662506|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2389631|NCT00662506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2389632|NCT00662506|Antimetabolites|antimetabolites|mesh-ancestor
2389633|NCT00662506|Antiviral Agents|antiviral agents|mesh-ancestor
2389634|NCT00662506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389635|NCT00662519|Sargramostim|sargramostim|mesh-list
2389636|NCT00662519|Lenograstim|lenograstim|mesh-list
2389637|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
2389638|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389639|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2389640|NCT00662571|Acamprosate|acamprosate|mesh-list
2389641|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2389642|NCT00662597|Paclitaxel|paclitaxel|mesh-list
2389643|NCT00662597|Carboplatin|carboplatin|mesh-list
2389644|NCT00662597|Vadimezan|vadimezan|mesh-list
2389645|NCT00662597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2389646|NCT00662597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389647|NCT00662597|Tubulin Modulators|tubulin modulators|mesh-ancestor
2389648|NCT00662597|Antimitotic Agents|antimitotic agents|mesh-ancestor
2389649|NCT00662597|Mitosis Modulators|mitosis modulators|mesh-ancestor
2389650|NCT00662597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389651|NCT00662610|Naproxen|naproxen|mesh-list
2389652|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
2389653|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2389654|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2389655|NCT00662610|Analgesics|analgesics|mesh-ancestor
2511140|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511141|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
2511142|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
2511143|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511144|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2511145|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2511146|NCT01275638|Protective Agents|protective agents|mesh-ancestor
2511147|NCT01275729|Furosemide|furosemide|mesh-list
2511148|NCT01275729|Diuretics|diuretics|mesh-ancestor
2511149|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
2511150|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511151|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2389656|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
2389657|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389658|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389659|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2389660|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2511152|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2511153|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511154|NCT01275859|Letrozole|letrozole|mesh-list
2511155|NCT01275859|Lapatinib|lapatinib|mesh-list
2511156|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511157|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2511158|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2389661|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
2389662|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2389663|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389664|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389665|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2389666|NCT00662636|Dasatinib|dasatinib|mesh-list
2389667|NCT00662636|Lapatinib|lapatinib|mesh-list
2389668|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389669|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2389670|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389671|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389672|NCT00662714|Insulin|insulin|mesh-list
2389673|NCT00662714|Repaglinide|repaglinide|mesh-list
2389674|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2511159|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389675|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
2389676|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2511160|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511161|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2511162|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
2511163|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511164|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511165|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2511166|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
2511167|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2511168|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511169|NCT01275885|Vitamins|vitamins|mesh-ancestor
2511170|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
2511171|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2389677|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389678|NCT00662740|Tiotropium Bromide|tiotropium bromide|mesh-list
2389679|NCT00662740|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2389680|NCT00662740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2511172|NCT01275911|Remifentanil|remifentanil|mesh-list
2511173|NCT01275911|Esmolol|esmolol|mesh-list
2511174|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2511175|NCT01275911|Narcotics|narcotics|mesh-ancestor
2511176|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511177|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511178|NCT01275911|Analgesics|analgesics|mesh-ancestor
2511179|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
2511180|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511181|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2511182|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2511183|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2511184|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
2511185|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511186|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511187|NCT01275937|Esomeprazole|esomeprazole|mesh-list
2511188|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2511189|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2511190|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2511191|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511192|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511193|NCT01275976|Complement C1s|complement c1s|mesh-list
2511194|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2511195|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2511196|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
2511197|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511198|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2511199|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2511200|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
2511201|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2511202|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2511203|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2511204|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2511205|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511206|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
2511207|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511208|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511209|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2511210|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511211|NCT01276067|Donepezil|donepezil|mesh-list
2511212|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2511213|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511214|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511215|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
2511216|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511217|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511218|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
2511219|NCT01276080|Donepezil|donepezil|mesh-list
2511220|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2511221|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511222|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511223|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
2511224|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511225|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511226|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
2511227|NCT01276093|Amiodarone|amiodarone|mesh-list
2511228|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2511229|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
2511230|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2511231|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2511232|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511233|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2511234|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2511235|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2511236|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389681|NCT00662740|Autonomic Agents|autonomic agents|mesh-ancestor
2389682|NCT00662740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389683|NCT00662740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389684|NCT00662740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2389685|NCT00662740|Respiratory System Agents|respiratory system agents|mesh-ancestor
2389686|NCT00662740|Parasympatholytics|parasympatholytics|mesh-ancestor
2389687|NCT00662740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2389688|NCT00662740|Cholinergic Agents|cholinergic agents|mesh-ancestor
2511237|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2511238|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2511239|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2511240|NCT01276210|Sorafenib|sorafenib|mesh-list
2511241|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511242|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2511243|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511244|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511245|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
2511246|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2511247|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2511248|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
2511249|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2511250|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511251|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2511252|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2389689|NCT00662740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389690|NCT00662740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389691|NCT00662740|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2389692|NCT00662740|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2389693|NCT00662740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2389694|NCT00662740|Adrenergic Agents|adrenergic agents|mesh-ancestor
2389695|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
2389696|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2389697|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
2389698|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389699|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389700|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2389701|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
2389702|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2389703|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2511253|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2511254|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2511255|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2511256|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2511257|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2511258|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2511259|NCT01276431|Buprenorphine|buprenorphine|mesh-list
2511260|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2511261|NCT01276431|Narcotics|narcotics|mesh-ancestor
2389704|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2389705|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
2389706|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389707|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389708|NCT00662792|Tiotropium Bromide|tiotropium bromide|mesh-list
2389709|NCT00662792|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2389710|NCT00662792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2389711|NCT00662792|Autonomic Agents|autonomic agents|mesh-ancestor
2389712|NCT00662792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389713|NCT00662792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389714|NCT00662792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2389715|NCT00662792|Respiratory System Agents|respiratory system agents|mesh-ancestor
2389716|NCT00662792|Parasympatholytics|parasympatholytics|mesh-ancestor
2389717|NCT00662792|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2389718|NCT00662792|Cholinergic Agents|cholinergic agents|mesh-ancestor
2389719|NCT00662792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389720|NCT00662792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389721|NCT00662792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2389722|NCT00662792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2389723|NCT00662792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2389724|NCT00662792|Adrenergic Agents|adrenergic agents|mesh-ancestor
2389725|NCT00662805|Fluticasone|fluticasone|mesh-list
2389726|NCT00662805|Xhance|xhance|mesh-list
2389727|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2389728|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2389729|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2389730|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
2389731|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389732|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389733|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2389734|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
2389735|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
2389736|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2389737|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2389738|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2389739|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2389740|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
2389741|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389742|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389743|NCT00662844|Vitamin D|vitamin d|mesh-list
2511262|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511263|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511264|NCT01276431|Analgesics|analgesics|mesh-ancestor
2511265|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
2511266|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511267|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2511268|NCT01276496|Paclitaxel|paclitaxel|mesh-list
2511269|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2511270|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2511271|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511272|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
2511273|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
2511274|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
2511275|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511276|NCT01276548|Carboplatin|carboplatin|mesh-list
2511277|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511278|NCT01276587|Vitamin D|vitamin d|mesh-list
2511279|NCT01276587|Ergocalciferols|ergocalciferols|mesh-list
2511280|NCT01276587|Cholecalciferol|cholecalciferol|mesh-list
2511281|NCT01276587|Vitamins|vitamins|mesh-list
2511282|NCT01276587|Micronutrients|micronutrients|mesh-ancestor
2511283|NCT01276587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511284|NCT01276587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2511285|NCT01276587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2511286|NCT01276600|Tenofovir|tenofovir|mesh-list
2511287|NCT01276600|Emtricitabine|emtricitabine|mesh-list
2511288|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
2511289|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511290|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2511291|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2511292|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511293|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511294|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2511295|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2511296|NCT01276613|Gemcitabine|gemcitabine|mesh-list
2511297|NCT01276613|Losartan|losartan|mesh-list
2511298|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2511299|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
2389744|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
2389745|NCT00662844|Vitamins|vitamins|mesh-ancestor
2389746|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
2389747|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389748|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2389749|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2389750|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
2511300|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511301|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511302|NCT01276613|Antiviral Agents|antiviral agents|mesh-ancestor
2511303|NCT01276613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511304|NCT01276613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389751|NCT00662883|Ketamine|ketamine|mesh-list
2511305|NCT01276613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2511306|NCT01276613|Immunologic Factors|immunologic factors|mesh-ancestor
2511307|NCT01276613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511308|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2511309|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2511310|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2389752|NCT00662883|Analgesics|analgesics|mesh-ancestor
2389753|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
2389754|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389755|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389756|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2389757|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2389758|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
2389759|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
2389760|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2389761|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2389762|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2511311|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2511312|NCT01276691|Aspirin|aspirin|mesh-list
2511313|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2511314|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2511315|NCT01276691|Analgesics|analgesics|mesh-ancestor
2511316|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
2511317|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511318|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511319|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2511320|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2511321|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2511322|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2511323|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511324|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2511325|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2511326|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511327|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
2511328|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
2511329|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
2511330|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2511331|NCT01276704|Estrogens|estrogens|mesh-ancestor
2511332|NCT01276704|Hormones|hormones|mesh-ancestor
2511333|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511334|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511335|NCT01276717|Vorinostat|vorinostat|mesh-list
2389763|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389764|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389765|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2389766|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
2389767|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2389768|NCT00662896|Ibuprofen|ibuprofen|mesh-list
2389769|NCT00662896|Naproxen|naproxen|mesh-list
2389770|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
2389771|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2389772|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2511336|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511337|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2511338|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511339|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511340|NCT01276730|Interferons|interferons|mesh-list
2511341|NCT01276730|Tretinoin|tretinoin|mesh-list
2511342|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511343|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
2511344|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511345|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
2511346|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
2511347|NCT01276769|Paclitaxel|paclitaxel|mesh-list
2511348|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2511349|NCT01276769|Carboplatin|carboplatin|mesh-list
2511350|NCT01276769|Epirubicin|epirubicin|mesh-list
2511351|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2511352|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511353|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
2511354|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
2511355|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
2511356|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389773|NCT00662896|Analgesics|analgesics|mesh-ancestor
2511357|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2389774|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
2511358|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2511359|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2511360|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511361|NCT01276834|Everolimus|everolimus|mesh-list
2511362|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511363|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2511364|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
2511365|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511366|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2511367|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511368|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
2511369|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2511370|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511371|NCT01276925|Bupivacaine|bupivacaine|mesh-list
2511372|NCT01276925|Ropivacaine|ropivacaine|mesh-list
2511373|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
2511374|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
2511375|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511376|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511377|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
2511378|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511379|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
2511380|NCT01276977|Eletriptan|eletriptan|mesh-list
2511381|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2511382|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2511383|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
2511384|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511385|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511386|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511387|NCT01277016|Melphalan|melphalan|mesh-list
2511388|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2511389|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
2511390|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511391|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511392|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2511393|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2511394|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
2511395|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511396|NCT01277107|Zaleplon|zaleplon|mesh-list
2511397|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
2511398|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2511399|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511400|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511401|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
2511402|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
2511403|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511404|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511405|NCT01277172|Rituximab|rituximab|mesh-list
2511406|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2511407|NCT01277172|Antibodies|antibodies|mesh-list
2511408|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
2511409|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2511410|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
2511411|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511412|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511413|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2511414|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
2511415|NCT01277185|Calcium|calcium|mesh-list
2511416|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2511417|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511418|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2511419|NCT01277289|Dexamethasone|dexamethasone|mesh-list
2511420|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2511421|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
2511422|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
2511423|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511424|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511425|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2511426|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
2511427|NCT01277289|Hormones|hormones|mesh-ancestor
2511428|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511429|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2511430|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511431|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2389775|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389776|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389777|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2389778|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2389779|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2389780|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389781|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389782|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
2389783|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2389784|NCT00662948|Rituximab|rituximab|mesh-list
2389785|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2389786|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389787|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
2511432|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2511433|NCT01277484|Decitabine|decitabine|mesh-list
2511434|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2511435|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
2511436|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511437|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511438|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511439|NCT01277497|Calcium|calcium|mesh-list
2511440|NCT01277497|Sevelamer|sevelamer|mesh-list
2389788|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389789|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2389790|NCT00662987|Amoxicillin|amoxicillin|mesh-list
2389791|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2389792|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511441|NCT01277497|Calcium acetate|calcium acetate|mesh-list
2511442|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2511443|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511444|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
2511445|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
2511446|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389793|NCT00663052|Etanercept|etanercept|mesh-list
2389794|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2389795|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2389796|NCT00663052|Analgesics|analgesics|mesh-ancestor
2389797|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
2389798|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389799|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511447|NCT01277627|Efavirenz|efavirenz|mesh-list
2511448|NCT01277627|Nevirapine|nevirapine|mesh-list
2511449|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2511450|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
2511451|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2511452|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2389800|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2389801|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2389802|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2389803|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2389804|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
2389805|NCT00663130|Tadalafil|tadalafil|mesh-list
2389806|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2389807|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
2389808|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2389809|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2389810|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389811|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389812|NCT00663130|Urological Agents|urological agents|mesh-ancestor
2389813|NCT00663182|Entecavir|entecavir|mesh-list
2389814|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
2389815|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389816|NCT00663195|Furosemide|furosemide|mesh-list
2389817|NCT00663195|Spironolactone|spironolactone|mesh-list
2389818|NCT00663195|Diuretics|diuretics|mesh-ancestor
2389819|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
2389820|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389821|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2389822|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2389823|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389824|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2389825|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
2389826|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2389827|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2389828|NCT00663221|Vitamin D|vitamin d|mesh-list
2389829|NCT00663221|Calcium|calcium|mesh-list
2389830|NCT00663221|Vitamins|vitamins|mesh-ancestor
2389831|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
2389832|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389833|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2389834|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2389835|NCT00663247|Mesalamine|mesalamine|mesh-list
2389836|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2389837|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2389838|NCT00663247|Analgesics|analgesics|mesh-ancestor
2389839|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
2511453|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511454|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511455|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
2511456|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511457|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2511458|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2511459|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2511460|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2511461|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2511462|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2511463|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2511464|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2511465|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2511466|NCT01277640|Dapivirine|dapivirine|mesh-list
2511467|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2511468|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2511469|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
2511470|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511471|NCT01277705|Vaccines|vaccines|mesh-list
2511472|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
2511473|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511474|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
2511475|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2511476|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2511477|NCT01277731|Prednisolone|prednisolone|mesh-list
2389840|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389841|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389842|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2389843|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2389844|NCT00663286|Clindamycin|clindamycin|mesh-list
2389845|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
2389846|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
2389847|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2389848|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2389849|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389850|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2389851|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389852|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389853|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
2389854|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2389855|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511478|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
2511479|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2511480|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
2511481|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2511482|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
2511483|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
2511484|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511485|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511486|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2511487|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
2511488|NCT01277731|Hormones|hormones|mesh-ancestor
2511489|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511490|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2511491|NCT01277731|Protective Agents|protective agents|mesh-ancestor
2511492|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2511493|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511494|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
2511495|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2511496|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
2511497|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511498|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2511499|NCT01277835|Lidocaine|lidocaine|mesh-list
2511500|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
2389856|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389857|NCT00663338|Rotigotine|rotigotine|mesh-list
2389858|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
2389859|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
2389860|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389861|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511501|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
2511502|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511503|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511504|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
2511505|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511506|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2511507|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2511508|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2511509|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2511510|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511511|NCT01277913|Vitamin D|vitamin d|mesh-list
2511512|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
2511513|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
2511514|NCT01277913|Vitamins|vitamins|mesh-list
2511515|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
2511516|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511517|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2511518|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2511519|NCT01278004|Ethosuximide|ethosuximide|mesh-list
2511520|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
2511521|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
2511522|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2511523|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511524|NCT01278056|Deferasirox|deferasirox|mesh-list
2511525|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2511526|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
2511527|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
2511528|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511529|NCT01278082|Budesonide|budesonide|mesh-list
2511530|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2511531|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2511532|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
2389862|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389863|NCT00663377|Losartan|losartan|mesh-list
2389864|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2389865|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2389866|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2389867|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2389868|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511533|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511534|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511535|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2511536|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
2511537|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
2511538|NCT01278082|Hormones|hormones|mesh-ancestor
2511539|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511540|NCT01278134|Ritonavir|ritonavir|mesh-list
2511541|NCT01278134|Ribavirin|ribavirin|mesh-list
2511542|NCT01278134|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2511543|NCT01278134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2511544|NCT01278134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2511545|NCT01278134|Protease Inhibitors|protease inhibitors|mesh-ancestor
2511546|NCT01278134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389869|NCT00663442|Methylphenidate|methylphenidate|mesh-list
2389870|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2389871|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389872|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2389873|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2389874|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2389875|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389876|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
2389877|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389878|NCT00663455|Cyclosporine|cyclosporine|mesh-list
2389879|NCT00663455|Cyclosporins|cyclosporins|mesh-list
2389880|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389881|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389882|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2389883|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
2511547|NCT01278134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511548|NCT01278134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2511549|NCT01278134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2511550|NCT01278134|Antiviral Agents|antiviral agents|mesh-ancestor
2511551|NCT01278134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511552|NCT01278134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2511553|NCT01278134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2511554|NCT01278134|Antimetabolites|antimetabolites|mesh-ancestor
2389884|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389885|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
2389886|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389887|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
2389888|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2511555|NCT01278186|Paclitaxel|paclitaxel|mesh-list
2511556|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2511557|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511558|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
2511559|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
2511560|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
2511561|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511562|NCT01278238|Phenylephrine|phenylephrine|mesh-list
2511563|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
2511564|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2511565|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
2511566|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
2511567|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511568|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511569|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
2511570|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2389889|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2389890|NCT00663481|Leucovorin|leucovorin|mesh-list
2389891|NCT00663481|Antidotes|antidotes|mesh-ancestor
2389892|NCT00663481|Protective Agents|protective agents|mesh-ancestor
2389893|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389894|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
2389895|NCT00663481|Vitamins|vitamins|mesh-ancestor
2389896|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
2389897|NCT00663559|Sunitinib|sunitinib|mesh-list
2389898|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389899|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2389900|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2389901|NCT00663559|Growth Substances|growth substances|mesh-ancestor
2389902|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389903|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
2389904|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2389905|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389906|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389907|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2389908|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
2389909|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2389910|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2511571|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
2511572|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
2511573|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2511574|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2511575|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2511576|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
2511577|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511578|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511579|NCT01278238|Protective Agents|protective agents|mesh-ancestor
2511580|NCT01278264|Ropivacaine|ropivacaine|mesh-list
2511581|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
2511582|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
2511583|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511584|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511585|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
2511586|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511587|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2389911|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389912|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389913|NCT00663598|Urological Agents|urological agents|mesh-ancestor
2389914|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
2389915|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2389916|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389917|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2511588|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2389918|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389919|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2389920|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389921|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389922|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2389923|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
2389924|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2389925|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2389926|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389927|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389928|NCT00663728|Urological Agents|urological agents|mesh-ancestor
2389929|NCT00663741|Sorafenib|sorafenib|mesh-list
2389930|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389931|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2511589|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
2511590|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2511591|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
2511592|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2511593|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511594|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2511595|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2511596|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511597|NCT01278290|Hormones|hormones|mesh-ancestor
2511598|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511599|NCT01278446|Caseins|caseins|mesh-list
2511600|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
2511601|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
2511602|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511603|NCT01278459|Atorvastatin|atorvastatin|mesh-list
2511604|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2511605|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2511606|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
2511607|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511608|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2511609|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2511610|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511611|NCT01278498|Citalopram|citalopram|mesh-list
2511612|NCT01278498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2511613|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2511614|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2511615|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511616|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511617|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
2511618|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511619|NCT01278498|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2511620|NCT01278498|Antidepressive Agents|antidepressive agents|mesh-ancestor
2511621|NCT01278498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2511622|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
2511623|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2511624|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2511625|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2511626|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2511627|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511628|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
2511629|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511630|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389932|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389933|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389934|NCT00663767|Celecoxib|celecoxib|mesh-list
2389935|NCT00663767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
2389936|NCT00663767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2389937|NCT00663767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2389938|NCT00663767|Analgesics|analgesics|mesh-ancestor
2389939|NCT00663767|Sensory System Agents|sensory system agents|mesh-ancestor
2389940|NCT00663767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2389941|NCT00663767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389942|NCT00663767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2389943|NCT00663767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2389944|NCT00663767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2389945|NCT00663767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511631|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2511632|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511633|NCT01278602|Rituximab|rituximab|mesh-list
2511634|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2511635|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511636|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
2511637|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511638|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2511639|NCT01278758|Vadimezan|vadimezan|mesh-list
2511640|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511641|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
2389946|NCT00663767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389947|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
2389948|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2389949|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2389950|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2389951|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2389952|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389953|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389954|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2389955|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2389956|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2389957|NCT00663832|Panobinostat|panobinostat|mesh-list
2389958|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511642|NCT01278784|Chitosan|chitosan|mesh-list
2511643|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2511644|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2511645|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2511646|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
2511647|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511648|NCT01278784|Expectorants|expectorants|mesh-ancestor
2511649|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
2511650|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2511651|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
2511652|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511653|NCT01278784|Protective Agents|protective agents|mesh-ancestor
2511654|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511655|NCT01278784|Antidotes|antidotes|mesh-ancestor
2511656|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2511657|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2511658|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
2511659|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2511660|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
2511661|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
2511662|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
2511663|NCT01278784|Coagulants|coagulants|mesh-ancestor
2511664|NCT01278849|Vadimezan|vadimezan|mesh-list
2511665|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511666|NCT01279083|Timolol|timolol|mesh-list
2389959|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2389960|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389961|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389962|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2389963|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
2389964|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2389965|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2389966|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389967|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389968|NCT00663845|Urological Agents|urological agents|mesh-ancestor
2389969|NCT00663884|Voglibose|voglibose|mesh-list
2389970|NCT00663884|Mitiglinide|mitiglinide|mesh-list
2389971|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2389972|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389973|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2389974|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389975|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389976|NCT00663897|Lansoprazole|lansoprazole|mesh-list
2389977|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
2511667|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2511668|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2511669|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2511670|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
2511671|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511672|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511673|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511674|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2511675|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2511676|NCT01279096|Dexamethasone|dexamethasone|mesh-list
2511677|NCT01279096|Etoposide|etoposide|mesh-list
2511678|NCT01279096|Asparaginase|asparaginase|mesh-list
2511679|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
2511680|NCT01279096|Clofarabine|clofarabine|mesh-list
2511681|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2511682|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
2511683|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
2511684|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511685|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511686|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2511687|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
2511688|NCT01279096|Hormones|hormones|mesh-ancestor
2511689|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511690|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2511691|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511692|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511693|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511694|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2511695|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2511696|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2389978|NCT00663897|Mosapride|mosapride|mesh-list
2389979|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2389980|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2389981|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2389982|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389983|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389984|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2389985|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
2389986|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2389987|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2389988|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2511697|NCT01279096|Analgesics|analgesics|mesh-ancestor
2511698|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
2511699|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2511700|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
2511701|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2511702|NCT01279213|Clozapine|clozapine|mesh-list
2511703|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2511704|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2511705|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511706|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511707|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2511708|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2511709|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2511710|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
2511711|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511712|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511713|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2511714|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2511715|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
2511716|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
2511717|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
2511718|NCT01279252|Metronidazole|metronidazole|mesh-list
2511719|NCT01279252|Clarithromycin|clarithromycin|mesh-list
2389989|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2389990|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
2389991|NCT00663949|Captopril|captopril|mesh-list
2511720|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
2511721|NCT01279252|Lansoprazole|lansoprazole|mesh-list
2511722|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
2511723|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511724|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2511725|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2511726|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2511727|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2511728|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511729|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511730|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2511731|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2511732|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2511733|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2389992|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
2389993|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2511734|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668484|NCT02142595|Analgesics|analgesics|mesh-ancestor
2511735|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2511736|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2511737|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2511738|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2511739|NCT01279291|Gemcitabine|gemcitabine|mesh-list
2511740|NCT01279291|Paclitaxel|paclitaxel|mesh-list
2511741|NCT01279291|Carboplatin|carboplatin|mesh-list
2511742|NCT01279291|Doxorubicin|doxorubicin|mesh-list
2511743|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2511744|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2511745|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511746|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
2511747|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
2511748|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
2511749|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511750|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2511751|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
2511752|NCT01279291|Antiviral Agents|antiviral agents|mesh-ancestor
2511753|NCT01279291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511754|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511755|NCT01279291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2389994|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2389995|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2389996|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2389997|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2389998|NCT00663949|Protective Agents|protective agents|mesh-ancestor
2389999|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390000|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
2390001|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2390002|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
2390003|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2390004|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
2390005|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2390006|NCT00664001|Antioxidants|antioxidants|mesh-list
2390007|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390008|NCT00664001|Protective Agents|protective agents|mesh-ancestor
2390009|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390010|NCT00664014|Tolvaptan|tolvaptan|mesh-list
2390011|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2390012|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390013|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
2390014|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390015|NCT00664040|Aspirin|aspirin|mesh-list
2390016|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2390017|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2390018|NCT00664040|Analgesics|analgesics|mesh-ancestor
2390019|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
2390020|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390021|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390022|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2390023|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390024|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2390025|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2390026|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390027|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2390028|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2390029|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390030|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
2390031|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2390032|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2390033|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
2390034|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390035|NCT00664144|Rasburicase|rasburicase|mesh-list
2390036|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
2390037|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390038|NCT00664170|Docetaxel|docetaxel|mesh-list
2390039|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390040|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
2390041|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
2390042|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
2390043|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390044|NCT00664196|Hormones|hormones|mesh-list
2390045|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511756|NCT01279291|Immunologic Factors|immunologic factors|mesh-ancestor
2390046|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390047|NCT00664222|Furosemide|furosemide|mesh-list
2390048|NCT00664222|Spironolactone|spironolactone|mesh-list
2511757|NCT01279291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511758|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2511759|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2511760|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2511761|NCT01279434|Vitamins|vitamins|mesh-list
2511762|NCT01279434|Vitamin E|vitamin e|mesh-list
2511763|NCT01279434|Tocopherols|tocopherols|mesh-list
2511764|NCT01279434|Tocotrienols|tocotrienols|mesh-list
2511765|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
2390049|NCT00664222|Diuretics|diuretics|mesh-ancestor
2390050|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
2390051|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390052|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2390053|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2390054|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390055|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2390056|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
2390057|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2390058|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2390059|NCT00664248|Clindamycin|clindamycin|mesh-list
2390060|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
2390061|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
2390062|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2390063|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2390064|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390065|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2390066|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390067|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390068|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
2390069|NCT00664287|Niacin|niacin|mesh-list
2390070|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2390071|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
2390072|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390073|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2390074|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
2390075|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
2390076|NCT00664287|Vitamins|vitamins|mesh-ancestor
2390077|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
2390078|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390079|NCT00664313|Linezolid|linezolid|mesh-list
2390080|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2390081|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390082|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2390083|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390084|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390085|NCT00664417|Vaccines|vaccines|mesh-list
2390086|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
2390087|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390088|NCT00664469|Atorvastatin|atorvastatin|mesh-list
2390089|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2390090|NCT00664469|Simvastatin|simvastatin|mesh-list
2390091|NCT00664469|Ezetimibe|ezetimibe|mesh-list
2390092|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2390093|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2390094|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
2390095|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390096|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2390097|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2390098|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390099|NCT00664586|Masoprocol|masoprocol|mesh-list
2390100|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
2390101|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390102|NCT00664586|Protective Agents|protective agents|mesh-ancestor
2390103|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511766|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
2511767|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511768|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
2511769|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511770|NCT01279434|Protective Agents|protective agents|mesh-ancestor
2511771|NCT01279499|Remifentanil|remifentanil|mesh-list
2511772|NCT01279499|Propofol|propofol|mesh-list
2511773|NCT01279499|Sevoflurane|sevoflurane|mesh-list
2511774|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2390104|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2390105|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390106|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2390107|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2390108|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2390109|NCT00664586|Analgesics|analgesics|mesh-ancestor
2390110|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
2390111|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390112|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2511775|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511776|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511777|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2511778|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
2511779|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
2511780|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2511781|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2511782|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2511783|NCT01279499|Narcotics|narcotics|mesh-ancestor
2511784|NCT01279499|Analgesics|analgesics|mesh-ancestor
2511785|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
2511786|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511787|NCT01279512|Metformin|metformin|mesh-list
2511788|NCT01279512|Acarbose|acarbose|mesh-list
2511789|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2511790|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511791|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2511792|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511793|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511794|NCT01279551|Lidocaine|lidocaine|mesh-list
2511795|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
2511796|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
2511797|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
2390113|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390114|NCT00664599|Rituximab|rituximab|mesh-list
2390115|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2390116|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390117|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
2390118|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390119|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390120|NCT00664677|Masoprocol|masoprocol|mesh-list
2390121|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
2390122|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390123|NCT00664677|Protective Agents|protective agents|mesh-ancestor
2390124|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390125|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2390126|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390127|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2511798|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511799|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511800|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
2511801|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511802|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2511803|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2511804|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2511805|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2511806|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511807|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
2511808|NCT01279590|Atorvastatin|atorvastatin|mesh-list
2511809|NCT01279590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2511810|NCT01279590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2511811|NCT01279590|Antimetabolites|antimetabolites|mesh-ancestor
2511812|NCT01279590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511813|NCT01279590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2511814|NCT01279590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2511815|NCT01279590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511816|NCT01279629|Tazarotene|tazarotene|mesh-list
2511817|NCT01279629|Calcipotriene|calcipotriene|mesh-list
2390128|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2390129|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2390130|NCT00664677|Analgesics|analgesics|mesh-ancestor
2390131|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
2390132|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390133|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2390134|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390135|NCT00664690|Celecoxib|celecoxib|mesh-list
2390136|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2390137|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2390138|NCT00664690|Analgesics|analgesics|mesh-ancestor
2390139|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
2390140|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390141|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390142|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2390143|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390144|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2390145|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2390146|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390147|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390148|NCT00664703|Methylphenidate|methylphenidate|mesh-list
2390149|NCT00664703|Lobeline|lobeline|mesh-list
2390150|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2511818|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
2511819|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
2511820|NCT01279668|Montelukast|montelukast|mesh-list
2511821|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2511822|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
2511823|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2511824|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
2511825|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511826|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511827|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2511828|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2511829|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511830|NCT01279694|Prednisone|prednisone|mesh-list
2511831|NCT01279694|Melphalan|melphalan|mesh-list
2511832|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2511833|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
2511834|NCT01279694|Hormones|hormones|mesh-ancestor
2511835|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511836|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511837|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2511838|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511839|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2511840|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
2511841|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511842|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2511843|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2511844|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
2511845|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2511846|NCT01279707|Epratuzumab|epratuzumab|mesh-list
2511847|NCT01279707|Veltuzumab|veltuzumab|mesh-list
2511848|NCT01279707|Antibodies|antibodies|mesh-list
2511849|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
2511850|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2511851|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
2511852|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511853|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511854|NCT01279811|Dopamine|dopamine|mesh-list
2511855|NCT01279811|Norepinephrine|norepinephrine|mesh-list
2511856|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2511857|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2511858|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2511859|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
2511860|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511861|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511862|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511863|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
2511864|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
2511865|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511866|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2511867|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
2511868|NCT01279811|Protective Agents|protective agents|mesh-ancestor
2511869|NCT01279876|Melatonin|melatonin|mesh-list
2511870|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
2511871|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511872|NCT01279876|Protective Agents|protective agents|mesh-ancestor
2511873|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511874|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511875|NCT01279902|Rituximab|rituximab|mesh-list
2511876|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2511877|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511878|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
2511879|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511880|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2511881|NCT01279915|Linaclotide|linaclotide|mesh-list
2511882|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2511883|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
2511884|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511885|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2511886|NCT01279980|Anesthetics|anesthetics|mesh-list
2511887|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
2511888|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511889|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511890|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
2511891|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511892|NCT01280006|Celecoxib|celecoxib|mesh-list
2511893|NCT01280006|Indomethacin|indomethacin|mesh-list
2511894|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2511895|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2511896|NCT01280006|Analgesics|analgesics|mesh-ancestor
2511897|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
2511898|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511899|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390151|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390152|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2390153|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2390154|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2390155|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390156|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
2390157|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390158|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2390159|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
2390160|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390161|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2511900|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2511901|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2511902|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2511903|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2511904|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511905|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511906|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
2511907|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
2511908|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2511909|NCT01280071|Aminophylline|aminophylline|mesh-list
2511910|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2511911|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
2511912|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511913|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511914|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2511915|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
2511916|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2511917|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2511918|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2511919|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511920|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2511921|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2511922|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
2511923|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390162|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2390163|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
2390164|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
2390165|NCT00664781|Rucaparib|rucaparib|mesh-list
2390166|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2390167|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390168|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390169|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390170|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2390171|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
2390172|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2390173|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2390174|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390175|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511924|NCT01280071|Protective Agents|protective agents|mesh-ancestor
2511925|NCT01280149|Substance P|substance p|mesh-list
2511926|NCT01280149|Neurokinin A|neurokinin a|mesh-list
2511927|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2511928|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511929|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511930|NCT01280162|Piperaquine|piperaquine|mesh-list
2511931|NCT01280162|Artenimol|artenimol|mesh-list
2390176|NCT00664833|Urological Agents|urological agents|mesh-ancestor
2390177|NCT00664846|Aspirin|aspirin|mesh-list
2390178|NCT00664846|Clopidogrel|clopidogrel|mesh-list
2390179|NCT00664846|Atorvastatin|atorvastatin|mesh-list
2390180|NCT00664846|Simvastatin|simvastatin|mesh-list
2511932|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
2511933|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2511934|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2511935|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511936|NCT01280175|Charcoal|charcoal|mesh-list
2511937|NCT01280175|Antidotes|antidotes|mesh-ancestor
2511938|NCT01280175|Protective Agents|protective agents|mesh-ancestor
2511939|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511940|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2511941|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
2511942|NCT01280188|Coagulants|coagulants|mesh-ancestor
2511943|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2511944|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
2511945|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511946|NCT01280214|Triamcinolone|triamcinolone|mesh-list
2390181|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2390182|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2390183|NCT00664846|Analgesics|analgesics|mesh-ancestor
2390184|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
2390185|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390186|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511947|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2511948|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
2511949|NCT01280214|Hormones|hormones|mesh-ancestor
2511950|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511951|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511952|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2511953|NCT01280240|Hematinics|hematinics|mesh-ancestor
2511954|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2511955|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2511956|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
2511957|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2511958|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511959|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2511960|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2511961|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2511962|NCT01280331|Morphine|morphine|mesh-list
2511963|NCT01280331|Oxycodone|oxycodone|mesh-list
2511964|NCT01280331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2511965|NCT01280331|Narcotics|narcotics|mesh-ancestor
2511966|NCT01280331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2511967|NCT01280331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511968|NCT01280331|Analgesics|analgesics|mesh-ancestor
2511969|NCT01280331|Sensory System Agents|sensory system agents|mesh-ancestor
2511970|NCT01280331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2511971|NCT01280526|Romidepsin|romidepsin|mesh-list
2511972|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2511973|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511974|NCT01280565|Dacarbazine|dacarbazine|mesh-list
2511975|NCT01280565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2511976|NCT01280565|Alkylating Agents|alkylating agents|mesh-ancestor
2511977|NCT01280565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511978|NCT01280565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511979|NCT01280669|Sirolimus|sirolimus|mesh-list
2511980|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2511981|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2511982|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2511983|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511984|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
2511985|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2511986|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
2511987|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390187|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2390188|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2511988|NCT01280682|Rituximab|rituximab|mesh-list
2511989|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2511990|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2511991|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
2511992|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511993|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2511994|NCT01280734|Melatonin|melatonin|mesh-list
2511995|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
2511996|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2511997|NCT01280734|Protective Agents|protective agents|mesh-ancestor
2511998|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2511999|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2512000|NCT01280929|Ranibizumab|ranibizumab|mesh-list
2512001|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2512002|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2390189|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2390190|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2390191|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390192|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2390193|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2390194|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390195|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
2390196|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2390197|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2390198|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
2390199|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2390200|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2390201|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2390202|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2390203|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2390204|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
2390205|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512003|NCT01280929|Growth Substances|growth substances|mesh-ancestor
2512004|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512005|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
2512006|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512007|NCT01280994|Xenon|xenon|mesh-list
2512008|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2512009|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
2512010|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
2512011|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2512012|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512013|NCT01281111|Aspirin|aspirin|mesh-list
2512014|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2512015|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2512016|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2512017|NCT01281111|Analgesics|analgesics|mesh-ancestor
2512018|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
2512019|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2512020|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512021|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2512022|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2512023|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2390206|NCT00664898|Bortezomib|bortezomib|mesh-list
2390207|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390208|NCT00664937|Montelukast|montelukast|mesh-list
2390209|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2390210|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
2390211|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2390212|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
2390213|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2390214|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390215|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2390216|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2390217|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512024|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2512025|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512026|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2512027|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2512028|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512029|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
2512030|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
2512031|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512032|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
2512033|NCT01281150|Paclitaxel|paclitaxel|mesh-list
2512034|NCT01281150|Carboplatin|carboplatin|mesh-list
2390218|NCT00664963|Sirolimus|sirolimus|mesh-list
2390219|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2390220|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390221|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2390222|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390223|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
2390224|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2390225|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
2390226|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390227|NCT00665041|Quinagolide|quinagolide|mesh-list
2390228|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
2390229|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
2390230|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390231|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390232|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512035|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2512036|NCT01281150|Veliparib|veliparib|mesh-list
2512037|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2512038|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512039|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
2512040|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
2512041|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
2512042|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512043|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2512044|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512045|NCT01281163|Lapatinib|lapatinib|mesh-list
2512046|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390233|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2390234|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
2390235|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2390236|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2512047|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2512048|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512049|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390237|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390238|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512062|NCT01281228|Exenatide|exenatide|mesh-list
2512063|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2390239|NCT00665054|Urological Agents|urological agents|mesh-ancestor
2390240|NCT00665093|Insulin|insulin|mesh-list
2390241|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2390242|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
2390243|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
2390244|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
2390245|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2390246|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2390247|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390248|NCT00665119|Remifentanil|remifentanil|mesh-list
2390249|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2390250|NCT00665119|Narcotics|narcotics|mesh-ancestor
2390251|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2390252|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390253|NCT00665119|Analgesics|analgesics|mesh-ancestor
2390254|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
2390255|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390256|NCT00665314|Plerixafor|plerixafor|mesh-list
2390257|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2390258|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2390259|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
2390260|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390261|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
2512064|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512065|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2512066|NCT01281228|Incretins|incretins|mesh-ancestor
2512067|NCT01281228|Hormones|hormones|mesh-ancestor
2512068|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2512069|NCT01281254|Trebananib|trebananib|mesh-list
2512070|NCT01281254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2512071|NCT01281254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2512072|NCT01281254|Growth Substances|growth substances|mesh-ancestor
2512073|NCT01281254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512074|NCT01281254|Growth Inhibitors|growth inhibitors|mesh-ancestor
2512075|NCT01281254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512076|NCT01281462|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2512077|NCT01281462|Cephalosporins|cephalosporins|mesh-list
2512078|NCT01281462|Doripenem|doripenem|mesh-list
2512079|NCT01281462|Avibactam|avibactam|mesh-list
2512080|NCT01281462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2512081|NCT01281462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512082|NCT01281462|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2512083|NCT01281462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512084|NCT01281462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512085|NCT01281514|Carboplatin|carboplatin|mesh-list
2512086|NCT01281514|Doxorubicin|doxorubicin|mesh-list
2512087|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2512088|NCT01281514|Everolimus|everolimus|mesh-list
2512089|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512090|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2512091|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2390262|NCT00665327|Levofloxacin|levofloxacin|mesh-list
2390263|NCT00665327|Ofloxacin|ofloxacin|mesh-list
2390264|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2390265|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2390266|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390267|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2390268|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2390269|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390270|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390271|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390272|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2512092|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2512093|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512094|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512095|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512096|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
2512097|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512098|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2512099|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2512100|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2512101|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2512102|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512103|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2390273|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
2390274|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2390275|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390276|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2390277|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2390278|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2390279|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2390280|NCT00665327|Renal Agents|renal agents|mesh-ancestor
2390281|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2390282|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2390283|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2512104|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2512105|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2512106|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
2512107|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512108|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512109|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2512110|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2512111|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
2512112|NCT01281540|Cisapride|cisapride|mesh-list
2512113|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2512114|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2512115|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2512116|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
2512117|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512118|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512119|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512120|NCT01281553|Cisapride|cisapride|mesh-list
2390284|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
2390285|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2390286|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2390287|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390288|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390289|NCT00665340|Urological Agents|urological agents|mesh-ancestor
2390290|NCT00665418|Sevoflurane|sevoflurane|mesh-list
2512121|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2512122|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2512123|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2512124|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
2512125|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512126|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512127|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512128|NCT01281566|Cisapride|cisapride|mesh-list
2512129|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2512130|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2512131|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2512132|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
2390291|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2390292|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2390293|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
2390294|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
2512133|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512134|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512135|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512136|NCT01281579|Canagliflozin|canagliflozin|mesh-list
2512137|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2512138|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512139|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2512140|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512141|NCT01281605|Insulin|insulin|mesh-list
2512142|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2512143|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
2512144|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2512145|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512146|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2512147|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2512148|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512149|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512150|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
2512151|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512152|NCT01281696|Bevacizumab|bevacizumab|mesh-list
2512153|NCT01281696|Methotrexate|methotrexate|mesh-list
2512154|NCT01281696|Etoposide|etoposide|mesh-list
2512155|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2512156|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512157|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2512158|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2512159|NCT01281696|Growth Substances|growth substances|mesh-ancestor
2512160|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512161|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
2512162|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2512163|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
2512164|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2512165|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2512166|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
2512167|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512168|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
2512169|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512170|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2512171|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512172|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
2512173|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2512174|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2512175|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2512176|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2512177|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2512178|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
2512179|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2512180|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2512181|NCT01281748|Prednisolone|prednisolone|mesh-list
2512182|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
2512183|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2512184|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
2512185|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2512186|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
2512187|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
2512188|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2512189|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512190|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2512191|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
2512192|NCT01281748|Hormones|hormones|mesh-ancestor
2512193|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2512194|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2512195|NCT01281748|Protective Agents|protective agents|mesh-ancestor
2512196|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2512197|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512198|NCT01281761|Irinotecan|irinotecan|mesh-list
2512199|NCT01281761|Cetuximab|cetuximab|mesh-list
2512200|NCT01281761|Simvastatin|simvastatin|mesh-list
2512201|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2512202|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2512203|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512204|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512205|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512206|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2512207|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2512208|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2512209|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
2512210|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2512211|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2512212|NCT01281787|Losartan|losartan|mesh-list
2512213|NCT01281787|Metoprolol|metoprolol|mesh-list
2512214|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2512215|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2390295|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2390296|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390297|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2512216|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2512217|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2512218|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512219|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
2512220|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
2512221|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2512222|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512223|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2512224|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2512225|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2512226|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
2512227|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512228|NCT01281800|Gemcitabine|gemcitabine|mesh-list
2512229|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2512230|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
2512231|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512232|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512233|NCT01281800|Antiviral Agents|antiviral agents|mesh-ancestor
2512234|NCT01281800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512235|NCT01281800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512236|NCT01281800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512237|NCT01281800|Immunologic Factors|immunologic factors|mesh-ancestor
2512238|NCT01281800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512239|NCT01281813|Ritonavir|ritonavir|mesh-list
2512240|NCT01281813|Darunavir|darunavir|mesh-list
2390298|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
2390299|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2390300|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2390301|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390302|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390303|NCT00665496|Urological Agents|urological agents|mesh-ancestor
2390304|NCT00665522|Fentanyl|fentanyl|mesh-list
2390305|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2512241|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2512242|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2512243|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
2512244|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512245|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512246|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2512247|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2512248|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
2512249|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512250|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2512251|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2512252|NCT01281852|Paclitaxel|paclitaxel|mesh-list
2512253|NCT01281852|Cisplatin|cisplatin|mesh-list
2512254|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2512255|NCT01281852|Veliparib|veliparib|mesh-list
2512256|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2512257|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512258|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
2390306|NCT00665522|Narcotics|narcotics|mesh-ancestor
2390307|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2390308|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390309|NCT00665522|Analgesics|analgesics|mesh-ancestor
2390310|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
2390311|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390312|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2390313|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2390314|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
2390315|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
2390316|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2390317|NCT00665600|Albuterol|albuterol|mesh-list
2390318|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2512259|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
2512260|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
2512261|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512262|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2512263|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512264|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
2512265|NCT01281878|Pyridoxal|pyridoxal|mesh-list
2512266|NCT01281878|Pyridoxine|pyridoxine|mesh-list
2512267|NCT01281878|Vitamins|vitamins|mesh-ancestor
2512268|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
2512269|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512270|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
2512271|NCT01281891|Morphine|morphine|mesh-list
2512272|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2512273|NCT01281891|Narcotics|narcotics|mesh-ancestor
2512274|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2512275|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512276|NCT01281891|Analgesics|analgesics|mesh-ancestor
2512277|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
2512278|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2512279|NCT01281943|Sirolimus|sirolimus|mesh-list
2512280|NCT01281943|Doxorubicin|doxorubicin|mesh-list
2512281|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2512282|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2512283|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512284|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2512285|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2512286|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512287|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512288|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2512289|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512290|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
2512291|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512292|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
2512293|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512294|NCT01282047|Lenalidomide|lenalidomide|mesh-list
2512295|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
2512296|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512297|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2512298|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2512299|NCT01282047|Growth Substances|growth substances|mesh-ancestor
2512300|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
2512301|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512302|NCT01282073|Cyclosporine|cyclosporine|mesh-list
2512303|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
2512304|NCT01282073|Cyclosporins|cyclosporins|mesh-list
2390319|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
2512305|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512306|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512307|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512308|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
2512309|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512310|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
2512311|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512312|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
2512313|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2512314|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2512315|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2512316|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512317|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2512318|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
2512319|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2512320|NCT01282151|Cisplatin|cisplatin|mesh-list
2512321|NCT01282151|Pemetrexed|pemetrexed|mesh-list
2512322|NCT01282151|Docetaxel|docetaxel|mesh-list
2512323|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512324|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512325|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512326|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2512327|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2512328|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
2512329|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
2512330|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
2512331|NCT01282333|Gemcitabine|gemcitabine|mesh-list
2512332|NCT01282333|Veliparib|veliparib|mesh-list
2390320|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390321|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390322|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2390323|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
2390324|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
2390325|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2390326|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2390327|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2390328|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2512333|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512334|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2512335|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
2512336|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512337|NCT01282333|Antiviral Agents|antiviral agents|mesh-ancestor
2512338|NCT01282333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512339|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512340|NCT01282333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512341|NCT01282333|Immunologic Factors|immunologic factors|mesh-ancestor
2512342|NCT01282333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512343|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2512344|NCT01282385|Simvastatin|simvastatin|mesh-list
2512345|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2512346|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2512347|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
2512348|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512349|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2512350|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2512351|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512352|NCT01282398|Simvastatin|simvastatin|mesh-list
2512353|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2512354|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2512355|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
2512356|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512357|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2512358|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2512359|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512360|NCT01282502|Midostaurin|midostaurin|mesh-list
2512361|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512362|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2512363|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512364|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512365|NCT01282515|Clobetasol|clobetasol|mesh-list
2512366|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2512367|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
2512368|NCT01282515|Hormones|hormones|mesh-ancestor
2512369|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2512370|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512371|NCT01282528|Infliximab|infliximab|mesh-list
2512372|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
2512373|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2512374|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2512375|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
2512376|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2512377|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2512378|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2390329|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
2390330|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390331|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390332|NCT00665639|Caspofungin|caspofungin|mesh-list
2390333|NCT00665639|Micafungin|micafungin|mesh-list
2390334|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
2390335|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390336|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390337|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390338|NCT00665678|Paroxetine|paroxetine|mesh-list
2390339|NCT00665678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2390340|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2512379|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2512380|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512381|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
2512382|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512383|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512384|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2512385|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2512386|NCT01282619|Huperzine A|huperzine a|mesh-list
2512387|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2512388|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512389|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512390|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
2390341|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2390342|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390343|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390344|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
2390345|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390346|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2390347|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
2390348|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2390349|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2390350|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2390351|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390352|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
2390353|NCT00665717|Pravastatin|pravastatin|mesh-list
2390354|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2390355|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2390356|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
2390357|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390358|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2390359|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2390360|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390361|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390362|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2390363|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2390364|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
2390365|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2390366|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2390367|NCT00665743|Naproxen|naproxen|mesh-list
2390368|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2390369|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2512391|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512392|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512393|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2512394|NCT01282619|Protective Agents|protective agents|mesh-ancestor
2512395|NCT01282632|Olanzapine|olanzapine|mesh-list
2512396|NCT01282632|Risperidone|risperidone|mesh-list
2512397|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2390370|NCT00665743|Analgesics|analgesics|mesh-ancestor
2390371|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
2390372|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390373|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512398|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
2512399|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512400|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512401|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512402|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2512403|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2512404|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2512405|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2512406|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2390374|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2390375|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390376|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
2390377|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2390378|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390379|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390380|NCT00665756|Mitomycins|mitomycins|mesh-list
2512407|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
2512408|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
2512409|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
2512410|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2512411|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2512412|NCT01282632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2512413|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2512414|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2512415|NCT01282697|Sirolimus|sirolimus|mesh-list
2512416|NCT01282697|Irinotecan|irinotecan|mesh-list
2512417|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2512418|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2512419|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512420|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512421|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512422|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2512423|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512424|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2512425|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
2512426|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512427|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
2512428|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512429|NCT01282762|Vaccines|vaccines|mesh-list
2512430|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
2512431|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512432|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2512433|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2512434|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2512435|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
2512436|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512437|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512438|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512439|NCT01282840|Urological Agents|urological agents|mesh-ancestor
2512440|NCT01282879|Itraconazole|itraconazole|mesh-list
2512441|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
2512442|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512443|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2512444|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2512445|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512446|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512447|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2512448|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
2512449|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2390381|NCT00665756|Mitomycin|mitomycin|mesh-list
2390382|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2512450|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512451|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2512452|NCT01283048|Bevacizumab|bevacizumab|mesh-list
2512453|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2390383|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390384|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
2390385|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390386|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2390387|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390388|NCT00665808|Insulin|insulin|mesh-list
2390389|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2390390|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
2512454|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512455|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2390391|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
2390392|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
2390393|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
2390394|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2390395|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512456|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2512457|NCT01283048|Growth Substances|growth substances|mesh-ancestor
2512458|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512459|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
2512460|NCT01283061|Zafirlukast|zafirlukast|mesh-list
2512461|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2512462|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
2512463|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2512464|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
2512465|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2512466|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512467|NCT01283100|Dolutegravir|dolutegravir|mesh-list
2512468|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2512469|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2512470|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512471|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512472|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2512473|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2512474|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
2512475|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512476|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2512477|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512478|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2512479|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2512480|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512481|NCT01283204|Leucovorin|leucovorin|mesh-list
2512482|NCT01283204|Paclitaxel|paclitaxel|mesh-list
2512483|NCT01283204|Docetaxel|docetaxel|mesh-list
2512484|NCT01283204|Cisplatin|cisplatin|mesh-list
2512485|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
2512486|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
2512487|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2512488|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512489|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
2512490|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
2512491|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
2512492|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512493|NCT01283204|Antidotes|antidotes|mesh-ancestor
2512494|NCT01283204|Protective Agents|protective agents|mesh-ancestor
2512495|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512496|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
2512497|NCT01283204|Vitamins|vitamins|mesh-ancestor
2512498|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
2390396|NCT00665834|Atorvastatin|atorvastatin|mesh-list
2390397|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2512499|NCT01283217|Cisplatin|cisplatin|mesh-list
2512500|NCT01283217|Docetaxel|docetaxel|mesh-list
2512501|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114591|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
2114592|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2114593|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2114594|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2114595|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2114596|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114597|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512502|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
2512503|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
2512504|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
2512505|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512506|NCT01283256|Zonisamide|zonisamide|mesh-list
2390398|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2512507|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
2114598|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
2114599|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2114600|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2114601|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2114602|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2114603|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2114604|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2114605|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
2114606|NCT02605304|Ribavirin|ribavirin|mesh-list
2114607|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
2512508|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2512509|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2512510|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512511|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2512512|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512513|NCT01283360|Tenofovir|tenofovir|mesh-list
2512514|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
2512515|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512516|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2512517|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2512518|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512519|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512520|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2512521|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2512522|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
2390399|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2390400|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
2390401|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390402|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2390403|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2390404|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390405|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2390406|NCT00665873|Amoxicillin|amoxicillin|mesh-list
2390407|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
2390408|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
2390409|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2390410|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390411|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
2390412|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512523|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2512524|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2512525|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512526|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2512527|NCT01283412|Analgesics|analgesics|mesh-ancestor
2512528|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
2512529|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2512530|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2512531|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2512532|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2512533|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
2512534|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512535|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512536|NCT01283594|Levodopa|levodopa|mesh-list
2512537|NCT01283594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2512538|NCT01283594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2512539|NCT01283594|Dopamine Agents|dopamine agents|mesh-ancestor
2512540|NCT01283594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512541|NCT01283594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512542|NCT01283594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390413|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390414|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2390415|NCT00665951|Ritonavir|ritonavir|mesh-list
2390416|NCT00665951|Lopinavir|lopinavir|mesh-list
2390417|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2390418|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2390419|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
2390420|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390421|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390422|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2390423|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2390424|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
2390425|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390426|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2390427|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2390428|NCT00665977|Triamcinolone|triamcinolone|mesh-list
2390429|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2390430|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2390431|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2390432|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2390433|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
2390434|NCT00665977|Hormones|hormones|mesh-ancestor
2390435|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2390436|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390437|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512543|NCT01283646|Vitamins|vitamins|mesh-list
2512544|NCT01283646|Ascorbic Acid|ascorbic acid|mesh-list
2512545|NCT01283646|Folic Acid|folic acid|mesh-list
2512546|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
2512547|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
2512548|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512549|NCT01283646|Antioxidants|antioxidants|mesh-ancestor
2512550|NCT01283646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512551|NCT01283646|Protective Agents|protective agents|mesh-ancestor
2512552|NCT01283646|Hematinics|hematinics|mesh-ancestor
2512553|NCT01283724|Dienogest|dienogest|mesh-list
2512554|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2512555|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
2512556|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2512557|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512558|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2512559|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2512560|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2512561|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2512562|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
2512563|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2512564|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2512565|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512566|NCT01283763|Imiquimod|imiquimod|mesh-list
2512567|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2512568|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
2512569|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512570|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512571|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
2512572|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
2512573|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512574|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
2512575|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512576|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2512577|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2512578|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
2390438|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
2390439|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390440|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390441|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
2390442|NCT00665990|Bevacizumab|bevacizumab|mesh-list
2390443|NCT00665990|Sorafenib|sorafenib|mesh-list
2390444|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512579|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512580|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512581|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2512582|NCT01283789|Everolimus|everolimus|mesh-list
2512583|NCT01283789|Lapatinib|lapatinib|mesh-list
2512584|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512585|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512586|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
2390445|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
2390446|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390447|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390448|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2390449|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
2390450|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390451|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390452|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2390453|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2390454|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2390455|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2390456|NCT00665990|Growth Substances|growth substances|mesh-ancestor
2390457|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
2390458|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2390459|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390460|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
2390461|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2390462|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2390463|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2390464|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2390465|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390466|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2512587|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512588|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2512589|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512590|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512591|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
2512592|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2512593|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512594|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2512595|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
2512596|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2512597|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512598|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512599|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512600|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
2512601|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2512602|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390467|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2390468|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390469|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390470|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390471|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2390472|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
2390473|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2390474|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390475|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2390476|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2390477|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2390478|NCT00666055|Ritonavir|ritonavir|mesh-list
2390479|NCT00666055|Lopinavir|lopinavir|mesh-list
2512603|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2512604|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
2512605|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2512606|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512607|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512608|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512609|NCT01283919|Pantoprazole|pantoprazole|mesh-list
2512610|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2512611|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2512612|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2512613|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512614|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512615|NCT01283932|Pantoprazole|pantoprazole|mesh-list
2512616|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2512617|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2512618|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2512619|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512620|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512621|NCT01283997|Minocycline|minocycline|mesh-list
2512622|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2512623|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512624|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2512625|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2512626|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2512627|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2512628|NCT01284166|Timolol|timolol|mesh-list
2512629|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2512630|NCT01284166|Dorzolamide|dorzolamide|mesh-list
2512631|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2512632|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2512633|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2512634|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2512635|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
2512636|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512637|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512638|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512639|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2512640|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2512641|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2512642|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2512643|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2512644|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2512645|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512646|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
2512647|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2512648|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
2512649|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512650|NCT01284309|Mirabegron|mirabegron|mesh-list
2512651|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2512652|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2512653|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2512654|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
2512655|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512656|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512657|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512658|NCT01284309|Urological Agents|urological agents|mesh-ancestor
2512659|NCT01284413|Gemcitabine|gemcitabine|mesh-list
2512660|NCT01284413|Cisplatin|cisplatin|mesh-list
2512661|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512662|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2512663|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
2512664|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512665|NCT01284413|Antiviral Agents|antiviral agents|mesh-ancestor
2512666|NCT01284413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512667|NCT01284413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512668|NCT01284413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512669|NCT01284413|Immunologic Factors|immunologic factors|mesh-ancestor
2512670|NCT01284413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512671|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
2512672|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2512673|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
2512674|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512675|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
2512676|NCT01284439|Protective Agents|protective agents|mesh-ancestor
2512677|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
2512678|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2390480|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2390481|NCT00666055|Tenofovir|tenofovir|mesh-list
2390482|NCT00666055|Lamivudine|lamivudine|mesh-list
2390483|NCT00666055|Zidovudine|zidovudine|mesh-list
2390484|NCT00666055|Emtricitabine|emtricitabine|mesh-list
2390485|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
2390486|NCT00666055|Maraviroc|maraviroc|mesh-list
2390487|NCT00666055|Efavirenz|efavirenz|mesh-list
2390488|NCT00666055|Etravirine|etravirine|mesh-list
2390489|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2390490|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2390491|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
2390492|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390493|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390494|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2512679|NCT01284478|Dexamethasone|dexamethasone|mesh-list
2512680|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2512681|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
2512682|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
2512683|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2512684|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512685|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2512686|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
2512687|NCT01284478|Hormones|hormones|mesh-ancestor
2512688|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2512689|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2512690|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512691|NCT01284556|Phenobarbital|phenobarbital|mesh-list
2512692|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
2512693|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2512694|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2512695|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512696|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2512697|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2512698|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512699|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512700|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
2390495|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2390496|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
2390497|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390498|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2512701|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
2390499|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2390500|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2512702|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2512703|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2512704|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2512705|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
2512706|NCT01284647|Sucralfate|sucralfate|mesh-list
2512707|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2512708|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2512709|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512710|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
2512711|NCT01284725|Azathioprine|azathioprine|mesh-list
2390501|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2390502|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
2390503|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2390504|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2390505|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2390506|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2390507|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2390508|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2390509|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2390510|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2390511|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2390512|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2390513|NCT00666068|Hormones|hormones|mesh-list
2390514|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2390515|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
2390516|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2390517|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390518|NCT00666107|Vaccines|vaccines|mesh-list
2390519|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
2390520|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390521|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
2390522|NCT00666159|Tacrolimus|tacrolimus|mesh-list
2390523|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2390524|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
2390525|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390526|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2390527|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390528|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390529|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2390530|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2390531|NCT00666159|Analgesics|analgesics|mesh-ancestor
2390532|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
2390533|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390534|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2390535|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390536|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
2390537|NCT00666185|Fluconazole|fluconazole|mesh-list
2390538|NCT00666185|Micafungin|micafungin|mesh-list
2390539|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
2390540|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390541|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2390542|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2390543|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390544|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390545|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2390546|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
2512712|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2512713|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2512714|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512715|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2512716|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
2512717|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2512718|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512719|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512720|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512721|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
2512722|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2512723|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
2512724|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512725|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2512726|NCT01284764|Mosapride|mosapride|mesh-list
2512727|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2512728|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2512729|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
2512730|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390547|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2390548|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390549|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2390550|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2390551|NCT00666237|Mitomycins|mitomycins|mesh-list
2390552|NCT00666237|Mitomycin|mitomycin|mesh-list
2390553|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2390554|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390555|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
2512731|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512732|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512733|NCT01284855|Antivenins|antivenins|mesh-list
2512734|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
2512735|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512736|NCT01284868|Propranolol|propranolol|mesh-list
2512737|NCT01284868|Bisoprolol|bisoprolol|mesh-list
2512738|NCT01284868|Mirabegron|mirabegron|mesh-list
2512739|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2512740|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2512741|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
2512742|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512743|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512744|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512745|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2512746|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2512747|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
2512748|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2512749|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2512750|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2512751|NCT01284868|Urological Agents|urological agents|mesh-ancestor
2512752|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
2512753|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
2512754|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2512755|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2512756|NCT01284907|Vitamin D|vitamin d|mesh-list
2512757|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
2512758|NCT01284907|Vitamins|vitamins|mesh-ancestor
2512759|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
2512760|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512761|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2512762|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2512763|NCT01284946|Deferasirox|deferasirox|mesh-list
2512764|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2512765|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
2512766|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
2512767|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512768|NCT01285037|Gemcitabine|gemcitabine|mesh-list
2512769|NCT01285037|Cetuximab|cetuximab|mesh-list
2512770|NCT01285037|Ramucirumab|ramucirumab|mesh-list
2512771|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512772|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2512773|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
2512774|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512775|NCT01285037|Antiviral Agents|antiviral agents|mesh-ancestor
2512776|NCT01285037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512777|NCT01285037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512778|NCT01285037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512779|NCT01285037|Immunologic Factors|immunologic factors|mesh-ancestor
2512780|NCT01285037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512781|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2512788|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
2512789|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2512790|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
2512791|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390556|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390557|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2390558|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512792|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2390559|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
2390560|NCT00666302|Tacrolimus|tacrolimus|mesh-list
2390561|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2390562|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
2390563|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390564|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2390565|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390566|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390567|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2390568|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2390569|NCT00666302|Analgesics|analgesics|mesh-ancestor
2390570|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
2390571|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2512793|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512794|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
2512795|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512796|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
2512797|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2512798|NCT01285141|Protective Agents|protective agents|mesh-ancestor
2512799|NCT01285219|Lenograstim|lenograstim|mesh-list
2512800|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2512801|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
2512802|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512803|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2512804|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2512805|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2512806|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2512807|NCT01285271|Sevoflurane|sevoflurane|mesh-list
2512808|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2512809|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2512810|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
2512811|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
2512812|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2512813|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512814|NCT01285375|Curcumin|curcumin|mesh-list
2512815|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2512816|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2512817|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2512818|NCT01285375|Analgesics|analgesics|mesh-ancestor
2512819|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
2512820|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2512821|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512822|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2512823|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2512824|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512825|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512826|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512827|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
2512828|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390572|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2390573|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390574|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
2390575|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
2390576|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390577|NCT00666354|Methotrexate|methotrexate|mesh-list
2390578|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2512829|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2512830|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2512831|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390579|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
2390580|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2390581|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512832|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512833|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
2512834|NCT01285414|Temozolomide|temozolomide|mesh-list
2512835|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2512836|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
2512837|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512838|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512839|NCT01285453|Vadimezan|vadimezan|mesh-list
2512840|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512841|NCT01285466|Paclitaxel|paclitaxel|mesh-list
2512842|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2390582|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2390583|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
2512843|NCT01285466|Trastuzumab|trastuzumab|mesh-list
2512844|NCT01285466|Dactolisib|dactolisib|mesh-list
2512845|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2512846|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512847|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
2512848|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
2512849|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
2512850|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512851|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2512852|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2512853|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2512854|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512855|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512856|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
2512857|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512858|NCT01285505|Alprazolam|alprazolam|mesh-list
2512859|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2390584|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390585|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390586|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
2390587|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390588|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2390589|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2390590|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
2390591|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390592|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2390593|NCT00666393|Fentanyl|fentanyl|mesh-list
2390594|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2512860|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2512861|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512862|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2512863|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2512864|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2512865|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
2512866|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
2512867|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512868|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512869|NCT01285544|Atorvastatin|atorvastatin|mesh-list
2512870|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2512871|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2390595|NCT00666393|Narcotics|narcotics|mesh-ancestor
2390596|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2390597|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390598|NCT00666393|Analgesics|analgesics|mesh-ancestor
2390599|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
2390600|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390601|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2390602|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2390603|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
2390604|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
2390605|NCT00666484|Prednisolone|prednisolone|mesh-list
2390606|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
2390607|NCT00666484|Doxorubicin|doxorubicin|mesh-list
2390608|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2390609|NCT00666484|Etoposide|etoposide|mesh-list
2390610|NCT00666484|Vincristine|vincristine|mesh-list
2390611|NCT00666484|Procarbazine|procarbazine|mesh-list
2512872|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
2512873|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512874|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2512875|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2512876|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512877|NCT01285557|Cisplatin|cisplatin|mesh-list
2512878|NCT01285557|Fluorouracil|fluorouracil|mesh-list
2512879|NCT01285557|Tegafur|tegafur|mesh-list
2512880|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512881|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
2512882|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512883|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2512884|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512885|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
2390612|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2390613|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
2390614|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390615|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390616|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2390617|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
2390618|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390619|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390620|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2390621|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2390622|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2390623|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2390624|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390625|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2390626|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
2390627|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
2512886|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512887|NCT01285596|Mirabegron|mirabegron|mesh-list
2512888|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2512889|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2512890|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2512891|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
2512892|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512893|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512894|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512895|NCT01285596|Urological Agents|urological agents|mesh-ancestor
2512896|NCT01285661|Vitamin K|vitamin k|mesh-list
2512897|NCT01285661|Warfarin|warfarin|mesh-list
2512898|NCT01285661|Anticoagulants|anticoagulants|mesh-list
2512899|NCT01285661|Vitamins|vitamins|mesh-ancestor
2512900|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
2512901|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512902|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2512903|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2512904|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512905|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
2512906|NCT01285661|Coagulants|coagulants|mesh-ancestor
2512907|NCT01285674|Cisplatin|cisplatin|mesh-list
2512908|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512909|NCT01285765|Rituximab|rituximab|mesh-list
2512910|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2390628|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
2390629|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2390630|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
2390631|NCT00666484|Hormones|hormones|mesh-ancestor
2390632|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2390633|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2390634|NCT00666497|Azacitidine|azacitidine|mesh-list
2390635|NCT00666497|Mocetinostat|mocetinostat|mesh-list
2390636|NCT00666497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2390637|NCT00666497|Antimetabolites|antimetabolites|mesh-ancestor
2390638|NCT00666497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390639|NCT00666497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390640|NCT00666497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390641|NCT00666497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2390642|NCT00666575|Gabapentin|gabapentin|mesh-list
2390643|NCT00666575|Analgesics|analgesics|mesh-ancestor
2390644|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
2390645|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390646|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390647|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
2512911|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512912|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
2512913|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512914|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2512915|NCT01285778|Panitumumab|panitumumab|mesh-list
2512916|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2512917|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512918|NCT01285817|Celecoxib|celecoxib|mesh-list
2512919|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
2512920|NCT01285817|Methotrexate|methotrexate|mesh-list
2390648|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2390649|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2390650|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2390651|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2390652|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2390653|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2512921|NCT01285817|Vinblastine|vinblastine|mesh-list
2512922|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2512923|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
2390654|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390655|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390656|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
2390657|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
2512924|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512925|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2512926|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2512927|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
2512928|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512929|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2512930|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2512931|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2512932|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
2512933|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2512934|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2512935|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
2512936|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
2512937|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512938|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2512939|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2512940|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2512941|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2512942|NCT01285817|Analgesics|analgesics|mesh-ancestor
2512943|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
2512944|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2512945|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2512946|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2512947|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2512948|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2512949|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
2390658|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2390659|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512950|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
2512951|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
2512952|NCT01285934|Insulin|insulin|mesh-list
2512953|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2512954|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512955|NCT01286051|Ganirelix|ganirelix|mesh-list
2512956|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
2512957|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2512958|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512959|NCT01286090|Cisapride|cisapride|mesh-list
2512960|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2512961|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2512962|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2512963|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
2512964|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390660|NCT00666627|Alendronate|alendronate|mesh-list
2390661|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
2390662|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
2512965|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512966|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390663|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2390664|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390665|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2390666|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2390667|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390668|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2390669|NCT00666653|Pramipexole|pramipexole|mesh-list
2390670|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
2390671|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390672|NCT00666653|Protective Agents|protective agents|mesh-ancestor
2390673|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390674|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2390675|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2390676|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
2390677|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
2390678|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390679|NCT00666692|Paclitaxel|paclitaxel|mesh-list
2390680|NCT00666692|Bevacizumab|bevacizumab|mesh-list
2390681|NCT00666692|Carboplatin|carboplatin|mesh-list
2390682|NCT00666692|Volociximab|volociximab|mesh-list
2390683|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2390684|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2512967|NCT01286103|Canagliflozin|canagliflozin|mesh-list
2512968|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2512969|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512970|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2512971|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512972|NCT01286194|Rabeprazole|rabeprazole|mesh-list
2512973|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2390685|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390686|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
2390687|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
2390688|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
2390689|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390690|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2390691|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2390692|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2390693|NCT00666692|Growth Substances|growth substances|mesh-ancestor
2512974|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2512975|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2512976|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512977|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512978|NCT01286233|Metformin|metformin|mesh-list
2512979|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2512980|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512981|NCT01286246|Progesterone|progesterone|mesh-list
2512982|NCT01286246|Progestins|progestins|mesh-ancestor
2512983|NCT01286246|Hormones|hormones|mesh-ancestor
2512984|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2512985|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512986|NCT01286584|Varenicline|varenicline|mesh-list
2512987|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2512988|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2512989|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
2512990|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2512991|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512992|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512993|NCT01286688|Terbinafine|terbinafine|mesh-list
2512994|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
2390694|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390695|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
2390696|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
2390697|NCT00666770|Gabapentin|gabapentin|mesh-list
2390698|NCT00666770|Analgesics|analgesics|mesh-ancestor
2390699|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
2390700|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390701|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390702|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
2390703|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2390704|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2390705|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2390706|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2390707|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2390708|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2390709|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390710|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390711|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
2390712|NCT00666783|Palonosetron|palonosetron|mesh-list
2390713|NCT00666783|Granisetron|granisetron|mesh-list
2390714|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
2390715|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
2390716|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390717|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2512995|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2512996|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2512997|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2512998|NCT01286701|Terbinafine|terbinafine|mesh-list
2512999|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
2513000|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513001|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513002|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513003|NCT01286766|Cisplatin|cisplatin|mesh-list
2513004|NCT01286766|Docetaxel|docetaxel|mesh-list
2513005|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513006|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
2513007|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
2390718|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2513008|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
2513009|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513010|NCT01286857|Silicon|silicon|mesh-list
2513011|NCT01286857|Trace Elements|trace elements|mesh-ancestor
2513012|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
2513013|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513014|NCT01286896|Sunitinib|sunitinib|mesh-list
2513015|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513016|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2513017|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2513018|NCT01286896|Growth Substances|growth substances|mesh-ancestor
2513019|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513020|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
2513021|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2513022|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513023|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513024|NCT01286909|Lycopene|lycopene|mesh-list
2513025|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2513026|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
2513027|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513028|NCT01286909|Protective Agents|protective agents|mesh-ancestor
2513029|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513030|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2513031|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2513032|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513033|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
2513034|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2513035|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
2513036|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2513037|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513038|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2513039|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2513040|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2513041|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
2513042|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2513043|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
2513044|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
2513045|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2513046|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390719|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2390720|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2513047|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2513048|NCT01287052|Analgesics|analgesics|mesh-ancestor
2513049|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
2513050|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513051|NCT01287091|Rabeprazole|rabeprazole|mesh-list
2513052|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2513053|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2513054|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2513055|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513056|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513057|NCT01287130|Cetuximab|cetuximab|mesh-list
2513058|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2513059|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513060|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
2513061|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2513062|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2513063|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2513064|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513065|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
2513066|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513067|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513068|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2513069|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390721|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
2390722|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390723|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390724|NCT00666796|Ethanol|ethanol|mesh-list
2513070|NCT01287260|Nifedipine|nifedipine|mesh-list
2513071|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2513072|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2513073|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513074|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2390725|NCT00666796|Gabapentin|gabapentin|mesh-list
2390726|NCT00666796|Analgesics|analgesics|mesh-ancestor
2390727|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
2390728|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390729|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390730|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
2390731|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2390732|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2390733|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2390734|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2390735|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2390736|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2390737|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390738|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390739|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
2390740|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2390741|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390742|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2390743|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
2390744|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2390745|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2390746|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390747|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390748|NCT00666809|Urological Agents|urological agents|mesh-ancestor
2390749|NCT00666887|Minocycline|minocycline|mesh-list
2390750|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2513075|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513076|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
2513077|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
2513078|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2513079|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2513080|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2513081|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2513082|NCT01287338|Analgesics|analgesics|mesh-ancestor
2513083|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
2513084|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513085|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513086|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2513087|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2513088|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2513089|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2513090|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2513091|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
2513092|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
2513093|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513094|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513095|NCT01287351|Fluticasone|fluticasone|mesh-list
2513096|NCT01287351|Xhance|xhance|mesh-list
2513097|NCT01287351|Beclomethasone|beclomethasone|mesh-list
2513098|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2513099|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2513100|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
2513101|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513102|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513103|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2513104|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
2513105|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
2513106|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2390751|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390752|NCT00666939|Gabapentin|gabapentin|mesh-list
2390753|NCT00666939|Analgesics|analgesics|mesh-ancestor
2390754|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
2390755|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390756|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390757|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
2390758|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2390759|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2390760|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2390761|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2390762|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2390763|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2390764|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390765|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390766|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
2513107|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
2513108|NCT01287351|Hormones|hormones|mesh-ancestor
2513109|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2513110|NCT01287455|Vitamin D|vitamin d|mesh-list
2513111|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
2390767|NCT00666991|Paclitaxel|paclitaxel|mesh-list
2390768|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2390769|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390770|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
2390771|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
2390772|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
2390773|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390774|NCT00667043|Fentanyl|fentanyl|mesh-list
2390775|NCT00667043|Midazolam|midazolam|mesh-list
2390776|NCT00667043|Remifentanil|remifentanil|mesh-list
2390777|NCT00667043|Propofol|propofol|mesh-list
2390778|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2390779|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2390780|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390781|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2390782|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
2390783|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
2390784|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2390785|NCT00667043|Narcotics|narcotics|mesh-ancestor
2390786|NCT00667043|Analgesics|analgesics|mesh-ancestor
2513112|NCT01287455|Vitamins|vitamins|mesh-ancestor
2513113|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
2513114|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513115|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2513116|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2513117|NCT01287494|Sertraline|sertraline|mesh-list
2390787|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
2390788|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513118|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
2513119|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2513120|NCT01287494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2390789|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2390790|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2390791|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2390792|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2390793|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
2513121|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2513122|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2513123|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513124|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513125|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
2513126|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513127|NCT01287507|Lactoferrin|lactoferrin|mesh-list
2513128|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513129|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
2513130|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2513131|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513132|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2513133|NCT01287546|Trametinib|trametinib|mesh-list
2513134|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513135|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2390794|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
2390795|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390796|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390797|NCT00667056|Tacrolimus|tacrolimus|mesh-list
2390798|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2390799|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
2390800|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390801|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2390802|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390803|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390804|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2390805|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
2390806|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2390807|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
2513136|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513137|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513138|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
2390808|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2390809|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390810|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2390811|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2513139|NCT01287598|Midazolam|midazolam|mesh-list
2513140|NCT01287598|Omeprazole|omeprazole|mesh-list
2513141|NCT01287598|Warfarin|warfarin|mesh-list
2513142|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2513143|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2513144|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2513145|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513146|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2513147|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2513148|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2513149|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2513150|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
2513151|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
2513152|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
2513153|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
2513154|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513155|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513156|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
2513157|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2513158|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2513159|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2513160|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513161|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2513162|NCT01287624|Gemcitabine|gemcitabine|mesh-list
2513163|NCT01287624|Paclitaxel|paclitaxel|mesh-list
2513164|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2390812|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390813|NCT00667082|Vorinostat|vorinostat|mesh-list
2390814|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2390815|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
2390816|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390817|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390818|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390819|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
2390820|NCT00667108|Gabapentin|gabapentin|mesh-list
2390821|NCT00667108|Analgesics|analgesics|mesh-ancestor
2390822|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
2390823|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390824|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390825|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
2390826|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2390827|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2390828|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2390829|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2390830|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2390831|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2390832|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513165|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513166|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
2513167|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
2513168|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
2513169|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513170|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2513171|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
2513172|NCT01287624|Antiviral Agents|antiviral agents|mesh-ancestor
2513173|NCT01287624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513174|NCT01287624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513175|NCT01287624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2513176|NCT01287624|Immunologic Factors|immunologic factors|mesh-ancestor
2513177|NCT01287624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513178|NCT01287663|Permethrin|permethrin|mesh-list
2513179|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513180|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513181|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
2513182|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2513183|NCT01287689|Antibodies|antibodies|mesh-list
2513184|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
2513185|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
2513186|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513187|NCT01287715|Etanercept|etanercept|mesh-list
2513188|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2513189|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2513190|NCT01287715|Analgesics|analgesics|mesh-ancestor
2513191|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
2513192|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513193|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513194|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2513195|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390833|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390834|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
2390835|NCT00667121|Tamoxifen|tamoxifen|mesh-list
2390836|NCT00667121|Gabapentin|gabapentin|mesh-list
2390837|NCT00667121|Dexetimide|dexetimide|mesh-list
2390838|NCT00667121|Citalopram|citalopram|mesh-list
2390839|NCT00667121|Sertraline|sertraline|mesh-list
2390840|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2390841|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390842|NCT00667121|Analgesics|analgesics|mesh-ancestor
2390843|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
2390844|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390845|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390846|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
2390847|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2390848|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2390849|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2390850|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2390851|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2390852|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2513196|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2513197|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2513198|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
2513199|NCT01287741|Prednisone|prednisone|mesh-list
2513200|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
2513201|NCT01287741|Rituximab|rituximab|mesh-list
2513202|NCT01287741|Doxorubicin|doxorubicin|mesh-list
2513203|NCT01287741|Vincristine|vincristine|mesh-list
2513204|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
2513205|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2513206|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
2513207|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513208|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2513209|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2513210|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
2513211|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513212|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513213|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2513214|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2513215|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2513216|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2513217|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2513218|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513219|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2513220|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
2513221|NCT01287741|Hormones|hormones|mesh-ancestor
2513222|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2513223|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2513224|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2513225|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
2513226|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
2513227|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
2513228|NCT01287780|Gentamicins|gentamicins|mesh-list
2513229|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2513230|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513231|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2513232|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513233|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513234|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
2513235|NCT01287793|Tigecycline|tigecycline|mesh-list
2513236|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2513237|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513238|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2513239|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2513240|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513241|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513242|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513243|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2513244|NCT01287806|Urinastatin|urinastatin|mesh-list
2513245|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2513246|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2513247|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
2513248|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513249|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390853|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390854|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
2390855|NCT00667121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2390856|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2513250|NCT01287949|Vaccines|vaccines|mesh-list
2513251|NCT01287949|Immunologic Factors|immunologic factors|mesh-ancestor
2513252|NCT01287949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513253|NCT01287962|Apatinib|apatinib|mesh-list
2513254|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513255|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2513256|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513257|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513258|NCT01288092|Dactolisib|dactolisib|mesh-list
2390857|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2390858|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
2390859|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2390860|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
2390861|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2390862|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2390863|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
2390864|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
2390865|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2390866|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2390867|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
2390868|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2390869|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
2390870|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2390871|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2390872|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390873|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2390874|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2390875|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2390876|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2390877|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2390878|NCT00667147|Paclitaxel|paclitaxel|mesh-list
2390879|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390880|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2390881|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
2390882|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
2390883|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
2390884|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390885|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
2513259|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513260|NCT01288131|Cyclosporine|cyclosporine|mesh-list
2513261|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
2513262|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
2513263|NCT01288131|Cyclosporins|cyclosporins|mesh-list
2513264|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2513265|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
2513266|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390886|NCT00667160|Tacrolimus|tacrolimus|mesh-list
2390887|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2390888|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
2390889|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390890|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2390891|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390892|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390893|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2390894|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2390895|NCT00667160|Analgesics|analgesics|mesh-ancestor
2390896|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
2390897|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390898|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2390899|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390900|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
2390901|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2390902|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390903|NCT00667264|Ropivacaine|ropivacaine|mesh-list
2390904|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
2390905|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
2390906|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2390907|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390908|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
2390909|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513267|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390910|NCT00667303|Antibodies|antibodies|mesh-list
2390911|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
2390912|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390913|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
2390914|NCT00667329|Rituximab|rituximab|mesh-list
2390915|NCT00667329|Cladribine|cladribine|mesh-list
2390916|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2390917|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
2390918|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390919|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2390920|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2390921|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
2390922|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390923|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513268|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2513269|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
2513270|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513271|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513272|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2513273|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513274|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
2390924|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2390925|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2390926|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2390927|NCT00667407|Albuterol|albuterol|mesh-list
2390928|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2390929|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
2390930|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2390931|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390932|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2390933|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
2390934|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
2390935|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2390936|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2390937|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2513275|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513276|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
2513277|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2513278|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2513279|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2513280|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
2513281|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2513282|NCT01288157|Golimumab|golimumab|mesh-list
2513283|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2513284|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2513285|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2513286|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2513287|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
2513288|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513289|NCT01288170|Tobramycin|tobramycin|mesh-list
2513290|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2513291|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513292|NCT01288261|Paclitaxel|paclitaxel|mesh-list
2513293|NCT01288261|Bavituximab|bavituximab|mesh-list
2513294|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2513295|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513296|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
2513297|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
2513298|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
2513299|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513300|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2390938|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2390939|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
2390940|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390941|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390942|NCT00667433|Tenofovir|tenofovir|mesh-list
2390943|NCT00667433|Emtricitabine|emtricitabine|mesh-list
2513301|NCT01288326|Liraglutide|liraglutide|mesh-list
2513302|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2513303|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513304|NCT01288326|Incretins|incretins|mesh-ancestor
2513305|NCT01288326|Hormones|hormones|mesh-ancestor
2513306|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2513307|NCT01288339|Leucovorin|leucovorin|mesh-list
2513308|NCT01288339|Fluorouracil|fluorouracil|mesh-list
2513309|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
2513310|NCT01288339|Panitumumab|panitumumab|mesh-list
2513311|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
2513312|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513313|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2513314|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513315|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2513316|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
2513317|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513318|NCT01288339|Antidotes|antidotes|mesh-ancestor
2513319|NCT01288339|Protective Agents|protective agents|mesh-ancestor
2513320|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
2513321|NCT01288339|Vitamins|vitamins|mesh-ancestor
2513322|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
2513323|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2513324|NCT01288378|Caspofungin|caspofungin|mesh-list
2513325|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
2513326|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513327|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513328|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513329|NCT01288404|Fluorometholone|fluorometholone|mesh-list
2513330|NCT01288404|Bevacizumab|bevacizumab|mesh-list
2513331|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2513332|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513333|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2513334|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2513335|NCT01288404|Growth Substances|growth substances|mesh-ancestor
2513336|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513337|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
2513338|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2513339|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
2513340|NCT01288404|Hormones|hormones|mesh-ancestor
2513341|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2513342|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2513343|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
2513344|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2513345|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2513346|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
2513347|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513348|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2513349|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2513350|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513351|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513352|NCT01288495|Psyllium|psyllium|mesh-list
2513353|NCT01288495|Cathartics|cathartics|mesh-ancestor
2513354|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2513355|NCT01288508|Psyllium|psyllium|mesh-list
2513356|NCT01288508|Cathartics|cathartics|mesh-ancestor
2513357|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2513358|NCT01288547|Theobromine|theobromine|mesh-list
2513359|NCT01288547|Caffeine|caffeine|mesh-list
2513360|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2513361|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513362|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2513363|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513364|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513365|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2513366|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2513367|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
2513368|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2390944|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
2390945|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2513369|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2513370|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
2513371|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513372|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2513373|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
2513374|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
2513375|NCT01288573|Plerixafor|plerixafor|mesh-list
2513376|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2513377|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2513378|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
2513379|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513380|NCT01288664|Tacrolimus|tacrolimus|mesh-list
2513381|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2513382|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
2513383|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513384|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2513385|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513386|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513387|NCT01288716|Baclofen|baclofen|mesh-list
2513388|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2513389|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513390|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2513391|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513392|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2513393|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
2513394|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
2513395|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513396|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513397|NCT01288742|Simeprevir|simeprevir|mesh-list
2513398|NCT01288742|Digoxin|digoxin|mesh-list
2513399|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2513400|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2513401|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2513402|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
2513403|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513404|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2513405|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2513406|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513407|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2513408|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2513409|NCT01288742|Protective Agents|protective agents|mesh-ancestor
2513410|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513411|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
2513412|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513413|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
2513414|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
2513415|NCT01288755|Rilpivirine|rilpivirine|mesh-list
2513416|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2390946|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
2390947|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390948|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2390949|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2390950|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390951|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2390952|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2390953|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2390954|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2390955|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2390956|NCT00667472|Ranibizumab|ranibizumab|mesh-list
2390957|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2390958|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2390959|NCT00667472|Growth Substances|growth substances|mesh-ancestor
2390960|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390961|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
2390962|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390963|NCT00667485|Sirolimus|sirolimus|mesh-list
2390964|NCT00667485|Bevacizumab|bevacizumab|mesh-list
2513417|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2513418|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
2513419|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513420|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2513421|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2513422|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513423|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513424|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2513425|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2513426|NCT01288794|Furosemide|furosemide|mesh-list
2513427|NCT01288794|Diuretics|diuretics|mesh-list
2513428|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
2513429|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513430|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2513431|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2513432|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513433|NCT01288820|Artesunate|artesunate|mesh-list
2513434|NCT01288820|Piperaquine|piperaquine|mesh-list
2513435|NCT01288820|Primaquine|primaquine|mesh-list
2513436|NCT01288820|Amodiaquine|amodiaquine|mesh-list
2513437|NCT01288820|Artenimol|artenimol|mesh-list
2390965|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2390966|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390967|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2390968|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2390969|NCT00667485|Growth Substances|growth substances|mesh-ancestor
2390970|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390971|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
2390972|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2390973|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2390974|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2390975|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
2390976|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2390977|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
2390978|NCT00667498|Metformin|metformin|mesh-list
2390979|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2390980|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390981|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2390982|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2390983|NCT00667641|Paclitaxel|paclitaxel|mesh-list
2390984|NCT00667641|Bortezomib|bortezomib|mesh-list
2390985|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2390986|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513438|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
2513439|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2513440|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2513441|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513442|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513443|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
2513444|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
2513445|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2513446|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
2513447|NCT01288872|Praziquantel|praziquantel|mesh-list
2513448|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
2513449|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2513450|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513451|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
2513452|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2513453|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513454|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2513455|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513456|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
2513457|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2513458|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513459|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2513460|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513461|NCT01288924|Parecoxib|parecoxib|mesh-list
2513462|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2513463|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2513464|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2390987|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
2390988|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
2513465|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513466|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2513467|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2513468|NCT01288924|Analgesics|analgesics|mesh-ancestor
2513469|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
2513470|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513471|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513472|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2513473|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2513474|NCT01288950|Vitamin D|vitamin d|mesh-list
2513475|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
2513476|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
2513477|NCT01288950|Vitamins|vitamins|mesh-list
2513478|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
2513479|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513480|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2513481|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2513482|NCT01288963|Aldesleukin|aldesleukin|mesh-list
2513483|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513484|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2513485|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2513486|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
2513487|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513488|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
2513489|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513490|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2390989|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
2390990|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513491|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513492|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513493|NCT01289132|Candesartan|candesartan|mesh-list
2513494|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
2513495|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2390991|NCT00667758|Cetrorelix|cetrorelix|mesh-list
2390992|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2390993|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
2390994|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2390995|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2390996|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
2390997|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2513496|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2513497|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2513498|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2513499|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513500|NCT01289171|Glycolic acid|glycolic acid|mesh-list
2513501|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
2513502|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
2513503|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2513504|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2513505|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
2513506|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513507|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513508|NCT01289236|Milnacipran|milnacipran|mesh-list
2513509|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
2513510|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2513511|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2513512|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2513513|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513514|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513515|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513516|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2513517|NCT01289236|Analgesics|analgesics|mesh-ancestor
2513518|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
2513519|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513520|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
2513521|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2513522|NCT01289301|Cyclosporine|cyclosporine|mesh-list
2513523|NCT01289301|Sirolimus|sirolimus|mesh-list
2513524|NCT01289301|Everolimus|everolimus|mesh-list
2513525|NCT01289301|Tacrolimus|tacrolimus|mesh-list
2513526|NCT01289301|Cyclosporins|cyclosporins|mesh-list
2513527|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2513528|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2513529|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
2513530|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513531|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513532|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513533|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
2513534|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513535|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
2513536|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2513537|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513538|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2513539|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2390998|NCT00667771|Naltrexone|naltrexone|mesh-list
2390999|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2391000|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2391001|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391002|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
2391003|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2391004|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2391005|NCT00667797|Albuterol|albuterol|mesh-list
2391006|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2391007|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
2391008|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2391009|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391010|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2391011|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
2391012|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
2391013|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2391014|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2391015|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2513540|NCT01289327|Midazolam|midazolam|mesh-list
2513541|NCT01289327|Alfentanil|alfentanil|mesh-list
2513542|NCT01289327|Propofol|propofol|mesh-list
2513543|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2513544|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2513545|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513546|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2513547|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
2513548|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
2513549|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2513550|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2513551|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2513552|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2513553|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
2513554|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
2513555|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513556|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513557|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2513558|NCT01289327|Narcotics|narcotics|mesh-ancestor
2513559|NCT01289327|Analgesics|analgesics|mesh-ancestor
2513560|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
2391016|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2391017|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
2391018|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2391019|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391020|NCT00667823|Macitentan|macitentan|mesh-list
2513561|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513562|NCT01289483|Fospropofol|fospropofol|mesh-list
2513563|NCT01289483|Propofol|propofol|mesh-list
2513564|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2513565|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2513566|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513567|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2513568|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
2513569|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
2513570|NCT01289496|Interferons|interferons|mesh-list
2513571|NCT01289496|Ribavirin|ribavirin|mesh-list
2513572|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
2513573|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
2513574|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2513575|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513576|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
2513577|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513578|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
2513579|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513580|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
2513581|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513582|NCT01289561|Ethanol|ethanol|mesh-list
2513583|NCT01289561|Quinine|quinine|mesh-list
2513584|NCT01289561|Caffeine|caffeine|mesh-list
2114608|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2114609|NCT02605304|Ledipasvir|ledipasvir|mesh-list
2114610|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
2114611|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114612|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
2114613|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114614|NCT02605395|Rabeprazole|rabeprazole|mesh-list
2114615|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2513585|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2513586|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513587|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2513588|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513589|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2513590|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2513591|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513592|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513593|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2513594|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2513595|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
2513596|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513597|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
2513598|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2513599|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2513600|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2513601|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2513602|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513603|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2513604|NCT01289561|Analgesics|analgesics|mesh-ancestor
2513605|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
2513606|NCT01289730|Etanercept|etanercept|mesh-list
2513607|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2513608|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2513609|NCT01289730|Analgesics|analgesics|mesh-ancestor
2513610|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
2513611|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513612|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513613|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2513614|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2513615|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2513616|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2513617|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
2513618|NCT01289743|Etanercept|etanercept|mesh-list
2391021|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2391022|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2391023|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391024|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2391025|NCT00667901|Riluzole|riluzole|mesh-list
2391026|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
2391027|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2391028|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2391029|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2391030|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391031|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391032|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2391033|NCT00667901|Protective Agents|protective agents|mesh-ancestor
2391034|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
2391035|NCT00667927|Busulfan|busulfan|mesh-list
2391036|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2391037|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
2391038|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391039|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2391040|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2391041|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
2391042|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391043|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391044|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2391045|NCT00667953|Temozolomide|temozolomide|mesh-list
2391046|NCT00667953|Imatinib Mesylate|imatinib mesylate|mesh-list
2391047|NCT00667953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2391048|NCT00667953|Alkylating Agents|alkylating agents|mesh-ancestor
2391049|NCT00667953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391050|NCT00667953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391051|NCT00667953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2391052|NCT00667953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391053|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2513619|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2513620|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2513621|NCT01289743|Analgesics|analgesics|mesh-ancestor
2513622|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
2513623|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513624|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513625|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2513626|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2513627|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2513628|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2513629|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
2513630|NCT01289756|Clarithromycin|clarithromycin|mesh-list
2513631|NCT01289756|Paroxetine|paroxetine|mesh-list
2513632|NCT01289756|Clomiphene|clomiphene|mesh-list
2513633|NCT01289756|Enclomiphene|enclomiphene|mesh-list
2513634|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
2513635|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2513636|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513637|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2513638|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513639|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391054|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391055|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2391056|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2391057|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391058|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513640|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2513641|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2513642|NCT01289756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2513643|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2513644|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2513645|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513646|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
2513647|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513648|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2513649|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
2513650|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2513651|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2513652|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2513653|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
2513654|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2513655|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2513656|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
2513657|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2513658|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2513659|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2513660|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
2391059|NCT00667966|Urological Agents|urological agents|mesh-ancestor
2391060|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2391061|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391062|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2391063|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2391064|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513661|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2513662|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2513663|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513664|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2513665|NCT01289769|Analgesics|analgesics|mesh-ancestor
2513666|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
2513667|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513668|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2513669|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2513670|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2391065|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391066|NCT00667979|Urological Agents|urological agents|mesh-ancestor
2391067|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2391068|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391069|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2391070|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2391071|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513671|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
2513672|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513673|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513674|NCT01289925|Selenium|selenium|mesh-list
2513675|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
2513676|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513677|NCT01289925|Protective Agents|protective agents|mesh-ancestor
2513678|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513679|NCT01289925|Trace Elements|trace elements|mesh-ancestor
2513680|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
2513681|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
2513682|NCT01289938|Promethazine|promethazine|mesh-list
2513683|NCT01289938|Metoclopramide|metoclopramide|mesh-list
2513684|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2513685|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2513686|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2513687|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513688|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
2513689|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
2513690|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
2513691|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513692|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
2513693|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
2513694|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2513695|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2513696|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
2513697|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
2513698|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513699|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513700|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2513701|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
2513702|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
2391072|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391073|NCT00668005|Urological Agents|urological agents|mesh-ancestor
2391074|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2391075|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391076|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2391077|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2513703|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2513704|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2513705|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
2513706|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
2513707|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2513708|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2513709|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
2513710|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513711|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2513712|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2513713|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513714|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513715|NCT01290003|Tazobactam|tazobactam|mesh-list
2513716|NCT01290003|Piperacillin|piperacillin|mesh-list
2513717|NCT01290003|Amikacin|amikacin|mesh-list
2391078|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391079|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391080|NCT00668018|Urological Agents|urological agents|mesh-ancestor
2391081|NCT00668031|Aprotinin|aprotinin|mesh-list
2391082|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
2391083|NCT00668031|Coagulants|coagulants|mesh-ancestor
2391084|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2391085|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2391086|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
2391087|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391088|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391089|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
2391090|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391091|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391092|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2391093|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2391094|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391095|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391096|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391097|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2391098|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2391099|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2391100|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391101|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2391102|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2391103|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391104|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513718|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2513719|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2513720|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513721|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2513722|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513723|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513724|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2513725|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
2513726|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513727|NCT01290120|Rituximab|rituximab|mesh-list
2513728|NCT01290120|Doxorubicin|doxorubicin|mesh-list
2513729|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2513730|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513731|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
2513732|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513733|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2513734|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2513735|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2513736|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2513737|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513738|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513739|NCT01290133|Vestipitant|vestipitant|mesh-list
2513740|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2513741|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513742|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513743|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513744|NCT01290146|Simendan|simendan|mesh-list
2513745|NCT01290146|Diuretics|diuretics|mesh-list
2513746|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
2513747|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513748|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2513749|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
2513750|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2513751|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2513752|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513753|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513754|NCT01290146|Protective Agents|protective agents|mesh-ancestor
2513755|NCT01290172|Somatostatin|somatostatin|mesh-list
2513756|NCT01290172|Hormones|hormones|mesh-ancestor
2513757|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2391105|NCT00668057|Urological Agents|urological agents|mesh-ancestor
2391106|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2391107|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391108|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2391109|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2391110|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391111|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391112|NCT00668096|Urological Agents|urological agents|mesh-ancestor
2391113|NCT00668109|Tadalafil|tadalafil|mesh-list
2391114|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2391115|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391116|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2391117|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2391118|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391119|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391120|NCT00668109|Urological Agents|urological agents|mesh-ancestor
2391121|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
2391122|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391123|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513758|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513759|NCT01290198|Fluconazole|fluconazole|mesh-list
2513760|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
2513761|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
2513762|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513763|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2513764|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2513765|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513766|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513767|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2513768|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
2513769|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2513770|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513771|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2513772|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2513773|NCT01290211|Ritonavir|ritonavir|mesh-list
2513774|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
2513775|NCT01290211|Maraviroc|maraviroc|mesh-list
2513776|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2513777|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2513778|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
2513779|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513780|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513781|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2513782|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2513783|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
2513784|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513785|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2513786|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2513787|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2513788|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2513789|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2513790|NCT01290276|Ondansetron|ondansetron|mesh-list
2513791|NCT01290276|Methylphenidate|methylphenidate|mesh-list
2513792|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2513793|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513794|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2391124|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2391125|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2391126|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391127|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391128|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391129|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2391130|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2391131|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2391132|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391133|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2391134|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2391135|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513795|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2513796|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2513797|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513798|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
2513799|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513800|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
2513801|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
2513802|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513803|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2513804|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
2513805|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
2513806|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2513807|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
2513808|NCT01290276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2513809|NCT01290276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2513810|NCT01290276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2513811|NCT01290276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2513812|NCT01290276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2513813|NCT01290302|Azacitidine|azacitidine|mesh-list
2513814|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2513815|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
2513816|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513817|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513818|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513819|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
2513820|NCT01290328|Hematinics|hematinics|mesh-ancestor
2513821|NCT01290354|Lapatinib|lapatinib|mesh-list
2513822|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513823|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2513824|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513825|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513826|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
2513827|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2513828|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
2513829|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513830|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
2513831|NCT01290367|Protective Agents|protective agents|mesh-ancestor
2513832|NCT01290380|Vadimezan|vadimezan|mesh-list
2513833|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513834|NCT01290406|Dactolisib|dactolisib|mesh-list
2513835|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513836|NCT01290419|Vaccines|vaccines|mesh-list
2513837|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
2513838|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513839|NCT01290432|Folic Acid|folic acid|mesh-list
2513840|NCT01290432|Melatonin|melatonin|mesh-list
2513841|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
2513842|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513843|NCT01290432|Protective Agents|protective agents|mesh-ancestor
2513844|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513845|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2513846|NCT01290432|Hematinics|hematinics|mesh-ancestor
2513847|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
2513848|NCT01290432|Vitamins|vitamins|mesh-ancestor
2513849|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
2513850|NCT01290458|Vitamins|vitamins|mesh-list
2513851|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
2513852|NCT01290458|Vitamin E|vitamin e|mesh-list
2513853|NCT01290458|Tocopherols|tocopherols|mesh-list
2513854|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
2513855|NCT01290458|Antioxidants|antioxidants|mesh-list
2513856|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
2513857|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513858|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513859|NCT01290458|Protective Agents|protective agents|mesh-ancestor
2513860|NCT01290471|U3-1565|u3-1565|mesh-list
2391136|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391137|NCT00668135|Urological Agents|urological agents|mesh-ancestor
2391138|NCT00668239|Triamcinolone|triamcinolone|mesh-list
2391139|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2391140|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
2391141|NCT00668239|Hormones|hormones|mesh-ancestor
2391142|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2513861|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2513862|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513863|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
2513864|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2513865|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
2513866|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513867|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
2513868|NCT01290497|Protective Agents|protective agents|mesh-ancestor
2513869|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
2513870|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2513871|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
2513872|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513873|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
2513874|NCT01290510|Protective Agents|protective agents|mesh-ancestor
2513875|NCT01290549|Rituximab|rituximab|mesh-list
2513876|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2513877|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513878|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
2513879|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513880|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2513881|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
2513882|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
2513883|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513884|NCT01290744|Clofazimine|clofazimine|mesh-list
2513885|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2513886|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
2513887|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2513888|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513889|NCT01290783|Irinotecan|irinotecan|mesh-list
2513890|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2513891|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2391143|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391144|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
2391145|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2391146|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391147|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391148|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2391149|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2391150|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391151|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513892|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513893|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513894|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513895|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
2513896|NCT01290900|Ceftazidime|ceftazidime|mesh-list
2513897|NCT01290900|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2513898|NCT01290900|Avibactam|avibactam|mesh-list
2513899|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2513900|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2513901|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2513902|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2513903|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513904|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513905|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513906|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2513907|NCT01290926|Sorafenib|sorafenib|mesh-list
2513908|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513909|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2513910|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513911|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513912|NCT01290939|Bevacizumab|bevacizumab|mesh-list
2513913|NCT01290939|Lomustine|lomustine|mesh-list
2391152|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391153|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2513914|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2513915|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513916|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2513917|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2513918|NCT01290939|Growth Substances|growth substances|mesh-ancestor
2513919|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513920|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
2513921|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2513922|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
2513923|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391154|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
2391155|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2391156|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513949|NCT01291069|Tadalafil|tadalafil|mesh-list
2513950|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513951|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
2513952|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2513953|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2513954|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513955|NCT01291069|Urological Agents|urological agents|mesh-ancestor
2513956|NCT01291095|Cisplatin|cisplatin|mesh-list
2391157|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2391158|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2391159|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2391160|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
2391161|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
2391162|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
2391163|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2391164|NCT00668330|Calcium|calcium|mesh-list
2513957|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513958|NCT01291121|Ranibizumab|ranibizumab|mesh-list
2391165|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2391166|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391167|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2391168|NCT00668330|Vitamins|vitamins|mesh-ancestor
2391169|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
2391170|NCT00668343|Simvastatin|simvastatin|mesh-list
2391171|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2391172|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2391173|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
2391174|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391175|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2391176|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2391177|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391178|NCT00668356|Didanosine|didanosine|mesh-list
2391179|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
2391180|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391181|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2391182|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2513959|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2513960|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2513961|NCT01291121|Growth Substances|growth substances|mesh-ancestor
2513962|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513963|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
2391183|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391184|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
2391185|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391186|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2391187|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2391188|NCT00668499|Pemetrexed|pemetrexed|mesh-list
2391189|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391190|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513964|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2513965|NCT01291186|Epinephrine|epinephrine|mesh-list
2513966|NCT01291186|Racepinephrine|racepinephrine|mesh-list
2513967|NCT01291186|Bupivacaine|bupivacaine|mesh-list
2513968|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
2513969|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
2513970|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
2513971|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2513972|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2513973|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
2513974|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2513975|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2513976|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2513977|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
2513978|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2513979|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513980|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2513981|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2513982|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
2513983|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2391191|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391192|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2391193|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2391194|NCT00668538|Miconazole|miconazole|mesh-list
2391195|NCT00668538|Clotrimazole|clotrimazole|mesh-list
2391196|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
2391197|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391198|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2391199|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2391200|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391201|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391202|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2114616|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2114617|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2114618|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114619|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114620|NCT02605642|Infliximab|infliximab|mesh-list
2114621|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
2114622|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2114623|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2114624|NCT02605837|Budesonide|budesonide|mesh-list
2114625|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2114626|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2513984|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
2513985|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
2513986|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
2513987|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2513988|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2513989|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
2513990|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2513991|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2513992|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2513993|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2513994|NCT01291199|Urological Agents|urological agents|mesh-ancestor
2513995|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
2513996|NCT01291212|Testosterone|testosterone|mesh-list
2513997|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
2513998|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
2513999|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2514000|NCT01291212|Androgens|androgens|mesh-ancestor
2514001|NCT01291212|Hormones|hormones|mesh-ancestor
2514002|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2514003|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514004|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2514005|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514006|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
2114627|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
2391203|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
2514007|NCT01291316|Clonazepam|clonazepam|mesh-list
2514008|NCT01291316|Clobazam|clobazam|mesh-list
2514009|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2514010|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2514011|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2514012|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
2514013|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514014|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514015|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391204|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2391205|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391206|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2391207|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2391208|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2391209|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2391210|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2391211|NCT00668603|Estradiol|estradiol|mesh-list
2391212|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2391213|NCT00668603|Estrogens|estrogens|mesh-ancestor
2391214|NCT00668603|Hormones|hormones|mesh-ancestor
2391215|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2391216|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391217|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2391218|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
2391219|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2391220|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2514016|NCT01291316|Urological Agents|urological agents|mesh-ancestor
2514017|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
2514018|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
2514019|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
2514020|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2514021|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2514022|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2391221|NCT00668616|Paclitaxel|paclitaxel|mesh-list
2391222|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2391223|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
2391224|NCT00668616|Epirubicin|epirubicin|mesh-list
2391225|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2391226|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391227|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
2391228|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
2514023|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2514024|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2514025|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
2514026|NCT01291420|Vaccines|vaccines|mesh-list
2514027|NCT01291420|Immunologic Factors|immunologic factors|mesh-ancestor
2514028|NCT01291420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514029|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
2514030|NCT01291433|Tocopherols|tocopherols|mesh-list
2514031|NCT01291433|Vitamin E|vitamin e|mesh-list
2514032|NCT01291433|Tocotrienols|tocotrienols|mesh-list
2514033|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
2514034|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
2514035|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2514036|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391229|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
2391230|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391231|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2391232|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
2391233|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391234|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2391235|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2391236|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
2391237|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2391238|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2391239|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2391240|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2391241|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391242|NCT00668642|Dutasteride|dutasteride|mesh-list
2391243|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2391244|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2514037|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514038|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2514039|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2514040|NCT01291433|Protective Agents|protective agents|mesh-ancestor
2514041|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514042|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
2514043|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2514044|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
2514045|NCT01291433|Vitamins|vitamins|mesh-ancestor
2114628|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114629|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114630|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2114631|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
2114632|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
2114633|NCT02605837|Hormones|hormones|mesh-ancestor
2114634|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2391245|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514046|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
2514047|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2514048|NCT01291459|Tenofovir|tenofovir|mesh-list
2514049|NCT01291459|Emtricitabine|emtricitabine|mesh-list
2514050|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
2514051|NCT01291459|Maraviroc|maraviroc|mesh-list
2514052|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
2514053|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514054|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2514055|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2391246|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391247|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
2391248|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2391249|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391250|NCT00668655|Metronidazole|metronidazole|mesh-list
2391251|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514056|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514057|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514058|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2514059|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2514060|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2514061|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2514062|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2514063|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2514064|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2514065|NCT01291472|Ketorolac|ketorolac|mesh-list
2391252|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391253|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2391254|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2391255|NCT00668759|Amiodarone|amiodarone|mesh-list
2391256|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2391257|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391258|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2391259|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2391260|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391261|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2391262|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2391263|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2391264|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514066|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2514067|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2514068|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2514069|NCT01291472|Analgesics|analgesics|mesh-ancestor
2514070|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
2514071|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514072|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514073|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2514074|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2514075|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2514076|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514077|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514078|NCT01291511|Iloperidone|iloperidone|mesh-list
2514079|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2514080|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2514081|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2514082|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514083|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2514084|NCT01291524|Pregabalin|pregabalin|mesh-list
2514085|NCT01291524|Analgesics|analgesics|mesh-ancestor
2514086|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
2514087|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514088|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514089|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
2514090|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2514091|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2514092|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514093|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2514094|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2514095|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2514096|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2514097|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2514098|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2514099|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2514100|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
2514101|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514102|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2514103|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2514104|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
2514105|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
2514106|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514107|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514108|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
2514109|NCT01291563|Bedaquiline|bedaquiline|mesh-list
2514110|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
2514111|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2514112|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2514113|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514114|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2514115|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2514116|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514117|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514118|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514119|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2514120|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
2514121|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2514122|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514123|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2514124|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2514125|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2514126|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
2514127|NCT01291602|Avibactam|avibactam|mesh-list
2514128|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2514129|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514130|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391265|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2391266|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2391267|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2391268|NCT00668772|Tiotropium Bromide|tiotropium bromide|mesh-list
2391269|NCT00668772|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2391270|NCT00668772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2391271|NCT00668772|Autonomic Agents|autonomic agents|mesh-ancestor
2391272|NCT00668772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2391273|NCT00668772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391274|NCT00668772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2391275|NCT00668772|Respiratory System Agents|respiratory system agents|mesh-ancestor
2391276|NCT00668772|Parasympatholytics|parasympatholytics|mesh-ancestor
2391277|NCT00668772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2391278|NCT00668772|Cholinergic Agents|cholinergic agents|mesh-ancestor
2391279|NCT00668772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2391280|NCT00668772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391281|NCT00668772|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2391282|NCT00668772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2391283|NCT00668772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2391284|NCT00668772|Adrenergic Agents|adrenergic agents|mesh-ancestor
2391285|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2391286|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2391287|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2391288|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2391289|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391290|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2391291|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2514131|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2514132|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514133|NCT01291615|Gemcitabine|gemcitabine|mesh-list
2514134|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2514135|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
2514136|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514137|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514138|NCT01291615|Antiviral Agents|antiviral agents|mesh-ancestor
2514139|NCT01291615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514140|NCT01291615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514141|NCT01291615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2514142|NCT01291615|Immunologic Factors|immunologic factors|mesh-ancestor
2514143|NCT01291615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514144|NCT01291628|Copper|copper|mesh-list
2514145|NCT01291628|Trace Elements|trace elements|mesh-ancestor
2514146|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
2514147|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514148|NCT01291641|Cilostazol|cilostazol|mesh-list
2514149|NCT01291641|Probucol|probucol|mesh-list
2514150|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2514151|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2514152|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
2514153|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514154|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514155|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2514156|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
2514157|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2514158|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2514159|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514160|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2514161|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
2514162|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2514163|NCT01291641|Protective Agents|protective agents|mesh-ancestor
2514164|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2514165|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2514166|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514167|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2514168|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2514169|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
2514170|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2514171|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
2514172|NCT01291654|Acetaminophen|acetaminophen|mesh-list
2391292|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2391293|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
2391294|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2391295|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391296|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2391297|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2391298|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
2391299|NCT00668850|Insulin|insulin|mesh-list
2391300|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2391301|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2391302|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391303|NCT00668941|Vitamin D|vitamin d|mesh-list
2391304|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
2391305|NCT00668941|Alendronate|alendronate|mesh-list
2391306|NCT00668941|Teriparatide|teriparatide|mesh-list
2391307|NCT00668941|Calcium|calcium|mesh-list
2391308|NCT00668941|Vitamins|vitamins|mesh-ancestor
2391309|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
2391310|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391311|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2391312|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2391313|NCT00668967|Verapamil|verapamil|mesh-list
2391314|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2391315|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2391316|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2391317|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514173|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2514174|NCT01291654|Analgesics|analgesics|mesh-ancestor
2514175|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
2514176|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514177|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514178|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
2514179|NCT01291719|Insulin|insulin|mesh-list
2514180|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2514181|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391318|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2391319|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514182|NCT01291823|Gefitinib|gefitinib|mesh-list
2391320|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391321|NCT00669149|Aspirin|aspirin|mesh-list
2391322|NCT00669149|Heparin|heparin|mesh-list
2391323|NCT00669149|Enoxaparin|enoxaparin|mesh-list
2391324|NCT00669149|Bivalirudin|bivalirudin|mesh-list
2391325|NCT00669149|Clopidogrel|clopidogrel|mesh-list
2391326|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2391327|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2391328|NCT00669149|Analgesics|analgesics|mesh-ancestor
2391329|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
2391330|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2391331|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391332|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2391333|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2391334|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2391335|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2391336|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391337|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2391338|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2391339|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391340|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
2391341|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2391342|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2391343|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2391344|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
2391345|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2391346|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
2391347|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
2391348|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2514183|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514184|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2514185|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514186|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514187|NCT01291927|Pancrelipase|pancrelipase|mesh-list
2514188|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2514189|NCT01291940|Petrolatum|petrolatum|mesh-list
2514190|NCT01291940|Emollients|emollients|mesh-ancestor
2514191|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
2514192|NCT01291979|Lidocaine|lidocaine|mesh-list
2514193|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
2514194|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
2514195|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2514196|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514197|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
2514198|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514199|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2514200|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2514201|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2514202|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2514203|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514204|NCT01292031|Meropenem|meropenem|mesh-list
2514205|NCT01292031|Colistin|colistin|mesh-list
2514206|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391349|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
2391350|NCT00669344|Rivastigmine|rivastigmine|mesh-list
2391351|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2391352|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391353|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391354|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
2391355|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2391356|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391357|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2391358|NCT00669344|Protective Agents|protective agents|mesh-ancestor
2391359|NCT00669370|Docetaxel|docetaxel|mesh-list
2391360|NCT00669370|Capecitabine|capecitabine|mesh-list
2391361|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391362|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
2391363|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
2391364|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
2391365|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391366|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2391367|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
2391368|NCT00669435|Losartan|losartan|mesh-list
2391369|NCT00669435|Amlodipine|amlodipine|mesh-list
2391370|NCT00669435|Simvastatin|simvastatin|mesh-list
2391371|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2514207|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514208|NCT01292083|Azacitidine|azacitidine|mesh-list
2514209|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2514210|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
2514211|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514212|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514213|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514214|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
2514215|NCT01292109|Cathartics|cathartics|mesh-ancestor
2514216|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2514217|NCT01292161|Silymarin|silymarin|mesh-list
2514218|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
2514219|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514220|NCT01292161|Protective Agents|protective agents|mesh-ancestor
2514221|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514222|NCT01292174|Ibalizumab|ibalizumab|mesh-list
2514223|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2514224|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2514225|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2514226|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
2514227|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514228|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
2514229|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391372|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2391373|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2391374|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391375|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2391376|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391377|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391378|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2391379|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2391380|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
2391381|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2391382|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2514230|NCT01292343|Listerine|listerine|mesh-list
2514231|NCT01292343|Triclosan|triclosan|mesh-list
2514232|NCT01292343|Fluorides|fluorides|mesh-list
2514233|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
2514234|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
2514235|NCT01292343|Protective Agents|protective agents|mesh-ancestor
2514236|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514237|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2514238|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514239|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2514240|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2514241|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
2514242|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514243|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2514244|NCT01292356|Cetuximab|cetuximab|mesh-list
2514245|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2514246|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514247|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
2514248|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
2514249|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2514250|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2514251|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514252|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514253|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514254|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2514255|NCT01292460|Timolol|timolol|mesh-list
2514256|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2514257|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2514258|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
2514259|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514260|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514261|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514262|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2514263|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2514264|NCT01292525|Tacrolimus|tacrolimus|mesh-list
2514265|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2514266|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
2514267|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514268|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2514269|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514270|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514271|NCT01292551|Bosentan|bosentan|mesh-list
2391383|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391384|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2391385|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2391386|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2391387|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2391388|NCT00669487|Lamivudine|lamivudine|mesh-list
2391389|NCT00669487|Stavudine|stavudine|mesh-list
2391390|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2391391|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2514272|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2514273|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2514274|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514275|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
2514276|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2514277|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2514278|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2514279|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
2514280|NCT01292694|Losartan|losartan|mesh-list
2514281|NCT01292694|Captopril|captopril|mesh-list
2514282|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2514283|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2391392|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391393|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391394|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
2391395|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391396|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2391397|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2391398|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
2391399|NCT00669565|Bavituximab|bavituximab|mesh-list
2391400|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2391401|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391402|NCT00669591|Bavituximab|bavituximab|mesh-list
2391403|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2391404|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514284|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2514285|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2514286|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514287|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2514288|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
2514289|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514290|NCT01292720|Vitamin D|vitamin d|mesh-list
2514291|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
2514292|NCT01292720|Vitamins|vitamins|mesh-ancestor
2514293|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
2514294|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391405|NCT00669643|Rifampin|rifampin|mesh-list
2391406|NCT00669643|Dapsone|dapsone|mesh-list
2391407|NCT00669643|Clofazimine|clofazimine|mesh-list
2391408|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2391409|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
2391410|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391411|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391412|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
2391413|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2391414|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391415|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391416|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2391417|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2391418|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2391419|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2514295|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2514296|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2514297|NCT01292785|Hormones|hormones|mesh-list
2514298|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2514299|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514300|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2514301|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
2514302|NCT01292993|Metformin|metformin|mesh-list
2514303|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2514304|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2514305|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668485|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
2514306|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2514307|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514308|NCT01293058|Naloxone|naloxone|mesh-list
2514309|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2514310|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514311|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
2514312|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514313|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2514314|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2514315|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514316|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
2514317|NCT01293097|Atorvastatin|atorvastatin|mesh-list
2514318|NCT01293097|Pravastatin|pravastatin|mesh-list
2514319|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2514320|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2514321|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
2514322|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514323|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2514324|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2514325|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514326|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
2514327|NCT01293136|Narcotics|narcotics|mesh-ancestor
2514328|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2514329|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514330|NCT01293136|Analgesics|analgesics|mesh-ancestor
2514331|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
2514332|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514333|NCT01293149|Clonidine|clonidine|mesh-list
2514334|NCT01293149|Ropivacaine|ropivacaine|mesh-list
2514335|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
2514336|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
2514337|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2514338|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514339|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
2514340|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514341|NCT01293149|Analgesics|analgesics|mesh-ancestor
2514342|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2514343|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
2514344|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
2514345|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2514346|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2514347|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2514348|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
2514349|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514350|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514351|NCT01293162|Folic Acid|folic acid|mesh-list
2514352|NCT01293162|Policosanol|policosanol|mesh-list
2514353|NCT01293162|Hematinics|hematinics|mesh-ancestor
2514354|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
2514355|NCT01293162|Vitamins|vitamins|mesh-ancestor
2514356|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
2514357|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514358|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2514359|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2514360|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
2514361|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514362|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2514363|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2514364|NCT01293266|Propofol|propofol|mesh-list
2514365|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2514366|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2514367|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514368|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2514369|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
2514370|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
2514371|NCT01293292|Teriparatide|teriparatide|mesh-list
2514372|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2514373|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391420|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2391421|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2391422|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
2391423|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2391424|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2391425|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2514374|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2514375|NCT01293422|Rifampin|rifampin|mesh-list
2391426|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2391427|NCT00669656|Vitamin D|vitamin d|mesh-list
2391428|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
2391429|NCT00669656|Vitamins|vitamins|mesh-list
2391430|NCT00669656|Vitamin E|vitamin e|mesh-list
2391431|NCT00669656|Tocopherols|tocopherols|mesh-list
2391432|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
2391433|NCT00669656|Selenium|selenium|mesh-list
2391434|NCT00669656|Lycopene|lycopene|mesh-list
2391435|NCT00669656|Daidzein|daidzein|mesh-list
2391436|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
2391437|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391438|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2391439|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2391440|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
2391441|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391442|NCT00669656|Protective Agents|protective agents|mesh-ancestor
2391443|NCT00669656|Trace Elements|trace elements|mesh-ancestor
2391444|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2391445|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2391446|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2391447|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391448|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
2391449|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2391450|NCT00669656|Estrogens|estrogens|mesh-ancestor
2391451|NCT00669656|Hormones|hormones|mesh-ancestor
2391452|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2391453|NCT00669695|Atorvastatin|atorvastatin|mesh-list
2391454|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2514376|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2514377|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
2514378|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2514379|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514380|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
2514381|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2514382|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514383|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514384|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2514385|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2514386|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2391455|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2391456|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
2391457|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391458|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2391459|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2391460|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391461|NCT00669721|Heparin|heparin|mesh-list
2391462|NCT00669721|Calcium heparin|calcium heparin|mesh-list
2391463|NCT00669721|Nadroparin|nadroparin|mesh-list
2391464|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
2391465|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2391466|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2391467|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514387|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2514388|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2514389|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2514390|NCT01293630|Paclitaxel|paclitaxel|mesh-list
2514391|NCT01293630|Carboplatin|carboplatin|mesh-list
2514392|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2514393|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514394|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
2514395|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
2514396|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
2514397|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514398|NCT01293643|Clindamycin|clindamycin|mesh-list
2514399|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
2514400|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
2514401|NCT01293643|Amphotericin B|amphotericin b|mesh-list
2514402|NCT01293643|Tetracycline|tetracycline|mesh-list
2391487|NCT00669747|Carboplatin|carboplatin|mesh-list
2391488|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391489|NCT00669773|Docetaxel|docetaxel|mesh-list
2391490|NCT00669773|Doxorubicin|doxorubicin|mesh-list
2391491|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2391492|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391493|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
2391494|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
2391495|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
2391496|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391497|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2391498|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2391499|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2391500|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514403|NCT01293643|Ketoconazole|ketoconazole|mesh-list
2514404|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2514405|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2514406|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514407|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2514408|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514409|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514410|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
2514411|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2514412|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2514413|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2514414|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
2514415|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2514416|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514417|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2514418|NCT01293643|Amebicides|amebicides|mesh-ancestor
2514419|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2514420|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2514421|NCT01293734|Budesonide|budesonide|mesh-list
2514422|NCT01293734|Theophylline|theophylline|mesh-list
2514423|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2391501|NCT00669786|Menotropins|menotropins|mesh-list
2391502|NCT00669786|Hormones|hormones|mesh-list
2391503|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2391504|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2391505|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391506|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2391507|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
2391508|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2391509|NCT00669812|Cytarabine|cytarabine|mesh-list
2391510|NCT00669812|Prednisolone|prednisolone|mesh-list
2391511|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
2391512|NCT00669812|Melphalan|melphalan|mesh-list
2391513|NCT00669812|Ifosfamide|ifosfamide|mesh-list
2391514|NCT00669812|Carmustine|carmustine|mesh-list
2391515|NCT00669812|Doxorubicin|doxorubicin|mesh-list
2514424|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2514425|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
2514426|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514427|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514428|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2514429|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
2514430|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
2514431|NCT01293734|Hormones|hormones|mesh-ancestor
2514432|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2514433|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2514434|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514435|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514436|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391516|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2391517|NCT00669812|Methotrexate|methotrexate|mesh-list
2391518|NCT00669812|Etoposide|etoposide|mesh-list
2514437|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2514438|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2514439|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
2514440|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514441|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2514442|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2514443|NCT01293747|Estradiol|estradiol|mesh-list
2514444|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2514445|NCT01293747|Progesterone|progesterone|mesh-list
2514446|NCT01293747|Estrogens|estrogens|mesh-ancestor
2514447|NCT01293747|Hormones|hormones|mesh-ancestor
2514448|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2391519|NCT00669812|Vincristine|vincristine|mesh-list
2391520|NCT00669812|Epirubicin|epirubicin|mesh-list
2391521|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2391522|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
2391523|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391524|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2391525|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2391526|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
2391527|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391528|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391529|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2391530|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2514449|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514450|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2514451|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
2514452|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2514453|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2514454|NCT01293747|Progestins|progestins|mesh-ancestor
2514455|NCT01293838|Citalopram|citalopram|mesh-list
2514456|NCT01293838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2514457|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2391531|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2391532|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2391533|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391534|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2391535|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
2391536|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2391537|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2391538|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
2391539|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
2391540|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2391541|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2391542|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2391543|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
2391544|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391545|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
2391546|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
2391547|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
2391548|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2391549|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
2391550|NCT00669812|Hormones|hormones|mesh-ancestor
2391551|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2391552|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2391553|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
2514458|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2514459|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514460|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514461|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
2514462|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514463|NCT01293838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2514464|NCT01293838|Antidepressive Agents|antidepressive agents|mesh-ancestor
2514465|NCT01293838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2514466|NCT01293942|Bevacizumab|bevacizumab|mesh-list
2514467|NCT01293942|Capecitabine|capecitabine|mesh-list
2514468|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
2514469|NCT01293942|Irinotecan|irinotecan|mesh-list
2514470|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2514471|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514472|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2514473|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2391554|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
2391555|NCT00669890|Busulfan|busulfan|mesh-list
2391556|NCT00669890|Methotrexate|methotrexate|mesh-list
2514474|NCT01293942|Growth Substances|growth substances|mesh-ancestor
2514475|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514476|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
2514477|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2514478|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
2514479|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514480|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2514481|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2514482|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514490|NCT01294059|Milnacipran|milnacipran|mesh-list
2514491|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
2514492|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2514493|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2514494|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2514495|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514496|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514497|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514498|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2514499|NCT01294059|Analgesics|analgesics|mesh-ancestor
2514500|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
2514501|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514502|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
2514503|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2514504|NCT01294072|Curcumin|curcumin|mesh-list
2514505|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2514506|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2514507|NCT01294072|Analgesics|analgesics|mesh-ancestor
2514508|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
2514509|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514510|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514511|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2514512|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2514513|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514514|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514515|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514516|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
2514517|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
2514518|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514519|NCT01294176|Protective Agents|protective agents|mesh-ancestor
2514520|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514521|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
2514522|NCT01294176|Vitamins|vitamins|mesh-ancestor
2514523|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
2514524|NCT01294202|Imatinib Mesylate|imatinib mesylate|mesh-list
2514525|NCT01294202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514526|NCT01294202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2391557|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
2391558|NCT00669890|Tacrolimus|tacrolimus|mesh-list
2391559|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
2391560|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2391561|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
2391562|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391563|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2391564|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2391565|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
2391566|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391567|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391568|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2391569|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2391570|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
2391571|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2391572|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2391573|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
2514527|NCT01294202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514528|NCT01294202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514529|NCT01294215|Nifedipine|nifedipine|mesh-list
2514530|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2514531|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2514532|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514533|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2514534|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514535|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
2514536|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
2514537|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2514538|NCT01294293|Paclitaxel|paclitaxel|mesh-list
2514539|NCT01294293|Doxorubicin|doxorubicin|mesh-list
2514540|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2514541|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2514542|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514543|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
2514544|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
2514545|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
2514546|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514547|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2514548|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2514549|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2514550|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514551|NCT01294410|Antibodies|antibodies|mesh-list
2514552|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
2514553|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
2514554|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514555|NCT01294605|Edetic Acid|edetic acid|mesh-list
2514556|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
2514557|NCT01294605|Antidotes|antidotes|mesh-ancestor
2514558|NCT01294605|Protective Agents|protective agents|mesh-ancestor
2514559|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391574|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
2391575|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391576|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2391577|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2391578|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2391579|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2391580|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2391581|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
2391582|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391583|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391584|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2391585|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
2391586|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391587|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391588|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2391589|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2391590|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391591|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391592|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391593|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2391594|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2391595|NCT00670033|Travoprost|travoprost|mesh-list
2391596|NCT00670033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2391597|NCT00670033|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2391598|NCT00670033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2391599|NCT00670124|Menthol|menthol|mesh-list
2391600|NCT00670124|Antipruritics|antipruritics|mesh-ancestor
2391601|NCT00670124|Dermatologic Agents|dermatologic agents|mesh-ancestor
2391602|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
2514560|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
2514561|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
2514562|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514563|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2391603|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391604|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
2391605|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391606|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391607|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2514564|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
2514565|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2514566|NCT01294618|Interferons|interferons|mesh-list
2514567|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514568|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
2391608|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2391609|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422937|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2514569|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391610|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514570|NCT01294631|Canagliflozin|canagliflozin|mesh-list
2514571|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2514572|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514573|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2514574|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514575|NCT01294735|Temozolomide|temozolomide|mesh-list
2514576|NCT01294735|Niraparib|niraparib|mesh-list
2514577|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2514578|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
2514579|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514580|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514581|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2514582|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391611|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391612|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2391613|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2391614|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
2391615|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2391616|NCT00670293|Raclopride|raclopride|mesh-list
2391617|NCT00670293|Methylphenidate|methylphenidate|mesh-list
2391618|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2391619|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391620|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2391621|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2391622|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2391623|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391624|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
2391625|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2391626|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2391627|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2391628|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2391629|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2514583|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
2514584|NCT01294761|Darunavir|darunavir|mesh-list
2514585|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2514586|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2514587|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
2514588|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514589|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2514590|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2514591|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514592|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514593|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2514594|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2514595|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
2514596|NCT01294826|Cetuximab|cetuximab|mesh-list
2514597|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2514598|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514599|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2514600|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
2514601|NCT01294878|Omalizumab|omalizumab|mesh-list
2514602|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2514603|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2514604|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
2514605|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2514606|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2514607|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
2514608|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2514609|NCT01294956|Laxatives|laxatives|mesh-ancestor
2514610|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2514611|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2514612|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2514613|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2514614|NCT01294969|Analgesics|analgesics|mesh-ancestor
2514615|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
2514616|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514617|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514618|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2514619|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2514620|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2514621|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2514622|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2391630|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2391631|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2391632|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2391633|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
2391634|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2391635|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391636|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2391637|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2391638|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2391639|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
2391640|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2391641|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2391642|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391643|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
2391644|NCT00670345|Coagulants|coagulants|mesh-ancestor
2391645|NCT00670410|Fludarabine|fludarabine|mesh-list
2391646|NCT00670410|Busulfan|busulfan|mesh-list
2391647|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
2391648|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391649|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391650|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2391651|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
2391652|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391653|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
2391654|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2391655|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2391656|NCT00670423|Sirolimus|sirolimus|mesh-list
2391657|NCT00670423|Bortezomib|bortezomib|mesh-list
2391658|NCT00670423|Tacrolimus|tacrolimus|mesh-list
2391659|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2391660|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
2391661|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514623|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
2514624|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
2514625|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514626|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514627|NCT01295047|Atenolol|atenolol|mesh-list
2514628|NCT01295047|Verapamil|verapamil|mesh-list
2514629|NCT01295047|Perindopril|perindopril|mesh-list
2514630|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2514631|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2514632|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
2514633|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
2514634|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514635|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514636|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2514637|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2514638|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2514639|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
2514640|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514641|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514642|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2514643|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2514644|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2514645|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
2514646|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2514647|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
2514648|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514649|NCT01295060|Octreotide|octreotide|mesh-list
2114635|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2114636|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
2114637|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114638|NCT02605967|Spartalizumab|spartalizumab|mesh-list
2114639|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2114640|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114641|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114642|NCT02605993|Ravulizumab|ravulizumab|mesh-list
2114643|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2114644|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2114645|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
2114646|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114647|NCT02606253|Metolazone|metolazone|mesh-list
2114648|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
2114649|NCT02606253|Tolvaptan|tolvaptan|mesh-list
2184832|NCT00002833|Cyclosporins|cyclosporins|mesh-list
2391662|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2391663|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391664|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391665|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391666|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391667|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391668|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2391669|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
2391670|NCT00670436|Paclitaxel|paclitaxel|mesh-list
2391671|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2391672|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2391673|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391674|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
2391675|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
2391676|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
2391677|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391678|NCT00670475|Piroxicam|piroxicam|mesh-list
2391679|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2391680|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2391681|NCT00670475|Analgesics|analgesics|mesh-ancestor
2391682|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
2391683|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514650|NCT01295060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2514651|NCT01295060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2514652|NCT01295060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514653|NCT01295073|Trientine|trientine|mesh-list
2514654|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
2514655|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
2514656|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514657|NCT01295086|Docetaxel|docetaxel|mesh-list
2514658|NCT01295086|Capecitabine|capecitabine|mesh-list
2514659|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
2514660|NCT01295086|Trastuzumab|trastuzumab|mesh-list
2514661|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514662|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
2514663|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
2514664|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
2514665|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514666|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2514667|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
2514668|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2514669|NCT01295099|Triamcinolone|triamcinolone|mesh-list
2514670|NCT01295099|Fluorouracil|fluorouracil|mesh-list
2514671|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
2514672|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514673|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2514674|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514675|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2514676|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
2514677|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514678|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2514679|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
2514680|NCT01295099|Hormones|hormones|mesh-ancestor
2514681|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2514682|NCT01295138|Lactulose|lactulose|mesh-list
2514683|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2514684|NCT01295151|Adalimumab|adalimumab|mesh-list
2514685|NCT01295151|Etanercept|etanercept|mesh-list
2514686|NCT01295151|Golimumab|golimumab|mesh-list
2514687|NCT01295151|Rituximab|rituximab|mesh-list
2514688|NCT01295151|Abatacept|abatacept|mesh-list
2514689|NCT01295151|Infliximab|infliximab|mesh-list
2514690|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
2514691|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2514692|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514693|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
2514694|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514695|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2514696|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2514697|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2514698|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2514699|NCT01295151|Analgesics|analgesics|mesh-ancestor
2514700|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
2514701|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514702|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2514703|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2514704|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
2391684|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391685|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2391686|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2391687|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2391688|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391689|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391690|NCT00670501|Vitamin D|vitamin d|mesh-list
2391691|NCT00670501|Teriparatide|teriparatide|mesh-list
2514705|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2514706|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514707|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2514708|NCT01295177|Insulin|insulin|mesh-list
2514709|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2514710|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2514711|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514712|NCT01295268|Emu Oil|emu oil|mesh-list
2514713|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2391692|NCT00670501|Calcium|calcium|mesh-list
2391693|NCT00670501|Vitamins|vitamins|mesh-ancestor
2391694|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
2391695|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391696|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2391697|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2391698|NCT00670553|Panobinostat|panobinostat|mesh-list
2391699|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514714|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
2514715|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
2514716|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
2514717|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
2514718|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2514719|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2514720|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514721|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
2514722|NCT01295294|Coagulants|coagulants|mesh-ancestor
2514723|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2514724|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
2514725|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2514726|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514727|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2514728|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2514729|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2514730|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2514731|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2514732|NCT01295294|Analgesics|analgesics|mesh-ancestor
2514733|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
2514734|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514735|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2514736|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2514737|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2514738|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514739|NCT01295307|Clofarabine|clofarabine|mesh-list
2514740|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2514741|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
2514742|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514743|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514744|NCT01295372|Risperidone|risperidone|mesh-list
2514745|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2514746|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
2514747|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514748|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514749|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514750|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2514751|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2514752|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2514753|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2514754|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2514755|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
2514756|NCT01295450|Vitamins|vitamins|mesh-list
2514757|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
2514758|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514759|NCT01295502|Paclitaxel|paclitaxel|mesh-list
2514760|NCT01295502|Cisplatin|cisplatin|mesh-list
2514761|NCT01295502|Carboplatin|carboplatin|mesh-list
2514762|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2514763|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2514764|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514765|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
2514766|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
2514767|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
2514768|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514769|NCT01295567|Dipyridamole|dipyridamole|mesh-list
2514770|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2514771|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514772|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514773|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2514774|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
2514775|NCT01295593|Cladribine|cladribine|mesh-list
2514776|NCT01295593|Valproic Acid|valproic acid|mesh-list
2514777|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
2514778|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514779|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514780|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
2514781|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514782|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514783|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
2514784|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2514785|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2514786|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2514787|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514788|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2514789|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
2514790|NCT01295606|Cefazolin|cefazolin|mesh-list
2514791|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2514792|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514793|NCT01295645|Cidofovir|cidofovir|mesh-list
2514794|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
2514795|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514796|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514797|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514798|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
2514799|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
2514800|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2514801|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2514802|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514803|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514804|NCT01295736|Urological Agents|urological agents|mesh-ancestor
2514805|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
2391700|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2391701|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391702|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391703|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2391704|NCT00670566|Irbesartan|irbesartan|mesh-list
2391705|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2391706|NCT00670566|Diuretics|diuretics|mesh-ancestor
2391707|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
2391708|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391709|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2391710|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2391711|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391712|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2514806|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
2514807|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2514808|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
2514809|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514810|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2514811|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2514812|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2514813|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2514814|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514815|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
2391713|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2391714|NCT00670618|Fluorides|fluorides|mesh-list
2391715|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
2391716|NCT00670618|Protective Agents|protective agents|mesh-ancestor
2391717|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391718|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2391719|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
2391720|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391721|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2514816|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2391722|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2391723|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
2391724|NCT00670670|Caseins|caseins|mesh-list
2391725|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2391726|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
2391727|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2391728|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391729|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391730|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
2391731|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
2391732|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
2391733|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2514817|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
2514818|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514819|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514820|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2514821|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
2514822|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2514823|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
2514824|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514825|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514826|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2514827|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
2514828|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
2514829|NCT01295866|Protective Agents|protective agents|mesh-ancestor
2514830|NCT01295892|Estrogens|estrogens|mesh-list
2514831|NCT01295892|Hormones|hormones|mesh-ancestor
2514832|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2514833|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514834|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2514835|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514845|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2514846|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2514847|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
2514848|NCT01296074|Hormones|hormones|mesh-ancestor
2514849|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2514850|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514851|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2514852|NCT01296074|Protective Agents|protective agents|mesh-ancestor
2514853|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2514854|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514855|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2514856|NCT01296139|Hematinics|hematinics|mesh-ancestor
2514857|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2514858|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2514859|NCT01296178|Idarubicin|idarubicin|mesh-list
2514860|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2514861|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514862|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2514863|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2514864|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514865|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514866|NCT01296204|Antibodies|antibodies|mesh-list
2514867|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
2514868|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514869|NCT01296230|Hormones|hormones|mesh-list
2514870|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2514871|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514872|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2391734|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391735|NCT00670696|Tetracaine|tetracaine|mesh-list
2391736|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
2391737|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
2391738|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2391739|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514873|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2514874|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
2514875|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514876|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514877|NCT01296269|Vasopressins|vasopressins|mesh-list
2514878|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
2514879|NCT01296269|Oxytocin|oxytocin|mesh-list
2514880|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
2514881|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2514882|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514883|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
2514884|NCT01296269|Coagulants|coagulants|mesh-ancestor
2514885|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2514886|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2514887|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
2514888|NCT01296334|Morphine|morphine|mesh-list
2514889|NCT01296334|Buprenorphine|buprenorphine|mesh-list
2514890|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2514891|NCT01296334|Narcotics|narcotics|mesh-ancestor
2514892|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2514893|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514894|NCT01296334|Analgesics|analgesics|mesh-ancestor
2514895|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
2514896|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514897|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2514898|NCT01296438|Insulin|insulin|mesh-list
2514899|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2514900|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
2514901|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
2514902|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2514903|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2514904|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514905|NCT01296464|Carbidopa|carbidopa|mesh-list
2514906|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2514907|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2514908|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
2514909|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2391740|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
2514910|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514911|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514912|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2514913|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514914|NCT01296503|Thalidomide|thalidomide|mesh-list
2514915|NCT01296503|Dexamethasone|dexamethasone|mesh-list
2514916|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
2514917|NCT01296503|BB 1101|bb 1101|mesh-list
2514918|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2514919|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
2514920|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
2514921|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2514922|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514923|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2514924|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
2391741|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2391742|NCT00670722|Insulin|insulin|mesh-list
2391743|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2391744|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
2391745|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
2391746|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2391747|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
2391748|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
2391749|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2391750|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2391751|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391752|NCT00670761|Misoprostol|misoprostol|mesh-list
2391753|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2514925|NCT01296503|Hormones|hormones|mesh-ancestor
2514926|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2514927|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2514928|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514929|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
2514930|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514931|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514932|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2514933|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
2514934|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
2514935|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2514936|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514937|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2514938|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2514939|NCT01296503|Growth Substances|growth substances|mesh-ancestor
2514940|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
2514941|NCT01296555|Letrozole|letrozole|mesh-list
2514942|NCT01296555|Fulvestrant|fulvestrant|mesh-list
2514943|NCT01296555|Midazolam|midazolam|mesh-list
2514944|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2514945|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2514946|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2391754|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
2391755|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2391756|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391757|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2391758|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2391759|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
2391760|NCT00670787|Losartan|losartan|mesh-list
2514947|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514948|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2514949|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2391761|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2391762|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2391763|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2391764|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2391765|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2391766|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391767|NCT00670787|Diuretics|diuretics|mesh-ancestor
2391768|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
2391769|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391770|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2391771|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2391772|NCT00670813|Modafinil|modafinil|mesh-list
2391773|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2391774|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514950|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2514951|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2514952|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
2514953|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
2514954|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
2514955|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
2514956|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514957|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514958|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2514959|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2514960|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2514961|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2514962|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2514963|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
2514964|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2514965|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2514966|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2514967|NCT01296802|Fenfluramine|fenfluramine|mesh-list
2514968|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
2514969|NCT01296802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2514970|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2514971|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2514972|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514973|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2514974|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
2514975|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514976|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2514977|NCT01296958|Niclosamide|niclosamide|mesh-list
2514978|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
2514979|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2514980|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
2514981|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2514982|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514983|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
2514984|NCT01296971|Ribavirin|ribavirin|mesh-list
2514985|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2514986|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
2391775|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2391776|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2514987|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2514988|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
2514989|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2514990|NCT01296997|Calcium|calcium|mesh-list
2514991|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2514992|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2514993|NCT01297010|Dexamethasone|dexamethasone|mesh-list
2514994|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
2514995|NCT01297010|BB 1101|bb 1101|mesh-list
2514996|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2514997|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
2514998|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
2514999|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515000|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515001|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2515002|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
2515003|NCT01297010|Hormones|hormones|mesh-ancestor
2515004|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515005|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2515006|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515007|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
2515008|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391777|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2391778|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391779|NCT00670878|Gemcitabine|gemcitabine|mesh-list
2391780|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2391781|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
2391782|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391783|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391784|NCT00670878|Antiviral Agents|antiviral agents|mesh-ancestor
2391785|NCT00670878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391786|NCT00670878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391787|NCT00670878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2391788|NCT00670878|Immunologic Factors|immunologic factors|mesh-ancestor
2391789|NCT00670878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391790|NCT00671008|Insulin|insulin|mesh-list
2391791|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2391792|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
2391793|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
2391794|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
2515009|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515010|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
2515011|NCT01297023|Vitamin D|vitamin d|mesh-list
2515012|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
2515013|NCT01297023|Vitamins|vitamins|mesh-list
2515014|NCT01297023|Calcium|calcium|mesh-list
2515015|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
2515016|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515017|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2515018|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2515019|NCT01297036|Donepezil|donepezil|mesh-list
2515020|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2515021|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515022|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515023|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
2114650|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2114651|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114652|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
2114653|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114654|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2114655|NCT02606253|Diuretics|diuretics|mesh-ancestor
2114656|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2114657|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2114658|NCT02606877|Pirfenidone|pirfenidone|mesh-list
2114659|NCT02606877|Nintedanib|nintedanib|mesh-list
2114660|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114661|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2114662|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114663|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114664|NCT02606877|Analgesics|analgesics|mesh-ancestor
2114665|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
2114666|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114667|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184914|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
2515024|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515025|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515026|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
2515027|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2515028|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515029|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2515030|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515031|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515032|NCT01297166|Calcitriol|calcitriol|mesh-list
2515033|NCT01297166|Calcipotriene|calcipotriene|mesh-list
2515034|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
2515035|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2515036|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515037|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2515038|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2515039|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515040|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2515041|NCT01297166|Vitamins|vitamins|mesh-ancestor
2515042|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
2515043|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2515044|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
2515045|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2391795|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2391796|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2391797|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391798|NCT00671112|Everolimus|everolimus|mesh-list
2391799|NCT00671112|Bortezomib|bortezomib|mesh-list
2391800|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391801|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2391802|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
2391803|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391804|NCT00671138|Vaccines|vaccines|mesh-list
2391805|NCT00671138|Immunologic Factors|immunologic factors|mesh-ancestor
2391806|NCT00671138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391807|NCT00671151|Theophylline|theophylline|mesh-list
2391808|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2391809|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
2391810|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2391811|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391812|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2391813|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
2391814|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2391815|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391816|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391817|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391818|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2391819|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2391820|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
2391821|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2391822|NCT00671203|Erythromycin|erythromycin|mesh-list
2391823|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
2391824|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2391825|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
2391826|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391827|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391828|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2515046|NCT01297179|Mirabegron|mirabegron|mesh-list
2515047|NCT01297179|Estradiol|estradiol|mesh-list
2515048|NCT01297179|Estrogens|estrogens|mesh-ancestor
2515049|NCT01297179|Hormones|hormones|mesh-ancestor
2515050|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515051|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515052|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2515053|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
2515054|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2515055|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2515056|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2515057|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2515058|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2515059|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2515060|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2515061|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2515062|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
2515063|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515064|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515065|NCT01297179|Urological Agents|urological agents|mesh-ancestor
2515066|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
2515067|NCT01297192|Mirabegron|mirabegron|mesh-list
2515068|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2515069|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2515070|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
2515071|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515072|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515073|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515074|NCT01297192|Urological Agents|urological agents|mesh-ancestor
2515075|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2515076|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2515077|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2515078|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
2515079|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
2515080|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2391829|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2391830|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391831|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391832|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
2391833|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2391834|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2391835|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391836|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
2391837|NCT00671281|Coagulants|coagulants|mesh-ancestor
2391838|NCT00671320|Diclofenac|diclofenac|mesh-list
2391839|NCT00671320|Valdecoxib|valdecoxib|mesh-list
2391840|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2391841|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2515081|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2515082|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515083|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2515084|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2515085|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
2515086|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2515087|NCT01297452|Paclitaxel|paclitaxel|mesh-list
2515088|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2515089|NCT01297452|Carboplatin|carboplatin|mesh-list
2515090|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2515091|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515092|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
2515093|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
2515094|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
2515095|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515096|NCT01297543|Lenograstim|lenograstim|mesh-list
2515097|NCT01297543|Sargramostim|sargramostim|mesh-list
2515098|NCT01297543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2515099|NCT01297543|Immunologic Factors|immunologic factors|mesh-ancestor
2515100|NCT01297543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515101|NCT01297569|Ranibizumab|ranibizumab|mesh-list
2515102|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2515103|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2515104|NCT01297569|Growth Substances|growth substances|mesh-ancestor
2515105|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515106|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
2515107|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515108|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
2515109|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2515110|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2515111|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2515112|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2515113|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515114|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
2515115|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515116|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515117|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2515118|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515119|NCT01297686|Dexamethasone|dexamethasone|mesh-list
2515120|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2515121|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
2515122|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
2515123|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515124|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515125|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2515126|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
2515127|NCT01297686|Hormones|hormones|mesh-ancestor
2515128|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515129|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2515130|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515131|NCT01297764|Dexamethasone|dexamethasone|mesh-list
2515132|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
2515133|NCT01297764|Lenalidomide|lenalidomide|mesh-list
2515134|NCT01297764|Vorinostat|vorinostat|mesh-list
2515135|NCT01297764|BB 1101|bb 1101|mesh-list
2515136|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2515137|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
2515138|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
2515139|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515140|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515141|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2515142|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
2515143|NCT01297764|Hormones|hormones|mesh-ancestor
2515144|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515145|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2515146|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515147|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
2515148|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391842|NCT00671320|Analgesics|analgesics|mesh-ancestor
2391843|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
2391844|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2391845|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391846|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2391847|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2391848|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2515149|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515150|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
2515151|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2515152|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2515153|NCT01297764|Growth Substances|growth substances|mesh-ancestor
2515154|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
2515155|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2515156|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
2515157|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391849|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391850|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391851|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2391852|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
2391853|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391854|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391855|NCT00671372|Bevacizumab|bevacizumab|mesh-list
2391856|NCT00671372|Cetuximab|cetuximab|mesh-list
2515158|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2515159|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515160|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515161|NCT01297803|Mitomycins|mitomycins|mesh-list
2515162|NCT01297803|Mitomycin|mitomycin|mesh-list
2515163|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2515164|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515165|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
2515166|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515167|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2515168|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515169|NCT01297816|Minocycline|minocycline|mesh-list
2515170|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2515171|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515172|NCT01297829|Ibuprofen|ibuprofen|mesh-list
2515173|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2515174|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2515175|NCT01297829|Analgesics|analgesics|mesh-ancestor
2515176|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
2515177|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515178|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515179|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2515180|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2515181|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2515182|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515183|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515184|NCT01297842|Meropenem|meropenem|mesh-list
2515185|NCT01297842|Imipenem|imipenem|mesh-list
2515186|NCT01297842|Ertapenem|ertapenem|mesh-list
2114668|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2114669|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2114670|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2114671|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2114672|NCT02607254|Pregabalin|pregabalin|mesh-list
2114673|NCT02607254|Analgesics|analgesics|mesh-ancestor
2114674|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
2114675|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114676|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114677|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
2114678|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2114679|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2114680|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114681|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2114682|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2114683|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2114684|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2114685|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2114686|NCT02607306|Insulin|insulin|mesh-list
2114687|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2391857|NCT00671372|Irinotecan|irinotecan|mesh-list
2391858|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2391859|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391860|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2391861|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2391862|NCT00671372|Growth Substances|growth substances|mesh-ancestor
2391863|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391864|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
2515187|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2515188|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515189|NCT01297855|Rifampin|rifampin|mesh-list
2515190|NCT01297855|Colistin|colistin|mesh-list
2515191|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2515192|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
2515193|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2515194|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515195|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
2515196|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2515197|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391865|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2391866|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2391867|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391868|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391869|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
2391870|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2391871|NCT00671424|Furosemide|furosemide|mesh-list
2391872|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2391873|NCT00671424|Diuretics|diuretics|mesh-ancestor
2391874|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
2391875|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391876|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2391877|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2391878|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391879|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2391880|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2391881|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2391882|NCT00671476|Doxorubicin|doxorubicin|mesh-list
2391883|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2515198|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515199|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2515200|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2515201|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2515202|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2515203|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2515204|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2515205|NCT01297894|Colistin|colistin|mesh-list
2515206|NCT01297894|Fosfomycin|fosfomycin|mesh-list
2515207|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2515208|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515209|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
2515210|NCT01297907|Miotics|miotics|mesh-ancestor
2515211|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
2114688|NCT02607306|Liraglutide|liraglutide|mesh-list
2114689|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
2391884|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2391885|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391886|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2391887|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2391888|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391889|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391890|NCT00671541|Gentamicins|gentamicins|mesh-list
2515212|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515213|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515214|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2391891|NCT00671541|Bacitracin|bacitracin|mesh-list
2391892|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391893|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391894|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2391895|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515215|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2515216|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
2515217|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2515218|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2515219|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
2515220|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515221|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515222|NCT01297946|Hormones|hormones|mesh-list
2515223|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515224|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515225|NCT01297998|Gemcitabine|gemcitabine|mesh-list
2515226|NCT01297998|Cisplatin|cisplatin|mesh-list
2515227|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515228|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2515229|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
2515230|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515231|NCT01297998|Antiviral Agents|antiviral agents|mesh-ancestor
2515232|NCT01297998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515233|NCT01297998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515234|NCT01297998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2515235|NCT01297998|Immunologic Factors|immunologic factors|mesh-ancestor
2515236|NCT01297998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515237|NCT01298011|Gemcitabine|gemcitabine|mesh-list
2515238|NCT01298011|Paclitaxel|paclitaxel|mesh-list
2515239|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2515240|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2515241|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515242|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
2515243|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
2515244|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
2515245|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515246|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2515247|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
2515248|NCT01298011|Antiviral Agents|antiviral agents|mesh-ancestor
2515249|NCT01298011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515250|NCT01298011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515251|NCT01298011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2391896|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391897|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2391898|NCT00671593|Phenol|phenol|mesh-list
2391899|NCT00671593|Glycerol|glycerol|mesh-list
2391900|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2391901|NCT00671593|Protective Agents|protective agents|mesh-ancestor
2391902|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391903|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2391904|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391905|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
2515252|NCT01298011|Immunologic Factors|immunologic factors|mesh-ancestor
2515253|NCT01298011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515254|NCT01298076|Dexamethasone|dexamethasone|mesh-list
2515255|NCT01298076|Bevacizumab|bevacizumab|mesh-list
2515256|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2515257|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515258|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2515259|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2391906|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2391907|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2391908|NCT00671632|Triazolam|triazolam|mesh-list
2391909|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2391910|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2515260|NCT01298076|Growth Substances|growth substances|mesh-ancestor
2515261|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515262|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
2515263|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2515264|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
2391911|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2391912|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2391913|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391914|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2391915|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
2391916|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
2391917|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2391918|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391919|NCT00671645|Bevacizumab|bevacizumab|mesh-list
2391920|NCT00671645|Capecitabine|capecitabine|mesh-list
2391921|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2515265|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
2515266|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515267|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2515268|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
2515269|NCT01298076|Hormones|hormones|mesh-ancestor
2515270|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515271|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2515272|NCT01298180|Hormones|hormones|mesh-list
2515273|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515274|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515275|NCT01298271|Propranolol|propranolol|mesh-list
2515276|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2515277|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2515278|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
2515279|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515280|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515281|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515282|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2515283|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2515284|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
2515285|NCT01298284|Propranolol|propranolol|mesh-list
2515286|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2515287|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2515288|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
2515289|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515290|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515291|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515292|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2515293|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2515294|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
2515295|NCT01298297|Morphine|morphine|mesh-list
2515296|NCT01298297|Buprenorphine|buprenorphine|mesh-list
2515297|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2515298|NCT01298297|Narcotics|narcotics|mesh-ancestor
2391922|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391923|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2391924|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2391925|NCT00671645|Growth Substances|growth substances|mesh-ancestor
2391926|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391927|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
2391928|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2391929|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
2391930|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391931|NCT00671697|Decitabine|decitabine|mesh-list
2391932|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
2391933|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2391934|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
2391935|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391936|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391937|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391938|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2391939|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2391940|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
2391941|NCT00671801|Irinotecan|irinotecan|mesh-list
2391942|NCT00671801|Lenalidomide|lenalidomide|mesh-list
2391943|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2391944|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2391945|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515299|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2515300|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515301|NCT01298297|Analgesics|analgesics|mesh-ancestor
2515302|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
2515303|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515304|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2515305|NCT01298310|Lidocaine|lidocaine|mesh-list
2515306|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
2515307|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
2515308|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2515309|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515310|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
2515311|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515312|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2515313|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2515314|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2515315|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2515316|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515317|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
2515318|NCT01298336|Clarithromycin|clarithromycin|mesh-list
2515319|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2515320|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515321|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2515322|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2515323|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515324|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515325|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515326|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2515327|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2515328|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2515329|NCT01298401|Gemcitabine|gemcitabine|mesh-list
2515330|NCT01298401|Capecitabine|capecitabine|mesh-list
2515331|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2515332|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
2515333|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515334|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515335|NCT01298401|Antiviral Agents|antiviral agents|mesh-ancestor
2515336|NCT01298401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515337|NCT01298401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515338|NCT01298401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2515339|NCT01298401|Immunologic Factors|immunologic factors|mesh-ancestor
2515340|NCT01298401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515341|NCT01298466|Pregabalin|pregabalin|mesh-list
2515342|NCT01298466|Analgesics|analgesics|mesh-ancestor
2515343|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
2515344|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515345|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515346|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
2515347|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2515348|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2515349|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515350|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2515351|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2515352|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2515353|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2515354|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2515355|NCT01298505|Fexofenadine|fexofenadine|mesh-list
2515356|NCT01298505|Terfenadine|terfenadine|mesh-list
2515357|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2515358|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2515359|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2515360|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
2515361|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
2515362|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515363|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515364|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515365|NCT01298687|Travoprost|travoprost|mesh-list
2515366|NCT01298687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2515367|NCT01298687|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2515368|NCT01298687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2515369|NCT01298713|Tamoxifen|tamoxifen|mesh-list
2515370|NCT01298713|Everolimus|everolimus|mesh-list
2515371|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515372|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2515373|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
2391946|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391947|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391948|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
2391949|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391950|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2391951|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2391952|NCT00671801|Growth Substances|growth substances|mesh-ancestor
2391953|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
2391954|NCT00671814|Linezolid|linezolid|mesh-list
2391955|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2391956|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391957|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2391958|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391959|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391960|NCT00672022|Miglustat|miglustat|mesh-list
2391961|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2391962|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391963|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2391964|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2391965|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
2391966|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2391967|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2391968|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2391969|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391970|NCT00672113|Nifedipine|nifedipine|mesh-list
2515374|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515375|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2515376|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
2515377|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515378|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2515379|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2515380|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2515381|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2515382|NCT01298843|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2515383|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2515384|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515385|NCT01298882|Diacetylrhein|diacetylrhein|mesh-list
2515386|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2515387|NCT01298934|Panobinostat|panobinostat|mesh-list
2515388|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515389|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2515390|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515391|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515392|NCT01299012|Liraglutide|liraglutide|mesh-list
2515393|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2515394|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515395|NCT01299012|Incretins|incretins|mesh-ancestor
2515396|NCT01299012|Hormones|hormones|mesh-ancestor
2515397|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515398|NCT01299181|Atorvastatin|atorvastatin|mesh-list
2515399|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2515400|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2515401|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
2515402|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515403|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2515404|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2515405|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515406|NCT01299194|Atorvastatin|atorvastatin|mesh-list
2515407|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2515408|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2515409|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
2515410|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391971|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2391972|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2391973|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391974|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2391975|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391976|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
2391977|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
2391978|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2391979|NCT00672165|Antibodies|antibodies|mesh-list
2391980|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2391981|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
2391982|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391983|NCT00672282|Bicalutamide|bicalutamide|mesh-list
2391984|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
2515411|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2515412|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2515413|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515414|NCT01299220|Acitretin|acitretin|mesh-list
2515415|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
2391985|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
2391986|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2391987|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391988|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391989|NCT00672295|Paclitaxel|paclitaxel|mesh-list
2515416|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
2515417|NCT01299298|Mipomersen|mipomersen|mesh-list
2515418|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2515419|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2515420|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
2515421|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515422|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2515423|NCT01299415|Vadimezan|vadimezan|mesh-list
2515424|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515425|NCT01299558|Fluticasone|fluticasone|mesh-list
2515426|NCT01299558|Xhance|xhance|mesh-list
2515427|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2515428|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2515429|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
2515430|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515431|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2391990|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2391991|NCT00672295|Carboplatin|carboplatin|mesh-list
2391992|NCT00672295|Dasatinib|dasatinib|mesh-list
2391993|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2391994|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2391995|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
2391996|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
2391997|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
2391998|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2391999|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2392000|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392001|NCT00672347|Clonidine|clonidine|mesh-list
2392002|NCT00672347|Morphine|morphine|mesh-list
2392003|NCT00672347|Bupivacaine|bupivacaine|mesh-list
2392004|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
2392005|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
2392006|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392007|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392008|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
2392009|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392010|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2392011|NCT00672347|Narcotics|narcotics|mesh-ancestor
2392012|NCT00672347|Analgesics|analgesics|mesh-ancestor
2392013|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2392014|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
2392015|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
2392016|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2392017|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2392018|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2392019|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
2392020|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392021|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392022|NCT00672360|Folic Acid|folic acid|mesh-list
2392023|NCT00672360|Hematinics|hematinics|mesh-ancestor
2392024|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
2392025|NCT00672360|Vitamins|vitamins|mesh-ancestor
2392026|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
2392027|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392028|NCT00672386|Metformin|metformin|mesh-list
2392029|NCT00672386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2392030|NCT00672386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392031|NCT00672399|Exenatide|exenatide|mesh-list
2515432|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2515433|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
2515434|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
2515435|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2515436|NCT01299597|Atorvastatin|atorvastatin|mesh-list
2515437|NCT01299597|Simvastatin|simvastatin|mesh-list
2515438|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2515439|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2392032|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
2392033|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2392034|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2392035|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2392036|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2392037|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392038|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392039|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392040|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392041|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2392042|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2392043|NCT00672399|Incretins|incretins|mesh-ancestor
2392044|NCT00672399|Hormones|hormones|mesh-ancestor
2392045|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2392046|NCT00672464|Metformin|metformin|mesh-list
2392047|NCT00672464|Olanzapine|olanzapine|mesh-list
2392048|NCT00672464|Simvastatin|simvastatin|mesh-list
2392049|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2392050|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392051|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2392052|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2392053|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
2392054|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392055|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2392056|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2392057|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392058|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
2392059|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
2392060|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392061|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2392062|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2392063|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2515440|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
2515441|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392064|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392065|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2392066|NCT00672464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2392067|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2392068|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2392069|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392070|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
2392071|NCT00672568|Capsaicin|capsaicin|mesh-list
2392072|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
2392073|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
2392074|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
2392075|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392076|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392077|NCT00672659|Dexetimide|dexetimide|mesh-list
2392078|NCT00672659|Pipamperone|pipamperone|mesh-list
2392079|NCT00672659|Citalopram|citalopram|mesh-list
2515442|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2515443|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2515444|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515445|NCT01299662|Poly ICLC|poly iclc|mesh-list
2515446|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
2515447|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
2515448|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515449|NCT01299701|Vadimezan|vadimezan|mesh-list
2515450|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515451|NCT01299753|Propranolol|propranolol|mesh-list
2515452|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2515453|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2515454|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
2515455|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515456|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515457|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515458|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2515459|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2515460|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
2515461|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2515462|NCT01299779|Laxatives|laxatives|mesh-ancestor
2392080|NCT00672659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2392081|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2392082|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2392083|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392084|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392085|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
2392086|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392087|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2515463|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2515464|NCT01299831|Hormones|hormones|mesh-list
2515465|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515466|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515467|NCT01299857|Rituximab|rituximab|mesh-list
2515468|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2515469|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515470|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
2515471|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515472|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2515473|NCT01299922|Cyclosporine|cyclosporine|mesh-list
2515474|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
2515475|NCT01299922|Cyclosporins|cyclosporins|mesh-list
2515476|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515477|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515478|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2515479|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
2515480|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515481|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
2515482|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515483|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
2515484|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2515485|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2515486|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2392088|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
2392089|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2392090|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2515487|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515488|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2515489|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
2515490|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2515491|NCT01299948|Prednisolone|prednisolone|mesh-list
2392091|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2392092|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
2392093|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
2392094|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392095|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2392096|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2392097|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
2515492|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2515493|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
2515494|NCT01299948|Hormones|hormones|mesh-ancestor
2515495|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515496|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515497|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2515498|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515499|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
2515500|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515501|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515510|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
2515511|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392098|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2392099|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2392100|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2392101|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392102|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
2392103|NCT00672763|Vitamin D|vitamin d|mesh-list
2392104|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
2392105|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
2392106|NCT00672763|Vitamins|vitamins|mesh-list
2392107|NCT00672763|Calcium|calcium|mesh-list
2392108|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
2392109|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515512|NCT01300312|Diclofenac|diclofenac|mesh-list
2515513|NCT01300312|Eperisone|eperisone|mesh-list
2515514|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2515515|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2515516|NCT01300312|Analgesics|analgesics|mesh-ancestor
2515517|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
2515518|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515519|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515520|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2515521|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2515522|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2515523|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515524|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515525|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
2515526|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2515527|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2392110|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2392111|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2392112|NCT00672776|Paroxetine|paroxetine|mesh-list
2392113|NCT00672776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2392114|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2392115|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2392116|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392117|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392118|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
2392119|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392120|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2392121|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
2392122|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2392123|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2392124|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2392125|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392126|NCT00672867|Adefovir|adefovir|mesh-list
2392127|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2392128|NCT00672867|Clevudine|clevudine|mesh-list
2392129|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
2392130|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2392131|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2392132|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2392133|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392134|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392135|NCT00672919|Pioglitazone|pioglitazone|mesh-list
2392136|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2392137|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392138|NCT00672971|Permethrin|permethrin|mesh-list
2392139|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515528|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2515529|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2515530|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2515531|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
2515532|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
2515533|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
2515534|NCT01300364|Citalopram|citalopram|mesh-list
2515535|NCT01300364|Reboxetine|reboxetine|mesh-list
2515536|NCT01300364|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2515537|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2515538|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2515539|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515540|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515541|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
2515542|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515543|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2515544|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
2515545|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2515546|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2515547|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
2515548|NCT01300377|Lidocaine|lidocaine|mesh-list
2515549|NCT01300377|Bupivacaine|bupivacaine|mesh-list
2515550|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
2515551|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
2515552|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2515553|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515554|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
2515555|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515556|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2515557|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2515558|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2515559|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2392140|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392141|NCT00672997|Timolol|timolol|mesh-list
2392142|NCT00672997|Travoprost|travoprost|mesh-list
2392143|NCT00672997|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2392144|NCT00672997|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2392145|NCT00672997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2392146|NCT00672997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2392147|NCT00672997|Adrenergic Agents|adrenergic agents|mesh-ancestor
2392148|NCT00672997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392149|NCT00672997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392150|NCT00672997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392151|NCT00672997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2392152|NCT00672997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2392153|NCT00673010|Iodine|iodine|mesh-list
2392154|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2392155|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2392156|NCT00673010|Trace Elements|trace elements|mesh-ancestor
2392157|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
2392158|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392159|NCT00673062|Pseudoephedrine|pseudoephedrine|mesh-list
2515560|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515561|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2515562|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2515563|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
2515564|NCT01300637|Metformin|metformin|mesh-list
2515565|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2515566|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515567|NCT01300676|Estradiol|estradiol|mesh-list
2515568|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
2515569|NCT01300676|Estrogens|estrogens|mesh-ancestor
2392160|NCT00673062|Ephedrine|ephedrine|mesh-list
2392161|NCT00673062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2392162|NCT00673062|Autonomic Agents|autonomic agents|mesh-ancestor
2392163|NCT00673062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392164|NCT00673062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392165|NCT00673062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2392166|NCT00673062|Respiratory System Agents|respiratory system agents|mesh-ancestor
2392167|NCT00673062|Nasal Decongestants|nasal decongestants|mesh-ancestor
2392168|NCT00673062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2392169|NCT00673062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2392170|NCT00673062|Sympathomimetics|sympathomimetics|mesh-ancestor
2392171|NCT00673062|Adrenergic Agents|adrenergic agents|mesh-ancestor
2392172|NCT00673062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392173|NCT00673062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392174|NCT00673088|Ropinirole|ropinirole|mesh-list
2392175|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2392176|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2515570|NCT01300676|Hormones|hormones|mesh-ancestor
2515571|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515572|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515573|NCT01300676|Progestins|progestins|mesh-ancestor
2515574|NCT01300754|Lidocaine|lidocaine|mesh-list
2515575|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
2515576|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
2515577|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2515578|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515579|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
2515580|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515581|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2515582|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2515583|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2515584|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2392177|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
2392178|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
2392179|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392180|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392181|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392182|NCT00673205|Bicalutamide|bicalutamide|mesh-list
2515585|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515586|NCT01300780|Etoricoxib|etoricoxib|mesh-list
2668486|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515587|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2515588|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2515589|NCT01300780|Analgesics|analgesics|mesh-ancestor
2515590|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
2515591|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515592|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515593|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2392183|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
2392184|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
2392185|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2392186|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392187|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392188|NCT00673218|Omalizumab|omalizumab|mesh-list
2392189|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2392190|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2392191|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
2392192|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
2392193|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2392194|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2392195|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2392196|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
2392197|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2392198|NCT00673296|Bevacizumab|bevacizumab|mesh-list
2392199|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2392200|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392201|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2392202|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2392203|NCT00673296|Growth Substances|growth substances|mesh-ancestor
2392204|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392205|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
2392206|NCT00673335|Letrozole|letrozole|mesh-list
2392207|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392208|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2515594|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2515595|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2515596|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2515597|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515598|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515599|NCT01300793|Rituximab|rituximab|mesh-list
2515600|NCT01300793|Carboplatin|carboplatin|mesh-list
2515601|NCT01300793|Etoposide|etoposide|mesh-list
2515602|NCT01300793|Bortezomib|bortezomib|mesh-list
2515603|NCT01300793|Ifosfamide|ifosfamide|mesh-list
2392209|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2392210|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392211|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392212|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2392213|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
2392214|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2392215|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392216|NCT00673426|Enoxaparin|enoxaparin|mesh-list
2392217|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
2515604|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
2515605|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2515606|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515607|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
2515608|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515609|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2515610|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2515611|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2515612|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2515613|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515614|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515615|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2515616|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
2515617|NCT01300962|Capecitabine|capecitabine|mesh-list
2515618|NCT01300962|Trastuzumab|trastuzumab|mesh-list
2515619|NCT01300962|Lapatinib|lapatinib|mesh-list
2515620|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2515621|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
2515622|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515623|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515624|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2515625|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2515626|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515627|NCT01300988|Aprepitant|aprepitant|mesh-list
2515628|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
2515629|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
2515630|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
2515631|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515632|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515633|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2515634|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2515635|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515636|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515637|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
2515638|NCT01301040|Docetaxel|docetaxel|mesh-list
2515639|NCT01301040|Epirubicin|epirubicin|mesh-list
2515640|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2515641|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
2515642|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392218|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2392219|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2392220|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392221|NCT00673478|Tiotropium Bromide|tiotropium bromide|mesh-list
2392222|NCT00673478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2515643|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2515644|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2515645|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
2515646|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515647|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515648|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2515649|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
2392223|NCT00673478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2392224|NCT00673478|Autonomic Agents|autonomic agents|mesh-ancestor
2392225|NCT00673478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392226|NCT00673478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392227|NCT00673478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2392228|NCT00673478|Respiratory System Agents|respiratory system agents|mesh-ancestor
2392229|NCT00673478|Parasympatholytics|parasympatholytics|mesh-ancestor
2392230|NCT00673478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2392231|NCT00673478|Cholinergic Agents|cholinergic agents|mesh-ancestor
2392232|NCT00673478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392233|NCT00673478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392234|NCT00673478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2392235|NCT00673478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2392236|NCT00673478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2392237|NCT00673478|Adrenergic Agents|adrenergic agents|mesh-ancestor
2392238|NCT00673504|Gemcitabine|gemcitabine|mesh-list
2392239|NCT00673504|Sunitinib|sunitinib|mesh-list
2392240|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2392241|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
2392242|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392243|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515650|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
2515651|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
2515652|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2515653|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2515654|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2515655|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515656|NCT01301053|Insulin|insulin|mesh-list
2515657|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2515658|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2515659|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515660|NCT01301157|Calcipotriene|calcipotriene|mesh-list
2515661|NCT01301157|Dermatologic Agents|dermatologic agents|mesh-ancestor
2515662|NCT01301222|Octreotide|octreotide|mesh-list
2515663|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2515664|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2515665|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515666|NCT01301248|Cisplatin|cisplatin|mesh-list
2515667|NCT01301248|Cetuximab|cetuximab|mesh-list
2515668|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515669|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2515670|NCT01301313|Simendan|simendan|mesh-list
2515671|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2392244|NCT00673504|Antiviral Agents|antiviral agents|mesh-ancestor
2392245|NCT00673504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2392246|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392247|NCT00673504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2515672|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
2392248|NCT00673504|Immunologic Factors|immunologic factors|mesh-ancestor
2515673|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2515674|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2515675|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515676|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515677|NCT01301313|Protective Agents|protective agents|mesh-ancestor
2515678|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515679|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2515680|NCT01301586|Doxycycline|doxycycline|mesh-list
2515681|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2515682|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515683|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
2515684|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2515685|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2515686|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
2515687|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
2515688|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2515689|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
2515690|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515691|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515692|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515693|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2515694|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515695|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
2515696|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515697|NCT01301612|Cisplatin|cisplatin|mesh-list
2515698|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
2392249|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392250|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2392251|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2392252|NCT00673504|Growth Substances|growth substances|mesh-ancestor
2392253|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
2392254|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2392255|NCT00673556|Alefacept|alefacept|mesh-list
2392256|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
2392257|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
2515699|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515700|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2515701|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
2515702|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2515703|NCT01301716|Paclitaxel|paclitaxel|mesh-list
2515704|NCT01301716|Bevacizumab|bevacizumab|mesh-list
2515705|NCT01301716|Carboplatin|carboplatin|mesh-list
2515706|NCT01301716|Pemetrexed|pemetrexed|mesh-list
2515707|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2515708|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515709|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
2515710|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
2515711|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
2515712|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515713|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2515714|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2392258|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392259|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2392260|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392261|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2392262|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392263|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392264|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2392265|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2392266|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2392267|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
2392268|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392269|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2392270|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2392271|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515715|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2515716|NCT01301716|Growth Substances|growth substances|mesh-ancestor
2515717|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515718|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
2515719|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515720|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2515721|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2515722|NCT01301807|Panobinostat|panobinostat|mesh-list
2392272|NCT00673608|Deferasirox|deferasirox|mesh-list
2392273|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2392274|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
2392275|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
2392276|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392277|NCT00673621|Albuterol|albuterol|mesh-list
2392278|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
2392279|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392280|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2392281|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
2392282|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392283|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2392284|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
2392285|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
2392286|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2515723|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515724|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2515725|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515726|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515727|NCT01301820|Lenalidomide|lenalidomide|mesh-list
2515728|NCT01301820|Azacitidine|azacitidine|mesh-list
2515729|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
2515730|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515731|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2515732|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2515733|NCT01301820|Growth Substances|growth substances|mesh-ancestor
2515734|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
2515735|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515736|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2515737|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
2515738|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515739|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515740|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2515741|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2515742|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2515743|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515744|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2515745|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2515746|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2515747|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515748|NCT01302002|Metformin|metformin|mesh-list
2515749|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2515750|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515751|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
2515752|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2515753|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515754|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2515755|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515756|NCT01302093|Racecadotril|racecadotril|mesh-list
2515757|NCT01302093|Thiorphan|thiorphan|mesh-list
2515758|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
2515759|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2515760|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
2515761|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515762|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515763|NCT01302106|Clofarabine|clofarabine|mesh-list
2515764|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2515765|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
2392287|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2392288|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2392289|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2392290|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
2392291|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392292|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392293|NCT00673621|Miotics|miotics|mesh-ancestor
2392294|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2392295|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2392296|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2392297|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2515766|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515767|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515768|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
2515769|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2668487|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2392298|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
2392299|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2392300|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2392301|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515770|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515771|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2515772|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515773|NCT01302145|Metformin|metformin|mesh-list
2515774|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
2515775|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2515776|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515777|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2515778|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515779|NCT01302158|Glimepiride|glimepiride|mesh-list
2515780|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
2515781|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2515782|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2515783|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515784|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2515785|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
2515786|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2515787|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515788|NCT01302171|Sargramostim|sargramostim|mesh-list
2515789|NCT01302171|Lenograstim|lenograstim|mesh-list
2515790|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
2392302|NCT00673829|Interleukin-2|interleukin-2|mesh-list
2392303|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392304|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2392305|NCT00673829|Analgesics|analgesics|mesh-ancestor
2392306|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
2392307|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392308|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392309|NCT00674011|Bevacizumab|bevacizumab|mesh-list
2515791|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515792|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2515793|NCT01302210|Mupirocin|mupirocin|mesh-list
2515794|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2515795|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515796|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2515797|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515798|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515799|NCT01302236|Eplerenone|eplerenone|mesh-list
2515800|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2515801|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
2515802|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515803|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515804|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2515805|NCT01302236|Diuretics|diuretics|mesh-ancestor
2392310|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2392311|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392312|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2392313|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2392314|NCT00674011|Growth Substances|growth substances|mesh-ancestor
2515806|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
2515807|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2515808|NCT01302249|Timolol|timolol|mesh-list
2515809|NCT01302249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2515810|NCT01302249|Latanoprost|latanoprost|mesh-list
2515811|NCT01302249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2515812|NCT01302249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2515813|NCT01302249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2515814|NCT01302249|Adrenergic Agents|adrenergic agents|mesh-ancestor
2515815|NCT01302249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515816|NCT01302249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515817|NCT01302249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515818|NCT01302249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2515819|NCT01302249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2515820|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
2515821|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
2392315|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392316|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
2392317|NCT00674050|Fluticasone|fluticasone|mesh-list
2392318|NCT00674050|Albuterol|albuterol|mesh-list
2392319|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392320|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2515822|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2515823|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2515824|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2515825|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515826|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2515827|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2515828|NCT01302327|Exenatide|exenatide|mesh-list
2515829|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2515830|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515831|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2515832|NCT01302327|Incretins|incretins|mesh-ancestor
2515833|NCT01302327|Hormones|hormones|mesh-ancestor
2515834|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515835|NCT01302340|Dronabinol|dronabinol|mesh-list
2515836|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
2392321|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2392322|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
2392323|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392324|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2392325|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
2392326|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
2392327|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2392328|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
2392329|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2392330|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2392331|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2392332|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2392333|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
2392334|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515837|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515838|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2515839|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2515840|NCT01302340|Analgesics|analgesics|mesh-ancestor
2515841|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
2515842|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515843|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2515844|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2515845|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515846|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515847|NCT01302340|Hormones|hormones|mesh-ancestor
2515848|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2515849|NCT01302353|Isoflurane|isoflurane|mesh-list
2515850|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2515851|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
2515852|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
2515853|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2515854|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515855|NCT01302496|Ipilimumab|ipilimumab|mesh-list
2515856|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2515857|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515858|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2515859|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515860|NCT01302587|Albuterol|albuterol|mesh-list
2515861|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2515862|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
2515863|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515864|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515865|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2515866|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
2515867|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
2515868|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2515869|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2515870|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2515871|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2515872|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
2515873|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515874|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515875|NCT01302613|Leucovorin|leucovorin|mesh-list
2515876|NCT01302613|Capecitabine|capecitabine|mesh-list
2515877|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
2515878|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2515879|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
2515880|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515881|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515882|NCT01302613|Antidotes|antidotes|mesh-ancestor
2515883|NCT01302613|Protective Agents|protective agents|mesh-ancestor
2515884|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515885|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
2515886|NCT01302613|Vitamins|vitamins|mesh-ancestor
2515887|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
2515888|NCT01302756|Folic Acid|folic acid|mesh-list
2515889|NCT01302756|Hematinics|hematinics|mesh-ancestor
2515890|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
2392335|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392336|NCT00674063|Alefacept|alefacept|mesh-list
2515891|NCT01302756|Vitamins|vitamins|mesh-ancestor
2515892|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
2515893|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515894|NCT01302821|Tryptophan|tryptophan|mesh-list
2392337|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
2392338|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
2392339|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392340|NCT00674089|Vitamin A|vitamin a|mesh-list
2392341|NCT00674089|Vitamins|vitamins|mesh-ancestor
2515895|NCT01302821|Vaccines|vaccines|mesh-list
2515896|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
2515897|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515898|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2515899|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
2515900|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2515901|NCT01302847|Dolutegravir|dolutegravir|mesh-list
2515902|NCT01302847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2515903|NCT01302847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2392342|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
2392343|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392344|NCT00674102|Vadimezan|vadimezan|mesh-list
2392345|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392346|NCT00674141|Dexamethasone|dexamethasone|mesh-list
2392347|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2392348|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
2392349|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
2392350|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392351|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392352|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2392353|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
2392354|NCT00674141|Hormones|hormones|mesh-ancestor
2392355|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2392356|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2392357|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392358|NCT00674167|Docetaxel|docetaxel|mesh-list
2392359|NCT00674167|Capecitabine|capecitabine|mesh-list
2392360|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392361|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
2392362|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
2392363|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
2392364|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392365|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2392366|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
2392367|NCT00674232|Misoprostol|misoprostol|mesh-list
2392368|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2392369|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
2392370|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2392371|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392372|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2515904|NCT01302847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515905|NCT01302847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515906|NCT01302847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2515907|NCT01302847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2515908|NCT01302847|Antiviral Agents|antiviral agents|mesh-ancestor
2392373|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2392374|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
2392375|NCT00674245|Pantoprazole|pantoprazole|mesh-list
2392376|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2392377|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2392378|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2392379|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392380|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392381|NCT00674310|Ropinirole|ropinirole|mesh-list
2392382|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2392383|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2515909|NCT01302847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515910|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
2515911|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2515912|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515913|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2515914|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2515915|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515916|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515917|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515918|NCT01303029|Gemcitabine|gemcitabine|mesh-list
2515919|NCT01303029|Capecitabine|capecitabine|mesh-list
2515920|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2515921|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2515922|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
2515923|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515924|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515925|NCT01303029|Antiviral Agents|antiviral agents|mesh-ancestor
2515926|NCT01303029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2515927|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515928|NCT01303029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2515929|NCT01303029|Immunologic Factors|immunologic factors|mesh-ancestor
2515930|NCT01303029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515931|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2515932|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
2515933|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
2515934|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2515935|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515936|NCT01303055|Metformin|metformin|mesh-list
2515937|NCT01303055|Alogliptin|alogliptin|mesh-list
2515938|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2515939|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515940|NCT01303055|Incretins|incretins|mesh-ancestor
2515941|NCT01303055|Hormones|hormones|mesh-ancestor
2515942|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2392384|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
2392385|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
2392386|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392387|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392388|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392389|NCT00674414|Trastuzumab|trastuzumab|mesh-list
2392390|NCT00674414|Everolimus|everolimus|mesh-list
2392391|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2515943|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2515944|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
2515945|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2515946|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515947|NCT01303094|Trabectedin|trabectedin|mesh-list
2515948|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2515949|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
2515950|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515951|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515952|NCT01303107|Bupivacaine|bupivacaine|mesh-list
2515953|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
2515954|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
2515955|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2515956|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515957|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
2515958|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515959|NCT01303237|Cetuximab|cetuximab|mesh-list
2515960|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2515961|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515962|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2515963|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
2515964|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
2515965|NCT01303471|Remifentanil|remifentanil|mesh-list
2515966|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2515967|NCT01303471|Narcotics|narcotics|mesh-ancestor
2515968|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392392|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392393|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2392394|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
2392395|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392396|NCT00674440|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
2392397|NCT00674440|Dopamine Agents|dopamine agents|mesh-ancestor
2392398|NCT00674440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422938|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
2392399|NCT00674440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515969|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515970|NCT01303471|Analgesics|analgesics|mesh-ancestor
2515971|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
2515972|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515973|NCT01303497|Paclitaxel|paclitaxel|mesh-list
2515974|NCT01303497|Bevacizumab|bevacizumab|mesh-list
2515975|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2392400|NCT00674440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392401|NCT00674557|Exemestane|exemestane|mesh-list
2515976|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2515977|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
2515978|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
2515979|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
2515980|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515981|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2515982|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2392402|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2392403|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392404|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2392405|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2392406|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392407|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392408|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2392409|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
2392410|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2392411|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392412|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
2392413|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
2392414|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2392415|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2392416|NCT00674557|Growth Substances|growth substances|mesh-ancestor
2392417|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
2392418|NCT00674596|Ramipril|ramipril|mesh-list
2392419|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2392420|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
2392421|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392422|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392423|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2392424|NCT00674674|Topotecan|topotecan|mesh-list
2392425|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2392426|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2392427|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392428|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392429|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392430|NCT00674687|Gabapentin|gabapentin|mesh-list
2392431|NCT00674687|Analgesics|analgesics|mesh-ancestor
2392432|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
2392433|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392434|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392435|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
2392436|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2392437|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2392438|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392439|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2392440|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2392441|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2392442|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392443|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392444|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
2392445|NCT00674713|Ondansetron|ondansetron|mesh-list
2392446|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2392447|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
2392448|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
2392449|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392450|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392451|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2392452|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
2392453|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
2392454|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2392455|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
2392456|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392457|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392458|NCT00674713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2515983|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2515984|NCT01303497|Growth Substances|growth substances|mesh-ancestor
2515985|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515986|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
2515987|NCT01303536|Ondansetron|ondansetron|mesh-list
2515988|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
2515989|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
2515990|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2515991|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2515992|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2515993|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
2515994|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
2515995|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2515996|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
2515997|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2515998|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2515999|NCT01303536|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2516000|NCT01303536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2516001|NCT01303536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516002|NCT01303536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2516003|NCT01303536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2516004|NCT01303549|Amphotericin B|amphotericin b|mesh-list
2516005|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2516006|NCT01303549|Anidulafungin|anidulafungin|mesh-list
2516007|NCT01303549|Amebicides|amebicides|mesh-ancestor
2516008|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2516009|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2516010|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2516011|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2516012|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
2516013|NCT01303601|Olanzapine|olanzapine|mesh-list
2516014|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
2516015|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
2516016|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516017|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516018|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2516019|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2392459|NCT00674713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2392460|NCT00674713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392461|NCT00674713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2392462|NCT00674713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2392463|NCT00674752|Gabapentin|gabapentin|mesh-list
2392464|NCT00674752|Analgesics|analgesics|mesh-ancestor
2392465|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
2392466|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392467|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392468|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
2392469|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2392470|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2516020|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2516021|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516022|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2516023|NCT01303601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2516024|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2516025|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2516026|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392471|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392472|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2392473|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2392474|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2392475|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392476|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392477|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
2392478|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
2392479|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2392480|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392481|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2392482|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2392483|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2392484|NCT00674921|Renal Agents|renal agents|mesh-ancestor
2392485|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2392486|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
2516027|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516028|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
2516029|NCT01303614|Lidocaine|lidocaine|mesh-list
2516030|NCT01303614|Prilocaine|prilocaine|mesh-list
2516031|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2516032|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
2516033|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
2516034|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516035|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516036|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
2516037|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516038|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2516039|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2516040|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2516041|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2516042|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516043|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2516044|NCT01303640|Everolimus|everolimus|mesh-list
2516045|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516046|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2392487|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2392488|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2392489|NCT00674999|Bacitracin|bacitracin|mesh-list
2392490|NCT00674999|Nystatin|nystatin|mesh-list
2392491|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2392492|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2392493|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2392494|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
2392495|NCT00674999|Ionophores|ionophores|mesh-ancestor
2392496|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2516047|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
2516048|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516049|NCT01303679|Paclitaxel|paclitaxel|mesh-list
2516050|NCT01303679|Bevacizumab|bevacizumab|mesh-list
2516051|NCT01303679|Exemestane|exemestane|mesh-list
2516052|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2516053|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516054|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
2516055|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
2516056|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
2516057|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516058|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2516059|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2516060|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2516061|NCT01303679|Growth Substances|growth substances|mesh-ancestor
2516062|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516063|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
2516064|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2516065|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2516066|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516067|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2516068|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
2516069|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2516070|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
2516071|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2516072|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
2516073|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516074|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2516075|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2516076|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
2516077|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516078|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516079|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2392497|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392498|NCT00675012|Capecitabine|capecitabine|mesh-list
2392499|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
2392500|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2392501|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
2392502|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392503|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392504|NCT00675181|Melatonin|melatonin|mesh-list
2392505|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
2392506|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392507|NCT00675181|Protective Agents|protective agents|mesh-ancestor
2392508|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392509|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392510|NCT00675194|Capecitabine|capecitabine|mesh-list
2392511|NCT00675194|Irinotecan|irinotecan|mesh-list
2392512|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392513|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2392514|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
2392515|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392516|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2392517|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2392518|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392519|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2392520|NCT00675207|Dorzolamide|dorzolamide|mesh-list
2392521|NCT00675207|Brinzolamide|brinzolamide|mesh-list
2392522|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2392523|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2392524|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2392525|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2392526|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
2392527|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392528|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392529|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516080|NCT01303731|Fentanyl|fentanyl|mesh-list
2516081|NCT01303731|Bupivacaine|bupivacaine|mesh-list
2516082|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
2516083|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
2516084|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516085|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516086|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
2516087|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516088|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2516089|NCT01303731|Narcotics|narcotics|mesh-ancestor
2516090|NCT01303731|Analgesics|analgesics|mesh-ancestor
2516091|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2516092|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2516093|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
2516094|NCT01303783|Candesartan|candesartan|mesh-list
2516095|NCT01303783|Candesartan cilexetil|candesartan cilexetil|mesh-list
2516096|NCT01303783|Nifedipine|nifedipine|mesh-list
2516097|NCT01303783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2516098|NCT01303783|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2516099|NCT01303783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2516100|NCT01303783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516101|NCT01303783|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2516102|NCT01303783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2516103|NCT01303783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2516104|NCT01303783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516105|NCT01303783|Vasodilator Agents|vasodilator agents|mesh-ancestor
2516106|NCT01303783|Tocolytic Agents|tocolytic agents|mesh-ancestor
2516107|NCT01303783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2516108|NCT01303796|Decitabine|decitabine|mesh-list
2516109|NCT01303796|Sapacitabine|sapacitabine|mesh-list
2516110|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2516111|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
2516112|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516113|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516114|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516115|NCT01303874|Etanercept|etanercept|mesh-list
2516116|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2516117|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2516118|NCT01303874|Analgesics|analgesics|mesh-ancestor
2516119|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
2516120|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516121|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516122|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2516123|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2516124|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2392530|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2392531|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392532|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
2392533|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2392534|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392535|NCT00675246|Betamethasone|betamethasone|mesh-list
2392536|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
2392537|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2392538|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
2392539|NCT00675246|Hormones|hormones|mesh-ancestor
2516125|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2516126|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
2516127|NCT01303887|Prednisolone|prednisolone|mesh-list
2392540|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2392541|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392542|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2516128|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
2516129|NCT01303887|Rituximab|rituximab|mesh-list
2516130|NCT01303887|Fludarabine|fludarabine|mesh-list
2516131|NCT01303887|Vincristine|vincristine|mesh-list
2516132|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2516133|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
2516134|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516135|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2516136|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2516137|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
2516138|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516139|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392543|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
2392544|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2392545|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
2392546|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392547|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
2392548|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2392549|NCT00675285|Montelukast|montelukast|mesh-list
2392550|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2392551|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
2392552|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2392553|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
2392554|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2392555|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516140|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2516141|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2516142|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2516143|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
2516144|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
2516145|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
2516146|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2516147|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
2516148|NCT01303887|Hormones|hormones|mesh-ancestor
2392556|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2392557|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2392558|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392559|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
2392560|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2392561|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392562|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2392563|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392564|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392565|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
2392566|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
2392567|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2392568|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2392569|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392570|NCT00675545|Carboplatin|carboplatin|mesh-list
2516149|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2516150|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2516151|NCT01303926|Paclitaxel|paclitaxel|mesh-list
2516152|NCT01303926|Bevacizumab|bevacizumab|mesh-list
2516153|NCT01303926|Carboplatin|carboplatin|mesh-list
2516154|NCT01303926|Pemetrexed|pemetrexed|mesh-list
2516155|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2516156|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516157|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
2516158|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
2516159|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
2516160|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516161|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2516162|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2516163|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2516164|NCT01303926|Growth Substances|growth substances|mesh-ancestor
2516165|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516166|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
2516167|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516168|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2392571|NCT00675545|Docetaxel|docetaxel|mesh-list
2392572|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392573|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
2392574|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
2392575|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
2392576|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392577|NCT00675649|Golimumab|golimumab|mesh-list
2392578|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2392579|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2392580|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2392581|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
2392582|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392583|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2392584|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
2392585|NCT00675688|Estrogens|estrogens|mesh-list
2392586|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2392587|NCT00675688|Hormones|hormones|mesh-ancestor
2392588|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2392589|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392590|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2392591|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
2392592|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2392593|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2392594|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2392595|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
2392596|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2392597|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2392598|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2392599|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2392600|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516169|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2516170|NCT01303952|Eculizumab|eculizumab|mesh-list
2516171|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2516172|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2516173|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
2516174|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516175|NCT01304069|Etoricoxib|etoricoxib|mesh-list
2516176|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2516177|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2516178|NCT01304069|Analgesics|analgesics|mesh-ancestor
2516179|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
2516180|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516181|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516182|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2516183|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2516184|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2516185|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2516186|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516187|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516188|NCT01304095|Ranolazine|ranolazine|mesh-list
2516189|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2516190|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2516191|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516192|NCT01304134|Morphine|morphine|mesh-list
2516193|NCT01304134|Oxycodone|oxycodone|mesh-list
2516194|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2516195|NCT01304134|Narcotics|narcotics|mesh-ancestor
2516196|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516197|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516198|NCT01304134|Analgesics|analgesics|mesh-ancestor
2516199|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
2516200|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516201|NCT01304212|Ketorolac|ketorolac|mesh-list
2516202|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2516203|NCT01304212|Epinephrine|epinephrine|mesh-list
2516204|NCT01304212|Racepinephrine|racepinephrine|mesh-list
2516205|NCT01304212|Morphine|morphine|mesh-list
2516206|NCT01304212|Ropivacaine|ropivacaine|mesh-list
2516207|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
2516208|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2516209|NCT01304212|Narcotics|narcotics|mesh-ancestor
2516210|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516211|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516212|NCT01304212|Analgesics|analgesics|mesh-ancestor
2516213|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
2516214|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516215|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
2516216|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
2516217|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2516218|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2516219|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
2516220|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392601|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392602|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392603|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
2392604|NCT00675714|Itraconazole|itraconazole|mesh-list
2392605|NCT00675714|Fluconazole|fluconazole|mesh-list
2392606|NCT00675714|Ketoconazole|ketoconazole|mesh-list
2392607|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
2392608|NCT00675714|Propranolol|propranolol|mesh-list
2392609|NCT00675714|Metoprolol|metoprolol|mesh-list
2392610|NCT00675714|Hormones|hormones|mesh-list
2392611|NCT00675714|Testosterone|testosterone|mesh-list
2392612|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
2392613|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
2392614|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2392615|NCT00675714|Oxandrolone|oxandrolone|mesh-list
2392616|NCT00675714|Nandrolone|nandrolone|mesh-list
2392617|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
2392618|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2392619|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392620|NCT00675714|Androgens|androgens|mesh-ancestor
2392621|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2516221|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516222|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2516223|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2516224|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
2516225|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2516226|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
2516227|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
2516228|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
2516229|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2516230|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2516231|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2516232|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2516233|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2516234|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2516235|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516236|NCT01304264|Maleic acid|maleic acid|mesh-list
2516237|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516238|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516239|NCT01304316|Phenylephrine|phenylephrine|mesh-list
2516240|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
2516241|NCT01304316|Tetracaine|tetracaine|mesh-list
2516242|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
2516243|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
2516244|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516245|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516246|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
2516247|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516248|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2516249|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2516250|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
2516251|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516252|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516253|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
2516254|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
2516255|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
2516256|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2516257|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
2516258|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2516259|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
2516260|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2516261|NCT01304316|Protective Agents|protective agents|mesh-ancestor
2516262|NCT01304342|Fentanyl|fentanyl|mesh-list
2516263|NCT01304342|Remifentanil|remifentanil|mesh-list
2516264|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2516265|NCT01304342|Narcotics|narcotics|mesh-ancestor
2516266|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516267|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516268|NCT01304342|Analgesics|analgesics|mesh-ancestor
2516269|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
2392622|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392623|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
2516270|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516271|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2516272|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2516273|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
2516274|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
2516275|NCT01304472|Clopidogrel|clopidogrel|mesh-list
2516276|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2516277|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2516278|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2516279|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2516280|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2516281|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
2516282|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516283|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516284|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516285|NCT01304511|Ganirelix|ganirelix|mesh-list
2516286|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
2516287|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2516288|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516289|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2516290|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
2516291|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2516292|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2516293|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
2516294|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516295|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516296|NCT01304563|Vaccines|vaccines|mesh-list
2516297|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
2516298|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516299|NCT01304602|Irinotecan|irinotecan|mesh-list
2516300|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2516301|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2516302|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516303|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516304|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516305|NCT01304784|Paclitaxel|paclitaxel|mesh-list
2516306|NCT01304784|Docetaxel|docetaxel|mesh-list
2516307|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2516308|NCT01304784|Capecitabine|capecitabine|mesh-list
2516309|NCT01304784|Trastuzumab|trastuzumab|mesh-list
2516310|NCT01304784|Lapatinib|lapatinib|mesh-list
2516311|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2516312|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2516313|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516314|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
2516315|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
2516316|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
2516317|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516318|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2516319|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
2516320|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2516321|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2516322|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516323|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
2516324|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516325|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
2516326|NCT01304797|Trastuzumab|trastuzumab|mesh-list
2516327|NCT01304797|Doxorubicin|doxorubicin|mesh-list
2392624|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2392625|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2392626|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
2392627|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392628|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392629|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2392630|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2392631|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
2392632|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
2392633|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2392634|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2516328|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
2516329|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2516330|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
2516331|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516332|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2516333|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2516334|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
2516335|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516336|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516337|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2516338|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2516339|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2516340|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2516341|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2516342|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516343|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
2516344|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
2516345|NCT01304836|Prednisolone|prednisolone|mesh-list
2516346|NCT01304836|Tacrolimus|tacrolimus|mesh-list
2392635|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2392636|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392637|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2392638|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
2392639|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2392640|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
2392641|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
2392642|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516347|NCT01304836|Basiliximab|basiliximab|mesh-list
2516348|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2516349|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
2516350|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516351|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2516352|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516353|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516354|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2516355|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516356|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2516357|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
2516358|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2516359|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2516360|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2516361|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
2516362|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
2516363|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516364|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2516365|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
2516366|NCT01304836|Hormones|hormones|mesh-ancestor
2516367|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2516368|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2516369|NCT01304836|Protective Agents|protective agents|mesh-ancestor
2516370|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2516371|NCT01304901|Montelukast|montelukast|mesh-list
2516372|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2516373|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
2516374|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2516375|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
2516376|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2516377|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516378|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2516379|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2516380|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516381|NCT01304927|Vitamin D|vitamin d|mesh-list
2516382|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
2516383|NCT01304927|Calcium|calcium|mesh-list
2516384|NCT01304927|Vitamins|vitamins|mesh-ancestor
2516385|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
2516386|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516387|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2516388|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2516389|NCT01305057|Pyridoxine|pyridoxine|mesh-list
2516390|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
2516391|NCT01305057|Vitamins|vitamins|mesh-ancestor
2516392|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
2516393|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516394|NCT01305083|Udenafil|udenafil|mesh-list
2516395|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2516396|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2516397|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516398|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516399|NCT01305135|Azacitidine|azacitidine|mesh-list
2516400|NCT01305135|Idarubicin|idarubicin|mesh-list
2516401|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2516402|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
2516403|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516404|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516405|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516406|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2516407|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2516408|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2516409|NCT01305148|Warfarin|warfarin|mesh-list
2516410|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
2516411|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
2516412|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2516413|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
2516414|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516415|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
2516416|NCT01305187|Protective Agents|protective agents|mesh-ancestor
2516417|NCT01305226|Streptokinase|streptokinase|mesh-list
2516418|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2516419|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2516420|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516421|NCT01305317|Atorvastatin|atorvastatin|mesh-list
2516422|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2516423|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2516424|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
2516425|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516426|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2516427|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2516428|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392643|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2392644|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2392645|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2392646|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2392647|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
2392648|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2392649|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392650|NCT00675779|Atorvastatin|atorvastatin|mesh-list
2392651|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
2516429|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2516430|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2516431|NCT01305395|Sirolimus|sirolimus|mesh-list
2516432|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2516433|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2516434|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2516435|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516436|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
2516437|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2516438|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
2392652|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
2392653|NCT00675779|Dacuronium|dacuronium|mesh-list
2392654|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2392655|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2392656|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
2392657|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392658|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2392659|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2392660|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392661|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2392662|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392663|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2516439|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516446|NCT01305499|Azacitidine|azacitidine|mesh-list
2516447|NCT01305499|Entinostat|entinostat|mesh-list
2516448|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2516449|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
2516450|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516451|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516452|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516453|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2392664|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2516454|NCT01305551|Metformin|metformin|mesh-list
2516455|NCT01305551|Saxagliptin|saxagliptin|mesh-list
2516456|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2392665|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2392666|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2392667|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392668|NCT00675844|Dexelvucitabine|dexelvucitabine|mesh-list
2392669|NCT00675844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2392670|NCT00675844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2392671|NCT00675844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392672|NCT00675844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392673|NCT00675844|Antiviral Agents|antiviral agents|mesh-ancestor
2392674|NCT00675844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2392675|NCT00675844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2392676|NCT00675844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2392677|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2392678|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
2392679|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2392680|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2392681|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2392682|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392683|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392684|NCT00675961|Naltrexone|naltrexone|mesh-list
2392685|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2392686|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2392687|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392688|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
2392689|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392690|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2392691|NCT00676039|Citalopram|citalopram|mesh-list
2392692|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2392693|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2392694|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2392695|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392696|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392697|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392698|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2392699|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
2392700|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2392701|NCT00676039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2392702|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
2392703|NCT00676117|Loxoprofen|loxoprofen|mesh-list
2516457|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516458|NCT01305551|Incretins|incretins|mesh-ancestor
2516459|NCT01305551|Hormones|hormones|mesh-ancestor
2516460|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2516461|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2516462|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
2516463|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516464|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516465|NCT01305603|Bupivacaine|bupivacaine|mesh-list
2516466|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
2516467|NCT01305603|Anesthetics|anesthetics|mesh-list
2392704|NCT00676117|Esomeprazole|esomeprazole|mesh-list
2392705|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2392706|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2392707|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2392708|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516468|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516469|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516470|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
2516471|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516472|NCT01305707|Diazepam|diazepam|mesh-list
2516473|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2516474|NCT01305707|Lorazepam|lorazepam|mesh-list
2516475|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
2516476|NCT01305707|Dexetimide|dexetimide|mesh-list
2516477|NCT01305707|Olanzapine|olanzapine|mesh-list
2516478|NCT01305707|Risperidone|risperidone|mesh-list
2516479|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2516480|NCT01305707|Aripiprazole|aripiprazole|mesh-list
2516481|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
2516482|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
2516483|NCT01305707|Mirtazapine|mirtazapine|mesh-list
2516484|NCT01305707|Citalopram|citalopram|mesh-list
2516485|NCT01305707|Sertraline|sertraline|mesh-list
2392709|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392710|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2516486|NCT01305707|Fluoxetine|fluoxetine|mesh-list
2516487|NCT01305707|Paroxetine|paroxetine|mesh-list
2516488|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2516489|NCT01305707|Nortriptyline|nortriptyline|mesh-list
2392711|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2392712|NCT00676117|Analgesics|analgesics|mesh-ancestor
2392713|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
2392714|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392715|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392716|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2392717|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2392718|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
2516490|NCT01305707|Imipramine|imipramine|mesh-list
2516491|NCT01305707|Clomipramine|clomipramine|mesh-list
2516492|NCT01305707|Mianserin|mianserin|mesh-list
2516493|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
2516494|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2516495|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
2516496|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516497|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516498|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516499|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2516500|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516501|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2516502|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2516503|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
2516504|NCT01305707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2516505|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2516506|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2516507|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2516508|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2516509|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2516510|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
2516511|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
2516512|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516513|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2516514|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2516515|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
2516516|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
2516517|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2516518|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
2516519|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2516520|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2516521|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2516522|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2516523|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2516524|NCT01305707|Analgesics|analgesics|mesh-ancestor
2516525|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
2516526|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2516527|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2516528|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516529|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
2516530|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
2516531|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2516532|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2516533|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
2516534|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
2516535|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2516536|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
2516537|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
2516538|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2392719|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
2392720|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392721|NCT00676156|Protective Agents|protective agents|mesh-ancestor
2392722|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392723|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
2392724|NCT00676156|Vitamins|vitamins|mesh-ancestor
2392725|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
2516539|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2516540|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2516541|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
2516542|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2516543|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2392726|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
2392727|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2392728|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392729|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2392730|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
2392731|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2392732|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2392733|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392734|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392735|NCT00676260|Pioglitazone|pioglitazone|mesh-list
2392736|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2392737|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392738|NCT00676286|Choline|choline|mesh-list
2392739|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
2392740|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2392741|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
2392742|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392743|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2392744|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2392745|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
2392746|NCT00676377|Neostigmine|neostigmine|mesh-list
2392747|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2392748|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392749|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392750|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
2392751|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392752|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392753|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2392754|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
2392755|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392756|NCT00676416|Propofol|propofol|mesh-list
2392757|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2392758|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392759|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392760|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2392761|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
2392762|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
2392763|NCT00676429|Ziprasidone|ziprasidone|mesh-list
2516544|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2516545|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2516546|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2516547|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
2516548|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
2516549|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2516550|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2516551|NCT01305733|Ketorolac|ketorolac|mesh-list
2516552|NCT01305733|Epinephrine|epinephrine|mesh-list
2516553|NCT01305733|Racepinephrine|racepinephrine|mesh-list
2516554|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
2516555|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
2516556|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2516557|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2516558|NCT01305733|Analgesics|analgesics|mesh-ancestor
2516559|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
2516560|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516561|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516562|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2516563|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2516564|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2516565|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516566|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516567|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
2516568|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
2516569|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516570|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2516571|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2516572|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
2516573|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516574|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2516575|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2516576|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
2516577|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2516578|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
2392764|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2392765|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
2392766|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392767|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392768|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392769|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2392770|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2392771|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392772|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2392773|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2516579|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
2516580|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
2516581|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2516582|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
2516583|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2516584|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2516585|NCT01305837|Prednisolone|prednisolone|mesh-list
2516586|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
2516587|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2516588|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
2516589|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2516590|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
2516591|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
2516592|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516593|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516594|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2516595|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
2516596|NCT01305837|Hormones|hormones|mesh-ancestor
2516597|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2516598|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2516599|NCT01305837|Protective Agents|protective agents|mesh-ancestor
2516600|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2516601|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516602|NCT01305850|Losartan|losartan|mesh-list
2516603|NCT01305850|Enalapril|enalapril|mesh-list
2516604|NCT01305850|Enalaprilat|enalaprilat|mesh-list
2516605|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2516606|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2516607|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2516608|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2516609|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516610|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2516611|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
2516612|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516613|NCT01305889|Sertraline|sertraline|mesh-list
2516614|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
2516615|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2516616|NCT01305889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2516617|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2516618|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2516619|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516620|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392774|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
2392775|NCT00676468|Montelukast|montelukast|mesh-list
2392776|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2392777|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
2392778|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2392779|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
2392780|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2516621|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
2516622|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516623|NCT01306006|Vaccines|vaccines|mesh-list
2516624|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
2516625|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516626|NCT01306097|Zinc|zinc|mesh-list
2516627|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
2516628|NCT01306097|Trace Elements|trace elements|mesh-ancestor
2516629|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
2516630|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516631|NCT01306097|Astringents|astringents|mesh-ancestor
2516632|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
2516633|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
2516634|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
2516635|NCT01306123|Vitamins|vitamins|mesh-ancestor
2516636|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
2392781|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392782|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2392783|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2516637|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516638|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
2516639|NCT01306123|Hematinics|hematinics|mesh-ancestor
2392784|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392785|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
2392786|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2392787|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2392788|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2392789|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2392790|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516640|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2516641|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
2516642|NCT01306266|Rizatriptan|rizatriptan|mesh-list
2516643|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2516644|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
2516645|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516646|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516647|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516648|NCT01306318|Diclofenac|diclofenac|mesh-list
2516649|NCT01306318|Eperisone|eperisone|mesh-list
2516650|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2516651|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2516652|NCT01306318|Analgesics|analgesics|mesh-ancestor
2516653|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
2516654|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516655|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516656|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2516657|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2516658|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2392791|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392792|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392793|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2392794|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2392795|NCT00676559|Ranibizumab|ranibizumab|mesh-list
2392796|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2392797|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2392798|NCT00676559|Growth Substances|growth substances|mesh-ancestor
2392799|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392800|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
2392801|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516659|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516660|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516661|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
2516662|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2516663|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2516664|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2516665|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2516666|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2516667|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
2516668|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
2516669|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
2392802|NCT00676637|Timolol|timolol|mesh-list
2392803|NCT00676637|Travoprost|travoprost|mesh-list
2392804|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2392805|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2516670|NCT01306357|Hormones|hormones|mesh-list
2516671|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2516672|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516673|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
2516674|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2516675|NCT01306370|Hemostatics|hemostatics|mesh-list
2516676|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2516677|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2516678|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516679|NCT01306370|Coagulants|coagulants|mesh-ancestor
2516680|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
2516681|NCT01306409|Hematinics|hematinics|mesh-ancestor
2516682|NCT01306461|Timolol|timolol|mesh-list
2516683|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2516684|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2516685|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
2516686|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516687|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516688|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516689|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2516690|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2516691|NCT01306565|Atorvastatin|atorvastatin|mesh-list
2516692|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2516693|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2516694|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
2516695|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516696|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2516697|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2516698|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516699|NCT01306591|Bevacizumab|bevacizumab|mesh-list
2516700|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2516701|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516702|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2516703|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2516704|NCT01306591|Growth Substances|growth substances|mesh-ancestor
2516705|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516706|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
2516707|NCT01306630|Capecitabine|capecitabine|mesh-list
2516708|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2516709|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
2516710|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516711|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516712|NCT01306708|Amitriptyline|amitriptyline|mesh-list
2516713|NCT01306708|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2516714|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2516715|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
2516716|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2516717|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2516718|NCT01306708|Analgesics|analgesics|mesh-ancestor
2516719|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
2516720|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516721|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516722|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2516723|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2516724|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2516725|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516726|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
2516727|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516728|NCT01306708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2516729|NCT01306708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2516730|NCT01306708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516731|NCT01306721|Fexofenadine|fexofenadine|mesh-list
2516732|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
2516733|NCT01306721|Ephedrine|ephedrine|mesh-list
2516734|NCT01306721|Terfenadine|terfenadine|mesh-list
2516735|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2516736|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
2516737|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516738|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516739|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2516740|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
2516741|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
2516742|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2516743|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2516744|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
2516745|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
2516746|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516747|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516748|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2516749|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2516750|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2516751|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
2516752|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
2516753|NCT01306760|Ketamine|ketamine|mesh-list
2516754|NCT01306760|Propofol|propofol|mesh-list
2516755|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2516756|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516757|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516758|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2516759|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
2516760|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
2516761|NCT01306760|Analgesics|analgesics|mesh-ancestor
2516762|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
2516763|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516764|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2516765|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2516766|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2516767|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516768|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516769|NCT01306773|Oseltamivir|oseltamivir|mesh-list
2516770|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
2516771|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2516772|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516773|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516774|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2516775|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
2516776|NCT01306851|Coagulants|coagulants|mesh-ancestor
2516777|NCT01306864|Hemostatics|hemostatics|mesh-list
2516778|NCT01306864|Coagulants|coagulants|mesh-ancestor
2516779|NCT01306981|Ranibizumab|ranibizumab|mesh-list
2392806|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2392807|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2392808|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
2392809|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2392810|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392811|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392812|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2392813|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2392814|NCT00676702|Vitamin K|vitamin k|mesh-list
2392815|NCT00676702|Pancrelipase|pancrelipase|mesh-list
2392816|NCT00676702|Pancreatin|pancreatin|mesh-list
2392817|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2392818|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2392819|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2392820|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392821|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
2392822|NCT00676702|Coagulants|coagulants|mesh-ancestor
2392823|NCT00676702|Vitamins|vitamins|mesh-ancestor
2392824|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
2392825|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392826|NCT00676741|Insulin|insulin|mesh-list
2392827|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2392828|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
2392829|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
2392830|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2392831|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
2392832|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
2392833|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2392834|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2392835|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392836|NCT00676819|Insulin|insulin|mesh-list
2392837|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2392838|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
2392839|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2392840|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392841|NCT00676832|Prednisolone|prednisolone|mesh-list
2392842|NCT00676832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2516780|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2516781|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2516782|NCT01306981|Growth Substances|growth substances|mesh-ancestor
2516783|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516784|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
2516785|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516786|NCT01306994|Adenosine|adenosine|mesh-list
2516787|NCT01306994|Analgesics|analgesics|mesh-ancestor
2516788|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
2516789|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516790|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516791|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2516792|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
2516793|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2516794|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
2516795|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
2516796|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516797|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516798|NCT01307124|Lopinavir|lopinavir|mesh-list
2516799|NCT01307124|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2516800|NCT01307124|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2516801|NCT01307124|Protease Inhibitors|protease inhibitors|mesh-ancestor
2516802|NCT01307124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392843|NCT00676832|Methylprednisolone|methylprednisolone|mesh-list
2516803|NCT01307124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516804|NCT01307124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2516805|NCT01307124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2516806|NCT01307124|Antiviral Agents|antiviral agents|mesh-ancestor
2516807|NCT01307124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2516808|NCT01307124|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2516809|NCT01307124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2516810|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
2516811|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2516812|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
2516813|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516814|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516815|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2516816|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
2516817|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
2516818|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2516819|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
2516820|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516821|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516822|NCT01307202|Gabapentin|gabapentin|mesh-list
2516823|NCT01307202|Analgesics|analgesics|mesh-ancestor
2516824|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
2516825|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516826|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516827|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
2392844|NCT00676832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2392845|NCT00676832|Prednisolone acetate|prednisolone acetate|mesh-list
2392846|NCT00676832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2392847|NCT00676832|Prednisolone phosphate|prednisolone phosphate|mesh-list
2392848|NCT00676832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2392849|NCT00676832|Glucocorticoids|glucocorticoids|mesh-ancestor
2392850|NCT00676832|Hormones|hormones|mesh-ancestor
2392851|NCT00676832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2392852|NCT00676832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392853|NCT00676832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2392854|NCT00676832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392855|NCT00676832|Antiemetics|antiemetics|mesh-ancestor
2392856|NCT00676832|Autonomic Agents|autonomic agents|mesh-ancestor
2392857|NCT00676832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392858|NCT00676832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2392859|NCT00676832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2392860|NCT00676832|Protective Agents|protective agents|mesh-ancestor
2516828|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2516829|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2516830|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392861|NCT00676845|Olmesartan|olmesartan|mesh-list
2392862|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2392863|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2392864|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2392865|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2392866|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392867|NCT00676871|Blinatumomab|blinatumomab|mesh-list
2392868|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392869|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
2392870|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2392871|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2392872|NCT00676936|Prednisolone|prednisolone|mesh-list
2392873|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
2392874|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2392875|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
2392876|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2392877|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
2392878|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
2392879|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392880|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392881|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2516831|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2516832|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2516833|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2516834|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516835|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516836|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
2516837|NCT01307215|Ropivacaine|ropivacaine|mesh-list
2516838|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
2516839|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
2392882|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
2392883|NCT00676936|Hormones|hormones|mesh-ancestor
2392884|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2392885|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2392886|NCT00676936|Protective Agents|protective agents|mesh-ancestor
2392887|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2392888|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392889|NCT00677001|R 306465|r 306465|mesh-list
2392890|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2392891|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392892|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392893|NCT00677027|Lentinan|lentinan|mesh-list
2392894|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2516840|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516841|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516842|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
2516843|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516844|NCT01307306|Metformin|metformin|mesh-list
2516845|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2516846|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516847|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
2516848|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2516849|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392895|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
2392896|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392897|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392898|NCT00677053|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
2392899|NCT00677053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2516850|NCT01307475|Adenosine|adenosine|mesh-list
2516851|NCT01307475|Analgesics|analgesics|mesh-ancestor
2516852|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
2516853|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516854|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516855|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2516856|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
2516857|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2516858|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
2516859|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
2516860|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516861|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516862|NCT01307488|Ritonavir|ritonavir|mesh-list
2516863|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2516864|NCT01307488|Lamivudine|lamivudine|mesh-list
2516865|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2516866|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2516867|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
2516868|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516869|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516870|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2516871|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2392900|NCT00677053|Antithrombins|antithrombins|mesh-ancestor
2392901|NCT00677053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2392902|NCT00677053|Protease Inhibitors|protease inhibitors|mesh-ancestor
2392903|NCT00677053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392904|NCT00677053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392905|NCT00677053|Anticoagulants|anticoagulants|mesh-ancestor
2392906|NCT00677079|Iniparib|iniparib|mesh-list
2516872|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
2516873|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2516874|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2516875|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2516876|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2516877|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2516878|NCT01307527|Riboflavin|riboflavin|mesh-list
2516879|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
2516880|NCT01307527|Vitamins|vitamins|mesh-ancestor
2516881|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
2516882|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516883|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2516884|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
2392907|NCT00677079|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2392908|NCT00677079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516885|NCT01307592|Gemcitabine|gemcitabine|mesh-list
2392909|NCT00677079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392910|NCT00677079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392911|NCT00677118|Cisplatin|cisplatin|mesh-list
2392912|NCT00677118|Fluorouracil|fluorouracil|mesh-list
2392913|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392914|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
2392915|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392916|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2392917|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2516886|NCT01307592|Rituximab|rituximab|mesh-list
2516887|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
2516888|NCT01307592|Lenalidomide|lenalidomide|mesh-list
2516889|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2516890|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516891|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
2516892|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516893|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2516894|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2516895|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
2516896|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516897|NCT01307592|Antiviral Agents|antiviral agents|mesh-ancestor
2516898|NCT01307592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2516899|NCT01307592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2516900|NCT01307592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2516901|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2516902|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2516903|NCT01307592|Growth Substances|growth substances|mesh-ancestor
2516904|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
2516905|NCT01307605|Rituximab|rituximab|mesh-list
2516906|NCT01307605|Lenalidomide|lenalidomide|mesh-list
2516907|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2516908|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516909|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
2516910|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516911|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2516912|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2516913|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2516914|NCT01307605|Growth Substances|growth substances|mesh-ancestor
2516915|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
2516916|NCT01307839|Lidocaine|lidocaine|mesh-list
2516917|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
2516918|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
2516919|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516920|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516921|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
2516922|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516923|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2516924|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2516925|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2516926|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2516927|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516928|NCT01307865|Mannitol|mannitol|mesh-list
2516929|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2516930|NCT01307865|Diuretics|diuretics|mesh-ancestor
2516931|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
2516932|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516933|NCT01307969|Lidocaine|lidocaine|mesh-list
2516934|NCT01307969|Epinephrine|epinephrine|mesh-list
2516935|NCT01307969|Racepinephrine|racepinephrine|mesh-list
2516936|NCT01307969|Ropivacaine|ropivacaine|mesh-list
2516937|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
2516938|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
2516939|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
2516940|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392918|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
2392919|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392920|NCT00677144|Capecitabine|capecitabine|mesh-list
2392921|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
2392922|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2392923|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
2392924|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392925|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392926|NCT00677170|Pevonedistat|pevonedistat|mesh-list
2392927|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392928|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392929|NCT00677248|Ezetimibe|ezetimibe|mesh-list
2516941|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516942|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
2392930|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2392931|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2392932|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
2392933|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392934|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2392935|NCT00677261|Anesthetics|anesthetics|mesh-list
2392936|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
2392937|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2392938|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392939|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
2516943|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516944|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2516945|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2516946|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2516947|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2516948|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516949|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2516950|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2516951|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
2516952|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2516953|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2516954|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2516955|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
2516956|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2516957|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
2516958|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
2516959|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
2516960|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2516971|NCT01308047|Bupivacaine|bupivacaine|mesh-list
2516972|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
2516973|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
2516974|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2516975|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516976|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
2516977|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2516978|NCT01308086|Leucovorin|leucovorin|mesh-list
2392940|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2392941|NCT00677300|Ritonavir|ritonavir|mesh-list
2392942|NCT00677300|Darunavir|darunavir|mesh-list
2392943|NCT00677300|Tenofovir|tenofovir|mesh-list
2392944|NCT00677300|Emtricitabine|emtricitabine|mesh-list
2392945|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
2392946|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2392947|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2392948|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
2392949|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392950|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392951|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2392952|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2392953|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
2392954|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2392955|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2392956|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2392957|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2392958|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2392959|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2392960|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2392961|NCT00677339|Vitamin D|vitamin d|mesh-list
2392962|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
2392963|NCT00677339|Vitamins|vitamins|mesh-list
2392964|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
2392965|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392966|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2516979|NCT01308086|Fluorouracil|fluorouracil|mesh-list
2516980|NCT01308086|Capecitabine|capecitabine|mesh-list
2516981|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
2516982|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
2516983|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
2516984|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2516985|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2516986|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2516987|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2516988|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
2516989|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2516990|NCT01308086|Antidotes|antidotes|mesh-ancestor
2516991|NCT01308086|Protective Agents|protective agents|mesh-ancestor
2516992|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
2516993|NCT01308086|Vitamins|vitamins|mesh-ancestor
2516994|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
2516995|NCT01308177|Ecabet|ecabet|mesh-list
2516996|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2516997|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2516998|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2516999|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
2517000|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517001|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517002|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2517003|NCT01308177|Protective Agents|protective agents|mesh-ancestor
2517004|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517005|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517006|NCT01308203|Niacin|niacin|mesh-list
2517007|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2517008|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
2517009|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517010|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2517011|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
2517012|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
2517013|NCT01308203|Vitamins|vitamins|mesh-ancestor
2517014|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
2517015|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517016|NCT01308229|Paclitaxel|paclitaxel|mesh-list
2517017|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2517018|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517019|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
2517020|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
2517021|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
2517022|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517023|NCT01308242|Sevelamer|sevelamer|mesh-list
2517024|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
2517025|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
2517026|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517027|NCT01308255|Vitamins|vitamins|mesh-list
2517028|NCT01308255|Folic Acid|folic acid|mesh-list
2517029|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
2517030|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2517031|NCT01308255|Methotrexate|methotrexate|mesh-list
2517032|NCT01308255|Infliximab|infliximab|mesh-list
2517033|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
2517034|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517035|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2517036|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
2517037|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2517038|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2517039|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
2517040|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517041|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517042|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
2392967|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2392968|NCT00677391|Sibutramine|sibutramine|mesh-list
2392969|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
2517043|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517044|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2517045|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2517046|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
2517047|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2517048|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2517049|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2517050|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
2517051|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
2517052|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517053|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2392970|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2392971|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
2392972|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2392973|NCT00677443|Capecitabine|capecitabine|mesh-list
2392974|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
2517054|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
2517055|NCT01308255|Hormones|hormones|mesh-ancestor
2517056|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2517057|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2517058|NCT01308255|Protective Agents|protective agents|mesh-ancestor
2517059|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2517060|NCT01308255|Hematinics|hematinics|mesh-ancestor
2517061|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
2517062|NCT01308268|Ivermectin|ivermectin|mesh-list
2517063|NCT01308268|Albendazole|albendazole|mesh-list
2517064|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2517065|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517066|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
2517067|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
2392975|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2392976|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
2392977|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392978|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2392979|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
2392980|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2392981|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2392982|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
2392983|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392984|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2392985|NCT00677521|Acarbose|acarbose|mesh-list
2392986|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2392987|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2392988|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2392989|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2392990|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2392991|NCT00677586|Liver Extracts|liver extracts|mesh-list
2517068|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2517069|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2517070|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
2517071|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
2517072|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
2517073|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517074|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517075|NCT01308320|Fentanyl|fentanyl|mesh-list
2517076|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2517077|NCT01308320|Narcotics|narcotics|mesh-ancestor
2517078|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2517079|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517080|NCT01308320|Analgesics|analgesics|mesh-ancestor
2517081|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
2517082|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517083|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2517084|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2517085|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
2517086|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
2517087|NCT01308346|Everolimus|everolimus|mesh-list
2517088|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517089|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2517090|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
2517091|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517092|NCT01308437|Insulin|insulin|mesh-list
2517093|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2517094|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
2517095|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2517096|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517097|NCT01308528|Enoxaparin|enoxaparin|mesh-list
2517098|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
2517099|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
2517100|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2517101|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2517102|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517103|NCT01308541|Propofol|propofol|mesh-list
2517104|NCT01308541|Fospropofol|fospropofol|mesh-list
2517105|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2517106|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2517107|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517108|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2517109|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
2517110|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
2517111|NCT01308554|Bupivacaine|bupivacaine|mesh-list
2517112|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
2517113|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
2517114|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2517115|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517116|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
2517117|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114690|NCT02607306|Xultophy|xultophy|mesh-list
2114691|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2114692|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114693|NCT02607306|Incretins|incretins|mesh-ancestor
2114694|NCT02607306|Hormones|hormones|mesh-ancestor
2114695|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2114696|NCT02607618|Vancomycin|vancomycin|mesh-list
2114697|NCT02607618|Iclaprim|iclaprim|mesh-list
2114698|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2114699|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114700|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2114701|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114702|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114703|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
2114704|NCT02607735|Velpatasvir|velpatasvir|mesh-list
2392992|NCT00677586|Hematinics|hematinics|mesh-ancestor
2392993|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
2392994|NCT00677664|Mannitol|mannitol|mesh-list
2392995|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
2392996|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2392997|NCT00677664|Diuretics|diuretics|mesh-ancestor
2392998|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
2392999|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393000|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2393001|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
2393002|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393003|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2393004|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2393005|NCT00677729|Albuterol|albuterol|mesh-list
2517118|NCT01308606|Simeprevir|simeprevir|mesh-list
2517119|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
2517120|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517121|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
2517122|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517123|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393006|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2393007|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
2393008|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393009|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393010|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2393011|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
2393012|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
2393013|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2393014|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2393015|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2393016|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2393017|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
2393018|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393019|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393020|NCT00677755|Misoprostol|misoprostol|mesh-list
2393021|NCT00677755|Mifepristone|mifepristone|mesh-list
2393022|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2393023|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
2393024|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2393025|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393026|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2393027|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2393028|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
2393029|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2393030|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2393031|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2393032|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2393033|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
2393034|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2393035|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2393036|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
2517124|NCT01308632|Irinotecan|irinotecan|mesh-list
2517125|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2114705|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
2393037|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2393038|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
2393039|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2517126|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2517127|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517128|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517129|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517130|NCT01308658|Ritonavir|ritonavir|mesh-list
2517131|NCT01308658|Darunavir|darunavir|mesh-list
2517132|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2517133|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2517134|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
2517135|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517136|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517137|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2517138|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2517139|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
2517140|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517141|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2517142|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2517143|NCT01308671|Varenicline|varenicline|mesh-list
2517144|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2517145|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2393040|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2393041|NCT00678106|Dalbavancin|dalbavancin|mesh-list
2393042|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2393043|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393044|NCT00678119|Sunitinib|sunitinib|mesh-list
2393045|NCT00678119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393046|NCT00678119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2393047|NCT00678119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2393048|NCT00678119|Growth Substances|growth substances|mesh-ancestor
2393049|NCT00678119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393050|NCT00678119|Growth Inhibitors|growth inhibitors|mesh-ancestor
2393051|NCT00678119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2517146|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
2517147|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517148|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517149|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517150|NCT01308684|Bevacizumab|bevacizumab|mesh-list
2517151|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2517152|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517153|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2517154|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2517155|NCT01308684|Growth Substances|growth substances|mesh-ancestor
2517156|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517157|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
2517158|NCT01308723|Sorafenib|sorafenib|mesh-list
2517159|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2517160|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517161|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2517162|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517163|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517164|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
2517165|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517166|NCT01308944|Propranolol|propranolol|mesh-list
2517167|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2517168|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2393052|NCT00678119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393053|NCT00678119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393054|NCT00678132|Gemcitabine|gemcitabine|mesh-list
2393055|NCT00678132|Olaparib|olaparib|mesh-list
2393056|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393057|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2393058|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
2517169|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
2517170|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517171|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517172|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517173|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2517174|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2517175|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
2517176|NCT01308983|Amiloride|amiloride|mesh-list
2517177|NCT01308983|Diuretics|diuretics|mesh-ancestor
2517178|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
2517179|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517180|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2517181|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2517182|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2517183|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517184|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2517185|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2517186|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2517187|NCT01309009|MEN 11420|men 11420|mesh-list
2517188|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2517189|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
2517190|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517191|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517192|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2517193|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
2517194|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
2517195|NCT01309022|Sirolimus|sirolimus|mesh-list
2517196|NCT01309022|Tacrolimus|tacrolimus|mesh-list
2517197|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393059|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393060|NCT00678132|Antiviral Agents|antiviral agents|mesh-ancestor
2393061|NCT00678132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393062|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393063|NCT00678132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393064|NCT00678132|Immunologic Factors|immunologic factors|mesh-ancestor
2393065|NCT00678132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393066|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2393067|NCT00678145|Epinephrine|epinephrine|mesh-list
2393068|NCT00678145|Morphine|morphine|mesh-list
2393069|NCT00678145|Naloxone|naloxone|mesh-list
2393070|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393071|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2393072|NCT00678145|Narcotics|narcotics|mesh-ancestor
2393073|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2393074|NCT00678145|Analgesics|analgesics|mesh-ancestor
2393075|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
2393076|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393077|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2393078|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2393079|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
2393080|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393081|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393082|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2393083|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2517198|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
2517199|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517200|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2517201|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517202|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517203|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2517204|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517205|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2517206|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
2517207|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2517208|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517209|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
2517210|NCT01309074|Pregabalin|pregabalin|mesh-list
2517211|NCT01309074|Sertraline|sertraline|mesh-list
2517212|NCT01309074|Analgesics|analgesics|mesh-ancestor
2517213|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
2517214|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517215|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517216|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
2517217|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2517218|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2517219|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517220|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2517221|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2393084|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
2393085|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2393086|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
2393087|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
2393088|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
2393089|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2393090|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2393091|NCT00678184|Atorvastatin|atorvastatin|mesh-list
2393092|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2393093|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2393094|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
2393095|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393096|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2393097|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2517222|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2517223|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2517224|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2517225|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
2517226|NCT01309074|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2517227|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2517228|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517229|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
2517230|NCT01309126|Cetuximab|cetuximab|mesh-list
2517231|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2517232|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517233|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
2517234|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2517235|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
2517236|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517237|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517238|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2517239|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
2517240|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
2517241|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2517242|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
2517243|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517244|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517245|NCT01309178|Mannitol|mannitol|mesh-list
2517246|NCT01309178|Amitriptyline|amitriptyline|mesh-list
2517247|NCT01309178|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2517248|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2517249|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
2517250|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2517251|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2517252|NCT01309178|Analgesics|analgesics|mesh-ancestor
2517253|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
2517254|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517255|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517256|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2517257|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2517258|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2517259|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517260|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
2517261|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517262|NCT01309178|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2517263|NCT01309178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2517264|NCT01309178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2517265|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2393098|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393099|NCT00678236|Gentamicins|gentamicins|mesh-list
2393100|NCT00678236|Cimetidine|cimetidine|mesh-list
2393101|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2517266|NCT01309178|Diuretics|diuretics|mesh-ancestor
2517267|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
2517268|NCT01309191|Minoxidil|minoxidil|mesh-list
2517269|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2517270|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
2517271|NCT01309399|Teriparatide|teriparatide|mesh-list
2517272|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2517273|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517274|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2517275|NCT01309412|Siltuximab|siltuximab|mesh-list
2517276|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517277|NCT01309425|Tapentadol|tapentadol|mesh-list
2517278|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2517279|NCT01309425|Narcotics|narcotics|mesh-ancestor
2517280|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2517281|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517282|NCT01309425|Analgesics|analgesics|mesh-ancestor
2393102|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2517283|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
2517284|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517285|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2517286|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2517287|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2393103|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2393104|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
2393105|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
2393106|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393107|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393108|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393109|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2393110|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2393111|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393112|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2393113|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393114|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2393115|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2393116|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
2393117|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393118|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393119|NCT00678314|Ropivacaine|ropivacaine|mesh-list
2517288|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517289|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
2517290|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517291|NCT01309438|Erythromycin|erythromycin|mesh-list
2517292|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
2517293|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2517294|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
2517295|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
2517296|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2517297|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
2517298|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2517299|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
2517300|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517301|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517302|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
2517303|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2517304|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517305|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2517306|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2517307|NCT01309477|Tacrolimus|tacrolimus|mesh-list
2517308|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393120|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
2393121|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
2393122|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2393123|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393124|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
2393125|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393126|NCT00678327|Prednisolone|prednisolone|mesh-list
2393127|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
2393128|NCT00678327|Dacarbazine|dacarbazine|mesh-list
2393129|NCT00678327|Doxorubicin|doxorubicin|mesh-list
2393130|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2393131|NCT00678327|Etoposide|etoposide|mesh-list
2393132|NCT00678327|Vincristine|vincristine|mesh-list
2393133|NCT00678327|Bleomycin|bleomycin|mesh-list
2393134|NCT00678327|Vinblastine|vinblastine|mesh-list
2517309|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
2393135|NCT00678327|Procarbazine|procarbazine|mesh-list
2393136|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393137|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
2393138|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393139|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2393140|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2393141|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
2393142|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393143|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393144|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2393145|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2393146|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2393147|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2393148|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393149|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2393150|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
2393151|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
2393152|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
2517310|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517311|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2517312|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517313|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517314|NCT01309490|Ribavirin|ribavirin|mesh-list
2517315|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
2517316|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517317|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
2517318|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393153|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2393154|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
2393155|NCT00678327|Hormones|hormones|mesh-ancestor
2393156|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2393157|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2393158|NCT00678431|Resveratrol|resveratrol|mesh-list
2393159|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
2393160|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393161|NCT00678431|Protective Agents|protective agents|mesh-ancestor
2393162|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393163|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393164|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2393165|NCT00678457|Ondansetron|ondansetron|mesh-list
2393166|NCT00678457|Olanzapine|olanzapine|mesh-list
2393167|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
2393168|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
2393169|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393170|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393171|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2393172|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
2393173|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
2393174|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2517319|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2517320|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2517321|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2517322|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2517323|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517324|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517325|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393175|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
2393176|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393177|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393178|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2393179|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2393180|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2393181|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2393182|NCT00678457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2393183|NCT00678457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2393184|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2393185|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2393186|NCT00678483|Rimonabant|rimonabant|mesh-list
2393187|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2393188|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2393189|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2393190|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393191|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393192|NCT00678483|Hormones|hormones|mesh-ancestor
2393193|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2393194|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393195|NCT00678522|Atorvastatin|atorvastatin|mesh-list
2393196|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2393197|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2517326|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
2517327|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2517328|NCT01309607|Paclitaxel|paclitaxel|mesh-list
2517329|NCT01309607|Carboplatin|carboplatin|mesh-list
2517330|NCT01309607|Lapatinib|lapatinib|mesh-list
2517331|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2517332|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517333|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
2517334|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
2517335|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
2517336|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517337|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2517338|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517339|NCT01309620|Zinc|zinc|mesh-list
2517340|NCT01309620|Trace Elements|trace elements|mesh-ancestor
2517341|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
2517342|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517343|NCT01309633|Gemcitabine|gemcitabine|mesh-list
2517344|NCT01309633|Bevacizumab|bevacizumab|mesh-list
2517345|NCT01309633|Sunitinib|sunitinib|mesh-list
2517346|NCT01309633|Cisplatin|cisplatin|mesh-list
2517347|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2517348|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517349|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2517350|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2517351|NCT01309633|Growth Substances|growth substances|mesh-ancestor
2517352|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517353|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
2517354|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2517355|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
2517356|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517357|NCT01309633|Antiviral Agents|antiviral agents|mesh-ancestor
2393198|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
2393199|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393200|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2517358|NCT01309633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517359|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517360|NCT01309633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2517361|NCT01309633|Immunologic Factors|immunologic factors|mesh-ancestor
2517362|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2517363|NCT01309685|Varenicline|varenicline|mesh-list
2517364|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2517365|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2517366|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
2517367|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517368|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517369|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517370|NCT01309698|Inositol|inositol|mesh-list
2517371|NCT01309698|Vildagliptin|vildagliptin|mesh-list
2517372|NCT01309698|Voglibose|voglibose|mesh-list
2517373|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2517374|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517375|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2517376|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
2517377|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517378|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517379|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2517380|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
2517381|NCT01309698|Vitamins|vitamins|mesh-ancestor
2517382|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
2517383|NCT01309776|Citalopram|citalopram|mesh-list
2517384|NCT01309776|Tianeptine|tianeptine|mesh-list
2517385|NCT01309776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2517386|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2517387|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2517388|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517389|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517390|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
2517391|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517392|NCT01309776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2517393|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
2517394|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2517395|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2517396|NCT01309789|Prednisone|prednisone|mesh-list
2517397|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
2517398|NCT01309789|Doxorubicin|doxorubicin|mesh-list
2517399|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2517400|NCT01309789|Vincristine|vincristine|mesh-list
2517401|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2517402|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2517403|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2517404|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
2517405|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517406|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2517407|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2517408|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
2517409|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517410|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517411|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2517412|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2517413|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2517414|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2517415|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517416|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2517417|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
2517418|NCT01309789|Hormones|hormones|mesh-ancestor
2517419|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2517420|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2517421|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2517422|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
2517423|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
2517424|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
2517425|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2517426|NCT01309854|Pioglitazone|pioglitazone|mesh-list
2517427|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2517428|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517429|NCT01309932|Interferons|interferons|mesh-list
2517430|NCT01309932|Ribavirin|ribavirin|mesh-list
2517431|NCT01309932|Interferon-alpha|interferon-alpha|mesh-list
2517432|NCT01309932|Interferon alpha-2|interferon alpha-2|mesh-list
2517433|NCT01309932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2517434|NCT01309932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2517435|NCT01309932|Protease Inhibitors|protease inhibitors|mesh-list
2517436|NCT01309932|Asunaprevir|asunaprevir|mesh-list
2517437|NCT01309932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517438|NCT01309932|Antiviral Agents|antiviral agents|mesh-ancestor
2517439|NCT01309932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517440|NCT01309932|Antimetabolites|antimetabolites|mesh-ancestor
2517441|NCT01309932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517442|NCT01309932|Immunologic Factors|immunologic factors|mesh-ancestor
2517443|NCT01309932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517444|NCT01309932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517445|NCT01309932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2517446|NCT01309932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2517447|NCT01309932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2517448|NCT01309945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2517449|NCT01309945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2517450|NCT01309945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2517451|NCT01309945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2517452|NCT01309945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517453|NCT01309945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517454|NCT01309945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517455|NCT01309945|Analgesics|analgesics|mesh-ancestor
2517456|NCT01309945|Sensory System Agents|sensory system agents|mesh-ancestor
2517457|NCT01309945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517458|NCT01309945|Antidepressive Agents|antidepressive agents|mesh-ancestor
2517459|NCT01309945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2517460|NCT01309945|Dopamine Agents|dopamine agents|mesh-ancestor
2517461|NCT01309984|Propofol|propofol|mesh-list
2517462|NCT01309984|Fospropofol|fospropofol|mesh-list
2517463|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2517464|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2517465|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517466|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2517467|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
2517468|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
2517469|NCT01310010|Dasatinib|dasatinib|mesh-list
2517470|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517471|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2517472|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517473|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517474|NCT01310101|Dexamethasone|dexamethasone|mesh-list
2517475|NCT01310101|Ofatumumab|ofatumumab|mesh-list
2517476|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2517477|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
2517478|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
2517479|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517480|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517481|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2517482|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
2517483|NCT01310101|Hormones|hormones|mesh-ancestor
2517484|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2517485|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2517486|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668488|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2668489|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2668490|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
2668491|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668492|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668493|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2668494|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2668495|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2668496|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2668497|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2668498|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
2668499|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
2668500|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
2668501|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
2668502|NCT02142634|Budesonide|budesonide|mesh-list
2668503|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2668504|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2668505|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
2668506|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668507|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668508|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2668509|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
2668510|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
2668511|NCT02142634|Hormones|hormones|mesh-ancestor
2668512|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2668513|NCT02142751|Meropenem|meropenem|mesh-list
2668514|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
2668515|NCT02142751|Fosfomycin|fosfomycin|mesh-list
2668516|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2668517|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2668518|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2668519|NCT02142777|Equol|equol|mesh-list
2668520|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
2668521|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2668522|NCT02142777|Estrogens|estrogens|mesh-ancestor
2668523|NCT02142777|Hormones|hormones|mesh-ancestor
2668524|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2668525|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668526|NCT02142790|Paclitaxel|paclitaxel|mesh-list
2668527|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2668528|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668529|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
2668530|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
2668531|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
2393201|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2393202|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393203|NCT00678613|Norfloxacin|norfloxacin|mesh-list
2393204|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2393205|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393206|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2393207|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2393208|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393209|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393210|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393211|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2393212|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2393213|NCT00678626|Docetaxel|docetaxel|mesh-list
2393214|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668532|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668533|NCT02142829|Bupivacaine|bupivacaine|mesh-list
2668534|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
2668535|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
2668536|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2668537|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668538|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
2668539|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668540|NCT02142868|Letrozole|letrozole|mesh-list
2668541|NCT02142868|Palbociclib|palbociclib|mesh-list
2393215|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
2393216|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
2393217|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
2393218|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517487|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2517488|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2517489|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517490|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2517491|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
2517492|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517493|NCT01310192|Choline|choline|mesh-list
2517494|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
2517495|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2517496|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
2517497|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517498|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2517499|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2517500|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
2517501|NCT01310244|Paclitaxel|paclitaxel|mesh-list
2517502|NCT01310244|Carboplatin|carboplatin|mesh-list
2517503|NCT01310244|Belinostat|belinostat|mesh-list
2517504|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2517505|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517506|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
2517507|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
2517508|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
2517509|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517510|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2517511|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517512|NCT01310283|Fluorides|fluorides|mesh-list
2517513|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
2517514|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
2517515|NCT01310283|Protective Agents|protective agents|mesh-ancestor
2517516|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517517|NCT01310296|Lofexidine|lofexidine|mesh-list
2517518|NCT01310296|Clonidine|clonidine|mesh-list
2517519|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2517520|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2517521|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517522|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
2517523|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517524|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2517525|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2517526|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2517527|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
2517528|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517529|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517530|NCT01310296|Analgesics|analgesics|mesh-ancestor
2517531|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
2517532|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
2517533|NCT01310361|Amoxicillin|amoxicillin|mesh-list
2517534|NCT01310361|Penicillins|penicillins|mesh-list
2517535|NCT01310361|Penicillin G|penicillin g|mesh-list
2517536|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2517537|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
2517538|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2517539|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517540|NCT01310452|Insulin|insulin|mesh-list
2517541|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2517542|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
2517543|NCT01310452|Protamines|protamines|mesh-list
2517544|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2517545|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517546|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
2517547|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517548|NCT01310452|Coagulants|coagulants|mesh-ancestor
2517549|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
2517550|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2517551|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517552|NCT01310478|Endostatins|endostatins|mesh-list
2517553|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2517554|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2517555|NCT01310478|Growth Substances|growth substances|mesh-ancestor
2517556|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517557|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
2517558|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517559|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2517560|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
2517561|NCT01310647|Estradiol|estradiol|mesh-list
2517562|NCT01310647|Testosterone|testosterone|mesh-list
2517563|NCT01310647|Estrogens|estrogens|mesh-ancestor
2517564|NCT01310647|Hormones|hormones|mesh-ancestor
2393219|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2393220|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
2393221|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2393222|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2393223|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393224|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393225|NCT00678704|Urological Agents|urological agents|mesh-ancestor
2393226|NCT00678730|Dronabinol|dronabinol|mesh-list
2517565|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2517566|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517567|NCT01310647|Androgens|androgens|mesh-ancestor
2517568|NCT01310673|Allopurinol|allopurinol|mesh-list
2517569|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
2517570|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517571|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517572|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
2517573|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2517574|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2393227|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
2393228|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393229|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2393230|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2393231|NCT00678730|Analgesics|analgesics|mesh-ancestor
2393232|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
2517575|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
2517576|NCT01310673|Protective Agents|protective agents|mesh-ancestor
2517577|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517578|NCT01310712|Oxybutynin|oxybutynin|mesh-list
2517579|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
2517580|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
2517581|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517582|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517583|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2517584|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2517585|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
2517586|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517587|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517588|NCT01310712|Urological Agents|urological agents|mesh-ancestor
2517589|NCT01310738|Amphotericin B|amphotericin b|mesh-list
2517590|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2517591|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
2393233|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393234|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2393235|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2393236|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393237|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393238|NCT00678730|Hormones|hormones|mesh-ancestor
2393239|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2393240|NCT00678743|Simvastatin|simvastatin|mesh-list
2393241|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2393242|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2393243|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
2393244|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393245|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2393246|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2517592|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2517593|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
2517594|NCT01310738|Amebicides|amebicides|mesh-ancestor
2517595|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2517596|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2517597|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517598|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2114706|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114707|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
2114708|NCT02607800|Velpatasvir|velpatasvir|mesh-list
2517599|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
2517600|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2517601|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2114709|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
2114710|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114711|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2114712|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2114713|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114714|NCT02607865|Incretins|incretins|mesh-ancestor
2114715|NCT02607865|Hormones|hormones|mesh-ancestor
2517602|NCT01310751|Iloprost|iloprost|mesh-list
2517603|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2517604|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
2517605|NCT01310842|Nicotine|nicotine|mesh-list
2517606|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2517607|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
2517608|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517609|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517610|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2517611|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2517612|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
2517613|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517614|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517615|NCT01310985|Capecitabine|capecitabine|mesh-list
2517616|NCT01310985|Cetuximab|cetuximab|mesh-list
2517617|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2517618|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
2517619|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517620|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517621|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2393247|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393248|NCT00678756|Ketoconazole|ketoconazole|mesh-list
2393249|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
2393250|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393251|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2393252|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2393253|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393254|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393255|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2517622|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2517623|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2517624|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393256|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
2393257|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2393258|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517625|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517626|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2517627|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
2517628|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2517629|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517630|NCT01311050|Bevacizumab|bevacizumab|mesh-list
2517631|NCT01311050|Capecitabine|capecitabine|mesh-list
2517632|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
2517633|NCT01311050|Irinotecan|irinotecan|mesh-list
2517634|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2517635|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517636|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2517637|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2517638|NCT01311050|Growth Substances|growth substances|mesh-ancestor
2517639|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517640|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
2517641|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2517642|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
2517643|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517644|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2517645|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2393259|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2393260|NCT00678769|Sirolimus|sirolimus|mesh-list
2393261|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2393262|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2393263|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393264|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2393265|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393266|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
2393267|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393268|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
2393269|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393270|NCT00678782|Etanercept|etanercept|mesh-list
2393271|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2393272|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2393273|NCT00678782|Analgesics|analgesics|mesh-ancestor
2393274|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
2393275|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517646|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517647|NCT01311076|Insulin|insulin|mesh-list
2517648|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2517649|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
2517650|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2517651|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517652|NCT01311141|Doripenem|doripenem|mesh-list
2517653|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2517654|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517655|NCT01311167|Dexamethasone|dexamethasone|mesh-list
2393276|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393277|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2393278|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2393279|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2393280|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393281|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
2393282|NCT00678964|Carboplatin|carboplatin|mesh-list
2393283|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2393284|NCT00678964|Vinorelbine|vinorelbine|mesh-list
2393285|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393286|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2393287|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393288|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393289|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2393290|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
2393291|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
2393292|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
2393293|NCT00678977|Gemcitabine|gemcitabine|mesh-list
2393294|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393295|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2393296|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
2517656|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2517657|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
2517658|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
2517659|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517660|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517661|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2517662|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
2517663|NCT01311167|Hormones|hormones|mesh-ancestor
2517664|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2517665|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2517666|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517667|NCT01311336|Loratadine|loratadine|mesh-list
2517668|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
2517669|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
2517670|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2517671|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2517672|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2517673|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
2517674|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
2517675|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517676|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517677|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517678|NCT01311414|Urapidil|urapidil|mesh-list
2517679|NCT01311414|Theodrenaline|theodrenaline|mesh-list
2393297|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393298|NCT00678977|Antiviral Agents|antiviral agents|mesh-ancestor
2393299|NCT00678977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393300|NCT00678977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393301|NCT00678977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393302|NCT00678977|Immunologic Factors|immunologic factors|mesh-ancestor
2393303|NCT00678977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393304|NCT00678990|Heparin|heparin|mesh-list
2393305|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
2393306|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2393307|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2393308|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393309|NCT00679068|Bosentan|bosentan|mesh-list
2393310|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2393311|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2393312|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393313|NCT00679120|Cimetidine|cimetidine|mesh-list
2393314|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2393315|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2393316|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2393317|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
2517680|NCT01311414|Cafedrine|cafedrine|mesh-list
2517681|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2517682|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
2517683|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2517684|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
2517685|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517686|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393318|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
2393319|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393320|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393321|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393322|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2393323|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2393324|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393325|NCT00679146|Ketoprofen|ketoprofen|mesh-list
2393326|NCT00679146|Colchicine|colchicine|mesh-list
2393327|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2393328|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2393329|NCT00679146|Analgesics|analgesics|mesh-ancestor
2393330|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
2393331|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393332|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517687|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517688|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2517689|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2517690|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2517691|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
2517692|NCT01311570|Buprenorphine|buprenorphine|mesh-list
2517693|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2517694|NCT01311570|Narcotics|narcotics|mesh-ancestor
2517695|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2517696|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517697|NCT01311570|Analgesics|analgesics|mesh-ancestor
2517698|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
2517699|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517700|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2517701|NCT01311622|Warfarin|warfarin|mesh-list
2517702|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
2517703|NCT01311700|Metoprolol|metoprolol|mesh-list
2517704|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2517705|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2393333|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2393334|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2393335|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2517706|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
2517707|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
2517708|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517709|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517710|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2517711|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2517712|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2517713|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
2517714|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517715|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517716|NCT01311713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2517717|NCT01311713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517718|NCT01311713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517719|NCT01311713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517720|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
2517721|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
2517722|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
2517723|NCT01311739|Vitamins|vitamins|mesh-ancestor
2393336|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393337|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393338|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
2393339|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
2393340|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
2393341|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
2517724|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
2517725|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517726|NCT01311739|Hematinics|hematinics|mesh-ancestor
2517727|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2517728|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517729|NCT01311778|Fentanyl|fentanyl|mesh-list
2517730|NCT01311778|Cannabidiol|cannabidiol|mesh-list
2517731|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2517732|NCT01311778|Narcotics|narcotics|mesh-ancestor
2517733|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2517734|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517735|NCT01311778|Analgesics|analgesics|mesh-ancestor
2517736|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
2517737|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517738|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2517739|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2517740|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
2517741|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
2393342|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393343|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2393344|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
2393345|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393346|NCT00679224|Ambrisentan|ambrisentan|mesh-list
2393347|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2393348|NCT00679237|Metformin|metformin|mesh-list
2393349|NCT00679237|Glimepiride|glimepiride|mesh-list
2393350|NCT00679237|Ezetimibe|ezetimibe|mesh-list
2393351|NCT00679237|Diuretics|diuretics|mesh-list
2393352|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2393353|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393354|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2393355|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2393356|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
2393357|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393358|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2393359|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2393360|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393361|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
2393362|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
2393363|NCT00679250|Cetirizine|cetirizine|mesh-list
2393364|NCT00679250|Levocetirizine|levocetirizine|mesh-list
2393365|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2393366|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2393367|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
2393368|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
2393369|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393370|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393371|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393372|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2393373|NCT00679315|Alfuzosin|alfuzosin|mesh-list
2393374|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2393375|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2393376|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2393377|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
2393378|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393379|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393380|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393381|NCT00679315|Urological Agents|urological agents|mesh-ancestor
2517742|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
2517743|NCT01311804|Parecoxib|parecoxib|mesh-list
2517744|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2517745|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2517746|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517747|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517748|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2517749|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2517750|NCT01311804|Analgesics|analgesics|mesh-ancestor
2517751|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
2517752|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517753|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517754|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2517755|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2517756|NCT01311882|Zopiclone|zopiclone|mesh-list
2517757|NCT01311882|Suvorexant|suvorexant|mesh-list
2517758|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2517759|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2517760|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517761|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2517762|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2517763|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517764|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517765|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2517766|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
2517767|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517768|NCT01311960|Bevacizumab|bevacizumab|mesh-list
2517769|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2517770|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2517771|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517772|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2517773|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2517774|NCT01311960|Growth Substances|growth substances|mesh-ancestor
2517775|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517776|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
2517777|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2517778|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
2393382|NCT00679458|Buprenorphine|buprenorphine|mesh-list
2393383|NCT00679458|Naloxone|naloxone|mesh-list
2393384|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2393385|NCT00679458|Narcotics|narcotics|mesh-ancestor
2393386|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2393387|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393388|NCT00679458|Analgesics|analgesics|mesh-ancestor
2393389|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
2393390|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393391|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2393392|NCT00679484|Candesartan|candesartan|mesh-list
2393393|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
2393394|NCT00679484|Olmesartan|olmesartan|mesh-list
2393395|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2393396|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2393397|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2393398|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2393399|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393400|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2393401|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2393402|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2393403|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
2393404|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393405|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2393406|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2517779|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517780|NCT01312064|Rituximab|rituximab|mesh-list
2517781|NCT01312064|Everolimus|everolimus|mesh-list
2517782|NCT01312064|Tacrolimus|tacrolimus|mesh-list
2517783|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
2517784|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2517785|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517786|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
2517787|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517788|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2517789|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2517790|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2517791|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517792|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517793|NCT01312077|Morphine|morphine|mesh-list
2517794|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
2517795|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2517796|NCT01312077|Narcotics|narcotics|mesh-ancestor
2517797|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2393407|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393408|NCT00679523|Tavaborole|tavaborole|mesh-list
2393409|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2393410|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
2393411|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393412|NCT00679536|Fludarabine|fludarabine|mesh-list
2393413|NCT00679536|Busulfan|busulfan|mesh-list
2393414|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
2393415|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393416|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393417|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393418|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
2393419|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393420|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
2393421|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2393422|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2393423|NCT00679588|Enoxaparin|enoxaparin|mesh-list
2393424|NCT00679588|Semuloparin|semuloparin|mesh-list
2393425|NCT00679588|Enoxaparin sodium|enoxaparin sodium|mesh-list
2393426|NCT00679588|Anticoagulants|anticoagulants|mesh-ancestor
2393427|NCT00679588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2393428|NCT00679588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2393429|NCT00679588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393430|NCT00679601|Tavaborole|tavaborole|mesh-list
2517798|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517799|NCT01312077|Analgesics|analgesics|mesh-ancestor
2517800|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
2517801|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517802|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
2517803|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
2517804|NCT01312298|Bupivacaine|bupivacaine|mesh-list
2517805|NCT01312298|Anesthetics|anesthetics|mesh-list
2517806|NCT01312298|Propofol|propofol|mesh-list
2517807|NCT01312298|Succinylcholine|succinylcholine|mesh-list
2517808|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
2517809|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2517810|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517811|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
2517812|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517813|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2517814|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2393431|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
2393432|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393433|NCT00679614|Acetaminophen|acetaminophen|mesh-list
2393434|NCT00679614|Tramadol|tramadol|mesh-list
2393435|NCT00679614|Naloxone|naloxone|mesh-list
2393436|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2393437|NCT00679614|Analgesics|analgesics|mesh-ancestor
2393438|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
2393439|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393440|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393441|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
2393442|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2393443|NCT00679614|Narcotics|narcotics|mesh-ancestor
2393444|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2393445|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2393446|NCT00679640|Candesartan|candesartan|mesh-list
2393447|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2393448|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2393449|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2393450|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393451|NCT00679653|Sibutramine|sibutramine|mesh-list
2393452|NCT00679653|Metoprolol|metoprolol|mesh-list
2393453|NCT00679653|Verapamil|verapamil|mesh-list
2393454|NCT00679653|Felodipine|felodipine|mesh-list
2393455|NCT00679653|Ramipril|ramipril|mesh-list
2393456|NCT00679653|Trandolapril|trandolapril|mesh-list
2393457|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2393458|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2393459|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
2393460|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
2393461|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393462|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393463|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2393464|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2393465|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2393466|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
2393467|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393468|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393469|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2393470|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
2393471|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393472|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2393473|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2393474|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2393475|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
2393476|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
2393477|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2517815|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
2517816|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2517817|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2517818|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2517819|NCT01312311|Docetaxel|docetaxel|mesh-list
2517820|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517821|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
2393478|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
2393479|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2517822|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
2517823|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
2517824|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517825|NCT01312324|Docetaxel|docetaxel|mesh-list
2517826|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517827|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
2517828|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
2517829|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
2517830|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517831|NCT01312337|Gefitinib|gefitinib|mesh-list
2517832|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517833|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2517834|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517835|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517836|NCT01312350|Docetaxel|docetaxel|mesh-list
2517837|NCT01312350|Fluorouracil|fluorouracil|mesh-list
2517838|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517839|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
2517840|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
2517841|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
2517842|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517843|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
2517844|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2517845|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2517846|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
2517847|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517848|NCT01312363|Rivastigmine|rivastigmine|mesh-list
2517849|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2517850|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517851|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517852|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
2517853|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517854|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517855|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2517856|NCT01312363|Protective Agents|protective agents|mesh-ancestor
2517857|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
2517858|NCT01312376|Bevacizumab|bevacizumab|mesh-list
2517859|NCT01312376|Fludarabine|fludarabine|mesh-list
2517860|NCT01312376|Vaccines|vaccines|mesh-list
2517861|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
2517862|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517863|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2517864|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2517865|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2517866|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
2517867|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517868|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517869|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2517870|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2393480|NCT00679666|Riboflavin|riboflavin|mesh-list
2393481|NCT00679666|Vitamins|vitamins|mesh-ancestor
2393482|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
2393483|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393484|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
2393485|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2393486|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
2393487|NCT00679679|Metformin|metformin|mesh-list
2393488|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2393489|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393490|NCT00679705|Atosiban|atosiban|mesh-list
2114716|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2114717|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2114718|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
2114719|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114720|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114721|NCT02607930|Lamivudine|lamivudine|mesh-list
2114722|NCT02607930|Triumeq|triumeq|mesh-list
2114723|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2114724|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2393491|NCT00679705|Ritodrine|ritodrine|mesh-list
2517871|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2517872|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2517873|NCT01312376|Growth Substances|growth substances|mesh-ancestor
2517874|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
2517875|NCT01312402|Brinzolamide|brinzolamide|mesh-list
2517876|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2393492|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
2517877|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517878|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517879|NCT01312415|Morphine|morphine|mesh-list
2517880|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
2517881|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2517882|NCT01312415|Narcotics|narcotics|mesh-ancestor
2114725|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114726|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114727|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
2114728|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114729|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2114730|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2114731|NCT02607956|Dolutegravir|dolutegravir|mesh-list
2114732|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2114733|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2114734|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2114735|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114736|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114737|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2114738|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2114739|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
2114740|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114741|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2114742|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2114743|NCT02608099|Apixaban|apixaban|mesh-list
2114744|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2114745|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
2114746|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2114747|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
2114748|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114749|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114750|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
2114751|NCT02608177|Linagliptin|linagliptin|mesh-list
2114752|NCT02608177|Glipizide|glipizide|mesh-list
2114753|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2114754|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114755|NCT02608177|Incretins|incretins|mesh-ancestor
2114756|NCT02608177|Hormones|hormones|mesh-ancestor
2114757|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2114758|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2114759|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
2114760|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184833|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2517883|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2517884|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517885|NCT01312415|Analgesics|analgesics|mesh-ancestor
2517886|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
2517887|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517888|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
2517889|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
2517890|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
2517891|NCT01312441|Vitamin D|vitamin d|mesh-list
2517892|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2517893|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517894|NCT01312441|Vitamins|vitamins|mesh-ancestor
2517895|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
2517896|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2517897|NCT01312454|Travoprost|travoprost|mesh-list
2517898|NCT01312454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2517899|NCT01312454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2517900|NCT01312493|Panitumumab|panitumumab|mesh-list
2517901|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2517902|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517903|NCT01312714|Vitamin D|vitamin d|mesh-list
2517904|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
2517905|NCT01312714|Vitamins|vitamins|mesh-ancestor
2517906|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
2517907|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517908|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2517909|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2517910|NCT01312792|Ampicillin|ampicillin|mesh-list
2517911|NCT01312792|Cephradine|cephradine|mesh-list
2517912|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2517913|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517914|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
2517915|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
2517916|NCT01312831|Vitamins|vitamins|mesh-ancestor
2517917|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
2517918|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517919|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
2517920|NCT01312831|Hematinics|hematinics|mesh-ancestor
2517921|NCT01312857|Panitumumab|panitumumab|mesh-list
2517922|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2517923|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517924|NCT01312922|Dexetimide|dexetimide|mesh-list
2517925|NCT01312922|Pipamperone|pipamperone|mesh-list
2517926|NCT01312922|Citalopram|citalopram|mesh-list
2517927|NCT01312922|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2393493|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2393494|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393495|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
2393496|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2393497|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
2393498|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
2393499|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517928|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2517929|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2517930|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517931|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517932|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
2517933|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517934|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2517935|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
2517936|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2517937|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2517938|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2517939|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
2517940|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
2517941|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517942|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2517943|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2517944|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
2517945|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2517946|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2517947|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2517948|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2517949|NCT01313143|Esmolol|esmolol|mesh-list
2517950|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2517951|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2517952|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2517953|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
2517954|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2517955|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517956|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517957|NCT01313247|Acetaminophen|acetaminophen|mesh-list
2517958|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2517959|NCT01313247|Analgesics|analgesics|mesh-ancestor
2517960|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
2517961|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2517962|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517963|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
2517964|NCT01313377|Gemcitabine|gemcitabine|mesh-list
2517965|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
2517966|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2517967|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
2517968|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517969|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517970|NCT01313377|Antiviral Agents|antiviral agents|mesh-ancestor
2517971|NCT01313377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2517972|NCT01313377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2517973|NCT01313377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2517974|NCT01313377|Immunologic Factors|immunologic factors|mesh-ancestor
2517975|NCT01313377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517976|NCT01313390|Docetaxel|docetaxel|mesh-list
2517977|NCT01313390|Everolimus|everolimus|mesh-list
2517978|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517979|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
2517980|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
2517981|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
2517982|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517983|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2517984|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
2517985|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517986|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
2517987|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2517988|NCT01313429|Celecoxib|celecoxib|mesh-list
2517989|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
2517990|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2517991|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
2517992|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2517993|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2517994|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2517995|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
2517996|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2517997|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2517998|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2517999|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2518000|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2518001|NCT01313429|Analgesics|analgesics|mesh-ancestor
2518002|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
2518003|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518004|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2518005|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2518006|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2518007|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518008|NCT01313572|Adenosine|adenosine|mesh-list
2518009|NCT01313572|Analgesics|analgesics|mesh-ancestor
2518010|NCT01313572|Sensory System Agents|sensory system agents|mesh-ancestor
2518011|NCT01313572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518012|NCT01313572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518013|NCT01313572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2518014|NCT01313572|Vasodilator Agents|vasodilator agents|mesh-ancestor
2518015|NCT01313572|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2518016|NCT01313572|Purinergic Agonists|purinergic agonists|mesh-ancestor
2518017|NCT01313572|Purinergic Agents|purinergic agents|mesh-ancestor
2518018|NCT01313572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518019|NCT01313572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518020|NCT01313585|Beclomethasone|beclomethasone|mesh-list
2518021|NCT01313585|Albuterol|albuterol|mesh-list
2518022|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2518023|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
2518024|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518025|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518026|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2518027|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
2518028|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
2518029|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2518030|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2518031|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2518032|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2518033|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
2518034|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393500|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2393501|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2393502|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2393503|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
2393504|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393505|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393506|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2393507|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2393508|NCT00679731|Methotrexate|methotrexate|mesh-list
2393509|NCT00679731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2393510|NCT00679731|Abortifacient Agents|abortifacient agents|mesh-ancestor
2393511|NCT00679731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2393512|NCT00679731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393513|NCT00679731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2518035|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518036|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2518037|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
2518038|NCT01313585|Hormones|hormones|mesh-ancestor
2518039|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2518040|NCT01313611|Rituximab|rituximab|mesh-list
2518041|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2518042|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2518043|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518044|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
2518045|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393514|NCT00679731|Antimetabolites|antimetabolites|mesh-ancestor
2393515|NCT00679731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393516|NCT00679731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393517|NCT00679731|Dermatologic Agents|dermatologic agents|mesh-ancestor
2393518|NCT00679731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393519|NCT00679731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2393520|NCT00679731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393521|NCT00679731|Immunologic Factors|immunologic factors|mesh-ancestor
2393522|NCT00679731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2393523|NCT00679731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2393524|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
2393525|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
2393526|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2393527|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2393528|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393529|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2393530|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393531|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393532|NCT00679770|Tavaborole|tavaborole|mesh-list
2393533|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
2393534|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393535|NCT00679835|Daptomycin|daptomycin|mesh-list
2518046|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2518047|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2518048|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
2393536|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2393537|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393538|NCT00679900|SR 46349B|sr 46349b|mesh-list
2393539|NCT00679900|Lormetazepam|lormetazepam|mesh-list
2393540|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2393541|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2393542|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393543|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2393544|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2393545|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
2393546|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393547|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393548|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2393549|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2393550|NCT00679965|Tavaborole|tavaborole|mesh-list
2393551|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
2393552|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393553|NCT00680095|Tavaborole|tavaborole|mesh-list
2393554|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
2393555|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393556|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2393557|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2393558|NCT00680134|Tavaborole|tavaborole|mesh-list
2393559|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
2393560|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393561|NCT00680160|Tavaborole|tavaborole|mesh-list
2393562|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
2393563|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393564|NCT00680173|Interferons|interferons|mesh-list
2393565|NCT00680173|Ribavirin|ribavirin|mesh-list
2393566|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
2518049|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518050|NCT01313689|Ofatumumab|ofatumumab|mesh-list
2518051|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518052|NCT01313702|Atenolol|atenolol|mesh-list
2518053|NCT01313702|Lisinopril|lisinopril|mesh-list
2518054|NCT01313702|Simvastatin|simvastatin|mesh-list
2518055|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2518056|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2518057|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
2518058|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518059|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2518060|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2518061|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518062|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2518063|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
2518064|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2518065|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2518066|NCT01313702|Protective Agents|protective agents|mesh-ancestor
2518067|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393567|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
2393568|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2393569|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393570|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
2393571|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393572|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
2393573|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518068|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2518069|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
2518070|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
2518071|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518072|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2518073|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2518074|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2518075|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
2518076|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518077|NCT01313819|Amantadine|amantadine|mesh-list
2518078|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2518079|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2518080|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
2518081|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518082|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
2518083|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518084|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518085|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518086|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2518087|NCT01313819|Analgesics|analgesics|mesh-ancestor
2518088|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
2518089|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393574|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
2393575|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393576|NCT00680212|Beta Carotene|beta carotene|mesh-list
2393577|NCT00680212|Carotenoids|carotenoids|mesh-list
2393578|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
2393579|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393580|NCT00680212|Protective Agents|protective agents|mesh-ancestor
2393581|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393582|NCT00680212|Provitamins|provitamins|mesh-ancestor
2393583|NCT00680212|Vitamins|vitamins|mesh-ancestor
2393584|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
2393585|NCT00680277|Carotenoids|carotenoids|mesh-list
2393586|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
2393587|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393588|NCT00680277|Protective Agents|protective agents|mesh-ancestor
2393589|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393590|NCT00680329|Timolol|timolol|mesh-list
2393591|NCT00680329|Travoprost|travoprost|mesh-list
2393592|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2393593|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2393594|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2393595|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2393596|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
2393597|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393598|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393599|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393600|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2393601|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2393602|NCT00680342|Silymarin|silymarin|mesh-list
2393603|NCT00680342|Antioxidants|antioxidants|mesh-ancestor
2393604|NCT00680342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393605|NCT00680342|Protective Agents|protective agents|mesh-ancestor
2393606|NCT00680342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393607|NCT00680355|Carotenoids|carotenoids|mesh-list
2393608|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
2393609|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393610|NCT00680355|Protective Agents|protective agents|mesh-ancestor
2393611|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393612|NCT00680394|Misoprostol|misoprostol|mesh-list
2393613|NCT00680394|Mifepristone|mifepristone|mesh-list
2393614|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2393615|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
2393616|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2393617|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393618|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2393619|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2393620|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
2393621|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2393622|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2393623|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2518090|NCT01313845|Amantadine|amantadine|mesh-list
2518091|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2518092|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2518093|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
2518094|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518095|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
2518096|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393624|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2393625|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
2393626|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2393627|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2393628|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
2393629|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2393630|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
2393631|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2393632|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2393633|NCT00680433|Ketamine|ketamine|mesh-list
2393634|NCT00680433|Analgesics|analgesics|mesh-ancestor
2518097|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518098|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518099|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2518100|NCT01313845|Analgesics|analgesics|mesh-ancestor
2518101|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
2393635|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
2393636|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393637|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393638|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2393639|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2393640|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
2393641|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
2393642|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2393643|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2393644|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2393645|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393646|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393647|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
2393648|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2393649|NCT00680446|Antibodies|antibodies|mesh-list
2393650|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
2393651|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
2393652|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393653|NCT00680472|Ketoprofen|ketoprofen|mesh-list
2393654|NCT00680472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2393655|NCT00680472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2393656|NCT00680472|Analgesics|analgesics|mesh-ancestor
2393657|NCT00680472|Sensory System Agents|sensory system agents|mesh-ancestor
2393658|NCT00680472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518102|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518103|NCT01314027|Gemcitabine|gemcitabine|mesh-list
2518104|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
2518105|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2518106|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
2518107|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518108|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518109|NCT01314027|Antiviral Agents|antiviral agents|mesh-ancestor
2518110|NCT01314027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518111|NCT01314027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518112|NCT01314027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2518113|NCT01314027|Immunologic Factors|immunologic factors|mesh-ancestor
2518114|NCT01314027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518115|NCT01314066|Bevacizumab|bevacizumab|mesh-list
2518116|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2518117|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518118|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2518119|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2518120|NCT01314066|Growth Substances|growth substances|mesh-ancestor
2518121|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518122|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
2518123|NCT01314144|Bupivacaine|bupivacaine|mesh-list
2518124|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
2518125|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
2518126|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518127|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518128|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
2393659|NCT00680472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393660|NCT00680472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2393661|NCT00680472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2393662|NCT00680472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2393663|NCT00680472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393664|NCT00680472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518129|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518130|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
2518131|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2518132|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518133|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518134|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2518135|NCT01314209|Analgesics|analgesics|mesh-ancestor
2518136|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
2518137|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518138|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2518139|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2518140|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2518141|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
2518142|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518143|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518144|NCT01314222|Pregabalin|pregabalin|mesh-list
2518145|NCT01314222|Analgesics|analgesics|mesh-ancestor
2393665|NCT00680485|Ketoconazole|ketoconazole|mesh-list
2393666|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
2393667|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393668|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2393669|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2393670|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393671|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393672|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2393673|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
2393674|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2393675|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393676|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2393677|NCT00680498|Ranibizumab|ranibizumab|mesh-list
2393678|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2393679|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2393680|NCT00680498|Growth Substances|growth substances|mesh-ancestor
2393681|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393682|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
2393683|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518146|NCT01314222|Sensory System Agents|sensory system agents|mesh-ancestor
2518147|NCT01314222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518148|NCT01314222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518149|NCT01314222|Anticonvulsants|anticonvulsants|mesh-ancestor
2518150|NCT01314222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2518151|NCT01314222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2518152|NCT01314222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518153|NCT01314222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2518154|NCT01314222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2518155|NCT01314222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2518156|NCT01314222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518157|NCT01314222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2518158|NCT01314274|Bevacizumab|bevacizumab|mesh-list
2518159|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2518160|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518161|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2518162|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2518163|NCT01314274|Growth Substances|growth substances|mesh-ancestor
2393684|NCT00680511|Methamphetamine|methamphetamine|mesh-list
2393685|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2393686|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393687|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
2393688|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
2518164|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518165|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
2518166|NCT01314300|Lidocaine|lidocaine|mesh-list
2518167|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
2518168|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
2518169|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518170|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393689|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393690|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
2393691|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393692|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393693|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
2393694|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2393695|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2393696|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2393697|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2393698|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
2393699|NCT00680563|Hematinics|hematinics|mesh-ancestor
2393700|NCT00680602|Sertraline|sertraline|mesh-list
2393701|NCT00680602|Fluoxetine|fluoxetine|mesh-list
2393702|NCT00680602|Paroxetine|paroxetine|mesh-list
2393703|NCT00680602|Citalopram|citalopram|mesh-list
2393704|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
2393705|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2393706|NCT00680602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2393707|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2518171|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
2518172|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518173|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2518174|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2518175|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2518176|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2518177|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518178|NCT01314339|Desloratadine|desloratadine|mesh-list
2518179|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2518180|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
2518181|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518182|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518183|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518184|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2518185|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2518186|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
2518187|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
2518188|NCT01314352|Desloratadine|desloratadine|mesh-list
2518189|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2518190|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
2518191|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518192|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518193|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518194|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2518195|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2518196|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
2518197|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
2518198|NCT01314482|Minocycline|minocycline|mesh-list
2518199|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2518200|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518201|NCT01314495|Abatacept|abatacept|mesh-list
2518202|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2518203|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518204|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518205|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2518206|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
2518207|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518208|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2518209|NCT01314508|Mecasermin|mecasermin|mesh-list
2518210|NCT01314508|Growth Substances|growth substances|mesh-ancestor
2518211|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518212|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
2518213|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
2518214|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2518215|NCT01314586|Estrogens|estrogens|mesh-ancestor
2518216|NCT01314586|Hormones|hormones|mesh-ancestor
2518217|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2518218|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518219|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2518220|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2518221|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2518222|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518223|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
2518224|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2518225|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2393708|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2393709|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518226|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
2518227|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518228|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518229|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518230|NCT01314781|Urological Agents|urological agents|mesh-ancestor
2518231|NCT01314833|Paclitaxel|paclitaxel|mesh-list
2518232|NCT01314833|Docetaxel|docetaxel|mesh-list
2518233|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
2518234|NCT01314833|Fluorouracil|fluorouracil|mesh-list
2518235|NCT01314833|Epirubicin|epirubicin|mesh-list
2393710|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393711|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
2393712|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393713|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2393714|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2518236|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2518237|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518238|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
2518239|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
2518240|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
2518241|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518242|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2518243|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
2518244|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518245|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2518246|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2518247|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
2518248|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2518249|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
2518250|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2518251|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2518252|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2518253|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2518254|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518255|NCT01314859|Nifedipine|nifedipine|mesh-list
2518256|NCT01314859|Atosiban|atosiban|mesh-list
2518257|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2518258|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2518259|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518260|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2518261|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518262|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
2518263|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
2518264|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2518265|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
2393715|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2393716|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393717|NCT00680641|Simvastatin|simvastatin|mesh-list
2518266|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2518267|NCT01314898|Spironolactone|spironolactone|mesh-list
2518268|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2393718|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2393719|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2393720|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
2393721|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393722|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2393723|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2393724|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393725|NCT00680654|Riociguat|riociguat|mesh-list
2393726|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
2393727|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393728|NCT00680680|Dutasteride|dutasteride|mesh-list
2518269|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
2518270|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2518271|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518272|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2518273|NCT01314898|Diuretics|diuretics|mesh-ancestor
2518274|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
2518275|NCT01314937|Mebendazole|mebendazole|mesh-list
2518276|NCT01314937|Piperazine|piperazine|mesh-list
2518277|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
2518278|NCT01314937|DMP 777|dmp 777|mesh-list
2518279|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
2518280|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
2518281|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2518282|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518283|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
2518284|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
2518285|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
2518286|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393729|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2393730|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2393731|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393732|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393733|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
2393734|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2393735|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393736|NCT00680732|Folic Acid|folic acid|mesh-list
2393737|NCT00680732|Micronutrients|micronutrients|mesh-list
2393738|NCT00680732|Trace Elements|trace elements|mesh-list
2393739|NCT00680732|Chloroquine|chloroquine|mesh-list
2393740|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
2393741|NCT00680732|Hematinics|hematinics|mesh-ancestor
2393742|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
2393743|NCT00680732|Vitamins|vitamins|mesh-ancestor
2393744|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518287|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518288|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518289|NCT01314976|Metronidazole|metronidazole|mesh-list
2518290|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518291|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2518292|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2518293|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2518294|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
2518295|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
2518296|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
2518297|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2518298|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2518299|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
2518300|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
2518301|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518302|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518303|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518304|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2518305|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
2518306|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2518307|NCT01315093|Heparin|heparin|mesh-list
2518308|NCT01315093|Calcium heparin|calcium heparin|mesh-list
2518309|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2518310|NCT01315093|Tinzaparin|tinzaparin|mesh-list
2518311|NCT01315093|Dalteparin|dalteparin|mesh-list
2393745|NCT00680732|Amebicides|amebicides|mesh-ancestor
2393746|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2393747|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2518312|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
2518313|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2518314|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2518315|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518316|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
2518317|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
2393748|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393749|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
2393750|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2393751|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2393752|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393753|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393754|NCT00680758|Paclitaxel|paclitaxel|mesh-list
2393755|NCT00680758|Everolimus|everolimus|mesh-list
2393756|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2393757|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518318|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2518319|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2518320|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518321|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518322|NCT01315262|Urological Agents|urological agents|mesh-ancestor
2518323|NCT01315275|Ranibizumab|ranibizumab|mesh-list
2518324|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2518325|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2518326|NCT01315275|Growth Substances|growth substances|mesh-ancestor
2393758|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
2393759|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
2393760|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
2393761|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393762|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393763|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
2393764|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393765|NCT00680784|Ketoprofen|ketoprofen|mesh-list
2393766|NCT00680784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2393767|NCT00680784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2393768|NCT00680784|Analgesics|analgesics|mesh-ancestor
2393769|NCT00680784|Sensory System Agents|sensory system agents|mesh-ancestor
2393770|NCT00680784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393771|NCT00680784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393772|NCT00680784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2393773|NCT00680784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2393774|NCT00680784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2393775|NCT00680784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393776|NCT00680784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393777|NCT00680940|Paclitaxel|paclitaxel|mesh-list
2393778|NCT00680940|Cisplatin|cisplatin|mesh-list
2393779|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2393780|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393781|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
2393782|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
2393783|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
2518327|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518328|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
2518329|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518330|NCT01315431|Capecitabine|capecitabine|mesh-list
2518331|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2518332|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
2518333|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518334|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518335|NCT01315470|Lenograstim|lenograstim|mesh-list
2518336|NCT01315470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2518337|NCT01315470|Immunologic Factors|immunologic factors|mesh-ancestor
2518338|NCT01315470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518339|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
2518340|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2518341|NCT01315496|Antibodies|antibodies|mesh-list
2518342|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
2518343|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
2518344|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518345|NCT01315691|Amikacin|amikacin|mesh-list
2518346|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2518347|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518348|NCT01315704|Vitamin D|vitamin d|mesh-list
2518349|NCT01315704|Vitamins|vitamins|mesh-ancestor
2518350|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
2518351|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518352|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2518353|NCT01315795|Lanreotide|lanreotide|mesh-list
2518354|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518355|NCT01315886|Fentanyl|fentanyl|mesh-list
2518356|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2518357|NCT01315886|Narcotics|narcotics|mesh-ancestor
2518358|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518359|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518360|NCT01315886|Analgesics|analgesics|mesh-ancestor
2518361|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
2518362|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518363|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2518364|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2518365|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
2518366|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
2518367|NCT01315912|Letrozole|letrozole|mesh-list
2518368|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518369|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2518370|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2518371|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518372|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393784|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393785|NCT00681005|Rabeprazole|rabeprazole|mesh-list
2393786|NCT00681005|Pantoprazole|pantoprazole|mesh-list
2518373|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2518374|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
2393787|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2393788|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2393789|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2393790|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393791|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393792|NCT00681135|Olaflur|olaflur|mesh-list
2393793|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
2393794|NCT00681135|Protective Agents|protective agents|mesh-ancestor
2393795|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393796|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2393797|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2518375|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2518376|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518377|NCT01315938|Abatacept|abatacept|mesh-list
2518378|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2518379|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518380|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518381|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2518382|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
2518383|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518384|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2518385|NCT01315951|Petrolatum|petrolatum|mesh-list
2518386|NCT01315951|Emollients|emollients|mesh-ancestor
2518387|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
2518388|NCT01315990|Cetuximab|cetuximab|mesh-list
2518389|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2518390|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518391|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
2518392|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
2518393|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2518394|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
2518395|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518396|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2518397|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2518398|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2518399|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2518400|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518401|NCT01316081|Vitamins|vitamins|mesh-list
2518402|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
2518403|NCT01316081|Vitamin E|vitamin e|mesh-list
2518404|NCT01316081|Tocopherols|tocopherols|mesh-list
2518405|NCT01316081|Tocotrienols|tocotrienols|mesh-list
2518406|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
2518407|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
2518408|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518409|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
2518410|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393798|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393799|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393800|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2393801|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2393802|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393803|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
2393804|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393805|NCT00681174|Acetaminophen|acetaminophen|mesh-list
2393806|NCT00681174|Morphine|morphine|mesh-list
2393807|NCT00681174|Remifentanil|remifentanil|mesh-list
2393808|NCT00681174|Oxycodone|oxycodone|mesh-list
2393809|NCT00681174|Propofol|propofol|mesh-list
2393810|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2393811|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2393812|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393813|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2518411|NCT01316081|Protective Agents|protective agents|mesh-ancestor
2518412|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
2518413|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2518414|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518415|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2518416|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518417|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
2518418|NCT01316107|Nateglinide|nateglinide|mesh-list
2518419|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2393814|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
2393815|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
2518420|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518421|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2518422|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518423|NCT01316133|Tacrolimus|tacrolimus|mesh-list
2518424|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2518425|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
2518426|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518427|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2518428|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518429|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518430|NCT01316250|Imatinib Mesylate|imatinib mesylate|mesh-list
2518431|NCT01316250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518432|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2518433|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518434|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518435|NCT01316445|Midazolam|midazolam|mesh-list
2518436|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2393816|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2393817|NCT00681174|Narcotics|narcotics|mesh-ancestor
2393818|NCT00681174|Analgesics|analgesics|mesh-ancestor
2393819|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
2393820|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393821|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2393822|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
2393823|NCT00681213|Sirolimus|sirolimus|mesh-list
2393824|NCT00681213|Tacrolimus|tacrolimus|mesh-list
2393825|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393826|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
2393827|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393828|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2393829|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393830|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393831|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2393832|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2393833|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2393834|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393835|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
2393836|NCT00681226|Ramipril|ramipril|mesh-list
2518437|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2518438|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518439|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518440|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2518441|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2518442|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2518443|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2518444|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
2518445|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
2518446|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
2518447|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
2518448|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518449|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518450|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
2518451|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518452|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2518453|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518454|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518455|NCT01316549|Fludarabine|fludarabine|mesh-list
2518456|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518457|NCT01316718|Mesalamine|mesalamine|mesh-list
2518458|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2518459|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2518460|NCT01316718|Analgesics|analgesics|mesh-ancestor
2518461|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
2518462|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518463|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518464|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2518465|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2518466|NCT01316744|Ketamine|ketamine|mesh-list
2518467|NCT01316744|Analgesics|analgesics|mesh-ancestor
2518468|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
2518469|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518470|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518471|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2518472|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2518473|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
2518474|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
2393837|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2393838|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
2393839|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393840|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393841|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2393842|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
2393843|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
2393844|NCT00681343|Daclizumab|daclizumab|mesh-list
2393845|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
2393846|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518475|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518476|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2393847|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393848|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2393849|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393850|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2393851|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2393852|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2393853|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
2393854|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393855|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2393856|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2393857|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393858|NCT00681460|Metformin|metformin|mesh-list
2393859|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2393860|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393861|NCT00681525|Atorvastatin|atorvastatin|mesh-list
2393862|NCT00681525|Ezetimibe|ezetimibe|mesh-list
2393863|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
2393864|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2393865|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2518477|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2518478|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518479|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518480|NCT01316757|Paclitaxel|paclitaxel|mesh-list
2518481|NCT01316757|Carboplatin|carboplatin|mesh-list
2518482|NCT01316757|Cetuximab|cetuximab|mesh-list
2518483|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2518484|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2518485|NCT01316757|Antibodies|antibodies|mesh-list
2518486|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
2518487|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2518488|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2518489|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518490|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
2518491|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
2518492|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
2518493|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518494|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
2518495|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518496|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2518497|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518498|NCT01316861|Acarbose|acarbose|mesh-list
2518499|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2518500|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518501|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518502|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2518503|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518504|NCT01316874|Valrubicin|valrubicin|mesh-list
2518505|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518506|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2518507|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2518508|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518509|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518510|NCT01316952|Carvedilol|carvedilol|mesh-list
2518511|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2518512|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
2518513|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
2518514|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518515|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518516|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518517|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2518518|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
2518519|NCT01316952|Protective Agents|protective agents|mesh-ancestor
2518520|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2393866|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
2393867|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393868|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2518521|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2518522|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2518523|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
2518524|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2518525|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2518526|NCT01316978|Ibuprofen|ibuprofen|mesh-list
2518527|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2393869|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2393870|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393871|NCT00681603|Bevacizumab|bevacizumab|mesh-list
2393872|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2393873|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393874|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2393875|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2518528|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2518529|NCT01316978|Analgesics|analgesics|mesh-ancestor
2518530|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
2518531|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518532|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518533|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2518534|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2518535|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2518536|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518537|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518538|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
2518539|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
2518540|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518541|NCT01317069|Fluorouracil|fluorouracil|mesh-list
2518542|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
2518543|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518544|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2518545|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518546|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2518547|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
2518548|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518549|NCT01317212|Carboplatin|carboplatin|mesh-list
2518550|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518551|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2518552|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2518553|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2518554|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
2518555|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2518556|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518557|NCT01317225|Progestins|progestins|mesh-ancestor
2518558|NCT01317225|Hormones|hormones|mesh-ancestor
2518559|NCT01317368|Ropivacaine|ropivacaine|mesh-list
2518560|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
2518561|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
2518562|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518563|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518564|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
2518565|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518566|NCT01317433|Doxycycline|doxycycline|mesh-list
2518567|NCT01317433|Cetuximab|cetuximab|mesh-list
2518568|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2518569|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518570|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2518571|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518572|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
2518573|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2518574|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2518575|NCT01317446|Fluorides|fluorides|mesh-list
2518576|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
2518577|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
2518578|NCT01317446|Protective Agents|protective agents|mesh-ancestor
2518579|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518580|NCT01317511|Caseins|caseins|mesh-list
2518581|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
2518582|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
2518583|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518584|NCT01317563|Vitamin A|vitamin a|mesh-list
2518585|NCT01317563|Selenium|selenium|mesh-list
2518586|NCT01317563|Vitamins|vitamins|mesh-ancestor
2518587|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
2518588|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518589|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
2518590|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518591|NCT01317563|Protective Agents|protective agents|mesh-ancestor
2518592|NCT01317563|Trace Elements|trace elements|mesh-ancestor
2518593|NCT01317589|Fentanyl|fentanyl|mesh-list
2518594|NCT01317589|Methadone|methadone|mesh-list
2518595|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2518596|NCT01317589|Narcotics|narcotics|mesh-ancestor
2518597|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518598|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518599|NCT01317589|Analgesics|analgesics|mesh-ancestor
2518600|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
2518601|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518602|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2518603|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2518604|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
2518605|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
2518606|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
2518607|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
2518608|NCT01317784|Antibodies|antibodies|mesh-list
2393876|NCT00681603|Growth Substances|growth substances|mesh-ancestor
2393877|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393878|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
2393879|NCT00681720|Flumazenil|flumazenil|mesh-list
2393880|NCT00681720|Antidotes|antidotes|mesh-ancestor
2393881|NCT00681720|Protective Agents|protective agents|mesh-ancestor
2393882|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393883|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
2393884|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
2393885|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393886|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393887|NCT00681733|Pioglitazone|pioglitazone|mesh-list
2393888|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
2393889|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2393890|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393891|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2393892|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393893|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393894|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2393895|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2393896|NCT00681733|Protective Agents|protective agents|mesh-ancestor
2393897|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
2393898|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2393899|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
2393900|NCT00681746|Flumazenil|flumazenil|mesh-list
2393901|NCT00681746|Antidotes|antidotes|mesh-ancestor
2393902|NCT00681746|Protective Agents|protective agents|mesh-ancestor
2393903|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393904|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
2393905|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
2393906|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393907|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393908|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2393909|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
2393910|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2393911|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2393912|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393913|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393914|NCT00681772|Urological Agents|urological agents|mesh-ancestor
2393915|NCT00681785|Dalteparin|dalteparin|mesh-list
2393916|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2393917|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
2393918|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2393919|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2393920|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393921|NCT00681876|Bevacizumab|bevacizumab|mesh-list
2393922|NCT00681876|Cetuximab|cetuximab|mesh-list
2518609|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
2518610|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
2518611|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
2518612|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518613|NCT01317849|Vitamins|vitamins|mesh-list
2518614|NCT01317849|Folic Acid|folic acid|mesh-list
2518615|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
2518616|NCT01317849|Hydroxocobalamin|hydroxocobalamin|mesh-list
2518617|NCT01317849|Pyridoxine|pyridoxine|mesh-list
2518618|NCT01317849|Pyridoxal|pyridoxal|mesh-list
2393923|NCT00681876|Irinotecan|irinotecan|mesh-list
2393924|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2393925|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393926|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2393927|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2393928|NCT00681876|Growth Substances|growth substances|mesh-ancestor
2393929|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393930|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
2393931|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2393932|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2393933|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393934|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393935|NCT00681902|Lidocaine|lidocaine|mesh-list
2393936|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
2393937|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
2393938|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2393939|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393940|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
2393941|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2393942|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2393943|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2393944|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2114761|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114762|NCT02608229|Gemcitabine|gemcitabine|mesh-list
2114763|NCT02608229|Paclitaxel|paclitaxel|mesh-list
2114764|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2114765|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2114766|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114767|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
2114768|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
2114769|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
2114770|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114771|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2114772|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
2114773|NCT02608229|Antiviral Agents|antiviral agents|mesh-ancestor
2114774|NCT02608229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114775|NCT02608229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114776|NCT02608229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2114777|NCT02608229|Immunologic Factors|immunologic factors|mesh-ancestor
2114778|NCT02608229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114779|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
2114780|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2114781|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
2114782|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114783|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
2114784|NCT02608489|Protective Agents|protective agents|mesh-ancestor
2114785|NCT02608684|Gemcitabine|gemcitabine|mesh-list
2114786|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
2114787|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114788|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2114789|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
2184834|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
2518619|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
2518620|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
2518621|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
2518622|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518623|NCT01317849|Hematinics|hematinics|mesh-ancestor
2518624|NCT01317927|Belinostat|belinostat|mesh-list
2518625|NCT01317927|Warfarin|warfarin|mesh-list
2518626|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
2518627|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518628|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2518629|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518630|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518631|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2518632|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
2518633|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518634|NCT01317953|Protective Agents|protective agents|mesh-ancestor
2518635|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518636|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2518637|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2518638|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518639|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2518640|NCT01317966|Rituximab|rituximab|mesh-list
2518641|NCT01317966|Oprelvekin|oprelvekin|mesh-list
2518642|NCT01317966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2518643|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518644|NCT01317966|Immunologic Factors|immunologic factors|mesh-ancestor
2518645|NCT01317966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518646|NCT01317966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2518647|NCT01317992|Ibudilast|ibudilast|mesh-list
2518648|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2518649|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
2518650|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518651|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518652|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2393945|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2393946|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393947|NCT00681928|Letrozole|letrozole|mesh-list
2518653|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
2518654|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2518655|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518656|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518657|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2518658|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
2518659|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
2518660|NCT01318005|Norinyl|norinyl|mesh-list
2518661|NCT01318005|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2518662|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
2518663|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2518664|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518665|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2518666|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2518667|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2518668|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2518669|NCT01318005|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2518670|NCT01318005|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2518671|NCT01318044|Thiopental|thiopental|mesh-list
2518672|NCT01318044|Propofol|propofol|mesh-list
2518673|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2518674|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518675|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518676|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2518677|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
2518678|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
2518679|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
2518680|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
2518681|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
2518682|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518683|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518684|NCT01318096|Tenofovir|tenofovir|mesh-list
2518685|NCT01318096|Lamivudine|lamivudine|mesh-list
2393948|NCT00681928|Anastrozole|anastrozole|mesh-list
2393949|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393950|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2393951|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2393952|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393953|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393954|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2393955|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
2518686|NCT01318096|Efavirenz|efavirenz|mesh-list
2518687|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
2518688|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
2518689|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518690|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2518691|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2518692|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518693|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518694|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2518695|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2518696|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2518697|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2518698|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2518699|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2518700|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2518701|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2518702|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2518703|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2518704|NCT01318148|Caspofungin|caspofungin|mesh-list
2518705|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
2518706|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518707|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518708|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518709|NCT01318161|Morphine|morphine|mesh-list
2518710|NCT01318161|Ropivacaine|ropivacaine|mesh-list
2518711|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2518712|NCT01318161|Narcotics|narcotics|mesh-ancestor
2518713|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518714|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518715|NCT01318161|Analgesics|analgesics|mesh-ancestor
2518716|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
2518717|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518718|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
2518719|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
2518720|NCT01318187|Acetaminophen|acetaminophen|mesh-list
2518721|NCT01318187|Morphine|morphine|mesh-list
2518722|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2518723|NCT01318187|Narcotics|narcotics|mesh-ancestor
2518724|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518725|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518726|NCT01318187|Analgesics|analgesics|mesh-ancestor
2518727|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
2518728|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518729|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2518730|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
2114790|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114791|NCT02608684|Antiviral Agents|antiviral agents|mesh-ancestor
2114792|NCT02608684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114793|NCT02608684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114794|NCT02608684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2518731|NCT01318252|Latanoprost|latanoprost|mesh-list
2518732|NCT01318252|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2518733|NCT01318252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2518734|NCT01318265|Ketoconazole|ketoconazole|mesh-list
2518735|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
2518736|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518737|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2518738|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2518739|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518740|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518741|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2518742|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
2518743|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2518744|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518745|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2518757|NCT01318369|Diazepam|diazepam|mesh-list
2518758|NCT01318369|Dronabinol|dronabinol|mesh-list
2518759|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
2518760|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518761|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2393956|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2393957|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393958|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2393959|NCT00681941|Sevelamer|sevelamer|mesh-list
2393960|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
2518762|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2518763|NCT01318369|Analgesics|analgesics|mesh-ancestor
2518764|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
2518765|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518766|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2518767|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2518768|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518769|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518770|NCT01318369|Hormones|hormones|mesh-ancestor
2518771|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2518772|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2518773|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
2518774|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
2518775|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
2518776|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2518777|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2518778|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518779|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2518780|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2518781|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2518782|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2518783|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2518784|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
2393961|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
2393962|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393963|NCT00681967|Gefitinib|gefitinib|mesh-list
2393964|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2393965|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2393966|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393967|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393968|NCT00681980|Valproic Acid|valproic acid|mesh-list
2393969|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
2518785|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
2518786|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
2518787|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
2518788|NCT01318460|Simendan|simendan|mesh-list
2518789|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2518790|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
2518791|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2518792|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2518793|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518794|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518795|NCT01318460|Protective Agents|protective agents|mesh-ancestor
2518796|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518802|NCT01318564|Metformin|metformin|mesh-list
2518803|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2518804|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518805|NCT01318590|Triamcinolone|triamcinolone|mesh-list
2518806|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2518807|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2518808|NCT01318590|Bupivacaine|bupivacaine|mesh-list
2393970|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2393971|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393972|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
2393973|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393974|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2393975|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
2393976|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2393977|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2393978|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2393979|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
2393980|NCT00681993|Carboplatin|carboplatin|mesh-list
2393981|NCT00681993|Docetaxel|docetaxel|mesh-list
2393982|NCT00681993|Trastuzumab|trastuzumab|mesh-list
2393983|NCT00681993|Doxorubicin|doxorubicin|mesh-list
2393984|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2393985|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2393986|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
2393987|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518809|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2518810|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
2518811|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
2518812|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518813|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518814|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
2518815|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518816|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2518817|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
2518818|NCT01318590|Hormones|hormones|mesh-ancestor
2393988|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2393989|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2393990|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
2393991|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2393992|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518819|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2518820|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2518821|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
2518822|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518823|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518824|NCT01318642|Gemcitabine|gemcitabine|mesh-list
2518825|NCT01318642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2518826|NCT01318642|Antimetabolites|antimetabolites|mesh-ancestor
2518827|NCT01318642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518828|NCT01318642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518829|NCT01318642|Antiviral Agents|antiviral agents|mesh-ancestor
2518830|NCT01318642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518831|NCT01318642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518832|NCT01318642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2518833|NCT01318642|Immunologic Factors|immunologic factors|mesh-ancestor
2518834|NCT01318642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518835|NCT01318655|Naloxegol|naloxegol|mesh-list
2518836|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2518837|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518838|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
2518839|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518840|NCT01318668|Vaccines|vaccines|mesh-list
2518841|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
2518842|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518843|NCT01318681|Fluticasone|fluticasone|mesh-list
2518844|NCT01318681|Xhance|xhance|mesh-list
2518845|NCT01318681|Cetirizine|cetirizine|mesh-list
2518846|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2518847|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2518848|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
2518849|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518850|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518851|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2518852|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
2518853|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
2518854|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2518855|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2518856|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2518857|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
2518858|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
2518859|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2393993|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2393994|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
2393995|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
2393996|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
2393997|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2393998|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2393999|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2394000|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2394001|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394002|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
2394003|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2394004|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2394005|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394006|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
2394007|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
2394008|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2394009|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
2394010|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2394011|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2394012|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394013|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394014|NCT00682019|Urological Agents|urological agents|mesh-ancestor
2394015|NCT00682136|Ropivacaine|ropivacaine|mesh-list
2394016|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
2394017|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
2394018|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2394019|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394020|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
2518860|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518861|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
2518862|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2394021|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394022|NCT00682149|Ascorbic Acid|ascorbic acid|mesh-list
2394023|NCT00682149|Vitamins|vitamins|mesh-ancestor
2394024|NCT00682149|Micronutrients|micronutrients|mesh-ancestor
2394025|NCT00682149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394026|NCT00682149|Antioxidants|antioxidants|mesh-ancestor
2394027|NCT00682149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394028|NCT00682149|Protective Agents|protective agents|mesh-ancestor
2518863|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2518864|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
2518865|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394029|NCT00682214|Vitamin D|vitamin d|mesh-list
2394030|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
2394031|NCT00682214|Vitamins|vitamins|mesh-ancestor
2518866|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518867|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394032|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
2394033|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394034|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2518868|NCT01318837|Urological Agents|urological agents|mesh-ancestor
2518869|NCT01318928|Metronidazole|metronidazole|mesh-list
2518870|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518871|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2518872|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2518873|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2394035|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2394036|NCT00682279|Topotecan|topotecan|mesh-list
2394037|NCT00682279|Lapatinib|lapatinib|mesh-list
2394038|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2394039|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2394040|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394041|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394042|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394043|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2394044|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
2394045|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2394046|NCT00682292|Daclizumab|daclizumab|mesh-list
2394047|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
2518874|NCT01318941|Ranibizumab|ranibizumab|mesh-list
2518875|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2518876|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2518877|NCT01318941|Growth Substances|growth substances|mesh-ancestor
2518878|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518879|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
2518880|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518881|NCT01319006|Glycine|glycine|mesh-list
2518882|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
2518883|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518884|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518885|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518886|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2518887|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2518888|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
2518889|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518890|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518891|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2518892|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
2518893|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2518894|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2518895|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2518896|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
2518897|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518898|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394048|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394049|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2394050|NCT00682318|Ethanol|ethanol|mesh-list
2394051|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2394052|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394053|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2394054|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394055|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
2394056|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
2394057|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
2394058|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518899|NCT01319188|Ranibizumab|ranibizumab|mesh-list
2394059|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394060|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
2394061|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394062|NCT00682383|Docetaxel|docetaxel|mesh-list
2394063|NCT00682383|Etoposide|etoposide|mesh-list
2394064|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394065|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
2394066|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
2394067|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
2518900|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2518901|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2518902|NCT01319188|Growth Substances|growth substances|mesh-ancestor
2518903|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518904|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
2518905|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518906|NCT01319214|Propranolol|propranolol|mesh-list
2518907|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2518908|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2518909|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
2518910|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2518911|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518912|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518913|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2518914|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2518915|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
2518916|NCT01319240|Insulin|insulin|mesh-list
2518917|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2518918|NCT01319240|Liraglutide|liraglutide|mesh-list
2518919|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
2518920|NCT01319240|Xultophy|xultophy|mesh-list
2518921|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2518922|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518923|NCT01319240|Incretins|incretins|mesh-ancestor
2518924|NCT01319240|Hormones|hormones|mesh-ancestor
2518925|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2518926|NCT01319266|Hydrocodone|hydrocodone|mesh-list
2518927|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2518928|NCT01319266|Narcotics|narcotics|mesh-ancestor
2518929|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518930|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518931|NCT01319266|Analgesics|analgesics|mesh-ancestor
2518932|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
2518933|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518934|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
2518935|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
2518936|NCT01319279|Hydrocodone|hydrocodone|mesh-list
2518937|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2518938|NCT01319279|Narcotics|narcotics|mesh-ancestor
2518939|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2518940|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518941|NCT01319279|Analgesics|analgesics|mesh-ancestor
2518942|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
2518943|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2518944|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
2518945|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
2518946|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2518947|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
2518948|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2518949|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2518950|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
2518951|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518952|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518953|NCT01319344|Eplerenone|eplerenone|mesh-list
2518954|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2518955|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
2518956|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2518957|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2518958|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2518959|NCT01319344|Diuretics|diuretics|mesh-ancestor
2518960|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
2518961|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2518962|NCT01319357|Saxagliptin|saxagliptin|mesh-list
2518963|NCT01319357|Incretins|incretins|mesh-ancestor
2518964|NCT01319357|Hormones|hormones|mesh-ancestor
2518965|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2518966|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394068|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394069|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2394070|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2394071|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2394072|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394073|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
2518967|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2518968|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
2518969|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518970|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518971|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2518972|NCT01319370|Minoxidil|minoxidil|mesh-list
2518973|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2518974|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
2518975|NCT01319448|Artesunate|artesunate|mesh-list
2518976|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
2518977|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
2518978|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2518979|NCT01319448|Amodiaquine|amodiaquine|mesh-list
2518980|NCT01319448|Mefloquine|mefloquine|mesh-list
2518981|NCT01319448|Proguanil|proguanil|mesh-list
2518982|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
2518983|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2518984|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2518985|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2518986|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2518987|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
2518988|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
2518989|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2518990|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
2518991|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2518992|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2518993|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2518994|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2518995|NCT01319448|Renal Agents|renal agents|mesh-ancestor
2518996|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
2518997|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
2518998|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2518999|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
2519000|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519001|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
2519002|NCT01319461|Protective Agents|protective agents|mesh-ancestor
2519003|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2519004|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2394074|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2394075|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2394076|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2394077|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2394078|NCT00682500|Calfactant|calfactant|mesh-list
2519021|NCT01319682|Lidocaine|lidocaine|mesh-list
2519022|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
2519023|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
2519024|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2519025|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519026|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
2519027|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519028|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2519029|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2519030|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2519031|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2519032|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519033|NCT01319695|Hormones|hormones|mesh-list
2519034|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2519035|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2519036|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519037|NCT01319734|Ascorbic Acid|ascorbic acid|mesh-list
2519038|NCT01319734|Glyburide|glyburide|mesh-list
2519039|NCT01319734|Vitamins|vitamins|mesh-ancestor
2519040|NCT01319734|Micronutrients|micronutrients|mesh-ancestor
2519041|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519042|NCT01319734|Antioxidants|antioxidants|mesh-ancestor
2519043|NCT01319734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519044|NCT01319734|Protective Agents|protective agents|mesh-ancestor
2519045|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2519046|NCT01319825|Milnacipran|milnacipran|mesh-list
2519047|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
2519048|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2519049|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2519050|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2519051|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519052|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2519053|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519054|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2519055|NCT01319825|Analgesics|analgesics|mesh-ancestor
2519056|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
2519057|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519058|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
2519059|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2519060|NCT01319838|Isotretinoin|isotretinoin|mesh-list
2519061|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
2519062|NCT01319864|Plerixafor|plerixafor|mesh-list
2519063|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2519064|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2519065|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
2519066|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519067|NCT01319903|Antibodies|antibodies|mesh-list
2519068|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2519069|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
2519070|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519071|NCT01319942|Sorafenib|sorafenib|mesh-list
2519072|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519073|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2519074|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519075|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519076|NCT01319981|Cytarabine|cytarabine|mesh-list
2519077|NCT01319981|Dexamethasone|dexamethasone|mesh-list
2519078|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
2519079|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2519080|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2519081|NCT01319981|Prednisolone|prednisolone|mesh-list
2519082|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
2519083|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
2519084|NCT01319981|Rituximab|rituximab|mesh-list
2519085|NCT01319981|Doxorubicin|doxorubicin|mesh-list
2519086|NCT01319981|Methotrexate|methotrexate|mesh-list
2519087|NCT01319981|Vincristine|vincristine|mesh-list
2519088|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
2519089|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2519090|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
2519091|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2519092|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
2519093|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519094|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2519095|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2519096|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
2519097|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519098|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394079|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2394080|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
2394081|NCT00682578|Artesunate|artesunate|mesh-list
2394082|NCT00682578|Chloroquine|chloroquine|mesh-list
2394083|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
2394084|NCT00682578|Piperaquine|piperaquine|mesh-list
2519099|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2519100|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2519101|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
2519102|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
2519103|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519104|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2519105|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
2519106|NCT01319981|Hormones|hormones|mesh-ancestor
2519107|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2519108|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2519109|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2519110|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2519111|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2519112|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2519113|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519114|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2519115|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
2519116|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2519117|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2519118|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
2394085|NCT00682578|Artenimol|artenimol|mesh-list
2394086|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
2394087|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2394088|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2394089|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519119|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
2519120|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2519121|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2519122|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
2519123|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519124|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2519125|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
2519126|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
2519127|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
2519128|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2519129|NCT01319981|Protective Agents|protective agents|mesh-ancestor
2519130|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2519131|NCT01320007|Furosemide|furosemide|mesh-list
2519132|NCT01320007|Diuretics|diuretics|mesh-ancestor
2394090|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394091|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
2394092|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
2394093|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2394094|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
2519133|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
2519134|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519135|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2519136|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2519137|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519138|NCT01320020|Catumaxomab|catumaxomab|mesh-list
2519139|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2519140|NCT01320111|Paclitaxel|paclitaxel|mesh-list
2394095|NCT00682578|Amebicides|amebicides|mesh-ancestor
2394096|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2394097|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2394098|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394099|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394100|NCT00682630|Artesunate|artesunate|mesh-list
2394101|NCT00682630|Pyronaridine|pyronaridine|mesh-list
2394102|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
2394103|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2394104|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2394105|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519141|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2519142|NCT01320111|Sorafenib|sorafenib|mesh-list
2519143|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2519144|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519145|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
2519146|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
2519147|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
2519148|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519149|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2519150|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519151|NCT01320176|Vaccines|vaccines|mesh-list
2519152|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
2519153|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519154|NCT01320254|Gemcitabine|gemcitabine|mesh-list
2394106|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394107|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
2394108|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
2519155|NCT01320254|Cisplatin|cisplatin|mesh-list
2519156|NCT01320254|Panitumumab|panitumumab|mesh-list
2394109|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2394110|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
2394111|NCT00682656|Azithromycin|azithromycin|mesh-list
2394112|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2394113|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2394114|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394115|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2394116|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2394117|NCT00682721|Valacyclovir|valacyclovir|mesh-list
2394118|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
2394119|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394120|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
2394121|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2394122|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2394123|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2394124|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2394125|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394126|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
2394127|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394128|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394129|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2394130|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394131|NCT00682825|Anesthetics|anesthetics|mesh-list
2394132|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
2394133|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2394134|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394135|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
2394136|NCT00682955|Zinc|zinc|mesh-list
2394137|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
2394138|NCT00682955|Trace Elements|trace elements|mesh-ancestor
2394139|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
2394140|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394141|NCT00682955|Astringents|astringents|mesh-ancestor
2394142|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
2394143|NCT00682981|Carboplatin|carboplatin|mesh-list
2394144|NCT00682981|Etoposide|etoposide|mesh-list
2394145|NCT00682981|Obatoclax|obatoclax|mesh-list
2394146|NCT00682981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394147|NCT00682981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2394148|NCT00682981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2394149|NCT00682981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2394150|NCT00682981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394151|NCT00682981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394152|NCT00683059|Paclitaxel|paclitaxel|mesh-list
2394153|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2394154|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394155|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
2394156|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
2394157|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
2394158|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394159|NCT00683111|Esomeprazole|esomeprazole|mesh-list
2394160|NCT00683111|Famotidine|famotidine|mesh-list
2394161|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2394162|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2394163|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2394164|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394165|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394166|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2394167|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
2394168|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
2394169|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394170|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394171|NCT00683124|Losartan|losartan|mesh-list
2519157|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2519158|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519159|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2519160|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
2519161|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519162|NCT01320254|Antiviral Agents|antiviral agents|mesh-ancestor
2519163|NCT01320254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394172|NCT00683124|Nebivolol|nebivolol|mesh-list
2394173|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2394174|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2394175|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2394176|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2394177|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519164|NCT01320254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519165|NCT01320254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2519166|NCT01320254|Immunologic Factors|immunologic factors|mesh-ancestor
2519167|NCT01320254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519168|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2519169|NCT01320280|Afatinib|afatinib|mesh-list
2519170|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519171|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2519172|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519173|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519174|NCT01320345|Fenofibrate|fenofibrate|mesh-list
2519175|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2519176|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
2519177|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519178|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2519179|NCT01320397|Losartan|losartan|mesh-list
2519180|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2394178|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
2394179|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2394180|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2394181|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2394182|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
2394183|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394184|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394185|NCT00683137|Valdecoxib|valdecoxib|mesh-list
2394186|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2394187|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2519181|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2519182|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2519183|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2519184|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519185|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
2519186|NCT01320436|Curcumin|curcumin|mesh-list
2519187|NCT01320436|Mesalamine|mesalamine|mesh-list
2519188|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2519189|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2519190|NCT01320436|Analgesics|analgesics|mesh-ancestor
2519191|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
2519192|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519193|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519194|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2519195|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2519196|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519197|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519198|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519199|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
2519200|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2519201|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519202|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
2519203|NCT01320449|Hematinics|hematinics|mesh-ancestor
2519204|NCT01320475|Sufentanil|sufentanil|mesh-list
2519205|NCT01320475|Ketamine|ketamine|mesh-list
2519206|NCT01320475|Analgesics|analgesics|mesh-ancestor
2519207|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
2519208|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519209|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519210|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2519211|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2519212|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
2519213|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
2519214|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2519215|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2519216|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2519217|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2519218|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519219|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2394188|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394189|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394190|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2394191|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2394192|NCT00683137|Analgesics|analgesics|mesh-ancestor
2394193|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
2394194|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394195|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519220|NCT01320475|Narcotics|narcotics|mesh-ancestor
2519221|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2519222|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2519223|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519224|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2519225|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519226|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519227|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2519228|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
2519229|NCT01320514|Coagulants|coagulants|mesh-ancestor
2519230|NCT01320579|Tacrolimus|tacrolimus|mesh-list
2519231|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2519232|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
2519233|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519234|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2519235|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519236|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519237|NCT01320592|Paclitaxel|paclitaxel|mesh-list
2519238|NCT01320592|Palbociclib|palbociclib|mesh-list
2519239|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2394196|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2394197|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2394198|NCT00683176|Choline|choline|mesh-list
2394199|NCT00683176|Fenofibrate|fenofibrate|mesh-list
2394200|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2394201|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
2394202|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394203|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2394204|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
2394205|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2394206|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
2394207|NCT00683189|Warfarin|warfarin|mesh-list
2394208|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
2394209|NCT00683202|Aspirin|aspirin|mesh-list
2394210|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2394211|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2394212|NCT00683202|Analgesics|analgesics|mesh-ancestor
2394213|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
2394214|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394215|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394216|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2394217|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2394218|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2519240|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519241|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
2519242|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
2519243|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
2519244|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519245|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2519246|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519247|NCT01320709|Piroxicam|piroxicam|mesh-list
2519248|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2519249|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2519250|NCT01320709|Analgesics|analgesics|mesh-ancestor
2519251|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
2519252|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519253|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519254|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2519255|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2519256|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2519257|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519258|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114795|NCT02608684|Immunologic Factors|immunologic factors|mesh-ancestor
2114796|NCT02608684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114797|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2114798|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
2114799|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2114800|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114801|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
2114802|NCT02609399|Oseltamivir|oseltamivir|mesh-list
2114803|NCT02609399|Peramivir|peramivir|mesh-list
2114804|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
2114805|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114806|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114807|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519259|NCT01320878|Iloprost|iloprost|mesh-list
2519260|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2394219|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2394220|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394221|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2394222|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2394223|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394224|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
2394225|NCT00683267|Capsaicin|capsaicin|mesh-list
2394226|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
2394227|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
2394228|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
2394229|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394230|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394231|NCT00683306|Gefitinib|gefitinib|mesh-list
2394232|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394233|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2394234|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394235|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394236|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
2519261|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2519262|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
2519263|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
2519264|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2519265|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
2519266|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2519267|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519268|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2519269|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2519270|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2519271|NCT01320982|Aspirin|aspirin|mesh-list
2519272|NCT01320982|Minocycline|minocycline|mesh-list
2519273|NCT01320982|Pramipexole|pramipexole|mesh-list
2519274|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2394237|NCT00683319|Carboplatin|carboplatin|mesh-list
2394238|NCT00683319|Methotrexate|methotrexate|mesh-list
2394239|NCT00683319|Vincristine|vincristine|mesh-list
2394240|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2394241|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
2394242|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394243|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2394244|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2394245|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
2394246|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394247|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394248|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2394249|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2394250|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
2394251|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2394252|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2394253|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
2394254|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
2394255|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394256|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2394257|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2394258|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2394259|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
2394260|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
2394261|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
2394262|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2519275|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2519276|NCT01320982|Analgesics|analgesics|mesh-ancestor
2519277|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
2519278|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519279|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519280|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2519281|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2519282|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2519283|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2519284|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519285|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2519286|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2519287|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519288|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
2519289|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2519290|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519291|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
2394263|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2394264|NCT00683436|Adipiplon|adipiplon|mesh-list
2394265|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2394266|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394267|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
2394268|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
2394269|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394270|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394271|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2394272|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2394273|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2394274|NCT00683514|Cisplatin|cisplatin|mesh-list
2394275|NCT00683514|Vinorelbine|vinorelbine|mesh-list
2394276|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394277|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2394278|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
2394279|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
2394280|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
2394281|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394282|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
2394283|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2394284|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
2394285|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519292|NCT01320982|Protective Agents|protective agents|mesh-ancestor
2519293|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2519294|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2519295|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
2519296|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
2519297|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2519298|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
2519299|NCT01321021|Promethazine|promethazine|mesh-list
2519300|NCT01321021|Losartan|losartan|mesh-list
2519301|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2519302|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2519303|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2519304|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2519305|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519306|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2519307|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2519308|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2519309|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519310|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
2519311|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
2519312|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
2394286|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2394287|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2394288|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
2394289|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394290|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394291|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2394296|NCT00683735|Metformin|metformin|mesh-list
2394297|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2394298|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2394299|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519313|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519314|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
2519315|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
2519316|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2519317|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2519318|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
2519319|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
2519320|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2519321|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2519322|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
2519323|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
2519324|NCT01321034|Niacin|niacin|mesh-list
2519325|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2519326|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
2394300|NCT00683735|Incretins|incretins|mesh-ancestor
2394301|NCT00683735|Hormones|hormones|mesh-ancestor
2394302|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2519327|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519328|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2519329|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
2519330|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
2519331|NCT01321034|Vitamins|vitamins|mesh-ancestor
2519332|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
2519333|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519334|NCT01321047|Propofol|propofol|mesh-list
2519335|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2519336|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2519337|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519338|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2519339|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
2519340|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
2519341|NCT01321099|Ascorbic Acid|ascorbic acid|mesh-list
2519342|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
2519343|NCT01321099|Vitamins|vitamins|mesh-ancestor
2519344|NCT01321099|Micronutrients|micronutrients|mesh-ancestor
2519345|NCT01321099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519346|NCT01321099|Antioxidants|antioxidants|mesh-ancestor
2519347|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519348|NCT01321099|Protective Agents|protective agents|mesh-ancestor
2519349|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2519350|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
2519351|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
2519352|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
2519353|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2519354|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
2519355|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2519356|NCT01321125|Povidone|povidone|mesh-list
2519357|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519358|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
2394303|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2394304|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
2394305|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394306|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394307|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
2394308|NCT00683865|Ofloxacin|ofloxacin|mesh-list
2394309|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2394310|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2394311|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394312|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2394313|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2394314|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394315|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394316|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519359|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
2519360|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
2519361|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
2519362|NCT01321138|Morphine|morphine|mesh-list
2519363|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2519364|NCT01321138|Narcotics|narcotics|mesh-ancestor
2519365|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2519366|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519367|NCT01321138|Analgesics|analgesics|mesh-ancestor
2519368|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
2519369|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519370|NCT01321255|Aspirin|aspirin|mesh-list
2519371|NCT01321255|Ramipril|ramipril|mesh-list
2519372|NCT01321255|Simvastatin|simvastatin|mesh-list
2519373|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2519374|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2519375|NCT01321255|Analgesics|analgesics|mesh-ancestor
2519376|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
2519377|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519378|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394317|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2394318|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
2394319|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2394320|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394321|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2394322|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2394323|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2519379|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2519380|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2519381|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2519382|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2519383|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519384|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2519385|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2519386|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519387|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
2519388|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2519389|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2519390|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
2519391|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2519392|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2519393|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2519394|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
2519395|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2519396|NCT01321268|Beta Carotene|beta carotene|mesh-list
2519397|NCT01321268|Lycopene|lycopene|mesh-list
2519398|NCT01321268|Resveratrol|resveratrol|mesh-list
2519399|NCT01321268|Carotenoids|carotenoids|mesh-list
2519400|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
2519401|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519402|NCT01321268|Protective Agents|protective agents|mesh-ancestor
2519403|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519404|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519405|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2519406|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2519407|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2519408|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2519409|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519410|NCT01321268|Provitamins|provitamins|mesh-ancestor
2519411|NCT01321268|Vitamins|vitamins|mesh-ancestor
2519412|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
2519413|NCT01321346|Cytarabine|cytarabine|mesh-list
2519414|NCT01321346|Panobinostat|panobinostat|mesh-list
2519415|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2394324|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2394325|NCT00683865|Renal Agents|renal agents|mesh-ancestor
2394326|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2394327|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2394328|NCT00683891|Clozapine|clozapine|mesh-list
2394329|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2394330|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
2394331|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394332|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519416|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
2519417|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519418|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519419|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
2519420|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519421|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2519422|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
2519423|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519424|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2519425|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519426|NCT01321359|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
2519427|NCT01321359|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
2519428|NCT01321359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519429|NCT01321359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519430|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
2519431|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519432|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
2519433|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2519434|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2519435|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519436|NCT01321489|Urological Agents|urological agents|mesh-ancestor
2519437|NCT01321502|Famciclovir|famciclovir|mesh-list
2519438|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
2519439|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519440|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2519441|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519442|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519443|NCT01321515|Famciclovir|famciclovir|mesh-list
2519444|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
2519445|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519446|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2519447|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519448|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519449|NCT01321567|Rabeprazole|rabeprazole|mesh-list
2519450|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2519451|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2519452|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2519453|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519454|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519455|NCT01321671|Pregabalin|pregabalin|mesh-list
2519456|NCT01321671|Analgesics|analgesics|mesh-ancestor
2519457|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
2519458|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519459|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519460|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
2519461|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2519462|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2519463|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519464|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2519465|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2519466|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2519467|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2519468|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2519469|NCT01321775|Paclitaxel|paclitaxel|mesh-list
2519470|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
2519471|NCT01321775|Bevacizumab|bevacizumab|mesh-list
2519472|NCT01321775|Trastuzumab|trastuzumab|mesh-list
2519473|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2519474|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519475|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
2519476|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
2519477|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
2519478|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519479|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2519480|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
2519481|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394333|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394334|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2394335|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2394336|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2394337|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2394338|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
2394339|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
2394340|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
2394341|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
2394342|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2394343|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394344|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394345|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
2394346|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2394347|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2394348|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394349|NCT00683956|Propofol|propofol|mesh-list
2394350|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
2394351|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2394352|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519482|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2519483|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2519484|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
2519485|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2394353|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2394354|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2394355|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
2394356|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
2394357|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2394358|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394359|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2394360|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
2394361|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2394362|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394363|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519486|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2519487|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2519488|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2519489|NCT01321775|Growth Substances|growth substances|mesh-ancestor
2519490|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
2519491|NCT01321788|Tinzaparin|tinzaparin|mesh-list
2519492|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2519493|NCT01321788|Dalteparin|dalteparin|mesh-list
2519494|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
2519495|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2519496|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2519497|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519498|NCT01321801|Pregabalin|pregabalin|mesh-list
2519499|NCT01321801|Analgesics|analgesics|mesh-ancestor
2519500|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
2519501|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519502|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519503|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
2519504|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2519505|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2519506|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519507|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2519508|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2519509|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2519510|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2519511|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2519512|NCT01321827|Itraconazole|itraconazole|mesh-list
2519513|NCT01321827|Prednisolone|prednisolone|mesh-list
2519514|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
2519515|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2519516|NCT01321827|Hormones|hormones|mesh-ancestor
2519517|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2519518|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519519|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2519520|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519521|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
2519522|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519523|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2519524|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2519525|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519526|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394364|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394365|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
2394366|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2394367|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394368|NCT00683995|Fentanyl|fentanyl|mesh-list
2394369|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2394370|NCT00683995|Narcotics|narcotics|mesh-ancestor
2394371|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2394372|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394373|NCT00683995|Analgesics|analgesics|mesh-ancestor
2394374|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
2394375|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394376|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2394377|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2394378|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
2394379|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
2394380|NCT00684099|Docetaxel|docetaxel|mesh-list
2394381|NCT00684099|Pemetrexed|pemetrexed|mesh-list
2394382|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394383|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
2519527|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2519528|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
2519529|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2519530|NCT01321905|Vitamin D|vitamin d|mesh-list
2519531|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
2519532|NCT01321905|Vitamins|vitamins|mesh-ancestor
2519533|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
2519534|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519535|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2519536|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2519537|NCT01321931|Nicotine|nicotine|mesh-list
2519538|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2519539|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
2519540|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519541|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519542|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2519543|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2519544|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
2519545|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2519546|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394384|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
2519547|NCT01321944|Nicotine|nicotine|mesh-list
2519548|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2519549|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
2519550|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519551|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519552|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2519553|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2519554|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
2519555|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2519556|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519557|NCT01321957|Bevacizumab|bevacizumab|mesh-list
2519558|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
2519559|NCT01321957|Irinotecan|irinotecan|mesh-list
2519560|NCT01321957|Fluorouracil|fluorouracil|mesh-list
2519561|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2519562|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519563|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2519564|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2519565|NCT01321957|Growth Substances|growth substances|mesh-ancestor
2519566|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519567|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
2519568|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2519569|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2519570|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519571|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519572|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
2519573|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2519574|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2519575|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
2519576|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
2394385|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
2394386|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394387|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394388|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2394389|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2394390|NCT00684112|Gabapentin|gabapentin|mesh-list
2394391|NCT00684112|Analgesics|analgesics|mesh-ancestor
2394392|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
2394393|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519577|NCT01322061|Vitamins|vitamins|mesh-ancestor
2519578|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
2519579|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394394|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394395|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
2394396|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2394397|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2519580|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
2519581|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519582|NCT01322061|Protective Agents|protective agents|mesh-ancestor
2519583|NCT01322100|Bleomycin|bleomycin|mesh-list
2519584|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2519585|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519586|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
2519587|NCT01322139|Nabiximols|nabiximols|mesh-list
2519588|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2519589|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2519590|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519591|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2519592|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2519593|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519594|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519595|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519596|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2519597|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
2519598|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2519599|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519600|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2519601|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2519602|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2519603|NCT01322139|Analgesics|analgesics|mesh-ancestor
2519604|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
2519605|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519606|NCT01322152|Capecitabine|capecitabine|mesh-list
2519607|NCT01322152|Irinotecan|irinotecan|mesh-list
2519608|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2519609|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
2519610|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519611|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519612|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2519613|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2519614|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519615|NCT01322178|Cetuximab|cetuximab|mesh-list
2519616|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2519617|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519618|NCT01322191|Morphine|morphine|mesh-list
2519619|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2519620|NCT01322191|Narcotics|narcotics|mesh-ancestor
2519621|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2519622|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519623|NCT01322191|Analgesics|analgesics|mesh-ancestor
2519624|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
2519625|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519626|NCT01322204|Codeine|codeine|mesh-list
2519627|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2519628|NCT01322204|Narcotics|narcotics|mesh-ancestor
2519629|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2519630|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519631|NCT01322204|Analgesics|analgesics|mesh-ancestor
2519632|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
2519633|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519634|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
2519635|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
2519636|NCT01322282|Cetirizine|cetirizine|mesh-list
2519637|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2519638|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2519639|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2519640|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
2519641|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
2519642|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2519643|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519644|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519645|NCT01322308|Pioglitazone|pioglitazone|mesh-list
2519646|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2519647|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519648|NCT01322438|Rifampin|rifampin|mesh-list
2519649|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2519650|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
2519651|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2519652|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519653|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
2519654|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2519655|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394398|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2394399|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2394400|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2394401|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2394402|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2519656|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519657|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2519658|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2519659|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2519660|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2519661|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2519662|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2519663|NCT01322464|Nabiximols|nabiximols|mesh-list
2519664|NCT01322464|Analgesics|analgesics|mesh-ancestor
2519665|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
2519666|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519667|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519668|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2519669|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2519670|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519671|NCT01322711|Atorvastatin|atorvastatin|mesh-list
2519672|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2519673|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2519674|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
2519675|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519676|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2519677|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2519678|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519679|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
2519680|NCT01322776|Fludarabine|fludarabine|mesh-list
2519681|NCT01322776|Bortezomib|bortezomib|mesh-list
2519682|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2519683|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
2519684|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519685|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2519686|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2519687|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
2519688|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519689|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519690|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2519691|NCT01322867|Alprazolam|alprazolam|mesh-list
2519692|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2519693|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2519694|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519695|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2519696|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2519697|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2519698|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
2519699|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
2519700|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2519701|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519702|NCT01323062|Bavituximab|bavituximab|mesh-list
2519703|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2519704|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519705|NCT01323101|Doxycycline|doxycycline|mesh-list
2519706|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2519707|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394403|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394404|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
2394405|NCT00684164|Conivaptan|conivaptan|mesh-list
2394406|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2394407|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394408|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
2394409|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394410|NCT00684190|Esomeprazole|esomeprazole|mesh-list
2394411|NCT00684190|Lesogaberan|lesogaberan|mesh-list
2394412|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2394413|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2394414|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2394415|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394416|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394417|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2394418|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
2519708|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
2519709|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2519710|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2519711|NCT01323205|Antipsychotic Agents|antipsychotic agents|mesh-list
2519712|NCT01323205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2519713|NCT01323205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2519714|NCT01323205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519715|NCT01323205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2519716|NCT01323218|Vitamin D|vitamin d|mesh-list
2519717|NCT01323218|Vitamins|vitamins|mesh-ancestor
2519718|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
2519719|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519720|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2519721|NCT01323244|Simeprevir|simeprevir|mesh-list
2519722|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
2519723|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519724|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
2519725|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519726|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519727|NCT01323257|Ritonavir|ritonavir|mesh-list
2394419|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
2394420|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394421|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394422|NCT00684216|Tamoxifen|tamoxifen|mesh-list
2394423|NCT00684216|Capecitabine|capecitabine|mesh-list
2394424|NCT00684216|Letrozole|letrozole|mesh-list
2394425|NCT00684216|Anastrozole|anastrozole|mesh-list
2394426|NCT00684216|Exemestane|exemestane|mesh-list
2394427|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2394428|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
2394429|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519728|NCT01323257|Darunavir|darunavir|mesh-list
2519729|NCT01323257|Erythromycin|erythromycin|mesh-list
2519730|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
2519731|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2519732|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
2519733|NCT01323257|Simeprevir|simeprevir|mesh-list
2519734|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2519735|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2519736|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
2519737|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519738|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519739|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2519740|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2519741|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
2519742|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519743|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2519744|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2519745|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2519746|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2519747|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2519748|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2519749|NCT01323296|Hematinics|hematinics|mesh-ancestor
2519750|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2519751|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2519752|NCT01323335|Rasburicase|rasburicase|mesh-list
2519753|NCT01323335|Uric Acid|uric acid|mesh-list
2519754|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
2519755|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2394430|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394431|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2394432|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2394433|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394434|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2394435|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
2519756|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
2519757|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519758|NCT01323335|Protective Agents|protective agents|mesh-ancestor
2519759|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519760|NCT01323374|Carbidopa|carbidopa|mesh-list
2519761|NCT01323374|Droxidopa|droxidopa|mesh-list
2519762|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2519763|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2519764|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
2519765|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2519766|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519767|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519768|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2519769|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519770|NCT01323452|Entecavir|entecavir|mesh-list
2519771|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
2519772|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519773|NCT01323465|Ketoconazole|ketoconazole|mesh-list
2519774|NCT01323465|Rifampin|rifampin|mesh-list
2519775|NCT01323465|Nabiximols|nabiximols|mesh-list
2519776|NCT01323465|Omeprazole|omeprazole|mesh-list
2519777|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2519778|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2519779|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2519780|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519781|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394436|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2394437|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394438|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2394439|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2394440|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2394441|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2394442|NCT00684229|Anesthetics|anesthetics|mesh-list
2394443|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2394444|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394445|NCT00684268|Silybin|silybin|mesh-list
2394446|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2394447|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394448|NCT00684268|Protective Agents|protective agents|mesh-ancestor
2519782|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
2519783|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519784|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2519785|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2394449|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394450|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2394451|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2394452|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394453|NCT00684372|Leflunomide|leflunomide|mesh-list
2394454|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519786|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2519787|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
2519788|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2519789|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519790|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2519791|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2519792|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
2519793|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2519794|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
2519795|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2519796|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2394455|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394456|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2394457|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
2394458|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394459|NCT00684385|Gefitinib|gefitinib|mesh-list
2114811|NCT02609607|Bisacodyl|bisacodyl|mesh-list
2114812|NCT02609607|Cathartics|cathartics|mesh-ancestor
2114813|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2114814|NCT02609607|Laxatives|laxatives|mesh-ancestor
2114815|NCT02609659|Ritonavir|ritonavir|mesh-list
2114816|NCT02609659|Ribavirin|ribavirin|mesh-list
2114817|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2114818|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2114819|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
2114820|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114821|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114822|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2114823|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2114824|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
2114825|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114826|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2114827|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2114828|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
2114829|NCT02609984|Atezolizumab|atezolizumab|mesh-list
2114830|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114831|NCT02610140|Vinorelbine|vinorelbine|mesh-list
2114832|NCT02610140|Maytansine|maytansine|mesh-list
2114833|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2114834|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114835|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
2114836|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
2114837|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
2114838|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114839|NCT02610231|Istradefylline|istradefylline|mesh-list
2114840|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2114841|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2114842|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2114843|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
2114844|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2114845|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114846|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114847|NCT02610777|Azacitidine|azacitidine|mesh-list
2114848|NCT02610777|Pevonedistat|pevonedistat|mesh-list
2114849|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2114850|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
2114851|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114852|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114853|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114854|NCT02610816|Fluticasone|fluticasone|mesh-list
2114855|NCT02610816|Xhance|xhance|mesh-list
2114856|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2114857|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2114858|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
2519797|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2519798|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2519799|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2519800|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2519801|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2519802|NCT01323465|Analgesics|analgesics|mesh-ancestor
2519803|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
2519804|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519805|NCT01323491|Nicotine|nicotine|mesh-list
2519806|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2519807|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
2519808|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519809|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519810|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2519811|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2519812|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
2519813|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2519814|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394460|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394461|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2394462|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394463|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394464|NCT00684450|Protamines|protamines|mesh-list
2394465|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
2394466|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394467|NCT00684450|Coagulants|coagulants|mesh-ancestor
2394468|NCT00684463|Palonosetron|palonosetron|mesh-list
2394469|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
2394470|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
2394471|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394472|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394473|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2394474|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2394475|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2394476|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
2394477|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394478|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519815|NCT01323569|Nabiximols|nabiximols|mesh-list
2519816|NCT01323569|Dronabinol|dronabinol|mesh-list
2519817|NCT01323569|Analgesics|analgesics|mesh-ancestor
2519818|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
2519819|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519820|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394479|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
2394480|NCT00684489|Coal Tar|coal tar|mesh-list
2394481|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
2394482|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
2394483|NCT00684528|Metformin|metformin|mesh-list
2394484|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2394485|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394486|NCT00684606|Oxytocin|oxytocin|mesh-list
2394487|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
2394488|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2394489|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394490|NCT00684632|Fentanyl|fentanyl|mesh-list
2394491|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2394492|NCT00684632|Narcotics|narcotics|mesh-ancestor
2394493|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2394494|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394495|NCT00684632|Analgesics|analgesics|mesh-ancestor
2519821|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
2519822|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2519823|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2519824|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2519825|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2394496|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
2394497|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394498|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2394499|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2394500|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
2394501|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
2394502|NCT00684827|Albuterol|albuterol|mesh-list
2394503|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2394504|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
2394505|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394506|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519826|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2519827|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519828|NCT01323569|Hormones|hormones|mesh-ancestor
2394507|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2394508|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
2394509|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
2394510|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2394511|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2394512|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2394513|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2394514|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
2394515|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394516|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394517|NCT00684853|Bevacizumab|bevacizumab|mesh-list
2394518|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2394519|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394520|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2394521|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2394522|NCT00684853|Growth Substances|growth substances|mesh-ancestor
2394523|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394524|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
2394525|NCT00684866|Albuterol|albuterol|mesh-list
2394526|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2394527|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
2394528|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394529|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394530|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2394531|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
2519829|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2519830|NCT01323608|Vitamin D|vitamin d|mesh-list
2519831|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
2519832|NCT01323608|Vitamins|vitamins|mesh-ancestor
2519833|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
2519834|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519835|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2519836|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2519837|NCT01323712|Vitamin D|vitamin d|mesh-list
2519838|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
2519839|NCT01323712|Vitamins|vitamins|mesh-ancestor
2519840|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
2519841|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519842|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2519843|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2519844|NCT01323751|Ricolinostat|ricolinostat|mesh-list
2114859|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114860|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114861|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2114862|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
2114863|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
2114864|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2114865|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
2114866|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
2114867|NCT02610868|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2114868|NCT02610868|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2114869|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2114870|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2114871|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114872|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
2114873|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2114874|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114875|NCT02610868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2114876|NCT02610868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114877|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2114878|NCT02611154|Testosterone|testosterone|mesh-list
2114879|NCT02611154|Androgens|androgens|mesh-ancestor
2114880|NCT02611154|Hormones|hormones|mesh-ancestor
2114881|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2114882|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114883|NCT02611752|Buprenorphine|buprenorphine|mesh-list
2114884|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2114885|NCT02611752|Narcotics|narcotics|mesh-ancestor
2114886|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2114887|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394532|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
2519845|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394533|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2394534|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2394535|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2394536|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2394537|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
2394538|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394539|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394540|NCT00684905|Leuprolide|leuprolide|mesh-list
2394541|NCT00684905|Bicalutamide|bicalutamide|mesh-list
2394542|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2394543|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
2394544|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2394545|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519846|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2519847|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519848|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519849|NCT01324063|Cytarabine|cytarabine|mesh-list
2519850|NCT01324063|Daunorubicin|daunorubicin|mesh-list
2519851|NCT01324063|Amsacrine|amsacrine|mesh-list
2519852|NCT01324063|Sargramostim|sargramostim|mesh-list
2519853|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2519854|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
2519855|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519856|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519857|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
2519858|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519859|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2519860|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
2519861|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519862|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2519863|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2519864|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2519865|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519866|NCT01324076|Doxorubicin|doxorubicin|mesh-list
2519867|NCT01324076|Sorafenib|sorafenib|mesh-list
2519868|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2519869|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519870|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2519871|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2519872|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519873|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519874|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2519875|NCT01324089|Resveratrol|resveratrol|mesh-list
2519876|NCT01324089|Piperine|piperine|mesh-list
2519877|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
2519878|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519879|NCT01324089|Protective Agents|protective agents|mesh-ancestor
2394546|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2394547|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394548|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
2394549|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
2394550|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2394551|NCT00684918|Obatoclax|obatoclax|mesh-list
2394552|NCT00684918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394553|NCT00684918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394554|NCT00684957|Hormones|hormones|mesh-list
2394555|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2394556|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394557|NCT00685009|Hormones|hormones|mesh-list
2394558|NCT00685009|Progesterone|progesterone|mesh-list
2394559|NCT00685009|Estrogens|estrogens|mesh-list
2394560|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2394561|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394562|NCT00685009|Progestins|progestins|mesh-ancestor
2394563|NCT00685022|Albuterol|albuterol|mesh-list
2394564|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2394565|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
2394566|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394567|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394568|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2394569|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
2394570|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
2519880|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519881|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519882|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2519883|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2519884|NCT01324115|Nitroarginine|nitroarginine|mesh-list
2519885|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519886|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519887|NCT01324180|Metformin|metformin|mesh-list
2519888|NCT01324180|Dexamethasone|dexamethasone|mesh-list
2394571|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2394572|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2394573|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2394574|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2394575|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
2519889|NCT01324180|Doxorubicin|doxorubicin|mesh-list
2519890|NCT01324180|Vincristine|vincristine|mesh-list
2519891|NCT01324180|Asparaginase|asparaginase|mesh-list
2519892|NCT01324180|Pegaspargase|pegaspargase|mesh-list
2519893|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2519894|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
2519895|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
2519896|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519897|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519898|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2519899|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
2519900|NCT01324180|Hormones|hormones|mesh-ancestor
2519901|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2519902|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2394576|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394577|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394578|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
2394579|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
2394580|NCT00685061|Daclizumab|daclizumab|mesh-list
2394581|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
2394582|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394583|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2394584|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2394585|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394586|NCT00685100|Triamcinolone|triamcinolone|mesh-list
2394587|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2394588|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
2394589|NCT00685100|Hormones|hormones|mesh-ancestor
2394590|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2394591|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394592|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2394593|NCT00685126|Albuterol|albuterol|mesh-list
2394594|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2394595|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
2394596|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394597|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394598|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2394599|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
2394600|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
2394601|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2394602|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2394603|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2394604|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2394605|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
2394606|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394607|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519903|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519904|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2519905|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2114888|NCT02611752|Analgesics|analgesics|mesh-ancestor
2114889|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
2114890|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114891|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2114892|NCT02611765|Penicillins|penicillins|mesh-list
2114893|NCT02611765|Penicillin G|penicillin g|mesh-list
2114894|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2114895|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
2114896|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2114897|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114898|NCT02611778|Ranibizumab|ranibizumab|mesh-list
2114899|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2114900|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2114901|NCT02611778|Growth Substances|growth substances|mesh-ancestor
2114902|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519906|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2519907|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2519908|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519909|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519910|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2519911|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
2519912|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
2519913|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
2519914|NCT01324245|Fenoldopam|fenoldopam|mesh-list
2519915|NCT01324245|Enalaprilat|enalaprilat|mesh-list
2519916|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2519917|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
2519918|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
2519919|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
2519920|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2519921|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519922|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519923|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2519924|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
2519925|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519926|NCT01324258|Gemcitabine|gemcitabine|mesh-list
2519927|NCT01324258|Trametinib|trametinib|mesh-list
2519928|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2519929|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
2519930|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519931|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519932|NCT01324258|Antiviral Agents|antiviral agents|mesh-ancestor
2519933|NCT01324258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2519934|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519935|NCT01324258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2519936|NCT01324258|Immunologic Factors|immunologic factors|mesh-ancestor
2519937|NCT01324258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519938|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2519939|NCT01324284|Lubiprostone|lubiprostone|mesh-list
2519940|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2519941|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2519942|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519943|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
2519944|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
2668542|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394608|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
2394609|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2394610|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2394611|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
2394612|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394613|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2394614|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2394615|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394616|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394617|NCT00685230|Antivenins|antivenins|mesh-list
2394618|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
2394619|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394620|NCT00685269|Eszopiclone|eszopiclone|mesh-list
2394621|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2114903|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
2114904|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114905|NCT02611817|Vedolizumab|vedolizumab|mesh-list
2114906|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2114907|NCT02611830|Vedolizumab|vedolizumab|mesh-list
2114908|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2114909|NCT02611882|Edetic Acid|edetic acid|mesh-list
2114910|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
2114911|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
2114912|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
2114913|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114914|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
2114915|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2114916|NCT02612064|Fluorides|fluorides|mesh-list
2114917|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
2114918|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
2114919|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
2114920|NCT02612064|Protective Agents|protective agents|mesh-ancestor
2114921|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114922|NCT02612077|Bevacizumab|bevacizumab|mesh-list
2114923|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2394622|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2519945|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519946|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2519947|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519948|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2519949|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
2519950|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519951|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2394623|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394624|NCT00685347|Albuterol|albuterol|mesh-list
2394625|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2394626|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
2394627|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394628|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394629|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2394630|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
2394631|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
2394632|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2519952|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519953|NCT01324466|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
2519954|NCT01324466|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
2519955|NCT01324466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2519956|NCT01324466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519957|NCT01324492|Everolimus|everolimus|mesh-list
2519958|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519959|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2519960|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
2519961|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519962|NCT01324544|Buprenorphine|buprenorphine|mesh-list
2519963|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2519964|NCT01324544|Narcotics|narcotics|mesh-ancestor
2519965|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2519966|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114924|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114925|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2114926|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2114927|NCT02612077|Growth Substances|growth substances|mesh-ancestor
2114928|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114929|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
2114930|NCT02612194|Crizotinib|crizotinib|mesh-list
2114931|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519967|NCT01324544|Analgesics|analgesics|mesh-ancestor
2519968|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
2519969|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2519970|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2519971|NCT01324583|Prednisolone|prednisolone|mesh-list
2519972|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2519973|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
2519974|NCT01324583|Hormones|hormones|mesh-ancestor
2519975|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2519976|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519977|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2519978|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2519979|NCT01324596|Prednisolone|prednisolone|mesh-list
2519980|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2519981|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
2519982|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2519983|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
2519984|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
2519985|NCT01324596|Rituximab|rituximab|mesh-list
2519986|NCT01324596|Doxorubicin|doxorubicin|mesh-list
2519987|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2519988|NCT01324596|Vincristine|vincristine|mesh-list
2519989|NCT01324596|Bortezomib|bortezomib|mesh-list
2519990|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2519991|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
2519992|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2519993|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
2519994|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2519995|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2519996|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2519997|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
2519998|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2519999|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520000|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2520001|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2394633|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2394634|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2394635|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2394636|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
2394637|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394638|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394639|NCT00685425|Albuterol|albuterol|mesh-list
2394640|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2394641|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
2394642|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394643|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394644|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2394645|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
2394646|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
2394647|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2394648|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2394649|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2394650|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2394651|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
2394652|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520002|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2520003|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2520004|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2520005|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520006|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2520007|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
2394653|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394654|NCT00685464|Abciximab|abciximab|mesh-list
2394655|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
2394656|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2394657|NCT00685503|Ranibizumab|ranibizumab|mesh-list
2394658|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2394659|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2394660|NCT00685503|Growth Substances|growth substances|mesh-ancestor
2520008|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
2520009|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
2520010|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2520011|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
2520012|NCT01324596|Hormones|hormones|mesh-ancestor
2520013|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2520014|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2520015|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
2520016|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
2520017|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520018|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2520019|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2520020|NCT01324596|Protective Agents|protective agents|mesh-ancestor
2520021|NCT01324635|Panobinostat|panobinostat|mesh-list
2520022|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2520023|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520024|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520025|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520026|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2520027|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
2520028|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520029|NCT01324752|Losartan|losartan|mesh-list
2520030|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2520031|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2520032|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2394661|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394662|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
2394663|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394664|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
2394665|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2394666|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
2394667|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394668|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394669|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2394670|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
2394671|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2394672|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2394673|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2394674|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
2394675|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520033|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2520034|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520035|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2394676|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394677|NCT00685542|Diacetylrhein|diacetylrhein|mesh-list
2394678|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2520036|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
2520037|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
2520038|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2520039|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520040|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
2520041|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520042|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2520043|NCT01324960|Aldesleukin|aldesleukin|mesh-list
2520044|NCT01324960|Azacitidine|azacitidine|mesh-list
2520045|NCT01324960|Histamine|histamine|mesh-list
2520046|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2520047|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
2520048|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520049|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520050|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520051|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520052|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2520053|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2520054|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
2520055|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520056|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
2394679|NCT00685568|Celecoxib|celecoxib|mesh-list
2394680|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2394681|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2394682|NCT00685568|Analgesics|analgesics|mesh-ancestor
2394683|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
2394684|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394685|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394686|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2394687|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2394688|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2394689|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2394690|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394691|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394692|NCT00685594|Vitamin D|vitamin d|mesh-list
2394693|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
2394694|NCT00685594|Vitamins|vitamins|mesh-ancestor
2394695|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
2394696|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394697|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2394698|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2394699|NCT00685607|Simethicone|simethicone|mesh-list
2394700|NCT00685607|Loperamide|loperamide|mesh-list
2394701|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
2394702|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2394703|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
2114932|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2114933|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114934|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114935|NCT02612779|Dexamethasone|dexamethasone|mesh-list
2114936|NCT02612779|Nivolumab|nivolumab|mesh-list
2114937|NCT02612779|Pomalidomide|pomalidomide|mesh-list
2114938|NCT02612779|Elotuzumab|elotuzumab|mesh-list
2114939|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2114940|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
2114941|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
2114942|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2114943|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114944|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2114945|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
2114946|NCT02612779|Hormones|hormones|mesh-ancestor
2114947|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2114948|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2114949|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114950|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2114951|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2114952|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114953|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
2114954|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2394704|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394705|NCT00685607|Emollients|emollients|mesh-ancestor
2394706|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
2394707|NCT00685633|Bicalutamide|bicalutamide|mesh-list
2394708|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
2394709|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
2394710|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2394711|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394712|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394713|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
2394714|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
2394715|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2394716|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394717|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
2394718|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2394719|NCT00685672|Epinephrine|epinephrine|mesh-list
2394720|NCT00685672|Racepinephrine|racepinephrine|mesh-list
2394721|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
2394722|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2394723|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2394724|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
2394725|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394726|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394727|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394728|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2394729|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2394730|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
2394731|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394732|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2394733|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
2520057|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
2520058|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520059|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
2520060|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2520061|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2394734|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
2394735|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
2394736|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2394737|NCT00685776|Anacetrapib|anacetrapib|mesh-list
2394738|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2394739|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2394740|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
2394741|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394742|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2394743|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
2520062|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
2520063|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520064|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2520065|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2520066|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520067|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520068|NCT01325168|Oxytocin|oxytocin|mesh-list
2520069|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
2520070|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2394744|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394745|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2394746|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394747|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394748|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2394749|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
2394750|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2394751|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2394752|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
2394753|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394754|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394755|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2394756|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
2394757|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2394758|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2394759|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2394760|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
2394761|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394762|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394763|NCT00685854|Ranibizumab|ranibizumab|mesh-list
2520071|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520072|NCT01325194|Cytarabine|cytarabine|mesh-list
2394764|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2394765|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2394766|NCT00685854|Growth Substances|growth substances|mesh-ancestor
2394767|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394768|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
2394769|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394770|NCT00685906|Ticagrelor|ticagrelor|mesh-list
2394771|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
2394772|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2394773|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2394774|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2394775|NCT00685906|Estradiol|estradiol|mesh-list
2394776|NCT00685906|Estrogens|estrogens|mesh-ancestor
2394777|NCT00685906|Hormones|hormones|mesh-ancestor
2394778|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2394779|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394780|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2394781|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
2394782|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2394783|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2394784|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2394785|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2394786|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2394787|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2394788|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2394789|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2394790|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2394791|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
2394792|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394793|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394794|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2520073|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2520074|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
2520075|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520076|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520077|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
2520078|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520079|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2520080|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
2520081|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520082|NCT01325220|Baclofen|baclofen|mesh-list
2520083|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2520084|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520085|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2520086|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520087|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2520088|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
2520089|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
2520090|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520091|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520092|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2520093|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2520094|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520095|NCT01325298|Riboflavin|riboflavin|mesh-list
2520096|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
2520097|NCT01325298|Vitamins|vitamins|mesh-ancestor
2520098|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
2520099|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520100|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2394795|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2520101|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
2520102|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
2520103|NCT01325415|Naloxegol|naloxegol|mesh-list
2520104|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2520105|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520106|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2520107|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2520108|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520109|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520110|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520111|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394796|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2394797|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2394798|NCT00685958|Enoxaparin|enoxaparin|mesh-list
2394799|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
2394800|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2394801|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2394802|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394803|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
2394804|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2394805|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394806|NCT00685971|Vitamins|vitamins|mesh-ancestor
2394807|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
2394808|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2394809|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
2394810|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2394811|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2394812|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
2394813|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394814|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2394815|NCT00686114|Paclitaxel|paclitaxel|mesh-list
2394816|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2394817|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2394818|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394819|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
2394820|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
2520112|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2520113|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
2520114|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394821|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
2394822|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394823|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2520115|NCT01325441|Paclitaxel|paclitaxel|mesh-list
2520116|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2520117|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520118|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
2520119|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
2520120|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
2520121|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520122|NCT01325558|Gemcitabine|gemcitabine|mesh-list
2520123|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2520124|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
2114955|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2114956|NCT02612779|Growth Substances|growth substances|mesh-ancestor
2114957|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
2114958|NCT02613117|Fluorides|fluorides|mesh-list
2114959|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
2114960|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
2114961|NCT02613117|Protective Agents|protective agents|mesh-ancestor
2114962|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114963|NCT02613169|Isoniazid|isoniazid|mesh-list
2114964|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
2114965|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2114966|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114967|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2114968|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2114969|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
2114970|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114971|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2114972|NCT02613208|Paclitaxel|paclitaxel|mesh-list
2114973|NCT02613208|Bevacizumab|bevacizumab|mesh-list
2114974|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2114975|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114976|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
2114977|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
2114978|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
2114979|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114980|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2114981|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2114982|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2114983|NCT02613208|Growth Substances|growth substances|mesh-ancestor
2114984|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114985|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
2114986|NCT02613221|Panitumumab|panitumumab|mesh-list
2114987|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2394824|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2114988|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114989|NCT02613403|Ribavirin|ribavirin|mesh-list
2114990|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
2114991|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
2114992|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2114993|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
2114994|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2114995|NCT02613507|Docetaxel|docetaxel|mesh-list
2520125|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520126|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520127|NCT01325558|Antiviral Agents|antiviral agents|mesh-ancestor
2520128|NCT01325558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520129|NCT01325558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520130|NCT01325558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2520131|NCT01325558|Immunologic Factors|immunologic factors|mesh-ancestor
2520132|NCT01325558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520133|NCT01325571|Tacrolimus|tacrolimus|mesh-list
2520134|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2520135|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
2520136|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520137|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2520138|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520139|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520140|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
2520141|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2520142|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520143|NCT01325610|Vitamins|vitamins|mesh-ancestor
2520144|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
2520145|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2520146|NCT01325779|Heparin|heparin|mesh-list
2520147|NCT01325779|Enoxaparin|enoxaparin|mesh-list
2520148|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
2520149|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2520150|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2520151|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520152|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2520153|NCT01325818|Pravastatin|pravastatin|mesh-list
2520154|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2520155|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2520156|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
2520157|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520158|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2520159|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2520160|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520161|NCT01325844|Anesthetics|anesthetics|mesh-list
2394825|NCT00686140|Celecoxib|celecoxib|mesh-list
2394826|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2394827|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2394828|NCT00686140|Analgesics|analgesics|mesh-ancestor
2394829|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
2394830|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394831|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2114996|NCT02613507|Nivolumab|nivolumab|mesh-list
2114997|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2114998|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
2114999|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
2115000|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
2115001|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115002|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2115003|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2115004|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
2115005|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
2115006|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115007|NCT02613572|Protective Agents|protective agents|mesh-ancestor
2115008|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115009|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
2115010|NCT02613572|Vitamins|vitamins|mesh-ancestor
2115011|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
2115012|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
2115013|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2115014|NCT02613871|Ledipasvir|ledipasvir|mesh-list
2115015|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
2115016|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115017|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
2115018|NCT02613897|Saxagliptin|saxagliptin|mesh-list
2115019|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2520162|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2520163|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520164|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2520165|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
2520166|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520167|NCT01325935|Clopidogrel|clopidogrel|mesh-list
2520168|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2520169|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2520170|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2520171|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2520172|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
2520173|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394832|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2394833|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2394834|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2394835|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2394836|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394837|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394838|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
2394839|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2520174|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520175|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520176|NCT01325987|Vitamin D|vitamin d|mesh-list
2520177|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
2520178|NCT01325987|Vitamins|vitamins|mesh-list
2520179|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
2520180|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520181|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2520182|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2520183|NCT01326000|Cetuximab|cetuximab|mesh-list
2520184|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2520185|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520186|NCT01326039|Bupivacaine|bupivacaine|mesh-list
2520187|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
2520188|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
2520189|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2520190|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520191|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
2520192|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520193|NCT01326078|Propofol|propofol|mesh-list
2520194|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2520195|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2520196|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520197|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2520198|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
2520199|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
2520200|NCT01326117|Tadalafil|tadalafil|mesh-list
2520201|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
2520202|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2520203|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2520204|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520205|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520206|NCT01326117|Urological Agents|urological agents|mesh-ancestor
2520207|NCT01326221|Tenofovir|tenofovir|mesh-list
2520208|NCT01326221|Emtricitabine|emtricitabine|mesh-list
2520209|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
2520210|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520211|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2520212|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2520213|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520214|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520215|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2520216|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2520217|NCT01326312|Leuprolide|leuprolide|mesh-list
2520218|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2520219|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
2520220|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2520221|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520222|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2520223|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520224|NCT01326325|Ketamine|ketamine|mesh-list
2520225|NCT01326325|Analgesics|analgesics|mesh-ancestor
2520226|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
2520227|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520228|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520229|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2520230|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2520231|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
2520232|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
2394840|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394841|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2394842|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2394843|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394844|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394845|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394846|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
2394847|NCT00686192|Calcium|calcium|mesh-list
2394848|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2520233|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2520234|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2520235|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2520236|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520237|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520238|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
2520239|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2520240|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520241|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
2520242|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2520243|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2520244|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520245|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
2520246|NCT01326403|Coagulants|coagulants|mesh-ancestor
2520247|NCT01326442|Vitamin D|vitamin d|mesh-list
2520248|NCT01326442|Vitamins|vitamins|mesh-ancestor
2520249|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
2520250|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520251|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2520252|NCT01326468|Sirolimus|sirolimus|mesh-list
2520253|NCT01326468|Cisplatin|cisplatin|mesh-list
2520254|NCT01326468|Cetuximab|cetuximab|mesh-list
2520255|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520256|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2520257|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2520258|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520259|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2520260|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
2520261|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2115020|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115021|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2115022|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115023|NCT02613897|Incretins|incretins|mesh-ancestor
2115024|NCT02613897|Hormones|hormones|mesh-ancestor
2115025|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2115026|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2115027|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
2115028|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115029|NCT02613910|Acetaminophen|acetaminophen|mesh-list
2115030|NCT02613910|Cetirizine|cetirizine|mesh-list
2115031|NCT02613910|Prednisone|prednisone|mesh-list
2115032|NCT02613910|Prednisolone|prednisolone|mesh-list
2115033|NCT02613910|Ofatumumab|ofatumumab|mesh-list
2115034|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
2115035|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2115036|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2115037|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
2115038|NCT02613910|Hormones|hormones|mesh-ancestor
2115039|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2115040|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115041|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2115042|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115043|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2115044|NCT02613910|Analgesics|analgesics|mesh-ancestor
2115045|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
2115046|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115047|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
2115048|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2115049|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2115050|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
2115051|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115052|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520262|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
2520263|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520264|NCT01326494|Prednisone|prednisone|mesh-list
2520265|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2520266|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
2520267|NCT01326494|Hormones|hormones|mesh-ancestor
2520268|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2520269|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520270|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2520271|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520272|NCT01326559|Docetaxel|docetaxel|mesh-list
2520273|NCT01326559|Cetuximab|cetuximab|mesh-list
2520274|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520275|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
2520276|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
2520277|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
2394849|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394850|NCT00686192|Antacids|antacids|mesh-ancestor
2394851|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394852|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2394853|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
2520278|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520279|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2520280|NCT01326585|Dexamethasone|dexamethasone|mesh-list
2520281|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
2520282|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2520283|NCT01326585|BB 1101|bb 1101|mesh-list
2520284|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2520285|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
2520286|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
2520287|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520288|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520289|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2520290|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
2520291|NCT01326585|Hormones|hormones|mesh-ancestor
2520292|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2394854|NCT00686218|Panobinostat|panobinostat|mesh-list
2394855|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2394856|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394857|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2394858|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394859|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394860|NCT00686322|Paclitaxel|paclitaxel|mesh-list
2394861|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2394862|NCT00686322|Cisplatin|cisplatin|mesh-list
2394863|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2394864|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394865|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
2394866|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
2394867|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
2394868|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115071|NCT02614560|Fludarabine|fludarabine|mesh-list
2115072|NCT02614560|Melphalan|melphalan|mesh-list
2115073|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115074|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115075|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2394869|NCT00686361|Choline|choline|mesh-list
2520293|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2520294|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520295|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
2520296|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520297|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520298|NCT01326611|Clarithromycin|clarithromycin|mesh-list
2520299|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2520300|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520301|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2520302|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520303|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520304|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2520305|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2520306|NCT01326650|Vitamin D|vitamin d|mesh-list
2520307|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
2520308|NCT01326650|Vitamins|vitamins|mesh-list
2520309|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2520310|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
2520311|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520312|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2394870|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
2394871|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2394872|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
2394873|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394874|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2394875|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2394876|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
2394877|NCT00686374|Adalimumab|adalimumab|mesh-list
2394878|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2394879|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2394880|NCT00686439|Adalimumab|adalimumab|mesh-list
2394881|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2394882|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2394883|NCT00686478|Interferons|interferons|mesh-list
2394884|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
2394885|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
2394886|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394887|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
2394888|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394889|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
2394890|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394891|NCT00686556|Cyclosporine|cyclosporine|mesh-list
2394892|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
2394893|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
2394894|NCT00686556|Fludarabine|fludarabine|mesh-list
2394895|NCT00686556|Cyclosporins|cyclosporins|mesh-list
2394896|NCT00686556|Sargramostim|sargramostim|mesh-list
2394897|NCT00686556|Lenograstim|lenograstim|mesh-list
2394898|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2394899|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
2520313|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2520314|NCT01326754|Artesunate|artesunate|mesh-list
2520315|NCT01326754|Lumefantrine|lumefantrine|mesh-list
2520316|NCT01326754|Artemether|artemether|mesh-list
2115076|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
2115077|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115078|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2115079|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
2115080|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2115086|NCT02614703|Acetic Acid|acetic acid|mesh-list
2115087|NCT02614703|Retinol acetate|retinol acetate|mesh-list
2115088|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2115089|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115090|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2115091|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
2115092|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115093|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2115094|NCT02614703|Protective Agents|protective agents|mesh-ancestor
2115095|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115096|NCT02614794|Capecitabine|capecitabine|mesh-list
2115097|NCT02614794|Trastuzumab|trastuzumab|mesh-list
2394900|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394901|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2394902|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2520317|NCT01326754|Piperaquine|piperaquine|mesh-list
2520318|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2520319|NCT01326754|Amodiaquine|amodiaquine|mesh-list
2520320|NCT01326754|Artenimol|artenimol|mesh-list
2520321|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
2520322|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
2520323|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2520324|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2520325|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520326|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520327|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
2520328|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
2520329|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2520330|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
2520331|NCT01326767|Paclitaxel|paclitaxel|mesh-list
2520332|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2520333|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2520334|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520335|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
2520336|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
2520337|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
2520338|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520339|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2520340|NCT01326858|Ketotifen|ketotifen|mesh-list
2520341|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2520342|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2520343|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2520344|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2520345|NCT01326858|Analgesics|analgesics|mesh-ancestor
2520346|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
2394903|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
2394904|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394905|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394906|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2115098|NCT02614794|Tucatinib|tucatinib|mesh-list
2115099|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2115100|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
2115101|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115102|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115103|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2115104|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2115105|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115106|NCT02615470|Vaccines|vaccines|mesh-list
2115107|NCT02615470|Immunologic Factors|immunologic factors|mesh-ancestor
2115108|NCT02615470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115109|NCT02615535|Alprostadil|alprostadil|mesh-list
2115110|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2115111|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
2115112|NCT02615535|Urological Agents|urological agents|mesh-ancestor
2115113|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2115114|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2115115|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2115116|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
2115117|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115118|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2115119|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2115120|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
2115121|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2115122|NCT02616146|Etonogestrel|etonogestrel|mesh-list
2115123|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2115124|NCT02616146|Estradiol|estradiol|mesh-list
2115125|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2115126|NCT02616146|Estrogens|estrogens|mesh-ancestor
2115127|NCT02616146|Hormones|hormones|mesh-ancestor
2115128|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2115129|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115130|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2115131|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
2115132|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2115133|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2115134|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2115135|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2115136|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2520347|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668543|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2520348|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520349|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2520350|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2520351|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2520352|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2520353|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2520354|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
2520355|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
2520356|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520357|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520358|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
2520359|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
2520360|NCT01326871|Gemcitabine|gemcitabine|mesh-list
2520361|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520362|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2394907|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394908|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
2394909|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394910|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
2394911|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2394912|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2394913|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2394914|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
2520363|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
2520364|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520365|NCT01326871|Antiviral Agents|antiviral agents|mesh-ancestor
2520366|NCT01326871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520367|NCT01326871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394915|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2394916|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2394917|NCT00686621|Posaconazole|posaconazole|mesh-list
2394918|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
2394919|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394920|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2394921|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2394922|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2394923|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2394924|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2394925|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115137|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2115138|NCT02616250|Ivermectin|ivermectin|mesh-list
2115139|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2115140|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2115141|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115142|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2115143|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2115144|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2115145|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2115146|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
2115147|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115148|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115149|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115150|NCT02616393|XL647|xl647|mesh-list
2115151|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115152|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2115153|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115154|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115155|NCT02616523|Lidocaine|lidocaine|mesh-list
2115156|NCT02616523|Fentanyl|fentanyl|mesh-list
2115157|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
2115158|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
2115159|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
2115160|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2115161|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115162|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
2115163|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115164|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2115165|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2115166|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2115167|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2115168|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115169|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2115170|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2115171|NCT02616523|Analgesics|analgesics|mesh-ancestor
2394926|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394927|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2394928|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
2394929|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2394930|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394931|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
2394932|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2394933|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2394934|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
2394935|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394936|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2394937|NCT00686868|Ofatumumab|ofatumumab|mesh-list
2394938|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394939|NCT00686985|Carboplatin|carboplatin|mesh-list
2394940|NCT00686985|Docetaxel|docetaxel|mesh-list
2394941|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394942|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
2394943|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
2394944|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
2394945|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520368|NCT01326871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2520369|NCT01326871|Immunologic Factors|immunologic factors|mesh-ancestor
2520370|NCT01326871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394946|NCT00687011|Dexamethasone|dexamethasone|mesh-list
2394947|NCT00687011|Palonosetron|palonosetron|mesh-list
2394948|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2520371|NCT01326988|Anesthetics|anesthetics|mesh-list
2520372|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2520373|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520374|NCT01327027|Vasopressins|vasopressins|mesh-list
2520375|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
2520376|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
2520377|NCT01327027|Coagulants|coagulants|mesh-ancestor
2520378|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2520379|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2520380|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
2520381|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520382|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
2520383|NCT01327066|Droxidopa|droxidopa|mesh-list
2520384|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2520385|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520386|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2520387|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2520388|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520389|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520390|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520391|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2520392|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2394949|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
2394950|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
2394951|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2394952|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394953|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2394954|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
2394955|NCT00687011|Hormones|hormones|mesh-ancestor
2394956|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2520393|NCT01327079|Methadone|methadone|mesh-list
2520394|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2115172|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2115173|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2115174|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2115175|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
2115176|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115177|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2115178|NCT02616523|Narcotics|narcotics|mesh-ancestor
2115179|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2115180|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2115181|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
2115182|NCT02616601|Fluorouracil|fluorouracil|mesh-list
2115183|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
2115184|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115185|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2115186|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115187|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2115188|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
2115189|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520395|NCT01327079|Narcotics|narcotics|mesh-ancestor
2520396|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2520397|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520398|NCT01327079|Analgesics|analgesics|mesh-ancestor
2520399|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
2520400|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520401|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
2520402|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
2520403|NCT01327118|Dinoprost|dinoprost|mesh-list
2520404|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
2520405|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2520406|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
2520407|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2520408|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520409|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
2394957|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2394958|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394959|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2394960|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2394961|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
2394962|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2394963|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394964|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
2394965|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2394966|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394967|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
2394968|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2394969|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394970|NCT00687206|Valsartan|valsartan|mesh-list
2394971|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2394972|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2394973|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2394974|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394975|NCT00687245|Esomeprazole|esomeprazole|mesh-list
2394976|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2394977|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2394978|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2394979|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2394980|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394981|NCT00687258|Vitamin E|vitamin e|mesh-list
2394982|NCT00687258|Vitamins|vitamins|mesh-ancestor
2394983|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
2394984|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394985|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
2394986|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2394987|NCT00687258|Protective Agents|protective agents|mesh-ancestor
2394988|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
2520410|NCT01327144|Acyclovir|acyclovir|mesh-list
2520411|NCT01327144|Famciclovir|famciclovir|mesh-list
2520412|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
2520413|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520414|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2394989|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2394990|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2394991|NCT00687388|Celecoxib|celecoxib|mesh-list
2394992|NCT00687388|Doxazosin|doxazosin|mesh-list
2394993|NCT00687388|Prazosin|prazosin|mesh-list
2115190|NCT02616614|Clindamycin|clindamycin|mesh-list
2115191|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
2115192|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
2115193|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2115194|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2115195|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115196|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2115197|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115198|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115199|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
2115200|NCT02616783|Lamivudine|lamivudine|mesh-list
2115201|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2115202|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2115203|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115204|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115205|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
2115206|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2394994|NCT00687388|Tamsulosin|tamsulosin|mesh-list
2520415|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520416|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520417|NCT01327222|Bevacizumab|bevacizumab|mesh-list
2520418|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2520419|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520420|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2520421|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2520422|NCT01327222|Growth Substances|growth substances|mesh-ancestor
2520423|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520424|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
2520425|NCT01327235|Cisplatin|cisplatin|mesh-list
2520426|NCT01327235|Endostar protein|endostar protein|mesh-list
2520427|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2394995|NCT00687388|Alfuzosin|alfuzosin|mesh-list
2394996|NCT00687388|Terazosin|terazosin|mesh-list
2394997|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
2394998|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2394999|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2395000|NCT00687388|Analgesics|analgesics|mesh-ancestor
2395001|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
2395002|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395003|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395004|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2395005|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2395006|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2395007|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2520428|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2520429|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2520430|NCT01327235|Growth Substances|growth substances|mesh-ancestor
2520431|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520432|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
2520433|NCT01327261|Levodopa|levodopa|mesh-list
2520434|NCT01327261|Benserazide|benserazide|mesh-list
2520435|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2520436|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2395008|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395009|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395010|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2395011|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2395012|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
2395013|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395014|NCT00687388|Urological Agents|urological agents|mesh-ancestor
2395015|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2395016|NCT00687466|Insulin|insulin|mesh-list
2115207|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2115208|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2115209|NCT02617589|Nivolumab|nivolumab|mesh-list
2115210|NCT02617589|Temozolomide|temozolomide|mesh-list
2115211|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2115212|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115213|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2115214|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115215|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2115216|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
2115217|NCT02617628|Naltrexone|naltrexone|mesh-list
2115218|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2115219|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2115220|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115221|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
2115222|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115223|NCT02617667|Cyclosporine|cyclosporine|mesh-list
2115224|NCT02617667|Cyclosporins|cyclosporins|mesh-list
2115225|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115226|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115227|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2115228|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
2115229|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115230|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
2115231|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115232|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
2115233|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2115234|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2115235|NCT02617784|Oseltamivir|oseltamivir|mesh-list
2115236|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
2115237|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115238|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395017|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2520437|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
2520438|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520439|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520440|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520441|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520442|NCT01327326|Naltrexone|naltrexone|mesh-list
2520443|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2520444|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2395018|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395019|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
2395020|NCT00687518|Hematinics|hematinics|mesh-ancestor
2395021|NCT00687622|Trametinib|trametinib|mesh-list
2395022|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395023|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2395024|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395025|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395026|NCT00687648|Prednisolone|prednisolone|mesh-list
2395027|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
2395028|NCT00687648|Methotrexate|methotrexate|mesh-list
2395029|NCT00687648|Letrozole|letrozole|mesh-list
2395030|NCT00687648|Anastrozole|anastrozole|mesh-list
2395031|NCT00687648|Exemestane|exemestane|mesh-list
2395032|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2395033|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
2395034|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395035|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2395036|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2395037|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
2395038|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395039|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395040|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2395041|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2395042|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
2395043|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2395044|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2395045|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
2395046|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
2395047|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395048|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2395049|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2395050|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2395051|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
2395052|NCT00687648|Hormones|hormones|mesh-ancestor
2395053|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2395054|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2395055|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2395056|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2115239|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115240|NCT02617888|Bismuth|bismuth|mesh-list
2115241|NCT02617888|Antacids|antacids|mesh-ancestor
2115242|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115243|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2115244|NCT02618187|Vancomycin|vancomycin|mesh-list
2115245|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2115246|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115247|NCT02618343|Ondansetron|ondansetron|mesh-list
2115248|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
2115249|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
2115250|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115251|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115252|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2115253|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
2115254|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
2115255|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2115256|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
2115257|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115258|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115259|NCT02618343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2115260|NCT02618343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2115261|NCT02618343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2115262|NCT02618343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2115263|NCT02618343|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2115264|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
2115265|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2115266|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2395057|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2520445|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520446|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
2520447|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520448|NCT01327469|Albendazole|albendazole|mesh-list
2520449|NCT01327469|Mebendazole|mebendazole|mesh-list
2520450|NCT01327469|Piperazine|piperazine|mesh-list
2520451|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
2520452|NCT01327469|Pyrantel|pyrantel|mesh-list
2520453|NCT01327469|Oxantel|oxantel|mesh-list
2520454|NCT01327469|DMP 777|dmp 777|mesh-list
2520455|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
2520456|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2520457|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520458|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
2520459|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2520460|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2520461|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
2520462|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
2395058|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
2395059|NCT00687661|Diphosphonates|diphosphonates|mesh-list
2395060|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2395061|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395062|NCT00687687|Paclitaxel|paclitaxel|mesh-list
2395063|NCT00687687|Carboplatin|carboplatin|mesh-list
2395064|NCT00687687|Iniparib|iniparib|mesh-list
2395065|NCT00687687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2520463|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
2520464|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520465|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520466|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
2520467|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520468|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2520469|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2520470|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2520471|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520472|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520473|NCT01327521|Gemcitabine|gemcitabine|mesh-list
2520474|NCT01327521|Cisplatin|cisplatin|mesh-list
2115267|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115268|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
2115269|NCT02618382|Coagulants|coagulants|mesh-ancestor
2115270|NCT02618772|Midazolam|midazolam|mesh-list
2115271|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2115272|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2115273|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2115274|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115275|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2115276|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2115277|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2115278|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2115279|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
2115280|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
2115281|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
2115282|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
2115283|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115284|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115285|NCT02619409|Bupivacaine|bupivacaine|mesh-list
2115286|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
2115287|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
2115288|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2115289|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115290|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
2115291|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115292|NCT02619617|Pasireotide|pasireotide|mesh-list
2115293|NCT02619617|Hormones|hormones|mesh-ancestor
2115294|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2115295|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115296|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
2115297|NCT02619799|Midazolam|midazolam|mesh-list
2115298|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2115299|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2115300|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2115301|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115302|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2115303|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2115304|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2520475|NCT01327521|Doxorubicin|doxorubicin|mesh-list
2520476|NCT01327521|Fluorouracil|fluorouracil|mesh-list
2520477|NCT01327521|Epirubicin|epirubicin|mesh-list
2395066|NCT00687687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395067|NCT00687687|Tubulin Modulators|tubulin modulators|mesh-ancestor
2395068|NCT00687687|Antimitotic Agents|antimitotic agents|mesh-ancestor
2395069|NCT00687687|Mitosis Modulators|mitosis modulators|mesh-ancestor
2395070|NCT00687687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395071|NCT00687687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2395072|NCT00687687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395073|NCT00687700|Propranolol|propranolol|mesh-list
2395074|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2395075|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2395076|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
2395077|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395078|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395079|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395080|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2395081|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2395082|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
2395083|NCT00687765|Temozolomide|temozolomide|mesh-list
2115305|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2115306|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
2115307|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
2115308|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
2115309|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
2115310|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115311|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115312|NCT02619799|Analgesics|analgesics|mesh-ancestor
2115313|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
2115314|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115315|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2115316|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
2115317|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2115318|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2115319|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2115320|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
2115321|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2115322|NCT02620020|Fasinumab|fasinumab|mesh-list
2115323|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2115324|NCT02620020|Analgesics|analgesics|mesh-ancestor
2115325|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
2115326|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115327|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115328|NCT02620384|Metolazone|metolazone|mesh-list
2115329|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2115330|NCT02620384|Diuretics|diuretics|mesh-ancestor
2115331|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
2115332|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115333|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2115334|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2115335|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115336|NCT02620683|Lidocaine|lidocaine|mesh-list
2115337|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
2115338|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
2115339|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2115340|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115341|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
2115342|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115343|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2115344|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2115345|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2115346|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2115347|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115348|NCT02620774|Tazobactam|tazobactam|mesh-list
2115349|NCT02620774|Ceftolozane|ceftolozane|mesh-list
2115350|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2115351|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2115352|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115353|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2115354|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115355|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115356|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2115357|NCT02620774|Renal Agents|renal agents|mesh-ancestor
2115358|NCT02620787|Tedizolid|tedizolid|mesh-list
2115359|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2115360|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395084|NCT00687765|Iniparib|iniparib|mesh-list
2395085|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2395086|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
2520478|NCT01327521|Mitomycins|mitomycins|mesh-list
2520479|NCT01327521|Mitomycin|mitomycin|mesh-list
2520480|NCT01327521|Maleic acid|maleic acid|mesh-list
2520481|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520482|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2115361|NCT02620878|Pancrelipase|pancrelipase|mesh-list
2115362|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2115363|NCT02620904|Mifepristone|mifepristone|mesh-list
2115364|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2115365|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
2115366|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2115367|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115368|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2115369|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2115370|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2115371|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
2115372|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2115373|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2115374|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
2115375|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2115376|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
2115377|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2115378|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2115379|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
2115380|NCT02621060|Antacids|antacids|mesh-ancestor
2115381|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115382|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2115383|NCT02621619|Acetaminophen|acetaminophen|mesh-list
2115384|NCT02621619|Hydromorphone|hydromorphone|mesh-list
2115385|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2115386|NCT02621619|Analgesics|analgesics|mesh-ancestor
2115387|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
2115388|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115389|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115390|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
2115391|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2115392|NCT02621619|Narcotics|narcotics|mesh-ancestor
2115393|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2115394|NCT02621931|Calcitonin|calcitonin|mesh-list
2115395|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2115396|NCT02621931|Katacalcin|katacalcin|mesh-list
2115397|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2115398|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115399|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2115400|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
2115401|NCT02622074|Paclitaxel|paclitaxel|mesh-list
2115402|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2115403|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
2115404|NCT02622074|Carboplatin|carboplatin|mesh-list
2115405|NCT02622074|Doxorubicin|doxorubicin|mesh-list
2115406|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
2115407|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2115408|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115409|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
2115410|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
2115411|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
2115412|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115413|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2115414|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
2115415|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115416|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2115417|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2115418|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
2115419|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2115420|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2115421|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2115422|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2115423|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115424|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2115425|NCT02622113|Canagliflozin|canagliflozin|mesh-list
2115426|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2422939|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2520483|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
2395087|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395088|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395089|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2395090|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395091|NCT00687817|Paclitaxel|paclitaxel|mesh-list
2395092|NCT00687817|Carboplatin|carboplatin|mesh-list
2395093|NCT00687817|Bavituximab|bavituximab|mesh-list
2395094|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2395095|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395096|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
2395097|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
2520484|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520485|NCT01327521|Antiviral Agents|antiviral agents|mesh-ancestor
2520486|NCT01327521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520487|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520488|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2520489|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
2520490|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520491|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2520492|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2520493|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2520494|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
2520495|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2520496|NCT01327534|Clopidogrel|clopidogrel|mesh-list
2520497|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2520498|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2520499|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2520500|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2520501|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2520502|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
2520503|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115427|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115428|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2115429|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115430|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
2115431|NCT02622321|Coagulants|coagulants|mesh-ancestor
2115432|NCT02622724|Interferons|interferons|mesh-list
2115433|NCT02622724|Interferon-beta|interferon-beta|mesh-list
2115434|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
2115435|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115436|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
2115437|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115438|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
2115439|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115440|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2115441|NCT02623803|Lidocaine|lidocaine|mesh-list
2115442|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
2115443|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
2115444|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2115445|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115446|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
2115447|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115448|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2115449|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2115450|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2115451|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2115452|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115453|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
2115454|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2115455|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2115456|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2115457|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115458|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
2115459|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115460|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115461|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2115462|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115463|NCT02624050|Propofol|propofol|mesh-list
2115464|NCT02624050|Methohexital|methohexital|mesh-list
2115465|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2115466|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2184915|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
2395098|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
2520504|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520505|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520506|NCT01327625|Azithromycin|azithromycin|mesh-list
2520507|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2520508|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520509|NCT01327638|Etoricoxib|etoricoxib|mesh-list
2520510|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
2520511|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2520512|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2520513|NCT01327638|Analgesics|analgesics|mesh-ancestor
2520514|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
2520515|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520516|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520517|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2520518|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2520519|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2520520|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520521|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520522|NCT01327729|Interferons|interferons|mesh-list
2520523|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
2520524|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
2520525|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2520526|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520527|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
2115467|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115468|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2115469|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
2115470|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
2115471|NCT02624180|Colchicine|colchicine|mesh-list
2115472|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
2115473|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2115474|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
2115475|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
2115476|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
2115477|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115478|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115479|NCT02624492|Rituximab|rituximab|mesh-list
2115480|NCT02624492|BI 836826|bi 836826|mesh-list
2115481|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2115482|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115483|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
2115484|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115485|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2115486|NCT02624700|Pemetrexed|pemetrexed|mesh-list
2115487|NCT02624700|Sorafenib|sorafenib|mesh-list
2115488|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115489|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115490|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115491|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2115492|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2115493|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2115494|NCT02624843|Ethanol|ethanol|mesh-list
2115495|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
2115496|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2115497|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115498|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2115499|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115500|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
2115501|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
2115502|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
2115503|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115504|NCT02624986|Rituximab|rituximab|mesh-list
2115505|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
2115506|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2115507|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115508|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
2115509|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115510|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2115511|NCT02625181|Promethazine|promethazine|mesh-list
2115512|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
2115513|NCT02625181|Meclizine|meclizine|mesh-list
2115514|NCT02625181|Dexamethasone|dexamethasone|mesh-list
2115515|NCT02625181|Fentanyl|fentanyl|mesh-list
2115516|NCT02625181|Sufentanil|sufentanil|mesh-list
2115517|NCT02625181|Scopolamine|scopolamine|mesh-list
2115518|NCT02625181|Oxymorphone|oxymorphone|mesh-list
2115519|NCT02625181|Meperidine|meperidine|mesh-list
2520528|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395099|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395100|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2395101|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
2395102|NCT00687843|Tegafur|tegafur|mesh-list
2395103|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2395104|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
2520529|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
2520530|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395105|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395106|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395107|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2395108|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
2395109|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395110|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2395111|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
2395112|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395113|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
2115520|NCT02625181|Droperidol|droperidol|mesh-list
2115521|NCT02625181|Morphine|morphine|mesh-list
2115522|NCT02625181|Remifentanil|remifentanil|mesh-list
2115523|NCT02625181|Oxycodone|oxycodone|mesh-list
2115524|NCT02625181|Methadone|methadone|mesh-list
2115525|NCT02625181|Hydromorphone|hydromorphone|mesh-list
2115526|NCT02625181|Hydrocodone|hydrocodone|mesh-list
2115527|NCT02625181|Alfentanil|alfentanil|mesh-list
2115528|NCT02625181|Ketamine|ketamine|mesh-list
2115529|NCT02625181|Haloperidol|haloperidol|mesh-list
2115530|NCT02625181|Ondansetron|ondansetron|mesh-list
2115531|NCT02625181|Aprepitant|aprepitant|mesh-list
2115532|NCT02625181|Palonosetron|palonosetron|mesh-list
2115533|NCT02625181|Metoclopramide|metoclopramide|mesh-list
2115534|NCT02625181|Granisetron|granisetron|mesh-list
2115535|NCT02625181|Ramosetron|ramosetron|mesh-list
2115536|NCT02625181|Tropisetron|tropisetron|mesh-list
2115537|NCT02625181|Dolasetron|dolasetron|mesh-list
2115538|NCT02625181|Anesthetics|anesthetics|mesh-list
2115539|NCT02625181|Propofol|propofol|mesh-list
2115540|NCT02625181|Sevoflurane|sevoflurane|mesh-list
2115541|NCT02625181|Desflurane|desflurane|mesh-list
2115542|NCT02625181|Isoflurane|isoflurane|mesh-list
2115543|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2115544|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2115545|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
2115546|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
2115547|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115548|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115549|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2115550|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
2115551|NCT02625181|Hormones|hormones|mesh-ancestor
2115552|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2115553|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2115554|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115555|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2115556|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2115557|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2115558|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
2115559|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2115560|NCT02625181|Narcotics|narcotics|mesh-ancestor
2115561|NCT02625181|Analgesics|analgesics|mesh-ancestor
2115562|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
2115563|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2115564|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2115565|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2115566|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115567|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115568|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2115569|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2115570|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2115571|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
2115572|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
2115573|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2115574|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
2115575|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2115576|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2115577|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2115578|NCT02625181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2115579|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
2115580|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
2115581|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2395114|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2395115|NCT00687843|Protective Agents|protective agents|mesh-ancestor
2395117|NCT00687999|Interferons|interferons|mesh-list
2395118|NCT00687999|Ribavirin|ribavirin|mesh-list
2395119|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
2395120|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395121|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
2395122|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395123|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
2395124|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395125|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
2395126|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395127|NCT00688077|Calcitonin|calcitonin|mesh-list
2395128|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
2395129|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2115582|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2115583|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
2115584|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2115585|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2115586|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2115587|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
2115588|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2115589|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
2115590|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2115591|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
2115592|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2115593|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
2115594|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
2115595|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2115596|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2115597|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
2115598|NCT02625207|Maraviroc|maraviroc|mesh-list
2115599|NCT02625207|Darunavir|darunavir|mesh-list
2115600|NCT02625207|Cobicistat|cobicistat|mesh-list
2115601|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2115602|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2115603|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115604|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2115605|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2115606|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
2115607|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115608|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2115609|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2115610|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2115611|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
2115612|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115613|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2115614|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2115615|NCT02625259|Lansoprazole|lansoprazole|mesh-list
2115616|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
2115617|NCT02625259|Serabelisib|serabelisib|mesh-list
2115618|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2115619|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2115620|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2115621|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115622|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115623|NCT02625298|Pemetrexed|pemetrexed|mesh-list
2115624|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115625|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115626|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115627|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2115628|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2115629|NCT02625610|Leucovorin|leucovorin|mesh-list
2115630|NCT02625610|Fluorouracil|fluorouracil|mesh-list
2115631|NCT02625610|Capecitabine|capecitabine|mesh-list
2115632|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
2115633|NCT02625610|Avelumab|avelumab|mesh-list
2115634|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
2115635|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
2115636|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115637|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2115638|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115639|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2115640|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
2115641|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115642|NCT02625610|Antidotes|antidotes|mesh-ancestor
2115643|NCT02625610|Protective Agents|protective agents|mesh-ancestor
2395130|NCT00688077|Katacalcin|katacalcin|mesh-list
2520531|NCT01327755|Selenium|selenium|mesh-list
2520532|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
2520533|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520534|NCT01327755|Protective Agents|protective agents|mesh-ancestor
2520535|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520536|NCT01327755|Trace Elements|trace elements|mesh-ancestor
2520537|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
2115644|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
2115645|NCT02625610|Vitamins|vitamins|mesh-ancestor
2115646|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
2115647|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2115648|NCT02625623|Paclitaxel|paclitaxel|mesh-list
2115649|NCT02625623|Irinotecan|irinotecan|mesh-list
2115650|NCT02625623|Avelumab|avelumab|mesh-list
2115651|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2115652|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115653|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
2115654|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
2115655|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
2115656|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115657|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2115658|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2115659|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115660|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2115661|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
2115662|NCT02625909|Velpatasvir|velpatasvir|mesh-list
2115663|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
2115664|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115665|NCT02625974|Nifurtimox|nifurtimox|mesh-list
2115666|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2115667|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2115668|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2115669|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115670|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
2115671|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2115672|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2115673|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115674|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
2115675|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2115676|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
2115677|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
2115678|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2115679|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2115680|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115681|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115682|NCT02626182|Urological Agents|urological agents|mesh-ancestor
2115683|NCT02626611|Omalizumab|omalizumab|mesh-list
2115684|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2115685|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2115686|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
2115687|NCT02627144|Interferons|interferons|mesh-list
2115688|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
2115689|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
2115690|NCT02627144|Bevacizumab|bevacizumab|mesh-list
2115691|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2115692|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115693|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2115694|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2115695|NCT02627144|Growth Substances|growth substances|mesh-ancestor
2115696|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115697|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
2115698|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
2115699|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115700|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
2115701|NCT02627677|Ponatinib|ponatinib|mesh-list
2115702|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115703|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2115704|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115705|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115711|NCT02628106|Alprostadil|alprostadil|mesh-list
2115712|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2115713|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
2395131|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2395132|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395133|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2520548|NCT01327859|Donepezil|donepezil|mesh-list
2520549|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2520550|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520551|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520552|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
2520553|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520554|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520555|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
2520556|NCT01328015|Oxybutynin|oxybutynin|mesh-list
2520557|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2115714|NCT02628106|Urological Agents|urological agents|mesh-ancestor
2115715|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2115716|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2115717|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
2115718|NCT02628600|Amikacin|amikacin|mesh-list
2115719|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2115720|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115721|NCT02628769|Solithromycin|solithromycin|mesh-list
2115722|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2115723|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115724|NCT02629094|Eplerenone|eplerenone|mesh-list
2115725|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2115726|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
2115727|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2115728|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115729|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2115730|NCT02629094|Diuretics|diuretics|mesh-ancestor
2115731|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
2115732|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2115741|NCT02629354|Ibuprofen|ibuprofen|mesh-list
2115742|NCT02629354|Caffeine|caffeine|mesh-list
2115743|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2115744|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2115745|NCT02629354|Analgesics|analgesics|mesh-ancestor
2115746|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
2115747|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115748|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115749|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2115750|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2115751|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2115752|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115753|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115754|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2115755|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2115756|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2115757|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2115758|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
2115759|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115760|NCT02629822|Tenofovir|tenofovir|mesh-list
2115761|NCT02629822|Lamivudine|lamivudine|mesh-list
2115762|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
2115763|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115764|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2115765|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2395134|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
2395135|NCT00688194|Letrozole|letrozole|mesh-list
2395136|NCT00688194|Lapatinib|lapatinib|mesh-list
2115766|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115767|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115768|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2115769|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2115770|NCT02629861|Calcitonin|calcitonin|mesh-list
2115771|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2115772|NCT02629861|Katacalcin|katacalcin|mesh-list
2115773|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2115774|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115775|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2115776|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
2115777|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
2115778|NCT02629965|Olodaterol|olodaterol|mesh-list
2115779|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2115780|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
2115781|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115782|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115783|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2115784|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
2115785|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
2115786|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2115787|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
2115788|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115789|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115790|NCT02629991|Oxytocin|oxytocin|mesh-list
2115791|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
2115792|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2115793|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115794|NCT02630017|Methylphenidate|methylphenidate|mesh-list
2115795|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2115796|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115797|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2115798|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2115799|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2115800|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115801|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
2115802|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115803|NCT02630030|Ixazomib|ixazomib|mesh-list
2115804|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115805|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
2115806|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115807|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115808|NCT02630186|Atezolizumab|atezolizumab|mesh-list
2115809|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115810|NCT02630316|Treprostinil|treprostinil|mesh-list
2115811|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2115812|NCT02630459|Erenumab|erenumab|mesh-list
2115813|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2115814|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2115815|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115816|NCT02630459|Analgesics|analgesics|mesh-ancestor
2115817|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
2115818|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115819|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115820|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
2115821|NCT02630563|Cyclosporine|cyclosporine|mesh-list
2115822|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
2115823|NCT02630563|Cyclosporins|cyclosporins|mesh-list
2115824|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115825|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115826|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2115827|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
2115828|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115829|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
2115830|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115831|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
2115832|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2115833|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2115834|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2115835|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115836|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2395137|NCT00688194|Fulvestrant|fulvestrant|mesh-list
2520558|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
2520559|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
2520560|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520561|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520562|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2520563|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
2520564|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520565|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520566|NCT01328015|Urological Agents|urological agents|mesh-ancestor
2520567|NCT01328093|Aripiprazole|aripiprazole|mesh-list
2520568|NCT01328093|Antidepressive Agents|antidepressive agents|mesh-ancestor
2520569|NCT01328093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2520570|NCT01328093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2520571|NCT01328093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2520572|NCT01328093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2520573|NCT01328093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520574|NCT01328093|Dopamine Agonists|dopamine agonists|mesh-ancestor
2520575|NCT01328093|Dopamine Agents|dopamine agents|mesh-ancestor
2115837|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
2115838|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2115839|NCT02630693|Tamoxifen|tamoxifen|mesh-list
2115840|NCT02630693|Fulvestrant|fulvestrant|mesh-list
2115841|NCT02630693|Palbociclib|palbociclib|mesh-list
2115842|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2115843|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2115844|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
2115845|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2115846|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115847|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2115848|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115849|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2115850|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2115851|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2115852|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2115853|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2115854|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115855|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115856|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2115857|NCT02630706|Metformin|metformin|mesh-list
2115858|NCT02630706|Glimepiride|glimepiride|mesh-list
2115859|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
2115860|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2115861|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115862|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2115863|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2115864|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
2115865|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2115866|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115867|NCT02630719|Timolol|timolol|mesh-list
2115868|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2115869|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
2115870|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2115871|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2115872|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2115873|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
2115874|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115875|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115876|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115877|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2115878|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2115879|NCT02630966|Vedolizumab|vedolizumab|mesh-list
2115880|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2115881|NCT02630992|Amoxicillin|amoxicillin|mesh-list
2115882|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
2115883|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
2115884|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2115885|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2115886|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115887|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2115888|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115889|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115890|NCT02631057|Warfarin|warfarin|mesh-list
2115891|NCT02631057|Dabigatran|dabigatran|mesh-list
2115892|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
2520576|NCT01328093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520577|NCT01328093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520578|NCT01328093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2520579|NCT01328093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2520580|NCT01328093|Serotonin Agents|serotonin agents|mesh-ancestor
2520581|NCT01328093|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2520582|NCT01328093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2520583|NCT01328093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2520584|NCT01328093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2520585|NCT01328106|Trametinib|trametinib|mesh-list
2520586|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115893|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
2115894|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2115895|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
2115896|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115897|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115900|NCT02631525|Propofol|propofol|mesh-list
2115901|NCT02631525|Desflurane|desflurane|mesh-list
2115902|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2115903|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2115904|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115905|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2115906|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
2115907|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
2115908|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2115909|NCT02631538|Rituximab|rituximab|mesh-list
2115910|NCT02631538|Belimumab|belimumab|mesh-list
2115911|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2115912|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115913|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
2115914|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115915|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2115916|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2115917|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
2115918|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2115919|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2115920|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
2115921|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2115922|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2115923|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2115924|NCT02631551|Analgesics|analgesics|mesh-ancestor
2115925|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
2115926|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2115927|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115928|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2115929|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2115930|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2115931|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
2115932|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
2115933|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2115934|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115935|NCT02631577|Lenalidomide|lenalidomide|mesh-list
2115936|NCT02631577|Atezolizumab|atezolizumab|mesh-list
2115937|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
2115938|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
2115939|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115940|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2115941|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2115942|NCT02631577|Growth Substances|growth substances|mesh-ancestor
2115943|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
2115944|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115945|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2115946|NCT02631590|Gemcitabine|gemcitabine|mesh-list
2115947|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115948|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2115949|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
2115950|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115951|NCT02631590|Antiviral Agents|antiviral agents|mesh-ancestor
2115952|NCT02631590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115953|NCT02631590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115954|NCT02631590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2115955|NCT02631590|Immunologic Factors|immunologic factors|mesh-ancestor
2115956|NCT02631590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115957|NCT02631746|Nivolumab|nivolumab|mesh-list
2395138|NCT00688194|Anastrozole|anastrozole|mesh-list
2395139|NCT00688194|Exemestane|exemestane|mesh-list
2115958|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2115959|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115960|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2115961|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115962|NCT02631772|Ribavirin|ribavirin|mesh-list
2115963|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
2115964|NCT02631772|Ledipasvir|ledipasvir|mesh-list
2115965|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
2115966|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115967|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
2115968|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115969|NCT02631876|Paclitaxel|paclitaxel|mesh-list
2115970|NCT02631876|Maytansine|maytansine|mesh-list
2115971|NCT02631876|Doxorubicin|doxorubicin|mesh-list
2115972|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2115973|NCT02631876|Topotecan|topotecan|mesh-list
2115974|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2115975|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2115976|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
2115977|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
2115978|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
2115979|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115980|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2115981|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2115982|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2115983|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115984|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2115985|NCT02631954|Voriconazole|voriconazole|mesh-list
2115986|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
2115987|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2115988|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2115989|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2115990|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2115991|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2115992|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2115993|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
2115994|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2115995|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2115996|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2115997|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2115998|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2115999|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
2116000|NCT02632747|Empagliflozin|empagliflozin|mesh-list
2116001|NCT02632747|Ramipril|ramipril|mesh-list
2116002|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2116003|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116004|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2116005|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116006|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2116007|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
2116008|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116009|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2116010|NCT02632812|Naproxen|naproxen|mesh-list
2116011|NCT02632812|Rebamipide|rebamipide|mesh-list
2116012|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2116013|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2116014|NCT02632812|Analgesics|analgesics|mesh-ancestor
2116015|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
2116016|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116017|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116018|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2116019|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2116020|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
2116021|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2116022|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116023|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116024|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2116025|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2116026|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
2116027|NCT02632812|Protective Agents|protective agents|mesh-ancestor
2116028|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2116029|NCT02633046|Hormones|hormones|mesh-ancestor
2184916|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
2395140|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395141|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2395142|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2395143|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395144|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395145|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2116030|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2116031|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116050|NCT02633371|Oxybutynin|oxybutynin|mesh-list
2116051|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
2116052|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
2116053|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116054|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116055|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2116056|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2116057|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
2116058|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116059|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116060|NCT02633371|Urological Agents|urological agents|mesh-ancestor
2116061|NCT02633488|Metformin|metformin|mesh-list
2116062|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2116063|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116064|NCT02633800|Carboplatin|carboplatin|mesh-list
2116065|NCT02633800|Cetuximab|cetuximab|mesh-list
2116066|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116067|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2116068|NCT02633956|Atorvastatin|atorvastatin|mesh-list
2116069|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2116070|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2116071|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
2116072|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116073|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2116074|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2116075|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116076|NCT02634073|Lamivudine|lamivudine|mesh-list
2116077|NCT02634073|Sorbitol|sorbitol|mesh-list
2116078|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2116079|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2116080|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116081|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116082|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
2116083|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2116084|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2116085|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2116086|NCT02634073|Cathartics|cathartics|mesh-ancestor
2116087|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2116088|NCT02634320|Aripiprazole|aripiprazole|mesh-list
2116089|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
2116090|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
2116091|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2116092|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2116093|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2116094|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116095|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116096|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
2116097|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
2116098|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395146|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
2395147|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2395148|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395149|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2395150|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2395151|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2395152|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
2395153|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2395154|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395155|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
2520587|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2520588|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520589|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520590|NCT01328145|Aspirin|aspirin|mesh-list
2520591|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2520592|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2520593|NCT01328145|Analgesics|analgesics|mesh-ancestor
2520594|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
2520595|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520596|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520597|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2520598|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2520599|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2520600|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2520601|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520602|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2520603|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2520604|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520605|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
2520606|NCT01328171|Folic Acid|folic acid|mesh-list
2520607|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
2520608|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
2520609|NCT01328171|Irinotecan|irinotecan|mesh-list
2520610|NCT01328171|Panitumumab|panitumumab|mesh-list
2520611|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520612|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2520613|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2520614|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520615|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520616|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520617|NCT01328171|Hematinics|hematinics|mesh-ancestor
2520618|NCT01328171|Vitamins|vitamins|mesh-ancestor
2520619|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
2395156|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2395157|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395158|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2395159|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2395160|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395161|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395162|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395163|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2395164|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2395165|NCT00688298|Imidacloprid|imidacloprid|mesh-list
2395166|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
2520620|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2520621|NCT01328223|Sorafenib|sorafenib|mesh-list
2520622|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520623|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2395167|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395168|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395169|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395170|NCT00688402|Lesogaberan|lesogaberan|mesh-list
2395171|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2395172|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2395173|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
2395174|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
2395175|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395176|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395177|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395178|NCT00688428|Aspirin|aspirin|mesh-list
2395179|NCT00688428|Esomeprazole|esomeprazole|mesh-list
2395180|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2395181|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2395182|NCT00688428|Analgesics|analgesics|mesh-ancestor
2395183|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
2395184|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395185|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395186|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2395187|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2520624|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520625|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520626|NCT01328236|Dexamethasone|dexamethasone|mesh-list
2520627|NCT01328236|Doxorubicin|doxorubicin|mesh-list
2520628|NCT01328236|Bortezomib|bortezomib|mesh-list
2520629|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2520630|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
2520631|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
2520632|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520633|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520634|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2520635|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
2520636|NCT01328236|Hormones|hormones|mesh-ancestor
2520637|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2520638|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2520639|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520640|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2520641|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2520642|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2520643|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520644|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520645|NCT01328301|Methamphetamine|methamphetamine|mesh-list
2520646|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2520647|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520648|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
2520649|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
2520650|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520651|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
2395188|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2395189|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2395190|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395191|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2395192|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2395193|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395194|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
2395195|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2395196|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2395197|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2395198|NCT00688480|Allopurinol|allopurinol|mesh-list
2395199|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
2395200|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395201|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395202|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
2520652|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520653|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520654|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
2520655|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2520656|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2520657|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2520658|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2520659|NCT01328340|Methamphetamine|methamphetamine|mesh-list
2520660|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2520661|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520662|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
2520663|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
2520664|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520665|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
2520666|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520667|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520668|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
2395203|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2395204|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2395205|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
2395206|NCT00688480|Protective Agents|protective agents|mesh-ancestor
2395207|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395208|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
2520669|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2520670|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2520671|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2520672|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2520673|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
2520674|NCT01328392|Lansoprazole|lansoprazole|mesh-list
2520675|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2520676|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2520677|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2520678|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520679|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520680|NCT01328457|Paromomycin|paromomycin|mesh-list
2520681|NCT01328457|Neomycin|neomycin|mesh-list
2520682|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2520683|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520684|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2520685|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2520686|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2520687|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520688|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520689|NCT01328470|Cilostazol|cilostazol|mesh-list
2520690|NCT01328470|Clopidogrel|clopidogrel|mesh-list
2520691|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2520692|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2520693|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2520694|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2520695|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
2520696|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395209|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
2395210|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2395211|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2395212|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395213|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2395214|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2395215|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395216|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395217|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395218|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2395219|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
2395220|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2395221|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395222|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2395223|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2395224|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2395225|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2395226|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2395227|NCT00688558|Simvastatin|simvastatin|mesh-list
2395228|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
2395229|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2395230|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2395231|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
2395232|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395233|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2395234|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2395235|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395236|NCT00688805|Propranolol|propranolol|mesh-list
2395237|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2395238|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2395239|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
2395240|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395241|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395242|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395243|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2395244|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2395245|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
2395246|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2395247|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
2520697|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520698|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520699|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2520700|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
2520701|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520702|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2520703|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
2520704|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2520705|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2520706|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
2520707|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2520708|NCT01328470|Protective Agents|protective agents|mesh-ancestor
2520709|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2520710|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2520711|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520712|NCT01328626|Venetoclax|venetoclax|mesh-list
2520713|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520714|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
2520715|NCT01328652|Lansoprazole|lansoprazole|mesh-list
2520716|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2520717|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395248|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2395249|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2395250|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2395251|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2395252|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395253|NCT00688857|Diazoxide|diazoxide|mesh-list
2395254|NCT00688857|Choline|choline|mesh-list
2395255|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
2395256|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2395257|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
2395258|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395259|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2395260|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2395261|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
2395262|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2395263|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
2395264|NCT00688883|Fludarabine|fludarabine|mesh-list
2395265|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
2395266|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395267|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2520718|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520719|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2520720|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2395268|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
2395269|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395270|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2395271|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
2395272|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395273|NCT00688896|Pravastatin|pravastatin|mesh-list
2395274|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
2395275|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2395276|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2395277|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
2395278|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395279|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2395280|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2395281|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395282|NCT00688922|Pravastatin|pravastatin|mesh-list
2395283|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2395284|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2395285|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
2395286|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395287|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2395288|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2395289|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395290|NCT00688948|Alfuzosin|alfuzosin|mesh-list
2520728|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
2520729|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2520730|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520731|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520732|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2520733|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2520734|NCT01328821|Protective Agents|protective agents|mesh-ancestor
2520735|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520736|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
2520737|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2395291|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2395292|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2395293|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2395294|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
2395295|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395296|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395297|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395298|NCT00688948|Urological Agents|urological agents|mesh-ancestor
2395299|NCT00688961|Aspirin|aspirin|mesh-list
2395300|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2395301|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2395302|NCT00688961|Analgesics|analgesics|mesh-ancestor
2395303|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
2395304|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395305|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395306|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2395307|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2520738|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
2520739|NCT01328834|Tacrolimus|tacrolimus|mesh-list
2520740|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2520741|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
2520742|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520743|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2520744|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520745|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395308|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2395309|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2395310|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395311|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2395312|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2395313|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395314|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
2395315|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
2395316|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2395317|NCT00689000|Tosedostat|tosedostat|mesh-list
2395318|NCT00689000|Glycine|glycine|mesh-list
2395319|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395320|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395321|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
2395322|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395323|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395324|NCT00689143|Sargramostim|sargramostim|mesh-list
2395325|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
2395326|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395327|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
2395328|NCT00689156|Docetaxel|docetaxel|mesh-list
2395329|NCT00689156|Epirubicin|epirubicin|mesh-list
2395330|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2395331|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
2395332|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395333|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2395334|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2520746|NCT01328886|Omalizumab|omalizumab|mesh-list
2520747|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2520748|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2520749|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
2520750|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
2520751|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2520752|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520753|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
2520754|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
2520755|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2520756|NCT01328990|Amodiaquine|amodiaquine|mesh-list
2520757|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
2520758|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2520759|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2520760|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520761|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2520762|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395335|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
2395336|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395337|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395338|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2395339|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
2520763|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520764|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2395340|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
2395341|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
2395342|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2395343|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2520765|NCT01328990|Renal Agents|renal agents|mesh-ancestor
2520766|NCT01329016|Metformin|metformin|mesh-list
2520767|NCT01329016|Glyburide|glyburide|mesh-list
2520768|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2520769|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395344|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2395345|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395346|NCT00689169|Cytarabine|cytarabine|mesh-list
2395347|NCT00689169|Rituximab|rituximab|mesh-list
2395348|NCT00689169|Etoposide|etoposide|mesh-list
2395349|NCT00689169|Melphalan|melphalan|mesh-list
2395350|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2395351|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520770|NCT01329042|Citric Acid|citric acid|mesh-list
2520771|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
2520772|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
2520773|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2520774|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
2520775|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
2520776|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520777|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
2520778|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2520779|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520780|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2520781|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2520782|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520783|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520784|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520785|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2520786|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2520787|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
2520788|NCT01329289|Dexamethasone|dexamethasone|mesh-list
2520789|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
2520790|NCT01329289|Bortezomib|bortezomib|mesh-list
2520791|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2520792|NCT01329289|Pasireotide|pasireotide|mesh-list
2520793|NCT01329289|BB 1101|bb 1101|mesh-list
2520794|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2520795|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
2395352|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
2395353|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395354|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2395355|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2395356|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2395357|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2395358|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395359|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395360|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2395361|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
2395362|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2520796|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
2520797|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520798|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520799|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2520800|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
2520801|NCT01329289|Hormones|hormones|mesh-ancestor
2520802|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2520803|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2520804|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520805|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
2520806|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520807|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520808|NCT01329367|Antioxidants|antioxidants|mesh-list
2520809|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520810|NCT01329367|Protective Agents|protective agents|mesh-ancestor
2520811|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520812|NCT01329406|Milnacipran|milnacipran|mesh-list
2520813|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
2520814|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2395363|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2395364|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2520815|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2520816|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2520817|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520818|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520819|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520820|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2520821|NCT01329406|Analgesics|analgesics|mesh-ancestor
2520822|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
2520823|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520824|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
2520825|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2520826|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2520827|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520828|NCT01329614|Nicotine|nicotine|mesh-list
2520829|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2520830|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
2520831|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520832|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520833|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2520834|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2520835|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
2520836|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520837|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520838|NCT01329627|Paclitaxel|paclitaxel|mesh-list
2520839|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2520840|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
2520841|NCT01329627|Doxorubicin|doxorubicin|mesh-list
2395365|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
2395366|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
2395367|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395368|NCT00689195|Curcumin|curcumin|mesh-list
2395369|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2395370|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2395371|NCT00689195|Analgesics|analgesics|mesh-ancestor
2395372|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
2395373|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395374|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395375|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2395376|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2395377|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395378|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395379|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395380|NCT00689208|Atropine|atropine|mesh-list
2395381|NCT00689208|Physostigmine|physostigmine|mesh-list
2395382|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2395383|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2520842|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2520843|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2520844|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520845|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
2520846|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
2520847|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
2395384|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2395385|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
2395386|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395387|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395388|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2395389|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
2395390|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
2395391|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
2395392|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2395393|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2395394|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
2395395|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395396|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395397|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2395398|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395399|NCT00689208|Miotics|miotics|mesh-ancestor
2395400|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2395401|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2395402|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2520848|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520849|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2520850|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
2520851|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520852|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2395403|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
2520853|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2520854|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
2520855|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2395404|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395405|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2395406|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2395407|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395408|NCT00689442|Atorvastatin|atorvastatin|mesh-list
2395409|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
2395410|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2395411|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2395412|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
2395413|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395414|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2520856|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2520857|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2520858|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2520859|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520860|NCT01329640|Paclitaxel|paclitaxel|mesh-list
2520861|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
2520862|NCT01329640|Trastuzumab|trastuzumab|mesh-list
2520863|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2395415|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2395416|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395417|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
2395418|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2395419|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
2395420|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2395421|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395422|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2395423|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2395424|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2395425|NCT00689520|Vitamin K|vitamin k|mesh-list
2395426|NCT00689520|Tinzaparin|tinzaparin|mesh-list
2395427|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2395428|NCT00689520|Dalteparin|dalteparin|mesh-list
2395429|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
2395430|NCT00689520|Vitamins|vitamins|mesh-ancestor
2395431|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
2520864|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520865|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
2520866|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
2520867|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
2520868|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520869|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2520870|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
2395432|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395433|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2395434|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2395435|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395436|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
2395437|NCT00689520|Coagulants|coagulants|mesh-ancestor
2395438|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
2395439|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2395440|NCT00689559|Aripiprazole|aripiprazole|mesh-list
2395441|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
2395442|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2395443|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2395444|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2395445|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2395446|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395447|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
2395448|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
2395449|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395450|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395451|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2395452|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2395453|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
2395454|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2395455|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2395456|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2395457|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2395458|NCT00689585|Ethosuximide|ethosuximide|mesh-list
2395459|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
2395460|NCT00689598|Spironolactone|spironolactone|mesh-list
2395461|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2395462|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
2395463|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2395464|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395465|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2395466|NCT00689598|Diuretics|diuretics|mesh-ancestor
2395467|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
2395468|NCT00689624|Leucovorin|leucovorin|mesh-list
2395469|NCT00689624|Fluorouracil|fluorouracil|mesh-list
2395470|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
2395471|NCT00689624|Irinotecan|irinotecan|mesh-list
2395472|NCT00689624|Cetuximab|cetuximab|mesh-list
2395473|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
2395474|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395475|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2395476|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395477|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2395478|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
2395479|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395480|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2395481|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2395482|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395483|NCT00689624|Antidotes|antidotes|mesh-ancestor
2395484|NCT00689624|Protective Agents|protective agents|mesh-ancestor
2395485|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
2395486|NCT00689624|Vitamins|vitamins|mesh-ancestor
2395487|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
2395488|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2395489|NCT00689637|Warfarin|warfarin|mesh-list
2395490|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
2395491|NCT00689702|Capecitabine|capecitabine|mesh-list
2395492|NCT00689702|Cetuximab|cetuximab|mesh-list
2395493|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2395494|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
2395495|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395496|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395497|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2395498|NCT00689715|Ethanol|ethanol|mesh-list
2395499|NCT00689715|Paclitaxel|paclitaxel|mesh-list
2395500|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2395501|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2520871|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520872|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2520873|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2520874|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
2520875|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2520876|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2520877|NCT01329666|Vitamin D|vitamin d|mesh-list
2520878|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
2520879|NCT01329666|Vitamins|vitamins|mesh-ancestor
2520880|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
2520881|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520882|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2520883|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2520884|NCT01329731|Olaflur|olaflur|mesh-list
2395502|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395503|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
2395504|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
2395505|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
2395506|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395507|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2395508|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395509|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2395510|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395511|NCT00689780|Midazolam|midazolam|mesh-list
2395512|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2395513|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2395514|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2395515|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395516|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2395517|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2395518|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2395519|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2395520|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
2395521|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
2395522|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
2520885|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
2395523|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
2395524|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395525|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395526|NCT00689806|Lovastatin|lovastatin|mesh-list
2395527|NCT00689806|L 647318|l 647318|mesh-list
2395528|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
2395529|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2395530|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2395531|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
2395532|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395533|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2395534|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2395535|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395536|NCT00689832|Fluticasone|fluticasone|mesh-list
2395537|NCT00689832|Tacrolimus|tacrolimus|mesh-list
2395538|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2395539|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
2395540|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395541|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2395542|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395543|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395544|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2395545|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2395546|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
2395547|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395548|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2395549|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
2395550|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
2395551|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2395552|NCT00689845|Cytarabine|cytarabine|mesh-list
2395553|NCT00689845|Prednisone|prednisone|mesh-list
2520886|NCT01329731|Protective Agents|protective agents|mesh-ancestor
2520887|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520888|NCT01329744|Mecasermin|mecasermin|mesh-list
2395554|NCT00689845|Prednisolone|prednisolone|mesh-list
2395555|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
2395556|NCT00689845|Ifosfamide|ifosfamide|mesh-list
2395557|NCT00689845|Rituximab|rituximab|mesh-list
2395558|NCT00689845|Doxorubicin|doxorubicin|mesh-list
2395559|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2395560|NCT00689845|Methotrexate|methotrexate|mesh-list
2395561|NCT00689845|Etoposide|etoposide|mesh-list
2395562|NCT00689845|Vincristine|vincristine|mesh-list
2395563|NCT00689845|Bleomycin|bleomycin|mesh-list
2395564|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
2395565|NCT00689845|Vindesine|vindesine|mesh-list
2395566|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2395567|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
2395568|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395569|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2395570|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2395571|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
2395572|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395573|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395574|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2520889|NCT01329744|Growth Substances|growth substances|mesh-ancestor
2520890|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520891|NCT01329770|Vitamins|vitamins|mesh-list
2520892|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
2520893|NCT01329770|Vitamin E|vitamin e|mesh-list
2520894|NCT01329770|Tocopherols|tocopherols|mesh-list
2520895|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
2520896|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
2520897|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520898|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
2395575|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2395576|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2395577|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2395578|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2395579|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395580|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2395581|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
2395582|NCT00689845|Hormones|hormones|mesh-ancestor
2395583|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2395584|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2520899|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395585|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2395586|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
2395587|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2395588|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2395589|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
2395590|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
2395591|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2395592|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2520900|NCT01329770|Protective Agents|protective agents|mesh-ancestor
2520901|NCT01329783|Maraviroc|maraviroc|mesh-list
2520902|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2520903|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2520904|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520905|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2520906|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2520907|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
2520908|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520909|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2520910|NCT01329796|Lidocaine|lidocaine|mesh-list
2520911|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
2520912|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
2520913|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2520914|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520915|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
2520916|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520917|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2520918|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2395593|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2395594|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
2395595|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520919|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2520920|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2520921|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520922|NCT01329809|Molgramostim|molgramostim|mesh-list
2520923|NCT01329809|Sargramostim|sargramostim|mesh-list
2520924|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
2520925|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520926|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520927|NCT01329887|Ketanserin|ketanserin|mesh-list
2520928|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2520929|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2520930|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2520931|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
2520932|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520933|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520934|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520935|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
2520936|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
2520937|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
2520938|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2520939|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520940|NCT01330446|Modafinil|modafinil|mesh-list
2520941|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2395596|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
2395597|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
2395598|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
2395599|NCT00689858|Cilostazol|cilostazol|mesh-list
2395600|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2395601|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
2520942|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520943|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2520944|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2520945|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2520946|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520947|NCT01330472|Alprazolam|alprazolam|mesh-list
2395602|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395603|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395604|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2395605|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
2395606|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2395607|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2395608|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395609|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2395610|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
2395611|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2395612|NCT00689858|Protective Agents|protective agents|mesh-ancestor
2395613|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2395614|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2395615|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395616|NCT00689949|Folic Acid|folic acid|mesh-list
2395617|NCT00689949|Hematinics|hematinics|mesh-ancestor
2395618|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
2395619|NCT00689949|Vitamins|vitamins|mesh-ancestor
2395620|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
2520948|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2520949|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2520950|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520951|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2520952|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2520953|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2520954|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
2520955|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
2520956|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2520957|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520958|NCT01330524|Triamcinolone|triamcinolone|mesh-list
2520959|NCT01330524|Bevacizumab|bevacizumab|mesh-list
2520960|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2520961|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2520962|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2520963|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2520964|NCT01330524|Growth Substances|growth substances|mesh-ancestor
2520965|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520966|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
2520967|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2520968|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
2520969|NCT01330524|Hormones|hormones|mesh-ancestor
2520970|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2520971|NCT01330563|Ketoconazole|ketoconazole|mesh-list
2520972|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
2520973|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2520974|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2520975|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2520976|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2520977|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520978|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2520979|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
2520980|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2520981|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520982|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2520983|NCT01330615|Lidocaine|lidocaine|mesh-list
2520984|NCT01330615|Prilocaine|prilocaine|mesh-list
2520985|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
2520986|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
2520987|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2520988|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2520989|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
2520990|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2520991|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2520992|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2395621|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395622|NCT00690014|Probenecid|probenecid|mesh-list
2395623|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
2395624|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
2395625|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2395626|NCT00690014|Renal Agents|renal agents|mesh-ancestor
2520993|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2520994|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2520995|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2520996|NCT01330654|Metoprolol|metoprolol|mesh-list
2520997|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2520998|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2520999|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
2521000|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
2521001|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521002|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395631|NCT00690105|Fluticasone|fluticasone|mesh-list
2395632|NCT00690105|Tacrolimus|tacrolimus|mesh-list
2395633|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2395634|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
2395635|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395636|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2395637|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395638|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521003|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2521004|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2521005|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2521006|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
2395639|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2395640|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2395641|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
2395642|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395643|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2395644|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
2395645|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
2395646|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2395647|NCT00690118|Pioglitazone|pioglitazone|mesh-list
2395648|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2395649|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395650|NCT00690170|Ketamine|ketamine|mesh-list
2395651|NCT00690170|Nicotine|nicotine|mesh-list
2395652|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2395653|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
2395654|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395655|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395656|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2395657|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2395658|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
2395659|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395660|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395661|NCT00690170|Analgesics|analgesics|mesh-ancestor
2395662|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
2395663|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2395664|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2395665|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
2395666|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
2395667|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2395668|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2395669|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2395670|NCT00690222|Mydriatics|mydriatics|mesh-list
2395671|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
2395672|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395673|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395674|NCT00690300|Docetaxel|docetaxel|mesh-list
2395675|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
2395676|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395677|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
2395678|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
2521007|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2521008|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521009|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2521010|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2521011|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2521012|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2521013|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521014|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
2521015|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2521016|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521017|NCT01330706|Polihexanide|polihexanide|mesh-list
2521018|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
2395679|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
2395680|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395681|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
2395682|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2395683|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2395684|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395685|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2395686|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2395687|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422940|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
2521019|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521020|NCT01330810|Curcumin|curcumin|mesh-list
2521021|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2521022|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2521023|NCT01330810|Analgesics|analgesics|mesh-ancestor
2521024|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
2521025|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521026|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521027|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521028|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2521029|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395688|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395689|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395690|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2395691|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
2395692|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2395693|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395694|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2395695|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2395696|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2395697|NCT00690417|Vitamin D|vitamin d|mesh-list
2395698|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
2395699|NCT00690417|Vitamins|vitamins|mesh-ancestor
2395700|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
2395701|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395702|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2395703|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2395704|NCT00690456|Metformin|metformin|mesh-list
2395705|NCT00690456|Rimonabant|rimonabant|mesh-list
2395706|NCT00690456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2395707|NCT00690456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395708|NCT00690456|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2395709|NCT00690456|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2395710|NCT00690456|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2395711|NCT00690456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395712|NCT00690456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521030|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521031|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521032|NCT01330901|Ustekinumab|ustekinumab|mesh-list
2521033|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
2521034|NCT01330979|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2521035|NCT01330979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2395713|NCT00690456|Hormones|hormones|mesh-ancestor
2395714|NCT00690456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2395715|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2395716|NCT00690521|Metolazone|metolazone|mesh-list
2395717|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2395718|NCT00690521|Diuretics|diuretics|mesh-ancestor
2395719|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
2395720|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395721|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2395722|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2395723|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395724|NCT00690534|Insulin|insulin|mesh-list
2395725|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2395726|NCT00690534|Nitroprusside|nitroprusside|mesh-list
2395727|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2521066|NCT01331122|Droxidopa|droxidopa|mesh-list
2521067|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2521068|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2521069|NCT01331135|Sirolimus|sirolimus|mesh-list
2521070|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2521071|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521072|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2521073|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521074|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
2521075|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521076|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
2521077|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521078|NCT01331148|Vitamin D|vitamin d|mesh-list
2521079|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
2395728|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395729|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2395730|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
2395731|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2521080|NCT01331148|Vitamins|vitamins|mesh-ancestor
2521081|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
2521082|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521083|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2521084|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2521085|NCT01331382|Resveratrol|resveratrol|mesh-list
2521086|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
2521087|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521088|NCT01331382|Protective Agents|protective agents|mesh-ancestor
2521089|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521090|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521091|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2521092|NCT01331421|Exemestane|exemestane|mesh-list
2521093|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521094|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2521095|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2521096|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521097|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521098|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2521099|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
2521100|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521101|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521102|NCT01331434|Exemestane|exemestane|mesh-list
2521103|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521104|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2521105|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2395732|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395733|NCT00690560|Prednisone|prednisone|mesh-list
2395734|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
2395735|NCT00690560|Rituximab|rituximab|mesh-list
2395736|NCT00690560|Doxorubicin|doxorubicin|mesh-list
2395737|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2395738|NCT00690560|Vincristine|vincristine|mesh-list
2395739|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2395740|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
2395741|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395742|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2395743|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2395744|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
2395745|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521106|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521107|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521108|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2521109|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
2521110|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521111|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521112|NCT01331447|Exemestane|exemestane|mesh-list
2395746|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521113|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521114|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2521115|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2521116|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521117|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521118|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2521119|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
2521120|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521121|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521122|NCT01331525|Ipilimumab|ipilimumab|mesh-list
2521123|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2521124|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521125|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2521126|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521127|NCT01331590|Dexamethasone|dexamethasone|mesh-list
2395747|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2395748|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2521128|NCT01331590|Etoposide|etoposide|mesh-list
2521129|NCT01331590|Ifosfamide|ifosfamide|mesh-list
2521130|NCT01331590|Lenograstim|lenograstim|mesh-list
2521131|NCT01331590|Sargramostim|sargramostim|mesh-list
2521132|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521133|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
2521134|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
2521135|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521136|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521137|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2521138|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
2521139|NCT01331590|Hormones|hormones|mesh-ancestor
2521140|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521141|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2395749|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2395750|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2395751|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2395752|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395753|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2395754|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
2395755|NCT00690560|Hormones|hormones|mesh-ancestor
2395756|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2395757|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2395758|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2395759|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
2395760|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
2395761|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
2395762|NCT00690677|Panobinostat|panobinostat|mesh-list
2395763|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395764|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2395765|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395766|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395767|NCT00690768|Bevacizumab|bevacizumab|mesh-list
2395768|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2395769|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395770|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2395771|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2395772|NCT00690768|Growth Substances|growth substances|mesh-ancestor
2395773|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395774|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
2395775|NCT00690781|Caseins|caseins|mesh-list
2395776|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
2395777|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
2395778|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395779|NCT00690846|Adalimumab|adalimumab|mesh-list
2395780|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2395781|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2395782|NCT00690872|Gemcitabine|gemcitabine|mesh-list
2521142|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521143|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2521144|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2521145|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2521146|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521147|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521148|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2521149|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
2521150|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2395783|NCT00690872|Carboplatin|carboplatin|mesh-list
2395784|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395785|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2395786|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
2395787|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395788|NCT00690872|Antiviral Agents|antiviral agents|mesh-ancestor
2395789|NCT00690872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395790|NCT00690872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395791|NCT00690872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2395792|NCT00690872|Immunologic Factors|immunologic factors|mesh-ancestor
2395793|NCT00690872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395794|NCT00690885|Interferons|interferons|mesh-list
2395795|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
2395796|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
2395797|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2395798|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395799|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
2395800|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395801|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
2395802|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395803|NCT00690911|Adalimumab|adalimumab|mesh-list
2395804|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2395805|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2395806|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2395807|NCT00690937|Sevelamer|sevelamer|mesh-list
2395808|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
2395809|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
2395810|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395811|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2395812|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2521151|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
2395813|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
2395814|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2395815|NCT00690950|Dutasteride|dutasteride|mesh-list
2395816|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2395817|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2395818|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395819|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395820|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
2521160|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
2521161|NCT01331655|Drospirenone|drospirenone|mesh-list
2521162|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2395821|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2395822|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395823|NCT00691067|Mifepristone|mifepristone|mesh-list
2395824|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2395825|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
2395826|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2395827|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395828|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2395829|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2395830|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2395831|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
2521163|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
2521164|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521165|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521166|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2521167|NCT01331655|Diuretics|diuretics|mesh-ancestor
2521168|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
2521169|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
2521170|NCT01331655|Vitamins|vitamins|mesh-ancestor
2521171|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
2521172|NCT01331707|Everolimus|everolimus|mesh-list
2521173|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521174|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521175|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
2521176|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521177|NCT01331785|Midodrine|midodrine|mesh-list
2521178|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
2521179|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
2521180|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521181|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521182|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2521183|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2521184|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2521185|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2521186|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
2521187|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2521188|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521189|NCT01331850|Ritonavir|ritonavir|mesh-list
2395832|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2395833|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2395834|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
2395835|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2395836|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
2395837|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2395838|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2395839|NCT00691145|Tacrolimus|tacrolimus|mesh-list
2395840|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2395841|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
2395842|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395843|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2395844|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395845|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395846|NCT00691158|Pramlintide|pramlintide|mesh-list
2395847|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
2521190|NCT01331850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2521191|NCT01331850|Interferon-alpha|interferon-alpha|mesh-list
2521192|NCT01331850|Ribavirin|ribavirin|mesh-list
2521193|NCT01331850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2521194|NCT01331850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2521195|NCT01331850|Protease Inhibitors|protease inhibitors|mesh-ancestor
2521196|NCT01331850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521197|NCT01331850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521198|NCT01331850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2521199|NCT01331850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2521200|NCT01331850|Antiviral Agents|antiviral agents|mesh-ancestor
2521201|NCT01331850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521202|NCT01331850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2521203|NCT01331850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2521204|NCT01331850|Immunologic Factors|immunologic factors|mesh-ancestor
2521205|NCT01331850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395848|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2395849|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395850|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
2521206|NCT01331850|Antimetabolites|antimetabolites|mesh-ancestor
2521207|NCT01331902|Nicorandil|nicorandil|mesh-list
2521208|NCT01331902|Adenosine|adenosine|mesh-list
2521209|NCT01331902|Analgesics|analgesics|mesh-ancestor
2521210|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
2521211|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395851|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2395852|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
2395853|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395854|NCT00691184|Terbinafine|terbinafine|mesh-list
2521212|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521213|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2521214|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
2521215|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2521216|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
2521217|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
2521218|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2521219|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521220|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2521221|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
2521222|NCT01331902|Vitamins|vitamins|mesh-ancestor
2521223|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
2521224|NCT01331928|Docetaxel|docetaxel|mesh-list
2521225|NCT01331928|Capecitabine|capecitabine|mesh-list
2521226|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
2521227|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521228|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
2521229|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
2521230|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
2521231|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521232|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2521233|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
2521234|NCT01331941|Paclitaxel|paclitaxel|mesh-list
2521235|NCT01331941|Trebananib|trebananib|mesh-list
2521236|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2521237|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521238|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
2521239|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
2521240|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
2521241|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521242|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2521243|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2521244|NCT01331941|Growth Substances|growth substances|mesh-ancestor
2521245|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521246|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
2521247|NCT01331967|Pioglitazone|pioglitazone|mesh-list
2521248|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2521249|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521250|NCT01331993|Naproxen|naproxen|mesh-list
2521251|NCT01331993|Esomeprazole|esomeprazole|mesh-list
2521252|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2521253|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2521254|NCT01331993|Analgesics|analgesics|mesh-ancestor
2521255|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
2521256|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521257|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521258|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2395855|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
2395856|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395857|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395858|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395859|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
2395860|NCT00691236|Doxorubicin|doxorubicin|mesh-list
2395861|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2395862|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395863|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2395864|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2395865|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395866|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521259|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2521260|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
2521261|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2395867|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2395868|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395869|NCT00691262|Tacrolimus|tacrolimus|mesh-list
2395870|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2395871|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
2395872|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521262|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521263|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521264|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2521265|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2521266|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2521267|NCT01332097|Prednisone|prednisone|mesh-list
2521268|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521269|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
2521270|NCT01332097|Hormones|hormones|mesh-ancestor
2521271|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521272|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521273|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2521274|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521275|NCT01332201|Tacrolimus|tacrolimus|mesh-list
2521276|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521277|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
2521278|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521279|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2521280|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521281|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521285|NCT01332279|Everolimus|everolimus|mesh-list
2395873|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2395874|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395875|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395876|NCT00691275|Ondansetron|ondansetron|mesh-list
2521286|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2521287|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521288|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521289|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
2521290|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395877|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
2395878|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
2395879|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395880|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395881|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2395882|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
2395883|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
2395884|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2395885|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
2395886|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395887|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395888|NCT00691275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2395889|NCT00691275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2395890|NCT00691275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2395891|NCT00691275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2395892|NCT00691275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2395893|NCT00691379|Paclitaxel|paclitaxel|mesh-list
2395894|NCT00691379|Bevacizumab|bevacizumab|mesh-list
2395895|NCT00691379|Carboplatin|carboplatin|mesh-list
2395896|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2395897|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395898|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
2395899|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
2395900|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
2395901|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395902|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2395903|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2395904|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2521291|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2521292|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521293|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521294|NCT01332344|Fluticasone|fluticasone|mesh-list
2521295|NCT01332344|Xhance|xhance|mesh-list
2521296|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2521297|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521298|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2521299|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
2521300|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521301|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521302|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2521303|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
2521304|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
2521305|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2521306|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2521307|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2521308|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2521309|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
2395905|NCT00691379|Growth Substances|growth substances|mesh-ancestor
2395906|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395907|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
2395908|NCT00691392|Linezolid|linezolid|mesh-list
2521310|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2521311|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521312|NCT01332370|Metformin|metformin|mesh-list
2521313|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2395909|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2395910|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395911|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2395912|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2395913|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395914|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2395915|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
2395916|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2395917|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
2395918|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521314|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
2395919|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395920|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2395921|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
2395922|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2395923|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2395924|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2395925|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
2395926|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395927|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395928|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
2395929|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2395930|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
2395931|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2395932|NCT00691470|Warfarin|warfarin|mesh-list
2395933|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
2395934|NCT00691548|Cetuximab|cetuximab|mesh-list
2395935|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2395936|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521315|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2521316|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521317|NCT01332370|Incretins|incretins|mesh-ancestor
2521318|NCT01332370|Hormones|hormones|mesh-ancestor
2521319|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521320|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2521321|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
2521322|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521323|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521324|NCT01332383|Naratriptan|naratriptan|mesh-list
2521325|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2521326|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2521327|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2521328|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
2521329|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2521330|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521331|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521332|NCT01332396|Lapatinib|lapatinib|mesh-list
2521333|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521334|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2521335|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521336|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521337|NCT01332409|Fluticasone|fluticasone|mesh-list
2521338|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2395937|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
2395938|NCT00691613|Hematinics|hematinics|mesh-ancestor
2395939|NCT00691717|Hydrocortisone|hydrocortisone|mesh-list
2395940|NCT00691717|Anecortave|anecortave|mesh-list
2395941|NCT00691717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2395942|NCT00691717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2395943|NCT00691717|Growth Substances|growth substances|mesh-ancestor
2395944|NCT00691717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395945|NCT00691717|Growth Inhibitors|growth inhibitors|mesh-ancestor
2395946|NCT00691717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395947|NCT00691717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521339|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2521340|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521341|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2521342|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
2521343|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521344|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521345|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2521346|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
2521347|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
2521348|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2521349|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2521350|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2521351|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2521352|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
2521353|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2521354|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521355|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
2521356|NCT01332409|Hormones|hormones|mesh-ancestor
2521357|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521358|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
2521359|NCT01332422|Fluticasone|fluticasone|mesh-list
2395948|NCT00691795|Clonidine|clonidine|mesh-list
2395949|NCT00691795|Fentanyl|fentanyl|mesh-list
2395950|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2521360|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2521361|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2521362|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521363|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2521364|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
2521365|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521366|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521367|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2521368|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
2521369|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
2521370|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2521371|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2521372|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2521373|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2521374|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
2521375|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2521376|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521377|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
2521378|NCT01332422|Hormones|hormones|mesh-ancestor
2521379|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521380|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
2521381|NCT01332448|Orlistat|orlistat|mesh-list
2521382|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521383|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521384|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2521385|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2521386|NCT01332552|Ritonavir|ritonavir|mesh-list
2521387|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2521388|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2521389|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
2521390|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521391|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521392|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2521393|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2521394|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
2521395|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521396|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2395951|NCT00691795|Narcotics|narcotics|mesh-ancestor
2395952|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2395953|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395954|NCT00691795|Analgesics|analgesics|mesh-ancestor
2395955|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
2395956|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395957|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2395958|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2521397|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2521398|NCT01332565|Dolutegravir|dolutegravir|mesh-list
2521399|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2521400|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2521401|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521402|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395959|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
2395960|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
2395961|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2395962|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
2395963|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
2521403|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2521404|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2521405|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
2521406|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521407|NCT01332604|Bevacizumab|bevacizumab|mesh-list
2521408|NCT01332604|Capecitabine|capecitabine|mesh-list
2521409|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2521410|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521411|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2521412|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2521413|NCT01332604|Growth Substances|growth substances|mesh-ancestor
2521414|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521415|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
2521416|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2521417|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
2521418|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521419|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
2521420|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
2521421|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2521422|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2521423|NCT01332617|Prednisolone|prednisolone|mesh-list
2521424|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
2521425|NCT01332617|Diclofenac|diclofenac|mesh-list
2521426|NCT01332617|Bortezomib|bortezomib|mesh-list
2521427|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2521428|NCT01332617|Simvastatin|simvastatin|mesh-list
2521429|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2521430|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
2521431|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395964|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2395965|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2395966|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2395967|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
2521432|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521433|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
2521434|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
2521435|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521436|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521437|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2521438|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
2521439|NCT01332617|Hormones|hormones|mesh-ancestor
2395968|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395969|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395970|NCT00691873|Omalizumab|omalizumab|mesh-list
2521440|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521441|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2521442|NCT01332617|Protective Agents|protective agents|mesh-ancestor
2521443|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2395971|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2395972|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2395973|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
2395974|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
2395975|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2395976|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2395977|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2395978|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2395979|NCT00691886|Analgesics|analgesics|mesh-ancestor
2395980|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
2521444|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2521445|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2521446|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
2521447|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521448|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2521449|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2521450|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521451|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2395981|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2395982|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2395983|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2395984|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2395985|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
2395986|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2395987|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395988|NCT00691912|Paclitaxel|paclitaxel|mesh-list
2395989|NCT00691912|Doxorubicin|doxorubicin|mesh-list
2395990|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2395991|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2395992|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2395993|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
2395994|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
2395995|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
2395996|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2395997|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2395998|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2395999|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2396000|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396001|NCT00691951|Budesonide|budesonide|mesh-list
2521452|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
2521453|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2521454|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2521455|NCT01332617|Analgesics|analgesics|mesh-ancestor
2521456|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
2521457|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2521458|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2521459|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2521460|NCT01332656|Paclitaxel|paclitaxel|mesh-list
2521461|NCT01332656|Carboplatin|carboplatin|mesh-list
2521462|NCT01332656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2521463|NCT01332656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521464|NCT01332656|Tubulin Modulators|tubulin modulators|mesh-ancestor
2521465|NCT01332656|Antimitotic Agents|antimitotic agents|mesh-ancestor
2521466|NCT01332656|Mitosis Modulators|mitosis modulators|mesh-ancestor
2521467|NCT01332656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521468|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
2521469|NCT01332734|Analgesics|analgesics|mesh-ancestor
2521470|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
2521471|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521472|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521473|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
2521474|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2521475|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2521476|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
2521477|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2521478|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2521479|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521480|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2521481|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
2521482|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2521483|NCT01332747|Atorvastatin|atorvastatin|mesh-list
2521484|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2521485|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2521486|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
2521487|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521488|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2521489|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2521490|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521491|NCT01332786|Tigecycline|tigecycline|mesh-list
2521492|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2521493|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521494|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2521495|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521496|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521497|NCT01332812|Dexamethasone|dexamethasone|mesh-list
2521498|NCT01332812|Dexamethasone acetate|dexamethasone acetate|mesh-list
2521499|NCT01332812|BB 1101|bb 1101|mesh-list
2116099|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116100|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2396002|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
2521500|NCT01332812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521501|NCT01332812|Antiemetics|antiemetics|mesh-ancestor
2521502|NCT01332812|Autonomic Agents|autonomic agents|mesh-ancestor
2521503|NCT01332812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521504|NCT01332812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521505|NCT01332812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2396003|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396004|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2396005|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
2396006|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396007|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396008|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2396009|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
2396010|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
2396011|NCT00691951|Hormones|hormones|mesh-ancestor
2396012|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2396013|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2396014|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2396015|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2396016|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
2396017|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396018|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521506|NCT01332812|Glucocorticoids|glucocorticoids|mesh-ancestor
2521507|NCT01332812|Hormones|hormones|mesh-ancestor
2521508|NCT01332812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521509|NCT01332812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2396019|NCT00691964|Etanercept|etanercept|mesh-list
2396020|NCT00691964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2521510|NCT01332812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521511|NCT01332812|Protease Inhibitors|protease inhibitors|mesh-ancestor
2521512|NCT01332812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521513|NCT01332812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521514|NCT01332929|Bevacizumab|bevacizumab|mesh-list
2521515|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2521516|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521517|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2521518|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2521519|NCT01332929|Growth Substances|growth substances|mesh-ancestor
2521520|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521521|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
2521522|NCT01332955|Ribavirin|ribavirin|mesh-list
2521523|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2521524|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
2521525|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521526|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
2521527|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521528|NCT01333046|Azacitidine|azacitidine|mesh-list
2521529|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2521530|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
2521531|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521532|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521533|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396021|NCT00691964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2396022|NCT00691964|Analgesics|analgesics|mesh-ancestor
2396023|NCT00691964|Sensory System Agents|sensory system agents|mesh-ancestor
2396024|NCT00691964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396025|NCT00691964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396026|NCT00691964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396027|NCT00691964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2396028|NCT00691964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2521534|NCT01333085|Paclitaxel|paclitaxel|mesh-list
2521535|NCT01333085|Carboplatin|carboplatin|mesh-list
2521536|NCT01333085|Everolimus|everolimus|mesh-list
2521537|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2521538|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521539|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
2521540|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
2521541|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
2521542|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521543|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521544|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
2521545|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521546|NCT01333124|Gemcitabine|gemcitabine|mesh-list
2521547|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2521548|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
2521549|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521550|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396029|NCT00691964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2396030|NCT00691964|Immunologic Factors|immunologic factors|mesh-ancestor
2396031|NCT00692016|Naproxen|naproxen|mesh-list
2396032|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2396033|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2396034|NCT00692016|Analgesics|analgesics|mesh-ancestor
2396035|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
2396036|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396037|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521551|NCT01333124|Antiviral Agents|antiviral agents|mesh-ancestor
2521552|NCT01333124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521553|NCT01333124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396038|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396039|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2396040|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
2396041|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2396042|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396043|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396044|NCT00692055|Naproxen|naproxen|mesh-list
2396045|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2396046|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2396047|NCT00692055|Analgesics|analgesics|mesh-ancestor
2396048|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
2396049|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521554|NCT01333124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521555|NCT01333124|Immunologic Factors|immunologic factors|mesh-ancestor
2521556|NCT01333124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521557|NCT01333137|Gemcitabine|gemcitabine|mesh-list
2521558|NCT01333137|Carboplatin|carboplatin|mesh-list
2521559|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521560|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2521561|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
2521562|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521563|NCT01333137|Antiviral Agents|antiviral agents|mesh-ancestor
2521564|NCT01333137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521565|NCT01333137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521566|NCT01333137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521567|NCT01333137|Immunologic Factors|immunologic factors|mesh-ancestor
2521568|NCT01333137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521569|NCT01333150|Propranolol|propranolol|mesh-list
2521570|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2521571|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2521572|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
2521573|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2521574|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521575|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521576|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2521577|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2521578|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
2521579|NCT01333267|Hormones|hormones|mesh-list
2521580|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
2521581|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
2521582|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
2521583|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
2521584|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521585|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521586|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2521587|NCT01333332|Capecitabine|capecitabine|mesh-list
2521588|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2521589|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
2521590|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521591|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521592|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
2521593|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2521594|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521595|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
2521596|NCT01333410|Tacrolimus|tacrolimus|mesh-list
2521597|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521598|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
2521599|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521600|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2521601|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521602|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521603|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521604|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
2521605|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2521606|NCT01333423|Roscovitine|roscovitine|mesh-list
2521607|NCT01333423|Doxorubicin|doxorubicin|mesh-list
2521608|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2521609|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2521610|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521611|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2521612|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2521613|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521614|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521615|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
2521616|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521617|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2521618|NCT01333449|Decitabine|decitabine|mesh-list
2521619|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2521620|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
2521621|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521622|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521623|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521624|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
2521625|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
2521626|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2521627|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2521628|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521629|NCT01333631|Valproic Acid|valproic acid|mesh-list
2521630|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
2521631|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521632|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521633|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
2521634|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2521635|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521636|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
2521637|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2521638|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2521639|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2521640|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2521641|NCT01333696|Pemetrexed|pemetrexed|mesh-list
2521642|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521643|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521644|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521645|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2521646|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2396050|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396051|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396052|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2396053|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
2396054|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2396055|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396056|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396057|NCT00692120|Vitamin D|vitamin d|mesh-list
2396058|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
2396059|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
2396060|NCT00692120|Vitamins|vitamins|mesh-list
2396061|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
2396062|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396063|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2396064|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2396065|NCT00692159|Pemetrexed|pemetrexed|mesh-list
2396066|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396067|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396068|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396069|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2396070|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2396071|NCT00692172|Alefacept|alefacept|mesh-list
2396072|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
2396073|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
2396074|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396075|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2396076|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2396077|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2396078|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
2396079|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396080|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2521647|NCT01333709|Folfirinox|folfirinox|mesh-list
2521648|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521649|NCT01333774|Acarbose|acarbose|mesh-list
2521650|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2521651|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521652|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396081|NCT00692263|Tramadol|tramadol|mesh-list
2396082|NCT00692263|Citalopram|citalopram|mesh-list
2396083|NCT00692263|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2396084|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2396085|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2396086|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396087|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396088|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
2396089|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396090|NCT00692263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2396091|NCT00692263|Antidepressive Agents|antidepressive agents|mesh-ancestor
2396092|NCT00692263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2396093|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396094|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2396095|NCT00692263|Narcotics|narcotics|mesh-ancestor
2396096|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2396097|NCT00692263|Analgesics|analgesics|mesh-ancestor
2396098|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
2396099|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
2396100|NCT00692315|Vitamins|vitamins|mesh-ancestor
2396101|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
2396102|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396103|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
2396104|NCT00692328|Levodopa|levodopa|mesh-list
2521653|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2521654|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521655|NCT01333800|Ciclesonide|ciclesonide|mesh-list
2521656|NCT01333800|Beclomethasone|beclomethasone|mesh-list
2521657|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521658|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
2521659|NCT01333800|Hormones|hormones|mesh-ancestor
2521660|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521661|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521662|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2521663|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
2521664|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2521665|NCT01333852|Metformin|metformin|mesh-list
2521666|NCT01333852|Paclitaxel|paclitaxel|mesh-list
2521667|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2521668|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521669|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
2521670|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
2396105|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2396106|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2396107|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
2396108|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396109|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396110|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396111|NCT00692354|Tosedostat|tosedostat|mesh-list
2396112|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396113|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396114|NCT00692445|Mecamylamine|mecamylamine|mesh-list
2396115|NCT00692445|Dexetimide|dexetimide|mesh-list
2396116|NCT00692445|Citalopram|citalopram|mesh-list
2396117|NCT00692445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2396118|NCT00692445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2396119|NCT00692445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2396120|NCT00692445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396121|NCT00692445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396122|NCT00692445|Serotonin Agents|serotonin agents|mesh-ancestor
2396123|NCT00692445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396124|NCT00692445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2396125|NCT00692445|Antidepressive Agents|antidepressive agents|mesh-ancestor
2396126|NCT00692445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2396127|NCT00692445|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2396128|NCT00692445|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2396129|NCT00692445|Parasympatholytics|parasympatholytics|mesh-ancestor
2521671|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
2521672|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521673|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2521674|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521675|NCT01333878|Abatacept|abatacept|mesh-list
2521676|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2521677|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521678|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521679|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521680|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
2521681|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521682|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2521683|NCT01333891|Nitroprusside|nitroprusside|mesh-list
2521684|NCT01333891|Phenylephrine|phenylephrine|mesh-list
2521685|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
2521686|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2521687|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
2521688|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
2521689|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521690|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521691|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
2521692|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2521693|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
2521694|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
2521695|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2521696|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2521697|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2396130|NCT00692445|Autonomic Agents|autonomic agents|mesh-ancestor
2521698|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
2521699|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2521700|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521701|NCT01333891|Protective Agents|protective agents|mesh-ancestor
2396131|NCT00692445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396132|NCT00692445|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2396133|NCT00692445|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2396134|NCT00692445|Cholinergic Agents|cholinergic agents|mesh-ancestor
2396135|NCT00692445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2396136|NCT00692445|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2396137|NCT00692445|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2396138|NCT00692484|Chlorhexidine|chlorhexidine|mesh-list
2396139|NCT00692484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2396140|NCT00692484|Povidone-Iodine|povidone-iodine|mesh-list
2396141|NCT00692484|Povidone|povidone|mesh-list
2396142|NCT00692484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2396143|NCT00692484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396144|NCT00692484|Disinfectants|disinfectants|mesh-ancestor
2396145|NCT00692484|Dermatologic Agents|dermatologic agents|mesh-ancestor
2396146|NCT00692484|Plasma Substitutes|plasma substitutes|mesh-ancestor
2521702|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2521703|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
2521704|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2521705|NCT01333917|Curcumin|curcumin|mesh-list
2521706|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2521707|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2521708|NCT01333917|Analgesics|analgesics|mesh-ancestor
2521709|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
2521710|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521711|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521712|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521713|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2521714|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521715|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521716|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521717|NCT01333982|Amoxicillin|amoxicillin|mesh-list
2396147|NCT00692484|Blood Substitutes|blood substitutes|mesh-ancestor
2396148|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
2396149|NCT00692510|Midazolam|midazolam|mesh-list
2396150|NCT00692510|Caffeine|caffeine|mesh-list
2396151|NCT00692510|Bupropion|bupropion|mesh-list
2396152|NCT00692510|Omeprazole|omeprazole|mesh-list
2396153|NCT00692510|Bilirubin|bilirubin|mesh-list
2396154|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2396155|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2396156|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2396157|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396158|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2396159|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2396160|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2396161|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2396162|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
2396163|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
2396164|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
2396165|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
2396166|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396167|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396168|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2396169|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2396170|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2396171|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521718|NCT01333982|Gentamicins|gentamicins|mesh-list
2521719|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2521720|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521721|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2521722|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521723|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521724|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
2521725|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2521726|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521727|NCT01334047|Vaccines|vaccines|mesh-list
2521728|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
2521729|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396172|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2396173|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2396174|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2396175|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2521730|NCT01334060|Vaccines|vaccines|mesh-list
2396176|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
2396177|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2396178|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
2396179|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2396180|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2396181|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2396182|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
2396183|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2396184|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2396185|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2396186|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
2396187|NCT00692510|Protective Agents|protective agents|mesh-ancestor
2396188|NCT00692601|Capsaicin|capsaicin|mesh-list
2396189|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
2396190|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
2396191|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
2396192|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396193|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396194|NCT00692614|Triamcinolone|triamcinolone|mesh-list
2396195|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2396196|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2521731|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
2521732|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521733|NCT01334073|Everolimus|everolimus|mesh-list
2521734|NCT01334073|Axitinib|axitinib|mesh-list
2521735|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521736|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521737|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
2521738|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521739|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2521740|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521741|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521742|NCT01334099|Tremelimumab|tremelimumab|mesh-list
2521743|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521744|NCT01334112|Axitinib|axitinib|mesh-list
2521745|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521746|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2521747|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521748|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521749|NCT01334151|Insulin|insulin|mesh-list
2521750|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2521751|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
2521752|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2521753|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521754|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2521755|NCT01334177|Cetuximab|cetuximab|mesh-list
2396197|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2396198|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396199|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
2396200|NCT00692614|Hormones|hormones|mesh-ancestor
2396201|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2396202|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396203|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2396204|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
2396205|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521756|NCT01334177|Antibodies|antibodies|mesh-list
2521757|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
2521758|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2521759|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
2521760|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521761|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521762|NCT01334203|Ranolazine|ranolazine|mesh-list
2521763|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2521764|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2521765|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521766|NCT01334268|Paclitaxel|paclitaxel|mesh-list
2521767|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2521768|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521769|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
2521770|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
2521771|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
2521772|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521773|NCT01334333|Tacrolimus|tacrolimus|mesh-list
2521774|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521775|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
2521776|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116101|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2116102|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
2116103|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2116104|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2116105|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2116106|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2116107|NCT02634333|Aflibercept|aflibercept|mesh-list
2116108|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
2116109|NCT02634333|Mitogens|mitogens|mesh-list
2116110|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2116111|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2116112|NCT02634333|Growth Substances|growth substances|mesh-ancestor
2521777|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2521778|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521779|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521780|NCT01334424|Propofol|propofol|mesh-list
2521781|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2521782|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2521783|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521784|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2396206|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396207|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2396208|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396209|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2396210|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396211|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521785|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
2521786|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
2521787|NCT01334502|Prednisone|prednisone|mesh-list
2521788|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
2521789|NCT01334502|Rituximab|rituximab|mesh-list
2521790|NCT01334502|Doxorubicin|doxorubicin|mesh-list
2521791|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2521792|NCT01334502|Vincristine|vincristine|mesh-list
2521793|NCT01334502|Everolimus|everolimus|mesh-list
2521794|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521795|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
2521796|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521797|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2521798|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2521799|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
2521800|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521801|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521802|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2521803|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2521804|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2521805|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2521806|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2521807|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521808|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521809|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
2521810|NCT01334502|Hormones|hormones|mesh-ancestor
2521811|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521812|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2521813|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2521814|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
2521815|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
2521816|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
2521817|NCT01334567|Tenofovir|tenofovir|mesh-list
2521818|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
2521819|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521820|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2521821|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2521822|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521823|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521824|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2521825|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2521826|NCT01334580|Methadone|methadone|mesh-list
2521827|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2521828|NCT01334580|Narcotics|narcotics|mesh-ancestor
2521829|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2521830|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521831|NCT01334580|Analgesics|analgesics|mesh-ancestor
2521832|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
2521833|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521834|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
2521835|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
2521836|NCT01334619|Ropivacaine|ropivacaine|mesh-list
2521837|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
2521838|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
2521839|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2521840|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521841|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
2521842|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521843|NCT01334632|Morphine|morphine|mesh-list
2521844|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2521845|NCT01334632|Narcotics|narcotics|mesh-ancestor
2396212|NCT00692731|Caffeine|caffeine|mesh-list
2396213|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2396214|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396215|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2396216|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396217|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396218|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2396219|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2396220|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
2521846|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2521847|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521848|NCT01334632|Analgesics|analgesics|mesh-ancestor
2521849|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
2521850|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2521851|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
2521852|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
2521853|NCT01334645|Coagulants|coagulants|mesh-ancestor
2521854|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2521855|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2521856|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
2521857|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521858|NCT01334671|Atorvastatin|atorvastatin|mesh-list
2521859|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2521860|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2521861|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
2521862|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521863|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2521864|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2521865|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521866|NCT01334684|Metformin|metformin|mesh-list
2521867|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2521868|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521869|NCT01334762|Letrozole|letrozole|mesh-list
2521870|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521871|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2521872|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2521873|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521874|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521875|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2521876|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
2521877|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521878|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521879|NCT01334879|Ranibizumab|ranibizumab|mesh-list
2521880|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2521881|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2521882|NCT01334879|Growth Substances|growth substances|mesh-ancestor
2521883|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521884|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
2521885|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521886|NCT01334892|Cyclosporine|cyclosporine|mesh-list
2521887|NCT01334892|Cyclosporins|cyclosporins|mesh-list
2521888|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521889|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521890|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521891|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
2521892|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521893|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
2521894|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521895|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
2521896|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2521897|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2521898|NCT01334905|Mirabegron|mirabegron|mesh-list
2521899|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2521900|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2521901|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2521902|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
2521903|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2521904|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521905|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521906|NCT01334905|Urological Agents|urological agents|mesh-ancestor
2521907|NCT01335035|Deferasirox|deferasirox|mesh-list
2521908|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2521909|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
2521910|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
2521911|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521912|NCT01335048|Clopidogrel|clopidogrel|mesh-list
2521913|NCT01335048|Atorvastatin|atorvastatin|mesh-list
2521914|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2521915|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2521916|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
2521917|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521918|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2521919|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2521920|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521921|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2521922|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2521923|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2521924|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2521925|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
2521926|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2521927|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521928|NCT01335074|Sirolimus|sirolimus|mesh-list
2521929|NCT01335074|Sorafenib|sorafenib|mesh-list
2521930|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2521931|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2521932|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521933|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521934|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2521935|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521936|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2521937|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
2521938|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2521939|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
2521940|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521941|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
2521942|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2521943|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2521944|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
2521945|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521946|NCT01335321|Triamcinolone|triamcinolone|mesh-list
2521947|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
2521948|NCT01335321|Hylan|hylan|mesh-list
2521949|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2521950|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
2521951|NCT01335321|Hormones|hormones|mesh-ancestor
2521952|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521953|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2521954|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
2521955|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
2521956|NCT01335321|Protective Agents|protective agents|mesh-ancestor
2521957|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2521958|NCT01335334|Metronidazole|metronidazole|mesh-list
2521959|NCT01335334|Tetracycline|tetracycline|mesh-list
2521960|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
2521961|NCT01335334|Omeprazole|omeprazole|mesh-list
2521962|NCT01335334|Bismuth|bismuth|mesh-list
2521963|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396221|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396222|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
2396223|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2521964|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2521965|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2521966|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2521967|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2521968|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2521969|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2521970|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521971|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521972|NCT01335334|Antacids|antacids|mesh-ancestor
2396224|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396225|NCT00692900|Docetaxel|docetaxel|mesh-list
2396226|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
2396227|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396228|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
2396229|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
2396230|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
2396231|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396232|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
2396233|NCT00692939|Melphalan|melphalan|mesh-list
2396234|NCT00692939|Thiotepa|thiotepa|mesh-list
2396235|NCT00692939|Rituximab|rituximab|mesh-list
2396236|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
2396237|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
2396238|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2396239|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2396240|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
2521973|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2521974|NCT01335360|Nevirapine|nevirapine|mesh-list
2521975|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2521976|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2521977|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521978|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2521979|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
2521980|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521981|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2521982|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2521983|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2521984|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2521985|NCT01335373|Metronidazole|metronidazole|mesh-list
2521986|NCT01335373|Miconazole|miconazole|mesh-list
2521987|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2521988|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2521989|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2521990|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2521991|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
2521992|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2521993|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2521994|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2521995|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396241|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396242|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2396243|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2396244|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
2396245|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396246|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396247|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2396248|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2396249|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
2396250|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
2396251|NCT00692952|Nonoxynol|nonoxynol|mesh-list
2396252|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2396253|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396254|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2396255|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396256|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2396257|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2521996|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2521997|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
2521998|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2521999|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522000|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2522001|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2522002|NCT01335386|Glycerol|glycerol|mesh-list
2522003|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2522004|NCT01335386|Protective Agents|protective agents|mesh-ancestor
2522005|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522006|NCT01335516|Terlipressin|terlipressin|mesh-list
2522007|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2522008|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2396258|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2396259|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2396260|NCT00693004|Donepezil|donepezil|mesh-list
2396261|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2396262|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522009|NCT01335529|Interferons|interferons|mesh-list
2522010|NCT01335529|Ribavirin|ribavirin|mesh-list
2522011|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
2522012|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
2522013|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2522014|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522015|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
2522016|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396263|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396264|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
2396265|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396266|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396267|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
2396268|NCT00693030|Sirolimus|sirolimus|mesh-list
2396269|NCT00693030|Paclitaxel|paclitaxel|mesh-list
2396270|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2396271|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396272|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
2396273|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
2396274|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
2396275|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396276|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2396277|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396278|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2396279|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
2396280|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2396281|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
2396282|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396283|NCT00693043|Lidocaine|lidocaine|mesh-list
2396284|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
2396285|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
2396286|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2396287|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396288|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
2396289|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396290|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2396291|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2396292|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2396293|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2396294|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396295|NCT00693056|beta-Lactams|beta-lactams|mesh-list
2396296|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2396297|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396298|NCT00693069|Clopidogrel|clopidogrel|mesh-list
2396299|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2396300|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2396301|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2396302|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2396303|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
2396304|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396305|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396306|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396307|NCT00693108|Testosterone|testosterone|mesh-list
2396308|NCT00693108|Androgens|androgens|mesh-ancestor
2396309|NCT00693108|Hormones|hormones|mesh-ancestor
2396310|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2396311|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396312|NCT00693121|Amantadine|amantadine|mesh-list
2396313|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2396314|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2396315|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
2396316|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396317|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
2396318|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396319|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396320|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396321|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2396322|NCT00693121|Analgesics|analgesics|mesh-ancestor
2522017|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
2522018|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522019|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
2522020|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522021|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2522022|NCT01335646|Analgesics|analgesics|mesh-list
2522023|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
2522024|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522025|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522026|NCT01335685|Prednisone|prednisone|mesh-list
2522027|NCT01335685|Melphalan|melphalan|mesh-list
2522028|NCT01335685|Ixazomib|ixazomib|mesh-list
2522029|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2522030|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
2522031|NCT01335685|Hormones|hormones|mesh-ancestor
2522032|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522033|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396323|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
2396324|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396325|NCT00693199|Amlodipine|amlodipine|mesh-list
2396326|NCT00693199|Prazosin|prazosin|mesh-list
2396327|NCT00693199|Terazosin|terazosin|mesh-list
2396328|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2396329|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2396330|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2396331|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396332|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2396333|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396334|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
2396335|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2396336|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2396337|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2396338|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
2396339|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396340|NCT00693199|Urological Agents|urological agents|mesh-ancestor
2396341|NCT00693212|Methylphenidate|methylphenidate|mesh-list
2396342|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2396343|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396344|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2396345|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2396346|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2396347|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396348|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
2396349|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396350|NCT00693251|Sirolimus|sirolimus|mesh-list
2396351|NCT00693251|Paclitaxel|paclitaxel|mesh-list
2396352|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2396353|NCT00693251|Everolimus|everolimus|mesh-list
2396354|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2396355|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396356|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
2396357|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
2396358|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
2396359|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396360|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522034|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2522035|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522036|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2522037|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
2522038|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522039|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2522040|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522041|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
2522042|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
2522043|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522044|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
2522045|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2522046|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522047|NCT01336010|Ribavirin|ribavirin|mesh-list
2522048|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2522049|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
2522050|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522051|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
2522052|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522053|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
2522054|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2522055|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522056|NCT01336062|Paclitaxel|paclitaxel|mesh-list
2522057|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2522058|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2522059|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396361|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
2522060|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
2522061|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
2522062|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
2522063|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522064|NCT01336166|Vaccines|vaccines|mesh-list
2522065|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
2522066|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522067|NCT01336192|Gemcitabine|gemcitabine|mesh-list
2522068|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2522069|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
2522070|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522071|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522072|NCT01336192|Antiviral Agents|antiviral agents|mesh-ancestor
2522073|NCT01336192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522074|NCT01336192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522075|NCT01336192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522076|NCT01336192|Immunologic Factors|immunologic factors|mesh-ancestor
2522077|NCT01336192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522078|NCT01336218|Rifampin|rifampin|mesh-list
2522079|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2522080|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
2522081|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2522082|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522083|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
2522084|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2522085|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522086|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522087|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2522088|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2522089|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2522090|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2522091|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2522092|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2522093|NCT01336322|Metformin|metformin|mesh-list
2522094|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2522095|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2522096|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522097|NCT01336322|Incretins|incretins|mesh-ancestor
2522098|NCT01336322|Hormones|hormones|mesh-ancestor
2522099|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522100|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2396362|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396363|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2396364|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396365|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2396366|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
2396367|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
2396368|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
2396369|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396370|NCT00693355|Butyric Acid|butyric acid|mesh-list
2396371|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
2396372|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
2396373|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396374|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396375|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396376|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
2396377|NCT00693381|Prednisone|prednisone|mesh-list
2522101|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
2522102|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522103|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522104|NCT01336348|Tirofiban|tirofiban|mesh-list
2522105|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2522106|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2522107|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2522108|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2522109|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522110|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
2396378|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
2396379|NCT00693381|Tacrolimus|tacrolimus|mesh-list
2396380|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396381|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
2396382|NCT00693381|Hormones|hormones|mesh-ancestor
2396383|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522111|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2522112|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2522113|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2522114|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2522115|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396384|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396385|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2396386|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522116|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
2522117|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2522118|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396387|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2396388|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
2396389|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2396390|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522119|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2522120|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522121|NCT01336465|Etrolizumab|etrolizumab|mesh-list
2522122|NCT01336465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2522123|NCT01336465|Immunologic Factors|immunologic factors|mesh-ancestor
2522124|NCT01336465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522125|NCT01336530|Oxethazaine|oxethazaine|mesh-list
2522126|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2522127|NCT01336530|Antacids|antacids|mesh-list
2522128|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
2522129|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2522130|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
2522131|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522132|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522133|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2522134|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
2522135|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
2522136|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2522137|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
2522138|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522139|NCT01336543|Gemcitabine|gemcitabine|mesh-list
2522140|NCT01336543|Cisplatin|cisplatin|mesh-list
2522141|NCT01336543|Etoposide|etoposide|mesh-list
2522142|NCT01336543|Pemetrexed|pemetrexed|mesh-list
2522143|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522144|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2522145|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
2522146|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522147|NCT01336543|Antiviral Agents|antiviral agents|mesh-ancestor
2522148|NCT01336543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522149|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522150|NCT01336543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522151|NCT01336543|Immunologic Factors|immunologic factors|mesh-ancestor
2522152|NCT01336543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522153|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2522154|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2522155|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2522156|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2522157|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2522158|NCT01336582|Docetaxel|docetaxel|mesh-list
2522159|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522160|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
2522161|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
2522162|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
2522163|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522164|NCT01336595|Cobalt|cobalt|mesh-list
2522165|NCT01336595|Triamcinolone|triamcinolone|mesh-list
2522166|NCT01336595|Trace Elements|trace elements|mesh-ancestor
2522167|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
2396391|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396392|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2396393|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2396394|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
2396395|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2396396|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396397|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
2396398|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
2396399|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522168|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522169|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2522170|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
2396400|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2396401|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2396402|NCT00693381|Protective Agents|protective agents|mesh-ancestor
2396403|NCT00693407|Capsaicin|capsaicin|mesh-list
2396404|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
2396405|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
2396406|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
2396407|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396408|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396409|NCT00693433|Sirolimus|sirolimus|mesh-list
2396410|NCT00693433|Dexamethasone|dexamethasone|mesh-list
2116113|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116114|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
2116115|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116116|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
2116117|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116118|NCT02634346|Olanzapine|olanzapine|mesh-list
2116119|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
2116120|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
2116121|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116122|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396411|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396412|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
2396413|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
2396414|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396415|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396416|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2396417|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
2396418|NCT00693433|Hormones|hormones|mesh-ancestor
2396419|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2396420|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2396421|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396422|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2396423|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396424|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2396425|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
2396426|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2396427|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
2396428|NCT00693446|Sirolimus|sirolimus|mesh-list
2396429|NCT00693446|Tacrolimus|tacrolimus|mesh-list
2396430|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2396431|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
2396432|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396433|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2396434|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396435|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396436|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2522171|NCT01336595|Hormones|hormones|mesh-ancestor
2522172|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522173|NCT01336621|Ezogabine|ezogabine|mesh-list
2522174|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
2522175|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2522176|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522177|NCT01336660|Antivenins|antivenins|mesh-list
2522178|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
2522179|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522180|NCT01336686|Colchicine|colchicine|mesh-list
2522181|NCT01336686|Gout Suppressants|gout suppressants|mesh-ancestor
2522182|NCT01336686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2522183|NCT01336686|Tubulin Modulators|tubulin modulators|mesh-ancestor
2522184|NCT01336686|Antimitotic Agents|antimitotic agents|mesh-ancestor
2522185|NCT01336686|Mitosis Modulators|mitosis modulators|mesh-ancestor
2522186|NCT01336686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522187|NCT01336686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522188|NCT01336751|Insulin|insulin|mesh-list
2522189|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2522190|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
2522191|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
2522192|NCT01336751|Protamines|protamines|mesh-list
2522193|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2522194|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522195|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
2522196|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522197|NCT01336751|Coagulants|coagulants|mesh-ancestor
2522198|NCT01336829|Rilpivirine|rilpivirine|mesh-list
2522199|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2396437|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396438|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2396439|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396440|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
2396441|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
2396442|NCT00693524|Prednisone|prednisone|mesh-list
2396443|NCT00693524|Tacrolimus|tacrolimus|mesh-list
2396444|NCT00693524|Daclizumab|daclizumab|mesh-list
2396445|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396446|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
2396447|NCT00693524|Hormones|hormones|mesh-ancestor
2396448|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2396449|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396450|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2396451|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396452|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2396453|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
2396454|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2396455|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522200|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2522201|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522202|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522203|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
2522204|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522205|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2522206|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2396456|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396457|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2396458|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2396459|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
2396460|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2396461|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396462|NCT00693576|Simvastatin|simvastatin|mesh-list
2396463|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2396464|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2396465|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
2396466|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396467|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2396468|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2396469|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396470|NCT00693589|Folic Acid|folic acid|mesh-list
2396471|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
2396472|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
2396473|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2396474|NCT00693589|Vitamins|vitamins|mesh-ancestor
2396475|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
2396476|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396477|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2396478|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2396479|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
2396480|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396481|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2396482|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2522207|NCT01336842|Pemetrexed|pemetrexed|mesh-list
2522208|NCT01336842|Panobinostat|panobinostat|mesh-list
2522209|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522210|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522211|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522212|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2522213|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2522214|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2522215|NCT01336985|Irinotecan|irinotecan|mesh-list
2522216|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2522217|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2522218|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522219|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522220|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522221|NCT01337219|Tobramycin|tobramycin|mesh-list
2396483|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396484|NCT00693589|Hematinics|hematinics|mesh-ancestor
2396485|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
2396486|NCT00693602|Asparaginase|asparaginase|mesh-list
2396487|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396488|NCT00693615|Vaccines|vaccines|mesh-list
2396489|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
2396490|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522222|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2522223|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522224|NCT01337258|Dutasteride|dutasteride|mesh-list
2522225|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2522226|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2522227|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522228|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522229|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
2522230|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522231|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522232|NCT01337323|Fluticasone|fluticasone|mesh-list
2522233|NCT01337323|Xhance|xhance|mesh-list
2522234|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2522235|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2522236|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
2522237|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522238|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522239|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2522240|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
2522241|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
2522242|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2522243|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
2522244|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2522245|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396491|NCT00693680|Imipramine|imipramine|mesh-list
2396492|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2396493|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
2396494|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2396495|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2396496|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2522246|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522247|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2522248|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2522249|NCT01337349|Protective Agents|protective agents|mesh-ancestor
2522250|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522251|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
2522252|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2522253|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
2522254|NCT01337362|Insulin|insulin|mesh-list
2522255|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2522256|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2522257|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522258|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2522259|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
2522260|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
2522261|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522262|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
2522263|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522264|NCT01337401|Cediranib|cediranib|mesh-list
2522265|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522266|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2522267|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522268|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522269|NCT01337427|Interferons|interferons|mesh-list
2522270|NCT01337427|Interferon-beta|interferon-beta|mesh-list
2522271|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
2522272|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396497|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2396498|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396499|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
2396500|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396501|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396502|NCT00693732|Citalopram|citalopram|mesh-list
2396503|NCT00693732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2396504|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2396505|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2396506|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396507|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396508|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
2396509|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396510|NCT00693732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2396511|NCT00693732|Antidepressive Agents|antidepressive agents|mesh-ancestor
2396512|NCT00693732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2522273|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
2522274|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522275|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
2522276|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522277|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2522278|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2522279|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2522280|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2522281|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522282|NCT01337440|Incretins|incretins|mesh-ancestor
2522283|NCT01337440|Hormones|hormones|mesh-ancestor
2522284|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522285|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2522286|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
2396513|NCT00693758|Adenosine|adenosine|mesh-list
2396514|NCT00693758|Analgesics|analgesics|mesh-ancestor
2396515|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
2396516|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396517|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396518|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2396519|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
2522287|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522288|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522289|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2522290|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2522291|NCT01337466|Fialuridine|fialuridine|mesh-list
2522292|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
2522293|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522294|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2522295|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522296|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522297|NCT01337492|Sorafenib|sorafenib|mesh-list
2522298|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522299|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2522300|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522301|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522302|NCT01337518|Androgens|androgens|mesh-list
2522303|NCT01337518|Hormones|hormones|mesh-ancestor
2522304|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522305|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522306|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
2522307|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2522308|NCT01337570|Dapivirine|dapivirine|mesh-list
2522309|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2522310|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2522311|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
2522312|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522313|NCT01337583|Dapivirine|dapivirine|mesh-list
2396520|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2396521|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
2396522|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
2396523|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396524|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396525|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
2396526|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2396527|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396528|NCT00693849|Citalopram|citalopram|mesh-list
2396529|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2396530|NCT00693849|Sertraline|sertraline|mesh-list
2396531|NCT00693849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2396532|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2396533|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2396534|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396535|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396536|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
2396537|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396538|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2396539|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
2396540|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2396541|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2396542|NCT00693862|Levodopa|levodopa|mesh-list
2396543|NCT00693862|Carbidopa|carbidopa|mesh-list
2396544|NCT00693862|Entacapone|entacapone|mesh-list
2396545|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2396546|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2522314|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2522315|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2522316|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
2522317|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522318|NCT01337752|Dexamethasone|dexamethasone|mesh-list
2522319|NCT01337752|Bortezomib|bortezomib|mesh-list
2522320|NCT01337752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2522321|NCT01337752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2522322|NCT01337752|Antiemetics|antiemetics|mesh-ancestor
2522323|NCT01337752|Autonomic Agents|autonomic agents|mesh-ancestor
2522324|NCT01337752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522325|NCT01337752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522326|NCT01337752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2396547|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
2396548|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396549|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396550|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396551|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2396552|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396553|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2396554|NCT00693927|Fludarabine|fludarabine|mesh-list
2396555|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396556|NCT00693966|Vaccines|vaccines|mesh-list
2396557|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
2396558|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522327|NCT01337752|Glucocorticoids|glucocorticoids|mesh-ancestor
2522328|NCT01337752|Hormones|hormones|mesh-ancestor
2522329|NCT01337752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522330|NCT01337752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2522331|NCT01337752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522332|NCT01337752|Immunologic Factors|immunologic factors|mesh-ancestor
2522333|NCT01337765|Dactolisib|dactolisib|mesh-list
2522334|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522335|NCT01337791|Telbivudine|telbivudine|mesh-list
2522336|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
2522337|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522338|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2522339|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522340|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522341|NCT01337804|Omeprazole|omeprazole|mesh-list
2522342|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2522343|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2522344|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2522345|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522346|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522347|NCT01338077|Omeprazole|omeprazole|mesh-list
2522348|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2522349|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2522350|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2522351|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522352|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522353|NCT01338090|Bevacizumab|bevacizumab|mesh-list
2522354|NCT01338090|Everolimus|everolimus|mesh-list
2522355|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
2522356|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2522357|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522358|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2522359|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2522360|NCT01338090|Growth Substances|growth substances|mesh-ancestor
2522361|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522362|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
2522363|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522364|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
2522365|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2522366|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522367|NCT01338103|Rituximab|rituximab|mesh-list
2522368|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2522369|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522370|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
2522371|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522372|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2522373|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2522374|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522375|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
2522376|NCT01338129|Vitamins|vitamins|mesh-ancestor
2522377|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
2522378|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522379|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
2522380|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522381|NCT01338129|Protective Agents|protective agents|mesh-ancestor
2522382|NCT01338311|Albuterol|albuterol|mesh-list
2522383|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2522384|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
2522385|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522386|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522387|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2522388|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
2522389|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
2522390|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2522391|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2522392|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2522393|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2522394|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
2522395|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2522396|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522397|NCT01338324|Simvastatin|simvastatin|mesh-list
2522398|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2522399|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2522400|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
2522401|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522402|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2522403|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2396559|NCT00693979|Paclitaxel|paclitaxel|mesh-list
2396560|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2396561|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522404|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522405|NCT01338337|Azacitidine|azacitidine|mesh-list
2522406|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2522407|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
2522408|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522409|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522410|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522411|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2522412|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
2522413|NCT01338441|Erythromycin|erythromycin|mesh-list
2522414|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
2522415|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2522416|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
2522417|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2522418|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522419|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2522420|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2522421|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522422|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522423|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
2522424|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2522425|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2522426|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522427|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
2522428|NCT01338454|Coagulants|coagulants|mesh-ancestor
2522429|NCT01338558|Bevacizumab|bevacizumab|mesh-list
2522430|NCT01338558|Cetuximab|cetuximab|mesh-list
2522431|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2522432|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522433|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2522434|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2522435|NCT01338558|Growth Substances|growth substances|mesh-ancestor
2522436|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522437|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
2522438|NCT01338675|Busulfan|busulfan|mesh-list
2522439|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
2396562|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
2396563|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
2396564|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
2396565|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396566|NCT00694005|Sirolimus|sirolimus|mesh-list
2396567|NCT00694005|Paclitaxel|paclitaxel|mesh-list
2396568|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2396569|NCT00694005|Everolimus|everolimus|mesh-list
2396570|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2396571|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396572|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
2396573|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
2396574|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
2396575|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396576|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2396577|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
2396578|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396579|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2396580|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396581|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2396582|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
2396583|NCT00694044|Varenicline|varenicline|mesh-list
2396584|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2396585|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2522440|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522441|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522442|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
2522443|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522444|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2522445|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522446|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2522447|NCT01338740|Adalimumab|adalimumab|mesh-list
2522448|NCT01338740|Infliximab|infliximab|mesh-list
2522449|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2522450|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2522451|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
2522452|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2522453|NCT01338753|Bevacizumab|bevacizumab|mesh-list
2522454|NCT01338753|Docetaxel|docetaxel|mesh-list
2522455|NCT01338753|Doxorubicin|doxorubicin|mesh-list
2522456|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2522457|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522458|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2522459|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2522460|NCT01338753|Growth Substances|growth substances|mesh-ancestor
2522461|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522462|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
2522463|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
2522464|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
2522465|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
2522466|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396586|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
2396587|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396588|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396589|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396590|NCT00694135|Dexamethasone|dexamethasone|mesh-list
2396591|NCT00694135|Dexamethasone acetate|dexamethasone acetate|mesh-list
2396592|NCT00694135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2396593|NCT00694135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2396594|NCT00694135|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2396595|NCT00694135|BB 1101|bb 1101|mesh-list
2396596|NCT00694135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396597|NCT00694135|Antiemetics|antiemetics|mesh-ancestor
2396598|NCT00694135|Autonomic Agents|autonomic agents|mesh-ancestor
2396599|NCT00694135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396600|NCT00694135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396601|NCT00694135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2396602|NCT00694135|Glucocorticoids|glucocorticoids|mesh-ancestor
2396603|NCT00694135|Hormones|hormones|mesh-ancestor
2396604|NCT00694135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2396605|NCT00694135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2522467|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2522468|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2522469|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2522470|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522471|NCT01338844|Inositol|inositol|mesh-list
2522472|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
2522473|NCT01338844|Vitamins|vitamins|mesh-ancestor
2522474|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
2522475|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522476|NCT01338883|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2522477|NCT01338883|Efavirenz|efavirenz|mesh-list
2522478|NCT01338883|Cenicriviroc|cenicriviroc|mesh-list
2522479|NCT01338883|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2396606|NCT00694135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522480|NCT01338883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2396607|NCT00694135|Protease Inhibitors|protease inhibitors|mesh-ancestor
2396608|NCT00694135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396609|NCT00694135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522481|NCT01338883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522482|NCT01338883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522483|NCT01338883|Antiviral Agents|antiviral agents|mesh-ancestor
2522484|NCT01338883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522485|NCT01338883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2522486|NCT01338883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2522487|NCT01338883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2522488|NCT01338883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2522489|NCT01338883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2522490|NCT01338883|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2522491|NCT01338883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2522492|NCT01338883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2522493|NCT01338883|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2522494|NCT01338896|Rotigotine|rotigotine|mesh-list
2522495|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
2522496|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
2522497|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2522498|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522499|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522500|NCT01338909|Clopidogrel|clopidogrel|mesh-list
2522501|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2522502|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2522503|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2522504|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2522505|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2522506|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
2522507|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396610|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2396611|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2396612|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396613|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396614|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2396615|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2396616|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396617|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
2396618|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396619|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2396620|NCT00694187|Zaleplon|zaleplon|mesh-list
2396621|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
2396622|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2396623|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2396624|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396625|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
2396626|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
2396627|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396628|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396629|NCT00694200|Bevacizumab|bevacizumab|mesh-list
2396630|NCT00694200|Vinorelbine|vinorelbine|mesh-list
2396631|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2396632|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396633|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2396634|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2396635|NCT00694200|Growth Substances|growth substances|mesh-ancestor
2396636|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396637|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
2396638|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2522508|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522509|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522510|NCT01338922|Insulin|insulin|mesh-list
2522511|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2522512|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522513|NCT01339026|Clopidogrel|clopidogrel|mesh-list
2396639|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
2396640|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
2396641|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
2396642|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396643|NCT00694252|Lapatinib|lapatinib|mesh-list
2396644|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396645|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2522514|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2522515|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2522516|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2522517|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2522518|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2522519|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
2522520|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2522521|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522522|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396646|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396647|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396648|NCT00694291|Sorafenib|sorafenib|mesh-list
2396649|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396650|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2396651|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522523|NCT01339039|Plerixafor|plerixafor|mesh-list
2522524|NCT01339039|Bevacizumab|bevacizumab|mesh-list
2522525|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2522526|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522527|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2522528|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2522529|NCT01339039|Growth Substances|growth substances|mesh-ancestor
2522530|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522531|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
2522532|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2522533|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2522534|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
2522535|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522536|NCT01339065|Ketamine|ketamine|mesh-list
2522537|NCT01339065|Analgesics|analgesics|mesh-ancestor
2522538|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
2522539|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522540|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522541|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2522542|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2522543|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
2522544|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
2522545|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2522546|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2522547|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2522548|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2522549|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522550|NCT01339143|Pioglitazone|pioglitazone|mesh-list
2522551|NCT01339143|Vildagliptin|vildagliptin|mesh-list
2522552|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2522553|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522554|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2522555|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
2522556|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522557|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522558|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2522559|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2522560|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2522561|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2522562|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396652|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396653|NCT00694317|Zaleplon|zaleplon|mesh-list
2396654|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
2396655|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2396656|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2396657|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396658|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
2396659|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
2396660|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396661|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396662|NCT00694330|Vaccines|vaccines|mesh-list
2396663|NCT00694330|Immunologic Factors|immunologic factors|mesh-ancestor
2396664|NCT00694330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522563|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
2522564|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2522565|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522566|NCT01339312|Vaccines|vaccines|mesh-list
2522567|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
2522568|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522569|NCT01339442|Fulvestrant|fulvestrant|mesh-list
2396665|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2396666|NCT00694382|Semuloparin|semuloparin|mesh-list
2396667|NCT00694382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2396668|NCT00694382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2396669|NCT00694382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2396670|NCT00694382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396671|NCT00694382|Anticoagulants|anticoagulants|mesh-ancestor
2396672|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
2396673|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2396674|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2522570|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2522571|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522572|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2396675|NCT00694408|Prednisolone|prednisolone|mesh-list
2396676|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
2396677|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
2396678|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2396679|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2396680|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2396681|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2396682|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
2396683|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396684|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
2396685|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
2396686|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396687|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396688|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2396689|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
2396690|NCT00694408|Hormones|hormones|mesh-ancestor
2396691|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2396692|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2396693|NCT00694408|Protective Agents|protective agents|mesh-ancestor
2522573|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2522574|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
2522575|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522576|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522577|NCT01339468|Tacrolimus|tacrolimus|mesh-list
2522578|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522579|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
2522580|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522581|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2522582|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522583|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522584|NCT01339481|Abatacept|abatacept|mesh-list
2522585|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2522586|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522587|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522588|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522589|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
2522590|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522591|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2522592|NCT01339572|Plerixafor|plerixafor|mesh-list
2522593|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2522594|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2522595|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
2522596|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522597|NCT01339624|Ketorolac|ketorolac|mesh-list
2522598|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2522599|NCT01339624|Fentanyl|fentanyl|mesh-list
2522600|NCT01339624|Morphine|morphine|mesh-list
2522601|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2522602|NCT01339624|Narcotics|narcotics|mesh-ancestor
2522603|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2522604|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522605|NCT01339624|Analgesics|analgesics|mesh-ancestor
2522606|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
2522607|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522608|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2522609|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2522610|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
2522611|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
2522612|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2522613|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2522614|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396694|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2396695|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396696|NCT00694460|Vaccines|vaccines|mesh-list
2396697|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
2396698|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396699|NCT00694590|Plerixafor|plerixafor|mesh-list
2396700|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2522615|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2522616|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2522617|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396701|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2396702|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
2396703|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396704|NCT00694629|Rifampin|rifampin|mesh-list
2396705|NCT00694629|Rifapentine|rifapentine|mesh-list
2396706|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2396707|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
2396708|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2396709|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396710|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
2396711|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2396712|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396713|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396714|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2396715|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2396716|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2396717|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2396718|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2396719|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2396720|NCT00694694|Azithromycin|azithromycin|mesh-list
2396721|NCT00694694|Artesunate|artesunate|mesh-list
2396722|NCT00694694|Lumefantrine|lumefantrine|mesh-list
2396723|NCT00694694|Artemether|artemether|mesh-list
2396724|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2396725|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2396726|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396727|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
2396728|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2396729|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2396730|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396731|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
2396732|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
2396733|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2396734|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
2522618|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522619|NCT01339663|Aldesleukin|aldesleukin|mesh-list
2522620|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
2522621|NCT01339663|Interleukin-2|interleukin-2|mesh-list
2522622|NCT01339663|Vaccines|vaccines|mesh-list
2522623|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
2522624|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522625|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522626|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2522627|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2522628|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
2522629|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522630|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522631|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2522632|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2522633|NCT01339663|Analgesics|analgesics|mesh-ancestor
2522634|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
2522635|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522636|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2522637|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2396735|NCT00694733|Anastrozole|anastrozole|mesh-list
2396736|NCT00694733|Leuprolide|leuprolide|mesh-list
2396737|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
2396738|NCT00694733|Estradiol|estradiol|mesh-list
2396739|NCT00694733|Estrogens|estrogens|mesh-list
2396740|NCT00694733|Testosterone|testosterone|mesh-list
2522638|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
2522639|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522640|NCT01339676|Vitamin D|vitamin d|mesh-list
2522641|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
2522642|NCT01339676|Vitamins|vitamins|mesh-ancestor
2522643|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
2522644|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396741|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
2396742|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
2522645|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2522646|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2522647|NCT01339689|Ganaxolone|ganaxolone|mesh-list
2522648|NCT01339689|Neurosteroids|neurosteroids|mesh-ancestor
2522649|NCT01339689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2522650|NCT01339689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522651|NCT01339689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522652|NCT01339689|GABA Modulators|gaba modulators|mesh-ancestor
2522653|NCT01339689|GABA Agents|gaba agents|mesh-ancestor
2522654|NCT01339741|Vitamin D|vitamin d|mesh-list
2522655|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
2522656|NCT01339741|Vitamins|vitamins|mesh-ancestor
2522657|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
2522658|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522659|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2522660|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2522661|NCT01339754|Trabectedin|trabectedin|mesh-list
2522662|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2522663|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
2522664|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522665|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522666|NCT01339819|Dabigatran|dabigatran|mesh-list
2522667|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
2522668|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
2522669|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2522670|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
2522671|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522672|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522673|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
2522674|NCT01339871|Vorinostat|vorinostat|mesh-list
2522675|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522676|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2522677|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522678|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396743|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2396744|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2396745|NCT00694733|Hormones|hormones|mesh-ancestor
2396746|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2396747|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396748|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2396749|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2396750|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396751|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2396752|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396753|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396754|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2396755|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
2396756|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2396757|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
2396758|NCT00694733|Androgens|androgens|mesh-ancestor
2396759|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
2396760|NCT00694759|Metformin|metformin|mesh-list
2396761|NCT00694759|Pioglitazone|pioglitazone|mesh-list
2522679|NCT01339884|Resveratrol|resveratrol|mesh-list
2522680|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
2522681|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522682|NCT01339884|Protective Agents|protective agents|mesh-ancestor
2522683|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522684|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396762|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2396763|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396764|NCT00694837|Nelfinavir|nelfinavir|mesh-list
2396765|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2396766|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2522685|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2522686|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
2396767|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
2396768|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522687|NCT01339988|Busulfan|busulfan|mesh-list
2522688|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522689|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
2522690|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522691|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2522692|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2522693|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
2522694|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522695|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522696|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2522697|NCT01340118|Budesonide|budesonide|mesh-list
2522698|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2522699|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2522700|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
2522701|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522702|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522703|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2396769|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396770|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2396771|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2396772|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
2396773|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396777|NCT00694863|Cosyntropin|cosyntropin|mesh-list
2396778|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
2396779|NCT00694863|Hormones|hormones|mesh-ancestor
2396780|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2396781|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396782|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
2396783|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2396784|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
2396785|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396786|NCT00694928|Clindamycin|clindamycin|mesh-list
2396787|NCT00694928|Clindamycin palmitate|clindamycin palmitate|mesh-list
2396788|NCT00694928|Clindamycin phosphate|clindamycin phosphate|mesh-list
2396789|NCT00694928|Butoconazole|butoconazole|mesh-list
2396790|NCT00694928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2396791|NCT00694928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396792|NCT00694928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2396793|NCT00694928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396794|NCT00694928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396795|NCT00694928|Antifungal Agents|antifungal agents|mesh-ancestor
2396796|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2396797|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2396798|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2396799|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
2396800|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2396801|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396802|NCT00694967|Progestins|progestins|mesh-ancestor
2396803|NCT00694967|Hormones|hormones|mesh-ancestor
2396804|NCT00694980|Etrolizumab|etrolizumab|mesh-list
2396805|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2396806|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
2396807|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396808|NCT00695032|Ifosfamide|ifosfamide|mesh-list
2396809|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396810|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2396811|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
2396812|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396813|NCT00695045|Morphine|morphine|mesh-list
2396814|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2396815|NCT00695045|Narcotics|narcotics|mesh-ancestor
2396816|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2522704|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
2522705|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
2522706|NCT01340118|Hormones|hormones|mesh-ancestor
2522707|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522708|NCT01340235|Erythromycin|erythromycin|mesh-list
2522709|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
2522710|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2522711|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
2522712|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2522713|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522714|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2522715|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2522716|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668544|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2396817|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396818|NCT00695045|Analgesics|analgesics|mesh-ancestor
2396819|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
2522717|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522718|NCT01340248|Carvedilol|carvedilol|mesh-list
2522719|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2522720|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2522721|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
2522722|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2522723|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396820|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396821|NCT00695071|Itraconazole|itraconazole|mesh-list
2396822|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
2396823|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396824|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2396825|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2396826|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396827|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522724|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522725|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2522726|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
2522727|NCT01340248|Protective Agents|protective agents|mesh-ancestor
2522728|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2522729|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2522730|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2522731|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
2522732|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2522733|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2522734|NCT01340326|Valsartan|valsartan|mesh-list
2522735|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2522736|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2522737|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2522738|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522739|NCT01340417|Melatonin|melatonin|mesh-list
2396828|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2396829|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
2396830|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2396831|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396832|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2396833|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
2522740|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
2522741|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522742|NCT01340417|Protective Agents|protective agents|mesh-ancestor
2522743|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522744|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2522745|NCT01340430|Trastuzumab|trastuzumab|mesh-list
2522746|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2522747|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396834|NCT00695201|Irinotecan|irinotecan|mesh-list
2396835|NCT00695201|Floxuridine|floxuridine|mesh-list
2396836|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396837|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2396838|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2396839|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396840|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396841|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2396842|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
2396843|NCT00695214|Propofol|propofol|mesh-list
2522748|NCT01340456|Rifampin|rifampin|mesh-list
2522749|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2522750|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
2522751|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2522752|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522753|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
2522754|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2522755|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522756|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522757|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2522758|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2522759|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2522760|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2522761|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2522762|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2522763|NCT01340521|Clomiphene|clomiphene|mesh-list
2396844|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2396845|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2396846|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396847|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2396848|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
2396849|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
2396850|NCT00695240|Bupivacaine|bupivacaine|mesh-list
2396851|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
2396852|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
2396853|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2396854|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396855|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
2396856|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396860|NCT00695331|Misoprostol|misoprostol|mesh-list
2396861|NCT00695331|Oxytocin|oxytocin|mesh-list
2396862|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
2396863|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2522764|NCT01340521|Enclomiphene|enclomiphene|mesh-list
2522765|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
2522766|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2522767|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
2522768|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522769|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522770|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2522771|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
2522772|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2522773|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2522774|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2522775|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
2522776|NCT01340547|Ifosfamide|ifosfamide|mesh-list
2396864|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396865|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2396866|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
2396867|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2396868|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2396869|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
2396870|NCT00695344|Everolimus|everolimus|mesh-list
2396871|NCT00695344|Azathioprine|azathioprine|mesh-list
2396872|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396873|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2396874|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
2396875|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396876|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2396877|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2396878|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
2396879|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2396880|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396881|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396882|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396883|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
2396884|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2396885|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2522777|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2522778|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
2522779|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522780|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522781|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2396886|NCT00695604|Fluticasone|fluticasone|mesh-list
2396887|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396888|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2396889|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
2396890|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396891|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396892|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2396893|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
2522782|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
2522783|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522784|NCT01340599|Protective Agents|protective agents|mesh-ancestor
2522785|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522786|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2396894|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
2396895|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2522787|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2522788|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522789|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2522790|NCT01340677|Canagliflozin|canagliflozin|mesh-list
2522791|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2522792|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522793|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2522794|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522795|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
2522796|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2522797|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
2522798|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522799|NCT01340833|Dabrafenib|dabrafenib|mesh-list
2522800|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522801|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2522802|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522803|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522804|NCT01340846|Ketoconazole|ketoconazole|mesh-list
2522805|NCT01340846|Dabrafenib|dabrafenib|mesh-list
2522806|NCT01340846|Warfarin|warfarin|mesh-list
2522807|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
2522808|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
2522809|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
2522810|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522811|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2522812|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2522813|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522814|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522815|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2522816|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
2522817|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522818|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522819|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2522820|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522821|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2522822|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2522823|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
2522824|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2522825|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2522826|NCT01340950|Tenofovir|tenofovir|mesh-list
2522827|NCT01340950|Lamivudine|lamivudine|mesh-list
2522828|NCT01340950|Zidovudine|zidovudine|mesh-list
2522829|NCT01340950|Efavirenz|efavirenz|mesh-list
2522830|NCT01340950|Nevirapine|nevirapine|mesh-list
2522831|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2522832|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
2522833|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522834|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2522835|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2522836|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522837|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522838|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2522839|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2522840|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
2522841|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2522842|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2522843|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2522844|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2522845|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2522846|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2522847|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
2522848|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
2522849|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
2522850|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522851|NCT01341080|Varenicline|varenicline|mesh-list
2522852|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2522853|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2396896|NCT00695630|Flumazenil|flumazenil|mesh-list
2396897|NCT00695630|Antidotes|antidotes|mesh-ancestor
2396898|NCT00695630|Protective Agents|protective agents|mesh-ancestor
2396899|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396900|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
2396901|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
2396902|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2522854|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
2668545|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522855|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2522856|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522857|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522858|NCT01341106|Entecavir|entecavir|mesh-list
2522859|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
2522860|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522861|NCT01341158|Interferons|interferons|mesh-list
2522862|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396903|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396904|NCT00695643|Mesalamine|mesalamine|mesh-list
2396905|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2396906|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2396907|NCT00695643|Analgesics|analgesics|mesh-ancestor
2396908|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
2396909|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396910|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396911|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396912|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2396913|NCT00695682|Infliximab|infliximab|mesh-list
2396914|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
2396915|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2396916|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2396917|NCT00695929|Simendan|simendan|mesh-list
2396918|NCT00695929|Milrinone|milrinone|mesh-list
2396919|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2396920|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
2522863|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
2522864|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522865|NCT01341184|Rifampin|rifampin|mesh-list
2522866|NCT01341184|Rifabutin|rifabutin|mesh-list
2522867|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2522868|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
2522869|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2522870|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522871|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
2522872|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2522873|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522874|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522875|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2522876|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2522877|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2522878|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2522879|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2522880|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2522881|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
2522882|NCT01341262|Thalidomide|thalidomide|mesh-list
2522883|NCT01341262|Dexamethasone|dexamethasone|mesh-list
2522884|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
2522885|NCT01341262|Melphalan|melphalan|mesh-list
2522886|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522887|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
2522888|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522889|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2396921|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2396922|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2396923|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396924|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396925|NCT00695929|Protective Agents|protective agents|mesh-ancestor
2522890|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2522891|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
2522892|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522893|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522894|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2522895|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396926|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396927|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2396928|NCT00695994|Gemcitabine|gemcitabine|mesh-list
2396929|NCT00695994|Carboplatin|carboplatin|mesh-list
2396930|NCT00695994|Docetaxel|docetaxel|mesh-list
2396931|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522896|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
2522897|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
2522898|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522899|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2522900|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
2522901|NCT01341262|Hormones|hormones|mesh-ancestor
2522902|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522903|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2522904|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
2522905|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2522906|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522907|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2522908|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2522909|NCT01341262|Growth Substances|growth substances|mesh-ancestor
2522910|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
2396932|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2396933|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
2396934|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396935|NCT00695994|Antiviral Agents|antiviral agents|mesh-ancestor
2396936|NCT00695994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396937|NCT00695994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396938|NCT00695994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2116123|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2116124|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2116125|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2116126|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116127|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2522911|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2522912|NCT01341275|Vaccines|vaccines|mesh-list
2522913|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
2522914|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522915|NCT01341340|Everolimus|everolimus|mesh-list
2522916|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522917|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522918|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
2396939|NCT00695994|Immunologic Factors|immunologic factors|mesh-ancestor
2396940|NCT00695994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396941|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
2396942|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
2396943|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
2396944|NCT00696007|Gemcitabine|gemcitabine|mesh-list
2396945|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396946|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2396947|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
2396948|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396949|NCT00696007|Antiviral Agents|antiviral agents|mesh-ancestor
2396950|NCT00696007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2396951|NCT00696007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2396952|NCT00696007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2396953|NCT00696007|Immunologic Factors|immunologic factors|mesh-ancestor
2396954|NCT00696007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522919|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522920|NCT01341353|Amiodarone|amiodarone|mesh-list
2522921|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
2522922|NCT01341353|Calcium|calcium|mesh-list
2396955|NCT00696033|Diazepam|diazepam|mesh-list
2396956|NCT00696033|Lorazepam|lorazepam|mesh-list
2396957|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
2396958|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
2396959|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
2396960|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2396961|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396962|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2396963|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2396964|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2396965|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2396966|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2396967|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2396968|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
2396969|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
2396970|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396971|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396972|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2116128|NCT02634346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2116129|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2116130|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2116131|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116132|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116133|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
2116134|NCT02634580|Ezetimibe|ezetimibe|mesh-list
2116135|NCT02634580|Evolocumab|evolocumab|mesh-list
2116136|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2522923|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2522924|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522925|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2522926|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
2522927|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2522928|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2522929|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522930|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2522931|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2522932|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2522933|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522934|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2522935|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2522936|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2522937|NCT01341392|Amlodipine|amlodipine|mesh-list
2522938|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2522939|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2522940|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2522941|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522942|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2522943|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522944|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
2522945|NCT01341405|Celecoxib|celecoxib|mesh-list
2522946|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2522947|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2522948|NCT01341405|Analgesics|analgesics|mesh-ancestor
2522949|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
2522950|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522951|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522952|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2522953|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2522954|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2396973|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2396974|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2396975|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2396976|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
2396977|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
2396978|NCT00696059|Adalimumab|adalimumab|mesh-list
2396979|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2396980|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2396981|NCT00696098|Butyric Acid|butyric acid|mesh-list
2396982|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
2396983|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
2522955|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2522956|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522957|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522958|NCT01341496|Celecoxib|celecoxib|mesh-list
2522959|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
2522960|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522961|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
2522962|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522963|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2522964|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2522965|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
2522966|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522967|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2522968|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2522969|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2396984|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2396985|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2396986|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396987|NCT00696111|Leuprolide|leuprolide|mesh-list
2396988|NCT00696111|Progesterone|progesterone|mesh-list
2396989|NCT00696111|Estrogens|estrogens|mesh-list
2396990|NCT00696111|Progestins|progestins|mesh-ancestor
2396991|NCT00696111|Hormones|hormones|mesh-ancestor
2396992|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2396993|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2396994|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2396995|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
2396996|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2396997|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2522970|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2522971|NCT01341496|Analgesics|analgesics|mesh-ancestor
2522972|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
2522973|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2522974|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2522975|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2522976|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2522977|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522978|NCT01341717|Metformin|metformin|mesh-list
2522979|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2522980|NCT01341717|Glimepiride|glimepiride|mesh-list
2522981|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2522982|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2522983|NCT01341717|Incretins|incretins|mesh-ancestor
2522984|NCT01341717|Hormones|hormones|mesh-ancestor
2522985|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2522986|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2396998|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2396999|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
2397000|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
2397001|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2397002|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397003|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397004|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
2397005|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2397006|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
2397007|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2397008|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397009|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2522987|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
2522988|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2522989|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2522990|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2522991|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2522992|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
2522993|NCT01341743|Entecavir|entecavir|mesh-list
2522994|NCT01341743|Adefovir|adefovir|mesh-list
2522995|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2522996|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
2522997|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2522998|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2522999|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2523000|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523001|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523002|NCT01341834|Everolimus|everolimus|mesh-list
2523003|NCT01341834|Panobinostat|panobinostat|mesh-list
2523004|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523005|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2523006|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
2523007|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523008|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2523009|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523010|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523011|NCT01341886|Metformin|metformin|mesh-list
2523012|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2523013|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523014|NCT01341938|Nicotine|nicotine|mesh-list
2523015|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2523016|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
2523017|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523018|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523019|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2523020|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2523021|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
2397010|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2397011|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2397012|NCT00696215|Rasagiline|rasagiline|mesh-list
2397013|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2397014|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397015|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397016|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2397017|NCT00696215|Protective Agents|protective agents|mesh-ancestor
2523022|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523023|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523024|NCT01341951|Sargramostim|sargramostim|mesh-list
2523025|NCT01341951|Lenograstim|lenograstim|mesh-list
2523026|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
2523027|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523028|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2523029|NCT01341964|Aspirin|aspirin|mesh-list
2523030|NCT01341964|Clopidogrel|clopidogrel|mesh-list
2397018|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397019|NCT00696332|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid|mesh-list
2397020|NCT00696332|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2397021|NCT00696332|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2397022|NCT00696332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397023|NCT00696332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397024|NCT00696332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397025|NCT00696475|Diazoxide|diazoxide|mesh-list
2397026|NCT00696475|Choline|choline|mesh-list
2397027|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
2397028|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2397029|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
2397030|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397031|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2397032|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2397033|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
2397034|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2397035|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
2397036|NCT00696514|Vitamin D|vitamin d|mesh-list
2397037|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
2397038|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
2397039|NCT00696514|Vitamins|vitamins|mesh-list
2397040|NCT00696514|Folic Acid|folic acid|mesh-list
2397041|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
2397042|NCT00696514|Hydroxocobalamin|hydroxocobalamin|mesh-list
2397043|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
2397044|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397045|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2397046|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2397047|NCT00696514|Hematinics|hematinics|mesh-ancestor
2397048|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
2397049|NCT00696540|Albuterol|albuterol|mesh-list
2397050|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2397051|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
2523031|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2523032|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2523033|NCT01341964|Analgesics|analgesics|mesh-ancestor
2523034|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
2523035|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523036|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523037|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523038|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523039|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2523040|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2523041|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523042|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2523043|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2523044|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523045|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
2523046|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2397052|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397053|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397054|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2523047|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2523048|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2523049|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
2523050|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523051|NCT01342016|Prednisone|prednisone|mesh-list
2523052|NCT01342016|Tacrolimus|tacrolimus|mesh-list
2523053|NCT01342016|Leflunomide|leflunomide|mesh-list
2397055|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
2397056|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
2397057|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2397058|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2397059|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2397060|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2397061|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
2397062|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397063|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523054|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2397064|NCT00696566|Rifampin|rifampin|mesh-list
2523055|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
2523056|NCT01342016|Hormones|hormones|mesh-ancestor
2523057|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2523058|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523059|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2523060|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523061|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2523062|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
2523063|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2523064|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523065|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523066|NCT01342146|Hormones|hormones|mesh-list
2523067|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2523068|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523069|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
2523070|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523071|NCT01342198|Erythromycin|erythromycin|mesh-list
2523072|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
2523073|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2523074|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
2523075|NCT01342198|Pregabalin|pregabalin|mesh-list
2523076|NCT01342198|Analgesics|analgesics|mesh-ancestor
2523077|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
2523078|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523079|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523080|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
2523081|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2523082|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2523083|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523084|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2523085|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2523086|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2523087|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523088|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2523089|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2523090|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523091|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2523092|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2397065|NCT00696566|Clopidogrel|clopidogrel|mesh-list
2397066|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2397067|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2397068|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2397069|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2397070|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
2397071|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397072|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397073|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397074|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2397075|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
2397076|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2397077|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2397078|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
2397079|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2397080|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397081|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2397082|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2397083|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2397084|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2397085|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2397086|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2397087|NCT00696579|Gemcitabine|gemcitabine|mesh-list
2523093|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523094|NCT01342224|Gemcitabine|gemcitabine|mesh-list
2523095|NCT01342224|Tadalafil|tadalafil|mesh-list
2523096|NCT01342224|Sargramostim|sargramostim|mesh-list
2523097|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
2523098|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523099|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2523100|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
2523101|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397088|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2523102|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523103|NCT01342224|Antiviral Agents|antiviral agents|mesh-ancestor
2523104|NCT01342224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523105|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523106|NCT01342224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2397089|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
2397090|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397091|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397092|NCT00696579|Antiviral Agents|antiviral agents|mesh-ancestor
2397093|NCT00696579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2397094|NCT00696579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397095|NCT00696579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2397096|NCT00696579|Immunologic Factors|immunologic factors|mesh-ancestor
2397097|NCT00696579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397098|NCT00696592|Bevacizumab|bevacizumab|mesh-list
2397099|NCT00696592|Verteporfin|verteporfin|mesh-list
2397100|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2397101|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397102|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2397103|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2397104|NCT00696592|Growth Substances|growth substances|mesh-ancestor
2397105|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397106|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
2397107|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2397108|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
2397109|NCT00696631|Dronedarone|dronedarone|mesh-list
2397110|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2397111|NCT00696644|Teriparatide|teriparatide|mesh-list
2397112|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2397113|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397114|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2397115|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2397116|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2397117|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2397118|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
2397119|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397120|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397121|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2397122|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2397123|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
2397124|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2397125|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
2397126|NCT00696748|Testosterone|testosterone|mesh-list
2397127|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
2397128|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
2397129|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2397130|NCT00696748|Androgens|androgens|mesh-ancestor
2397131|NCT00696748|Hormones|hormones|mesh-ancestor
2397132|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2397133|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397134|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2397135|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397136|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
2523107|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
2523108|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2523109|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2523110|NCT01342224|Urological Agents|urological agents|mesh-ancestor
2523111|NCT01342237|Carboplatin|carboplatin|mesh-list
2523112|NCT01342237|Etoposide|etoposide|mesh-list
2523113|NCT01342237|Melphalan|melphalan|mesh-list
2523114|NCT01342237|Topotecan|topotecan|mesh-list
2523115|NCT01342237|Thiotepa|thiotepa|mesh-list
2523116|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523117|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2523118|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2523119|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2523120|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523121|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523122|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2523123|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
2523124|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2523125|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2523126|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
2523127|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523128|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2523129|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
2523130|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
2523131|NCT01342289|Fludarabine|fludarabine|mesh-list
2523132|NCT01342289|Tacrolimus|tacrolimus|mesh-list
2523133|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2523134|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
2523135|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523136|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523137|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2523138|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
2523139|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523140|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523141|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2523142|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2523143|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523144|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2523145|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2523146|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
2523147|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2523148|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523149|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
2523150|NCT01342328|Propofol|propofol|mesh-list
2523151|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2523152|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523153|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523154|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2523155|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
2523156|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
2523157|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2523158|NCT01342328|Analgesics|analgesics|mesh-ancestor
2523159|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
2523160|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523161|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2523162|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2523163|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2523164|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
2523165|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523166|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523167|NCT01342562|Anesthetics|anesthetics|mesh-list
2523168|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523169|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523170|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2523171|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2523172|NCT01342614|Metformin|metformin|mesh-list
2523173|NCT01342614|Fosinopril|fosinopril|mesh-list
2523174|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2523175|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523176|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2523177|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
2523178|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523179|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523180|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2523181|NCT01342627|Sorafenib|sorafenib|mesh-list
2523182|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523183|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2523184|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523185|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523186|NCT01342679|Dasatinib|dasatinib|mesh-list
2523187|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523188|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2523189|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397137|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2397138|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397139|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397140|NCT00696826|Incretins|incretins|mesh-ancestor
2397141|NCT00696826|Hormones|hormones|mesh-ancestor
2397142|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2397143|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2397144|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
2397145|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397146|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397147|NCT00696930|Edotreotide|edotreotide|mesh-list
2397148|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2397149|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397150|NCT00696956|Paclitaxel|paclitaxel|mesh-list
2523190|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523191|NCT01342692|Lenalidomide|lenalidomide|mesh-list
2523192|NCT01342692|Azacitidine|azacitidine|mesh-list
2523193|NCT01342692|Idarubicin|idarubicin|mesh-list
2523194|NCT01342692|Valproic Acid|valproic acid|mesh-list
2523195|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
2523196|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523197|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2523198|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2523199|NCT01342692|Growth Substances|growth substances|mesh-ancestor
2523200|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
2523201|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523202|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2523203|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
2523204|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523205|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523206|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
2523207|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
2523208|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523209|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
2523210|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2523211|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523212|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2523213|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2523214|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2523215|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2523216|NCT01342731|Tigecycline|tigecycline|mesh-list
2523217|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2523218|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523219|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2523220|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523221|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523222|NCT01342744|Metformin|metformin|mesh-list
2523223|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2523224|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523225|NCT01342835|Propofol|propofol|mesh-list
2523226|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2523227|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523228|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523229|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2523230|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
2523231|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
2523232|NCT01342874|Inositol|inositol|mesh-list
2523233|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
2523234|NCT01342874|Vitamins|vitamins|mesh-ancestor
2523235|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
2523236|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523237|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2523238|NCT01342939|Incretins|incretins|mesh-list
2523239|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397151|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2397152|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397153|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
2397154|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
2397155|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
2397156|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397157|NCT00696969|Amphotericin B|amphotericin b|mesh-list
2397158|NCT00696969|Paromomycin|paromomycin|mesh-list
2397159|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2397160|NCT00696969|Miltefosine|miltefosine|mesh-list
2397161|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
2397162|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
2523240|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523241|NCT01342939|Hormones|hormones|mesh-ancestor
2523242|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2523243|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2523244|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
2523245|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523246|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523247|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
2523248|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523249|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2523250|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523251|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523252|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2397163|NCT00696969|Amebicides|amebicides|mesh-ancestor
2523253|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
2523254|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
2523255|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523256|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
2523257|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523258|NCT01343225|Ritonavir|ritonavir|mesh-list
2523259|NCT01343225|Darunavir|darunavir|mesh-list
2523260|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
2523261|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2523262|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2523263|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2397164|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2397165|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2397166|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523264|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
2523265|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523266|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397167|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2397168|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
2397169|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397170|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2397171|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2397172|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2397173|NCT00696982|Glyburide|glyburide|mesh-list
2397174|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397175|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397176|NCT00696982|Incretins|incretins|mesh-ancestor
2397177|NCT00696982|Hormones|hormones|mesh-ancestor
2397178|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2397179|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2397180|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
2397181|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397182|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397183|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
2397184|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
2397185|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2397186|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397187|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397188|NCT00697021|Aspirin|aspirin|mesh-list
2397189|NCT00697021|Clopidogrel|clopidogrel|mesh-list
2397190|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2397191|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2397192|NCT00697021|Analgesics|analgesics|mesh-ancestor
2397193|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
2397194|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397195|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397196|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2397197|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2397198|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2397199|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2523267|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2523268|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2523269|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
2523270|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523271|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2523272|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2523273|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2523274|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2523275|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2523276|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2523277|NCT01343290|Canagliflozin|canagliflozin|mesh-list
2523278|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2523279|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523280|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2523281|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523282|NCT01343303|Naproxen|naproxen|mesh-list
2523283|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2523284|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2523285|NCT01343303|Analgesics|analgesics|mesh-ancestor
2523286|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
2523287|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523288|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523289|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523290|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523291|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
2523292|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2523293|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523294|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523295|NCT01343329|Propranolol|propranolol|mesh-list
2523296|NCT01343329|Esmolol|esmolol|mesh-list
2523297|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2523298|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2397200|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397201|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2397202|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2397203|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523299|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
2523300|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523301|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523302|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523303|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2397204|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
2397205|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2397206|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2397207|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2397208|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
2397209|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397210|NCT00697034|Capsaicin|capsaicin|mesh-list
2397211|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
2397212|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
2397213|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
2397214|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397215|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397216|NCT00697060|Docetaxel|docetaxel|mesh-list
2397217|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397218|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
2397219|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
2397220|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
2397221|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397222|NCT00697086|Dronedarone|dronedarone|mesh-list
2523304|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2523305|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
2523306|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2523307|NCT01343381|Heparin|heparin|mesh-list
2523308|NCT01343381|Calcium heparin|calcium heparin|mesh-list
2523309|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
2523310|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2523311|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2523312|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523313|NCT01343498|Dactolisib|dactolisib|mesh-list
2523314|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523315|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2523316|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2523317|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2523318|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2523319|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523320|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
2523321|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523322|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523323|NCT01343680|Heparin|heparin|mesh-list
2523324|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
2523325|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2523326|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2523327|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523328|NCT01343706|BI 409306|bi 409306|mesh-list
2523329|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2523330|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523331|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523332|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
2523333|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2523334|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
2523335|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523336|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397223|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2397224|NCT00697099|Enoxaparin|enoxaparin|mesh-list
2397225|NCT00697099|Semuloparin|semuloparin|mesh-list
2397226|NCT00697099|Enoxaparin sodium|enoxaparin sodium|mesh-list
2397227|NCT00697099|Anticoagulants|anticoagulants|mesh-ancestor
2397228|NCT00697099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2397229|NCT00697099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2397230|NCT00697099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397231|NCT00697125|Vaccines|vaccines|mesh-list
2397232|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
2397233|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397234|NCT00697138|Amphetamine|amphetamine|mesh-list
2397235|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
2397236|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2397237|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2397238|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2397239|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2397240|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397241|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
2397242|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397243|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397244|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2397245|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
2397246|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
2397247|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397248|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
2397249|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2397250|NCT00697151|Aspirin|aspirin|mesh-list
2397251|NCT00697151|Warfarin|warfarin|mesh-list
2397252|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2397253|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2397254|NCT00697151|Analgesics|analgesics|mesh-ancestor
2397255|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
2397256|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397257|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397258|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2397259|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2397260|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2397261|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2397262|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397263|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2397264|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2397265|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397266|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
2397267|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
2397268|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
2397269|NCT00697164|Hematinics|hematinics|mesh-ancestor
2397270|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
2397271|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2397272|NCT00697281|Growth Substances|growth substances|mesh-ancestor
2397273|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397274|NCT00697372|Sirolimus|sirolimus|mesh-list
2397275|NCT00697372|Everolimus|everolimus|mesh-list
2397276|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397277|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2397278|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
2397279|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397280|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2397281|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2397282|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2397283|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
2397284|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
2397285|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2397286|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2397287|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397288|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
2397289|NCT00697385|Coagulants|coagulants|mesh-ancestor
2397290|NCT00697437|Ketoconazole|ketoconazole|mesh-list
2397291|NCT00697437|Docetaxel|docetaxel|mesh-list
2397292|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397293|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
2397294|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
2397295|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
2397296|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397297|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
2397298|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523337|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2523338|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
2523339|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2397299|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2397300|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2397301|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397302|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2397303|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
2397304|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2397305|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397306|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2397307|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
2397308|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397309|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397310|NCT00697476|Topotecan|topotecan|mesh-list
2397311|NCT00697476|Vorinostat|vorinostat|mesh-list
2397312|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2397313|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2397314|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397315|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397316|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523340|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2523341|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2523342|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
2523343|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523344|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116137|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2116138|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2116139|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
2116140|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116141|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2116142|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
2116143|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116144|NCT02634684|Amphetamine|amphetamine|mesh-list
2116145|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
2116146|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2523345|NCT01343862|Cycloserine|cycloserine|mesh-list
2523346|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2523347|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2397317|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2397318|NCT00697502|Capecitabine|capecitabine|mesh-list
2397319|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2397320|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
2397321|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397322|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397323|NCT00697554|Vaccines|vaccines|mesh-list
2397324|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
2397325|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397326|NCT00697567|Vaccines|vaccines|mesh-list
2397327|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
2397328|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397329|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2523348|NCT01343862|Renal Agents|renal agents|mesh-ancestor
2523349|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2523350|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
2523351|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2523352|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
2523353|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523354|NCT01343966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2523355|NCT01343966|Immunologic Factors|immunologic factors|mesh-ancestor
2523356|NCT01343966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523357|NCT01344031|Fulvestrant|fulvestrant|mesh-list
2523358|NCT01344031|Anastrozole|anastrozole|mesh-list
2523359|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2523360|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523361|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2523362|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2523363|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
2523364|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2523365|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523366|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2523367|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2523368|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523369|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523370|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2523371|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2523372|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2523373|NCT01344083|Analgesics|analgesics|mesh-ancestor
2523374|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
2523375|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523376|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523377|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523378|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523379|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2523380|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2523381|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2523382|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
2523383|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
2523384|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523385|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523386|NCT01344174|Lamivudine|lamivudine|mesh-list
2523387|NCT01344174|Dexamethasone|dexamethasone|mesh-list
2523388|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523389|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
2523390|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
2523391|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523392|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523393|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2523394|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
2523395|NCT01344174|Hormones|hormones|mesh-ancestor
2523396|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2523397|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2397330|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2397331|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2397332|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2397333|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397334|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2397335|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2397336|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2397337|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
2397338|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397339|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397340|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2397341|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2397342|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
2397343|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
2397344|NCT00697671|Etoposide|etoposide|mesh-list
2397345|NCT00697671|Interleukin-2|interleukin-2|mesh-list
2397346|NCT00697671|Clofarabine|clofarabine|mesh-list
2397347|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2397348|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
2397349|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397350|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2397351|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2397352|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
2397353|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397354|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397355|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2397356|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2397357|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2397358|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2397359|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397360|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2397361|NCT00697671|Analgesics|analgesics|mesh-ancestor
2397362|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
2397363|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397364|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2397365|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
2397375|NCT00697775|Vaccines|vaccines|mesh-list
2397376|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
2397377|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397378|NCT00697814|Clomiphene|clomiphene|mesh-list
2523398|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397379|NCT00697814|Enclomiphene|enclomiphene|mesh-list
2397380|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
2397381|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2397382|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
2523399|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2523400|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2523401|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523402|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523403|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
2523404|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523405|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2397383|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2397384|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397385|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2397386|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
2397387|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2397388|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2397389|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2397390|NCT00697866|Vaccines|vaccines|mesh-list
2397391|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
2523406|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2523407|NCT01344187|Riboflavin|riboflavin|mesh-list
2523408|NCT01344187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2523409|NCT01344187|Vitamin B Complex|vitamin b complex|mesh-ancestor
2523410|NCT01344187|Vitamins|vitamins|mesh-ancestor
2523411|NCT01344187|Micronutrients|micronutrients|mesh-ancestor
2523412|NCT01344187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523413|NCT01344187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2523414|NCT01344187|Dermatologic Agents|dermatologic agents|mesh-ancestor
2523415|NCT01344200|Celecoxib|celecoxib|mesh-list
2523416|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2523417|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2523418|NCT01344200|Analgesics|analgesics|mesh-ancestor
2523419|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
2523420|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523421|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523422|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523423|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523424|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2523425|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2523426|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523427|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523428|NCT01344213|Celecoxib|celecoxib|mesh-list
2523429|NCT01344213|Pregabalin|pregabalin|mesh-list
2523430|NCT01344213|Analgesics|analgesics|mesh-ancestor
2523431|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
2523432|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523433|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523434|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
2523435|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2523436|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2523437|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523438|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2523439|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2523440|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2523441|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523442|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2523443|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2523444|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2523445|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523446|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523447|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2397392|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397393|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2397394|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397395|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397396|NCT00697892|Ritonavir|ritonavir|mesh-list
2397397|NCT00697892|Lopinavir|lopinavir|mesh-list
2397398|NCT00697892|Efavirenz|efavirenz|mesh-list
2397399|NCT00697892|Lumefantrine|lumefantrine|mesh-list
2397400|NCT00697892|Artemether|artemether|mesh-list
2523448|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2523449|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523450|NCT01344252|Lidocaine|lidocaine|mesh-list
2397401|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2523451|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
2523452|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
2523453|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523454|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523455|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
2523456|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523457|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2523458|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2523459|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2523460|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2523461|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523462|NCT01344291|Curcumin|curcumin|mesh-list
2523463|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2523464|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2523465|NCT01344291|Analgesics|analgesics|mesh-ancestor
2523466|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
2523467|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397402|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2397403|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2397404|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
2397405|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397406|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397407|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2397408|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2397409|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
2397410|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2397411|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2397412|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2397413|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2397414|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2397415|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2397416|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2397417|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2397418|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2397419|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2397420|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
2397421|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2397422|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2397423|NCT00697905|Gemcitabine|gemcitabine|mesh-list
2397424|NCT00697905|Carboplatin|carboplatin|mesh-list
2397425|NCT00697905|Fluorouracil|fluorouracil|mesh-list
2397426|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397427|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2397428|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
2397429|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397430|NCT00697905|Antiviral Agents|antiviral agents|mesh-ancestor
2397431|NCT00697905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2397432|NCT00697905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397433|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2397434|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
2397435|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397436|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2397437|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
2397438|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2397439|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2397440|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2397441|NCT00697996|Rituximab|rituximab|mesh-list
2397442|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2397443|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523468|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523469|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523470|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523471|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523472|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523473|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523474|NCT01344304|Aprepitant|aprepitant|mesh-list
2523475|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
2523476|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
2523477|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
2523478|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523479|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523480|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2523481|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2397444|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
2397445|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523482|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523483|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523484|NCT01344395|Ketorolac|ketorolac|mesh-list
2523485|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2523486|NCT01344395|Ropivacaine|ropivacaine|mesh-list
2523487|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
2523488|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
2523489|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523490|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523491|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
2523492|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523493|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2523494|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2523495|NCT01344395|Analgesics|analgesics|mesh-ancestor
2523496|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523497|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523498|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2523499|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523500|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523501|NCT01344473|Caseins|caseins|mesh-list
2397446|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2397447|NCT00698126|Insulin|insulin|mesh-list
2397448|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2523502|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
2523503|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
2523504|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523505|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
2523506|NCT01344512|Ceftazidime|ceftazidime|mesh-list
2523507|NCT01344512|Voriconazole|voriconazole|mesh-list
2523508|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2523509|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523510|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2523511|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2523512|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523513|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523514|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523515|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2523516|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2523517|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
2523518|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2523519|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2523520|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
2523521|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2523522|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523523|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2523524|NCT01344564|Leuprolide|leuprolide|mesh-list
2523525|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2523526|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
2523527|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2523528|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523529|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2523530|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523531|NCT01344590|Ethanol|ethanol|mesh-list
2523532|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2523533|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523534|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523535|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523536|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2523537|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2523538|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
2523539|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523540|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523541|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2523542|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
2523543|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2523544|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2523545|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2523546|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
2523547|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523548|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397449|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
2523549|NCT01344681|Itraconazole|itraconazole|mesh-list
2523550|NCT01344681|Micafungin|micafungin|mesh-list
2523551|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
2523552|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523553|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2523554|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2523555|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523556|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523557|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2523558|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
2523559|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2523560|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523561|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2523562|NCT01344720|Etoricoxib|etoricoxib|mesh-list
2523563|NCT01344720|Oxycodone|oxycodone|mesh-list
2523564|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2523565|NCT01344720|Narcotics|narcotics|mesh-ancestor
2523566|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523567|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523568|NCT01344720|Analgesics|analgesics|mesh-ancestor
2523569|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
2523570|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397450|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
2397451|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397452|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397453|NCT00698230|Metformin|metformin|mesh-list
2397454|NCT00698230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397455|NCT00698230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397456|NCT00698269|Insulin|insulin|mesh-list
2397457|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2397458|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
2397459|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
2397460|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2397461|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
2397462|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
2397463|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2397464|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397465|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397466|NCT00698334|Rifampin|rifampin|mesh-list
2397467|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
2397468|NCT00698334|Ethambutol|ethambutol|mesh-list
2397469|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2397470|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
2397471|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2397472|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523571|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2523572|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2523573|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523574|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523575|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2523576|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2523577|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397473|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
2397474|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2397475|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397476|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397477|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2397478|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2397479|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2397480|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2397481|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2523578|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523579|NCT01344863|Trastuzumab|trastuzumab|mesh-list
2523580|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2523581|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523582|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
2523583|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2523584|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2523585|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
2523586|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2397482|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2397483|NCT00698425|Citric Acid|citric acid|mesh-list
2523587|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
2523588|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523589|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523590|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
2523591|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
2523592|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523593|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
2523594|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2523595|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523596|NCT01345045|Pregabalin|pregabalin|mesh-list
2523597|NCT01345045|Analgesics|analgesics|mesh-ancestor
2523598|NCT01345045|Sensory System Agents|sensory system agents|mesh-ancestor
2523599|NCT01345045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523600|NCT01345045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523601|NCT01345045|Anticonvulsants|anticonvulsants|mesh-ancestor
2523602|NCT01345045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2523603|NCT01345045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2523604|NCT01345045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523605|NCT01345045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2523606|NCT01345045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2523607|NCT01345045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2523608|NCT01345045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523609|NCT01345045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2523610|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
2523611|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523612|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2397484|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
2397485|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
2397486|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2397487|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
2397488|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
2397489|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397490|NCT00698464|Pasireotide|pasireotide|mesh-list
2397491|NCT00698464|Hormones|hormones|mesh-ancestor
2397492|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2397493|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397494|NCT00698607|Sirolimus|sirolimus|mesh-list
2397495|NCT00698607|Everolimus|everolimus|mesh-list
2397496|NCT00698607|Clopidogrel|clopidogrel|mesh-list
2397497|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397498|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2397499|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
2523613|NCT01345136|Everolimus|everolimus|mesh-list
2523614|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523615|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2523616|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
2523617|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523618|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2523619|NCT01345175|Metronidazole|metronidazole|mesh-list
2523620|NCT01345175|Rifaximin|rifaximin|mesh-list
2523621|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2523622|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523623|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
2523624|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2523625|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2523626|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2523627|NCT01345240|Vaccines|vaccines|mesh-list
2523628|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
2523629|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523630|NCT01345279|Paclitaxel|paclitaxel|mesh-list
2397500|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397501|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2397502|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2397503|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2397504|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2397505|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
2397506|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397507|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397508|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2397509|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2397510|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2397511|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
2397512|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
2523631|NCT01345279|Topotecan|topotecan|mesh-list
2523632|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2523633|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523634|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
2397513|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2397514|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
2397515|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2397516|NCT00698724|Prednisolone|prednisolone|mesh-list
2397517|NCT00698724|Bromfenac|bromfenac|mesh-list
2397518|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2397519|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
2397520|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2397521|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
2397522|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
2397523|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397524|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397525|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2397526|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
2397527|NCT00698724|Hormones|hormones|mesh-ancestor
2397528|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2397529|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2397530|NCT00698724|Protective Agents|protective agents|mesh-ancestor
2397531|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2523635|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
2523636|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
2523637|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523638|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2523639|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2523640|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523641|NCT01345357|Gemcitabine|gemcitabine|mesh-list
2523642|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523643|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2523644|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
2523645|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523646|NCT01345357|Antiviral Agents|antiviral agents|mesh-ancestor
2397532|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397533|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2397534|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2397535|NCT00698724|Analgesics|analgesics|mesh-ancestor
2397536|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
2397537|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2397538|NCT00698763|Simendan|simendan|mesh-list
2397539|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2397540|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
2397541|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2397542|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2397543|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397544|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397545|NCT00698763|Protective Agents|protective agents|mesh-ancestor
2397546|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397547|NCT00698776|Lenalidomide|lenalidomide|mesh-list
2397548|NCT00698776|KRN 7000|krn 7000|mesh-list
2397549|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
2397550|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397551|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2397552|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2397553|NCT00698776|Growth Substances|growth substances|mesh-ancestor
2397554|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
2397555|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397556|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2397557|NCT00698789|Metformin|metformin|mesh-list
2397558|NCT00698789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397559|NCT00698789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397560|NCT00698802|Insulin|insulin|mesh-list
2397561|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2397562|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397563|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397564|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2397565|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2397566|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2397567|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2397568|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2397569|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
2397570|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397571|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397572|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397573|NCT00699023|Simvastatin|simvastatin|mesh-list
2397574|NCT00699023|Ezetimibe|ezetimibe|mesh-list
2397575|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2397576|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2523647|NCT01345357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523648|NCT01345357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523649|NCT01345357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2523650|NCT01345357|Immunologic Factors|immunologic factors|mesh-ancestor
2523651|NCT01345357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523652|NCT01345370|Temozolomide|temozolomide|mesh-list
2523653|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2523654|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
2523655|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523656|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523657|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2523658|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2523659|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2523660|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2523661|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2523662|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
2523663|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523664|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523665|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523666|NCT01345604|Ropivacaine|ropivacaine|mesh-list
2523667|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
2523668|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
2397577|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
2397578|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397579|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2397580|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2397581|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397582|NCT00699036|Metformin|metformin|mesh-list
2397583|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
2397584|NCT00699036|Losartan|losartan|mesh-list
2397585|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2523669|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523670|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523671|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
2523672|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523673|NCT01345656|Spironolactone|spironolactone|mesh-list
2523674|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2523675|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
2523676|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2523677|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397586|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397587|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2397588|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2397589|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2397590|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2397591|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397592|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
2397593|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
2397594|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2397595|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2397596|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
2397597|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523678|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2523679|NCT01345656|Diuretics|diuretics|mesh-ancestor
2523680|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
2523681|NCT01345708|Prednisone|prednisone|mesh-list
2523682|NCT01345708|Rituximab|rituximab|mesh-list
2523683|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2523684|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523685|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
2523686|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523687|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523688|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523689|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
2397598|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397599|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397600|NCT00699049|Urological Agents|urological agents|mesh-ancestor
2397601|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2397602|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
2397603|NCT00699062|Montelukast|montelukast|mesh-list
2397604|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2397605|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
2397606|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2523690|NCT01345708|Hormones|hormones|mesh-ancestor
2523691|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2523692|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2523693|NCT01345734|Liraglutide|liraglutide|mesh-list
2523694|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2523695|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523696|NCT01345734|Incretins|incretins|mesh-ancestor
2523697|NCT01345734|Hormones|hormones|mesh-ancestor
2397607|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
2397608|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2397609|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397610|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2397611|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2397612|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397613|NCT00699114|Acetaminophen|acetaminophen|mesh-list
2397614|NCT00699114|Ibuprofen|ibuprofen|mesh-list
2397615|NCT00699114|Codeine|codeine|mesh-list
2397616|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2397617|NCT00699114|Analgesics|analgesics|mesh-ancestor
2397618|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
2397619|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397620|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397621|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
2523698|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2523699|NCT01345851|Paclitaxel|paclitaxel|mesh-list
2523700|NCT01345851|Carboplatin|carboplatin|mesh-list
2523701|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2523702|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523703|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
2523704|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
2523705|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
2523706|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523707|NCT01345864|Scopolamine|scopolamine|mesh-list
2523708|NCT01345864|Donepezil|donepezil|mesh-list
2523709|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2523710|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2523711|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523712|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523713|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
2523714|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523715|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523716|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
2523717|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2523718|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
2523719|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
2523720|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523721|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2523722|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
2397622|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2397623|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2397624|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2397625|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2397626|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397627|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397628|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2397629|NCT00699114|Narcotics|narcotics|mesh-ancestor
2397630|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2397631|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
2397632|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
2397633|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
2397634|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
2397635|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2397636|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397637|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397638|NCT00699244|Anesthetics|anesthetics|mesh-list
2397639|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2397640|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397641|NCT00699296|Panobinostat|panobinostat|mesh-list
2397642|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397643|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2523723|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2523724|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2523725|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
2523726|NCT01345981|Lidocaine|lidocaine|mesh-list
2523727|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
2523728|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
2523729|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523730|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523731|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
2523732|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523733|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2523734|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2523735|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2523736|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2523737|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523738|NCT01346007|Vaccines|vaccines|mesh-list
2397644|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397645|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397646|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2397647|NCT00699322|Glimepiride|glimepiride|mesh-list
2397648|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397649|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397650|NCT00699322|Incretins|incretins|mesh-ancestor
2397651|NCT00699322|Hormones|hormones|mesh-ancestor
2397652|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2397653|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2397654|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
2397655|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397656|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523739|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2523740|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
2523741|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523742|NCT01346137|Meloxicam|meloxicam|mesh-list
2523743|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2397657|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2397658|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2397659|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
2397660|NCT00699361|Pantoprazole|pantoprazole|mesh-list
2397661|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2397662|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1286125|NCT00838799|Pregabalin|pregabalin|mesh-list
1286126|NCT00838799|Analgesics|analgesics|mesh-ancestor
1286127|NCT00838799|Sensory System Agents|sensory system agents|mesh-ancestor
1286128|NCT00838799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1286129|NCT00838799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1286130|NCT00838799|Anticonvulsants|anticonvulsants|mesh-ancestor
1286131|NCT00838799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1286132|NCT00838799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1286133|NCT00838799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1286134|NCT00838799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1286135|NCT00838799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1286136|NCT00838799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1286137|NCT00838799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1286138|NCT00838799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2523744|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2523745|NCT01346137|Analgesics|analgesics|mesh-ancestor
2523746|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
2397663|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2397664|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397665|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397666|NCT00699387|Benzonidazole|benzonidazole|mesh-list
2397667|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2397668|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
2397669|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397670|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2397671|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2397672|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2397673|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2397674|NCT00699426|Esomeprazole|esomeprazole|mesh-list
2523747|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523748|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523749|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523750|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523751|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2523752|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2523753|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397675|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2523754|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523755|NCT01346215|Heparin|heparin|mesh-list
2523756|NCT01346215|Calcium heparin|calcium heparin|mesh-list
2523757|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
2523758|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2523759|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2523760|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523761|NCT01346254|Pioglitazone|pioglitazone|mesh-list
2523762|NCT01346254|Vildagliptin|vildagliptin|mesh-list
2523763|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2523764|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523765|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2397676|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2397677|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2397678|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397679|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397680|NCT00699452|Candesartan|candesartan|mesh-list
2397681|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2523766|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
2523767|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523768|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523769|NCT01346670|Lovastatin|lovastatin|mesh-list
2523770|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2523771|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2523772|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
2523773|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523774|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2523775|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2523776|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523777|NCT01346787|Dexamethasone|dexamethasone|mesh-list
2523778|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
2523779|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2523780|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
2523781|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523782|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523783|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2523784|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
2523785|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523786|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523787|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2523788|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523789|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
2523790|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
2523791|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523792|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2523793|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
2523794|NCT01346787|Hormones|hormones|mesh-ancestor
2523795|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2523796|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2523797|NCT01346800|Ritonavir|ritonavir|mesh-list
2523798|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2523799|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2523800|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2523801|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
2523802|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523803|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523804|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2523805|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2523806|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
2523807|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523808|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2523809|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2523810|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2523811|NCT01346826|Infliximab|infliximab|mesh-list
2523812|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
2523813|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2523814|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523815|NCT01346865|Cilostazol|cilostazol|mesh-list
2523816|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2523817|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
2523818|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523819|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523820|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2523821|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
2523822|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2523823|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2523824|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523825|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2523826|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
2523827|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2523828|NCT01346865|Protective Agents|protective agents|mesh-ancestor
2523829|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2523830|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2523831|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523832|NCT01346917|Lidocaine|lidocaine|mesh-list
2523833|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
2523834|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
2523835|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523836|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397682|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2397683|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2397684|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397685|NCT00699465|Enoxaparin|enoxaparin|mesh-list
2397686|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
2397687|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
2397688|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2397689|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2397690|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397691|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
2397692|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
2523837|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
2523838|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523839|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2523840|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2523841|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2523842|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2523843|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523844|NCT01346930|Macitentan|macitentan|mesh-list
2523845|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2523846|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2523847|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523848|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2523849|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2523850|NCT01347268|Hormones|hormones|mesh-ancestor
2523851|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2523852|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523853|NCT01347294|Bleomycin|bleomycin|mesh-list
2523854|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2523855|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523856|NCT01347424|Paclitaxel|paclitaxel|mesh-list
2523857|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2523858|NCT01347424|Carboplatin|carboplatin|mesh-list
2523859|NCT01347424|Endostatins|endostatins|mesh-list
2397693|NCT00699478|Vitamins|vitamins|mesh-ancestor
2397694|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
2397695|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397696|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
2397697|NCT00699504|Cangrelor|cangrelor|mesh-list
2397698|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2397699|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2397700|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2397701|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2397702|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397703|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397704|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397705|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397706|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2397707|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2397708|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2523860|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2523861|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523862|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
2523863|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
2523864|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
2523865|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523866|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2397709|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2397710|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
2397711|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397712|NCT00699530|Cabergoline|cabergoline|mesh-list
2397713|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2397714|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2523867|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2523868|NCT01347424|Growth Substances|growth substances|mesh-ancestor
2523869|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523870|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
2523871|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
2523872|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2523873|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2523874|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
2523875|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
2523876|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2523877|NCT01347814|Domperidone|domperidone|mesh-list
2523878|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
2397715|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
2397716|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
2397717|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397718|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397719|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397720|NCT00699634|Nabilone|nabilone|mesh-list
2397721|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
2397722|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
2397723|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397724|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397725|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2397726|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2397727|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2397728|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2397729|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2397730|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
2397731|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
2397732|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397733|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397734|NCT00699764|Vaccines|vaccines|mesh-list
2397735|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
2397736|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397737|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
2397738|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
2397739|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2397740|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2397741|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397742|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2397743|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397744|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2397745|NCT00699881|Cetuximab|cetuximab|mesh-list
2397746|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2397747|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397748|NCT00699894|Ondansetron|ondansetron|mesh-list
2397749|NCT00699894|Aprepitant|aprepitant|mesh-list
2397750|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
2397751|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
2397752|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397753|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397754|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2397755|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
2397756|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
2397757|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2397758|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
2397759|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397760|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397761|NCT00699894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2397762|NCT00699894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2397763|NCT00699894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2397764|NCT00699894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2397765|NCT00699894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2397766|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2397767|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2523879|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
2397768|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
2397769|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2397770|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2523880|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523881|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397771|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2397772|NCT00699946|Olanzapine|olanzapine|mesh-list
2397773|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
2397774|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
2397775|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397776|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397777|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2397778|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2397779|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2397780|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2397781|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2397782|NCT00699946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2397783|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2397784|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2397785|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397786|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397787|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
2397788|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
2397789|NCT00700024|Testosterone|testosterone|mesh-list
2397790|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
2397791|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
2523882|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2523883|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2523884|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
2523885|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523886|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523887|NCT01347853|Ketorolac|ketorolac|mesh-list
2523888|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2523889|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2523890|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2523891|NCT01347853|Analgesics|analgesics|mesh-ancestor
2523892|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
2523893|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523894|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523895|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2523896|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2523897|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2523898|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523899|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523900|NCT01347944|Lenalidomide|lenalidomide|mesh-list
2523901|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
2523902|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523903|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2523904|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2523905|NCT01347944|Growth Substances|growth substances|mesh-ancestor
2523906|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
2397792|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2397793|NCT00700024|Androgens|androgens|mesh-ancestor
2397794|NCT00700024|Hormones|hormones|mesh-ancestor
2397795|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2523907|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523908|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
2523909|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2523910|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
2523911|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523912|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523913|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2523914|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
2523915|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2523916|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
2523917|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523918|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523919|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2523920|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
2523921|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
2523922|NCT01347957|Protective Agents|protective agents|mesh-ancestor
2523923|NCT01347970|Carvedilol|carvedilol|mesh-list
2523924|NCT01347970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2523925|NCT01347970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2523926|NCT01347970|Adrenergic Agents|adrenergic agents|mesh-ancestor
2523927|NCT01347970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523928|NCT01347970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523929|NCT01347970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397796|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397797|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2523930|NCT01347970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2523931|NCT01347970|Antioxidants|antioxidants|mesh-ancestor
2523932|NCT01347970|Protective Agents|protective agents|mesh-ancestor
2523933|NCT01347970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2397798|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397799|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
2397800|NCT00700037|Atorvastatin|atorvastatin|mesh-list
2397801|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2397802|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2397803|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
2397804|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397805|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2397806|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2397807|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397808|NCT00700076|Ketamine|ketamine|mesh-list
2397809|NCT00700076|Analgesics|analgesics|mesh-ancestor
2397810|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
2397811|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523934|NCT01347970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2523935|NCT01347970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2523936|NCT01347970|Vasodilator Agents|vasodilator agents|mesh-ancestor
2523937|NCT01347970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2523938|NCT01347970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2523939|NCT01347983|Methotrexate|methotrexate|mesh-list
2523940|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2523941|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
2523942|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2523943|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523944|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2523945|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
2523946|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523947|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523948|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
2523949|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2523950|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2523951|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2523952|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
2523953|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2397812|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397813|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2397814|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2397815|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
2397816|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
2397817|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2397818|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2397819|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2397820|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397821|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397822|NCT00700128|Frovatriptan|frovatriptan|mesh-list
2397823|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2397824|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
2397825|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397826|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397827|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397828|NCT00700154|Insulin|insulin|mesh-list
2397829|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2397830|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
2397831|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397832|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397833|NCT00700193|Vaccines|vaccines|mesh-list
2397834|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
2397835|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397836|NCT00700284|Dapivirine|dapivirine|mesh-list
2397837|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2397838|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2397839|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
2397840|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2397841|NCT00700297|Colchicine|colchicine|mesh-list
2397842|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
2397843|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2397844|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
2397845|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
2397846|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
2523954|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2523955|NCT01347996|Interleukin-2|interleukin-2|mesh-list
2523956|NCT01347996|Histamine|histamine|mesh-list
2523957|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
2523958|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523959|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2523960|NCT01347996|Analgesics|analgesics|mesh-ancestor
2523961|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
2523962|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523963|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523964|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
2523965|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
2397847|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397848|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2397849|NCT00700362|Insulin|insulin|mesh-list
2397850|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397851|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397852|NCT00700466|Metoprolol|metoprolol|mesh-list
2397853|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2397854|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2397855|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2397856|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
2397857|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
2397858|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397859|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397860|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2397861|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2397862|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
2397863|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397864|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397865|NCT00700492|Progesterone|progesterone|mesh-list
2397866|NCT00700492|Progestins|progestins|mesh-ancestor
2397867|NCT00700492|Hormones|hormones|mesh-ancestor
2397868|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2397869|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523966|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2523967|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523968|NCT01348009|Cisplatin|cisplatin|mesh-list
2523969|NCT01348009|Capecitabine|capecitabine|mesh-list
2523970|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523971|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2523972|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
2523973|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523974|NCT01348126|Docetaxel|docetaxel|mesh-list
2523975|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2523976|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
2523977|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
2523978|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
2523979|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397870|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
2397871|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
2397872|NCT00700544|Norethandrolone|norethandrolone|mesh-list
2397873|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
2397874|NCT00700544|Hormones|hormones|mesh-ancestor
2397875|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2397876|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397877|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2397878|NCT00700583|Terazosin|terazosin|mesh-list
2523980|NCT01348204|Quercetin|quercetin|mesh-list
2523981|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
2523982|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523983|NCT01348204|Protective Agents|protective agents|mesh-ancestor
2523984|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523985|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
2523986|NCT01348243|Lidocaine|lidocaine|mesh-list
2523987|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
2523988|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
2523989|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2523990|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2523991|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
2523992|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2523993|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2523994|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2523995|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2523996|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2523997|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2523998|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2523999|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
2524000|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2524001|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524002|NCT01348282|Rivastigmine|rivastigmine|mesh-list
2524003|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524004|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397879|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2397880|NCT00700583|Diuretics|diuretics|mesh-ancestor
2397881|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
2397882|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397883|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2397884|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2397885|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397886|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2397887|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2397888|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2397889|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
2524005|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524006|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2524007|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
2524008|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524009|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2524010|NCT01348282|Protective Agents|protective agents|mesh-ancestor
2524011|NCT01348308|Maraviroc|maraviroc|mesh-list
2524012|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2524013|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2524014|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524015|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2524016|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2524017|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
2524018|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524019|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2524020|NCT01348321|Levamisole|levamisole|mesh-list
2524021|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2524022|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
2524023|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524024|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
2524025|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
2524026|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2524027|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524028|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2524029|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
2524030|NCT01348412|Raltitrexed|raltitrexed|mesh-list
2524031|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524032|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2524033|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
2524034|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524035|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2397890|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397891|NCT00700583|Urological Agents|urological agents|mesh-ancestor
2397896|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
2397897|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397898|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397899|NCT00700661|Montelukast|montelukast|mesh-list
2397900|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2397901|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
2397902|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2397903|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
2397904|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2397905|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397906|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2397907|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2397908|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397909|NCT00700687|Aspirin|aspirin|mesh-list
2397910|NCT00700687|Celecoxib|celecoxib|mesh-list
2397911|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2524036|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524037|NCT01348503|Lenalidomide|lenalidomide|mesh-list
2524038|NCT01348503|Sorafenib|sorafenib|mesh-list
2524039|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
2524040|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524041|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2524042|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2524043|NCT01348503|Growth Substances|growth substances|mesh-ancestor
2524044|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
2524045|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524046|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2524047|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524048|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524049|NCT01348724|Naloxegol|naloxegol|mesh-list
2524050|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2524051|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524052|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
2524053|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524054|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2524055|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
2524056|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2524057|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2524058|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524059|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524060|NCT01348880|Urological Agents|urological agents|mesh-ancestor
2524061|NCT01348919|Dexamethasone|dexamethasone|mesh-list
2524062|NCT01348919|Lenalidomide|lenalidomide|mesh-list
2524063|NCT01348919|Delanzomib|delanzomib|mesh-list
2524064|NCT01348919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2524065|NCT01348919|Antiemetics|antiemetics|mesh-ancestor
2524066|NCT01348919|Autonomic Agents|autonomic agents|mesh-ancestor
2524067|NCT01348919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524068|NCT01348919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524069|NCT01348919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2524070|NCT01348919|Glucocorticoids|glucocorticoids|mesh-ancestor
2524071|NCT01348919|Hormones|hormones|mesh-ancestor
2524072|NCT01348919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2524073|NCT01348919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2524074|NCT01348919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524075|NCT01348919|Immunologic Factors|immunologic factors|mesh-ancestor
2524076|NCT01348919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2524077|NCT01348919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2524078|NCT01348919|Growth Substances|growth substances|mesh-ancestor
2524079|NCT01348919|Growth Inhibitors|growth inhibitors|mesh-ancestor
2524080|NCT01348919|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
2397912|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2397913|NCT00700687|Analgesics|analgesics|mesh-ancestor
2397914|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
2397915|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397916|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397917|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2397918|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2397919|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2397920|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2397921|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397922|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2397923|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2397924|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397925|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
2397926|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2397927|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
2397928|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397929|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397930|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
2397931|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397932|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397933|NCT00700856|Pioglitazone|pioglitazone|mesh-list
2397934|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397935|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397936|NCT00700895|Warfarin|warfarin|mesh-list
2397937|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
2397938|NCT00700921|Lovastatin|lovastatin|mesh-list
2397939|NCT00700921|L 647318|l 647318|mesh-list
2397940|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
2397941|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2397942|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2397943|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
2524081|NCT01348919|Protease Inhibitors|protease inhibitors|mesh-ancestor
2524082|NCT01348919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524083|NCT01348919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524084|NCT01348984|Fentanyl|fentanyl|mesh-list
2524085|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2524086|NCT01348984|Narcotics|narcotics|mesh-ancestor
2524087|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524088|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524089|NCT01348984|Analgesics|analgesics|mesh-ancestor
2524090|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
2524091|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524092|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2524093|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2524094|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
2524095|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
2524096|NCT01349010|Probucol|probucol|mesh-list
2524097|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2524098|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2524099|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
2524100|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524101|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2524102|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
2524103|NCT01349010|Protective Agents|protective agents|mesh-ancestor
2524104|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524105|NCT01349088|Niacinamide|niacinamide|mesh-list
2524106|NCT01349088|Capecitabine|capecitabine|mesh-list
2524107|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
2524108|NCT01349088|Imetelstat|imetelstat|mesh-list
2524109|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2524110|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
2524111|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397944|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397945|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2397946|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2397947|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397948|NCT00700947|Metoprolol|metoprolol|mesh-list
2397949|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2397950|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2397951|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
2397952|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397953|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397954|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397955|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2397956|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2397957|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
2397958|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
2397959|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2397960|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2397961|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
2397962|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2397963|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397964|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
2397965|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2524112|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524113|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2524114|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524115|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
2524116|NCT01349088|Vitamins|vitamins|mesh-ancestor
2524117|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
2524118|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524119|NCT01349101|Vidarabine|vidarabine|mesh-list
2524120|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
2524121|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
2524122|NCT01349101|Busulfan|busulfan|mesh-list
2524123|NCT01349101|Fludarabine|fludarabine|mesh-list
2524124|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
2524125|NCT01349101|Tacrolimus|tacrolimus|mesh-list
2524126|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2524127|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
2524128|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524129|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2524130|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2524131|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
2524132|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524133|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524134|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2397966|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524135|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2524136|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
2397967|NCT00701220|Atorvastatin|atorvastatin|mesh-list
2397968|NCT00701220|Calcium|calcium|mesh-list
2397969|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2397970|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397971|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2397972|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2397973|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
2397974|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397975|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2397976|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2397977|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524137|NCT01349101|Antiviral Agents|antiviral agents|mesh-ancestor
2524138|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524139|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2524140|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524141|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2524142|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2524143|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
2524144|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2524145|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
2524146|NCT01349127|Vitamin D|vitamin d|mesh-list
2524147|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
2524148|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
2524149|NCT01349127|Vitamins|vitamins|mesh-list
2524150|NCT01349127|Calcium|calcium|mesh-list
2524151|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
2524152|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524153|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2524154|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2524155|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
2524156|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
2524157|NCT01349205|Caffeine|caffeine|mesh-list
2524158|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2524159|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397978|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
2397979|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2397980|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2397981|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397982|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
2397983|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2397984|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397985|NCT00701246|Folic Acid|folic acid|mesh-list
2397986|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
2397987|NCT00701246|Hematinics|hematinics|mesh-ancestor
2397988|NCT00701246|Vitamins|vitamins|mesh-ancestor
2397989|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
2397990|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2397991|NCT00701259|Lansoprazole|lansoprazole|mesh-list
2397992|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
2397993|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2397994|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2397995|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2397996|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2397997|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2397998|NCT00701285|Pravastatin|pravastatin|mesh-list
2397999|NCT00701285|Pitavastatin|pitavastatin|mesh-list
2398000|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2398001|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2398002|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
2398003|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398004|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2398005|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2398006|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398007|NCT00701298|Interferons|interferons|mesh-list
2398008|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
2398009|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
2398010|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2398011|NCT00701298|Decitabine|decitabine|mesh-list
2398012|NCT00701298|Azacitidine|azacitidine|mesh-list
2398013|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398014|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
2398015|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398016|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
2398017|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398018|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2524160|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2398019|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
2398020|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398021|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398022|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2398023|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2398024|NCT00701337|Estradiol|estradiol|mesh-list
2398025|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2524161|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524162|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524163|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2524164|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2524165|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
2524166|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524167|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
2524168|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524169|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2524170|NCT01349205|Protective Agents|protective agents|mesh-ancestor
2524171|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2524172|NCT01349205|Analgesics|analgesics|mesh-ancestor
2398026|NCT00701337|Estrogens|estrogens|mesh-ancestor
2398027|NCT00701337|Hormones|hormones|mesh-ancestor
2398028|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2398029|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398030|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2398031|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
2398032|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2398033|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2398034|NCT00701428|Losartan|losartan|mesh-list
2398035|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2398036|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2398037|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2524173|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
2524174|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524175|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
2524176|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2524177|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
2524178|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524179|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524180|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2524181|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
2524182|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2524183|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2524184|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2524185|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
2524186|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524187|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524188|NCT01349270|Prednisone|prednisone|mesh-list
2524189|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
2524190|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2524191|NCT01349270|Antibodies|antibodies|mesh-list
2524192|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2398038|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2398039|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398040|NCT00701493|Topiramate|topiramate|mesh-list
2398041|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
2398042|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2398043|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398044|NCT00701532|Modafinil|modafinil|mesh-list
2524193|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
2524194|NCT01349270|Hormones|hormones|mesh-ancestor
2524195|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2524196|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524197|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2524198|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524199|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
2524200|NCT01349296|Everolimus|everolimus|mesh-list
2524201|NCT01349296|Nintedanib|nintedanib|mesh-list
2524202|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524203|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2524204|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
2524205|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524206|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2524207|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398045|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2524208|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524209|NCT01349335|Tolvaptan|tolvaptan|mesh-list
2524210|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2524211|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524212|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
2524213|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524214|NCT01349348|Tolvaptan|tolvaptan|mesh-list
2524215|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2524216|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524217|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
2524218|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524219|NCT01349387|Metformin|metformin|mesh-list
2524220|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2524221|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524222|NCT01349413|Esomeprazole|esomeprazole|mesh-list
2524223|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2524224|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2524225|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2524226|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398046|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398047|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2398048|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2398049|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2398050|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398051|NCT00701597|Bosentan|bosentan|mesh-list
2398052|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2398053|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2398054|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398055|NCT00701623|Heparin|heparin|mesh-list
2398056|NCT00701623|Calcium heparin|calcium heparin|mesh-list
2398057|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
2398058|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2398059|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2398060|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398061|NCT00701740|Isotretinoin|isotretinoin|mesh-list
2398062|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
2398063|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
2524227|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398064|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
2398065|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2398066|NCT00701740|Protective Agents|protective agents|mesh-ancestor
2398067|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398068|NCT00701792|Liver Extracts|liver extracts|mesh-list
2398069|NCT00701792|Hematinics|hematinics|mesh-ancestor
2398070|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
2398071|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2398072|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398073|NCT00701857|Pemetrexed|pemetrexed|mesh-list
2398074|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398075|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398076|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398077|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2398078|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2398079|NCT00701883|Atorvastatin|atorvastatin|mesh-list
2398080|NCT00701883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2398081|NCT00701883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2398082|NCT00701883|Antimetabolites|antimetabolites|mesh-ancestor
2398083|NCT00701883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398084|NCT00701883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2398085|NCT00701883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2398086|NCT00701883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398087|NCT00701909|Morphine|morphine|mesh-list
2398088|NCT00701909|Ketamine|ketamine|mesh-list
2398089|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2398090|NCT00701909|Narcotics|narcotics|mesh-ancestor
2398091|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2398092|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398093|NCT00701909|Analgesics|analgesics|mesh-ancestor
2398094|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
2398095|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2398096|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2398097|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2398098|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
2524228|NCT01349439|Propranolol|propranolol|mesh-list
2524229|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2524230|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2524231|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
2524232|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524233|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524234|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524235|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2524236|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2524237|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
2398099|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
2398100|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2398101|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2398102|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2398103|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398104|NCT00701961|Artesunate|artesunate|mesh-list
2398105|NCT00701961|Mefloquine|mefloquine|mesh-list
2398106|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
2398107|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2398108|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2398109|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398110|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398111|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
2398112|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
2398113|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2398114|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
2398115|NCT00702091|Ramipril|ramipril|mesh-list
2398116|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2398117|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
2398118|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398119|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398120|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2398121|NCT00702117|Flecainide|flecainide|mesh-list
2398122|NCT00702117|Procainamide|procainamide|mesh-list
2398123|NCT00702117|Ajmaline|ajmaline|mesh-list
2398124|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2398125|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2398126|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2398127|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2398128|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398129|NCT00702130|Pravastatin|pravastatin|mesh-list
2398130|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2398131|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2398132|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
2398133|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398134|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2398135|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2398136|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398137|NCT00702156|Bisoprolol|bisoprolol|mesh-list
2398138|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2398139|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
2398140|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
2398141|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2398142|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398143|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2398144|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2398145|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2398146|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
2398147|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2398148|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398149|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2398150|NCT00702182|Vinorelbine|vinorelbine|mesh-list
2398151|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398152|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2398153|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524238|NCT01349452|Ganciclovir|ganciclovir|mesh-list
2524239|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2524240|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
2524241|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
2524242|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398154|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398155|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2398156|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
2398157|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
2398158|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
2398159|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2398160|NCT00702195|Hormones|hormones|mesh-ancestor
2524243|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2524244|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524245|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524246|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2524247|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2524248|NCT01349556|Tretinoin|tretinoin|mesh-list
2524249|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524250|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
2524251|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
2524252|NCT01349647|Vaccines|vaccines|mesh-list
2524253|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
2524254|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524255|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2524256|NCT01349699|Deferasirox|deferasirox|mesh-list
2524257|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2524258|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
2524259|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
2524260|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524261|NCT01349699|Hematinics|hematinics|mesh-ancestor
2524262|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2398161|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2398162|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398163|NCT00702260|Ramipril|ramipril|mesh-list
2398164|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2398165|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
2398166|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398167|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398168|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2398169|NCT00702416|Acetaminophen|acetaminophen|mesh-list
2398170|NCT00702416|Fentanyl|fentanyl|mesh-list
2398171|NCT00702416|Morphine|morphine|mesh-list
2398172|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
2398173|NCT00702416|Narcotics|narcotics|mesh-list
2398174|NCT00702416|Analgesics|analgesics|mesh-list
2398175|NCT00702416|Anesthetics|anesthetics|mesh-list
2398176|NCT00702416|Ropivacaine|ropivacaine|mesh-list
2398177|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
2398178|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2398179|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398180|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
2398181|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2398182|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2398183|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2398184|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
2398185|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2398186|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
2398187|NCT00702442|Droperidol|droperidol|mesh-list
2398188|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2398189|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
2398190|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
2398191|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2398192|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398193|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2398194|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2398195|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2398196|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2398197|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2398198|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2398199|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2398200|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
2398201|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2398202|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398203|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
2398204|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398205|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2398206|NCT00702572|Paclitaxel|paclitaxel|mesh-list
2398207|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2398208|NCT00702572|Bevacizumab|bevacizumab|mesh-list
2398209|NCT00702572|Carboplatin|carboplatin|mesh-list
2398210|NCT00702572|Vorinostat|vorinostat|mesh-list
2398211|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2398212|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398213|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
2398214|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
2398215|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
2398216|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398217|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2398218|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2398219|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2398220|NCT00702572|Growth Substances|growth substances|mesh-ancestor
2398221|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398222|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
2398223|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2398224|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398225|NCT00702637|Modafinil|modafinil|mesh-list
2398226|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2398227|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398228|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2398229|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2398230|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2398231|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398232|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2398233|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
2398234|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2398235|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2398236|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2398237|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2398238|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398239|NCT00702728|Furosemide|furosemide|mesh-list
2398240|NCT00702728|Diuretics|diuretics|mesh-ancestor
2524263|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
2524264|NCT01349738|Levofloxacin|levofloxacin|mesh-list
2524265|NCT01349738|Ofloxacin|ofloxacin|mesh-list
2398241|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
2398242|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398243|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2398244|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2398245|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398246|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2398247|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2398248|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2398249|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2398250|NCT00702793|Varenicline|varenicline|mesh-list
2398251|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2398252|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2398253|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
2398254|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2398255|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524266|NCT01349738|Gentamicins|gentamicins|mesh-list
2524267|NCT01349738|Cefazolin|cefazolin|mesh-list
2524268|NCT01349738|Tobramycin|tobramycin|mesh-list
2524269|NCT01349738|Ampicillin|ampicillin|mesh-list
2524270|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2524271|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
2398256|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398257|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2398258|NCT00702806|Ganirelix|ganirelix|mesh-list
2398259|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
2398260|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2398261|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524272|NCT01349738|Sulbactam|sulbactam|mesh-list
2524273|NCT01349738|Trimethoprim|trimethoprim|mesh-list
2524274|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
2524275|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524276|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2524277|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2524278|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524279|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524280|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524281|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2524282|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2524283|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2524284|NCT01349738|Renal Agents|renal agents|mesh-ancestor
2524285|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2398262|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2398263|NCT00702819|Bevacizumab|bevacizumab|mesh-list
2524286|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
2524287|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2524288|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2524289|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2524290|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2524291|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2524292|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2524293|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
2524294|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
2524295|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
2524296|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524297|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524298|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
2524299|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524300|NCT01349764|Vitamin D|vitamin d|mesh-list
2524301|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
2524302|NCT01349764|Vitamins|vitamins|mesh-ancestor
2524303|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
2524304|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524305|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2524306|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2398264|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2398265|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398266|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2398267|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2398268|NCT00702819|Growth Substances|growth substances|mesh-ancestor
2398269|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398270|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
2398271|NCT00702871|Ranitidine|ranitidine|mesh-list
2524307|NCT01349777|Clopidogrel|clopidogrel|mesh-list
2524308|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2524309|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2524310|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2524311|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2524312|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
2524313|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524314|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524315|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524316|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
2524317|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2524318|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524319|NCT01349868|Formoterol Fumarate|formoterol fumarate|mesh-list
2398272|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2398273|NCT00702871|Sucralfate|sucralfate|mesh-list
2398274|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2398275|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2398276|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2398277|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
2398278|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
2398279|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2398280|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398281|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398282|NCT00702936|Telmisartan|telmisartan|mesh-list
2398283|NCT00702936|Ramipril|ramipril|mesh-list
2398284|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2524320|NCT01349868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2524321|NCT01349868|Autonomic Agents|autonomic agents|mesh-ancestor
2524322|NCT01349868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524323|NCT01349868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524324|NCT01349868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2524325|NCT01349868|Respiratory System Agents|respiratory system agents|mesh-ancestor
2524326|NCT01349868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2524327|NCT01349868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2524328|NCT01349868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2524329|NCT01349868|Adrenergic Agents|adrenergic agents|mesh-ancestor
2524330|NCT01349868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524331|NCT01349868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524332|NCT01350024|Lidocaine|lidocaine|mesh-list
2524333|NCT01350024|Epinephrine|epinephrine|mesh-list
2524334|NCT01350024|Racepinephrine|racepinephrine|mesh-list
2398285|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2398286|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2398287|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398288|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2398289|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
2398290|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524335|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
2524336|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
2524337|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
2524338|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524339|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524340|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
2398291|NCT00702975|Paclitaxel|paclitaxel|mesh-list
2398292|NCT00702975|Bevacizumab|bevacizumab|mesh-list
2398293|NCT00702975|Carboplatin|carboplatin|mesh-list
2398294|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2398295|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2398296|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398297|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
2398298|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
2398299|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
2398300|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398301|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2398302|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2398303|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2398304|NCT00702975|Growth Substances|growth substances|mesh-ancestor
2398305|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398306|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
2398307|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2398308|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398309|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2398310|NCT00702988|Hormones|hormones|mesh-ancestor
2398311|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2398312|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398313|NCT00703066|Vaccines|vaccines|mesh-list
2398314|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
2398315|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398316|NCT00703079|Octreotide|octreotide|mesh-list
2398317|NCT00703079|Lanreotide|lanreotide|mesh-list
2398318|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2524341|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524342|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2524343|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2524344|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2524345|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2524346|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398319|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2398320|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398321|NCT00703105|Vaccines|vaccines|mesh-list
2398322|NCT00703105|Immunologic Factors|immunologic factors|mesh-ancestor
2398323|NCT00703105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398324|NCT00703144|Tazobactam|tazobactam|mesh-list
2398325|NCT00703144|Piperacillin|piperacillin|mesh-list
2398326|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2398327|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2398328|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398329|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2398330|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398331|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398332|NCT00703170|Sirolimus|sirolimus|mesh-list
2398333|NCT00703170|Doxorubicin|doxorubicin|mesh-list
2398334|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2398335|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2398336|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398337|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2398338|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2398339|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398340|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398341|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2398342|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398343|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
2398344|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2398345|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
2398346|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524347|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2524348|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2524349|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
2524350|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2398347|NCT00703196|Folic Acid|folic acid|mesh-list
2398348|NCT00703196|Hematinics|hematinics|mesh-ancestor
2398349|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
2398350|NCT00703196|Vitamins|vitamins|mesh-ancestor
2398351|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
2398352|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398353|NCT00703222|Interleukin-2|interleukin-2|mesh-list
2398354|NCT00703222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398355|NCT00703222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2398356|NCT00703222|Analgesics|analgesics|mesh-ancestor
2524351|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2524352|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2524353|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
2524354|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2524355|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
2524356|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
2524357|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
2524358|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2524359|NCT01350037|Remifentanil|remifentanil|mesh-list
2524360|NCT01350037|Alfentanil|alfentanil|mesh-list
2524361|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2398357|NCT00703222|Sensory System Agents|sensory system agents|mesh-ancestor
2398358|NCT00703222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2398359|NCT00703222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398360|NCT00703235|Bevacizumab|bevacizumab|mesh-list
2398361|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2398362|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398363|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2398364|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2398365|NCT00703235|Growth Substances|growth substances|mesh-ancestor
2398366|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398367|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
2398368|NCT00703300|Bortezomib|bortezomib|mesh-list
2398369|NCT00703300|Decitabine|decitabine|mesh-list
2398370|NCT00703300|Azacitidine|azacitidine|mesh-list
2398371|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398372|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2398373|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
2398374|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398375|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398376|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
2398377|NCT00703313|Levofloxacin|levofloxacin|mesh-list
2398378|NCT00703313|Ofloxacin|ofloxacin|mesh-list
2398379|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
2398380|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2398381|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2524362|NCT01350037|Narcotics|narcotics|mesh-ancestor
2524363|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524364|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398382|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2398383|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2398384|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398385|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2398386|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2398387|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398388|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524365|NCT01350037|Analgesics|analgesics|mesh-ancestor
2524366|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
2524367|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524368|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2524369|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
2524370|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
2524371|NCT01350050|Carticaine|carticaine|mesh-list
2524372|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
2524373|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
2524374|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524375|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524376|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
2524377|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524378|NCT01350063|Troclosene|troclosene|mesh-list
2524379|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
2524380|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524381|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
2524382|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
2524383|NCT01350089|Ethanol|ethanol|mesh-list
2524384|NCT01350089|Caffeine|caffeine|mesh-list
2524385|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2398389|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398390|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2398391|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
2524386|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524387|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524388|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524389|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2524390|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2524391|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524392|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524393|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2524394|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2524395|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
2524396|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524397|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
2524398|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
2524399|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2524400|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2524401|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524402|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524403|NCT01350154|Urological Agents|urological agents|mesh-ancestor
2524404|NCT01350323|Bevacizumab|bevacizumab|mesh-list
2524405|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2524406|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524407|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2524408|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2524409|NCT01350323|Growth Substances|growth substances|mesh-ancestor
2524410|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524411|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
2524412|NCT01350570|Loperamide|loperamide|mesh-list
2398392|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2398393|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398394|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2398395|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2398396|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2398397|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2398398|NCT00703313|Renal Agents|renal agents|mesh-ancestor
2398399|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2398400|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2398401|NCT00703352|Eplerenone|eplerenone|mesh-list
2398402|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2398403|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
2398404|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2398405|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398406|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2398407|NCT00703352|Diuretics|diuretics|mesh-ancestor
2524413|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
2524414|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2524415|NCT01350596|Ibuprofen|ibuprofen|mesh-list
2524416|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2524417|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2524418|NCT01350596|Analgesics|analgesics|mesh-ancestor
2524419|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
2524420|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524421|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524422|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2524423|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2524424|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2524425|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524426|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524427|NCT01350609|Candesartan|candesartan|mesh-list
2524428|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
2524429|NCT01350609|Nifedipine|nifedipine|mesh-list
2524430|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2524431|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2524432|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2524433|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398408|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
2398409|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2398410|NCT00703365|Gemcitabine|gemcitabine|mesh-list
2398411|NCT00703365|Sorafenib|sorafenib|mesh-list
2398412|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2398413|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
2398414|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398415|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398416|NCT00703365|Antiviral Agents|antiviral agents|mesh-ancestor
2398417|NCT00703365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398418|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398419|NCT00703365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2398420|NCT00703365|Immunologic Factors|immunologic factors|mesh-ancestor
2398421|NCT00703365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398422|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2398423|NCT00703378|Docetaxel|docetaxel|mesh-list
2398424|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398425|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
2398426|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
2398427|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
2398428|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398429|NCT00703430|Memantine|memantine|mesh-list
2398430|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2398431|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2398432|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
2398433|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2398434|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398435|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398436|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2524434|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2524435|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2524436|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2524437|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398437|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2398438|NCT00703469|Nivolumab|nivolumab|mesh-list
2398439|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2398440|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398441|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2398442|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398443|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
2398444|NCT00703482|Ubiquinone|ubiquinone|mesh-list
2398445|NCT00703482|Fenofibrate|fenofibrate|mesh-list
2524438|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
2524439|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
2524440|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2524441|NCT01350622|Diclofenac|diclofenac|mesh-list
2524442|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
2524443|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2398446|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2398447|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
2398448|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398449|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2398450|NCT00703482|Vitamins|vitamins|mesh-ancestor
2398451|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
2398452|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398453|NCT00703586|Maraviroc|maraviroc|mesh-list
2398454|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2398455|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2398456|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398457|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2398458|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2524444|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2524445|NCT01350622|Analgesics|analgesics|mesh-ancestor
2524446|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
2524447|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524448|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524449|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2524450|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2524451|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2524452|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524453|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524454|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
2524455|NCT01350713|Povidone|povidone|mesh-list
2524456|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
2524457|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
2398459|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
2398460|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398461|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2398462|NCT00703625|Sirolimus|sirolimus|mesh-list
2398463|NCT00703625|Docetaxel|docetaxel|mesh-list
2398464|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398465|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
2398466|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
2398467|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
2524458|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2524459|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524460|NCT01350817|Docetaxel|docetaxel|mesh-list
2524461|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2524462|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524463|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
2524464|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
2524465|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
2524466|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524467|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2398468|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398469|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2398470|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398471|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2398472|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
2398473|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2398474|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
2398475|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398476|NCT00703638|Pemetrexed|pemetrexed|mesh-list
2398477|NCT00703638|Sorafenib|sorafenib|mesh-list
2398478|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398479|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398480|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524468|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524469|NCT01350856|Artesunate|artesunate|mesh-list
2524470|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
2524471|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2524472|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2524473|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524474|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524475|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
2524476|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
2524477|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2524478|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
2524479|NCT01350882|Rituximab|rituximab|mesh-list
2524480|NCT01350882|Citric Acid|citric acid|mesh-list
2524481|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
2524482|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2524483|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524484|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
2524485|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524486|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2524487|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
2524488|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2524489|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
2524490|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
2524491|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524492|NCT01350921|Ticagrelor|ticagrelor|mesh-list
2524493|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2524494|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2524495|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2524496|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2524497|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
2524498|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524499|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524500|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524501|NCT01351038|Capecitabine|capecitabine|mesh-list
2524502|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
2524503|NCT01351038|Panitumumab|panitumumab|mesh-list
2398481|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2398482|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2398483|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2524504|NCT01351038|Epirubicin|epirubicin|mesh-list
2524505|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2524506|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
2524507|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524508|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524509|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2524510|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2524511|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2398484|NCT00703651|Vaccines|vaccines|mesh-list
2398485|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
2398486|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398487|NCT00703690|Fenofibrate|fenofibrate|mesh-list
2398488|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2524512|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2524513|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524520|NCT01351168|Levodopa|levodopa|mesh-list
2524521|NCT01351168|Zolpidem|zolpidem|mesh-list
2524522|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2524523|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2524524|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
2524525|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524526|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524527|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524528|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2524529|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2524530|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524531|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2524532|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
2524533|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
2524534|NCT01351272|Methylphenidate|methylphenidate|mesh-list
2524535|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2524536|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524537|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2524538|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2524539|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2524540|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524541|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
2398489|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
2398490|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398491|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2524542|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524543|NCT01351285|Remifentanil|remifentanil|mesh-list
2524544|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2524545|NCT01351285|Narcotics|narcotics|mesh-ancestor
2524546|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524547|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524548|NCT01351285|Analgesics|analgesics|mesh-ancestor
2524549|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
2524550|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524551|NCT01351298|Lidocaine|lidocaine|mesh-list
2524552|NCT01351298|Xylometazoline|xylometazoline|mesh-list
2524553|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
2524554|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
2524555|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524556|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524557|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
2524558|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524559|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2524560|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2524561|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2524562|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2524563|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524564|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
2524565|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2524566|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
2524567|NCT01351428|Nifedipine|nifedipine|mesh-list
2524568|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2398492|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2398493|NCT00703703|Darifenacin|darifenacin|mesh-list
2398494|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2398495|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2398496|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
2398497|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2398498|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398499|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398500|NCT00703703|Urological Agents|urological agents|mesh-ancestor
2398501|NCT00703742|Citalopram|citalopram|mesh-list
2398502|NCT00703742|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2398503|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2398504|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2398505|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524569|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2524570|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524571|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2398506|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2398507|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
2398508|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398509|NCT00703742|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2398510|NCT00703742|Antidepressive Agents|antidepressive agents|mesh-ancestor
2398511|NCT00703742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2398512|NCT00703755|Metformin|metformin|mesh-list
2398513|NCT00703755|Fenofibrate|fenofibrate|mesh-list
2398514|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2398515|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398516|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2398517|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
2398518|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398519|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2398520|NCT00703807|Everolimus|everolimus|mesh-list
2398521|NCT00703807|Topotecan|topotecan|mesh-list
2524572|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524573|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
2524574|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
2398522|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398523|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2398524|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
2398525|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398526|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2398527|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2398528|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398529|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398530|NCT00703872|Interferons|interferons|mesh-list
2398531|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398532|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
2398533|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524575|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2524576|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
2524577|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2524578|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
2524579|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2398534|NCT00703898|Nevirapine|nevirapine|mesh-list
2398535|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2398536|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2398537|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398538|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398539|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
2398540|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398541|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2398542|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2398543|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2398544|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2398545|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
2398546|NCT00703989|Benphothiamine|benphothiamine|mesh-list
2398547|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
2398548|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524580|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524581|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2524582|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
2524583|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2524584|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
2524585|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524586|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524587|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2524588|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
2524589|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
2524590|NCT01351493|Protective Agents|protective agents|mesh-ancestor
2524591|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2524592|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2524593|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
2524594|NCT01351597|Docetaxel|docetaxel|mesh-list
2524595|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
2524596|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524597|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
2524598|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
2524599|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
2524600|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398549|NCT00703989|Protective Agents|protective agents|mesh-ancestor
2524601|NCT01351636|Arotinolol|arotinolol|mesh-list
2524602|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2524603|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2524604|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
2524605|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524606|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524607|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524608|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2524609|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2524610|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2524611|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
2524612|NCT01351818|Hormones|hormones|mesh-list
2524613|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2524614|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398550|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398551|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
2398552|NCT00703989|Vitamins|vitamins|mesh-ancestor
2398553|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
2398554|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2398555|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
2398556|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
2398557|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
2398558|NCT00704080|Temozolomide|temozolomide|mesh-list
2398559|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2398560|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
2398561|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398562|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398563|NCT00704106|Entecavir|entecavir|mesh-list
2398564|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
2398565|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398566|NCT00704145|Paclitaxel|paclitaxel|mesh-list
2398567|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2398568|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398569|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
2398570|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
2398571|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
2398572|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398573|NCT00704158|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
2398574|NCT00704158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2398575|NCT00704158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398576|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
2398577|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
2398578|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2398579|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398580|NCT00704249|Nevirapine|nevirapine|mesh-list
2398581|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2398582|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2398583|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398584|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398585|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
2398586|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398587|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2398588|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2398589|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2398590|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2398591|NCT00704275|Cyclosporine|cyclosporine|mesh-list
2398592|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2398593|NCT00704275|Cyclosporins|cyclosporins|mesh-list
2398594|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398595|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524638|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2524639|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2524640|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
2524641|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524642|NCT01351948|Antacids|antacids|mesh-ancestor
2524643|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524644|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2524645|NCT01352026|Metformin|metformin|mesh-list
2524646|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2524647|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524648|NCT01352039|Heparin|heparin|mesh-list
2524649|NCT01352039|Calcium heparin|calcium heparin|mesh-list
2524650|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
2524651|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2524652|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2398596|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2398597|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
2398598|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398599|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
2398600|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398601|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
2398602|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2398603|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2398604|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2398605|NCT00704301|Rivastigmine|rivastigmine|mesh-list
2398606|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2398607|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398608|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398609|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
2398610|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2398611|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398612|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2398613|NCT00704301|Protective Agents|protective agents|mesh-ancestor
2398614|NCT00704314|Simvastatin|simvastatin|mesh-list
2398615|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2398616|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2398617|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
2398618|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398619|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2398620|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2398621|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398622|NCT00704366|Saracatinib|saracatinib|mesh-list
2398623|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398624|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398625|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398626|NCT00704392|XL647|xl647|mesh-list
2398627|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398628|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2398629|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398630|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398631|NCT00704431|Darapladib|darapladib|mesh-list
2398632|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2398633|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398634|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398635|NCT00704444|Ezetimibe|ezetimibe|mesh-list
2398636|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2398637|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2398638|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
2398639|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398640|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2398641|NCT00704483|Ferric Compounds|ferric compounds|mesh-list
2398642|NCT00704483|Sevelamer|sevelamer|mesh-list
2398643|NCT00704483|Chelating Agents|chelating agents|mesh-ancestor
2398644|NCT00704483|Sequestering Agents|sequestering agents|mesh-ancestor
2398645|NCT00704483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524653|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524654|NCT01352065|Bosentan|bosentan|mesh-list
2524655|NCT01352065|Ambrisentan|ambrisentan|mesh-list
2524656|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2524657|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2524658|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524659|NCT01352091|Goserelin|goserelin|mesh-list
2524660|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2524661|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524662|NCT01352130|Ondansetron|ondansetron|mesh-list
2524663|NCT01352130|Granisetron|granisetron|mesh-list
2524664|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
2524665|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
2524666|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
2524667|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524668|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524669|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2524670|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
2524671|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
2524672|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2524673|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
2524674|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524675|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524676|NCT01352130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2524677|NCT01352130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2524678|NCT01352130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524679|NCT01352130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2524680|NCT01352130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2524681|NCT01352143|Thrombin|thrombin|mesh-list
2524682|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
2524683|NCT01352143|Coagulants|coagulants|mesh-ancestor
2524684|NCT01352234|Aspirin|aspirin|mesh-list
2524685|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2524686|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2524687|NCT01352234|Analgesics|analgesics|mesh-ancestor
2524688|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
2524689|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524690|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524691|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2524692|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2524693|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2398646|NCT00704483|Hematinics|hematinics|mesh-ancestor
2398647|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2398648|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
2398649|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2398650|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2398651|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2398652|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2398653|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398654|NCT00704548|Simvastatin|simvastatin|mesh-list
2398655|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2398656|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2398657|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
2398658|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398659|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2398660|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2398661|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398662|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
2398663|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2398664|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398665|NCT00704600|Nelfinavir|nelfinavir|mesh-list
2398666|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2398667|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2398668|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
2398669|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398670|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398671|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2398672|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2398673|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
2398674|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398675|NCT00704639|Carboplatin|carboplatin|mesh-list
2398676|NCT00704639|Cetuximab|cetuximab|mesh-list
2398677|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398678|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2398679|NCT00704665|Methocarbamol|methocarbamol|mesh-list
2524694|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2524695|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524696|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2524697|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2524698|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524699|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
2524700|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
2524701|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
2524702|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
2524703|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2524704|NCT01352312|Ofatumumab|ofatumumab|mesh-list
2524705|NCT01352312|Pentostatin|pentostatin|mesh-list
2524706|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2524707|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
2524708|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524709|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524710|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2524711|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524712|NCT01352338|Prednisone|prednisone|mesh-list
2524713|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
2524714|NCT01352338|Lenalidomide|lenalidomide|mesh-list
2524715|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2524716|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
2524717|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524718|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2524719|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2524720|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
2524721|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524722|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524723|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2524724|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2524725|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
2524726|NCT01352338|Hormones|hormones|mesh-ancestor
2524727|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2524728|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2524729|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2398680|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2398681|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398682|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2398683|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2398684|NCT00704678|Sevelamer|sevelamer|mesh-list
2398685|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
2398686|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
2398687|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398688|NCT00704691|Lenalidomide|lenalidomide|mesh-list
2398689|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
2398690|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398691|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2524730|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2524731|NCT01352338|Growth Substances|growth substances|mesh-ancestor
2524732|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
2524733|NCT01352494|Gemcitabine|gemcitabine|mesh-list
2524734|NCT01352494|Docetaxel|docetaxel|mesh-list
2524735|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2524736|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
2524737|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524738|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524739|NCT01352494|Antiviral Agents|antiviral agents|mesh-ancestor
2524740|NCT01352494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524741|NCT01352494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524742|NCT01352494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2524743|NCT01352494|Immunologic Factors|immunologic factors|mesh-ancestor
2524744|NCT01352494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398692|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2398693|NCT00704691|Growth Substances|growth substances|mesh-ancestor
2398694|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
2398695|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398696|NCT00704704|Thalidomide|thalidomide|mesh-list
2398697|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2524745|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
2524746|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
2524747|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
2524748|NCT01352559|Milnacipran|milnacipran|mesh-list
2524749|NCT01352559|Mirtazapine|mirtazapine|mesh-list
2524750|NCT01352559|Sertraline|sertraline|mesh-list
2524751|NCT01352559|Fluoxetine|fluoxetine|mesh-list
2398698|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
2524752|NCT01352559|Paroxetine|paroxetine|mesh-list
2524753|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2398699|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398700|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
2398701|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2398702|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398703|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2398704|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2398705|NCT00704704|Growth Substances|growth substances|mesh-ancestor
2398706|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
2398707|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524754|NCT01352559|Nortriptyline|nortriptyline|mesh-list
2524755|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
2524756|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2524757|NCT01352559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2524758|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2524759|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2524760|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524761|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524762|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
2524763|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524764|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2398708|NCT00704743|Calpastatin|calpastatin|mesh-list
2398709|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2398710|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
2398711|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398712|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398713|NCT00704756|Ribavirin|ribavirin|mesh-list
2398714|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2398715|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
2398716|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
2398717|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398718|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
2398719|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398720|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
2398721|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398722|NCT00704821|Docetaxel|docetaxel|mesh-list
2398723|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398724|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
2398725|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
2398726|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
2524765|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2524766|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2524767|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524768|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2398727|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398728|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
2398729|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2398730|NCT00704899|Amitriptyline|amitriptyline|mesh-list
2398731|NCT00704899|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2398732|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2398733|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
2398734|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2398735|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2398736|NCT00704899|Analgesics|analgesics|mesh-ancestor
2398737|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
2398738|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2398739|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398740|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2398741|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2398742|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2398743|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398744|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
2398745|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2398746|NCT00704899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2398747|NCT00704899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2524769|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2398748|NCT00704899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2398749|NCT00704925|Amifampridine|amifampridine|mesh-list
2398750|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2398751|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2398752|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398753|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2398754|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2524770|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
2524771|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
2524772|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2524773|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2524774|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524775|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2524776|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2398755|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398756|NCT00704951|Posaconazole|posaconazole|mesh-list
2398757|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
2398758|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398759|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2398760|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2398761|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2398762|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2398763|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2398764|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398765|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398766|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2398767|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
2398768|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2398769|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398770|NCT00704990|Vitamins|vitamins|mesh-list
2398771|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
2398772|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
2398773|NCT00704990|Pyridoxal|pyridoxal|mesh-list
2398774|NCT00704990|Pyridoxine|pyridoxine|mesh-list
2398775|NCT00704990|Zinc|zinc|mesh-list
2398776|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
2398777|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
2398778|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398779|NCT00704990|Trace Elements|trace elements|mesh-ancestor
2398780|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
2398781|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398782|NCT00704990|Protective Agents|protective agents|mesh-ancestor
2398783|NCT00705042|Etanercept|etanercept|mesh-list
2398784|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2398785|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2398786|NCT00705042|Analgesics|analgesics|mesh-ancestor
2524777|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2524778|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
2524779|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2524780|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2524781|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2524782|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2524783|NCT01352559|Analgesics|analgesics|mesh-ancestor
2524784|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
2524785|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524786|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2398787|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
2398788|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2398789|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398790|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2398791|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2398792|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2398793|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2398794|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
2398795|NCT00705120|Cyclosporine|cyclosporine|mesh-list
2398796|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
2398797|NCT00705120|Busulfan|busulfan|mesh-list
2524787|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2524788|NCT01352572|Milnacipran|milnacipran|mesh-list
2524789|NCT01352572|Mirtazapine|mirtazapine|mesh-list
2524790|NCT01352572|Sertraline|sertraline|mesh-list
2524791|NCT01352572|Fluoxetine|fluoxetine|mesh-list
2524792|NCT01352572|Paroxetine|paroxetine|mesh-list
2524793|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2524794|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
2524795|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
2524796|NCT01352572|Nortriptyline|nortriptyline|mesh-list
2524797|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2524798|NCT01352572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2398798|NCT00705120|Cyclosporins|cyclosporins|mesh-list
2398799|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2398800|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
2398801|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398802|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2524799|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2398803|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2398804|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
2398805|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398806|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398807|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2398808|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398809|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
2398810|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398811|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
2398812|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2398813|NCT00705198|Temozolomide|temozolomide|mesh-list
2398814|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2398815|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
2398816|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398817|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398818|NCT00705211|Ezetimibe|ezetimibe|mesh-list
2398819|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2398820|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2398821|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
2398822|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398823|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2398824|NCT00705315|Bevacizumab|bevacizumab|mesh-list
2398825|NCT00705315|Docetaxel|docetaxel|mesh-list
2398826|NCT00705315|Epirubicin|epirubicin|mesh-list
2398827|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2398828|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398829|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2398830|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2398831|NCT00705315|Growth Substances|growth substances|mesh-ancestor
2398832|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398833|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
2398834|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
2398835|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
2398836|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
2398837|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398838|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2524800|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2524801|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524802|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524803|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
2524804|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524805|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2524806|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2524807|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2524808|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524809|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2524810|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2524811|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
2524812|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
2524813|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2524814|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2398839|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2398840|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2398841|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398842|NCT00705354|Bacitracin|bacitracin|mesh-list
2398843|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2398844|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398845|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2398846|NCT00705419|Tenofovir|tenofovir|mesh-list
2398847|NCT00705419|Emtricitabine|emtricitabine|mesh-list
2398848|NCT00705419|Maleic acid|maleic acid|mesh-list
2398849|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
2398850|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398851|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2398852|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2398853|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398854|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398855|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2398856|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2398857|NCT00705445|Zinc|zinc|mesh-list
2398858|NCT00705445|Trace Elements|trace elements|mesh-list
2398859|NCT00705445|Micronutrients|micronutrients|mesh-list
2398860|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398861|NCT00705471|Infliximab|infliximab|mesh-list
2398862|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
2398863|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2524815|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524816|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2524817|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2524818|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2524819|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
2524820|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2524821|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2524822|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2524823|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2524824|NCT01352572|Analgesics|analgesics|mesh-ancestor
2524825|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
2524826|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524827|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2524828|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2524829|NCT01352611|Baclofen|baclofen|mesh-list
2524830|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2524831|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524832|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2524833|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524834|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2524835|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
2524836|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
2524837|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524838|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524839|NCT01352650|Plerixafor|plerixafor|mesh-list
2524840|NCT01352650|Decitabine|decitabine|mesh-list
2524841|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2398864|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2398865|NCT00705510|Cyclosporine|cyclosporine|mesh-list
2398866|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2398867|NCT00705510|Cyclosporins|cyclosporins|mesh-list
2398868|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398869|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398870|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2398871|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
2398872|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398873|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
2398874|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398875|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
2398876|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2398877|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2398878|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2398879|NCT00705549|Gemcitabine|gemcitabine|mesh-list
2398880|NCT00705549|Cisplatin|cisplatin|mesh-list
2398881|NCT00705549|Docetaxel|docetaxel|mesh-list
2524842|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
2524843|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524844|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524845|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524846|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2524847|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2524848|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
2524849|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524850|NCT01352663|Insulin|insulin|mesh-list
2524851|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
2524852|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2524853|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524854|NCT01352702|Dabigatran|dabigatran|mesh-list
2524855|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
2524856|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
2524857|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2524858|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
2524859|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398882|NCT00705549|Vinorelbine|vinorelbine|mesh-list
2398883|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398884|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2398885|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
2398886|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398887|NCT00705549|Antiviral Agents|antiviral agents|mesh-ancestor
2398888|NCT00705549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398889|NCT00705549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398890|NCT00705549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2398891|NCT00705549|Immunologic Factors|immunologic factors|mesh-ancestor
2398892|NCT00705549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524860|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524861|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
2524862|NCT01352728|Axitinib|axitinib|mesh-list
2398893|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
2398894|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
2398895|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
2398896|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2398897|NCT00705562|Caseins|caseins|mesh-list
2398898|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
2398899|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
2398900|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398901|NCT00705588|Tadalafil|tadalafil|mesh-list
2398902|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2398903|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
2398904|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2524863|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524864|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2524865|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524866|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398905|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2398906|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2398907|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398908|NCT00705588|Urological Agents|urological agents|mesh-ancestor
2398909|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
2398910|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2398911|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
2398912|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398913|NCT00705692|Levamisole|levamisole|mesh-list
2398914|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2398915|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
2398916|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398917|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
2398918|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
2398919|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2398920|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398921|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2398922|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
2398923|NCT00705770|Anecortave|anecortave|mesh-list
2524884|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2524885|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
2524886|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2524887|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
2524888|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524889|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
2524890|NCT01353170|Calcium|calcium|mesh-list
2524891|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2524892|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524893|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2524894|NCT01353209|Letrozole|letrozole|mesh-list
2524895|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524896|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2524897|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2524898|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524899|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524900|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2524901|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
2524902|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2398924|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2398925|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2398926|NCT00705770|Growth Substances|growth substances|mesh-ancestor
2398927|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398928|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
2398929|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398930|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2398931|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
2398932|NCT00705796|Testosterone|testosterone|mesh-list
2398933|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
2398934|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
2398935|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2398936|NCT00705796|Androgens|androgens|mesh-ancestor
2398937|NCT00705796|Hormones|hormones|mesh-ancestor
2398938|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2398939|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398940|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2398941|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398942|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
2398943|NCT00705822|Prednisone|prednisone|mesh-list
2398944|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
2398945|NCT00705822|Docetaxel|docetaxel|mesh-list
2398946|NCT00705822|Estramustine|estramustine|mesh-list
2398947|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398948|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
2398949|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
2398950|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
2398951|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398952|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2398953|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
2398954|NCT00705822|Hormones|hormones|mesh-ancestor
2398955|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2398956|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398957|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2398958|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2398959|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
2398960|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2398961|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2398962|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
2398963|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398964|NCT00705835|Antacids|antacids|mesh-ancestor
2398965|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398966|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2398967|NCT00705900|Calcipotriene|calcipotriene|mesh-list
2398968|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
2524903|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524904|NCT01353235|Prednisolone|prednisolone|mesh-list
2524905|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2524906|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
2524907|NCT01353235|Hormones|hormones|mesh-ancestor
2524908|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2524909|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524910|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2524911|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524912|NCT01353248|Ribavirin|ribavirin|mesh-list
2524913|NCT01353248|Ledipasvir|ledipasvir|mesh-list
2524914|NCT01353248|Antimetabolites|antimetabolites|mesh-ancestor
2398969|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2398970|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
2398971|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2398972|NCT00705978|Pancreatin|pancreatin|mesh-list
2398973|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2398974|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
2398975|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2398976|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398977|NCT00706069|Capecitabine|capecitabine|mesh-list
2398978|NCT00706069|Vinorelbine|vinorelbine|mesh-list
2398979|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2398980|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
2398981|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398982|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2398983|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2398984|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
2398985|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
2398986|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
2398987|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
2398988|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2398989|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
2524915|NCT01353248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2398990|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2398991|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2398992|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
2398993|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
2398994|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2398995|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2398996|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
2398997|NCT00706225|Estrogens|estrogens|mesh-list
2398998|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2398999|NCT00706225|Hormones|hormones|mesh-ancestor
2399000|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399001|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399002|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2399003|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2399004|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
2399005|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2399006|NCT00706277|Fentanyl|fentanyl|mesh-list
2399007|NCT00706277|Remifentanil|remifentanil|mesh-list
2399008|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
2399009|NCT00706277|Propofol|propofol|mesh-list
2399010|NCT00706277|Sevoflurane|sevoflurane|mesh-list
2399011|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2399012|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2399013|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399014|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2399015|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
2524916|NCT01353248|Antiviral Agents|antiviral agents|mesh-ancestor
2524917|NCT01353248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524918|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
2524919|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2524920|NCT01353339|Levofloxacin|levofloxacin|mesh-list
2524921|NCT01353339|Ofloxacin|ofloxacin|mesh-list
2524922|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2524923|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524924|NCT01353339|Renal Agents|renal agents|mesh-ancestor
2524925|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2524926|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2524927|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2524928|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524929|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524930|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524931|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2524932|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2524933|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
2524934|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2524935|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524936|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524937|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2524938|NCT01353378|Analgesics|analgesics|mesh-ancestor
2524939|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
2399016|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
2399017|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2399018|NCT00706277|Narcotics|narcotics|mesh-ancestor
2399019|NCT00706277|Analgesics|analgesics|mesh-ancestor
2399020|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
2399021|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399022|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2399023|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2399024|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2399025|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2399026|NCT00706576|Mitogens|mitogens|mesh-list
2399027|NCT00706576|Enkephalin, Methionine|enkephalin, methionine|mesh-list
2399028|NCT00706576|Enkephalins|enkephalins|mesh-list
2399029|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524940|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524941|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2524942|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2524943|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2524944|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
2524945|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524946|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524947|NCT01353391|Metformin|metformin|mesh-list
2399030|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
2399031|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399032|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524948|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2524949|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524950|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
2524951|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2524952|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2524953|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524954|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2524955|NCT01353456|Analgesics|analgesics|mesh-ancestor
2524956|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
2524957|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2524958|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2524959|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2524960|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2524961|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
2399033|NCT00706680|Cyclosporine|cyclosporine|mesh-list
2399034|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
2399035|NCT00706680|Prednisone|prednisone|mesh-list
2399036|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2399037|NCT00706680|Cyclosporins|cyclosporins|mesh-list
2399038|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
2399039|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2399040|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
2399041|NCT00706680|Hormones|hormones|mesh-ancestor
2399042|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399043|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399044|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2399045|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399046|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524962|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2524963|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524964|NCT01353469|Insulin|insulin|mesh-list
2524965|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2524966|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2524967|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2524968|NCT01353482|Pemetrexed|pemetrexed|mesh-list
2524969|NCT01353482|Vorinostat|vorinostat|mesh-list
2524970|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524971|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524972|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524973|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2399047|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399048|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2399049|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
2524974|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2524975|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2524976|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
2524977|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2524978|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
2524979|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2524980|NCT01353716|Dolutegravir|dolutegravir|mesh-list
2399050|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
2399051|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399052|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
2399053|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2399054|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2399055|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2399056|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2524981|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2524982|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2524983|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524984|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524985|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2524986|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2524987|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
2524988|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524989|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
2524990|NCT01353729|Zanamivir|zanamivir|mesh-list
2524991|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2524992|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2524993|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2524994|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2524995|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2524996|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2524997|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2524998|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2524999|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2399057|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
2399058|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2399059|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2399060|NCT00706680|Protective Agents|protective agents|mesh-ancestor
2399061|NCT00706862|Lactoferrin|lactoferrin|mesh-list
2399062|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
2399063|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399064|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399065|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
2399066|NCT00706888|Pyridoxal|pyridoxal|mesh-list
2399067|NCT00706888|Pyridoxine|pyridoxine|mesh-list
2399068|NCT00706888|Vitamins|vitamins|mesh-ancestor
2399069|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
2399070|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399071|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
2399072|NCT00706927|Timolol|timolol|mesh-list
2399073|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2399074|NCT00706927|Latanoprost|latanoprost|mesh-list
2399075|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2399076|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2399077|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
2399078|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2399079|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399080|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399081|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2399082|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2399083|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2399084|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2399085|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2399086|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2399087|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2399088|NCT00706953|Doxorubicin|doxorubicin|mesh-list
2525000|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
2525001|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2525002|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525003|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2525004|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2525005|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2525006|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
2525007|NCT01353742|Lamivudine|lamivudine|mesh-list
2525008|NCT01353742|Adefovir|adefovir|mesh-list
2525009|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2525010|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2525011|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2525012|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525013|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525014|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
2525015|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525016|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2399089|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2399090|NCT00706953|Bortezomib|bortezomib|mesh-list
2399091|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2399092|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399093|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2399094|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2399095|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399096|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399097|NCT00707070|Acitretin|acitretin|mesh-list
2399098|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2399099|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
2399100|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399101|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
2399102|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
2399103|NCT00707083|Dexamethasone|dexamethasone|mesh-list
2399104|NCT00707083|Methotrexate|methotrexate|mesh-list
2399105|NCT00707083|Vincristine|vincristine|mesh-list
2399106|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
2399107|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2399108|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
2399109|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
2399110|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399111|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399112|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2399113|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
2399114|NCT00707083|Hormones|hormones|mesh-ancestor
2399115|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399116|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2399117|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525017|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2525018|NCT01353794|Sorafenib|sorafenib|mesh-list
2525019|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525020|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2525021|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525022|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525023|NCT01353833|Aldesleukin|aldesleukin|mesh-list
2525024|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525025|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2525026|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2525027|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
2399118|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2399119|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
2399120|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2399121|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2399122|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
2399123|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399124|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
2399125|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399126|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2399127|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2399128|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
2399129|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2399130|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2399131|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2399132|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
2399133|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
2399134|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
2399135|NCT00707135|Sirolimus|sirolimus|mesh-list
2399136|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2399137|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399138|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2399139|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399140|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
2399141|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2399142|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
2399143|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399144|NCT00707187|Tadalafil|tadalafil|mesh-list
2399145|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
2399146|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2399147|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2399148|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399149|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399150|NCT00707187|Urological Agents|urological agents|mesh-ancestor
2399151|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2399152|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399153|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2399154|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399155|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399156|NCT00707278|Capecitabine|capecitabine|mesh-list
2399157|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
2399158|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2399159|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
2399160|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399161|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399162|NCT00707304|Lactoferrin|lactoferrin|mesh-list
2399163|NCT00707304|Talactoferrin alfa|talactoferrin alfa|mesh-list
2399164|NCT00707304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399165|NCT00707304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399166|NCT00707330|Clarithromycin|clarithromycin|mesh-list
2399167|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2399168|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399169|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2399170|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399171|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399172|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2399173|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2399174|NCT00707369|Amoxicillin|amoxicillin|mesh-list
2399175|NCT00707369|Metronidazole|metronidazole|mesh-list
2399176|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2399177|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399178|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2399179|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2525028|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525029|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2525030|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2525031|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2525032|NCT01353846|Estradiol|estradiol|mesh-list
2525033|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2525034|NCT01353846|Progesterone|progesterone|mesh-list
2399180|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
2399181|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399182|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2399183|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399184|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525035|NCT01353846|Estrogens|estrogens|mesh-ancestor
2525036|NCT01353846|Hormones|hormones|mesh-ancestor
2525037|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2525038|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525039|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2525040|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
2525041|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2525042|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2525043|NCT01353846|Progestins|progestins|mesh-ancestor
2525044|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
2525045|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2525046|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399185|NCT00707421|Fluorometholone|fluorometholone|mesh-list
2399186|NCT00707421|Ketorolac|ketorolac|mesh-list
2399187|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2399188|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2399189|NCT00707421|Analgesics|analgesics|mesh-ancestor
2399190|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
2399191|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399192|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399193|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2399194|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2399195|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2399196|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399197|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399198|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
2399199|NCT00707421|Hormones|hormones|mesh-ancestor
2399200|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399201|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2399202|NCT00707473|Cisplatin|cisplatin|mesh-list
2399203|NCT00707473|Carboplatin|carboplatin|mesh-list
2399204|NCT00707473|Docetaxel|docetaxel|mesh-list
2399205|NCT00707473|Fluorouracil|fluorouracil|mesh-list
2399206|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399207|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
2399208|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
2399209|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
2399210|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399211|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
2399212|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2399213|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2399214|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
2399215|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399216|NCT00707512|Natalizumab|natalizumab|mesh-list
2525047|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
2525048|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2525049|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
2525050|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525051|NCT01353937|Plerixafor|plerixafor|mesh-list
2525052|NCT01353937|Becaplermin|becaplermin|mesh-list
2525053|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2525054|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2525055|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
2525056|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525057|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
2525058|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2525059|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2399217|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
2399218|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399219|NCT00707551|Ketoconazole|ketoconazole|mesh-list
2399220|NCT00707551|Verapamil|verapamil|mesh-list
2399221|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
2399222|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525060|NCT01353937|Growth Substances|growth substances|mesh-ancestor
2399223|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2525061|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525062|NCT01354158|Droxidopa|droxidopa|mesh-list
2399224|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2399225|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399226|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399227|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2399228|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
2399229|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399230|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399231|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2399232|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2399233|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2399234|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2399235|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2399236|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
2399237|NCT00707642|Vaccines|vaccines|mesh-list
2399238|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
2399239|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399240|NCT00707707|Paclitaxel|paclitaxel|mesh-list
2399241|NCT00707707|Olaparib|olaparib|mesh-list
2399242|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2399243|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399244|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
2399245|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
2399246|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
2399247|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399248|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2399249|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399250|NCT00707772|Ribavirin|ribavirin|mesh-list
2399251|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2399252|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
2525063|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2525064|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2525065|NCT01354262|Vitamin D|vitamin d|mesh-list
2525066|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
2525067|NCT01354262|Vitamins|vitamins|mesh-list
2525068|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
2525069|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525070|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2525071|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2525072|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2525073|NCT01354275|Hormones|hormones|mesh-ancestor
2525074|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2525075|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525076|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
2525077|NCT01354301|Everolimus|everolimus|mesh-list
2525078|NCT01354301|Tacrolimus|tacrolimus|mesh-list
2525079|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
2525080|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2525081|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
2525082|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399253|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
2399254|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399255|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
2399256|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399257|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
2399258|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399259|NCT00707785|Vitamin A|vitamin a|mesh-list
2399260|NCT00707785|Vitamins|vitamins|mesh-ancestor
2399261|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
2399262|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399263|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2399264|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
2399265|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399266|NCT00707824|Nalbuphine|nalbuphine|mesh-list
2525083|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2525084|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525085|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525086|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525087|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2525088|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2525089|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
2525090|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2525091|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525092|NCT01354405|Lanreotide|lanreotide|mesh-list
2525093|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525094|NCT01354418|Phenylephrine|phenylephrine|mesh-list
2399267|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2399268|NCT00707824|Narcotics|narcotics|mesh-ancestor
2399269|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2399270|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399271|NCT00707824|Analgesics|analgesics|mesh-ancestor
2399272|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
2399273|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399274|NCT00707850|Ribavirin|ribavirin|mesh-list
2399275|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2399276|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
2399277|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
2525095|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
2525096|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2525097|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
2399278|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399279|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
2399280|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399281|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
2399282|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399283|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2399284|NCT00707876|Hematinics|hematinics|mesh-ancestor
2399285|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2399286|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2399287|NCT00707889|Leucovorin|leucovorin|mesh-list
2399288|NCT00707889|Folic Acid|folic acid|mesh-list
2399289|NCT00707889|Bevacizumab|bevacizumab|mesh-list
2399290|NCT00707889|Fluorouracil|fluorouracil|mesh-list
2399291|NCT00707889|Oxaliplatin|oxaliplatin|mesh-list
2399292|NCT00707889|Levoleucovorin|levoleucovorin|mesh-list
2399293|NCT00707889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2399294|NCT00707889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399295|NCT00707889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2399296|NCT00707889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2399297|NCT00707889|Growth Substances|growth substances|mesh-ancestor
2399298|NCT00707889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525098|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
2525099|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525100|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525101|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
2525102|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2525103|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
2525104|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
2525105|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2525106|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2525107|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2525108|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
2525109|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2525110|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525111|NCT01354418|Protective Agents|protective agents|mesh-ancestor
2525112|NCT01354457|Epratuzumab|epratuzumab|mesh-list
2525113|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2525114|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525115|NCT01354470|Modafinil|modafinil|mesh-list
2525116|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2525117|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525118|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2525119|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2525120|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2525121|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525122|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
2399299|NCT00707889|Growth Inhibitors|growth inhibitors|mesh-ancestor
2399300|NCT00707889|Antimetabolites|antimetabolites|mesh-ancestor
2399301|NCT00707889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399302|NCT00707889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2399303|NCT00707889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2399304|NCT00707889|Immunologic Factors|immunologic factors|mesh-ancestor
2399305|NCT00707889|Antidotes|antidotes|mesh-ancestor
2399306|NCT00707889|Protective Agents|protective agents|mesh-ancestor
2399307|NCT00707889|Vitamin B Complex|vitamin b complex|mesh-ancestor
2525123|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2525124|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2525125|NCT01354483|Prednisolone|prednisolone|mesh-list
2525126|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
2525127|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
2525128|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2525129|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
2399308|NCT00707889|Vitamins|vitamins|mesh-ancestor
2399309|NCT00707889|Micronutrients|micronutrients|mesh-ancestor
2399310|NCT00707889|Hematinics|hematinics|mesh-ancestor
2399311|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
2399312|NCT00707902|Lidocaine|lidocaine|mesh-list
2399313|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
2399314|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
2399315|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2399316|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399317|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
2399318|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399319|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2399320|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2399321|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2399322|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2399323|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399324|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2399325|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399326|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
2525130|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2525131|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
2525132|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
2525133|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525134|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525135|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2525136|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
2525137|NCT01354483|Hormones|hormones|mesh-ancestor
2525138|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2525139|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2525140|NCT01354483|Protective Agents|protective agents|mesh-ancestor
2525141|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2525142|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525143|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
2525144|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2525145|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525146|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525147|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
2525148|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2525149|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2525150|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
2525151|NCT01354522|Docetaxel|docetaxel|mesh-list
2525152|NCT01354522|Doxorubicin|doxorubicin|mesh-list
2525153|NCT01354522|Capecitabine|capecitabine|mesh-list
2525154|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2525155|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
2525156|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525157|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2525158|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2525159|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
2525160|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525161|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399327|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
2399328|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
2399329|NCT00707941|Oseltamivir|oseltamivir|mesh-list
2399330|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
2525162|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2525163|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
2525164|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
2525165|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
2525166|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2525167|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2525168|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2525169|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525170|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2525171|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
2525172|NCT01354613|Amlodipine|amlodipine|mesh-list
2525173|NCT01354613|Dobutamine|dobutamine|mesh-list
2525174|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2525175|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2525176|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2525177|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525178|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2525179|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525180|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
2525181|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2525182|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
2525183|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
2399331|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399332|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399333|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525184|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525185|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2525186|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2525187|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2525188|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
2525189|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2525190|NCT01354613|Protective Agents|protective agents|mesh-ancestor
2525191|NCT01354665|Interferons|interferons|mesh-list
2525192|NCT01354665|Interferon-beta|interferon-beta|mesh-list
2525193|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
2525194|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525195|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
2525196|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525197|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
2525198|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525199|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2525200|NCT01354704|Enoxaparin|enoxaparin|mesh-list
2525201|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
2525202|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2525203|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2525204|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525205|NCT01354717|Fluorouracil|fluorouracil|mesh-list
2525206|NCT01354717|Antimetabolites|antimetabolites|mesh-ancestor
2525207|NCT01354717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525208|NCT01354717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2525209|NCT01354717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525210|NCT01354717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2525211|NCT01354717|Immunologic Factors|immunologic factors|mesh-ancestor
2525212|NCT01354717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525213|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2525214|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2525215|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2525216|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525217|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
2525218|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2399334|NCT00708149|Lansoprazole|lansoprazole|mesh-list
2399335|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
2399336|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2399337|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2399338|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2399339|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399340|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399341|NCT00708240|Citalopram|citalopram|mesh-list
2399342|NCT00708240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2399343|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2399344|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2399345|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399346|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2399347|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
2399348|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525219|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525220|NCT01354860|Lobeline|lobeline|mesh-list
2525221|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2525222|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
2525223|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525224|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525225|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2525226|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2525227|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
2399349|NCT00708240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2399350|NCT00708240|Antidepressive Agents|antidepressive agents|mesh-ancestor
2399351|NCT00708240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2399352|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2399353|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2399354|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2399355|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2399356|NCT00708292|Dexamethasone|dexamethasone|mesh-list
2399357|NCT00708292|Bortezomib|bortezomib|mesh-list
2399358|NCT00708292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2399359|NCT00708292|Antiemetics|antiemetics|mesh-ancestor
2399360|NCT00708292|Autonomic Agents|autonomic agents|mesh-ancestor
2399361|NCT00708292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399362|NCT00708292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399363|NCT00708292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2399364|NCT00708292|Glucocorticoids|glucocorticoids|mesh-ancestor
2525228|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2525229|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525230|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
2525231|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2525232|NCT01354886|Hormones|hormones|mesh-ancestor
2525233|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2525234|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525235|NCT01354925|Insulin|insulin|mesh-list
2525236|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2525237|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525238|NCT01354977|Resveratrol|resveratrol|mesh-list
2525239|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
2525240|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525241|NCT01354977|Protective Agents|protective agents|mesh-ancestor
2525242|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525243|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525244|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2525245|NCT01355120|Ipilimumab|ipilimumab|mesh-list
2525246|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2525247|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525248|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2525249|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525250|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
2525251|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2525252|NCT01355198|Glycine|glycine|mesh-list
2525253|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
2525254|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525255|NCT01355198|Expectorants|expectorants|mesh-ancestor
2525256|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
2399365|NCT00708292|Hormones|hormones|mesh-ancestor
2399366|NCT00708292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399367|NCT00708292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2399368|NCT00708292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399369|NCT00708318|Fentanyl|fentanyl|mesh-list
2399370|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2399371|NCT00708318|Narcotics|narcotics|mesh-ancestor
2399372|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2399373|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399374|NCT00708318|Analgesics|analgesics|mesh-ancestor
2399375|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
2399376|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399377|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2399378|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2399379|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
2399380|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
2399381|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2399382|NCT00708344|Irbesartan|irbesartan|mesh-list
2399383|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2399384|NCT00708344|Diuretics|diuretics|mesh-ancestor
2399385|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
2399386|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399387|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2399388|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2399389|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399390|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2399391|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2399392|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2399393|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399394|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399395|NCT00708396|Citalopram|citalopram|mesh-list
2399396|NCT00708396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2399397|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2399398|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2399399|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399400|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2399401|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
2525257|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2525258|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
2525259|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399402|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399403|NCT00708396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2399404|NCT00708396|Antidepressive Agents|antidepressive agents|mesh-ancestor
2399405|NCT00708396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2525260|NCT01355198|Protective Agents|protective agents|mesh-ancestor
2525261|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525262|NCT01355198|Antidotes|antidotes|mesh-ancestor
2525263|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
2525264|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2525265|NCT01355263|Vitamin A|vitamin a|mesh-list
2525266|NCT01355263|Vitamins|vitamins|mesh-ancestor
2525267|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
2525268|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525269|NCT01355276|Domperidone|domperidone|mesh-list
2525270|NCT01355276|Cinitapride|cinitapride|mesh-list
2525271|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
2525272|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
2525273|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525274|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525275|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2525276|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2525277|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
2525278|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2525279|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525280|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2525281|NCT01355354|Digoxin|digoxin|mesh-list
2525282|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2525283|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2525284|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525285|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525286|NCT01355354|Protective Agents|protective agents|mesh-ancestor
2525287|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525288|NCT01355367|Nifedipine|nifedipine|mesh-list
2525289|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2525290|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2525291|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525292|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2525293|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525294|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
2525295|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
2525296|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2525297|NCT01355380|Iloprost|iloprost|mesh-list
2525298|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2525299|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
2525300|NCT01355393|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2525301|NCT01355393|Sargramostim|sargramostim|mesh-list
2525302|NCT01355393|Immunologic Factors|immunologic factors|mesh-ancestor
2525303|NCT01355393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525304|NCT01355393|Antiviral Agents|antiviral agents|mesh-ancestor
2525305|NCT01355393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525306|NCT01355445|Irinotecan|irinotecan|mesh-list
2525307|NCT01355445|Vincristine|vincristine|mesh-list
2525308|NCT01355445|Temozolomide|temozolomide|mesh-list
2525309|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2525310|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2525311|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525312|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525313|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525314|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2525315|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
2525316|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
2525317|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
2525318|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2525319|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
2525320|NCT01355562|Interleukin-2|interleukin-2|mesh-list
2525321|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399418|NCT00708539|Progesterone|progesterone|mesh-list
2399419|NCT00708539|Progestins|progestins|mesh-ancestor
2525322|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2525323|NCT01355562|Analgesics|analgesics|mesh-ancestor
2525324|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
2525325|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525326|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525327|NCT01355614|Infliximab|infliximab|mesh-list
2525328|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
2525329|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2399420|NCT00708539|Hormones|hormones|mesh-ancestor
2399421|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399422|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399423|NCT00708565|Iloprost|iloprost|mesh-list
2399424|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2399425|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
2399426|NCT00708578|Metformin|metformin|mesh-list
2399427|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
2399428|NCT00708578|Glimepiride|glimepiride|mesh-list
2399429|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2399430|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399431|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2399432|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2399433|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
2399434|NCT00708591|Sirolimus|sirolimus|mesh-list
2399435|NCT00708591|Ketoconazole|ketoconazole|mesh-list
2399436|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2399437|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399438|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2399439|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399440|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
2399441|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2399442|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
2399443|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399444|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2399445|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2399446|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399447|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399448|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2399449|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
2399450|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399451|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2399452|NCT00708656|Mesalamine|mesalamine|mesh-list
2399453|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2399454|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2399455|NCT00708656|Analgesics|analgesics|mesh-ancestor
2399456|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
2399457|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399458|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399459|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2399460|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2525330|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2525331|NCT01355718|Repaglinide|repaglinide|mesh-list
2525332|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2525333|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525334|NCT01355757|Anesthetics|anesthetics|mesh-list
2525335|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
2525336|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2525337|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399461|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
2399462|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2399463|NCT00708747|Antibodies|antibodies|mesh-list
2399464|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
2399465|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399466|NCT00708773|Irinotecan|irinotecan|mesh-list
2399467|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2399468|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2399469|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399470|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399471|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525338|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
2525339|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525340|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
2399472|NCT00708799|Azithromycin|azithromycin|mesh-list
2399473|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2399474|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399475|NCT00708812|Paclitaxel|paclitaxel|mesh-list
2399476|NCT00708812|Carboplatin|carboplatin|mesh-list
2399477|NCT00708812|Endostar protein|endostar protein|mesh-list
2399478|NCT00708812|Endostatins|endostatins|mesh-list
2399479|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2525341|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
2525342|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
2525343|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2525344|NCT01355939|Protective Agents|protective agents|mesh-ancestor
2525345|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525346|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
2525347|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
2525348|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525349|NCT01355952|Protective Agents|protective agents|mesh-ancestor
2525350|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525351|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
2525352|NCT01355952|Vitamins|vitamins|mesh-ancestor
2525353|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
2525354|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
2525355|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2399480|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399481|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
2399482|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
2399483|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
2399484|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399485|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2399486|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2399487|NCT00708812|Growth Substances|growth substances|mesh-ancestor
2399488|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399489|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
2399490|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
2399491|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2399492|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399493|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2399494|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2399495|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399496|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399497|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399498|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2399499|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
2399500|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399501|NCT00709046|Pantoprazole|pantoprazole|mesh-list
2399502|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2399503|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2399504|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2399505|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399506|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399507|NCT00709137|Amiloride|amiloride|mesh-list
2399508|NCT00709137|Spironolactone|spironolactone|mesh-list
2399509|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2399510|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
2399511|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399512|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399513|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2399514|NCT00709137|Diuretics|diuretics|mesh-ancestor
2399515|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
2399516|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2399517|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2399518|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2399519|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399520|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2399521|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2399522|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
2399523|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399524|NCT00709189|Folic Acid|folic acid|mesh-list
2399525|NCT00709189|Norgestimate|norgestimate|mesh-list
2399526|NCT00709189|Estradiol|estradiol|mesh-list
2399527|NCT00709189|Estrogens|estrogens|mesh-ancestor
2399528|NCT00709189|Hormones|hormones|mesh-ancestor
2399529|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399530|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399531|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2399532|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
2525356|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2525357|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
2525358|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525359|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525360|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2525361|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
2399533|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2399534|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2399535|NCT00709189|Hematinics|hematinics|mesh-ancestor
2399536|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
2399537|NCT00709189|Vitamins|vitamins|mesh-ancestor
2399538|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
2399539|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2399540|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2399541|NCT00709215|Cordycepin|cordycepin|mesh-list
2399542|NCT00709215|Pentostatin|pentostatin|mesh-list
2399543|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399544|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2399545|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399546|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399547|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
2399548|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399549|NCT00709254|Fentanyl|fentanyl|mesh-list
2399550|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2399551|NCT00709254|Narcotics|narcotics|mesh-ancestor
2399552|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2399553|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399554|NCT00709254|Analgesics|analgesics|mesh-ancestor
2399555|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
2399556|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525362|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
2525363|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2525364|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
2525365|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2525366|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525367|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2525368|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2525369|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2525370|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
2525371|NCT01356017|Amlodipine|amlodipine|mesh-list
2525372|NCT01356017|Telmisartan|telmisartan|mesh-list
2525373|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2525374|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2525375|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2525376|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525377|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2525378|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525379|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
2525380|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2525381|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2525382|NCT01356043|Niacin|niacin|mesh-list
2525383|NCT01356043|Amlodipine|amlodipine|mesh-list
2525384|NCT01356043|Telmisartan|telmisartan|mesh-list
2525385|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2525386|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2525387|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2525388|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525389|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2525390|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525391|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
2525392|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2525393|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2525394|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2525395|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
2525396|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2525397|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
2525398|NCT01356043|Vitamins|vitamins|mesh-ancestor
2525399|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
2525400|NCT01356121|Midazolam|midazolam|mesh-list
2525401|NCT01356121|Propofol|propofol|mesh-list
2525402|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2525403|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2525404|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525405|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2399557|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2399558|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2399559|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
2399560|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
2399561|NCT00709267|Folic Acid|folic acid|mesh-list
2399562|NCT00709267|Hematinics|hematinics|mesh-ancestor
2399563|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
2399564|NCT00709267|Vitamins|vitamins|mesh-ancestor
2399565|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
2399566|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399567|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2525406|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
2525407|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
2525408|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2525409|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2525410|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2525411|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2525412|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
2525413|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
2525414|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2525415|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525416|NCT01356160|Ribavirin|ribavirin|mesh-list
2525417|NCT01356160|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2525418|NCT01356160|Ledipasvir|ledipasvir|mesh-list
2525419|NCT01356160|Antimetabolites|antimetabolites|mesh-ancestor
2525420|NCT01356160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525421|NCT01356160|Antiviral Agents|antiviral agents|mesh-ancestor
2525422|NCT01356160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525423|NCT01356212|Ketorolac|ketorolac|mesh-list
2525424|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2525425|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2525426|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2525427|NCT01356212|Analgesics|analgesics|mesh-ancestor
2525428|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
2525429|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525430|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525431|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2525432|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2525433|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2525434|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525435|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525436|NCT01356225|Ketorolac|ketorolac|mesh-list
2525437|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2525438|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2525439|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2525440|NCT01356225|Analgesics|analgesics|mesh-ancestor
2525441|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
2525442|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525443|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525444|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2525445|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2525446|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2525447|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525448|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525449|NCT01356290|Cytarabine|cytarabine|mesh-list
2525450|NCT01356290|Thalidomide|thalidomide|mesh-list
2525451|NCT01356290|Celecoxib|celecoxib|mesh-list
2399568|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
2399569|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399570|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2399571|NCT00709332|Folic Acid|folic acid|mesh-list
2399572|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2399573|NCT00709332|Norgestimate|norgestimate|mesh-list
2399574|NCT00709332|Estradiol|estradiol|mesh-list
2399575|NCT00709332|Estrogens|estrogens|mesh-ancestor
2399576|NCT00709332|Hormones|hormones|mesh-ancestor
2399577|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399578|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399579|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2399580|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
2525452|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
2525453|NCT01356290|Bevacizumab|bevacizumab|mesh-list
2525454|NCT01356290|Etoposide|etoposide|mesh-list
2525455|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
2525456|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
2399581|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2399582|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2525457|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2525458|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
2525459|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525460|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2525461|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2525462|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
2525463|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525464|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525465|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2525466|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2525467|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2525468|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2525469|NCT01356290|Growth Substances|growth substances|mesh-ancestor
2525470|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
2525471|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2525472|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2525473|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2525474|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525475|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2525476|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
2525477|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
2525478|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525479|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2525480|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2525481|NCT01356290|Analgesics|analgesics|mesh-ancestor
2525482|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
2525483|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525484|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2525485|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2525486|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2525487|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
2525488|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2525489|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2525490|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2525491|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2525492|NCT01356303|Docetaxel|docetaxel|mesh-list
2525493|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525494|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
2525495|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
2525496|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
2525497|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525498|NCT01356329|Heparin|heparin|mesh-list
2525499|NCT01356329|Enoxaparin|enoxaparin|mesh-list
2399583|NCT00709332|Hematinics|hematinics|mesh-ancestor
2399584|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
2399585|NCT00709332|Vitamins|vitamins|mesh-ancestor
2399586|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
2399587|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2399588|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2399589|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2399590|NCT00709371|Zonisamide|zonisamide|mesh-list
2399591|NCT00709371|Bupropion|bupropion|mesh-list
2399592|NCT00709371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2399593|NCT00709371|Antidepressive Agents|antidepressive agents|mesh-ancestor
2399594|NCT00709371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2399595|NCT00709371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2399596|NCT00709371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2399597|NCT00709371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2399598|NCT00709371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399599|NCT00709371|Dopamine Agents|dopamine agents|mesh-ancestor
2399600|NCT00709371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2399601|NCT00709371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399602|NCT00709371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2399603|NCT00709371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2399604|NCT00709371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399605|NCT00709371|Anticonvulsants|anticonvulsants|mesh-ancestor
2399606|NCT00709371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2399607|NCT00709371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2399608|NCT00709423|Moxaverine|moxaverine|mesh-list
2399609|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
2399610|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
2399611|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399612|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399613|NCT00709436|Ketamine|ketamine|mesh-list
2399614|NCT00709436|Analgesics|analgesics|mesh-ancestor
2399615|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
2399616|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399617|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399618|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2399619|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2399620|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
2399621|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
2525500|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
2525501|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2525502|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2525503|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525504|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2525505|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2525506|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2525507|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
2525508|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2525509|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525510|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525511|NCT01356355|Urological Agents|urological agents|mesh-ancestor
2525512|NCT01356368|Docetaxel|docetaxel|mesh-list
2525513|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525514|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
2525515|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
2525516|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
2525517|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525518|NCT01356381|Vildagliptin|vildagliptin|mesh-list
2525519|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2525520|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525521|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2525522|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
2525523|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525524|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525525|NCT01356433|Vitamins|vitamins|mesh-list
2525526|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
2525527|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
2525528|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525529|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
2525530|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525531|NCT01356433|Protective Agents|protective agents|mesh-ancestor
2525532|NCT01356472|Imipenem|imipenem|mesh-list
2525533|NCT01356472|Cilastatin|cilastatin|mesh-list
2525534|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2525535|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525536|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
2525537|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525538|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525539|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2525540|NCT01356511|Dexamethasone|dexamethasone|mesh-list
2525541|NCT01356511|Prednisone|prednisone|mesh-list
2525542|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2525543|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
2399622|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2399623|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2399624|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2399625|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2399626|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399627|NCT00709449|Papaverine|papaverine|mesh-list
2399628|NCT00709449|Moxaverine|moxaverine|mesh-list
2399629|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
2399630|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
2399631|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399632|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399633|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2399634|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399635|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399636|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
2399637|NCT00709449|Urological Agents|urological agents|mesh-ancestor
2399638|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
2399639|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2525544|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
2525545|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525546|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525547|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2525548|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
2525549|NCT01356511|Hormones|hormones|mesh-ancestor
2525550|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2525551|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2525552|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525553|NCT01356524|Progesterone|progesterone|mesh-list
2525554|NCT01356524|Progestins|progestins|mesh-ancestor
2525555|NCT01356524|Hormones|hormones|mesh-ancestor
2525556|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2525557|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525558|NCT01356615|Heparin|heparin|mesh-list
2525559|NCT01356615|Calcium heparin|calcium heparin|mesh-list
2399640|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399641|NCT00709488|Talaporfin|talaporfin|mesh-list
2399642|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399643|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2399644|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
2399645|NCT00709553|Midazolam|midazolam|mesh-list
2399646|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2399647|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2399648|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2399649|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399650|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2399651|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2399652|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2399653|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2399654|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
2399655|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
2525560|NCT01356615|Enoxaparin|enoxaparin|mesh-list
2525561|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2525562|NCT01356615|Tinzaparin|tinzaparin|mesh-list
2525563|NCT01356615|Dalteparin|dalteparin|mesh-list
2525564|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
2399656|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
2399657|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
2399658|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2399659|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399660|NCT00709644|Folic Acid|folic acid|mesh-list
2399661|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2399662|NCT00709644|Norgestimate|norgestimate|mesh-list
2399663|NCT00709644|Estradiol|estradiol|mesh-list
2399664|NCT00709644|Estrogens|estrogens|mesh-ancestor
2399665|NCT00709644|Hormones|hormones|mesh-ancestor
2399666|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399667|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399668|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2399669|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
2399670|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2399671|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2399672|NCT00709644|Hematinics|hematinics|mesh-ancestor
2399673|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
2399674|NCT00709644|Vitamins|vitamins|mesh-ancestor
2399675|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
2399676|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2399677|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2399678|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2399679|NCT00709657|Bevacizumab|bevacizumab|mesh-list
2399680|NCT00709657|Ranibizumab|ranibizumab|mesh-list
2399681|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2525565|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
2525566|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2525567|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2525568|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525569|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2525570|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525571|NCT01356680|Prednisone|prednisone|mesh-list
2525572|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
2525573|NCT01356680|Dacarbazine|dacarbazine|mesh-list
2525574|NCT01356680|Etoposide|etoposide|mesh-list
2525575|NCT01356680|Vincristine|vincristine|mesh-list
2525576|NCT01356680|Doxorubicin|doxorubicin|mesh-list
2525577|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2525578|NCT01356680|Bleomycin|bleomycin|mesh-list
2525579|NCT01356680|Vinblastine|vinblastine|mesh-list
2525580|NCT01356680|Procarbazine|procarbazine|mesh-list
2525581|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2525582|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
2525583|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525584|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2399682|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399683|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2399684|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2525585|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2525586|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
2525587|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525588|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525589|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2399685|NCT00709657|Growth Substances|growth substances|mesh-ancestor
2399686|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399687|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
2399688|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
2399689|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
2399690|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2399691|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2399692|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525590|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2525591|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
2525592|NCT01356680|Hormones|hormones|mesh-ancestor
2525593|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2525594|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2525595|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2525596|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2525597|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2525598|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525599|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
2525600|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
2525601|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
2525602|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2525603|NCT01356732|Sufentanil|sufentanil|mesh-list
2525604|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2525605|NCT01356732|Narcotics|narcotics|mesh-ancestor
2525606|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2525607|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525608|NCT01356732|Analgesics|analgesics|mesh-ancestor
2525609|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
2525610|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525611|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2399693|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
2399694|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2399695|NCT00709865|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|mesh-list
2399696|NCT00709865|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-ancestor
2399697|NCT00709865|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2399698|NCT00709865|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2399699|NCT00709865|Purinergic Agents|purinergic agents|mesh-ancestor
2399700|NCT00709865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2399701|NCT00709865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399702|NCT00709865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399703|NCT00709904|Semuloparin|semuloparin|mesh-list
2399704|NCT00709904|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2399705|NCT00709904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2399706|NCT00709904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2399707|NCT00709904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399708|NCT00709904|Anticoagulants|anticoagulants|mesh-ancestor
2399709|NCT00709917|Repaglinide|repaglinide|mesh-list
2399710|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2399711|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399712|NCT00709969|Lumefantrine|lumefantrine|mesh-list
2525612|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2525613|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
2525614|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
2525615|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
2525616|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2525617|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
2525618|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
2525619|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2525620|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525621|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2525622|NCT01356745|Analgesics|analgesics|mesh-ancestor
2525623|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
2525624|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525625|NCT01356758|Adalimumab|adalimumab|mesh-list
2525626|NCT01356758|Etanercept|etanercept|mesh-list
2525627|NCT01356758|Infliximab|infliximab|mesh-list
2525628|NCT01356758|Ustekinumab|ustekinumab|mesh-list
2525629|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2525630|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2525631|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2525632|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2525633|NCT01356758|Analgesics|analgesics|mesh-ancestor
2525634|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
2399713|NCT00709969|Artemether|artemether|mesh-list
2399714|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2525635|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525636|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525637|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2525638|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2525639|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
2525640|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
2525641|NCT01356797|Fentanyl|fentanyl|mesh-list
2525642|NCT01356797|Bupivacaine|bupivacaine|mesh-list
2525643|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
2525644|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
2525645|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
2525646|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2399715|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
2399716|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2399717|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2399718|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399719|NCT00709982|Folic Acid|folic acid|mesh-list
2399720|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2399721|NCT00709982|Norgestimate|norgestimate|mesh-list
2399722|NCT00709982|Estradiol|estradiol|mesh-list
2399723|NCT00709982|Estrogens|estrogens|mesh-ancestor
2399724|NCT00709982|Hormones|hormones|mesh-ancestor
2399725|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399726|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525647|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525648|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
2525649|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399727|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2399728|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
2399729|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2399730|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2399731|NCT00709982|Hematinics|hematinics|mesh-ancestor
2399732|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
2399733|NCT00709982|Vitamins|vitamins|mesh-ancestor
2399734|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
2399735|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2399736|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2399737|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2399738|NCT00710086|Remifentanil|remifentanil|mesh-list
2399739|NCT00710086|Hydromorphone|hydromorphone|mesh-list
2399740|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2399741|NCT00710086|Narcotics|narcotics|mesh-ancestor
2399742|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2399743|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399744|NCT00710086|Analgesics|analgesics|mesh-ancestor
2399745|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
2399746|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399747|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
2399748|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
2399749|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2399750|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2399751|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399752|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399753|NCT00710099|Urological Agents|urological agents|mesh-ancestor
2399754|NCT00710125|Doxorubicin|doxorubicin|mesh-list
2399755|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2525650|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2525651|NCT01356797|Narcotics|narcotics|mesh-ancestor
2525652|NCT01356797|Analgesics|analgesics|mesh-ancestor
2525653|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2525654|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2525655|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
2525656|NCT01356849|Atrasentan|atrasentan|mesh-list
2525657|NCT01356849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525658|NCT01356849|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2525659|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2525660|NCT01356849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525661|NCT01356862|Pasireotide|pasireotide|mesh-list
2525662|NCT01356862|Hormones|hormones|mesh-ancestor
2525663|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2525664|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399756|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399757|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2399758|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2525665|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2525666|NCT01356927|Etonogestrel|etonogestrel|mesh-list
2525667|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2525668|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
2525669|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2525670|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525671|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2525672|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2525673|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2525674|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525675|NCT01356992|Enoxaparin|enoxaparin|mesh-list
2525676|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
2525677|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2525678|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2525679|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525680|NCT01357031|Amitriptyline|amitriptyline|mesh-list
2525681|NCT01357031|Melatonin|melatonin|mesh-list
2525682|NCT01357031|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2525683|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
2525684|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525685|NCT01357031|Protective Agents|protective agents|mesh-ancestor
2525686|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525687|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2525688|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2525689|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
2525690|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2525691|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2525692|NCT01357031|Analgesics|analgesics|mesh-ancestor
2525693|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
2525694|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525695|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2525696|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2399759|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399760|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399761|NCT00710138|Vitamins|vitamins|mesh-list
2399762|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
2399763|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
2399764|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
2399765|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
2399766|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399767|NCT00710138|Hematinics|hematinics|mesh-ancestor
2399768|NCT00710216|Lamivudine|lamivudine|mesh-list
2399769|NCT00710216|Telbivudine|telbivudine|mesh-list
2399770|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2525697|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2525698|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
2525699|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2525700|NCT01357031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2525701|NCT01357031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2525702|NCT01357109|Bosentan|bosentan|mesh-list
2525703|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2525704|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2525705|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525706|NCT01357252|Vildagliptin|vildagliptin|mesh-list
2399771|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2525707|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2525708|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525709|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2525710|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
2116147|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116148|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
2116149|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
2116150|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525711|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525712|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525713|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
2525714|NCT01357317|Calcium|calcium|mesh-list
2525715|NCT01357317|Calcium acetate|calcium acetate|mesh-list
2525716|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2525717|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525718|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2116151|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
2116152|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116153|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116154|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
2399772|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399773|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399774|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
2399775|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399776|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2399777|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2399778|NCT00710229|Bevacizumab|bevacizumab|mesh-list
2399779|NCT00710229|Ranibizumab|ranibizumab|mesh-list
2399780|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2399781|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399782|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2399783|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2399784|NCT00710229|Growth Substances|growth substances|mesh-ancestor
2399785|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399786|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
2399787|NCT00710268|Bevacizumab|bevacizumab|mesh-list
2525719|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
2525720|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
2525721|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399788|NCT00710268|Olaparib|olaparib|mesh-list
2399789|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2399790|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399791|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2399792|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2399793|NCT00710268|Growth Substances|growth substances|mesh-ancestor
2399794|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399795|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
2399796|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2399797|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399798|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399799|NCT00710320|Anesthetics|anesthetics|mesh-list
2399800|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2399801|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399802|NCT00710359|Vitamins|vitamins|mesh-list
2399803|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
2525722|NCT01357486|Sorafenib|sorafenib|mesh-list
2525723|NCT01357486|Pravastatin|pravastatin|mesh-list
2525724|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525725|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2525726|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525727|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525728|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2399804|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
2399805|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
2399806|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
2399807|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399808|NCT00710359|Hematinics|hematinics|mesh-ancestor
2399809|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
2399810|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2399811|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2399812|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399813|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2399814|NCT00710437|Analgesics|analgesics|mesh-ancestor
2399815|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
2399816|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399817|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2399818|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2399819|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2525729|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2525730|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
2525731|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2525732|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2525733|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
2525734|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2525735|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525736|NCT01357642|Epinephrine|epinephrine|mesh-list
2525737|NCT01357642|Racepinephrine|racepinephrine|mesh-list
2525738|NCT01357642|Epinephryl borate|epinephryl borate|mesh-list
2525739|NCT01357642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2399820|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
2399821|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2399822|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525740|NCT01357642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2399823|NCT00710528|Idelalisib|idelalisib|mesh-list
2399824|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525741|NCT01357642|Adrenergic Agents|adrenergic agents|mesh-ancestor
2525742|NCT01357642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2525743|NCT01357642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525744|NCT01357642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525745|NCT01357642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2525746|NCT01357642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2525747|NCT01357642|Autonomic Agents|autonomic agents|mesh-ancestor
2525748|NCT01357642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525749|NCT01357642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2525750|NCT01357642|Respiratory System Agents|respiratory system agents|mesh-ancestor
2525751|NCT01357642|Mydriatics|mydriatics|mesh-ancestor
2525752|NCT01357642|Sympathomimetics|sympathomimetics|mesh-ancestor
2399825|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399826|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399827|NCT00710580|Etanercept|etanercept|mesh-list
2399828|NCT00710580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2399829|NCT00710580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2399830|NCT00710580|Analgesics|analgesics|mesh-ancestor
2399831|NCT00710580|Sensory System Agents|sensory system agents|mesh-ancestor
2399832|NCT00710580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399833|NCT00710580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399834|NCT00710580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2399835|NCT00710580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2399836|NCT00710580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2399837|NCT00710580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2399838|NCT00710580|Immunologic Factors|immunologic factors|mesh-ancestor
2399839|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
2399840|NCT00710619|Coagulants|coagulants|mesh-ancestor
2399841|NCT00710736|Fluorouracil|fluorouracil|mesh-list
2399842|NCT00710736|Capecitabine|capecitabine|mesh-list
2399843|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
2399844|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399845|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2399846|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399847|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2399848|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
2399849|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399850|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
2399851|NCT00710788|Calcium|calcium|mesh-list
2399852|NCT00710788|Sevelamer|sevelamer|mesh-list
2399853|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2399854|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399855|NCT00710788|Antacids|antacids|mesh-ancestor
2399856|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399857|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2399858|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
2399859|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
2399860|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
2399861|NCT00710827|Androgens|androgens|mesh-ancestor
2399862|NCT00710827|Hormones|hormones|mesh-ancestor
2399863|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2525753|NCT01357642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2525754|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2525755|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
2525756|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525757|NCT01357681|Protective Agents|protective agents|mesh-ancestor
2525758|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399864|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399865|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
2399866|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2399867|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399868|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2399869|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2399870|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
2399871|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399872|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
2399873|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2399874|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
2399875|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2525759|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2525760|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2525761|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525762|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2399876|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2399877|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2399878|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2399879|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
2399880|NCT00711204|Donepezil|donepezil|mesh-list
2399881|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2399882|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399883|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399884|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
2399885|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2399886|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399887|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
2399888|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
2399889|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2399890|NCT00711256|Protective Agents|protective agents|mesh-ancestor
2399891|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399892|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
2399893|NCT00711295|Vaccines|vaccines|mesh-list
2399894|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
2525763|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
2525764|NCT01357772|Tamoxifen|tamoxifen|mesh-list
2525765|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2525766|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
2525767|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2525768|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525769|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2525770|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525771|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2525772|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2525773|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2525774|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
2525775|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2525776|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2525777|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2525778|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2525779|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525780|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
2525781|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2525782|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525783|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2525784|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399895|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399896|NCT00711308|Vitamin K|vitamin k|mesh-list
2399897|NCT00711308|Tinzaparin|tinzaparin|mesh-list
2525785|NCT01357811|Digoxin|digoxin|mesh-list
2525786|NCT01357811|Eliglustat|eliglustat|mesh-list
2525787|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2525788|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2525789|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525790|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525791|NCT01357811|Protective Agents|protective agents|mesh-ancestor
2525792|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525793|NCT01357876|Metformin|metformin|mesh-list
2525794|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2525795|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525796|NCT01357902|Lamotrigine|lamotrigine|mesh-list
2399898|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2399899|NCT00711308|Dalteparin|dalteparin|mesh-list
2399900|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
2399901|NCT00711308|Vitamins|vitamins|mesh-ancestor
2399902|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
2399903|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399904|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2399905|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2399906|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399907|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
2399908|NCT00711308|Coagulants|coagulants|mesh-ancestor
2399909|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
2399910|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2525797|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
2525798|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2399911|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2399912|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2399913|NCT00711607|Estradiol|estradiol|mesh-list
2525799|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2399914|NCT00711607|Estrogens|estrogens|mesh-ancestor
2399915|NCT00711607|Hormones|hormones|mesh-ancestor
2399916|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399917|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399918|NCT00711620|Thymalfasin|thymalfasin|mesh-list
2399919|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2399920|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
2399921|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399922|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
2399923|NCT00711698|Narcotics|narcotics|mesh-ancestor
2399924|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2399925|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2399926|NCT00711698|Analgesics|analgesics|mesh-ancestor
2399927|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
2399928|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399929|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
2525800|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525801|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2525802|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525803|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2525804|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2525805|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2525806|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2525807|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2525808|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2525809|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
2525810|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2525811|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2525812|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2525813|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2525814|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525815|NCT01358045|Calcitriol|calcitriol|mesh-list
2525816|NCT01358045|Diclofenac|diclofenac|mesh-list
2525817|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2525818|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2525819|NCT01358045|Analgesics|analgesics|mesh-ancestor
2525820|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
2525821|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525822|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525823|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2525824|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2525825|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2525826|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525827|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525828|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2525829|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2525830|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2525831|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2525832|NCT01358045|Vitamins|vitamins|mesh-ancestor
2525833|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
2525834|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2525835|NCT01358071|Doxorubicin|doxorubicin|mesh-list
2525836|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2525837|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2525838|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525839|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2525840|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2525841|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525842|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399930|NCT00711789|Giapreza|giapreza|mesh-list
2399931|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
2399932|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2399933|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2399934|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
2399935|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399936|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399937|NCT00711841|Dexamethasone|dexamethasone|mesh-list
2399938|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
2399939|NCT00711841|BB 1101|bb 1101|mesh-list
2399940|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2399941|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
2399942|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
2399943|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2399944|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525877|NCT01358240|Econazole|econazole|mesh-list
2525878|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
2525879|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525880|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2525881|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2525882|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525883|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525884|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2525885|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
2399945|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2399946|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
2399947|NCT00711841|Hormones|hormones|mesh-ancestor
2399948|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2399949|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2399950|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2399951|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
2399952|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525886|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2525887|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525888|NCT01358253|Cytarabine|cytarabine|mesh-list
2525889|NCT01358253|Dexamethasone|dexamethasone|mesh-list
2525890|NCT01358253|Prednisone|prednisone|mesh-list
2525891|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
2525892|NCT01358253|Rituximab|rituximab|mesh-list
2525893|NCT01358253|Doxorubicin|doxorubicin|mesh-list
2525894|NCT01358253|Methotrexate|methotrexate|mesh-list
2525895|NCT01358253|Vincristine|vincristine|mesh-list
2525896|NCT01358253|Asparaginase|asparaginase|mesh-list
2525897|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
2525898|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2525899|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
2525900|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525901|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2525902|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2525903|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
2525904|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525905|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2525906|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2525907|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2525908|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
2525909|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
2525910|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525911|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2525912|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
2399953|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399954|NCT00711854|Rifampin|rifampin|mesh-list
2399955|NCT00711854|Linezolid|linezolid|mesh-list
2399956|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2399957|NCT00711854|Trimethoprim|trimethoprim|mesh-list
2399958|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
2399959|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2399960|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
2399961|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2525913|NCT01358253|Hormones|hormones|mesh-ancestor
2525914|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2525915|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2525916|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2525917|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2525918|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2525919|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2525920|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525921|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2525922|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
2399962|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399963|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
2399964|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2399965|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399966|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399967|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2399968|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2399969|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2399970|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2399971|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2399972|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2399973|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2399974|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2399975|NCT00711854|Renal Agents|renal agents|mesh-ancestor
2399976|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
2399977|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2399978|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2399979|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2525923|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2525924|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2525925|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
2525926|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
2525927|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2525928|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2525929|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
2399980|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2399981|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2399982|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2399983|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
2399984|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
2399985|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2399986|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2399987|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
2399988|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2399989|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2399990|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2399991|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2525930|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2525931|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2525932|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
2525933|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
2525934|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
2525935|NCT01358344|Pantoprazole|pantoprazole|mesh-list
2525936|NCT01358344|Vorapaxar|vorapaxar|mesh-list
2525937|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2525938|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2525939|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2525940|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525941|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525942|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2525943|NCT01358383|Naproxen|naproxen|mesh-list
2525944|NCT01358383|Esomeprazole|esomeprazole|mesh-list
2525945|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2525946|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2525947|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2525948|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525949|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399992|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2399993|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2399994|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2399995|NCT00711906|Renal Agents|renal agents|mesh-ancestor
2399996|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2399997|NCT00711919|Pitavastatin|pitavastatin|mesh-list
2399998|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2399999|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2400000|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2400001|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
2525950|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2525951|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2525952|NCT01358383|Analgesics|analgesics|mesh-ancestor
2400002|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400003|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400004|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2400005|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
2400006|NCT00712049|Niacin|niacin|mesh-list
2400007|NCT00712049|Niacinamide|niacinamide|mesh-list
2400008|NCT00712049|Simvastatin|simvastatin|mesh-list
2400009|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2400010|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2400011|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
2400012|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525953|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
2525954|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525955|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525956|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2525957|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2525958|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
2525959|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2525960|NCT01358409|Nebivolol|nebivolol|mesh-list
2525961|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2400013|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2400014|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2400015|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400016|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
2400017|NCT00712049|Vitamins|vitamins|mesh-ancestor
2400018|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
2400019|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400020|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
2400021|NCT00712062|Pemetrexed|pemetrexed|mesh-list
2400022|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400023|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400024|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525962|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
2525963|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2525964|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2525965|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2525966|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
2525967|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2525968|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525969|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525970|NCT01358435|Insulin|insulin|mesh-list
2400025|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2400026|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2400027|NCT00712101|Abciximab|abciximab|mesh-list
2400028|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
2400029|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2400030|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2400031|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2400032|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
2400033|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525971|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2525972|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
2525973|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
2525974|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
2525975|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2525976|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525977|NCT01358500|Fentanyl|fentanyl|mesh-list
2525978|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2400034|NCT00712140|Trastuzumab|trastuzumab|mesh-list
2525979|NCT01358500|Narcotics|narcotics|mesh-ancestor
2400035|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2400036|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400037|NCT00712205|Calcitriol|calcitriol|mesh-list
2400038|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2400039|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400040|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2400041|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2400042|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400043|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2400044|NCT00712205|Vitamins|vitamins|mesh-ancestor
2400045|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
2400046|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2400047|NCT00712257|Heparin|heparin|mesh-list
2400048|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
2400049|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2400050|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2400051|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400052|NCT00712322|Darifenacin|darifenacin|mesh-list
2400053|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2400054|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2400055|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
2400056|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400057|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400058|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400059|NCT00712322|Urological Agents|urological agents|mesh-ancestor
2400060|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
2400061|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
2400062|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2400063|NCT00712374|Amodiaquine|amodiaquine|mesh-list
2400064|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
2400065|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2400066|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2400067|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400068|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2400069|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2525980|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2525981|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525982|NCT01358500|Analgesics|analgesics|mesh-ancestor
2525983|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
2525984|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2525985|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2525986|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2400070|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400071|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2400072|NCT00712374|Renal Agents|renal agents|mesh-ancestor
2400073|NCT00712400|Latanoprost|latanoprost|mesh-list
2400074|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2400075|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2400076|NCT00712439|Gabapentin|gabapentin|mesh-list
2525987|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
2525988|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
2525989|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
2525990|NCT01358591|Calcium|calcium|mesh-list
2525991|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2525992|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525993|NCT01358591|Antacids|antacids|mesh-ancestor
2525994|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2525995|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2525996|NCT01358669|Denosumab|denosumab|mesh-list
2525997|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2525998|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2525999|NCT01358695|Botulinum Toxins|botulinum toxins|mesh-list
2526000|NCT01358695|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2526001|NCT01358695|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2526002|NCT01358695|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2526003|NCT01358695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2526004|NCT01358695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526005|NCT01358695|Cholinergic Agents|cholinergic agents|mesh-ancestor
2526006|NCT01358695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526007|NCT01358695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526008|NCT01358695|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2400077|NCT00712439|Analgesics|analgesics|mesh-ancestor
2400078|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
2400079|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526009|NCT01358695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400080|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400081|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
2400082|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2526010|NCT01358812|Panitumumab|panitumumab|mesh-list
2526011|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2526012|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526013|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2526014|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526015|NCT01359020|Acetaminophen|acetaminophen|mesh-list
2526016|NCT01359020|Dipyrone|dipyrone|mesh-list
2526017|NCT01359020|Ibuprofen|ibuprofen|mesh-list
2526018|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2526019|NCT01359020|Analgesics|analgesics|mesh-ancestor
2526020|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
2526021|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526022|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526023|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
2526024|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2526025|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2526026|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2526027|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2526028|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526029|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526030|NCT01359059|Pregabalin|pregabalin|mesh-list
2526031|NCT01359059|Analgesics|analgesics|mesh-ancestor
2526032|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
2526033|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526034|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526035|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
2526036|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2526037|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2526038|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526039|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2526040|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2526041|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2526042|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526043|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2526044|NCT01359085|Pregabalin|pregabalin|mesh-list
2526045|NCT01359085|Analgesics|analgesics|mesh-ancestor
2526046|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
2526047|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526048|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526049|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
2526050|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2526051|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2526052|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526053|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2526054|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2526055|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2526056|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526057|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2526058|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
2526059|NCT01359098|Dexamethasone|dexamethasone|mesh-list
2526060|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2526061|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
2526062|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
2526063|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526064|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400083|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2400084|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2400085|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2400086|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2400087|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2400088|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400089|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400090|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
2400091|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
2400092|NCT00712452|Vinblastine|vinblastine|mesh-list
2400093|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2400094|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
2400095|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400096|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2400097|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2400098|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
2526065|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2400099|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400100|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400101|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2400102|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2400103|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
2400104|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
2400105|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
2400106|NCT00712465|Digoxin|digoxin|mesh-list
2400107|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2400108|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2400109|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400110|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400111|NCT00712465|Protective Agents|protective agents|mesh-ancestor
2400112|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400113|NCT00712478|Insulin|insulin|mesh-list
2400114|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2400115|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400116|NCT00712491|Sirolimus|sirolimus|mesh-list
2400117|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2400118|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400119|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2400120|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400121|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
2400122|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2526066|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
2526067|NCT01359098|Hormones|hormones|mesh-ancestor
2526068|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2526069|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2526070|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526071|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526072|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526073|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2526074|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526075|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2526076|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2526077|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2526078|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2526079|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
2526080|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2526081|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2526082|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2526083|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
2526084|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2526085|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526086|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2526087|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2526088|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2526089|NCT01359228|Rifaximin|rifaximin|mesh-list
2526090|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2526091|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526092|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2526093|NCT01359241|Insulin|insulin|mesh-list
2526094|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2526095|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526096|NCT01359397|Bevacizumab|bevacizumab|mesh-list
2526097|NCT01359397|Trastuzumab|trastuzumab|mesh-list
2526098|NCT01359397|Docetaxel|docetaxel|mesh-list
2526099|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
2526100|NCT01359397|Capecitabine|capecitabine|mesh-list
2526101|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2526102|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526103|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2526104|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2526105|NCT01359397|Growth Substances|growth substances|mesh-ancestor
2526106|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526107|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
2526108|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
2526109|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
2526110|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
2526111|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526112|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2526113|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
2526114|NCT01359423|Cilostazol|cilostazol|mesh-list
2526115|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2526116|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
2526117|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526118|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526119|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2526120|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
2526121|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2526122|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2526123|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526124|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2526125|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
2526126|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2526127|NCT01359423|Protective Agents|protective agents|mesh-ancestor
2526128|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2526129|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2526130|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526131|NCT01359436|Antibodies|antibodies|mesh-list
2526132|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
2526133|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526134|NCT01359462|Tolvaptan|tolvaptan|mesh-list
2526135|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2526136|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526137|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
2526138|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526139|NCT01359488|Hormones|hormones|mesh-list
2526140|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
2526141|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2526142|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526143|NCT01359514|Pregabalin|pregabalin|mesh-list
2526144|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
2400123|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
2400124|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400125|NCT00712504|Docetaxel|docetaxel|mesh-list
2400126|NCT00712504|Sunitinib|sunitinib|mesh-list
2400127|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400128|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
2526145|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2526146|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2526147|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526148|NCT01359514|Analgesics|analgesics|mesh-ancestor
2526149|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
2526150|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526151|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
2526152|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2526153|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526154|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2526155|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2526156|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526157|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2526158|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2526159|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2526160|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526161|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
2526162|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
2526163|NCT01359566|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
2526164|NCT01359566|Baclofen|baclofen|mesh-list
2526165|NCT01359566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2526166|NCT01359566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526167|NCT01359566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2400129|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
2400130|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
2400131|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400132|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2400133|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2526168|NCT01359566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526169|NCT01359566|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2526170|NCT01359566|GABA Agonists|gaba agonists|mesh-ancestor
2526171|NCT01359566|GABA Agents|gaba agents|mesh-ancestor
2526172|NCT01359566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526173|NCT01359566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526174|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
2526175|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2526176|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526177|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526178|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
2400134|NCT00712504|Growth Substances|growth substances|mesh-ancestor
2400135|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400136|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
2400137|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2400138|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400139|NCT00712517|Propofol|propofol|mesh-list
2400140|NCT00712517|Sevoflurane|sevoflurane|mesh-list
2400141|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2400142|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2400143|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400144|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2400145|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
2400146|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
2400147|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2400148|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2400149|NCT00712556|Fluorides|fluorides|mesh-list
2400150|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
2400151|NCT00712556|Protective Agents|protective agents|mesh-ancestor
2400152|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400153|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
2400154|NCT00712582|Ifosfamide|ifosfamide|mesh-list
2400155|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
2400156|NCT00712582|Carmustine|carmustine|mesh-list
2400157|NCT00712582|Rituximab|rituximab|mesh-list
2400158|NCT00712582|Carboplatin|carboplatin|mesh-list
2400159|NCT00712582|Etoposide|etoposide|mesh-list
2400160|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
2400161|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
2400162|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2400163|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
2400164|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400165|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2400166|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2400167|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
2400168|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400169|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400170|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2400171|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2400172|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2400173|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2400174|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2526179|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2526180|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526181|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526182|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
2526183|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2526184|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2526185|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526186|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2526187|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2526188|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400175|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400176|NCT00712582|Analgesics|analgesics|mesh-ancestor
2400177|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
2400178|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400179|NCT00712595|Mifepristone|mifepristone|mesh-list
2400180|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2400181|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
2400182|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2400183|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400184|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2400185|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2400186|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2400187|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
2526189|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526190|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526191|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2526192|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
2526193|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2526194|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526195|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2526196|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2400188|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2400189|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2526197|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2526198|NCT01359657|Dexamethasone|dexamethasone|mesh-list
2526199|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
2526200|NCT01359657|Lenalidomide|lenalidomide|mesh-list
2526201|NCT01359657|Bortezomib|bortezomib|mesh-list
2526202|NCT01359657|BB 1101|bb 1101|mesh-list
2526203|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2526204|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2526205|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
2526206|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
2526207|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526208|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526209|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2526210|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
2526211|NCT01359657|Hormones|hormones|mesh-ancestor
2526212|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2526213|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2526214|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526215|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
2526216|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526217|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526218|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
2526219|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2526220|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2400190|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
2400191|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2400192|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
2400193|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2400194|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2400195|NCT00712647|Beta Carotene|beta carotene|mesh-list
2400196|NCT00712647|Vitamin A|vitamin a|mesh-list
2400197|NCT00712647|Carotenoids|carotenoids|mesh-list
2400198|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
2400199|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400200|NCT00712647|Protective Agents|protective agents|mesh-ancestor
2400201|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400202|NCT00712647|Provitamins|provitamins|mesh-ancestor
2400203|NCT00712647|Vitamins|vitamins|mesh-ancestor
2400204|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
2526221|NCT01359657|Growth Substances|growth substances|mesh-ancestor
2526222|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
2526223|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
2526224|NCT01359670|Tadalafil|tadalafil|mesh-list
2526225|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
2526226|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2526227|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2526228|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526229|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526230|NCT01359670|Urological Agents|urological agents|mesh-ancestor
2526231|NCT01359696|Gemcitabine|gemcitabine|mesh-list
2526232|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2526233|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
2526234|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526235|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526236|NCT01359696|Antiviral Agents|antiviral agents|mesh-ancestor
2526237|NCT01359696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526238|NCT01359696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526239|NCT01359696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2526240|NCT01359696|Immunologic Factors|immunologic factors|mesh-ancestor
2526241|NCT01359696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400205|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
2400206|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2400207|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2400208|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400209|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2400210|NCT00712686|Olanzapine|olanzapine|mesh-list
2400211|NCT00712686|Aripiprazole|aripiprazole|mesh-list
2400212|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
2400213|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
2400214|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400215|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400216|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2400217|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2400218|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2400219|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2400220|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2400221|NCT00712686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2526242|NCT01359709|Nicotine|nicotine|mesh-list
2526243|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2526244|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
2526245|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526246|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526247|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2526248|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2526249|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
2400222|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2400223|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2400224|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400225|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400226|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
2400227|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
2526250|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526251|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526252|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
2526253|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2526254|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
2526255|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400228|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
2400229|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
2400230|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2400231|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2400232|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2400233|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2400234|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2400235|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2400236|NCT00712699|Adderall|adderall|mesh-list
2400237|NCT00712699|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2400238|NCT00712699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400239|NCT00712738|Nifedipine|nifedipine|mesh-list
2400240|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2400241|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2400242|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400243|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2400244|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400245|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
2400246|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
2400247|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2400248|NCT00712764|Adenosine|adenosine|mesh-list
2400249|NCT00712764|Analgesics|analgesics|mesh-ancestor
2400250|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
2400251|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400252|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400253|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2400254|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
2400255|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2400256|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
2400257|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
2400258|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400259|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526256|NCT01359722|Expectorants|expectorants|mesh-ancestor
2526257|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
2526258|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2526259|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
2526260|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526261|NCT01359722|Protective Agents|protective agents|mesh-ancestor
2526262|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526263|NCT01359722|Antidotes|antidotes|mesh-ancestor
2526264|NCT01359826|Milnacipran|milnacipran|mesh-list
2526265|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
2526266|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2526267|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2526268|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2526269|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400260|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2400261|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2400262|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2526270|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526271|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526272|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2526273|NCT01359826|Analgesics|analgesics|mesh-ancestor
2400263|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2400264|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2400265|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
2526274|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
2526275|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526276|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
2526277|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2526278|NCT01359930|Naltrexone|naltrexone|mesh-list
2526279|NCT01359930|Bupropion|bupropion|mesh-list
2526280|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2526281|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2526282|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526283|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
2526284|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526285|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2526286|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
2526287|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2526288|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2526289|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2526290|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2526291|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526292|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
2526293|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526294|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2526295|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2526296|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526297|NCT01360034|Indomethacin|indomethacin|mesh-list
2526298|NCT01360034|Nifedipine|nifedipine|mesh-list
2526299|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2526300|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2400266|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400267|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400268|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400269|NCT00712790|Sorafenib|sorafenib|mesh-list
2400270|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400271|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2400272|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400273|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526301|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526302|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2526303|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526304|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
2526305|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
2526306|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2526307|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2526308|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2526309|NCT01360034|Analgesics|analgesics|mesh-ancestor
2526310|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
2526311|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526312|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2526313|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2526314|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
2526315|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2526316|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526317|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
2526318|NCT01360060|Analgesics|analgesics|mesh-ancestor
2526319|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
2526320|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526321|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526322|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
2526323|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526324|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2526325|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
2526326|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2526327|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2526328|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526329|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2526330|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
2526331|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2526332|NCT01360086|Leucovorin|leucovorin|mesh-list
2526333|NCT01360086|Fluorouracil|fluorouracil|mesh-list
2526334|NCT01360086|Cetuximab|cetuximab|mesh-list
2526335|NCT01360086|Calcium|calcium|mesh-list
2526336|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
2526337|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526338|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2526339|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526340|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
2526341|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526342|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2526343|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2526344|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
2526345|NCT01360086|Antidotes|antidotes|mesh-ancestor
2526346|NCT01360086|Protective Agents|protective agents|mesh-ancestor
2400274|NCT00712855|Sorafenib|sorafenib|mesh-list
2400275|NCT00712855|Mapatumumab|mapatumumab|mesh-list
2400276|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400277|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2400278|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400279|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400280|NCT00712894|Verapamil|verapamil|mesh-list
2400281|NCT00712894|Diltiazem|diltiazem|mesh-list
2400282|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
2400283|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
2400284|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2400285|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2400286|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2400287|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400288|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2400289|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400290|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2400291|NCT00712907|Ascorbic Acid|ascorbic acid|mesh-list
2400292|NCT00712907|Vitamins|vitamins|mesh-ancestor
2400293|NCT00712907|Micronutrients|micronutrients|mesh-ancestor
2400294|NCT00712907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400295|NCT00712907|Antioxidants|antioxidants|mesh-ancestor
2400296|NCT00712907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526347|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
2526348|NCT01360086|Vitamins|vitamins|mesh-ancestor
2526349|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
2400297|NCT00712907|Protective Agents|protective agents|mesh-ancestor
2400298|NCT00712933|Belimumab|belimumab|mesh-list
2400299|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2400300|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
2400301|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400302|NCT00713011|Nifedipine|nifedipine|mesh-list
2400303|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2400304|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2400305|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400306|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2400307|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526350|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2526351|NCT01360151|Ranibizumab|ranibizumab|mesh-list
2526352|NCT01360151|Verteporfin|verteporfin|mesh-list
2526353|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2526354|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2400308|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
2400309|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
2400310|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2400311|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
2400312|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2526355|NCT01360151|Growth Substances|growth substances|mesh-ancestor
2526356|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526357|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
2526358|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526359|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2526360|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
2526361|NCT01360190|Fluoxetine|fluoxetine|mesh-list
2526362|NCT01360190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2526363|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2526364|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2526365|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526366|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400313|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400314|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
2400315|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400316|NCT00713167|Protective Agents|protective agents|mesh-ancestor
2400317|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526367|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
2526368|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400318|NCT00713193|Cyclosporine|cyclosporine|mesh-list
2400319|NCT00713193|Prednisone|prednisone|mesh-list
2400320|NCT00713193|Cyclosporins|cyclosporins|mesh-list
2400321|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2400322|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
2400323|NCT00713193|Hormones|hormones|mesh-ancestor
2400324|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2400325|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400326|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2400327|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526369|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2526370|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
2526371|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2526372|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2526373|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2526374|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526375|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
2526376|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2526377|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526378|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
2526379|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400328|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400329|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400330|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2400331|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
2400332|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
2400333|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400334|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
2400335|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2526380|NCT01360424|Teriparatide|teriparatide|mesh-list
2526381|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2526382|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526383|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2526384|NCT01360437|Ticagrelor|ticagrelor|mesh-list
2526385|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2526386|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2526387|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2526388|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2400336|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2400337|NCT00713271|AZD-3199|azd-3199|mesh-list
2400338|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2400339|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2400340|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2400341|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
2400342|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526389|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2526390|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
2526391|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526392|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526393|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526394|NCT01360463|Methadone|methadone|mesh-list
2526395|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2526396|NCT01360463|Narcotics|narcotics|mesh-ancestor
2526397|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526398|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526399|NCT01360463|Analgesics|analgesics|mesh-ancestor
2526400|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
2526401|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526402|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
2526403|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
2526404|NCT01360476|Vitamin D|vitamin d|mesh-list
2526405|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
2526406|NCT01360476|Vitamins|vitamins|mesh-ancestor
2526407|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
2526408|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526409|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2400343|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400344|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400345|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
2400346|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2400347|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2526410|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2526411|NCT01360593|Gemcitabine|gemcitabine|mesh-list
2526412|NCT01360593|Capecitabine|capecitabine|mesh-list
2526413|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2526414|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
2526415|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526416|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526417|NCT01360593|Antiviral Agents|antiviral agents|mesh-ancestor
2526418|NCT01360593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526419|NCT01360593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526420|NCT01360593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2526421|NCT01360593|Immunologic Factors|immunologic factors|mesh-ancestor
2526422|NCT01360593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526423|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
2526424|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2526425|NCT01360658|Antibodies|antibodies|mesh-list
2526426|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
2526427|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2526428|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
2526429|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526430|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
2526431|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
2526432|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2400348|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400349|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2400350|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2400351|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400352|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400353|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400354|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2400355|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
2400356|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2400357|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400358|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2526433|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2526434|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526435|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526436|NCT01360671|Urological Agents|urological agents|mesh-ancestor
2526437|NCT01360710|Irbesartan|irbesartan|mesh-list
2526438|NCT01360710|Moxonidine|moxonidine|mesh-list
2526439|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2526440|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2526441|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2526442|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526443|NCT01360749|Lidocaine|lidocaine|mesh-list
2526444|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
2526445|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
2526446|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526447|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526448|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
2526449|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526450|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2526451|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2526452|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2526453|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2400359|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2400360|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2400361|NCT00713401|Esmolol|esmolol|mesh-list
2400362|NCT00713401|Tecadenoson|tecadenoson|mesh-list
2400363|NCT00713401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2400364|NCT00713401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2400365|NCT00713401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2400366|NCT00713401|Adrenergic Agents|adrenergic agents|mesh-ancestor
2400367|NCT00713401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526454|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526455|NCT01360788|Albuterol|albuterol|mesh-list
2526456|NCT01360788|Ipratropium|ipratropium|mesh-list
2526457|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2526458|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
2526459|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526460|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526461|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2526462|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
2526463|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
2526464|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2526465|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2526466|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2526467|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2526468|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
2526469|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526470|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526471|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2526472|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
2526473|NCT01360827|Cisplatin|cisplatin|mesh-list
2526474|NCT01360827|Fluorouracil|fluorouracil|mesh-list
2526475|NCT01360827|Cetuximab|cetuximab|mesh-list
2526476|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526477|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
2400368|NCT00713401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400369|NCT00713401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400370|NCT00713401|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2400371|NCT00713401|Purinergic Agonists|purinergic agonists|mesh-ancestor
2400372|NCT00713401|Purinergic Agents|purinergic agents|mesh-ancestor
2400373|NCT00713440|Acetaminophen|acetaminophen|mesh-list
2400374|NCT00713440|Prednisolone|prednisolone|mesh-list
2400375|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2400376|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
2400377|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2400378|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
2400379|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2526478|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526479|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2526480|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2526481|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
2526482|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526483|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2526484|NCT01360853|Gemcitabine|gemcitabine|mesh-list
2526485|NCT01360853|ON 01910|on 01910|mesh-list
2526486|NCT01360853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2526487|NCT01360853|Antimetabolites|antimetabolites|mesh-ancestor
2526488|NCT01360853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526489|NCT01360853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526490|NCT01360853|Antiviral Agents|antiviral agents|mesh-ancestor
2526491|NCT01360853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526492|NCT01360853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400380|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
2400381|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2400382|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
2400383|NCT00713440|Hormones|hormones|mesh-ancestor
2400384|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2526493|NCT01360853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2526494|NCT01360853|Immunologic Factors|immunologic factors|mesh-ancestor
2526495|NCT01360853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526496|NCT01360853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2526497|NCT01361022|Brotizolam|brotizolam|mesh-list
2526498|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2526499|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526500|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526501|NCT01361269|Clindamycin|clindamycin|mesh-list
2526502|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
2526503|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
2526504|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
2526505|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2526506|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526507|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2526508|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526509|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526510|NCT01361373|Levodopa|levodopa|mesh-list
2526511|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2526512|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2526513|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
2400385|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400386|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2400387|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400388|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
2400389|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
2400390|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526514|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526515|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526516|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526517|NCT01361399|Aspirin|aspirin|mesh-list
2526518|NCT01361399|Lidocaine|lidocaine|mesh-list
2526519|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
2526520|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
2526521|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526522|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526523|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
2526524|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526525|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2526526|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2526527|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2526528|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2526529|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526530|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2526531|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2526532|NCT01361399|Analgesics|analgesics|mesh-ancestor
2526533|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2526534|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2526535|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2526536|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2526537|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2526538|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2526539|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526540|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
2526541|NCT01361425|Methyldopa|methyldopa|mesh-list
2526542|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2526543|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
2526544|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
2526545|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526546|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526547|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2526548|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2526549|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2526550|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
2526551|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526552|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526553|NCT01361516|Anesthetics|anesthetics|mesh-list
2526554|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526555|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526556|NCT01361542|Etanercept|etanercept|mesh-list
2526557|NCT01361542|Infliximab|infliximab|mesh-list
2526558|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2526559|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2526560|NCT01361542|Analgesics|analgesics|mesh-ancestor
2526561|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
2526562|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526563|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526564|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2526565|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2526566|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2526567|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2526568|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
2526569|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
2526570|NCT01361763|Dabigatran|dabigatran|mesh-list
2526571|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
2526572|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2526573|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
2526574|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526575|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526576|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
2526577|NCT01361789|Dexamethasone|dexamethasone|mesh-list
2526578|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
2526579|NCT01361789|Etoricoxib|etoricoxib|mesh-list
2526580|NCT01361789|Parecoxib|parecoxib|mesh-list
2526581|NCT01361789|Valdecoxib|valdecoxib|mesh-list
2526582|NCT01361789|BB 1101|bb 1101|mesh-list
2526583|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2526584|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
2526585|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
2526586|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526587|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526588|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2526589|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
2526590|NCT01361789|Hormones|hormones|mesh-ancestor
2526591|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2526592|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2526593|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526594|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
2526595|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526596|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526597|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2526598|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2526599|NCT01361789|Analgesics|analgesics|mesh-ancestor
2526600|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
2526601|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2526602|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2526603|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2526604|NCT01361802|Ambroxol|ambroxol|mesh-list
2526605|NCT01361802|Expectorants|expectorants|mesh-ancestor
2526606|NCT01361802|Respiratory System Agents|respiratory system agents|mesh-ancestor
2526607|NCT01361841|Bimatoprost|bimatoprost|mesh-list
2526608|NCT01361841|Travoprost|travoprost|mesh-list
2526609|NCT01361841|Latanoprost|latanoprost|mesh-list
2526610|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2526611|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2526612|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2526613|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2526614|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
2526615|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2526616|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
2526617|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526618|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526619|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2526620|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
2526621|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2526622|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2526623|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2526624|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
2526625|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526626|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526627|NCT01361997|Ethanol|ethanol|mesh-list
2526628|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
2526629|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2526630|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526631|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526632|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526633|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
2526634|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2526635|NCT01362010|Minocycline|minocycline|mesh-list
2526636|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526637|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2526638|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2526639|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
2526640|NCT01362153|Golimumab|golimumab|mesh-list
2526641|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2526642|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2526643|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2526644|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2526645|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
2526646|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526647|NCT01362218|Aspirin|aspirin|mesh-list
2526648|NCT01362218|Ramipril|ramipril|mesh-list
2526649|NCT01362218|Simvastatin|simvastatin|mesh-list
2526650|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2526651|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2526652|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
2526653|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526654|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2526655|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2526656|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526657|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2526658|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2526659|NCT01362218|Analgesics|analgesics|mesh-ancestor
2526660|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
2526661|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526662|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526663|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2526664|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2526665|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2526666|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2526667|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2400391|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2400392|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2400393|NCT00713440|Protective Agents|protective agents|mesh-ancestor
2400394|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2400395|NCT00713440|Analgesics|analgesics|mesh-ancestor
2400396|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
2400397|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
2400398|NCT00713518|Ranibizumab|ranibizumab|mesh-list
2400399|NCT00713518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2400400|NCT00713518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2400401|NCT00713518|Growth Substances|growth substances|mesh-ancestor
2400402|NCT00713518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400403|NCT00713518|Growth Inhibitors|growth inhibitors|mesh-ancestor
2400404|NCT00713518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400405|NCT00713557|Tirofiban|tirofiban|mesh-list
2400406|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2400407|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2400408|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400409|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2400410|NCT00713622|Zonisamide|zonisamide|mesh-list
2400411|NCT00713622|Valproic Acid|valproic acid|mesh-list
2400412|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
2400413|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400414|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400415|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
2400416|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400417|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400418|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
2400419|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2400420|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2400421|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2400422|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2400423|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2400424|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2400425|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2400426|NCT00713674|Mupirocin|mupirocin|mesh-list
2400427|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400428|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2400429|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400430|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400431|NCT00713687|Gemcitabine|gemcitabine|mesh-list
2400432|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
2400433|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2400434|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
2400435|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400436|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400437|NCT00713687|Antiviral Agents|antiviral agents|mesh-ancestor
2400438|NCT00713687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400439|NCT00713687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400440|NCT00713687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2400441|NCT00713687|Immunologic Factors|immunologic factors|mesh-ancestor
2400442|NCT00713687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400443|NCT00713726|Fentanyl|fentanyl|mesh-list
2400444|NCT00713726|Tramadol|tramadol|mesh-list
2400445|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2400446|NCT00713726|Narcotics|narcotics|mesh-ancestor
2400447|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2400448|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400449|NCT00713726|Analgesics|analgesics|mesh-ancestor
2400450|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
2400451|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400452|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2400453|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2400454|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
2400455|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
2400456|NCT00713739|Prazosin|prazosin|mesh-list
2400457|NCT00713739|Doxazosin|doxazosin|mesh-list
2400458|NCT00713739|Nifedipine|nifedipine|mesh-list
2400459|NCT00713739|Alfuzosin|alfuzosin|mesh-list
2400460|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2400461|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2400462|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400463|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2400464|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400465|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
2400466|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
2400467|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2526668|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2526669|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
2526670|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2526671|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
2526672|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2526673|NCT01362309|Cycloserine|cycloserine|mesh-list
2526674|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2526675|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526676|NCT01362309|Renal Agents|renal agents|mesh-ancestor
2526677|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2526678|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
2526679|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2526680|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
2526681|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526682|NCT01362361|Nintedanib|nintedanib|mesh-list
2526683|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400468|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2400469|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2400470|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2400471|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2400472|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
2400473|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400474|NCT00713739|Urological Agents|urological agents|mesh-ancestor
2400475|NCT00713765|Donepezil|donepezil|mesh-list
2400476|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2400477|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400478|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400479|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
2400480|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526684|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2526685|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526686|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400481|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400482|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
2400483|NCT00713921|Fesoterodine|fesoterodine|mesh-list
2400484|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2400485|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2400486|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
2400487|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400488|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400489|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400490|NCT00713921|Urological Agents|urological agents|mesh-ancestor
2400491|NCT00713947|Amoxicillin|amoxicillin|mesh-list
2400492|NCT00713947|Metronidazole|metronidazole|mesh-list
2400493|NCT00713947|Clarithromycin|clarithromycin|mesh-list
2400494|NCT00713947|Pantoprazole|pantoprazole|mesh-list
2400495|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2400496|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400497|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2400498|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2400499|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2400500|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400501|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400502|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2400503|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2526703|NCT01362400|Docetaxel|docetaxel|mesh-list
2526704|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526705|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
2526706|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
2526707|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
2526708|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526709|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2526710|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2526711|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2526712|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526713|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526714|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2526715|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2526716|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2526717|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
2526718|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526719|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526720|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2526721|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2526722|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
2526723|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
2526724|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526725|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2526726|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526727|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526728|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
2526729|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2526730|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526731|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2526732|NCT01362998|Fentanyl|fentanyl|mesh-list
2526733|NCT01362998|Morphine|morphine|mesh-list
2526734|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2526735|NCT01362998|Narcotics|narcotics|mesh-ancestor
2526736|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526737|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526738|NCT01362998|Analgesics|analgesics|mesh-ancestor
2526739|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
2526740|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526741|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2526742|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2400504|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2400505|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2400506|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2400507|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
2400508|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
2400509|NCT00713986|Protective Agents|protective agents|mesh-ancestor
2400510|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400511|NCT00713999|Praziquantel|praziquantel|mesh-list
2400512|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
2400513|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2400514|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400515|NCT00714025|Everolimus|everolimus|mesh-list
2400516|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400517|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2400518|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
2400519|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400520|NCT00714064|Edetic Acid|edetic acid|mesh-list
2400521|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
2400522|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2400523|NCT00714064|Antidotes|antidotes|mesh-ancestor
2400524|NCT00714064|Protective Agents|protective agents|mesh-ancestor
2400525|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400526|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
2400527|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
2400528|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400529|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2400530|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
2400531|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2400532|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
2400533|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2400534|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2400535|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2400536|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2400537|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526743|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
2526744|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
2526745|NCT01363037|Maraviroc|maraviroc|mesh-list
2526746|NCT01363037|Dapivirine|dapivirine|mesh-list
2400538|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526747|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2526748|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2526749|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526750|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2526751|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2526752|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
2526753|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526754|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2526755|NCT01363063|Ketorolac|ketorolac|mesh-list
2526756|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2526757|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2526758|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2526759|NCT01363063|Analgesics|analgesics|mesh-ancestor
2526760|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
2526761|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526762|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526763|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2526764|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2526765|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2526766|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526767|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526768|NCT01363089|Ketorolac|ketorolac|mesh-list
2526769|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2526770|NCT01363089|Phenylephrine|phenylephrine|mesh-list
2526771|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
2526772|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2526773|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2526774|NCT01363089|Analgesics|analgesics|mesh-ancestor
2526775|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
2526776|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526777|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526778|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2526779|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2526780|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2526781|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526782|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526783|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2526784|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2526785|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
2526786|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526787|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
2526788|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
2526789|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
2526790|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2400539|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400540|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2400541|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
2526791|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
2526792|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2526793|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
2526794|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2526795|NCT01363089|Protective Agents|protective agents|mesh-ancestor
2526796|NCT01363115|Vitamin D|vitamin d|mesh-list
2526797|NCT01363115|Calcium|calcium|mesh-list
2400542|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2400543|NCT00714103|Adenosine|adenosine|mesh-list
2400544|NCT00714103|Analgesics|analgesics|mesh-ancestor
2400545|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
2400546|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400547|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400548|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2526798|NCT01363115|Vitamins|vitamins|mesh-ancestor
2526799|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
2400549|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
2400550|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2400551|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
2400552|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
2400553|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400554|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400555|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
2400556|NCT00714181|Temozolomide|temozolomide|mesh-list
2400557|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2400558|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
2400559|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400560|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400561|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
2400562|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2400563|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2400564|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400565|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400566|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2400567|NCT00714246|Carboplatin|carboplatin|mesh-list
2400568|NCT00714246|Docetaxel|docetaxel|mesh-list
2400569|NCT00714246|Bortezomib|bortezomib|mesh-list
2400570|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400571|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
2526800|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400572|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
2400573|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
2400574|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400575|NCT00714376|Docetaxel|docetaxel|mesh-list
2400576|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400577|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
2400578|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
2400579|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
2400580|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400581|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
2400582|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2400583|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
2400584|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400585|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2400586|NCT00714519|Castor Oil|castor oil|mesh-list
2400587|NCT00714519|Cathartics|cathartics|mesh-ancestor
2400588|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2400589|NCT00714558|Fentanyl|fentanyl|mesh-list
2400590|NCT00714558|Naltrexone|naltrexone|mesh-list
2400591|NCT00714558|Naloxone|naloxone|mesh-list
2400592|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2526801|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2526802|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2526803|NCT01363167|Vitamin D|vitamin d|mesh-list
2526804|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
2526805|NCT01363167|Vitamins|vitamins|mesh-ancestor
2526806|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
2526807|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526808|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2526809|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2526810|NCT01363193|Heparin|heparin|mesh-list
2526811|NCT01363193|Calcium heparin|calcium heparin|mesh-list
2526812|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
2400593|NCT00714558|Narcotics|narcotics|mesh-ancestor
2400594|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2400595|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400596|NCT00714558|Analgesics|analgesics|mesh-ancestor
2526813|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2526814|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2526815|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526816|NCT01363206|Ipilimumab|ipilimumab|mesh-list
2526817|NCT01363206|Molgramostim|molgramostim|mesh-list
2526818|NCT01363206|Sargramostim|sargramostim|mesh-list
2526819|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2400597|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
2400598|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400599|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2400600|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2400601|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
2400602|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
2400603|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2400604|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2400605|NCT00714584|Naltrexone|naltrexone|mesh-list
2400606|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2400607|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2400608|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400609|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
2400610|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526820|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526821|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2526822|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526823|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
2526824|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400611|NCT00714597|Enoxaparin|enoxaparin|mesh-list
2400612|NCT00714597|Semuloparin|semuloparin|mesh-list
2400613|NCT00714597|Enoxaparin sodium|enoxaparin sodium|mesh-list
2400614|NCT00714597|Anticoagulants|anticoagulants|mesh-ancestor
2400615|NCT00714597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2400616|NCT00714597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2400617|NCT00714597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400618|NCT00714623|Sirolimus|sirolimus|mesh-list
2526825|NCT01363271|Vancomycin|vancomycin|mesh-list
2526826|NCT01363271|Linezolid|linezolid|mesh-list
2526827|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2526828|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526829|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2526830|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526831|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526832|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2526833|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2526834|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2526835|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2526836|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526837|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526838|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526839|NCT01363284|Analgesics|analgesics|mesh-ancestor
2526840|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
2526841|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526842|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
2526843|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2526844|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
2526845|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2526846|NCT01363310|Citalopram|citalopram|mesh-list
2526847|NCT01363310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2526848|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2526849|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2526850|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526851|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526852|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
2526853|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526854|NCT01363310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2526855|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
2526856|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2526857|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2526858|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2526859|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2400619|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2400620|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400621|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2400622|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400623|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
2400624|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2400625|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
2400626|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400627|NCT00714649|Cetuximab|cetuximab|mesh-list
2526860|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
2526861|NCT01363323|Naltrexone|naltrexone|mesh-list
2526862|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
2526863|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2526864|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526865|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2526866|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2526867|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526868|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526869|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526870|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526871|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2526872|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
2526873|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526874|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2526875|NCT01363336|Nifedipine|nifedipine|mesh-list
2526876|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2526877|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2526878|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526879|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2526880|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526881|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
2526882|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
2526883|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2526884|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
2400628|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2400629|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400630|NCT00714740|Acetazolamide|acetazolamide|mesh-list
2400631|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
2400632|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2400633|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400634|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400635|NCT00714740|Diuretics|diuretics|mesh-ancestor
2400636|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
2400637|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400638|NCT00714779|Fluoxetine|fluoxetine|mesh-list
2400639|NCT00714779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2400640|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2400641|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2400642|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526885|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2526886|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526887|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
2526888|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2526889|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
2526890|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526891|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
2526892|NCT01363414|Protective Agents|protective agents|mesh-ancestor
2526893|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2526894|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526895|NCT01363544|Methylphenidate|methylphenidate|mesh-list
2526896|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2526897|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526898|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2526899|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2526900|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2526901|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526902|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
2526903|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2526904|NCT01363557|Gefitinib|gefitinib|mesh-list
2526905|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400643|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400644|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
2400645|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400646|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2400647|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
2400648|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2400649|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2400650|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2400651|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400652|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
2400653|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2400654|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526906|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2526907|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526908|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526909|NCT01363570|Ranibizumab|ranibizumab|mesh-list
2526910|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2526911|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2526912|NCT01363570|Growth Substances|growth substances|mesh-ancestor
2526913|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526914|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
2526915|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526916|NCT01363583|Epoprostenol|epoprostenol|mesh-list
2526917|NCT01363583|Tezosentan|tezosentan|mesh-list
2526918|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2526919|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2526920|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
2526921|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
2526922|NCT01363609|Liraglutide|liraglutide|mesh-list
2526923|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2526924|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400655|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526925|NCT01363609|Incretins|incretins|mesh-ancestor
2526926|NCT01363609|Hormones|hormones|mesh-ancestor
2526927|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2526928|NCT01363648|Choline|choline|mesh-list
2526929|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
2526930|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2400656|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2400657|NCT00714857|Analgesics|analgesics|mesh-ancestor
2400658|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
2400659|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400660|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2400661|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2400662|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2400663|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
2400664|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400665|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400666|NCT00714883|Sirolimus|sirolimus|mesh-list
2400667|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2400668|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400669|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2400670|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400671|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
2400672|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2526931|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
2526932|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526933|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2526934|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2526935|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
2526936|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
2526937|NCT01363752|Sirolimus|sirolimus|mesh-list
2526938|NCT01363752|Tacrolimus|tacrolimus|mesh-list
2526939|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2526940|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
2526941|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526942|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2526943|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526944|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526945|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2526946|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526947|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2526948|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
2526949|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2526950|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2526951|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
2526952|NCT01363817|Dexamethasone|dexamethasone|mesh-list
2526953|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2526954|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
2526955|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
2526956|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526957|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526958|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2526959|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
2526960|NCT01363817|Hormones|hormones|mesh-ancestor
2526961|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2526962|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2526963|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400673|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
2400674|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400675|NCT00714961|Clopidogrel|clopidogrel|mesh-list
2400676|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2400677|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2526964|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
2526965|NCT01363934|Hematinics|hematinics|mesh-ancestor
2526966|NCT01364012|Paclitaxel|paclitaxel|mesh-list
2526967|NCT01364012|Bevacizumab|bevacizumab|mesh-list
2526968|NCT01364012|Carboplatin|carboplatin|mesh-list
2526969|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2526970|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526971|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
2526972|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
2526973|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
2526974|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526975|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2526976|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2526977|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2526978|NCT01364012|Growth Substances|growth substances|mesh-ancestor
2526979|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526980|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
2526981|NCT01364051|Cediranib|cediranib|mesh-list
2526982|NCT01364051|Maleic acid|maleic acid|mesh-list
2526983|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526984|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526985|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2526986|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2526987|NCT01364181|Udenafil|udenafil|mesh-list
2526988|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2526989|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2526990|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2526991|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2526992|NCT01364194|Bupivacaine|bupivacaine|mesh-list
2526993|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
2526994|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
2526995|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2526996|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2526997|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
2526998|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2526999|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2527000|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2527001|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2527002|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
2527003|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527004|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2527005|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2527006|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527007|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
2527008|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2527009|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527010|NCT01364376|Leucovorin|leucovorin|mesh-list
2527011|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
2527012|NCT01364376|Calcium|calcium|mesh-list
2527013|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
2527014|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2527015|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527016|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527017|NCT01364376|Antidotes|antidotes|mesh-ancestor
2527018|NCT01364376|Protective Agents|protective agents|mesh-ancestor
2527019|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
2527020|NCT01364376|Vitamins|vitamins|mesh-ancestor
2527021|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
2527022|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
2527023|NCT01364402|Hematinics|hematinics|mesh-ancestor
2400678|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2400679|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2400680|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
2400681|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400682|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400683|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400684|NCT00715013|Epothilone B|epothilone b|mesh-list
2400685|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400686|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
2400687|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
2400688|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
2400689|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400690|NCT00715039|Lorazepam|lorazepam|mesh-list
2400691|NCT00715039|Paroxetine|paroxetine|mesh-list
2400692|NCT00715039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2527024|NCT01364415|Pasireotide|pasireotide|mesh-list
2527025|NCT01364415|Hormones|hormones|mesh-ancestor
2527026|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2527027|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527028|NCT01364493|Capecitabine|capecitabine|mesh-list
2527029|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
2527030|NCT01364493|Trastuzumab|trastuzumab|mesh-list
2527031|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2527032|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
2527033|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527034|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527035|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2527036|NCT01364519|Fluticasone|fluticasone|mesh-list
2527037|NCT01364519|Xhance|xhance|mesh-list
2527038|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2527039|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2527040|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
2527041|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527042|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527043|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2527044|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
2527045|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
2527046|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2527047|NCT01364571|Vaccines|vaccines|mesh-list
2527048|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
2527049|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527050|NCT01364675|Metformin|metformin|mesh-list
2527051|NCT01364675|Enalapril|enalapril|mesh-list
2527052|NCT01364675|Simvastatin|simvastatin|mesh-list
2400693|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2400694|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2400695|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400696|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400697|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
2400698|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400699|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2400700|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
2400701|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2400702|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2400703|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2400704|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400705|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
2527053|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2527054|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527055|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2527056|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2527057|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
2400706|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
2400707|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
2400708|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400709|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2400710|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2400711|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2400712|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2400713|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2400714|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
2400715|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
2400716|NCT00715091|Diclofenac|diclofenac|mesh-list
2400717|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2400718|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2400719|NCT00715091|Analgesics|analgesics|mesh-ancestor
2527058|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527059|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2527060|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2527061|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527062|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2527063|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
2527064|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2400720|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
2400721|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400722|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400723|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2400724|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2400725|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2400726|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400727|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400728|NCT00715273|Niacin|niacin|mesh-list
2527065|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
2527066|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2527067|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2527068|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527069|NCT01364688|Vitamins|vitamins|mesh-ancestor
2527070|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
2400729|NCT00715273|Niacinamide|niacinamide|mesh-list
2400730|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
2400731|NCT00715273|Atorvastatin|atorvastatin|mesh-list
2400732|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2400733|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2400734|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2400735|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
2400736|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400737|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2400738|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2400739|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400740|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
2400741|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
2527071|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
2527072|NCT01364701|Tadalafil|tadalafil|mesh-list
2527073|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
2527074|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2527075|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2527076|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527077|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527078|NCT01364701|Urological Agents|urological agents|mesh-ancestor
2527079|NCT01364792|Valacyclovir|valacyclovir|mesh-list
2527080|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
2527081|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527082|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
2527083|NCT01364805|Gemcitabine|gemcitabine|mesh-list
2527084|NCT01364805|Vitamins|vitamins|mesh-ancestor
2527085|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
2400742|NCT00715273|Vitamins|vitamins|mesh-ancestor
2400743|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
2400744|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400745|NCT00715351|Insulin|insulin|mesh-list
2400746|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2400747|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
2400748|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
2400749|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
2400750|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
2527086|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527087|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2527088|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
2527089|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527090|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527091|NCT01364805|Antiviral Agents|antiviral agents|mesh-ancestor
2527092|NCT01364805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527093|NCT01364805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527094|NCT01364805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2527095|NCT01364805|Immunologic Factors|immunologic factors|mesh-ancestor
2527096|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
2527097|NCT01364805|Protective Agents|protective agents|mesh-ancestor
2527098|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
2527099|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
2527100|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
2527101|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400751|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2400752|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400753|NCT00715377|Benztropine|benztropine|mesh-list
2400754|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2400755|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2400756|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
2527102|NCT01364883|Vaccines|vaccines|mesh-list
2527103|NCT01364883|Immunologic Factors|immunologic factors|mesh-ancestor
2527104|NCT01364883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527105|NCT01364961|Resveratrol|resveratrol|mesh-list
2527106|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
2527107|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527108|NCT01364961|Protective Agents|protective agents|mesh-ancestor
2527109|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527110|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527111|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2527112|NCT01364974|Peficitinib|peficitinib|mesh-list
2527113|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527114|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400757|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
2400758|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400759|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400760|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2400761|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2400762|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
2400763|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400764|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400765|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2400766|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2400767|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2400768|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
2400769|NCT00715442|Sunitinib|sunitinib|mesh-list
2400770|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400771|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2527115|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2527116|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
2527117|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400772|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2400773|NCT00715442|Growth Substances|growth substances|mesh-ancestor
2400774|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400775|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
2400776|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2400777|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400778|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400779|NCT00715455|Heparin|heparin|mesh-list
2400780|NCT00715455|Calcium heparin|calcium heparin|mesh-list
2400781|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
2400782|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2400783|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2400784|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400792|NCT00715637|Cytarabine|cytarabine|mesh-list
2400793|NCT00715637|Amonafide|amonafide|mesh-list
2400794|NCT00715637|Daunorubicin|daunorubicin|mesh-list
2400795|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2400796|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
2527118|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
2527119|NCT01364987|Peficitinib|peficitinib|mesh-list
2527120|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2527121|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527122|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2527123|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
2527124|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2527125|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527126|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527127|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527128|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2527129|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
2527130|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527131|NCT01365000|Naloxegol|naloxegol|mesh-list
2527132|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527133|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527134|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
2527135|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527136|NCT01365065|Vorinostat|vorinostat|mesh-list
2527137|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527138|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2527139|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527140|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527141|NCT01365104|Deferoxamine|deferoxamine|mesh-list
2527142|NCT01365104|Siderophores|siderophores|mesh-ancestor
2527143|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2527144|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
2527145|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
2527146|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527147|NCT01365117|Insulin|insulin|mesh-list
2527148|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2527149|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2527150|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400797|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400798|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400799|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
2527165|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2527166|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2527167|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
2527168|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2527169|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
2527170|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527171|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
2527172|NCT01365260|Protective Agents|protective agents|mesh-ancestor
2527173|NCT01365312|Ethanol|ethanol|mesh-list
2527174|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2527175|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527176|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2527177|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527178|NCT01365351|Hormones|hormones|mesh-list
2527179|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2527180|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527181|NCT01365403|Carbamazepine|carbamazepine|mesh-list
2527182|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
2527183|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
2527184|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2527185|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2527186|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527187|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2527188|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2527189|NCT01365403|Analgesics|analgesics|mesh-ancestor
2527190|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
2527191|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527192|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2527193|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2527194|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527195|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2527196|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2527197|NCT01365598|Primaquine|primaquine|mesh-list
2527198|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
2527199|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2527200|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2527201|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527202|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2527203|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2527204|NCT01365871|Anesthetics|anesthetics|mesh-list
2527205|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2527206|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527207|NCT01365897|Modafinil|modafinil|mesh-list
2527208|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2527209|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527210|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2527211|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2527212|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2527213|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527214|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
2527215|NCT01365923|Remifentanil|remifentanil|mesh-list
2527216|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2527217|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2527218|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527219|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2527220|NCT01365923|Analgesics|analgesics|mesh-ancestor
2527221|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
2527222|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527223|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2527224|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2527225|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2527226|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
2527227|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400800|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400801|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2400802|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
2400803|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400804|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2400805|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2400806|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2400807|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400808|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
2400809|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
2400810|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2400811|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2400812|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400813|NCT00715689|Hormones|hormones|mesh-list
2400814|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2400815|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400816|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
2400817|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2400818|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400819|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2400820|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2400821|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
2400822|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400823|NCT00715715|Prednisone|prednisone|mesh-list
2400824|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2400825|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
2400826|NCT00715715|Hormones|hormones|mesh-ancestor
2400827|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2400828|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400829|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2400830|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400831|NCT00715780|Insulin|insulin|mesh-list
2400832|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2400833|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
2400834|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
2400835|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2400836|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
2400837|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
2400838|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
2400839|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
2400840|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
2400841|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2400842|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400843|NCT00715832|Vaccines|vaccines|mesh-list
2400844|NCT00715832|Immunologic Factors|immunologic factors|mesh-ancestor
2400845|NCT00715832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400846|NCT00715858|Doxycycline|doxycycline|mesh-list
2400847|NCT00715858|Rifampin|rifampin|mesh-list
2400848|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2400849|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400850|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
2400851|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2400852|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2400853|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2400854|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
2400855|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
2400856|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2527228|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527229|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2527230|NCT01365923|Narcotics|narcotics|mesh-ancestor
2527231|NCT01365936|Menotropins|menotropins|mesh-list
2527232|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2527233|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
2527234|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2527235|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527236|NCT01366001|Buprenorphine|buprenorphine|mesh-list
2527237|NCT01366001|ALKS-33|alks-33|mesh-list
2527238|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2527239|NCT01366001|Narcotics|narcotics|mesh-ancestor
2527240|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2527241|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527242|NCT01366001|Analgesics|analgesics|mesh-ancestor
2527243|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
2527244|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527245|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527246|NCT01366014|Oxycodone|oxycodone|mesh-list
2527247|NCT01366014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2527248|NCT01366014|Narcotics|narcotics|mesh-ancestor
2527249|NCT01366014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2527250|NCT01366014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527251|NCT01366014|Analgesics|analgesics|mesh-ancestor
2527252|NCT01366014|Sensory System Agents|sensory system agents|mesh-ancestor
2527253|NCT01366014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527254|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
2527255|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527256|NCT01366131|Paclitaxel|paclitaxel|mesh-list
2527257|NCT01366131|Bevacizumab|bevacizumab|mesh-list
2527258|NCT01366131|Carboplatin|carboplatin|mesh-list
2527259|NCT01366131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2527260|NCT01366131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527261|NCT01366131|Tubulin Modulators|tubulin modulators|mesh-ancestor
2527262|NCT01366131|Antimitotic Agents|antimitotic agents|mesh-ancestor
2527263|NCT01366131|Mitosis Modulators|mitosis modulators|mesh-ancestor
2527264|NCT01366131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527265|NCT01366131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2527266|NCT01366131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2527267|NCT01366131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2527268|NCT01366131|Growth Substances|growth substances|mesh-ancestor
2527269|NCT01366131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527270|NCT01366131|Growth Inhibitors|growth inhibitors|mesh-ancestor
2527271|NCT01366183|Paclitaxel|paclitaxel|mesh-list
2527272|NCT01366183|Carboplatin|carboplatin|mesh-list
2527273|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2527274|NCT01366183|Lenograstim|lenograstim|mesh-list
2527275|NCT01366183|Sargramostim|sargramostim|mesh-list
2527276|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2527277|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527278|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
2527279|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
2527280|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
2527281|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400857|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400858|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400859|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2400860|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2400861|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2400862|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2400863|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2400864|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2400865|NCT00715871|Nicotine|nicotine|mesh-list
2400866|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2400867|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
2400868|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400869|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400870|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2400871|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2400872|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
2527282|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2527283|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
2527284|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527285|NCT01366235|Chloroquine|chloroquine|mesh-list
2527286|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2527287|NCT01366235|Amebicides|amebicides|mesh-ancestor
2527288|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2527289|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2527290|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527291|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
2527292|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2527293|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2527294|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2527295|NCT01366235|Analgesics|analgesics|mesh-ancestor
2527296|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
2527297|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527298|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527299|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2400873|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2400874|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400875|NCT00715975|Clobetasol|clobetasol|mesh-list
2400876|NCT00715975|Halobetasol|halobetasol|mesh-list
2400877|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2400878|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
2400879|NCT00715975|Hormones|hormones|mesh-ancestor
2400880|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2400881|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400882|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2400883|NCT00715988|Methadone|methadone|mesh-list
2400884|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2400885|NCT00715988|Narcotics|narcotics|mesh-ancestor
2527300|NCT01366235|Filaricides|filaricides|mesh-ancestor
2527301|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
2400886|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2400887|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400888|NCT00715988|Analgesics|analgesics|mesh-ancestor
2400889|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
2527302|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
2527303|NCT01366300|Lidocaine|lidocaine|mesh-list
2527304|NCT01366300|Propofol|propofol|mesh-list
2527305|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
2527306|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
2527307|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2527308|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527309|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
2400890|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400891|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
2400892|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
2400893|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
2400894|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2400895|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
2400896|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527310|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527311|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2527312|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2527313|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2527314|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2527315|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527316|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2527317|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2527318|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
2527319|NCT01366313|Acetaminophen|acetaminophen|mesh-list
2527320|NCT01366313|Morphine|morphine|mesh-list
2527321|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2527322|NCT01366313|Narcotics|narcotics|mesh-ancestor
2527323|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2527324|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527325|NCT01366313|Analgesics|analgesics|mesh-ancestor
2527326|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
2527327|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400897|NCT00716001|Expectorants|expectorants|mesh-ancestor
2400898|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
2400899|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2400900|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
2400901|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400902|NCT00716001|Protective Agents|protective agents|mesh-ancestor
2400903|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400904|NCT00716001|Antidotes|antidotes|mesh-ancestor
2527328|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2527329|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
2527330|NCT01366326|Bromides|bromides|mesh-list
2527331|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
2527332|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
2527333|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527334|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527335|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
2527336|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527337|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
2400905|NCT00716066|Cytarabine|cytarabine|mesh-list
2400906|NCT00716066|Prednisone|prednisone|mesh-list
2400907|NCT00716066|Cortisone|cortisone|mesh-list
2400908|NCT00716066|Etoposide|etoposide|mesh-list
2527338|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527339|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527340|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
2400909|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
2400910|NCT00716066|Melphalan|melphalan|mesh-list
2400911|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
2400912|NCT00716066|Carmustine|carmustine|mesh-list
2400913|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
2400914|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2400915|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
2400916|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2400917|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2400918|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
2400919|NCT00716066|Hormones|hormones|mesh-ancestor
2400920|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2400921|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400922|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2400923|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400924|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2527341|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527342|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
2527343|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527344|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527345|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
2527346|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527347|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
2527348|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527349|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527350|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
2527351|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527352|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
2527353|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527354|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527355|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
2527356|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527357|NCT01366391|Metformin|metformin|mesh-list
2527358|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2527359|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527360|NCT01366547|Lamivudine|lamivudine|mesh-list
2527361|NCT01366547|Abacavir|abacavir|mesh-list
2527362|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
2527363|NCT01366547|Dolutegravir|dolutegravir|mesh-list
2527364|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2527365|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2527366|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527367|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116155|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2116156|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2116157|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2527368|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
2527369|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527370|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2400925|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2400926|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2400927|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400928|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400929|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2400930|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
2400931|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
2400932|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400933|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2400934|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
2400935|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2400936|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
2400937|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2400938|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
2400939|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
2400940|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
2400941|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
2400942|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
2400943|NCT00716170|Glucagon|glucagon|mesh-list
2400944|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
2400945|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2400946|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2400947|NCT00716170|Hormones|hormones|mesh-ancestor
2400948|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2400949|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400950|NCT00716170|Incretins|incretins|mesh-ancestor
2400951|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2400952|NCT00716183|Amoxicillin|amoxicillin|mesh-list
2116158|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2116159|NCT02634788|Buprenorphine|buprenorphine|mesh-list
2116160|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2116161|NCT02634788|Narcotics|narcotics|mesh-ancestor
2116162|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116163|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116164|NCT02634788|Analgesics|analgesics|mesh-ancestor
2116165|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
2116166|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116167|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2116168|NCT02634801|Methotrexate|methotrexate|mesh-list
2116169|NCT02634801|Ixekizumab|ixekizumab|mesh-list
2116170|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2116171|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
2527371|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2527372|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
2527373|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2527374|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2527375|NCT01366612|Vidarabine|vidarabine|mesh-list
2527376|NCT01366612|Fludarabine|fludarabine|mesh-list
2527377|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
2527378|NCT01366612|Busulfan|busulfan|mesh-list
2527379|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527380|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2527381|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
2527382|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527383|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2527384|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
2527385|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527386|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
2527387|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527388|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
2527389|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2527390|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2527391|NCT01366651|Doripenem|doripenem|mesh-list
2527392|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2527393|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400953|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
2400954|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
2400955|NCT00716183|Lactams|lactams|mesh-list
2400956|NCT00716183|beta-Lactams|beta-lactams|mesh-list
2400957|NCT00716183|Cloxacillin|cloxacillin|mesh-list
2400958|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2400959|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400960|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400961|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2400962|NCT00716248|Bucillamine|bucillamine|mesh-list
2400963|NCT00716248|Methotrexate|methotrexate|mesh-list
2400964|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2400965|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
2400966|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2400967|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400968|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2400969|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
2400970|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2400971|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400972|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
2400973|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2400974|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2400975|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2400976|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
2400977|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2400978|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2400979|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2400980|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2400981|NCT00716248|Analgesics|analgesics|mesh-ancestor
2400982|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
2400983|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2400984|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2400985|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
2527414|NCT01367028|Bevacizumab|bevacizumab|mesh-list
2527415|NCT01367028|Trastuzumab|trastuzumab|mesh-list
2527416|NCT01367028|Docetaxel|docetaxel|mesh-list
2527417|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2527418|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527419|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2527420|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2527421|NCT01367028|Growth Substances|growth substances|mesh-ancestor
2527422|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527423|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
2527424|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
2527425|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
2527426|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
2527427|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527428|NCT01367054|Metformin|metformin|mesh-list
2527429|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2527430|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2400986|NCT00716248|Protective Agents|protective agents|mesh-ancestor
2400987|NCT00716391|Cisplatin|cisplatin|mesh-list
2400988|NCT00716391|Cetuximab|cetuximab|mesh-list
2400989|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400990|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2400991|NCT00716469|Talaporfin|talaporfin|mesh-list
2400992|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2400993|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2400994|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
2400995|NCT00716521|Zolpidem|zolpidem|mesh-list
2400996|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2400997|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2400998|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2400999|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401000|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2527431|NCT01367210|Maraviroc|maraviroc|mesh-list
2527432|NCT01367210|Darunavir|darunavir|mesh-list
2527433|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2527434|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2527435|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2527436|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527437|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2401001|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
2401002|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
2401003|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2401004|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527438|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
2527439|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527440|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2527441|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2527442|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2527443|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
2527444|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527445|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
2527446|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2527447|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2527448|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
2527449|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2527450|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527451|NCT01367301|Paclitaxel|paclitaxel|mesh-list
2527452|NCT01367301|Carboplatin|carboplatin|mesh-list
2527453|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2527454|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527455|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
2527456|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
2527457|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
2527458|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527459|NCT01367418|Sufentanil|sufentanil|mesh-list
2527460|NCT01367418|Morphine|morphine|mesh-list
2401005|NCT00716534|Paclitaxel|paclitaxel|mesh-list
2401006|NCT00716534|Carboplatin|carboplatin|mesh-list
2401007|NCT00716534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2401008|NCT00716534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401009|NCT00716534|Tubulin Modulators|tubulin modulators|mesh-ancestor
2401010|NCT00716534|Antimitotic Agents|antimitotic agents|mesh-ancestor
2401011|NCT00716534|Mitosis Modulators|mitosis modulators|mesh-ancestor
2527461|NCT01367418|Bupivacaine|bupivacaine|mesh-list
2527462|NCT01367418|Ropivacaine|ropivacaine|mesh-list
2527463|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
2527464|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
2527465|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2527466|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527467|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
2527468|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527469|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2527470|NCT01367418|Narcotics|narcotics|mesh-ancestor
2527471|NCT01367418|Analgesics|analgesics|mesh-ancestor
2527472|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2527473|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2527474|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
2527475|NCT01367431|Xanthohumol|xanthohumol|mesh-list
2527476|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401012|NCT00716534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401013|NCT00716547|Celecoxib|celecoxib|mesh-list
2401014|NCT00716547|Ketoprofen|ketoprofen|mesh-list
2401015|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2401016|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2401017|NCT00716547|Analgesics|analgesics|mesh-ancestor
2401018|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
2401019|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2401020|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401021|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2527477|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2527478|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2527479|NCT01367431|Growth Substances|growth substances|mesh-ancestor
2527480|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527481|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
2527482|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
2527483|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527484|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527485|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
2527486|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527487|NCT01367496|Naltrexone|naltrexone|mesh-list
2527488|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
2527489|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527490|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527491|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
2527492|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527493|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2527494|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
2527495|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527496|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527497|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
2527498|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527499|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
2527500|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527501|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527502|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
2527503|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527504|NCT01367535|Naltrexone|naltrexone|mesh-list
2527505|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
2527506|NCT01367535|Paroxetine|paroxetine|mesh-list
2527507|NCT01367535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2527508|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2527509|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2527510|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527511|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527512|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
2527513|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527514|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2527515|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
2527516|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2527517|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2527518|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2527519|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527520|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527521|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
2527522|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527523|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2527524|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
2527525|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527526|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527527|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
2527528|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527529|NCT01367561|Naloxone|naloxone|mesh-list
2401022|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2527530|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
2527531|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527532|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401023|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2401024|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2401025|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401026|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401027|NCT00716573|Everolimus|everolimus|mesh-list
2401028|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401029|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401030|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
2527533|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
2527534|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527535|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
2527536|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527537|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527538|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
2401031|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401032|NCT00716612|Ubiquinone|ubiquinone|mesh-list
2401033|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
2401034|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
2401035|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401036|NCT00716612|Vitamins|vitamins|mesh-ancestor
2527539|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527540|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
2527541|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527542|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527543|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
2527544|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527545|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
2527546|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527547|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527548|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
2527549|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527550|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
2527551|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2527552|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527553|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
2527554|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527555|NCT01367626|Letrozole|letrozole|mesh-list
2527556|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527557|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2527558|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2527559|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527560|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527561|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2527562|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
2527563|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2527564|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527565|NCT01367652|Letrozole|letrozole|mesh-list
2527566|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527567|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2527568|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2527569|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527570|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527571|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2527572|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
2527573|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2527574|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401037|NCT00716755|Olanzapine|olanzapine|mesh-list
2401038|NCT00716755|Risperidone|risperidone|mesh-list
2401039|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2401040|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
2401041|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2401042|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401043|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401044|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2401045|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2401046|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2401047|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2401048|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2527575|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
2527576|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2527577|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527578|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
2527579|NCT01367743|Epinephrine|epinephrine|mesh-list
2527580|NCT01367743|Norepinephrine|norepinephrine|mesh-list
2527581|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2527582|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2527583|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2527584|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
2527585|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527586|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527587|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401049|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
2401050|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
2401051|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
2401052|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2401053|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2401054|NCT00716755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2401055|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2401056|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2401057|NCT00716846|Atorvastatin|atorvastatin|mesh-list
2401058|NCT00716846|Simvastatin|simvastatin|mesh-list
2401059|NCT00716846|Pitavastatin|pitavastatin|mesh-list
2401060|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2401061|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2401062|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
2527588|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2527589|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2527590|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
2527591|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527592|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2527593|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
2527594|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
2527595|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
2527596|NCT01367756|Citalopram|citalopram|mesh-list
2527597|NCT01367756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2527598|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2527599|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2527600|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527601|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527602|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
2527603|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527604|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2527605|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
2527606|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2527607|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2527608|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2527609|NCT01367912|Estradiol|estradiol|mesh-list
2527610|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2527611|NCT01367912|Estrogens|estrogens|mesh-ancestor
2527612|NCT01367912|Hormones|hormones|mesh-ancestor
2527613|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2527614|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527615|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2527616|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
2527617|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2527618|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2527619|NCT01367964|Hormones|hormones|mesh-list
2527620|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2527621|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2527622|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
2527623|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2527624|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527625|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527626|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527627|NCT01367990|Norepinephrine|norepinephrine|mesh-list
2527628|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2527629|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2527630|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
2527631|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527632|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527633|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527634|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
2527635|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
2527636|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527637|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2527638|NCT01368003|Dutasteride|dutasteride|mesh-list
2401063|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401064|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2401065|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2401066|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401067|NCT00716911|Ganciclovir|ganciclovir|mesh-list
2401068|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2401069|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
2401070|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401071|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2401072|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401073|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401074|NCT00716924|Clopidogrel|clopidogrel|mesh-list
2401075|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2401076|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2401077|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2401078|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2401079|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
2116172|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2116173|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116174|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2116175|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
2116176|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116177|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116178|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
2116179|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116180|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2401080|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527639|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2527640|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2527641|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527642|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527643|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
2527644|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2527645|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527646|NCT01368016|Nicotine|nicotine|mesh-list
2527647|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2527648|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
2401081|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401082|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401083|NCT00716950|Losartan|losartan|mesh-list
2401084|NCT00716950|Valsartan|valsartan|mesh-list
2401085|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2401086|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2401087|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2401088|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401089|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2401090|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
2401091|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
2401092|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2401093|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2527649|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527650|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527651|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2527652|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2527653|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
2527654|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527655|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527656|NCT01368068|Tibolone|tibolone|mesh-list
2527657|NCT01368068|Citalopram|citalopram|mesh-list
2527658|NCT01368068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2527659|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2527660|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2527661|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527662|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527663|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
2527664|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527665|NCT01368068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2527666|NCT01368068|Antidepressive Agents|antidepressive agents|mesh-ancestor
2527667|NCT01368068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2527668|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
2527669|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
2401094|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401095|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2401096|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401097|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2401098|NCT00717210|Temozolomide|temozolomide|mesh-list
2401099|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2401100|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
2527670|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2527671|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2527672|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2527673|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527674|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2527675|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
2527676|NCT01368068|Hormones|hormones|mesh-ancestor
2527677|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2527678|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
2527679|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2527680|NCT01368328|Chromium|chromium|mesh-list
2527681|NCT01368328|Niacin|niacin|mesh-list
2527682|NCT01368328|Trace Elements|trace elements|mesh-ancestor
2527683|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
2527684|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527685|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2527686|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
2527687|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527688|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2527689|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
2527690|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
2527691|NCT01368328|Vitamins|vitamins|mesh-ancestor
2527692|NCT01368341|Amoxicillin|amoxicillin|mesh-list
2527693|NCT01368341|Doxycycline|doxycycline|mesh-list
2527694|NCT01368341|Penicillin V|penicillin v|mesh-list
2527695|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2527696|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527697|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
2527698|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2527699|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2527700|NCT01368419|Endostar protein|endostar protein|mesh-list
2527701|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2527702|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2527703|NCT01368419|Growth Substances|growth substances|mesh-ancestor
2527704|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527705|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
2527706|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527707|NCT01368445|Azelastine|azelastine|mesh-list
2527708|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2527709|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
2527710|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527711|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527712|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2527713|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
2527714|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2527715|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527716|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527717|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2527718|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2527719|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2527720|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
2527721|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
2527722|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527723|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
2527724|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2527725|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2527726|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527727|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2527728|NCT01368627|Sirolimus|sirolimus|mesh-list
2527729|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2527730|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527731|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2527732|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527733|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
2527734|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2527735|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
2527736|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527737|NCT01368757|Lenalidomide|lenalidomide|mesh-list
2527738|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
2527739|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527740|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2527741|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2527742|NCT01368757|Growth Substances|growth substances|mesh-ancestor
2527743|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
2527744|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527745|NCT01368783|Ritonavir|ritonavir|mesh-list
2527746|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2527747|NCT01368783|Tenofovir|tenofovir|mesh-list
2401101|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401102|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401103|NCT00717340|Paclitaxel|paclitaxel|mesh-list
2401104|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2401105|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401106|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
2401107|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
2401108|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
2401109|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401110|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
2401111|NCT00717379|Prednisone|prednisone|mesh-list
2401112|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
2401113|NCT00717379|Tacrolimus|tacrolimus|mesh-list
2401114|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2401115|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
2401116|NCT00717379|Hormones|hormones|mesh-ancestor
2401117|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2401118|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401119|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2401120|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401121|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401122|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
2401123|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2401124|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401125|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401126|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2401127|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2401128|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
2401129|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2401130|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401131|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
2401132|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
2401133|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2401134|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2527748|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2527749|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2527750|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
2527751|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527752|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527753|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2527754|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2527755|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
2527756|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527757|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2527758|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2527759|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2527760|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2527761|NCT01368848|Bevacizumab|bevacizumab|mesh-list
2527762|NCT01368848|Docetaxel|docetaxel|mesh-list
2527763|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2527764|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527765|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2527766|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2527767|NCT01368848|Growth Substances|growth substances|mesh-ancestor
2527768|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527769|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
2527770|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
2527771|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
2527772|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
2527773|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527774|NCT01368887|Niacinamide|niacinamide|mesh-list
2527775|NCT01368887|Niacin|niacin|mesh-list
2527776|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
2527777|NCT01368887|Calcipotriene|calcipotriene|mesh-list
2527778|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
2527779|NCT01368887|Vitamins|vitamins|mesh-ancestor
2527780|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
2527781|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527782|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2527783|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
2527784|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527785|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2527786|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
2527787|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
2527788|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2527789|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2527790|NCT01369043|Vitamins|vitamins|mesh-list
2527791|NCT01369043|Ascorbic Acid|ascorbic acid|mesh-list
2527792|NCT01369043|Vitamin E|vitamin e|mesh-list
2527793|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
2527794|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527795|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
2527796|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527797|NCT01369043|Protective Agents|protective agents|mesh-ancestor
2527798|NCT01369082|Cyclosporine|cyclosporine|mesh-list
2527799|NCT01369082|Sirolimus|sirolimus|mesh-list
2527800|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
2527801|NCT01369082|Tacrolimus|tacrolimus|mesh-list
2527802|NCT01369082|Cyclosporins|cyclosporins|mesh-list
2527803|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2527804|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
2527805|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527806|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2527807|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527808|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527809|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
2527810|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527811|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
2527812|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2527813|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2527814|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527815|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2527816|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
2527817|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2527818|NCT01369095|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2527819|NCT01369095|Citalopram|citalopram|mesh-list
2527820|NCT01369095|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2527821|NCT01369095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2527822|NCT01369095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2527823|NCT01369095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527824|NCT01369095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527825|NCT01369095|Serotonin Agents|serotonin agents|mesh-ancestor
2527826|NCT01369095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527827|NCT01369095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2527828|NCT01369095|Antidepressive Agents|antidepressive agents|mesh-ancestor
2527829|NCT01369095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2401135|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2401136|NCT00717379|Protective Agents|protective agents|mesh-ancestor
2401137|NCT00717457|Exenatide|exenatide|mesh-list
2401138|NCT00717457|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2401139|NCT00717457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2401140|NCT00717457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401141|NCT00717457|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2401142|NCT00717457|Incretins|incretins|mesh-ancestor
2401143|NCT00717457|Hormones|hormones|mesh-ancestor
2527830|NCT01369095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527831|NCT01369095|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2527832|NCT01369095|Analgesics|analgesics|mesh-ancestor
2527833|NCT01369095|Sensory System Agents|sensory system agents|mesh-ancestor
2527834|NCT01369095|Dopamine Agents|dopamine agents|mesh-ancestor
2527835|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
2527836|NCT01369121|Hormones|hormones|mesh-ancestor
2527837|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2527838|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401144|NCT00717457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2401145|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
2401146|NCT00717470|Prednisone|prednisone|mesh-list
2401147|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
2401148|NCT00717470|Tacrolimus|tacrolimus|mesh-list
2401149|NCT00717470|Basiliximab|basiliximab|mesh-list
2401150|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2401151|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
2401152|NCT00717470|Hormones|hormones|mesh-ancestor
2401153|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2401154|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401155|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2401156|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401157|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401158|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
2401159|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2401160|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401161|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401162|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2401163|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2401164|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
2401165|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2401166|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401167|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
2401168|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
2401169|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2401170|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2401171|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2401172|NCT00717470|Protective Agents|protective agents|mesh-ancestor
2401173|NCT00717561|Amoxicillin|amoxicillin|mesh-list
2401174|NCT00717561|Azithromycin|azithromycin|mesh-list
2401175|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
2401176|NCT00717561|Clarithromycin|clarithromycin|mesh-list
2401177|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
2401178|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
2401179|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
2401180|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2401181|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2401182|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2401183|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401184|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2401185|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2401186|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401187|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401188|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401189|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2401190|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
2527843|NCT01369186|Morphine|morphine|mesh-list
2527844|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2527845|NCT01369186|Narcotics|narcotics|mesh-ancestor
2527846|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2527847|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527848|NCT01369186|Analgesics|analgesics|mesh-ancestor
2527849|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
2527850|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527851|NCT01369212|Tenofovir|tenofovir|mesh-list
2527852|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2527853|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
2527854|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527855|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2527856|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2527857|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527858|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527859|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2527860|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2527861|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
2527862|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2527863|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2527864|NCT01369238|Analgesics|analgesics|mesh-ancestor
2527865|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
2527866|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527867|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527868|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2527869|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2527870|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
2527871|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
2527872|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
2527873|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527874|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527875|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
2527876|NCT01369277|Vitamins|vitamins|mesh-ancestor
2527877|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
2527878|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527879|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2527880|NCT01369290|Citalopram|citalopram|mesh-list
2527881|NCT01369290|Bupropion|bupropion|mesh-list
2527882|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2527883|NCT01369290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2527884|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2527885|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2527886|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527887|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527888|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
2527889|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527890|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2527891|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
2527892|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2527893|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527894|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2527895|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
2527896|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2527897|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2527898|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527899|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2527900|NCT01369290|Analgesics|analgesics|mesh-ancestor
2527901|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
2527902|NCT01369303|Tenofovir|tenofovir|mesh-list
2527903|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
2527904|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2527905|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2527906|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2527907|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527908|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527909|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2527910|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2527911|NCT01369368|Azacitidine|azacitidine|mesh-list
2527912|NCT01369368|Valproic Acid|valproic acid|mesh-list
2527913|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2527914|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
2401191|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2401192|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401193|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2401194|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2401195|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2401196|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2401197|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2401198|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2401199|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2401200|NCT00717587|Sunitinib|sunitinib|mesh-list
2401201|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
2401202|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401203|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2401204|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2401205|NCT00717587|Growth Substances|growth substances|mesh-ancestor
2401206|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401207|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
2401208|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2401209|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401210|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401211|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2401212|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
2401213|NCT00717652|Triamcinolone|triamcinolone|mesh-list
2401214|NCT00717652|Tretinoin|tretinoin|mesh-list
2527915|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527916|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2527917|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527918|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
2527919|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
2527920|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527921|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527922|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
2527923|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2527924|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2527925|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2527926|NCT01369472|Carvedilol|carvedilol|mesh-list
2527927|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2527928|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2527929|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
2527930|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527931|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527932|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527933|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2527934|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
2527935|NCT01369472|Protective Agents|protective agents|mesh-ancestor
2527936|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2527937|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2527938|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2527939|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
2527940|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2527941|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2527942|NCT01369576|Zopiclone|zopiclone|mesh-list
2527943|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2527944|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2527945|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527946|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
2527947|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
2527948|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2527949|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527950|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
2527951|NCT01369602|Vitamins|vitamins|mesh-ancestor
2527952|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
2527953|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527954|NCT01369667|Vitamin D|vitamin d|mesh-list
2527955|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
2527956|NCT01369667|Vitamins|vitamins|mesh-ancestor
2527957|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
2527958|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527959|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2527960|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2527961|NCT01369693|Lobeline|lobeline|mesh-list
2527962|NCT01369693|Nicotine|nicotine|mesh-list
2527963|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2527964|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
2401215|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2401216|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
2401217|NCT00717652|Hormones|hormones|mesh-ancestor
2527965|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2527966|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527967|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2527968|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2527969|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
2527970|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527971|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527972|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
2527973|NCT01369719|Deferasirox|deferasirox|mesh-list
2527974|NCT01369719|Deferoxamine|deferoxamine|mesh-list
2527975|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2527976|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
2527977|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
2527978|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527979|NCT01369719|Siderophores|siderophores|mesh-ancestor
2527980|NCT01369979|Imidacloprid|imidacloprid|mesh-list
2527981|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
2527982|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527983|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2527984|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527985|NCT01370031|Charcoal|charcoal|mesh-list
2527986|NCT01370031|Antidotes|antidotes|mesh-ancestor
2527987|NCT01370031|Protective Agents|protective agents|mesh-ancestor
2527988|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527989|NCT01370096|Epoprostenol|epoprostenol|mesh-list
2527990|NCT01370096|Vasopressins|vasopressins|mesh-list
2527991|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
2527992|NCT01370096|Tezosentan|tezosentan|mesh-list
2527993|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
2527994|NCT01370096|Coagulants|coagulants|mesh-ancestor
2527995|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2527996|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2401218|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2401219|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401220|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401221|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
2401222|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
2401223|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
2401224|NCT00717678|Tacrolimus|tacrolimus|mesh-list
2401225|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401226|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
2401227|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401228|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2401229|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401230|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401231|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2401232|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401233|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2401234|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
2401235|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2401236|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401237|NCT00717704|Dasatinib|dasatinib|mesh-list
2401238|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401239|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2401240|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401241|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401242|NCT00717730|Vitamins|vitamins|mesh-list
2401243|NCT00717730|Folic Acid|folic acid|mesh-list
2401244|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
2401245|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
2401246|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
2401247|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
2401248|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401249|NCT00717730|Hematinics|hematinics|mesh-ancestor
2401250|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
2401251|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2401252|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2401253|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401254|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
2401255|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2527997|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
2527998|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2527999|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2528000|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2528001|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
2528002|NCT01370135|Ranibizumab|ranibizumab|mesh-list
2528003|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2528004|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2528005|NCT01370135|Growth Substances|growth substances|mesh-ancestor
2528006|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528007|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
2528008|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528009|NCT01370148|Conivaptan|conivaptan|mesh-list
2528010|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2528011|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528012|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
2528013|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528014|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2528015|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2528016|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
2528017|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528018|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401256|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401257|NCT00717808|Tranilast|tranilast|mesh-list
2401258|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
2401259|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2401260|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2401261|NCT00717808|Analgesics|analgesics|mesh-ancestor
2401262|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
2401263|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2401264|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401265|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2528019|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528020|NCT01370187|Montelukast|montelukast|mesh-list
2528021|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2528022|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
2528023|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2528024|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
2528025|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2528026|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528027|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2528028|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2528029|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528030|NCT01370291|Risperidone|risperidone|mesh-list
2528031|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2528032|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
2528033|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528034|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528035|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528036|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2528037|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2528038|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2528039|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2528040|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2528041|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
2528042|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2528043|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2401266|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2401267|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2401268|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2401269|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401270|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2401271|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2401272|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
2401273|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
2528044|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2528045|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2528046|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528047|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528048|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528049|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2528050|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
2528051|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2528052|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2528053|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528054|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528055|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401274|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2401275|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2401276|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2401277|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
2401278|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
2401279|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
2401280|NCT00717821|Hematinics|hematinics|mesh-ancestor
2401281|NCT00717834|Formaldehyde|formaldehyde|mesh-list
2401282|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
2401283|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401284|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2401285|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2401286|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401287|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2401288|NCT00717938|Carboplatin|carboplatin|mesh-list
2401289|NCT00717938|Etoposide|etoposide|mesh-list
2401290|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
2401291|NCT00717938|Cisplatin|cisplatin|mesh-list
2401292|NCT00717938|Enoxaparin|enoxaparin|mesh-list
2401293|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
2401294|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401295|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2528056|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2528057|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
2528058|NCT01370343|Cyclosporine|cyclosporine|mesh-list
2528059|NCT01370343|Cyclosporins|cyclosporins|mesh-list
2528060|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
2528061|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528062|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401296|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2401297|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2528063|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2528064|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
2528065|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528066|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
2528067|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528068|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
2528069|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2528070|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2528071|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
2528072|NCT01370343|Vitamins|vitamins|mesh-ancestor
2528073|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
2528074|NCT01370434|Dexamethasone|dexamethasone|mesh-list
2528075|NCT01370434|Doxorubicin|doxorubicin|mesh-list
2528076|NCT01370434|Vincristine|vincristine|mesh-list
2528077|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2528078|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
2528079|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
2401298|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401299|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401300|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
2401301|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2401302|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2401303|NCT00717951|Capecitabine|capecitabine|mesh-list
2401304|NCT00717951|Docetaxel|docetaxel|mesh-list
2401305|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401306|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2528080|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528081|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528082|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2528083|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
2528084|NCT01370434|Hormones|hormones|mesh-ancestor
2528085|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2528086|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2528087|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528088|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528089|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528090|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2528091|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2528092|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2528093|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2528094|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
2528095|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
2528096|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
2528097|NCT01370486|Melatonin|melatonin|mesh-list
2528098|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
2528099|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528100|NCT01370486|Protective Agents|protective agents|mesh-ancestor
2528101|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528102|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2528115|NCT01370707|Metformin|metformin|mesh-list
2528116|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2401307|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
2401308|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401309|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
2401310|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
2528117|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528118|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
2528119|NCT01370772|Rituximab|rituximab|mesh-list
2528120|NCT01370772|Fludarabine|fludarabine|mesh-list
2528121|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401311|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
2401312|NCT00717990|Bevacizumab|bevacizumab|mesh-list
2401313|NCT00717990|Capecitabine|capecitabine|mesh-list
2401314|NCT00717990|Irinotecan|irinotecan|mesh-list
2401315|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2528122|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
2528123|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528124|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2528125|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2528126|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
2528127|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401316|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401317|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2401318|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2401319|NCT00717990|Growth Substances|growth substances|mesh-ancestor
2401320|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401321|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
2401322|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2401323|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
2528128|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528129|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2528130|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2528131|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2528132|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
2528133|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528134|NCT01370889|Resveratrol|resveratrol|mesh-list
2528135|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
2528136|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528137|NCT01370889|Protective Agents|protective agents|mesh-ancestor
2528138|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528139|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528140|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2528141|NCT01370915|Vitamins|vitamins|mesh-list
2528142|NCT01370915|Pregabalin|pregabalin|mesh-list
2528143|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
2528144|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528145|NCT01370915|Analgesics|analgesics|mesh-ancestor
2528146|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
2528147|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528148|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
2528149|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2528150|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2528151|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528152|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2528153|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2528154|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2528155|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2528156|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2528157|NCT01371058|Clopidogrel|clopidogrel|mesh-list
2528158|NCT01371058|Policosanol|policosanol|mesh-list
2528159|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2528160|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2528161|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2528162|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2528163|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
2528164|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528165|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528166|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528167|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2528168|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2528169|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
2528170|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2528171|NCT01371201|Sunitinib|sunitinib|mesh-list
2528172|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528173|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2528174|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2528175|NCT01371201|Growth Substances|growth substances|mesh-ancestor
2528176|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528177|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
2528178|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2528179|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528180|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528181|NCT01371240|Secretin|secretin|mesh-list
2528182|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2528183|NCT01371240|Hormones|hormones|mesh-ancestor
2528184|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2528185|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528186|NCT01371331|Tacrolimus|tacrolimus|mesh-list
2528187|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2528188|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
2401324|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401325|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2401326|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2401327|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401328|NCT00718146|Vaccines|vaccines|mesh-list
2401329|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
2401330|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528189|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528190|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2401331|NCT00718172|Ribavirin|ribavirin|mesh-list
2401332|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
2401333|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401334|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
2401335|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401336|NCT00718224|Enoxaparin|enoxaparin|mesh-list
2401337|NCT00718224|Semuloparin|semuloparin|mesh-list
2401338|NCT00718224|Anticoagulants|anticoagulants|mesh-ancestor
2401339|NCT00718224|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2401340|NCT00718224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2401341|NCT00718224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528191|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528192|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528193|NCT01371344|Tacrolimus|tacrolimus|mesh-list
2528194|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401342|NCT00718276|Vitamin D|vitamin d|mesh-list
2401343|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
2401344|NCT00718276|Vitamins|vitamins|mesh-ancestor
2401345|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
2401346|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401347|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2401348|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2401349|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
2401350|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2401351|NCT00718354|Cisplatin|cisplatin|mesh-list
2401352|NCT00718354|Carboplatin|carboplatin|mesh-list
2401353|NCT00718354|Fluorouracil|fluorouracil|mesh-list
2401354|NCT00718354|Capecitabine|capecitabine|mesh-list
2401355|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
2401356|NCT00718354|Epirubicin|epirubicin|mesh-list
2401357|NCT00718354|Enoxaparin|enoxaparin|mesh-list
2401358|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401359|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
2401360|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401361|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2401362|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401363|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
2528195|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
2528196|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528197|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2528198|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528199|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528200|NCT01371435|Paroxetine|paroxetine|mesh-list
2528201|NCT01371435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2528202|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2528203|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2528204|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401364|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401365|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2401366|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2401367|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2401368|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401369|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
2401370|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2401371|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2401372|NCT00718406|Metoprolol|metoprolol|mesh-list
2401373|NCT00718406|Morphine|morphine|mesh-list
2528205|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528206|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
2528207|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528208|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2528209|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
2528210|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2528211|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2401374|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2401375|NCT00718406|Narcotics|narcotics|mesh-ancestor
2401376|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2401377|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401378|NCT00718406|Analgesics|analgesics|mesh-ancestor
2401379|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
2401380|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528212|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2528213|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528214|NCT01371448|Paroxetine|paroxetine|mesh-list
2528215|NCT01371448|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2528216|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2528217|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2528218|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528219|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528220|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
2528221|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528222|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2528223|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
2528224|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2528225|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2528226|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2528227|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528228|NCT01371461|Paroxetine|paroxetine|mesh-list
2528229|NCT01371461|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2528230|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2528231|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2528232|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528233|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528234|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
2528235|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528236|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2401381|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2401382|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2401383|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
2401384|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
2401385|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2401386|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2401387|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2528237|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
2528238|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2528239|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2528240|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2528241|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528242|NCT01371474|Paroxetine|paroxetine|mesh-list
2528243|NCT01371474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2528244|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2528245|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2528246|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528247|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528248|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
2528249|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528250|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2528251|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
2528252|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2528253|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2528254|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2528255|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528256|NCT01371487|Trametinib|trametinib|mesh-list
2528257|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528258|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2528259|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528260|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528261|NCT01371526|Cosyntropin|cosyntropin|mesh-list
2528262|NCT01371526|Hormones|hormones|mesh-ancestor
2528263|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2528264|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528265|NCT01371578|Ribavirin|ribavirin|mesh-list
2528266|NCT01371578|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2528267|NCT01371578|Ledipasvir|ledipasvir|mesh-list
2528268|NCT01371578|Antimetabolites|antimetabolites|mesh-ancestor
2528269|NCT01371578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528270|NCT01371578|Antiviral Agents|antiviral agents|mesh-ancestor
2528271|NCT01371578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528272|NCT01371604|Ribavirin|ribavirin|mesh-list
2528273|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2528274|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
2528275|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528276|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
2528277|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401388|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
2401389|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2401390|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401391|NCT00718471|Heparin|heparin|mesh-list
2401392|NCT00718471|Enoxaparin|enoxaparin|mesh-list
2401393|NCT00718471|Calcium heparin|calcium heparin|mesh-list
2401394|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
2401395|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2401396|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2401397|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401398|NCT00718484|Doxorubicin|doxorubicin|mesh-list
2401399|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2401400|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
2401401|NCT00718484|Ifosfamide|ifosfamide|mesh-list
2401402|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2528278|NCT01371630|Cytarabine|cytarabine|mesh-list
2528279|NCT01371630|Prednisone|prednisone|mesh-list
2528280|NCT01371630|Cortisone|cortisone|mesh-list
2528281|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
2401403|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401404|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2401405|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2401406|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401407|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401408|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2401409|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
2401410|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
2401411|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2401412|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2401413|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
2401414|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401415|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2401416|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2401417|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401418|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401419|NCT00718601|Imetelstat|imetelstat|mesh-list
2401420|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
2401421|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401422|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401423|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2401424|NCT00718705|Josamycin|josamycin|mesh-list
2401425|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2401426|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401427|NCT00718757|Dexamethasone|dexamethasone|mesh-list
2401428|NCT00718757|Irinotecan|irinotecan|mesh-list
2401429|NCT00718757|Vincristine|vincristine|mesh-list
2401430|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2401431|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
2401432|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
2528282|NCT01371630|Rituximab|rituximab|mesh-list
2528283|NCT01371630|Methotrexate|methotrexate|mesh-list
2528284|NCT01371630|Vincristine|vincristine|mesh-list
2528285|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
2528286|NCT01371630|Blinatumomab|blinatumomab|mesh-list
2528287|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2528288|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2528289|NCT01371630|Muromonab-CD3|muromonab-cd3|mesh-list
2528290|NCT01371630|Antibodies|antibodies|mesh-list
2528291|NCT01371630|Immunoglobulins|immunoglobulins|mesh-list
2528292|NCT01371630|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2528293|NCT01371630|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2528294|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2528295|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
2401433|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2401434|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401435|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2401436|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
2401437|NCT00718757|Hormones|hormones|mesh-ancestor
2401438|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2401439|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2401440|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528296|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528297|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2528298|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2528299|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
2528300|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528301|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528302|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2528303|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2528304|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
2528305|NCT01371630|Hormones|hormones|mesh-ancestor
2528306|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2528307|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2528308|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2528309|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
2528310|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2528311|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2528312|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
2528313|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
2528314|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528315|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2528316|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2528317|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
2528318|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528319|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2528320|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
2528321|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
2528322|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
2528323|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2528324|NCT01371682|Ropinirole|ropinirole|mesh-list
2528325|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2528326|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2528327|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
2528328|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
2528329|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528330|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528331|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528332|NCT01371968|Alfentanil|alfentanil|mesh-list
2528333|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2528334|NCT01371968|Narcotics|narcotics|mesh-ancestor
2528335|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2528336|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528337|NCT01371968|Analgesics|analgesics|mesh-ancestor
2528338|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
2528339|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528340|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2528341|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
2528342|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
2528343|NCT01372007|Lanreotide|lanreotide|mesh-list
2401441|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2401442|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2401443|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401444|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401445|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2401446|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
2401447|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
2401448|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
2401449|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
2401450|NCT00718796|Ubiquinone|ubiquinone|mesh-list
2401451|NCT00718796|Atorvastatin|atorvastatin|mesh-list
2401452|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2401453|NCT00718796|Simvastatin|simvastatin|mesh-list
2401454|NCT00718796|Pravastatin|pravastatin|mesh-list
2401455|NCT00718796|Lovastatin|lovastatin|mesh-list
2401456|NCT00718796|L 647318|l 647318|mesh-list
2401457|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
2401458|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
2401459|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2401460|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
2401461|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401462|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2401463|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2401464|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401465|NCT00718796|Vitamins|vitamins|mesh-ancestor
2401466|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
2401467|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401468|NCT00718913|Docetaxel|docetaxel|mesh-list
2401469|NCT00718913|Capecitabine|capecitabine|mesh-list
2401470|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401471|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
2401472|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
2401473|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
2401474|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401475|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2401476|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
2401477|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2401478|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
2401479|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2116181|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2116182|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
2116183|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2528344|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528345|NCT01372111|Cisplatin|cisplatin|mesh-list
2528346|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528347|NCT01372280|Galantamine|galantamine|mesh-list
2528348|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2528349|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528350|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528351|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
2528352|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2401480|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2401481|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401482|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401483|NCT00718952|Urological Agents|urological agents|mesh-ancestor
2401484|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
2401485|NCT00719056|Lactams|lactams|mesh-list
2401486|NCT00719056|Cephalosporins|cephalosporins|mesh-list
2528353|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528354|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2528355|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
2528356|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528357|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
2528358|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
2528359|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
2528360|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2528361|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2528362|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528363|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2528364|NCT01372306|Galantamine|galantamine|mesh-list
2528365|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2528366|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528367|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528368|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
2528369|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528370|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528371|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2528372|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
2528373|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528374|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
2528375|NCT01372371|Vancomycin|vancomycin|mesh-list
2528376|NCT01372371|Gentamicins|gentamicins|mesh-list
2528377|NCT01372371|Cefuroxime|cefuroxime|mesh-list
2528378|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
2528379|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2528380|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528381|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2528382|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528383|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528384|NCT01372423|Lubiprostone|lubiprostone|mesh-list
2528385|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2528386|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2528387|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528388|NCT01372449|Memantine|memantine|mesh-list
2528389|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2528390|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2528391|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
2528392|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528393|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528394|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116184|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2116185|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2116186|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2116187|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116188|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2116189|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2528395|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2528396|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2528397|NCT01372475|Hyaluronic Acid|hyaluronic acid|mesh-list
2528398|NCT01372475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2528399|NCT01372475|Immunologic Factors|immunologic factors|mesh-ancestor
2528400|NCT01372475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528401|NCT01372475|Viscosupplements|viscosupplements|mesh-ancestor
2528402|NCT01372475|Protective Agents|protective agents|mesh-ancestor
2528403|NCT01372540|Filanesib|filanesib|mesh-list
2528404|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
2528405|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
2528406|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528407|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528408|NCT01372579|Carboplatin|carboplatin|mesh-list
2528409|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528410|NCT01372644|Pasireotide|pasireotide|mesh-list
2528411|NCT01372644|Hormones|hormones|mesh-ancestor
2528412|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2528413|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528414|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
2528415|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
2528416|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
2528417|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2401487|NCT00719056|Teicoplanin|teicoplanin|mesh-list
2401488|NCT00719056|beta-Lactams|beta-lactams|mesh-list
2401489|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2401490|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401491|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2401492|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2401493|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401494|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401495|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401496|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2401497|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2401498|NCT00719095|Naltrexone|naltrexone|mesh-list
2401499|NCT00719095|Buprenorphine|buprenorphine|mesh-list
2401500|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2401501|NCT00719095|Narcotics|narcotics|mesh-ancestor
2401502|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2401503|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401504|NCT00719095|Analgesics|analgesics|mesh-ancestor
2401505|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
2528418|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
2528419|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
2528420|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528421|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528422|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528423|NCT01372761|CKD732|ckd732|mesh-list
2528424|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2528425|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2528426|NCT01372761|Growth Substances|growth substances|mesh-ancestor
2528427|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528428|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
2528429|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528430|NCT01372826|Naloxegol|naloxegol|mesh-list
2528431|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2528432|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528433|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
2528434|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528435|NCT01372839|Atorvastatin|atorvastatin|mesh-list
2528436|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2528437|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2528438|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
2528439|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528440|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2528441|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2528442|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528443|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
2528444|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2528445|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
2528446|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2528447|NCT01372904|Dexamethasone|dexamethasone|mesh-list
2528448|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
2401506|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528449|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2528450|NCT01372904|BB 1101|bb 1101|mesh-list
2528451|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2528452|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
2528453|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
2528454|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528455|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528456|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2528457|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
2528458|NCT01372904|Hormones|hormones|mesh-ancestor
2528459|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2528460|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2528461|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528462|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
2528463|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528464|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528465|NCT01372930|Etanercept|etanercept|mesh-list
2528466|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2528467|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2528468|NCT01372930|Analgesics|analgesics|mesh-ancestor
2528469|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
2528470|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528471|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528472|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2528473|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2528474|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2528475|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2528476|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
2528477|NCT01372982|Letrozole|letrozole|mesh-list
2528478|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528479|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2528480|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2528481|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528482|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528483|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2528484|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
2528485|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2401507|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2401508|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2401509|NCT00719108|Insulin|insulin|mesh-list
2401510|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2401511|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2401512|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401513|NCT00719121|Adapalene|adapalene|mesh-list
2401514|NCT00719121|R 115866|r 115866|mesh-list
2401515|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2401516|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2401517|NCT00719121|Analgesics|analgesics|mesh-ancestor
2401518|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
2401519|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528486|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528487|NCT01373008|Beclomethasone|beclomethasone|mesh-list
2528488|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2528489|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
2528490|NCT01373008|Hormones|hormones|mesh-ancestor
2528491|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2528492|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528493|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2528494|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
2528495|NCT01373021|Fentanyl|fentanyl|mesh-list
2528496|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
2528497|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2401520|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401521|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2401522|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2401523|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
2401524|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2401525|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401526|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401527|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
2401528|NCT00719173|Aprepitant|aprepitant|mesh-list
2401529|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401530|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
2401531|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401532|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2401533|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2401534|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
2528498|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2528499|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528500|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2528501|NCT01373021|Analgesics|analgesics|mesh-ancestor
2528502|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
2528503|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528504|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2528505|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2528506|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2528507|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
2528508|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528509|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528510|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2528511|NCT01373021|Narcotics|narcotics|mesh-ancestor
2528512|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2528513|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2528514|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
2528515|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
2528516|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
2528517|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2528518|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528519|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2528520|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528521|NCT01373086|Eplerenone|eplerenone|mesh-list
2528522|NCT01373086|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2528523|NCT01373086|Hormone Antagonists|hormone antagonists|mesh-ancestor
2528524|NCT01373086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2528525|NCT01373086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528526|NCT01373086|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2528527|NCT01373086|Diuretics|diuretics|mesh-ancestor
2528528|NCT01373086|Natriuretic Agents|natriuretic agents|mesh-ancestor
2528529|NCT01373086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2528530|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
2528531|NCT01373138|Ephedrine|ephedrine|mesh-list
2528532|NCT01373138|Desloratadine|desloratadine|mesh-list
2528533|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2528534|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
2528535|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528536|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528537|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2528538|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
2528539|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
2528540|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2528541|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2528542|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
2528543|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
2528544|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528545|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528546|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2528547|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
2528548|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2528549|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2528550|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
2528551|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
2401535|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401536|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401537|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2401538|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
2401539|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
2401540|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2401541|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2528570|NCT01373216|Exenatide|exenatide|mesh-list
2528571|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2401542|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2401543|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2401544|NCT00719199|Cetuximab|cetuximab|mesh-list
2401545|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2401546|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401547|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
2401548|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2401549|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
2528572|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528573|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2528574|NCT01373216|Incretins|incretins|mesh-ancestor
2528575|NCT01373216|Hormones|hormones|mesh-ancestor
2528576|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2528577|NCT01373333|Amifampridine|amifampridine|mesh-list
2528578|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2528579|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528580|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528581|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2528582|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2528583|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528584|NCT01373359|Misoprostol|misoprostol|mesh-list
2528585|NCT01373359|Oxytocin|oxytocin|mesh-list
2528586|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
2528587|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2528588|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528589|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2528590|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
2528591|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2528592|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2528593|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
2528594|NCT01373372|Hormones|hormones|mesh-ancestor
2528595|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2528596|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528597|NCT01373398|Apaziquone|apaziquone|mesh-list
2528598|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528599|NCT01373411|Ticagrelor|ticagrelor|mesh-list
2528600|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2528601|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2528602|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2528603|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2528604|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
2528605|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528606|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528607|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528608|NCT01373463|Carboplatin|carboplatin|mesh-list
2528609|NCT01373463|Pemetrexed|pemetrexed|mesh-list
2528610|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528611|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528612|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528613|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2528614|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2528615|NCT01373528|Budesonide|budesonide|mesh-list
2528616|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2528617|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2528618|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
2528619|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528620|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528621|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2528622|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
2528623|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
2528624|NCT01373528|Hormones|hormones|mesh-ancestor
2528625|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2528626|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
2528627|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528628|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528629|NCT01373554|Oltipraz|oltipraz|mesh-list
2528630|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
2528631|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528632|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
2528633|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2528634|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
2528635|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2528636|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2528637|NCT01373554|Protective Agents|protective agents|mesh-ancestor
2528638|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528639|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528640|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2528641|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2528642|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528643|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528644|NCT01373593|Lidocaine|lidocaine|mesh-list
2528645|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
2528646|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
2528647|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2528648|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401550|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401551|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
2401552|NCT00719290|Protective Agents|protective agents|mesh-ancestor
2401553|NCT00719381|Pioglitazone|pioglitazone|mesh-list
2401554|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2401555|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401556|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
2401557|NCT00719407|Hematinics|hematinics|mesh-ancestor
2401558|NCT00719420|Amoxicillin|amoxicillin|mesh-list
2401559|NCT00719420|Metronidazole|metronidazole|mesh-list
2401560|NCT00719420|Clarithromycin|clarithromycin|mesh-list
2401561|NCT00719420|Omeprazole|omeprazole|mesh-list
2401562|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2528649|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
2528650|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528651|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2528652|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2528653|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2528654|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2528655|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528656|NCT01373606|Terlipressin|terlipressin|mesh-list
2528657|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2528658|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2528659|NCT01373632|Sirolimus|sirolimus|mesh-list
2528660|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2528661|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528662|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2528663|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528664|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
2528665|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2528666|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
2528667|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528668|NCT01373684|Tenofovir|tenofovir|mesh-list
2401563|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401564|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2401565|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2401566|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2401567|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2401568|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2401569|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401570|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401571|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2401572|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2401573|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2401574|NCT00719433|Armin|armin|mesh-list
2401575|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2401576|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401577|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401578|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
2401579|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2401580|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401581|NCT00719459|Iron|iron|mesh-list
2401582|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2528669|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2528670|NCT01373684|Entecavir|entecavir|mesh-list
2401583|NCT00719459|Trace Elements|trace elements|mesh-ancestor
2401584|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
2528671|NCT01373684|Adefovir|adefovir|mesh-list
2528672|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
2528673|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528674|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2528675|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2528676|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528677|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528678|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2528679|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2528680|NCT01373697|Ibuprofen|ibuprofen|mesh-list
2528681|NCT01373697|Ketoprofen|ketoprofen|mesh-list
2528682|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2528683|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2528684|NCT01373697|Analgesics|analgesics|mesh-ancestor
2528685|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
2528686|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528687|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528688|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2528689|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2528690|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2528691|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528692|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528693|NCT01373710|Trastuzumab|trastuzumab|mesh-list
2401585|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401586|NCT00719459|Hematinics|hematinics|mesh-ancestor
2401587|NCT00719550|Capecitabine|capecitabine|mesh-list
2401588|NCT00719550|Epirubicin|epirubicin|mesh-list
2401589|NCT00719550|Rilotumumab|rilotumumab|mesh-list
2401590|NCT00719550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401591|NCT00719550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2401592|NCT00719550|Antimetabolites|antimetabolites|mesh-ancestor
2401593|NCT00719550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401594|NCT00719550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2401595|NCT00719550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2401596|NCT00719550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2401597|NCT00719550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401598|NCT00719550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2401599|NCT00719602|Ritonavir|ritonavir|mesh-list
2401600|NCT00719602|Lopinavir|lopinavir|mesh-list
2401601|NCT00719602|Lamivudine|lamivudine|mesh-list
2528694|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2528695|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528696|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2528697|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528698|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528699|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528700|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2528701|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
2528702|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
2528703|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2528704|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2528705|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528706|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528707|NCT01373749|Urological Agents|urological agents|mesh-ancestor
2528708|NCT01373970|Pantoprazole|pantoprazole|mesh-list
2528709|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2528710|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2528711|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2528712|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528713|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528714|NCT01373983|Ziconotide|ziconotide|mesh-list
2528715|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2528716|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2528717|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528718|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2528719|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401602|NCT00719602|Zidovudine|zidovudine|mesh-list
2401603|NCT00719602|Nevirapine|nevirapine|mesh-list
2401604|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2401605|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2528720|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2528721|NCT01373983|Protective Agents|protective agents|mesh-ancestor
2528722|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2528723|NCT01373983|Analgesics|analgesics|mesh-ancestor
2401606|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
2401607|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401608|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401609|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2401610|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2401611|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
2401612|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401613|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2401614|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2401615|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2401616|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2401617|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
2401618|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2401619|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2401620|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
2401621|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2401622|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
2401623|NCT00719693|Fenofibrate|fenofibrate|mesh-list
2401624|NCT00719693|Calcium|calcium|mesh-list
2401625|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2401626|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528724|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
2528725|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528726|NCT01374126|Azithromycin|azithromycin|mesh-list
2528727|NCT01374126|Artesunate|artesunate|mesh-list
2528728|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2528729|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528730|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
2528731|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2528732|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2528733|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528734|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
2528735|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
2528736|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2528737|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
2528738|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
2528739|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2528740|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2401627|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2401628|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2401629|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2401630|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
2401631|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401632|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2401633|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2401634|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401635|NCT00719745|Tacrolimus|tacrolimus|mesh-list
2401636|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401637|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
2401638|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401639|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2401640|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401641|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401642|NCT00719758|Beraprost|beraprost|mesh-list
2401643|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2401644|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
2401645|NCT00719797|Leucovorin|leucovorin|mesh-list
2401646|NCT00719797|Bevacizumab|bevacizumab|mesh-list
2401647|NCT00719797|Fluorouracil|fluorouracil|mesh-list
2401648|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
2401649|NCT00719797|Irinotecan|irinotecan|mesh-list
2401650|NCT00719797|Calcium|calcium|mesh-list
2401651|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
2401652|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2401653|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401654|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2528741|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2528742|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2528743|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528744|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
2528745|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528746|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528747|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2528748|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528749|NCT01374282|Penicillamine|penicillamine|mesh-list
2528750|NCT01374282|Antidotes|antidotes|mesh-ancestor
2528751|NCT01374282|Protective Agents|protective agents|mesh-ancestor
2401655|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2528752|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528753|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
2528754|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
2528755|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528756|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2528757|NCT01374308|Interferons|interferons|mesh-list
2528758|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
2528759|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
2528760|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2528761|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528762|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
2528763|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528764|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
2528765|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528766|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
2528767|NCT01374373|Hematinics|hematinics|mesh-ancestor
2528768|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
2528769|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
2528770|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
2528771|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2528772|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401656|NCT00719797|Growth Substances|growth substances|mesh-ancestor
2401657|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401658|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
2401659|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2401660|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
2401661|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401662|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2401663|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401664|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
2401665|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2401666|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2401667|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401668|NCT00719797|Antidotes|antidotes|mesh-ancestor
2401669|NCT00719797|Protective Agents|protective agents|mesh-ancestor
2401670|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
2401671|NCT00719797|Vitamins|vitamins|mesh-ancestor
2401672|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
2401673|NCT00719823|Maraviroc|maraviroc|mesh-list
2401674|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2401675|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2401676|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401677|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2401678|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2401679|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
2401680|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401681|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2401682|NCT00719875|Vorinostat|vorinostat|mesh-list
2401683|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2401684|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401685|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401686|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401687|NCT00719888|Cyclosporine|cyclosporine|mesh-list
2401688|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
2401689|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
2401690|NCT00719888|Thiotepa|thiotepa|mesh-list
2401691|NCT00719888|Fludarabine|fludarabine|mesh-list
2401692|NCT00719888|Cyclosporins|cyclosporins|mesh-list
2401693|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401694|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
2401695|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528773|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
2528774|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528775|NCT01374581|Artesunate|artesunate|mesh-list
2528776|NCT01374581|Lumefantrine|lumefantrine|mesh-list
2528777|NCT01374581|Artemether|artemether|mesh-list
2528778|NCT01374581|Amodiaquine|amodiaquine|mesh-list
2528779|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2528780|NCT01374581|Quinine|quinine|mesh-list
2528781|NCT01374581|Clindamycin|clindamycin|mesh-list
2528782|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
2528783|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
2401696|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2401697|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2401698|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
2401699|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401700|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528784|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
2528785|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2528786|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2528787|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528788|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528789|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
2528790|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
2528791|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2528792|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
2528793|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2528794|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2528795|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528796|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528797|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2528798|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528799|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2528800|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528801|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2528802|NCT01374581|Analgesics|analgesics|mesh-ancestor
2528803|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
2528804|NCT01374620|Paclitaxel|paclitaxel|mesh-list
2528805|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2528806|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
2401701|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2401702|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401703|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
2401704|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528807|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2528808|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528809|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
2528810|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
2528811|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
2528812|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528813|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2528814|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
2528815|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528816|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2528817|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2528818|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
2528819|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2528820|NCT01374633|Sevoflurane|sevoflurane|mesh-list
2528821|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2528822|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2528823|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
2528824|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
2528825|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2528826|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528827|NCT01374698|Aspirin|aspirin|mesh-list
2401705|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
2401706|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2401707|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2401708|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2401709|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
2528828|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2528829|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2528830|NCT01374698|Analgesics|analgesics|mesh-ancestor
2401710|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2401724|NCT00720018|Sumatriptan|sumatriptan|mesh-list
2401725|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2401726|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2401727|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2401728|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
2401729|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2401730|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401731|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401732|NCT00720135|Rituximab|rituximab|mesh-list
2401733|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2401734|NCT00720135|Interleukin-2|interleukin-2|mesh-list
2401735|NCT00720135|Antibodies|antibodies|mesh-list
2401736|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
2401737|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2401738|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
2401739|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401740|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401741|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2401742|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2401743|NCT00720135|Analgesics|analgesics|mesh-ancestor
2401744|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
2401745|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2401746|NCT00720148|Bortezomib|bortezomib|mesh-list
2401747|NCT00720148|Sunitinib|sunitinib|mesh-list
2401748|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401749|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2401750|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2401751|NCT00720148|Growth Substances|growth substances|mesh-ancestor
2401752|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401753|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
2401754|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2401755|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401756|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401757|NCT00720161|Metformin|metformin|mesh-list
2401758|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2401759|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528831|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
2528832|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528833|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528834|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2528835|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2528836|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2528837|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2528838|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528839|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2528840|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2528841|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528842|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
2528843|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
2528844|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2528845|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2528846|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528847|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2528848|NCT01374737|Analgesics|analgesics|mesh-ancestor
2528849|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
2528850|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528851|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2528852|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2528853|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2528854|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
2528855|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528856|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528857|NCT01374750|Cyclosporine|cyclosporine|mesh-list
2528858|NCT01374750|Sirolimus|sirolimus|mesh-list
2528859|NCT01374750|Tacrolimus|tacrolimus|mesh-list
2528860|NCT01374750|Cyclosporins|cyclosporins|mesh-list
2401760|NCT00720174|Doxorubicin|doxorubicin|mesh-list
2401761|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2401762|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2401763|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2401764|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401765|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2401766|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2401767|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401768|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401769|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
2401770|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401771|NCT00720265|Tacrolimus|tacrolimus|mesh-list
2528861|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401772|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401773|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
2528862|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
2528863|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528864|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2528865|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528866|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528867|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
2528868|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528869|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
2401774|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401775|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2401776|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401777|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401778|NCT00720291|Metronidazole|metronidazole|mesh-list
2401779|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401780|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2401781|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2401782|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2401783|NCT00720304|Docetaxel|docetaxel|mesh-list
2401784|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2401785|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401786|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
2401787|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
2401788|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
2401789|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401790|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2401791|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401792|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
2401793|NCT00720408|Tacrolimus|tacrolimus|mesh-list
2401794|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401795|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
2401796|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401797|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2401798|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401799|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528870|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2528871|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2528872|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2528873|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528874|NCT01374763|Oxycodone|oxycodone|mesh-list
2528875|NCT01374763|Naloxone|naloxone|mesh-list
2528876|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2528877|NCT01374763|Narcotics|narcotics|mesh-ancestor
2528878|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2528879|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528880|NCT01374763|Analgesics|analgesics|mesh-ancestor
2528881|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
2528882|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528883|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2528884|NCT01374789|Panitumumab|panitumumab|mesh-list
2528885|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2528886|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528887|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2401800|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2401801|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401802|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2401803|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
2401804|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2401805|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401806|NCT00720421|Lorazepam|lorazepam|mesh-list
2401807|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
2401808|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
2401809|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
2401810|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528888|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2528889|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2528890|NCT01374828|Analgesics|analgesics|mesh-ancestor
2528891|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
2528892|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528893|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528894|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2528895|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2528896|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2528897|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528898|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528899|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
2528900|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401811|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401812|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2401813|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2401814|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2401815|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2401816|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2401817|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2528901|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
2528902|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528903|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2528904|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2528905|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
2528906|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528907|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2528908|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2528909|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
2528910|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
2401818|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
2401819|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
2401820|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2401821|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401822|NCT00720447|Cytarabine|cytarabine|mesh-list
2401823|NCT00720447|Etoposide|etoposide|mesh-list
2401824|NCT00720447|Melphalan|melphalan|mesh-list
2401825|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
2401826|NCT00720447|Carmustine|carmustine|mesh-list
2401827|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2401828|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401829|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2401830|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2401831|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528911|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2528912|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2528913|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
2528914|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528915|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
2528916|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2528917|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
2528918|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528919|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2528920|NCT01375088|Propolis|propolis|mesh-list
2528921|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528922|NCT01375101|Quercetin|quercetin|mesh-list
2401832|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401833|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2401834|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
2401835|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
2401836|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401837|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401838|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
2401839|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401840|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2401841|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
2401842|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2401843|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2401844|NCT00720512|Leucovorin|leucovorin|mesh-list
2401845|NCT00720512|Bevacizumab|bevacizumab|mesh-list
2401846|NCT00720512|Fluorouracil|fluorouracil|mesh-list
2401847|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
2401848|NCT00720512|Irinotecan|irinotecan|mesh-list
2401849|NCT00720512|Calcium|calcium|mesh-list
2401850|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
2401851|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2401852|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401853|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2401854|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2401855|NCT00720512|Growth Substances|growth substances|mesh-ancestor
2401856|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401857|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
2528923|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
2528924|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528925|NCT01375101|Protective Agents|protective agents|mesh-ancestor
2528926|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401858|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2401859|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
2401860|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528927|NCT01375244|Lisinopril|lisinopril|mesh-list
2528928|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2528929|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
2528930|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528931|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528932|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2528933|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2528934|NCT01375244|Protective Agents|protective agents|mesh-ancestor
2528935|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528936|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2528937|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2401861|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2401862|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401863|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
2401864|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2401865|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2401866|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401867|NCT00720512|Antidotes|antidotes|mesh-ancestor
2401868|NCT00720512|Protective Agents|protective agents|mesh-ancestor
2401869|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
2401870|NCT00720512|Vitamins|vitamins|mesh-ancestor
2401871|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
2401872|NCT00720538|Thalidomide|thalidomide|mesh-list
2401873|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2401874|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
2401875|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401876|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
2401877|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2401878|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401879|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2401880|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2401881|NCT00720538|Growth Substances|growth substances|mesh-ancestor
2528938|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2528939|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
2528940|NCT01375322|Amlodipine|amlodipine|mesh-list
2528941|NCT01375322|Valsartan|valsartan|mesh-list
2528942|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2528943|NCT01375322|Benazepril|benazepril|mesh-list
2528944|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2528945|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2528946|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2528947|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528948|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2528949|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528950|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
2528951|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2528952|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2528953|NCT01375322|Diuretics|diuretics|mesh-ancestor
2528954|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
2528955|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2401882|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
2401883|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401884|NCT00720564|Temozolomide|temozolomide|mesh-list
2401885|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
2401886|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2528956|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2528957|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
2528958|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2528959|NCT01375335|Dobutamine|dobutamine|mesh-list
2528960|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2528961|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
2528962|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
2528963|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528964|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528965|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2528966|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2528967|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2528968|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
2528969|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528970|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528971|NCT01375335|Protective Agents|protective agents|mesh-ancestor
2528972|NCT01375348|Remifentanil|remifentanil|mesh-list
2528973|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2528974|NCT01375348|Narcotics|narcotics|mesh-ancestor
2528975|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2401887|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
2528976|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528977|NCT01375348|Analgesics|analgesics|mesh-ancestor
2528978|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
2528979|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528980|NCT01375361|Albuterol|albuterol|mesh-list
2528981|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2528982|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
2528983|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2528984|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2528985|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2528986|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
2528987|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
2528988|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2528989|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2528990|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2528991|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2528992|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
2528993|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2528994|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2528995|NCT01375387|Lacosamide|lacosamide|mesh-list
2528996|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
2528997|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2528998|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2528999|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2529000|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529001|NCT01375400|Aspirin|aspirin|mesh-list
2529002|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2529003|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2529004|NCT01375400|Analgesics|analgesics|mesh-ancestor
2529005|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
2529006|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529007|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529008|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2529009|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2529010|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2401888|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401889|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401890|NCT00720577|Pioglitazone|pioglitazone|mesh-list
2401891|NCT00720577|Losartan|losartan|mesh-list
2401892|NCT00720577|Simvastatin|simvastatin|mesh-list
2401893|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2401894|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2401895|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
2401896|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401897|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2401898|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2401899|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401900|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2401901|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401902|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2401903|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2401904|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2401905|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2529011|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2529012|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529013|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2529014|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2529015|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529016|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
2529017|NCT01375426|Amoxicillin|amoxicillin|mesh-list
2529018|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2529019|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529020|NCT01375452|Letrozole|letrozole|mesh-list
2529021|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529022|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2529023|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2529024|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529025|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529026|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2529027|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
2529028|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2529029|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529030|NCT01375556|Ethanol|ethanol|mesh-list
2529031|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2529032|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529033|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2529034|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529035|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2529036|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
2529037|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2529038|NCT01375634|Midazolam|midazolam|mesh-list
2529039|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2529040|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2529041|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2529042|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529043|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2529044|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2529045|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2529046|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2529047|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
2529048|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
2529049|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
2529050|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
2529051|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529052|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529053|NCT01375699|Doxorubicin|doxorubicin|mesh-list
2529054|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2529055|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
2529056|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2529057|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529058|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2529059|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2529060|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529061|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529062|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
2529063|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2529064|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2529065|NCT01375699|Urological Agents|urological agents|mesh-ancestor
2529066|NCT01375816|Leucovorin|leucovorin|mesh-list
2529067|NCT01375816|Bevacizumab|bevacizumab|mesh-list
2529068|NCT01375816|Fluorouracil|fluorouracil|mesh-list
2529069|NCT01375816|Irinotecan|irinotecan|mesh-list
2529070|NCT01375816|Calcium|calcium|mesh-list
2529071|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
2529072|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2529073|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529074|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2529075|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2529076|NCT01375816|Growth Substances|growth substances|mesh-ancestor
2529077|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529078|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
2529079|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2529080|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
2529081|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529082|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2529083|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2529084|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
2529085|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2529086|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2529087|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529088|NCT01375816|Antidotes|antidotes|mesh-ancestor
2529089|NCT01375816|Protective Agents|protective agents|mesh-ancestor
2529090|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
2529091|NCT01375816|Vitamins|vitamins|mesh-ancestor
2529092|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
2529093|NCT01375829|Sirolimus|sirolimus|mesh-list
2529094|NCT01375829|Epothilone B|epothilone b|mesh-list
2529095|NCT01375829|Epothilones|epothilones|mesh-list
2529096|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2529097|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529098|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2529099|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529100|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
2529101|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2529102|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
2529103|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529104|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
2529105|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
2529106|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
2529107|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529108|NCT01375842|Atezolizumab|atezolizumab|mesh-list
2529109|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529110|NCT01375881|Ritonavir|ritonavir|mesh-list
2529111|NCT01375881|Darunavir|darunavir|mesh-list
2529112|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2529113|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2529114|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
2529115|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529116|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529117|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2401906|NCT00720590|Ritonavir|ritonavir|mesh-list
2401907|NCT00720590|Lopinavir|lopinavir|mesh-list
2401908|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2401909|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2401910|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2401911|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
2401912|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529118|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2529119|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
2529120|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529121|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2529122|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2529123|NCT01375920|Metyrapone|metyrapone|mesh-list
2529124|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
2529125|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529126|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529127|NCT01375972|Gemcitabine|gemcitabine|mesh-list
2529128|NCT01375972|Cisplatin|cisplatin|mesh-list
2529129|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529130|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2529131|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
2529132|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529133|NCT01375972|Antiviral Agents|antiviral agents|mesh-ancestor
2529134|NCT01375972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529135|NCT01375972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529136|NCT01375972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2529137|NCT01375972|Immunologic Factors|immunologic factors|mesh-ancestor
2529138|NCT01375972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529139|NCT01375985|Radavirsen|radavirsen|mesh-list
2529140|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
2529141|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529142|NCT01376011|Quercetin|quercetin|mesh-list
2529143|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
2529144|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529145|NCT01376011|Protective Agents|protective agents|mesh-ancestor
2529146|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529147|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
2529148|NCT01376076|Risperidone|risperidone|mesh-list
2529149|NCT01376076|Cariprazine|cariprazine|mesh-list
2529150|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2529151|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2529152|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529153|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2529154|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2529155|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529156|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529157|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529158|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2529159|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
2529160|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2529161|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529162|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2529163|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2529164|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2529165|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2529166|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
2529167|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529168|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2529169|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2529170|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2529171|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2529172|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2529173|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
2529174|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
2529175|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2529176|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529177|NCT01376128|Paroxetine|paroxetine|mesh-list
2529178|NCT01376128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2529179|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2529180|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2529181|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529182|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529183|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
2529184|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529185|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2529186|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
2401913|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401914|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2401915|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2401916|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
2401917|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529187|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2529188|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2529189|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2529190|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529191|NCT01376141|Sumatriptan|sumatriptan|mesh-list
2529192|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2529193|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2529194|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2529195|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
2529196|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529197|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529198|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529199|NCT01376154|Lamivudine|lamivudine|mesh-list
2529200|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2529201|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2529202|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529203|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529204|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
2529205|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529206|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2529207|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2529208|NCT01376180|Lamotrigine|lamotrigine|mesh-list
2529209|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
2401918|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2401919|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2401920|NCT00720603|Plerixafor|plerixafor|mesh-list
2401921|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2401922|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2401923|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
2401924|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401925|NCT00720616|Insulin|insulin|mesh-list
2401926|NCT00720616|Hormones|hormones|mesh-list
2401927|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2401928|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401929|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2401930|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
2401931|NCT00720772|Antidotes|antidotes|mesh-ancestor
2401932|NCT00720772|Protective Agents|protective agents|mesh-ancestor
2401933|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401934|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
2401935|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401936|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
2401937|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2401938|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401939|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
2401940|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
2401941|NCT00720811|Acetaminophen|acetaminophen|mesh-list
2401942|NCT00720811|Amoxicillin|amoxicillin|mesh-list
2401943|NCT00720811|Lumefantrine|lumefantrine|mesh-list
2401944|NCT00720811|Artemether|artemether|mesh-list
2401945|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2401946|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2401947|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2401948|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2401949|NCT00720811|Analgesics|analgesics|mesh-ancestor
2401950|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
2401951|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2401952|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401953|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
2401954|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
2401955|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2529210|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2529211|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2529212|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529213|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2529214|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529215|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2529216|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2529217|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2529218|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2529219|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2529220|NCT01376193|Naratriptan|naratriptan|mesh-list
2529221|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2529222|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2529223|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2529224|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
2529225|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529226|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529227|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529228|NCT01376206|Fluticasone|fluticasone|mesh-list
2529229|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2529230|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2529231|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
2529232|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529233|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529234|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2529235|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
2529236|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
2401956|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2401957|NCT00720824|Anesthetics|anesthetics|mesh-list
2401958|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2401959|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
2401960|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2401961|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401962|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
2529237|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2529238|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
2529239|NCT01376232|Glycine|glycine|mesh-list
2529240|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
2529241|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529242|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529243|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529244|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2529245|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
2529246|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2529247|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2529248|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2529249|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529250|NCT01376258|Finasteride|finasteride|mesh-list
2529251|NCT01376258|Dutasteride|dutasteride|mesh-list
2529252|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2529253|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2529254|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529255|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529256|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
2529257|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2529258|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529259|NCT01376258|Urological Agents|urological agents|mesh-ancestor
2529260|NCT01376271|Paroxetine|paroxetine|mesh-list
2529261|NCT01376271|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2529262|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2529263|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2529264|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529265|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2401963|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2401964|NCT00720850|Lenalidomide|lenalidomide|mesh-list
2401965|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
2401966|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401967|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2401968|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2401969|NCT00720850|Growth Substances|growth substances|mesh-ancestor
2401970|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
2401971|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2401972|NCT00720902|Hormones|hormones|mesh-list
2401973|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
2401974|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2529266|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
2529267|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529268|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2529269|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
2529270|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2529271|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2529272|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2529273|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529274|NCT01376284|Dutasteride|dutasteride|mesh-list
2529275|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2529276|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2401975|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2401976|NCT00720915|Anticoagulants|anticoagulants|mesh-list
2401977|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
2401978|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2401979|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2401980|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401981|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
2401982|NCT00720915|Coagulants|coagulants|mesh-ancestor
2401983|NCT00721032|Amiodarone|amiodarone|mesh-list
2401984|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2401985|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
2401986|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2401987|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2401988|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2401989|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2401990|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2401991|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2401992|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2401993|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2401994|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2401995|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2401996|NCT00721201|Mifepristone|mifepristone|mesh-list
2401997|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2401998|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
2401999|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2529277|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529278|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529279|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
2529280|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2529281|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529282|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2529283|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2529284|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529285|NCT01376323|Incretins|incretins|mesh-ancestor
2529286|NCT01376323|Hormones|hormones|mesh-ancestor
2529287|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2529288|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2529289|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
2529290|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529291|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529292|NCT01376401|Prednisone|prednisone|mesh-list
2529293|NCT01376401|Bortezomib|bortezomib|mesh-list
2402000|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402001|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2402002|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2402003|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2402004|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
2402005|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2402006|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2402007|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
2402008|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2402009|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
2402010|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2402011|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2402012|NCT00721240|Montelukast|montelukast|mesh-list
2402013|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2402014|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
2529294|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2529295|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2529296|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
2529297|NCT01376401|Hormones|hormones|mesh-ancestor
2529298|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2529299|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529300|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2529301|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529302|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2529303|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
2529304|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402015|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2402016|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
2402017|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2402018|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402019|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2402020|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2529336|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2529337|NCT01376440|Eusol|eusol|mesh-list
2529338|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
2529339|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529340|NCT01376453|Fluorouracil|fluorouracil|mesh-list
2529341|NCT01376453|Sorafenib|sorafenib|mesh-list
2529342|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
2529343|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529344|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2529345|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529346|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2529347|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
2529348|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529349|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2529350|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529351|NCT01376505|Vaccines|vaccines|mesh-list
2529352|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
2529353|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529354|NCT01376713|Dacarbazine|dacarbazine|mesh-list
2529355|NCT01376713|Ofatumumab|ofatumumab|mesh-list
2529356|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2529357|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2529358|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
2529359|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529360|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529361|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
2529362|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529363|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2529364|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2529365|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
2529366|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529367|NCT01376765|Antacids|antacids|mesh-ancestor
2529368|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529369|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2529370|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2529371|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2529372|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2529373|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2529374|NCT01376882|Caffeine|caffeine|mesh-list
2529375|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2529376|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529377|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2402021|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402022|NCT00721305|Lovastatin|lovastatin|mesh-list
2402023|NCT00721305|L 647318|l 647318|mesh-list
2402024|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
2402025|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2402026|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2402027|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
2402028|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402029|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2402030|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2529378|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529379|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529380|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2529381|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2529382|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
2529383|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402031|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402032|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
2402033|NCT00721331|Loratadine|loratadine|mesh-list
2402034|NCT00721331|Nortriptyline|nortriptyline|mesh-list
2402035|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2402036|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
2402037|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2402038|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
2402039|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2402040|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2402041|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
2402042|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
2402043|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402044|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529384|NCT01376999|Hormones|hormones|mesh-list
2529385|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2529386|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529387|NCT01377025|Sorafenib|sorafenib|mesh-list
2529388|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529389|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2529390|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529391|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529392|NCT01377051|Maleic acid|maleic acid|mesh-list
2529393|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529394|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529395|NCT01377103|Testosterone|testosterone|mesh-list
2402045|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402046|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2402047|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
2402048|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2402049|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2402050|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2402051|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2402052|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
2402053|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
2402054|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2402055|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402056|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2402057|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2402058|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402059|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402060|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402061|NCT00721448|Ticagrelor|ticagrelor|mesh-list
2402062|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2402063|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2402064|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2402065|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2402066|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
2402067|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402068|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402069|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402070|NCT00721487|Fluconazole|fluconazole|mesh-list
2402071|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
2402072|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402073|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2402074|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2402075|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402076|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402077|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2529396|NCT01377103|Androgens|androgens|mesh-ancestor
2529397|NCT01377103|Hormones|hormones|mesh-ancestor
2529398|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2529399|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529400|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
2529401|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2529402|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529403|NCT01377168|Naltrexone|naltrexone|mesh-list
2529404|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2529405|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2529406|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529407|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
2529408|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529409|NCT01377220|Choline|choline|mesh-list
2529410|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
2529411|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2529412|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
2529413|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529414|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2529415|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2402078|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
2402079|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2402080|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402081|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2529416|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
2529417|NCT01377246|Octreotide|octreotide|mesh-list
2529418|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2402082|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2402083|NCT00721526|Disulfiram|disulfiram|mesh-list
2402084|NCT00721526|Lorazepam|lorazepam|mesh-list
2402085|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
2402086|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
2402087|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
2402088|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402089|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402090|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2402091|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2402092|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2402093|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2402094|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2402095|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2402096|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
2402097|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
2402098|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402099|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402100|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2402101|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2402102|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402103|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2402104|NCT00721552|Prednisolone|prednisolone|mesh-list
2402105|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2402106|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
2402107|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2402108|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
2402109|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2402110|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
2402111|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2402112|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
2402113|NCT00721552|Hormones|hormones|mesh-ancestor
2402114|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2402115|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402116|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2402117|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402118|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
2402119|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
2402120|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402121|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2402122|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2402123|NCT00721552|Protective Agents|protective agents|mesh-ancestor
2402124|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2402125|NCT00721552|Incretins|incretins|mesh-ancestor
2529419|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2529420|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529421|NCT01377259|Anesthetics|anesthetics|mesh-list
2529422|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2529423|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529424|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
2529425|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2529426|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2529427|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529428|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529429|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2529430|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2529431|NCT01377285|Protective Agents|protective agents|mesh-ancestor
2529432|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529433|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
2529434|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2529435|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
2529436|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2529437|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2529438|NCT01377324|Estradiol|estradiol|mesh-list
2529439|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2529440|NCT01377324|Estrogens|estrogens|mesh-ancestor
2529441|NCT01377324|Hormones|hormones|mesh-ancestor
2529442|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2529443|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529444|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2529445|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
2529446|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2529447|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2529448|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2529449|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529450|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2529451|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529452|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529453|NCT01377415|Bupivacaine|bupivacaine|mesh-list
2529454|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
2529455|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
2529456|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2529457|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529458|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
2529459|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529460|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
2529461|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2529462|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
2529463|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529464|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529465|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2529466|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
2529467|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2529468|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2529469|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2529470|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
2529471|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529472|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529473|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2402126|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2402127|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
2402128|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402129|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402130|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2402131|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
2402132|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
2402133|NCT00721695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2402134|NCT00721695|Mydriatics|mydriatics|mesh-list
2529474|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529475|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529476|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529477|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2529478|NCT01377545|Anesthetics|anesthetics|mesh-list
2402135|NCT00721695|Autonomic Agents|autonomic agents|mesh-ancestor
2402136|NCT00721695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402137|NCT00721695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402138|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
2402139|NCT00721747|Docetaxel|docetaxel|mesh-list
2402140|NCT00721747|Doxorubicin|doxorubicin|mesh-list
2402141|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2402142|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2402143|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
2402144|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402145|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2402146|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2402147|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
2402148|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402149|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402150|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2402151|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
2402152|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
2402153|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
2402154|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2402155|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2402156|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2402157|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402158|NCT00721760|Enoxaparin|enoxaparin|mesh-list
2402159|NCT00721760|Semuloparin|semuloparin|mesh-list
2402160|NCT00721760|Enoxaparin sodium|enoxaparin sodium|mesh-list
2402161|NCT00721760|Anticoagulants|anticoagulants|mesh-ancestor
2402162|NCT00721760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2402163|NCT00721760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2402164|NCT00721760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402165|NCT00721773|Valsartan|valsartan|mesh-list
2529479|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
2529480|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2529481|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529482|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
2529483|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529484|NCT01377597|Ranibizumab|ranibizumab|mesh-list
2529485|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2529486|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2529487|NCT01377597|Growth Substances|growth substances|mesh-ancestor
2529488|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529489|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
2529490|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529491|NCT01377610|Naltrexone|naltrexone|mesh-list
2529492|NCT01377610|Buprenorphine|buprenorphine|mesh-list
2529493|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2529494|NCT01377610|Narcotics|narcotics|mesh-ancestor
2529495|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2529496|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529497|NCT01377610|Analgesics|analgesics|mesh-ancestor
2529498|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
2529499|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529500|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2529501|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2529502|NCT01377662|Methylphenidate|methylphenidate|mesh-list
2529503|NCT01377662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2529504|NCT01377662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402166|NCT00721773|Benazepril|benazepril|mesh-list
2402167|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2402168|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2402169|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2402170|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402171|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2529505|NCT01377662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2529506|NCT01377662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2529507|NCT01377662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2529508|NCT01377662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529509|NCT01377662|Dopamine Agents|dopamine agents|mesh-ancestor
2529510|NCT01377662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529511|NCT01377961|Lycopene|lycopene|mesh-list
2529512|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2529513|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
2529514|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529515|NCT01377961|Protective Agents|protective agents|mesh-ancestor
2529516|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529517|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2529518|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2529519|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529520|NCT01377974|Miltefosine|miltefosine|mesh-list
2529521|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2529522|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
2529523|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529524|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529525|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2529526|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2529527|NCT01378039|Budesonide|budesonide|mesh-list
2529528|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2529529|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2529530|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
2529531|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529532|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529533|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2529534|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
2529535|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
2529536|NCT01378039|Hormones|hormones|mesh-ancestor
2529537|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2529538|NCT01378091|Prednisone|prednisone|mesh-list
2529539|NCT01378091|Docetaxel|docetaxel|mesh-list
2529540|NCT01378091|Lenalidomide|lenalidomide|mesh-list
2529541|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529542|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
2529543|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
2529544|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
2529545|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402172|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
2402173|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402174|NCT00721877|Resveratrol|resveratrol|mesh-list
2402175|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
2402176|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402177|NCT00721877|Protective Agents|protective agents|mesh-ancestor
2402178|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402179|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402180|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2402181|NCT00721916|Leucovorin|leucovorin|mesh-list
2402182|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
2402183|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402184|NCT00721916|Antidotes|antidotes|mesh-ancestor
2402185|NCT00721916|Protective Agents|protective agents|mesh-ancestor
2402186|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402187|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
2529546|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2529547|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
2529548|NCT01378091|Hormones|hormones|mesh-ancestor
2529549|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2529550|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529551|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2529552|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
2529553|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2529554|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2529555|NCT01378091|Growth Substances|growth substances|mesh-ancestor
2529556|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
2529557|NCT01378143|Pentamidine|pentamidine|mesh-list
2529558|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
2529559|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529560|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2529561|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2529562|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2529563|NCT01378156|Vaccines|vaccines|mesh-list
2529564|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
2402188|NCT00721916|Vitamins|vitamins|mesh-ancestor
2529565|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529566|NCT01378286|Artesunate|artesunate|mesh-list
2529567|NCT01378286|Chloroquine|chloroquine|mesh-list
2529568|NCT01378286|Amodiaquine|amodiaquine|mesh-list
2529569|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
2529570|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2529571|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2529572|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529573|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402189|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
2402190|NCT00722033|Indomethacin|indomethacin|mesh-list
2529574|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
2529575|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
2529576|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2529577|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
2529578|NCT01378286|Amebicides|amebicides|mesh-ancestor
2529579|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2529580|NCT01378481|Vorinostat|vorinostat|mesh-list
2529581|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402191|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2402192|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2402193|NCT00722033|Analgesics|analgesics|mesh-ancestor
2402194|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
2402195|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402196|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529582|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2529583|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529584|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529585|NCT01378533|Paclitaxel|paclitaxel|mesh-list
2529586|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
2529587|NCT01378533|Carboplatin|carboplatin|mesh-list
2529588|NCT01378533|Epirubicin|epirubicin|mesh-list
2529589|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2529590|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529591|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
2529592|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
2529593|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
2529594|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529595|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2529596|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
2529597|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529598|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2529599|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2529600|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
2529601|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2529602|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2529603|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2529604|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2529605|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529606|NCT01378546|Amifampridine|amifampridine|mesh-list
2529607|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2529608|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529609|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529610|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2529611|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2529612|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529613|NCT01378650|Cilostazol|cilostazol|mesh-list
2529614|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2529615|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
2529616|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529617|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529618|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2529619|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
2529620|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2529621|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2529622|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529623|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2529624|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
2529625|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2529626|NCT01378650|Protective Agents|protective agents|mesh-ancestor
2529627|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2529628|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2529629|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529630|NCT01378676|Riluzole|riluzole|mesh-list
2529631|NCT01378676|Anticonvulsants|anticonvulsants|mesh-ancestor
2529632|NCT01378676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2529633|NCT01378676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2529634|NCT01378676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529635|NCT01378676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529636|NCT01378676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529637|NCT01378676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2529638|NCT01378676|Protective Agents|protective agents|mesh-ancestor
2529639|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2529640|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2529641|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2529642|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
2529643|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529644|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2529645|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2529646|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529647|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
2529648|NCT01378741|Propofol|propofol|mesh-list
2529649|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2529650|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2529651|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529652|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2529653|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
2529654|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
2529655|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2529656|NCT01378741|Analgesics|analgesics|mesh-ancestor
2529657|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
2529658|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529659|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2529660|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2529661|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2529662|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
2529663|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529664|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529665|NCT01378754|Fospropofol|fospropofol|mesh-list
2529666|NCT01378754|Propofol|propofol|mesh-list
2529667|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2529668|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2529669|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529670|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2529671|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
2529672|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
2529673|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2529674|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529675|NCT01378845|Bosentan|bosentan|mesh-list
2529676|NCT01378845|Alprostadil|alprostadil|mesh-list
2529677|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2529678|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2529679|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529680|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2529681|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
2529682|NCT01378845|Urological Agents|urological agents|mesh-ancestor
2529683|NCT01378884|Domperidone|domperidone|mesh-list
2529684|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
2529685|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
2529686|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529687|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529688|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2529689|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2529690|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
2529691|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529692|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529693|NCT01378949|Morphine|morphine|mesh-list
2529694|NCT01378949|Bupivacaine|bupivacaine|mesh-list
2529695|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
2529696|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
2529697|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2529698|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529699|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
2529700|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529701|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2402197|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2402198|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2402199|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
2402200|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
2402201|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2402202|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2529702|NCT01378949|Narcotics|narcotics|mesh-ancestor
2529703|NCT01378949|Analgesics|analgesics|mesh-ancestor
2529704|NCT01379001|Scopolamine|scopolamine|mesh-list
2529705|NCT01379001|Donepezil|donepezil|mesh-list
2529706|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2529707|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2529708|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529709|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529710|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
2529711|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529712|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529713|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
2529714|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2529715|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
2529716|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
2529717|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402203|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402204|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402205|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
2402206|NCT00722098|Vaccines|vaccines|mesh-list
2529718|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2529719|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
2529720|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2529721|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2529722|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
2529723|NCT01379079|Aspirin|aspirin|mesh-list
2529724|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
2529725|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
2529726|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
2116190|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2116191|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116192|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
2116193|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116194|NCT02635204|Clobetasol|clobetasol|mesh-list
2116195|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2116196|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
2116197|NCT02635204|Hormones|hormones|mesh-ancestor
2402207|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
2402208|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402209|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2402210|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2402211|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2402212|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
2402213|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402214|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402215|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2402216|NCT00722150|Artesunate|artesunate|mesh-list
2402217|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
2402218|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2402219|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2402220|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402221|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402222|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
2402223|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
2402224|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2402225|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
2402226|NCT00722176|Risperidone|risperidone|mesh-list
2402227|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2402228|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
2402229|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402230|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402231|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402232|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2402233|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2402234|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2402235|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2402236|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2402237|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
2402238|NCT00722215|Nifedipine|nifedipine|mesh-list
2402239|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
2402240|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2402241|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2402242|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402243|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2402244|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529727|NCT01379079|Calcium|calcium|mesh-list
2529728|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2402245|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
2529729|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529730|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2529731|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2529732|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2529733|NCT01379079|Analgesics|analgesics|mesh-ancestor
2402246|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
2402247|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2402248|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2402249|NCT00722293|Doxorubicin|doxorubicin|mesh-list
2402250|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2402251|NCT00722293|Epirubicin|epirubicin|mesh-list
2402252|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2402253|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402254|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2402255|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2402256|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402257|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402258|NCT00722358|Asunaprevir|asunaprevir|mesh-list
2402259|NCT00722358|Protease Inhibitors|protease inhibitors|mesh-ancestor
2402260|NCT00722358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402261|NCT00722358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402262|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
2402263|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2402264|NCT00722475|Antibodies|antibodies|mesh-list
2402265|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
2402266|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2402267|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
2402268|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529734|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
2529735|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529736|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2529737|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2529738|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2529739|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2529740|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529741|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2529742|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2529743|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529744|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
2402269|NCT00722488|Pevonedistat|pevonedistat|mesh-list
2402270|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402271|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402272|NCT00722579|Cobalt|cobalt|mesh-list
2402273|NCT00722579|Chromium|chromium|mesh-list
2402274|NCT00722579|Trace Elements|trace elements|mesh-ancestor
2402275|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
2402276|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402277|NCT00722592|Doxorubicin|doxorubicin|mesh-list
2402278|NCT00722592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2402279|NCT00722592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2402280|NCT00722592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402281|NCT00722592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2402282|NCT00722592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2402283|NCT00722592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402284|NCT00722592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402285|NCT00722631|Pioglitazone|pioglitazone|mesh-list
2402286|NCT00722631|Glimepiride|glimepiride|mesh-list
2402287|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2402288|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402289|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2402290|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2402291|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
2402292|NCT00722709|Ropivacaine|ropivacaine|mesh-list
2402293|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
2402294|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
2402295|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2402296|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402297|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
2402298|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402299|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
2402300|NCT00722735|Finafloxacin|finafloxacin|mesh-list
2402301|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2402302|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402303|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2402304|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2402305|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402306|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402307|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402308|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2402309|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2402310|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2402311|NCT00722735|Renal Agents|renal agents|mesh-ancestor
2402312|NCT00722839|Vaccines|vaccines|mesh-list
2402313|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
2529745|NCT01379144|Latanoprost|latanoprost|mesh-list
2529746|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2529747|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2529748|NCT01379157|Imipenem|imipenem|mesh-list
2529749|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2529750|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529751|NCT01379196|Azithromycin|azithromycin|mesh-list
2529752|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2529753|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529754|NCT01379209|Mycophenolic Acid|mycophenolic acid|mesh-list
2529755|NCT01379209|Sirolimus|sirolimus|mesh-list
2402314|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402315|NCT00722852|Ketoprofen|ketoprofen|mesh-list
2402316|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2402317|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2402318|NCT00722852|Analgesics|analgesics|mesh-ancestor
2402319|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
2402320|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402321|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402322|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2402323|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2402324|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2402325|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402326|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402327|NCT00722917|Pioglitazone|pioglitazone|mesh-list
2402328|NCT00722917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2402329|NCT00722917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402330|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2402331|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
2402332|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402333|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
2402334|NCT00722956|Atorvastatin|atorvastatin|mesh-list
2402335|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2402336|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2402337|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
2402338|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402339|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2402340|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2402341|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402342|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2402343|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2402344|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2402345|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
2402346|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402347|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2402348|NCT00722969|Sorafenib|sorafenib|mesh-list
2402349|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402350|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2402351|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402352|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402353|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2402354|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
2402355|NCT00723047|Coagulants|coagulants|mesh-ancestor
2529756|NCT01379209|Methotrexate|methotrexate|mesh-list
2529757|NCT01379209|KRN 7000|krn 7000|mesh-list
2529758|NCT01379209|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2529759|NCT01379209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2529760|NCT01379209|Abortifacient Agents|abortifacient agents|mesh-ancestor
2529761|NCT01379209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2529762|NCT01379209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529763|NCT01379209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2402356|NCT00723060|Citalopram|citalopram|mesh-list
2529764|NCT01379209|Antimetabolites|antimetabolites|mesh-ancestor
2529765|NCT01379209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529766|NCT01379209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402357|NCT00723060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2402358|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2402359|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2402360|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402361|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402362|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
2402363|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402364|NCT00723060|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2402365|NCT00723060|Antidepressive Agents|antidepressive agents|mesh-ancestor
2402366|NCT00723060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2402367|NCT00723086|Docetaxel|docetaxel|mesh-list
2529767|NCT01379209|Dermatologic Agents|dermatologic agents|mesh-ancestor
2529768|NCT01379209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529769|NCT01379209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2529770|NCT01379209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2529771|NCT01379209|Immunologic Factors|immunologic factors|mesh-ancestor
2529772|NCT01379209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2529773|NCT01379209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2529774|NCT01379209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2529775|NCT01379209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2529776|NCT01379209|Antitubercular Agents|antitubercular agents|mesh-ancestor
2529777|NCT01379209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2529778|NCT01379209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529779|NCT01379209|Antifungal Agents|antifungal agents|mesh-ancestor
2116198|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2116199|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116200|NCT02635386|Metformin|metformin|mesh-list
2116201|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
2529780|NCT01379209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2529781|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
2529782|NCT01379300|Dabigatran|dabigatran|mesh-list
2529783|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2529784|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
2402368|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529785|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2529786|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
2529787|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529788|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529789|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
2529790|NCT01379326|Mebendazole|mebendazole|mesh-list
2529791|NCT01379326|Piperazine|piperazine|mesh-list
2529792|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
2529793|NCT01379326|DMP 777|dmp 777|mesh-list
2529794|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
2529795|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
2529796|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2529797|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529798|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
2529799|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
2529800|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
2529801|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529802|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529803|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529804|NCT01379482|Paclitaxel|paclitaxel|mesh-list
2529805|NCT01379482|Docetaxel|docetaxel|mesh-list
2529806|NCT01379482|Cisplatin|cisplatin|mesh-list
2529807|NCT01379482|Doxorubicin|doxorubicin|mesh-list
2529808|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
2529809|NCT01379482|Irinotecan|irinotecan|mesh-list
2529810|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2529811|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529812|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
2529813|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
2529814|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
2529815|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529816|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2529817|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2529818|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2529819|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529820|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2529821|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2116202|NCT02635386|Exenatide|exenatide|mesh-list
2116203|NCT02635386|Topiramate|topiramate|mesh-list
2116204|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2116205|NCT02635386|Phentermine|phentermine|mesh-list
2116206|NCT02635386|Glucagon|glucagon|mesh-list
2116207|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2116208|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2529822|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529823|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
2529824|NCT01379560|Dinoprost|dinoprost|mesh-list
2529825|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2529826|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2529827|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
2529828|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2529829|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529830|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
2529831|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
2529832|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2529833|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529834|NCT01379807|Docetaxel|docetaxel|mesh-list
2529835|NCT01379807|Panitumumab|panitumumab|mesh-list
2529836|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529837|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
2529838|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
2529839|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
2529840|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529841|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2529842|NCT01379846|Vaccines|vaccines|mesh-list
2529843|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
2529844|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529845|NCT01379898|Doxazosin|doxazosin|mesh-list
2529846|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
2402369|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
2402370|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
2402371|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
2402372|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402373|NCT00723164|Fentanyl|fentanyl|mesh-list
2402374|NCT00723164|Midazolam|midazolam|mesh-list
2402375|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2402376|NCT00723164|Narcotics|narcotics|mesh-ancestor
2402377|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2402378|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402379|NCT00723164|Analgesics|analgesics|mesh-ancestor
2402380|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
2402381|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402382|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2402383|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2402384|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
2402385|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
2402386|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2402387|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2402388|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2402389|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2402390|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
2402391|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
2402392|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402393|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402394|NCT00723216|Enoxaparin|enoxaparin|mesh-list
2402395|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
2402396|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2402397|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2529847|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2529848|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2529849|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2529850|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2529851|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
2529852|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529853|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529854|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402398|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402399|NCT00723242|Ribavirin|ribavirin|mesh-list
2402400|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
2402401|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402402|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
2402403|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402404|NCT00723268|Prednisolone|prednisolone|mesh-list
2402405|NCT00723268|Colchicine|colchicine|mesh-list
2402406|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2402407|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
2529855|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
2402408|NCT00723268|Hormones|hormones|mesh-ancestor
2402409|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2402410|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402411|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2402412|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402413|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
2402414|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2402415|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
2402416|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
2402417|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
2402418|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402419|NCT00723307|Metformin|metformin|mesh-list
2402420|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2402421|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402422|NCT00723320|Atorvastatin|atorvastatin|mesh-list
2402423|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2402424|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2402425|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
2402426|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402427|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2402428|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2402429|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402430|NCT00723346|Asparaginase|asparaginase|mesh-list
2402431|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402432|NCT00723385|Vitamin D|vitamin d|mesh-list
2402433|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
2402434|NCT00723385|Vitamins|vitamins|mesh-ancestor
2402435|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
2529856|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
2529857|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
2529858|NCT01379976|Vitamins|vitamins|mesh-ancestor
2529859|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
2402436|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402437|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2402438|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2402439|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
2402440|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2402441|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
2402442|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402443|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
2402444|NCT00723424|Digoxin|digoxin|mesh-list
2402445|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2402446|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2402447|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402448|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402449|NCT00723424|Protective Agents|protective agents|mesh-ancestor
2402450|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402451|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2529860|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529861|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
2529862|NCT01379989|Carboplatin|carboplatin|mesh-list
2529863|NCT01379989|Doxorubicin|doxorubicin|mesh-list
2529864|NCT01379989|Trabectedin|trabectedin|mesh-list
2529865|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529866|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2529867|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2529868|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2529869|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529870|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529871|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2529872|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
2529873|NCT01380015|Rosmarinic acid|rosmarinic acid|mesh-list
2529874|NCT01380015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2529875|NCT01380015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2529876|NCT01380015|Analgesics|analgesics|mesh-ancestor
2529877|NCT01380015|Sensory System Agents|sensory system agents|mesh-ancestor
2529878|NCT01380015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529879|NCT01380015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529880|NCT01380015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2529881|NCT01380015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2529882|NCT01380015|Antioxidants|antioxidants|mesh-ancestor
2529883|NCT01380015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529884|NCT01380015|Protective Agents|protective agents|mesh-ancestor
2529885|NCT01380015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2529886|NCT01380015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2529887|NCT01380015|Protease Inhibitors|protease inhibitors|mesh-ancestor
2529888|NCT01380015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402452|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2402453|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2402454|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
2402455|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402456|NCT00723437|Acitretin|acitretin|mesh-list
2402457|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
2402458|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
2402459|NCT00723502|Amoxicillin|amoxicillin|mesh-list
2402460|NCT00723502|Finafloxacin|finafloxacin|mesh-list
2529897|NCT01380249|Bromides|bromides|mesh-list
2529898|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
2529899|NCT01380275|Docetaxel|docetaxel|mesh-list
2529900|NCT01380275|Irinotecan|irinotecan|mesh-list
2529901|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529902|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
2529903|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
2529904|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
2529905|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529906|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2529907|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2529908|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529909|NCT01380288|Rivastigmine|rivastigmine|mesh-list
2529910|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2402461|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
2402462|NCT00723502|Esomeprazole|esomeprazole|mesh-list
2402463|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2402464|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402465|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2402466|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2402467|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2402468|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402469|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402470|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2529911|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529912|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529913|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
2529914|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529915|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529916|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2529917|NCT01380288|Protective Agents|protective agents|mesh-ancestor
2529918|NCT01380301|Miltefosine|miltefosine|mesh-list
2529919|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
2529920|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529921|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529922|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2402471|NCT00723502|Renal Agents|renal agents|mesh-ancestor
2402472|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2402473|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2402474|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402475|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2402476|NCT00723515|Listerine|listerine|mesh-list
2402477|NCT00723515|Calcium|calcium|mesh-list
2402478|NCT00723515|Fluorides|fluorides|mesh-list
2402479|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
2402480|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2402481|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402482|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
2529923|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2529924|NCT01380314|Miltefosine|miltefosine|mesh-list
2529925|NCT01380314|Imiquimod|imiquimod|mesh-list
2529926|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2529927|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
2529928|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529929|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2529930|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
2529931|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
2529932|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529933|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2402483|NCT00723515|Protective Agents|protective agents|mesh-ancestor
2529934|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2529935|NCT01380353|Diclofenac|diclofenac|mesh-list
2529936|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
2529937|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2529938|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2529939|NCT01380353|Analgesics|analgesics|mesh-ancestor
2529940|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
2402484|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2402485|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402486|NCT00723658|Cytarabine|cytarabine|mesh-list
2402487|NCT00723658|Thalidomide|thalidomide|mesh-list
2402488|NCT00723658|Dexamethasone|dexamethasone|mesh-list
2402489|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
2402490|NCT00723658|Melphalan|melphalan|mesh-list
2402491|NCT00723658|Carmustine|carmustine|mesh-list
2402492|NCT00723658|Rituximab|rituximab|mesh-list
2402493|NCT00723658|Doxorubicin|doxorubicin|mesh-list
2402494|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2402495|NCT00723658|Etoposide|etoposide|mesh-list
2402496|NCT00723658|Bortezomib|bortezomib|mesh-list
2402497|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2402498|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
2402499|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402500|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2402501|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2402502|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
2402503|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402504|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402505|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2402506|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2402507|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
2402508|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
2402509|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402510|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2402511|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
2402512|NCT00723658|Hormones|hormones|mesh-ancestor
2402513|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2402514|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2402515|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2529941|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529942|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529943|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2529944|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2529945|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2529946|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529947|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529948|NCT01380431|Lisinopril|lisinopril|mesh-list
2529949|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2529950|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
2529951|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2529952|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529953|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2402516|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2402517|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2402518|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2402519|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402520|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2402521|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2402522|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
2402523|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
2402524|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402525|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
2402526|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2402527|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2402528|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2402529|NCT00723658|Growth Substances|growth substances|mesh-ancestor
2402530|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
2402531|NCT00723775|Lopinavir|lopinavir|mesh-list
2402532|NCT00723775|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2402533|NCT00723775|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2402534|NCT00723775|Protease Inhibitors|protease inhibitors|mesh-ancestor
2402535|NCT00723775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402536|NCT00723775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402537|NCT00723775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2402538|NCT00723775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2402539|NCT00723775|Antiviral Agents|antiviral agents|mesh-ancestor
2402540|NCT00723775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402541|NCT00723775|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2529954|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2529955|NCT01380431|Protective Agents|protective agents|mesh-ancestor
2402542|NCT00723775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2402543|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2402544|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2402545|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2402546|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529956|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529957|NCT01380457|Dronabinol|dronabinol|mesh-list
2529958|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
2529959|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529960|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2529961|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2529962|NCT01380457|Analgesics|analgesics|mesh-ancestor
2529963|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
2529964|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2529965|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2529966|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2529967|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2529968|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2529969|NCT01380457|Hormones|hormones|mesh-ancestor
2529970|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2529971|NCT01380483|Doxycycline|doxycycline|mesh-list
2529972|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2529973|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529974|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
2529975|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2529976|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2529977|NCT01380496|Doxycycline|doxycycline|mesh-list
2529978|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2529979|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529980|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
2529981|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2529982|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2529983|NCT01380509|Metronidazole|metronidazole|mesh-list
2529984|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402547|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402548|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2402549|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2402550|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402551|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
2402552|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402553|NCT00723879|Ribavirin|ribavirin|mesh-list
2402554|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2402555|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
2529985|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2529986|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2529987|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2529988|NCT01380522|Metronidazole|metronidazole|mesh-list
2529989|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2529990|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2529991|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2529992|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2529993|NCT01380548|Iron|iron|mesh-list
2529994|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2529995|NCT01380548|Trace Elements|trace elements|mesh-ancestor
2529996|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
2529997|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2529998|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2529999|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
2530000|NCT01380600|Molgramostim|molgramostim|mesh-list
2530001|NCT01380600|Sargramostim|sargramostim|mesh-list
2530002|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
2530003|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530004|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530005|NCT01380678|Bevacizumab|bevacizumab|mesh-list
2530006|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2530007|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
2530008|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2530009|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2530010|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530011|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2530012|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2530013|NCT01380678|Growth Substances|growth substances|mesh-ancestor
2530014|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530015|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
2530016|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
2402556|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402557|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
2402558|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402559|NCT00723918|Methadone|methadone|mesh-list
2402560|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2402561|NCT00723918|Narcotics|narcotics|mesh-ancestor
2530017|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530018|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530019|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
2530020|NCT01380717|Calcium|calcium|mesh-list
2530021|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2530022|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2530023|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2530024|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530025|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2530026|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
2530027|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530028|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530029|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
2530030|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530031|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2530032|NCT01380808|Capecitabine|capecitabine|mesh-list
2530033|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2530034|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
2530035|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530036|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530037|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2530038|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
2530039|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2530040|NCT01380912|Prednisolone|prednisolone|mesh-list
2530041|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
2530042|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2530043|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
2530044|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2402562|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2402563|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402564|NCT00723918|Analgesics|analgesics|mesh-ancestor
2402565|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
2402566|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402567|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
2402568|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
2402569|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2402570|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
2402571|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2402572|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2402573|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2402574|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2402575|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402576|NCT00723983|Sumatriptan|sumatriptan|mesh-list
2402577|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2402578|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2402579|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2402580|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
2402581|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402582|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402583|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402584|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
2402585|NCT00724022|Prednisolone|prednisolone|mesh-list
2402586|NCT00724022|Tacrolimus|tacrolimus|mesh-list
2402587|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
2402588|NCT00724022|Basiliximab|basiliximab|mesh-list
2402589|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2530045|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
2530046|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
2530047|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530048|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530049|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2530050|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
2530051|NCT01380912|Hormones|hormones|mesh-ancestor
2530052|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2530053|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2530054|NCT01380912|Protective Agents|protective agents|mesh-ancestor
2530055|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2530056|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530057|NCT01380938|Ribavirin|ribavirin|mesh-list
2530058|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2530059|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
2530060|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
2530061|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530062|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
2530063|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530064|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
2402590|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
2402591|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402592|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2402593|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402594|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530065|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530066|NCT01380951|Telbivudine|telbivudine|mesh-list
2530067|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
2530068|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530069|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2530070|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530071|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530072|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
2530073|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2530074|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530075|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530076|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2530077|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2530078|NCT01381055|Protective Agents|protective agents|mesh-ancestor
2402595|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2402596|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
2402597|NCT00724022|Hormones|hormones|mesh-ancestor
2402598|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2402599|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2402600|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402601|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2402602|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2402603|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
2402604|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2402605|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402606|NCT00724035|Fentanyl|fentanyl|mesh-list
2402607|NCT00724035|Midazolam|midazolam|mesh-list
2402608|NCT00724035|Analgesics|analgesics|mesh-list
2402609|NCT00724035|Anesthetics|anesthetics|mesh-list
2402610|NCT00724035|Ropivacaine|ropivacaine|mesh-list
2402611|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
2402612|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2402613|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402614|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
2402615|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402616|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2402617|NCT00724035|Narcotics|narcotics|mesh-ancestor
2530079|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530080|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
2530081|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2402618|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2402619|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2402620|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
2402621|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2402622|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2402623|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2402624|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2402625|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
2402626|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
2402627|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402628|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402629|NCT00724074|Bupivacaine|bupivacaine|mesh-list
2402630|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
2402631|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
2402632|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2402633|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402634|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
2402635|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402636|NCT00724113|Lidocaine|lidocaine|mesh-list
2402637|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
2402638|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
2402639|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2402640|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530082|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
2530083|NCT01381185|Aspirin|aspirin|mesh-list
2530084|NCT01381185|Clopidogrel|clopidogrel|mesh-list
2530085|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2530086|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2530087|NCT01381185|Analgesics|analgesics|mesh-ancestor
2530088|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
2402641|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
2402642|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402643|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2402644|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2402645|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2402646|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2402647|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402648|NCT00724178|Vitamin D|vitamin d|mesh-list
2402649|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
2402650|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
2402651|NCT00724178|Calcium|calcium|mesh-list
2402652|NCT00724178|Vitamins|vitamins|mesh-ancestor
2402653|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
2402654|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530089|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530090|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530091|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2530092|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2530093|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2530094|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2402655|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2402656|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2402657|NCT00724178|Antacids|antacids|mesh-ancestor
2402658|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402659|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2402660|NCT00724230|Ribavirin|ribavirin|mesh-list
2402661|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2402662|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
2402663|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
2402664|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402665|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
2402666|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402667|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
2402668|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402669|NCT00724256|Ceftibuten|ceftibuten|mesh-list
2402670|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2530095|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530096|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2530097|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2530098|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530099|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
2530100|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2530101|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2530102|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2530103|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
2530104|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530105|NCT01381276|Beta Carotene|beta carotene|mesh-list
2530106|NCT01381276|Vitamin A|vitamin a|mesh-list
2530107|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
2530108|NCT01381276|Carotenoids|carotenoids|mesh-list
2530109|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
2530110|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530111|NCT01381276|Protective Agents|protective agents|mesh-ancestor
2530112|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530113|NCT01381276|Provitamins|provitamins|mesh-ancestor
2530114|NCT01381276|Vitamins|vitamins|mesh-ancestor
2530115|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
2530116|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2530117|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530118|NCT01381289|Ivacaftor|ivacaftor|mesh-list
2530119|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2530120|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2530121|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530122|NCT01381354|Riboflavin|riboflavin|mesh-list
2530123|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
2530124|NCT01381354|Thiamine|thiamine|mesh-list
2530125|NCT01381354|Niacinamide|niacinamide|mesh-list
2530126|NCT01381354|Niacin|niacin|mesh-list
2530127|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
2530128|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
2530129|NCT01381354|Ubiquinone|ubiquinone|mesh-list
2402671|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402672|NCT00724295|Ribavirin|ribavirin|mesh-list
2402673|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2402674|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
2402675|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402676|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
2402677|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402678|NCT00724321|Iloprost|iloprost|mesh-list
2402679|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2402680|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
2402681|NCT00724360|Trastuzumab|trastuzumab|mesh-list
2402682|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2402683|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402684|NCT00724386|Paclitaxel|paclitaxel|mesh-list
2402685|NCT00724386|Vinorelbine|vinorelbine|mesh-list
2402686|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2402687|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402688|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
2402689|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
2402690|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
2402691|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402692|NCT00724529|Infliximab|infliximab|mesh-list
2402693|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
2402694|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2402695|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2530130|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
2530131|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
2530132|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2530133|NCT01381354|Vitamins|vitamins|mesh-ancestor
2530134|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
2530135|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530136|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
2530137|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530138|NCT01381354|Expectorants|expectorants|mesh-ancestor
2530139|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
2530140|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2530141|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
2530142|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530143|NCT01381354|Protective Agents|protective agents|mesh-ancestor
2530144|NCT01381354|Antidotes|antidotes|mesh-ancestor
2530145|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
2530146|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2530147|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
2530148|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2530149|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
2530150|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2530151|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
2402696|NCT00724542|Voglibose|voglibose|mesh-list
2402697|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2402698|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402699|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2402700|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402701|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402702|NCT00724581|Amiodarone|amiodarone|mesh-list
2402703|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2402704|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
2402705|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2402706|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2402707|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402708|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2402709|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2402710|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2402711|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402712|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2402713|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2402714|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2402715|NCT00724620|Ribavirin|ribavirin|mesh-list
2402716|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2402717|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
2402718|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402719|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
2402720|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402721|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
2402722|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2402723|NCT00724672|Adalimumab|adalimumab|mesh-list
2402724|NCT00724672|Etanercept|etanercept|mesh-list
2402725|NCT00724672|Infliximab|infliximab|mesh-list
2402726|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2402727|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2402728|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2402729|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2402730|NCT00724672|Analgesics|analgesics|mesh-ancestor
2402731|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
2402732|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402733|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402734|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2402735|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2402736|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
2402737|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
2402738|NCT00724685|Ropivacaine|ropivacaine|mesh-list
2402739|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
2530152|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2530153|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
2530154|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2530155|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
2530156|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530157|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
2530158|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2530159|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530160|NCT01381432|Azathioprine|azathioprine|mesh-list
2530161|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
2530162|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530163|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2530164|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402740|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
2402741|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2402742|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402743|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
2402744|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402745|NCT00724724|Aspirin|aspirin|mesh-list
2402746|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
2402747|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2402748|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2116209|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116210|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116211|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2116212|NCT02635386|Incretins|incretins|mesh-ancestor
2530165|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2530166|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
2530167|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402749|NCT00724724|Analgesics|analgesics|mesh-ancestor
2402750|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
2402751|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402752|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402753|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2402754|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2402755|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2402756|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2402757|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402758|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2402759|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2402760|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402761|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
2402762|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2402763|NCT00724724|Protective Agents|protective agents|mesh-ancestor
2402764|NCT00724789|Ganirelix|ganirelix|mesh-list
2116213|NCT02635386|Hormones|hormones|mesh-ancestor
2116214|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2116215|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
2116216|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2116217|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2116218|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
2116219|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
2116220|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
2116221|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116222|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
2116223|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116224|NCT02635542|Cisatracurium|cisatracurium|mesh-list
2116225|NCT02635542|Succinylcholine|succinylcholine|mesh-list
2116226|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2116227|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2402765|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
2402766|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2530168|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2530169|NCT01381445|Clobetasol|clobetasol|mesh-list
2530170|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2530171|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
2530172|NCT01381445|Hormones|hormones|mesh-ancestor
2530173|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2530174|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530175|NCT01381497|Naproxen|naproxen|mesh-list
2530176|NCT01381497|Sumatriptan|sumatriptan|mesh-list
2530177|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2530178|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2402767|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402768|NCT00724802|Triacetin|triacetin|mesh-list
2402769|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
2402770|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402771|NCT00724841|Temozolomide|temozolomide|mesh-list
2402772|NCT00724841|Obatoclax|obatoclax|mesh-list
2402773|NCT00724841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2402774|NCT00724841|Alkylating Agents|alkylating agents|mesh-ancestor
2402775|NCT00724841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530179|NCT01381497|Analgesics|analgesics|mesh-ancestor
2530180|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
2530181|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530182|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530183|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2530184|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2530185|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
2530186|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2530187|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530188|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530189|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2530190|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2530191|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2530192|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
2530193|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530194|NCT01381510|Finasteride|finasteride|mesh-list
2530195|NCT01381510|Dutasteride|dutasteride|mesh-list
2530196|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
2530197|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2530198|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530199|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530200|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
2530201|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2530202|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530203|NCT01381510|Urological Agents|urological agents|mesh-ancestor
2530204|NCT01381523|Naproxen|naproxen|mesh-list
2530205|NCT01381523|Sumatriptan|sumatriptan|mesh-list
2530206|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2530207|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2530208|NCT01381523|Analgesics|analgesics|mesh-ancestor
2530209|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
2530210|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530211|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530212|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2530213|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2530214|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
2530215|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2530216|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530217|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530218|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2530219|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2530220|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2530221|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
2530222|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530223|NCT01381536|Belimumab|belimumab|mesh-list
2530224|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2530225|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
2530226|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530227|NCT01381601|Bevacizumab|bevacizumab|mesh-list
2530228|NCT01381601|Sunitinib|sunitinib|mesh-list
2530229|NCT01381601|Sorafenib|sorafenib|mesh-list
2530230|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2402776|NCT00724841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402777|NCT00724841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402778|NCT00724880|Clopidogrel|clopidogrel|mesh-list
2402779|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2530231|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530232|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2530233|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2530234|NCT01381601|Growth Substances|growth substances|mesh-ancestor
2530235|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530236|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
2530237|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2402780|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2402781|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2402782|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2402783|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
2402784|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402785|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402786|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402787|NCT00725036|Insulin|insulin|mesh-list
2402788|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2402789|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
2402790|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
2402791|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
2402792|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
2402793|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2402794|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402795|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
2402796|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
2402797|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
2402798|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2402799|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402800|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
2402801|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402802|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2402803|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2402804|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530238|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530239|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530240|NCT01381614|Bevacizumab|bevacizumab|mesh-list
2530241|NCT01381614|Sunitinib|sunitinib|mesh-list
2530242|NCT01381614|Sorafenib|sorafenib|mesh-list
2530243|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2530244|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530245|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2530246|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2530247|NCT01381614|Growth Substances|growth substances|mesh-ancestor
2530248|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530249|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
2530250|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2530251|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530252|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530253|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
2530254|NCT01381627|Remifentanil|remifentanil|mesh-list
2530255|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2530256|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2530257|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530258|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2530259|NCT01381627|Analgesics|analgesics|mesh-ancestor
2530260|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
2530261|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530262|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2530263|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2530264|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2530265|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
2530266|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530267|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530268|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2530269|NCT01381627|Narcotics|narcotics|mesh-ancestor
2530270|NCT01381640|Acetaminophen|acetaminophen|mesh-list
2530271|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2530272|NCT01381640|Analgesics|analgesics|mesh-ancestor
2530273|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
2530274|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530275|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530276|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
2530277|NCT01381666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2530278|NCT01381705|Rituximab|rituximab|mesh-list
2530279|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2530280|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530281|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
2530282|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530283|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2530284|NCT01381731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2530285|NCT01381731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2530286|NCT01381796|Sumatriptan|sumatriptan|mesh-list
2530287|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2530288|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2530289|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2530290|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
2530291|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530292|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530293|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530294|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
2530295|NCT01381809|Hematinics|hematinics|mesh-ancestor
2530296|NCT01381835|Simeprevir|simeprevir|mesh-list
2530297|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
2530298|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530299|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
2530300|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530301|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530302|NCT01381848|Doripenem|doripenem|mesh-list
2530303|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2530304|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530305|NCT01381887|Canagliflozin|canagliflozin|mesh-list
2530306|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2530307|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530308|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2530309|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530310|NCT01382004|Azithromycin|azithromycin|mesh-list
2530311|NCT01382004|Penicillins|penicillins|mesh-list
2116228|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116229|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116230|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2116231|NCT02635724|Peramivir|peramivir|mesh-list
2116232|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
2116233|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402821|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
2402822|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
2530312|NCT01382004|Penicillin G|penicillin g|mesh-list
2530313|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2530314|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
2530315|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2530316|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530317|NCT01382017|Lacosamide|lacosamide|mesh-list
2530318|NCT01382017|Carbamazepine|carbamazepine|mesh-list
2530319|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
2530320|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2530321|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2530322|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2530323|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530324|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
2116234|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116235|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116236|NCT02635828|Promethazine|promethazine|mesh-list
2402823|NCT00725218|Analgesics|analgesics|mesh-ancestor
2402824|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
2402825|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402826|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402827|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2402828|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2402829|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2402830|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2402831|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2402832|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402833|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402834|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
2402835|NCT00725231|Doxorubicin|doxorubicin|mesh-list
2402836|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2530325|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2530326|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2530327|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530328|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2530329|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2530330|NCT01382017|Analgesics|analgesics|mesh-ancestor
2530331|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
2530332|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530333|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2530334|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2530335|NCT01382134|Aspirin|aspirin|mesh-list
2530336|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2530337|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2530338|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2530339|NCT01382134|Analgesics|analgesics|mesh-ancestor
2530340|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
2530341|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530342|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530343|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2530344|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2530345|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2530346|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2530347|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402837|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2402838|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402839|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2402840|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2402841|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2402842|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402843|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402844|NCT00725348|R 115866|r 115866|mesh-list
2530348|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2530349|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2530350|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530351|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
2530352|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
2530353|NCT01382134|Coagulants|coagulants|mesh-ancestor
2530354|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2530355|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
2530356|NCT01382147|Daunorubicin|daunorubicin|mesh-list
2530357|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
2530358|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2530359|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402845|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2402846|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402847|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402848|NCT00725374|Tibolone|tibolone|mesh-list
2402849|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
2402850|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
2402851|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2402852|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402853|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2530360|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2530361|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2530362|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530363|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530364|NCT01382147|Analgesics|analgesics|mesh-ancestor
2530365|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
2530366|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530367|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530368|NCT01382160|Adalimumab|adalimumab|mesh-list
2530369|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2530370|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2530371|NCT01382199|Lactoferrin|lactoferrin|mesh-list
2530372|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530373|NCT01382238|Dolutegravir|dolutegravir|mesh-list
2530374|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2530375|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2530376|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530377|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530378|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2530379|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2530380|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
2530381|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530382|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2530383|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2530384|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2530385|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
2530386|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530387|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2402854|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2402855|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402856|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2402857|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
2402858|NCT00725374|Hormones|hormones|mesh-ancestor
2402859|NCT00725400|Cetuximab|cetuximab|mesh-list
2402860|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2402861|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402862|NCT00725413|Etonogestrel|etonogestrel|mesh-list
2402863|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2402864|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
2530388|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2530389|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530390|NCT01382342|Rasagiline|rasagiline|mesh-list
2530391|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2530392|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530393|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530394|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2530395|NCT01382342|Protective Agents|protective agents|mesh-ancestor
2116237|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
2116238|NCT02635828|Dexamethasone|dexamethasone|mesh-list
2116239|NCT02635828|Palonosetron|palonosetron|mesh-list
2402865|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2402866|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402867|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2402868|NCT00725439|R 115866|r 115866|mesh-list
2402869|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2402870|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402871|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402872|NCT00725478|Piribedil|piribedil|mesh-list
2530396|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530397|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
2530398|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
2530399|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2530400|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2530401|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530402|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530403|NCT01382368|Urological Agents|urological agents|mesh-ancestor
2530404|NCT01382407|Cetuximab|cetuximab|mesh-list
2530405|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2530406|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530407|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2530408|NCT01382472|Simvastatin|simvastatin|mesh-list
2116240|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2116241|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
2116242|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
2116243|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116244|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116245|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2116246|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
2116247|NCT02635828|Hormones|hormones|mesh-ancestor
2116248|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2116249|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2116250|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530409|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2530410|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2530411|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
2530412|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530413|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2530414|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2530415|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530416|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
2530417|NCT01382498|Calcium|calcium|mesh-list
2530418|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2530419|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530420|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
2530421|NCT01382498|Coagulants|coagulants|mesh-ancestor
2530422|NCT01382511|Simvastatin|simvastatin|mesh-list
2530423|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2530424|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2530425|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
2530426|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530427|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2530428|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2530429|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530430|NCT01382589|Afamelanotide|afamelanotide|mesh-list
2530431|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
2530432|NCT01382654|Azelastine|azelastine|mesh-list
2530433|NCT01382654|Epinastine|epinastine|mesh-list
2530434|NCT01382654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2530435|NCT01382654|Autonomic Agents|autonomic agents|mesh-ancestor
2530436|NCT01382654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530437|NCT01382654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530438|NCT01382654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2530439|NCT01382654|Respiratory System Agents|respiratory system agents|mesh-ancestor
2530440|NCT01382654|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2530441|NCT01382654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530442|NCT01382654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530443|NCT01382654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2530444|NCT01382654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2402873|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2402874|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2402875|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
2402876|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
2402877|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402878|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402879|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402880|NCT00725517|Icodextrin|icodextrin|mesh-list
2530445|NCT01382654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2530446|NCT01382654|Histamine Antagonists|histamine antagonists|mesh-ancestor
2530447|NCT01382654|Histamine Agents|histamine agents|mesh-ancestor
2530448|NCT01382654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402881|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
2402882|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2402883|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2402884|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2530449|NCT01382706|Docetaxel|docetaxel|mesh-list
2530450|NCT01382706|Lapatinib|lapatinib|mesh-list
2530451|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530452|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
2530453|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
2530454|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
2530455|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530456|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2530457|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530458|NCT01382732|Oxytocin|oxytocin|mesh-list
2530459|NCT01382732|Carbetocin|carbetocin|mesh-list
2530460|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
2530461|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2402885|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402886|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2402887|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402888|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402889|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
2402890|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402891|NCT00725777|Lumefantrine|lumefantrine|mesh-list
2402892|NCT00725777|Artemether|artemether|mesh-list
2402893|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2402894|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
2530462|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402895|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2402896|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2402897|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402898|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2402899|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
2402900|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2402901|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2402902|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402903|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402904|NCT00725790|Urological Agents|urological agents|mesh-ancestor
2402905|NCT00725829|Simvastatin|simvastatin|mesh-list
2530463|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
2530464|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2530465|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530466|NCT01382888|Heparin|heparin|mesh-list
2530467|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
2530468|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2530469|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2530470|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530471|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
2530472|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2530473|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402906|NCT00725829|Ezetimibe|ezetimibe|mesh-list
2402907|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2402908|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2402909|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
2402910|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402911|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2402912|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2402913|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402914|NCT00725881|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
2402915|NCT00725881|Antioxidants|antioxidants|mesh-ancestor
2402916|NCT00725881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402917|NCT00725881|Protective Agents|protective agents|mesh-ancestor
2402918|NCT00725881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402919|NCT00725881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2530474|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
2530475|NCT01383044|Carvedilol|carvedilol|mesh-list
2530476|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2530477|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2530478|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
2530479|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530480|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530481|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530482|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2530483|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
2530484|NCT01383044|Protective Agents|protective agents|mesh-ancestor
2530485|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2530486|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2530487|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2530488|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
2530489|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2530490|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2530496|NCT01383148|Gemcitabine|gemcitabine|mesh-list
2530497|NCT01383148|Paclitaxel|paclitaxel|mesh-list
2530498|NCT01383148|Cisplatin|cisplatin|mesh-list
2530499|NCT01383148|Carboplatin|carboplatin|mesh-list
2530500|NCT01383148|Pemetrexed|pemetrexed|mesh-list
2530501|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2530502|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530503|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
2530504|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
2530505|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
2530506|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530507|NCT01383148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530508|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2530509|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
2530510|NCT01383148|Antiviral Agents|antiviral agents|mesh-ancestor
2530511|NCT01383148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530512|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530513|NCT01383148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2402920|NCT00725881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402921|NCT00725946|Iodine|iodine|mesh-list
2530514|NCT01383148|Immunologic Factors|immunologic factors|mesh-ancestor
2530515|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2530516|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2530517|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
2530518|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2402922|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
2402923|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2402924|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402925|NCT00725946|Trace Elements|trace elements|mesh-ancestor
2402926|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
2402927|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402928|NCT00725985|Cladribine|cladribine|mesh-list
2402929|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402930|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2530519|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530520|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
2530521|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2530522|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530523|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
2530524|NCT01383343|Leucovorin|leucovorin|mesh-list
2530525|NCT01383343|Folic Acid|folic acid|mesh-list
2530526|NCT01383343|Bevacizumab|bevacizumab|mesh-list
2530527|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2530528|NCT01383343|Fluorouracil|fluorouracil|mesh-list
2530529|NCT01383343|Irinotecan|irinotecan|mesh-list
2530530|NCT01383343|Sorafenib|sorafenib|mesh-list
2530531|NCT01383343|Camptothecin|camptothecin|mesh-list
2530532|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
2530533|NCT01383343|Antibodies|antibodies|mesh-list
2530534|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
2530535|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2530536|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
2530537|NCT01383343|Calcium|calcium|mesh-list
2530538|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
2530539|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530540|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2530541|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2530542|NCT01383343|Growth Substances|growth substances|mesh-ancestor
2530543|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530544|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
2530545|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
2530546|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2530547|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2530548|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
2530549|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530550|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2530551|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2530552|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2530553|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2530554|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530555|NCT01383343|Antidotes|antidotes|mesh-ancestor
2530556|NCT01383343|Protective Agents|protective agents|mesh-ancestor
2530557|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
2530558|NCT01383343|Vitamins|vitamins|mesh-ancestor
2530559|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
2530560|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2530561|NCT01383343|Hematinics|hematinics|mesh-ancestor
2530562|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2530563|NCT01383395|Cilostazol|cilostazol|mesh-list
2402931|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
2402932|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530564|NCT01383395|Simvastatin|simvastatin|mesh-list
2530565|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2530566|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2530567|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
2530568|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530569|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2530570|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2530571|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530572|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2530573|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
2530574|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530575|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402933|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
2530576|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2530577|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
2402934|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
2402935|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
2402936|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2402937|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402938|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
2402939|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2402940|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2402941|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2402942|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402943|NCT00726258|Ketamine|ketamine|mesh-list
2402944|NCT00726258|Analgesics|analgesics|mesh-ancestor
2402945|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
2402946|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530578|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2530579|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2530580|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2530581|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
2530582|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2530583|NCT01383395|Protective Agents|protective agents|mesh-ancestor
2530584|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2530585|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2530586|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
2530587|NCT01383460|Sargramostim|sargramostim|mesh-list
2530588|NCT01383460|Lenograstim|lenograstim|mesh-list
2530589|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
2530590|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530591|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2530592|NCT01383460|Hematinics|hematinics|mesh-ancestor
2402947|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402948|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2402949|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2402950|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
2530593|NCT01383538|Leucovorin|leucovorin|mesh-list
2530594|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
2402951|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
2402952|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2402953|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2402954|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2402955|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2402956|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402957|NCT00726336|Tenofovir|tenofovir|mesh-list
2530595|NCT01383538|Irinotecan|irinotecan|mesh-list
2530596|NCT01383538|Folfirinox|folfirinox|mesh-list
2530597|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530598|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2530599|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2530600|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530601|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530602|NCT01383538|Antidotes|antidotes|mesh-ancestor
2530603|NCT01383538|Protective Agents|protective agents|mesh-ancestor
2530604|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530605|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
2530606|NCT01383538|Vitamins|vitamins|mesh-ancestor
2530607|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
2530608|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
2530609|NCT01383655|Analgesics|analgesics|mesh-ancestor
2530610|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
2530611|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530612|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530613|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
2530614|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2530615|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2530616|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
2530617|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2530618|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2530619|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530620|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2402958|NCT00726336|Dolutegravir|dolutegravir|mesh-list
2402959|NCT00726336|Antiviral Agents|antiviral agents|mesh-ancestor
2402960|NCT00726336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402961|NCT00726336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2402962|NCT00726336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2530621|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
2530622|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2530623|NCT01383668|Sirolimus|sirolimus|mesh-list
2530624|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
2402963|NCT00726336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402964|NCT00726336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402965|NCT00726336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2402966|NCT00726336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2402967|NCT00726336|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2402968|NCT00726336|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2402969|NCT00726466|Ranibizumab|ranibizumab|mesh-list
2402970|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2402971|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2402972|NCT00726466|Growth Substances|growth substances|mesh-ancestor
2402973|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402974|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
2402975|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2402976|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
2402977|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2402978|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402979|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2402980|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2402981|NCT00726570|Heparin|heparin|mesh-list
2530625|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2530626|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530627|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2530628|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530629|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
2530630|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2530631|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
2530632|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530633|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2530634|NCT01383694|Piperine|piperine|mesh-list
2530635|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2530636|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530637|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530638|NCT01383785|Abciximab|abciximab|mesh-list
2530639|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
2530640|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2530641|NCT01384058|Simvastatin|simvastatin|mesh-list
2530642|NCT01384058|Ezetimibe|ezetimibe|mesh-list
2530643|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2530644|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2530645|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
2530646|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530647|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2530648|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2530649|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530650|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
2530651|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2530652|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2530653|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2530654|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2530655|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530656|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
2530657|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530658|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530659|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2402982|NCT00726570|Calcium heparin|calcium heparin|mesh-list
2402983|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2402984|NCT00726570|Tinzaparin|tinzaparin|mesh-list
2402985|NCT00726570|Dalteparin|dalteparin|mesh-list
2402986|NCT00726570|Anticoagulants|anticoagulants|mesh-list
2402987|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2402988|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2402989|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402990|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
2402991|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
2402992|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2402993|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2402994|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2402995|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2402996|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2402997|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2402998|NCT00726687|Capecitabine|capecitabine|mesh-list
2402999|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2403000|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
2403001|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530660|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530661|NCT01384227|Proflavine|proflavine|mesh-list
2530662|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2530663|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530664|NCT01384240|Proflavine|proflavine|mesh-list
2530665|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2530666|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530667|NCT01384253|Trastuzumab|trastuzumab|mesh-list
2530668|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2530669|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530670|NCT01384279|Metformin|metformin|mesh-list
2530671|NCT01384279|Topiramate|topiramate|mesh-list
2530672|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2530673|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530674|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
2530675|NCT01384331|NuvaRing|nuvaring|mesh-list
2530676|NCT01384331|Desogestrel|desogestrel|mesh-list
2530677|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2530678|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
2530679|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2530680|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530681|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2530682|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2530683|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2530684|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2530685|NCT01384331|Progestins|progestins|mesh-ancestor
2403002|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403003|NCT00726700|Prednisone|prednisone|mesh-list
2403004|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
2403005|NCT00726700|Rituximab|rituximab|mesh-list
2403006|NCT00726700|Doxorubicin|doxorubicin|mesh-list
2403007|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2403008|NCT00726700|Vincristine|vincristine|mesh-list
2403009|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403010|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
2403011|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403012|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403013|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2403014|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
2403015|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403016|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403017|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2530686|NCT01384331|Hormones|hormones|mesh-ancestor
2530687|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2530688|NCT01384383|Ledipasvir|ledipasvir|mesh-list
2530689|NCT01384383|Antiviral Agents|antiviral agents|mesh-ancestor
2530690|NCT01384383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530691|NCT01384448|Dobutamine|dobutamine|mesh-list
2403018|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2403019|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2403020|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2403021|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2403022|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403023|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403024|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
2530692|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2530693|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
2530694|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
2530695|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530696|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530697|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2530698|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2530699|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2530700|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
2530701|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530702|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530703|NCT01384448|Protective Agents|protective agents|mesh-ancestor
2530704|NCT01384513|Vidarabine|vidarabine|mesh-list
2530705|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
2530706|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
2530707|NCT01384513|Busulfan|busulfan|mesh-list
2530708|NCT01384513|Fludarabine|fludarabine|mesh-list
2530709|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
2403025|NCT00726700|Hormones|hormones|mesh-ancestor
2403026|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2403027|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2530710|NCT01384513|Tacrolimus|tacrolimus|mesh-list
2530711|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2530712|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
2530713|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530714|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2530715|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2530716|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
2530717|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530718|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530719|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2530720|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2530721|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
2530722|NCT01384513|Antiviral Agents|antiviral agents|mesh-ancestor
2530723|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530724|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2530725|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530726|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2530727|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2530728|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
2530729|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2530730|NCT01384578|Vitamins|vitamins|mesh-list
2530731|NCT01384578|Vitamin E|vitamin e|mesh-list
2530732|NCT01384578|Tocopherols|tocopherols|mesh-list
2530733|NCT01384578|Tocotrienols|tocotrienols|mesh-list
2530734|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
2530735|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
2530736|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
2403028|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2403029|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
2403030|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
2403031|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
2403032|NCT00726726|Vitamin K|vitamin k|mesh-list
2403033|NCT00726726|Midazolam|midazolam|mesh-list
2403034|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
2403035|NCT00726726|Caffeine|caffeine|mesh-list
2403036|NCT00726726|Omeprazole|omeprazole|mesh-list
2403037|NCT00726726|Warfarin|warfarin|mesh-list
2403038|NCT00726726|Vitamins|vitamins|mesh-ancestor
2403039|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
2403040|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403041|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2403042|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2403043|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2530737|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530738|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
2530739|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530740|NCT01384578|Protective Agents|protective agents|mesh-ancestor
2530741|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2530742|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530743|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2530744|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2530745|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
2530746|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2530747|NCT01384643|Propofol|propofol|mesh-list
2530748|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2530749|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2530750|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530751|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2530752|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
2530753|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
2530754|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2530755|NCT01384682|Maraviroc|maraviroc|mesh-list
2530756|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2530757|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2530758|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403044|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2403045|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2403046|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2403047|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2403048|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
2403049|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
2403050|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
2403051|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
2403052|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403053|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403054|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
2403055|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2403056|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2403057|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2530759|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2530760|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2403058|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403059|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2403060|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2403061|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2403062|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2403063|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
2403064|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2403065|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2403066|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
2403067|NCT00726726|Coagulants|coagulants|mesh-ancestor
2403068|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
2403069|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
2403070|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2403071|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2403072|NCT00726804|Adalimumab|adalimumab|mesh-list
2403073|NCT00726804|Etanercept|etanercept|mesh-list
2403074|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403075|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403076|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2403077|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2403078|NCT00726804|Analgesics|analgesics|mesh-ancestor
2403079|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
2403080|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116251|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2116252|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2116253|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
2116254|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116255|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116256|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
2116257|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
2116258|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2116259|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
2116260|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
2116261|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2116262|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2116263|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2116264|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116265|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
2116266|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
2116267|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
2116268|NCT02635984|Olanzapine|olanzapine|mesh-list
2116269|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
2116270|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
2116271|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116272|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116273|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2116274|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2116275|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2116276|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116277|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2116278|NCT02635984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2116279|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2116280|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2116281|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116282|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530761|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
2530762|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530763|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2530764|NCT01384695|Proflavine|proflavine|mesh-list
2530765|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2530766|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530767|NCT01384708|Proflavine|proflavine|mesh-list
2530768|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2530769|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530770|NCT01384773|Riboflavin|riboflavin|mesh-list
2530771|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2530772|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2530773|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
2530774|NCT01384773|Vitamins|vitamins|mesh-ancestor
2116283|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
2116284|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
2116285|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2116286|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116287|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
2116288|NCT02636725|Axitinib|axitinib|mesh-list
2116289|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2530775|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
2403081|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403082|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2403083|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2530776|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530777|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2530778|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
2530779|NCT01384799|Cisplatin|cisplatin|mesh-list
2530780|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530781|NCT01384812|Dinoprostone|dinoprostone|mesh-list
2530782|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
2530783|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2530784|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530785|NCT01384864|Proflavine|proflavine|mesh-list
2530786|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2530787|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530788|NCT01384903|Antithrombins|antithrombins|mesh-list
2530789|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
2530790|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2530791|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
2530792|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530793|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530794|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
2530795|NCT01384994|Folic Acid|folic acid|mesh-list
2530796|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
2530797|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
2530798|NCT01384994|Fluorouracil|fluorouracil|mesh-list
2530799|NCT01384994|Panitumumab|panitumumab|mesh-list
2530800|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530801|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
2530802|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530803|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2530804|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2530805|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
2530806|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530807|NCT01384994|Hematinics|hematinics|mesh-ancestor
2530808|NCT01384994|Vitamins|vitamins|mesh-ancestor
2530809|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
2530810|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2530811|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
2530812|NCT01385020|Red yeast rice|red yeast rice|mesh-list
2116290|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116291|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2116292|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116293|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116294|NCT02637037|Metformin|metformin|mesh-list
2116295|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
2116296|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2116297|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530813|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2530814|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
2530815|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530816|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2530817|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2530818|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2530819|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530820|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2530821|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2530822|NCT01385059|Axitinib|axitinib|mesh-list
2530823|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530824|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2530825|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530826|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530827|NCT01385124|Cannabidiol|cannabidiol|mesh-list
2530828|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
2530829|NCT01385228|Prednisone|prednisone|mesh-list
2530830|NCT01385228|Docetaxel|docetaxel|mesh-list
2530831|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530832|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
2530833|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
2530834|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
2530835|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530836|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2530837|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
2530838|NCT01385228|Hormones|hormones|mesh-ancestor
2530839|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2530840|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403084|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
2403085|NCT00726856|Ezetimibe|ezetimibe|mesh-list
2403086|NCT00726856|Fenofibrate|fenofibrate|mesh-list
2403087|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2403088|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2403089|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
2403090|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403091|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2403092|NCT00726869|Elotuzumab|elotuzumab|mesh-list
2403093|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403094|NCT00726960|Buprenorphine|buprenorphine|mesh-list
2403095|NCT00726960|Aprepitant|aprepitant|mesh-list
2403096|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2403097|NCT00726960|Narcotics|narcotics|mesh-ancestor
2403098|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2403099|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403100|NCT00726960|Analgesics|analgesics|mesh-ancestor
2403101|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
2403102|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403103|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2530841|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2530842|NCT01385345|Vitamin D|vitamin d|mesh-list
2530843|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
2530844|NCT01385345|Vitamins|vitamins|mesh-ancestor
2530845|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
2530846|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530847|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2530848|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2530849|NCT01385527|Triamcinolone|triamcinolone|mesh-list
2530850|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2530851|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
2530852|NCT01385527|Hormones|hormones|mesh-ancestor
2530853|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2530854|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530855|NCT01385631|Ezetimibe|ezetimibe|mesh-list
2530856|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2530857|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2530858|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
2530859|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530860|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2530861|NCT01385683|Clarithromycin|clarithromycin|mesh-list
2530862|NCT01385683|Dabigatran|dabigatran|mesh-list
2530863|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2530864|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530865|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2530866|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530867|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530868|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2530869|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2530870|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
2530871|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2530872|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
2530873|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
2530874|NCT01385735|Rasagiline|rasagiline|mesh-list
2530875|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2530876|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530877|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530878|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2530879|NCT01385735|Protective Agents|protective agents|mesh-ancestor
2530880|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530881|NCT01385826|Antibodies|antibodies|mesh-list
2530882|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2530883|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
2530884|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530885|NCT01385891|Etoposide|etoposide|mesh-list
2403104|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
2403105|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
2403106|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2403107|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2403108|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403109|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403110|NCT00726973|Ranibizumab|ranibizumab|mesh-list
2403111|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2403112|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2403113|NCT00726973|Growth Substances|growth substances|mesh-ancestor
2403114|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403115|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
2403116|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403117|NCT00727038|Ranibizumab|ranibizumab|mesh-list
2403118|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2530886|NCT01385891|Clofarabine|clofarabine|mesh-list
2530887|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2530888|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530889|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2530890|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2530891|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530892|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530893|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2530894|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
2530895|NCT01385956|Gemcitabine|gemcitabine|mesh-list
2530896|NCT01385956|Pasireotide|pasireotide|mesh-list
2530897|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2530898|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
2530899|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530900|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530901|NCT01385956|Antiviral Agents|antiviral agents|mesh-ancestor
2530902|NCT01385956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530903|NCT01385956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530904|NCT01385956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2530905|NCT01385956|Immunologic Factors|immunologic factors|mesh-ancestor
2530906|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530907|NCT01385956|Hormones|hormones|mesh-ancestor
2530908|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2530909|NCT01386086|Aripiprazole|aripiprazole|mesh-list
2530910|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
2530911|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2530912|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2530913|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2530914|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2403119|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2403120|NCT00727038|Growth Substances|growth substances|mesh-ancestor
2403121|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403122|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
2403123|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403124|NCT00727077|Interferons|interferons|mesh-list
2403125|NCT00727077|Ribavirin|ribavirin|mesh-list
2403126|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
2403127|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
2530915|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530916|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
2530917|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
2530918|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530919|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530920|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2403128|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403129|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
2403130|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2403131|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
2403132|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403133|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
2403134|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403135|NCT00727103|Varenicline|varenicline|mesh-list
2403136|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2403137|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2403138|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
2403139|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403140|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403141|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403142|NCT00727207|Everolimus|everolimus|mesh-list
2403143|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403144|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403145|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
2403146|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403147|NCT00727233|Sorafenib|sorafenib|mesh-list
2530921|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2530922|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
2530923|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2530924|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2530925|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2530926|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2403148|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403149|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2530927|NCT01386151|Mitogens|mitogens|mesh-list
2530928|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
2530929|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530930|NCT01386164|Vaccines|vaccines|mesh-list
2116298|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2116299|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116300|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
2116301|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2403150|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530931|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
2530932|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530933|NCT01386177|Doxazosin|doxazosin|mesh-list
2530934|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2530935|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2530936|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2530937|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2530938|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2530939|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
2530940|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403151|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403152|NCT00727493|Alendronate|alendronate|mesh-list
2403153|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2403154|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403155|NCT00727545|Chelating Agents|chelating agents|mesh-list
2403156|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
2403157|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403158|NCT00727727|Piribedil|piribedil|mesh-list
2403159|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2403160|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2530941|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530942|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530943|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
2530944|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2530945|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
2530946|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2530947|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2530948|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2530949|NCT01386229|Ketamine|ketamine|mesh-list
2530950|NCT01386229|Etomidate|etomidate|mesh-list
2530951|NCT01386229|Analgesics|analgesics|mesh-ancestor
2530952|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
2530953|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530954|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530955|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2530956|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2530957|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
2530958|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
2530959|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2530960|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2530961|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2530962|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530963|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530964|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2530965|NCT01386242|Interferons|interferons|mesh-list
2530966|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2530967|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
2530968|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530969|NCT01386255|Baclofen|baclofen|mesh-list
2530970|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2530971|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530972|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2530973|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2530974|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2530975|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
2530976|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
2530977|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2530978|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530979|NCT01386268|Factor VIII|factor viii|mesh-list
2530980|NCT01386268|Coagulants|coagulants|mesh-ancestor
2530981|NCT01386294|Tenofovir|tenofovir|mesh-list
2530982|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
2530983|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2530984|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2530985|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2403161|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
2403162|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
2403163|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403164|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403165|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403166|NCT00727753|Bevacizumab|bevacizumab|mesh-list
2403167|NCT00727753|Ranibizumab|ranibizumab|mesh-list
2403168|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2403169|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403170|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2530986|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2530987|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2530988|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2530989|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2530990|NCT01386333|Oxytocin|oxytocin|mesh-list
2530991|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
2530992|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2530993|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2530994|NCT01386346|Capecitabine|capecitabine|mesh-list
2530995|NCT01386346|Azacitidine|azacitidine|mesh-list
2530996|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
2530997|NCT01386346|Epirubicin|epirubicin|mesh-list
2530998|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2530999|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
2531000|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531001|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531002|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531003|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2531004|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2531005|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2531006|NCT01386372|Tolvaptan|tolvaptan|mesh-list
2531007|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2531008|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531009|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
2531010|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531011|NCT01386398|Bortezomib|bortezomib|mesh-list
2531012|NCT01386398|Vorinostat|vorinostat|mesh-list
2531013|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531014|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2531015|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531016|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531017|NCT01386502|Pidilizumab|pidilizumab|mesh-list
2531018|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2531019|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531020|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
2531021|NCT01386567|Citric Acid|citric acid|mesh-list
2531022|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
2531023|NCT01386567|Enclomiphene|enclomiphene|mesh-list
2531024|NCT01386567|Clomiphene|clomiphene|mesh-list
2531025|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
2531026|NCT01386567|Testosterone|testosterone|mesh-list
2531027|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
2531028|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
2403171|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2403172|NCT00727753|Growth Substances|growth substances|mesh-ancestor
2403173|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403174|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
2403175|NCT00727766|Clofarabine|clofarabine|mesh-list
2403176|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2403177|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
2403178|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531029|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2531030|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
2531031|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2531032|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
2531033|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
2531034|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531035|NCT01386567|Androgens|androgens|mesh-ancestor
2531036|NCT01386567|Hormones|hormones|mesh-ancestor
2531037|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2531038|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531039|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2531040|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531041|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
2531042|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2531043|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
2403179|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531044|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2531045|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
2531046|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2531047|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2116302|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2116303|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
2116304|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
2116305|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116306|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116307|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2116308|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2116309|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2116310|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2116311|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2403180|NCT00727831|Leucovorin|leucovorin|mesh-list
2403181|NCT00727831|Methotrexate|methotrexate|mesh-list
2403182|NCT00727831|Calcium|calcium|mesh-list
2403183|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
2403184|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2531048|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2531049|NCT01386580|Doxorubicin|doxorubicin|mesh-list
2531050|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2531051|NCT01386580|Trastuzumab|trastuzumab|mesh-list
2531052|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2531053|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531054|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2403185|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403186|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2403187|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
2403188|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2403189|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2403190|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
2403191|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403192|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403193|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
2403194|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403195|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2531055|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2531056|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531057|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531058|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2531059|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
2531060|NCT01386593|Rifampin|rifampin|mesh-list
2531061|NCT01386593|Fluconazole|fluconazole|mesh-list
2403196|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403197|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
2403198|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403199|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2403200|NCT00727831|Antidotes|antidotes|mesh-ancestor
2403201|NCT00727831|Protective Agents|protective agents|mesh-ancestor
2403202|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
2403203|NCT00727831|Vitamins|vitamins|mesh-ancestor
2403204|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
2403205|NCT00727870|Glycerol|glycerol|mesh-list
2403206|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2403207|NCT00727870|Protective Agents|protective agents|mesh-ancestor
2403208|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403209|NCT00727935|Lidocaine|lidocaine|mesh-list
2403210|NCT00727935|Ropivacaine|ropivacaine|mesh-list
2403211|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
2403212|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
2403213|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2403214|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403215|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
2403216|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403217|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2531062|NCT01386593|Paroxetine|paroxetine|mesh-list
2531063|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2531064|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531065|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2531066|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2531067|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531068|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531069|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403218|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2403219|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2403220|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2403221|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403222|NCT00727948|Aspirin|aspirin|mesh-list
2531070|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2531071|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2531072|NCT01386593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2531073|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2531074|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2531075|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403223|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2403224|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2403225|NCT00727948|Analgesics|analgesics|mesh-ancestor
2403226|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
2403227|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403228|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403229|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403230|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403231|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2403232|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2403233|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403234|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2403235|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2403236|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531076|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
2531077|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531078|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2531079|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
2531080|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2531081|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2531082|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
2531083|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2531084|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2531085|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
2531086|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2531087|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2531088|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2531089|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2531090|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
2403237|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
2403238|NCT00727987|Golimumab|golimumab|mesh-list
2403239|NCT00727987|Methotrexate|methotrexate|mesh-list
2403240|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2403241|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
2403242|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2403243|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403244|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2403245|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
2531091|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
2531092|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2531093|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2403246|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403247|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531094|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2531095|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2531096|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2531097|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2531098|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2531099|NCT01386658|Icatibant|icatibant|mesh-list
2531100|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2531101|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2531102|NCT01386658|Analgesics|analgesics|mesh-ancestor
2531103|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
2531104|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531105|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531106|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2531107|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2531108|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
2531109|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
2668612|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2531110|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531111|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2531112|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2531113|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
2531114|NCT01386671|Metformin|metformin|mesh-list
2403248|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
2403249|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403250|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2403251|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403252|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
2403253|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403254|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2403255|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2403256|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403257|NCT00728000|Gemcitabine|gemcitabine|mesh-list
2403258|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
2403259|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2403260|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2403261|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
2403262|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403263|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403264|NCT00728000|Antiviral Agents|antiviral agents|mesh-ancestor
2403265|NCT00728000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2403266|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403267|NCT00728000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2531115|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2531116|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531117|NCT01386710|Bevacizumab|bevacizumab|mesh-list
2531118|NCT01386710|Carboplatin|carboplatin|mesh-list
2531119|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2531120|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531121|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2531122|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2531123|NCT01386710|Growth Substances|growth substances|mesh-ancestor
2531124|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531125|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
2531126|NCT01386736|Vitamin D|vitamin d|mesh-list
2531127|NCT01386736|Vitamins|vitamins|mesh-ancestor
2531128|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
2531129|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531130|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2531131|NCT01386827|Vaccines|vaccines|mesh-list
2531132|NCT01386827|Immunologic Factors|immunologic factors|mesh-ancestor
2531133|NCT01386827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531134|NCT01386853|Atorvastatin|atorvastatin|mesh-list
2531135|NCT01386853|Pitavastatin|pitavastatin|mesh-list
2531136|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2531137|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2531138|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
2531139|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531140|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2531141|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2531142|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403268|NCT00728000|Immunologic Factors|immunologic factors|mesh-ancestor
2403269|NCT00728000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403270|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2403271|NCT00728013|Atorvastatin|atorvastatin|mesh-list
2403272|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2403273|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2403274|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
2403275|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403276|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2403277|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2531143|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
2531144|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2531145|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531146|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531147|NCT01386879|Methylene Blue|methylene blue|mesh-list
2531148|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531149|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531150|NCT01386996|Budesonide|budesonide|mesh-list
2531151|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
2531152|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2668613|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
2403278|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531153|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2531154|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2531155|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
2531156|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531157|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531158|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2531159|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
2531160|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
2531161|NCT01386996|Hormones|hormones|mesh-ancestor
2531162|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2531163|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2116312|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
2116313|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116314|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531164|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2531165|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2531166|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
2531167|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2531168|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531169|NCT01387048|Adapalene|adapalene|mesh-list
2531170|NCT01387048|Azelaic acid|azelaic acid|mesh-list
2531171|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2531172|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2531173|NCT01387048|Analgesics|analgesics|mesh-ancestor
2531174|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
2531175|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531176|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531177|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403279|NCT00728078|Thalidomide|thalidomide|mesh-list
2403280|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403281|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
2403282|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403283|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
2403284|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2403285|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531178|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2531179|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
2531180|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531181|NCT01387087|Peficitinib|peficitinib|mesh-list
2531182|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531183|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531184|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2531185|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
2531186|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531187|NCT01387191|Epoprostenol|epoprostenol|mesh-list
2531188|NCT01387191|Tezosentan|tezosentan|mesh-list
2531189|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2531190|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2531191|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
2531192|NCT01387204|Trametinib|trametinib|mesh-list
2531193|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531194|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2116315|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116316|NCT02637323|Triamcinolone|triamcinolone|mesh-list
2116317|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2116318|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2116319|NCT02637323|FX006|fx006|mesh-list
2116320|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2116321|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2116322|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
2116323|NCT02637323|Hormones|hormones|mesh-ancestor
2116324|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2116325|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116326|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2116327|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
2116328|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116329|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116330|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
2116331|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
2116332|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116333|NCT02637895|Vortioxetine|vortioxetine|mesh-list
2116334|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
2116335|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2116336|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2403286|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2403287|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2403288|NCT00728078|Growth Substances|growth substances|mesh-ancestor
2403289|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
2403290|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403291|NCT00728091|Satavaptan|satavaptan|mesh-list
2403292|NCT00728091|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2403293|NCT00728091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403294|NCT00728091|Natriuretic Agents|natriuretic agents|mesh-ancestor
2403295|NCT00728091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403296|NCT00728156|Clopidogrel|clopidogrel|mesh-list
2403297|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2403298|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2403299|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2403300|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2403301|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
2403302|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403303|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531195|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531196|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531197|NCT01387243|Orlistat|orlistat|mesh-list
2116337|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2116338|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116339|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531198|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531199|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531200|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2531201|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2531202|NCT01387295|Capecitabine|capecitabine|mesh-list
2531203|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
2531204|NCT01387295|Trastuzumab|trastuzumab|mesh-list
2531205|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2531206|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
2531207|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531208|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531209|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2531210|NCT01387373|Capecitabine|capecitabine|mesh-list
2531211|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
2531212|NCT01387373|Trastuzumab|trastuzumab|mesh-list
2531213|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2531214|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
2531215|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531216|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531217|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2531218|NCT01387399|Cisplatin|cisplatin|mesh-list
2531219|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531220|NCT01387425|Varenicline|varenicline|mesh-list
2531221|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2531222|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2531223|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
2531224|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2531225|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531226|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531227|NCT01387568|Lidocaine|lidocaine|mesh-list
2531228|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
2531229|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
2531230|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2531231|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531232|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
2531233|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531234|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2531235|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2531236|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2531237|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2116340|NCT02637895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2116341|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2116342|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2116343|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116344|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116345|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
2116346|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2531238|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531239|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
2531240|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2531241|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
2531242|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531243|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
2531244|NCT01387620|Protective Agents|protective agents|mesh-ancestor
2531245|NCT01387763|Interferons|interferons|mesh-list
2531246|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
2531247|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
2531248|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2531249|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2531250|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
2531251|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531252|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
2531253|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531254|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
2531255|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531256|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
2531257|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531258|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531259|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2531260|NCT01387880|Everolimus|everolimus|mesh-list
2531261|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531262|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403304|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403305|NCT00728195|Olanzapine|olanzapine|mesh-list
2403306|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
2403307|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
2403308|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
2403309|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403310|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403311|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2403312|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2403313|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2403314|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2403315|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2531263|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
2531264|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531265|NCT01387906|Bimatoprost|bimatoprost|mesh-list
2531266|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2531267|NCT01387997|Antibodies|antibodies|mesh-list
2531268|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
2531269|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531270|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
2531271|NCT01388023|Listerine|listerine|mesh-list
2531272|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2531273|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531274|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
2531275|NCT01388036|Esmolol|esmolol|mesh-list
2531276|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2531277|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2531278|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2531279|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
2531280|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2531281|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531282|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531283|NCT01388049|Antibodies|antibodies|mesh-list
2531284|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
2531285|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531286|NCT01388062|Antibodies|antibodies|mesh-list
2531287|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
2531288|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531289|NCT01388075|Rifampin|rifampin|mesh-list
2531290|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2531291|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
2531292|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2531293|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531294|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
2531295|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2531296|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531297|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531298|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2531299|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2531300|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2531301|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2531302|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2531303|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2531304|NCT01388088|Amiloride|amiloride|mesh-list
2531305|NCT01388088|Spironolactone|spironolactone|mesh-list
2531306|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2531307|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
2531308|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2531309|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531310|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2531311|NCT01388088|Diuretics|diuretics|mesh-ancestor
2531312|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
2531313|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2531314|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2531315|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2531316|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531317|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2531318|NCT01388101|Antibodies|antibodies|mesh-list
2531319|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
2531320|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531321|NCT01388114|Antibodies|antibodies|mesh-list
2531322|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
2531323|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531324|NCT01388153|Acarbose|acarbose|mesh-list
2531325|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2531326|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531327|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531328|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2531329|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531330|NCT01388270|Heparin|heparin|mesh-list
2531331|NCT01388270|Calcium heparin|calcium heparin|mesh-list
2531332|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
2531333|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2531334|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2403316|NCT00728195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2403317|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2403318|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2403319|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403320|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403321|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
2403322|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2403323|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2403324|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
2403325|NCT00728273|Micronutrients|micronutrients|mesh-list
2403326|NCT00728273|Trace Elements|trace elements|mesh-list
2403327|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403328|NCT00728312|Aripiprazole|aripiprazole|mesh-list
2403329|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
2403330|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2403331|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2403332|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2403333|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2403334|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403335|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
2403336|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
2403337|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403338|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403339|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2403340|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2403341|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
2403342|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2531335|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531336|NCT01388322|Enoxaparin|enoxaparin|mesh-list
2531337|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
2531338|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2531339|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2531340|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531341|NCT01388387|Tacrolimus|tacrolimus|mesh-list
2531342|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2531343|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
2531344|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531345|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2531346|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531347|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531348|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2531349|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531350|NCT01388439|Oseltamivir|oseltamivir|mesh-list
2531351|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
2531352|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531353|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531354|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531355|NCT01388517|Vitamin D|vitamin d|mesh-list
2403343|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2403344|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2403345|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2403346|NCT00728351|Metformin|metformin|mesh-list
2403347|NCT00728351|Vildagliptin|vildagliptin|mesh-list
2531356|NCT01388517|Calcitriol|calcitriol|mesh-list
2531357|NCT01388517|Petrolatum|petrolatum|mesh-list
2531358|NCT01388517|Tacrolimus|tacrolimus|mesh-list
2531359|NCT01388517|Vitamins|vitamins|mesh-ancestor
2531360|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
2531361|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531362|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2531363|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2531364|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
2531365|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2531366|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531367|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531368|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2531369|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2531370|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2531371|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2531372|NCT01388517|Emollients|emollients|mesh-ancestor
2531373|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
2531374|NCT01388582|Copper|copper|mesh-list
2531375|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
2531376|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
2531377|NCT01388582|Etonogestrel|etonogestrel|mesh-list
2531378|NCT01388582|Desogestrel|desogestrel|mesh-list
2531379|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
2531380|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2531381|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531382|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2531383|NCT01388582|Trace Elements|trace elements|mesh-ancestor
2531384|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
2531385|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2531386|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2531387|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2531388|NCT01388582|Progestins|progestins|mesh-ancestor
2531389|NCT01388582|Hormones|hormones|mesh-ancestor
2531390|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2531391|NCT01388595|Fluticasone|fluticasone|mesh-list
2531392|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2531393|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2531394|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2531395|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
2531396|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531397|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531398|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2531399|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
2531400|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
2403348|NCT00728351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2403349|NCT00728351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403350|NCT00728351|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2403351|NCT00728351|Protease Inhibitors|protease inhibitors|mesh-ancestor
2403352|NCT00728351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403353|NCT00728351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403354|NCT00728520|Azacitidine|azacitidine|mesh-list
2403355|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2403356|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
2403357|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403358|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403359|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403360|NCT00728546|Isoniazid|isoniazid|mesh-list
2403361|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
2403362|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2403363|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531401|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2403364|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2403365|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2403366|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
2403367|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403368|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2403369|NCT00728559|Bupivacaine|bupivacaine|mesh-list
2403370|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
2531402|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2531403|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2531404|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2531405|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
2531406|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2531407|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531408|NCT01388621|Gemcitabine|gemcitabine|mesh-list
2531409|NCT01388621|Carboplatin|carboplatin|mesh-list
2531410|NCT01388621|Doxorubicin|doxorubicin|mesh-list
2116347|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2116348|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2116349|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2531411|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2531412|NCT01388621|Panitumumab|panitumumab|mesh-list
2531413|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403371|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
2403372|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2403373|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403374|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
2403375|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403376|NCT00728585|Mitogens|mitogens|mesh-list
2403377|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
2403378|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403379|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
2403380|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2403381|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
2403382|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403383|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
2403384|NCT00728611|Protective Agents|protective agents|mesh-ancestor
2403385|NCT00728663|Docetaxel|docetaxel|mesh-list
2403386|NCT00728663|Cetuximab|cetuximab|mesh-list
2403387|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403388|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
2403389|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
2403390|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
2403391|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403392|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2403393|NCT00728715|Budesonide|budesonide|mesh-list
2403394|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
2403395|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403396|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2403397|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
2403398|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403399|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403400|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2403401|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
2403402|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
2403403|NCT00728715|Hormones|hormones|mesh-ancestor
2403404|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2403405|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2403406|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2403407|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2403408|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
2403409|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2531414|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2116350|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2116351|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
2116352|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
2116353|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2116354|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116355|NCT02638012|Hemostatics|hemostatics|mesh-list
2116356|NCT02638012|Coagulants|coagulants|mesh-ancestor
2116357|NCT02638168|Methylphenidate|methylphenidate|mesh-list
2116358|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2116359|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116360|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2116361|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2116362|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2531415|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
2531416|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531417|NCT01388621|Antiviral Agents|antiviral agents|mesh-ancestor
2531418|NCT01388621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531419|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531420|NCT01388621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2531421|NCT01388621|Immunologic Factors|immunologic factors|mesh-ancestor
2531422|NCT01388621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531423|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2531424|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2531425|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2531426|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2531427|NCT01388660|Clopidogrel|clopidogrel|mesh-list
2116363|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116364|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
2116365|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116366|NCT02638259|GP2015|gp2015|mesh-list
2116367|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
2116368|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
2116369|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2116370|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
2116371|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531428|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2531429|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2531430|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2531431|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2531432|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
2531433|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2531434|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531435|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531436|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
2531437|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2531438|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
2531439|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2531440|NCT01388738|Protective Agents|protective agents|mesh-ancestor
2531441|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531442|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
2531443|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2531444|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
2531445|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531446|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531447|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2531448|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
2531449|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2531450|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
2531451|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531452|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2531453|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2531454|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
2531455|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
2531456|NCT01388842|Protective Agents|protective agents|mesh-ancestor
2531457|NCT01388855|Vitamin D|vitamin d|mesh-list
2531458|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
2531459|NCT01388855|Vitamins|vitamins|mesh-ancestor
2531460|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
2531461|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531462|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2531463|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2531464|NCT01388959|Rituximab|rituximab|mesh-list
2403410|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403411|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2403412|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2403413|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2403414|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
2403415|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403416|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2403417|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2403418|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403419|NCT00728832|Morphine|morphine|mesh-list
2403420|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2403421|NCT00728832|Narcotics|narcotics|mesh-ancestor
2403422|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2403423|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531465|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2531466|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531467|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
2531468|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403424|NCT00728832|Analgesics|analgesics|mesh-ancestor
2403425|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
2403426|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403427|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2403428|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
2403429|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403430|NCT00729118|Lenalidomide|lenalidomide|mesh-list
2403431|NCT00729118|Vorinostat|vorinostat|mesh-list
2403432|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
2403433|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403434|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2403435|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2403436|NCT00729118|Growth Substances|growth substances|mesh-ancestor
2403437|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
2403438|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403439|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2403440|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403441|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403442|NCT00729131|Etanercept|etanercept|mesh-list
2403443|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2403444|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2403445|NCT00729131|Analgesics|analgesics|mesh-ancestor
2403446|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
2403447|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403448|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403449|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403450|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403451|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2403452|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403453|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
2403454|NCT00729170|Calcium|calcium|mesh-list
2403455|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2403456|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403457|NCT00729222|Rolofylline|rolofylline|mesh-list
2403458|NCT00729222|Diuretics|diuretics|mesh-ancestor
2403459|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
2403460|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531469|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2116372|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2116373|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2116374|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2116375|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116376|NCT02638948|Methotrexate|methotrexate|mesh-list
2116377|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2116378|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
2116379|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2116380|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116381|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2116382|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
2531470|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
2531471|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531472|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
2531473|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531474|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531475|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2531476|NCT01389063|Maraviroc|maraviroc|mesh-list
2531477|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2531478|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2531479|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531480|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2531481|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2531482|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
2531483|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531484|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2531485|NCT01389167|Naltrexone|naltrexone|mesh-list
2531486|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2531487|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2531488|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531489|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
2531490|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403461|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2403462|NCT00729287|Selenium|selenium|mesh-list
2403463|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
2403464|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403465|NCT00729287|Protective Agents|protective agents|mesh-ancestor
2403466|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403467|NCT00729287|Trace Elements|trace elements|mesh-ancestor
2403468|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
2403469|NCT00729300|Disulfiram|disulfiram|mesh-list
2403470|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2403471|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2403472|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403473|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403474|NCT00729313|Lanreotide|lanreotide|mesh-list
2403475|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403476|NCT00729339|Mosapride|mosapride|mesh-list
2403477|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2403478|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2403479|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
2531491|NCT01389193|Ibudilast|ibudilast|mesh-list
2531492|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2531493|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
2531494|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531495|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531496|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2531497|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
2531498|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2531499|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403480|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403481|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403482|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531500|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531501|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2531502|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
2531503|NCT01389206|Bosentan|bosentan|mesh-list
2531504|NCT01389206|Selexipag|selexipag|mesh-list
2531505|NCT01389206|Iloprost|iloprost|mesh-list
2531506|NCT01389206|Macitentan|macitentan|mesh-list
2531507|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2531508|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
2531509|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2531510|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2531511|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531512|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2531513|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2403483|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2403484|NCT00729404|Gestodene|gestodene|mesh-list
2403485|NCT00729404|Femovan|femovan|mesh-list
2403486|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2403487|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2403488|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2403489|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
2403490|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2403491|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403492|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2403493|NCT00729404|Estrogens|estrogens|mesh-ancestor
2403494|NCT00729404|Hormones|hormones|mesh-ancestor
2531514|NCT01389271|Iloprost|iloprost|mesh-list
2531515|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2531516|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
2531517|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2531518|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2116383|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116384|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116385|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
2116386|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116387|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2116388|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2116389|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
2116390|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2116391|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2116392|NCT02639182|Axitinib|axitinib|mesh-list
2116393|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116394|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2116395|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184835|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403495|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2403496|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2403497|NCT00729404|Progestins|progestins|mesh-ancestor
2403498|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2403499|NCT00729495|Celecoxib|celecoxib|mesh-list
2403500|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2403501|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2403502|NCT00729495|Analgesics|analgesics|mesh-ancestor
2403503|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
2403504|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403505|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403506|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403507|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403508|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2403509|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2403510|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403511|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403512|NCT00729573|Tenofovir|tenofovir|mesh-list
2403513|NCT00729573|Emtricitabine|emtricitabine|mesh-list
2403514|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2403515|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
2531519|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2531520|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
2531521|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531522|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2531523|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2531524|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531525|NCT01389401|Omeprazole|omeprazole|mesh-list
2531526|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2531527|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2531528|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2531529|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531530|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531531|NCT01389414|Gemcitabine|gemcitabine|mesh-list
2531532|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
2531533|NCT01389414|Panitumumab|panitumumab|mesh-list
2531534|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2531535|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
2531536|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531537|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531538|NCT01389414|Antiviral Agents|antiviral agents|mesh-ancestor
2531539|NCT01389414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531540|NCT01389414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403516|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2403517|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2403518|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2403519|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403520|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403521|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2403522|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2403523|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
2403524|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2403525|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2403526|NCT00729638|Lenalidomide|lenalidomide|mesh-list
2531541|NCT01389414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2531542|NCT01389414|Immunologic Factors|immunologic factors|mesh-ancestor
2531543|NCT01389414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531544|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2531545|NCT01389427|Sirolimus|sirolimus|mesh-list
2531546|NCT01389427|Prednisone|prednisone|mesh-list
2531547|NCT01389427|Doxorubicin|doxorubicin|mesh-list
2531548|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
2531549|NCT01389427|Vincristine|vincristine|mesh-list
2531550|NCT01389427|Rituximab|rituximab|mesh-list
2531551|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2531552|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531553|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2531554|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531555|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
2531556|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2531557|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
2531558|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531559|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2531560|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2531561|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
2531562|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531563|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2531564|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2531565|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
2531566|NCT01389427|Hormones|hormones|mesh-ancestor
2531567|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2531568|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2531569|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2531570|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
2531571|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
2531572|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
2531573|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2531574|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2531575|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2531576|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531577|NCT01389440|Gemcitabine|gemcitabine|mesh-list
2531578|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2531579|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2531580|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
2531581|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531582|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403527|NCT00729638|Everolimus|everolimus|mesh-list
2403528|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
2403529|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403530|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2403531|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2403532|NCT00729638|Growth Substances|growth substances|mesh-ancestor
2403533|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
2403534|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403535|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403536|NCT00729664|Atezolizumab|atezolizumab|mesh-list
2403537|NCT00729664|BMS-936559|bms-936559|mesh-list
2403538|NCT00729664|Antibodies|antibodies|mesh-list
2403539|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
2403540|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2403541|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
2403542|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403543|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403544|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2531583|NCT01389440|Antiviral Agents|antiviral agents|mesh-ancestor
2531584|NCT01389440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531585|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531586|NCT01389440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2531587|NCT01389440|Immunologic Factors|immunologic factors|mesh-ancestor
2403545|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2403546|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403547|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2403548|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403549|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531588|NCT01389440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531589|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2531590|NCT01389505|Bevacizumab|bevacizumab|mesh-list
2531591|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2531592|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531593|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2403550|NCT00729768|Cyclosporine|cyclosporine|mesh-list
2403551|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
2403552|NCT00729768|Cyclosporins|cyclosporins|mesh-list
2403553|NCT00729768|Basiliximab|basiliximab|mesh-list
2403554|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403555|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403556|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403557|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
2403558|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403559|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
2403560|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2403561|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
2403562|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403563|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2403564|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2403565|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403566|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2403567|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
2403568|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2531594|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2531595|NCT01389505|Growth Substances|growth substances|mesh-ancestor
2531596|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531597|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
2531598|NCT01389544|Ritonavir|ritonavir|mesh-list
2531599|NCT01389544|Methadone|methadone|mesh-list
2531600|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2531601|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2531602|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
2531603|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531604|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531605|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2531606|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2531607|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
2531608|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531609|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2531610|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2531611|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2531612|NCT01389544|Narcotics|narcotics|mesh-ancestor
2531613|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2531614|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531615|NCT01389544|Analgesics|analgesics|mesh-ancestor
2531616|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
2531617|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531618|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
2531619|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
2531620|NCT01389557|Piperaquine|piperaquine|mesh-list
2531621|NCT01389557|Primaquine|primaquine|mesh-list
2531622|NCT01389557|Artenimol|artenimol|mesh-list
2531623|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
2531624|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2531625|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2531626|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531627|NCT01389609|Doxazosin|doxazosin|mesh-list
2531628|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2531629|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2531630|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2531631|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2531632|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
2531633|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2531634|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531635|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531636|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2531637|NCT01389713|Clomiphene|clomiphene|mesh-list
2531638|NCT01389713|Enclomiphene|enclomiphene|mesh-list
2531639|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
2531640|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2116396|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116397|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
2116398|NCT02639247|Velpatasvir|velpatasvir|mesh-list
2116399|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
2116400|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2116401|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
2116402|NCT02639338|Velpatasvir|velpatasvir|mesh-list
2116403|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
2116404|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2116405|NCT02639429|Misoprostol|misoprostol|mesh-list
2116406|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2116407|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
2116408|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2116409|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403569|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
2403570|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
2403571|NCT00729794|Vasopressins|vasopressins|mesh-list
2403572|NCT00729794|Arginine Vasopressin|arginine vasopressin|mesh-list
2403573|NCT00729794|Epinephrine|epinephrine|mesh-list
2403574|NCT00729794|Racepinephrine|racepinephrine|mesh-list
2403575|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
2403576|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403577|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
2403578|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
2403579|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403580|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403581|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2403582|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
2403583|NCT00729794|Hormones|hormones|mesh-ancestor
2531641|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
2531642|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2403584|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2403585|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2403586|NCT00729794|Protective Agents|protective agents|mesh-ancestor
2403587|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2403588|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2403589|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
2403590|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403591|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403592|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2403593|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2403594|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2403595|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
2403596|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
2403597|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
2403598|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2403599|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
2403600|NCT00729794|Coagulants|coagulants|mesh-ancestor
2403601|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2403602|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
2403603|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
2403604|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
2403605|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2403606|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2403607|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403608|NCT00729911|Amiodarone|amiodarone|mesh-list
2403609|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2403610|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
2403611|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2403612|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2403613|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403614|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2403615|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2531643|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531644|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2531645|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
2531646|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2531647|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2531648|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2531649|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
2531650|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2531651|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
2531652|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2531653|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2531654|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531655|NCT01389778|Metformin|metformin|mesh-list
2531656|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2531657|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531658|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
2531659|NCT01389791|Rocuronium|rocuronium|mesh-list
2531660|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2531661|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2531662|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2531663|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531664|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531665|NCT01389791|Analgesics|analgesics|mesh-ancestor
2531666|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
2531667|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
2531668|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2531669|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2531670|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
2531671|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2531672|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2531673|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531674|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2531675|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
2531676|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2531677|NCT01389908|Olanzapine|olanzapine|mesh-list
2531678|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
2403616|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2403617|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403618|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2403619|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2403620|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2531679|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
2531680|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531681|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531682|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2531683|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2531684|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2531685|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2531686|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2531687|NCT01389908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2531688|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2531689|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2531690|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531691|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2531692|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
2531693|NCT01390012|Dexamethasone|dexamethasone|mesh-list
2403621|NCT00729950|Ipilimumab|ipilimumab|mesh-list
2403622|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2403623|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403624|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2403625|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403626|NCT00729963|Sibutramine|sibutramine|mesh-list
2403627|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
2403628|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2403629|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
2403630|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2403631|NCT00729976|Ibuprofen|ibuprofen|mesh-list
2403632|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2531694|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
2531695|NCT01390012|BB 1101|bb 1101|mesh-list
2531696|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2531697|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
2531698|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
2531699|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403633|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2403634|NCT00729976|Analgesics|analgesics|mesh-ancestor
2403635|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
2403636|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403637|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403638|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403639|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403640|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2403641|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403642|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403643|NCT00730054|Clonidine|clonidine|mesh-list
2403644|NCT00730054|Remifentanil|remifentanil|mesh-list
2403645|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2403646|NCT00730054|Narcotics|narcotics|mesh-ancestor
2403647|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2403648|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403649|NCT00730054|Analgesics|analgesics|mesh-ancestor
2403650|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
2403651|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403652|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2403653|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
2403654|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
2403655|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2403656|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2403657|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2403658|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
2531700|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531701|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2531702|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
2531703|NCT01390012|Hormones|hormones|mesh-ancestor
2531704|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2531705|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2531706|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531707|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
2531708|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531709|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531710|NCT01390051|Tinzaparin|tinzaparin|mesh-list
2531711|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2531712|NCT01390051|Dalteparin|dalteparin|mesh-list
2531713|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
2531714|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2531715|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2403659|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403660|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403661|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
2403662|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
2403663|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2403664|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2403665|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403666|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403667|NCT00730067|Urological Agents|urological agents|mesh-ancestor
2403668|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
2403669|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
2403670|NCT00730093|Vitamins|vitamins|mesh-ancestor
2403671|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
2403672|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403673|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
2403674|NCT00730093|Hematinics|hematinics|mesh-ancestor
2531716|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531717|NCT01390311|Azacitidine|azacitidine|mesh-list
2531718|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2531719|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
2531720|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531721|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531722|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531723|NCT01390324|Naproxen|naproxen|mesh-list
2531724|NCT01390324|Naratriptan|naratriptan|mesh-list
2531725|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2531726|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2531727|NCT01390324|Analgesics|analgesics|mesh-ancestor
2531728|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
2531729|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531730|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531731|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2531732|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403675|NCT00730197|Albuterol|albuterol|mesh-list
2403676|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2403677|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
2403678|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531733|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
2531734|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2531735|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531736|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531737|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2531738|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2531739|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2531740|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
2531741|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2531742|NCT01390337|Cytarabine|cytarabine|mesh-list
2531743|NCT01390337|Daunorubicin|daunorubicin|mesh-list
2531744|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2531745|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
2531746|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531747|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531748|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
2531749|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531750|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2531751|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
2531752|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531753|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2531754|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2531755|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2531756|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531757|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
2531758|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2531759|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531760|NCT01390480|Vitamins|vitamins|mesh-ancestor
2531761|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
2531762|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2531763|NCT01390506|Selenious Acid|selenious acid|mesh-list
2531764|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
2531765|NCT01390506|Trace Elements|trace elements|mesh-ancestor
2531766|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
2531767|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531768|NCT01390519|Everolimus|everolimus|mesh-list
2531769|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403679|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531770|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403680|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2403681|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
2403682|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
2403683|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2403684|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2403685|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2403686|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2403687|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
2403688|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403689|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403690|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
2403691|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2403692|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403693|NCT00730223|Efavirenz|efavirenz|mesh-list
2403694|NCT00730223|Nevirapine|nevirapine|mesh-list
2403695|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2403696|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2403697|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403698|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403699|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
2403700|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2403701|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2531771|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
2531772|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531773|NCT01390545|Veltuzumab|veltuzumab|mesh-list
2531774|NCT01390545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531775|NCT01390571|Temozolomide|temozolomide|mesh-list
2531776|NCT01390571|Olaparib|olaparib|mesh-list
2531777|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2531778|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
2531779|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531780|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531781|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2531782|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531783|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
2531784|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2531785|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531786|NCT01390662|Vitamin D|vitamin d|mesh-list
2531787|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
2531788|NCT01390662|Vitamins|vitamins|mesh-ancestor
2531789|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
2531790|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531791|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2531792|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2403702|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2403703|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2403704|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2403705|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2403706|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2403707|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2403708|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2403709|NCT00730249|Methylphenidate|methylphenidate|mesh-list
2403710|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2403711|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531793|NCT01390766|Azathioprine|azathioprine|mesh-list
2531794|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
2531795|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531796|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2531797|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531798|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2531799|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
2531800|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531801|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2531802|NCT01390792|Zanamivir|zanamivir|mesh-list
2531803|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
2403712|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2403713|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2403714|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2531804|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531805|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531806|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531807|NCT01390805|Valacyclovir|valacyclovir|mesh-list
2531808|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
2531809|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531810|NCT01390883|PENTA|penta|mesh-list
2531811|NCT01390883|Fondaparinux|fondaparinux|mesh-list
2531812|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2531813|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
2531814|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2531815|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
2531816|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531817|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531818|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
2531819|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2531820|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2531821|NCT01390896|PENTA|penta|mesh-list
2531822|NCT01390896|Fondaparinux|fondaparinux|mesh-list
2531823|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2531824|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
2531825|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2531826|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
2531827|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531828|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531829|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
2403715|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403716|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
2403717|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2531830|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2531831|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2531832|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
2531833|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2531834|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2531835|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2531836|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2531837|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531838|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
2531839|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2531840|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531841|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2403718|NCT00730288|Vaccines|vaccines|mesh-list
2403719|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
2403720|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403721|NCT00730366|Chloroquine|chloroquine|mesh-list
2403722|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
2403723|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
2403724|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2403725|NCT00730366|Amebicides|amebicides|mesh-ancestor
2531842|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531843|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
2403726|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2403727|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2403728|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2403729|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
2403730|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403731|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2403732|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403733|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403734|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2403735|NCT00730366|Renal Agents|renal agents|mesh-ancestor
2403736|NCT00730392|Etanercept|etanercept|mesh-list
2403737|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2403738|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2403739|NCT00730392|Analgesics|analgesics|mesh-ancestor
2403740|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
2403741|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403742|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403743|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403744|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403745|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2403746|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403747|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
2403748|NCT00730418|Doxazosin|doxazosin|mesh-list
2403749|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2403750|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2403751|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2403752|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2403753|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
2531844|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
2531845|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2403754|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403755|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403756|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403757|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2403758|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403759|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403760|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403761|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2403762|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
2403763|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
2531846|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531847|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2531848|NCT01390935|Diuretics|diuretics|mesh-ancestor
2531849|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
2531850|NCT01390961|Pheniramine|pheniramine|mesh-list
2531851|NCT01390961|Naphazoline|naphazoline|mesh-list
2531852|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531853|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2403764|NCT00730509|Vitamins|vitamins|mesh-ancestor
2403765|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
2403766|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403767|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
2403768|NCT00730509|Hematinics|hematinics|mesh-ancestor
2531854|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2531855|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
2531856|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2531857|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531858|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
2531859|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2531860|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
2531861|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2531862|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
2531863|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
2531864|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
2531865|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
2531866|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2531867|NCT01391052|Norethindrone|norethindrone|mesh-list
2531868|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
2531869|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2531870|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2531871|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2531872|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
2531873|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2531874|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531875|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2403769|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2403770|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2403771|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2403772|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
2403773|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403774|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403775|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403776|NCT00730535|Urological Agents|urological agents|mesh-ancestor
2403777|NCT00730574|Vitamins|vitamins|mesh-list
2403778|NCT00730574|Folic Acid|folic acid|mesh-list
2403779|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
2403780|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
2531876|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2531877|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
2531878|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
2531879|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2531880|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2531881|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531882|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531883|NCT01391104|Urological Agents|urological agents|mesh-ancestor
2531884|NCT01391156|Minoxidil|minoxidil|mesh-list
2531885|NCT01391156|Finasteride|finasteride|mesh-list
2531886|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2531887|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2531888|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531889|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531890|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
2531891|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2403781|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
2403782|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
2116410|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2116411|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2116412|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
2116413|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2116414|NCT02639637|Valsartan|valsartan|mesh-list
2116415|NCT02639637|Enalaprilat|enalaprilat|mesh-list
2116416|NCT02639637|Enalapril|enalapril|mesh-list
2116417|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2116418|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116419|NCT02639637|Incretins|incretins|mesh-ancestor
2116420|NCT02639637|Hormones|hormones|mesh-ancestor
2116421|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2116422|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2116423|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
2116424|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403783|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403784|NCT00730574|Hematinics|hematinics|mesh-ancestor
2403785|NCT00730665|Esomeprazole|esomeprazole|mesh-list
2403786|NCT00730665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2403787|NCT00730665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2403788|NCT00730665|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2403789|NCT00730665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403790|NCT00730665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403791|NCT00730717|Adalimumab|adalimumab|mesh-list
2403792|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403793|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403794|NCT00730769|Valganciclovir|valganciclovir|mesh-list
2403795|NCT00730769|Ganciclovir|ganciclovir|mesh-list
2403796|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2403797|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
2403798|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2403799|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2403800|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531892|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531893|NCT01391156|Urological Agents|urological agents|mesh-ancestor
2531894|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2531895|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
2531896|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2531897|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2531898|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2531899|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2531900|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403801|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403802|NCT00730821|Nintedanib|nintedanib|mesh-list
2403803|NCT00730821|Afatinib|afatinib|mesh-list
2531901|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403804|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403805|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2403806|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531902|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531903|NCT01391221|Analgesics|analgesics|mesh-ancestor
2531904|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
2531905|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531906|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
2531907|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2531908|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
2531909|NCT01391260|Gefitinib|gefitinib|mesh-list
2531910|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531911|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2531912|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531913|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531914|NCT01391377|Niacin|niacin|mesh-list
2403807|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403808|NCT00730938|Cefuroxime|cefuroxime|mesh-list
2403809|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
2403810|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2403811|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2403812|NCT00730977|Mannitol|mannitol|mesh-list
2403813|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2403814|NCT00730977|Diuretics|diuretics|mesh-ancestor
2403815|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
2403816|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403817|NCT00731003|Tryptophan|tryptophan|mesh-list
2116425|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403818|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
2403819|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2403820|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
2403821|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2403822|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
2403823|NCT00731016|Pravastatin|pravastatin|mesh-list
2403824|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2403825|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403826|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2403827|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2403828|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
2531915|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2531916|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
2531917|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531918|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2531919|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
2531920|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
2531921|NCT01391377|Vitamins|vitamins|mesh-ancestor
2531922|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
2531923|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531924|NCT01391390|Melatonin|melatonin|mesh-list
2403829|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403830|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2403831|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2403832|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403833|NCT00731068|Mitogens|mitogens|mesh-list
2403834|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
2403835|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403836|NCT00731146|Anesthetics|anesthetics|mesh-list
2403837|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2403838|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403839|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
2403840|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
2403841|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2403842|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
2403843|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403844|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403845|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403846|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
2403847|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403848|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
2403849|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2403850|NCT00731224|Rivastigmine|rivastigmine|mesh-list
2403851|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2403852|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403853|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403854|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
2403855|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403856|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403857|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2403858|NCT00731224|Protective Agents|protective agents|mesh-ancestor
2403859|NCT00731276|Irinotecan|irinotecan|mesh-list
2403860|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2531925|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
2531926|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531927|NCT01391390|Protective Agents|protective agents|mesh-ancestor
2531928|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531929|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2531930|NCT01391403|Artemisinins|artemisinins|mesh-list
2531931|NCT01391403|Artemisinin|artemisinin|mesh-list
2531932|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
2531933|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2531934|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2531935|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2531936|NCT01391520|Deferiprone|deferiprone|mesh-list
2531937|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2531938|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
2531939|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
2531940|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531941|NCT01391572|Fluorouracil|fluorouracil|mesh-list
2531942|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531943|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
2531944|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531945|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2531946|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403861|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2403862|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2531947|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
2531948|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403863|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403864|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403865|NCT00731289|Triamcinolone|triamcinolone|mesh-list
2403866|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2403867|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2403868|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
2403869|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2403870|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403871|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
2403872|NCT00731289|Hormones|hormones|mesh-ancestor
2403873|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2403874|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403875|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2531949|NCT01391598|Lidocaine|lidocaine|mesh-list
2531950|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
2531951|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
2531952|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2531953|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531954|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
2531955|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2531956|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2531957|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2531958|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2531959|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2531960|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531961|NCT01391624|Mineral Oil|mineral oil|mesh-list
2531962|NCT01391624|Emollients|emollients|mesh-ancestor
2531963|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
2531964|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
2531965|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2531966|NCT01391689|Protective Agents|protective agents|mesh-ancestor
2531967|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531968|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2531969|NCT01391715|Rabeprazole|rabeprazole|mesh-list
2531970|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2531971|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2531972|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2531973|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403876|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
2403877|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403878|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403879|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2403880|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
2403881|NCT00731289|Protective Agents|protective agents|mesh-ancestor
2403882|NCT00731302|Aspirin|aspirin|mesh-list
2403883|NCT00731302|Meloxicam|meloxicam|mesh-list
2403884|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2403885|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2403886|NCT00731302|Analgesics|analgesics|mesh-ancestor
2531974|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2531975|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
2531976|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2531977|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
2531978|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2531979|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2531980|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2403887|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
2403888|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403889|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403890|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403891|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403892|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2403893|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2403894|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403895|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2403896|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2531992|NCT01392014|Piperaquine|piperaquine|mesh-list
2531993|NCT01392014|Primaquine|primaquine|mesh-list
2403897|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403898|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
2403899|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2403900|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2403901|NCT00731367|Laxatives|laxatives|mesh-ancestor
2403902|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2403903|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2531994|NCT01392014|Artenimol|artenimol|mesh-list
2531995|NCT01392014|Artemisinins|artemisinins|mesh-list
2531996|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
2531997|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2531998|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2531999|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532000|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
2532001|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2532002|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532003|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
2532004|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2532005|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
2532006|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532007|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532008|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2532009|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
2532010|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2532011|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
2532012|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532013|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532014|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2532015|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
2403904|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403905|NCT00731393|Vaccines|vaccines|mesh-list
2403906|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
2403907|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403908|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2403909|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2403910|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403911|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403912|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
2403913|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403914|NCT00731562|Varenicline|varenicline|mesh-list
2403915|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2403916|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2403917|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
2403918|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532016|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
2532017|NCT01392144|Protective Agents|protective agents|mesh-ancestor
2532018|NCT01392157|Copper|copper|mesh-list
2532019|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
2532020|NCT01392157|Trace Elements|trace elements|mesh-ancestor
2532021|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
2532022|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532023|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2532024|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
2532025|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2532026|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2532027|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2532028|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2532029|NCT01392209|Bevacizumab|bevacizumab|mesh-list
2532030|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2532031|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532032|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2532033|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2532034|NCT01392209|Growth Substances|growth substances|mesh-ancestor
2532035|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532036|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
2403919|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403920|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403921|NCT00731575|Prednisolone|prednisolone|mesh-list
2403922|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2403923|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
2532037|NCT01392287|Memantine|memantine|mesh-list
2532038|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2532039|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2532040|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
2532041|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532042|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532043|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532044|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2532045|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2532046|NCT01392430|Azithromycin|azithromycin|mesh-list
2532047|NCT01392430|Dapsone|dapsone|mesh-list
2532048|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2532049|NCT01392430|Itraconazole|itraconazole|mesh-list
2532050|NCT01392430|Fluconazole|fluconazole|mesh-list
2532051|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2532052|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532053|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
2532054|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2532055|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2532056|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532057|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532058|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2532059|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
2532060|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2532061|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532062|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2532063|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2532064|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2532065|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
2403924|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2403925|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
2403926|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2403927|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
2403928|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403929|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
2403930|NCT00731575|Hormones|hormones|mesh-ancestor
2403931|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2403932|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403933|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2403934|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403935|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
2403936|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
2403937|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2403938|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2403939|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2403940|NCT00731575|Protective Agents|protective agents|mesh-ancestor
2403941|NCT00731601|Pantoprazole|pantoprazole|mesh-list
2403942|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2403943|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2403944|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2403945|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532066|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2532067|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2532068|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2532069|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
2532070|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2532071|NCT01392430|Renal Agents|renal agents|mesh-ancestor
2532072|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2532073|NCT01392534|Telmisartan|telmisartan|mesh-list
2532074|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
2532075|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2532076|NCT01392534|Diuretics|diuretics|mesh-ancestor
2532077|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
2532078|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532079|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2532080|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2532081|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532082|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2532083|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2532084|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
2532085|NCT01392612|Hematinics|hematinics|mesh-ancestor
2532086|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
2532087|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
2532088|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2532089|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2532090|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532091|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532092|NCT01392638|Urological Agents|urological agents|mesh-ancestor
2532093|NCT01392716|Rituximab|rituximab|mesh-list
2532094|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2532095|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532096|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
2532097|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532098|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2532099|NCT01392755|Ritonavir|ritonavir|mesh-list
2532100|NCT01392755|Omeprazole|omeprazole|mesh-list
2532101|NCT01392755|Ranitidine|ranitidine|mesh-list
2532102|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2532103|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2532104|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2403946|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403947|NCT00731627|Simvastatin|simvastatin|mesh-list
2403948|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2403949|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2403950|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
2403951|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403952|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2403953|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2403954|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403955|NCT00731757|Adalimumab|adalimumab|mesh-list
2403956|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2403957|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2403958|NCT00731861|Paclitaxel|paclitaxel|mesh-list
2403959|NCT00731861|Vatalanib|vatalanib|mesh-list
2403960|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2403961|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403962|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
2403963|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
2403964|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
2403965|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403966|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2403967|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403968|NCT00731926|Vitamins|vitamins|mesh-list
2403969|NCT00731926|Ascorbic Acid|ascorbic acid|mesh-list
2403970|NCT00731926|Vitamin E|vitamin e|mesh-list
2403971|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
2403972|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403973|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
2403974|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403975|NCT00731926|Protective Agents|protective agents|mesh-ancestor
2403976|NCT00731952|Bortezomib|bortezomib|mesh-list
2403977|NCT00731952|Vorinostat|vorinostat|mesh-list
2403978|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403979|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2532105|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
2532106|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532107|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532108|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2532109|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2532110|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
2532111|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532112|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2532113|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2532114|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2532115|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2532116|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2532117|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2532118|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
2403980|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403981|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403982|NCT00731965|Vaccines|vaccines|mesh-list
2403983|NCT00731965|Immunologic Factors|immunologic factors|mesh-ancestor
2403984|NCT00731965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403985|NCT00732082|Gemcitabine|gemcitabine|mesh-list
2403986|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2403987|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
2532119|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
2532120|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2403988|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2403989|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2403990|NCT00732082|Antiviral Agents|antiviral agents|mesh-ancestor
2403991|NCT00732082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532121|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532122|NCT01392768|Levetiracetam|levetiracetam|mesh-list
2532123|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
2532124|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
2532125|NCT01392794|Ramosetron|ramosetron|mesh-list
2532126|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
2532127|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
2532128|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532129|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532130|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2532131|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2532132|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
2532133|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532134|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532135|NCT01392807|Naloxegol|naloxegol|mesh-list
2532136|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2532137|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532138|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
2532139|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532140|NCT01392833|Prednisone|prednisone|mesh-list
2532141|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
2532142|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2532143|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2532144|NCT01392833|Prednisolone|prednisolone|mesh-list
2532145|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
2532146|NCT01392833|Azathioprine|azathioprine|mesh-list
2532147|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2532148|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
2532149|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2532150|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
2532151|NCT01392833|Hormones|hormones|mesh-ancestor
2532152|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2532153|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532154|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2532155|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532156|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
2532157|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
2532158|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532159|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2532160|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2532161|NCT01392833|Protective Agents|protective agents|mesh-ancestor
2532162|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
2532163|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532164|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2403992|NCT00732082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2403993|NCT00732082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2403994|NCT00732082|Immunologic Factors|immunologic factors|mesh-ancestor
2403995|NCT00732082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2403996|NCT00732108|Topiramate|topiramate|mesh-list
2403997|NCT00732108|Lactulose|lactulose|mesh-list
2403998|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
2403999|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2404000|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404001|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2404002|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2404003|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2404004|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404005|NCT00732121|Incretins|incretins|mesh-ancestor
2404006|NCT00732121|Hormones|hormones|mesh-ancestor
2404007|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2404008|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2404009|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
2404010|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404011|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404012|NCT00732147|Pramlintide|pramlintide|mesh-list
2404013|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2404014|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404015|NCT00732186|Ipilimumab|ipilimumab|mesh-list
2404016|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2404017|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404018|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2532165|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2532166|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
2532167|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2532168|NCT01392898|Liraglutide|liraglutide|mesh-list
2532169|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2532170|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532171|NCT01392898|Incretins|incretins|mesh-ancestor
2532172|NCT01392898|Hormones|hormones|mesh-ancestor
2532173|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2532174|NCT01392911|Rifampin|rifampin|mesh-list
2532175|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2532176|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
2532177|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2532178|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532179|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
2532180|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2532181|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532182|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532183|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2532184|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2532185|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2532186|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2532187|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2532188|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2532189|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
2532190|NCT01393080|Cisplatin|cisplatin|mesh-list
2532191|NCT01393080|Paclitaxel|paclitaxel|mesh-list
2532192|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2532193|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532194|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2532195|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
2532196|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
2532197|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
2532198|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532199|NCT01393145|Fluticasone|fluticasone|mesh-list
2532200|NCT01393145|Xhance|xhance|mesh-list
2532201|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
2532202|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2532203|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2532204|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2532205|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2532206|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
2532207|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532208|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532209|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2532210|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
2532211|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
2532212|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2532213|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2532214|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2532215|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2532216|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
2532217|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532218|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532219|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
2532220|NCT01393145|Hormones|hormones|mesh-ancestor
2532221|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2532222|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
2532223|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
2532224|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2532225|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532226|NCT01393288|Lorazepam|lorazepam|mesh-list
2532227|NCT01393288|Ondansetron|ondansetron|mesh-list
2532228|NCT01393288|Aprepitant|aprepitant|mesh-list
2532229|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
2532230|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
2532231|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532232|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532233|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2532234|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
2532235|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
2532236|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2532237|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
2532238|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532239|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532240|NCT01393288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2532241|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2532242|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2532243|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2532244|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2532245|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2532246|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
2532247|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2532248|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
2532249|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
2532250|NCT01393340|Omalizumab|omalizumab|mesh-list
2532251|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2532252|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2532253|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
2532254|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
2532255|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532256|NCT01393522|Milnacipran|milnacipran|mesh-list
2532257|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
2532258|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2532259|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2532260|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2532261|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532262|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532263|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532264|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2532265|NCT01393522|Analgesics|analgesics|mesh-ancestor
2404019|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404020|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
2404021|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2404022|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2404023|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2404024|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404025|NCT00732290|Fluoxetine|fluoxetine|mesh-list
2404026|NCT00732290|Clopidogrel|clopidogrel|mesh-list
2404027|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2404028|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2404029|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2404030|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2404031|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
2404032|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404033|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404034|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404035|NCT00732290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2404036|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2404037|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2404038|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
2404039|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2404040|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
2404041|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2532266|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
2532267|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532268|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
2532269|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2532270|NCT01393548|Brompheniramine|brompheniramine|mesh-list
2532271|NCT01393548|Phenylephrine|phenylephrine|mesh-list
2532272|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
2532273|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
2532274|NCT01393548|Ephedrine|ephedrine|mesh-list
2532275|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2532276|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
2532277|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
2532278|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532279|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532280|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
2532281|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2532282|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
2532283|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
2532284|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2532285|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2532286|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2532287|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
2532288|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532289|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532290|NCT01393548|Protective Agents|protective agents|mesh-ancestor
2532291|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2532292|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2532293|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2532294|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2532295|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
2532296|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
2532297|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2532298|NCT01393574|Melatonin|melatonin|mesh-list
2532299|NCT01393574|Methylphenidate|methylphenidate|mesh-list
2532300|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2532301|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532302|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2532303|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2404042|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2404043|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2404044|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404045|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
2404046|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404047|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
2404048|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2404049|NCT00732407|Losartan|losartan|mesh-list
2404050|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2404051|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2404052|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2404053|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2404054|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404055|NCT00732420|Topotecan|topotecan|mesh-list
2404056|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2404057|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2404058|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404059|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404060|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404061|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
2404062|NCT00732446|Dexamethasone|dexamethasone|mesh-list
2404063|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
2404064|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2532304|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2532305|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532306|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
2532307|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532308|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
2532309|NCT01393574|Protective Agents|protective agents|mesh-ancestor
2532310|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2532311|NCT01393639|Prednisone|prednisone|mesh-list
2532312|NCT01393639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2532313|NCT01393639|Glucocorticoids|glucocorticoids|mesh-ancestor
2532314|NCT01393639|Hormones|hormones|mesh-ancestor
2532315|NCT01393639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2532316|NCT01393639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404065|NCT00732446|BB 1101|bb 1101|mesh-list
2404066|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404067|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
2404068|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
2404069|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404070|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404071|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2404072|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
2404073|NCT00732446|Hormones|hormones|mesh-ancestor
2404074|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2404075|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2404076|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404077|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
2404078|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404079|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404080|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2404081|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2404082|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2404083|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2404084|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2404085|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
2404086|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2404087|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2404088|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2532317|NCT01393639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2532318|NCT01393639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532319|NCT01393756|Lenalidomide|lenalidomide|mesh-list
2532320|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
2532321|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532322|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2532323|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2532324|NCT01393756|Growth Substances|growth substances|mesh-ancestor
2532325|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
2532326|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532327|NCT01393769|Melphalan|melphalan|mesh-list
2532328|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2532329|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
2532330|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532331|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532332|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2532333|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2532334|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
2532335|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532336|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
2532337|NCT01393782|Giapreza|giapreza|mesh-list
2532338|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
2532339|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2532340|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2532341|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
2532342|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532343|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532344|NCT01393795|Capsaicin|capsaicin|mesh-list
2532345|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
2532346|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
2532347|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
2532348|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532349|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532350|NCT01393912|Crenolanib|crenolanib|mesh-list
2532351|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532352|NCT01393925|Parecoxib|parecoxib|mesh-list
2532353|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2532354|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2532355|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532356|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532357|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2532358|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2532359|NCT01393925|Analgesics|analgesics|mesh-ancestor
2532360|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
2532361|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532362|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532363|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2532364|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2532365|NCT01394016|Fulvestrant|fulvestrant|mesh-list
2532366|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2532367|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532368|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2532369|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2532370|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
2532371|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2532372|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532373|NCT01394029|Deferasirox|deferasirox|mesh-list
2532374|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2532375|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
2532376|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
2404089|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2404090|NCT00732485|Fenofibrate|fenofibrate|mesh-list
2404091|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2404092|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
2404093|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404094|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2404095|NCT00732511|Metoprolol|metoprolol|mesh-list
2404096|NCT00732511|Carvedilol|carvedilol|mesh-list
2404097|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2404098|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2404099|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
2404100|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
2532377|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532378|NCT01394094|Calcium|calcium|mesh-list
2532379|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2404101|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532380|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532381|NCT01394133|Ritonavir|ritonavir|mesh-list
2532382|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2532383|NCT01394133|Tenofovir|tenofovir|mesh-list
2532384|NCT01394133|Emtricitabine|emtricitabine|mesh-list
2532385|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2532386|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2532387|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
2532388|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404102|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404103|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2404104|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2404105|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2404106|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
2404107|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404108|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404109|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
2404110|NCT00732511|Protective Agents|protective agents|mesh-ancestor
2404111|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2404112|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2404113|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2532389|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532390|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2532391|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2532392|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
2532393|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532394|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2532395|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2532396|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2532397|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2532398|NCT01394224|Levetiracetam|levetiracetam|mesh-list
2532399|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
2532400|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
2532401|NCT01394263|Goserelin|goserelin|mesh-list
2532402|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2532403|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532404|NCT01394341|Liraglutide|liraglutide|mesh-list
2532405|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2532406|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532407|NCT01394341|Incretins|incretins|mesh-ancestor
2532408|NCT01394341|Hormones|hormones|mesh-ancestor
2532409|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2532410|NCT01394354|Dexamethasone|dexamethasone|mesh-list
2532411|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
2532412|NCT01394354|Doxorubicin|doxorubicin|mesh-list
2532413|NCT01394354|Bortezomib|bortezomib|mesh-list
2532414|NCT01394354|Vorinostat|vorinostat|mesh-list
2532415|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2532416|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
2532417|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
2532418|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532419|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532420|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2532421|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
2532422|NCT01394354|Hormones|hormones|mesh-ancestor
2532423|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2532424|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2532425|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532426|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2532427|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2532428|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2532429|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532430|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532431|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2532432|NCT01394406|Ketamine|ketamine|mesh-list
2532433|NCT01394406|Analgesics|analgesics|mesh-ancestor
2532434|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
2532435|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532436|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532437|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2532438|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2404114|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
2404115|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2404116|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2532439|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
2532440|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
2532441|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2532442|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2532443|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2532444|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532445|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532446|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
2532447|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2532448|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
2532449|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532450|NCT01394419|Expectorants|expectorants|mesh-ancestor
2532451|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
2532452|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2532453|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
2532454|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532455|NCT01394419|Protective Agents|protective agents|mesh-ancestor
2532456|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532457|NCT01394419|Antidotes|antidotes|mesh-ancestor
2532458|NCT01394445|Physostigmine|physostigmine|mesh-list
2532459|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2532460|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532461|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532462|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
2532463|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532464|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532465|NCT01394445|Miotics|miotics|mesh-ancestor
2532466|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
2532467|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532468|NCT01394458|Ethanol|ethanol|mesh-list
2532469|NCT01394458|Heparin|heparin|mesh-list
2532470|NCT01394458|Citric Acid|citric acid|mesh-list
2532471|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
2532472|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
2532473|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2532474|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
2532475|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
2532476|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532477|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2532478|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2532479|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2532480|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532481|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2532482|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532483|NCT01394471|Oxytocin|oxytocin|mesh-list
2404117|NCT00732524|Glipizide|glipizide|mesh-list
2404118|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2404119|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404120|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
2404121|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2404122|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
2404123|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404124|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404125|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2404126|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
2404127|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2532484|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
2532485|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2532486|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532487|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
2532488|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
2532489|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532490|NCT01394497|Expectorants|expectorants|mesh-ancestor
2532491|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
2532492|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2532493|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
2532494|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532495|NCT01394497|Protective Agents|protective agents|mesh-ancestor
2532496|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532497|NCT01394640|Vaccines|vaccines|mesh-list
2404128|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
2404129|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404130|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404131|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2404132|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
2532498|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
2532499|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404133|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
2404134|NCT00732537|Protective Agents|protective agents|mesh-ancestor
2404135|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2404136|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2404137|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404138|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
2532500|NCT01394653|Ramosetron|ramosetron|mesh-list
2532501|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
2532502|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
2532503|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532504|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532505|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2532506|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2532507|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
2532508|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532509|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532510|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
2532511|NCT01394679|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2532512|NCT01394679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2532513|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532514|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
2532515|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
2532516|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532517|NCT01394731|Acetaminophen|acetaminophen|mesh-list
2532518|NCT01394731|Meperidine|meperidine|mesh-list
2532519|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2532520|NCT01394731|Analgesics|analgesics|mesh-ancestor
2532521|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
2404139|NCT00732576|Vitamin K|vitamin k|mesh-list
2404140|NCT00732576|Vitamin MK 7|vitamin mk 7|mesh-list
2404141|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2404142|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2404143|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404144|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
2404145|NCT00732576|Coagulants|coagulants|mesh-ancestor
2404146|NCT00732576|Vitamins|vitamins|mesh-ancestor
2404147|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
2404148|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404149|NCT00732589|Lidocaine|lidocaine|mesh-list
2404150|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
2404151|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
2404152|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2532522|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532523|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532524|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
2532525|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2532526|NCT01394731|Narcotics|narcotics|mesh-ancestor
2532527|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2532528|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2532529|NCT01394757|Ketamine|ketamine|mesh-list
2532530|NCT01394757|Esketamine|esketamine|mesh-list
2404153|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404154|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
2404155|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404156|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2404157|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2404158|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2404159|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2404160|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404161|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2404162|NCT00732693|Norethindrone|norethindrone|mesh-list
2404163|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
2404164|NCT00732693|Estradiol|estradiol|mesh-list
2404165|NCT00732693|Progesterone|progesterone|mesh-list
2532531|NCT01394757|Analgesics|analgesics|mesh-ancestor
2532532|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
2532533|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532534|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532535|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2404166|NCT00732693|Estrogens|estrogens|mesh-ancestor
2404167|NCT00732693|Hormones|hormones|mesh-ancestor
2404168|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2404169|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404170|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2532536|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2532537|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
2532538|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
2404171|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
2404172|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2404173|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2404174|NCT00732693|Progestins|progestins|mesh-ancestor
2404175|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2404176|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2404177|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2404178|NCT00732745|Docetaxel|docetaxel|mesh-list
2404179|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
2404180|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404181|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
2404182|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
2404183|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
2404184|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404185|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
2404186|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
2404187|NCT00732784|Calcium|calcium|mesh-list
2404188|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2404189|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404190|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532539|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2532540|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2532541|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2532542|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532543|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532544|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
2532545|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2532546|NCT01394770|Amlodipine|amlodipine|mesh-list
2532547|NCT01394770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2532548|NCT01394770|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2532549|NCT01394770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2532550|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532551|NCT01394770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2532552|NCT01394770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532553|NCT01394770|Vasodilator Agents|vasodilator agents|mesh-ancestor
2532554|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2532555|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
2532556|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532557|NCT01394796|Protective Agents|protective agents|mesh-ancestor
2532558|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404191|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2404192|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404193|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404194|NCT00732784|Antacids|antacids|mesh-ancestor
2404195|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2404196|NCT00732810|Capecitabine|capecitabine|mesh-list
2404197|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2404198|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2404199|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
2404200|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532559|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2532560|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2532561|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532562|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2532563|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2532564|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
2532565|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2532566|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2532567|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
2532568|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532569|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532570|NCT01394848|Everolimus|everolimus|mesh-list
2532571|NCT01394848|Clopidogrel|clopidogrel|mesh-list
2532572|NCT01394848|Atorvastatin|atorvastatin|mesh-list
2532573|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2532574|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2532575|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
2532576|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532577|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2532578|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2532579|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532580|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404201|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532581|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2532582|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
2532583|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404202|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2404203|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404204|NCT00732836|Paclitaxel|paclitaxel|mesh-list
2404205|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2404206|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2404207|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404208|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
2404209|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
2404210|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
2404211|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404212|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
2404213|NCT00732888|Calcium|calcium|mesh-list
2404214|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2404215|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404216|NCT00732888|Antacids|antacids|mesh-ancestor
2404217|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404218|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2404219|NCT00732914|Sorafenib|sorafenib|mesh-list
2404220|NCT00732914|Sunitinib|sunitinib|mesh-list
2404221|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404222|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2404223|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404224|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404225|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2404226|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2404227|NCT00732914|Growth Substances|growth substances|mesh-ancestor
2404228|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404229|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
2404230|NCT00732927|Aspirin|aspirin|mesh-list
2404231|NCT00732927|Parnaparin|parnaparin|mesh-list
2404232|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2404233|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2404234|NCT00732927|Analgesics|analgesics|mesh-ancestor
2404235|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
2404236|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404237|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404238|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404239|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2404240|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2404241|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2404242|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404243|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2404244|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2404245|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404246|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
2404247|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
2404248|NCT00732953|Paclitaxel|paclitaxel|mesh-list
2404249|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2404250|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404251|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
2404252|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
2404253|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
2404254|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404255|NCT00732966|Losartan|losartan|mesh-list
2404256|NCT00732966|Valsartan|valsartan|mesh-list
2404257|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2404258|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2404259|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2532584|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2532585|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2532586|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2532587|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2532588|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
2532589|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532590|NCT01394887|Metformin|metformin|mesh-list
2532591|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2532592|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532593|NCT01394913|Etanercept|etanercept|mesh-list
2532594|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2532595|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2532596|NCT01394913|Analgesics|analgesics|mesh-ancestor
2532597|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
2532598|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532599|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532600|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2532601|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2532602|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2532603|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2532604|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
2532605|NCT01395069|Ketorolac|ketorolac|mesh-list
2532606|NCT01395069|Nepafenac|nepafenac|mesh-list
2532607|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2532608|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2532609|NCT01395069|Analgesics|analgesics|mesh-ancestor
2532610|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
2532611|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532612|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532613|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2532614|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2532615|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2532616|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532617|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532618|NCT01395147|Vortioxetine|vortioxetine|mesh-list
2532619|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
2532620|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2532621|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2532622|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2532623|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2532624|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532625|NCT01395147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2532626|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2532627|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2404260|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404261|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2404262|NCT00733031|Gemcitabine|gemcitabine|mesh-list
2532628|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532629|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532630|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
2532631|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2532632|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2532633|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2532634|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2532635|NCT01395199|Amlodipine|amlodipine|mesh-list
2532636|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2532637|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2532638|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2532639|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532640|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2532641|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532642|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
2532643|NCT01395251|Prednisolone|prednisolone|mesh-list
2532644|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
2532645|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2532646|NCT01395251|Hormones|hormones|mesh-ancestor
2532647|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2532648|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532649|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2532650|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532651|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
2532652|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2532653|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532654|NCT01395290|Vitamins|vitamins|mesh-ancestor
2532655|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
2532656|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2532657|NCT01395381|Albendazole|albendazole|mesh-list
2532658|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
2532659|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2532660|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532661|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
2532662|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2532663|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2404263|NCT00733031|Pemetrexed|pemetrexed|mesh-list
2404264|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2404265|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
2404266|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404267|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404268|NCT00733031|Antiviral Agents|antiviral agents|mesh-ancestor
2404269|NCT00733031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2404270|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404271|NCT00733031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2404272|NCT00733031|Immunologic Factors|immunologic factors|mesh-ancestor
2404273|NCT00733031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404274|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2532664|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
2532665|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
2532666|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
2532667|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532668|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532669|NCT01395420|Ceftazidime|ceftazidime|mesh-list
2532670|NCT01395420|Avibactam|avibactam|mesh-list
2532671|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2404275|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2404276|NCT00733057|Minocycline|minocycline|mesh-list
2404277|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2404278|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2404279|NCT00733083|Dexamethasone|dexamethasone|mesh-list
2404280|NCT00733083|Morphine|morphine|mesh-list
2404281|NCT00733083|Oxycodone|oxycodone|mesh-list
2404282|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404283|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
2532672|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532673|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2532674|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532675|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532676|NCT01395433|Dexetimide|dexetimide|mesh-list
2532677|NCT01395433|Citalopram|citalopram|mesh-list
2532678|NCT01395433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2532679|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2532680|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2532681|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532682|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532683|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
2532684|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532685|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2532686|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
2532687|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2532688|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2532689|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2532690|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
2532691|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
2532692|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532693|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2532694|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2532695|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
2532696|NCT01395485|Brodalumab|brodalumab|mesh-list
2532697|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
2532698|NCT01395589|Vitamin D|vitamin d|mesh-list
2532699|NCT01395589|Vitamins|vitamins|mesh-ancestor
2532700|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
2532701|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532702|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2532703|NCT01395602|Cabergoline|cabergoline|mesh-list
2404284|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
2404285|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404286|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404287|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2404288|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
2404289|NCT00733083|Hormones|hormones|mesh-ancestor
2404290|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2404291|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2404292|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404293|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2404294|NCT00733083|Narcotics|narcotics|mesh-ancestor
2404295|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2404296|NCT00733083|Analgesics|analgesics|mesh-ancestor
2404297|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
2404298|NCT00733148|Insulin|insulin|mesh-list
2404299|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2404300|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404301|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
2404302|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2532704|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2404303|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532705|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2532706|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
2532707|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
2532708|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532709|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532710|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532711|NCT01395654|Rifampin|rifampin|mesh-list
2532712|NCT01395654|Isoniazid|isoniazid|mesh-list
2532713|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
2532714|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2532715|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
2532716|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2532717|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532718|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
2532719|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2532720|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532721|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532722|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2532723|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2532724|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2532725|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2532726|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2532727|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2532728|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2532729|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2532730|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
2532731|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2532732|NCT01395667|Leucovorin|leucovorin|mesh-list
2532733|NCT01395667|Fluorouracil|fluorouracil|mesh-list
2532734|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
2532735|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532736|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532737|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
2404304|NCT00733239|Cycloserine|cycloserine|mesh-list
2404305|NCT00733239|Verapamil|verapamil|mesh-list
2404306|NCT00733239|Diltiazem|diltiazem|mesh-list
2404307|NCT00733239|Isradipine|isradipine|mesh-list
2404308|NCT00733239|Nifedipine|nifedipine|mesh-list
2404309|NCT00733239|Gabapentin|gabapentin|mesh-list
2404310|NCT00733239|Naloxone|naloxone|mesh-list
2404311|NCT00733239|Analgesics|analgesics|mesh-ancestor
2404312|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
2404313|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404314|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404315|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
2532738|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532739|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2532740|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2532741|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
2532742|NCT01395667|Antidotes|antidotes|mesh-ancestor
2532743|NCT01395667|Protective Agents|protective agents|mesh-ancestor
2532744|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
2532745|NCT01395667|Vitamins|vitamins|mesh-ancestor
2532746|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
2532747|NCT01395732|Bosentan|bosentan|mesh-list
2532748|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2532749|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2532750|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532751|NCT01395849|Fluticasone|fluticasone|mesh-list
2532752|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2532753|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2532754|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2532755|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2532756|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
2532757|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532758|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532759|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2532760|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
2532761|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
2532762|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2532763|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2532764|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2404316|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2404317|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2404318|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2404319|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2404320|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2404321|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2404322|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404323|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404324|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
2404325|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2404326|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2404327|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2532765|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2532766|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
2532767|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532768|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532769|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
2532770|NCT01395849|Hormones|hormones|mesh-ancestor
2532771|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2532772|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
2532773|NCT01395862|Fluticasone|fluticasone|mesh-list
2532774|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2532775|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2532776|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2532777|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2404328|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2404329|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
2404330|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
2404331|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2404332|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2404333|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2404334|NCT00733239|Renal Agents|renal agents|mesh-ancestor
2404335|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2404336|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
2404337|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2404338|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
2404339|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2404340|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2404341|NCT00733265|Ticagrelor|ticagrelor|mesh-list
2404342|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2404343|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2404344|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2404345|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2404346|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
2404347|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404348|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404349|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404350|NCT00733317|Budesonide|budesonide|mesh-list
2404351|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404352|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2404353|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
2404354|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404355|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404356|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2404357|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
2404358|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
2404359|NCT00733317|Hormones|hormones|mesh-ancestor
2404360|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2404361|NCT00733434|Alprostadil|alprostadil|mesh-list
2532778|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
2532779|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532780|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532781|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2532782|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
2532783|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
2532784|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2532785|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2532786|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2532787|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2532788|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
2532789|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532790|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532791|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
2532792|NCT01395862|Hormones|hormones|mesh-ancestor
2532793|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2532794|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
2532795|NCT01395875|Fluticasone|fluticasone|mesh-list
2532796|NCT01395875|Xhance|xhance|mesh-list
2532797|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2532798|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2532799|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2532800|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2532801|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
2532802|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532803|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532804|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2532805|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
2532806|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
2532807|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2532808|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2532809|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2532810|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2532811|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
2532812|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532813|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532814|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
2532815|NCT01395927|Canagliflozin|canagliflozin|mesh-list
2532816|NCT01395927|Rifampin|rifampin|mesh-list
2532817|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2532818|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
2532819|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2532820|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532821|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
2532822|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2532823|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532824|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532825|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2532826|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2532827|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2532828|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2532829|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2532830|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2532831|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2532832|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2532833|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532834|NCT01395953|Buspirone|buspirone|mesh-list
2532835|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2532836|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2532837|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2532838|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532839|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2532840|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2532841|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
2532842|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532843|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532844|NCT01395992|Asenapine|asenapine|mesh-list
2404362|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2404363|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
2404364|NCT00733434|Urological Agents|urological agents|mesh-ancestor
2404365|NCT00733473|Budesonide|budesonide|mesh-list
2404366|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404367|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2404368|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
2404369|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404370|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404371|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2404372|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
2404373|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
2404374|NCT00733473|Hormones|hormones|mesh-ancestor
2404375|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2404376|NCT00733525|Fluoxetine|fluoxetine|mesh-list
2532845|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2532846|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2532847|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2532848|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532849|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2532850|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
2532851|NCT01396200|Sirolimus|sirolimus|mesh-list
2404377|NCT00733525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2404378|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2404379|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2404380|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404381|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404382|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
2404383|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404384|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2404385|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
2404386|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2404387|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2404388|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2404389|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404390|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
2532852|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
2532853|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2532854|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2532855|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532856|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404391|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2404392|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404393|NCT00733564|Lidocaine|lidocaine|mesh-list
2404394|NCT00733564|Propofol|propofol|mesh-list
2404395|NCT00733564|Sevoflurane|sevoflurane|mesh-list
2404396|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
2404397|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
2404398|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2404399|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404400|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
2404401|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404402|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2404403|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2404404|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2404405|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2404406|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404407|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2404408|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2404409|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
2404410|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2404411|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2404412|NCT00733616|Docetaxel|docetaxel|mesh-list
2404413|NCT00733616|Capecitabine|capecitabine|mesh-list
2404414|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
2404415|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404416|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
2404417|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
2532857|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532858|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2532859|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2532860|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2532861|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532862|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
2532863|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2532864|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
2532865|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532866|NCT01396278|Fluticasone|fluticasone|mesh-list
2532867|NCT01396278|Xhance|xhance|mesh-list
2532868|NCT01396278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2532869|NCT01396278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2532870|NCT01396278|Autonomic Agents|autonomic agents|mesh-ancestor
2404418|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
2404419|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404420|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2404421|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
2404422|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2404423|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
2404424|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2404425|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2404426|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2404427|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2404428|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404429|NCT00733720|Naltrexone|naltrexone|mesh-list
2404430|NCT00733720|Buprenorphine|buprenorphine|mesh-list
2404431|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2404432|NCT00733720|Naloxone|naloxone|mesh-list
2404433|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2532871|NCT01396278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532872|NCT01396278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532873|NCT01396278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2532874|NCT01396278|Respiratory System Agents|respiratory system agents|mesh-ancestor
2532875|NCT01396278|Dermatologic Agents|dermatologic agents|mesh-ancestor
2532876|NCT01396278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2532877|NCT01396291|Asenapine|asenapine|mesh-list
2532878|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2532879|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2532880|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2532881|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532882|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2532883|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2532884|NCT01396304|Calcium|calcium|mesh-list
2532885|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2532886|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532887|NCT01396304|Laxatives|laxatives|mesh-ancestor
2532888|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2532889|NCT01396408|Sirolimus|sirolimus|mesh-list
2532890|NCT01396408|Sunitinib|sunitinib|mesh-list
2532891|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532892|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2532893|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2404434|NCT00733720|Narcotics|narcotics|mesh-ancestor
2404435|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2404436|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404437|NCT00733720|Analgesics|analgesics|mesh-ancestor
2404438|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
2404439|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404440|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2404441|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2404442|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
2404443|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2404444|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404445|NCT00733811|Deferiprone|deferiprone|mesh-list
2404446|NCT00733811|Deferoxamine|deferoxamine|mesh-list
2404447|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2404448|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
2404449|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
2404450|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404451|NCT00733811|Siderophores|siderophores|mesh-ancestor
2404452|NCT00733850|Gemcitabine|gemcitabine|mesh-list
2404453|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2404454|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
2404455|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404456|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404457|NCT00733850|Antiviral Agents|antiviral agents|mesh-ancestor
2404458|NCT00733850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2404459|NCT00733850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404460|NCT00733850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2404461|NCT00733850|Immunologic Factors|immunologic factors|mesh-ancestor
2404462|NCT00733850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404463|NCT00733889|Docetaxel|docetaxel|mesh-list
2404464|NCT00733889|Fluorouracil|fluorouracil|mesh-list
2404465|NCT00733889|Cetuximab|cetuximab|mesh-list
2404466|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404467|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
2404468|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
2404469|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
2404470|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404471|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
2404472|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2404473|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2404474|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
2404475|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404476|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2404477|NCT00733967|Varenicline|varenicline|mesh-list
2404478|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2404479|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2404480|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
2404481|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532894|NCT01396408|Growth Substances|growth substances|mesh-ancestor
2532895|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532896|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
2532897|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2404482|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404483|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404484|NCT00734123|Aspirin|aspirin|mesh-list
2404485|NCT00734123|Rimonabant|rimonabant|mesh-list
2532898|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532899|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532900|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2532901|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532902|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2532903|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
2532904|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2532905|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
2532906|NCT01396564|Metformin|metformin|mesh-list
2532907|NCT01396564|Pioglitazone|pioglitazone|mesh-list
2532908|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2532909|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532910|NCT01396642|Emollients|emollients|mesh-list
2532911|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
2532912|NCT01396655|Docetaxel|docetaxel|mesh-list
2532913|NCT01396655|Doxorubicin|doxorubicin|mesh-list
2532914|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532915|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
2532916|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
2532917|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
2532918|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532919|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2532920|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2532921|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2532922|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532923|NCT01396668|Gemcitabine|gemcitabine|mesh-list
2532924|NCT01396668|Capecitabine|capecitabine|mesh-list
2532925|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532926|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2532927|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
2532928|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532929|NCT01396668|Antiviral Agents|antiviral agents|mesh-ancestor
2532930|NCT01396668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2404486|NCT00734123|Enalapril|enalapril|mesh-list
2404487|NCT00734123|Clopidogrel|clopidogrel|mesh-list
2404488|NCT00734123|Atorvastatin|atorvastatin|mesh-list
2404489|NCT00734123|Simvastatin|simvastatin|mesh-list
2404490|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2404491|NCT00734123|Diuretics|diuretics|mesh-list
2404492|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2404493|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2404494|NCT00734123|Analgesics|analgesics|mesh-ancestor
2404495|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
2532931|NCT01396668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532932|NCT01396668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2532933|NCT01396668|Immunologic Factors|immunologic factors|mesh-ancestor
2532934|NCT01396668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532935|NCT01396681|Gemcitabine|gemcitabine|mesh-list
2532936|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532937|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2532938|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
2532939|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532940|NCT01396681|Antiviral Agents|antiviral agents|mesh-ancestor
2532941|NCT01396681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2532942|NCT01396681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532943|NCT01396681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2404496|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404497|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404498|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404499|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2404500|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2404501|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2404502|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404503|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2404504|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2404505|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404506|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
2532944|NCT01396681|Immunologic Factors|immunologic factors|mesh-ancestor
2532945|NCT01396681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532946|NCT01396707|Capecitabine|capecitabine|mesh-list
2532947|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
2532948|NCT01396707|Trastuzumab|trastuzumab|mesh-list
2532949|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2532950|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
2404507|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2532951|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532952|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2532953|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2532954|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
2404508|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2404509|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
2404510|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2404511|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2404512|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2404513|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2404514|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2404515|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
2404516|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404517|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
2404518|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2532955|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2532956|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2532957|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2532958|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532959|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2532960|NCT01396720|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2532961|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2532962|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2532963|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532964|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2532965|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
2532966|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2532967|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
2532968|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2532969|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2532970|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2532971|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2532972|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
2532973|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
2532974|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532975|NCT01396733|Protective Agents|protective agents|mesh-ancestor
2532976|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2532977|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
2532978|NCT01396733|Vitamins|vitamins|mesh-ancestor
2532979|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
2532980|NCT01397006|Pregabalin|pregabalin|mesh-list
2532981|NCT01397006|Analgesics|analgesics|mesh-ancestor
2532982|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
2532983|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2532984|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404519|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
2404520|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2404521|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2404522|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2404523|NCT00734123|Hormones|hormones|mesh-ancestor
2404524|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2404525|NCT00734253|Pyridoxamine|pyridoxamine|mesh-list
2404526|NCT00734253|Vitamin B Complex|vitamin b complex|mesh-ancestor
2404527|NCT00734253|Vitamins|vitamins|mesh-ancestor
2404528|NCT00734253|Micronutrients|micronutrients|mesh-ancestor
2404529|NCT00734253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404530|NCT00734279|Leuprolide|leuprolide|mesh-list
2404531|NCT00734279|Ganirelix|ganirelix|mesh-list
2404532|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2404533|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
2404534|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2532985|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
2532986|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2532987|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2532988|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2532989|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2532990|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2404535|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404536|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2404537|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404538|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
2404539|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2532991|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2532992|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2532993|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2532994|NCT01397019|Leucovorin|leucovorin|mesh-list
2532995|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
2532996|NCT01397019|Irinotecan|irinotecan|mesh-list
2532997|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404540|NCT00734292|Fluticasone|fluticasone|mesh-list
2404541|NCT00734292|Xhance|xhance|mesh-list
2404542|NCT00734292|Formoterol Fumarate|formoterol fumarate|mesh-list
2404543|NCT00734292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404544|NCT00734292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2404545|NCT00734292|Autonomic Agents|autonomic agents|mesh-ancestor
2404546|NCT00734292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404547|NCT00734292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404548|NCT00734292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2404549|NCT00734292|Respiratory System Agents|respiratory system agents|mesh-ancestor
2404550|NCT00734292|Dermatologic Agents|dermatologic agents|mesh-ancestor
2404551|NCT00734292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2532998|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2532999|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2533000|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533001|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533002|NCT01397019|Antidotes|antidotes|mesh-ancestor
2404552|NCT00734292|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2404553|NCT00734292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2404554|NCT00734292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2404555|NCT00734292|Adrenergic Agents|adrenergic agents|mesh-ancestor
2404556|NCT00734292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404557|NCT00734292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404558|NCT00734318|Fluticasone|fluticasone|mesh-list
2404559|NCT00734318|Xhance|xhance|mesh-list
2404560|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
2533003|NCT01397019|Protective Agents|protective agents|mesh-ancestor
2533004|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533005|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
2533006|NCT01397019|Vitamins|vitamins|mesh-ancestor
2533007|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
2533008|NCT01397097|Etonogestrel|etonogestrel|mesh-list
2533009|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2533010|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
2533011|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2533012|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533013|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2533014|NCT01397162|Fluticasone|fluticasone|mesh-list
2533015|NCT01397162|Xhance|xhance|mesh-list
2533016|NCT01397162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2533017|NCT01397162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2533018|NCT01397162|Autonomic Agents|autonomic agents|mesh-ancestor
2533019|NCT01397162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533020|NCT01397162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533021|NCT01397162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2533022|NCT01397162|Respiratory System Agents|respiratory system agents|mesh-ancestor
2533023|NCT01397162|Dermatologic Agents|dermatologic agents|mesh-ancestor
2533024|NCT01397162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2533025|NCT01397175|Everolimus|everolimus|mesh-list
2533026|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533027|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2533028|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
2533029|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533030|NCT01397201|Fluticasone|fluticasone|mesh-list
2533031|NCT01397201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404561|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2404562|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
2404563|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404564|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404565|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2404566|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
2404567|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2404568|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2404569|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2404570|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
2404571|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404572|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404573|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404574|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
2404575|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2533032|NCT01397201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2533033|NCT01397201|Autonomic Agents|autonomic agents|mesh-ancestor
2533034|NCT01397201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533035|NCT01397201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533036|NCT01397201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2533037|NCT01397201|Respiratory System Agents|respiratory system agents|mesh-ancestor
2533038|NCT01397201|Dermatologic Agents|dermatologic agents|mesh-ancestor
2533039|NCT01397201|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2533040|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
2533041|NCT01397214|Megestrol|megestrol|mesh-list
2533042|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2533043|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533044|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
2533045|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2533046|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533047|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2533048|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2533049|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2533050|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
2533051|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2533052|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2533053|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2533054|NCT01397305|Pemetrexed|pemetrexed|mesh-list
2533055|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533056|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533057|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533058|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2533059|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2533060|NCT01397331|Propofol|propofol|mesh-list
2533061|NCT01397331|Isoflurane|isoflurane|mesh-list
2533062|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2533063|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2533064|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533065|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2533066|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
2533067|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
2533068|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2533069|NCT01397500|Testosterone|testosterone|mesh-list
2533070|NCT01397500|Androgens|androgens|mesh-ancestor
2533071|NCT01397500|Hormones|hormones|mesh-ancestor
2533072|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2533073|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533074|NCT01397513|Aspirin|aspirin|mesh-list
2533075|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2533076|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2533077|NCT01397513|Analgesics|analgesics|mesh-ancestor
2533078|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
2533079|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533080|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533081|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404576|NCT00734383|Propofol|propofol|mesh-list
2404577|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2404578|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2404579|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404580|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2404581|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
2404582|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
2533082|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2533083|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2533084|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2533085|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533086|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2533087|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2533088|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533089|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
2533090|NCT01397578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2533091|NCT01397578|Immunologic Factors|immunologic factors|mesh-ancestor
2533092|NCT01397578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533093|NCT01397630|Oxytocin|oxytocin|mesh-list
2533094|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
2533095|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2533096|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533097|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
2533098|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533099|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
2404583|NCT00734435|Zonisamide|zonisamide|mesh-list
2533100|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533101|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533102|NCT01397968|Cenobamate|cenobamate|mesh-list
2404584|NCT00734435|Olanzapine|olanzapine|mesh-list
2404585|NCT00734435|Antiemetics|antiemetics|mesh-ancestor
2404586|NCT00734435|Autonomic Agents|autonomic agents|mesh-ancestor
2404587|NCT00734435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404588|NCT00734435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404589|NCT00734435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2404590|NCT00734435|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2404591|NCT00734435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2404592|NCT00734435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2404593|NCT00734435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2404594|NCT00734435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2404595|NCT00734435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2404596|NCT00734435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2404597|NCT00734435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404598|NCT00734435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404599|NCT00734435|Serotonin Agents|serotonin agents|mesh-ancestor
2533103|NCT01397968|Anticonvulsants|anticonvulsants|mesh-ancestor
2533104|NCT01397994|Nicorandil|nicorandil|mesh-list
2533105|NCT01397994|Atenolol|atenolol|mesh-list
2533106|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2533107|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2533108|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
2533109|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
2533110|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533111|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533112|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2533113|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2533114|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2533115|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
2533116|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533117|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404600|NCT00734435|Anticonvulsants|anticonvulsants|mesh-ancestor
2404601|NCT00734435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2404602|NCT00734435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2404603|NCT00734448|Inositol|inositol|mesh-list
2404604|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
2404605|NCT00734448|Vitamins|vitamins|mesh-ancestor
2533118|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
2533119|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
2533120|NCT01397994|Vitamins|vitamins|mesh-ancestor
2533121|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
2533122|NCT01398033|Paclitaxel|paclitaxel|mesh-list
2533123|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2533124|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533125|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
2533126|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
2533127|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
2404606|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
2404607|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404608|NCT00734461|Naltrexone|naltrexone|mesh-list
2404609|NCT00734461|Oxycodone|oxycodone|mesh-list
2404610|NCT00734461|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2404611|NCT00734461|Narcotics|narcotics|mesh-ancestor
2533128|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533129|NCT01398046|Dasatinib|dasatinib|mesh-list
2533130|NCT01398046|Rabeprazole|rabeprazole|mesh-list
2533131|NCT01398046|Betaine|betaine|mesh-list
2533132|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533133|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2533134|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533135|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533136|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2533137|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2533138|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2533139|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
2533140|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2533141|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
2533142|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2533143|NCT01398072|Azithromycin|azithromycin|mesh-list
2533144|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
2533145|NCT01398072|Doxycycline|doxycycline|mesh-list
2533146|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2404612|NCT00734461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2533147|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533148|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2533149|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2533150|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533151|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533152|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533153|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
2533154|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2533155|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2533156|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
2533157|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
2533158|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2533159|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
2533160|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533161|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533162|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2533163|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
2533164|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2533165|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2533166|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2533167|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
2533168|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533169|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533170|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2533171|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2533172|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2533173|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
2533174|NCT01398189|Clozapine|clozapine|mesh-list
2533175|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2533176|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
2533177|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533178|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533179|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533180|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2533181|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2533182|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2533183|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2533184|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
2533185|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
2533186|NCT01398202|Vitamin D|vitamin d|mesh-list
2533187|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
2533188|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2533189|NCT01398202|Calcifediol|calcifediol|mesh-list
2533190|NCT01398202|Vitamins|vitamins|mesh-ancestor
2533191|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
2533192|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533193|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2533194|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2533195|NCT01398267|Lisinopril|lisinopril|mesh-list
2533196|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2533197|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
2533198|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533199|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533200|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2533201|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2533202|NCT01398267|Protective Agents|protective agents|mesh-ancestor
2533203|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533204|NCT01398293|Ritonavir|ritonavir|mesh-list
2533205|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
2533206|NCT01398293|Lactams|lactams|mesh-list
2404613|NCT00734461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404614|NCT00734461|Analgesics|analgesics|mesh-ancestor
2404615|NCT00734461|Sensory System Agents|sensory system agents|mesh-ancestor
2404616|NCT00734461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404617|NCT00734461|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2404618|NCT00734461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2404619|NCT00734526|Temozolomide|temozolomide|mesh-list
2404620|NCT00734526|Sorafenib|sorafenib|mesh-list
2404621|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2404622|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
2404623|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404624|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404625|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2404626|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404627|NCT00734669|Glyburide|glyburide|mesh-list
2404628|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2533207|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2533208|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2404629|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404630|NCT00734682|Irinotecan|irinotecan|mesh-list
2404631|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2404632|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2404633|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404634|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404635|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404636|NCT00734695|Vitamins|vitamins|mesh-list
2404637|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
2404638|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
2404639|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404640|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
2404641|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404642|NCT00734695|Protective Agents|protective agents|mesh-ancestor
2533209|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2533210|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
2533211|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533212|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533213|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2533214|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2533215|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
2533216|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2404643|NCT00734773|Cytarabine|cytarabine|mesh-list
2404644|NCT00734773|Rituximab|rituximab|mesh-list
2404645|NCT00734773|Methotrexate|methotrexate|mesh-list
2404646|NCT00734773|Vincristine|vincristine|mesh-list
2404647|NCT00734773|Procarbazine|procarbazine|mesh-list
2404648|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
2404649|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2404650|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404651|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
2404652|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533217|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2533218|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2533219|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2533220|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2533221|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2533222|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533223|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2533224|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
2533225|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2533226|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533227|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2533228|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2404653|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2404654|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2404655|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
2404656|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2404657|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2404658|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
2404659|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404660|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
2404661|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404662|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2404663|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2533229|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2533230|NCT01398371|Digoxin|digoxin|mesh-list
2533231|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2533232|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2533233|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533234|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533235|NCT01398371|Protective Agents|protective agents|mesh-ancestor
2533236|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533237|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
2533238|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2533239|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
2533240|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533241|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533242|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2533243|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
2533244|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2533245|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
2404664|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2404665|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
2668614|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533246|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533247|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533248|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2533249|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
2533250|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
2533251|NCT01398384|Protective Agents|protective agents|mesh-ancestor
2533252|NCT01398501|Sorafenib|sorafenib|mesh-list
2533253|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533254|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2533255|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533256|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533257|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2533258|NCT01398592|Vildagliptin|vildagliptin|mesh-list
2533259|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2533260|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533261|NCT01398592|Incretins|incretins|mesh-ancestor
2533262|NCT01398592|Hormones|hormones|mesh-ancestor
2533263|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2533264|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2533265|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
2533266|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404666|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2404667|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2404668|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
2404669|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
2404670|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
2404671|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2404672|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
2404673|NCT00734877|Thalidomide|thalidomide|mesh-list
2404674|NCT00734877|Dexamethasone|dexamethasone|mesh-list
2404675|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
2404676|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
2404677|NCT00734877|Melphalan|melphalan|mesh-list
2404678|NCT00734877|Cisplatin|cisplatin|mesh-list
2404679|NCT00734877|Etoposide|etoposide|mesh-list
2404680|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
2404681|NCT00734877|Doxorubicin|doxorubicin|mesh-list
2404682|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2404683|NCT00734877|Bortezomib|bortezomib|mesh-list
2404684|NCT00734877|BB 1101|bb 1101|mesh-list
2404685|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2404686|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
2404687|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404688|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2404689|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2404690|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
2404691|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533267|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533268|NCT01398618|Rifampin|rifampin|mesh-list
2533269|NCT01398618|Isoniazid|isoniazid|mesh-list
2533270|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2533271|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
2533272|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2533273|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533274|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
2404692|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404693|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2404694|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404695|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
2404696|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
2404697|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404698|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2404699|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
2404700|NCT00734877|Hormones|hormones|mesh-ancestor
2404701|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2404702|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2404703|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
2404704|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404705|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2404706|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2404707|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2404708|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2404709|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
2404710|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2404711|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2404712|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2404713|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2404714|NCT00734877|Growth Substances|growth substances|mesh-ancestor
2404715|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
2404716|NCT00734890|Bevacizumab|bevacizumab|mesh-list
2404717|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2404718|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404719|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2404720|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2404721|NCT00734890|Growth Substances|growth substances|mesh-ancestor
2404722|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533275|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2533276|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533277|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533278|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2533279|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2533280|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2533281|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2533282|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2533283|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2533284|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2533285|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2533286|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
2533287|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2533288|NCT01398657|Androgens|androgens|mesh-list
2533289|NCT01398657|Hormones|hormones|mesh-ancestor
2533290|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2533291|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533292|NCT01398670|Insulin|insulin|mesh-list
2533293|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2533294|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
2533295|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2533296|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533297|NCT01398722|Insulin|insulin|mesh-list
2533298|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2533299|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2533300|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533301|NCT01398995|Insulin|insulin|mesh-list
2533302|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2533303|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533304|NCT01399086|Fulvestrant|fulvestrant|mesh-list
2533305|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2533306|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533307|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2533308|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2533309|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
2404723|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
2404724|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2404725|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2404726|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2404727|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2404728|NCT00735020|Vaccines|vaccines|mesh-list
2404729|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
2404730|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404731|NCT00735124|Gabapentin|gabapentin|mesh-list
2404732|NCT00735124|Analgesics|analgesics|mesh-ancestor
2404733|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
2404734|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404735|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404736|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
2404737|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2533310|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2533311|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533312|NCT01399151|Vitamin D|vitamin d|mesh-list
2533313|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
2533314|NCT01399151|Vitamins|vitamins|mesh-list
2533315|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
2404738|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2404739|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2404740|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2404741|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2404742|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2404743|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404744|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404745|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
2533316|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533317|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2533318|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2533319|NCT01399216|Fucoidan|fucoidan|mesh-list
2533320|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2533321|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2404746|NCT00735228|Pancrelipase|pancrelipase|mesh-list
2404747|NCT00735228|Pancreatin|pancreatin|mesh-list
2404748|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2533322|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
2533323|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533324|NCT01399242|Everolimus|everolimus|mesh-list
2533325|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2533326|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
2533327|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533328|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533329|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
2533330|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2533331|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404749|NCT00735241|Leucovorin|leucovorin|mesh-list
2404750|NCT00735241|Folic Acid|folic acid|mesh-list
2404751|NCT00735241|Bevacizumab|bevacizumab|mesh-list
2404752|NCT00735241|Fluorouracil|fluorouracil|mesh-list
2404753|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
2404754|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
2404755|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2404756|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404757|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2404758|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2404759|NCT00735241|Growth Substances|growth substances|mesh-ancestor
2404760|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404761|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
2404762|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
2533332|NCT01399346|Insulin|insulin|mesh-list
2533333|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2533334|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
2533335|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
2533336|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2533337|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2533338|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533339|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2533340|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2533341|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2533342|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2533343|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533344|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2533345|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2533346|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2404763|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404764|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2404765|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2404766|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
2404767|NCT00735241|Antidotes|antidotes|mesh-ancestor
2404768|NCT00735241|Protective Agents|protective agents|mesh-ancestor
2533347|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
2533348|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533349|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533350|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2533351|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2533352|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
2533353|NCT01399463|Paclitaxel|paclitaxel|mesh-list
2533354|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2533355|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533356|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
2533357|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
2533358|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
2533359|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533360|NCT01399515|Valproic Acid|valproic acid|mesh-list
2404769|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
2404770|NCT00735241|Vitamins|vitamins|mesh-ancestor
2404771|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
2404772|NCT00735241|Hematinics|hematinics|mesh-ancestor
2404773|NCT00735280|Heparin|heparin|mesh-list
2404774|NCT00735280|Calcium heparin|calcium heparin|mesh-list
2404775|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
2404776|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2533361|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
2533362|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533363|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533364|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
2533365|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533366|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533367|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
2533368|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2533369|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2533370|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2533371|NCT01399580|Atrasentan|atrasentan|mesh-list
2533372|NCT01399580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404777|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2404778|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404779|NCT00735345|Docetaxel|docetaxel|mesh-list
2404780|NCT00735345|Cetuximab|cetuximab|mesh-list
2404781|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404782|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
2404783|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
2404784|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
2404785|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404786|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2404787|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
2404788|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2404789|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404790|NCT00735527|Lorazepam|lorazepam|mesh-list
2404791|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
2404792|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
2533373|NCT01399580|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2533374|NCT01399580|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2533375|NCT01399580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533376|NCT01399645|Insulin|insulin|mesh-list
2533377|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2533378|NCT01399645|Metformin|metformin|mesh-list
2533379|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
2533380|NCT01399645|Liraglutide|liraglutide|mesh-list
2533381|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2533382|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533383|NCT01399645|Incretins|incretins|mesh-ancestor
2533384|NCT01399645|Hormones|hormones|mesh-ancestor
2533385|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2533386|NCT01399684|Leucovorin|leucovorin|mesh-list
2533387|NCT01399684|Folic Acid|folic acid|mesh-list
2533388|NCT01399684|Bevacizumab|bevacizumab|mesh-list
2533389|NCT01399684|Fluorouracil|fluorouracil|mesh-list
2533390|NCT01399684|Oxaliplatin|oxaliplatin|mesh-list
2404793|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
2404794|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404795|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404796|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2404797|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2404798|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2404799|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2404800|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2404801|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2404802|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
2404803|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
2404804|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404805|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404806|NCT00735748|Tramadol|tramadol|mesh-list
2404807|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2404808|NCT00735748|Narcotics|narcotics|mesh-ancestor
2404809|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2404810|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404811|NCT00735748|Analgesics|analgesics|mesh-ancestor
2404812|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
2404813|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404814|NCT00735761|Acyclovir|acyclovir|mesh-list
2404815|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
2404816|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
2533391|NCT01399684|Levoleucovorin|levoleucovorin|mesh-list
2533392|NCT01399684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2116426|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2116427|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2116428|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2116429|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2404817|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533393|NCT01399684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533394|NCT01399684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2533395|NCT01399684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2533396|NCT01399684|Growth Substances|growth substances|mesh-ancestor
2533397|NCT01399684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533398|NCT01399684|Growth Inhibitors|growth inhibitors|mesh-ancestor
2533399|NCT01399684|Antimetabolites|antimetabolites|mesh-ancestor
2533400|NCT01399684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533401|NCT01399684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2533402|NCT01399684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2533403|NCT01399684|Immunologic Factors|immunologic factors|mesh-ancestor
2533404|NCT01399684|Antidotes|antidotes|mesh-ancestor
2533405|NCT01399684|Protective Agents|protective agents|mesh-ancestor
2533406|NCT01399684|Vitamin B Complex|vitamin b complex|mesh-ancestor
2533407|NCT01399684|Vitamins|vitamins|mesh-ancestor
2533408|NCT01399684|Micronutrients|micronutrients|mesh-ancestor
2533409|NCT01399684|Hematinics|hematinics|mesh-ancestor
2533410|NCT01399840|Talazoparib|talazoparib|mesh-list
2533411|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2533412|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533413|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533414|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533415|NCT01399853|Vaccines|vaccines|mesh-list
2533416|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
2533417|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533429|NCT01400009|Vitamin D|vitamin d|mesh-list
2533430|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
2533431|NCT01400009|Vitamins|vitamins|mesh-ancestor
2533432|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
2404818|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404819|NCT00735813|Heparin|heparin|mesh-list
2404820|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
2404821|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2404822|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2404823|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404824|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2404825|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
2404826|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2404827|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
2404828|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2404829|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404830|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2404831|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2404832|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404833|NCT00735930|Lenalidomide|lenalidomide|mesh-list
2404834|NCT00735930|Alvocidib|alvocidib|mesh-list
2404835|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
2404836|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404837|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2404838|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2404839|NCT00735930|Growth Substances|growth substances|mesh-ancestor
2404840|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
2404841|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404842|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2404843|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404844|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404845|NCT00736021|Citalopram|citalopram|mesh-list
2404846|NCT00736021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2404847|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2404848|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2404849|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533433|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533434|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2533435|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2533436|NCT01400022|Cortisone|cortisone|mesh-list
2533437|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2533438|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
2533439|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533440|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2533441|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533442|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533443|NCT01400100|Octreotide|octreotide|mesh-list
2533444|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2533445|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2533446|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2533447|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533448|NCT01400165|Pindolol|pindolol|mesh-list
2533449|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2404850|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404851|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
2404852|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404853|NCT00736021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2404854|NCT00736021|Antidepressive Agents|antidepressive agents|mesh-ancestor
2404855|NCT00736021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2404856|NCT00736164|Selenium|selenium|mesh-list
2404857|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
2404858|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533450|NCT01400165|Trazodone|trazodone|mesh-list
2533451|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
2533452|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2533453|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2533454|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2533455|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2533456|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533457|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2533458|NCT01400165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2533459|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2533460|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2533461|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533462|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533463|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
2533464|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2533465|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2533466|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2533467|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
2533468|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2533469|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2533470|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
2533471|NCT01400191|Metformin|metformin|mesh-list
2533472|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2533473|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533474|NCT01400217|Beclomethasone|beclomethasone|mesh-list
2533475|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2533476|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
2533477|NCT01400217|Hormones|hormones|mesh-ancestor
2533478|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2533479|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533480|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2533481|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
2533482|NCT01400256|Valsartan|valsartan|mesh-list
2533483|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2533484|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2533485|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2533486|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533487|NCT01400308|Mupirocin|mupirocin|mesh-list
2533488|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2533489|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533490|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2533491|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533492|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533493|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
2533494|NCT01400464|Prednisone|prednisone|mesh-list
2533495|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2533496|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
2533497|NCT01400464|Hormones|hormones|mesh-ancestor
2404859|NCT00736164|Protective Agents|protective agents|mesh-ancestor
2533498|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2533499|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533500|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2533501|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533502|NCT01400568|Fluticasone|fluticasone|mesh-list
2533503|NCT01400568|Xhance|xhance|mesh-list
2533504|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2533505|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2533506|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
2533507|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533508|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533509|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2533510|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
2533511|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
2533512|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2533513|NCT01400633|Decitabine|decitabine|mesh-list
2533514|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2533515|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
2533516|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533517|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533518|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533519|NCT01400646|Vitamins|vitamins|mesh-list
2533520|NCT01400646|Vitamin K|vitamin k|mesh-list
2533521|NCT01400646|Warfarin|warfarin|mesh-list
2533522|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
2533523|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
2533524|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533525|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
2533526|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2533527|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
2533528|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2533529|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
2533530|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533531|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533532|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2533533|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2533534|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
2533535|NCT01400646|Coagulants|coagulants|mesh-ancestor
2533536|NCT01400672|Imiquimod|imiquimod|mesh-list
2533537|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2533538|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
2533539|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533540|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533541|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
2533542|NCT01400685|Rituximab|rituximab|mesh-list
2533543|NCT01400685|Lenalidomide|lenalidomide|mesh-list
2533544|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2533545|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2533546|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533547|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
2533548|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533549|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2533550|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2404860|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404861|NCT00736164|Trace Elements|trace elements|mesh-ancestor
2404862|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
2404863|NCT00736294|Ramipril|ramipril|mesh-list
2404864|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2404865|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
2404866|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404867|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404868|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2404869|NCT00736320|Vincristine|vincristine|mesh-list
2404870|NCT00736320|Doxorubicin|doxorubicin|mesh-list
2404871|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2404872|NCT00736320|Dacarbazine|dacarbazine|mesh-list
2404873|NCT00736320|Bleomycin|bleomycin|mesh-list
2404874|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2404875|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404876|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
2404877|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
2404878|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
2404879|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404880|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2404881|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2404882|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2533551|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2533552|NCT01400685|Growth Substances|growth substances|mesh-ancestor
2533553|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
2533554|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2533555|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
2533556|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404883|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404884|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2404885|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
2404886|NCT00736346|Paroxetine|paroxetine|mesh-list
2404887|NCT00736346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2404888|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2404889|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2404890|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404891|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404892|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
2404893|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404894|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2404895|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
2404896|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2404897|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2404898|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2404899|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404900|NCT00736463|Atorvastatin|atorvastatin|mesh-list
2404901|NCT00736463|Simvastatin|simvastatin|mesh-list
2404902|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2404903|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2404904|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
2404905|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404906|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2404907|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2404908|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404909|NCT00736515|Insulin|insulin|mesh-list
2404910|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2404911|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
2404912|NCT00736515|Gliclazide|gliclazide|mesh-list
2404913|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2404914|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404915|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
2404916|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2404917|NCT00736541|Cystatins|cystatins|mesh-list
2404918|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
2404919|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2404920|NCT00736541|Expectorants|expectorants|mesh-ancestor
2404921|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
2404922|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2404923|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
2404924|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404925|NCT00736541|Protective Agents|protective agents|mesh-ancestor
2404926|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404927|NCT00736541|Antidotes|antidotes|mesh-ancestor
2404928|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2404929|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
2404930|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404931|NCT00736606|Simvastatin|simvastatin|mesh-list
2404932|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2404933|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2404934|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
2404935|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404936|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2404937|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2404938|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404939|NCT00736619|Paclitaxel|paclitaxel|mesh-list
2404940|NCT00736619|Cetuximab|cetuximab|mesh-list
2404941|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2404942|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2404943|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533557|NCT01400737|Ibuprofen|ibuprofen|mesh-list
2533558|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2533559|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2533560|NCT01400737|Analgesics|analgesics|mesh-ancestor
2533561|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
2533562|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533563|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533564|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2533565|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2533566|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2533567|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533568|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533569|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
2533570|NCT01400750|Tobramycin|tobramycin|mesh-list
2533571|NCT01400750|Colistin|colistin|mesh-list
2533572|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2533573|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533574|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2533575|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2533576|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533577|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533578|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533579|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2533580|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2533581|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
2533582|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
2533583|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2404944|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
2404945|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
2404946|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
2404947|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404948|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2404949|NCT00736697|Moxidectin|moxidectin|mesh-list
2404950|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
2404951|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2533584|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533585|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
2533586|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2533587|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533588|NCT01400828|Desloratadine|desloratadine|mesh-list
2533589|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2533590|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
2533591|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533592|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533593|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533594|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2533595|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2533596|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
2533597|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
2533598|NCT01400867|Vancomycin|vancomycin|mesh-list
2533599|NCT01400867|Clindamycin|clindamycin|mesh-list
2533600|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
2533601|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
2533602|NCT01400867|Cefazolin|cefazolin|mesh-list
2533603|NCT01400867|Linezolid|linezolid|mesh-list
2533604|NCT01400867|Cephalexin|cephalexin|mesh-list
2533605|NCT01400867|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2533606|NCT01400867|Aztreonam|aztreonam|mesh-list
2533607|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2533608|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533609|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2533610|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533611|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533612|NCT01400945|Pantoprazole|pantoprazole|mesh-list
2533613|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2533614|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2533615|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2533616|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533617|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533618|NCT01401036|Umirolimus|umirolimus|mesh-list
2533619|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404952|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2404953|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
2404954|NCT00736801|Fluticasone|fluticasone|mesh-list
2404955|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2404956|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2404957|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2404958|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
2404959|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2404960|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404961|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2404962|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
2404963|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
2404964|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2533620|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2533621|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
2533622|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533623|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
2533624|NCT01401075|Doxifluridine|doxifluridine|mesh-list
2533625|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533626|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2533627|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2533628|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
2533629|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533630|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2533631|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
2533632|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533633|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2533634|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
2533635|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533636|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
2533637|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2533638|NCT01401179|Clarithromycin|clarithromycin|mesh-list
2533639|NCT01401179|Cefazolin|cefazolin|mesh-list
2533640|NCT01401179|Erythromycin|erythromycin|mesh-list
2533641|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
2404965|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2404966|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2404967|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2404968|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
2404969|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2404970|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404971|NCT00736814|Gemcitabine|gemcitabine|mesh-list
2404972|NCT00736814|Carboplatin|carboplatin|mesh-list
2404973|NCT00736814|Docetaxel|docetaxel|mesh-list
2404974|NCT00736814|Vinorelbine|vinorelbine|mesh-list
2533642|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2533643|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
2533644|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2533645|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533646|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2533647|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533648|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533649|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2533650|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2533651|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2533652|NCT01401192|Gemcitabine|gemcitabine|mesh-list
2533653|NCT01401192|Cisplatin|cisplatin|mesh-list
2533654|NCT01401192|Pemetrexed|pemetrexed|mesh-list
2533655|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533656|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2533657|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
2533658|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533659|NCT01401192|Antiviral Agents|antiviral agents|mesh-ancestor
2533660|NCT01401192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533661|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533662|NCT01401192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2533663|NCT01401192|Immunologic Factors|immunologic factors|mesh-ancestor
2533664|NCT01401192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533665|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2533666|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2533667|NCT01401387|Pancreatin|pancreatin|mesh-list
2533668|NCT01401387|Pancrelipase|pancrelipase|mesh-list
2533669|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2533670|NCT01401491|Clozapine|clozapine|mesh-list
2533671|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
2533672|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2533673|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
2533674|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533675|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533676|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533677|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2533678|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2404975|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2404976|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2404977|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
2404978|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404979|NCT00736814|Antiviral Agents|antiviral agents|mesh-ancestor
2404980|NCT00736814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2404981|NCT00736814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2404982|NCT00736814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2404983|NCT00736814|Immunologic Factors|immunologic factors|mesh-ancestor
2404984|NCT00736814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2404985|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
2404986|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
2404987|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
2404988|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2404989|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
2404990|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2404991|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
2404992|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2404993|NCT00736866|Expectorants|expectorants|mesh-ancestor
2404994|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
2404995|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2404996|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
2404997|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2404998|NCT00736866|Protective Agents|protective agents|mesh-ancestor
2533679|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2533680|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2533681|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
2533682|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
2533683|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2533684|NCT01401491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2533685|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2533686|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2533687|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2533688|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
2404999|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405000|NCT00736866|Antidotes|antidotes|mesh-ancestor
2405001|NCT00736905|Rilpivirine|rilpivirine|mesh-list
2405002|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2405003|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2405004|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405005|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405006|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
2405007|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405008|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2405009|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2405010|NCT00736931|Levetiracetam|levetiracetam|mesh-list
2405011|NCT00736931|Lorazepam|lorazepam|mesh-list
2405012|NCT00736931|Brivaracetam|brivaracetam|mesh-list
2405013|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
2405014|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
2533689|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2533690|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2533691|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533692|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2533693|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2533694|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2533695|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2533696|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533697|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
2533698|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533699|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533700|NCT01401933|Rifampin|rifampin|mesh-list
2533701|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2533702|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
2533703|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2533704|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533705|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
2533706|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2533707|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533708|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405015|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
2405016|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
2405017|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405018|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405019|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2405020|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2405021|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2405022|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2405023|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2405024|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2405025|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
2405026|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
2405027|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2405028|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533709|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2533710|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2533711|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2533712|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2533713|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2533714|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2533715|NCT01402024|Aprepitant|aprepitant|mesh-list
2533716|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
2533717|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
2533718|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533719|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533720|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2533721|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2533722|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533723|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533724|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
2533725|NCT01402076|Midazolam|midazolam|mesh-list
2533726|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2533727|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2533728|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2533729|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533730|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2533731|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2533732|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2533733|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2533734|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
2533735|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
2533736|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
2533737|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
2533738|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533739|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533740|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2533741|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2533742|NCT01402089|Sunitinib|sunitinib|mesh-list
2533743|NCT01402089|Midazolam|midazolam|mesh-list
2533744|NCT01402089|Caffeine|caffeine|mesh-list
2533745|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2533746|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2533747|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2533748|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533749|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2533750|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2533751|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2533752|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2533753|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
2533754|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
2533755|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
2533756|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
2533757|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533758|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533759|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533760|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2533761|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533762|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2533763|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2533764|NCT01402089|Growth Substances|growth substances|mesh-ancestor
2116435|NCT02640053|Paclitaxel|paclitaxel|mesh-list
2116436|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2116437|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2116438|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116439|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
2116440|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
2116441|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
2116442|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116443|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
2116444|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
2405029|NCT00736970|Sirolimus|sirolimus|mesh-list
2405030|NCT00736970|Trastuzumab|trastuzumab|mesh-list
2405031|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2405032|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405033|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2405034|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405035|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2533765|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
2533766|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2533767|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2533768|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2533769|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2533770|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
2533771|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
2533772|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2533773|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533774|NCT01402193|Anastrozole|anastrozole|mesh-list
2533775|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2533776|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533777|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2405036|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
2405037|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405038|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
2405039|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405040|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
2405041|NCT00736983|Adalimumab|adalimumab|mesh-list
2405042|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2405043|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2533778|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2533779|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533780|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533781|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2533782|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
2533783|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2533784|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533785|NCT01402245|Vaccines|vaccines|mesh-list
2533786|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2533787|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
2533788|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533789|NCT01402271|Paclitaxel|paclitaxel|mesh-list
2533790|NCT01402271|Carboplatin|carboplatin|mesh-list
2533791|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2533792|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533793|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
2533794|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
2533795|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
2533796|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533797|NCT01402297|Acetovanillone|acetovanillone|mesh-list
2533798|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2533799|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2533800|NCT01402297|Analgesics|analgesics|mesh-ancestor
2533801|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
2533802|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533803|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533804|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2533805|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2533806|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
2533807|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533808|NCT01402297|Protective Agents|protective agents|mesh-ancestor
2533809|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533810|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2533811|NCT01402336|Cetrorelix|cetrorelix|mesh-list
2533812|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2533813|NCT01402336|Hormones|hormones|mesh-ancestor
2533814|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2533815|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533816|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
2533817|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2533818|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
2533819|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2533820|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2533821|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2533822|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533823|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2533824|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
2533825|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
2533826|NCT01402401|Trastuzumab|trastuzumab|mesh-list
2533827|NCT01402401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2533828|NCT01402401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533829|NCT01402479|Ramipril|ramipril|mesh-list
2405044|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2533830|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2533831|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
2533832|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533833|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533834|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2533835|NCT01402583|Ribavirin|ribavirin|mesh-list
2533836|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
2533837|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533838|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
2533839|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533840|NCT01402596|Midazolam|midazolam|mesh-list
2533841|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
2533842|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2533843|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2533844|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2533845|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533846|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2533847|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2533848|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2533849|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2533850|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
2405045|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405046|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2405047|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2405048|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405049|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405050|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405051|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2405052|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2405053|NCT00737113|Hormones|hormones|mesh-list
2405054|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2405055|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405056|NCT00737126|Folic Acid|folic acid|mesh-list
2405057|NCT00737126|Hematinics|hematinics|mesh-ancestor
2405058|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
2405059|NCT00737126|Vitamins|vitamins|mesh-ancestor
2405060|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
2405061|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405062|NCT00737139|Epinephrine|epinephrine|mesh-list
2405063|NCT00737139|Bupivacaine|bupivacaine|mesh-list
2405064|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2405065|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2405066|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
2405067|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2405068|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405069|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405070|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2405071|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2405072|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
2405073|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405074|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2533851|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
2533852|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
2533853|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
2533854|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533855|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533856|NCT01402622|Propofol|propofol|mesh-list
2533857|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
2533858|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2533859|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405075|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
2405076|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
2405077|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
2405078|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2405079|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
2405080|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
2405081|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2405082|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
2405083|NCT00737191|Olanzapine|olanzapine|mesh-list
2405084|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
2405085|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
2533860|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2533861|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2533862|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
2533863|NCT01402674|Phentermine|phentermine|mesh-list
2405086|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533864|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2405087|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405088|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2405089|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2405090|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2405091|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2405092|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2405093|NCT00737191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2405094|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2405095|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2405096|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405097|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2405098|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
2405099|NCT00737256|Aripiprazole|aripiprazole|mesh-list
2405100|NCT00737256|Perphenazine|perphenazine|mesh-list
2405101|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
2405102|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2533865|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533866|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
2533867|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2533868|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
2533869|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
2533870|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533871|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
2533872|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2533873|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533874|NCT01402843|Valsartan|valsartan|mesh-list
2533875|NCT01402843|Pitavastatin|pitavastatin|mesh-list
2533876|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2533877|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2533878|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2533879|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533880|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2533881|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2533882|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2533883|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
2533884|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533885|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2533886|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
2533887|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2533888|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2533889|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533890|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
2533891|NCT01402882|Coagulants|coagulants|mesh-ancestor
2533892|NCT01403025|Liraglutide|liraglutide|mesh-list
2405103|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2405104|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2405105|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2405106|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405107|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
2405108|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
2405109|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2405110|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405111|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2405112|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2405113|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
2405114|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2533893|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2533894|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533895|NCT01403025|Incretins|incretins|mesh-ancestor
2533896|NCT01403025|Hormones|hormones|mesh-ancestor
2533897|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2533898|NCT01403103|Vitamin D|vitamin d|mesh-list
2533899|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
2533900|NCT01403103|Vitamins|vitamins|mesh-ancestor
2533901|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
2533902|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405115|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2405116|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2405117|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2405118|NCT00737373|Leucovorin|leucovorin|mesh-list
2405119|NCT00737373|Folic Acid|folic acid|mesh-list
2405120|NCT00737373|Docetaxel|docetaxel|mesh-list
2405121|NCT00737373|Fluorouracil|fluorouracil|mesh-list
2405122|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
2405123|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
2533903|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2533904|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2533905|NCT01403168|Analgesics|analgesics|mesh-list
2533906|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
2533907|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533908|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533909|NCT01403181|Ribavirin|ribavirin|mesh-list
2533910|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2533911|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
2533912|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533913|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
2533914|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533915|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
2533916|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533917|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
2533918|NCT01403285|Molgramostim|molgramostim|mesh-list
2405124|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405125|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
2405126|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
2405127|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
2405128|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405129|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
2405130|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2405131|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405132|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
2405133|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405134|NCT00737373|Antidotes|antidotes|mesh-ancestor
2405135|NCT00737373|Protective Agents|protective agents|mesh-ancestor
2405136|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
2405137|NCT00737373|Vitamins|vitamins|mesh-ancestor
2405138|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
2405139|NCT00737373|Hematinics|hematinics|mesh-ancestor
2405140|NCT00737542|Lidocaine|lidocaine|mesh-list
2405141|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
2405142|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
2405143|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2405144|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405145|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
2405146|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405147|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2405148|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2405149|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2405150|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2405151|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405152|NCT00737555|Tosedostat|tosedostat|mesh-list
2405153|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405154|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405155|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
2405156|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2405157|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405158|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2405159|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
2405160|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2405161|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405162|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405163|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405164|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
2405165|NCT00737685|Fludarabine|fludarabine|mesh-list
2405166|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
2405167|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405168|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
2405169|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405170|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2533919|NCT01403285|Imiquimod|imiquimod|mesh-list
2533920|NCT01403285|Sargramostim|sargramostim|mesh-list
2533921|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405171|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2405172|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
2405173|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405174|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405175|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2405176|NCT00737724|Efavirenz|efavirenz|mesh-list
2405177|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2533922|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
2533923|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533924|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2533925|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2533926|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
2533927|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405178|NCT00737724|Isoniazid|isoniazid|mesh-list
2405179|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2533928|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405180|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2405181|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405182|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405183|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
2405184|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405185|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2533929|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2533930|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2533931|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
2533932|NCT01403363|Fentanyl|fentanyl|mesh-list
2533933|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2533934|NCT01403363|Narcotics|narcotics|mesh-ancestor
2533935|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2405186|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2405187|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2405188|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2405189|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2405190|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2405191|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2405192|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2405193|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
2405194|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2405195|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2405196|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2533936|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533937|NCT01403363|Analgesics|analgesics|mesh-ancestor
2533938|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
2533939|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533940|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2533941|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2533942|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
2533943|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
2533944|NCT01403389|Eculizumab|eculizumab|mesh-list
2533945|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2533946|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2533947|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
2533948|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533949|NCT01403415|Sirolimus|sirolimus|mesh-list
2533950|NCT01403415|Dexamethasone|dexamethasone|mesh-list
2533951|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
2533952|NCT01403415|Methotrexate|methotrexate|mesh-list
2533953|NCT01403415|Vincristine|vincristine|mesh-list
2533954|NCT01403415|Asparaginase|asparaginase|mesh-list
2533955|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
2533956|NCT01403415|Pegaspargase|pegaspargase|mesh-list
2533957|NCT01403415|BB 1101|bb 1101|mesh-list
2533958|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2533959|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
2533960|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
2533961|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2533962|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2533963|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2533964|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
2533965|NCT01403415|Hormones|hormones|mesh-ancestor
2533966|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2533967|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2533968|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2533969|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2533970|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
2533971|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2533972|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2533973|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
2533974|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2533975|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
2533976|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2533977|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2533978|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2533979|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
2533980|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2533981|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2533982|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2533983|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
2405197|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
2405198|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2405199|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
2405200|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
2405201|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2533984|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
2533985|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
2533986|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2533987|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533988|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2533989|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
2533990|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
2533991|NCT01403415|Analgesics|analgesics|mesh-ancestor
2533992|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
2533993|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2533994|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2533995|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
2533996|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2533997|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
2533998|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2533999|NCT01403506|Expectorants|expectorants|mesh-ancestor
2534000|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
2534001|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2534002|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
2534003|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534004|NCT01403506|Protective Agents|protective agents|mesh-ancestor
2534005|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534006|NCT01403506|Antidotes|antidotes|mesh-ancestor
2534007|NCT01403545|Curcumin|curcumin|mesh-list
2534008|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2534009|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2534010|NCT01403545|Analgesics|analgesics|mesh-ancestor
2534011|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
2534012|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534013|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534014|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2534015|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2534016|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534017|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534018|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534019|NCT01403649|Vaccines|vaccines|mesh-list
2534020|NCT01403649|Immunologic Factors|immunologic factors|mesh-ancestor
2534021|NCT01403649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405202|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2405203|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405204|NCT00737789|Mesalamine|mesalamine|mesh-list
2405205|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2405206|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2405207|NCT00737789|Analgesics|analgesics|mesh-ancestor
2405208|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
2405209|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405210|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405211|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2405212|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2405213|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
2405214|NCT00737815|Cathartics|cathartics|mesh-ancestor
2405215|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2405216|NCT00737867|Gemcitabine|gemcitabine|mesh-list
2534022|NCT01403662|Minocycline|minocycline|mesh-list
2534023|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2534024|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534025|NCT01403740|Cyclosporine|cyclosporine|mesh-list
2534026|NCT01403740|Rituximab|rituximab|mesh-list
2534027|NCT01403740|Azathioprine|azathioprine|mesh-list
2405217|NCT00737867|Carboplatin|carboplatin|mesh-list
2405218|NCT00737867|Vinorelbine|vinorelbine|mesh-list
2405219|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405220|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2405221|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
2405222|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405223|NCT00737867|Antiviral Agents|antiviral agents|mesh-ancestor
2405224|NCT00737867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405225|NCT00737867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534028|NCT01403740|Cyclosporins|cyclosporins|mesh-list
2534029|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2534030|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534031|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
2534032|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534033|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2534034|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534035|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534036|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2534037|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
2534038|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534039|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
2534040|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2534041|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
2534042|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2534043|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
2534044|NCT01403818|Mitiglinide|mitiglinide|mesh-list
2534045|NCT01403818|Calcium|calcium|mesh-list
2534046|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2534047|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534048|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2534049|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534050|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2534051|NCT01403844|Carotenoids|carotenoids|mesh-list
2534052|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
2534053|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534054|NCT01403844|Protective Agents|protective agents|mesh-ancestor
2534055|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534056|NCT01403896|Plerixafor|plerixafor|mesh-list
2534057|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2534058|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2534059|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
2534060|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405226|NCT00737867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405227|NCT00737867|Immunologic Factors|immunologic factors|mesh-ancestor
2405228|NCT00737867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405229|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2405230|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
2405231|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
2405232|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
2405233|NCT00737880|Pancrelipase|pancrelipase|mesh-list
2405234|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2405235|NCT00737971|Triamcinolone|triamcinolone|mesh-list
2405236|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2405237|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2405238|NCT00737971|Bevacizumab|bevacizumab|mesh-list
2405239|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2405240|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2405241|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405242|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2534061|NCT01403948|BI 836826|bi 836826|mesh-list
2534062|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2534063|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534064|NCT01404000|Charcoal|charcoal|mesh-list
2534065|NCT01404000|Antidotes|antidotes|mesh-ancestor
2534066|NCT01404000|Protective Agents|protective agents|mesh-ancestor
2534067|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534068|NCT01404013|Montelukast|montelukast|mesh-list
2534069|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2534070|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2534071|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
2534072|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2534073|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
2534074|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2534075|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534076|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2534077|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2534078|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534079|NCT01404104|Sirolimus|sirolimus|mesh-list
2534080|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2534081|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534082|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2534083|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534084|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
2534085|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2534086|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
2534087|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534088|NCT01404117|Interferons|interferons|mesh-list
2534089|NCT01404117|Interferon-beta|interferon-beta|mesh-list
2534090|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
2534091|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
2534092|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534093|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
2405243|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2405244|NCT00737971|Growth Substances|growth substances|mesh-ancestor
2405245|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405246|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
2534094|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534095|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
2534096|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534097|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2534098|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2534099|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2534100|NCT01404130|Isotretinoin|isotretinoin|mesh-list
2534101|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
2534102|NCT01404156|Leucovorin|leucovorin|mesh-list
2534103|NCT01404156|Paclitaxel|paclitaxel|mesh-list
2534104|NCT01404156|Docetaxel|docetaxel|mesh-list
2534105|NCT01404156|Carboplatin|carboplatin|mesh-list
2534106|NCT01404156|Fluorouracil|fluorouracil|mesh-list
2534107|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
2534108|NCT01404156|Epirubicin|epirubicin|mesh-list
2534109|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2534110|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534111|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
2534112|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
2534113|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
2534114|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534115|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
2534116|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2534117|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2534118|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
2534119|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534120|NCT01404156|Antidotes|antidotes|mesh-ancestor
2534121|NCT01404156|Protective Agents|protective agents|mesh-ancestor
2534122|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
2534123|NCT01404156|Vitamins|vitamins|mesh-ancestor
2534124|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
2534125|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2534126|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2534127|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2534128|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534129|NCT01404169|Donepezil|donepezil|mesh-list
2534130|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2405247|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2405248|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
2405249|NCT00737971|Hormones|hormones|mesh-ancestor
2405250|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2405251|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405252|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
2405253|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405254|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405255|NCT00737997|Morphine|morphine|mesh-list
2405256|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2405257|NCT00737997|Narcotics|narcotics|mesh-ancestor
2405258|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2534131|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534132|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534133|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
2534134|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534135|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534136|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
2534137|NCT01404182|Vaccines|vaccines|mesh-list
2534138|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
2534139|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534140|NCT01404312|Pyridoxine|pyridoxine|mesh-list
2534141|NCT01404312|Pyridoxal|pyridoxal|mesh-list
2534142|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
2534143|NCT01404312|Isoniazid|isoniazid|mesh-list
2534144|NCT01404312|Rifapentine|rifapentine|mesh-list
2534145|NCT01404312|Vitamins|vitamins|mesh-ancestor
2534146|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
2534147|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534148|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
2534149|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
2405259|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405260|NCT00737997|Analgesics|analgesics|mesh-ancestor
2405261|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
2405262|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405263|NCT00738088|Gliclazide|gliclazide|mesh-list
2405264|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2405265|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405266|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
2405267|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2405268|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405269|NCT00738192|Fentanyl|fentanyl|mesh-list
2405270|NCT00738192|Sufentanil|sufentanil|mesh-list
2405271|NCT00738192|Dsuvia|dsuvia|mesh-list
2405272|NCT00738192|Butorphanol|butorphanol|mesh-list
2405273|NCT00738192|Citric Acid|citric acid|mesh-list
2405274|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
2405275|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2405276|NCT00738192|Narcotics|narcotics|mesh-ancestor
2405277|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2534150|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2534151|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534152|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2534153|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2534154|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
2534155|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534156|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2534157|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2405278|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405279|NCT00738192|Analgesics|analgesics|mesh-ancestor
2405280|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
2405281|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405282|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2405283|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2405284|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
2405285|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
2405286|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
2405287|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2405288|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
2405289|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
2405290|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405291|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
2405292|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
2405293|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2405294|NCT00738257|Pamidronate|pamidronate|mesh-list
2534158|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
2534159|NCT01404338|Halobetasol|halobetasol|mesh-list
2534160|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2534161|NCT01404364|Triamcinolone|triamcinolone|mesh-list
2534162|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
2534163|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2534164|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
2534165|NCT01404364|Hormones|hormones|mesh-ancestor
2534166|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2534167|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534168|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534169|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
2534170|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
2534171|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534172|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2534173|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2534174|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2534175|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2534176|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2534177|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2534178|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
2534179|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2405295|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2405296|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405297|NCT00738296|Simvastatin|simvastatin|mesh-list
2405298|NCT00738296|Ezetimibe|ezetimibe|mesh-list
2405299|NCT00738296|Pravastatin|pravastatin|mesh-list
2405300|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2405301|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2405302|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
2405303|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405304|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2405305|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2534180|NCT01404377|Ropivacaine|ropivacaine|mesh-list
2405306|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405307|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2405308|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405309|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2534181|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
2534182|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
2534183|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2534184|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534185|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
2534186|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534187|NCT01404442|Midazolam|midazolam|mesh-list
2534188|NCT01404442|Ketamine|ketamine|mesh-list
2534189|NCT01404442|Analgesics|analgesics|mesh-ancestor
2534190|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
2534191|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534192|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534193|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2534194|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2534195|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
2534196|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
2534197|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2534198|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2534199|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2534200|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534201|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534202|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2534203|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2534204|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2405310|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405311|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405312|NCT00738387|Docetaxel|docetaxel|mesh-list
2405313|NCT00738387|Vadimezan|vadimezan|mesh-list
2405314|NCT00738387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405315|NCT00738387|Tubulin Modulators|tubulin modulators|mesh-ancestor
2405316|NCT00738387|Antimitotic Agents|antimitotic agents|mesh-ancestor
2405317|NCT00738387|Mitosis Modulators|mitosis modulators|mesh-ancestor
2405318|NCT00738387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405319|NCT00738413|Deferasirox|deferasirox|mesh-list
2405320|NCT00738413|Deferoxamine|deferoxamine|mesh-list
2405321|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2405322|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
2405323|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
2405324|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405325|NCT00738413|Siderophores|siderophores|mesh-ancestor
2534205|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2534206|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2534207|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
2534208|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
2534209|NCT01404468|Lidocaine|lidocaine|mesh-list
2534210|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
2534211|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
2534212|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2534213|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534214|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
2534215|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534216|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2534217|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2534218|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2534219|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2534220|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405326|NCT00738452|Antibodies|antibodies|mesh-list
2405327|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2405328|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
2405329|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405330|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
2405331|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2405332|NCT00738517|Antibodies|antibodies|mesh-list
2405333|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
2405334|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405335|NCT00738556|Sirolimus|sirolimus|mesh-list
2405336|NCT00738556|Paclitaxel|paclitaxel|mesh-list
2405337|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2405338|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405339|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
2405340|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
2405341|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
2116445|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2116446|NCT02640404|Vaccines|vaccines|mesh-list
2116447|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
2116448|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116449|NCT02640755|Paclitaxel|paclitaxel|mesh-list
2116450|NCT02640755|Fulvestrant|fulvestrant|mesh-list
2116451|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2116452|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116453|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
2116454|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
2116455|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
2116456|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116457|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2116458|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2116459|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2116460|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
2116461|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2116462|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116463|NCT02641080|Aspirin|aspirin|mesh-list
2116464|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2116465|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2116466|NCT02641080|Analgesics|analgesics|mesh-ancestor
2116467|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
2116468|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116469|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116470|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2116471|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2116472|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2116473|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2116474|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116475|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2116476|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2116477|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116478|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
2116479|NCT02641353|Thalidomide|thalidomide|mesh-list
2116480|NCT02641353|Apremilast|apremilast|mesh-list
2116481|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2116482|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2116483|NCT02641353|Analgesics|analgesics|mesh-ancestor
2116484|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
2116485|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116486|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116487|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2116488|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2116489|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2116490|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2116491|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116492|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116493|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2116494|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
2116495|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
2116496|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2116497|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2116498|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2116499|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2116500|NCT02641353|Growth Substances|growth substances|mesh-ancestor
2116501|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
2116502|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116503|NCT02641379|Ribavirin|ribavirin|mesh-list
2116504|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2116505|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
2405342|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405343|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2405344|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405345|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2534221|NCT01404507|Abciximab|abciximab|mesh-list
2534222|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
2534223|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2534224|NCT01404598|Naproxen|naproxen|mesh-list
2534225|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
2534226|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2534227|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2534228|NCT01404598|Analgesics|analgesics|mesh-ancestor
2405346|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
2405347|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405348|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
2405349|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405350|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
2405351|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2405352|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2405353|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
2405354|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405355|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2405356|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2405357|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405358|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405359|NCT00738582|Pemetrexed|pemetrexed|mesh-list
2405360|NCT00738582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534229|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
2534230|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534231|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534232|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2534233|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2534234|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
2534235|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2534236|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534237|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534238|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2534239|NCT01404637|Tamsulosin|tamsulosin|mesh-list
2534240|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2534241|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2534242|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2534243|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
2534244|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534245|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534246|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534247|NCT01404637|Urological Agents|urological agents|mesh-ancestor
2534248|NCT01404676|Glimepiride|glimepiride|mesh-list
2534249|NCT01404676|Vildagliptin|vildagliptin|mesh-list
2534250|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2534251|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2534252|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534253|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2534254|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
2534255|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2534256|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
2534257|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534258|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534259|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
2534260|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2534261|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2534262|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534263|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2534264|NCT01404689|Analgesics|analgesics|mesh-ancestor
2534265|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
2534266|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534267|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2534268|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2534269|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2534270|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
2534271|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534272|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534273|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
2534274|NCT01404702|Aldesleukin|aldesleukin|mesh-list
2534275|NCT01404702|Interleukin-2|interleukin-2|mesh-list
2534276|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534277|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2534278|NCT01404702|Analgesics|analgesics|mesh-ancestor
2534279|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
2534280|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534281|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534282|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2534283|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2534284|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
2534285|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405361|NCT00738582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405362|NCT00738582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534286|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2534287|NCT01404715|Metformin|metformin|mesh-list
2534288|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
2534289|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2534290|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534291|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534292|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2534293|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534294|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534295|NCT01404741|Azacitidine|azacitidine|mesh-list
2534296|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2534297|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
2534298|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534299|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534300|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405363|NCT00738582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2405364|NCT00738582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2405365|NCT00738595|Nicotine|nicotine|mesh-list
2405366|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2405367|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
2405368|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405369|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405370|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2405371|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2405372|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
2405373|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2405374|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405375|NCT00738621|Dexamethasone|dexamethasone|mesh-list
2405376|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
2405377|NCT00738621|Ondansetron|ondansetron|mesh-list
2405378|NCT00738621|Aprepitant|aprepitant|mesh-list
2405379|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
2405380|NCT00738621|BB 1101|bb 1101|mesh-list
2405381|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2405382|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
2405383|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
2405384|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405385|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534312|NCT01404767|Metoprolol|metoprolol|mesh-list
2534313|NCT01404767|Esmolol|esmolol|mesh-list
2534314|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2534315|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2534316|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
2534317|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
2534318|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534319|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534320|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2534321|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2534322|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2405386|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2405387|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
2405388|NCT00738621|Hormones|hormones|mesh-ancestor
2405389|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2405390|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2405391|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405392|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
2405393|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405394|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405395|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
2405396|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
2405397|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2405398|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
2534323|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
2534324|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2405399|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116506|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116507|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
2116508|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2116509|NCT02641522|Siltuximab|siltuximab|mesh-list
2116510|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116511|NCT02641561|Indomethacin|indomethacin|mesh-list
2116512|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2534325|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534326|NCT01404793|Rocuronium|rocuronium|mesh-list
2534327|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2534328|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2534329|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2534330|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534331|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534332|NCT01404806|Dolutegravir|dolutegravir|mesh-list
2405400|NCT00738621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2405401|NCT00738621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2405402|NCT00738621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2405403|NCT00738621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2405404|NCT00738621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2405405|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2534333|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2534334|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2534335|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534336|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534337|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2534338|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2534339|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
2534340|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534341|NCT01404819|Anesthetics|anesthetics|mesh-list
2534342|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2534343|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534344|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2534345|NCT01404871|Citalopram|citalopram|mesh-list
2534346|NCT01404871|Clomipramine|clomipramine|mesh-list
2534347|NCT01404871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2534348|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2534349|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2534350|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534351|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534352|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
2534353|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534354|NCT01404871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2534355|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
2534356|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2534357|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534358|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2534359|NCT01404871|Analgesics|analgesics|mesh-ancestor
2534360|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
2405406|NCT00738660|Telmisartan|telmisartan|mesh-list
2405407|NCT00738660|Ramipril|ramipril|mesh-list
2405408|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2534361|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
2534362|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2405409|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2405410|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2405411|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405412|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2405413|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
2405414|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405415|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2405416|NCT00738751|Panobinostat|panobinostat|mesh-list
2405417|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2405418|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405419|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2405420|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405421|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405422|NCT00738777|Tamoxifen|tamoxifen|mesh-list
2405423|NCT00738777|Fulvestrant|fulvestrant|mesh-list
2405424|NCT00738777|Anastrozole|anastrozole|mesh-list
2405425|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2405426|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
2116513|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2405427|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2405428|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405429|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2405430|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405431|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2405432|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2405433|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2405434|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2405435|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2405436|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2405437|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405438|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405439|NCT00738829|Vidarabine|vidarabine|mesh-list
2534363|NCT01405079|Vinorelbine|vinorelbine|mesh-list
2534364|NCT01405079|Gefitinib|gefitinib|mesh-list
2534365|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534366|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2534367|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
2534368|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
2534369|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
2534370|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534371|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2534372|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534373|NCT01405118|Metformin|metformin|mesh-list
2405440|NCT00738829|Rituximab|rituximab|mesh-list
2405441|NCT00738829|Fludarabine|fludarabine|mesh-list
2405442|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
2405443|NCT00738829|Lenalidomide|lenalidomide|mesh-list
2405444|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2405445|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405446|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
2534374|NCT01405118|Tofacitinib|tofacitinib|mesh-list
2534375|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2534376|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534377|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2534378|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534379|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534380|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
2534381|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2534382|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2534383|NCT01405131|Prednisolone|prednisolone|mesh-list
2534384|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
2534385|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2534386|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
2534387|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2405447|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405448|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2405449|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2405450|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
2405451|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405452|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405453|NCT00738829|Antiviral Agents|antiviral agents|mesh-ancestor
2405454|NCT00738829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405455|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2405456|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2405457|NCT00738829|Growth Substances|growth substances|mesh-ancestor
2405458|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
2405459|NCT00738842|Ticagrelor|ticagrelor|mesh-list
2405460|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2405461|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2405462|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2405463|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2405464|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
2405465|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2405466|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405467|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405468|NCT00738868|Cetuximab|cetuximab|mesh-list
2405469|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2405470|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405471|NCT00738985|Simvastatin|simvastatin|mesh-list
2405472|NCT00738985|Ezetimibe|ezetimibe|mesh-list
2405473|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2405474|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2534388|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
2405475|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2405476|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
2405477|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405478|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2405479|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2405480|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534389|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
2534390|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534391|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534392|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2534393|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
2534394|NCT01405131|Hormones|hormones|mesh-ancestor
2534395|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2534396|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2534397|NCT01405131|Protective Agents|protective agents|mesh-ancestor
2534398|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2534399|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534400|NCT01405144|Fluorouracil|fluorouracil|mesh-list
2534401|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
2534402|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534403|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2534404|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534405|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2534406|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
2534407|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534408|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
2534409|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2405481|NCT00739128|Vaccines|vaccines|mesh-list
2405482|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
2405483|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405484|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
2405485|NCT00739141|Thiotepa|thiotepa|mesh-list
2405486|NCT00739141|Fludarabine|fludarabine|mesh-list
2405487|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405488|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
2405489|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405490|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2405491|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2405492|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
2405493|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405494|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405495|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2405496|NCT00739193|Amiodarone|amiodarone|mesh-list
2405497|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2405498|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
2405499|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2405500|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2405501|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405502|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2405503|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2405504|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2405505|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405506|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2405507|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2405508|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2405509|NCT00739349|Cyclosporine|cyclosporine|mesh-list
2405510|NCT00739349|Cyclosporins|cyclosporins|mesh-list
2405511|NCT00739349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405512|NCT00739349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405513|NCT00739349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405514|NCT00739349|Immunologic Factors|immunologic factors|mesh-ancestor
2405515|NCT00739349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405516|NCT00739349|Antifungal Agents|antifungal agents|mesh-ancestor
2405517|NCT00739349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405518|NCT00739349|Dermatologic Agents|dermatologic agents|mesh-ancestor
2405519|NCT00739349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2405520|NCT00739349|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2405521|NCT00739388|Azacitidine|azacitidine|mesh-list
2405522|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2405523|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
2405524|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405525|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405526|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534410|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2534411|NCT01405157|Prednisolone|prednisolone|mesh-list
2534412|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
2534413|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2534414|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
2534415|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2534416|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
2534417|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
2405527|NCT00739414|Panobinostat|panobinostat|mesh-list
2405528|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405529|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2405530|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405531|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405532|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2405533|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405534|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2405535|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405536|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405537|NCT00739466|Alendronate|alendronate|mesh-list
2405538|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2405539|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405540|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
2405541|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
2405542|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405543|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
2405544|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2405545|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
2405546|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405547|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534418|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534419|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405548|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2405549|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
2405550|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2405551|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
2405552|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534420|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2534421|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
2534422|NCT01405157|Hormones|hormones|mesh-ancestor
2534423|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2534424|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2534425|NCT01405157|Protective Agents|protective agents|mesh-ancestor
2534426|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2534427|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534428|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
2534429|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2534430|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2534431|NCT01405170|Prednisolone|prednisolone|mesh-list
2534432|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
2534433|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2534434|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
2534435|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2534436|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
2534437|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
2534438|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534439|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534440|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2534441|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
2534442|NCT01405170|Hormones|hormones|mesh-ancestor
2534443|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2534444|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2534445|NCT01405170|Protective Agents|protective agents|mesh-ancestor
2534446|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2534447|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534448|NCT01405235|Paclitaxel|paclitaxel|mesh-list
2534449|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2534450|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2534451|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534452|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
2534453|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
2534454|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
2534455|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534456|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
2534457|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2405553|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2405554|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2405555|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
2405556|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
2405557|NCT00739531|Protective Agents|protective agents|mesh-ancestor
2405558|NCT00739609|Tryptophan|tryptophan|mesh-list
2405559|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2405560|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
2405561|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2405562|NCT00739622|Rilpivirine|rilpivirine|mesh-list
2534458|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2534459|NCT01405248|Protective Agents|protective agents|mesh-ancestor
2534460|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534461|NCT01405326|Adalimumab|adalimumab|mesh-list
2534462|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2534463|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2534464|NCT01405339|Budesonide|budesonide|mesh-list
2405563|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2405564|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2405565|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405566|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405567|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
2405568|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405569|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2405570|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2405571|NCT00739830|Sirolimus|sirolimus|mesh-list
2405572|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2405573|NCT00739830|Megestrol|megestrol|mesh-list
2405574|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
2405575|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
2405576|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2534465|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2534466|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2534467|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
2534468|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534469|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534470|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2534471|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
2534472|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
2534473|NCT01405339|Hormones|hormones|mesh-ancestor
2534474|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2534475|NCT01405352|Vitamin A|vitamin a|mesh-list
2534476|NCT01405352|Vitamins|vitamins|mesh-ancestor
2534477|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
2534478|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534479|NCT01405365|Metronidazole|metronidazole|mesh-list
2534480|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405577|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2405578|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2405579|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
2405580|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2405581|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405582|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2405583|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2534481|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2534482|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2534483|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2534484|NCT01405430|Bevacizumab|bevacizumab|mesh-list
2534485|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2534486|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534487|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2534488|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2534489|NCT01405430|Growth Substances|growth substances|mesh-ancestor
2534490|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534491|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
2534492|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
2534493|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2534494|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2534495|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2534496|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2534497|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534498|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
2534499|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534500|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534501|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2534502|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405584|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2405585|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2405586|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405587|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
2405588|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2534503|NCT01405521|Vaccines|vaccines|mesh-list
2534504|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
2534505|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534506|NCT01405573|Sorafenib|sorafenib|mesh-list
2534507|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534508|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2534509|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534510|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534511|NCT01405586|Gemcitabine|gemcitabine|mesh-list
2534512|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534513|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2534514|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
2534515|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534516|NCT01405586|Antiviral Agents|antiviral agents|mesh-ancestor
2534517|NCT01405586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534518|NCT01405586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534519|NCT01405586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2534520|NCT01405586|Immunologic Factors|immunologic factors|mesh-ancestor
2534521|NCT01405586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534522|NCT01405612|Midazolam|midazolam|mesh-list
2534523|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2534524|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2534525|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2534526|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534527|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2534528|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2534529|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2534530|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2534531|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
2534532|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
2534533|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
2534534|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
2534535|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534536|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534537|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
2534538|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2534539|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534540|NCT01405846|Gefitinib|gefitinib|mesh-list
2534541|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534542|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2534543|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534544|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534545|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
2534546|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2534547|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
2534548|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534549|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534550|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
2534551|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534552|NCT01405989|Ketoconazole|ketoconazole|mesh-list
2534553|NCT01405989|Darexaban|darexaban|mesh-list
2534554|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
2534555|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534556|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2534557|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2534558|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534559|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534560|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2534561|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
2534562|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2534563|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534564|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2534565|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2534566|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
2534567|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2534568|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
2534569|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
2534570|NCT01406002|Rifampin|rifampin|mesh-list
2534571|NCT01406002|Darexaban|darexaban|mesh-list
2534572|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2405589|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2405590|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405591|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2405592|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
2405593|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2534573|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
2534574|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2534575|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534576|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
2534577|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2534578|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534579|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534580|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2534581|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2534582|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2534583|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2534584|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2405594|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
2405595|NCT00739986|Semapimod|semapimod|mesh-list
2405596|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2405597|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2405598|NCT00739986|Analgesics|analgesics|mesh-ancestor
2405599|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
2405600|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405601|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405602|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2405603|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2405604|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405605|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
2534585|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2534586|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2534587|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
2534588|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2534589|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
2534590|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
2534591|NCT01406080|Adapalene|adapalene|mesh-list
2534592|NCT01406080|Tretinoin|tretinoin|mesh-list
2534593|NCT01406080|Emollients|emollients|mesh-list
2534594|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2534595|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2534596|NCT01406080|Analgesics|analgesics|mesh-ancestor
2534597|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
2534598|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534599|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534600|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2534601|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2534602|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
2534603|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534604|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
2534605|NCT01406132|Peficitinib|peficitinib|mesh-list
2534606|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534607|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534608|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2534609|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
2534610|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534611|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
2534612|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2534613|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2534614|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
2534615|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534616|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534617|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534618|NCT01406158|Urological Agents|urological agents|mesh-ancestor
2534619|NCT01406171|Isavuconazole|isavuconazole|mesh-list
2534620|NCT01406171|Midazolam|midazolam|mesh-list
2534621|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2534622|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2534623|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2534624|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534625|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2534626|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2534627|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2534628|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2534629|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
2534630|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
2534631|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
2534632|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
2534633|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534634|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534635|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
2534636|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534637|NCT01406197|Progesterone|progesterone|mesh-list
2534638|NCT01406197|Progestins|progestins|mesh-ancestor
2534639|NCT01406197|Hormones|hormones|mesh-ancestor
2534640|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2534641|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534642|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
2534643|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
2534644|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2534645|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534646|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2534647|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2534648|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534649|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534650|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534651|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405606|NCT00740064|Lamivudine|lamivudine|mesh-list
2405607|NCT00740064|Abacavir|abacavir|mesh-list
2405608|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
2405609|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2405610|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2405611|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405612|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405613|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
2405614|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405615|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2405616|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2405617|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2405618|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2534652|NCT01406262|Incretins|incretins|mesh-ancestor
2534653|NCT01406262|Hormones|hormones|mesh-ancestor
2534654|NCT01406262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2534655|NCT01406275|Amoxicillin|amoxicillin|mesh-list
2534656|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
2534657|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
2534658|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2534659|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534660|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2534661|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534662|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534663|NCT01406301|PENTA|penta|mesh-list
2534664|NCT01406301|Fondaparinux|fondaparinux|mesh-list
2534665|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2534666|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
2534667|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2534668|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
2534669|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534670|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534671|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
2534672|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2534673|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2534674|NCT01406327|Ambrisentan|ambrisentan|mesh-list
2534675|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2534676|NCT01406392|Misoprostol|misoprostol|mesh-list
2534677|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2534678|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
2534679|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2534680|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534681|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2534682|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2534683|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
2534684|NCT01406431|Valsartan|valsartan|mesh-list
2534685|NCT01406431|Pitavastatin|pitavastatin|mesh-list
2534686|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2534687|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2534688|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2534689|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534690|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2534691|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2534692|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2405619|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2534693|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
2534694|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534695|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2534696|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
2405620|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2405621|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
2405622|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405623|NCT00740090|Antacids|antacids|mesh-ancestor
2405624|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405625|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2405626|NCT00740103|Semapimod|semapimod|mesh-list
2405627|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2405628|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2405629|NCT00740103|Analgesics|analgesics|mesh-ancestor
2405630|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
2405631|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405632|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405633|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2405634|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2405635|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405636|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
2405637|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
2405638|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2405639|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2405640|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405641|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
2405642|NCT00740116|Coagulants|coagulants|mesh-ancestor
2405643|NCT00740142|Lactulose|lactulose|mesh-list
2405644|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
2405645|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2405646|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2534697|NCT01406470|Antibodies|antibodies|mesh-list
2534698|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
2534699|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2534700|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2534701|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
2534702|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
2534703|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534704|NCT01406496|Insulin|insulin|mesh-list
2534705|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2405647|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2405648|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2405649|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405650|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405651|NCT00740168|Bevacizumab|bevacizumab|mesh-list
2405652|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2405653|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405654|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2405655|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2405656|NCT00740168|Growth Substances|growth substances|mesh-ancestor
2534706|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2534707|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534708|NCT01406522|Tacrine|tacrine|mesh-list
2534709|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2534710|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534711|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405657|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534712|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
2534713|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534714|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534715|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2534716|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
2534717|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534718|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
2534719|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2534720|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
2534721|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2534722|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2534723|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534724|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534725|NCT01406535|Urological Agents|urological agents|mesh-ancestor
2534726|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2534727|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
2534728|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534729|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2534730|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2534731|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534732|NCT01406639|Ranibizumab|ranibizumab|mesh-list
2534733|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2534734|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2405658|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
2405659|NCT00740194|Estradiol|estradiol|mesh-list
2405660|NCT00740194|Estrogens|estrogens|mesh-ancestor
2405661|NCT00740194|Hormones|hormones|mesh-ancestor
2405662|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2405663|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405664|NCT00740259|Flunarizine|flunarizine|mesh-list
2405665|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
2405666|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2534735|NCT01406639|Growth Substances|growth substances|mesh-ancestor
2534736|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534737|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
2534738|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534739|NCT01406678|Sufentanil|sufentanil|mesh-list
2534740|NCT01406678|Dsuvia|dsuvia|mesh-list
2534741|NCT01406678|Isoflurane|isoflurane|mesh-list
2405667|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2405668|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405669|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2405670|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405671|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2405672|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
2405673|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
2405674|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2405675|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
2405676|NCT00740285|Lidocaine|lidocaine|mesh-list
2405677|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
2405678|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
2405679|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2405680|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405681|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
2405682|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405683|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2405684|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2405685|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2405686|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2405687|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405688|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2405689|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2405690|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405691|NCT00740363|Incretins|incretins|mesh-ancestor
2405692|NCT00740363|Hormones|hormones|mesh-ancestor
2405693|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2405694|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2405695|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
2405696|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405697|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534742|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
2534743|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2534744|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534745|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2534746|NCT01406678|Narcotics|narcotics|mesh-ancestor
2534747|NCT01406678|Analgesics|analgesics|mesh-ancestor
2405698|NCT00740389|Etravirine|etravirine|mesh-list
2405699|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2405700|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2405701|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405702|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405703|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
2534748|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
2534749|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534750|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2534751|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2534752|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
2534753|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2534754|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
2534755|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
2534756|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2534757|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534758|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
2405704|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405705|NCT00740415|Dexamethasone|dexamethasone|mesh-list
2405706|NCT00740415|Rituximab|rituximab|mesh-list
2405707|NCT00740415|Bortezomib|bortezomib|mesh-list
2405708|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2405709|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2405710|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
2405711|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
2405712|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405713|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534759|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534760|NCT01406704|Protective Agents|protective agents|mesh-ancestor
2534761|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
2534762|NCT01406704|Vitamins|vitamins|mesh-ancestor
2534763|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
2534764|NCT01406782|Rituximab|rituximab|mesh-list
2534765|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2534766|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534767|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
2534768|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534769|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2534770|NCT01407003|Licogliflozin|licogliflozin|mesh-list
2534771|NCT01407003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2534772|NCT01407003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534773|NCT01407003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2405714|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2405715|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
2405716|NCT00740415|Hormones|hormones|mesh-ancestor
2405717|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2405718|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2405719|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405720|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2116514|NCT02641561|Analgesics|analgesics|mesh-ancestor
2116515|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
2116516|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116517|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116518|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2116519|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2116520|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
2116521|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
2116522|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2116523|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2116524|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116525|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116526|NCT02641691|Leucovorin|leucovorin|mesh-list
2534774|NCT01407003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534775|NCT01407016|Metronidazole|metronidazole|mesh-list
2534776|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534777|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2534778|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2534779|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2534780|NCT01407211|Vitamin A|vitamin a|mesh-list
2534781|NCT01407211|Vitamins|vitamins|mesh-ancestor
2534782|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
2534783|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534784|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
2534785|NCT01407237|Giapreza|giapreza|mesh-list
2534786|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
2534787|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2534788|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2534789|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
2534790|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534791|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534792|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2534793|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534794|NCT01407289|Insulin|insulin|mesh-list
2534795|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
2534796|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
2534797|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2534798|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534799|NCT01407432|Folic Acid|folic acid|mesh-list
2534800|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
2534801|NCT01407432|Hematinics|hematinics|mesh-ancestor
2534802|NCT01407432|Vitamins|vitamins|mesh-ancestor
2534803|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
2534804|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534805|NCT01407471|Clobetasol|clobetasol|mesh-list
2534806|NCT01407471|Spironolactone|spironolactone|mesh-list
2405721|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
2405722|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2405723|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2405724|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
2405725|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405726|NCT00740467|Cyclosporine|cyclosporine|mesh-list
2405727|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
2405728|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
2405729|NCT00740467|Busulfan|busulfan|mesh-list
2405730|NCT00740467|Fludarabine|fludarabine|mesh-list
2405731|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
2405732|NCT00740467|Cyclosporins|cyclosporins|mesh-list
2405733|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2405734|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405735|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
2405736|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405737|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2405738|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2405739|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
2405740|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405741|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405742|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2405743|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2405744|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
2405745|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405746|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
2405747|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405748|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
2405749|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2405750|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2405751|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2405752|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
2405753|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2405754|NCT00740493|Warfarin|warfarin|mesh-list
2405755|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
2534807|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2534808|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
2534809|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2534810|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534811|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2534812|NCT01407471|Diuretics|diuretics|mesh-ancestor
2534813|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
2534814|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2534815|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
2405756|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
2405757|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2405758|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534816|NCT01407471|Hormones|hormones|mesh-ancestor
2534817|NCT01407484|Prednisone|prednisone|mesh-list
2534818|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2534819|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
2534820|NCT01407484|Hormones|hormones|mesh-ancestor
2534821|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2534822|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534823|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2534824|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405759|NCT00740545|Enoxaparin|enoxaparin|mesh-list
2405760|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
2405761|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2405762|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2405763|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405764|NCT00740571|Pregabalin|pregabalin|mesh-list
2405765|NCT00740571|Amitriptyline|amitriptyline|mesh-list
2405766|NCT00740571|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2405767|NCT00740571|Analgesics|analgesics|mesh-ancestor
2405768|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
2405769|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405770|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405771|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
2405772|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2405773|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2405774|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534825|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2534826|NCT01407562|Paclitaxel|paclitaxel|mesh-list
2534827|NCT01407562|Carboplatin|carboplatin|mesh-list
2534828|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2405775|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2405776|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2405777|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2405778|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2405779|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2405780|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2405781|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
2405782|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2534829|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534830|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
2534831|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
2534832|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
2534833|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534834|NCT01407666|Anesthetics|anesthetics|mesh-list
2534835|NCT01407666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2534836|NCT01407666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534837|NCT01407679|Alitretinoin|alitretinoin|mesh-list
2534838|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534839|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
2534840|NCT01407822|Gemcitabine|gemcitabine|mesh-list
2534841|NCT01407822|Cisplatin|cisplatin|mesh-list
2534842|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2534843|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534844|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2534845|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
2534846|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534847|NCT01407822|Antiviral Agents|antiviral agents|mesh-ancestor
2534848|NCT01407822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534849|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534850|NCT01407822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405783|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2405784|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2405785|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
2405786|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2405787|NCT00740571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2405788|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
2405789|NCT00740805|Doxorubicin|doxorubicin|mesh-list
2405790|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2405791|NCT00740805|Veliparib|veliparib|mesh-list
2405792|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2405793|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
2405794|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405795|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2405796|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2405797|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
2405798|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405799|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405800|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2405801|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2405802|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2405803|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2405804|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405805|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2405806|NCT00740883|Warfarin|warfarin|mesh-list
2405807|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
2405808|NCT00740922|Becaplermin|becaplermin|mesh-list
2534851|NCT01407822|Immunologic Factors|immunologic factors|mesh-ancestor
2534852|NCT01407822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534853|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2534854|NCT01407848|Furosemide|furosemide|mesh-list
2534855|NCT01407848|Diuretics|diuretics|mesh-ancestor
2534856|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
2534857|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534858|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2534859|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2534860|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534861|NCT01407887|Artesunate|artesunate|mesh-list
2405809|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
2405810|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2405811|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2405812|NCT00740922|Growth Substances|growth substances|mesh-ancestor
2405813|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405814|NCT00740948|Rituximab|rituximab|mesh-list
2405815|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2405816|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405817|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
2405818|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405819|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2405820|NCT00741052|Azithromycin|azithromycin|mesh-list
2405821|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
2405822|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2405823|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405824|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2405825|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2405826|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405827|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405828|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405829|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2405830|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2405831|NCT00741078|Amlodipine|amlodipine|mesh-list
2405832|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2405833|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2405834|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2405835|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405836|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2405837|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405838|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
2534862|NCT01407887|Amodiaquine|amodiaquine|mesh-list
2534863|NCT01407887|Methylene Blue|methylene blue|mesh-list
2534864|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
2534865|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2405839|NCT00741117|Bilirubin|bilirubin|mesh-list
2405840|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
2405841|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405842|NCT00741117|Protective Agents|protective agents|mesh-ancestor
2405843|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405844|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
2405845|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2405846|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
2405847|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
2405848|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405849|NCT00741169|Rifampin|rifampin|mesh-list
2405850|NCT00741169|Simeprevir|simeprevir|mesh-list
2405851|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2405852|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
2405853|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2405854|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405855|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
2405856|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2405857|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405858|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405859|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2534866|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2534867|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534868|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534869|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
2534870|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
2534871|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2534872|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
2534873|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534874|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534875|NCT01407978|Vaccines|vaccines|mesh-list
2534876|NCT01407978|Immunologic Factors|immunologic factors|mesh-ancestor
2534877|NCT01407978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534878|NCT01408004|Everolimus|everolimus|mesh-list
2534879|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534880|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2534881|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
2534882|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534883|NCT01408056|Mupirocin|mupirocin|mesh-list
2534884|NCT01408056|Timolol|timolol|mesh-list
2405860|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2534885|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2534886|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2534887|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
2534888|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534889|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534890|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534891|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2534892|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2534893|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2534894|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534895|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2534896|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534897|NCT01408095|Glimepiride|glimepiride|mesh-list
2534898|NCT01408095|Globalagliatin|globalagliatin|mesh-list
2534899|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2534900|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2534901|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405861|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2405862|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2405863|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2534902|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2534903|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
2534904|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
2534905|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534906|NCT01408160|Cytarabine|cytarabine|mesh-list
2534907|NCT01408160|Immunotoxins|immunotoxins|mesh-list
2534908|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2534909|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
2534910|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534911|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116527|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
2116528|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
2116529|NCT02641691|Fluorouracil|fluorouracil|mesh-list
2116530|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
2116531|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
2116532|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
2116533|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116534|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2116535|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116536|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2116537|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
2116538|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116539|NCT02641691|Antidotes|antidotes|mesh-ancestor
2116540|NCT02641691|Protective Agents|protective agents|mesh-ancestor
2116541|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
2116542|NCT02641691|Vitamins|vitamins|mesh-ancestor
2116543|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
2534912|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
2534913|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534914|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2534915|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
2534916|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534917|NCT01408173|Caffeine|caffeine|mesh-list
2534918|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
2534919|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534920|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2534921|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534922|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2534923|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534924|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2534925|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2405864|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2405865|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
2405866|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
2405867|NCT00741182|Teriparatide|teriparatide|mesh-list
2405868|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2405869|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405870|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2405871|NCT00741195|Bevacizumab|bevacizumab|mesh-list
2405872|NCT00741195|Docetaxel|docetaxel|mesh-list
2405873|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2405874|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405875|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2405876|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2405877|NCT00741195|Growth Substances|growth substances|mesh-ancestor
2405878|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405879|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
2405880|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
2405881|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
2405882|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
2405883|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405884|NCT00741221|Bevacizumab|bevacizumab|mesh-list
2405885|NCT00741221|Pemetrexed|pemetrexed|mesh-list
2405886|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2405887|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405888|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2405889|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2405890|NCT00741221|Growth Substances|growth substances|mesh-ancestor
2405891|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405892|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
2405893|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405894|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405895|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2405896|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2405897|NCT00741234|Azacitidine|azacitidine|mesh-list
2405898|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2405899|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
2405900|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405901|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405902|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405903|NCT00741325|Plerixafor|plerixafor|mesh-list
2405904|NCT00741325|Sargramostim|sargramostim|mesh-list
2405905|NCT00741325|Lenograstim|lenograstim|mesh-list
2405906|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
2405907|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405908|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2405909|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2405910|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2405911|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
2405912|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2534926|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
2534927|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534928|NCT01408186|Rabeprazole|rabeprazole|mesh-list
2534929|NCT01408186|Famotidine|famotidine|mesh-list
2534930|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2534931|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2534932|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2534933|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2534934|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534935|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2534936|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
2534937|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
2534938|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534939|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534940|NCT01408199|Lenalidomide|lenalidomide|mesh-list
2534941|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
2534942|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534943|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2534944|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2534945|NCT01408199|Growth Substances|growth substances|mesh-ancestor
2534946|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
2534947|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2534948|NCT01408290|Vaccines|vaccines|mesh-list
2534949|NCT01408290|Immunologic Factors|immunologic factors|mesh-ancestor
2534950|NCT01408290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534951|NCT01408342|Rituximab|rituximab|mesh-list
2534952|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
2534953|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2534954|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405913|NCT00741351|Fentanyl|fentanyl|mesh-list
2405914|NCT00741351|Remifentanil|remifentanil|mesh-list
2405915|NCT00741351|Propofol|propofol|mesh-list
2405916|NCT00741351|Sevoflurane|sevoflurane|mesh-list
2405917|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2405918|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2405919|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405920|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2405921|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
2534955|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
2534956|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534957|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2534958|NCT01408394|Ecopipam|ecopipam|mesh-list
2405922|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
2405923|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2534959|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2534960|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2534961|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2534962|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534963|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2534964|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2534965|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
2534966|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534967|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534968|NCT01408446|Menthol|menthol|mesh-list
2534969|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
2534970|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
2534971|NCT01408498|Testosterone|testosterone|mesh-list
2534972|NCT01408498|Androgens|androgens|mesh-ancestor
2534973|NCT01408498|Hormones|hormones|mesh-ancestor
2534974|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2534975|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534976|NCT01408524|Diltiazem|diltiazem|mesh-list
2534977|NCT01408524|Labetalol|labetalol|mesh-list
2534978|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2534979|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2534980|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2534981|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534982|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2534983|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2534984|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
2534985|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2534986|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2534987|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
2534988|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2534989|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
2534990|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
2534991|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2534992|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2534993|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2534994|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2534995|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2534996|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2534997|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2534998|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2534999|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
2535000|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535001|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535002|NCT01408680|Ubiquinone|ubiquinone|mesh-list
2535003|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
2535004|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
2535005|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405924|NCT00741351|Narcotics|narcotics|mesh-ancestor
2405925|NCT00741351|Analgesics|analgesics|mesh-ancestor
2405926|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
2405927|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405928|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2405929|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2405930|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2405931|NCT00741364|Vitamin D|vitamin d|mesh-list
2405932|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
2405933|NCT00741364|Vitamins|vitamins|mesh-ancestor
2405934|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
2405935|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405936|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2405937|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2405938|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
2405939|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2405940|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405941|NCT00741429|Insulin|insulin|mesh-list
2405942|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2535006|NCT01408680|Vitamins|vitamins|mesh-ancestor
2535007|NCT01408797|Bortezomib|bortezomib|mesh-list
2535008|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535009|NCT01408810|Infliximab|infliximab|mesh-list
2535010|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
2535011|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535012|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2535013|NCT01408836|Prednisolone|prednisolone|mesh-list
2535014|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2535015|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
2535016|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2535017|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
2535018|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2535019|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
2535020|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2535021|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
2535022|NCT01408836|Hormones|hormones|mesh-ancestor
2405943|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405944|NCT00741507|Ethanol|ethanol|mesh-list
2405945|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2405946|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2405947|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2405948|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405949|NCT00741585|Atenolol|atenolol|mesh-list
2405950|NCT00741585|Amlodipine|amlodipine|mesh-list
2535023|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2535024|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535025|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2535026|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535027|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
2535028|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
2535029|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535030|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535031|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2535032|NCT01408836|Protective Agents|protective agents|mesh-ancestor
2535033|NCT01408849|Omeprazole|omeprazole|mesh-list
2535034|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2535035|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535036|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2405951|NCT00741585|Valsartan|valsartan|mesh-list
2405952|NCT00741585|Telmisartan|telmisartan|mesh-list
2405953|NCT00741585|Carvedilol|carvedilol|mesh-list
2535037|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535038|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535039|NCT01408927|Aspirin|aspirin|mesh-list
2535040|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2535041|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2535042|NCT01408927|Analgesics|analgesics|mesh-ancestor
2535043|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
2535044|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535045|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535046|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2535047|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2535048|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2535049|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2535050|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535051|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2535052|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2535053|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535054|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
2535055|NCT01408953|Bevacizumab|bevacizumab|mesh-list
2535056|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2535057|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535058|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2405954|NCT00741585|Candesartan|candesartan|mesh-list
2405955|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
2405956|NCT00741585|Ramipril|ramipril|mesh-list
2405957|NCT00741585|Olmesartan|olmesartan|mesh-list
2405958|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2405959|NCT00741585|Enalapril|enalapril|mesh-list
2405960|NCT00741585|Enalaprilat|enalaprilat|mesh-list
2405961|NCT00741585|Lisinopril|lisinopril|mesh-list
2405962|NCT00741585|Irbesartan|irbesartan|mesh-list
2535059|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2535060|NCT01408953|Growth Substances|growth substances|mesh-ancestor
2535061|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535062|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
2535063|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
2535064|NCT01408979|Analgesics|analgesics|mesh-ancestor
2535065|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
2535066|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535067|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535068|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
2535069|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2535070|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2535071|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
2535072|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2405963|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
2405964|NCT00741585|Quinapril|quinapril|mesh-list
2405965|NCT00741585|Lercanidipine|lercanidipine|mesh-list
2535073|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2535074|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535075|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2535076|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
2535077|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2535078|NCT01409005|Gemcitabine|gemcitabine|mesh-list
2535079|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2535080|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
2535081|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535082|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535083|NCT01409005|Antiviral Agents|antiviral agents|mesh-ancestor
2535084|NCT01409005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535085|NCT01409005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535086|NCT01409005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2535087|NCT01409005|Immunologic Factors|immunologic factors|mesh-ancestor
2535088|NCT01409005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535089|NCT01409018|Itraconazole|itraconazole|mesh-list
2535090|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
2535091|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
2535092|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535093|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2535094|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2405966|NCT00741585|Manidipine|manidipine|mesh-list
2405967|NCT00741585|Doxazosin|doxazosin|mesh-list
2405968|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2405969|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2405970|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2405971|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2405972|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405973|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
2405974|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2405975|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2405976|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2405977|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2405978|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
2405979|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535095|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535096|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535097|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2535098|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
2535099|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2535100|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535101|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2535102|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2535103|NCT01409148|Antibodies|antibodies|mesh-list
2535104|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2535105|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
2535106|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535107|NCT01409161|Vitamins|vitamins|mesh-list
2535108|NCT01409161|Vitamin A|vitamin a|mesh-list
2535109|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
2535110|NCT01409161|Tretinoin|tretinoin|mesh-list
2535111|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
2535112|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
2535113|NCT01409161|Calicheamicins|calicheamicins|mesh-list
2405980|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
2535114|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
2535115|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535116|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
2535117|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535118|NCT01409161|Protective Agents|protective agents|mesh-ancestor
2535119|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2535120|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535121|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
2535122|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
2535123|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2535124|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2535125|NCT01409174|Interferons|interferons|mesh-list
2535126|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
2535127|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
2535128|NCT01409174|Aldesleukin|aldesleukin|mesh-list
2535129|NCT01409174|Cisplatin|cisplatin|mesh-list
2535130|NCT01409174|Temozolomide|temozolomide|mesh-list
2535131|NCT01409174|Ipilimumab|ipilimumab|mesh-list
2535132|NCT01409174|Interleukin-2|interleukin-2|mesh-list
2535133|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2405981|NCT00741585|Protective Agents|protective agents|mesh-ancestor
2405982|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2535134|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
2535135|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535136|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2535137|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
2535138|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535139|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2535140|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2535141|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
2535142|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535143|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2535144|NCT01409174|Analgesics|analgesics|mesh-ancestor
2535145|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
2535146|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535147|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2535148|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2535149|NCT01409187|Interferons|interferons|mesh-list
2535150|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
2535151|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
2535152|NCT01409187|Aldesleukin|aldesleukin|mesh-list
2535153|NCT01409187|Ipilimumab|ipilimumab|mesh-list
2535154|NCT01409187|Interleukin-2|interleukin-2|mesh-list
2535155|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535156|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
2535157|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535158|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2535159|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2535160|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535161|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
2535162|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535163|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2535164|NCT01409187|Analgesics|analgesics|mesh-ancestor
2535165|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
2535166|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535167|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2535168|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2535169|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
2535170|NCT01409200|Axitinib|axitinib|mesh-list
2535171|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
2535172|NCT01409200|Hormones|hormones|mesh-list
2535173|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2535174|NCT01409200|Androgens|androgens|mesh-list
2405983|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2405984|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2405985|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
2405986|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2405987|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2405988|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2405989|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
2405990|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
2405991|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2405992|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2405993|NCT00741663|Furosemide|furosemide|mesh-list
2405994|NCT00741663|Spironolactone|spironolactone|mesh-list
2405995|NCT00741663|Diuretics|diuretics|mesh-ancestor
2405996|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
2405997|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2405998|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2405999|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2406000|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406001|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2406002|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
2406003|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406004|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2535175|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
2535176|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2535177|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535178|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535179|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2535180|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535181|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535182|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
2535183|NCT01409200|Protective Agents|protective agents|mesh-ancestor
2535184|NCT01409200|Vitamins|vitamins|mesh-ancestor
2535185|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
2535186|NCT01409200|Estrogens|estrogens|mesh-ancestor
2535187|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2535188|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
2535189|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
2535190|NCT01409278|Ropivacaine|ropivacaine|mesh-list
2535191|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
2535192|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
2535193|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2535194|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535195|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
2535196|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535197|NCT01409369|Charcoal|charcoal|mesh-list
2535198|NCT01409369|Antidotes|antidotes|mesh-ancestor
2406005|NCT00741715|Atorvastatin|atorvastatin|mesh-list
2406006|NCT00741715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2406007|NCT00741715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2535199|NCT01409369|Protective Agents|protective agents|mesh-ancestor
2535200|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535201|NCT01409395|Metformin|metformin|mesh-list
2535202|NCT01409395|Nizatidine|nizatidine|mesh-list
2535203|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2535204|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535205|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2535206|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535207|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2535208|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
2535209|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
2535210|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535211|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535212|NCT01409408|Amlodipine|amlodipine|mesh-list
2535213|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2535214|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2535215|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2535216|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535217|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2535218|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535219|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
2535220|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2535221|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2535222|NCT01409499|Sorafenib|sorafenib|mesh-list
2535223|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535224|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2535225|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535226|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535227|NCT01409603|Naproxen|naproxen|mesh-list
2535228|NCT01409603|Darexaban|darexaban|mesh-list
2535229|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2535230|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2535231|NCT01409603|Analgesics|analgesics|mesh-ancestor
2535232|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
2535233|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535234|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535235|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2535236|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2535237|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
2535238|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2535239|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535240|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535241|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2535242|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
2535243|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2535244|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
2535245|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
2406008|NCT00741715|Antimetabolites|antimetabolites|mesh-ancestor
2406009|NCT00741715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406010|NCT00741715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2406011|NCT00741715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2535246|NCT01409616|Aspirin|aspirin|mesh-list
2535247|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
2535248|NCT01409616|Salicylates|salicylates|mesh-list
2535249|NCT01409616|Darexaban|darexaban|mesh-list
2535250|NCT01409616|Clopidogrel|clopidogrel|mesh-list
2535251|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2535252|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2535253|NCT01409616|Analgesics|analgesics|mesh-ancestor
2535254|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
2535255|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535256|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535257|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2535258|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2535259|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2535260|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2535261|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535262|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2535263|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2535264|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535265|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
2535266|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2535267|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2535268|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2535269|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
2535270|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535271|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535272|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
2535273|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
2535274|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
2406012|NCT00741715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406013|NCT00741741|Rilpivirine|rilpivirine|mesh-list
2406014|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2406015|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2406016|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535275|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2535276|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
2535277|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2535278|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
2535279|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
2535280|NCT01409694|Vitamin D|vitamin d|mesh-list
2535281|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
2535282|NCT01409694|Vitamins|vitamins|mesh-list
2535283|NCT01409694|Memantine|memantine|mesh-list
2535284|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
2535285|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535286|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2535287|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2406017|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406018|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
2406019|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406020|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2406021|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2406022|NCT00741767|Fluticasone|fluticasone|mesh-list
2406023|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2406024|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2406025|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406026|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2406027|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
2406028|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406029|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406030|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2406031|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
2406032|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
2406033|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2406034|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2406035|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2406036|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2406037|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
2406038|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406039|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406040|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
2406041|NCT00741767|Hormones|hormones|mesh-ancestor
2406042|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2535288|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2535289|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2535290|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
2535291|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535292|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535293|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2535294|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2535295|NCT01409733|Doxorubicin|doxorubicin|mesh-list
2406043|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
2406044|NCT00741780|Plerixafor|plerixafor|mesh-list
2535296|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2535297|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535298|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2535299|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2535300|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535301|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535302|NCT01409772|Ethanol|ethanol|mesh-list
2535303|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2535304|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535305|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2535306|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535307|NCT01410162|Tacrolimus|tacrolimus|mesh-list
2535308|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2535309|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
2535310|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535311|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2535312|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535313|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535314|NCT01410188|Latanoprost|latanoprost|mesh-list
2535315|NCT01410188|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2535316|NCT01410188|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2535317|NCT01410201|Dexamethasone|dexamethasone|mesh-list
2406045|NCT00741780|Sargramostim|sargramostim|mesh-list
2406046|NCT00741780|Lenograstim|lenograstim|mesh-list
2406047|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
2406048|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406049|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2535318|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
2535319|NCT01410201|BB 1101|bb 1101|mesh-list
2535320|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2535321|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
2406050|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2535322|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
2535323|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535324|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535325|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535326|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
2535327|NCT01410201|Hormones|hormones|mesh-ancestor
2535328|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2535329|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2535330|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535331|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
2535332|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535333|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535334|NCT01410214|Cisplatin|cisplatin|mesh-list
2535335|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2535336|NCT01410214|Vinorelbine|vinorelbine|mesh-list
2535337|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535338|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2535339|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535340|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535341|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2535342|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
2535343|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
2535344|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
2535345|NCT01410370|Endostar protein|endostar protein|mesh-list
2535346|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2535347|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2535348|NCT01410370|Growth Substances|growth substances|mesh-ancestor
2535349|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535350|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
2535351|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535352|NCT01410630|Telbivudine|telbivudine|mesh-list
2535353|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
2535354|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535355|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2535356|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535357|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535358|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
2535359|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2535360|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535361|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
2535362|NCT01410695|Methotrexate|methotrexate|mesh-list
2535363|NCT01410695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2535364|NCT01410695|Abortifacient Agents|abortifacient agents|mesh-ancestor
2406051|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2406052|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
2406053|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406054|NCT00741845|Metronidazole|metronidazole|mesh-list
2406055|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406056|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2406057|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2406058|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2406059|NCT00741884|Varenicline|varenicline|mesh-list
2406060|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2406061|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2406062|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
2406063|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406064|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406065|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406066|NCT00741897|Fexofenadine|fexofenadine|mesh-list
2406067|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2406068|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2406069|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2406070|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
2406071|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
2535365|NCT01410695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2535366|NCT01410695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535367|NCT01410695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2535368|NCT01410695|Antimetabolites|antimetabolites|mesh-ancestor
2535369|NCT01410695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535370|NCT01410695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535371|NCT01410695|Dermatologic Agents|dermatologic agents|mesh-ancestor
2535372|NCT01410695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535373|NCT01410695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2535374|NCT01410695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2406072|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406073|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406074|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406075|NCT00741910|Semapimod|semapimod|mesh-list
2406076|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2406077|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2406078|NCT00741910|Analgesics|analgesics|mesh-ancestor
2406079|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
2406080|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406081|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406082|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406083|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2406084|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2406085|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
2406086|NCT00741949|Propofol|propofol|mesh-list
2406087|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2406088|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2406089|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406090|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2406091|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
2406092|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
2406093|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
2406094|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
2406095|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2406096|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2406097|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535375|NCT01410695|Immunologic Factors|immunologic factors|mesh-ancestor
2535376|NCT01410695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2535377|NCT01410695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2535378|NCT01410708|Dasatinib|dasatinib|mesh-list
2116553|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
2116554|NCT02642159|Niacin|niacin|mesh-list
2535379|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535380|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2535381|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535382|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535383|NCT01410747|Tacrolimus|tacrolimus|mesh-list
2535384|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2116555|NCT02642159|Niacinamide|niacinamide|mesh-list
2116556|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2116557|NCT02642159|Ezetimibe|ezetimibe|mesh-list
2116558|NCT02642159|Fenofibrate|fenofibrate|mesh-list
2535385|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
2535386|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535387|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2535388|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535389|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406098|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406099|NCT00742014|Urological Agents|urological agents|mesh-ancestor
2406100|NCT00742040|Captopril|captopril|mesh-list
2406101|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2406102|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
2406103|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406104|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406105|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2406106|NCT00742066|Felodipine|felodipine|mesh-list
2406107|NCT00742066|Irbesartan|irbesartan|mesh-list
2406108|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2406109|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2406110|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2406111|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406112|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2406113|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2406114|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2406115|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2535390|NCT01410916|Eculizumab|eculizumab|mesh-list
2535391|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2535392|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2535393|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
2535394|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535395|NCT01410942|Methylphenidate|methylphenidate|mesh-list
2535396|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2535397|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535398|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2535399|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2535400|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2535401|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535402|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
2535403|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535404|NCT01410968|Poly ICLC|poly iclc|mesh-list
2535405|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
2535406|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
2535407|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535408|NCT01411072|Gemcitabine|gemcitabine|mesh-list
2535409|NCT01411072|Fluorouracil|fluorouracil|mesh-list
2535410|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2535411|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
2535412|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535413|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535414|NCT01411072|Antiviral Agents|antiviral agents|mesh-ancestor
2535415|NCT01411072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535416|NCT01411072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535417|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2535418|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
2535419|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535420|NCT01411098|Etoposide|etoposide|mesh-list
2535421|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
2535422|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535423|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2535424|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2535425|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2535426|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535427|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535428|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2535429|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2535430|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2535431|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
2535432|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406116|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406117|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
2406118|NCT00742092|Miglustat|miglustat|mesh-list
2406119|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406120|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406121|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2535433|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2535434|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2535435|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535436|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
2535437|NCT01411124|Promethazine|promethazine|mesh-list
2535438|NCT01411124|Gabapentin|gabapentin|mesh-list
2535439|NCT01411124|Analgesics|analgesics|mesh-ancestor
2535440|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
2535441|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535442|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535443|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
2535444|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2535445|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2535446|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2535447|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2535448|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2535449|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2535450|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535451|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535452|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
2535453|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2535454|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2535455|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
2535456|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
2116559|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2116560|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2116561|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
2116562|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116563|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2406122|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2406123|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
2406124|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406125|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2406126|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2406127|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406128|NCT00742144|Ofatumumab|ofatumumab|mesh-list
2535457|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
2535458|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
2535459|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535460|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2535461|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
2535462|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
2535463|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2535464|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
2535465|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
2535466|NCT01411176|Menthol|menthol|mesh-list
2535467|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
2406129|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406130|NCT00742157|Hormones|hormones|mesh-list
2406131|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406132|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406133|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
2406134|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2406135|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
2406136|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535468|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
2535469|NCT01411189|Menthol|menthol|mesh-list
2535470|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
2535471|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
2535472|NCT01411202|Doxycycline|doxycycline|mesh-list
2535473|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2535474|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535475|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
2535476|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2535477|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2535478|NCT01411254|Betamethasone|betamethasone|mesh-list
2535479|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
2116564|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
2116565|NCT02642159|Vitamins|vitamins|mesh-ancestor
2116566|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
2116567|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116568|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
2184836|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184837|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
2184838|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184839|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184840|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
2406137|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406138|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2406139|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
2406140|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2406141|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2406142|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2406143|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
2406144|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535480|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2535481|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
2535482|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2535483|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2535484|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
2535485|NCT01411254|Hormones|hormones|mesh-ancestor
2535486|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2535487|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535488|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2535489|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
2535490|NCT01411280|Methylphenidate|methylphenidate|mesh-list
2535491|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2535492|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535493|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2535494|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2406145|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406146|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
2406147|NCT00742287|Procyanidin|procyanidin|mesh-list
2406148|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
2406149|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406150|NCT00742287|Protective Agents|protective agents|mesh-ancestor
2406151|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406152|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2406153|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2406154|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406155|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
2406156|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2406157|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
2406158|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406159|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2406160|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2535495|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2535496|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535497|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
2535498|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535499|NCT01411410|Paclitaxel|paclitaxel|mesh-list
2535500|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2535501|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535502|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
2535503|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
2535504|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
2535505|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535506|NCT01411423|Sorafenib|sorafenib|mesh-list
2535507|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535508|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2535509|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406161|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
2406162|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406163|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406164|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2406165|NCT00742339|Octreotide|octreotide|mesh-list
2406166|NCT00742339|Terlipressin|terlipressin|mesh-list
2406167|NCT00742339|Midodrine|midodrine|mesh-list
2406168|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535510|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535511|NCT01411436|Sorafenib|sorafenib|mesh-list
2535512|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535513|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2535514|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535515|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535516|NCT01411514|Prednisone|prednisone|mesh-list
2535517|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2535518|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
2535519|NCT01411514|Hormones|hormones|mesh-ancestor
2406169|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2406170|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406171|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
2406172|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
2406173|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406174|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406175|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2406176|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2406177|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2406178|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2406179|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
2406180|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406181|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406182|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2406183|NCT00742404|Dexamethasone|dexamethasone|mesh-list
2406184|NCT00742404|Doxorubicin|doxorubicin|mesh-list
2406185|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2406186|NCT00742404|Bortezomib|bortezomib|mesh-list
2406187|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406188|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
2406189|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
2406190|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406191|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406192|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2406193|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
2406194|NCT00742404|Hormones|hormones|mesh-ancestor
2406195|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406196|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2406197|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406198|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2406199|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2406200|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2535520|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2535521|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535522|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2535523|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535524|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
2535525|NCT01411670|Protein C|protein c|mesh-list
2535526|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
2535527|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2535528|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2535529|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535530|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535531|NCT01411735|Enalapril|enalapril|mesh-list
2535532|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2406201|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406202|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406203|NCT00742638|Valproic Acid|valproic acid|mesh-list
2406204|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2406205|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
2406206|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2535533|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
2535534|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535535|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535536|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2535537|NCT01411930|Olanzapine|olanzapine|mesh-list
2535538|NCT01411930|Aripiprazole|aripiprazole|mesh-list
2535539|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
2535540|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
2535541|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535542|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535543|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535544|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2535545|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2535546|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2535547|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2535548|NCT01411930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2535549|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2535550|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2535551|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535552|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535553|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
2535554|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
2535555|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
2406207|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2406208|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2406209|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2406210|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406211|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
2406212|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406213|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406214|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
2406215|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406216|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
2406217|NCT00742690|Terlipressin|terlipressin|mesh-list
2535556|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
2535557|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2535558|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2535559|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2535560|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2535561|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2535562|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2535563|NCT01411969|Phenylephrine|phenylephrine|mesh-list
2535564|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
2535565|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2535566|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2535567|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
2535568|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535569|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535570|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535571|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
2535572|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
2535573|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535574|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
2535575|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2535576|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
2535577|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2535578|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
2535579|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2535580|NCT01411969|Protective Agents|protective agents|mesh-ancestor
2535581|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
2535582|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2535583|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2535584|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535585|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
2535586|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535587|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535588|NCT01412073|Misoprostol|misoprostol|mesh-list
2535589|NCT01412073|Oxytocin|oxytocin|mesh-list
2535590|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
2535591|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2535592|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535593|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2535594|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
2535595|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2535596|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535597|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
2535598|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2535599|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
2535600|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535601|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
2535602|NCT01412190|Protective Agents|protective agents|mesh-ancestor
2406218|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2406219|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2406220|NCT00742768|Vitamins|vitamins|mesh-list
2406221|NCT00742768|Vitamin K|vitamin k|mesh-list
2406222|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
2406223|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
2406224|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406225|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2406226|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2406227|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406228|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
2406229|NCT00742768|Coagulants|coagulants|mesh-ancestor
2406230|NCT00742807|Alfentanil|alfentanil|mesh-list
2406231|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2406232|NCT00742807|Narcotics|narcotics|mesh-ancestor
2406233|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2535603|NCT01412294|Capecitabine|capecitabine|mesh-list
2406234|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406235|NCT00742807|Analgesics|analgesics|mesh-ancestor
2535604|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535605|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2535606|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
2535607|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535608|NCT01412307|Lenalidomide|lenalidomide|mesh-list
2535609|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2535610|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
2535611|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535612|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2535613|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2535614|NCT01412307|Growth Substances|growth substances|mesh-ancestor
2535615|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
2535616|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535617|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2535618|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
2535619|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535620|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
2535621|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2535622|NCT01412385|Antibodies|antibodies|mesh-list
2535623|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
2406236|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
2406237|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406238|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2406239|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
2406240|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
2406241|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
2406242|NCT00742820|Calcium|calcium|mesh-list
2406243|NCT00742820|Calcium acetate|calcium acetate|mesh-list
2406244|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2406245|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535624|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2535625|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
2535626|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
2535627|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535628|NCT01412411|Micronutrients|micronutrients|mesh-list
2535629|NCT01412411|Trace Elements|trace elements|mesh-list
2535630|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535631|NCT01412437|Verapamil|verapamil|mesh-list
2535632|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2535633|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2535634|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2535635|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535636|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2535637|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535638|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
2535639|NCT01412515|Everolimus|everolimus|mesh-list
2535640|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535641|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2406246|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2406247|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
2406248|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
2406249|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406250|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2406251|NCT00742846|Triamcinolone|triamcinolone|mesh-list
2535642|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
2535643|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535644|NCT01412567|Vaccines|vaccines|mesh-list
2535645|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
2535646|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535647|NCT01412632|Remifentanil|remifentanil|mesh-list
2535648|NCT01412632|Propofol|propofol|mesh-list
2535649|NCT01412632|Prilocaine|prilocaine|mesh-list
2406252|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2406253|NCT00742846|Lidocaine|lidocaine|mesh-list
2406254|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2406255|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
2406256|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
2406257|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2406258|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406259|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
2406260|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535650|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2535651|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2535652|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535653|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2535654|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
2535655|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
2535656|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2535657|NCT01412632|Narcotics|narcotics|mesh-ancestor
2535658|NCT01412632|Analgesics|analgesics|mesh-ancestor
2535659|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
2535660|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535661|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
2535662|NCT01412645|Resveratrol|resveratrol|mesh-list
2535663|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
2535664|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535665|NCT01412645|Protective Agents|protective agents|mesh-ancestor
2535666|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535667|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535668|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2535669|NCT01412658|Caseins|caseins|mesh-list
2535670|NCT01412658|Glycerol|glycerol|mesh-list
2535671|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
2535672|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
2535673|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535674|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2535675|NCT01412658|Protective Agents|protective agents|mesh-ancestor
2535676|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535677|NCT01412671|Sorafenib|sorafenib|mesh-list
2406261|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2406262|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2406263|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2406264|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2406265|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406266|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406267|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
2535678|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535679|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2535680|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535681|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535682|NCT01412840|Diclofenac|diclofenac|mesh-list
2535683|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2535684|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2535685|NCT01412840|Analgesics|analgesics|mesh-ancestor
2535686|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
2535687|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535688|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535689|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2535690|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2535691|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2535692|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535693|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535694|NCT01412892|Everolimus|everolimus|mesh-list
2535695|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535696|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2535697|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
2535698|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535699|NCT01413022|Leucovorin|leucovorin|mesh-list
2535700|NCT01413022|Fluorouracil|fluorouracil|mesh-list
2535701|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
2535702|NCT01413022|Irinotecan|irinotecan|mesh-list
2535703|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
2535704|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535705|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2535706|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535707|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2406268|NCT00742846|Hormones|hormones|mesh-ancestor
2406269|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406270|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2406271|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
2406272|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406273|NCT00742911|Copper|copper|mesh-list
2406274|NCT00742911|Disulfiram|disulfiram|mesh-list
2406275|NCT00742911|Trace Elements|trace elements|mesh-ancestor
2406276|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
2406277|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406278|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2406279|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2406280|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535708|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
2535709|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535710|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2406281|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406282|NCT00742937|Vitamin A|vitamin a|mesh-list
2406283|NCT00742937|Vitamins|vitamins|mesh-ancestor
2406284|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
2406285|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406286|NCT00742976|Insulin|insulin|mesh-list
2406287|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2406288|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
2406289|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
2406290|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
2406291|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
2406292|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2406293|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406294|NCT00743002|Metformin|metformin|mesh-list
2406295|NCT00743002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2406296|NCT00743002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406297|NCT00743028|Navitoclax|navitoclax|mesh-list
2406298|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406299|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2535711|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2535712|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535713|NCT01413022|Antidotes|antidotes|mesh-ancestor
2535714|NCT01413022|Protective Agents|protective agents|mesh-ancestor
2535715|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
2535716|NCT01413022|Vitamins|vitamins|mesh-ancestor
2535717|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
2535718|NCT01413048|Carvedilol|carvedilol|mesh-list
2535719|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2535720|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2535721|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
2535722|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535723|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535724|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535725|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2535726|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
2535727|NCT01413048|Protective Agents|protective agents|mesh-ancestor
2535728|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2535729|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2535730|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2535731|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
2535732|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2535733|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2406300|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2406301|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406302|NCT00743327|Pioglitazone|pioglitazone|mesh-list
2406303|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2406304|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406305|NCT00743470|Ritonavir|ritonavir|mesh-list
2406306|NCT00743470|Lopinavir|lopinavir|mesh-list
2406307|NCT00743470|Rifabutin|rifabutin|mesh-list
2406308|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2406309|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2406310|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
2406311|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406312|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406313|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2406314|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2406315|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
2406316|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406317|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2406318|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2406319|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2406320|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2406321|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
2406322|NCT00743496|Antibodies|antibodies|mesh-list
2406323|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
2406324|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406325|NCT00743587|Naproxen|naproxen|mesh-list
2406326|NCT00743587|Oxycodone|oxycodone|mesh-list
2406327|NCT00743587|Tramadol|tramadol|mesh-list
2406328|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2406329|NCT00743587|Narcotics|narcotics|mesh-ancestor
2406330|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2406331|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406332|NCT00743587|Analgesics|analgesics|mesh-ancestor
2406333|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
2406334|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406335|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2406336|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2535760|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
2535761|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2535762|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535763|NCT01413230|Vitamins|vitamins|mesh-ancestor
2535764|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
2535765|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2535766|NCT01413477|Calcitriol|calcitriol|mesh-list
2535767|NCT01413477|Betamethasone|betamethasone|mesh-list
2535768|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
2535769|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2535770|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
2535771|NCT01413477|Calcipotriene|calcipotriene|mesh-list
2535772|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2535773|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2535774|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
2535775|NCT01413477|Hormones|hormones|mesh-ancestor
2535776|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2535777|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535778|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2535779|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
2535780|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
2535781|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2535782|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2535783|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2535784|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535785|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2535786|NCT01413477|Vitamins|vitamins|mesh-ancestor
2535787|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
2535788|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2535789|NCT01413490|Rimantadine|rimantadine|mesh-list
2535790|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
2535791|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535792|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2535793|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535794|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535795|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
2535796|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535797|NCT01413620|Vitamins|vitamins|mesh-list
2535798|NCT01413620|Vitamin E|vitamin e|mesh-list
2535799|NCT01413620|Tocopherols|tocopherols|mesh-list
2535800|NCT01413620|Tocotrienols|tocotrienols|mesh-list
2535801|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
2535802|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
2535803|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535804|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
2535805|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406337|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2535806|NCT01413620|Protective Agents|protective agents|mesh-ancestor
2535807|NCT01413711|Vigabatrin|vigabatrin|mesh-list
2535808|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
2535809|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535810|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535811|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
2535812|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535813|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535814|NCT01413763|Imiquimod|imiquimod|mesh-list
2535815|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2535816|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
2535817|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535818|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535819|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
2535820|NCT01413854|Diclofenac|diclofenac|mesh-list
2535821|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2535822|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2535823|NCT01413854|Analgesics|analgesics|mesh-ancestor
2535824|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
2535825|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535826|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535827|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2535828|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2535829|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2535830|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535831|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535832|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
2535833|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2535834|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
2535835|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2406338|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2406339|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
2406340|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2406341|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406342|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406343|NCT00743678|Cetuximab|cetuximab|mesh-list
2535836|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535837|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2535838|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2535839|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2535840|NCT01414231|Cytarabine|cytarabine|mesh-list
2535841|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2535842|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
2535843|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535844|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535845|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
2535846|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535847|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2406344|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2406345|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406346|NCT00743743|Resveratrol|resveratrol|mesh-list
2406347|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
2406348|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406349|NCT00743743|Protective Agents|protective agents|mesh-ancestor
2406350|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406351|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406352|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2406353|NCT00743782|Hormones|hormones|mesh-list
2406354|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
2406355|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406356|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406357|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2406358|NCT00743795|Ribavirin|ribavirin|mesh-list
2406359|NCT00743795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2406360|NCT00743795|Antimetabolites|antimetabolites|mesh-ancestor
2406361|NCT00743795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535848|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
2535849|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535850|NCT01414465|Orlistat|orlistat|mesh-list
2535851|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535852|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535853|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2535854|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2535855|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2535856|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
2535857|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406362|NCT00743795|Antiviral Agents|antiviral agents|mesh-ancestor
2406363|NCT00743795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406364|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
2406365|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2406366|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2406367|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2406368|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406369|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2406370|NCT00743834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2406371|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2406372|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2406373|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406374|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406375|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
2406376|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2406377|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
2406378|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2406379|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2406380|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406381|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2406382|NCT00743847|Varenicline|varenicline|mesh-list
2406383|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2535858|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
2535859|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
2535860|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2535861|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535862|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2535863|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
2535864|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535865|NCT01414556|Incretins|incretins|mesh-ancestor
2535866|NCT01414556|Hormones|hormones|mesh-ancestor
2535867|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2535868|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535869|NCT01414569|Dexamethasone|dexamethasone|mesh-list
2535870|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
2535871|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2535872|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
2535873|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
2535874|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535875|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535876|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535877|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
2535878|NCT01414569|Hormones|hormones|mesh-ancestor
2535879|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2535880|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2535881|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535882|NCT01414608|Paclitaxel|paclitaxel|mesh-list
2535883|NCT01414608|Cisplatin|cisplatin|mesh-list
2535884|NCT01414608|Carboplatin|carboplatin|mesh-list
2535885|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2406384|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2406385|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
2406386|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406387|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406388|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406389|NCT00743860|Darapladib|darapladib|mesh-list
2406390|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2406391|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406392|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406393|NCT00743873|Mitogens|mitogens|mesh-list
2406394|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
2406395|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406396|NCT00743886|Mitogens|mitogens|mesh-list
2406397|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
2406398|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535886|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2535887|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535888|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
2535889|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
2535890|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
2535891|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535892|NCT01414777|Ondansetron|ondansetron|mesh-list
2535893|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
2535894|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
2535895|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2535896|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535897|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535898|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
2406399|NCT00743912|Rifaximin|rifaximin|mesh-list
2406400|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2406401|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406402|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2406403|NCT00743925|Atorvastatin|atorvastatin|mesh-list
2406404|NCT00743925|Varespladib methyl|varespladib methyl|mesh-list
2406405|NCT00743925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2406406|NCT00743925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2406407|NCT00743925|Antimetabolites|antimetabolites|mesh-ancestor
2406408|NCT00743925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406409|NCT00743925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2406410|NCT00743925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2535899|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
2535900|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2535901|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
2535902|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535903|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535904|NCT01414777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2535905|NCT01414777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2535906|NCT01414777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2535907|NCT01414777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2535908|NCT01414777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2535909|NCT01414816|Interferons|interferons|mesh-list
2535910|NCT01414816|Interferon-beta|interferon-beta|mesh-list
2535911|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
2535912|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535913|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
2535914|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535915|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
2535916|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535917|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2535918|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
2535919|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2535920|NCT01414868|Montelukast|montelukast|mesh-list
2406411|NCT00743925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406412|NCT00743925|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2406413|NCT00743938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2406414|NCT00743938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406415|NCT00743938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2406416|NCT00743938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406417|NCT00743938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406418|NCT00743964|Capecitabine|capecitabine|mesh-list
2406419|NCT00743964|Epirubicin|epirubicin|mesh-list
2406420|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406421|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2406422|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
2535921|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
2535922|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2535923|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
2406423|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406424|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2406425|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2406426|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2406427|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406428|NCT00743990|Camphor|camphor|mesh-list
2406429|NCT00743990|Menthol|menthol|mesh-list
2406430|NCT00743990|Petrolatum|petrolatum|mesh-list
2535924|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
2535925|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2535926|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535927|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2535928|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2535929|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535930|NCT01414881|Mipomersen|mipomersen|mesh-list
2535931|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2535932|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2535933|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
2535934|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535935|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2535936|NCT01414920|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2406431|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
2535937|NCT01414920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2535938|NCT01414920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535939|NCT01414920|Incretins|incretins|mesh-ancestor
2535940|NCT01414920|Hormones|hormones|mesh-ancestor
2535941|NCT01414920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2535942|NCT01414920|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2535943|NCT01414920|Protease Inhibitors|protease inhibitors|mesh-ancestor
2535944|NCT01414920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535945|NCT01414920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535946|NCT01414972|Vitamin A|vitamin a|mesh-list
2535947|NCT01414972|Vitamins|vitamins|mesh-ancestor
2535948|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
2535949|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535950|NCT01414998|Nicotine|nicotine|mesh-list
2535951|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2535952|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
2535953|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406432|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
2406433|NCT00743990|Emollients|emollients|mesh-ancestor
2406434|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2406435|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406436|NCT00744016|Mesalamine|mesalamine|mesh-list
2406437|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2406438|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2406439|NCT00744016|Analgesics|analgesics|mesh-ancestor
2406440|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
2406441|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406442|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406443|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406444|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2406445|NCT00744081|Topotecan|topotecan|mesh-list
2406446|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
2535954|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535955|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2535956|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2535957|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
2535958|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535959|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535960|NCT01415011|Afatinib|afatinib|mesh-list
2535961|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2535962|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2535963|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535964|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535965|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
2535966|NCT01415128|Desipramine|desipramine|mesh-list
2535967|NCT01415128|Omeprazole|omeprazole|mesh-list
2535968|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2535969|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2535970|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2535971|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2535972|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535973|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2535974|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535975|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2535976|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
2535977|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2535978|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2535979|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2535980|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2535981|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
2535982|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2535983|NCT01415141|Ribavirin|ribavirin|mesh-list
2535984|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2535985|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
2535986|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2535987|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
2535988|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2535989|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2535990|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
2535991|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
2535992|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
2535993|NCT01415336|Doxorubicin|doxorubicin|mesh-list
2535994|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2535995|NCT01415336|Capecitabine|capecitabine|mesh-list
2535996|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2535997|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
2535998|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2535999|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2536000|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2536001|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
2536002|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536003|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536004|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2536005|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2536006|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2536007|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2536008|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536009|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2536010|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
2536011|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2536012|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2536013|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2536014|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2536015|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536016|NCT01415505|Valsartan|valsartan|mesh-list
2536017|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2536018|NCT01415505|Nebivolol|nebivolol|mesh-list
2536019|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2536020|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2536021|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2536022|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536023|NCT01415505|Diuretics|diuretics|mesh-ancestor
2536024|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
2536025|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536026|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2536027|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2536028|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
2536029|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2406447|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2406448|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2406449|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406450|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406451|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406452|NCT00744081|Analgesics|analgesics|mesh-ancestor
2406453|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
2406454|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406455|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406456|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2406457|NCT00744107|Cobalt|cobalt|mesh-list
2406458|NCT00744107|Trace Elements|trace elements|mesh-ancestor
2406459|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
2406460|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406461|NCT00744185|Propranolol|propranolol|mesh-list
2406462|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2406463|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2406464|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
2406465|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406466|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406467|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536030|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2536031|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2536032|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
2536033|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536034|NCT01415557|Micronutrients|micronutrients|mesh-list
2536035|NCT01415557|Trace Elements|trace elements|mesh-list
2536036|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536037|NCT01415596|Albuterol|albuterol|mesh-list
2406468|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2406469|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2406470|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
2406471|NCT00744224|Exenatide|exenatide|mesh-list
2406472|NCT00744224|Prednisolone|prednisolone|mesh-list
2406473|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2406474|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
2406475|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2406476|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
2406477|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2406478|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
2406479|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406480|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
2406481|NCT00744224|Hormones|hormones|mesh-ancestor
2406482|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406483|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406484|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2406485|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406486|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
2406487|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
2406488|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406489|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2406490|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2406491|NCT00744224|Protective Agents|protective agents|mesh-ancestor
2406492|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2406493|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2406494|NCT00744224|Incretins|incretins|mesh-ancestor
2406495|NCT00744250|Pancrelipase|pancrelipase|mesh-list
2406496|NCT00744250|Pancreatin|pancreatin|mesh-list
2406497|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2406498|NCT00744276|Danazol|danazol|mesh-list
2406499|NCT00744276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2406500|NCT00744276|Hormone Antagonists|hormone antagonists|mesh-ancestor
2406501|NCT00744276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406502|NCT00744276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406503|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
2536038|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2536039|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
2536040|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536041|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536042|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2536043|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
2536044|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
2536045|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2536046|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2536047|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2536048|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2536049|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
2536050|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536051|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536052|NCT01415674|Afatinib|afatinib|mesh-list
2536053|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536054|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2406504|NCT00744302|Calcium|calcium|mesh-list
2406505|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2406506|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406507|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2406508|NCT00744354|Doxorubicin|doxorubicin|mesh-list
2406509|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2406510|NCT00744354|Bortezomib|bortezomib|mesh-list
2406511|NCT00744354|Vorinostat|vorinostat|mesh-list
2406512|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2406513|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406514|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2406515|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2406516|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406517|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406518|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2406519|NCT00744367|Metformin|metformin|mesh-list
2406520|NCT00744367|Pioglitazone|pioglitazone|mesh-list
2406521|NCT00744367|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2406522|NCT00744367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2406523|NCT00744367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406524|NCT00744367|Incretins|incretins|mesh-ancestor
2536055|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536056|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536057|NCT01415687|Bisacodyl|bisacodyl|mesh-list
2536058|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
2536059|NCT01415687|Citric Acid|citric acid|mesh-list
2536060|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
2536061|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
2536062|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2536063|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
2536064|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
2536065|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536066|NCT01415687|Cathartics|cathartics|mesh-ancestor
2406525|NCT00744367|Hormones|hormones|mesh-ancestor
2536067|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2536068|NCT01415687|Laxatives|laxatives|mesh-ancestor
2536069|NCT01415713|Leucovorin|leucovorin|mesh-list
2536070|NCT01415713|Gemcitabine|gemcitabine|mesh-list
2536071|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
2536072|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2536073|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
2536074|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406526|NCT00744367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406527|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
2406528|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2406529|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2406530|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
2406531|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
2406532|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2406533|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406534|NCT00744406|Sertraline|sertraline|mesh-list
2406535|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2406536|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
2406537|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2406538|NCT00744406|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2406539|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2406540|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2406541|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406542|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406543|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
2406544|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406545|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2406546|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2406547|NCT00744419|Pantoprazole|pantoprazole|mesh-list
2406548|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2406549|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2406550|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2406551|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536075|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536076|NCT01415713|Antiviral Agents|antiviral agents|mesh-ancestor
2536077|NCT01415713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536078|NCT01415713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536079|NCT01415713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536080|NCT01415713|Immunologic Factors|immunologic factors|mesh-ancestor
2536081|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536082|NCT01415713|Antidotes|antidotes|mesh-ancestor
2536083|NCT01415713|Protective Agents|protective agents|mesh-ancestor
2536084|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
2536085|NCT01415713|Vitamins|vitamins|mesh-ancestor
2536086|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
2536103|NCT01415765|Prednisone|prednisone|mesh-list
2536104|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
2536105|NCT01415765|Rituximab|rituximab|mesh-list
2536106|NCT01415765|Doxorubicin|doxorubicin|mesh-list
2536107|NCT01415765|Etoposide|etoposide|mesh-list
2536108|NCT01415765|Vincristine|vincristine|mesh-list
2536109|NCT01415765|Pevonedistat|pevonedistat|mesh-list
2536110|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536111|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
2536112|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406552|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406553|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
2406554|NCT00744445|Hematinics|hematinics|mesh-ancestor
2406555|NCT00744536|Lenalidomide|lenalidomide|mesh-list
2406556|NCT00744536|Melphalan|melphalan|mesh-list
2406557|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
2536113|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2536114|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2536115|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
2406558|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406559|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2406560|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2406561|NCT00744536|Growth Substances|growth substances|mesh-ancestor
2406562|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
2406563|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406564|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2406565|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
2406566|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406567|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2406568|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2406569|NCT00744549|Vitamin D|vitamin d|mesh-list
2406570|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
2406571|NCT00744549|Vitamins|vitamins|mesh-list
2406572|NCT00744549|Vitamin E|vitamin e|mesh-list
2406573|NCT00744549|Selenium|selenium|mesh-list
2406574|NCT00744549|Lycopene|lycopene|mesh-list
2406575|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
2406576|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406577|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2406578|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2536116|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536117|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536118|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2536119|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2536120|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2536121|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2536122|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2536123|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536124|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2536125|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
2536126|NCT01415765|Hormones|hormones|mesh-ancestor
2536127|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2536128|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2536129|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2536130|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
2536131|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
2536132|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
2536133|NCT01415778|Bicalutamide|bicalutamide|mesh-list
2536134|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
2536135|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
2536136|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2536137|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536138|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536139|NCT01415791|Bicalutamide|bicalutamide|mesh-list
2536140|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
2536141|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
2536142|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2536143|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536144|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536145|NCT01415882|Dexamethasone|dexamethasone|mesh-list
2536146|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
2536147|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
2536148|NCT01415882|Daratumumab|daratumumab|mesh-list
2536149|NCT01415882|Ixazomib|ixazomib|mesh-list
2536150|NCT01415882|Ichthammol|ichthammol|mesh-list
2536151|NCT01415882|BB 1101|bb 1101|mesh-list
2536152|NCT01415882|Glycine|glycine|mesh-list
2536153|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536154|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
2536155|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536156|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2536157|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2536158|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
2536159|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536160|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536161|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2536162|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2536163|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
2536164|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
2536165|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536166|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2536167|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
2536168|NCT01415882|Hormones|hormones|mesh-ancestor
2406579|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
2406580|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406581|NCT00744549|Protective Agents|protective agents|mesh-ancestor
2406582|NCT00744549|Trace Elements|trace elements|mesh-ancestor
2406583|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406584|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2406585|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2406586|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406587|NCT00744640|Gemcitabine|gemcitabine|mesh-list
2406588|NCT00744640|Capecitabine|capecitabine|mesh-list
2406589|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
2406590|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2406591|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
2406592|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406593|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536169|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2536170|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2536171|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
2536172|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536173|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
2536174|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
2536175|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536176|NCT01415895|Clonidine|clonidine|mesh-list
2536177|NCT01415895|Naltrexone|naltrexone|mesh-list
2536178|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2406594|NCT00744640|Antiviral Agents|antiviral agents|mesh-ancestor
2406595|NCT00744640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406596|NCT00744640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406597|NCT00744640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2406598|NCT00744640|Immunologic Factors|immunologic factors|mesh-ancestor
2406599|NCT00744640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406600|NCT00744666|Prednisolone|prednisolone|mesh-list
2406601|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2406602|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406603|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
2406604|NCT00744666|Hormones|hormones|mesh-ancestor
2406605|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406606|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406607|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2406608|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406609|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2406610|NCT00744679|Natalizumab|natalizumab|mesh-list
2406611|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
2406612|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406613|NCT00744718|Bevacizumab|bevacizumab|mesh-list
2406614|NCT00744718|Carboplatin|carboplatin|mesh-list
2406615|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2406616|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406617|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2406618|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2536179|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2536180|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536181|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
2536182|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536183|NCT01415895|Analgesics|analgesics|mesh-ancestor
2536184|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2536185|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
2536186|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
2536187|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2536188|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2536189|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2536190|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
2536191|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536192|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536193|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
2536194|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536195|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
2536196|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536197|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2536198|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2536199|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
2536200|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536201|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536202|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2536203|NCT01416064|Molindone|molindone|mesh-list
2406619|NCT00744718|Growth Substances|growth substances|mesh-ancestor
2406620|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406621|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
2536204|NCT01416064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2536205|NCT01416064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2536206|NCT01416064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2536207|NCT01416064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536208|NCT01416064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2536209|NCT01416116|Lidocaine|lidocaine|mesh-list
2536210|NCT01416116|Tramadol|tramadol|mesh-list
2536211|NCT01416116|Capsaicin|capsaicin|mesh-list
2536212|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
2536213|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
2536214|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2536215|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536216|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
2536217|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406622|NCT00744770|Rilpivirine|rilpivirine|mesh-list
2406623|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2406624|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2406625|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406626|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406627|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
2406628|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406629|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2406630|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2406631|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
2406632|NCT00744809|Efavirenz|efavirenz|mesh-list
2406633|NCT00744809|Rilpivirine|rilpivirine|mesh-list
2406634|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2406635|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406636|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2406637|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2536218|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2536219|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2536220|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2536221|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2536222|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536223|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2536224|NCT01416116|Narcotics|narcotics|mesh-ancestor
2536225|NCT01416116|Analgesics|analgesics|mesh-ancestor
2536226|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
2536227|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
2536228|NCT01416207|Interferons|interferons|mesh-list
2536229|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
2536230|NCT01416207|Interferon-beta|interferon-beta|mesh-list
2536231|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536232|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
2406638|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406639|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406640|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406641|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2406642|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2406643|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
2406644|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2406645|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2406646|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2406647|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2406648|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2406649|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2406650|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2406651|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2406652|NCT00744887|Darunavir|darunavir|mesh-list
2406653|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2406654|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2406655|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
2406656|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406657|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406658|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2406659|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2406660|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
2406661|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406662|NCT00744900|Pemetrexed|pemetrexed|mesh-list
2406663|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406664|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536233|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536234|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2536235|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
2536236|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536237|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
2536238|NCT01416220|Paroxetine|paroxetine|mesh-list
2536239|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
2536240|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2536241|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536242|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536243|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
2536244|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2536245|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2536246|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536247|NCT01416220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2536248|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2536249|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2536250|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536251|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
2536252|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2536253|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2536254|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2536255|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
2536256|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2536257|NCT01416337|Trametinib|trametinib|mesh-list
2536258|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536259|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2536260|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406665|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406666|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2406667|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2406668|NCT00744913|Nicotine|nicotine|mesh-list
2406669|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2406670|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
2406671|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406672|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406673|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2406674|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2406675|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
2536261|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536262|NCT01416350|Azithromycin|azithromycin|mesh-list
2536263|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2536264|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536265|NCT01416402|Colchicine|colchicine|mesh-list
2536266|NCT01416402|Febuxostat|febuxostat|mesh-list
2536267|NCT01416402|Gout Suppressants|gout suppressants|mesh-ancestor
2536268|NCT01416402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2536269|NCT01416402|Tubulin Modulators|tubulin modulators|mesh-ancestor
2536270|NCT01416402|Antimitotic Agents|antimitotic agents|mesh-ancestor
2406676|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406677|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406678|NCT00744926|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2406679|NCT00744926|Incretins|incretins|mesh-ancestor
2406680|NCT00744926|Hormones|hormones|mesh-ancestor
2406681|NCT00744926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406682|NCT00744926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406683|NCT00745004|Ondansetron|ondansetron|mesh-list
2406684|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
2406685|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
2406686|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406687|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406688|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2406689|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
2406690|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
2406691|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2406692|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
2406693|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406694|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406695|NCT00745004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2406696|NCT00745004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2406697|NCT00745004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2406698|NCT00745004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2406699|NCT00745004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2406700|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
2406701|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2536271|NCT01416402|Mitosis Modulators|mitosis modulators|mesh-ancestor
2536272|NCT01416402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536273|NCT01416402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536274|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2536275|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2536276|NCT01416480|Theobromine|theobromine|mesh-list
2536277|NCT01416480|Dipropizine|dipropizine|mesh-list
2536278|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2536279|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
2406702|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
2406703|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
2406704|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406705|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406706|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2406707|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
2536280|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536281|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536282|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2406708|NCT00745069|Tapentadol|tapentadol|mesh-list
2406709|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2406710|NCT00745069|Narcotics|narcotics|mesh-ancestor
2406711|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2406712|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406713|NCT00745069|Analgesics|analgesics|mesh-ancestor
2536283|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
2536284|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
2536285|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
2536286|NCT01416558|Paclitaxel|paclitaxel|mesh-list
2406714|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
2406715|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406716|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2536287|NCT01416558|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2536288|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2536289|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536290|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
2536291|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
2536292|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
2536293|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536294|NCT01416649|Exenatide|exenatide|mesh-list
2536295|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2536296|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536297|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2536298|NCT01416649|Incretins|incretins|mesh-ancestor
2536299|NCT01416649|Hormones|hormones|mesh-ancestor
2536300|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2536301|NCT01416662|Gemcitabine|gemcitabine|mesh-list
2536302|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2536303|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
2536304|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536305|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536306|NCT01416662|Antiviral Agents|antiviral agents|mesh-ancestor
2536307|NCT01416662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536308|NCT01416662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406717|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2406718|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2406719|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406720|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
2406721|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406722|NCT00745108|Tibolone|tibolone|mesh-list
2406723|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536309|NCT01416662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536310|NCT01416662|Immunologic Factors|immunologic factors|mesh-ancestor
2536311|NCT01416662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536312|NCT01416701|Vitamin D|vitamin d|mesh-list
2536313|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
2536314|NCT01416701|Vitamins|vitamins|mesh-list
2536315|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
2536316|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536317|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2536318|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2536319|NCT01416831|Interleukin-2|interleukin-2|mesh-list
2536320|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536321|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2536322|NCT01416831|Analgesics|analgesics|mesh-ancestor
2536323|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
2536324|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536325|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536326|NCT01416870|Bicalutamide|bicalutamide|mesh-list
2536327|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
2536328|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
2536329|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2536330|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536331|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536332|NCT01416883|Bicalutamide|bicalutamide|mesh-list
2536333|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
2406724|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2406725|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406726|NCT00745108|Hormones|hormones|mesh-ancestor
2406727|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406728|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
2406729|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
2406730|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2406731|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2406732|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
2406733|NCT00745134|Curcumin|curcumin|mesh-list
2406734|NCT00745134|Capecitabine|capecitabine|mesh-list
2406735|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2406736|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
2406737|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406738|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406739|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2406740|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2406741|NCT00745134|Analgesics|analgesics|mesh-ancestor
2406742|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
2406743|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406744|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406745|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406746|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2406747|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406748|NCT00745147|Laxatives|laxatives|mesh-list
2536334|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
2536335|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2536336|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536337|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536338|NCT01416909|Laxatives|laxatives|mesh-list
2536339|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2406749|NCT00745147|Lactulose|lactulose|mesh-list
2406750|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2406751|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2406752|NCT00745173|Estrogens|estrogens|mesh-ancestor
2406753|NCT00745173|Hormones|hormones|mesh-ancestor
2406754|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406755|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406756|NCT00745186|Glucagon|glucagon|mesh-list
2406757|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2406758|NCT00745186|Hormones|hormones|mesh-ancestor
2406759|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406760|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536353|NCT01416948|Methylphenidate|methylphenidate|mesh-list
2536354|NCT01416948|Galantamine|galantamine|mesh-list
2536355|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2536356|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536357|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2536358|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2536359|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2406761|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
2536360|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536361|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
2536362|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536363|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2536364|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536365|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
2536366|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2536367|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
2536368|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536369|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
2536370|NCT01416961|Etoposide|etoposide|mesh-list
2536371|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
2536372|NCT01416961|Cisplatin|cisplatin|mesh-list
2536373|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2536374|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536375|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2536376|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2536377|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536378|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536379|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
2536380|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536381|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
2536382|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536383|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2536384|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2536385|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
2536386|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536387|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536388|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2536389|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2536390|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
2536391|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2536392|NCT01417065|Sirolimus|sirolimus|mesh-list
2536393|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2536394|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536395|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2536396|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536397|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
2536398|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536399|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
2536400|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536401|NCT01417169|Micafungin|micafungin|mesh-list
2536402|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
2536403|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536404|NCT01417273|Vitamin A|vitamin a|mesh-list
2536405|NCT01417273|Vitamins|vitamins|mesh-ancestor
2536406|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
2536407|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536408|NCT01417351|Vitamin D|vitamin d|mesh-list
2536409|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
2536410|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
2536411|NCT01417351|Vitamins|vitamins|mesh-list
2536412|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
2536413|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536414|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2536415|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2536416|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
2536417|NCT01417364|Testosterone|testosterone|mesh-list
2536418|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
2536419|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
2406762|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
2406763|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
2406764|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406765|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406766|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2406767|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
2406768|NCT00745225|Pioglitazone|pioglitazone|mesh-list
2406769|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2406770|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536420|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2536421|NCT01417364|Androgens|androgens|mesh-ancestor
2536422|NCT01417364|Hormones|hormones|mesh-ancestor
2536423|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2536424|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406771|NCT00745316|Adenosine|adenosine|mesh-list
2536425|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2536426|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406772|NCT00745316|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-list
2406773|NCT00745316|Analgesics|analgesics|mesh-ancestor
2406774|NCT00745316|Sensory System Agents|sensory system agents|mesh-ancestor
2406775|NCT00745316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536427|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
2536428|NCT01417390|Gemcitabine|gemcitabine|mesh-list
2536429|NCT01417390|Cisplatin|cisplatin|mesh-list
2536430|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536431|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2536432|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
2536433|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536434|NCT01417390|Antiviral Agents|antiviral agents|mesh-ancestor
2536435|NCT01417390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536436|NCT01417390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536437|NCT01417390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536438|NCT01417390|Immunologic Factors|immunologic factors|mesh-ancestor
2406776|NCT00745316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406777|NCT00745316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2406778|NCT00745316|Vasodilator Agents|vasodilator agents|mesh-ancestor
2406779|NCT00745316|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2406780|NCT00745316|Purinergic Agonists|purinergic agonists|mesh-ancestor
2406781|NCT00745316|Purinergic Agents|purinergic agents|mesh-ancestor
2406782|NCT00745316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406783|NCT00745316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406784|NCT00745316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2536439|NCT01417390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536440|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
2536441|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
2536442|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2536443|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2536444|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536445|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536446|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536447|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2536448|NCT01417429|Galantamine|galantamine|mesh-list
2536449|NCT01417429|Nicotine|nicotine|mesh-list
2536450|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2536451|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
2536452|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536453|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536454|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2536455|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2536456|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
2406785|NCT00745316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2406786|NCT00745407|Fenofibrate|fenofibrate|mesh-list
2406787|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2406788|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
2406789|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406790|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2406791|NCT00745433|Metformin|metformin|mesh-list
2406792|NCT00745433|Repaglinide|repaglinide|mesh-list
2406793|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2406794|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406795|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
2406796|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2406797|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406798|NCT00745511|Bevacizumab|bevacizumab|mesh-list
2406799|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2406800|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406801|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2406802|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2406803|NCT00745511|Growth Substances|growth substances|mesh-ancestor
2406804|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406805|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
2406806|NCT00745589|Sevelamer|sevelamer|mesh-list
2406807|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
2406808|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
2406809|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536457|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536458|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536459|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2536460|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536461|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2536462|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
2536463|NCT01417494|Leucovorin|leucovorin|mesh-list
2536464|NCT01417494|Bevacizumab|bevacizumab|mesh-list
2536465|NCT01417494|Fluorouracil|fluorouracil|mesh-list
2536466|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
2536467|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2536468|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536469|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2536470|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2536471|NCT01417494|Growth Substances|growth substances|mesh-ancestor
2536472|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536473|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
2536474|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
2536475|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536476|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2536477|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536478|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
2536479|NCT01417494|Antidotes|antidotes|mesh-ancestor
2536480|NCT01417494|Protective Agents|protective agents|mesh-ancestor
2536481|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
2536482|NCT01417494|Vitamins|vitamins|mesh-ancestor
2536483|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
2536484|NCT01417572|Lidocaine|lidocaine|mesh-list
2536485|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
2536486|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
2536487|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2536488|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536489|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
2536490|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536491|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2536492|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2536493|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2536494|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2536495|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536496|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2536497|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2536498|NCT01417754|Toremifene|toremifene|mesh-list
2536499|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2536500|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536501|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2536502|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2536503|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
2536504|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2536505|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536506|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2536507|NCT01417767|Decitabine|decitabine|mesh-list
2536508|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2536509|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
2536510|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536511|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536512|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536513|NCT01417806|Topotecan|topotecan|mesh-list
2536514|NCT01417806|Pasireotide|pasireotide|mesh-list
2536515|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2536516|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2536517|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536518|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536519|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536520|NCT01417806|Hormones|hormones|mesh-ancestor
2536521|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2536522|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536523|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2536524|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2536525|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2536526|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2536527|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2536528|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
2536529|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536530|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536531|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536532|NCT01417897|Insulin|insulin|mesh-list
2536533|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2536534|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
2536535|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
2536536|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2536537|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536538|NCT01417923|Vitamin D|vitamin d|mesh-list
2536539|NCT01417923|Vitamins|vitamins|mesh-ancestor
2536540|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
2406810|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
2406811|NCT00745693|BQ 788|bq 788|mesh-list
2406812|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2406813|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2406814|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406815|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2406816|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
2406817|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
2406818|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406819|NCT00745914|Pioglitazone|pioglitazone|mesh-list
2406820|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2406821|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406822|NCT00745953|Valsartan|valsartan|mesh-list
2406823|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2406824|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2406825|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2536541|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536542|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2536543|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2536544|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
2536545|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536546|NCT01418118|Dobutamine|dobutamine|mesh-list
2536547|NCT01418118|Epinephrine|epinephrine|mesh-list
2406826|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2406827|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536548|NCT01418118|Norepinephrine|norepinephrine|mesh-list
2536549|NCT01418118|Dopexamine|dopexamine|mesh-list
2536550|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2536551|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2536552|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
2536553|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536554|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536555|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536556|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2536557|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2406828|NCT00745953|Diuretics|diuretics|mesh-ancestor
2406829|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
2406830|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406831|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2406832|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2406833|NCT00746031|Goserelin|goserelin|mesh-list
2406834|NCT00746031|Cetrorelix|cetrorelix|mesh-list
2406835|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2406836|NCT00746031|Hormones|hormones|mesh-ancestor
2406837|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406838|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406839|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2406840|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406841|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2406842|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
2406843|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2406844|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
2406845|NCT00746070|Spironolactone|spironolactone|mesh-list
2406846|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2406847|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
2406848|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406849|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406850|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2406851|NCT00746070|Diuretics|diuretics|mesh-ancestor
2406852|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
2406853|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
2406854|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2406855|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406856|NCT00746447|Mesalamine|mesalamine|mesh-list
2406857|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2406858|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2406859|NCT00746447|Analgesics|analgesics|mesh-ancestor
2406860|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
2536558|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
2536559|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536560|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2536561|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
2536562|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
2536563|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
2536564|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2536565|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2536566|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2406861|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406862|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406863|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406864|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2406865|NCT00746486|Budesonide|budesonide|mesh-list
2406866|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406867|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2406868|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
2406869|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406870|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406871|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2406872|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
2406873|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
2406874|NCT00746486|Hormones|hormones|mesh-ancestor
2406875|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406876|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
2406877|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2406878|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2406879|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
2406880|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406881|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2406882|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2536567|NCT01418118|Protective Agents|protective agents|mesh-ancestor
2536568|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
2536569|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
2536570|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
2536571|NCT01418131|Tacrolimus|tacrolimus|mesh-list
2536572|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2536573|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536574|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
2536575|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536576|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536577|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536578|NCT01418144|Ropivacaine|ropivacaine|mesh-list
2536579|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
2536580|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
2536581|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2536582|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536583|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
2536584|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536585|NCT01418157|Acetazolamide|acetazolamide|mesh-list
2536586|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
2536587|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2536588|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536589|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536590|NCT01418157|Diuretics|diuretics|mesh-ancestor
2536591|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
2536592|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536593|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
2536594|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
2406883|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406884|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406885|NCT00746655|Cisplatin|cisplatin|mesh-list
2406886|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406887|NCT00746681|Pregabalin|pregabalin|mesh-list
2406888|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2406889|NCT00746681|Analgesics|analgesics|mesh-ancestor
2406890|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
2406891|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406892|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406893|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
2406894|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2406895|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2406896|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536595|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
2536596|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2536597|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536598|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
2536599|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536600|NCT01418222|Leucovorin|leucovorin|mesh-list
2536601|NCT01418222|Bevacizumab|bevacizumab|mesh-list
2536602|NCT01418222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2536603|NCT01418222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536604|NCT01418222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2536605|NCT01418222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2536606|NCT01418222|Growth Substances|growth substances|mesh-ancestor
2536607|NCT01418222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536608|NCT01418222|Growth Inhibitors|growth inhibitors|mesh-ancestor
2536609|NCT01418222|Antidotes|antidotes|mesh-ancestor
2536610|NCT01418222|Protective Agents|protective agents|mesh-ancestor
2536611|NCT01418222|Vitamin B Complex|vitamin b complex|mesh-ancestor
2536612|NCT01418222|Vitamins|vitamins|mesh-ancestor
2536613|NCT01418222|Micronutrients|micronutrients|mesh-ancestor
2536614|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
2536615|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2536616|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
2536617|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536618|NCT01418274|Ritonavir|ritonavir|mesh-list
2536619|NCT01418274|Citalopram|citalopram|mesh-list
2536620|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2536621|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2536622|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
2536623|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536624|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536625|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2536626|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2536627|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
2536628|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536629|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2536630|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2536631|NCT01418274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2536632|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2536633|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2536634|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536635|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
2536636|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536637|NCT01418274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2536638|NCT01418274|Antidepressive Agents|antidepressive agents|mesh-ancestor
2536639|NCT01418274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2536640|NCT01418417|Pantoprazole|pantoprazole|mesh-list
2536641|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2536642|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2536643|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2536644|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536645|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536646|NCT01418430|Daclizumab|daclizumab|mesh-list
2536647|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536648|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
2536649|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536650|NCT01418443|Pantoprazole|pantoprazole|mesh-list
2536651|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2536652|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2536653|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2536654|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536655|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536656|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2536657|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536658|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2536659|NCT01418534|Isosorbide|isosorbide|mesh-list
2536660|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2536661|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2536662|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2536663|NCT01418534|Diuretics|diuretics|mesh-ancestor
2536664|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
2536665|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536666|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
2536667|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2536668|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536669|NCT01418547|Isosorbide|isosorbide|mesh-list
2536670|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2536671|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2536672|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2536673|NCT01418547|Diuretics|diuretics|mesh-ancestor
2406897|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2406898|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2406899|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2536674|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
2536675|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406900|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2406901|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2406902|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2406903|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2406904|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
2536676|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
2536677|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2536678|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536679|NCT01418586|Alfuzosin|alfuzosin|mesh-list
2536680|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2536681|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2536682|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2536683|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
2536684|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536685|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536686|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536687|NCT01418586|Urological Agents|urological agents|mesh-ancestor
2536688|NCT01418599|Alfuzosin|alfuzosin|mesh-list
2536689|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2536690|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2536691|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2536692|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
2536693|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536694|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536695|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536696|NCT01418599|Urological Agents|urological agents|mesh-ancestor
2536697|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2536698|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2536699|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2536700|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2536701|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536702|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536703|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536704|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2536705|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
2536706|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2536707|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2536708|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2536709|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2536710|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2536711|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536712|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536713|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536714|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2536715|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
2536716|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2536717|NCT01418651|Milnacipran|milnacipran|mesh-list
2536718|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2536719|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2536720|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2536721|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536722|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536723|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536724|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2536725|NCT01418651|Analgesics|analgesics|mesh-ancestor
2536726|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
2536727|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536728|NCT01418729|Pravastatin|pravastatin|mesh-list
2536729|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2536730|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2536731|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
2536732|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536733|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2536734|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2536735|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536736|NCT01418742|Doxycycline|doxycycline|mesh-list
2536737|NCT01418742|Panitumumab|panitumumab|mesh-list
2406905|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2406906|NCT00746681|Urological Agents|urological agents|mesh-ancestor
2406907|NCT00746720|Etoricoxib|etoricoxib|mesh-list
2536738|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2536739|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536740|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
2536741|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2536742|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2536743|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2536744|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536745|NCT01418794|Sirolimus|sirolimus|mesh-list
2536746|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2536747|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536748|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2536749|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536750|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
2536751|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536752|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
2536753|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536754|NCT01419041|Crizotinib|crizotinib|mesh-list
2536755|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536756|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2536757|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536758|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536762|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
2536763|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2536764|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2536765|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536766|NCT01419119|Vitamins|vitamins|mesh-ancestor
2536767|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
2536768|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2536769|NCT01419132|Furosemide|furosemide|mesh-list
2536770|NCT01419132|Diuretics|diuretics|mesh-list
2536771|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
2536772|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536773|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2536774|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2536775|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536776|NCT01419262|Vitamin D|vitamin d|mesh-list
2536777|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
2536778|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
2536779|NCT01419262|Vitamins|vitamins|mesh-list
2536780|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
2536781|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536782|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2536783|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2536784|NCT01419340|Donepezil|donepezil|mesh-list
2536785|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2536786|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536787|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536788|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
2536789|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536790|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536791|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
2536792|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2536793|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2536794|NCT01419353|Estradiol|estradiol|mesh-list
2536795|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2536796|NCT01419353|Estrogens|estrogens|mesh-ancestor
2536797|NCT01419353|Hormones|hormones|mesh-ancestor
2536798|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2536799|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536800|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2536801|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
2536802|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2536803|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2536804|NCT01419366|Donepezil|donepezil|mesh-list
2406908|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2406909|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2406910|NCT00746720|Analgesics|analgesics|mesh-ancestor
2406911|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
2406912|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406913|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406914|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2536805|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2536806|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536807|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536808|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
2536809|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2536810|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536811|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
2536812|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
2536813|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536814|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
2536815|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2536816|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2536817|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536818|NCT01419392|Urological Agents|urological agents|mesh-ancestor
2536819|NCT01419405|Pregabalin|pregabalin|mesh-list
2536820|NCT01419405|Remifentanil|remifentanil|mesh-list
2536821|NCT01419405|Analgesics|analgesics|mesh-ancestor
2536822|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
2536823|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536824|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536825|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
2536826|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2536827|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2536828|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536829|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2536830|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2536831|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2536832|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2536833|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2536834|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2536835|NCT01419405|Narcotics|narcotics|mesh-ancestor
2536836|NCT01419457|Favipiravir|favipiravir|mesh-list
2536837|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
2536838|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536839|NCT01419548|Paclitaxel|paclitaxel|mesh-list
2536840|NCT01419548|Carboplatin|carboplatin|mesh-list
2536841|NCT01419548|Veliparib|veliparib|mesh-list
2536842|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2536843|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536844|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
2536845|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
2536846|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
2536847|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536848|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2536849|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406915|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2406916|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2406917|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2406918|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406919|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406920|NCT00746746|Interferons|interferons|mesh-list
2406921|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
2406922|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
2406923|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2406924|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406925|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
2406926|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406927|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
2406928|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406929|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
2406930|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2536871|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2536872|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536873|NCT01419691|Auranofin|auranofin|mesh-list
2536874|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2536875|NCT01419730|Vitamin D|vitamin d|mesh-list
2536876|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
2536877|NCT01419730|Vitamins|vitamins|mesh-ancestor
2536878|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
2536879|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536880|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2536881|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2536882|NCT01419821|Vitamin D|vitamin d|mesh-list
2536883|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
2536884|NCT01419821|Vitamins|vitamins|mesh-list
2536885|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
2536886|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536887|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2536888|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2536889|NCT01419834|Antibodies|antibodies|mesh-list
2536890|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2536891|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
2536892|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536893|NCT01419847|Ciclopirox|ciclopirox|mesh-list
2536894|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
2536895|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536896|NCT01419873|Insulin|insulin|mesh-list
2536897|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2536898|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2536899|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536900|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2536901|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2536902|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536903|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536904|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
2536905|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536906|NCT01420094|Aspirin|aspirin|mesh-list
2536907|NCT01420094|Acetaminophen|acetaminophen|mesh-list
2536908|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2536909|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2536910|NCT01420094|Analgesics|analgesics|mesh-ancestor
2536911|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
2536912|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536913|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536914|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406931|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406932|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2406933|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2406934|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
2406935|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406936|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
2406937|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
2406938|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2406939|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2406940|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406941|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406942|NCT00746967|Urological Agents|urological agents|mesh-ancestor
2406943|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
2406944|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2406945|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406946|NCT00747097|Gemcitabine|gemcitabine|mesh-list
2406947|NCT00747097|Cetuximab|cetuximab|mesh-list
2536915|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2536916|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2536917|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2536918|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536919|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2536920|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2536921|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536922|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
2536923|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
2406948|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2406949|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
2406950|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406951|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406952|NCT00747097|Antiviral Agents|antiviral agents|mesh-ancestor
2406953|NCT00747097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2406954|NCT00747097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406955|NCT00747097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2406956|NCT00747097|Immunologic Factors|immunologic factors|mesh-ancestor
2406957|NCT00747097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406958|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2406959|NCT00747110|Budesonide|budesonide|mesh-list
2406960|NCT00747110|Mesalamine|mesalamine|mesh-list
2406961|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406962|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2406963|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
2406964|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406965|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406966|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2406967|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
2406968|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
2406969|NCT00747110|Hormones|hormones|mesh-ancestor
2406970|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2406971|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2406972|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2406973|NCT00747110|Analgesics|analgesics|mesh-ancestor
2406974|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
2406975|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2406976|NCT00747279|Insulin|insulin|mesh-list
2406977|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2406978|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406979|NCT00747305|Sunitinib|sunitinib|mesh-list
2406980|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2406981|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2406982|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2406983|NCT00747305|Growth Substances|growth substances|mesh-ancestor
2536924|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2536925|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
2536926|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
2536927|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2536928|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536929|NCT01420250|Bicalutamide|bicalutamide|mesh-list
2536930|NCT01420250|Hormones|hormones|mesh-list
2406984|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406985|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
2406986|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2406987|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2406988|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2406989|NCT00747318|Fluticasone|fluticasone|mesh-list
2406990|NCT00747318|Xhance|xhance|mesh-list
2406991|NCT00747318|Formoterol Fumarate|formoterol fumarate|mesh-list
2406992|NCT00747318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2406993|NCT00747318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2406994|NCT00747318|Autonomic Agents|autonomic agents|mesh-ancestor
2406995|NCT00747318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2406996|NCT00747318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2406997|NCT00747318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2406998|NCT00747318|Respiratory System Agents|respiratory system agents|mesh-ancestor
2406999|NCT00747318|Dermatologic Agents|dermatologic agents|mesh-ancestor
2407000|NCT00747318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2407001|NCT00747318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2407002|NCT00747318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2407003|NCT00747318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2407004|NCT00747318|Adrenergic Agents|adrenergic agents|mesh-ancestor
2407005|NCT00747318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407006|NCT00747318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407007|NCT00747331|Fenoldopam|fenoldopam|mesh-list
2407008|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2407009|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
2536931|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2536932|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
2536933|NCT01420250|Androgens|androgens|mesh-list
2407010|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
2536934|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2536935|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536936|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
2536937|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536938|NCT01420302|Insulin|insulin|mesh-list
2536939|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2536940|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2536941|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536942|NCT01420328|Simvastatin|simvastatin|mesh-list
2536943|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2536944|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2536945|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2536946|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
2536947|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536948|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2536949|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2536950|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536951|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2536952|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2536953|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536954|NCT01420341|Renal Agents|renal agents|mesh-ancestor
2536955|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2536956|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
2536957|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2536958|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2536959|NCT01420367|Metronidazole|metronidazole|mesh-list
2407011|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
2407012|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407013|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407014|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407015|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2407016|NCT00747383|Glimepiride|glimepiride|mesh-list
2407017|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2407018|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407019|NCT00747383|Incretins|incretins|mesh-ancestor
2407020|NCT00747383|Hormones|hormones|mesh-ancestor
2407021|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2407022|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2407023|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
2407024|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407025|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407026|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2536960|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536961|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2536962|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2536963|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2536964|NCT01420406|Vitamin A|vitamin a|mesh-list
2536965|NCT01420406|Vitamins|vitamins|mesh-ancestor
2536966|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
2536967|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536968|NCT01420471|Triamcinolone|triamcinolone|mesh-list
2536969|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2536970|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2536971|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2536972|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2536973|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
2536974|NCT01420471|Hormones|hormones|mesh-ancestor
2536975|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2536976|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2536977|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2536978|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
2536979|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536980|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407027|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2407028|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
2407029|NCT00747409|Insulin|insulin|mesh-list
2407030|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2407031|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
2407032|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
2407033|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
2407034|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2407035|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
2407036|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
2407037|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
2536981|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
2536982|NCT01420523|Maraviroc|maraviroc|mesh-list
2536983|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2536984|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2536985|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
2536986|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2536987|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2536988|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2536989|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2536990|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2536991|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2536992|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2536993|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2536994|NCT01420575|Olanzapine|olanzapine|mesh-list
2536995|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
2536996|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
2536997|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2536998|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407038|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2407039|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407040|NCT00747487|Idebenone|idebenone|mesh-list
2407041|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
2407042|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407043|NCT00747487|Protective Agents|protective agents|mesh-ancestor
2407044|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407045|NCT00747526|Rabeprazole|rabeprazole|mesh-list
2407046|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2407047|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2407048|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2407049|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407050|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407051|NCT00747539|Interferons|interferons|mesh-list
2407052|NCT00747539|Ribavirin|ribavirin|mesh-list
2407053|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
2407054|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2536999|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2537000|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2537001|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2537002|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2537003|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2537004|NCT01420575|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2537005|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2537006|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2537007|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407055|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
2407056|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407057|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
2407058|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407059|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
2407060|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407061|NCT00747604|Mecasermin|mecasermin|mesh-list
2407062|NCT00747604|Growth Substances|growth substances|mesh-ancestor
2407063|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407064|NCT00747669|Lidocaine|lidocaine|mesh-list
2407065|NCT00747669|Tetracaine|tetracaine|mesh-list
2407066|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
2407067|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
2407068|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2407069|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537008|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537009|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
2537010|NCT01420666|Acetaminophen|acetaminophen|mesh-list
2537011|NCT01420666|Ibuprofen|ibuprofen|mesh-list
2537012|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2537013|NCT01420666|Analgesics|analgesics|mesh-ancestor
2537014|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
2537015|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537016|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537017|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
2537018|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2537019|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537020|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2537021|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2537022|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537023|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537024|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
2407070|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
2537025|NCT01420692|Gliclazide|gliclazide|mesh-list
2537026|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2537027|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537028|NCT01420822|Fluticasone|fluticasone|mesh-list
2537029|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537030|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2537031|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
2537032|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537033|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537034|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2537035|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
2537036|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
2537037|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2537038|NCT01420874|Leucovorin|leucovorin|mesh-list
2537039|NCT01420874|Fluorouracil|fluorouracil|mesh-list
2537040|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
2537041|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
2537042|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537043|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2537044|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537045|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2537046|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
2537047|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537048|NCT01420874|Antidotes|antidotes|mesh-ancestor
2537049|NCT01420874|Protective Agents|protective agents|mesh-ancestor
2537050|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
2537051|NCT01420874|Vitamins|vitamins|mesh-ancestor
2537052|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
2407071|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407072|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2407073|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2407074|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2407075|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2407076|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407077|NCT00747695|Rabeprazole|rabeprazole|mesh-list
2407078|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2407079|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2537053|NCT01420900|Tacrine|tacrine|mesh-list
2537054|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2537055|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537056|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537057|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
2537058|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537059|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537060|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2537061|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
2537062|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537063|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
2537064|NCT01420913|Pregabalin|pregabalin|mesh-list
2537065|NCT01420913|Analgesics|analgesics|mesh-ancestor
2537066|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
2537067|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537068|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537069|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
2537070|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2537071|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2537072|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537073|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2537074|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2537075|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2537076|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2537077|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2537078|NCT01421043|Triazolam|triazolam|mesh-list
2537079|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2537080|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2537081|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2537082|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2537083|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537084|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2537085|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
2537086|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
2537087|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537088|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537089|NCT01421056|Flurbiprofen|flurbiprofen|mesh-list
2537090|NCT01421056|Analgesics|analgesics|mesh-ancestor
2537091|NCT01421056|Sensory System Agents|sensory system agents|mesh-ancestor
2537092|NCT01421056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537093|NCT01421056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537094|NCT01421056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2537095|NCT01421056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2537096|NCT01421056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537097|NCT01421056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2537098|NCT01421056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2537099|NCT01421056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537100|NCT01421056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537101|NCT01421069|Etanercept|etanercept|mesh-list
2537102|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2537103|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2537104|NCT01421069|Analgesics|analgesics|mesh-ancestor
2537105|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
2537106|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537107|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537108|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537109|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2537110|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2537111|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2537112|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
2537113|NCT01421121|Vaccines|vaccines|mesh-list
2537114|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
2537115|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537116|NCT01421160|Citric Acid|citric acid|mesh-list
2407080|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2407081|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407082|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407083|NCT00747708|Sargramostim|sargramostim|mesh-list
2407084|NCT00747708|Lenograstim|lenograstim|mesh-list
2407085|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
2407086|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407087|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2407088|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
2407089|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2407090|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2407091|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407092|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2407093|NCT00747721|Analgesics|analgesics|mesh-ancestor
2407094|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
2407095|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407096|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2407097|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2407098|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2407099|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
2407100|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537117|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
2537118|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
2537119|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2537120|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
2537121|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
2537122|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537123|NCT01421173|Gemcitabine|gemcitabine|mesh-list
2537124|NCT01421173|Dexamethasone|dexamethasone|mesh-list
2537125|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
2537126|NCT01421173|Rituximab|rituximab|mesh-list
2537127|NCT01421173|Melphalan|melphalan|mesh-list
2537128|NCT01421173|Busulfan|busulfan|mesh-list
2537129|NCT01421173|Vorinostat|vorinostat|mesh-list
2537130|NCT01421173|BB 1101|bb 1101|mesh-list
2537131|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537132|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
2537133|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
2537134|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537135|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537136|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2537137|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
2537138|NCT01421173|Hormones|hormones|mesh-ancestor
2537139|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2537140|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2537141|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537142|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2537143|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
2537144|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2537145|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2537146|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
2407101|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407102|NCT00747799|Fluorouracil|fluorouracil|mesh-list
2537147|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537148|NCT01421173|Antiviral Agents|antiviral agents|mesh-ancestor
2537149|NCT01421173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537150|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537151|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2537152|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2537153|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
2537154|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2537155|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2537156|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
2537157|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
2537158|NCT01421212|Antibodies|antibodies|mesh-list
2537159|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
2537160|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2537161|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2537162|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
2537163|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
2537164|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537165|NCT01421264|Gabapentin|gabapentin|mesh-list
2537166|NCT01421264|Analgesics|analgesics|mesh-ancestor
2537167|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
2537168|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537169|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537170|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
2537171|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2537172|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2537173|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2537174|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2537175|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2116569|NCT02642653|Lovastatin|lovastatin|mesh-list
2116570|NCT02642653|L 647318|l 647318|mesh-list
2116571|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
2116572|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2116573|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2116574|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
2116575|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116576|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2407103|NCT00747799|Sorafenib|sorafenib|mesh-list
2407104|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407105|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
2407106|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407107|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2407108|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2407109|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
2407110|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407111|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2407112|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407113|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
2407114|NCT00747877|Melphalan|melphalan|mesh-list
2537176|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2537177|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537178|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537179|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
2407115|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2407116|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
2407117|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537180|NCT01421368|Tenofovir|tenofovir|mesh-list
2537181|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2537182|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
2407118|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2407119|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2407120|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
2407121|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537183|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
2537184|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
2537185|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
2537186|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537187|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2537188|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2537189|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537190|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537191|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2407122|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537192|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2537193|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2537194|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537195|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2537196|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2537197|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2537198|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2537199|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2537200|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2537201|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537202|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
2537203|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
2537204|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2537205|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537206|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2537207|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2537208|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2537209|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2537210|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537211|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537212|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537213|NCT01421706|Clarithromycin|clarithromycin|mesh-list
2537214|NCT01421706|Sibutramine|sibutramine|mesh-list
2537215|NCT01421706|Clopidogrel|clopidogrel|mesh-list
2537216|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2537217|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2537218|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2537219|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2407123|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2407124|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2407125|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2407126|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
2407127|NCT00747968|Exenatide|exenatide|mesh-list
2407128|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2407129|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407130|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2407131|NCT00747968|Incretins|incretins|mesh-ancestor
2407132|NCT00747968|Hormones|hormones|mesh-ancestor
2407133|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2407134|NCT00748007|Rivastigmine|rivastigmine|mesh-list
2407135|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
2407136|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407137|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407138|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
2407139|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407140|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407141|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2407142|NCT00748007|Protective Agents|protective agents|mesh-ancestor
2407143|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2407144|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407145|NCT00748059|Propranolol|propranolol|mesh-list
2407146|NCT00748059|Atropine|atropine|mesh-list
2407147|NCT00748059|Clonidine|clonidine|mesh-list
2407148|NCT00748059|Nitroprusside|nitroprusside|mesh-list
2407149|NCT00748059|Methyldopa|methyldopa|mesh-list
2407150|NCT00748059|Phenylephrine|phenylephrine|mesh-list
2407151|NCT00748059|Isoproterenol|isoproterenol|mesh-list
2407152|NCT00748059|Metoclopramide|metoclopramide|mesh-list
2407153|NCT00748059|Yohimbine|yohimbine|mesh-list
2407154|NCT00748059|Tyramine|tyramine|mesh-list
2407155|NCT00748059|Edrophonium|edrophonium|mesh-list
2407156|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2407157|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2407158|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
2407159|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407160|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407161|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407162|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2407163|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2407164|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
2407165|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2407166|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
2407167|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
2407168|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407169|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
2407170|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2407171|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
2537220|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
2537221|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537222|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537223|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537224|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2537225|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537226|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2537227|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537228|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2537229|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2537230|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
2537231|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2537232|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
2537233|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2537234|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
2537235|NCT01421797|Dexamethasone|dexamethasone|mesh-list
2537236|NCT01421797|Cosyntropin|cosyntropin|mesh-list
2537237|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537238|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
2537239|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
2537240|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537241|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537242|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2537243|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
2537244|NCT01421797|Hormones|hormones|mesh-ancestor
2537245|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2537246|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2537247|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537248|NCT01421810|Dexamethasone|dexamethasone|mesh-list
2537249|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537250|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
2537251|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
2537252|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537253|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537254|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2537255|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
2537256|NCT01421810|Hormones|hormones|mesh-ancestor
2537257|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2537258|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2537259|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537260|NCT01421901|Ertapenem|ertapenem|mesh-list
2537261|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2537262|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407172|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
2407173|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2407174|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2407175|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2407176|NCT00748059|Protective Agents|protective agents|mesh-ancestor
2407177|NCT00748059|Analgesics|analgesics|mesh-ancestor
2407178|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
2407179|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
2407180|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2407181|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2407182|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2537263|NCT01421914|Bupivacaine|bupivacaine|mesh-list
2537264|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
2537265|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
2537266|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2537267|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537268|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
2537269|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407183|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2407184|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
2407185|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2407186|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2407187|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
2407188|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
2407189|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2407190|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2407191|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2407192|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
2407193|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2407194|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2407195|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2407196|NCT00748059|Urological Agents|urological agents|mesh-ancestor
2537270|NCT01421927|Lenalidomide|lenalidomide|mesh-list
2537271|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
2537272|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537273|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2537274|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2537275|NCT01421927|Growth Substances|growth substances|mesh-ancestor
2537276|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
2537277|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537278|NCT01421940|Udenafil|udenafil|mesh-list
2537279|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2537280|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2537281|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537282|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537283|NCT01421979|Caffeine|caffeine|mesh-list
2537284|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2537285|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537286|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2537287|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407197|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2407198|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2407199|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2407200|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2407201|NCT00748059|Antidotes|antidotes|mesh-ancestor
2407202|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2407203|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407204|NCT00748150|Vaccines|vaccines|mesh-list
2407205|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
2407206|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407207|NCT00748163|Paclitaxel|paclitaxel|mesh-list
2537288|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537289|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2537290|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2537291|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
2537292|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537293|NCT01421992|Methylphenidate|methylphenidate|mesh-list
2537294|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2537295|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537296|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2537297|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2537298|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2537299|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537300|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
2407208|NCT00748163|Sunitinib|sunitinib|mesh-list
2407209|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2407210|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2407211|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407212|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
2407213|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
2407214|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
2407215|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407216|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2407217|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2407218|NCT00748163|Growth Substances|growth substances|mesh-ancestor
2407219|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407220|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
2407221|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2407222|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407223|NCT00748176|Anesthetics|anesthetics|mesh-list
2407224|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2407225|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407226|NCT00748202|Complement C1s|complement c1s|mesh-list
2407227|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2407228|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2407229|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
2407230|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407231|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2407232|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2407233|NCT00748345|Caspofungin|caspofungin|mesh-list
2407234|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
2407235|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407236|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407237|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407238|NCT00748358|Sunitinib|sunitinib|mesh-list
2537301|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537302|NCT01422018|Bevacizumab|bevacizumab|mesh-list
2537303|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2537304|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537305|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2537306|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2537307|NCT01422018|Growth Substances|growth substances|mesh-ancestor
2537308|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537309|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
2537310|NCT01422096|Leuprolide|leuprolide|mesh-list
2537311|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2537312|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
2537313|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2537314|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537315|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2537316|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537317|NCT01422109|Aspirin|aspirin|mesh-list
2537318|NCT01422109|Clopidogrel|clopidogrel|mesh-list
2537319|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2537320|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2537321|NCT01422109|Analgesics|analgesics|mesh-ancestor
2537322|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
2537323|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537324|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537325|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537326|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2537327|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2537328|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2537329|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537330|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2537331|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2537332|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537333|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
2537334|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2537335|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2537336|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2537337|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
2537338|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537339|NCT01422122|Vitamin D|vitamin d|mesh-list
2537340|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
2537341|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
2537342|NCT01422122|Vitamins|vitamins|mesh-list
2537343|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
2537344|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537345|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2537346|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2537347|NCT01422148|Minocycline|minocycline|mesh-list
2537348|NCT01422148|Amiodarone|amiodarone|mesh-list
2537349|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2537350|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537351|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2537352|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
2407239|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407240|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2407241|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2407242|NCT00748358|Growth Substances|growth substances|mesh-ancestor
2407243|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407244|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
2407245|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2407246|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407247|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407248|NCT00748371|Aspirin|aspirin|mesh-list
2407249|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2407250|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2407251|NCT00748371|Analgesics|analgesics|mesh-ancestor
2407252|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
2407253|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407254|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407255|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2407256|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2407257|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2407258|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2537353|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2537354|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2537355|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537356|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2537357|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2537358|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2537359|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537360|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2537361|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2537362|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2537363|NCT01422291|Acetaminophen|acetaminophen|mesh-list
2537364|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2537365|NCT01422291|Morphine|morphine|mesh-list
2537366|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2407259|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407260|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2407261|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2407262|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407263|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
2407264|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
2407265|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2407266|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
2407267|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407268|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407269|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2407270|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
2407271|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2407272|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
2407273|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407274|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407275|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2407276|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
2407277|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
2537367|NCT01422291|Narcotics|narcotics|mesh-ancestor
2537368|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2537369|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537370|NCT01422291|Analgesics|analgesics|mesh-ancestor
2537371|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
2537372|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537373|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2537374|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
2537375|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2537376|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537377|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2407278|NCT00748423|Protective Agents|protective agents|mesh-ancestor
2407279|NCT00748436|Betahistine|betahistine|mesh-list
2407280|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
2407281|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
2407282|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
2407283|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407284|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407285|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407286|NCT00748527|Carboplatin|carboplatin|mesh-list
2407287|NCT00748527|Decitabine|decitabine|mesh-list
2407288|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407289|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2407290|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
2407291|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407292|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407293|NCT00748618|Vitamin D|vitamin d|mesh-list
2407294|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
2407295|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
2407296|NCT00748618|Vitamins|vitamins|mesh-list
2407297|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
2407298|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537378|NCT01422317|Tocopherols|tocopherols|mesh-list
2537379|NCT01422317|Vitamin E|vitamin e|mesh-list
2537380|NCT01422317|Tocotrienols|tocotrienols|mesh-list
2537381|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
2537382|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
2537383|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537384|NCT01422317|Protective Agents|protective agents|mesh-ancestor
2537385|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537386|NCT01422317|Vitamins|vitamins|mesh-ancestor
2407299|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2407300|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2537387|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
2537388|NCT01422330|Etravirine|etravirine|mesh-list
2537389|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2537390|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2537391|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537392|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537393|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
2537394|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537395|NCT01422460|Mitogens|mitogens|mesh-list
2537396|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
2537397|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407301|NCT00748644|Rituximab|rituximab|mesh-list
2407302|NCT00748644|Azathioprine|azathioprine|mesh-list
2407303|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2407304|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407305|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
2407306|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407307|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2407308|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
2407309|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407310|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2407311|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2407312|NCT00748787|Psyllium|psyllium|mesh-list
2407313|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
2537398|NCT01422499|Vorinostat|vorinostat|mesh-list
2537399|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537400|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2537401|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537402|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537403|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2537404|NCT01422590|Mitiglinide|mitiglinide|mesh-list
2537405|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2537406|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537407|NCT01422590|Incretins|incretins|mesh-ancestor
2537408|NCT01422590|Hormones|hormones|mesh-ancestor
2537409|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2537410|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2537411|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
2537412|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537413|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537414|NCT01422603|Clofarabine|clofarabine|mesh-list
2537415|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2537416|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
2537417|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537418|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537419|NCT01422616|Metoprolol|metoprolol|mesh-list
2537420|NCT01422616|Clonidine|clonidine|mesh-list
2537421|NCT01422616|Hydralazine|hydralazine|mesh-list
2537422|NCT01422616|Labetalol|labetalol|mesh-list
2537423|NCT01422616|Nicardipine|nicardipine|mesh-list
2537424|NCT01422616|Phentolamine|phentolamine|mesh-list
2537425|NCT01422616|Urapidil|urapidil|mesh-list
2537426|NCT01422616|Enalaprilat|enalaprilat|mesh-list
2537427|NCT01422616|Enalapril|enalapril|mesh-list
2537428|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2537429|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
2537430|NCT01422616|Esmolol|esmolol|mesh-list
2537431|NCT01422616|Glycerol|glycerol|mesh-list
2537432|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2537433|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2537434|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
2537435|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
2537436|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537437|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537438|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2537439|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2537440|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2537441|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
2537442|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537443|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537444|NCT01422616|Analgesics|analgesics|mesh-ancestor
2537445|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
2537446|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2537447|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2407314|NCT00748787|Cathartics|cathartics|mesh-ancestor
2407315|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2537448|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2537449|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2537450|NCT01422616|Protective Agents|protective agents|mesh-ancestor
2537451|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
2537452|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
2537453|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2537454|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2537455|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2537456|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2537457|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2537458|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2537459|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2537460|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2407316|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
2407317|NCT00748891|Cediranib|cediranib|mesh-list
2407318|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407319|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2407320|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407321|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537461|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
2537462|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2537463|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
2537464|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537465|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
2537466|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537467|NCT01422733|Dexamethasone|dexamethasone|mesh-list
2537468|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
2537469|NCT01422733|Cosyntropin|cosyntropin|mesh-list
2537470|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537471|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
2537472|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
2537473|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537474|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537475|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2537476|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
2537477|NCT01422733|Hormones|hormones|mesh-ancestor
2537478|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2537479|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2537480|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537481|NCT01422746|Metformin|metformin|mesh-list
2537482|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2537483|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537484|NCT01422759|Spironolactone|spironolactone|mesh-list
2537485|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2537486|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
2537487|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2537488|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537489|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2537490|NCT01422759|Diuretics|diuretics|mesh-ancestor
2537491|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
2537492|NCT01422785|Clindamycin|clindamycin|mesh-list
2537493|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
2537494|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
2537495|NCT01422785|Tretinoin|tretinoin|mesh-list
2537496|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2537497|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2537498|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537499|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2537500|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537501|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537502|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2537503|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407322|NCT00748904|Rifaximin|rifaximin|mesh-list
2407323|NCT00748904|Lactulose|lactulose|mesh-list
2407324|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2407325|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407326|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2407327|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
2537504|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
2537505|NCT01422954|Chloroquine|chloroquine|mesh-list
2537506|NCT01422954|Mefloquine|mefloquine|mesh-list
2537507|NCT01422954|Proguanil|proguanil|mesh-list
2537508|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2537509|NCT01422954|Vaccines|vaccines|mesh-list
2407328|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
2407329|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
2537510|NCT01422954|Amebicides|amebicides|mesh-ancestor
2537511|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2537512|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2537513|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537514|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
2537515|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2537516|NCT01422954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537517|NCT01422954|Immunologic Factors|immunologic factors|mesh-ancestor
2537518|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
2537519|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537520|NCT01423019|Synephrine|synephrine|mesh-list
2537521|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2537522|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2537523|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
2537524|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537525|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537526|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537527|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
2537528|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
2537529|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537530|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2537531|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
2537532|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
2537533|NCT01423032|Fludarabine|fludarabine|mesh-list
2537534|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2537535|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537536|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537537|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2537538|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
2537539|NCT01423058|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2537540|NCT01423058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2537541|NCT01423058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537542|NCT01423058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537543|NCT01423123|Paclitaxel|paclitaxel|mesh-list
2537544|NCT01423123|Trastuzumab|trastuzumab|mesh-list
2537545|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2537546|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407330|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407331|NCT00749021|Ranibizumab|ranibizumab|mesh-list
2407332|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2407333|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2407334|NCT00749021|Growth Substances|growth substances|mesh-ancestor
2407335|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407336|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
2407337|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407338|NCT00749047|Pioglitazone|pioglitazone|mesh-list
2407339|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2407340|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407341|NCT00749099|Pancrelipase|pancrelipase|mesh-list
2407342|NCT00749099|Pancreatin|pancreatin|mesh-list
2407343|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2407344|NCT00749112|Rituximab|rituximab|mesh-list
2407345|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
2407346|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2407347|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407348|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
2407349|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407350|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2407351|NCT00749138|Tamoxifen|tamoxifen|mesh-list
2407352|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2407353|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
2407354|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2407355|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407356|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2407357|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407358|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2407359|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2407360|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2537547|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
2537548|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
2537549|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
2537550|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537551|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2537552|NCT01423149|Fosbretabulin|fosbretabulin|mesh-list
2537553|NCT01423149|Combretastatin|combretastatin|mesh-list
2537554|NCT01423149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2537555|NCT01423149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537556|NCT01423149|Tubulin Modulators|tubulin modulators|mesh-ancestor
2537557|NCT01423149|Antimitotic Agents|antimitotic agents|mesh-ancestor
2537558|NCT01423149|Mitosis Modulators|mitosis modulators|mesh-ancestor
2537559|NCT01423149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537560|NCT01423175|Clofarabine|clofarabine|mesh-list
2537561|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2537562|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
2537563|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537564|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537565|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2537566|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2537567|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2537568|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2537569|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537570|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2537571|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2537572|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2537573|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2537574|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
2407361|NCT00749346|Pemetrexed|pemetrexed|mesh-list
2407362|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407363|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537575|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537576|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537577|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2537578|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2537579|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
2537580|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2537581|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2537582|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
2537583|NCT01423292|Bupivacaine|bupivacaine|mesh-list
2407364|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407365|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2407366|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2537584|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
2537585|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
2537586|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2537587|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537588|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
2537589|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537590|NCT01423305|Budesonide|budesonide|mesh-list
2537591|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
2537592|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2537593|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2407367|NCT00749359|Paroxetine|paroxetine|mesh-list
2407368|NCT00749359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2407369|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2407370|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2407371|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407372|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407373|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
2407374|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407375|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2407376|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
2407377|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2407378|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2407379|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2407380|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407381|NCT00749385|Naproxen|naproxen|mesh-list
2407382|NCT00749385|Esomeprazole|esomeprazole|mesh-list
2407383|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2407384|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2407385|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2407386|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407387|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407388|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2407389|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2407390|NCT00749385|Analgesics|analgesics|mesh-ancestor
2407391|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
2407392|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407393|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537594|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2407394|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2407395|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2407396|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
2407397|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2407398|NCT00749450|Fluorouracil|fluorouracil|mesh-list
2407399|NCT00749450|Capecitabine|capecitabine|mesh-list
2407400|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
2407401|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
2407402|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537595|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
2537596|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537597|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537598|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2537599|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
2537600|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
2537601|NCT01423305|Hormones|hormones|mesh-ancestor
2537602|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2537603|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2537604|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2537605|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2537606|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
2537607|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537608|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537609|NCT01423370|Tadalafil|tadalafil|mesh-list
2407403|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2407404|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537610|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
2537611|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2537612|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2537613|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537614|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537615|NCT01423370|Urological Agents|urological agents|mesh-ancestor
2537616|NCT01423435|Beraprost|beraprost|mesh-list
2537617|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2407405|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2407406|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
2407407|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407408|NCT00749502|Niraparib|niraparib|mesh-list
2407409|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2407410|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407411|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407412|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407413|NCT00749567|Bevacizumab|bevacizumab|mesh-list
2407414|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2407415|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2407416|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407417|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2407418|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2407419|NCT00749567|Growth Substances|growth substances|mesh-ancestor
2407420|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407421|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
2407422|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2407423|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407424|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407425|NCT00749619|Taurolidine|taurolidine|mesh-list
2407426|NCT00749619|Heparin|heparin|mesh-list
2407427|NCT00749619|Calcium heparin|calcium heparin|mesh-list
2407428|NCT00749619|Citric Acid|citric acid|mesh-list
2407429|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
2407430|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2407431|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
2407432|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2407433|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
2407434|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
2407435|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407436|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2407437|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2407438|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407439|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2407440|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407441|NCT00749632|Mandelic Acids|mandelic acids|mesh-list
2407442|NCT00749632|Oxybutynin|oxybutynin|mesh-list
2537618|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
2537619|NCT01423487|Metformin|metformin|mesh-list
2537620|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2407443|NCT00749632|Parasympatholytics|parasympatholytics|mesh-ancestor
2407444|NCT00749632|Autonomic Agents|autonomic agents|mesh-ancestor
2407445|NCT00749632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407446|NCT00749632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407447|NCT00749632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2407448|NCT00749632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2407449|NCT00749632|Cholinergic Agents|cholinergic agents|mesh-ancestor
2407450|NCT00749632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407451|NCT00749632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407452|NCT00749632|Urological Agents|urological agents|mesh-ancestor
2407453|NCT00749632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2407454|NCT00749632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407455|NCT00749632|Renal Agents|renal agents|mesh-ancestor
2537621|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537622|NCT01423500|Fludarabine|fludarabine|mesh-list
2537623|NCT01423500|Etoposide|etoposide|mesh-list
2537624|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
2537625|NCT01423500|Thiotepa|thiotepa|mesh-list
2537626|NCT01423500|Treosulfan|treosulfan|mesh-list
2537627|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537628|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407456|NCT00749710|Clopidogrel|clopidogrel|mesh-list
2407457|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2407458|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2537629|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2537630|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
2537631|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537632|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2537633|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2537634|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2537635|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537636|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2537637|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
2537638|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2537639|NCT01423539|Rituximab|rituximab|mesh-list
2537640|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2537641|NCT01423539|Navitoclax|navitoclax|mesh-list
2537642|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2537643|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537644|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
2537645|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537646|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2537647|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2537648|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
2537649|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537650|NCT01423591|Infliximab|infliximab|mesh-list
2537651|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
2537652|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2537653|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2537654|NCT01423695|Paclitaxel|paclitaxel|mesh-list
2537655|NCT01423695|Trastuzumab|trastuzumab|mesh-list
2537656|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2537657|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537658|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
2537659|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
2537660|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
2537661|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407459|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2407460|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2407461|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
2537662|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2537663|NCT01423708|Everolimus|everolimus|mesh-list
2537664|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537665|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2537666|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
2537667|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537668|NCT01423747|Fludarabine|fludarabine|mesh-list
2537669|NCT01423747|Etoposide|etoposide|mesh-list
2537670|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
2537671|NCT01423747|Thiotepa|thiotepa|mesh-list
2537672|NCT01423747|Treosulfan|treosulfan|mesh-list
2537673|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537674|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537675|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2537676|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
2537677|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537678|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2537679|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2537680|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2537681|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537682|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2537683|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
2537684|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2537685|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
2537686|NCT01423838|Oxybutynin|oxybutynin|mesh-list
2537687|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2537688|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2537689|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
2537690|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537691|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537692|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537693|NCT01423838|Urological Agents|urological agents|mesh-ancestor
2537694|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
2537695|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
2537696|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537697|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2537698|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2537699|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
2537700|NCT01423864|Prednisolone|prednisolone|mesh-list
2537701|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
2537702|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2537703|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2537704|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
2407462|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407463|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407464|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407465|NCT00749723|Carboplatin|carboplatin|mesh-list
2407466|NCT00749723|Etoposide|etoposide|mesh-list
2407467|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
2407468|NCT00749723|Temozolomide|temozolomide|mesh-list
2407469|NCT00749723|Thiotepa|thiotepa|mesh-list
2537705|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537706|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
2537707|NCT01423864|Hormones|hormones|mesh-ancestor
2537708|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2537709|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537710|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2537711|NCT01423864|Protective Agents|protective agents|mesh-ancestor
2537712|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2537713|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537714|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
2537715|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
2537716|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537717|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2537718|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
2537719|NCT01423955|Hematinics|hematinics|mesh-ancestor
2537720|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
2537721|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2537722|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537723|NCT01424111|Citalopram|citalopram|mesh-list
2537724|NCT01424111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2537725|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2537726|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2537727|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537728|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537729|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
2537730|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537731|NCT01424111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2537732|NCT01424111|Antidepressive Agents|antidepressive agents|mesh-ancestor
2537733|NCT01424111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2537734|NCT01424124|Montelukast|montelukast|mesh-list
2537735|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2537736|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
2537737|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2537738|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
2537739|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2537740|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537741|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2537742|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2407470|NCT00749723|Trofosfamide|trofosfamide|mesh-list
2407471|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
2407472|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407473|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2407474|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2407475|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2407476|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407477|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407478|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2407479|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
2537743|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537744|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2537745|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2407480|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2407481|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2407482|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
2407483|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407484|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2407485|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
2537746|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
2537747|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537748|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537749|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2537750|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
2537751|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
2537752|NCT01424137|Hormones|hormones|mesh-ancestor
2537753|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2537754|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
2407486|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2407487|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2407488|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407489|NCT00749736|Vitamins|vitamins|mesh-ancestor
2407490|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
2407491|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2407492|NCT00749814|Melatonin|melatonin|mesh-list
2407493|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
2407494|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407495|NCT00749814|Protective Agents|protective agents|mesh-ancestor
2407496|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407497|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2407498|NCT00749853|Buserelin|buserelin|mesh-list
2407499|NCT00749853|Hormones|hormones|mesh-list
2407500|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2407501|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2407502|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407503|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2537755|NCT01424176|Pramipexole|pramipexole|mesh-list
2537756|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
2537757|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537758|NCT01424176|Protective Agents|protective agents|mesh-ancestor
2537759|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537760|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2537761|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2537762|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
2537763|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
2537764|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537765|NCT01424241|Octreotide|octreotide|mesh-list
2537766|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2537767|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2407504|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
2407505|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2407506|NCT00749866|Gentamicins|gentamicins|mesh-list
2407507|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2407508|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407509|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2407510|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407511|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407512|NCT00749918|Vitamin D|vitamin d|mesh-list
2407513|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
2407514|NCT00749918|Vitamins|vitamins|mesh-ancestor
2407515|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
2407516|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407517|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2407518|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2407519|NCT00750048|Acetaminophen|acetaminophen|mesh-list
2407520|NCT00750048|Naloxone|naloxone|mesh-list
2537768|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537769|NCT01424319|Atrasentan|atrasentan|mesh-list
2537770|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537771|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2537772|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2537773|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537774|NCT01424332|Aspirin|aspirin|mesh-list
2537775|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
2537776|NCT01424332|Salicylates|salicylates|mesh-list
2537777|NCT01424332|Darexaban|darexaban|mesh-list
2537778|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2537779|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2537780|NCT01424332|Analgesics|analgesics|mesh-ancestor
2537781|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
2537782|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537783|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537784|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2407521|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2407522|NCT00750048|Analgesics|analgesics|mesh-ancestor
2407523|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
2407524|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407525|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407526|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
2407527|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2407528|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2407529|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2407530|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407531|NCT00750113|Telmisartan|telmisartan|mesh-list
2407532|NCT00750113|Nifedipine|nifedipine|mesh-list
2407533|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2537785|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2537786|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2537787|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2537788|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537789|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2537790|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2537791|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537792|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
2537793|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537794|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
2537795|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
2537796|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
2537797|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2537798|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
2537799|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2537800|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
2537801|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
2537802|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2537803|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
2537804|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537805|NCT01424384|Citalopram|citalopram|mesh-list
2537806|NCT01424384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2537807|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2537808|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2537809|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407534|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2407535|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2407536|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407537|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2407538|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2407539|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2407540|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407541|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
2407542|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
2407543|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2407544|NCT00750126|Fludarabine|fludarabine|mesh-list
2407545|NCT00750126|Busulfan|busulfan|mesh-list
2407546|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
2407547|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407548|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407549|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2407550|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
2407551|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537810|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537811|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
2407552|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
2407553|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2407554|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2407555|NCT00750178|Vorinostat|vorinostat|mesh-list
2407556|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407557|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2407558|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407559|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537812|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537813|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2537814|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
2537815|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2537816|NCT01424449|Aripiprazole|aripiprazole|mesh-list
2537817|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
2537818|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2537819|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2537820|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2537821|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2537822|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407560|NCT00750217|Buprenorphine|buprenorphine|mesh-list
2407561|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2407562|NCT00750217|Narcotics|narcotics|mesh-ancestor
2407563|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2407564|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407565|NCT00750217|Analgesics|analgesics|mesh-ancestor
2407566|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
2407567|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407568|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2407569|NCT00750243|Naproxen|naproxen|mesh-list
2407570|NCT00750243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2407571|NCT00750243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2407572|NCT00750243|Analgesics|analgesics|mesh-ancestor
2407573|NCT00750243|Sensory System Agents|sensory system agents|mesh-ancestor
2407574|NCT00750243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407575|NCT00750243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407576|NCT00750243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2407577|NCT00750243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2407578|NCT00750243|Gout Suppressants|gout suppressants|mesh-ancestor
2407579|NCT00750243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2407580|NCT00750243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407581|NCT00750243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407582|NCT00750295|Ferric Compounds|ferric compounds|mesh-list
2407583|NCT00750295|Hematinics|hematinics|mesh-ancestor
2407584|NCT00750334|Clofarabine|clofarabine|mesh-list
2407585|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2407586|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
2407587|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407588|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407589|NCT00750347|Acetaminophen|acetaminophen|mesh-list
2537823|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
2537824|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
2537825|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537826|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537827|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2537828|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2537829|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
2537830|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2537831|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2537832|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2537833|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2537834|NCT01424618|Leuprolide|leuprolide|mesh-list
2537835|NCT01424618|Ganirelix|ganirelix|mesh-list
2537836|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2537837|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
2537838|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2537839|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537840|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2537841|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537842|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
2537843|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2537844|NCT01424709|Gemcitabine|gemcitabine|mesh-list
2407590|NCT00750347|Rimonabant|rimonabant|mesh-list
2407591|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2407592|NCT00750347|Analgesics|analgesics|mesh-ancestor
2407593|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
2407594|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407595|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407596|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
2407597|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2407598|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2537845|NCT01424709|Cisplatin|cisplatin|mesh-list
2537846|NCT01424709|Docetaxel|docetaxel|mesh-list
2537847|NCT01424709|Irinotecan|irinotecan|mesh-list
2537848|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537849|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2537850|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
2537851|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537852|NCT01424709|Antiviral Agents|antiviral agents|mesh-ancestor
2537853|NCT01424709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537854|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537855|NCT01424709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2537856|NCT01424709|Immunologic Factors|immunologic factors|mesh-ancestor
2537857|NCT01424709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537858|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
2537859|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
2537860|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
2537861|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2537862|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2537863|NCT01424761|Ubiquinone|ubiquinone|mesh-list
2537864|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
2537865|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
2537866|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537867|NCT01424761|Vitamins|vitamins|mesh-ancestor
2407599|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2407600|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407601|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407602|NCT00750347|Hormones|hormones|mesh-ancestor
2407603|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2407604|NCT00750386|Paclitaxel|paclitaxel|mesh-list
2407605|NCT00750386|Carboplatin|carboplatin|mesh-list
2407606|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2407607|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407608|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
2407609|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
2407610|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
2407611|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407612|NCT00750399|Ranibizumab|ranibizumab|mesh-list
2407613|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2407614|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2407615|NCT00750399|Growth Substances|growth substances|mesh-ancestor
2407616|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407617|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
2407618|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407619|NCT00750425|Cediranib|cediranib|mesh-list
2407620|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407621|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2407622|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407623|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407624|NCT00750451|Heparin|heparin|mesh-list
2407625|NCT00750451|Enoxaparin|enoxaparin|mesh-list
2407626|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2407627|NCT00750451|Tinzaparin|tinzaparin|mesh-list
2407628|NCT00750451|Dalteparin|dalteparin|mesh-list
2407629|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
2407630|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
2407631|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2407632|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2407633|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407634|NCT00750529|Donepezil|donepezil|mesh-list
2407635|NCT00750529|Galantamine|galantamine|mesh-list
2407636|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2407637|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407638|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537868|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
2537869|NCT01424826|Rifampin|rifampin|mesh-list
2537870|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2537871|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2537872|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
2537873|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537874|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2537875|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2407639|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
2537876|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537877|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537878|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2537879|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
2537880|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2537881|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
2537882|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2537883|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2537884|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2537885|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2537886|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2537887|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2537888|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2537889|NCT01424839|Cisplatin|cisplatin|mesh-list
2537890|NCT01424839|Carboplatin|carboplatin|mesh-list
2537891|NCT01424839|Etoposide|etoposide|mesh-list
2537892|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
2407640|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407641|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407642|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
2537893|NCT01424839|Ifosfamide|ifosfamide|mesh-list
2537894|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
2537895|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537896|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2537897|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2537898|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2537899|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537900|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537901|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2537902|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
2537903|NCT01424891|Simvastatin|simvastatin|mesh-list
2116577|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2116578|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537904|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2537905|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2537906|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
2537907|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537908|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2537909|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2537910|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537911|NCT01424982|Cytarabine|cytarabine|mesh-list
2537912|NCT01424982|Dexamethasone|dexamethasone|mesh-list
2537913|NCT01424982|Prednisone|prednisone|mesh-list
2407643|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2407644|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
2407645|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407646|NCT00750581|Indomethacin|indomethacin|mesh-list
2407647|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2407648|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2407649|NCT00750581|Analgesics|analgesics|mesh-ancestor
2407650|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
2407651|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407652|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407653|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2407654|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2537914|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
2537915|NCT01424982|Cortisone|cortisone|mesh-list
2537916|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
2537917|NCT01424982|Rituximab|rituximab|mesh-list
2537918|NCT01424982|Doxorubicin|doxorubicin|mesh-list
2537919|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2537920|NCT01424982|Methotrexate|methotrexate|mesh-list
2537921|NCT01424982|Vincristine|vincristine|mesh-list
2537922|NCT01424982|Daunorubicin|daunorubicin|mesh-list
2537923|NCT01424982|Ponatinib|ponatinib|mesh-list
2537924|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2537925|NCT01424982|Antibodies|antibodies|mesh-list
2537926|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
2407655|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
2407656|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
2407657|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2407658|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2407659|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407660|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407661|NCT00750620|Mirabegron|mirabegron|mesh-list
2407662|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2407663|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2407664|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2407665|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
2407666|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407667|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407668|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407669|NCT00750620|Urological Agents|urological agents|mesh-ancestor
2407670|NCT00750633|Moxifloxacin|moxifloxacin|mesh-list
2407671|NCT00750633|Dexamethasone|dexamethasone|mesh-list
2407672|NCT00750633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2407673|NCT00750633|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2407674|NCT00750633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2407675|NCT00750633|Antiemetics|antiemetics|mesh-ancestor
2407676|NCT00750633|Autonomic Agents|autonomic agents|mesh-ancestor
2407677|NCT00750633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407678|NCT00750633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407679|NCT00750633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2407680|NCT00750633|Glucocorticoids|glucocorticoids|mesh-ancestor
2407681|NCT00750633|Hormones|hormones|mesh-ancestor
2407682|NCT00750633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2407683|NCT00750633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2407684|NCT00750633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407685|NCT00750633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2407686|NCT00750633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407687|NCT00750633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2407688|NCT00750633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2407689|NCT00750633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407690|NCT00750633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407691|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2407692|NCT00750698|Entinostat|entinostat|mesh-list
2407693|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407694|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2407695|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407696|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407697|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2407698|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
2407699|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2407700|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
2407701|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407702|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
2407703|NCT00750724|Protective Agents|protective agents|mesh-ancestor
2407704|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
2407705|NCT00750750|Amoxicillin|amoxicillin|mesh-list
2407706|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2407707|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407708|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2407709|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
2407710|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2537927|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2537928|NCT01424982|BB 1101|bb 1101|mesh-list
2537929|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2537930|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
2537931|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537932|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2537933|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2537934|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
2537935|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537936|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407711|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
2407712|NCT00750763|Cathartics|cathartics|mesh-ancestor
2407713|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2407714|NCT00750802|Lorazepam|lorazepam|mesh-list
2407715|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
2407716|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
2407717|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
2407718|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407719|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407720|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2407721|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2537937|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2537938|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537939|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
2407722|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2407723|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2407724|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2407725|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2407726|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
2407727|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
2407728|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407729|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407735|NCT00750997|Dextrans|dextrans|mesh-list
2407736|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
2407737|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
2407738|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
2407739|NCT00751049|Timolol|timolol|mesh-list
2537940|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
2537941|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2537942|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2537943|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
2537944|NCT01424982|Hormones|hormones|mesh-ancestor
2537945|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2537946|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2537947|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2407740|NCT00751049|Latanoprost|latanoprost|mesh-list
2407741|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2407742|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2407743|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
2407744|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407745|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407746|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537948|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2537949|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2537950|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537951|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2537952|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
2537953|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2537954|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2537955|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
2537956|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
2537957|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2537958|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2537959|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
2537960|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537961|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2537962|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
2537963|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
2537964|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
2537965|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
2537966|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2537967|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
2537968|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2537969|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537970|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2537971|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2537972|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537973|NCT01425073|Renal Agents|renal agents|mesh-ancestor
2537974|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2537975|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
2407747|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2407748|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2407749|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2407750|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2407751|NCT00751062|Timolol|timolol|mesh-list
2407752|NCT00751062|Latanoprost|latanoprost|mesh-list
2407753|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2407754|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2407755|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
2407756|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407757|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407758|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407759|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2407760|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2407761|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2407762|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2407763|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
2407764|NCT00751075|Amoxicillin|amoxicillin|mesh-list
2407765|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2407766|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407767|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2407768|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
2537976|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2537977|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2537978|NCT01425099|Dolutegravir|dolutegravir|mesh-list
2537979|NCT01425099|Prednisone|prednisone|mesh-list
2537980|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2537981|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
2537982|NCT01425099|Hormones|hormones|mesh-ancestor
2537983|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2537984|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2537985|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2537986|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2537987|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2537988|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2407769|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2407770|NCT00751127|Timolol|timolol|mesh-list
2407771|NCT00751127|Latanoprost|latanoprost|mesh-list
2407772|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2407773|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2407774|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
2407775|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2537989|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2537990|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537991|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2537992|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2537993|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
2537994|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2537995|NCT01425125|Tolvaptan|tolvaptan|mesh-list
2537996|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2537997|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2537998|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
2537999|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538000|NCT01425164|Carvedilol|carvedilol|mesh-list
2538001|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2538002|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2538003|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
2538004|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538005|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538006|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538007|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2538008|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
2538009|NCT01425164|Protective Agents|protective agents|mesh-ancestor
2538010|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2538011|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2538012|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2538013|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
2538014|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2538015|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2538016|NCT01425216|Sorafenib|sorafenib|mesh-list
2538017|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538018|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2538019|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538020|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538021|NCT01425242|Amlodipine|amlodipine|mesh-list
2538022|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2538023|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2538024|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2538025|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538026|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2538027|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538028|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
2538029|NCT01425320|Dapsone|dapsone|mesh-list
2538030|NCT01425320|Adapalene|adapalene|mesh-list
2538031|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2538032|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2538033|NCT01425320|Analgesics|analgesics|mesh-ancestor
2538034|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
2538035|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538036|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538037|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2538038|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2538039|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
2538040|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538041|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
2538042|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2538043|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2538044|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2538045|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538046|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538047|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
2538048|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2538049|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2538050|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2538051|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2538052|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
2538053|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538054|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2538055|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2538056|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538057|NCT01425411|Valsartan|valsartan|mesh-list
2538058|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2538059|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2538060|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2538061|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538062|NCT01425424|Vitamin D|vitamin d|mesh-list
2538063|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
2538064|NCT01425424|Vitamins|vitamins|mesh-list
2538065|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
2538066|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538067|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2538068|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2538069|NCT01425476|Vitamin D|vitamin d|mesh-list
2538070|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
2538071|NCT01425476|Celecoxib|celecoxib|mesh-list
2538072|NCT01425476|Vitamins|vitamins|mesh-ancestor
2538073|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
2538074|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538075|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2538076|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2538077|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2538078|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2538079|NCT01425476|Analgesics|analgesics|mesh-ancestor
2538080|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
2538081|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538082|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2538083|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2407776|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407777|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407778|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2407779|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2407780|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2407781|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2407782|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
2407783|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2407784|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2407785|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2407786|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
2407787|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538084|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2407788|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2407789|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2407790|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538085|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2538086|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538087|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538088|NCT01425541|Progesterone|progesterone|mesh-list
2538089|NCT01425541|Estradiol|estradiol|mesh-list
2538090|NCT01425541|Estrogens|estrogens|mesh-list
2538091|NCT01425541|Progestins|progestins|mesh-ancestor
2538092|NCT01425541|Hormones|hormones|mesh-ancestor
2538093|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2538094|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538095|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
2538096|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2538097|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2538098|NCT01425580|Metformin|metformin|mesh-list
2538099|NCT01425580|Liraglutide|liraglutide|mesh-list
2538100|NCT01425580|Glimepiride|glimepiride|mesh-list
2538101|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2538102|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538103|NCT01425580|Incretins|incretins|mesh-ancestor
2538104|NCT01425580|Hormones|hormones|mesh-ancestor
2538105|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2538106|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2538107|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538108|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
2538109|NCT01425619|Lidocaine|lidocaine|mesh-list
2538110|NCT01425619|Prilocaine|prilocaine|mesh-list
2407791|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407792|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2407793|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2407794|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
2407795|NCT00751166|Cetirizine|cetirizine|mesh-list
2407796|NCT00751166|Desloratadine|desloratadine|mesh-list
2407797|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2407798|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2407799|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2407800|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
2407801|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
2407802|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407803|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407804|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407805|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2407806|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
2538111|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
2538112|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
2538113|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538114|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538115|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
2538116|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538117|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2538118|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2538119|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2407807|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
2407808|NCT00751205|Prednisone|prednisone|mesh-list
2538120|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2538121|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538122|NCT01425658|Clonidine|clonidine|mesh-list
2538123|NCT01425658|Fentanyl|fentanyl|mesh-list
2538124|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2538125|NCT01425658|Narcotics|narcotics|mesh-ancestor
2538126|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538127|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538128|NCT01425658|Analgesics|analgesics|mesh-ancestor
2538129|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
2538130|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538131|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2538132|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2538133|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
2538134|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
2538135|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2538136|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
2538137|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
2538138|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2538139|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2407809|NCT00751205|Prednisolone|prednisolone|mesh-list
2538140|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2538141|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
2538142|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538143|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538144|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
2538145|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2538146|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2538147|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538148|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
2538149|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
2538150|NCT01425736|Cisplatin|cisplatin|mesh-list
2538151|NCT01425736|Docetaxel|docetaxel|mesh-list
2538152|NCT01425736|Fluorouracil|fluorouracil|mesh-list
2538153|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
2538154|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538155|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
2538156|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
2538157|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
2538158|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538159|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
2538160|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2538161|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538162|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
2538163|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538164|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2538165|NCT01425775|Vitamin D|vitamin d|mesh-list
2538166|NCT01425775|Vitamins|vitamins|mesh-ancestor
2538167|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
2538168|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538169|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2538170|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2538171|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2538172|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2538173|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2538174|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538175|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538176|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538177|NCT01425827|Analgesics|analgesics|mesh-ancestor
2538178|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
2538179|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538180|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
2538181|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2538182|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
2538183|NCT01425840|Lidocaine|lidocaine|mesh-list
2538184|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
2538185|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
2538186|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538187|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538188|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
2538189|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538190|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2538191|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2538192|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2538193|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2538194|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538195|NCT01425970|Interferons|interferons|mesh-list
2538196|NCT01425970|Ribavirin|ribavirin|mesh-list
2538197|NCT01425970|Interferon-alpha|interferon-alpha|mesh-list
2538198|NCT01425970|Interferon alpha-2|interferon alpha-2|mesh-list
2538199|NCT01425970|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2538200|NCT01425970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538201|NCT01425970|Antiviral Agents|antiviral agents|mesh-ancestor
2538202|NCT01425970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538203|NCT01425970|Antimetabolites|antimetabolites|mesh-ancestor
2538204|NCT01425970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538205|NCT01425970|Immunologic Factors|immunologic factors|mesh-ancestor
2538206|NCT01425970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538207|NCT01425996|Camptothecin|camptothecin|mesh-list
2538208|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2538209|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538210|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2538211|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2538212|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538213|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538214|NCT01426022|Ethanol|ethanol|mesh-list
2538215|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2538216|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538217|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538218|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538219|NCT01426074|Bevacizumab|bevacizumab|mesh-list
2538220|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2538221|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538222|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2538223|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2538224|NCT01426074|Growth Substances|growth substances|mesh-ancestor
2538225|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538226|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
2538227|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2538228|NCT01426087|Somatostatin|somatostatin|mesh-list
2538229|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538230|NCT01426087|Hormones|hormones|mesh-ancestor
2407810|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2407811|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
2407812|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2538231|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2538232|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538233|NCT01426100|Telmisartan|telmisartan|mesh-list
2538234|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2538235|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2538236|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2538237|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407813|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
2407814|NCT00751205|Sagopilone|sagopilone|mesh-list
2407815|NCT00751205|Epothilones|epothilones|mesh-list
2407816|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2407817|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
2407818|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2407819|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
2407820|NCT00751205|Hormones|hormones|mesh-ancestor
2407821|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2407822|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407823|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2407824|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2407825|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
2407826|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
2407827|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407828|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2407829|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2407830|NCT00751205|Protective Agents|protective agents|mesh-ancestor
2407831|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
2407832|NCT00751205|Vitamins|vitamins|mesh-ancestor
2407833|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
2407834|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
2407835|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
2407836|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
2407837|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
2407838|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407839|NCT00751218|Cetirizine|cetirizine|mesh-list
2407840|NCT00751218|Desloratadine|desloratadine|mesh-list
2407841|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2407842|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2407843|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2407844|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
2407845|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
2407846|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407847|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407848|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407849|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2407850|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
2407851|NCT00751231|Clopidogrel|clopidogrel|mesh-list
2407852|NCT00751231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2407853|NCT00751231|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2407854|NCT00751231|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2407855|NCT00751231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2407856|NCT00751231|Purinergic Agents|purinergic agents|mesh-ancestor
2407857|NCT00751231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407858|NCT00751231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407859|NCT00751231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538238|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
2538239|NCT01426165|Analgesics|analgesics|mesh-ancestor
2538240|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
2538241|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538242|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538243|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
2538244|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538245|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2538246|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
2538247|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2538248|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2407860|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
2407861|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2407862|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
2407863|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407864|NCT00751257|Expectorants|expectorants|mesh-ancestor
2407865|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
2407866|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2538249|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538250|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2538251|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
2538252|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2538253|NCT01426243|Vaccines|vaccines|mesh-list
2538254|NCT01426243|Immunologic Factors|immunologic factors|mesh-ancestor
2538255|NCT01426243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538256|NCT01426256|Vitamin D|vitamin d|mesh-list
2538257|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
2538258|NCT01426256|Vitamins|vitamins|mesh-ancestor
2538259|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
2538260|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538261|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2538262|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2538263|NCT01426334|Cyclosporine|cyclosporine|mesh-list
2538264|NCT01426334|Dasatinib|dasatinib|mesh-list
2538265|NCT01426334|Cyclosporins|cyclosporins|mesh-list
2538266|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538267|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538268|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538269|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
2538270|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538271|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
2538272|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538273|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
2538274|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2538275|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2538276|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538277|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2407867|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
2407868|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407869|NCT00751257|Protective Agents|protective agents|mesh-ancestor
2407870|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407871|NCT00751257|Antidotes|antidotes|mesh-ancestor
2538278|NCT01426399|Metformin|metformin|mesh-list
2538279|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2538280|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538281|NCT01426464|Latanoprost|latanoprost|mesh-list
2538282|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2407872|NCT00751270|Valacyclovir|valacyclovir|mesh-list
2407873|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
2407874|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407875|NCT00751374|Gentamicins|gentamicins|mesh-list
2407876|NCT00751374|Mupirocin|mupirocin|mesh-list
2407877|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2407878|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407879|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2538283|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2538284|NCT01426490|Vitamins|vitamins|mesh-list
2538285|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
2538286|NCT01426490|Folic Acid|folic acid|mesh-list
2538287|NCT01426490|Pyridoxine|pyridoxine|mesh-list
2538288|NCT01426490|Pyridoxal|pyridoxal|mesh-list
2407880|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407881|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407882|NCT00751478|Naltrexone|naltrexone|mesh-list
2407883|NCT00751478|Morphine|morphine|mesh-list
2407884|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2538289|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
2538290|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
2538291|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
2538292|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538293|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
2538294|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538295|NCT01426490|Protective Agents|protective agents|mesh-ancestor
2538296|NCT01426490|Hematinics|hematinics|mesh-ancestor
2538297|NCT01426529|Norepinephrine|norepinephrine|mesh-list
2538298|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
2538299|NCT01426529|Giapreza|giapreza|mesh-list
2538300|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
2538301|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2538302|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2538303|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
2538304|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538305|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538306|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538307|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
2538308|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
2538309|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538310|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2538311|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2538312|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
2538313|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538314|NCT01426542|Topiramate|topiramate|mesh-list
2538315|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
2538316|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2538317|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538318|NCT01426633|Gemcitabine|gemcitabine|mesh-list
2538319|NCT01426633|Trabectedin|trabectedin|mesh-list
2407885|NCT00751478|Narcotics|narcotics|mesh-ancestor
2407886|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538320|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2538321|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
2538322|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538323|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538324|NCT01426633|Antiviral Agents|antiviral agents|mesh-ancestor
2538325|NCT01426633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538326|NCT01426633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538327|NCT01426633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538328|NCT01426633|Immunologic Factors|immunologic factors|mesh-ancestor
2538329|NCT01426633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538330|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2538331|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
2538332|NCT01426646|Cisplatin|cisplatin|mesh-list
2538333|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538334|NCT01426737|Vildagliptin|vildagliptin|mesh-list
2538335|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2538336|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538337|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2538338|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
2538339|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538340|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538341|NCT01426802|Vildagliptin|vildagliptin|mesh-list
2538342|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2407887|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407888|NCT00751478|Analgesics|analgesics|mesh-ancestor
2407889|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
2407890|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407891|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2407892|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2407893|NCT00751491|Clopidogrel|clopidogrel|mesh-list
2407894|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2407895|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2407896|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2407897|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2407898|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
2407899|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407900|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407901|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407902|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2407903|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
2407904|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2407905|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2407906|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2407907|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538343|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538344|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2538345|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
2538346|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538347|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538348|NCT01426815|Golimumab|golimumab|mesh-list
2538349|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2538350|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2538351|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538352|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
2538353|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538354|NCT01426880|Paclitaxel|paclitaxel|mesh-list
2538355|NCT01426880|Carboplatin|carboplatin|mesh-list
2538356|NCT01426880|Lapatinib|lapatinib|mesh-list
2538357|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2538358|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538359|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
2538360|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
2538361|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
2538362|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538363|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2538364|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538365|NCT01426906|Ketoconazole|ketoconazole|mesh-list
2538366|NCT01426906|Rifampin|rifampin|mesh-list
2538367|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
2538368|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538369|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2538370|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2538371|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538372|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538373|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2538374|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
2538375|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2538376|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538377|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2538378|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2538379|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
2538380|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2538381|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
2538382|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2538383|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2538384|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2538385|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2538386|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2538387|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2538388|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2538389|NCT01426971|Ibuprofen|ibuprofen|mesh-list
2538390|NCT01426971|Caffeine|caffeine|mesh-list
2538391|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2538392|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2538393|NCT01426971|Analgesics|analgesics|mesh-ancestor
2538394|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
2538395|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538396|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538397|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2538398|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2407908|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407909|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
2407910|NCT00751517|Methotrexate|methotrexate|mesh-list
2407911|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2407912|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
2407913|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407914|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2407915|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2407916|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
2407917|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407918|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538399|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2538400|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538401|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538402|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2538403|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2407919|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2538404|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2538405|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2538406|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
2407920|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2407921|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
2407922|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2407923|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2407924|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
2407925|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
2407926|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407927|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2407928|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2407929|NCT00751556|Naproxen|naproxen|mesh-list
2407930|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2407931|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2407932|NCT00751556|Analgesics|analgesics|mesh-ancestor
2407933|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
2407934|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538407|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538408|NCT01426984|Methylphenidate|methylphenidate|mesh-list
2538409|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2538410|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538411|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2538412|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2538413|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2538414|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538415|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
2407935|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407936|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2407937|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2407938|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
2407939|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2407940|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407941|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407942|NCT00751699|Mesalamine|mesalamine|mesh-list
2407943|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2407944|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2407945|NCT00751699|Analgesics|analgesics|mesh-ancestor
2407946|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
2407947|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2407948|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407949|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2407950|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2407951|NCT00751738|Azimilide|azimilide|mesh-list
2407952|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2407953|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2407954|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2407955|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407956|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2407957|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407958|NCT00751751|Losartan|losartan|mesh-list
2407959|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2407960|NCT00751751|Olmesartan|olmesartan|mesh-list
2407961|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2407962|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2407963|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2538416|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538417|NCT01427114|Prednisolone|prednisolone|mesh-list
2538418|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
2538419|NCT01427114|Rituximab|rituximab|mesh-list
2538420|NCT01427114|Vincristine|vincristine|mesh-list
2538421|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538422|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
2538423|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538424|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2538425|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2538426|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
2538427|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538428|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538429|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2538430|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2538431|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2538432|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
2538433|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
2538434|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
2538435|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2538436|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
2538437|NCT01427114|Hormones|hormones|mesh-ancestor
2538438|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2538439|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2538440|NCT01427127|Ramosetron|ramosetron|mesh-list
2538441|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
2538442|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
2538443|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538444|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538445|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2538446|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2538447|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
2538448|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538449|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538450|NCT01427192|Acetazolamide|acetazolamide|mesh-list
2538451|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
2538452|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2538453|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2407964|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2407965|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2407966|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407967|NCT00751751|Diuretics|diuretics|mesh-ancestor
2407968|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
2538454|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538455|NCT01427192|Diuretics|diuretics|mesh-ancestor
2538456|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
2538457|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538458|NCT01427205|Cetuximab|cetuximab|mesh-list
2538459|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2538460|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538461|NCT01427244|Trastuzumab|trastuzumab|mesh-list
2538462|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2538463|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538464|NCT01427270|Oxycodone|oxycodone|mesh-list
2538465|NCT01427270|Naloxone|naloxone|mesh-list
2538466|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2538467|NCT01427270|Narcotics|narcotics|mesh-ancestor
2538468|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538469|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538470|NCT01427270|Analgesics|analgesics|mesh-ancestor
2538471|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
2538472|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538473|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2407969|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407970|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2407971|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2407972|NCT00751764|Moxidectin|moxidectin|mesh-list
2407973|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
2407974|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2407975|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2407976|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
2407977|NCT00751803|Eletriptan|eletriptan|mesh-list
2407978|NCT00751803|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2407979|NCT00751803|Serotonin Agents|serotonin agents|mesh-ancestor
2407980|NCT00751803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2407981|NCT00751803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407982|NCT00751803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407983|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2407984|NCT00751829|Olmesartan|olmesartan|mesh-list
2407985|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2407986|NCT00751829|Nitrendipine|nitrendipine|mesh-list
2407987|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2407988|NCT00751829|Diuretics|diuretics|mesh-ancestor
2407989|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
2407990|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538474|NCT01427283|Oxycodone|oxycodone|mesh-list
2538475|NCT01427283|Naloxone|naloxone|mesh-list
2538476|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2538477|NCT01427283|Narcotics|narcotics|mesh-ancestor
2538478|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538479|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538480|NCT01427283|Analgesics|analgesics|mesh-ancestor
2538481|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
2538482|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538483|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2538484|NCT01427322|Lapatinib|lapatinib|mesh-list
2538485|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538486|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2538487|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538488|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538489|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
2538490|NCT01427335|Calcium|calcium|mesh-list
2538491|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2538492|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2407991|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2407992|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2407993|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2407994|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2407995|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2407996|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2538493|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2538494|NCT01427387|Linaclotide|linaclotide|mesh-list
2538495|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2538496|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
2538497|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538498|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2538499|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
2538500|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2538501|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2538502|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2538503|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2538504|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538505|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
2538506|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538507|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538508|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2538509|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538510|NCT01427478|Afatinib|afatinib|mesh-list
2538511|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538512|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2538513|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538514|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538515|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2538516|NCT01427491|Laxatives|laxatives|mesh-ancestor
2538517|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2538518|NCT01427582|Trabectedin|trabectedin|mesh-list
2538519|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2538520|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
2538521|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538522|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538523|NCT01427686|Dobutamine|dobutamine|mesh-list
2538524|NCT01427686|Dopamine|dopamine|mesh-list
2538525|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2538526|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
2538527|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
2538528|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538529|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538530|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2407997|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2407998|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
2407999|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
2408000|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2408001|NCT00751907|Atorvastatin|atorvastatin|mesh-list
2538531|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2538532|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2538533|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
2538534|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538535|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538536|NCT01427686|Protective Agents|protective agents|mesh-ancestor
2538537|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
2538538|NCT01427699|Antibodies|antibodies|mesh-list
2538539|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
2538540|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538541|NCT01427842|Vancomycin|vancomycin|mesh-list
2538542|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2538543|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538544|NCT01427868|Maleic acid|maleic acid|mesh-list
2538545|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538546|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538547|NCT01427946|Everolimus|everolimus|mesh-list
2538548|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538549|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538550|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
2538551|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538552|NCT01427985|Atropine|atropine|mesh-list
2538553|NCT01427985|Fentanyl|fentanyl|mesh-list
2538554|NCT01427985|Mivacurium|mivacurium|mesh-list
2538555|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2538556|NCT01427985|Narcotics|narcotics|mesh-ancestor
2538557|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538558|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538559|NCT01427985|Analgesics|analgesics|mesh-ancestor
2538560|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
2538561|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538562|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2538563|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2538564|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
2538565|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
2538566|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2538567|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2538568|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
2408002|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2408003|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2408004|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
2408005|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408006|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2408007|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2408008|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408009|NCT00751959|Poractant alfa|poractant alfa|mesh-list
2408010|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2408011|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
2408012|NCT00752011|Carboplatin|carboplatin|mesh-list
2408013|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408014|NCT00752024|Hemostatics|hemostatics|mesh-list
2408015|NCT00752024|Coagulants|coagulants|mesh-ancestor
2408016|NCT00752037|Ritonavir|ritonavir|mesh-list
2408017|NCT00752037|Lopinavir|lopinavir|mesh-list
2408018|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
2538569|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2538570|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
2538571|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
2538572|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
2538573|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2538574|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2538575|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
2538576|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538577|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538578|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2538579|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2538580|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2538581|NCT01428037|Misoprostol|misoprostol|mesh-list
2538582|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2538583|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
2538584|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2538585|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538586|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2538587|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2538588|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
2538589|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2538590|NCT01428089|Progesterone|progesterone|mesh-list
2538591|NCT01428089|Progestins|progestins|mesh-ancestor
2538592|NCT01428089|Hormones|hormones|mesh-ancestor
2408019|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2408020|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2408021|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
2408022|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408023|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408024|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2408025|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2408026|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
2408027|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408028|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2408029|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2538593|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2538594|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538595|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
2538596|NCT01428154|Hematinics|hematinics|mesh-ancestor
2538597|NCT01428180|Ibuprofen|ibuprofen|mesh-list
2538598|NCT01428180|Indomethacin|indomethacin|mesh-list
2538599|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2538600|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2538601|NCT01428180|Analgesics|analgesics|mesh-ancestor
2538602|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
2538603|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408030|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2408031|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2408032|NCT00752050|Botulinum Toxins|botulinum toxins|mesh-list
2408033|NCT00752050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2538604|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538605|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2538606|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2538607|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2538608|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538609|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538610|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
2538611|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
2538612|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2538613|NCT01428284|Canagliflozin|canagliflozin|mesh-list
2538614|NCT01428284|Probenecid|probenecid|mesh-list
2538615|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2538616|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538617|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2538618|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408034|NCT00752050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2408035|NCT00752050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2408036|NCT00752050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2408037|NCT00752050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408038|NCT00752050|Cholinergic Agents|cholinergic agents|mesh-ancestor
2408039|NCT00752050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408040|NCT00752050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408041|NCT00752050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2408042|NCT00752050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408043|NCT00752063|Capecitabine|capecitabine|mesh-list
2408044|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
2408045|NCT00752063|Sorafenib|sorafenib|mesh-list
2538619|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
2538620|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
2538621|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2538622|NCT01428284|Renal Agents|renal agents|mesh-ancestor
2538623|NCT01428375|Acetaminophen|acetaminophen|mesh-list
2538624|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2538625|NCT01428375|Analgesics|analgesics|mesh-ancestor
2408046|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2408047|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
2408048|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408049|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408050|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2408051|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408052|NCT00752115|Paclitaxel|paclitaxel|mesh-list
2408053|NCT00752115|Carboplatin|carboplatin|mesh-list
2408054|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
2408055|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2408056|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408057|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
2408058|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
2408059|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
2408060|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408061|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
2408062|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2408063|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2408064|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408065|NCT00752115|Urological Agents|urological agents|mesh-ancestor
2408066|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
2408067|NCT00752141|Oxybutynin|oxybutynin|mesh-list
2408068|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
2408069|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
2408070|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408071|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408072|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2408073|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2538626|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
2408074|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
2408075|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408076|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408077|NCT00752141|Urological Agents|urological agents|mesh-ancestor
2408078|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2408079|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408080|NCT00752141|Renal Agents|renal agents|mesh-ancestor
2408081|NCT00752154|Curcumin|curcumin|mesh-list
2408082|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2408083|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2408084|NCT00752154|Analgesics|analgesics|mesh-ancestor
2408085|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
2408086|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408087|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408088|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2408089|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2408090|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408091|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538627|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538628|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538629|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
2538630|NCT01428388|Bevacizumab|bevacizumab|mesh-list
2538631|NCT01428388|Ranibizumab|ranibizumab|mesh-list
2538632|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2538633|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538634|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2538635|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2538636|NCT01428388|Growth Substances|growth substances|mesh-ancestor
2538637|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538638|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
2538639|NCT01428414|Paclitaxel|paclitaxel|mesh-list
2538640|NCT01428414|Carboplatin|carboplatin|mesh-list
2538641|NCT01428414|Trastuzumab|trastuzumab|mesh-list
2538642|NCT01428414|Epirubicin|epirubicin|mesh-list
2538643|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2538644|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538645|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
2538646|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
2538647|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
2538648|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538649|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2538650|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2538651|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2408092|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408093|NCT00752180|Insulin|insulin|mesh-list
2408094|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2408095|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2408096|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408097|NCT00752258|Botulinum Toxins|botulinum toxins|mesh-list
2408098|NCT00752258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2408099|NCT00752258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2538652|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2538653|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538654|NCT01428427|Gemcitabine|gemcitabine|mesh-list
2538655|NCT01428427|Trametinib|trametinib|mesh-list
2538656|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2538657|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
2538658|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538659|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538660|NCT01428427|Antiviral Agents|antiviral agents|mesh-ancestor
2538661|NCT01428427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538662|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538663|NCT01428427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538664|NCT01428427|Immunologic Factors|immunologic factors|mesh-ancestor
2538665|NCT01428427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538666|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2538667|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2538668|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
2538669|NCT01428492|Dexamethasone|dexamethasone|mesh-list
2538670|NCT01428492|Bortezomib|bortezomib|mesh-list
2538671|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2538672|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
2408100|NCT00752258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2538673|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
2538674|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408101|NCT00752258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2408102|NCT00752258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408103|NCT00752258|Cholinergic Agents|cholinergic agents|mesh-ancestor
2408104|NCT00752258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408105|NCT00752258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408106|NCT00752258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2408107|NCT00752258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408108|NCT00752297|Botulinum Toxins|botulinum toxins|mesh-list
2408109|NCT00752297|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2408110|NCT00752297|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2408111|NCT00752297|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2538675|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538676|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2538677|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
2538678|NCT01428492|Hormones|hormones|mesh-ancestor
2538679|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2538680|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2538681|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538682|NCT01428518|Lamotrigine|lamotrigine|mesh-list
2538683|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
2538684|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2538685|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2538686|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538687|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2538688|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538689|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2538690|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2538691|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538692|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2538693|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2538694|NCT01428531|PENTA|penta|mesh-list
2538695|NCT01428531|Fondaparinux|fondaparinux|mesh-list
2538696|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2538697|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
2538698|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2538699|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
2538700|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538701|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538702|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
2538703|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2538704|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2538705|NCT01428544|PENTA|penta|mesh-list
2538706|NCT01428544|Fondaparinux|fondaparinux|mesh-list
2538707|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2538708|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
2538709|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2538710|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
2538711|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538712|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408112|NCT00752297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2538713|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
2538714|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2538715|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2538716|NCT01428622|Olodaterol|olodaterol|mesh-list
2538717|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2538718|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
2538719|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538720|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538721|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2538722|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
2538723|NCT01428817|Carbetocin|carbetocin|mesh-list
2538724|NCT01428817|Oxytocin|oxytocin|mesh-list
2538725|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
2538726|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2538727|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538728|NCT01428908|Vaccines|vaccines|mesh-list
2538729|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
2538730|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538731|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
2538732|NCT01428973|Sirolimus|sirolimus|mesh-list
2538733|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2538734|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538735|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2538736|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
2538737|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2538738|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538739|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538740|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538741|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
2538742|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538743|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
2538744|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538745|NCT01428986|Maraviroc|maraviroc|mesh-list
2538746|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2538747|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2538748|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538749|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2408113|NCT00752297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408114|NCT00752297|Cholinergic Agents|cholinergic agents|mesh-ancestor
2408115|NCT00752297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408116|NCT00752297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408117|NCT00752297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2408118|NCT00752297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408119|NCT00752310|Darunavir|darunavir|mesh-list
2408120|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2538750|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2538751|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
2538752|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408121|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2408122|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
2408123|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408124|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538753|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2538754|NCT01429025|Rituximab|rituximab|mesh-list
2538755|NCT01429025|Lenalidomide|lenalidomide|mesh-list
2538756|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2538757|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2538758|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538759|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
2538760|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538761|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2538762|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2538763|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2408125|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2408126|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2408127|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
2408128|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408129|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2408130|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2408131|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
2408132|NCT00752375|Trimethoprim|trimethoprim|mesh-list
2408133|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2408134|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
2408135|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2408136|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408137|NCT00752375|Renal Agents|renal agents|mesh-ancestor
2408138|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
2408139|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2408140|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2408141|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2408142|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408143|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408144|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2408145|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2408146|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2538764|NCT01429025|Growth Substances|growth substances|mesh-ancestor
2538765|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
2538766|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2538767|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
2538768|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538769|NCT01429090|Methantheline|methantheline|mesh-list
2538770|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2538771|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2538772|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
2538773|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538774|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538775|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538776|NCT01429129|Nicotine|nicotine|mesh-list
2538777|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2538778|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
2538779|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408147|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2408148|NCT00752401|Vitamin D|vitamin d|mesh-list
2408149|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
2408150|NCT00752401|Vitamins|vitamins|mesh-ancestor
2408151|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
2408152|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408153|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2408154|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2408155|NCT00752414|Levofloxacin|levofloxacin|mesh-list
2408156|NCT00752414|Ofloxacin|ofloxacin|mesh-list
2408157|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2408158|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408159|NCT00752414|Renal Agents|renal agents|mesh-ancestor
2538780|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538781|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2538782|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2538783|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
2538784|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538785|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538786|NCT01429168|Etoricoxib|etoricoxib|mesh-list
2538787|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2538788|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2538789|NCT01429168|Analgesics|analgesics|mesh-ancestor
2538790|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
2538791|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538792|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538793|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2538794|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2538795|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2538796|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2538797|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538798|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538799|NCT01429181|Methadone|methadone|mesh-list
2538800|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2538801|NCT01429181|Narcotics|narcotics|mesh-ancestor
2538802|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538803|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538804|NCT01429181|Analgesics|analgesics|mesh-ancestor
2538805|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
2538806|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408160|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2408161|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2408162|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2408163|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538807|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
2538808|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
2538809|NCT01429337|Midostaurin|midostaurin|mesh-list
2538810|NCT01429337|Staurosporine|staurosporine|mesh-list
2538811|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538812|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2538813|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538814|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408164|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408165|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408166|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2408167|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2408168|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2408169|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2408170|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2408171|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2408172|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408173|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2408174|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2408175|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2408176|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
2408177|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408178|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408179|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2408180|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2408181|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
2408182|NCT00752466|Topiramate|topiramate|mesh-list
2538815|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
2538816|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2408183|NCT00752466|Flunarizine|flunarizine|mesh-list
2538817|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2538818|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2538819|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2538820|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538821|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
2538822|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538823|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538824|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2538825|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538826|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
2538827|NCT01429415|Analgesics|analgesics|mesh-ancestor
2538828|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
2538829|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538830|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538831|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
2538832|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538833|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2538834|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
2538835|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2538836|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2538837|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538838|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2538839|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
2538840|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2538841|NCT01429545|Nifedipine|nifedipine|mesh-list
2538842|NCT01429545|Vasotocin|vasotocin|mesh-list
2538843|NCT01429545|Atosiban|atosiban|mesh-list
2408184|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
2408185|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2408186|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408187|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2408188|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2538844|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2538845|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2538846|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538847|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2538848|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538849|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
2538850|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
2538851|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2538852|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
2538853|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2538854|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
2538855|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2538856|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2538857|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538858|NCT01429610|Cytarabine|cytarabine|mesh-list
2538859|NCT01429610|Rituximab|rituximab|mesh-list
2538860|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2538861|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538862|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
2538863|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538864|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2538865|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2538866|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
2538867|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538868|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
2538869|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538870|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538871|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
2538872|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2538873|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538874|NCT01429701|Gentamicins|gentamicins|mesh-list
2538875|NCT01429701|Polymyxins|polymyxins|mesh-list
2538876|NCT01429701|Polymyxin B|polymyxin b|mesh-list
2538877|NCT01429701|Prednisolone|prednisolone|mesh-list
2538878|NCT01429701|Betamethasone|betamethasone|mesh-list
2538879|NCT01429701|Benzocaine|benzocaine|mesh-list
2538880|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2538881|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
2538882|NCT01429701|Hormones|hormones|mesh-ancestor
2538883|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2538884|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538885|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2538886|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538887|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538888|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2538889|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
2408189|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408190|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2408191|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2408192|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
2408193|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
2408194|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408195|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
2408196|NCT00752479|Cyclosporine|cyclosporine|mesh-list
2408197|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
2408198|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
2408199|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2408200|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2408201|NCT00752479|Prednisolone|prednisolone|mesh-list
2408202|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
2408203|NCT00752479|Cyclosporins|cyclosporins|mesh-list
2408204|NCT00752479|Basiliximab|basiliximab|mesh-list
2408205|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
2408206|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2408207|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
2538890|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2538891|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538892|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2538893|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538894|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538895|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
2538896|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
2538897|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538898|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
2538899|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
2538900|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2538901|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2538902|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
2538903|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538904|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538905|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538906|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
2538907|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
2538908|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538909|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
2538910|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2538911|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
2538912|NCT01429818|Metformin|metformin|mesh-list
2538913|NCT01429818|Glimepiride|glimepiride|mesh-list
2538914|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2538915|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538916|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2408208|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408209|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408210|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2408211|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
2408212|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408213|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
2408214|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408215|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
2408216|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2408217|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2408218|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2408219|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408220|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2408221|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
2408222|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2538917|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538918|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
2538919|NCT01429831|Aripiprazole|aripiprazole|mesh-list
2538920|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
2538921|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2538922|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2538923|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2538924|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2538925|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538926|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
2538927|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
2408223|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2408224|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
2408225|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
2538928|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2538929|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538930|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2538931|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2538932|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
2538933|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2538934|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2538935|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2538936|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2538937|NCT01429844|Cyclosporine|cyclosporine|mesh-list
2538938|NCT01429844|Tacrolimus|tacrolimus|mesh-list
2538939|NCT01429844|Cyclosporins|cyclosporins|mesh-list
2538940|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538941|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
2538942|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538943|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2538944|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538945|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538946|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
2538947|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538948|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
2538949|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2538950|NCT01429870|Triamcinolone|triamcinolone|mesh-list
2538951|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2538952|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
2538953|NCT01429870|Hormones|hormones|mesh-ancestor
2408226|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408227|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2408228|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
2408229|NCT00752479|Hormones|hormones|mesh-ancestor
2408230|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2538954|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2538955|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538956|NCT01429935|Ibuprofen|ibuprofen|mesh-list
2538957|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2408231|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2408232|NCT00752479|Protective Agents|protective agents|mesh-ancestor
2408233|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2408234|NCT00752518|Bortezomib|bortezomib|mesh-list
2408235|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408236|NCT00752544|Simeprevir|simeprevir|mesh-list
2408237|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
2408238|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408239|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
2408240|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538958|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2538959|NCT01429935|Analgesics|analgesics|mesh-ancestor
2538960|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
2538961|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2538962|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538963|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2538964|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2538965|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2538966|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538967|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538968|NCT01430013|Endostar protein|endostar protein|mesh-list
2538969|NCT01430013|Endostatins|endostatins|mesh-list
2538970|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2538971|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2538972|NCT01430013|Growth Substances|growth substances|mesh-ancestor
2538973|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538974|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
2538975|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538976|NCT01430052|Gemcitabine|gemcitabine|mesh-list
2538977|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2538978|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
2538979|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538980|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2538981|NCT01430052|Antiviral Agents|antiviral agents|mesh-ancestor
2538982|NCT01430052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2538983|NCT01430052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538984|NCT01430052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538985|NCT01430052|Immunologic Factors|immunologic factors|mesh-ancestor
2538986|NCT01430052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538987|NCT01430065|Tacrolimus|tacrolimus|mesh-list
2538988|NCT01430065|Peficitinib|peficitinib|mesh-list
2538989|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2538990|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
2538991|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2538992|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2538993|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538994|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538995|NCT01430078|Niacinamide|niacinamide|mesh-list
2538996|NCT01430078|Peficitinib|peficitinib|mesh-list
2538997|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2538998|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2538999|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2539000|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
2539001|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539002|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
2539003|NCT01430078|Vitamins|vitamins|mesh-ancestor
2539004|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
2539005|NCT01430195|Afamelanotide|afamelanotide|mesh-list
2539006|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
2539007|NCT01430234|Pancreatin|pancreatin|mesh-list
2539008|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2539009|NCT01430260|Ciclesonide|ciclesonide|mesh-list
2539010|NCT01430260|Cetirizine|cetirizine|mesh-list
2539011|NCT01430260|Levocetirizine|levocetirizine|mesh-list
2539012|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
2539013|NCT01430260|Hormones|hormones|mesh-ancestor
2539014|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2539015|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539016|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2539017|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2539018|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2539019|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
2539020|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
2539021|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539022|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539023|NCT01430312|Azelaic acid|azelaic acid|mesh-list
2539024|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539025|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
2539026|NCT01430351|Metformin|metformin|mesh-list
2539027|NCT01430351|Mefloquine|mefloquine|mesh-list
2539028|NCT01430351|Temozolomide|temozolomide|mesh-list
2539029|NCT01430351|Memantine|memantine|mesh-list
2539030|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2539031|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539032|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2539033|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
2539034|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539035|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539036|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2539037|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2539038|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
2539039|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539040|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2539041|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2539042|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
2539043|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2539044|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2539045|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539046|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
2539047|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2539048|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
2539049|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408241|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408242|NCT00752570|Trebananib|trebananib|mesh-list
2408243|NCT00752570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2408244|NCT00752570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2408245|NCT00752570|Growth Substances|growth substances|mesh-ancestor
2408246|NCT00752570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408247|NCT00752570|Growth Inhibitors|growth inhibitors|mesh-ancestor
2408248|NCT00752570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408249|NCT00752596|Azimilide|azimilide|mesh-list
2408250|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2408251|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2539050|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2408252|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2408253|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408254|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2408255|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408256|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
2408257|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
2408258|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2408259|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2408260|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2539051|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2539052|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
2539053|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539054|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539055|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2539056|NCT01430520|Citalopram|citalopram|mesh-list
2539057|NCT01430520|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2539058|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2539059|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2539060|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539061|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539062|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
2539063|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539064|NCT01430520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2539065|NCT01430520|Antidepressive Agents|antidepressive agents|mesh-ancestor
2539066|NCT01430520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2539067|NCT01430533|Azelaic acid|azelaic acid|mesh-list
2539068|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539069|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
2539070|NCT01430572|Everolimus|everolimus|mesh-list
2539071|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539072|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2539073|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
2539074|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539075|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
2539076|NCT01430650|Urological Agents|urological agents|mesh-ancestor
2539077|NCT01430689|Vaccines|vaccines|mesh-list
2539078|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
2539079|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539080|NCT01430793|Vitamin D|vitamin d|mesh-list
2539081|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
2539082|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
2539083|NCT01430793|Vitamins|vitamins|mesh-list
2539084|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
2539085|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539086|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2539087|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2539088|NCT01430806|Dronedarone|dronedarone|mesh-list
2539089|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2539090|NCT01430910|Ceftazidime|ceftazidime|mesh-list
2539091|NCT01430910|Avibactam|avibactam|mesh-list
2539092|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2539093|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539094|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2408261|NCT00752635|Norgestimate|norgestimate|mesh-list
2408262|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2408263|NCT00752635|Estradiol|estradiol|mesh-list
2408264|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2408265|NCT00752635|Cyproterone|cyproterone|mesh-list
2408266|NCT00752635|Estrogens|estrogens|mesh-ancestor
2408267|NCT00752635|Hormones|hormones|mesh-ancestor
2408268|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2539095|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539096|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539097|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2539098|NCT01430923|Latanoprost|latanoprost|mesh-list
2539099|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2408269|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408270|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2408271|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
2408272|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2408273|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2408274|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2408275|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2408276|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
2539100|NCT01431053|Aspirin|aspirin|mesh-list
2539101|NCT01431053|Exemestane|exemestane|mesh-list
2539102|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2539103|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2539104|NCT01431053|Analgesics|analgesics|mesh-ancestor
2539105|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
2539106|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539107|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539108|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2539109|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2539110|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2539111|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2539112|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539113|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2539114|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2539115|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539116|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
2539117|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539118|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2539119|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2539120|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2539121|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
2539122|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2539123|NCT01431092|Melatonin|melatonin|mesh-list
2539124|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
2539125|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539126|NCT01431092|Protective Agents|protective agents|mesh-ancestor
2539127|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539128|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2539129|NCT01431118|Camphor|camphor|mesh-list
2539130|NCT01431118|Salicylates|salicylates|mesh-list
2539131|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
2539132|NCT01431118|Menthol|menthol|mesh-list
2539133|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2539134|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539135|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
2539136|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
2539137|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2539138|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2539139|NCT01431118|Analgesics|analgesics|mesh-ancestor
2539140|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
2539141|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539142|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408277|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
2408278|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408279|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2408280|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2408281|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2408282|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408283|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2539143|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2539144|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2539145|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2539146|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539147|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539148|NCT01431183|Vaccines|vaccines|mesh-list
2539149|NCT01431183|Immunologic Factors|immunologic factors|mesh-ancestor
2539150|NCT01431183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539151|NCT01431196|Vaccines|vaccines|mesh-list
2539152|NCT01431196|Immunologic Factors|immunologic factors|mesh-ancestor
2539153|NCT01431196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539154|NCT01431326|Vancomycin|vancomycin|mesh-list
2539155|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
2539156|NCT01431326|Tazobactam|tazobactam|mesh-list
2539157|NCT01431326|Piperacillin|piperacillin|mesh-list
2539158|NCT01431326|Tobramycin|tobramycin|mesh-list
2539159|NCT01431326|Amikacin|amikacin|mesh-list
2539160|NCT01431326|Cefepime|cefepime|mesh-list
2539161|NCT01431326|Fosfomycin|fosfomycin|mesh-list
2539162|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2539163|NCT01431326|Nafcillin|nafcillin|mesh-list
2539164|NCT01431326|Cidofovir|cidofovir|mesh-list
2539165|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
2539166|NCT01431326|Bosentan|bosentan|mesh-list
2539167|NCT01431326|Labetalol|labetalol|mesh-list
2539168|NCT01431326|Nifedipine|nifedipine|mesh-list
2539169|NCT01431326|Spironolactone|spironolactone|mesh-list
2539170|NCT01431326|Pentobarbital|pentobarbital|mesh-list
2539171|NCT01431326|Oxycodone|oxycodone|mesh-list
2539172|NCT01431326|Alfentanil|alfentanil|mesh-list
2539173|NCT01431326|Haloperidol|haloperidol|mesh-list
2539174|NCT01431326|Zolpidem|zolpidem|mesh-list
2539175|NCT01431326|Ziprasidone|ziprasidone|mesh-list
2408284|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2408285|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539176|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2539177|NCT01431326|Clozapine|clozapine|mesh-list
2539178|NCT01431326|Molindone|molindone|mesh-list
2539179|NCT01431326|Warfarin|warfarin|mesh-list
2539180|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
2539181|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
2408286|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408287|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2408288|NCT00752648|Simeprevir|simeprevir|mesh-list
2408289|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
2408290|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408291|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
2408292|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408293|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408294|NCT00752661|Tramadol|tramadol|mesh-list
2408295|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2408296|NCT00752661|Narcotics|narcotics|mesh-ancestor
2408297|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2408298|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408299|NCT00752661|Analgesics|analgesics|mesh-ancestor
2408300|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
2408301|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408302|NCT00752739|Selenium|selenium|mesh-list
2408303|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
2408304|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408305|NCT00752739|Protective Agents|protective agents|mesh-ancestor
2408306|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408307|NCT00752739|Trace Elements|trace elements|mesh-ancestor
2408308|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
2408309|NCT00752843|Mifepristone|mifepristone|mesh-list
2408310|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2408311|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
2408312|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2408313|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408314|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2408315|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2408316|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2408317|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
2408318|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2408319|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2408320|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
2408321|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2408322|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
2408323|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2408324|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2408325|NCT00752869|Dutasteride|dutasteride|mesh-list
2408326|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2408327|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2408328|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408329|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408330|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
2408331|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2408332|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408333|NCT00752882|Ceftazidime|ceftazidime|mesh-list
2539182|NCT01431326|Rocuronium|rocuronium|mesh-list
2539183|NCT01431326|Sevelamer|sevelamer|mesh-list
2539184|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2539185|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
2539186|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
2539187|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539188|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539189|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2539190|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
2539191|NCT01431326|Hormones|hormones|mesh-ancestor
2539192|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2539193|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2539194|NCT01431326|Protective Agents|protective agents|mesh-ancestor
2539195|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539196|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2539197|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2539198|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539199|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
2539200|NCT01431326|Coagulants|coagulants|mesh-ancestor
2408334|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2408335|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408336|NCT00752921|Etoricoxib|etoricoxib|mesh-list
2408337|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2408338|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2408339|NCT00752921|Analgesics|analgesics|mesh-ancestor
2408340|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
2408341|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408342|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408343|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2408344|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2408345|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2408346|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2408347|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408348|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539201|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2539202|NCT01431326|Narcotics|narcotics|mesh-ancestor
2539203|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2539204|NCT01431326|Analgesics|analgesics|mesh-ancestor
2539205|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
2539206|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
2539207|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2539208|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539209|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2539210|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2539211|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2539212|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2539213|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2539214|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539215|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2539216|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2539217|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2539218|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
2539219|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2408349|NCT00752934|Baclofen|baclofen|mesh-list
2408350|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2408351|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408352|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2408353|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408354|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2408355|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
2408356|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
2408357|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408358|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408359|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
2408360|NCT00752947|Metronidazole|metronidazole|mesh-list
2408361|NCT00752947|Levofloxacin|levofloxacin|mesh-list
2408362|NCT00752947|Ofloxacin|ofloxacin|mesh-list
2539220|NCT01431326|Diuretics|diuretics|mesh-ancestor
2539221|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
2539222|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2539223|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2539224|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2539225|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
2539226|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
2408363|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2408364|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408365|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2408366|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2408367|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408368|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408369|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539227|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2539228|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2539229|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2539230|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2539231|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2539232|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2539233|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
2539234|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539235|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2539236|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2408370|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2408371|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2408372|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2408373|NCT00752947|Renal Agents|renal agents|mesh-ancestor
2408374|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2408375|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2408376|NCT00753038|Paclitaxel|paclitaxel|mesh-list
2408377|NCT00753038|Carboplatin|carboplatin|mesh-list
2408378|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2408379|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408380|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
2539237|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2539238|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2539239|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
2539240|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
2539241|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2539242|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
2539243|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2539244|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2539245|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
2539246|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
2539247|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2408381|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
2408382|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
2408383|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408384|NCT00753051|Haloperidol|haloperidol|mesh-list
2408385|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
2408386|NCT00753051|Clozapine|clozapine|mesh-list
2408387|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
2408388|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
2408389|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408390|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408391|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2408392|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2539248|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2539249|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2539250|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
2539251|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2539252|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2539253|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
2539254|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2539255|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
2539256|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2539257|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2539258|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
2539259|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
2539260|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
2539261|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2408393|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2408394|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2408395|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2408396|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2408397|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
2408398|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408399|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408400|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2408401|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2408402|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
2408403|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
2408404|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
2408405|NCT00753064|Prazosin|prazosin|mesh-list
2408406|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2408407|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2408408|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2408409|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2408410|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
2539262|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
2539263|NCT01431352|Letrozole|letrozole|mesh-list
2539264|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539265|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2539266|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2539267|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539268|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539269|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2539270|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
2539271|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2539272|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539273|NCT01431404|Etanercept|etanercept|mesh-list
2539274|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2539275|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2539276|NCT01431404|Analgesics|analgesics|mesh-ancestor
2539277|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
2539278|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539279|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539280|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2539281|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2539282|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2539283|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2408411|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408412|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408413|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408414|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
2408415|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
2408416|NCT00753103|Prednisolone|prednisolone|mesh-list
2408417|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
2408418|NCT00753103|Azathioprine|azathioprine|mesh-list
2408419|NCT00753103|Infliximab|infliximab|mesh-list
2408420|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2408421|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
2408422|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408423|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2408424|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2408425|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
2408426|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408427|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408428|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2408429|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2408430|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2408431|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
2408432|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2408433|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408434|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408435|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2408436|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
2408437|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
2408438|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408439|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2408440|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
2408441|NCT00753103|Hormones|hormones|mesh-ancestor
2408442|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2408443|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2408444|NCT00753103|Protective Agents|protective agents|mesh-ancestor
2408445|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2408446|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
2408447|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
2408448|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2408449|NCT00753168|Timolol|timolol|mesh-list
2408450|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2408451|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2408452|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2408453|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2408454|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
2408455|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408456|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408457|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408458|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2408459|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2408460|NCT00753207|Epirubicin|epirubicin|mesh-list
2408461|NCT00753207|Lapatinib|lapatinib|mesh-list
2408462|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2408463|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408464|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2408465|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2408466|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408467|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408468|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2408469|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
2408470|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2408471|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408472|NCT00753311|Rizatriptan|rizatriptan|mesh-list
2408473|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2408474|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
2408475|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408476|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408477|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408478|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2408479|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
2408480|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539284|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
2539285|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
2539286|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2539287|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539288|NCT01431430|Vitamins|vitamins|mesh-ancestor
2539289|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
2539290|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2539291|NCT01431443|Theobromine|theobromine|mesh-list
2539292|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2539293|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
2539294|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408481|NCT00753389|Anesthetics|anesthetics|mesh-list
2408482|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2408483|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408484|NCT00753402|Epinephrine|epinephrine|mesh-list
2408485|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2408486|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2408487|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
2408488|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408489|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539295|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539296|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2539297|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
2539298|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
2539299|NCT01431456|Nadroparin|nadroparin|mesh-list
2539300|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
2408490|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408491|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2408492|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2408493|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
2408494|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408495|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2408496|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
2408497|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
2408498|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
2408499|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2408500|NCT00753467|Interferons|interferons|mesh-list
2539301|NCT01431456|Dabigatran|dabigatran|mesh-list
2539302|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2539303|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
2539304|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2539305|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
2408501|NCT00753467|Adefovir|adefovir|mesh-list
2408502|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2408503|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
2408504|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408505|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
2408506|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408507|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2408508|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2408509|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408510|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408511|NCT00753493|Topiramate|topiramate|mesh-list
2408512|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
2408513|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2408514|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408515|NCT00753532|Vitamin E|vitamin e|mesh-list
2408516|NCT00753532|Tocopherols|tocopherols|mesh-list
2408517|NCT00753532|Tocotrienols|tocotrienols|mesh-list
2408518|NCT00753532|Tocovid|tocovid|mesh-list
2408519|NCT00753532|Vitamins|vitamins|mesh-ancestor
2408520|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
2408521|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408522|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
2539306|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539307|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539308|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
2539309|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2539310|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2539311|NCT01431495|Clopidogrel|clopidogrel|mesh-list
2408523|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539312|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2408524|NCT00753532|Protective Agents|protective agents|mesh-ancestor
2408525|NCT00753558|Gentamicins|gentamicins|mesh-list
2408526|NCT00753558|Polymyxins|polymyxins|mesh-list
2539313|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2539314|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2539315|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2539316|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
2539317|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539318|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539319|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539320|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2539321|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
2539322|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539323|NCT01431612|Phenylephrine|phenylephrine|mesh-list
2539324|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
2539325|NCT01431612|Esmolol|esmolol|mesh-list
2539326|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2539327|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
2539328|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
2539329|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539330|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539331|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
2539332|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2539333|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
2539334|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
2539335|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2408527|NCT00753558|Colistin|colistin|mesh-list
2408528|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2408529|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408530|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2408531|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408532|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408533|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
2408534|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2408535|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2408536|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408537|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408538|NCT00753571|Protective Agents|protective agents|mesh-ancestor
2408539|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408540|NCT00753597|Rituximab|rituximab|mesh-list
2408541|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2408542|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408543|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
2408544|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539336|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2539337|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2539338|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
2539339|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539340|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539341|NCT01431612|Protective Agents|protective agents|mesh-ancestor
2539342|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2539343|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2408545|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2408546|NCT00753727|Sunitinib|sunitinib|mesh-list
2408547|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408548|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2408549|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2408550|NCT00753727|Growth Substances|growth substances|mesh-ancestor
2408551|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408552|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
2408553|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2539344|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2539345|NCT01431690|Warfarin|warfarin|mesh-list
2539346|NCT01431690|Anticoagulants|anticoagulants|mesh-list
2539347|NCT01431729|Propolis|propolis|mesh-list
2539348|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539349|NCT01431742|Buprenorphine|buprenorphine|mesh-list
2539350|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2539351|NCT01431742|Narcotics|narcotics|mesh-ancestor
2539352|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2539353|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408554|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408555|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408556|NCT00753740|Camptothecin|camptothecin|mesh-list
2408557|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2539354|NCT01431742|Analgesics|analgesics|mesh-ancestor
2408558|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539355|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
2539356|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539357|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2539358|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2539359|NCT01431781|Somatostatin|somatostatin|mesh-list
2539360|NCT01431781|Hormones|hormones|mesh-ancestor
2539361|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2539362|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539363|NCT01431820|Luliconazole|luliconazole|mesh-list
2539364|NCT01431820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2539365|NCT01431820|Antifungal Agents|antifungal agents|mesh-ancestor
2539366|NCT01431820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539367|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
2539368|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2539369|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539370|NCT01431924|Fluticasone|fluticasone|mesh-list
2539371|NCT01431924|Xhance|xhance|mesh-list
2539372|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2539373|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2539374|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2539375|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
2539376|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539377|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539378|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2539379|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
2539380|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
2539381|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2539382|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2539383|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2408559|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2408560|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2408561|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408562|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408563|NCT00753779|Simvastatin|simvastatin|mesh-list
2408564|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2408565|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2408566|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2408567|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
2408568|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408569|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2408570|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2408571|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408572|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
2408573|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2408574|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2408575|NCT00753792|Prednisolone|prednisolone|mesh-list
2408576|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
2408577|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2408578|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
2408579|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2408580|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
2539384|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2539385|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
2539386|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539387|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539388|NCT01432028|Drospirenone|drospirenone|mesh-list
2539389|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2539390|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2539391|NCT01432028|Estradiol|estradiol|mesh-list
2539392|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2539393|NCT01432028|Progesterone|progesterone|mesh-list
2539394|NCT01432028|Estrogens|estrogens|mesh-ancestor
2539395|NCT01432028|Hormones|hormones|mesh-ancestor
2539396|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2539397|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539398|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2539399|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
2539400|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2539401|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2539402|NCT01432028|Progestins|progestins|mesh-ancestor
2539403|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2539404|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
2539405|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2539406|NCT01432028|Diuretics|diuretics|mesh-ancestor
2539407|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
2539408|NCT01432080|Azithromycin|azithromycin|mesh-list
2539409|NCT01432080|Prednisone|prednisone|mesh-list
2539410|NCT01432080|Budesonide|budesonide|mesh-list
2539411|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
2539412|NCT01432080|Montelukast|montelukast|mesh-list
2539413|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2539414|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2539415|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
2539416|NCT01432080|Hormones|hormones|mesh-ancestor
2539417|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2539418|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539419|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2408581|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
2408582|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408583|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408584|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2408585|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
2408586|NCT00753792|Hormones|hormones|mesh-ancestor
2408587|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2408588|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2408589|NCT00753792|Protective Agents|protective agents|mesh-ancestor
2408590|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2408591|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539420|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539421|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2539422|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
2539423|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408592|NCT00753883|Simvastatin|simvastatin|mesh-list
2408593|NCT00753883|Ezetimibe|ezetimibe|mesh-list
2408594|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2408595|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2408596|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
2408597|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408598|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2408599|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2408600|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408601|NCT00753909|Paclitaxel|paclitaxel|mesh-list
2408602|NCT00753909|Bevacizumab|bevacizumab|mesh-list
2408603|NCT00753909|Carboplatin|carboplatin|mesh-list
2408604|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2408605|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408606|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
2408607|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
2408608|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
2408609|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539424|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2539425|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
2539426|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2539427|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539428|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2539429|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2539430|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2539431|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
2539432|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539433|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539434|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2539435|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
2539436|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2539437|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2539438|NCT01432106|Valsartan|valsartan|mesh-list
2539439|NCT01432106|Ramipril|ramipril|mesh-list
2539440|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2539441|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2539442|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2408610|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2408611|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2408612|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2408613|NCT00753909|Growth Substances|growth substances|mesh-ancestor
2408614|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539443|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539444|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2539445|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
2539446|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539447|NCT01432119|Cetuximab|cetuximab|mesh-list
2539448|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2539449|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2539450|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539451|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2539452|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539453|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539454|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2539455|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
2539456|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539457|NCT01432223|Paclitaxel|paclitaxel|mesh-list
2539458|NCT01432223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2539459|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2539460|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539461|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
2539462|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
2539463|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
2539464|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539465|NCT01432249|Etanercept|etanercept|mesh-list
2539466|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2539467|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2539468|NCT01432249|Analgesics|analgesics|mesh-ancestor
2539469|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
2539470|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539471|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408615|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
2408616|NCT00754039|Fenofibrate|fenofibrate|mesh-list
2408617|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2408618|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2408619|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
2408620|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408621|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2408622|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2408623|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2408624|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408625|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2408626|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408627|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408628|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2408629|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
2408630|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408631|NCT00754221|Reboxetine|reboxetine|mesh-list
2408632|NCT00754221|Antidepressive Agents|antidepressive agents|mesh-ancestor
2408633|NCT00754221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2408634|NCT00754221|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2408635|NCT00754221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2408636|NCT00754221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2408637|NCT00754221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408638|NCT00754221|Adrenergic Agents|adrenergic agents|mesh-ancestor
2408639|NCT00754221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408640|NCT00754221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408641|NCT00754260|Caffeine|caffeine|mesh-list
2408642|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2539472|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2539473|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2539474|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2539475|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2539476|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
2539477|NCT01432470|Oxytocin|oxytocin|mesh-list
2539478|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
2539479|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2539480|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539481|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
2539482|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539483|NCT01432496|Ropivacaine|ropivacaine|mesh-list
2539484|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
2539485|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
2539486|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2539487|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539488|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
2539489|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539490|NCT01432522|Epinephrine|epinephrine|mesh-list
2539491|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2539492|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2539493|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
2539494|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539495|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539496|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539497|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2539498|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2539499|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
2539500|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539501|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2539502|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
2539503|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
2539504|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
2539505|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2539506|NCT01432587|Diflunisal|diflunisal|mesh-list
2539507|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2539508|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2539509|NCT01432587|Analgesics|analgesics|mesh-ancestor
2539510|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
2539511|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539512|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539513|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2539514|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2539515|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2539516|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539517|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539518|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
2539519|NCT01432665|Testosterone|testosterone|mesh-list
2539520|NCT01432665|Androgens|androgens|mesh-ancestor
2539521|NCT01432665|Hormones|hormones|mesh-ancestor
2539522|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2539523|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539524|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
2539525|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2539526|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2539527|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539528|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539529|NCT01432665|Urological Agents|urological agents|mesh-ancestor
2408643|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408644|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2408645|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408646|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408647|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2408648|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2408649|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
2408650|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408651|NCT00754312|Entinostat|entinostat|mesh-list
2408652|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408653|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2539530|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
2539531|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2539532|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408654|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408655|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408656|NCT00754351|Gemcitabine|gemcitabine|mesh-list
2408657|NCT00754351|Bevacizumab|bevacizumab|mesh-list
2408658|NCT00754351|Docetaxel|docetaxel|mesh-list
2408659|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2408660|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408661|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2539533|NCT01432704|Vitamins|vitamins|mesh-ancestor
2539534|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
2539535|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2539536|NCT01432717|Luspatercept|luspatercept|mesh-list
2539537|NCT01432717|Hematinics|hematinics|mesh-ancestor
2539538|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
2539539|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2539540|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2408662|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2408663|NCT00754351|Growth Substances|growth substances|mesh-ancestor
2408664|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408665|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
2408666|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2408667|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
2539541|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2408668|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408669|NCT00754351|Antiviral Agents|antiviral agents|mesh-ancestor
2408670|NCT00754351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408671|NCT00754351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539542|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2539543|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539544|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
2539545|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539546|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539547|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2539548|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539549|NCT01432821|Apomorphine|apomorphine|mesh-list
2539550|NCT01432821|Emetics|emetics|mesh-ancestor
2539551|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539552|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
2539553|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539554|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2408672|NCT00754351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2408673|NCT00754351|Immunologic Factors|immunologic factors|mesh-ancestor
2408674|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
2408675|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
2408676|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
2408677|NCT00754364|Gemcitabine|gemcitabine|mesh-list
2408678|NCT00754364|Carboplatin|carboplatin|mesh-list
2408679|NCT00754364|Pemetrexed|pemetrexed|mesh-list
2408680|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408681|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2408682|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
2408683|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408684|NCT00754364|Antiviral Agents|antiviral agents|mesh-ancestor
2408685|NCT00754364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408686|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408687|NCT00754364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2408688|NCT00754364|Immunologic Factors|immunologic factors|mesh-ancestor
2408689|NCT00754364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539555|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
2539556|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
2539557|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539558|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539559|NCT01432873|Selenium|selenium|mesh-list
2539560|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
2539561|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408690|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2408691|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2408692|NCT00754403|Metformin|metformin|mesh-list
2408693|NCT00754403|Pioglitazone|pioglitazone|mesh-list
2408694|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2408695|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408696|NCT00754429|Losartan|losartan|mesh-list
2408697|NCT00754429|Amlodipine|amlodipine|mesh-list
2408698|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2408699|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2408700|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2408701|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408702|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2408703|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408704|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
2408705|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2408706|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2408707|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2408708|NCT00754507|Atorvastatin|atorvastatin|mesh-list
2408709|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2408710|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2408711|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2408712|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
2408713|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408714|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2408715|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2408716|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408717|NCT00754689|Metformin|metformin|mesh-list
2408718|NCT00754689|Rimonabant|rimonabant|mesh-list
2408719|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2408720|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408721|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2408722|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2408723|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2408724|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408725|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408726|NCT00754689|Hormones|hormones|mesh-ancestor
2408727|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2408728|NCT00754702|Vinorelbine|vinorelbine|mesh-list
2408729|NCT00754702|Lapatinib|lapatinib|mesh-list
2408730|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2408731|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408732|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
2408733|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
2408734|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
2408735|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408736|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2408737|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408738|NCT00754780|Pirfenidone|pirfenidone|mesh-list
2539562|NCT01432873|Protective Agents|protective agents|mesh-ancestor
2539563|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539564|NCT01432873|Trace Elements|trace elements|mesh-ancestor
2539565|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
2539566|NCT01432977|Acetaminophen|acetaminophen|mesh-list
2539567|NCT01432977|Droperidol|droperidol|mesh-list
2539568|NCT01432977|Ondansetron|ondansetron|mesh-list
2539569|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2539570|NCT01432977|Analgesics|analgesics|mesh-ancestor
2539571|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
2539572|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539573|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539574|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
2408739|NCT00754780|Analgesics|analgesics|mesh-ancestor
2408740|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
2408741|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539575|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
2539576|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
2539577|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2539578|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
2539579|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
2539580|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2539581|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
2539582|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539583|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539584|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2539585|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2539586|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2539587|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2539588|NCT01432977|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2539589|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2539590|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2539591|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2539592|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
2539593|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2539594|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
2539595|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539596|NCT01433289|Protective Agents|protective agents|mesh-ancestor
2539597|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539598|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2539599|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2539600|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539601|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2539602|NCT01433328|Lidocaine|lidocaine|mesh-list
2408742|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408743|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2408744|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2408745|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2408746|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2408747|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408748|NCT00754819|Colchicine|colchicine|mesh-list
2408749|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
2408750|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2408751|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
2408752|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
2408753|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
2408754|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408755|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539603|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
2539604|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
2408756|NCT00754858|Belotecan|belotecan|mesh-list
2408757|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408758|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2408759|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2408760|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539605|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2539606|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539607|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
2539608|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539609|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2539610|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2539611|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2539612|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2539613|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539614|NCT01433445|Panobinostat|panobinostat|mesh-list
2539615|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539616|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2408761|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408762|NCT00754871|Dienogest|dienogest|mesh-list
2408763|NCT00754871|Nandrolone|nandrolone|mesh-list
2539617|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539618|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539619|NCT01433614|Paclitaxel|paclitaxel|mesh-list
2539620|NCT01433614|Capecitabine|capecitabine|mesh-list
2539621|NCT01433614|Epirubicin|epirubicin|mesh-list
2539622|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2539623|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539624|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
2539625|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
2539626|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
2539627|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539628|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2539629|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
2539630|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2539631|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2539632|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2539633|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539634|NCT01433627|Hirudins|hirudins|mesh-list
2539635|NCT01433627|Bivalirudin|bivalirudin|mesh-list
2539636|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
2539637|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2539638|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
2539639|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539640|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408764|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2408765|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
2408766|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2408767|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408768|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2408769|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2408770|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2408771|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2408772|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
2408773|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2408774|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2408775|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408776|NCT00754871|Androgens|androgens|mesh-ancestor
2408777|NCT00754871|Hormones|hormones|mesh-ancestor
2408778|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
2408779|NCT00754884|Calcitonin|calcitonin|mesh-list
2408780|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
2408781|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2408782|NCT00754884|Glycerol|glycerol|mesh-list
2408783|NCT00754884|Katacalcin|katacalcin|mesh-list
2408784|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2408785|NCT00754884|Protective Agents|protective agents|mesh-ancestor
2408786|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539641|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
2408787|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2408788|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2408789|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
2408790|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2408791|NCT00754910|Trioxsalen|trioxsalen|mesh-list
2408792|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408793|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
2539642|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2408794|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2408795|NCT00754962|Protriptyline|protriptyline|mesh-list
2408796|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2408797|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
2408798|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2408799|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2408800|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2408801|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2408802|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539643|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2539644|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
2539645|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2539646|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539647|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539648|NCT01433705|Regadenoson|regadenoson|mesh-list
2539649|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539650|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2539651|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2539652|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
2539653|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
2539654|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539655|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539656|NCT01433757|Ampicillin|ampicillin|mesh-list
2539657|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2539658|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539659|NCT01433770|Alefacept|alefacept|mesh-list
2539660|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
2539661|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
2539662|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539663|NCT01433887|Ribavirin|ribavirin|mesh-list
2539664|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2539665|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
2539666|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539667|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
2539668|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539669|NCT01433900|Latanoprost|latanoprost|mesh-list
2539670|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2539671|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2539672|NCT01433952|Thiamine|thiamine|mesh-list
2539673|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
2539674|NCT01433952|Vitamins|vitamins|mesh-ancestor
2539675|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
2539676|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539677|NCT01433965|Lenalidomide|lenalidomide|mesh-list
2539678|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
2539679|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539680|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2539681|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2116599|NCT02643251|Clonidine|clonidine|mesh-list
2116600|NCT02643251|Analgesics|analgesics|mesh-ancestor
2116601|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
2116602|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408803|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
2408804|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408805|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408806|NCT00754988|Metformin|metformin|mesh-list
2408807|NCT00754988|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2408808|NCT00754988|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2408809|NCT00754988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2408810|NCT00754988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408811|NCT00754988|Incretins|incretins|mesh-ancestor
2408812|NCT00754988|Hormones|hormones|mesh-ancestor
2422941|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422942|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422943|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2422944|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
2422945|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
2422946|NCT00819676|Protective Agents|protective agents|mesh-ancestor
2422947|NCT00819728|Docetaxel|docetaxel|mesh-list
2422948|NCT00819728|Irinotecan|irinotecan|mesh-list
2422949|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422950|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
2422951|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
2422952|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
2539682|NCT01433965|Growth Substances|growth substances|mesh-ancestor
2539683|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
2539684|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539685|NCT01434017|Dexamethasone|dexamethasone|mesh-list
2539686|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
2539687|NCT01434017|Droperidol|droperidol|mesh-list
2539688|NCT01434017|Ondansetron|ondansetron|mesh-list
2539689|NCT01434017|BB 1101|bb 1101|mesh-list
2539690|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2539691|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
2539692|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
2539693|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539694|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539695|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2539696|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
2539697|NCT01434017|Hormones|hormones|mesh-ancestor
2539698|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2539699|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2539700|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539701|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
2539702|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539703|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539704|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
2539705|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
2539706|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2539707|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
2539708|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539709|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2539710|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2539711|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2539712|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2539713|NCT01434017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2539714|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2539715|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2539716|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2539717|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
2539718|NCT01434069|Leucovorin|leucovorin|mesh-list
2539719|NCT01434069|Fluorouracil|fluorouracil|mesh-list
2539720|NCT01434069|Pasireotide|pasireotide|mesh-list
2539721|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
2539722|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539723|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2539724|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539725|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2539726|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
2539727|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539728|NCT01434069|Antidotes|antidotes|mesh-ancestor
2539729|NCT01434069|Protective Agents|protective agents|mesh-ancestor
2539730|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
2539731|NCT01434069|Vitamins|vitamins|mesh-ancestor
2539732|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
2539733|NCT01434069|Hormones|hormones|mesh-ancestor
2539734|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2539735|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
2539736|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2539737|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
2539738|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539739|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539740|NCT01434134|Metoprolol|metoprolol|mesh-list
2539741|NCT01434134|Candesartan|candesartan|mesh-list
2408813|NCT00754988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2408814|NCT00754988|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2408815|NCT00754988|Protease Inhibitors|protease inhibitors|mesh-ancestor
2408816|NCT00754988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408817|NCT00754988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408818|NCT00755014|Ethanol|ethanol|mesh-list
2408819|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2408820|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408821|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2539742|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2539743|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2539744|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
2539745|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
2539746|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539747|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539748|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2539749|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2539750|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2539751|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
2539752|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539753|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539754|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2539755|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2539756|NCT01434147|Bevacizumab|bevacizumab|mesh-list
2539757|NCT01434147|Capecitabine|capecitabine|mesh-list
2539758|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
2539759|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2539760|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539761|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2539762|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2539763|NCT01434147|Growth Substances|growth substances|mesh-ancestor
2539764|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539765|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
2539766|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2539767|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
2539768|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539769|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
2539770|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2539771|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
2539772|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2539773|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539774|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2539775|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2539776|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2539777|NCT01434173|Amoxicillin|amoxicillin|mesh-list
2539778|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
2539779|NCT01434173|Clarithromycin|clarithromycin|mesh-list
2539780|NCT01434173|Doxycycline|doxycycline|mesh-list
2539781|NCT01434173|Levofloxacin|levofloxacin|mesh-list
2539782|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
2539783|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
2539784|NCT01434173|Cefuroxime|cefuroxime|mesh-list
2539785|NCT01434173|Telithromycin|telithromycin|mesh-list
2539786|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2539787|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2539788|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539789|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2539790|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2539791|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539792|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539793|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539794|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2408822|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408823|NCT00755027|Rasagiline|rasagiline|mesh-list
2408824|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2408825|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408826|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408827|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2408828|NCT00755027|Protective Agents|protective agents|mesh-ancestor
2408829|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408830|NCT00755053|Clotrimazole|clotrimazole|mesh-list
2408831|NCT00755053|Miconazole|miconazole|mesh-list
2408832|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2408833|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408834|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
2408835|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2408836|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2408837|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408838|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408839|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2408840|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
2408841|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2408842|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408843|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2539795|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
2539796|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2539797|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539798|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2539799|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2408844|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2408845|NCT00755066|Fluticasone|fluticasone|mesh-list
2408846|NCT00755066|Xhance|xhance|mesh-list
2408847|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2408848|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2408849|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
2408850|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408851|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408852|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2408853|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
2408854|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
2408855|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2408856|NCT00755118|Leucovorin|leucovorin|mesh-list
2539800|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2539801|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2539802|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2539803|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2539804|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
2539805|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2539806|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2539807|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2539808|NCT01434173|Renal Agents|renal agents|mesh-ancestor
2539809|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2539810|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2539811|NCT01434212|Interferons|interferons|mesh-list
2539812|NCT01434212|Ribavirin|ribavirin|mesh-list
2539813|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
2539814|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
2539815|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539816|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
2539817|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539818|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
2539819|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539820|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
2539821|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539822|NCT01434225|Bumetanide|bumetanide|mesh-list
2539823|NCT01434225|Diuretics|diuretics|mesh-ancestor
2539824|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
2539825|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539826|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2539827|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2539828|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539829|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
2539830|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2539831|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2539832|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2539833|NCT01434303|Trastuzumab|trastuzumab|mesh-list
2539834|NCT01434303|Lapatinib|lapatinib|mesh-list
2539835|NCT01434303|Entinostat|entinostat|mesh-list
2539836|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2408857|NCT00755118|Bevacizumab|bevacizumab|mesh-list
2408858|NCT00755118|Cetuximab|cetuximab|mesh-list
2408859|NCT00755118|Fluorouracil|fluorouracil|mesh-list
2408860|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
2408861|NCT00755118|Irinotecan|irinotecan|mesh-list
2408862|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2408863|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408864|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2408865|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2408866|NCT00755118|Growth Substances|growth substances|mesh-ancestor
2408867|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408868|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
2408869|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
2408870|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408871|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2408872|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2408873|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
2408874|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2408875|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2408876|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539837|NCT01434303|Antibodies|antibodies|mesh-list
2539838|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
2539839|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2539840|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2408877|NCT00755118|Antidotes|antidotes|mesh-ancestor
2408878|NCT00755118|Protective Agents|protective agents|mesh-ancestor
2408879|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
2408880|NCT00755118|Vitamins|vitamins|mesh-ancestor
2408881|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
2408882|NCT00755157|Bevacizumab|bevacizumab|mesh-list
2408883|NCT00755157|Docetaxel|docetaxel|mesh-list
2408884|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2408885|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408886|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2408887|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2408888|NCT00755157|Growth Substances|growth substances|mesh-ancestor
2408889|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408890|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
2408891|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
2408892|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
2408893|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
2408894|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408895|NCT00755170|Bevacizumab|bevacizumab|mesh-list
2408896|NCT00755170|Vinorelbine|vinorelbine|mesh-list
2408897|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2408898|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408899|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2408900|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2408901|NCT00755170|Growth Substances|growth substances|mesh-ancestor
2408902|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408903|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
2408904|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2408905|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
2408906|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
2539841|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
2539842|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539843|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539844|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2539845|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539846|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539852|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2539853|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2539854|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
2539855|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539856|NCT01434381|Antacids|antacids|mesh-ancestor
2539857|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539858|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2539859|NCT01434394|Cetuximab|cetuximab|mesh-list
2539860|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2539861|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539862|NCT01434459|Gemcitabine|gemcitabine|mesh-list
2539863|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2539864|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
2539865|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539866|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539867|NCT01434459|Antiviral Agents|antiviral agents|mesh-ancestor
2539868|NCT01434459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408907|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
2408908|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408909|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
2408910|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2408911|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2408912|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408913|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
2408914|NCT00755209|Coagulants|coagulants|mesh-ancestor
2408915|NCT00755287|Metformin|metformin|mesh-list
2408916|NCT00755287|Insulin Glargine|insulin glargine|mesh-list
2408917|NCT00755287|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2408918|NCT00755287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2408919|NCT00755287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408920|NCT00755287|Incretins|incretins|mesh-ancestor
2408921|NCT00755287|Hormones|hormones|mesh-ancestor
2408922|NCT00755287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2408923|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
2408924|NCT00755313|Carboplatin|carboplatin|mesh-list
2408925|NCT00755313|Docetaxel|docetaxel|mesh-list
2408926|NCT00755313|Doxorubicin|doxorubicin|mesh-list
2408927|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2408928|NCT00755313|Trastuzumab|trastuzumab|mesh-list
2408929|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2408930|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2408931|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2408932|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
2408933|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408934|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2408935|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2408936|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
2408937|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539869|NCT01434459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539870|NCT01434459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2539871|NCT01434459|Immunologic Factors|immunologic factors|mesh-ancestor
2539872|NCT01434459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539873|NCT01434498|Ribavirin|ribavirin|mesh-list
2539874|NCT01434498|Ledipasvir|ledipasvir|mesh-list
2408938|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2408939|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2408940|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
2408941|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
2408942|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
2408943|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2408944|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2408945|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2408946|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408947|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2408948|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2408949|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2408950|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2408951|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
2539875|NCT01434498|Antimetabolites|antimetabolites|mesh-ancestor
2539876|NCT01434498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539877|NCT01434498|Antiviral Agents|antiviral agents|mesh-ancestor
2539878|NCT01434498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2408952|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2408953|NCT00755352|Pravastatin|pravastatin|mesh-list
2408954|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2408955|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2408956|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2408957|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
2408958|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408959|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2408960|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2408961|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2408962|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2408963|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2408964|NCT00755495|Doxepin|doxepin|mesh-list
2408965|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2408966|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2408967|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2408968|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408969|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2408970|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
2408971|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2539888|NCT01434849|Timolol|timolol|mesh-list
2539889|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2539890|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2539891|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
2539892|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539893|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539894|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539895|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2539896|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2539897|NCT01434862|Pramlintide|pramlintide|mesh-list
2539898|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
2539899|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2539900|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539901|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
2539902|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2539903|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
2539904|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539905|NCT01434888|Timolol|timolol|mesh-list
2539906|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2539907|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2539908|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2539909|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2539910|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
2539911|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539912|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539913|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539914|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2539915|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2539916|NCT01434901|Bethanechol|bethanechol|mesh-list
2539917|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2539918|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
2539919|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539920|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539921|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2539922|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2539923|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
2539924|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408972|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
2408973|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
2408974|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408975|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408976|NCT00755508|Gabapentin|gabapentin|mesh-list
2408977|NCT00755508|Analgesics|analgesics|mesh-ancestor
2408978|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
2408979|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2408980|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539925|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539926|NCT01434914|Octenidine|octenidine|mesh-list
2539927|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539928|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2539929|NCT01435044|Sofosbuvir|sofosbuvir|mesh-list
2539930|NCT01435044|Ribavirin|ribavirin|mesh-list
2539931|NCT01435044|Antiviral Agents|antiviral agents|mesh-ancestor
2539932|NCT01435044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2539933|NCT01435044|Antimetabolites|antimetabolites|mesh-ancestor
2539934|NCT01435044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539935|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2539936|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
2539937|NCT01435083|Coagulants|coagulants|mesh-ancestor
2539938|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2539939|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
2539940|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539941|NCT01435161|Telmisartan|telmisartan|mesh-list
2539942|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
2539943|NCT01435161|Nifedipine|nifedipine|mesh-list
2539944|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2539945|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2408981|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
2408982|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2408983|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2408984|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2408985|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2408986|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2408987|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2408988|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2408989|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2408990|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
2408991|NCT00755521|Etoricoxib|etoricoxib|mesh-list
2408992|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2408993|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2408994|NCT00755521|Analgesics|analgesics|mesh-ancestor
2539946|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539947|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2408995|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
2408996|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539948|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2539949|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2539950|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539951|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
2539952|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
2539953|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2539954|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2539955|NCT01435200|Hematinics|hematinics|mesh-ancestor
2539956|NCT01435213|Insulin|insulin|mesh-list
2539957|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2539958|NCT01435213|Ketamine|ketamine|mesh-list
2539959|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2539960|NCT01435213|Atipamezole|atipamezole|mesh-list
2539961|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2539962|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539963|NCT01435213|Analgesics|analgesics|mesh-ancestor
2539964|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
2539965|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539966|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2539967|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2539968|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
2539969|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
2539970|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2539971|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2539972|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2539973|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2539974|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539975|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2539976|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2539977|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2539978|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
2539979|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2539980|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2408997|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2408998|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2408999|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2409000|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2409001|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2409002|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409003|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409004|NCT00755534|Capecitabine|capecitabine|mesh-list
2409005|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
2409006|NCT00755534|Irinotecan|irinotecan|mesh-list
2409007|NCT00755534|Cetuximab|cetuximab|mesh-list
2409008|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2409009|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
2409010|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409011|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539981|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2539982|NCT01435226|Ribavirin|ribavirin|mesh-list
2539983|NCT01435226|Ledipasvir|ledipasvir|mesh-list
2539984|NCT01435226|Antimetabolites|antimetabolites|mesh-ancestor
2539985|NCT01435226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539986|NCT01435226|Antiviral Agents|antiviral agents|mesh-ancestor
2539987|NCT01435226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409012|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2409013|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2409014|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409015|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2409016|NCT00755560|Albendazole|albendazole|mesh-list
2409017|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
2409018|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2409019|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409020|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
2409021|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2409022|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2409023|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
2409024|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
2409025|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
2409026|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409027|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409028|NCT00755573|Pregabalin|pregabalin|mesh-list
2409029|NCT00755573|Analgesics|analgesics|mesh-ancestor
2409030|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
2409031|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2539988|NCT01435252|Cetuximab|cetuximab|mesh-list
2539989|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2539990|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2539991|NCT01435291|Tacrolimus|tacrolimus|mesh-list
2539992|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2539993|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
2539994|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2539995|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2539996|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2539997|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2539998|NCT01435343|Cytarabine|cytarabine|mesh-list
2539999|NCT01435343|Plerixafor|plerixafor|mesh-list
2540000|NCT01435343|Fludarabine|fludarabine|mesh-list
2540001|NCT01435343|Idarubicin|idarubicin|mesh-list
2540002|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540003|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2540004|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
2540005|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540006|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2540007|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
2540008|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540009|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
2540010|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2540011|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2540012|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2540013|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2409032|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409033|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
2409034|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2409035|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2409036|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409037|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2409038|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2409039|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2409040|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2409041|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2409042|NCT00755664|Vitamins|vitamins|mesh-list
2409043|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
2409044|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
2409045|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409046|NCT00755781|Cyclosporine|cyclosporine|mesh-list
2409047|NCT00755781|Cyclosporins|cyclosporins|mesh-list
2409048|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409049|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409050|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2409051|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
2409052|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409053|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
2409054|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409055|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
2409056|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2409057|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2409058|NCT00755794|Montelukast|montelukast|mesh-list
2409059|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2409060|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
2409061|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2409062|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
2409063|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409064|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409065|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2409066|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2409067|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409068|NCT00755820|Cycloserine|cycloserine|mesh-list
2409069|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2409070|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409071|NCT00755820|Renal Agents|renal agents|mesh-ancestor
2409072|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2409073|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
2409074|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2409075|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
2409076|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409077|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
2409078|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
2409079|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540014|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540015|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2540016|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2540017|NCT01435369|Pidilizumab|pidilizumab|mesh-list
2540018|NCT01435369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2540019|NCT01435369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540020|NCT01435395|Bevacizumab|bevacizumab|mesh-list
2540021|NCT01435395|Bortezomib|bortezomib|mesh-list
2540022|NCT01435395|Temozolomide|temozolomide|mesh-list
2540023|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2540024|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540025|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2540026|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2540027|NCT01435395|Growth Substances|growth substances|mesh-ancestor
2540028|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540029|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
2409080|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409081|NCT00755859|Prednisone|prednisone|mesh-list
2409082|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2409083|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2409084|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
2409085|NCT00755859|Prednisolone|prednisolone|mesh-list
2409086|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
2409087|NCT00755859|Azathioprine|azathioprine|mesh-list
2409088|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2409089|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
2409090|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
2409091|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409092|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2409093|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409094|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2409095|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
2409096|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409097|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2409098|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2409099|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
2409100|NCT00755859|Hormones|hormones|mesh-ancestor
2409101|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409102|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2409103|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2409104|NCT00755859|Protective Agents|protective agents|mesh-ancestor
2409105|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
2409106|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
2409107|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409108|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2409109|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
2409110|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
2409111|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2409112|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2409113|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409114|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2409115|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409116|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2409117|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
2409118|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409119|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2409120|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409121|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409122|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
2409123|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409124|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409125|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2409126|NCT00755898|Amantadine|amantadine|mesh-list
2540030|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2540031|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
2409127|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2409128|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2409129|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
2409130|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409131|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
2409132|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409133|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409134|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409135|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2540032|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540033|NCT01435486|Caffeine|caffeine|mesh-list
2540034|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
2540035|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540036|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2540037|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540038|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2540039|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540040|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2540041|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2540042|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
2409136|NCT00755898|Analgesics|analgesics|mesh-ancestor
2409137|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
2409138|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409139|NCT00755924|Acetic Acid|acetic acid|mesh-list
2409140|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2409141|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409142|NCT00755950|Silymarin|silymarin|mesh-list
2409143|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
2409144|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409145|NCT00755950|Protective Agents|protective agents|mesh-ancestor
2409146|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409147|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2409148|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2409149|NCT00755963|Estradiol|estradiol|mesh-list
2409150|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2409151|NCT00755963|Progesterone|progesterone|mesh-list
2409152|NCT00755963|Estrogens|estrogens|mesh-ancestor
2409153|NCT00755963|Hormones|hormones|mesh-ancestor
2409154|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409155|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409156|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2409157|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
2409158|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2409159|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2409160|NCT00755963|Progestins|progestins|mesh-ancestor
2409161|NCT00755976|Sulindac|sulindac|mesh-list
2540043|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540044|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
2540045|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2540046|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
2540047|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540048|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2540049|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2409162|NCT00755976|Epirubicin|epirubicin|mesh-list
2409163|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2409164|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540050|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
2540051|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540052|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540053|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2540054|NCT01435707|Triamcinolone|triamcinolone|mesh-list
2540055|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2540056|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2540057|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2540058|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2540059|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
2540060|NCT01435707|Hormones|hormones|mesh-ancestor
2540061|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540062|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540063|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2409165|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2409166|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2409167|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409168|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409169|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2409170|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2540064|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
2540065|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540066|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540067|NCT01435837|Caffeine|caffeine|mesh-list
2540068|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2540069|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409171|NCT00755976|Analgesics|analgesics|mesh-ancestor
2409172|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
2409173|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409174|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409175|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2409176|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2409177|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2409178|NCT00755989|Morphine|morphine|mesh-list
2409179|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2409180|NCT00755989|Narcotics|narcotics|mesh-ancestor
2409181|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2409182|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409183|NCT00755989|Analgesics|analgesics|mesh-ancestor
2409184|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
2409185|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409186|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2409187|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
2409188|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409189|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2409190|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2409191|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2409192|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
2409193|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409194|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2409195|NCT00756184|Travoprost|travoprost|mesh-list
2409196|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2409199|NCT00756301|Lidocaine|lidocaine|mesh-list
2409200|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
2409201|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
2409202|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2409203|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540070|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2540071|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540072|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540073|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2540074|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2540075|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
2540076|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540077|NCT01435902|Fluticasone|fluticasone|mesh-list
2540078|NCT01435902|Xhance|xhance|mesh-list
2540079|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2540080|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2540081|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
2540082|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540083|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540084|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2540085|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
2540086|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
2540087|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2540088|NCT01435915|Ropinirole|ropinirole|mesh-list
2540089|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2540090|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2409204|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
2409205|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409206|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2409207|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2409208|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2409209|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2409210|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409211|NCT00756340|Bevacizumab|bevacizumab|mesh-list
2409212|NCT00756340|Everolimus|everolimus|mesh-list
2409213|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2409214|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409215|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2409216|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2540091|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
2540092|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
2540093|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540094|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540095|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540096|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2540097|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2540098|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2540099|NCT01435941|Analgesics|analgesics|mesh-ancestor
2540100|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
2540101|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540102|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540103|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2540104|NCT01435954|Doxazosin|doxazosin|mesh-list
2540105|NCT01435954|Tamsulosin|tamsulosin|mesh-list
2540106|NCT01435954|Finasteride|finasteride|mesh-list
2540107|NCT01435954|Silodosin|silodosin|mesh-list
2540108|NCT01435954|Terazosin|terazosin|mesh-list
2540109|NCT01435954|Alfuzosin|alfuzosin|mesh-list
2540110|NCT01435954|Dutasteride|dutasteride|mesh-list
2540111|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2540112|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2540113|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2540114|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
2540115|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540116|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540117|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540118|NCT01435954|Urological Agents|urological agents|mesh-ancestor
2540119|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2540120|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2540121|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540122|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
2540123|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540124|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2540125|NCT01435980|Exenatide|exenatide|mesh-list
2540126|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540127|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540128|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2540129|NCT01435980|Incretins|incretins|mesh-ancestor
2540130|NCT01435980|Hormones|hormones|mesh-ancestor
2540131|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540132|NCT01436032|Ketorolac|ketorolac|mesh-list
2540133|NCT01436032|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2540134|NCT01436032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2540135|NCT01436032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2540136|NCT01436032|Analgesics|analgesics|mesh-ancestor
2540137|NCT01436032|Sensory System Agents|sensory system agents|mesh-ancestor
2540138|NCT01436032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540139|NCT01436032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540140|NCT01436032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2409217|NCT00756340|Growth Substances|growth substances|mesh-ancestor
2409218|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409219|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
2409220|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2409221|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
2409222|NCT00756405|Antioxidants|antioxidants|mesh-list
2409223|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409224|NCT00756405|Protective Agents|protective agents|mesh-ancestor
2409225|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409226|NCT00756418|Theophylline|theophylline|mesh-list
2409227|NCT00756418|Montelukast|montelukast|mesh-list
2409228|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2409229|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
2409230|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2409231|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
2409232|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409233|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409234|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2409235|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2409236|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409237|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2409238|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
2409239|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409240|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2409241|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409242|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
2409243|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2409244|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2409245|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
2409246|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540141|NCT01436032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2540142|NCT01436032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2540143|NCT01436032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540144|NCT01436032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540145|NCT01436123|Everolimus|everolimus|mesh-list
2540146|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540147|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2540148|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
2540149|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540150|NCT01436188|Ibuprofen|ibuprofen|mesh-list
2540151|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2540152|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2540153|NCT01436188|Analgesics|analgesics|mesh-ancestor
2540154|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
2540155|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540156|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540157|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2540158|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2540159|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2540160|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540161|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540162|NCT01436422|Vaccines|vaccines|mesh-list
2540163|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
2540164|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540165|NCT01436474|Varenicline|varenicline|mesh-list
2540166|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2540167|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2409247|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
2409248|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2409249|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409250|NCT00756847|Paclitaxel|paclitaxel|mesh-list
2409251|NCT00756847|Carboplatin|carboplatin|mesh-list
2409252|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2409253|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409254|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
2409255|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
2409256|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
2409257|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409258|NCT00756860|Sevelamer|sevelamer|mesh-list
2409259|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
2409260|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
2409261|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409262|NCT00756873|Etoricoxib|etoricoxib|mesh-list
2409263|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2409264|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2409265|NCT00756873|Analgesics|analgesics|mesh-ancestor
2540168|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
2540169|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540170|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540171|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540172|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2540173|NCT01436513|Estrogens|estrogens|mesh-ancestor
2540174|NCT01436513|Hormones|hormones|mesh-ancestor
2540175|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540176|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540177|NCT01436539|Adefovir|adefovir|mesh-list
2540178|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2540179|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
2540180|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
2540181|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2540182|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2540183|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2540184|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540185|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540186|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2540187|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
2540188|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2540189|NCT01436578|Posaconazole|posaconazole|mesh-list
2540190|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
2540191|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2540192|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2540193|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2540194|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2540195|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2540196|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2540197|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540198|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540199|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2540200|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
2540201|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540202|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540203|NCT01436825|Factor VIII|factor viii|mesh-list
2540204|NCT01436825|Coagulants|coagulants|mesh-ancestor
2409266|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
2409267|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409268|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409269|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2409270|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2409271|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2409272|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2409273|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409274|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409275|NCT00756990|Naltrexone|naltrexone|mesh-list
2409276|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2409277|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2540205|NCT01436838|Interferons|interferons|mesh-list
2540206|NCT01436838|Interferon-beta|interferon-beta|mesh-list
2540207|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
2540208|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540209|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
2540210|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2540211|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
2540212|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540213|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2409278|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409279|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
2409280|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409281|NCT00757016|Triamcinolone|triamcinolone|mesh-list
2540214|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
2540215|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2540216|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540217|NCT01436916|Vitamins|vitamins|mesh-ancestor
2540218|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
2540219|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2540220|NCT01436929|Silymarin|silymarin|mesh-list
2540221|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
2540222|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540223|NCT01436929|Protective Agents|protective agents|mesh-ancestor
2540224|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540225|NCT01436968|Valacyclovir|valacyclovir|mesh-list
2540226|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
2540227|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409282|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2409283|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2409284|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2409285|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2409286|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
2409287|NCT00757016|Hormones|hormones|mesh-ancestor
2409288|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409289|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409290|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2409291|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
2116603|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116604|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2116605|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
2116606|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
2116607|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2116608|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2116609|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2116610|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
2116611|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116612|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116613|NCT02643355|Clonidine|clonidine|mesh-list
2116614|NCT02643355|Olanzapine|olanzapine|mesh-list
2116615|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
2116616|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
2116617|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116618|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116619|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2116620|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2116621|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2540228|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
2540229|NCT01436994|Carbimazole|carbimazole|mesh-list
2540230|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
2540231|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540232|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
2540233|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
2540234|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540235|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540236|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2540237|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
2540238|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2540239|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2540240|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2540241|NCT01437046|Doxazosin|doxazosin|mesh-list
2540242|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2540243|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2409292|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409293|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409294|NCT00757029|Norepinephrine|norepinephrine|mesh-list
2409295|NCT00757029|Methylphenidate|methylphenidate|mesh-list
2409296|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2409297|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409298|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2409299|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2409300|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2409301|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409302|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
2409303|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409304|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2540244|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2540245|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2540246|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
2540247|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540248|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540249|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540250|NCT01437189|Sertraline|sertraline|mesh-list
2540251|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
2540252|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2540253|NCT01437189|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2540254|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2540255|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2540256|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540257|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540258|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
2540259|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540260|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
2540261|NCT01437228|Povidone|povidone|mesh-list
2540262|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
2540263|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
2540264|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2540265|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2540266|NCT01437293|Carbidopa|carbidopa|mesh-list
2540267|NCT01437293|Entacapone|entacapone|mesh-list
2540268|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2540269|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2540270|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
2540271|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540272|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540273|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540274|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2409305|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2540275|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540276|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2540277|NCT01437306|Lofexidine|lofexidine|mesh-list
2540278|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2540279|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2540280|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540281|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
2540282|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540283|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2540284|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2540285|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2540286|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
2540287|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540288|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540289|NCT01437371|Ramipril|ramipril|mesh-list
2540290|NCT01437371|Enalapril|enalapril|mesh-list
2540291|NCT01437371|Lisinopril|lisinopril|mesh-list
2540292|NCT01437371|Captopril|captopril|mesh-list
2540293|NCT01437371|Trandolapril|trandolapril|mesh-list
2540294|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2540295|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2540296|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
2409306|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
2409307|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
2409308|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
2409309|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409310|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2409311|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
2409312|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2409313|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2409314|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
2409315|NCT00757185|Testosterone|testosterone|mesh-list
2409316|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
2409317|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
2409318|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2409319|NCT00757185|Ganirelix|ganirelix|mesh-list
2409320|NCT00757185|Androgens|androgens|mesh-ancestor
2409321|NCT00757185|Hormones|hormones|mesh-ancestor
2409322|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409323|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409324|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2409325|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409326|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
2409327|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
2409328|NCT00757198|Remifentanil|remifentanil|mesh-list
2409329|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2409330|NCT00757198|Narcotics|narcotics|mesh-ancestor
2409331|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2409332|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409333|NCT00757198|Analgesics|analgesics|mesh-ancestor
2409334|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
2409335|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409336|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2409337|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2409338|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
2409339|NCT00757315|Triamcinolone|triamcinolone|mesh-list
2409340|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2409341|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2409342|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2409343|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2409344|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
2409345|NCT00757315|Hormones|hormones|mesh-ancestor
2409346|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409347|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409348|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2409349|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
2409350|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409351|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409352|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
2409353|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2409354|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2409355|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409356|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2409357|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
2409358|NCT00757393|Vitamin D|vitamin d|mesh-list
2409359|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
2409360|NCT00757393|Vitamins|vitamins|mesh-list
2540297|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540298|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2540299|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2540300|NCT01437371|Protective Agents|protective agents|mesh-ancestor
2540301|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540302|NCT01437462|Propofol|propofol|mesh-list
2540303|NCT01437462|Sevoflurane|sevoflurane|mesh-list
2540304|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2540305|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2409361|NCT00757393|Calcium|calcium|mesh-list
2409362|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
2409363|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540306|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409364|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2409365|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2409366|NCT00757419|Lesogaberan|lesogaberan|mesh-list
2409367|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2409368|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2409369|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
2409370|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
2409371|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409372|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409373|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409374|NCT00757458|Propofol|propofol|mesh-list
2409375|NCT00757458|Edetic Acid|edetic acid|mesh-list
2409376|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
2409377|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2540307|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2540308|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
2540309|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
2540310|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2540311|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2540312|NCT01437566|Fulvestrant|fulvestrant|mesh-list
2540313|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2540314|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540315|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2540316|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2540317|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
2540318|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540319|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540320|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
2540321|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2540322|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2409378|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2409379|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409380|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2409381|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
2409382|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
2409383|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
2409384|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2409385|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
2409386|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
2409387|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409388|NCT00757458|Antidotes|antidotes|mesh-ancestor
2409389|NCT00757458|Protective Agents|protective agents|mesh-ancestor
2409390|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2409391|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
2409392|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2409393|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2409394|NCT00757523|Analgesics|analgesics|mesh-ancestor
2409395|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
2409396|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409397|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409398|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2540323|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540324|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
2540325|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540326|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540327|NCT01437592|Insulin|insulin|mesh-list
2540328|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540329|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540330|NCT01437618|Bevacizumab|bevacizumab|mesh-list
2540331|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2540332|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540333|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2540334|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2540335|NCT01437618|Growth Substances|growth substances|mesh-ancestor
2409399|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2409400|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
2409401|NCT00757549|Cetuximab|cetuximab|mesh-list
2409402|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2409403|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409404|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2409405|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2409406|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409407|NCT00757562|Desloratadine|desloratadine|mesh-list
2409408|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2540336|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540337|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
2540338|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
2540339|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2540340|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2540341|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540342|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
2540343|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540344|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540345|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
2540346|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2540347|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2540348|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
2540349|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540350|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540351|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540352|NCT01437670|Urological Agents|urological agents|mesh-ancestor
2540353|NCT01437696|Vitamin D|vitamin d|mesh-list
2540354|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
2540355|NCT01437696|Vitamins|vitamins|mesh-list
2540356|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
2540357|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540358|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2540359|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2540360|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2540361|NCT01437709|Ofatumumab|ofatumumab|mesh-list
2540362|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2540363|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2540364|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
2540365|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540366|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409409|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
2409410|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409411|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409412|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409413|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2409414|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2409415|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
2409416|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
2409417|NCT00757679|Milnacipran|milnacipran|mesh-list
2409418|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
2540367|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
2540368|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540369|NCT01437735|Montelukast|montelukast|mesh-list
2540370|NCT01437735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2540371|NCT01437735|Respiratory System Agents|respiratory system agents|mesh-ancestor
2540372|NCT01437735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2540373|NCT01437735|Hormone Antagonists|hormone antagonists|mesh-ancestor
2540374|NCT01437735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540375|NCT01437735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540376|NCT01437735|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2540377|NCT01437735|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2540378|NCT01437735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540379|NCT01437748|Bromides|bromides|mesh-list
2540380|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
2540381|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2540382|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
2540383|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540384|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540385|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2540386|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
2540387|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
2540388|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2540389|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
2540390|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540391|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540392|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
2540393|NCT01437800|Metformin|metformin|mesh-list
2540394|NCT01437800|Glimepiride|glimepiride|mesh-list
2540395|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540396|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540397|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2540398|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2540399|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
2540400|NCT01437813|Metformin|metformin|mesh-list
2540401|NCT01437813|Glimepiride|glimepiride|mesh-list
2540402|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540403|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540404|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2540405|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2540406|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
2540407|NCT01437826|Selenium|selenium|mesh-list
2540408|NCT01437826|Antioxidants|antioxidants|mesh-list
2540409|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409419|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2409420|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2409421|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2409422|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409423|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409424|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409425|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2409426|NCT00757679|Analgesics|analgesics|mesh-ancestor
2409427|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
2409428|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409429|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
2409430|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2409431|NCT00757692|Bicalutamide|bicalutamide|mesh-list
2540410|NCT01437826|Protective Agents|protective agents|mesh-ancestor
2540411|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540412|NCT01437826|Trace Elements|trace elements|mesh-ancestor
2540413|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
2540414|NCT01437839|Apixaban|apixaban|mesh-list
2540415|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2540416|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
2540417|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2540418|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
2540419|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540420|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540421|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
2540422|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2540423|NCT01437982|Prednisolone|prednisolone|mesh-list
2540424|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2540425|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
2540426|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2540427|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
2540428|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2540429|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
2540430|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2540431|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
2540432|NCT01437982|Hormones|hormones|mesh-ancestor
2409432|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
2409433|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
2409434|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409435|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409436|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409437|NCT00757731|Milnacipran|milnacipran|mesh-list
2409438|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
2409439|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2409440|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2409441|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2409442|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409443|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409444|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409445|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2409446|NCT00757731|Analgesics|analgesics|mesh-ancestor
2409447|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
2409448|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409449|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
2409450|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2409451|NCT00757835|Timolol|timolol|mesh-list
2409452|NCT00757835|Latanoprost|latanoprost|mesh-list
2540433|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540434|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540435|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2540436|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540437|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
2540438|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
2409453|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2409454|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2409455|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
2409456|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540439|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540440|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2540441|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2540442|NCT01437982|Protective Agents|protective agents|mesh-ancestor
2540443|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2540444|NCT01438021|Methotrexate|methotrexate|mesh-list
2540445|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2540446|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
2409457|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409458|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409459|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2409460|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2409461|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2409462|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2409463|NCT00757874|Clobetasol|clobetasol|mesh-list
2409464|NCT00757874|Tacrolimus|tacrolimus|mesh-list
2409465|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2409466|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
2409467|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540447|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2540448|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540449|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2540450|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
2540451|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540452|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540453|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
2540454|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540455|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2540456|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2540457|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
2540458|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2540459|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2540460|NCT01438073|Hormones|hormones|mesh-list
2540461|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540462|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540463|NCT01438086|Mecasermin|mecasermin|mesh-list
2540464|NCT01438086|Growth Substances|growth substances|mesh-ancestor
2540465|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540466|NCT01438112|Gemcitabine|gemcitabine|mesh-list
2540467|NCT01438112|Interferons|interferons|mesh-list
2540468|NCT01438112|Mitomycins|mitomycins|mesh-list
2540469|NCT01438112|Mitomycin|mitomycin|mesh-list
2540470|NCT01438112|Valrubicin|valrubicin|mesh-list
2540471|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2540472|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
2409468|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2409469|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409470|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409471|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2409472|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
2409473|NCT00757874|Hormones|hormones|mesh-ancestor
2409474|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409475|NCT00757978|Memantine|memantine|mesh-list
2409476|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2409477|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2409478|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
2409479|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409480|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409481|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409482|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2409483|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2409484|NCT00758004|Atorvastatin|atorvastatin|mesh-list
2409485|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2409486|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2409487|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
2409488|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540473|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540474|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540475|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
2540476|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2540477|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540478|NCT01438112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2540479|NCT01438112|Immunologic Factors|immunologic factors|mesh-ancestor
2540480|NCT01438112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540481|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2540482|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
2540483|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2540484|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2540485|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2540486|NCT01438190|Metformin|metformin|mesh-list
2540487|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540488|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409489|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2409490|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2409491|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409492|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2409493|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2409494|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2409495|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2409496|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409497|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2409498|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2409499|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2409500|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
2409501|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409502|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409503|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2409504|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2409505|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
2409506|NCT00758134|Trastuzumab|trastuzumab|mesh-list
2409507|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2409508|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540489|NCT01438320|Quercetin|quercetin|mesh-list
2540490|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
2540491|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540492|NCT01438320|Protective Agents|protective agents|mesh-ancestor
2540493|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540494|NCT01438359|Furosemide|furosemide|mesh-list
2540495|NCT01438359|Diuretics|diuretics|mesh-ancestor
2540496|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
2540497|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540498|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2540499|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2540500|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540501|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2540502|NCT01438372|Hematinics|hematinics|mesh-ancestor
2540503|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
2540504|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2540505|NCT01438515|Doxycycline|doxycycline|mesh-list
2540506|NCT01438515|Rifampin|rifampin|mesh-list
2540507|NCT01438515|Mupirocin|mupirocin|mesh-list
2540508|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2540509|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2540510|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
2540511|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
2540512|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2540513|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
2540514|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2540515|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2540516|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2540517|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
2540518|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
2540519|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2540520|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409509|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
2409510|NCT00758199|Prednisolone|prednisolone|mesh-list
2409511|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2409512|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
2409513|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2409514|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
2409515|NCT00758199|Bromfenac|bromfenac|mesh-list
2409516|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2409517|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2409518|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
2409519|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2540521|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540522|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2540523|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2540524|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2540525|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2540526|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2540527|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2409520|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
2409521|NCT00758199|Hormones|hormones|mesh-ancestor
2409522|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409523|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409524|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2409525|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409526|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
2409527|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
2409528|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409529|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2409530|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2409531|NCT00758199|Protective Agents|protective agents|mesh-ancestor
2409532|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2409533|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409534|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2540528|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2540529|NCT01438554|Trametinib|trametinib|mesh-list
2540530|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540531|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2540532|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540533|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409535|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2409536|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409537|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540534|NCT01438567|Oxycodone|oxycodone|mesh-list
2540535|NCT01438567|Naloxone|naloxone|mesh-list
2540536|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2540537|NCT01438567|Narcotics|narcotics|mesh-ancestor
2540538|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2540539|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540540|NCT01438567|Analgesics|analgesics|mesh-ancestor
2540541|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
2540542|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540543|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2540544|NCT01438580|Aspirin|aspirin|mesh-list
2540545|NCT01438580|Warfarin|warfarin|mesh-list
2540546|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2540547|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2540548|NCT01438580|Analgesics|analgesics|mesh-ancestor
2540549|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
2540550|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540551|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540552|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2540553|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2540554|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2540555|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2540556|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540557|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2540558|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2540559|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540560|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
2540561|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
2540562|NCT01438632|Insulin|insulin|mesh-list
2540563|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540564|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540565|NCT01438723|Metformin|metformin|mesh-list
2540566|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540567|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540568|NCT01438736|Etonogestrel|etonogestrel|mesh-list
2540569|NCT01438736|Desogestrel|desogestrel|mesh-list
2540570|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2540571|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
2409538|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2409539|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
2409540|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2409541|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2409542|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2540572|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2540573|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409543|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2409544|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2409545|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2409546|NCT00758199|Analgesics|analgesics|mesh-ancestor
2409547|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
2409548|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2409549|NCT00758212|Vaccines|vaccines|mesh-list
2409550|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
2540574|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2540575|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2540576|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2540577|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2540578|NCT01438736|Progestins|progestins|mesh-ancestor
2540579|NCT01438736|Hormones|hormones|mesh-ancestor
2540580|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540581|NCT01438749|Diazepam|diazepam|mesh-list
2540582|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2540583|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
2540584|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
2540585|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
2540586|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540587|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540588|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2540589|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2540590|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2540591|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2540592|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2540593|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2540594|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2540595|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2540596|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2409551|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409552|NCT00758225|Idebenone|idebenone|mesh-list
2409553|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
2409554|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409555|NCT00758225|Protective Agents|protective agents|mesh-ancestor
2409556|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409557|NCT00758277|Levetiracetam|levetiracetam|mesh-list
2409558|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
2540597|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
2540598|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
2540599|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
2540600|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
2540601|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540602|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540603|NCT01438866|Fluorides|fluorides|mesh-list
2540604|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
2540605|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
2540606|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
2540607|NCT01438866|Protective Agents|protective agents|mesh-ancestor
2540608|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540609|NCT01438944|Nicotine|nicotine|mesh-list
2540610|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2540611|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
2540612|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540613|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540614|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2540615|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2540616|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
2540617|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540618|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540619|NCT01439100|Oxycodone|oxycodone|mesh-list
2540620|NCT01439100|Naloxone|naloxone|mesh-list
2540621|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2540622|NCT01439100|Narcotics|narcotics|mesh-ancestor
2540623|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2540624|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540625|NCT01439100|Analgesics|analgesics|mesh-ancestor
2540626|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
2540627|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540628|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2540629|NCT01439152|Maytansine|maytansine|mesh-list
2540630|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
2540631|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2540632|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409559|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
2540633|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
2540634|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
2540635|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
2540636|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540637|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
2540638|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540639|NCT01439178|Bevacizumab|bevacizumab|mesh-list
2540640|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2540641|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540642|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2116622|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116623|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2116624|NCT02643355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2409560|NCT00758368|Apomorphine|apomorphine|mesh-list
2409561|NCT00758368|Emetics|emetics|mesh-ancestor
2540643|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2540644|NCT01439178|Growth Substances|growth substances|mesh-ancestor
2540645|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540646|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
2540647|NCT01439191|Vinorelbine|vinorelbine|mesh-list
2409562|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409563|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
2409564|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409565|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2409566|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
2409567|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
2540648|NCT01439191|Antibodies|antibodies|mesh-list
2540649|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
2540650|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540651|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2540652|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540653|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
2540654|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
2540655|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
2540656|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540657|NCT01439230|Donepezil|donepezil|mesh-list
2540658|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2540659|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409568|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409569|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409570|NCT00758381|Sorafenib|sorafenib|mesh-list
2409571|NCT00758381|Cisplatin|cisplatin|mesh-list
2409572|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409573|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2409574|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409575|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409576|NCT00758407|Methylphenidate|methylphenidate|mesh-list
2409577|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2409578|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409579|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2409580|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2409581|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2409582|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409583|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
2409584|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409585|NCT00758433|Capsaicin|capsaicin|mesh-list
2409586|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
2409587|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
2409588|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
2409589|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409590|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409591|NCT00758693|Rituximab|rituximab|mesh-list
2409592|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2409593|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2540660|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540661|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
2540662|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540663|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540664|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
2540665|NCT01439243|Donepezil|donepezil|mesh-list
2540666|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2540667|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540668|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540669|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
2540670|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540671|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409594|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409595|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
2409596|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409597|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2409598|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2409599|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
2540672|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
2540673|NCT01439399|Lidocaine|lidocaine|mesh-list
2540674|NCT01439399|Ketamine|ketamine|mesh-list
2540675|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
2540676|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
2540677|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2409600|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409601|NCT00758732|Carboplatin|carboplatin|mesh-list
2409602|NCT00758732|Docetaxel|docetaxel|mesh-list
2540678|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540679|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
2540680|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540681|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2540682|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2540683|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2540684|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2540685|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540686|NCT01439399|Analgesics|analgesics|mesh-ancestor
2409603|NCT00758732|Doxorubicin|doxorubicin|mesh-list
2409604|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2409605|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409606|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
2409607|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
2409608|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
2409609|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409610|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2409611|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2409612|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2540687|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2540688|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2540689|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
2540690|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2540691|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2540692|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540693|NCT01439438|Topiramate|topiramate|mesh-list
2540694|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
2540695|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540696|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540697|NCT01439542|Hormones|hormones|mesh-list
2540698|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2540699|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540700|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540701|NCT01439750|Rituximab|rituximab|mesh-list
2540702|NCT01439750|Bortezomib|bortezomib|mesh-list
2540703|NCT01439750|Cladribine|cladribine|mesh-list
2540704|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2540705|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540706|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
2540707|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540708|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2540709|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2540710|NCT01439802|Copper|copper|mesh-list
2540711|NCT01439802|Trace Elements|trace elements|mesh-ancestor
2540712|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
2540713|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540714|NCT01439984|Clomipramine|clomipramine|mesh-list
2540715|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2540716|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
2540717|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2540718|NCT01439984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2540719|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2540720|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2540721|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540722|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540723|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
2540724|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540725|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2540726|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
2540727|NCT01439997|Coagulants|coagulants|mesh-ancestor
2540728|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2540729|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
2540730|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540731|NCT01440062|Vitamin D|vitamin d|mesh-list
2540732|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
2540733|NCT01440062|Vitamins|vitamins|mesh-list
2540734|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
2540735|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540736|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2540737|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2540738|NCT01440088|Doxorubicin|doxorubicin|mesh-list
2540739|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2540740|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2540741|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409613|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409614|NCT00758914|Vitamin E|vitamin e|mesh-list
2409615|NCT00758914|Vitamins|vitamins|mesh-ancestor
2409616|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
2409617|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409618|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
2409619|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409620|NCT00758914|Protective Agents|protective agents|mesh-ancestor
2409621|NCT00758953|Danazol|danazol|mesh-list
2409622|NCT00758953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2409623|NCT00758953|Hormone Antagonists|hormone antagonists|mesh-ancestor
2540742|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2540743|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2540744|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409624|NCT00758953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409625|NCT00758953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409626|NCT00758966|Naltrexone|naltrexone|mesh-list
2409627|NCT00758966|Fluoxetine|fluoxetine|mesh-list
2409628|NCT00758966|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2409629|NCT00758966|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2409630|NCT00758966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409631|NCT00758966|Sensory System Agents|sensory system agents|mesh-ancestor
2409632|NCT00758966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409633|NCT00758966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2409634|NCT00758966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2409635|NCT00758966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2409636|NCT00758966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409637|NCT00758966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409638|NCT00758966|Serotonin Agents|serotonin agents|mesh-ancestor
2409639|NCT00758966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2409640|NCT00758966|Antidepressive Agents|antidepressive agents|mesh-ancestor
2409641|NCT00758966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2540745|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540746|NCT01440114|Fentanyl|fentanyl|mesh-list
2540747|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2540748|NCT01440114|Narcotics|narcotics|mesh-ancestor
2540749|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2540750|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540751|NCT01440114|Analgesics|analgesics|mesh-ancestor
2540752|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
2540753|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540754|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2540755|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2540756|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
2540757|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
2540758|NCT01440127|Metformin|metformin|mesh-list
2540759|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540760|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540761|NCT01440140|Insulin|insulin|mesh-list
2540762|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540763|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540764|NCT01440270|Cetuximab|cetuximab|mesh-list
2540765|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2540766|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540767|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2540768|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2540769|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2540770|NCT01440335|Fenoterol|fenoterol|mesh-list
2540771|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2540772|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
2540773|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540774|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409642|NCT00758966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2409643|NCT00758966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2409644|NCT00758966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409645|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
2409646|NCT00759005|Propranolol|propranolol|mesh-list
2409647|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2409648|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2409649|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
2409650|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409651|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540775|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2540776|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
2540777|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
2540778|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
2540779|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2540780|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2540781|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2540782|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2540783|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
2540784|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409652|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409653|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2409654|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2409655|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
2409656|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2409657|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
2409658|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2409659|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
2409660|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409661|NCT00759070|Ritonavir|ritonavir|mesh-list
2409662|NCT00759070|Lopinavir|lopinavir|mesh-list
2409663|NCT00759070|Tenofovir|tenofovir|mesh-list
2540785|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540786|NCT01440361|Belimumab|belimumab|mesh-list
2540787|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2540788|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
2540789|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540790|NCT01440400|Anesthetics|anesthetics|mesh-list
2540791|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2540792|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540793|NCT01440439|Insulin|insulin|mesh-list
2540794|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2540795|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
2540796|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
2540797|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540798|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540799|NCT01440582|Dexamethasone|dexamethasone|mesh-list
2540800|NCT01440582|Lenalidomide|lenalidomide|mesh-list
2540801|NCT01440582|Bortezomib|bortezomib|mesh-list
2409664|NCT00759070|Emtricitabine|emtricitabine|mesh-list
2409665|NCT00759070|Efavirenz|efavirenz|mesh-list
2409666|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2409667|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2409668|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
2409669|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409670|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409671|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2409672|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2409673|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
2409674|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409675|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2409676|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2409677|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2409678|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2409679|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2409680|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2409681|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2409682|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2409683|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2540802|NCT01440582|Panobinostat|panobinostat|mesh-list
2540803|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2540804|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
2540805|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
2409684|NCT00759083|Bivalirudin|bivalirudin|mesh-list
2540806|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540807|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540808|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2540809|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
2540810|NCT01440582|Hormones|hormones|mesh-ancestor
2540811|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540812|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2540813|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540814|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
2540815|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2540816|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2540817|NCT01440582|Growth Substances|growth substances|mesh-ancestor
2540818|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
2540819|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2540820|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540821|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540822|NCT01440608|Albendazole|albendazole|mesh-list
2540823|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
2540824|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2540825|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2540826|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
2409685|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
2409686|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2409687|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
2409688|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409689|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409690|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
2409691|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2409692|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2409693|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2409694|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2409695|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409696|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409697|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409698|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2409699|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
2409700|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2409701|NCT00759135|Finasteride|finasteride|mesh-list
2409702|NCT00759135|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2409703|NCT00759135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2409704|NCT00759135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540827|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2540828|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2540829|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
2540830|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
2540831|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
2540832|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540833|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540834|NCT01440621|Pyridoxine|pyridoxine|mesh-list
2540835|NCT01440621|Modafinil|modafinil|mesh-list
2540836|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2540837|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540838|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2540839|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2540840|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2540841|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540842|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
2540843|NCT01440621|Vitamins|vitamins|mesh-ancestor
2540844|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
2540845|NCT01440673|Aprepitant|aprepitant|mesh-list
2540846|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
2540847|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
2540848|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540849|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540850|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2540851|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2540852|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540853|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540854|NCT01440725|Mitogens|mitogens|mesh-list
2540855|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
2540856|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540857|NCT01440751|Mitomycins|mitomycins|mesh-list
2540858|NCT01440751|Mitomycin|mitomycin|mesh-list
2540859|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2540860|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540861|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
2540862|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540863|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2540864|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540865|NCT01440790|Vitamins|vitamins|mesh-list
2540866|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
2540867|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
2540868|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540869|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
2540870|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540871|NCT01440790|Protective Agents|protective agents|mesh-ancestor
2540872|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
2540873|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2540874|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2540875|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540876|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540877|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540878|NCT01440842|Insulin|insulin|mesh-list
2540879|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2540880|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540881|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540882|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
2409705|NCT00759135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409706|NCT00759135|Hormone Antagonists|hormone antagonists|mesh-ancestor
2409707|NCT00759135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409708|NCT00759135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409709|NCT00759135|Urological Agents|urological agents|mesh-ancestor
2409710|NCT00759200|Interferons|interferons|mesh-list
2409711|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
2409712|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
2409713|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409714|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
2409715|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409716|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
2409717|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409718|NCT00759226|Leucovorin|leucovorin|mesh-list
2540883|NCT01440933|Analgesics|analgesics|mesh-ancestor
2540884|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
2540885|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540886|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540887|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
2540888|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2540889|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2540890|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
2540891|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2540892|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2540893|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540894|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2540895|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
2409719|NCT00759226|Folic Acid|folic acid|mesh-list
2409720|NCT00759226|Gemcitabine|gemcitabine|mesh-list
2409721|NCT00759226|Cisplatin|cisplatin|mesh-list
2409722|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
2409723|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409724|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2409725|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
2409726|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409727|NCT00759226|Antiviral Agents|antiviral agents|mesh-ancestor
2409728|NCT00759226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2540896|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2540897|NCT01440985|Nicotine|nicotine|mesh-list
2540898|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2540899|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
2540900|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2540901|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540902|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2540903|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2540904|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
2540905|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2540906|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540907|NCT01440998|Paclitaxel|paclitaxel|mesh-list
2540908|NCT01440998|Carboplatin|carboplatin|mesh-list
2540909|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2540910|NCT01440998|Dasatinib|dasatinib|mesh-list
2409729|NCT00759226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540911|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2540912|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540913|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
2540914|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
2540915|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
2409730|NCT00759226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2409731|NCT00759226|Immunologic Factors|immunologic factors|mesh-ancestor
2409732|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409733|NCT00759226|Antidotes|antidotes|mesh-ancestor
2409734|NCT00759226|Protective Agents|protective agents|mesh-ancestor
2409735|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
2409736|NCT00759226|Vitamins|vitamins|mesh-ancestor
2409737|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
2409738|NCT00759226|Hematinics|hematinics|mesh-ancestor
2409739|NCT00759239|Timolol|timolol|mesh-list
2409740|NCT00759239|Travoprost|travoprost|mesh-list
2409741|NCT00759239|Maleic acid|maleic acid|mesh-list
2409742|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2409743|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2540916|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540917|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2540918|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540919|NCT01441128|Crizotinib|crizotinib|mesh-list
2540920|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540921|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2540922|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540923|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540924|NCT01441193|Vaccines|vaccines|mesh-list
2540925|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
2540926|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540927|NCT01441206|Rifampin|rifampin|mesh-list
2540928|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2540929|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
2540930|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2540931|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2540932|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
2540933|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2540934|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540935|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540936|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2540937|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2540938|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2540939|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2540940|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2540941|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2540942|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2540943|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2540944|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2540945|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540946|NCT01441232|Incretins|incretins|mesh-ancestor
2540947|NCT01441232|Hormones|hormones|mesh-ancestor
2540948|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2540949|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2540950|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
2540951|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540952|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540953|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2540954|NCT01441284|Pramipexole|pramipexole|mesh-list
2540955|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
2540956|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540957|NCT01441284|Protective Agents|protective agents|mesh-ancestor
2540958|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540959|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2540960|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2540961|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
2540962|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
2540963|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409744|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
2409745|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409746|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409747|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409748|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2409749|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2409750|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409751|NCT00759291|Acipimox|acipimox|mesh-list
2409752|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2409753|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
2409754|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409755|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2409756|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2409757|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2409758|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2409759|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2409760|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409761|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409762|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409763|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2409764|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
2409765|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2409766|NCT00759421|Olanzapine|olanzapine|mesh-list
2409767|NCT00759421|Sertindole|sertindole|mesh-list
2540964|NCT01441297|Nintedanib|nintedanib|mesh-list
2540965|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540966|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2540967|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540968|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540969|NCT01441349|Simvastatin|simvastatin|mesh-list
2540970|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2540971|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2540972|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
2540973|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540974|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2540975|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2540976|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540977|NCT01441388|Bevacizumab|bevacizumab|mesh-list
2540978|NCT01441388|Sunitinib|sunitinib|mesh-list
2540979|NCT01441388|Sorafenib|sorafenib|mesh-list
2540980|NCT01441388|Axitinib|axitinib|mesh-list
2540981|NCT01441388|Crizotinib|crizotinib|mesh-list
2540982|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2540983|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2540984|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2540985|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2540986|NCT01441388|Growth Substances|growth substances|mesh-ancestor
2540987|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540988|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
2540989|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2540990|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2540991|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2540992|NCT01441427|Lenograstim|lenograstim|mesh-list
2540993|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2540994|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
2540995|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2540996|NCT01441505|Midazolam|midazolam|mesh-list
2540997|NCT01441505|Ketamine|ketamine|mesh-list
2540998|NCT01441505|Analgesics|analgesics|mesh-ancestor
2540999|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
2541000|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541001|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541002|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2541003|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2541004|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
2541005|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
2541006|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2541007|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2541008|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2541009|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541010|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541011|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2541012|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2541013|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2541014|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2541015|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2541016|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
2541017|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
2541018|NCT01441531|Gabapentin|gabapentin|mesh-list
2541019|NCT01441531|Analgesics|analgesics|mesh-ancestor
2541020|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
2541021|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541022|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541023|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
2541024|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2541025|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2541026|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2541027|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2541028|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2541029|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2541030|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409768|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
2409769|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
2409770|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409771|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409772|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2409773|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2409774|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2409775|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2409776|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2409777|NCT00759421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2541031|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541032|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
2541033|NCT01441557|Amifampridine|amifampridine|mesh-list
2541034|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2541035|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541036|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541037|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2541038|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2541039|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541040|NCT01441700|Anesthetics|anesthetics|mesh-list
2541041|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2541042|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541043|NCT01441804|Ribavirin|ribavirin|mesh-list
2541044|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2541045|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
2541046|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
2541047|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409778|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2409779|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2541048|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
2541049|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541050|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
2541051|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541052|NCT01441869|Metformin|metformin|mesh-list
2541053|NCT01441869|Saxagliptin|saxagliptin|mesh-list
2541054|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2541055|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541056|NCT01441869|Incretins|incretins|mesh-ancestor
2541057|NCT01441869|Hormones|hormones|mesh-ancestor
2541058|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2541059|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2541060|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
2541061|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541062|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541063|NCT01441908|Pravastatin|pravastatin|mesh-list
2541064|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2541065|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2541066|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
2541067|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541068|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2541069|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2541070|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541071|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
2541072|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541073|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
2541074|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2541075|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2541076|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541077|NCT01441934|Urological Agents|urological agents|mesh-ancestor
2541078|NCT01441947|Fulvestrant|fulvestrant|mesh-list
2541079|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2541080|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541081|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2409780|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541082|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2541083|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
2541084|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2541085|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541086|NCT01441986|Amantadine|amantadine|mesh-list
2541087|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
2541088|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
2541089|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
2541090|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2541091|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2541092|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541093|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541094|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541095|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2541096|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2541097|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
2541098|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541099|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
2541100|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2541101|NCT01441986|Analgesics|analgesics|mesh-ancestor
2409781|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409782|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
2409783|NCT00759460|Olanzapine|olanzapine|mesh-list
2409784|NCT00759460|Sertindole|sertindole|mesh-list
2409785|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
2409786|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
2409787|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409788|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409789|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2409790|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2409791|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2409792|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2409793|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2409794|NCT00759460|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2409795|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2409796|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2409797|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116625|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2116626|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2116627|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116628|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116629|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
2116630|NCT02643355|Analgesics|analgesics|mesh-ancestor
2116631|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
2116632|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2409798|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409799|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
2409800|NCT00759551|Olmesartan|olmesartan|mesh-list
2409801|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2409802|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2409803|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2409804|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2541102|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
2541103|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541104|NCT01442025|Infliximab|infliximab|mesh-list
2541105|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
2541106|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2541107|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2541108|NCT01442090|Everolimus|everolimus|mesh-list
2541109|NCT01442090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541110|NCT01442090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2541111|NCT01442090|Immunologic Factors|immunologic factors|mesh-ancestor
2541112|NCT01442090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541113|NCT01442168|Atovaquone|atovaquone|mesh-list
2541114|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541115|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
2541116|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2541117|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2541118|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541119|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116633|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
2541126|NCT01442246|Leuprolide|leuprolide|mesh-list
2541127|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2541128|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
2541129|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2541130|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541131|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2541132|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541133|NCT01442272|Calcifediol|calcifediol|mesh-list
2541134|NCT01442272|Vitamins|vitamins|mesh-ancestor
2541135|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
2409805|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409806|NCT00759720|Glyburide|glyburide|mesh-list
2409807|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2541136|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541137|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2541138|NCT01442311|Interferons|interferons|mesh-list
2541139|NCT01442311|Ribavirin|ribavirin|mesh-list
2541140|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
2541141|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
2541142|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2541143|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541144|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
2541145|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541146|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
2541147|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541148|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
2541149|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541150|NCT01442428|Dexamethasone|dexamethasone|mesh-list
2541151|NCT01442428|Naproxen|naproxen|mesh-list
2541152|NCT01442428|Atorvastatin|atorvastatin|mesh-list
2541153|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2541154|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
2541155|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
2541156|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541157|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541158|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2541159|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
2541160|NCT01442428|Hormones|hormones|mesh-ancestor
2541161|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2541162|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2541163|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541164|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2541165|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2541166|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
2541167|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541168|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2541169|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2541170|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541171|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2541172|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2541173|NCT01442428|Analgesics|analgesics|mesh-ancestor
2541174|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
2541175|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2541176|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
2541177|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2541178|NCT01442519|Mitomycins|mitomycins|mesh-list
2541179|NCT01442519|Mitomycin|mitomycin|mesh-list
2541180|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
2541181|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2541182|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541183|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
2541184|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541185|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2541186|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541187|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2409808|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409809|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2409810|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
2409811|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409812|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
2409813|NCT00759824|Doxorubicin|doxorubicin|mesh-list
2409814|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2541188|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
2541189|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541190|NCT01442532|Midazolam|midazolam|mesh-list
2541191|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2541192|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2541193|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2541194|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541195|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2541196|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2541197|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2541198|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2541199|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
2541200|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
2541201|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
2541202|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
2541203|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541204|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541205|NCT01442558|Bupivacaine|bupivacaine|mesh-list
2541206|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
2541207|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
2541208|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2541209|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541210|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
2541211|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541212|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
2541213|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2541214|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
2541215|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541216|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
2541217|NCT01442571|Protective Agents|protective agents|mesh-ancestor
2541218|NCT01442610|Rasagiline|rasagiline|mesh-list
2541219|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2541220|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541221|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541222|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2541223|NCT01442610|Protective Agents|protective agents|mesh-ancestor
2541224|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409815|NCT00759824|Vindesine|vindesine|mesh-list
2409816|NCT00759824|Valproic Acid|valproic acid|mesh-list
2409817|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2409818|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
2409819|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409820|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2409821|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2409822|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
2409823|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409824|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409825|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2409826|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2409827|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2409828|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2409829|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409830|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
2541254|NCT01442662|Gemcitabine|gemcitabine|mesh-list
2541255|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2541256|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
2541257|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541258|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541259|NCT01442662|Antiviral Agents|antiviral agents|mesh-ancestor
2541260|NCT01442662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541261|NCT01442662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541262|NCT01442662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2541263|NCT01442662|Immunologic Factors|immunologic factors|mesh-ancestor
2541264|NCT01442662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541265|NCT01442701|Triclosan|triclosan|mesh-list
2541266|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2541267|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541268|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2541269|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2541270|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
2541271|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409831|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
2409832|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409833|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
2541272|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2541273|NCT01442727|Selenium|selenium|mesh-list
2541274|NCT01442727|Selenious Acid|selenious acid|mesh-list
2541275|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
2541276|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
2541277|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541278|NCT01442727|Protective Agents|protective agents|mesh-ancestor
2541279|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541280|NCT01442727|Trace Elements|trace elements|mesh-ancestor
2541281|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
2541282|NCT01442766|Donepezil|donepezil|mesh-list
2541283|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2541284|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541285|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541286|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
2541287|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541288|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541289|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
2541290|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
2541291|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2541292|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
2541293|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2541294|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
2541295|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541296|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541297|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
2541298|NCT01442818|Hydromorphone|hydromorphone|mesh-list
2541299|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2541300|NCT01442818|Narcotics|narcotics|mesh-ancestor
2541301|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2541302|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541303|NCT01442818|Analgesics|analgesics|mesh-ancestor
2541304|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
2541305|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541306|NCT01442870|Metformin|metformin|mesh-list
2541307|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2541308|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541309|NCT01442909|Docetaxel|docetaxel|mesh-list
2541310|NCT01442909|Pemetrexed|pemetrexed|mesh-list
2541311|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541312|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
2541313|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
2541314|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
2409834|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2409835|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2409836|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2409837|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2409838|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
2409839|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
2541315|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541316|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541317|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2409840|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
2409841|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2541318|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2541319|NCT01442935|Leucovorin|leucovorin|mesh-list
2541320|NCT01442935|Folic Acid|folic acid|mesh-list
2541321|NCT01442935|Bevacizumab|bevacizumab|mesh-list
2541322|NCT01442935|Cetuximab|cetuximab|mesh-list
2409842|NCT00759928|Sorafenib|sorafenib|mesh-list
2409843|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409844|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2409845|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409846|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409847|NCT00759993|Chromium|chromium|mesh-list
2409848|NCT00759993|Trace Elements|trace elements|mesh-ancestor
2409849|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
2409850|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409851|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
2409852|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2409853|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409854|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2409855|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2409856|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409857|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409858|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409859|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2409860|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2409861|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2409862|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
2541323|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
2541324|NCT01442935|Irinotecan|irinotecan|mesh-list
2541325|NCT01442935|Fluorouracil|fluorouracil|mesh-list
2541326|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
2541327|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2541328|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541329|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2541330|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2541331|NCT01442935|Growth Substances|growth substances|mesh-ancestor
2541332|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541333|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
2541334|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2541335|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2541336|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541337|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541338|NCT01442935|Antidotes|antidotes|mesh-ancestor
2541339|NCT01442935|Protective Agents|protective agents|mesh-ancestor
2541340|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
2541341|NCT01442935|Vitamins|vitamins|mesh-ancestor
2541342|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
2541343|NCT01442935|Hematinics|hematinics|mesh-ancestor
2541344|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
2541345|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2541346|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2541347|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
2541348|NCT01442974|Gemcitabine|gemcitabine|mesh-list
2541349|NCT01442974|Paclitaxel|paclitaxel|mesh-list
2541350|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2541351|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541352|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
2541353|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
2541354|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
2541355|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541356|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2541357|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
2409863|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2409864|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2409865|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
2409866|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409867|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
2409868|NCT00760045|Protective Agents|protective agents|mesh-ancestor
2409869|NCT00760149|Rifampin|rifampin|mesh-list
2409870|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2409871|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
2409872|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2409873|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409874|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
2541358|NCT01442974|Antiviral Agents|antiviral agents|mesh-ancestor
2541359|NCT01442974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541360|NCT01442974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541361|NCT01442974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2541362|NCT01442974|Immunologic Factors|immunologic factors|mesh-ancestor
2541363|NCT01442974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541364|NCT01442987|Irbesartan|irbesartan|mesh-list
2541365|NCT01442987|Atorvastatin|atorvastatin|mesh-list
2409875|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2409876|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409877|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409878|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2409879|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2409880|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2409881|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2409882|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2409883|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2409884|NCT00760175|Vaccines|vaccines|mesh-list
2409885|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
2541366|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2541367|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2541368|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
2541369|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541370|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2541371|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2541372|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541373|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2541374|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2541375|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2541376|NCT01443065|Leucovorin|leucovorin|mesh-list
2541377|NCT01443065|Folic Acid|folic acid|mesh-list
2541378|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
2541379|NCT01443065|Panitumumab|panitumumab|mesh-list
2541380|NCT01443065|Fluorouracil|fluorouracil|mesh-list
2541381|NCT01443065|Rilotumumab|rilotumumab|mesh-list
2541382|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
2541383|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541384|NCT01443065|Antidotes|antidotes|mesh-ancestor
2541385|NCT01443065|Protective Agents|protective agents|mesh-ancestor
2541386|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541387|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
2541388|NCT01443065|Vitamins|vitamins|mesh-ancestor
2541389|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
2541390|NCT01443065|Hematinics|hematinics|mesh-ancestor
2541391|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2541392|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
2541393|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541394|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2541395|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2541396|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
2541397|NCT01443104|Sirolimus|sirolimus|mesh-list
2541398|NCT01443104|Everolimus|everolimus|mesh-list
2541399|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541400|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2541401|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
2541402|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541403|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2541404|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541405|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2541406|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
2541407|NCT01443117|Vaccines|vaccines|mesh-list
2541408|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
2541409|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541410|NCT01443169|Pregabalin|pregabalin|mesh-list
2541411|NCT01443169|Analgesics|analgesics|mesh-ancestor
2541412|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
2541413|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541414|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541415|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
2541416|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2541417|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2541418|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541419|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2541420|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2541421|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2541422|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2541423|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2541424|NCT01443195|Iron|iron|mesh-list
2541425|NCT01443195|Trace Elements|trace elements|mesh-ancestor
2541426|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
2541427|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541428|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2541429|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2541430|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2541431|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2541432|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541433|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541434|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541435|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
2541436|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2541437|NCT01443221|Metformin|metformin|mesh-list
2541438|NCT01443221|Mitiglinide|mitiglinide|mesh-list
2541439|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2541440|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541441|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
2541442|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2541443|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2541444|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
2541445|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541446|NCT01443325|Lidocaine|lidocaine|mesh-list
2541447|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
2541448|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
2541449|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2541450|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541451|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
2541452|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541453|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2541454|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2541455|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2541456|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2541457|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541458|NCT01443338|Acitretin|acitretin|mesh-list
2541459|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
2541460|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
2541461|NCT01443377|Panitumumab|panitumumab|mesh-list
2541462|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2541463|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541464|NCT01443416|Vaccines|vaccines|mesh-list
2541465|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2541466|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
2541467|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541468|NCT01443429|Beraprost|beraprost|mesh-list
2541469|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2541470|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
2541471|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2541472|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2541473|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2541474|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2541475|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2541476|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541477|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541478|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541479|NCT01443520|Analgesics|analgesics|mesh-ancestor
2541480|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
2541481|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541482|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
2541483|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2541484|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
2541485|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2541486|NCT01443572|Sevoflurane|sevoflurane|mesh-list
2541487|NCT01443572|Desflurane|desflurane|mesh-list
2541488|NCT01443572|Anesthetics|anesthetics|mesh-list
2541489|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2541490|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2541491|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
2541492|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2541493|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541494|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2541495|NCT01443624|Hematinics|hematinics|mesh-ancestor
2541496|NCT01443676|Bevacizumab|bevacizumab|mesh-list
2541497|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2541498|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409886|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409887|NCT00760279|Azithromycin|azithromycin|mesh-list
2409888|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2409889|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409890|NCT00760318|Levetiracetam|levetiracetam|mesh-list
2409891|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
2409892|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
2409893|NCT00760344|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2409894|NCT00760344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2409895|NCT00760344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409896|NCT00760344|Incretins|incretins|mesh-ancestor
2409897|NCT00760344|Hormones|hormones|mesh-ancestor
2409898|NCT00760344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409899|NCT00760344|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2409900|NCT00760344|Protease Inhibitors|protease inhibitors|mesh-ancestor
2541499|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2541500|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2541501|NCT01443676|Growth Substances|growth substances|mesh-ancestor
2541502|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541503|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
2541504|NCT01443728|Vitamin D|vitamin d|mesh-list
2541505|NCT01443728|Ergocalciferols|ergocalciferols|mesh-list
2541506|NCT01443728|Cholecalciferol|cholecalciferol|mesh-list
2541507|NCT01443728|Vitamins|vitamins|mesh-list
2541508|NCT01443728|Micronutrients|micronutrients|mesh-ancestor
2541509|NCT01443728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541510|NCT01443728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2541511|NCT01443728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2541512|NCT01443741|Insulin|insulin|mesh-list
2541513|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2541514|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2541515|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541516|NCT01443780|Selenium|selenium|mesh-list
2541517|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
2541518|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541519|NCT01443780|Protective Agents|protective agents|mesh-ancestor
2541520|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541521|NCT01443780|Trace Elements|trace elements|mesh-ancestor
2541522|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
2541523|NCT01443806|Oseltamivir|oseltamivir|mesh-list
2541524|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
2541525|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541526|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541527|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541528|NCT01443897|Vitamin D|vitamin d|mesh-list
2541529|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
2541530|NCT01443897|Vitamins|vitamins|mesh-list
2541531|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
2541532|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541533|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2541534|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2541535|NCT01443936|Vaccines|vaccines|mesh-list
2541536|NCT01443936|Immunologic Factors|immunologic factors|mesh-ancestor
2541537|NCT01443936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541538|NCT01443988|Travoprost|travoprost|mesh-list
2541539|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2541540|NCT01444001|Vaccines|vaccines|mesh-list
2541541|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2541542|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
2541543|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541544|NCT01444040|Travoprost|travoprost|mesh-list
2541545|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2541546|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
2541547|NCT01444118|Vaccines|vaccines|mesh-list
2541548|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
2541549|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541550|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2541551|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2541552|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2541553|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
2541554|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541555|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541556|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2409901|NCT00760344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541557|NCT01444131|Nicotine|nicotine|mesh-list
2541558|NCT01444131|Varenicline|varenicline|mesh-list
2541559|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2541560|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
2541561|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541562|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541563|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2409902|NCT00760344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409903|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
2409904|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2409905|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409906|NCT00760448|Insulin|insulin|mesh-list
2409907|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2409908|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
2409909|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
2409910|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
2409911|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
2409912|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2409913|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409914|NCT00760539|Timolol|timolol|mesh-list
2409915|NCT00760539|Travoprost|travoprost|mesh-list
2409916|NCT00760539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2409917|NCT00760539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2541564|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2541565|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
2541566|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541567|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409918|NCT00760539|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2409919|NCT00760539|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2409920|NCT00760539|Adrenergic Agents|adrenergic agents|mesh-ancestor
2409921|NCT00760539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409922|NCT00760539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409923|NCT00760539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409924|NCT00760539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2409925|NCT00760539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2409926|NCT00760695|Dronabinol|dronabinol|mesh-list
2409927|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
2409928|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409929|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2409930|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2409931|NCT00760695|Analgesics|analgesics|mesh-ancestor
2409932|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
2409933|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409934|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2409935|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2409936|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409937|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409938|NCT00760695|Hormones|hormones|mesh-ancestor
2409939|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2409940|NCT00760864|Methotrexate|methotrexate|mesh-list
2409941|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2409942|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
2409943|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2409944|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541568|NCT01444196|Desloratadine|desloratadine|mesh-list
2541569|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2541570|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
2541571|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541572|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541573|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541574|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2541575|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2541576|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
2541577|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
2541578|NCT01444248|Metformin|metformin|mesh-list
2541579|NCT01444248|Glimepiride|glimepiride|mesh-list
2541580|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2541581|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541582|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2541583|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2541584|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
2541585|NCT01444339|Vaccines|vaccines|mesh-list
2541586|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2541587|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
2541588|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541589|NCT01444352|Vaccines|vaccines|mesh-list
2541590|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2541591|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
2409945|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2409946|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
2409947|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409948|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409949|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
2541592|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541593|NCT01444365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2541594|NCT01444365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2541595|NCT01444365|Analgesics|analgesics|mesh-ancestor
2541596|NCT01444365|Sensory System Agents|sensory system agents|mesh-ancestor
2541597|NCT01444365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541598|NCT01444365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541599|NCT01444365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2541600|NCT01444365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2541601|NCT01444469|Azithromycin|azithromycin|mesh-list
2541602|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2541603|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541604|NCT01444521|Irinotecan|irinotecan|mesh-list
2541605|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541606|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2541607|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2541608|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541609|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541610|NCT01444547|Paclitaxel|paclitaxel|mesh-list
2541611|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2541612|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2541613|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541614|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
2541615|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
2541616|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
2541617|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541618|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
2541619|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2541620|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
2541621|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2541622|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
2541623|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541624|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541625|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
2541626|NCT01444612|Heparin|heparin|mesh-list
2541627|NCT01444612|Calcium heparin|calcium heparin|mesh-list
2541628|NCT01444612|Enoxaparin|enoxaparin|mesh-list
2541629|NCT01444612|Dalteparin|dalteparin|mesh-list
2541630|NCT01444612|Tinzaparin|tinzaparin|mesh-list
2541631|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2541632|NCT01444612|PENTA|penta|mesh-list
2541633|NCT01444612|Fondaparinux|fondaparinux|mesh-list
2541634|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
2541635|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2541636|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2541637|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541638|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2541639|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
2541640|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2541641|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
2541642|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541643|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
2541644|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541645|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2541646|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2541647|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541648|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541649|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
2541650|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2541651|NCT01444807|Sorafenib|sorafenib|mesh-list
2541652|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541653|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2541654|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541655|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541656|NCT01444833|Candesartan|candesartan|mesh-list
2541657|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2541658|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2541659|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2409950|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409951|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2409952|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2409953|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
2409954|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2409955|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2409956|NCT00760916|Treprostinil|treprostinil|mesh-list
2409957|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2409958|NCT00760968|Methotrexate|methotrexate|mesh-list
2409959|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2409960|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
2409961|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2409962|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409963|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2409964|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
2409965|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409966|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409967|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
2541660|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541661|NCT01444846|Ebselen|ebselen|mesh-list
2541662|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2541663|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2541664|NCT01444846|Analgesics|analgesics|mesh-ancestor
2541665|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
2541666|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541667|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541668|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2409968|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409969|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2409970|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2409971|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
2409972|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2409973|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2409974|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
2409975|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409976|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2409977|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2409978|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409979|NCT00761020|Mefloquine|mefloquine|mesh-list
2409980|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
2409981|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2409982|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2409983|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2409984|NCT00761228|Apomorphine|apomorphine|mesh-list
2409985|NCT00761228|Emetics|emetics|mesh-ancestor
2409986|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2409987|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
2409988|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2409989|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2541669|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2541670|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2541671|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2541672|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
2541673|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541674|NCT01444846|Protective Agents|protective agents|mesh-ancestor
2541675|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2541676|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541677|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2541678|NCT01444885|Amlodipine|amlodipine|mesh-list
2541679|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
2541680|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2541681|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2541682|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2541683|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541684|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2541685|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541686|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
2409990|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
2409991|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
2409992|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2409993|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2409994|NCT00761241|Gemcitabine|gemcitabine|mesh-list
2409995|NCT00761241|Interferons|interferons|mesh-list
2409996|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
2541687|NCT01444976|Midazolam|midazolam|mesh-list
2541688|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
2541689|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2409997|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2409998|NCT00761241|Docetaxel|docetaxel|mesh-list
2541690|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541691|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2541692|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2541693|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2541694|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2541695|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2541696|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2541697|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
2541698|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
2541699|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
2541700|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541701|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541702|NCT01445067|Calcitonin|calcitonin|mesh-list
2541703|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2541704|NCT01445067|Katacalcin|katacalcin|mesh-list
2541705|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
2541706|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2541707|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541708|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2541709|NCT01445106|Nelfinavir|nelfinavir|mesh-list
2541710|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2541711|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2541712|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
2541713|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541714|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541715|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2541716|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2541717|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
2541718|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541719|NCT01445119|Carboplatin|carboplatin|mesh-list
2541720|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2409999|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
2410000|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2410001|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
2410002|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410003|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410004|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
2410005|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410006|NCT00761241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410007|NCT00761241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2410008|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
2410009|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410010|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
2410011|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
2410012|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
2410013|NCT00761254|Domperidone|domperidone|mesh-list
2410014|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
2410015|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
2410016|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410017|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410018|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2541721|NCT01445210|Ropivacaine|ropivacaine|mesh-list
2541722|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
2541723|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
2541724|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2541725|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541726|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
2541727|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410019|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2410020|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
2410021|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410022|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541728|NCT01445223|Ritonavir|ritonavir|mesh-list
2541729|NCT01445223|Lopinavir|lopinavir|mesh-list
2541730|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2541731|NCT01445223|Efavirenz|efavirenz|mesh-list
2541732|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2541733|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2541734|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
2541735|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541736|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541737|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2541738|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2541739|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
2541740|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541741|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2410023|NCT00761332|Teriparatide|teriparatide|mesh-list
2410024|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2410025|NCT00761332|Diphosphonates|diphosphonates|mesh-list
2410026|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2410027|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410028|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2410029|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2410030|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
2410031|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2410032|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2410033|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2410034|NCT00761358|Z 338|z 338|mesh-list
2410035|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2410036|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410037|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410038|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
2410039|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410040|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410041|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2410042|NCT00761371|Imiquimod|imiquimod|mesh-list
2410043|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2410044|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
2410045|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410046|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410047|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
2410048|NCT00761449|Lenalidomide|lenalidomide|mesh-list
2410049|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
2410050|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410051|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2410052|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2410053|NCT00761449|Growth Substances|growth substances|mesh-ancestor
2410054|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
2410055|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410056|NCT00761501|Naproxen|naproxen|mesh-list
2410057|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2410058|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2410059|NCT00761501|Analgesics|analgesics|mesh-ancestor
2410060|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
2410061|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541742|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2541743|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2541744|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2541745|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2541746|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2541747|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2541748|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2541749|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2541750|NCT01445236|Cyclosporine|cyclosporine|mesh-list
2541751|NCT01445236|Tacrolimus|tacrolimus|mesh-list
2541752|NCT01445236|Cyclosporins|cyclosporins|mesh-list
2541753|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2541754|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
2541755|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541756|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2541757|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541758|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541759|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
2541760|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541761|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
2541762|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2541763|NCT01445262|Levocetirizine|levocetirizine|mesh-list
2541764|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2541765|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2541766|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
2541767|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
2541768|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541769|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541770|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541771|NCT01445340|Romidepsin|romidepsin|mesh-list
2541772|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2541773|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541774|NCT01445379|Ipilimumab|ipilimumab|mesh-list
2541775|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2541776|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541777|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2541778|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541779|NCT01445392|Pemetrexed|pemetrexed|mesh-list
2541780|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2541781|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541782|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541783|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541784|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2541785|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2541786|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
2541787|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541788|NCT01445405|Cetuximab|cetuximab|mesh-list
2541789|NCT01445405|Bortezomib|bortezomib|mesh-list
2541790|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541791|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2541792|NCT01445418|Carboplatin|carboplatin|mesh-list
2541793|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541794|NCT01445431|Mineral Oil|mineral oil|mesh-list
2541795|NCT01445431|Emollients|emollients|mesh-ancestor
2541796|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
2541809|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
2541810|NCT01445522|Veliparib|veliparib|mesh-list
2541811|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2541812|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
2541813|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541814|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2541815|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2541816|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
2541817|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541818|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541819|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2541820|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2541821|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541822|NCT01445561|Interleukin-2|interleukin-2|mesh-list
2541823|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541824|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2541825|NCT01445561|Analgesics|analgesics|mesh-ancestor
2541826|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
2541827|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541828|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541829|NCT01445587|Bortezomib|bortezomib|mesh-list
2541830|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541831|NCT01445600|Retapamulin|retapamulin|mesh-list
2541832|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2541833|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541834|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
2541835|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2541836|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2541837|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541838|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2541839|NCT01445639|Analgesics|analgesics|mesh-ancestor
2541840|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
2541841|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541842|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2541843|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2541844|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2541845|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
2541846|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541847|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541848|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2541849|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2541850|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
2541851|NCT01445743|Vaccines|vaccines|mesh-list
2541852|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
2541853|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541854|NCT01445756|Lidocaine|lidocaine|mesh-list
2541855|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
2541856|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
2541857|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2541858|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541859|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
2541860|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541861|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2541862|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2541863|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2541864|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2541865|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541866|NCT01445795|Ribavirin|ribavirin|mesh-list
2541867|NCT01445795|Antimetabolites|antimetabolites|mesh-ancestor
2541868|NCT01445795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541869|NCT01445795|Antiviral Agents|antiviral agents|mesh-ancestor
2541870|NCT01445795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541871|NCT01445860|Simvastatin|simvastatin|mesh-list
2541872|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2541873|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2541874|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
2541875|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541876|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2541877|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2541878|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541879|NCT01445899|Ranibizumab|ranibizumab|mesh-list
2541880|NCT01445899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2541881|NCT01445899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2541882|NCT01445899|Growth Substances|growth substances|mesh-ancestor
2541883|NCT01445899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541884|NCT01445899|Growth Inhibitors|growth inhibitors|mesh-ancestor
2541885|NCT01445899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541886|NCT01445938|Lumefantrine|lumefantrine|mesh-list
2541887|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
2541888|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2541889|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2541890|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2541891|NCT01445964|Atenolol|atenolol|mesh-list
2541892|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2410062|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410063|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410064|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2410065|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
2410066|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2541893|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2541894|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
2541895|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
2541896|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541897|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541898|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2541899|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2541900|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2541901|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
2541902|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541903|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410067|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410068|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410069|NCT00761540|Liraglutide|liraglutide|mesh-list
2410070|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2410071|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410072|NCT00761540|Incretins|incretins|mesh-ancestor
2410073|NCT00761540|Hormones|hormones|mesh-ancestor
2410074|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2410075|NCT00761644|Sirolimus|sirolimus|mesh-list
2410076|NCT00761644|Bevacizumab|bevacizumab|mesh-list
2410077|NCT00761644|Doxorubicin|doxorubicin|mesh-list
2410078|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2410079|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2410080|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541914|NCT01446094|Regadenoson|regadenoson|mesh-list
2541915|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2541916|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2410081|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2410082|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2410083|NCT00761644|Growth Substances|growth substances|mesh-ancestor
2410084|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410085|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
2410086|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2410087|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2410088|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2410089|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410090|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410091|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2410092|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410093|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
2410094|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2410095|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
2410096|NCT00761670|Risperidone|risperidone|mesh-list
2410097|NCT00761670|Amisulpride|amisulpride|mesh-list
2410098|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2410099|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
2410100|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410101|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410102|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410103|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2410104|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2410105|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410106|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2410107|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2541917|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
2541918|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
2541919|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541920|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541921|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541922|NCT01446107|Fluorides|fluorides|mesh-list
2541923|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
2541924|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
2541925|NCT01446107|Protective Agents|protective agents|mesh-ancestor
2541926|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541927|NCT01446120|Insulin|insulin|mesh-list
2541928|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2541929|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
2541930|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
2541931|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
2541932|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2541933|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541934|NCT01446211|Gusperimus|gusperimus|mesh-list
2541935|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
2541936|NCT01446211|Methotrexate|methotrexate|mesh-list
2541937|NCT01446211|Azathioprine|azathioprine|mesh-list
2541938|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
2541939|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2541940|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
2541941|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541942|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2541943|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2541944|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
2541945|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541946|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541947|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2541948|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2541949|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
2541950|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2541951|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2541952|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
2410108|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
2541953|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
2541954|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541955|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2541956|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2541957|NCT01446211|Hormones|hormones|mesh-ancestor
2541958|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2541959|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2541960|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2541961|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2541962|NCT01446211|Protective Agents|protective agents|mesh-ancestor
2541963|NCT01446224|Bevacizumab|bevacizumab|mesh-list
2541964|NCT01446224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2541965|NCT01446224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2541966|NCT01446224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2541967|NCT01446224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2541968|NCT01446224|Growth Substances|growth substances|mesh-ancestor
2541969|NCT01446224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541970|NCT01446224|Growth Inhibitors|growth inhibitors|mesh-ancestor
2541971|NCT01446276|Resveratrol|resveratrol|mesh-list
2541972|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
2410109|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2410110|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
2410111|NCT00761709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2410112|NCT00761709|Latanoprost|latanoprost|mesh-list
2410113|NCT00761709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2410114|NCT00761722|Azacitidine|azacitidine|mesh-list
2410115|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2410116|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
2410117|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541973|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541974|NCT01446276|Protective Agents|protective agents|mesh-ancestor
2541975|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541976|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2541977|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2541978|NCT01446328|Olanzapine|olanzapine|mesh-list
2541979|NCT01446328|Aripiprazole|aripiprazole|mesh-list
2541980|NCT01446328|Amisulpride|amisulpride|mesh-list
2541981|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
2541982|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
2541983|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2541984|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2541985|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2541986|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2541987|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2541988|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2541989|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2541990|NCT01446328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2410118|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410119|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410120|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
2410121|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410122|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410123|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2410124|NCT00761904|Simvastatin|simvastatin|mesh-list
2541991|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2541992|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2541993|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2541994|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2541995|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
2541996|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
2541997|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
2541998|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
2541999|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2542000|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2542001|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2542002|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2542003|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2542004|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2542005|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2410125|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2410126|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2410127|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
2410128|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410129|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2410130|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2116634|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2542006|NCT01446445|Valganciclovir|valganciclovir|mesh-list
2542007|NCT01446445|Ganciclovir|ganciclovir|mesh-list
2542008|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2542009|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
2542010|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542011|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2542012|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542013|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542014|NCT01446458|Folfirinox|folfirinox|mesh-list
2542015|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542016|NCT01446484|Cyclosporine|cyclosporine|mesh-list
2542017|NCT01446484|Sirolimus|sirolimus|mesh-list
2542018|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
2542019|NCT01446484|Everolimus|everolimus|mesh-list
2542020|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
2542021|NCT01446484|Tacrolimus|tacrolimus|mesh-list
2542022|NCT01446484|Cyclosporins|cyclosporins|mesh-list
2542023|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2542024|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
2542025|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542026|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2542027|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542028|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542029|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
2410131|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410132|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2410133|NCT00761904|Diuretics|diuretics|mesh-ancestor
2410134|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
2410135|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410136|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2410137|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2410138|NCT00762060|Anesthetics|anesthetics|mesh-list
2410139|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
2410140|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410141|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410142|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
2410143|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410144|NCT00762099|Pregabalin|pregabalin|mesh-list
2410145|NCT00762099|Analgesics|analgesics|mesh-ancestor
2410146|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
2410147|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410148|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410149|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
2410150|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2410151|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2410152|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410153|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2410154|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2410155|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2410156|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410157|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2410158|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2410159|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410160|NCT00762190|Insulin|insulin|mesh-list
2410161|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2410162|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2410163|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410164|NCT00762255|Bevacizumab|bevacizumab|mesh-list
2542030|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542031|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
2542032|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2410165|NCT00762255|Irinotecan|irinotecan|mesh-list
2542033|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542034|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2542035|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2542036|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
2542037|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2542038|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2542039|NCT01446497|Timolol|timolol|mesh-list
2116635|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2116636|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2116637|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
2116638|NCT02643394|Acetaminophen|acetaminophen|mesh-list
2116639|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2116640|NCT02643394|Analgesics|analgesics|mesh-ancestor
2116641|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
2410166|NCT00762255|Vorinostat|vorinostat|mesh-list
2410167|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2410168|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410169|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2410170|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2410171|NCT00762255|Growth Substances|growth substances|mesh-ancestor
2542040|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2542041|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2542042|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2542043|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
2542044|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542045|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542046|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542047|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2542048|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2542049|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2542050|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2542051|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2542052|NCT01446523|Lactulose|lactulose|mesh-list
2542053|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2542054|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2542055|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
2542056|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542057|NCT01446679|Atorvastatin|atorvastatin|mesh-list
2542058|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2542059|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2542060|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
2542061|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542062|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2542063|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2542064|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542065|NCT01446731|Docetaxel|docetaxel|mesh-list
2542066|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542067|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
2542068|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
2542069|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
2542070|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542071|NCT01446783|Mecasermin|mecasermin|mesh-list
2542072|NCT01446783|Growth Substances|growth substances|mesh-ancestor
2542073|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542074|NCT01446900|Rituximab|rituximab|mesh-list
2542075|NCT01446900|Cladribine|cladribine|mesh-list
2542076|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2410172|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410173|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
2410174|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2410175|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2410176|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410177|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410178|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2410179|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
2410180|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2410181|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410182|NCT00762554|Fentanyl|fentanyl|mesh-list
2410183|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2410184|NCT00762554|Narcotics|narcotics|mesh-ancestor
2410185|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410186|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410187|NCT00762554|Analgesics|analgesics|mesh-ancestor
2410188|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
2410189|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410190|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2410191|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2410192|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
2410193|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
2410194|NCT00762567|Phenylephrine|phenylephrine|mesh-list
2410195|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
2410196|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
2410197|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2410198|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
2542077|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542078|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
2542079|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542080|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2410199|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
2410200|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542081|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2542082|NCT01446926|Vaccines|vaccines|mesh-list
2542083|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2410201|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410202|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
2410203|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2410204|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
2410205|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2542084|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
2542085|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542086|NCT01446952|Vitamin E|vitamin e|mesh-list
2542087|NCT01446952|Tocopherols|tocopherols|mesh-list
2542088|NCT01446952|Tocotrienols|tocotrienols|mesh-list
2542089|NCT01446952|Vitamins|vitamins|mesh-ancestor
2542090|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
2542091|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542092|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
2542093|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542094|NCT01446952|Protective Agents|protective agents|mesh-ancestor
2542095|NCT01446978|Vaccines|vaccines|mesh-list
2542096|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
2542097|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542098|NCT01447043|Ranibizumab|ranibizumab|mesh-list
2542099|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2542100|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2542101|NCT01447043|Growth Substances|growth substances|mesh-ancestor
2542102|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542103|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
2542104|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542105|NCT01447069|Albuterol|albuterol|mesh-list
2542106|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2542107|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
2542108|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542109|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542110|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2542111|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
2542112|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
2542113|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2542114|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2410206|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2410207|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2410208|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
2410209|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410210|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410211|NCT00762567|Protective Agents|protective agents|mesh-ancestor
2410212|NCT00762632|Everolimus|everolimus|mesh-list
2410213|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410214|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2410215|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
2410216|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542115|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2542116|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2542117|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
2542118|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542119|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542120|NCT01447095|Epoprostenol|epoprostenol|mesh-list
2542121|NCT01447095|Tezosentan|tezosentan|mesh-list
2542122|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2542123|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2542124|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
2542125|NCT01447160|Cortisone|cortisone|mesh-list
2542126|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542127|NCT01447173|Vitamin D|vitamin d|mesh-list
2542128|NCT01447173|Vitamins|vitamins|mesh-ancestor
2542129|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
2542130|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542131|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2542132|NCT01447212|Hydromorphone|hydromorphone|mesh-list
2542133|NCT01447212|Heroin|heroin|mesh-list
2542134|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2542135|NCT01447212|Narcotics|narcotics|mesh-ancestor
2542136|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2542137|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542138|NCT01447212|Analgesics|analgesics|mesh-ancestor
2542139|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
2410217|NCT00762658|Betamethasone|betamethasone|mesh-list
2542140|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542141|NCT01447355|Vitamin D|vitamin d|mesh-list
2410218|NCT00762658|Tacrolimus|tacrolimus|mesh-list
2410219|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2410220|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2410221|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
2410222|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410223|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2410224|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410225|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410226|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410227|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
2410228|NCT00762658|Hormones|hormones|mesh-ancestor
2410229|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2542142|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
2542143|NCT01447355|Vitamins|vitamins|mesh-ancestor
2542144|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
2542145|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542146|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2542147|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2542148|NCT01447368|Cinacalcet|cinacalcet|mesh-list
2542149|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2542150|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542151|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2542152|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
2542153|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2542154|NCT01447394|Interferons|interferons|mesh-list
2542155|NCT01447394|Ribavirin|ribavirin|mesh-list
2542156|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
2542157|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
2542158|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2542159|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542160|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
2542161|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542162|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
2542163|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542164|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
2542165|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542166|NCT01447485|Valsartan|valsartan|mesh-list
2542167|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2542168|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2542169|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2542170|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542171|NCT01447550|Bosentan|bosentan|mesh-list
2542172|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2542173|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2542174|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542175|NCT01447563|Clopidogrel|clopidogrel|mesh-list
2542176|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2542177|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2542178|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2542179|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2542180|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
2542181|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410230|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2410231|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
2410232|NCT00762671|Ebselen|ebselen|mesh-list
2410233|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2410234|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2410235|NCT00762671|Analgesics|analgesics|mesh-ancestor
2410236|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
2410237|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410238|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410239|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410240|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2410241|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2410242|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2410243|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
2410244|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410245|NCT00762671|Protective Agents|protective agents|mesh-ancestor
2410246|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2410247|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410248|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2410249|NCT00762736|Pioglitazone|pioglitazone|mesh-list
2410250|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2410251|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2410252|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410253|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2410254|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2410255|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410256|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
2410257|NCT00762749|Promethazine|promethazine|mesh-list
2410258|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2410259|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2410260|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410261|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410262|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
2410263|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
2410264|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
2410265|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410266|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
2410267|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
2410268|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2410269|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2542182|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542183|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542184|NCT01447589|Nelfinavir|nelfinavir|mesh-list
2542185|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2542186|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2542187|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
2542188|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542189|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542190|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2542191|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2542192|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
2542193|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542194|NCT01447654|Losartan|losartan|mesh-list
2542195|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2542196|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2542197|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2542198|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2542199|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542200|NCT01447797|Irbesartan|irbesartan|mesh-list
2542201|NCT01447797|Atorvastatin|atorvastatin|mesh-list
2542202|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2542203|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2542204|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
2542205|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542206|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2542207|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2542208|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542209|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2542210|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2542211|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2542212|NCT01447862|Ibutilide|ibutilide|mesh-list
2542213|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2542214|NCT01447875|Propofol|propofol|mesh-list
2542215|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2542216|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2542217|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542218|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2542219|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
2542220|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
2542221|NCT01447979|Pancrelipase|pancrelipase|mesh-list
2542222|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2542223|NCT01447992|Pancrelipase|pancrelipase|mesh-list
2542224|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2542225|NCT01448018|Ranibizumab|ranibizumab|mesh-list
2542226|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2542227|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2542228|NCT01448018|Growth Substances|growth substances|mesh-ancestor
2542229|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542230|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
2542231|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542232|NCT01448031|Esomeprazole|esomeprazole|mesh-list
2542233|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2410270|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
2410271|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
2410272|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542234|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2542235|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2410273|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542236|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542237|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542238|NCT01448070|Insulin|insulin|mesh-list
2542239|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2542240|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2542241|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542242|NCT01448096|Rituximab|rituximab|mesh-list
2542243|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2542244|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542245|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
2542246|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542247|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2542248|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
2542249|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2542250|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542251|NCT01448174|Atorvastatin|atorvastatin|mesh-list
2542252|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2542253|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2410274|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2410275|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
2410276|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
2410277|NCT00762775|Vitamin D|vitamin d|mesh-list
2410278|NCT00762775|Calcium|calcium|mesh-list
2410279|NCT00762775|Vitamins|vitamins|mesh-ancestor
2410280|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
2410281|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410282|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2410283|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2410284|NCT00762918|Vitamin D|vitamin d|mesh-list
2410285|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
2410286|NCT00762918|Vitamins|vitamins|mesh-ancestor
2542254|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
2542255|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542256|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2542257|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2542258|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542259|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2542260|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
2542261|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542262|NCT01448252|Vaccines|vaccines|mesh-list
2542263|NCT01448252|Immunologic Factors|immunologic factors|mesh-ancestor
2542264|NCT01448252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542265|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2542266|NCT01448291|Etonogestrel|etonogestrel|mesh-list
2542267|NCT01448291|NuvaRing|nuvaring|mesh-list
2542268|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
2542269|NCT01448291|Estradiol|estradiol|mesh-list
2542270|NCT01448291|Estrogens|estrogens|mesh-ancestor
2542271|NCT01448291|Hormones|hormones|mesh-ancestor
2542272|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2542273|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542274|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2542275|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2542276|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2542277|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2542278|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2542279|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2542280|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2542281|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
2542282|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542283|NCT01448330|Aspirin|aspirin|mesh-list
2542284|NCT01448330|Clopidogrel|clopidogrel|mesh-list
2542285|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2542286|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2542287|NCT01448330|Analgesics|analgesics|mesh-ancestor
2542288|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
2542289|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542290|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542291|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542292|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2542293|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2542294|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2542295|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542296|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2410287|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
2542297|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2542298|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542299|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
2542300|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2542301|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2542302|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2542303|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
2542304|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542305|NCT01448395|Avibactam|avibactam|mesh-list
2542306|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2542307|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542308|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542309|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2542310|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542311|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
2542312|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2542313|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2542314|NCT01448499|Clozapine|clozapine|mesh-list
2542315|NCT01448499|Amisulpride|amisulpride|mesh-list
2542316|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2542317|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
2410288|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410289|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2410290|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2410291|NCT00762944|Cimetidine|cimetidine|mesh-list
2410292|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2410293|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2410294|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2410295|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
2410296|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
2410297|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410298|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410299|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410300|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2542318|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542319|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542320|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542321|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2542322|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2542323|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2542324|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2410301|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2410302|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410303|NCT00762957|Metformin|metformin|mesh-list
2410304|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2410305|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542325|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
2542326|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
2542327|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2542328|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
2542329|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2542330|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
2542331|NCT01448538|Bevacizumab|bevacizumab|mesh-list
2542332|NCT01448538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2542333|NCT01448538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542334|NCT01448538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2542335|NCT01448538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2542336|NCT01448538|Growth Substances|growth substances|mesh-ancestor
2542337|NCT01448538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542338|NCT01448538|Growth Inhibitors|growth inhibitors|mesh-ancestor
2542339|NCT01448642|Atorvastatin|atorvastatin|mesh-list
2542340|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2542341|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2542342|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
2542343|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542344|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2542345|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2542346|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542347|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2542348|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2542349|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2542350|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2542351|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542352|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2542353|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2542354|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2542355|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
2542356|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410306|NCT00762983|Loratadine|loratadine|mesh-list
2410307|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
2410308|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
2410309|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2410310|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2410311|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2410312|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
2410313|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
2410314|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410315|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410316|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410317|NCT00763165|Triclosan|triclosan|mesh-list
2410318|NCT00763165|Fluorides|fluorides|mesh-list
2410319|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
2410320|NCT00763165|Protective Agents|protective agents|mesh-ancestor
2410321|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410322|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2410323|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410324|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2542357|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542358|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2542359|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2542360|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
2542361|NCT01448733|Clindamycin|clindamycin|mesh-list
2542362|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
2542363|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
2542364|NCT01448733|Tretinoin|tretinoin|mesh-list
2542365|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2542366|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2542367|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542368|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2410325|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2410326|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
2410327|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410328|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2410329|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2410330|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2410331|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2410332|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2410333|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410334|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410335|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410336|NCT00763178|Analgesics|analgesics|mesh-ancestor
2410337|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
2410338|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410339|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
2410340|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2542369|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542370|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542371|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
2542372|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542373|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
2542374|NCT01448746|Heparin|heparin|mesh-list
2542375|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2542376|NCT01448746|Tinzaparin|tinzaparin|mesh-list
2542377|NCT01448746|Dalteparin|dalteparin|mesh-list
2542378|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
2542379|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2542380|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2542381|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542382|NCT01448772|Dronabinol|dronabinol|mesh-list
2542383|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
2410341|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
2410342|NCT00763204|Betamethasone|betamethasone|mesh-list
2410343|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2410344|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410345|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
2542384|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410346|NCT00763204|Hormones|hormones|mesh-ancestor
2542385|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2542386|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2542387|NCT01448772|Analgesics|analgesics|mesh-ancestor
2410347|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2410348|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410349|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2410350|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
2410351|NCT00763347|Alogliptin|alogliptin|mesh-list
2410352|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2410353|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410354|NCT00763347|Incretins|incretins|mesh-ancestor
2410355|NCT00763347|Hormones|hormones|mesh-ancestor
2410356|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2410357|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2410358|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
2410359|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410360|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410361|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2410362|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2410363|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410364|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
2410365|NCT00763438|Sertindole|sertindole|mesh-list
2410366|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2410367|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2410368|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410369|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410370|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2410371|NCT00763503|Calcitriol|calcitriol|mesh-list
2410372|NCT00763503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2410373|NCT00763503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410374|NCT00763503|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2410375|NCT00763503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2410376|NCT00763503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410377|NCT00763503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2542388|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
2542389|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542390|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2542391|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2542392|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542393|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542394|NCT01448772|Hormones|hormones|mesh-ancestor
2542395|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2542396|NCT01448798|Thrombin|thrombin|mesh-list
2542397|NCT01448798|Hemostatics|hemostatics|mesh-list
2542398|NCT01448798|Coagulants|coagulants|mesh-ancestor
2542399|NCT01448837|Timolol|timolol|mesh-list
2542400|NCT01448837|Bimatoprost|bimatoprost|mesh-list
2542401|NCT01448837|Latanoprost|latanoprost|mesh-list
2542402|NCT01448837|Cloprostenol|cloprostenol|mesh-list
2542403|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2542404|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2542405|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
2542406|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542407|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542408|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542409|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2542410|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2542411|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2542412|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2542413|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
2542414|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2542415|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
2542416|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2542417|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2542418|NCT01448993|Azithromycin|azithromycin|mesh-list
2542419|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2542420|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542421|NCT01449045|Lumefantrine|lumefantrine|mesh-list
2542422|NCT01449045|Artemether|artemether|mesh-list
2542423|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2410378|NCT00763503|Vitamins|vitamins|mesh-ancestor
2410379|NCT00763503|Micronutrients|micronutrients|mesh-ancestor
2410380|NCT00763503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2410381|NCT00763529|Fluticasone|fluticasone|mesh-list
2410382|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
2542424|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
2542425|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2542426|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2542427|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542428|NCT01449071|Epratuzumab|epratuzumab|mesh-list
2542429|NCT01449071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2542430|NCT01449071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542431|NCT01449110|Resveratrol|resveratrol|mesh-list
2542432|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
2410383|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410384|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2410385|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
2410386|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410387|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410388|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2410389|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
2410390|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
2410391|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2410392|NCT00763555|Calcitriol|calcitriol|mesh-list
2410393|NCT00763555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2410394|NCT00763555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410395|NCT00763555|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2410396|NCT00763555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2410397|NCT00763555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410398|NCT00763555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2410399|NCT00763555|Vitamins|vitamins|mesh-ancestor
2410400|NCT00763555|Micronutrients|micronutrients|mesh-ancestor
2410401|NCT00763555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2410402|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2410403|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
2410404|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
2410405|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542433|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542434|NCT01449110|Protective Agents|protective agents|mesh-ancestor
2542435|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542436|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542437|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2542438|NCT01449123|Mannitol|mannitol|mesh-list
2542439|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2410406|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2410407|NCT00763633|Vitamins|vitamins|mesh-list
2410408|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
2410409|NCT00763633|Pyridoxal|pyridoxal|mesh-list
2410410|NCT00763633|Pyridoxine|pyridoxine|mesh-list
2410411|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
2410412|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
2410413|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410414|NCT00763646|Docetaxel|docetaxel|mesh-list
2410415|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410416|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
2410417|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
2410418|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
2410419|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410420|NCT00763685|Etoricoxib|etoricoxib|mesh-list
2410421|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2410422|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2410423|NCT00763685|Analgesics|analgesics|mesh-ancestor
2410424|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
2410425|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410426|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410427|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410428|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2410429|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2410430|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2410431|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410432|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410433|NCT00763763|Interferons|interferons|mesh-list
2410434|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2410435|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
2410436|NCT00763763|Dexamethasone|dexamethasone|mesh-list
2410437|NCT00763763|Vincristine|vincristine|mesh-list
2410438|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
2410439|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410440|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
2410441|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
2410442|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410443|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410444|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2410445|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
2410446|NCT00763763|Hormones|hormones|mesh-ancestor
2542440|NCT01449123|Diuretics|diuretics|mesh-ancestor
2542441|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
2542442|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542443|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2542444|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542445|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
2542446|NCT01449188|Ondansetron|ondansetron|mesh-list
2542447|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2542448|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542449|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2542450|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2542451|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542452|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542453|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542454|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542455|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
2542456|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
2542457|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542458|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2542459|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
2542460|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
2542461|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2542462|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
2542463|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542464|NCT01449188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2542465|NCT01449188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2542466|NCT01449188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2542467|NCT01449188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2542468|NCT01449188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2542469|NCT01449253|Bosentan|bosentan|mesh-list
2542470|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
2542471|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
2542472|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2542473|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2542474|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542475|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542476|NCT01449253|Urological Agents|urological agents|mesh-ancestor
2542477|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2542478|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2542479|NCT01449344|Cytarabine|cytarabine|mesh-list
2542480|NCT01449344|Dexamethasone|dexamethasone|mesh-list
2542481|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
2542482|NCT01449344|Rituximab|rituximab|mesh-list
2542483|NCT01449344|Bortezomib|bortezomib|mesh-list
2542484|NCT01449344|BB 1101|bb 1101|mesh-list
2542485|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542486|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
2542487|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
2542488|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542489|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542490|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2542491|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
2542492|NCT01449344|Hormones|hormones|mesh-ancestor
2542493|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2542494|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2542495|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542496|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
2542497|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542498|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542499|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2542500|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
2542501|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2542502|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2542503|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
2542504|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
2542505|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542506|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2542507|NCT01449357|Zalutumumab|zalutumumab|mesh-list
2542508|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2542509|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542510|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
2542511|NCT01449435|Miotics|miotics|mesh-ancestor
2542512|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
2542513|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542514|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542515|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2542516|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2542517|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
2542518|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2542519|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2542520|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
2542521|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542522|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542523|NCT01449448|Triamcinolone|triamcinolone|mesh-list
2542524|NCT01449448|Ketorolac|ketorolac|mesh-list
2542525|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542526|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
2542527|NCT01449448|Hormones|hormones|mesh-ancestor
2542528|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2542529|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542530|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542531|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542532|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2542533|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2542534|NCT01449448|Analgesics|analgesics|mesh-ancestor
2542535|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
2542536|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542537|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2542538|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2542539|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
2542540|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2542541|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2542542|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542543|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
2542544|NCT01449552|Coagulants|coagulants|mesh-ancestor
2542545|NCT01449565|Naltrexone|naltrexone|mesh-list
2542546|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2542547|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2410447|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2410448|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2410449|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410450|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
2410451|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410452|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2410453|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
2410454|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
2410455|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
2410456|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410457|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2410458|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410459|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
2542548|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542549|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
2542550|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542551|NCT01449578|Pramipexole|pramipexole|mesh-list
2542552|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
2542553|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542554|NCT01449578|Protective Agents|protective agents|mesh-ancestor
2542555|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542556|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2542557|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2542558|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
2542559|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
2542560|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542561|NCT01449591|Metronidazole|metronidazole|mesh-list
2542562|NCT01449591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542563|NCT01449591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2542564|NCT01449591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2542565|NCT01449591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2542566|NCT01449617|Aspirin|aspirin|mesh-list
2542567|NCT01449617|Clopidogrel|clopidogrel|mesh-list
2542568|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2410460|NCT00763789|Remifentanil|remifentanil|mesh-list
2410461|NCT00763789|Anesthetics|anesthetics|mesh-list
2410462|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410463|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410464|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2410465|NCT00763789|Narcotics|narcotics|mesh-ancestor
2410466|NCT00763789|Analgesics|analgesics|mesh-ancestor
2410467|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
2410468|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410469|NCT00763880|Lidocaine|lidocaine|mesh-list
2410470|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
2542569|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2542570|NCT01449617|Analgesics|analgesics|mesh-ancestor
2542571|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
2542572|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542573|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542574|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410471|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
2410472|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410473|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410474|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
2410475|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410476|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2410477|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2410478|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2410479|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2410480|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410481|NCT00763893|Losartan|losartan|mesh-list
2410482|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2410483|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2410484|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2410485|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2410486|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410487|NCT00763906|Norepinephrine|norepinephrine|mesh-list
2410488|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2410489|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2410490|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
2410491|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410492|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410493|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410494|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
2410495|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
2410496|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410497|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2410498|NCT00763997|Acetaminophen|acetaminophen|mesh-list
2410499|NCT00763997|Dipyrone|dipyrone|mesh-list
2410500|NCT00763997|Ibuprofen|ibuprofen|mesh-list
2410501|NCT00763997|Parecoxib|parecoxib|mesh-list
2542575|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2542576|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2542577|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2542578|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542579|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2542580|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2542581|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542582|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
2542583|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2542584|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2542585|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2542586|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
2542587|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542588|NCT01449799|Fluticasone|fluticasone|mesh-list
2542589|NCT01449799|Xhance|xhance|mesh-list
2542590|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542591|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2542592|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
2542593|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542594|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542595|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2542596|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
2542597|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
2542598|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2542599|NCT01449825|Bevacizumab|bevacizumab|mesh-list
2542600|NCT01449825|Sunitinib|sunitinib|mesh-list
2542601|NCT01449825|Sorafenib|sorafenib|mesh-list
2542602|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2542603|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542604|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2542605|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2542606|NCT01449825|Growth Substances|growth substances|mesh-ancestor
2542607|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542608|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
2410502|NCT00763997|Valdecoxib|valdecoxib|mesh-list
2410503|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2410504|NCT00763997|Analgesics|analgesics|mesh-ancestor
2410505|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
2542609|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2542610|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542611|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542612|NCT01449877|Trimethoprim|trimethoprim|mesh-list
2542613|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2542614|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
2542615|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2542616|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542617|NCT01449877|Renal Agents|renal agents|mesh-ancestor
2542618|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
2542619|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2542620|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2542621|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2542622|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542623|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542624|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2542625|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2542626|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2542627|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2542628|NCT01450046|Vitamin E|vitamin e|mesh-list
2542629|NCT01450046|Tocopherols|tocopherols|mesh-list
2542630|NCT01450046|Tocotrienols|tocotrienols|mesh-list
2542631|NCT01450046|Vitamins|vitamins|mesh-ancestor
2542632|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
2542633|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542634|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
2542635|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542636|NCT01450046|Protective Agents|protective agents|mesh-ancestor
2542637|NCT01450111|Lacosamide|lacosamide|mesh-list
2542638|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
2542639|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2542640|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2542641|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2542642|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542643|NCT01450124|Boswellic acid|boswellic acid|mesh-list
2542644|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2542645|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2542646|NCT01450124|Analgesics|analgesics|mesh-ancestor
2542647|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
2542648|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542649|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542650|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542651|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2542652|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
2542653|NCT01450163|Pregabalin|pregabalin|mesh-list
2542654|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542655|NCT01450163|Analgesics|analgesics|mesh-ancestor
2542656|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
2542657|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542658|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542659|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
2542660|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2542661|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2542662|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542663|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2542664|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2542665|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2542666|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2542667|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2542668|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2542669|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
2542670|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2542671|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2542672|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2410506|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410507|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410508|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
2410509|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2410510|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410511|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2410512|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2410513|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410514|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410515|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2542673|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2542674|NCT01450176|Analgesics|analgesics|mesh-ancestor
2542675|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
2542676|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542677|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542678|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542679|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2542680|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2542681|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2542682|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2542683|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
2542684|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
2542685|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542686|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542687|NCT01450215|Lenalidomide|lenalidomide|mesh-list
2542688|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
2542689|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542690|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2542691|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2542692|NCT01450215|Growth Substances|growth substances|mesh-ancestor
2542693|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
2542694|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542695|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2542696|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542697|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2542698|NCT01450345|Pregabalin|pregabalin|mesh-list
2542699|NCT01450345|Analgesics|analgesics|mesh-ancestor
2542700|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
2542701|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542702|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542703|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
2542704|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2542705|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2542706|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542707|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2542708|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2542709|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2542710|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2542711|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2542712|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2542713|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542714|NCT01450384|Pemetrexed|pemetrexed|mesh-list
2542715|NCT01450384|Sorafenib|sorafenib|mesh-list
2542716|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542717|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542718|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542719|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2542720|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2542721|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2542722|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
2542723|NCT01450410|Niacin|niacin|mesh-list
2542724|NCT01450410|Niacinamide|niacinamide|mesh-list
2542725|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
2542726|NCT01450410|Vitamins|vitamins|mesh-ancestor
2542727|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
2542728|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542729|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2542730|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
2542731|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542732|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2542733|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
2542734|NCT01450462|Vitamin D|vitamin d|mesh-list
2542735|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
2542736|NCT01450462|Vitamins|vitamins|mesh-ancestor
2542737|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
2410516|NCT00764036|Artesunate|artesunate|mesh-list
2410517|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
2410518|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2542738|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542739|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2410519|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2410520|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410521|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410522|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
2410523|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
2410524|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2410525|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
2542740|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2542741|NCT01450514|Pipamperone|pipamperone|mesh-list
2542742|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2542743|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
2542744|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542745|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542746|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542747|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2542748|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2542749|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2542750|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2542751|NCT01450566|Lidocaine|lidocaine|mesh-list
2542752|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
2542753|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
2542754|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410526|NCT00764062|Amoxicillin|amoxicillin|mesh-list
2410527|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2410528|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410529|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2410530|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410531|NCT00764140|Mitogens|mitogens|mesh-list
2410532|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
2410533|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410534|NCT00764166|Docetaxel|docetaxel|mesh-list
2410535|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2410536|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410537|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
2410538|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
2410539|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
2542755|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542756|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
2542757|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542758|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2542759|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2542760|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2542761|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2542762|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542763|NCT01450774|Beclomethasone|beclomethasone|mesh-list
2542764|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
2542765|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2542766|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
2542767|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542768|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542769|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2542770|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
2542771|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2542772|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2542773|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2542774|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
2542775|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542776|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542777|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542778|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
2542779|NCT01450774|Hormones|hormones|mesh-ancestor
2542780|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2542781|NCT01450865|Flupirtine|flupirtine|mesh-list
2542782|NCT01450865|Analgesics|analgesics|mesh-ancestor
2542783|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
2542784|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542785|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542786|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
2542787|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2542788|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2542789|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2542790|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542791|NCT01450956|Sevoflurane|sevoflurane|mesh-list
2542792|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2542793|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2542794|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
2542795|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
2542796|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2542797|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542798|NCT01450995|Sumatriptan|sumatriptan|mesh-list
2542799|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2542800|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2542801|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2542802|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
2542803|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410540|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410541|NCT00764166|Hormones|hormones|mesh-ancestor
2410542|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2410543|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410544|NCT00764244|Triamcinolone|triamcinolone|mesh-list
2410545|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2410546|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2410547|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2410548|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542804|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542805|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542806|NCT01451060|Ephedrine|ephedrine|mesh-list
2542807|NCT01451060|Metaraminol|metaraminol|mesh-list
2542808|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2542809|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542810|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
2542811|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
2542812|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542813|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2410549|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
2410550|NCT00764244|Hormones|hormones|mesh-ancestor
2410551|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2410552|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542814|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
2542815|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542816|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542817|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2542818|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2542819|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2542820|NCT01451086|Vaccines|vaccines|mesh-list
2542821|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
2542822|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542823|NCT01451229|Higenamine|higenamine|mesh-list
2542824|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2542825|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2542826|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
2542827|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542828|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542829|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542830|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2542831|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2542832|NCT01451229|Analgesics|analgesics|mesh-ancestor
2542833|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
2542834|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542835|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542836|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2542837|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2542838|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2542839|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2542840|NCT01451229|Protective Agents|protective agents|mesh-ancestor
2542841|NCT01451268|Panobinostat|panobinostat|mesh-list
2542842|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542843|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2542844|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542845|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542846|NCT01451294|Phenylephrine|phenylephrine|mesh-list
2542847|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
2542848|NCT01451294|Ephedrine|ephedrine|mesh-list
2542849|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2542850|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
2542851|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
2410553|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2410554|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
2410555|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410556|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410557|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
2410558|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
2410559|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410560|NCT00764270|Protective Agents|protective agents|mesh-ancestor
2542852|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542853|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542854|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
2542855|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2542856|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
2542857|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
2542858|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2542859|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2542860|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2542861|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
2410561|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410562|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
2410563|NCT00764270|Vitamins|vitamins|mesh-ancestor
2410564|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
2410565|NCT00764374|Z 338|z 338|mesh-list
2410566|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2410567|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410568|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410569|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
2410570|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410571|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410572|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2410573|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
2410574|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2410575|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2410576|NCT00764413|Prednisolone|prednisolone|mesh-list
2410577|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
2410578|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2410579|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
2410580|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410581|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
2410582|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
2410583|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410584|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410585|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2410586|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
2410587|NCT00764413|Hormones|hormones|mesh-ancestor
2410588|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2542862|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542863|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542864|NCT01451294|Protective Agents|protective agents|mesh-ancestor
2542865|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2542866|NCT01451320|Plasminogen|plasminogen|mesh-list
2542867|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2542868|NCT01451320|Streptokinase|streptokinase|mesh-list
2542869|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2542870|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2542871|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542872|NCT01451333|Efavirenz|efavirenz|mesh-list
2542873|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2542874|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2542875|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542876|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542877|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
2542878|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542879|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2542880|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2542881|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2542882|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2542883|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2542884|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2542885|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
2542886|NCT01451489|Tacrolimus|tacrolimus|mesh-list
2542887|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2542888|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
2542889|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542890|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2542891|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2542892|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
2542893|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542894|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542895|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2542896|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2410589|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2542897|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542898|NCT01451515|Cytarabine|cytarabine|mesh-list
2542899|NCT01451515|Dexamethasone|dexamethasone|mesh-list
2542900|NCT01451515|Prednisone|prednisone|mesh-list
2542901|NCT01451515|Prednisolone|prednisolone|mesh-list
2542902|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
2542903|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
2542904|NCT01451515|Doxorubicin|doxorubicin|mesh-list
2542905|NCT01451515|Methotrexate|methotrexate|mesh-list
2542906|NCT01451515|Etoposide|etoposide|mesh-list
2542907|NCT01451515|Vincristine|vincristine|mesh-list
2542908|NCT01451515|Daunorubicin|daunorubicin|mesh-list
2542909|NCT01451515|Asparaginase|asparaginase|mesh-list
2542910|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
2542911|NCT01451515|Clofarabine|clofarabine|mesh-list
2542912|NCT01451515|Thioguanine|thioguanine|mesh-list
2542913|NCT01451515|Pegaspargase|pegaspargase|mesh-list
2542914|NCT01451515|Antimetabolites|antimetabolites|mesh-list
2542915|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2542916|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
2542917|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542918|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2542919|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2542920|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
2542921|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542922|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542923|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2542924|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542925|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
2542926|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
2542927|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2542928|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2542929|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
2542930|NCT01451515|Hormones|hormones|mesh-ancestor
2410590|NCT00764413|Protective Agents|protective agents|mesh-ancestor
2410591|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2410592|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410593|NCT00764426|Ethanol|ethanol|mesh-list
2410594|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2410595|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410596|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410597|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410598|NCT00764439|Nicotine|nicotine|mesh-list
2410599|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2410600|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
2410601|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410602|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410603|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2410604|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2410605|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
2410606|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410607|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410608|NCT00764556|Insulin|insulin|mesh-list
2410609|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2410610|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410611|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
2410612|NCT00764582|Levofloxacin|levofloxacin|mesh-list
2410613|NCT00764582|Ofloxacin|ofloxacin|mesh-list
2410614|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2410615|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2410616|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2410617|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410618|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2410619|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2410620|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410621|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410622|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410623|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2410624|NCT00764582|Renal Agents|renal agents|mesh-ancestor
2410625|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2542931|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2542932|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2542933|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2542934|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2542935|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2542936|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2542937|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2542938|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
2542939|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2542940|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2542941|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
2542942|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2542943|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2542944|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2542945|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
2542946|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2542947|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
2542948|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
2542949|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
2542950|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2410626|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2410627|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
2410628|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410629|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2542951|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2542952|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542953|NCT01451593|Phenytoin|phenytoin|mesh-list
2542954|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
2542955|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2542956|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2542957|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2542958|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542959|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2542960|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2542961|NCT01451658|Propranolol|propranolol|mesh-list
2542962|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2542963|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2542964|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
2542965|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542966|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542967|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542968|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2542969|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2542970|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
2542971|NCT01451710|Prednisone|prednisone|mesh-list
2542972|NCT01451710|Prednisolone|prednisolone|mesh-list
2542973|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2542974|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
2542975|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2542976|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
2542977|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2542978|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
2542979|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2542980|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
2542981|NCT01451710|Hormones|hormones|mesh-ancestor
2542982|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2542983|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410630|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410631|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410632|NCT00764634|Vaccines|vaccines|mesh-list
2410633|NCT00764634|Immunologic Factors|immunologic factors|mesh-ancestor
2410634|NCT00764634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542984|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2542985|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542986|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
2542987|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
2542988|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410635|NCT00764712|Insulin|insulin|mesh-list
2410636|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2410637|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410638|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
2410639|NCT00764725|Methotrexate|methotrexate|mesh-list
2410640|NCT00764725|Infliximab|infliximab|mesh-list
2410641|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2410642|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
2410643|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2410644|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410645|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2410646|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
2410647|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410648|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2542989|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2542990|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2542991|NCT01451710|Protective Agents|protective agents|mesh-ancestor
2542992|NCT01451736|Risperidone|risperidone|mesh-list
2542993|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2542994|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2542995|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
2542996|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2542997|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2542998|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2542999|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2543000|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2543001|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2543002|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2543003|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2543004|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
2543005|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2543006|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2543007|NCT01451788|Thrombin|thrombin|mesh-list
2543008|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
2543009|NCT01451788|Coagulants|coagulants|mesh-ancestor
2543010|NCT01451840|Lidocaine|lidocaine|mesh-list
2543011|NCT01451840|Remifentanil|remifentanil|mesh-list
2543012|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
2543013|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
2543014|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2543015|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543016|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
2543017|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543018|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2543019|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2543020|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2543021|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2543022|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543023|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2543024|NCT01451840|Narcotics|narcotics|mesh-ancestor
2543025|NCT01451840|Analgesics|analgesics|mesh-ancestor
2410649|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
2410650|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410651|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2410652|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2410653|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
2410654|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2410655|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2410656|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2410657|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410658|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2410659|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2410660|NCT00764725|Analgesics|analgesics|mesh-ancestor
2410661|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
2410662|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410663|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410664|NCT00764816|Caseins|caseins|mesh-list
2410665|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
2410666|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
2543026|NCT01451853|Ebselen|ebselen|mesh-list
2543027|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2543028|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2543029|NCT01451853|Analgesics|analgesics|mesh-ancestor
2543030|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
2543031|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543032|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543033|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2543034|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2410667|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410668|NCT00764855|Propofol|propofol|mesh-list
2410669|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2410670|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2543035|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2543036|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2543037|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
2543038|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543039|NCT01451853|Protective Agents|protective agents|mesh-ancestor
2543040|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2543041|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410671|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543042|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2543043|NCT01451879|Miglustat|miglustat|mesh-list
2543044|NCT01451879|Rituximab|rituximab|mesh-list
2543045|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2410672|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2410673|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
2410674|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
2410675|NCT00764907|Leucovorin|leucovorin|mesh-list
2410676|NCT00764907|Cytarabine|cytarabine|mesh-list
2410677|NCT00764907|Dexamethasone|dexamethasone|mesh-list
2410678|NCT00764907|Prednisone|prednisone|mesh-list
2410679|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
2410680|NCT00764907|Ifosfamide|ifosfamide|mesh-list
2410681|NCT00764907|Doxorubicin|doxorubicin|mesh-list
2410682|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2410683|NCT00764907|Methotrexate|methotrexate|mesh-list
2410684|NCT00764907|Etoposide|etoposide|mesh-list
2410685|NCT00764907|Vincristine|vincristine|mesh-list
2410686|NCT00764907|Daunorubicin|daunorubicin|mesh-list
2410687|NCT00764907|Asparaginase|asparaginase|mesh-list
2410688|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
2543046|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543047|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
2543048|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543049|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2543050|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543051|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543052|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2543053|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2543054|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
2543055|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543056|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2543057|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543058|NCT01451905|Liraglutide|liraglutide|mesh-list
2543059|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543060|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543061|NCT01451905|Incretins|incretins|mesh-ancestor
2543062|NCT01451905|Hormones|hormones|mesh-ancestor
2543063|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543064|NCT01451918|Resveratrol|resveratrol|mesh-list
2543065|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
2543066|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543067|NCT01451918|Protective Agents|protective agents|mesh-ancestor
2543068|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543069|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543070|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2543071|NCT01452009|Travoprost|travoprost|mesh-list
2543072|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2543073|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2543074|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2543075|NCT01452100|Prednisone|prednisone|mesh-list
2543076|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2543077|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
2543078|NCT01452100|Hormones|hormones|mesh-ancestor
2543079|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543080|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543081|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2543082|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543083|NCT01452113|Vildagliptin|vildagliptin|mesh-list
2543084|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543085|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543086|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2543087|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
2543088|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543089|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543090|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2543091|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2543092|NCT01452217|Secretin|secretin|mesh-list
2543093|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2543094|NCT01452217|Hormones|hormones|mesh-ancestor
2543095|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543096|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543097|NCT01452243|Vitamin D|vitamin d|mesh-list
2543098|NCT01452243|Calcium|calcium|mesh-list
2410689|NCT00764907|Thioguanine|thioguanine|mesh-list
2410690|NCT00764907|Vindesine|vindesine|mesh-list
2410691|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
2410692|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2410693|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
2543099|NCT01452243|Vitamins|vitamins|mesh-ancestor
2543100|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
2543101|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543102|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2543103|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2543104|NCT01452256|Propofol|propofol|mesh-list
2543105|NCT01452256|Desflurane|desflurane|mesh-list
2543106|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2543107|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2543108|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543109|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2543110|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
2543111|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
2543112|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2543113|NCT01452334|BMS-936559|bms-936559|mesh-list
2543114|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2543115|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543116|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2543117|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2543118|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
2543119|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410694|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410695|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2410696|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2410697|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
2410698|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543120|NCT01452451|Exenatide|exenatide|mesh-list
2543121|NCT01452451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543122|NCT01452451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543123|NCT01452451|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2543124|NCT01452451|Incretins|incretins|mesh-ancestor
2543125|NCT01452451|Hormones|hormones|mesh-ancestor
2543126|NCT01452451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2410699|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410700|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2410701|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410702|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
2410703|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
2410704|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410705|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2410706|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
2410707|NCT00764907|Hormones|hormones|mesh-ancestor
2410708|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2410709|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2543127|NCT01452477|Tanshinone|tanshinone|mesh-list
2543128|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543129|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2543130|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2543131|NCT01452477|Analgesics|analgesics|mesh-ancestor
2543132|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
2543133|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543134|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543135|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2543136|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2543137|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
2543138|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2543139|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543140|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2543141|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
2543142|NCT01452542|Eliglustat|eliglustat|mesh-list
2543143|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543144|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543145|NCT01452568|Aspirin|aspirin|mesh-list
2543146|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
2543147|NCT01452568|Salicylates|salicylates|mesh-list
2543148|NCT01452568|Warfarin|warfarin|mesh-list
2543149|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2543150|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2543151|NCT01452568|Analgesics|analgesics|mesh-ancestor
2543152|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
2543153|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543154|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543155|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2543156|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2543157|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2410710|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2410711|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2410712|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2410713|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410714|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2410715|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
2410716|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2410717|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2410718|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
2543158|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2543159|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543160|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2543161|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2543162|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543163|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
2543164|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
2543165|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543166|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
2543167|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
2543168|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
2543169|NCT01452607|Ebselen|ebselen|mesh-list
2410719|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
2410720|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2410721|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2410722|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2410723|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
2410724|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410725|NCT00764907|Antidotes|antidotes|mesh-ancestor
2410726|NCT00764907|Protective Agents|protective agents|mesh-ancestor
2410727|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
2410728|NCT00764907|Vitamins|vitamins|mesh-ancestor
2410729|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
2410730|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
2543170|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2543171|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2543172|NCT01452607|Analgesics|analgesics|mesh-ancestor
2543173|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
2543174|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543175|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543176|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2543177|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2543178|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2543179|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2543180|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
2543181|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543182|NCT01452607|Protective Agents|protective agents|mesh-ancestor
2543183|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2543184|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543185|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2543186|NCT01452633|Bupivacaine|bupivacaine|mesh-list
2543187|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
2543188|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
2543189|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2543190|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543191|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
2543192|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543193|NCT01452659|Relugolix|relugolix|mesh-list
2543194|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
2543195|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
2543196|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543197|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543198|NCT01452685|Leuprolide|leuprolide|mesh-list
2543199|NCT01452685|Relugolix|relugolix|mesh-list
2543200|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2543201|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
2543202|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2543203|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543204|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2543205|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410731|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
2410732|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
2410733|NCT00764972|Sorafenib|sorafenib|mesh-list
2410734|NCT00764972|Vinorelbine|vinorelbine|mesh-list
2410735|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410736|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2410737|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410738|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543206|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
2543207|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
2543208|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543209|NCT01452698|Lansoprazole|lansoprazole|mesh-list
2543210|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
2543211|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2543212|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2543213|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2543214|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543215|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543216|NCT01452711|Lansoprazole|lansoprazole|mesh-list
2543217|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
2543218|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2543219|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2543220|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2543221|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543222|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543223|NCT01452724|Lansoprazole|lansoprazole|mesh-list
2543224|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
2543225|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2543226|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2410739|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2410740|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
2410741|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
2410742|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
2410743|NCT00765011|Cetuximab|cetuximab|mesh-list
2410744|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2410745|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410746|NCT00765024|Ivermectin|ivermectin|mesh-list
2410747|NCT00765024|Albendazole|albendazole|mesh-list
2410748|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2410749|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410750|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
2410751|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
2410752|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2410753|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2410754|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
2410755|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
2410756|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
2410757|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410758|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410759|NCT00765154|Ritonavir|ritonavir|mesh-list
2410760|NCT00765154|Darunavir|darunavir|mesh-list
2410761|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2410762|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2410763|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
2410764|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410765|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410766|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2410767|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2410768|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
2410769|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543227|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2543228|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543229|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543230|NCT01452737|Bisacodyl|bisacodyl|mesh-list
2543231|NCT01452737|Cathartics|cathartics|mesh-ancestor
2543232|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2543233|NCT01452737|Laxatives|laxatives|mesh-ancestor
2543234|NCT01452750|Lansoprazole|lansoprazole|mesh-list
2543235|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
2543236|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2543237|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2543238|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2543239|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543240|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543241|NCT01452763|Lansoprazole|lansoprazole|mesh-list
2543242|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
2543243|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2543244|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2543245|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2543246|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543247|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543248|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
2410770|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2543249|NCT01452828|Tedizolid|tedizolid|mesh-list
2543250|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
2543251|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2543252|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543253|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2543254|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410771|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2410772|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
2410773|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2410774|NCT00765167|Triclosan|triclosan|mesh-list
2410775|NCT00765167|Fluorides|fluorides|mesh-list
2410776|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
2410777|NCT00765167|Protective Agents|protective agents|mesh-ancestor
2410778|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410779|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2410780|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410781|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
2410782|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
2410783|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2410784|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2410785|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
2543255|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543256|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
2543257|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2410786|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410787|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2410788|NCT00765271|Ritonavir|ritonavir|mesh-list
2410789|NCT00765271|Darunavir|darunavir|mesh-list
2410790|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
2410791|NCT00765271|Abacavir|abacavir|mesh-list
2410792|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2410793|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2543258|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543259|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
2543260|NCT01452880|Remifentanil|remifentanil|mesh-list
2543261|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2543262|NCT01452880|Narcotics|narcotics|mesh-ancestor
2543263|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410794|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
2410795|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410796|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410797|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2410798|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2410799|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
2410800|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410801|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2410802|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2410803|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2410804|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2410805|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2410806|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2410807|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
2410808|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
2410809|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410810|NCT00765310|Protective Agents|protective agents|mesh-ancestor
2410811|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410812|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
2543264|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543265|NCT01452880|Analgesics|analgesics|mesh-ancestor
2543266|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
2543267|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543268|NCT01452906|Omeprazole|omeprazole|mesh-list
2543269|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2543270|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2543271|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2543272|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543273|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543274|NCT01453062|Ofatumumab|ofatumumab|mesh-list
2543275|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543276|NCT01453088|Bortezomib|bortezomib|mesh-list
2543277|NCT01453088|Melphalan|melphalan|mesh-list
2543278|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543279|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2543280|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
2410813|NCT00765310|Vitamins|vitamins|mesh-ancestor
2410814|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
2410815|NCT00765323|Octreotide|octreotide|mesh-list
2410816|NCT00765323|Somatostatin|somatostatin|mesh-list
2543281|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410817|NCT00765323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2410818|NCT00765323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2410819|NCT00765323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410820|NCT00765323|Hormones|hormones|mesh-ancestor
2410821|NCT00765323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2410822|NCT00765323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410823|NCT00765427|Retinol acetate|retinol acetate|mesh-list
2410824|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2410825|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
2410826|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410827|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2410828|NCT00765427|Protective Agents|protective agents|mesh-ancestor
2410829|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543282|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2543283|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2543284|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
2543285|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543286|NCT01453101|Fludarabine|fludarabine|mesh-list
2543287|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
2543288|NCT01453101|Bortezomib|bortezomib|mesh-list
2543289|NCT01453101|Melphalan|melphalan|mesh-list
2543290|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543291|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2543292|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
2543293|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543294|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2543295|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
2543296|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543297|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2543298|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
2543299|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2543300|NCT01453140|Sirolimus|sirolimus|mesh-list
2543301|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
2543302|NCT01453140|Interleukin-2|interleukin-2|mesh-list
2543303|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2543304|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
2543305|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543306|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2543307|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2543308|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
2543309|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543310|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543311|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2543312|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2543313|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543314|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2543315|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
2543316|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2410830|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2410831|NCT00765557|Laxatives|laxatives|mesh-ancestor
2410832|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2410833|NCT00765700|Ketoprofen|ketoprofen|mesh-list
2410834|NCT00765700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2410835|NCT00765700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2410836|NCT00765700|Analgesics|analgesics|mesh-ancestor
2410837|NCT00765700|Sensory System Agents|sensory system agents|mesh-ancestor
2410838|NCT00765700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410839|NCT00765700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543317|NCT01453140|Analgesics|analgesics|mesh-ancestor
2543318|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
2543319|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543320|NCT01453179|Diclofenac|diclofenac|mesh-list
2543321|NCT01453179|Imiquimod|imiquimod|mesh-list
2410840|NCT00765700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410841|NCT00765700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2410842|NCT00765700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2410843|NCT00765700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410844|NCT00765700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410845|NCT00765804|Dexamethasone|dexamethasone|mesh-list
2410846|NCT00765804|Citric Acid|citric acid|mesh-list
2410847|NCT00765804|Sodium Citrate|sodium citrate|mesh-list
2410848|NCT00765804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2410849|NCT00765804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2410850|NCT00765804|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2410851|NCT00765804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2410852|NCT00765804|Antiemetics|antiemetics|mesh-ancestor
2543322|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2543323|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2543324|NCT01453179|Analgesics|analgesics|mesh-ancestor
2543325|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
2543326|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543327|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543328|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2543329|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2543330|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2543331|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543332|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543333|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2543334|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
2543335|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543336|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
2543337|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
2543338|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2543339|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2410853|NCT00765804|Autonomic Agents|autonomic agents|mesh-ancestor
2410854|NCT00765804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410855|NCT00765804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543340|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
2543341|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543342|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2543343|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2543344|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543345|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543346|NCT01453283|Trabectedin|trabectedin|mesh-list
2543347|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2543348|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
2543349|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543350|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543351|NCT01453400|Aspirin|aspirin|mesh-list
2543352|NCT01453400|Acetaminophen|acetaminophen|mesh-list
2543353|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2543354|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2543355|NCT01453400|Analgesics|analgesics|mesh-ancestor
2543356|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
2543357|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543358|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543359|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2543360|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2543361|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2543362|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2543363|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543364|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2543365|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2543366|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543367|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
2543368|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2543369|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
2543370|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2543371|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
2543372|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410856|NCT00765804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2410857|NCT00765804|Glucocorticoids|glucocorticoids|mesh-ancestor
2410858|NCT00765804|Hormones|hormones|mesh-ancestor
2410859|NCT00765804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2410860|NCT00765804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2410861|NCT00765804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410862|NCT00765804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543373|NCT01453504|Everolimus|everolimus|mesh-list
2543374|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543375|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2410863|NCT00765804|Anticoagulants|anticoagulants|mesh-ancestor
2410864|NCT00765804|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2410865|NCT00765804|Chelating Agents|chelating agents|mesh-ancestor
2410866|NCT00765804|Sequestering Agents|sequestering agents|mesh-ancestor
2410867|NCT00765830|Vildagliptin|vildagliptin|mesh-list
2410868|NCT00765830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543376|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
2543377|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543378|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
2543379|NCT01453530|Neostigmine|neostigmine|mesh-list
2543380|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2543381|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543382|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543383|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
2543384|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2543385|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543386|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2543387|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
2543388|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543389|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2543390|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2410869|NCT00765830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410870|NCT00765830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2543391|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2543392|NCT01453582|Propolis|propolis|mesh-list
2543393|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543394|NCT01453660|Cisplatin|cisplatin|mesh-list
2543395|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543396|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
2543397|NCT01453686|Clobetasol|clobetasol|mesh-list
2543398|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2543399|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
2543400|NCT01453686|Hormones|hormones|mesh-ancestor
2543401|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2410871|NCT00765830|Protease Inhibitors|protease inhibitors|mesh-ancestor
2410872|NCT00765830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410873|NCT00765830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410874|NCT00765921|Ranibizumab|ranibizumab|mesh-list
2410875|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2410876|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2410877|NCT00765921|Growth Substances|growth substances|mesh-ancestor
2410878|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410879|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
2410880|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410881|NCT00765934|Lidocaine|lidocaine|mesh-list
2410882|NCT00765934|Tetracaine|tetracaine|mesh-list
2410883|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
2410884|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
2410885|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410886|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410887|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
2410888|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410889|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2410890|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2410891|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2410892|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2410893|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410894|NCT00765973|Topotecan|topotecan|mesh-list
2410895|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2410896|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2410897|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410898|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543402|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543403|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
2543404|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2543405|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2543406|NCT01453881|Beclomethasone|beclomethasone|mesh-list
2543407|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
2543408|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2543409|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
2410899|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410900|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2410901|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
2410902|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2410903|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410904|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2410905|NCT00766025|Calcium|calcium|mesh-list
2410906|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2410907|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410908|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2543410|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543411|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543412|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2543413|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
2543414|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2543415|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2543416|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2543417|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
2543418|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2543419|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543420|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2543421|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
2543422|NCT01453881|Hormones|hormones|mesh-ancestor
2543423|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543424|NCT01453920|Ranibizumab|ranibizumab|mesh-list
2543425|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2543426|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2543427|NCT01453920|Growth Substances|growth substances|mesh-ancestor
2543428|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543429|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
2543430|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543431|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
2543432|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2543433|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2543434|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
2543435|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543436|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2543437|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2543438|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543439|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543440|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
2543441|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2543442|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
2543443|NCT01454011|Testosterone|testosterone|mesh-list
2543444|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
2543445|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
2543446|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2543447|NCT01454011|Androgens|androgens|mesh-ancestor
2543448|NCT01454011|Hormones|hormones|mesh-ancestor
2543449|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543450|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543451|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2543452|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543453|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
2543454|NCT01454089|Gemcitabine|gemcitabine|mesh-list
2543455|NCT01454089|Carboplatin|carboplatin|mesh-list
2543456|NCT01454089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543457|NCT01454089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2543458|NCT01454089|Antimetabolites|antimetabolites|mesh-ancestor
2543459|NCT01454089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543460|NCT01454089|Antiviral Agents|antiviral agents|mesh-ancestor
2543461|NCT01454089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543462|NCT01454089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543463|NCT01454089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2543464|NCT01454089|Immunologic Factors|immunologic factors|mesh-ancestor
2543465|NCT01454089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543466|NCT01454154|Glyburide|glyburide|mesh-list
2543467|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543468|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543469|NCT01454180|Leucovorin|leucovorin|mesh-list
2543470|NCT01454180|Gemcitabine|gemcitabine|mesh-list
2543471|NCT01454180|Capecitabine|capecitabine|mesh-list
2543472|NCT01454180|Fluorouracil|fluorouracil|mesh-list
2543473|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2543474|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
2543475|NCT01454180|Folfirinox|folfirinox|mesh-list
2410909|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2410910|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
2410911|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410912|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2410913|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2410914|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410915|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2410916|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2410917|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2410918|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410919|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410920|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2410921|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2410922|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2410923|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
2410924|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2410925|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410926|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2410927|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2410928|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
2410929|NCT00766155|Capecitabine|capecitabine|mesh-list
2410930|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
2410931|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2410932|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
2410933|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410934|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410935|NCT00766181|Lidocaine|lidocaine|mesh-list
2410936|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
2410937|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
2410938|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410939|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410940|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
2410941|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2410942|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2410943|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2410944|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2410945|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2410946|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543476|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2543477|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
2543478|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543479|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543480|NCT01454180|Antiviral Agents|antiviral agents|mesh-ancestor
2543481|NCT01454180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543482|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543483|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2543484|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
2543485|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543486|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2543487|NCT01454180|Antidotes|antidotes|mesh-ancestor
2543488|NCT01454180|Protective Agents|protective agents|mesh-ancestor
2543489|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
2543490|NCT01454180|Vitamins|vitamins|mesh-ancestor
2543491|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
2543492|NCT01454440|Eptifibatide|eptifibatide|mesh-list
2543493|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2543494|NCT01454479|Lapatinib|lapatinib|mesh-list
2543495|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543496|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2543497|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543498|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543499|NCT01454518|Anesthetics|anesthetics|mesh-list
2543500|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
2543501|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2543502|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543503|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
2543504|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543505|NCT01454609|Clonidine|clonidine|mesh-list
2543506|NCT01454609|Bupivacaine|bupivacaine|mesh-list
2543507|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
2543508|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
2543509|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2410947|NCT00766220|Irinotecan|irinotecan|mesh-list
2410948|NCT00766220|Cetuximab|cetuximab|mesh-list
2410949|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2410950|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2410951|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2410952|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410953|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410954|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2410955|NCT00766246|Bevacizumab|bevacizumab|mesh-list
2410956|NCT00766246|Carboplatin|carboplatin|mesh-list
2410957|NCT00766246|Docetaxel|docetaxel|mesh-list
2410958|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2410959|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410960|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2410961|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2410962|NCT00766246|Growth Substances|growth substances|mesh-ancestor
2410963|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543510|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543511|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
2543512|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543513|NCT01454609|Analgesics|analgesics|mesh-ancestor
2543514|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2543515|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
2543516|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
2543517|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2543518|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2543519|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2543520|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
2543521|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2543522|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543523|NCT01454622|Metformin|metformin|mesh-list
2543524|NCT01454622|Canagliflozin|canagliflozin|mesh-list
2543525|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543526|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543527|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2543528|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543529|NCT01454635|Sertraline|sertraline|mesh-list
2543530|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
2543531|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2543532|NCT01454635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2410964|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
2410965|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
2410966|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
2410967|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
2410968|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2410969|NCT00766285|Vaccines|vaccines|mesh-list
2410970|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
2410971|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410972|NCT00766337|Sirolimus|sirolimus|mesh-list
2410973|NCT00766337|Ranibizumab|ranibizumab|mesh-list
2410974|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2410975|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2410976|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2410977|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2410978|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
2410979|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2410980|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
2410981|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410982|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2410983|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2410984|NCT00766337|Growth Substances|growth substances|mesh-ancestor
2410985|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
2410986|NCT00766350|Amitriptyline|amitriptyline|mesh-list
2410987|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2410988|NCT00766350|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2410989|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
2410990|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2410991|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2410992|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2410993|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2543533|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2543534|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2543535|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543536|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2543537|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
2543538|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543539|NCT01454700|Insulin|insulin|mesh-list
2543540|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2543541|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543542|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543543|NCT01454804|Trastuzumab|trastuzumab|mesh-list
2543544|NCT01454804|Lapatinib|lapatinib|mesh-list
2543545|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2543546|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543547|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2543548|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543549|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543550|NCT01454869|Heparin|heparin|mesh-list
2543551|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
2543552|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2543553|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2543554|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543555|NCT01455025|Plerixafor|plerixafor|mesh-list
2410994|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2410995|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2543556|NCT01455025|Sargramostim|sargramostim|mesh-list
2543557|NCT01455025|Lenograstim|lenograstim|mesh-list
2543558|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
2410996|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2410997|NCT00766350|Analgesics|analgesics|mesh-ancestor
2410998|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
2410999|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411000|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2411001|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2411002|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2411003|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411004|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
2411005|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411006|NCT00766402|Acetaminophen|acetaminophen|mesh-list
2411007|NCT00766402|Diclofenac|diclofenac|mesh-list
2543559|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543560|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2543561|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2543562|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2543563|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
2543564|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543565|NCT01455051|Ofatumumab|ofatumumab|mesh-list
2543566|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543567|NCT01455090|Ribavirin|ribavirin|mesh-list
2543568|NCT01455090|Asunaprevir|asunaprevir|mesh-list
2411008|NCT00766402|Tramadol|tramadol|mesh-list
2411009|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2411010|NCT00766402|Analgesics|analgesics|mesh-ancestor
2411011|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
2411012|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411013|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411014|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
2411015|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2411016|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2411017|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2411018|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2411019|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411020|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411021|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2411022|NCT00766402|Narcotics|narcotics|mesh-ancestor
2411023|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2411024|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2411025|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411026|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411027|NCT00766441|Incretins|incretins|mesh-ancestor
2411028|NCT00766441|Hormones|hormones|mesh-ancestor
2411029|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2411030|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2543569|NCT01455090|Antimetabolites|antimetabolites|mesh-ancestor
2543570|NCT01455090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543571|NCT01455090|Antiviral Agents|antiviral agents|mesh-ancestor
2543572|NCT01455090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543573|NCT01455090|Protease Inhibitors|protease inhibitors|mesh-ancestor
2543574|NCT01455090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543575|NCT01455103|BMS-936559|bms-936559|mesh-list
2543576|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2543577|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2543578|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543579|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
2543580|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543581|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
2543582|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2543583|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
2543584|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543585|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543586|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2543587|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
2543588|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
2543589|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2543590|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
2543591|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2543592|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543593|NCT01455142|Insulin|insulin|mesh-list
2543594|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
2411031|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
2543595|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543596|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543597|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
2543598|NCT01455233|Besifloxacin|besifloxacin|mesh-list
2543599|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2543600|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2543601|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2543602|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2543603|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543604|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2543605|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2543606|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543607|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543608|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543609|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2543610|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
2543611|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2543612|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543613|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2543614|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2411032|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411033|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411034|NCT00766480|Fluorouracil|fluorouracil|mesh-list
2411035|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411036|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
2411037|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411038|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2411039|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2411040|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
2411041|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411042|NCT00766545|Cilostazol|cilostazol|mesh-list
2411043|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2411044|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
2411045|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411046|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411047|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2411048|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
2411049|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2411050|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2411051|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411052|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2411053|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
2411054|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2411055|NCT00766545|Protective Agents|protective agents|mesh-ancestor
2543615|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2543616|NCT01455246|Meropenem|meropenem|mesh-list
2543617|NCT01455246|Daptomycin|daptomycin|mesh-list
2543618|NCT01455246|Ceftazidime|ceftazidime|mesh-list
2543619|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2543620|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543621|NCT01455337|Prednisolone|prednisolone|mesh-list
2543622|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
2543623|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2543624|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
2543625|NCT01455337|Hormones|hormones|mesh-ancestor
2543626|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543627|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543628|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2543629|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543630|NCT01455337|Protective Agents|protective agents|mesh-ancestor
2543631|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2543632|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543633|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543634|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2543635|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2543636|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
2543637|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2543638|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
2543639|NCT01455350|Lidocaine|lidocaine|mesh-list
2543640|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
2543641|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
2543642|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2543643|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411056|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2543644|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
2543645|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543646|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2543647|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2543648|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2543649|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2543650|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543651|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
2543652|NCT01455389|Promethazine|promethazine|mesh-list
2543653|NCT01455389|Dexamethasone|dexamethasone|mesh-list
2543654|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2543655|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2543656|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
2543657|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
2543658|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543659|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543660|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2543661|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
2543662|NCT01455389|Hormones|hormones|mesh-ancestor
2543663|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543664|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2543665|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543666|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2543667|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543668|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543669|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2543670|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2543671|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2543672|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
2543673|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
2543674|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
2543675|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2543676|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
2543677|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
2411057|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2411058|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411059|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
2411060|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
2411061|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2411062|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
2411063|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2411064|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2411065|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411066|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2411067|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411068|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411069|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2411070|NCT00766662|Renal Agents|renal agents|mesh-ancestor
2411071|NCT00766805|Propranolol|propranolol|mesh-list
2411072|NCT00766805|Isosorbide|isosorbide|mesh-list
2411073|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2411074|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2411075|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2411076|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2411077|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
2411078|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411079|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411080|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411081|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2411082|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2543678|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2543679|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2543680|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
2543681|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
2543682|NCT01455441|Liraglutide|liraglutide|mesh-list
2543683|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543684|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543685|NCT01455441|Incretins|incretins|mesh-ancestor
2543686|NCT01455441|Hormones|hormones|mesh-ancestor
2543687|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543688|NCT01455506|Fludarabine|fludarabine|mesh-list
2543689|NCT01455506|Busulfan|busulfan|mesh-list
2543690|NCT01455506|Decitabine|decitabine|mesh-list
2543691|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411083|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
2411084|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2411085|NCT00766805|Diuretics|diuretics|mesh-ancestor
2411086|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
2411087|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2411088|NCT00766818|Lopinavir|lopinavir|mesh-list
2411089|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2411090|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2411091|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
2411092|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411093|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543692|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2543693|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
2543694|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543695|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2411094|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2411095|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2411096|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
2411097|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411098|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2411099|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2411100|NCT00766857|Insulin|insulin|mesh-list
2411101|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2411102|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
2411103|NCT00766857|Exenatide|exenatide|mesh-list
2411104|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411105|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411106|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2411107|NCT00766857|Incretins|incretins|mesh-ancestor
2411108|NCT00766857|Hormones|hormones|mesh-ancestor
2411109|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2411110|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2411111|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2411112|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2411113|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2411114|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411115|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411116|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411117|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2411118|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
2411119|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2411120|NCT00766896|Aspirin|aspirin|mesh-list
2543696|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
2543697|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543698|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
2543699|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2543700|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2543701|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543702|NCT01455532|Gemcitabine|gemcitabine|mesh-list
2543703|NCT01455532|Carboplatin|carboplatin|mesh-list
2543704|NCT01455532|Doxorubicin|doxorubicin|mesh-list
2543705|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2543706|NCT01455532|Iniparib|iniparib|mesh-list
2543707|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543708|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2543709|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
2543710|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543711|NCT01455532|Antiviral Agents|antiviral agents|mesh-ancestor
2543712|NCT01455532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543713|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543714|NCT01455532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2543715|NCT01455532|Immunologic Factors|immunologic factors|mesh-ancestor
2543716|NCT01455532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543717|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2543718|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2543719|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2411121|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2411122|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2411123|NCT00766896|Analgesics|analgesics|mesh-ancestor
2411124|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
2411125|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411126|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411127|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2411128|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2411129|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2411130|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2411131|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411132|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2411133|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2411134|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411135|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
2411136|NCT00766909|Cyclosporine|cyclosporine|mesh-list
2411137|NCT00766909|Tacrolimus|tacrolimus|mesh-list
2411138|NCT00766909|Cyclosporins|cyclosporins|mesh-list
2411139|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2543720|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2543721|NCT01455597|Estradiol|estradiol|mesh-list
2543722|NCT01455597|Estrogens|estrogens|mesh-ancestor
2543723|NCT01455597|Hormones|hormones|mesh-ancestor
2543724|NCT01455597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543725|NCT01455597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543726|NCT01455636|Micronutrients|micronutrients|mesh-list
2543727|NCT01455636|Trace Elements|trace elements|mesh-list
2543728|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
2543729|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543730|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2543731|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543732|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
2543733|NCT01455649|Cyclosporine|cyclosporine|mesh-list
2543734|NCT01455649|Everolimus|everolimus|mesh-list
2543735|NCT01455649|Tacrolimus|tacrolimus|mesh-list
2543736|NCT01455649|Cyclosporins|cyclosporins|mesh-list
2543737|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2543738|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2543739|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
2543740|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543741|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411140|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
2411141|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411142|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2411143|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543742|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543743|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
2543744|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543745|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
2543746|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2543747|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543748|NCT01455831|Tinzaparin|tinzaparin|mesh-list
2543749|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2543750|NCT01455831|Dalteparin|dalteparin|mesh-list
2543751|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
2543752|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2543753|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2543754|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411144|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411145|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
2411146|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411147|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
2411148|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2411149|NCT00767091|Rivastigmine|rivastigmine|mesh-list
2411150|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
2411151|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411152|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411153|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
2411154|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411155|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411156|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2411157|NCT00767091|Protective Agents|protective agents|mesh-ancestor
2411158|NCT00767117|Ritonavir|ritonavir|mesh-list
2411159|NCT00767117|Lopinavir|lopinavir|mesh-list
2411160|NCT00767117|Etravirine|etravirine|mesh-list
2411161|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2411162|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2411163|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
2411164|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411165|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411166|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2411167|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2411168|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
2411169|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543755|NCT01455857|Exenatide|exenatide|mesh-list
2411170|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2543756|NCT01455857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543757|NCT01455857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543758|NCT01455857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2543759|NCT01455857|Incretins|incretins|mesh-ancestor
2543760|NCT01455857|Hormones|hormones|mesh-ancestor
2543761|NCT01455857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543762|NCT01455870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2543763|NCT01455870|Exenatide|exenatide|mesh-list
2543764|NCT01455870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543765|NCT01455870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543766|NCT01455870|Incretins|incretins|mesh-ancestor
2543767|NCT01455870|Hormones|hormones|mesh-ancestor
2543768|NCT01455870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543769|NCT01455870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2543770|NCT01455870|Protease Inhibitors|protease inhibitors|mesh-ancestor
2543771|NCT01455870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543772|NCT01455870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543773|NCT01455870|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2543774|NCT01455883|Glimepiride|glimepiride|mesh-list
2543775|NCT01455883|Exenatide|exenatide|mesh-list
2543776|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2543777|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543778|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543779|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2543780|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
2543781|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2543782|NCT01455883|Incretins|incretins|mesh-ancestor
2543783|NCT01455883|Hormones|hormones|mesh-ancestor
2543784|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543785|NCT01455896|Exenatide|exenatide|mesh-list
2543786|NCT01455896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543787|NCT01455896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411171|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2411172|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2411173|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2411174|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
2411175|NCT00767169|Pamidronate|pamidronate|mesh-list
2411176|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2411177|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411178|NCT00767221|Budesonide|budesonide|mesh-list
2411179|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2411180|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2411181|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
2411182|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411183|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411184|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2411185|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
2543788|NCT01455896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2543789|NCT01455896|Incretins|incretins|mesh-ancestor
2543790|NCT01455896|Hormones|hormones|mesh-ancestor
2543791|NCT01455896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543792|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2543793|NCT01455909|Exenatide|exenatide|mesh-list
2543794|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543795|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543796|NCT01455909|Incretins|incretins|mesh-ancestor
2543797|NCT01455909|Hormones|hormones|mesh-ancestor
2543798|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543799|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2543800|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
2543801|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543802|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543803|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2543804|NCT01455922|Glimepiride|glimepiride|mesh-list
2543805|NCT01455922|Exenatide|exenatide|mesh-list
2543806|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2543807|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543808|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543809|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2543810|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
2411186|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
2411187|NCT00767221|Hormones|hormones|mesh-ancestor
2411188|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543811|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2543812|NCT01455922|Incretins|incretins|mesh-ancestor
2543813|NCT01455922|Hormones|hormones|mesh-ancestor
2543814|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2543815|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2543816|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2543817|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2543818|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543819|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
2543820|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2543821|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2543822|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2543823|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543824|NCT01456117|Pioglitazone|pioglitazone|mesh-list
2543825|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543826|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543827|NCT01456208|Norepinephrine|norepinephrine|mesh-list
2543828|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
2543829|NCT01456208|Giapreza|giapreza|mesh-list
2543830|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
2543831|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2543832|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2543833|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
2543834|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2543835|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543836|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543837|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
2543838|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
2543839|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543840|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2543841|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2543842|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
2543843|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543844|NCT01456234|Oseltamivir|oseltamivir|mesh-list
2411189|NCT00767260|Insulin|insulin|mesh-list
2411190|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411191|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411192|NCT00767286|Cobalt|cobalt|mesh-list
2411193|NCT00767286|Goserelin|goserelin|mesh-list
2411194|NCT00767286|Flutamide|flutamide|mesh-list
2411195|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2411196|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411197|NCT00767286|Trace Elements|trace elements|mesh-ancestor
2411198|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
2411199|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411200|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
2411201|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
2411202|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2411203|NCT00767468|Sorafenib|sorafenib|mesh-list
2411204|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411205|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2543845|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
2543846|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543847|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543848|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543849|NCT01456247|Lansoprazole|lansoprazole|mesh-list
2543850|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
2543851|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2543852|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2543853|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2543854|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543855|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543856|NCT01456260|Lansoprazole|lansoprazole|mesh-list
2543857|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
2543858|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2543859|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2543860|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2543861|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543862|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543863|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2543864|NCT01456312|Entecavir|entecavir|mesh-list
2411206|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411207|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411208|NCT00767481|Travoprost|travoprost|mesh-list
2411209|NCT00767481|Brinzolamide|brinzolamide|mesh-list
2411210|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2543865|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
2411211|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2411212|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411213|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543866|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543867|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2543868|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543869|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2543870|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543871|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543872|NCT01456351|Rituximab|rituximab|mesh-list
2543873|NCT01456351|Fludarabine|fludarabine|mesh-list
2543874|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2543875|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2543876|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543877|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
2543878|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543879|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2411214|NCT00767494|Travoprost|travoprost|mesh-list
2411215|NCT00767494|Brinzolamide|brinzolamide|mesh-list
2411216|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2411217|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2411218|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411219|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411220|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
2411221|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2411222|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2411223|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411224|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
2411225|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411226|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411227|NCT00767559|PENTA|penta|mesh-list
2411228|NCT00767559|Warfarin|warfarin|mesh-list
2411229|NCT00767559|Fondaparinux|fondaparinux|mesh-list
2411230|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
2411231|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2411232|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
2411233|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2411234|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
2411235|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411236|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411237|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2411238|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2411239|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
2411240|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2411241|NCT00767598|Udenafil|udenafil|mesh-list
2411242|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
2411243|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
2543880|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543881|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2543882|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
2543883|NCT01456364|Ticagrelor|ticagrelor|mesh-list
2411244|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2411245|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411246|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411247|NCT00767598|Urological Agents|urological agents|mesh-ancestor
2411248|NCT00767663|Dipyridamole|dipyridamole|mesh-list
2411249|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2411250|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411251|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411252|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2411253|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
2411254|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
2411255|NCT00767689|Pyridoxal|pyridoxal|mesh-list
2411256|NCT00767689|Pyridoxine|pyridoxine|mesh-list
2411257|NCT00767689|Vitamins|vitamins|mesh-ancestor
2411258|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
2411259|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411260|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
2411261|NCT00767715|Haloperidol|haloperidol|mesh-list
2411262|NCT00767715|Olanzapine|olanzapine|mesh-list
2411263|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
2543884|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2543885|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2543886|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2543887|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2411264|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
2411265|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
2411266|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411267|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543888|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2543889|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
2543890|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2543891|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543892|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543893|NCT01456468|Tretinoin|tretinoin|mesh-list
2543894|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543895|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
2543896|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
2543897|NCT01456481|Midodrine|midodrine|mesh-list
2543898|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
2543899|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
2543900|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543901|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411268|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2411269|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2411270|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2411271|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2411272|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2411273|NCT00767715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2411274|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2411275|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2543902|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2543903|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2543904|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2543905|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2543906|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
2543907|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2543908|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543909|NCT01456507|Naltrexone|naltrexone|mesh-list
2543910|NCT01456507|Oxycodone|oxycodone|mesh-list
2543911|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2543912|NCT01456507|Narcotics|narcotics|mesh-ancestor
2543913|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2543914|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543915|NCT01456507|Analgesics|analgesics|mesh-ancestor
2543916|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
2543917|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543918|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2543919|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2543920|NCT01456546|Proguanil|proguanil|mesh-list
2543921|NCT01456546|Clopidogrel|clopidogrel|mesh-list
2543922|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2543923|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2543924|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2543925|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2543926|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
2543927|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2543928|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543929|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543930|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
2543931|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2543932|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2543933|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543934|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
2543935|NCT01456585|Gemcitabine|gemcitabine|mesh-list
2543936|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2543937|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
2543938|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543939|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543940|NCT01456585|Antiviral Agents|antiviral agents|mesh-ancestor
2543941|NCT01456585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2543942|NCT01456585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543943|NCT01456585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2543944|NCT01456585|Immunologic Factors|immunologic factors|mesh-ancestor
2543945|NCT01456585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543946|NCT01456611|Diclofenac|diclofenac|mesh-list
2543947|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2543948|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2543949|NCT01456611|Analgesics|analgesics|mesh-ancestor
2543950|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
2543951|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2543952|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543953|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2543954|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2543955|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2543956|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543957|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543958|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
2543959|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2543960|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543961|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
2543962|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2543963|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543964|NCT01456650|Glyburide|glyburide|mesh-list
2543965|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2543966|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543967|NCT01456689|Midazolam|midazolam|mesh-list
2543968|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2543969|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2543970|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2543971|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543972|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2543973|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2543974|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2543975|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2543976|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
2543977|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
2543978|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
2543979|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
2543980|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2543981|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543982|NCT01456715|Vaccines|vaccines|mesh-list
2543983|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
2543984|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543985|NCT01457001|Vitamin D|vitamin d|mesh-list
2543986|NCT01457001|Vitamins|vitamins|mesh-list
2543987|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
2543988|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2543989|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2543990|NCT01457040|Etoposide|etoposide|mesh-list
2543991|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
2543992|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2543993|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2543994|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2543995|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2543996|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2543997|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2543998|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
2543999|NCT01457131|Fludarabine|fludarabine|mesh-list
2544000|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2544001|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
2544002|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544003|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2544004|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2544005|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
2544006|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411276|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411277|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411278|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
2411279|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2411280|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
2411281|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2411282|NCT00767728|Mesalamine|mesalamine|mesh-list
2411283|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2411284|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2411285|NCT00767728|Analgesics|analgesics|mesh-ancestor
2411286|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
2411287|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411288|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411289|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2411290|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2411291|NCT00767754|Paroxetine|paroxetine|mesh-list
2411292|NCT00767754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2411293|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2411294|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2411295|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411296|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411297|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
2411298|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411299|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2411300|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
2544007|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544008|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2544009|NCT01457261|Albuterol|albuterol|mesh-list
2544010|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2544011|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
2411301|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2411302|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2411303|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2411304|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411305|NCT00767871|Citalopram|citalopram|mesh-list
2411306|NCT00767871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2411307|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2411308|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2411309|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411310|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411311|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
2411312|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411313|NCT00767871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2411314|NCT00767871|Antidepressive Agents|antidepressive agents|mesh-ancestor
2411315|NCT00767871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2411316|NCT00767975|Rifampin|rifampin|mesh-list
2411317|NCT00767975|Isoniazid|isoniazid|mesh-list
2411318|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2411319|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
2411320|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2411321|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411322|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
2411323|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2411324|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544012|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544013|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544014|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2544015|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
2544016|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
2544017|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2544018|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2544019|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2544020|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2544021|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
2544022|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544023|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544024|NCT01457469|Nicotine|nicotine|mesh-list
2544025|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2544026|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
2544027|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544028|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544029|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2544030|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2544031|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
2116642|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116643|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116644|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
2116645|NCT02643615|Propofol|propofol|mesh-list
2116646|NCT02643615|Desflurane|desflurane|mesh-list
2116647|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2116648|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116649|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116650|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2116651|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
2116652|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
2116653|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2544032|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544033|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544034|NCT01457495|Edetic Acid|edetic acid|mesh-list
2544035|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
2544036|NCT01457495|Antidotes|antidotes|mesh-ancestor
2544037|NCT01457495|Protective Agents|protective agents|mesh-ancestor
2544038|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544039|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
2544040|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
2116654|NCT02643862|Omalizumab|omalizumab|mesh-list
2411325|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411326|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2411327|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2411328|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2544041|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544042|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2544043|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
2544044|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2544045|NCT01457508|Edetic Acid|edetic acid|mesh-list
2544046|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
2544047|NCT01457508|Antidotes|antidotes|mesh-ancestor
2544048|NCT01457508|Protective Agents|protective agents|mesh-ancestor
2544049|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544050|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
2544051|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
2544052|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544053|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2544054|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
2544055|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2544056|NCT01457547|Edetic Acid|edetic acid|mesh-list
2544057|NCT01457547|Vaccines|vaccines|mesh-list
2411329|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2411330|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2411331|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2411332|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2411333|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2411334|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
2411335|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2411336|NCT00768131|Paclitaxel|paclitaxel|mesh-list
2411337|NCT00768131|Carboplatin|carboplatin|mesh-list
2411338|NCT00768131|Cetuximab|cetuximab|mesh-list
2411339|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2411340|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411341|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
2411342|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
2544058|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
2544059|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
2544060|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544061|NCT01457547|Antidotes|antidotes|mesh-ancestor
2544062|NCT01457547|Protective Agents|protective agents|mesh-ancestor
2544063|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
2544064|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
2544065|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544066|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2544067|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
2544068|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2544069|NCT01457690|Tocopherols|tocopherols|mesh-list
2544070|NCT01457690|Vitamin E|vitamin e|mesh-list
2544071|NCT01457690|Tocotrienols|tocotrienols|mesh-list
2544072|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
2544073|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
2544074|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544075|NCT01457690|Protective Agents|protective agents|mesh-ancestor
2544076|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544077|NCT01457690|Vitamins|vitamins|mesh-ancestor
2544078|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
2544079|NCT01457716|Budesonide|budesonide|mesh-list
2544080|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
2544081|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2544082|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2544083|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
2544084|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544085|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544086|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2544087|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
2544088|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
2544089|NCT01457716|Hormones|hormones|mesh-ancestor
2544090|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2544091|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2544092|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2544093|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2544094|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
2544095|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544096|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544097|NCT01457781|Nitric Oxide|nitric oxide|mesh-list
2544098|NCT01457781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2544099|NCT01457781|Autonomic Agents|autonomic agents|mesh-ancestor
2544100|NCT01457781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544101|NCT01457781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544102|NCT01457781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2544103|NCT01457781|Respiratory System Agents|respiratory system agents|mesh-ancestor
2544104|NCT01457781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2544105|NCT01457781|Antioxidants|antioxidants|mesh-ancestor
2544106|NCT01457781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544107|NCT01457781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544108|NCT01457781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2544109|NCT01457781|Vasodilator Agents|vasodilator agents|mesh-ancestor
2544110|NCT01457781|Gasotransmitters|gasotransmitters|mesh-ancestor
2544111|NCT01457781|Protective Agents|protective agents|mesh-ancestor
2544112|NCT01457820|Allopurinol|allopurinol|mesh-list
2544113|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
2411343|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
2411344|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411345|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2411346|NCT00768157|Lamivudine|lamivudine|mesh-list
2411347|NCT00768157|Entecavir|entecavir|mesh-list
2411348|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
2411349|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2411350|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2411351|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411352|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411353|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411354|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2411355|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2411356|NCT00768183|Ethanol|ethanol|mesh-list
2411357|NCT00768183|Morphine|morphine|mesh-list
2411358|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2544114|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544115|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544116|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
2544117|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2544118|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2544119|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
2544120|NCT01457820|Protective Agents|protective agents|mesh-ancestor
2544121|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544122|NCT01457859|Triclosan|triclosan|mesh-list
2544123|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2544124|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411359|NCT00768183|Narcotics|narcotics|mesh-ancestor
2411360|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2411361|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411362|NCT00768183|Analgesics|analgesics|mesh-ancestor
2411363|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
2411364|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411365|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2411366|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411367|NCT00768209|Topiramate|topiramate|mesh-list
2411368|NCT00768209|Phentermine|phentermine|mesh-list
2411369|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
2411370|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411371|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411372|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2411373|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
2411374|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2411375|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
2411376|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
2411377|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411378|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
2411379|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411380|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411381|NCT00768391|Olaratumab|olaratumab|mesh-list
2411382|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411383|NCT00768404|Phentermine|phentermine|mesh-list
2411384|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2411385|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411386|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
2411387|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2411388|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
2411389|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
2411390|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544125|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2544126|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2544127|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
2544128|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544129|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2544130|NCT01457911|Metformin|metformin|mesh-list
2544131|NCT01457911|Glimepiride|glimepiride|mesh-list
2411391|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
2411392|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411393|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411394|NCT00768456|Ropivacaine|ropivacaine|mesh-list
2411395|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
2411396|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
2411397|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2411398|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411399|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
2411400|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411401|NCT00768482|Buprenorphine|buprenorphine|mesh-list
2411402|NCT00768482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2411403|NCT00768482|Narcotics|narcotics|mesh-ancestor
2411404|NCT00768482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2544132|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2544133|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544134|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2544135|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2411405|NCT00768482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411406|NCT00768482|Analgesics|analgesics|mesh-ancestor
2411407|NCT00768482|Sensory System Agents|sensory system agents|mesh-ancestor
2411408|NCT00768482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411409|NCT00768482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2411410|NCT00768508|Naltrexone|naltrexone|mesh-list
2411411|NCT00768508|Ondansetron|ondansetron|mesh-list
2411412|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2411413|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2411414|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411415|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
2411416|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544136|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
2544137|NCT01457937|Interferons|interferons|mesh-list
2544138|NCT01457937|Ribavirin|ribavirin|mesh-list
2544139|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2544140|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544141|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
2544142|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544143|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
2544144|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544145|NCT01457989|Ezogabine|ezogabine|mesh-list
2544146|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
2544147|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2544148|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544149|NCT01458015|Oxycodone|oxycodone|mesh-list
2544150|NCT01458015|Tapentadol|tapentadol|mesh-list
2411417|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
2411418|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
2411419|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2411420|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
2411421|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
2411422|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2411423|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
2411424|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411425|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411426|NCT00768508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2411427|NCT00768508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2411428|NCT00768508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2411429|NCT00768508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2411430|NCT00768508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2411431|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
2411432|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
2544151|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2544152|NCT01458015|Narcotics|narcotics|mesh-ancestor
2544153|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2544154|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544155|NCT01458015|Analgesics|analgesics|mesh-ancestor
2544156|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
2544157|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411433|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2411434|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2544158|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2544159|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2411435|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411436|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411437|NCT00768573|Urological Agents|urological agents|mesh-ancestor
2411438|NCT00768612|Risperidone|risperidone|mesh-list
2411439|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2544160|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2544161|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544162|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
2544163|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544164|NCT01458041|Iloprost|iloprost|mesh-list
2544165|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2544166|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
2544167|NCT01458054|Ritonavir|ritonavir|mesh-list
2544168|NCT01458054|Omeprazole|omeprazole|mesh-list
2544169|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2411440|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
2411441|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411442|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411443|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411444|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2411445|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2411446|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2411447|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2411448|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2544170|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2544171|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
2544172|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544173|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544174|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2544175|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2544176|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
2544177|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544178|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2544179|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2544180|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2544181|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2544182|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2411449|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
2411450|NCT00768638|Atorvastatin|atorvastatin|mesh-list
2411451|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2411452|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2411453|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
2411454|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411455|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2411456|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2411457|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411458|NCT00768677|Topiramate|topiramate|mesh-list
2411459|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
2411460|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411461|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411462|NCT00768690|Ketoconazole|ketoconazole|mesh-list
2411463|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
2411464|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544183|NCT01458067|GSK2636771|gsk2636771|mesh-list
2544184|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544185|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2544186|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544187|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544188|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2544189|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2544190|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544191|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
2544192|NCT01458236|Beraprost|beraprost|mesh-list
2544193|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2544194|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
2544195|NCT01458301|Leuprolide|leuprolide|mesh-list
2544196|NCT01458301|Relugolix|relugolix|mesh-list
2544197|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2544198|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
2544199|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2544200|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544201|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2544202|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544203|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
2544204|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
2544205|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2544206|NCT01458431|Anesthetics|anesthetics|mesh-list
2544207|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
2544208|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
2544209|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2544210|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544211|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
2544212|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544213|NCT01458470|Memantine|memantine|mesh-list
2544214|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2411465|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2411466|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2411467|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411468|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411469|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2411470|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
2411471|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2411472|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544215|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2544216|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
2544217|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544218|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544219|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544220|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2544221|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2544222|NCT01458548|Rituximab|rituximab|mesh-list
2544223|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2411473|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2411474|NCT00768729|Sirolimus|sirolimus|mesh-list
2411475|NCT00768729|Azathioprine|azathioprine|mesh-list
2411476|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2411477|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411478|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2411479|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411480|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
2411481|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2411482|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
2411483|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411484|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
2411485|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411486|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2411487|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2411488|NCT00768768|Terbinafine|terbinafine|mesh-list
2411489|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
2411490|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411491|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411492|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411493|NCT00768820|Risperidone|risperidone|mesh-list
2411494|NCT00768820|Methylphenidate|methylphenidate|mesh-list
2411495|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2411496|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
2411497|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411498|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411499|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411500|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2411501|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2411502|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2411503|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2411504|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2411505|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
2411506|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2411507|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2411508|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2411509|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2411510|NCT00768859|Paclitaxel|paclitaxel|mesh-list
2411511|NCT00768859|Carboplatin|carboplatin|mesh-list
2411512|NCT00768859|Trastuzumab|trastuzumab|mesh-list
2411513|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2411514|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411515|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
2544224|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544225|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
2544226|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544227|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2544228|NCT01458600|Diclofenac|diclofenac|mesh-list
2544229|NCT01458600|Propranolol|propranolol|mesh-list
2544230|NCT01458600|Metoprolol|metoprolol|mesh-list
2544231|NCT01458600|Methimazole|methimazole|mesh-list
2544232|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2544233|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2544234|NCT01458600|Analgesics|analgesics|mesh-ancestor
2544235|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
2544236|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544237|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544238|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2544239|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2544240|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2544241|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544242|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544243|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2411516|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
2411517|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
2411518|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544244|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2544245|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
2544246|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544247|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2544248|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2544249|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
2544250|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
2544251|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
2544252|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2544253|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
2544254|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
2544255|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2544256|NCT01458626|Mirtazapine|mirtazapine|mesh-list
2544257|NCT01458626|Paroxetine|paroxetine|mesh-list
2544258|NCT01458626|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2544259|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2544260|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2544261|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544262|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544263|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
2544264|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544265|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2544266|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
2544267|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2544268|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2544269|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2411519|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2411520|NCT00768911|Temozolomide|temozolomide|mesh-list
2411521|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2411522|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
2411523|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411524|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411525|NCT00768937|Sorafenib|sorafenib|mesh-list
2411526|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411527|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2411528|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411529|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411530|NCT00768963|Ranibizumab|ranibizumab|mesh-list
2411531|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2411532|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2411533|NCT00768963|Growth Substances|growth substances|mesh-ancestor
2544270|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544271|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2544272|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
2544273|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
2544274|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2544275|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2544276|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2544277|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2544278|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2544279|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2544280|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
2544281|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2544282|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2544283|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2544284|NCT01458743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2544285|NCT01458743|Cephalosporins|cephalosporins|mesh-list
2544286|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2544287|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544288|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2544289|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2544290|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2544291|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
2544292|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544293|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544294|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2544295|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2544296|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
2544297|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544298|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
2544299|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2544300|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2544301|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2544302|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
2544303|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2544304|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2544305|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2411534|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411535|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
2411536|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411537|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
2411538|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2544306|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2544307|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544308|NCT01458977|Tenofovir|tenofovir|mesh-list
2544309|NCT01458977|Emtricitabine|emtricitabine|mesh-list
2544310|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2544311|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
2544312|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544313|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2544314|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2544315|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544316|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544317|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2544318|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2544319|NCT01459081|Zanamivir|zanamivir|mesh-list
2544320|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
2544321|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544322|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544323|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544324|NCT01459133|Insulin|insulin|mesh-list
2544325|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2544326|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544327|NCT01459146|Lumefantrine|lumefantrine|mesh-list
2544328|NCT01459146|Artemether|artemether|mesh-list
2544329|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2544330|NCT01459146|Albendazole|albendazole|mesh-list
2544331|NCT01459146|Praziquantel|praziquantel|mesh-list
2544332|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
2544333|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2544334|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2411539|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411540|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2411541|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2411542|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411543|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411544|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411545|NCT00769054|Ropivacaine|ropivacaine|mesh-list
2411546|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
2411547|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
2411548|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2411549|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411550|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
2411551|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411552|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2411553|NCT00769093|Hematinics|hematinics|mesh-ancestor
2411554|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2544335|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544336|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
2544337|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
2544338|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2544339|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
2544340|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
2544341|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
2544342|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411555|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2411556|NCT00769145|Ranibizumab|ranibizumab|mesh-list
2411557|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2411558|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2411559|NCT00769145|Growth Substances|growth substances|mesh-ancestor
2411560|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411561|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
2411562|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411563|NCT00769158|Topiramate|topiramate|mesh-list
2411564|NCT00769158|Naltrexone|naltrexone|mesh-list
2411565|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2411566|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2411567|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411568|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
2411569|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544343|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544344|NCT01459198|Vaccines|vaccines|mesh-list
2544345|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
2544346|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411570|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
2411571|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411572|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
2411573|NCT00769171|Metronidazole|metronidazole|mesh-list
2544347|NCT01459211|Dexamethasone|dexamethasone|mesh-list
2544348|NCT01459211|Lenalidomide|lenalidomide|mesh-list
2544349|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2544350|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
2544351|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
2544352|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544353|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544354|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2544355|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
2544356|NCT01459211|Hormones|hormones|mesh-ancestor
2544357|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2544358|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2544359|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544360|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
2544361|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2544362|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2544363|NCT01459211|Growth Substances|growth substances|mesh-ancestor
2544364|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
2544365|NCT01459250|S 20098|s 20098|mesh-list
2544366|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2544367|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2544368|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544369|NCT01459276|Vaccines|vaccines|mesh-list
2544370|NCT01459276|Immunologic Factors|immunologic factors|mesh-ancestor
2544371|NCT01459276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544372|NCT01459315|Dolutegravir|dolutegravir|mesh-list
2544373|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2544374|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2544375|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544376|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544377|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2544378|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2544379|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
2544380|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544381|NCT01459367|Lansoprazole|lansoprazole|mesh-list
2544382|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
2544383|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2544384|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2544385|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2544386|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544387|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544388|NCT01459380|Bevacizumab|bevacizumab|mesh-list
2544389|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2411574|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
2544390|NCT01459380|Carboplatin|carboplatin|mesh-list
2544391|NCT01459380|Doxorubicin|doxorubicin|mesh-list
2544392|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2544393|NCT01459380|Veliparib|veliparib|mesh-list
2411575|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2411576|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2411577|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411578|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2411579|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2411580|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411581|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411582|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411583|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2411584|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
2411585|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2411586|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411587|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2411588|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2411589|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2411590|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2411591|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2411592|NCT00769210|Simvastatin|simvastatin|mesh-list
2411593|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2411594|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2411595|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
2411596|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411597|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2411598|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2411599|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411600|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
2411601|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
2411602|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
2411603|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544394|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
2544395|NCT01459380|Antibodies|antibodies|mesh-list
2544396|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
2544397|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2544398|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
2544399|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544400|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2544401|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2544402|NCT01459380|Growth Substances|growth substances|mesh-ancestor
2544403|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544404|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
2544405|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
2544406|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2544407|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2544408|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2544409|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544410|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544411|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2544412|NCT01459406|Levan|levan|mesh-list
2544413|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544414|NCT01459419|Antibodies|antibodies|mesh-list
2544415|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2544416|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
2544417|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544418|NCT01459445|Metformin|metformin|mesh-list
2544419|NCT01459445|Drospirenone|drospirenone|mesh-list
2544420|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2544421|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2544422|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544423|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2544424|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2544425|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2544426|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
2544427|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2544428|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2544429|NCT01459445|Estrogens|estrogens|mesh-ancestor
2544430|NCT01459445|Hormones|hormones|mesh-ancestor
2544431|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2544432|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2544433|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
2544434|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2544435|NCT01459445|Diuretics|diuretics|mesh-ancestor
2544436|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
2544437|NCT01459484|Cisplatin|cisplatin|mesh-list
2544438|NCT01459484|Doxorubicin|doxorubicin|mesh-list
2544439|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2544440|NCT01459484|Methotrexate|methotrexate|mesh-list
2544441|NCT01459484|Ifosfamide|ifosfamide|mesh-list
2544442|NCT01459484|Mifamurtide|mifamurtide|mesh-list
2544443|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
2411604|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
2411605|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411606|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
2411607|NCT00769288|Growth Substances|growth substances|mesh-ancestor
2411608|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411614|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2411615|NCT00769379|Trastuzumab|trastuzumab|mesh-list
2411616|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2411617|NCT00769379|Antibodies|antibodies|mesh-list
2411618|NCT00769379|Immunoglobulins|immunoglobulins|mesh-list
2411619|NCT00769379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2411620|NCT00769379|Immunologic Factors|immunologic factors|mesh-ancestor
2411621|NCT00769379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411622|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411623|NCT00769405|Leucovorin|leucovorin|mesh-list
2411624|NCT00769405|Fluorouracil|fluorouracil|mesh-list
2411625|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
2411626|NCT00769405|Calcium|calcium|mesh-list
2411627|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
2411628|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2411629|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411630|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
2411631|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411632|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2411633|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411634|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2411635|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
2411636|NCT00769405|Antidotes|antidotes|mesh-ancestor
2411637|NCT00769405|Protective Agents|protective agents|mesh-ancestor
2411638|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
2411639|NCT00769405|Vitamins|vitamins|mesh-ancestor
2411640|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
2411641|NCT00769470|Carboplatin|carboplatin|mesh-list
2411642|NCT00769470|Docetaxel|docetaxel|mesh-list
2411643|NCT00769470|Trastuzumab|trastuzumab|mesh-list
2411644|NCT00769470|Lapatinib|lapatinib|mesh-list
2411645|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411646|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
2411647|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
2411648|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
2411649|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411650|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2411651|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2411652|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411653|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
2411654|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2411655|NCT00769522|Rituximab|rituximab|mesh-list
2411656|NCT00769522|Fludarabine|fludarabine|mesh-list
2411657|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2411658|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
2411659|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411660|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2411661|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2411662|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
2411663|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411664|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411665|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2411666|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2411667|NCT00769548|Goserelin|goserelin|mesh-list
2411668|NCT00769548|Flutamide|flutamide|mesh-list
2411669|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2411670|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411671|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
2411672|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
2411673|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2411674|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544444|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544445|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2411675|NCT00769587|Thalidomide|thalidomide|mesh-list
2411676|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2411677|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
2411678|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411679|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
2411680|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2411681|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411682|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2411683|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2411684|NCT00769587|Growth Substances|growth substances|mesh-ancestor
2411685|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
2411686|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411687|NCT00769795|Goserelin|goserelin|mesh-list
2544446|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2544447|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2544448|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544449|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544450|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2544451|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
2544452|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2544453|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544454|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2544455|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
2544456|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
2544457|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2544458|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2544459|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
2544460|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2544461|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2544462|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2544463|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
2544464|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2544465|NCT01459601|Cabergoline|cabergoline|mesh-list
2544466|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2544467|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2544468|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
2544469|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
2544470|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411688|NCT00769795|Bicalutamide|bicalutamide|mesh-list
2411689|NCT00769795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2411690|NCT00769795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411691|NCT00769795|Androgen Antagonists|androgen antagonists|mesh-ancestor
2411692|NCT00769795|Hormone Antagonists|hormone antagonists|mesh-ancestor
2411693|NCT00769795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2411694|NCT00769795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411695|NCT00769873|Heparin|heparin|mesh-list
2411696|NCT00769873|Enoxaparin|enoxaparin|mesh-list
2411697|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2411698|NCT00769873|Tinzaparin|tinzaparin|mesh-list
2544471|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544472|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544473|NCT01459627|Ticagrelor|ticagrelor|mesh-list
2544474|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2544475|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2411699|NCT00769873|Dalteparin|dalteparin|mesh-list
2411700|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
2411701|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2411702|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2411703|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411704|NCT00769990|Genistein|genistein|mesh-list
2411705|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2411706|NCT00769990|Protective Agents|protective agents|mesh-ancestor
2411707|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544476|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2544477|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2544478|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2544479|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
2544480|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544481|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544482|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544483|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
2544484|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2411708|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411709|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2411710|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411711|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411712|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
2411713|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2411714|NCT00769990|Estrogens|estrogens|mesh-ancestor
2411715|NCT00769990|Hormones|hormones|mesh-ancestor
2411716|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2411717|NCT00770042|Ritonavir|ritonavir|mesh-list
2411718|NCT00770042|Ketoconazole|ketoconazole|mesh-list
2411719|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2411720|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2411721|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
2411722|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411723|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411724|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2411725|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2411726|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
2411727|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411728|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2411729|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2411730|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
2411731|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2411732|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2411733|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
2411734|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2411735|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411736|NCT00770081|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2411737|NCT00770081|Vildagliptin|vildagliptin|mesh-list
2411738|NCT00770081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411739|NCT00770081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411740|NCT00770081|Incretins|incretins|mesh-ancestor
2544485|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
2544486|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544487|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
2544488|NCT01459640|Protective Agents|protective agents|mesh-ancestor
2544489|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2544490|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2544491|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
2544492|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2544493|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2544494|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544495|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
2544496|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544497|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544498|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2544499|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544500|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
2544501|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
2544502|NCT01459679|Riboflavin|riboflavin|mesh-list
2544503|NCT01459679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2544504|NCT01459679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2544505|NCT01459679|Vitamin B Complex|vitamin b complex|mesh-ancestor
2544506|NCT01459679|Vitamins|vitamins|mesh-ancestor
2544507|NCT01459679|Micronutrients|micronutrients|mesh-ancestor
2544508|NCT01459679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544509|NCT01459679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2544510|NCT01459679|Dermatologic Agents|dermatologic agents|mesh-ancestor
2544511|NCT01459809|Metformin|metformin|mesh-list
2544512|NCT01459809|Glimepiride|glimepiride|mesh-list
2544513|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2544514|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544515|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2544516|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2544517|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
2544518|NCT01459887|Prednisone|prednisone|mesh-list
2544519|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
2544520|NCT01459887|Doxorubicin|doxorubicin|mesh-list
2544521|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2544522|NCT01459887|Vincristine|vincristine|mesh-list
2544523|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2544524|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
2411741|NCT00770081|Hormones|hormones|mesh-ancestor
2544525|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544526|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2544527|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2544528|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
2411742|NCT00770081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2411743|NCT00770081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2411744|NCT00770081|Protease Inhibitors|protease inhibitors|mesh-ancestor
2411745|NCT00770081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411746|NCT00770081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411747|NCT00770107|Thiamine|thiamine|mesh-list
2411748|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
2411749|NCT00770107|Vitamins|vitamins|mesh-ancestor
2411750|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
2411751|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544529|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544530|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544531|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2544532|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2544533|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2544534|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2544535|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544536|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2544537|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
2544538|NCT01459887|Hormones|hormones|mesh-ancestor
2544539|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2544540|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2544541|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2544542|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
2544543|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
2544544|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
2411752|NCT00770172|Lenograstim|lenograstim|mesh-list
2411753|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2411754|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
2411755|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411756|NCT00770263|Sirolimus|sirolimus|mesh-list
2544545|NCT01460030|Cinacalcet|cinacalcet|mesh-list
2544546|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2544547|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544548|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2544549|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
2544550|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2544551|NCT01460069|Liraglutide|liraglutide|mesh-list
2544552|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2544553|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544554|NCT01460069|Incretins|incretins|mesh-ancestor
2544555|NCT01460069|Hormones|hormones|mesh-ancestor
2544556|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2544557|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2544558|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
2544559|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411757|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2411758|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411759|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2411760|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411761|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411762|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2411763|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411764|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2411765|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
2411766|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2411767|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
2411768|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411769|NCT00770302|Saxagliptin|saxagliptin|mesh-list
2411770|NCT00770302|Incretins|incretins|mesh-ancestor
2411771|NCT00770302|Hormones|hormones|mesh-ancestor
2411772|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2544560|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
2544561|NCT01460212|Citalopram|citalopram|mesh-list
2544562|NCT01460212|Fluoxetine|fluoxetine|mesh-list
2544563|NCT01460212|Paroxetine|paroxetine|mesh-list
2544564|NCT01460212|Sertraline|sertraline|mesh-list
2544565|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
2544566|NCT01460212|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2544567|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2544568|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2544569|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544570|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411773|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544571|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
2544572|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544573|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2544574|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2544575|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2544576|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2544577|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544578|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2544579|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2544580|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2544581|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2544582|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2544583|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
2544584|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2544585|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2544586|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2544587|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2544588|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544589|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
2544590|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544591|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544592|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2544593|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544594|NCT01460420|Lenalidomide|lenalidomide|mesh-list
2544595|NCT01460420|Bortezomib|bortezomib|mesh-list
2544596|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
2544597|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544598|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2544599|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2544600|NCT01460420|Growth Substances|growth substances|mesh-ancestor
2544601|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
2544602|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544603|NCT01460498|Azacitidine|azacitidine|mesh-list
2544604|NCT01460498|Decitabine|decitabine|mesh-list
2544605|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2544606|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
2544607|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544608|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544609|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544610|NCT01460511|Epinephrine|epinephrine|mesh-list
2544611|NCT01460511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2544612|NCT01460511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2544613|NCT01460511|Adrenergic Agents|adrenergic agents|mesh-ancestor
2544614|NCT01460511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544615|NCT01460511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544616|NCT01460511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544617|NCT01460511|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2544618|NCT01460511|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2544619|NCT01460511|Autonomic Agents|autonomic agents|mesh-ancestor
2544620|NCT01460511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544621|NCT01460511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2544622|NCT01460511|Respiratory System Agents|respiratory system agents|mesh-ancestor
2544623|NCT01460511|Mydriatics|mydriatics|mesh-ancestor
2544624|NCT01460511|Sympathomimetics|sympathomimetics|mesh-ancestor
2544625|NCT01460511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2544626|NCT01460537|Gemcitabine|gemcitabine|mesh-list
2544627|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544628|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2544629|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
2544630|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544631|NCT01460537|Antiviral Agents|antiviral agents|mesh-ancestor
2544632|NCT01460537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544633|NCT01460537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544634|NCT01460537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2411774|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2411775|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
2411776|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411777|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411778|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411779|NCT00770354|Letrozole|letrozole|mesh-list
2411780|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411781|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2544635|NCT01460537|Immunologic Factors|immunologic factors|mesh-ancestor
2544636|NCT01460537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411782|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2411783|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411784|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411785|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2411786|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
2411787|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2411788|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411789|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
2544637|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
2544638|NCT01460563|Analgesics|analgesics|mesh-ancestor
2544639|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
2544640|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544641|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544642|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
2544643|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2544644|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2544645|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
2544646|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2544647|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2544648|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544649|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2544650|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
2544651|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2544652|NCT01460602|Rituximab|rituximab|mesh-list
2544653|NCT01460602|Bortezomib|bortezomib|mesh-list
2544654|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2544655|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544656|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
2544657|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544658|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2544659|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
2544660|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2544661|NCT01460654|Alendronate|alendronate|mesh-list
2544662|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
2544663|NCT01460654|Testosterone|testosterone|mesh-list
2544664|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
2544665|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
2544666|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2544667|NCT01460654|Androgens|androgens|mesh-ancestor
2544668|NCT01460654|Hormones|hormones|mesh-ancestor
2544669|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2544670|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544671|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2544672|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411790|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2411791|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2411792|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2411793|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2411794|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411795|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
2411796|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411797|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544673|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
2544674|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2544675|NCT01460667|Acetaminophen|acetaminophen|mesh-list
2544676|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2544677|NCT01460667|Analgesics|analgesics|mesh-ancestor
2544678|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
2544679|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544680|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544681|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
2544682|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
2544683|NCT01460693|Dasatinib|dasatinib|mesh-list
2411798|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2411799|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411800|NCT00770445|Insulin|insulin|mesh-list
2411801|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2411802|NCT00770445|Metformin|metformin|mesh-list
2411803|NCT00770445|Pioglitazone|pioglitazone|mesh-list
2411804|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411805|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411806|NCT00770471|Temozolomide|temozolomide|mesh-list
2411807|NCT00770471|Veliparib|veliparib|mesh-list
2411808|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2411809|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
2544684|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544685|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2411810|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411811|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411812|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2411813|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411814|NCT00770497|Pioglitazone|pioglitazone|mesh-list
2411815|NCT00770497|Ramipril|ramipril|mesh-list
2411816|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411817|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411818|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2411819|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
2411820|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411821|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544686|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544687|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544688|NCT01460706|Edotreotide|edotreotide|mesh-list
2544689|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2544690|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544691|NCT01460797|Metformin|metformin|mesh-list
2544692|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2544693|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544694|NCT01460810|Silicon|silicon|mesh-list
2544695|NCT01460810|Trace Elements|trace elements|mesh-ancestor
2411822|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2411823|NCT00770536|Doxorubicin|doxorubicin|mesh-list
2411824|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2411825|NCT00770536|Topotecan|topotecan|mesh-list
2411826|NCT00770536|Trebananib|trebananib|mesh-list
2411827|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2411828|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411829|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2411830|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2411831|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411832|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411833|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2411834|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2411835|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2411836|NCT00770536|Growth Substances|growth substances|mesh-ancestor
2411837|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411838|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
2544696|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
2544697|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544698|NCT01460836|Tobramycin|tobramycin|mesh-list
2544699|NCT01460836|Aztreonam|aztreonam|mesh-list
2544700|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2544701|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544702|NCT01460888|Olaparib|olaparib|mesh-list
2544703|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2544704|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544705|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544706|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411839|NCT00770575|Pioglitazone|pioglitazone|mesh-list
2411840|NCT00770575|Atorvastatin|atorvastatin|mesh-list
2411841|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2411842|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2544707|NCT01460979|Sirolimus|sirolimus|mesh-list
2544708|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2544709|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544710|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2544711|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544712|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
2544713|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2544714|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
2544715|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544716|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
2544717|NCT01461018|Antibodies|antibodies|mesh-list
2544718|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
2544719|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2544720|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2544721|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
2544722|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544723|NCT01461031|Nefopam|nefopam|mesh-list
2544724|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2544725|NCT01461031|Analgesics|analgesics|mesh-ancestor
2544726|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
2544727|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544728|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544729|NCT01461174|Memantine|memantine|mesh-list
2544730|NCT01461174|Modafinil|modafinil|mesh-list
2544731|NCT01461174|Donepezil|donepezil|mesh-list
2544732|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2544733|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411843|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
2411844|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411845|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2411846|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2411847|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411848|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411849|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411850|NCT00770640|Insulin|insulin|mesh-list
2411851|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2411852|NCT00770640|Pioglitazone|pioglitazone|mesh-list
2544734|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544735|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
2544736|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411853|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411854|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411855|NCT00770666|Bupropion|bupropion|mesh-list
2411856|NCT00770666|Nicotine|nicotine|mesh-list
2411857|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2411858|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
2411859|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411860|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411861|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2411862|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2411863|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
2411864|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411865|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411866|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2411867|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
2411868|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2411869|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2411870|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2411871|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2411872|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
2411873|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2411874|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2411875|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544737|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544738|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
2544739|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2544740|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2544741|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
2544742|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2544743|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2544744|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2544745|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2544746|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2544747|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2411876|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
2411877|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2411878|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2411879|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
2411880|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411881|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411882|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411883|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2411884|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
2411885|NCT00770718|Thrombin|thrombin|mesh-list
2411886|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
2411887|NCT00770718|Coagulants|coagulants|mesh-ancestor
2411888|NCT00770731|Sirolimus|sirolimus|mesh-list
2411889|NCT00770731|Bortezomib|bortezomib|mesh-list
2411890|NCT00770731|Topotecan|topotecan|mesh-list
2411891|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544748|NCT01461317|Etrolizumab|etrolizumab|mesh-list
2544749|NCT01461317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2544750|NCT01461317|Immunologic Factors|immunologic factors|mesh-ancestor
2411892|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2411893|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2411894|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544751|NCT01461317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544752|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
2544753|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
2544754|NCT01461460|Tedizolid|tedizolid|mesh-list
2544755|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
2544756|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2544757|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544758|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2544759|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2544760|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544761|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544762|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544763|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2544764|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
2411895|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411896|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2411897|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411898|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2411899|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
2411900|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2411901|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
2411902|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411903|NCT00770744|Olanzapine|olanzapine|mesh-list
2411904|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
2411905|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
2411906|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411907|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411908|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2411909|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2411910|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2411911|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2411912|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2411913|NCT00770744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2411914|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2411915|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2411916|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411917|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2411918|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
2411919|NCT00770796|Atorvastatin|atorvastatin|mesh-list
2411920|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2411921|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2411922|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
2411923|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411924|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2411925|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2411926|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544765|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2544766|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544767|NCT01461616|Insulin|insulin|mesh-list
2544768|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2544769|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
2544770|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
2544771|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2544772|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544773|NCT01461746|Docetaxel|docetaxel|mesh-list
2544774|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544775|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
2544776|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
2544777|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
2544778|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544779|NCT01461759|Cisplatin|cisplatin|mesh-list
2544780|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544781|NCT01461772|Carboplatin|carboplatin|mesh-list
2544782|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544783|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2544784|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
2544785|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544786|NCT01461915|Gemcitabine|gemcitabine|mesh-list
2544787|NCT01461915|Paclitaxel|paclitaxel|mesh-list
2544788|NCT01461915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2544789|NCT01461915|Heparin|heparin|mesh-list
2544790|NCT01461915|Calcium heparin|calcium heparin|mesh-list
2544791|NCT01461915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2544792|NCT01461915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411927|NCT00770835|Metformin|metformin|mesh-list
2411928|NCT00770835|Pioglitazone|pioglitazone|mesh-list
2544793|NCT01461915|Tubulin Modulators|tubulin modulators|mesh-ancestor
2411929|NCT00770835|Glyburide|glyburide|mesh-list
2411930|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411931|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411932|NCT00770848|Prednisone|prednisone|mesh-list
2411933|NCT00770848|Mitoxantrone|mitoxantrone|mesh-list
2411934|NCT00770848|Rilotumumab|rilotumumab|mesh-list
2411935|NCT00770848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2544794|NCT01461915|Antimitotic Agents|antimitotic agents|mesh-ancestor
2544795|NCT01461915|Mitosis Modulators|mitosis modulators|mesh-ancestor
2544796|NCT01461915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544797|NCT01461915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2544798|NCT01461915|Antimetabolites|antimetabolites|mesh-ancestor
2544799|NCT01461915|Antiviral Agents|antiviral agents|mesh-ancestor
2411936|NCT00770848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2411937|NCT00770848|Glucocorticoids|glucocorticoids|mesh-ancestor
2411938|NCT00770848|Hormones|hormones|mesh-ancestor
2411939|NCT00770848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2411940|NCT00770848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411941|NCT00770848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2411942|NCT00770848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411943|NCT00770848|Analgesics|analgesics|mesh-ancestor
2544800|NCT01461915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544801|NCT01461915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544802|NCT01461915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2544803|NCT01461915|Immunologic Factors|immunologic factors|mesh-ancestor
2544804|NCT01461915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544805|NCT01461915|Anticoagulants|anticoagulants|mesh-ancestor
2544806|NCT01461915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2544807|NCT01461915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2544808|NCT01462006|Sirolimus|sirolimus|mesh-list
2544809|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2544810|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544811|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2544812|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544813|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
2544814|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2544815|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
2411944|NCT00770848|Sensory System Agents|sensory system agents|mesh-ancestor
2411945|NCT00770848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2411946|NCT00770848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2411947|NCT00770848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2411948|NCT00770848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2411949|NCT00770848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544816|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544817|NCT01462058|Vitamin D|vitamin d|mesh-list
2544818|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
2544819|NCT01462058|Vitamins|vitamins|mesh-ancestor
2544820|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
2544821|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544822|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2544823|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2544824|NCT01462149|Carboplatin|carboplatin|mesh-list
2544825|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544826|NCT01462214|Everolimus|everolimus|mesh-list
2544827|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544828|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2544829|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
2544830|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544831|NCT01462422|Misoprostol|misoprostol|mesh-list
2544832|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2544833|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
2544834|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2544835|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544836|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2544837|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2544838|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
2544839|NCT01462474|Cisplatin|cisplatin|mesh-list
2411950|NCT00770848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2411951|NCT00770848|Immunologic Factors|immunologic factors|mesh-ancestor
2411952|NCT00770900|Montelukast|montelukast|mesh-list
2411953|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2544840|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544841|NCT01462487|Zanamivir|zanamivir|mesh-list
2544842|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
2544843|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544844|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544845|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544846|NCT01462500|Miltefosine|miltefosine|mesh-list
2544847|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
2544848|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544849|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544850|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2544851|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2544852|NCT01462617|Nemiralisib|nemiralisib|mesh-list
2544853|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2544854|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544855|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544856|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2544857|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2544858|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544859|NCT01462669|Ezogabine|ezogabine|mesh-list
2544860|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
2544861|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2544862|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544863|NCT01462890|Paclitaxel|paclitaxel|mesh-list
2544864|NCT01462890|Bevacizumab|bevacizumab|mesh-list
2544865|NCT01462890|Carboplatin|carboplatin|mesh-list
2544866|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2544867|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411954|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
2411955|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2411956|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
2411957|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2411958|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411959|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2411960|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2411961|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2411962|NCT00770952|Pioglitazone|pioglitazone|mesh-list
2411963|NCT00770952|Glimepiride|glimepiride|mesh-list
2411964|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2411965|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544868|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
2544869|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
2544870|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
2544871|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544872|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2544873|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2544874|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2544875|NCT01462890|Growth Substances|growth substances|mesh-ancestor
2544876|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544877|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
2544878|NCT01462968|Heparin|heparin|mesh-list
2544879|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
2544880|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2544881|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2544882|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544883|NCT01463046|Cytarabine|cytarabine|mesh-list
2544884|NCT01463046|Daunorubicin|daunorubicin|mesh-list
2544885|NCT01463046|Panobinostat|panobinostat|mesh-list
2544886|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2544887|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
2544888|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544889|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544890|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
2411966|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2411967|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2411968|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
2544891|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544892|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2544893|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
2544894|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544895|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2544896|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2544897|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2544898|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544899|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2544900|NCT01463072|Paclitaxel|paclitaxel|mesh-list
2544901|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2544902|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2544903|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544904|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
2544905|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
2544906|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
2544907|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544908|NCT01463150|Clopidogrel|clopidogrel|mesh-list
2544909|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2544910|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2544911|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2544912|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2544913|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2544914|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
2544915|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544916|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544917|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544918|NCT01463163|Ticagrelor|ticagrelor|mesh-list
2544919|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2544920|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2544921|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2411969|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
2411970|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2411971|NCT00770978|Cephalosporins|cephalosporins|mesh-list
2411972|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2411973|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2411974|NCT00771004|Pioglitazone|pioglitazone|mesh-list
2411975|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2544922|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2544923|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2544924|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
2544925|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544926|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544927|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544928|NCT01463215|Ambroxol|ambroxol|mesh-list
2544929|NCT01463215|Expectorants|expectorants|mesh-ancestor
2544930|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
2544931|NCT01463228|Metformin|metformin|mesh-list
2544932|NCT01463228|Canagliflozin|canagliflozin|mesh-list
2544933|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2544934|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544935|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2544936|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544937|NCT01463280|Lidocaine|lidocaine|mesh-list
2544938|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
2544939|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
2544940|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2544941|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544942|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
2544943|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544944|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2411976|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411977|NCT00771017|Leuprolide|leuprolide|mesh-list
2411978|NCT00771017|Goserelin|goserelin|mesh-list
2411979|NCT00771017|Bicalutamide|bicalutamide|mesh-list
2411980|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2411981|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
2411982|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2411983|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411984|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2411985|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2411986|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
2411987|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
2411988|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2411989|NCT00771043|Natalizumab|natalizumab|mesh-list
2411990|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
2411991|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411992|NCT00771134|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2411993|NCT00771134|Antidepressive Agents|antidepressive agents|mesh-ancestor
2411994|NCT00771134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2411995|NCT00771134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2411996|NCT00771134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2411997|NCT00771134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2411998|NCT00771134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2411999|NCT00771147|Sorafenib|sorafenib|mesh-list
2412000|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412001|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2412002|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2544945|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2544946|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2544947|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2544948|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544949|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
2544950|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2544951|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2544952|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544953|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2544954|NCT01463332|Analgesics|analgesics|mesh-ancestor
2544955|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
2544956|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2544957|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2544958|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2544959|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2544960|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
2544961|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2544962|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412003|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412004|NCT00771160|Montelukast|montelukast|mesh-list
2412005|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2412006|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
2412007|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2544963|NCT01463371|Azithromycin|azithromycin|mesh-list
2544964|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2544965|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544966|NCT01463592|Iodine|iodine|mesh-list
2544967|NCT01463592|Interferons|interferons|mesh-list
2544968|NCT01463592|Ribavirin|ribavirin|mesh-list
2544969|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
2544970|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
2544971|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
2412008|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
2412009|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2412010|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412011|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2412012|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2412013|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412014|NCT00771199|Fentanyl|fentanyl|mesh-list
2412015|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2544972|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544973|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
2544974|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2544975|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
2544976|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2544977|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
2544978|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544979|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2544980|NCT01463592|Trace Elements|trace elements|mesh-ancestor
2544981|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
2544982|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
2544983|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2544984|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544985|NCT01463670|Lenalidomide|lenalidomide|mesh-list
2544986|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
2544987|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544988|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2544989|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2544990|NCT01463670|Growth Substances|growth substances|mesh-ancestor
2544991|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
2412016|NCT00771199|Narcotics|narcotics|mesh-ancestor
2412017|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2412018|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412019|NCT00771199|Analgesics|analgesics|mesh-ancestor
2412020|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
2412021|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412022|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2412023|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2412024|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
2412025|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
2412026|NCT00771251|Golimumab|golimumab|mesh-list
2412027|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2544992|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2544993|NCT01463735|Vitamin E|vitamin e|mesh-list
2544994|NCT01463735|Vitamins|vitamins|mesh-ancestor
2544995|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
2544996|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2544997|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
2544998|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412028|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2412029|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2412030|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
2412031|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412032|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
2412033|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2412034|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2412035|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412036|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
2412037|NCT00771303|Coagulants|coagulants|mesh-ancestor
2412038|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
2412039|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2412040|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
2412041|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412042|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412043|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2412044|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
2412045|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2412046|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
2412047|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412048|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412049|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2412050|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
2412051|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
2412052|NCT00771342|Protective Agents|protective agents|mesh-ancestor
2544999|NCT01463735|Protective Agents|protective agents|mesh-ancestor
2545000|NCT01463774|Metformin|metformin|mesh-list
2545001|NCT01463774|Canagliflozin|canagliflozin|mesh-list
2545002|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2545003|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545004|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2545005|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545006|NCT01463813|Vitamin D|vitamin d|mesh-list
2545007|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
2545008|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
2545009|NCT01463813|Vitamins|vitamins|mesh-list
2545010|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
2545011|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545012|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2545013|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2545014|NCT01463852|Vincristine|vincristine|mesh-list
2545015|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2545016|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545017|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
2545018|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
2545019|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
2545020|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545021|NCT01463865|Ropivacaine|ropivacaine|mesh-list
2545022|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
2545023|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
2545024|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2545025|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545026|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
2545027|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545028|NCT01463956|Interferons|interferons|mesh-list
2545029|NCT01463956|Ribavirin|ribavirin|mesh-list
2545030|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545031|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
2545032|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545033|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
2545034|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545035|NCT01464008|Interferons|interferons|mesh-list
2545036|NCT01464008|Ribavirin|ribavirin|mesh-list
2545037|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
2545038|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
2545039|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2545040|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545041|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
2545042|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545043|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
2545044|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412053|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
2545045|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
2545046|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545047|NCT01464034|Dexamethasone|dexamethasone|mesh-list
2545048|NCT01464034|Pomalidomide|pomalidomide|mesh-list
2545049|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2412054|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2412055|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
2545050|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
2545051|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
2545052|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545053|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545054|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2545055|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
2545056|NCT01464034|Hormones|hormones|mesh-ancestor
2545057|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2545058|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2545059|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545060|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
2545061|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2545062|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2412056|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412057|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412058|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2545063|NCT01464034|Growth Substances|growth substances|mesh-ancestor
2545064|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
2545065|NCT01464060|Amoxicillin|amoxicillin|mesh-list
2545066|NCT01464060|Metronidazole|metronidazole|mesh-list
2545067|NCT01464060|Clarithromycin|clarithromycin|mesh-list
2545068|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2412059|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
2412060|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2412061|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
2412062|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412063|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412064|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2412065|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
2412066|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
2412067|NCT00771368|Protective Agents|protective agents|mesh-ancestor
2412068|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
2412069|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2412070|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412071|NCT00771394|Tamsulosin|tamsulosin|mesh-list
2412072|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
2412073|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2412074|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2412075|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2412076|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
2412077|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412078|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412079|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412080|NCT00771394|Urological Agents|urological agents|mesh-ancestor
2412081|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2412082|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2412083|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
2412084|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
2412085|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2412086|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2412087|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
2412088|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412089|NCT00771433|Lenograstim|lenograstim|mesh-list
2412090|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2412091|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
2412092|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412093|NCT00771459|Ropivacaine|ropivacaine|mesh-list
2412094|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
2412095|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
2412096|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2412097|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412098|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
2412099|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412100|NCT00771498|Lopinavir|lopinavir|mesh-list
2412101|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2412102|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2412103|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
2412104|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545069|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412105|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412106|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2412107|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2412108|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
2412109|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412110|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2412111|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2412112|NCT00771511|Capsaicin|capsaicin|mesh-list
2412113|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
2412114|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
2412115|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
2412116|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412117|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412118|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
2412119|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2412120|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2412121|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412122|NCT00771563|Cisplatin|cisplatin|mesh-list
2412123|NCT00771563|Docetaxel|docetaxel|mesh-list
2412124|NCT00771563|Enoxaparin|enoxaparin|mesh-list
2412125|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412126|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
2412127|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
2412128|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
2412129|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412130|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
2412131|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2412132|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2412133|NCT00771641|Cobalt|cobalt|mesh-list
2412134|NCT00771641|Trace Elements|trace elements|mesh-ancestor
2412135|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
2412136|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412137|NCT00771654|Phentermine|phentermine|mesh-list
2412138|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2412139|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412140|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
2412141|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2412142|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
2412143|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
2412144|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412145|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
2412146|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412147|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412148|NCT00771680|Insulin|insulin|mesh-list
2412149|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2412150|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
2412151|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
2412152|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2412153|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
2412154|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
2412155|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2412156|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2412157|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412158|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
2412159|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
2412160|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2412161|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2412162|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412163|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2412164|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412165|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412166|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
2412167|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2412168|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2412169|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412170|NCT00771823|Maraviroc|maraviroc|mesh-list
2412171|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2412172|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2412173|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545070|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2545071|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2545072|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2545073|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545074|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412174|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2545075|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2545076|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2545077|NCT01464099|Insulin|insulin|mesh-list
2545078|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2545079|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
2545080|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
2545081|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2545082|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2545083|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545084|NCT01464112|Dexamethasone|dexamethasone|mesh-list
2545085|NCT01464112|Bortezomib|bortezomib|mesh-list
2545086|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545087|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
2545088|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
2545089|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545090|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545091|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2545092|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
2545093|NCT01464112|Hormones|hormones|mesh-ancestor
2545094|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2545095|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2545096|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545097|NCT01464125|Azithromycin|azithromycin|mesh-list
2545098|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
2545099|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2545100|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545101|NCT01464138|Clindamycin|clindamycin|mesh-list
2545102|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
2545103|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
2545104|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
2545105|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2545106|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545107|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2545108|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545109|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545118|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2545119|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
2545120|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2545121|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545122|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545123|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2545124|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2545125|NCT01464242|Protective Agents|protective agents|mesh-ancestor
2545126|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545127|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
2545128|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2545129|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
2545130|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2545131|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2545132|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545133|NCT01464268|Riboflavin|riboflavin|mesh-list
2545134|NCT01464268|Dextrans|dextrans|mesh-list
2545135|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
2545136|NCT01464268|Vitamins|vitamins|mesh-ancestor
2545137|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
2545138|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545139|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2545140|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
2545141|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
2545142|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
2545143|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
2545144|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2545145|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
2545146|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545147|NCT01464437|Metformin|metformin|mesh-list
2545148|NCT01464437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2545149|NCT01464437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545150|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
2545151|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2545152|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
2545153|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2545154|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
2545155|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545156|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545157|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
2545158|NCT01464476|Azimilide|azimilide|mesh-list
2545159|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2545160|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2545161|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2412175|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2412176|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
2412177|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412178|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2412179|NCT00771888|Lanreotide|lanreotide|mesh-list
2412180|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412181|NCT00771979|Saracatinib|saracatinib|mesh-list
2412182|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412183|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545162|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545163|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2545164|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545165|NCT01464489|Atropine|atropine|mesh-list
2545166|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2545167|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2545168|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2545169|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
2545170|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412184|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412185|NCT00772057|Propranolol|propranolol|mesh-list
2412186|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2412187|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2412188|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
2545171|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545172|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2545173|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
2545174|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
2545175|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
2545176|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2545177|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2545178|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
2545179|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545180|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545181|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
2412189|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412190|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412191|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412192|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2545182|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2545183|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
2545184|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545185|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
2545186|NCT01464528|Protective Agents|protective agents|mesh-ancestor
2545187|NCT01464593|Doxorubicin|doxorubicin|mesh-list
2545188|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2545189|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2545190|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545191|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2545192|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2412193|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2412194|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
2545193|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545194|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545195|NCT01464606|Dactinomycin|dactinomycin|mesh-list
2545196|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
2545197|NCT01464606|Ifosfamide|ifosfamide|mesh-list
2545198|NCT01464606|Doxorubicin|doxorubicin|mesh-list
2545199|NCT01464606|Vincristine|vincristine|mesh-list
2545200|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2545201|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
2545202|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545203|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2545204|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2545205|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
2545206|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545207|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545208|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2545209|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2545210|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2412195|NCT00772122|Lenograstim|lenograstim|mesh-list
2412196|NCT00772122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2412197|NCT00772122|Immunologic Factors|immunologic factors|mesh-ancestor
2412198|NCT00772122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412199|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
2545211|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2545212|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545213|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2545214|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
2545215|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
2545216|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
2545217|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2545218|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545219|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2545220|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2545221|NCT01464671|Heparin|heparin|mesh-list
2545222|NCT01464671|Bivalirudin|bivalirudin|mesh-list
2412200|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412201|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
2412202|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2412203|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2412204|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412205|NCT00772135|Urological Agents|urological agents|mesh-ancestor
2412206|NCT00772161|Methylphenidate|methylphenidate|mesh-list
2412207|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2412208|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412209|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2412210|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2412211|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2545223|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
2545224|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2545225|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2545226|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545227|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
2545228|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2545229|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
2545230|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545231|NCT01464762|Bedaquiline|bedaquiline|mesh-list
2545232|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
2545233|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2545234|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545235|NCT01464801|Resveratrol|resveratrol|mesh-list
2545236|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
2545237|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545238|NCT01464801|Protective Agents|protective agents|mesh-ancestor
2545239|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545240|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545241|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2545242|NCT01464944|Aspirin|aspirin|mesh-list
2545243|NCT01464944|Acetaminophen|acetaminophen|mesh-list
2545244|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2545245|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2545246|NCT01464944|Analgesics|analgesics|mesh-ancestor
2545247|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
2545248|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545249|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545250|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545251|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2545252|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2545253|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2545254|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545255|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2545256|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2545257|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545258|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
2545259|NCT01464983|Aspirin|aspirin|mesh-list
2545260|NCT01464983|Ibuprofen|ibuprofen|mesh-list
2545261|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2545262|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2545263|NCT01464983|Analgesics|analgesics|mesh-ancestor
2545264|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
2545265|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545266|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545267|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545268|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2545269|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2545270|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2545271|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545272|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2545273|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2545274|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545275|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
2545276|NCT01465009|Aspirin|aspirin|mesh-list
2545277|NCT01465009|Acetaminophen|acetaminophen|mesh-list
2545278|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2545279|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2545280|NCT01465009|Analgesics|analgesics|mesh-ancestor
2412212|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412213|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
2412214|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412215|NCT00772174|Metformin|metformin|mesh-list
2412216|NCT00772174|Pioglitazone|pioglitazone|mesh-list
2412217|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2412218|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412219|NCT00772187|Fentanyl|fentanyl|mesh-list
2412220|NCT00772187|Morphine|morphine|mesh-list
2545281|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
2545282|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545283|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545284|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545285|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2545286|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2545287|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2545288|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545289|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2545290|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2545291|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545292|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
2545293|NCT01465074|Nicotine|nicotine|mesh-list
2545294|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2545295|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
2545296|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412221|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
2412222|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2412223|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412224|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2412225|NCT00772187|Narcotics|narcotics|mesh-ancestor
2412226|NCT00772187|Analgesics|analgesics|mesh-ancestor
2412227|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
2412228|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412229|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2412230|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2412231|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
2412232|NCT00772265|Insulin|insulin|mesh-list
2412233|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
2412234|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2412235|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412236|NCT00772291|Pregabalin|pregabalin|mesh-list
2412237|NCT00772291|Analgesics|analgesics|mesh-ancestor
2412238|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
2412239|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412240|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412241|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
2412242|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2412243|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2412244|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412245|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2412246|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2412247|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2412248|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2412249|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2412250|NCT00772343|Vaccines|vaccines|mesh-list
2545297|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545298|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2545299|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2545300|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
2545301|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412251|NCT00772343|Immunologic Factors|immunologic factors|mesh-ancestor
2545302|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545305|NCT01465113|Vitamin D|vitamin d|mesh-list
2545306|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
2545307|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
2545308|NCT01465113|Vitamins|vitamins|mesh-list
2545309|NCT01465113|Metformin|metformin|mesh-list
2545310|NCT01465113|Omeprazole|omeprazole|mesh-list
2545311|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
2545312|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545313|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2545314|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2545315|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2545316|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2545317|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2545318|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2545319|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545320|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545321|NCT01465152|Metformin|metformin|mesh-list
2545322|NCT01465152|Repaglinide|repaglinide|mesh-list
2545323|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2545324|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412252|NCT00772343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412253|NCT00772356|Insulin|insulin|mesh-list
2412254|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2412255|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2412256|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412257|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
2412258|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2412259|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2412260|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412261|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2412262|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412263|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2412264|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
2412265|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2412266|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
2412267|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412268|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412269|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412270|NCT00772499|Atenolol|atenolol|mesh-list
2412271|NCT00772499|Amlodipine|amlodipine|mesh-list
2412272|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2412273|NCT00772499|Olmesartan|olmesartan|mesh-list
2412274|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2412275|NCT00772499|Hydralazine|hydralazine|mesh-list
2412276|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2412277|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2412278|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2412279|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412280|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2412281|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412282|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
2412283|NCT00772499|Diuretics|diuretics|mesh-ancestor
2412284|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
2545325|NCT01465256|Aspirin|aspirin|mesh-list
2545326|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2545327|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2545328|NCT01465256|Analgesics|analgesics|mesh-ancestor
2545329|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
2545330|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545331|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545332|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545333|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2412285|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2412286|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2412287|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2412288|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2412289|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
2412290|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
2412291|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412292|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2545334|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2545335|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2545336|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545337|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2545338|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2545339|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545340|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
2545341|NCT01465373|Progesterone|progesterone|mesh-list
2545342|NCT01465373|Progestins|progestins|mesh-ancestor
2545343|NCT01465373|Hormones|hormones|mesh-ancestor
2545344|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2545345|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545346|NCT01465399|Mitogens|mitogens|mesh-list
2545347|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
2545348|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545349|NCT01465438|Adalimumab|adalimumab|mesh-list
2545350|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545351|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2545352|NCT01465503|Heparin|heparin|mesh-list
2545353|NCT01465503|Calcium heparin|calcium heparin|mesh-list
2545354|NCT01465503|Hirudins|hirudins|mesh-list
2412293|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2412294|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2412295|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
2545355|NCT01465503|Bivalirudin|bivalirudin|mesh-list
2545356|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
2545357|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2545358|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2545359|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545360|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
2545361|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2412296|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412297|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
2412298|NCT00772551|Ezetimibe|ezetimibe|mesh-list
2412299|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2412300|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2412301|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
2412302|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412303|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2412304|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2545362|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
2545363|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545364|NCT01465568|Denosumab|denosumab|mesh-list
2412305|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2412306|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
2545365|NCT01465568|Diphosphonates|diphosphonates|mesh-list
2545366|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2545367|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545368|NCT01465685|Methylphenidate|methylphenidate|mesh-list
2545369|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2412307|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412308|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2412309|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2412310|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412311|NCT00772564|Atorvastatin|atorvastatin|mesh-list
2412312|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2412313|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2412314|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
2412315|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412316|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2412317|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2116655|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2116656|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2116657|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
2116658|NCT02643979|Ketamine|ketamine|mesh-list
2116659|NCT02643979|Propofol|propofol|mesh-list
2116660|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2116661|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116662|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116663|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2116664|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
2116665|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
2545370|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2545371|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545372|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2545373|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2116666|NCT02643979|Analgesics|analgesics|mesh-ancestor
2412318|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545374|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2545375|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545376|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
2545377|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545378|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
2545379|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2545380|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
2545381|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2545382|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
2545383|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2545384|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545385|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2545386|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545387|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545388|NCT01465828|Clopidogrel|clopidogrel|mesh-list
2545389|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2545390|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2545391|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2545392|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2545393|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2545394|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
2545395|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545396|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545397|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545398|NCT01465867|Selenium|selenium|mesh-list
2545399|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
2545400|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545401|NCT01465867|Protective Agents|protective agents|mesh-ancestor
2545402|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545403|NCT01465867|Trace Elements|trace elements|mesh-ancestor
2545404|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
2545405|NCT01465893|Vitamin D|vitamin d|mesh-list
2545406|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
2545407|NCT01465893|Vitamins|vitamins|mesh-list
2545408|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
2545409|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545410|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2545411|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2545412|NCT01465906|Bromides|bromides|mesh-list
2412319|NCT00772616|Sufentanil|sufentanil|mesh-list
2412320|NCT00772616|Remifentanil|remifentanil|mesh-list
2412321|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2412322|NCT00772616|Narcotics|narcotics|mesh-ancestor
2412323|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2412324|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412325|NCT00772616|Analgesics|analgesics|mesh-ancestor
2412326|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
2412327|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545413|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
2545414|NCT01465906|Tulobuterol|tulobuterol|mesh-list
2545415|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2545416|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
2545417|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545418|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545419|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2545420|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
2545421|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
2545422|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2545423|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
2545424|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545425|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545426|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
2545427|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2545428|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2545429|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
2545430|NCT01465919|Mirtazapine|mirtazapine|mesh-list
2545431|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
2545432|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2545433|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2545434|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
2545435|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
2545436|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545437|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545438|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412328|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2545439|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2545440|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2545441|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2545442|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2545443|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2545444|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2545445|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
2545446|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2545447|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2545448|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
2545449|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2545450|NCT01465984|Acetaminophen|acetaminophen|mesh-list
2545451|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2545452|NCT01465984|Analgesics|analgesics|mesh-ancestor
2545453|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
2545454|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545455|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545456|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
2545457|NCT01466088|Donepezil|donepezil|mesh-list
2545458|NCT01466088|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2545459|NCT01466088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545460|NCT01466088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545461|NCT01466088|Cholinergic Agents|cholinergic agents|mesh-ancestor
2545462|NCT01466088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545463|NCT01466088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545464|NCT01466088|Nootropic Agents|nootropic agents|mesh-ancestor
2545465|NCT01466101|Pregabalin|pregabalin|mesh-list
2545466|NCT01466101|Analgesics|analgesics|mesh-ancestor
2545467|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
2545468|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545469|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545470|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
2412329|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2412330|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
2412331|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
2412332|NCT00772655|Rituximab|rituximab|mesh-list
2412333|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2412334|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412335|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
2412336|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412337|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2412338|NCT00772681|Docetaxel|docetaxel|mesh-list
2545471|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2545472|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2545473|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545474|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2545475|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2545476|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2412339|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412340|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
2412341|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
2412342|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
2412343|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412344|NCT00772694|Sorafenib|sorafenib|mesh-list
2412345|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412346|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2412347|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412348|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412349|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
2412350|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2412351|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2412352|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
2412353|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412354|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2412355|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2412356|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412357|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545477|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2545478|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2545479|NCT01466114|Norethindrone|norethindrone|mesh-list
2412358|NCT00772759|AZD-3199|azd-3199|mesh-list
2412359|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2412360|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2412361|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2412362|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
2412363|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412364|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412365|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412366|NCT00772785|Buprenorphine|buprenorphine|mesh-list
2545480|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
2545481|NCT01466114|Progestins|progestins|mesh-list
2545482|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2545483|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2545484|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2545485|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
2545486|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2545487|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545488|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2545489|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2412367|NCT00772785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2412368|NCT00772785|Narcotics|narcotics|mesh-ancestor
2412369|NCT00772785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2412370|NCT00772785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412371|NCT00772785|Analgesics|analgesics|mesh-ancestor
2412372|NCT00772785|Sensory System Agents|sensory system agents|mesh-ancestor
2412373|NCT00772785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412374|NCT00772785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2412375|NCT00772798|Paclitaxel|paclitaxel|mesh-list
2412376|NCT00772798|Carboplatin|carboplatin|mesh-list
2412377|NCT00772798|Vorinostat|vorinostat|mesh-list
2412378|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2412379|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412380|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
2412381|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
2116667|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
2116668|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116669|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2116670|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2116671|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2116672|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116673|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412382|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
2412383|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412384|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2412385|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412386|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2412387|NCT00772837|Amoxicillin|amoxicillin|mesh-list
2412388|NCT00772837|Clarithromycin|clarithromycin|mesh-list
2412389|NCT00772837|Omeprazole|omeprazole|mesh-list
2412390|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412391|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2412392|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2412393|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2412394|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412395|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545490|NCT01466114|Hormones|hormones|mesh-ancestor
2545491|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2545492|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
2545493|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
2545494|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
2545495|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545496|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545497|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545498|NCT01466231|Everolimus|everolimus|mesh-list
2545499|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545500|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2545501|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
2545502|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545503|NCT01466244|Cetuximab|cetuximab|mesh-list
2545504|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545505|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2545506|NCT01466257|Cetuximab|cetuximab|mesh-list
2545507|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545508|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2545509|NCT01466374|Antibodies|antibodies|mesh-list
2545510|NCT01466374|Immunoglobulins|immunoglobulins|mesh-list
2545511|NCT01466374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2545512|NCT01466374|Immunologic Factors|immunologic factors|mesh-ancestor
2545513|NCT01466374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545514|NCT01466452|Aspirin|aspirin|mesh-list
2412396|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2412397|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2412398|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2412399|NCT00772863|Docetaxel|docetaxel|mesh-list
2412400|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412401|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
2412402|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
2545515|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2545516|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2545517|NCT01466452|Analgesics|analgesics|mesh-ancestor
2545518|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
2545519|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545520|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545521|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545522|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2412403|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
2412404|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412405|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2412406|NCT00772902|Lopinavir|lopinavir|mesh-list
2412407|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2412408|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2545523|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2545524|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2545525|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545526|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2545527|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2545528|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545529|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
2545530|NCT01466465|Vitamin D|vitamin d|mesh-list
2545531|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
2545532|NCT01466465|Vitamins|vitamins|mesh-ancestor
2545533|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
2545534|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545535|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2545536|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2545537|NCT01466478|Calcitriol|calcitriol|mesh-list
2545538|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2545539|NCT01466478|Calcipotriene|calcipotriene|mesh-list
2545540|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
2412409|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412410|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412411|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
2412412|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412413|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2545541|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2545542|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545543|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2545544|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2545545|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545546|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2545547|NCT01466478|Vitamins|vitamins|mesh-ancestor
2545548|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
2545549|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2545550|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545551|NCT01466517|Ibuprofen|ibuprofen|mesh-list
2412414|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2412415|NCT00772902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2412416|NCT00772902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2412417|NCT00772902|Protease Inhibitors|protease inhibitors|mesh-ancestor
2412418|NCT00772902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2412419|NCT00772902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2412420|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
2412421|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
2412422|NCT00773058|Hormones|hormones|mesh-ancestor
2412423|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2545552|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2545553|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2545554|NCT01466517|Analgesics|analgesics|mesh-ancestor
2545555|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
2545556|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412424|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412425|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2412426|NCT00773084|Lisinopril|lisinopril|mesh-list
2412427|NCT00773084|Spironolactone|spironolactone|mesh-list
2412428|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2412429|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
2412430|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2412431|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412432|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2412433|NCT00773084|Diuretics|diuretics|mesh-ancestor
2412434|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
2412435|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2412436|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
2412437|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412438|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412439|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2412440|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2412441|NCT00773084|Protective Agents|protective agents|mesh-ancestor
2412442|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
2412443|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2412444|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545557|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545558|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545559|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2545560|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2545561|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545562|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545563|NCT01466530|Misoprostol|misoprostol|mesh-list
2545564|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2412445|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2412446|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
2412447|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2412448|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2412449|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2412450|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2412451|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412452|NCT00773188|Bevacizumab|bevacizumab|mesh-list
2412453|NCT00773188|Vinorelbine|vinorelbine|mesh-list
2412454|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2412455|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412456|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2545565|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
2545566|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2545567|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545568|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2545569|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2545570|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
2545571|NCT01466543|Udenafil|udenafil|mesh-list
2545572|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2545573|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2545574|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545575|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545576|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2545577|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2545578|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2545579|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
2545580|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545581|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2545582|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2545583|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545584|NCT01466686|Temozolomide|temozolomide|mesh-list
2412457|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2412458|NCT00773188|Growth Substances|growth substances|mesh-ancestor
2412459|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412460|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
2412461|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2412462|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
2412463|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
2412464|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
2412465|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412466|NCT00773201|Sotalol|sotalol|mesh-list
2412467|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2412468|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2412469|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
2412470|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545585|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2545586|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
2545587|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545588|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545589|NCT01466712|Beclomethasone|beclomethasone|mesh-list
2545590|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
2545591|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
2545592|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2545593|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
2412471|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412472|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412473|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2412474|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
2412475|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
2412476|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412477|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
2412478|NCT00773331|Hematinics|hematinics|mesh-ancestor
2412479|NCT00773357|Carvedilol|carvedilol|mesh-list
2412480|NCT00773357|Guanfacine|guanfacine|mesh-list
2412481|NCT00773357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2412482|NCT00773357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2412483|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
2412484|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412485|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412486|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545594|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545595|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545596|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2545597|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
2545598|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2545599|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2545600|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2545601|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
2545602|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545603|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545604|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
2545605|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2545606|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
2412487|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2412488|NCT00773357|Antioxidants|antioxidants|mesh-ancestor
2412489|NCT00773357|Protective Agents|protective agents|mesh-ancestor
2412490|NCT00773357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2412491|NCT00773357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2412492|NCT00773357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2412493|NCT00773357|Vasodilator Agents|vasodilator agents|mesh-ancestor
2412494|NCT00773357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2412495|NCT00773357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2412496|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2412497|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2412498|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2412499|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
2412500|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2412501|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2412502|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
2412503|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412504|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412505|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412506|NCT00773552|Urological Agents|urological agents|mesh-ancestor
2412507|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
2412508|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2545607|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545608|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
2545609|NCT01466712|Hormones|hormones|mesh-ancestor
2545610|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2545611|NCT01466829|Hormones|hormones|mesh-list
2545612|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
2545613|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2545614|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545615|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2545616|NCT01466855|Topotecan|topotecan|mesh-list
2545617|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2545618|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2545619|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545620|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545621|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545622|NCT01466959|Acetic Acid|acetic acid|mesh-list
2545623|NCT01466959|Retinol acetate|retinol acetate|mesh-list
2545624|NCT01466959|Citric Acid|citric acid|mesh-list
2412509|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
2412510|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412511|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412512|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2412513|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
2412514|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2412515|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
2412516|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412517|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412518|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2412519|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
2412520|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
2412521|NCT00773578|Protective Agents|protective agents|mesh-ancestor
2412522|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2412523|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
2412524|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2412525|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2412526|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412527|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412528|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2412529|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2412530|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412531|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
2412532|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412533|NCT00773630|Cilostazol|cilostazol|mesh-list
2412534|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2412535|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
2412536|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412537|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412538|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2545625|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
2545626|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
2545627|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2545628|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
2545629|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
2545630|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545631|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2545632|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2545633|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545634|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2545635|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
2545636|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545637|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2545638|NCT01466959|Protective Agents|protective agents|mesh-ancestor
2545639|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545640|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
2545641|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2545642|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545643|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2545644|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
2545645|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2545646|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545647|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545648|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545649|NCT01467115|Leucovorin|leucovorin|mesh-list
2545650|NCT01467115|Docetaxel|docetaxel|mesh-list
2545651|NCT01467115|Fluorouracil|fluorouracil|mesh-list
2545652|NCT01467115|Cetuximab|cetuximab|mesh-list
2545653|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
2545654|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
2545655|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545656|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
2545657|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
2545658|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
2545659|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545660|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
2545661|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2545662|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2545663|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
2545664|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545665|NCT01467115|Antidotes|antidotes|mesh-ancestor
2545666|NCT01467115|Protective Agents|protective agents|mesh-ancestor
2412539|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
2412540|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2412541|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2412542|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412543|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2412544|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
2412545|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2412546|NCT00773630|Protective Agents|protective agents|mesh-ancestor
2412547|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2412548|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2412549|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545667|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
2545668|NCT01467115|Vitamins|vitamins|mesh-ancestor
2545669|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
2545670|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2545671|NCT01467115|Hematinics|hematinics|mesh-ancestor
2545672|NCT01467141|Insulin|insulin|mesh-list
2545673|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2545674|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
2545675|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
2545676|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
2545677|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
2545678|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2545679|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545680|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2545681|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2545682|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545683|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2545684|NCT01467258|Amantadine|amantadine|mesh-list
2545685|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2545686|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2545687|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
2545688|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545689|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
2545690|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545691|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545692|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545693|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2545694|NCT01467258|Analgesics|analgesics|mesh-ancestor
2545695|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
2545696|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545697|NCT01467297|Levofloxacin|levofloxacin|mesh-list
2545698|NCT01467297|Ofloxacin|ofloxacin|mesh-list
2545699|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2545700|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545701|NCT01467297|Renal Agents|renal agents|mesh-ancestor
2545702|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2545703|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2545704|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2545705|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545706|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545707|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545708|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2545709|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2545710|NCT01467310|Trametinib|trametinib|mesh-list
2545711|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545712|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2545713|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545714|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545715|NCT01467323|Insulin|insulin|mesh-list
2545716|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2545717|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
2545718|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
2545719|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2545720|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545721|NCT01467362|Desonide|desonide|mesh-list
2545722|NCT01467362|V0034CR|v0034cr|mesh-list
2545723|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545724|NCT01467362|Emollients|emollients|mesh-ancestor
2545725|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
2545726|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
2545727|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
2545728|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2545729|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545730|NCT01467401|Insulin|insulin|mesh-list
2545731|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2412585|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
2412586|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2412587|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2412588|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
2412589|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412590|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2412591|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2412592|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412593|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412594|NCT00773812|Mecamylamine|mecamylamine|mesh-list
2412595|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2412596|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2412597|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
2412598|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412599|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412600|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2412601|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2412602|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
2412603|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545732|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
2545733|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
2545734|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2545735|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545736|NCT01467414|Insulin|insulin|mesh-list
2545737|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2545738|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545739|NCT01467518|Dolutegravir|dolutegravir|mesh-list
2545740|NCT01467518|Methadone|methadone|mesh-list
2545741|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2545742|NCT01467518|Narcotics|narcotics|mesh-ancestor
2545743|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2545744|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545745|NCT01467518|Analgesics|analgesics|mesh-ancestor
2545746|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
2545747|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545748|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
2545749|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
2545750|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2545751|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2545752|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412604|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545753|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545754|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2412605|NCT00773916|Methylphenidate|methylphenidate|mesh-list
2412606|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2412607|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412608|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2412609|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2412610|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2412611|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412612|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
2412613|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412614|NCT00774007|Mesalamine|mesalamine|mesh-list
2412615|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2412616|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2412617|NCT00774007|Analgesics|analgesics|mesh-ancestor
2412618|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
2412619|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412620|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412621|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2412622|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2412623|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
2412624|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2412625|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412626|NCT00774072|Tobramycin|tobramycin|mesh-list
2412627|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2412628|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412629|NCT00774111|Dolutegravir|dolutegravir|mesh-list
2412630|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2412631|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2412632|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412633|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412634|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2412635|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2412636|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
2412637|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412638|NCT00774189|Clarithromycin|clarithromycin|mesh-list
2412639|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2545755|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2545756|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
2545757|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545758|NCT01467531|Dolutegravir|dolutegravir|mesh-list
2545759|NCT01467531|Cabotegravir|cabotegravir|mesh-list
2545760|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2545761|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2545762|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412640|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412641|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2412642|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412643|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412644|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2412645|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2412646|NCT00774241|Bevacizumab|bevacizumab|mesh-list
2412647|NCT00774241|Docetaxel|docetaxel|mesh-list
2545763|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545764|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2545765|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2545766|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
2545767|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545768|NCT01467596|Lidocaine|lidocaine|mesh-list
2545769|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
2545770|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
2545771|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
2545772|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2545773|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545774|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
2545775|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545776|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2545777|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2545778|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2545779|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2545780|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545781|NCT01467648|Doripenem|doripenem|mesh-list
2545782|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2545783|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545784|NCT01467687|Verapamil|verapamil|mesh-list
2545785|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2545786|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2412648|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2412649|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412650|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2412651|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2412652|NCT00774241|Growth Substances|growth substances|mesh-ancestor
2412653|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412654|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
2412655|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
2412656|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
2545787|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2545788|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545789|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2412657|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
2412658|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412659|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
2412660|NCT00774280|Busulfan|busulfan|mesh-list
2412661|NCT00774280|Fludarabine|fludarabine|mesh-list
2545790|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545791|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
2545792|NCT01467804|Sertraline|sertraline|mesh-list
2545793|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
2545794|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2412662|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2412663|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
2412664|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412665|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2412666|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2412667|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
2412668|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412669|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412670|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2412671|NCT00774319|Cisplatin|cisplatin|mesh-list
2412672|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412673|NCT00774358|Aldesleukin|aldesleukin|mesh-list
2412674|NCT00774358|Interleukin-2|interleukin-2|mesh-list
2412675|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412676|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2412677|NCT00774358|Analgesics|analgesics|mesh-ancestor
2412678|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
2412679|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412680|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412681|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2545795|NCT01467804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2545796|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2545797|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2545798|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545799|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545800|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
2545801|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545802|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
2545803|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545804|NCT01467986|Sirolimus|sirolimus|mesh-list
2545805|NCT01467986|Irinotecan|irinotecan|mesh-list
2545806|NCT01467986|Temozolomide|temozolomide|mesh-list
2545807|NCT01467986|Dasatinib|dasatinib|mesh-list
2545808|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2545809|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2545810|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545811|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545812|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545813|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2545814|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
2412682|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2412683|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
2412684|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412685|NCT00774423|Riluzole|riluzole|mesh-list
2412686|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
2412687|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2412688|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2412689|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412690|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412691|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412692|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2412693|NCT00774423|Protective Agents|protective agents|mesh-ancestor
2545815|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2545816|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545817|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2545818|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
2545819|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2545820|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
2545821|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545822|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2545823|NCT01468025|Naproxen|naproxen|mesh-list
2545824|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2545825|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2412694|NCT00774462|Rituximab|rituximab|mesh-list
2412695|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2412696|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545826|NCT01468025|Analgesics|analgesics|mesh-ancestor
2545827|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
2545828|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545829|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545830|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545831|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2545832|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
2545833|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2545834|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545835|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545836|NCT01468038|Trazodone|trazodone|mesh-list
2545837|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2545838|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2545839|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2412697|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
2412698|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412699|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2412700|NCT00774475|Clopidogrel|clopidogrel|mesh-list
2412701|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2412702|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2412703|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2412704|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2412705|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
2545840|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545841|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2545842|NCT01468038|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2545843|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2545844|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2545845|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545846|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545847|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
2545848|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2545849|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
2545850|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2545851|NCT01468051|Vaccines|vaccines|mesh-list
2545852|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
2545853|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545854|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2545855|NCT01468051|Antacids|antacids|mesh-ancestor
2545856|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545857|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2412706|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412707|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412708|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412709|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
2412710|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2412711|NCT00774488|Incretins|incretins|mesh-ancestor
2412712|NCT00774488|Hormones|hormones|mesh-ancestor
2412713|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2545858|NCT01468155|Dabigatran|dabigatran|mesh-list
2545859|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
2545860|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2545861|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
2545862|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545863|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545864|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
2545865|NCT01468259|Droxidopa|droxidopa|mesh-list
2545866|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2545867|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2545868|NCT01468272|Beclomethasone|beclomethasone|mesh-list
2545869|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
2545870|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2545871|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
2545872|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545873|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545874|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2545875|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
2545876|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2412714|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412715|NCT00774501|Anesthetics|anesthetics|mesh-list
2412716|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2412717|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412718|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
2412719|NCT00774527|Fludarabine|fludarabine|mesh-list
2412720|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2412721|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2412722|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
2412723|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412724|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2412725|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2412726|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
2412727|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412728|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412729|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2545877|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2545878|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2545879|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
2545880|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545881|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545882|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545883|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
2545884|NCT01468272|Hormones|hormones|mesh-ancestor
2545885|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2545886|NCT01468285|Betahistine|betahistine|mesh-list
2545887|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
2545888|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
2545889|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
2545890|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545891|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545892|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545893|NCT01468389|Capecitabine|capecitabine|mesh-list
2545894|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2545895|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
2545896|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545897|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545898|NCT01468415|Phenol|phenol|mesh-list
2545899|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2545900|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545901|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
2545902|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2545903|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2545904|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2545905|NCT01468441|Cetrorelix|cetrorelix|mesh-list
2545906|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
2545907|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2545908|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
2545909|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2545910|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545911|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2545912|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2545913|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545914|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2545915|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
2545916|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
2545917|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2545918|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
2545919|NCT01468480|Calcium|calcium|mesh-list
2545920|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2545921|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545922|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2545923|NCT01468519|Insulin|insulin|mesh-list
2545924|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2545925|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2545926|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412730|NCT00774540|Ketorolac|ketorolac|mesh-list
2412731|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2412732|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2412733|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2412734|NCT00774540|Analgesics|analgesics|mesh-ancestor
2412735|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
2412736|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412737|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116674|NCT02645617|Imidacloprid|imidacloprid|mesh-list
2116675|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
2116676|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116677|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116678|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116679|NCT02646124|Naproxen|naproxen|mesh-list
2412738|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2412739|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2412740|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2412741|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412742|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412743|NCT00774605|Varenicline|varenicline|mesh-list
2412744|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2412745|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2412746|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
2412747|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412748|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412749|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412750|NCT00774644|Clarithromycin|clarithromycin|mesh-list
2412751|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2412752|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412753|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2412754|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412755|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412756|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2412757|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2412758|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
2412759|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2412760|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2412761|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
2412762|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412763|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2412764|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2412765|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412766|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412767|NCT00774696|Clarithromycin|clarithromycin|mesh-list
2412768|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2545927|NCT01468545|Iloprost|iloprost|mesh-list
2545928|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2545929|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
2545930|NCT01468571|Spironolactone|spironolactone|mesh-list
2545931|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2545932|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
2116680|NCT02646124|Diazepam|diazepam|mesh-list
2116681|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2116682|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2116683|NCT02646124|Analgesics|analgesics|mesh-ancestor
2116684|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
2116685|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116686|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116687|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2116688|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2116689|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
2116690|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2116691|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116692|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116693|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2116694|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
2116695|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
2116696|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
2116697|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2116698|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2116699|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116700|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2116701|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2545933|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2545934|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545935|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2545936|NCT01468571|Diuretics|diuretics|mesh-ancestor
2545937|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
2412769|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412770|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2412771|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412772|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412773|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2412774|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2412775|NCT00774722|Metronidazole|metronidazole|mesh-list
2412776|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412777|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2412778|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2412779|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2412780|NCT00774735|Dolutegravir|dolutegravir|mesh-list
2412781|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2412782|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2412783|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545938|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2545939|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2545940|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2545941|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2545942|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545943|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545944|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545945|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
2412784|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412785|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2412786|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2412787|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
2412788|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412789|NCT00774761|Fluticasone|fluticasone|mesh-list
2412790|NCT00774761|Xhance|xhance|mesh-list
2412791|NCT00774761|Formoterol Fumarate|formoterol fumarate|mesh-list
2412792|NCT00774761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2412793|NCT00774761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2412794|NCT00774761|Autonomic Agents|autonomic agents|mesh-ancestor
2412795|NCT00774761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2545946|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2545947|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
2545948|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545949|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2412796|NCT00774761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412797|NCT00774761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2412798|NCT00774761|Respiratory System Agents|respiratory system agents|mesh-ancestor
2412799|NCT00774761|Dermatologic Agents|dermatologic agents|mesh-ancestor
2412800|NCT00774761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2412801|NCT00774761|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2412802|NCT00774761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2412803|NCT00774761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2412804|NCT00774761|Adrenergic Agents|adrenergic agents|mesh-ancestor
2412805|NCT00774761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412806|NCT00774761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412807|NCT00774813|Citalopram|citalopram|mesh-list
2412808|NCT00774813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2412809|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2412810|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2412811|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412812|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2545950|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545951|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545952|NCT01468714|Ketoconazole|ketoconazole|mesh-list
2545953|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
2545954|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2545955|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2545956|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2412813|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
2412814|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412815|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2412816|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
2412817|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2412818|NCT00774878|Fulvestrant|fulvestrant|mesh-list
2412819|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2412820|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412821|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2412822|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2412823|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
2545957|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545958|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545959|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2545960|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
2545961|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2545962|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545963|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2545964|NCT01468740|Prednisone|prednisone|mesh-list
2545965|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
2545966|NCT01468740|Dacarbazine|dacarbazine|mesh-list
2545967|NCT01468740|Doxorubicin|doxorubicin|mesh-list
2545968|NCT01468740|Etoposide|etoposide|mesh-list
2545969|NCT01468740|Vincristine|vincristine|mesh-list
2545970|NCT01468740|Bleomycin|bleomycin|mesh-list
2545971|NCT01468740|Vinblastine|vinblastine|mesh-list
2545972|NCT01468740|Procarbazine|procarbazine|mesh-list
2545973|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2545974|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
2545975|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2545976|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2545977|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2545978|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
2545979|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2545980|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2545981|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2545982|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2545983|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2545984|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2545985|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2545986|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2545987|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
2545988|NCT01468740|Hormones|hormones|mesh-ancestor
2545989|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2545990|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2545991|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2545992|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
2545993|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
2545994|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
2545998|NCT01469143|Insulin|insulin|mesh-list
2545999|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2546000|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
2546001|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
2546002|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2546003|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2546004|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546005|NCT01469156|Ranibizumab|ranibizumab|mesh-list
2546006|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2546007|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2546008|NCT01469156|Growth Substances|growth substances|mesh-ancestor
2546009|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546010|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
2546011|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546012|NCT01469169|Iloprost|iloprost|mesh-list
2546013|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2546014|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
2546015|NCT01469338|Prednisone|prednisone|mesh-list
2546016|NCT01469338|Octreotide|octreotide|mesh-list
2546017|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2546018|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
2546019|NCT01469338|Hormones|hormones|mesh-ancestor
2412824|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2412825|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412826|NCT00774904|Losartan|losartan|mesh-list
2412827|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2412828|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2412829|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2546020|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546021|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546022|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2546023|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546024|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2546025|NCT01469351|Liraglutide|liraglutide|mesh-list
2546026|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2546027|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546028|NCT01469351|Incretins|incretins|mesh-ancestor
2546029|NCT01469351|Hormones|hormones|mesh-ancestor
2412830|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2412831|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412832|NCT00774969|Metronidazole|metronidazole|mesh-list
2412833|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412834|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2412835|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2412836|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2412837|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
2412838|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
2412839|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412840|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2412841|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412842|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2546030|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546031|NCT01469416|Clopidogrel|clopidogrel|mesh-list
2546032|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2546033|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2412843|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
2412844|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412845|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2412846|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412847|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2412848|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
2412849|NCT00775034|Coagulants|coagulants|mesh-ancestor
2412850|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2412851|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
2412852|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2412853|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
2412854|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2412855|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412856|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2412857|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2412858|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2412859|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412860|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2412861|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2412862|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2546034|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2546035|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2546036|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2546037|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
2546038|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2546039|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546040|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546041|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2546042|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2546043|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
2546044|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2412863|NCT00775073|Bevacizumab|bevacizumab|mesh-list
2412864|NCT00775073|Everolimus|everolimus|mesh-list
2412865|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2412866|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2412867|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2412868|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2412869|NCT00775073|Growth Substances|growth substances|mesh-ancestor
2412870|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412871|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
2412872|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2412873|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
2412874|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2412875|NCT00775086|Norelgestromin|norelgestromin|mesh-list
2412876|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
2412877|NCT00775086|Estradiol|estradiol|mesh-list
2412878|NCT00775086|Estrogens|estrogens|mesh-ancestor
2546045|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2546046|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546047|NCT01469468|Simvastatin|simvastatin|mesh-list
2546048|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2546049|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2546050|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
2546051|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546052|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2546053|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2546054|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546055|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
2546056|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412879|NCT00775086|Hormones|hormones|mesh-ancestor
2412880|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2412881|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412882|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2412883|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2412884|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2412885|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2412886|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2412887|NCT00775125|Ritonavir|ritonavir|mesh-list
2546057|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546058|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
2546059|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2546060|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
2546061|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546062|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
2546063|NCT01469507|Protective Agents|protective agents|mesh-ancestor
2546064|NCT01469520|Lamivudine|lamivudine|mesh-list
2546065|NCT01469520|Zidovudine|zidovudine|mesh-list
2546066|NCT01469520|Nevirapine|nevirapine|mesh-list
2546067|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2546068|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2546069|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546070|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546071|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
2412888|NCT00775125|Darunavir|darunavir|mesh-list
2412889|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
2412890|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2412891|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2412892|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
2412893|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546072|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546073|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2546074|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2546075|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
2546076|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2546077|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2546078|NCT01469559|Insulin|insulin|mesh-list
2546079|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2546080|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546081|NCT01469572|Everolimus|everolimus|mesh-list
2546082|NCT01469572|Pasireotide|pasireotide|mesh-list
2546083|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546084|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2546085|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
2546086|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546087|NCT01469572|Hormones|hormones|mesh-ancestor
2546088|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546089|NCT01469598|Gemcitabine|gemcitabine|mesh-list
2412894|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412895|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2412896|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2412897|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
2412898|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412899|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2412900|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2412901|NCT00775151|Amlodipine|amlodipine|mesh-list
2412902|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2412903|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2412904|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2412905|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546090|NCT01469598|Docetaxel|docetaxel|mesh-list
2546091|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2546092|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
2546093|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546094|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546095|NCT01469598|Antiviral Agents|antiviral agents|mesh-ancestor
2412906|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2412907|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412908|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
2412909|NCT00775164|Metformin|metformin|mesh-list
2412910|NCT00775164|Pioglitazone|pioglitazone|mesh-list
2546096|NCT01469598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546097|NCT01469598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546098|NCT01469598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2546099|NCT01469598|Immunologic Factors|immunologic factors|mesh-ancestor
2546100|NCT01469598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546101|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
2546102|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
2546103|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
2546104|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
2412911|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2412912|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412913|NCT00775177|Doxycycline|doxycycline|mesh-list
2412914|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2412915|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412916|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
2412917|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2412918|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2412919|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2412920|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2412921|NCT00775242|Estradiol|estradiol|mesh-list
2412922|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2412923|NCT00775242|Estrogens|estrogens|mesh-list
2546105|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2546106|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546107|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546108|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2546109|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2546110|NCT01469624|Protective Agents|protective agents|mesh-ancestor
2546111|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546112|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
2546113|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2546114|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
2546115|NCT01469650|Vitamin D|vitamin d|mesh-list
2546116|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
2546117|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
2546118|NCT01469650|Vitamins|vitamins|mesh-list
2546119|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
2546120|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546121|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2546122|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2412924|NCT00775242|Progesterone|progesterone|mesh-list
2412925|NCT00775242|Progestins|progestins|mesh-list
2412926|NCT00775242|Hormones|hormones|mesh-ancestor
2412927|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2412928|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412929|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2412930|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
2412931|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2412932|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2412933|NCT00775255|Clarithromycin|clarithromycin|mesh-list
2412934|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2412935|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412936|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2412937|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412938|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412939|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2412940|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2412941|NCT00775294|Maraviroc|maraviroc|mesh-list
2546123|NCT01469702|Azithromycin|azithromycin|mesh-list
2546124|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2546125|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546126|NCT01469884|Cyclosporine|cyclosporine|mesh-list
2546127|NCT01469884|Everolimus|everolimus|mesh-list
2546128|NCT01469884|Tacrolimus|tacrolimus|mesh-list
2546129|NCT01469884|Cyclosporins|cyclosporins|mesh-list
2412942|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2546130|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2412943|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2412944|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412945|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2412946|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2412947|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
2412948|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412949|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2412950|NCT00775359|Fenofibrate|fenofibrate|mesh-list
2412951|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2412952|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
2412953|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412954|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2412955|NCT00775372|Clarithromycin|clarithromycin|mesh-list
2412956|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2412957|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2412958|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2412959|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2412960|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412961|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2412962|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2412963|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
2412964|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2412965|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
2412966|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546131|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
2546132|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546133|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2546134|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546135|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546136|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
2546137|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546138|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
2546139|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2546140|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546141|NCT01469975|Edetic Acid|edetic acid|mesh-list
2546142|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
2546143|NCT01469975|Antidotes|antidotes|mesh-ancestor
2546144|NCT01469975|Protective Agents|protective agents|mesh-ancestor
2546145|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546146|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
2546147|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
2546148|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546149|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2546150|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
2546151|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2546152|NCT01469988|Testosterone|testosterone|mesh-list
2546153|NCT01469988|Androgens|androgens|mesh-ancestor
2546154|NCT01469988|Hormones|hormones|mesh-ancestor
2546155|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546156|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546157|NCT01470040|Aspirin|aspirin|mesh-list
2546158|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2546159|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2412967|NCT00775476|Expectorants|expectorants|mesh-ancestor
2412968|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
2412969|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2412970|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
2412971|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412972|NCT00775476|Protective Agents|protective agents|mesh-ancestor
2412973|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546160|NCT01470040|Analgesics|analgesics|mesh-ancestor
2546161|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
2546162|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2546163|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546164|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2546165|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2546166|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2546167|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2546168|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546169|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2546170|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2546171|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546172|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
2412974|NCT00775476|Antidotes|antidotes|mesh-ancestor
2412975|NCT00775489|Beclomethasone|beclomethasone|mesh-list
2546173|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
2546174|NCT01470053|Azelastine|azelastine|mesh-list
2546175|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2546176|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
2546177|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2546178|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2546179|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
2546180|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2546181|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546182|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2546183|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
2546184|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2546185|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546186|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546187|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2546188|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2546189|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
2546190|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
2546191|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2546192|NCT01470092|Tibolone|tibolone|mesh-list
2546193|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
2546194|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
2546195|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546196|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546197|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2546198|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2546199|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546200|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2546201|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
2546202|NCT01470092|Hormones|hormones|mesh-ancestor
2546203|NCT01470131|Dexamethasone|dexamethasone|mesh-list
2546204|NCT01470131|Bortezomib|bortezomib|mesh-list
2546205|NCT01470131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2546206|NCT01470131|Antiemetics|antiemetics|mesh-ancestor
2546207|NCT01470131|Autonomic Agents|autonomic agents|mesh-ancestor
2546208|NCT01470131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2546209|NCT01470131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546210|NCT01470131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2546211|NCT01470131|Glucocorticoids|glucocorticoids|mesh-ancestor
2546212|NCT01470131|Hormones|hormones|mesh-ancestor
2546213|NCT01470131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546214|NCT01470131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2546215|NCT01470131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546216|NCT01470157|Ketamine|ketamine|mesh-list
2546217|NCT01470157|Analgesics|analgesics|mesh-ancestor
2546218|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
2546219|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2546220|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546221|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2546222|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2546223|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
2546224|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
2546225|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2546226|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2546227|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2546228|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2412976|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2412977|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
2412978|NCT00775489|Hormones|hormones|mesh-ancestor
2412979|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2412980|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412981|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2412982|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
2412983|NCT00775541|Ascorbic Acid|ascorbic acid|mesh-list
2412984|NCT00775541|Vitamins|vitamins|mesh-ancestor
2412985|NCT00775541|Micronutrients|micronutrients|mesh-ancestor
2412986|NCT00775541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412987|NCT00775541|Antioxidants|antioxidants|mesh-ancestor
2412988|NCT00775541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2412989|NCT00775541|Protective Agents|protective agents|mesh-ancestor
2412990|NCT00775580|Atenolol|atenolol|mesh-list
2412991|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2412992|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2412993|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
2412994|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
2546229|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546230|NCT01470209|Everolimus|everolimus|mesh-list
2546231|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546232|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2546233|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
2546234|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546235|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
2546236|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2546237|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2546238|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
2546239|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546240|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546241|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2546242|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2546243|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2546244|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2546245|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2546246|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546247|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2546248|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546249|NCT01470339|Analgesics|analgesics|mesh-ancestor
2546250|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
2546251|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2546252|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
2546253|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2546254|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
2546255|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2546256|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2546257|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2546258|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2546259|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546260|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2546261|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546262|NCT01470352|Analgesics|analgesics|mesh-ancestor
2546263|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
2546264|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2546265|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
2546266|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2546267|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
2546268|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
2546269|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546270|NCT01470456|Rituximab|rituximab|mesh-list
2546271|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2546272|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546273|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
2546274|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546275|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2546276|NCT01470495|Sorafenib|sorafenib|mesh-list
2546277|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546278|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2546279|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546280|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546281|NCT01470690|Omeprazole|omeprazole|mesh-list
2546282|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2412995|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2412996|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2412997|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2412998|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2412999|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2413000|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
2413001|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413002|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413003|NCT00775619|Carvedilol|carvedilol|mesh-list
2413004|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2546283|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2546284|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2546285|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546286|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546287|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2546288|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546289|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2413005|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2413006|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
2546290|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546291|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546292|NCT01470742|Capecitabine|capecitabine|mesh-list
2546293|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2546294|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
2546295|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546296|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546297|NCT01470755|Albuterol|albuterol|mesh-list
2546298|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2546299|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
2546300|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2546301|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546302|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2546303|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
2546304|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
2546305|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2546306|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2546307|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2546308|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2546309|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
2546310|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2546311|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546312|NCT01470794|Flucytosine|flucytosine|mesh-list
2546313|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
2546314|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546315|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
2413007|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413008|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413009|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413010|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2413011|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
2413012|NCT00775619|Protective Agents|protective agents|mesh-ancestor
2413013|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2413014|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2413015|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2413016|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
2546316|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546317|NCT01470807|Pancrelipase|pancrelipase|mesh-list
2546318|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2546319|NCT01470937|Acarbose|acarbose|mesh-list
2546320|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2546321|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546322|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546323|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2546324|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546325|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
2546326|NCT01471067|Rituximab|rituximab|mesh-list
2546327|NCT01471067|Fludarabine|fludarabine|mesh-list
2546328|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
2546329|NCT01471067|Melphalan|melphalan|mesh-list
2546330|NCT01471067|Busulfan|busulfan|mesh-list
2546331|NCT01471067|Clofarabine|clofarabine|mesh-list
2546332|NCT01471067|Tacrolimus|tacrolimus|mesh-list
2546333|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
2546334|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2546335|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2546336|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546337|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
2546338|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546339|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2546340|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2546341|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
2546342|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413017|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2413018|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2413019|NCT00775632|Cyclosporine|cyclosporine|mesh-list
2413020|NCT00775632|Methotrexate|methotrexate|mesh-list
2413021|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
2413022|NCT00775632|Cyclosporins|cyclosporins|mesh-list
2413023|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2413024|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
2413025|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2546343|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2546344|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546345|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2546346|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413026|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546347|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2546348|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2546349|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
2546350|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2546351|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2546352|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
2546353|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2546354|NCT01471106|Dasatinib|dasatinib|mesh-list
2546355|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546356|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2546357|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546358|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546359|NCT01471132|Paclitaxel|paclitaxel|mesh-list
2546360|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
2546361|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2546362|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546363|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
2546364|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
2546365|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
2546366|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546367|NCT01471145|Naltrexone|naltrexone|mesh-list
2413027|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2413028|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
2413029|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413030|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413031|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
2413032|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413033|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2413034|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2413035|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
2413036|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2546368|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2546369|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2546370|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546371|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
2546372|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2546373|NCT01471158|Timolol|timolol|mesh-list
2546374|NCT01471158|Dorzolamide|dorzolamide|mesh-list
2546375|NCT01471158|Maleic acid|maleic acid|mesh-list
2546376|NCT01471158|Brinzolamide|brinzolamide|mesh-list
2546377|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2546378|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2546379|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
2546380|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2546381|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546382|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413037|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2413038|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
2413039|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413040|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2413041|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2413042|NCT00775697|Montelukast|montelukast|mesh-list
2413043|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
2413044|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2413045|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
2413046|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
2413047|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2413048|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413049|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2413050|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2413051|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413052|NCT00775736|Insulin|insulin|mesh-list
2413053|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2413054|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
2413055|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
2413056|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2413057|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
2546383|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2546384|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2546385|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546386|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2546387|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2546388|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2546389|NCT01471262|Liver Extracts|liver extracts|mesh-list
2546390|NCT01471262|Hematinics|hematinics|mesh-ancestor
2546391|NCT01471275|Metformin|metformin|mesh-list
2546392|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2546393|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546394|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2546395|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2546396|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546427|NCT01471470|Bevacizumab|bevacizumab|mesh-list
2546428|NCT01471470|Docetaxel|docetaxel|mesh-list
2546429|NCT01471470|Capecitabine|capecitabine|mesh-list
2546430|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2546431|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546432|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2546433|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2546434|NCT01471470|Growth Substances|growth substances|mesh-ancestor
2546435|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546436|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
2546437|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
2546438|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
2546439|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
2546440|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413058|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2413059|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2413060|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413061|NCT00775749|Nicotine|nicotine|mesh-list
2413062|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2413063|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
2413064|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413065|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413066|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2413067|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2413068|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
2413069|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413070|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413071|NCT00775762|Aspirin|aspirin|mesh-list
2413072|NCT00775762|Clopidogrel|clopidogrel|mesh-list
2413073|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2413074|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2413075|NCT00775762|Analgesics|analgesics|mesh-ancestor
2413076|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
2413077|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2546441|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2546442|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
2546443|NCT01471535|Interferons|interferons|mesh-list
2546444|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
2546445|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
2546446|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2546447|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546448|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
2546449|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546450|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
2413078|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413079|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2413080|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2413081|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2413082|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2413083|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413084|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2413085|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2413086|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413087|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
2413088|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2413089|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2413090|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2413091|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
2413092|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413093|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2413094|NCT00775814|Candesartan|candesartan|mesh-list
2413095|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2546451|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546452|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
2546453|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
2546454|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2546455|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546456|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546457|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
2546458|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2546459|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2546460|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546461|NCT01471678|Tamsulosin|tamsulosin|mesh-list
2546462|NCT01471678|Dutasteride|dutasteride|mesh-list
2546463|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2413096|NCT00775814|Diuretics|diuretics|mesh-ancestor
2413097|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
2413098|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546464|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2546465|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2546466|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
2546467|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2546468|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546469|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546470|NCT01471678|Urological Agents|urological agents|mesh-ancestor
2546471|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2546472|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2546473|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546474|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
2546475|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546476|NCT01471704|Verapamil|verapamil|mesh-list
2546477|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2546478|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2546479|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2546480|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546481|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2546482|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546483|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
2546484|NCT01471730|Thrombin|thrombin|mesh-list
2546485|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
2546486|NCT01471730|Coagulants|coagulants|mesh-ancestor
2546487|NCT01471808|Metformin|metformin|mesh-list
2546488|NCT01471808|Pioglitazone|pioglitazone|mesh-list
2546489|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2546490|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2546491|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546492|NCT01471808|Incretins|incretins|mesh-ancestor
2546493|NCT01471808|Hormones|hormones|mesh-ancestor
2546494|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546495|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2413099|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2413100|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2413101|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413102|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2413103|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2413104|NCT00775827|Fenofibrate|fenofibrate|mesh-list
2413105|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2413106|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
2413107|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413108|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2413109|NCT00775840|Candesartan|candesartan|mesh-list
2413110|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2413111|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2413112|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2413113|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413114|NCT00775879|Sevoflurane|sevoflurane|mesh-list
2413115|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2413116|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2413117|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
2413118|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
2413119|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2413120|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413121|NCT00775905|Amlodipine|amlodipine|mesh-list
2413122|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2413123|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2413124|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2413125|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546496|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
2546497|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546498|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546499|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2546500|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
2546501|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546502|NCT01471847|Capecitabine|capecitabine|mesh-list
2546503|NCT01471847|Trastuzumab|trastuzumab|mesh-list
2546504|NCT01471847|Lapatinib|lapatinib|mesh-list
2546505|NCT01471847|Dactolisib|dactolisib|mesh-list
2546506|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2546507|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
2546508|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546509|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546510|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2546511|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2546512|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546513|NCT01471886|Ketorolac|ketorolac|mesh-list
2546514|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2546515|NCT01471886|Naproxen|naproxen|mesh-list
2546516|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2546517|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2546518|NCT01471886|Analgesics|analgesics|mesh-ancestor
2546519|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
2413126|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2413127|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413128|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
2413129|NCT00775918|Doxycycline|doxycycline|mesh-list
2413130|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413131|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413132|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
2413133|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2413134|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2413135|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
2413136|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
2413137|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2413138|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2413139|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2413140|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413141|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2413142|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
2413143|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
2413144|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413145|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413146|NCT00776022|Cetirizine|cetirizine|mesh-list
2413147|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2413148|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2413149|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2546520|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2546521|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546522|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2413150|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
2413151|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
2413152|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413153|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413154|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413155|NCT00776074|Leuprolide|leuprolide|mesh-list
2413156|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2413157|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
2413158|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2413159|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413160|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2413161|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546523|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2546524|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2546525|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546526|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546527|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
2546528|NCT01471899|Ketorolac|ketorolac|mesh-list
2546529|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2546530|NCT01471899|Naproxen|naproxen|mesh-list
2413162|NCT00776113|Carvedilol|carvedilol|mesh-list
2413163|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2413164|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2413165|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
2413166|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413167|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413168|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413169|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2413170|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
2413171|NCT00776113|Protective Agents|protective agents|mesh-ancestor
2413172|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2413173|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2413174|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2413175|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
2413176|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2413177|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2413178|NCT00776139|Cetirizine|cetirizine|mesh-list
2413179|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2413180|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2413181|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2413182|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
2413183|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
2413184|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413185|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413186|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413187|NCT00776217|Loratadine|loratadine|mesh-list
2413188|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
2413189|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
2413190|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2413191|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2413192|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2413193|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
2413194|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
2413195|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413196|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413197|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413198|NCT00776282|Loratadine|loratadine|mesh-list
2546531|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2546532|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2546533|NCT01471899|Analgesics|analgesics|mesh-ancestor
2546534|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
2546535|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2546536|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546537|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2546538|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2546539|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2546540|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413199|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
2413200|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
2413201|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2413202|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2413203|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2413204|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
2413205|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
2413206|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413207|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546541|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546542|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
2546543|NCT01471925|Esomeprazole|esomeprazole|mesh-list
2546544|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2546545|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2546546|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2546547|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546548|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546549|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2546550|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546551|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2546552|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546553|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546554|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
2546555|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
2546556|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2546557|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
2546558|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2546559|NCT01471990|Protective Agents|protective agents|mesh-ancestor
2546560|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546561|NCT01471990|Growth Substances|growth substances|mesh-ancestor
2546562|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2546563|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546564|NCT01472016|Docetaxel|docetaxel|mesh-list
2546565|NCT01472016|Cetuximab|cetuximab|mesh-list
2546566|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2546567|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546568|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
2546569|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
2546570|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
2546571|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546572|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2546573|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2546574|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413208|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413209|NCT00776334|Fosinopril|fosinopril|mesh-list
2413210|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2413211|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
2413212|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413213|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546575|NCT01472029|Leucovorin|leucovorin|mesh-list
2546576|NCT01472029|Docetaxel|docetaxel|mesh-list
2546577|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
2546578|NCT01472029|Trastuzumab|trastuzumab|mesh-list
2546579|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546580|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
2546581|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
2546582|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
2546583|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546584|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2546585|NCT01472029|Antidotes|antidotes|mesh-ancestor
2546586|NCT01472029|Protective Agents|protective agents|mesh-ancestor
2546587|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413214|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2413215|NCT00776347|Donepezil|donepezil|mesh-list
2413216|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2413217|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413218|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546588|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
2546589|NCT01472029|Vitamins|vitamins|mesh-ancestor
2546590|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
2546591|NCT01472055|Fludarabine|fludarabine|mesh-list
2546592|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546593|NCT01472146|Doxorubicin|doxorubicin|mesh-list
2546594|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413219|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
2546595|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2546596|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2546597|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2546598|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546599|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546600|NCT01472198|Gemcitabine|gemcitabine|mesh-list
2546601|NCT01472198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2546602|NCT01472198|Antimetabolites|antimetabolites|mesh-ancestor
2546603|NCT01472198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546604|NCT01472198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546605|NCT01472198|Antiviral Agents|antiviral agents|mesh-ancestor
2546606|NCT01472198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413220|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413221|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413222|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
2413223|NCT00776360|Oxytocin|oxytocin|mesh-list
2413224|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
2413225|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2413226|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413227|NCT00776373|Cytarabine|cytarabine|mesh-list
2413228|NCT00776373|Sirolimus|sirolimus|mesh-list
2413229|NCT00776373|Etoposide|etoposide|mesh-list
2413230|NCT00776373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2413231|NCT00776373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413232|NCT00776373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2413233|NCT00776373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2413234|NCT00776373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413235|NCT00776373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413236|NCT00776373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2413237|NCT00776373|Antimetabolites|antimetabolites|mesh-ancestor
2413238|NCT00776373|Antiviral Agents|antiviral agents|mesh-ancestor
2413239|NCT00776373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413240|NCT00776373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2413241|NCT00776373|Immunologic Factors|immunologic factors|mesh-ancestor
2413242|NCT00776373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413243|NCT00776373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413244|NCT00776373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2413245|NCT00776373|Antifungal Agents|antifungal agents|mesh-ancestor
2413246|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
2413247|NCT00776425|Hematinics|hematinics|mesh-ancestor
2546607|NCT01472198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546608|NCT01472198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2546609|NCT01472198|Immunologic Factors|immunologic factors|mesh-ancestor
2546610|NCT01472198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546611|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
2546612|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2546613|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546614|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546615|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2546616|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2546617|NCT01472263|Protective Agents|protective agents|mesh-ancestor
2546618|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546619|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
2546620|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2546621|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
2546622|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2546623|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
2546624|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2546625|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2546626|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2546627|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
2413248|NCT00776438|Vaccines|vaccines|mesh-list
2413249|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
2413250|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413251|NCT00776477|Aspirin|aspirin|mesh-list
2413252|NCT00776477|Clopidogrel|clopidogrel|mesh-list
2413253|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2413254|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2413255|NCT00776477|Analgesics|analgesics|mesh-ancestor
2413256|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
2413257|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413258|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413259|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2413260|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2413261|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2413262|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2413263|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546628|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2546629|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546630|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2546631|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2546632|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2546633|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2546634|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546635|NCT01472406|Pancrelipase|pancrelipase|mesh-list
2546636|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2546637|NCT01472497|Pioglitazone|pioglitazone|mesh-list
2546638|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2546639|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546640|NCT01472510|Ranibizumab|ranibizumab|mesh-list
2546641|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2546642|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2546643|NCT01472510|Growth Substances|growth substances|mesh-ancestor
2546644|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546645|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
2546646|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546647|NCT01472640|Liraglutide|liraglutide|mesh-list
2546648|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2546649|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546650|NCT01472640|Incretins|incretins|mesh-ancestor
2546651|NCT01472640|Hormones|hormones|mesh-ancestor
2546652|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546653|NCT01472653|Cetuximab|cetuximab|mesh-list
2546654|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546655|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2413264|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2413265|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2413266|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413267|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
2413268|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2413269|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2413270|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2413271|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
2413272|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413273|NCT00776490|Glimepiride|glimepiride|mesh-list
2413274|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2413275|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2413276|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413277|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2413278|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
2413279|NCT00776503|Vorinostat|vorinostat|mesh-list
2413280|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413281|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2413282|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413283|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413284|NCT00776516|Rifampin|rifampin|mesh-list
2413285|NCT00776516|Mirabegron|mirabegron|mesh-list
2413286|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2413287|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
2413288|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413289|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413290|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
2413291|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2413292|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413293|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413294|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2413295|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2413296|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2413297|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2413298|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2413299|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2413300|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2413301|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2413302|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2413303|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
2413304|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413305|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413306|NCT00776516|Urological Agents|urological agents|mesh-ancestor
2413307|NCT00776542|Minocycline|minocycline|mesh-list
2413308|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413309|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413310|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
2413311|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2413312|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2413313|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413314|NCT00776620|Glimepiride|glimepiride|mesh-list
2413315|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2413316|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2413317|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413318|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2413319|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
2413320|NCT00776633|Aspirin|aspirin|mesh-list
2413321|NCT00776633|Clopidogrel|clopidogrel|mesh-list
2413322|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2413323|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2413324|NCT00776633|Analgesics|analgesics|mesh-ancestor
2413325|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
2413326|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413327|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413328|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2413329|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2413330|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2413331|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2413332|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413333|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2116702|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2116703|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2116704|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2116705|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2116706|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
2116707|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
2116708|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
2546656|NCT01472666|Caseins|caseins|mesh-list
2546657|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
2546658|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
2546659|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546660|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2546661|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
2546662|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546663|NCT01472770|Gemcitabine|gemcitabine|mesh-list
2546664|NCT01472770|Capecitabine|capecitabine|mesh-list
2546665|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2413334|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2413335|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413336|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
2413337|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2413338|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2413339|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2413340|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
2413341|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413342|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2413343|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2413344|NCT00776646|Diuretics|diuretics|mesh-ancestor
2546666|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
2546667|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546668|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546669|NCT01472770|Antiviral Agents|antiviral agents|mesh-ancestor
2546670|NCT01472770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546671|NCT01472770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546672|NCT01472770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2546673|NCT01472770|Immunologic Factors|immunologic factors|mesh-ancestor
2546674|NCT01472770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546675|NCT01472783|Veliparib|veliparib|mesh-list
2546676|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2546677|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546678|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546679|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546680|NCT01472796|Vitamin D|vitamin d|mesh-list
2546681|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
2546682|NCT01472796|Vitamins|vitamins|mesh-ancestor
2546683|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
2116709|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
2116710|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116711|NCT02646332|Amoxicillin|amoxicillin|mesh-list
2116712|NCT02646332|Metronidazole|metronidazole|mesh-list
2116713|NCT02646332|Clarithromycin|clarithromycin|mesh-list
2116714|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
2116715|NCT02646332|Lansoprazole|lansoprazole|mesh-list
2546684|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546685|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2546686|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2546687|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2546688|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
2546689|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2546690|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
2546691|NCT01472913|Coagulants|coagulants|mesh-ancestor
2546692|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2413345|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
2413346|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413347|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2413348|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2413349|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413350|NCT00776672|Fosinopril|fosinopril|mesh-list
2413351|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2413352|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
2413353|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413354|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413355|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2413356|NCT00776698|Bevacizumab|bevacizumab|mesh-list
2413357|NCT00776698|Etoposide|etoposide|mesh-list
2413358|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2413359|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413360|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2413361|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2413362|NCT00776698|Growth Substances|growth substances|mesh-ancestor
2413363|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413364|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
2546693|NCT01472926|Plasminogen|plasminogen|mesh-list
2546694|NCT01472926|Tenecteplase|tenecteplase|mesh-list
2546695|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2546696|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2546697|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413365|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2413366|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2413367|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2413368|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413369|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413370|NCT00776724|Docetaxel|docetaxel|mesh-list
2413371|NCT00776724|Epirubicin|epirubicin|mesh-list
2413372|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413373|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
2413374|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
2413375|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
2413376|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413377|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2413378|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2413379|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2413380|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413381|NCT00776763|Bevacizumab|bevacizumab|mesh-list
2413382|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2413383|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413384|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2413385|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2413386|NCT00776763|Growth Substances|growth substances|mesh-ancestor
2546698|NCT01472978|Metronidazole|metronidazole|mesh-list
2546699|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546700|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2546701|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2546702|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2546703|NCT01473043|Axitinib|axitinib|mesh-list
2546704|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546705|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2546706|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546707|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546708|NCT01473069|Ketoconazole|ketoconazole|mesh-list
2546709|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
2546710|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546711|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2546712|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2546713|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546714|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413387|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413388|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
2413389|NCT00776802|Dexamethasone|dexamethasone|mesh-list
2413390|NCT00776802|Etoposide|etoposide|mesh-list
2413391|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2413392|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
2413393|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
2413394|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413395|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413396|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2413397|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
2413398|NCT00776802|Hormones|hormones|mesh-ancestor
2413399|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2413400|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2413401|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546715|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2546716|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
2546717|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546718|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546719|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2546720|NCT01473108|Eplerenone|eplerenone|mesh-list
2546721|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2546722|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
2546723|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546724|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546725|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2546726|NCT01473108|Diuretics|diuretics|mesh-ancestor
2546727|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
2546728|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2546729|NCT01473147|Exenatide|exenatide|mesh-list
2546730|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2546731|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413402|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2413403|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2413404|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2413405|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413406|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413407|NCT00776828|Cilostazol|cilostazol|mesh-list
2413408|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2413409|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
2413410|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413411|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413412|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2413413|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
2413414|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2413415|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2413416|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413417|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2413418|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
2413419|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2413420|NCT00776828|Protective Agents|protective agents|mesh-ancestor
2413421|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2413422|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2413423|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413424|NCT00776841|Cholic Acids|cholic acids|mesh-list
2413425|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
2413426|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2413427|NCT00777114|Bortezomib|bortezomib|mesh-list
2413428|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413429|NCT00777127|Diclofenac|diclofenac|mesh-list
2413430|NCT00777127|Imiquimod|imiquimod|mesh-list
2413431|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2413432|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2413433|NCT00777127|Analgesics|analgesics|mesh-ancestor
2413434|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
2413435|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413436|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413437|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2413438|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2413439|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2413440|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413441|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546732|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2546733|NCT01473147|Incretins|incretins|mesh-ancestor
2413442|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2413443|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
2413444|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413445|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
2413446|NCT00777140|Deferoxamine|deferoxamine|mesh-list
2413447|NCT00777140|Siderophores|siderophores|mesh-ancestor
2413448|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2413449|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
2546734|NCT01473147|Hormones|hormones|mesh-ancestor
2546735|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546736|NCT01473173|Esomeprazole|esomeprazole|mesh-list
2546737|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2546738|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2546739|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2546740|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546741|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546742|NCT01473251|Bevacizumab|bevacizumab|mesh-list
2546743|NCT01473251|Ranibizumab|ranibizumab|mesh-list
2546744|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2546745|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546746|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2546747|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2546748|NCT01473251|Growth Substances|growth substances|mesh-ancestor
2546749|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546750|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
2413450|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
2413451|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413452|NCT00777166|Oxytocin|oxytocin|mesh-list
2413453|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
2413454|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2413455|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413456|NCT00777218|Topiramate|topiramate|mesh-list
2413457|NCT00777218|Propranolol|propranolol|mesh-list
2413458|NCT00777218|Zonisamide|zonisamide|mesh-list
2413459|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2413460|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2413461|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
2413462|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413463|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413464|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413465|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2413466|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2413467|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
2413468|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
2413469|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2413470|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2413471|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2413472|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2546751|NCT01473277|Triamcinolone|triamcinolone|mesh-list
2546752|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2546753|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2413473|NCT00777244|Mitotane|mitotane|mesh-list
2413474|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2413475|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413476|NCT00777309|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2413477|NCT00777309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413478|NCT00777309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2413479|NCT00777309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413480|NCT00777309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413481|NCT00777322|Riboflavin|riboflavin|mesh-list
2413482|NCT00777322|Dextrans|dextrans|mesh-list
2413483|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
2413484|NCT00777322|Vitamins|vitamins|mesh-ancestor
2413485|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
2413486|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413487|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2413488|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
2413489|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
2413490|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
2413491|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
2413492|NCT00777348|Reproterol|reproterol|mesh-list
2413493|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2413494|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2413495|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
2413496|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413497|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413498|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546754|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2546755|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2546756|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2546757|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
2546758|NCT01473277|Hormones|hormones|mesh-ancestor
2546759|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546760|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546761|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2546762|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
2546763|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546764|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413499|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2413500|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
2413501|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413502|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2413503|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
2546765|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2546766|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2546767|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
2546768|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2546769|NCT01473303|Leucovorin|leucovorin|mesh-list
2546770|NCT01473303|Fluorouracil|fluorouracil|mesh-list
2546771|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
2413504|NCT00777413|Minocycline|minocycline|mesh-list
2413505|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413506|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413507|NCT00777439|Domperidone|domperidone|mesh-list
2413508|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413509|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
2413510|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
2413511|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413512|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413513|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2413514|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2413515|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
2413516|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413517|NCT00777478|Sunitinib|sunitinib|mesh-list
2413518|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413519|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2413520|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2413521|NCT00777478|Growth Substances|growth substances|mesh-ancestor
2413522|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413523|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
2413524|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2546772|NCT01473303|Irinotecan|irinotecan|mesh-list
2546773|NCT01473303|Calcium|calcium|mesh-list
2546774|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
2546775|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2546776|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546777|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
2546778|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546779|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2546780|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413525|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413526|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413527|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
2413528|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2546781|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2546782|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
2413529|NCT00777504|Growth Substances|growth substances|mesh-ancestor
2413530|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413531|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
2413532|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413533|NCT00777517|Atorvastatin|atorvastatin|mesh-list
2413534|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2413535|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2413536|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
2546783|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2546784|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2546785|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546786|NCT01473303|Antidotes|antidotes|mesh-ancestor
2413537|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413538|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2413539|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2546787|NCT01473303|Protective Agents|protective agents|mesh-ancestor
2413540|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413541|NCT00777543|Ferulic acid|ferulic acid|mesh-list
2413542|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2546788|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
2546789|NCT01473303|Vitamins|vitamins|mesh-ancestor
2546790|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
2546791|NCT01473316|Ketoconazole|ketoconazole|mesh-list
2546792|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
2546793|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546794|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2546795|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2546796|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546797|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546798|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2546799|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
2546800|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546801|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546802|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2546803|NCT01473472|Tenofovir|tenofovir|mesh-list
2546804|NCT01473472|Emtricitabine|emtricitabine|mesh-list
2546805|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2546806|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
2546807|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2546808|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2546809|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2546810|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546811|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546812|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2546813|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2546814|NCT01473537|Calcium|calcium|mesh-list
2546815|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2546816|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546817|NCT01473628|Rituximab|rituximab|mesh-list
2546818|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2546819|NCT01473628|Antibodies|antibodies|mesh-list
2413543|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2413544|NCT00777543|Analgesics|analgesics|mesh-ancestor
2413545|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
2413546|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413547|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413548|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2413549|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2413550|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
2413551|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2413552|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2413553|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2413554|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2546820|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
2546821|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2546822|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
2546823|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546824|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546825|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2546826|NCT01473797|Cladribine|cladribine|mesh-list
2546827|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546828|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2546829|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
2546830|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413555|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
2413556|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413557|NCT00777543|Protective Agents|protective agents|mesh-ancestor
2413558|NCT00777569|Nicotine|nicotine|mesh-list
2413559|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2413560|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
2413561|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413562|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413563|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2413564|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2546831|NCT01473810|Endocine|endocine|mesh-list
2546832|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2546833|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
2546834|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546835|NCT01473901|Temozolomide|temozolomide|mesh-list
2546836|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2546837|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
2413565|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
2413566|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413567|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546838|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546839|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546840|NCT01473914|Vitamins|vitamins|mesh-list
2546841|NCT01473914|Vitamin E|vitamin e|mesh-list
2546842|NCT01473914|Tocopherols|tocopherols|mesh-list
2546843|NCT01473914|Tocotrienols|tocotrienols|mesh-list
2546844|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
2546845|NCT01473914|Zinc|zinc|mesh-list
2546846|NCT01473914|Selenium|selenium|mesh-list
2546847|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
2546848|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546849|NCT01473914|Trace Elements|trace elements|mesh-ancestor
2546850|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
2546851|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546852|NCT01473914|Protective Agents|protective agents|mesh-ancestor
2546853|NCT01474135|Travoprost|travoprost|mesh-list
2546854|NCT01474135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2546855|NCT01474174|Vaccines|vaccines|mesh-list
2546856|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
2546857|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546858|NCT01474187|Capecitabine|capecitabine|mesh-list
2546859|NCT01474187|Irinotecan|irinotecan|mesh-list
2546860|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2546861|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
2546862|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546863|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546864|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2116716|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2116717|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2116718|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2116719|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2116720|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2116721|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116722|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116723|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2116724|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2116725|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2116726|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2116727|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2546865|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2546866|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546867|NCT01474265|Varenicline|varenicline|mesh-list
2546868|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2546869|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2546870|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
2546871|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2546872|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546873|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546874|NCT01474304|Acetaminophen|acetaminophen|mesh-list
2546875|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2546876|NCT01474304|Analgesics|analgesics|mesh-ancestor
2546877|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
2546878|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2546879|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413568|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
2413569|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413570|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413571|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2546880|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
2546881|NCT01474330|Pomalidomide|pomalidomide|mesh-list
2413572|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2413573|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413574|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413575|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413576|NCT00777673|Paclitaxel|paclitaxel|mesh-list
2413577|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
2413578|NCT00777673|Bevacizumab|bevacizumab|mesh-list
2413579|NCT00777673|Carboplatin|carboplatin|mesh-list
2413580|NCT00777673|Doxorubicin|doxorubicin|mesh-list
2413581|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2413582|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2413583|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413584|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
2413585|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
2546882|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
2546883|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546884|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2546885|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2546886|NCT01474330|Growth Substances|growth substances|mesh-ancestor
2546887|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
2546888|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546889|NCT01474382|Phentolamine|phentolamine|mesh-list
2546890|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2546891|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2546892|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
2546893|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2546894|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546895|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546896|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2546897|NCT01474460|Vitamin K|vitamin k|mesh-list
2546898|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
2546899|NCT01474460|Vitamins|vitamins|mesh-ancestor
2546900|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
2546901|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546902|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2546903|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2546904|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546905|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
2546906|NCT01474460|Coagulants|coagulants|mesh-ancestor
2546907|NCT01474473|Calpastatin|calpastatin|mesh-list
2546908|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2546909|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
2546910|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546911|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413586|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
2413587|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413588|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2413589|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
2413590|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413591|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2413592|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2413593|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
2413594|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2413595|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2413596|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2413597|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2413598|NCT00777673|Growth Substances|growth substances|mesh-ancestor
2413599|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
2413600|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2413601|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2413602|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2413603|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413604|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2413605|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413606|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2413607|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413608|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413609|NCT00777738|Bortezomib|bortezomib|mesh-list
2413610|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413611|NCT00777933|Cyclosporine|cyclosporine|mesh-list
2413612|NCT00777933|Tacrolimus|tacrolimus|mesh-list
2413613|NCT00777933|Cyclosporins|cyclosporins|mesh-list
2413614|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2413615|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
2413616|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413617|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2413618|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413619|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413620|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
2413621|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413622|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
2413623|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2413624|NCT00777959|Sirolimus|sirolimus|mesh-list
2413625|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413626|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413627|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2413628|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413629|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
2413630|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2413631|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
2413632|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413633|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2413634|NCT00777972|Fosinopril|fosinopril|mesh-list
2413635|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2413636|NCT00777972|Diuretics|diuretics|mesh-ancestor
2413637|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
2413638|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413639|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2546912|NCT01474499|Sorbitol|sorbitol|mesh-list
2546913|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2546914|NCT01474499|Glycerol|glycerol|mesh-list
2546915|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2546916|NCT01474499|Protective Agents|protective agents|mesh-ancestor
2546917|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546918|NCT01474499|Cathartics|cathartics|mesh-ancestor
2546919|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2546920|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
2546921|NCT01474642|Capecitabine|capecitabine|mesh-list
2413640|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2413641|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413642|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2413643|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
2413644|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413645|NCT00777985|Bosentan|bosentan|mesh-list
2413646|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2413647|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2413648|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413649|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
2413650|NCT00777998|Thalidomide|thalidomide|mesh-list
2413651|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2413652|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
2413653|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413654|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
2413655|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413656|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413657|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2413658|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2413659|NCT00777998|Growth Substances|growth substances|mesh-ancestor
2413660|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
2413661|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413662|NCT00777998|Trace Elements|trace elements|mesh-ancestor
2413663|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
2413664|NCT00778011|Ondansetron|ondansetron|mesh-list
2413665|NCT00778011|Metoclopramide|metoclopramide|mesh-list
2413666|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
2413667|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
2413668|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413669|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413670|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2413671|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
2413672|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
2413673|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2413674|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
2413675|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413676|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546922|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546923|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2546924|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
2546925|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546926|NCT01474902|Enoxaparin|enoxaparin|mesh-list
2546927|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
2546928|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2413677|NCT00778011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2413678|NCT00778011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2413679|NCT00778011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2413680|NCT00778011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2413681|NCT00778011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2413682|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2413683|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2413684|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
2413685|NCT00778024|Fluoxetine|fluoxetine|mesh-list
2413686|NCT00778024|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2413687|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2413688|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2546929|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2413689|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413690|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413691|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
2413692|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413693|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2413694|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
2413695|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2413696|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2413697|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2413698|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546930|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546931|NCT01474967|Metformin|metformin|mesh-list
2546932|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2546933|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546934|NCT01475019|Orlistat|orlistat|mesh-list
2546935|NCT01475019|Sibutramine|sibutramine|mesh-list
2546936|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546937|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546938|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2546939|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2546940|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
2546941|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2546942|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
2546943|NCT01475032|Beclomethasone|beclomethasone|mesh-list
2546944|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
2546945|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2546946|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
2546947|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2546948|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546949|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2546950|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
2546951|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2546952|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2546953|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2546954|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
2546955|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2546956|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546957|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2546958|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
2546959|NCT01475032|Hormones|hormones|mesh-ancestor
2413699|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
2413700|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2413701|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
2413702|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2413703|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2413704|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413705|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2413706|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413707|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2413708|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2413709|NCT00778050|Amoxicillin|amoxicillin|mesh-list
2413710|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413711|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413712|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
2413713|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2413714|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2546960|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546966|NCT01475123|Nicorandil|nicorandil|mesh-list
2546967|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2546968|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2546969|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
2546970|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
2546971|NCT01475123|Vitamins|vitamins|mesh-ancestor
2546972|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
2546973|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413715|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413716|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2546974|NCT01475227|Zinc|zinc|mesh-list
2413717|NCT00778063|Analgesics|analgesics|mesh-ancestor
2546975|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
2546976|NCT01475227|Trace Elements|trace elements|mesh-ancestor
2546977|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
2546978|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546979|NCT01475227|Astringents|astringents|mesh-ancestor
2546980|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
2413718|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
2413719|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413720|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2413721|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2413722|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2413723|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
2413724|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413725|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413726|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
2413727|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2413728|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
2413729|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546981|NCT01475266|Apaziquone|apaziquone|mesh-list
2546982|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546983|NCT01475279|Warfarin|warfarin|mesh-list
2546984|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
2546985|NCT01475318|Letrozole|letrozole|mesh-list
2546986|NCT01475318|Misoprostol|misoprostol|mesh-list
2546987|NCT01475318|Mifepristone|mifepristone|mesh-list
2546988|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2546989|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2546990|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2413730|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
2413731|NCT00778076|Protective Agents|protective agents|mesh-ancestor
2413732|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2413733|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
2413734|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2413735|NCT00778089|Protective Agents|protective agents|mesh-ancestor
2413736|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413737|NCT00778115|Simethicone|simethicone|mesh-list
2413738|NCT00778115|Loperamide|loperamide|mesh-list
2546991|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2546992|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2546993|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2546994|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
2546995|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2546996|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2546997|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2546998|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
2546999|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2547000|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2547001|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2547002|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
2547003|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2547004|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2547005|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2547006|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2547007|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
2547008|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2547009|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2547010|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
2547011|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2547012|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2547013|NCT01475552|Aspirin|aspirin|mesh-list
2547014|NCT01475552|Abciximab|abciximab|mesh-list
2547015|NCT01475552|Clopidogrel|clopidogrel|mesh-list
2547016|NCT01475552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2547017|NCT01475552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2547018|NCT01475552|Analgesics|analgesics|mesh-ancestor
2547019|NCT01475552|Sensory System Agents|sensory system agents|mesh-ancestor
2547020|NCT01475552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547021|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547022|NCT01475552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2547023|NCT01475552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2547024|NCT01475552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2547025|NCT01475552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2547026|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547027|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2547028|NCT01475552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2413739|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
2547029|NCT01475552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547030|NCT01475552|Antipyretics|antipyretics|mesh-ancestor
2547031|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2413740|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2413741|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
2413742|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413743|NCT00778115|Emollients|emollients|mesh-ancestor
2413744|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
2413745|NCT00778128|Gemcitabine|gemcitabine|mesh-list
2413746|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2413747|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
2547032|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2547033|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2547034|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
2547035|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547036|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
2547037|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
2547038|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
2547039|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2547040|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2547041|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
2547042|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547043|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547044|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547045|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
2547046|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
2547047|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
2413748|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413749|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413750|NCT00778128|Antiviral Agents|antiviral agents|mesh-ancestor
2413751|NCT00778128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413752|NCT00778128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413753|NCT00778128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2413754|NCT00778128|Immunologic Factors|immunologic factors|mesh-ancestor
2413755|NCT00778128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413756|NCT00778141|Metformin|metformin|mesh-list
2413757|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2413758|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413759|NCT00778180|Furosemide|furosemide|mesh-list
2413760|NCT00778180|Diuretics|diuretics|mesh-ancestor
2413761|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
2413762|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547048|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
2547049|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
2547050|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
2547051|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
2547052|NCT01475617|Calcium|calcium|mesh-list
2547053|NCT01475617|Vitamins|vitamins|mesh-ancestor
2547054|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
2547055|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547056|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2547057|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2547058|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
2547059|NCT01475617|Hematinics|hematinics|mesh-ancestor
2547060|NCT01475656|Levetiracetam|levetiracetam|mesh-list
2547061|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
2547062|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
2547063|NCT01475708|Doxycycline|doxycycline|mesh-list
2547064|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2547065|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547066|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
2413763|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2413764|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2413765|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413766|NCT00778193|Aspirin|aspirin|mesh-list
2413767|NCT00778193|Celecoxib|celecoxib|mesh-list
2413768|NCT00778193|Naproxen|naproxen|mesh-list
2413769|NCT00778193|Clopidogrel|clopidogrel|mesh-list
2413770|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2413771|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2413772|NCT00778193|Analgesics|analgesics|mesh-ancestor
2413773|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
2413774|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413775|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413776|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2413777|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2547067|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2547068|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2547069|NCT01475760|Chitosan|chitosan|mesh-list
2413778|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2413779|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2413780|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413781|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2413782|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2413783|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413784|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
2413785|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2413786|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2413787|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2547070|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2547071|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2547072|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
2547073|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547074|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2547075|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
2547076|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
2547077|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
2547078|NCT01475760|Coagulants|coagulants|mesh-ancestor
2547079|NCT01475877|Bromfenac|bromfenac|mesh-list
2547080|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2547081|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2547082|NCT01475877|Analgesics|analgesics|mesh-ancestor
2547083|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
2547084|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547085|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547086|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2547087|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2547088|NCT01475890|Vitamin D|vitamin d|mesh-list
2547089|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
2547090|NCT01475890|Vitamins|vitamins|mesh-ancestor
2547091|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
2547092|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547093|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2547094|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2547095|NCT01476007|Vitamins|vitamins|mesh-list
2547096|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
2547097|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
2547098|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
2547099|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
2547100|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547101|NCT01476007|Hematinics|hematinics|mesh-ancestor
2547102|NCT01476124|Morphine|morphine|mesh-list
2547103|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2547104|NCT01476124|Narcotics|narcotics|mesh-ancestor
2547105|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2547106|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547107|NCT01476124|Analgesics|analgesics|mesh-ancestor
2547108|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
2547109|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547110|NCT01476137|Trametinib|trametinib|mesh-list
2547111|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547112|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2547113|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547114|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547115|NCT01476176|Acetaminophen|acetaminophen|mesh-list
2547116|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2547117|NCT01476176|Analgesics|analgesics|mesh-ancestor
2547118|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
2547119|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547120|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547121|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
2547122|NCT01476189|Acetaminophen|acetaminophen|mesh-list
2547123|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2547124|NCT01476189|Analgesics|analgesics|mesh-ancestor
2547125|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
2547126|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547127|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547128|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
2413788|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
2413789|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413790|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2547129|NCT01476215|Acetaminophen|acetaminophen|mesh-list
2547130|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2547131|NCT01476215|Analgesics|analgesics|mesh-ancestor
2547132|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
2547133|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413791|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
2413792|NCT00778232|Gabapentin|gabapentin|mesh-list
2413793|NCT00778232|Analgesics|analgesics|mesh-ancestor
2413794|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
2413795|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413796|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413797|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
2413798|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2413799|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2413800|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2413801|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2413802|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2413803|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2413804|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413805|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413806|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
2413807|NCT00778245|Cefprozil|cefprozil|mesh-list
2413808|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413809|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413810|NCT00778271|Gabapentin|gabapentin|mesh-list
2413811|NCT00778271|Analgesics|analgesics|mesh-ancestor
2413812|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
2413813|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413814|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413815|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
2413816|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2413817|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2413818|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2413819|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2413820|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2413821|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2413822|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413823|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413824|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
2413825|NCT00778284|Amoxicillin|amoxicillin|mesh-list
2413826|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413827|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547134|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547135|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
2547136|NCT01476280|Palonosetron|palonosetron|mesh-list
2547137|NCT01476280|Ramosetron|ramosetron|mesh-list
2547138|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
2547139|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
2547140|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547141|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547142|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2547143|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2547144|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2547145|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
2547146|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413828|NCT00778297|Vaccines|vaccines|mesh-list
2413829|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
2413830|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547147|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547148|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2547149|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2413831|NCT00778349|Metformin|metformin|mesh-list
2547150|NCT01476358|Vitamin A|vitamin a|mesh-list
2547151|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
2547152|NCT01476358|Vitamins|vitamins|mesh-ancestor
2547153|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
2547154|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547155|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
2547156|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547157|NCT01476358|Protective Agents|protective agents|mesh-ancestor
2547158|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2547159|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547160|NCT01476410|Doxorubicin|doxorubicin|mesh-list
2547161|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2547162|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2547163|NCT01476410|Dacarbazine|dacarbazine|mesh-list
2547164|NCT01476410|Vinblastine|vinblastine|mesh-list
2547165|NCT01476410|Antibodies|antibodies|mesh-list
2547166|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
2547167|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2547168|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
2547169|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2547170|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
2413832|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2413833|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413834|NCT00778401|Gabapentin|gabapentin|mesh-list
2413835|NCT00778401|Analgesics|analgesics|mesh-ancestor
2413836|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
2413837|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413838|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547171|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547172|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2547173|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547174|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2547175|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2547176|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547177|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547178|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2547179|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2547180|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
2547181|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2547182|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2547183|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
2547184|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
2547185|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
2547186|NCT01476488|Tacrolimus|tacrolimus|mesh-list
2547187|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2547188|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
2547189|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547190|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2547191|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547192|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547193|NCT01476501|Vitamin D|vitamin d|mesh-list
2547194|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
2547195|NCT01476501|Vitamins|vitamins|mesh-ancestor
2413839|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
2413840|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2413841|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2413842|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2413843|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2413844|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2413845|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2413846|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413847|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413848|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
2413849|NCT00778414|Amoxicillin|amoxicillin|mesh-list
2413850|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
2413851|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
2413852|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2413853|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413854|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413855|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413856|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413857|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2413858|NCT00778427|Metformin|metformin|mesh-list
2413859|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2413860|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413861|NCT00778466|Metformin|metformin|mesh-list
2413862|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2413863|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413864|NCT00778505|Remifentanil|remifentanil|mesh-list
2413865|NCT00778505|Propofol|propofol|mesh-list
2413866|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2413867|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2413868|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413869|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2413870|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
2413871|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
2413872|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2413873|NCT00778505|Narcotics|narcotics|mesh-ancestor
2413874|NCT00778505|Analgesics|analgesics|mesh-ancestor
2413875|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
2413876|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413877|NCT00778544|Amoxicillin|amoxicillin|mesh-list
2413878|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
2413879|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
2547196|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
2547197|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547198|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2547199|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2547200|NCT01476592|Resveratrol|resveratrol|mesh-list
2547201|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
2547202|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547203|NCT01476592|Protective Agents|protective agents|mesh-ancestor
2547204|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547205|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547206|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2547207|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
2547208|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2547209|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2547210|NCT01476683|Racecadotril|racecadotril|mesh-list
2413880|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2413881|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413882|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413883|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413884|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413885|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2413886|NCT00778557|Cefprozil|cefprozil|mesh-list
2413887|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413888|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413889|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
2413890|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2413891|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413892|NCT00778583|Renal Agents|renal agents|mesh-ancestor
2413893|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413894|NCT00778596|Prednisolone|prednisolone|mesh-list
2413895|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2413896|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
2413897|NCT00778596|Hormones|hormones|mesh-ancestor
2413898|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2413899|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547211|NCT01476683|Thiorphan|thiorphan|mesh-list
2547212|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
2547213|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2547214|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
2547215|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547216|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547217|NCT01476774|Buprenorphine|buprenorphine|mesh-list
2547218|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2547219|NCT01476774|Narcotics|narcotics|mesh-ancestor
2547220|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2547221|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547222|NCT01476774|Analgesics|analgesics|mesh-ancestor
2547223|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
2547224|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547225|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2547226|NCT01476787|Rituximab|rituximab|mesh-list
2413900|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2413901|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413902|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2413903|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2413904|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2413905|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
2413906|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2413907|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413908|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2547227|NCT01476787|Lenalidomide|lenalidomide|mesh-list
2547228|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2547229|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2547230|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547231|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
2547232|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547233|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2547234|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2547235|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2547236|NCT01476787|Growth Substances|growth substances|mesh-ancestor
2547237|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
2547238|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2547239|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
2547240|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547241|NCT01476800|Ketoconazole|ketoconazole|mesh-list
2547242|NCT01476800|Mirabegron|mirabegron|mesh-list
2547243|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
2547244|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547245|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2547246|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2547247|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547248|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547249|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2547250|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
2547251|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2547252|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547253|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2547254|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2547255|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2547256|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2547257|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
2547258|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413909|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2413910|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2413911|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2413912|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2413913|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2413914|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2413915|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2413916|NCT00778661|Amoxicillin|amoxicillin|mesh-list
2413917|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413918|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413919|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2413920|NCT00778674|Benazepril|benazepril|mesh-list
2547259|NCT01476800|Urological Agents|urological agents|mesh-ancestor
2547260|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
2547261|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2413921|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2413922|NCT00778674|Diuretics|diuretics|mesh-ancestor
2413923|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
2413924|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547262|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2547263|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2547264|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
2413925|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2413926|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2413927|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413928|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2413929|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
2413930|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413931|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2413932|NCT00778713|Fosinopril|fosinopril|mesh-list
2413933|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2547265|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547266|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547267|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547268|NCT01476839|Cytarabine|cytarabine|mesh-list
2547269|NCT01476839|Etoposide|etoposide|mesh-list
2547270|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
2547271|NCT01476839|Melphalan|melphalan|mesh-list
2547272|NCT01476839|Carmustine|carmustine|mesh-list
2547273|NCT01476839|Basiliximab|basiliximab|mesh-list
2547274|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2547275|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547276|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2547277|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2547278|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547279|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413934|NCT00778713|Diuretics|diuretics|mesh-ancestor
2413935|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
2413936|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413937|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2413938|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2413939|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413940|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2547280|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2547281|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
2547282|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
2547283|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547284|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2547285|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
2547286|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547287|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2547288|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
2547289|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2547290|NCT01476904|Epinephrine|epinephrine|mesh-list
2547291|NCT01476904|Racepinephrine|racepinephrine|mesh-list
2547292|NCT01476904|Epinephryl borate|epinephryl borate|mesh-list
2547293|NCT01476904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2547294|NCT01476904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2547295|NCT01476904|Adrenergic Agents|adrenergic agents|mesh-ancestor
2547296|NCT01476904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547297|NCT01476904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547298|NCT01476904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547299|NCT01476904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2547300|NCT01476904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2547301|NCT01476904|Autonomic Agents|autonomic agents|mesh-ancestor
2547302|NCT01476904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547303|NCT01476904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2547304|NCT01476904|Respiratory System Agents|respiratory system agents|mesh-ancestor
2547305|NCT01476904|Mydriatics|mydriatics|mesh-ancestor
2547306|NCT01476904|Sympathomimetics|sympathomimetics|mesh-ancestor
2547307|NCT01476904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2547308|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
2547309|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2547310|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
2547311|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547312|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2547313|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2547314|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
2547315|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547316|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547317|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2547318|NCT01477034|Vitamin D|vitamin d|mesh-list
2547319|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
2547320|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
2547321|NCT01477034|Vitamins|vitamins|mesh-list
2547322|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
2547323|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413941|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
2413942|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413943|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2413944|NCT00778726|Benazepril|benazepril|mesh-list
2413945|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2413946|NCT00778726|Diuretics|diuretics|mesh-ancestor
2413947|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
2413948|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413949|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2413950|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2413951|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413952|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2413953|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
2413954|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2413955|NCT00778739|Cefprozil|cefprozil|mesh-list
2413956|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413957|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413958|NCT00778752|Lenalidomide|lenalidomide|mesh-list
2413959|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
2413960|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413961|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2547324|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2547325|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2547326|NCT01477060|Metformin|metformin|mesh-list
2547327|NCT01477060|Lapatinib|lapatinib|mesh-list
2547328|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2547329|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547330|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547331|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2413962|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2413963|NCT00778752|Growth Substances|growth substances|mesh-ancestor
2413964|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
2413965|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413966|NCT00778765|Gabapentin|gabapentin|mesh-list
2413967|NCT00778765|Analgesics|analgesics|mesh-ancestor
2413968|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
2547332|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547333|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547334|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2547335|NCT01477073|Hormones|hormones|mesh-ancestor
2547336|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2413969|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2413970|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413971|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
2413972|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2413973|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2413974|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2547337|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547338|NCT01477112|Beta Carotene|beta carotene|mesh-list
2547339|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547340|NCT01477112|Provitamins|provitamins|mesh-ancestor
2547341|NCT01477112|Vitamins|vitamins|mesh-ancestor
2547342|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
2547343|NCT01477151|Anesthetics|anesthetics|mesh-list
2413975|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2413976|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2413977|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2413978|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413979|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413980|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
2413981|NCT00778778|Cefprozil|cefprozil|mesh-list
2413982|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2413983|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2413984|NCT00778791|Metformin|metformin|mesh-list
2413985|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2413986|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413987|NCT00778908|Cisplatin|cisplatin|mesh-list
2413988|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2413989|NCT00778973|Sertraline|sertraline|mesh-list
2413990|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
2413991|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2413992|NCT00778973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2413993|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2413994|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2413995|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2413996|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2413997|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
2413998|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2413999|NCT00779012|Infliximab|infliximab|mesh-list
2414000|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
2414001|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2414002|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2414003|NCT00779051|Zolpidem|zolpidem|mesh-list
2414004|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2414005|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2414006|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2414007|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414008|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2414009|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
2414010|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
2414011|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414012|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414013|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
2414014|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2414015|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
2414016|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2414017|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
2414018|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414019|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414020|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
2414021|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
2414022|NCT00779129|Doxorubicin|doxorubicin|mesh-list
2414023|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2414024|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
2414025|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414026|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2414027|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2414028|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
2414029|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414030|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414031|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2547344|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2547345|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547346|NCT01477190|Morphine|morphine|mesh-list
2547347|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2547348|NCT01477190|Narcotics|narcotics|mesh-ancestor
2547349|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2547350|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547351|NCT01477190|Analgesics|analgesics|mesh-ancestor
2547352|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
2547353|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547354|NCT01477203|Citalopram|citalopram|mesh-list
2547355|NCT01477203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2547356|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2547357|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2547358|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547359|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547360|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
2547361|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547362|NCT01477203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2547363|NCT01477203|Antidepressive Agents|antidepressive agents|mesh-ancestor
2547364|NCT01477203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2547365|NCT01477242|Ondansetron|ondansetron|mesh-list
2547366|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
2547367|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
2547368|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547369|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547370|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2547371|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
2547372|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
2547373|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2547374|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
2547375|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547376|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547377|NCT01477242|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2547378|NCT01477242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2547379|NCT01477242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2547380|NCT01477242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2547381|NCT01477242|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2547382|NCT01477268|Sertraline|sertraline|mesh-list
2547383|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
2547384|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2547385|NCT01477268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2547386|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2547387|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2547388|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547389|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547390|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
2547391|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547392|NCT01477294|Caffeine|caffeine|mesh-list
2547393|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2414032|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2414033|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2414034|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2414035|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414036|NCT00779194|Sirolimus|sirolimus|mesh-list
2414037|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2414038|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414039|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2414040|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414041|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
2414042|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2414043|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
2414044|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414045|NCT00779220|Methotrexate|methotrexate|mesh-list
2414046|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
2414047|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2547394|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547395|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2547396|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547397|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547398|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2547399|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2547400|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
2414048|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
2414049|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2414050|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414051|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2414052|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
2414053|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414054|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414055|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
2414056|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414057|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2414058|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2414059|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
2414060|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2414061|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2414062|NCT00779233|Zidovudine|zidovudine|mesh-list
2414063|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
2414064|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414065|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2414066|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2414067|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414068|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
2414069|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414070|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2414071|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2547401|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547402|NCT01477385|Fluorides|fluorides|mesh-list
2547403|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
2547404|NCT01477385|Protective Agents|protective agents|mesh-ancestor
2547405|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547406|NCT01477411|Digoxin|digoxin|mesh-list
2547407|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2547408|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2547409|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547410|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547411|NCT01477411|Protective Agents|protective agents|mesh-ancestor
2547412|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547413|NCT01477424|Warfarin|warfarin|mesh-list
2547414|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
2547415|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2547416|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2547417|NCT01477489|Veliparib|veliparib|mesh-list
2547418|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2547419|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547420|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547421|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547422|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2547423|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2547424|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
2547425|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547426|NCT01477580|Antacids|antacids|mesh-ancestor
2547427|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547428|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2547429|NCT01477606|Cytarabine|cytarabine|mesh-list
2547430|NCT01477606|Daunorubicin|daunorubicin|mesh-list
2547431|NCT01477606|Midostaurin|midostaurin|mesh-list
2547432|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2547433|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
2547434|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547435|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547436|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
2547437|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547438|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2547439|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
2547440|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547441|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2414072|NCT00779350|Sertraline|sertraline|mesh-list
2414073|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
2414074|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2547442|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2547443|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2547444|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547445|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2547446|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2547447|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2547448|NCT01477632|Norethindrone|norethindrone|mesh-list
2414075|NCT00779350|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2547449|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
2547450|NCT01477632|Estradiol|estradiol|mesh-list
2547451|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2547452|NCT01477632|Estrogens|estrogens|mesh-ancestor
2547453|NCT01477632|Hormones|hormones|mesh-ancestor
2547454|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2547455|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547456|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2547457|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
2547458|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2547459|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2547460|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2547461|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2547462|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2547463|NCT01477736|Oxybutynin|oxybutynin|mesh-list
2547464|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
2547465|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2547466|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2547467|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2547468|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2547469|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547470|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
2547471|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547472|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547473|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2547474|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547475|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
2547476|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
2547477|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2547478|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2547479|NCT01477736|Urological Agents|urological agents|mesh-ancestor
2547480|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
2547481|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2547482|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547483|NCT01477801|Vitamins|vitamins|mesh-ancestor
2547484|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
2547485|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2547486|NCT01477840|Misoprostol|misoprostol|mesh-list
2547487|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2414076|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2414077|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2414078|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414079|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414080|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
2414081|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414082|NCT00779376|Zidovudine|zidovudine|mesh-list
2414083|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
2414084|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414085|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2414086|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2414087|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414088|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
2414089|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414090|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2414091|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2414092|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2414093|NCT00779389|Dasatinib|dasatinib|mesh-list
2414094|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414095|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2414096|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414097|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414098|NCT00779441|Zolpidem|zolpidem|mesh-list
2116728|NCT02646449|Mirtazapine|mirtazapine|mesh-list
2116729|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
2116730|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2116731|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2116732|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
2116733|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
2116734|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116735|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116736|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414099|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2414100|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2414101|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2547488|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
2547489|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2547490|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547491|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2547492|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2547493|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
2547494|NCT01477931|Bupropion|bupropion|mesh-list
2547495|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2547496|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
2547497|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2547498|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2547499|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2547500|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2547501|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547502|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
2547503|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547504|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547505|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2547506|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2547507|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547508|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2547509|NCT01477983|Flecainide|flecainide|mesh-list
2547510|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2547511|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2547512|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2547513|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547514|NCT01478022|Ibuprofen|ibuprofen|mesh-list
2547515|NCT01478022|Isosorbide|isosorbide|mesh-list
2547516|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2414102|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414103|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2414104|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
2414105|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
2414106|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414107|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414108|NCT00779454|Gemcitabine|gemcitabine|mesh-list
2414109|NCT00779454|Capecitabine|capecitabine|mesh-list
2414110|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
2414111|NCT00779454|Panitumumab|panitumumab|mesh-list
2414112|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2414113|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
2414114|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414115|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414116|NCT00779454|Antiviral Agents|antiviral agents|mesh-ancestor
2414117|NCT00779454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547517|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2547518|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2547519|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2547520|NCT01478022|Analgesics|analgesics|mesh-ancestor
2547521|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
2547522|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547523|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547524|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2547525|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2547526|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2547527|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547528|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547529|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2547530|NCT01478022|Diuretics|diuretics|mesh-ancestor
2547531|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
2547532|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
2547533|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2547534|NCT01478035|Phenytoin|phenytoin|mesh-list
2547535|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
2414118|NCT00779454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414119|NCT00779454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2414120|NCT00779454|Immunologic Factors|immunologic factors|mesh-ancestor
2414121|NCT00779454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414122|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2414123|NCT00779493|Curcumin|curcumin|mesh-list
2414124|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414125|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2414126|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2414127|NCT00779493|Analgesics|analgesics|mesh-ancestor
2414128|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
2547536|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2547537|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2547538|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2547539|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547540|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2547541|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2547542|NCT01478074|Cytarabine|cytarabine|mesh-list
2547543|NCT01478074|Fludarabine|fludarabine|mesh-list
2414129|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414130|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2414131|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2414132|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414133|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414134|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414135|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
2414136|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2414137|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2414138|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414139|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2547544|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547545|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2547546|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
2547547|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547548|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2547549|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
2547550|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547551|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
2547552|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547553|NCT01478165|Palonosetron|palonosetron|mesh-list
2547554|NCT01478165|Anesthetics|anesthetics|mesh-list
2547555|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2547556|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547557|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
2547558|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
2547559|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547560|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2547561|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2547562|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2547563|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
2414140|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2414141|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414142|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414143|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414144|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2414145|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
2414146|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2414147|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547564|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547565|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547566|NCT01478178|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
2547567|NCT01478178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2547568|NCT01478178|Alkylating Agents|alkylating agents|mesh-ancestor
2547569|NCT01478178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547570|NCT01478178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547571|NCT01478230|Nicotine|nicotine|mesh-list
2547572|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2547573|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
2547574|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547575|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547576|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2547577|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2547578|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
2547579|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547580|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547581|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
2547582|NCT01478282|Dabigatran|dabigatran|mesh-list
2547583|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2547584|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
2547585|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2547586|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
2547587|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547588|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547589|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
2547590|NCT01478308|Metformin|metformin|mesh-list
2547591|NCT01478308|Prednisone|prednisone|mesh-list
2547592|NCT01478308|Docetaxel|docetaxel|mesh-list
2547593|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2547594|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547595|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547596|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
2547597|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
2547598|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
2547599|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547600|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2547601|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
2414148|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2414149|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2414150|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2414151|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
2414152|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2414153|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
2414154|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2414155|NCT00779636|Desloratadine|desloratadine|mesh-list
2414156|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2414157|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
2414158|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414159|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414160|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414161|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2414162|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2414163|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
2414164|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
2414165|NCT00779649|Bisacodyl|bisacodyl|mesh-list
2414166|NCT00779649|Cathartics|cathartics|mesh-ancestor
2414167|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2414168|NCT00779649|Laxatives|laxatives|mesh-ancestor
2414169|NCT00779714|Cytarabine|cytarabine|mesh-list
2414170|NCT00779714|Paclitaxel|paclitaxel|mesh-list
2414171|NCT00779714|Cisplatin|cisplatin|mesh-list
2547602|NCT01478308|Hormones|hormones|mesh-ancestor
2547603|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2547604|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2547605|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
2547606|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2547607|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
2547608|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547609|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
2547610|NCT01478386|Protective Agents|protective agents|mesh-ancestor
2547611|NCT01478490|Metoprolol|metoprolol|mesh-list
2547612|NCT01478490|Mirabegron|mirabegron|mesh-list
2547613|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2547614|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2547615|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
2547616|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
2547617|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547618|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547619|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2414172|NCT00779714|Dacarbazine|dacarbazine|mesh-list
2414173|NCT00779714|Treosulfan|treosulfan|mesh-list
2414174|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2414175|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414176|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
2414177|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
2414178|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
2414179|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414180|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2414181|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
2414182|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
2414183|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414184|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2414185|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
2414186|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414187|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2414188|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
2414189|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
2414190|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2414191|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
2547620|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2547621|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2547622|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
2547623|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547624|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547625|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2547626|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2547627|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2547628|NCT01478490|Urological Agents|urological agents|mesh-ancestor
2547629|NCT01478503|Mirabegron|mirabegron|mesh-list
2547630|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2547631|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2547632|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2547633|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
2547634|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547635|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547636|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547637|NCT01478503|Urological Agents|urological agents|mesh-ancestor
2547638|NCT01478529|Mirabegron|mirabegron|mesh-list
2547639|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2547640|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2547641|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2547642|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
2547643|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414192|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2414193|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
2414194|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2414195|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2414196|NCT00779792|Triamcinolone|triamcinolone|mesh-list
2414197|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2547644|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547645|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547646|NCT01478529|Urological Agents|urological agents|mesh-ancestor
2547647|NCT01478568|Desipramine|desipramine|mesh-list
2547648|NCT01478568|Mirabegron|mirabegron|mesh-list
2547649|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2547650|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2547651|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2547652|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
2547653|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547654|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547655|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547656|NCT01478568|Urological Agents|urological agents|mesh-ancestor
2547657|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2547658|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
2547659|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2547660|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547661|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2547662|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2547663|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2414198|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2414199|NCT00779792|Clobetasol|clobetasol|mesh-list
2414200|NCT00779792|Mineral Oil|mineral oil|mesh-list
2414201|NCT00779792|Tacrolimus|tacrolimus|mesh-list
2414202|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2414203|NCT00779792|Glycerol|glycerol|mesh-list
2414204|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2414205|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
2414206|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414207|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2414208|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414209|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414210|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2414211|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
2547664|NCT01478607|Capsaicin|capsaicin|mesh-list
2547665|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
2547666|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
2547667|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
2547668|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414212|NCT00779792|Hormones|hormones|mesh-ancestor
2414213|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2414214|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2414215|NCT00779792|Protective Agents|protective agents|mesh-ancestor
2414216|NCT00779792|Emollients|emollients|mesh-ancestor
2414217|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
2414218|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
2414219|NCT00779805|Ephedrine|ephedrine|mesh-list
2414220|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2414221|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
2414222|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414223|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414224|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2547669|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547670|NCT01478633|Galantamine|galantamine|mesh-list
2547671|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2547672|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547673|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547674|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
2547675|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547676|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547677|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2547678|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
2547679|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547680|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
2547681|NCT01478685|Paclitaxel|paclitaxel|mesh-list
2547682|NCT01478685|Carboplatin|carboplatin|mesh-list
2547683|NCT01478685|Azacitidine|azacitidine|mesh-list
2547684|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2547685|NCT01478685|Cc-486|cc-486|mesh-list
2547686|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2547687|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547688|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
2547689|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
2547690|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
2547691|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547692|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2547693|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
2547694|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547695|NCT01478698|Plasminogen|plasminogen|mesh-list
2547696|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2547697|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2547698|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2547699|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547700|NCT01478724|Caseins|caseins|mesh-list
2547701|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
2547702|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
2547703|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547704|NCT01478737|Dexamethasone|dexamethasone|mesh-list
2547705|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
2547706|NCT01478737|BB 1101|bb 1101|mesh-list
2547707|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2547708|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
2547709|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
2547710|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547711|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547712|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2547713|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
2547714|NCT01478737|Hormones|hormones|mesh-ancestor
2547715|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2547716|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2547717|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414225|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
2414226|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
2414227|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2414228|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2414229|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
2414230|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
2414231|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414232|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414233|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
2547718|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
2547719|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547720|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547721|NCT01478997|Acetaminophen|acetaminophen|mesh-list
2547722|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2547723|NCT01478997|Analgesics|analgesics|mesh-ancestor
2547724|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
2547725|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547726|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547727|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
2547728|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2547729|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
2547730|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547731|NCT01479036|Docetaxel|docetaxel|mesh-list
2414234|NCT00779831|Ephedrine|ephedrine|mesh-list
2414235|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2414236|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
2414237|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414238|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414239|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2414240|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
2414241|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
2414242|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2414243|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2414244|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
2414245|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
2414246|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414247|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414248|NCT00779896|Tazarotene|tazarotene|mesh-list
2414249|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
2414250|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
2414251|NCT00779922|Lenalidomide|lenalidomide|mesh-list
2414252|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
2414253|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547732|NCT01479036|Epirubicin|epirubicin|mesh-list
2547733|NCT01479036|Endostatins|endostatins|mesh-list
2547734|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547735|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
2547736|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
2547737|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
2547738|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547739|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2414254|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2414255|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2414256|NCT00779922|Growth Substances|growth substances|mesh-ancestor
2414257|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
2414258|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414259|NCT00779935|Infliximab|infliximab|mesh-list
2414260|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
2414261|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2414262|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2414263|NCT00780013|Metformin|metformin|mesh-list
2414264|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2414265|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414266|NCT00780039|Carboplatin|carboplatin|mesh-list
2414267|NCT00780039|Doxorubicin|doxorubicin|mesh-list
2414268|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2414269|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414270|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2414271|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2414272|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2547740|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2547741|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2547742|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547743|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2547744|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2547745|NCT01479036|Growth Substances|growth substances|mesh-ancestor
2547746|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547747|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
2547748|NCT01479075|Insulin|insulin|mesh-list
2547749|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2547750|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2547751|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547752|NCT01479088|Cinacalcet|cinacalcet|mesh-list
2547753|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2547754|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547755|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2547756|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
2547757|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2547758|NCT01479114|Sargramostim|sargramostim|mesh-list
2547759|NCT01479114|Lenograstim|lenograstim|mesh-list
2547760|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
2547761|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547762|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2547763|NCT01479179|Trastuzumab|trastuzumab|mesh-list
2547764|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2547765|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547766|NCT01479192|Fenretinide|fenretinide|mesh-list
2547767|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547768|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2414273|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414274|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414275|NCT00780104|Cytarabine|cytarabine|mesh-list
2414276|NCT00780104|Sirolimus|sirolimus|mesh-list
2414277|NCT00780104|Etoposide|etoposide|mesh-list
2414278|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
2414279|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2547769|NCT01479192|Protective Agents|protective agents|mesh-ancestor
2547770|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547771|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
2414280|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414281|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2414282|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2414283|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414284|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414285|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2414286|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
2414287|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
2414288|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414289|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2414290|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
2414291|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414292|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2414293|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2414294|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
2414295|NCT00780104|Analgesics|analgesics|mesh-ancestor
2414296|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
2414297|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414298|NCT00780169|Sorafenib|sorafenib|mesh-list
2414299|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414300|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2414301|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414302|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414303|NCT00780182|Brincidofovir|brincidofovir|mesh-list
2414304|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
2414305|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414306|NCT00780325|Celecoxib|celecoxib|mesh-list
2414307|NCT00780325|Naproxen|naproxen|mesh-list
2414308|NCT00780325|Acetazolamide|acetazolamide|mesh-list
2414309|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2414310|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2414311|NCT00780325|Analgesics|analgesics|mesh-ancestor
2414312|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
2414313|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414314|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414315|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2414316|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2414317|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2414318|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2414319|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414320|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414321|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
2414322|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
2414323|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2414324|NCT00780325|Diuretics|diuretics|mesh-ancestor
2414325|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
2414326|NCT00780377|Bradykinin|bradykinin|mesh-list
2414327|NCT00780377|Kininogens|kininogens|mesh-list
2414328|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
2414329|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2414330|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
2414331|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414332|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414333|NCT00780598|Tosedostat|tosedostat|mesh-list
2414334|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414335|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414336|NCT00780637|Bradykinin|bradykinin|mesh-list
2414337|NCT00780637|Kininogens|kininogens|mesh-list
2414338|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
2414339|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2414340|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
2414341|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414342|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414343|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2414344|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2547772|NCT01479231|Lansoprazole|lansoprazole|mesh-list
2414345|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2547773|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2547774|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2547775|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2547776|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547777|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547778|NCT01479244|Molgramostim|molgramostim|mesh-list
2547779|NCT01479244|Sargramostim|sargramostim|mesh-list
2414346|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2414347|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414348|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
2414349|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414350|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414351|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
2414352|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
2414353|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2414354|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2414355|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547780|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
2547781|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547782|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547783|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2547784|NCT01479283|Cefazolin|cefazolin|mesh-list
2547785|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2547786|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547787|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
2547788|NCT01479296|Vaccines|vaccines|mesh-list
2547789|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
2547790|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547791|NCT01479361|Atovaquone|atovaquone|mesh-list
2547792|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547793|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
2547794|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2547795|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2547796|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547797|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547798|NCT01479504|Cisplatin|cisplatin|mesh-list
2547799|NCT01479504|Docetaxel|docetaxel|mesh-list
2547800|NCT01479504|Nedaplatin|nedaplatin|mesh-list
2547801|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547802|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
2547803|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
2547804|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
2547805|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547806|NCT01479556|Pregabalin|pregabalin|mesh-list
2547807|NCT01479556|Analgesics|analgesics|mesh-ancestor
2547808|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
2547809|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547810|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547811|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
2547812|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2547813|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2547814|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547815|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2547816|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2547817|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2547818|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2547819|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2547820|NCT01479634|Efavirenz|efavirenz|mesh-list
2547821|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2547822|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2547823|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547824|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547825|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
2547826|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547827|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2547828|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2547829|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2547830|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2547831|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2547832|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2547833|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
2547834|NCT01479751|Ketamine|ketamine|mesh-list
2547835|NCT01479751|Rocuronium|rocuronium|mesh-list
2547836|NCT01479751|Analgesics|analgesics|mesh-ancestor
2547837|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
2547838|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547839|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547840|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2547841|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2547842|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
2547843|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
2547844|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2547845|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2547846|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2547847|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547848|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547849|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2547850|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2547851|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2547852|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2547853|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
2547854|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2547855|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2547856|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2547857|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
2547858|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2414356|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414357|NCT00780728|Urological Agents|urological agents|mesh-ancestor
2414358|NCT00780754|Dutasteride|dutasteride|mesh-list
2414359|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2414360|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2547859|NCT01479842|Rituximab|rituximab|mesh-list
2547860|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2547861|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2414361|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414362|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414363|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
2414364|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2414365|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414366|NCT00780780|Triamcinolone|triamcinolone|mesh-list
2414367|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2414368|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2414369|NCT00780780|Nepafenac|nepafenac|mesh-list
2414370|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2414371|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2414372|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
2414373|NCT00780780|Hormones|hormones|mesh-ancestor
2414374|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2414375|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414376|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2414377|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
2414378|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414379|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414380|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2414381|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2414382|NCT00780780|Analgesics|analgesics|mesh-ancestor
2414383|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
2414384|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414385|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2414386|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
2414387|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2414388|NCT00780832|Caffeine|caffeine|mesh-list
2414389|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2414390|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2414391|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414392|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2414393|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547862|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547863|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
2547864|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547865|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2547866|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2547867|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
2547868|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547869|NCT01479881|Cyclosporine|cyclosporine|mesh-list
2547870|NCT01479881|Simeprevir|simeprevir|mesh-list
2547871|NCT01479881|Tacrolimus|tacrolimus|mesh-list
2547872|NCT01479881|Cyclosporins|cyclosporins|mesh-list
2547873|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2547874|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
2547875|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547876|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2547877|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547878|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547879|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
2547880|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547881|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
2547882|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2547883|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
2547884|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
2547885|NCT01479920|Fluoxetine|fluoxetine|mesh-list
2547886|NCT01479920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2547887|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2547888|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2547889|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547890|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2547891|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
2414394|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414395|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2414396|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2414397|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
2414398|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414399|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
2547892|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547893|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2547894|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
2414400|NCT00780858|Ganirelix|ganirelix|mesh-list
2414401|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
2414402|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2414403|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414404|NCT00781105|Telbivudine|telbivudine|mesh-list
2414405|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
2414406|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414407|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2414408|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414409|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414410|NCT00781131|Pregabalin|pregabalin|mesh-list
2414411|NCT00781131|Analgesics|analgesics|mesh-ancestor
2414412|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
2414413|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414414|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414415|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
2414416|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2414417|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2414418|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414419|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2547895|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2547896|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2547897|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2547898|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547899|NCT01479933|Vitamin D|vitamin d|mesh-list
2547900|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
2547901|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
2547902|NCT01479933|Vitamins|vitamins|mesh-list
2547903|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
2547904|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547905|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2414420|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2414421|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2414422|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2414423|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2414424|NCT00781157|Phenylephrine|phenylephrine|mesh-list
2414425|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
2414426|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2414427|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
2547906|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2547907|NCT01480050|Temozolomide|temozolomide|mesh-list
2547908|NCT01480050|Mibefradil|mibefradil|mesh-list
2547909|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2547910|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
2547911|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547912|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547913|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2547914|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2547915|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2547916|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2547917|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547918|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
2547919|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2547920|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2547921|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547922|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
2547923|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2547924|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2547925|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547926|NCT01480141|Afatinib|afatinib|mesh-list
2547927|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547928|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2547929|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547930|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414428|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
2414429|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414430|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414431|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
2414432|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2414433|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
2414434|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
2414435|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2414436|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2414437|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2414438|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
2414439|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414440|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414441|NCT00781157|Protective Agents|protective agents|mesh-ancestor
2414442|NCT00781196|Folic Acid|folic acid|mesh-list
2414443|NCT00781196|Hematinics|hematinics|mesh-ancestor
2414444|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
2414445|NCT00781196|Vitamins|vitamins|mesh-ancestor
2547939|NCT01480323|Aldesleukin|aldesleukin|mesh-list
2547940|NCT01480323|Ipilimumab|ipilimumab|mesh-list
2547941|NCT01480323|Interleukin-2|interleukin-2|mesh-list
2547942|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2547943|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547944|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2547945|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547946|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2547947|NCT01480323|Analgesics|analgesics|mesh-ancestor
2547948|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
2547949|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2547950|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547951|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2547952|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2547953|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
2547954|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547955|NCT01480336|Amiodarone|amiodarone|mesh-list
2547956|NCT01480336|Ranolazine|ranolazine|mesh-list
2547957|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2547958|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
2547959|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2547960|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2547961|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547962|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2547963|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2547964|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2547965|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547966|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2414446|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
2414447|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414448|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
2414449|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2414450|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414451|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
2547967|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2547968|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2547969|NCT01480479|Temozolomide|temozolomide|mesh-list
2547970|NCT01480479|Molgramostim|molgramostim|mesh-list
2547971|NCT01480479|Rindopepimut|rindopepimut|mesh-list
2414452|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2414453|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2414454|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
2414455|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414456|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2414457|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2414458|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414459|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414460|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2414461|NCT00781300|Dexamethasone|dexamethasone|mesh-list
2414462|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2414463|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
2414464|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
2414465|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414466|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414467|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2414468|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
2414469|NCT00781300|Hormones|hormones|mesh-ancestor
2414470|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2414471|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2414472|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414473|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2414474|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
2414475|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2414476|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
2414477|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
2414478|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2414479|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414480|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2414481|NCT00781352|Analgesics|analgesics|mesh-ancestor
2414482|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
2414483|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414484|NCT00781378|Plasminogen|plasminogen|mesh-list
2414485|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2414486|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2414487|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2414488|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414489|NCT00781404|Adenosine|adenosine|mesh-list
2414490|NCT00781404|Analgesics|analgesics|mesh-ancestor
2414491|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
2414492|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414493|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414494|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2547972|NCT01480479|Sargramostim|sargramostim|mesh-list
2547973|NCT01480479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2547974|NCT01480479|Alkylating Agents|alkylating agents|mesh-ancestor
2414495|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
2414496|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2414497|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
2414498|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
2414499|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414500|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547975|NCT01480479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547976|NCT01480479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547977|NCT01480479|Immunologic Factors|immunologic factors|mesh-ancestor
2547978|NCT01480479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547979|NCT01480479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2547980|NCT01480492|Telbivudine|telbivudine|mesh-list
2547981|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
2547982|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547983|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2547984|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2547985|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547986|NCT01480531|Clevidipine|clevidipine|mesh-list
2414501|NCT00781417|Vitamin D|vitamin d|mesh-list
2414502|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
2414503|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
2414504|NCT00781417|Vitamins|vitamins|mesh-list
2414505|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
2547987|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2547988|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2547989|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2547990|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2547991|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2547992|NCT01480583|Alovudine|alovudine|mesh-list
2547993|NCT01480583|Trastuzumab|trastuzumab|mesh-list
2547994|NCT01480583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2547995|NCT01480583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2547996|NCT01480583|Antiviral Agents|antiviral agents|mesh-ancestor
2547997|NCT01480583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2547998|NCT01480609|Ezogabine|ezogabine|mesh-list
2547999|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
2548000|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2548001|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548002|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
2548003|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2548004|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
2548005|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548006|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2548007|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
2548008|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2548009|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2548010|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
2548011|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548012|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2414506|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414507|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2414508|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2414509|NCT00781482|Zolpidem|zolpidem|mesh-list
2414510|NCT00781482|Eszopiclone|eszopiclone|mesh-list
2414511|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2414512|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2414513|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2414514|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414515|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2414516|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
2414517|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
2414518|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414519|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548013|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2548014|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548015|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548016|NCT01480752|Lornoxicam|lornoxicam|mesh-list
2548017|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2548018|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2548019|NCT01480752|Analgesics|analgesics|mesh-ancestor
2548020|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
2548021|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548022|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548023|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2414520|NCT00781521|Ofloxacin|ofloxacin|mesh-list
2414521|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2414522|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414523|NCT00781521|Renal Agents|renal agents|mesh-ancestor
2414524|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2414525|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2414526|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2414527|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414528|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548024|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2548025|NCT01480765|Pregabalin|pregabalin|mesh-list
2548026|NCT01480765|Ketamine|ketamine|mesh-list
2414529|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414530|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2414531|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2414532|NCT00781547|Hormones|hormones|mesh-list
2414533|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2414534|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548027|NCT01480765|Analgesics|analgesics|mesh-ancestor
2414535|NCT00781573|Clopidogrel|clopidogrel|mesh-list
2414536|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2548028|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
2548029|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548030|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548031|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2548032|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2548033|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
2548034|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
2548035|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2548036|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2548037|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2548038|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548039|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548040|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
2548041|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2548042|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2548043|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2548044|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2548045|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2548046|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2548047|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2548048|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2548049|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2548050|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2548051|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
2548052|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2548053|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548054|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2548055|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2548056|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2548057|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2548058|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2548059|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2548060|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2548061|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2548062|NCT01480791|Diuretics|diuretics|mesh-ancestor
2548063|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
2548064|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548065|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2548066|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2548067|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548068|NCT01480817|Sorafenib|sorafenib|mesh-list
2414537|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2414538|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2414539|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2548069|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548070|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2548071|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548072|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548073|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
2548074|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
2548075|NCT01480869|Calcium|calcium|mesh-list
2548076|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2414540|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
2414541|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414542|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548077|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548078|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2548079|NCT01480869|Vitamins|vitamins|mesh-ancestor
2548080|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
2548081|NCT01480986|Irinotecan|irinotecan|mesh-list
2548082|NCT01480986|Octreotide|octreotide|mesh-list
2548083|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548084|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2548085|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2548086|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548087|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548088|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2548089|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2548090|NCT01481051|Latanoprost|latanoprost|mesh-list
2414543|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548091|NCT01481051|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2548092|NCT01481051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2548093|NCT01481077|Latanoprost|latanoprost|mesh-list
2548094|NCT01481077|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2548095|NCT01481077|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2548096|NCT01481194|Dexamethasone|dexamethasone|mesh-list
2548097|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
2548098|NCT01481194|Doxorubicin|doxorubicin|mesh-list
2548099|NCT01481194|Lenalidomide|lenalidomide|mesh-list
2548100|NCT01481194|Bortezomib|bortezomib|mesh-list
2548101|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2548102|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
2548103|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548104|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2548105|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2548106|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
2548107|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548108|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548109|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2548110|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2548111|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
2548112|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
2548113|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548114|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2548115|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
2548116|NCT01481194|Hormones|hormones|mesh-ancestor
2548117|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2548118|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2548119|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2548120|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2548121|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2548122|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548123|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2548124|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2548125|NCT01481194|Growth Substances|growth substances|mesh-ancestor
2548126|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
2548127|NCT01481233|Colchicine|colchicine|mesh-list
2548128|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
2548129|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2414544|NCT00781586|Caffeine|caffeine|mesh-list
2414545|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414546|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2414547|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2414548|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414549|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414550|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2414551|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2414552|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
2414553|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414554|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
2414555|NCT00781625|Methenamine|methenamine|mesh-list
2414556|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
2414557|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2414558|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414559|NCT00781625|Renal Agents|renal agents|mesh-ancestor
2414560|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2414561|NCT00781755|Varenicline|varenicline|mesh-list
2414562|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2414563|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2414564|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
2414565|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414566|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414567|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414568|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
2414569|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2548130|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
2548131|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
2548132|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
2548133|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548134|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548135|NCT01481259|Pemetrexed|pemetrexed|mesh-list
2548136|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548137|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548138|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548139|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2548140|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2548174|NCT01481311|Bromides|bromides|mesh-list
2548175|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
2548176|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
2548177|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
2548178|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2548179|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2548180|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548181|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548182|NCT01481350|Urological Agents|urological agents|mesh-ancestor
2548183|NCT01481389|Theobromine|theobromine|mesh-list
2548184|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2548185|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
2548186|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548187|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548188|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2548189|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
2548190|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
2548191|NCT01481454|Vaccines|vaccines|mesh-list
2548192|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
2548193|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548194|NCT01481467|Vaccines|vaccines|mesh-list
2548195|NCT01481467|Immunologic Factors|immunologic factors|mesh-ancestor
2548196|NCT01481467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548197|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
2548198|NCT01481519|Dexamethasone|dexamethasone|mesh-list
2548199|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
2548200|NCT01481519|Povidone|povidone|mesh-list
2548201|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
2548202|NCT01481519|BB 1101|bb 1101|mesh-list
2548203|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2548204|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
2548205|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
2548206|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548207|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548208|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2548209|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
2548210|NCT01481519|Hormones|hormones|mesh-ancestor
2548211|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2548212|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2548213|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548214|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
2548215|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548216|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548217|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
2548218|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
2548219|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2548220|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548221|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2548222|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2548223|NCT01481532|Histamine Antagonists|histamine antagonists|mesh-list
2548224|NCT01481532|Histamine Agents|histamine agents|mesh-ancestor
2548225|NCT01481532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548226|NCT01481532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548227|NCT01481532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548228|NCT01481610|Diclofenac|diclofenac|mesh-list
2548229|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
2548230|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2548231|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2548232|NCT01481610|Analgesics|analgesics|mesh-ancestor
2548233|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
2548234|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548235|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548236|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2548237|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2548238|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2548239|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548240|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548241|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2548242|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
2548243|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548244|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
2548245|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
2548246|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
2414570|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414571|NCT00781820|Bifonazole|bifonazole|mesh-list
2414572|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
2414573|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414574|NCT00781846|Sirolimus|sirolimus|mesh-list
2414575|NCT00781846|Bevacizumab|bevacizumab|mesh-list
2414576|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2414577|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548247|NCT01481714|Citric Acid|citric acid|mesh-list
2548248|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
2548249|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2548250|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
2548251|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
2548252|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548253|NCT01481714|Cathartics|cathartics|mesh-ancestor
2548254|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2414578|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2414579|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2414580|NCT00781846|Growth Substances|growth substances|mesh-ancestor
2414581|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414582|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
2414583|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2414584|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414585|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2414586|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
2414587|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2414588|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
2414589|NCT00782041|Leucovorin|leucovorin|mesh-list
2414590|NCT00782041|Folic Acid|folic acid|mesh-list
2414591|NCT00782041|Fluorouracil|fluorouracil|mesh-list
2548255|NCT01481714|Antacids|antacids|mesh-ancestor
2548256|NCT01481831|Palonosetron|palonosetron|mesh-list
2548257|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
2548258|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
2548259|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548260|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548261|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2548262|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2548263|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2548264|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
2548265|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548266|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548267|NCT01481844|Amoxicillin|amoxicillin|mesh-list
2548268|NCT01481844|Metronidazole|metronidazole|mesh-list
2548269|NCT01481844|Clarithromycin|clarithromycin|mesh-list
2414592|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
2414593|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
2548270|NCT01481844|Tetracycline|tetracycline|mesh-list
2548271|NCT01481844|Tinidazole|tinidazole|mesh-list
2414594|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
2414595|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414596|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2414597|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414598|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2414599|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
2414600|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548272|NCT01481844|Lansoprazole|lansoprazole|mesh-list
2548273|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
2548274|NCT01481844|Bismuth|bismuth|mesh-list
2548275|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2548276|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2548277|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548278|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2548279|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2548280|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2548281|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548282|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548283|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2548284|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2548285|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2548286|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2548287|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2548288|NCT01481844|Antacids|antacids|mesh-ancestor
2548289|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
2548290|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2548291|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
2548292|NCT01481870|Sorafenib|sorafenib|mesh-list
2548293|NCT01481870|Sunitinib|sunitinib|mesh-list
2548294|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548295|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2548296|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548297|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548298|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2548299|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2548300|NCT01481870|Growth Substances|growth substances|mesh-ancestor
2548301|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548302|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
2548303|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2548304|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2548305|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
2548306|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2548307|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548308|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2548309|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2548310|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2548313|NCT01482052|Vaccines|vaccines|mesh-list
2548314|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
2548315|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548316|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2414601|NCT00782041|Antidotes|antidotes|mesh-ancestor
2414602|NCT00782041|Protective Agents|protective agents|mesh-ancestor
2548317|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2548318|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2548319|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
2548320|NCT01482117|Cilostazol|cilostazol|mesh-list
2548321|NCT01482117|Clopidogrel|clopidogrel|mesh-list
2548322|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2548323|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2548324|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2548325|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2548326|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
2548327|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548328|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548329|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548330|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2548331|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
2414603|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
2414604|NCT00782041|Vitamins|vitamins|mesh-ancestor
2414605|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
2414606|NCT00782041|Hematinics|hematinics|mesh-ancestor
2414607|NCT00782093|Volociximab|volociximab|mesh-list
2414608|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2548332|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548333|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2548334|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
2548335|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2548336|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2414609|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2414610|NCT00782093|Growth Substances|growth substances|mesh-ancestor
2414611|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414612|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
2414613|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414614|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
2414615|NCT00782106|Antibodies|antibodies|mesh-list
2414616|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
2548337|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
2548338|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2548339|NCT01482117|Protective Agents|protective agents|mesh-ancestor
2548340|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2548341|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2548342|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548343|NCT01482156|Everolimus|everolimus|mesh-list
2548344|NCT01482156|Dactolisib|dactolisib|mesh-list
2548345|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548346|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2548347|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
2548348|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548349|NCT01482286|Metformin|metformin|mesh-list
2548350|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2548351|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548352|NCT01482299|Everolimus|everolimus|mesh-list
2548353|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548354|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2548355|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
2548356|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548357|NCT01482338|Drospirenone|drospirenone|mesh-list
2548358|NCT01482338|Desogestrel|desogestrel|mesh-list
2548359|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2548360|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
2548361|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2548362|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548363|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2548364|NCT01482338|Diuretics|diuretics|mesh-ancestor
2548365|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
2548366|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2548367|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2548368|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2548369|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
2548370|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2548371|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2548372|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2548373|NCT01482338|Progestins|progestins|mesh-ancestor
2548374|NCT01482338|Hormones|hormones|mesh-ancestor
2548375|NCT01482377|Cetuximab|cetuximab|mesh-list
2548376|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2548377|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2548378|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548379|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2548380|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548381|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548382|NCT01482390|Ribavirin|ribavirin|mesh-list
2548383|NCT01482390|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2548384|NCT01482390|Antimetabolites|antimetabolites|mesh-ancestor
2548385|NCT01482390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548386|NCT01482390|Antiviral Agents|antiviral agents|mesh-ancestor
2548387|NCT01482390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548388|NCT01482403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2548389|NCT01482403|Interferon-alpha|interferon-alpha|mesh-list
2548390|NCT01482403|Ribavirin|ribavirin|mesh-list
2548391|NCT01482403|Antiviral Agents|antiviral agents|mesh-ancestor
2548392|NCT01482403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548393|NCT01482403|Immunologic Factors|immunologic factors|mesh-ancestor
2548394|NCT01482403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548395|NCT01482403|Antimetabolites|antimetabolites|mesh-ancestor
2548396|NCT01482403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548397|NCT01482416|Estrogens|estrogens|mesh-list
2548398|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2548399|NCT01482416|Hormones|hormones|mesh-ancestor
2548400|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2548401|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548402|NCT01482442|Sorafenib|sorafenib|mesh-list
2414617|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2414618|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2414619|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
2414620|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
2414621|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414622|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
2548403|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548404|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2548405|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414623|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2414624|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
2414625|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548406|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548407|NCT01482468|Palonosetron|palonosetron|mesh-list
2548408|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
2548409|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
2548410|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548411|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548412|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2548413|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2548414|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2414626|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
2414627|NCT00782197|Protective Agents|protective agents|mesh-ancestor
2414628|NCT00782301|Maraviroc|maraviroc|mesh-list
2414629|NCT00782301|Etravirine|etravirine|mesh-list
2414630|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2414631|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2414632|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414633|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2414634|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2414635|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
2414636|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414637|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2414638|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2414639|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2414640|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414641|NCT00782327|Losartan|losartan|mesh-list
2414642|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2414643|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2414644|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2414645|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2414646|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414647|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2414648|NCT00782405|Mirtazapine|mirtazapine|mesh-list
2414649|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
2414650|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2414651|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2414652|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2414653|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2414654|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414655|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2414656|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
2414657|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
2414658|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414659|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414660|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2414661|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2414662|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2414663|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2414664|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
2414665|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2414666|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2414667|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
2414668|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2414669|NCT00782431|Vaccines|vaccines|mesh-list
2414670|NCT00782431|Immunologic Factors|immunologic factors|mesh-ancestor
2414671|NCT00782431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414672|NCT00782470|Factor VIII|factor viii|mesh-list
2414673|NCT00782470|Coagulants|coagulants|mesh-ancestor
2414674|NCT00782548|Morphine|morphine|mesh-list
2414675|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2414676|NCT00782548|Narcotics|narcotics|mesh-ancestor
2548415|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
2548416|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548417|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548418|NCT01482559|Dopamine|dopamine|mesh-list
2548419|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2548420|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
2548421|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
2548422|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548423|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548424|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
2548425|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548426|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548427|NCT01482559|Protective Agents|protective agents|mesh-ancestor
2548428|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
2548429|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2548430|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
2548431|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548432|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
2548433|NCT01482624|Protective Agents|protective agents|mesh-ancestor
2548434|NCT01482728|Dasatinib|dasatinib|mesh-list
2548435|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548436|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2548437|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414677|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2414678|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414679|NCT00782548|Analgesics|analgesics|mesh-ancestor
2414680|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
2414681|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414682|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
2414683|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2414684|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
2414685|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414686|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414687|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2414688|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
2414689|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2414690|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
2414691|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414692|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414693|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2548438|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548439|NCT01482754|Rituximab|rituximab|mesh-list
2548440|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2548441|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548442|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
2548443|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548444|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2548445|NCT01482897|Prednisolone|prednisolone|mesh-list
2548446|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2548447|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
2414694|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
2414695|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
2414696|NCT00782652|Protective Agents|protective agents|mesh-ancestor
2414697|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
2414698|NCT00782847|Cyproterone|cyproterone|mesh-list
2414699|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
2548448|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2548449|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
2548450|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2548451|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
2548452|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2548453|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
2548454|NCT01482897|Hormones|hormones|mesh-ancestor
2548455|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2548456|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548457|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2548458|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548459|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
2548460|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
2548461|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548462|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2548463|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2548464|NCT01482897|Protective Agents|protective agents|mesh-ancestor
2548465|NCT01482936|Oxycodone|oxycodone|mesh-list
2414700|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
2548466|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2414701|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2414702|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414703|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414704|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2414705|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
2414706|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2414707|NCT00782951|Morphine|morphine|mesh-list
2414708|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2414709|NCT00782951|Narcotics|narcotics|mesh-ancestor
2414710|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2414711|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414712|NCT00782951|Analgesics|analgesics|mesh-ancestor
2414713|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
2414714|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414715|NCT00783016|Morphine|morphine|mesh-list
2414716|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2414717|NCT00783016|Narcotics|narcotics|mesh-ancestor
2414718|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2414719|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414720|NCT00783016|Analgesics|analgesics|mesh-ancestor
2414721|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
2414722|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414723|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2414724|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2414725|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2414726|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
2414727|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414728|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2414729|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2414730|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414731|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
2414732|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2414733|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2414734|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
2414735|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414736|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414737|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414738|NCT00783081|Cilostazol|cilostazol|mesh-list
2414739|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2116737|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2116738|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2116739|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116740|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2116741|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2116742|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2116743|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
2414740|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
2548467|NCT01482936|Narcotics|narcotics|mesh-ancestor
2548468|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2548469|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548470|NCT01482936|Analgesics|analgesics|mesh-ancestor
2548471|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
2548472|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548473|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
2414741|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414742|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414743|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2414744|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
2414745|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2414746|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2414747|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414748|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2414749|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
2414750|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2414751|NCT00783081|Protective Agents|protective agents|mesh-ancestor
2414752|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2414753|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2414754|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414755|NCT00783107|Cyclosporine|cyclosporine|mesh-list
2414756|NCT00783107|Cyclosporins|cyclosporins|mesh-list
2414757|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414758|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414759|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2548474|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548475|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2548476|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548477|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548478|NCT01483053|S 20098|s 20098|mesh-list
2548479|NCT01483053|Citalopram|citalopram|mesh-list
2548480|NCT01483053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2548481|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2548482|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2548483|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548484|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548485|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
2548486|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548487|NCT01483053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2548488|NCT01483053|Antidepressive Agents|antidepressive agents|mesh-ancestor
2548489|NCT01483053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2548490|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2548491|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2414760|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
2414761|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414762|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
2414763|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414764|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
2414765|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2414766|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2414767|NCT00783133|Fexofenadine|fexofenadine|mesh-list
2414768|NCT00783133|Desloratadine|desloratadine|mesh-list
2414769|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2414770|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
2414771|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414772|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414773|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548492|NCT01483248|Interferons|interferons|mesh-list
2548493|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2548494|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548495|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
2548496|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548497|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2548498|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2548499|NCT01483274|Vaccines|vaccines|mesh-list
2548500|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
2548501|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548502|NCT01483300|Cisplatin|cisplatin|mesh-list
2548503|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548504|NCT01483365|Progesterone|progesterone|mesh-list
2548505|NCT01483365|Progestins|progestins|mesh-ancestor
2548506|NCT01483365|Hormones|hormones|mesh-ancestor
2548507|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2548508|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548509|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
2548510|NCT01483508|Procyanidin|procyanidin|mesh-list
2548511|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
2548512|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548513|NCT01483508|Protective Agents|protective agents|mesh-ancestor
2548514|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548515|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2548516|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2548517|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548518|NCT01483638|Axitinib|axitinib|mesh-list
2548519|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548520|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2548521|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548522|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548523|NCT01483729|Ritonavir|ritonavir|mesh-list
2548524|NCT01483729|Lactams|lactams|mesh-list
2548525|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2548526|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2548527|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
2548528|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548529|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548530|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2548531|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2548532|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
2548533|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548534|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2414774|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2414775|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2414776|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
2414777|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
2414778|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2414779|NCT00783146|Fexofenadine|fexofenadine|mesh-list
2414780|NCT00783146|Desloratadine|desloratadine|mesh-list
2414781|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2414782|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
2414783|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414784|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414785|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414786|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2414787|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2414788|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
2414789|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
2414790|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2414791|NCT00783172|Gemcitabine|gemcitabine|mesh-list
2414792|NCT00783172|Mitogens|mitogens|mesh-list
2414793|NCT00783172|Enkephalin, Methionine|enkephalin, methionine|mesh-list
2414794|NCT00783172|Enkephalins|enkephalins|mesh-list
2414795|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2414796|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
2414797|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414798|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414799|NCT00783172|Antiviral Agents|antiviral agents|mesh-ancestor
2414800|NCT00783172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548535|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2548536|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2548537|NCT01483742|Ritonavir|ritonavir|mesh-list
2548538|NCT01483742|Ribavirin|ribavirin|mesh-list
2548539|NCT01483742|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2548540|NCT01483742|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2548541|NCT01483742|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2548542|NCT01483742|Protease Inhibitors|protease inhibitors|mesh-ancestor
2548543|NCT01483742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548544|NCT01483742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548545|NCT01483742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2548546|NCT01483742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2548547|NCT01483742|Antiviral Agents|antiviral agents|mesh-ancestor
2548548|NCT01483742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548549|NCT01483742|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2548550|NCT01483742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2548551|NCT01483742|Antimetabolites|antimetabolites|mesh-ancestor
2548552|NCT01483781|Canagliflozin|canagliflozin|mesh-list
2548553|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2548554|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548555|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2548556|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548557|NCT01483859|Liver Extracts|liver extracts|mesh-list
2548558|NCT01483859|Hematinics|hematinics|mesh-ancestor
2548559|NCT01483911|Gontivimab|gontivimab|mesh-list
2548560|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
2548561|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548562|NCT01484015|Cefepime|cefepime|mesh-list
2548563|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2548564|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548565|NCT01484080|Paclitaxel|paclitaxel|mesh-list
2548566|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2548567|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2548568|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548569|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
2548570|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
2548571|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
2548572|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548573|NCT01484119|Cetirizine|cetirizine|mesh-list
2548574|NCT01484119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2548575|NCT01484119|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2548576|NCT01484119|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2548577|NCT01484119|Histamine Antagonists|histamine antagonists|mesh-ancestor
2548578|NCT01484119|Histamine Agents|histamine agents|mesh-ancestor
2548579|NCT01484119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548580|NCT01484119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548581|NCT01484119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548582|NCT01484145|Terbinafine|terbinafine|mesh-list
2414801|NCT00783172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414802|NCT00783172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2414803|NCT00783172|Immunologic Factors|immunologic factors|mesh-ancestor
2414804|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414805|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
2414806|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414807|NCT00783211|Fexofenadine|fexofenadine|mesh-list
2414808|NCT00783211|Desloratadine|desloratadine|mesh-list
2414809|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2548583|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
2548584|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548585|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548586|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548587|NCT01484171|Idarubicin|idarubicin|mesh-list
2548588|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2548589|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548590|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2548591|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2548592|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548593|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548594|NCT01484184|Levodopa|levodopa|mesh-list
2548595|NCT01484184|Buspirone|buspirone|mesh-list
2548596|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2548597|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2548598|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
2414810|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
2414811|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414812|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414813|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414814|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2414815|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2414816|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
2414817|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
2548599|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548600|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548601|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548602|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2548603|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2548604|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2548605|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2548606|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2548607|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
2548608|NCT01484262|Liraglutide|liraglutide|mesh-list
2548609|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2548610|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414818|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2414819|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
2414820|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2414821|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
2414822|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2414823|NCT00783250|Albuterol|albuterol|mesh-list
2414824|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
2414825|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2414826|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
2414827|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414828|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414829|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2414830|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
2414831|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
2414832|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2414833|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
2414834|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414835|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414836|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
2414837|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2414838|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2548611|NCT01484262|Incretins|incretins|mesh-ancestor
2548612|NCT01484262|Hormones|hormones|mesh-ancestor
2548613|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2548614|NCT01484327|Carvedilol|carvedilol|mesh-list
2548615|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2548616|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2548617|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
2548618|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548619|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548620|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548621|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2548622|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
2548623|NCT01484327|Protective Agents|protective agents|mesh-ancestor
2548624|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2414839|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2414840|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2414841|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
2414842|NCT00783354|Loratadine|loratadine|mesh-list
2414843|NCT00783354|Desloratadine|desloratadine|mesh-list
2414844|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2414845|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
2414846|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414847|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414848|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414849|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2414850|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2414851|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
2414852|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
2414853|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
2414854|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
2414855|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2414856|NCT00783380|Vaccines|vaccines|mesh-list
2414857|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
2414858|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414859|NCT00783393|Temozolomide|temozolomide|mesh-list
2414860|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2414861|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
2414862|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414863|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414864|NCT00783458|Fluticasone|fluticasone|mesh-list
2414865|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
2414866|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2414867|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2414868|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
2414869|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414870|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414871|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2414872|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
2414873|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
2414874|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2414875|NCT00783471|Docetaxel|docetaxel|mesh-list
2414876|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2414877|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414878|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
2414879|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
2414880|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
2414881|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414882|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2414883|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414884|NCT00783484|Maraviroc|maraviroc|mesh-list
2414885|NCT00783484|Darunavir|darunavir|mesh-list
2414886|NCT00783484|Midazolam|midazolam|mesh-list
2414887|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2414888|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2414889|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2548625|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2548626|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2548627|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
2548628|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2548629|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2548630|NCT01484457|Pancrelipase|pancrelipase|mesh-list
2548631|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2548632|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2548633|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
2548634|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548635|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2548636|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2548637|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
2548638|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2548639|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548640|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2548641|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2548642|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2548643|NCT01484691|Budesonide|budesonide|mesh-list
2414890|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548644|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2548645|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2548646|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
2548647|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116744|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2116745|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2548648|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548649|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2548650|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
2548651|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
2548652|NCT01484691|Hormones|hormones|mesh-ancestor
2548653|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2548654|NCT01484717|Nicotine|nicotine|mesh-list
2548655|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2548656|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
2548657|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548658|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548659|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2548660|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2548661|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
2548662|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548663|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548664|NCT01484756|Micronutrients|micronutrients|mesh-list
2548665|NCT01484756|Trace Elements|trace elements|mesh-list
2548666|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548667|NCT01484964|Peficitinib|peficitinib|mesh-list
2548668|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548669|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548670|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2548671|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
2548672|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548673|NCT01484990|Levodopa|levodopa|mesh-list
2548674|NCT01484990|Carbidopa|carbidopa|mesh-list
2548675|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2548676|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2548677|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2548678|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
2548679|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548680|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548681|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548682|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2548683|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548684|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2548685|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
2548686|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
2548687|NCT01485003|Natalizumab|natalizumab|mesh-list
2548688|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
2548689|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548690|NCT01485068|Paclitaxel|paclitaxel|mesh-list
2414891|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2414892|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2414893|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2414894|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2414895|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
2414896|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
2414897|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
2414898|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
2414899|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414900|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414901|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2414902|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2414903|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2414904|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2414905|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
2414906|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414907|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2414908|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2116746|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
2116747|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2116748|NCT02647203|Fluorides|fluorides|mesh-list
2116749|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
2116750|NCT02647203|Protective Agents|protective agents|mesh-ancestor
2116751|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116752|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2116753|NCT02647320|Firuglipel|firuglipel|mesh-list
2548691|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2548692|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414909|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2414910|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
2414911|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414912|NCT00783510|Adalimumab|adalimumab|mesh-list
2414913|NCT00783510|Methotrexate|methotrexate|mesh-list
2414914|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2414915|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
2414916|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2414917|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414918|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2414919|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
2414920|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548693|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
2548694|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
2548695|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
2548696|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548697|NCT01485081|Paclitaxel|paclitaxel|mesh-list
2548698|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2548699|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548700|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
2548701|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
2548702|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
2548703|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548704|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2414921|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414922|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
2414923|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414924|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2414925|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2414926|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
2414927|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2414928|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2414929|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2414930|NCT00783523|Doxycycline|doxycycline|mesh-list
2414931|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2414932|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2414933|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
2414934|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2414935|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2414936|NCT00783536|Etanercept|etanercept|mesh-list
2414937|NCT00783536|Methotrexate|methotrexate|mesh-list
2414938|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2548705|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2548706|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
2548707|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548708|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2548709|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548710|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2414939|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
2414940|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2414941|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414942|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2414943|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
2414944|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414945|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414946|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
2414947|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414948|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2414949|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2414950|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
2414951|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2414952|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2414953|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2414954|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2414955|NCT00783536|Analgesics|analgesics|mesh-ancestor
2414956|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
2414957|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2414958|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2414959|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2414960|NCT00783601|Montelukast|montelukast|mesh-list
2414961|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2414962|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
2414963|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2414964|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
2414965|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2414966|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414967|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2414968|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2414969|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414970|NCT00783653|Sunitinib|sunitinib|mesh-list
2414971|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2414972|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2414973|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2414974|NCT00783653|Growth Substances|growth substances|mesh-ancestor
2414975|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414976|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
2414977|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2414978|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2414979|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414980|NCT00783731|Midazolam|midazolam|mesh-list
2414981|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2414982|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2414983|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2414984|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2414985|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2548711|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548712|NCT01485185|Gabapentin|gabapentin|mesh-list
2548713|NCT01485185|Donepezil|donepezil|mesh-list
2548714|NCT01485185|Analgesics|analgesics|mesh-ancestor
2548715|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
2548716|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548717|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548718|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
2548719|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2548720|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2548721|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2548722|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2548723|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2548724|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2548725|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548726|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548727|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
2548728|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2548729|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548730|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
2548731|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
2548732|NCT01485198|Acetaminophen|acetaminophen|mesh-list
2548733|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2548734|NCT01485198|Analgesics|analgesics|mesh-ancestor
2548735|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
2548736|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548737|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548738|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
2548739|NCT01485211|Riboflavin|riboflavin|mesh-list
2548740|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
2548741|NCT01485211|Vitamins|vitamins|mesh-ancestor
2548742|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
2116754|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2116755|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116756|NCT02647320|Incretins|incretins|mesh-ancestor
2116757|NCT02647320|Hormones|hormones|mesh-ancestor
2116758|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2116759|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2116760|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
2116761|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116762|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116763|NCT02647788|Acetaminophen|acetaminophen|mesh-list
2116764|NCT02647788|Ibuprofen|ibuprofen|mesh-list
2116765|NCT02647788|Codeine|codeine|mesh-list
2116766|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2116767|NCT02647788|Analgesics|analgesics|mesh-ancestor
2116768|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
2116769|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116770|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116771|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
2116772|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2414986|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2414987|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2414988|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2414989|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
2414990|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
2548743|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548744|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2548745|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
2548746|NCT01485224|Thalidomide|thalidomide|mesh-list
2548747|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2548748|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
2548749|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548750|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
2548751|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2548752|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548753|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2548754|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2548755|NCT01485224|Growth Substances|growth substances|mesh-ancestor
2548756|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
2548757|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548758|NCT01485315|Mannitol|mannitol|mesh-list
2548759|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2548760|NCT01485315|Diuretics|diuretics|mesh-ancestor
2548761|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
2414991|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
2414992|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
2414993|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2414994|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2414995|NCT00783744|Insulin|insulin|mesh-list
2414996|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2414997|NCT00783744|Metformin|metformin|mesh-list
2414998|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
2414999|NCT00783744|Glimepiride|glimepiride|mesh-list
2415000|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
2415001|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
2415002|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
2415003|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2415004|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415005|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2415006|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2415007|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
2415008|NCT00783900|Metoprolol|metoprolol|mesh-list
2415009|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2415010|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2415011|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
2415012|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
2415013|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415014|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415015|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2415016|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2415017|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2415018|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
2415019|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415020|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415021|NCT00783926|Vaccines|vaccines|mesh-list
2548762|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548763|NCT01485367|Adapalene|adapalene|mesh-list
2548764|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2548765|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2548766|NCT01485367|Analgesics|analgesics|mesh-ancestor
2548767|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
2548768|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548769|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415022|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
2415023|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
2415024|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415025|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
2415026|NCT00784017|Asparaginase|asparaginase|mesh-list
2415027|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415028|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
2415029|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415030|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
2415031|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415032|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415033|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2415034|NCT00784186|Misoprostol|misoprostol|mesh-list
2415035|NCT00784186|Mifepristone|mifepristone|mesh-list
2548770|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2415036|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2415037|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
2415038|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2415039|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415040|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2415041|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2415042|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
2548771|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2548772|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
2548773|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2548774|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
2548775|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548776|NCT01485445|Fluticasone|fluticasone|mesh-list
2548777|NCT01485445|Xhance|xhance|mesh-list
2548778|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2548779|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2548780|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
2548781|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548782|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548783|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2548784|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
2548785|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
2548786|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2548787|NCT01485562|Misoprostol|misoprostol|mesh-list
2548788|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2548789|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
2548790|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2548791|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548792|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2548793|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2548794|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
2548795|NCT01485653|Mepivacaine|mepivacaine|mesh-list
2548796|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
2548797|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
2548798|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2548799|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548800|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
2548801|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548802|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
2548803|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
2548804|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548805|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
2548806|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548807|NCT01485692|Promethazine|promethazine|mesh-list
2548808|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
2548809|NCT01485692|Midazolam|midazolam|mesh-list
2548810|NCT01485692|Haloperidol|haloperidol|mesh-list
2548811|NCT01485692|Olanzapine|olanzapine|mesh-list
2548812|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
2548813|NCT01485692|Ziprasidone|ziprasidone|mesh-list
2548814|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2548815|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2548816|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2548817|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548818|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2548819|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2548820|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2548821|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2548822|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
2415043|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2415044|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2415045|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2415046|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2415047|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
2415048|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2415049|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2415050|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
2415051|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2415052|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
2415053|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2415054|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2415055|NCT00784290|Orantinib|orantinib|mesh-list
2415056|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2415057|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415058|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415059|NCT00784316|Metoprolol|metoprolol|mesh-list
2415060|NCT00784316|Amiodarone|amiodarone|mesh-list
2415061|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2415062|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2415063|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
2415064|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
2415065|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415066|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415067|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2415068|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2415069|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2415070|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
2415071|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415072|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415073|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
2415074|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2415075|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2415076|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2415077|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2415078|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2415079|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415080|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2415081|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2415082|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2415083|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
2415084|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2415085|NCT00784394|Protective Agents|protective agents|mesh-ancestor
2415086|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415087|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415088|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
2415089|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2415090|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2415091|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
2415092|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415093|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2415094|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2415095|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415096|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415097|NCT00784446|Bevacizumab|bevacizumab|mesh-list
2415098|NCT00784446|Capecitabine|capecitabine|mesh-list
2415099|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
2415100|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
2415101|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2415102|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415103|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2415104|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2415105|NCT00784446|Growth Substances|growth substances|mesh-ancestor
2548823|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
2548824|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
2548825|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
2548826|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2548827|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415106|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415107|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
2415108|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2415109|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
2415110|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415111|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2415112|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415113|NCT00784472|Morphine|morphine|mesh-list
2415114|NCT00784472|Oxycodone|oxycodone|mesh-list
2548828|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
2548829|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
2548830|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548831|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2548832|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2548833|NCT01485692|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2548834|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2548835|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2548836|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
2548837|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2548838|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
2548839|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2548840|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2548841|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
2548842|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
2548843|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2548844|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
2548845|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
2548846|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2548847|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2548848|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
2548849|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
2548850|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2548851|NCT01485718|Cathartics|cathartics|mesh-ancestor
2548852|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2548853|NCT01485731|Nelfinavir|nelfinavir|mesh-list
2548854|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2548855|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2548856|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
2548857|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548858|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548859|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2548860|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2548861|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
2548862|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548863|NCT01485744|Leucovorin|leucovorin|mesh-list
2548864|NCT01485744|Fluorouracil|fluorouracil|mesh-list
2548865|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
2548866|NCT01485744|Irinotecan|irinotecan|mesh-list
2548867|NCT01485744|Folfirinox|folfirinox|mesh-list
2415115|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2415116|NCT00784472|Narcotics|narcotics|mesh-ancestor
2415117|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2415118|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415119|NCT00784472|Analgesics|analgesics|mesh-ancestor
2415120|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
2415121|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548868|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
2548869|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548870|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2548871|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548872|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2548873|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
2548874|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548875|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2548876|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2548877|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548878|NCT01485744|Antidotes|antidotes|mesh-ancestor
2548879|NCT01485744|Protective Agents|protective agents|mesh-ancestor
2548880|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
2548881|NCT01485744|Vitamins|vitamins|mesh-ancestor
2415122|NCT00784485|Omalizumab|omalizumab|mesh-list
2415123|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2415124|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2415125|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
2415126|NCT00784498|Midazolam|midazolam|mesh-list
2415127|NCT00784498|Ketamine|ketamine|mesh-list
2415128|NCT00784498|Propofol|propofol|mesh-list
2415129|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2415130|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2548882|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
2548883|NCT01485809|Gefitinib|gefitinib|mesh-list
2548884|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548885|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2548886|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548887|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548888|NCT01485822|Travoprost|travoprost|mesh-list
2548889|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2548890|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2548891|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2548892|NCT01485835|Dexamethasone|dexamethasone|mesh-list
2548893|NCT01485835|Bortezomib|bortezomib|mesh-list
2548894|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2415131|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415132|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2415133|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
2415134|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
2415135|NCT00784498|Analgesics|analgesics|mesh-ancestor
2415136|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
2548895|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
2548896|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
2548897|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548898|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548899|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2415137|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415138|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2415139|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2415140|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2415141|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415142|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415143|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2415144|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2415145|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2415146|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2415147|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
2415148|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
2548900|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
2548901|NCT01485835|Hormones|hormones|mesh-ancestor
2548902|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2548903|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2548904|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548905|NCT01485848|Paclitaxel|paclitaxel|mesh-list
2548906|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2548907|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548908|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
2548909|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
2548910|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
2548911|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548921|NCT01485874|Doxorubicin|doxorubicin|mesh-list
2548922|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2548923|NCT01485874|Nintedanib|nintedanib|mesh-list
2548924|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2548925|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548926|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2548927|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2548928|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548929|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548930|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2548931|NCT01485926|Carboplatin|carboplatin|mesh-list
2548932|NCT01485926|Docetaxel|docetaxel|mesh-list
2548933|NCT01485926|Trastuzumab|trastuzumab|mesh-list
2548934|NCT01485926|Lapatinib|lapatinib|mesh-list
2548935|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548936|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
2548937|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
2548938|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
2548939|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548940|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2548941|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2548942|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548943|NCT01485939|Lidocaine|lidocaine|mesh-list
2548944|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
2548945|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
2548946|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2415149|NCT00784511|Vitamin D|vitamin d|mesh-list
2415150|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
2415151|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
2415152|NCT00784511|Vitamins|vitamins|mesh-list
2548947|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548948|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
2548949|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2548950|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2548951|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2548952|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2548953|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2548954|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548955|NCT01485978|Ramipril|ramipril|mesh-list
2548956|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2548957|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
2415153|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
2548958|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548959|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548960|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2548961|NCT01486004|Simeprevir|simeprevir|mesh-list
2548962|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
2548963|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548964|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
2548965|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548966|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415154|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415155|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2415156|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2415157|NCT00784589|Rituximab|rituximab|mesh-list
2415158|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2415159|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415160|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
2415161|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415162|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2415163|NCT00784667|Cetuximab|cetuximab|mesh-list
2415164|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2415165|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2415166|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415167|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2415168|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415169|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415170|NCT00784680|Tamoxifen|tamoxifen|mesh-list
2415171|NCT00784680|Anastrozole|anastrozole|mesh-list
2415172|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2415173|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
2415174|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2415175|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415176|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2415177|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415178|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2415179|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2415180|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2548967|NCT01486017|Peficitinib|peficitinib|mesh-list
2548968|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548969|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548970|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2548971|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
2548972|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548973|NCT01486082|Amoxicillin|amoxicillin|mesh-list
2548974|NCT01486082|Clarithromycin|clarithromycin|mesh-list
2548975|NCT01486082|Omeprazole|omeprazole|mesh-list
2548976|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2548977|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2548978|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2548979|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2548980|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2548981|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548982|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548983|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2548984|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2548985|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2548986|NCT01486251|Axitinib|axitinib|mesh-list
2548987|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2548988|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2548989|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2548990|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2548991|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
2548992|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
2548993|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2548994|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2548995|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2548996|NCT01486433|Aspirin|aspirin|mesh-list
2548997|NCT01486433|Simvastatin|simvastatin|mesh-list
2548998|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2548999|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2549000|NCT01486433|Analgesics|analgesics|mesh-ancestor
2549001|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
2549002|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415181|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2415182|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2415183|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415184|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415185|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
2415186|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2415187|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
2415188|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2415189|NCT00784745|Dexamethasone|dexamethasone|mesh-list
2415190|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2415191|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
2415192|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
2415193|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415194|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415195|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2415196|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
2415197|NCT00784745|Hormones|hormones|mesh-ancestor
2549003|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549004|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2549005|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2549006|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2549007|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2549008|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549009|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2549010|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2549011|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549012|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
2549013|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2549014|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2549015|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
2549016|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2549017|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2549018|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
2549019|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
2549020|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2549021|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415198|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2415199|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2415200|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415201|NCT00784797|Oxytocin|oxytocin|mesh-list
2415202|NCT00784797|Mifepristone|mifepristone|mesh-list
2116773|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2116774|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2116775|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2116776|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116777|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116778|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2116779|NCT02647788|Narcotics|narcotics|mesh-ancestor
2116780|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116781|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
2116782|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
2116783|NCT02647866|KHK4083|khk4083|mesh-list
2116784|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
2116785|NCT02647944|Liraglutide|liraglutide|mesh-list
2116786|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2116787|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116788|NCT02647944|Incretins|incretins|mesh-ancestor
2116789|NCT02647944|Hormones|hormones|mesh-ancestor
2116790|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2116791|NCT02648204|Dulaglutide|dulaglutide|mesh-list
2116792|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2116793|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116794|NCT02648217|Insulin|insulin|mesh-list
2116795|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2116796|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
2116797|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
2116798|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2116799|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
2116800|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2116801|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116802|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2116803|NCT02648698|Levofloxacin|levofloxacin|mesh-list
2116804|NCT02648698|Tinidazole|tinidazole|mesh-list
2116805|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2116806|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2116807|NCT02648698|Renal Agents|renal agents|mesh-ancestor
2549022|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549023|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
2549024|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2415203|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
2415204|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2415205|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415206|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2415207|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
2415208|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2415209|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2415210|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2415211|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
2415212|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2415213|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2415214|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
2415215|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2415216|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
2415217|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2415218|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2415219|NCT00784823|Bortezomib|bortezomib|mesh-list
2415220|NCT00784823|Melphalan|melphalan|mesh-list
2415221|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415222|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2415223|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
2415224|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415225|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2415226|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2415227|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
2415228|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415229|NCT00784862|Tamoxifen|tamoxifen|mesh-list
2415230|NCT00784862|Anastrozole|anastrozole|mesh-list
2415231|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2415232|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
2415233|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2549025|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549026|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549027|NCT01486485|Nafamostat|nafamostat|mesh-list
2549028|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2549029|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2549030|NCT01486485|Analgesics|analgesics|mesh-ancestor
2549031|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
2549032|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549033|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549034|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2549035|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2549036|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
2415234|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415235|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2415236|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415237|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2415238|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2415239|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2415240|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2415241|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2415242|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415243|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415244|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2415245|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2415246|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415247|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415248|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2549037|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
2549038|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549039|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549040|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2549041|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2549042|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2549043|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549044|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
2549045|NCT01486511|Liver Extracts|liver extracts|mesh-list
2549046|NCT01486511|Hematinics|hematinics|mesh-ancestor
2549047|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2549048|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
2549049|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
2549050|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2549051|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
2549052|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
2549053|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2415249|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
2415250|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2415251|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415252|NCT00784914|Sirolimus|sirolimus|mesh-list
2415253|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2415254|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415255|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2415256|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415257|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
2415258|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2415259|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
2415260|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415261|NCT00784940|Tamoxifen|tamoxifen|mesh-list
2415262|NCT00784940|Anastrozole|anastrozole|mesh-list
2415263|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2415264|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
2415265|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2415266|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415267|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2415268|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549054|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
2549055|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
2549056|NCT01486602|Paclitaxel|paclitaxel|mesh-list
2549057|NCT01486602|Carboplatin|carboplatin|mesh-list
2549058|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2549059|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549060|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
2549061|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
2549062|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
2549063|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415269|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2415270|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2415271|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2415272|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2415273|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2415274|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549064|NCT01486706|Gabapentin|gabapentin|mesh-list
2549065|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
2549066|NCT01486706|Analgesics|analgesics|mesh-ancestor
2549067|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
2549068|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549069|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549070|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
2549071|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2549072|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2549073|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549074|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2549075|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2549076|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2549077|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549078|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549079|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
2415275|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415276|NCT00784966|Etanercept|etanercept|mesh-list
2415277|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2415278|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2415279|NCT00784966|Analgesics|analgesics|mesh-ancestor
2415280|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
2415281|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415282|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415283|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2415284|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2549080|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2549081|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2549082|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
2549083|NCT01486706|Urological Agents|urological agents|mesh-ancestor
2549084|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2549085|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
2549086|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549087|NCT01486849|Riluzole|riluzole|mesh-list
2549088|NCT01486849|Anticonvulsants|anticonvulsants|mesh-ancestor
2549089|NCT01486849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2549090|NCT01486849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2549091|NCT01486849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549092|NCT01486849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549093|NCT01486849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549094|NCT01486849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2549095|NCT01486849|Protective Agents|protective agents|mesh-ancestor
2549096|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
2549097|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
2549098|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2549099|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549100|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549101|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
2549102|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
2549103|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2549104|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549105|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549106|NCT01486888|Insulin|insulin|mesh-list
2549107|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2549108|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549109|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549110|NCT01486901|Insulin|insulin|mesh-list
2549111|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2549112|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
2549113|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
2549114|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
2549115|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549116|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549117|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
2549118|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549119|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549120|NCT01486940|Insulin|insulin|mesh-list
2415285|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2415286|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2415287|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
2415288|NCT00785018|Complement C1s|complement c1s|mesh-list
2415289|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2549121|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2549122|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
2549123|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
2549124|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
2549125|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
2549126|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
2549127|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549128|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549129|NCT01486953|Sevoflurane|sevoflurane|mesh-list
2549130|NCT01486953|Desflurane|desflurane|mesh-list
2549131|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2549132|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2549133|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
2549134|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
2549135|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549136|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549137|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2549138|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2549139|NCT01486979|Estradiol|estradiol|mesh-list
2549140|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2549141|NCT01486979|Estrogens|estrogens|mesh-ancestor
2549142|NCT01486979|Hormones|hormones|mesh-ancestor
2549143|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2549144|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549145|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2549146|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
2549147|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2549148|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2549149|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
2549150|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2415290|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2415291|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
2415292|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415293|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2415294|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549151|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549152|NCT01487096|Teriflunomide|teriflunomide|mesh-list
2549153|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2549154|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2549155|NCT01487096|Analgesics|analgesics|mesh-ancestor
2549156|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
2549157|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549158|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549159|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2549160|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2549161|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549162|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
2549163|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
2415295|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2415296|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2415297|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415298|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2415299|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
2415300|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415301|NCT00785109|Vitamin K|vitamin k|mesh-list
2415302|NCT00785109|Vitamins|vitamins|mesh-ancestor
2415303|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
2415304|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415305|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2415306|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2415307|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415308|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
2415309|NCT00785109|Coagulants|coagulants|mesh-ancestor
2549164|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2549165|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549166|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2549167|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2549168|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549169|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549170|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549171|NCT01487174|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2549172|NCT01487174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549173|NCT01487174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2549174|NCT01487174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549175|NCT01487174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549176|NCT01487226|Paclitaxel|paclitaxel|mesh-list
2549177|NCT01487226|Cisplatin|cisplatin|mesh-list
2549178|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2549179|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549180|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
2549181|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
2549182|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
2549183|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549184|NCT01487278|Misoprostol|misoprostol|mesh-list
2549185|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2549186|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
2549187|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2549188|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549189|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2549190|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2549191|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
2549192|NCT01487304|Hormones|hormones|mesh-list
2415310|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
2415311|NCT00785122|Molgramostim|molgramostim|mesh-list
2415312|NCT00785122|Imiquimod|imiquimod|mesh-list
2415313|NCT00785122|Sargramostim|sargramostim|mesh-list
2415314|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2415315|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
2415316|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549193|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2549194|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549195|NCT01487317|Rivastigmine|rivastigmine|mesh-list
2549196|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2549197|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549198|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549199|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
2549200|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549201|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549202|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2549203|NCT01487317|Protective Agents|protective agents|mesh-ancestor
2549204|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
2549205|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549206|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549207|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
2549208|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549209|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549210|NCT01487395|Donepezil|donepezil|mesh-list
2549211|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2549212|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549213|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549214|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
2549215|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549216|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549217|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
2549218|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
2549219|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549220|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549221|NCT01487421|Insulin|insulin|mesh-list
2549222|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2549223|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
2549224|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
2549225|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549226|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549227|NCT01487512|Hydromorphone|hydromorphone|mesh-list
2549228|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2549229|NCT01487512|Narcotics|narcotics|mesh-ancestor
2415317|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2415318|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2415319|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
2415320|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415321|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415322|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2415323|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2415324|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
2415325|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
2415326|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2549230|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549231|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549232|NCT01487512|Analgesics|analgesics|mesh-ancestor
2549233|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
2549234|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549235|NCT01487564|Hydromorphone|hydromorphone|mesh-list
2549236|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2549237|NCT01487564|Narcotics|narcotics|mesh-ancestor
2549238|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549239|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549240|NCT01487564|Analgesics|analgesics|mesh-ancestor
2415327|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415328|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
2415329|NCT00785226|Sorafenib|sorafenib|mesh-list
2415330|NCT00785226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415331|NCT00785226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2415332|NCT00785226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415333|NCT00785226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415334|NCT00785330|Rituximab|rituximab|mesh-list
2415335|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2415336|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415337|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
2415338|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415339|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2415340|NCT00785382|Pregabalin|pregabalin|mesh-list
2415341|NCT00785382|Analgesics|analgesics|mesh-ancestor
2415342|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
2415343|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415344|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415345|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
2549241|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
2549242|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549243|NCT01487629|Bevacizumab|bevacizumab|mesh-list
2549244|NCT01487629|Ranibizumab|ranibizumab|mesh-list
2549245|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2549246|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549247|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2549248|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2549249|NCT01487629|Growth Substances|growth substances|mesh-ancestor
2549250|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549251|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
2549252|NCT01487785|Gemcitabine|gemcitabine|mesh-list
2549253|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2549254|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
2549255|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549256|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549257|NCT01487785|Antiviral Agents|antiviral agents|mesh-ancestor
2549258|NCT01487785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549259|NCT01487785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549260|NCT01487785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549261|NCT01487785|Immunologic Factors|immunologic factors|mesh-ancestor
2549262|NCT01487785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549263|NCT01487798|Insulin|insulin|mesh-list
2549264|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2549265|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
2549266|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
2549267|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2549268|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549269|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549270|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
2549271|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
2549272|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2549273|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549274|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549275|NCT01487993|Metformin|metformin|mesh-list
2549276|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549277|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549278|NCT01488045|Fentanyl|fentanyl|mesh-list
2549279|NCT01488045|Midazolam|midazolam|mesh-list
2549280|NCT01488045|Propofol|propofol|mesh-list
2549281|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2549282|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2415346|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2415347|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2415348|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415349|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2415350|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2415351|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2415352|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2415353|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2415354|NCT00785395|Oxytocin|oxytocin|mesh-list
2415355|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
2415356|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2415357|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415358|NCT00785421|Leucovorin|leucovorin|mesh-list
2415359|NCT00785421|Folic Acid|folic acid|mesh-list
2415360|NCT00785421|Gemcitabine|gemcitabine|mesh-list
2415361|NCT00785421|Cisplatin|cisplatin|mesh-list
2415362|NCT00785421|Enoxaparin|enoxaparin|mesh-list
2549283|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549284|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2549285|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
2549286|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
2549287|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2549288|NCT01488045|Narcotics|narcotics|mesh-ancestor
2549289|NCT01488045|Analgesics|analgesics|mesh-ancestor
2549290|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
2549291|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549292|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2549293|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2549294|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2549295|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2549296|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
2549297|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
2549298|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549299|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549300|NCT01488136|Diazoxide|diazoxide|mesh-list
2415363|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
2415364|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
2415365|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415366|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2415367|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
2415368|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415369|NCT00785421|Antiviral Agents|antiviral agents|mesh-ancestor
2415370|NCT00785421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415371|NCT00785421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549301|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2549302|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
2549303|NCT01488201|Brodalumab|brodalumab|mesh-list
2549304|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
2549305|NCT01488227|Vitamin D|vitamin d|mesh-list
2549306|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
2549307|NCT01488227|Vitamins|vitamins|mesh-list
2549308|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
2549309|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549310|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2549311|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2549312|NCT01488253|Sirolimus|sirolimus|mesh-list
2549313|NCT01488253|Tacrolimus|tacrolimus|mesh-list
2549314|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549315|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
2549316|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549317|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2549318|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549319|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549320|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2549321|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549322|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2549323|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549324|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
2549325|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2549326|NCT01488266|Milnacipran|milnacipran|mesh-list
2549327|NCT01488266|Aripiprazole|aripiprazole|mesh-list
2549328|NCT01488266|Mirtazapine|mirtazapine|mesh-list
2549329|NCT01488266|Citalopram|citalopram|mesh-list
2549330|NCT01488266|Bupropion|bupropion|mesh-list
2549331|NCT01488266|Fluoxetine|fluoxetine|mesh-list
2549332|NCT01488266|Paroxetine|paroxetine|mesh-list
2549333|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2549334|NCT01488266|Sertraline|sertraline|mesh-list
2549335|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
2549336|NCT01488266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2549337|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2415372|NCT00785421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2415373|NCT00785421|Immunologic Factors|immunologic factors|mesh-ancestor
2415374|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415375|NCT00785421|Antidotes|antidotes|mesh-ancestor
2415376|NCT00785421|Protective Agents|protective agents|mesh-ancestor
2415377|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
2415378|NCT00785421|Vitamins|vitamins|mesh-ancestor
2415379|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
2549338|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2549339|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549340|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549341|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
2549342|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549343|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2549344|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2549345|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549346|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2549347|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
2549348|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2549349|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2549350|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415380|NCT00785421|Hematinics|hematinics|mesh-ancestor
2415381|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
2415382|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2415383|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2415384|NCT00785434|Citalopram|citalopram|mesh-list
2415385|NCT00785434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2415386|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2549351|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2549352|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2549353|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549354|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
2549355|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2549356|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2549357|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2415387|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2415388|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415389|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415390|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
2415391|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415392|NCT00785434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2549358|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2549359|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2549360|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2549361|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2415393|NCT00785434|Antidepressive Agents|antidepressive agents|mesh-ancestor
2415394|NCT00785434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2415395|NCT00785460|Benphothiamine|benphothiamine|mesh-list
2415396|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2415397|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
2415398|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415399|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
2415400|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
2415401|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415402|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
2415403|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
2415404|NCT00785473|Calcium|calcium|mesh-list
2415405|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2415406|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415407|NCT00785473|Vitamins|vitamins|mesh-ancestor
2415408|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
2415409|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2415410|NCT00785473|Antacids|antacids|mesh-ancestor
2415411|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415412|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2415413|NCT00785525|Lenograstim|lenograstim|mesh-list
2415414|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2415415|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
2415416|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415417|NCT00785551|Quinine|quinine|mesh-list
2415418|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
2415419|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2415420|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2415421|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415422|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2415423|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549362|NCT01488266|Analgesics|analgesics|mesh-ancestor
2549363|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
2549364|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2549365|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
2549366|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
2549367|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2549368|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2549369|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2549370|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2549371|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
2549372|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2549373|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2549374|NCT01488305|Micronutrients|micronutrients|mesh-list
2549375|NCT01488305|Trace Elements|trace elements|mesh-list
2549376|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549377|NCT01488344|Nintedanib|nintedanib|mesh-list
2549378|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549379|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2549380|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549381|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549382|NCT01488396|Cyclosporine|cyclosporine|mesh-list
2549383|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2549384|NCT01488396|Cyclosporins|cyclosporins|mesh-list
2549385|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549386|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549387|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549388|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
2415424|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2415425|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415426|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2415427|NCT00785551|Analgesics|analgesics|mesh-ancestor
2415428|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
2415429|NCT00785603|Tramadol|tramadol|mesh-list
2415430|NCT00785603|Paroxetine|paroxetine|mesh-list
2415431|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2415432|NCT00785603|Narcotics|narcotics|mesh-ancestor
2549389|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549390|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
2549391|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549392|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
2549393|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2549394|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2549395|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2415433|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2415434|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415435|NCT00785603|Analgesics|analgesics|mesh-ancestor
2415436|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
2415437|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415438|NCT00785603|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2415439|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2415440|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2415441|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415442|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415443|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
2415444|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2415445|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
2415446|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2415447|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2415448|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2415449|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415450|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
2415451|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2415452|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2415453|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415454|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415455|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415456|NCT00785863|Ketorolac|ketorolac|mesh-list
2415457|NCT00785863|Parecoxib|parecoxib|mesh-list
2415458|NCT00785863|Remifentanil|remifentanil|mesh-list
2415459|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2549396|NCT01488526|Tenofovir|tenofovir|mesh-list
2549397|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
2549398|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549399|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2549400|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2549401|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549402|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549403|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2549404|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2549405|NCT01488552|Metformin|metformin|mesh-list
2549406|NCT01488552|Gemcitabine|gemcitabine|mesh-list
2549407|NCT01488552|Paclitaxel|paclitaxel|mesh-list
2549408|NCT01488552|Folfirinox|folfirinox|mesh-list
2549409|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2549410|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549411|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
2415460|NCT00785863|Narcotics|narcotics|mesh-ancestor
2415461|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2415462|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415463|NCT00785863|Analgesics|analgesics|mesh-ancestor
2415464|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
2415465|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415466|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2415467|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2415468|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2415469|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2415470|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2415471|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415472|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415473|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2415474|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2415475|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
2415476|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415477|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2549412|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
2549413|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
2549414|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549415|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2549416|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
2549417|NCT01488552|Antiviral Agents|antiviral agents|mesh-ancestor
2549418|NCT01488552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549419|NCT01488552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549420|NCT01488552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549421|NCT01488552|Immunologic Factors|immunologic factors|mesh-ancestor
2549422|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549423|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549424|NCT01488565|Azacitidine|azacitidine|mesh-list
2549425|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2549426|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
2549427|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549428|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549429|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549430|NCT01488656|Vitamin D|vitamin d|mesh-list
2549431|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2549432|NCT01488656|Antioxidants|antioxidants|mesh-list
2549433|NCT01488656|Vitamins|vitamins|mesh-ancestor
2549434|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
2549435|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549436|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2549437|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549438|NCT01488656|Protective Agents|protective agents|mesh-ancestor
2549439|NCT01488734|Vitamin D|vitamin d|mesh-list
2549440|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
2549441|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
2549442|NCT01488734|Vitamins|vitamins|mesh-list
2549443|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
2549444|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549445|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2549446|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2549447|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2549448|NCT01488773|Montelukast|montelukast|mesh-list
2549449|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2549450|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
2549451|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549452|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549453|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2549454|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
2549455|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2549456|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2549457|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2549458|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
2549459|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549460|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549461|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2549462|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
2549463|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2549464|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2415478|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
2415479|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415480|NCT00786058|Fluorouracil|fluorouracil|mesh-list
2415481|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
2415482|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549465|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2549466|NCT01488838|Cisplatin|cisplatin|mesh-list
2549467|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549468|NCT01488955|Fosfomycin|fosfomycin|mesh-list
2549469|NCT01488955|Ibuprofen|ibuprofen|mesh-list
2549470|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2549471|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2549472|NCT01488955|Analgesics|analgesics|mesh-ancestor
2549473|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
2549474|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549475|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549476|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2549477|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2549478|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2549479|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549480|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549481|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2549482|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549483|NCT01489046|Tenofovir|tenofovir|mesh-list
2549484|NCT01489046|Lamivudine|lamivudine|mesh-list
2415483|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2415484|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415485|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2415486|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
2415487|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415488|NCT00786110|Paclitaxel|paclitaxel|mesh-list
2415489|NCT00786110|Sorafenib|sorafenib|mesh-list
2415490|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2415491|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415492|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
2415493|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
2415494|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
2415495|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415496|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2415497|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415498|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2415499|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2415500|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2415501|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
2415502|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415503|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2415504|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2415505|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415506|NCT00786149|Varenicline|varenicline|mesh-list
2415507|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2415508|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2415509|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
2415510|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415511|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415512|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415513|NCT00786201|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2415514|NCT00786201|Immunologic Factors|immunologic factors|mesh-ancestor
2415515|NCT00786201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415516|NCT00786240|Fesoterodine|fesoterodine|mesh-list
2415517|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2415518|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2415519|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
2415520|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415521|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415522|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415523|NCT00786240|Urological Agents|urological agents|mesh-ancestor
2415524|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2415525|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
2415526|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2415527|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2415528|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415529|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415530|NCT00786253|Urological Agents|urological agents|mesh-ancestor
2415531|NCT00786279|Ethanol|ethanol|mesh-list
2415532|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2415533|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415534|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2415535|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415536|NCT00786305|Amikacin|amikacin|mesh-list
2415537|NCT00786305|Ceftazidime|ceftazidime|mesh-list
2415538|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2415539|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415540|NCT00786318|Ziprasidone|ziprasidone|mesh-list
2415541|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2415542|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
2415543|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415544|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415545|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415546|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2415547|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2415548|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2415549|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2415550|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2415551|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
2415552|NCT00786331|Carboplatin|carboplatin|mesh-list
2415553|NCT00786331|Pemetrexed|pemetrexed|mesh-list
2415554|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415555|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415556|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415557|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2415558|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2415559|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
2415560|NCT00786370|Propofol|propofol|mesh-list
2415561|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2415562|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2415563|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415564|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2415565|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
2415566|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
2415567|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2415568|NCT00786370|Analgesics|analgesics|mesh-ancestor
2415569|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
2415570|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415571|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2415572|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2415573|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2415574|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
2415575|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415576|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549485|NCT01489046|Efavirenz|efavirenz|mesh-list
2549486|NCT01489046|Antiviral Agents|antiviral agents|mesh-ancestor
2549487|NCT01489046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549488|NCT01489046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2549489|NCT01489046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2549490|NCT01489046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549491|NCT01489046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549492|NCT01489046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2549493|NCT01489046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2549494|NCT01489046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2549495|NCT01489046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2549496|NCT01489046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2549497|NCT01489046|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2549498|NCT01489046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2549499|NCT01489046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2549500|NCT01489059|Ipilimumab|ipilimumab|mesh-list
2549501|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2549502|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549503|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2549504|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549505|NCT01489072|Remifentanil|remifentanil|mesh-list
2549506|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2549507|NCT01489072|Narcotics|narcotics|mesh-ancestor
2549508|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549509|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549510|NCT01489072|Analgesics|analgesics|mesh-ancestor
2549511|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
2549512|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549513|NCT01489124|Imipenem|imipenem|mesh-list
2549514|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2549515|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549516|NCT01489137|Remifentanil|remifentanil|mesh-list
2549517|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2549518|NCT01489137|Narcotics|narcotics|mesh-ancestor
2549519|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549520|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549521|NCT01489137|Analgesics|analgesics|mesh-ancestor
2549522|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
2549523|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549524|NCT01489176|Regadenoson|regadenoson|mesh-list
2415577|NCT00786383|Ramucirumab|ramucirumab|mesh-list
2415578|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415579|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2415580|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
2415581|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415582|NCT00786448|Darifenacin|darifenacin|mesh-list
2415583|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2415584|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2415585|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
2415586|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415587|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549525|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2549526|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2549527|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
2549528|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
2549529|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549530|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549531|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549532|NCT01489202|Cobalt|cobalt|mesh-list
2549533|NCT01489202|Chromium|chromium|mesh-list
2549534|NCT01489202|Everolimus|everolimus|mesh-list
2415588|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415589|NCT00786448|Urological Agents|urological agents|mesh-ancestor
2415590|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
2549535|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415591|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2415592|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415593|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
2415594|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2415595|NCT00786552|Paclitaxel|paclitaxel|mesh-list
2415596|NCT00786552|Pemetrexed|pemetrexed|mesh-list
2415597|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2415598|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415599|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
2415600|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
2415601|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
2415602|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415603|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415604|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2415605|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2415606|NCT00786669|Cefixime|cefixime|mesh-list
2415607|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
2415608|NCT00786669|Bevacizumab|bevacizumab|mesh-list
2415609|NCT00786669|Irinotecan|irinotecan|mesh-list
2415610|NCT00786669|Vincristine|vincristine|mesh-list
2415611|NCT00786669|Temozolomide|temozolomide|mesh-list
2415612|NCT00786669|Camptothecin|camptothecin|mesh-list
2415613|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2415614|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415615|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2415616|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2415617|NCT00786669|Growth Substances|growth substances|mesh-ancestor
2415618|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415619|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
2415620|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2415621|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2415622|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415623|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415624|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2415625|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
2415626|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
2415627|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
2415628|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2415629|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
2415630|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2415631|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549536|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549537|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
2549538|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549539|NCT01489202|Trace Elements|trace elements|mesh-ancestor
2549540|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
2549541|NCT01489228|Benzonidazole|benzonidazole|mesh-list
2549542|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549543|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
2549544|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549545|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2549546|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2415632|NCT00786695|Esomeprazole|esomeprazole|mesh-list
2415633|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2415634|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2415635|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2415636|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549547|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2549548|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549549|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2549550|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
2549551|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2549552|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2549553|NCT01489319|Analgesics|analgesics|mesh-ancestor
2549554|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
2549555|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549556|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549557|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2549558|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2415637|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415638|NCT00786734|Pitavastatin|pitavastatin|mesh-list
2415639|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2415640|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2415641|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2549559|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2549560|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549561|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549562|NCT01489371|Doxorubicin|doxorubicin|mesh-list
2549563|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2549564|NCT01489371|Interleukin-12|interleukin-12|mesh-list
2549565|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2549566|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549567|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2549568|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2549569|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549570|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549571|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2549572|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
2549573|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549574|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2549575|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2549576|NCT01489371|Growth Substances|growth substances|mesh-ancestor
2549577|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
2549578|NCT01489410|Ethanol|ethanol|mesh-list
2549579|NCT01489410|Doxorubicin|doxorubicin|mesh-list
2549580|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2549581|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
2549582|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2549583|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549584|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2549585|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2549586|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549587|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549588|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2549589|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549590|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549591|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549592|NCT01489488|Riociguat|riociguat|mesh-list
2549593|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
2549594|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549595|NCT01489566|Fluorouracil|fluorouracil|mesh-list
2549596|NCT01489566|Mitomycins|mitomycins|mesh-list
2549597|NCT01489566|Mitomycin|mitomycin|mesh-list
2549598|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
2549599|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549600|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2549601|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549602|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549603|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
2549604|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415642|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
2415643|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549605|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2549606|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
2549607|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2549608|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549609|NCT01489592|Turmeric extract|turmeric extract|mesh-list
2549610|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
2549611|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549612|NCT01489592|Protective Agents|protective agents|mesh-ancestor
2549613|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549614|NCT01489631|Sufentanil|sufentanil|mesh-list
2549615|NCT01489631|Gabapentin|gabapentin|mesh-list
2549616|NCT01489631|Bupivacaine|bupivacaine|mesh-list
2549617|NCT01489631|Ropivacaine|ropivacaine|mesh-list
2549618|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
2549619|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
2549620|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549621|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415644|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415645|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2415646|NCT00786851|Lenalidomide|lenalidomide|mesh-list
2415647|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
2415648|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415649|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2415650|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2415651|NCT00786851|Growth Substances|growth substances|mesh-ancestor
2415652|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
2415653|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415654|NCT00787007|Equol|equol|mesh-list
2549622|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
2549623|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549624|NCT01489631|Analgesics|analgesics|mesh-ancestor
2549625|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
2549626|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2415655|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
2415656|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2415657|NCT00787007|Estrogens|estrogens|mesh-ancestor
2415658|NCT00787007|Hormones|hormones|mesh-ancestor
2415659|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2415660|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415661|NCT00787111|Fluoxetine|fluoxetine|mesh-list
2415662|NCT00787111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2415663|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2549627|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2549628|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2549629|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2549630|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2549631|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549632|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549633|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
2549634|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2549635|NCT01489631|Narcotics|narcotics|mesh-ancestor
2549636|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2549637|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2549638|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
2549639|NCT01489644|Metformin|metformin|mesh-list
2549640|NCT01489644|Repaglinide|repaglinide|mesh-list
2549641|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549642|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549643|NCT01489683|Lidocaine|lidocaine|mesh-list
2549644|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
2549645|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
2549646|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549647|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549648|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
2549649|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549650|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2549651|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2549652|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2549653|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2549654|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549655|NCT01489696|Tamsulosin|tamsulosin|mesh-list
2549656|NCT01489696|Mirabegron|mirabegron|mesh-list
2549657|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2549658|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2549659|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2549660|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
2549661|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549662|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549663|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549664|NCT01489696|Urological Agents|urological agents|mesh-ancestor
2415664|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2415665|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415666|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415667|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
2415668|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415669|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2415670|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
2415671|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2415672|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2415673|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2415674|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415679|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2549665|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2549666|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2549667|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2549668|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
2415680|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
2415681|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
2415682|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415683|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
2415684|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415685|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
2415686|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415687|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2549669|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2549670|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2549671|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
2549672|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549673|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549674|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549675|NCT01489709|Urological Agents|urological agents|mesh-ancestor
2415688|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415689|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415690|NCT00787410|Gefitinib|gefitinib|mesh-list
2415691|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415692|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2415693|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415694|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415695|NCT00787436|Thalidomide|thalidomide|mesh-list
2415696|NCT00787436|Timolol|timolol|mesh-list
2415697|NCT00787436|Propranolol|propranolol|mesh-list
2415698|NCT00787436|Nadolol|nadolol|mesh-list
2415699|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2415700|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
2415701|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415702|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
2415703|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2415704|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415705|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2415706|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2415707|NCT00787436|Growth Substances|growth substances|mesh-ancestor
2415708|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
2415709|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415710|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2415711|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2415712|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
2415713|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415714|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415715|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2415716|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2415717|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
2415718|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
2415719|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
2415720|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415721|NCT00787462|Pregabalin|pregabalin|mesh-list
2415722|NCT00787462|Analgesics|analgesics|mesh-ancestor
2415723|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
2415724|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415725|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415726|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
2415727|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2415728|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2415729|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415730|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2415731|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2415732|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2415733|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2415734|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2415735|NCT00787501|Citalopram|citalopram|mesh-list
2415736|NCT00787501|Fluoxetine|fluoxetine|mesh-list
2415737|NCT00787501|Sertraline|sertraline|mesh-list
2415738|NCT00787501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2415739|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2415740|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2415741|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415742|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415743|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
2415744|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549689|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2549690|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2549691|NCT01489852|Estradiol|estradiol|mesh-list
2549692|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2549693|NCT01489852|Estrogens|estrogens|mesh-ancestor
2549694|NCT01489852|Hormones|hormones|mesh-ancestor
2549695|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2549696|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549697|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2549698|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
2549699|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2549700|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2549701|NCT01489865|Fluorouracil|fluorouracil|mesh-list
2549702|NCT01489865|Veliparib|veliparib|mesh-list
2549703|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
2549704|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549705|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2549706|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549707|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549708|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
2549709|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549710|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2549711|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549712|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
2549713|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2415745|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2415746|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
2549714|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2549715|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2549716|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2549717|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549718|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
2549719|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549720|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549721|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2549722|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549723|NCT01489917|Heparin|heparin|mesh-list
2549724|NCT01489917|Hemostatics|hemostatics|mesh-list
2549725|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
2549726|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2549727|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2549728|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549729|NCT01489917|Coagulants|coagulants|mesh-ancestor
2549730|NCT01489943|Pioglitazone|pioglitazone|mesh-list
2549731|NCT01489943|Midazolam|midazolam|mesh-list
2549732|NCT01489943|Omeprazole|omeprazole|mesh-list
2549733|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2549734|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2549735|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2549736|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549737|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549738|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2549739|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2549740|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2549741|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2549742|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
2549743|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
2549744|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
2549745|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
2549746|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549747|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549748|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2549749|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2549750|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
2549751|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2549752|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2549753|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549754|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549755|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2549756|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2549757|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2549758|NCT01489982|Zopiclone|zopiclone|mesh-list
2549759|NCT01489982|Doxepin|doxepin|mesh-list
2549760|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2549761|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549762|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549763|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2549764|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2549765|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
2549766|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2549767|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
2549768|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
2549769|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549770|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549771|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
2549772|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
2549773|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549774|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549775|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549776|NCT01490047|Etanercept|etanercept|mesh-list
2549777|NCT01490047|Doxorubicin|doxorubicin|mesh-list
2549778|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2549779|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2549780|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549781|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2549782|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2549783|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549784|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549785|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2549786|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2549787|NCT01490047|Analgesics|analgesics|mesh-ancestor
2549788|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
2549789|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549790|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549791|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2549792|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2549793|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2549794|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549795|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
2549796|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
2549797|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549798|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549799|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
2549800|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549801|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549802|NCT01490203|Edetic Acid|edetic acid|mesh-list
2549803|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
2549804|NCT01490203|Antidotes|antidotes|mesh-ancestor
2549805|NCT01490203|Protective Agents|protective agents|mesh-ancestor
2549806|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549807|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
2549808|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
2549809|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549810|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2549811|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
2549812|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2549813|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2549814|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2549815|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549816|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2549817|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2549818|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2549819|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549820|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
2549821|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549822|NCT01490229|Ezetimibe|ezetimibe|mesh-list
2549823|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2549824|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2549825|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
2549826|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549827|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2549828|NCT01490255|Amlodipine|amlodipine|mesh-list
2549829|NCT01490255|Ranolazine|ranolazine|mesh-list
2549830|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2549831|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2549832|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2549833|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549834|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2549835|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549836|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
2549837|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2549838|NCT01490268|Sufentanil|sufentanil|mesh-list
2549839|NCT01490268|Dsuvia|dsuvia|mesh-list
2549840|NCT01490268|Hydromorphone|hydromorphone|mesh-list
2549841|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2549842|NCT01490268|Narcotics|narcotics|mesh-ancestor
2549843|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549844|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549845|NCT01490268|Analgesics|analgesics|mesh-ancestor
2549846|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
2549847|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549848|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2549849|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2549850|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
2549851|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
2549852|NCT01490333|Vitamin D|vitamin d|mesh-list
2549853|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
2549854|NCT01490333|Vitamins|vitamins|mesh-ancestor
2549855|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
2549856|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549857|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2549858|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2549859|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2549860|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
2549861|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549862|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2549863|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2549864|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2549865|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
2549866|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549867|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2549868|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2549869|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549870|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
2549871|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549872|NCT01490437|Dexamethasone|dexamethasone|mesh-list
2549873|NCT01490437|Pemetrexed|pemetrexed|mesh-list
2415747|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2415748|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2415749|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2415750|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415751|NCT00787553|Cefazolin|cefazolin|mesh-list
2415752|NCT00787553|Tinidazole|tinidazole|mesh-list
2415753|NCT00787553|Imidazole|imidazole|mesh-list
2415754|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2415755|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415756|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415757|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415758|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
2415759|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2415760|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2549874|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549875|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549876|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2549877|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
2549878|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
2549879|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549880|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2549881|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
2549882|NCT01490437|Hormones|hormones|mesh-ancestor
2549883|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2549884|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2549885|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549886|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549887|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2549888|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2549889|NCT01490476|Everolimus|everolimus|mesh-list
2549890|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549891|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549892|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
2549893|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549894|NCT01490502|Vitamin D|vitamin d|mesh-list
2549895|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
2549896|NCT01490502|Vitamins|vitamins|mesh-ancestor
2549897|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
2549898|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549899|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2549900|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2549901|NCT01490567|Donepezil|donepezil|mesh-list
2549902|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2549903|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415761|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2415762|NCT00787657|Interferons|interferons|mesh-list
2415763|NCT00787657|Interferon-beta|interferon-beta|mesh-list
2415764|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
2415765|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415766|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
2415767|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549904|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549905|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
2549906|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549907|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549908|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
2549909|NCT01490658|Metformin|metformin|mesh-list
2549910|NCT01490658|Repaglinide|repaglinide|mesh-list
2415768|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
2415769|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415770|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2549911|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549912|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549913|NCT01490671|Tenofovir|tenofovir|mesh-list
2549914|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
2549915|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2549916|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2549917|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2549918|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549919|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549920|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2549921|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2549922|NCT01490749|Carboplatin|carboplatin|mesh-list
2549923|NCT01490749|Capecitabine|capecitabine|mesh-list
2549924|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
2549925|NCT01490749|Everolimus|everolimus|mesh-list
2549926|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549927|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2549928|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
2549929|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549930|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2549931|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
2549932|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549933|NCT01490762|Insulin|insulin|mesh-list
2549934|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2549935|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2549936|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549937|NCT01490905|Ibuprofen|ibuprofen|mesh-list
2549938|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2549939|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2549940|NCT01490905|Analgesics|analgesics|mesh-ancestor
2549941|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
2549942|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549943|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549944|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2549945|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2549946|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2549947|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549948|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549949|NCT01490944|Iron|iron|mesh-list
2549950|NCT01490944|Folic Acid|folic acid|mesh-list
2549951|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
2549952|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
2549953|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
2549954|NCT01490944|Trace Elements|trace elements|mesh-ancestor
2549955|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
2415771|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
2549956|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549957|NCT01490944|Hematinics|hematinics|mesh-ancestor
2415772|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2415773|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2549958|NCT01490944|Vitamins|vitamins|mesh-ancestor
2549959|NCT01490996|Curcumin|curcumin|mesh-list
2549960|NCT01490996|Capecitabine|capecitabine|mesh-list
2549961|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2549962|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
2549963|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549964|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2549965|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2549966|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2549967|NCT01490996|Analgesics|analgesics|mesh-ancestor
2549968|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
2549969|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549970|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549971|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2549972|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2549973|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549974|NCT01491009|Midazolam|midazolam|mesh-list
2549975|NCT01491009|Remifentanil|remifentanil|mesh-list
2549976|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2549977|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2549978|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2549979|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2549980|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2549981|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2549982|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2549983|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2549984|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
2549985|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
2549986|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
2549987|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
2549988|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2549989|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549990|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2549991|NCT01491009|Narcotics|narcotics|mesh-ancestor
2549992|NCT01491009|Analgesics|analgesics|mesh-ancestor
2549993|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
2549994|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2549995|NCT01491048|Tacrine|tacrine|mesh-list
2549996|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2549997|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2549998|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2549999|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
2550000|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550001|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550002|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2550003|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
2550004|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550005|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
2550006|NCT01491061|Ranolazine|ranolazine|mesh-list
2550007|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2550008|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2550009|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550010|NCT01491100|Interferons|interferons|mesh-list
2550011|NCT01491100|Interferon-beta|interferon-beta|mesh-list
2550012|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
2550013|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550014|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
2550015|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550016|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
2550017|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550018|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2550019|NCT01491139|Olaparib|olaparib|mesh-list
2550020|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550021|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2550022|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415774|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
2415775|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415776|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2415777|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2415778|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415779|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415780|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
2415781|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2415782|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
2116808|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2116809|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2116810|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415783|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415784|NCT00787813|Expectorants|expectorants|mesh-ancestor
2415785|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
2415786|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2415787|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
2415788|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415789|NCT00787813|Protective Agents|protective agents|mesh-ancestor
2415790|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415791|NCT00787813|Antidotes|antidotes|mesh-ancestor
2415792|NCT00787826|Vaccines|vaccines|mesh-list
2415793|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
2415794|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415795|NCT00787969|Sirolimus|sirolimus|mesh-list
2415796|NCT00787969|Rituximab|rituximab|mesh-list
2415797|NCT00787969|Cladribine|cladribine|mesh-list
2415798|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2415799|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550023|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550024|NCT01491191|Palmidrol|palmidrol|mesh-list
2550025|NCT01491191|Analgesics|analgesics|mesh-ancestor
2550026|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
2550027|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550028|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550029|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2550030|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2550031|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2550032|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550033|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
2550034|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550035|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2550036|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2550037|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550038|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550039|NCT01491191|Hormones|hormones|mesh-ancestor
2550040|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2550041|NCT01491204|Paclitaxel|paclitaxel|mesh-list
2550042|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2550043|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550044|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
2550045|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
2550046|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
2550047|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550048|NCT01491217|Paclitaxel|paclitaxel|mesh-list
2550049|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2550050|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550051|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
2550052|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
2550053|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
2550054|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550055|NCT01491256|Atorvastatin|atorvastatin|mesh-list
2550056|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2550057|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2550058|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
2550059|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550060|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2550061|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2415800|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
2116811|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116812|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116813|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2116814|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2116815|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
2116816|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2116817|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2116818|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2116819|NCT02649192|Vitamin D|vitamin d|mesh-list
2116820|NCT02649192|Vitamin A|vitamin a|mesh-list
2116821|NCT02649192|Vitamins|vitamins|mesh-ancestor
2116822|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
2116823|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116824|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2415801|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415802|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2415803|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2415804|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415805|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2415806|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
2415807|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2415808|NCT00788034|Vortioxetine|vortioxetine|mesh-list
2415809|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
2415810|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2415811|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2415812|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2415813|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550062|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550063|NCT01491295|Tenofovir|tenofovir|mesh-list
2550064|NCT01491295|Lamivudine|lamivudine|mesh-list
2550065|NCT01491295|Adefovir|adefovir|mesh-list
2550066|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
2550067|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550068|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2550069|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2550070|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550071|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550072|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2550073|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2415814|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415815|NCT00788034|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2415816|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2415817|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2415818|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415819|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415820|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
2415821|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2415822|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2415823|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2415824|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2415825|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
2415826|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
2415827|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
2415828|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2415829|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2415830|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415831|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415832|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415833|NCT00788060|Everolimus|everolimus|mesh-list
2415834|NCT00788060|Sunitinib|sunitinib|mesh-list
2415835|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415836|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2550074|NCT01491321|Loxoprofen|loxoprofen|mesh-list
2550075|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2550076|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2550077|NCT01491321|Analgesics|analgesics|mesh-ancestor
2550078|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
2550079|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550080|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550081|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2550082|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550083|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2550084|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2550085|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550086|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
2550087|NCT01491503|Cetirizine|cetirizine|mesh-list
2550088|NCT01491503|Montelukast|montelukast|mesh-list
2550089|NCT01491503|Levocetirizine|levocetirizine|mesh-list
2550090|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2550091|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
2550092|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2550093|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
2550094|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2550095|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550096|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2550097|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2550098|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550099|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2550100|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2550101|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
2550102|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
2550103|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550104|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2415837|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
2415838|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415839|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2415840|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2415841|NCT00788060|Growth Substances|growth substances|mesh-ancestor
2415842|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
2415843|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2550105|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2550106|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2550107|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2550108|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
2415844|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415845|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415846|NCT00788099|Gemcitabine|gemcitabine|mesh-list
2415847|NCT00788099|Sorafenib|sorafenib|mesh-list
2550114|NCT01491815|Abatacept|abatacept|mesh-list
2550115|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2550116|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550117|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550118|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2550119|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
2550120|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550121|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550122|NCT01491867|Travoprost|travoprost|mesh-list
2550123|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2550124|NCT01492062|Pancrelipase|pancrelipase|mesh-list
2550125|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2550126|NCT01492114|Resveratrol|resveratrol|mesh-list
2550127|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
2550128|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550129|NCT01492114|Protective Agents|protective agents|mesh-ancestor
2550130|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550131|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550132|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2550133|NCT01492153|Insulin|insulin|mesh-list
2550134|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2550135|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
2550136|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
2550137|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
2550138|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2550139|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550140|NCT01492166|Insulin|insulin|mesh-list
2550141|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2550142|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2550143|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550144|NCT01492179|Lidocaine|lidocaine|mesh-list
2550145|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
2550146|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
2550147|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550148|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550149|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
2550150|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550151|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2550152|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2550153|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2415848|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2415849|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
2415850|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415851|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415852|NCT00788099|Antiviral Agents|antiviral agents|mesh-ancestor
2415853|NCT00788099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415854|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550154|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2550155|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550156|NCT01492205|Insulin|insulin|mesh-list
2550157|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2550158|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2550159|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550160|NCT01492218|Insulin|insulin|mesh-list
2550161|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2550162|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2550163|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116825|NCT02649231|Ketamine|ketamine|mesh-list
2116826|NCT02649231|Analgesics|analgesics|mesh-ancestor
2116827|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
2116828|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116829|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116830|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2116831|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2116832|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
2116833|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
2116834|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116835|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2116836|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2116837|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116838|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116839|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
2116840|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2116841|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2116842|NCT02650193|Lenograstim|lenograstim|mesh-list
2116843|NCT02650193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2116844|NCT02650193|Immunologic Factors|immunologic factors|mesh-ancestor
2415855|NCT00788099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2550164|NCT01492361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2550165|NCT01492361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2550166|NCT01492361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2550167|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2550168|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550169|NCT01492504|Asunaprevir|asunaprevir|mesh-list
2550170|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
2550171|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550172|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550173|NCT01492543|Tegafur|tegafur|mesh-list
2550174|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2550175|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
2550176|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550177|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550178|NCT01492556|Etoposide|etoposide|mesh-list
2415856|NCT00788099|Immunologic Factors|immunologic factors|mesh-ancestor
2415857|NCT00788099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415858|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2415859|NCT00788112|Vorinostat|vorinostat|mesh-list
2415860|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415861|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2415862|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415863|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415864|NCT00788125|Carboplatin|carboplatin|mesh-list
2415865|NCT00788125|Etoposide|etoposide|mesh-list
2415866|NCT00788125|Ifosfamide|ifosfamide|mesh-list
2415867|NCT00788125|Dasatinib|dasatinib|mesh-list
2415868|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
2415869|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415870|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2415871|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2415872|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2415873|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415874|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415875|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2415876|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
2550179|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2550180|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550181|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2550182|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2550183|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550184|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550185|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
2550186|NCT01492608|Analgesics|analgesics|mesh-ancestor
2550187|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
2550188|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550189|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415877|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2415878|NCT00788138|Vitamin D|vitamin d|mesh-list
2415879|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
2415880|NCT00788138|Vitamins|vitamins|mesh-ancestor
2415881|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
2415882|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415883|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2415884|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2415885|NCT00788164|Imiquimod|imiquimod|mesh-list
2415886|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2415887|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
2415888|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415889|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415890|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
2415891|NCT00788242|Insulin|insulin|mesh-list
2415892|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2415893|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415894|NCT00788294|Tanezumab|tanezumab|mesh-list
2415895|NCT00788294|Analgesics|analgesics|mesh-ancestor
2415896|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
2415897|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2415898|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415899|NCT00788320|Vitamin D|vitamin d|mesh-list
2415900|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
2415901|NCT00788320|Vitamins|vitamins|mesh-ancestor
2415902|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
2415903|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415904|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2415905|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2415906|NCT00788333|Trastuzumab|trastuzumab|mesh-list
2415907|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2550190|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
2550191|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550192|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2550193|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
2550194|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2550195|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2550196|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550197|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2550198|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
2550199|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2550200|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2550201|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2550202|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2550203|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2550204|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415908|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415909|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2415910|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
2415911|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2415912|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
2415913|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415914|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415915|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2415916|NCT00788424|Protective Agents|protective agents|mesh-ancestor
2415917|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2415918|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2415919|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415920|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415921|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
2415922|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415923|NCT00788463|Beclomethasone|beclomethasone|mesh-list
2415924|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2415925|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
2415926|NCT00788463|Hormones|hormones|mesh-ancestor
2415927|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2415928|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415929|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2415930|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
2415931|NCT00788515|Lormetazepam|lormetazepam|mesh-list
2415932|NCT00788515|Volinanserin|volinanserin|mesh-list
2415933|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2550205|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550206|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550207|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
2550208|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2550209|NCT01492712|Propofol|propofol|mesh-list
2550210|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2550211|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550212|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550213|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2550214|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
2550215|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
2550216|NCT01492725|Plasminogen|plasminogen|mesh-list
2550217|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2550218|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2550219|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2550220|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550221|NCT01492881|Doxorubicin|doxorubicin|mesh-list
2550222|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2550223|NCT01492881|Bortezomib|bortezomib|mesh-list
2550224|NCT01492881|Vorinostat|vorinostat|mesh-list
2550225|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2550226|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550227|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2550228|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2550229|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550230|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550231|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2550232|NCT01492894|Cyclosporine|cyclosporine|mesh-list
2550233|NCT01492894|Sirolimus|sirolimus|mesh-list
2550234|NCT01492894|Tacrolimus|tacrolimus|mesh-list
2550235|NCT01492894|Cyclosporins|cyclosporins|mesh-list
2550236|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2550237|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
2550238|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550239|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2550240|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550241|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550242|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
2550243|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550244|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
2550245|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550246|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2550247|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2550248|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550249|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
2550250|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
2550251|NCT01492920|Vitamins|vitamins|mesh-ancestor
2550252|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
2550253|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550254|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
2415934|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2415935|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415936|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2415937|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
2415938|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2415939|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415940|NCT00788541|Hydrocortisone|hydrocortisone|mesh-list
2415941|NCT00788541|Anecortave|anecortave|mesh-list
2415942|NCT00788541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2415943|NCT00788541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2415944|NCT00788541|Growth Substances|growth substances|mesh-ancestor
2415945|NCT00788541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415946|NCT00788541|Growth Inhibitors|growth inhibitors|mesh-ancestor
2415947|NCT00788541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415948|NCT00788541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2415949|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
2415950|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2415951|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415952|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2415953|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
2415954|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2550255|NCT01492959|Insulin|insulin|mesh-list
2550256|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2550257|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2550258|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550259|NCT01492972|Leuprolide|leuprolide|mesh-list
2550260|NCT01492972|Goserelin|goserelin|mesh-list
2550261|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2550262|NCT01492972|Buserelin|buserelin|mesh-list
2550263|NCT01492972|Androgens|androgens|mesh-list
2550264|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2550265|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
2550266|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2550267|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550268|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2550269|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550270|NCT01492972|Hormones|hormones|mesh-ancestor
2550271|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2550272|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
2550273|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2550274|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
2550275|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2550276|NCT01492985|Vaccines|vaccines|mesh-list
2550277|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
2550278|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550279|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
2550280|NCT01493050|Calcium|calcium|mesh-list
2550281|NCT01493050|Sevelamer|sevelamer|mesh-list
2550282|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2550283|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550284|NCT01493050|Antacids|antacids|mesh-ancestor
2550285|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550286|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2550287|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
2550288|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
2550289|NCT01493102|Vasopressins|vasopressins|mesh-list
2550290|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
2550291|NCT01493102|Norepinephrine|norepinephrine|mesh-list
2550292|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2550293|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2550294|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
2550295|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550296|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550297|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550298|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
2550299|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
2550300|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550301|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2550302|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
2550303|NCT01493102|Coagulants|coagulants|mesh-ancestor
2550304|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2415955|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415956|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2415957|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2415958|NCT00788580|Sirolimus|sirolimus|mesh-list
2415959|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2415960|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2415961|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2415962|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415963|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
2415964|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2415965|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
2415966|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415967|NCT00788606|Bevacizumab|bevacizumab|mesh-list
2550305|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
2550306|NCT01493115|Insulin|insulin|mesh-list
2550307|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2550308|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
2550309|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2550310|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550311|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
2550312|NCT01493154|Vaccines|vaccines|mesh-list
2550313|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
2550314|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550315|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2550316|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2415968|NCT00788606|Rituximab|rituximab|mesh-list
2415969|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2415970|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415971|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2415972|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2415973|NCT00788606|Growth Substances|growth substances|mesh-ancestor
2550317|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2550318|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
2550319|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550320|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550321|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2550322|NCT01493310|Paclitaxel|paclitaxel|mesh-list
2550323|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2550324|NCT01493310|Mifepristone|mifepristone|mesh-list
2550325|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2550326|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550327|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
2550328|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
2550329|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
2550330|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550331|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2550332|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
2550333|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2550334|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550335|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2550336|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2550337|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2550338|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
2550339|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2550340|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2550341|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
2415974|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550342|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2550343|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
2550344|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2550345|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2550346|NCT01493336|Capecitabine|capecitabine|mesh-list
2550347|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2550348|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
2550349|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550350|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550351|NCT01493388|Insulin|insulin|mesh-list
2550352|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2415975|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
2415976|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
2415977|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2415978|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
2415979|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2550353|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550354|NCT01493440|Atosiban|atosiban|mesh-list
2550355|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
2550356|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2550357|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550358|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
2415980|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
2415981|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2415982|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415983|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2415984|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2415985|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2415986|NCT00788684|Rituximab|rituximab|mesh-list
2415987|NCT00788684|Navitoclax|navitoclax|mesh-list
2415988|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2415989|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2415990|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
2415991|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2415992|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2415993|NCT00788749|Fluticasone|fluticasone|mesh-list
2415994|NCT00788749|Xhance|xhance|mesh-list
2415995|NCT00788749|Prednisolone|prednisolone|mesh-list
2415996|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2415997|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2415998|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
2415999|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416000|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416001|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2416002|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
2416003|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
2416004|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2416005|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
2416006|NCT00788749|Hormones|hormones|mesh-ancestor
2416007|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2550359|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2550360|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
2550361|NCT01493453|Fludarabine|fludarabine|mesh-list
2550362|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2550363|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
2550364|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550365|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550366|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2416008|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2416009|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416010|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
2416011|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
2416012|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
2416013|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2416014|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416015|NCT00788918|Interferons|interferons|mesh-list
2416016|NCT00788918|Ribavirin|ribavirin|mesh-list
2416017|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416018|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
2416019|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416020|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
2416021|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416022|NCT00788931|Paclitaxel|paclitaxel|mesh-list
2416023|NCT00788931|Trastuzumab|trastuzumab|mesh-list
2416024|NCT00788931|Panobinostat|panobinostat|mesh-list
2416025|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2416026|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416027|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
2416028|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
2416029|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
2416030|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416031|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2416032|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2416033|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416034|NCT00789061|Lansoprazole|lansoprazole|mesh-list
2416035|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2416036|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2416037|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2416038|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416039|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416040|NCT00789152|Levocetirizine|levocetirizine|mesh-list
2416041|NCT00789152|Desloratadine|desloratadine|mesh-list
2416042|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2416043|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2550367|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
2550368|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550369|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550370|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2550371|NCT01493479|Rituximab|rituximab|mesh-list
2550372|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2550373|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550374|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
2550375|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550376|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550377|NCT01493505|Paclitaxel|paclitaxel|mesh-list
2550378|NCT01493505|Carboplatin|carboplatin|mesh-list
2416044|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
2416045|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
2416046|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416047|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416048|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416049|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2416050|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
2416051|NCT00789165|Quinidine|quinidine|mesh-list
2416052|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2416053|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2416054|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
2416055|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550379|NCT01493505|Trebananib|trebananib|mesh-list
2550380|NCT01493505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2550381|NCT01493505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416056|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416057|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416058|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2416059|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
2550382|NCT01493505|Tubulin Modulators|tubulin modulators|mesh-ancestor
2550383|NCT01493505|Antimitotic Agents|antimitotic agents|mesh-ancestor
2550384|NCT01493505|Mitosis Modulators|mitosis modulators|mesh-ancestor
2550385|NCT01493505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550386|NCT01493505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2550387|NCT01493505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2550388|NCT01493505|Growth Substances|growth substances|mesh-ancestor
2550389|NCT01493505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550390|NCT01493505|Growth Inhibitors|growth inhibitors|mesh-ancestor
2550391|NCT01493570|BI 409306|bi 409306|mesh-list
2550392|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2550393|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550394|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550395|NCT01493622|Minocycline|minocycline|mesh-list
2550396|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2550397|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550398|NCT01493635|Analgesics|analgesics|mesh-list
2416060|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2416061|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2416062|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550399|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
2550400|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550401|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550402|NCT01493648|Vitamin D|vitamin d|mesh-list
2550403|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
2550404|NCT01493648|Vitamins|vitamins|mesh-ancestor
2550405|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
2550406|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550407|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2550408|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2550409|NCT01493674|Folic Acid|folic acid|mesh-list
2550410|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
2550411|NCT01493674|Hematinics|hematinics|mesh-ancestor
2550412|NCT01493674|Vitamins|vitamins|mesh-ancestor
2550413|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
2550414|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550415|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
2550416|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2416063|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416064|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2416065|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2416066|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
2416067|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2416068|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2416069|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2416070|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2416071|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2416072|NCT00789308|Cyclosporine|cyclosporine|mesh-list
2416073|NCT00789308|Sirolimus|sirolimus|mesh-list
2416074|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
2416075|NCT00789308|Etanercept|etanercept|mesh-list
2416076|NCT00789308|Heparin|heparin|mesh-list
2416077|NCT00789308|Dextrans|dextrans|mesh-list
2416078|NCT00789308|Tacrolimus|tacrolimus|mesh-list
2416079|NCT00789308|Cyclosporins|cyclosporins|mesh-list
2416080|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
2416081|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2416082|NCT00789308|Basiliximab|basiliximab|mesh-list
2416083|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2416084|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
2416085|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416086|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2550417|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
2550418|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2550419|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550420|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2550421|NCT01493843|Paclitaxel|paclitaxel|mesh-list
2550422|NCT01493843|Bevacizumab|bevacizumab|mesh-list
2550423|NCT01493843|Carboplatin|carboplatin|mesh-list
2550424|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2550425|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550426|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
2550427|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
2550428|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
2550429|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550430|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2416087|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416088|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416089|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
2416090|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416091|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
2416092|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2416093|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2416094|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416095|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2416096|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
2416097|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2416098|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
2416099|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2416100|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2416101|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2416102|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2416103|NCT00789308|Analgesics|analgesics|mesh-ancestor
2416104|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
2416105|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550431|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2550432|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2550433|NCT01493843|Growth Substances|growth substances|mesh-ancestor
2550434|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550435|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
2550436|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2550437|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2550438|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2550439|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2550440|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550441|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
2550442|NCT01493973|Hematinics|hematinics|mesh-ancestor
2550443|NCT01493986|Ropivacaine|ropivacaine|mesh-list
2550444|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
2550445|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
2550446|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550447|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550448|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
2550449|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416106|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2416107|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2416108|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
2416109|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
2416110|NCT00789386|Midazolam|midazolam|mesh-list
2416111|NCT00789386|Remifentanil|remifentanil|mesh-list
2550450|NCT01493999|Clopidogrel|clopidogrel|mesh-list
2550451|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2116845|NCT02650193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116846|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
2116847|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2116848|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2116849|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116850|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
2116851|NCT02650856|Coagulants|coagulants|mesh-ancestor
2116852|NCT02650921|Lidocaine|lidocaine|mesh-list
2116853|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
2116854|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
2116855|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416112|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2416113|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2416114|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416115|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416116|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2416117|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2550452|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2550453|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2550454|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2550455|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2550456|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
2550457|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550458|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550459|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550460|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2416118|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416119|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2416120|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
2116856|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416121|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
2416122|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
2416123|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
2416124|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416125|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416126|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2416127|NCT00789386|Narcotics|narcotics|mesh-ancestor
2416128|NCT00789386|Analgesics|analgesics|mesh-ancestor
2550461|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2550462|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550463|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2550464|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2550465|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2416129|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
2416130|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416131|NCT00789399|PENTA|penta|mesh-list
2416132|NCT00789399|Fondaparinux|fondaparinux|mesh-list
2416133|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2416134|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
2416135|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2550466|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
2550467|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550468|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2550469|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2550470|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550471|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
2550472|NCT01494155|Capecitabine|capecitabine|mesh-list
2550473|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2550474|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
2550475|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416136|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
2416137|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416138|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416139|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
2416140|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2416141|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2416142|NCT00789464|Trimethoprim|trimethoprim|mesh-list
2416143|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
2416144|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2416145|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416146|NCT00789464|Renal Agents|renal agents|mesh-ancestor
2416147|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
2416148|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2550476|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550477|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
2550478|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2550479|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2550480|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550481|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550482|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550483|NCT01494259|Epinephrine|epinephrine|mesh-list
2550484|NCT01494259|Bupivacaine|bupivacaine|mesh-list
2550485|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
2550486|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
2550487|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550488|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416149|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2416150|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2416151|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416152|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416153|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2416154|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2416155|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2416156|NCT00789503|Vitamin D|vitamin d|mesh-list
2416157|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
2550489|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
2550490|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550491|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2550492|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2550493|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
2550494|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550495|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550496|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2416158|NCT00789503|Calcium|calcium|mesh-list
2416159|NCT00789503|Vitamins|vitamins|mesh-ancestor
2416160|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
2416161|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416162|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2416163|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2416164|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
2416165|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2416166|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2416167|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416168|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2416169|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2416170|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416171|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416172|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416173|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2416174|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
2416175|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2416176|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416177|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2416178|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2416179|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2416180|NCT00789620|Lidocaine|lidocaine|mesh-list
2550497|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2550498|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
2550499|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2550500|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
2550501|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
2416181|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
2416182|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
2416183|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550502|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
2550503|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2416184|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416185|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
2416186|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416187|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2416188|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2416189|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2416190|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2416191|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416192|NCT00789633|Gemcitabine|gemcitabine|mesh-list
2416193|NCT00789633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2416194|NCT00789633|Antimetabolites|antimetabolites|mesh-ancestor
2416195|NCT00789633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416196|NCT00789633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416197|NCT00789633|Antiviral Agents|antiviral agents|mesh-ancestor
2416198|NCT00789633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550504|NCT01494311|Lidocaine|lidocaine|mesh-list
2550505|NCT01494311|Tetracaine|tetracaine|mesh-list
2550506|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
2550507|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
2550508|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550509|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550510|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
2550511|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550512|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2550513|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2550514|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2550515|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2550516|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550517|NCT01494363|Leucovorin|leucovorin|mesh-list
2550518|NCT01494363|Fluorouracil|fluorouracil|mesh-list
2550519|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
2550520|NCT01494363|Irinotecan|irinotecan|mesh-list
2550521|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
2550522|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550523|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2550524|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550525|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2550526|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
2550527|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550528|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2550529|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2550530|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550531|NCT01494363|Antidotes|antidotes|mesh-ancestor
2550532|NCT01494363|Protective Agents|protective agents|mesh-ancestor
2416199|NCT00789633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416200|NCT00789633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2416201|NCT00789633|Immunologic Factors|immunologic factors|mesh-ancestor
2550533|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
2550534|NCT01494363|Vitamins|vitamins|mesh-ancestor
2550535|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
2550536|NCT01494402|Aspirin|aspirin|mesh-list
2550537|NCT01494402|Esomeprazole|esomeprazole|mesh-list
2550538|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2550539|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2416202|NCT00789633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416203|NCT00789646|Lidocaine|lidocaine|mesh-list
2416204|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
2416205|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
2416206|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416207|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416208|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
2416209|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416210|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2416211|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2416212|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2416213|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2416214|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416215|NCT00789711|Insulin|insulin|mesh-list
2416216|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2416217|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
2416218|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
2416219|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
2416220|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2416221|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2416222|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416223|NCT00789763|Gemcitabine|gemcitabine|mesh-list
2416224|NCT00789763|Sorafenib|sorafenib|mesh-list
2416225|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2416226|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
2416227|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416228|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416229|NCT00789763|Antiviral Agents|antiviral agents|mesh-ancestor
2416230|NCT00789763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416231|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416232|NCT00789763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2416233|NCT00789763|Immunologic Factors|immunologic factors|mesh-ancestor
2416234|NCT00789763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550540|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2550541|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550542|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550543|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2550544|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2550545|NCT01494402|Analgesics|analgesics|mesh-ancestor
2550546|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
2550547|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550548|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550549|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2550550|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550551|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2550552|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2550553|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2550554|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2550555|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
2550556|NCT01494415|Paclitaxel|paclitaxel|mesh-list
2550557|NCT01494415|Carboplatin|carboplatin|mesh-list
2550558|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2550559|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550560|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
2550561|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
2550562|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
2550563|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550564|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
2550565|NCT01494441|Calcium|calcium|mesh-list
2550566|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2416235|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2416236|NCT00789945|Insulin|insulin|mesh-list
2416237|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2416238|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2416239|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416240|NCT00789971|Triamcinolone|triamcinolone|mesh-list
2550567|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550568|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2416241|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2416242|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2416243|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2416244|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2416245|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
2416246|NCT00789971|Hormones|hormones|mesh-ancestor
2416247|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2416248|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416249|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2416250|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
2550569|NCT01494597|Cyclosporine|cyclosporine|mesh-list
2550570|NCT01494597|Isavuconazole|isavuconazole|mesh-list
2550571|NCT01494597|Cyclosporins|cyclosporins|mesh-list
2550572|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550573|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550574|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2550575|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
2550576|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550577|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
2550578|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550579|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
2550580|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550581|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2550582|NCT01494636|Lidocaine|lidocaine|mesh-list
2550583|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2550584|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
2550585|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
2550586|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550587|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550588|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
2550589|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550590|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2550591|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2550592|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2550593|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2550594|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416251|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416252|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416253|NCT00790075|Risperidone|risperidone|mesh-list
2416254|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2416255|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
2416256|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550608|NCT01494688|Paclitaxel|paclitaxel|mesh-list
2550609|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2550610|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550611|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
2550612|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
2550613|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
2416257|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416258|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416259|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2416260|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2416261|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416262|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416263|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2416264|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
2416265|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
2416266|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2416267|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2416268|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2550614|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550615|NCT01494714|Petrolatum|petrolatum|mesh-list
2550616|NCT01494714|Emollients|emollients|mesh-ancestor
2550617|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
2550618|NCT01494727|Amlodipine|amlodipine|mesh-list
2550619|NCT01494727|Valsartan|valsartan|mesh-list
2550620|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
2550621|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2550622|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2550623|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2550624|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550625|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2550626|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550627|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
2550628|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2550629|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2550630|NCT01494740|Vaccines|vaccines|mesh-list
2416269|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416270|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2416271|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416272|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2416273|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2416274|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
2550631|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
2550632|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550633|NCT01494805|Ranibizumab|ranibizumab|mesh-list
2550634|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2550635|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2550636|NCT01494805|Growth Substances|growth substances|mesh-ancestor
2550637|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550638|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
2550639|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550640|NCT01494857|Adalimumab|adalimumab|mesh-list
2416275|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2416276|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2416277|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2416278|NCT00790114|Midazolam|midazolam|mesh-list
2416279|NCT00790114|Caffeine|caffeine|mesh-list
2416280|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2416281|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2416282|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416283|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416284|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2416285|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2416286|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416287|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2416288|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
2416289|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
2416290|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
2550641|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2550642|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550643|NCT01495013|Glimepiride|glimepiride|mesh-list
2550644|NCT01495013|Atorvastatin|atorvastatin|mesh-list
2416291|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
2416292|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416293|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416294|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2416295|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2416296|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416297|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2416298|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2550645|NCT01495013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2550646|NCT01495013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2550647|NCT01495013|Antimetabolites|antimetabolites|mesh-ancestor
2550648|NCT01495013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550649|NCT01495013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2550650|NCT01495013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2550651|NCT01495013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550652|NCT01495013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2550653|NCT01495013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2550654|NCT01495013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550655|NCT01495013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2550656|NCT01495013|Immunologic Factors|immunologic factors|mesh-ancestor
2416299|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
2416300|NCT00790153|Insulin|insulin|mesh-list
2416301|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2416302|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416303|NCT00790179|Ropivacaine|ropivacaine|mesh-list
2416304|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
2416305|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
2416306|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550657|NCT01495026|Tamsulosin|tamsulosin|mesh-list
2550658|NCT01495026|Dutasteride|dutasteride|mesh-list
2550659|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2550660|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2550661|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2550662|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
2550663|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550664|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550665|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550666|NCT01495026|Urological Agents|urological agents|mesh-ancestor
2550667|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2550668|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2550669|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550670|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
2550671|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2550672|NCT01495039|Nystatin|nystatin|mesh-list
2550673|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2550674|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550675|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
2550676|NCT01495039|Ionophores|ionophores|mesh-ancestor
2550677|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2550678|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550679|NCT01495104|Valproic Acid|valproic acid|mesh-list
2550680|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
2550681|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550682|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550683|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
2550684|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550685|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550686|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
2550687|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2416307|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416308|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
2416309|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416310|NCT00790244|Doxorubicin|doxorubicin|mesh-list
2416311|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2416312|NCT00790244|Ifosfamide|ifosfamide|mesh-list
2416313|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
2416314|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2416315|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416316|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2416317|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2416318|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416319|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416320|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2416321|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
2416322|NCT00790387|Heparin|heparin|mesh-list
2416323|NCT00790387|Enoxaparin|enoxaparin|mesh-list
2416324|NCT00790387|Calcium heparin|calcium heparin|mesh-list
2416325|NCT00790387|Tirofiban|tirofiban|mesh-list
2416326|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
2416327|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2416328|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2416329|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416330|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2416331|NCT00790413|Rituximab|rituximab|mesh-list
2550688|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550689|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2550690|NCT01495117|Iodine|iodine|mesh-list
2550691|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
2550692|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2550693|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
2550694|NCT01495117|Povidone|povidone|mesh-list
2550695|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2550696|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2550697|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416332|NCT00790413|Fludarabine|fludarabine|mesh-list
2416333|NCT00790413|Thiotepa|thiotepa|mesh-list
2550698|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
2550699|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
2550700|NCT01495117|Trace Elements|trace elements|mesh-ancestor
2550701|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
2550702|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550703|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
2550704|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
2550705|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
2550706|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2550707|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2550708|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550709|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550710|NCT01495169|Iloperidone|iloperidone|mesh-list
2550711|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2550712|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2550713|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550714|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550715|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2550716|NCT01495195|Selegiline|selegiline|mesh-list
2550717|NCT01495195|Donepezil|donepezil|mesh-list
2550718|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2550719|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550720|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550721|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
2550722|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550723|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550724|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
2550725|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
2550726|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2550727|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2550728|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2550729|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2550730|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2550731|NCT01495195|Protective Agents|protective agents|mesh-ancestor
2550732|NCT01495208|Aflibercept|aflibercept|mesh-list
2550733|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2550734|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2550735|NCT01495208|Growth Substances|growth substances|mesh-ancestor
2550736|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550737|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
2550738|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550739|NCT01495247|Paclitaxel|paclitaxel|mesh-list
2550740|NCT01495247|Dactolisib|dactolisib|mesh-list
2550741|NCT01495247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2550742|NCT01495247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550743|NCT01495247|Tubulin Modulators|tubulin modulators|mesh-ancestor
2550744|NCT01495247|Antimitotic Agents|antimitotic agents|mesh-ancestor
2550745|NCT01495247|Mitosis Modulators|mitosis modulators|mesh-ancestor
2550746|NCT01495247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550747|NCT01495260|Vitamin E|vitamin e|mesh-list
2550748|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
2416334|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2416335|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2416336|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550749|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
2550750|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2550751|NCT01495260|Vitamins|vitamins|mesh-ancestor
2550752|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
2550753|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550754|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
2550755|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550756|NCT01495260|Expectorants|expectorants|mesh-ancestor
2550757|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
2550758|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2550759|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
2550760|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550761|NCT01495260|Protective Agents|protective agents|mesh-ancestor
2550762|NCT01495260|Antidotes|antidotes|mesh-ancestor
2550763|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
2550764|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2416337|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
2416338|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416339|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2416340|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550765|NCT01495338|Cetirizine|cetirizine|mesh-list
2550766|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2550767|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2416341|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2416342|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2416343|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
2416344|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2416345|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416346|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2416347|NCT00790439|Cyclosporine|cyclosporine|mesh-list
2416348|NCT00790439|Sirolimus|sirolimus|mesh-list
2416349|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
2416350|NCT00790439|Heparin|heparin|mesh-list
2416351|NCT00790439|Calcium heparin|calcium heparin|mesh-list
2416352|NCT00790439|Dextrans|dextrans|mesh-list
2416353|NCT00790439|Tacrolimus|tacrolimus|mesh-list
2416354|NCT00790439|Cyclosporins|cyclosporins|mesh-list
2416355|NCT00790439|Basiliximab|basiliximab|mesh-list
2416356|NCT00790439|Daclizumab|daclizumab|mesh-list
2416357|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2416358|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
2416359|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416360|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2416361|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416362|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416363|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
2416364|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416365|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
2416366|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2416367|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2416368|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416369|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2416370|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
2416371|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2416372|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
2416373|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2416374|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2416375|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
2416376|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
2416377|NCT00790595|Sunitinib|sunitinib|mesh-list
2416378|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416379|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2416380|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2416381|NCT00790595|Growth Substances|growth substances|mesh-ancestor
2416382|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416383|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
2416384|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2416385|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416386|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416387|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
2416388|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2416389|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
2416390|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416391|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416392|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2550768|NCT01495338|Analgesics|analgesics|mesh-ancestor
2550769|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
2550770|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550771|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550772|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2550773|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550774|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2550775|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2550776|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2550777|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
2550778|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
2550779|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416393|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
2416394|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2416395|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
2416396|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416397|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550780|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550781|NCT01495351|Bortezomib|bortezomib|mesh-list
2550782|NCT01495351|Veliparib|veliparib|mesh-list
2550783|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550784|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2550785|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416398|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2550786|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550787|NCT01495377|Remifentanil|remifentanil|mesh-list
2550788|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2550789|NCT01495377|Narcotics|narcotics|mesh-ancestor
2550790|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550791|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550792|NCT01495377|Analgesics|analgesics|mesh-ancestor
2550793|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
2550794|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550795|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
2550796|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
2416399|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
2416400|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
2416401|NCT00790608|Protective Agents|protective agents|mesh-ancestor
2416402|NCT00790660|Ipragliflozin|ipragliflozin|mesh-list
2416403|NCT00790660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2416404|NCT00790660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416405|NCT00790660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2416406|NCT00790660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416407|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2550797|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2550798|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2550799|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550800|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550801|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550802|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550803|NCT01495468|Hormones|hormones|mesh-list
2550804|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2550805|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550806|NCT01495520|Ranolazine|ranolazine|mesh-list
2550807|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2550808|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2550809|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550810|NCT01495624|Dexamethasone|dexamethasone|mesh-list
2550811|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
2550812|NCT01495624|Ropivacaine|ropivacaine|mesh-list
2550813|NCT01495624|Anesthetics|anesthetics|mesh-list
2550814|NCT01495624|BB 1101|bb 1101|mesh-list
2550815|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2550816|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
2550817|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
2550818|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550819|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550820|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2550821|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
2550822|NCT01495624|Hormones|hormones|mesh-ancestor
2550823|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2550824|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2550825|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550826|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
2550827|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550828|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416408|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2416409|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2416410|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416411|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416412|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416413|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2416414|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2416415|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
2416416|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416417|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416418|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2416419|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2416420|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
2416421|NCT00790816|Lapatinib|lapatinib|mesh-list
2416422|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
2416423|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2416424|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416425|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550829|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
2550830|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550831|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
2550832|NCT01495637|Sargramostim|sargramostim|mesh-list
2550833|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
2550834|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550847|NCT01495715|Idebenone|idebenone|mesh-list
2416436|NCT00790881|Lumefantrine|lumefantrine|mesh-list
2416437|NCT00790881|Artemether|artemether|mesh-list
2416438|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2416439|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
2416440|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2416441|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2416442|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416443|NCT00790894|Epothilones|epothilones|mesh-list
2416444|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
2416445|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
2416446|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
2416447|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416448|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416449|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
2416450|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2416451|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2416452|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416453|NCT00790946|Valsartan|valsartan|mesh-list
2416454|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2416455|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2416456|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2416457|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416458|NCT00790985|Naproxen|naproxen|mesh-list
2416459|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2416460|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2416461|NCT00790985|Analgesics|analgesics|mesh-ancestor
2416462|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
2416463|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416464|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416465|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2416466|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550848|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
2550849|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550850|NCT01495715|Protective Agents|protective agents|mesh-ancestor
2550851|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550852|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2550853|NCT01495806|Cathartics|cathartics|mesh-ancestor
2550854|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2550855|NCT01495845|Clopidogrel|clopidogrel|mesh-list
2550856|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2550857|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2550858|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2550859|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2550860|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
2550861|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416467|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
2416468|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2416469|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550862|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550863|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550864|NCT01495884|Lapatinib|lapatinib|mesh-list
2550865|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550866|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2416470|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416471|NCT00790998|Ivermectin|ivermectin|mesh-list
2416472|NCT00790998|Moxidectin|moxidectin|mesh-list
2550867|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550868|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550869|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
2550870|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550871|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2550872|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550873|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550874|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
2550875|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2550876|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550877|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2550878|NCT01495949|Thiopental|thiopental|mesh-list
2550879|NCT01495949|Etomidate|etomidate|mesh-list
2550880|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2550881|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550882|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416473|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2416474|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416475|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
2416476|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
2416477|NCT00791011|Bortezomib|bortezomib|mesh-list
2416478|NCT00791011|Vorinostat|vorinostat|mesh-list
2416479|NCT00791011|Conatumumab|conatumumab|mesh-list
2416480|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416481|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2416482|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550883|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2550884|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
2550885|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
2550886|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
2550887|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
2550888|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
2550889|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550890|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550891|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
2550892|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2550893|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2550894|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2416483|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416484|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2550895|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2550896|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550897|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
2550898|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550899|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550900|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2550901|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550902|NCT01496105|Lidocaine|lidocaine|mesh-list
2550903|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
2550904|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
2550905|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550906|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550907|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
2550908|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416485|NCT00791024|Lidocaine|lidocaine|mesh-list
2416486|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
2416487|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
2416488|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416489|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416490|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
2416491|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416492|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2416493|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2416494|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2416495|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2416496|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416497|NCT00791141|Cetuximab|cetuximab|mesh-list
2416498|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2550909|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2550910|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2550911|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2550912|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2550913|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550914|NCT01496118|Panobinostat|panobinostat|mesh-list
2550915|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550916|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2550917|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550918|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550919|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
2550920|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2550921|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2550922|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550923|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
2550924|NCT01496196|Coagulants|coagulants|mesh-ancestor
2550925|NCT01496261|Aspirin|aspirin|mesh-list
2550926|NCT01496261|Clopidogrel|clopidogrel|mesh-list
2550927|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2550928|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2550929|NCT01496261|Analgesics|analgesics|mesh-ancestor
2550930|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
2550931|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550932|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550933|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2550934|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550935|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2550936|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2550937|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550938|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2550939|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2550940|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550941|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
2416499|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416500|NCT00791154|Carboplatin|carboplatin|mesh-list
2416501|NCT00791154|Etoposide|etoposide|mesh-list
2416502|NCT00791154|Rilotumumab|rilotumumab|mesh-list
2416503|NCT00791154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416504|NCT00791154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2416505|NCT00791154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2416506|NCT00791154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2416507|NCT00791154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416508|NCT00791154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416509|NCT00791154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2416510|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2416511|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2416512|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2416513|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416514|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416515|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416516|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2416517|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2416518|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
2416519|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416520|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416521|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2416522|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2416523|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
2416524|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2416525|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2416526|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2416527|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416528|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416529|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416530|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2416531|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2416532|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
2416533|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416534|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416535|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2416536|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2416537|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
2416538|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2416539|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2416540|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2416541|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2550942|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2550943|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2550944|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2550945|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
2550946|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416542|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416543|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416544|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2416545|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2416546|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
2416547|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416548|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416549|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2416550|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2416551|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
2550947|NCT01496326|Ibuprofen|ibuprofen|mesh-list
2550948|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2550949|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2550950|NCT01496326|Analgesics|analgesics|mesh-ancestor
2550951|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
2550952|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416552|NCT00791271|Interferons|interferons|mesh-list
2416553|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
2416554|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
2416555|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2416556|NCT00791271|Decitabine|decitabine|mesh-list
2416557|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416558|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
2416559|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416560|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
2416561|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416562|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2416563|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
2416564|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416565|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416566|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2416567|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2416568|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2416569|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416570|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416571|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416572|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2416573|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2416574|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
2550953|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550954|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2550955|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550956|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2550957|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550958|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550959|NCT01496417|Abatacept|abatacept|mesh-list
2550960|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2550961|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550962|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550963|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2550964|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
2550965|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550966|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550967|NCT01496443|Glimepiride|glimepiride|mesh-list
2550968|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2550969|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2550970|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550971|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2550972|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
2550973|NCT01496521|Aspirin|aspirin|mesh-list
2550974|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2416575|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2550975|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2550976|NCT01496521|Analgesics|analgesics|mesh-ancestor
2550977|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
2550978|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550979|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550980|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2550981|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2550982|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2550983|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2550984|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2550985|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2550986|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2550987|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2550988|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
2550989|NCT01496534|Carboplatin|carboplatin|mesh-list
2550990|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2550991|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
2550992|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2550993|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2550994|NCT01496690|Pregabalin|pregabalin|mesh-list
2550995|NCT01496690|Analgesics|analgesics|mesh-ancestor
2550996|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
2550997|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2550998|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2550999|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
2551000|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2551001|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2551002|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551003|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2551004|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2551005|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2551006|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2551007|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2551008|NCT01496742|Paclitaxel|paclitaxel|mesh-list
2551009|NCT01496742|Bevacizumab|bevacizumab|mesh-list
2551010|NCT01496742|Carboplatin|carboplatin|mesh-list
2551011|NCT01496742|Pemetrexed|pemetrexed|mesh-list
2551012|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2551013|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551014|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
2551015|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
2551016|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
2551017|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551018|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2551019|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2551020|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2551021|NCT01496742|Growth Substances|growth substances|mesh-ancestor
2551022|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551023|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
2551024|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416576|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416577|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2416578|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2551025|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2416579|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
2416580|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
2416581|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2416582|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
2416583|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2416584|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416585|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2416586|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2416587|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2416588|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2416589|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416590|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416591|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416592|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2416593|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2416594|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
2416595|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416596|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416597|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2416598|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2416599|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
2416600|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2551026|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2551027|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
2551028|NCT01496911|Levocetirizine|levocetirizine|mesh-list
2551029|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2551030|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2551031|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
2551032|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
2551033|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2551034|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551035|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551036|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
2551037|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
2551038|NCT01496989|Interleukin-12|interleukin-12|mesh-list
2551039|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2551040|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
2551041|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551042|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2551043|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2551044|NCT01496989|Growth Substances|growth substances|mesh-ancestor
2551045|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
2551046|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416601|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2416602|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2551047|NCT01497002|Cytarabine|cytarabine|mesh-list
2551048|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2551049|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
2551050|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551051|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551052|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
2551053|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551054|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2551055|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
2551056|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551057|NCT01497041|Docetaxel|docetaxel|mesh-list
2551058|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
2551059|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551060|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
2551061|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
2551062|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
2551063|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551064|NCT01497093|Thalidomide|thalidomide|mesh-list
2416603|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416604|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416605|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416606|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2416607|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2416608|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
2416609|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416610|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416611|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2416612|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2416613|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
2416614|NCT00791427|Ranibizumab|ranibizumab|mesh-list
2416615|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2416616|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2416617|NCT00791427|Growth Substances|growth substances|mesh-ancestor
2416618|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416619|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
2416620|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416621|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
2416622|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2416623|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
2416624|NCT00791505|Trimethoprim|trimethoprim|mesh-list
2416625|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
2416626|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2416627|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416628|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2416629|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2416630|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416631|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551065|NCT01497093|Dexamethasone|dexamethasone|mesh-list
2551066|NCT01497093|Bortezomib|bortezomib|mesh-list
2551067|NCT01497093|Pomalidomide|pomalidomide|mesh-list
2551068|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2551069|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
2551070|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
2551071|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551072|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551073|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2551074|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
2551075|NCT01497093|Hormones|hormones|mesh-ancestor
2551076|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2551077|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2551078|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551079|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
2416632|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416633|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2416634|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2416635|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2416636|NCT00791505|Renal Agents|renal agents|mesh-ancestor
2416637|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
2416638|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2416639|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2416640|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2416641|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2416642|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2416643|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2416644|NCT00791531|Methotrexate|methotrexate|mesh-list
2416645|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2416646|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
2416647|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2416648|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416649|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2416650|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
2551080|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2551081|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2551082|NCT01497093|Growth Substances|growth substances|mesh-ancestor
2551083|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
2551084|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2551085|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
2551086|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2551087|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551088|NCT01497132|Vitamin D|vitamin d|mesh-list
2551089|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
2551090|NCT01497132|Vitamins|vitamins|mesh-ancestor
2551091|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
2551092|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551093|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2551094|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2551095|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
2551096|NCT01497145|Hematinics|hematinics|mesh-ancestor
2551097|NCT01497288|Fentanyl|fentanyl|mesh-list
2551098|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2551099|NCT01497288|Narcotics|narcotics|mesh-ancestor
2551100|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2551101|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551102|NCT01497288|Analgesics|analgesics|mesh-ancestor
2551103|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
2551104|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551105|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2551106|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2551107|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
2551108|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
2551109|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
2551110|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
2551111|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551112|NCT01497392|Gemcitabine|gemcitabine|mesh-list
2551113|NCT01497392|Capecitabine|capecitabine|mesh-list
2551114|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2551115|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
2551116|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551117|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551118|NCT01497392|Antiviral Agents|antiviral agents|mesh-ancestor
2551119|NCT01497392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551120|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551121|NCT01497392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2551122|NCT01497392|Immunologic Factors|immunologic factors|mesh-ancestor
2551123|NCT01497392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551124|NCT01497431|Selenium|selenium|mesh-list
2551125|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
2551126|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
2551127|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551128|NCT01497431|Protective Agents|protective agents|mesh-ancestor
2551129|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551130|NCT01497431|Trace Elements|trace elements|mesh-ancestor
2551131|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
2551132|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2551133|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551134|NCT01497444|Sorafenib|sorafenib|mesh-list
2551135|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551136|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2551137|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551138|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416651|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416652|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416653|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
2416654|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416655|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2416656|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2416657|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
2416658|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2416659|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2416660|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2416661|NCT00791544|Sorafenib|sorafenib|mesh-list
2551139|NCT01497470|Paclitaxel|paclitaxel|mesh-list
2551140|NCT01497470|Carboplatin|carboplatin|mesh-list
2551141|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2551142|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551143|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
2551144|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
2551145|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
2416662|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416663|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2416664|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416665|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416666|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2551146|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551147|NCT01497483|Cyclosporine|cyclosporine|mesh-list
2551148|NCT01497483|Pravastatin|pravastatin|mesh-list
2551149|NCT01497483|Cyclosporins|cyclosporins|mesh-list
2551150|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551151|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551152|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2551153|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
2551154|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551155|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
2551156|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551157|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
2551158|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2551159|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2551160|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2551161|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2551162|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
2416667|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2416668|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2416669|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416670|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416671|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416672|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2416673|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2416674|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
2416675|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416676|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416677|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2416678|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2416679|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
2551163|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2551164|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2551165|NCT01497509|Epinephrine|epinephrine|mesh-list
2551166|NCT01497509|Racepinephrine|racepinephrine|mesh-list
2551167|NCT01497509|Fentanyl|fentanyl|mesh-list
2551168|NCT01497509|Bupivacaine|bupivacaine|mesh-list
2416680|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2551169|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
2551170|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
2551171|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
2551172|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2551173|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416681|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2416682|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2416683|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2551174|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
2551175|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551176|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2416684|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416685|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416686|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2416687|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2416688|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
2416689|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416690|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416691|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2416692|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2416693|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
2416694|NCT00791739|Pregabalin|pregabalin|mesh-list
2416695|NCT00791739|Trazodone|trazodone|mesh-list
2551177|NCT01497509|Narcotics|narcotics|mesh-ancestor
2551178|NCT01497509|Analgesics|analgesics|mesh-ancestor
2551179|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2551180|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2551181|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
2551182|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2551183|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2551184|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
2551185|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2551186|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551187|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2551188|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2551189|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
2551190|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2551191|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
2551192|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
2416696|NCT00791739|Analgesics|analgesics|mesh-ancestor
2416697|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
2416698|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416699|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416700|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
2416701|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2416702|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2551193|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
2551194|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2551195|NCT01497522|Vildagliptin|vildagliptin|mesh-list
2551196|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551197|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551198|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2551199|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
2551200|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551201|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416703|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416704|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2416705|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2551202|NCT01497535|Insulin|insulin|mesh-list
2551203|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2551204|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
2551205|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
2551206|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551207|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551208|NCT01497548|Methylphenidate|methylphenidate|mesh-list
2551209|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2551210|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551211|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2551212|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2551213|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2551214|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551215|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
2416706|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2416707|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416708|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416709|NCT00791739|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2416710|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2416711|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416712|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
2416713|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2416714|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
2416715|NCT00791804|Fentanyl|fentanyl|mesh-list
2551216|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2551217|NCT01497561|Insulin|insulin|mesh-list
2551218|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2551219|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
2551220|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
2551221|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
2551222|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
2551223|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551224|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551225|NCT01497574|Insulin|insulin|mesh-list
2551226|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2551227|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
2416716|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2416717|NCT00791804|Narcotics|narcotics|mesh-ancestor
2416718|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416719|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416720|NCT00791804|Analgesics|analgesics|mesh-ancestor
2416721|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
2416722|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416723|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2551228|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
2551229|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551230|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551231|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
2551232|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551233|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551234|NCT01497600|Insulin|insulin|mesh-list
2551235|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2551236|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
2551237|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
2551238|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
2551239|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
2551240|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551241|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551242|NCT01497626|Bortezomib|bortezomib|mesh-list
2551243|NCT01497626|Lapatinib|lapatinib|mesh-list
2551244|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551245|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2551246|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551247|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551248|NCT01497652|Rasagiline|rasagiline|mesh-list
2551249|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2551250|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551251|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551252|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2551253|NCT01497652|Protective Agents|protective agents|mesh-ancestor
2551254|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551255|NCT01497704|Apatinib|apatinib|mesh-list
2551256|NCT01497704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551257|NCT01497704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2551258|NCT01497704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551259|NCT01497704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551260|NCT01497717|Adalimumab|adalimumab|mesh-list
2551261|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2551262|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2551263|NCT01497834|Asunaprevir|asunaprevir|mesh-list
2551264|NCT01497834|Protease Inhibitors|protease inhibitors|mesh-ancestor
2551265|NCT01497834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551266|NCT01497834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551267|NCT01497873|Topotecan|topotecan|mesh-list
2551268|NCT01497873|Belotecan|belotecan|mesh-list
2551269|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2551270|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2551271|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551272|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551273|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551274|NCT01497912|Atorvastatin|atorvastatin|mesh-list
2416724|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2551275|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2551276|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2551277|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
2416725|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
2416726|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
2416727|NCT00791830|Irbesartan|irbesartan|mesh-list
2551278|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551279|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2551280|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2551281|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551282|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
2551283|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2551284|NCT01497977|Estrogens|estrogens|mesh-ancestor
2551285|NCT01497977|Hormones|hormones|mesh-ancestor
2551286|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2551287|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551288|NCT01497990|Ertapenem|ertapenem|mesh-list
2551289|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2551290|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551291|NCT01498003|Tirofiban|tirofiban|mesh-list
2551292|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2551293|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2551294|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551295|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2551296|NCT01498016|Busulfan|busulfan|mesh-list
2551297|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
2551298|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551299|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2551300|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
2551301|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551302|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2551303|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551304|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2551305|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
2551306|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2551307|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
2551308|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551309|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551310|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2551311|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
2551312|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
2551313|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2551314|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
2551315|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2551316|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551317|NCT01498328|Bevacizumab|bevacizumab|mesh-list
2551318|NCT01498328|Rindopepimut|rindopepimut|mesh-list
2551319|NCT01498328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2551320|NCT01498328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551321|NCT01498328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2551322|NCT01498328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2551323|NCT01498328|Growth Substances|growth substances|mesh-ancestor
2551324|NCT01498328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551325|NCT01498328|Growth Inhibitors|growth inhibitors|mesh-ancestor
2551326|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
2551327|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2551328|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2551329|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551330|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2551331|NCT01498380|Analgesics|analgesics|mesh-ancestor
2551332|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
2551333|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551334|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2551335|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2551336|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2551337|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
2551338|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416728|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2416729|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2416730|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2416731|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416732|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
2416733|NCT00791856|Testosterone|testosterone|mesh-list
2416734|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
2416735|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
2416736|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2416737|NCT00791856|Androgens|androgens|mesh-ancestor
2416738|NCT00791856|Hormones|hormones|mesh-ancestor
2416739|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2416740|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416741|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2416742|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416743|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
2416744|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
2416745|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
2416746|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2416747|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2416748|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416749|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
2416750|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
2416751|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
2416752|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416753|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416754|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2416755|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2416756|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
2416757|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
2416758|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416759|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416760|NCT00792012|Temozolomide|temozolomide|mesh-list
2416761|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2416762|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
2416763|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416764|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416765|NCT00792025|Sunitinib|sunitinib|mesh-list
2416766|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416767|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2416768|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2416769|NCT00792025|Growth Substances|growth substances|mesh-ancestor
2416770|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416771|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
2416772|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2416773|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416774|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416775|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2416776|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2416777|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2416778|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2416779|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416780|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116857|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
2116858|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116859|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2116860|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2116861|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2116862|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2116863|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116864|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
2116865|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2416781|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416782|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2416783|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
2416784|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416785|NCT00792181|Midazolam|midazolam|mesh-list
2416786|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2551339|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551340|NCT01498406|Vitamin D|vitamin d|mesh-list
2551341|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
2551342|NCT01498406|Vitamins|vitamins|mesh-list
2551343|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
2551344|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551345|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2551346|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2551347|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2551348|NCT01498562|Gefitinib|gefitinib|mesh-list
2551349|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
2551350|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551351|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2416787|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2416788|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416789|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416790|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2416791|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2416792|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2416793|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2416794|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
2416795|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
2416796|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
2416797|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
2416798|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416799|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416800|NCT00792246|Voriconazole|voriconazole|mesh-list
2416801|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
2551352|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551353|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551354|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2551355|NCT01498718|Vaccines|vaccines|mesh-list
2551356|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
2551357|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416802|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416803|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2416804|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2416805|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416806|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416807|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2416808|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
2416809|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2416810|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416811|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2416812|NCT00792324|Efavirenz|efavirenz|mesh-list
2416813|NCT00792324|Etravirine|etravirine|mesh-list
2416814|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2416815|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2416816|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416817|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416818|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
2416819|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416820|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2416821|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2416822|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2416823|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2416824|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2416825|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2416826|NCT00792337|Simvastatin|simvastatin|mesh-list
2416827|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2551358|NCT01498770|Olanzapine|olanzapine|mesh-list
2551359|NCT01498770|Risperidone|risperidone|mesh-list
2551360|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2551361|NCT01498770|Aripiprazole|aripiprazole|mesh-list
2551362|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2551363|NCT01498770|Ziprasidone|ziprasidone|mesh-list
2551364|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2551365|NCT01498770|Clozapine|clozapine|mesh-list
2551366|NCT01498770|Asenapine|asenapine|mesh-list
2551367|NCT01498770|Amisulpride|amisulpride|mesh-list
2551368|NCT01498770|Iloperidone|iloperidone|mesh-list
2551369|NCT01498770|Sertindole|sertindole|mesh-list
2551370|NCT01498770|Zotepine|zotepine|mesh-list
2551371|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2551372|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
2551373|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2551374|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551375|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551376|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2551377|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2551378|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2551379|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2551380|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2551381|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
2551382|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
2551383|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
2551384|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551385|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2551386|NCT01498770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2551387|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2551388|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2551389|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
2551390|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
2551391|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2551392|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2551393|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2551394|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2551395|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2551396|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2551397|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2551398|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
2551399|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
2551400|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
2551401|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2551402|NCT01498783|Fluorouracil|fluorouracil|mesh-list
2551403|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
2551404|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551405|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2551406|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551407|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2551408|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
2551409|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551410|NCT01498796|Ketorolac|ketorolac|mesh-list
2416828|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2416829|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
2416830|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416831|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2416832|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2416833|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416834|NCT00792350|Sorafenib|sorafenib|mesh-list
2416835|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416836|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2416837|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416838|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416839|NCT00792363|Irinotecan|irinotecan|mesh-list
2416840|NCT00792363|Panitumumab|panitumumab|mesh-list
2416841|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2416842|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2416843|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416844|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416845|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416846|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2416847|NCT00792376|Diclofenac|diclofenac|mesh-list
2416848|NCT00792376|Etoricoxib|etoricoxib|mesh-list
2416849|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2416850|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2416851|NCT00792376|Analgesics|analgesics|mesh-ancestor
2416852|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
2416853|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416854|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416855|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2416856|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2416857|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2416858|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416859|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416860|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2416861|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
2416862|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2416863|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551411|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2551412|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2551413|NCT01498796|Analgesics|analgesics|mesh-ancestor
2551414|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
2551415|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551416|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551417|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2551418|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2551419|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2551420|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551421|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416864|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416865|NCT00792584|Efavirenz|efavirenz|mesh-list
2416866|NCT00792584|Etravirine|etravirine|mesh-list
2416867|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2416868|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2416869|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416870|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416871|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
2416872|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551422|NCT01498809|Midodrine|midodrine|mesh-list
2551423|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
2551424|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
2551425|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551426|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551427|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2551428|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2551429|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2551430|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2551431|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
2551432|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2551433|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551434|NCT01498835|Sunitinib|sunitinib|mesh-list
2551435|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551436|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2551437|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2551438|NCT01498835|Growth Substances|growth substances|mesh-ancestor
2551439|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551440|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
2551441|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2551442|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551443|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551444|NCT01498861|Dolutegravir|dolutegravir|mesh-list
2551445|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
2551446|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2551447|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2551448|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2551449|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551450|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551451|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2551452|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2551453|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
2416873|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2416874|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2416875|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2416876|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2416877|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2416878|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2416879|NCT00792662|Methylphenidate|methylphenidate|mesh-list
2416880|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2416881|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416882|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2416883|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2416884|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2551454|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551455|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2551456|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2551457|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2551458|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551459|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2551460|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
2551461|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2551462|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551463|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2551464|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2551465|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2551466|NCT01498900|Repaglinide|repaglinide|mesh-list
2551467|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551468|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551469|NCT01498913|Repaglinide|repaglinide|mesh-list
2551470|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551471|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551472|NCT01498926|Insulin|insulin|mesh-list
2416885|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416886|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
2416887|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2416888|NCT00792714|Mannitol|mannitol|mesh-list
2416889|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2416890|NCT00792714|Diuretics|diuretics|mesh-ancestor
2416891|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
2416892|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416893|NCT00792727|Ketoprofen|ketoprofen|mesh-list
2416894|NCT00792727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2416895|NCT00792727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2416896|NCT00792727|Analgesics|analgesics|mesh-ancestor
2416897|NCT00792727|Sensory System Agents|sensory system agents|mesh-ancestor
2416898|NCT00792727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416899|NCT00792727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416900|NCT00792727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2416901|NCT00792727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2416902|NCT00792727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2416903|NCT00792727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416904|NCT00792727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416905|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
2416906|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2416907|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416908|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416909|NCT00792766|Everolimus|everolimus|mesh-list
2416910|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416911|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2416912|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
2416913|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416914|NCT00792779|Propofol|propofol|mesh-list
2416915|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2416916|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2416917|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416918|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2416919|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
2416920|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
2416921|NCT00792818|Ibuprofen|ibuprofen|mesh-list
2551473|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2551474|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
2551475|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551476|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551477|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
2551478|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551479|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551480|NCT01499004|Tofacitinib|tofacitinib|mesh-list
2551481|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2551482|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551483|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416922|NCT00792818|Curcumin|curcumin|mesh-list
2416923|NCT00792818|Turmeric extract|turmeric extract|mesh-list
2416924|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2416925|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2416926|NCT00792818|Analgesics|analgesics|mesh-ancestor
2416927|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
2416928|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416929|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416930|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2416931|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2416932|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2416933|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416934|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416935|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416936|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
2416937|NCT00792818|Protective Agents|protective agents|mesh-ancestor
2551484|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
2551485|NCT01499069|Fesoterodine|fesoterodine|mesh-list
2551486|NCT01499069|Propiverine|propiverine|mesh-list
2551487|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2551488|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2551489|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
2551490|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2551491|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551492|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551493|NCT01499069|Urological Agents|urological agents|mesh-ancestor
2551494|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
2551495|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
2551496|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551497|NCT01499108|Liraglutide|liraglutide|mesh-list
2551498|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551499|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551500|NCT01499108|Incretins|incretins|mesh-ancestor
2551501|NCT01499108|Hormones|hormones|mesh-ancestor
2551502|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2551503|NCT01499121|Sunitinib|sunitinib|mesh-list
2551504|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551505|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2551506|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2551507|NCT01499121|Growth Substances|growth substances|mesh-ancestor
2551508|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416942|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2416943|NCT00792857|Vitamins|vitamins|mesh-ancestor
2416944|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
2416945|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416946|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2416947|NCT00793052|Dexamethasone|dexamethasone|mesh-list
2551509|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
2551510|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2551511|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416948|NCT00793052|Etoricoxib|etoricoxib|mesh-list
2416949|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2416950|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
2416951|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
2551512|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551513|NCT01499225|Doxycycline|doxycycline|mesh-list
2551514|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2416952|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2416953|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416954|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2551515|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551516|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
2551517|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2551518|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2551519|NCT01499251|Temozolomide|temozolomide|mesh-list
2551520|NCT01499251|Macitentan|macitentan|mesh-list
2551521|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2551522|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
2551523|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551524|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551525|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2551526|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2551527|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2551528|NCT01499407|Abciximab|abciximab|mesh-list
2551529|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
2551530|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2551531|NCT01499433|Caspofungin|caspofungin|mesh-list
2416955|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
2416956|NCT00793052|Hormones|hormones|mesh-ancestor
2416957|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2416958|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2416959|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551532|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
2551533|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551534|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551535|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551536|NCT01499446|Fluticasone|fluticasone|mesh-list
2551537|NCT01499446|Xhance|xhance|mesh-list
2551538|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2551539|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2551540|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
2551541|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551542|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551543|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2551544|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
2551545|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
2551546|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2551547|NCT01499485|Acetazolamide|acetazolamide|mesh-list
2551548|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
2551549|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2551550|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551551|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551552|NCT01499485|Diuretics|diuretics|mesh-ancestor
2551553|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
2416960|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2416961|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2416962|NCT00793052|Analgesics|analgesics|mesh-ancestor
2416963|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
2416964|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2416965|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2416966|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2416967|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416968|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416969|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2416970|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2416971|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2416972|NCT00793195|SMOFlipid|smoflipid|mesh-list
2416973|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2416974|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2416975|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2416976|NCT00793221|Sirolimus|sirolimus|mesh-list
2416977|NCT00793221|Everolimus|everolimus|mesh-list
2416978|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2416979|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2416980|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
2416981|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416982|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2416983|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2416984|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2416985|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
2416986|NCT00793234|Enoxaparin|enoxaparin|mesh-list
2416987|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
2416988|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2416989|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2416990|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2416991|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
2416992|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2416993|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2416994|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
2416995|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
2416996|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2416997|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2416998|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2416999|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417000|NCT00793338|Urological Agents|urological agents|mesh-ancestor
2417001|NCT00793377|Tamoxifen|tamoxifen|mesh-list
2417002|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
2417003|NCT00793377|Docetaxel|docetaxel|mesh-list
2417004|NCT00793377|Doxorubicin|doxorubicin|mesh-list
2417005|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2417006|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2417007|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
2417008|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417009|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2417010|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2417011|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
2551554|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551555|NCT01499563|Risperidone|risperidone|mesh-list
2551556|NCT01499563|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2551557|NCT01499563|Serotonin Agents|serotonin agents|mesh-ancestor
2551558|NCT01499563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2551559|NCT01499563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551560|NCT01499563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417012|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417013|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417014|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2417015|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
2417016|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
2417017|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
2417018|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2417019|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2417020|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2417021|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417022|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2551561|NCT01499563|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2551562|NCT01499563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2551563|NCT01499563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2551564|NCT01499563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2551565|NCT01499563|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2551566|NCT01499563|Dopamine Agents|dopamine agents|mesh-ancestor
2551567|NCT01499589|Anesthetics|anesthetics|mesh-list
2551568|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417023|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
2417024|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2417025|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2417026|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2551569|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551570|NCT01499602|Norethindrone|norethindrone|mesh-list
2551571|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
2551572|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2551573|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
2417027|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2417028|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2417029|NCT00793429|Prucalopride|prucalopride|mesh-list
2417030|NCT00793429|Laxatives|laxatives|mesh-ancestor
2417031|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2417032|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2417033|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2417034|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
2417035|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417036|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417037|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417038|NCT00793468|Nicotine|nicotine|mesh-list
2551574|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2551575|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551576|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2551577|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2551578|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2551579|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2551580|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
2551581|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2551582|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2551583|NCT01499641|Prednisolone|prednisolone|mesh-list
2551584|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
2551585|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2551586|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
2551587|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2551588|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
2551589|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
2551590|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551591|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551592|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2551593|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
2551594|NCT01499641|Hormones|hormones|mesh-ancestor
2551595|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2551596|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2551597|NCT01499641|Protective Agents|protective agents|mesh-ancestor
2551598|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2551599|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551600|NCT01499693|Pantoprazole|pantoprazole|mesh-list
2551601|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2551602|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2417039|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2417040|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
2417041|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417042|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417043|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2417044|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2417045|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
2417046|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417047|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417048|NCT00793559|Terlipressin|terlipressin|mesh-list
2417049|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2417050|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2417051|NCT00793663|Dexamethasone|dexamethasone|mesh-list
2417052|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
2417053|NCT00793663|Ondansetron|ondansetron|mesh-list
2417054|NCT00793663|Sevoflurane|sevoflurane|mesh-list
2417055|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2417056|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
2417057|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
2417058|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417059|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417060|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2417061|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
2417062|NCT00793663|Hormones|hormones|mesh-ancestor
2417063|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2417064|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2417065|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417066|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2417067|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2417068|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
2417069|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
2417070|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417071|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
2417072|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
2417073|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2417074|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
2417075|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417076|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417077|NCT00793663|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2417078|NCT00793663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2551603|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2551604|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551605|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551606|NCT01499758|Atorvastatin|atorvastatin|mesh-list
2417079|NCT00793663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417080|NCT00793663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2417081|NCT00793741|Somatostatin|somatostatin|mesh-list
2417082|NCT00793741|Hormones|hormones|mesh-ancestor
2417083|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2551607|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2551608|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2551609|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
2551610|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551611|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2551612|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2551613|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417084|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417085|NCT00793754|Aspirin|aspirin|mesh-list
2417086|NCT00793754|Atorvastatin|atorvastatin|mesh-list
2417087|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2417088|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2417089|NCT00793754|Analgesics|analgesics|mesh-ancestor
2417090|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
2417091|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417092|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417093|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2551614|NCT01499771|Atorvastatin|atorvastatin|mesh-list
2551615|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2551616|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2551617|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
2551618|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551619|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2551620|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2551621|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551622|NCT01499875|Penicillin V|penicillin v|mesh-list
2551623|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2417094|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2417095|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2417096|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2417097|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551624|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551625|NCT01499888|Sirolimus|sirolimus|mesh-list
2551626|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
2551627|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2551628|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551629|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2551630|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551631|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
2551632|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2551633|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
2551634|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551635|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2551636|NCT01499914|Vaccines|vaccines|mesh-list
2551637|NCT01499914|Immunologic Factors|immunologic factors|mesh-ancestor
2551638|NCT01499914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551639|NCT01499953|PENTA|penta|mesh-list
2551640|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
2551641|NCT01499953|Fondaparinux|fondaparinux|mesh-list
2551642|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2551643|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
2551644|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2551645|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
2551646|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551647|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551648|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
2551649|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2551650|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2551651|NCT01500005|Vitamin D|vitamin d|mesh-list
2551652|NCT01500005|Vitamins|vitamins|mesh-ancestor
2417098|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2417099|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2417100|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417101|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
2417102|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2417103|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2417104|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
2417105|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2417106|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2417107|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
2551653|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
2551654|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551655|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2551656|NCT01500018|Phentermine|phentermine|mesh-list
2551657|NCT01500018|Ketamine|ketamine|mesh-list
2417108|NCT00793767|Hematinics|hematinics|mesh-ancestor
2417109|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
2417110|NCT00793845|Melphalan|melphalan|mesh-list
2417111|NCT00793845|Thiotepa|thiotepa|mesh-list
2417112|NCT00793845|Carboplatin|carboplatin|mesh-list
2551658|NCT01500018|Analgesics|analgesics|mesh-ancestor
2551659|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
2551660|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551661|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551662|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2551663|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2551664|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
2551665|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
2551666|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2551667|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2551668|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2551669|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417113|NCT00793845|Etoposide|etoposide|mesh-list
2417114|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2417115|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
2417116|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417117|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2417118|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2417119|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
2417120|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551670|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551671|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2551672|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
2551673|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2551674|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
2551675|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
2551676|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
2551677|NCT01500070|Everolimus|everolimus|mesh-list
2417121|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417122|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2417123|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2417124|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2417125|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2417126|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551678|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551679|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2551680|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
2417127|NCT00793858|Ciclesonide|ciclesonide|mesh-list
2417128|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
2417129|NCT00793858|Hormones|hormones|mesh-ancestor
2417130|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2417131|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417132|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2417133|NCT00793897|Paclitaxel|paclitaxel|mesh-list
2417134|NCT00793897|Carboplatin|carboplatin|mesh-list
2417135|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2417136|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551681|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551682|NCT01500161|Cytarabine|cytarabine|mesh-list
2551683|NCT01500161|Fludarabine|fludarabine|mesh-list
2551684|NCT01500161|Etoposide|etoposide|mesh-list
2551685|NCT01500161|Melphalan|melphalan|mesh-list
2551686|NCT01500161|Busulfan|busulfan|mesh-list
2551687|NCT01500161|Carmustine|carmustine|mesh-list
2551688|NCT01500161|Clofarabine|clofarabine|mesh-list
2551689|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551690|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2551691|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
2551692|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551693|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2551694|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
2551695|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551696|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2551697|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2551698|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2551699|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551700|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
2551701|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551702|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2551703|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
2551704|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2551705|NCT01500408|Interferons|interferons|mesh-list
2551706|NCT01500408|Interferon-beta|interferon-beta|mesh-list
2551707|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
2551708|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551709|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
2551710|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551711|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
2551712|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551713|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2551714|NCT01500473|Desogestrel|desogestrel|mesh-list
2551715|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2551716|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2551717|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2551718|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
2551719|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2551720|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551721|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2551722|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2551723|NCT01500473|Progestins|progestins|mesh-ancestor
2551724|NCT01500473|Hormones|hormones|mesh-ancestor
2551725|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2551726|NCT01500538|Vorinostat|vorinostat|mesh-list
2551727|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551728|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2551729|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551730|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551731|NCT01500577|Nimesulide|nimesulide|mesh-list
2551732|NCT01500577|Simvastatin|simvastatin|mesh-list
2551733|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2551734|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2551735|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
2551736|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551737|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2551738|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2551739|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551740|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2551741|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2551742|NCT01500577|Analgesics|analgesics|mesh-ancestor
2551743|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
2551744|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551745|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551746|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2417137|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
2551747|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2417138|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
2417139|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
2417140|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417141|NCT00793923|Dexamethasone|dexamethasone|mesh-list
2417142|NCT00793923|Ranibizumab|ranibizumab|mesh-list
2551748|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2551749|NCT01500590|Ramipril|ramipril|mesh-list
2551750|NCT01500590|Irbesartan|irbesartan|mesh-list
2551751|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2551752|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
2551753|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551754|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551755|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2551756|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2551757|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2551758|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
2551759|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
2551760|NCT01500785|Simendan|simendan|mesh-list
2551761|NCT01500785|Vitamins|vitamins|mesh-ancestor
2551762|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
2551763|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551764|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
2551765|NCT01500785|Hematinics|hematinics|mesh-ancestor
2551766|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2551767|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
2551768|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2551769|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2417143|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2417144|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
2417145|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
2417146|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417147|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417148|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2417149|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
2417150|NCT00793923|Hormones|hormones|mesh-ancestor
2417151|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2417152|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2551770|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551771|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551772|NCT01500785|Protective Agents|protective agents|mesh-ancestor
2551773|NCT01500824|Crizotinib|crizotinib|mesh-list
2551774|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551775|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2551776|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551777|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551778|NCT01500837|Levofloxacin|levofloxacin|mesh-list
2551779|NCT01500837|Ofloxacin|ofloxacin|mesh-list
2551780|NCT01500837|Rifampin|rifampin|mesh-list
2551781|NCT01500837|Clindamycin|clindamycin|mesh-list
2551782|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
2417153|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417154|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2417155|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2417156|NCT00793923|Growth Substances|growth substances|mesh-ancestor
2417157|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
2417158|NCT00793975|Ramucirumab|ramucirumab|mesh-list
2417159|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417160|NCT00793988|Anesthetics|anesthetics|mesh-list
2417161|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417162|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417163|NCT00794209|Fentanyl|fentanyl|mesh-list
2417164|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2417165|NCT00794209|Narcotics|narcotics|mesh-ancestor
2551783|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
2551784|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2551785|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551786|NCT01500837|Renal Agents|renal agents|mesh-ancestor
2551787|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2551788|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2551789|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2551790|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551791|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551792|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551793|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2551794|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2551795|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2551796|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
2551797|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
2417166|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417167|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417168|NCT00794209|Analgesics|analgesics|mesh-ancestor
2417169|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
2417170|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417171|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2417172|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2417173|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
2417174|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
2417175|NCT00794235|Sorafenib|sorafenib|mesh-list
2551798|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2551799|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2551800|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2551801|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2551802|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2551803|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2551804|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2551805|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2551806|NCT01500850|Insulin|insulin|mesh-list
2551807|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2551808|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
2551809|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
2551810|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
2551811|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
2551812|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
2551813|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551814|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551815|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2551816|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2551817|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2551818|NCT01500863|Estradiol|estradiol|mesh-list
2551819|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2551820|NCT01500863|Progesterone|progesterone|mesh-list
2551821|NCT01500863|Estrogens|estrogens|mesh-ancestor
2551822|NCT01500863|Hormones|hormones|mesh-ancestor
2551823|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2551824|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551825|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2551826|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
2551827|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2551828|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2551829|NCT01500863|Progestins|progestins|mesh-ancestor
2551830|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
2551831|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2551832|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551833|NCT01500915|Ranibizumab|ranibizumab|mesh-list
2551834|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2551835|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2551836|NCT01500915|Growth Substances|growth substances|mesh-ancestor
2551837|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551838|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
2551839|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551840|NCT01500928|Insulin|insulin|mesh-list
2551841|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551842|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417176|NCT00794235|Dacarbazine|dacarbazine|mesh-list
2417177|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417178|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2417179|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417180|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417181|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2417182|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
2417183|NCT00794248|Fexofenadine|fexofenadine|mesh-list
2417184|NCT00794248|Desloratadine|desloratadine|mesh-list
2417185|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2417186|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
2417187|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417188|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417189|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551843|NCT01500980|Chloroquine|chloroquine|mesh-list
2551844|NCT01500980|Primaquine|primaquine|mesh-list
2551845|NCT01500980|Amebicides|amebicides|mesh-ancestor
2551846|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2551847|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2417190|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2417191|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2417192|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
2417193|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
2417194|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2417195|NCT00794261|Lenograstim|lenograstim|mesh-list
2417196|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2417197|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
2417198|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417199|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
2417200|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2417201|NCT00794378|Cetirizine|cetirizine|mesh-list
2417202|NCT00794378|Desloratadine|desloratadine|mesh-list
2417203|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2417204|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2417205|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2417206|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
2551848|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551849|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
2551850|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2551851|NCT01500993|Fluorouracil|fluorouracil|mesh-list
2551852|NCT01500993|Capecitabine|capecitabine|mesh-list
2551853|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
2417207|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
2417208|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417209|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417210|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417211|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2417212|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
2417213|NCT00794443|Diphosphonates|diphosphonates|mesh-list
2417214|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2417215|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417216|NCT00794495|Cetirizine|cetirizine|mesh-list
2417217|NCT00794495|Desloratadine|desloratadine|mesh-list
2417218|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2417219|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2417220|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2417221|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
2551854|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551855|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2551856|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417222|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
2417223|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417224|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417225|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417226|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2417227|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
2417228|NCT00794599|Cetirizine|cetirizine|mesh-list
2417229|NCT00794599|Desloratadine|desloratadine|mesh-list
2417230|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2417231|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2417232|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2417233|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
2417234|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
2551857|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2551858|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
2551859|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551860|NCT01501032|Pancrelipase|pancrelipase|mesh-list
2551861|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2551862|NCT01501084|Exenatide|exenatide|mesh-list
2551863|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2551864|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551865|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2551866|NCT01501084|Incretins|incretins|mesh-ancestor
2551867|NCT01501084|Hormones|hormones|mesh-ancestor
2551868|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2551869|NCT01501123|Midazolam|midazolam|mesh-list
2551870|NCT01501123|Haloperidol|haloperidol|mesh-list
2551871|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
2551872|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2551873|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2551874|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2551875|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417235|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417236|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417237|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551876|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2551877|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2417238|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2417239|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
2417240|NCT00794625|Valproic Acid|valproic acid|mesh-list
2417241|NCT00794625|Risperidone|risperidone|mesh-list
2417242|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
2417243|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2417244|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
2417245|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417246|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417247|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417248|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2417249|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2417250|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417251|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417252|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2417253|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
2417254|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
2417255|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417256|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
2417257|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
2417258|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2417259|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2417260|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2417261|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2417262|NCT00794638|Rituximab|rituximab|mesh-list
2417263|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2417264|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2417265|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551878|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2551879|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2551880|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
2551881|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
2551882|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
2551883|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
2551884|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2551885|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551886|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
2551887|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
2551888|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551889|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2551890|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2551891|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2551892|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
2551893|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2551894|NCT01501136|Gemcitabine|gemcitabine|mesh-list
2551895|NCT01501136|Dexamethasone|dexamethasone|mesh-list
2551896|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
2551897|NCT01501136|Cisplatin|cisplatin|mesh-list
2551898|NCT01501136|Etoposide|etoposide|mesh-list
2551899|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
2551900|NCT01501136|Ifosfamide|ifosfamide|mesh-list
2551901|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
2551902|NCT01501136|Pegaspargase|pegaspargase|mesh-list
2551903|NCT01501136|Asparaginase|asparaginase|mesh-list
2551904|NCT01501136|BB 1101|bb 1101|mesh-list
2551905|NCT01501136|Mesna|mesna|mesh-list
2551906|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551907|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2551908|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
2417266|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
2417267|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417268|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2417269|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2417270|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
2417271|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417272|NCT00794703|Itraconazole|itraconazole|mesh-list
2417273|NCT00794703|Micafungin|micafungin|mesh-list
2417274|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
2417275|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2417276|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2417277|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2417278|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551909|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
2551910|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551911|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551912|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2551913|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
2417279|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417280|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2417281|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
2417282|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2417283|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417284|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2417285|NCT00794755|Vitamin K|vitamin k|mesh-list
2417286|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
2417287|NCT00794755|Vitamins|vitamins|mesh-ancestor
2551914|NCT01501136|Hormones|hormones|mesh-ancestor
2551915|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2551916|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2551917|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
2551918|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551919|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551920|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2551921|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
2551922|NCT01501136|Antiviral Agents|antiviral agents|mesh-ancestor
2551923|NCT01501136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551924|NCT01501136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2551925|NCT01501136|Immunologic Factors|immunologic factors|mesh-ancestor
2551926|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2551927|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2551928|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2551929|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2551930|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
2551931|NCT01501136|Protective Agents|protective agents|mesh-ancestor
2551932|NCT01501149|Gemcitabine|gemcitabine|mesh-list
2551933|NCT01501149|Dexamethasone|dexamethasone|mesh-list
2551934|NCT01501149|Etoposide|etoposide|mesh-list
2551935|NCT01501149|Pegaspargase|pegaspargase|mesh-list
2551936|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551937|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2551938|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
2551939|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
2551940|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551941|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551942|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2551943|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
2551944|NCT01501149|Hormones|hormones|mesh-ancestor
2551945|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2551946|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2551947|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2551948|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
2551949|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551950|NCT01501149|Antiviral Agents|antiviral agents|mesh-ancestor
2551951|NCT01501149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2551952|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551953|NCT01501149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2551954|NCT01501149|Immunologic Factors|immunologic factors|mesh-ancestor
2551955|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2551956|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2551957|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2551958|NCT01501214|Atosiban|atosiban|mesh-list
2417288|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
2417289|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417290|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2417291|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2417292|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417293|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
2417294|NCT00794755|Coagulants|coagulants|mesh-ancestor
2417295|NCT00794768|Fexofenadine|fexofenadine|mesh-list
2417296|NCT00794768|Desloratadine|desloratadine|mesh-list
2417297|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2417298|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
2417299|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417300|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417301|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417302|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2417303|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2417304|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
2417305|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
2417306|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2417307|NCT00794794|Cetirizine|cetirizine|mesh-list
2417308|NCT00794794|Desloratadine|desloratadine|mesh-list
2417309|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2417310|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2417311|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2417312|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
2417313|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
2417314|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417315|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417316|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417317|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2417318|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
2417319|NCT00794807|Alefacept|alefacept|mesh-list
2417320|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
2417321|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
2551959|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
2551960|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2551961|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551962|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
2551963|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2551964|NCT01501253|Amlodipine|amlodipine|mesh-list
2551965|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2551966|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2551967|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2551968|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551969|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2551970|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551971|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
2551972|NCT01501344|Calcium|calcium|mesh-list
2551973|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2551974|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417322|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417323|NCT00794846|Cetirizine|cetirizine|mesh-list
2417324|NCT00794846|Desloratadine|desloratadine|mesh-list
2417325|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2417326|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2551975|NCT01501370|Dexamethasone|dexamethasone|mesh-list
2551976|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
2551977|NCT01501370|Lenalidomide|lenalidomide|mesh-list
2551978|NCT01501370|Vorinostat|vorinostat|mesh-list
2551979|NCT01501370|BB 1101|bb 1101|mesh-list
2551980|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2551981|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
2551982|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
2551983|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2551984|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2551985|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2551986|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
2551987|NCT01501370|Hormones|hormones|mesh-ancestor
2551988|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2417327|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2417328|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
2417329|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
2417330|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417331|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417332|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417333|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2417334|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
2551989|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2551990|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2551991|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
2551992|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2551993|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2551994|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
2551995|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2551996|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2551997|NCT01501370|Growth Substances|growth substances|mesh-ancestor
2551998|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
2551999|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2552000|NCT01501396|Megestrol|megestrol|mesh-list
2552001|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
2552002|NCT01501396|Mirtazapine|mirtazapine|mesh-list
2552003|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
2552004|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2552005|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2552006|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
2552007|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
2552008|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552009|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552010|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552011|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2552012|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2552013|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2552014|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2552015|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2552016|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2417335|NCT00794859|Sorafenib|sorafenib|mesh-list
2417336|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417337|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2417338|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417339|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417340|NCT00794885|Folic Acid|folic acid|mesh-list
2417341|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
2417342|NCT00794885|Enalapril|enalapril|mesh-list
2417343|NCT00794885|Enalaprilat|enalaprilat|mesh-list
2417344|NCT00794885|Maleic acid|maleic acid|mesh-list
2417345|NCT00794885|Hematinics|hematinics|mesh-ancestor
2417346|NCT00794885|Vitamins|vitamins|mesh-ancestor
2417347|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
2417348|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417349|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417350|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417351|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2417352|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
2417353|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2552017|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
2552018|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2552019|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2552020|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
2552021|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2552022|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2552023|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2552024|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2552025|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
2552026|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2552027|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2552028|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2552029|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2552030|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552031|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
2552032|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2552033|NCT01501422|Estrogens|estrogens|mesh-list
2552034|NCT01501422|Hormones|hormones|mesh-ancestor
2552035|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2552036|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552037|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
2552038|NCT01501435|Fenofibrate|fenofibrate|mesh-list
2552039|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2552040|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2552041|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
2552042|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552043|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2552044|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2552045|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2552046|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
2552047|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2552048|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2552049|NCT01501448|Estradiol|estradiol|mesh-list
2552050|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2552051|NCT01501448|Estrogens|estrogens|mesh-ancestor
2552052|NCT01501448|Hormones|hormones|mesh-ancestor
2552053|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2417354|NCT00794898|Infliximab|infliximab|mesh-list
2417355|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
2417356|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2417357|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2417358|NCT00794976|Dexamethasone|dexamethasone|mesh-list
2417359|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
2417360|NCT00794976|BB 1101|bb 1101|mesh-list
2417361|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2417362|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
2417363|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
2552054|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552055|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2552056|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
2552057|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2552058|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2552059|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2552060|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2417364|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417365|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417366|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2417367|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
2417368|NCT00794976|Hormones|hormones|mesh-ancestor
2417369|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2417370|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2417371|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552061|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2552062|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2552063|NCT01501487|Paclitaxel|paclitaxel|mesh-list
2552064|NCT01501487|Docetaxel|docetaxel|mesh-list
2552065|NCT01501487|Trastuzumab|trastuzumab|mesh-list
2552066|NCT01501487|Pertuzumab|pertuzumab|mesh-list
2552067|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2552068|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552069|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
2552070|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
2552071|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
2552072|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417372|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
2417373|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552073|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2552074|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2552075|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2552076|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552077|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552078|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2552079|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2552080|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552081|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
2552082|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552083|NCT01501513|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2552084|NCT01501513|Laxatives|laxatives|mesh-ancestor
2552085|NCT01501513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2552086|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
2552087|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
2552088|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
2552089|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2552090|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
2552091|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
2552092|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552093|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552094|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552095|NCT01501669|Capecitabine|capecitabine|mesh-list
2552096|NCT01501669|Irinotecan|irinotecan|mesh-list
2552097|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2552098|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
2552099|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552100|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552101|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2552102|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2552103|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552104|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
2417374|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417375|NCT00795015|Insulin|insulin|mesh-list
2417376|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2417377|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2417378|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417379|NCT00795106|Capsaicin|capsaicin|mesh-list
2417380|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
2417381|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
2552105|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2552106|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2552107|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2552108|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552109|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417382|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
2417383|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417384|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417385|NCT00795158|Desloratadine|desloratadine|mesh-list
2417386|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2417387|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
2417388|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417389|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417390|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417391|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2417392|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2417393|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
2417394|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
2417395|NCT00795171|Docetaxel|docetaxel|mesh-list
2417396|NCT00795171|Sunitinib|sunitinib|mesh-list
2417397|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417398|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
2417399|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
2417400|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
2417401|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417402|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2417403|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2417404|NCT00795171|Growth Substances|growth substances|mesh-ancestor
2552110|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2552111|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
2552112|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552113|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552114|NCT01501708|Voriconazole|voriconazole|mesh-list
2552115|NCT01501708|Amphotericin B|amphotericin b|mesh-list
2552116|NCT01501708|Caspofungin|caspofungin|mesh-list
2552117|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
2552118|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552119|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2552120|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2552121|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552122|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552123|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2552124|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
2552125|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2552126|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552127|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2552128|NCT01501708|Amebicides|amebicides|mesh-ancestor
2552129|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2417405|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417406|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
2417407|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2417408|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417409|NCT00795223|Morphine|morphine|mesh-list
2417410|NCT00795223|Bupivacaine|bupivacaine|mesh-list
2417411|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
2417412|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
2552130|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2552131|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2552132|NCT01501747|Acetaminophen|acetaminophen|mesh-list
2552133|NCT01501747|Cephalexin|cephalexin|mesh-list
2552134|NCT01501747|Ibuprofen|ibuprofen|mesh-list
2552135|NCT01501747|Caffeine|caffeine|mesh-list
2552136|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2552137|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2552138|NCT01501747|Analgesics|analgesics|mesh-ancestor
2417413|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417414|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116866|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116867|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
2116868|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
2116869|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
2116870|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2116871|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2116872|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116873|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116874|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116875|NCT02651155|Lubiprostone|lubiprostone|mesh-list
2116876|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2116877|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2417415|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
2417416|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417417|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2552139|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
2552140|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552141|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552142|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2552143|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2552144|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2552145|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552146|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552147|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
2417418|NCT00795223|Narcotics|narcotics|mesh-ancestor
2417419|NCT00795223|Analgesics|analgesics|mesh-ancestor
2417420|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
2417421|NCT00795262|Quinapril|quinapril|mesh-list
2417422|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
2417423|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417424|NCT00795262|Protective Agents|protective agents|mesh-ancestor
2417425|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417426|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
2417427|NCT00795262|Vitamins|vitamins|mesh-ancestor
2417428|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
2417429|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2417430|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
2417431|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417432|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2417433|NCT00795301|Capecitabine|capecitabine|mesh-list
2417434|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
2417435|NCT00795301|Cetuximab|cetuximab|mesh-list
2417436|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2417437|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
2417438|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552148|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2552149|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2552150|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2552151|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2552152|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
2552153|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552154|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2552155|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552156|NCT01501760|Bevacizumab|bevacizumab|mesh-list
2552157|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2552158|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552159|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2552160|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2552161|NCT01501760|Growth Substances|growth substances|mesh-ancestor
2552162|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552163|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
2552164|NCT01501786|Ketamine|ketamine|mesh-list
2552165|NCT01501786|Propofol|propofol|mesh-list
2552166|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2552167|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2552168|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552169|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2552170|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
2552171|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
2552172|NCT01501786|Analgesics|analgesics|mesh-ancestor
2552173|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
2552174|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552175|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2552176|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2552177|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2417439|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417440|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2417441|NCT00795314|Fentanyl|fentanyl|mesh-list
2417442|NCT00795314|Butorphanol|butorphanol|mesh-list
2417443|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2417444|NCT00795314|Narcotics|narcotics|mesh-ancestor
2417445|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417446|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417447|NCT00795314|Analgesics|analgesics|mesh-ancestor
2417448|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
2417449|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417450|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2417451|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2552178|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552179|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552180|NCT01501799|Adapalene|adapalene|mesh-list
2552181|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2552182|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
2552183|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2552184|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2552185|NCT01501799|Analgesics|analgesics|mesh-ancestor
2552186|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
2552187|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552188|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552189|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2552190|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2552191|NCT01501890|Algestone|algestone|mesh-list
2552192|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2552193|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2552194|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2552195|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
2552196|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2552197|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552198|NCT01501890|Progestins|progestins|mesh-ancestor
2552199|NCT01501890|Hormones|hormones|mesh-ancestor
2552200|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2552201|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2552202|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2552203|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
2552204|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2552205|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2552206|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2552207|NCT01501916|Vitamin D|vitamin d|mesh-list
2552208|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
2552209|NCT01501916|Vitamins|vitamins|mesh-ancestor
2552210|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
2552211|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552212|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2552213|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2417452|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
2417453|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
2417454|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
2417455|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
2417456|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2417457|NCT00795353|Alefacept|alefacept|mesh-list
2417458|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
2417459|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
2417460|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417461|NCT00795444|Maraviroc|maraviroc|mesh-list
2417462|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2417463|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2417464|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417465|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2417466|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2417467|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
2417468|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2417469|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2417470|NCT00795457|Poly I-C|poly i-c|mesh-list
2417471|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2417472|NCT00795457|Vaccines|vaccines|mesh-list
2417473|NCT00795457|Poly ICLC|poly iclc|mesh-list
2417474|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
2417475|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417476|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
2417477|NCT00795457|Laxatives|laxatives|mesh-ancestor
2417478|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2417479|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
2417480|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552214|NCT01501942|Glycine|glycine|mesh-list
2552215|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
2552216|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552217|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552218|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552219|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
2552220|NCT01501968|Colistin|colistin|mesh-list
2552221|NCT01501968|Vitamins|vitamins|mesh-ancestor
2552222|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
2417481|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
2417482|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2417483|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
2552223|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552224|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
2552225|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552226|NCT01501968|Protective Agents|protective agents|mesh-ancestor
2552227|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2552228|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552229|NCT01502020|Imiquimod|imiquimod|mesh-list
2417484|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2417485|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417486|NCT00795496|Histamine|histamine|mesh-list
2417487|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
2417488|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
2417489|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417490|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417491|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552230|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2552231|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
2552232|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552233|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552234|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
2552235|NCT01502046|Dronabinol|dronabinol|mesh-list
2552236|NCT01502046|Cannabidiol|cannabidiol|mesh-list
2552237|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
2552238|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
2552239|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552240|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2552241|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2552242|NCT01502046|Analgesics|analgesics|mesh-ancestor
2552243|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
2552244|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417492|NCT00795522|Desloratadine|desloratadine|mesh-list
2417493|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2417494|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
2417495|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417496|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417497|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417498|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2417499|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2417500|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
2417501|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
2417502|NCT00795548|Azacitidine|azacitidine|mesh-list
2417503|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2417504|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
2417505|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417506|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417507|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417508|NCT00795574|Infliximab|infliximab|mesh-list
2552245|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2552246|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2552247|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552248|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552249|NCT01502046|Hormones|hormones|mesh-ancestor
2552250|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2417509|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
2417510|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2417511|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2417512|NCT00795587|Mannitol|mannitol|mesh-list
2417513|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2417514|NCT00795587|Diuretics|diuretics|mesh-ancestor
2417515|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
2417516|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417517|NCT00795613|Doxorubicin|doxorubicin|mesh-list
2417518|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2417519|NCT00795613|Vincristine|vincristine|mesh-list
2417520|NCT00795613|Procarbazine|procarbazine|mesh-list
2417521|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2417522|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417523|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2417524|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2417525|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417526|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417527|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2417528|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
2417529|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
2552267|NCT01502202|Pemetrexed|pemetrexed|mesh-list
2552268|NCT01502202|Gefitinib|gefitinib|mesh-list
2552269|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552270|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552271|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552272|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2552273|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2552274|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2552275|NCT01502241|Temozolomide|temozolomide|mesh-list
2552276|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2552277|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
2552278|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552279|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552280|NCT01502267|Rituximab|rituximab|mesh-list
2552281|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2417530|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
2417531|NCT00795678|Gemcitabine|gemcitabine|mesh-list
2417532|NCT00795678|Paclitaxel|paclitaxel|mesh-list
2417533|NCT00795678|Vinorelbine|vinorelbine|mesh-list
2417534|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2417535|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
2417536|NCT00795678|Doxorubicin|doxorubicin|mesh-list
2417537|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2417538|NCT00795678|Capecitabine|capecitabine|mesh-list
2417539|NCT00795678|Trastuzumab|trastuzumab|mesh-list
2417540|NCT00795678|Lapatinib|lapatinib|mesh-list
2417541|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2417542|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417543|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
2417544|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
2417545|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
2417546|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417547|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2417548|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
2417549|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417550|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2417551|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2417552|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
2417553|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2417554|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2552282|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2552283|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552284|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
2552285|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552286|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2552287|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
2552288|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2552289|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
2552290|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552291|NCT01502280|Protective Agents|protective agents|mesh-ancestor
2552292|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552293|NCT01502280|Vitamins|vitamins|mesh-ancestor
2552294|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
2552295|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2552296|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
2552297|NCT01502358|Vaccines|vaccines|mesh-list
2552298|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
2552299|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552300|NCT01502592|Ipilimumab|ipilimumab|mesh-list
2552301|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2552302|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417555|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
2417556|NCT00795678|Antiviral Agents|antiviral agents|mesh-ancestor
2552303|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2552304|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552305|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2552306|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2552307|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
2417557|NCT00795678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2417558|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417559|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2417560|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2417561|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2417562|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2417563|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2417564|NCT00795756|Cytarabine|cytarabine|mesh-list
2417565|NCT00795756|Methotrexate|methotrexate|mesh-list
2417566|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2417567|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
2417568|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2417569|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417570|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2417571|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
2417572|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417573|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417574|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
2417575|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417576|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2417577|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2552308|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
2552309|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2552310|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
2552311|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552312|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552313|NCT01502774|Cyclosporine|cyclosporine|mesh-list
2552314|NCT01502774|Cyclosporins|cyclosporins|mesh-list
2552315|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552316|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552317|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2552318|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
2552319|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552320|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
2552321|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2417578|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
2417579|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2417580|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2417581|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
2417582|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2417583|NCT00795808|Metformin|metformin|mesh-list
2417584|NCT00795808|Clomiphene|clomiphene|mesh-list
2417585|NCT00795808|Enclomiphene|enclomiphene|mesh-list
2417586|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
2417587|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2417588|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417589|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2552322|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
2552323|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2552324|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2552325|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
2552326|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552327|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2552328|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2552329|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552330|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552331|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
2552332|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
2552333|NCT01502878|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
2552334|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2552335|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552336|NCT01502904|Sirolimus|sirolimus|mesh-list
2552337|NCT01502904|Pravastatin|pravastatin|mesh-list
2552338|NCT01502904|Pitavastatin|pitavastatin|mesh-list
2552339|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2552340|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552341|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2552342|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552343|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
2417590|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
2417591|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2417592|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2417593|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
2417594|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2417595|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2552344|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2552345|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
2552346|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552347|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2552348|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2552349|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
2552350|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552351|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2552352|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2552353|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552354|NCT01502917|Antibodies|antibodies|mesh-list
2417596|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2417597|NCT00795847|Losartan|losartan|mesh-list
2417598|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2552355|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2552356|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
2552357|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417599|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2417600|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2417601|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2417602|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2417603|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417604|NCT00795847|Diuretics|diuretics|mesh-ancestor
2417605|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
2417606|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552358|NCT01502943|Aspirin|aspirin|mesh-list
2552359|NCT01502943|Atorvastatin|atorvastatin|mesh-list
2552360|NCT01502943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552361|NCT01502943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2552362|NCT01502943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2552363|NCT01502943|Analgesics|analgesics|mesh-ancestor
2552364|NCT01502943|Sensory System Agents|sensory system agents|mesh-ancestor
2552365|NCT01502943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552366|NCT01502943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2552367|NCT01502943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2552368|NCT01502943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2552369|NCT01502943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2552370|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552371|NCT01502943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2552372|NCT01502943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2552373|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552374|NCT01502943|Antipyretics|antipyretics|mesh-ancestor
2552375|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2552376|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2552377|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
2552378|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2552379|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2552380|NCT01503008|Metformin|metformin|mesh-list
2552381|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2552382|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2552383|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
2552384|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2552385|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552386|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552387|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552388|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
2552389|NCT01503060|Lidocaine|lidocaine|mesh-list
2552390|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
2552391|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
2552392|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2552393|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552394|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
2552395|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552396|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2552397|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2552398|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2552399|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2552400|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552401|NCT01503216|Vitamin D|vitamin d|mesh-list
2417607|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2417608|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2552402|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
2552403|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
2552404|NCT01503216|Vitamins|vitamins|mesh-ancestor
2417609|NCT00795899|Paclitaxel|paclitaxel|mesh-list
2417610|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
2417611|NCT00795899|Trastuzumab|trastuzumab|mesh-list
2417612|NCT00795899|Epirubicin|epirubicin|mesh-list
2417613|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2417614|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417615|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
2417616|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
2417617|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
2417618|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417619|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2417620|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
2417621|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417622|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2417623|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2417624|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
2417625|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2552405|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
2552406|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552407|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2552408|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2552409|NCT01503242|Cyclosporine|cyclosporine|mesh-list
2552410|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
2552411|NCT01503242|Fludarabine|fludarabine|mesh-list
2552412|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
2552413|NCT01503242|Antibodies|antibodies|mesh-list
2552414|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2552415|NCT01503242|Cyclosporins|cyclosporins|mesh-list
2552416|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
2552417|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552418|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552419|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2552420|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
2552421|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552422|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2552423|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552424|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
2552425|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552426|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
2552427|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2552428|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2552429|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2552430|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2417626|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2552431|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
2552432|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2552433|NCT01503359|Glycine|glycine|mesh-list
2552434|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
2552435|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552436|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552437|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552438|NCT01503372|Leucovorin|leucovorin|mesh-list
2116878|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116879|NCT02651220|Adapalene|adapalene|mesh-list
2116880|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
2116881|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2116882|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
2116883|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2116884|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2116885|NCT02651220|Analgesics|analgesics|mesh-ancestor
2116886|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
2116887|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116888|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116889|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2116890|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2116891|NCT02651259|Vitamins|vitamins|mesh-list
2116892|NCT02651259|Pyridoxine|pyridoxine|mesh-list
2116893|NCT02651259|Pyridoxal|pyridoxal|mesh-list
2116894|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
2116895|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
2116896|NCT02651259|Isoniazid|isoniazid|mesh-list
2116897|NCT02651259|Rifapentine|rifapentine|mesh-list
2417627|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2417628|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2417629|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2417630|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552439|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
2552440|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552441|NCT01503372|Antidotes|antidotes|mesh-ancestor
2552442|NCT01503372|Protective Agents|protective agents|mesh-ancestor
2552443|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552444|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
2552445|NCT01503372|Vitamins|vitamins|mesh-ancestor
2552446|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
2552447|NCT01503385|Celecoxib|celecoxib|mesh-list
2552448|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2552449|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2552450|NCT01503385|Analgesics|analgesics|mesh-ancestor
2552451|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
2552452|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552453|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552454|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2552455|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2552456|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2552457|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2552458|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552459|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552460|NCT01503398|Olanzapine|olanzapine|mesh-list
2552461|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
2417631|NCT00795912|Atorvastatin|atorvastatin|mesh-list
2417632|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2417633|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2417634|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
2417635|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417636|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2552462|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
2552463|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552464|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552465|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2552466|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2552467|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2552468|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2552469|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2552470|NCT01503398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2552471|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2552472|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2552473|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552474|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552475|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
2552476|NCT01503424|Olanzapine|olanzapine|mesh-list
2552477|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
2552478|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
2552479|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552480|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552481|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2552482|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2552483|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2552484|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2552485|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2552486|NCT01503424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2552487|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2552488|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2552489|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552490|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552491|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
2116898|NCT02651259|Rifamycins|rifamycins|mesh-list
2116899|NCT02651259|Hydrazine|hydrazine|mesh-list
2116900|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
2116901|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116902|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
2116903|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2116904|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2116905|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2116906|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2116907|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
2116908|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116909|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2552492|NCT01503437|Olanzapine|olanzapine|mesh-list
2552493|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
2552494|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
2552495|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552496|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417637|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2417638|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417639|NCT00795925|Propiverine|propiverine|mesh-list
2417640|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
2417641|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
2417642|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417643|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417644|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2417645|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2417646|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
2417647|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417648|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417649|NCT00795925|Urological Agents|urological agents|mesh-ancestor
2417650|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
2417651|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
2417652|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2417653|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2417654|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417655|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417656|NCT00795938|Urological Agents|urological agents|mesh-ancestor
2417657|NCT00795977|Picibanil|picibanil|mesh-list
2417658|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417659|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2552497|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2552498|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2552499|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2552500|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2552501|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2552502|NCT01503437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2552503|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2552504|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2552505|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552506|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552507|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
2552508|NCT01503450|Olanzapine|olanzapine|mesh-list
2552509|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
2552510|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
2552511|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552512|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552513|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2552514|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2552515|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2552516|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2552517|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2552518|NCT01503450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2552519|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2552520|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2552521|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552522|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552523|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
2552524|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
2552525|NCT01503502|HH-GV-678|hh-gv-678|mesh-list
2552526|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552527|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2552528|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552529|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552530|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
2552531|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2552532|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2552533|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2552534|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
2552535|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552536|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552537|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552538|NCT01503580|Urological Agents|urological agents|mesh-ancestor
2552539|NCT01503593|Calcium|calcium|mesh-list
2552540|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2417660|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2417661|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2417662|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417663|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417664|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417665|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2417666|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2417667|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
2417668|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552541|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552542|NCT01503606|Clarithromycin|clarithromycin|mesh-list
2552543|NCT01503606|Cefazolin|cefazolin|mesh-list
2552544|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2552545|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552546|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2552547|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552548|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552549|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2552550|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2552561|NCT01503658|Aspirin|aspirin|mesh-list
2552562|NCT01503658|Clopidogrel|clopidogrel|mesh-list
2552563|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2552564|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2552565|NCT01503658|Analgesics|analgesics|mesh-ancestor
2552566|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
2552567|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552568|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552569|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2552570|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2552571|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2552572|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2552573|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552574|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2552575|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2552576|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552577|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
2552578|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2552579|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2552580|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2552581|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
2552582|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552583|NCT01503671|Atorvastatin|atorvastatin|mesh-list
2552584|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2552585|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2552586|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
2552587|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552588|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2552589|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2552590|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552591|NCT01503736|Citric Acid|citric acid|mesh-list
2552592|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
2552593|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
2552594|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
2552595|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2552596|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
2116910|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2116911|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
2116912|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116913|NCT02651272|Macitentan|macitentan|mesh-list
2116914|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2116915|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2116916|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116917|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2116918|NCT02651415|Perindopril|perindopril|mesh-list
2116919|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2552597|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
2552598|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552599|NCT01503736|Hematinics|hematinics|mesh-ancestor
2552600|NCT01503788|Midazolam|midazolam|mesh-list
2552601|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2552602|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2552603|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116920|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
2116921|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116922|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2116923|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2116924|NCT02651428|Taurolidine|taurolidine|mesh-list
2116925|NCT02651428|Heparin|heparin|mesh-list
2116926|NCT02651428|Calcium heparin|calcium heparin|mesh-list
2116927|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
2116928|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417669|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417670|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2417671|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2417672|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
2552604|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552605|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2552606|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2552607|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2552608|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2552609|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
2552610|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
2552611|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
2552612|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
2552613|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552614|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552615|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
2552616|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
2552617|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2552618|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
2552619|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552620|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552621|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2552622|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
2552623|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2552624|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
2552625|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552626|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552627|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
2552628|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
2552629|NCT01503801|Protective Agents|protective agents|mesh-ancestor
2552630|NCT01503905|Tamoxifen|tamoxifen|mesh-list
2552631|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
2552632|NCT01503905|Docetaxel|docetaxel|mesh-list
2552633|NCT01503905|Trastuzumab|trastuzumab|mesh-list
2552634|NCT01503905|Epirubicin|epirubicin|mesh-list
2552635|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2552636|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
2552637|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552638|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2552639|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2552640|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
2552641|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552642|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552643|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2417700|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2417701|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2417702|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2417703|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417704|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552644|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
2552645|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
2552646|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
2552647|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2552648|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2552649|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2552650|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2552651|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552652|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2552653|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
2552654|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2552655|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2552656|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2417705|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417706|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2417707|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2417708|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
2417709|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417710|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417711|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2552657|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2552658|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2552659|NCT01503918|Valacyclovir|valacyclovir|mesh-list
2552660|NCT01503918|Valganciclovir|valganciclovir|mesh-list
2552661|NCT01503918|Acyclovir|acyclovir|mesh-list
2552662|NCT01503918|Ganciclovir|ganciclovir|mesh-list
2552663|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2552664|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
2552665|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552666|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2552667|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552668|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552669|NCT01503983|Capecitabine|capecitabine|mesh-list
2552670|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
2552671|NCT01503983|Trastuzumab|trastuzumab|mesh-list
2552672|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2552673|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
2552674|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552675|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552676|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2552677|NCT01504074|Triamcinolone|triamcinolone|mesh-list
2552678|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2552679|NCT01504074|Levobunolol|levobunolol|mesh-list
2552680|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2552681|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
2552682|NCT01504074|Hormones|hormones|mesh-ancestor
2552683|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2552684|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552685|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552686|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2552687|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552688|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2552689|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2552690|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
2552691|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552692|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
2552693|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
2552694|NCT01504126|Propranolol|propranolol|mesh-list
2552695|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2552696|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2552697|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
2552698|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552699|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552700|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552701|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2552702|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2552703|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
2552704|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2552705|NCT01504139|Estradiol|estradiol|mesh-list
2552706|NCT01504139|Progesterone|progesterone|mesh-list
2552707|NCT01504139|Estrogens|estrogens|mesh-ancestor
2552708|NCT01504139|Hormones|hormones|mesh-ancestor
2552709|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2552710|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552711|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2552712|NCT01504139|Progestins|progestins|mesh-ancestor
2552713|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2552714|NCT01504178|Levodopa|levodopa|mesh-list
2552715|NCT01504178|Apomorphine|apomorphine|mesh-list
2552716|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
2552717|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2552718|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2552719|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2552720|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552721|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552722|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552723|NCT01504178|Analgesics|analgesics|mesh-ancestor
2552724|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
2552725|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552726|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
2552727|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2552728|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
2552729|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2552730|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2552731|NCT01504178|Emetics|emetics|mesh-ancestor
2417712|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2417713|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
2417714|NCT00796159|Olmesartan|olmesartan|mesh-list
2417715|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2417716|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2417717|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2417718|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2417719|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417720|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2417721|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2417722|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2417723|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417724|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417725|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417726|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2417727|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2417728|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
2552732|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
2552733|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2552734|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
2552735|NCT01504256|Leucovorin|leucovorin|mesh-list
2552736|NCT01504256|Docetaxel|docetaxel|mesh-list
2552737|NCT01504256|Fluorouracil|fluorouracil|mesh-list
2552738|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
2552739|NCT01504256|Catumaxomab|catumaxomab|mesh-list
2552740|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2552741|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
2552742|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552743|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
2552744|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
2552745|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
2552746|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552747|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
2552748|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2552749|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2552750|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
2552751|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552752|NCT01504256|Antidotes|antidotes|mesh-ancestor
2552753|NCT01504256|Protective Agents|protective agents|mesh-ancestor
2116929|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2552754|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
2552755|NCT01504256|Vitamins|vitamins|mesh-ancestor
2552756|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
2417729|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417730|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417731|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2417732|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2417733|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
2417734|NCT00796198|Latanoprost|latanoprost|mesh-list
2417735|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2552757|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2552758|NCT01504282|Mitomycins|mitomycins|mesh-list
2552759|NCT01504282|Mitomycin|mitomycin|mesh-list
2552760|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2552761|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552762|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
2552763|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552764|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2552765|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552766|NCT01504295|Metadoxine|metadoxine|mesh-list
2552767|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2552768|NCT01504321|Moxonidine|moxonidine|mesh-list
2552769|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2552770|NCT01504334|Pirfenidone|pirfenidone|mesh-list
2552771|NCT01504334|Analgesics|analgesics|mesh-ancestor
2552772|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
2552773|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552774|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552775|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2552776|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2552777|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2552778|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2552779|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552780|NCT01504347|Vaccines|vaccines|mesh-list
2552781|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
2552782|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552783|NCT01504386|Ropivacaine|ropivacaine|mesh-list
2552784|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
2552785|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
2552786|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2552787|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417736|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2417737|NCT00796211|Nortriptyline|nortriptyline|mesh-list
2417738|NCT00796211|Calcipotriene|calcipotriene|mesh-list
2417739|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
2417740|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2417741|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
2417742|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417743|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2417744|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2552788|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
2552789|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552790|NCT01504490|Bexarotene|bexarotene|mesh-list
2552791|NCT01504490|Efatutazone|efatutazone|mesh-list
2552792|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552793|NCT01504503|Donepezil|donepezil|mesh-list
2552794|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2552795|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552796|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552797|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
2552798|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2116930|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2116931|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2116932|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2116933|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116934|NCT02651584|Buprenorphine|buprenorphine|mesh-list
2116935|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2116936|NCT02651584|Narcotics|narcotics|mesh-ancestor
2116937|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116938|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116939|NCT02651584|Analgesics|analgesics|mesh-ancestor
2116940|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
2116941|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116942|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2116943|NCT02651688|Enclomiphene|enclomiphene|mesh-list
2116944|NCT02651688|Clomiphene|clomiphene|mesh-list
2552799|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552800|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
2552801|NCT01504516|Donepezil|donepezil|mesh-list
2552802|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2552803|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116945|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
2116946|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2116947|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
2116948|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2116949|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116950|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2116951|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
2116952|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2116953|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2116954|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2116955|NCT02651987|Lanreotide|lanreotide|mesh-list
2116956|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2116957|NCT02652156|Bupivacaine|bupivacaine|mesh-list
2116958|NCT02652156|Ropivacaine|ropivacaine|mesh-list
2116959|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
2116960|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
2116961|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2116962|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552804|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552805|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
2552806|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552807|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552808|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
2552809|NCT01504542|Vaccines|vaccines|mesh-list
2552810|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
2552811|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552812|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2552813|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
2552814|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552815|NCT01504620|Insulin|insulin|mesh-list
2552816|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2552817|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552818|NCT01504646|Lyprinol|lyprinol|mesh-list
2552819|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2552820|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
2552821|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2552822|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552823|NCT01504659|Ketamine|ketamine|mesh-list
2552824|NCT01504659|Analgesics|analgesics|mesh-ancestor
2552825|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
2552826|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552827|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552828|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2552829|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2552830|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
2552831|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
2552832|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2552833|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2552834|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2552835|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552836|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552837|NCT01504724|Bevacizumab|bevacizumab|mesh-list
2552838|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2552839|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552840|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2552841|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2552842|NCT01504724|Growth Substances|growth substances|mesh-ancestor
2552843|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552844|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
2552845|NCT01504776|Bortezomib|bortezomib|mesh-list
2417745|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2417746|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417747|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
2417748|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417749|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417750|NCT00796250|Prednisolone|prednisolone|mesh-list
2417751|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2417752|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
2417753|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2417754|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
2417755|NCT00796250|Azathioprine|azathioprine|mesh-list
2417756|NCT00796250|Infliximab|infliximab|mesh-list
2552846|NCT01504776|Panobinostat|panobinostat|mesh-list
2417757|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2417758|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
2417759|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2417760|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
2417761|NCT00796250|Hormones|hormones|mesh-ancestor
2417762|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2552847|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552848|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2552849|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552850|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552851|NCT01504815|Cisplatin|cisplatin|mesh-list
2552852|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552853|NCT01504828|Ramipril|ramipril|mesh-list
2552854|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2552855|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
2552856|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552857|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552858|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2552859|NCT01504906|Cyclosporine|cyclosporine|mesh-list
2552860|NCT01504906|Ticagrelor|ticagrelor|mesh-list
2552861|NCT01504906|Cyclosporins|cyclosporins|mesh-list
2116963|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
2116964|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116965|NCT02652260|Tenofovir|tenofovir|mesh-list
2116966|NCT02652260|Lamivudine|lamivudine|mesh-list
2116967|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2116968|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
2116969|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2116970|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2116971|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2116972|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2116973|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417763|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552862|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552863|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552864|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2552865|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
2552866|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552867|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
2552868|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552869|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
2552870|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2552871|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2552872|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2552873|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2552874|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2552875|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2552876|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
2552877|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552878|NCT01504919|Nicotine|nicotine|mesh-list
2552879|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2552880|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
2552881|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552882|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552883|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2552884|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2552885|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
2552886|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552887|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552888|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
2552889|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552890|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2552891|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552892|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552893|NCT01505049|Vaccines|vaccines|mesh-list
2417764|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2417765|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417766|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
2417767|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
2417768|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417769|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2417770|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2417771|NCT00796250|Protective Agents|protective agents|mesh-ancestor
2552894|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
2552895|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552896|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
2552897|NCT01505088|Dexamethasone|dexamethasone|mesh-list
2552898|NCT01505088|Prednisolone|prednisolone|mesh-list
2552899|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2552900|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
2552901|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2552902|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
2552903|NCT01505088|Citric Acid|citric acid|mesh-list
2552904|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
2417772|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
2417773|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2417774|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
2417775|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417776|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2417777|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2417778|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
2417779|NCT00796263|Dolutegravir|dolutegravir|mesh-list
2417780|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2417781|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2552905|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2552906|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2552907|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2552908|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
2552909|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2552910|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2552911|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
2552912|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
2552913|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552914|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552915|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2552916|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
2552917|NCT01505088|Hormones|hormones|mesh-ancestor
2552918|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2552919|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2552920|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552921|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
2552922|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2552923|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
2552924|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
2552925|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552926|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2552927|NCT01505088|Protective Agents|protective agents|mesh-ancestor
2552928|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2552929|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552930|NCT01505127|Amoxicillin|amoxicillin|mesh-list
2552931|NCT01505127|Clarithromycin|clarithromycin|mesh-list
2552932|NCT01505127|Lansoprazole|lansoprazole|mesh-list
2552933|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
2552934|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2552935|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552936|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2552937|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552938|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552939|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2552940|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2552941|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2552942|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2552943|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2552944|NCT01505218|Propofol|propofol|mesh-list
2552945|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2552946|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2552947|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552948|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2552949|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
2552950|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
2116974|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2116975|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2116976|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
2116977|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2116978|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2116979|NCT02652390|Prednisolone|prednisolone|mesh-list
2116980|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
2116981|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2116982|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
2116983|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2417782|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417783|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417784|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2417785|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2417786|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
2417787|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2417788|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2552951|NCT01505231|Vasopressins|vasopressins|mesh-list
2552952|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
2552953|NCT01505231|Norepinephrine|norepinephrine|mesh-list
2552954|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2552955|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2552956|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
2552957|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2552958|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552959|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552960|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
2417789|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2417790|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2417791|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417792|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417793|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417794|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2417795|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2417796|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
2417797|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417798|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417799|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2417800|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2417801|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
2417802|NCT00796289|Citric Acid|citric acid|mesh-list
2417803|NCT00796289|Sodium Citrate|sodium citrate|mesh-list
2417804|NCT00796289|Clomiphene|clomiphene|mesh-list
2552961|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
2552962|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552963|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2116984|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
2116985|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
2116986|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2116987|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2116988|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2116989|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
2116990|NCT02652390|Hormones|hormones|mesh-ancestor
2116991|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2116992|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2116993|NCT02652390|Protective Agents|protective agents|mesh-ancestor
2116994|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2116995|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552964|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
2552965|NCT01505231|Coagulants|coagulants|mesh-ancestor
2552966|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2552967|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
2552968|NCT01505283|Lidocaine|lidocaine|mesh-list
2552969|NCT01505283|Sufentanil|sufentanil|mesh-list
2552970|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
2552971|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
2552972|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2552973|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2552974|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
2552975|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2552976|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2552977|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2552978|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2552979|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2552980|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552981|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2552982|NCT01505283|Narcotics|narcotics|mesh-ancestor
2552983|NCT01505283|Analgesics|analgesics|mesh-ancestor
2552984|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2417805|NCT00796289|Enclomiphene|enclomiphene|mesh-list
2417806|NCT00796289|Zuclomiphene|zuclomiphene|mesh-list
2417807|NCT00796289|Hormones|hormones|mesh-list
2417808|NCT00796289|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2417809|NCT00796289|Anticoagulants|anticoagulants|mesh-ancestor
2417810|NCT00796289|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2417811|NCT00796289|Chelating Agents|chelating agents|mesh-ancestor
2417812|NCT00796289|Sequestering Agents|sequestering agents|mesh-ancestor
2417813|NCT00796289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417814|NCT00796289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2417815|NCT00796289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417816|NCT00796289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2417817|NCT00796289|Hormone Antagonists|hormone antagonists|mesh-ancestor
2417818|NCT00796289|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2417819|NCT00796289|Fertility Agents|fertility agents|mesh-ancestor
2417820|NCT00796289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2417821|NCT00796289|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2417822|NCT00796289|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2417823|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2417824|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2417825|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2417826|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417827|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417828|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417829|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2552985|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2552986|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
2552987|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2552988|NCT01505413|Gemcitabine|gemcitabine|mesh-list
2552989|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
2552990|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2552991|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2552992|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
2552993|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2552994|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2552995|NCT01505413|Antiviral Agents|antiviral agents|mesh-ancestor
2552996|NCT01505413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2552997|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2552998|NCT01505413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2552999|NCT01505413|Immunologic Factors|immunologic factors|mesh-ancestor
2417830|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2417831|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
2417832|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417833|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417834|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2417835|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2417836|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
2417837|NCT00796458|Docetaxel|docetaxel|mesh-list
2417838|NCT00796458|Hormones|hormones|mesh-list
2417839|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417840|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
2417841|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
2417842|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
2417843|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417844|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2417845|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417846|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2417847|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2417848|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2417849|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417850|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553000|NCT01505413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417851|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417852|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2417853|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2417854|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
2417855|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417856|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553001|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2553002|NCT01505426|Metformin|metformin|mesh-list
2553003|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
2553004|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2553005|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553006|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2553007|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553008|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
2553009|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2553010|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2553011|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
2553012|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553013|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553014|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553015|NCT01505439|Urological Agents|urological agents|mesh-ancestor
2553016|NCT01505504|Mirtazapine|mirtazapine|mesh-list
2553017|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
2553018|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2553019|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2553020|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
2553021|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
2553022|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553023|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553024|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553025|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2553026|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2553027|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2553028|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2553029|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2553030|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2553031|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
2553032|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2553033|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2553034|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
2553035|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2553036|NCT01505569|Etoposide|etoposide|mesh-list
2553037|NCT01505569|Carboplatin|carboplatin|mesh-list
2417857|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2417858|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2417859|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
2553038|NCT01505569|Melphalan|melphalan|mesh-list
2553039|NCT01505569|Busulfan|busulfan|mesh-list
2553040|NCT01505569|Ifosfamide|ifosfamide|mesh-list
2553041|NCT01505569|Thiotepa|thiotepa|mesh-list
2553042|NCT01505569|Lenograstim|lenograstim|mesh-list
2553043|NCT01505569|Mesna|mesna|mesh-list
2553044|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2553045|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553046|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553047|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2553048|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2553049|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553050|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2553051|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
2553052|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2553053|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2553054|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
2553055|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553056|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2117021|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2117022|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
2553057|NCT01505569|Protective Agents|protective agents|mesh-ancestor
2553058|NCT01505777|Mosapride|mosapride|mesh-list
2553059|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2553060|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2553061|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
2553062|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553063|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553064|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553065|NCT01505790|Clopidogrel|clopidogrel|mesh-list
2553066|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2553067|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2553068|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2553069|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2553070|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2553071|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
2553072|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553073|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553074|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553075|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2553076|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
2553077|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553078|NCT01505894|BI 409306|bi 409306|mesh-list
2553079|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2553080|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553081|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553082|NCT01505920|Lidocaine|lidocaine|mesh-list
2553083|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
2553084|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
2553085|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2553086|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553087|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
2553088|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553089|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2553090|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2553091|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2553092|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2553093|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553094|NCT01505946|Thrombin|thrombin|mesh-list
2553095|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
2553096|NCT01505946|Coagulants|coagulants|mesh-ancestor
2553097|NCT01505998|Amlodipine|amlodipine|mesh-list
2553098|NCT01505998|Benazepril|benazepril|mesh-list
2553099|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2553100|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2553101|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2553102|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553103|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2553104|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553105|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
2553106|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2553107|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
2553108|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553109|NCT01506011|Amlodipine|amlodipine|mesh-list
2553110|NCT01506011|Benazepril|benazepril|mesh-list
2553111|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2553112|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2553113|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2553114|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553115|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2553116|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553117|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
2553118|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2553119|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
2553120|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553121|NCT01506024|Tacrine|tacrine|mesh-list
2417860|NCT00796497|Ondansetron|ondansetron|mesh-list
2417861|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
2417862|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
2417863|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417864|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417865|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2417866|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
2417867|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
2417868|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2417869|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
2417870|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417871|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417872|NCT00796497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2417873|NCT00796497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2417874|NCT00796497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417875|NCT00796497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417876|NCT00796497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2417877|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2417878|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2417879|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2417880|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417881|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417882|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417883|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2417884|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2417885|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
2553122|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2553123|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553124|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553125|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
2553126|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553127|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553128|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2417886|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417887|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417888|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2417889|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2417890|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
2417891|NCT00796692|Heparin|heparin|mesh-list
2117023|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2117024|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2117025|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2117026|NCT02653144|Dexamethasone|dexamethasone|mesh-list
2117027|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
2117028|NCT02653144|Ropivacaine|ropivacaine|mesh-list
2117029|NCT02653144|Anesthetics|anesthetics|mesh-list
2117030|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2117031|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
2117032|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
2117033|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117034|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117035|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2553129|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
2553130|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553131|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
2553132|NCT01506037|Desloratadine|desloratadine|mesh-list
2553133|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2553134|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
2553135|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553136|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553137|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553138|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2553139|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2553140|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
2553141|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
2553142|NCT01506050|Desloratadine|desloratadine|mesh-list
2553143|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2553144|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
2553145|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553146|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553147|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553148|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2553149|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2553150|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
2553151|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
2553152|NCT01506063|Levocetirizine|levocetirizine|mesh-list
2553153|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2117036|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
2117037|NCT02653144|Hormones|hormones|mesh-ancestor
2117038|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2117039|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2117040|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417892|NCT00796692|Calcium heparin|calcium heparin|mesh-list
2417893|NCT00796692|Nadroparin|nadroparin|mesh-list
2417894|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
2417895|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2417896|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2417897|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553154|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2553155|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
2553156|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
2553157|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553158|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553159|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553160|NCT01506076|Levocetirizine|levocetirizine|mesh-list
2553161|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2553162|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2553163|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
2553164|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
2553165|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553166|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553167|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553168|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2553169|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
2553170|NCT01506115|Trioxsalen|trioxsalen|mesh-list
2553171|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553172|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
2553173|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2553174|NCT01506167|Leucovorin|leucovorin|mesh-list
2553175|NCT01506167|Folic Acid|folic acid|mesh-list
2553176|NCT01506167|Bevacizumab|bevacizumab|mesh-list
2553177|NCT01506167|Fluorouracil|fluorouracil|mesh-list
2553178|NCT01506167|Capecitabine|capecitabine|mesh-list
2553179|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
2553180|NCT01506167|Irinotecan|irinotecan|mesh-list
2553181|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
2553182|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2553183|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553184|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2553185|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2553186|NCT01506167|Growth Substances|growth substances|mesh-ancestor
2553187|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553188|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
2553189|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
2553190|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553191|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2117041|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2117042|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117043|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2117044|NCT02653144|Analgesics|analgesics|mesh-ancestor
2117045|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
2117046|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2117047|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2117048|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2117049|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
2117050|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117051|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117052|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
2117053|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2417898|NCT00796796|Sirolimus|sirolimus|mesh-list
2553192|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2553193|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
2553194|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2553195|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2553196|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553197|NCT01506167|Antidotes|antidotes|mesh-ancestor
2553198|NCT01506167|Protective Agents|protective agents|mesh-ancestor
2553199|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
2553200|NCT01506167|Vitamins|vitamins|mesh-ancestor
2553201|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
2553202|NCT01506167|Hematinics|hematinics|mesh-ancestor
2553203|NCT01506336|Sunitinib|sunitinib|mesh-list
2417899|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2417900|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2417901|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2417902|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2417903|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
2417904|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2417905|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
2553204|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553205|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2553206|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2553207|NCT01506336|Growth Substances|growth substances|mesh-ancestor
2553208|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553209|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
2553210|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2553211|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417906|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417907|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2417908|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2417909|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2417910|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417911|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417912|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417913|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2417914|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2417915|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
2553212|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553213|NCT01506388|Misoprostol|misoprostol|mesh-list
2553214|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2553215|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
2553216|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2553217|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553218|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2553219|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2553220|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
2553221|NCT01506414|Rituximab|rituximab|mesh-list
2553222|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2553223|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553224|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
2553225|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553226|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2553227|NCT01506505|Aspirin|aspirin|mesh-list
2553228|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2553229|NCT01506505|Lisinopril|lisinopril|mesh-list
2553230|NCT01506505|Simvastatin|simvastatin|mesh-list
2553231|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2553232|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2553233|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
2553234|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553235|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2553236|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2553237|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553238|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2553239|NCT01506505|Diuretics|diuretics|mesh-ancestor
2553240|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
2553241|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553242|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2553243|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2553244|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2553245|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2553246|NCT01506505|Analgesics|analgesics|mesh-ancestor
2553247|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
2553248|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553249|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2553250|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2553251|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2553252|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2553253|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2553254|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2553255|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
2553256|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2553257|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
2553258|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2553259|NCT01506505|Protective Agents|protective agents|mesh-ancestor
2553260|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
2553261|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553262|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
2553263|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553264|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553265|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2553266|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
2553267|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2417916|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2417917|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417918|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2417919|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2417920|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
2417921|NCT00796887|Niacin|niacin|mesh-list
2417922|NCT00796887|Niacinamide|niacinamide|mesh-list
2417923|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
2417924|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2417925|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
2417926|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417927|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2553268|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553269|NCT01506557|Vitamins|vitamins|mesh-ancestor
2553270|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
2417928|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
2417929|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
2417930|NCT00796887|Vitamins|vitamins|mesh-ancestor
2417931|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
2417932|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417933|NCT00796900|Dantrolene|dantrolene|mesh-list
2417934|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2417935|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417936|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2417937|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417938|NCT00797017|Fentanyl|fentanyl|mesh-list
2417939|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2417940|NCT00797017|Narcotics|narcotics|mesh-ancestor
2417941|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417942|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417943|NCT00797017|Analgesics|analgesics|mesh-ancestor
2417944|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
2417945|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417946|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2417947|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2417948|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
2117054|NCT02653183|Laxatives|laxatives|mesh-ancestor
2117055|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2117056|NCT02653300|Insulin|insulin|mesh-list
2117057|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2117058|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117059|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2117060|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2117061|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
2117062|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
2117063|NCT02653560|Citric Acid|citric acid|mesh-list
2117064|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
2117065|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
2117066|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2117067|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
2117068|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
2117069|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117070|NCT02653560|Diuretics|diuretics|mesh-ancestor
2553271|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2553272|NCT01506570|Vaccines|vaccines|mesh-list
2553273|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
2553274|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553275|NCT01506622|Fentanyl|fentanyl|mesh-list
2553276|NCT01506622|Propofol|propofol|mesh-list
2553277|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2553278|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2553279|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553280|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2553281|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
2553282|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
2553283|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2553284|NCT01506622|Narcotics|narcotics|mesh-ancestor
2553285|NCT01506622|Analgesics|analgesics|mesh-ancestor
2553286|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
2553287|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553288|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2553289|NCT01506635|Timolol|timolol|mesh-list
2553290|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2553291|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2117071|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
2117072|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417949|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
2417950|NCT00797030|Cyclosporine|cyclosporine|mesh-list
2417951|NCT00797030|Cyclosporins|cyclosporins|mesh-list
2553292|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
2417952|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417953|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417954|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2417955|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
2553293|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553294|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553295|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553296|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2553297|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2553298|NCT01506713|Clopidogrel|clopidogrel|mesh-list
2553299|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2417956|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417957|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
2417958|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2417959|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
2417960|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2417961|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2417962|NCT00797056|Aspirin|aspirin|mesh-list
2417963|NCT00797056|Clopidogrel|clopidogrel|mesh-list
2417964|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2553300|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2553301|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2553302|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2553303|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
2553304|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553305|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553306|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553307|NCT01506739|Donepezil|donepezil|mesh-list
2553308|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2553309|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553310|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553311|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
2553312|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553313|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553314|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
2553315|NCT01506752|Donepezil|donepezil|mesh-list
2553316|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2553317|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417965|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2417966|NCT00797056|Analgesics|analgesics|mesh-ancestor
2417967|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
2417968|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2417969|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417970|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2417971|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2553318|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553319|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
2553320|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553321|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553322|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
2553323|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
2553324|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2553325|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
2553326|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2553327|NCT01506765|Expectorants|expectorants|mesh-ancestor
2117073|NCT02653560|Expectorants|expectorants|mesh-ancestor
2117074|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
2117075|NCT02653560|Cathartics|cathartics|mesh-ancestor
2117076|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2117077|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
2117078|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2553328|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
2553329|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2553330|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
2553331|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553332|NCT01506765|Protective Agents|protective agents|mesh-ancestor
2553333|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553334|NCT01506765|Antidotes|antidotes|mesh-ancestor
2117079|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117080|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2117081|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2117082|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
2117083|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2117084|NCT02653872|Itraconazole|itraconazole|mesh-list
2117085|NCT02653872|Verapamil|verapamil|mesh-list
2553335|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
2553336|NCT01506791|Ephedrine|ephedrine|mesh-list
2553337|NCT01506791|Desloratadine|desloratadine|mesh-list
2553338|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2553339|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
2553340|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553341|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553342|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2553343|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
2553344|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
2553345|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2553346|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2553347|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
2553348|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
2553349|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553350|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553351|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2553352|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
2553353|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2553354|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2553355|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
2553356|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
2553357|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
2553358|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2553359|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2553360|NCT01506804|Prednisolone|prednisolone|mesh-list
2553361|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
2553362|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2553363|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
2417972|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2417973|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2417974|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2417975|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2417976|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2417977|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2417978|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
2417979|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2417980|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2417981|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2417982|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
2417983|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553364|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2553365|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
2553366|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
2553367|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553368|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553369|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2553370|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
2553371|NCT01506804|Hormones|hormones|mesh-ancestor
2553372|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553373|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2553374|NCT01506804|Protective Agents|protective agents|mesh-ancestor
2553375|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2553376|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553377|NCT01506856|Paclitaxel|paclitaxel|mesh-list
2553378|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2553379|NCT01506856|Carboplatin|carboplatin|mesh-list
2553380|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2553381|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117086|NCT02653872|Diltiazem|diltiazem|mesh-list
2117087|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
2117088|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2117089|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2117090|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2117091|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117092|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117093|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2117094|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
2553382|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
2553383|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
2553384|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
2553385|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553386|NCT01506895|Darapladib|darapladib|mesh-list
2553387|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2553388|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553389|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553390|NCT01506921|Ketamine|ketamine|mesh-list
2553391|NCT01506921|Esketamine|esketamine|mesh-list
2553392|NCT01506921|Analgesics|analgesics|mesh-ancestor
2553393|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
2553394|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553395|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417984|NCT00797160|Propofol|propofol|mesh-list
2417985|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2417986|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417987|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2417988|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2417989|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
2553396|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2553397|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2553398|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
2553399|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
2553400|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2553401|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2553402|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2553403|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553404|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553405|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
2553406|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2553407|NCT01506973|Gemcitabine|gemcitabine|mesh-list
2553408|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
2553409|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2553410|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2553411|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
2553412|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553413|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553414|NCT01506973|Antiviral Agents|antiviral agents|mesh-ancestor
2117095|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2117096|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117097|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2553415|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2553416|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553417|NCT01506973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2553418|NCT01506973|Immunologic Factors|immunologic factors|mesh-ancestor
2553419|NCT01506973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553420|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
2553421|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2553422|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2553423|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2553424|NCT01506986|Metronidazole|metronidazole|mesh-list
2553425|NCT01506986|Clarithromycin|clarithromycin|mesh-list
2553426|NCT01506986|Lansoprazole|lansoprazole|mesh-list
2553427|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
2553428|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2553429|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2553430|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2553431|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2553432|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2553433|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553434|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553435|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2553436|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2553437|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2553438|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2553439|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2553440|NCT01507064|Sorafenib|sorafenib|mesh-list
2553441|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553442|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2553443|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553444|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553445|NCT01507077|CKD732|ckd732|mesh-list
2553446|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2117098|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2417990|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
2417991|NCT00797264|Morphine|morphine|mesh-list
2553447|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2417992|NCT00797264|Ketamine|ketamine|mesh-list
2417993|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2417994|NCT00797264|Narcotics|narcotics|mesh-ancestor
2417995|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2417996|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553448|NCT01507077|Growth Substances|growth substances|mesh-ancestor
2553449|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553450|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
2553451|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553452|NCT01507194|Ondansetron|ondansetron|mesh-list
2553453|NCT01507194|Vestipitant|vestipitant|mesh-list
2553454|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
2553455|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
2553456|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553457|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553458|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2553459|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
2553460|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
2553461|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2553462|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
2553463|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553464|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553465|NCT01507194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2553466|NCT01507194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2553467|NCT01507194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2553468|NCT01507194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2417997|NCT00797264|Analgesics|analgesics|mesh-ancestor
2417998|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
2117099|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2117100|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2117101|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2117102|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
2117103|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2117104|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2117105|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2117106|NCT02654054|Norethindrone|norethindrone|mesh-list
2117107|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
2117108|NCT02654054|Estradiol|estradiol|mesh-list
2117109|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2117110|NCT02654054|Estrogens|estrogens|mesh-ancestor
2117111|NCT02654054|Hormones|hormones|mesh-ancestor
2117112|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2117113|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117114|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2117115|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
2117116|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2117117|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2117118|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2117119|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2117120|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2553469|NCT01507194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2553470|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2553471|NCT01507272|Liraglutide|liraglutide|mesh-list
2553472|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2553473|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553474|NCT01507272|Incretins|incretins|mesh-ancestor
2553475|NCT01507272|Hormones|hormones|mesh-ancestor
2553476|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553477|NCT01507285|Liraglutide|liraglutide|mesh-list
2553478|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2553479|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553480|NCT01507285|Incretins|incretins|mesh-ancestor
2553481|NCT01507285|Hormones|hormones|mesh-ancestor
2553482|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553483|NCT01507311|Liraglutide|liraglutide|mesh-list
2553484|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2417999|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418000|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2418001|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2418002|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
2418003|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
2418004|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2418005|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2418006|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418007|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553485|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418008|NCT00797303|Bevacizumab|bevacizumab|mesh-list
2418009|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2418010|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418011|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2418012|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2418013|NCT00797303|Growth Substances|growth substances|mesh-ancestor
2418014|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553486|NCT01507311|Incretins|incretins|mesh-ancestor
2553487|NCT01507311|Hormones|hormones|mesh-ancestor
2553488|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2418015|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
2418016|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
2418017|NCT00797394|Urological Agents|urological agents|mesh-ancestor
2418018|NCT00797420|Fluconazole|fluconazole|mesh-list
2418019|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
2418020|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418021|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2418022|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2418023|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418024|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117145|NCT02654145|Omalizumab|omalizumab|mesh-list
2117146|NCT02654145|Albuterol|albuterol|mesh-list
2117147|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2117148|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
2117149|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117150|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117151|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2117152|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
2117153|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
2117154|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2117155|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2117156|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2117157|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2117158|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
2117159|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117160|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117161|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2117162|NCT02654314|Melatonin|melatonin|mesh-list
2117163|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
2117164|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553489|NCT01507337|Liraglutide|liraglutide|mesh-list
2553490|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2117165|NCT02654314|Protective Agents|protective agents|mesh-ancestor
2418025|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2553491|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553492|NCT01507337|Incretins|incretins|mesh-ancestor
2553493|NCT01507337|Hormones|hormones|mesh-ancestor
2553494|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553495|NCT01507363|Gabapentin|gabapentin|mesh-list
2553496|NCT01507363|Analgesics|analgesics|mesh-ancestor
2553497|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
2553498|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553499|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553500|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
2418026|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
2418027|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2418028|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418029|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2418030|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2418031|NCT00797472|Bleomycin|bleomycin|mesh-list
2418032|NCT00797472|Dacarbazine|dacarbazine|mesh-list
2418033|NCT00797472|Vinblastine|vinblastine|mesh-list
2117166|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117167|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117168|NCT02654483|Serlopitant|serlopitant|mesh-list
2117169|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2117170|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117171|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117172|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117173|NCT02654860|Acetaminophen|acetaminophen|mesh-list
2117174|NCT02654860|Bupivacaine|bupivacaine|mesh-list
2117175|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
2117176|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
2117177|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117178|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117179|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
2117180|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117181|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2117182|NCT02654860|Analgesics|analgesics|mesh-ancestor
2117183|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
2117189|NCT02655224|Relugolix|relugolix|mesh-list
2117190|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
2117191|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
2117192|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2418034|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2553501|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2553502|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2553503|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2553504|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2553505|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2553506|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2553507|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553508|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553509|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
2553510|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2553511|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2553512|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553513|NCT01507389|Liraglutide|liraglutide|mesh-list
2553514|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2553515|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553516|NCT01507389|Incretins|incretins|mesh-ancestor
2553517|NCT01507389|Hormones|hormones|mesh-ancestor
2553518|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553519|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
2553520|NCT01507428|Misonidazole|misonidazole|mesh-list
2553521|NCT01507428|Paclitaxel|paclitaxel|mesh-list
2553522|NCT01507428|Carboplatin|carboplatin|mesh-list
2553523|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2553524|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2553525|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2553526|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553527|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
2553528|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
2553529|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
2553530|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553531|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2553532|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
2553533|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
2553534|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2553535|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2553536|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2553537|NCT01507454|Estradiol|estradiol|mesh-list
2553538|NCT01507454|Estrogens|estrogens|mesh-ancestor
2418035|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418036|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418037|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2553539|NCT01507454|Hormones|hormones|mesh-ancestor
2553540|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553541|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553542|NCT01507467|Nimorazole|nimorazole|mesh-list
2553543|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2553544|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2553545|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2553546|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2553547|NCT01507480|Bevacizumab|bevacizumab|mesh-list
2553548|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2553549|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553550|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2553551|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2553552|NCT01507480|Growth Substances|growth substances|mesh-ancestor
2553553|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553554|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
2553555|NCT01507519|Sirolimus|sirolimus|mesh-list
2553556|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2553557|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2553558|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2553559|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553560|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
2418038|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
2418039|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2418040|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
2418041|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
2418042|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
2418043|NCT00797485|Leucovorin|leucovorin|mesh-list
2418044|NCT00797485|Bevacizumab|bevacizumab|mesh-list
2117193|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117194|NCT02655237|Leuprolide|leuprolide|mesh-list
2117195|NCT02655237|Relugolix|relugolix|mesh-list
2117196|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2117197|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
2117198|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2117199|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117200|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2117201|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117202|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
2117203|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
2117204|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2117205|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
2117206|NCT02655354|Promethazine|promethazine|mesh-list
2117207|NCT02655354|Prazosin|prazosin|mesh-list
2117208|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2117209|NCT02655354|Mirtazapine|mirtazapine|mesh-list
2117210|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
2117211|NCT02655354|Trazodone|trazodone|mesh-list
2117212|NCT02655354|Sertraline|sertraline|mesh-list
2117213|NCT02655354|Fluoxetine|fluoxetine|mesh-list
2117214|NCT02655354|Paroxetine|paroxetine|mesh-list
2553561|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2553562|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
2553563|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553564|NCT01507558|Dexamethasone|dexamethasone|mesh-list
2553565|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
2553566|NCT01507558|BB 1101|bb 1101|mesh-list
2553567|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2553568|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
2553569|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
2553570|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553571|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553572|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2553573|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
2553574|NCT01507558|Hormones|hormones|mesh-ancestor
2553575|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553576|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2553577|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553578|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
2553579|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553580|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553581|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
2553582|NCT01507597|Glucagon|glucagon|mesh-list
2553583|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2117215|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2117216|NCT02655354|Citalopram|citalopram|mesh-list
2553584|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2553585|NCT01507597|Hormones|hormones|mesh-ancestor
2553586|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553587|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553588|NCT01507597|Incretins|incretins|mesh-ancestor
2553589|NCT01507610|Sumatriptan|sumatriptan|mesh-list
2553590|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2553591|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2553592|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2553593|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
2553594|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553595|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553596|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553597|NCT01507701|Clonidine|clonidine|mesh-list
2553598|NCT01507701|Analgesics|analgesics|mesh-ancestor
2553599|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
2553600|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553601|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553602|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2553603|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
2553604|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
2553605|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2553606|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2553607|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2553608|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
2553609|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553610|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553611|NCT01507727|Tolvaptan|tolvaptan|mesh-list
2553612|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2553613|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553614|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
2418045|NCT00797485|Fluorouracil|fluorouracil|mesh-list
2418046|NCT00797485|Capecitabine|capecitabine|mesh-list
2418047|NCT00797485|Irinotecan|irinotecan|mesh-list
2418048|NCT00797485|Calcium|calcium|mesh-list
2418049|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
2418050|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2418051|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418052|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2418053|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2418054|NCT00797485|Growth Substances|growth substances|mesh-ancestor
2117217|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2117218|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2117219|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2117220|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117221|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117222|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117223|NCT02655354|Analgesics|analgesics|mesh-ancestor
2553615|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553616|NCT01507740|Bevacizumab|bevacizumab|mesh-list
2553617|NCT01507740|Sorafenib|sorafenib|mesh-list
2553618|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2553619|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553620|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2553621|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2553622|NCT01507740|Growth Substances|growth substances|mesh-ancestor
2553623|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553624|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
2553625|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2553626|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553627|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553628|NCT01507792|Loratadine|loratadine|mesh-list
2553629|NCT01507792|Omeprazole|omeprazole|mesh-list
2553630|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2553631|NCT01507792|Histamine|histamine|mesh-list
2553632|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2553633|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2553634|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117224|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
2117225|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117226|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
2117227|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2418055|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553635|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553636|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
2553637|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
2553638|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2553639|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2553640|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2553641|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
2418056|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
2418057|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2418058|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
2418059|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418060|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2418061|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418062|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
2418063|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2418064|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2418065|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418066|NCT00797485|Antidotes|antidotes|mesh-ancestor
2418067|NCT00797485|Protective Agents|protective agents|mesh-ancestor
2418068|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
2418069|NCT00797485|Vitamins|vitamins|mesh-ancestor
2418070|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
2418071|NCT00797693|Misoprostol|misoprostol|mesh-list
2418072|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2418073|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
2418074|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2418075|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418076|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2418077|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2418078|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
2418079|NCT00797745|Ritonavir|ritonavir|mesh-list
2553642|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
2553643|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553644|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553645|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
2553646|NCT01507857|Vaccines|vaccines|mesh-list
2553647|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
2553648|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553649|NCT01507922|Fenoverine|fenoverine|mesh-list
2553650|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
2117228|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
2117229|NCT02655354|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2117230|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
2117231|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2117232|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2117233|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2117234|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117235|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
2117236|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2553651|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
2553652|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553653|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553654|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2553655|NCT01507974|Amoxicillin|amoxicillin|mesh-list
2553656|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
2553657|NCT01507974|Cephalexin|cephalexin|mesh-list
2553658|NCT01507974|Cefuroxime|cefuroxime|mesh-list
2553659|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
2553660|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2553661|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2553662|NCT01507974|Trimethoprim|trimethoprim|mesh-list
2553663|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
2553664|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2553665|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
2553666|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2553667|NCT01507974|Renal Agents|renal agents|mesh-ancestor
2553668|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
2553669|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2553670|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2553671|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2553672|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553673|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553674|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2553675|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2117237|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2553676|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2553677|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2553678|NCT01508000|Bevacizumab|bevacizumab|mesh-list
2418080|NCT00797745|Ribavirin|ribavirin|mesh-list
2418081|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2418082|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2418083|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2418084|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
2418085|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418086|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418087|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2117238|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117239|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
2117240|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
2117241|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
2117242|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2117243|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2117244|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
2117245|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
2117246|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2117247|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
2117248|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
2117249|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2117250|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2117251|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2553679|NCT01508000|Panitumumab|panitumumab|mesh-list
2553680|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2553681|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553682|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2553683|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2553684|NCT01508000|Growth Substances|growth substances|mesh-ancestor
2553685|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553686|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
2117252|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2117253|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2117254|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
2117255|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2117256|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2117257|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2117258|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2553687|NCT01508026|Valsartan|valsartan|mesh-list
2553688|NCT01508026|Nebivolol|nebivolol|mesh-list
2553689|NCT01508026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2553690|NCT01508026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2553691|NCT01508026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2553692|NCT01508026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553693|NCT01508026|Vasodilator Agents|vasodilator agents|mesh-ancestor
2553694|NCT01508026|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2553695|NCT01508026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2553696|NCT01508026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2553697|NCT01508026|Adrenergic Agents|adrenergic agents|mesh-ancestor
2553698|NCT01508026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553699|NCT01508026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553700|NCT01508104|Everolimus|everolimus|mesh-list
2553701|NCT01508104|Dactolisib|dactolisib|mesh-list
2553702|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553703|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2553704|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
2553705|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553706|NCT01508143|Misoprostol|misoprostol|mesh-list
2553707|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2553708|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
2553709|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2553710|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553711|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2553712|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2553713|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
2553714|NCT01508182|Metformin|metformin|mesh-list
2553715|NCT01508182|Canagliflozin|canagliflozin|mesh-list
2553716|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2553717|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553718|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2553719|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553720|NCT01508195|Metformin|metformin|mesh-list
2553721|NCT01508195|Canagliflozin|canagliflozin|mesh-list
2553722|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2553723|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553724|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2117259|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2117260|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2117261|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2117262|NCT02655419|Metronidazole|metronidazole|mesh-list
2117263|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2117264|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2553725|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553726|NCT01508221|Vitamin E|vitamin e|mesh-list
2553727|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
2553728|NCT01508221|Vitamins|vitamins|mesh-ancestor
2553729|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
2553730|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553731|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
2553732|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553733|NCT01508221|Protective Agents|protective agents|mesh-ancestor
2553734|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2553735|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553736|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2553737|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2553738|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
2553739|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2553740|NCT01508260|Furosemide|furosemide|mesh-list
2553741|NCT01508260|Diuretics|diuretics|mesh-ancestor
2553742|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
2553743|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553744|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2553745|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2553746|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418088|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2418089|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
2418090|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418091|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2418092|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2418093|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
2418094|NCT00797771|Insulin|insulin|mesh-list
2418095|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2418096|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418097|NCT00797784|Etanercept|etanercept|mesh-list
2418098|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2418099|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2418100|NCT00797784|Analgesics|analgesics|mesh-ancestor
2418101|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
2418102|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553747|NCT01508286|Ribavirin|ribavirin|mesh-list
2553748|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
2553749|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553750|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
2553751|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2553752|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2553753|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2553754|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2553755|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553756|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
2553757|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553758|NCT01508364|Sorafenib|sorafenib|mesh-list
2553759|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553760|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2117265|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2117266|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2117267|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
2117268|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
2117269|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2117270|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2117271|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117272|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
2117273|NCT02655653|Coagulants|coagulants|mesh-ancestor
2117274|NCT02655679|Ether|ether|mesh-list
2117275|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2117276|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
2117277|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
2117278|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117279|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117280|NCT02656069|Glucagon|glucagon|mesh-list
2117281|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2117282|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2117283|NCT02656069|Hormones|hormones|mesh-ancestor
2553761|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553762|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553763|NCT01508429|Misoprostol|misoprostol|mesh-list
2553764|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2553765|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
2553766|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2553767|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553768|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2553769|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2553770|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
2553771|NCT01508468|Rituximab|rituximab|mesh-list
2553772|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
2553773|NCT01508468|Giapreza|giapreza|mesh-list
2553774|NCT01508468|Calcium|calcium|mesh-list
2553775|NCT01508468|Diuretics|diuretics|mesh-list
2553776|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2553777|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2553778|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
2553779|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
2553780|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2553781|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553782|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
2553783|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553784|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2553785|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2553786|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
2553787|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2553788|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
2553789|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553790|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553791|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2553792|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2553793|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
2553794|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
2553795|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553796|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2553797|NCT01508494|Galantamine|galantamine|mesh-list
2553798|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2553799|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553800|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418103|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418104|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2418105|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2418106|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2418107|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418108|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
2418109|NCT00797810|Cytarabine|cytarabine|mesh-list
2418110|NCT00797810|Dexamethasone|dexamethasone|mesh-list
2418111|NCT00797810|Prednisone|prednisone|mesh-list
2418112|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
2418113|NCT00797810|Ifosfamide|ifosfamide|mesh-list
2553801|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
2553802|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553803|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553804|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2553805|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
2553806|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553807|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
2553808|NCT01508572|Bevacizumab|bevacizumab|mesh-list
2553809|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2553810|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553811|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2553812|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2553813|NCT01508572|Growth Substances|growth substances|mesh-ancestor
2553814|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553815|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
2553816|NCT01508611|Fluorides|fluorides|mesh-list
2553817|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
2553818|NCT01508611|Protective Agents|protective agents|mesh-ancestor
2553819|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553820|NCT01508637|Terazosin|terazosin|mesh-list
2553821|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2553822|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2553823|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2553824|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
2184841|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418114|NCT00797810|Rituximab|rituximab|mesh-list
2418115|NCT00797810|Vincristine|vincristine|mesh-list
2418116|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418117|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
2418118|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553825|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553826|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553827|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553828|NCT01508637|Urological Agents|urological agents|mesh-ancestor
2553829|NCT01508663|Everolimus|everolimus|mesh-list
2553830|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2553831|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553832|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2553833|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
2553834|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553835|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
2553836|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553837|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553838|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2553839|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2553840|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
2553841|NCT01508806|Liraglutide|liraglutide|mesh-list
2553842|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2553843|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553844|NCT01508806|Incretins|incretins|mesh-ancestor
2553845|NCT01508806|Hormones|hormones|mesh-ancestor
2553846|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553847|NCT01508845|Vitamin D|vitamin d|mesh-list
2553848|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
2553849|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
2553850|NCT01508845|Vitamins|vitamins|mesh-list
2553851|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
2553852|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553853|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2553854|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2553855|NCT01508858|Liraglutide|liraglutide|mesh-list
2553856|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
2553857|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2553858|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2553859|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553860|NCT01508858|Incretins|incretins|mesh-ancestor
2553861|NCT01508858|Hormones|hormones|mesh-ancestor
2117284|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2117285|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117286|NCT02656069|Incretins|incretins|mesh-ancestor
2117287|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
2117288|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2117289|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2117290|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117291|NCT02656173|Tamsulosin|tamsulosin|mesh-list
2117292|NCT02656173|Mirabegron|mirabegron|mesh-list
2117293|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2117294|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2117295|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2117296|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
2117297|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2184842|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
2418119|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2418120|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2418121|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
2418122|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418123|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418124|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2418125|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2418126|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
2418127|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
2418128|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418129|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2418130|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
2418131|NCT00797810|Hormones|hormones|mesh-ancestor
2418132|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2418133|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2418134|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2418135|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2418136|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
2418137|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
2418138|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2117298|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117299|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117300|NCT02656173|Urological Agents|urological agents|mesh-ancestor
2117301|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2117302|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2117303|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2117304|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2117305|NCT02656329|Lugol's solution|lugol's solution|mesh-list
2117306|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117307|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117308|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117309|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2117310|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
2117311|NCT02656329|Coagulants|coagulants|mesh-ancestor
2553862|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553863|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2553864|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
2553865|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2553866|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2553867|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2553868|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2553869|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2553870|NCT01508858|Estrogens|estrogens|mesh-ancestor
2553871|NCT01508884|Imiquimod|imiquimod|mesh-list
2553872|NCT01508884|Vaccines|vaccines|mesh-list
2553873|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
2553874|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553875|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2553876|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418139|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2418140|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
2418141|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
2418142|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
2418143|NCT00797836|Interferons|interferons|mesh-list
2418144|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418145|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
2418146|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418147|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2418148|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
2418149|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
2418150|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2418151|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2418152|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2418153|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418154|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
2553877|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
2553878|NCT01508897|Liraglutide|liraglutide|mesh-list
2553879|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2553880|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553881|NCT01508897|Incretins|incretins|mesh-ancestor
2553882|NCT01508897|Hormones|hormones|mesh-ancestor
2553883|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553884|NCT01508923|Liraglutide|liraglutide|mesh-list
2117312|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
2117313|NCT02657031|Promethazine|promethazine|mesh-list
2117314|NCT02657031|Ketamine|ketamine|mesh-list
2117315|NCT02657031|Ondansetron|ondansetron|mesh-list
2117316|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
2117317|NCT02657031|Analgesics|analgesics|mesh-ancestor
2117318|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
2117319|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117320|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117321|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2117322|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2553885|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2553886|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553887|NCT01508923|Incretins|incretins|mesh-ancestor
2553888|NCT01508923|Hormones|hormones|mesh-ancestor
2553889|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553890|NCT01508949|Liraglutide|liraglutide|mesh-list
2553891|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2553892|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553893|NCT01508949|Incretins|incretins|mesh-ancestor
2418155|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
2418156|NCT00798070|Fluorouracil|fluorouracil|mesh-list
2418157|NCT00798070|Docetaxel|docetaxel|mesh-list
2418158|NCT00798070|Epirubicin|epirubicin|mesh-list
2418159|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2117323|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
2117324|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
2117325|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2553894|NCT01508949|Hormones|hormones|mesh-ancestor
2553895|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2553896|NCT01509001|Metformin|metformin|mesh-list
2553897|NCT01509001|Glimepiride|glimepiride|mesh-list
2553898|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2553899|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553900|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2553901|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2553902|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
2553903|NCT01509131|Bisacodyl|bisacodyl|mesh-list
2117326|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2117327|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2117328|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117329|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117330|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
2117331|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
2117332|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2553904|NCT01509131|Cathartics|cathartics|mesh-ancestor
2553905|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2117333|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
2117334|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
2117335|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2117336|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
2117337|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2117338|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2117339|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2117340|NCT02657031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2117341|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2117342|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2117343|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
2117344|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2117345|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
2117346|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
2117347|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2117348|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2117349|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
2117350|NCT02657252|Polidocanol|polidocanol|mesh-list
2117351|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2117352|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2117353|NCT02657369|Lenvatinib|lenvatinib|mesh-list
2117354|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553906|NCT01509131|Laxatives|laxatives|mesh-ancestor
2553907|NCT01509144|Vaccines|vaccines|mesh-list
2553908|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
2553909|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553910|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
2553911|NCT01509209|Ephedrine|ephedrine|mesh-list
2553912|NCT01509209|Levocetirizine|levocetirizine|mesh-list
2553913|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2117355|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2117356|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117357|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553914|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2553915|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
2553916|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
2553917|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553918|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418160|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
2418161|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418162|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2418163|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2418164|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
2418165|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418166|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418167|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2418168|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
2418169|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2418170|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
2418171|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
2418172|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
2553919|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553920|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2553921|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
2553922|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553923|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2553924|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
2418173|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2418174|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2418175|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2418176|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418177|NCT00798083|Lidocaine|lidocaine|mesh-list
2418178|NCT00798083|Ketamine|ketamine|mesh-list
2418179|NCT00798083|Amitriptyline|amitriptyline|mesh-list
2553925|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
2553926|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2553927|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2553928|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
2553929|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
2553930|NCT01509261|Lansoprazole|lansoprazole|mesh-list
2553931|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
2553932|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2553933|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2553934|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2553935|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553936|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553937|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
2553938|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
2553939|NCT01509300|Rituximab|rituximab|mesh-list
2553940|NCT01509300|Fludarabine|fludarabine|mesh-list
2553941|NCT01509300|Tacrolimus|tacrolimus|mesh-list
2553942|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2553943|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2553944|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
2553945|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553946|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2553947|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2553948|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
2553949|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553950|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2553951|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2553952|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2553953|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2553954|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2553955|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2553956|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2553957|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
2553958|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2553959|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2553963|NCT01509365|Clopidogrel|clopidogrel|mesh-list
2553964|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2553965|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2553966|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2553967|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2553968|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
2553969|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553970|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553971|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553972|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2553973|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2553974|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
2553975|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553976|NCT01509469|Caseins|caseins|mesh-list
2553977|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
2553978|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
2553979|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418180|NCT00798083|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2553980|NCT01509521|Phenylephrine|phenylephrine|mesh-list
2553981|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
2553982|NCT01509521|Ephedrine|ephedrine|mesh-list
2553983|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
2553984|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2553985|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
2553986|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
2553987|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2553988|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2553989|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
2553990|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2553991|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
2553992|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
2553993|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2553994|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2553995|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2553996|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
2553997|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2553998|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2553999|NCT01509521|Protective Agents|protective agents|mesh-ancestor
2554000|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2554001|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2554002|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2554003|NCT01509560|Everolimus|everolimus|mesh-list
2554004|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554005|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2554006|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
2554007|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554008|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
2554009|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2554010|NCT01509742|Liraglutide|liraglutide|mesh-list
2554011|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2554012|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554013|NCT01509742|Incretins|incretins|mesh-ancestor
2554014|NCT01509742|Hormones|hormones|mesh-ancestor
2554015|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554016|NCT01509755|Liraglutide|liraglutide|mesh-list
2554017|NCT01509755|Glimepiride|glimepiride|mesh-list
2554018|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2554019|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554020|NCT01509755|Incretins|incretins|mesh-ancestor
2554021|NCT01509755|Hormones|hormones|mesh-ancestor
2554022|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554023|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2554024|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2554025|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
2554026|NCT01509911|Gemcitabine|gemcitabine|mesh-list
2554027|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2554028|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
2554029|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554030|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554031|NCT01509911|Antiviral Agents|antiviral agents|mesh-ancestor
2554032|NCT01509911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554033|NCT01509911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554034|NCT01509911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2554035|NCT01509911|Immunologic Factors|immunologic factors|mesh-ancestor
2554036|NCT01509911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554037|NCT01509976|Triclosan|triclosan|mesh-list
2554038|NCT01509976|Triclocarban|triclocarban|mesh-list
2554039|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2554040|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554041|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2554042|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2554043|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
2554044|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554045|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2554046|NCT01510015|Risperidone|risperidone|mesh-list
2554047|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2554048|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
2554049|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554050|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554051|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554052|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2554053|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2554054|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2554055|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2554056|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2554057|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
2418181|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
2554058|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
2554059|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2554060|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554061|NCT01510119|Hydroxychloroquine|hydroxychloroquine|mesh-list
2554062|NCT01510119|Everolimus|everolimus|mesh-list
2554063|NCT01510119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554064|NCT01510119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2554065|NCT01510119|Immunologic Factors|immunologic factors|mesh-ancestor
2554066|NCT01510119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554067|NCT01510119|Antimalarials|antimalarials|mesh-ancestor
2554068|NCT01510119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2554069|NCT01510119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2554070|NCT01510119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554071|NCT01510119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554072|NCT01510119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554073|NCT01510119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2554074|NCT01510132|Timolol|timolol|mesh-list
2554075|NCT01510132|Travoprost|travoprost|mesh-list
2554076|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2554077|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2554078|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
2554079|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554080|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554081|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554082|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2554083|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2554084|NCT01510171|Ticagrelor|ticagrelor|mesh-list
2554085|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2554086|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2554087|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2554088|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2554089|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2554090|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
2554091|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554092|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117366|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
2117367|NCT02657889|Niraparib|niraparib|mesh-list
2117368|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2554093|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554094|NCT01510288|Ipilimumab|ipilimumab|mesh-list
2554095|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2554096|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554097|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2554098|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554099|NCT01510366|Vaccines|vaccines|mesh-list
2554100|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
2117369|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117370|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2117371|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117372|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117373|NCT02657928|Letrozole|letrozole|mesh-list
2117374|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117375|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2117376|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2117377|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117378|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117379|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2117380|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
2117381|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2117382|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117383|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
2117384|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2418182|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
2418183|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2418184|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418185|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
2418186|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418187|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2418188|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2418189|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2554101|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554102|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
2554103|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2554104|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
2554105|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554106|NCT01510509|Everolimus|everolimus|mesh-list
2554107|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554108|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418190|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2418191|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418192|NCT00798083|Analgesics|analgesics|mesh-ancestor
2418193|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2418194|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2418195|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
2418196|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2418197|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2418198|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418199|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2418200|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
2418201|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2418202|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2418203|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2418204|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2418205|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
2418206|NCT00798083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2418207|NCT00798083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2418208|NCT00798148|Carboplatin|carboplatin|mesh-list
2418209|NCT00798148|Etoposide|etoposide|mesh-list
2418210|NCT00798148|Melphalan|melphalan|mesh-list
2418211|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418212|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2418213|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2554109|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
2117385|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117386|NCT02658084|Trastuzumab|trastuzumab|mesh-list
2117387|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2117388|NCT02658084|Vinorelbine|vinorelbine|mesh-list
2117389|NCT02658084|Maytansine|maytansine|mesh-list
2554110|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554111|NCT01510522|Metformin|metformin|mesh-list
2554112|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2554113|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554114|NCT01510548|Adalimumab|adalimumab|mesh-list
2554115|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2554116|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2554117|NCT01510561|Gemcitabine|gemcitabine|mesh-list
2554118|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2554119|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
2554120|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2554121|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
2554122|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554123|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554124|NCT01510561|Antiviral Agents|antiviral agents|mesh-ancestor
2554125|NCT01510561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554126|NCT01510561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554127|NCT01510561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2554128|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
2554129|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554130|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
2554131|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
2554132|NCT01510574|Misoprostol|misoprostol|mesh-list
2554133|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2554134|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
2554135|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2554136|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554137|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2554138|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2554139|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
2554140|NCT01510613|Dexamethasone|dexamethasone|mesh-list
2554141|NCT01510613|Pomalidomide|pomalidomide|mesh-list
2554142|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2554143|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
2554144|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
2554145|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554146|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117390|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2554147|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2554148|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
2554149|NCT01510613|Hormones|hormones|mesh-ancestor
2554150|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554151|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2554152|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554153|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
2554154|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2554155|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2554156|NCT01510613|Growth Substances|growth substances|mesh-ancestor
2554157|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
2554158|NCT01510626|Omalizumab|omalizumab|mesh-list
2554159|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2554160|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2418214|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2418215|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418216|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418217|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2418218|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
2418219|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2418220|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418221|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
2418222|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418223|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
2418224|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2418225|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418226|NCT00798252|Paclitaxel|paclitaxel|mesh-list
2418227|NCT00798252|Docetaxel|docetaxel|mesh-list
2418228|NCT00798252|Doxorubicin|doxorubicin|mesh-list
2418229|NCT00798252|Capecitabine|capecitabine|mesh-list
2418230|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2418231|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418232|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
2554161|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
2554162|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
2554163|NCT01510665|Cathartics|cathartics|mesh-ancestor
2554164|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2554165|NCT01510795|Spironolactone|spironolactone|mesh-list
2554166|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2554167|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
2554168|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554169|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554170|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2554171|NCT01510795|Diuretics|diuretics|mesh-ancestor
2554172|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
2554173|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
2554174|NCT01510847|Androgens|androgens|mesh-ancestor
2554175|NCT01510847|Hormones|hormones|mesh-ancestor
2554176|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554177|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554178|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2554179|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2117391|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117392|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2117393|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
2117394|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
2117395|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
2117396|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117397|NCT02658149|Ketorolac|ketorolac|mesh-list
2117398|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2117399|NCT02658149|Epinephrine|epinephrine|mesh-list
2117400|NCT02658149|Morphine|morphine|mesh-list
2117401|NCT02658149|Ropivacaine|ropivacaine|mesh-list
2117402|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2117403|NCT02658149|Narcotics|narcotics|mesh-ancestor
2117404|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117405|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117406|NCT02658149|Analgesics|analgesics|mesh-ancestor
2117407|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
2117408|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117409|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
2117410|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
2117411|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2117412|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2117413|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
2117414|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2184843|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554180|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2554181|NCT01510977|Bisacodyl|bisacodyl|mesh-list
2554182|NCT01510977|Cathartics|cathartics|mesh-ancestor
2554183|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2554184|NCT01510977|Laxatives|laxatives|mesh-ancestor
2554185|NCT01510990|Gefitinib|gefitinib|mesh-list
2554186|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554187|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2554188|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554189|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554190|NCT01511003|Tacrolimus|tacrolimus|mesh-list
2554191|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2554192|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
2554193|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554194|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2554195|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554196|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554197|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
2554198|NCT01511029|Pramipexole|pramipexole|mesh-list
2554199|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2554200|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554201|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2554202|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2554203|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554204|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554205|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554206|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554207|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
2554208|NCT01511029|Protective Agents|protective agents|mesh-ancestor
2554209|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2554210|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2554211|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
2554212|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
2554213|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554214|NCT01511042|Norepinephrine|norepinephrine|mesh-list
2554215|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
2554216|NCT01511042|Giapreza|giapreza|mesh-list
2554217|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
2554218|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2554219|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2554220|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
2554221|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554222|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554223|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554224|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
2554225|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
2554226|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554227|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2554228|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2554229|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
2554230|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554231|NCT01511146|Gemcitabine|gemcitabine|mesh-list
2554232|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
2554233|NCT01511146|Mitomycins|mitomycins|mesh-list
2554234|NCT01511146|Mitomycin|mitomycin|mesh-list
2554235|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2117415|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117416|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2117417|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2117418|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
2117419|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2554236|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
2554237|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554238|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554239|NCT01511146|Antiviral Agents|antiviral agents|mesh-ancestor
2554240|NCT01511146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554241|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554242|NCT01511146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2554243|NCT01511146|Immunologic Factors|immunologic factors|mesh-ancestor
2554244|NCT01511146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554245|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2554246|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
2554247|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2554248|NCT01511159|Insulin|insulin|mesh-list
2554249|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2554250|NCT01511159|Liraglutide|liraglutide|mesh-list
2554251|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2418233|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
2418234|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
2418235|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418236|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2418237|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2418238|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2418239|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554252|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117420|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
2117421|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
2117422|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
2117423|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2117424|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2117425|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2117426|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2117427|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2554253|NCT01511159|Incretins|incretins|mesh-ancestor
2554254|NCT01511159|Hormones|hormones|mesh-ancestor
2554255|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554256|NCT01511172|Metformin|metformin|mesh-list
2554257|NCT01511172|Liraglutide|liraglutide|mesh-list
2554258|NCT01511172|Glimepiride|glimepiride|mesh-list
2554259|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2554260|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554261|NCT01511172|Incretins|incretins|mesh-ancestor
2554262|NCT01511172|Hormones|hormones|mesh-ancestor
2554263|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554264|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2554265|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2554266|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
2554267|NCT01511185|Liraglutide|liraglutide|mesh-list
2554268|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2554269|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554270|NCT01511185|Incretins|incretins|mesh-ancestor
2554271|NCT01511185|Hormones|hormones|mesh-ancestor
2554272|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554273|NCT01511198|Metformin|metformin|mesh-list
2554274|NCT01511198|Liraglutide|liraglutide|mesh-list
2554275|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2554276|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554277|NCT01511198|Incretins|incretins|mesh-ancestor
2554278|NCT01511198|Hormones|hormones|mesh-ancestor
2554279|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554280|NCT01511211|Dexamethasone|dexamethasone|mesh-list
2554281|NCT01511211|Ropivacaine|ropivacaine|mesh-list
2554282|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2554283|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
2554284|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
2554285|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554286|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117428|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2117429|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117430|NCT02658240|Epinephrine|epinephrine|mesh-list
2117431|NCT02658240|Ropivacaine|ropivacaine|mesh-list
2117432|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
2117433|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
2117434|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117435|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117436|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
2117437|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117438|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2117439|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2117440|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
2117441|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117442|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117443|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2117444|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2117445|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
2117446|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2117447|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
2117448|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
2117449|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
2117450|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2117451|NCT02658461|Trastuzumab|trastuzumab|mesh-list
2117452|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2117453|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117454|NCT02658487|Cytarabine|cytarabine|mesh-list
2418240|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2554287|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2554288|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
2554289|NCT01511211|Hormones|hormones|mesh-ancestor
2554290|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554291|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2117455|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2117456|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
2117457|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418241|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
2418242|NCT00798343|Vaccines|vaccines|mesh-list
2418243|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
2418244|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418245|NCT00798395|Zopiclone|zopiclone|mesh-list
2418246|NCT00798395|Mirtazapine|mirtazapine|mesh-list
2418247|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2418248|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2418249|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418250|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
2117458|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117459|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
2117460|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554292|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554293|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
2554294|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
2554295|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2554296|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
2554297|NCT01511237|Lamivudine|lamivudine|mesh-list
2554298|NCT01511237|Zidovudine|zidovudine|mesh-list
2554299|NCT01511237|Nevirapine|nevirapine|mesh-list
2554300|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2554301|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2554302|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554303|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554304|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
2554305|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554306|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2554307|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2554308|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
2554309|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2117461|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2117462|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
2117463|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117464|NCT02658734|Trastuzumab|trastuzumab|mesh-list
2117465|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2117466|NCT02658734|Maytansine|maytansine|mesh-list
2117467|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2117468|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117469|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2117470|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
2117471|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
2117472|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
2117473|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117474|NCT02659020|Gemcitabine|gemcitabine|mesh-list
2117475|NCT02659020|Docetaxel|docetaxel|mesh-list
2117476|NCT02659020|Olaratumab|olaratumab|mesh-list
2418251|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2554310|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2554311|NCT01511263|Amiodarone|amiodarone|mesh-list
2554312|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2554313|NCT01511263|Diuretics|diuretics|mesh-list
2554314|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
2554315|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554316|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
2554317|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2554318|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2554319|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554320|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2554321|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2554322|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2554323|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554324|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2554325|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2554326|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2554327|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
2554328|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554329|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2554330|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554331|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554332|NCT01511302|Budesonide|budesonide|mesh-list
2554333|NCT01511302|RNS60|rns60|mesh-list
2554334|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2554335|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2554336|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
2554337|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554338|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554339|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2554340|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
2554341|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
2554342|NCT01511302|Hormones|hormones|mesh-ancestor
2554343|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554344|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2554345|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2554346|NCT01511302|Analgesics|analgesics|mesh-ancestor
2554347|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
2554348|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2554349|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2554350|NCT01511367|Fluticasone|fluticasone|mesh-list
2554351|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2554352|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2554353|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
2554354|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554355|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554356|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2554357|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
2554358|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
2554359|NCT01511367|Hormones|hormones|mesh-ancestor
2554360|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554361|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
2554362|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2554363|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
2418252|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2418253|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
2418254|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
2418255|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418256|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418257|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2418258|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2418259|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2418260|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2554364|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2554365|NCT01511471|Ticagrelor|ticagrelor|mesh-list
2554366|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2554367|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2554368|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2554369|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2554370|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
2554371|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554372|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554373|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554374|NCT01511562|Cytarabine|cytarabine|mesh-list
2554375|NCT01511562|Etoposide|etoposide|mesh-list
2554376|NCT01511562|Thiotepa|thiotepa|mesh-list
2554377|NCT01511562|Carmustine|carmustine|mesh-list
2554378|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2554379|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554380|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2554381|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2554382|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554383|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554384|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2554385|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
2554386|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
2554387|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554388|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2554389|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
2554390|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554391|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2554392|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
2418261|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2418262|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
2418263|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2418264|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2418265|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
2418266|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2554393|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2554394|NCT01511627|Anesthetics|anesthetics|mesh-list
2117477|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2117478|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
2117479|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117480|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117481|NCT02659020|Antiviral Agents|antiviral agents|mesh-ancestor
2117482|NCT02659020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2117483|NCT02659020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117484|NCT02659020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2117485|NCT02659020|Immunologic Factors|immunologic factors|mesh-ancestor
2117486|NCT02659020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117487|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
2117488|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
2117489|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
2117490|NCT02659059|Paclitaxel|paclitaxel|mesh-list
2117491|NCT02659059|Cisplatin|cisplatin|mesh-list
2117492|NCT02659059|Carboplatin|carboplatin|mesh-list
2117493|NCT02659059|Nivolumab|nivolumab|mesh-list
2117494|NCT02659059|Pemetrexed|pemetrexed|mesh-list
2117495|NCT02659059|Ipilimumab|ipilimumab|mesh-list
2117496|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2117497|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117498|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
2117499|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
2117500|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
2117501|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117502|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2117503|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2117504|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117505|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2117506|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2117507|NCT02659501|Acetaminophen|acetaminophen|mesh-list
2117508|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2117509|NCT02659501|Epinephrine|epinephrine|mesh-list
2117510|NCT02659501|Diazepam|diazepam|mesh-list
2117511|NCT02659501|Morphine|morphine|mesh-list
2117512|NCT02659501|Hydrocodone|hydrocodone|mesh-list
2117513|NCT02659501|Bupivacaine|bupivacaine|mesh-list
2117514|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
2117515|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
2117516|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117517|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117518|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
2117519|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117520|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2117521|NCT02659501|Narcotics|narcotics|mesh-ancestor
2554395|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2554396|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117522|NCT02659501|Analgesics|analgesics|mesh-ancestor
2117523|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2117524|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
2117525|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2117526|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2117527|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
2117528|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117529|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117530|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2117531|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2117532|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
2418267|NCT00798460|Lamivudine|lamivudine|mesh-list
2418268|NCT00798460|Adefovir|adefovir|mesh-list
2418269|NCT00798460|Clevudine|clevudine|mesh-list
2418270|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2418271|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2418272|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418273|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418274|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
2418275|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418276|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2418277|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2554397|NCT01511692|Liraglutide|liraglutide|mesh-list
2554398|NCT01511692|Glimepiride|glimepiride|mesh-list
2554399|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2554400|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554401|NCT01511692|Incretins|incretins|mesh-ancestor
2554402|NCT01511692|Hormones|hormones|mesh-ancestor
2554403|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554404|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2554405|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2554406|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
2554407|NCT01511705|Ondansetron|ondansetron|mesh-list
2554408|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
2554409|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
2554410|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554411|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554412|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2554413|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
2554414|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
2554415|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2554416|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
2554417|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554418|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554419|NCT01511705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2554420|NCT01511705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2554421|NCT01511705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2554422|NCT01511705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2554423|NCT01511705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2554424|NCT01511718|Ondansetron|ondansetron|mesh-list
2554425|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
2554426|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
2554427|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554428|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554429|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2554430|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
2554431|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
2554432|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2554433|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
2554434|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554435|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554436|NCT01511718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2554437|NCT01511718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2554438|NCT01511718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2554439|NCT01511718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2554440|NCT01511718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2554441|NCT01511731|Famotidine|famotidine|mesh-list
2554442|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2554443|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2554444|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2554445|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
2554446|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
2554447|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554448|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554449|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554450|NCT01511757|Fluconazole|fluconazole|mesh-list
2554451|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
2554452|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554453|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2554454|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2554455|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117533|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2117534|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
2117535|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
2117536|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
2117537|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2117538|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
2117539|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2117540|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
2117541|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
2117542|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2117543|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2117544|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2117545|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2117546|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2117547|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2117548|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2117549|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2554456|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554457|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2554458|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
2554459|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554460|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554461|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2554462|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2554463|NCT01511770|Fluconazole|fluconazole|mesh-list
2554464|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
2554465|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554466|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2554467|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2418278|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
2418279|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2418280|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418281|NCT00798525|Lepirudin|lepirudin|mesh-list
2418282|NCT00798525|Argatroban|argatroban|mesh-list
2418283|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
2554468|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554469|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554470|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2554471|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
2554472|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554473|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554474|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2554475|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2554476|NCT01511822|Inositol|inositol|mesh-list
2554477|NCT01511822|Drospirenone|drospirenone|mesh-list
2554478|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2554479|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2554480|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2554481|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2554482|NCT01511822|Estradiol|estradiol|mesh-list
2554483|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2554484|NCT01511822|Estrogens|estrogens|mesh-ancestor
2554485|NCT01511822|Hormones|hormones|mesh-ancestor
2554486|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554487|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554488|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2554489|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
2554490|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2554491|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2554492|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2554493|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2554494|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
2554495|NCT01511822|Vitamins|vitamins|mesh-ancestor
2554496|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
2554497|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2554498|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
2554499|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2554500|NCT01511822|Diuretics|diuretics|mesh-ancestor
2554501|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
2554502|NCT01511835|Folic Acid|folic acid|mesh-list
2554503|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
2554504|NCT01511835|Inositol|inositol|mesh-list
2554505|NCT01511835|Hematinics|hematinics|mesh-ancestor
2554506|NCT01511835|Vitamins|vitamins|mesh-ancestor
2554507|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
2554508|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554509|NCT01511848|Deferasirox|deferasirox|mesh-list
2554510|NCT01511848|Deferiprone|deferiprone|mesh-list
2554511|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2554512|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
2117550|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
2117551|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
2418284|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2418285|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
2418286|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418287|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418288|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
2418289|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2418290|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2418291|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2418292|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
2418293|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2418294|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2418295|NCT00798616|Prednisolone|prednisolone|mesh-list
2418296|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
2418297|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2418298|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
2418299|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2418300|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
2418301|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
2418302|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418303|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418304|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2418305|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
2418306|NCT00798616|Hormones|hormones|mesh-ancestor
2418307|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2418308|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2418309|NCT00798616|Protective Agents|protective agents|mesh-ancestor
2418310|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2418311|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418312|NCT00798772|Micronutrients|micronutrients|mesh-list
2418313|NCT00798772|Trace Elements|trace elements|mesh-list
2418314|NCT00798772|Antioxidants|antioxidants|mesh-list
2418315|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418316|NCT00798772|Protective Agents|protective agents|mesh-ancestor
2418317|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418318|NCT00798785|Rituximab|rituximab|mesh-list
2418319|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2418320|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418321|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
2418322|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418323|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2418324|NCT00798876|Vitamin E|vitamin e|mesh-list
2117552|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
2117553|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2117554|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2117555|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2117556|NCT02659540|Nivolumab|nivolumab|mesh-list
2117557|NCT02659540|Ipilimumab|ipilimumab|mesh-list
2554513|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
2554514|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554515|NCT01511874|Leuprolide|leuprolide|mesh-list
2554516|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2554517|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
2554518|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2554519|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554520|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2554521|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554522|NCT01511887|Ibuprofen|ibuprofen|mesh-list
2554523|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2554524|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2554525|NCT01511887|Analgesics|analgesics|mesh-ancestor
2554526|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
2554527|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554528|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554529|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2554530|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2554531|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2554532|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554533|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554534|NCT01511991|Sevoflurane|sevoflurane|mesh-list
2554535|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2554536|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2554537|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
2554538|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
2554539|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117558|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2117559|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117560|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2117561|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117562|NCT02659787|Buprenorphine|buprenorphine|mesh-list
2117563|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2117564|NCT02659787|Narcotics|narcotics|mesh-ancestor
2117565|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117566|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117567|NCT02659787|Analgesics|analgesics|mesh-ancestor
2117568|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
2418325|NCT00798876|Vitamins|vitamins|mesh-ancestor
2418326|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
2418327|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418328|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
2418329|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418330|NCT00798876|Protective Agents|protective agents|mesh-ancestor
2418331|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
2418332|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2418333|NCT00798915|Incretins|incretins|mesh-ancestor
2117569|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117570|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2117571|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
2117572|NCT02659943|Fludarabine|fludarabine|mesh-list
2117573|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2117574|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
2117575|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117576|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2117577|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2117578|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
2554540|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554541|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2554542|NCT01512004|Propiverine|propiverine|mesh-list
2554543|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2554544|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2554545|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
2554546|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554547|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554548|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554549|NCT01512004|Urological Agents|urological agents|mesh-ancestor
2554550|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
2554551|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
2554552|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554553|NCT01512017|Petrolatum|petrolatum|mesh-list
2554554|NCT01512017|Emollients|emollients|mesh-ancestor
2554555|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
2554556|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
2554557|NCT01512147|Propofol|propofol|mesh-list
2554558|NCT01512147|Isoflurane|isoflurane|mesh-list
2554559|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2554560|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117579|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117580|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117581|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2117582|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
2117583|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2117584|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2117585|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
2117586|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2554561|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554562|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2554563|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
2554564|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
2554565|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2554566|NCT01512147|Analgesics|analgesics|mesh-ancestor
2554567|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
2554568|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554569|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2554570|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2554571|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2554572|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
2554573|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554574|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554575|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2554576|NCT01512173|Propranolol|propranolol|mesh-list
2554577|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2554578|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2554579|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
2554580|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554581|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554582|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554583|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2554584|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2554585|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
2554586|NCT01512199|Paclitaxel|paclitaxel|mesh-list
2554587|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2554588|NCT01512199|Trastuzumab|trastuzumab|mesh-list
2117587|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2418334|NCT00798915|Hormones|hormones|mesh-ancestor
2117588|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117589|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
2117590|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117591|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117592|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2117593|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117594|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
2117595|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
2117596|NCT02660229|Morphine|morphine|mesh-list
2117597|NCT02660229|Oxycodone|oxycodone|mesh-list
2117598|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2117599|NCT02660229|Narcotics|narcotics|mesh-ancestor
2117600|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117601|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117602|NCT02660229|Analgesics|analgesics|mesh-ancestor
2117603|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
2117604|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117605|NCT02660242|Glucagon|glucagon|mesh-list
2117606|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2117607|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117608|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2117609|NCT02660242|Hormones|hormones|mesh-ancestor
2117610|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2117611|NCT02660242|Incretins|incretins|mesh-ancestor
2117612|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
2117613|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2117614|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2117615|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
2117616|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2117617|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2117618|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117619|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
2117620|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117621|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117622|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2554589|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2554590|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2554591|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554592|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
2554593|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
2554594|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
2554595|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554596|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2554597|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
2554598|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554599|NCT01512316|Cycloserine|cycloserine|mesh-list
2554600|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2554601|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554602|NCT01512316|Renal Agents|renal agents|mesh-ancestor
2554603|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2554604|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
2554605|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2554606|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
2554607|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554608|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
2554609|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2554610|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2554611|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117623|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117624|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
2117625|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
2117626|NCT02660580|Adalimumab|adalimumab|mesh-list
2117627|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2554612|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2554613|NCT01512355|Analgesics|analgesics|mesh-ancestor
2554614|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
2554615|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554616|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2554617|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2554618|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2554619|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
2554620|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554621|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117628|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2554622|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
2554623|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554624|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2554625|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2554626|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2554627|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2554628|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554629|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554630|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554631|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2554632|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
2554633|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2554634|NCT01512485|Clopidogrel|clopidogrel|mesh-list
2554635|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2554636|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2554637|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2554638|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2554639|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
2554640|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554641|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554642|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554643|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
2554644|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2554645|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
2554646|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
2554647|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2554648|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554649|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2554650|NCT01512511|Analgesics|analgesics|mesh-ancestor
2554651|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
2554652|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554653|NCT01512537|Vitamin D|vitamin d|mesh-list
2554654|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
2554655|NCT01512537|Vitamins|vitamins|mesh-list
2554656|NCT01512537|Calcium|calcium|mesh-list
2554657|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
2554658|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554659|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2554660|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2554661|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2554662|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
2554663|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
2554664|NCT01512680|Insulin|insulin|mesh-list
2554665|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2554666|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554667|NCT01512784|Vaccines|vaccines|mesh-list
2117632|NCT02660918|Bupivacaine|bupivacaine|mesh-list
2117633|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
2117634|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
2117635|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117636|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117637|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
2117638|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117639|NCT02660983|Donepezil|donepezil|mesh-list
2117640|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2117641|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117642|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117643|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
2117644|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117645|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117646|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
2117647|NCT02661061|Midazolam|midazolam|mesh-list
2117648|NCT02661061|Ketamine|ketamine|mesh-list
2117649|NCT02661061|Analgesics|analgesics|mesh-ancestor
2117650|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
2117651|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117652|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117653|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2117654|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2117655|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
2117656|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
2117657|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117658|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2117659|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2117660|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117661|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117662|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2117663|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2117664|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2554668|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
2554669|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554670|NCT01512862|Calcitriol|calcitriol|mesh-list
2554671|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2117665|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2117666|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2117667|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
2117668|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
2117669|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
2117670|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
2117671|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2117672|NCT02661178|Emodepside|emodepside|mesh-list
2117673|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2117674|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2117675|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2554672|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554673|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2554674|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2554675|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554676|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2554677|NCT01512862|Vitamins|vitamins|mesh-ancestor
2554678|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
2554679|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2554689|NCT01512901|Betamethasone|betamethasone|mesh-list
2554690|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
2554691|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2554692|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
2554693|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2554694|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2554695|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
2554696|NCT01512901|Hormones|hormones|mesh-ancestor
2554697|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554698|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554699|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2554700|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
2554701|NCT01512914|Ropivacaine|ropivacaine|mesh-list
2554702|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
2554703|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
2554704|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2554705|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554706|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
2117676|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2117677|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117678|NCT02661490|Vaccines|vaccines|mesh-list
2117679|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
2117680|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117681|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
2117682|NCT02661594|Amisulpride|amisulpride|mesh-list
2117683|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2117684|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2117685|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2117686|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2117687|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117688|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117689|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117690|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117691|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2554707|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554708|NCT01512953|Lansoprazole|lansoprazole|mesh-list
2554709|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
2554710|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2554711|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2554712|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2554713|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554714|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554715|NCT01512966|Aflibercept|aflibercept|mesh-list
2554716|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2554717|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2554718|NCT01512966|Growth Substances|growth substances|mesh-ancestor
2554719|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554720|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
2554721|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554722|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
2554723|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2554724|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554725|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2554726|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
2554727|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2554728|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554729|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554730|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554731|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
2554732|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2554733|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554734|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2554735|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
2554736|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2554737|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554738|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554739|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554740|NCT01513070|Aspirin|aspirin|mesh-list
2554741|NCT01513070|Isosorbide|isosorbide|mesh-list
2554742|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2554743|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2554744|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2554745|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2554746|NCT01513070|Analgesics|analgesics|mesh-ancestor
2554747|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
2554748|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554749|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554750|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2554751|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2554752|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2554753|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2554754|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554755|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2554756|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2554757|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554758|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
2554759|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2554760|NCT01513070|Diuretics|diuretics|mesh-ancestor
2554761|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
2554762|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
2554763|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2554764|NCT01513083|Trastuzumab|trastuzumab|mesh-list
2554765|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2554766|NCT01513083|Maytansine|maytansine|mesh-list
2554767|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2554768|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554769|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2117692|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2117693|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117694|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2117695|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2117696|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
2117697|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117698|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2117699|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
2117700|NCT02661815|Paclitaxel|paclitaxel|mesh-list
2117701|NCT02661815|Bevacizumab|bevacizumab|mesh-list
2117702|NCT02661815|Ricolinostat|ricolinostat|mesh-list
2117703|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2117704|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117705|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
2554770|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
2554771|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
2554772|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
2554773|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554774|NCT01513174|Olaparib|olaparib|mesh-list
2554775|NCT01513174|Gefitinib|gefitinib|mesh-list
2554776|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2554777|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554778|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554779|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554780|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2554781|NCT01513187|Interferons|interferons|mesh-list
2554782|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
2554783|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
2554784|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554785|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
2554786|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554787|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
2554788|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554789|NCT01513200|Heparin|heparin|mesh-list
2554790|NCT01513200|Calcium heparin|calcium heparin|mesh-list
2554791|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
2554792|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2554793|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2554794|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554795|NCT01513499|Oxytocin|oxytocin|mesh-list
2554796|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
2554797|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2554798|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554799|NCT01513525|Liraglutide|liraglutide|mesh-list
2554800|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2554801|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554802|NCT01513525|Incretins|incretins|mesh-ancestor
2554803|NCT01513525|Hormones|hormones|mesh-ancestor
2554804|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2554805|NCT01513564|Morphine|morphine|mesh-list
2554806|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2554807|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554808|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2554809|NCT01513564|Narcotics|narcotics|mesh-ancestor
2554810|NCT01513564|Analgesics|analgesics|mesh-ancestor
2554811|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
2554812|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554813|NCT01513603|Cytarabine|cytarabine|mesh-list
2554814|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
2554815|NCT01513603|Cladribine|cladribine|mesh-list
2554816|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2554817|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
2554818|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554819|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554820|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
2554821|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554822|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2554823|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
2554824|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554825|NCT01513603|Analgesics|analgesics|mesh-ancestor
2554826|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
2554827|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554828|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2554829|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2554830|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554831|NCT01513668|Acetaminophen|acetaminophen|mesh-list
2554832|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2554833|NCT01513668|Analgesics|analgesics|mesh-ancestor
2554834|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
2554835|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554836|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117706|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
2117707|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
2117708|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117709|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2117710|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2117711|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2117712|NCT02661815|Growth Substances|growth substances|mesh-ancestor
2554837|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
2554838|NCT01513681|Lamotrigine|lamotrigine|mesh-list
2554839|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
2117713|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117714|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
2117715|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2117716|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554840|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2554841|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2554842|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554843|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2554844|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554845|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2554846|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2554847|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2554848|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2554849|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2554850|NCT01513720|Lamotrigine|lamotrigine|mesh-list
2554851|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
2554852|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2554853|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2554854|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554855|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2554856|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117717|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
2117718|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2117719|NCT02662036|Bupivacaine|bupivacaine|mesh-list
2117720|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
2117721|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
2117722|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117723|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117724|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
2117725|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117726|NCT02662556|Sufentanil|sufentanil|mesh-list
2117727|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2117728|NCT02662556|Narcotics|narcotics|mesh-ancestor
2117729|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117730|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117731|NCT02662556|Analgesics|analgesics|mesh-ancestor
2117732|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
2117733|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554857|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2554858|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2554859|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2554860|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2554861|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2554862|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
2554863|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2554864|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2554865|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117734|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2117735|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2117736|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
2117737|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
2117738|NCT02662569|Atorvastatin|atorvastatin|mesh-list
2117739|NCT02662569|Evolocumab|evolocumab|mesh-list
2117740|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2117741|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2117742|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
2117743|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117744|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2117745|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2117746|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554866|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2554867|NCT01513772|Analgesics|analgesics|mesh-ancestor
2117747|NCT02662764|Sufentanil|sufentanil|mesh-list
2117748|NCT02662764|Dsuvia|dsuvia|mesh-list
2117749|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2117750|NCT02662764|Narcotics|narcotics|mesh-ancestor
2117751|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117752|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117753|NCT02662764|Analgesics|analgesics|mesh-ancestor
2117754|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
2117755|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117756|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2117757|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2117758|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
2117759|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
2554868|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
2554869|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554870|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2554871|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2554872|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2554873|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
2554874|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554875|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554876|NCT01513785|Amoxicillin|amoxicillin|mesh-list
2554877|NCT01513785|Rabeprazole|rabeprazole|mesh-list
2554878|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2554879|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554880|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2554881|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2554882|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2554883|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554884|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554885|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2554886|NCT01513863|Metronidazole|metronidazole|mesh-list
2554887|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2117760|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2117761|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2117762|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2117763|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2554888|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2554889|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2554890|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2554891|NCT01513941|Interferons|interferons|mesh-list
2554892|NCT01513941|Ribavirin|ribavirin|mesh-list
2554893|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
2554894|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
2554895|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2554896|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554897|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
2554898|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554899|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
2554900|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554901|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
2554902|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554903|NCT01514019|Acebutolol|acebutolol|mesh-list
2554904|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2554905|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2554906|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
2554907|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
2554908|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554909|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554910|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2554911|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2554912|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2554913|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
2554914|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2554915|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554916|NCT01514110|Paclitaxel|paclitaxel|mesh-list
2117782|NCT02663674|Fluconazole|fluconazole|mesh-list
2117783|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
2117784|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2554917|NCT01514110|Carboplatin|carboplatin|mesh-list
2554918|NCT01514110|Everolimus|everolimus|mesh-list
2117785|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2117786|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2117787|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117788|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117789|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2117790|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
2117791|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2117792|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117793|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2554919|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2554920|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554921|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
2554922|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
2554923|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
2554924|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554925|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2554926|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
2418335|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2418336|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418337|NCT00798954|Sirolimus|sirolimus|mesh-list
2418338|NCT00798954|Paclitaxel|paclitaxel|mesh-list
2418339|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2418340|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117794|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2117795|NCT02663687|Complement C1s|complement c1s|mesh-list
2117796|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2117797|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2117798|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
2117799|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117800|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2117801|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2117802|NCT02663895|Treprostinil|treprostinil|mesh-list
2117803|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2117814|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
2117815|NCT02664220|Povidone|povidone|mesh-list
2117816|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
2117817|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
2117818|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2117819|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2117820|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
2117821|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2117822|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2117823|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117824|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
2117825|NCT02664909|Coagulants|coagulants|mesh-ancestor
2117826|NCT02664922|Ketamine|ketamine|mesh-list
2117827|NCT02664922|Remifentanil|remifentanil|mesh-list
2117828|NCT02664922|Propofol|propofol|mesh-list
2117829|NCT02664922|Sevoflurane|sevoflurane|mesh-list
2117830|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2117831|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117832|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117833|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2117834|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
2418341|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
2418342|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
2418343|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
2418344|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418345|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2418346|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418347|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2418348|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
2418349|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2117835|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
2117836|NCT02664922|Analgesics|analgesics|mesh-ancestor
2117837|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
2117838|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117839|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2117840|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2117841|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2117842|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117843|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117844|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2554927|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554928|NCT01514123|Bevacizumab|bevacizumab|mesh-list
2554929|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2554930|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554931|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2554932|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2554933|NCT01514123|Growth Substances|growth substances|mesh-ancestor
2554934|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554935|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
2554936|NCT01514175|Ibuprofen|ibuprofen|mesh-list
2554937|NCT01514175|Ketorolac|ketorolac|mesh-list
2554938|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2554939|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2418350|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
2418351|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418352|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
2418353|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2418354|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
2418355|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2418356|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418357|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2418358|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2418359|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2418360|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
2418361|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2418362|NCT00798993|Calcifediol|calcifediol|mesh-list
2418363|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2418364|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418365|NCT00798993|Vitamins|vitamins|mesh-ancestor
2418366|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
2418367|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2554940|NCT01514175|Analgesics|analgesics|mesh-ancestor
2554941|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
2554942|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554943|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554944|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2554945|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2554946|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2554947|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554948|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554949|NCT01514188|Doxorubicin|doxorubicin|mesh-list
2554950|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2554951|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117845|NCT02664922|Narcotics|narcotics|mesh-ancestor
2117846|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2117847|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2117848|NCT02664961|Bevacizumab|bevacizumab|mesh-list
2117849|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2117850|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117851|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2117852|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2554952|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2554953|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2554954|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554955|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554956|NCT01514227|Aspirin|aspirin|mesh-list
2554957|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2554958|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2554959|NCT01514227|Analgesics|analgesics|mesh-ancestor
2554960|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
2117853|NCT02664961|Growth Substances|growth substances|mesh-ancestor
2117854|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117855|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
2554961|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554962|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554963|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2554964|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2554965|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2554966|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2554967|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554968|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2554969|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2554970|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2554971|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
2554972|NCT01514266|Curcumin|curcumin|mesh-list
2554973|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2554974|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2117856|NCT02665260|Cantharidin|cantharidin|mesh-list
2117857|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117858|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117859|NCT02665273|Bupivacaine|bupivacaine|mesh-list
2117860|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
2117861|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
2117862|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2117863|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117864|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
2117865|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117866|NCT02665286|Naproxen|naproxen|mesh-list
2117867|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2117868|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2554975|NCT01514266|Analgesics|analgesics|mesh-ancestor
2554976|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
2554977|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2554978|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554979|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2554980|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2554981|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554982|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117869|NCT02665286|Orphenadrine|orphenadrine|mesh-list
2117870|NCT02665286|Methocarbamol|methocarbamol|mesh-list
2117871|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2117872|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2117873|NCT02665286|Analgesics|analgesics|mesh-ancestor
2117874|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
2117875|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117876|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117877|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2117878|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
2117879|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2117880|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117881|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117882|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
2117883|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2117884|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2117885|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2117886|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2117887|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2117888|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
2117889|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
2117890|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2117891|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
2117892|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2117893|NCT02665689|Ranibizumab|ranibizumab|mesh-list
2117894|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2117895|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2117896|NCT02665689|Growth Substances|growth substances|mesh-ancestor
2554983|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2554984|NCT01514344|Rituximab|rituximab|mesh-list
2554985|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2554986|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2554987|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
2554988|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554989|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2554990|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
2554991|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2554992|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
2554993|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2554994|NCT01514487|Liraglutide|liraglutide|mesh-list
2554995|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2117897|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117898|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
2117899|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117900|NCT02665728|Laxatives|laxatives|mesh-list
2117901|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2117902|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
2117903|NCT02666352|Ruzasvir|ruzasvir|mesh-list
2117904|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
2117905|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2117906|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
2554996|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2554997|NCT01514487|Incretins|incretins|mesh-ancestor
2554998|NCT01514487|Hormones|hormones|mesh-ancestor
2554999|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555000|NCT01514695|Fentanyl|fentanyl|mesh-list
2555001|NCT01514695|Midazolam|midazolam|mesh-list
2555002|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2555003|NCT01514695|Narcotics|narcotics|mesh-ancestor
2555004|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2555005|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117907|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2117908|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117909|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2117910|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2117911|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
2117912|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117913|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2117914|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117915|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2117916|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117917|NCT02666742|Aspirin|aspirin|mesh-list
2117918|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
2117919|NCT02666742|Edoxaban|edoxaban|mesh-list
2117920|NCT02666742|Dabigatran|dabigatran|mesh-list
2117921|NCT02666742|Anticoagulants|anticoagulants|mesh-list
2117922|NCT02666742|Coagulants|coagulants|mesh-list
2117923|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2117924|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2117925|NCT02666742|Analgesics|analgesics|mesh-ancestor
2117926|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
2117927|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117928|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117929|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2117930|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2117931|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2117932|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2117933|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117934|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2117935|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2117936|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117937|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
2117938|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2117939|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
2117940|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2117941|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
2117942|NCT02666846|Ibuprofen|ibuprofen|mesh-list
2117943|NCT02666846|Diclofenac|diclofenac|mesh-list
2117944|NCT02666846|Salicylates|salicylates|mesh-list
2117945|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
2117946|NCT02666846|Menthol|menthol|mesh-list
2555006|NCT01514695|Analgesics|analgesics|mesh-ancestor
2555007|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
2555008|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555009|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2555010|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2555011|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
2555012|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
2555013|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2117947|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2117948|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2117949|NCT02666846|Analgesics|analgesics|mesh-ancestor
2117950|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
2117951|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2117952|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117953|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2117954|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2117955|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2555014|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2555015|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2555016|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2555017|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
2555018|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
2555019|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2555020|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555021|NCT01514721|Timolol|timolol|mesh-list
2555022|NCT01514721|Travoprost|travoprost|mesh-list
2555023|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2555024|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2555025|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
2555026|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2555027|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555028|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555029|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2555030|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2117956|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117957|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117958|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
2117959|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
2117960|NCT02666950|Cytarabine|cytarabine|mesh-list
2117961|NCT02666950|Adavosertib|adavosertib|mesh-list
2117962|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2117963|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
2117964|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117965|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117966|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
2117967|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2117968|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2117969|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
2117970|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2117971|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117972|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2117973|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2117974|NCT02667704|Nintedanib|nintedanib|mesh-list
2117975|NCT02667704|Bosentan|bosentan|mesh-list
2117976|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117977|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2117978|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2117979|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117980|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2117981|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2117982|NCT02668393|Docetaxel|docetaxel|mesh-list
2117983|NCT02668393|Nintedanib|nintedanib|mesh-list
2117984|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2117985|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
2117986|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
2117987|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
2117988|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117989|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2117990|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555031|NCT01514812|Digoxin|digoxin|mesh-list
2555032|NCT01514812|Darexaban|darexaban|mesh-list
2555033|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2555034|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2555035|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555036|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555037|NCT01514812|Protective Agents|protective agents|mesh-ancestor
2555038|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555039|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2555040|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
2555041|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2555042|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
2555043|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
2555044|NCT01514825|Darexaban|darexaban|mesh-list
2555045|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2555046|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
2555047|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2555048|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
2555049|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555050|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555051|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
2555052|NCT01514838|Acarbose|acarbose|mesh-list
2555053|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
2555054|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2555055|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555056|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555057|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555058|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555059|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2555060|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
2555061|NCT01514851|Calcium|calcium|mesh-list
2555062|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2555063|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555064|NCT01514851|Antacids|antacids|mesh-ancestor
2555065|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555066|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2555067|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
2555068|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
2555069|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2555070|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2555071|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555072|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555073|NCT01514903|Urological Agents|urological agents|mesh-ancestor
2555074|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
2555075|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2555076|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555077|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2555078|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2555079|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555080|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117991|NCT02668432|Amiodarone|amiodarone|mesh-list
2117992|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2117993|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
2117994|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2117995|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2117996|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2117997|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2117998|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2117999|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2118000|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118001|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2118002|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2118003|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2118004|NCT02668640|Adalimumab|adalimumab|mesh-list
2118005|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2118006|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2118007|NCT02668783|Ibuprofen|ibuprofen|mesh-list
2118008|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2118009|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2118010|NCT02668783|Etonogestrel|etonogestrel|mesh-list
2118011|NCT02668783|Estradiol|estradiol|mesh-list
2118012|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2118013|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2118014|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2118015|NCT02668783|Analgesics|analgesics|mesh-ancestor
2118016|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
2118017|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118018|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118019|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2118020|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2118021|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2118022|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118023|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118024|NCT02668783|Estrogens|estrogens|mesh-ancestor
2555081|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555082|NCT01514942|Folic Acid|folic acid|mesh-list
2555083|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
2555084|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
2555085|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
2555086|NCT01514942|Inositol|inositol|mesh-list
2555087|NCT01514942|Manganese|manganese|mesh-list
2555088|NCT01514942|Hematinics|hematinics|mesh-ancestor
2555089|NCT01514942|Vitamins|vitamins|mesh-ancestor
2555090|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
2555091|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555092|NCT01514942|Trace Elements|trace elements|mesh-ancestor
2555093|NCT01514968|Cyclosporine|cyclosporine|mesh-list
2555094|NCT01514968|Ritonavir|ritonavir|mesh-list
2555095|NCT01514968|Cyclosporins|cyclosporins|mesh-list
2555096|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555097|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555098|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2118025|NCT02668783|Hormones|hormones|mesh-ancestor
2118026|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118027|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2118028|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
2118029|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2118030|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2118031|NCT02668822|Ibuprofen|ibuprofen|mesh-list
2118032|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2118033|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2118034|NCT02668822|Analgesics|analgesics|mesh-ancestor
2118035|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
2118036|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118037|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118038|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2118039|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2118040|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2118041|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118042|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118043|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
2555099|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
2555100|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555101|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
2118044|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2118045|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118046|NCT02669043|Ketamine|ketamine|mesh-list
2118047|NCT02669043|Analgesics|analgesics|mesh-ancestor
2118048|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
2118049|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118050|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118051|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2118052|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2118053|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
2118054|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
2118055|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118056|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2118057|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2118058|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118059|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118060|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
2118061|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2118062|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118063|NCT02669407|Lidocaine|lidocaine|mesh-list
2118064|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
2118065|NCT02669407|Anesthetics|anesthetics|mesh-list
2118066|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118067|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555102|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555103|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
2555104|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2555105|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2555106|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2555107|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2555108|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
2555109|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2555110|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2555111|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
2555112|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2555113|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2555114|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
2555115|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555116|NCT01515007|Ciprofloxacin|ciprofloxacin|mesh-list
2555117|NCT01515007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2555118|NCT01515007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555119|NCT01515007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2555120|NCT01515007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2555121|NCT01515007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555122|NCT01515007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555123|NCT01515007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555124|NCT01515007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2555125|NCT01515007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2555126|NCT01515020|Vancomycin|vancomycin|mesh-list
2555127|NCT01515020|Daptomycin|daptomycin|mesh-list
2555128|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2555129|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2118068|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
2118069|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118070|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2118071|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2118072|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2118073|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2118074|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555130|NCT01515137|Sulindac|sulindac|mesh-list
2555131|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2555132|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555133|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2555134|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555135|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555136|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2555137|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2555138|NCT01515137|Analgesics|analgesics|mesh-ancestor
2555139|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
2555140|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555141|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555142|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2555143|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2555144|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2555145|NCT01515228|Paclitaxel|paclitaxel|mesh-list
2555146|NCT01515228|Everolimus|everolimus|mesh-list
2555147|NCT01515228|Cilostazol|cilostazol|mesh-list
2555148|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2555149|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555150|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
2555151|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
2555152|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
2555153|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555154|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2555155|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
2555156|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555157|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2555158|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
2555159|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555160|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2555161|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
2555162|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2555163|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2555164|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2555165|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
2555166|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2555167|NCT01515228|Protective Agents|protective agents|mesh-ancestor
2555168|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2555169|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2555170|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555171|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2118075|NCT02669615|Melphalan|melphalan|mesh-list
2118076|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2118077|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
2118078|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118079|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118080|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2555172|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2555173|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555174|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555175|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2555176|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2555177|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555178|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
2555179|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118081|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2118082|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
2118083|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118084|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2118085|NCT02669914|Durvalumab|durvalumab|mesh-list
2118086|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2118087|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118088|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
2118089|NCT02670343|Testosterone|testosterone|mesh-list
2118090|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
2555180|NCT01515397|Polygeline|polygeline|mesh-list
2555181|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
2555182|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
2555183|NCT01515553|Liraglutide|liraglutide|mesh-list
2118091|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
2118092|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2118093|NCT02670343|Androgens|androgens|mesh-ancestor
2118094|NCT02670343|Hormones|hormones|mesh-ancestor
2118095|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118096|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118097|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2118098|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118099|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
2118100|NCT02670538|Cariprazine|cariprazine|mesh-list
2118101|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2118102|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2118103|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118104|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118105|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2118106|NCT02670551|Cariprazine|cariprazine|mesh-list
2555184|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555185|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555186|NCT01515553|Incretins|incretins|mesh-ancestor
2555187|NCT01515553|Hormones|hormones|mesh-ancestor
2555188|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555189|NCT01515579|Liraglutide|liraglutide|mesh-list
2555190|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555191|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555192|NCT01515579|Incretins|incretins|mesh-ancestor
2555193|NCT01515579|Hormones|hormones|mesh-ancestor
2555194|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555195|NCT01515592|Liraglutide|liraglutide|mesh-list
2555196|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555197|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555198|NCT01515592|Incretins|incretins|mesh-ancestor
2555199|NCT01515592|Hormones|hormones|mesh-ancestor
2555200|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555201|NCT01515683|Anesthetics|anesthetics|mesh-list
2555202|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2555203|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555204|NCT01515774|Pramipexole|pramipexole|mesh-list
2555205|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
2555206|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555207|NCT01515774|Protective Agents|protective agents|mesh-ancestor
2555208|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555209|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2555210|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2555211|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
2118107|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2118108|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2118109|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118110|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118111|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2118112|NCT02670915|Insulin|insulin|mesh-list
2118113|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2118114|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
2118115|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
2118116|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2118117|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2118118|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118119|NCT02671266|Oxytocin|oxytocin|mesh-list
2118120|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
2118121|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2118122|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118123|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
2118124|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2118125|NCT02671500|Velpatasvir|velpatasvir|mesh-list
2118126|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
2118127|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2118128|NCT02672111|Buprenorphine|buprenorphine|mesh-list
2118129|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2118130|NCT02672111|Narcotics|narcotics|mesh-ancestor
2118131|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118132|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118133|NCT02672111|Analgesics|analgesics|mesh-ancestor
2118134|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
2555212|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
2555213|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2555214|NCT01515813|Tenofovir|tenofovir|mesh-list
2555215|NCT01515813|Emtricitabine|emtricitabine|mesh-list
2555216|NCT01515813|Efavirenz|efavirenz|mesh-list
2555217|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2555218|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2555219|NCT01515813|Pravastatin|pravastatin|mesh-list
2555220|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
2555221|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555222|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2555223|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2555224|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555225|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555226|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2555227|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2555228|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2555229|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2555230|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2555231|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2555232|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2555233|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2555234|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2555235|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2555236|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
2555237|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2555238|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2555239|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
2555240|NCT01515826|Dexamethasone|dexamethasone|mesh-list
2555241|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
2555242|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2555243|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2555244|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2555245|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2555246|NCT01515826|BB 1101|bb 1101|mesh-list
2555247|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2555248|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
2555249|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
2555250|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118135|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118136|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2118137|NCT02673138|Canagliflozin|canagliflozin|mesh-list
2118138|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2118139|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118140|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2118141|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118142|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
2118143|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2118144|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118145|NCT02673372|Morphine|morphine|mesh-list
2118146|NCT02673372|Ketamine|ketamine|mesh-list
2118147|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2118148|NCT02673372|Narcotics|narcotics|mesh-ancestor
2118149|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118150|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118151|NCT02673372|Analgesics|analgesics|mesh-ancestor
2118152|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
2118153|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118154|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2118155|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2118156|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
2118157|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
2118158|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2118159|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2118160|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118161|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118162|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
2118163|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2118164|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118165|NCT02674399|Hylan|hylan|mesh-list
2118166|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
2118167|NCT02674399|Protective Agents|protective agents|mesh-ancestor
2118168|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118169|NCT02674412|Buspirone|buspirone|mesh-list
2118170|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2118171|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2118172|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118173|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118174|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2118175|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2118176|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
2118177|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118178|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118179|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2118180|NCT02674854|Latanoprost|latanoprost|mesh-list
2118181|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2118182|NCT02675231|Trastuzumab|trastuzumab|mesh-list
2118183|NCT02675231|Fulvestrant|fulvestrant|mesh-list
2118184|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2118185|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118186|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2118187|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2118188|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2118189|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
2118190|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555251|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555252|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2555253|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
2555254|NCT01515826|Hormones|hormones|mesh-ancestor
2555255|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555256|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2555257|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118191|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118192|NCT02675426|Upadacitinib|upadacitinib|mesh-list
2118193|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2118194|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2118195|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118196|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118197|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2118198|NCT02675907|Meloxicam|meloxicam|mesh-list
2118199|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2555258|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
2555259|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555260|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555261|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2118200|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2118201|NCT02675907|Analgesics|analgesics|mesh-ancestor
2118202|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
2118203|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118204|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118205|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2118206|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2118207|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2118208|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2555262|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555263|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2555264|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2555265|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2555266|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
2555267|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2555268|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2555269|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2555270|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2555271|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
2555272|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
2555273|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
2555274|NCT01515839|Vinpocetine|vinpocetine|mesh-list
2555275|NCT01515839|Huperzine A|huperzine a|mesh-list
2555276|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
2555277|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555278|NCT01515839|Protective Agents|protective agents|mesh-ancestor
2555279|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555280|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
2555281|NCT01515839|Vitamins|vitamins|mesh-ancestor
2555282|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
2118209|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184844|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555283|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
2555284|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2118210|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118211|NCT02676375|Bupropion|bupropion|mesh-list
2118212|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2118213|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
2418368|NCT00799045|Clopidogrel|clopidogrel|mesh-list
2418369|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2418370|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2418371|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2418372|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2418373|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
2418374|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118214|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2118215|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2118216|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2118217|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2555285|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555286|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
2555287|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2555288|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2555289|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
2555290|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555291|NCT01515839|Expectorants|expectorants|mesh-ancestor
2555292|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
2555293|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2555294|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2118218|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118219|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
2118220|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118221|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118222|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2118223|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2118224|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118225|NCT02676466|Losartan|losartan|mesh-list
2118226|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2118227|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2118228|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2118229|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2118230|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118231|NCT02676895|Vaccines|vaccines|mesh-list
2555295|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
2118232|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
2118233|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118234|NCT02677116|Doxorubicin|doxorubicin|mesh-list
2118235|NCT02677116|Irinotecan|irinotecan|mesh-list
2118236|NCT02677116|Vincristine|vincristine|mesh-list
2118237|NCT02677116|Ifosfamide|ifosfamide|mesh-list
2118238|NCT02677116|Olaratumab|olaratumab|mesh-list
2118239|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2118240|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118241|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2118242|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2118243|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118244|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118245|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2118246|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2118247|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
2118248|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
2118249|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
2118250|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2118251|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
2118252|NCT02677324|Venetoclax|venetoclax|mesh-list
2118253|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118254|NCT02677493|Vaccines|vaccines|mesh-list
2118255|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
2118256|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118257|NCT02677623|Mannitol|mannitol|mesh-list
2118258|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2118259|NCT02677623|Diuretics|diuretics|mesh-ancestor
2418375|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418376|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418377|NCT00799058|Dapivirine|dapivirine|mesh-list
2418378|NCT00799058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2418379|NCT00799058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2418380|NCT00799058|Antiviral Agents|antiviral agents|mesh-ancestor
2118260|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
2118261|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118262|NCT02677701|Azithromycin|azithromycin|mesh-list
2118263|NCT02677701|Tobramycin|tobramycin|mesh-list
2118264|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2118265|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2118266|NCT02677844|Loperamide|loperamide|mesh-list
2118267|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
2118268|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2118269|NCT02678286|Meloxicam|meloxicam|mesh-list
2118270|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2118271|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2118272|NCT02678286|Analgesics|analgesics|mesh-ancestor
2118273|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
2118274|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118275|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118276|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2118277|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2118278|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2118279|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2118280|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118281|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118282|NCT02678416|Acetaminophen|acetaminophen|mesh-list
2118283|NCT02678416|Morphine|morphine|mesh-list
2555296|NCT01515852|Anesthetics|anesthetics|mesh-list
2555297|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2555298|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555299|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2555300|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
2555301|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2555302|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555303|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2555304|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555305|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555306|NCT01516060|Efavirenz|efavirenz|mesh-list
2555307|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2555308|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2555309|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555310|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555311|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
2555312|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555313|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2555314|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2555315|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2555316|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2118284|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2118285|NCT02678416|Narcotics|narcotics|mesh-ancestor
2118286|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118287|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118288|NCT02678416|Analgesics|analgesics|mesh-ancestor
2118289|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
2555317|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2555318|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2555319|NCT01516073|Fluticasone|fluticasone|mesh-list
2555320|NCT01516073|Xhance|xhance|mesh-list
2555321|NCT01516073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2555322|NCT01516073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2555323|NCT01516073|Autonomic Agents|autonomic agents|mesh-ancestor
2555324|NCT01516073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555325|NCT01516073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555326|NCT01516073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2555327|NCT01516073|Respiratory System Agents|respiratory system agents|mesh-ancestor
2555328|NCT01516073|Dermatologic Agents|dermatologic agents|mesh-ancestor
2555329|NCT01516073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2555330|NCT01516086|Fluticasone|fluticasone|mesh-list
2555331|NCT01516086|Xhance|xhance|mesh-list
2555332|NCT01516086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2555333|NCT01516086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2555334|NCT01516086|Autonomic Agents|autonomic agents|mesh-ancestor
2555335|NCT01516086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118290|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118291|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2118292|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
2118293|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
2118294|NCT02679274|Testosterone|testosterone|mesh-list
2118295|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
2118296|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
2118297|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2118298|NCT02679274|Androgens|androgens|mesh-ancestor
2118299|NCT02679274|Hormones|hormones|mesh-ancestor
2118300|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118301|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118302|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2118303|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118304|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
2118305|NCT02679469|Nalmefene|nalmefene|mesh-list
2118306|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2118307|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555336|NCT01516086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555337|NCT01516086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2555338|NCT01516086|Respiratory System Agents|respiratory system agents|mesh-ancestor
2555339|NCT01516086|Dermatologic Agents|dermatologic agents|mesh-ancestor
2555340|NCT01516086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2555341|NCT01516138|Insulin|insulin|mesh-list
2118308|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
2118309|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118310|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
2118311|NCT02679573|Linezolid|linezolid|mesh-list
2118312|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2118313|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2118314|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2118315|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2118316|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118317|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118318|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118319|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2118320|NCT02679755|Letrozole|letrozole|mesh-list
2118321|NCT02679755|Palbociclib|palbociclib|mesh-list
2118322|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118323|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2118324|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2118325|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118326|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118327|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2118328|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
2555342|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555343|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555344|NCT01516203|Rifampin|rifampin|mesh-list
2555345|NCT01516203|Isoniazid|isoniazid|mesh-list
2555346|NCT01516203|Pyrazinamide|pyrazinamide|mesh-list
2555347|NCT01516203|Ethambutol|ethambutol|mesh-list
2118329|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118330|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118331|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2118332|NCT02679911|Amorolfine|amorolfine|mesh-list
2118333|NCT02679911|Ciclopirox|ciclopirox|mesh-list
2118334|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
2118335|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555348|NCT01516203|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2555349|NCT01516203|Antitubercular Agents|antitubercular agents|mesh-ancestor
2555350|NCT01516203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2118336|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
2118337|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2118338|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
2118339|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118340|NCT02680054|Insulin|insulin|mesh-list
2118341|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
2118342|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2118343|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118344|NCT02680301|Triamcinolone|triamcinolone|mesh-list
2118345|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2118346|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2555351|NCT01516203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555352|NCT01516203|Leprostatic Agents|leprostatic agents|mesh-ancestor
2555353|NCT01516203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2555354|NCT01516203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555355|NCT01516203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555356|NCT01516203|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2555357|NCT01516203|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2555358|NCT01516203|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2118347|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2118348|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2555359|NCT01516203|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2555360|NCT01516203|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2555361|NCT01516203|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2555362|NCT01516203|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2555363|NCT01516203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2555364|NCT01516203|Antimetabolites|antimetabolites|mesh-ancestor
2555365|NCT01516203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2555366|NCT01516216|Vitamin D|vitamin d|mesh-list
2555367|NCT01516216|Ergocalciferols|ergocalciferols|mesh-list
2555368|NCT01516216|Vitamins|vitamins|mesh-list
2118349|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
2118350|NCT02680301|Hormones|hormones|mesh-ancestor
2118351|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118352|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118353|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2118354|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
2118355|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118356|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118357|NCT02680314|Methotrexate|methotrexate|mesh-list
2118358|NCT02680314|Misoprostol|misoprostol|mesh-list
2118359|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2118360|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
2118361|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2118362|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118363|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2118364|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
2118365|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118366|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118367|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
2118368|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118369|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2118370|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2118371|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
2118372|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2118373|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2118374|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2118375|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2118376|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
2118377|NCT02680457|Insulin|insulin|mesh-list
2118378|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2118379|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
2118380|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2118381|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118382|NCT02680756|Ferric maltol|ferric maltol|mesh-list
2118383|NCT02680756|Hematinics|hematinics|mesh-ancestor
2118384|NCT02680847|Naltrexone|naltrexone|mesh-list
2118385|NCT02680847|Oxycodone|oxycodone|mesh-list
2118386|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2555369|NCT01516216|Leucovorin|leucovorin|mesh-list
2555370|NCT01516216|Bevacizumab|bevacizumab|mesh-list
2555371|NCT01516216|Fluorouracil|fluorouracil|mesh-list
2555372|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
2555373|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2555374|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555375|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2555376|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2555377|NCT01516216|Growth Substances|growth substances|mesh-ancestor
2555378|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555379|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
2555380|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
2555381|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2555382|NCT01516216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2555383|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
2555384|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555385|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2555386|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2555387|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
2555388|NCT01516216|Antidotes|antidotes|mesh-ancestor
2555389|NCT01516216|Protective Agents|protective agents|mesh-ancestor
2555390|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
2555391|NCT01516255|Liraglutide|liraglutide|mesh-list
2118387|NCT02680847|Narcotics|narcotics|mesh-ancestor
2118388|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118389|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555392|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
2118390|NCT02680847|Analgesics|analgesics|mesh-ancestor
2555393|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2118391|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
2118392|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118393|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2118394|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2118395|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
2118396|NCT02681094|Saxagliptin|saxagliptin|mesh-list
2118397|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2118398|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118399|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555394|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555395|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2555396|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2555397|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555398|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555399|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555400|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555401|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555402|NCT01516255|Incretins|incretins|mesh-ancestor
2555403|NCT01516255|Hormones|hormones|mesh-ancestor
2555404|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555405|NCT01516307|Cyclophosphamide|cyclophosphamide|mesh-list
2555406|NCT01516307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2555407|NCT01516307|Immunologic Factors|immunologic factors|mesh-ancestor
2555408|NCT01516307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555409|NCT01516307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2555410|NCT01516307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2555411|NCT01516307|Alkylating Agents|alkylating agents|mesh-ancestor
2118400|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118401|NCT02681094|Incretins|incretins|mesh-ancestor
2118402|NCT02681094|Hormones|hormones|mesh-ancestor
2118403|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118404|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2118405|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
2118406|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118407|NCT02681510|Nicotine|nicotine|mesh-list
2118408|NCT02681510|Varenicline|varenicline|mesh-list
2118409|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2118410|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
2118411|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118412|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118413|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2118414|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2118415|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
2118416|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118417|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118418|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2118419|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555412|NCT01516307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555413|NCT01516307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555414|NCT01516307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2555415|NCT01516346|Hydralazine|hydralazine|mesh-list
2555416|NCT01516346|Isosorbide|isosorbide|mesh-list
2555417|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2118420|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
2118421|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2118422|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2118423|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118424|NCT02682381|Teduglutide|teduglutide|mesh-list
2118425|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2118426|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2118427|NCT02682381|Protective Agents|protective agents|mesh-ancestor
2118428|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118429|NCT02682498|Bupivacaine|bupivacaine|mesh-list
2118430|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
2118431|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
2118432|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118433|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118434|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
2118435|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118436|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
2118437|NCT02682563|Gliclazide|gliclazide|mesh-list
2118438|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2118439|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118440|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2118441|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118442|NCT02682602|Tacrine|tacrine|mesh-list
2118443|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2118444|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118445|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118446|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
2118447|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418381|NCT00799058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418382|NCT00799071|Posaconazole|posaconazole|mesh-list
2418383|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
2418384|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418385|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2418386|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2418387|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2418388|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2418389|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2418390|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418391|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418392|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2555418|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2555419|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2555420|NCT01516346|Diuretics|diuretics|mesh-ancestor
2555421|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
2555422|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555423|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
2555424|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2555425|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555426|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2555427|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
2555428|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2555429|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2555430|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555431|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2555432|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2555433|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555434|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555435|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555436|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2555437|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
2555438|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2555439|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555440|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2555441|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2555442|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2555443|NCT01516450|Belimumab|belimumab|mesh-list
2555444|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2555445|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
2555446|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555447|NCT01516463|Bacitracin|bacitracin|mesh-list
2555448|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2555449|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555450|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2555451|NCT01516476|Liraglutide|liraglutide|mesh-list
2555452|NCT01516476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555453|NCT01516476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555454|NCT01516476|Incretins|incretins|mesh-ancestor
2555455|NCT01516476|Hormones|hormones|mesh-ancestor
2555456|NCT01516476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555457|NCT01516541|Dalcetrapib|dalcetrapib|mesh-list
2555458|NCT01516541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2555459|NCT01516541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2555460|NCT01516541|Antimetabolites|antimetabolites|mesh-ancestor
2555461|NCT01516541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555462|NCT01516541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2555463|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
2555464|NCT01516554|Testosterone|testosterone|mesh-list
2555465|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
2555466|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
2555467|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2555468|NCT01516554|Androgens|androgens|mesh-ancestor
2555469|NCT01516554|Hormones|hormones|mesh-ancestor
2555470|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118448|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555471|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555472|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2555473|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555474|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
2555475|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
2555476|NCT01516567|Rituximab|rituximab|mesh-list
2555477|NCT01516567|Doxorubicin|doxorubicin|mesh-list
2555478|NCT01516567|Etoposide|etoposide|mesh-list
2555479|NCT01516567|Vincristine|vincristine|mesh-list
2555480|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2555481|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
2555482|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555483|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2555484|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2555485|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
2555486|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555487|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118449|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2118450|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
2118451|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118452|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
2118453|NCT02682784|Oxytocin|oxytocin|mesh-list
2118454|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
2118455|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2118456|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118457|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
2118458|NCT02683109|Olodaterol|olodaterol|mesh-list
2118459|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2118460|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
2118461|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118462|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118463|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2118464|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
2118465|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
2118466|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2118467|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
2118468|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118469|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118470|NCT02683161|Varenicline|varenicline|mesh-list
2118471|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2118472|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2118473|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
2118474|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2555488|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2555489|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2555490|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2555491|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2555492|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2555493|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555494|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2555495|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
2555496|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
2555497|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
2555498|NCT01516580|Cytarabine|cytarabine|mesh-list
2555499|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
2555500|NCT01516580|Rituximab|rituximab|mesh-list
2555501|NCT01516580|Doxorubicin|doxorubicin|mesh-list
2555502|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2555503|NCT01516580|Methotrexate|methotrexate|mesh-list
2555504|NCT01516580|Vincristine|vincristine|mesh-list
2555505|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2555506|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
2118475|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118476|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118477|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2118478|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2118479|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118480|NCT02683187|Incretins|incretins|mesh-ancestor
2118481|NCT02683187|Hormones|hormones|mesh-ancestor
2118482|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118483|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2118484|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
2118485|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118486|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118487|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2118488|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555507|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555508|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2555509|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2555510|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
2555511|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555512|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555513|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2555514|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2555515|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2555516|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2555517|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2555518|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555519|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2555520|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
2555521|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2555522|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2555523|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
2555524|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
2555525|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2555526|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2555527|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
2555528|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555529|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2555530|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
2555531|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
2555532|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
2555533|NCT01516593|Cytarabine|cytarabine|mesh-list
2555534|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2555535|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
2555536|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555537|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555538|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
2555539|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555540|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2555541|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
2555542|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555543|NCT01516606|Clarithromycin|clarithromycin|mesh-list
2555544|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2555545|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555546|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2555547|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555548|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555549|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2418393|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
2418394|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2418395|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555550|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2555551|NCT01516710|Liver Extracts|liver extracts|mesh-list
2555552|NCT01516710|Hematinics|hematinics|mesh-ancestor
2555553|NCT01516723|Sirolimus|sirolimus|mesh-list
2555554|NCT01516723|Everolimus|everolimus|mesh-list
2555555|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555556|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2555557|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
2555558|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555559|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2555560|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555561|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2555562|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
2555563|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2555564|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555565|NCT01516814|Heparin|heparin|mesh-list
2555566|NCT01516814|Calcium heparin|calcium heparin|mesh-list
2555567|NCT01516814|Warfarin|warfarin|mesh-list
2555568|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
2555569|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
2555570|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2555571|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2418403|NCT00799136|Prednisone|prednisone|mesh-list
2418404|NCT00799136|Vincristine|vincristine|mesh-list
2555572|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555573|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2555574|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
2555575|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2555576|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
2555577|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555578|NCT01516840|Heparin|heparin|mesh-list
2555579|NCT01516840|Calcium heparin|calcium heparin|mesh-list
2555580|NCT01516840|Warfarin|warfarin|mesh-list
2555581|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
2555582|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
2555583|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2555584|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2555585|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555586|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2555587|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
2555588|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2555589|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
2555590|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555591|NCT01516866|Listerine|listerine|mesh-list
2555592|NCT01516866|Fluorides|fluorides|mesh-list
2555593|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
2555594|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
2555595|NCT01516866|Protective Agents|protective agents|mesh-ancestor
2555596|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555597|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2555598|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555599|NCT01516918|Ribavirin|ribavirin|mesh-list
2555600|NCT01516918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2555601|NCT01516918|Antimetabolites|antimetabolites|mesh-ancestor
2555602|NCT01516918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555603|NCT01516918|Antiviral Agents|antiviral agents|mesh-ancestor
2555604|NCT01516918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555605|NCT01516944|Capecitabine|capecitabine|mesh-list
2555606|NCT01516944|Tegafur|tegafur|mesh-list
2555607|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
2555608|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2555609|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
2555610|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555611|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555612|NCT01516996|Docetaxel|docetaxel|mesh-list
2555613|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
2555614|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555615|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
2555616|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
2118489|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118490|NCT02683525|Incretins|incretins|mesh-ancestor
2118491|NCT02683525|Hormones|hormones|mesh-ancestor
2118492|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118493|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2118494|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
2118495|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118496|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118497|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
2555617|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
2555618|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118498|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2118499|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
2118500|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118501|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118502|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2118503|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
2118504|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
2118505|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2118506|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
2118507|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118508|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118509|NCT02683707|Lidocaine|lidocaine|mesh-list
2118510|NCT02683707|Fentanyl|fentanyl|mesh-list
2118511|NCT02683707|Midazolam|midazolam|mesh-list
2118512|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
2118513|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
2118514|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118515|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118516|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
2555619|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2555620|NCT01517009|Docetaxel|docetaxel|mesh-list
2555621|NCT01517009|Capecitabine|capecitabine|mesh-list
2118517|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118518|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2118519|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2555622|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555623|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
2555624|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
2555625|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
2555626|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555627|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2555628|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
2555629|NCT01517022|Nicotine|nicotine|mesh-list
2555630|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2555631|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
2555632|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555633|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555634|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2555635|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2555636|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
2555637|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2555638|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118520|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2118521|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2118522|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555639|NCT01517165|Pioglitazone|pioglitazone|mesh-list
2555640|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555641|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555642|NCT01517243|Sirolimus|sirolimus|mesh-list
2555643|NCT01517243|Sunitinib|sunitinib|mesh-list
2118523|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2118524|NCT02683707|Narcotics|narcotics|mesh-ancestor
2118525|NCT02683707|Analgesics|analgesics|mesh-ancestor
2118526|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2118527|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2118528|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
2118529|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2118530|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2118531|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2118532|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2555644|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555645|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2555646|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2555647|NCT01517243|Growth Substances|growth substances|mesh-ancestor
2555648|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555649|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
2555650|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2555651|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555652|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555653|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2555654|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555655|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2555656|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
2555657|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2555658|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
2555659|NCT01517308|Interferons|interferons|mesh-list
2555660|NCT01517308|Ribavirin|ribavirin|mesh-list
2555661|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
2118533|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
2118534|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
2118535|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118536|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
2118537|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2555662|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
2555663|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2555664|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118538|NCT02683746|Incretins|incretins|mesh-ancestor
2118539|NCT02683746|Hormones|hormones|mesh-ancestor
2118540|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118541|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118542|NCT02683941|Lanreotide|lanreotide|mesh-list
2118543|NCT02683941|Somatostatin|somatostatin|mesh-list
2118544|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118545|NCT02683941|Hormones|hormones|mesh-ancestor
2118546|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555665|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
2555666|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555667|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
2555668|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555669|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
2555670|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555671|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2555672|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555673|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555674|NCT01517321|Incretins|incretins|mesh-ancestor
2555675|NCT01517321|Hormones|hormones|mesh-ancestor
2555676|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555677|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2555678|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
2555679|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555680|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555681|NCT01517334|Minocycline|minocycline|mesh-list
2555682|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2555683|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555684|NCT01517347|Interleukin-2|interleukin-2|mesh-list
2555685|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555686|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2555687|NCT01517347|Analgesics|analgesics|mesh-ancestor
2555688|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
2555689|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555690|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555691|NCT01517360|Oxytocin|oxytocin|mesh-list
2555692|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
2555693|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2555694|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555695|NCT01517399|Vitamin K|vitamin k|mesh-list
2118547|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118548|NCT02684136|Suvorexant|suvorexant|mesh-list
2118549|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2118550|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2118551|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118552|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118553|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2118554|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118555|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118556|NCT02684344|Tamsulosin|tamsulosin|mesh-list
2555696|NCT01517399|Digoxin|digoxin|mesh-list
2555697|NCT01517399|Midazolam|midazolam|mesh-list
2555698|NCT01517399|Caffeine|caffeine|mesh-list
2555699|NCT01517399|Omeprazole|omeprazole|mesh-list
2555700|NCT01517399|Warfarin|warfarin|mesh-list
2555701|NCT01517399|Vitamins|vitamins|mesh-ancestor
2555702|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
2555703|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555704|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2555705|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2555706|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2555707|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2555708|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2555709|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2555710|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2555711|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
2555712|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
2555713|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
2555714|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
2555715|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2555716|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555717|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
2555718|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2118557|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2118558|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2118559|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2118560|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
2118561|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118562|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555719|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2555720|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2555721|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555722|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2555723|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2555724|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2555725|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2555726|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
2555727|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2555728|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2555729|NCT01517399|Protective Agents|protective agents|mesh-ancestor
2555730|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2555731|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2555732|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
2555733|NCT01517399|Coagulants|coagulants|mesh-ancestor
2555734|NCT01517451|Androgens|androgens|mesh-list
2555735|NCT01517451|Hormones|hormones|mesh-ancestor
2555736|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555737|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555738|NCT01517490|Insulin|insulin|mesh-list
2555739|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2555740|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555741|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555742|NCT01517555|Acetaminophen|acetaminophen|mesh-list
2118563|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118564|NCT02684344|Urological Agents|urological agents|mesh-ancestor
2118565|NCT02684357|Ustekinumab|ustekinumab|mesh-list
2118566|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2118567|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
2118568|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
2118569|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118570|NCT02684370|Ustekinumab|ustekinumab|mesh-list
2118571|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2118572|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
2118573|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
2118574|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118575|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
2118576|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2118577|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118578|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
2118579|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
2118580|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
2118581|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2118582|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118583|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
2118584|NCT02684851|Coagulants|coagulants|mesh-ancestor
2118585|NCT02684942|Fentanyl|fentanyl|mesh-list
2118586|NCT02684942|Meperidine|meperidine|mesh-list
2118587|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2118588|NCT02684942|Narcotics|narcotics|mesh-ancestor
2118589|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118590|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118591|NCT02684942|Analgesics|analgesics|mesh-ancestor
2118592|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
2555743|NCT01517555|Liraglutide|liraglutide|mesh-list
2555744|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2555745|NCT01517555|Analgesics|analgesics|mesh-ancestor
2555746|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
2555747|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555748|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555749|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
2555750|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555751|NCT01517555|Incretins|incretins|mesh-ancestor
2555752|NCT01517555|Hormones|hormones|mesh-ancestor
2555753|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555754|NCT01517568|Liraglutide|liraglutide|mesh-list
2555755|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555756|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555757|NCT01517568|Incretins|incretins|mesh-ancestor
2555758|NCT01517568|Hormones|hormones|mesh-ancestor
2555759|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555760|NCT01517607|Mesalamine|mesalamine|mesh-list
2118593|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118594|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2118595|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2118596|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
2118597|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
2118598|NCT02685033|Dalbavancin|dalbavancin|mesh-list
2118599|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2118600|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2118601|NCT02685072|Progesterone|progesterone|mesh-list
2118602|NCT02685072|Progestins|progestins|mesh-ancestor
2118603|NCT02685072|Hormones|hormones|mesh-ancestor
2118604|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555761|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2555762|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2555763|NCT01517607|Analgesics|analgesics|mesh-ancestor
2555764|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
2118605|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118606|NCT02685267|Prednisone|prednisone|mesh-list
2118607|NCT02685267|Docetaxel|docetaxel|mesh-list
2118608|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118609|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
2118610|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
2118611|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
2118612|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118613|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2118614|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
2118615|NCT02685267|Hormones|hormones|mesh-ancestor
2118616|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118617|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118618|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2555765|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555766|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555767|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2555768|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2555769|NCT01517711|Tramadol|tramadol|mesh-list
2555770|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2555771|NCT01517711|Narcotics|narcotics|mesh-ancestor
2555772|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2555773|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555774|NCT01517711|Analgesics|analgesics|mesh-ancestor
2555775|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
2555776|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555777|NCT01517724|Bortezomib|bortezomib|mesh-list
2555778|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555779|NCT01517776|Temozolomide|temozolomide|mesh-list
2555780|NCT01517776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2555781|NCT01517776|Alkylating Agents|alkylating agents|mesh-ancestor
2555782|NCT01517776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555783|NCT01517776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555784|NCT01517802|Prednisone|prednisone|mesh-list
2555785|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
2555786|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2555787|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
2555788|NCT01517802|Hormones|hormones|mesh-ancestor
2555789|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555790|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555791|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2555792|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555793|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2555794|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555795|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555796|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
2555797|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2118619|NCT02685436|Domperidone|domperidone|mesh-list
2118620|NCT02685436|Omeprazole|omeprazole|mesh-list
2118621|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2118622|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2118623|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2118624|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118625|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118626|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
2118627|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
2118628|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118629|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118630|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2118631|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
2118632|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118633|NCT02685826|Dexamethasone|dexamethasone|mesh-list
2118634|NCT02685826|Lenalidomide|lenalidomide|mesh-list
2118635|NCT02685826|Durvalumab|durvalumab|mesh-list
2118636|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2118637|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
2118638|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
2118639|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118640|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118641|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2555798|NCT01517815|Tazobactam|tazobactam|mesh-list
2555799|NCT01517815|Piperacillin|piperacillin|mesh-list
2555800|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2555801|NCT01517815|Doripenem|doripenem|mesh-list
2118642|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
2118643|NCT02685826|Hormones|hormones|mesh-ancestor
2555802|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2118644|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118645|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2118646|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118647|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
2118648|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2555803|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555804|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2555805|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555806|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555807|NCT01517828|Midazolam|midazolam|mesh-list
2555808|NCT01517828|Ketamine|ketamine|mesh-list
2555809|NCT01517828|Analgesics|analgesics|mesh-ancestor
2555810|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
2555811|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555812|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555813|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2555814|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2555815|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
2555816|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
2555817|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2555818|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2555819|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2555820|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2555821|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555822|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2555823|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2555824|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2555825|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2555826|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2555827|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
2555828|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
2555829|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
2555830|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
2555831|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2555832|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2118649|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2118650|NCT02685826|Growth Substances|growth substances|mesh-ancestor
2118651|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
2118652|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2118653|NCT02686164|Lenvatinib|lenvatinib|mesh-list
2118654|NCT02686164|Midazolam|midazolam|mesh-list
2118655|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2118656|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2118657|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118658|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118659|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2118660|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2118661|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2118662|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2118663|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
2118664|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
2118665|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
2118666|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
2118667|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118668|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555833|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555834|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555835|NCT01517854|Urological Agents|urological agents|mesh-ancestor
2555836|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
2555837|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2555838|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2555839|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555840|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2555841|NCT01517932|Analgesics|analgesics|mesh-ancestor
2555842|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
2555843|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555844|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2555845|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2555846|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2555847|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
2555848|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2555849|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555850|NCT01517997|Paclitaxel|paclitaxel|mesh-list
2118669|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118670|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2118671|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118672|NCT02687451|Oxymorphone|oxymorphone|mesh-list
2118673|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2118674|NCT02687451|Narcotics|narcotics|mesh-ancestor
2118675|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118676|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118677|NCT02687451|Analgesics|analgesics|mesh-ancestor
2118678|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
2118679|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118680|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2118681|NCT02687815|Vitamin D|vitamin d|mesh-list
2118682|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
2118683|NCT02687815|Vitamins|vitamins|mesh-ancestor
2118684|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
2118685|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118686|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2118687|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2118688|NCT02688387|Ambrisentan|ambrisentan|mesh-list
2118689|NCT02688387|Tadalafil|tadalafil|mesh-list
2118690|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
2118691|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2118692|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2555851|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2555852|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555853|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
2555854|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
2555855|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
2555856|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555857|NCT01518062|Estrogens|estrogens|mesh-list
2555858|NCT01518062|Hormones|hormones|mesh-ancestor
2555859|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555860|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118693|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118694|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118695|NCT02688387|Urological Agents|urological agents|mesh-ancestor
2118696|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2118697|NCT02688556|Cyclosporine|cyclosporine|mesh-list
2118698|NCT02688556|Cyclosporins|cyclosporins|mesh-list
2555861|NCT01518101|Metformin|metformin|mesh-list
2555862|NCT01518101|Liraglutide|liraglutide|mesh-list
2555863|NCT01518101|Vildagliptin|vildagliptin|mesh-list
2555864|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555865|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555866|NCT01518101|Incretins|incretins|mesh-ancestor
2555867|NCT01518101|Hormones|hormones|mesh-ancestor
2555868|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555869|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2555870|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
2555871|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555872|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555873|NCT01518166|Liraglutide|liraglutide|mesh-list
2555874|NCT01518166|Griseofulvin|griseofulvin|mesh-list
2555875|NCT01518166|Digoxin|digoxin|mesh-list
2555876|NCT01518166|Lisinopril|lisinopril|mesh-list
2555877|NCT01518166|Atorvastatin|atorvastatin|mesh-list
2555878|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2555879|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2555880|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
2555881|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555882|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2555883|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2555884|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555885|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555886|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555887|NCT01518166|Incretins|incretins|mesh-ancestor
2555888|NCT01518166|Hormones|hormones|mesh-ancestor
2555889|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555890|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2555891|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2555892|NCT01518166|Protective Agents|protective agents|mesh-ancestor
2555893|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2555894|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
2555895|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2555896|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
2118699|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118700|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118701|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2118702|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
2118703|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118704|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
2118705|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2118706|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
2118707|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2118708|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2118709|NCT02688764|Calcium|calcium|mesh-list
2118710|NCT02688764|Calcium acetate|calcium acetate|mesh-list
2118711|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2555897|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2555898|NCT01518231|Aspirin|aspirin|mesh-list
2555899|NCT01518231|Edaravone|edaravone|mesh-list
2555900|NCT01518231|Warfarin|warfarin|mesh-list
2555901|NCT01518231|Atorvastatin|atorvastatin|mesh-list
2555902|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2118712|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118713|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
2118714|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
2118715|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118716|NCT02688829|Sirolimus|sirolimus|mesh-list
2555903|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2555904|NCT01518231|Analgesics|analgesics|mesh-ancestor
2555905|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
2555906|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555907|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118717|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2118718|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2118719|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2118720|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118721|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
2118722|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2118723|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
2555908|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2555909|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2555910|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2555911|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2555912|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555913|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2555914|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2555915|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555916|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
2555917|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2555918|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2555919|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
2555920|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2555921|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2555922|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
2555923|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2555924|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
2555925|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2555926|NCT01518231|Protective Agents|protective agents|mesh-ancestor
2555927|NCT01518413|Irinotecan|irinotecan|mesh-list
2555928|NCT01518413|Sorafenib|sorafenib|mesh-list
2555929|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2555930|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2555931|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555932|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555933|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118724|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118725|NCT02688842|Sirolimus|sirolimus|mesh-list
2118726|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2118727|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2118728|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2118729|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118730|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
2118731|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2118732|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
2118733|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118734|NCT02688933|Insulin|insulin|mesh-list
2118735|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2118736|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
2118737|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2555934|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2555935|NCT01518465|Dexamethasone|dexamethasone|mesh-list
2118738|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118739|NCT02689063|Acetaminophen|acetaminophen|mesh-list
2118740|NCT02689063|Ibuprofen|ibuprofen|mesh-list
2118741|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2118742|NCT02689063|Analgesics|analgesics|mesh-ancestor
2118743|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
2118744|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118745|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118746|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
2555936|NCT01518465|Lenalidomide|lenalidomide|mesh-list
2555937|NCT01518465|Dalteparin|dalteparin|mesh-list
2555938|NCT01518465|Tinzaparin|tinzaparin|mesh-list
2555939|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2555940|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2555941|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
2555942|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
2555943|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555944|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555945|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2118747|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2118748|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2118749|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2118750|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2118751|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118752|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118753|NCT02689206|Glycine|glycine|mesh-list
2118754|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
2118755|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118756|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118757|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118758|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2555946|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
2555947|NCT01518465|Hormones|hormones|mesh-ancestor
2555948|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2555949|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2555950|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555951|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
2118759|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2118760|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118761|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
2118762|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
2118763|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
2118764|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
2118765|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2555952|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2555953|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2555954|NCT01518465|Growth Substances|growth substances|mesh-ancestor
2555955|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
2118766|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118767|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2118768|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2118769|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2118770|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2118771|NCT02690558|Gemcitabine|gemcitabine|mesh-list
2118772|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
2555956|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
2555957|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2555958|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2555959|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555960|NCT01518517|Asparaginase|asparaginase|mesh-list
2555961|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555962|NCT01518556|Idarubicin|idarubicin|mesh-list
2555963|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2555964|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555965|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2555966|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2555967|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118773|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118774|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2555968|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555969|NCT01518569|Urinastatin|urinastatin|mesh-list
2555970|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2555971|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2555972|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
2555973|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555974|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555975|NCT01518595|Bosentan|bosentan|mesh-list
2555976|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2555977|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2555978|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555979|NCT01518608|Alfentanil|alfentanil|mesh-list
2555980|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2555981|NCT01518608|Narcotics|narcotics|mesh-ancestor
2555982|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2555983|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2555984|NCT01518608|Analgesics|analgesics|mesh-ancestor
2555985|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
2555986|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2555987|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2555988|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
2555989|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
2555990|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2555991|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2555992|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2555993|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2555994|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2555995|NCT01518634|Imipramine|imipramine|mesh-list
2555996|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2555997|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
2555998|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2555999|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2556000|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2556001|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2556002|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556003|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
2556004|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556005|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556006|NCT01518712|Metformin|metformin|mesh-list
2556007|NCT01518712|Canagliflozin|canagliflozin|mesh-list
2556008|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2556009|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556010|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2556011|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556012|NCT01518725|Vitamin D|vitamin d|mesh-list
2556013|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
2556014|NCT01518725|Vitamins|vitamins|mesh-ancestor
2556015|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
2556016|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556017|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2556018|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2556019|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2556020|NCT01518790|Laxatives|laxatives|mesh-ancestor
2556021|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2556022|NCT01518855|Amlodipine|amlodipine|mesh-list
2556023|NCT01518855|Nifedipine|nifedipine|mesh-list
2556024|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2556025|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2556026|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2556027|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556028|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2556029|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556030|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
2556031|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
2556032|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2556033|NCT01518933|Silybin|silybin|mesh-list
2556034|NCT01518933|Silymarin|silymarin|mesh-list
2556035|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
2556036|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118775|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
2118776|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118777|NCT02690558|Antiviral Agents|antiviral agents|mesh-ancestor
2118778|NCT02690558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2118779|NCT02690558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118780|NCT02690558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2118781|NCT02690558|Immunologic Factors|immunologic factors|mesh-ancestor
2118782|NCT02690558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118783|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2118784|NCT02690714|Plasminogen|plasminogen|mesh-list
2118785|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2118786|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2118787|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118788|NCT02690727|Tenalisib|tenalisib|mesh-list
2118789|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
2118790|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118791|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118792|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
2118793|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2118794|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118795|NCT02690974|Valsartan|valsartan|mesh-list
2118796|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2118797|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2118798|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2118799|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2118800|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118801|NCT02691416|Propofol|propofol|mesh-list
2118802|NCT02691416|Sevoflurane|sevoflurane|mesh-list
2118803|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2118804|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118805|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118806|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2118807|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
2118808|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
2418405|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2418406|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
2418407|NCT00799136|Hormones|hormones|mesh-ancestor
2418408|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2418409|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418410|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2418411|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418412|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2556037|NCT01518933|Protective Agents|protective agents|mesh-ancestor
2556038|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556039|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2556040|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556041|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
2556042|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2556043|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556044|NCT01518959|Vitamins|vitamins|mesh-ancestor
2556045|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
2556046|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2556047|NCT01518998|Amlodipine|amlodipine|mesh-list
2556048|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2556049|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2556050|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2556051|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556052|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2556053|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556054|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
2556055|NCT01519011|Azacitidine|azacitidine|mesh-list
2556056|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2118809|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2556057|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
2556058|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556059|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556060|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556061|NCT01519037|Cinacalcet|cinacalcet|mesh-list
2556062|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2556063|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556064|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2556065|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
2556066|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2556067|NCT01519076|Coal Tar|coal tar|mesh-list
2556068|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
2556069|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
2556070|NCT01519102|Hormones|hormones|mesh-list
2556071|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2556072|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556073|NCT01519128|Rilpivirine|rilpivirine|mesh-list
2556074|NCT01519128|Digoxin|digoxin|mesh-list
2556075|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2556076|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2556077|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556078|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556079|NCT01519128|Protective Agents|protective agents|mesh-ancestor
2556080|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556081|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2556082|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2556083|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
2556084|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2556085|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2556086|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2556087|NCT01519154|Ketamine|ketamine|mesh-list
2556088|NCT01519154|Propofol|propofol|mesh-list
2556089|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2556090|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2556091|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556092|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2556093|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
2556094|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
2556095|NCT01519154|Analgesics|analgesics|mesh-ancestor
2556096|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
2556097|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556098|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2556099|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2556100|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2556101|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556102|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556103|NCT01519297|Irbesartan|irbesartan|mesh-list
2556104|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2556105|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2556106|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2556107|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556108|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2556109|NCT01519310|Metronidazole|metronidazole|mesh-list
2556110|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
2556111|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2556112|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2556113|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2556114|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2556115|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2556116|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556117|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556118|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556119|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2556120|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2556121|NCT01519336|Ritonavir|ritonavir|mesh-list
2556122|NCT01519336|Darunavir|darunavir|mesh-list
2556123|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2556124|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2556125|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
2556126|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556127|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556128|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2556129|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2556130|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
2556131|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2556132|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2556133|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2556134|NCT01519401|Drospirenone|drospirenone|mesh-list
2556135|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2556136|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2556137|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2556138|NCT01519401|Estradiol|estradiol|mesh-list
2556139|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2556140|NCT01519401|Estrogens|estrogens|mesh-ancestor
2556141|NCT01519401|Hormones|hormones|mesh-ancestor
2556142|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2556143|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556144|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2556145|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
2556146|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2556147|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2556148|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2556149|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2118810|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2556150|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2556151|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
2556152|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2556153|NCT01519401|Diuretics|diuretics|mesh-ancestor
2556154|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
2556155|NCT01519544|Acetazolamide|acetazolamide|mesh-list
2556156|NCT01519544|Temazepam|temazepam|mesh-list
2556157|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
2556158|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2556159|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556160|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556161|NCT01519544|Diuretics|diuretics|mesh-ancestor
2556162|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
2556163|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556164|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2556165|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2556166|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2556167|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2556168|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2118811|NCT02691468|Silicon|silicon|mesh-list
2118812|NCT02691468|Trace Elements|trace elements|mesh-ancestor
2118813|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
2118814|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118815|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2118816|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2118817|NCT02691494|Norethindrone|norethindrone|mesh-list
2118818|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
2118819|NCT02691494|Estradiol|estradiol|mesh-list
2118820|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2556169|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
2556170|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
2556171|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556172|NCT01519687|Tofisopam|tofisopam|mesh-list
2556173|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
2556174|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2556175|NCT01519726|Midazolam|midazolam|mesh-list
2556176|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2556177|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2556178|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2556179|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556180|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2556181|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2556182|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2556183|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2556184|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
2556185|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
2556186|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
2556187|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
2556188|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556189|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556190|NCT01519752|Oxiconazole|oxiconazole|mesh-list
2556191|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
2556192|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2556193|NCT01519804|Paclitaxel|paclitaxel|mesh-list
2556194|NCT01519804|Carboplatin|carboplatin|mesh-list
2556195|NCT01519804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2556196|NCT01519804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556197|NCT01519804|Tubulin Modulators|tubulin modulators|mesh-ancestor
2556198|NCT01519804|Antimitotic Agents|antimitotic agents|mesh-ancestor
2556199|NCT01519804|Mitosis Modulators|mitosis modulators|mesh-ancestor
2556200|NCT01519804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556201|NCT01519856|Piribedil|piribedil|mesh-list
2556202|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2556203|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2556204|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
2556205|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
2556206|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556207|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556208|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556209|NCT01519986|Vitamin D|vitamin d|mesh-list
2556210|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
2556211|NCT01519986|Vitamins|vitamins|mesh-ancestor
2556212|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
2556213|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118821|NCT02691494|Estrogens|estrogens|mesh-ancestor
2556214|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2556215|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2556216|NCT01520012|Esomeprazole|esomeprazole|mesh-list
2118822|NCT02691494|Hormones|hormones|mesh-ancestor
2118823|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2556217|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2556218|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2556219|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2556220|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556221|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556222|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2556223|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2556224|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556225|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2556226|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2556227|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2556228|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
2556229|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556230|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2556231|NCT01520103|Everolimus|everolimus|mesh-list
2556232|NCT01520103|Vinorelbine|vinorelbine|mesh-list
2556233|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556234|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2556235|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
2556236|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556237|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2556238|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
2556239|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
2556240|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
2556241|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556242|NCT01520116|Timolol|timolol|mesh-list
2556243|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2118824|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118825|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2118826|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
2118827|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2118828|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2556244|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2556245|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
2556246|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556247|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556248|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556249|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2556250|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2556251|NCT01520181|Lactams|lactams|mesh-list
2556252|NCT01520181|beta-Lactams|beta-lactams|mesh-list
2556253|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2556254|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2556255|NCT01520285|Felodipine|felodipine|mesh-list
2118829|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2118830|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2118831|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2118832|NCT02691507|Decanoic acid|decanoic acid|mesh-list
2556256|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2556257|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2556258|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2556259|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2556260|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556261|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2556262|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556263|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
2556264|NCT01520298|Acetaminophen|acetaminophen|mesh-list
2556265|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2556266|NCT01520298|Analgesics|analgesics|mesh-ancestor
2556267|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
2556268|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556269|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556270|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
2556271|NCT01520350|Aripiprazole|aripiprazole|mesh-list
2556272|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
2556273|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2556274|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2556275|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2556276|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2556277|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556278|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
2118833|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
2118834|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2118835|NCT02691572|Acetaminophen|acetaminophen|mesh-list
2118836|NCT02691572|Ketorolac|ketorolac|mesh-list
2118837|NCT02691572|Fentanyl|fentanyl|mesh-list
2556279|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
2556280|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556281|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556282|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2556283|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2556284|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
2556285|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2556286|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2556287|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2556288|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2556289|NCT01520389|Irinotecan|irinotecan|mesh-list
2556290|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2556291|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2556292|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2556293|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556294|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556295|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556296|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
2556297|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556298|NCT01520415|Lidocaine|lidocaine|mesh-list
2556299|NCT01520415|Bupivacaine|bupivacaine|mesh-list
2556300|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
2556301|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
2556302|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2556303|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556304|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
2556305|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556306|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2556307|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2556308|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2556309|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2556310|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556311|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2118838|NCT02691572|Bupivacaine|bupivacaine|mesh-list
2118839|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
2118840|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
2118841|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118842|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118843|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
2118844|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118845|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2118846|NCT02691572|Narcotics|narcotics|mesh-ancestor
2118847|NCT02691572|Analgesics|analgesics|mesh-ancestor
2118848|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2556312|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2556313|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556314|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556315|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2556316|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2556317|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118849|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2118850|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
2118851|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2118852|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
2118853|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2118854|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2118855|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2118856|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2118857|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118858|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118859|NCT02691702|Melatonin|melatonin|mesh-list
2118860|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
2118861|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118862|NCT02691702|Protective Agents|protective agents|mesh-ancestor
2118863|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118864|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118865|NCT02691936|Estrogens|estrogens|mesh-list
2118866|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2118867|NCT02691936|Hormones|hormones|mesh-ancestor
2118868|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118869|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118870|NCT02692391|Indomethacin|indomethacin|mesh-list
2556318|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
2556319|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556320|NCT01520467|Anastrozole|anastrozole|mesh-list
2556321|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2556322|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556323|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2556324|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2556325|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556326|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556327|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2556328|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
2556329|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118871|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2118872|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2118873|NCT02692391|Analgesics|analgesics|mesh-ancestor
2118874|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
2118875|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118876|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118877|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2118878|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2118879|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
2118880|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
2118881|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2118882|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2118883|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118884|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556330|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556331|NCT01520545|Baclofen|baclofen|mesh-list
2556332|NCT01520545|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2556333|NCT01520545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556334|NCT01520545|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2556335|NCT01520545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118885|NCT02692755|Letrozole|letrozole|mesh-list
2118886|NCT02692755|Fulvestrant|fulvestrant|mesh-list
2118887|NCT02692755|Palbociclib|palbociclib|mesh-list
2118888|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118889|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2118890|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2118891|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118892|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118893|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2118894|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
2118895|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2118896|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556336|NCT01520545|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2556337|NCT01520545|GABA Agonists|gaba agonists|mesh-ancestor
2556338|NCT01520545|GABA Agents|gaba agents|mesh-ancestor
2556339|NCT01520545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556340|NCT01520545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556341|NCT01520584|Vitamins|vitamins|mesh-list
2556342|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
2556343|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556344|NCT01520753|Insulin|insulin|mesh-list
2118897|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2118898|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2118899|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2118900|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2118901|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2118902|NCT02694328|Olanzapine|olanzapine|mesh-list
2118903|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
2118904|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
2118905|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118906|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118907|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2118908|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2118909|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2118910|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118911|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2118912|NCT02694328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2118913|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2118914|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2118915|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118916|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118917|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
2118918|NCT02694523|Adalimumab|adalimumab|mesh-list
2118919|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2118920|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2118921|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2118922|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
2418413|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
2418414|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
2418415|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
2418416|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418417|NCT00799149|Etoricoxib|etoricoxib|mesh-list
2418418|NCT00799149|Gabapentin|gabapentin|mesh-list
2418419|NCT00799149|Analgesics|analgesics|mesh-ancestor
2556345|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2556346|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
2556347|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
2556348|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2556349|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
2556350|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2556351|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556352|NCT01520766|Methamphetamine|methamphetamine|mesh-list
2556353|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2556354|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556355|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
2556356|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
2118923|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118924|NCT02694536|Gemcitabine|gemcitabine|mesh-list
2118925|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2118926|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2118927|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
2118928|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118929|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118930|NCT02694536|Antiviral Agents|antiviral agents|mesh-ancestor
2118931|NCT02694536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2118932|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118933|NCT02694536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2118934|NCT02694536|Immunologic Factors|immunologic factors|mesh-ancestor
2118935|NCT02694536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118936|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2118937|NCT02694601|Caffeine|caffeine|mesh-list
2118938|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2118939|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118940|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2118941|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2118942|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118943|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2118944|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2118945|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
2118946|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2118947|NCT02694718|Capecitabine|capecitabine|mesh-list
2118948|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
2118949|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2118950|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
2118951|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118952|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118953|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2118954|NCT02694978|Hematinics|hematinics|mesh-ancestor
2118955|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2118956|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2118957|NCT02695290|Afatinib|afatinib|mesh-list
2118958|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118959|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2118960|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184845|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
2418420|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
2418421|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418422|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418423|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
2418424|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2418425|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2418426|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2418427|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2118961|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556357|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556358|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
2556359|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556360|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556361|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
2556362|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2556363|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2556364|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2556365|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2556366|NCT01520792|Acetaminophen|acetaminophen|mesh-list
2556367|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2556368|NCT01520792|Analgesics|analgesics|mesh-ancestor
2118962|NCT02695446|Minocycline|minocycline|mesh-list
2118963|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2118964|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2118965|NCT02695537|Cannabidiol|cannabidiol|mesh-list
2118966|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
2556369|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
2556370|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556371|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556372|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
2556373|NCT01520818|Insulin|insulin|mesh-list
2556374|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2556375|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
2556376|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
2556377|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2556378|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
2556379|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2556380|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556381|NCT01520831|Insulin|insulin|mesh-list
2556382|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2556383|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
2556384|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
2556385|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2556386|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
2556387|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2556388|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2556389|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556390|NCT01520896|Ketoconazole|ketoconazole|mesh-list
2556391|NCT01520896|Naloxegol|naloxegol|mesh-list
2556392|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
2556393|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2556394|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2556395|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2556396|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556397|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556398|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2556399|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
2556400|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2556401|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556402|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2118967|NCT02695628|Misonidazole|misonidazole|mesh-list
2118968|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2118969|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2118970|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2118971|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2118972|NCT02695719|Lubiprostone|lubiprostone|mesh-list
2118973|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2556403|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2556404|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
2556405|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556406|NCT01521130|Levetiracetam|levetiracetam|mesh-list
2556407|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
2556408|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
2556409|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
2556410|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556411|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
2556412|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556413|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556414|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2556415|NCT01521312|Saxagliptin|saxagliptin|mesh-list
2556416|NCT01521312|Incretins|incretins|mesh-ancestor
2118974|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2556417|NCT01521312|Hormones|hormones|mesh-ancestor
2118975|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2118976|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2118977|NCT02696434|Naltrexone|naltrexone|mesh-list
2118978|NCT02696434|Buprenorphine|buprenorphine|mesh-list
2118979|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2118980|NCT02696434|Narcotics|narcotics|mesh-ancestor
2556418|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2556419|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556420|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2556421|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
2556422|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556423|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556424|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2556425|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2556426|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
2556427|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556428|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
2556429|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2556430|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2556431|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2556432|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2556433|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2118981|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2118982|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2118983|NCT02696434|Analgesics|analgesics|mesh-ancestor
2118984|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
2118985|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2118986|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2118987|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2118988|NCT02696785|Adalimumab|adalimumab|mesh-list
2118989|NCT02696785|Ixekizumab|ixekizumab|mesh-list
2118990|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2118991|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2118992|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2118993|NCT02696798|Ixekizumab|ixekizumab|mesh-list
2118994|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
2118995|NCT02696850|Budesonide|budesonide|mesh-list
2556434|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556435|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556436|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556437|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2556438|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
2556439|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2556440|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556441|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2556442|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2556443|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2556444|NCT01521403|Metronidazole|metronidazole|mesh-list
2556445|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2556446|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2556447|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2556448|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2118996|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2118997|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2118998|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
2118999|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119000|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119001|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2119002|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
2119003|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
2119004|NCT02696850|Hormones|hormones|mesh-ancestor
2119005|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2119006|NCT02697071|Ketamine|ketamine|mesh-list
2119007|NCT02697071|Analgesics|analgesics|mesh-ancestor
2119008|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
2119009|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119010|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119011|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2119012|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2119013|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
2119014|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
2119015|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119016|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2184846|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
2556449|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2556450|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2556451|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
2556452|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556453|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556454|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2556455|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
2556456|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
2556457|NCT01521455|Hormones|hormones|mesh-ancestor
2556458|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2556459|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
2556460|NCT01521481|Anesthetics|anesthetics|mesh-list
2556461|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2556462|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556463|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2556464|NCT01521520|Hematinics|hematinics|mesh-ancestor
2556465|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2556466|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2556467|NCT01521572|Albuterol|albuterol|mesh-list
2556468|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2556469|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
2556470|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119017|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2119018|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119019|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119020|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
2119021|NCT02697188|Testosterone|testosterone|mesh-list
2119022|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
2119023|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
2119024|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2119025|NCT02697188|Androgens|androgens|mesh-ancestor
2119026|NCT02697188|Hormones|hormones|mesh-ancestor
2119027|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2119028|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119029|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2119030|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119031|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
2119032|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
2119033|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2119034|NCT02697292|Antibodies|antibodies|mesh-list
2119035|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
2119036|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2556471|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556472|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2556473|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
2556474|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
2556475|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2556476|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2556477|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2556478|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2556479|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
2556480|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556481|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556482|NCT01521624|Metformin|metformin|mesh-list
2556483|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2556484|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556485|NCT01521689|Rituximab|rituximab|mesh-list
2556486|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2556487|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556488|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
2556489|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556490|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2556491|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2556492|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2556493|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2556494|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
2556495|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556496|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556497|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119037|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
2119038|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119039|NCT02697617|Pioglitazone|pioglitazone|mesh-list
2119040|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2119041|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119042|NCT02697773|Tanezumab|tanezumab|mesh-list
2556498|NCT01521767|Urological Agents|urological agents|mesh-ancestor
2556499|NCT01521793|Retinol acetate|retinol acetate|mesh-list
2556500|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2556501|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
2556502|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556503|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2556504|NCT01521793|Protective Agents|protective agents|mesh-ancestor
2556505|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119043|NCT02697773|Analgesics|analgesics|mesh-ancestor
2119044|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
2119045|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119046|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556506|NCT01521819|Ranibizumab|ranibizumab|mesh-list
2556507|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2556508|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2556509|NCT01521819|Growth Substances|growth substances|mesh-ancestor
2556510|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556511|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
2556512|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556513|NCT01521936|Vitamin D|vitamin d|mesh-list
2556514|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
2556515|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
2556516|NCT01521936|Vitamins|vitamins|mesh-list
2556517|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
2119047|NCT02697916|Aspirin|aspirin|mesh-list
2119048|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2119049|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2119050|NCT02697916|Analgesics|analgesics|mesh-ancestor
2119051|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
2119052|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119053|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119054|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2119055|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2556518|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556519|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2556520|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2556521|NCT01521962|Alogliptin|alogliptin|mesh-list
2556522|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2556523|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556524|NCT01521962|Incretins|incretins|mesh-ancestor
2556525|NCT01521962|Hormones|hormones|mesh-ancestor
2556526|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2556527|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2556528|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
2418428|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2418429|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2418430|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418431|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418432|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
2418433|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2418434|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2418435|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2556529|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556530|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556531|NCT01521975|Adefovir|adefovir|mesh-list
2556532|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2556533|NCT01521975|Telbivudine|telbivudine|mesh-list
2556534|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
2556535|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2556536|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2556537|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2556538|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556539|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556540|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
2556541|NCT01522040|Analgesics|analgesics|mesh-ancestor
2556542|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
2556543|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556544|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556545|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
2556546|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2418436|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2418437|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2418438|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2418439|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418440|NCT00799175|Ketorolac|ketorolac|mesh-list
2556547|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2556548|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
2556549|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2556550|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2556551|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556552|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2556553|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
2556554|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2556555|NCT01522092|Citalopram|citalopram|mesh-list
2556556|NCT01522092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2556557|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2556558|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2556559|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556560|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556561|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
2556562|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556563|NCT01522092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2556564|NCT01522092|Antidepressive Agents|antidepressive agents|mesh-ancestor
2556565|NCT01522092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2556566|NCT01522105|Daptomycin|daptomycin|mesh-list
2556567|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2556568|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119056|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2119057|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2119058|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119059|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2119060|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2119061|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119062|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
2119063|NCT02698215|Naltrexone|naltrexone|mesh-list
2556569|NCT01522196|Varespladib methyl|varespladib methyl|mesh-list
2556570|NCT01522196|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2556571|NCT01522196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556572|NCT01522196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556573|NCT01522326|Ibuprofen|ibuprofen|mesh-list
2556574|NCT01522326|Metoclopramide|metoclopramide|mesh-list
2556575|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2556576|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2556577|NCT01522326|Analgesics|analgesics|mesh-ancestor
2556578|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
2556579|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556580|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556581|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2556582|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2556583|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2556584|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556585|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556586|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
2556587|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
2556588|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2556589|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2119064|NCT02698215|Varenicline|varenicline|mesh-list
2119065|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2119066|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2119067|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556590|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2556591|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
2556592|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556593|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2556594|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556595|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556596|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556597|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2556598|NCT01522469|Crenolanib|crenolanib|mesh-list
2556599|NCT01522469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556600|NCT01522534|Morphine|morphine|mesh-list
2556601|NCT01522534|Mepivacaine|mepivacaine|mesh-list
2556602|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2556603|NCT01522534|Narcotics|narcotics|mesh-ancestor
2556604|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2556605|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556606|NCT01522534|Analgesics|analgesics|mesh-ancestor
2556607|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
2556608|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556609|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
2556610|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
2556611|NCT01522547|Pomalidomide|pomalidomide|mesh-list
2119068|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
2119069|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119070|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2119071|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2119072|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
2119073|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119074|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119075|NCT02698410|Temozolomide|temozolomide|mesh-list
2119076|NCT02698410|Lanreotide|lanreotide|mesh-list
2119077|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2556612|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
2556613|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556614|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2556615|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2556616|NCT01522547|Growth Substances|growth substances|mesh-ancestor
2556617|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
2556618|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556619|NCT01522612|Leucovorin|leucovorin|mesh-list
2556620|NCT01522612|Fluorouracil|fluorouracil|mesh-list
2556621|NCT01522612|Cetuximab|cetuximab|mesh-list
2556622|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
2119078|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
2119079|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119080|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119081|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2119082|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
2119083|NCT02698475|Ustekinumab|ustekinumab|mesh-list
2119084|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
2119085|NCT02698566|Ranibizumab|ranibizumab|mesh-list
2119086|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2119087|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2556623|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556624|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2556625|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556626|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2556627|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
2556628|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556629|NCT01522612|Antidotes|antidotes|mesh-ancestor
2556630|NCT01522612|Protective Agents|protective agents|mesh-ancestor
2556631|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
2556632|NCT01522612|Vitamins|vitamins|mesh-ancestor
2556633|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
2556634|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2556635|NCT01522625|Tenofovir|tenofovir|mesh-list
2556636|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
2556637|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2556638|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2556639|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2556640|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556641|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556642|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2556643|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2556644|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2556645|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2556646|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
2556647|NCT01522729|Fentanyl|fentanyl|mesh-list
2556648|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2556649|NCT01522729|Narcotics|narcotics|mesh-ancestor
2556650|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2556651|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556652|NCT01522729|Analgesics|analgesics|mesh-ancestor
2556653|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
2556654|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556655|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2556656|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2119088|NCT02698566|Growth Substances|growth substances|mesh-ancestor
2119089|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119090|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
2119091|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119092|NCT02698735|Gentamicins|gentamicins|mesh-list
2119093|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2119094|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2556657|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
2556658|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
2556659|NCT01522768|Paclitaxel|paclitaxel|mesh-list
2556660|NCT01522768|Afatinib|afatinib|mesh-list
2119095|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2119096|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119097|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119098|NCT02699099|Vitamin A|vitamin a|mesh-list
2556661|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2556662|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556663|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
2556664|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
2556665|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
2556666|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556667|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2556668|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556669|NCT01522820|Sirolimus|sirolimus|mesh-list
2556670|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2556671|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2556672|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2556673|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556674|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
2556675|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2556676|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
2556677|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556678|NCT01522846|Heparin|heparin|mesh-list
2556679|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
2556680|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2556681|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2119099|NCT02699099|Vaccines|vaccines|mesh-list
2119100|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
2119101|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119102|NCT02699099|Vitamins|vitamins|mesh-ancestor
2119103|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
2119104|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2119105|NCT02699125|Guanfacine|guanfacine|mesh-list
2119106|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2119107|NCT02699125|Diuretics|diuretics|mesh-ancestor
2119108|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
2119109|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119110|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2119111|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119112|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119113|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2119114|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2119115|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2119116|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
2119117|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119118|NCT02699450|Ranibizumab|ranibizumab|mesh-list
2119119|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2119120|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2119121|NCT02699450|Growth Substances|growth substances|mesh-ancestor
2119122|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119123|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
2119124|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119125|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2119126|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2119127|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2119128|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119129|NCT02699892|Rituximab|rituximab|mesh-list
2119130|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2119131|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119132|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
2119133|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119134|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2119135|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
2556682|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556683|NCT01522872|Dexamethasone|dexamethasone|mesh-list
2556684|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
2556685|NCT01522872|Bortezomib|bortezomib|mesh-list
2556686|NCT01522872|Pomalidomide|pomalidomide|mesh-list
2556687|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
2556688|NCT01522872|BB 1101|bb 1101|mesh-list
2556689|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2119136|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2119137|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119138|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2119139|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556690|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
2556691|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
2119140|NCT02700412|Cannabidiol|cannabidiol|mesh-list
2119141|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
2119142|NCT02700815|Diclofenac|diclofenac|mesh-list
2119143|NCT02700815|Capsaicin|capsaicin|mesh-list
2119144|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2119145|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2119146|NCT02700815|Analgesics|analgesics|mesh-ancestor
2119147|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
2119148|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119149|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119150|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2119151|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2556692|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556693|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556694|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2556695|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
2556696|NCT01522872|Hormones|hormones|mesh-ancestor
2556697|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2556698|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2556699|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556700|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
2556701|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556702|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556703|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
2556704|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2556705|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2556706|NCT01522872|Growth Substances|growth substances|mesh-ancestor
2556707|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
2556708|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2556709|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
2556710|NCT01522989|Fluorouracil|fluorouracil|mesh-list
2556711|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
2556712|NCT01522989|Palbociclib|palbociclib|mesh-list
2556713|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
2556714|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556715|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2556716|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556717|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2556718|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
2556719|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556720|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2556721|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556722|NCT01523002|Artesunate|artesunate|mesh-list
2556723|NCT01523002|Pyronaridine|pyronaridine|mesh-list
2556724|NCT01523002|Metoprolol|metoprolol|mesh-list
2556725|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2556726|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2556727|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
2556728|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
2556729|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556730|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556731|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2556732|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2556733|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2119152|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2119153|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119154|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119155|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
2119156|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
2119157|NCT02701062|Warfarin|warfarin|mesh-list
2119158|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
2119159|NCT02701062|Dabigatran|dabigatran|mesh-list
2119160|NCT02701062|Apixaban|apixaban|mesh-list
2556734|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
2556735|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556736|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556737|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
2556738|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2556739|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2556740|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2556741|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556742|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
2556743|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
2556744|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2556745|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
2556746|NCT01523015|Docetaxel|docetaxel|mesh-list
2556747|NCT01523015|Fluorouracil|fluorouracil|mesh-list
2556748|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
2556749|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556750|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
2556751|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
2556752|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
2556753|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556754|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
2556755|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2556756|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2556757|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
2556758|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556759|NCT01523041|Insulin|insulin|mesh-list
2556760|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2556761|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
2556762|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
2556763|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2556764|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
2556765|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2556766|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556767|NCT01523054|Metoprolol|metoprolol|mesh-list
2556768|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2556769|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2556770|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
2556771|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
2556772|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556773|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556774|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2556775|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2556776|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2556777|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
2119161|NCT02701062|Anticoagulants|anticoagulants|mesh-list
2119162|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2119163|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
2119164|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2119165|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
2119166|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119167|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119168|NCT02701257|Glucagon|glucagon|mesh-list
2119169|NCT02701257|Pancrelipase|pancrelipase|mesh-list
2119170|NCT02701257|Pancreatin|pancreatin|mesh-list
2119171|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2119172|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2119173|NCT02701257|Hormones|hormones|mesh-ancestor
2119174|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2119175|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119176|NCT02701257|Incretins|incretins|mesh-ancestor
2119177|NCT02701296|Epinephrine|epinephrine|mesh-list
2119178|NCT02701296|Ropivacaine|ropivacaine|mesh-list
2119179|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
2119180|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
2119181|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119182|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119183|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
2119184|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119185|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2119186|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2119187|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
2119188|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119189|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119190|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2119191|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2119192|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
2119193|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2119194|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
2119195|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
2119196|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
2119197|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2119198|NCT02701400|Durvalumab|durvalumab|mesh-list
2119199|NCT02701400|Ipilimumab|ipilimumab|mesh-list
2119200|NCT02701400|Tremelimumab|tremelimumab|mesh-list
2119201|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2556778|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556779|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556780|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
2556781|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
2556782|NCT01523080|Acetaminophen|acetaminophen|mesh-list
2119202|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119203|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2119204|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556783|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2556784|NCT01523080|Analgesics|analgesics|mesh-ancestor
2556785|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
2556786|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556787|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556788|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
2556789|NCT01523093|Ondansetron|ondansetron|mesh-list
2556790|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
2556791|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
2556792|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556793|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556794|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2119205|NCT02701582|Phenylephrine|phenylephrine|mesh-list
2119206|NCT02701582|Epinephrine|epinephrine|mesh-list
2119207|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
2119208|NCT02701582|Synephrine|synephrine|mesh-list
2119209|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2119210|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2556795|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
2556796|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
2556797|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2556798|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
2556799|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556800|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556801|NCT01523093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2556802|NCT01523093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2556803|NCT01523093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119211|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
2119212|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119213|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119214|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119215|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2119216|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2119217|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
2119218|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119219|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2119220|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
2119221|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
2119222|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
2119223|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2119224|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2119225|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
2119226|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2119227|NCT02701582|Protective Agents|protective agents|mesh-ancestor
2119228|NCT02701764|Pregabalin|pregabalin|mesh-list
2119229|NCT02701764|Analgesics|analgesics|mesh-ancestor
2556804|NCT01523093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2556805|NCT01523093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2556806|NCT01523119|Ondansetron|ondansetron|mesh-list
2556807|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
2556808|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
2556809|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556810|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556811|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2556812|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
2556813|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
2556814|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2556815|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
2556816|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556817|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556818|NCT01523119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2556819|NCT01523119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2556820|NCT01523119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2556821|NCT01523119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2119230|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
2119231|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119232|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119233|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
2119234|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2119235|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119236|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119237|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2119238|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2556822|NCT01523119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2119239|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2119240|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119241|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2119242|NCT02702011|Empagliflozin|empagliflozin|mesh-list
2556823|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
2556824|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2556825|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
2556826|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2556827|NCT01523314|Dexamethasone|dexamethasone|mesh-list
2556828|NCT01523314|Bevacizumab|bevacizumab|mesh-list
2556829|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2556830|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2556831|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
2556832|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
2556833|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556834|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556835|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2556836|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
2556837|NCT01523314|Hormones|hormones|mesh-ancestor
2556838|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2556839|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2556840|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556841|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2556842|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2556843|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2556844|NCT01523314|Growth Substances|growth substances|mesh-ancestor
2556845|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
2556846|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2556847|NCT01523327|Uric Acid|uric acid|mesh-list
2556848|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
2556849|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556850|NCT01523327|Protective Agents|protective agents|mesh-ancestor
2556851|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119243|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2119244|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119245|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2119246|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119247|NCT02702388|Lenvatinib|lenvatinib|mesh-list
2119248|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556852|NCT01523379|Parecoxib|parecoxib|mesh-list
2556853|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2556854|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2556855|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556856|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556857|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2556858|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2556859|NCT01523379|Analgesics|analgesics|mesh-ancestor
2556860|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
2556861|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556862|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556863|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2556864|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2556865|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
2556866|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2556867|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
2556868|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2556869|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
2556870|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556871|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556872|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
2556873|NCT01523431|Leucovorin|leucovorin|mesh-list
2556874|NCT01523431|Fluorouracil|fluorouracil|mesh-list
2556875|NCT01523431|Irinotecan|irinotecan|mesh-list
2556876|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
2556877|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556878|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2556879|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556880|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2556881|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
2556882|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119249|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2119250|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119251|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119252|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
2556883|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2119253|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2119254|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119255|NCT02703259|Acetaminophen|acetaminophen|mesh-list
2119256|NCT02703259|Celecoxib|celecoxib|mesh-list
2119257|NCT02703259|Gabapentin|gabapentin|mesh-list
2119258|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2119259|NCT02703259|Analgesics|analgesics|mesh-ancestor
2119260|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
2119261|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119262|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119263|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
2119264|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2119265|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2119266|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2119267|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2119268|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2119269|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556884|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2556885|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556886|NCT01523431|Antidotes|antidotes|mesh-ancestor
2556887|NCT01523431|Protective Agents|protective agents|mesh-ancestor
2556888|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
2556889|NCT01523431|Vitamins|vitamins|mesh-ancestor
2556890|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
2556891|NCT01523483|Progesterone|progesterone|mesh-list
2556892|NCT01523483|Progestins|progestins|mesh-ancestor
2556893|NCT01523483|Hormones|hormones|mesh-ancestor
2556894|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2556895|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556896|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
2556897|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
2556898|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556899|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
2556900|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2556901|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556902|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
2556903|NCT01523574|Vitamin E|vitamin e|mesh-list
2556904|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
2556905|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
2556906|NCT01523574|Calcium|calcium|mesh-list
2556907|NCT01523574|Vitamins|vitamins|mesh-ancestor
2556908|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
2556909|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556910|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2556911|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2556912|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556913|NCT01523574|Analgesics|analgesics|mesh-ancestor
2556914|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
2556915|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556916|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
2119270|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119271|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
2119272|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2119273|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2119274|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119275|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2119276|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2119277|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2119278|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119279|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
2119280|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
2119281|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2119282|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119283|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
2119284|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2119285|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119286|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
2119287|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2556917|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2556918|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2556919|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
2556920|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2556921|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2556922|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556923|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
2184847|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2556924|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2556925|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
2556926|NCT01523574|Protective Agents|protective agents|mesh-ancestor
2556927|NCT01523639|Metformin|metformin|mesh-list
2556928|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2556929|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556930|NCT01523678|Paclitaxel|paclitaxel|mesh-list
2556931|NCT01523678|Carboplatin|carboplatin|mesh-list
2556932|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2556933|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556934|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
2556935|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
2556936|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
2556937|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556938|NCT01523847|Doxorubicin|doxorubicin|mesh-list
2556939|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2556940|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556941|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2556942|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2556943|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556944|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556945|NCT01523860|Rituximab|rituximab|mesh-list
2556946|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2556947|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
2556948|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2556949|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556950|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
2556951|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556952|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2556953|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2556954|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
2556955|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2556956|NCT01523860|Analgesics|analgesics|mesh-ancestor
2556957|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
2556958|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2556959|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2556960|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2556961|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2556990|NCT01524068|Rituximab|rituximab|mesh-list
2556991|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2556992|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2556993|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
2556994|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2556995|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2556996|NCT01524081|Amoxicillin|amoxicillin|mesh-list
2556997|NCT01524081|Metronidazole|metronidazole|mesh-list
2556998|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
2556999|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
2557000|NCT01524081|Cefuroxime|cefuroxime|mesh-list
2557001|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
2557002|NCT01524081|Fluconazole|fluconazole|mesh-list
2557003|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2119288|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119289|NCT02703636|Rivastigmine|rivastigmine|mesh-list
2119290|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2119291|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119292|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119293|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
2119294|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119295|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119296|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2119297|NCT02703636|Protective Agents|protective agents|mesh-ancestor
2119298|NCT02703779|Plerixafor|plerixafor|mesh-list
2557004|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2557005|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2557006|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2557007|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2557008|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
2557009|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2557010|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2557011|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418441|NCT00799175|Epinephrine|epinephrine|mesh-list
2418442|NCT00799175|Ropivacaine|ropivacaine|mesh-list
2418443|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
2418444|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
2418445|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557012|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557013|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2557014|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
2557015|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557016|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557017|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2557018|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2557019|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2557020|NCT01524094|Leucovorin|leucovorin|mesh-list
2557021|NCT01524094|Fluorouracil|fluorouracil|mesh-list
2557022|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
2557023|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
2557024|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
2557025|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557026|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2557027|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557028|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2119299|NCT02703779|Bortezomib|bortezomib|mesh-list
2119300|NCT02703779|Lenograstim|lenograstim|mesh-list
2119301|NCT02703779|Sargramostim|sargramostim|mesh-list
2119302|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2119303|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
2119304|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119305|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119306|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2557029|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
2557030|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557031|NCT01524094|Antidotes|antidotes|mesh-ancestor
2557032|NCT01524094|Protective Agents|protective agents|mesh-ancestor
2557033|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
2557034|NCT01524094|Vitamins|vitamins|mesh-ancestor
2557035|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
2557036|NCT01524237|Ketamine|ketamine|mesh-list
2119307|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2119308|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
2119309|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119310|NCT02703909|Rocuronium|rocuronium|mesh-list
2119311|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2119312|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2119313|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2119314|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119315|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119316|NCT02703948|Lidocaine|lidocaine|mesh-list
2119317|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
2119318|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
2119319|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119320|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557037|NCT01524237|Analgesics|analgesics|mesh-ancestor
2418446|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418447|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
2418448|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557038|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
2119321|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
2119322|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119323|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2119324|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2119325|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2119326|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119327|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119328|NCT02704104|Hemostatics|hemostatics|mesh-list
2119329|NCT02704104|Coagulants|coagulants|mesh-ancestor
2557039|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557040|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557041|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2557042|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2557043|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
2557044|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
2557045|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557046|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2557047|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2557048|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2557049|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557050|NCT01524315|Vitamins|vitamins|mesh-list
2557051|NCT01524315|Thiamine|thiamine|mesh-list
2557052|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
2557053|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
2119330|NCT02704156|Gemcitabine|gemcitabine|mesh-list
2119331|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
2119332|NCT02704156|Trametinib|trametinib|mesh-list
2119333|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2119334|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
2119335|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119336|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119337|NCT02704156|Antiviral Agents|antiviral agents|mesh-ancestor
2119338|NCT02704156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119339|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119340|NCT02704156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2119341|NCT02704156|Immunologic Factors|immunologic factors|mesh-ancestor
2557054|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557055|NCT01524354|Anesthetics|anesthetics|mesh-list
2557056|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557057|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557058|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
2557059|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2557060|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557061|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557062|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2557063|NCT01524367|Analgesics|analgesics|mesh-ancestor
2557064|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
2557065|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557066|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2557067|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2557068|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2557069|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
2557070|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2557071|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557072|NCT01524432|Clotrimazole|clotrimazole|mesh-list
2557073|NCT01524432|Miconazole|miconazole|mesh-list
2557074|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
2557075|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2557076|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2557077|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2557078|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2557079|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557080|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557081|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2557082|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
2557083|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557084|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557085|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2557086|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2557087|NCT01524445|Bortezomib|bortezomib|mesh-list
2557088|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119342|NCT02704156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557089|NCT01524497|Trazodone|trazodone|mesh-list
2119343|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2119344|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2119345|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2119346|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2119347|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2119348|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
2119349|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119350|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2119351|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2119352|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119353|NCT02705105|Nivolumab|nivolumab|mesh-list
2119354|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
2119355|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2119356|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557090|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2557091|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2557092|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557093|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557094|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2557095|NCT01524497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2557096|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2557097|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2557098|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557099|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2557100|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
2119357|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2119358|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119359|NCT02705352|Fluorouracil|fluorouracil|mesh-list
2119360|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
2119361|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119362|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2119363|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119364|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2119365|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
2119366|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119367|NCT02705716|Fluorides|fluorides|mesh-list
2119368|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
2119369|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
2119370|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
2119371|NCT02705716|Protective Agents|protective agents|mesh-ancestor
2119372|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119373|NCT02705807|Epoprostenol|epoprostenol|mesh-list
2119374|NCT02705807|Tezosentan|tezosentan|mesh-list
2119375|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2418449|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2418450|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2418451|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
2418452|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418453|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418454|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2418455|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2119376|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2119377|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
2119378|NCT02706249|Enoxaparin|enoxaparin|mesh-list
2119379|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
2119380|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2119381|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2119382|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119383|NCT02706483|Plecanatide|plecanatide|mesh-list
2119384|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2119385|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
2119386|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119387|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2418456|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
2418457|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2418458|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
2418459|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
2418460|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
2418461|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2418462|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2418463|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2418464|NCT00799175|Analgesics|analgesics|mesh-ancestor
2557101|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2557102|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
2557103|NCT01524536|Prednisone|prednisone|mesh-list
2557104|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2557105|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
2557106|NCT01524536|Hormones|hormones|mesh-ancestor
2557107|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557108|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557109|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2557110|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557111|NCT01524575|Gemcitabine|gemcitabine|mesh-list
2557112|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
2557113|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2557114|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
2557115|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557116|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557117|NCT01524575|Antiviral Agents|antiviral agents|mesh-ancestor
2557118|NCT01524575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2557119|NCT01524575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557120|NCT01524575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2557121|NCT01524575|Immunologic Factors|immunologic factors|mesh-ancestor
2557122|NCT01524575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557123|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2557124|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2557125|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2557126|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
2557127|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557128|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2557129|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2557130|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557131|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2557132|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2557133|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2557134|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
2557135|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557136|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2557137|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2557138|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557139|NCT01524705|Insulin|insulin|mesh-list
2557140|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2557141|NCT01524705|Metformin|metformin|mesh-list
2557142|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
2557143|NCT01524705|Exenatide|exenatide|mesh-list
2557144|NCT01524705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2557145|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557146|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557147|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2557148|NCT01524705|Incretins|incretins|mesh-ancestor
2557149|NCT01524705|Hormones|hormones|mesh-ancestor
2557150|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557151|NCT01524731|Dexamethasone|dexamethasone|mesh-list
2557152|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
2557153|NCT01524731|BB 1101|bb 1101|mesh-list
2557154|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2557155|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
2557156|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
2557157|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557158|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557159|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2557160|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
2557161|NCT01524731|Hormones|hormones|mesh-ancestor
2557162|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557163|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2557164|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557165|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
2557166|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557167|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557168|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
2557169|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2557170|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2557171|NCT01524744|Analgesics|analgesics|mesh-ancestor
2557172|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
2557173|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557174|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557175|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2119388|NCT02706847|Upadacitinib|upadacitinib|mesh-list
2119389|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2119390|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2119391|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119392|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119393|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2119394|NCT02706873|Methotrexate|methotrexate|mesh-list
2119395|NCT02706873|Upadacitinib|upadacitinib|mesh-list
2119396|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2119397|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
2119398|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2119399|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119400|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2119401|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
2119402|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119403|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119404|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
2119405|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119406|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2119407|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2119408|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
2119409|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2119410|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2557176|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2557177|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
2557178|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2557179|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
2557180|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2557181|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557182|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119411|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2119412|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2119413|NCT02706899|Azacitidine|azacitidine|mesh-list
2119414|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2557183|NCT01524757|Pantoprazole|pantoprazole|mesh-list
2557184|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2557185|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2557186|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2557187|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119415|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
2119416|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119417|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119418|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119419|NCT02706951|Methotrexate|methotrexate|mesh-list
2119420|NCT02706951|Upadacitinib|upadacitinib|mesh-list
2119421|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2119422|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
2119423|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2119424|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119425|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2119426|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
2119427|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119428|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119429|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
2119430|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119431|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2119432|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2119433|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
2557188|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557189|NCT01524809|Insulin|insulin|mesh-list
2557190|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2557191|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
2557192|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
2557193|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2557194|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
2557195|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2557196|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557197|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557198|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
2119434|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2119435|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2119436|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2119437|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2557199|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
2119438|NCT02707523|Azithromycin|azithromycin|mesh-list
2119439|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2119440|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119441|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
2119442|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2119443|NCT02707601|Ledipasvir|ledipasvir|mesh-list
2119444|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2119445|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
2119446|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119447|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2119448|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2119449|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
2119450|NCT02707640|Pirfenidone|pirfenidone|mesh-list
2119451|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2119452|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
2119453|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119454|NCT02707640|Expectorants|expectorants|mesh-ancestor
2119455|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
2119456|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2119457|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
2119458|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119459|NCT02707640|Protective Agents|protective agents|mesh-ancestor
2119460|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119461|NCT02707640|Antidotes|antidotes|mesh-ancestor
2119462|NCT02707640|Analgesics|analgesics|mesh-ancestor
2119463|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
2119464|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557200|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
2557201|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557202|NCT01524861|Protective Agents|protective agents|mesh-ancestor
2557203|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557204|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
2557205|NCT01524861|Vitamins|vitamins|mesh-ancestor
2557206|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
2557207|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
2557208|NCT01524874|Vitamin D|vitamin d|mesh-list
2557209|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
2557210|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
2557211|NCT01524874|Calcitriol|calcitriol|mesh-list
2557212|NCT01524874|Vitamins|vitamins|mesh-list
2557213|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
2557214|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557215|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2557216|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2557217|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2557218|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2557219|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557220|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2557221|NCT01524926|Crizotinib|crizotinib|mesh-list
2557222|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557223|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2557224|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557225|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557226|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
2557227|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2557228|NCT01524939|Antibodies|antibodies|mesh-list
2557229|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
2557230|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
2557231|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557232|NCT01525004|Vaccines|vaccines|mesh-list
2557233|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
2119465|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2119466|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2119467|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2119468|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2119469|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119470|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2119471|NCT02707757|Hematinics|hematinics|mesh-ancestor
2119472|NCT02707861|Ibalizumab|ibalizumab|mesh-list
2119473|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2119474|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
2119475|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119476|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2119477|NCT02707952|Ritonavir|ritonavir|mesh-list
2119478|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2119479|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2557234|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557235|NCT01525043|Naproxen|naproxen|mesh-list
2557236|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2557237|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2557238|NCT01525043|Analgesics|analgesics|mesh-ancestor
2557239|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
2557240|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557241|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557242|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2557243|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2557244|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
2418465|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2418466|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2418467|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2418468|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418469|NCT00799188|Everolimus|everolimus|mesh-list
2418470|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418471|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418472|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
2418473|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418474|NCT00799201|Naloxone|naloxone|mesh-list
2418475|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2418476|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418477|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
2418478|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119480|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
2119481|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119482|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119483|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2119484|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2119485|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
2119486|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119487|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2119488|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2119489|NCT02707965|Topiramate|topiramate|mesh-list
2119490|NCT02707965|Lamotrigine|lamotrigine|mesh-list
2119491|NCT02707965|Zonisamide|zonisamide|mesh-list
2119492|NCT02707965|Carbamazepine|carbamazepine|mesh-list
2119493|NCT02707965|Phenytoin|phenytoin|mesh-list
2119494|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
2119495|NCT02707965|Levetiracetam|levetiracetam|mesh-list
2119496|NCT02707965|Valproic Acid|valproic acid|mesh-list
2119497|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
2119498|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2119499|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119500|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
2119501|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2119502|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119503|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119504|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2119505|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2119506|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2119507|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119508|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2119509|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2119510|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119511|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
2557245|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2557246|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557247|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557248|NCT01525069|Gemcitabine|gemcitabine|mesh-list
2557249|NCT01525069|Dexamethasone|dexamethasone|mesh-list
2557250|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
2557251|NCT01525069|Floxuridine|floxuridine|mesh-list
2557252|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2557253|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
2557254|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
2557255|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557256|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557257|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2557258|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
2557259|NCT01525069|Hormones|hormones|mesh-ancestor
2557260|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557261|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2557262|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119512|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119513|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
2418479|NCT00799214|Metronidazole|metronidazole|mesh-list
2418480|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119514|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2119515|NCT02707965|Analgesics|analgesics|mesh-ancestor
2119516|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
2119517|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119518|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2119519|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2119520|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2119521|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2119522|NCT02708238|Simethicone|simethicone|mesh-list
2119523|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
2119524|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119525|NCT02708238|Emollients|emollients|mesh-ancestor
2119526|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
2119527|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
2119528|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2119529|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119530|NCT02708355|Esomeprazole|esomeprazole|mesh-list
2119531|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2119532|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2119533|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2119534|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119535|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119536|NCT02708433|Lidocaine|lidocaine|mesh-list
2119537|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
2119538|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
2557263|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2557264|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
2557265|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557266|NCT01525069|Antiviral Agents|antiviral agents|mesh-ancestor
2557267|NCT01525069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2557268|NCT01525069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557269|NCT01525069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2557270|NCT01525069|Immunologic Factors|immunologic factors|mesh-ancestor
2557271|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2557272|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2557273|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2557274|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557277|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
2557278|NCT01525394|Lenvatinib|lenvatinib|mesh-list
2557279|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2557280|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2557281|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2557282|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2557283|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557284|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557285|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557286|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2557287|NCT01525537|Sufentanil|sufentanil|mesh-list
2557288|NCT01525537|Dsuvia|dsuvia|mesh-list
2557289|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2557290|NCT01525537|Narcotics|narcotics|mesh-ancestor
2557291|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557292|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557293|NCT01525537|Analgesics|analgesics|mesh-ancestor
2557294|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
2557295|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557296|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2557297|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2557298|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
2557299|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
2557300|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
2557301|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2557302|NCT01525706|Ethanol|ethanol|mesh-list
2557303|NCT01525706|Paclitaxel|paclitaxel|mesh-list
2119539|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119540|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119541|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
2119542|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119543|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2119544|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2119545|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2557304|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2557305|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2557306|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557307|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
2557308|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
2557309|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
2557310|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557311|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2557312|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2557313|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557314|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557315|NCT01525719|Everolimus|everolimus|mesh-list
2557316|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557317|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2557318|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
2557319|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557320|NCT01525771|Cisplatin|cisplatin|mesh-list
2557321|NCT01525771|Docetaxel|docetaxel|mesh-list
2557322|NCT01525771|Capecitabine|capecitabine|mesh-list
2557323|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557324|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
2557325|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
2557326|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
2557327|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557328|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2557329|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
2557330|NCT01525823|Metformin|metformin|mesh-list
2557331|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557332|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557333|NCT01525836|Rituximab|rituximab|mesh-list
2557334|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2557335|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557336|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
2557337|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557338|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2557339|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2557340|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2557341|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2557342|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557343|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
2557344|NCT01525901|Mitogens|mitogens|mesh-list
2557345|NCT01525901|Mecasermin|mecasermin|mesh-list
2557346|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557347|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
2557348|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557349|NCT01525901|Growth Substances|growth substances|mesh-ancestor
2557350|NCT01525914|Dutasteride|dutasteride|mesh-list
2557351|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2557352|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2557353|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557354|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557355|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
2557356|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557357|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557358|NCT01525966|Paclitaxel|paclitaxel|mesh-list
2557359|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2557360|NCT01525966|Carboplatin|carboplatin|mesh-list
2557361|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2557362|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557363|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
2557364|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
2557365|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
2557366|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557367|NCT01526005|Nicotine|nicotine|mesh-list
2557368|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2557369|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
2557370|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557371|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557372|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2557373|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2557374|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
2557375|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2557376|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557377|NCT01526070|Aflibercept|aflibercept|mesh-list
2557378|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2557379|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2557380|NCT01526070|Growth Substances|growth substances|mesh-ancestor
2557381|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557382|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
2557383|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557384|NCT01526083|Lacosamide|lacosamide|mesh-list
2557385|NCT01526083|Warfarin|warfarin|mesh-list
2557386|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
2557387|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
2557388|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2557389|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2119546|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119547|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119548|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
2119549|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2119550|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119551|NCT02709005|Monolaurin|monolaurin|mesh-list
2119552|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
2119553|NCT02709005|Protective Agents|protective agents|mesh-ancestor
2119554|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119555|NCT02709018|Losartan|losartan|mesh-list
2119556|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2119557|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2557390|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2557391|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557392|NCT01526096|Plerixafor|plerixafor|mesh-list
2557393|NCT01526096|Melphalan|melphalan|mesh-list
2557394|NCT01526096|Basiliximab|basiliximab|mesh-list
2557395|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2557396|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
2557397|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557398|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557399|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2557400|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2557401|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
2557402|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557403|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2557404|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2557405|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
2557406|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2557407|NCT01526122|Aspirin|aspirin|mesh-list
2557408|NCT01526122|Clopidogrel|clopidogrel|mesh-list
2119558|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2119559|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2119560|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119561|NCT02709109|Ivacaftor|ivacaftor|mesh-list
2119562|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2119563|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119564|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119565|NCT02709486|Tanezumab|tanezumab|mesh-list
2119566|NCT02709486|Analgesics|analgesics|mesh-ancestor
2119567|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
2119568|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119569|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119570|NCT02709746|Vortioxetine|vortioxetine|mesh-list
2119571|NCT02709746|Fluoxetine|fluoxetine|mesh-list
2119572|NCT02709746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2119573|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2119574|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119575|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119576|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119577|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
2119578|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119579|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2119580|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
2119581|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2119582|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2119583|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2119584|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119585|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2119586|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2119587|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557409|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2557410|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2557411|NCT01526122|Analgesics|analgesics|mesh-ancestor
2119588|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2119589|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2119590|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2119591|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2119592|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
2119593|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2119594|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119595|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
2119596|NCT02709889|Dexamethasone|dexamethasone|mesh-list
2119597|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2119598|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
2557412|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
2557413|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557414|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557415|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2557416|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2557417|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2557418|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2557419|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557420|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2557421|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2557422|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557423|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
2557424|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2557425|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2557426|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2557427|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
2557428|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119599|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
2119600|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119601|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119602|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2119603|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
2119604|NCT02709889|Hormones|hormones|mesh-ancestor
2119605|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2119606|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2119607|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119608|NCT02710045|Vaccines|vaccines|mesh-list
2119609|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
2119610|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119611|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2119612|NCT02710071|Nebivolol|nebivolol|mesh-list
2119613|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2119614|NCT02710071|Diuretics|diuretics|mesh-ancestor
2119615|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
2119616|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119617|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2119618|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119619|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119620|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
2119621|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2119622|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2119623|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2119624|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
2119625|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119626|NCT02710214|Estrogens|estrogens|mesh-list
2119627|NCT02710214|Hormones|hormones|mesh-ancestor
2119628|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2119629|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119630|NCT02710526|Buprenorphine|buprenorphine|mesh-list
2119631|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2119632|NCT02710526|Narcotics|narcotics|mesh-ancestor
2119633|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119634|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119635|NCT02710526|Analgesics|analgesics|mesh-ancestor
2119636|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
2557440|NCT01526161|Fluticasone|fluticasone|mesh-list
2557441|NCT01526161|Xhance|xhance|mesh-list
2557442|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2557443|NCT01526161|Montelukast|montelukast|mesh-list
2557444|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2557445|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2557446|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
2557447|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557448|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557449|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2557450|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
2557451|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
2557452|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2557453|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2557454|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2557455|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2557456|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
2557457|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2557458|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557459|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2557460|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
2557461|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557462|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2557463|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2557464|NCT01526174|Golimumab|golimumab|mesh-list
2119637|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119638|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2119639|NCT02710630|Dabigatran|dabigatran|mesh-list
2119640|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
2119641|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2119642|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
2119643|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119644|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557465|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2557466|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2557467|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2557468|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
2557469|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557470|NCT01526278|Alendronate|alendronate|mesh-list
2557471|NCT01526278|Calcitriol|calcitriol|mesh-list
2418481|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2418482|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2418483|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2418484|NCT00799240|Cisplatin|cisplatin|mesh-list
2418485|NCT00799240|Pemetrexed|pemetrexed|mesh-list
2418486|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2418487|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119645|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
2119646|NCT02710669|Propafenone|propafenone|mesh-list
2119647|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2119648|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2119649|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2119650|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119651|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119652|NCT02710890|Lacosamide|lacosamide|mesh-list
2119653|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
2119654|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2119655|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2119656|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119657|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119658|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
2119659|NCT02710981|Clomiphene|clomiphene|mesh-list
2119660|NCT02710981|Enclomiphene|enclomiphene|mesh-list
2119661|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
2119662|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119663|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
2119664|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2119665|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2418488|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418489|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418490|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2418491|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2119666|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119667|NCT02710981|Urological Agents|urological agents|mesh-ancestor
2119668|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2119669|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
2119670|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2119671|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557472|NCT01526278|Maxmarvil|maxmarvil|mesh-list
2557473|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2557474|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557475|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2557476|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2557477|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2557478|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557479|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2557480|NCT01526278|Vitamins|vitamins|mesh-ancestor
2557481|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
2557482|NCT01526317|Metformin|metformin|mesh-list
2557483|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2557484|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557485|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557486|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2557487|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2557488|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
2557489|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119672|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2119673|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
2119674|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2119675|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2557490|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2557491|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2557492|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557493|NCT01526369|Paclitaxel|paclitaxel|mesh-list
2557494|NCT01526369|Trastuzumab|trastuzumab|mesh-list
2557495|NCT01526369|Lapatinib|lapatinib|mesh-list
2557496|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2557497|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557498|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
2119676|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2119677|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2119678|NCT02711306|Cathartics|cathartics|mesh-ancestor
2119679|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2119680|NCT02711553|Gemcitabine|gemcitabine|mesh-list
2119681|NCT02711553|Ramucirumab|ramucirumab|mesh-list
2418492|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
2418493|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418494|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
2418495|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2418496|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418497|NCT00799448|Insulin|insulin|mesh-list
2418498|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2418499|NCT00799448|Repaglinide|repaglinide|mesh-list
2418500|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
2418501|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
2418502|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
2418503|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2418504|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418505|NCT00799513|Lenalidomide|lenalidomide|mesh-list
2418506|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
2418507|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418508|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2418509|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2418510|NCT00799513|Growth Substances|growth substances|mesh-ancestor
2418511|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
2418512|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418513|NCT00799539|Prednisone|prednisone|mesh-list
2418514|NCT00799539|Bortezomib|bortezomib|mesh-list
2418515|NCT00799539|Melphalan|melphalan|mesh-list
2418516|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2418517|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
2418518|NCT00799539|Hormones|hormones|mesh-ancestor
2418519|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557499|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
2557500|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
2557501|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557502|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2418520|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557503|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2557504|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557505|NCT01526395|Propofol|propofol|mesh-list
2557506|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2557507|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557508|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557509|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2557510|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
2557511|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
2557512|NCT01526460|Atorvastatin|atorvastatin|mesh-list
2557513|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2557514|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2557515|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2557516|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
2557517|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557518|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2557519|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2557520|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557521|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
2557522|NCT01526499|Docetaxel|docetaxel|mesh-list
2557523|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2557524|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
2557525|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557526|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2557527|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2557528|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
2557529|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557530|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557531|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2557532|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
2557533|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
2557534|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
2557535|NCT01526525|Acetaminophen|acetaminophen|mesh-list
2557536|NCT01526525|Parecoxib|parecoxib|mesh-list
2557537|NCT01526525|Morphine|morphine|mesh-list
2557538|NCT01526525|Tramadol|tramadol|mesh-list
2557539|NCT01526525|Ketamine|ketamine|mesh-list
2557540|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2557541|NCT01526525|Narcotics|narcotics|mesh-ancestor
2557542|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557543|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557544|NCT01526525|Analgesics|analgesics|mesh-ancestor
2557545|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
2557546|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557547|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2557548|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2557549|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
2557550|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
2557551|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2557552|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2119682|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119683|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2119684|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
2119685|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119686|NCT02711553|Antiviral Agents|antiviral agents|mesh-ancestor
2119687|NCT02711553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119688|NCT02711553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119689|NCT02711553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2119690|NCT02711553|Immunologic Factors|immunologic factors|mesh-ancestor
2119691|NCT02711553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119692|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2119693|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
2119694|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2119695|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119696|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119697|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
2119698|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119699|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119700|NCT02711995|Laxatives|laxatives|mesh-ancestor
2119701|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2119702|NCT02712008|Aflibercept|aflibercept|mesh-list
2119703|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2119704|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2119705|NCT02712008|Growth Substances|growth substances|mesh-ancestor
2119706|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557553|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2557554|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557555|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2557556|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
2557557|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2557558|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2557559|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557560|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2557561|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2557562|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2557563|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
2557564|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
2557565|NCT01526564|Vitamins|vitamins|mesh-ancestor
2557566|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
2557567|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119707|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
2119708|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119709|NCT02712047|Fluticasone|fluticasone|mesh-list
2557568|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
2557569|NCT01526603|Carboplatin|carboplatin|mesh-list
2557570|NCT01526603|Etoposide|etoposide|mesh-list
2557571|NCT01526603|Melphalan|melphalan|mesh-list
2557572|NCT01526603|Tretinoin|tretinoin|mesh-list
2557573|NCT01526603|Isotretinoin|isotretinoin|mesh-list
2557574|NCT01526603|Sargramostim|sargramostim|mesh-list
2557575|NCT01526603|Lenograstim|lenograstim|mesh-list
2557576|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557577|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2557578|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2557579|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2557580|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557581|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557582|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2557583|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
2557584|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2557585|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2557586|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
2557587|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557588|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2557589|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
2557590|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
2557591|NCT01526616|Metformin|metformin|mesh-list
2119710|NCT02712047|Xhance|xhance|mesh-list
2119711|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2119712|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2119713|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
2119714|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119715|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119716|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2119717|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
2557592|NCT01526616|Spironolactone|spironolactone|mesh-list
2557593|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557594|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557595|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2557596|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
2557597|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2119718|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
2119719|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2119720|NCT02712788|Milrinone|milrinone|mesh-list
2119721|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2119722|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2119723|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
2119724|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2119725|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2119726|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119727|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119728|NCT02712788|Protective Agents|protective agents|mesh-ancestor
2119729|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119730|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2119731|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2119732|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119733|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2119734|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2119735|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119736|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557598|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2557599|NCT01526616|Diuretics|diuretics|mesh-ancestor
2557600|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
2557601|NCT01526694|Thalidomide|thalidomide|mesh-list
2557602|NCT01526694|Dexamethasone|dexamethasone|mesh-list
2557603|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2557604|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2557605|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
2557606|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
2119737|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
2119738|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119739|NCT02713178|Bupivacaine|bupivacaine|mesh-list
2119740|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
2119741|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
2119742|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119743|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119744|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
2119745|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119746|NCT02713204|Aflibercept|aflibercept|mesh-list
2119747|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2119748|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2119749|NCT02713204|Growth Substances|growth substances|mesh-ancestor
2119750|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119751|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
2557607|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557608|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557609|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2557610|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
2557611|NCT01526694|Hormones|hormones|mesh-ancestor
2557612|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557613|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2557614|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557615|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2557616|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
2557617|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557618|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2557619|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
2557620|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
2557621|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2557622|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2557623|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2557624|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2119752|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119753|NCT02713230|Bupivacaine|bupivacaine|mesh-list
2119754|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
2119755|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
2119756|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119757|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119758|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
2119759|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119760|NCT02713490|Bupivacaine|bupivacaine|mesh-list
2119761|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
2119762|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
2119763|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119764|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119765|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
2119766|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119767|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
2119768|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2119769|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557625|NCT01526694|Growth Substances|growth substances|mesh-ancestor
2557626|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
2557627|NCT01526837|Bevacizumab|bevacizumab|mesh-list
2557628|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2557629|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557630|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2557631|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2557632|NCT01526837|Growth Substances|growth substances|mesh-ancestor
2557633|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557634|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
2557635|NCT01526850|Cyclosporine|cyclosporine|mesh-list
2119770|NCT02713698|Propofol|propofol|mesh-list
2119771|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2119772|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119773|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557636|NCT01526850|Cyclosporins|cyclosporins|mesh-list
2557637|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
2119774|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2119775|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
2119776|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
2557638|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557639|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557640|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2557641|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
2557642|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557643|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
2557644|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2557645|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
2557646|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2557647|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2557648|NCT01526850|Hormones|hormones|mesh-ancestor
2557649|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557650|NCT01526876|Clevidipine|clevidipine|mesh-list
2557651|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2557652|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2557653|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557654|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2557655|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557656|NCT01526941|Insulin|insulin|mesh-list
2557657|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2557658|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
2557659|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
2557660|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2557661|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
2557662|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2557663|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557664|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557665|NCT01526980|Insulin|insulin|mesh-list
2557666|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2557667|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
2557668|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
2557669|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2557670|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
2557671|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2557672|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557673|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119777|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
2119778|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2119779|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2119780|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119781|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
2119782|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557674|NCT01527019|Cephalosporins|cephalosporins|mesh-list
2557675|NCT01527019|Norfloxacin|norfloxacin|mesh-list
2557676|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2557677|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2557678|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2557679|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2557680|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557681|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557682|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557683|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2557684|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2557685|NCT01527032|Thalidomide|thalidomide|mesh-list
2119783|NCT02713867|Nivolumab|nivolumab|mesh-list
2119784|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2119785|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557686|NCT01527032|Dexamethasone|dexamethasone|mesh-list
2557687|NCT01527032|Melphalan|melphalan|mesh-list
2557688|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2557689|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
2557690|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
2557691|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557692|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557693|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2557694|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
2557695|NCT01527032|Hormones|hormones|mesh-ancestor
2557696|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557697|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2557698|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418521|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2418522|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418523|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2418524|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
2418525|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418526|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2418527|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418528|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
2418529|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
2418530|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
2418531|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418532|NCT00799682|Travoprost|travoprost|mesh-list
2418533|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2418534|NCT00799682|Latanoprost|latanoprost|mesh-list
2418535|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2418536|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2418537|NCT00799760|Oseltamivir|oseltamivir|mesh-list
2418538|NCT00799760|Zanamivir|zanamivir|mesh-list
2418539|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
2557699|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2557700|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
2557701|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557702|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2557703|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2557704|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
2557705|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
2557706|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2557707|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2557708|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2119786|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2119787|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119788|NCT02714062|Topiramate|topiramate|mesh-list
2119789|NCT02714062|Phentermine|phentermine|mesh-list
2119790|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
2119791|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2119792|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557709|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2557710|NCT01527032|Growth Substances|growth substances|mesh-ancestor
2557711|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
2557712|NCT01527097|Atorvastatin|atorvastatin|mesh-list
2557713|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2557714|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2557715|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
2557716|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557717|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2557718|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2557719|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557720|NCT01527279|Antazoline|antazoline|mesh-list
2557721|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2119793|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2119794|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
2119795|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2119796|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
2119797|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
2557722|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
2557723|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
2557724|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2557725|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557726|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557727|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2557728|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2557729|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2557730|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2557731|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557732|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557733|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2557734|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2557735|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2557736|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
2557737|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2557738|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557739|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2418540|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119798|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119799|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
2119800|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119801|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557740|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2557741|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
2557742|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
2557743|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2557744|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2557745|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
2557746|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557747|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2557748|NCT01527422|Prednisone|prednisone|mesh-list
2557749|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
2557750|NCT01527422|Doxorubicin|doxorubicin|mesh-list
2557751|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2557752|NCT01527422|Vincristine|vincristine|mesh-list
2557753|NCT01527422|Sargramostim|sargramostim|mesh-list
2557754|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2557755|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
2557756|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557757|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2557758|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2557759|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
2557760|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557761|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557762|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2557763|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2557764|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2557765|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2119808|NCT02714283|Azithromycin|azithromycin|mesh-list
2119809|NCT02714283|Erythromycin|erythromycin|mesh-list
2119810|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2119811|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119812|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2119813|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2119814|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119815|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119816|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2119817|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2119818|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2119819|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119820|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119821|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119822|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557766|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557767|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2557768|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
2557769|NCT01527422|Hormones|hormones|mesh-ancestor
2557770|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557771|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2557772|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2557773|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
2557774|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
2557775|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
2557776|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2557777|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
2557778|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2557779|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2119823|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2119824|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
2557780|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2557781|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557782|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557783|NCT01527474|Citalopram|citalopram|mesh-list
2557784|NCT01527474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2557785|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2557786|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2557787|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557788|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2557789|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
2557790|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557791|NCT01527474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2557792|NCT01527474|Antidepressive Agents|antidepressive agents|mesh-ancestor
2557793|NCT01527474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2557794|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
2119825|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2119826|NCT02714504|Voriconazole|voriconazole|mesh-list
2119827|NCT02714504|Posaconazole|posaconazole|mesh-list
2119828|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
2119829|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119830|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2119831|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2119832|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119833|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119834|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2119835|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
2119836|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2119837|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119838|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2119839|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2119840|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2119841|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2119842|NCT02714569|Atorvastatin|atorvastatin|mesh-list
2557795|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
2557796|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2557797|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557798|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557799|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
2557800|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
2557801|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557802|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557803|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
2557804|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
2557805|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557806|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557807|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2557808|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
2557809|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557810|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
2557811|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
2557812|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557813|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557814|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
2557815|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
2557816|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557817|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557818|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
2557819|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
2557820|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557821|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557822|NCT01527669|Lovastatin|lovastatin|mesh-list
2557823|NCT01527669|L 647318|l 647318|mesh-list
2557824|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
2119843|NCT02714569|Simvastatin|simvastatin|mesh-list
2119844|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2119845|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2119846|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
2119847|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119848|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2119849|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2119850|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119851|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
2557825|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2557826|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2557827|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
2557828|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557829|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2557830|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2557831|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557832|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
2557833|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
2119852|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2119853|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119854|NCT02715700|Methadone|methadone|mesh-list
2119855|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2119856|NCT02715700|Narcotics|narcotics|mesh-ancestor
2119857|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119858|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119859|NCT02715700|Analgesics|analgesics|mesh-ancestor
2119860|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
2119861|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119862|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
2119863|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
2119864|NCT02715726|Atorvastatin|atorvastatin|mesh-list
2119865|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2119866|NCT02715726|Simvastatin|simvastatin|mesh-list
2119867|NCT02715726|Ezetimibe|ezetimibe|mesh-list
2557834|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
2557835|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557836|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557837|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
2557838|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557839|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2119868|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2119869|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2119870|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2119871|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
2119872|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119873|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2119874|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2119875|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119876|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
2119877|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119878|NCT02715804|Gemcitabine|gemcitabine|mesh-list
2119879|NCT02715804|Paclitaxel|paclitaxel|mesh-list
2119880|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2119881|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119882|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
2119883|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
2119884|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
2119885|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557840|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2557841|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557842|NCT01527747|Saxagliptin|saxagliptin|mesh-list
2557843|NCT01527747|Incretins|incretins|mesh-ancestor
2557844|NCT01527747|Hormones|hormones|mesh-ancestor
2557845|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2557846|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557847|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2557848|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
2557849|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557850|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557851|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2557852|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2557853|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2557854|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2557855|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2557856|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557857|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2557858|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557859|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
2557860|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2557861|NCT01527864|Paclitaxel|paclitaxel|mesh-list
2557862|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2557863|NCT01527864|Carboplatin|carboplatin|mesh-list
2557864|NCT01527864|Endostatins|endostatins|mesh-list
2557865|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2557866|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557867|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
2557868|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
2557869|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
2119886|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2119887|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
2119888|NCT02715804|Antiviral Agents|antiviral agents|mesh-ancestor
2557870|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557871|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2418541|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418542|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418543|NCT00799838|Amoxicillin|amoxicillin|mesh-list
2418544|NCT00799838|Ketoprofen|ketoprofen|mesh-list
2418545|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2418546|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418547|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2418548|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2418549|NCT00799838|Analgesics|analgesics|mesh-ancestor
2418550|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
2418551|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418552|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418553|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2418554|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2418555|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2418556|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418557|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418558|NCT00799864|Tenofovir|tenofovir|mesh-list
2418559|NCT00799864|Lamivudine|lamivudine|mesh-list
2418560|NCT00799864|Zidovudine|zidovudine|mesh-list
2418561|NCT00799864|Emtricitabine|emtricitabine|mesh-list
2418562|NCT00799864|Abacavir|abacavir|mesh-list
2418563|NCT00799864|Rilpivirine|rilpivirine|mesh-list
2418564|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
2418565|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418566|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2418567|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2418568|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418569|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418570|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2418571|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2418572|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
2418573|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2418574|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
2418575|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418576|NCT00799890|Protective Agents|protective agents|mesh-ancestor
2418577|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557872|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2557873|NCT01527864|Growth Substances|growth substances|mesh-ancestor
2557874|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557875|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
2557876|NCT01527890|Fentanyl|fentanyl|mesh-list
2557877|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2557878|NCT01527890|Narcotics|narcotics|mesh-ancestor
2119889|NCT02715804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119890|NCT02715804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119891|NCT02715804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2119892|NCT02715804|Immunologic Factors|immunologic factors|mesh-ancestor
2119893|NCT02715804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119894|NCT02716194|Factor VIII|factor viii|mesh-list
2119895|NCT02716194|Coagulants|coagulants|mesh-ancestor
2119896|NCT02716779|Interferons|interferons|mesh-list
2119897|NCT02716779|Ribavirin|ribavirin|mesh-list
2119898|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119899|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
2119900|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119901|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
2119902|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119903|NCT02716805|Melphalan|melphalan|mesh-list
2119904|NCT02716805|Durvalumab|durvalumab|mesh-list
2119905|NCT02716805|Tremelimumab|tremelimumab|mesh-list
2119906|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2119907|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
2119908|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119909|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119910|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2119911|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2119912|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
2119913|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119914|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2119915|NCT02716818|Dexamethasone|dexamethasone|mesh-list
2119916|NCT02716818|Prednisone|prednisone|mesh-list
2119917|NCT02716818|Prednisolone|prednisolone|mesh-list
2119918|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
2119919|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2119920|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2119921|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2119922|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
2119923|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2119924|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
2119925|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
2119926|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119927|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119928|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2119929|NCT02716818|Hormones|hormones|mesh-ancestor
2119930|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2119931|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2119932|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119933|NCT02717195|Olanzapine|olanzapine|mesh-list
2119934|NCT02717195|Risperidone|risperidone|mesh-list
2119935|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2119936|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
2119937|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119938|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119939|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119940|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2119941|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2119942|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2119943|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2119944|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2119945|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
2119946|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
2119947|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
2119948|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119949|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2119950|NCT02717195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2119951|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2119952|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119953|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2119954|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2119955|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119956|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
2119957|NCT02717754|Oseltamivir|oseltamivir|mesh-list
2119958|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
2119959|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119960|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2119961|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119962|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2119963|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2119964|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2119965|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2119966|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119967|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
2119968|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2119969|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119970|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2119971|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119972|NCT02718326|Aflibercept|aflibercept|mesh-list
2119973|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2119974|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2119975|NCT02718326|Growth Substances|growth substances|mesh-ancestor
2119976|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119977|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
2119978|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119979|NCT02718417|Paclitaxel|paclitaxel|mesh-list
2119980|NCT02718417|Carboplatin|carboplatin|mesh-list
2119981|NCT02718417|Avelumab|avelumab|mesh-list
2557879|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557880|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557881|NCT01527890|Analgesics|analgesics|mesh-ancestor
2557882|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
2557883|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557884|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2557885|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2557886|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
2557887|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
2557888|NCT01527903|Midazolam|midazolam|mesh-list
2557889|NCT01527903|Propofol|propofol|mesh-list
2557890|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2119982|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2557891|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557892|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418578|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2418579|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2418580|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418581|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2418582|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
2418583|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2418584|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418585|NCT00800137|Heparin|heparin|mesh-list
2557893|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2557894|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
2557895|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
2557896|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2557897|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2557898|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2557899|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2557900|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
2557901|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
2557902|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2557903|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557904|NCT01527916|Donepezil|donepezil|mesh-list
2557905|NCT01527916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2557906|NCT01527916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557907|NCT01527916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119983|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2119984|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2119985|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
2119986|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
2557908|NCT01527916|Cholinergic Agents|cholinergic agents|mesh-ancestor
2557909|NCT01527916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2557910|NCT01527916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557911|NCT01527916|Nootropic Agents|nootropic agents|mesh-ancestor
2557912|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
2557913|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
2557914|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2557915|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2557916|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557917|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
2557918|NCT01527968|Coagulants|coagulants|mesh-ancestor
2557919|NCT01527994|Aprepitant|aprepitant|mesh-list
2557920|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
2557921|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
2557922|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2557923|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557924|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2557925|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2557926|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2557927|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557928|NCT01528007|Naltrexone|naltrexone|mesh-list
2557929|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2557930|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2557931|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557932|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
2557933|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2119987|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
2119988|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2119989|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2119990|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
2119991|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2119992|NCT02718898|Ixekizumab|ixekizumab|mesh-list
2557952|NCT01528137|Lactoferrin|lactoferrin|mesh-list
2557953|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
2557954|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2557955|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557956|NCT01528163|Methotrexate|methotrexate|mesh-list
2557957|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2557958|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
2557959|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2557960|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557961|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2557962|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
2557963|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557964|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557965|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
2119993|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
2119994|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
2119995|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2119996|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2119997|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2119998|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2119999|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120000|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557966|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2557967|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2557968|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2557969|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
2557970|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2557971|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2557972|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
2557973|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2557974|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557975|NCT01528176|Vitamins|vitamins|mesh-ancestor
2557976|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
2557977|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2557978|NCT01528280|Vaccines|vaccines|mesh-list
2557979|NCT01528280|Immunologic Factors|immunologic factors|mesh-ancestor
2557980|NCT01528280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557981|NCT01528371|Midazolam|midazolam|mesh-list
2557982|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2557983|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2557984|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2557985|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2557986|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2557987|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2120001|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120002|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2120003|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2120004|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2120005|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
2120006|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120007|NCT02720081|Albuterol|albuterol|mesh-list
2120008|NCT02720081|Montelukast|montelukast|mesh-list
2120009|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2120010|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
2120011|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2120012|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
2120013|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120014|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120015|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2557988|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2557989|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2557990|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
2557991|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
2557992|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
2557993|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
2557994|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120016|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2120017|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120018|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2120019|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
2557995|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2557996|NCT01528501|Panobinostat|panobinostat|mesh-list
2120020|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120021|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
2120022|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2120023|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2120024|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2120025|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2120026|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
2120027|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120028|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2120029|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2120030|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120031|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2120032|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
2120033|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120034|NCT02720198|Milnacipran|milnacipran|mesh-list
2120035|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2120036|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
2120037|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
2120038|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2120039|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2120040|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2120041|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2120042|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120043|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2120044|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2120045|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2120046|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120047|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120048|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2120049|NCT02720198|Analgesics|analgesics|mesh-ancestor
2120050|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
2120051|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120052|NCT02720484|Nivolumab|nivolumab|mesh-list
2120053|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2557997|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2557998|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2557999|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558000|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558001|NCT01528540|Pregabalin|pregabalin|mesh-list
2558002|NCT01528540|Antioxidants|antioxidants|mesh-list
2558003|NCT01528540|Analgesics|analgesics|mesh-ancestor
2558004|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
2120054|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120055|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2120056|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120057|NCT02720523|Upadacitinib|upadacitinib|mesh-list
2120058|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2120059|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2558005|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558006|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558007|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
2558008|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2558009|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2558010|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558011|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2558012|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2558013|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2558014|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2558015|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2558016|NCT01528540|Protective Agents|protective agents|mesh-ancestor
2558017|NCT01528618|Gemcitabine|gemcitabine|mesh-list
2558018|NCT01528618|Cisplatin|cisplatin|mesh-list
2558019|NCT01528618|Fluorouracil|fluorouracil|mesh-list
2558020|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558021|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2558022|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
2558023|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558024|NCT01528618|Antiviral Agents|antiviral agents|mesh-ancestor
2558025|NCT01528618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558026|NCT01528618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120060|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558027|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2558028|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
2558029|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558030|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
2558031|NCT01528644|Iron|iron|mesh-list
2558032|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
2558033|NCT01528644|Calcium|calcium|mesh-list
2558034|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2558035|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558036|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2558037|NCT01528644|Trace Elements|trace elements|mesh-ancestor
2558038|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
2558039|NCT01528644|Hematinics|hematinics|mesh-ancestor
2558040|NCT01528722|Bupivacaine|bupivacaine|mesh-list
2558041|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
2558042|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
2558043|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2558044|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558045|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
2558046|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558047|NCT01528800|Vitamin K|vitamin k|mesh-list
2558048|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
2558049|NCT01528800|Vitamins|vitamins|mesh-ancestor
2558050|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
2558051|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558052|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2558053|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2558054|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558055|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
2558056|NCT01528800|Coagulants|coagulants|mesh-ancestor
2558057|NCT01528813|Amorolfine|amorolfine|mesh-list
2558058|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
2558059|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558060|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
2558061|NCT01528826|Vinorelbine|vinorelbine|mesh-list
2558062|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558063|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2558064|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
2558065|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
2558066|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
2558067|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120061|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120062|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2120063|NCT02720536|Deferasirox|deferasirox|mesh-list
2120064|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2120065|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
2120066|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
2120067|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558068|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
2558069|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2558070|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2558071|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558072|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
2558073|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
2558074|NCT01528865|Tenofovir|tenofovir|mesh-list
2558075|NCT01528865|Lamivudine|lamivudine|mesh-list
2558076|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
2558077|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120068|NCT02721017|Fentanyl|fentanyl|mesh-list
2120069|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2120070|NCT02721017|Narcotics|narcotics|mesh-ancestor
2120071|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2120072|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120073|NCT02721017|Analgesics|analgesics|mesh-ancestor
2120074|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
2558078|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2558079|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2558080|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558081|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558082|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2558083|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2558084|NCT01528930|Amikacin|amikacin|mesh-list
2558085|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2558086|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558087|NCT01528943|Epoprostenol|epoprostenol|mesh-list
2558088|NCT01528943|Tezosentan|tezosentan|mesh-list
2558089|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2558090|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2558091|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
2558092|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
2558093|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2558094|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558095|NCT01529125|Lamivudine|lamivudine|mesh-list
2558096|NCT01529125|Zidovudine|zidovudine|mesh-list
2558097|NCT01529125|Nevirapine|nevirapine|mesh-list
2120075|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120076|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2120077|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2120078|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
2120079|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
2120080|NCT02721641|Trastuzumab|trastuzumab|mesh-list
2120081|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2120082|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120083|NCT02721875|Azacitidine|azacitidine|mesh-list
2120084|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2120085|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
2120086|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120087|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120088|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120089|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2120090|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
2558098|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2558099|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2558100|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558101|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558102|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
2558103|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120091|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120092|NCT02722044|Adalimumab|adalimumab|mesh-list
2120093|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2120094|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2120095|NCT02722239|Metformin|metformin|mesh-list
2120096|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
2120097|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2120098|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120099|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2120100|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120101|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
2120102|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2120103|NCT02722278|Testosterone|testosterone|mesh-list
2120104|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
2120105|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
2120106|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2120107|NCT02722278|Androgens|androgens|mesh-ancestor
2120108|NCT02722278|Hormones|hormones|mesh-ancestor
2120109|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120110|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120111|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2120112|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120113|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
2120114|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
2120115|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2558104|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2558105|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2558106|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
2558107|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2558108|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2558109|NCT01529138|Sirolimus|sirolimus|mesh-list
2558110|NCT01529138|Axitinib|axitinib|mesh-list
2120116|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120117|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120118|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2120119|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2120120|NCT02722564|Ethanol|ethanol|mesh-list
2120121|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2120122|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120123|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2558111|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2558112|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558113|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2558114|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558115|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
2558116|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2558117|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
2558118|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558119|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2558120|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558121|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558122|NCT01529164|Leucovorin|leucovorin|mesh-list
2558123|NCT01529164|Fluorouracil|fluorouracil|mesh-list
2558124|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
2558125|NCT01529164|Endostar protein|endostar protein|mesh-list
2558126|NCT01529164|Endostatins|endostatins|mesh-list
2558127|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
2558128|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558129|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2558130|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120124|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120125|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
2120126|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2120127|NCT02722837|Velpatasvir|velpatasvir|mesh-list
2120128|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
2120129|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558131|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2558132|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
2558133|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558134|NCT01529164|Antidotes|antidotes|mesh-ancestor
2558135|NCT01529164|Protective Agents|protective agents|mesh-ancestor
2558136|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
2558137|NCT01529164|Vitamins|vitamins|mesh-ancestor
2558138|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
2558139|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2558140|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2558141|NCT01529164|Growth Substances|growth substances|mesh-ancestor
2558142|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
2558143|NCT01529177|Metformin|metformin|mesh-list
2558144|NCT01529177|Citric Acid|citric acid|mesh-list
2558145|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
2558146|NCT01529177|Clomiphene|clomiphene|mesh-list
2558147|NCT01529177|Enclomiphene|enclomiphene|mesh-list
2558148|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
2558149|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2558150|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418586|NCT00800137|Calcium heparin|calcium heparin|mesh-list
2418587|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2418588|NCT00800137|Tinzaparin|tinzaparin|mesh-list
2418589|NCT00800137|Dalteparin|dalteparin|mesh-list
2418590|NCT00800137|Warfarin|warfarin|mesh-list
2418591|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
2418592|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2120135|NCT02722967|Aripiprazole|aripiprazole|mesh-list
2120136|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
2120137|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2120138|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2120139|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2120140|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2120141|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120142|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
2120143|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
2120144|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120145|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120146|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2120147|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2120148|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
2120149|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2120150|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2120151|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2120152|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2120153|NCT02723006|Nivolumab|nivolumab|mesh-list
2558151|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
2558152|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2558153|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
2558154|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
2120154|NCT02723006|Ipilimumab|ipilimumab|mesh-list
2418593|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2418594|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418595|NCT00800150|Fludarabine|fludarabine|mesh-list
2418596|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
2418597|NCT00800150|Melphalan|melphalan|mesh-list
2418598|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418599|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2558155|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558156|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2558157|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
2558158|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2558159|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2558160|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
2558161|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2558162|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2558163|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2558164|NCT01529190|Pregabalin|pregabalin|mesh-list
2558165|NCT01529190|Analgesics|analgesics|mesh-ancestor
2558166|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
2558167|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558168|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558169|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
2558170|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2120155|NCT02723006|Vedolizumab|vedolizumab|mesh-list
2120156|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2120157|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120158|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2120159|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558171|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2558172|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120160|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2120161|NCT02723084|Ribavirin|ribavirin|mesh-list
2120162|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
2120163|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
2120164|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120165|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
2120166|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120167|NCT02723591|Tacrolimus|tacrolimus|mesh-list
2120168|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2120169|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
2120170|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120171|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2120172|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120173|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120174|NCT02723630|Lenvatinib|lenvatinib|mesh-list
2120175|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120176|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2120177|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120178|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120179|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
2120180|NCT02723786|Azathioprine|azathioprine|mesh-list
2120181|NCT02723786|Tacrolimus|tacrolimus|mesh-list
2120182|NCT02723786|Basiliximab|basiliximab|mesh-list
2120183|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2120184|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
2120185|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120186|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2120187|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120188|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120189|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2120190|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120191|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2120192|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
2120193|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2120194|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120195|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
2120196|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2120197|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2120198|NCT02724020|Everolimus|everolimus|mesh-list
2120199|NCT02724020|Serabelisib|serabelisib|mesh-list
2120200|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120201|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2120202|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
2120203|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558173|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2558174|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2558175|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2558176|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2558177|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2558178|NCT01529229|Prednisolone|prednisolone|mesh-list
2120204|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558179|NCT01529229|Betamethasone|betamethasone|mesh-list
2558180|NCT01529229|Desloratadine|desloratadine|mesh-list
2558181|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
2558182|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2558183|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
2558184|NCT01529229|Hormones|hormones|mesh-ancestor
2558185|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2558186|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558187|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2558188|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558189|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2558190|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
2558191|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2558192|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
2558193|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558194|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558195|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2558196|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2558197|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
2558198|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
2558199|NCT01529242|Prednisolone|prednisolone|mesh-list
2558200|NCT01529242|Betamethasone|betamethasone|mesh-list
2558201|NCT01529242|Desloratadine|desloratadine|mesh-list
2558202|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
2120205|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120206|NCT02724033|Dexamethasone|dexamethasone|mesh-list
2120207|NCT02724033|Ondansetron|ondansetron|mesh-list
2120208|NCT02724033|Antiemetics|antiemetics|mesh-list
2120209|NCT02724033|Bupivacaine|bupivacaine|mesh-list
2120210|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2120211|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
2120212|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120213|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120214|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2120215|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
2120216|NCT02724033|Hormones|hormones|mesh-ancestor
2120217|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120218|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2120219|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120220|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120221|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
2120222|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
2120223|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2120224|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
2120225|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
2120226|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
2120227|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2120228|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
2120229|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120230|NCT02724033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2120231|NCT02724033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2120232|NCT02724033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2120233|NCT02724033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2120234|NCT02724111|Rocuronium|rocuronium|mesh-list
2120235|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2120236|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2120237|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2120238|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120239|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120240|NCT02724423|Diazepam|diazepam|mesh-list
2120241|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2120242|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
2120243|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
2120244|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
2120245|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120246|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120247|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2120248|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2120249|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2120250|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2120251|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2120252|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2120253|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2120254|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2558203|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2558204|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
2120255|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2120256|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
2120257|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
2120258|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
2120259|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
2120260|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120261|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558205|NCT01529242|Hormones|hormones|mesh-ancestor
2558206|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2558207|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558208|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2558209|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558210|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2120262|NCT02724592|Fluorides|fluorides|mesh-list
2120263|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
2120264|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
2120265|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
2120266|NCT02724592|Protective Agents|protective agents|mesh-ancestor
2120267|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120268|NCT02724878|Bevacizumab|bevacizumab|mesh-list
2558211|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
2558212|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2558213|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
2558214|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558215|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558216|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2558217|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2558218|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
2558219|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
2558220|NCT01529255|Telbivudine|telbivudine|mesh-list
2558221|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
2120269|NCT02724878|Atezolizumab|atezolizumab|mesh-list
2120270|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2120271|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120272|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2120273|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2120274|NCT02724878|Growth Substances|growth substances|mesh-ancestor
2120275|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120276|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
2120277|NCT02725008|Dexamethasone|dexamethasone|mesh-list
2120278|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2120279|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
2558222|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558223|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2558224|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558225|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558226|NCT01529294|Iloperidone|iloperidone|mesh-list
2558227|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2558228|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2558229|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2558230|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558231|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2558232|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
2558233|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2558234|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2558235|NCT01529320|Prednisolone|prednisolone|mesh-list
2558236|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
2558237|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
2558238|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2120280|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
2120281|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120282|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120283|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2120284|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
2120285|NCT02725008|Hormones|hormones|mesh-ancestor
2120286|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120287|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2120288|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120289|NCT02725268|Paclitaxel|paclitaxel|mesh-list
2120290|NCT02725268|Serabelisib|serabelisib|mesh-list
2120291|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2120292|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120293|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
2558239|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
2120294|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
2120295|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
2120296|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120297|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120298|NCT02725411|Celecoxib|celecoxib|mesh-list
2120299|NCT02725411|Tanezumab|tanezumab|mesh-list
2120300|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2120301|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2120302|NCT02725411|Analgesics|analgesics|mesh-ancestor
2120303|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
2120304|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120305|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120306|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2120307|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2120308|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2120309|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2120310|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120311|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120312|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
2120313|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2558240|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2558241|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
2558242|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
2558243|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558244|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558245|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2558246|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
2558247|NCT01529320|Hormones|hormones|mesh-ancestor
2558248|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2558249|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2558250|NCT01529320|Protective Agents|protective agents|mesh-ancestor
2558251|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2558252|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558253|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
2558254|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558255|NCT01529476|Levofloxacin|levofloxacin|mesh-list
2558256|NCT01529476|Ofloxacin|ofloxacin|mesh-list
2558257|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2558258|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558259|NCT01529476|Renal Agents|renal agents|mesh-ancestor
2558260|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2558261|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2558262|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2558263|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558264|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558265|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558266|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2558267|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2558268|NCT01529528|Anagliptin|anagliptin|mesh-list
2558269|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2558270|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
2120314|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120315|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2120316|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120317|NCT02725710|Gabapentin|gabapentin|mesh-list
2120318|NCT02725710|Analgesics|analgesics|mesh-ancestor
2120319|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
2120320|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120321|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120322|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
2120323|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2120324|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2120325|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2120326|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2120327|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2120328|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2558271|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558272|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558273|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2558274|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558275|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2120329|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120330|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120331|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
2120332|NCT02725866|Ritonavir|ritonavir|mesh-list
2120333|NCT02725866|Ribavirin|ribavirin|mesh-list
2558276|NCT01529541|Anagliptin|anagliptin|mesh-list
2558277|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2558278|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558279|NCT01529541|Incretins|incretins|mesh-ancestor
2558280|NCT01529541|Hormones|hormones|mesh-ancestor
2558281|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2558282|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2558283|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
2558284|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558285|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558286|NCT01529554|Everolimus|everolimus|mesh-list
2558287|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558288|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2120334|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2120335|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2120336|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
2120337|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120338|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120339|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2120340|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2120341|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
2120342|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120343|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2120344|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2120345|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
2120346|NCT02726022|Ribavirin|ribavirin|mesh-list
2120347|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2120348|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
2558289|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
2558290|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558291|NCT01529619|Rivastigmine|rivastigmine|mesh-list
2558292|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2558293|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558294|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558295|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
2558296|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558297|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558298|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2558299|NCT01529619|Protective Agents|protective agents|mesh-ancestor
2558300|NCT01529710|Praziquantel|praziquantel|mesh-list
2558301|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
2558302|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2558303|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558304|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2558305|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2558306|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2558307|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558308|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558309|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2558310|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2558311|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558312|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
2558313|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558314|NCT01529892|Methamphetamine|methamphetamine|mesh-list
2558315|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2558316|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418600|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
2418601|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418602|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418603|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
2418604|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418605|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2418606|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
2418607|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2418608|NCT00800215|Lacosamide|lacosamide|mesh-list
2418609|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
2418610|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2418611|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2418612|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2418613|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418614|NCT00800267|Timolol|timolol|mesh-list
2418615|NCT00800267|Latanoprost|latanoprost|mesh-list
2558317|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
2558318|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
2558319|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558320|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
2558321|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120349|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120350|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
2120351|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120352|NCT02726113|Vitamin D|vitamin d|mesh-list
2120353|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
2120354|NCT02726113|Vitamins|vitamins|mesh-ancestor
2120355|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
2120356|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120357|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2120358|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2120359|NCT02726178|Ibuprofen|ibuprofen|mesh-list
2120360|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2120361|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2120362|NCT02726178|Analgesics|analgesics|mesh-ancestor
2120363|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
2120364|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120365|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120366|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2120367|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2120368|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2120369|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120370|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120371|NCT02726620|Lidocaine|lidocaine|mesh-list
2120372|NCT02726620|Atropine|atropine|mesh-list
2120373|NCT02726620|Terlipressin|terlipressin|mesh-list
2120374|NCT02726620|Phenylephrine|phenylephrine|mesh-list
2120375|NCT02726620|Dobutamine|dobutamine|mesh-list
2120376|NCT02726620|Dopamine|dopamine|mesh-list
2120377|NCT02726620|Milrinone|milrinone|mesh-list
2120378|NCT02726620|Isoproterenol|isoproterenol|mesh-list
2120379|NCT02726620|Vasopressins|vasopressins|mesh-list
2120380|NCT02726620|Arginine Vasopressin|arginine vasopressin|mesh-list
2120381|NCT02726620|Epinephrine|epinephrine|mesh-list
2120382|NCT02726620|Norepinephrine|norepinephrine|mesh-list
2558322|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558323|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
2558324|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2558325|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2558326|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2558327|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2558328|NCT01530009|Amoxicillin|amoxicillin|mesh-list
2558329|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2558330|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558331|NCT01530022|Lacosamide|lacosamide|mesh-list
2120383|NCT02726620|Ephedrine|ephedrine|mesh-list
2120384|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
2120385|NCT02726620|Bupivacaine|bupivacaine|mesh-list
2120386|NCT02726620|Ropivacaine|ropivacaine|mesh-list
2120387|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
2120388|NCT02726620|Tetracaine|tetracaine|mesh-list
2120389|NCT02726620|Prilocaine|prilocaine|mesh-list
2120390|NCT02726620|Mepivacaine|mepivacaine|mesh-list
2120391|NCT02726620|Benzocaine|benzocaine|mesh-list
2120392|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
2120393|NCT02726620|Procaine|procaine|mesh-list
2120394|NCT02726620|Anesthetics|anesthetics|mesh-list
2120395|NCT02726620|Propofol|propofol|mesh-list
2120396|NCT02726620|Sevoflurane|sevoflurane|mesh-list
2120397|NCT02726620|Desflurane|desflurane|mesh-list
2120398|NCT02726620|Isoflurane|isoflurane|mesh-list
2120399|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2120400|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
2558332|NCT01530022|Carbamazepine|carbamazepine|mesh-list
2558333|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
2558334|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2558335|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2558336|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2558337|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558338|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
2558339|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2558340|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2120401|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
2120402|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2120403|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120404|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
2558341|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120405|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120406|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2120407|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2120408|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2120409|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2120410|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120411|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2120412|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2120413|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
2120414|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2120415|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2120416|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2120417|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2120418|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
2558342|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2558343|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2558344|NCT01530022|Analgesics|analgesics|mesh-ancestor
2558345|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
2558346|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558347|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2558348|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2558349|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
2558350|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2558351|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558352|NCT01530126|Becaplermin|becaplermin|mesh-list
2558353|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
2558354|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2558355|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2558356|NCT01530126|Growth Substances|growth substances|mesh-ancestor
2120419|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120420|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2120421|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2120422|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
2120423|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2120424|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
2120425|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
2120426|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
2120427|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2558357|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558358|NCT01530152|Lidocaine|lidocaine|mesh-list
2558359|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
2558360|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
2558361|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2558362|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558363|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
2558364|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558365|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2558366|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2120428|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2120429|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
2120430|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2120431|NCT02726620|Protective Agents|protective agents|mesh-ancestor
2120432|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2120433|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
2120434|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2120435|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2120436|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
2120437|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
2120438|NCT02726620|Coagulants|coagulants|mesh-ancestor
2120439|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2120440|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
2120441|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2558367|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2558368|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2558369|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558370|NCT01530217|Ibuprofen|ibuprofen|mesh-list
2558371|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2558372|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2558373|NCT01530217|Analgesics|analgesics|mesh-ancestor
2558374|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
2558375|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558376|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120442|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2120443|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
2558377|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2558378|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2558379|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2558380|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558381|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558382|NCT01530230|Oxytocin|oxytocin|mesh-list
2558383|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
2558384|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2558385|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558386|NCT01530295|Docetaxel|docetaxel|mesh-list
2558387|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558388|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
2558389|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
2558390|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
2558391|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558392|NCT01530308|Dopamine|dopamine|mesh-list
2558393|NCT01530308|Haloperidol|haloperidol|mesh-list
2558394|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
2558395|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
2558396|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
2558397|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
2558398|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
2558399|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558400|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558401|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2558402|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2558403|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2558404|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2558405|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
2558406|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558407|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558408|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2558409|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2558410|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
2558411|NCT01530308|Protective Agents|protective agents|mesh-ancestor
2558412|NCT01530373|Clonidine|clonidine|mesh-list
2558413|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
2558414|NCT01530373|Analgesics|analgesics|mesh-ancestor
2558415|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
2558416|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558417|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558418|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2558419|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
2558420|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
2558421|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2558422|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2558423|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2558424|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
2558425|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558426|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558427|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2558428|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2558429|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
2558430|NCT01530373|Urological Agents|urological agents|mesh-ancestor
2558431|NCT01530386|Lacosamide|lacosamide|mesh-list
2558432|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
2120444|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2120445|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
2120446|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2120447|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2120448|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120449|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2120450|NCT02726789|Interferons|interferons|mesh-list
2120451|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
2120452|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
2120453|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2120454|NCT02726789|Entecavir|entecavir|mesh-list
2558433|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2558434|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2558435|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2558436|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558437|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2558438|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2558439|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558440|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2120455|NCT02726789|REP 2139|rep 2139|mesh-list
2558441|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
2120456|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120457|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
2120458|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120459|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
2120460|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120461|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
2120462|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2120463|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120464|NCT02727322|Renal Agents|renal agents|mesh-ancestor
2120465|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2120466|NCT02727660|Budesonide|budesonide|mesh-list
2120467|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
2120468|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2120469|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2120470|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
2120471|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120472|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120473|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2120474|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
2120475|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
2120476|NCT02727660|Hormones|hormones|mesh-ancestor
2120477|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120478|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2120479|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2120480|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2120481|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
2120482|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120483|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120484|NCT02728089|Tazobactam|tazobactam|mesh-list
2120485|NCT02728089|Ceftolozane|ceftolozane|mesh-list
2120486|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2120487|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120488|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2120489|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120490|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120491|NCT02728102|Lenalidomide|lenalidomide|mesh-list
2120492|NCT02728102|Melphalan|melphalan|mesh-list
2120493|NCT02728102|Molgramostim|molgramostim|mesh-list
2558442|NCT01530451|Coagulants|coagulants|mesh-ancestor
2558443|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2558444|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
2558445|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558446|NCT01530490|Cabergoline|cabergoline|mesh-list
2558447|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2558448|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2558449|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2558450|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
2558451|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
2558452|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558453|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558454|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558455|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
2558456|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
2558457|NCT01530503|Capecitabine|capecitabine|mesh-list
2558458|NCT01530503|Mitomycins|mitomycins|mesh-list
2558459|NCT01530503|Mitomycin|mitomycin|mesh-list
2558460|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2558461|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
2558462|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558463|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558464|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2558465|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
2558466|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2558467|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558468|NCT01530542|Oxycodone|oxycodone|mesh-list
2558469|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2558470|NCT01530542|Narcotics|narcotics|mesh-ancestor
2558471|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2558472|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558473|NCT01530542|Analgesics|analgesics|mesh-ancestor
2558474|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
2558475|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558476|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
2558477|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
2558478|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558479|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2558480|NCT01530594|Lenalidomide|lenalidomide|mesh-list
2558481|NCT01530594|Bortezomib|bortezomib|mesh-list
2120494|NCT02728102|Vaccines|vaccines|mesh-list
2120495|NCT02728102|Sargramostim|sargramostim|mesh-list
2120496|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
2120497|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120498|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2120499|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2120500|NCT02728102|Growth Substances|growth substances|mesh-ancestor
2120501|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
2120502|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120503|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2120504|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
2120505|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120506|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2120507|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2120508|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
2120509|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2120510|NCT02728206|Velpatasvir|velpatasvir|mesh-list
2120511|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
2120512|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120518|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
2120519|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2120520|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120521|NCT02728895|Vedolizumab|vedolizumab|mesh-list
2120522|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2558482|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
2558483|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558484|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2558485|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2558486|NCT01530594|Growth Substances|growth substances|mesh-ancestor
2558487|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
2558488|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558489|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
2558490|NCT01530607|Goserelin|goserelin|mesh-list
2558491|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2558492|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
2558493|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558494|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2558495|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2558496|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
2120523|NCT02729025|Evolocumab|evolocumab|mesh-list
2120524|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2120525|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2120526|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
2120527|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120528|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2120529|NCT02729051|Albuterol|albuterol|mesh-list
2120530|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2120531|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
2120532|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120533|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120534|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2120535|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
2120536|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
2120537|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2120538|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2120539|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2120540|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2120541|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
2120542|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120543|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120544|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
2120545|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2120546|NCT02729545|Cyproterone|cyproterone|mesh-list
2120547|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2120548|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2558497|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558498|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558499|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2558500|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2558501|NCT01530620|Propiverine|propiverine|mesh-list
2558502|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
2558503|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
2558504|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558505|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558506|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2558507|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2558508|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
2558509|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558510|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558511|NCT01530620|Urological Agents|urological agents|mesh-ancestor
2558512|NCT01530698|Vaccines|vaccines|mesh-list
2558513|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
2120549|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2120550|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
2120551|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2120552|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120553|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2120554|NCT02729545|Estrogens|estrogens|mesh-ancestor
2120555|NCT02729545|Hormones|hormones|mesh-ancestor
2120556|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120557|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
2120558|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
2120559|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120560|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2120561|NCT02729896|Rituximab|rituximab|mesh-list
2120562|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
2120563|NCT02729896|Atezolizumab|atezolizumab|mesh-list
2120564|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2120565|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120566|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
2120567|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120568|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2120569|NCT02729909|Lubiprostone|lubiprostone|mesh-list
2120570|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2120571|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2120572|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120573|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
2120574|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2120575|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120576|NCT02730195|Pioglitazone|pioglitazone|mesh-list
2120577|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2120578|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120579|NCT02730208|Ivacaftor|ivacaftor|mesh-list
2120580|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2120581|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2120582|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120583|NCT02730247|Paclitaxel|paclitaxel|mesh-list
2120584|NCT02730247|Ramucirumab|ramucirumab|mesh-list
2120585|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2120586|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120587|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
2120588|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
2120589|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
2120590|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120591|NCT02730351|Fluticasone|fluticasone|mesh-list
2120592|NCT02730351|Xhance|xhance|mesh-list
2120593|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2418616|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2418617|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2418618|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
2418619|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418620|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418621|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418622|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2418623|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2418624|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2418625|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2418626|NCT00800280|Cimetidine|cimetidine|mesh-list
2418627|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2418628|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2418629|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2418630|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
2418631|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
2418632|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120594|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2120595|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
2120596|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120597|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120598|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2120599|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
2120600|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
2120601|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2120602|NCT02730377|Liraglutide|liraglutide|mesh-list
2120603|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2120604|NCT02730377|Meglitinide|meglitinide|mesh-list
2120605|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2120606|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2120607|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
2120608|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2120609|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120610|NCT02730377|Incretins|incretins|mesh-ancestor
2120611|NCT02730377|Hormones|hormones|mesh-ancestor
2120612|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120613|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120614|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
2120615|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120616|NCT02730455|Natalizumab|natalizumab|mesh-list
2558514|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558515|NCT01530711|Terlipressin|terlipressin|mesh-list
2558516|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2558517|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2558518|NCT01530737|Antithrombins|antithrombins|mesh-list
2558519|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
2558520|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2558521|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
2558522|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558523|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558524|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
2120617|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
2120618|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120619|NCT02730871|Timolol|timolol|mesh-list
2120620|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2120621|NCT02730871|Travoprost|travoprost|mesh-list
2120622|NCT02730871|Brinzolamide|brinzolamide|mesh-list
2120623|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2120624|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2120625|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
2120626|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120627|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120628|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120629|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2120630|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2120631|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2120632|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2120633|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2120634|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2120635|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120636|NCT02730884|ON 01910|on 01910|mesh-list
2120637|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120638|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2120639|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120640|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120641|NCT02730962|Vancomycin|vancomycin|mesh-list
2120642|NCT02730962|Clindamycin|clindamycin|mesh-list
2120643|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
2120644|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
2120645|NCT02730962|Neomycin|neomycin|mesh-list
2120646|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2120647|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120648|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2120649|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558525|NCT01530763|Amoxicillin|amoxicillin|mesh-list
2558526|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
2558527|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
2558528|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
2558529|NCT01530763|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2558530|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2120650|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558531|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2558532|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558533|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2558534|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120651|NCT02731131|Ribavirin|ribavirin|mesh-list
2120652|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2120653|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
2120654|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120655|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
2120656|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120657|NCT02731313|Trastuzumab|trastuzumab|mesh-list
2120658|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2120659|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120660|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
2120661|NCT02731469|Hematinics|hematinics|mesh-ancestor
2120662|NCT02731638|Voriconazole|voriconazole|mesh-list
2120663|NCT02731638|Natamycin|natamycin|mesh-list
2120664|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
2120665|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120666|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2120667|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2120668|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120669|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120670|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2120671|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
2120672|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120673|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120674|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2120675|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2120676|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2120677|NCT02731729|Nivolumab|nivolumab|mesh-list
2120678|NCT02731729|Ipilimumab|ipilimumab|mesh-list
2120679|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2120680|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120681|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2120682|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120683|NCT02731820|Vitamin D|vitamin d|mesh-list
2120684|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
2120685|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
2120686|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
2120687|NCT02731820|Calcium|calcium|mesh-list
2120688|NCT02731820|Vitamins|vitamins|mesh-ancestor
2120689|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
2120690|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120691|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2120692|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2120693|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120694|NCT02731820|Antacids|antacids|mesh-ancestor
2120695|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2120696|NCT02731820|Diuretics|diuretics|mesh-ancestor
2120697|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
2120698|NCT02731820|Expectorants|expectorants|mesh-ancestor
2120699|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
2120700|NCT02731833|Fluorides|fluorides|mesh-list
2120701|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
2120702|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
2120703|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
2120704|NCT02731833|Protective Agents|protective agents|mesh-ancestor
2120705|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120706|NCT02732015|Dexamethasone|dexamethasone|mesh-list
2120707|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
2120708|NCT02732015|Doxorubicin|doxorubicin|mesh-list
2120709|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2120710|NCT02732015|Vincristine|vincristine|mesh-list
2120711|NCT02732015|Daunorubicin|daunorubicin|mesh-list
2120712|NCT02732015|Ifosfamide|ifosfamide|mesh-list
2120713|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
2120714|NCT02732015|Ondansetron|ondansetron|mesh-list
2120715|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
2120716|NCT02732015|Aprepitant|aprepitant|mesh-list
2558535|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558536|NCT01530815|Bupivacaine|bupivacaine|mesh-list
2558537|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
2558538|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
2558539|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2120717|NCT02732015|BB 1101|bb 1101|mesh-list
2120718|NCT02732015|Rolapitant|rolapitant|mesh-list
2120719|NCT02732015|Mesna|mesna|mesh-list
2120720|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2120721|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
2120722|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
2120723|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120724|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120725|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2558540|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558541|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
2558542|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558543|NCT01530984|Ipilimumab|ipilimumab|mesh-list
2558544|NCT01530984|Sargramostim|sargramostim|mesh-list
2558545|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2558546|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558547|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2558548|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558549|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
2558550|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558551|NCT01531049|Nicotine|nicotine|mesh-list
2558552|NCT01531049|Varenicline|varenicline|mesh-list
2558553|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2558554|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
2558555|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558556|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558557|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2558558|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2558559|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
2558560|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558561|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558562|NCT01531114|Ticagrelor|ticagrelor|mesh-list
2558563|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2558564|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2558565|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2558566|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2558567|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2558568|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
2558569|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558570|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558571|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558572|NCT01531140|Bisacodyl|bisacodyl|mesh-list
2558573|NCT01531140|Senna Extract|senna extract|mesh-list
2558574|NCT01531140|Sennosides|sennosides|mesh-list
2558575|NCT01531140|Cathartics|cathartics|mesh-ancestor
2558576|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2558577|NCT01531140|Laxatives|laxatives|mesh-ancestor
2558578|NCT01531166|Interferons|interferons|mesh-list
2558579|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
2558580|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
2558581|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2558582|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558583|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
2558584|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558585|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
2558586|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558587|NCT01531192|Nystatin|nystatin|mesh-list
2558588|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2558589|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558590|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
2558591|NCT01531192|Ionophores|ionophores|mesh-ancestor
2558592|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2558593|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558594|NCT01531218|Azithromycin|azithromycin|mesh-list
2558595|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2558596|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558597|NCT01531244|Dactinomycin|dactinomycin|mesh-list
2558598|NCT01531244|Cactinomycin|cactinomycin|mesh-list
2558599|NCT01531244|Melphalan|melphalan|mesh-list
2558600|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2120726|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
2120727|NCT02732015|Hormones|hormones|mesh-ancestor
2120728|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120729|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2120730|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120731|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
2120732|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120733|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558601|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
2558602|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558603|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120734|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2120735|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2120736|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2120737|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2120738|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
2120739|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
2120740|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
2120741|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2558604|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2558605|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2558606|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
2558607|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558608|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2558609|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558610|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2558611|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2558612|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558613|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2558614|NCT01531309|S 20098|s 20098|mesh-list
2558615|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2558616|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2558617|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558618|NCT01531322|Vaccines|vaccines|mesh-list
2558619|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2558620|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
2558621|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558622|NCT01531361|Sorafenib|sorafenib|mesh-list
2558623|NCT01531361|Vemurafenib|vemurafenib|mesh-list
2558624|NCT01531361|Crizotinib|crizotinib|mesh-list
2558625|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558626|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2558627|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558628|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558629|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
2558630|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558631|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
2558632|NCT01531517|Propolis|propolis|mesh-list
2558633|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
2558634|NCT01531517|Vitamins|vitamins|mesh-ancestor
2558635|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
2558636|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558637|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558638|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
2120742|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
2120743|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
2120744|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
2120745|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2120746|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
2120747|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120748|NCT02732015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2120749|NCT02732015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2558639|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
2558640|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2558641|NCT01531569|Estrogens|estrogens|mesh-ancestor
2558642|NCT01531569|Hormones|hormones|mesh-ancestor
2558643|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2558644|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558645|NCT01531582|Minocycline|minocycline|mesh-list
2120750|NCT02732015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2120751|NCT02732015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2120752|NCT02732015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2120753|NCT02732015|Protective Agents|protective agents|mesh-ancestor
2120754|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2120755|NCT02732119|Everolimus|everolimus|mesh-list
2120756|NCT02732119|Exemestane|exemestane|mesh-list
2120757|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120758|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2120759|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
2120760|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120761|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2558646|NCT01531582|Tetracycline|tetracycline|mesh-list
2558647|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2558648|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558649|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2120762|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2558650|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558651|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558652|NCT01531595|Bevacizumab|bevacizumab|mesh-list
2558653|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
2558654|NCT01531595|Irinotecan|irinotecan|mesh-list
2558655|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2558656|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558657|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2558658|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2558659|NCT01531595|Growth Substances|growth substances|mesh-ancestor
2558660|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558661|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
2558662|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2558663|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2558664|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558665|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558666|NCT01531647|Ritonavir|ritonavir|mesh-list
2558667|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
2558668|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2558669|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2558670|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
2558671|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558672|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558673|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2558674|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2558675|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
2558676|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558677|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2558678|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2558679|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2558680|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2558681|NCT01531699|Povidone-Iodine|povidone-iodine|mesh-list
2558682|NCT01531699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2558683|NCT01531699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2558684|NCT01531699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558685|NCT01531712|Gemcitabine|gemcitabine|mesh-list
2558686|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
2558687|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2558688|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2558689|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
2558690|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558691|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558692|NCT01531712|Antiviral Agents|antiviral agents|mesh-ancestor
2558693|NCT01531712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120763|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120764|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120765|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2120766|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
2120767|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2558694|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558695|NCT01531712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2558696|NCT01531712|Immunologic Factors|immunologic factors|mesh-ancestor
2558697|NCT01531712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558698|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2558699|NCT01531764|Vinorelbine|vinorelbine|mesh-list
2558700|NCT01531764|Afatinib|afatinib|mesh-list
2558701|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2558702|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558703|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
2558704|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
2558705|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
2558706|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558707|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2558708|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558709|NCT01531777|Apatinib|apatinib|mesh-list
2558710|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558711|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2558712|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558713|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558714|NCT01531790|Carboplatin|carboplatin|mesh-list
2558715|NCT01531790|Pemetrexed|pemetrexed|mesh-list
2558716|NCT01531790|Endostar protein|endostar protein|mesh-list
2558717|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558718|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558719|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558720|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2558721|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2558722|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2558723|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2558724|NCT01531790|Growth Substances|growth substances|mesh-ancestor
2558725|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558726|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
2558727|NCT01531829|Heparin|heparin|mesh-list
2558728|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2558729|NCT01531829|Tinzaparin|tinzaparin|mesh-list
2558730|NCT01531829|Dalteparin|dalteparin|mesh-list
2558731|NCT01531829|Plasminogen|plasminogen|mesh-list
2558732|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2558733|NCT01531829|Nadroparin|nadroparin|mesh-list
2558734|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
2558735|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2558736|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2558737|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558738|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2558739|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558740|NCT01531855|Insulin|insulin|mesh-list
2558741|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
2558742|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
2558743|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2558744|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558745|NCT01531920|Ethanol|ethanol|mesh-list
2558746|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2558747|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558748|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2558749|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558750|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2558751|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558752|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2558753|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558754|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558755|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2558756|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
2558757|NCT01532076|Coagulants|coagulants|mesh-ancestor
2558758|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
2120768|NCT02732587|Saracatinib|saracatinib|mesh-list
2120769|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120770|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120771|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120772|NCT02732639|Interferons|interferons|mesh-list
2120773|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120774|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
2120775|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120776|NCT02732899|Sirolimus|sirolimus|mesh-list
2120777|NCT02732899|Aflibercept|aflibercept|mesh-list
2120778|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2120779|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120780|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2120781|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120782|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
2120783|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2120784|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
2120785|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120786|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2120787|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2120788|NCT02732899|Growth Substances|growth substances|mesh-ancestor
2120789|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
2120790|NCT02732912|Zopiclone|zopiclone|mesh-list
2120791|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2558759|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558760|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
2558761|NCT01532115|Opicapone|opicapone|mesh-list
2558762|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2558763|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558764|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2558765|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2558766|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558767|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558768|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558769|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2558770|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2120792|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2558771|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2558772|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
2418633|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418634|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418635|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2418636|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2120793|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120794|NCT02732938|Gemcitabine|gemcitabine|mesh-list
2120795|NCT02732938|Paclitaxel|paclitaxel|mesh-list
2120796|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2120797|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120798|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
2120799|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
2120800|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
2120801|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120802|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2120803|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
2120804|NCT02732938|Antiviral Agents|antiviral agents|mesh-ancestor
2120805|NCT02732938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558773|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2558774|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2558775|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558776|NCT01532232|Varenicline|varenicline|mesh-list
2558777|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2558778|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2558779|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
2120806|NCT02732938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120807|NCT02732938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2120808|NCT02732938|Immunologic Factors|immunologic factors|mesh-ancestor
2120809|NCT02732938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120826|NCT02733588|Glucagon|glucagon|mesh-list
2120827|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2120828|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2120829|NCT02733588|Hormones|hormones|mesh-ancestor
2120830|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120831|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120832|NCT02733588|Incretins|incretins|mesh-ancestor
2120833|NCT02733757|Clonidine|clonidine|mesh-list
2120834|NCT02733757|Analgesics|analgesics|mesh-ancestor
2120835|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
2120836|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120837|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120838|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2120839|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
2120840|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
2120841|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2120842|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2120843|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2120844|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
2120845|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120846|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120847|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
2120848|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
2418637|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418638|NCT00800293|Betamethasone|betamethasone|mesh-list
2418639|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
2418640|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2418641|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
2418642|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2418643|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2120849|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120850|NCT02734147|Protective Agents|protective agents|mesh-ancestor
2120851|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120852|NCT02734147|Vitamins|vitamins|mesh-ancestor
2120853|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
2120854|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
2120855|NCT02734238|Testosterone|testosterone|mesh-list
2120856|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
2120857|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
2120858|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2120859|NCT02734238|Androgens|androgens|mesh-ancestor
2120860|NCT02734238|Hormones|hormones|mesh-ancestor
2120861|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120862|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120863|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2120864|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120865|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
2120866|NCT02734355|Amlodipine|amlodipine|mesh-list
2120867|NCT02734355|Telmisartan|telmisartan|mesh-list
2120868|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2120869|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2120870|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2120871|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2120872|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120873|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2120874|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418644|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
2418645|NCT00800293|Hormones|hormones|mesh-ancestor
2418646|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120875|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
2120876|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2120877|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2120878|NCT02734862|Fluconazole|fluconazole|mesh-list
2120879|NCT02734862|Caspofungin|caspofungin|mesh-list
2120880|NCT02734862|Rezafungin|rezafungin|mesh-list
2120881|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
2120882|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120883|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2120884|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2120885|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120886|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120887|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2120888|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
2120889|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120890|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120891|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2120892|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2120893|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
2120894|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2120895|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
2120896|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120897|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120898|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2120899|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
2120900|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2558780|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558781|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558782|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558783|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
2558784|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2558789|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2558790|NCT01532466|Rocuronium|rocuronium|mesh-list
2558791|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2558792|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2558793|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2558794|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558795|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558796|NCT01532518|MEN 11420|men 11420|mesh-list
2120901|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
2558797|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2558798|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
2558799|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558800|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558801|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2558802|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
2558803|NCT01532544|Heparin|heparin|mesh-list
2558804|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2558805|NCT01532544|Tinzaparin|tinzaparin|mesh-list
2558806|NCT01532544|Dalteparin|dalteparin|mesh-list
2558807|NCT01532544|Eptifibatide|eptifibatide|mesh-list
2558808|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
2558809|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2558810|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2558811|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558812|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2558813|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
2558814|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2558815|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2558816|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
2558817|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2558818|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2558819|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2558820|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558821|NCT01532804|Bevacizumab|bevacizumab|mesh-list
2558822|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
2558823|NCT01532804|Raltitrexed|raltitrexed|mesh-list
2558824|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2558825|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558826|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2558827|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2558828|NCT01532804|Growth Substances|growth substances|mesh-ancestor
2558829|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558830|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
2558831|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2558832|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
2558833|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558834|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2558835|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558836|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2558837|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
2558838|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558839|NCT01532856|Thalidomide|thalidomide|mesh-list
2558840|NCT01532856|Dexamethasone|dexamethasone|mesh-list
2558841|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
2558842|NCT01532856|Prednisone|prednisone|mesh-list
2558843|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
2558844|NCT01532856|Melphalan|melphalan|mesh-list
2558845|NCT01532856|BB 1101|bb 1101|mesh-list
2558846|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2558847|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
2558848|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558849|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2558850|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2558851|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
2558852|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558853|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2558854|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2558855|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2120902|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120903|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120904|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2120905|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
2120906|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
2120907|NCT02734953|Protective Agents|protective agents|mesh-ancestor
2558856|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
2558857|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
2558858|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558859|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2558860|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
2558861|NCT01532856|Hormones|hormones|mesh-ancestor
2558862|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2558863|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2558864|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
2558865|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558866|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
2558867|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2558868|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558869|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2558870|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2558871|NCT01532856|Growth Substances|growth substances|mesh-ancestor
2558872|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
2558873|NCT01532895|Hydromorphone|hydromorphone|mesh-list
2558874|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2120908|NCT02735044|Insulin|insulin|mesh-list
2120909|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2120910|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
2120911|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2120912|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120913|NCT02735187|Vitamin D|vitamin d|mesh-list
2120914|NCT02735187|Vitamins|vitamins|mesh-ancestor
2120915|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
2120916|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120917|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2120918|NCT02735200|Vitamin D|vitamin d|mesh-list
2558875|NCT01532895|Narcotics|narcotics|mesh-ancestor
2558876|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2558877|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558878|NCT01532895|Analgesics|analgesics|mesh-ancestor
2558879|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
2558880|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558881|NCT01532960|Poly ICLC|poly iclc|mesh-list
2558882|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
2558883|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
2558884|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558885|NCT01533090|Bisacodyl|bisacodyl|mesh-list
2558886|NCT01533090|Cathartics|cathartics|mesh-ancestor
2558887|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2558888|NCT01533090|Laxatives|laxatives|mesh-ancestor
2558889|NCT01533129|Testosterone|testosterone|mesh-list
2120919|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
2120920|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
2120921|NCT02735200|Vitamins|vitamins|mesh-list
2120922|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
2120923|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120924|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2120925|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2120926|NCT02735421|Adapalene|adapalene|mesh-list
2120927|NCT02735421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2120928|NCT02735421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2120929|NCT02735421|Analgesics|analgesics|mesh-ancestor
2120930|NCT02735421|Sensory System Agents|sensory system agents|mesh-ancestor
2120931|NCT02735421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120932|NCT02735421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120933|NCT02735421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2120934|NCT02735421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2120935|NCT02735421|Dermatologic Agents|dermatologic agents|mesh-ancestor
2120936|NCT02735577|Disulfiram|disulfiram|mesh-list
2120937|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2120938|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2120939|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120940|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120941|NCT02736175|Dexamethasone|dexamethasone|mesh-list
2120942|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2120943|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
2558890|NCT01533129|Androgens|androgens|mesh-ancestor
2558891|NCT01533129|Hormones|hormones|mesh-ancestor
2558892|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2558893|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558894|NCT01533155|Quinidine|quinidine|mesh-list
2558895|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
2558896|NCT01533155|Morphine|morphine|mesh-list
2558897|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2558898|NCT01533155|Narcotics|narcotics|mesh-ancestor
2558899|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2558900|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558901|NCT01533155|Analgesics|analgesics|mesh-ancestor
2558902|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
2558903|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2558904|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2120944|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
2558905|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2558906|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
2558907|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558908|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558909|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2558910|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
2558911|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2558912|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2558913|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558914|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558915|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2558916|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2558917|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
2558918|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2558919|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2558920|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2558921|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2558922|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2558923|NCT01533220|Pheniramine|pheniramine|mesh-list
2558924|NCT01533220|Naphazoline|naphazoline|mesh-list
2558925|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558926|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2558927|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2558928|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
2558929|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558930|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558931|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
2558932|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2558933|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
2558934|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
2558935|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
2558936|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2558937|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
2558938|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
2558939|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2558940|NCT01533272|Tenofovir|tenofovir|mesh-list
2558941|NCT01533272|Emtricitabine|emtricitabine|mesh-list
2558942|NCT01533272|Lopinavir|lopinavir|mesh-list
2558943|NCT01533272|Maraviroc|maraviroc|mesh-list
2558944|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
2558945|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2558946|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2558947|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2558948|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2558949|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558950|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2558951|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2558952|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2558953|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2558954|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
2558955|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2558956|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2558957|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2558958|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2558959|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2558960|NCT01533324|Leucovorin|leucovorin|mesh-list
2558961|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
2558962|NCT01533324|Antidotes|antidotes|mesh-ancestor
2558963|NCT01533324|Protective Agents|protective agents|mesh-ancestor
2558964|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558965|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
2558966|NCT01533324|Vitamins|vitamins|mesh-ancestor
2558967|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
2558968|NCT01533376|Timolol|timolol|mesh-list
2558969|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
2558970|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2558971|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2558972|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
2558973|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558974|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558975|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558976|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2558977|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2558978|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2120945|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120946|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120947|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2120948|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
2558979|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2558980|NCT01533389|Silodosin|silodosin|mesh-list
2558981|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2558982|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2558983|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2558984|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
2558985|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2558986|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558987|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558988|NCT01533389|Urological Agents|urological agents|mesh-ancestor
2558989|NCT01533441|Vitamin K|vitamin k|mesh-list
2558990|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
2558991|NCT01533441|Vitamins|vitamins|mesh-ancestor
2558992|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
2558993|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2558994|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2558995|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2558996|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2558997|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
2558998|NCT01533441|Coagulants|coagulants|mesh-ancestor
2558999|NCT01533506|Stiripentol|stiripentol|mesh-list
2559000|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
2559001|NCT01533545|Epinephrine|epinephrine|mesh-list
2559002|NCT01533545|Mepivacaine|mepivacaine|mesh-list
2559003|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2559004|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2559005|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
2559006|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559007|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559008|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120949|NCT02736175|Hormones|hormones|mesh-ancestor
2120950|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2559009|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2559010|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2559011|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
2559012|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559013|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2559014|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
2559015|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
2559016|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
2559017|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2559018|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
2559019|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
2559020|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2559021|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
2559022|NCT01533558|Caspofungin|caspofungin|mesh-list
2559023|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
2559024|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559025|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559026|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559027|NCT01533662|Phenylephrine|phenylephrine|mesh-list
2559028|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
2559029|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2559030|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
2559031|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
2559032|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559033|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559034|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
2559035|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2559036|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
2559037|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
2559038|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2559039|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2559040|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2559041|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
2559042|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559043|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559044|NCT01533662|Protective Agents|protective agents|mesh-ancestor
2559045|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2559046|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2559047|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559048|NCT01533740|Leucovorin|leucovorin|mesh-list
2559049|NCT01533740|Folic Acid|folic acid|mesh-list
2559050|NCT01533740|Bevacizumab|bevacizumab|mesh-list
2559051|NCT01533740|Fluorouracil|fluorouracil|mesh-list
2559052|NCT01533740|Irinotecan|irinotecan|mesh-list
2559053|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
2559054|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2559055|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559056|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2559057|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2559058|NCT01533740|Growth Substances|growth substances|mesh-ancestor
2559059|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559060|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
2559061|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
2559062|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559063|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2559064|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2559065|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
2559066|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2559067|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2559068|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559069|NCT01533740|Antidotes|antidotes|mesh-ancestor
2120951|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2120952|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120953|NCT02736409|Budesonide|budesonide|mesh-list
2120954|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2120955|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2120956|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
2120957|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120958|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120959|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2120960|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
2120961|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
2120962|NCT02736409|Hormones|hormones|mesh-ancestor
2120963|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2120964|NCT02736474|Naltrexone|naltrexone|mesh-list
2120965|NCT02736474|Bupropion|bupropion|mesh-list
2120966|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2120967|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2120968|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120969|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
2120970|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2120971|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2120972|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
2559070|NCT01533740|Protective Agents|protective agents|mesh-ancestor
2559071|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
2559072|NCT01533740|Vitamins|vitamins|mesh-ancestor
2559073|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
2559074|NCT01533740|Hematinics|hematinics|mesh-ancestor
2559075|NCT01533818|Amoxicillin|amoxicillin|mesh-list
2559076|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2559077|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559078|NCT01533870|Rifampin|rifampin|mesh-list
2559079|NCT01533870|Naloxegol|naloxegol|mesh-list
2559080|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2559081|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
2559082|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2559083|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559084|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
2559085|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2559086|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559087|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559088|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2559089|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2559090|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2559091|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2559092|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2559093|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2559094|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2559095|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559096|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
2559097|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559098|NCT01534026|Aspirin|aspirin|mesh-list
2559099|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2559100|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2559101|NCT01534026|Analgesics|analgesics|mesh-ancestor
2559102|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
2559103|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559104|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120973|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2120974|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2120975|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2120976|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2120977|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120978|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
2120979|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120980|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2120981|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2120982|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2120983|NCT02736578|Cetuximab|cetuximab|mesh-list
2120984|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2120985|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2120986|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2120987|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
2120988|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2120989|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
2120990|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2120991|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2120992|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2120993|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2120994|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2120995|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
2120996|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2120997|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2120998|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2120999|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121000|NCT02737072|Durvalumab|durvalumab|mesh-list
2121001|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2121002|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121003|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
2559105|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2559106|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2559107|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2559108|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2559109|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559110|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2559111|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2559112|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559113|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
2559114|NCT01534169|Dexamethasone|dexamethasone|mesh-list
2559115|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2559116|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
2559117|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
2559118|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559119|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559120|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2559121|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
2559122|NCT01534169|Hormones|hormones|mesh-ancestor
2559123|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2559124|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2559125|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559126|NCT01534247|Metronidazole|metronidazole|mesh-list
2559127|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559128|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2559129|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2559130|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2559131|NCT01534312|Mesalamine|mesalamine|mesh-list
2559132|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2559133|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2559134|NCT01534312|Analgesics|analgesics|mesh-ancestor
2559135|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
2559136|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559137|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559138|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2559139|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2559140|NCT01534403|Epratuzumab|epratuzumab|mesh-list
2559141|NCT01534403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2121004|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121005|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2121006|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121007|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121008|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
2121009|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2559142|NCT01534403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559143|NCT01534442|Atropine|atropine|mesh-list
2121010|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121011|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2121012|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
2121013|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2121014|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
2121015|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559144|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2559145|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2559146|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2559147|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
2559148|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559149|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559150|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2559151|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
2121016|NCT02737358|Expectorants|expectorants|mesh-ancestor
2121017|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
2121018|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2121019|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
2121020|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121021|NCT02737358|Protective Agents|protective agents|mesh-ancestor
2121022|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121023|NCT02737358|Antidotes|antidotes|mesh-ancestor
2121024|NCT02737501|Crizotinib|crizotinib|mesh-list
2121025|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121026|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2121027|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121028|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121029|NCT02737826|Buprenorphine|buprenorphine|mesh-list
2121030|NCT02737826|Gabapentin|gabapentin|mesh-list
2121031|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2121032|NCT02737826|Narcotics|narcotics|mesh-ancestor
2121033|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121034|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121035|NCT02737826|Analgesics|analgesics|mesh-ancestor
2121036|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
2121037|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121038|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2121039|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
2121040|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2121041|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2121042|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2559152|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
2559153|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
2559154|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2559155|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2559156|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
2559157|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559158|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559159|NCT01534455|Lapatinib|lapatinib|mesh-list
2121043|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2121044|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2121045|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121046|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121047|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
2121048|NCT02737891|Metoprolol|metoprolol|mesh-list
2121049|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2121050|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2559160|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559161|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2559162|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559163|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559164|NCT01534494|Psilocybin|psilocybin|mesh-list
2121051|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
2121052|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
2121053|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121054|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121055|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2121056|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2121057|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2121058|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
2121059|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121060|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559165|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
2559166|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559167|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2559168|NCT01534546|Capecitabine|capecitabine|mesh-list
2559169|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
2559170|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2559171|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
2121061|NCT02737930|Fluoxetine|fluoxetine|mesh-list
2121062|NCT02737930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2121063|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2121064|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2121065|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121066|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559172|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559173|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559174|NCT01534585|Paclitaxel|paclitaxel|mesh-list
2559175|NCT01534585|Mitogens|mitogens|mesh-list
2559176|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2559177|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559178|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
2559179|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
2559180|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
2559181|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559182|NCT01534702|Cytarabine|cytarabine|mesh-list
2559183|NCT01534702|Clofarabine|clofarabine|mesh-list
2559184|NCT01534702|Idarubicin|idarubicin|mesh-list
2559185|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2559186|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
2559187|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559188|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559189|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
2559190|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559191|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2559192|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
2559193|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559194|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2559195|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2121067|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
2121068|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121069|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2121070|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
2121071|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2121072|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2559196|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2559197|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559198|NCT01534754|Mesalamine|mesalamine|mesh-list
2559199|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2559200|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2559201|NCT01534754|Analgesics|analgesics|mesh-ancestor
2559202|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
2559203|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559204|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559205|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2559206|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2559207|NCT01534806|Ketorolac|ketorolac|mesh-list
2559208|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2559209|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2559210|NCT01534806|Analgesics|analgesics|mesh-ancestor
2559211|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
2559212|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559213|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559214|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2559215|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2559216|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2559217|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559218|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559219|NCT01534845|Temozolomide|temozolomide|mesh-list
2559220|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2559221|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
2559222|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559223|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559224|NCT01534858|Polihexanide|polihexanide|mesh-list
2559225|NCT01534858|Betaine|betaine|mesh-list
2559226|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2559227|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
2121073|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2121074|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121075|NCT02738008|Tenofovir|tenofovir|mesh-list
2559228|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2559229|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
2121076|NCT02738008|Entecavir|entecavir|mesh-list
2121077|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
2121078|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2121079|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
2121080|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2121081|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2121082|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2121083|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121084|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121085|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2121086|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2121087|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
2121088|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121089|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121090|NCT02738151|Insulin|insulin|mesh-list
2121091|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2121092|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
2121093|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2121094|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121095|NCT02738203|Lidocaine|lidocaine|mesh-list
2121096|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
2121097|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
2121098|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121099|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121100|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
2559230|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559231|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2559232|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
2559233|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559234|NCT01534884|Rituximab|rituximab|mesh-list
2559235|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2559236|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559237|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
2559238|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559239|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2559240|NCT01534949|Rituximab|rituximab|mesh-list
2559241|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2559242|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559243|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
2559244|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559245|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2559246|NCT01535027|Alendronate|alendronate|mesh-list
2559247|NCT01535027|Teriparatide|teriparatide|mesh-list
2559248|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2559249|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2559250|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559251|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2559252|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2559253|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
2559254|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2559255|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2559256|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2559257|NCT01535079|Ibuprofen|ibuprofen|mesh-list
2559258|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2559259|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2559260|NCT01535079|Analgesics|analgesics|mesh-ancestor
2559261|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
2559262|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559263|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559264|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2559265|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2559266|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2559267|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559268|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559269|NCT01535092|Silybin|silybin|mesh-list
2559270|NCT01535092|Protective Agents|protective agents|mesh-ancestor
2559271|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559272|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2121101|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121102|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2121103|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2121104|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2121105|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2121106|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121107|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
2121108|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
2121109|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2121110|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2121111|NCT02738580|Hormones|hormones|mesh-ancestor
2121112|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2121113|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121114|NCT02738879|Metformin|metformin|mesh-list
2121115|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
2121116|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2121117|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2121118|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121119|NCT02738879|Incretins|incretins|mesh-ancestor
2121120|NCT02738879|Hormones|hormones|mesh-ancestor
2121121|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2121122|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2121123|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
2121124|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121125|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121126|NCT02739360|Idelalisib|idelalisib|mesh-list
2559273|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559274|NCT01535157|Ketoconazole|ketoconazole|mesh-list
2559275|NCT01535157|Fenretinide|fenretinide|mesh-list
2121127|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121128|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121129|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121130|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
2121131|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
2121132|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2121133|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121134|NCT02739698|Paclitaxel|paclitaxel|mesh-list
2121135|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2121136|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121137|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
2121138|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
2559276|NCT01535157|Retinamide|retinamide|mesh-list
2559277|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
2559278|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559279|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2559280|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2559281|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559282|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559283|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2559284|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
2559285|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2559286|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559287|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2559288|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559289|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2559290|NCT01535157|Protective Agents|protective agents|mesh-ancestor
2559291|NCT01535170|Lactoferrin|lactoferrin|mesh-list
2559292|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559293|NCT01535183|Irinotecan|irinotecan|mesh-list
2559294|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2559295|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2559296|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559297|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559298|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559299|NCT01535417|Celecoxib|celecoxib|mesh-list
2559300|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2559301|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2559302|NCT01535417|Analgesics|analgesics|mesh-ancestor
2559303|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
2559304|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559305|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559306|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2559307|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2559308|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2559309|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2559310|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559311|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559312|NCT01535469|Fluconazole|fluconazole|mesh-list
2559313|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
2559314|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559315|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2559316|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2559317|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559318|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121139|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
2121140|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121141|NCT02739828|Adalimumab|adalimumab|mesh-list
2121142|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2121143|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2121144|NCT02739984|Evolocumab|evolocumab|mesh-list
2121145|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2121146|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2121147|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2559319|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2559320|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
2559321|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2559322|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559323|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2559324|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2559325|NCT01535495|Propranolol|propranolol|mesh-list
2559326|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2559327|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2559328|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
2559329|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559330|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559331|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559332|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2559333|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2559334|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
2559335|NCT01535508|Vitamin D|vitamin d|mesh-list
2559336|NCT01535508|Vitamins|vitamins|mesh-ancestor
2559337|NCT01535508|Micronutrients|micronutrients|mesh-ancestor
2559338|NCT01535508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559339|NCT01535508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2559340|NCT01535547|Isavuconazole|isavuconazole|mesh-list
2559341|NCT01535547|Tacrolimus|tacrolimus|mesh-list
2559342|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2559343|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
2559344|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559345|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2559346|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559347|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559348|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
2559349|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559350|NCT01535612|Insulin|insulin|mesh-list
2559351|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2559352|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559353|NCT01535677|Metformin|metformin|mesh-list
2559354|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
2559355|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2559356|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559357|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2559358|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559359|NCT01535690|Methylene Blue|methylene blue|mesh-list
2121148|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
2121149|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121150|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2121151|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
2121152|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121153|NCT02739997|Metronidazole|metronidazole|mesh-list
2121154|NCT02739997|Tazobactam|tazobactam|mesh-list
2121155|NCT02739997|Ceftolozane|ceftolozane|mesh-list
2121156|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2121157|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2559360|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559361|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559362|NCT01535768|Travoprost|travoprost|mesh-list
2559363|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2559364|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2559365|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2559366|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2559367|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2559368|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2559369|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2559370|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
2559371|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559372|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559373|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121158|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2121159|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2121160|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2121161|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121162|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121163|NCT02740114|Oxycodone|oxycodone|mesh-list
2121164|NCT02740114|Bupivacaine|bupivacaine|mesh-list
2121165|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
2121166|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
2121167|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121168|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121169|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
2121170|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121171|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2121172|NCT02740114|Narcotics|narcotics|mesh-ancestor
2121173|NCT02740114|Analgesics|analgesics|mesh-ancestor
2559374|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
2559375|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2559376|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2559377|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559378|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
2559379|NCT01535781|Coagulants|coagulants|mesh-ancestor
2559380|NCT01535820|Ortho Evra|ortho evra|mesh-list
2559381|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2559382|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
2559383|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2559384|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559385|NCT01535859|Cabergoline|cabergoline|mesh-list
2559386|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2559387|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2559388|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
2559389|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
2559390|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559391|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559392|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559393|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2559394|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2559395|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
2559396|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559397|NCT01535989|Sirolimus|sirolimus|mesh-list
2559398|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2559399|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2559400|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559401|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2559402|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559403|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
2559404|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2559405|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
2559406|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559407|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2559408|NCT01536002|Propofol|propofol|mesh-list
2559409|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2559410|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2559411|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559412|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2559413|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
2559414|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
2559415|NCT01536028|Insulin|insulin|mesh-list
2559416|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2559417|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
2559418|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
2559419|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2559420|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
2559421|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2121213|NCT02740543|Fluticasone|fluticasone|mesh-list
2559422|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2559423|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559424|NCT01536041|Montelukast|montelukast|mesh-list
2559425|NCT01536041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2559426|NCT01536041|Respiratory System Agents|respiratory system agents|mesh-ancestor
2559427|NCT01536041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2559428|NCT01536041|Hormone Antagonists|hormone antagonists|mesh-ancestor
2559429|NCT01536041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2559430|NCT01536041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559431|NCT01536041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2559432|NCT01536041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2559433|NCT01536041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559434|NCT01536054|Sirolimus|sirolimus|mesh-list
2559435|NCT01536054|Sargramostim|sargramostim|mesh-list
2559436|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2559437|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559438|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2559439|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559440|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
2559441|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2559442|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
2559443|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559444|NCT01536132|Simendan|simendan|mesh-list
2559445|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2559446|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
2559447|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2559448|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2559449|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559450|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559451|NCT01536132|Protective Agents|protective agents|mesh-ancestor
2559452|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559453|NCT01536158|Acetaminophen|acetaminophen|mesh-list
2559454|NCT01536158|Ibuprofen|ibuprofen|mesh-list
2559455|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2559456|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2559457|NCT01536158|Analgesics|analgesics|mesh-ancestor
2121214|NCT02740543|Xhance|xhance|mesh-list
2559458|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
2559459|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559460|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559461|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2559462|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2559463|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2559464|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121215|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2121216|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2121217|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
2121218|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121219|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121220|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2121221|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
2121222|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
2121223|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2121224|NCT02740582|Tolcapone|tolcapone|mesh-list
2559465|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559466|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
2559467|NCT01536223|Cisplatin|cisplatin|mesh-list
2559468|NCT01536223|Docetaxel|docetaxel|mesh-list
2559469|NCT01536223|Fluorouracil|fluorouracil|mesh-list
2559470|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559471|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
2559472|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
2559473|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
2559474|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559475|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
2559476|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2559477|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2559478|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
2559479|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559480|NCT01536249|Pramipexole|pramipexole|mesh-list
2559481|NCT01536249|Cimetidine|cimetidine|mesh-list
2559482|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2559483|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2559484|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2121225|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2121226|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2121227|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2121228|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121229|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121230|NCT02740660|Caffeine|caffeine|mesh-list
2121231|NCT02740660|Albuterol|albuterol|mesh-list
2121232|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2121233|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121234|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2121235|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121236|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121237|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2121238|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2121239|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
2121240|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121241|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2121242|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
2559485|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
2559486|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
2559487|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559488|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559489|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559490|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2559491|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2559492|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559493|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
2559494|NCT01536249|Protective Agents|protective agents|mesh-ancestor
2559495|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2559496|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2559497|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
2559498|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
2559499|NCT01536301|Morphine|morphine|mesh-list
2559500|NCT01536301|Oxycodone|oxycodone|mesh-list
2559501|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2559502|NCT01536301|Narcotics|narcotics|mesh-ancestor
2559503|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2559504|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559505|NCT01536301|Analgesics|analgesics|mesh-ancestor
2121243|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121244|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2121245|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
2121246|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
2121247|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2121248|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2121249|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2121250|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2121251|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
2121252|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
2121253|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2559506|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
2559507|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559508|NCT01536314|Memantine|memantine|mesh-list
2559509|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2559510|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2559511|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
2559512|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559513|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559514|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559515|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2559516|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2559517|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
2559518|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2559519|NCT01536431|Insulin|insulin|mesh-list
2559520|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2559521|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2559522|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559523|NCT01536470|Norepinephrine|norepinephrine|mesh-list
2559524|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2559525|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2559526|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
2559527|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559528|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559529|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559530|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
2559531|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
2559532|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559533|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2559534|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
2559535|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
2559536|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2559537|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2559538|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559539|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
2559540|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
2559541|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2559542|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2559543|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559544|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
2559545|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
2559546|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2559547|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2121254|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121255|NCT02741076|Oxymorphone|oxymorphone|mesh-list
2121256|NCT02741076|Morphine|morphine|mesh-list
2121257|NCT02741076|Oxycodone|oxycodone|mesh-list
2121258|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
2121259|NCT02741076|Narcotics|narcotics|mesh-ancestor
2121260|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121261|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121262|NCT02741076|Analgesics|analgesics|mesh-ancestor
2121263|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
2121264|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121265|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2121266|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2559548|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559549|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
2559550|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
2559551|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2559552|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2559553|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559554|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
2121267|NCT02741245|Ezetimibe|ezetimibe|mesh-list
2559555|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
2559556|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2559557|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2559558|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559559|NCT01536665|Liraglutide|liraglutide|mesh-list
2559560|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2559561|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559562|NCT01536665|Incretins|incretins|mesh-ancestor
2559563|NCT01536665|Hormones|hormones|mesh-ancestor
2559564|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2559565|NCT01536691|Ondansetron|ondansetron|mesh-list
2559566|NCT01536691|Aprepitant|aprepitant|mesh-list
2559567|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
2559568|NCT01536691|Ramosetron|ramosetron|mesh-list
2559569|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
2559570|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
2559571|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559572|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559573|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2559574|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
2559575|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
2559576|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2559577|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
2559578|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559579|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559580|NCT01536691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2559581|NCT01536691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2559582|NCT01536691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2559583|NCT01536691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2559584|NCT01536691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2559585|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2559586|NCT01536717|Carticaine|carticaine|mesh-list
2559587|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
2559588|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
2559589|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2559590|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559591|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
2559592|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559593|NCT01536743|Palbociclib|palbociclib|mesh-list
2559594|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559595|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2559596|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559597|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559598|NCT01536873|Dolutegravir|dolutegravir|mesh-list
2559599|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2559600|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2559601|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559602|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559603|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2559604|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2559605|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
2559606|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559607|NCT01536964|Morphine|morphine|mesh-list
2559608|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2121268|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2121269|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2121270|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
2121271|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121272|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2121273|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2121274|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121275|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
2559609|NCT01536964|Narcotics|narcotics|mesh-ancestor
2559610|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2559611|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559612|NCT01536964|Analgesics|analgesics|mesh-ancestor
2559613|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
2559614|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559615|NCT01537055|Amoxicillin|amoxicillin|mesh-list
2559616|NCT01537055|Levofloxacin|levofloxacin|mesh-list
2559617|NCT01537055|Ofloxacin|ofloxacin|mesh-list
2559618|NCT01537055|Lansoprazole|lansoprazole|mesh-list
2559619|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
2559620|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2559621|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559622|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2559623|NCT01537055|Renal Agents|renal agents|mesh-ancestor
2559624|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2559625|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2559626|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559627|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559628|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559629|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2559630|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2559631|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2559632|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2559633|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2559634|NCT01537094|Vitamins|vitamins|mesh-list
2559635|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
2559636|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
2559637|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559638|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
2559639|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559640|NCT01537094|Protective Agents|protective agents|mesh-ancestor
2559641|NCT01537107|Sirolimus|sirolimus|mesh-list
2559642|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2559643|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2559644|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559645|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2559646|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559647|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
2559648|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2559649|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
2559650|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559651|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2559652|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559653|NCT01537146|Ropivacaine|ropivacaine|mesh-list
2559654|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
2559655|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
2559656|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2559657|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559658|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
2559659|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559660|NCT01537250|Levofloxacin|levofloxacin|mesh-list
2559661|NCT01537250|Ofloxacin|ofloxacin|mesh-list
2559662|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2559663|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559664|NCT01537250|Renal Agents|renal agents|mesh-ancestor
2559665|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2559666|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2559667|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2559668|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559669|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559670|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559671|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2559672|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2559673|NCT01537354|Poractant alfa|poractant alfa|mesh-list
2559674|NCT01537354|Beractant|beractant|mesh-list
2559675|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2559676|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
2559677|NCT01537380|Cefazolin|cefazolin|mesh-list
2559678|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2559679|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2121276|NCT02741271|Prednisone|prednisone|mesh-list
2121277|NCT02741271|Prednisolone|prednisolone|mesh-list
2121278|NCT02741271|Albuterol|albuterol|mesh-list
2121279|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2121280|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
2121281|NCT02741271|Hormones|hormones|mesh-ancestor
2121282|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2121283|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121284|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2121285|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121286|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
2121287|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121288|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2121289|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2121290|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
2121291|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
2121292|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2559680|NCT01537471|Meclizine|meclizine|mesh-list
2559681|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
2559682|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
2559683|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
2559684|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559685|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559686|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2559687|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2559688|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
2559689|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
2559690|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559691|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559692|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2559693|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
2559694|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2559695|NCT01537575|Antibodies|antibodies|mesh-list
2559696|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
2559697|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2559698|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
2559699|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559700|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2559701|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559702|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2559703|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
2559704|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559705|NCT01537744|Azacitidine|azacitidine|mesh-list
2559706|NCT01537744|Romidepsin|romidepsin|mesh-list
2559707|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2559708|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
2559709|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559710|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559711|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559712|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2559713|NCT01537770|Lidocaine|lidocaine|mesh-list
2559714|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
2559715|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
2559716|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2559717|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559718|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
2559719|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559720|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2559721|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2559722|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2559723|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2559724|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559725|NCT01537809|Vitamin D|vitamin d|mesh-list
2559726|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
2559727|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
2559728|NCT01537809|Vitamins|vitamins|mesh-list
2559729|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
2559730|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121293|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2121294|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2121295|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2121296|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
2121297|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121298|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121299|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
2121300|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2559731|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2559732|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2559733|NCT01537861|Thalidomide|thalidomide|mesh-list
2559734|NCT01537861|Dexamethasone|dexamethasone|mesh-list
2559735|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
2559736|NCT01537861|Lenalidomide|lenalidomide|mesh-list
2559737|NCT01537861|Bortezomib|bortezomib|mesh-list
2559738|NCT01537861|Pomalidomide|pomalidomide|mesh-list
2559739|NCT01537861|Lenograstim|lenograstim|mesh-list
2559740|NCT01537861|Sargramostim|sargramostim|mesh-list
2559741|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2559742|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
2559743|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559744|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2559745|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2559746|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
2559747|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559748|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559749|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2559750|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2121301|NCT02741310|Sumatriptan|sumatriptan|mesh-list
2121302|NCT02741310|Erenumab|erenumab|mesh-list
2121303|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2121304|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2121305|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2121306|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
2559751|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
2559752|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
2559753|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559754|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2559755|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
2559756|NCT01537861|Hormones|hormones|mesh-ancestor
2559757|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2559758|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2559759|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2559760|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2559761|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2559762|NCT01537861|Growth Substances|growth substances|mesh-ancestor
2559763|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
2559764|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
2559765|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2559766|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2121307|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121308|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121309|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121310|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2121311|NCT02741310|Analgesics|analgesics|mesh-ancestor
2121312|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
2121313|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559767|NCT01538095|Trebananib|trebananib|mesh-list
2559768|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2559769|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2559770|NCT01538095|Growth Substances|growth substances|mesh-ancestor
2559771|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559772|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
2559773|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559774|NCT01538108|Paclitaxel|paclitaxel|mesh-list
2559775|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2559776|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559777|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
2559778|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
2559779|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
2559780|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559781|NCT01538225|Nabiximols|nabiximols|mesh-list
2559782|NCT01538225|Analgesics|analgesics|mesh-ancestor
2559783|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
2559784|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559785|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559786|NCT01538316|Genistein|genistein|mesh-list
2559787|NCT01538316|Quercetin|quercetin|mesh-list
2559788|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
2559789|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559790|NCT01538316|Protective Agents|protective agents|mesh-ancestor
2559791|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559792|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2559793|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559794|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2559795|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559796|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
2559797|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2559798|NCT01538316|Estrogens|estrogens|mesh-ancestor
2559799|NCT01538316|Hormones|hormones|mesh-ancestor
2559800|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2559801|NCT01538329|Amantadine|amantadine|mesh-list
2559802|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2559803|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2559804|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
2559805|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559806|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
2559807|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121314|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2121315|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
2121316|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121317|NCT02741687|Insulin|insulin|mesh-list
2559808|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121318|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2121319|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
2121320|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
2121321|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2121322|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
2121323|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
2121324|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2121325|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121326|NCT02741687|Incretins|incretins|mesh-ancestor
2559809|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559810|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2559811|NCT01538329|Analgesics|analgesics|mesh-ancestor
2559812|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
2559813|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559814|NCT01538381|Afatinib|afatinib|mesh-list
2559815|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559816|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2559817|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559818|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559819|NCT01538394|Nicotine|nicotine|mesh-list
2559820|NCT01538394|Varenicline|varenicline|mesh-list
2559821|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2559822|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
2559823|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559824|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559825|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2559826|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2559827|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
2559828|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559829|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559830|NCT01538446|Clopidogrel|clopidogrel|mesh-list
2559831|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2559832|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2559833|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2559834|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2559835|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2121327|NCT02741687|Hormones|hormones|mesh-ancestor
2121328|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2121329|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2121330|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
2121331|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121332|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121333|NCT02741713|Lidocaine|lidocaine|mesh-list
2559836|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
2559837|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559838|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559839|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559840|NCT01538459|Dexamethasone|dexamethasone|mesh-list
2559841|NCT01538459|Bupivacaine|bupivacaine|mesh-list
2559842|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2559843|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
2559844|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
2559845|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559846|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559847|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2559848|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
2559849|NCT01538459|Hormones|hormones|mesh-ancestor
2559850|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2559851|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2559852|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559853|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
2559854|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
2559855|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2559856|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
2559857|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
2559858|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2121334|NCT02741713|Clonidine|clonidine|mesh-list
2121335|NCT02741713|Epinephrine|epinephrine|mesh-list
2121336|NCT02741713|Racepinephrine|racepinephrine|mesh-list
2121337|NCT02741713|Bupivacaine|bupivacaine|mesh-list
2121338|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2121339|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
2121340|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
2121341|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
2121342|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121343|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559859|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559860|NCT01538485|Vitamins|vitamins|mesh-ancestor
2559861|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
2559862|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2559863|NCT01538511|Insulin|insulin|mesh-list
2559864|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2559865|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
2559866|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
2559867|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2559868|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
2559869|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2559870|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2559871|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559872|NCT01538537|ON 01910|on 01910|mesh-list
2559873|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559874|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2559875|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559876|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559877|NCT01538563|ON 01910|on 01910|mesh-list
2559878|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559879|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2559880|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559881|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559882|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
2559883|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2559884|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559885|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
2559886|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2559887|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559888|NCT01538641|Gemcitabine|gemcitabine|mesh-list
2121344|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
2121345|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121346|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2121347|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2121348|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2121349|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2121350|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121351|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2121352|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2559889|NCT01538641|Rituximab|rituximab|mesh-list
2559890|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
2559891|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2559892|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559893|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
2121353|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
2121354|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121355|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2121356|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2121357|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
2121358|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2559894|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559895|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2559896|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2559897|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
2559898|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559899|NCT01538641|Antiviral Agents|antiviral agents|mesh-ancestor
2559900|NCT01538641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559901|NCT01538641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559902|NCT01538641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2559903|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
2559904|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2559905|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559906|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2559907|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2121359|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
2121360|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
2121361|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
2121362|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2121363|NCT02741713|Analgesics|analgesics|mesh-ancestor
2121364|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2121365|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
2121366|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2121367|NCT02742519|Ivacaftor|ivacaftor|mesh-list
2121368|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2559908|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121369|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2121370|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121371|NCT02742532|Oxytocin|oxytocin|mesh-list
2121372|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
2121373|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2121374|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121375|NCT02742649|Timolol|timolol|mesh-list
2121376|NCT02742649|Bimatoprost|bimatoprost|mesh-list
2121377|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2121378|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2121379|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
2121380|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121381|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121382|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121383|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2121384|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2121385|NCT02742987|Clopidogrel|clopidogrel|mesh-list
2121386|NCT02742987|Ticagrelor|ticagrelor|mesh-list
2121387|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2121388|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2121389|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2121390|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2121391|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
2559909|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559910|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559911|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2559912|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2559913|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
2559914|NCT01538693|Dexetimide|dexetimide|mesh-list
2559915|NCT01538693|Citalopram|citalopram|mesh-list
2559916|NCT01538693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2559917|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2559918|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2559919|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418647|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418648|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2418649|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
2418650|NCT00800306|Simendan|simendan|mesh-list
2418651|NCT00800306|Dobutamine|dobutamine|mesh-list
2418652|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2418653|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
2121392|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121393|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121394|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121395|NCT02743078|Bevacizumab|bevacizumab|mesh-list
2121396|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2121397|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121398|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2121399|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2121400|NCT02743078|Growth Substances|growth substances|mesh-ancestor
2121401|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121402|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
2121403|NCT02743221|Trifluridine|trifluridine|mesh-list
2121404|NCT02743221|Bevacizumab|bevacizumab|mesh-list
2121405|NCT02743221|Capecitabine|capecitabine|mesh-list
2121406|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2121407|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121408|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2121409|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2121410|NCT02743221|Growth Substances|growth substances|mesh-ancestor
2121411|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121412|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
2418654|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2418655|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2418656|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418657|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418658|NCT00800306|Protective Agents|protective agents|mesh-ancestor
2418659|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418660|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
2418661|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
2418662|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418663|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2418664|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2559920|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559921|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
2559922|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559923|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2559924|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
2559925|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2559926|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2559927|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2559928|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
2559929|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
2559930|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559931|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2559932|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2559933|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
2559934|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
2559935|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
2559936|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2559937|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2559938|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
2559939|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
2559940|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2559941|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2559942|NCT01538732|Alitretinoin|alitretinoin|mesh-list
2559943|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559944|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
2559945|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
2559946|NCT01538771|Hematinics|hematinics|mesh-ancestor
2559947|NCT01538797|Ranitidine|ranitidine|mesh-list
2121413|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2121414|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
2121415|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121416|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
2121417|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2121418|NCT02743377|Rolipram|rolipram|mesh-list
2121419|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
2559948|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2559949|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2559950|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2559951|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2559952|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
2559953|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
2559954|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559955|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559956|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559957|NCT01538849|Esomeprazole|esomeprazole|mesh-list
2559958|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2559959|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2559960|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2559961|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2559962|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559963|NCT01538875|Hydralazine|hydralazine|mesh-list
2559964|NCT01538875|Labetalol|labetalol|mesh-list
2559965|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2559966|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
2559967|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2559968|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2559969|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
2559970|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2559971|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559972|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559973|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
2559974|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
2559975|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2559976|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2559977|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2559978|NCT01538901|Imiquimod|imiquimod|mesh-list
2559979|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2121420|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2121421|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2121422|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2121423|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121424|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2559980|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
2559981|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559982|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559983|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
2559984|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2559985|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
2559986|NCT01538927|Coagulants|coagulants|mesh-ancestor
2559987|NCT01538940|Vaccines|vaccines|mesh-list
2559988|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
2559989|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2559990|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2559991|NCT01538953|Disinfectants|disinfectants|mesh-list
2559992|NCT01538953|Eusol|eusol|mesh-list
2559993|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2559994|NCT01538966|Octreotide|octreotide|mesh-list
2559995|NCT01538966|Lanreotide|lanreotide|mesh-list
2559996|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2559997|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2559998|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2559999|NCT01539018|Sorafenib|sorafenib|mesh-list
2560000|NCT01539018|Tegafur|tegafur|mesh-list
2560001|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560002|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2560003|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560004|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121425|NCT02743494|Nivolumab|nivolumab|mesh-list
2121426|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2121427|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121428|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2121429|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121430|NCT02743780|MGV354|mgv354|mesh-list
2121431|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
2121432|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121433|NCT02743949|Esomeprazole|esomeprazole|mesh-list
2121434|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2121435|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2121436|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2121437|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121438|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560005|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2560006|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
2560007|NCT01539031|Donepezil|donepezil|mesh-list
2560008|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2560009|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560010|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560011|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
2560012|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560013|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560014|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
2560015|NCT01539044|Atropine|atropine|mesh-list
2560016|NCT01539044|Neostigmine|neostigmine|mesh-list
2560017|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2560018|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2560019|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2121439|NCT02744391|Levodopa|levodopa|mesh-list
2121440|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2121441|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2121442|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
2121443|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2184848|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2560020|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
2560021|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560022|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560023|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2560024|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
2560025|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
2560026|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
2560027|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2560028|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2560029|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
2560030|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560031|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560032|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2560033|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560034|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2560035|NCT01539174|Prednisone|prednisone|mesh-list
2560036|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
2560037|NCT01539174|Rituximab|rituximab|mesh-list
2560038|NCT01539174|Doxorubicin|doxorubicin|mesh-list
2560039|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2560040|NCT01539174|Vincristine|vincristine|mesh-list
2560041|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2560042|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
2560043|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560044|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2560045|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2560046|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
2560047|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560048|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560049|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2560050|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2560051|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2560052|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2560053|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2560054|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560055|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2560056|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
2560057|NCT01539174|Hormones|hormones|mesh-ancestor
2560058|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2560059|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2560060|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2560061|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
2560062|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
2560063|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
2560064|NCT01539226|Dapivirine|dapivirine|mesh-list
2560065|NCT01539226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2560066|NCT01539226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2121444|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121445|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121446|NCT02744755|Adalimumab|adalimumab|mesh-list
2121447|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2121448|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2121449|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2121450|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2121451|NCT02744898|Paclitaxel|paclitaxel|mesh-list
2560067|NCT01539226|Antiviral Agents|antiviral agents|mesh-ancestor
2560068|NCT01539226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2560069|NCT01539265|Silodosin|silodosin|mesh-list
2560070|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2560071|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2560072|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2560073|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
2560074|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560075|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560076|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560077|NCT01539265|Urological Agents|urological agents|mesh-ancestor
2560078|NCT01539330|Voriconazole|voriconazole|mesh-list
2560079|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
2560080|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2560081|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2560082|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2560083|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560084|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121452|NCT02744898|Carboplatin|carboplatin|mesh-list
2121453|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2121454|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2121455|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121456|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
2121457|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
2121458|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
2121459|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121460|NCT02745080|Adalimumab|adalimumab|mesh-list
2121461|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2121462|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2121463|NCT02745353|Naloxegol|naloxegol|mesh-list
2121464|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2121465|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121466|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
2121467|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121468|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
2121469|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2121470|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2560085|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2560086|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
2560087|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2560088|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560089|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2560090|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
2560091|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2560092|NCT01539408|Misoprostol|misoprostol|mesh-list
2560093|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2560094|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
2560095|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2560096|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121471|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
2121472|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121473|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121474|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121475|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
2121476|NCT02745535|Velpatasvir|velpatasvir|mesh-list
2121477|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
2121478|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2121479|NCT02746575|Metoprolol|metoprolol|mesh-list
2121480|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2121481|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2121482|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
2121483|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
2121484|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121485|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560097|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2560098|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2560099|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
2560113|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
2560114|NCT01539473|Tedizolid|tedizolid|mesh-list
2560115|NCT01539473|Tyramine|tyramine|mesh-list
2560116|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2560117|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2560118|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
2560119|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
2560120|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560121|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560122|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2121486|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2121487|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2121488|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2560123|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2560124|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2560125|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560126|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
2560127|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560128|NCT01539564|Minocycline|minocycline|mesh-list
2560129|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2560130|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2560131|NCT01539577|Dexamethasone|dexamethasone|mesh-list
2560132|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2560133|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
2560134|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
2560135|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121489|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
2121490|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121491|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121492|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2121493|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2121494|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
2121495|NCT02746991|Hormones|hormones|mesh-ancestor
2121496|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2560136|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560137|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2418665|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2418666|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
2560138|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
2560139|NCT01539577|Hormones|hormones|mesh-ancestor
2560140|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2560141|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2560142|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560143|NCT01539603|Sirolimus|sirolimus|mesh-list
2560144|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2560145|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2560146|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2560147|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560148|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
2121497|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121498|NCT02747004|Tamoxifen|tamoxifen|mesh-list
2121499|NCT02747004|Loperamide|loperamide|mesh-list
2121500|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
2121501|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2121502|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
2121503|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2121504|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121505|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2121506|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121507|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2121508|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2121509|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2121510|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2121511|NCT02747043|Rituximab|rituximab|mesh-list
2121512|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2121513|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121514|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
2121515|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121516|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2121517|NCT02747186|Lidocaine|lidocaine|mesh-list
2121518|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
2121519|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
2560149|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2560150|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
2560151|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560152|NCT01539616|Fenofibrate|fenofibrate|mesh-list
2560153|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2560154|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
2560155|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560156|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2560157|NCT01539655|Omeprazole|omeprazole|mesh-list
2121520|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121521|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121522|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
2121523|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121524|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2121525|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2121526|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2121527|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2121528|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121529|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
2121530|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2121531|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2560158|NCT01539655|Ranitidine|ranitidine|mesh-list
2560159|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2560160|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2560161|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2560162|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2560163|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560164|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560165|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2560166|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
2418667|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418668|NCT00800319|ALKS-33|alks-33|mesh-list
2418669|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2418670|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418671|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
2418672|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418673|NCT00800358|Calcitriol|calcitriol|mesh-list
2418674|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2121532|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121533|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
2121534|NCT02747615|Coagulants|coagulants|mesh-ancestor
2121535|NCT02747628|Melatonin|melatonin|mesh-list
2121536|NCT02747628|Nicotine|nicotine|mesh-list
2121537|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2121538|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
2121539|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121540|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121541|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2121542|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2121543|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
2121544|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121545|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121546|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
2121547|NCT02747628|Protective Agents|protective agents|mesh-ancestor
2560167|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
2560168|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560169|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560170|NCT01539681|Sorafenib|sorafenib|mesh-list
2560171|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560172|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2560173|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560174|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560175|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
2560176|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2560177|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2560178|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
2560179|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560180|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560181|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560182|NCT01539707|Urological Agents|urological agents|mesh-ancestor
2560183|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
2560184|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
2560185|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2560186|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
2560187|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2560188|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560189|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2560190|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2560191|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2560192|NCT01539733|Haloperidol|haloperidol|mesh-list
2121548|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121549|NCT02747875|Fentanyl|fentanyl|mesh-list
2121550|NCT02747875|Methadone|methadone|mesh-list
2121551|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2121552|NCT02747875|Narcotics|narcotics|mesh-ancestor
2121553|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121554|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121555|NCT02747875|Analgesics|analgesics|mesh-ancestor
2121556|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
2121557|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121558|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2121559|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2121560|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
2121561|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
2121562|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
2121563|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
2121564|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2121565|NCT02748057|Ezetimibe|ezetimibe|mesh-list
2121566|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2121567|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2121568|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
2121569|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121570|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2121571|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2121572|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121573|NCT02748070|Fluticasone|fluticasone|mesh-list
2560193|NCT01539733|Olanzapine|olanzapine|mesh-list
2560194|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
2560195|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
2560196|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
2560197|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560198|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560199|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2121574|NCT02748070|Prednisone|prednisone|mesh-list
2560200|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2121575|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2121576|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
2121577|NCT02748070|Hormones|hormones|mesh-ancestor
2121578|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2121579|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121580|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2121581|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121582|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2121583|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
2121584|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121585|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2121586|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
2121587|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
2121588|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2121589|NCT02748213|Docetaxel|docetaxel|mesh-list
2121590|NCT02748213|Capecitabine|capecitabine|mesh-list
2121591|NCT02748213|Trastuzumab|trastuzumab|mesh-list
2121592|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121593|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
2121594|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
2121595|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
2121596|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121597|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2121598|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
2121599|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2121600|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2121601|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2121602|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
2560201|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2560202|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560203|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2560204|NCT01539733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2560205|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2560206|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2560207|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560208|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560209|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
2560210|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2560211|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
2560212|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2560213|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2560214|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
2560215|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2560216|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
2560217|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560218|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2560219|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2560220|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
2560221|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560222|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121603|NCT02748512|Hormones|hormones|mesh-ancestor
2121604|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2121605|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121606|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
2121607|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2121608|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2121612|NCT02748785|Methotrexate|methotrexate|mesh-list
2121613|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2121614|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
2121615|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2121616|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121617|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2121618|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
2121619|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121620|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121621|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2121622|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121623|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2121624|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2121625|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
2560223|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2560224|NCT01540032|Salicylates|salicylates|mesh-list
2560225|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2560226|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2560227|NCT01540032|Analgesics|analgesics|mesh-ancestor
2560228|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
2560229|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560230|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560231|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2560232|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2560233|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2560234|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560235|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560236|NCT01540084|Propofol|propofol|mesh-list
2560237|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2560238|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560239|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560240|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2560241|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
2560242|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
2560243|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
2121626|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2121627|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2121628|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2121629|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
2121630|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121631|NCT02748889|Carboplatin|carboplatin|mesh-list
2121632|NCT02748889|Etoposide|etoposide|mesh-list
2121633|NCT02748889|Atezolizumab|atezolizumab|mesh-list
2121634|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121635|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2121636|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2121637|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2121638|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121639|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121640|NCT02749370|Etanercept|etanercept|mesh-list
2560244|NCT01540110|Docetaxel|docetaxel|mesh-list
2560245|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2560246|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
2560247|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560248|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2560249|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2560250|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
2121641|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2121642|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2121643|NCT02749370|Analgesics|analgesics|mesh-ancestor
2121644|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
2121645|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121646|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121647|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2121648|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2121649|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2121650|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2121651|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
2121652|NCT02749721|Vortioxetine|vortioxetine|mesh-list
2121653|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
2121654|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2121655|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2121656|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2121657|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121658|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121659|NCT02749721|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2121660|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2121661|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2121662|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121663|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121664|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
2121665|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2121666|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2121667|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2121668|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2121669|NCT02749799|Betamethasone|betamethasone|mesh-list
2121670|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
2121671|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2560251|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560252|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560253|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2560254|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
2560255|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
2560256|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
2560257|NCT01540136|Nedaplatin|nedaplatin|mesh-list
2560258|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560259|NCT01540240|Zidovudine|zidovudine|mesh-list
2418675|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418676|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2121672|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
2121673|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2121674|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2121675|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
2121676|NCT02749799|Hormones|hormones|mesh-ancestor
2121677|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2121678|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121679|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2121680|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
2121681|NCT02750306|Suvorexant|suvorexant|mesh-list
2560260|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
2560261|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560262|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2560263|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2560264|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560265|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
2560266|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2560267|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2560268|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2560269|NCT01540253|Docetaxel|docetaxel|mesh-list
2560270|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560271|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
2560272|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
2560273|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
2560274|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560275|NCT01540435|Bevacizumab|bevacizumab|mesh-list
2560276|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2560277|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560278|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2560279|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2560280|NCT01540435|Growth Substances|growth substances|mesh-ancestor
2560281|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560282|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
2121682|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2121683|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2121684|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121685|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121686|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2121687|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121688|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121689|NCT02750332|Nitisinone|nitisinone|mesh-list
2121690|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121691|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121692|NCT02750345|Nitisinone|nitisinone|mesh-list
2121693|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121694|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121695|NCT02750410|Dulaglutide|dulaglutide|mesh-list
2121696|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2121697|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560283|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
2560284|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2560285|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2560286|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560287|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560288|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2121698|NCT02750514|Nivolumab|nivolumab|mesh-list
2121699|NCT02750514|Ipilimumab|ipilimumab|mesh-list
2121700|NCT02750514|Dasatinib|dasatinib|mesh-list
2418677|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2418678|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418679|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2418680|NCT00800358|Vitamins|vitamins|mesh-ancestor
2418681|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
2121701|NCT02750514|Linrodostat|linrodostat|mesh-list
2121702|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2121703|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121704|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2121705|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121706|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2121707|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121708|NCT02750709|Nitisinone|nitisinone|mesh-list
2121709|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121710|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121711|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
2121712|NCT02750761|Tedizolid|tedizolid|mesh-list
2121713|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
2121714|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2121715|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2121716|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2121717|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560289|NCT01540500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2560290|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2560291|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2560292|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560293|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560294|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
2560295|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2560296|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
2560297|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2560298|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2560299|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560300|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2560301|NCT01540526|Axitinib|axitinib|mesh-list
2560302|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560303|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2560304|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560305|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121718|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121719|NCT02750800|Adalimumab|adalimumab|mesh-list
2121720|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2121721|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2121722|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
2121723|NCT02750930|Incretins|incretins|mesh-ancestor
2121724|NCT02750930|Hormones|hormones|mesh-ancestor
2121725|NCT02750930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2121726|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121727|NCT02750943|Fluorides|fluorides|mesh-list
2121728|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
2121729|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
2121730|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
2121731|NCT02750943|Protective Agents|protective agents|mesh-ancestor
2560306|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2560307|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2560308|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2560309|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2560310|NCT01540682|Cetuximab|cetuximab|mesh-list
2560311|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2560312|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560313|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2560314|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2560315|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
2560316|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560317|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560318|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2560319|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
2560320|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
2560321|NCT01540708|Hormones|hormones|mesh-ancestor
2560322|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2560323|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
2560324|NCT01540721|Acetaminophen|acetaminophen|mesh-list
2560325|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2560326|NCT01540721|Analgesics|analgesics|mesh-ancestor
2560327|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
2560328|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560329|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121732|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121733|NCT02751320|Citric Acid|citric acid|mesh-list
2121734|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
2560330|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
2560331|NCT01540734|Acetaminophen|acetaminophen|mesh-list
2560332|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2560333|NCT01540734|Analgesics|analgesics|mesh-ancestor
2560334|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
2560335|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560336|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560337|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
2560338|NCT01540747|Folic Acid|folic acid|mesh-list
2121735|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
2121736|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2121737|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
2121738|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
2560339|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
2560340|NCT01540747|Inositol|inositol|mesh-list
2560341|NCT01540747|Melatonin|melatonin|mesh-list
2560342|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
2560343|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560344|NCT01540747|Protective Agents|protective agents|mesh-ancestor
2560345|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560346|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560347|NCT01540747|Hematinics|hematinics|mesh-ancestor
2560348|NCT01540747|Vitamins|vitamins|mesh-ancestor
2560349|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
2560350|NCT01540812|Cytarabine|cytarabine|mesh-list
2560351|NCT01540812|Dexamethasone|dexamethasone|mesh-list
2560352|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
2560353|NCT01540812|Prednisone|prednisone|mesh-list
2560354|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
2560355|NCT01540812|Fludarabine|fludarabine|mesh-list
2560356|NCT01540812|Vincristine|vincristine|mesh-list
2121739|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121740|NCT02751359|Cannabidiol|cannabidiol|mesh-list
2121741|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
2121742|NCT02751385|Nintedanib|nintedanib|mesh-list
2121743|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2121744|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2121745|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121746|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2121747|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121748|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121749|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2121750|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
2121751|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2121752|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121753|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2121754|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2121755|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2121756|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2121757|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2121758|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2121759|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2121760|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2121761|NCT02751450|Fluorides|fluorides|mesh-list
2121762|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
2121763|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
2560357|NCT01540812|Daunorubicin|daunorubicin|mesh-list
2560358|NCT01540812|Idarubicin|idarubicin|mesh-list
2560359|NCT01540812|Methotrexate|methotrexate|mesh-list
2560360|NCT01540812|Pegaspargase|pegaspargase|mesh-list
2560361|NCT01540812|Asparaginase|asparaginase|mesh-list
2560362|NCT01540812|BB 1101|bb 1101|mesh-list
2560363|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2560364|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
2560365|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
2560366|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560367|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560368|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2560369|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
2560370|NCT01540812|Hormones|hormones|mesh-ancestor
2560371|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2560372|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2560373|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560374|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
2560375|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560376|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560377|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2560378|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
2560379|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2560380|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
2560381|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
2560382|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2560383|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2560384|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
2560385|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
2560386|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
2560387|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2560388|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2560389|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2560390|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2560391|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
2560392|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2560393|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
2560394|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2560395|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2560396|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2560397|NCT01540877|Anesthetics|anesthetics|mesh-list
2560398|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2560399|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
2560400|NCT01540877|Capsaicin|capsaicin|mesh-list
2560401|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560402|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560403|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
2560404|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121764|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
2121765|NCT02751450|Protective Agents|protective agents|mesh-ancestor
2121766|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121767|NCT02751931|Mirabegron|mirabegron|mesh-list
2121768|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2121769|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2121770|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2121771|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
2121772|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121773|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121774|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121775|NCT02751931|Urological Agents|urological agents|mesh-ancestor
2121776|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
2121777|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2121778|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121779|NCT02752256|Plasminogen|plasminogen|mesh-list
2121780|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2121781|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2560405|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
2560406|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
2560407|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2560408|NCT01541059|Ropivacaine|ropivacaine|mesh-list
2560409|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
2560410|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
2560411|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560412|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560413|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
2560414|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560415|NCT01541072|Lenograstim|lenograstim|mesh-list
2560416|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2560417|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
2560418|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560419|NCT01541085|Ritonavir|ritonavir|mesh-list
2121782|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2121783|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121784|NCT02752633|Allopurinol|allopurinol|mesh-list
2121785|NCT02752633|Febuxostat|febuxostat|mesh-list
2121786|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
2121787|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121788|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121789|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
2121790|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2121791|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2121792|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
2121793|NCT02752633|Protective Agents|protective agents|mesh-ancestor
2121794|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121795|NCT02752906|Vaccines|vaccines|mesh-list
2560420|NCT01541085|Darunavir|darunavir|mesh-list
2560421|NCT01541085|Efavirenz|efavirenz|mesh-list
2560422|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2560423|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2560424|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
2560425|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560426|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121796|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
2121797|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121798|NCT02752958|Fluorides|fluorides|mesh-list
2121799|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
2121800|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
2121801|NCT02752958|Protective Agents|protective agents|mesh-ancestor
2121802|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121803|NCT02753075|Fluorides|fluorides|mesh-list
2121804|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
2121805|NCT02753075|Protective Agents|protective agents|mesh-ancestor
2121806|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121807|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
2121808|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2121809|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2121810|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121811|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
2121812|NCT02753816|Coagulants|coagulants|mesh-ancestor
2121813|NCT02753881|Doxorubicin|doxorubicin|mesh-list
2121814|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2121815|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2121816|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121817|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2121818|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2121819|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121820|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121821|NCT02753946|Tazobactam|tazobactam|mesh-list
2121822|NCT02753946|Piperacillin|piperacillin|mesh-list
2121823|NCT02753946|Fosfomycin|fosfomycin|mesh-list
2121824|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2121825|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2121826|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2121827|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2121828|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121829|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121830|NCT02754518|Valsartan|valsartan|mesh-list
2121831|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2121832|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2121833|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2121834|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2121835|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121836|NCT02754570|Pilocarpine|pilocarpine|mesh-list
2121837|NCT02754570|Miotics|miotics|mesh-ancestor
2121838|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
2121839|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121840|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560427|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2560428|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2560429|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
2560430|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2560431|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2560432|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2560433|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2560434|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2121841|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2121842|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2121843|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
2121844|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121845|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121846|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
2560435|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2560436|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2560437|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2560438|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2560439|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2560440|NCT01541124|Morphine|morphine|mesh-list
2560441|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2560442|NCT01541124|Narcotics|narcotics|mesh-ancestor
2560443|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121847|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2121848|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
2560444|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560445|NCT01541124|Analgesics|analgesics|mesh-ancestor
2560446|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
2560447|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560448|NCT01541137|Diclofenac|diclofenac|mesh-list
2560449|NCT01541137|Parecoxib|parecoxib|mesh-list
2560450|NCT01541137|Valdecoxib|valdecoxib|mesh-list
2560451|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2560452|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2560453|NCT01541137|Analgesics|analgesics|mesh-ancestor
2560454|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
2560455|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560456|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560457|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2121849|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
2121850|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121851|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121852|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2121853|NCT02755090|Analgesics|analgesics|mesh-ancestor
2121854|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
2121855|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121856|NCT02755116|Olanzapine|olanzapine|mesh-list
2121857|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
2121858|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
2121859|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121860|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121861|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2121862|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2418682|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2418683|NCT00800423|Timolol|timolol|mesh-list
2418684|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2418685|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2418686|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2418687|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
2418688|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418689|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418690|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418691|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2418692|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2418693|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2418694|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2560458|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2121863|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2121864|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121865|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2121866|NCT02755116|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2121867|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2121868|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2121869|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121870|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121871|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
2121872|NCT02755818|Heparin|heparin|mesh-list
2121873|NCT02755818|Calcium heparin|calcium heparin|mesh-list
2121874|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
2121875|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2121876|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2121877|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121878|NCT02756013|Paclitaxel|paclitaxel|mesh-list
2121879|NCT02756013|Carboplatin|carboplatin|mesh-list
2121880|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2121881|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560459|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2560460|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560461|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560462|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2560463|NCT01541189|Valsartan|valsartan|mesh-list
2560464|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2560465|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2560466|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2560467|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560468|NCT01541267|Telmisartan|telmisartan|mesh-list
2121882|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
2560469|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2560470|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2560471|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2560472|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560473|NCT01541280|Azacitidine|azacitidine|mesh-list
2560474|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2560475|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
2560476|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560477|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560478|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121883|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
2121884|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
2121885|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121889|NCT02756364|Fulvestrant|fulvestrant|mesh-list
2560479|NCT01541293|Lidocaine|lidocaine|mesh-list
2560480|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
2560481|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
2560482|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560483|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560484|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
2560485|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560486|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2560487|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2560488|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2560489|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2560490|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560491|NCT01541332|Dexamethasone|dexamethasone|mesh-list
2560492|NCT01541332|Doxorubicin|doxorubicin|mesh-list
2560493|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2560494|NCT01541332|Pomalidomide|pomalidomide|mesh-list
2560495|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2560496|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
2560497|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
2560498|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560499|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560500|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2121890|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2121891|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121892|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2121893|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2121894|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
2121895|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2418695|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2560501|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
2560502|NCT01541332|Hormones|hormones|mesh-ancestor
2560503|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2560504|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2560505|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560506|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2560507|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2560508|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2560509|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560510|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560511|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
2560512|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2418696|NCT00800462|Bromides|bromides|mesh-list
2418697|NCT00800462|Oxybutynin|oxybutynin|mesh-list
2418698|NCT00800462|Darifenacin|darifenacin|mesh-list
2418699|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
2418700|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
2418701|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
2418702|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418703|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418704|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2418705|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2418706|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
2418707|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418708|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418709|NCT00800462|Urological Agents|urological agents|mesh-ancestor
2418710|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
2121896|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121897|NCT02756572|Cytarabine|cytarabine|mesh-list
2121898|NCT02756572|Cyclosporine|cyclosporine|mesh-list
2121899|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
2121900|NCT02756572|Sirolimus|sirolimus|mesh-list
2121901|NCT02756572|Fludarabine|fludarabine|mesh-list
2121902|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
2121903|NCT02756572|Melphalan|melphalan|mesh-list
2560513|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2560514|NCT01541332|Growth Substances|growth substances|mesh-ancestor
2560515|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
2560516|NCT01541436|Capsaicin|capsaicin|mesh-list
2560517|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
2560518|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
2560519|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
2560520|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560521|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560522|NCT01541475|Dexetimide|dexetimide|mesh-list
2560523|NCT01541475|Citalopram|citalopram|mesh-list
2560524|NCT01541475|Bupropion|bupropion|mesh-list
2560525|NCT01541475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2560526|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2560527|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2560528|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560529|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560530|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
2560531|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560532|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2560533|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
2560534|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2560535|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2560536|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2560537|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
2560538|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
2560539|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560540|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2560541|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2560542|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
2560543|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2560544|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
2560545|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2560546|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2560547|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560548|NCT01541605|Methylphenidate|methylphenidate|mesh-list
2560549|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2560550|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560551|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2560552|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2560553|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2560554|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560555|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
2560556|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560557|NCT01541631|Albendazole|albendazole|mesh-list
2121904|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
2121905|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
2121906|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2121907|NCT02756572|Cladribine|cladribine|mesh-list
2121908|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
2121909|NCT02756572|Cyclosporins|cyclosporins|mesh-list
2121910|NCT02756572|Lenograstim|lenograstim|mesh-list
2121911|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121912|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2560558|NCT01541631|Praziquantel|praziquantel|mesh-list
2560559|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
2560560|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2560561|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2560562|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
2560563|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2121913|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
2121914|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121915|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2121916|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
2121917|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121918|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2560564|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2121919|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
2121920|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2560565|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
2560566|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
2560567|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
2560568|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560569|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560570|NCT01541670|Antibodies|antibodies|mesh-list
2560571|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
2560572|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560573|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2560574|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
2560575|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560576|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2560577|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560578|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560579|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2560580|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2560581|NCT01541943|Losartan|losartan|mesh-list
2560582|NCT01541943|Atorvastatin|atorvastatin|mesh-list
2560583|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2560584|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2560585|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
2121921|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121922|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
2121923|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
2121924|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2121925|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2121926|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2121927|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2121928|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
2121929|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2121930|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2121931|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
2121932|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2121933|NCT02756572|Analgesics|analgesics|mesh-ancestor
2560586|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560587|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2560588|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2560589|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560590|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2560591|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2560592|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2560593|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2560594|NCT01541956|Metformin|metformin|mesh-list
2560595|NCT01541956|Vildagliptin|vildagliptin|mesh-list
2121934|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
2121935|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121936|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2121937|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2121938|NCT02756611|Venetoclax|venetoclax|mesh-list
2121939|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2121940|NCT02756624|Cetirizine|cetirizine|mesh-list
2121941|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2560596|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2560597|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560598|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2560599|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
2560600|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560601|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560602|NCT01542021|Androgens|androgens|mesh-list
2560603|NCT01542021|Hormones|hormones|mesh-ancestor
2560604|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2560605|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560606|NCT01542047|Carboplatin|carboplatin|mesh-list
2560607|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560608|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
2560609|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
2560610|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2560611|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2560612|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560613|NCT01542099|Remifentanil|remifentanil|mesh-list
2560614|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2560615|NCT01542099|Narcotics|narcotics|mesh-ancestor
2560616|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560617|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560618|NCT01542099|Analgesics|analgesics|mesh-ancestor
2121942|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2121943|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2121944|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
2121945|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
2121946|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121947|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121948|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121949|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2560619|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
2560620|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560621|NCT01542138|Niacinamide|niacinamide|mesh-list
2560622|NCT01542138|Niacin|niacin|mesh-list
2560623|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
2560624|NCT01542138|Desonide|desonide|mesh-list
2560625|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
2560626|NCT01542138|Vitamins|vitamins|mesh-ancestor
2560627|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
2560628|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560629|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2560630|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
2560631|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560632|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2560633|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
2560634|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2560635|NCT01542190|Ketorolac|ketorolac|mesh-list
2560636|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2560637|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2560638|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2560639|NCT01542190|Analgesics|analgesics|mesh-ancestor
2560640|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
2121950|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2121951|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2121952|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121953|NCT02756832|Alogliptin|alogliptin|mesh-list
2121954|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2121955|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560641|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560642|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560643|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2560644|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2560645|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2560646|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560647|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560648|NCT01542242|Liraglutide|liraglutide|mesh-list
2560649|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2560650|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560651|NCT01542242|Incretins|incretins|mesh-ancestor
2560652|NCT01542242|Hormones|hormones|mesh-ancestor
2560653|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2560654|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
2560655|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2560656|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560657|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560658|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2560659|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2560660|NCT01542268|Protective Agents|protective agents|mesh-ancestor
2560661|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560662|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
2560663|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2560664|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
2560665|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
2560666|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560667|NCT01542424|Insulin|insulin|mesh-list
2560668|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2560669|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
2560670|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
2560671|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
2560672|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2560673|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2560674|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560675|NCT01542437|Afatinib|afatinib|mesh-list
2560676|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560677|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2121956|NCT02756832|Incretins|incretins|mesh-ancestor
2560678|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560679|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560680|NCT01542450|Insulin|insulin|mesh-list
2560681|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2560682|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
2560683|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
2560684|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
2560685|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
2560686|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2560687|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560688|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
2560689|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2560690|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560691|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
2560692|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2560693|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121957|NCT02756832|Hormones|hormones|mesh-ancestor
2121958|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2418711|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2560694|NCT01542489|Insulin|insulin|mesh-list
2560695|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2560696|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
2560697|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
2560698|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2560699|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560700|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
2560701|NCT01542697|Analgesics|analgesics|mesh-ancestor
2560702|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
2560703|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560704|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560705|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
2560706|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560707|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2560708|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
2560709|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2560710|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2560711|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560712|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2560713|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
2560714|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2560715|NCT01542710|Timolol|timolol|mesh-list
2560716|NCT01542710|Bimatoprost|bimatoprost|mesh-list
2560717|NCT01542710|Travoprost|travoprost|mesh-list
2560718|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2560719|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2560720|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
2560721|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560722|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560723|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560724|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2560725|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2560726|NCT01542723|Nadroparin|nadroparin|mesh-list
2560727|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
2560728|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2560729|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2560730|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418712|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
2418713|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418714|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2418715|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2418716|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2418717|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418718|NCT00800514|Amantadine|amantadine|mesh-list
2418719|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2418720|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2418721|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
2418722|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418723|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
2418724|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418725|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418726|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418727|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2418728|NCT00800514|Analgesics|analgesics|mesh-ancestor
2418729|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
2121959|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2121960|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
2121961|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2121962|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121963|NCT02757105|Ondansetron|ondansetron|mesh-list
2121964|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
2121965|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
2121966|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121967|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121968|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2121969|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
2121970|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
2121971|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2121972|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
2121973|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121974|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121975|NCT02757105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2121976|NCT02757105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2121977|NCT02757105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121978|NCT02757105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2560739|NCT01542762|Nadroparin|nadroparin|mesh-list
2560740|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
2560741|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2560742|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2560743|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560744|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
2560745|NCT01542801|Norfloxacin|norfloxacin|mesh-list
2121979|NCT02757105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2121980|NCT02757352|Ixekizumab|ixekizumab|mesh-list
2121981|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
2121982|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
2121983|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2121984|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2121985|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2121986|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2121987|NCT02757625|Analgesics|analgesics|mesh-ancestor
2121988|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
2560746|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2560747|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2560748|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2560749|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2560750|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560751|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560752|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560753|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2560754|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2560755|NCT01542827|Analgesics|analgesics|mesh-list
2560756|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
2560757|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560758|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560759|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2560760|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2560761|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2560762|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121989|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2121990|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2560763|NCT01542879|Hematinics|hematinics|mesh-ancestor
2560764|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2560765|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2560766|NCT01542918|Rituximab|rituximab|mesh-list
2560767|NCT01542918|Lenalidomide|lenalidomide|mesh-list
2121991|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2121992|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2121993|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
2121994|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2121995|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2121996|NCT02757768|Tamsulosin|tamsulosin|mesh-list
2121997|NCT02757768|Mirabegron|mirabegron|mesh-list
2560768|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2560769|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560770|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
2560771|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560772|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2560773|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2560774|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2560775|NCT01542918|Growth Substances|growth substances|mesh-ancestor
2121998|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2121999|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2122000|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2122001|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
2122002|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2122003|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122004|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122005|NCT02757768|Urological Agents|urological agents|mesh-ancestor
2122006|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2122007|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2122008|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2122009|NCT02758171|Empagliflozin|empagliflozin|mesh-list
2122010|NCT02758171|Linagliptin|linagliptin|mesh-list
2122011|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2122012|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122013|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2122014|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122015|NCT02758171|Incretins|incretins|mesh-ancestor
2122016|NCT02758171|Hormones|hormones|mesh-ancestor
2122017|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122018|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2122019|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
2122020|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122033|NCT02759016|BI 836826|bi 836826|mesh-list
2122034|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2122035|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122036|NCT02759120|Doxycycline|doxycycline|mesh-list
2122037|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2122038|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2122039|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
2122040|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
2560776|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
2560777|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2560778|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
2560779|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2560780|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2560781|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2560782|NCT01543139|Valproic Acid|valproic acid|mesh-list
2560783|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
2560784|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122041|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2122042|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2122043|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2122044|NCT02759120|Renal Agents|renal agents|mesh-ancestor
2122045|NCT02759185|Dronabinol|dronabinol|mesh-list
2122046|NCT02759185|Cannabidiol|cannabidiol|mesh-list
2122047|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
2122048|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
2122049|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122050|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2122051|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2122052|NCT02759185|Analgesics|analgesics|mesh-ancestor
2122053|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
2122054|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560785|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122055|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2122056|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2122057|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2122058|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122059|NCT02759185|Hormones|hormones|mesh-ancestor
2122060|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122061|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
2122062|NCT02759315|Ruzasvir|ruzasvir|mesh-list
2122063|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
2560786|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
2560787|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560788|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560789|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
2560790|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2560791|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560792|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2560793|NCT01543165|Ketorolac|ketorolac|mesh-list
2122064|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122065|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
2122066|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122067|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2122068|NCT02760069|Ondansetron|ondansetron|mesh-list
2122069|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
2122070|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
2122071|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122072|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560794|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2560795|NCT01543165|Morphine|morphine|mesh-list
2560796|NCT01543165|Analgesics|analgesics|mesh-list
2560797|NCT01543165|Nefopam|nefopam|mesh-list
2560798|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2560799|NCT01543165|Narcotics|narcotics|mesh-ancestor
2560800|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2418730|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418731|NCT00800527|Diclofenac|diclofenac|mesh-list
2418732|NCT00800527|Gabapentin|gabapentin|mesh-list
2418733|NCT00800527|Analgesics|analgesics|mesh-ancestor
2418734|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
2418735|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418736|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418737|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
2122073|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2122074|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
2122075|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
2122076|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2122077|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
2122078|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560801|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560802|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
2560803|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560804|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2560805|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2560806|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2560807|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2560808|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2122079|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122080|NCT02760069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2122081|NCT02760069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2122082|NCT02760069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560809|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560810|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560811|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
2560812|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2560813|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2560814|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2560815|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560816|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
2560817|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560818|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560819|NCT01543347|Temocillin|temocillin|mesh-list
2560820|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2560821|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2560822|NCT01543386|Curcumin|curcumin|mesh-list
2560823|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2560824|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2560825|NCT01543386|Analgesics|analgesics|mesh-ancestor
2560826|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
2560827|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560828|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560829|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2560830|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2560831|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560832|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560833|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560834|NCT01543399|Tibolone|tibolone|mesh-list
2560835|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
2560836|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
2560837|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2560838|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560839|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2560840|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2122083|NCT02760069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2122084|NCT02760069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2122085|NCT02760407|Adalimumab|adalimumab|mesh-list
2122086|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122087|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2122088|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
2122089|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2122090|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2122091|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2122092|NCT02760862|Mannitol|mannitol|mesh-list
2122093|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122094|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2122095|NCT02760862|Diuretics|diuretics|mesh-ancestor
2122096|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
2122097|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122098|NCT02761252|Montelukast|montelukast|mesh-list
2122099|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2122100|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
2122101|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2122102|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
2122103|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122104|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122105|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2122106|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2122107|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122108|NCT02761330|Ketamine|ketamine|mesh-list
2560841|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560842|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2560843|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
2560844|NCT01543399|Hormones|hormones|mesh-ancestor
2560845|NCT01543464|Temozolomide|temozolomide|mesh-list
2560846|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2560847|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
2560848|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560849|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560850|NCT01543555|Atorvastatin|atorvastatin|mesh-list
2560851|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2560852|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2560853|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
2560854|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560855|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2560856|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2560857|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418738|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2418739|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2418740|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2418741|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2418742|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2418743|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2418744|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418745|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418746|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
2418747|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2560865|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
2560866|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
2560867|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2560868|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560869|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560870|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
2560871|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2560872|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560873|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560874|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
2560875|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2560876|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
2560877|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560878|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
2560879|NCT01543737|Protective Agents|protective agents|mesh-ancestor
2560880|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
2560881|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2560882|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2560883|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560884|NCT01543763|Abexinostat|abexinostat|mesh-list
2560885|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2560886|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560887|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560888|NCT01543906|Retinol acetate|retinol acetate|mesh-list
2560889|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2560890|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
2560891|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560892|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2560893|NCT01543906|Protective Agents|protective agents|mesh-ancestor
2560894|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560895|NCT01543932|Clopidogrel|clopidogrel|mesh-list
2560896|NCT01543932|Ticagrelor|ticagrelor|mesh-list
2560897|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2560898|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2560899|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2560900|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2560901|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2560902|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
2560903|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560904|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560905|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560906|NCT01543945|Dexamethasone|dexamethasone|mesh-list
2560907|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
2560908|NCT01543945|Ondansetron|ondansetron|mesh-list
2560909|NCT01543945|Antiemetics|antiemetics|mesh-list
2560910|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
2560911|NCT01543945|BB 1101|bb 1101|mesh-list
2560912|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2560913|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
2560914|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560915|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560916|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2560917|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
2560918|NCT01543945|Hormones|hormones|mesh-ancestor
2560919|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2560920|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2560921|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2560922|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
2560923|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560924|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560925|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
2560926|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
2122109|NCT02761330|Analgesics|analgesics|mesh-ancestor
2122110|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
2122111|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122112|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122113|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2122114|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2560927|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2560928|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
2560929|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560930|NCT01543945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2560931|NCT01543945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2122115|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
2122116|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
2122117|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2122118|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2122119|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2122120|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2122121|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122122|NCT02761629|Interferons|interferons|mesh-list
2122123|NCT02761629|Ribavirin|ribavirin|mesh-list
2122124|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
2122125|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
2122126|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2122127|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122128|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
2122129|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122130|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
2122131|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122132|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
2122133|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122134|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
2122135|NCT02761642|Hematinics|hematinics|mesh-ancestor
2122136|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
2122137|NCT02761915|Fludarabine|fludarabine|mesh-list
2122138|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2122139|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
2122140|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122141|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2122142|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2122143|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
2122144|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122145|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122146|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2122147|NCT02761980|Acetaminophen|acetaminophen|mesh-list
2122148|NCT02761980|Ibuprofen|ibuprofen|mesh-list
2122149|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2122150|NCT02761980|Analgesics|analgesics|mesh-ancestor
2122151|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
2122152|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122153|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122154|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
2122155|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2122156|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122157|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2122158|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2122159|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122160|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122161|NCT02762071|Bupivacaine|bupivacaine|mesh-list
2122162|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
2122163|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
2122164|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2122165|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122166|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
2122167|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122168|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
2122169|NCT02762331|Vitamins|vitamins|mesh-ancestor
2122170|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
2122171|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122172|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
2122173|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122174|NCT02762331|Protective Agents|protective agents|mesh-ancestor
2122175|NCT02762370|Triamcinolone|triamcinolone|mesh-list
2122176|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2122177|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2122178|NCT02762370|FX006|fx006|mesh-list
2560932|NCT01543945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560933|NCT01543945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2560934|NCT01543945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2560935|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2560936|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
2560937|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
2560938|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2560939|NCT01543971|Lenograstim|lenograstim|mesh-list
2560940|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2560941|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
2560942|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560943|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2122179|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2122180|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122181|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
2122182|NCT02762370|Hormones|hormones|mesh-ancestor
2560944|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
2560945|NCT01544075|Vaccines|vaccines|mesh-list
2560946|NCT01544075|Immunologic Factors|immunologic factors|mesh-ancestor
2560947|NCT01544075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560948|NCT01544140|Midazolam|midazolam|mesh-list
2560949|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2560950|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2560951|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560952|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560953|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2560954|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2560955|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2122183|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122184|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122185|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2122186|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
2122187|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122188|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122189|NCT02762513|Axitinib|axitinib|mesh-list
2122190|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122191|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2122192|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122193|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122194|NCT02762578|Insulin|insulin|mesh-list
2122195|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2122196|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
2122197|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
2560956|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2560957|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
2560958|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
2560959|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
2560960|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
2560961|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2560962|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560963|NCT01544192|Tocopherols|tocopherols|mesh-list
2560964|NCT01544192|Vitamin E|vitamin e|mesh-list
2560965|NCT01544192|Tocotrienols|tocotrienols|mesh-list
2560966|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
2560967|NCT01544192|Antioxidants|antioxidants|mesh-list
2122198|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2122199|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
2122200|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2122201|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122202|NCT02762799|Lenograstim|lenograstim|mesh-list
2122203|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2122204|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
2122205|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122206|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2560968|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560969|NCT01544192|Protective Agents|protective agents|mesh-ancestor
2560970|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560971|NCT01544192|Vitamins|vitamins|mesh-ancestor
2560972|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
2560973|NCT01544283|Triamcinolone|triamcinolone|mesh-list
2560974|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2560975|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2560976|NCT01544283|Lidocaine|lidocaine|mesh-list
2560977|NCT01544283|Tetracaine|tetracaine|mesh-list
2560978|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2560979|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
2560980|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
2560981|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2560982|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560983|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
2560984|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2560985|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2560986|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2560987|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2560988|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2560989|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2560990|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122207|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
2560991|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
2560992|NCT01544283|Hormones|hormones|mesh-ancestor
2122208|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122209|NCT02763566|Letrozole|letrozole|mesh-list
2122210|NCT02763566|Fulvestrant|fulvestrant|mesh-list
2122211|NCT02763566|Anastrozole|anastrozole|mesh-list
2122212|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122213|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2122214|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2122215|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122216|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122217|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2122218|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
2122219|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122220|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2560993|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2560994|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2560995|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
2560996|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2560997|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
2560998|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122221|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2122222|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2122223|NCT02763579|Carboplatin|carboplatin|mesh-list
2122224|NCT02763579|Etoposide|etoposide|mesh-list
2122225|NCT02763579|Atezolizumab|atezolizumab|mesh-list
2122226|NCT02763579|Antibodies|antibodies|mesh-list
2122227|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2560999|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
2561000|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
2561001|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
2561002|NCT01544504|Norepinephrine|norepinephrine|mesh-list
2561003|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2561004|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2561005|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
2561006|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561007|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561008|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561009|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
2561010|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
2561011|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561012|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2561013|NCT01544517|Amoxicillin|amoxicillin|mesh-list
2561014|NCT01544517|Levofloxacin|levofloxacin|mesh-list
2561015|NCT01544517|Ofloxacin|ofloxacin|mesh-list
2561016|NCT01544517|Tinidazole|tinidazole|mesh-list
2561017|NCT01544517|Esomeprazole|esomeprazole|mesh-list
2561018|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2561019|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2561020|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561021|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2561022|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2561023|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561024|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561025|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2561026|NCT01544517|Renal Agents|renal agents|mesh-ancestor
2561027|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2561028|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2561029|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561030|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2561031|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2561032|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
2561033|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2561034|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2561035|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2561036|NCT01544634|Beclomethasone|beclomethasone|mesh-list
2122228|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
2122229|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122230|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122231|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2122232|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2122233|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2122234|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122235|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122236|NCT02764333|Durvalumab|durvalumab|mesh-list
2561037|NCT01544634|Propranolol|propranolol|mesh-list
2561038|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2561039|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2561040|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
2561041|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561042|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561043|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561044|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2122237|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2122238|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122239|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2122240|NCT02764697|Hormones|hormones|mesh-ancestor
2122241|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122242|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561045|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2561046|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
2561047|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2561048|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
2561049|NCT01544634|Hormones|hormones|mesh-ancestor
2561050|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2561051|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2561052|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
2561053|NCT01544673|Linezolid|linezolid|mesh-list
2561054|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2561055|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561056|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2561057|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561058|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561059|NCT01544725|Ketamine|ketamine|mesh-list
2561060|NCT01544725|Propofol|propofol|mesh-list
2561061|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2561062|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561063|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561064|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2561065|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
2561066|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
2561067|NCT01544725|Analgesics|analgesics|mesh-ancestor
2561068|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
2561069|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561070|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2561071|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2561072|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2561073|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561074|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561075|NCT01544751|Metformin|metformin|mesh-list
2561076|NCT01544751|Atorvastatin|atorvastatin|mesh-list
2561077|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2122243|NCT02764762|Adalimumab|adalimumab|mesh-list
2122244|NCT02764762|Methotrexate|methotrexate|mesh-list
2122245|NCT02764762|Vedolizumab|vedolizumab|mesh-list
2122246|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2122247|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
2122248|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2122249|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561078|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561079|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2561080|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2561081|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
2561082|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561083|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2561084|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2122250|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2122251|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
2122252|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122253|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122254|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
2122255|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122256|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2122257|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2122258|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
2122259|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2122260|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2122261|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122262|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2122263|NCT02765100|Minocycline|minocycline|mesh-list
2122264|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2561085|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122265|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122266|NCT02765165|Lomustine|lomustine|mesh-list
2122267|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2122268|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
2122269|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122270|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122271|NCT02765256|Promethazine|promethazine|mesh-list
2122272|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
2122273|NCT02765256|Vancomycin|vancomycin|mesh-list
2122274|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
2122275|NCT02765256|Neomycin|neomycin|mesh-list
2122276|NCT02765256|Fluconazole|fluconazole|mesh-list
2122277|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2122278|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2122279|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122280|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2122281|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2122282|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122283|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122284|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122285|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2122286|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2122287|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
2561086|NCT01544829|Theobromine|theobromine|mesh-list
2561087|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2561088|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
2561089|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561090|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561091|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2561092|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
2122288|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2122289|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2122290|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
2122291|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122292|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122293|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2122294|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2122295|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
2122296|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
2122297|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2122298|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
2122299|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
2122300|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2122301|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2122302|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2122303|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2122304|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2122305|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
2122306|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
2122307|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
2122308|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122309|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
2122310|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
2122311|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2122312|NCT02765256|Laxatives|laxatives|mesh-ancestor
2122313|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2122314|NCT02765490|Simeprevir|simeprevir|mesh-list
2122315|NCT02765490|Odalasvir|odalasvir|mesh-list
2122316|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
2122317|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561093|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
2561094|NCT01544842|Triamcinolone|triamcinolone|mesh-list
2122318|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
2122319|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122320|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122321|NCT02766023|Metronidazole|metronidazole|mesh-list
2122322|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122323|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2122324|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2122325|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2122326|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2122327|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122328|NCT02766517|Capsaicin|capsaicin|mesh-list
2122329|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
2122330|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
2561095|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2561096|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2561097|NCT01544842|Tacrolimus|tacrolimus|mesh-list
2561098|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2561099|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2561100|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
2561101|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561102|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2561103|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561104|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561105|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2561106|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
2561107|NCT01544842|Hormones|hormones|mesh-ancestor
2561108|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2561109|NCT01544881|Insulin|insulin|mesh-list
2561110|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2561111|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561112|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2122331|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
2122332|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122333|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122334|NCT02766608|Budesonide|budesonide|mesh-list
2122335|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
2122336|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2122337|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122338|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2122339|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
2122340|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122341|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122342|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2122343|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
2122344|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
2122345|NCT02766608|Hormones|hormones|mesh-ancestor
2122346|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122347|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2122348|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2122349|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2122350|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
2122351|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2122352|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122353|NCT02766673|Albuterol|albuterol|mesh-list
2122354|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2122355|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
2122356|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122357|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122358|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2122359|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
2122360|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
2561113|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
2561114|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2561115|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
2561116|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2561117|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561118|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2561119|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2561120|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2561121|NCT01544907|Paclitaxel|paclitaxel|mesh-list
2561122|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2561123|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561124|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
2561125|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
2561126|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
2561127|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561128|NCT01544959|Fentanyl|fentanyl|mesh-list
2561129|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2561130|NCT01544959|Esmolol|esmolol|mesh-list
2561131|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2561132|NCT01544959|Narcotics|narcotics|mesh-ancestor
2561133|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561134|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561135|NCT01544959|Analgesics|analgesics|mesh-ancestor
2561136|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
2561137|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561138|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2122361|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2122362|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2122363|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2122364|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2122365|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
2122366|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2122367|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122368|NCT02766777|Lubiprostone|lubiprostone|mesh-list
2122369|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2122370|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2561139|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2561140|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
2561141|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
2561142|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2561143|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
2561144|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561145|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561146|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2561147|NCT01544972|Acetaminophen|acetaminophen|mesh-list
2561148|NCT01544972|Ibuprofen|ibuprofen|mesh-list
2561149|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2561150|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2561151|NCT01544972|Analgesics|analgesics|mesh-ancestor
2561152|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
2561153|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561154|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561155|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2561156|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2561157|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2561158|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561159|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561160|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
2561161|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2561162|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2561163|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561164|NCT01545024|Incretins|incretins|mesh-ancestor
2561165|NCT01545024|Hormones|hormones|mesh-ancestor
2561166|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2561167|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2561168|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
2561169|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561170|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561171|NCT01545271|Xenon|xenon|mesh-list
2561172|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2561173|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
2561174|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
2561175|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561176|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561177|NCT01545284|Acitretin|acitretin|mesh-list
2561178|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
2561179|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
2561180|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
2561181|NCT01545297|Remifentanil|remifentanil|mesh-list
2561182|NCT01545297|Propofol|propofol|mesh-list
2561183|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2561184|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561185|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561186|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2561187|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
2561188|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
2561189|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2561190|NCT01545297|Analgesics|analgesics|mesh-ancestor
2561191|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
2561192|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561193|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2561194|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2561195|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2561196|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
2561197|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561198|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561199|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2561200|NCT01545297|Narcotics|narcotics|mesh-ancestor
2561201|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
2561202|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561203|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2561204|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561205|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561206|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2561207|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
2561208|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561209|NCT01545453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2561210|NCT01545453|Immunologic Factors|immunologic factors|mesh-ancestor
2561211|NCT01545453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561212|NCT01545479|Captopril|captopril|mesh-list
2561213|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2561214|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
2561215|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561216|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561217|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2561218|NCT01545557|Lidocaine|lidocaine|mesh-list
2561219|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
2561220|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
2561221|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
2561222|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561223|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561224|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
2561225|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561226|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2561227|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2561228|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2561229|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2561230|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561231|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2561232|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
2561233|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
2122371|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122372|NCT02767128|Citric Acid|citric acid|mesh-list
2122373|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
2122374|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
2122375|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2122376|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
2122377|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
2122378|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122379|NCT02767271|Luliconazole|luliconazole|mesh-list
2122380|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
2122381|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122382|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
2122383|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2122384|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2122385|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122386|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
2122387|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
2122388|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2122389|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122390|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
2122391|NCT02767492|Hormones|hormones|mesh-ancestor
2122392|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122393|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122394|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2122395|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
2122401|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
2122402|NCT02767765|Hematinics|hematinics|mesh-ancestor
2122403|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
2122404|NCT02767869|Antacids|antacids|mesh-ancestor
2122405|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122406|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2122407|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
2122408|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2122409|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122410|NCT02767947|Luliconazole|luliconazole|mesh-list
2122411|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
2122412|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122413|NCT02768194|Fluorides|fluorides|mesh-list
2122414|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
2122415|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
2122416|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
2122417|NCT02768194|Protective Agents|protective agents|mesh-ancestor
2122418|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122419|NCT02768298|Enalapril|enalapril|mesh-list
2122420|NCT02768298|Enalaprilat|enalaprilat|mesh-list
2561234|NCT01545557|Protective Agents|protective agents|mesh-ancestor
2561235|NCT01545596|Anesthetics|anesthetics|mesh-list
2122421|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2122422|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2122423|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
2122424|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561236|NCT01545596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561237|NCT01545596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561238|NCT01545635|Thrombin|thrombin|mesh-list
2561239|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
2561240|NCT01545635|Coagulants|coagulants|mesh-ancestor
2122425|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122426|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2122427|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2122428|NCT02768558|Nivolumab|nivolumab|mesh-list
2122429|NCT02768558|Etoposide|etoposide|mesh-list
2122430|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122431|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2122432|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2122433|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122434|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2122435|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2122436|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2122437|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122438|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
2122439|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2122440|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122441|NCT02769065|Donepezil|donepezil|mesh-list
2122442|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2122443|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561241|NCT01545778|Oxycodone|oxycodone|mesh-list
2561242|NCT01545778|Tapentadol|tapentadol|mesh-list
2561243|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2561244|NCT01545778|Narcotics|narcotics|mesh-ancestor
2561245|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561246|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561247|NCT01545778|Analgesics|analgesics|mesh-ancestor
2122444|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122445|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
2122446|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2122447|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122448|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
2122449|NCT02769247|Naproxen|naproxen|mesh-list
2122450|NCT02769247|Lidocaine|lidocaine|mesh-list
2122451|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
2122452|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
2122453|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2122454|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122455|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
2561248|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
2561249|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561250|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2561251|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2561252|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2561253|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561254|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
2561255|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561256|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
2561257|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2122456|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122457|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2122458|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2122459|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2122460|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2122461|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122462|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2122463|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2122464|NCT02769247|Analgesics|analgesics|mesh-ancestor
2122465|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122466|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2561258|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561259|NCT01545804|Lenalidomide|lenalidomide|mesh-list
2561260|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
2561261|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561262|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2561263|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2561264|NCT01545804|Growth Substances|growth substances|mesh-ancestor
2561265|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
2561266|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561267|NCT01545830|Vitamin D|vitamin d|mesh-list
2561268|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
2561269|NCT01545830|Vitamins|vitamins|mesh-ancestor
2561270|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
2561271|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561272|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2561273|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2561274|NCT01545856|Levodopa|levodopa|mesh-list
2561275|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2561276|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2561277|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
2561278|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561279|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561280|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561281|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2561282|NCT01545947|Azacitidine|azacitidine|mesh-list
2561283|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561284|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2561285|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561286|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561287|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2561288|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
2561289|NCT01546051|BCI-838|bci-838|mesh-list
2561290|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2561291|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2561292|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561293|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561294|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561295|NCT01546090|Alprazolam|alprazolam|mesh-list
2561296|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2561297|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561298|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561299|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2122467|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
2122468|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2122469|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122470|NCT02769481|Glimepiride|glimepiride|mesh-list
2122471|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
2122472|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2122473|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2122474|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122475|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2122476|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
2122477|NCT02769624|Treprostinil|treprostinil|mesh-list
2122478|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2122479|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2122480|NCT02769702|Hormones|hormones|mesh-ancestor
2122481|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122482|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122483|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2122484|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122485|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2122486|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122487|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122488|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2122489|NCT02770248|Brinzolamide|brinzolamide|mesh-list
2122490|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2122491|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2122492|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2122493|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2122494|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
2122495|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2122496|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561300|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2561301|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2561302|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
2561303|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
2561304|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561305|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561306|NCT01546103|Vitamin D|vitamin d|mesh-list
2561307|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
2561308|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
2561309|NCT01546103|Vitamins|vitamins|mesh-list
2561310|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
2561311|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561312|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2122497|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122498|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2122499|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122500|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2122501|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2122502|NCT02770365|Estradiol|estradiol|mesh-list
2122503|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2122504|NCT02770365|Estrogens|estrogens|mesh-ancestor
2122505|NCT02770365|Hormones|hormones|mesh-ancestor
2122506|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122507|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122508|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2122509|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
2122510|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2122511|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2122512|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
2122513|NCT02770521|Treprostinil|treprostinil|mesh-list
2122514|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2122515|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122516|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2122517|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
2561313|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2561314|NCT01546116|Lamivudine|lamivudine|mesh-list
2561315|NCT01546116|Adefovir|adefovir|mesh-list
2561316|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2561317|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2561318|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2561319|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561320|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561321|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
2561322|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561323|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2561324|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2561325|NCT01546389|Chloroquine|chloroquine|mesh-list
2561326|NCT01546389|Amebicides|amebicides|mesh-ancestor
2561327|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2561328|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2561329|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561330|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
2561331|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2561332|NCT01546558|Metformin|metformin|mesh-list
2561333|NCT01546558|Ranolazine|ranolazine|mesh-list
2561334|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2561335|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561336|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2561337|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2561338|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561339|NCT01546597|Metformin|metformin|mesh-list
2561340|NCT01546597|Ranolazine|ranolazine|mesh-list
2561341|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2122518|NCT02770612|Narcotics|narcotics|mesh-ancestor
2122519|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2122520|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122521|NCT02770612|Analgesics|analgesics|mesh-ancestor
2122522|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
2122523|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122524|NCT02770820|Aldesleukin|aldesleukin|mesh-list
2122525|NCT02770820|Interleukin-2|interleukin-2|mesh-list
2122526|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122527|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2561342|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561343|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2561344|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2122528|NCT02770820|Analgesics|analgesics|mesh-ancestor
2122529|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
2561345|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561346|NCT01546701|Morphine|morphine|mesh-list
2561347|NCT01546701|Buprenorphine|buprenorphine|mesh-list
2561348|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2561349|NCT01546701|Narcotics|narcotics|mesh-ancestor
2561350|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561351|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561352|NCT01546701|Analgesics|analgesics|mesh-ancestor
2561353|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
2561354|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561355|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2561356|NCT01546896|Alprazolam|alprazolam|mesh-list
2561357|NCT01546896|Buspirone|buspirone|mesh-list
2561358|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2561359|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561360|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561361|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2561362|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2561363|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2561364|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
2561365|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
2561366|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561367|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122530|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122531|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122532|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2122533|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2122534|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
2122535|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122536|NCT02771093|Alogliptin|alogliptin|mesh-list
2122537|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2122538|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561368|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2561369|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
2561370|NCT01546909|Vaccines|vaccines|mesh-list
2561371|NCT01546909|Immunologic Factors|immunologic factors|mesh-ancestor
2561372|NCT01546909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561373|NCT01546935|Oseltamivir|oseltamivir|mesh-list
2561374|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
2561375|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561376|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561377|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561389|NCT01546961|Chloroquine|chloroquine|mesh-list
2561390|NCT01546961|Amebicides|amebicides|mesh-ancestor
2561391|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2561392|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2561393|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561394|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
2561395|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2561396|NCT01546987|Leuprolide|leuprolide|mesh-list
2561397|NCT01546987|Goserelin|goserelin|mesh-list
2561398|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2561399|NCT01546987|Flutamide|flutamide|mesh-list
2561400|NCT01546987|Bicalutamide|bicalutamide|mesh-list
2561401|NCT01546987|Buserelin|buserelin|mesh-list
2561402|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2561403|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
2561404|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2561405|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561406|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2561407|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561408|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-ancestor
2561409|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
2561410|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122539|NCT02771093|Incretins|incretins|mesh-ancestor
2561411|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
2561412|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2561413|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
2561414|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2561415|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
2122540|NCT02771093|Hormones|hormones|mesh-ancestor
2561416|NCT01547104|Glimepiride|glimepiride|mesh-list
2561417|NCT01547104|Linagliptin|linagliptin|mesh-list
2561418|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2561419|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2561420|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561421|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2561422|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
2561423|NCT01547104|Incretins|incretins|mesh-ancestor
2561424|NCT01547104|Hormones|hormones|mesh-ancestor
2561425|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2561426|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2561427|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
2561428|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561429|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561430|NCT01547143|Cyclosporine|cyclosporine|mesh-list
2561431|NCT01547143|Dexamethasone|dexamethasone|mesh-list
2561432|NCT01547143|Etoposide|etoposide|mesh-list
2561433|NCT01547143|Cyclosporins|cyclosporins|mesh-list
2561434|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
2561435|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2561436|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
2561437|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
2561438|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561439|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561440|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2561441|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
2561442|NCT01547143|Hormones|hormones|mesh-ancestor
2561443|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2561444|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2561445|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561446|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561447|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561448|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2561449|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2561450|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2561451|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2561452|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
2561453|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
2561454|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561455|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
2561456|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2561457|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2561458|NCT01547169|Insulin|insulin|mesh-list
2561459|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2561460|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
2561461|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2561462|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122541|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122542|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2122543|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
2122544|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122545|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122546|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2122547|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2122548|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
2122549|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122550|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
2122551|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
2561463|NCT01547221|Clotrimazole|clotrimazole|mesh-list
2561464|NCT01547221|Miconazole|miconazole|mesh-list
2561465|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2561466|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561467|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
2561468|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2561469|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2561470|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561471|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561472|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2561473|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
2561474|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2561475|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561476|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2561477|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2561478|NCT01547260|Gemcitabine|gemcitabine|mesh-list
2561479|NCT01547260|Lenalidomide|lenalidomide|mesh-list
2561480|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2561481|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
2561482|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561483|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561484|NCT01547260|Antiviral Agents|antiviral agents|mesh-ancestor
2122552|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122553|NCT02772783|Insulin|insulin|mesh-list
2122554|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2122555|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2122556|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122557|NCT02772978|Tolcapone|tolcapone|mesh-list
2122558|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2122559|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2122560|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2122561|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122562|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122563|NCT02773368|Insulin|insulin|mesh-list
2561485|NCT01547260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561486|NCT01547260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561487|NCT01547260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2561488|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
2561489|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561490|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2561491|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2561492|NCT01547260|Growth Substances|growth substances|mesh-ancestor
2561493|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
2561494|NCT01547312|Interferons|interferons|mesh-list
2561495|NCT01547312|Ribavirin|ribavirin|mesh-list
2561496|NCT01547312|Grazoprevir|grazoprevir|mesh-list
2561497|NCT01547312|Liver Extracts|liver extracts|mesh-list
2561498|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561499|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
2561500|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561501|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
2561502|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561503|NCT01547312|Hematinics|hematinics|mesh-ancestor
2561504|NCT01547325|Doxycycline|doxycycline|mesh-list
2561505|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2561506|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561507|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
2561508|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2561509|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2561510|NCT01547377|Zinc|zinc|mesh-list
2561511|NCT01547377|Selenium|selenium|mesh-list
2561512|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2561513|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2561514|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2561515|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
2561516|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561517|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2122564|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2122565|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
2122566|NCT02773368|Liraglutide|liraglutide|mesh-list
2122567|NCT02773368|Xultophy|xultophy|mesh-list
2122568|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2122569|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122570|NCT02773368|Incretins|incretins|mesh-ancestor
2122571|NCT02773368|Hormones|hormones|mesh-ancestor
2122572|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122573|NCT02773758|Fluorides|fluorides|mesh-list
2122574|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
2122575|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
2122576|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
2122577|NCT02773758|Protective Agents|protective agents|mesh-ancestor
2122578|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122579|NCT02774226|Vitamins|vitamins|mesh-list
2561518|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2561519|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561520|NCT01547377|Trace Elements|trace elements|mesh-ancestor
2561521|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
2561522|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561523|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
2122580|NCT02774226|Vitamin E|vitamin e|mesh-list
2122581|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
2122582|NCT02774226|Antioxidants|antioxidants|mesh-list
2122583|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
2561524|NCT01547377|Protective Agents|protective agents|mesh-ancestor
2561525|NCT01547416|Fentanyl|fentanyl|mesh-list
2561526|NCT01547416|Ropivacaine|ropivacaine|mesh-list
2122584|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122585|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122586|NCT02774226|Protective Agents|protective agents|mesh-ancestor
2122587|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
2561527|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
2561528|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
2561529|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561530|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561531|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
2561532|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561533|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2561534|NCT01547416|Narcotics|narcotics|mesh-ancestor
2561535|NCT01547416|Analgesics|analgesics|mesh-ancestor
2561536|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2561537|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2561538|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
2561539|NCT01547455|Atorvastatin|atorvastatin|mesh-list
2561540|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2561541|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2561542|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
2561543|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561544|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2561545|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2561546|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561547|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
2561548|NCT01547468|Narcotics|narcotics|mesh-ancestor
2561549|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561550|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561551|NCT01547468|Analgesics|analgesics|mesh-ancestor
2561552|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
2561553|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561554|NCT01547494|Vitamins|vitamins|mesh-list
2561555|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
2561556|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561557|NCT01547520|Meperidine|meperidine|mesh-list
2122610|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2122611|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122612|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2122613|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561558|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2561559|NCT01547520|Narcotics|narcotics|mesh-ancestor
2561560|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561561|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561562|NCT01547520|Analgesics|analgesics|mesh-ancestor
2561563|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
2561564|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561565|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2561566|NCT01547546|GDC-0084|gdc-0084|mesh-list
2561567|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561568|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561569|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
2561570|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2122614|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122615|NCT02774343|Pioglitazone|pioglitazone|mesh-list
2561571|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2561572|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561573|NCT01547741|Paclitaxel|paclitaxel|mesh-list
2561574|NCT01547741|Docetaxel|docetaxel|mesh-list
2122616|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2122617|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122618|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2122619|NCT02774681|Trastuzumab|trastuzumab|mesh-list
2122620|NCT02774681|Palbociclib|palbociclib|mesh-list
2122621|NCT02774681|Antibodies|antibodies|mesh-list
2122622|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
2122623|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2122624|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
2122625|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122626|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122627|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2122628|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122629|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122630|NCT02775240|Maribavir|maribavir|mesh-list
2122631|NCT02775240|Digoxin|digoxin|mesh-list
2122632|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
2122633|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2122634|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2122635|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122636|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122637|NCT02775240|Protective Agents|protective agents|mesh-ancestor
2122638|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122639|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
2122640|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
2122641|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2122642|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2122643|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2122644|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
2122645|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122657|NCT02775617|Azithromycin|azithromycin|mesh-list
2122658|NCT02775617|Ivermectin|ivermectin|mesh-list
2122659|NCT02775617|Permethrin|permethrin|mesh-list
2122660|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2122661|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122662|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2122663|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122664|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122665|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
2561575|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
2561576|NCT01547741|Doxorubicin|doxorubicin|mesh-list
2561577|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2561578|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561579|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
2561580|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
2561581|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
2561582|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561583|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2561584|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
2561585|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561586|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2561587|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2561588|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
2561589|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2561590|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2561591|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2561592|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2122666|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
2122667|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2122668|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2122669|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561593|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561594|NCT01548001|Methotrexate|methotrexate|mesh-list
2561595|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2561596|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
2561597|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2561598|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561599|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2561600|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
2561601|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122670|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122671|NCT02775903|Azacitidine|azacitidine|mesh-list
2122672|NCT02775903|Durvalumab|durvalumab|mesh-list
2122673|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2122674|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
2122675|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122676|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122677|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122678|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2122679|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2122680|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
2122681|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2122682|NCT02776683|Bevacizumab|bevacizumab|mesh-list
2122683|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2122684|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122685|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2122686|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2122687|NCT02776683|Growth Substances|growth substances|mesh-ancestor
2122688|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122689|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
2122690|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
2122691|NCT02777242|Testosterone|testosterone|mesh-list
2122692|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
2122693|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
2122694|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2122695|NCT02777242|Androgens|androgens|mesh-ancestor
2122696|NCT02777242|Hormones|hormones|mesh-ancestor
2122697|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122698|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122699|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2122700|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122701|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
2122702|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
2122703|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122704|NCT02777554|Thalidomide|thalidomide|mesh-list
2122705|NCT02777554|Apremilast|apremilast|mesh-list
2122706|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2122707|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2122708|NCT02777554|Analgesics|analgesics|mesh-ancestor
2561602|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561603|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
2561604|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561605|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2561606|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2561607|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
2561608|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2561609|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2561610|NCT01548027|Anesthetics|anesthetics|mesh-list
2561611|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
2561612|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561613|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561614|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
2561615|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561616|NCT01548066|Valproic Acid|valproic acid|mesh-list
2561617|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
2561618|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561619|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561620|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
2561621|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561622|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561623|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
2561624|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2561625|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561626|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2561627|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2561628|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2122709|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
2122710|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122711|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418748|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2418749|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122712|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122713|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2122714|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2561629|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2561630|NCT01548118|Vaccines|vaccines|mesh-list
2561631|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
2561632|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561633|NCT01548144|Pemetrexed|pemetrexed|mesh-list
2561634|NCT01548144|Crizotinib|crizotinib|mesh-list
2561635|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561636|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561637|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561638|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2561639|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2561640|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2561641|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2561642|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2561643|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2561644|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
2561645|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561646|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2561647|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2561648|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561649|NCT01548170|Ketoconazole|ketoconazole|mesh-list
2561650|NCT01548170|Sunitinib|sunitinib|mesh-list
2561651|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561652|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2561653|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2561654|NCT01548170|Growth Substances|growth substances|mesh-ancestor
2561655|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561656|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
2561657|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2561658|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561659|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561660|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
2561661|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561662|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2561663|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2561664|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2561665|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
2561666|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122715|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2122716|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122717|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122718|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2122719|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
2122720|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
2418750|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2418751|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2418752|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418753|NCT00800553|Donepezil|donepezil|mesh-list
2418754|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2418755|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418756|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418757|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
2418758|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418759|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418760|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
2561667|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2561668|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
2561669|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2561670|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561671|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561672|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2561673|NCT01548209|Analgesics|analgesics|mesh-ancestor
2561674|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
2561675|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122721|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2122722|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122723|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2122724|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2122725|NCT02777554|Growth Substances|growth substances|mesh-ancestor
2561676|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2561677|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2561678|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2561679|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
2561680|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561681|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561682|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
2561683|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
2561684|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2561685|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2561686|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561687|NCT01548248|Insulin|insulin|mesh-list
2561688|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2561689|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
2561690|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
2561691|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2561692|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561693|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
2561694|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2561695|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2561696|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561697|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2561698|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2561699|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
2561700|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561701|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561702|NCT01548326|Atorvastatin|atorvastatin|mesh-list
2561703|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2561704|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2561705|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
2561706|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561707|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2561708|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2561709|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561710|NCT01548482|Sirolimus|sirolimus|mesh-list
2561711|NCT01548482|Trebananib|trebananib|mesh-list
2561712|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2561713|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561714|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2561715|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561716|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
2561717|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2561718|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
2122726|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
2122727|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122728|NCT02777749|Bupivacaine|bupivacaine|mesh-list
2122729|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
2122730|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
2122731|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2122732|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122733|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
2122734|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122735|NCT02777970|Acetaminophen|acetaminophen|mesh-list
2122736|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2122737|NCT02777970|Tramadol|tramadol|mesh-list
2122738|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2122739|NCT02777970|Analgesics|analgesics|mesh-ancestor
2122740|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
2122741|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122742|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122743|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
2122744|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2122745|NCT02777970|Narcotics|narcotics|mesh-ancestor
2122746|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2122747|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2122748|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122749|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2122750|NCT02778100|Phenylephrine|phenylephrine|mesh-list
2122751|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
2561719|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561720|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2122752|NCT02778100|Glucagon|glucagon|mesh-list
2122753|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2122754|NCT02778100|Hormones|hormones|mesh-ancestor
2122755|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122756|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122757|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2122758|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2122759|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
2122760|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2122761|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122762|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
2122763|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
2561721|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2561722|NCT01548482|Growth Substances|growth substances|mesh-ancestor
2561723|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
2561724|NCT01548521|Oxytocin|oxytocin|mesh-list
2561725|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
2561726|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2561727|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561728|NCT01548560|Dapivirine|dapivirine|mesh-list
2122764|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122765|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
2122766|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2122767|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
2122768|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2122769|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
2122770|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2122771|NCT02778100|Protective Agents|protective agents|mesh-ancestor
2122772|NCT02778113|Glucagon|glucagon|mesh-list
2122773|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2122774|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2122775|NCT02778113|Hormones|hormones|mesh-ancestor
2122776|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122777|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122778|NCT02778113|Incretins|incretins|mesh-ancestor
2122788|NCT02778867|Fluticasone|fluticasone|mesh-list
2122789|NCT02778867|Xhance|xhance|mesh-list
2418761|NCT00800566|Clofarabine|clofarabine|mesh-list
2561729|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2561730|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2561731|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
2561732|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561733|NCT01548612|Nitroprusside|nitroprusside|mesh-list
2561734|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2561735|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
2561736|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2561737|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561738|NCT01548677|Trastuzumab|trastuzumab|mesh-list
2561739|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2561740|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561741|NCT01548703|BCI-838|bci-838|mesh-list
2561742|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2561743|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2418762|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2418763|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
2418764|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418765|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418766|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
2418767|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
2418768|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2418769|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2418770|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418771|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418772|NCT00800592|Urological Agents|urological agents|mesh-ancestor
2418773|NCT00800709|Memantine|memantine|mesh-list
2418774|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2418775|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2561744|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561745|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561746|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561747|NCT01548794|Lidocaine|lidocaine|mesh-list
2561748|NCT01548794|Bupivacaine|bupivacaine|mesh-list
2561749|NCT01548794|Anesthetics|anesthetics|mesh-list
2561750|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
2561751|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561752|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561753|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
2561754|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561755|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2561756|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2561757|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2561758|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2561759|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561760|NCT01548807|Everolimus|everolimus|mesh-list
2561761|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561762|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2561763|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
2561764|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561765|NCT01548859|Midazolam|midazolam|mesh-list
2561766|NCT01548859|Sevoflurane|sevoflurane|mesh-list
2561767|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2561768|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2561769|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561770|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561771|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2561772|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2561773|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2561774|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2561775|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
2561776|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
2561777|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
2561778|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
2561779|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561780|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561781|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2561782|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2561783|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
2561784|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2561785|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
2561786|NCT01548911|Calicheamicins|calicheamicins|mesh-list
2561787|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2561788|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561789|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2561790|NCT01548924|Paclitaxel|paclitaxel|mesh-list
2561791|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2561792|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561793|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
2561794|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
2561795|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
2561796|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561797|NCT01548950|Bosentan|bosentan|mesh-list
2561798|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
2561799|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
2561800|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2561801|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2561802|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561803|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561804|NCT01548950|Urological Agents|urological agents|mesh-ancestor
2561805|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2561806|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2561807|NCT01549093|Gemcitabine|gemcitabine|mesh-list
2561808|NCT01549093|Carboplatin|carboplatin|mesh-list
2561809|NCT01549093|Endostar protein|endostar protein|mesh-list
2561810|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561811|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2561812|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
2561813|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561814|NCT01549093|Antiviral Agents|antiviral agents|mesh-ancestor
2561815|NCT01549093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561816|NCT01549093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561817|NCT01549093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2561818|NCT01549093|Immunologic Factors|immunologic factors|mesh-ancestor
2561819|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122790|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122791|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2122792|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
2122793|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122794|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122795|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2561820|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2561821|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2561822|NCT01549093|Growth Substances|growth substances|mesh-ancestor
2561823|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
2561824|NCT01549158|Torsemide|torsemide|mesh-list
2561825|NCT01549158|Furosemide|furosemide|mesh-list
2561826|NCT01549158|Diuretics|diuretics|mesh-ancestor
2561827|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
2561828|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561829|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2561830|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2561831|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561832|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2561833|NCT01549171|Iloprost|iloprost|mesh-list
2561834|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2561835|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
2561836|NCT01549236|Benzonidazole|benzonidazole|mesh-list
2561837|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2561838|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
2561839|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561840|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2561841|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2561842|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2561843|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2561844|NCT01549301|Lenograstim|lenograstim|mesh-list
2561845|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2561846|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
2561847|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561848|NCT01549418|Aspirin|aspirin|mesh-list
2561849|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2561850|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2561851|NCT01549418|Analgesics|analgesics|mesh-ancestor
2561852|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
2561853|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561854|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561855|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2561856|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2561857|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2561858|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2561859|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561860|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2561861|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2561862|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561863|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
2561864|NCT01549431|Dexamethasone|dexamethasone|mesh-list
2561865|NCT01549431|Panobinostat|panobinostat|mesh-list
2561866|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2561867|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
2561868|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
2561869|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561870|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561871|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2122796|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
2122797|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
2122798|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2122799|NCT02778880|Fentanyl|fentanyl|mesh-list
2122800|NCT02778880|Ketamine|ketamine|mesh-list
2122801|NCT02778880|Analgesics|analgesics|mesh-ancestor
2122802|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
2122803|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122804|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122805|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2122806|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2122807|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
2122808|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
2122809|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2122810|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2561872|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
2561873|NCT01549431|Hormones|hormones|mesh-ancestor
2561874|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2561875|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2561876|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561877|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2561878|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561879|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561880|NCT01549496|Amlodipine|amlodipine|mesh-list
2561881|NCT01549496|Diltiazem|diltiazem|mesh-list
2561882|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2561883|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2561884|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2561885|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561886|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2561887|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561888|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
2561889|NCT01549548|Ponatinib|ponatinib|mesh-list
2561890|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122811|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2122812|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2122813|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122814|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2122815|NCT02778880|Narcotics|narcotics|mesh-ancestor
2122816|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2122817|NCT02779166|Celecoxib|celecoxib|mesh-list
2561891|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2561892|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561893|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561894|NCT01549574|Crizotinib|crizotinib|mesh-list
2561895|NCT01549574|Esomeprazole|esomeprazole|mesh-list
2561896|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2561897|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2561898|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2561899|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561900|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561901|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561902|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2561903|NCT01549600|Psyllium|psyllium|mesh-list
2561904|NCT01549600|Cathartics|cathartics|mesh-ancestor
2561905|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2561906|NCT01549691|Alprazolam|alprazolam|mesh-list
2561907|NCT01549691|Zopiclone|zopiclone|mesh-list
2561908|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2561909|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561910|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561911|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2561912|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2561913|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2561914|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
2561915|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
2561916|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2561917|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561918|NCT01549704|Ropivacaine|ropivacaine|mesh-list
2561919|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
2561920|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
2561921|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561922|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561923|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
2561924|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561925|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
2561926|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2561927|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561928|NCT01549743|Celecoxib|celecoxib|mesh-list
2561929|NCT01549743|Rebamipide|rebamipide|mesh-list
2561930|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2561931|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2561932|NCT01549743|Analgesics|analgesics|mesh-ancestor
2561933|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
2561934|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2561935|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561936|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2561937|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2561938|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2561939|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2561940|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122818|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2122819|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2122820|NCT02779166|Analgesics|analgesics|mesh-ancestor
2122821|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
2561941|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561942|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2561943|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2561944|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
2561945|NCT01549743|Protective Agents|protective agents|mesh-ancestor
2561946|NCT01549795|Capecitabine|capecitabine|mesh-list
2561947|NCT01549795|Liver Extracts|liver extracts|mesh-list
2561948|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2561949|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
2561950|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2561951|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561952|NCT01549795|Hematinics|hematinics|mesh-ancestor
2122822|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122823|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122824|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122825|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2122826|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2122827|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2122828|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122829|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122839|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2122840|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2122841|NCT02780167|Abrocitinib|abrocitinib|mesh-list
2122842|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2561953|NCT01549847|Piracetam|piracetam|mesh-list
2561954|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2561955|NCT01549847|Protective Agents|protective agents|mesh-ancestor
2561956|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561957|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
2561958|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
2561959|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2561960|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561961|NCT01549938|Vitamins|vitamins|mesh-ancestor
2122843|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122844|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122845|NCT02780622|Oseltamivir|oseltamivir|mesh-list
2122846|NCT02780622|Warfarin|warfarin|mesh-list
2122847|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
2122848|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
2122849|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122850|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122851|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122852|NCT02780687|Afatinib|afatinib|mesh-list
2122853|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561962|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
2561963|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2561964|NCT01549990|Sevoflurane|sevoflurane|mesh-list
2561965|NCT01549990|Desflurane|desflurane|mesh-list
2561966|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2561967|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2561968|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
2561969|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
2561970|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561971|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561972|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
2561973|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2561974|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
2561975|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561976|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2561977|NCT01550055|Irinotecan|irinotecan|mesh-list
2561978|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2561979|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2561980|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561981|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122854|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2122855|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122856|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122857|NCT02780700|Capecitabine|capecitabine|mesh-list
2122858|NCT02780700|Nintedanib|nintedanib|mesh-list
2122859|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2122860|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
2122861|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122862|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122863|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2122864|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122865|NCT02780869|Thrombin|thrombin|mesh-list
2122866|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
2122867|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
2122868|NCT02780869|Coagulants|coagulants|mesh-ancestor
2122869|NCT02781311|Finasteride|finasteride|mesh-list
2122870|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2122871|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2122872|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122873|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122874|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
2122875|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122876|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122877|NCT02781311|Urological Agents|urological agents|mesh-ancestor
2122878|NCT02781454|Mexiletine|mexiletine|mesh-list
2122879|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2122880|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2122881|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2122882|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2122883|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122884|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
2122885|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2122886|NCT02781558|Velpatasvir|velpatasvir|mesh-list
2122887|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
2122888|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122889|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
2122890|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2122891|NCT02781571|Velpatasvir|velpatasvir|mesh-list
2122892|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
2122893|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122894|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2122895|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122896|NCT02781649|Ribavirin|ribavirin|mesh-list
2122897|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
2122898|NCT02781649|Grazoprevir|grazoprevir|mesh-list
2122899|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
2561982|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2561983|NCT01550107|Allopurinol|allopurinol|mesh-list
2561984|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
2561985|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122900|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
2122901|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122902|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
2122903|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2122904|NCT02781818|Triamcinolone|triamcinolone|mesh-list
2122905|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2122906|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2122907|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2122908|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122909|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
2122910|NCT02781818|Hormones|hormones|mesh-ancestor
2122911|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122912|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122913|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2122914|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
2122915|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561986|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2561987|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
2561988|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2561989|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2561990|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
2122916|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122917|NCT02782169|Pregabalin|pregabalin|mesh-list
2122918|NCT02782169|Analgesics|analgesics|mesh-ancestor
2122919|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
2122920|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2122921|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122922|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
2122923|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2122924|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2122925|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122926|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2122927|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2122928|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2122929|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2122930|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2122931|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
2122932|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2122933|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
2122934|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122935|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
2561991|NCT01550107|Protective Agents|protective agents|mesh-ancestor
2561992|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2561993|NCT01550146|Dexamethasone|dexamethasone|mesh-list
2561994|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
2561995|NCT01550146|BB 1101|bb 1101|mesh-list
2561996|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2561997|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
2561998|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
2122936|NCT02782676|Protective Agents|protective agents|mesh-ancestor
2122937|NCT02783170|Vaccines|vaccines|mesh-list
2122938|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
2122939|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122940|NCT02783443|Anesthetics|anesthetics|mesh-list
2122941|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2122942|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122943|NCT02783599|Doxorubicin|doxorubicin|mesh-list
2122944|NCT02783599|Olaratumab|olaratumab|mesh-list
2122945|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2122946|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2122947|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2122948|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2122949|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2122950|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122951|NCT02783729|Zolpidem|zolpidem|mesh-list
2122952|NCT02783729|Lemborexant|lemborexant|mesh-list
2122953|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2122954|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2122955|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2561999|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562000|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562001|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2562002|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
2562003|NCT01550146|Hormones|hormones|mesh-ancestor
2562004|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562005|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2562006|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562007|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
2562008|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562009|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562010|NCT01550302|Bupivacaine|bupivacaine|mesh-list
2562011|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
2562012|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
2562013|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2122956|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122957|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2122958|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
2122959|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
2122960|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2562014|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562015|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
2122961|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122962|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2122966|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2122967|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
2122968|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2562016|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562017|NCT01550354|Alfentanil|alfentanil|mesh-list
2562018|NCT01550354|Propofol|propofol|mesh-list
2562019|NCT01550354|Rocuronium|rocuronium|mesh-list
2562020|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2562021|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2562022|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562023|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2562024|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
2562025|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
2562026|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2562027|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2562028|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2562029|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562030|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2122969|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
2122970|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122971|NCT02785159|Tazarotene|tazarotene|mesh-list
2122972|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
2122973|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
2562031|NCT01550354|Narcotics|narcotics|mesh-ancestor
2562032|NCT01550354|Analgesics|analgesics|mesh-ancestor
2562033|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
2562034|NCT01550419|Atorvastatin|atorvastatin|mesh-list
2562035|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2562036|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2562037|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
2562038|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562039|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2562040|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2562041|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562042|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
2562043|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2562044|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
2562045|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562046|NCT01550432|Expectorants|expectorants|mesh-ancestor
2562047|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
2562048|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2562049|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
2562050|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562051|NCT01550432|Protective Agents|protective agents|mesh-ancestor
2562052|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562053|NCT01550432|Antidotes|antidotes|mesh-ancestor
2122974|NCT02785172|Clobetasol|clobetasol|mesh-list
2122975|NCT02785172|Halobetasol|halobetasol|mesh-list
2122976|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2122977|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122978|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
2122979|NCT02785172|Hormones|hormones|mesh-ancestor
2122980|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122981|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122982|NCT02785185|Clobetasol|clobetasol|mesh-list
2122983|NCT02785185|Halobetasol|halobetasol|mesh-list
2122984|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2562054|NCT01550445|Prednisolone|prednisolone|mesh-list
2562055|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2562056|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
2562057|NCT01550445|Hormones|hormones|mesh-ancestor
2562058|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562059|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562060|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2562061|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562062|NCT01550458|Mibefradil|mibefradil|mesh-list
2562063|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2562064|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2562065|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2562066|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562067|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2562068|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562069|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
2562070|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2562071|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2562072|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562073|NCT01550640|Remifentanil|remifentanil|mesh-list
2562074|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2562075|NCT01550640|Narcotics|narcotics|mesh-ancestor
2562076|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2562077|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562078|NCT01550640|Analgesics|analgesics|mesh-ancestor
2562079|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
2562080|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562081|NCT01550653|Liraglutide|liraglutide|mesh-list
2562082|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2562083|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562084|NCT01550653|Incretins|incretins|mesh-ancestor
2562085|NCT01550653|Hormones|hormones|mesh-ancestor
2562086|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562087|NCT01550770|Propofol|propofol|mesh-list
2562088|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2562089|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2562090|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562091|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2562092|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
2562093|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
2562094|NCT01550848|Gemcitabine|gemcitabine|mesh-list
2562095|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2562096|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2122985|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2122986|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
2122987|NCT02785185|Hormones|hormones|mesh-ancestor
2122988|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2122989|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562097|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
2562098|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562099|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562100|NCT01550848|Antiviral Agents|antiviral agents|mesh-ancestor
2562101|NCT01550848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562102|NCT01550848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562103|NCT01550848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2562104|NCT01550848|Immunologic Factors|immunologic factors|mesh-ancestor
2562105|NCT01550848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562106|NCT01550900|Metformin|metformin|mesh-list
2562107|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2562108|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562109|NCT01550926|Orlistat|orlistat|mesh-list
2562110|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562111|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562112|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2562113|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2562114|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
2562115|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
2562116|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2562117|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2122990|NCT02785406|Suvorexant|suvorexant|mesh-list
2122991|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2122992|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2122993|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2122994|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2122995|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2122996|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2122997|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2122998|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
2122999|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2123000|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123001|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2123002|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2123003|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562118|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562119|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562120|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562121|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2562122|NCT01551147|Montelukast|montelukast|mesh-list
2562123|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2562124|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
2562125|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2562126|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
2562127|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562128|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562129|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2562130|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2123004|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123005|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562131|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562132|NCT01551225|Citalopram|citalopram|mesh-list
2562133|NCT01551225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2562134|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2562135|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2562136|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562137|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2562138|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
2562139|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562140|NCT01551225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2562141|NCT01551225|Antidepressive Agents|antidepressive agents|mesh-ancestor
2562142|NCT01551225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2562143|NCT01551290|Infliximab|infliximab|mesh-list
2562144|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
2562145|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2562146|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2562147|NCT01551329|Ketamine|ketamine|mesh-list
2562148|NCT01551329|Analgesics|analgesics|mesh-ancestor
2562149|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
2562150|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562151|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562152|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2562153|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2562154|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
2562155|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
2562156|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2562157|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2562158|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2562159|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2562160|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562161|NCT01551368|Nimodipine|nimodipine|mesh-list
2562162|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2562163|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2562164|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2562165|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562166|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2562167|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562168|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
2562169|NCT01551394|Gentamicins|gentamicins|mesh-list
2562170|NCT01551394|Meropenem|meropenem|mesh-list
2562171|NCT01551394|Ampicillin|ampicillin|mesh-list
2562172|NCT01551394|Cefotaxime|cefotaxime|mesh-list
2562173|NCT01551394|Cefoxitin|cefoxitin|mesh-list
2562174|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2562175|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562176|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2562177|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562178|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562179|NCT01551459|Sunitinib|sunitinib|mesh-list
2562180|NCT01551459|Dacarbazine|dacarbazine|mesh-list
2562181|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562182|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2562183|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2562184|NCT01551459|Growth Substances|growth substances|mesh-ancestor
2562185|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562186|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
2562187|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2562188|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562189|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562190|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2562191|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
2562192|NCT01551472|Vitamin E|vitamin e|mesh-list
2562193|NCT01551472|Vitamins|vitamins|mesh-ancestor
2562194|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
2562195|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562196|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
2562197|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562198|NCT01551472|Protective Agents|protective agents|mesh-ancestor
2562199|NCT01551485|Zolpidem|zolpidem|mesh-list
2123006|NCT02785900|Azacitidine|azacitidine|mesh-list
2123007|NCT02785900|Decitabine|decitabine|mesh-list
2123008|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2562200|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2562201|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2562202|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2562203|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562204|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2123009|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
2123010|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123011|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123012|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123013|NCT02785939|Docetaxel|docetaxel|mesh-list
2123014|NCT02785939|Palbociclib|palbociclib|mesh-list
2123015|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123016|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
2123017|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
2123018|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
2123019|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123020|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2123021|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123022|NCT02786498|Vitamin D|vitamin d|mesh-list
2123023|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
2123024|NCT02786498|Vitamins|vitamins|mesh-ancestor
2123025|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
2123026|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123027|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2123028|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2123046|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
2123047|NCT02786719|Doxorubicin|doxorubicin|mesh-list
2562205|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
2562206|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
2562207|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2562208|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562209|NCT01551511|Dronabinol|dronabinol|mesh-list
2562210|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
2562211|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562212|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2562213|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2123048|NCT02786719|Etoposide|etoposide|mesh-list
2123049|NCT02786719|Vincristine|vincristine|mesh-list
2123050|NCT02786719|Topotecan|topotecan|mesh-list
2123051|NCT02786719|Sargramostim|sargramostim|mesh-list
2123052|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2123053|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
2562214|NCT01551511|Analgesics|analgesics|mesh-ancestor
2562215|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
2562216|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562217|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2562218|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2562219|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2562220|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562221|NCT01551511|Hormones|hormones|mesh-ancestor
2562222|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562223|NCT01551589|Docetaxel|docetaxel|mesh-list
2562224|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562225|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
2562226|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
2562227|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
2562228|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123054|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123055|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2123056|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2562229|NCT01551615|Metformin|metformin|mesh-list
2562230|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2562231|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562232|NCT01551628|BCT-100|bct-100|mesh-list
2562233|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562234|NCT01551641|Thalidomide|thalidomide|mesh-list
2562235|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2562236|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
2562237|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562238|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
2562239|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2562240|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562241|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2562242|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2562243|NCT01551641|Growth Substances|growth substances|mesh-ancestor
2562244|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
2562245|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562246|NCT01551667|Antibodies|antibodies|mesh-list
2562247|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
2562248|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562249|NCT01551680|Iniparib|iniparib|mesh-list
2562250|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2562251|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562252|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562253|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562254|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2562255|NCT01551719|Vancomycin|vancomycin|mesh-list
2562256|NCT01551719|Linezolid|linezolid|mesh-list
2562257|NCT01551719|Daptomycin|daptomycin|mesh-list
2562258|NCT01551719|Penicillins|penicillins|mesh-list
2562259|NCT01551719|Tigecycline|tigecycline|mesh-list
2562260|NCT01551719|Cephalosporins|cephalosporins|mesh-list
2562261|NCT01551719|Teicoplanin|teicoplanin|mesh-list
2562262|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562263|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2562264|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562265|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562266|NCT01551797|Acetaminophen|acetaminophen|mesh-list
2562267|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2562268|NCT01551797|Analgesics|analgesics|mesh-ancestor
2562269|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
2562270|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562271|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562272|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
2562273|NCT01551810|Vaccines|vaccines|mesh-list
2562274|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
2562275|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562276|NCT01551823|Vaccines|vaccines|mesh-list
2562277|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
2562278|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562279|NCT01551836|Acetaminophen|acetaminophen|mesh-list
2562280|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2562281|NCT01551836|Analgesics|analgesics|mesh-ancestor
2562282|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
2562283|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562284|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562285|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
2562286|NCT01552005|Saxagliptin|saxagliptin|mesh-list
2562287|NCT01552005|Incretins|incretins|mesh-ancestor
2562288|NCT01552005|Hormones|hormones|mesh-ancestor
2562289|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562290|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562291|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2562292|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
2562293|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562294|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562295|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2562296|NCT01552018|Saxagliptin|saxagliptin|mesh-list
2562297|NCT01552018|Incretins|incretins|mesh-ancestor
2562298|NCT01552018|Hormones|hormones|mesh-ancestor
2562299|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562300|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562301|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2562302|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
2562303|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562304|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562305|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2562306|NCT01552044|Spironolactone|spironolactone|mesh-list
2562307|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2562308|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
2562309|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562310|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562311|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2562312|NCT01552044|Diuretics|diuretics|mesh-ancestor
2562313|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
2562314|NCT01552122|Vitamin D|vitamin d|mesh-list
2562315|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
2562316|NCT01552122|Alendronate|alendronate|mesh-list
2562317|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
2562318|NCT01552122|Calcium|calcium|mesh-list
2562319|NCT01552122|Vitamins|vitamins|mesh-ancestor
2562320|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
2562321|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562322|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2562323|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2562324|NCT01552122|Antacids|antacids|mesh-ancestor
2562325|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562326|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2562327|NCT01552148|Morphine|morphine|mesh-list
2562328|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2562329|NCT01552148|Narcotics|narcotics|mesh-ancestor
2562330|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2562331|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123057|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
2123058|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123059|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123060|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2123061|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2123062|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2123063|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2123064|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123065|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2123066|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
2123067|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
2123068|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
2123069|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2123070|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2123071|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2123075|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
2123076|NCT02787057|Vancomycin|vancomycin|mesh-list
2123077|NCT02787057|Ceftazidime|ceftazidime|mesh-list
2123078|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2123079|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123080|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2123081|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2123082|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123083|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562332|NCT01552148|Analgesics|analgesics|mesh-ancestor
2562333|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
2562334|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562335|NCT01552187|Colchicine|colchicine|mesh-list
2562336|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
2562337|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2562338|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
2562339|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
2562340|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
2562341|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562342|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562343|NCT01552330|Artesunate|artesunate|mesh-list
2562344|NCT01552330|Primaquine|primaquine|mesh-list
2562345|NCT01552330|Pyronaridine|pyronaridine|mesh-list
2562346|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
2562347|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2562348|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2562349|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562350|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562351|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
2562352|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
2562353|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2562354|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
2123084|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123085|NCT02787083|Mirabegron|mirabegron|mesh-list
2123086|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2123087|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2123088|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2123089|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
2123090|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123091|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123092|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123093|NCT02787083|Urological Agents|urological agents|mesh-ancestor
2123094|NCT02787304|Volixibat|volixibat|mesh-list
2123095|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2123096|NCT02787551|Metformin|metformin|mesh-list
2123097|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
2123098|NCT02787551|Pioglitazone|pioglitazone|mesh-list
2123099|NCT02787551|Liraglutide|liraglutide|mesh-list
2123100|NCT02787551|Exenatide|exenatide|mesh-list
2562386|NCT01552590|Tolvaptan|tolvaptan|mesh-list
2562387|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2562388|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562389|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
2562390|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562391|NCT01552629|Cyclosporine|cyclosporine|mesh-list
2562392|NCT01552629|Cyclosporins|cyclosporins|mesh-list
2562393|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123101|NCT02787551|Dulaglutide|dulaglutide|mesh-list
2123102|NCT02787551|Lixisenatide|lixisenatide|mesh-list
2123103|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2123104|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2123105|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
2123106|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123107|NCT02787551|Incretins|incretins|mesh-ancestor
2123108|NCT02787551|Hormones|hormones|mesh-ancestor
2123109|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123110|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2123111|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123112|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2562394|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562395|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2562396|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
2562397|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562398|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
2562399|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562400|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
2562401|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2562402|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2562403|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
2562404|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2562405|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123113|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
2123114|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123115|NCT02788019|Ropivacaine|ropivacaine|mesh-list
2123116|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
2123117|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
2123118|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2123119|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123120|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
2123121|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123122|NCT02788097|Progesterone|progesterone|mesh-list
2123123|NCT02788097|Progestins|progestins|mesh-ancestor
2123124|NCT02788097|Hormones|hormones|mesh-ancestor
2123125|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123126|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123127|NCT02788175|Vedolizumab|vedolizumab|mesh-list
2123128|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2123129|NCT02788279|Atezolizumab|atezolizumab|mesh-list
2123130|NCT02788279|Antibodies|antibodies|mesh-list
2123131|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
2123132|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123133|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123134|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2123135|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2123136|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2123137|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2123138|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123139|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
2123140|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123141|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123142|NCT02788474|Nintedanib|nintedanib|mesh-list
2123143|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123144|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2123145|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123146|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123147|NCT02788513|BI 425809|bi 425809|mesh-list
2123148|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
2123149|NCT02788656|Valsartan|valsartan|mesh-list
2123150|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
2123151|NCT02788656|Giapreza|giapreza|mesh-list
2123152|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
2123153|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2123154|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2123155|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2562406|NCT01552798|Aspirin|aspirin|mesh-list
2562407|NCT01552798|Acetaminophen|acetaminophen|mesh-list
2562408|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2562409|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2562410|NCT01552798|Analgesics|analgesics|mesh-ancestor
2562411|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
2562412|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562413|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562414|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2562415|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2562416|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2562417|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2562418|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562419|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2562420|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2562421|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562422|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
2562423|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2562424|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
2562425|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2562426|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2562427|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2562428|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2562429|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562430|NCT01552850|Oxycodone|oxycodone|mesh-list
2562431|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2562432|NCT01552850|Narcotics|narcotics|mesh-ancestor
2562433|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2562434|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562435|NCT01552850|Analgesics|analgesics|mesh-ancestor
2562436|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
2562437|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123156|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
2123157|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2123158|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562438|NCT01552863|Oxycodone|oxycodone|mesh-list
2562439|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2562440|NCT01552863|Narcotics|narcotics|mesh-ancestor
2562441|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2562442|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562443|NCT01552863|Analgesics|analgesics|mesh-ancestor
2562444|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
2562445|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562446|NCT01552967|Capecitabine|capecitabine|mesh-list
2562447|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2562448|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
2562449|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562450|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562451|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
2562452|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562453|NCT01552993|Acetaminophen|acetaminophen|mesh-list
2562454|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2562455|NCT01552993|Analgesics|analgesics|mesh-ancestor
2562456|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
2562457|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562458|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562459|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
2562460|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
2562461|NCT01553006|Cefditoren|cefditoren|mesh-list
2562462|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2562463|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562464|NCT01553019|Gemcitabine|gemcitabine|mesh-list
2562465|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2562466|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
2123159|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
2123160|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2123161|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2123162|NCT02789033|Isosorbide|isosorbide|mesh-list
2123163|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2123164|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2123165|NCT02789033|Chitosan|chitosan|mesh-list
2123166|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2123167|NCT02789033|Diuretics|diuretics|mesh-ancestor
2123168|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
2123169|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123170|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
2123171|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2123172|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123173|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2123174|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2123175|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
2562467|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562468|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562469|NCT01553019|Antiviral Agents|antiviral agents|mesh-ancestor
2562470|NCT01553019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562471|NCT01553019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562472|NCT01553019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2562473|NCT01553019|Immunologic Factors|immunologic factors|mesh-ancestor
2562474|NCT01553019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562475|NCT01553032|Cetuximab|cetuximab|mesh-list
2562476|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2562477|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562478|NCT01553071|Fenretinide|fenretinide|mesh-list
2562479|NCT01553071|Safingol|safingol|mesh-list
2562480|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562481|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2562482|NCT01553071|Protective Agents|protective agents|mesh-ancestor
2562483|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562484|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562485|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562486|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
2562487|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2562488|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
2562489|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2562490|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562491|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2123176|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2123177|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
2123178|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
2123179|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
2123180|NCT02789033|Coagulants|coagulants|mesh-ancestor
2123181|NCT02789111|Alvimopan|alvimopan|mesh-list
2123182|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2562504|NCT01553357|Dexamethasone|dexamethasone|mesh-list
2562505|NCT01553357|Lenalidomide|lenalidomide|mesh-list
2562506|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2562507|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
2562508|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
2562509|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562510|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562511|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2562512|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
2562513|NCT01553357|Hormones|hormones|mesh-ancestor
2562514|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562515|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2562516|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562517|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
2562518|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2562519|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2562520|NCT01553357|Growth Substances|growth substances|mesh-ancestor
2562521|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
2562522|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
2562523|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
2562524|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
2562525|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2562526|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2123183|NCT02789410|Morphine|morphine|mesh-list
2123184|NCT02789410|Hydromorphone|hydromorphone|mesh-list
2123185|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2562527|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2562528|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562529|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562530|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2562531|NCT01553500|Cathartics|cathartics|mesh-ancestor
2562532|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2562533|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2562534|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
2562535|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
2562536|NCT01553721|Udenafil|udenafil|mesh-list
2562537|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2562538|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2562539|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562540|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562541|NCT01553773|Estradiol|estradiol|mesh-list
2562542|NCT01553773|Estrogens|estrogens|mesh-ancestor
2562543|NCT01553773|Hormones|hormones|mesh-ancestor
2562544|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123186|NCT02789410|Narcotics|narcotics|mesh-ancestor
2418776|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
2418777|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418778|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418779|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418780|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2418781|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2418782|NCT00800722|Sirolimus|sirolimus|mesh-list
2418783|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2418784|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418785|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2418786|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418787|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
2418788|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418789|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
2418790|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123187|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2123188|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123189|NCT02789410|Analgesics|analgesics|mesh-ancestor
2123190|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
2123191|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123192|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
2123193|NCT02790138|Vedolizumab|vedolizumab|mesh-list
2123194|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2123195|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562545|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562546|NCT01553786|Lenalidomide|lenalidomide|mesh-list
2562547|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
2562548|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562549|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2562550|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2123196|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2123197|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2123198|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123199|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123200|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123201|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2123202|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2123203|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2123204|NCT02790736|Propranolol|propranolol|mesh-list
2123205|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2123206|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2562551|NCT01553786|Growth Substances|growth substances|mesh-ancestor
2562552|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
2562553|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562554|NCT01553903|Tamoxifen|tamoxifen|mesh-list
2562555|NCT01553903|Letrozole|letrozole|mesh-list
2562556|NCT01553903|Anastrozole|anastrozole|mesh-list
2562557|NCT01553903|Exemestane|exemestane|mesh-list
2562558|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418791|NCT00800748|Ribavirin|ribavirin|mesh-list
2418792|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2418793|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
2418794|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418795|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
2418796|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418797|NCT00800761|Deferiprone|deferiprone|mesh-list
2418798|NCT00800761|Deferoxamine|deferoxamine|mesh-list
2418799|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2562559|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2562560|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2562561|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562562|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562563|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2562564|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
2562565|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562566|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562567|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2562568|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2562569|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2562570|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2562571|NCT01553942|Pemetrexed|pemetrexed|mesh-list
2562572|NCT01553942|Afatinib|afatinib|mesh-list
2562573|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562574|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562575|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562576|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2562577|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2562578|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2562579|NCT01553981|Tadalafil|tadalafil|mesh-list
2562580|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
2562581|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2562582|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2562583|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562584|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562585|NCT01553981|Urological Agents|urological agents|mesh-ancestor
2562586|NCT01554046|Methylphenidate|methylphenidate|mesh-list
2562587|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2123207|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
2418800|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
2562588|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562589|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2562590|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2562591|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2562592|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562593|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
2562594|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2562595|NCT01554059|Bevacizumab|bevacizumab|mesh-list
2562596|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
2562597|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2562598|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562599|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2562600|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2562601|NCT01554059|Growth Substances|growth substances|mesh-ancestor
2562602|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562603|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
2562604|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
2562605|NCT01554111|Cathartics|cathartics|mesh-ancestor
2562606|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2562607|NCT01554124|Meropenem|meropenem|mesh-list
2562608|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2562609|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562610|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2123208|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123209|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123210|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123211|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2123212|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2123213|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
2123214|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
2123215|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2123216|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2123217|NCT02790788|Prednisolone|prednisolone|mesh-list
2123218|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
2123219|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
2123220|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2123221|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2123222|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
2123223|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2123224|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
2123225|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
2123226|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123227|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123228|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2123229|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
2123230|NCT02790788|Hormones|hormones|mesh-ancestor
2123231|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123232|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2123233|NCT02790788|Protective Agents|protective agents|mesh-ancestor
2123234|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2123235|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123236|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2123237|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
2123238|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123239|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
2123240|NCT02791308|Tacrolimus|tacrolimus|mesh-list
2123241|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2123242|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2123243|NCT02791308|Analgesics|analgesics|mesh-ancestor
2123244|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
2123245|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123246|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123247|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2123248|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2123249|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
2123250|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2123251|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
2123252|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2562611|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2562612|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
2562613|NCT01554345|Vitamin E|vitamin e|mesh-list
2562614|NCT01554345|Selenium|selenium|mesh-list
2562615|NCT01554345|Vitamins|vitamins|mesh-ancestor
2562616|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
2562617|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562618|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
2123253|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123254|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123255|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2123256|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2123257|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2562619|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562620|NCT01554345|Protective Agents|protective agents|mesh-ancestor
2562621|NCT01554345|Trace Elements|trace elements|mesh-ancestor
2562622|NCT01554397|Cisplatin|cisplatin|mesh-list
2562623|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123258|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123259|NCT02791490|Metformin|metformin|mesh-list
2123260|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2123261|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2123262|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123263|NCT02791490|Incretins|incretins|mesh-ancestor
2123264|NCT02791490|Hormones|hormones|mesh-ancestor
2562624|NCT01554410|Gemcitabine|gemcitabine|mesh-list
2562625|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562626|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2562627|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
2562628|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562629|NCT01554410|Antiviral Agents|antiviral agents|mesh-ancestor
2562630|NCT01554410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562631|NCT01554410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562632|NCT01554410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2562633|NCT01554410|Immunologic Factors|immunologic factors|mesh-ancestor
2562634|NCT01554410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562635|NCT01554540|Treprostinil|treprostinil|mesh-list
2562636|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2562637|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2562638|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2562639|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2562640|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
2562641|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562642|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562643|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2562644|NCT01554631|Acarbose|acarbose|mesh-list
2562645|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2562646|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562647|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123265|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123266|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2123267|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
2123268|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123269|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123270|NCT02791763|Glycine|glycine|mesh-list
2123271|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
2123272|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123273|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562648|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2562649|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562650|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2562651|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2562652|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562653|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
2562654|NCT01554696|Methotrexate|methotrexate|mesh-list
2562655|NCT01554696|Peficitinib|peficitinib|mesh-list
2562656|NCT01554696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2562657|NCT01554696|Abortifacient Agents|abortifacient agents|mesh-ancestor
2562658|NCT01554696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2562659|NCT01554696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562660|NCT01554696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2562661|NCT01554696|Antimetabolites|antimetabolites|mesh-ancestor
2123274|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123275|NCT02791906|Ascorbic Acid|ascorbic acid|mesh-list
2123276|NCT02791906|Vitamins|vitamins|mesh-ancestor
2123277|NCT02791906|Micronutrients|micronutrients|mesh-ancestor
2123278|NCT02791906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123279|NCT02791906|Antioxidants|antioxidants|mesh-ancestor
2123280|NCT02791906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123281|NCT02791906|Protective Agents|protective agents|mesh-ancestor
2123282|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
2123283|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2123284|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
2562662|NCT01554696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562663|NCT01554696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562664|NCT01554696|Dermatologic Agents|dermatologic agents|mesh-ancestor
2562665|NCT01554696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562666|NCT01554696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2562667|NCT01554696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2562668|NCT01554696|Immunologic Factors|immunologic factors|mesh-ancestor
2562669|NCT01554696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2562670|NCT01554696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2562671|NCT01554813|Vaccines|vaccines|mesh-list
2562672|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
2562673|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562674|NCT01554826|Vaccines|vaccines|mesh-list
2562675|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
2562676|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562677|NCT01554852|Thalidomide|thalidomide|mesh-list
2562678|NCT01554852|Dexamethasone|dexamethasone|mesh-list
2562679|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
2562680|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
2562681|NCT01554852|Melphalan|melphalan|mesh-list
2562682|NCT01554852|Lenalidomide|lenalidomide|mesh-list
2562683|NCT01554852|Bortezomib|bortezomib|mesh-list
2562684|NCT01554852|Vorinostat|vorinostat|mesh-list
2562685|NCT01554852|BB 1101|bb 1101|mesh-list
2562686|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2562687|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
2562688|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562689|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2562690|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2562691|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
2562692|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562693|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562694|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2562695|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2562696|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
2562697|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
2562698|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562699|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2562700|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
2562701|NCT01554852|Hormones|hormones|mesh-ancestor
2562702|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562703|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2562704|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
2562705|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562706|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2562707|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2562708|NCT01554852|Growth Substances|growth substances|mesh-ancestor
2562709|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
2562710|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
2562711|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2562712|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562713|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2562714|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
2562715|NCT01554930|Mannitol|mannitol|mesh-list
2562716|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
2562717|NCT01554930|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2562718|NCT01554930|Antibodies|antibodies|mesh-list
2562719|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2562720|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
2562721|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
2562722|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562723|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562724|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2562725|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
2562726|NCT01554930|Hormones|hormones|mesh-ancestor
2562727|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562728|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2562729|NCT01554930|Protective Agents|protective agents|mesh-ancestor
2562730|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
2562731|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2562732|NCT01554930|Diuretics|diuretics|mesh-ancestor
2562733|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
2562734|NCT01554956|Plasminogen|plasminogen|mesh-list
2562735|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2562736|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2562737|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562738|NCT01554969|Capecitabine|capecitabine|mesh-list
2562739|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2562740|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
2562741|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562742|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562743|NCT01554995|Linezolid|linezolid|mesh-list
2562744|NCT01554995|Delpazolid|delpazolid|mesh-list
2562745|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2562746|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562747|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2562748|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562749|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562750|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2562751|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2562752|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562753|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2562754|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562755|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
2562756|NCT01555060|Hematinics|hematinics|mesh-ancestor
2562757|NCT01555099|Budesonide|budesonide|mesh-list
2562758|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2562759|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2123285|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123286|NCT02791945|Expectorants|expectorants|mesh-ancestor
2123287|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
2123288|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2123289|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
2123290|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123291|NCT02791945|Protective Agents|protective agents|mesh-ancestor
2123292|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123293|NCT02791945|Antidotes|antidotes|mesh-ancestor
2123294|NCT02792062|Relugolix|relugolix|mesh-list
2123295|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
2123296|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
2123297|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123298|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123299|NCT02792192|Atezolizumab|atezolizumab|mesh-list
2123300|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123301|NCT02792218|Teriflunomide|teriflunomide|mesh-list
2562760|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
2562761|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562762|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562763|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2562764|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
2562765|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
2562766|NCT01555099|Hormones|hormones|mesh-ancestor
2562767|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562768|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
2562769|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2562770|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
2562771|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562772|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562773|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2562774|NCT01555112|Protective Agents|protective agents|mesh-ancestor
2562775|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2562776|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2562777|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562778|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562779|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
2562780|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562781|NCT01555190|Folic Acid|folic acid|mesh-list
2562782|NCT01555190|Inositol|inositol|mesh-list
2562783|NCT01555190|Hematinics|hematinics|mesh-ancestor
2562784|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
2562785|NCT01555190|Vitamins|vitamins|mesh-ancestor
2562786|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
2562787|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562788|NCT01555216|Ropivacaine|ropivacaine|mesh-list
2562789|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
2562790|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
2562791|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2562792|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562793|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
2123302|NCT02792218|Ofatumumab|ofatumumab|mesh-list
2123303|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2123304|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123305|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
2123306|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123307|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2123308|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2123309|NCT02792218|Analgesics|analgesics|mesh-ancestor
2123310|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
2123311|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123312|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2123313|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2123314|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2562794|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562795|NCT01555268|Cytarabine|cytarabine|mesh-list
2562796|NCT01555268|Trebananib|trebananib|mesh-list
2562797|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2562798|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
2562799|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562800|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562801|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
2562802|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562803|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2562804|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
2562805|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562806|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2562807|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2562808|NCT01555268|Growth Substances|growth substances|mesh-ancestor
2562809|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
2562838|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
2562839|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2562840|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2562841|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
2562842|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562843|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2562844|NCT01555476|Ibuprofen|ibuprofen|mesh-list
2562845|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2562846|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2562847|NCT01555476|Analgesics|analgesics|mesh-ancestor
2562848|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
2562849|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2562850|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562851|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2562852|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2562853|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2562854|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562855|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562856|NCT01555554|Propranolol|propranolol|mesh-list
2562857|NCT01555554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2562858|NCT01555554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2562859|NCT01555554|Adrenergic Agents|adrenergic agents|mesh-ancestor
2562860|NCT01555554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2562861|NCT01555554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562862|NCT01555554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562863|NCT01555554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2562864|NCT01555554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2562865|NCT01555554|Vasodilator Agents|vasodilator agents|mesh-ancestor
2562866|NCT01555580|Molgramostim|molgramostim|mesh-list
2123315|NCT02792231|Teriflunomide|teriflunomide|mesh-list
2123316|NCT02792231|Ofatumumab|ofatumumab|mesh-list
2123317|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2562867|NCT01555580|Sargramostim|sargramostim|mesh-list
2562868|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
2562869|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562870|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562871|NCT01555632|Atorvastatin|atorvastatin|mesh-list
2562872|NCT01555632|Calcium|calcium|mesh-list
2562873|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2562874|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562875|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2562876|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2562877|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
2562878|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562879|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2562880|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2562881|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562882|NCT01555658|Heparin|heparin|mesh-list
2562883|NCT01555658|Bivalirudin|bivalirudin|mesh-list
2562884|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
2562885|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2562886|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2562887|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562888|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
2562889|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2562890|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
2562891|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562892|NCT01555710|Carboplatin|carboplatin|mesh-list
2562893|NCT01555710|Etoposide|etoposide|mesh-list
2562894|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
2562895|NCT01555710|Ifosfamide|ifosfamide|mesh-list
2562896|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562897|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2562898|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2562899|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2562900|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562901|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562902|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2562903|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
2562904|NCT01555788|Pancrelipase|pancrelipase|mesh-list
2562905|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2562906|NCT01555814|Amisulpride|amisulpride|mesh-list
2562907|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2562908|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2562909|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2562910|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562911|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2562912|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2562913|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
2562914|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2562915|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562916|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2562917|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
2562918|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2562919|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562920|NCT01555866|Isavuconazole|isavuconazole|mesh-list
2562921|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
2562922|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562923|NCT01555879|Abatacept|abatacept|mesh-list
2562924|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2562925|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562926|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562927|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2562928|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
2123318|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123319|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
2123320|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123321|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2123322|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2123323|NCT02792231|Analgesics|analgesics|mesh-ancestor
2123324|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
2123325|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123326|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2123327|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2123328|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2562929|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562930|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2562931|NCT01555918|Isavuconazole|isavuconazole|mesh-list
2562932|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
2562933|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562934|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
2562935|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2562936|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
2562937|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562938|NCT01555970|Expectorants|expectorants|mesh-ancestor
2562939|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
2562940|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2562941|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
2562942|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562943|NCT01555970|Protective Agents|protective agents|mesh-ancestor
2562944|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562945|NCT01555970|Antidotes|antidotes|mesh-ancestor
2562946|NCT01556035|Lenalidomide|lenalidomide|mesh-list
2562947|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
2562948|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562949|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2562950|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2562951|NCT01556035|Growth Substances|growth substances|mesh-ancestor
2562952|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
2562953|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562954|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2562955|NCT01556191|Gefitinib|gefitinib|mesh-list
2562956|NCT01556191|Fulvestrant|fulvestrant|mesh-list
2562957|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562958|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2562959|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562960|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562961|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2562962|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2562963|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2562964|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
2562965|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2562966|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562967|NCT01556321|Caffeine|caffeine|mesh-list
2562968|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2562969|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562970|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2123329|NCT02792517|Erenumab|erenumab|mesh-list
2123330|NCT02792517|Norgestimate|norgestimate|mesh-list
2123331|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
2123332|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
2123333|NCT02792517|Estradiol|estradiol|mesh-list
2123334|NCT02792517|Estrogens|estrogens|mesh-ancestor
2123335|NCT02792517|Hormones|hormones|mesh-ancestor
2123336|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123337|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123338|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2123339|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2123340|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2123341|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2123342|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123343|NCT02792517|Analgesics|analgesics|mesh-ancestor
2123344|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
2123345|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123346|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2123347|NCT02792699|Rituximab|rituximab|mesh-list
2562971|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562972|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123348|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2123349|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123350|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
2123351|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123352|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2123353|NCT02792829|Lenvatinib|lenvatinib|mesh-list
2123354|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123355|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2123356|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123357|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123358|NCT02793128|Mitomycins|mitomycins|mesh-list
2123359|NCT02793128|Mitomycin|mitomycin|mesh-list
2123360|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2123361|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123362|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
2123363|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123364|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2123365|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123366|NCT02793154|Exenatide|exenatide|mesh-list
2562973|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2562974|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2562975|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
2562976|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2562977|NCT01556334|Azithromycin|azithromycin|mesh-list
2562978|NCT01556334|Erythromycin|erythromycin|mesh-list
2562979|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
2562980|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2562981|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
2562982|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2562983|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2562984|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2562985|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2562986|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2562987|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2562988|NCT01556477|Lenalidomide|lenalidomide|mesh-list
2562989|NCT01556477|Azacitidine|azacitidine|mesh-list
2562990|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
2123367|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
2123368|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2562991|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2562992|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2562993|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2562994|NCT01556477|Growth Substances|growth substances|mesh-ancestor
2562995|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
2562996|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2562997|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2562998|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
2562999|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563000|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563001|NCT01556529|Unithiol|unithiol|mesh-list
2563002|NCT01556529|Antidotes|antidotes|mesh-ancestor
2563003|NCT01556529|Protective Agents|protective agents|mesh-ancestor
2563004|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563005|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
2563006|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
2563007|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563008|NCT01556542|Paclitaxel|paclitaxel|mesh-list
2563009|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2563010|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563011|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
2563012|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
2563013|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
2563014|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563015|NCT01556646|Tolvaptan|tolvaptan|mesh-list
2563016|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2563017|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563018|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
2563019|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563020|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
2563021|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
2563022|NCT01556672|Adalimumab|adalimumab|mesh-list
2563023|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2563024|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2563025|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
2563026|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2563027|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
2563028|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563029|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563030|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2563031|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
2563032|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2563033|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
2563034|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563035|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563036|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2563037|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
2563038|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
2563039|NCT01556698|Protective Agents|protective agents|mesh-ancestor
2563040|NCT01556737|Genistein|genistein|mesh-list
2563041|NCT01556737|Daidzein|daidzein|mesh-list
2563042|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2563043|NCT01556737|Protective Agents|protective agents|mesh-ancestor
2563044|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563045|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563046|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2563047|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563048|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563049|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
2563050|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2563051|NCT01556737|Estrogens|estrogens|mesh-ancestor
2563052|NCT01556737|Hormones|hormones|mesh-ancestor
2563053|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2563062|NCT01556815|Sorafenib|sorafenib|mesh-list
2563063|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
2563064|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563065|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2563066|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563067|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563068|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2563069|NCT01556815|Estrogens|estrogens|mesh-ancestor
2563070|NCT01556815|Hormones|hormones|mesh-ancestor
2563071|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2563072|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563073|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2563074|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2563075|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2563076|NCT01557075|Atorvastatin|atorvastatin|mesh-list
2563077|NCT01557075|Pravastatin|pravastatin|mesh-list
2563078|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2563079|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2563080|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2563081|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
2563082|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563083|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2563084|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563085|NCT01557114|Ipilimumab|ipilimumab|mesh-list
2563086|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2563087|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563088|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2563089|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563090|NCT01557127|Sorafenib|sorafenib|mesh-list
2563091|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563092|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2563093|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563094|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563095|NCT01557140|Carvedilol|carvedilol|mesh-list
2563096|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2563097|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2563098|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
2563099|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563100|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563101|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563102|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2123369|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123370|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2123371|NCT02793154|Incretins|incretins|mesh-ancestor
2123372|NCT02793154|Hormones|hormones|mesh-ancestor
2123373|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123374|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
2563103|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
2563104|NCT01557140|Protective Agents|protective agents|mesh-ancestor
2563105|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2563106|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2563107|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2563108|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
2563109|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2563110|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2563111|NCT01557153|Amlodipine|amlodipine|mesh-list
2563112|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2563113|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2563114|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2563115|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563116|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2563117|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563118|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
2563119|NCT01557257|Naltrexone|naltrexone|mesh-list
2563120|NCT01557257|Oxycodone|oxycodone|mesh-list
2563121|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2563122|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2563123|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563124|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
2563125|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563126|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2563127|NCT01557257|Narcotics|narcotics|mesh-ancestor
2563128|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563129|NCT01557257|Analgesics|analgesics|mesh-ancestor
2563130|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
2563131|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2563132|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563133|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563134|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2563135|NCT01557270|Analgesics|analgesics|mesh-ancestor
2563136|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
2563137|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563138|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2563139|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2563140|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2563141|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
2563142|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563143|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563144|NCT01557335|Aspirin|aspirin|mesh-list
2563145|NCT01557335|Omeprazole|omeprazole|mesh-list
2563146|NCT01557335|Clopidogrel|clopidogrel|mesh-list
2563147|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2563148|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2563149|NCT01557335|Analgesics|analgesics|mesh-ancestor
2563150|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
2563151|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563152|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563153|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2563154|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2563155|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2563156|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2563157|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563158|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2563159|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2563160|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563161|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
2563162|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2563163|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2563164|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2563165|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
2563166|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563167|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2563168|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2563169|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2563170|NCT01557374|Abatacept|abatacept|mesh-list
2563171|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2563172|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563173|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563174|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2563175|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
2563176|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563177|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2563178|NCT01557439|Levocetirizine|levocetirizine|mesh-list
2563179|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2563180|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2563181|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
2563182|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
2563183|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563184|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563185|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563186|NCT01557478|Melatonin|melatonin|mesh-list
2563187|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
2563188|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563189|NCT01557478|Protective Agents|protective agents|mesh-ancestor
2563190|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563191|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563192|NCT01557634|Insulin|insulin|mesh-list
2563193|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2563194|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563195|NCT01557647|Treprostinil|treprostinil|mesh-list
2563196|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2563197|NCT01557660|Treprostinil|treprostinil|mesh-list
2563198|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2563199|NCT01557712|Ketamine|ketamine|mesh-list
2563200|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2563201|NCT01557712|Analgesics|analgesics|mesh-ancestor
2563202|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
2563203|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563204|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563205|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2563206|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2563207|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
2563208|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
2563209|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563210|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2563211|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2563212|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563213|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563214|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2563215|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2563216|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2563217|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2563218|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
2563219|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2563220|NCT01557764|Trastuzumab|trastuzumab|mesh-list
2563221|NCT01557764|Lapatinib|lapatinib|mesh-list
2563222|NCT01557764|Antibodies|antibodies|mesh-list
2563223|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2563224|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
2563225|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563226|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2563227|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563228|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2563229|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563230|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563231|NCT01557777|Navitoclax|navitoclax|mesh-list
2563232|NCT01557777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563233|NCT01557816|Naproxen|naproxen|mesh-list
2563234|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2563235|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2563236|NCT01557816|Analgesics|analgesics|mesh-ancestor
2563237|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
2563238|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563239|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563240|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2563241|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2563242|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
2563243|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2563244|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563245|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563246|NCT01557829|Silicon|silicon|mesh-list
2123375|NCT02793622|Piperaquine|piperaquine|mesh-list
2123376|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
2123377|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2123378|NCT02793622|Artenimol|artenimol|mesh-list
2123379|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
2123380|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2123381|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2123382|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123383|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2123384|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123385|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123386|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2123387|NCT02793622|Renal Agents|renal agents|mesh-ancestor
2123388|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2123389|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2123390|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
2123391|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2123392|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
2123393|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123394|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2123395|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2123396|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
2123397|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123398|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123399|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2123400|NCT02793947|Epinephrine|epinephrine|mesh-list
2123401|NCT02793947|Morphine|morphine|mesh-list
2123402|NCT02793947|Ropivacaine|ropivacaine|mesh-list
2123403|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2123404|NCT02793947|Narcotics|narcotics|mesh-ancestor
2123405|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563247|NCT01557829|Trace Elements|trace elements|mesh-ancestor
2563248|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
2563249|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563250|NCT01557907|Insulin|insulin|mesh-list
2563251|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2563252|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2563253|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563254|NCT01557985|Bupivacaine|bupivacaine|mesh-list
2563255|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
2563256|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
2563257|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563258|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563259|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
2563260|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563261|NCT01558011|Docetaxel|docetaxel|mesh-list
2563262|NCT01558011|Capecitabine|capecitabine|mesh-list
2563263|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
2563264|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563265|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
2563266|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
2563267|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
2563268|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563269|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2563270|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
2563271|NCT01558115|Denosumab|denosumab|mesh-list
2563272|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2563273|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123406|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123407|NCT02793947|Analgesics|analgesics|mesh-ancestor
2123408|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
2123409|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123410|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
2123411|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
2123412|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2123413|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2123414|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
2123415|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123416|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123417|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2563274|NCT01558167|Rituximab|rituximab|mesh-list
2563275|NCT01558167|Lenalidomide|lenalidomide|mesh-list
2563276|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2563277|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2563278|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563279|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
2563280|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563281|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2563282|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2563283|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2563284|NCT01558167|Growth Substances|growth substances|mesh-ancestor
2563285|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
2563286|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2563287|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
2563288|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563289|NCT01558193|Vitamins|vitamins|mesh-list
2563290|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
2563291|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
2563292|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563293|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2563294|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2563295|NCT01558193|Analgesics|analgesics|mesh-ancestor
2563296|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
2563297|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563298|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2563299|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2563300|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2563301|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
2563302|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563303|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2563304|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
2563305|NCT01558245|Kallikreins|kallikreins|mesh-list
2563306|NCT01558245|Coagulants|coagulants|mesh-ancestor
2563307|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
2563308|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
2563309|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2563310|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563311|NCT01558310|Ustekinumab|ustekinumab|mesh-list
2563312|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
2563313|NCT01558336|Praziquantel|praziquantel|mesh-list
2563314|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
2563315|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2563316|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2563317|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2563318|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2563319|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
2563320|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563321|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
2563322|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
2563323|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2563324|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2563325|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563326|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563327|NCT01558466|Urological Agents|urological agents|mesh-ancestor
2563328|NCT01558622|Ascorbic Acid|ascorbic acid|mesh-list
2563329|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2563330|NCT01558622|Ketoprofen|ketoprofen|mesh-list
2563331|NCT01558622|Meperidine|meperidine|mesh-list
2563332|NCT01558622|Tramadol|tramadol|mesh-list
2563333|NCT01558622|Vitamins|vitamins|mesh-ancestor
2563334|NCT01558622|Micronutrients|micronutrients|mesh-ancestor
2563335|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563336|NCT01558622|Antioxidants|antioxidants|mesh-ancestor
2563337|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563338|NCT01558622|Protective Agents|protective agents|mesh-ancestor
2563339|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2563340|NCT01558622|Narcotics|narcotics|mesh-ancestor
2563341|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563342|NCT01558622|Analgesics|analgesics|mesh-ancestor
2563343|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
2563344|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563345|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2563346|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2563347|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2563348|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2563349|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2563350|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2563351|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563352|NCT01558648|Analgesics|analgesics|mesh-list
2563353|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
2563354|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123418|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2123419|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
2123420|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2123421|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
2123422|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
2123423|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
2123424|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2123425|NCT02794441|Dexamethasone|dexamethasone|mesh-list
2123426|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2123427|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
2123428|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
2123429|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123430|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123431|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2123432|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
2123433|NCT02794441|Hormones|hormones|mesh-ancestor
2563355|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563356|NCT01558713|Fentanyl|fentanyl|mesh-list
2563357|NCT01558713|Bupivacaine|bupivacaine|mesh-list
2563358|NCT01558713|Ropivacaine|ropivacaine|mesh-list
2563359|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
2563360|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
2563361|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
2563362|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563363|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563364|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
2563365|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563366|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2563367|NCT01558713|Narcotics|narcotics|mesh-ancestor
2563368|NCT01558713|Analgesics|analgesics|mesh-ancestor
2563369|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2563370|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2563371|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
2563372|NCT01558830|Ranolazine|ranolazine|mesh-list
2563373|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2563374|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2563375|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563376|NCT01558869|Capecitabine|capecitabine|mesh-list
2563377|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
2563378|NCT01558869|Irinotecan|irinotecan|mesh-list
2563379|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2563380|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
2563381|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563382|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563383|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2563384|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2563385|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563386|NCT01558934|Lofexidine|lofexidine|mesh-list
2563387|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2563388|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2563389|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563390|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
2563391|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563392|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2563393|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2563394|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2563395|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
2563396|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563397|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563398|NCT01558960|Melphalan|melphalan|mesh-list
2563399|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2563400|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
2563401|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563402|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563403|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2563404|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2123434|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123435|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2123436|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123437|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2123438|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123439|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123440|NCT02794974|Anesthetics|anesthetics|mesh-list
2563405|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
2563406|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563407|NCT01558986|Cefazolin|cefazolin|mesh-list
2563408|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2563409|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2563410|NCT01559025|Vildagliptin|vildagliptin|mesh-list
2563411|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2563412|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2563413|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563414|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
2563415|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563416|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563417|NCT01559051|Anesthetics|anesthetics|mesh-list
2563418|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563419|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563420|NCT01559142|Azathioprine|azathioprine|mesh-list
2563421|NCT01559142|Infliximab|infliximab|mesh-list
2563422|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
2563423|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2563424|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2563425|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
2563426|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563427|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2563428|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563429|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2563430|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
2563431|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563432|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2563433|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2563434|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2563435|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563436|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563437|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2563438|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2563439|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2563440|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
2563441|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563442|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563443|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2563444|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2563445|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
2563446|NCT01559285|Ropivacaine|ropivacaine|mesh-list
2563447|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
2563448|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
2563449|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563450|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563451|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
2563452|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563453|NCT01559298|Aspirin|aspirin|mesh-list
2563454|NCT01559298|Clopidogrel|clopidogrel|mesh-list
2563455|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2563456|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2563457|NCT01559298|Analgesics|analgesics|mesh-ancestor
2563458|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
2563459|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563460|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563461|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2563462|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2563463|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2563464|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2563465|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563466|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2563467|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2563468|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563469|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
2563470|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2563471|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2123441|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2123442|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123443|NCT02795117|Ivermectin|ivermectin|mesh-list
2123444|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2123445|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123446|NCT02796144|Metformin|metformin|mesh-list
2123447|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2123448|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563472|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2123449|NCT02796352|Interleukin-2|interleukin-2|mesh-list
2123450|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123451|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2123452|NCT02796352|Analgesics|analgesics|mesh-ancestor
2123453|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
2123454|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123455|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123456|NCT02796560|Travoprost|travoprost|mesh-list
2123457|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2123458|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2563473|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
2563474|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563475|NCT01559363|XL647|xl647|mesh-list
2563476|NCT01559363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563477|NCT01559363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2563478|NCT01559363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563479|NCT01559363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563480|NCT01559480|Desogestrel|desogestrel|mesh-list
2563481|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2563482|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2563483|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2563484|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
2563485|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2563486|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563487|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2563488|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2563489|NCT01559480|Progestins|progestins|mesh-ancestor
2563490|NCT01559480|Hormones|hormones|mesh-ancestor
2563491|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2563492|NCT01559545|Metronidazole|metronidazole|mesh-list
2563493|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2563494|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2563495|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2563496|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2563497|NCT01559584|Triamcinolone|triamcinolone|mesh-list
2563498|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2563499|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2563500|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2563501|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2563502|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
2563503|NCT01559584|Hormones|hormones|mesh-ancestor
2563504|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2563505|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563506|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2563507|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
2563508|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563509|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563510|NCT01559727|Prednisone|prednisone|mesh-list
2563511|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2563512|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
2563513|NCT01559727|Hormones|hormones|mesh-ancestor
2563514|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2563515|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563516|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2563517|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563518|NCT01559740|Bupivacaine|bupivacaine|mesh-list
2563519|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
2563520|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
2563521|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563522|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563523|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
2563524|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563525|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2563526|NCT01559753|Amoxicillin|amoxicillin|mesh-list
2563527|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
2563528|NCT01559753|Tobramycin|tobramycin|mesh-list
2563529|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2563530|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
2563531|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
2563532|NCT01559753|Cefotaxime|cefotaxime|mesh-list
2563533|NCT01559753|Cefoxitin|cefoxitin|mesh-list
2563534|NCT01559753|Netilmicin|netilmicin|mesh-list
2563535|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2563536|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2563537|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563538|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563539|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2563540|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
2563541|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2563542|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563543|NCT01559974|Vitamins|vitamins|mesh-ancestor
2563544|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
2563545|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2563546|NCT01560013|Naltrexone|naltrexone|mesh-list
2563547|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2563548|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2563549|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563550|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
2563551|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563552|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
2563553|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2563554|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2563555|NCT01560052|Prednisolone|prednisolone|mesh-list
2563556|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
2563557|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2563558|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
2563559|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2563560|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
2563561|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
2563562|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563563|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563564|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2563565|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
2563566|NCT01560052|Hormones|hormones|mesh-ancestor
2563567|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2563568|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2563569|NCT01560052|Protective Agents|protective agents|mesh-ancestor
2563570|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2563571|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563572|NCT01560065|Folic Acid|folic acid|mesh-list
2563573|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
2563574|NCT01560065|Inositol|inositol|mesh-list
2563575|NCT01560065|Hematinics|hematinics|mesh-ancestor
2563576|NCT01560065|Vitamins|vitamins|mesh-ancestor
2563577|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
2563578|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563579|NCT01560091|Tamsulosin|tamsulosin|mesh-list
2563580|NCT01560091|Silodosin|silodosin|mesh-list
2563581|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2563582|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2563583|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2563584|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
2563585|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563586|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563587|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563588|NCT01560091|Urological Agents|urological agents|mesh-ancestor
2123459|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
2123460|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2123461|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
2123462|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123463|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123464|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2418801|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
2563589|NCT01560104|Paclitaxel|paclitaxel|mesh-list
2563590|NCT01560104|Carboplatin|carboplatin|mesh-list
2563591|NCT01560104|Veliparib|veliparib|mesh-list
2563592|NCT01560104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2563593|NCT01560104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563594|NCT01560104|Tubulin Modulators|tubulin modulators|mesh-ancestor
2563595|NCT01560104|Antimitotic Agents|antimitotic agents|mesh-ancestor
2563596|NCT01560104|Mitosis Modulators|mitosis modulators|mesh-ancestor
2563597|NCT01560104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563598|NCT01560104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2563599|NCT01560104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563600|NCT01560117|Rituximab|rituximab|mesh-list
2418802|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418803|NCT00800761|Siderophores|siderophores|mesh-ancestor
2418804|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
2418805|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
2418806|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418807|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2418808|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2563601|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2563602|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563603|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
2563604|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563605|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2563606|NCT01560221|Buprenorphine|buprenorphine|mesh-list
2563607|NCT01560221|Methadone|methadone|mesh-list
2563608|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2563609|NCT01560221|Narcotics|narcotics|mesh-ancestor
2563610|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563611|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563612|NCT01560221|Analgesics|analgesics|mesh-ancestor
2563613|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
2563614|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563615|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2563616|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
2563617|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
2563618|NCT01560299|Methimazole|methimazole|mesh-list
2563619|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
2123465|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
2123466|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2123467|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2123468|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2123469|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
2123470|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123471|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123472|NCT02796677|Bromides|bromides|mesh-list
2123473|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
2563620|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
2563621|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2563622|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563623|NCT01560390|Ketamine|ketamine|mesh-list
2563624|NCT01560390|Analgesics|analgesics|mesh-ancestor
2563625|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
2563626|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563627|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563628|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2563629|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2563630|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
2563631|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
2563632|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563633|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2563634|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2563635|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563636|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563637|NCT01560442|Buprenorphine|buprenorphine|mesh-list
2563638|NCT01560442|Methadone|methadone|mesh-list
2563639|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2563640|NCT01560442|Narcotics|narcotics|mesh-ancestor
2563641|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563642|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563643|NCT01560442|Analgesics|analgesics|mesh-ancestor
2563644|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
2563645|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563646|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2563647|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
2563648|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
2563649|NCT01560481|Metformin|metformin|mesh-list
2563650|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2563651|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563652|NCT01560546|Testosterone|testosterone|mesh-list
2563653|NCT01560546|Androgens|androgens|mesh-ancestor
2563654|NCT01560546|Hormones|hormones|mesh-ancestor
2563655|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2563656|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123474|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
2123475|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2123476|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
2123477|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123478|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123479|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2123480|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
2123481|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2123482|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2123483|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2123484|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
2123485|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123486|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123487|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
2123488|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2123489|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
2123490|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
2123491|NCT02796755|Riluzole|riluzole|mesh-list
2123492|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
2123493|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2123494|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2123495|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123496|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123497|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123498|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2123499|NCT02796755|Protective Agents|protective agents|mesh-ancestor
2123500|NCT02797080|Interferons|interferons|mesh-list
2123501|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
2123502|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123503|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
2123504|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123505|NCT02797522|Acetaminophen|acetaminophen|mesh-list
2123506|NCT02797522|Tenofovir|tenofovir|mesh-list
2123507|NCT02797522|Entecavir|entecavir|mesh-list
2123508|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
2123509|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2123510|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2123511|NCT02797522|Analgesics|analgesics|mesh-ancestor
2563677|NCT01560585|Isotretinoin|isotretinoin|mesh-list
2563678|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
2563679|NCT01560637|Treprostinil|treprostinil|mesh-list
2563680|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2563681|NCT01560663|Carboplatin|carboplatin|mesh-list
2563682|NCT01560663|Docetaxel|docetaxel|mesh-list
2563683|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563684|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
2563685|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
2563686|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
2563687|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563688|NCT01560689|Budesonide|budesonide|mesh-list
2563689|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
2563690|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2563691|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2563692|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
2563693|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563694|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563695|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2563696|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
2563697|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
2563698|NCT01560689|Hormones|hormones|mesh-ancestor
2563699|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2563700|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2563701|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2563702|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2563703|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
2563704|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123512|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
2563705|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563706|NCT01560702|Epinephrine|epinephrine|mesh-list
2563707|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2563708|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2563709|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
2563710|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563711|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563712|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563713|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2563714|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2563715|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
2563716|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563717|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2563718|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
2563719|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
2563720|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
2563721|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2563722|NCT01560754|Nicotine|nicotine|mesh-list
2563723|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2563724|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
2563725|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563726|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563727|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2563728|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2563729|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
2563730|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563731|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563732|NCT01560962|Azithromycin|azithromycin|mesh-list
2563733|NCT01560962|Tobramycin|tobramycin|mesh-list
2563734|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
2563735|NCT01560962|Povidone|povidone|mesh-list
2563736|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2563737|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2563738|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
2563739|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
2563740|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2563741|NCT01561014|Fluorouracil|fluorouracil|mesh-list
2563742|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
2563743|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2563744|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2563745|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
2563746|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563747|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2563748|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563749|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2563750|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
2563751|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563752|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2563753|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563754|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2563755|NCT01561040|Vitamin D|vitamin d|mesh-list
2563756|NCT01561040|Vitamin A|vitamin a|mesh-list
2563757|NCT01561040|Vitamins|vitamins|mesh-ancestor
2563758|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
2563759|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563760|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2563761|NCT01561066|Octreotide|octreotide|mesh-list
2563762|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2563763|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2563764|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2563765|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563766|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
2563767|NCT01561066|Coagulants|coagulants|mesh-ancestor
2563768|NCT01561092|Citalopram|citalopram|mesh-list
2563769|NCT01561092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2563770|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2563771|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2563772|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563773|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563774|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
2563775|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563776|NCT01561092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2563777|NCT01561092|Antidepressive Agents|antidepressive agents|mesh-ancestor
2563778|NCT01561092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2563779|NCT01561131|Calcium|calcium|mesh-list
2563780|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2563781|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563782|NCT01561209|Amitriptyline|amitriptyline|mesh-list
2563783|NCT01561209|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2563784|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2563785|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
2563786|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2563787|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2563788|NCT01561209|Analgesics|analgesics|mesh-ancestor
2563789|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
2563790|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563791|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563792|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2563793|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2563794|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2563795|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563796|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
2563797|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563798|NCT01561209|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2563799|NCT01561209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2563800|NCT01561209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563801|NCT01561222|Calcitriol|calcitriol|mesh-list
2563802|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2563803|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563804|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2563805|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2563806|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563807|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2563808|NCT01561222|Vitamins|vitamins|mesh-ancestor
2563809|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
2563810|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2563811|NCT01561235|Hormones|hormones|mesh-list
2563812|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2563813|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563814|NCT01561274|Bupivacaine|bupivacaine|mesh-list
2563815|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
2563816|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
2563817|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563818|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563819|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
2563820|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563821|NCT01561391|Factor VIII|factor viii|mesh-list
2563822|NCT01561391|Coagulants|coagulants|mesh-ancestor
2563823|NCT01561404|Everolimus|everolimus|mesh-list
2563824|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563825|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2563826|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
2563827|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563828|NCT01561456|Docetaxel|docetaxel|mesh-list
2563829|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563830|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
2563831|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
2563832|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
2563833|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563834|NCT01561482|Metformin|metformin|mesh-list
2563835|NCT01561482|Simvastatin|simvastatin|mesh-list
2563836|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2563837|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563838|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2563839|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2563840|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
2563841|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563842|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2563843|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2563844|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563845|NCT01561508|Butyric Acid|butyric acid|mesh-list
2563846|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
2563847|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
2563848|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563849|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563850|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563851|NCT01561586|Cisplatin|cisplatin|mesh-list
2563852|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563853|NCT01561742|Minocycline|minocycline|mesh-list
2563854|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2563855|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123513|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123514|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123515|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
2123516|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
2123517|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2563856|NCT01561768|Vaccines|vaccines|mesh-list
2563857|NCT01561768|Immunologic Factors|immunologic factors|mesh-ancestor
2563858|NCT01561768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563859|NCT01561781|Digoxin|digoxin|mesh-list
2563860|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2563861|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2563862|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563863|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563864|NCT01561781|Protective Agents|protective agents|mesh-ancestor
2563865|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563866|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
2563867|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2563868|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2563869|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2563870|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2563871|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563872|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563873|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563874|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2563875|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2563876|NCT01561911|Antibodies|antibodies|mesh-list
2563877|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2563878|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
2563879|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563880|NCT01561937|Warfarin|warfarin|mesh-list
2563881|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
2563882|NCT01561950|Clopidogrel|clopidogrel|mesh-list
2563883|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2563884|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2563885|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2563886|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2563887|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
2563888|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563889|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563890|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563891|NCT01562197|Axitinib|axitinib|mesh-list
2563892|NCT01562197|Lomustine|lomustine|mesh-list
2563893|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563894|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2563895|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563896|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563897|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2563898|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
2563899|NCT01562210|Olaparib|olaparib|mesh-list
2563900|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563901|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2563902|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563903|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563904|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
2563905|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563906|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2563907|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
2563908|NCT01562301|Carboplatin|carboplatin|mesh-list
2563909|NCT01562301|Docetaxel|docetaxel|mesh-list
2563910|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563911|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
2563912|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
2563913|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
2563914|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563915|NCT01562405|Dexamethasone|dexamethasone|mesh-list
2563916|NCT01562405|Lenalidomide|lenalidomide|mesh-list
2563917|NCT01562405|Pomalidomide|pomalidomide|mesh-list
2563918|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2563919|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
2563920|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
2563921|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563922|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123518|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2563923|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2563924|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
2563925|NCT01562405|Hormones|hormones|mesh-ancestor
2563926|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2563927|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2563928|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2563929|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
2563930|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2563931|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2563932|NCT01562405|Growth Substances|growth substances|mesh-ancestor
2563933|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
2563934|NCT01562483|Dronabinol|dronabinol|mesh-list
2563935|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
2563936|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563937|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2563938|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2563939|NCT01562483|Analgesics|analgesics|mesh-ancestor
2563940|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
2563941|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563942|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2563943|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2563944|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2563945|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563946|NCT01562483|Hormones|hormones|mesh-ancestor
2563947|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2563948|NCT01562561|Repaglinide|repaglinide|mesh-list
2563949|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
2563950|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
2563951|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
2563952|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2563953|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563954|NCT01562626|Flucytosine|flucytosine|mesh-list
2563955|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
2563956|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2563957|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
2563958|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563959|NCT01562691|Petrolatum|petrolatum|mesh-list
2563960|NCT01562691|Emollients|emollients|mesh-ancestor
2563961|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
2563962|NCT01562704|Acetaminophen|acetaminophen|mesh-list
2563963|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2563964|NCT01562704|Analgesics|analgesics|mesh-ancestor
2563965|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
2563966|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563967|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563968|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
2563969|NCT01562717|Ibuprofen|ibuprofen|mesh-list
2563970|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2563971|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2563972|NCT01562717|Analgesics|analgesics|mesh-ancestor
2563973|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
2563974|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2563975|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563976|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2563977|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2563978|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2563979|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2563980|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2563981|NCT01562795|Fluorometholone|fluorometholone|mesh-list
2563982|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2563983|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
2563984|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2563985|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2563986|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
2563987|NCT01562795|Hormones|hormones|mesh-ancestor
2563988|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2563989|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563990|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2563991|NCT01562808|Aripiprazole|aripiprazole|mesh-list
2563992|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
2563993|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2563994|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2563995|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2563996|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2563997|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2563998|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
2563999|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
2123519|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2123520|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123521|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123522|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2123523|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2123524|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
2123525|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123526|NCT02797808|Sertraline|sertraline|mesh-list
2123527|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
2564000|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564001|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564002|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2564003|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2564004|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
2564005|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2564006|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2564007|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2564008|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2564009|NCT01562951|Adalimumab|adalimumab|mesh-list
2564010|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2564011|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2564012|NCT01562977|Gemcitabine|gemcitabine|mesh-list
2564013|NCT01562977|Rituximab|rituximab|mesh-list
2564014|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
2564015|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2564016|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564017|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
2564018|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564019|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2564020|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2564021|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
2564022|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564023|NCT01562977|Antiviral Agents|antiviral agents|mesh-ancestor
2564024|NCT01562977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564025|NCT01562977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564026|NCT01562977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564027|NCT01562990|Gemcitabine|gemcitabine|mesh-list
2564028|NCT01562990|Rituximab|rituximab|mesh-list
2564029|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2564030|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
2564031|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2564032|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564033|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
2564034|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564035|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2564036|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2564037|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
2564038|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564039|NCT01562990|Antiviral Agents|antiviral agents|mesh-ancestor
2564040|NCT01562990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564041|NCT01562990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564042|NCT01562990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564043|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2564044|NCT01563068|Calcipotriene|calcipotriene|mesh-list
2564045|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
2564046|NCT01563120|Metformin|metformin|mesh-list
2564047|NCT01563120|Glyburide|glyburide|mesh-list
2564048|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2564049|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564050|NCT01563224|Baclofen|baclofen|mesh-list
2564051|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2564052|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564053|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2564054|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564055|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2564056|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
2564057|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
2564058|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564059|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564060|NCT01563289|Ibuprofen|ibuprofen|mesh-list
2564061|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2564062|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2564063|NCT01563289|Analgesics|analgesics|mesh-ancestor
2564064|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
2564065|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564066|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123528|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2123529|NCT02797808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2123530|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2123531|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2123532|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123533|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123534|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
2123535|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123536|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2123537|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
2123538|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123539|NCT02798835|Dexamethasone|dexamethasone|mesh-list
2123540|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
2123541|NCT02798835|Fentanyl|fentanyl|mesh-list
2123542|NCT02798835|Bupivacaine|bupivacaine|mesh-list
2123543|NCT02798835|Ropivacaine|ropivacaine|mesh-list
2123544|NCT02798835|BB 1101|bb 1101|mesh-list
2123545|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2123546|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
2123547|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
2123548|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123549|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123550|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2564067|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2564068|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2564069|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2564070|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564071|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564072|NCT01563328|Dolutegravir|dolutegravir|mesh-list
2564073|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2564074|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2564075|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564076|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564077|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2564078|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2564079|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
2564080|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564081|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2564082|NCT01563367|Hematinics|hematinics|mesh-ancestor
2564083|NCT01563601|Carboplatin|carboplatin|mesh-list
2564084|NCT01563601|Etoposide|etoposide|mesh-list
2564085|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
2564086|NCT01563601|Obatoclax|obatoclax|mesh-list
2564087|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564088|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2564089|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2564090|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2564091|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564092|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564093|NCT01563614|Cytarabine|cytarabine|mesh-list
2564094|NCT01563614|Lomustine|lomustine|mesh-list
2564095|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2564096|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
2564097|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564098|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564099|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
2564100|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564101|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564102|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
2564103|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564104|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2564105|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
2564106|NCT01563640|Permethrin|permethrin|mesh-list
2564107|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564108|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564109|NCT01563718|Naltrexone|naltrexone|mesh-list
2564110|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2564111|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2564112|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564113|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
2564114|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564115|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
2564116|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
2564117|NCT01563731|Atorvastatin|atorvastatin|mesh-list
2564118|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2123551|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
2123552|NCT02798835|Hormones|hormones|mesh-ancestor
2123553|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123554|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2123555|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123556|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
2123557|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123558|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123559|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
2123560|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
2123561|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2123562|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
2123563|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2123564|NCT02798835|Narcotics|narcotics|mesh-ancestor
2123565|NCT02798835|Analgesics|analgesics|mesh-ancestor
2123566|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2123567|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2123568|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
2123569|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2123570|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2564119|NCT01563731|Simvastatin|simvastatin|mesh-list
2564120|NCT01563731|Pravastatin|pravastatin|mesh-list
2564121|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2564122|NCT01563731|Diuretics|diuretics|mesh-list
2564123|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2564124|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2564125|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
2564126|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
2564127|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2564128|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564129|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2564130|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2564131|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
2564132|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564133|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2564134|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2564135|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
2564136|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
2564137|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2564138|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
2564139|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2564140|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2564141|NCT01563835|Fentanyl|fentanyl|mesh-list
2564142|NCT01563835|Bupivacaine|bupivacaine|mesh-list
2564143|NCT01563835|Citric Acid|citric acid|mesh-list
2564144|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
2564145|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
2564146|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
2564147|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564148|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564149|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
2564150|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564151|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2564152|NCT01563835|Narcotics|narcotics|mesh-ancestor
2564153|NCT01563835|Analgesics|analgesics|mesh-ancestor
2564154|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2564155|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2564156|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
2564157|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
2564158|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2564159|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
2564160|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
2564161|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564162|NCT01563939|Remifentanil|remifentanil|mesh-list
2564163|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2564164|NCT01563939|Narcotics|narcotics|mesh-ancestor
2564165|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564166|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123571|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
2123572|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2123573|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2123574|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
2123575|NCT02799381|Levodopa|levodopa|mesh-list
2123576|NCT02799381|Carbidopa|carbidopa|mesh-list
2123577|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2123578|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
2564167|NCT01563939|Analgesics|analgesics|mesh-ancestor
2123579|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2123580|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
2123581|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123582|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564168|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
2564169|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564170|NCT01563952|Sirolimus|sirolimus|mesh-list
2564171|NCT01563952|Umirolimus|umirolimus|mesh-list
2564172|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2564173|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564174|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2564175|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564176|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
2564177|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2123583|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123584|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2123585|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123586|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2123587|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
2123588|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
2123589|NCT02799784|Albuterol|albuterol|mesh-list
2123590|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2564178|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
2564179|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564180|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2564181|NCT01564095|Tryptophan|tryptophan|mesh-list
2564182|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2564183|NCT01564095|Tacrolimus|tacrolimus|mesh-list
2564184|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564185|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
2564186|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564187|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2564188|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564189|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564190|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2564191|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
2564192|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2564193|NCT01564108|Ranibizumab|ranibizumab|mesh-list
2564194|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2564195|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2564196|NCT01564108|Growth Substances|growth substances|mesh-ancestor
2564197|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564198|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
2564199|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564200|NCT01564199|Fluticasone|fluticasone|mesh-list
2564201|NCT01564199|Xhance|xhance|mesh-list
2564202|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2564203|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2564204|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2564205|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
2564206|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564207|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564208|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2564209|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
2564210|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
2564211|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2564212|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2564213|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2564214|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2564215|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
2564216|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564217|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564218|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
2564219|NCT01564238|Calcium|calcium|mesh-list
2564220|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2564221|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564222|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2564223|NCT01564251|Gemcitabine|gemcitabine|mesh-list
2564224|NCT01564251|GDC-0575|gdc-0575|mesh-list
2564225|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2564226|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
2564227|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564228|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123591|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
2564229|NCT01564251|Antiviral Agents|antiviral agents|mesh-ancestor
2564230|NCT01564251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564231|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564232|NCT01564251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564233|NCT01564251|Immunologic Factors|immunologic factors|mesh-ancestor
2564234|NCT01564251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564235|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2564236|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
2564237|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2564238|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
2564239|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
2564240|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564241|NCT01564303|Expectorants|expectorants|mesh-ancestor
2564242|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
2564243|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2564244|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
2564245|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564246|NCT01564303|Protective Agents|protective agents|mesh-ancestor
2564247|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564248|NCT01564303|Antidotes|antidotes|mesh-ancestor
2564249|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2564250|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564251|NCT01564329|Endostar protein|endostar protein|mesh-list
2564252|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2564253|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2564254|NCT01564329|Growth Substances|growth substances|mesh-ancestor
2564255|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564256|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
2564257|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564258|NCT01564355|Triamcinolone|triamcinolone|mesh-list
2564259|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2564260|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
2564261|NCT01564355|Hormones|hormones|mesh-ancestor
2564262|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2564263|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564264|NCT01564381|Resveratrol|resveratrol|mesh-list
2564265|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
2564266|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564267|NCT01564381|Protective Agents|protective agents|mesh-ancestor
2564268|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564269|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564270|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2564271|NCT01564550|Insulin|insulin|mesh-list
2564272|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2564273|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2564274|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564275|NCT01564576|Bromides|bromides|mesh-list
2564276|NCT01564576|Rocuronium|rocuronium|mesh-list
2564277|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
2564278|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2564279|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2564280|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2564281|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564282|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564283|NCT01564680|Acetaminophen|acetaminophen|mesh-list
2564284|NCT01564680|Lornoxicam|lornoxicam|mesh-list
2564285|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2564286|NCT01564680|Analgesics|analgesics|mesh-ancestor
2564287|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
2564288|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564289|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564290|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
2564291|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2564292|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2564293|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2564294|NCT01564810|Cetuximab|cetuximab|mesh-list
2564295|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2123592|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418809|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2564296|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564297|NCT01564823|Metronidazole|metronidazole|mesh-list
2564298|NCT01564823|Adalimumab|adalimumab|mesh-list
2418810|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
2418811|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418812|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2418813|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2418814|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418815|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
2564299|NCT01564823|Azathioprine|azathioprine|mesh-list
2564300|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2564301|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2564302|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564303|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2564304|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2564305|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2564306|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
2564307|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564308|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2564309|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564310|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564311|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
2564312|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564313|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
2564314|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564315|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2564316|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564317|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564318|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
2564319|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2564320|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2564321|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2564322|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2564323|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564324|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
2564325|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564326|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564327|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2564328|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564329|NCT01565018|Rotigotine|rotigotine|mesh-list
2564330|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
2564331|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
2564332|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564333|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564334|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564335|NCT01565096|Metformin|metformin|mesh-list
2564336|NCT01565096|Glimepiride|glimepiride|mesh-list
2564337|NCT01565096|Vildagliptin|vildagliptin|mesh-list
2564338|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2564339|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564340|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2418816|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2418817|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2418818|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418819|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2418820|NCT00800826|Analgesics|analgesics|mesh-ancestor
2418821|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
2418822|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418823|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2418824|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2418825|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2418826|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
2418827|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418828|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418829|NCT00800917|Sirolimus|sirolimus|mesh-list
2418830|NCT00800917|Bevacizumab|bevacizumab|mesh-list
2418831|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2418832|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564341|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564342|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
2564343|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2564344|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
2564345|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564346|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564347|NCT01565109|Docetaxel|docetaxel|mesh-list
2564348|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564349|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
2564350|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
2564351|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
2564352|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564353|NCT01565200|Trastuzumab|trastuzumab|mesh-list
2564354|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2564355|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2564356|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564357|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
2564358|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
2564359|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
2564360|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564361|NCT01565239|Thrombin|thrombin|mesh-list
2564362|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
2564363|NCT01565239|Coagulants|coagulants|mesh-ancestor
2564364|NCT01565265|Cetrorelix|cetrorelix|mesh-list
2564365|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2564366|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2564367|NCT01565265|Hormones|hormones|mesh-ancestor
2564368|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2564369|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564370|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2564371|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
2564372|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2564373|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
2564374|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2564375|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2564376|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2564377|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2564378|NCT01565512|Bupivacaine|bupivacaine|mesh-list
2564379|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
2564380|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
2564381|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564382|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564383|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
2564384|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564385|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
2564386|NCT01565590|Propofol|propofol|mesh-list
2564387|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2564388|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564389|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564390|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2564391|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
2564392|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
2564393|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2564394|NCT01565590|Analgesics|analgesics|mesh-ancestor
2564395|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
2564396|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564397|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2564398|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2564399|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2564400|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
2564401|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564402|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564403|NCT01565655|Peficitinib|peficitinib|mesh-list
2564404|NCT01565655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564405|NCT01565655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564406|NCT01565655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564407|NCT01565655|Immunologic Factors|immunologic factors|mesh-ancestor
2564408|NCT01565655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564409|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
2564410|NCT01565720|Isavuconazole|isavuconazole|mesh-list
2564411|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2564412|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564413|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2123593|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123594|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2123595|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
2564414|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2564415|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564416|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564417|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564418|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
2564419|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
2564420|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
2564421|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2564422|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2564423|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564424|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2564425|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564426|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
2564427|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
2564428|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2564429|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564430|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564431|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
2564432|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2564433|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564434|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564435|NCT01565772|Etoposide|etoposide|mesh-list
2564436|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564437|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2564438|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2564439|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2564440|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564441|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564442|NCT01565798|Copper|copper|mesh-list
2564443|NCT01565798|Trace Elements|trace elements|mesh-ancestor
2564444|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
2564445|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564446|NCT01565837|Ipilimumab|ipilimumab|mesh-list
2564447|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2564448|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564449|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2564450|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564451|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
2564452|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
2564453|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2564454|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564455|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2564456|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
2564457|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2564458|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564459|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564460|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564461|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2564462|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2564463|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2564464|NCT01566240|Paclitaxel|paclitaxel|mesh-list
2564465|NCT01566240|Carboplatin|carboplatin|mesh-list
2564466|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2564467|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564468|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
2564469|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
2564470|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
2564471|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564472|NCT01566253|Acetaminophen|acetaminophen|mesh-list
2564473|NCT01566253|Ketoprofen|ketoprofen|mesh-list
2564474|NCT01566253|Morphine|morphine|mesh-list
2564475|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2564476|NCT01566253|Narcotics|narcotics|mesh-ancestor
2564477|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564478|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564479|NCT01566253|Analgesics|analgesics|mesh-ancestor
2564480|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
2564481|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564482|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2564483|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
2564484|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2564485|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2564486|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2564487|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2564488|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564489|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564490|NCT01566266|Amoxicillin|amoxicillin|mesh-list
2564491|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2564492|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564493|NCT01566279|Everolimus|everolimus|mesh-list
2564494|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564495|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564496|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
2564497|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564498|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
2564499|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2564500|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2564501|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2564502|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2564503|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564504|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
2564505|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564506|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564507|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2564508|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564509|NCT01566422|Vancomycin|vancomycin|mesh-list
2564510|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2564511|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564512|NCT01566474|Melatonin|melatonin|mesh-list
2123596|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
2123597|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2123598|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2123599|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2564513|NCT01566474|Omeprazole|omeprazole|mesh-list
2564514|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
2564515|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564516|NCT01566474|Protective Agents|protective agents|mesh-ancestor
2564517|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564518|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564519|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2564520|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2564521|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2564522|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564523|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2564524|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
2564525|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2564526|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2564527|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2564528|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564529|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564530|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2564531|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
2564532|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564533|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2564534|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2564535|NCT01566565|Theophylline|theophylline|mesh-list
2564536|NCT01566565|Bambuterol|bambuterol|mesh-list
2564537|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2564538|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
2564539|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564540|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564541|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2564542|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
2564543|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2564544|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564545|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564546|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
2564547|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2564548|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2564549|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
2564550|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564551|NCT01566578|Mitogens|mitogens|mesh-list
2564552|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
2564553|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564554|NCT01566643|Metronidazole|metronidazole|mesh-list
2564555|NCT01566643|Rabeprazole|rabeprazole|mesh-list
2564556|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564557|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2564558|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2564559|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2564560|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2564561|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2564562|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2564563|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564564|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564565|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2564566|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
2564567|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564568|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564569|NCT01566669|Parecoxib|parecoxib|mesh-list
2564570|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2564571|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2564572|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564573|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564574|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2564575|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2564576|NCT01566669|Analgesics|analgesics|mesh-ancestor
2564577|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
2564578|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564579|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564580|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2564581|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2564582|NCT01566734|Cefazolin|cefazolin|mesh-list
2564583|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2564584|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564585|NCT01566760|Fesoterodine|fesoterodine|mesh-list
2564586|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2564587|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2564588|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
2564589|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564590|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564591|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564592|NCT01566760|Urological Agents|urological agents|mesh-ancestor
2564593|NCT01566799|Metformin|metformin|mesh-list
2564594|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2564595|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564596|NCT01566825|Amitriptyline|amitriptyline|mesh-list
2564597|NCT01566825|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2564598|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2564599|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
2564600|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2564601|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2564602|NCT01566825|Analgesics|analgesics|mesh-ancestor
2564603|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
2564604|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564605|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564606|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2564607|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2564608|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2564609|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564610|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
2564611|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564612|NCT01566825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2564613|NCT01566825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2564614|NCT01566825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564615|NCT01566890|Regadenoson|regadenoson|mesh-list
2564616|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2564617|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2564618|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
2564619|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
2564620|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564621|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564622|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564623|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
2564624|NCT01566942|Irinotecan|irinotecan|mesh-list
2564625|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564626|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2564627|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2564628|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123600|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2123601|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
2123602|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123603|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123604|NCT02800148|Azelaic acid|azelaic acid|mesh-list
2123605|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123606|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
2123607|NCT02800642|Aflibercept|aflibercept|mesh-list
2123608|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2123609|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2123610|NCT02800642|Growth Substances|growth substances|mesh-ancestor
2123611|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123612|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
2123613|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123614|NCT02800928|Aticaprant|aticaprant|mesh-list
2123615|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2564629|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564630|NCT01567059|Cytarabine|cytarabine|mesh-list
2564631|NCT01567059|Decitabine|decitabine|mesh-list
2564632|NCT01567059|Azacitidine|azacitidine|mesh-list
2564633|NCT01567059|Tosedostat|tosedostat|mesh-list
2564634|NCT01567059|Glycine|glycine|mesh-list
2564635|NCT01567059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2564636|NCT01567059|Antimetabolites|antimetabolites|mesh-ancestor
2564637|NCT01567059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564638|NCT01567059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564639|NCT01567059|Antiviral Agents|antiviral agents|mesh-ancestor
2564640|NCT01567059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564641|NCT01567059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564642|NCT01567059|Immunologic Factors|immunologic factors|mesh-ancestor
2564643|NCT01567059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564644|NCT01567059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564645|NCT01567059|Glycine Agents|glycine agents|mesh-ancestor
2564646|NCT01567059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123616|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123617|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
2123618|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123619|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
2123620|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2123621|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564647|NCT01567072|Ibuprofen|ibuprofen|mesh-list
2564648|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2564649|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2564650|NCT01567072|Analgesics|analgesics|mesh-ancestor
2564651|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
2564652|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564653|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564654|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2564655|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2564656|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2564657|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123622|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2123623|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2564658|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564659|NCT01567111|Metomidate|metomidate|mesh-list
2564660|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2564661|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564662|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564663|NCT01567124|Moxonidine|moxonidine|mesh-list
2564664|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2564665|NCT01567202|Vaccines|vaccines|mesh-list
2564666|NCT01567202|Immunologic Factors|immunologic factors|mesh-ancestor
2564667|NCT01567202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564668|NCT01567215|Ethanol|ethanol|mesh-list
2564669|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
2564670|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2564671|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564672|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564673|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564674|NCT01567358|Infliximab|infliximab|mesh-list
2564675|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
2564676|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2123624|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123625|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123626|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123627|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2123628|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2123629|NCT02801617|Latanoprost|latanoprost|mesh-list
2123630|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2123631|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2123632|NCT02801669|Edoxaban|edoxaban|mesh-list
2123633|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2123634|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
2564677|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2564678|NCT01567384|Pemetrexed|pemetrexed|mesh-list
2564679|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564680|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564681|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564682|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2564683|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2564684|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2564685|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
2564686|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2564687|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2564688|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564689|NCT01567475|Rituximab|rituximab|mesh-list
2564690|NCT01567475|Everolimus|everolimus|mesh-list
2564691|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2564692|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564693|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
2564694|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564695|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2564696|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564697|NCT01567488|Everolimus|everolimus|mesh-list
2564698|NCT01567488|Octreotide|octreotide|mesh-list
2564699|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564700|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564701|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
2564702|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564703|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2564704|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2564705|NCT01567501|Cetirizine|cetirizine|mesh-list
2564706|NCT01567501|Levocetirizine|levocetirizine|mesh-list
2564707|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2564708|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2564709|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
2564710|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
2564711|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564712|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564713|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564714|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2564715|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2564716|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2564717|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564718|NCT01567540|Incretins|incretins|mesh-ancestor
2564719|NCT01567540|Hormones|hormones|mesh-ancestor
2564720|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2564721|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2564722|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
2564723|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564724|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564725|NCT01567605|Lidocaine|lidocaine|mesh-list
2564726|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
2564727|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
2564728|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564729|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564730|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
2564731|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564732|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2564733|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2564734|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2564735|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2564736|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564737|NCT01567618|Docetaxel|docetaxel|mesh-list
2564738|NCT01567618|Fluorouracil|fluorouracil|mesh-list
2564739|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564740|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
2564741|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
2123635|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2123636|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
2123637|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123638|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123639|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
2123640|NCT02802111|Albuterol|albuterol|mesh-list
2123641|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2123642|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
2123643|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564742|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
2564743|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564744|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
2564745|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2564746|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564747|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
2564748|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564749|NCT01567657|Midazolam|midazolam|mesh-list
2564750|NCT01567657|Meperidine|meperidine|mesh-list
2564751|NCT01567657|Propofol|propofol|mesh-list
2564752|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2564753|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564754|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564755|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2564756|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
2564757|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
2564758|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2564759|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2564760|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2564761|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2564762|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
2564763|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
2564764|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564765|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564766|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2564767|NCT01567657|Narcotics|narcotics|mesh-ancestor
2564768|NCT01567657|Analgesics|analgesics|mesh-ancestor
2564769|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
2564770|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564771|NCT01567670|Naloxone|naloxone|mesh-list
2564772|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2564773|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564774|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
2564775|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564776|NCT01567683|Imiquimod|imiquimod|mesh-list
2564777|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2564778|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
2564779|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564780|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564781|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
2564782|NCT01567709|Vorinostat|vorinostat|mesh-list
2564783|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564784|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2564785|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564786|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564787|NCT01567735|Simeprevir|simeprevir|mesh-list
2564788|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
2564789|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564790|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
2564791|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564792|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564793|NCT01567774|Atorvastatin|atorvastatin|mesh-list
2564794|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2564795|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2564796|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2564797|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
2564798|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564799|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2564800|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2564801|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564802|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
2564803|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2564804|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564805|NCT01567904|Semuloparin|semuloparin|mesh-list
2564806|NCT01567904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2564807|NCT01567904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2564808|NCT01567904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564809|NCT01567930|Sirolimus|sirolimus|mesh-list
2564810|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2564811|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564812|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2564813|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564814|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
2564815|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2564816|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
2564817|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564818|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
2564819|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2564820|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
2564821|NCT01567995|Hormones|hormones|mesh-ancestor
2564822|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2564823|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564824|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2564825|NCT01568125|Incretins|incretins|mesh-list
2564826|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564827|NCT01568125|Hormones|hormones|mesh-ancestor
2564828|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2564829|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
2564830|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2564831|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564832|NCT01568268|Palonosetron|palonosetron|mesh-list
2564833|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
2564834|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
2564835|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564836|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564837|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2564838|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2564839|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2564840|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
2564841|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564842|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564843|NCT01568281|Anastrozole|anastrozole|mesh-list
2564844|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2564845|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123644|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123645|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2123646|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
2123647|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
2123648|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2123649|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2123650|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2123651|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2123652|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
2123653|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123654|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123655|NCT02802241|Peppermint oil|peppermint oil|mesh-list
2123656|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
2564846|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2564847|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2564848|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564849|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564850|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2564851|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
2564852|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2564853|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564854|NCT01568294|Pomalidomide|pomalidomide|mesh-list
2564855|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
2564856|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564857|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2564858|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2564859|NCT01568294|Growth Substances|growth substances|mesh-ancestor
2564860|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
2564861|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564862|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
2564863|NCT01568307|Serotonin|serotonin|mesh-list
2564864|NCT01568307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2564865|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2564866|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2564867|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
2564868|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564869|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123657|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
2123658|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123659|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123660|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2123661|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
2123662|NCT02802345|Nintedanib|nintedanib|mesh-list
2123663|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
2123664|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
2123665|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2123666|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2123667|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564870|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564871|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2564872|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2564873|NCT01568333|Decitabine|decitabine|mesh-list
2564874|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2564875|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
2564876|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564877|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123668|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123669|NCT02802345|Urological Agents|urological agents|mesh-ancestor
2123670|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123671|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2123672|NCT02802449|Vitamin D|vitamin d|mesh-list
2123673|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
2123674|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
2123675|NCT02802449|Calcifediol|calcifediol|mesh-list
2123676|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2564878|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564879|NCT01568411|Itraconazole|itraconazole|mesh-list
2564880|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
2564881|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564882|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2564883|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2564884|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564885|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564886|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2564887|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
2564888|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2564889|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564890|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2564891|NCT01568450|Oxycodone|oxycodone|mesh-list
2564892|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2564893|NCT01568450|Narcotics|narcotics|mesh-ancestor
2564894|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564895|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564896|NCT01568450|Analgesics|analgesics|mesh-ancestor
2564897|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
2564898|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564899|NCT01568632|Imetelstat|imetelstat|mesh-list
2564900|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
2564901|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564902|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564903|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2564904|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
2564905|NCT01568645|Carvedilol|carvedilol|mesh-list
2564906|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564907|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2564908|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2564909|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564910|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2564911|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2564912|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
2564913|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564914|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564915|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2564916|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
2564917|NCT01568645|Protective Agents|protective agents|mesh-ancestor
2564918|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2564919|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2564920|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2564921|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
2564922|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2564923|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2564924|NCT01568684|Citalopram|citalopram|mesh-list
2123677|NCT02802449|Vitamins|vitamins|mesh-list
2123678|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
2123679|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564925|NCT01568684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2564926|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2564927|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2123680|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2123681|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2123682|NCT02802501|Piperaquine|piperaquine|mesh-list
2123683|NCT02802501|Primaquine|primaquine|mesh-list
2123684|NCT02802501|Artenimol|artenimol|mesh-list
2123685|NCT02802501|Tafenoquine|tafenoquine|mesh-list
2123686|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
2123687|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2123688|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2123689|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2564928|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123690|NCT02802514|Exenatide|exenatide|mesh-list
2123691|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
2564929|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564930|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
2564931|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564932|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2564933|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
2564934|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2564935|NCT01568749|Acetaminophen|acetaminophen|mesh-list
2564936|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2564937|NCT01568749|Analgesics|analgesics|mesh-ancestor
2564938|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
2564939|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564940|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564941|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
2564942|NCT01568788|Vaccines|vaccines|mesh-list
2564943|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
2564944|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564945|NCT01568853|Norepinephrine|norepinephrine|mesh-list
2564946|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2564947|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2564948|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
2564949|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564950|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564951|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564952|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
2564953|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
2564954|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564955|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2564956|NCT01568918|Tamsulosin|tamsulosin|mesh-list
2564957|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2564958|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2564959|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2564960|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
2564961|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564962|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564963|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564964|NCT01568918|Urological Agents|urological agents|mesh-ancestor
2564965|NCT01568931|Coal Tar|coal tar|mesh-list
2564966|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
2564967|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
2564968|NCT01568996|Sulforaphane|sulforaphane|mesh-list
2564969|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2564970|NCT01568996|Protective Agents|protective agents|mesh-ancestor
2564971|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564972|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2564973|NCT01569035|Warfarin|warfarin|mesh-list
2564974|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
2564975|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
2564976|NCT01569048|Remifentanil|remifentanil|mesh-list
2564977|NCT01569048|Propofol|propofol|mesh-list
2564978|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2564979|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2564980|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2564981|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2564982|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
2564983|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
2564984|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2564985|NCT01569048|Analgesics|analgesics|mesh-ancestor
2564986|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
2564987|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2564988|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2564989|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2564990|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2564991|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
2564992|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2564993|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2564994|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2564995|NCT01569048|Narcotics|narcotics|mesh-ancestor
2564996|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
2564997|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2564998|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
2564999|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2565000|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2565001|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2565002|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
2565003|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2565004|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565005|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2565006|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2565007|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2565008|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2565009|NCT01569113|Estrogens|estrogens|mesh-ancestor
2565010|NCT01569113|Hormones|hormones|mesh-ancestor
2565011|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565012|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2565013|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2565014|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2565015|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2565016|NCT01569165|Fluorides|fluorides|mesh-list
2565017|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
2565018|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
2565019|NCT01569165|Protective Agents|protective agents|mesh-ancestor
2565020|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565021|NCT01569204|Dexamethasone|dexamethasone|mesh-list
2565022|NCT01569204|Prednisone|prednisone|mesh-list
2565023|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
2565024|NCT01569204|Dacarbazine|dacarbazine|mesh-list
2565025|NCT01569204|Doxorubicin|doxorubicin|mesh-list
2565026|NCT01569204|Etoposide|etoposide|mesh-list
2565027|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2565028|NCT01569204|Procarbazine|procarbazine|mesh-list
2565029|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2565030|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
2565031|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565032|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2565033|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2565034|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
2565035|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565036|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565037|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2565038|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2565039|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
2565040|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
2565041|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2565042|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2565043|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
2565044|NCT01569204|Hormones|hormones|mesh-ancestor
2565045|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565046|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2565047|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2565048|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2565049|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2565050|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565051|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2565052|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2565053|NCT01569256|Cabergoline|cabergoline|mesh-list
2565054|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2565055|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2565056|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
2565057|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
2565058|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2565059|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565060|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565061|NCT01569633|Erythromycin|erythromycin|mesh-list
2565062|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
2565063|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2565064|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
2565065|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2565066|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565067|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2565068|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2565069|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123692|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2123693|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2123694|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123695|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2123696|NCT02802514|Incretins|incretins|mesh-ancestor
2123697|NCT02802514|Hormones|hormones|mesh-ancestor
2123698|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565070|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565071|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2565072|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2565073|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2565074|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2565075|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565076|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2565077|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2565078|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2565079|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2565080|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
2565081|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2565082|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565083|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2565084|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2565085|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
2565086|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2565087|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2565088|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
2565089|NCT01569685|Sertraline|sertraline|mesh-list
2565090|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2565091|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
2565092|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2565093|NCT01569685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2565094|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2565095|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2565096|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565097|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2565098|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
2565099|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565100|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2565101|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2565102|NCT01569919|Folic Acid|folic acid|mesh-list
2565103|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
2565104|NCT01569919|Hydroxocobalamin|hydroxocobalamin|mesh-list
2565105|NCT01569919|Dexamethasone|dexamethasone|mesh-list
2565106|NCT01569919|Pemetrexed|pemetrexed|mesh-list
2565107|NCT01569919|Vitamins|vitamins|mesh-ancestor
2565108|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
2565109|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565110|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565111|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2565112|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
2565113|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
2565114|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2565115|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2565116|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
2565117|NCT01569919|Hormones|hormones|mesh-ancestor
2565118|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565119|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2565120|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565121|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565122|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2565123|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2565124|NCT01569919|Hematinics|hematinics|mesh-ancestor
2565125|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
2565126|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2565127|NCT01569945|Clomiphene|clomiphene|mesh-list
2565128|NCT01569945|Menotropins|menotropins|mesh-list
2565129|NCT01569945|Estradiol|estradiol|mesh-list
2565130|NCT01569945|Estrogens|estrogens|mesh-ancestor
2565131|NCT01569945|Hormones|hormones|mesh-ancestor
2565132|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565133|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565134|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2565135|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
2565136|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2565137|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2565138|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2565139|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2565140|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2565141|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
2565142|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2565143|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
2565144|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2565145|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2565146|NCT01569984|Bevacizumab|bevacizumab|mesh-list
2565147|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2565148|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565149|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2565150|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2565151|NCT01569984|Growth Substances|growth substances|mesh-ancestor
2565152|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565153|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
2123699|NCT02802735|Apremilast|apremilast|mesh-list
2123700|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2123701|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2123702|NCT02802735|Analgesics|analgesics|mesh-ancestor
2123703|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
2123704|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123705|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123706|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2123707|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2123708|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2123709|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2123710|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123711|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123712|NCT02802865|Letrozole|letrozole|mesh-list
2565154|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2565155|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2565156|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
2565157|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565158|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565159|NCT01570088|Folic Acid|folic acid|mesh-list
2565160|NCT01570088|Hematinics|hematinics|mesh-ancestor
2565161|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
2565162|NCT01570088|Vitamins|vitamins|mesh-ancestor
2565163|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
2565164|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565165|NCT01570296|Gefitinib|gefitinib|mesh-list
2565166|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565167|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2565168|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565169|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565170|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2565171|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2565172|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
2565173|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2565174|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565175|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2565176|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
2565177|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
2565178|NCT01570478|Hormones|hormones|mesh-ancestor
2565179|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565180|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
2565181|NCT01570504|Ivermectin|ivermectin|mesh-list
2565182|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2565183|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565184|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2565185|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565186|NCT01570569|Losartan|losartan|mesh-list
2565187|NCT01570569|Midazolam|midazolam|mesh-list
2565188|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
2565189|NCT01570569|Caffeine|caffeine|mesh-list
2565190|NCT01570569|Omeprazole|omeprazole|mesh-list
2565191|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2565192|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2565193|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2565194|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565195|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2565196|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2565197|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2565198|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2565199|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
2565200|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
2565201|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
2565202|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
2565203|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2565204|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565205|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2565206|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2565207|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2565208|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2565209|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2565210|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2565211|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2565212|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565213|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2565214|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2565215|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2565216|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2565217|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
2565218|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
2565219|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
2565220|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2565221|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2565222|NCT01570582|Gemcitabine|gemcitabine|mesh-list
2565223|NCT01570582|Paclitaxel|paclitaxel|mesh-list
2565224|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2565225|NCT01570582|Carboplatin|carboplatin|mesh-list
2565226|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2565227|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565228|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
2565229|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
2565230|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
2565231|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565232|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2565233|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
2565234|NCT01570582|Antiviral Agents|antiviral agents|mesh-ancestor
2565235|NCT01570582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565236|NCT01570582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565237|NCT01570582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2565238|NCT01570582|Immunologic Factors|immunologic factors|mesh-ancestor
2565239|NCT01570582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565240|NCT01570608|Ranibizumab|ranibizumab|mesh-list
2565241|NCT01570608|Verteporfin|verteporfin|mesh-list
2565242|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2565243|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2565244|NCT01570608|Growth Substances|growth substances|mesh-ancestor
2565245|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565246|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
2565247|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565248|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2565249|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
2565250|NCT01570660|Pioglitazone|pioglitazone|mesh-list
2565251|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2565252|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565253|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
2565254|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2565255|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
2565256|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565257|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2565258|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2565259|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
2565260|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565261|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565262|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2565263|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
2123713|NCT02802865|Clomiphene|clomiphene|mesh-list
2123714|NCT02802865|Enclomiphene|enclomiphene|mesh-list
2123715|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
2565264|NCT01570790|Combretastatin|combretastatin|mesh-list
2565265|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2565266|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565267|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
2565268|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
2565269|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
2565270|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565271|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2565272|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
2565273|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2565274|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2565275|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2565276|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2565277|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565278|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2565279|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
2565280|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2565281|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2565282|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2565283|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2565284|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565285|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2565286|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
2565287|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2565288|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2565289|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2565290|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2565291|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565292|NCT01570985|Triamcinolone|triamcinolone|mesh-list
2565293|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2565294|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2565295|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2565296|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2565297|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
2565298|NCT01570985|Hormones|hormones|mesh-ancestor
2565299|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565300|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565301|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2565302|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
2565303|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565304|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565305|NCT01571024|Leucovorin|leucovorin|mesh-list
2565306|NCT01571024|Fluorouracil|fluorouracil|mesh-list
2565307|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
2565308|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
2565309|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565310|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2565311|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565312|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2565313|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
2565314|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565315|NCT01571024|Antidotes|antidotes|mesh-ancestor
2565316|NCT01571024|Protective Agents|protective agents|mesh-ancestor
2565317|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
2565318|NCT01571024|Vitamins|vitamins|mesh-ancestor
2565319|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
2565320|NCT01571037|Milrinone|milrinone|mesh-list
2565321|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2565322|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2565323|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
2565324|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2565325|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2565326|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565327|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565328|NCT01571037|Protective Agents|protective agents|mesh-ancestor
2565329|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565330|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
2565331|NCT01571050|Antacids|antacids|mesh-ancestor
2565332|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565333|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2565334|NCT01571063|Vitamin D|vitamin d|mesh-list
2565335|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
2565336|NCT01571063|Vitamins|vitamins|mesh-ancestor
2565337|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
2123716|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123717|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565338|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565339|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2565340|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2565341|NCT01571128|Tenofovir|tenofovir|mesh-list
2565342|NCT01571128|Emtricitabine|emtricitabine|mesh-list
2565343|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
2565344|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565345|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2123718|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2123719|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2123720|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123721|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2565346|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2565347|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565348|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565349|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2565350|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2565351|NCT01571167|Varenicline|varenicline|mesh-list
2565352|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2565353|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2565354|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
2565355|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2565356|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565357|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565358|NCT01571206|Infliximab|infliximab|mesh-list
2565359|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
2565360|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2565361|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2565362|NCT01571219|Infliximab|infliximab|mesh-list
2565363|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
2565364|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2565365|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2565366|NCT01571323|Misoprostol|misoprostol|mesh-list
2565367|NCT01571323|Oxytocin|oxytocin|mesh-list
2565368|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
2565369|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2565370|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565371|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2565372|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
2565373|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2565374|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2565375|NCT01571414|Ritonavir|ritonavir|mesh-list
2565376|NCT01571414|Lopinavir|lopinavir|mesh-list
2565377|NCT01571414|Efavirenz|efavirenz|mesh-list
2565378|NCT01571414|Rifampin|rifampin|mesh-list
2565379|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2565380|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2565381|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
2565382|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565383|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565384|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2565385|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2565386|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
2565387|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565388|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2565389|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2565390|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2565391|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2565392|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2565393|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2123722|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
2123723|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123724|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123725|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2123726|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
2123727|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2123728|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2123729|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2123730|NCT02803138|Ritonavir|ritonavir|mesh-list
2123731|NCT02803138|Ribavirin|ribavirin|mesh-list
2123732|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2123733|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2123734|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
2123735|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123736|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123737|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2123738|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2123739|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
2123740|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123741|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2123742|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2123743|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
2123744|NCT02803229|Amphetamine|amphetamine|mesh-list
2123745|NCT02803229|Adderall|adderall|mesh-list
2565394|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2565395|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2565396|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2565397|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2565398|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
2565399|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2565400|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
2565401|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2565402|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2565403|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2565404|NCT01571466|Vaccines|vaccines|mesh-list
2565405|NCT01571466|Immunologic Factors|immunologic factors|mesh-ancestor
2565406|NCT01571466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565407|NCT01571505|Vaccines|vaccines|mesh-list
2565408|NCT01571505|Immunologic Factors|immunologic factors|mesh-ancestor
2565409|NCT01571505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565410|NCT01571570|Simeprevir|simeprevir|mesh-list
2565411|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
2565412|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565413|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
2565414|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565415|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565416|NCT01571583|Interferons|interferons|mesh-list
2565417|NCT01571583|Ribavirin|ribavirin|mesh-list
2565418|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
2565419|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
2565420|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2565421|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565422|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
2565423|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565424|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
2123746|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2123747|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123748|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
2123749|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
2123750|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123751|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
2123752|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418833|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2418834|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2418835|NCT00800917|Growth Substances|growth substances|mesh-ancestor
2418836|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418837|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
2418838|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2565425|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565426|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
2565427|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565428|NCT01571609|Insulin|insulin|mesh-list
2565429|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2565430|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565431|NCT01571648|Azacitidine|azacitidine|mesh-list
2565432|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2565433|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
2565434|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565435|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565436|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565437|NCT01571687|Antioxidants|antioxidants|mesh-list
2565438|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565439|NCT01571687|Protective Agents|protective agents|mesh-ancestor
2565440|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565441|NCT01571791|Ketorolac|ketorolac|mesh-list
2565442|NCT01571791|Lidocaine|lidocaine|mesh-list
2565443|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
2565444|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
2123753|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123754|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
2123755|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2123756|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2123757|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2123758|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2123759|NCT02803749|Buspirone|buspirone|mesh-list
2565445|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2418839|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418840|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2418841|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
2418842|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418843|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
2418844|NCT00800930|Butyric Acid|butyric acid|mesh-list
2418845|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
2418846|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
2418847|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2418848|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565446|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565447|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
2565448|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2565449|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2565450|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2565451|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2565452|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2565453|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565454|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2565455|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2565456|NCT01571791|Analgesics|analgesics|mesh-ancestor
2565457|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2565458|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2565459|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2565460|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418849|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418850|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
2418851|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2418852|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418853|NCT00801034|Calcium|calcium|mesh-list
2418854|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2418855|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418856|NCT00801047|Remifentanil|remifentanil|mesh-list
2418857|NCT00801047|Bupivacaine|bupivacaine|mesh-list
2565461|NCT01571804|Pregabalin|pregabalin|mesh-list
2565462|NCT01571804|Analgesics|analgesics|mesh-ancestor
2565463|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
2565464|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2565465|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565466|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
2565467|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2565468|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2565469|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565470|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2123760|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2123761|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2123762|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2123763|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565471|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2565472|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2565473|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2565474|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2565475|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
2565476|NCT01571856|Astringents|astringents|mesh-ancestor
2565477|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565478|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
2565479|NCT01571882|Policosanol|policosanol|mesh-list
2565480|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2565481|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2565482|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
2565483|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565484|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2565485|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2565486|NCT01571908|Rocuronium|rocuronium|mesh-list
2565487|NCT01571908|Succinylcholine|succinylcholine|mesh-list
2565488|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2565489|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2565490|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2565491|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2565492|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565493|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2565494|NCT01571921|Tocotrienols|tocotrienols|mesh-list
2565495|NCT01571921|Vitamin E|vitamin e|mesh-list
2565496|NCT01571921|Tocopherols|tocopherols|mesh-list
2565497|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
2565498|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565499|NCT01571921|Protective Agents|protective agents|mesh-ancestor
2565500|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565501|NCT01571921|Vitamins|vitamins|mesh-ancestor
2565502|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
2565503|NCT01571960|Vaccines|vaccines|mesh-list
2565504|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
2565505|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565506|NCT01572012|Ondansetron|ondansetron|mesh-list
2565507|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
2565508|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
2565509|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2565510|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565511|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2565512|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
2565513|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
2565514|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2565515|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
2565516|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2565517|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565518|NCT01572012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2565519|NCT01572012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2565520|NCT01572012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2565521|NCT01572012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2565522|NCT01572012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2565523|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2565524|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2565525|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
2565526|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565527|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2565528|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565529|NCT01572116|Lidocaine|lidocaine|mesh-list
2565530|NCT01572116|Epinephrine|epinephrine|mesh-list
2565531|NCT01572116|Racepinephrine|racepinephrine|mesh-list
2565532|NCT01572116|Sufentanil|sufentanil|mesh-list
2123764|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2123765|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2123766|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
2123767|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2123768|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123769|NCT02804399|Rifampin|rifampin|mesh-list
2123770|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2123771|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
2565533|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
2565534|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
2565535|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
2565536|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2565537|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565538|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
2565539|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2565540|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2565541|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2565542|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2565543|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2565544|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565545|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2123772|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2123773|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123774|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
2123775|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2123776|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123777|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123778|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2123779|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2123780|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2123781|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2123782|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2123783|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2123784|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
2123785|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2123786|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
2123787|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123788|NCT02804594|Expectorants|expectorants|mesh-ancestor
2123789|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
2123790|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2123791|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
2123792|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123793|NCT02804594|Protective Agents|protective agents|mesh-ancestor
2123794|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123795|NCT02804594|Antidotes|antidotes|mesh-ancestor
2123796|NCT02805179|Temozolomide|temozolomide|mesh-list
2123797|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2565546|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2565547|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
2565548|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2565549|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2565550|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2565551|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
2565552|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2123798|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
2123799|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123800|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123801|NCT02805660|Durvalumab|durvalumab|mesh-list
2123802|NCT02805660|Mocetinostat|mocetinostat|mesh-list
2123803|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2123804|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123805|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2123806|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565553|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
2565554|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
2565555|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
2565556|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2565557|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2565558|NCT01572116|Narcotics|narcotics|mesh-ancestor
2565559|NCT01572116|Analgesics|analgesics|mesh-ancestor
2565560|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2565561|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2565562|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
2565563|NCT01572129|Clopidogrel|clopidogrel|mesh-list
2565564|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2565565|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2565566|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2565567|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2565568|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
2565569|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2565570|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565571|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565572|NCT01572181|Fludarabine|fludarabine|mesh-list
2565573|NCT01572181|Busulfan|busulfan|mesh-list
2565574|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
2565575|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565576|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565577|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2565578|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
2565579|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565580|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
2565581|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2565582|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2565583|NCT01572259|Hormones|hormones|mesh-list
2565584|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565585|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565586|NCT01572285|Dexamethasone|dexamethasone|mesh-list
2565587|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
2565588|NCT01572285|BB 1101|bb 1101|mesh-list
2565589|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2565590|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
2565591|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
2565592|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2565593|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565594|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2565595|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
2565596|NCT01572285|Hormones|hormones|mesh-ancestor
2565597|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123807|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123808|NCT02805907|Calcifediol|calcifediol|mesh-list
2123809|NCT02805907|Vitamins|vitamins|mesh-ancestor
2123810|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
2123811|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123812|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2123813|NCT02805972|Naloxone|naloxone|mesh-list
2123814|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2123815|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123816|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
2123817|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123818|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
2123819|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2123820|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2123821|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123822|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
2565598|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2565599|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565600|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
2565601|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565602|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565603|NCT01572324|Leucovorin|leucovorin|mesh-list
2565604|NCT01572324|Fluorouracil|fluorouracil|mesh-list
2565605|NCT01572324|Capecitabine|capecitabine|mesh-list
2565606|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
2565607|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
2565608|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565609|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2565610|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565611|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2565612|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
2565613|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565614|NCT01572324|Antidotes|antidotes|mesh-ancestor
2565615|NCT01572324|Protective Agents|protective agents|mesh-ancestor
2565616|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
2565617|NCT01572324|Vitamins|vitamins|mesh-ancestor
2565618|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
2565619|NCT01572350|Triamcinolone|triamcinolone|mesh-list
2565620|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2565621|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2565622|NCT01572350|Bevacizumab|bevacizumab|mesh-list
2565623|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2565624|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2565625|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565626|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2565627|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2565628|NCT01572350|Growth Substances|growth substances|mesh-ancestor
2565629|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565630|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
2565631|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2565632|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
2565633|NCT01572350|Hormones|hormones|mesh-ancestor
2565634|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565635|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2123823|NCT02806024|Coagulants|coagulants|mesh-ancestor
2123824|NCT02806232|Praziquantel|praziquantel|mesh-list
2123825|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
2123826|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2123827|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123828|NCT02806414|Ivermectin|ivermectin|mesh-list
2123829|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2123830|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123831|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2123832|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
2123833|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123834|NCT02806544|Tamoxifen|tamoxifen|mesh-list
2123835|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2123836|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
2123837|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123838|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123839|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2123840|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123841|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2123842|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2123843|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2123844|NCT02806869|Ibuprofen|ibuprofen|mesh-list
2123845|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2123846|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2123847|NCT02806869|Analgesics|analgesics|mesh-ancestor
2123848|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
2123849|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123850|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123851|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2123852|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2123853|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2123854|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123855|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123856|NCT02806947|Sirolimus|sirolimus|mesh-list
2123857|NCT02806947|Prednisone|prednisone|mesh-list
2123858|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2565636|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
2565637|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565638|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565639|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
2565640|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
2565641|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2565642|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2565643|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565644|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565645|NCT01572363|Urological Agents|urological agents|mesh-ancestor
2565646|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
2565647|NCT01572454|Remifentanil|remifentanil|mesh-list
2565648|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2565649|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2565650|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565651|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2565652|NCT01572454|Analgesics|analgesics|mesh-ancestor
2565653|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
2565654|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2565655|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2565656|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2565657|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2565658|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
2565659|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2565660|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565661|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2565662|NCT01572454|Narcotics|narcotics|mesh-ancestor
2565686|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
2565687|NCT01572545|Denosumab|denosumab|mesh-list
2565688|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2565689|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565690|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
2565691|NCT01572558|Meropenem|meropenem|mesh-list
2565692|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2565693|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565694|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2565695|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2565696|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565697|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565698|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565699|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2565700|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2565701|NCT01572597|Metronidazole|metronidazole|mesh-list
2565702|NCT01572597|Clarithromycin|clarithromycin|mesh-list
2565703|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
2565704|NCT01572597|Rabeprazole|rabeprazole|mesh-list
2123859|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
2123860|NCT02806947|Hormones|hormones|mesh-ancestor
2123861|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2123862|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123863|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2565705|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565706|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2565707|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2565708|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2565709|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2565710|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2565711|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2565712|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565713|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565714|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2565715|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2565716|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2565717|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
2565718|NCT01572597|Expectorants|expectorants|mesh-ancestor
2565719|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
2565720|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2565721|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
2565722|NCT01572597|Protective Agents|protective agents|mesh-ancestor
2565723|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565724|NCT01572623|Clopidogrel|clopidogrel|mesh-list
2565725|NCT01572623|Atorvastatin|atorvastatin|mesh-list
2565726|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2565727|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2565728|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
2565729|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565730|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2565731|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2565732|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565733|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2565734|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2565735|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2565736|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2565737|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
2565738|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2565739|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565740|NCT01572649|Lixisenatide|lixisenatide|mesh-list
2565741|NCT01572649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2565742|NCT01572649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565743|NCT01572662|Vidarabine|vidarabine|mesh-list
2565744|NCT01572662|Methotrexate|methotrexate|mesh-list
2565745|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
2565746|NCT01572662|Fludarabine|fludarabine|mesh-list
2565747|NCT01572662|Busulfan|busulfan|mesh-list
2565748|NCT01572662|Tacrolimus|tacrolimus|mesh-list
2565749|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2123864|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123865|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2123866|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123867|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2123868|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
2565750|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
2565751|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2565752|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565753|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2565754|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
2565755|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565756|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123869|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2123870|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
2123871|NCT02806973|Glucagon|glucagon|mesh-list
2123872|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2123873|NCT02806973|Hormones|hormones|mesh-ancestor
2123874|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565757|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
2565758|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565759|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2565760|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2565761|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
2565762|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2565763|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2565764|NCT01572662|Antiviral Agents|antiviral agents|mesh-ancestor
2565765|NCT01572662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565766|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2565767|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
2565768|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2565769|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2565770|NCT01572688|Melphalan|melphalan|mesh-list
2565771|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2123875|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565772|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
2565773|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565774|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565775|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2565776|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2123876|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
2123877|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
2123878|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2123879|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2123880|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
2123881|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123882|NCT02807623|Ibuprofen|ibuprofen|mesh-list
2123883|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2123884|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2123885|NCT02807623|Analgesics|analgesics|mesh-ancestor
2123886|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
2123887|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123888|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123889|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2123890|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2123891|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2565777|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
2565778|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565779|NCT01572805|Melatonin|melatonin|mesh-list
2565780|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
2565781|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565782|NCT01572805|Protective Agents|protective agents|mesh-ancestor
2565783|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565784|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2565785|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
2565786|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
2565787|NCT01572831|Protective Agents|protective agents|mesh-ancestor
2565788|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565789|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
2565790|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2565791|NCT01572857|Antibodies|antibodies|mesh-list
2565792|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
2565793|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565794|NCT01572961|Aspirin|aspirin|mesh-list
2565795|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2565796|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2565797|NCT01572961|Analgesics|analgesics|mesh-ancestor
2565798|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
2565799|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2565800|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565801|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2565802|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2123892|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184849|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2565803|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2565804|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2565805|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565806|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2565807|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2565808|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565809|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
2565810|NCT01573013|Iron|iron|mesh-list
2565811|NCT01573013|Trace Elements|trace elements|mesh-ancestor
2565812|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
2565813|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565814|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2565815|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2565816|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2565817|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
2565818|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565819|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2565820|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2565821|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565822|NCT01573286|Glucagon|glucagon|mesh-list
2565823|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2565824|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2565825|NCT01573286|Hormones|hormones|mesh-ancestor
2565826|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565827|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565828|NCT01573286|Incretins|incretins|mesh-ancestor
2565829|NCT01573338|Carboplatin|carboplatin|mesh-list
2565830|NCT01573338|Etoposide|etoposide|mesh-list
2565831|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565832|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2565833|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2565834|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2565835|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565836|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565837|NCT01573351|Interferons|interferons|mesh-list
2565838|NCT01573351|Ribavirin|ribavirin|mesh-list
2565839|NCT01573351|Interferon-alpha|interferon-alpha|mesh-list
2565840|NCT01573351|Interferon alpha-2|interferon alpha-2|mesh-list
2565841|NCT01573351|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2565842|NCT01573351|Asunaprevir|asunaprevir|mesh-list
2565843|NCT01573351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565844|NCT01573351|Antiviral Agents|antiviral agents|mesh-ancestor
2565845|NCT01573351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565846|NCT01573351|Antimetabolites|antimetabolites|mesh-ancestor
2565847|NCT01573351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565848|NCT01573351|Immunologic Factors|immunologic factors|mesh-ancestor
2565849|NCT01573351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565850|NCT01573351|Protease Inhibitors|protease inhibitors|mesh-ancestor
2565851|NCT01573351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565852|NCT01573377|Metformin|metformin|mesh-list
2565853|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
2565854|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2565855|NCT01573377|Cyproterone|cyproterone|mesh-list
2565856|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2565857|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565858|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2565859|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2565860|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2565861|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
2565862|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2565863|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2565864|NCT01573377|Estrogens|estrogens|mesh-ancestor
2565865|NCT01573377|Hormones|hormones|mesh-ancestor
2565866|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565867|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
2565868|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
2565869|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565870|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2565871|NCT01573468|Capecitabine|capecitabine|mesh-list
2565872|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2565873|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
2565874|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565875|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565876|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2565877|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
2123893|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123894|NCT02807844|Spartalizumab|spartalizumab|mesh-list
2123895|NCT02807844|Sargramostim|sargramostim|mesh-list
2123896|NCT02807844|Immunologic Factors|immunologic factors|mesh-ancestor
2123897|NCT02807844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123898|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2123899|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123900|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123901|NCT02808052|Minocycline|minocycline|mesh-list
2123902|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2123903|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2123904|NCT02808819|Benralizumab|benralizumab|mesh-list
2123905|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2123906|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
2123907|NCT02808975|Adalimumab|adalimumab|mesh-list
2123908|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2123909|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2123910|NCT02809053|Rituximab|rituximab|mesh-list
2123911|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2123912|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123913|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
2123914|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123915|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2123916|NCT02810392|Insulin|insulin|mesh-list
2123917|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2123918|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2123919|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565878|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2565879|NCT01573598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2565880|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2565881|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2565882|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565883|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2565884|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
2565885|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565886|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2565887|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2565888|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2565889|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2123928|NCT02810457|Paclitaxel|paclitaxel|mesh-list
2123929|NCT02810457|Bevacizumab|bevacizumab|mesh-list
2123930|NCT02810457|Carboplatin|carboplatin|mesh-list
2123931|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2123932|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123933|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
2123934|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
2123935|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
2123936|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123937|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2123938|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2123939|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2123940|NCT02810457|Growth Substances|growth substances|mesh-ancestor
2565890|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
2565891|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565892|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565893|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2565894|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2565895|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2565896|NCT01573663|Dipropizine|dipropizine|mesh-list
2123941|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123942|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
2123943|NCT02810873|Copper|copper|mesh-list
2123944|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
2123945|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2123946|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2123947|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123948|NCT02810873|Trace Elements|trace elements|mesh-ancestor
2123949|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
2123950|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123951|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
2123952|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
2123953|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565897|NCT01573663|Ambroxol|ambroxol|mesh-list
2565898|NCT01573663|Expectorants|expectorants|mesh-ancestor
2565899|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
2565900|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
2565901|NCT01573715|Cisatracurium|cisatracurium|mesh-list
2565902|NCT01573715|Atracurium|atracurium|mesh-list
2565903|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2565904|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2565905|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2565906|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565907|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2565908|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2565909|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2565910|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
2565911|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2565912|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565913|NCT01573741|Ketamine|ketamine|mesh-list
2565914|NCT01573741|Analgesics|analgesics|mesh-ancestor
2565915|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
2565916|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2565917|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123954|NCT02810964|Sulforaphane|sulforaphane|mesh-list
2565918|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2418858|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
2418859|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
2418860|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2418861|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418862|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
2565919|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2565920|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
2565921|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
2565922|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2565923|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2565924|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2565925|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2565926|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565927|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
2565928|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
2565929|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2565930|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2565931|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565932|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123955|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2123956|NCT02810964|Protective Agents|protective agents|mesh-ancestor
2123957|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123958|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123959|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
2123960|NCT02811861|Everolimus|everolimus|mesh-list
2123961|NCT02811861|Sunitinib|sunitinib|mesh-list
2123962|NCT02811861|Lenvatinib|lenvatinib|mesh-list
2123963|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2123964|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2123965|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2123966|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
2123967|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565933|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123968|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2123969|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2123970|NCT02811861|Growth Substances|growth substances|mesh-ancestor
2123971|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
2123972|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2123973|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123974|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123975|NCT02812186|Rocuronium|rocuronium|mesh-list
2123976|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2123977|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2123978|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2123979|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2123980|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123981|NCT02812238|Niacinamide|niacinamide|mesh-list
2123982|NCT02812238|Niacin|niacin|mesh-list
2123983|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
2123984|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
2123985|NCT02812238|Vitamins|vitamins|mesh-ancestor
2123986|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
2123987|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123988|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2123989|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
2123990|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123991|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2123992|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
2123993|NCT02812342|Tofacitinib|tofacitinib|mesh-list
2123994|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2418863|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2418864|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2418865|NCT00801047|Narcotics|narcotics|mesh-ancestor
2418866|NCT00801047|Analgesics|analgesics|mesh-ancestor
2418867|NCT00801086|Ethanol|ethanol|mesh-list
2418868|NCT00801086|Tempol|tempol|mesh-list
2418869|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2418870|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418871|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2418872|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418873|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
2418874|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418875|NCT00801086|Protective Agents|protective agents|mesh-ancestor
2418876|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2565934|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2565935|NCT01573780|Gemcitabine|gemcitabine|mesh-list
2565936|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2565937|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
2565938|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565939|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565940|NCT01573780|Antiviral Agents|antiviral agents|mesh-ancestor
2565941|NCT01573780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565942|NCT01573780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565943|NCT01573780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2565944|NCT01573780|Immunologic Factors|immunologic factors|mesh-ancestor
2565945|NCT01573780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565946|NCT01573806|Exenatide|exenatide|mesh-list
2565947|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2565948|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2123995|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2123996|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2123997|NCT02812771|Efinaconazole|efinaconazole|mesh-list
2565949|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2565950|NCT01573806|Incretins|incretins|mesh-ancestor
2565951|NCT01573806|Hormones|hormones|mesh-ancestor
2565952|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2565953|NCT01573975|Clarithromycin|clarithromycin|mesh-list
2565954|NCT01573975|Rabeprazole|rabeprazole|mesh-list
2565955|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2565956|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2565957|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2565958|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2565959|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565960|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2565961|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2565962|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2565963|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2565964|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2565965|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
2565966|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2565967|NCT01574027|Vitamin D|vitamin d|mesh-list
2565968|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
2565969|NCT01574027|Vitamins|vitamins|mesh-ancestor
2565970|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
2565971|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565972|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2565973|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2565974|NCT01574092|Irinotecan|irinotecan|mesh-list
2565975|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565976|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2565977|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2565978|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418877|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418878|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2418879|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2418880|NCT00801125|Natalizumab|natalizumab|mesh-list
2418881|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
2418882|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418883|NCT00801151|Vinorelbine|vinorelbine|mesh-list
2418884|NCT00801151|Vorinostat|vorinostat|mesh-list
2418885|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2418886|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418887|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
2418888|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
2418889|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
2418890|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418891|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2418892|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418893|NCT00801177|Necitumumab|necitumumab|mesh-list
2123998|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
2123999|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124000|NCT02813070|Flutemetamol|flutemetamol|mesh-list
2124001|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2124002|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124003|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2124004|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2124005|NCT02813551|Torsemide|torsemide|mesh-list
2124006|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2124007|NCT02813551|Diuretics|diuretics|mesh-ancestor
2124008|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
2124009|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124010|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2124011|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2565979|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565980|NCT01574131|Fenofibrate|fenofibrate|mesh-list
2565981|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2565982|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
2565983|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2565984|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2565985|NCT01574261|Inositol|inositol|mesh-list
2565986|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
2565987|NCT01574261|Vitamins|vitamins|mesh-ancestor
2565988|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
2565989|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2565990|NCT01574274|Pegaspargase|pegaspargase|mesh-list
2565991|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2565992|NCT01574313|Tocopherols|tocopherols|mesh-list
2565993|NCT01574313|Vitamin E|vitamin e|mesh-list
2565994|NCT01574313|Tocotrienols|tocotrienols|mesh-list
2565995|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
2565996|NCT01574313|Niacin|niacin|mesh-list
2565997|NCT01574313|Diphenidol|diphenidol|mesh-list
2565998|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
2565999|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566000|NCT01574313|Protective Agents|protective agents|mesh-ancestor
2566001|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566002|NCT01574313|Vitamins|vitamins|mesh-ancestor
2566003|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
2566004|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2566005|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
2566006|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2566007|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
2566008|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
2566009|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
2566010|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
2566011|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566012|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2566013|NCT01574508|Insulin|insulin|mesh-list
2566014|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2566015|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2566016|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566017|NCT01574638|Rifapentine|rifapentine|mesh-list
2566018|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2566019|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
2566020|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2566021|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566022|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
2566023|NCT01574742|Minocycline|minocycline|mesh-list
2566024|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2566025|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566026|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
2566027|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2566028|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566029|NCT01575158|Citalopram|citalopram|mesh-list
2566030|NCT01575158|Clomipramine|clomipramine|mesh-list
2566031|NCT01575158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2566032|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2566033|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2566034|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566035|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566036|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
2566037|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566038|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2566039|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
2566040|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2566041|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2124012|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124013|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
2124014|NCT02813694|Lefamulin|lefamulin|mesh-list
2124015|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2124016|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124017|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2124018|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2124019|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124020|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566042|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
2566043|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2566044|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124021|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124022|NCT02814175|Adalimumab|adalimumab|mesh-list
2124023|NCT02814175|Methotrexate|methotrexate|mesh-list
2124024|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2124025|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
2124026|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2124027|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124028|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2124029|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
2566045|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
2566046|NCT01575301|Liraglutide|liraglutide|mesh-list
2566047|NCT01575301|Exenatide|exenatide|mesh-list
2566048|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2566049|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566050|NCT01575301|Incretins|incretins|mesh-ancestor
2566051|NCT01575301|Hormones|hormones|mesh-ancestor
2566052|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566053|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2566054|NCT01575405|Tenofovir|tenofovir|mesh-list
2566055|NCT01575405|Glycerol|glycerol|mesh-list
2566056|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
2566057|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566058|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2566059|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2566060|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566061|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566062|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2124030|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124031|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124032|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
2124033|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124034|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2124035|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2124036|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
2124037|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2124038|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2124039|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2124040|NCT02814279|Dipyrone|dipyrone|mesh-list
2124041|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
2124042|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2124043|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124044|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
2124045|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2124046|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2124047|NCT02814279|Analgesics|analgesics|mesh-ancestor
2124048|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
2124049|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124050|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124051|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2124052|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2124053|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
2124054|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
2124055|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2566063|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2566064|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2566065|NCT01575405|Protective Agents|protective agents|mesh-ancestor
2566066|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566067|NCT01575418|Tenofovir|tenofovir|mesh-list
2566068|NCT01575418|Glycerol|glycerol|mesh-list
2566069|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
2566070|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566071|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2566072|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2124056|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
2124057|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2124058|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2124059|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124060|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2124061|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124062|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2124063|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124064|NCT02814643|Benralizumab|benralizumab|mesh-list
2124065|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2124066|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
2566073|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566074|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566075|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2566076|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2566077|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2566078|NCT01575418|Protective Agents|protective agents|mesh-ancestor
2566079|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566080|NCT01575483|Saxagliptin|saxagliptin|mesh-list
2566081|NCT01575483|Incretins|incretins|mesh-ancestor
2566082|NCT01575483|Hormones|hormones|mesh-ancestor
2566083|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566084|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566085|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2566086|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
2566087|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566088|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566089|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2566090|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2566091|NCT01575613|Lumefantrine|lumefantrine|mesh-list
2124073|NCT02815644|Empagliflozin|empagliflozin|mesh-list
2124074|NCT02815644|Linagliptin|linagliptin|mesh-list
2124075|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2124076|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124077|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2124078|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124079|NCT02815644|Incretins|incretins|mesh-ancestor
2124080|NCT02815644|Hormones|hormones|mesh-ancestor
2124081|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2124082|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2124083|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
2124084|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124085|NCT02815709|Morphine|morphine|mesh-list
2124086|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2124087|NCT02815709|Narcotics|narcotics|mesh-ancestor
2124088|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124089|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124090|NCT02815709|Analgesics|analgesics|mesh-ancestor
2124091|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
2124092|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124093|NCT02816138|Nicotine|nicotine|mesh-list
2566092|NCT01575613|Artemether|artemether|mesh-list
2566093|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2566094|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
2566095|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2566096|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2566097|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566098|NCT01575626|Sevoflurane|sevoflurane|mesh-list
2566099|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2566100|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2566101|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
2566102|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
2566103|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2566104|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566105|NCT01575639|Prednisolone|prednisolone|mesh-list
2566106|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2566107|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
2566108|NCT01575639|Hormones|hormones|mesh-ancestor
2566109|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566110|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566111|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2566112|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566113|NCT01575652|Lisinopril|lisinopril|mesh-list
2566114|NCT01575652|Perindopril|perindopril|mesh-list
2566115|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2566116|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2566117|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
2566118|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566119|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2566120|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2566121|NCT01575652|Protective Agents|protective agents|mesh-ancestor
2566122|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124094|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2566123|NCT01575678|Melatonin|melatonin|mesh-list
2566124|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
2566125|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566126|NCT01575678|Protective Agents|protective agents|mesh-ancestor
2566127|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566128|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2566129|NCT01575717|Vitamin D|vitamin d|mesh-list
2566130|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
2566131|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
2566132|NCT01575717|Vitamins|vitamins|mesh-list
2566133|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
2566134|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566135|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2566136|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2566137|NCT01575782|Chloroquine|chloroquine|mesh-list
2566138|NCT01575782|Amebicides|amebicides|mesh-ancestor
2566139|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2566140|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2566141|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566142|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
2566143|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2566144|NCT01575795|Ticagrelor|ticagrelor|mesh-list
2566145|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2566146|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2566147|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2566148|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2566149|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
2566150|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566151|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566152|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566153|NCT01575925|Thalidomide|thalidomide|mesh-list
2566154|NCT01575925|Dexamethasone|dexamethasone|mesh-list
2566155|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
2566156|NCT01575925|Pomalidomide|pomalidomide|mesh-list
2566157|NCT01575925|BB 1101|bb 1101|mesh-list
2566158|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2566159|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
2566160|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
2566161|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566162|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566163|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2566164|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
2566165|NCT01575925|Hormones|hormones|mesh-ancestor
2566166|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566167|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2566168|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566169|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
2566170|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566171|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566172|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
2566173|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2566174|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2566175|NCT01575925|Growth Substances|growth substances|mesh-ancestor
2566176|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
2566177|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2566178|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
2566179|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2566180|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566181|NCT01576029|Docetaxel|docetaxel|mesh-list
2566182|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566183|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
2566184|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
2566185|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
2566186|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566187|NCT01576094|Simendan|simendan|mesh-list
2566188|NCT01576094|Milrinone|milrinone|mesh-list
2566189|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2566190|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
2566191|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2566192|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2566193|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566194|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566195|NCT01576094|Protective Agents|protective agents|mesh-ancestor
2566196|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566197|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2566198|NCT01576185|Sorafenib|sorafenib|mesh-list
2566199|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566200|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2566201|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566202|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566203|NCT01576263|Ropivacaine|ropivacaine|mesh-list
2124095|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
2124096|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124097|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124098|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2124099|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2124100|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
2124101|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2124102|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124103|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
2124104|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
2124105|NCT02817555|Hematinics|hematinics|mesh-ancestor
2124106|NCT02817763|Dipyrone|dipyrone|mesh-list
2124107|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2124108|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2566204|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
2566205|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
2566206|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2566207|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566208|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
2566209|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566210|NCT01576315|Itraconazole|itraconazole|mesh-list
2566211|NCT01576315|Voriconazole|voriconazole|mesh-list
2566212|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
2566213|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566214|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2566215|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2566216|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566217|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566218|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2566219|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
2124109|NCT02817763|Analgesics|analgesics|mesh-ancestor
2124110|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
2124111|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566220|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566221|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566222|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2566223|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
2566224|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2566225|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2566226|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566227|NCT01576419|Celecoxib|celecoxib|mesh-list
2566228|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2566229|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2566230|NCT01576419|Analgesics|analgesics|mesh-ancestor
2566231|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
2566232|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566233|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566234|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2566235|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2566236|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2566237|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2566238|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566239|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566240|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2566241|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2566242|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2566243|NCT01576627|Zinc|zinc|mesh-list
2566244|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
2566245|NCT01576627|Trace Elements|trace elements|mesh-ancestor
2566246|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
2566247|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566248|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
2566249|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
2124112|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124113|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2124114|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2124115|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
2124116|NCT02817828|Drospirenone|drospirenone|mesh-list
2124117|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2566250|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2566251|NCT01576627|Protective Agents|protective agents|mesh-ancestor
2566252|NCT01576640|Bupropion|bupropion|mesh-list
2566253|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2566254|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
2566255|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2566256|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2566257|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2566258|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2566259|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566260|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
2566261|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566262|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566263|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2566264|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2566265|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566266|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2566267|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2566268|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2566269|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566270|NCT01576692|Aldesleukin|aldesleukin|mesh-list
2566271|NCT01576692|Antibodies|antibodies|mesh-list
2566272|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
2566273|NCT01576692|Sargramostim|sargramostim|mesh-list
2566274|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
2566275|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124118|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
2124119|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566276|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566277|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2124120|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124121|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2124122|NCT02817828|Diuretics|diuretics|mesh-ancestor
2124123|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
2124124|NCT02817841|Drospirenone|drospirenone|mesh-list
2124125|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2124126|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
2124127|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2124128|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124129|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2124130|NCT02817841|Diuretics|diuretics|mesh-ancestor
2124131|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
2124132|NCT02818036|Naltrexone|naltrexone|mesh-list
2566278|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2566279|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
2566280|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566281|NCT01576731|Tenofovir|tenofovir|mesh-list
2566282|NCT01576731|Emtricitabine|emtricitabine|mesh-list
2566283|NCT01576731|Lopinavir|lopinavir|mesh-list
2566284|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
2566285|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
2566286|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566287|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2566288|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2566289|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566290|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566291|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2566292|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2566293|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2566294|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2566295|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
2566296|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2566297|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2566298|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2566299|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2566300|NCT01576770|Lidocaine|lidocaine|mesh-list
2566301|NCT01576770|Tetracaine|tetracaine|mesh-list
2566302|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
2566303|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
2566304|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
2566305|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2566306|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566307|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
2566308|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566309|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2566310|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2566311|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2566312|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2566313|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566314|NCT01576848|Caseins|caseins|mesh-list
2566315|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
2566316|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
2566317|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566318|NCT01577017|Letrozole|letrozole|mesh-list
2566319|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2566320|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566321|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2566322|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566323|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566324|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2566325|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
2566326|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566327|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566328|NCT01577043|Racecadotril|racecadotril|mesh-list
2566329|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
2566330|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2566331|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
2566332|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566333|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566334|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
2566335|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2566336|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566337|NCT01577121|Indomethacin|indomethacin|mesh-list
2566338|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2566339|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2566340|NCT01577121|Analgesics|analgesics|mesh-ancestor
2566341|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
2566342|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566343|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566344|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2566345|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2566346|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
2566347|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
2566348|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2566349|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2566350|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566351|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566352|NCT01577173|Cetuximab|cetuximab|mesh-list
2566353|NCT01577173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2566354|NCT01577173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566355|NCT01577199|Clomiphene|clomiphene|mesh-list
2566356|NCT01577199|Enclomiphene|enclomiphene|mesh-list
2124133|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2124134|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2124135|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124136|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
2124137|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124138|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
2124139|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2124140|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124141|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566357|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
2566358|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2566359|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
2566360|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566361|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566362|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2566363|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
2566364|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2566365|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2566366|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2566367|NCT01577316|Vaccines|vaccines|mesh-list
2566368|NCT01577316|Immunologic Factors|immunologic factors|mesh-ancestor
2566369|NCT01577316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566370|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
2566371|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2566372|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566373|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2566374|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2566375|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566376|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566377|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566378|NCT01577368|Tazobactam|tazobactam|mesh-list
2566379|NCT01577368|Piperacillin|piperacillin|mesh-list
2566380|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2566381|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2566382|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566383|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2566384|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566385|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566386|NCT01577407|Nefopam|nefopam|mesh-list
2566387|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2566388|NCT01577407|Analgesics|analgesics|mesh-ancestor
2566389|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
2566390|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566391|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566392|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
2566393|NCT01577459|Tedizolid|tedizolid|mesh-list
2566394|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2566395|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566396|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
2566397|NCT01577524|Povidone|povidone|mesh-list
2566398|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
2566399|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
2566400|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2566401|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566402|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2566403|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
2566404|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566405|NCT01577589|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2566406|NCT01577589|Cephalosporins|cephalosporins|mesh-list
2566407|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2566408|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566409|NCT01577654|Folic Acid|folic acid|mesh-list
2566410|NCT01577654|Docetaxel|docetaxel|mesh-list
2566411|NCT01577654|Vinca Alkaloids|vinca alkaloids|mesh-list
2566412|NCT01577654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566413|NCT01577654|Tubulin Modulators|tubulin modulators|mesh-ancestor
2566414|NCT01577654|Antimitotic Agents|antimitotic agents|mesh-ancestor
2566415|NCT01577654|Mitosis Modulators|mitosis modulators|mesh-ancestor
2566416|NCT01577654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566417|NCT01577654|Hematinics|hematinics|mesh-ancestor
2566418|NCT01577654|Vitamin B Complex|vitamin b complex|mesh-ancestor
2566419|NCT01577654|Vitamins|vitamins|mesh-ancestor
2566420|NCT01577654|Micronutrients|micronutrients|mesh-ancestor
2566421|NCT01577654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566422|NCT01577693|Dutasteride|dutasteride|mesh-list
2566423|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2566424|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2566425|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566426|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566427|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
2566428|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566429|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566430|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2566431|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
2566432|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566433|NCT01577849|Vitamin D|vitamin d|mesh-list
2566434|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
2566435|NCT01577849|Vitamins|vitamins|mesh-ancestor
2566436|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
2566437|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124142|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2124143|NCT02818569|Analgesics|analgesics|mesh-ancestor
2124144|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
2124145|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124146|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2124147|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2124148|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2124149|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
2124150|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2184850|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
2566438|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2566439|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2566440|NCT01577862|Rifampin|rifampin|mesh-list
2566441|NCT01577862|Colistin|colistin|mesh-list
2566442|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2566443|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
2566444|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2566445|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566446|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
2566447|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2124151|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124152|NCT02818777|Cannabidiol|cannabidiol|mesh-list
2124153|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
2124154|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
2124155|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2124156|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124157|NCT02818998|Aflibercept|aflibercept|mesh-list
2124158|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2124159|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2124160|NCT02818998|Growth Substances|growth substances|mesh-ancestor
2124161|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124162|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
2124163|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124164|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2124165|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2124166|NCT02819297|Laxatives|laxatives|mesh-list
2124167|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2124168|NCT02819310|Laxatives|laxatives|mesh-list
2124169|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2124170|NCT02819479|Bevacizumab|bevacizumab|mesh-list
2124171|NCT02819479|Mannitol|mannitol|mesh-list
2124172|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2566448|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566449|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566450|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2566451|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2566452|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2566453|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2566454|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2566455|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2566456|NCT01577914|Carvedilol|carvedilol|mesh-list
2566457|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2566458|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2566459|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
2566460|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566461|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566462|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566463|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2566464|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
2566465|NCT01577914|Protective Agents|protective agents|mesh-ancestor
2566466|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2566467|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2566468|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2566469|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
2566470|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2566471|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2566472|NCT01577940|Ropivacaine|ropivacaine|mesh-list
2566473|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
2566474|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
2566475|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2566476|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566477|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
2566478|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566479|NCT01577992|Levodopa|levodopa|mesh-list
2566480|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2566481|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2566482|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
2566483|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566484|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566485|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566486|NCT01578057|Ethanol|ethanol|mesh-list
2566487|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2566488|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566489|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2566490|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124173|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566491|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
2566492|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566493|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
2566494|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
2566495|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
2566496|NCT01578109|Sorafenib|sorafenib|mesh-list
2566497|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566498|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2566499|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566500|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566501|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
2566502|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2566503|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2566504|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566505|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2566506|NCT01578161|Analgesics|analgesics|mesh-ancestor
2566507|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
2566508|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566509|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2566510|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2566511|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2566512|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
2566513|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566514|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566515|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
2566516|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2566517|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2566518|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566519|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2566520|NCT01578174|Analgesics|analgesics|mesh-ancestor
2566521|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
2566522|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566523|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2566524|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2566525|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2566526|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
2566527|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2124174|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2124175|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2124176|NCT02819479|Growth Substances|growth substances|mesh-ancestor
2124177|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124178|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
2124179|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2124180|NCT02819479|Diuretics|diuretics|mesh-ancestor
2124181|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
2124182|NCT02819726|Rituximab|rituximab|mesh-list
2124183|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2124184|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124185|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
2566528|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566529|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
2566530|NCT01578200|Calcium|calcium|mesh-list
2566531|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2566532|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566533|NCT01578200|Antacids|antacids|mesh-ancestor
2566534|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566535|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2566536|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
2566537|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566538|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2566539|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566540|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566541|NCT01578252|Ondansetron|ondansetron|mesh-list
2566542|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
2566543|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
2566544|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566545|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566546|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2566547|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
2566548|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
2566549|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2566550|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
2566551|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566552|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566553|NCT01578252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2566554|NCT01578252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2566555|NCT01578252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2566556|NCT01578252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2566557|NCT01578252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2566558|NCT01578265|Ondansetron|ondansetron|mesh-list
2566559|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
2566560|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
2566561|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566562|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566563|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2566564|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
2566565|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
2566566|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2566567|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
2566568|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566569|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566570|NCT01578265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2566571|NCT01578265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2566572|NCT01578265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2566573|NCT01578265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2566574|NCT01578265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2566575|NCT01578304|Fesoterodine|fesoterodine|mesh-list
2566576|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2566577|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2566578|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
2566579|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566580|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566581|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566582|NCT01578304|Urological Agents|urological agents|mesh-ancestor
2566583|NCT01578343|Vidarabine|vidarabine|mesh-list
2566584|NCT01578343|Dexamethasone|dexamethasone|mesh-list
2566585|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
2566586|NCT01578343|Fludarabine|fludarabine|mesh-list
2566587|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
2566588|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
2566589|NCT01578343|Vorinostat|vorinostat|mesh-list
2566590|NCT01578343|BB 1101|bb 1101|mesh-list
2566591|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2566592|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
2566593|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
2566594|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566595|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566596|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2566597|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
2566598|NCT01578343|Hormones|hormones|mesh-ancestor
2566599|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566600|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2566601|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566602|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
2566603|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566604|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566605|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2566606|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
2566607|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2566608|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
2566609|NCT01578343|Antiviral Agents|antiviral agents|mesh-ancestor
2566610|NCT01578343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566611|NCT01578343|Analgesics|analgesics|mesh-ancestor
2566612|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
2566613|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2566614|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2566615|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2566616|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
2566617|NCT01578434|Vitamin D|vitamin d|mesh-list
2566618|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
2566619|NCT01578434|Vitamins|vitamins|mesh-list
2566620|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
2566621|NCT01578434|Calcium|calcium|mesh-list
2566622|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
2566623|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566624|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2566625|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2566626|NCT01578434|Antacids|antacids|mesh-ancestor
2566627|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566628|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2566629|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2566630|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
2566631|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2566632|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
2566633|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2566634|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566635|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2566636|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2566637|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2566638|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566639|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2566640|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2566641|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2566642|NCT01578473|Vitamin D|vitamin d|mesh-list
2566643|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
2566644|NCT01578473|Vitamins|vitamins|mesh-list
2566645|NCT01578473|Vitamin E|vitamin e|mesh-list
2566646|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
2566647|NCT01578473|Testosterone|testosterone|mesh-list
2566648|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
2566649|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
2566650|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2566651|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
2566652|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566653|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2566654|NCT01578473|Androgens|androgens|mesh-ancestor
2566655|NCT01578473|Hormones|hormones|mesh-ancestor
2566656|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566657|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2566658|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566659|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
2566660|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
2566661|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566662|NCT01578473|Protective Agents|protective agents|mesh-ancestor
2566663|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2566664|NCT01578564|SOR-C13|sor-c13|mesh-list
2566665|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566666|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2566667|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2566668|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566669|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2566670|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566671|NCT01578603|Calcium|calcium|mesh-list
2566672|NCT01578603|Caseins|caseins|mesh-list
2566673|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2566674|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566675|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
2124186|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124187|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2124188|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
2124189|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2124190|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124191|NCT02820324|Morphine|morphine|mesh-list
2124192|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2124193|NCT02820324|Narcotics|narcotics|mesh-ancestor
2124194|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124195|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124196|NCT02820324|Analgesics|analgesics|mesh-ancestor
2566676|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
2566677|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566678|NCT01578629|Aspirin|aspirin|mesh-list
2566679|NCT01578629|Vitamin E|vitamin e|mesh-list
2566680|NCT01578629|Tocopherols|tocopherols|mesh-list
2566681|NCT01578629|Tocotrienols|tocotrienols|mesh-list
2566682|NCT01578629|Vitamins|vitamins|mesh-ancestor
2566683|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
2566684|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566685|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2566686|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2566687|NCT01578629|Analgesics|analgesics|mesh-ancestor
2566688|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
2566689|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566690|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2566691|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2566692|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2566693|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2566694|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566695|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2566696|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2566697|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566698|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
2566699|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
2566700|NCT01578629|Protective Agents|protective agents|mesh-ancestor
2566701|NCT01578655|Prednisone|prednisone|mesh-list
2566702|NCT01578655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2566703|NCT01578655|Glucocorticoids|glucocorticoids|mesh-ancestor
2566704|NCT01578655|Hormones|hormones|mesh-ancestor
2566705|NCT01578655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566706|NCT01578655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566707|NCT01578655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2566708|NCT01578655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566709|NCT01578668|Pemetrexed|pemetrexed|mesh-list
2566710|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2566711|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566712|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566713|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566714|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2566715|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2566716|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2566717|NCT01578720|Aflibercept|aflibercept|mesh-list
2566718|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2566719|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2566720|NCT01578720|Growth Substances|growth substances|mesh-ancestor
2566721|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566722|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
2566723|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566724|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
2566725|NCT01578824|Miotics|miotics|mesh-ancestor
2566726|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
2566727|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566728|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566729|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2566730|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2566731|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
2566732|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2566733|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2566734|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
2566735|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566736|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566737|NCT01578889|Vaccines|vaccines|mesh-list
2566738|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
2566739|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566740|NCT01578928|Pasireotide|pasireotide|mesh-list
2566741|NCT01578928|Hormones|hormones|mesh-ancestor
2566742|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566743|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566752|NCT01579019|Ritonavir|ritonavir|mesh-list
2566753|NCT01579019|Ribavirin|ribavirin|mesh-list
2124197|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
2124198|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124199|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2124200|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124204|NCT02821338|Lamotrigine|lamotrigine|mesh-list
2124205|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
2124206|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2124207|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2124208|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124209|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2566754|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2566755|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2566756|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2566757|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
2566758|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566759|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566760|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2566761|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2566762|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
2566763|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566764|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2566765|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2566766|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
2566767|NCT01579058|Bisoprolol|bisoprolol|mesh-list
2566768|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2566769|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
2566770|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
2566771|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566772|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566773|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2566774|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2566775|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2566776|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
2566777|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566778|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566779|NCT01579110|Levamisole|levamisole|mesh-list
2566780|NCT01579110|Prednisone|prednisone|mesh-list
2566781|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2566782|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
2566783|NCT01579110|Hormones|hormones|mesh-ancestor
2566784|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566785|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566786|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2566787|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566788|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2566789|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
2566790|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
2566791|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
2566792|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2566793|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566794|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2566795|NCT01579149|Plerixafor|plerixafor|mesh-list
2566796|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2566797|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2566798|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
2566799|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566800|NCT01579201|Carbetocin|carbetocin|mesh-list
2566801|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
2566802|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2566803|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566804|NCT01579227|Tamoxifen|tamoxifen|mesh-list
2566805|NCT01579227|Tocotrienols|tocotrienols|mesh-list
2566806|NCT01579227|Vitamin E|vitamin e|mesh-list
2566807|NCT01579227|Tocopherols|tocopherols|mesh-list
2566808|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2566809|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
2566810|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566811|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566812|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2566813|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566814|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2566815|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2566816|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2418894|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2418895|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2418896|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418897|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
2418898|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418899|NCT00801255|Lactams|lactams|mesh-list
2418900|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2566817|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
2124210|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124211|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2124212|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2124213|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2418901|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2418902|NCT00801268|Emodin|emodin|mesh-list
2418903|NCT00801268|Cathartics|cathartics|mesh-ancestor
2418904|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2566818|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566819|NCT01579227|Protective Agents|protective agents|mesh-ancestor
2566820|NCT01579227|Vitamins|vitamins|mesh-ancestor
2566821|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
2566822|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2124214|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2124215|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2124216|NCT02821416|Benralizumab|benralizumab|mesh-list
2124217|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2124218|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
2124219|NCT02821715|Flecainide|flecainide|mesh-list
2124220|NCT02821715|Modafinil|modafinil|mesh-list
2124221|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2124222|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124223|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2124224|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2124225|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2124226|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124227|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2124228|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2124229|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2124230|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2124231|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2124232|NCT02821819|Hormones|hormones|mesh-ancestor
2124233|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2124234|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124235|NCT02821910|Metformin|metformin|mesh-list
2124236|NCT02821910|Empagliflozin|empagliflozin|mesh-list
2124237|NCT02821910|Linagliptin|linagliptin|mesh-list
2124238|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2566823|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2566824|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2566825|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2566826|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566827|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566828|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566829|NCT01579279|Analgesics|analgesics|mesh-ancestor
2566830|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
2566831|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566832|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
2566833|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2566834|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
2566835|NCT01579383|Sumatriptan|sumatriptan|mesh-list
2566836|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2566837|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2566838|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2566839|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
2566840|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566841|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566842|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124239|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124240|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2124241|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124242|NCT02821910|Incretins|incretins|mesh-ancestor
2124243|NCT02821910|Hormones|hormones|mesh-ancestor
2124244|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2124245|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2124246|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
2124247|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124248|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
2566843|NCT01579448|Vaccines|vaccines|mesh-list
2566844|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
2566845|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566846|NCT01579461|Mirabegron|mirabegron|mesh-list
2566847|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2566848|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2566849|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2566850|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
2566851|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566852|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566853|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566854|NCT01579461|Urological Agents|urological agents|mesh-ancestor
2124249|NCT02822222|Cathartics|cathartics|mesh-ancestor
2124250|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2124251|NCT02822794|Ribavirin|ribavirin|mesh-list
2124252|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
2124253|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2124254|NCT02822794|Velpatasvir|velpatasvir|mesh-list
2124255|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
2124256|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124257|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
2124258|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124259|NCT02822950|Ceftazidime|ceftazidime|mesh-list
2124260|NCT02822950|Avibactam|avibactam|mesh-list
2124261|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
2124262|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2124263|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124264|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2124265|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124266|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124267|NCT02823080|Cetrorelix|cetrorelix|mesh-list
2124268|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2124269|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
2124270|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2124271|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124272|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
2566855|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
2566856|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2566857|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2566858|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2566859|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2566860|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566861|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
2566862|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2566863|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566864|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2566865|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566866|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
2566867|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2566868|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2566869|NCT01579539|Prednisolone|prednisolone|mesh-list
2566870|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
2566871|NCT01579539|Esomeprazole|esomeprazole|mesh-list
2566872|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2566873|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
2566874|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2566875|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
2566876|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
2566877|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566878|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566879|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2566880|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
2566881|NCT01579539|Hormones|hormones|mesh-ancestor
2566882|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566883|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2566884|NCT01579539|Protective Agents|protective agents|mesh-ancestor
2566885|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2566886|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566887|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2418905|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2418906|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418907|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418908|NCT00801281|Prednisone|prednisone|mesh-list
2418909|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
2418910|NCT00801281|Rituximab|rituximab|mesh-list
2418911|NCT00801281|Doxorubicin|doxorubicin|mesh-list
2418912|NCT00801281|Vincristine|vincristine|mesh-list
2418913|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418914|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
2418915|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418916|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2418917|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2418918|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
2566888|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2566889|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124273|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566890|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566891|NCT01579630|Pemetrexed|pemetrexed|mesh-list
2566892|NCT01579630|Gefitinib|gefitinib|mesh-list
2566893|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566894|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566895|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566896|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2566897|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2566898|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2566899|NCT01579695|Tesamorelin|tesamorelin|mesh-list
2566900|NCT01579695|Growth Substances|growth substances|mesh-ancestor
2566901|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566902|NCT01579734|Tamoxifen|tamoxifen|mesh-list
2566903|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2566904|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
2566905|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2566906|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566907|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2566908|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566909|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2566910|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2566911|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2566912|NCT01579760|Aflibercept|aflibercept|mesh-list
2566913|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2124274|NCT02823431|Lidocaine|lidocaine|mesh-list
2124275|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
2124276|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
2124277|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124278|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124279|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
2124280|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124281|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2124282|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2124283|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2124284|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2124285|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124286|NCT02823470|Ivacaftor|ivacaftor|mesh-list
2124287|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2124288|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2124289|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124290|NCT02824224|Tamoxifen|tamoxifen|mesh-list
2124291|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2566914|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2566915|NCT01579760|Growth Substances|growth substances|mesh-ancestor
2566916|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566917|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
2566918|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124292|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
2124293|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2124294|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124295|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2124296|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124297|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2124298|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2124299|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2566919|NCT01579786|Acetaminophen|acetaminophen|mesh-list
2566920|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2566921|NCT01579786|Analgesics|analgesics|mesh-ancestor
2124300|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2124301|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2124302|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
2124303|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2124304|NCT02825212|Ledipasvir|ledipasvir|mesh-list
2124305|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2124306|NCT02825212|Velpatasvir|velpatasvir|mesh-list
2124307|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
2124308|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124309|NCT02825251|Insulin|insulin|mesh-list
2124310|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2124311|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
2124312|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
2124313|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2124314|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2124315|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124316|NCT02825420|Trabectedin|trabectedin|mesh-list
2566922|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
2566923|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566924|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566925|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
2566926|NCT01579838|Eculizumab|eculizumab|mesh-list
2566927|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2566928|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2566929|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
2566930|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566931|NCT01579864|Rocuronium|rocuronium|mesh-list
2124317|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2124318|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
2124319|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124320|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124321|NCT02826603|Ustekinumab|ustekinumab|mesh-list
2124322|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
2124323|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
2124324|NCT02828358|Leucovorin|leucovorin|mesh-list
2124325|NCT02828358|Folic Acid|folic acid|mesh-list
2124326|NCT02828358|Cytarabine|cytarabine|mesh-list
2124327|NCT02828358|Dexamethasone|dexamethasone|mesh-list
2124328|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
2124329|NCT02828358|Prednisolone|prednisolone|mesh-list
2124330|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2124331|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
2124332|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2124333|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
2124334|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
2124335|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2124336|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2124337|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2124338|NCT02828358|Cortisone|cortisone|mesh-list
2124339|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
2124340|NCT02828358|Methotrexate|methotrexate|mesh-list
2124341|NCT02828358|Vincristine|vincristine|mesh-list
2124342|NCT02828358|Azacitidine|azacitidine|mesh-list
2124343|NCT02828358|Daunorubicin|daunorubicin|mesh-list
2124344|NCT02828358|Asparaginase|asparaginase|mesh-list
2124345|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
2124346|NCT02828358|Thioguanine|thioguanine|mesh-list
2124347|NCT02828358|Pegaspargase|pegaspargase|mesh-list
2124348|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2124349|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
2124350|NCT02828358|BB 1101|bb 1101|mesh-list
2124351|NCT02828358|Calcium|calcium|mesh-list
2124352|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
2124353|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
2124354|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2124355|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
2124356|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124357|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2124358|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2124359|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
2124360|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124361|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566932|NCT01579864|Succinylcholine|succinylcholine|mesh-list
2566933|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2124362|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2124363|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2124364|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
2124365|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
2124366|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124367|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2124368|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
2124369|NCT02828358|Hormones|hormones|mesh-ancestor
2124370|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2124371|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2124372|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
2124373|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124374|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2124375|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2124376|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2124377|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
2124378|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2124379|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2124380|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
2124381|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
2124382|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2566934|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2566935|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2566936|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566937|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566938|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2566939|NCT01579890|Diclofenac|diclofenac|mesh-list
2566940|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2566941|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2566942|NCT01579890|Analgesics|analgesics|mesh-ancestor
2566943|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
2566944|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566945|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566946|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2566947|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2566948|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2566949|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566950|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566951|NCT01579903|Factor VIII|factor viii|mesh-list
2566952|NCT01579903|Coagulants|coagulants|mesh-ancestor
2566953|NCT01579929|Etoposide|etoposide|mesh-list
2566954|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566955|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2566956|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2566957|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2566958|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566959|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566960|NCT01579994|Crizotinib|crizotinib|mesh-list
2566961|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566962|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2566963|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566964|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566965|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
2566966|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2566967|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2566968|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566969|NCT01580007|Vitamins|vitamins|mesh-ancestor
2566970|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
2566971|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2566972|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566973|NCT01580033|Vaccines|vaccines|mesh-list
2566974|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
2566975|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566976|NCT01580163|Methadone|methadone|mesh-list
2566977|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2566978|NCT01580163|Narcotics|narcotics|mesh-ancestor
2566979|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2566980|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2566981|NCT01580163|Analgesics|analgesics|mesh-ancestor
2566982|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
2566983|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2566984|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
2566985|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
2566986|NCT01580202|Lamivudine|lamivudine|mesh-list
2566987|NCT01580202|Entecavir|entecavir|mesh-list
2566988|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2566989|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2566990|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2566991|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2566992|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
2566993|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2566994|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2566995|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2566996|NCT01580228|Ofatumumab|ofatumumab|mesh-list
2566997|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2566998|NCT01580254|Latanoprost|latanoprost|mesh-list
2566999|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2567000|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2567001|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2567002|NCT01580371|CKD-581|ckd-581|mesh-list
2567003|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567004|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567005|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
2567006|NCT01580501|Tadalafil|tadalafil|mesh-list
2567007|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
2567008|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2124383|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2124384|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
2124385|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124386|NCT02828358|Antidotes|antidotes|mesh-ancestor
2124387|NCT02828358|Protective Agents|protective agents|mesh-ancestor
2124388|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
2124389|NCT02828358|Vitamins|vitamins|mesh-ancestor
2124390|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
2124391|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2124392|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
2124393|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
2567009|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2567010|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567011|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567012|NCT01580501|Urological Agents|urological agents|mesh-ancestor
2567013|NCT01580514|Exenatide|exenatide|mesh-list
2567014|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2567015|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567016|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2567017|NCT01580514|Incretins|incretins|mesh-ancestor
2567018|NCT01580514|Hormones|hormones|mesh-ancestor
2567019|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2567020|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
2567021|NCT01580683|Vitamins|vitamins|mesh-ancestor
2567022|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
2567023|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567024|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
2567025|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567026|NCT01580683|Protective Agents|protective agents|mesh-ancestor
2567027|NCT01580696|Molgramostim|molgramostim|mesh-list
2567028|NCT01580696|Vaccines|vaccines|mesh-list
2567029|NCT01580696|Sargramostim|sargramostim|mesh-list
2567030|NCT01580696|Immunologic Factors|immunologic factors|mesh-ancestor
2567031|NCT01580696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124394|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
2124395|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2124396|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2124397|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2124398|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2567032|NCT01580696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567033|NCT01580813|Acipimox|acipimox|mesh-list
2567034|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2567035|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
2567036|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567037|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2567038|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2567039|NCT01580839|Plasminogen|plasminogen|mesh-list
2567040|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2567041|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2567042|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567043|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
2567044|NCT01580865|Tacrolimus|tacrolimus|mesh-list
2567045|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2567046|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
2567047|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567048|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2567049|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567050|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567051|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2567052|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567053|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2567054|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
2567055|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2124399|NCT02828358|Hematinics|hematinics|mesh-ancestor
2124400|NCT02829034|Ranolazine|ranolazine|mesh-list
2124401|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2124402|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2124403|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124404|NCT02829775|Interferons|interferons|mesh-list
2124405|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
2124406|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
2124407|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2124408|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124409|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
2124410|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124411|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
2124412|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567056|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567057|NCT01580878|Butenafine|butenafine|mesh-list
2567058|NCT01580878|Clotrimazole|clotrimazole|mesh-list
2567059|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
2567060|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567061|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2567062|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2567063|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2567064|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567065|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124413|NCT02829918|Nivolumab|nivolumab|mesh-list
2124414|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2124415|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124416|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2124417|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124418|NCT02829944|Ketorolac|ketorolac|mesh-list
2124419|NCT02829944|Ropivacaine|ropivacaine|mesh-list
2124420|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
2124421|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
2124422|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124423|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567066|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2567067|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
2567068|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2567069|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567070|NCT01580891|Naftifine|naftifine|mesh-list
2567071|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
2567072|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567073|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
2567074|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2567075|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2567076|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567077|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
2567078|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
2567079|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
2567080|NCT01581073|Hematinics|hematinics|mesh-ancestor
2567081|NCT01581138|Ribavirin|ribavirin|mesh-list
2567082|NCT01581138|Antimetabolites|antimetabolites|mesh-ancestor
2567083|NCT01581138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567084|NCT01581138|Antiviral Agents|antiviral agents|mesh-ancestor
2567085|NCT01581138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567086|NCT01581151|Dexamethasone|dexamethasone|mesh-list
2567087|NCT01581151|Ranibizumab|ranibizumab|mesh-list
2567088|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2567089|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
2567090|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
2124424|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
2124425|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124426|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2124427|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2124428|NCT02829944|Analgesics|analgesics|mesh-ancestor
2124429|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2124430|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2124431|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2124432|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124433|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124434|NCT02829983|Clarithromycin|clarithromycin|mesh-list
2124435|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2124436|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124437|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2124438|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567091|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567092|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567093|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2567094|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
2567095|NCT01581151|Hormones|hormones|mesh-ancestor
2567096|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2567097|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2567098|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567099|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2567100|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2567101|NCT01581151|Growth Substances|growth substances|mesh-ancestor
2567102|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
2567103|NCT01581164|Vaccines|vaccines|mesh-list
2567104|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
2567105|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184851|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
2567106|NCT01581177|Albuterol|albuterol|mesh-list
2567107|NCT01581177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2567108|NCT01581177|Autonomic Agents|autonomic agents|mesh-ancestor
2567109|NCT01581177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567110|NCT01581177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124439|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124440|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2567111|NCT01581177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2567112|NCT01581177|Respiratory System Agents|respiratory system agents|mesh-ancestor
2567113|NCT01581177|Tocolytic Agents|tocolytic agents|mesh-ancestor
2567114|NCT01581177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2567115|NCT01581177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2567116|NCT01581177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2567117|NCT01581177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2567118|NCT01581177|Adrenergic Agents|adrenergic agents|mesh-ancestor
2567119|NCT01581177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567120|NCT01581177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567121|NCT01581203|Interferons|interferons|mesh-list
2567122|NCT01581203|Ribavirin|ribavirin|mesh-list
2567123|NCT01581203|Interferon-alpha|interferon-alpha|mesh-list
2567124|NCT01581203|Interferon alpha-2|interferon alpha-2|mesh-list
2567125|NCT01581203|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2567126|NCT01581203|Asunaprevir|asunaprevir|mesh-list
2567127|NCT01581203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567128|NCT01581203|Antiviral Agents|antiviral agents|mesh-ancestor
2567129|NCT01581203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567130|NCT01581203|Antimetabolites|antimetabolites|mesh-ancestor
2567131|NCT01581203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567132|NCT01581203|Immunologic Factors|immunologic factors|mesh-ancestor
2567133|NCT01581203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567134|NCT01581203|Protease Inhibitors|protease inhibitors|mesh-ancestor
2567135|NCT01581203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567136|NCT01581242|Adefovir|adefovir|mesh-list
2567137|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2567138|NCT01581242|Clevudine|clevudine|mesh-list
2567139|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
2567140|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567141|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2567142|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2567143|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567144|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567145|NCT01581320|Vitamin D|vitamin d|mesh-list
2567146|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
2567147|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
2567148|NCT01581320|Vitamins|vitamins|mesh-ancestor
2567149|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
2567150|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567151|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2567152|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2567153|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
2567154|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2567155|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2567156|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
2567157|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2567158|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
2567159|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2567160|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567161|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2567162|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2567163|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567164|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2567165|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
2567166|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
2567167|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567168|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
2567169|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567170|NCT01581411|Plasminogen|plasminogen|mesh-list
2567171|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2567172|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2567173|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2567174|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567175|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
2124441|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2124442|NCT02829996|Latanoprost|latanoprost|mesh-list
2567176|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2567177|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
2567178|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
2567179|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567180|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567181|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2567182|NCT01581450|Analgesics|analgesics|mesh-ancestor
2567183|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
2567184|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567185|NCT01581476|Quinapril|quinapril|mesh-list
2567186|NCT01581476|Atorvastatin|atorvastatin|mesh-list
2567187|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2567188|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2567189|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2567190|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
2567191|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567192|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2567193|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2567194|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567195|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
2124443|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2124444|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2124445|NCT02830776|Bimatoprost|bimatoprost|mesh-list
2124446|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2124447|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2124448|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2124449|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2124450|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2124451|NCT02831569|Loxoprofen|loxoprofen|mesh-list
2124452|NCT02831569|Methocarbamol|methocarbamol|mesh-list
2124453|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2124454|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2124455|NCT02831569|Analgesics|analgesics|mesh-ancestor
2124456|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
2124457|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124458|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124459|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2124460|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2124461|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2124462|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2567196|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2567197|NCT01581515|Everolimus|everolimus|mesh-list
2567198|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567199|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2567200|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
2567201|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567202|NCT01581736|Insulin|insulin|mesh-list
2567203|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2567204|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2567205|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567206|NCT01581775|Valproic Acid|valproic acid|mesh-list
2567207|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
2567208|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567209|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567210|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
2567211|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567212|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567213|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
2567214|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2567215|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567216|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2567217|NCT01581788|Valproic Acid|valproic acid|mesh-list
2567218|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
2567219|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567220|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567221|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
2567222|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567223|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567224|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
2567225|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2567226|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567227|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2567228|NCT01581814|Metformin|metformin|mesh-list
2567229|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2567230|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2567231|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2567232|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567233|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2567234|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2567235|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2567236|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2124491|NCT02831816|Ethanol|ethanol|mesh-list
2124492|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
2124493|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2124494|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2124495|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124496|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124497|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124498|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
2567237|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
2567238|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2567239|NCT01581814|Estrogens|estrogens|mesh-ancestor
2567240|NCT01581814|Hormones|hormones|mesh-ancestor
2567241|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2567242|NCT01581840|Panitumumab|panitumumab|mesh-list
2567243|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2567244|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567245|NCT01581853|Ritonavir|ritonavir|mesh-list
2124499|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
2124500|NCT02831855|Methotrexate|methotrexate|mesh-list
2124501|NCT02831855|Tofacitinib|tofacitinib|mesh-list
2567246|NCT01581853|Lopinavir|lopinavir|mesh-list
2567247|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2567248|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2567249|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
2567250|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567251|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567252|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2567253|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2567254|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
2567255|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567256|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2567257|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2567258|NCT01581866|Ziprasidone|ziprasidone|mesh-list
2567259|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2567260|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
2567261|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567262|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567263|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567264|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2567265|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2567266|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567267|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2567268|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2567269|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
2124502|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2567270|NCT01581879|Ziprasidone|ziprasidone|mesh-list
2567271|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2567272|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
2567273|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567274|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567275|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567276|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2567277|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2567278|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567279|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2567280|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2567281|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
2567282|NCT01581918|Carbamazepine|carbamazepine|mesh-list
2567283|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
2567284|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
2567285|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2567286|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567287|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124503|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
2124504|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2124505|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124506|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2124507|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
2124508|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124509|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124510|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
2124511|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124512|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2124513|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2124514|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
2567288|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2567289|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2567290|NCT01581918|Analgesics|analgesics|mesh-ancestor
2567291|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
2567292|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567293|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2567294|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2567295|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567296|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2567297|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2567298|NCT01581944|Goserelin|goserelin|mesh-list
2567299|NCT01581944|Hormones|hormones|mesh-list
2567300|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2567301|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567302|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2567303|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567304|NCT01582022|Bupivacaine|bupivacaine|mesh-list
2567305|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
2567306|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
2567307|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567308|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567309|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
2567310|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567311|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2567312|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
2567313|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2567314|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2567315|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2567316|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
2567317|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567318|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2567319|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2567320|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567321|NCT01582191|Everolimus|everolimus|mesh-list
2567322|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567323|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2567324|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
2567325|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567326|NCT01582230|Vildagliptin|vildagliptin|mesh-list
2567327|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2567328|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567329|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2567330|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
2567331|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124515|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2124516|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2124517|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2124518|NCT02831998|Ethanol|ethanol|mesh-list
2124519|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
2124520|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2124521|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2124522|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124523|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124524|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124525|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
2124526|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
2124527|NCT02832037|BI 425809|bi 425809|mesh-list
2124528|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
2124529|NCT02832115|Lidocaine|lidocaine|mesh-list
2124530|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
2124531|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
2124532|NCT02832115|Anesthetics|anesthetics|mesh-list
2124533|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124534|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567332|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567333|NCT01582269|Lomustine|lomustine|mesh-list
2567334|NCT01582269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2567335|NCT01582269|Alkylating Agents|alkylating agents|mesh-ancestor
2567336|NCT01582269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567337|NCT01582269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567338|NCT01582321|Cantharidin|cantharidin|mesh-list
2567339|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567340|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567341|NCT01582347|Buprenorphine|buprenorphine|mesh-list
2124535|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
2124536|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124537|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2124538|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2124539|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2124540|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2124541|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124542|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
2124543|NCT02832167|Nivolumab|nivolumab|mesh-list
2124544|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2124545|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124546|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2124547|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124548|NCT02832375|Fluorides|fluorides|mesh-list
2124549|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
2124550|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
2124551|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
2124552|NCT02832375|Protective Agents|protective agents|mesh-ancestor
2124553|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124554|NCT02833350|Folic Acid|folic acid|mesh-list
2124555|NCT02833350|Adalimumab|adalimumab|mesh-list
2124556|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2124557|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2124558|NCT02833350|Hematinics|hematinics|mesh-ancestor
2124559|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
2124560|NCT02833350|Vitamins|vitamins|mesh-ancestor
2124561|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
2124562|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124563|NCT02833415|Empagliflozin|empagliflozin|mesh-list
2124564|NCT02833415|Glycerol|glycerol|mesh-list
2124565|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2124566|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124567|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2124568|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124569|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2124570|NCT02833415|Protective Agents|protective agents|mesh-ancestor
2124571|NCT02833844|Evolocumab|evolocumab|mesh-list
2124572|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2124573|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2124574|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
2124575|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124576|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2124577|NCT02833948|Aspirin|aspirin|mesh-list
2124578|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
2124579|NCT02833948|Clopidogrel|clopidogrel|mesh-list
2124580|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2124581|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2567342|NCT01582347|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2567343|NCT01582347|Naloxone|naloxone|mesh-list
2567344|NCT01582347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2567345|NCT01582347|Narcotics|narcotics|mesh-ancestor
2567346|NCT01582347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124582|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2124583|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2124584|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
2124585|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2124586|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124587|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124588|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2124589|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
2124590|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2124591|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
2124592|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124593|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
2567347|NCT01582347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567348|NCT01582347|Analgesics|analgesics|mesh-ancestor
2567349|NCT01582347|Sensory System Agents|sensory system agents|mesh-ancestor
2567350|NCT01582347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567351|NCT01582347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2567352|NCT01582412|Isavuconazole|isavuconazole|mesh-list
2567353|NCT01582412|Digoxin|digoxin|mesh-list
2567354|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2124594|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2124595|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2124596|NCT02833948|Analgesics|analgesics|mesh-ancestor
2124597|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
2124598|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124599|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2124600|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2124601|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2124602|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2124603|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2124604|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
2124605|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2124606|NCT02834247|Nivolumab|nivolumab|mesh-list
2124607|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2567355|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2567356|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567357|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567358|NCT01582412|Protective Agents|protective agents|mesh-ancestor
2567359|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567360|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
2567361|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567362|NCT01582425|Isavuconazole|isavuconazole|mesh-list
2567363|NCT01582425|Methadone|methadone|mesh-list
2567364|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2567365|NCT01582425|Narcotics|narcotics|mesh-ancestor
2567366|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567367|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567368|NCT01582425|Analgesics|analgesics|mesh-ancestor
2567369|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
2567370|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567371|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
2567372|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
2567373|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
2567374|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567375|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
2567376|NCT01582438|Citric Acid|citric acid|mesh-list
2567377|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
2567378|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
2567379|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2567380|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
2567381|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
2567382|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567383|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
2567384|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2567385|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2567386|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567387|NCT01582438|Urological Agents|urological agents|mesh-ancestor
2567388|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2567389|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
2124608|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567390|NCT01582542|Coagulants|coagulants|mesh-ancestor
2124609|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2124610|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124611|NCT02834390|Cytarabine|cytarabine|mesh-list
2124612|NCT02834390|Daunorubicin|daunorubicin|mesh-list
2124613|NCT02834390|Idarubicin|idarubicin|mesh-list
2124614|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2124615|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
2124616|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124617|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124618|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
2124619|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124620|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2124621|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
2124622|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124623|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2124624|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2124625|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2567391|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2567392|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
2567393|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567394|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
2567395|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2567396|NCT01582555|Antidotes|antidotes|mesh-ancestor
2567397|NCT01582555|Protective Agents|protective agents|mesh-ancestor
2567398|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567399|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
2567400|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124626|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124627|NCT02834624|Poractant alfa|poractant alfa|mesh-list
2124628|NCT02834624|Calfactant|calfactant|mesh-list
2567401|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
2567402|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567403|NCT01582555|Expectorants|expectorants|mesh-ancestor
2567404|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
2567405|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2567406|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
2567407|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2567408|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
2567409|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567410|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2567411|NCT01582607|Fentanyl|fentanyl|mesh-list
2567412|NCT01582607|Bupivacaine|bupivacaine|mesh-list
2567413|NCT01582607|Ropivacaine|ropivacaine|mesh-list
2567414|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
2567415|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
2567416|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
2124629|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2124630|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
2124631|NCT02834663|Ranibizumab|ranibizumab|mesh-list
2124632|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2124633|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2124634|NCT02834663|Growth Substances|growth substances|mesh-ancestor
2124635|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124636|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
2124637|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124638|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
2124639|NCT02835339|Analgesics|analgesics|mesh-ancestor
2567417|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567418|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567419|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
2567420|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567421|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2567422|NCT01582607|Narcotics|narcotics|mesh-ancestor
2567423|NCT01582607|Analgesics|analgesics|mesh-ancestor
2567424|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2567425|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2567426|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
2567427|NCT01582646|Terbutaline|terbutaline|mesh-list
2567428|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2567429|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
2567430|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567431|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567432|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2567433|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
2567434|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
2124640|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
2567435|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
2567436|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2124641|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124642|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124643|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
2124644|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124645|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2124646|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
2567437|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2567438|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2567439|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2567440|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
2567441|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567442|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567443|NCT01582672|Sunitinib|sunitinib|mesh-list
2567444|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567445|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2567446|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2567447|NCT01582672|Growth Substances|growth substances|mesh-ancestor
2567448|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567449|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
2567450|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2567451|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567452|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567453|NCT01582711|Isoniazid|isoniazid|mesh-list
2567454|NCT01582711|Rifapentine|rifapentine|mesh-list
2567455|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
2567456|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2567457|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567458|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2567459|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2567460|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
2567461|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567462|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2567463|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2567464|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
2567465|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
2567466|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2567467|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
2567468|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2567469|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
2567470|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567471|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567472|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
2567473|NCT01582776|Lenalidomide|lenalidomide|mesh-list
2567474|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
2567475|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
2567476|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567477|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2567478|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2567479|NCT01582776|Growth Substances|growth substances|mesh-ancestor
2567480|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
2567481|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567482|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2567483|NCT01582932|Calcipotriene|calcipotriene|mesh-list
2567484|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
2567485|NCT01582997|Dabrafenib|dabrafenib|mesh-list
2567486|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567487|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2567488|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567489|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567490|NCT01583023|Bupropion|bupropion|mesh-list
2567491|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2567492|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
2567493|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2567494|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2567495|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2567496|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2567497|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567498|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
2567499|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567500|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567501|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2567502|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2567503|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124647|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2567504|NCT01583036|Digoxin|digoxin|mesh-list
2567505|NCT01583036|Ezogabine|ezogabine|mesh-list
2567506|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2567507|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2567508|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124648|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2124649|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124650|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2567509|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567510|NCT01583036|Protective Agents|protective agents|mesh-ancestor
2567511|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567512|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
2567513|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2567514|NCT01583062|Amoxicillin|amoxicillin|mesh-list
2567515|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
2567516|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
2567517|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2124651|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
2124652|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2124656|NCT02835846|Estrogens|estrogens|mesh-list
2124657|NCT02835846|Hormones|hormones|mesh-ancestor
2124658|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2124659|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124660|NCT02836496|Prednisone|prednisone|mesh-list
2124661|NCT02836496|Prednisolone|prednisolone|mesh-list
2124662|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2124663|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
2124664|NCT02836496|Hormones|hormones|mesh-ancestor
2124665|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2124666|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124667|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2124668|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124669|NCT02836652|Aspirin|aspirin|mesh-list
2124670|NCT02836652|Warfarin|warfarin|mesh-list
2124671|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2124672|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2124673|NCT02836652|Analgesics|analgesics|mesh-ancestor
2124674|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
2124675|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124676|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124677|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2124678|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2124679|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2124680|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2124681|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124682|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2124683|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2124684|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124685|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
2124686|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
2124687|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
2124688|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2124689|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124695|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
2124696|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
2124697|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
2124698|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2124699|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124700|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2124701|NCT02837237|Diuretics|diuretics|mesh-ancestor
2124702|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
2124703|NCT02837237|Hormones|hormones|mesh-ancestor
2124704|NCT02837744|Hemostatics|hemostatics|mesh-list
2124705|NCT02837744|Coagulants|coagulants|mesh-ancestor
2124706|NCT02838134|Rocuronium|rocuronium|mesh-list
2124707|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2567518|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124708|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2124709|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2124710|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124711|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124712|NCT02838420|Crizotinib|crizotinib|mesh-list
2124713|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124714|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2124715|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124716|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124717|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
2124718|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124719|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124720|NCT02839200|Zolpidem|zolpidem|mesh-list
2124721|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2124722|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2124723|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567519|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567520|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567521|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2567522|NCT01583114|Perindopril|perindopril|mesh-list
2567523|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2567524|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
2567525|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567526|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567527|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2567528|NCT01583244|Abatacept|abatacept|mesh-list
2567529|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2567530|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567531|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567532|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2124724|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124725|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2567533|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
2567534|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567535|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2567536|NCT01583283|Dexamethasone|dexamethasone|mesh-list
2567537|NCT01583283|Lenalidomide|lenalidomide|mesh-list
2567538|NCT01583283|Ricolinostat|ricolinostat|mesh-list
2567539|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2567540|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2567541|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
2567542|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
2567543|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567544|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567545|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2567546|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
2567547|NCT01583283|Hormones|hormones|mesh-ancestor
2567548|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2567549|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2567550|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567551|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
2567552|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2567553|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2567554|NCT01583283|Growth Substances|growth substances|mesh-ancestor
2567555|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
2567556|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567557|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567558|NCT01583322|Nintedanib|nintedanib|mesh-list
2567559|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567560|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2567561|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567562|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567563|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
2567564|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567565|NCT01583426|Paclitaxel|paclitaxel|mesh-list
2567566|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2567567|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2567568|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567569|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
2567570|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
2567571|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
2567572|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567573|NCT01583439|Ritonavir|ritonavir|mesh-list
2567574|NCT01583439|Lopinavir|lopinavir|mesh-list
2567575|NCT01583439|Tenofovir|tenofovir|mesh-list
2567576|NCT01583439|Lamivudine|lamivudine|mesh-list
2567577|NCT01583439|Zidovudine|zidovudine|mesh-list
2567578|NCT01583439|Emtricitabine|emtricitabine|mesh-list
2567579|NCT01583439|Efavirenz|efavirenz|mesh-list
2567580|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2567581|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2567582|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2567583|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
2567584|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567585|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567586|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2567587|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
2567588|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567589|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2567590|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2567591|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2567592|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2567593|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
2567594|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2567595|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2567596|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2567597|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2567598|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2567599|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2567600|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2567601|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567602|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567603|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2567604|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2567605|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567606|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
2567607|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567608|NCT01583504|Anesthetics|anesthetics|mesh-list
2567609|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
2567610|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567611|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567612|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
2567613|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567614|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
2567615|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2567616|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567617|NCT01583621|Vitamins|vitamins|mesh-ancestor
2567618|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
2567619|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2418919|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418920|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418921|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2124726|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
2124727|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
2124728|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2124729|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124730|NCT02839681|Maytansine|maytansine|mesh-list
2124731|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2124732|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124733|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
2124734|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
2124735|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
2124736|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124737|NCT02839772|Glycerol|glycerol|mesh-list
2124738|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2124739|NCT02839772|Protective Agents|protective agents|mesh-ancestor
2418922|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2567620|NCT01583660|Acetaminophen|acetaminophen|mesh-list
2567621|NCT01583660|Celecoxib|celecoxib|mesh-list
2567622|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2567623|NCT01583660|Oxycodone|oxycodone|mesh-list
2418923|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2418924|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2418925|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2418926|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418927|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2418928|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
2418929|NCT00801281|Hormones|hormones|mesh-ancestor
2124740|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124741|NCT02839876|Acetaminophen|acetaminophen|mesh-list
2124742|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2567624|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2567625|NCT01583660|Analgesics|analgesics|mesh-ancestor
2567626|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
2567627|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567628|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567629|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
2567630|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2567631|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2567632|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2567633|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2567634|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2567635|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567636|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567637|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2567638|NCT01583660|Narcotics|narcotics|mesh-ancestor
2567639|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567640|NCT01583777|Belinostat|belinostat|mesh-list
2567641|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567642|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2567643|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567644|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567645|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2567646|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567647|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567648|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567649|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2567650|NCT01583959|Folic Acid|folic acid|mesh-list
2124743|NCT02839876|Analgesics|analgesics|mesh-ancestor
2124744|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
2124745|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124746|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124747|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
2124748|NCT02839889|Naloxegol|naloxegol|mesh-list
2124749|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2567651|NCT01583959|Hematinics|hematinics|mesh-ancestor
2567652|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
2567653|NCT01583959|Vitamins|vitamins|mesh-ancestor
2567654|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
2567655|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567656|NCT01583972|Vitamin A|vitamin a|mesh-list
2567657|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
2567658|NCT01583972|Vitamins|vitamins|mesh-ancestor
2567659|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
2567660|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567661|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
2567662|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567663|NCT01583972|Protective Agents|protective agents|mesh-ancestor
2567664|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2124750|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124751|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
2124752|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124753|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
2124754|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2124755|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2124756|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124757|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
2567665|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567666|NCT01584050|Folic Acid|folic acid|mesh-list
2567667|NCT01584050|Hematinics|hematinics|mesh-ancestor
2567668|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
2567669|NCT01584050|Vitamins|vitamins|mesh-ancestor
2567670|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
2567671|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567672|NCT01584076|Donepezil|donepezil|mesh-list
2567673|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2567674|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567675|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567676|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
2567677|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567678|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567679|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
2567680|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
2567681|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2567682|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
2124758|NCT02840097|Coagulants|coagulants|mesh-ancestor
2124759|NCT02840461|Ivermectin|ivermectin|mesh-list
2124760|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2124761|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567683|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567684|NCT01584206|Ezetimibe|ezetimibe|mesh-list
2567685|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2567686|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2567687|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
2567688|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567689|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2567690|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2567691|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
2567692|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567693|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2567694|NCT01584297|Ketoconazole|ketoconazole|mesh-list
2567695|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
2124762|NCT02841033|Daratumumab|daratumumab|mesh-list
2124763|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124764|NCT02841241|Esmolol|esmolol|mesh-list
2124765|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2124766|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2124767|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2124768|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
2124769|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2124770|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124771|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124772|NCT02842073|Naltrexone|naltrexone|mesh-list
2124773|NCT02842073|Bupropion|bupropion|mesh-list
2124774|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2124775|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2124776|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124777|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
2124778|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124779|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2124780|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
2124781|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2124782|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2567696|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567697|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2567698|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2567699|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567700|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567701|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2567702|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
2567703|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2567704|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567705|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2567706|NCT01584362|Oxfendazole|oxfendazole|mesh-list
2567707|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
2124783|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2124784|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2124785|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124786|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
2124787|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2124788|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2124789|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2124790|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124791|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2124792|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2124793|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2124794|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2567708|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2567709|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567710|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
2567711|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2567712|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2567713|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2567714|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567715|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567716|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2567717|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2567718|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2567719|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
2567720|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567721|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567722|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2567723|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2567724|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
2567725|NCT01584492|Beclomethasone|beclomethasone|mesh-list
2567726|NCT01584492|Albuterol|albuterol|mesh-list
2567727|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
2567728|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2567729|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
2567730|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567731|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567732|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2567733|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
2567734|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2567735|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2567736|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2567737|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
2567738|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567739|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567740|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2567741|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
2567742|NCT01584492|Hormones|hormones|mesh-ancestor
2567743|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2567744|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
2567745|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2567746|NCT01584531|ON 01910|on 01910|mesh-list
2567747|NCT01584531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567748|NCT01584531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2567749|NCT01584531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567750|NCT01584531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567751|NCT01584557|Tolvaptan|tolvaptan|mesh-list
2567752|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2567753|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567754|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
2567755|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567756|NCT01584687|Omalizumab|omalizumab|mesh-list
2124795|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124796|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124797|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
2124798|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2124799|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2124800|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2124801|NCT02842853|Vaccines|vaccines|mesh-list
2124802|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
2124803|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567757|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2567758|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2567759|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
2567760|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
2567761|NCT01584726|Analgesics|analgesics|mesh-ancestor
2567762|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
2567763|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567764|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567765|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
2567766|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567767|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2567768|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
2567769|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2567770|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2567771|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567772|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2567773|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
2567774|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2567775|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
2567776|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
2567777|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567778|NCT01584791|Aspirin|aspirin|mesh-list
2567779|NCT01584791|Clopidogrel|clopidogrel|mesh-list
2567780|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2567781|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2124804|NCT02842866|Vaccines|vaccines|mesh-list
2567782|NCT01584791|Analgesics|analgesics|mesh-ancestor
2567783|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
2567784|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124805|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
2124806|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124807|NCT02844439|XL647|xl647|mesh-list
2124808|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124809|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2124810|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124811|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124812|NCT02844582|Prednisone|prednisone|mesh-list
2124813|NCT02844582|Cortisone|cortisone|mesh-list
2124814|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2124815|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
2124816|NCT02844582|Hormones|hormones|mesh-ancestor
2124817|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2124818|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567785|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567786|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2567787|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2567788|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2567789|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2567790|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567791|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2567792|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2567793|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567794|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
2567795|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2567796|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2567797|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2567798|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
2567799|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567800|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
2567801|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
2567802|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
2567803|NCT01584921|Hematinics|hematinics|mesh-ancestor
2567804|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
2567805|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2567806|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2567807|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
2567808|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
2124819|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2124820|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124821|NCT02845336|Celecoxib|celecoxib|mesh-list
2124822|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
2124823|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2124824|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2124825|NCT02845336|Analgesics|analgesics|mesh-ancestor
2124826|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
2124827|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124828|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124829|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2124830|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2124831|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2124832|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2124833|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124834|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124835|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2124836|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2567809|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567810|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567811|NCT01584947|Bupivacaine|bupivacaine|mesh-list
2567812|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
2567813|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
2567814|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124837|NCT02845375|Neostigmine|neostigmine|mesh-list
2124838|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2124839|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124840|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124841|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
2124842|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2124843|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124844|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2567815|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567816|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
2124845|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
2567817|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567818|NCT01585051|Vitamin D|vitamin d|mesh-list
2567819|NCT01585051|Vitamins|vitamins|mesh-ancestor
2567820|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
2567821|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567822|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2567823|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
2567824|NCT01585350|Poly ICLC|poly iclc|mesh-list
2567825|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2567826|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
2567827|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567828|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
2567829|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
2124846|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124847|NCT02845752|Bromides|bromides|mesh-list
2124848|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
2124849|NCT02845752|Olodaterol|olodaterol|mesh-list
2124850|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2124851|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
2124852|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124853|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124854|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2124855|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
2124856|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
2124857|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2124858|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
2124859|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2124860|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124861|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
2124862|NCT02846233|Metformin|metformin|mesh-list
2124863|NCT02846233|Empagliflozin|empagliflozin|mesh-list
2124864|NCT02846233|Dulaglutide|dulaglutide|mesh-list
2124865|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2124866|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
2124867|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2124868|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124869|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124870|NCT02846233|Incretins|incretins|mesh-ancestor
2124871|NCT02846233|Hormones|hormones|mesh-ancestor
2124872|NCT02846233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2124873|NCT02846792|Nivolumab|nivolumab|mesh-list
2124874|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2124875|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567830|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2567831|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567832|NCT01585415|Aldesleukin|aldesleukin|mesh-list
2567833|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
2567834|NCT01585415|Fludarabine|fludarabine|mesh-list
2567835|NCT01585415|Vemurafenib|vemurafenib|mesh-list
2567836|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2567837|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
2567838|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567839|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2567840|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2567841|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
2567842|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567843|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567844|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2567845|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2567846|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2567847|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
2567848|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567849|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2567850|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124876|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2124877|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124878|NCT02847260|Treprostinil|treprostinil|mesh-list
2124879|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2124880|NCT02847494|Dexamethasone|dexamethasone|mesh-list
2124881|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
2124882|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2124883|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2124884|NCT02847494|Prednisolone|prednisolone|mesh-list
2567851|NCT01585623|Metoprolol|metoprolol|mesh-list
2567852|NCT01585623|Midazolam|midazolam|mesh-list
2567853|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2567854|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2124885|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
2124886|NCT02847494|Metoclopramide|metoclopramide|mesh-list
2124887|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2124888|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
2124889|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2567855|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567856|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567857|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2567858|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2567859|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2567860|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2567861|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
2567862|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
2567863|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
2567864|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
2567865|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567866|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567867|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2567868|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2567869|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
2567870|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
2567871|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567872|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2567873|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2567874|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2567875|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
2567876|NCT01585753|Maraviroc|maraviroc|mesh-list
2567877|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2567878|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2567879|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567880|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2567881|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2567882|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
2567883|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567884|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2567885|NCT01585792|Glimepiride|glimepiride|mesh-list
2567886|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2567887|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2567888|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567889|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2567890|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
2567905|NCT01585870|Sorafenib|sorafenib|mesh-list
2567906|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567907|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2567908|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567909|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567910|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2567911|NCT01585935|SMOFlipid|smoflipid|mesh-list
2567912|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2567913|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2567914|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2124890|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
2124891|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
2124892|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124893|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124894|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2124895|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
2124896|NCT02847494|Hormones|hormones|mesh-ancestor
2124897|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2567915|NCT01586013|Propofol|propofol|mesh-list
2567916|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2567917|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124898|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2124899|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124900|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2124901|NCT02847494|Protective Agents|protective agents|mesh-ancestor
2567918|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567919|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2567920|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
2567921|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
2567922|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
2567923|NCT01586052|Hematinics|hematinics|mesh-ancestor
2567924|NCT01586117|Amifostine|amifostine|mesh-list
2567925|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2567926|NCT01586117|Protective Agents|protective agents|mesh-ancestor
2567927|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567928|NCT01586143|Acetaminophen|acetaminophen|mesh-list
2567929|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2567930|NCT01586143|Analgesics|analgesics|mesh-ancestor
2418930|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2418931|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2418932|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2418933|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
2418934|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
2418935|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
2418936|NCT00801294|Nintedanib|nintedanib|mesh-list
2418937|NCT00801294|Afatinib|afatinib|mesh-list
2418938|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418939|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2418940|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418941|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418942|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2418943|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2418944|NCT00801385|Sorafenib|sorafenib|mesh-list
2418945|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567931|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
2567932|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567933|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567934|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
2567935|NCT01586169|Azithromycin|azithromycin|mesh-list
2567936|NCT01586169|Ivermectin|ivermectin|mesh-list
2567937|NCT01586169|Albendazole|albendazole|mesh-list
2124902|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2124903|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2124904|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
2124905|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2124906|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124907|NCT02848599|Morphine|morphine|mesh-list
2124908|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
2567938|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2567939|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2567940|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2567941|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
2567942|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
2567943|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2567944|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2567945|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
2567946|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
2567947|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
2567948|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567949|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2567950|NCT01586208|Phenytoin|phenytoin|mesh-list
2567951|NCT01586208|Valproic Acid|valproic acid|mesh-list
2567952|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
2567953|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567954|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567955|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
2567956|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2567957|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124909|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2124910|NCT02848599|Narcotics|narcotics|mesh-ancestor
2124911|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124912|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124913|NCT02848599|Analgesics|analgesics|mesh-ancestor
2567958|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
2567959|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2567960|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2567961|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2567962|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2567963|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2567964|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2567965|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2567966|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2567967|NCT01586286|Nifedipine|nifedipine|mesh-list
2567968|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2567969|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2567970|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567971|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2567972|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567973|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
2567974|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
2567975|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2567976|NCT01586299|Acetaminophen|acetaminophen|mesh-list
2567977|NCT01586299|Ibuprofen|ibuprofen|mesh-list
2567978|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2567979|NCT01586299|Analgesics|analgesics|mesh-ancestor
2567980|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
2124914|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
2124915|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124916|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
2124917|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
2124918|NCT02848651|Atezolizumab|atezolizumab|mesh-list
2124919|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2124920|NCT02848729|Acetaminophen|acetaminophen|mesh-list
2124921|NCT02848729|Morphine|morphine|mesh-list
2124922|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2124923|NCT02848729|Narcotics|narcotics|mesh-ancestor
2124924|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124925|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124926|NCT02848729|Analgesics|analgesics|mesh-ancestor
2124927|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
2567981|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2567982|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567983|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
2567984|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2567985|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2567986|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2567987|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2567988|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2567989|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2567990|NCT01586442|Eplerenone|eplerenone|mesh-list
2567991|NCT01586442|Spironolactone|spironolactone|mesh-list
2567992|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2567993|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
2567994|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2567995|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2567996|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2567997|NCT01586442|Diuretics|diuretics|mesh-ancestor
2567998|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
2567999|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2568000|NCT01586494|Tramadol|tramadol|mesh-list
2568001|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2568002|NCT01586494|Narcotics|narcotics|mesh-ancestor
2568003|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2568004|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568005|NCT01586494|Analgesics|analgesics|mesh-ancestor
2568006|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
2568007|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568008|NCT01586507|Tramadol|tramadol|mesh-list
2568009|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2568010|NCT01586507|Narcotics|narcotics|mesh-ancestor
2568011|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2568012|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568013|NCT01586507|Analgesics|analgesics|mesh-ancestor
2568014|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
2568015|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568016|NCT01586533|Mesalamine|mesalamine|mesh-list
2568017|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2568018|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2568019|NCT01586533|Analgesics|analgesics|mesh-ancestor
2568020|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
2568021|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568022|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124928|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124929|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2568023|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2568024|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2568025|NCT01586572|Vaccines|vaccines|mesh-list
2124930|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
2124931|NCT02848833|Empagliflozin|empagliflozin|mesh-list
2124932|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2124933|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124934|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2124935|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124936|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2124937|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2124938|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124939|NCT02849080|Incretins|incretins|mesh-ancestor
2124940|NCT02849080|Hormones|hormones|mesh-ancestor
2124941|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2124942|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2124943|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
2124944|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124945|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124946|NCT02849184|Suvorexant|suvorexant|mesh-list
2124947|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2124948|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2124949|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124950|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124951|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2124952|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2124953|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124954|NCT02849509|Vitamin K|vitamin k|mesh-list
2124955|NCT02849509|Dabigatran|dabigatran|mesh-list
2124956|NCT02849509|Vitamins|vitamins|mesh-ancestor
2124957|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
2124958|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124959|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
2568026|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
2568027|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568028|NCT01586611|Leucovorin|leucovorin|mesh-list
2568029|NCT01586611|Gemcitabine|gemcitabine|mesh-list
2568030|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
2568031|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2568032|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
2568033|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568034|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568035|NCT01586611|Antiviral Agents|antiviral agents|mesh-ancestor
2568036|NCT01586611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568037|NCT01586611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568038|NCT01586611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2568039|NCT01586611|Immunologic Factors|immunologic factors|mesh-ancestor
2568040|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568041|NCT01586611|Antidotes|antidotes|mesh-ancestor
2568042|NCT01586611|Protective Agents|protective agents|mesh-ancestor
2568043|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
2568044|NCT01586611|Vitamins|vitamins|mesh-ancestor
2568045|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
2568046|NCT01586845|Cyclosporine|cyclosporine|mesh-list
2568047|NCT01586845|Tacrolimus|tacrolimus|mesh-list
2568048|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2568049|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
2568050|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124960|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2124961|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
2124962|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2124963|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124964|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
2124965|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2124966|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2124967|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
2124968|NCT02849509|Coagulants|coagulants|mesh-ancestor
2124969|NCT02849678|Lidocaine|lidocaine|mesh-list
2124970|NCT02849678|Ropivacaine|ropivacaine|mesh-list
2124971|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
2124972|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
2124973|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2124974|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2124975|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
2568051|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2568052|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568053|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568054|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
2568055|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568056|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
2568057|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2124976|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2124977|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2124978|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2124979|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2124980|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2124981|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2124982|NCT02849704|Pancrelipase|pancrelipase|mesh-list
2124983|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2184852|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568058|NCT01587066|Valproic Acid|valproic acid|mesh-list
2568059|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2568060|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
2568061|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2568062|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2568063|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2568064|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2568065|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568066|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
2568067|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568068|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568069|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
2568070|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568071|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
2568072|NCT01587144|Lucanthone|lucanthone|mesh-list
2568073|NCT01587144|Temozolomide|temozolomide|mesh-list
2568074|NCT01587144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2568075|NCT01587144|Alkylating Agents|alkylating agents|mesh-ancestor
2568076|NCT01587144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568077|NCT01587144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568078|NCT01587144|Schistosomicides|schistosomicides|mesh-ancestor
2568079|NCT01587144|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2568080|NCT01587144|Anthelmintics|anthelmintics|mesh-ancestor
2568081|NCT01587144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2568082|NCT01587144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568083|NCT01587196|Naltrexone|naltrexone|mesh-list
2568084|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2568085|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2568086|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568087|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
2568088|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568089|NCT01587222|Octreotide|octreotide|mesh-list
2568090|NCT01587222|Midodrine|midodrine|mesh-list
2568091|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2568092|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2568093|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568094|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
2568095|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
2568096|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568097|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568098|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2568099|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2568100|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2568101|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2568102|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
2568103|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568104|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568105|NCT01587235|Simvastatin|simvastatin|mesh-list
2125010|NCT02850276|Bromides|bromides|mesh-list
2125011|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2125012|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
2125013|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2125014|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568106|NCT01587235|Ezetimibe|ezetimibe|mesh-list
2568107|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2568108|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2568109|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2568110|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
2568111|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568112|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2568113|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2568114|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568115|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
2568116|NCT01587261|Vitamins|vitamins|mesh-ancestor
2418946|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2418947|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418948|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418949|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
2418950|NCT00801411|Docetaxel|docetaxel|mesh-list
2418951|NCT00801411|Doxorubicin|doxorubicin|mesh-list
2418952|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2418953|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418954|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
2418955|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418956|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2418957|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2418958|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
2418959|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568117|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
2568118|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568119|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
2568120|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568121|NCT01587261|Protective Agents|protective agents|mesh-ancestor
2568122|NCT01587313|Hydralazine|hydralazine|mesh-list
2568123|NCT01587313|Isosorbide|isosorbide|mesh-list
2568124|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2568125|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2568126|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2568127|NCT01587313|Diuretics|diuretics|mesh-ancestor
2568128|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
2568129|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568130|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
2568131|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2568132|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568133|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2568134|NCT01587326|Citalopram|citalopram|mesh-list
2568135|NCT01587326|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2568136|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2568137|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2568138|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568139|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568140|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
2568141|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568142|NCT01587326|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2568143|NCT01587326|Antidepressive Agents|antidepressive agents|mesh-ancestor
2568144|NCT01587326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2568145|NCT01587339|Pregabalin|pregabalin|mesh-list
2568146|NCT01587339|Zonisamide|zonisamide|mesh-list
2568147|NCT01587339|Lacosamide|lacosamide|mesh-list
2568148|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2568149|NCT01587339|Ezogabine|ezogabine|mesh-list
2568150|NCT01587339|Analgesics|analgesics|mesh-ancestor
2568151|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
2568152|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568153|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568154|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
2568155|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2568156|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2568157|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568158|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2568159|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2568160|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2568161|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2568162|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2568163|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2568164|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2568170|NCT01587378|Metformin|metformin|mesh-list
2568171|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2568172|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568173|NCT01587430|Cytarabine|cytarabine|mesh-list
2568174|NCT01587430|Daunorubicin|daunorubicin|mesh-list
2568175|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
2568176|NCT01587430|Idarubicin|idarubicin|mesh-list
2568177|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2568178|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
2568179|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125015|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125016|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
2125017|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125018|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125019|NCT02850601|Dexamethasone|dexamethasone|mesh-list
2125020|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2125021|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
2125022|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
2125023|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2125024|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125025|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2125026|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
2125027|NCT02850601|Hormones|hormones|mesh-ancestor
2125028|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2125029|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2125030|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125031|NCT02850965|Adalimumab|adalimumab|mesh-list
2125032|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2125033|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2125034|NCT02851108|Primaquine|primaquine|mesh-list
2125035|NCT02851108|Phenothiazine|phenothiazine|mesh-list
2568180|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568181|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
2568182|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568183|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2568184|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
2568185|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568186|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2568187|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2568188|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2568189|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568190|NCT01587430|Analgesics|analgesics|mesh-ancestor
2568191|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
2568192|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2125036|NCT02851108|Methylene Blue|methylene blue|mesh-list
2125037|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
2125038|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2125039|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2125040|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125041|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125042|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125043|NCT02852005|Vaccines|vaccines|mesh-list
2125044|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
2125045|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568193|NCT01587482|Paclitaxel|paclitaxel|mesh-list
2568194|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2568195|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125046|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
2125047|NCT02852265|Etonogestrel|etonogestrel|mesh-list
2125048|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2125049|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125050|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2125051|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2125052|NCT02852434|Lidocaine|lidocaine|mesh-list
2125053|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
2125054|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
2125055|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2125056|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125057|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
2125058|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2125059|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2125060|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2125061|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2568196|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
2568197|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
2568198|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
2568199|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568200|NCT01587495|Ertapenem|ertapenem|mesh-list
2568201|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2568202|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125062|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2125063|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125064|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
2125065|NCT02853123|Olodaterol|olodaterol|mesh-list
2125066|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2125067|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
2125068|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2125069|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125070|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2125071|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
2125072|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
2125073|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2125074|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
2125075|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125076|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125077|NCT02853305|Gemcitabine|gemcitabine|mesh-list
2125078|NCT02853305|Carboplatin|carboplatin|mesh-list
2125079|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
2125080|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125081|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2125082|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
2125083|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125084|NCT02853305|Antiviral Agents|antiviral agents|mesh-ancestor
2125085|NCT02853305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125086|NCT02853305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125087|NCT02853305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2125088|NCT02853305|Immunologic Factors|immunologic factors|mesh-ancestor
2125089|NCT02853305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125090|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125091|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
2125092|NCT02853318|Bevacizumab|bevacizumab|mesh-list
2125093|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
2125094|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2125095|NCT02853318|Antibodies|antibodies|mesh-list
2125096|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
2125097|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2125098|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
2125099|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
2125100|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2568203|NCT01587508|Meloxicam|meloxicam|mesh-list
2568204|NCT01587508|Amitriptyline|amitriptyline|mesh-list
2568205|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
2568206|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2568207|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2568208|NCT01587508|Analgesics|analgesics|mesh-ancestor
2568209|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
2568210|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568211|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568212|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2568213|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2568214|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2568215|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2568216|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125101|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
2125102|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125103|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2125104|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2125105|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
2125106|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125107|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125108|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2125109|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2125110|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2125111|NCT02853318|Growth Substances|growth substances|mesh-ancestor
2125112|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
2125113|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
2568217|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568218|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2568219|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
2568220|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2568221|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2568222|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2568223|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2568224|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2568225|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2568226|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2568227|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2568228|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
2568229|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568230|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2568231|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
2568232|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125114|NCT02853331|Sunitinib|sunitinib|mesh-list
2125115|NCT02853331|Axitinib|axitinib|mesh-list
2125116|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125117|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125118|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2568233|NCT01587625|Oxytocin|oxytocin|mesh-list
2568234|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
2568235|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2568236|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568237|NCT01587638|Metoprolol|metoprolol|mesh-list
2568238|NCT01587638|Atenolol|atenolol|mesh-list
2568239|NCT01587638|Carvedilol|carvedilol|mesh-list
2568240|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
2568241|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2568242|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2568243|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
2568244|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
2568245|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568246|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125119|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2125120|NCT02853331|Growth Substances|growth substances|mesh-ancestor
2125121|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125122|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
2125123|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2125124|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125125|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125126|NCT02854527|Metformin|metformin|mesh-list
2125127|NCT02854527|Digoxin|digoxin|mesh-list
2125128|NCT02854527|Furosemide|furosemide|mesh-list
2125129|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2125130|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2125131|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125132|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2125133|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2125134|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
2125135|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125136|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2125137|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2125138|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125139|NCT02854527|Diuretics|diuretics|mesh-ancestor
2568247|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2568248|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2568249|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
2568250|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568251|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568252|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
2568253|NCT01587638|Protective Agents|protective agents|mesh-ancestor
2568254|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2568255|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2568256|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2568257|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
2568258|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2568259|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2568260|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
2568261|NCT01587729|Serotonin|serotonin|mesh-list
2568262|NCT01587729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2568263|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2568264|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2568265|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
2568266|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125140|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
2125141|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2125142|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2125143|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2125144|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2125145|NCT02854527|Protective Agents|protective agents|mesh-ancestor
2125146|NCT02854631|Prednisolone|prednisolone|mesh-list
2125147|NCT02854631|Selonsertib|selonsertib|mesh-list
2125148|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2125149|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
2125150|NCT02854631|Hormones|hormones|mesh-ancestor
2568267|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568268|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568269|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2568270|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2568271|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2568272|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568273|NCT01587820|Cisplatin|cisplatin|mesh-list
2568274|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568275|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2568276|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2568277|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125151|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2125152|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125153|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2125154|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125155|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2125156|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125157|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125158|NCT02854800|Varenicline|varenicline|mesh-list
2125159|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2125160|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2125161|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
2568278|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
2568279|NCT01588002|Ritonavir|ritonavir|mesh-list
2568280|NCT01588002|Efavirenz|efavirenz|mesh-list
2568281|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2568282|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2568283|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
2568284|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568285|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568286|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2568287|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2568288|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
2568289|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568290|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2568291|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2568292|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2568293|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2568294|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2568295|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2568296|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2568297|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2568298|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2568299|NCT01588093|Mecasermin|mecasermin|mesh-list
2568300|NCT01588093|Growth Substances|growth substances|mesh-ancestor
2568301|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568302|NCT01588171|Enoxaparin|enoxaparin|mesh-list
2568303|NCT01588171|Bemiparin|bemiparin|mesh-list
2568304|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
2568305|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2568306|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2568307|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568308|NCT01588314|Gabapentin|gabapentin|mesh-list
2125162|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125163|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125164|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125165|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2125166|NCT02855086|Cetuximab|cetuximab|mesh-list
2125167|NCT02855086|Antibodies|antibodies|mesh-list
2125168|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
2125169|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2125170|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
2125171|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125172|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125173|NCT02855359|Prednisone|prednisone|mesh-list
2125174|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
2125175|NCT02855359|Rituximab|rituximab|mesh-list
2125176|NCT02855359|Doxorubicin|doxorubicin|mesh-list
2125177|NCT02855359|Vincristine|vincristine|mesh-list
2125178|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2125179|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
2125180|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125181|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2125182|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2125183|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
2125184|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125185|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125186|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2125187|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2568309|NCT01588314|Analgesics|analgesics|mesh-ancestor
2568310|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
2568311|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568312|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568313|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
2568314|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2568315|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2568316|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2568317|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2568318|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2568319|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2568320|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568321|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568322|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
2125188|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2125189|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2125190|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2125191|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125192|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2125193|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
2125194|NCT02855359|Hormones|hormones|mesh-ancestor
2125195|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2125196|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2125197|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2125198|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
2125199|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
2125200|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
2125201|NCT02856555|Firsocostat|firsocostat|mesh-list
2125202|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125203|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125204|NCT02856802|Sumatriptan|sumatriptan|mesh-list
2568338|NCT01588522|Calcitriol|calcitriol|mesh-list
2568339|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2125205|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2125206|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2125207|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2125208|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
2125209|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125210|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125211|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125212|NCT02856880|Zinc|zinc|mesh-list
2568340|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568341|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2568342|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2568343|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568344|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2568345|NCT01588522|Vitamins|vitamins|mesh-ancestor
2568346|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
2568347|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2568348|NCT01588535|Benzocaine|benzocaine|mesh-list
2125213|NCT02856880|Trace Elements|trace elements|mesh-ancestor
2125214|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
2125215|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125221|NCT02858076|Aflibercept|aflibercept|mesh-list
2125222|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
2125223|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2125224|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2125225|NCT02858076|Growth Substances|growth substances|mesh-ancestor
2125226|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125227|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
2125228|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125229|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
2125230|NCT02858180|Ledipasvir|ledipasvir|mesh-list
2125231|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
2125232|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125233|NCT02858401|Vesatolimod|vesatolimod|mesh-list
2125234|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
2125235|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125236|NCT02858713|Betamethasone|betamethasone|mesh-list
2125237|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
2125238|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2125239|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
2125240|NCT02858713|Calcipotriene|calcipotriene|mesh-list
2125241|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2125242|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2125243|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
2125244|NCT02858713|Hormones|hormones|mesh-ancestor
2125245|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2125246|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125247|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2125248|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
2568349|NCT01588535|Anesthetics, Local|anesthetics, local|mesh-ancestor
2568350|NCT01588535|Anesthetics|anesthetics|mesh-ancestor
2568351|NCT01588535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2568352|NCT01588535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568353|NCT01588535|Sensory System Agents|sensory system agents|mesh-ancestor
2568354|NCT01588535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568355|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2125249|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
2125250|NCT02859142|Nicotine|nicotine|mesh-list
2125251|NCT02859142|Varenicline|varenicline|mesh-list
2125252|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2125253|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
2125254|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2125255|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125256|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2125257|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2125258|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
2125259|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125260|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125261|NCT02859246|Guaifenesin|guaifenesin|mesh-list
2125262|NCT02859246|Expectorants|expectorants|mesh-ancestor
2125263|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
2125264|NCT02859324|Nivolumab|nivolumab|mesh-list
2125265|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2568356|NCT01588587|Vildagliptin|vildagliptin|mesh-list
2568357|NCT01588587|Alogliptin|alogliptin|mesh-list
2568358|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2568359|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568360|NCT01588587|Incretins|incretins|mesh-ancestor
2568361|NCT01588587|Hormones|hormones|mesh-ancestor
2568362|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2568363|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2568364|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
2568365|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568366|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568367|NCT01588626|Ticagrelor|ticagrelor|mesh-list
2568368|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2568369|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2568370|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2568371|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2568372|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
2568373|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568374|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125266|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125267|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2125268|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125269|NCT02859441|Ranibizumab|ranibizumab|mesh-list
2125270|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2125271|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2125272|NCT02859441|Growth Substances|growth substances|mesh-ancestor
2125273|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125274|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
2125275|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125276|NCT02859454|Avelumab|avelumab|mesh-list
2125277|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125278|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125279|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
2125280|NCT02860507|Neostigmine|neostigmine|mesh-list
2125281|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2125282|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125283|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125284|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
2125285|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125286|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568375|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568376|NCT01588639|Insulin|insulin|mesh-list
2568377|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2568378|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2568379|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568380|NCT01588704|Bevacizumab|bevacizumab|mesh-list
2568381|NCT01588704|Pemetrexed|pemetrexed|mesh-list
2125287|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2125288|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
2125289|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568382|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2568383|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568384|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2568385|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2568386|NCT01588704|Growth Substances|growth substances|mesh-ancestor
2568387|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568388|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
2568389|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568390|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568391|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2568392|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2568393|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
2568394|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2568395|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2568396|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2568397|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
2568398|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568399|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568400|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568401|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
2568402|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2568403|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568404|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
2568405|NCT01588756|Goralatide|goralatide|mesh-list
2568406|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
2568407|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568408|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2568409|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568410|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
2125290|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2125291|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2125292|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2125293|NCT02860546|Nivolumab|nivolumab|mesh-list
2125294|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125295|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125296|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2125297|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125298|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2125299|NCT02860845|Clindamycin|clindamycin|mesh-list
2568411|NCT01588756|Growth Substances|growth substances|mesh-ancestor
2568412|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568413|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2568414|NCT01588756|Protective Agents|protective agents|mesh-ancestor
2568415|NCT01588782|Ketoconazole|ketoconazole|mesh-list
2568416|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
2568417|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568418|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2568419|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2568420|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568421|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568422|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2568423|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
2568424|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2568425|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568426|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2568427|NCT01588795|Vitamin D|vitamin d|mesh-list
2568428|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
2568429|NCT01588795|Diuretics|diuretics|mesh-list
2568430|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2568431|NCT01588795|Vitamins|vitamins|mesh-ancestor
2568432|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
2568433|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568434|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2568435|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2568436|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
2568437|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568438|NCT01588847|Sufentanil|sufentanil|mesh-list
2568439|NCT01588847|Bupivacaine|bupivacaine|mesh-list
2568440|NCT01588847|Anesthetics|anesthetics|mesh-list
2568441|NCT01588847|Propofol|propofol|mesh-list
2568442|NCT01588847|Sevoflurane|sevoflurane|mesh-list
2418960|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418961|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2418962|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
2418963|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
2418964|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
2418965|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2418966|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2568443|NCT01588847|Rocuronium|rocuronium|mesh-list
2568444|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
2568445|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2568446|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568447|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
2568448|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568449|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2568450|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2568451|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
2568452|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2418967|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2125300|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
2125301|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
2568453|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2568454|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2568455|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2568456|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2568457|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2568458|NCT01588847|Narcotics|narcotics|mesh-ancestor
2568459|NCT01588847|Analgesics|analgesics|mesh-ancestor
2568460|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2568461|NCT01588873|Desogestrel|desogestrel|mesh-list
2568462|NCT01588873|NuvaRing|nuvaring|mesh-list
2568463|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2568464|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2568465|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2568466|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
2568467|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2568468|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568469|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2568470|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2568471|NCT01588873|Progestins|progestins|mesh-ancestor
2568472|NCT01588873|Hormones|hormones|mesh-ancestor
2568473|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2568474|NCT01588912|Tenofovir|tenofovir|mesh-list
2568475|NCT01588912|Entecavir|entecavir|mesh-list
2568476|NCT01588912|Telbivudine|telbivudine|mesh-list
2568477|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
2568478|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568479|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2568480|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2568481|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568482|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568483|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2568484|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2568485|NCT01588925|Dexamethasone|dexamethasone|mesh-list
2568486|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
2568487|NCT01588925|BB 1101|bb 1101|mesh-list
2568488|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
2568489|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2568490|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
2568491|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
2568492|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568493|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568494|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2568495|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
2568496|NCT01588925|Hormones|hormones|mesh-ancestor
2568497|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2568498|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2568499|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568500|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
2568501|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568502|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568503|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2568504|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
2568505|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
2568506|NCT01588925|Protective Agents|protective agents|mesh-ancestor
2568507|NCT01589055|Nicotine|nicotine|mesh-list
2568508|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2568509|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
2568510|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568511|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568512|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2568513|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2568514|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
2568515|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568516|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568517|NCT01589068|Nicotine|nicotine|mesh-list
2568518|NCT01589068|Progesterone|progesterone|mesh-list
2568519|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2568520|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
2568521|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568522|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568523|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2568524|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2568525|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
2568526|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568527|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568528|NCT01589068|Progestins|progestins|mesh-ancestor
2568529|NCT01589068|Hormones|hormones|mesh-ancestor
2568530|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2568531|NCT01589081|Nicotine|nicotine|mesh-list
2568532|NCT01589081|Progesterone|progesterone|mesh-list
2568533|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2568534|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
2568535|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568536|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568537|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2568538|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2568539|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
2568540|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568541|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568542|NCT01589081|Progestins|progestins|mesh-ancestor
2568543|NCT01589081|Hormones|hormones|mesh-ancestor
2568544|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2568545|NCT01589146|Heparin|heparin|mesh-list
2568546|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2568547|NCT01589146|Tinzaparin|tinzaparin|mesh-list
2568548|NCT01589146|Dalteparin|dalteparin|mesh-list
2568549|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
2568550|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2125302|NCT02860845|Clotrimazole|clotrimazole|mesh-list
2125303|NCT02860845|Miconazole|miconazole|mesh-list
2125304|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
2125305|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125306|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2125307|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125308|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125309|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2125310|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2568551|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2568552|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568553|NCT01589159|Capecitabine|capecitabine|mesh-list
2568554|NCT01589159|Etoposide|etoposide|mesh-list
2568555|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2568556|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
2568557|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568558|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568559|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2568560|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2568561|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2568562|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568563|NCT01589354|Ropivacaine|ropivacaine|mesh-list
2568564|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
2568565|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
2568566|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2125311|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2125312|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2125313|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
2125314|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2125315|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125316|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2125317|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2125321|NCT02861131|Neostigmine|neostigmine|mesh-list
2125322|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2125323|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125324|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125325|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
2125326|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125327|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125328|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2125329|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
2125330|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568567|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568568|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
2568569|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568570|NCT01589367|Metformin|metformin|mesh-list
2568571|NCT01589367|Letrozole|letrozole|mesh-list
2568572|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2568573|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568574|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568575|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2125331|NCT02861586|Vaccines|vaccines|mesh-list
2125332|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
2125333|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125334|NCT02861664|Fluorides|fluorides|mesh-list
2125335|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
2125336|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
2125337|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
2125338|NCT02861664|Protective Agents|protective agents|mesh-ancestor
2125339|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125340|NCT02862106|Vaccines|vaccines|mesh-list
2125341|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
2568576|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2568577|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568578|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568579|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2568580|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
2568581|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2568582|NCT01589393|Enoxaparin|enoxaparin|mesh-list
2568583|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
2568584|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2568585|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2568586|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568587|NCT01589419|Capecitabine|capecitabine|mesh-list
2568588|NCT01589419|Veliparib|veliparib|mesh-list
2568589|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2568590|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
2568591|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568592|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568593|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2568594|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568595|NCT01589432|Lidocaine|lidocaine|mesh-list
2568596|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
2568597|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
2568598|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2568599|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568600|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
2568601|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568602|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2568603|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2568604|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2568605|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2568606|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568607|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
2568608|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2418968|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418969|NCT00801450|Triamcinolone|triamcinolone|mesh-list
2418970|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2418971|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2418972|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2125342|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125343|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
2125344|NCT02862535|Nivolumab|nivolumab|mesh-list
2418973|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2418974|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
2418975|NCT00801450|Hormones|hormones|mesh-ancestor
2418976|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2418977|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418978|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418979|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
2418980|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2418981|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418982|NCT00801489|Cytarabine|cytarabine|mesh-list
2418983|NCT00801489|Fludarabine|fludarabine|mesh-list
2418984|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
2418985|NCT00801489|Decitabine|decitabine|mesh-list
2418986|NCT00801489|Idarubicin|idarubicin|mesh-list
2418987|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
2418988|NCT00801489|Calicheamicins|calicheamicins|mesh-list
2418989|NCT00801489|Lenograstim|lenograstim|mesh-list
2418990|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2418991|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2418992|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
2418993|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2418994|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2418995|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
2568609|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2568610|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2568611|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2568612|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568613|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
2568614|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568615|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568616|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2568617|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568618|NCT01589523|Cholic Acids|cholic acids|mesh-list
2568619|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
2568620|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2568621|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2568622|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
2568623|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2568624|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
2568625|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
2568626|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568627|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568628|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2568629|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
2568630|NCT01589549|Hormones|hormones|mesh-ancestor
2568631|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2568632|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2568633|NCT01589549|Protective Agents|protective agents|mesh-ancestor
2568634|NCT01589562|Megestrol|megestrol|mesh-list
2568635|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
2125345|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125346|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125347|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2125348|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125349|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
2125350|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568636|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2568637|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2568638|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2568639|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
2568640|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2568641|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568642|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2568643|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2568644|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2568645|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568646|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
2568647|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2568648|NCT01589614|Erythromycin|erythromycin|mesh-list
2568649|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
2568650|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2568651|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
2568652|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2568653|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568654|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2568655|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2568656|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568657|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568658|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2568659|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
2568660|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2568661|NCT01589744|Hemostatics|hemostatics|mesh-list
2568662|NCT01589744|Coagulants|coagulants|mesh-ancestor
2568663|NCT01589809|Niacinamide|niacinamide|mesh-list
2568664|NCT01589809|Niacin|niacin|mesh-list
2568665|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
2568666|NCT01589809|Vitamins|vitamins|mesh-ancestor
2568667|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
2568668|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568669|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
2568670|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2568671|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
2568672|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568673|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2125351|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
2568674|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
2568675|NCT01589861|Lapatinib|lapatinib|mesh-list
2568676|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568677|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2568678|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568679|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568680|NCT01589952|Interferons|interferons|mesh-list
2568681|NCT01589952|Entecavir|entecavir|mesh-list
2568682|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568683|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
2568684|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568685|NCT01590069|Aldesleukin|aldesleukin|mesh-list
2568686|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568687|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2568688|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2568689|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
2568690|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568691|NCT01590173|Prednisolone|prednisolone|mesh-list
2568692|NCT01590173|Heparin|heparin|mesh-list
2568693|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2568694|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
2568695|NCT01590173|Hormones|hormones|mesh-ancestor
2568696|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2568697|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568698|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2568699|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568700|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
2568701|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2568702|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2568703|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568704|NCT01590199|Everolimus|everolimus|mesh-list
2125352|NCT02862574|Methotrexate|methotrexate|mesh-list
2125353|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2568705|NCT01590199|Pasireotide|pasireotide|mesh-list
2568706|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568707|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2568708|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
2568709|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568710|NCT01590199|Hormones|hormones|mesh-ancestor
2568711|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2568712|NCT01590225|Ribavirin|ribavirin|mesh-list
2568713|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2568714|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
2568715|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
2568716|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568717|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
2568718|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568719|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
2568720|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568721|NCT01590277|Ethanol|ethanol|mesh-list
2568722|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2568723|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568724|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2125354|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
2125355|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2125356|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568725|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568726|NCT01590303|Ascorbic Acid|ascorbic acid|mesh-list
2568727|NCT01590303|Vitamins|vitamins|mesh-ancestor
2568728|NCT01590303|Micronutrients|micronutrients|mesh-ancestor
2568729|NCT01590303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568730|NCT01590303|Antioxidants|antioxidants|mesh-ancestor
2568731|NCT01590303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568732|NCT01590303|Protective Agents|protective agents|mesh-ancestor
2568733|NCT01590342|Diclofenac|diclofenac|mesh-list
2568734|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2568735|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2568736|NCT01590342|Analgesics|analgesics|mesh-ancestor
2568737|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
2568738|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568739|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568740|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2568741|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2568742|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2568743|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568744|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568745|NCT01590537|Copper|copper|mesh-list
2568746|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
2568747|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2125357|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2125358|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
2125359|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125360|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125361|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
2125362|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125363|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2125364|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2125365|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
2125366|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2125367|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2125368|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2125369|NCT02862600|Perhexiline|perhexiline|mesh-list
2125370|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2125371|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2125372|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125373|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2125374|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125375|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
2125376|NCT02862730|Pancrelipase|pancrelipase|mesh-list
2125377|NCT02862730|Pancreatin|pancreatin|mesh-list
2125378|NCT02862730|Hormones|hormones|mesh-list
2125379|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125380|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2125381|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2125382|NCT02862912|Fentanyl|fentanyl|mesh-list
2125383|NCT02862912|Bupivacaine|bupivacaine|mesh-list
2125384|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
2125385|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
2125386|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
2125387|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2125388|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125389|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
2125390|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2125391|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2125392|NCT02862912|Narcotics|narcotics|mesh-ancestor
2125393|NCT02862912|Analgesics|analgesics|mesh-ancestor
2125394|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2125395|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2125396|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
2125397|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
2125398|NCT02863263|Povidone|povidone|mesh-list
2125399|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
2125400|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
2125401|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2125402|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125403|NCT02863328|Empagliflozin|empagliflozin|mesh-list
2125404|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2125405|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125406|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2568748|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
2568749|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2568750|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568751|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2568752|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2568753|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2568754|NCT01590537|Trace Elements|trace elements|mesh-ancestor
2568755|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
2568756|NCT01590641|Vesatolimod|vesatolimod|mesh-list
2568757|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
2568758|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568759|NCT01590654|Vesatolimod|vesatolimod|mesh-list
2568760|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
2568761|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568762|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2568763|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568764|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568765|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568766|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2568767|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
2568768|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2568769|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2568770|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2568771|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2125407|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125408|NCT02863354|Aflibercept|aflibercept|mesh-list
2125409|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2125410|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2568772|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568773|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
2568774|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568775|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568776|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2568777|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568778|NCT01590719|Leucovorin|leucovorin|mesh-list
2568779|NCT01590719|Folic Acid|folic acid|mesh-list
2568780|NCT01590719|Fluorouracil|fluorouracil|mesh-list
2125411|NCT02863354|Growth Substances|growth substances|mesh-ancestor
2125412|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125413|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
2125414|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125415|NCT02863419|Liraglutide|liraglutide|mesh-list
2125416|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2125417|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125418|NCT02863419|Incretins|incretins|mesh-ancestor
2125419|NCT02863419|Hormones|hormones|mesh-ancestor
2125420|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2125421|NCT02863575|Ibuprofen|ibuprofen|mesh-list
2125422|NCT02863575|Caffeine|caffeine|mesh-list
2125423|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2418996|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2418997|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2418998|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
2418999|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419000|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419001|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2419002|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2419003|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2419004|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2419005|NCT00801515|Maraviroc|maraviroc|mesh-list
2419006|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2568781|NCT01590719|Oxaliplatin|oxaliplatin|mesh-list
2568782|NCT01590719|Levoleucovorin|levoleucovorin|mesh-list
2568783|NCT01590719|Antimetabolites|antimetabolites|mesh-ancestor
2568784|NCT01590719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568785|NCT01590719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2125424|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2125425|NCT02863575|Analgesics|analgesics|mesh-ancestor
2125426|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
2125427|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2125428|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125429|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2125430|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2125431|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2125432|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125433|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125434|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2125435|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2568786|NCT01590719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568787|NCT01590719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2568788|NCT01590719|Immunologic Factors|immunologic factors|mesh-ancestor
2568789|NCT01590719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568790|NCT01590719|Antidotes|antidotes|mesh-ancestor
2568791|NCT01590719|Protective Agents|protective agents|mesh-ancestor
2568792|NCT01590719|Vitamin B Complex|vitamin b complex|mesh-ancestor
2568793|NCT01590719|Vitamins|vitamins|mesh-ancestor
2568794|NCT01590719|Micronutrients|micronutrients|mesh-ancestor
2568795|NCT01590719|Hematinics|hematinics|mesh-ancestor
2568796|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2568797|NCT01590732|Carboplatin|carboplatin|mesh-list
2568798|NCT01590732|Etoposide|etoposide|mesh-list
2568799|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
2568800|NCT01590732|Ifosfamide|ifosfamide|mesh-list
2568801|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
2568802|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
2568803|NCT01590732|Romidepsin|romidepsin|mesh-list
2568804|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568805|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2568806|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2568807|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2568808|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568809|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568810|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568811|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2568812|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
2568813|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
2568814|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
2568815|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
2568816|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
2568817|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
2568818|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2568819|NCT01590823|Dabigatran|dabigatran|mesh-list
2568820|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
2568821|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2568822|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
2568823|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568824|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568825|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
2568826|NCT01590836|Insulin|insulin|mesh-list
2568827|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2568828|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
2568829|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
2419007|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2419008|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419009|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2419010|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2419011|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
2419012|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419013|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2419014|NCT00801528|Diclofenac|diclofenac|mesh-list
2419015|NCT00801528|Ropivacaine|ropivacaine|mesh-list
2419016|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
2419017|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
2419018|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2419019|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568830|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2568831|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568832|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
2568833|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
2568834|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2568835|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2568836|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568837|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2568838|NCT01590901|Probucol|probucol|mesh-list
2568839|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2568840|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2568841|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
2568842|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568843|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2568844|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
2568845|NCT01590901|Protective Agents|protective agents|mesh-ancestor
2568846|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568847|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
2568848|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2568849|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
2568850|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568851|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2568852|NCT01591031|Sevoflurane|sevoflurane|mesh-list
2568853|NCT01591031|Rocuronium|rocuronium|mesh-list
2568854|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2568855|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2125436|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2125437|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2125438|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
2125439|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125440|NCT02864316|Nivolumab|nivolumab|mesh-list
2125441|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125442|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125443|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2125444|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125445|NCT02864368|Temozolomide|temozolomide|mesh-list
2125446|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2125447|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
2125448|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419020|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
2568856|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
2568857|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
2568858|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2568859|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125449|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125450|NCT02864381|Nivolumab|nivolumab|mesh-list
2125451|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125452|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125453|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2125454|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125455|NCT02864394|Docetaxel|docetaxel|mesh-list
2125456|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
2125457|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125458|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
2125459|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
2125460|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
2125461|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125462|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125463|NCT02864706|Cyclosporine|cyclosporine|mesh-list
2125464|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
2125465|NCT02864706|Everolimus|everolimus|mesh-list
2125466|NCT02864706|Cyclosporins|cyclosporins|mesh-list
2125467|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125468|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125469|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2125470|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
2125471|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125472|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
2125473|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568860|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2568861|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2568862|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2568863|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568864|NCT01591070|Tacrolimus|tacrolimus|mesh-list
2568865|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2568866|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
2568867|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568868|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2568869|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568870|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568871|NCT01591083|Esomeprazole|esomeprazole|mesh-list
2125474|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
2125475|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2125476|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2125477|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125478|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2125479|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2125480|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
2125481|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2125482|NCT02865187|Vitamin D|vitamin d|mesh-list
2125483|NCT02865187|Vitamins|vitamins|mesh-ancestor
2125484|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
2125485|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125486|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2125487|NCT02865499|Acarbose|acarbose|mesh-list
2125488|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2125489|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125490|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125491|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2125492|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125493|NCT02865590|Cimetidine|cimetidine|mesh-list
2125494|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2125495|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2125496|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2125497|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
2125498|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
2125499|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125500|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125501|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125502|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2125503|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2125504|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125505|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2568872|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2568873|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2568874|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2568875|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568876|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568877|NCT01591122|Prednisone|prednisone|mesh-list
2125506|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2125507|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2125508|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
2125509|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125510|NCT02865811|Doxorubicin|doxorubicin|mesh-list
2125511|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2125512|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
2125513|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2125514|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125515|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2125516|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2125517|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125518|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125519|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125520|NCT02866175|Vitamin K|vitamin k|mesh-list
2125521|NCT02866175|Edoxaban|edoxaban|mesh-list
2125522|NCT02866175|Clopidogrel|clopidogrel|mesh-list
2125523|NCT02866175|Ticagrelor|ticagrelor|mesh-list
2125524|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2125525|NCT02866175|Vitamins|vitamins|mesh-ancestor
2125526|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
2125527|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125528|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2125529|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2125530|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2125531|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2125532|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
2125533|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125534|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125535|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2125536|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2125537|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
2125538|NCT02866175|Coagulants|coagulants|mesh-ancestor
2125539|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2568878|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
2568879|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2568880|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
2568881|NCT01591122|Hormones|hormones|mesh-ancestor
2568882|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2568883|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568884|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2568885|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568886|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2568887|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568888|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568889|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
2568890|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2568891|NCT01591135|Paclitaxel|paclitaxel|mesh-list
2568892|NCT01591135|Fluorouracil|fluorouracil|mesh-list
2568893|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2568894|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125540|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
2125541|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2125542|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
2125543|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125544|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
2125545|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
2125546|NCT02866643|Etonogestrel|etonogestrel|mesh-list
2125547|NCT02866643|Desogestrel|desogestrel|mesh-list
2125548|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2125549|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568895|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
2568896|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
2568897|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
2568898|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568899|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
2568900|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2568901|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2568902|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
2568903|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568904|NCT01591148|Propofol|propofol|mesh-list
2125550|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2125551|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2568905|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2568906|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2568907|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568908|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2125552|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2125553|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2125554|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2125555|NCT02866643|Progestins|progestins|mesh-ancestor
2125556|NCT02866643|Hormones|hormones|mesh-ancestor
2125557|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2125558|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
2125559|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2125560|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2125561|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125562|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
2125563|NCT02867163|Coagulants|coagulants|mesh-ancestor
2125564|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
2125565|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2125566|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125567|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
2125568|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2125569|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
2125570|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125571|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
2125572|NCT02867605|Protective Agents|protective agents|mesh-ancestor
2125573|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2125574|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2125575|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
2125576|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2125577|NCT02868242|Ledipasvir|ledipasvir|mesh-list
2125578|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
2125579|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125580|NCT02869438|Benralizumab|benralizumab|mesh-list
2125581|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2125582|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
2125583|NCT02869451|Bupropion|bupropion|mesh-list
2125584|NCT02869451|Nicotine|nicotine|mesh-list
2125585|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2125586|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
2125587|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2125588|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125589|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2125590|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2125591|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
2125592|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125593|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125594|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2125595|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
2125596|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2125597|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2125598|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2125599|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2125600|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
2125601|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2125602|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2125603|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125604|NCT02869893|Secretin|secretin|mesh-list
2125605|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2125606|NCT02869893|Hormones|hormones|mesh-ancestor
2125607|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2125608|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125609|NCT02870283|Carbamazepine|carbamazepine|mesh-list
2125610|NCT02870283|Valproic Acid|valproic acid|mesh-list
2125611|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2125612|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125613|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125614|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
2125615|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2125616|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2125617|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125618|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
2125619|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
2125620|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125621|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2125622|NCT02870283|Analgesics|analgesics|mesh-ancestor
2125623|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
2125624|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568909|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
2568910|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
2568911|NCT01591226|Mannitol|mannitol|mesh-list
2568912|NCT01591226|Caffeine|caffeine|mesh-list
2568913|NCT01591226|Citric Acid|citric acid|mesh-list
2125625|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2125626|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2125627|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2125628|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2125629|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2125630|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2125631|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2125632|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
2125633|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125634|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125635|NCT02870920|Durvalumab|durvalumab|mesh-list
2125636|NCT02870920|Tremelimumab|tremelimumab|mesh-list
2125637|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125638|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125639|NCT02870972|Berotralstat|berotralstat|mesh-list
2125640|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125641|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125642|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
2125643|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2568914|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
2568915|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
2568916|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2568917|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
2568918|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
2568919|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568920|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2568921|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568922|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2125644|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
2125645|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2125646|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125647|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2125648|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
2125649|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2125650|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
2125651|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125652|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125653|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2125654|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
2568923|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2568924|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2568925|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2568926|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
2568927|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568928|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2568929|NCT01591226|Diuretics|diuretics|mesh-ancestor
2568930|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
2568931|NCT01591291|Ondansetron|ondansetron|mesh-list
2568932|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
2568933|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
2568934|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568935|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568936|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2568937|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
2568938|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
2568939|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2568940|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
2568941|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568942|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568943|NCT01591291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2568944|NCT01591291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2568945|NCT01591291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2568946|NCT01591291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2568947|NCT01591291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2568948|NCT01591421|Panitumumab|panitumumab|mesh-list
2568949|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2568950|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2568951|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2568952|NCT01591434|Laxatives|laxatives|mesh-ancestor
2125655|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
2125656|NCT02871011|Protective Agents|protective agents|mesh-ancestor
2125657|NCT02871492|Acyclovir|acyclovir|mesh-list
2125658|NCT02871492|Pritelivir|pritelivir|mesh-list
2125659|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
2125660|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125661|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125662|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125663|NCT02871635|Adalimumab|adalimumab|mesh-list
2125664|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2125665|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2125666|NCT02872012|Lidocaine|lidocaine|mesh-list
2125667|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
2125668|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
2125669|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2125670|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125671|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
2125672|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2125673|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2125674|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2125675|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2125676|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2125677|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568953|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2568954|NCT01591447|Solithromycin|solithromycin|mesh-list
2568955|NCT01591447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2568956|NCT01591447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568957|NCT01591473|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2568958|NCT01591473|Poly I-C|poly i-c|mesh-list
2568959|NCT01591473|Antiviral Agents|antiviral agents|mesh-ancestor
2568960|NCT01591473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568961|NCT01591473|Interferon Inducers|interferon inducers|mesh-ancestor
2568962|NCT01591473|Immunologic Factors|immunologic factors|mesh-ancestor
2568963|NCT01591473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568964|NCT01591551|Natalizumab|natalizumab|mesh-list
2568965|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
2568966|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568975|NCT01591629|Dronabinol|dronabinol|mesh-list
2568976|NCT01591629|Naloxone|naloxone|mesh-list
2568977|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2568978|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2568979|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
2568980|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2568981|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
2568982|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2568983|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2568984|NCT01591629|Analgesics|analgesics|mesh-ancestor
2568985|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2568986|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2568987|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2568988|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2568989|NCT01591629|Hormones|hormones|mesh-ancestor
2568990|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2568991|NCT01591668|Vesatolimod|vesatolimod|mesh-list
2568992|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
2568993|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2568994|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2568995|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
2568996|NCT01591850|Ritonavir|ritonavir|mesh-list
2568997|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2568998|NCT01591850|Ketoconazole|ketoconazole|mesh-list
2568999|NCT01591850|Rifampin|rifampin|mesh-list
2569000|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2569001|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2125678|NCT02872311|Vaccines|vaccines|mesh-list
2125679|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
2569002|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
2569003|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569004|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569005|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2125680|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125681|NCT02872857|Galantamine|galantamine|mesh-list
2125682|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2125683|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125684|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125685|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
2125686|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125687|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569006|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2569007|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
2569008|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569009|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2569010|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2569011|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
2569012|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2125688|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2125689|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
2125690|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569013|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2569014|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
2569015|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569016|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569017|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2569018|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
2569019|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2569020|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
2569021|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2569022|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2569023|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2569024|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2569025|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2569026|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2569027|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2569028|NCT01591889|Tinidazole|tinidazole|mesh-list
2569029|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
2569030|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569031|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2569032|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125691|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
2125692|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
2125693|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2125694|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2125695|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2125696|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
2125697|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125698|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125699|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419021|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419022|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2419023|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419024|NCT00801528|Analgesics|analgesics|mesh-ancestor
2419025|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419026|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2569033|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2419027|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2419028|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419029|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419030|NCT00801580|Doxorubicin|doxorubicin|mesh-list
2419031|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2419032|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2419033|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419034|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2419035|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2419036|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569034|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2569035|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2569036|NCT01591902|Tesamorelin|tesamorelin|mesh-list
2569037|NCT01591902|Growth Substances|growth substances|mesh-ancestor
2569038|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569039|NCT01591980|Pregabalin|pregabalin|mesh-list
2569040|NCT01591980|Analgesics|analgesics|mesh-ancestor
2569041|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
2569042|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569043|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569044|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
2569045|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2569046|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2569047|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569048|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2569049|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2569050|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2569051|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569052|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2569053|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
2569054|NCT01592019|Diclofenac|diclofenac|mesh-list
2569055|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2569056|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2569057|NCT01592019|Analgesics|analgesics|mesh-ancestor
2569058|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
2569059|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569060|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569061|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2569062|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2569063|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2569064|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569065|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569066|NCT01592032|Vancomycin|vancomycin|mesh-list
2569067|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2569068|NCT01592032|Linezolid|linezolid|mesh-list
2569069|NCT01592032|Daptomycin|daptomycin|mesh-list
2569070|NCT01592032|Tigecycline|tigecycline|mesh-list
2569071|NCT01592032|Teicoplanin|teicoplanin|mesh-list
2569072|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
2569073|NCT01592032|Heparin|heparin|mesh-list
2569074|NCT01592032|Calcium heparin|calcium heparin|mesh-list
2569075|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2569076|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
2569077|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2569078|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2569079|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569080|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2569081|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569082|NCT01592110|Risperidone|risperidone|mesh-list
2569083|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2569084|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
2569085|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2569086|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569087|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569088|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2569089|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2569090|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569091|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2569092|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2569093|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
2569094|NCT01592136|Ponatinib|ponatinib|mesh-list
2569095|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569096|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2569097|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569098|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569099|NCT01592162|Remifentanil|remifentanil|mesh-list
2569100|NCT01592162|Propofol|propofol|mesh-list
2569101|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2569102|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569103|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569104|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2569105|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
2569106|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
2569107|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2569108|NCT01592162|Narcotics|narcotics|mesh-ancestor
2569109|NCT01592162|Analgesics|analgesics|mesh-ancestor
2569110|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
2569111|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569112|NCT01592201|Olanzapine|olanzapine|mesh-list
2569113|NCT01592201|Risperidone|risperidone|mesh-list
2569114|NCT01592201|Aripiprazole|aripiprazole|mesh-list
2569115|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
2569116|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2569117|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
2569118|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2569119|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569120|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569121|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2569122|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569123|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2569124|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2569125|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
2569126|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
2569127|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
2569128|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569129|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2125719|NCT02873338|Cytarabine|cytarabine|mesh-list
2125720|NCT02873338|Idarubicin|idarubicin|mesh-list
2125721|NCT02873338|Heparin|heparin|mesh-list
2125722|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2125723|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
2125724|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125725|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125726|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
2125727|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125728|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2125729|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
2125730|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125731|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
2125732|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2125733|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2125734|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2125735|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2125736|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2125737|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125738|NCT02873377|Nicotine|nicotine|mesh-list
2125739|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2125740|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
2125741|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2125742|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569130|NCT01592201|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2569131|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2569132|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2569133|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
2569134|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
2569135|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2569136|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2569137|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2569138|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2569139|NCT01592214|Benzocaine|benzocaine|mesh-list
2569140|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
2569141|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
2569142|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569143|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569144|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
2569145|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569146|NCT01592227|Acetaminophen|acetaminophen|mesh-list
2569147|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2569148|NCT01592227|Analgesics|analgesics|mesh-ancestor
2569149|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
2569150|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569151|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569152|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
2569153|NCT01592253|Sirolimus|sirolimus|mesh-list
2569154|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2569155|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569156|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2125743|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2125744|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2125745|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
2125746|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125747|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125748|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
2125749|NCT02873689|Lansoprazole|lansoprazole|mesh-list
2125750|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2125751|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2125752|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2125753|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125754|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125755|NCT02873702|Lansoprazole|lansoprazole|mesh-list
2125756|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
2125757|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2125758|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2125759|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2125760|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125761|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125762|NCT02873754|Bupropion|bupropion|mesh-list
2125763|NCT02873754|Nicotine|nicotine|mesh-list
2125764|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2125765|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
2125766|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2125767|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125768|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2569157|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569158|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
2569159|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2569160|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
2569161|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569162|NCT01592279|Liraglutide|liraglutide|mesh-list
2569163|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2569164|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569165|NCT01592279|Incretins|incretins|mesh-ancestor
2569166|NCT01592279|Hormones|hormones|mesh-ancestor
2569167|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569168|NCT01592305|Ritonavir|ritonavir|mesh-list
2125769|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2125770|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
2125771|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125772|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125773|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2419037|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419038|NCT00801606|Zinc|zinc|mesh-list
2419039|NCT00801606|Trace Elements|trace elements|mesh-list
2419040|NCT00801606|Micronutrients|micronutrients|mesh-list
2419041|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419042|NCT00801697|Vaccines|vaccines|mesh-list
2419043|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
2419044|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419045|NCT00801736|Paclitaxel|paclitaxel|mesh-list
2419046|NCT00801736|Cisplatin|cisplatin|mesh-list
2419047|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2419048|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569169|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2569170|NCT01592305|Tenofovir|tenofovir|mesh-list
2569171|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2569172|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2569173|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
2569174|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569175|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569176|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2569177|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2569178|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
2569179|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125774|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
2125775|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2125776|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2419049|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
2569180|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2569181|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2569182|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2569183|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2569184|NCT01592318|Ritonavir|ritonavir|mesh-list
2569185|NCT01592318|Lactams|lactams|mesh-list
2569186|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2569187|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2569188|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
2569189|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569190|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569191|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2569192|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2569193|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
2569194|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569195|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2569196|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2569197|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2569198|NCT01592370|Dexamethasone|dexamethasone|mesh-list
2569199|NCT01592370|Nivolumab|nivolumab|mesh-list
2569200|NCT01592370|Ipilimumab|ipilimumab|mesh-list
2125777|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2125778|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2125779|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
2125780|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2125781|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2125782|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125783|NCT02874092|Ticagrelor|ticagrelor|mesh-list
2125784|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2125785|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2125786|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2125787|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2125788|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
2125789|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125790|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125791|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569201|NCT01592370|Pomalidomide|pomalidomide|mesh-list
2569202|NCT01592370|Daratumumab|daratumumab|mesh-list
2569203|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2569204|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
2569205|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
2569206|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569207|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569208|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2569209|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
2569210|NCT01592370|Hormones|hormones|mesh-ancestor
2569211|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569212|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2569213|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569214|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2569215|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2569216|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569217|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
2569218|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2569219|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2569220|NCT01592370|Growth Substances|growth substances|mesh-ancestor
2569221|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
2569222|NCT01592526|Nicotine|nicotine|mesh-list
2569223|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2569224|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
2569225|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569226|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569227|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2569228|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2569229|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
2569230|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2569231|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569232|NCT01592630|Ropivacaine|ropivacaine|mesh-list
2569233|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
2569234|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
2569235|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569236|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569237|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
2569238|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569239|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
2569240|NCT01592981|Rituximab|rituximab|mesh-list
2569241|NCT01592981|Fludarabine|fludarabine|mesh-list
2569242|NCT01592981|Bortezomib|bortezomib|mesh-list
2569243|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2569244|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
2569245|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125812|NCT02874794|Valsartan|valsartan|mesh-list
2569246|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2569247|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2569248|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
2569249|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569250|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569251|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2569252|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2569253|NCT01593033|Micronutrients|micronutrients|mesh-list
2569254|NCT01593033|Trace Elements|trace elements|mesh-list
2569255|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569256|NCT01593046|Cabotegravir|cabotegravir|mesh-list
2569257|NCT01593046|Rilpivirine|rilpivirine|mesh-list
2569258|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2569259|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2569260|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569261|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569262|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2569263|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2569264|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
2569265|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125813|NCT02874794|Enalapril|enalapril|mesh-list
2125814|NCT02874794|Enalaprilat|enalaprilat|mesh-list
2125815|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2125816|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2125817|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2125818|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2125819|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125820|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2125821|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
2125822|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125823|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2125824|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2125825|NCT02874924|Sirolimus|sirolimus|mesh-list
2125826|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2125827|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125828|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2125829|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125830|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
2125831|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2125832|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
2125833|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125834|NCT02875028|Vorapaxar|vorapaxar|mesh-list
2125835|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2125836|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
2125837|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
2125838|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125839|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125840|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125841|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
2125842|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
2125843|NCT02875340|Risperidone|risperidone|mesh-list
2125844|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2125845|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
2125846|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2125847|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125848|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569266|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2569267|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2569268|NCT01593124|Imiquimod|imiquimod|mesh-list
2569269|NCT01593124|Nonoxynol|nonoxynol|mesh-list
2569270|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2569271|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
2569272|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125849|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2125850|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2125851|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2125852|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2125853|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2125854|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
2125855|NCT02875366|Ivacaftor|ivacaftor|mesh-list
2125856|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2125857|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2125858|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569273|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569274|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
2569275|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2125859|NCT02875392|Fucoidan|fucoidan|mesh-list
2125860|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2125861|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2125862|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
2125863|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125864|NCT02875613|Avelumab|avelumab|mesh-list
2125865|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125866|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125867|NCT02876601|Defibrotide|defibrotide|mesh-list
2125868|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2125869|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2125870|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125871|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2125872|NCT02876900|Asenapine|asenapine|mesh-list
2125873|NCT02876900|Maleic acid|maleic acid|mesh-list
2125874|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125875|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125876|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2125877|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2125878|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2125879|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125880|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2569276|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2569277|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2569278|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
2569279|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2569280|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2569281|NCT01593137|Metformin|metformin|mesh-list
2569282|NCT01593137|Liraglutide|liraglutide|mesh-list
2569283|NCT01593137|Glimepiride|glimepiride|mesh-list
2569284|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2569285|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569286|NCT01593137|Incretins|incretins|mesh-ancestor
2569287|NCT01593137|Hormones|hormones|mesh-ancestor
2569288|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569289|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2569290|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2569291|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
2569292|NCT01593150|Dabigatran|dabigatran|mesh-list
2569293|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
2569294|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2569295|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
2569296|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569297|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569298|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
2569299|NCT01593163|Ibuprofen|ibuprofen|mesh-list
2569300|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2569301|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2569302|NCT01593163|Analgesics|analgesics|mesh-ancestor
2125881|NCT02877082|Bortezomib|bortezomib|mesh-list
2125882|NCT02877082|Tacrolimus|tacrolimus|mesh-list
2125883|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
2125884|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2125885|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2125886|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
2125887|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125888|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2125889|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125890|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125891|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125892|NCT02877095|Furosemide|furosemide|mesh-list
2125893|NCT02877095|Diuretics|diuretics|mesh-ancestor
2125894|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
2125895|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125896|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2125897|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2125898|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125899|NCT02877485|Triamcinolone|triamcinolone|mesh-list
2125900|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2125901|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2125902|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2125903|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2125904|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
2125905|NCT02877485|Hormones|hormones|mesh-ancestor
2125906|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2125907|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569303|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
2569304|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569305|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569306|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2569307|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2569308|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2569309|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569310|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569311|NCT01593228|Gemcitabine|gemcitabine|mesh-list
2569312|NCT01593228|Paclitaxel|paclitaxel|mesh-list
2569313|NCT01593228|Carboplatin|carboplatin|mesh-list
2569314|NCT01593228|Doxorubicin|doxorubicin|mesh-list
2569315|NCT01593228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2569316|NCT01593228|Irinotecan|irinotecan|mesh-list
2569317|NCT01593228|Topotecan|topotecan|mesh-list
2569318|NCT01593228|Iniparib|iniparib|mesh-list
2569319|NCT01593228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2569320|NCT01593228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569321|NCT01593228|Tubulin Modulators|tubulin modulators|mesh-ancestor
2569322|NCT01593228|Antimitotic Agents|antimitotic agents|mesh-ancestor
2569323|NCT01593228|Mitosis Modulators|mitosis modulators|mesh-ancestor
2125908|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2125909|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
2125910|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125911|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125912|NCT02877927|Linezolid|linezolid|mesh-list
2125913|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2125914|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419050|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
2419051|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
2419052|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419053|NCT00801788|Oxycodone|oxycodone|mesh-list
2419054|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2419055|NCT00801788|Narcotics|narcotics|mesh-ancestor
2419056|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2419057|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419058|NCT00801788|Analgesics|analgesics|mesh-ancestor
2419059|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
2419060|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419061|NCT00801853|Interleukin-4|interleukin-4|mesh-list
2419062|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2419063|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
2419064|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419065|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419066|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2419067|NCT00801866|Bevacizumab|bevacizumab|mesh-list
2419068|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2419069|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569324|NCT01593228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569325|NCT01593228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2569326|NCT01593228|Antimetabolites|antimetabolites|mesh-ancestor
2569327|NCT01593228|Antiviral Agents|antiviral agents|mesh-ancestor
2569328|NCT01593228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569329|NCT01593228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569330|NCT01593228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2569331|NCT01593228|Immunologic Factors|immunologic factors|mesh-ancestor
2569332|NCT01593228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569333|NCT01593228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2125915|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2125916|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125917|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125918|NCT02878057|Apatinib|apatinib|mesh-list
2125919|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125920|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2125921|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125922|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125923|NCT02878382|Calcipotriene|calcipotriene|mesh-list
2125924|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
2125925|NCT02879318|Gemcitabine|gemcitabine|mesh-list
2125926|NCT02879318|Paclitaxel|paclitaxel|mesh-list
2125927|NCT02879318|Durvalumab|durvalumab|mesh-list
2125928|NCT02879318|Tremelimumab|tremelimumab|mesh-list
2125929|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2125930|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125931|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
2125932|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
2125933|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
2125934|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125935|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2125936|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
2125937|NCT02879318|Antiviral Agents|antiviral agents|mesh-ancestor
2125938|NCT02879318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125939|NCT02879318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125940|NCT02879318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2125941|NCT02879318|Immunologic Factors|immunologic factors|mesh-ancestor
2125942|NCT02879318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125943|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125944|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
2125945|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125946|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569334|NCT01593228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2569335|NCT01593228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2569336|NCT01593228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2569337|NCT01593228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2569338|NCT01593280|Morphine|morphine|mesh-list
2569339|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2569340|NCT01593280|Narcotics|narcotics|mesh-ancestor
2569341|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569342|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569343|NCT01593280|Analgesics|analgesics|mesh-ancestor
2569344|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
2569345|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569346|NCT01593293|Pemetrexed|pemetrexed|mesh-list
2569347|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569348|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569349|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569350|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2569351|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2569352|NCT01593306|Paclitaxel|paclitaxel|mesh-list
2569353|NCT01593306|Cisplatin|cisplatin|mesh-list
2569354|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2569355|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569356|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
2569357|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
2569358|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
2569359|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569360|NCT01593319|Ropivacaine|ropivacaine|mesh-list
2569361|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
2569362|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
2569363|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569364|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125947|NCT02880228|Dexamethasone|dexamethasone|mesh-list
2125948|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
2125949|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
2125950|NCT02880228|Lenalidomide|lenalidomide|mesh-list
2125951|NCT02880228|Ichthammol|ichthammol|mesh-list
2125952|NCT02880228|BB 1101|bb 1101|mesh-list
2125953|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2125954|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
2125955|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
2125956|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2125957|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125958|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2125959|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
2125960|NCT02880228|Hormones|hormones|mesh-ancestor
2125961|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2125962|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2125963|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2125964|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2125965|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
2125966|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2125967|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2125968|NCT02880228|Growth Substances|growth substances|mesh-ancestor
2125969|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
2125970|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
2125971|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2125972|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2125973|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
2125974|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
2125975|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2125976|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
2125977|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2125978|NCT02880852|Belimumab|belimumab|mesh-list
2125979|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2125980|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
2125981|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125982|NCT02880865|Vaccines|vaccines|mesh-list
2125983|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
2125984|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125985|NCT02881008|Entecavir|entecavir|mesh-list
2125986|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
2125987|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2125988|NCT02881567|Daclizumab|daclizumab|mesh-list
2125989|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2125990|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
2125991|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125992|NCT02881957|Vitamin D|vitamin d|mesh-list
2125993|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
2125994|NCT02881957|Vitamins|vitamins|mesh-ancestor
2125995|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
2125996|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2125997|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2125998|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2125999|NCT02881996|Acetaminophen|acetaminophen|mesh-list
2126000|NCT02881996|Ketorolac|ketorolac|mesh-list
2126001|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2126002|NCT02881996|Analgesics|analgesics|mesh-ancestor
2126003|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
2126004|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419070|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2419071|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2419072|NCT00801866|Growth Substances|growth substances|mesh-ancestor
2419073|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419074|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
2569365|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
2569366|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569367|NCT01593332|Rituximab|rituximab|mesh-list
2569368|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2569369|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419075|NCT00801879|Mupirocin|mupirocin|mesh-list
2419076|NCT00801879|Calcium|calcium|mesh-list
2419077|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2419078|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419079|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2419080|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419081|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2419082|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419083|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419084|NCT00801905|Nepafenac|nepafenac|mesh-list
2419085|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2126005|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126006|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
2126007|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2126008|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2126009|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2126010|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2126011|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569370|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
2569371|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569372|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2569373|NCT01593371|Metformin|metformin|mesh-list
2569374|NCT01593371|Pioglitazone|pioglitazone|mesh-list
2569375|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2569376|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569377|NCT01593397|Fentanyl|fentanyl|mesh-list
2569378|NCT01593397|Propofol|propofol|mesh-list
2569379|NCT01593397|Anesthetics|anesthetics|mesh-list
2569380|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2569381|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569382|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569383|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2569384|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
2569385|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2126012|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126013|NCT02882152|Morphine|morphine|mesh-list
2126014|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2126015|NCT02882152|Narcotics|narcotics|mesh-ancestor
2126016|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126017|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126018|NCT02882152|Analgesics|analgesics|mesh-ancestor
2126019|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
2569386|NCT01593397|Narcotics|narcotics|mesh-ancestor
2569387|NCT01593397|Analgesics|analgesics|mesh-ancestor
2569388|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
2569389|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569390|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2569391|NCT01593410|Dexamethasone|dexamethasone|mesh-list
2569392|NCT01593410|Lenalidomide|lenalidomide|mesh-list
2569393|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2569394|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
2569395|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
2569396|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569397|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569398|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2569399|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
2569400|NCT01593410|Hormones|hormones|mesh-ancestor
2569401|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569402|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2569403|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569404|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
2569405|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2569406|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2569407|NCT01593410|Growth Substances|growth substances|mesh-ancestor
2569408|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
2569409|NCT01593488|Cytarabine|cytarabine|mesh-list
2569410|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2569411|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
2569412|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569413|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569414|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
2569415|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569416|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2569417|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
2569418|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569419|NCT01593501|Vitamin D|vitamin d|mesh-list
2569420|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
2569421|NCT01593501|Vitamins|vitamins|mesh-ancestor
2569422|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
2569423|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569424|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2569425|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2569426|NCT01593514|Lactitol|lactitol|mesh-list
2569427|NCT01593514|Vaccines|vaccines|mesh-list
2569428|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
2569429|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569430|NCT01593514|Cathartics|cathartics|mesh-ancestor
2569431|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2569432|NCT01593566|Bupivacaine|bupivacaine|mesh-list
2419086|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419087|NCT00801905|Analgesics|analgesics|mesh-ancestor
2419088|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
2569433|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
2569434|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
2569435|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569436|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569437|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
2569438|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569439|NCT01593605|Resveratrol|resveratrol|mesh-list
2569440|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
2569441|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569442|NCT01593605|Protective Agents|protective agents|mesh-ancestor
2569443|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569444|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569445|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2569446|NCT01593644|Adenosine|adenosine|mesh-list
2569447|NCT01593644|Dipyridamole|dipyridamole|mesh-list
2569448|NCT01593644|Analgesics|analgesics|mesh-ancestor
2569449|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
2569450|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569451|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569452|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2569453|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
2569454|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2569455|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
2569456|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
2569457|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2569458|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569459|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2569460|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569461|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2569462|NCT01593774|Melatonin|melatonin|mesh-list
2569463|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
2569464|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569465|NCT01593774|Protective Agents|protective agents|mesh-ancestor
2569466|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569467|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569468|NCT01593826|Budesonide|budesonide|mesh-list
2569469|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
2569470|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2569471|NCT01593826|Charcoal|charcoal|mesh-list
2569472|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2569473|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2569474|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
2569475|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569476|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569477|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2569478|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
2569479|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
2126020|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126021|NCT02882633|Bupivacaine|bupivacaine|mesh-list
2126022|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
2126023|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
2126024|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126025|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126026|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
2126027|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126028|NCT02882711|Ketamine|ketamine|mesh-list
2126029|NCT02882711|Analgesics|analgesics|mesh-ancestor
2126030|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
2126031|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126032|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126033|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2126034|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2126035|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
2126036|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
2419089|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419090|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419091|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419092|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2419093|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
2419094|NCT00801918|Ifosfamide|ifosfamide|mesh-list
2419095|NCT00801918|Etoposide|etoposide|mesh-list
2419096|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
2419097|NCT00801918|Interleukin-2|interleukin-2|mesh-list
2126037|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126038|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2126039|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2569480|NCT01593826|Hormones|hormones|mesh-ancestor
2569481|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569482|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2569483|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2569484|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2569485|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
2569486|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2569487|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569488|NCT01593826|Antidotes|antidotes|mesh-ancestor
2569489|NCT01593826|Protective Agents|protective agents|mesh-ancestor
2569490|NCT01593930|Lidocaine|lidocaine|mesh-list
2126040|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126041|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126042|NCT02882854|Guanfacine|guanfacine|mesh-list
2126043|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2126044|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2126045|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2126046|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2126047|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
2126048|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2569491|NCT01593930|Carticaine|carticaine|mesh-list
2569492|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
2569493|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
2569494|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569495|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569496|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
2569497|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569498|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2569499|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2569500|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2569501|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2569502|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569503|NCT01593995|Mitogens|mitogens|mesh-list
2569504|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
2569505|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569506|NCT01594047|Ketamine|ketamine|mesh-list
2569507|NCT01594047|Methadone|methadone|mesh-list
2569508|NCT01594047|Analgesics|analgesics|mesh-ancestor
2569509|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
2569510|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569511|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569512|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2569513|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2569514|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
2569515|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
2569516|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569517|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2569518|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2569519|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2569520|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569521|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2569522|NCT01594047|Narcotics|narcotics|mesh-ancestor
2569523|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
2569524|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
2569525|NCT01594060|Insulin|insulin|mesh-list
2569526|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2569527|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
2569528|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
2569529|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2569530|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569531|NCT01594099|Paclitaxel|paclitaxel|mesh-list
2569532|NCT01594099|Cisplatin|cisplatin|mesh-list
2569533|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2569534|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569535|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
2569536|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
2569537|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
2569538|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569539|NCT01594177|Paclitaxel|paclitaxel|mesh-list
2569540|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
2569541|NCT01594177|Trastuzumab|trastuzumab|mesh-list
2569542|NCT01594177|Epirubicin|epirubicin|mesh-list
2569543|NCT01594177|Afatinib|afatinib|mesh-list
2569544|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2569545|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569546|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
2569547|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
2569548|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
2569549|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569550|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2569551|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
2569552|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569553|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2569554|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2569555|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
2569556|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2569557|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2569558|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2569559|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2569560|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2569561|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569562|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2569563|NCT01594216|Exemestane|exemestane|mesh-list
2569564|NCT01594216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569565|NCT01594216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2569566|NCT01594216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2569567|NCT01594216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569568|NCT01594216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569569|NCT01594216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2569570|NCT01594216|Hormone Antagonists|hormone antagonists|mesh-ancestor
2569571|NCT01594216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569572|NCT01594216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569573|NCT01594229|Rituximab|rituximab|mesh-list
2569574|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2569575|NCT01594229|Venetoclax|venetoclax|mesh-list
2569576|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2569577|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569578|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
2569579|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569580|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2569581|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2569582|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
2569583|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569584|NCT01594242|Bortezomib|bortezomib|mesh-list
2569585|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569586|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
2569587|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2569588|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569589|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2569590|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2569591|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569592|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126049|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126050|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126051|NCT02883400|Spironolactone|spironolactone|mesh-list
2126052|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2126053|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
2126054|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2126055|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126056|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2126057|NCT02883400|Diuretics|diuretics|mesh-ancestor
2126058|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
2126059|NCT02883452|Infliximab|infliximab|mesh-list
2126060|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
2126061|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2126062|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2126063|NCT02884089|Metformin|metformin|mesh-list
2126064|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2126065|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126066|NCT02885012|Ambrisentan|ambrisentan|mesh-list
2126067|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2126068|NCT02885025|Fluticasone|fluticasone|mesh-list
2569593|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126069|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2126070|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2126071|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
2126072|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126073|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126074|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2126075|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
2126076|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
2126077|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2126078|NCT02885181|Methotrexate|methotrexate|mesh-list
2126079|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2126080|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
2126081|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2126082|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126083|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2126084|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
2126085|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126086|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126087|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
2126088|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126089|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2126090|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2126091|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
2126092|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2126093|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2126094|NCT02885636|Albuterol|albuterol|mesh-list
2126095|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2126096|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
2126097|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126098|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569594|NCT01594268|Everolimus|everolimus|mesh-list
2569595|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569596|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2569597|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
2569598|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569599|NCT01594346|Vitamin E|vitamin e|mesh-list
2569600|NCT01594346|Tocopherols|tocopherols|mesh-list
2569601|NCT01594346|Tocotrienols|tocotrienols|mesh-list
2569602|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
2569603|NCT01594346|Vitamins|vitamins|mesh-ancestor
2569604|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
2569605|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569606|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
2569607|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569608|NCT01594346|Protective Agents|protective agents|mesh-ancestor
2569609|NCT01594489|Aminophylline|aminophylline|mesh-list
2569610|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2569611|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
2569612|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569613|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569614|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2569615|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
2569616|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2569617|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2569618|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569619|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569620|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2569621|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2569622|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
2569623|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2569624|NCT01594489|Protective Agents|protective agents|mesh-ancestor
2569625|NCT01594502|Dutasteride|dutasteride|mesh-list
2569626|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2569627|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2569628|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569629|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569630|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
2569631|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569632|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569633|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
2569634|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2569635|NCT01594619|Diltiazem|diltiazem|mesh-list
2569636|NCT01594619|Naloxegol|naloxegol|mesh-list
2569637|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2569638|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2569639|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2569640|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569641|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2569642|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569643|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
2569644|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2126099|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2126100|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
2126101|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
2126102|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2126103|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2569645|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
2569646|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569647|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
2569648|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2569649|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2569650|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569651|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
2569652|NCT01594671|Coagulants|coagulants|mesh-ancestor
2569653|NCT01594697|Metformin|metformin|mesh-list
2569654|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2569655|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569656|NCT01594775|Oxytocin|oxytocin|mesh-list
2569657|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
2569658|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2569659|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569660|NCT01594866|Dexetimide|dexetimide|mesh-list
2569661|NCT01594866|Citalopram|citalopram|mesh-list
2569662|NCT01594866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2569663|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2569664|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2126104|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2126105|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2126106|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
2126107|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126108|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126109|NCT02886624|Grazoprevir|grazoprevir|mesh-list
2126110|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
2126111|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2126112|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
2126113|NCT02886702|Tazarotene|tazarotene|mesh-list
2126114|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
2126115|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
2126116|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
2126117|NCT02886702|Vitamins|vitamins|mesh-ancestor
2126118|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
2126119|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126120|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
2126121|NCT02886715|Tazarotene|tazarotene|mesh-list
2126122|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
2126123|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
2126124|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
2126125|NCT02886715|Vitamins|vitamins|mesh-ancestor
2126126|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
2126127|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126128|NCT02887183|Valsartan|valsartan|mesh-list
2126129|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2126130|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2126131|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2126132|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2126133|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126134|NCT02887404|Analgesics|analgesics|mesh-list
2569665|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569666|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2569667|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
2569668|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569669|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2569670|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
2569671|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2569672|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2569673|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2569674|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
2569675|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
2569676|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569677|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2126135|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
2126136|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569678|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2126137|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126138|NCT02888106|Tenofovir|tenofovir|mesh-list
2126139|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2126140|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
2126141|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
2126142|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2126143|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2126144|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2126145|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126146|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126147|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2126148|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2569679|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
2569680|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
2569681|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2569682|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
2569683|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2569684|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569685|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2569686|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2569687|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2569688|NCT01594905|Tenofovir|tenofovir|mesh-list
2569689|NCT01594905|Entecavir|entecavir|mesh-list
2569690|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
2569691|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569692|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2569693|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2569694|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569695|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569696|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2569697|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2569698|NCT01594918|Prednisone|prednisone|mesh-list
2569699|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
2569700|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2569701|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
2569702|NCT01594918|Hormones|hormones|mesh-ancestor
2569703|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569704|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569705|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2569706|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419098|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2419099|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
2419100|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419101|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2419102|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2419103|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
2419104|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569707|NCT01594918|Analgesics|analgesics|mesh-ancestor
2419105|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419106|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2419107|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2419108|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2419109|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2419110|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419111|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419112|NCT00801918|Analgesics|analgesics|mesh-ancestor
2419113|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
2419114|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419115|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
2419116|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2419117|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2419118|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
2419119|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419120|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419121|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419122|NCT00801944|Urological Agents|urological agents|mesh-ancestor
2419123|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
2419124|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2419125|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2419126|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2419127|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
2419128|NCT00801957|Tacrolimus|tacrolimus|mesh-list
2419129|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2569708|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
2569709|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569710|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2569711|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2569712|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569713|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569714|NCT01594983|Fenofibrate|fenofibrate|mesh-list
2569715|NCT01594983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2569716|NCT01594983|Antimetabolites|antimetabolites|mesh-ancestor
2126149|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126150|NCT02888665|Doxorubicin|doxorubicin|mesh-list
2126151|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2126152|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
2126153|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2126154|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126155|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2126156|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2126157|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126158|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126159|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2126160|NCT02889393|Teduglutide|teduglutide|mesh-list
2569717|NCT01594983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569718|NCT01594983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2569719|NCT01595009|Everolimus|everolimus|mesh-list
2569720|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569721|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2569722|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
2569723|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569724|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
2569725|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
2569726|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2569727|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569728|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2569729|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2569730|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2126161|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2126162|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2126163|NCT02889393|Protective Agents|protective agents|mesh-ancestor
2126164|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126165|NCT02889510|Liraglutide|liraglutide|mesh-list
2126166|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2126167|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126168|NCT02889510|Incretins|incretins|mesh-ancestor
2569731|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2126169|NCT02889510|Hormones|hormones|mesh-ancestor
2126170|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2126171|NCT02889562|Warfarin|warfarin|mesh-list
2126172|NCT02889562|Apixaban|apixaban|mesh-list
2126173|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
2126174|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2126175|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
2126176|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2126177|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
2126178|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126179|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126180|NCT02889796|Adalimumab|adalimumab|mesh-list
2126181|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2126182|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2126183|NCT02889900|Olaparib|olaparib|mesh-list
2126184|NCT02889900|Cediranib|cediranib|mesh-list
2126185|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2126186|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126187|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126188|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126189|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2569744|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
2569745|NCT01595152|Fesoterodine|fesoterodine|mesh-list
2569746|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2569747|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2569748|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
2569749|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2569750|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569751|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569752|NCT01595152|Urological Agents|urological agents|mesh-ancestor
2126219|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
2126220|NCT02890992|Niacin|niacin|mesh-list
2126221|NCT02890992|Niacinamide|niacinamide|mesh-list
2126222|NCT02890992|Ezetimibe|ezetimibe|mesh-list
2126223|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
2126224|NCT02890992|Fenofibrate|fenofibrate|mesh-list
2126225|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2126226|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2126227|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
2126228|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126229|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2126230|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
2126231|NCT02890992|Vitamins|vitamins|mesh-ancestor
2126232|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
2126233|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126234|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
2126235|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2126236|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
2126237|NCT02891070|Coagulants|coagulants|mesh-ancestor
2126238|NCT02891174|Acetaminophen|acetaminophen|mesh-list
2126239|NCT02891174|Ibuprofen|ibuprofen|mesh-list
2126240|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2126241|NCT02891174|Analgesics|analgesics|mesh-ancestor
2126242|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
2126243|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126244|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126245|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
2569779|NCT01595334|Cetrorelix|cetrorelix|mesh-list
2569780|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2569781|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
2569782|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2569783|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569784|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
2569785|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569786|NCT01595399|Atropine|atropine|mesh-list
2126246|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2126247|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2126248|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2569787|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2569788|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2569789|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2569790|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
2569791|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569792|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569793|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2569794|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
2569795|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
2569796|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
2569797|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2569798|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2569799|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
2569800|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2569801|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569802|NCT01595425|Esomeprazole|esomeprazole|mesh-list
2569803|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2569804|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2569805|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2569806|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569807|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569808|NCT01595581|Testosterone|testosterone|mesh-list
2569809|NCT01595581|Androgens|androgens|mesh-ancestor
2569810|NCT01595581|Hormones|hormones|mesh-ancestor
2569811|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569812|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569813|NCT01595594|Doxycycline|doxycycline|mesh-list
2569814|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2569815|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569816|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
2569817|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2569818|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2569819|NCT01595620|Capsaicin|capsaicin|mesh-list
2569820|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
2569821|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
2569822|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
2569823|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569824|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569825|NCT01595633|Tenofovir|tenofovir|mesh-list
2569826|NCT01595633|Adefovir|adefovir|mesh-list
2569827|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
2126249|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2126250|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126251|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126252|NCT02891408|Fenofibrate|fenofibrate|mesh-list
2126253|NCT02891408|Firsocostat|firsocostat|mesh-list
2126254|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2126255|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
2126256|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126257|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2126258|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126259|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
2126260|NCT02891850|Tadalafil|tadalafil|mesh-list
2569828|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569829|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2569830|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2569831|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569832|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569833|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2569834|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2569835|NCT01595685|Entecavir|entecavir|mesh-list
2126261|NCT02891850|Riociguat|riociguat|mesh-list
2126262|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
2126263|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2126264|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2569836|NCT01595685|Telbivudine|telbivudine|mesh-list
2569837|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
2569838|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569839|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2569840|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569841|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569842|NCT01595724|Dienogest|dienogest|mesh-list
2569843|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2569844|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
2569845|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2569846|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569847|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2569848|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2569849|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2569850|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2126265|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126266|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126267|NCT02891850|Urological Agents|urological agents|mesh-ancestor
2126268|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
2126269|NCT02891915|Amoxicillin|amoxicillin|mesh-list
2569851|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
2569852|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569853|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2569854|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569855|NCT01595737|Simendan|simendan|mesh-list
2569856|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2126270|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
2126271|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
2126272|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2126273|NCT02891915|Cefdinir|cefdinir|mesh-list
2126274|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2126275|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2126276|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2126277|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126278|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126279|NCT02892110|Varenicline|varenicline|mesh-list
2126280|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2569857|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
2569858|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2569859|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2569860|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569861|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569862|NCT01595737|Protective Agents|protective agents|mesh-ancestor
2569863|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569864|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
2569865|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2569866|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2569867|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569868|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
2569869|NCT01595763|Coagulants|coagulants|mesh-ancestor
2569870|NCT01595789|Liraglutide|liraglutide|mesh-list
2569871|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2126281|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2126282|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
2126283|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126284|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126285|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126286|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
2126287|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2126288|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
2126289|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2126290|NCT02892409|Amoxicillin|amoxicillin|mesh-list
2126291|NCT02892409|Clarithromycin|clarithromycin|mesh-list
2126292|NCT02892409|Lansoprazole|lansoprazole|mesh-list
2569872|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126293|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
2569873|NCT01595789|Incretins|incretins|mesh-ancestor
2569874|NCT01595789|Hormones|hormones|mesh-ancestor
2569875|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569876|NCT01595815|Calcium|calcium|mesh-list
2569877|NCT01595815|Ionophores|ionophores|mesh-list
2569878|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
2569879|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2569880|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126294|NCT02892409|Bismuth|bismuth|mesh-list
2126295|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2126296|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2126297|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2126298|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126299|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126300|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2126301|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2126302|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2569881|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2569882|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569883|NCT01595828|Pitavastatin|pitavastatin|mesh-list
2569884|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2569885|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2569886|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2569887|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
2569888|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569889|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569890|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2569891|NCT01595841|Sirolimus|sirolimus|mesh-list
2569892|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2569893|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569894|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2569895|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569896|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
2569897|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2569898|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
2569899|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569900|NCT01595867|Naltrexone|naltrexone|mesh-list
2569901|NCT01595867|Morphine|morphine|mesh-list
2569902|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2569903|NCT01595867|Narcotics|narcotics|mesh-ancestor
2569904|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2569905|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569906|NCT01595867|Analgesics|analgesics|mesh-ancestor
2569907|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
2569908|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569909|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2569910|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2569911|NCT01595880|Metformin|metformin|mesh-list
2569912|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2569913|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569914|NCT01595893|Vitamin D|vitamin d|mesh-list
2569915|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
2569916|NCT01595893|Vitamins|vitamins|mesh-ancestor
2569917|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
2569918|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569919|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2569920|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2126303|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2126304|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2126305|NCT02892409|Antacids|antacids|mesh-ancestor
2126306|NCT02892734|Nivolumab|nivolumab|mesh-list
2126307|NCT02892734|Ipilimumab|ipilimumab|mesh-list
2126308|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2126309|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126310|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2126311|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126312|NCT02895035|Ketorolac|ketorolac|mesh-list
2126313|NCT02895035|Phenylephrine|phenylephrine|mesh-list
2126314|NCT02895035|Epinephrine|epinephrine|mesh-list
2126315|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
2569921|NCT01595958|Cyclosporine|cyclosporine|mesh-list
2569922|NCT01595958|Cyclosporins|cyclosporins|mesh-list
2569923|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126316|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2569924|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569925|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2569926|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
2569927|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569928|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
2569929|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569930|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
2569931|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2569932|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2569933|NCT01595984|Cyclosporine|cyclosporine|mesh-list
2569934|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
2569935|NCT01595984|Everolimus|everolimus|mesh-list
2569936|NCT01595984|Cyclosporins|cyclosporins|mesh-list
2569937|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569938|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569939|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2569940|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
2569941|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569942|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
2569943|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569944|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
2569945|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2569946|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2569947|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569948|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2569949|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2569950|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
2569951|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2569952|NCT01596010|Norethindrone|norethindrone|mesh-list
2569953|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
2569954|NCT01596010|Estradiol|estradiol|mesh-list
2569955|NCT01596010|Estrogens|estrogens|mesh-ancestor
2569956|NCT01596010|Hormones|hormones|mesh-ancestor
2569957|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2569958|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569959|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2569960|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
2569961|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2569962|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2569963|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2569964|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2569965|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2569966|NCT01596075|Cannabidiol|cannabidiol|mesh-list
2569967|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
2569968|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
2569969|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
2569970|NCT01596114|Protective Agents|protective agents|mesh-ancestor
2569971|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569972|NCT01596140|Sirolimus|sirolimus|mesh-list
2569973|NCT01596140|Everolimus|everolimus|mesh-list
2569974|NCT01596140|Vemurafenib|vemurafenib|mesh-list
2569975|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2569976|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2569977|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
2569978|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569979|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2569980|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2569981|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2569982|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2569983|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
2569984|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2569985|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569986|NCT01596166|Ketorolac|ketorolac|mesh-list
2569987|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2569988|NCT01596166|Metoclopramide|metoclopramide|mesh-list
2569989|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2569990|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2569991|NCT01596166|Analgesics|analgesics|mesh-ancestor
2569992|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
2569993|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2569994|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2569995|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2569996|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2569997|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2569998|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2569999|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570000|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
2570001|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
2570002|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2570003|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2570004|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2570005|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
2570006|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570007|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2570008|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2570009|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570010|NCT01596296|Dinoprostone|dinoprostone|mesh-list
2570011|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
2570012|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2570013|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570014|NCT01596387|Propofol|propofol|mesh-list
2570015|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2570016|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2570017|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570018|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2570019|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
2570020|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
2570021|NCT01596400|Granisetron|granisetron|mesh-list
2570022|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
2570023|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
2570024|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570025|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570026|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2570027|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2570028|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
2570029|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570030|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570031|NCT01596413|Granisetron|granisetron|mesh-list
2570032|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
2570033|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
2570034|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570035|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570036|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2570037|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2570038|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
2570039|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570040|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570041|NCT01596426|Granisetron|granisetron|mesh-list
2126317|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2126318|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
2126319|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126320|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126321|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126322|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2126323|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2126324|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
2570042|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
2570043|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
2570044|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570045|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570046|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2570047|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2126325|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126326|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2126327|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
2126328|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
2126329|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
2126330|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2126331|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2126332|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2126333|NCT02895035|Analgesics|analgesics|mesh-ancestor
2126334|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
2126335|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2126336|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2126337|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2126338|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126339|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2570048|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
2570049|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570050|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570051|NCT01596517|Ribavirin|ribavirin|mesh-list
2570052|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2570053|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
2570054|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
2126340|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
2570055|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570056|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
2570057|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570058|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
2570059|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570060|NCT01596556|Nicotine|nicotine|mesh-list
2570061|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2570062|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
2570063|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570064|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570065|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2570066|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2570067|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
2570068|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570069|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570070|NCT01596634|Lactoferrin|lactoferrin|mesh-list
2570071|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570072|NCT01596647|Diclofenac|diclofenac|mesh-list
2570073|NCT01596647|Midazolam|midazolam|mesh-list
2570074|NCT01596647|Caffeine|caffeine|mesh-list
2570075|NCT01596647|Omeprazole|omeprazole|mesh-list
2570076|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2570077|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2570078|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2570079|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570080|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2570081|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2126341|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2126342|NCT02895035|Protective Agents|protective agents|mesh-ancestor
2126343|NCT02895945|Factor VIII|factor viii|mesh-list
2126344|NCT02895945|Coagulants|coagulants|mesh-ancestor
2126345|NCT02896296|Buprenorphine|buprenorphine|mesh-list
2126346|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2126347|NCT02896296|Narcotics|narcotics|mesh-ancestor
2126348|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126349|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126350|NCT02896296|Analgesics|analgesics|mesh-ancestor
2126351|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
2570082|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2570083|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2570084|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
2570085|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
2570086|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
2570087|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
2570088|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570089|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570090|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2570091|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2570092|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2570093|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570094|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2570095|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2570096|NCT01596647|Analgesics|analgesics|mesh-ancestor
2570097|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
2126352|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126353|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2126354|NCT02896400|Nicotine|nicotine|mesh-list
2126355|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2126356|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
2126357|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126358|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126359|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2126360|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2126361|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
2126362|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126363|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126364|NCT02896595|Anesthetics|anesthetics|mesh-list
2570098|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570099|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2570100|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2570101|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2570102|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2570103|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2570104|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2570105|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2126365|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126366|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570106|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
2570107|NCT01596660|Bupivacaine|bupivacaine|mesh-list
2570108|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
2570109|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
2570110|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2570111|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570112|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
2570113|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570114|NCT01596673|Hydrocodone|hydrocodone|mesh-list
2570115|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2570116|NCT01596673|Narcotics|narcotics|mesh-ancestor
2126376|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
2126377|NCT02896907|Vitamins|vitamins|mesh-list
2126378|NCT02896907|Leucovorin|leucovorin|mesh-list
2126379|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
2126380|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
2126381|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
2126382|NCT02896907|Fluorouracil|fluorouracil|mesh-list
2570117|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2570118|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570119|NCT01596673|Analgesics|analgesics|mesh-ancestor
2570120|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
2570121|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570122|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
2570123|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
2570124|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
2570125|NCT01596686|Cathartics|cathartics|mesh-ancestor
2126383|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
2126384|NCT02896907|Irinotecan|irinotecan|mesh-list
2126385|NCT02896907|Camptothecin|camptothecin|mesh-list
2126386|NCT02896907|Calcium|calcium|mesh-list
2126387|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
2126388|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
2126389|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126390|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2126391|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2126392|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
2126393|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126394|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2126395|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126396|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2126397|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
2126398|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2126399|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2126400|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126401|NCT02896907|Antidotes|antidotes|mesh-ancestor
2126402|NCT02896907|Protective Agents|protective agents|mesh-ancestor
2126403|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
2126404|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
2126405|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2126406|NCT02897115|Adalimumab|adalimumab|mesh-list
2126407|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2126408|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2126409|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2126410|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2126411|NCT02897115|Analgesics|analgesics|mesh-ancestor
2126412|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
2419130|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
2419131|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419132|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2419133|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419134|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419135|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419136|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
2419137|NCT00802009|Dexamethasone|dexamethasone|mesh-list
2419138|NCT00802009|Mepivacaine|mepivacaine|mesh-list
2419139|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419140|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
2570126|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2570127|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
2570128|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2570129|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2570130|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570131|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
2126413|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126414|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126415|NCT02897349|Linagliptin|linagliptin|mesh-list
2126416|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2126417|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126418|NCT02897349|Incretins|incretins|mesh-ancestor
2126419|NCT02897349|Hormones|hormones|mesh-ancestor
2126420|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2126421|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2126422|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
2126423|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126424|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126425|NCT02898077|Paclitaxel|paclitaxel|mesh-list
2126426|NCT02898077|Ramucirumab|ramucirumab|mesh-list
2126427|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2126428|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126429|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
2126430|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
2126431|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
2126432|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126433|NCT02898116|Durvalumab|durvalumab|mesh-list
2126434|NCT02898116|Ensartinib|ensartinib|mesh-list
2126435|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2126436|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126437|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2126438|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126439|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126440|NCT02898259|Rituximab|rituximab|mesh-list
2126441|NCT02898259|Lenalidomide|lenalidomide|mesh-list
2126442|NCT02898259|Ixazomib|ixazomib|mesh-list
2126443|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2126444|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126445|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
2126446|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126447|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2126448|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2126449|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2126450|NCT02898259|Growth Substances|growth substances|mesh-ancestor
2126451|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
2570132|NCT01596738|Coagulants|coagulants|mesh-ancestor
2570133|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
2570134|NCT01596764|Naloxone|naloxone|mesh-list
2570135|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
2570136|NCT01596764|Loperamide|loperamide|mesh-list
2570137|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
2570138|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2570139|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570140|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
2570141|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570142|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2570143|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570144|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2570145|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2570146|NCT01596764|Analgesics|analgesics|mesh-ancestor
2570147|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2570148|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2570149|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
2570150|NCT01596777|Naltrexone|naltrexone|mesh-list
2126452|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
2126453|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126454|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126455|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
2126456|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2126457|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
2126458|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2570151|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
2570152|NCT01596777|Loperamide|loperamide|mesh-list
2570153|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
2570154|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2570155|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2570156|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570157|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
2570158|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570159|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2570160|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570161|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2570162|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2570163|NCT01596777|Analgesics|analgesics|mesh-ancestor
2570164|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2570165|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2570166|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
2570167|NCT01596803|Vitamin E|vitamin e|mesh-list
2570168|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
2570169|NCT01596803|Tocopherols|tocopherols|mesh-list
2570170|NCT01596803|Antioxidants|antioxidants|mesh-list
2570171|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570172|NCT01596803|Protective Agents|protective agents|mesh-ancestor
2570173|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570174|NCT01596803|Vitamins|vitamins|mesh-ancestor
2570175|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
2570176|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
2570177|NCT01596855|Hematinics|hematinics|mesh-ancestor
2570178|NCT01596868|Gemcitabine|gemcitabine|mesh-list
2570179|NCT01596868|Cisplatin|cisplatin|mesh-list
2570180|NCT01596868|Docetaxel|docetaxel|mesh-list
2570181|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570182|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2570183|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
2570184|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570185|NCT01596868|Antiviral Agents|antiviral agents|mesh-ancestor
2570186|NCT01596868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570187|NCT01596868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570188|NCT01596868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2570189|NCT01596868|Immunologic Factors|immunologic factors|mesh-ancestor
2570190|NCT01596868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570191|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
2570192|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
2570193|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
2570194|NCT01596894|Azithromycin|azithromycin|mesh-list
2570195|NCT01596894|Metronidazole|metronidazole|mesh-list
2570196|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2570197|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570198|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2570199|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2570200|NCT01596907|Ephedrine|ephedrine|mesh-list
2126459|NCT02899156|Flumazenil|flumazenil|mesh-list
2126460|NCT02899156|Antidotes|antidotes|mesh-ancestor
2126461|NCT02899156|Protective Agents|protective agents|mesh-ancestor
2126462|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126463|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
2126464|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
2126465|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126466|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126467|NCT02899195|Durvalumab|durvalumab|mesh-list
2126468|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2126469|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126470|NCT02899299|Carboplatin|carboplatin|mesh-list
2126471|NCT02899299|Nivolumab|nivolumab|mesh-list
2570201|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
2570202|NCT01596907|Caffeine|caffeine|mesh-list
2570203|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2570204|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570205|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2419141|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
2419142|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419143|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419144|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2419145|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
2419146|NCT00802009|Hormones|hormones|mesh-ancestor
2419147|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2419148|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2419149|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419150|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
2419151|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
2126472|NCT02899299|Pemetrexed|pemetrexed|mesh-list
2126473|NCT02899299|Ipilimumab|ipilimumab|mesh-list
2126474|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126475|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2126476|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2570206|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570207|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570208|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2570209|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2570210|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
2570211|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570212|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
2570213|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
2570214|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570215|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2570216|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
2570217|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2570218|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2570219|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
2570220|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
2570221|NCT01596998|Epinephrine|epinephrine|mesh-list
2570222|NCT01596998|Racepinephrine|racepinephrine|mesh-list
2570223|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
2570224|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
2570225|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2570226|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2570227|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
2570228|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570229|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570230|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570231|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2570232|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2570233|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
2570234|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570235|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2126477|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126478|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126479|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2126480|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2126481|NCT02899377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2126482|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2126483|NCT02899377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2126484|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126485|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
2126486|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
2126487|NCT02899988|Mirikizumab|mirikizumab|mesh-list
2126488|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2126489|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2126490|NCT02899988|Analgesics|analgesics|mesh-ancestor
2126491|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
2126492|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126493|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126494|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2126495|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2126496|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2126497|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2126498|NCT02900092|Ganaxolone|ganaxolone|mesh-list
2126499|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
2126500|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126501|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126502|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126503|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
2126504|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
2126505|NCT02900378|Valsartan|valsartan|mesh-list
2126506|NCT02900378|Enalapril|enalapril|mesh-list
2126507|NCT02900378|Enalaprilat|enalaprilat|mesh-list
2419152|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2419153|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
2419154|NCT00802035|Baclofen|baclofen|mesh-list
2419155|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2419156|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419157|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2419158|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419159|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2419160|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
2419161|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
2419162|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419163|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419164|NCT00802048|Ropivacaine|ropivacaine|mesh-list
2570236|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
2570237|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
2570238|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
2570239|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2570240|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
2570241|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
2570242|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2570243|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
2570244|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2570245|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
2570246|NCT01597011|Coagulants|coagulants|mesh-ancestor
2570247|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
2570248|NCT01597167|Analgesics|analgesics|mesh-ancestor
2570249|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
2570250|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570251|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570252|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
2570253|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2570254|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2570255|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
2570256|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2570257|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2570258|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570259|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2570260|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
2570261|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2570262|NCT01597206|Cobalt|cobalt|mesh-list
2570263|NCT01597206|Trace Elements|trace elements|mesh-ancestor
2570264|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
2126508|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2126509|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2126510|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2126511|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2126512|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126513|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2126514|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
2126515|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126516|NCT02901054|Ondansetron|ondansetron|mesh-list
2126517|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
2126518|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
2126519|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126520|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126521|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2126522|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
2126523|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
2126524|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2126525|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
2126526|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126527|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126528|NCT02901054|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2126529|NCT02901054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2126530|NCT02901054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126531|NCT02901054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2126532|NCT02901054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2126533|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
2126534|NCT02901249|Sertraline|sertraline|mesh-list
2126535|NCT02901249|Nortriptyline|nortriptyline|mesh-list
2570265|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570266|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
2570267|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2570268|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2570269|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570270|NCT01597310|Pramipexole|pramipexole|mesh-list
2570271|NCT01597310|Warfarin|warfarin|mesh-list
2570272|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
2570273|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
2570274|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570275|NCT01597310|Protective Agents|protective agents|mesh-ancestor
2570276|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570277|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2570278|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2570279|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
2570280|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
2570281|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570282|NCT01597336|Plasminogen|plasminogen|mesh-list
2126536|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
2570283|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2570284|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2126537|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2126538|NCT02901249|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2126539|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2126540|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2126541|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126542|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570285|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2570286|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570287|NCT01597414|Trastuzumab|trastuzumab|mesh-list
2570288|NCT01597414|Pertuzumab|pertuzumab|mesh-list
2570289|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2570290|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570291|NCT01597427|Clonidine|clonidine|mesh-list
2570292|NCT01597427|Analgesics|analgesics|mesh-ancestor
2570293|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
2570294|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570295|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570296|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2570297|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
2570298|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
2570299|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2570300|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2570301|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2570302|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
2570303|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570304|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570305|NCT01597518|Riluzole|riluzole|mesh-list
2126543|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
2126544|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126545|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126546|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
2126547|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2126548|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126549|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2126550|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2570306|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
2570307|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2570308|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2570309|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570310|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570311|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570312|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2570313|NCT01597518|Protective Agents|protective agents|mesh-ancestor
2570314|NCT01597531|Liraglutide|liraglutide|mesh-list
2126551|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
2126552|NCT02901548|Durvalumab|durvalumab|mesh-list
2126553|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2126554|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126555|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
2126556|NCT02901899|Guadecitabine|guadecitabine|mesh-list
2126557|NCT02901899|Azacitidine|azacitidine|mesh-list
2570315|NCT01597531|Orlistat|orlistat|mesh-list
2570316|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2570317|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570318|NCT01597531|Incretins|incretins|mesh-ancestor
2570319|NCT01597531|Hormones|hormones|mesh-ancestor
2570320|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2570321|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570322|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570323|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2570324|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2570325|NCT01597609|Sibutramine|sibutramine|mesh-list
2570326|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
2570327|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2570328|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
2570329|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2570330|NCT01597648|Maraviroc|maraviroc|mesh-list
2570331|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2570332|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2570333|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2570334|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570335|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2570336|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2126558|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2570337|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
2570338|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570339|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2570340|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2570341|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2570342|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570343|NCT01597661|Bupropion|bupropion|mesh-list
2570344|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
2570345|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2570346|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2570347|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2570348|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2570349|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2570350|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570351|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
2570352|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570353|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570354|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2570355|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2570356|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570357|NCT01597700|Ezetimibe|ezetimibe|mesh-list
2570358|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2570359|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2570360|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
2570361|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570362|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2570363|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
2570364|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2570365|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126559|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126560|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2126561|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
2570366|NCT01597726|Misoprostol|misoprostol|mesh-list
2570367|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2570368|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
2570369|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2570370|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570371|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2570372|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2570373|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
2570374|NCT01597765|Vitamins|vitamins|mesh-list
2570375|NCT01597765|Vitamin E|vitamin e|mesh-list
2570376|NCT01597765|Tocopherols|tocopherols|mesh-list
2570377|NCT01597765|Tocotrienols|tocotrienols|mesh-list
2570378|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
2570379|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
2570380|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2570381|NCT01597765|Deferiprone|deferiprone|mesh-list
2126562|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126563|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126564|NCT02902081|Cannabidiol|cannabidiol|mesh-list
2126565|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
2126566|NCT02902172|Acetaminophen|acetaminophen|mesh-list
2126567|NCT02902172|Ibuprofen|ibuprofen|mesh-list
2126568|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2126569|NCT02902172|Analgesics|analgesics|mesh-ancestor
2126570|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
2126571|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126572|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126573|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
2126574|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2126575|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2570382|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
2126576|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2419165|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
2419166|NCT00802048|Anesthetics|anesthetics|mesh-list
2419167|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2419168|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419169|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
2419170|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419171|NCT00802087|Acetaminophen|acetaminophen|mesh-list
2419172|NCT00802087|Hydrocodone|hydrocodone|mesh-list
2419173|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419174|NCT00802087|Analgesics|analgesics|mesh-ancestor
2419175|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
2419176|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570383|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570384|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
2570385|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570386|NCT01597765|Expectorants|expectorants|mesh-ancestor
2570387|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
2570388|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2570389|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
2570390|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570391|NCT01597765|Protective Agents|protective agents|mesh-ancestor
2570392|NCT01597765|Antidotes|antidotes|mesh-ancestor
2570393|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2570394|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
2570395|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
2570396|NCT01597817|Chitosan|chitosan|mesh-list
2570397|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2570398|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2570399|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
2570400|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570401|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2570402|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
2570403|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
2570404|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
2570405|NCT01597817|Coagulants|coagulants|mesh-ancestor
2570406|NCT01597895|Maraviroc|maraviroc|mesh-list
2570407|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2570408|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2126577|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2126578|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126579|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570409|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570410|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2570411|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2570412|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
2570413|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570414|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2570415|NCT01597934|Tenofovir|tenofovir|mesh-list
2570416|NCT01597934|Entecavir|entecavir|mesh-list
2570417|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2570418|NCT01597934|Adefovir|adefovir|mesh-list
2570419|NCT01597934|Lamivudine|lamivudine|mesh-list
2570420|NCT01597934|Telbivudine|telbivudine|mesh-list
2570421|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
2570422|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570423|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2570424|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2570425|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570426|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570427|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2570428|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2570429|NCT01597986|Isavuconazole|isavuconazole|mesh-list
2570430|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2570431|NCT01597986|Norethindrone|norethindrone|mesh-list
2126580|NCT02902237|Thromboplastin|thromboplastin|mesh-list
2126581|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
2126582|NCT02902237|Coagulants|coagulants|mesh-ancestor
2126583|NCT02902770|Ketorolac|ketorolac|mesh-list
2126584|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2126585|NCT02902770|Lidocaine|lidocaine|mesh-list
2570432|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
2570433|NCT01597986|Norinyl|norinyl|mesh-list
2570434|NCT01597986|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2570435|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
2419177|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419178|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
2419179|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2419180|NCT00802087|Narcotics|narcotics|mesh-ancestor
2419181|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2419182|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
2419183|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
2419184|NCT00802139|Iron|iron|mesh-list
2419185|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2126586|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
2419186|NCT00802139|Trace Elements|trace elements|mesh-ancestor
2419187|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
2419188|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419189|NCT00802139|Hematinics|hematinics|mesh-ancestor
2419190|NCT00802217|Capsaicin|capsaicin|mesh-list
2419191|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
2419192|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
2419193|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
2126587|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
2126588|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126589|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126590|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
2126591|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126592|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2126593|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2126594|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2126595|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2126596|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126597|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2126598|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2570436|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
2570437|NCT01597986|Estradiol|estradiol|mesh-list
2570438|NCT01597986|Estrogens|estrogens|mesh-ancestor
2570439|NCT01597986|Hormones|hormones|mesh-ancestor
2570440|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2570441|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570442|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2570443|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2570444|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2570445|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2126599|NCT02902770|Analgesics|analgesics|mesh-ancestor
2126600|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2126601|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2126602|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2126603|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126604|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2126605|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
2126606|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126607|NCT02902913|Ibuprofen|ibuprofen|mesh-list
2126608|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2126609|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2126610|NCT02902913|Analgesics|analgesics|mesh-ancestor
2126611|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
2126612|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126613|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126614|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2126615|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2570446|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2570447|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
2570448|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570449|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2570450|NCT01597986|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2570451|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
2570452|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2570453|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2570454|NCT01598012|Analgesics|analgesics|mesh-ancestor
2570455|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
2570456|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570457|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570458|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2570459|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2570460|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2570461|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570462|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570463|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
2570464|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2570465|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
2570466|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2570467|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
2570468|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570469|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570470|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
2570471|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
2570472|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2570473|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
2570474|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2570475|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
2570476|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126616|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2126617|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126618|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570477|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570478|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
2570479|NCT01598259|Melatonin|melatonin|mesh-list
2570480|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
2570481|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570482|NCT01598259|Protective Agents|protective agents|mesh-ancestor
2570483|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570484|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2570485|NCT01598337|Aspirin|aspirin|mesh-list
2570486|NCT01598337|Tirofiban|tirofiban|mesh-list
2570487|NCT01598337|Clopidogrel|clopidogrel|mesh-list
2570488|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2570489|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2570490|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2570491|NCT01598337|Analgesics|analgesics|mesh-ancestor
2126619|NCT02902965|Dexamethasone|dexamethasone|mesh-list
2126620|NCT02902965|Bortezomib|bortezomib|mesh-list
2126621|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2126622|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
2126623|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
2126624|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570492|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
2570493|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570494|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570495|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2570496|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2570497|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2570498|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2570499|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570500|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2570501|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2570502|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570503|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
2570504|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2570505|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2570506|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2570507|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
2570508|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570509|NCT01598363|Digoxin|digoxin|mesh-list
2570510|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2570511|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2570512|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2570513|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
2570514|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570515|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2570516|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2570517|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570518|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2570519|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2570520|NCT01598363|Protective Agents|protective agents|mesh-ancestor
2570521|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570522|NCT01598402|Amoxicillin|amoxicillin|mesh-list
2570523|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
2570524|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
2570525|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2126625|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126626|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2126627|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
2126628|NCT02902965|Hormones|hormones|mesh-ancestor
2126629|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2126630|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2126631|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126632|NCT02903030|Silicon|silicon|mesh-list
2126633|NCT02903030|Trace Elements|trace elements|mesh-ancestor
2126634|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
2126635|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126636|NCT02903121|Tamoxifen|tamoxifen|mesh-list
2126637|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2126638|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
2126639|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2126640|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126641|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2126642|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126643|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2126644|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2570526|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2126645|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2126646|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2126647|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2126648|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2126649|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2126650|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126651|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126652|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126653|NCT02903238|Analgesics|analgesics|mesh-ancestor
2126654|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
2126655|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126656|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
2570527|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570528|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570529|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2570530|NCT01598441|Iloprost|iloprost|mesh-list
2570531|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2570532|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
2570533|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
2570534|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2570535|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2570536|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2570537|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
2570538|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2570539|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2570540|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2570541|NCT01598558|Rituximab|rituximab|mesh-list
2570542|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2570543|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570544|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
2570545|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570546|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2570547|NCT01598584|Gemcitabine|gemcitabine|mesh-list
2570548|NCT01598584|Mirtazapine|mirtazapine|mesh-list
2570549|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2570550|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
2570551|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570552|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126657|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2126658|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
2126659|NCT02903368|Prednisone|prednisone|mesh-list
2126660|NCT02903368|Leuprolide|leuprolide|mesh-list
2126661|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
2126662|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2126663|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
2126664|NCT02903368|Hormones|hormones|mesh-ancestor
2126665|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2126666|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126667|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2126668|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570553|NCT01598584|Antiviral Agents|antiviral agents|mesh-ancestor
2570554|NCT01598584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570555|NCT01598584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570556|NCT01598584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2570557|NCT01598584|Immunologic Factors|immunologic factors|mesh-ancestor
2570558|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570559|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
2570560|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2570561|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2570562|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
2570563|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
2570564|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570565|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2570566|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2570567|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2570568|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2570569|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2570570|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2570571|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
2570572|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2570573|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2570574|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
2570575|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2126669|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2126670|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
2126671|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2126672|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2126673|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126674|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126675|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
2126676|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2570576|NCT01598623|Oxytocin|oxytocin|mesh-list
2570577|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
2570578|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2570579|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570580|NCT01598649|Mannitol|mannitol|mesh-list
2126677|NCT02903407|Midazolam|midazolam|mesh-list
2126678|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
2126679|NCT02903407|Propofol|propofol|mesh-list
2126680|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2126681|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126682|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126683|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2126684|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
2126685|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
2126686|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2126687|NCT02903407|Analgesics|analgesics|mesh-ancestor
2126688|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
2126689|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126690|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2570581|NCT01598649|Caseins|caseins|mesh-list
2570582|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2570583|NCT01598649|Diuretics|diuretics|mesh-ancestor
2570584|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
2570585|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570586|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
2570587|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
2570588|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570589|NCT01598675|Methamphetamine|methamphetamine|mesh-list
2570590|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2126691|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2126692|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2126693|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
2126694|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126695|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126696|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2126697|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2126698|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2126699|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2126700|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
2126701|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
2126702|NCT02903446|Denosumab|denosumab|mesh-list
2126703|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2126704|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126705|NCT02903511|Metformin|metformin|mesh-list
2126706|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2126707|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126708|NCT02903823|Baclofen|baclofen|mesh-list
2126709|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2126710|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126711|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2126712|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126713|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2126714|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
2126715|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
2126716|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126717|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126718|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
2126719|NCT02903836|Nafithromycin|nafithromycin|mesh-list
2126720|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2126721|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2126722|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2126723|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2126724|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126725|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570591|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570592|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
2126726|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126727|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2126731|NCT02904096|Lidocaine|lidocaine|mesh-list
2126732|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
2126733|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
2419194|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419195|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419196|NCT00802230|Terbutaline|terbutaline|mesh-list
2419197|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2419198|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
2419199|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419200|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419201|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2419202|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
2419203|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
2419204|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
2419205|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2419206|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2419207|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2126734|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126735|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126736|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
2126737|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126738|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2126739|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2126740|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2126741|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2126742|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570593|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
2570594|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570595|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
2570596|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570597|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126743|NCT02904200|Silicon|silicon|mesh-list
2126744|NCT02904200|Trace Elements|trace elements|mesh-ancestor
2126745|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
2126746|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126747|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
2126748|NCT02904226|Nivolumab|nivolumab|mesh-list
2126749|NCT02904226|Ipilimumab|ipilimumab|mesh-list
2570598|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
2570599|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2570600|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2570601|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2570602|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2570603|NCT01598883|Heparin|heparin|mesh-list
2570604|NCT01598883|Calcium heparin|calcium heparin|mesh-list
2126750|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2126751|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126752|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2126753|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126754|NCT02904265|Acetazolamide|acetazolamide|mesh-list
2126755|NCT02904265|Diazepam|diazepam|mesh-list
2126756|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
2126757|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2126758|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126759|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126760|NCT02904265|Diuretics|diuretics|mesh-ancestor
2126761|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
2126762|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570605|NCT01598883|Antithrombins|antithrombins|mesh-list
2570606|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
2570607|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2570608|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2570609|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570610|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2570611|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
2126763|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2126764|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
2126765|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
2126766|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570612|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570613|NCT01598948|Mipomersen|mipomersen|mesh-list
2126767|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2570614|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2570615|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2570616|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
2570617|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570618|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2570619|NCT01599000|Lumefantrine|lumefantrine|mesh-list
2570620|NCT01599000|Artemether|artemether|mesh-list
2570621|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2570622|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
2570623|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2570624|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2570625|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570626|NCT01599013|Gemcitabine|gemcitabine|mesh-list
2570627|NCT01599013|Carboplatin|carboplatin|mesh-list
2570628|NCT01599013|Vinblastine|vinblastine|mesh-list
2570629|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570630|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2570631|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
2570632|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570633|NCT01599013|Antiviral Agents|antiviral agents|mesh-ancestor
2570634|NCT01599013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570635|NCT01599013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570636|NCT01599013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2570637|NCT01599013|Immunologic Factors|immunologic factors|mesh-ancestor
2570638|NCT01599013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570639|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2570640|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
2570641|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
2570642|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
2570643|NCT01599078|Paclitaxel|paclitaxel|mesh-list
2570644|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2570645|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570646|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
2570647|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
2570648|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
2570649|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570650|NCT01599117|Udenafil|udenafil|mesh-list
2570651|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2570652|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2570653|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570654|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570655|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2570656|NCT01599130|Entecavir|entecavir|mesh-list
2570657|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
2570658|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570659|NCT01599273|Triamcinolone|triamcinolone|mesh-list
2570660|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2570661|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
2570662|NCT01599273|Hormones|hormones|mesh-ancestor
2570663|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2570664|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570665|NCT01599312|Cobalt|cobalt|mesh-list
2570666|NCT01599312|Trace Elements|trace elements|mesh-ancestor
2570667|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
2570668|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570669|NCT01599338|Liraglutide|liraglutide|mesh-list
2570670|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2570671|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570672|NCT01599338|Incretins|incretins|mesh-ancestor
2570673|NCT01599338|Hormones|hormones|mesh-ancestor
2570674|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2570675|NCT01599364|Ritonavir|ritonavir|mesh-list
2570676|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2570677|NCT01599364|Lamivudine|lamivudine|mesh-list
2570678|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2570679|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2570680|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
2570681|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570682|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570683|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2570684|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2570685|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
2126768|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2126769|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126770|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2126771|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2570686|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570687|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2570688|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2570689|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2570690|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2570691|NCT01599377|Tofacitinib|tofacitinib|mesh-list
2570692|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2570693|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570694|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570695|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
2570696|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2570697|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2570698|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570699|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
2570700|NCT01599468|Coagulants|coagulants|mesh-ancestor
2570701|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2570702|NCT01599494|Progesterone|progesterone|mesh-list
2570703|NCT01599494|Ganirelix|ganirelix|mesh-list
2570704|NCT01599494|Progestins|progestins|mesh-ancestor
2570705|NCT01599494|Hormones|hormones|mesh-ancestor
2570706|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2570707|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570708|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2570709|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
2570710|NCT01599572|Zinc|zinc|mesh-list
2570711|NCT01599572|Trace Elements|trace elements|mesh-ancestor
2570712|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
2570713|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570714|NCT01599598|Imidacloprid|imidacloprid|mesh-list
2570715|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
2570716|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570717|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570718|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570719|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2570720|NCT01599702|Hematinics|hematinics|mesh-ancestor
2570721|NCT01599728|Substance P|substance p|mesh-list
2570722|NCT01599728|Neurokinin A|neurokinin a|mesh-list
2570723|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570724|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570725|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570726|NCT01599819|Factor VIII|factor viii|mesh-list
2570727|NCT01599819|BAX 855|bax 855|mesh-list
2570728|NCT01599819|Coagulants|coagulants|mesh-ancestor
2570729|NCT01599858|Omeprazole|omeprazole|mesh-list
2126772|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2126773|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2126774|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2126775|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2126776|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
2126777|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
2126778|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
2126779|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
2570730|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2570731|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2570732|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2570733|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570734|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570735|NCT01599871|Theophylline|theophylline|mesh-list
2570736|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2570737|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
2570738|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570739|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570740|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2570741|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
2570742|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2570743|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570744|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570745|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
2570746|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2570747|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2570748|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
2570749|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570750|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
2570751|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2570752|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
2126780|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126781|NCT02904902|Adalimumab|adalimumab|mesh-list
2570753|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570754|NCT01599884|Expectorants|expectorants|mesh-ancestor
2570755|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
2570756|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2570757|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
2570758|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570759|NCT01599884|Protective Agents|protective agents|mesh-ancestor
2570760|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570761|NCT01599884|Antidotes|antidotes|mesh-ancestor
2570762|NCT01599923|Antivenins|antivenins|mesh-list
2570763|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
2570764|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570765|NCT01599936|Antivenins|antivenins|mesh-list
2570766|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
2570767|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570768|NCT01599962|Cinacalcet|cinacalcet|mesh-list
2570769|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2570770|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126782|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2126783|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2126784|NCT02904915|Lidocaine|lidocaine|mesh-list
2126785|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
2126786|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
2126787|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126788|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126789|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
2126790|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126791|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2126792|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2126793|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2126794|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2126795|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126796|NCT02904954|Durvalumab|durvalumab|mesh-list
2126797|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2126798|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2126799|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126800|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
2126801|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126802|NCT02905266|Nivolumab|nivolumab|mesh-list
2126803|NCT02905266|Ipilimumab|ipilimumab|mesh-list
2126804|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2126805|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126806|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2126807|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126808|NCT02905981|Citric Acid|citric acid|mesh-list
2126809|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
2126810|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
2126811|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2126812|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
2126813|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
2126814|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126815|NCT02906566|Vitamin A|vitamin a|mesh-list
2126816|NCT02906566|Vitamins|vitamins|mesh-ancestor
2126817|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
2126818|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126819|NCT02906579|Praliciguat|praliciguat|mesh-list
2126820|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2570771|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2570772|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
2570773|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2570774|NCT01599975|Methylphenidate|methylphenidate|mesh-list
2570775|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2570776|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570777|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2570778|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2570779|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2570780|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570781|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
2570782|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570783|NCT01599988|Caseins|caseins|mesh-list
2570784|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
2570785|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
2570786|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570787|NCT01600079|Vaccines|vaccines|mesh-list
2570788|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
2570789|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570790|NCT01600235|Phenylephrine|phenylephrine|mesh-list
2570791|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
2570792|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2570793|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
2570794|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
2570795|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570796|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570797|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
2570798|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2570799|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
2570800|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
2570801|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2570802|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2570803|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2570804|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
2570805|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570806|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570807|NCT01600235|Protective Agents|protective agents|mesh-ancestor
2570808|NCT01600274|Dienogest|dienogest|mesh-list
2570809|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2570810|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2570811|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2570812|NCT01600274|Estradiol|estradiol|mesh-list
2570813|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2570814|NCT01600274|Nandrolone|nandrolone|mesh-list
2570815|NCT01600274|Estrogens|estrogens|mesh-ancestor
2570816|NCT01600274|Hormones|hormones|mesh-ancestor
2570817|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2570818|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570819|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2570820|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
2570821|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2570822|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2570823|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2570824|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2570825|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2570826|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
2570827|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2570828|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570829|NCT01600274|Androgens|androgens|mesh-ancestor
2570830|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
2570831|NCT01600365|Ganciclovir|ganciclovir|mesh-list
2570832|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2570833|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
2570834|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
2570835|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570836|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2570837|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570838|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570839|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2570840|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2570841|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
2570842|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2570843|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
2570844|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570845|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570846|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570847|NCT01600430|Vitamin D|vitamin d|mesh-list
2570848|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
2570849|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
2570850|NCT01600430|Vitamins|vitamins|mesh-list
2570851|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
2570852|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570853|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2570854|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2570855|NCT01600456|Sertraline|sertraline|mesh-list
2570856|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
2570857|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2570858|NCT01600456|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2570859|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2570860|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2570861|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570862|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570863|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
2570864|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570865|NCT01600573|Topotecan|topotecan|mesh-list
2570866|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2570867|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2570868|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570869|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570870|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570871|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
2570872|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2570873|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2570874|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570875|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
2570876|NCT01600599|Coagulants|coagulants|mesh-ancestor
2570877|NCT01600612|Oxytocin|oxytocin|mesh-list
2570878|NCT01600612|Carbetocin|carbetocin|mesh-list
2570879|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
2570880|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2570881|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570882|NCT01600625|Minocycline|minocycline|mesh-list
2570883|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2570884|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570885|NCT01600742|Vorinostat|vorinostat|mesh-list
2570886|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570887|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2570888|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570889|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570890|NCT01600768|Lactams|lactams|mesh-list
2570891|NCT01600768|beta-Lactams|beta-lactams|mesh-list
2570892|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2570893|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570894|NCT01600807|Gemcitabine|gemcitabine|mesh-list
2570895|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2570896|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2570897|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
2570898|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570899|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570900|NCT01600807|Antiviral Agents|antiviral agents|mesh-ancestor
2570901|NCT01600807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570902|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570903|NCT01600807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2570904|NCT01600807|Immunologic Factors|immunologic factors|mesh-ancestor
2570905|NCT01600807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570906|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2570907|NCT01600963|Bedaquiline|bedaquiline|mesh-list
2570908|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
2570909|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
2570910|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2570911|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570912|NCT01601002|Mirtazapine|mirtazapine|mesh-list
2570913|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
2570914|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2570915|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2570916|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
2570917|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
2570918|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570919|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570920|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570921|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2570922|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2570923|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2570924|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2570925|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2570926|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2570927|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
2126821|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
2126822|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126823|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2126824|NCT02906644|Nicotine|nicotine|mesh-list
2126825|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2126826|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
2126827|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126828|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126829|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2126830|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2126831|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
2126832|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2570928|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2126833|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126834|NCT02906709|Insulin|insulin|mesh-list
2126835|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2126836|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126837|NCT02906917|Insulin|insulin|mesh-list
2126838|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2126839|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
2126840|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
2126841|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
2126842|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2126843|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2126844|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126845|NCT02907177|Ponesimod|ponesimod|mesh-list
2126846|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2126847|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126848|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2126849|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
2126850|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570929|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2570930|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
2570931|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2570932|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
2570933|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
2570934|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2570935|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2570936|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570937|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570938|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570939|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2570940|NCT01601093|Sulbactam|sulbactam|mesh-list
2570941|NCT01601093|Cefoperazone|cefoperazone|mesh-list
2570942|NCT01601093|Sulperazone|sulperazone|mesh-list
2570943|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2570944|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2570945|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2570946|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2570947|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570948|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2570949|NCT01601093|Renal Agents|renal agents|mesh-ancestor
2570950|NCT01601106|Prednisolone|prednisolone|mesh-list
2570951|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2570952|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
2570953|NCT01601106|Hormones|hormones|mesh-ancestor
2570954|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2570955|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570956|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2570957|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570958|NCT01601184|Temozolomide|temozolomide|mesh-list
2570959|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2570960|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
2570961|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570962|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570963|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
2570964|NCT01601314|Analgesics|analgesics|mesh-ancestor
2570965|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
2570966|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2570967|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570968|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
2570969|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2570970|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2570971|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
2570972|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2570973|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2570974|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2570975|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2570976|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
2570977|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2570978|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
2570979|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2570980|NCT01601327|Testosterone|testosterone|mesh-list
2570981|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
2570982|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
2570983|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2570984|NCT01601327|Androgens|androgens|mesh-ancestor
2570985|NCT01601327|Hormones|hormones|mesh-ancestor
2570986|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2570987|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570988|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2570989|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2570990|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
2570991|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2570992|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
2126851|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2126852|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2126853|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2126854|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126855|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126856|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2126857|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2126858|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126859|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
2126860|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126861|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2126862|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2126863|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2126864|NCT02907918|Trastuzumab|trastuzumab|mesh-list
2126865|NCT02907918|Letrozole|letrozole|mesh-list
2126866|NCT02907918|Palbociclib|palbociclib|mesh-list
2126867|NCT02907918|Goserelin|goserelin|mesh-list
2126868|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2126869|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126870|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2126871|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2570993|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
2570994|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2570995|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2570996|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2570997|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2570998|NCT01601509|Tramazoline|tramazoline|mesh-list
2570999|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
2571000|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
2571001|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571002|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571003|NCT01601561|Insulin|insulin|mesh-list
2571004|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2571005|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2126872|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126873|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126874|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2126875|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
2126876|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2126877|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126878|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2126879|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2126880|NCT02908269|Vaccines|vaccines|mesh-list
2126881|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
2126882|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126883|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
2126884|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
2126885|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2126886|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2126887|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126888|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126889|NCT02908490|Urological Agents|urological agents|mesh-ancestor
2126890|NCT02908529|Oxybutynin|oxybutynin|mesh-list
2126891|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2126892|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2126893|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2126894|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2126895|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126896|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
2126897|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571006|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571007|NCT01601730|Dexetimide|dexetimide|mesh-list
2571008|NCT01601730|Modafinil|modafinil|mesh-list
2571009|NCT01601730|Citalopram|citalopram|mesh-list
2571010|NCT01601730|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2571011|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2126898|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126899|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
2571012|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2571013|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571014|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571015|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
2571016|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126900|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
2126901|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126902|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2126903|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2126904|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
2126905|NCT02908529|Urological Agents|urological agents|mesh-ancestor
2126906|NCT02908620|Anesthetics|anesthetics|mesh-list
2126907|NCT02908620|Tetracaine|tetracaine|mesh-list
2126908|NCT02908620|Benzocaine|benzocaine|mesh-list
2126909|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126910|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126911|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
2126912|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
2126913|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571017|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2571018|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
2571019|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2126927|NCT02909140|Lidocaine|lidocaine|mesh-list
2126928|NCT02909140|Phenylephrine|phenylephrine|mesh-list
2126929|NCT02909140|Epinephrine|epinephrine|mesh-list
2126930|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
2126931|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
2126932|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
2126933|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
2126934|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126935|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126936|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
2126937|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126938|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2126939|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2126940|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2126941|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2126942|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126943|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2126944|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2126945|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
2126946|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126947|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2126948|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2126949|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
2126950|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2126951|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
2126952|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
2126953|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
2126954|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2126955|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2126956|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
2126957|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2126958|NCT02909140|Protective Agents|protective agents|mesh-ancestor
2126959|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
2126960|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2126961|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2126962|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
2126963|NCT02909439|Neostigmine|neostigmine|mesh-list
2126964|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2126965|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126966|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126967|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
2126968|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571020|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2571021|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2571022|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
2571023|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
2571024|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571025|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2571026|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2571027|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
2571028|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2571029|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2571030|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2571031|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2571032|NCT01601795|Sevoflurane|sevoflurane|mesh-list
2571033|NCT01601795|Isoflurane|isoflurane|mesh-list
2571034|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2571035|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2571036|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
2571037|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
2571038|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571039|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571040|NCT01601899|Tenofovir|tenofovir|mesh-list
2571041|NCT01601899|Lamivudine|lamivudine|mesh-list
2571042|NCT01601899|Efavirenz|efavirenz|mesh-list
2571043|NCT01601899|Stavudine|stavudine|mesh-list
2571044|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
2571045|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571046|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2571047|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2126969|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126970|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2126971|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
2126972|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2126973|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
2126974|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
2126975|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2126976|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2126977|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2126978|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
2126979|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2126980|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2126981|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126982|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
2126983|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2571048|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571049|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571050|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2571051|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2571052|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2571053|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2571054|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2571055|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2571056|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2571057|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2571058|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
2571059|NCT01601912|Dexetimide|dexetimide|mesh-list
2571060|NCT01601912|Citalopram|citalopram|mesh-list
2571061|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2571062|NCT01601912|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2571063|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2571064|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2571065|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571066|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571067|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
2571068|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571069|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2571070|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
2571071|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2571072|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2126984|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2126985|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571073|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2571074|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
2571075|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
2571076|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571077|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2571078|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2571079|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
2126986|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
2126987|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2126988|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126989|NCT02909959|Sulforaphane|sulforaphane|mesh-list
2126990|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2126991|NCT02909959|Protective Agents|protective agents|mesh-ancestor
2126992|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2126993|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2126994|NCT02910011|Doxycycline|doxycycline|mesh-list
2126995|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2126996|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2126997|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
2126998|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2126999|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2127000|NCT02910063|Blinatumomab|blinatumomab|mesh-list
2127001|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127002|NCT02910167|Acetaminophen|acetaminophen|mesh-list
2127003|NCT02910167|Scopolamine|scopolamine|mesh-list
2127004|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2127005|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2127006|NCT02910167|Analgesics|analgesics|mesh-ancestor
2127007|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
2127008|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127009|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127010|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
2571080|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2571081|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
2571082|NCT01601938|Selenium|selenium|mesh-list
2571083|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
2571084|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571085|NCT01601938|Protective Agents|protective agents|mesh-ancestor
2571086|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571087|NCT01601938|Trace Elements|trace elements|mesh-ancestor
2571088|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
2571089|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2571090|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2571091|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571092|NCT01602003|Incretins|incretins|mesh-ancestor
2571093|NCT01602003|Hormones|hormones|mesh-ancestor
2571094|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2571095|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2571096|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
2571097|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571098|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571099|NCT01602029|Ondansetron|ondansetron|mesh-list
2571100|NCT01602029|Simvastatin|simvastatin|mesh-list
2571101|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2571102|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2571103|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
2571104|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571105|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2571106|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2571107|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571108|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
2571109|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
2571110|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571111|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571112|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2571113|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
2571114|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
2571115|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2571116|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
2571117|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571118|NCT01602029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2571119|NCT01602029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2571120|NCT01602029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127011|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2127012|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
2127013|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
2571121|NCT01602029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2571122|NCT01602029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2571123|NCT01602055|Azithromycin|azithromycin|mesh-list
2571124|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2571125|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571126|NCT01602185|Memantine|memantine|mesh-list
2571127|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
2571128|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
2127014|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2127015|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
2127016|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2127017|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
2127018|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127019|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127020|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2127021|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
2127022|NCT02911116|Ustekinumab|ustekinumab|mesh-list
2127023|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
2127024|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
2127025|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2127026|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
2127027|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2127028|NCT02911285|Expectorants|expectorants|mesh-ancestor
2127029|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
2127030|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2127031|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
2127032|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127033|NCT02911285|Protective Agents|protective agents|mesh-ancestor
2127034|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127035|NCT02911285|Antidotes|antidotes|mesh-ancestor
2571129|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2571130|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2571131|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
2571132|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571133|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571134|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571135|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2127036|NCT02911324|Nabilone|nabilone|mesh-list
2127037|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
2127038|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
2127039|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127040|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127041|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2127042|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2127043|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2127044|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571136|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2571137|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
2571138|NCT01602250|Ropivacaine|ropivacaine|mesh-list
2571139|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
2571140|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2571141|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
2571142|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
2571143|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571144|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571145|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
2571146|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571147|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2127045|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2127046|NCT02911688|Vitamin E|vitamin e|mesh-list
2127047|NCT02911688|Tocopherols|tocopherols|mesh-list
2127048|NCT02911688|Tocotrienols|tocotrienols|mesh-list
2127049|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
2127050|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
2571148|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2571149|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2127051|NCT02911688|Vitamins|vitamins|mesh-ancestor
2127052|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
2127053|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127054|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
2127055|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127056|NCT02911688|Protective Agents|protective agents|mesh-ancestor
2127057|NCT02911818|Liraglutide|liraglutide|mesh-list
2127058|NCT02911818|Phentermine|phentermine|mesh-list
2127059|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2127060|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127061|NCT02911818|Incretins|incretins|mesh-ancestor
2127062|NCT02911818|Hormones|hormones|mesh-ancestor
2127063|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2571150|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2571151|NCT01602289|Gefitinib|gefitinib|mesh-list
2571152|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571153|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2571154|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571155|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571156|NCT01602302|Adalimumab|adalimumab|mesh-list
2571157|NCT01602302|Etanercept|etanercept|mesh-list
2571158|NCT01602302|Golimumab|golimumab|mesh-list
2571159|NCT01602302|Abatacept|abatacept|mesh-list
2571160|NCT01602302|Infliximab|infliximab|mesh-list
2571161|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
2571162|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2571163|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2571164|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2571165|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2571166|NCT01602302|Analgesics|analgesics|mesh-ancestor
2571167|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
2127064|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2127065|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
2127066|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2571168|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571169|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571170|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2571171|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2571172|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
2571173|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
2571174|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2571175|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571176|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571177|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2571178|NCT01602393|Flurbiprofen|flurbiprofen|mesh-list
2571179|NCT01602393|Analgesics|analgesics|mesh-ancestor
2571180|NCT01602393|Sensory System Agents|sensory system agents|mesh-ancestor
2571181|NCT01602393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571182|NCT01602393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571183|NCT01602393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2571184|NCT01602393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2571185|NCT01602393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2571186|NCT01602393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2571187|NCT01602393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2571188|NCT01602393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571189|NCT01602393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571190|NCT01602406|Trastuzumab|trastuzumab|mesh-list
2571191|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2571192|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571193|NCT01602523|Budesonide|budesonide|mesh-list
2571194|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
2571195|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2571196|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2571197|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
2571198|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571199|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571200|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2571201|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
2571202|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
2571203|NCT01602523|Hormones|hormones|mesh-ancestor
2571204|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2571205|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2571206|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2571207|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2571208|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
2571209|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571210|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127067|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
2127068|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
2127069|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127070|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
2127071|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127072|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127073|NCT02911844|Fulvestrant|fulvestrant|mesh-list
2127074|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2127075|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127076|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2571211|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
2127077|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2127078|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
2127079|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2127080|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127081|NCT02911948|Insulin|insulin|mesh-list
2127082|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2127083|NCT02911948|Liraglutide|liraglutide|mesh-list
2127084|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
2127085|NCT02911948|Xultophy|xultophy|mesh-list
2127086|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2127087|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127088|NCT02911948|Incretins|incretins|mesh-ancestor
2127089|NCT02911948|Hormones|hormones|mesh-ancestor
2571212|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
2571213|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2571214|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2571215|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571216|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571217|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571218|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2571219|NCT01602640|Fentanyl|fentanyl|mesh-list
2571220|NCT01602640|Midazolam|midazolam|mesh-list
2571221|NCT01602640|Morphine|morphine|mesh-list
2571222|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2571223|NCT01602640|Narcotics|narcotics|mesh-ancestor
2571224|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127090|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2127091|NCT02912195|Lidocaine|lidocaine|mesh-list
2127092|NCT02912195|Morphine|morphine|mesh-list
2127093|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
2127094|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
2127095|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127096|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571225|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571226|NCT01602640|Analgesics|analgesics|mesh-ancestor
2571227|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
2571228|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571229|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2571230|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2571231|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
2571232|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
2571233|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2571234|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2571235|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2571236|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2571237|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
2571238|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
2571239|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571240|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571241|NCT01602757|Lidocaine|lidocaine|mesh-list
2571242|NCT01602757|Tetracaine|tetracaine|mesh-list
2571243|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
2571244|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
2571245|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571246|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571247|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
2571248|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571249|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2571250|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2571251|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2571252|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2127097|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
2419208|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2419209|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
2419210|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419211|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419212|NCT00802243|Leflunomide|leflunomide|mesh-list
2419213|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419214|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419215|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2419216|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
2419217|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419218|NCT00802282|Psilocybin|psilocybin|mesh-list
2419219|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
2419220|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419221|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2127098|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127099|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2127100|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2127101|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2127102|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2127103|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127104|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2127105|NCT02912195|Narcotics|narcotics|mesh-ancestor
2127106|NCT02912195|Analgesics|analgesics|mesh-ancestor
2127107|NCT02912364|Carbamazepine|carbamazepine|mesh-list
2127108|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2127109|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
2127110|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
2127111|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2127112|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127113|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127114|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2127115|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2127116|NCT02912364|Analgesics|analgesics|mesh-ancestor
2127117|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
2127118|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127119|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2127120|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2127121|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127122|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2127123|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2127124|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2127125|NCT02912455|Canagliflozin|canagliflozin|mesh-list
2127126|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2127127|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127128|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2127129|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127130|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
2127131|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2127132|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
2127133|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2127134|NCT02912650|Acetaminophen|acetaminophen|mesh-list
2127135|NCT02912650|Ibuprofen|ibuprofen|mesh-list
2127136|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2127137|NCT02912650|Analgesics|analgesics|mesh-ancestor
2127138|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
2127139|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127140|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127141|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
2127142|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2127143|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2127144|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2127145|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2127146|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127147|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127148|NCT02913326|Warfarin|warfarin|mesh-list
2127149|NCT02913326|Dabigatran|dabigatran|mesh-list
2127150|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
2127151|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
2571253|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571254|NCT01602822|Ritonavir|ritonavir|mesh-list
2571255|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2571256|NCT01602822|Tenofovir|tenofovir|mesh-list
2127152|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2127153|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
2127154|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127155|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127160|NCT02913521|Diclofenac|diclofenac|mesh-list
2127161|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2127162|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2127163|NCT02913521|Analgesics|analgesics|mesh-ancestor
2127164|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
2127165|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571257|NCT01602822|Emtricitabine|emtricitabine|mesh-list
2571258|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2571259|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2571260|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2571261|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
2571262|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571263|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571264|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2571265|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2571266|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
2571267|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571268|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2571269|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2571270|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2571271|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2571272|NCT01602861|Spironolactone|spironolactone|mesh-list
2571273|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2571274|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
2571275|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2571276|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571277|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2571278|NCT01602861|Diuretics|diuretics|mesh-ancestor
2571279|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
2571280|NCT01602874|Metronidazole|metronidazole|mesh-list
2571281|NCT01602874|Clarithromycin|clarithromycin|mesh-list
2571282|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
2571283|NCT01602874|Tigecycline|tigecycline|mesh-list
2571284|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571285|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2571286|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2571287|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2571288|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2571289|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571290|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571291|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2571292|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2571293|NCT01602887|Palbociclib|palbociclib|mesh-list
2571294|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571295|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2571296|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127166|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127167|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2127168|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2127169|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2127170|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127171|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127172|NCT02913924|Clonazepam|clonazepam|mesh-list
2127173|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
2127174|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
2127175|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
2127176|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127177|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127178|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127179|NCT02914119|Rocuronium|rocuronium|mesh-list
2127180|NCT02914119|Mivacurium|mivacurium|mesh-list
2127181|NCT02914119|Cisatracurium|cisatracurium|mesh-list
2127182|NCT02914119|Succinylcholine|succinylcholine|mesh-list
2127183|NCT02914119|Neostigmine|neostigmine|mesh-list
2419222|NCT00802308|Morphine|morphine|mesh-list
2419223|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2419224|NCT00802308|Narcotics|narcotics|mesh-ancestor
2419225|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2419226|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419227|NCT00802308|Analgesics|analgesics|mesh-ancestor
2419228|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
2419229|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419230|NCT00802321|Dutasteride|dutasteride|mesh-list
2419231|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2419232|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2419233|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419234|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419235|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
2419236|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2419237|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419238|NCT00802334|Ritonavir|ritonavir|mesh-list
2419239|NCT00802334|Lopinavir|lopinavir|mesh-list
2127184|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2571297|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571298|NCT01602900|Rolipram|rolipram|mesh-list
2571299|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
2571300|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2571301|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2571302|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2571303|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571304|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571305|NCT01602913|Paroxetine|paroxetine|mesh-list
2571306|NCT01602913|Pravastatin|pravastatin|mesh-list
2571307|NCT01602913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2571308|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2571309|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2571310|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571311|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571312|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
2571313|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571314|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2571315|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
2571316|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2571317|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2571318|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2571319|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571320|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2571321|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2571322|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
2571323|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2571324|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2571325|NCT01602939|Cladribine|cladribine|mesh-list
2127185|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2127186|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2127187|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127188|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127189|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2127190|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127191|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127192|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
2127193|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127194|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2127195|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
2127196|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2571326|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571327|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2571328|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
2571329|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571330|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
2571331|NCT01603030|Prednisolone|prednisolone|mesh-list
2571332|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2571333|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
2571334|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2571335|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
2571336|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2571337|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2571338|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
2571339|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2571340|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
2571341|NCT01603030|Hormones|hormones|mesh-ancestor
2571342|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2571343|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571344|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2571345|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571346|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
2571347|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
2571348|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571349|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2571350|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2571351|NCT01603030|Protective Agents|protective agents|mesh-ancestor
2571352|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2571353|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571354|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2571355|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2571356|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571357|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571358|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2571359|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
2571360|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2571361|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2571362|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2571363|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2571364|NCT01603108|Rifaximin|rifaximin|mesh-list
2571365|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2571366|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571367|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2571368|NCT01603134|Allopurinol|allopurinol|mesh-list
2571369|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
2571370|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571371|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571372|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
2571373|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2571374|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2571375|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
2571376|NCT01603134|Protective Agents|protective agents|mesh-ancestor
2571377|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571378|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2571379|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
2571380|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2571381|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2571382|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2571383|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571384|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571385|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2571386|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
2571387|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2571388|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2571389|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2571390|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571391|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571392|NCT01603212|Interferons|interferons|mesh-list
2571393|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
2571394|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
2571395|NCT01603212|Aldesleukin|aldesleukin|mesh-list
2571396|NCT01603212|Interleukin-2|interleukin-2|mesh-list
2571397|NCT01603212|Vemurafenib|vemurafenib|mesh-list
2571398|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571399|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
2571400|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571401|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
2571402|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571403|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2571404|NCT01603212|Analgesics|analgesics|mesh-ancestor
2571405|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
2571406|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571407|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2571408|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2571409|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2571410|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571411|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571412|NCT01603251|Ivermectin|ivermectin|mesh-list
2571413|NCT01603251|Lumefantrine|lumefantrine|mesh-list
2571414|NCT01603251|Artemether|artemether|mesh-list
2571415|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2571416|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2571417|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571418|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
2571419|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2571420|NCT01603264|Trastuzumab|trastuzumab|mesh-list
2571421|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2571422|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571423|NCT01603342|Clopidogrel|clopidogrel|mesh-list
2571424|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2571425|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2571426|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2571427|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2571428|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
2571429|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571430|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571431|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127197|NCT02914275|Vaccines|vaccines|mesh-list
2127198|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
2127199|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127200|NCT02914509|Travoprost|travoprost|mesh-list
2127201|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2127202|NCT02915016|Vaccines|vaccines|mesh-list
2127203|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
2127204|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
2127205|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571432|NCT01603407|Prednisone|prednisone|mesh-list
2571433|NCT01603407|Deflazacort|deflazacort|mesh-list
2571434|NCT01603407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2571435|NCT01603407|Glucocorticoids|glucocorticoids|mesh-ancestor
2571436|NCT01603407|Hormones|hormones|mesh-ancestor
2571437|NCT01603407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2571438|NCT01603407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571439|NCT01603407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2571440|NCT01603407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571441|NCT01603407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2571442|NCT01603407|Immunologic Factors|immunologic factors|mesh-ancestor
2571443|NCT01603498|Dexamethasone|dexamethasone|mesh-list
2571444|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
2571445|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2571446|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2571447|NCT01603498|Prednisolone|prednisolone|mesh-list
2571448|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
2571449|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2571450|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
2571451|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2571452|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
2571453|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
2571454|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571455|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127206|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2127207|NCT02915159|Abatacept|abatacept|mesh-list
2127208|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2127209|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127210|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127211|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2127212|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
2127213|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127214|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2127215|NCT02915302|Vaccines|vaccines|mesh-list
2127216|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
2127217|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571456|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2571457|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
2571458|NCT01603498|Hormones|hormones|mesh-ancestor
2571459|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2571460|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2571461|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571462|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2571463|NCT01603498|Protective Agents|protective agents|mesh-ancestor
2571464|NCT01603511|Charcoal|charcoal|mesh-list
2571465|NCT01603511|Antidotes|antidotes|mesh-ancestor
2571466|NCT01603511|Protective Agents|protective agents|mesh-ancestor
2571467|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571468|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
2571469|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
2571470|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
2571471|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571472|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
2571473|NCT01603654|Protective Agents|protective agents|mesh-ancestor
2571474|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571475|NCT01603654|Vitamins|vitamins|mesh-ancestor
2571476|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
2571477|NCT01603654|Cathartics|cathartics|mesh-ancestor
2571478|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2571479|NCT01603680|Anesthetics|anesthetics|mesh-list
2571480|NCT01603680|Mepivacaine|mepivacaine|mesh-list
2571481|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
2571482|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571483|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571484|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
2571485|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127218|NCT02915705|Vitamin D|vitamin d|mesh-list
2127219|NCT02915705|Vitamins|vitamins|mesh-ancestor
2127220|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
2571486|NCT01603693|Calcium|calcium|mesh-list
2419240|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2419241|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2419242|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
2419243|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419244|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419245|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2419246|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2419247|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
2419248|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419249|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2419250|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2419251|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
2419252|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2419253|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2419254|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2419255|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
2419256|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419257|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419258|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419259|NCT00802373|Urological Agents|urological agents|mesh-ancestor
2419260|NCT00802451|Mesalamine|mesalamine|mesh-list
2419261|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2419262|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419263|NCT00802451|Analgesics|analgesics|mesh-ancestor
2419264|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
2419265|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419266|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571487|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2127221|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127222|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2127223|NCT02915744|Gemcitabine|gemcitabine|mesh-list
2127224|NCT02915744|Paclitaxel|paclitaxel|mesh-list
2127225|NCT02915744|Vinorelbine|vinorelbine|mesh-list
2127226|NCT02915744|Docetaxel|docetaxel|mesh-list
2127227|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2127228|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
2127229|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2127230|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127231|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
2571488|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571489|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2571490|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2571491|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571492|NCT01603758|Ezetimibe|ezetimibe|mesh-list
2571493|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2571494|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2571495|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
2571496|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571497|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2571498|NCT01604031|Lenalidomide|lenalidomide|mesh-list
2571499|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
2571500|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571501|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2571502|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2571503|NCT01604031|Growth Substances|growth substances|mesh-ancestor
2571504|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
2571505|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571506|NCT01604057|Teriparatide|teriparatide|mesh-list
2127232|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
2127233|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
2127234|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127235|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2127236|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
2127237|NCT02915744|Antiviral Agents|antiviral agents|mesh-ancestor
2127238|NCT02915744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2127239|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127240|NCT02915744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2127241|NCT02915744|Immunologic Factors|immunologic factors|mesh-ancestor
2127242|NCT02915744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127243|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2127244|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2571507|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2571508|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571509|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2127254|NCT02915835|Riociguat|riociguat|mesh-list
2127255|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
2127256|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127257|NCT02915978|Fentanyl|fentanyl|mesh-list
2127258|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2127259|NCT02915978|Narcotics|narcotics|mesh-ancestor
2127260|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127261|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127262|NCT02915978|Analgesics|analgesics|mesh-ancestor
2127263|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
2127264|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127265|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2127266|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2127267|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
2127268|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
2127269|NCT02916407|Sevoflurane|sevoflurane|mesh-list
2127270|NCT02916407|Desflurane|desflurane|mesh-list
2127271|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2127272|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2127273|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
2127274|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
2127275|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127276|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127277|NCT02916433|Octreotide|octreotide|mesh-list
2127278|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2127279|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2127280|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127281|NCT02916693|Mirabegron|mirabegron|mesh-list
2127282|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2127283|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2127284|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2127285|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
2127286|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571510|NCT01604135|Riboflavin|riboflavin|mesh-list
2571511|NCT01604135|Dextrans|dextrans|mesh-list
2571512|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
2571513|NCT01604135|Vitamins|vitamins|mesh-ancestor
2571514|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
2571515|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571516|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2571517|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
2571518|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
2571519|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
2571520|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
2571521|NCT01604187|Fentanyl|fentanyl|mesh-list
2571522|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2571523|NCT01604187|Narcotics|narcotics|mesh-ancestor
2571524|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571525|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571526|NCT01604187|Analgesics|analgesics|mesh-ancestor
2571527|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
2571528|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571529|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2127287|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127288|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127289|NCT02916693|Urological Agents|urological agents|mesh-ancestor
2571530|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2571531|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
2571532|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
2571533|NCT01604213|Metformin|metformin|mesh-list
2571534|NCT01604213|Vildagliptin|vildagliptin|mesh-list
2571535|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2571536|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571537|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2571538|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
2127290|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2127291|NCT02916745|Trioxsalen|trioxsalen|mesh-list
2571539|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571540|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571541|NCT01604330|Baclofen|baclofen|mesh-list
2571542|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2571543|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571544|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2571545|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571546|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2571547|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
2571548|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
2571549|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571550|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571551|NCT01604382|Remifentanil|remifentanil|mesh-list
2571552|NCT01604382|Bupivacaine|bupivacaine|mesh-list
2571553|NCT01604382|Anesthetics|anesthetics|mesh-list
2127292|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127293|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
2127294|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2127295|NCT02916927|Ketamine|ketamine|mesh-list
2127296|NCT02916927|Analgesics|analgesics|mesh-ancestor
2127297|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
2127298|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127299|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127300|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2127301|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2571554|NCT01604382|Propofol|propofol|mesh-list
2571555|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
2571556|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571557|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571558|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
2571559|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571560|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2571561|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2571562|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
2571563|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2571564|NCT01604382|Narcotics|narcotics|mesh-ancestor
2571565|NCT01604382|Analgesics|analgesics|mesh-ancestor
2571566|NCT01604629|Adalimumab|adalimumab|mesh-list
2571567|NCT01604629|Etanercept|etanercept|mesh-list
2571568|NCT01604629|Golimumab|golimumab|mesh-list
2571569|NCT01604629|Infliximab|infliximab|mesh-list
2571570|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2571571|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2571572|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2571573|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2571574|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2571575|NCT01604629|Analgesics|analgesics|mesh-ancestor
2571576|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
2571577|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571578|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127302|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
2127303|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
2127304|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127305|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2127306|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2127307|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127308|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127309|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2127310|NCT02917031|Saxagliptin|saxagliptin|mesh-list
2127311|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2127312|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127313|NCT02917031|Incretins|incretins|mesh-ancestor
2127314|NCT02917031|Hormones|hormones|mesh-ancestor
2127315|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2127316|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2127317|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
2127318|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127319|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127320|NCT02917122|Sertraline|sertraline|mesh-list
2127321|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
2127322|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2127323|NCT02917122|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2127324|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2127325|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2127326|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571579|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2571580|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2571581|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
2571582|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
2571583|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2571584|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
2571585|NCT01604811|Tamsulosin|tamsulosin|mesh-list
2571586|NCT01604811|Urological Agents|urological agents|mesh-ancestor
2571587|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2571588|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2127327|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127328|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
2127329|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127330|NCT02917941|Dexamethasone|dexamethasone|mesh-list
2127331|NCT02917941|Lenalidomide|lenalidomide|mesh-list
2127332|NCT02917941|Ixazomib|ixazomib|mesh-list
2127333|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2127334|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
2127335|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
2571589|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2571590|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
2571591|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571592|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571593|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571594|NCT01604863|Paclitaxel|paclitaxel|mesh-list
2571595|NCT01604863|Etoposide|etoposide|mesh-list
2571596|NCT01604863|Docetaxel|docetaxel|mesh-list
2571597|NCT01604863|Carboplatin|carboplatin|mesh-list
2571598|NCT01604863|Immunoglobulin G|immunoglobulin g|mesh-list
2571599|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2571600|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571601|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
2571602|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
2571603|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
2571604|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571605|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2571606|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2571607|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571608|NCT01604863|Immunologic Factors|immunologic factors|mesh-ancestor
2571609|NCT01604863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127336|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127337|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127338|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2127339|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
2127340|NCT02917941|Hormones|hormones|mesh-ancestor
2127341|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2127342|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2127343|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127344|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
2127345|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2127346|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2127347|NCT02917941|Growth Substances|growth substances|mesh-ancestor
2127348|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
2127349|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
2127350|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127351|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127352|NCT02918071|Benralizumab|benralizumab|mesh-list
2127353|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2127354|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
2127355|NCT02918097|Risperidone|risperidone|mesh-list
2127356|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
2127357|NCT02918097|Sertraline|sertraline|mesh-list
2127358|NCT02918097|Nortriptyline|nortriptyline|mesh-list
2127359|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2127360|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
2127361|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127362|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127363|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127364|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2127365|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2127366|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127367|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2127368|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2127369|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
2127370|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
2127371|NCT02918097|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2127372|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2127373|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2127374|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127375|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
2127376|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2127377|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2127378|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
2127379|NCT02918266|Scopolamine|scopolamine|mesh-list
2127380|NCT02918266|Donepezil|donepezil|mesh-list
2127381|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2127382|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2127383|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127384|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127385|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
2127386|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571610|NCT01604889|Ipilimumab|ipilimumab|mesh-list
2571611|NCT01604889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2571612|NCT01604889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571613|NCT01604889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2571614|NCT01604889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571615|NCT01604928|Mirabegron|mirabegron|mesh-list
2571616|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2571617|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2571618|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2571619|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2571620|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
2571621|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571622|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571623|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571624|NCT01604928|Urological Agents|urological agents|mesh-ancestor
2571625|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2571626|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2571627|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
2571628|NCT01605084|Ritonavir|ritonavir|mesh-list
2571629|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2571630|NCT01605084|Darunavir|darunavir|mesh-list
2571631|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2571632|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2571633|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
2571634|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571635|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571636|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2571637|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2571638|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
2571639|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571640|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2571641|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2571642|NCT01605162|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
2571643|NCT01605162|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2571644|NCT01605162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571645|NCT01605162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571646|NCT01605162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571647|NCT01605240|Acetaminophen|acetaminophen|mesh-list
2571648|NCT01605240|Ibuprofen|ibuprofen|mesh-list
2571649|NCT01605240|Codeine|codeine|mesh-list
2127387|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127388|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
2127389|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2127390|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
2127391|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
2127392|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127393|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2127394|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
2127395|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2127396|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2127397|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
2127398|NCT02918279|Liraglutide|liraglutide|mesh-list
2127399|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2127400|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127401|NCT02918279|Incretins|incretins|mesh-ancestor
2127402|NCT02918279|Hormones|hormones|mesh-ancestor
2127403|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2127404|NCT02918318|Esketamine|esketamine|mesh-list
2127405|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
2127406|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2127407|NCT02918357|Edetic Acid|edetic acid|mesh-list
2127408|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
2127409|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
2127410|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127411|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
2127412|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2127413|NCT02918617|Fluorides|fluorides|mesh-list
2127414|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
2127415|NCT02918617|Protective Agents|protective agents|mesh-ancestor
2127416|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127417|NCT02918630|Nicotine|nicotine|mesh-list
2127418|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2127419|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
2127420|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127421|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127422|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2127423|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2127424|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
2127425|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127426|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127427|NCT02918721|Lidocaine|lidocaine|mesh-list
2127428|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
2127429|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
2127430|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
2127431|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127432|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127433|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
2127434|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127435|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2127436|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2127437|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2127438|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2127439|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127440|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2127441|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
2127442|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
2127443|NCT02918721|Protective Agents|protective agents|mesh-ancestor
2127444|NCT02918877|Propofol|propofol|mesh-list
2127445|NCT02918877|Sevoflurane|sevoflurane|mesh-list
2127446|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2127447|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127448|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127449|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2127450|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
2127451|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
2127452|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2127453|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2127454|NCT02918968|Flutamide|flutamide|mesh-list
2127455|NCT02918968|Androgens|androgens|mesh-list
2127456|NCT02918968|Hormones|hormones|mesh-ancestor
2127457|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2571650|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2571651|NCT01605240|Analgesics|analgesics|mesh-ancestor
2571652|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
2571653|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571654|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571655|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
2571656|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2571657|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2571658|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2571659|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2571660|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571661|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571662|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2571663|NCT01605240|Narcotics|narcotics|mesh-ancestor
2571664|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571665|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
2571666|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
2571667|NCT01605253|Eszopiclone|eszopiclone|mesh-list
2571668|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2571669|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571670|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571671|NCT01605279|Dobutamine|dobutamine|mesh-list
2571672|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2571673|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
2127458|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127459|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
2127460|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
2571674|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
2571675|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571676|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127461|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2127462|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127463|NCT02919111|Edetic Acid|edetic acid|mesh-list
2127464|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
2127465|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
2127466|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127467|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
2127468|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2127469|NCT02919683|Nivolumab|nivolumab|mesh-list
2127470|NCT02919683|Ipilimumab|ipilimumab|mesh-list
2127471|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2127472|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127473|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2127474|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127475|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2127476|NCT02919761|Hormones|hormones|mesh-ancestor
2127477|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2127478|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127479|NCT02920528|Ketamine|ketamine|mesh-list
2127480|NCT02920528|Analgesics|analgesics|mesh-ancestor
2127481|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
2127482|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127483|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127484|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2127485|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2127486|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
2127487|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
2127488|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127489|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2127490|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2127491|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127492|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127493|NCT02920749|Anesthetics|anesthetics|mesh-list
2127494|NCT02920749|Propofol|propofol|mesh-list
2127495|NCT02920749|Sevoflurane|sevoflurane|mesh-list
2127496|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127497|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127498|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2127499|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2127500|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
2127501|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2127502|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2127503|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2127504|NCT02920918|Canagliflozin|canagliflozin|mesh-list
2127505|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2127506|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127507|NCT02920918|Incretins|incretins|mesh-ancestor
2127508|NCT02920918|Hormones|hormones|mesh-ancestor
2127509|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2127510|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2127511|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
2127512|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127513|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127514|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2127515|NCT02921061|Cytarabine|cytarabine|mesh-list
2127516|NCT02921061|Decitabine|decitabine|mesh-list
2127517|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
2127518|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
2127519|NCT02921061|Cladribine|cladribine|mesh-list
2127520|NCT02921061|Lenograstim|lenograstim|mesh-list
2127521|NCT02921061|Sargramostim|sargramostim|mesh-list
2127522|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2127523|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
2127524|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127525|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2571677|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2571678|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2571679|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2571680|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
2571681|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127526|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
2571682|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571683|NCT01605279|Protective Agents|protective agents|mesh-ancestor
2571684|NCT01605318|Irinotecan|irinotecan|mesh-list
2571685|NCT01605318|Labetuzumab|labetuzumab|mesh-list
2571686|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
2571687|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
2571688|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127527|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127528|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127529|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
2127530|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2127531|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2127532|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127533|NCT02921061|Analgesics|analgesics|mesh-ancestor
2127534|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
2127535|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127536|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2127537|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2127538|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
2127539|NCT02921386|Testosterone|testosterone|mesh-list
2127540|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
2127541|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
2127542|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2127543|NCT02921386|Androgens|androgens|mesh-ancestor
2127544|NCT02921386|Hormones|hormones|mesh-ancestor
2127545|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2127546|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127547|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2127548|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127549|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
2127550|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2127551|NCT02921750|Laxatives|laxatives|mesh-ancestor
2127552|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2127553|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
2127554|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2127555|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2127556|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127557|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
2127558|NCT02922582|Coagulants|coagulants|mesh-ancestor
2127559|NCT02922959|Naloxone|naloxone|mesh-list
2127560|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127561|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
2127562|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127563|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2127582|NCT02923115|Enoxaparin|enoxaparin|mesh-list
2571689|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2571690|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2571691|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571692|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571693|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571694|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2571695|NCT01605344|Leucovorin|leucovorin|mesh-list
2571696|NCT01605344|Fluorouracil|fluorouracil|mesh-list
2571697|NCT01605344|Irinotecan|irinotecan|mesh-list
2571698|NCT01605344|Atorvastatin|atorvastatin|mesh-list
2571699|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
2571700|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571701|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2127583|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
2127584|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2127585|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2127586|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127587|NCT02923895|Fluorides|fluorides|mesh-list
2127588|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
2127589|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
2127590|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
2127591|NCT02923895|Protective Agents|protective agents|mesh-ancestor
2127592|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571702|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571703|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2571704|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
2571705|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571706|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2571707|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2571708|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571709|NCT01605344|Antidotes|antidotes|mesh-ancestor
2571710|NCT01605344|Protective Agents|protective agents|mesh-ancestor
2571711|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
2571712|NCT01605344|Vitamins|vitamins|mesh-ancestor
2571713|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
2571714|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2571715|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2571716|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2571717|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2571718|NCT01605357|Mannitol|mannitol|mesh-list
2571719|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2571720|NCT01605357|Diuretics|diuretics|mesh-ancestor
2571721|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
2571722|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571723|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
2571724|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
2571725|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
2571726|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2571727|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2571728|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
2571729|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
2127593|NCT02923921|Leucovorin|leucovorin|mesh-list
2127594|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
2127595|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127596|NCT02923921|Antidotes|antidotes|mesh-ancestor
2127597|NCT02923921|Protective Agents|protective agents|mesh-ancestor
2127598|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127599|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
2127600|NCT02923921|Vitamins|vitamins|mesh-ancestor
2127601|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
2127602|NCT02924350|Fluorides|fluorides|mesh-list
2127603|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
2127604|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
2127605|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
2127606|NCT02924350|Protective Agents|protective agents|mesh-ancestor
2127607|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127608|NCT02924688|Fluticasone|fluticasone|mesh-list
2127609|NCT02924688|Albuterol|albuterol|mesh-list
2127610|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2571730|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571731|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571732|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571733|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2571734|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
2571735|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2571736|NCT01605513|Interferons|interferons|mesh-list
2571737|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571738|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
2571739|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571740|NCT01605526|Doxorubicin|doxorubicin|mesh-list
2571741|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2571742|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571743|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2571744|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2571745|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571746|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571747|NCT01605721|Everolimus|everolimus|mesh-list
2571748|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571749|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2127611|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2127612|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2127613|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2127614|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
2127615|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127616|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127617|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2127618|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
2127619|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
2127620|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2127621|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2127622|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2127623|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2127624|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
2127625|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127626|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127627|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
2127628|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2127629|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
2127630|NCT02924688|Hormones|hormones|mesh-ancestor
2127631|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2127632|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
2571750|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
2571751|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571752|NCT01605734|Sorafenib|sorafenib|mesh-list
2571753|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
2571754|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571755|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2571756|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571757|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127633|NCT02924883|Trastuzumab|trastuzumab|mesh-list
2127634|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2571758|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2571759|NCT01605734|Estrogens|estrogens|mesh-ancestor
2571760|NCT01605734|Hormones|hormones|mesh-ancestor
2571761|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2571762|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571763|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2571764|NCT01605773|Glyburide|glyburide|mesh-list
2571765|NCT01605773|Repaglinide|repaglinide|mesh-list
2571766|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2571767|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127635|NCT02924883|Atezolizumab|atezolizumab|mesh-list
2127636|NCT02924883|Maytansine|maytansine|mesh-list
2127637|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2571768|NCT01605864|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2571769|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2571770|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571771|NCT01605929|Mepivacaine|mepivacaine|mesh-list
2571772|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
2571773|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
2571774|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571775|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571776|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
2571777|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571778|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2571779|NCT01605968|Laxatives|laxatives|mesh-ancestor
2571780|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2571781|NCT01605994|Antacids|antacids|mesh-list
2571782|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571783|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2571784|NCT01606046|Anesthetics|anesthetics|mesh-list
2571785|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
2571786|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2571787|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
2571788|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571789|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571790|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
2571791|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571792|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2127638|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127639|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2127640|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
2127641|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
2127642|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
2571793|NCT01606059|Acetaminophen|acetaminophen|mesh-list
2571794|NCT01606059|Tramadol|tramadol|mesh-list
2571795|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2571796|NCT01606059|Analgesics|analgesics|mesh-ancestor
2127643|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127644|NCT02925117|Upadacitinib|upadacitinib|mesh-list
2127645|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2127646|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2127647|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127648|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127649|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2127650|NCT02925494|Norethindrone|norethindrone|mesh-list
2127651|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
2127652|NCT02925494|Estradiol|estradiol|mesh-list
2127653|NCT02925494|Estrogens|estrogens|mesh-ancestor
2127654|NCT02925494|Hormones|hormones|mesh-ancestor
2127655|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2127656|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127657|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2127658|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
2571797|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
2571798|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571799|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571800|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
2571801|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2571802|NCT01606059|Narcotics|narcotics|mesh-ancestor
2571803|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571804|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2571805|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
2571806|NCT01606072|Coagulants|coagulants|mesh-ancestor
2571807|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2571808|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
2571809|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571810|NCT01606098|Bevacizumab|bevacizumab|mesh-list
2571811|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2571812|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571813|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2571814|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2571815|NCT01606098|Growth Substances|growth substances|mesh-ancestor
2571816|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127659|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2127660|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2127661|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2127662|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2127663|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2127664|NCT02925611|Desflurane|desflurane|mesh-list
2127665|NCT02925611|Isoflurane|isoflurane|mesh-list
2127666|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2127667|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
2571817|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
2571818|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
2571819|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2127668|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
2127669|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127670|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127671|NCT02925858|Ketamine|ketamine|mesh-list
2127672|NCT02925858|Analgesics|analgesics|mesh-ancestor
2127673|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
2127674|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127675|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571820|NCT01606111|Protective Agents|protective agents|mesh-ancestor
2571821|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571822|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
2571823|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
2571824|NCT01606241|Vaccines|vaccines|mesh-list
2571825|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
2571826|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571827|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2571828|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2571829|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2571830|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
2127676|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2127677|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2127678|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
2127679|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
2127680|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127681|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2127682|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2571831|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127683|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127684|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127685|NCT02925923|Clopidogrel|clopidogrel|mesh-list
2127686|NCT02925923|Ticagrelor|ticagrelor|mesh-list
2127687|NCT02925923|Eptifibatide|eptifibatide|mesh-list
2127688|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2127689|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2127690|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2127691|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2127692|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
2571832|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571833|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2571834|NCT01606345|Valrubicin|valrubicin|mesh-list
2571835|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571836|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2571837|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2571838|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571839|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571840|NCT01606358|Carboplatin|carboplatin|mesh-list
2571841|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571842|NCT01606384|Vasopressins|vasopressins|mesh-list
2571843|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
2571844|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
2571845|NCT01606384|Coagulants|coagulants|mesh-ancestor
2571846|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2571847|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2571848|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
2571849|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571850|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
2571851|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2571852|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571853|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2127693|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127694|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127695|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127696|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2127697|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2127698|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2127699|NCT02926573|Gabapentin|gabapentin|mesh-list
2127700|NCT02926573|Analgesics|analgesics|mesh-ancestor
2571854|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2571855|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571856|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571857|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571858|NCT01606462|Oxytocin|oxytocin|mesh-list
2571859|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
2571860|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2571861|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571862|NCT01606527|Ibuprofen|ibuprofen|mesh-list
2571863|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2571864|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2571865|NCT01606527|Analgesics|analgesics|mesh-ancestor
2571866|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
2571867|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571868|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127701|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
2127702|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127703|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127704|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
2127705|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2127706|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2127707|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571869|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2571870|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2571871|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2571872|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571873|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571874|NCT01606540|Ibuprofen|ibuprofen|mesh-list
2571875|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2571876|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2571877|NCT01606540|Analgesics|analgesics|mesh-ancestor
2571878|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
2571879|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2571880|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571881|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2127708|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2127709|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2127710|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2127711|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127712|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571882|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2571883|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2571884|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571885|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571886|NCT01606566|Bleomycin|bleomycin|mesh-list
2571887|NCT01606566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2571888|NCT01606566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571889|NCT01606722|Ritonavir|ritonavir|mesh-list
2571890|NCT01606722|Darunavir|darunavir|mesh-list
2127713|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
2127714|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2127715|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2127716|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127717|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2127718|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127719|NCT02926950|Metformin|metformin|mesh-list
2127720|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2127721|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2127722|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127723|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2127724|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571891|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2571892|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2571893|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
2571894|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571895|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571896|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2571897|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2571898|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
2571899|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2571900|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2571901|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2571902|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
2571903|NCT01606878|Doxorubicin|doxorubicin|mesh-list
2571904|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2571905|NCT01606878|Vincristine|vincristine|mesh-list
2127725|NCT02927223|Atropine|atropine|mesh-list
2127726|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2127727|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2127728|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2127729|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
2127730|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127731|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127732|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2127733|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
2127734|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
2571906|NCT01606878|Topotecan|topotecan|mesh-list
2571907|NCT01606878|Crizotinib|crizotinib|mesh-list
2571908|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
2571909|NCT01606878|Razoxane|razoxane|mesh-list
2571910|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2571911|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
2571912|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571913|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2127735|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
2127736|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2127737|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2571914|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2571915|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
2571916|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571917|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571918|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2571919|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2571920|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2571921|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2571922|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571923|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2127738|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
2127739|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127740|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127741|NCT02927301|Atezolizumab|atezolizumab|mesh-list
2127742|NCT02927301|Antibodies|antibodies|mesh-list
2127743|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2127744|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
2127745|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127746|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127747|NCT02927431|Oseltamivir|oseltamivir|mesh-list
2571924|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
2571925|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
2571926|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
2571927|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2571928|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2571929|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2571930|NCT01606878|Protective Agents|protective agents|mesh-ancestor
2571931|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2571932|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
2571933|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2571934|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
2571935|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2571936|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
2571937|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571938|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571939|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
2571940|NCT01607034|Pramipexole|pramipexole|mesh-list
2571941|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
2571942|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571943|NCT01607034|Protective Agents|protective agents|mesh-ancestor
2571944|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571945|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2571946|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2571947|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
2127748|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
2127749|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2127750|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127751|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127752|NCT02927457|GSK2646264|gsk2646264|mesh-list
2127753|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2571948|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
2571949|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571950|NCT01607086|Lamotrigine|lamotrigine|mesh-list
2571951|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
2571952|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2571953|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2571954|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571955|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2127754|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127755|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127756|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2127757|NCT02927834|Prednisone|prednisone|mesh-list
2127758|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2127759|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
2127760|NCT02927834|Hormones|hormones|mesh-ancestor
2127761|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2127762|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127763|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2127764|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127765|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2127766|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2127767|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2127768|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127769|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127770|NCT02927873|Vaccines|vaccines|mesh-list
2127771|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
2127772|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127773|NCT02927925|Daratumumab|daratumumab|mesh-list
2127774|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127775|NCT02927938|Cytarabine|cytarabine|mesh-list
2127776|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2127777|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
2127778|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127779|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127780|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
2127781|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2127782|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2127783|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
2127784|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127785|NCT02928029|Dexamethasone|dexamethasone|mesh-list
2127786|NCT02928029|Bortezomib|bortezomib|mesh-list
2127787|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2571956|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571957|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2571958|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2571959|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571960|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2571961|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2571962|NCT01607125|Vortioxetine|vortioxetine|mesh-list
2571963|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
2571964|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2127788|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2127789|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
2127790|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
2127791|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127792|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127793|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2127794|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
2127795|NCT02928029|Hormones|hormones|mesh-ancestor
2127796|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2127797|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2127798|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2571965|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2571966|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2571967|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571968|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571969|NCT01607125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2571970|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2571971|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2571972|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571973|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2571974|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
2571975|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2571976|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2571977|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2571978|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2571979|NCT01607294|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2571980|NCT01607294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2571981|NCT01607294|Antimetabolites|antimetabolites|mesh-ancestor
2571982|NCT01607294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571983|NCT01607294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2571984|NCT01607294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2571985|NCT01607294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2571986|NCT01607294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571987|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2571988|NCT01607333|Lamotrigine|lamotrigine|mesh-list
2571989|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
2571990|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2571991|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2571992|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2571993|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2571994|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2571995|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2571996|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2571997|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2571998|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2571999|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2572000|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
2572001|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2572002|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2572003|NCT01607580|Prednisolone|prednisolone|mesh-list
2127822|NCT02929498|Azacitidine|azacitidine|mesh-list
2127823|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2127824|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
2572004|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
2572005|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2572006|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
2572007|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
2572008|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2572009|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
2572010|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
2572011|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572012|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572013|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2572014|NCT01607580|Hormones|hormones|mesh-ancestor
2572015|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2572016|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2572017|NCT01607580|Protective Agents|protective agents|mesh-ancestor
2127825|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127826|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572018|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2572019|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572020|NCT01607671|Timolol|timolol|mesh-list
2572021|NCT01607671|Maleic acid|maleic acid|mesh-list
2572022|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2572023|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2572024|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
2572025|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572026|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572027|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572028|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2572029|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2572030|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572031|NCT01607762|Olanzapine|olanzapine|mesh-list
2572032|NCT01607762|Risperidone|risperidone|mesh-list
2572033|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2572034|NCT01607762|Aripiprazole|aripiprazole|mesh-list
2572035|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2572036|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2572037|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
2572038|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572039|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572040|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572041|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2572042|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2127827|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127828|NCT02929667|Fluoxetine|fluoxetine|mesh-list
2127829|NCT02929667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2127830|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2127831|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2127832|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127833|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127834|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
2127835|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127836|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2572043|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2572044|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2572045|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2572046|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
2572047|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
2572048|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
2572049|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572050|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2572051|NCT01607762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2572052|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2572053|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2572054|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
2572055|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
2572056|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2572057|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2572058|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2572059|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2572060|NCT01607879|Androgens|androgens|mesh-list
2572061|NCT01607879|Hormones|hormones|mesh-ancestor
2572062|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2572063|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572064|NCT01607918|Amoxicillin|amoxicillin|mesh-list
2572065|NCT01607918|Metronidazole|metronidazole|mesh-list
2572066|NCT01607918|Clarithromycin|clarithromycin|mesh-list
2572067|NCT01607918|Lansoprazole|lansoprazole|mesh-list
2572068|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
2572069|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2572070|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2127837|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
2127838|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2127839|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2127840|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2127841|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127842|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2127843|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2127844|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
2127845|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
2127846|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
2127847|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2127848|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2127849|NCT02930005|Analgesics|analgesics|mesh-ancestor
2127850|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
2127851|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572071|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2572072|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2572073|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2572074|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572075|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572076|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2572077|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2572078|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2572079|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2572080|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2572081|NCT01607970|Oxytocin|oxytocin|mesh-list
2572082|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
2572083|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2572084|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572085|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
2572086|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2572087|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
2572088|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572089|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572090|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2572091|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
2572092|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2572093|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
2572094|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419267|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419268|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2419269|NCT00802568|Fludarabine|fludarabine|mesh-list
2419270|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
2419271|NCT00802568|Busulfan|busulfan|mesh-list
2419272|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2419273|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419274|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2419275|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
2419276|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419277|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2419278|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
2572095|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572096|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2572097|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
2572098|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
2572099|NCT01607983|Protective Agents|protective agents|mesh-ancestor
2572100|NCT01607996|Anesthetics|anesthetics|mesh-list
2572101|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2572102|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572103|NCT01608009|Paclitaxel|paclitaxel|mesh-list
2572104|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2572105|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572106|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
2572107|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
2572108|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
2572109|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572110|NCT01608139|Curcumin|curcumin|mesh-list
2572111|NCT01608139|Sorafenib|sorafenib|mesh-list
2127852|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127853|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2127854|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2127855|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2127856|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127857|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127858|NCT02930343|Folic Acid|folic acid|mesh-list
2127859|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
2127860|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
2127861|NCT02930343|Prednisolone|prednisolone|mesh-list
2127862|NCT02930343|Methotrexate|methotrexate|mesh-list
2127863|NCT02930343|Leflunomide|leflunomide|mesh-list
2127864|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
2419279|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419280|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
2419281|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2419282|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2419283|NCT00802581|Anesthetics|anesthetics|mesh-list
2572112|NCT01608139|Vorinostat|vorinostat|mesh-list
2572113|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572114|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2572115|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572116|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572117|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2572118|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2572119|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2572120|NCT01608139|Analgesics|analgesics|mesh-ancestor
2572121|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
2572122|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572123|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572124|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2572125|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2572126|NCT01608217|Acetaminophen|acetaminophen|mesh-list
2572127|NCT01608217|Dronabinol|dronabinol|mesh-list
2572128|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2572129|NCT01608217|Analgesics|analgesics|mesh-ancestor
2572130|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
2572131|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572132|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572133|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
2572134|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
2572135|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2127865|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2127866|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
2419284|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
2419285|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2419286|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419287|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
2419288|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419289|NCT00802594|Pafuramidine|pafuramidine|mesh-list
2419290|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2419291|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2419292|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2419293|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419294|NCT00802646|Epinephrine|epinephrine|mesh-list
2419295|NCT00802646|Fentanyl|fentanyl|mesh-list
2419296|NCT00802646|Bupivacaine|bupivacaine|mesh-list
2419297|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
2419298|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
2419299|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127867|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2127868|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127869|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2127870|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
2127871|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127872|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127873|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
2127874|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127875|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2127876|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2127877|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
2127878|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2572136|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2572137|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2572138|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572139|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572140|NCT01608217|Hormones|hormones|mesh-ancestor
2572141|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2572142|NCT01608269|Lamivudine|lamivudine|mesh-list
2572143|NCT01608269|Abacavir|abacavir|mesh-list
2127879|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2127880|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2127881|NCT02930343|Hormones|hormones|mesh-ancestor
2127882|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2127883|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2127884|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127885|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2127886|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
2127887|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2127888|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2127889|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2127890|NCT02930343|Hematinics|hematinics|mesh-ancestor
2127891|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
2127892|NCT02930343|Vitamins|vitamins|mesh-ancestor
2572144|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2572145|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2572146|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572147|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572148|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
2572149|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572150|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2572151|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2572152|NCT01608334|Fentanyl|fentanyl|mesh-list
2572153|NCT01608334|Sufentanil|sufentanil|mesh-list
2572154|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2572155|NCT01608334|Narcotics|narcotics|mesh-ancestor
2572156|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2572157|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572158|NCT01608334|Analgesics|analgesics|mesh-ancestor
2572159|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
2127893|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
2127894|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2127895|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2127896|NCT02930343|Analgesics|analgesics|mesh-ancestor
2127897|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
2572160|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572161|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2572162|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2572163|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
2572164|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
2572165|NCT01608347|Folic Acid|folic acid|mesh-list
2572166|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
2572167|NCT01608347|Hematinics|hematinics|mesh-ancestor
2572168|NCT01608347|Vitamins|vitamins|mesh-ancestor
2572169|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
2572170|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572171|NCT01608360|Lidocaine|lidocaine|mesh-list
2572172|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
2572173|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
2572174|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2572175|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572176|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
2127898|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2127899|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2572177|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572178|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2572179|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2572180|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2572181|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2572182|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572183|NCT01608373|Lidocaine|lidocaine|mesh-list
2572184|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
2572185|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
2572186|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2572187|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572188|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
2572189|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572190|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2572191|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2572192|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2572193|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2572194|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572195|NCT01608412|Everolimus|everolimus|mesh-list
2572196|NCT01608412|Tacrolimus|tacrolimus|mesh-list
2572197|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2572198|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
2572199|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572200|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2572201|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572202|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572203|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572204|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
2572205|NCT01608451|Progesterone|progesterone|mesh-list
2572206|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2572207|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572208|NCT01608451|Vitamins|vitamins|mesh-ancestor
2572209|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
2572210|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2572211|NCT01608451|Progestins|progestins|mesh-ancestor
2572212|NCT01608451|Hormones|hormones|mesh-ancestor
2572213|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2572214|NCT01608464|Cisplatin|cisplatin|mesh-list
2572215|NCT01608464|Docetaxel|docetaxel|mesh-list
2572216|NCT01608464|Fluorouracil|fluorouracil|mesh-list
2572217|NCT01608464|Irinotecan|irinotecan|mesh-list
2572218|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572219|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
2572220|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
2572221|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
2572222|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572223|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
2572224|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2572225|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2127900|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2127901|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127902|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
2419300|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419301|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
2419302|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127903|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2127904|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2127905|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127906|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
2127907|NCT02930941|Coagulants|coagulants|mesh-ancestor
2127908|NCT02931045|Clopidogrel|clopidogrel|mesh-list
2127909|NCT02931045|Ticagrelor|ticagrelor|mesh-list
2419303|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2419304|NCT00802646|Narcotics|narcotics|mesh-ancestor
2419305|NCT00802646|Analgesics|analgesics|mesh-ancestor
2419306|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2419307|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2419308|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
2419309|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2419310|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2419311|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
2419312|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419313|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419314|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2419315|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2419316|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
2572226|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
2572227|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572228|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2572229|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2572230|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127910|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2127911|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2127912|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2127913|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2127914|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
2127915|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127916|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127917|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127918|NCT02931253|Metformin|metformin|mesh-list
2127919|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2127920|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127921|NCT02931539|Valganciclovir|valganciclovir|mesh-list
2572231|NCT01608555|Tobramycin|tobramycin|mesh-list
2572232|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2572233|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572234|NCT01608594|Ipilimumab|ipilimumab|mesh-list
2572235|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2572236|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572237|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2572238|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572239|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
2572240|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572241|NCT01608698|Drospirenone|drospirenone|mesh-list
2572242|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2572243|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
2572244|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2127922|NCT02931539|Ganciclovir|ganciclovir|mesh-list
2127923|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2127924|NCT02931539|Cidofovir|cidofovir|mesh-list
2127925|NCT02931539|Foscarnet|foscarnet|mesh-list
2127926|NCT02931539|Maribavir|maribavir|mesh-list
2127927|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
2127928|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2127929|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2127930|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127931|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127932|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2127933|NCT02931838|BMS-986165|bms-986165|mesh-list
2127934|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
2572245|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2572246|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2572247|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
2572248|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2572249|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572250|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2572251|NCT01608698|Estrogens|estrogens|mesh-ancestor
2572252|NCT01608698|Hormones|hormones|mesh-ancestor
2572253|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2572254|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2572255|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
2572256|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2572257|NCT01608698|Diuretics|diuretics|mesh-ancestor
2572258|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
2572259|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
2572260|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2572261|NCT01608711|Gemcitabine|gemcitabine|mesh-list
2572262|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2572263|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
2572264|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572265|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572266|NCT01608711|Antiviral Agents|antiviral agents|mesh-ancestor
2572267|NCT01608711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572268|NCT01608711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572269|NCT01608711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2572270|NCT01608711|Immunologic Factors|immunologic factors|mesh-ancestor
2572271|NCT01608711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572272|NCT01608750|Folic Acid|folic acid|mesh-list
2572273|NCT01608750|Hematinics|hematinics|mesh-ancestor
2572274|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
2572275|NCT01608750|Vitamins|vitamins|mesh-ancestor
2572276|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
2572277|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127935|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2127936|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127937|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127938|NCT02932267|Adapalene|adapalene|mesh-list
2127939|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2127940|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2127941|NCT02932267|Analgesics|analgesics|mesh-ancestor
2127942|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
2127943|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127944|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127945|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2127946|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2127947|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
2127948|NCT02932904|Vortioxetine|vortioxetine|mesh-list
2127949|NCT02932904|Paroxetine|paroxetine|mesh-list
2127950|NCT02932904|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2127951|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2127952|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2127953|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572278|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2572279|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572280|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2572281|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572282|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572283|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2572284|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572285|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
2572286|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
2572287|NCT01608893|Metoprolol|metoprolol|mesh-list
2127954|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127955|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
2127956|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127957|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2127958|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
2127959|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2127960|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2127961|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2127962|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2127963|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2127964|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2127965|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2127966|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2127967|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2572288|NCT01608893|Carvedilol|carvedilol|mesh-list
2572289|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2572290|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2572291|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
2127968|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2127969|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2127970|NCT02933034|Manganese|manganese|mesh-list
2127971|NCT02933034|Trace Elements|trace elements|mesh-ancestor
2127972|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
2572292|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
2572293|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572294|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572295|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2572296|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2572297|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2572298|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
2572299|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572300|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572301|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
2572302|NCT01608893|Protective Agents|protective agents|mesh-ancestor
2572303|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2572304|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2572305|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2572306|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
2572307|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2572308|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2572309|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
2572310|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2572311|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2572312|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2572313|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2572314|NCT01608958|Oxytocin|oxytocin|mesh-list
2572315|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
2572316|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2572317|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572318|NCT01608984|Sufentanil|sufentanil|mesh-list
2572319|NCT01608984|Isoflurane|isoflurane|mesh-list
2572320|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2127973|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127974|NCT02933320|Rituximab|rituximab|mesh-list
2127975|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2127976|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2127977|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
2127978|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127979|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2127980|NCT02933372|Varenicline|varenicline|mesh-list
2127981|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2127982|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2127983|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
2127984|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2127985|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2127986|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2127987|NCT02934191|Acetaminophen|acetaminophen|mesh-list
2127988|NCT02934191|Celecoxib|celecoxib|mesh-list
2127989|NCT02934191|Oxycodone|oxycodone|mesh-list
2127990|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
2127991|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572321|NCT01608984|Narcotics|narcotics|mesh-ancestor
2572322|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2572323|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572324|NCT01608984|Analgesics|analgesics|mesh-ancestor
2572325|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
2572326|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572327|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2572328|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2572329|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
2572330|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
2572331|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2572332|NCT01609049|Ribavirin|ribavirin|mesh-list
2572333|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2572334|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
2572335|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572336|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
2572337|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572338|NCT01609088|Erythritol|erythritol|mesh-list
2572339|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
2572340|NCT01609101|Cobalt|cobalt|mesh-list
2572341|NCT01609101|Trace Elements|trace elements|mesh-ancestor
2572342|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
2572343|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572344|NCT01609127|Capecitabine|capecitabine|mesh-list
2572345|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2572346|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
2127992|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2127993|NCT02934191|Analgesics|analgesics|mesh-ancestor
2127994|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
2127995|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2127996|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
2127997|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2127998|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2127999|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2128000|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2128001|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2128002|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128003|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128004|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2128005|NCT02934191|Narcotics|narcotics|mesh-ancestor
2128006|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2128007|NCT02934191|Antacids|antacids|mesh-ancestor
2128008|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2128009|NCT02934698|Ivacaftor|ivacaftor|mesh-list
2128010|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2128011|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2128012|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572347|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572348|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572349|NCT01609153|Olanzapine|olanzapine|mesh-list
2572350|NCT01609153|Amisulpride|amisulpride|mesh-list
2572351|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
2572352|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
2572353|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572354|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572355|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2572356|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2572357|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2572358|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2572359|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2572360|NCT01609153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2572361|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2572362|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2572363|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572364|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572365|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
2572366|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2572367|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
2572368|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2572369|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
2572370|NCT01609166|Allopurinol|allopurinol|mesh-list
2572371|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
2572372|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128027|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
2128028|NCT02935699|Promethazine|promethazine|mesh-list
2128029|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2128030|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2128031|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2128032|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128033|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
2128034|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
2128035|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
2128036|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128037|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
2128038|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
2128039|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2128040|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2128041|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
2128042|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
2128043|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2128044|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128045|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2128046|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
2128047|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
2128048|NCT02935738|Prednisolone|prednisolone|mesh-list
2128049|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128050|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
2572373|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572374|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
2572375|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2572376|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2572377|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
2572378|NCT01609166|Protective Agents|protective agents|mesh-ancestor
2572379|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572380|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
2572381|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572382|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
2572383|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572384|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572385|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2572386|NCT01609205|Adalimumab|adalimumab|mesh-list
2128051|NCT02935738|Hormones|hormones|mesh-ancestor
2128052|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128053|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128054|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2128055|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128056|NCT02935894|Ibuprofen|ibuprofen|mesh-list
2128057|NCT02935894|Pilocarpine|pilocarpine|mesh-list
2128058|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2128059|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2128060|NCT02935894|Analgesics|analgesics|mesh-ancestor
2128061|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
2128062|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572387|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2572388|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2572389|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2572390|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2572391|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572392|NCT01609387|Tocopherols|tocopherols|mesh-list
2572393|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
2572394|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572395|NCT01609387|Protective Agents|protective agents|mesh-ancestor
2572396|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572397|NCT01609387|Vitamins|vitamins|mesh-ancestor
2572398|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
2572399|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
2572400|NCT01609413|Antacids|antacids|mesh-ancestor
2572401|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572402|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2572403|NCT01609439|Vitamin D|vitamin d|mesh-list
2572404|NCT01609439|Vitamins|vitamins|mesh-ancestor
2572405|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
2572406|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572407|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2572408|NCT01609491|Phenylephrine|phenylephrine|mesh-list
2572409|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
2572410|NCT01609491|Norepinephrine|norepinephrine|mesh-list
2572411|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2572412|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
2572413|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
2572414|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572415|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572416|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
2572417|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2572418|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
2572419|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
2572420|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2572421|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2572422|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2572423|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
2572424|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572425|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572426|NCT01609491|Protective Agents|protective agents|mesh-ancestor
2572427|NCT01609517|Bupivacaine|bupivacaine|mesh-list
2572428|NCT01609517|Anesthetics|anesthetics|mesh-list
2572429|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
2572430|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2572431|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572432|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
2572433|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572434|NCT01609647|Clopidogrel|clopidogrel|mesh-list
2572435|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2572436|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2572437|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2572438|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2572439|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2572440|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
2572441|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572442|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572443|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572444|NCT01609673|Everolimus|everolimus|mesh-list
2572445|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572446|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2572447|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
2572448|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572449|NCT01609816|Dasatinib|dasatinib|mesh-list
2572450|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128063|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128064|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128065|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2128066|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2128067|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128068|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128069|NCT02935894|Miotics|miotics|mesh-ancestor
2128070|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
2128071|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2128072|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2128073|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
2128074|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2128075|NCT02936037|Biotin|biotin|mesh-list
2128076|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
2128077|NCT02936037|Vitamins|vitamins|mesh-ancestor
2128078|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
2128079|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128080|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2128081|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2572451|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2572452|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572453|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572454|NCT01609855|Scopolamine|scopolamine|mesh-list
2572455|NCT01609855|Bromides|bromides|mesh-list
2572456|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2572457|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
2572458|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2572459|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
2572460|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
2572461|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572462|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572463|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2572464|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
2572465|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2572466|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
2572467|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572468|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128082|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2128083|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128084|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
2128085|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128086|NCT02937116|Gemcitabine|gemcitabine|mesh-list
2128087|NCT02937116|Cisplatin|cisplatin|mesh-list
2128088|NCT02937116|Capecitabine|capecitabine|mesh-list
2128089|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
2128090|NCT02937116|Irinotecan|irinotecan|mesh-list
2128091|NCT02937116|Etoposide|etoposide|mesh-list
2572469|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2572470|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
2572471|NCT01609881|Ketorolac|ketorolac|mesh-list
2572472|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2572473|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2572474|NCT01609881|Analgesics|analgesics|mesh-ancestor
2572475|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
2572476|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572477|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572478|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2572479|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2572480|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2572481|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572482|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572483|NCT01609907|Valsartan|valsartan|mesh-list
2572484|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2572485|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2572486|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2572487|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
2572488|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572489|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2572490|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2572491|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128092|NCT02937116|Pemetrexed|pemetrexed|mesh-list
2128093|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128094|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2128095|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
2128096|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128097|NCT02937116|Antiviral Agents|antiviral agents|mesh-ancestor
2128098|NCT02937116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572492|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2572493|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2572494|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2572495|NCT01609959|Valsartan|valsartan|mesh-list
2572496|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2572497|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2572498|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2572499|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2128099|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128100|NCT02937116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128101|NCT02937116|Immunologic Factors|immunologic factors|mesh-ancestor
2128102|NCT02937116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128103|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2128104|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2128105|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2128106|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2128107|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2128108|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2128109|NCT02937168|Reslizumab|reslizumab|mesh-list
2128110|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2128111|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2128112|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128113|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2128114|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
2128115|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2128116|NCT02937350|Calcifediol|calcifediol|mesh-list
2572500|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572501|NCT01609998|Vaccines|vaccines|mesh-list
2572502|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
2572503|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572504|NCT01610141|Warfarin|warfarin|mesh-list
2572505|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
2572506|NCT01610245|Oseltamivir|oseltamivir|mesh-list
2572507|NCT01610245|Nitazoxanide|nitazoxanide|mesh-list
2572508|NCT01610245|Antiviral Agents|antiviral agents|mesh-ancestor
2572509|NCT01610245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128117|NCT02937350|Vitamins|vitamins|mesh-ancestor
2128118|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
2128119|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128120|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2128121|NCT02937506|Fentanyl|fentanyl|mesh-list
2128122|NCT02937506|Midazolam|midazolam|mesh-list
2128123|NCT02937506|Propofol|propofol|mesh-list
2128124|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2572510|NCT01610245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572511|NCT01610245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572512|NCT01610245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2572513|NCT01610310|Interferon-beta|interferon-beta|mesh-list
2572514|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419317|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2419318|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
2419319|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
2419320|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
2419321|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2419322|NCT00802802|Efavirenz|efavirenz|mesh-list
2419323|NCT00802802|Rifampin|rifampin|mesh-list
2419324|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2419325|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2419326|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419327|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419328|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
2419329|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572515|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
2572516|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572517|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
2572518|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572519|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
2572520|NCT01610362|Antibodies|antibodies|mesh-list
2572521|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
2572522|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2572523|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2572524|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
2128125|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2419330|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2572525|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
2572526|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572527|NCT01610401|Metformin|metformin|mesh-list
2128126|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128127|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2128128|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
2128129|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
2128130|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2128131|NCT02937506|Narcotics|narcotics|mesh-ancestor
2128132|NCT02937506|Analgesics|analgesics|mesh-ancestor
2128133|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
2128134|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128135|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2128136|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2128137|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2128138|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2128139|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
2128140|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
2128141|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2128142|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128143|NCT02937558|Glucagon|glucagon|mesh-list
2128144|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2128145|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2128146|NCT02937558|Hormones|hormones|mesh-ancestor
2128147|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128148|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128149|NCT02937558|Incretins|incretins|mesh-ancestor
2128150|NCT02937623|Calcium|calcium|mesh-list
2128151|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2128152|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128153|NCT02937636|Fluorides|fluorides|mesh-list
2128154|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
2128155|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
2128156|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
2128157|NCT02937636|Protective Agents|protective agents|mesh-ancestor
2128158|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572528|NCT01610401|Caffeine|caffeine|mesh-list
2572529|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2572530|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572531|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2572532|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2572533|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572534|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572535|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2572536|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2128159|NCT02937701|Infliximab|infliximab|mesh-list
2128160|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
2128161|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2128162|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2128163|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
2128164|NCT02937740|Testosterone|testosterone|mesh-list
2128165|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
2128166|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
2128167|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2128168|NCT02937740|Androgens|androgens|mesh-ancestor
2128169|NCT02937740|Hormones|hormones|mesh-ancestor
2128170|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128171|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128172|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2128173|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128174|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
2128175|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2128176|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2128177|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2128178|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
2128179|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128180|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128181|NCT02937766|Progestins|progestins|mesh-ancestor
2128182|NCT02937766|Hormones|hormones|mesh-ancestor
2128183|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
2128184|NCT02938013|Velpatasvir|velpatasvir|mesh-list
2419331|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2419332|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2419333|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2128185|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2128186|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
2419334|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2419335|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2128187|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128188|NCT02938494|Tazarotene|tazarotene|mesh-list
2128189|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
2128190|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
2128191|NCT02938520|Rilpivirine|rilpivirine|mesh-list
2128192|NCT02938520|Cabotegravir|cabotegravir|mesh-list
2128193|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2128194|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2128195|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128196|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128197|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
2572537|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
2572538|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572539|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
2572540|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572541|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2572542|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2572543|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
2572544|NCT01610869|Nintedanib|nintedanib|mesh-list
2572545|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572546|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2572547|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572548|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572549|NCT01610921|Adenosine|adenosine|mesh-list
2572550|NCT01610921|Analgesics|analgesics|mesh-ancestor
2572551|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
2572552|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572553|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572554|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2572555|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
2572556|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2572557|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
2572558|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
2128198|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128199|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2128200|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2128201|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2128202|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2128203|NCT02938585|Factor VIII|factor viii|mesh-list
2128204|NCT02938585|Coagulants|coagulants|mesh-ancestor
2128205|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2128206|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2128207|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128208|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2128209|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2128210|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128211|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128212|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
2128213|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128214|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
2128215|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2128216|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128217|NCT02939937|Phenytoin|phenytoin|mesh-list
2128218|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
2128219|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2128220|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2572559|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572560|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572561|NCT01610934|Liraglutide|liraglutide|mesh-list
2572562|NCT01610934|Glimepiride|glimepiride|mesh-list
2572563|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2572564|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572565|NCT01610934|Incretins|incretins|mesh-ancestor
2572566|NCT01610934|Hormones|hormones|mesh-ancestor
2572567|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2572568|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2572569|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2572570|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
2572571|NCT01610947|Adalimumab|adalimumab|mesh-list
2572572|NCT01610947|Etanercept|etanercept|mesh-list
2572573|NCT01610947|Golimumab|golimumab|mesh-list
2572574|NCT01610947|Infliximab|infliximab|mesh-list
2572575|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2572576|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2572577|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2572578|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2572579|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2572580|NCT01610947|Analgesics|analgesics|mesh-ancestor
2572581|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
2572582|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572583|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572584|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2572585|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2572586|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
2572587|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
2572588|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2572589|NCT01610999|Plerixafor|plerixafor|mesh-list
2572590|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2572591|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2572592|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
2572593|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572594|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
2572595|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2572596|NCT01611038|Protective Agents|protective agents|mesh-ancestor
2572597|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572598|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572599|NCT01611077|Amlodipine|amlodipine|mesh-list
2572600|NCT01611077|Candesartan|candesartan|mesh-list
2572601|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
2128221|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2128222|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128223|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2572602|NCT01611077|Olmesartan|olmesartan|mesh-list
2572603|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2572604|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2572605|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2572606|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2572607|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572608|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2572609|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572610|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
2572611|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2572612|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2572613|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
2572614|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572615|NCT01611311|BI 409306|bi 409306|mesh-list
2128224|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2128225|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2128226|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2128227|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2128228|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
2128229|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128230|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128231|NCT02940522|Progestins|progestins|mesh-ancestor
2128232|NCT02940522|Hormones|hormones|mesh-ancestor
2128233|NCT02940574|Oxytocin|oxytocin|mesh-list
2128234|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
2128235|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2128236|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128237|NCT02940691|Grazoprevir|grazoprevir|mesh-list
2128238|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
2128239|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128240|NCT02940730|Dalbavancin|dalbavancin|mesh-list
2128241|NCT02940730|Teicoplanin|teicoplanin|mesh-list
2128242|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2128243|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128244|NCT02940860|Iron|iron|mesh-list
2128245|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2128246|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2128247|NCT02940860|Trace Elements|trace elements|mesh-ancestor
2128248|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
2128249|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128250|NCT02940860|Hematinics|hematinics|mesh-ancestor
2128251|NCT02940886|Iron|iron|mesh-list
2128252|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2128253|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2128254|NCT02940886|Trace Elements|trace elements|mesh-ancestor
2128255|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
2128256|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128257|NCT02940886|Hematinics|hematinics|mesh-ancestor
2128258|NCT02941523|Carboplatin|carboplatin|mesh-list
2128259|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128260|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2572616|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2572617|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572618|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572619|NCT01611324|Epinephrine|epinephrine|mesh-list
2572620|NCT01611324|Mepivacaine|mepivacaine|mesh-list
2128261|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2128262|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
2128263|NCT02941640|Hormones|hormones|mesh-ancestor
2128264|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128265|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128266|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2128267|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128268|NCT02941692|Oxytocin|oxytocin|mesh-list
2128269|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
2128270|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2128271|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572621|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2572622|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2572623|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
2572624|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572625|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572626|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572627|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2572628|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2572629|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
2572630|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572631|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2572632|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
2572633|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
2572634|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
2572635|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2572636|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
2572637|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
2572638|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2572639|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
2572640|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
2572641|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2572642|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572643|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2572644|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572645|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
2572646|NCT01611415|Furosemide|furosemide|mesh-list
2572647|NCT01611415|Diuretics|diuretics|mesh-ancestor
2572648|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
2572649|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572650|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2572651|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2572652|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572653|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2572654|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2572655|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
2572656|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2572657|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572658|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2572659|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572660|NCT01611480|Imiquimod|imiquimod|mesh-list
2572661|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2572662|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
2572663|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572664|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572665|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
2572666|NCT01611506|Capecitabine|capecitabine|mesh-list
2572667|NCT01611506|Cetuximab|cetuximab|mesh-list
2572668|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572669|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2572670|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
2572671|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572672|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2572673|NCT01611675|Vemurafenib|vemurafenib|mesh-list
2572674|NCT01611675|Leflunomide|leflunomide|mesh-list
2572675|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572676|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2572677|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572678|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572679|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2572680|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
2572681|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572682|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2572683|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
2572684|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128289|NCT02942264|Temozolomide|temozolomide|mesh-list
2128290|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2128291|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
2128292|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128293|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128294|NCT02942407|Warfarin|warfarin|mesh-list
2128295|NCT02942407|Apixaban|apixaban|mesh-list
2128296|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
2128297|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2128298|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
2128299|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2128300|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
2128301|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128302|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128303|NCT02942485|Metronidazole|metronidazole|mesh-list
2128304|NCT02942485|Tinidazole|tinidazole|mesh-list
2128305|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128306|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2128307|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2128308|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2128309|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
2128310|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128311|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2128312|NCT02942576|Warfarin|warfarin|mesh-list
2128313|NCT02942576|Edoxaban|edoxaban|mesh-list
2128314|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
2128315|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
2128316|NCT02942576|Fluindione|fluindione|mesh-list
2128317|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
2128318|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2572685|NCT01611727|Cisplatin|cisplatin|mesh-list
2572686|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572687|NCT01611896|Selenium|selenium|mesh-list
2572688|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
2572689|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572690|NCT01611896|Protective Agents|protective agents|mesh-ancestor
2572691|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572692|NCT01611896|Trace Elements|trace elements|mesh-ancestor
2572693|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
2572694|NCT01611909|Terpin|terpin|mesh-list
2572695|NCT01611909|Expectorants|expectorants|mesh-ancestor
2572696|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
2572697|NCT01611961|Docetaxel|docetaxel|mesh-list
2572698|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572699|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
2128319|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
2128320|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2128321|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
2128322|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128323|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128324|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
2128325|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2128326|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128327|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
2572700|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
2572701|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
2128328|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
2128329|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
2128330|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128331|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128332|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2128333|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2128334|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2128335|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2128336|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2128337|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2128338|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
2128339|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2128340|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128341|NCT02943668|Deferasirox|deferasirox|mesh-list
2128342|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2128343|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
2128344|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
2128345|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572702|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572703|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2572704|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572705|NCT01612065|Misoprostol|misoprostol|mesh-list
2572706|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2572707|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
2572708|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2572709|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572710|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2572711|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2572712|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
2572713|NCT01612078|Droxidopa|droxidopa|mesh-list
2572714|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2572715|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2572716|NCT01612247|Aspirin|aspirin|mesh-list
2572717|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
2572718|NCT01612247|Methotrexate|methotrexate|mesh-list
2572719|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2572720|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
2572721|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128346|NCT02944461|Dapsone|dapsone|mesh-list
2128347|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128348|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
2572722|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2572723|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2572724|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
2572725|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572726|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572727|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2572728|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2572729|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
2572730|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2572731|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2572732|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
2572733|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
2572734|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572735|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2572736|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2572737|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2572738|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2572739|NCT01612247|Analgesics|analgesics|mesh-ancestor
2572740|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
2572741|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572742|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2572743|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2572744|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2572745|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2572746|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2572747|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
2572748|NCT01612273|Aspirin|aspirin|mesh-list
2572749|NCT01612273|Triflusal|triflusal|mesh-list
2572750|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2572751|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2572752|NCT01612273|Analgesics|analgesics|mesh-ancestor
2572753|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
2572754|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572755|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572756|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2572757|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2572758|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2572759|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2572760|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572761|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2572762|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2572763|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572764|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
2572765|NCT01612286|Endostatins|endostatins|mesh-list
2572766|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2572767|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2572768|NCT01612286|Growth Substances|growth substances|mesh-ancestor
2572769|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572770|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
2572771|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572772|NCT01612299|Everolimus|everolimus|mesh-list
2572773|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572774|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2572775|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
2572776|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572777|NCT01612377|Prednisone|prednisone|mesh-list
2572778|NCT01612377|Prednisolone|prednisolone|mesh-list
2572779|NCT01612377|Dipyridamole|dipyridamole|mesh-list
2572780|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2572781|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
2572782|NCT01612377|Hormones|hormones|mesh-ancestor
2572783|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2572784|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572785|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2572786|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572787|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2572788|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572789|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128349|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2128350|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2128351|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2128352|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128353|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128354|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
2128355|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2128356|NCT02944565|Daratumumab|daratumumab|mesh-list
2128357|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128358|NCT02944656|Gabapentin|gabapentin|mesh-list
2128359|NCT02944656|Analgesics|analgesics|mesh-ancestor
2128360|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
2128361|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128362|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128363|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
2128364|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2128365|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2128366|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2128367|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2128368|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2128369|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2128370|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2128371|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128372|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
2128373|NCT02945150|Grazoprevir|grazoprevir|mesh-list
2572790|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2572791|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
2572792|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
2572793|NCT01612403|Astringents|astringents|mesh-ancestor
2572794|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572795|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
2572796|NCT01612468|Liraglutide|liraglutide|mesh-list
2572797|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2572798|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572799|NCT01612468|Incretins|incretins|mesh-ancestor
2572800|NCT01612468|Hormones|hormones|mesh-ancestor
2572801|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2572802|NCT01612507|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2128374|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
2128375|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572803|NCT01612507|Cephalosporins|cephalosporins|mesh-list
2572804|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2572805|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572806|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2572807|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2128376|NCT02945410|Vitamin D|vitamin d|mesh-list
2128377|NCT02945410|Calcium|calcium|mesh-list
2128378|NCT02945410|Vitamins|vitamins|mesh-ancestor
2128379|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
2128380|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128381|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2128382|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2128383|NCT02946034|Ribavirin|ribavirin|mesh-list
2128384|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
2128385|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128386|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
2128387|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128388|NCT02946073|Buprenorphine|buprenorphine|mesh-list
2128389|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2128390|NCT02946073|Narcotics|narcotics|mesh-ancestor
2128391|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2572808|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572809|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572810|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2572811|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
2572812|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2572813|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572814|NCT01612741|Acarbose|acarbose|mesh-list
2572815|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2572816|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572817|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572818|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2572819|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572820|NCT01612832|Pregabalin|pregabalin|mesh-list
2572821|NCT01612832|Analgesics|analgesics|mesh-ancestor
2572822|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
2572823|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572824|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572825|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
2572826|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2572827|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2572828|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572829|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2572830|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2572831|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2572832|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2572833|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2572834|NCT01612871|Tamoxifen|tamoxifen|mesh-list
2572835|NCT01612871|Letrozole|letrozole|mesh-list
2572836|NCT01612871|Anastrozole|anastrozole|mesh-list
2572837|NCT01612871|Exemestane|exemestane|mesh-list
2572838|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572839|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2572840|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2572841|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572842|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572843|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2572844|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
2572845|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2572846|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572847|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2572848|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2572849|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2572850|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2572851|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
2572852|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2572853|NCT01612910|Protective Agents|protective agents|mesh-ancestor
2572854|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572855|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572856|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2572857|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2572858|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572859|NCT01612975|Naproxen|naproxen|mesh-list
2572860|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2128392|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128393|NCT02946073|Analgesics|analgesics|mesh-ancestor
2128394|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
2128395|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128396|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2128397|NCT02946385|Vaccines|vaccines|mesh-list
2128398|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
2128399|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128400|NCT02946463|Eculizumab|eculizumab|mesh-list
2419336|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2419337|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
2419338|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2419339|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
2419340|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2419341|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2419342|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2572861|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2572862|NCT01612975|Analgesics|analgesics|mesh-ancestor
2572863|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
2572864|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572865|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572866|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2572867|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2572868|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
2572869|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2572870|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572871|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572872|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
2572873|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2572874|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2572875|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572876|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2572877|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2572878|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572879|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572880|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572881|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2572882|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
2572883|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2572884|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572885|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2128401|NCT02946463|Ravulizumab|ravulizumab|mesh-list
2128402|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2128403|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128404|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
2128405|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128406|NCT02946489|Ketamine|ketamine|mesh-list
2128407|NCT02946489|Analgesics|analgesics|mesh-ancestor
2128408|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
2128409|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128410|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128411|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2128412|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2128413|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
2128414|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
2128415|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2128416|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2128417|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2128418|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2128419|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128420|NCT02946580|Naloxegol|naloxegol|mesh-list
2419343|NCT00802815|Etanercept|etanercept|mesh-list
2419344|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2419345|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419346|NCT00802815|Analgesics|analgesics|mesh-ancestor
2419347|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
2419348|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419349|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419350|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419351|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2419352|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2419353|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2419354|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
2419355|NCT00802828|Famotidine|famotidine|mesh-list
2572886|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2572887|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2572888|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
2572889|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572890|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2572891|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572892|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572893|NCT01613079|Methotrexate|methotrexate|mesh-list
2128421|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2128422|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128423|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
2128424|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128425|NCT02946892|Carvedilol|carvedilol|mesh-list
2128426|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2128427|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2128428|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
2128429|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2128430|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572894|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2572895|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
2572896|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2572897|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572898|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2572899|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
2572900|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572901|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572902|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
2572903|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572904|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2572905|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2572906|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
2572907|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2572908|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2572909|NCT01613092|Vancomycin|vancomycin|mesh-list
2572910|NCT01613092|Clindamycin|clindamycin|mesh-list
2572911|NCT01613092|Cefazolin|cefazolin|mesh-list
2572912|NCT01613092|Cephalexin|cephalexin|mesh-list
2572913|NCT01613092|Bacitracin|bacitracin|mesh-list
2572914|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2572915|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572916|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2572917|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572918|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572919|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2572920|NCT01613105|Acarbose|acarbose|mesh-list
2572921|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2572922|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572923|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572924|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2128431|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128432|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2128433|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
2128434|NCT02946892|Protective Agents|protective agents|mesh-ancestor
2128435|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2128436|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2128437|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2128438|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
2128439|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2128440|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2128441|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
2128442|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
2128443|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128444|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
2128445|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2128446|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2128447|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2128448|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2128449|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
2128450|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2128451|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128452|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128453|NCT02948777|Evolocumab|evolocumab|mesh-list
2128454|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2128455|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2128456|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
2572925|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572926|NCT01613170|Estrogens|estrogens|mesh-list
2572927|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2572928|NCT01613170|Hormones|hormones|mesh-ancestor
2572929|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2572930|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572931|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
2572932|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
2572933|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572934|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
2572935|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572936|NCT01613209|Candesartan|candesartan|mesh-list
2572937|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
2128457|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128458|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2128459|NCT02949011|Oseltamivir|oseltamivir|mesh-list
2128460|NCT02949011|Baloxavir|baloxavir|mesh-list
2128461|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
2128462|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128463|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419356|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2419357|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2419358|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2419359|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
2419360|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
2419361|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419362|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128464|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128465|NCT02949024|Triamcinolone|triamcinolone|mesh-list
2128466|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2128467|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2128468|NCT02949024|Aflibercept|aflibercept|mesh-list
2128469|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2128470|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128471|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
2128472|NCT02949024|Hormones|hormones|mesh-ancestor
2128473|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128474|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128475|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128476|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
2128477|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128478|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128479|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2128480|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2128481|NCT02949024|Growth Substances|growth substances|mesh-ancestor
2128482|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
2128483|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128484|NCT02949128|Ravulizumab|ravulizumab|mesh-list
2128485|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2128486|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128487|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
2128488|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128489|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
2128490|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2128491|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128492|NCT02949271|Fentanyl|fentanyl|mesh-list
2128493|NCT02949271|Ropivacaine|ropivacaine|mesh-list
2128494|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
2128495|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
2128496|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2128497|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128498|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
2128499|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128500|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2128501|NCT02949271|Narcotics|narcotics|mesh-ancestor
2128502|NCT02949271|Analgesics|analgesics|mesh-ancestor
2128503|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2128504|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2128505|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
2128506|NCT02949362|Teduglutide|teduglutide|mesh-list
2128507|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2128508|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2128509|NCT02949362|Protective Agents|protective agents|mesh-ancestor
2128510|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419363|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419364|NCT00802906|Bevacizumab|bevacizumab|mesh-list
2128511|NCT02949674|Bupivacaine|bupivacaine|mesh-list
2128512|NCT02949674|Ropivacaine|ropivacaine|mesh-list
2128513|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
2128514|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
2128515|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2128516|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128517|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
2128518|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128519|NCT02949921|Lidocaine|lidocaine|mesh-list
2128520|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
2128521|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
2128522|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2128523|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128524|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
2128525|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128526|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2128527|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2128528|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2128529|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2128530|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128531|NCT02950467|Psilocybin|psilocybin|mesh-list
2128532|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
2128533|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
2128534|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128535|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2128536|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2128537|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
2128538|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572938|NCT01613209|Olmesartan|olmesartan|mesh-list
2572939|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2572940|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2572941|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2572942|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572943|NCT01613300|Ofatumumab|ofatumumab|mesh-list
2572944|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572945|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
2572946|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2572947|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2572948|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572949|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
2572950|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
2572951|NCT01613469|Leucovorin|leucovorin|mesh-list
2572952|NCT01613469|Antidotes|antidotes|mesh-ancestor
2572953|NCT01613469|Protective Agents|protective agents|mesh-ancestor
2572954|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572955|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
2572956|NCT01613469|Vitamins|vitamins|mesh-ancestor
2572957|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
2128539|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128540|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2128541|NCT02950558|Ropivacaine|ropivacaine|mesh-list
2128542|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
2128543|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
2128544|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2128545|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128546|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
2128547|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2572958|NCT01613482|Trastuzumab|trastuzumab|mesh-list
2572959|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2572960|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572961|NCT01613495|Octreotide|octreotide|mesh-list
2572962|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2572963|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2572964|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2572965|NCT01613534|Sucralfate|sucralfate|mesh-list
2572966|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2572967|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2572968|NCT01613547|Amoxicillin|amoxicillin|mesh-list
2572969|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2572970|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2572971|NCT01613573|Hormones|hormones|mesh-list
2572972|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2572973|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572974|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2572975|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
2572976|NCT01613664|Coagulants|coagulants|mesh-ancestor
2572977|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
2572978|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2572979|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2572980|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2572981|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
2572982|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2572983|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572984|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572985|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2572986|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2572987|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2572988|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
2572989|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2572990|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2572991|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2572992|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572993|NCT01613755|Metformin|metformin|mesh-list
2572994|NCT01613755|Dipyridamole|dipyridamole|mesh-list
2572995|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2572996|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2572997|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2572998|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2572999|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573000|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2573001|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
2573002|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2573003|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2573004|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2573005|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
2573006|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573007|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2573008|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2128560|NCT02951156|Gemcitabine|gemcitabine|mesh-list
2128561|NCT02951156|Rituximab|rituximab|mesh-list
2128562|NCT02951156|Avelumab|avelumab|mesh-list
2128563|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
2128564|NCT02951156|Azacitidine|azacitidine|mesh-list
2573009|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573010|NCT01613807|Insulin|insulin|mesh-list
2573011|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2573012|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
2573013|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
2573014|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
2573015|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2573016|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573017|NCT01613820|Scopolamine|scopolamine|mesh-list
2573018|NCT01613820|Ketamine|ketamine|mesh-list
2573019|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2573020|NCT01613820|Analgesics|analgesics|mesh-ancestor
2573021|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
2573022|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573023|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573024|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2573025|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2573026|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
2573027|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
2573028|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573029|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2573030|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2573031|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2573032|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573033|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2128565|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2573034|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
2573035|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
2573036|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2573037|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
2573038|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2573039|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
2573040|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2128566|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2128567|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128568|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
2128569|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128570|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2128571|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2128572|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
2128573|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128574|NCT02951156|Antiviral Agents|antiviral agents|mesh-ancestor
2128575|NCT02951156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128576|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128577|NCT02951156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128578|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2128579|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
2128580|NCT02951182|Ivacaftor|ivacaftor|mesh-list
2128581|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2128582|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2128583|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128584|NCT02951195|Ivacaftor|ivacaftor|mesh-list
2128585|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2128586|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2128587|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128588|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
2573041|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
2573042|NCT01613846|Sorafenib|sorafenib|mesh-list
2573043|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573044|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2573045|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573046|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573047|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2573048|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
2573049|NCT01613963|Cyclosporine|cyclosporine|mesh-list
2573050|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
2573051|NCT01613963|Prednisolone|prednisolone|mesh-list
2573052|NCT01613963|Adalimumab|adalimumab|mesh-list
2573053|NCT01613963|Etanercept|etanercept|mesh-list
2573054|NCT01613963|Methotrexate|methotrexate|mesh-list
2573055|NCT01613963|Azathioprine|azathioprine|mesh-list
2573056|NCT01613963|Infliximab|infliximab|mesh-list
2573057|NCT01613963|Cyclosporins|cyclosporins|mesh-list
2573058|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2573059|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573060|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
2573061|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573062|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2573063|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2128589|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2128590|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2128591|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2128592|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2128593|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
2128594|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2128595|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128596|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128597|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
2128598|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
2128599|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
2128600|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2128601|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128602|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
2128603|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128604|NCT02951429|Pirfenidone|pirfenidone|mesh-list
2128605|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
2128606|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
2128607|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2128608|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2573064|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
2573065|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2573066|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2419365|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2419366|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419367|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2419368|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2419369|NCT00802906|Growth Substances|growth substances|mesh-ancestor
2419370|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419371|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
2419372|NCT00802958|Clobetasol|clobetasol|mesh-list
2419373|NCT00802958|Halobetasol|halobetasol|mesh-list
2419374|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2573067|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
2573068|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573069|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
2573070|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573071|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2573072|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2573073|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
2573074|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573075|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2573076|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2573077|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2573078|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
2573079|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2573080|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2573081|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
2573082|NCT01613963|Hormones|hormones|mesh-ancestor
2573083|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2573084|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2573085|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573086|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2573087|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2573088|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2128609|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128610|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128611|NCT02951429|Urological Agents|urological agents|mesh-ancestor
2128612|NCT02951429|Analgesics|analgesics|mesh-ancestor
2128613|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
2128614|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128615|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128616|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2128617|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2128618|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128619|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2128620|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128621|NCT02951702|Vancomycin|vancomycin|mesh-list
2573089|NCT01613963|Analgesics|analgesics|mesh-ancestor
2573090|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
2573091|NCT01613976|Panobinostat|panobinostat|mesh-list
2573092|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573093|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2573094|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573095|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573096|NCT01614041|Tandospirone|tandospirone|mesh-list
2573097|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2573098|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2128622|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2128623|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128626|NCT02951819|Dexamethasone|dexamethasone|mesh-list
2128627|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
2128628|NCT02951819|Bortezomib|bortezomib|mesh-list
2128629|NCT02951819|Daratumumab|daratumumab|mesh-list
2128630|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128631|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
2128632|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573099|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573100|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573101|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2573102|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2573103|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
2573104|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2573105|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573106|NCT01614132|Cisplatin|cisplatin|mesh-list
2419375|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419376|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
2419377|NCT00802958|Hormones|hormones|mesh-ancestor
2419378|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2573107|NCT01614132|Vincristine|vincristine|mesh-list
2573108|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573109|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573110|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2573111|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
2573112|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
2573113|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
2573114|NCT01614171|Hormones|hormones|mesh-list
2573115|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2573116|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573117|NCT01614197|Cytarabine|cytarabine|mesh-list
2573118|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
2573119|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2573120|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2573121|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2573122|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
2573123|NCT01614197|Methotrexate|methotrexate|mesh-list
2573124|NCT01614197|Etoposide|etoposide|mesh-list
2573125|NCT01614197|Etoposide phosphate|etoposide phosphate|mesh-list
2573126|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2573127|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
2573128|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573129|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2573130|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2573131|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
2573132|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573133|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573134|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2573135|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2573136|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
2573137|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2573138|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2573139|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
2573140|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
2573141|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573142|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2573143|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2573144|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2573145|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2573146|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2573147|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
2573148|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573149|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2573150|NCT01614223|Betamethasone|betamethasone|mesh-list
2573151|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2573152|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
2573153|NCT01614223|Hormones|hormones|mesh-ancestor
2573154|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2573155|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573156|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2573157|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
2573158|NCT01614236|Pregabalin|pregabalin|mesh-list
2573159|NCT01614236|Analgesics|analgesics|mesh-ancestor
2573160|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
2573161|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573162|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573163|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
2573164|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2573165|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2573166|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419379|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419380|NCT00803166|Clobetasol|clobetasol|mesh-list
2419381|NCT00803166|Halobetasol|halobetasol|mesh-list
2419382|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2419383|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419384|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
2419385|NCT00803166|Hormones|hormones|mesh-ancestor
2419386|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2419387|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419388|NCT00803192|Famotidine|famotidine|mesh-list
2419389|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2128633|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2128634|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2128635|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
2128636|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128637|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573167|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2573168|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2573169|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2573170|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573171|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2573172|NCT01614301|Pioglitazone|pioglitazone|mesh-list
2573173|NCT01614301|Sirolimus|sirolimus|mesh-list
2573174|NCT01614301|Etoricoxib|etoricoxib|mesh-list
2573175|NCT01614301|Dacarbazine|dacarbazine|mesh-list
2573176|NCT01614301|Trofosfamide|trofosfamide|mesh-list
2573177|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2573178|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573179|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2573180|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573181|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2573182|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573183|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
2128638|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2128639|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128640|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
2128641|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
2128642|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573184|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2573185|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
2573186|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2573187|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
2573188|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573189|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2573190|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2573191|NCT01614301|Analgesics|analgesics|mesh-ancestor
2573192|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
2573193|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128643|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2128644|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
2128645|NCT02951819|Hormones|hormones|mesh-ancestor
2128646|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128647|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2128648|NCT02951884|Bupivacaine|bupivacaine|mesh-list
2128649|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
2128650|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
2128651|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2128652|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128653|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
2128654|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128655|NCT02952001|Triamcinolone|triamcinolone|mesh-list
2128656|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2128657|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2128658|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2128659|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128660|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
2128661|NCT02952001|Hormones|hormones|mesh-ancestor
2128662|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128663|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128664|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128665|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
2128666|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128667|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128668|NCT02952586|Avelumab|avelumab|mesh-list
2128669|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2128670|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128671|NCT02952820|Lemborexant|lemborexant|mesh-list
2128672|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2573194|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2573195|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2573196|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2573197|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2573198|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573199|NCT01614366|Amlodipine|amlodipine|mesh-list
2573200|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2573201|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2128673|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2128674|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128675|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2128676|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2128677|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2128678|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128679|NCT02952898|Diclofenac|diclofenac|mesh-list
2128680|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2128681|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2128682|NCT02952898|Analgesics|analgesics|mesh-ancestor
2128683|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
2128684|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128685|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128686|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128687|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2573202|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2573203|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573204|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2573205|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573206|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
2573207|NCT01614405|Ritonavir|ritonavir|mesh-list
2573208|NCT01614405|Lopinavir|lopinavir|mesh-list
2573209|NCT01614405|Tenofovir|tenofovir|mesh-list
2573210|NCT01614405|Emtricitabine|emtricitabine|mesh-list
2573211|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2573212|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2419390|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2419391|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2419392|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
2419393|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
2419394|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419395|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419396|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573213|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2573214|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
2573215|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573216|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573217|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2573218|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2573219|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
2573220|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573221|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2573222|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2573223|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2573224|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2573225|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
2573226|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2573227|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
2573228|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573229|NCT01614431|Expectorants|expectorants|mesh-ancestor
2573230|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
2573231|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2128688|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2128689|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128690|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128691|NCT02953314|Ivacaftor|ivacaftor|mesh-list
2128692|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2128693|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2128694|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128695|NCT02953548|Cannabidiol|cannabidiol|mesh-list
2128696|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
2128697|NCT02953561|Azacitidine|azacitidine|mesh-list
2128698|NCT02953561|Avelumab|avelumab|mesh-list
2128699|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2128700|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2128701|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
2128702|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128703|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128704|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419397|NCT00803218|Fluticasone|fluticasone|mesh-list
2419398|NCT00803218|Xhance|xhance|mesh-list
2419399|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419400|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2573232|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
2573233|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573234|NCT01614431|Protective Agents|protective agents|mesh-ancestor
2573235|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573236|NCT01614431|Antidotes|antidotes|mesh-ancestor
2573237|NCT01614496|Insulin|insulin|mesh-list
2573238|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2573239|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573240|NCT01614535|Remifentanil|remifentanil|mesh-list
2573241|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2128705|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2128706|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
2128707|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128708|NCT02953678|Prednisone|prednisone|mesh-list
2128709|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
2128710|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2128711|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2128712|NCT02953678|Prednisolone|prednisolone|mesh-list
2128713|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
2128714|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2128715|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
2128716|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128717|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
2128718|NCT02953678|Hormones|hormones|mesh-ancestor
2128719|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128720|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128721|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2128722|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128723|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
2128724|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
2128725|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128726|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2128727|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2128728|NCT02953678|Protective Agents|protective agents|mesh-ancestor
2128729|NCT02953782|Cetuximab|cetuximab|mesh-list
2128730|NCT02953782|Magrolimab|magrolimab|mesh-list
2128731|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2128732|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128733|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2128734|NCT02953821|Hormones|hormones|mesh-ancestor
2128735|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128736|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128737|NCT02953860|Fulvestrant|fulvestrant|mesh-list
2128738|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2128739|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128740|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2128741|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2128742|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
2128743|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128744|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128745|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
2128746|NCT02953873|Prednisone|prednisone|mesh-list
2128747|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
2128748|NCT02953873|Tacrolimus|tacrolimus|mesh-list
2128749|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128750|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
2128751|NCT02953873|Hormones|hormones|mesh-ancestor
2128752|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128753|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128754|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2128755|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128756|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128757|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
2128758|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2128759|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573242|NCT01614535|Narcotics|narcotics|mesh-ancestor
2573243|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573244|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573245|NCT01614535|Analgesics|analgesics|mesh-ancestor
2573246|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
2128760|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128761|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2573247|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573248|NCT01614665|Tacrolimus|tacrolimus|mesh-list
2573249|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128762|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2128763|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
2128764|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2128765|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128766|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
2128767|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
2128768|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128769|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2128770|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2128771|NCT02953873|Protective Agents|protective agents|mesh-ancestor
2128772|NCT02953886|Fluorides|fluorides|mesh-list
2128773|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
2128774|NCT02953886|Protective Agents|protective agents|mesh-ancestor
2128775|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128776|NCT02953938|Ranibizumab|ranibizumab|mesh-list
2128777|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2128778|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2128779|NCT02953938|Growth Substances|growth substances|mesh-ancestor
2128780|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128781|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
2128782|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128783|NCT02954172|Paclitaxel|paclitaxel|mesh-list
2128784|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2128785|NCT02954172|Bevacizumab|bevacizumab|mesh-list
2573250|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
2573251|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573252|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2573253|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573254|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573255|NCT01614938|Cisplatin|cisplatin|mesh-list
2573256|NCT01614938|Docetaxel|docetaxel|mesh-list
2573257|NCT01614938|Cetuximab|cetuximab|mesh-list
2573258|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573259|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
2573260|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
2573261|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
2573262|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573263|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2573264|NCT01614964|Lumefantrine|lumefantrine|mesh-list
2573265|NCT01614964|Artemether|artemether|mesh-list
2128786|NCT02954172|Carboplatin|carboplatin|mesh-list
2128787|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2128788|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128789|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
2128790|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
2128791|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
2128792|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128793|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2128794|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2128795|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2128796|NCT02954172|Growth Substances|growth substances|mesh-ancestor
2128797|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128798|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
2128799|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
2128800|NCT02954198|Prednisone|prednisone|mesh-list
2128801|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
2128802|NCT02954198|Everolimus|everolimus|mesh-list
2128803|NCT02954198|Tacrolimus|tacrolimus|mesh-list
2128804|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128805|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
2128806|NCT02954198|Hormones|hormones|mesh-ancestor
2128807|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128808|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128809|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2128810|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128811|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128812|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
2573266|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2573267|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
2573268|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2573269|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2573270|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573271|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2573272|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
2573273|NCT01615042|Lenalidomide|lenalidomide|mesh-list
2128813|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2573274|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
2573275|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573276|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2573277|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2573278|NCT01615042|Growth Substances|growth substances|mesh-ancestor
2128814|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128815|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128816|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2128817|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2128818|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
2128819|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2128820|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128821|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
2128822|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
2128823|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128824|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2128825|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2128826|NCT02954198|Protective Agents|protective agents|mesh-ancestor
2128827|NCT02954354|Oseltamivir|oseltamivir|mesh-list
2128828|NCT02954354|Baloxavir|baloxavir|mesh-list
2128829|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
2128830|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573279|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
2573280|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573281|NCT01615055|Fluoxetine|fluoxetine|mesh-list
2573282|NCT01615055|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2573283|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2573284|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2573285|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573286|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2573287|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
2573288|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573289|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2573290|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
2573291|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2573292|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2573293|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2573294|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573295|NCT01615081|Insulin|insulin|mesh-list
2573296|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2573297|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573298|NCT01615107|Oxytocin|oxytocin|mesh-list
2573299|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
2573300|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2573301|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128831|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128832|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128833|NCT02954575|Factor VIII|factor viii|mesh-list
2128834|NCT02954575|Coagulants|coagulants|mesh-ancestor
2128835|NCT02954601|Insulin|insulin|mesh-list
2128836|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2128837|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2128838|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128839|NCT02954653|Cytarabine|cytarabine|mesh-list
2128840|NCT02954653|Azacitidine|azacitidine|mesh-list
2128841|NCT02954653|Decitabine|decitabine|mesh-list
2128842|NCT02954653|Daunorubicin|daunorubicin|mesh-list
2128843|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2128844|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
2128845|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128846|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573302|NCT01615185|Amisulpride|amisulpride|mesh-list
2573303|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2573304|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2573305|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573306|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573307|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2573308|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2573309|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
2573310|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2573311|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573312|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2573313|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
2573314|NCT01615211|Letrozole|letrozole|mesh-list
2573315|NCT01615211|Trilostane|trilostane|mesh-list
2573316|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573317|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2128847|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
2128848|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128849|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128850|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
2128851|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128852|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128853|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2128854|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2128855|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2128856|NCT02954887|Cannabidiol|cannabidiol|mesh-list
2128857|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
2128858|NCT02955069|Spartalizumab|spartalizumab|mesh-list
2128859|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2128860|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128861|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128862|NCT02955147|Prednisone|prednisone|mesh-list
2128863|NCT02955147|Ustekinumab|ustekinumab|mesh-list
2128864|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128865|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
2128866|NCT02955147|Hormones|hormones|mesh-ancestor
2128867|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128868|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128869|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2128870|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128871|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
2128872|NCT02955186|Saracatinib|saracatinib|mesh-list
2128873|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128874|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128875|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128876|NCT02955212|Upadacitinib|upadacitinib|mesh-list
2128877|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2128878|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2128879|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128880|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128881|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2128882|NCT02955329|Nicotine|nicotine|mesh-list
2573318|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2573319|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573320|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573321|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2573322|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
2573323|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2573324|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573325|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2573326|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
2573327|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2573328|NCT01615224|Misoprostol|misoprostol|mesh-list
2573329|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2573330|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
2573331|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2128883|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2128884|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
2128885|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128886|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128887|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2128888|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2573332|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573333|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2573334|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2573335|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
2573336|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2573337|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2573338|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2573339|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2573340|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
2573341|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2573342|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573343|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2573344|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2573345|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2573346|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2573347|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2128889|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
2573348|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2573349|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2573350|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2573351|NCT01615393|Ribavirin|ribavirin|mesh-list
2573352|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
2573353|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573354|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
2573355|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573356|NCT01615445|Resveratrol|resveratrol|mesh-list
2573357|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
2573358|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573359|NCT01615445|Protective Agents|protective agents|mesh-ancestor
2573360|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573361|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573362|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2573363|NCT01615510|Tapentadol|tapentadol|mesh-list
2128890|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2128891|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128892|NCT02955797|Vaccines|vaccines|mesh-list
2128893|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
2573364|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2573365|NCT01615510|Narcotics|narcotics|mesh-ancestor
2573366|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573367|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573368|NCT01615510|Analgesics|analgesics|mesh-ancestor
2573369|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
2573370|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573371|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2128894|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128895|NCT02956044|Metformin|metformin|mesh-list
2128896|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2128897|NCT02956044|Glimepiride|glimepiride|mesh-list
2128898|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
2128899|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2128900|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128901|NCT02956044|Incretins|incretins|mesh-ancestor
2128902|NCT02956044|Hormones|hormones|mesh-ancestor
2128903|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128904|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2128905|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
2128906|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128907|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128908|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2128909|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2128910|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
2128911|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
2128912|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
2128913|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
2128914|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128915|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
2128916|NCT02956057|Protective Agents|protective agents|mesh-ancestor
2128917|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128918|NCT02956057|Vitamins|vitamins|mesh-ancestor
2128919|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
2128920|NCT02956057|Cathartics|cathartics|mesh-ancestor
2128921|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2573372|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2573373|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2573374|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573375|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
2573376|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2128922|NCT02956070|Dexamethasone|dexamethasone|mesh-list
2128923|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
2128924|NCT02956070|BB 1101|bb 1101|mesh-list
2128925|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128926|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
2128927|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
2128928|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573377|NCT01615601|Ritonavir|ritonavir|mesh-list
2573378|NCT01615601|Darunavir|darunavir|mesh-list
2573379|NCT01615601|Etravirine|etravirine|mesh-list
2573380|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2573381|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2573382|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2573383|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
2128929|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128930|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2128931|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
2128932|NCT02956070|Hormones|hormones|mesh-ancestor
2128933|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2128934|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2128935|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2128936|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
2128937|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573384|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573385|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573386|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2573387|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
2573388|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128938|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128939|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
2128940|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2128941|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2128942|NCT02956122|Prednisolone|prednisolone|mesh-list
2128943|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
2128944|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2128945|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
2128946|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
2128947|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2128948|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128949|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
2128950|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
2128951|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128952|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128953|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2128954|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
2128955|NCT02956122|Hormones|hormones|mesh-ancestor
2128956|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2573389|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2573390|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2573391|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2573392|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2573393|NCT01615614|Rilpivirine|rilpivirine|mesh-list
2573394|NCT01615614|Rifabutin|rifabutin|mesh-list
2573395|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2573396|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2573397|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573398|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573399|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
2573400|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573401|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2573402|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2573403|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2573404|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2573405|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
2573406|NCT01615627|Treprostinil|treprostinil|mesh-list
2573407|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2573408|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2573409|NCT01615757|Cytarabine|cytarabine|mesh-list
2573410|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2573411|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
2573412|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573413|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573414|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
2573415|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573416|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2573417|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
2573418|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573419|NCT01615874|Prednisone|prednisone|mesh-list
2573420|NCT01615874|Prednisolone|prednisolone|mesh-list
2573421|NCT01615874|Montelukast|montelukast|mesh-list
2573422|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
2573423|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2573424|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
2573425|NCT01615874|Hormones|hormones|mesh-ancestor
2573426|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2573427|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573428|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2573429|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573430|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
2573431|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128957|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2128958|NCT02956122|Protective Agents|protective agents|mesh-ancestor
2128959|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2128960|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573432|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2573433|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
2573434|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2573435|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
2573436|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2573437|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2128961|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128962|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128963|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2128964|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2128965|NCT02956278|Allopurinol|allopurinol|mesh-list
2128966|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
2128967|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128968|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128969|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
2128970|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2128971|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2128972|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
2128973|NCT02956278|Protective Agents|protective agents|mesh-ancestor
2128974|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128975|NCT02956616|Ketorolac|ketorolac|mesh-list
2573438|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573439|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2573440|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2573441|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2573442|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573443|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2573444|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2573445|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2128976|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2128977|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2128978|NCT02956616|Analgesics|analgesics|mesh-ancestor
2128979|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
2128980|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2128981|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2128982|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2128983|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2128984|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2128985|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2128986|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128987|NCT02956629|Ribavirin|ribavirin|mesh-list
2128988|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
2128989|NCT02956629|Ruzasvir|ruzasvir|mesh-list
2128990|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
2128991|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2128992|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
2128993|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2128994|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
2128995|NCT02956746|Antibodies|antibodies|mesh-list
2128996|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
2128997|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2128998|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2128999|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
2129000|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129001|NCT02956837|Vaccines|vaccines|mesh-list
2129002|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
2129003|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129004|NCT02957305|Misoprostol|misoprostol|mesh-list
2129005|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2129006|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
2129007|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2129008|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129009|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2129010|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2129011|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
2129012|NCT02957331|Propranolol|propranolol|mesh-list
2129013|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2129014|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2129015|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
2129016|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129017|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129018|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129019|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2129020|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2129021|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
2129022|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
2129023|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2129024|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
2129025|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129026|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
2129027|NCT02958267|Protective Agents|protective agents|mesh-ancestor
2129028|NCT02958345|Vaccines|vaccines|mesh-list
2129029|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
2129030|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129031|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2129032|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2129033|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2129034|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2129035|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129036|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129037|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129038|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2129039|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
2129040|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2129041|NCT02958956|Pioglitazone|pioglitazone|mesh-list
2129042|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2129043|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129044|NCT02958969|Apixaban|apixaban|mesh-list
2129045|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2129046|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
2129047|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2129048|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
2129049|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129050|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129051|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
2573446|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573447|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
2573448|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2573449|NCT01615913|Ketoconazole|ketoconazole|mesh-list
2573450|NCT01615913|Terbinafine|terbinafine|mesh-list
2573451|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
2573452|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573453|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2573454|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2573455|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573456|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573457|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2573458|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
2573459|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2573460|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573461|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2573462|NCT01615978|Liraglutide|liraglutide|mesh-list
2573463|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2573464|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129052|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
2129053|NCT02959437|Azacitidine|azacitidine|mesh-list
2129054|NCT02959437|INCB057643|incb057643|mesh-list
2129055|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2129056|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129057|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2129058|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
2129059|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129060|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129061|NCT02959840|Ondansetron|ondansetron|mesh-list
2129062|NCT02959840|Metoclopramide|metoclopramide|mesh-list
2129063|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
2129064|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
2573465|NCT01615978|Incretins|incretins|mesh-ancestor
2573466|NCT01615978|Hormones|hormones|mesh-ancestor
2573467|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2573468|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
2573469|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2573470|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
2573471|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
2129065|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129066|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129067|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2129068|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
2129069|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
2129070|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2129071|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
2129072|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129073|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129074|NCT02959840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2129075|NCT02959840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2129076|NCT02959840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573472|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573473|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573474|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2573475|NCT01616004|Analgesics|analgesics|mesh-ancestor
2573476|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
2573477|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573478|NCT01616069|Simendan|simendan|mesh-list
2573479|NCT01616069|Epinephrine|epinephrine|mesh-list
2573480|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2573481|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2573482|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
2573483|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2573484|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573485|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573486|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2573487|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2573488|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
2573489|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573490|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2573491|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
2573492|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
2573493|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
2129077|NCT02959840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2129078|NCT02959840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2129079|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2129080|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2129081|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
2573494|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2573495|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2573496|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
2573497|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2129082|NCT02959853|Anastrozole|anastrozole|mesh-list
2129083|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2129084|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129085|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2129086|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2129087|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129088|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129089|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2129090|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
2129091|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2573498|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2573499|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573500|NCT01616069|Protective Agents|protective agents|mesh-ancestor
2573501|NCT01616108|Bupivacaine|bupivacaine|mesh-list
2573502|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
2573503|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
2573504|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573505|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573506|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
2573507|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573508|NCT01616186|Everolimus|everolimus|mesh-list
2573509|NCT01616186|Sorafenib|sorafenib|mesh-list
2573510|NCT01616186|Sunitinib|sunitinib|mesh-list
2573511|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573512|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2573513|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
2129092|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129093|NCT02959892|Amphetamine|amphetamine|mesh-list
2129094|NCT02959892|Naxagolide|naxagolide|mesh-list
2573514|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573515|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2573516|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129095|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2129096|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129097|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
2129098|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
2129099|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129100|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
2129101|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2573517|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573518|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2573519|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2573520|NCT01616186|Growth Substances|growth substances|mesh-ancestor
2573521|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
2573522|NCT01616199|Vemurafenib|vemurafenib|mesh-list
2573523|NCT01616199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573524|NCT01616199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2573525|NCT01616199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573526|NCT01616199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573527|NCT01616225|Hormones|hormones|mesh-list
2573528|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2573529|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573530|NCT01616303|Paclitaxel|paclitaxel|mesh-list
2573531|NCT01616303|Carboplatin|carboplatin|mesh-list
2573532|NCT01616303|Oregovomab|oregovomab|mesh-list
2573533|NCT01616303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2573534|NCT01616303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573535|NCT01616303|Tubulin Modulators|tubulin modulators|mesh-ancestor
2573536|NCT01616303|Antimitotic Agents|antimitotic agents|mesh-ancestor
2573537|NCT01616303|Mitosis Modulators|mitosis modulators|mesh-ancestor
2573538|NCT01616303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573539|NCT01616303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2573540|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2573541|NCT01616355|Eusol|eusol|mesh-list
2129102|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129103|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
2129104|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2129105|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2129106|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2129107|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2129108|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
2573542|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
2573543|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573544|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
2573545|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
2573546|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2573547|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2573548|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573549|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573550|NCT01616381|Urological Agents|urological agents|mesh-ancestor
2129109|NCT02959944|Prednisone|prednisone|mesh-list
2129110|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2129111|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
2129112|NCT02959944|Hormones|hormones|mesh-ancestor
2129113|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129114|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129115|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2129116|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573551|NCT01616407|Methylphenidate|methylphenidate|mesh-list
2573552|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2573553|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2573554|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573555|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2573556|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2573557|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2573558|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573559|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
2573560|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2573561|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
2573562|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2573563|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
2129117|NCT02959970|Dapsone|dapsone|mesh-list
2129118|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129119|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
2129120|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2573564|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2573565|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
2573566|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
2573567|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
2573568|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573569|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
2573570|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2573571|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2573572|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573573|NCT01616485|Urological Agents|urological agents|mesh-ancestor
2573574|NCT01616524|Interferons|interferons|mesh-list
2573575|NCT01616524|Ribavirin|ribavirin|mesh-list
2573576|NCT01616524|Interferon-alpha|interferon-alpha|mesh-list
2573577|NCT01616524|Interferon alpha-2|interferon alpha-2|mesh-list
2573578|NCT01616524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2573579|NCT01616524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573580|NCT01616524|Antiviral Agents|antiviral agents|mesh-ancestor
2129121|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2129122|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2129123|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129124|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129125|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
2129126|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2129127|NCT02959983|Eluxadoline|eluxadoline|mesh-list
2129128|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2129129|NCT02959996|Bupivacaine|bupivacaine|mesh-list
2129130|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
2129131|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
2129132|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2129133|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129134|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
2129135|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129136|NCT02960438|Quetmolimab|quetmolimab|mesh-list
2129137|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2129138|NCT02960490|Quetmolimab|quetmolimab|mesh-list
2129139|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2129140|NCT02960854|Nivolumab|nivolumab|mesh-list
2129141|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2129142|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573581|NCT01616524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573582|NCT01616524|Antimetabolites|antimetabolites|mesh-ancestor
2573583|NCT01616524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129143|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2129144|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129145|NCT02960997|Sirolimus|sirolimus|mesh-list
2129146|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2573584|NCT01616524|Immunologic Factors|immunologic factors|mesh-ancestor
2129147|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129148|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2129149|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129150|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
2129151|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2129152|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
2129153|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129154|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2129155|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129156|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2129157|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419401|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
2419402|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419403|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419404|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2419405|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
2419406|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
2419407|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2419408|NCT00803309|Interferons|interferons|mesh-list
2419409|NCT00803309|Ribavirin|ribavirin|mesh-list
2419410|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
2419411|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
2419412|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2419413|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419414|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
2419415|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419416|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
2419417|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419418|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
2129158|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129159|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
2129160|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2129161|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129162|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2129163|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2129164|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129165|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129166|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129167|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2129168|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2129169|NCT02961764|Dalbavancin|dalbavancin|mesh-list
2129170|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2129171|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129172|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
2129173|NCT02961790|Oxybutynin|oxybutynin|mesh-list
2129174|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
2129175|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
2129176|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129177|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129178|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2129179|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2129180|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
2129181|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129182|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129183|NCT02961790|Urological Agents|urological agents|mesh-ancestor
2129184|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2129185|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573585|NCT01616524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573586|NCT01616615|Aspirin|aspirin|mesh-list
2573587|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2573588|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2573589|NCT01616615|Analgesics|analgesics|mesh-ancestor
2573590|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
2573591|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573592|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573593|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2573594|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2573595|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2573596|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2573597|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573598|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2573599|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2573600|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573601|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
2573602|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2573603|NCT01616680|Antibodies|antibodies|mesh-list
2573604|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
2573605|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2573606|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
2573607|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
2573608|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573609|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2573610|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573611|NCT01616732|Testosterone|testosterone|mesh-list
2573612|NCT01616732|Androgens|androgens|mesh-ancestor
2573613|NCT01616732|Hormones|hormones|mesh-ancestor
2573614|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2573615|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573616|NCT01616784|Insulin|insulin|mesh-list
2573617|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2573618|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
2129186|NCT02961790|Renal Agents|renal agents|mesh-ancestor
2129187|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
2129188|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
2129189|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
2129190|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2129191|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2129192|NCT02962284|Prednisolone|prednisolone|mesh-list
2129193|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
2129194|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
2129195|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2573619|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2129196|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
2129197|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2573620|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573621|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
2573622|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573623|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2573624|NCT01616875|Cisplatin|cisplatin|mesh-list
2573625|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573626|NCT01616888|Paclitaxel|paclitaxel|mesh-list
2573627|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2573628|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573629|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
2573630|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
2573631|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
2573632|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573633|NCT01616927|Lanreotide|lanreotide|mesh-list
2573634|NCT01616927|Somatostatin|somatostatin|mesh-list
2573635|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573636|NCT01616927|Hormones|hormones|mesh-ancestor
2573637|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129198|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
2129199|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
2129200|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129201|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129202|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2129203|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
2129204|NCT02962284|Hormones|hormones|mesh-ancestor
2573638|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573639|NCT01616966|Remifentanil|remifentanil|mesh-list
2573640|NCT01616966|Propofol|propofol|mesh-list
2419419|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419420|NCT00803335|Estrogens|estrogens|mesh-list
2419421|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2419422|NCT00803335|Hormones|hormones|mesh-ancestor
2419423|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2419424|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419425|NCT00803374|Ipilimumab|ipilimumab|mesh-list
2419426|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2419427|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2419428|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419429|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2419430|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573641|NCT01616966|Sevoflurane|sevoflurane|mesh-list
2129205|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129206|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2129207|NCT02962284|Protective Agents|protective agents|mesh-ancestor
2573642|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2573643|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573644|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573645|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2573646|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
2573647|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
2573648|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2573649|NCT01616966|Narcotics|narcotics|mesh-ancestor
2573650|NCT01616966|Analgesics|analgesics|mesh-ancestor
2573651|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
2573652|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573653|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2129208|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2129209|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129210|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2129211|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129212|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129213|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
2129214|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2573654|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2573655|NCT01616992|Bupivacaine|bupivacaine|mesh-list
2573656|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
2573657|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
2573658|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573659|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573660|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
2573661|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573662|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
2573663|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2573664|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573665|NCT01617096|Dapivirine|dapivirine|mesh-list
2573666|NCT01617096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2129215|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2129216|NCT02962648|Hematinics|hematinics|mesh-ancestor
2129217|NCT02962739|Tenofovir|tenofovir|mesh-list
2129218|NCT02962739|Emtricitabine|emtricitabine|mesh-list
2129219|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
2129220|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129221|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2129222|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2129223|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129224|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129225|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2129226|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2129227|NCT02963701|Ibuprofen|ibuprofen|mesh-list
2129228|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
2129229|NCT02963701|Ephedrine|ephedrine|mesh-list
2129230|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2129231|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2129232|NCT02963701|Analgesics|analgesics|mesh-ancestor
2129233|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
2129234|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129235|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129236|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2129237|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2129238|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2129239|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129240|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129241|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2129242|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
2129243|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2573667|NCT01617096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2573668|NCT01617096|Antiviral Agents|antiviral agents|mesh-ancestor
2573669|NCT01617096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573670|NCT01617135|Levodopa|levodopa|mesh-list
2573671|NCT01617135|Carbidopa|carbidopa|mesh-list
2573672|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2573673|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2573674|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2573675|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
2573676|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2573677|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573678|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129244|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
2129245|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
2129246|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2129247|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2129248|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
2129249|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
2129250|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129251|NCT02963922|Liraglutide|liraglutide|mesh-list
2129252|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2129253|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129254|NCT02963922|Incretins|incretins|mesh-ancestor
2129255|NCT02963922|Hormones|hormones|mesh-ancestor
2129256|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129257|NCT02963935|Liraglutide|liraglutide|mesh-list
2129258|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2129259|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129260|NCT02963935|Incretins|incretins|mesh-ancestor
2129261|NCT02963935|Hormones|hormones|mesh-ancestor
2129262|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129277|NCT02964247|Liraglutide|liraglutide|mesh-list
2129278|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2419431|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
2573679|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2573680|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573681|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2573682|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
2573683|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
2573684|NCT01617200|Olanzapine|olanzapine|mesh-list
2573685|NCT01617200|Asenapine|asenapine|mesh-list
2573686|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
2573687|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
2573688|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573689|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573690|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2573691|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2573692|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2573693|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573694|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2573695|NCT01617200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2573696|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2573697|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2573698|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573699|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2573700|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
2573701|NCT01617213|Lenalidomide|lenalidomide|mesh-list
2573702|NCT01617213|Melphalan|melphalan|mesh-list
2573703|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
2573704|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573705|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2573706|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2573707|NCT01617213|Growth Substances|growth substances|mesh-ancestor
2573708|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
2573709|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573710|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2573711|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
2573712|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573713|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2573714|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2573715|NCT01617226|Azacitidine|azacitidine|mesh-list
2573716|NCT01617226|Vorinostat|vorinostat|mesh-list
2573717|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2573718|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
2573719|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573720|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573721|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573722|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2573723|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
2573724|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2573725|NCT01617317|Antibodies|antibodies|mesh-list
2129279|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129280|NCT02964247|Incretins|incretins|mesh-ancestor
2129281|NCT02964247|Hormones|hormones|mesh-ancestor
2129282|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129283|NCT02964416|Tramadol|tramadol|mesh-list
2129284|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2129285|NCT02964416|Narcotics|narcotics|mesh-ancestor
2129286|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2129287|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129288|NCT02964416|Analgesics|analgesics|mesh-ancestor
2129289|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
2129290|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129291|NCT02965378|Docetaxel|docetaxel|mesh-list
2129292|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129293|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
2129294|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
2129295|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
2129296|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573726|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
2573727|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2573728|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
2573729|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573730|NCT01617356|Lidocaine|lidocaine|mesh-list
2573731|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
2573732|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
2573733|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573734|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573735|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
2129297|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
2573736|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573737|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2573738|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2573739|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2573740|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2129298|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2129299|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
2129300|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129301|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
2129302|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2573741|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573742|NCT01617538|Atorvastatin|atorvastatin|mesh-list
2573743|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2573744|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2573745|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
2573746|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573747|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2573748|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2573749|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573750|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2573751|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573752|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573753|NCT01617564|Bupivacaine|bupivacaine|mesh-list
2573754|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
2573755|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
2573756|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573757|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573758|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
2573759|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573760|NCT01617590|Methotrexate|methotrexate|mesh-list
2573761|NCT01617590|Leflunomide|leflunomide|mesh-list
2573762|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2573763|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
2573764|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2573765|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573766|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2573767|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
2573768|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573769|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573770|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
2573771|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573772|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2573773|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2573774|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
2573775|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2573776|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2129303|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
2129304|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129305|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2129306|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
2129307|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2129308|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2129309|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129310|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
2129311|NCT02965924|Phenylephrine|phenylephrine|mesh-list
2129312|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
2129313|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2129314|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
2129315|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
2129316|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129317|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129318|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
2129319|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2129320|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
2129321|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
2129322|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2129323|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2129324|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2129325|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
2129326|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129327|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129328|NCT02965924|Protective Agents|protective agents|mesh-ancestor
2129329|NCT02966002|Aspirin|aspirin|mesh-list
2129330|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2573777|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
2573778|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2573779|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573780|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573781|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2573782|NCT01617694|Analgesics|analgesics|mesh-ancestor
2573783|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
2573784|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573785|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2573786|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2573787|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2573788|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
2573789|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129331|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2129332|NCT02966002|Analgesics|analgesics|mesh-ancestor
2129333|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
2129334|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129335|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129336|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2129337|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2129338|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2129339|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2129340|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129341|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2129342|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2129343|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129344|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
2573790|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573791|NCT01617707|Midazolam|midazolam|mesh-list
2573792|NCT01617707|Propofol|propofol|mesh-list
2573793|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2573794|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573795|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573796|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2573797|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
2573798|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
2573799|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2573800|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2573801|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2573802|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2573803|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
2573804|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
2573805|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2573806|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573807|NCT01617733|Pasireotide|pasireotide|mesh-list
2573808|NCT01617733|Hormones|hormones|mesh-ancestor
2573809|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129345|NCT02966275|Glucagon|glucagon|mesh-list
2129346|NCT02966275|Pancrelipase|pancrelipase|mesh-list
2129347|NCT02966275|Pancreatin|pancreatin|mesh-list
2129348|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2129349|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2129350|NCT02966275|Hormones|hormones|mesh-ancestor
2129351|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129352|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129353|NCT02966275|Incretins|incretins|mesh-ancestor
2129354|NCT02966314|Omalizumab|omalizumab|mesh-list
2129355|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2129356|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2129357|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
2129358|NCT02966340|Prazosin|prazosin|mesh-list
2129359|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2129360|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2129361|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2129362|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2129363|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
2573810|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573811|NCT01617746|Bosentan|bosentan|mesh-list
2573812|NCT01617746|Ambrisentan|ambrisentan|mesh-list
2573813|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2573814|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2573815|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129364|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2184853|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2573816|NCT01617772|Atorvastatin|atorvastatin|mesh-list
2573817|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2129365|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129366|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129367|NCT02967354|Tryptophan|tryptophan|mesh-list
2129368|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
2129369|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2129370|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
2129371|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2129372|NCT02967679|Biotin|biotin|mesh-list
2129373|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
2129374|NCT02967679|Vitamins|vitamins|mesh-ancestor
2129375|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
2129376|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129377|NCT02968134|Posaconazole|posaconazole|mesh-list
2129378|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
2129379|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129380|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2129381|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2129382|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2129383|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2129384|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2573818|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2573819|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
2573820|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573821|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2573822|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2573823|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573824|NCT01617798|Metolazone|metolazone|mesh-list
2573825|NCT01617798|Furosemide|furosemide|mesh-list
2573826|NCT01617798|Diuretics|diuretics|mesh-ancestor
2573827|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
2573828|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573829|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2573830|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2573831|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573832|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2573833|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2573834|NCT01617811|Anesthetics|anesthetics|mesh-list
2573835|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573836|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573837|NCT01617824|Linagliptin|linagliptin|mesh-list
2573838|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2573839|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573840|NCT01617824|Incretins|incretins|mesh-ancestor
2573841|NCT01617824|Hormones|hormones|mesh-ancestor
2573842|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2573843|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2573844|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
2573845|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573846|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573847|NCT01617928|Paclitaxel|paclitaxel|mesh-list
2129385|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129386|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129387|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2129388|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
2129389|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129390|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129391|NCT02968173|Palivizumab|palivizumab|mesh-list
2129392|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
2129393|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129394|NCT02968368|Ferric maltol|ferric maltol|mesh-list
2129395|NCT02968368|Hematinics|hematinics|mesh-ancestor
2129402|NCT02968576|Tenofovir|tenofovir|mesh-list
2129403|NCT02968576|Emtricitabine|emtricitabine|mesh-list
2129404|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2573848|NCT01617928|Carboplatin|carboplatin|mesh-list
2573849|NCT01617928|Veliparib|veliparib|mesh-list
2129405|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
2129406|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573850|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2573851|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573852|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
2573853|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
2573854|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
2573855|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573856|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2573857|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573858|NCT01618006|Aspirin|aspirin|mesh-list
2573859|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2573860|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2573861|NCT01618006|Analgesics|analgesics|mesh-ancestor
2573862|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
2573863|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573864|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573865|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2573866|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2573867|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2573868|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2573869|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573870|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2573871|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2573872|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573873|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
2573874|NCT01618136|Paclitaxel|paclitaxel|mesh-list
2573875|NCT01618136|Carboplatin|carboplatin|mesh-list
2573876|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2573877|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573878|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
2573879|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
2129407|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2129408|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2573880|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
2573881|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573882|NCT01618188|Insulin|insulin|mesh-list
2573883|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2573884|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
2573885|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
2573886|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2573887|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2129409|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129410|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129411|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2129412|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2129416|NCT02968914|Benralizumab|benralizumab|mesh-list
2129417|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2129418|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
2129419|NCT02969018|PF-06700841|pf-06700841|mesh-list
2129420|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2129421|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129422|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129423|NCT02969187|Bupivacaine|bupivacaine|mesh-list
2129424|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
2129425|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
2129426|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2129427|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129428|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
2129429|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573888|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573889|NCT01618253|Sorafenib|sorafenib|mesh-list
2573890|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129430|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
2129431|NCT02969317|Olodaterol|olodaterol|mesh-list
2129432|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2129433|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
2129434|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129435|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129436|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2129437|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
2129438|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
2573891|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2573892|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573893|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573894|NCT01618357|Veliparib|veliparib|mesh-list
2573895|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2573896|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2573897|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573898|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573899|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2573900|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573901|NCT01618396|Midazolam|midazolam|mesh-list
2573902|NCT01618396|Propofol|propofol|mesh-list
2573903|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2573904|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573905|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573906|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2129439|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2129440|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
2129441|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129442|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129443|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
2129444|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2129445|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2129446|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2129447|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2129448|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129449|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
2129450|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129451|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129452|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2129453|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573907|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
2573908|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
2573909|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2573910|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2573911|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2129454|NCT02969408|Albuterol|albuterol|mesh-list
2129455|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2129456|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
2129457|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129458|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129459|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2129460|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
2129461|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
2129462|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2129463|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2129464|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2129465|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2129466|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
2129467|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129468|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129469|NCT02969590|Leuprolide|leuprolide|mesh-list
2129470|NCT02969590|Norethindrone|norethindrone|mesh-list
2129471|NCT02969590|Estradiol|estradiol|mesh-list
2129472|NCT02969590|Estrogens|estrogens|mesh-list
2129473|NCT02969590|Progesterone|progesterone|mesh-list
2129474|NCT02969590|Progestins|progestins|mesh-list
2129475|NCT02969590|Hormones|hormones|mesh-ancestor
2129476|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129477|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129478|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2129479|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
2129480|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2573912|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2573913|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
2573914|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
2573915|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2573916|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573917|NCT01618448|Tolvaptan|tolvaptan|mesh-list
2573918|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2573919|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573920|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
2573921|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129481|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2129482|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2573922|NCT01618474|Docetaxel|docetaxel|mesh-list
2573923|NCT01618474|Capecitabine|capecitabine|mesh-list
2573924|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573925|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
2573926|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
2573927|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
2573928|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573929|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2573930|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
2573931|NCT01618513|Octreotide|octreotide|mesh-list
2573932|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2573933|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2573934|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129483|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
2129484|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2129485|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129486|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2129487|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2129488|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2129489|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
2129490|NCT02969655|Glycine|glycine|mesh-list
2129491|NCT02969655|Hematinics|hematinics|mesh-ancestor
2129492|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
2129493|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129494|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129495|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129496|NCT02969863|Pancrelipase|pancrelipase|mesh-list
2129497|NCT02969863|Pancreatin|pancreatin|mesh-list
2129498|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2129499|NCT02969876|Vortioxetine|vortioxetine|mesh-list
2129500|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
2129501|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2129502|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2129503|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2129504|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2129505|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129506|NCT02969876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2129507|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2129508|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2129509|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129510|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129511|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
2129512|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2129513|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2129514|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2129515|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2129528|NCT02970032|Heparin|heparin|mesh-list
2129529|NCT02970032|Calcium heparin|calcium heparin|mesh-list
2129530|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
2129531|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2129532|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2129533|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129534|NCT02970162|Amifampridine|amifampridine|mesh-list
2129535|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2129536|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129537|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129538|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2129539|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2129540|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129541|NCT02970292|Pimavanserin|pimavanserin|mesh-list
2129542|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2129543|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2129544|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2129545|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2573935|NCT01618539|Propofol|propofol|mesh-list
2573936|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2573937|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573938|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573939|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2129546|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2129547|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129548|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2129549|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2129550|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2129551|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
2129552|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129553|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129554|NCT02970305|Pimavanserin|pimavanserin|mesh-list
2129555|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2129556|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2129557|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2129558|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2129559|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2129560|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129561|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2129562|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2129563|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2129564|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
2129565|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129566|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129567|NCT02970552|Progesterone|progesterone|mesh-list
2129568|NCT02970552|Progestins|progestins|mesh-ancestor
2129569|NCT02970552|Hormones|hormones|mesh-ancestor
2573940|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
2573941|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
2573942|NCT01618591|Azithromycin|azithromycin|mesh-list
2573943|NCT01618591|Levofloxacin|levofloxacin|mesh-list
2573944|NCT01618591|Ofloxacin|ofloxacin|mesh-list
2573945|NCT01618591|Rifaximin|rifaximin|mesh-list
2129570|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129571|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129572|NCT02970669|Valsartan|valsartan|mesh-list
2129573|NCT02970669|Enalapril|enalapril|mesh-list
2129574|NCT02970669|Enalaprilat|enalaprilat|mesh-list
2129575|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2129576|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2129577|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2129578|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2129579|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129580|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2129581|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
2129582|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129589|NCT02971007|Fluconazole|fluconazole|mesh-list
2129590|NCT02971007|Amphotericin B|amphotericin b|mesh-list
2419432|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419433|NCT00803387|Travoprost|travoprost|mesh-list
2419434|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2419435|NCT00803439|Clobetasol|clobetasol|mesh-list
2419436|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419437|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
2419438|NCT00803439|Hormones|hormones|mesh-ancestor
2419439|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2419440|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419441|NCT00803465|Fluticasone|fluticasone|mesh-list
2573946|NCT01618591|Loperamide|loperamide|mesh-list
2573947|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
2573948|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2573949|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573950|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2573951|NCT01618591|Renal Agents|renal agents|mesh-ancestor
2573952|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2573953|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2573954|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419442|NCT00803465|Xhance|xhance|mesh-list
2573955|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129591|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2129592|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
2129593|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129594|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2129595|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2129596|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129597|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129598|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2129599|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
2129600|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129601|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129602|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2129603|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2129604|NCT02971007|Amebicides|amebicides|mesh-ancestor
2129605|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2129606|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2129607|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2129608|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
2129609|NCT02971228|Glucagon|glucagon|mesh-list
2129610|NCT02971228|Pancrelipase|pancrelipase|mesh-list
2573956|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573957|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2573958|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2573959|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2573960|NCT01618643|Acetic Acid|acetic acid|mesh-list
2573961|NCT01618643|Retinol acetate|retinol acetate|mesh-list
2573962|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2573963|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2573964|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2573965|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
2573966|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573967|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2573968|NCT01618643|Protective Agents|protective agents|mesh-ancestor
2573969|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2573970|NCT01618760|Risperidone|risperidone|mesh-list
2573971|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2573972|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
2573973|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2573974|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129611|NCT02971228|Pancreatin|pancreatin|mesh-list
2129612|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2129613|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2573975|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573976|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2573977|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2573978|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2573979|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2573980|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2573981|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
2573982|NCT01618773|Adapalene|adapalene|mesh-list
2573983|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2573984|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
2573985|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2129614|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129615|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2129616|NCT02971228|Hormones|hormones|mesh-ancestor
2129617|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129618|NCT02971228|Incretins|incretins|mesh-ancestor
2129619|NCT02971605|Psilocybin|psilocybin|mesh-list
2129620|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
2129621|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129622|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2129623|NCT02971683|Abatacept|abatacept|mesh-list
2129624|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2129625|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129626|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129627|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2129628|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
2129629|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129630|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2129631|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
2129632|NCT02972502|Promethazine|promethazine|mesh-list
2129633|NCT02972502|Haloperidol|haloperidol|mesh-list
2129634|NCT02972502|Metoclopramide|metoclopramide|mesh-list
2573986|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2573987|NCT01618773|Analgesics|analgesics|mesh-ancestor
2573988|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
2573989|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2573990|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2573991|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2573992|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2573993|NCT01618799|Lamotrigine|lamotrigine|mesh-list
2573994|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
2573995|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2573996|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2573997|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2573998|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2573999|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574000|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2574001|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2574002|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2129635|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
2129636|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2129637|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2129638|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2129639|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129640|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
2129641|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
2574003|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2574004|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2574005|NCT01618825|Lamotrigine|lamotrigine|mesh-list
2574006|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
2574007|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2574008|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2574009|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574010|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2574011|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574012|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2419443|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419444|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2419445|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
2419446|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419447|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419448|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2419449|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
2419450|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
2419451|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2419452|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
2419453|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
2419454|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419455|NCT00803530|Protective Agents|protective agents|mesh-ancestor
2419456|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419457|NCT00803530|Vitamins|vitamins|mesh-ancestor
2419458|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
2419459|NCT00803556|Paclitaxel|paclitaxel|mesh-list
2419460|NCT00803556|Trastuzumab|trastuzumab|mesh-list
2419461|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2419462|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419463|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
2419464|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
2419465|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
2419466|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419467|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2419468|NCT00803699|Selenium|selenium|mesh-list
2419469|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
2419470|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419471|NCT00803699|Protective Agents|protective agents|mesh-ancestor
2419472|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419473|NCT00803699|Trace Elements|trace elements|mesh-ancestor
2419474|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
2419475|NCT00803725|Fentanyl|fentanyl|mesh-list
2419476|NCT00803725|Mepivacaine|mepivacaine|mesh-list
2419477|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2419478|NCT00803725|Narcotics|narcotics|mesh-ancestor
2419479|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2419480|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419481|NCT00803725|Analgesics|analgesics|mesh-ancestor
2419482|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
2419483|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574013|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2574014|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2574015|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2574016|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2574017|NCT01618877|Levetiracetam|levetiracetam|mesh-list
2574018|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
2574019|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
2574020|NCT01618890|Propranolol|propranolol|mesh-list
2574021|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2574022|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2574023|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
2574024|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574025|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574026|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574027|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2574028|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2574029|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
2129642|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
2129643|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129644|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
2129645|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
2129646|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2129647|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2574030|NCT01618903|Levetiracetam|levetiracetam|mesh-list
2574031|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
2574032|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
2574033|NCT01618929|Montelukast|montelukast|mesh-list
2574034|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2574035|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
2574036|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2129648|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
2129649|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
2129650|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129651|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129652|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2574037|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
2574038|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2574039|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574040|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2574041|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2574042|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574043|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
2574044|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2574045|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
2574046|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2574047|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
2574048|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574049|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574050|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
2574051|NCT01619046|Factor VIII|factor viii|mesh-list
2574052|NCT01619046|Coagulants|coagulants|mesh-ancestor
2574053|NCT01619072|Misoprostol|misoprostol|mesh-list
2574054|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2574055|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
2574056|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2574057|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574058|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2574059|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2574060|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
2574061|NCT01619111|Lapatinib|lapatinib|mesh-list
2574062|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574063|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2574064|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574065|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574066|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
2574067|NCT01619137|Povidone|povidone|mesh-list
2574068|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
2574069|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
2574070|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2574071|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574072|NCT01619150|Etoricoxib|etoricoxib|mesh-list
2574073|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2574074|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2574075|NCT01619150|Analgesics|analgesics|mesh-ancestor
2129653|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
2574076|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
2129654|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
2129655|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2129656|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2129657|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2129658|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2129659|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
2129660|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2129661|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2129662|NCT02972554|Propranolol|propranolol|mesh-list
2129663|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2129664|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2129665|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
2129666|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129667|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129668|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129669|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2129670|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2574077|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574078|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574079|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2574080|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2574081|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2574082|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2129671|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
2129672|NCT02972632|Vortioxetine|vortioxetine|mesh-list
2129673|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
2574083|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574084|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574085|NCT01619163|Prednisolone|prednisolone|mesh-list
2574086|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2574087|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
2574088|NCT01619163|Hormones|hormones|mesh-ancestor
2574089|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2574090|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574091|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2574092|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574093|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2574094|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2574095|NCT01619176|Methotrexate|methotrexate|mesh-list
2574096|NCT01619176|Leflunomide|leflunomide|mesh-list
2574097|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2574098|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
2574099|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2574100|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574101|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2574102|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
2574103|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574104|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574105|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
2574106|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574107|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2129674|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2129675|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2129676|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2129677|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2129678|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129679|NCT02972632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2129680|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2129681|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2129682|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129683|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129684|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
2129685|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2129686|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2184854|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
2574108|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2574109|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
2574110|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2574111|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2574112|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2574113|NCT01619176|Analgesics|analgesics|mesh-ancestor
2574114|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
2574115|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574116|NCT01619280|Nitroprusside|nitroprusside|mesh-list
2574117|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2574118|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
2574119|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2574120|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574121|NCT01619332|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2574122|NCT01619332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2574123|NCT01619332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574124|NCT01619332|Incretins|incretins|mesh-ancestor
2574125|NCT01619332|Hormones|hormones|mesh-ancestor
2574126|NCT01619332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2574127|NCT01619332|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2419484|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2419485|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2419486|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
2419487|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
2419488|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
2419489|NCT00803764|Naproxen|naproxen|mesh-list
2419490|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2419491|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419492|NCT00803764|Analgesics|analgesics|mesh-ancestor
2419493|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
2419494|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419495|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419496|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419497|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2129687|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2129688|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2129689|NCT02973048|Bupivacaine|bupivacaine|mesh-list
2129690|NCT02973048|Prilocaine|prilocaine|mesh-list
2129691|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
2129692|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
2129693|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2574128|NCT01619332|Protease Inhibitors|protease inhibitors|mesh-ancestor
2574129|NCT01619332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574130|NCT01619332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574131|NCT01619436|Clonidine|clonidine|mesh-list
2574132|NCT01619436|Analgesics|analgesics|mesh-ancestor
2574133|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
2129694|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129695|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
2129696|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129697|NCT02973087|Factor VIII|factor viii|mesh-list
2129698|NCT02973087|Coagulants|coagulants|mesh-ancestor
2574134|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574135|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574136|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2574137|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
2574138|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
2574139|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2574140|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2574141|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2574142|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
2574143|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574144|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574145|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2574146|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
2574147|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574148|NCT01619527|Darunavir|darunavir|mesh-list
2574149|NCT01619527|Cobicistat|cobicistat|mesh-list
2574150|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2574151|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2574152|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
2574153|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574154|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574155|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2574156|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2129699|NCT02973100|Dulaglutide|dulaglutide|mesh-list
2129700|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2129701|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129702|NCT02973321|Metformin|metformin|mesh-list
2129703|NCT02973321|Liraglutide|liraglutide|mesh-list
2129704|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2129705|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129706|NCT02973321|Incretins|incretins|mesh-ancestor
2419498|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
2574157|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
2574158|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574159|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2574160|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2574161|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2574162|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2574163|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2574164|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2574165|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574166|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574167|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574168|NCT01619566|Analgesics|analgesics|mesh-ancestor
2574169|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
2574170|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574171|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
2574172|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2574173|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
2574174|NCT01619644|Valproic Acid|valproic acid|mesh-list
2574175|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
2574176|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574177|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574178|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
2574179|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574180|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574181|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
2574182|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2574183|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2574184|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2574185|NCT01619683|Enclomiphene|enclomiphene|mesh-list
2574186|NCT01619683|Clomiphene|clomiphene|mesh-list
2574187|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
2574188|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2574189|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
2574190|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2574191|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574192|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2574193|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
2574194|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2419499|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2419500|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419501|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419502|NCT00803803|Pilocarpine|pilocarpine|mesh-list
2574195|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2574196|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2574197|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
2574198|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
2574199|NCT01619761|Melphalan|melphalan|mesh-list
2574200|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
2574201|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2574202|NCT01619761|Rituximab|rituximab|mesh-list
2574203|NCT01619761|Fludarabine|fludarabine|mesh-list
2574204|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
2574205|NCT01619761|Lenalidomide|lenalidomide|mesh-list
2574206|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2574207|NCT01619761|Tacrolimus|tacrolimus|mesh-list
2574208|NCT01619761|Antibodies|antibodies|mesh-list
2129707|NCT02973321|Hormones|hormones|mesh-ancestor
2129708|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129709|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
2129710|NCT02973477|Glimepiride|glimepiride|mesh-list
2129711|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2129712|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129713|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2129714|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129715|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2129716|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2574209|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
2574210|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2419503|NCT00803803|Miotics|miotics|mesh-ancestor
2419504|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
2419505|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419506|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419507|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2419508|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2419509|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
2129717|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
2129718|NCT02973503|Grazoprevir|grazoprevir|mesh-list
2129719|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
2129720|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129721|NCT02974010|Cycloserine|cycloserine|mesh-list
2129722|NCT02974010|Ketamine|ketamine|mesh-list
2129723|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2574211|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2574212|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
2574213|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574214|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2574215|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2574216|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
2574217|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574218|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574219|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2574220|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2574221|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
2574222|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2574223|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574224|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2574225|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2574226|NCT01619761|Growth Substances|growth substances|mesh-ancestor
2574227|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
2574228|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2574229|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2574230|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
2574231|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2574232|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574233|NCT01619813|Prednisone|prednisone|mesh-list
2574234|NCT01619813|Docetaxel|docetaxel|mesh-list
2574235|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574236|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
2574237|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
2574238|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
2574239|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574240|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2574241|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
2574242|NCT01619813|Hormones|hormones|mesh-ancestor
2574243|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2574244|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574245|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2574246|NCT01619891|Vitamin D|vitamin d|mesh-list
2574247|NCT01619891|Vitamins|vitamins|mesh-ancestor
2574248|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
2574249|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574250|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2574251|NCT01620112|Lidocaine|lidocaine|mesh-list
2574252|NCT01620112|Clonidine|clonidine|mesh-list
2574253|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
2574254|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
2574255|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2574256|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574257|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
2574258|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574259|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2574260|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2574261|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2574262|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2574263|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574264|NCT01620112|Analgesics|analgesics|mesh-ancestor
2129724|NCT02974010|Analgesics|analgesics|mesh-ancestor
2129725|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
2129726|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129727|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129728|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2129729|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2129730|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
2129731|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
2129732|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2129733|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2129734|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2129735|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129736|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574265|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2129737|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2129738|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129739|NCT02974010|Renal Agents|renal agents|mesh-ancestor
2129740|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2129741|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
2129742|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2129743|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
2129744|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2129745|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2129746|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2129747|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2129748|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2129749|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2574266|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
2574267|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
2574268|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2574269|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2574270|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2574271|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
2574272|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574273|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2574274|NCT01620229|Antibodies|antibodies|mesh-list
2574275|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
2574276|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2574277|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
2574278|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
2574279|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574280|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2574281|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574282|NCT01620268|Leflunomide|leflunomide|mesh-list
2574283|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574284|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574285|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2574286|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
2574287|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574288|NCT01620307|Sirolimus|sirolimus|mesh-list
2574289|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2574290|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574291|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2574292|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574293|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
2129750|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
2129751|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2129752|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2129753|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
2129754|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2129755|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2129756|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
2129757|NCT02974114|Acetaminophen|acetaminophen|mesh-list
2129758|NCT02974114|Caffeine|caffeine|mesh-list
2129759|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2129760|NCT02974114|Analgesics|analgesics|mesh-ancestor
2129761|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
2129762|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129763|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129764|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
2129765|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2129766|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2129767|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129768|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129769|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2129770|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2129771|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
2129772|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129773|NCT02974868|PF-06700841|pf-06700841|mesh-list
2129774|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2129775|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129776|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129777|NCT02975206|Serlopitant|serlopitant|mesh-list
2129778|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2129779|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129780|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129781|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129782|NCT02975297|Exenatide|exenatide|mesh-list
2574294|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2574295|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
2574296|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574297|NCT01620320|Dobutamine|dobutamine|mesh-list
2574298|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2574299|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
2574300|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
2574301|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574302|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574303|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2574304|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2574305|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2574306|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
2129783|NCT02975297|Nicotine|nicotine|mesh-list
2129784|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2129785|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
2129786|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129787|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129788|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2129789|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2129790|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
2129791|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129792|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129793|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2129794|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2129795|NCT02975297|Incretins|incretins|mesh-ancestor
2129796|NCT02975297|Hormones|hormones|mesh-ancestor
2129797|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129798|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2574307|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574308|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574309|NCT01620320|Protective Agents|protective agents|mesh-ancestor
2574310|NCT01620333|Insulin|insulin|mesh-list
2574311|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2574312|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
2574313|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
2129799|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
2129800|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2129801|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
2129802|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129803|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2129804|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
2129805|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2129806|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2129807|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2129808|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2129809|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
2129810|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574314|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2574315|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
2574316|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2129811|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129812|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129813|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2129814|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2129815|NCT02976103|Analgesics|analgesics|mesh-list
2129816|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
2129817|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129818|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129819|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
2129820|NCT02977507|Hydroquinone|hydroquinone|mesh-list
2129821|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2129822|NCT02977507|Protective Agents|protective agents|mesh-ancestor
2574317|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574318|NCT01620424|Insulin|insulin|mesh-list
2574319|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2574320|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
2574321|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
2574322|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2574323|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
2574324|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2574325|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2574326|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129823|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129824|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
2574327|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
2574328|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
2574329|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2574330|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574331|NCT01620450|Insulin|insulin|mesh-list
2574332|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2574333|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2574334|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574335|NCT01620463|Liraglutide|liraglutide|mesh-list
2574336|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2574337|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574338|NCT01620463|Incretins|incretins|mesh-ancestor
2574339|NCT01620463|Hormones|hormones|mesh-ancestor
2574340|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2574341|NCT01620476|Liraglutide|liraglutide|mesh-list
2574342|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2574343|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129825|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
2129826|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129827|NCT02978157|Amoxicillin|amoxicillin|mesh-list
2129828|NCT02978157|Levofloxacin|levofloxacin|mesh-list
2574344|NCT01620476|Incretins|incretins|mesh-ancestor
2574345|NCT01620476|Hormones|hormones|mesh-ancestor
2574346|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2574347|NCT01620684|Metyrapone|metyrapone|mesh-list
2574348|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
2574349|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574350|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129829|NCT02978157|Ofloxacin|ofloxacin|mesh-list
2129830|NCT02978157|Tetracycline|tetracycline|mesh-list
2129831|NCT02978157|Esomeprazole|esomeprazole|mesh-list
2129832|NCT02978157|Bismuth|bismuth|mesh-list
2129833|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2129834|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129835|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2129836|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2129837|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2129838|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129839|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129840|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2129841|NCT02978157|Renal Agents|renal agents|mesh-ancestor
2129842|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2129843|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2129844|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129845|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2129846|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2129847|NCT02978157|Antacids|antacids|mesh-ancestor
2129848|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2129849|NCT02978339|Curcumin|curcumin|mesh-list
2129850|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2129851|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2129852|NCT02978339|Analgesics|analgesics|mesh-ancestor
2129853|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
2129854|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129855|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129856|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2129857|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2129858|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129859|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129860|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129861|NCT02978417|Naltrexone|naltrexone|mesh-list
2129862|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2129863|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2129864|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129865|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
2129866|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574351|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
2574352|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2129867|NCT02978508|Permethrin|permethrin|mesh-list
2129868|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129869|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129870|NCT02979197|Celecoxib|celecoxib|mesh-list
2129871|NCT02979197|Amlodipine|amlodipine|mesh-list
2129872|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2129873|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2129874|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2129875|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129876|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2129877|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129878|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
2129879|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2129880|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2129881|NCT02979197|Analgesics|analgesics|mesh-ancestor
2129882|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
2574353|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2574354|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
2574355|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574356|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2574357|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2574358|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129883|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129884|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2129885|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2129886|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2129887|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2129888|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129889|NCT02979301|Tamoxifen|tamoxifen|mesh-list
2129890|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2129891|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
2129892|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129893|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129894|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2129895|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129896|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2129897|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2129898|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2129899|NCT02979431|Gontivimab|gontivimab|mesh-list
2129900|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
2129901|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129902|NCT02979522|Doxorubicin|doxorubicin|mesh-list
2129903|NCT02979522|Dacarbazine|dacarbazine|mesh-list
2129904|NCT02979522|Vinblastine|vinblastine|mesh-list
2129905|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2129906|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2129907|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129908|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2129909|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2129910|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129911|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129912|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2129913|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
2129914|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2129915|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
2129916|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
2129917|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
2574359|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574360|NCT01620788|Losartan|losartan|mesh-list
2574361|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2574362|NCT01620788|Indapamide|indapamide|mesh-list
2574363|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2574364|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2574365|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2574366|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2574367|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574368|NCT01620788|Diuretics|diuretics|mesh-ancestor
2574369|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
2574370|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574371|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2574372|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2574373|NCT01620814|Misoprostol|misoprostol|mesh-list
2574374|NCT01620814|Dinoprostone|dinoprostone|mesh-list
2574375|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2574376|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
2574377|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2574378|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574379|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2574380|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2574381|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
2574382|NCT01620840|Lacosamide|lacosamide|mesh-list
2574383|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
2574384|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2129918|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2129919|NCT02979535|Vaccines|vaccines|mesh-list
2129920|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
2129921|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129922|NCT02980042|Rituximab|rituximab|mesh-list
2129923|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
2129924|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2129925|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129926|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
2129927|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129928|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2129929|NCT02980133|Fluticasone|fluticasone|mesh-list
2129930|NCT02980133|Xhance|xhance|mesh-list
2129931|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2129932|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2129933|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2129934|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
2129935|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129936|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129937|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2129938|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
2129939|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
2129940|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2129941|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2129942|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2129943|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2129944|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
2129945|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574385|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2574386|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2574387|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574388|NCT01620944|Ritonavir|ritonavir|mesh-list
2574389|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2574390|NCT01620944|Tenofovir|tenofovir|mesh-list
2574391|NCT01620944|Lamivudine|lamivudine|mesh-list
2574392|NCT01620944|Emtricitabine|emtricitabine|mesh-list
2574393|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2574394|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2574395|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
2574396|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574397|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574398|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2574399|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2574400|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
2574401|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574402|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2574403|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2574404|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2574405|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2574406|NCT01621022|Bupropion|bupropion|mesh-list
2574407|NCT01621022|Nicotine|nicotine|mesh-list
2574408|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2574409|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
2574410|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574411|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574412|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2574413|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2574414|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
2574415|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574416|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574417|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2574418|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
2574419|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2574420|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2574421|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2574422|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2574423|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
2574424|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2129946|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129947|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
2129948|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
2129949|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
2129950|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2129951|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
2129952|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2129953|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2129954|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2129955|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2129956|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2129957|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129958|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129959|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2129960|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129961|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2129962|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
2129963|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
2129964|NCT02980523|Protective Agents|protective agents|mesh-ancestor
2129965|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
2129966|NCT02980666|Teduglutide|teduglutide|mesh-list
2129967|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2129968|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2129969|NCT02980666|Protective Agents|protective agents|mesh-ancestor
2129970|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129971|NCT02980783|Lidocaine|lidocaine|mesh-list
2129972|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
2129973|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
2129974|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2129975|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129976|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
2129977|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2129978|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2129979|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2129980|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2129981|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2129982|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2129983|NCT02980874|Triamcinolone|triamcinolone|mesh-list
2129984|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2129985|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2129986|NCT02980874|Aflibercept|aflibercept|mesh-list
2129987|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2129988|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2129989|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
2129990|NCT02980874|Hormones|hormones|mesh-ancestor
2129991|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2129992|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2129993|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2129994|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
2129995|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2129996|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574425|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2574426|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574427|NCT01621100|Hydromorphone|hydromorphone|mesh-list
2574428|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2574429|NCT01621100|Narcotics|narcotics|mesh-ancestor
2574430|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2574431|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574432|NCT01621100|Analgesics|analgesics|mesh-ancestor
2574433|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
2574434|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574435|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
2574436|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2574437|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2574438|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574439|NCT01621165|Prazosin|prazosin|mesh-list
2574440|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2574441|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2574442|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2574443|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2574444|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
2574445|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2129997|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2129998|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2129999|NCT02980874|Growth Substances|growth substances|mesh-ancestor
2130000|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
2130001|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130002|NCT02981342|Gemcitabine|gemcitabine|mesh-list
2130003|NCT02981342|Capecitabine|capecitabine|mesh-list
2130004|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2130005|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
2184855|NCT00002833|Hormones|hormones|mesh-ancestor
2574446|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574447|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574448|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
2574449|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2574450|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
2574451|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2574452|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
2574453|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574454|NCT01621217|Cetuximab|cetuximab|mesh-list
2574455|NCT01621217|Mitomycins|mitomycins|mesh-list
2574456|NCT01621217|Mitomycin|mitomycin|mesh-list
2574457|NCT01621217|Fluorouracil|fluorouracil|mesh-list
2574458|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2574459|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574460|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2574461|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
2574462|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574463|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2574464|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574465|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
2574466|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2574467|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2574468|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
2574469|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574470|NCT01621243|Gemcitabine|gemcitabine|mesh-list
2574471|NCT01621243|Paclitaxel|paclitaxel|mesh-list
2574472|NCT01621243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2574473|NCT01621243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2574474|NCT01621243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574475|NCT01621243|Tubulin Modulators|tubulin modulators|mesh-ancestor
2574476|NCT01621243|Antimitotic Agents|antimitotic agents|mesh-ancestor
2574477|NCT01621243|Mitosis Modulators|mitosis modulators|mesh-ancestor
2574478|NCT01621243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574479|NCT01621243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2130006|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130007|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130008|NCT02981342|Antiviral Agents|antiviral agents|mesh-ancestor
2130009|NCT02981342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2130010|NCT02981342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130011|NCT02981342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2130012|NCT02981342|Immunologic Factors|immunologic factors|mesh-ancestor
2130013|NCT02981342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130014|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
2130015|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
2130016|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
2574480|NCT01621243|Antimetabolites|antimetabolites|mesh-ancestor
2574481|NCT01621243|Antiviral Agents|antiviral agents|mesh-ancestor
2574482|NCT01621243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574483|NCT01621243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574484|NCT01621243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2574485|NCT01621243|Immunologic Factors|immunologic factors|mesh-ancestor
2574486|NCT01621243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574487|NCT01621256|Ancrod|ancrod|mesh-list
2574488|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
2574489|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2574490|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2574491|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574492|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2130017|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130018|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2130019|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2130020|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2130021|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
2130022|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130023|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130024|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2130025|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2130026|NCT02982590|Warfarin|warfarin|mesh-list
2130027|NCT02982590|Apixaban|apixaban|mesh-list
2130028|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
2130029|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2130030|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
2130031|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2574493|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2574494|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574495|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2574496|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
2574497|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574498|NCT01621308|Insulin|insulin|mesh-list
2130032|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
2130033|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130034|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130035|NCT02982772|Nicotine|nicotine|mesh-list
2130036|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2130037|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
2130038|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130039|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130040|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2130041|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2130042|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
2130043|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130044|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130045|NCT02982954|Nivolumab|nivolumab|mesh-list
2130046|NCT02982954|Ipilimumab|ipilimumab|mesh-list
2130047|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2130048|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130049|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2574499|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2574500|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574501|NCT01621321|Voriconazole|voriconazole|mesh-list
2574502|NCT01621321|Prednisolone|prednisolone|mesh-list
2574503|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2574504|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
2574505|NCT01621321|Hormones|hormones|mesh-ancestor
2574506|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2574507|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574508|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2574509|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574510|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
2574511|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574512|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2574513|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2574514|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574515|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574516|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2574517|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
2574518|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2574519|NCT01621373|Propofol|propofol|mesh-list
2574520|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2574521|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2574522|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574523|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2574524|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
2130050|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130051|NCT02983604|Fulvestrant|fulvestrant|mesh-list
2130052|NCT02983604|Exemestane|exemestane|mesh-list
2130053|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2130054|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130055|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2130056|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2130057|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
2130058|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130059|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130060|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2130061|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2130062|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130063|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130067|NCT02983981|Desoximetasone|desoximetasone|mesh-list
2130068|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2574525|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
2574526|NCT01621386|Prednisone|prednisone|mesh-list
2574527|NCT01621386|Montelukast|montelukast|mesh-list
2574528|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2574529|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
2574530|NCT01621386|Hormones|hormones|mesh-ancestor
2574531|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130069|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
2130070|NCT02983981|Hormones|hormones|mesh-ancestor
2130071|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130072|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130073|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
2130074|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2130075|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130076|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2130077|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130078|NCT02984982|Anticoagulants|anticoagulants|mesh-list
2130079|NCT02984982|Atorvastatin|atorvastatin|mesh-list
2130080|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2130081|NCT02984982|Ezetimibe|ezetimibe|mesh-list
2130082|NCT02984982|Fenofibrate|fenofibrate|mesh-list
2130083|NCT02984982|Bezafibrate|bezafibrate|mesh-list
2130084|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2130085|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2130086|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
2130087|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574532|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574533|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2574534|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574535|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2574536|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
2574537|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2574538|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
2574539|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2574540|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2574541|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574542|NCT01621451|Aspirin|aspirin|mesh-list
2574543|NCT01621451|Clopidogrel|clopidogrel|mesh-list
2130088|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2130089|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2130090|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130091|NCT02985021|Carboplatin|carboplatin|mesh-list
2130092|NCT02985021|Docetaxel|docetaxel|mesh-list
2130093|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130094|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
2130095|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
2130096|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
2130097|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130098|NCT02985879|Tilavonemab|tilavonemab|mesh-list
2130099|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
2574544|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2574545|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2574546|NCT01621451|Analgesics|analgesics|mesh-ancestor
2574547|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
2574548|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574549|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574550|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2574551|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2574552|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2574553|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2574554|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574555|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2574556|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2574557|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574558|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
2574559|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2574560|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2574561|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2574562|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
2574563|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574564|NCT01621568|Sunitinib|sunitinib|mesh-list
2574565|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574566|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2574567|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2574568|NCT01621568|Growth Substances|growth substances|mesh-ancestor
2574569|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574570|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
2574571|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2574572|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130100|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2574573|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574574|NCT01621620|Yohimbine|yohimbine|mesh-list
2574575|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
2574576|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
2574577|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574578|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574579|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2574580|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2574581|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2574582|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
2574583|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574584|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574585|NCT01621620|Urological Agents|urological agents|mesh-ancestor
2574586|NCT01621698|Fentanyl|fentanyl|mesh-list
2574587|NCT01621698|Bupivacaine|bupivacaine|mesh-list
2574588|NCT01621698|Propofol|propofol|mesh-list
2574589|NCT01621698|Atracurium|atracurium|mesh-list
2574590|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
2574591|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
2574592|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2574593|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574594|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
2574595|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574596|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2574597|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2574598|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
2574599|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2574600|NCT01621698|Narcotics|narcotics|mesh-ancestor
2574601|NCT01621698|Analgesics|analgesics|mesh-ancestor
2574602|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2574603|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2574604|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2574605|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2574606|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2574607|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2574608|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
2574609|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574610|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574611|NCT01621750|Clopidogrel|clopidogrel|mesh-list
2574612|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2574613|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2574614|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2574615|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2574616|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
2574617|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574618|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574619|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130101|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2130102|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2130103|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2130104|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130105|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130106|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
2130107|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2130108|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2574620|NCT01621763|Clopidogrel|clopidogrel|mesh-list
2574621|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2574622|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2574623|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2574624|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2574625|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
2130109|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2130110|NCT02986139|Etanercept|etanercept|mesh-list
2130111|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2130112|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2130113|NCT02986139|Analgesics|analgesics|mesh-ancestor
2130114|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
2130115|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130116|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130117|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2130118|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2130119|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2130120|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2130121|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
2130122|NCT02987543|Olaparib|olaparib|mesh-list
2130123|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
2130124|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2574626|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574627|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574628|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574629|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
2574630|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2574631|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2574632|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574633|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2574634|NCT01621893|Calcium|calcium|mesh-list
2574635|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2574636|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574637|NCT01621906|Alovudine|alovudine|mesh-list
2574638|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
2130125|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130126|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130127|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130128|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2130129|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
2574639|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574640|NCT01621971|Milrinone|milrinone|mesh-list
2574641|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2574642|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2574643|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
2574644|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2574645|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2574646|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574647|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574648|NCT01621971|Protective Agents|protective agents|mesh-ancestor
2419510|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419511|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419512|NCT00803816|Everolimus|everolimus|mesh-list
2419513|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419514|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2130130|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130131|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130132|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2130133|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
2130134|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
2130135|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
2419515|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
2419516|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574649|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574650|NCT01622075|Paclitaxel|paclitaxel|mesh-list
2574651|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2574652|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2574653|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574654|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
2574655|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
2574656|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
2574657|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419517|NCT00803829|Sulfalene|sulfalene|mesh-list
2419518|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419519|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2419520|NCT00803829|Renal Agents|renal agents|mesh-ancestor
2419521|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
2419522|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2419523|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2419524|NCT00803842|Doxycycline|doxycycline|mesh-list
2419525|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2419526|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419527|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
2419528|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2419529|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2419530|NCT00803868|Varenicline|varenicline|mesh-list
2419531|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2419532|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2419533|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
2419534|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419535|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574658|NCT01622088|Pramipexole|pramipexole|mesh-list
2574659|NCT01622088|Antioxidants|antioxidants|mesh-ancestor
2574660|NCT01622088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574661|NCT01622088|Protective Agents|protective agents|mesh-ancestor
2574662|NCT01622088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574663|NCT01622088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2574664|NCT01622088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2574665|NCT01622088|Dopamine Agonists|dopamine agonists|mesh-ancestor
2574666|NCT01622088|Dopamine Agents|dopamine agents|mesh-ancestor
2574667|NCT01622088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574668|NCT01622283|Cetirizine|cetirizine|mesh-list
2574669|NCT01622283|Levocetirizine|levocetirizine|mesh-list
2574670|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2574671|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2574672|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2574673|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
2574674|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
2574675|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574676|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574677|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574678|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
2574679|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2574680|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
2574681|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
2574682|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2574683|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574684|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2574685|NCT01622322|Analgesics|analgesics|mesh-ancestor
2574686|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
2574687|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574698|NCT01622361|Tamoxifen|tamoxifen|mesh-list
2574699|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
2574700|NCT01622361|Docetaxel|docetaxel|mesh-list
2574701|NCT01622361|Doxorubicin|doxorubicin|mesh-list
2574702|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2574703|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2130136|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130137|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130138|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2130139|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
2130140|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574704|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
2574705|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574706|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2574707|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2574708|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
2574709|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574710|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574711|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2574712|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
2574713|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
2574714|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
2574715|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2574716|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2574717|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2574718|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574719|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2574720|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
2574721|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2574722|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2574723|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2574724|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2574725|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2574726|NCT01622439|Prednisone|prednisone|mesh-list
2130141|NCT02988050|Lidocaine|lidocaine|mesh-list
2130142|NCT02988050|Epinephrine|epinephrine|mesh-list
2130143|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
2130144|NCT02988050|Remifentanil|remifentanil|mesh-list
2130145|NCT02988050|Bupivacaine|bupivacaine|mesh-list
2130146|NCT02988050|Propofol|propofol|mesh-list
2130147|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
2130148|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
2130149|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2130150|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130151|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
2130152|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130153|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2130154|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2130155|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2130156|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2130157|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130158|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2130159|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2130160|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
2130161|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2130162|NCT02988050|Analgesics|analgesics|mesh-ancestor
2130163|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2574727|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
2574728|NCT01622439|Rituximab|rituximab|mesh-list
2574729|NCT01622439|Doxorubicin|doxorubicin|mesh-list
2574730|NCT01622439|Vincristine|vincristine|mesh-list
2574731|NCT01622439|Valproic Acid|valproic acid|mesh-list
2574732|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2574733|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
2574734|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130164|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2130165|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2130166|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
2130167|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130168|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2130169|NCT02988050|Narcotics|narcotics|mesh-ancestor
2130170|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2130171|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2130172|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
2130173|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2130174|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
2130175|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
2130176|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
2130177|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2130178|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2130179|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2130180|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
2130181|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130182|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2130183|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574735|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2574736|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2574737|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
2574738|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574739|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574740|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2574741|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2574742|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2574743|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2574744|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2574745|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574746|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2574747|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
2574748|NCT01622439|Hormones|hormones|mesh-ancestor
2574749|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2574750|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2574751|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2574752|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
2574753|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
2574754|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
2574755|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
2574756|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
2130184|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2574757|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574758|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
2130185|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130186|NCT02988219|Epinephrine|epinephrine|mesh-list
2130187|NCT02988219|Fentanyl|fentanyl|mesh-list
2130188|NCT02988219|Bupivacaine|bupivacaine|mesh-list
2130189|NCT02988219|Anesthetics|anesthetics|mesh-list
2130190|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
2574759|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2574760|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2574761|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2574762|NCT01622504|Naloxone|naloxone|mesh-list
2574763|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2574764|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574765|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
2574766|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574767|NCT01622556|Fludarabine|fludarabine|mesh-list
2574768|NCT01622556|Busulfan|busulfan|mesh-list
2574769|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
2574770|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574771|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574772|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2574773|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
2574774|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130191|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2130192|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574775|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
2574776|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2574777|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2574778|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2574779|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2574780|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2574781|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
2574782|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574783|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2130193|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
2130194|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130195|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2130196|NCT02988219|Narcotics|narcotics|mesh-ancestor
2130197|NCT02988219|Analgesics|analgesics|mesh-ancestor
2574784|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2574785|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574786|NCT01622790|Lamivudine|lamivudine|mesh-list
2574787|NCT01622790|Abacavir|abacavir|mesh-list
2574788|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
2574789|NCT01622790|Dolutegravir|dolutegravir|mesh-list
2574790|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2574791|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2574792|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574793|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130198|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2130199|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2130200|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
2130201|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2130202|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2130203|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
2130204|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130205|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130206|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2130207|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2130208|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
2130209|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2130210|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
2130211|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
2130212|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
2130213|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2130214|NCT02988349|Listerine|listerine|mesh-list
2130215|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
2130216|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
2574794|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
2574795|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574796|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2574797|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2574798|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
2574799|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2574800|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2130217|NCT02988349|Protective Agents|protective agents|mesh-ancestor
2130218|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130219|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2574801|NCT01622881|Nefopam|nefopam|mesh-list
2574802|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2574803|NCT01622881|Analgesics|analgesics|mesh-ancestor
2574804|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
2574805|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574806|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574807|NCT01622933|Interferons|interferons|mesh-list
2130220|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2130221|NCT02988843|Bevacizumab|bevacizumab|mesh-list
2130222|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2130223|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2130224|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130225|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2130226|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2574808|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
2574809|NCT01622933|Vaccines|vaccines|mesh-list
2574810|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574811|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
2574812|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574813|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
2574814|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574815|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
2574816|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2574817|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2574818|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574819|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
2574820|NCT01622946|Coagulants|coagulants|mesh-ancestor
2574821|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2574822|NCT01622972|Laxatives|laxatives|mesh-ancestor
2574823|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2574824|NCT01622998|Nicotine|nicotine|mesh-list
2574825|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2574826|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
2574827|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574828|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574829|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2574830|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2574831|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
2574832|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574833|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574834|NCT01623024|Vitamin D|vitamin d|mesh-list
2130227|NCT02988843|Growth Substances|growth substances|mesh-ancestor
2130228|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130229|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
2130230|NCT02988882|Dexamethasone|dexamethasone|mesh-list
2130231|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2130232|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
2130233|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
2130234|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574835|NCT01623024|Vitamins|vitamins|mesh-ancestor
2574836|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
2574837|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574838|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2574839|NCT01623102|Gemcitabine|gemcitabine|mesh-list
2574840|NCT01623102|Bevacizumab|bevacizumab|mesh-list
2574841|NCT01623102|Cisplatin|cisplatin|mesh-list
2574842|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2130235|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130236|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2130237|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
2130238|NCT02988882|Hormones|hormones|mesh-ancestor
2130239|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130240|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2130241|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130242|NCT02988986|Tamoxifen|tamoxifen|mesh-list
2130243|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2130244|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
2574843|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574844|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2574845|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2574846|NCT01623102|Growth Substances|growth substances|mesh-ancestor
2574847|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574848|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
2130245|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2574849|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2574850|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
2574851|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130246|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130247|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2130248|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130249|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2130250|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2130251|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2130252|NCT02989389|Itraconazole|itraconazole|mesh-list
2130253|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
2574852|NCT01623102|Antiviral Agents|antiviral agents|mesh-ancestor
2574853|NCT01623102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574854|NCT01623102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574855|NCT01623102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2574856|NCT01623102|Immunologic Factors|immunologic factors|mesh-ancestor
2574857|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2574858|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
2574859|NCT01623206|Coagulants|coagulants|mesh-ancestor
2574860|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2574861|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
2574862|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574863|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2574864|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2574865|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574866|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2574867|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2574868|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
2574869|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
2574870|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574871|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
2574872|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574873|NCT01623349|Olaparib|olaparib|mesh-list
2574874|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2574875|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574876|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574877|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574878|NCT01623362|Fluorides|fluorides|mesh-list
2130254|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2130255|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2574879|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
2574880|NCT01623362|Protective Agents|protective agents|mesh-ancestor
2574881|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574882|NCT01623375|Insulin|insulin|mesh-list
2574883|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2574884|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
2574885|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2574886|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574887|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
2574888|NCT01623401|Tedizolid|tedizolid|mesh-list
2130256|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2130257|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130258|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130259|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2130260|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
2130261|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130262|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130263|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2130264|NCT02989493|Doxazosin|doxazosin|mesh-list
2130265|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2130266|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2130267|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2130268|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2130269|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
2130270|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130271|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130272|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130273|NCT02989649|Metformin|metformin|mesh-list
2574889|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2574890|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574891|NCT01623440|Naltrexone|naltrexone|mesh-list
2574892|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2574893|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2574894|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574895|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
2574896|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574897|NCT01623505|Varenicline|varenicline|mesh-list
2574898|NCT01623505|Nicotine|nicotine|mesh-list
2574899|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2574900|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2574901|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
2574902|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574903|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130274|NCT02989649|Pioglitazone|pioglitazone|mesh-list
2130275|NCT02989649|Alogliptin|alogliptin|mesh-list
2130276|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2130277|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130278|NCT02989649|Incretins|incretins|mesh-ancestor
2130279|NCT02989649|Hormones|hormones|mesh-ancestor
2130280|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130281|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2130282|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
2130283|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130284|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130285|NCT02989714|Nivolumab|nivolumab|mesh-list
2130286|NCT02989714|Interleukin-2|interleukin-2|mesh-list
2130287|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2130288|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130289|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2130290|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130291|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2130292|NCT02989714|Analgesics|analgesics|mesh-ancestor
2130293|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
2130294|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130295|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130296|NCT02989727|Lamotrigine|lamotrigine|mesh-list
2130297|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
2130298|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2130299|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2130300|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130301|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2130302|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130303|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2130304|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2130305|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2130306|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2574904|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574905|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2574906|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
2574907|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574908|NCT01623570|Menotropins|menotropins|mesh-list
2574909|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2574910|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
2574911|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2574912|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574913|NCT01623609|Naloxegol|naloxegol|mesh-list
2574914|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2574915|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574916|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
2574917|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574918|NCT01623635|Ropivacaine|ropivacaine|mesh-list
2574919|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
2574920|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
2574921|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2574922|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574923|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
2574924|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574925|NCT01623713|Risperidone|risperidone|mesh-list
2574926|NCT01623713|Iloperidone|iloperidone|mesh-list
2574927|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2574928|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
2130307|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2130308|NCT02990338|Dexamethasone|dexamethasone|mesh-list
2130309|NCT02990338|Pomalidomide|pomalidomide|mesh-list
2130310|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2130311|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
2130312|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
2130313|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130314|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130315|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2130316|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
2130317|NCT02990338|Hormones|hormones|mesh-ancestor
2574929|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2574930|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574931|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574932|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2130318|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130319|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2130320|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130321|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
2130322|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2130323|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2130324|NCT02990338|Growth Substances|growth substances|mesh-ancestor
2130325|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
2130326|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
2130327|NCT02990910|Narcotics|narcotics|mesh-ancestor
2130328|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2130329|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130330|NCT02990910|Analgesics|analgesics|mesh-ancestor
2130331|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
2130332|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130333|NCT02991040|Lidocaine|lidocaine|mesh-list
2130334|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
2130335|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
2130336|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2130337|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130338|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
2130339|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130340|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2130341|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2130342|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2130343|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2130344|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130345|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2130346|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2130347|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
2130348|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130349|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2130350|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574933|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2574934|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2574935|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2574936|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2574937|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
2574938|NCT01623778|Interferons|interferons|mesh-list
2574939|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
2574940|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
2574941|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574942|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
2574943|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574944|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
2574945|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574946|NCT01623817|Vancomycin|vancomycin|mesh-list
2574947|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2574948|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2574949|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
2574950|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2574951|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574952|NCT01623921|Celecoxib|celecoxib|mesh-list
2130351|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2130352|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574953|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2574954|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2574955|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2130356|NCT02991859|Fluticasone|fluticasone|mesh-list
2130357|NCT02991859|Xhance|xhance|mesh-list
2130358|NCT02991859|Budesonide|budesonide|mesh-list
2130359|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2130360|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2130361|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
2130362|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130363|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130364|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2574956|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
2130365|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
2130366|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
2130367|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2130368|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
2130369|NCT02991859|Hormones|hormones|mesh-ancestor
2130370|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130371|NCT02992132|Pimavanserin|pimavanserin|mesh-list
2130372|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2130373|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2130374|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2130375|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2130376|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2130377|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130378|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2130379|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2130380|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2130381|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
2130382|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130383|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130384|NCT02992418|Vaccines|vaccines|mesh-list
2130385|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
2130386|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130387|NCT02993224|Deferasirox|deferasirox|mesh-list
2130388|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2130389|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
2130390|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
2130391|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130392|NCT02993250|Simeprevir|simeprevir|mesh-list
2130393|NCT02993250|Odalasvir|odalasvir|mesh-list
2130394|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
2130395|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2130396|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
2130397|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130398|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574957|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574958|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2574959|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2574960|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574961|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2574962|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2574963|NCT01623921|Analgesics|analgesics|mesh-ancestor
2574964|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
2574965|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2574966|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2574967|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2574968|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2574969|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2574970|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2574971|NCT01624025|Docetaxel|docetaxel|mesh-list
2574972|NCT01624025|Epirubicin|epirubicin|mesh-list
2574973|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574974|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
2574975|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
2574976|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
2574977|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574978|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2574979|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2574980|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2574981|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574982|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
2574983|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574984|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
2574985|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2574986|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2574987|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2574988|NCT01624051|Cisplatin|cisplatin|mesh-list
2574989|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2574990|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
2574991|NCT01624064|Enalapril|enalapril|mesh-list
2574992|NCT01624064|Calcium|calcium|mesh-list
2574993|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2574994|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2574995|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2574996|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130399|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
2130400|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
2130401|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2130402|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130403|NCT02993302|Vitamins|vitamins|mesh-ancestor
2130404|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
2130405|NCT02993471|Vitamin K|vitamin k|mesh-list
2130406|NCT02993471|Midazolam|midazolam|mesh-list
2130407|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
2130408|NCT02993471|Caffeine|caffeine|mesh-list
2130409|NCT02993471|Ixekizumab|ixekizumab|mesh-list
2130410|NCT02993471|Omeprazole|omeprazole|mesh-list
2130411|NCT02993471|Warfarin|warfarin|mesh-list
2130412|NCT02993471|Vitamins|vitamins|mesh-ancestor
2130413|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
2130414|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130415|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2130416|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2130417|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2574997|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2574998|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
2574999|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575000|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2575001|NCT01624103|Lidocaine|lidocaine|mesh-list
2575002|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
2575003|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
2575004|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
2575005|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2575006|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575007|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
2575008|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575009|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2575010|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2575011|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2575012|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2575013|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575014|NCT01624116|Metformin|metformin|mesh-list
2575015|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2575016|NCT01624116|Acarbose|acarbose|mesh-list
2575017|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2575018|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575019|NCT01624116|Incretins|incretins|mesh-ancestor
2575020|NCT01624116|Hormones|hormones|mesh-ancestor
2575021|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2575022|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2575023|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
2575024|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575025|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575026|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2575027|NCT01624129|Fluticasone|fluticasone|mesh-list
2575028|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2575029|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2575030|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
2575031|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575032|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575033|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2575034|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
2575035|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
2575036|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2575037|NCT01624207|Atorvastatin|atorvastatin|mesh-list
2575038|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2575039|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2575040|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
2575041|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575042|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2575043|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2575044|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575045|NCT01624246|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2575046|NCT01624246|Avibactam|avibactam|mesh-list
2575047|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2575048|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575049|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2575050|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575051|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130418|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2130419|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2575052|NCT01624285|Sorafenib|sorafenib|mesh-list
2575053|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575054|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2575055|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130420|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2130421|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2130422|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
2130423|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
2130424|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
2130425|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
2130426|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130427|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130428|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
2130429|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2130430|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2130431|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2130432|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130433|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2130434|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2130435|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2130436|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2130437|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
2130438|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2130439|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2130440|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
2130441|NCT02993471|Coagulants|coagulants|mesh-ancestor
2130442|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
2130443|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
2130444|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2130445|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2130446|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
2130447|NCT02993731|Gemcitabine|gemcitabine|mesh-list
2130448|NCT02993731|Paclitaxel|paclitaxel|mesh-list
2130449|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2130450|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130451|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
2130452|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
2130453|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
2130454|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130455|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2575056|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575057|NCT01624337|Piperaquine|piperaquine|mesh-list
2575058|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
2575059|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2575060|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2575061|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575062|NCT01624428|Varenicline|varenicline|mesh-list
2575063|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2575064|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2575065|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
2575066|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575067|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575068|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575069|NCT01624441|Epirubicin|epirubicin|mesh-list
2575070|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2575071|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575072|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2130456|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
2130457|NCT02993731|Antiviral Agents|antiviral agents|mesh-ancestor
2130458|NCT02993731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2130459|NCT02993731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130460|NCT02993731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2130461|NCT02993731|Immunologic Factors|immunologic factors|mesh-ancestor
2130462|NCT02993731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130463|NCT02993757|Vaccines|vaccines|mesh-list
2130464|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
2130465|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130466|NCT02993783|Vedolizumab|vedolizumab|mesh-list
2575073|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2575074|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575075|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575076|NCT01624493|Gemcitabine|gemcitabine|mesh-list
2575077|NCT01624493|Carboplatin|carboplatin|mesh-list
2575078|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575079|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2130467|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2575080|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
2130468|NCT02993926|Leuprolide|leuprolide|mesh-list
2130469|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2130470|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
2575081|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575082|NCT01624493|Antiviral Agents|antiviral agents|mesh-ancestor
2575083|NCT01624493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575084|NCT01624493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575085|NCT01624493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2575086|NCT01624493|Immunologic Factors|immunologic factors|mesh-ancestor
2575087|NCT01624493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575088|NCT01624649|Methylphenidate|methylphenidate|mesh-list
2575089|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2575090|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2575091|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575092|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2575093|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2575094|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2575095|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575096|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
2130471|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2130472|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130473|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2130474|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130475|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
2130476|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2130477|NCT02994056|Velpatasvir|velpatasvir|mesh-list
2130478|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
2130479|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2130480|NCT02994394|Tolvaptan|tolvaptan|mesh-list
2130481|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2130482|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130483|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
2130484|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130485|NCT02994940|Acetaminophen|acetaminophen|mesh-list
2130486|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2130487|NCT02994940|Analgesics|analgesics|mesh-ancestor
2130488|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
2130489|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130490|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130491|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
2130492|NCT02995915|Bupropion|bupropion|mesh-list
2130493|NCT02995915|Nicotine|nicotine|mesh-list
2130494|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2130495|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
2130496|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130497|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130498|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2575097|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575098|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2575099|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
2575100|NCT01624675|Risperidone|risperidone|mesh-list
2575101|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2575102|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
2575103|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575104|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130499|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2130500|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
2130501|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130502|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130503|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2130504|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
2130505|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2130506|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2130507|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2130508|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2130509|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
2130510|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2130511|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2130512|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130513|NCT02996097|Triamcinolone|triamcinolone|mesh-list
2130514|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2130515|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2130516|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2575105|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575106|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2575107|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2575108|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2575109|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2575110|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2575111|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
2575112|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
2575113|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2130517|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2130518|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
2130519|NCT02996097|Hormones|hormones|mesh-ancestor
2130520|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130521|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130522|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2130523|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
2130524|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130525|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130526|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
2130527|NCT02996474|Decitabine|decitabine|mesh-list
2575114|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575115|NCT01624766|Denosumab|denosumab|mesh-list
2575116|NCT01624766|Everolimus|everolimus|mesh-list
2575117|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2575118|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575119|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2575120|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
2575121|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575122|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2575123|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2575124|NCT01624805|Cyclosporine|cyclosporine|mesh-list
2575125|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
2575126|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2575127|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2575128|NCT01624805|Prednisolone|prednisolone|mesh-list
2575129|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
2575130|NCT01624805|Lenograstim|lenograstim|mesh-list
2575131|NCT01624805|Cyclosporins|cyclosporins|mesh-list
2575132|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
2575133|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2575134|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2575135|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
2575136|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2575137|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
2575138|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575139|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575140|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575141|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2575142|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
2575143|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575144|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
2575145|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2575146|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2575147|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2575148|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
2575149|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
2575150|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575151|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2575152|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
2575153|NCT01624805|Hormones|hormones|mesh-ancestor
2575154|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2575155|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2575156|NCT01624805|Protective Agents|protective agents|mesh-ancestor
2130528|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2130529|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130530|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2130531|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
2130532|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130533|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130534|NCT02996500|Tofacitinib|tofacitinib|mesh-list
2130535|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2130536|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184917|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2575157|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2575158|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575159|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2575160|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2575161|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2575162|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
2575163|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575164|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2575165|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2130537|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130538|NCT02996591|Dexamethasone|dexamethasone|mesh-list
2575166|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575167|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2575168|NCT01625026|Cathartics|cathartics|mesh-ancestor
2575169|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2575170|NCT01625156|Sirolimus|sirolimus|mesh-list
2575171|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2575172|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575173|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2575174|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575175|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
2575176|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2575177|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
2575178|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575179|NCT01625234|Ensartinib|ensartinib|mesh-list
2575180|NCT01625234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575181|NCT01625234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2575182|NCT01625234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575183|NCT01625234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575184|NCT01625260|Gemcitabine|gemcitabine|mesh-list
2575185|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2575186|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
2575187|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575188|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575189|NCT01625260|Antiviral Agents|antiviral agents|mesh-ancestor
2575190|NCT01625260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575191|NCT01625260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575192|NCT01625260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2575193|NCT01625260|Immunologic Factors|immunologic factors|mesh-ancestor
2575194|NCT01625260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575195|NCT01625351|Sirolimus|sirolimus|mesh-list
2575196|NCT01625351|Fludarabine|fludarabine|mesh-list
2575197|NCT01625351|Melphalan|melphalan|mesh-list
2575198|NCT01625351|Busulfan|busulfan|mesh-list
2130539|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
2130540|NCT02996591|Midazolam|midazolam|mesh-list
2130541|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
2130542|NCT02996591|Ketamine|ketamine|mesh-list
2130543|NCT02996591|Bupivacaine|bupivacaine|mesh-list
2130544|NCT02996591|Mepivacaine|mepivacaine|mesh-list
2130545|NCT02996591|Anesthetics|anesthetics|mesh-list
2130546|NCT02996591|Propofol|propofol|mesh-list
2130547|NCT02996591|Sevoflurane|sevoflurane|mesh-list
2130548|NCT02996591|BB 1101|bb 1101|mesh-list
2130549|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2130550|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
2130551|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
2130552|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575199|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
2575200|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
2575201|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575202|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575203|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2575204|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
2575205|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575206|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2575207|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575208|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2575209|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
2575210|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2575211|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
2575212|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2575213|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2575214|NCT01625429|Paclitaxel|paclitaxel|mesh-list
2575215|NCT01625429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2575216|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2575217|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130553|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130554|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2575218|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
2575219|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
2575220|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
2575221|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575222|NCT01625494|Amlodipine|amlodipine|mesh-list
2575223|NCT01625494|Irbesartan|irbesartan|mesh-list
2575224|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2575225|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2575226|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2575227|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575228|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2575229|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575230|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
2575231|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2575232|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2575233|NCT01625520|Everolimus|everolimus|mesh-list
2575234|NCT01625520|Pasireotide|pasireotide|mesh-list
2575235|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575236|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2575237|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
2575238|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575239|NCT01625520|Hormones|hormones|mesh-ancestor
2575240|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2575241|NCT01625572|Morphine|morphine|mesh-list
2575242|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2575243|NCT01625572|Narcotics|narcotics|mesh-ancestor
2575244|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2575245|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575246|NCT01625572|Analgesics|analgesics|mesh-ancestor
2575247|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
2575248|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575255|NCT01625715|Ketotifen|ketotifen|mesh-list
2575256|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
2575257|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
2575258|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2575259|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
2575260|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
2575261|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575262|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575263|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575264|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2575265|NCT01625741|Rituximab|rituximab|mesh-list
2575266|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2130555|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
2130556|NCT02996591|Hormones|hormones|mesh-ancestor
2130557|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130558|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2130559|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130560|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
2130561|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130562|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130563|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
2130564|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2130565|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
2130566|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2130567|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2575267|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575268|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
2575269|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575270|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2575271|NCT01625793|Interferons|interferons|mesh-list
2575272|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
2575273|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575274|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
2575275|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575276|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
2575277|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575278|NCT01625806|Ketoconazole|ketoconazole|mesh-list
2575279|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
2575280|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575281|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2575282|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2575283|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575284|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575285|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2575286|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
2575287|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2575288|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575289|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2575290|NCT01625871|Lumefantrine|lumefantrine|mesh-list
2575291|NCT01625871|Artemether|artemether|mesh-list
2575292|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2575293|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
2575294|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2130568|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
2130569|NCT02996591|Analgesics|analgesics|mesh-ancestor
2130570|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2130571|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2130572|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2130573|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130574|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2130575|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2130576|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2130577|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2130578|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
2130579|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
2130580|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2130581|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2130582|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2130583|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2130584|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
2575295|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2575296|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575297|NCT01625936|Bevacizumab|bevacizumab|mesh-list
2575298|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2575299|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575300|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2575301|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2575302|NCT01625936|Growth Substances|growth substances|mesh-ancestor
2130585|NCT02996682|Ribavirin|ribavirin|mesh-list
2130586|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2130587|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
2130588|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130589|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
2130590|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2130591|NCT02997163|Talazoparib|talazoparib|mesh-list
2130592|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2130593|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130594|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130595|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130596|NCT02997176|Talazoparib|talazoparib|mesh-list
2130597|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2130598|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130599|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130600|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130601|NCT02997722|Ketamine|ketamine|mesh-list
2130602|NCT02997722|Analgesics|analgesics|mesh-ancestor
2130603|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
2130604|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130605|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130606|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2130607|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2130608|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
2130609|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
2130610|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2130611|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2130612|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2130613|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130614|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130615|NCT02998151|Minocycline|minocycline|mesh-list
2130616|NCT02998151|Acamprosate|acamprosate|mesh-list
2130617|NCT02998151|Baclofen|baclofen|mesh-list
2130618|NCT02998151|Lovastatin|lovastatin|mesh-list
2130619|NCT02998151|L 647318|l 647318|mesh-list
2130620|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
2184918|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
2130621|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2130622|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2130623|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2130624|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130625|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2130626|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130627|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2130628|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
2130629|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
2130630|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130631|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130632|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2130633|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2130634|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
2130635|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2130636|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2130637|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130638|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2130639|NCT02998996|Endocine|endocine|mesh-list
2130640|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2130641|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
2130642|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130643|NCT02999100|Oxytocin|oxytocin|mesh-list
2130644|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
2130645|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2130646|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130647|NCT02999178|Nintedanib|nintedanib|mesh-list
2130648|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130649|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2130650|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130651|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130652|NCT02999633|Acetaminophen|acetaminophen|mesh-list
2130653|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
2130654|NCT02999633|Promethazine|promethazine|mesh-list
2130655|NCT02999633|Dexamethasone|dexamethasone|mesh-list
2130656|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
2130657|NCT02999633|Ranitidine|ranitidine|mesh-list
2130658|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2130659|NCT02999633|BB 1101|bb 1101|mesh-list
2130660|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2130661|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
2130662|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
2130663|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575303|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575304|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
2575305|NCT01626222|Everolimus|everolimus|mesh-list
2575306|NCT01626222|Exemestane|exemestane|mesh-list
2575307|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575308|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2575309|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
2575310|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575311|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2575312|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2575313|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575314|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575315|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2575316|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
2575317|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2575318|NCT01626339|Bevacizumab|bevacizumab|mesh-list
2575319|NCT01626339|Ranibizumab|ranibizumab|mesh-list
2575320|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2130664|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130665|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2130666|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
2130667|NCT02999633|Hormones|hormones|mesh-ancestor
2130668|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130669|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2130670|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130671|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
2130672|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575321|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575322|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2575323|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2575324|NCT01626339|Growth Substances|growth substances|mesh-ancestor
2130673|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130674|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2130675|NCT02999633|Analgesics|analgesics|mesh-ancestor
2575325|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575326|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
2575327|NCT01626443|Folic Acid|folic acid|mesh-list
2575328|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
2575329|NCT01626443|Inositol|inositol|mesh-list
2575330|NCT01626443|Hematinics|hematinics|mesh-ancestor
2575331|NCT01626443|Vitamins|vitamins|mesh-ancestor
2575332|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
2575333|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575334|NCT01626469|Captopril|captopril|mesh-list
2575335|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2575336|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
2575337|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575338|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575339|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2130676|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
2130677|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
2130678|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2130679|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2130680|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2130681|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
2130682|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
2130683|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2130684|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
2130685|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
2130686|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130687|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2130688|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
2130689|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
2130690|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2130691|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2130692|NCT02999672|Trastuzumab|trastuzumab|mesh-list
2130693|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2130694|NCT02999672|Maytansine|maytansine|mesh-list
2130695|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2130696|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130697|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2575340|NCT01626534|Clopidogrel|clopidogrel|mesh-list
2575341|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2575342|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2575343|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2575344|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2575345|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
2575346|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575347|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575348|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575349|NCT01626560|Vancomycin|vancomycin|mesh-list
2575350|NCT01626560|Daptomycin|daptomycin|mesh-list
2575351|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2575352|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575353|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
2575354|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2575355|NCT01626651|Ketoconazole|ketoconazole|mesh-list
2575356|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
2575357|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575358|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2575359|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2575360|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575361|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575362|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2130698|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
2130699|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
2130700|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
2130701|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130702|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2130703|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
2130704|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130705|NCT03000283|Conivaptan|conivaptan|mesh-list
2130706|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2130707|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130708|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
2575363|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
2130709|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130710|NCT03000309|Apremilast|apremilast|mesh-list
2575364|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2575365|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575366|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2575367|NCT01626911|Heparin|heparin|mesh-list
2575368|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2575369|NCT01626911|Tinzaparin|tinzaparin|mesh-list
2575370|NCT01626911|Dalteparin|dalteparin|mesh-list
2575371|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
2575372|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2575373|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2130711|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2130712|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2130713|NCT03000309|Analgesics|analgesics|mesh-ancestor
2130714|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
2130715|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130716|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130717|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2130718|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2130719|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2130720|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2130721|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130722|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130723|NCT03000348|Cysteamine|cysteamine|mesh-list
2130724|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2130725|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130726|NCT03000452|Durvalumab|durvalumab|mesh-list
2130727|NCT03000452|Daratumumab|daratumumab|mesh-list
2130728|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2130729|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130737|NCT03000673|Heparin|heparin|mesh-list
2130738|NCT03000673|Enoxaparin|enoxaparin|mesh-list
2130739|NCT03000673|Calcium heparin|calcium heparin|mesh-list
2130740|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
2130741|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2130742|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2130743|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130744|NCT03001011|Sevelamer|sevelamer|mesh-list
2130745|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
2130746|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
2130747|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130748|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2130749|NCT03001076|Ezetimibe|ezetimibe|mesh-list
2130750|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2130751|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2130752|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
2130753|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130754|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2130755|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130756|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2130757|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130758|NCT03001219|Methotrexate|methotrexate|mesh-list
2130759|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2130760|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
2130761|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2130762|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130763|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2130764|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
2130765|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130766|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575374|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575375|NCT01627041|Cytarabine|cytarabine|mesh-list
2575376|NCT01627041|Decitabine|decitabine|mesh-list
2575377|NCT01627041|Daunorubicin|daunorubicin|mesh-list
2575378|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2575379|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
2575380|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575381|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575382|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
2575383|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575384|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2575385|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
2575386|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575387|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2575388|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2575389|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2575390|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575391|NCT01627106|Amiodarone|amiodarone|mesh-list
2575392|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2575393|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
2575394|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2575395|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2575396|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575397|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2130767|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
2130768|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130769|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2130770|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2130771|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
2130772|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2130773|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2130774|NCT03001453|Epinephrine|epinephrine|mesh-list
2130775|NCT03001453|Bupivacaine|bupivacaine|mesh-list
2130776|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
2130777|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
2130778|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2130779|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130780|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
2130781|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130782|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2130783|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2575398|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2575399|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2575400|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575401|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2130784|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
2130785|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130786|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130787|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2130788|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2130789|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
2130790|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2130791|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
2130792|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
2130793|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
2130794|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2130795|NCT03001557|Lemborexant|lemborexant|mesh-list
2130796|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2130797|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130798|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575402|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2575403|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2575404|NCT01627132|Dasatinib|dasatinib|mesh-list
2575405|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575406|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2575407|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575408|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575409|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
2575410|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2575411|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2575412|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
2575413|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575414|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130799|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2130800|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2130801|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2130802|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130803|NCT03001843|Ketamine|ketamine|mesh-list
2130804|NCT03001843|Narcotics|narcotics|mesh-list
2130805|NCT03001843|Analgesics|analgesics|mesh-ancestor
2130806|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
2184919|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
2575415|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130807|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130808|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130809|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2130810|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2130811|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
2130812|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
2130813|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2130814|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2130815|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2130816|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130817|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130818|NCT03002012|Fluconazole|fluconazole|mesh-list
2130819|NCT03002012|Sertraline|sertraline|mesh-list
2130820|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
2130821|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2130822|NCT03002012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2575416|NCT01627145|Urological Agents|urological agents|mesh-ancestor
2575417|NCT01627158|Budesonide|budesonide|mesh-list
2575418|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
2575419|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2575420|NCT01627158|Charcoal|charcoal|mesh-list
2575421|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2575422|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2575423|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
2130823|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2130824|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2130825|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130826|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130827|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
2130828|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130829|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
2130830|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2130831|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2130832|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2130833|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130834|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2130835|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
2130836|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130837|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2130838|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2130839|NCT03002038|Rituximab|rituximab|mesh-list
2130840|NCT03002038|Azathioprine|azathioprine|mesh-list
2130841|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2575424|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575425|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575426|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2575427|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
2575428|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
2575429|NCT01627158|Hormones|hormones|mesh-ancestor
2575430|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2575431|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2575432|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2575433|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2575434|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
2575435|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575436|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575437|NCT01627158|Antidotes|antidotes|mesh-ancestor
2575438|NCT01627158|Protective Agents|protective agents|mesh-ancestor
2575439|NCT01627171|Bisacodyl|bisacodyl|mesh-list
2575440|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
2575441|NCT01627171|Cathartics|cathartics|mesh-ancestor
2575442|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2575443|NCT01627171|Laxatives|laxatives|mesh-ancestor
2575444|NCT01627223|Lamivudine|lamivudine|mesh-list
2575445|NCT01627223|Entecavir|entecavir|mesh-list
2575446|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2575447|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2575448|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575449|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575450|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
2575451|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575452|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2130842|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130843|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
2130844|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130845|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2575453|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2575454|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
2575455|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2575456|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2575457|NCT01627236|Prednisolone|prednisolone|mesh-list
2575458|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
2575459|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2575460|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
2575461|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2575462|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
2575463|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
2575464|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575465|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575466|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2575467|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
2575468|NCT01627236|Hormones|hormones|mesh-ancestor
2575469|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2575470|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2575471|NCT01627236|Protective Agents|protective agents|mesh-ancestor
2575472|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2575473|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575474|NCT01627262|Mesalamine|mesalamine|mesh-list
2575475|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2575476|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2575477|NCT01627262|Analgesics|analgesics|mesh-ancestor
2575478|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
2130846|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
2130847|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130848|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2130849|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2130850|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
2130851|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
2130852|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2130853|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130854|NCT03002506|Tazobactam|tazobactam|mesh-list
2130855|NCT03002506|Ceftolozane|ceftolozane|mesh-list
2130856|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2130857|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2130858|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2130859|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2130860|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130861|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130862|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2130863|NCT03002506|Renal Agents|renal agents|mesh-ancestor
2130864|NCT03002974|Triamcinolone|triamcinolone|mesh-list
2130865|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2130866|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2130867|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2575479|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575480|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575481|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2575482|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2575483|NCT01627353|Dexamethasone|dexamethasone|mesh-list
2575484|NCT01627353|Lidocaine|lidocaine|mesh-list
2575485|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
2575486|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2130868|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2130869|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2130870|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
2130871|NCT03002974|Hormones|hormones|mesh-ancestor
2130872|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130873|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130874|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2130875|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
2130876|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130877|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130878|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2130879|NCT03003000|Ibuprofen|ibuprofen|mesh-list
2130880|NCT03003000|Caffeine|caffeine|mesh-list
2575487|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
2575488|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
2130881|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2130882|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2130883|NCT03003000|Analgesics|analgesics|mesh-ancestor
2130884|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
2130885|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2130886|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130887|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2130888|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2130889|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2130890|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130891|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130892|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2130893|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2130894|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2130895|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2130896|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
2130897|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2130898|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
2130899|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2130900|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
2130901|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130902|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
2130903|NCT03003130|Protective Agents|protective agents|mesh-ancestor
2130904|NCT03003390|Enoxaparin|enoxaparin|mesh-list
2130905|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
2130906|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2575489|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575490|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575491|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2575492|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
2575493|NCT01627353|Hormones|hormones|mesh-ancestor
2575494|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2575495|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2575496|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575497|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575498|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
2575499|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
2575500|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2575501|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
2575502|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2575503|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2575504|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2575505|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2575506|NCT01627353|Analgesics|analgesics|mesh-ancestor
2575507|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
2575508|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2575509|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2575510|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
2575511|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2575512|NCT01627379|Panitumumab|panitumumab|mesh-list
2575513|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575514|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2575515|NCT01627431|Aspirin|aspirin|mesh-list
2575516|NCT01627431|Clopidogrel|clopidogrel|mesh-list
2575517|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2575518|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2575519|NCT01627431|Analgesics|analgesics|mesh-ancestor
2575520|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
2575521|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575522|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575523|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2575524|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2575525|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2575526|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2575527|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575528|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2575529|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2575530|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575531|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
2575532|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2575533|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2575534|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2575535|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
2575536|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575537|NCT01627587|Ketoconazole|ketoconazole|mesh-list
2575538|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
2575539|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575540|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2575541|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2575542|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575543|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575544|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2575545|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
2575546|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2575547|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130907|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2130908|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130944|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
2130945|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
2130946|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2130947|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
2130948|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130949|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2130950|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2130951|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
2130952|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130953|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2130954|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2130955|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2130956|NCT03003949|Estradiol|estradiol|mesh-list
2575548|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2575549|NCT01627626|Pilocarpine|pilocarpine|mesh-list
2575550|NCT01627626|Miotics|miotics|mesh-ancestor
2575551|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
2575552|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575553|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130957|NCT03003949|Progesterone|progesterone|mesh-list
2130958|NCT03003949|Estrogens|estrogens|mesh-ancestor
2130959|NCT03003949|Hormones|hormones|mesh-ancestor
2575554|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2575555|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2575556|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
2130960|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2575557|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575558|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130961|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130962|NCT03003949|Progestins|progestins|mesh-ancestor
2130963|NCT03004469|Finasteride|finasteride|mesh-list
2130964|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2130965|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2130966|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130967|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130968|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
2130969|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2130970|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130971|NCT03004469|Urological Agents|urological agents|mesh-ancestor
2130972|NCT03006341|Telmisartan|telmisartan|mesh-list
2130973|NCT03006341|Warfarin|warfarin|mesh-list
2130974|NCT03006341|Dabigatran|dabigatran|mesh-list
2130975|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
2130976|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2130977|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2130978|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2130979|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130980|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
2130981|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2130982|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
2130983|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2130984|NCT03006393|Infliximab|infliximab|mesh-list
2130985|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
2130986|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2130987|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2575559|NCT01627639|Acetazolamide|acetazolamide|mesh-list
2575560|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
2575561|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2575562|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575563|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575564|NCT01627639|Diuretics|diuretics|mesh-ancestor
2575565|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
2575566|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575567|NCT01627678|Molgramostim|molgramostim|mesh-list
2575568|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2575569|NCT01627678|Sargramostim|sargramostim|mesh-list
2575570|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
2575571|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575572|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575573|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2575574|NCT01627678|Antacids|antacids|mesh-ancestor
2575575|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575576|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2575577|NCT01627717|Maraviroc|maraviroc|mesh-list
2575578|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2575579|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2575580|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575581|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2575582|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2575583|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
2575584|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575585|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2575586|NCT01627834|Ropinirole|ropinirole|mesh-list
2575587|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2575588|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2575589|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
2575590|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
2575591|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575592|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575593|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575594|NCT01627847|Ropinirole|ropinirole|mesh-list
2575595|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2575596|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2575597|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
2575598|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
2130988|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
2130989|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2130990|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130991|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2575599|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575600|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575601|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575602|NCT01627873|Fentanyl|fentanyl|mesh-list
2575603|NCT01627873|Remifentanil|remifentanil|mesh-list
2575604|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2575605|NCT01627873|Narcotics|narcotics|mesh-ancestor
2575606|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2575607|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575608|NCT01627873|Analgesics|analgesics|mesh-ancestor
2575609|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
2575610|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575611|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2575612|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2575613|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
2575614|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
2575615|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
2575616|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2575617|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575618|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
2575619|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
2575620|NCT01627938|Razoxane|razoxane|mesh-list
2575621|NCT01627938|Analgesics|analgesics|mesh-ancestor
2575622|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
2130992|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2130993|NCT03006562|Heparin|heparin|mesh-list
2130994|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
2575623|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575624|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575625|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575626|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2575627|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2575628|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575629|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575630|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2130995|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2130996|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2130997|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2130998|NCT03006848|Avelumab|avelumab|mesh-list
2130999|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2131000|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131001|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
2131002|NCT03006887|Lenvatinib|lenvatinib|mesh-list
2131003|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2131004|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131005|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2131006|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131007|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131008|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
2131009|NCT03006926|Lenvatinib|lenvatinib|mesh-list
2131010|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2131011|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131012|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2131013|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131014|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131015|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
2131016|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2131017|NCT03007225|Estrogens|estrogens|mesh-ancestor
2131018|NCT03007225|Hormones|hormones|mesh-ancestor
2131019|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2131020|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131021|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2131022|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131023|NCT03007966|Clonidine|clonidine|mesh-list
2131024|NCT03007966|Epinephrine|epinephrine|mesh-list
2131025|NCT03007966|Bupivacaine|bupivacaine|mesh-list
2131026|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
2131027|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
2131028|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131029|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131030|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
2131031|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131032|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2131033|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2131034|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
2131035|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575631|NCT01627938|Protective Agents|protective agents|mesh-ancestor
2575632|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
2131036|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131037|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2131038|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2131039|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
2131040|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2575633|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
2575634|NCT01628029|Melatonin|melatonin|mesh-list
2575635|NCT01628029|Methylphenidate|methylphenidate|mesh-list
2575636|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2575637|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575638|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2575639|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2575640|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2575641|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575642|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
2575643|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575644|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
2575645|NCT01628029|Protective Agents|protective agents|mesh-ancestor
2575646|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2575647|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
2575648|NCT01628055|Antibodies|antibodies|mesh-list
2575649|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
2575650|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2575651|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2575652|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
2575653|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
2575654|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575655|NCT01628094|Ritonavir|ritonavir|mesh-list
2575656|NCT01628094|Ribavirin|ribavirin|mesh-list
2575657|NCT01628094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2575658|NCT01628094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2575659|NCT01628094|Protease Inhibitors|protease inhibitors|mesh-ancestor
2575660|NCT01628094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575661|NCT01628094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575662|NCT01628094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2575663|NCT01628094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2575664|NCT01628094|Antiviral Agents|antiviral agents|mesh-ancestor
2575665|NCT01628094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575666|NCT01628094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2131041|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
2131042|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
2131043|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
2131044|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2131045|NCT03007966|Analgesics|analgesics|mesh-ancestor
2131046|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2131047|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
2131048|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2131049|NCT03007979|Letrozole|letrozole|mesh-list
2131050|NCT03007979|Fulvestrant|fulvestrant|mesh-list
2131051|NCT03007979|Palbociclib|palbociclib|mesh-list
2131052|NCT03007979|Goserelin|goserelin|mesh-list
2131053|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131054|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2131055|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2131056|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131057|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131058|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2131059|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
2131060|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2131061|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575667|NCT01628094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2575668|NCT01628094|Antimetabolites|antimetabolites|mesh-ancestor
2575669|NCT01628211|Leucovorin|leucovorin|mesh-list
2575670|NCT01628211|Folic Acid|folic acid|mesh-list
2575671|NCT01628211|Fluorouracil|fluorouracil|mesh-list
2575672|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
2575673|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
2575674|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
2575675|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575676|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2575677|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575678|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2575679|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
2131062|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2131063|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2131064|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2575680|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575681|NCT01628211|Antidotes|antidotes|mesh-ancestor
2575682|NCT01628211|Protective Agents|protective agents|mesh-ancestor
2575683|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
2575684|NCT01628211|Vitamins|vitamins|mesh-ancestor
2575685|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
2575686|NCT01628211|Hematinics|hematinics|mesh-ancestor
2575687|NCT01628341|Insulin|insulin|mesh-list
2575688|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2575689|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575690|NCT01628354|Ranibizumab|ranibizumab|mesh-list
2575691|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2575692|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2575693|NCT01628354|Growth Substances|growth substances|mesh-ancestor
2575694|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575695|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
2575696|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575697|NCT01628445|Liraglutide|liraglutide|mesh-list
2575698|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2575699|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575700|NCT01628445|Incretins|incretins|mesh-ancestor
2575701|NCT01628445|Hormones|hormones|mesh-ancestor
2575702|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2575703|NCT01628471|Decitabine|decitabine|mesh-list
2575704|NCT01628471|Genistein|genistein|mesh-list
2575705|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2575706|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
2575707|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575708|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575709|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575710|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2131065|NCT03008213|Palonosetron|palonosetron|mesh-list
2131066|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
2131067|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
2131068|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131069|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575711|NCT01628471|Protective Agents|protective agents|mesh-ancestor
2575712|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575713|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2575714|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
2575715|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2575716|NCT01628471|Estrogens|estrogens|mesh-ancestor
2575717|NCT01628471|Hormones|hormones|mesh-ancestor
2575718|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2575719|NCT01628562|Remifentanil|remifentanil|mesh-list
2575720|NCT01628562|Esmolol|esmolol|mesh-list
2575721|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2575722|NCT01628562|Narcotics|narcotics|mesh-ancestor
2575723|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2575724|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575725|NCT01628562|Analgesics|analgesics|mesh-ancestor
2575726|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
2575727|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575728|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2575729|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2575730|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2575731|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
2575732|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575733|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575734|NCT01628640|Interferons|interferons|mesh-list
2575735|NCT01628640|Interferon-beta|interferon-beta|mesh-list
2575736|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575737|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
2575738|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575739|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
2575740|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575741|NCT01628666|Vancomycin|vancomycin|mesh-list
2575742|NCT01628666|Cefazolin|cefazolin|mesh-list
2575743|NCT01628666|Cephalexin|cephalexin|mesh-list
2575744|NCT01628666|Bacitracin|bacitracin|mesh-list
2575745|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2131070|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2575746|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575747|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2575748|NCT01628731|Furosemide|furosemide|mesh-list
2575749|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
2575750|NCT01628731|Diuretics|diuretics|mesh-ancestor
2575751|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
2575752|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575753|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2575754|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2575755|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575756|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575757|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2575758|NCT01628770|Hematinics|hematinics|mesh-ancestor
2575759|NCT01628783|Citalopram|citalopram|mesh-list
2575760|NCT01628783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2575761|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2575762|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2575763|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575764|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575765|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
2575766|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575767|NCT01628783|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2575768|NCT01628783|Antidepressive Agents|antidepressive agents|mesh-ancestor
2575769|NCT01628783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2575770|NCT01628952|Curare|curare|mesh-list
2575771|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2575772|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2575773|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2575774|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575775|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575776|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2575777|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2575778|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
2575779|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575780|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575781|NCT01629082|Lenalidomide|lenalidomide|mesh-list
2575782|NCT01629082|Clofarabine|clofarabine|mesh-list
2575783|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
2575784|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575785|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2575786|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2575787|NCT01629082|Growth Substances|growth substances|mesh-ancestor
2575788|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
2575789|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575790|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2575791|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
2575792|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575793|NCT01629173|Ethylene|ethylene|mesh-list
2575794|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2575795|NCT01629173|Growth Substances|growth substances|mesh-ancestor
2575796|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575797|NCT01629199|Mitogens|mitogens|mesh-list
2575798|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
2575799|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575800|NCT01629212|Octylonium|octylonium|mesh-list
2575801|NCT01629212|Bromides|bromides|mesh-list
2575802|NCT01629212|Tiropramide|tiropramide|mesh-list
2575803|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
2131071|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2131072|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2131073|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
2131074|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131075|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131076|NCT03008369|Lenvatinib|lenvatinib|mesh-list
2131077|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131078|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2131079|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131080|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131081|NCT03008590|Naltrexone|naltrexone|mesh-list
2131082|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2131083|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2131084|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131085|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
2131086|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131087|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
2131088|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2131089|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
2131090|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131091|NCT03008889|Expectorants|expectorants|mesh-ancestor
2131092|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
2131093|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2575804|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
2575805|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
2575806|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575807|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131094|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
2131095|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131096|NCT03008889|Protective Agents|protective agents|mesh-ancestor
2131097|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131098|NCT03008889|Antidotes|antidotes|mesh-ancestor
2131099|NCT03008915|Aspirin|aspirin|mesh-list
2131100|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2131101|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
2131102|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2131103|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2131104|NCT03008915|Analgesics|analgesics|mesh-ancestor
2131105|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
2131106|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575808|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2575809|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2575810|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575811|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2575812|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2575813|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2575814|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2575815|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
2575816|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575817|NCT01629225|Candesartan|candesartan|mesh-list
2575818|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2575819|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2575820|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2575821|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575822|NCT01629251|Insulin|insulin|mesh-list
2575823|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2575824|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575825|NCT01629277|Insulin|insulin|mesh-list
2575826|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2575827|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575828|NCT01629368|Carbamazepine|carbamazepine|mesh-list
2575829|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
2575830|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
2575831|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2575832|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2575833|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575834|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2575835|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2575836|NCT01629368|Analgesics|analgesics|mesh-ancestor
2575837|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
2575838|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575839|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2575840|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2575841|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575842|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2575843|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2575844|NCT01629394|Neostigmine|neostigmine|mesh-list
2575845|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2575846|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575847|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575848|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
2575849|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575850|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575851|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2575852|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
2575853|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575854|NCT01629446|Lofexidine|lofexidine|mesh-list
2575855|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2575856|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2575857|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575858|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
2575859|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575860|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2575861|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2575862|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2575863|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
2131107|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131108|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2131109|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2131110|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2131111|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2131112|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131113|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2131114|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2131115|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575864|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575865|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575866|NCT01629511|Gemcitabine|gemcitabine|mesh-list
2575867|NCT01629511|Methotrexate|methotrexate|mesh-list
2575868|NCT01629511|Clofarabine|clofarabine|mesh-list
2575869|NCT01629511|Busulfan|busulfan|mesh-list
2575870|NCT01629511|Tacrolimus|tacrolimus|mesh-list
2575871|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
2575872|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2575873|NCT01629511|Lenograstim|lenograstim|mesh-list
2575874|NCT01629511|Sargramostim|sargramostim|mesh-list
2575875|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2575876|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
2575877|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575878|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575879|NCT01629511|Antiviral Agents|antiviral agents|mesh-ancestor
2575880|NCT01629511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575881|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575882|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2575883|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
2575884|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575885|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2575886|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
2575887|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2575888|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
2575889|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2575890|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2575891|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2575892|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2575893|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2575894|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
2575895|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2575896|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2575897|NCT01629628|Adalimumab|adalimumab|mesh-list
2575898|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
2575899|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2575900|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2131116|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
2131117|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2131118|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2131119|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
2131120|NCT03009162|Lasmiditan|lasmiditan|mesh-list
2131121|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2131122|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
2131123|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131124|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131125|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131126|NCT03009396|Clarithromycin|clarithromycin|mesh-list
2131127|NCT03009396|Rifabutin|rifabutin|mesh-list
2131128|NCT03009396|Clofazimine|clofazimine|mesh-list
2131129|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2131130|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131131|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2131132|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575901|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
2575902|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575903|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2575904|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575905|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2575906|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
2575907|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575908|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2575909|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575910|NCT01629680|Moxaverine|moxaverine|mesh-list
2575911|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
2575912|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
2575913|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131133|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131134|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2131135|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2131136|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2131137|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
2131138|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2131139|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
2131140|NCT03010631|Lubiprostone|lubiprostone|mesh-list
2131141|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2131142|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2131143|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131144|NCT03010683|Metformin|metformin|mesh-list
2131145|NCT03010683|Liraglutide|liraglutide|mesh-list
2131146|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2131147|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131148|NCT03010683|Incretins|incretins|mesh-ancestor
2131149|NCT03010683|Hormones|hormones|mesh-ancestor
2131150|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2131151|NCT03011034|Daratumumab|daratumumab|mesh-list
2131152|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131153|NCT03011333|Epinephrine|epinephrine|mesh-list
2131154|NCT03011333|Bupivacaine|bupivacaine|mesh-list
2131155|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
2131156|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
2131157|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131158|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131159|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
2575914|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575915|NCT01629732|Ribavirin|ribavirin|mesh-list
2575916|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
2575917|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575918|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
2575919|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2575920|NCT01629758|Nivolumab|nivolumab|mesh-list
2575921|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2575922|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131160|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131161|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2131162|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2131163|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
2131164|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131165|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131166|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2131167|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2131168|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
2131169|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2131170|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
2131171|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
2131172|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
2575923|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2575924|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575925|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2575926|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2575927|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2575928|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131173|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2131174|NCT03011892|Triamcinolone|triamcinolone|mesh-list
2131175|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2131176|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
2131177|NCT03011892|Hormones|hormones|mesh-ancestor
2131178|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2131179|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131180|NCT03012061|Fluticasone|fluticasone|mesh-list
2131181|NCT03012061|Xhance|xhance|mesh-list
2131182|NCT03012061|Albuterol|albuterol|mesh-list
2131183|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2575929|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575930|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2575931|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2575932|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575933|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
2575934|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2575935|NCT01630018|Topotecan|topotecan|mesh-list
2131184|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2131185|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
2575936|NCT01630018|Belotecan|belotecan|mesh-list
2575937|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2575938|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2575939|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575940|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575941|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575942|NCT01630057|Zonisamide|zonisamide|mesh-list
2575943|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
2575944|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2575945|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2575946|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575947|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2575948|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575949|NCT01630070|Paclitaxel|paclitaxel|mesh-list
2575950|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2575951|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575952|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
2575953|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
2575954|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
2575955|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575956|NCT01630083|Capecitabine|capecitabine|mesh-list
2575957|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
2575958|NCT01630083|Epirubicin|epirubicin|mesh-list
2575959|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2575960|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
2575961|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575962|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575963|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2575964|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2575965|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2575966|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575967|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2575968|NCT01630096|Laxatives|laxatives|mesh-ancestor
2575969|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2575970|NCT01630148|Bemiparin|bemiparin|mesh-list
2575971|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
2575972|NCT01630187|Carbetocin|carbetocin|mesh-list
2575973|NCT01630187|Oxytocin|oxytocin|mesh-list
2575974|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
2575975|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2575976|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131186|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131187|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131188|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2131189|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
2131190|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
2131191|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2131192|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
2131193|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2131194|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2131195|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2131196|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2575977|NCT01630213|Vitamin D|vitamin d|mesh-list
2575978|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
2575979|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
2575980|NCT01630213|Vitamins|vitamins|mesh-list
2575981|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
2575982|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575983|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2575984|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2575985|NCT01630226|Cisplatin|cisplatin|mesh-list
2575986|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2575987|NCT01630278|Ibuprofen|ibuprofen|mesh-list
2575988|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2575989|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2575990|NCT01630278|Analgesics|analgesics|mesh-ancestor
2575991|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
2575992|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2575993|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2575994|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2575995|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2575996|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2575997|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2575998|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2575999|NCT01630343|Acetaminophen|acetaminophen|mesh-list
2576000|NCT01630343|Tramadol|tramadol|mesh-list
2131197|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
2131198|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576001|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2576002|NCT01630343|Analgesics|analgesics|mesh-ancestor
2576003|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
2576004|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576005|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576006|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
2576007|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2576008|NCT01630343|Narcotics|narcotics|mesh-ancestor
2576009|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2576010|NCT01630369|Insulin|insulin|mesh-list
2576011|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2131199|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131200|NCT03012191|Gentamicins|gentamicins|mesh-list
2131201|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2131202|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131203|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2131204|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131205|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131206|NCT03012334|Alprazolam|alprazolam|mesh-list
2131207|NCT03012334|Lasmiditan|lasmiditan|mesh-list
2131208|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2131209|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131210|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131211|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2131212|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2576012|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2576013|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576014|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
2576015|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2131213|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2131214|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
2131215|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
2131216|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131217|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131218|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2131219|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
2131220|NCT03012477|Adavosertib|adavosertib|mesh-list
2131221|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131222|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131223|NCT03012594|Lanreotide|lanreotide|mesh-list
2131224|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131225|NCT03012672|Cytarabine|cytarabine|mesh-list
2131226|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
2131227|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
2131228|NCT03012672|Cladribine|cladribine|mesh-list
2131229|NCT03012672|Lenograstim|lenograstim|mesh-list
2131230|NCT03012672|Sargramostim|sargramostim|mesh-list
2131231|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2131232|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
2184920|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576016|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
2576017|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576018|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2576019|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2576020|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
2576021|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576022|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576023|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2576024|NCT01630564|Aldesleukin|aldesleukin|mesh-list
2576025|NCT01630564|Interleukin-2|interleukin-2|mesh-list
2576026|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576027|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2576028|NCT01630564|Analgesics|analgesics|mesh-ancestor
2576029|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
2576030|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576031|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576032|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2576033|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2576034|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
2576035|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576036|NCT01630590|Androgens|androgens|mesh-list
2576037|NCT01630590|Hormones|hormones|mesh-ancestor
2576038|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2576039|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576040|NCT01630642|Clopidogrel|clopidogrel|mesh-list
2576041|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2576042|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2576043|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2576044|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2576045|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
2576046|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576047|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576048|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576049|NCT01630655|Felodipine|felodipine|mesh-list
2576050|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2576051|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2576052|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2576053|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2576054|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576055|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2576056|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576057|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
2576058|NCT01630720|Vitamin D|vitamin d|mesh-list
2576059|NCT01630720|Vitamins|vitamins|mesh-list
2576060|NCT01630720|Ascorbic Acid|ascorbic acid|mesh-list
2576061|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
2576062|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576063|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2576064|NCT01630720|Antioxidants|antioxidants|mesh-ancestor
2576065|NCT01630720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576066|NCT01630720|Protective Agents|protective agents|mesh-ancestor
2576067|NCT01630733|Docetaxel|docetaxel|mesh-list
2576068|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576069|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
2576070|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
2576071|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
2576072|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576073|NCT01630902|Felodipine|felodipine|mesh-list
2576074|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2576075|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2576076|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2576077|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2576078|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131233|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131234|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131235|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
2131236|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131237|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2131238|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
2131239|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131240|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2131241|NCT03012672|Analgesics|analgesics|mesh-ancestor
2131242|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
2131243|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131244|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2131245|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2131246|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131247|NCT03012828|Moxidectin|moxidectin|mesh-list
2131248|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
2131249|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2131250|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131251|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
2576079|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2576080|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576081|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
2576082|NCT01630915|Clopidogrel|clopidogrel|mesh-list
2576083|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2576084|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2576085|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2576086|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2576087|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
2576088|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576089|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576090|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576091|NCT01630941|Denosumab|denosumab|mesh-list
2576092|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2576093|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576094|NCT01631058|Prednisone|prednisone|mesh-list
2131252|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
2131253|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
2131254|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2131255|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131256|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2131257|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576095|NCT01631058|Everolimus|everolimus|mesh-list
2576096|NCT01631058|Lactitol|lactitol|mesh-list
2576097|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2576098|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
2576099|NCT01631058|Hormones|hormones|mesh-ancestor
2576100|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2576101|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576102|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2576103|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576104|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2576105|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
2576106|NCT01631058|Cathartics|cathartics|mesh-ancestor
2576107|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2576108|NCT01631136|Gemcitabine|gemcitabine|mesh-list
2576109|NCT01631136|Cisplatin|cisplatin|mesh-list
2576110|NCT01631136|Pemetrexed|pemetrexed|mesh-list
2576111|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576112|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2576113|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
2576114|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576115|NCT01631136|Antiviral Agents|antiviral agents|mesh-ancestor
2576116|NCT01631136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576117|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576118|NCT01631136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2576119|NCT01631136|Immunologic Factors|immunologic factors|mesh-ancestor
2576120|NCT01631136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576121|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2576122|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2576123|NCT01631201|Azithromycin|azithromycin|mesh-list
2576124|NCT01631201|KRM 1648|krm 1648|mesh-list
2576125|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2576126|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576127|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2576128|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
2576129|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
2576130|NCT01631292|Vitamin D|vitamin d|mesh-list
2576131|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
2576132|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
2576133|NCT01631292|Vitamins|vitamins|mesh-list
2576134|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
2576135|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576136|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2576137|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2576138|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
2419536|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419537|NCT00803907|Imiquimod|imiquimod|mesh-list
2419538|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
2419539|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2419540|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419541|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419542|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
2419543|NCT00803933|Pentamidine|pentamidine|mesh-list
2419544|NCT00803933|Pafuramidine|pafuramidine|mesh-list
2419545|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
2419546|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419547|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2419548|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2419549|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2419550|NCT00803946|Ibuprofen|ibuprofen|mesh-list
2419551|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2419552|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419553|NCT00803946|Analgesics|analgesics|mesh-ancestor
2419554|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
2419555|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419556|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419557|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419558|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2419559|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2419560|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419561|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576139|NCT01631305|Calcium|calcium|mesh-list
2576140|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2419562|NCT00803972|Insulin|insulin|mesh-list
2576141|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576142|NCT01631305|Antacids|antacids|mesh-ancestor
2576143|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576144|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2576145|NCT01631357|Gemcitabine|gemcitabine|mesh-list
2576146|NCT01631357|Cisplatin|cisplatin|mesh-list
2576147|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576148|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2576149|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
2576150|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576151|NCT01631357|Antiviral Agents|antiviral agents|mesh-ancestor
2576152|NCT01631357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576153|NCT01631357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576154|NCT01631357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2576155|NCT01631357|Immunologic Factors|immunologic factors|mesh-ancestor
2576156|NCT01631357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576157|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
2576158|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2576159|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2576160|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2576161|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2576162|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576163|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2576164|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576165|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2576166|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2576167|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2576168|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2576169|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2576170|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
2576171|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576172|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
2576173|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2576174|NCT01631383|Analgesics|analgesics|mesh-ancestor
2576175|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
2576176|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576177|NCT01631396|Neostigmine|neostigmine|mesh-list
2576178|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2576179|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576180|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576181|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
2576182|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576183|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576184|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2576185|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
2576186|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419563|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2419564|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
2419565|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2419566|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419567|NCT00804050|Vitamins|vitamins|mesh-list
2419568|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
2419569|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419570|NCT00804115|Timolol|timolol|mesh-list
2419571|NCT00804115|Latanoprost|latanoprost|mesh-list
2419572|NCT00804115|Pilocarpine|pilocarpine|mesh-list
2419573|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2419574|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2419575|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
2419576|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419577|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419578|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419579|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2419580|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2419581|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2419582|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2419583|NCT00804115|Miotics|miotics|mesh-ancestor
2419584|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
2419585|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419586|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2419587|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2419588|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
2419589|NCT00804206|Bevacizumab|bevacizumab|mesh-list
2419590|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2576187|NCT01631409|Aspirin|aspirin|mesh-list
2576188|NCT01631409|Atenolol|atenolol|mesh-list
2576189|NCT01631409|Enalapril|enalapril|mesh-list
2576190|NCT01631409|Enalaprilat|enalaprilat|mesh-list
2576191|NCT01631409|Amlodipine|amlodipine|mesh-list
2576192|NCT01631409|Isosorbide|isosorbide|mesh-list
2576193|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2576194|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2576195|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
2576196|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2576197|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2576198|NCT01631409|Analgesics|analgesics|mesh-ancestor
2576199|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
2576200|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576201|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576202|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2576203|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2576204|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2576205|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2576206|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576207|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2576208|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2576209|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576210|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
2576211|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2576212|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
2576213|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2576214|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2131258|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2131259|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
2131260|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131261|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131262|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2131263|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131264|NCT03015220|Dulaglutide|dulaglutide|mesh-list
2131265|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2131266|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131267|NCT03015532|Bupivacaine|bupivacaine|mesh-list
2131268|NCT03015532|Ropivacaine|ropivacaine|mesh-list
2131269|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
2131270|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
2131271|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131272|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131273|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
2131274|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131275|NCT03015961|Bupivacaine|bupivacaine|mesh-list
2576215|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
2576216|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
2576217|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2576218|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2576219|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2576220|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
2576221|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576222|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2576223|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2576224|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2576225|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
2576226|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2576227|NCT01631409|Diuretics|diuretics|mesh-ancestor
2576228|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
2576229|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2576230|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2576231|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
2576232|NCT01631448|Coagulants|coagulants|mesh-ancestor
2576233|NCT01631513|Tapentadol|tapentadol|mesh-list
2576234|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2576235|NCT01631513|Narcotics|narcotics|mesh-ancestor
2576236|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2576237|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576238|NCT01631513|Analgesics|analgesics|mesh-ancestor
2576239|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
2576240|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576241|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2576242|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2576243|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2576244|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576245|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
2576246|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576247|NCT01631526|Vitamin D|vitamin d|mesh-list
2576248|NCT01631526|Vitamins|vitamins|mesh-ancestor
2576249|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
2576250|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576251|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2576252|NCT01631539|Irinotecan|irinotecan|mesh-list
2576253|NCT01631539|Cetuximab|cetuximab|mesh-list
2576254|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2576255|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2576256|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576257|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576258|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576259|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2131276|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
2131277|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
2131278|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131279|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131280|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
2131281|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131284|NCT03016598|Oxytocin|oxytocin|mesh-list
2131285|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
2131286|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2131287|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131288|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
2131289|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
2131290|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
2131291|NCT03017235|Citric Acid|citric acid|mesh-list
2131292|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
2131293|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2131294|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
2131295|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
2131296|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131297|NCT03017235|Cathartics|cathartics|mesh-ancestor
2131298|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2131299|NCT03017235|Antacids|antacids|mesh-ancestor
2131300|NCT03017508|Riluzole|riluzole|mesh-list
2131301|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
2131302|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2131303|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2131304|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131305|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131306|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131307|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2131308|NCT03017508|Protective Agents|protective agents|mesh-ancestor
2131309|NCT03017846|Cantharidin|cantharidin|mesh-list
2576260|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
2576261|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2576262|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2576263|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576264|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
2576265|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576266|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131310|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131311|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131312|NCT03018028|Liraglutide|liraglutide|mesh-list
2131313|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2576287|NCT01631669|Celecoxib|celecoxib|mesh-list
2576288|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2576289|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2576290|NCT01631669|Analgesics|analgesics|mesh-ancestor
2576291|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
2576292|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576293|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576294|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2576295|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2576296|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2576297|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2576298|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576299|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576300|NCT01631838|Tocotrienols|tocotrienols|mesh-list
2576301|NCT01631838|Vitamin E|vitamin e|mesh-list
2576302|NCT01631838|Tocopherols|tocopherols|mesh-list
2576303|NCT01631838|Tocovid|tocovid|mesh-list
2576304|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
2576305|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576306|NCT01631838|Protective Agents|protective agents|mesh-ancestor
2576307|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576308|NCT01631838|Vitamins|vitamins|mesh-ancestor
2576309|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
2576310|NCT01631877|Enoxaparin|enoxaparin|mesh-list
2576311|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
2576312|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
2576313|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2576314|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2576315|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576316|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2576317|NCT01631968|Colistin|colistin|mesh-list
2576318|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576319|NCT01631994|Metoclopramide|metoclopramide|mesh-list
2576320|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
2131314|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131315|NCT03018028|Incretins|incretins|mesh-ancestor
2131316|NCT03018028|Hormones|hormones|mesh-ancestor
2131317|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2131318|NCT03018106|Estrogens|estrogens|mesh-list
2131319|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2131320|NCT03018106|Hormones|hormones|mesh-ancestor
2131321|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2131322|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131323|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
2131324|NCT03018223|Sirolimus|sirolimus|mesh-list
2576321|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
2576322|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576323|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576324|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2576325|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2576326|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2576327|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
2576328|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131325|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
2131326|NCT03018223|Busulfan|busulfan|mesh-list
2131327|NCT03018223|Fludarabine|fludarabine|mesh-list
2131328|NCT03018223|Lenograstim|lenograstim|mesh-list
2131329|NCT03018223|Sargramostim|sargramostim|mesh-list
2131330|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2131331|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
2131332|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131333|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2576329|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576330|NCT01632007|Alogliptin|alogliptin|mesh-list
2576331|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2576332|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576333|NCT01632007|Incretins|incretins|mesh-ancestor
2576334|NCT01632007|Hormones|hormones|mesh-ancestor
2576335|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2576336|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2576337|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
2576338|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576339|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131334|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2131335|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
2131336|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131337|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131338|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2131339|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2131340|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2131341|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2131342|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
2131343|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2131344|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131345|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131346|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
2131347|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2131348|NCT03018249|Entinostat|entinostat|mesh-list
2131349|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
2131350|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2131351|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2131352|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2131353|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2131354|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
2131355|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2131356|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131357|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2131358|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2131359|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2131360|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2131361|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131362|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131363|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576340|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
2576341|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2576342|NCT01632137|Rebamipide|rebamipide|mesh-list
2576343|NCT01632137|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2576344|NCT01632137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2576345|NCT01632137|Antioxidants|antioxidants|mesh-ancestor
2576346|NCT01632137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576347|NCT01632137|Protective Agents|protective agents|mesh-ancestor
2576348|NCT01632137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576349|NCT01632137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576350|NCT01632163|Lixisenatide|lixisenatide|mesh-list
2576351|NCT01632163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2576352|NCT01632163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576353|NCT01632189|Varenicline|varenicline|mesh-list
2576354|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2131364|NCT03018340|Pimavanserin|pimavanserin|mesh-list
2131365|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2131366|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2131367|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2131368|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2131369|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131370|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131371|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2131372|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2576355|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2576356|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
2576357|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576358|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576359|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576360|NCT01632228|Bevacizumab|bevacizumab|mesh-list
2576361|NCT01632228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2576362|NCT01632228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576363|NCT01632228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2576364|NCT01632228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2576365|NCT01632228|Growth Substances|growth substances|mesh-ancestor
2576366|NCT01632228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131373|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2131374|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
2131375|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131376|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131377|NCT03018925|Golimumab|golimumab|mesh-list
2131378|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2131379|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2131380|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2576367|NCT01632228|Growth Inhibitors|growth inhibitors|mesh-ancestor
2576368|NCT01632371|Paclitaxel|paclitaxel|mesh-list
2576369|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2576370|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2576371|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576372|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
2576373|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
2576374|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
2576375|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576376|NCT01632436|Pixantrone|pixantrone|mesh-list
2576377|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2131381|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
2131382|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131383|NCT03018938|Insulin|insulin|mesh-list
2131384|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2131385|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2131386|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131387|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2131388|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2131389|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2131390|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
2131391|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576378|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2576379|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576380|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576381|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576382|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
2576383|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2576384|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576385|NCT01632514|Vitamins|vitamins|mesh-ancestor
2576386|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
2576387|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2576388|NCT01632540|Beclomethasone|beclomethasone|mesh-list
2576389|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2576390|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
2576391|NCT01632540|Hormones|hormones|mesh-ancestor
2576392|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2576393|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576394|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2576395|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
2576396|NCT01632592|Tesamorelin|tesamorelin|mesh-list
2576397|NCT01632592|Growth Substances|growth substances|mesh-ancestor
2576398|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576399|NCT01632605|Sirolimus|sirolimus|mesh-list
2576400|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2576401|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576402|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2576403|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576404|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
2576405|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2576406|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
2576407|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576408|NCT01632657|Sumatriptan|sumatriptan|mesh-list
2576409|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2576410|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2576411|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2576412|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
2576413|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576414|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576415|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576416|NCT01632722|Bevacizumab|bevacizumab|mesh-list
2131392|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2131393|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2131394|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131395|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2131396|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2131397|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2131398|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
2131399|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131400|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131401|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2131402|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2131403|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
2131404|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131405|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
2131406|NCT03019887|Haloperidol|haloperidol|mesh-list
2576417|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2576418|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576419|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2576420|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2576421|NCT01632722|Growth Substances|growth substances|mesh-ancestor
2576422|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576423|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
2576424|NCT01632761|Vitamin D|vitamin d|mesh-list
2576425|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
2419591|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419592|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2419593|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2419594|NCT00804206|Growth Substances|growth substances|mesh-ancestor
2419595|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419596|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
2419597|NCT00804219|Vaccines|vaccines|mesh-list
2419598|NCT00804219|Immunologic Factors|immunologic factors|mesh-ancestor
2419599|NCT00804219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419600|NCT00804245|Choline|choline|mesh-list
2419601|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
2419602|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2419603|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
2419604|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131407|NCT03019887|Olanzapine|olanzapine|mesh-list
2131408|NCT03019887|Risperidone|risperidone|mesh-list
2131409|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2131410|NCT03019887|Aripiprazole|aripiprazole|mesh-list
2131411|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2131412|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
2131413|NCT03019887|Perphenazine|perphenazine|mesh-list
2419605|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2419606|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2419607|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
2419608|NCT00804271|Memantine|memantine|mesh-list
2419609|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2419610|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2419611|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
2419612|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131414|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2131415|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
2131416|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131417|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131418|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131419|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2131420|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2131421|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131422|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2131423|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2131424|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
2131425|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
2131426|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
2131427|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131428|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2131429|NCT03019887|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2131430|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2131431|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2131432|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
2131433|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
2131434|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2131435|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2131436|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2131437|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2131438|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2131439|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2131440|NCT03019887|Analgesics|analgesics|mesh-ancestor
2131441|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
2131442|NCT03019939|Isavuconazole|isavuconazole|mesh-list
2131443|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
2131444|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131445|NCT03019965|Meropenem|meropenem|mesh-list
2131446|NCT03019965|Tazobactam|tazobactam|mesh-list
2131447|NCT03019965|Piperacillin|piperacillin|mesh-list
2131448|NCT03019965|Imipenem|imipenem|mesh-list
2131449|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2131450|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2131451|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576426|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
2576427|NCT01632761|Vitamins|vitamins|mesh-list
2131452|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2576428|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
2576429|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576430|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2576431|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2576432|NCT01632826|Pomalidomide|pomalidomide|mesh-list
2576433|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
2576434|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576435|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2576436|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2576437|NCT01632826|Growth Substances|growth substances|mesh-ancestor
2576438|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
2576439|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576440|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
2576441|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2576442|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
2576443|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131453|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131454|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131455|NCT03020004|Ritonavir|ritonavir|mesh-list
2131456|NCT03020004|Ribavirin|ribavirin|mesh-list
2131457|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2131458|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2131459|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2131460|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
2131461|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131462|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131463|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2131464|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2131465|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
2131466|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131467|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2131468|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2131469|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
2131470|NCT03020082|Ritonavir|ritonavir|mesh-list
2131471|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2131472|NCT03020082|Ribavirin|ribavirin|mesh-list
2131473|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2131474|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2131475|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
2131476|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131477|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131478|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2131479|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2131480|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
2131481|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131482|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2131483|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2131484|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
2131485|NCT03020095|Ritonavir|ritonavir|mesh-list
2131486|NCT03020095|Ribavirin|ribavirin|mesh-list
2576444|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576445|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2576446|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
2576447|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2576448|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
2576449|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576450|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131487|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2131488|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2131489|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
2131490|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131491|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131492|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2131493|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2131494|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
2131495|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131496|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2131497|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2131498|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
2131499|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2131500|NCT03020407|Dopamine|dopamine|mesh-list
2131501|NCT03020407|Epinephrine|epinephrine|mesh-list
2131502|NCT03020407|Norepinephrine|norepinephrine|mesh-list
2131503|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2131504|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576451|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2576452|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
2576453|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
2576454|NCT01633086|Protective Agents|protective agents|mesh-ancestor
2576455|NCT01633099|Decitabine|decitabine|mesh-list
2576456|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2576457|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
2576458|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576459|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576460|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576461|NCT01633177|Vitamin D|vitamin d|mesh-list
2576462|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
2576463|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
2576464|NCT01633177|Vitamins|vitamins|mesh-list
2576465|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
2576466|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576467|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2576468|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2576469|NCT01633203|Capecitabine|capecitabine|mesh-list
2576470|NCT01633203|Epirubicin|epirubicin|mesh-list
2576471|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576472|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2131505|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2131506|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2131507|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
2131508|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131509|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131510|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131511|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2131512|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2131513|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
2131514|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131515|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2131516|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
2131517|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
2131518|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
2131519|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2131520|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
2576473|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
2576474|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576475|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2576476|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2576477|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2576478|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576479|NCT01633294|Gentamicins|gentamicins|mesh-list
2576480|NCT01633294|Ampicillin|ampicillin|mesh-list
2576481|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2576482|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576483|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2576484|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576485|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576486|NCT01633359|Atorvastatin|atorvastatin|mesh-list
2576487|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2576488|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2576489|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2576490|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
2576491|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576492|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2576493|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576494|NCT01633450|Zinc|zinc|mesh-list
2576495|NCT01633450|Trace Elements|trace elements|mesh-ancestor
2576496|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
2576497|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576498|NCT01633476|Valacyclovir|valacyclovir|mesh-list
2576499|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
2576500|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576508|NCT01633593|Donepezil|donepezil|mesh-list
2576509|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2131521|NCT03020407|Protective Agents|protective agents|mesh-ancestor
2576510|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576511|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576512|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
2576513|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576514|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576515|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
2131522|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
2131523|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131524|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
2131525|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131526|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131527|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2131528|NCT03020966|Acetaminophen|acetaminophen|mesh-list
2131529|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2131530|NCT03020966|Analgesics|analgesics|mesh-ancestor
2131531|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
2131532|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131533|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131534|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
2131535|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
2131536|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2131537|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
2131538|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131539|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2131540|NCT03021018|Lorazepam|lorazepam|mesh-list
2576516|NCT01633645|Gemcitabine|gemcitabine|mesh-list
2576517|NCT01633645|Bortezomib|bortezomib|mesh-list
2576518|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576519|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2576520|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
2576521|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576522|NCT01633645|Antiviral Agents|antiviral agents|mesh-ancestor
2576523|NCT01633645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576524|NCT01633645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576525|NCT01633645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2576526|NCT01633645|Immunologic Factors|immunologic factors|mesh-ancestor
2576527|NCT01633645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576528|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
2576529|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2576530|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576531|NCT01633658|Vitamins|vitamins|mesh-ancestor
2576532|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
2576533|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2576534|NCT01633749|Vaccines|vaccines|mesh-list
2576535|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
2576536|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131541|NCT03021018|Brivaracetam|brivaracetam|mesh-list
2131542|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
2131543|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
2131544|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
2131545|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131546|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131547|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2131548|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2131549|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131550|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2131551|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2131552|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2131553|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
2131554|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
2131555|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131556|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131557|NCT03021343|Colchicine|colchicine|mesh-list
2131558|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
2576537|NCT01633762|Vancomycin|vancomycin|mesh-list
2576538|NCT01633762|Gentamicins|gentamicins|mesh-list
2576539|NCT01633762|Meropenem|meropenem|mesh-list
2576540|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2576541|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576542|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2576543|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576544|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576545|NCT01633957|Warfarin|warfarin|mesh-list
2576546|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
2576547|NCT01633970|Leucovorin|leucovorin|mesh-list
2576548|NCT01633970|Paclitaxel|paclitaxel|mesh-list
2576549|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2131559|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2131560|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
2576550|NCT01633970|Bevacizumab|bevacizumab|mesh-list
2576551|NCT01633970|Carboplatin|carboplatin|mesh-list
2576552|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
2576553|NCT01633970|Pemetrexed|pemetrexed|mesh-list
2576554|NCT01633970|Atezolizumab|atezolizumab|mesh-list
2131561|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
2131562|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
2131563|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131564|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131565|NCT03021642|Tepotinib|tepotinib|mesh-list
2131566|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131567|NCT03022526|Fentanyl|fentanyl|mesh-list
2131568|NCT03022526|Bupivacaine|bupivacaine|mesh-list
2576555|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2576556|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576557|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
2576558|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
2576559|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
2576560|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131569|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
2131570|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
2131571|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131572|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131573|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
2131574|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131575|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2131576|NCT03022526|Narcotics|narcotics|mesh-ancestor
2131577|NCT03022526|Analgesics|analgesics|mesh-ancestor
2131578|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2131579|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2131580|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
2131581|NCT03022617|Apremilast|apremilast|mesh-list
2131582|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2131583|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2131584|NCT03022617|Analgesics|analgesics|mesh-ancestor
2131585|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
2131586|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131587|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131588|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2131589|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2131590|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2131591|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2131592|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131593|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131594|NCT03022916|Efinaconazole|efinaconazole|mesh-list
2131595|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2131596|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
2131597|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131598|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
2131599|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2131600|NCT03022981|Velpatasvir|velpatasvir|mesh-list
2131601|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
2131602|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131603|NCT03023423|Atezolizumab|atezolizumab|mesh-list
2131604|NCT03023423|Daratumumab|daratumumab|mesh-list
2131605|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131606|NCT03023722|Maytansine|maytansine|mesh-list
2131607|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2131608|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131609|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
2131610|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
2131611|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
2131612|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131613|NCT03023878|Dexamethasone|dexamethasone|mesh-list
2131614|NCT03023878|Blinatumomab|blinatumomab|mesh-list
2131615|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2131616|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
2131617|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
2131618|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131619|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131620|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2131621|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
2131622|NCT03023878|Hormones|hormones|mesh-ancestor
2131623|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2131624|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2131625|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131626|NCT03023891|Prednisone|prednisone|mesh-list
2576561|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2576562|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2576563|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2576564|NCT01633970|Growth Substances|growth substances|mesh-ancestor
2576565|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576566|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
2576567|NCT01633970|Antidotes|antidotes|mesh-ancestor
2576568|NCT01633970|Protective Agents|protective agents|mesh-ancestor
2576569|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
2576570|NCT01633970|Vitamins|vitamins|mesh-ancestor
2576571|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
2576572|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576573|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2576574|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2576575|NCT01633983|Methotrexate|methotrexate|mesh-list
2576576|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2576577|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
2576578|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2576579|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576580|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2576581|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
2576582|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576583|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576584|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
2576585|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576586|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2576587|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2576588|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
2576589|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2419613|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419614|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419615|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2131627|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2131628|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
2131629|NCT03023891|Hormones|hormones|mesh-ancestor
2131630|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2131631|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131632|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2131633|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131634|NCT03025945|Nepafenac|nepafenac|mesh-list
2131635|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2131636|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2131637|NCT03025945|Analgesics|analgesics|mesh-ancestor
2131638|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
2131639|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131640|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131641|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2131642|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2131643|NCT03026088|Bisoprolol|bisoprolol|mesh-list
2131644|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2131645|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
2131646|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
2131647|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131648|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131649|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2419616|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2576590|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2576591|NCT01634061|Dactolisib|dactolisib|mesh-list
2576592|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576593|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
2576594|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2576595|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
2576596|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419617|NCT00804297|Octreotide|octreotide|mesh-list
2419618|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2419619|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2419620|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419621|NCT00804310|Lapatinib|lapatinib|mesh-list
2419622|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419623|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2419624|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419625|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419626|NCT00804336|Everolimus|everolimus|mesh-list
2419627|NCT00804336|Pasireotide|pasireotide|mesh-list
2576597|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576598|NCT01634295|Niacin|niacin|mesh-list
2576599|NCT01634295|Amlodipine|amlodipine|mesh-list
2576600|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2576601|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2576602|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2576603|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576604|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2576605|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576606|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
2576607|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2576608|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
2576609|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2576610|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
2576611|NCT01634295|Vitamins|vitamins|mesh-ancestor
2576612|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
2576613|NCT01634321|Leuprolide|leuprolide|mesh-list
2576614|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2576615|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
2576616|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2576617|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576618|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2576619|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576620|NCT01634347|Propranolol|propranolol|mesh-list
2576621|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2576622|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2576623|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
2576624|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576625|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576626|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576627|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2576628|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2131650|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2131651|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2131652|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
2131653|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131654|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131655|NCT03026166|Nivolumab|nivolumab|mesh-list
2131656|NCT03026166|Ipilimumab|ipilimumab|mesh-list
2131657|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2131658|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131659|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2131660|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131661|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2576629|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
2576630|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2576631|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
2576632|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2576633|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2576634|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2576635|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2576636|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576637|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2131662|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
2131663|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2131664|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2131665|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131666|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
2131667|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
2131668|NCT03026556|Apixaban|apixaban|mesh-list
2131669|NCT03026556|Dabigatran|dabigatran|mesh-list
2131670|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2131671|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
2131672|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2131673|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
2131674|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131675|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131676|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
2131677|NCT03026803|Capecitabine|capecitabine|mesh-list
2131678|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
2131679|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2131680|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
2131681|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131682|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131683|NCT03027557|Denosumab|denosumab|mesh-list
2131684|NCT03027557|Cinacalcet|cinacalcet|mesh-list
2576638|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
2576639|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2576640|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2576641|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2576642|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2576643|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576644|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2576645|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
2131685|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2131686|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131687|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2131688|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2131689|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
2131690|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2131691|NCT03027661|Bupivacaine|bupivacaine|mesh-list
2131692|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
2131693|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
2131694|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131695|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131696|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
2131697|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131698|NCT03028012|Dexamethasone|dexamethasone|mesh-list
2131699|NCT03028012|Ketorolac|ketorolac|mesh-list
2576646|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2576647|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2576648|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2576649|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2576650|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576651|NCT01634412|Amitriptyline|amitriptyline|mesh-list
2576652|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
2576653|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2576654|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
2576655|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2576656|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2576657|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576658|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2576659|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576660|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2576661|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2576662|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2576663|NCT01634412|Analgesics|analgesics|mesh-ancestor
2576664|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
2576665|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2576666|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2131700|NCT03028012|Lidocaine|lidocaine|mesh-list
2131701|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2131702|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
2131703|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
2131704|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131705|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131706|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2131707|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
2131708|NCT03028012|Hormones|hormones|mesh-ancestor
2576667|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2576668|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576669|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
2576670|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576671|NCT01634438|Heparin|heparin|mesh-list
2576672|NCT01634438|Calcium heparin|calcium heparin|mesh-list
2576673|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
2576674|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2131709|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2131710|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2131711|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131712|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
2131713|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
2131714|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131715|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
2131716|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2131717|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2131718|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2131719|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2131720|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131721|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2131722|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2131723|NCT03028012|Analgesics|analgesics|mesh-ancestor
2131724|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2131725|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2131726|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131727|NCT03028025|Hemostatics|hemostatics|mesh-list
2131728|NCT03028025|Coagulants|coagulants|mesh-ancestor
2131729|NCT03028103|Repaglinide|repaglinide|mesh-list
2131730|NCT03028103|Fluconazole|fluconazole|mesh-list
2131731|NCT03028103|Omeprazole|omeprazole|mesh-list
2131732|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2131733|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2131734|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2576675|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2576676|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576677|NCT01634594|Nicardipine|nicardipine|mesh-list
2576678|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
2576679|NCT01634594|Remifentanil|remifentanil|mesh-list
2576680|NCT01634594|Sevoflurane|sevoflurane|mesh-list
2576681|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2576682|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2576683|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131735|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131736|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131737|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
2131738|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131739|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2131740|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2131741|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2131742|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
2131743|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2576684|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2576685|NCT01634594|Analgesics|analgesics|mesh-ancestor
2576686|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
2576687|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576688|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2576689|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2576690|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2576691|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
2576692|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576693|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576694|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2576695|NCT01634594|Narcotics|narcotics|mesh-ancestor
2576696|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2576697|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2576698|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
2576699|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
2576700|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2131744|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131745|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2131746|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2131747|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2131748|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2131749|NCT03028129|Isoniazid|isoniazid|mesh-list
2131750|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131751|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
2131752|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2131753|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2131754|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
2131755|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131756|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2131757|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
2131758|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2131759|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
2131760|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131761|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131762|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2131763|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
2131764|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
2131765|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2131766|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
2131767|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131768|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131769|NCT03028467|Folic Acid|folic acid|mesh-list
2131770|NCT03028467|Methotrexate|methotrexate|mesh-list
2131771|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2131772|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
2131773|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2131774|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131775|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2131776|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
2131777|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131778|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131779|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
2131780|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576701|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2576702|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2576703|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2131781|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2131782|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2131783|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
2131784|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2131785|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2131786|NCT03028467|Hematinics|hematinics|mesh-ancestor
2131787|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
2576704|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
2576705|NCT01634685|Capecitabine|capecitabine|mesh-list
2576706|NCT01634685|Bavituximab|bavituximab|mesh-list
2576707|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2576708|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
2576709|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576710|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576711|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2576712|NCT01634698|Vitamin A|vitamin a|mesh-list
2576713|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
2576714|NCT01634698|Vitamins|vitamins|mesh-ancestor
2576715|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
2576716|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576717|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
2576718|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576719|NCT01634698|Protective Agents|protective agents|mesh-ancestor
2576720|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2576721|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576722|NCT01634763|Ceritinib|ceritinib|mesh-list
2576723|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576724|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2576725|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576726|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576727|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
2576728|NCT01634789|Estrogens|estrogens|mesh-list
2576729|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2576730|NCT01634789|Hormones|hormones|mesh-ancestor
2576731|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2576732|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576733|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2576734|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2576735|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
2576736|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2131788|NCT03028467|Vitamins|vitamins|mesh-ancestor
2131789|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
2131790|NCT03028870|Naproxen|naproxen|mesh-list
2131791|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2131792|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2131793|NCT03028870|Analgesics|analgesics|mesh-ancestor
2131794|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
2131795|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131796|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131797|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2131798|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2131799|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
2131800|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2131801|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131802|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131807|NCT03029091|Losartan|losartan|mesh-list
2576737|NCT01634880|Panitumumab|panitumumab|mesh-list
2576738|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2576739|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576740|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
2576741|NCT01634893|Sorafenib|sorafenib|mesh-list
2131808|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2131809|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2131810|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2131811|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2131812|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131813|NCT03029143|Vedolizumab|vedolizumab|mesh-list
2131814|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2131815|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
2131816|NCT03029208|Hematinics|hematinics|mesh-ancestor
2131817|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
2131818|NCT03029247|Hematinics|hematinics|mesh-ancestor
2131819|NCT03029650|Scopolamine|scopolamine|mesh-list
2131820|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2131821|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2131822|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
2131823|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
2131824|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131825|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131826|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2131827|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
2131828|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2131829|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
2131830|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131831|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131832|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2131833|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
2131834|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
2131835|NCT03029715|Remifentanil|remifentanil|mesh-list
2131836|NCT03029715|Propofol|propofol|mesh-list
2131837|NCT03029715|Desflurane|desflurane|mesh-list
2131838|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2131839|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131840|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131841|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2131842|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
2131843|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
2131844|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2131845|NCT03029715|Analgesics|analgesics|mesh-ancestor
2131846|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
2131847|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131848|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2131849|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2131850|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2131851|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
2131852|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131853|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131854|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2131855|NCT03029715|Narcotics|narcotics|mesh-ancestor
2131856|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2131857|NCT03029780|Nivolumab|nivolumab|mesh-list
2131858|NCT03029780|Ipilimumab|ipilimumab|mesh-list
2131859|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2131860|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2131861|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2131862|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131863|NCT03029819|Nicotine|nicotine|mesh-list
2131864|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2131865|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
2131866|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131867|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131868|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2131869|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2131870|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
2131871|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131872|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131873|NCT03030638|Olodaterol|olodaterol|mesh-list
2131874|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2131875|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
2131876|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131877|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131878|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2576742|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576743|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2576744|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576745|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131879|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
2131880|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
2131881|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2131882|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2131883|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131884|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
2131885|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
2576746|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
2576747|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2576748|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2576749|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576750|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2576751|NCT01634906|Atorvastatin|atorvastatin|mesh-list
2576752|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2576753|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2131886|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2131887|NCT03031496|Amiloride|amiloride|mesh-list
2131888|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
2131889|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2131890|NCT03031496|Diuretics|diuretics|mesh-ancestor
2131891|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
2131892|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131893|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2131894|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2131895|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131896|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2131897|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2131898|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2131899|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2131900|NCT03031795|Ketorolac|ketorolac|mesh-list
2131901|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2131902|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2131903|NCT03031795|Analgesics|analgesics|mesh-ancestor
2131904|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
2131905|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131906|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131907|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2131908|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2131909|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2131910|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131911|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131912|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
2131913|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
2131914|NCT03031899|Coagulants|coagulants|mesh-ancestor
2131915|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
2131916|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131919|NCT03032380|Meropenem|meropenem|mesh-list
2131920|NCT03032380|Linezolid|linezolid|mesh-list
2131921|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2131922|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131923|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2131924|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131925|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131940|NCT03032965|Adenosine|adenosine|mesh-list
2576754|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2576755|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
2576756|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576757|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2576758|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2131941|NCT03032965|Isoproterenol|isoproterenol|mesh-list
2131942|NCT03032965|Analgesics|analgesics|mesh-ancestor
2131943|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
2131944|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131945|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131946|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2131947|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
2131948|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2576759|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576760|NCT01634932|Iron|iron|mesh-list
2576761|NCT01634932|Trace Elements|trace elements|mesh-ancestor
2576762|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
2576763|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576764|NCT01634945|Amodiaquine|amodiaquine|mesh-list
2576765|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
2131949|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
2131950|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
2131951|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131952|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131953|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2131954|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2131955|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
2131956|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2131957|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
2576766|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2576767|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2576768|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576769|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2576770|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2576771|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
2576772|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576773|NCT01634958|Antacids|antacids|mesh-ancestor
2576774|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576775|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2576776|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
2576777|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2576778|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
2576779|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2576780|NCT01635114|Resveratrol|resveratrol|mesh-list
2576781|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
2576782|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576783|NCT01635114|Protective Agents|protective agents|mesh-ancestor
2576784|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576785|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576786|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2576787|NCT01635205|Anesthetics|anesthetics|mesh-list
2576788|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131958|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2131959|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
2131960|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2131961|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
2131962|NCT03032965|Protective Agents|protective agents|mesh-ancestor
2131963|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2131964|NCT03033394|Penicillins|penicillins|mesh-list
2131965|NCT03033394|Lactams|lactams|mesh-list
2131966|NCT03033394|beta-Lactams|beta-lactams|mesh-list
2131967|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2131968|NCT03033511|Dexamethasone|dexamethasone|mesh-list
2131969|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
2131970|NCT03033511|BB 1101|bb 1101|mesh-list
2131971|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
2131972|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2131973|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
2131974|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
2131975|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2131976|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131977|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2131978|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
2131979|NCT03033511|Hormones|hormones|mesh-ancestor
2131980|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2131981|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2131982|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576789|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131983|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
2131984|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131985|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131986|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
2131987|NCT03033784|Oxytocin|oxytocin|mesh-list
2131988|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
2131989|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2131990|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2131991|NCT03034018|Suvorexant|suvorexant|mesh-list
2131992|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2131993|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2131994|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2131995|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576790|NCT01635296|Cytarabine|cytarabine|mesh-list
2576791|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2576792|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
2576793|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576794|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576795|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
2576796|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576797|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2576798|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
2576799|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576800|NCT01635400|Irinotecan|irinotecan|mesh-list
2576801|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2576802|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2576803|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2131996|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2131997|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2131998|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2131999|NCT03034135|Copper|copper|mesh-list
2132000|NCT03034135|Temozolomide|temozolomide|mesh-list
2132001|NCT03034135|Disulfiram|disulfiram|mesh-list
2132002|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2132003|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
2132004|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132005|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132006|NCT03034135|Trace Elements|trace elements|mesh-ancestor
2132007|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
2132008|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132009|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2132010|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2132011|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132012|NCT03034577|Neostigmine|neostigmine|mesh-list
2132013|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2132014|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132015|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132016|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
2132017|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132018|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132019|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2132020|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
2132021|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132022|NCT03034772|Timolol|timolol|mesh-list
2132023|NCT03034772|Dorzolamide|dorzolamide|mesh-list
2132024|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
2132025|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2132026|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2132027|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
2132028|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132029|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132030|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132031|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2132032|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2132033|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2132034|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2132035|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2132036|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132037|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2132038|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2132039|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
2132040|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132041|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132042|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2576804|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576805|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419628|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419629|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2419630|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
2419631|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419632|NCT00804336|Hormones|hormones|mesh-ancestor
2419633|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2419634|NCT00804388|Vitamin E|vitamin e|mesh-list
2419635|NCT00804388|Vitamins|vitamins|mesh-ancestor
2419636|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
2419637|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419638|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
2419639|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132043|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
2132044|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2132045|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2132046|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2132047|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
2132048|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576806|NCT01635426|Aspirin|aspirin|mesh-list
2576807|NCT01635426|Clopidogrel|clopidogrel|mesh-list
2576808|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2576809|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2576810|NCT01635426|Analgesics|analgesics|mesh-ancestor
2576811|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
2576812|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576813|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576814|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2576815|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2576816|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2576817|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2576818|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132049|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132050|NCT03035032|Leuprolide|leuprolide|mesh-list
2132051|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2132052|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
2132053|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2132054|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132055|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2132056|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132057|NCT03035708|Varenicline|varenicline|mesh-list
2132058|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2132059|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2132060|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
2132061|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132062|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132063|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132064|NCT03035760|Oxfendazole|oxfendazole|mesh-list
2132065|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
2132066|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2132067|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2132068|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
2132069|NCT03035916|Anesthetics|anesthetics|mesh-list
2132070|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132071|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132072|NCT03035929|Dexamethasone|dexamethasone|mesh-list
2132073|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
2132074|NCT03035929|BB 1101|bb 1101|mesh-list
2132075|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2132076|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
2132077|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
2132078|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132079|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132080|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2132081|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
2132082|NCT03035929|Hormones|hormones|mesh-ancestor
2132083|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2132084|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2132085|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132086|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
2132087|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132088|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419640|NCT00804388|Protective Agents|protective agents|mesh-ancestor
2132089|NCT03035942|Dexamethasone|dexamethasone|mesh-list
2132090|NCT03035942|Ondansetron|ondansetron|mesh-list
2132091|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2132092|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
2132093|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
2132094|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132095|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132096|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2132097|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
2132098|NCT03035942|Hormones|hormones|mesh-ancestor
2132099|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2132100|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2132101|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132102|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
2132103|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
2132104|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2132105|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
2132106|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132107|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132108|NCT03035942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2132109|NCT03035942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2132110|NCT03035942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132111|NCT03035942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2576819|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2576820|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2576821|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576822|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
2132112|NCT03035942|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2132113|NCT03035955|Azelaic acid|azelaic acid|mesh-list
2132114|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132115|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
2132116|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
2132117|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2132118|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132119|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2132120|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132121|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
2132122|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2132123|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132124|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2132125|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132126|NCT03036163|Macozinone|macozinone|mesh-list
2132127|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
2132128|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2132129|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2132130|NCT03036384|Sufentanil|sufentanil|mesh-list
2132131|NCT03036384|Morphine|morphine|mesh-list
2132132|NCT03036384|Prilocaine|prilocaine|mesh-list
2132133|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2132134|NCT03036384|Narcotics|narcotics|mesh-ancestor
2132135|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132136|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132137|NCT03036384|Analgesics|analgesics|mesh-ancestor
2132138|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
2132139|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132140|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2132141|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2132142|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
2132143|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
2132144|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
2132145|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
2132146|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2132147|NCT03036839|Ledipasvir|ledipasvir|mesh-list
2132148|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
2132149|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2132150|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
2132151|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2132152|NCT03036852|Velpatasvir|velpatasvir|mesh-list
2132153|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
2132154|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2132155|NCT03037580|Treprostinil|treprostinil|mesh-list
2132156|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2132157|NCT03038308|Ropinirole|ropinirole|mesh-list
2132158|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2132159|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2132160|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
2132161|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
2132162|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419641|NCT00804401|Naproxen|naproxen|mesh-list
2419642|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2419643|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419644|NCT00804401|Analgesics|analgesics|mesh-ancestor
2419645|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
2419646|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419647|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419648|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419649|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2132163|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132164|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132165|NCT03038620|Liraglutide|liraglutide|mesh-list
2132166|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2132167|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132168|NCT03038620|Incretins|incretins|mesh-ancestor
2132169|NCT03038620|Hormones|hormones|mesh-ancestor
2132170|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2132171|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2132172|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2132173|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2132174|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2132175|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132176|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132177|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132178|NCT03038867|Analgesics|analgesics|mesh-ancestor
2132179|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
2132180|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132181|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
2132182|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2132183|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
2132184|NCT03038880|Ranibizumab|ranibizumab|mesh-list
2132185|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2132186|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2132187|NCT03038880|Growth Substances|growth substances|mesh-ancestor
2132188|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132189|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
2132190|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132191|NCT03039023|Choline|choline|mesh-list
2132192|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
2132193|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2132194|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
2132195|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132196|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2132197|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2132198|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
2132199|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
2132200|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2132201|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
2132202|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132203|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132204|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132205|NCT03039192|Esketamine|esketamine|mesh-list
2132206|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
2576823|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2576824|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2576825|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2576826|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
2576827|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576828|NCT01635530|Doxycycline|doxycycline|mesh-list
2576829|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
2576830|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2576831|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576832|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
2576833|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2576834|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2576835|NCT01635608|Acetaminophen|acetaminophen|mesh-list
2576836|NCT01635608|Amoxicillin|amoxicillin|mesh-list
2576837|NCT01635608|Talinolol|talinolol|mesh-list
2576838|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2576839|NCT01635608|Analgesics|analgesics|mesh-ancestor
2576840|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
2576841|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576842|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576843|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
2576844|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2132207|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2132208|NCT03039543|Rocuronium|rocuronium|mesh-list
2132209|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2132210|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2132211|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2132212|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132213|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132214|NCT03040011|Dexamethasone|dexamethasone|mesh-list
2132215|NCT03040011|Bupivacaine|bupivacaine|mesh-list
2132216|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2132217|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
2132218|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
2132219|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132220|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132221|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2132222|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
2132223|NCT03040011|Hormones|hormones|mesh-ancestor
2132224|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2132225|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2132226|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132227|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
2132228|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
2132229|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132230|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
2132231|NCT03040024|Ketamine|ketamine|mesh-list
2576845|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576846|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2576847|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2576848|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
2576849|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576850|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576851|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2576852|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2576853|NCT01635686|Etanercept|etanercept|mesh-list
2576854|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2576855|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2576856|NCT01635686|Analgesics|analgesics|mesh-ancestor
2576857|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
2576858|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576859|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576860|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2576861|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2576862|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2576863|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2576864|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
2576865|NCT01635751|Pregabalin|pregabalin|mesh-list
2576866|NCT01635751|Analgesics|analgesics|mesh-ancestor
2576867|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
2576868|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576869|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576870|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
2576871|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2576872|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2576873|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576874|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2576875|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2576876|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2576877|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2576878|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2576879|NCT01635777|Miltefosine|miltefosine|mesh-list
2576880|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
2576881|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576882|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576883|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2576884|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2576885|NCT01635790|Bevacizumab|bevacizumab|mesh-list
2576886|NCT01635790|Ranibizumab|ranibizumab|mesh-list
2576887|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2576888|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576889|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2576890|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2576891|NCT01635790|Growth Substances|growth substances|mesh-ancestor
2576892|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576893|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
2132232|NCT03040024|Analgesics|analgesics|mesh-ancestor
2576894|NCT01635803|Bevacizumab|bevacizumab|mesh-list
2576895|NCT01635803|Ranibizumab|ranibizumab|mesh-list
2576896|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2576897|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576898|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2576899|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2576900|NCT01635803|Growth Substances|growth substances|mesh-ancestor
2132233|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
2132234|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132235|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576901|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576902|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
2576903|NCT01635816|Vaccines|vaccines|mesh-list
2576904|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
2576905|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576906|NCT01635829|Carbamazepine|carbamazepine|mesh-list
2576907|NCT01635829|Phenytoin|phenytoin|mesh-list
2576908|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
2576909|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
2576910|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2576911|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2576912|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576913|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2132236|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2132237|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2132238|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
2132239|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
2132240|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132241|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2132242|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2132243|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132244|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132245|NCT03040362|Lasmiditan|lasmiditan|mesh-list
2132246|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2576914|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2576915|NCT01635829|Analgesics|analgesics|mesh-ancestor
2576916|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
2576917|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2576918|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2132247|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
2132248|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132249|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132250|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132251|NCT03040479|Lasmiditan|lasmiditan|mesh-list
2132252|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2132253|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
2132254|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132255|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132256|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132257|NCT03041181|Gemcitabine|gemcitabine|mesh-list
2132258|NCT03041181|Docetaxel|docetaxel|mesh-list
2132259|NCT03041181|Nivolumab|nivolumab|mesh-list
2132260|NCT03041181|Pemetrexed|pemetrexed|mesh-list
2132261|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2132262|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
2132263|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132264|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132265|NCT03041181|Antiviral Agents|antiviral agents|mesh-ancestor
2132266|NCT03041181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2132267|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132268|NCT03041181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2132269|NCT03041181|Immunologic Factors|immunologic factors|mesh-ancestor
2132270|NCT03041181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132271|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
2132272|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
2132273|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
2132274|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2132275|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2132276|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2132277|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2132278|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2132279|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
2132280|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
2132281|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576919|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2576920|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576921|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2576922|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2576923|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2576924|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2576925|NCT01635946|Isavuconazole|isavuconazole|mesh-list
2576926|NCT01635946|Atorvastatin|atorvastatin|mesh-list
2576927|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2576928|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2576929|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
2576930|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576931|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2576932|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2576933|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576934|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
2576935|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2132282|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2132283|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2132284|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132285|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132286|NCT03041792|Liraglutide|liraglutide|mesh-list
2132287|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2132288|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132289|NCT03041792|Incretins|incretins|mesh-ancestor
2132290|NCT03041792|Hormones|hormones|mesh-ancestor
2132291|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2132292|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2132293|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2132294|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2132295|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576936|NCT01635972|Isavuconazole|isavuconazole|mesh-list
2576937|NCT01635972|Bupropion|bupropion|mesh-list
2576938|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2576939|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
2576940|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2576941|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2576942|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2576943|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2576944|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576945|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
2576946|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132296|NCT03042312|177Lu-PSMA-617|177lu-psma-617|mesh-list
2132297|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2132298|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132299|NCT03042910|Talazoparib|talazoparib|mesh-list
2132300|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2132301|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132302|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132303|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132304|NCT03043105|Thalidomide|thalidomide|mesh-list
2132305|NCT03043105|Prednisone|prednisone|mesh-list
2132306|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
2132307|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2132308|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
2132309|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132310|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2132311|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2132312|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
2132313|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132314|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132315|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2132316|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2132317|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
2132318|NCT03043105|Hormones|hormones|mesh-ancestor
2132319|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2132320|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2132321|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
2132322|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2132323|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2132324|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2132325|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2576947|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576948|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2576949|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2576950|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576951|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
2576952|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576953|NCT01636037|Levodopa|levodopa|mesh-list
2576954|NCT01636037|Carbidopa|carbidopa|mesh-list
2132326|NCT03043105|Growth Substances|growth substances|mesh-ancestor
2132327|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
2132328|NCT03043274|Cangrelor|cangrelor|mesh-list
2132329|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2132330|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2132331|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2132332|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2132333|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
2132334|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132335|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419650|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
2419651|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2419652|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419653|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419654|NCT00804440|Ibuprofen|ibuprofen|mesh-list
2419655|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2419656|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419657|NCT00804440|Analgesics|analgesics|mesh-ancestor
2419658|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
2419659|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419660|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419661|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2132336|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132337|NCT03043560|Ezogabine|ezogabine|mesh-list
2132338|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
2132339|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2132340|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132341|NCT03043599|Nivolumab|nivolumab|mesh-list
2132342|NCT03043599|Ipilimumab|ipilimumab|mesh-list
2132343|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2132344|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132345|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2132346|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132347|NCT03043651|Treprostinil|treprostinil|mesh-list
2132348|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2132349|NCT03043872|Carboplatin|carboplatin|mesh-list
2132350|NCT03043872|Etoposide|etoposide|mesh-list
2132351|NCT03043872|Durvalumab|durvalumab|mesh-list
2132352|NCT03043872|Tremelimumab|tremelimumab|mesh-list
2132353|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132354|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2132355|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2132356|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2132357|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132358|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132359|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2132360|NCT03044418|Propofol|propofol|mesh-list
2132361|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
2132362|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132363|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132364|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2132365|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2132366|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
2132367|NCT03044730|Capecitabine|capecitabine|mesh-list
2132368|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
2132369|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2132370|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
2132371|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132372|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132373|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2132374|NCT03044886|Vitamin D|vitamin d|mesh-list
2132375|NCT03044886|Vitamins|vitamins|mesh-ancestor
2132376|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
2132377|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132378|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2132379|NCT03045328|Venetoclax|venetoclax|mesh-list
2576955|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2576956|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2576957|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2576958|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
2576959|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576960|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576961|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576962|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2576963|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576964|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2576965|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
2576966|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
2576967|NCT01636128|Eflornithine|eflornithine|mesh-list
2576968|NCT01636128|Sulindac|sulindac|mesh-list
2132380|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132381|NCT03045653|Tamoxifen|tamoxifen|mesh-list
2132382|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2132383|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
2132384|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2132385|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132386|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2132387|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132388|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2132389|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2132390|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2132391|NCT03045861|Cobicistat|cobicistat|mesh-list
2132392|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
2132393|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2132394|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2132395|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
2132396|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2132397|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2132398|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2132399|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132400|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132401|NCT03046446|FX006|fx006|mesh-list
2132402|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2132403|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
2132404|NCT03046446|Hormones|hormones|mesh-ancestor
2132405|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2132406|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132407|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2132408|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
2132409|NCT03047980|Sirolimus|sirolimus|mesh-list
2132410|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2132411|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2132412|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2132413|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132414|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
2132415|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2132416|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
2132417|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132418|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2132419|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
2132420|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
2132421|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132422|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2132423|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2132424|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2132425|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2132426|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2132427|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
2132428|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132429|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132430|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132431|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2132432|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2132433|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2132434|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132435|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132436|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2132437|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2132438|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132439|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
2132440|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576969|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2576970|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2576971|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2576972|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2576973|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2576974|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2576975|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2576976|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132464|NCT03048500|Metformin|metformin|mesh-list
2132465|NCT03048500|Nivolumab|nivolumab|mesh-list
2132466|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2132467|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132468|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2132469|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132470|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2132471|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132472|NCT03048747|Tolvaptan|tolvaptan|mesh-list
2132473|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2132474|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132475|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
2132476|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132477|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2132478|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2132479|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
2132480|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132481|NCT03049488|Antacids|antacids|mesh-ancestor
2132482|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132483|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2132484|NCT03050294|Desoximetasone|desoximetasone|mesh-list
2132485|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2132486|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
2132487|NCT03050294|Hormones|hormones|mesh-ancestor
2132488|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2132489|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132490|NCT03050307|Lansoprazole|lansoprazole|mesh-list
2132491|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
2132492|NCT03050307|Bismuth|bismuth|mesh-list
2132493|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2132494|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2132495|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2132496|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132497|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132498|NCT03050307|Antacids|antacids|mesh-ancestor
2132499|NCT03050359|Lansoprazole|lansoprazole|mesh-list
2132500|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
2132501|NCT03050359|Bismuth|bismuth|mesh-list
2132502|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2132503|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2576977|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2576978|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2576979|NCT01636128|Analgesics|analgesics|mesh-ancestor
2576980|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
2576981|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132504|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2132505|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132506|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132507|NCT03050359|Antacids|antacids|mesh-ancestor
2132508|NCT03050450|Lenalidomide|lenalidomide|mesh-list
2132509|NCT03050450|Vorinostat|vorinostat|mesh-list
2132510|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
2132511|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132512|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2132513|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2132514|NCT03050450|Growth Substances|growth substances|mesh-ancestor
2132515|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
2576982|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576983|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2576984|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2576985|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2576986|NCT01636141|Dapansutrile|dapansutrile|mesh-list
2576987|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2576988|NCT01636180|Clopidogrel|clopidogrel|mesh-list
2576989|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2576990|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2576991|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2576992|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2576993|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
2576994|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2576995|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2576996|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2576997|NCT01636245|Vaccines|vaccines|mesh-list
2576998|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
2576999|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577000|NCT01636271|Darapladib|darapladib|mesh-list
2577001|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2577002|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577003|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577004|NCT01636310|Nicotine|nicotine|mesh-list
2577005|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2577006|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
2577007|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132516|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132517|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2132518|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132519|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132520|NCT03050619|Empagliflozin|empagliflozin|mesh-list
2132521|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2132522|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132523|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2132524|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132525|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2132526|NCT03051100|Atorvastatin|atorvastatin|mesh-list
2132527|NCT03051100|Ezetimibe|ezetimibe|mesh-list
2132528|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2132529|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2132530|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
2132531|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132532|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2132533|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2132534|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132535|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2132536|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132542|NCT03051256|Methadone|methadone|mesh-list
2132543|NCT03051256|D-methadone|d-methadone|mesh-list
2132544|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2132545|NCT03051256|Narcotics|narcotics|mesh-ancestor
2132546|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2577008|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577009|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2577010|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2577011|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
2577012|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2577013|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577014|NCT01636323|Nicotine|nicotine|mesh-list
2577015|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2577016|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
2577017|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577018|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577019|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2577020|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2577021|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
2577022|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2577023|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577024|NCT01636336|Nicotine|nicotine|mesh-list
2577025|NCT01636336|Progesterone|progesterone|mesh-list
2577026|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2577027|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
2577028|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577029|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577030|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2577031|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2577032|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
2577033|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2577034|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577035|NCT01636336|Progestins|progestins|mesh-ancestor
2577036|NCT01636336|Hormones|hormones|mesh-ancestor
2577037|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2577038|NCT01636401|Bromides|bromides|mesh-list
2577039|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
2577040|NCT01636505|Cetrorelix|cetrorelix|mesh-list
2577041|NCT01636505|Buserelin|buserelin|mesh-list
2577042|NCT01636505|Ganirelix|ganirelix|mesh-list
2577043|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2577044|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
2577045|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2577046|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577047|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
2132547|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132548|NCT03051256|Analgesics|analgesics|mesh-ancestor
2132549|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
2132550|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132551|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
2132552|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
2132553|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2132554|NCT03051620|Alendronate|alendronate|mesh-list
2132555|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2132556|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132557|NCT03051646|Aspirin|aspirin|mesh-list
2132558|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2132559|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2132560|NCT03051646|Analgesics|analgesics|mesh-ancestor
2132561|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
2132562|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132563|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132564|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2132565|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2132566|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2132567|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2132568|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132569|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2132570|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2132571|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132572|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
2132573|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
2132574|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2132575|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132576|NCT03052322|Adalimumab|adalimumab|mesh-list
2132577|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2132578|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2132579|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
2132580|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2132581|NCT03052517|Growth Substances|growth substances|mesh-ancestor
2577048|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2577049|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2577050|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
2577051|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577052|NCT01636557|Vitamin K|vitamin k|mesh-list
2577053|NCT01636557|Midazolam|midazolam|mesh-list
2577054|NCT01636557|Caffeine|caffeine|mesh-list
2577055|NCT01636557|Omeprazole|omeprazole|mesh-list
2577056|NCT01636557|Warfarin|warfarin|mesh-list
2577057|NCT01636557|Vitamins|vitamins|mesh-ancestor
2577058|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
2577059|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577060|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2577061|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2577062|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2577063|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2577064|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2577065|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2577066|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2577067|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
2577068|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
2577069|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
2577070|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
2132582|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132588|NCT03052725|Reslizumab|reslizumab|mesh-list
2132589|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2132590|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
2132591|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
2132592|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2132593|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
2132594|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132595|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
2132596|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2132597|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2132598|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2132599|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2132600|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132601|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
2132602|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132603|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132604|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2132605|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132606|NCT03052816|Hydromorphone|hydromorphone|mesh-list
2132607|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2132608|NCT03052816|Narcotics|narcotics|mesh-ancestor
2132609|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132610|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132611|NCT03052816|Analgesics|analgesics|mesh-ancestor
2132612|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
2132613|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132614|NCT03053050|Selonsertib|selonsertib|mesh-list
2132615|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2132616|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132617|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132618|NCT03053063|Selonsertib|selonsertib|mesh-list
2132619|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2132620|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132621|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132622|NCT03053401|Anesthetics|anesthetics|mesh-list
2132623|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
2132624|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132625|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132626|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
2132627|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132628|NCT03053427|Gabapentin|gabapentin|mesh-list
2132629|NCT03053427|Analgesics|analgesics|mesh-ancestor
2132630|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
2132631|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132632|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132633|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
2577071|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2577072|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577073|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
2132634|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2132635|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2132636|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132637|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2132638|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2132639|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2132640|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132641|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132642|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
2132643|NCT03054103|Midazolam|midazolam|mesh-list
2132644|NCT03054103|Ketamine|ketamine|mesh-list
2132645|NCT03054103|Analgesics|analgesics|mesh-ancestor
2132646|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
2132647|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132648|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132649|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2132650|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2132651|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
2132652|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
2132653|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132654|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2132655|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2132656|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132657|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132658|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2132659|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2132660|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2132661|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2132662|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2132663|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
2132664|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
2577074|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2577075|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2577076|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2577077|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577078|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2577079|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2577080|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2577081|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2577082|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
2577083|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2577084|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2577085|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
2132665|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2132666|NCT03054506|Laxatives|laxatives|mesh-ancestor
2132667|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2132668|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
2132669|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
2132670|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
2132671|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132672|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132673|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
2132674|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132675|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
2132676|NCT03054805|Antacids|antacids|mesh-ancestor
2132677|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132678|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2132679|NCT03054844|Lidocaine|lidocaine|mesh-list
2132680|NCT03054844|Midazolam|midazolam|mesh-list
2132681|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
2132682|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
2132683|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132684|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132685|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
2132686|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132687|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2132688|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2132689|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2132690|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2132691|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132692|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2132693|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2132694|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2132695|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2577086|NCT01636557|Coagulants|coagulants|mesh-ancestor
2132696|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2132697|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2132698|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
2132699|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
2132700|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
2132701|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132702|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
2132703|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2132704|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132705|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132706|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2132707|NCT03054857|Analgesics|analgesics|mesh-ancestor
2132708|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
2132709|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132710|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2132711|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2132712|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2132713|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
2132714|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132715|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132716|NCT03054870|Xenon|xenon|mesh-list
2132717|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2132718|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
2132719|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
2132720|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132721|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132722|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
2132723|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2132724|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2132725|NCT03055221|Treprostinil|treprostinil|mesh-list
2132726|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2132727|NCT03055338|Risperidone|risperidone|mesh-list
2132728|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2132729|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
2132730|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132731|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132732|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132733|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2132734|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2132735|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132736|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2132737|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2132738|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
2132739|NCT03055936|Levodopa|levodopa|mesh-list
2132740|NCT03055936|Carbidopa|carbidopa|mesh-list
2132741|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2132742|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2132743|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
2132744|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132745|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132746|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132747|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2132748|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132749|NCT03055988|Fluticasone|fluticasone|mesh-list
2132750|NCT03055988|Xhance|xhance|mesh-list
2132751|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
2132752|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2132753|NCT03055988|Olodaterol|olodaterol|mesh-list
2132754|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2132755|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2132756|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
2132757|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132758|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132759|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2132760|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
2132761|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
2132762|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2132763|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
2132764|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2132765|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
2132766|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132767|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132768|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2132769|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2132770|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2132771|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
2132772|NCT03056040|Eculizumab|eculizumab|mesh-list
2577087|NCT01636570|Vitamin D|vitamin d|mesh-list
2577088|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
2577089|NCT01636570|Vitamins|vitamins|mesh-ancestor
2577090|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
2132773|NCT03056040|Ravulizumab|ravulizumab|mesh-list
2132774|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2132775|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2132776|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
2132777|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132778|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
2132779|NCT03056352|Promethazine|promethazine|mesh-list
2577091|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577092|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2577093|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2577094|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
2577095|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2577096|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577097|NCT01636609|Cytarabine|cytarabine|mesh-list
2577098|NCT01636609|Azacitidine|azacitidine|mesh-list
2577099|NCT01636609|Tosedostat|tosedostat|mesh-list
2577100|NCT01636609|Glycine|glycine|mesh-list
2577101|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2577102|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
2577103|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577104|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577105|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
2577106|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577107|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2577108|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
2577109|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577110|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577111|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
2577112|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2577113|NCT01636622|Paclitaxel|paclitaxel|mesh-list
2577114|NCT01636622|Carboplatin|carboplatin|mesh-list
2132780|NCT03056352|Metoclopramide|metoclopramide|mesh-list
2132781|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2132782|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2132783|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132784|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132785|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
2132786|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
2132787|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
2132788|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132789|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
2132790|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
2132791|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2132792|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2132793|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
2132794|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
2132795|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132796|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132797|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2132798|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
2132799|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
2132800|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2132801|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2132802|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
2132803|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
2132804|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2132805|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132806|NCT03057132|Protective Agents|protective agents|mesh-list
2132807|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132808|NCT03057366|Paclitaxel|paclitaxel|mesh-list
2132809|NCT03057366|Docetaxel|docetaxel|mesh-list
2132810|NCT03057366|Carboplatin|carboplatin|mesh-list
2132811|NCT03057366|Pevonedistat|pevonedistat|mesh-list
2132812|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2132813|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132814|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
2132815|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
2132816|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
2132817|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132818|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132819|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
2132820|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2577115|NCT01636622|Vemurafenib|vemurafenib|mesh-list
2577116|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2577117|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577118|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
2577119|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
2577120|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
2132821|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132822|NCT03057704|Lidocaine|lidocaine|mesh-list
2132823|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
2132824|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
2132825|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132826|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132827|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
2132828|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132829|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2132830|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2132831|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2132832|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2132833|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132834|NCT03057977|Empagliflozin|empagliflozin|mesh-list
2132835|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2132836|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132837|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2132838|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132839|NCT03058692|Vaccines|vaccines|mesh-list
2132840|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
2132841|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132842|NCT03060447|Vesatolimod|vesatolimod|mesh-list
2132843|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
2132844|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2132845|NCT03060486|Hybenx|hybenx|mesh-list
2132846|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
2132847|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
2132848|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2132849|NCT03060512|Naloxegol|naloxegol|mesh-list
2132850|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2132851|NCT03060512|Laxatives|laxatives|mesh-ancestor
2132852|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2132853|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2132854|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132855|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
2132856|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132857|NCT03061188|Nivolumab|nivolumab|mesh-list
2132858|NCT03061188|Veliparib|veliparib|mesh-list
2132859|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2132860|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132861|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2132862|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132863|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2132864|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132865|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2132866|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2132867|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132868|NCT03061214|Incretins|incretins|mesh-ancestor
2132869|NCT03061214|Hormones|hormones|mesh-ancestor
2132870|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2132871|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2132872|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
2132873|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132874|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132875|NCT03061331|Ivacaftor|ivacaftor|mesh-list
2132876|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2132877|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2132878|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132879|NCT03061812|Dexamethasone|dexamethasone|mesh-list
2132880|NCT03061812|Topotecan|topotecan|mesh-list
2132881|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2132882|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
2132883|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
2132884|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132885|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132886|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2132887|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
2132888|NCT03061812|Hormones|hormones|mesh-ancestor
2132889|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2132890|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2132891|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577121|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577122|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2577123|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577124|NCT01636700|Tramadol|tramadol|mesh-list
2577125|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2577126|NCT01636700|Narcotics|narcotics|mesh-ancestor
2577127|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2577128|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577129|NCT01636700|Analgesics|analgesics|mesh-ancestor
2577130|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
2577131|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577132|NCT01636869|Bupivacaine|bupivacaine|mesh-list
2577133|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
2577134|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
2577135|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2577136|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577137|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
2577138|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577139|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
2577140|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2577141|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
2577142|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
2577143|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2577144|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2577145|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577146|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2577147|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577148|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577149|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2577150|NCT01636895|Renal Agents|renal agents|mesh-ancestor
2577151|NCT01636908|Everolimus|everolimus|mesh-list
2577152|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2577153|NCT01636908|Sorafenib|sorafenib|mesh-list
2577154|NCT01636908|Sunitinib|sunitinib|mesh-list
2577155|NCT01636908|Dasatinib|dasatinib|mesh-list
2577156|NCT01636908|Lapatinib|lapatinib|mesh-list
2577157|NCT01636908|Vemurafenib|vemurafenib|mesh-list
2132892|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2132893|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2132894|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132895|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132896|NCT03062488|Acetaminophen|acetaminophen|mesh-list
2132897|NCT03062488|Fentanyl|fentanyl|mesh-list
2132898|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2132899|NCT03062488|Narcotics|narcotics|mesh-ancestor
2132900|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132901|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132902|NCT03062488|Analgesics|analgesics|mesh-ancestor
2132903|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
2132904|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132905|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2132906|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2132907|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
2132908|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
2132909|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2132910|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
2132911|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
2132912|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2132913|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2132914|NCT03063086|Fluticasone|fluticasone|mesh-list
2132915|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2132916|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2132917|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2132918|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
2132919|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132920|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132921|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2132922|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
2132923|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
2132924|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2132925|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2132926|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2132927|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2132928|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
2132929|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2577158|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577159|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2577160|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
2577161|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577162|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2577163|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2132930|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132931|NCT03063255|Anesthetics|anesthetics|mesh-list
2132932|NCT03063255|Mepivacaine|mepivacaine|mesh-list
2132933|NCT03063255|Rocuronium|rocuronium|mesh-list
2132934|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132935|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132936|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2132937|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2132938|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2132939|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132940|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
2132941|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
2132942|NCT03064113|Ipratropium|ipratropium|mesh-list
2132943|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2132944|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
2132945|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132946|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132947|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2132948|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
2132949|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2132950|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
2132951|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132952|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132964|NCT03065179|Nivolumab|nivolumab|mesh-list
2132965|NCT03065179|Ipilimumab|ipilimumab|mesh-list
2132966|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2132967|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132968|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2132969|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132970|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
2132971|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2132972|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2132973|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
2132974|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2132975|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2132976|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132977|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2132978|NCT03065530|Analgesics|analgesics|mesh-ancestor
2132979|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
2132980|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132981|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2132982|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2132983|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2132984|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
2132985|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132986|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2132987|NCT03066193|Palmidrol|palmidrol|mesh-list
2132988|NCT03066193|Dronabinol|dronabinol|mesh-list
2132989|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
2132990|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2132991|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2132992|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2132993|NCT03066193|Analgesics|analgesics|mesh-ancestor
2132994|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
2132995|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2132996|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2132997|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2132998|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2132999|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133000|NCT03066193|Hormones|hormones|mesh-ancestor
2133001|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2133002|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2133003|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2133004|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2133005|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
2133006|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133007|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2133008|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
2133009|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133026|NCT03066778|Carboplatin|carboplatin|mesh-list
2133027|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
2133028|NCT03066778|Etoposide|etoposide|mesh-list
2133029|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133030|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2133031|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2133032|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2133033|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2133034|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133035|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133036|NCT03066804|Valsartan|valsartan|mesh-list
2133037|NCT03066804|Enalapril|enalapril|mesh-list
2133038|NCT03066804|Enalaprilat|enalaprilat|mesh-list
2133039|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2133040|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2133041|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2133042|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2133043|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133044|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2133045|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
2133046|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133047|NCT03066830|Metformin|metformin|mesh-list
2133048|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2133049|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2133050|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133051|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2133052|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133053|NCT03066947|Interferons|interferons|mesh-list
2133054|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
2133055|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
2133056|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
2133057|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2133058|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
2133059|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133060|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2133061|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2133062|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
2133063|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133064|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133065|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2133066|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
2133067|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133068|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2133069|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2133070|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
2419662|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2577164|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577165|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2577166|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2577167|NCT01636908|Growth Substances|growth substances|mesh-ancestor
2577168|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
2577169|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
2577170|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2577171|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
2577172|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
2577173|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2577174|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577175|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2577176|NCT01636999|Analgesics|analgesics|mesh-ancestor
2577177|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
2577178|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577179|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
2577180|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
2577181|NCT01637025|Coagulants|coagulants|mesh-ancestor
2577182|NCT01637155|Vitamin D|vitamin d|mesh-list
2577183|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
2577184|NCT01637155|Vitamins|vitamins|mesh-ancestor
2577185|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
2577186|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577187|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2577188|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2577189|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2577190|NCT01637194|Cetuximab|cetuximab|mesh-list
2577191|NCT01637194|Everolimus|everolimus|mesh-list
2577192|NCT01637194|Antibodies|antibodies|mesh-list
2577193|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
2577194|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2133071|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133072|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2133073|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133074|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2133075|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133076|NCT03068312|Ivacaftor|ivacaftor|mesh-list
2133077|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2133078|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2133079|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133080|NCT03068455|Nivolumab|nivolumab|mesh-list
2133081|NCT03068455|Ipilimumab|ipilimumab|mesh-list
2133082|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2133083|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133084|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2133085|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133086|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2133087|NCT03068754|Hormones|hormones|mesh-ancestor
2133088|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2133089|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133090|NCT03068767|Vitamin D|vitamin d|mesh-list
2133091|NCT03068767|Vitamins|vitamins|mesh-ancestor
2133092|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
2133093|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133094|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2133095|NCT03068897|Ibuprofen|ibuprofen|mesh-list
2133096|NCT03068897|Tizanidine|tizanidine|mesh-list
2133097|NCT03068897|Baclofen|baclofen|mesh-list
2133098|NCT03068897|Metaxalone|metaxalone|mesh-list
2133099|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2133100|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2133101|NCT03068897|Analgesics|analgesics|mesh-ancestor
2133102|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
2133103|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133104|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133105|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2133106|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2133107|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2133108|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133109|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133110|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2133111|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2133112|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2133113|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
2577195|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
2577196|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577197|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577198|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2133114|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
2133115|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133116|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
2133117|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
2133118|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
2133119|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2133120|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2133121|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2133122|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
2133123|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
2133124|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
2133125|NCT03069313|Vitamins|vitamins|mesh-ancestor
2133126|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
2133127|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133128|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
2133129|NCT03069313|Hematinics|hematinics|mesh-ancestor
2133130|NCT03069352|Cytarabine|cytarabine|mesh-list
2133131|NCT03069352|Venetoclax|venetoclax|mesh-list
2133132|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2133133|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
2133134|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133135|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133136|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
2133137|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133138|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2133139|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
2133140|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133141|NCT03069482|Nicotine|nicotine|mesh-list
2133142|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2133143|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
2133144|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133145|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133146|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2133147|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2133148|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
2133149|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133150|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133151|NCT03069677|Midazolam|midazolam|mesh-list
2133152|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2133153|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2133154|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2133155|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133156|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2133157|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2133158|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2133159|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2133160|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
2133161|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
2133162|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
2133163|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
2133164|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133165|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133166|NCT03070171|Dabigatran|dabigatran|mesh-list
2133167|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
2133168|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2133169|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
2133170|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133171|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133172|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
2133173|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
2133174|NCT03070392|Ipilimumab|ipilimumab|mesh-list
2133175|NCT03070392|Dacarbazine|dacarbazine|mesh-list
2133176|NCT03070392|Imidazole|imidazole|mesh-list
2133177|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2133178|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133179|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2133180|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133181|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2133182|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
2133183|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133184|NCT03070470|Ritonavir|ritonavir|mesh-list
2133185|NCT03070470|Lopinavir|lopinavir|mesh-list
2133186|NCT03070470|Chloroquine|chloroquine|mesh-list
2133187|NCT03070470|Verapamil|verapamil|mesh-list
2133188|NCT03070470|Dofetilide|dofetilide|mesh-list
2133189|NCT03070470|Diltiazem|diltiazem|mesh-list
2133190|NCT03070470|Ranolazine|ranolazine|mesh-list
2577199|NCT01637233|Ritonavir|ritonavir|mesh-list
2133191|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2133192|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2133193|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
2133194|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133195|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133196|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2133197|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2133198|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
2133199|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133200|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2133201|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2133202|NCT03070470|Amebicides|amebicides|mesh-ancestor
2133203|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2577200|NCT01637233|Lopinavir|lopinavir|mesh-list
2577201|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2577202|NCT01637233|Darunavir|darunavir|mesh-list
2577203|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
2577204|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2577205|NCT01637233|Tenofovir|tenofovir|mesh-list
2577206|NCT01637233|Lamivudine|lamivudine|mesh-list
2577207|NCT01637233|Zidovudine|zidovudine|mesh-list
2577208|NCT01637233|Emtricitabine|emtricitabine|mesh-list
2577209|NCT01637233|Maraviroc|maraviroc|mesh-list
2577210|NCT01637233|Abacavir|abacavir|mesh-list
2577211|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
2577212|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2577213|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
2577214|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2133204|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2133205|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
2133206|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2133207|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133208|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2133209|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2133210|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2133211|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2133212|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
2133213|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2133214|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2133215|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2133216|NCT03070483|Vitamin D|vitamin d|mesh-list
2133217|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
2133218|NCT03070483|Vitamins|vitamins|mesh-ancestor
2133219|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
2133220|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133221|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2133222|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2133223|NCT03070548|Talazoparib|talazoparib|mesh-list
2133224|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2133225|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133226|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133227|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133228|NCT03070730|Atenolol|atenolol|mesh-list
2133229|NCT03070730|Droxidopa|droxidopa|mesh-list
2133230|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2133231|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2133232|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
2133233|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
2133234|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133235|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133236|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2133237|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2133238|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2133239|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
2133240|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133241|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133242|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2133243|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2133244|NCT03071094|Nivolumab|nivolumab|mesh-list
2133245|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2133246|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133247|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2133248|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133249|NCT03071263|Spironolactone|spironolactone|mesh-list
2577215|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577216|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577217|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2133250|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2577218|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2577219|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
2577220|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577221|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2577222|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2133251|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
2133252|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2133253|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133254|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2133255|NCT03071263|Diuretics|diuretics|mesh-ancestor
2133256|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
2133257|NCT03071276|Vidarabine|vidarabine|mesh-list
2133258|NCT03071276|Cytarabine|cytarabine|mesh-list
2133259|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
2133260|NCT03071276|Methotrexate|methotrexate|mesh-list
2133261|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
2133262|NCT03071276|Fludarabine|fludarabine|mesh-list
2133263|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2133264|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
2133265|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2133266|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133267|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2133268|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
2133269|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133270|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133271|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
2133272|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133273|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2133274|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2133275|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
2133276|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2133277|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2133278|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
2133279|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133280|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2133281|NCT03071744|Fentanyl|fentanyl|mesh-list
2133282|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2133283|NCT03071744|Narcotics|narcotics|mesh-ancestor
2133284|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2133285|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133286|NCT03071744|Analgesics|analgesics|mesh-ancestor
2133287|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
2133288|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133289|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2133290|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2133291|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
2133292|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
2133299|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
2133300|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2133301|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133302|NCT03072719|Fluorides|fluorides|mesh-list
2133303|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
2133304|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
2133305|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
2133306|NCT03072719|Protective Agents|protective agents|mesh-ancestor
2133307|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577223|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2577224|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
2577225|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2577226|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2577227|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2577228|NCT01637259|Ritonavir|ritonavir|mesh-list
2577229|NCT01637259|Lopinavir|lopinavir|mesh-list
2577230|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2577231|NCT01637259|Darunavir|darunavir|mesh-list
2577232|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
2577233|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2577234|NCT01637259|Tenofovir|tenofovir|mesh-list
2133308|NCT03073200|Etanercept|etanercept|mesh-list
2133309|NCT03073200|Ixekizumab|ixekizumab|mesh-list
2577235|NCT01637259|Lamivudine|lamivudine|mesh-list
2577236|NCT01637259|Zidovudine|zidovudine|mesh-list
2577237|NCT01637259|Emtricitabine|emtricitabine|mesh-list
2577238|NCT01637259|Maraviroc|maraviroc|mesh-list
2577239|NCT01637259|Abacavir|abacavir|mesh-list
2577240|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
2577241|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2577242|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
2577243|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2577244|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577245|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577246|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2577247|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2577248|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
2577249|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577250|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2577251|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2577252|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2577253|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
2577254|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2577255|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2577256|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2577257|NCT01637376|Temoporfin|temoporfin|mesh-list
2577258|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577259|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2577260|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
2133310|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2133311|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2133312|NCT03073200|Analgesics|analgesics|mesh-ancestor
2133313|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
2133314|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133315|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133316|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2133317|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2133318|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2133319|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2133320|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
2133321|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
2133322|NCT03073213|Ixekizumab|ixekizumab|mesh-list
2133323|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
2133324|NCT03073876|Donepezil|donepezil|mesh-list
2133325|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2133326|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133327|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133328|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
2133329|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133330|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133331|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
2133332|NCT03074162|Diclofenac|diclofenac|mesh-list
2133333|NCT03074162|Capsaicin|capsaicin|mesh-list
2133334|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2133335|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2133336|NCT03074162|Analgesics|analgesics|mesh-ancestor
2133337|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
2133338|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133339|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133340|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2133341|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2133342|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2133343|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133344|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133345|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
2133346|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
2133347|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
2133348|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2133349|NCT03074331|Velpatasvir|velpatasvir|mesh-list
2133350|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
2133351|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133352|NCT03074409|Oxytocin|oxytocin|mesh-list
2133353|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
2133354|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2133355|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133356|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
2133357|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2133358|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2133359|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2133360|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
2133361|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577261|NCT01637454|Terlipressin|terlipressin|mesh-list
2577262|NCT01637454|Norepinephrine|norepinephrine|mesh-list
2577263|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2577264|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2577265|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2577266|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2577267|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
2577268|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2577269|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577270|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577271|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
2577272|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
2577273|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577274|NCT01637532|Interferons|interferons|mesh-list
2577275|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
2577276|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
2577277|NCT01637532|Carboplatin|carboplatin|mesh-list
2133362|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2133363|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2133364|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133365|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2133366|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2133367|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133368|NCT03075163|Ondansetron|ondansetron|mesh-list
2133369|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
2133370|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
2133371|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133372|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133373|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2133374|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
2133375|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
2133376|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2133377|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
2133378|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133379|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133380|NCT03075163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2133381|NCT03075163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2133382|NCT03075163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2133383|NCT03075163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2133384|NCT03075163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2133385|NCT03075267|Budesonide|budesonide|mesh-list
2133386|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
2133387|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
2133388|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2133389|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2133390|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
2577278|NCT01637532|Doxorubicin|doxorubicin|mesh-list
2577279|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577280|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2577281|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2577282|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2577283|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577284|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577285|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
2577286|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577287|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
2577288|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577289|NCT01637545|Ramosetron|ramosetron|mesh-list
2577290|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
2577291|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
2577292|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577293|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577294|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2577295|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2577296|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
2577297|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2577298|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577299|NCT01637558|Ritonavir|ritonavir|mesh-list
2577300|NCT01637558|Lopinavir|lopinavir|mesh-list
2577301|NCT01637558|Nevirapine|nevirapine|mesh-list
2577302|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2577303|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2577304|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
2577305|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133391|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577306|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577307|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2133392|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133393|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2133394|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
2133395|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
2133396|NCT03075267|Hormones|hormones|mesh-ancestor
2133397|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2133398|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2133399|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2133400|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2133401|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
2133402|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133403|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133404|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2133405|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2133406|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2133407|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
2133408|NCT03075410|GSK656|gsk656|mesh-list
2133409|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2133410|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133411|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2133412|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133413|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2133414|NCT03075527|Durvalumab|durvalumab|mesh-list
2133415|NCT03075527|Tremelimumab|tremelimumab|mesh-list
2133416|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2133417|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133418|NCT03075553|Nivolumab|nivolumab|mesh-list
2133419|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2133420|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133421|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2133422|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133423|NCT03075891|Doxycycline|doxycycline|mesh-list
2133424|NCT03075891|Ivermectin|ivermectin|mesh-list
2133425|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2133426|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133427|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
2419663|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2419664|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419665|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419666|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2419667|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
2419668|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2419669|NCT00804531|Prednisolone|prednisolone|mesh-list
2419670|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
2419671|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2419672|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
2419673|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419674|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
2419675|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
2419676|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133428|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2133429|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2133430|NCT03076970|Sumatriptan|sumatriptan|mesh-list
2133431|NCT03076970|Lasmiditan|lasmiditan|mesh-list
2133432|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2133433|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2133434|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2133435|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
2133436|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133437|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133438|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133439|NCT03077438|Vaccines|vaccines|mesh-list
2133440|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
2133441|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577308|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2577309|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
2577310|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577311|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2577312|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2577313|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2133442|NCT03077607|Itraconazole|itraconazole|mesh-list
2133443|NCT03077607|Rifampin|rifampin|mesh-list
2133444|NCT03077607|Talazoparib|talazoparib|mesh-list
2133445|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
2133446|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577314|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2577315|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2577316|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2577317|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
2577318|NCT01637571|Lansoprazole|lansoprazole|mesh-list
2577319|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2577320|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2577321|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2577322|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577323|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577324|NCT01637636|Rifampin|rifampin|mesh-list
2577325|NCT01637636|Ketoconazole|ketoconazole|mesh-list
2577326|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2577327|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
2577328|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2577329|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577330|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
2133447|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2133448|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2133449|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133450|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577331|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2577332|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577333|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577334|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2577335|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2577336|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2577337|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2577338|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2577339|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2577340|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
2577341|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2577342|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2577343|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2577344|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
2577345|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2577346|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577347|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2577348|NCT01637675|Tanshinone|tanshinone|mesh-list
2577349|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
2577350|NCT01637675|Citric Acid|citric acid|mesh-list
2577351|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
2577352|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
2577353|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2577354|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
2577355|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
2577356|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419677|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419678|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2419679|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
2419680|NCT00804531|Hormones|hormones|mesh-ancestor
2133451|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2133452|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
2133453|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2133454|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133455|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2133456|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2133457|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
2133458|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2419681|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2419682|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2419683|NCT00804531|Protective Agents|protective agents|mesh-ancestor
2419684|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2419685|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419686|NCT00804622|Tenofovir|tenofovir|mesh-list
2419687|NCT00804622|Telbivudine|telbivudine|mesh-list
2419688|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
2419689|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419690|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2419691|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2419692|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577357|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
2577358|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2577359|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2577360|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577361|NCT01637675|Urological Agents|urological agents|mesh-ancestor
2577362|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577363|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2577364|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2577365|NCT01637675|Analgesics|analgesics|mesh-ancestor
2577366|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
2577367|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577368|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577369|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2133459|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
2133460|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2133461|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2133462|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2133463|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2133464|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2133465|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2133466|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2133467|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2133468|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133469|NCT03077659|Paclitaxel|paclitaxel|mesh-list
2133470|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2133471|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133472|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
2133473|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
2133474|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
2133475|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133476|NCT03077711|Trimethoprim|trimethoprim|mesh-list
2133477|NCT03077711|Methenamine|methenamine|mesh-list
2133478|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
2133479|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
2133480|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2133481|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133482|NCT03077711|Renal Agents|renal agents|mesh-ancestor
2133483|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
2133484|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2133485|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2133486|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2133487|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133488|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133489|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2133490|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2133491|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2133492|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2133493|NCT03077919|Ropivacaine|ropivacaine|mesh-list
2133494|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
2133495|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
2133496|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2133497|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133498|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
2133499|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577370|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2577371|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2577372|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577373|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2577374|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
2577375|NCT01637753|Carmustine|carmustine|mesh-list
2577376|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2577377|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
2577378|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577379|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577380|NCT01637766|Melphalan|melphalan|mesh-list
2133500|NCT03078075|Naltrexone|naltrexone|mesh-list
2133501|NCT03078075|Bupropion|bupropion|mesh-list
2133502|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2133503|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2133504|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133505|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
2133506|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133507|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2577381|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2577382|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
2577383|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577384|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577385|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2577386|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2577387|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
2577388|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577389|NCT01637818|Acetaminophen|acetaminophen|mesh-list
2577390|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2577391|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2577392|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2577393|NCT01637818|Analgesics|analgesics|mesh-ancestor
2577394|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
2577395|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577396|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577397|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
2577398|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2577399|NCT01637844|Telbivudine|telbivudine|mesh-list
2577400|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
2577401|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577402|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2577403|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577404|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577405|NCT01637883|Benzydamine|benzydamine|mesh-list
2577406|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2133508|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
2577407|NCT01637948|Listerine|listerine|mesh-list
2577408|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2133509|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2133510|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2577409|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577410|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2577411|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
2577412|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2577413|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
2577414|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2577415|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577416|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2577417|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2577418|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577419|NCT01638078|Thalidomide|thalidomide|mesh-list
2577420|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2577421|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
2577422|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577423|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
2577424|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2133511|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2133512|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2133513|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133514|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
2133515|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133516|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2133517|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2133518|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419693|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419694|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2419695|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2419696|NCT00804674|Bupivacaine|bupivacaine|mesh-list
2419697|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
2419698|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
2419699|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2419700|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419701|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
2419702|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419703|NCT00804752|Vitamin D|vitamin d|mesh-list
2419704|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
2419705|NCT00804752|Vitamins|vitamins|mesh-list
2419706|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
2419707|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419708|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2419709|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2577425|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577426|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2577427|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2577428|NCT01638078|Growth Substances|growth substances|mesh-ancestor
2577429|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
2577430|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577431|NCT01638182|Vitamins|vitamins|mesh-list
2577432|NCT01638182|Vitamin K|vitamin k|mesh-list
2577433|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
2577434|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
2577435|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
2577436|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577437|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2577438|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2419710|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2419711|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
2419712|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2419713|NCT00804830|Bevacizumab|bevacizumab|mesh-list
2419714|NCT00804830|Doxorubicin|doxorubicin|mesh-list
2419715|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2419716|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419717|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2577439|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577440|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
2577441|NCT01638182|Coagulants|coagulants|mesh-ancestor
2577442|NCT01638234|Melatonin|melatonin|mesh-list
2577443|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
2577444|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577445|NCT01638234|Protective Agents|protective agents|mesh-ancestor
2577446|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577447|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2577448|NCT01638247|Tamoxifen|tamoxifen|mesh-list
2577449|NCT01638247|Goserelin|goserelin|mesh-list
2577450|NCT01638247|Exemestane|exemestane|mesh-list
2577451|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2577452|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2577453|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
2577454|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2577455|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577456|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2577457|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577458|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2577459|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2577460|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2577461|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2577462|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2577463|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577464|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577465|NCT01638247|Hormones|hormones|mesh-ancestor
2577466|NCT01638260|Liraglutide|liraglutide|mesh-list
2577467|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2577468|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577469|NCT01638260|Incretins|incretins|mesh-ancestor
2577470|NCT01638260|Hormones|hormones|mesh-ancestor
2577471|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2577472|NCT01638273|Pregabalin|pregabalin|mesh-list
2577473|NCT01638273|Analgesics|analgesics|mesh-ancestor
2133524|NCT03078556|Lamivudine|lamivudine|mesh-list
2133525|NCT03078556|Dolutegravir|dolutegravir|mesh-list
2133526|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2133527|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2133528|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133529|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133530|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
2133531|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133532|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2133533|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2133534|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2133535|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2133536|NCT03078907|Selexipag|selexipag|mesh-list
2133537|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2133538|NCT03078946|Midazolam|midazolam|mesh-list
2133539|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
2577474|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
2133540|NCT03078946|Morphine|morphine|mesh-list
2133541|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2133542|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2133543|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133544|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2133545|NCT03078946|Analgesics|analgesics|mesh-ancestor
2133546|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
2133547|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133548|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2133549|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2133550|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2133551|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
2133552|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133553|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133554|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2133555|NCT03078946|Narcotics|narcotics|mesh-ancestor
2133556|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2133557|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2133558|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2133559|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2133560|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2133561|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
2133562|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
2133563|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
2133564|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
2133565|NCT03080142|Bupivacaine|bupivacaine|mesh-list
2133566|NCT03080142|Ropivacaine|ropivacaine|mesh-list
2133567|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
2577475|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577476|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577477|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
2577478|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2577479|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2577480|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577481|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2577482|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2577483|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2419718|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2419719|NCT00804830|Growth Substances|growth substances|mesh-ancestor
2419720|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419721|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
2419722|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2419723|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2419724|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2419725|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419726|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419727|NCT00804856|Cytarabine|cytarabine|mesh-list
2419728|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2419729|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
2577484|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2133568|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
2133569|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2133570|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133571|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
2133572|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133573|NCT03080493|Acetaminophen|acetaminophen|mesh-list
2133574|NCT03080493|Ibuprofen|ibuprofen|mesh-list
2133575|NCT03080493|Gabapentin|gabapentin|mesh-list
2133576|NCT03080493|Codeine|codeine|mesh-list
2133577|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2133578|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2133579|NCT03080493|Analgesics|analgesics|mesh-ancestor
2133580|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
2133581|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577485|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2577486|NCT01638299|Insulin|insulin|mesh-list
2577487|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2577488|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577489|NCT01638325|Insulin|insulin|mesh-list
2577490|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2577491|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
2577492|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2577493|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577494|NCT01638364|Ethanol|ethanol|mesh-list
2577495|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2133582|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133583|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
2133584|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2133585|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2133586|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2133587|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2133588|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133589|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133590|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
2133591|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2133592|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2133593|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2419730|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419731|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419732|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
2419733|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419734|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2419735|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
2419736|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419737|NCT00804895|Cortivazol|cortivazol|mesh-list
2419738|NCT00804895|Verapamil|verapamil|mesh-list
2133594|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2133595|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2133596|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2133597|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133598|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
2133599|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2133600|NCT03080493|Narcotics|narcotics|mesh-ancestor
2133601|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
2133602|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
2133603|NCT03080493|Laxatives|laxatives|mesh-ancestor
2133604|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2133605|NCT03081117|Insulin|insulin|mesh-list
2133606|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2133607|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133608|NCT03082196|Fluorides|fluorides|mesh-list
2133609|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
2133610|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
2133611|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
2133612|NCT03082196|Protective Agents|protective agents|mesh-ancestor
2133613|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133614|NCT03083132|Modafinil|modafinil|mesh-list
2133615|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2133616|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133617|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2133618|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2133619|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2133620|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133621|NCT03083470|Paclitaxel|paclitaxel|mesh-list
2133622|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2133623|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133624|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
2133625|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
2133626|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
2133627|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133628|NCT03083639|Esomeprazole|esomeprazole|mesh-list
2133629|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2133630|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2133631|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2133632|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133633|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133634|NCT03083847|Chloroquine|chloroquine|mesh-list
2133635|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2133636|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
2133637|NCT03083847|Amebicides|amebicides|mesh-ancestor
2133638|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2577496|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577497|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2577498|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577499|NCT01638377|Naltrexone|naltrexone|mesh-list
2577500|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2577501|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2577502|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577503|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
2577504|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133639|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2133640|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133641|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
2133642|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2133643|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2133644|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2133645|NCT03083847|Analgesics|analgesics|mesh-ancestor
2133646|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
2133647|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133648|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133649|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2133650|NCT03083847|Filaricides|filaricides|mesh-ancestor
2133651|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
2133652|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
2133653|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2133654|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133655|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133656|NCT03083990|Bevacizumab|bevacizumab|mesh-list
2133657|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2133658|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133659|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2133660|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2133661|NCT03083990|Growth Substances|growth substances|mesh-ancestor
2133662|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133663|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
2133664|NCT03084315|Nicotine|nicotine|mesh-list
2133665|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2133666|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
2133667|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133668|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133669|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2133670|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2133671|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
2133672|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133673|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133674|NCT03084471|Durvalumab|durvalumab|mesh-list
2577505|NCT01638403|Modafinil|modafinil|mesh-list
2577506|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2577507|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577508|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2577509|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2577510|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2577511|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577512|NCT01638442|Tosedostat|tosedostat|mesh-list
2577513|NCT01638442|Glycine|glycine|mesh-list
2577514|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577515|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577516|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
2577517|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2577518|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577519|NCT01638624|Propofol|propofol|mesh-list
2577520|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2133675|NCT03084471|Tremelimumab|tremelimumab|mesh-list
2133676|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2133677|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2133678|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133679|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
2133680|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133681|NCT03084796|Bromides|bromides|mesh-list
2133682|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
2133683|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2133684|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
2133685|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133686|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133687|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2133688|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
2133689|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
2133690|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2133691|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
2133692|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133693|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133694|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
2577521|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2577522|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577523|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2577524|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
2577525|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
2577526|NCT01638650|Ritonavir|ritonavir|mesh-list
2577527|NCT01638650|Saquinavir|saquinavir|mesh-list
2577528|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2577529|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2577530|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2577531|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
2577532|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577533|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577534|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2577535|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2577536|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
2577537|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577538|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2577539|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2577540|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2577541|NCT01638663|Tolvaptan|tolvaptan|mesh-list
2577542|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2577543|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133706|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
2133707|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2133708|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
2133709|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2133710|NCT03085914|Leucovorin|leucovorin|mesh-list
2133711|NCT03085914|Gemcitabine|gemcitabine|mesh-list
2133712|NCT03085914|Paclitaxel|paclitaxel|mesh-list
2577544|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
2577545|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577546|NCT01638676|Metformin|metformin|mesh-list
2577547|NCT01638676|Vemurafenib|vemurafenib|mesh-list
2577548|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2577549|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577550|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577551|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2577552|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577553|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577554|NCT01638689|Citalopram|citalopram|mesh-list
2577555|NCT01638689|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2577556|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2577557|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2577558|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577559|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2577560|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
2577561|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577562|NCT01638689|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2577563|NCT01638689|Antidepressive Agents|antidepressive agents|mesh-ancestor
2577564|NCT01638689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2577565|NCT01638715|Rituximab|rituximab|mesh-list
2577566|NCT01638715|Abatacept|abatacept|mesh-list
2133713|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2133714|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
2133715|NCT03085914|Carboplatin|carboplatin|mesh-list
2419739|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2419740|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2419741|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2419742|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419743|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2133716|NCT03085914|Fluorouracil|fluorouracil|mesh-list
2133717|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
2419744|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419745|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
2419746|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419747|NCT00804921|Bevacizumab|bevacizumab|mesh-list
2419748|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2577567|NCT01638715|Infliximab|infliximab|mesh-list
2577568|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2577569|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577570|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
2577571|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577572|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2577573|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
2577574|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2577575|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2577576|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577577|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2577578|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
2133718|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
2133719|NCT03085914|Pemetrexed|pemetrexed|mesh-list
2133720|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2133721|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133722|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
2133723|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
2133724|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
2133725|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133726|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2133727|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
2133728|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133729|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2133730|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2133731|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
2133732|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2133733|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2577579|NCT01638767|NuvaRing|nuvaring|mesh-list
2577580|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
2577581|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2577582|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577583|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2577584|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2577585|NCT01638780|Resveratrol|resveratrol|mesh-list
2577586|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
2577587|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577588|NCT01638780|Protective Agents|protective agents|mesh-ancestor
2577589|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577590|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577591|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2577592|NCT01638858|Ranibizumab|ranibizumab|mesh-list
2577593|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2133734|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
2133735|NCT03085914|Antiviral Agents|antiviral agents|mesh-ancestor
2133736|NCT03085914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133737|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133738|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2133739|NCT03085914|Antidotes|antidotes|mesh-ancestor
2133740|NCT03085914|Protective Agents|protective agents|mesh-ancestor
2133741|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
2133742|NCT03085914|Vitamins|vitamins|mesh-ancestor
2133743|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
2133744|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2133745|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2133746|NCT03086213|Lidocaine|lidocaine|mesh-list
2133747|NCT03086213|Sufentanil|sufentanil|mesh-list
2133748|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
2577594|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2577595|NCT01638858|Growth Substances|growth substances|mesh-ancestor
2577596|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577597|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
2577598|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577599|NCT01638936|Maytansine|maytansine|mesh-list
2577600|NCT01638936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2577601|NCT01638936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577602|NCT01638936|Tubulin Modulators|tubulin modulators|mesh-ancestor
2577603|NCT01638936|Antimitotic Agents|antimitotic agents|mesh-ancestor
2577604|NCT01638936|Mitosis Modulators|mitosis modulators|mesh-ancestor
2577605|NCT01638936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577606|NCT01638962|Acetaminophen|acetaminophen|mesh-list
2577607|NCT01638962|Aspirin|aspirin|mesh-list
2577608|NCT01638962|Ibuprofen|ibuprofen|mesh-list
2577609|NCT01638962|Celecoxib|celecoxib|mesh-list
2133749|NCT03086213|Dsuvia|dsuvia|mesh-list
2133750|NCT03086213|Ropivacaine|ropivacaine|mesh-list
2577610|NCT01638962|Diclofenac|diclofenac|mesh-list
2577611|NCT01638962|Naproxen|naproxen|mesh-list
2577612|NCT01638962|Indomethacin|indomethacin|mesh-list
2577613|NCT01638962|Etoricoxib|etoricoxib|mesh-list
2577614|NCT01638962|Meloxicam|meloxicam|mesh-list
2577615|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2577616|NCT01638962|Etodolac|etodolac|mesh-list
2577617|NCT01638962|Lornoxicam|lornoxicam|mesh-list
2577618|NCT01638962|Nabumetone|nabumetone|mesh-list
2577619|NCT01638962|Tenoxicam|tenoxicam|mesh-list
2577620|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
2577621|NCT01638962|Analgesics|analgesics|mesh-list
2577622|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2577623|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
2577624|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577625|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577626|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
2577627|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2577628|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2577629|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2577630|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2577631|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577632|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577633|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2577634|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
2577635|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2577636|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2577637|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2133751|NCT03086213|Propofol|propofol|mesh-list
2133752|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
2133753|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
2133754|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2133755|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133756|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
2133757|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133758|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2133759|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2133760|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2133761|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2133762|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133763|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2133764|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2133765|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
2133766|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2133767|NCT03086213|Analgesics|analgesics|mesh-ancestor
2133768|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2133769|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2133770|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2133771|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
2133772|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133773|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2133774|NCT03086213|Narcotics|narcotics|mesh-ancestor
2133775|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2133776|NCT03086343|Abatacept|abatacept|mesh-list
2133777|NCT03086343|Upadacitinib|upadacitinib|mesh-list
2133778|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2133779|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133780|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133781|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2133782|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
2133783|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133784|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2133785|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2577638|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
2577639|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2577640|NCT01638988|Metformin|metformin|mesh-list
2577641|NCT01638988|Clomiphene|clomiphene|mesh-list
2577642|NCT01638988|Enclomiphene|enclomiphene|mesh-list
2577643|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
2577644|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2577645|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577646|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2133786|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2133787|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133788|NCT03086356|Dabigatran|dabigatran|mesh-list
2133789|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
2133790|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2577647|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
2577648|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2133791|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
2133792|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133793|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133794|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
2133795|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
2133796|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2133797|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
2133798|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133799|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133800|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2133801|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
2133802|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2133803|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2133804|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2577649|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2577650|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
2577651|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2577652|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2577653|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2577654|NCT01639027|Drotaverin|drotaverin|mesh-list
2577655|NCT01639027|Analgesics|analgesics|mesh-ancestor
2577656|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
2577657|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577658|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577659|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
2577660|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
2577661|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
2577662|NCT01639066|Tenofovir|tenofovir|mesh-list
2577663|NCT01639066|Entecavir|entecavir|mesh-list
2577664|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
2577665|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577666|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2577667|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2577668|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577669|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577670|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2577671|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2577672|NCT01639092|Tenofovir|tenofovir|mesh-list
2577673|NCT01639092|Entecavir|entecavir|mesh-list
2577674|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
2577675|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577676|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2577677|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2577678|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577679|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577680|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2577681|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2577682|NCT01639131|Gemcitabine|gemcitabine|mesh-list
2577683|NCT01639131|Docetaxel|docetaxel|mesh-list
2577684|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2577685|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
2577686|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577687|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577688|NCT01639131|Antiviral Agents|antiviral agents|mesh-ancestor
2577689|NCT01639131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577690|NCT01639131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577691|NCT01639131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2577692|NCT01639131|Immunologic Factors|immunologic factors|mesh-ancestor
2577693|NCT01639131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577694|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
2577695|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
2577696|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
2577697|NCT01639261|Interferons|interferons|mesh-list
2133805|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
2133806|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133807|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133808|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
2133809|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2133810|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133811|NCT03087604|Lidocaine|lidocaine|mesh-list
2133812|NCT03087604|Epinephrine|epinephrine|mesh-list
2133813|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
2133814|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
2133815|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2133816|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577698|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
2133817|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
2133818|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133819|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2133820|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2133821|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2133822|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2133823|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133824|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2133825|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2133826|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
2133827|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133828|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2133829|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2133830|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
2133831|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2133832|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
2133833|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
2133834|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
2133835|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2133836|NCT03087786|Nicotine|nicotine|mesh-list
2133837|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2133838|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
2133839|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133840|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133841|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2133842|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2133843|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
2133844|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133845|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133846|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
2133847|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2133848|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133849|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2133850|NCT03088137|Hormones|hormones|mesh-ancestor
2133851|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2133852|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133853|NCT03088267|Amphetamine|amphetamine|mesh-list
2133854|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2133855|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577699|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577700|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
2577701|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577702|NCT01639326|Irinotecan|irinotecan|mesh-list
2577703|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2577704|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2577705|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577706|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577707|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577708|NCT01639456|Aldesleukin|aldesleukin|mesh-list
2577709|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
2577710|NCT01639456|Fludarabine|fludarabine|mesh-list
2577711|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2577712|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
2577713|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577714|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2577715|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2577716|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
2577717|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577718|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133856|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
2133857|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
2133858|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133859|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
2133860|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133861|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133862|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
2133863|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2133864|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2133865|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2133866|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2133867|NCT03088345|Vasopressins|vasopressins|mesh-list
2133868|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
2133869|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
2133870|NCT03088345|Coagulants|coagulants|mesh-ancestor
2133871|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2133872|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2133873|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
2133874|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133875|NCT03088800|Ibuprofen|ibuprofen|mesh-list
2133876|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2133877|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2577719|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2577720|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2577721|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2577722|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
2577723|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577724|NCT01639521|Gemcitabine|gemcitabine|mesh-list
2577725|NCT01639521|Doxorubicin|doxorubicin|mesh-list
2577726|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2577727|NCT01639521|Methotrexate|methotrexate|mesh-list
2577728|NCT01639521|Vinblastine|vinblastine|mesh-list
2577729|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577730|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2577731|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
2577732|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577733|NCT01639521|Antiviral Agents|antiviral agents|mesh-ancestor
2577734|NCT01639521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577735|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577736|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2577737|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
2577738|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577739|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2577740|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2133878|NCT03088800|Analgesics|analgesics|mesh-ancestor
2133879|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
2133880|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133881|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133882|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2133883|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2133884|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2133885|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133886|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577741|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2577742|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2577743|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
2577744|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2577745|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
2577746|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2577747|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2577748|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2577749|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2577750|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
2577751|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
2577752|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
2577753|NCT01639547|Ribavirin|ribavirin|mesh-list
2577754|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2577755|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
2577756|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577757|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
2577758|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577759|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
2577760|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2577761|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419749|NCT00804921|Acetazolamide|acetazolamide|mesh-list
2419750|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2419751|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419752|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2419753|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2419754|NCT00804921|Growth Substances|growth substances|mesh-ancestor
2419755|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419756|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
2419757|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2419758|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2419759|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2419760|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2419761|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
2419762|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133887|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
2133888|NCT03089216|Calcium|calcium|mesh-list
2133889|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2133890|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133891|NCT03089216|Antacids|antacids|mesh-ancestor
2133892|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133893|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2133894|NCT03090620|Lorazepam|lorazepam|mesh-list
2133895|NCT03090620|Physostigmine|physostigmine|mesh-list
2133896|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
2133897|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
2133898|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
2577771|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
2577772|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2577773|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2577774|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
2577775|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2577776|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577777|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577778|NCT01639794|Urological Agents|urological agents|mesh-ancestor
2577779|NCT01639807|Latanoprost|latanoprost|mesh-list
2577780|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2577781|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2577782|NCT01639885|Interferons|interferons|mesh-list
2577783|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
2577784|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
2577785|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577786|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
2577787|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577788|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
2577789|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133899|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133900|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577790|NCT01639898|Dexamethasone|dexamethasone|mesh-list
2577791|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
2577792|NCT01639898|Lenalidomide|lenalidomide|mesh-list
2577793|NCT01639898|BB 1101|bb 1101|mesh-list
2577794|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2577795|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
2577796|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
2577797|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577798|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577799|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2419763|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419764|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
2419765|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2419766|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419767|NCT00804921|Diuretics|diuretics|mesh-ancestor
2419768|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
2419769|NCT00804934|Ranibizumab|ranibizumab|mesh-list
2419770|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2133901|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2133902|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2133903|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2133904|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2133905|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2133906|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2133907|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
2133908|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
2133909|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133910|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133911|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2133912|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133913|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
2133914|NCT03090620|Miotics|miotics|mesh-ancestor
2577800|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
2577801|NCT01639898|Hormones|hormones|mesh-ancestor
2577802|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2133915|NCT03091192|Sunitinib|sunitinib|mesh-list
2133916|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133917|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2133918|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2133919|NCT03091192|Growth Substances|growth substances|mesh-ancestor
2133920|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133921|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
2133922|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2133923|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133924|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133925|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
2133926|NCT03091348|Testosterone|testosterone|mesh-list
2133927|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
2133928|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
2577803|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2577804|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577805|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
2133929|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2133930|NCT03091348|Androgens|androgens|mesh-ancestor
2133931|NCT03091348|Hormones|hormones|mesh-ancestor
2133932|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2133933|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133934|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2133935|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133936|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
2133937|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2133938|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2133939|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2133940|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2133941|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133942|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
2133943|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2133944|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133945|NCT03091439|Dalbavancin|dalbavancin|mesh-list
2133946|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2133947|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133948|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
2133949|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2133950|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2133951|NCT03091673|Glucagon|glucagon|mesh-list
2133952|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2133953|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2133954|NCT03091673|Hormones|hormones|mesh-ancestor
2133955|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2133956|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133957|NCT03091673|Incretins|incretins|mesh-ancestor
2133958|NCT03091777|Metronidazole|metronidazole|mesh-list
2133959|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133960|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2133961|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2133962|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2133963|NCT03091920|Praliciguat|praliciguat|mesh-list
2133964|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2133965|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
2133966|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133967|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2133968|NCT03092375|Ribavirin|ribavirin|mesh-list
2133969|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
2133970|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133971|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
2133972|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2133973|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2133974|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577806|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577807|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577808|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
2577809|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2577810|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2577811|NCT01639898|Growth Substances|growth substances|mesh-ancestor
2133975|NCT03093207|Aspirin|aspirin|mesh-list
2133976|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2133977|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2133978|NCT03093207|Analgesics|analgesics|mesh-ancestor
2133979|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
2133980|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2133981|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2133982|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2133983|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2133984|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2133985|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2133986|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2133987|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2133988|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2133989|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2133990|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
2134007|NCT03093272|Prednisone|prednisone|mesh-list
2134008|NCT03093272|Docetaxel|docetaxel|mesh-list
2134009|NCT03093272|Leuprolide|leuprolide|mesh-list
2134010|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134011|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
2134012|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
2134013|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
2134014|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134015|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134016|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
2134017|NCT03093272|Hormones|hormones|mesh-ancestor
2134018|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2134019|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134020|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2134021|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2134022|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
2134023|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2134024|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2134025|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
2134026|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2134027|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
2134028|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134029|NCT03093415|Grazoprevir|grazoprevir|mesh-list
2134030|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
2134031|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2134032|NCT03093480|Factor VIII|factor viii|mesh-list
2134033|NCT03093480|Coagulants|coagulants|mesh-ancestor
2134034|NCT03093870|Capecitabine|capecitabine|mesh-list
2134035|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2134036|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
2134037|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134038|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134039|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2134040|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2134041|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134042|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2134043|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
2134044|NCT03094637|Azacitidine|azacitidine|mesh-list
2134045|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2134046|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134047|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2134048|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
2134049|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134050|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134051|NCT03095118|Daratumumab|daratumumab|mesh-list
2134052|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577812|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
2577813|NCT01640002|Bromides|bromides|mesh-list
2577814|NCT01640002|Propantheline|propantheline|mesh-list
2577815|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
2134053|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
2577816|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2134054|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2134055|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
2134056|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134057|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134058|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2134059|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
2134060|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
2134061|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2134062|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
2134063|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134064|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134065|NCT03095508|Menthol|menthol|mesh-list
2134066|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
2134067|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
2134068|NCT03095521|Menthol|menthol|mesh-list
2134069|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
2134070|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
2134071|NCT03095638|Dolutegravir|dolutegravir|mesh-list
2134072|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2134073|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2134074|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134075|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134076|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2134077|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2134078|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
2134079|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2134080|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
2134081|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2134082|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134083|NCT03096314|Vitamin D|vitamin d|mesh-list
2134084|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
2134085|NCT03096314|Vitamins|vitamins|mesh-ancestor
2134086|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
2577817|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2577818|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2577819|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2134087|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134088|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2577820|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
2577821|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2577822|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577823|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577824|NCT01640080|Esketamine|esketamine|mesh-list
2134089|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2134090|NCT03096353|Naloxone|naloxone|mesh-list
2134091|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2134092|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134093|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
2134094|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134095|NCT03096444|Lidocaine|lidocaine|mesh-list
2134096|NCT03096444|Ketamine|ketamine|mesh-list
2134097|NCT03096444|Amitriptyline|amitriptyline|mesh-list
2134098|NCT03096444|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2134099|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
2134100|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
2134101|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134102|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134103|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
2134104|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577825|NCT01640080|Antidepressive Agents|antidepressive agents|mesh-ancestor
2577826|NCT01640080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2134105|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2134106|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2577827|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
2577828|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577829|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2134107|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2134108|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2134109|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134110|NCT03096444|Analgesics|analgesics|mesh-ancestor
2134111|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2134112|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2134113|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
2134114|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2577830|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577831|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577832|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
2577833|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2577834|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577835|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2577836|NCT01640210|Insulin|insulin|mesh-list
2577837|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2577838|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577839|NCT01640275|Propofol|propofol|mesh-list
2577840|NCT01640275|Isoflurane|isoflurane|mesh-list
2577841|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2577842|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2577843|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577844|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2577845|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
2577846|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
2577847|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2577848|NCT01640301|Aldesleukin|aldesleukin|mesh-list
2577849|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
2577850|NCT01640301|Fludarabine|fludarabine|mesh-list
2577851|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
2577852|NCT01640301|Interleukin-2|interleukin-2|mesh-list
2577853|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2577854|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
2577855|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577856|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2577857|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2577858|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
2577859|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577860|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577861|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2134115|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2134116|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134117|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2134118|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
2134119|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2134120|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2134121|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2134122|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2134123|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
2134124|NCT03096444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2134125|NCT03096444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2134126|NCT03096730|Sufentanil|sufentanil|mesh-list
2134127|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
2134128|NCT03096730|Remifentanil|remifentanil|mesh-list
2134129|NCT03096730|Dsuvia|dsuvia|mesh-list
2134130|NCT03096730|Nalmefene|nalmefene|mesh-list
2577862|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2577863|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
2577864|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2577865|NCT01640301|Analgesics|analgesics|mesh-ancestor
2577866|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
2577867|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577868|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2577869|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2577870|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
2577871|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577872|NCT01640405|Bevacizumab|bevacizumab|mesh-list
2577873|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2577874|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577875|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2577876|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2577877|NCT01640405|Growth Substances|growth substances|mesh-ancestor
2577878|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134131|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2134132|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134133|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134134|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2134135|NCT03096730|Analgesics|analgesics|mesh-ancestor
2134136|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
2134137|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134138|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2134139|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2134140|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2134141|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
2577879|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
2134142|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134143|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134144|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2134145|NCT03096730|Narcotics|narcotics|mesh-ancestor
2134146|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2134147|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2134148|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
2134149|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
2134150|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2134151|NCT03096847|Letrozole|letrozole|mesh-list
2134152|NCT03096847|Goserelin|goserelin|mesh-list
2134153|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134154|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2134155|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2134156|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134157|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134158|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2134159|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
2577880|NCT01640444|Bevacizumab|bevacizumab|mesh-list
2577881|NCT01640444|Cetuximab|cetuximab|mesh-list
2577882|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2577883|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577884|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2577885|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2577886|NCT01640444|Growth Substances|growth substances|mesh-ancestor
2577887|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577888|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
2577889|NCT01640496|Vitamin D|vitamin d|mesh-list
2577890|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
2577891|NCT01640496|Vitamins|vitamins|mesh-ancestor
2577892|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
2577893|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577894|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2577895|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2577896|NCT01640535|Cetirizine|cetirizine|mesh-list
2577897|NCT01640535|Montelukast|montelukast|mesh-list
2577898|NCT01640535|Levocetirizine|levocetirizine|mesh-list
2577899|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2134160|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2134161|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134162|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2134163|NCT03097133|Esketamine|esketamine|mesh-list
2134164|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
2134165|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2134166|NCT03097315|Triamcinolone|triamcinolone|mesh-list
2134167|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2134168|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2134169|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2577900|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
2577901|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2577902|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
2577903|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2577904|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577905|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2577906|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2577907|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577908|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2577909|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2577910|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
2577911|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
2577912|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2577913|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2577914|NCT01640574|Chloroquine|chloroquine|mesh-list
2134170|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134171|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
2134172|NCT03097315|Hormones|hormones|mesh-ancestor
2134173|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2134174|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134175|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2134176|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
2134177|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134178|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134179|NCT03097588|Palonosetron|palonosetron|mesh-list
2134180|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
2134181|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
2134182|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134183|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134184|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2134185|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2134186|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2134187|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
2134188|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134189|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134190|NCT03097783|Lidocaine|lidocaine|mesh-list
2134191|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
2134192|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
2134193|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134194|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134195|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
2134196|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134197|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2134198|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2134199|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2134200|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2577915|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2577916|NCT01640574|Piperaquine|piperaquine|mesh-list
2577917|NCT01640574|Artenimol|artenimol|mesh-list
2577918|NCT01640574|Artemisinins|artemisinins|mesh-list
2577919|NCT01640574|Amebicides|amebicides|mesh-ancestor
2577920|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2577921|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2577922|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577923|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
2577924|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2577925|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2577926|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2577927|NCT01640574|Analgesics|analgesics|mesh-ancestor
2577928|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
2577929|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577930|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134201|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134202|NCT03097861|Lubiprostone|lubiprostone|mesh-list
2134203|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2134204|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2134205|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134206|NCT03098030|Irinotecan|irinotecan|mesh-list
2134207|NCT03098030|Topotecan|topotecan|mesh-list
2134208|NCT03098030|Dinutuximab|dinutuximab|mesh-list
2134209|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2134210|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2134211|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134212|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134213|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134214|NCT03098420|Dexamethasone|dexamethasone|mesh-list
2134215|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
2134216|NCT03098420|Morphine|morphine|mesh-list
2134217|NCT03098420|Bupivacaine|bupivacaine|mesh-list
2134218|NCT03098420|Ropivacaine|ropivacaine|mesh-list
2134219|NCT03098420|BB 1101|bb 1101|mesh-list
2134220|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134221|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
2134222|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
2134223|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134224|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134225|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2134226|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
2134227|NCT03098420|Hormones|hormones|mesh-ancestor
2134228|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2134229|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2134230|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134231|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
2134232|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134233|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134234|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
2134235|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
2134236|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134237|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
2134238|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2134239|NCT03098420|Narcotics|narcotics|mesh-ancestor
2134240|NCT03098420|Analgesics|analgesics|mesh-ancestor
2134241|NCT03098550|Nivolumab|nivolumab|mesh-list
2577931|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2577932|NCT01640574|Filaricides|filaricides|mesh-ancestor
2577933|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
2577934|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
2577935|NCT01640587|Artesunate|artesunate|mesh-list
2577936|NCT01640587|Piperaquine|piperaquine|mesh-list
2577937|NCT01640587|Artenimol|artenimol|mesh-list
2577938|NCT01640587|Mefloquine|mefloquine|mesh-list
2577939|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
2577940|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2134242|NCT03098550|Daratumumab|daratumumab|mesh-list
2134243|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2134244|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134245|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2134246|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134247|NCT03098615|Efinaconazole|efinaconazole|mesh-list
2134248|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
2134249|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2134250|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
2134251|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2134252|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134253|NCT03099187|Pirfenidone|pirfenidone|mesh-list
2577941|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2577942|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2577943|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134254|NCT03099187|Analgesics|analgesics|mesh-ancestor
2134255|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
2134256|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134257|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134258|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2134259|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2134260|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134261|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2134262|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134263|NCT03099538|Ixekizumab|ixekizumab|mesh-list
2134264|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
2134265|NCT03100058|Licogliflozin|licogliflozin|mesh-list
2577944|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
2577945|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
2577946|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2577947|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
2577948|NCT01640639|Thalidomide|thalidomide|mesh-list
2577949|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2577950|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
2577951|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577952|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
2577953|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2577954|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2134266|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2134267|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134268|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2134269|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134270|NCT03100123|Aspirin|aspirin|mesh-list
2134271|NCT03100123|Heparin|heparin|mesh-list
2134272|NCT03100123|Enoxaparin|enoxaparin|mesh-list
2134273|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2134274|NCT03100123|Tinzaparin|tinzaparin|mesh-list
2134275|NCT03100123|Dalteparin|dalteparin|mesh-list
2134276|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2134277|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2134278|NCT03100123|Analgesics|analgesics|mesh-ancestor
2134279|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
2134280|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134281|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134282|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134283|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2577955|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2577956|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2577957|NCT01640639|Growth Substances|growth substances|mesh-ancestor
2577958|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
2577959|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577960|NCT01640665|Capecitabine|capecitabine|mesh-list
2577961|NCT01640665|Sorafenib|sorafenib|mesh-list
2577962|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2577963|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
2577964|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134284|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2577965|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419771|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2419772|NCT00804934|Growth Substances|growth substances|mesh-ancestor
2419773|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419774|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
2419775|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419776|NCT00804947|Melphalan|melphalan|mesh-list
2419777|NCT00804947|Busulfan|busulfan|mesh-list
2419778|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2577966|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2577967|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2577968|NCT01640691|Vaccines|vaccines|mesh-list
2577969|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
2577970|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577971|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
2577972|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2577973|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2577974|NCT01640743|Prednisolone|prednisolone|mesh-list
2577975|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
2577976|NCT01640743|Everolimus|everolimus|mesh-list
2577977|NCT01640743|Tacrolimus|tacrolimus|mesh-list
2577978|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2577979|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
2577980|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2577981|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
2577982|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2577983|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2577984|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134285|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2134286|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134287|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2134288|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2134289|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134290|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
2134291|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
2134292|NCT03100838|Nifedipine|nifedipine|mesh-list
2134293|NCT03100838|Omeprazole|omeprazole|mesh-list
2134294|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2134295|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2134296|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2134297|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134298|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134299|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2134300|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2134301|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2134302|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134303|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
2134304|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
2134305|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2577985|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2577986|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2577987|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2577988|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
2577989|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
2577990|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2577991|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2577992|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
2577993|NCT01640743|Hormones|hormones|mesh-ancestor
2134306|NCT03101033|Betamethasone|betamethasone|mesh-list
2134307|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
2134308|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2134309|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
2577994|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2577995|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2577996|NCT01640743|Protective Agents|protective agents|mesh-ancestor
2577997|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2577998|NCT01640782|Leucovorin|leucovorin|mesh-list
2577999|NCT01640782|Docetaxel|docetaxel|mesh-list
2578000|NCT01640782|Fluorouracil|fluorouracil|mesh-list
2578001|NCT01640782|Irinotecan|irinotecan|mesh-list
2578002|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
2578003|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578004|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
2578005|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
2578006|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
2134310|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2578007|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578008|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
2134311|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134312|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
2134313|NCT03101033|Hormones|hormones|mesh-ancestor
2134314|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2134315|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134316|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2134317|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
2134318|NCT03101111|Vaccines|vaccines|mesh-list
2134319|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
2134320|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134321|NCT03101150|Vitamin D|vitamin d|mesh-list
2134322|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
2134323|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
2134324|NCT03101150|Vitamins|vitamins|mesh-list
2134325|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
2134326|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134327|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2134328|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2134329|NCT03101358|Paclitaxel|paclitaxel|mesh-list
2134330|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2134331|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2134332|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134333|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
2134334|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
2578009|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2578010|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2578011|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
2578012|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578013|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2578014|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2578015|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578016|NCT01640782|Antidotes|antidotes|mesh-ancestor
2578017|NCT01640782|Protective Agents|protective agents|mesh-ancestor
2578018|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
2578019|NCT01640782|Vitamins|vitamins|mesh-ancestor
2578020|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
2578021|NCT01640990|GW 328267|gw 328267|mesh-list
2578022|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2578023|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2578024|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
2578025|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
2578026|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578027|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578028|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578029|NCT01641016|Efavirenz|efavirenz|mesh-list
2578030|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2578031|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2578032|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578033|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578034|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
2578035|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578036|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2578037|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2578038|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2134335|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
2134336|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134337|NCT03101371|Iodine|iodine|mesh-list
2134338|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
2134339|NCT03101371|Povidone|povidone|mesh-list
2134340|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2134341|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2134342|NCT03101371|Trace Elements|trace elements|mesh-ancestor
2134343|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
2134344|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134345|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
2134346|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
2134347|NCT03101462|Vaccines|vaccines|mesh-list
2134348|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
2134349|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134365|NCT03102190|Verapamil|verapamil|mesh-list
2134366|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2134367|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2134368|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2134369|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134370|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2134371|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134372|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
2134373|NCT03102645|Imipramine|imipramine|mesh-list
2134374|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2134375|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
2134376|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2134377|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2134378|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2134379|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2134380|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134381|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
2134382|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134383|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134384|NCT03102710|Lidocaine|lidocaine|mesh-list
2134385|NCT03102710|Capsaicin|capsaicin|mesh-list
2134386|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
2134387|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
2134388|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134389|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134390|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
2134391|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134392|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2134393|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2134394|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2134395|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2419779|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
2578039|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2578040|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2578041|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2578042|NCT01641055|Caseins|caseins|mesh-list
2578043|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
2578044|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
2578045|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578046|NCT01641224|Pinaverium|pinaverium|mesh-list
2578047|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2578048|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2419780|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419781|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419782|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2419783|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2419784|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
2419785|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419786|NCT00804960|Letrozole|letrozole|mesh-list
2419787|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419788|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2419789|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2419790|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419791|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419792|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2419793|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
2419794|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2419795|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419796|NCT00805012|Docetaxel|docetaxel|mesh-list
2419797|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419798|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
2419799|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
2419800|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
2578049|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578050|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2578051|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578052|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
2578053|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
2578054|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578055|NCT01641250|Cytarabine|cytarabine|mesh-list
2578056|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2578057|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
2578058|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578059|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578060|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
2578061|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578062|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2578063|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
2578064|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578065|NCT01641289|Acetaminophen|acetaminophen|mesh-list
2578066|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2578067|NCT01641289|Analgesics|analgesics|mesh-ancestor
2578068|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
2578069|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578070|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134396|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134397|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
2134398|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
2134399|NCT03102736|Nitroprusside|nitroprusside|mesh-list
2134400|NCT03102736|Ketamine|ketamine|mesh-list
2134401|NCT03102736|Analgesics|analgesics|mesh-ancestor
2134402|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
2578071|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
2578072|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
2578073|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
2578074|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578075|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
2134403|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134404|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134405|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2134406|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2134407|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
2134408|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
2134409|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134410|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2134411|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2134412|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134413|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578076|NCT01641341|Pancrelipase|pancrelipase|mesh-list
2578077|NCT01641341|Pancreatin|pancreatin|mesh-list
2578078|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2578079|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578080|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2578081|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
2578082|NCT01641406|Bevacizumab|bevacizumab|mesh-list
2578083|NCT01641406|Docetaxel|docetaxel|mesh-list
2578084|NCT01641406|Capecitabine|capecitabine|mesh-list
2578085|NCT01641406|Trastuzumab|trastuzumab|mesh-list
2578086|NCT01641406|Epirubicin|epirubicin|mesh-list
2578087|NCT01641406|Vinorelbine|vinorelbine|mesh-list
2134414|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2134415|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
2134416|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2134417|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
2134418|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2134419|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2134420|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2134421|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2134422|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134423|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
2134424|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134425|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134426|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2134427|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578088|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2578089|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
2578090|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578091|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2578092|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2134428|NCT03102918|Cannabidiol|cannabidiol|mesh-list
2134429|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
2134430|NCT03103061|Regadenoson|regadenoson|mesh-list
2134431|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2134432|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2134433|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
2134434|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
2134435|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134436|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134437|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134438|NCT03103100|Lidocaine|lidocaine|mesh-list
2134439|NCT03103100|Bupivacaine|bupivacaine|mesh-list
2134440|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
2134441|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
2134442|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134443|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134444|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
2134445|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134446|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2134447|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2134448|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2134449|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2134450|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134451|NCT03103763|Warfarin|warfarin|mesh-list
2134452|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
2578093|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
2578094|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578095|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578096|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2578097|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2578098|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2578099|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2578100|NCT01641406|Growth Substances|growth substances|mesh-ancestor
2578101|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
2578102|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
2578103|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
2578104|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
2578105|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2578106|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
2578107|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2134453|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
2134454|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2134455|NCT03103906|Protective Agents|protective agents|mesh-ancestor
2134456|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134457|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
2134458|NCT03103919|Rotigotine|rotigotine|mesh-list
2134459|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
2134460|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
2134461|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134462|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134463|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134464|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
2134465|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2134466|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
2134467|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2134468|NCT03104725|Expectorants|expectorants|mesh-ancestor
2134469|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
2134470|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2134471|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
2134472|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134473|NCT03104725|Protective Agents|protective agents|mesh-ancestor
2134474|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134475|NCT03104725|Antidotes|antidotes|mesh-ancestor
2134476|NCT03104738|Insulin|insulin|mesh-list
2134477|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2134478|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134479|NCT03104816|Acetaminophen|acetaminophen|mesh-list
2134480|NCT03104816|Hydromorphone|hydromorphone|mesh-list
2578108|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2578109|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2578110|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578111|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2578112|NCT01641419|Dexamethasone|dexamethasone|mesh-list
2578113|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
2578114|NCT01641419|BB 1101|bb 1101|mesh-list
2578115|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134481|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2134482|NCT03104816|Analgesics|analgesics|mesh-ancestor
2134483|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
2134484|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134485|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134486|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
2134487|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2134488|NCT03104816|Narcotics|narcotics|mesh-ancestor
2134489|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134490|NCT03105479|Vancomycin|vancomycin|mesh-list
2134491|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2134492|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2134493|NCT03105518|Acetaminophen|acetaminophen|mesh-list
2134494|NCT03105518|Fentanyl|fentanyl|mesh-list
2134495|NCT03105518|Oxycodone|oxycodone|mesh-list
2134496|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2134497|NCT03105518|Narcotics|narcotics|mesh-ancestor
2134498|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134499|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134500|NCT03105518|Analgesics|analgesics|mesh-ancestor
2134501|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
2134502|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134503|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2134504|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2134505|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
2134506|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
2134507|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2134508|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
2134509|NCT03106077|Maytansine|maytansine|mesh-list
2134510|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2134511|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134512|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
2134513|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
2134514|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
2134515|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134516|NCT03106753|Bupivacaine|bupivacaine|mesh-list
2134517|NCT03106753|Terbutaline|terbutaline|mesh-list
2134518|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
2134519|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
2578116|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
2578117|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
2578118|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578119|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578120|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2578121|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
2578122|NCT01641419|Hormones|hormones|mesh-ancestor
2578123|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2578124|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2578125|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578126|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
2578127|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578128|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578129|NCT01641458|Capecitabine|capecitabine|mesh-list
2134520|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134521|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134522|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
2134523|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134524|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2134525|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
2134526|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2134527|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
2134528|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
2134529|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
2134530|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2134531|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2134532|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2134533|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2134534|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
2134535|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134536|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134537|NCT03106870|Insulin|insulin|mesh-list
2134538|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2578130|NCT01641458|Fluorouracil|fluorouracil|mesh-list
2578131|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2578132|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
2578133|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134539|NCT03106870|Metformin|metformin|mesh-list
2134540|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
2134541|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2134542|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134543|NCT03107091|Terlipressin|terlipressin|mesh-list
2134544|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2134545|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2134546|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
2134547|NCT03107611|Tacrolimus|tacrolimus|mesh-list
2134548|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2134549|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2134550|NCT03107611|Analgesics|analgesics|mesh-ancestor
2134551|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
2134552|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134553|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134554|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134555|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2134556|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
2134557|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2134558|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
2134559|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2578134|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578135|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2578136|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
2578137|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578138|NCT01641510|Clopidogrel|clopidogrel|mesh-list
2578139|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2578140|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2578141|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2578142|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2578143|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2578144|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
2578145|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578146|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578147|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578148|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2578149|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
2578150|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2578151|NCT01641523|Protective Agents|protective agents|mesh-ancestor
2578152|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578153|NCT01641536|Entecavir|entecavir|mesh-list
2578154|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
2578155|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578156|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
2578157|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2578158|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578159|NCT01641575|Gemcitabine|gemcitabine|mesh-list
2578160|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578161|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2134560|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134561|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134562|NCT03107754|Lidocaine|lidocaine|mesh-list
2134563|NCT03107754|Anesthetics|anesthetics|mesh-list
2134564|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
2134565|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2419801|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419802|NCT00805064|Triamcinolone|triamcinolone|mesh-list
2419803|NCT00805064|Bevacizumab|bevacizumab|mesh-list
2419804|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2419805|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419806|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2419807|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2419808|NCT00805064|Growth Substances|growth substances|mesh-ancestor
2419809|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419810|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
2419811|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419812|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
2419813|NCT00805064|Hormones|hormones|mesh-ancestor
2578162|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
2578163|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578164|NCT01641575|Antiviral Agents|antiviral agents|mesh-ancestor
2578165|NCT01641575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578166|NCT01641575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578167|NCT01641575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2134566|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134567|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
2134568|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134569|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2134570|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2134571|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2134572|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2134573|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134574|NCT03107793|Ustekinumab|ustekinumab|mesh-list
2134575|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
2134576|NCT03108482|Celecoxib|celecoxib|mesh-list
2134577|NCT03108482|Tramadol|tramadol|mesh-list
2134578|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2134579|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2134580|NCT03108482|Analgesics|analgesics|mesh-ancestor
2134581|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
2134582|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134583|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134584|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134585|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2134586|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2134587|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2134588|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134589|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134590|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2134591|NCT03108482|Narcotics|narcotics|mesh-ancestor
2578168|NCT01641575|Immunologic Factors|immunologic factors|mesh-ancestor
2578169|NCT01641575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578170|NCT01641666|Ribavirin|ribavirin|mesh-list
2578171|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2578172|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
2578173|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
2578174|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578175|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
2578176|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578177|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
2578178|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578179|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2578180|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
2578181|NCT01641718|Coagulants|coagulants|mesh-ancestor
2134592|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134593|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2134594|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2134595|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134596|NCT03108521|Incretins|incretins|mesh-ancestor
2134597|NCT03108521|Hormones|hormones|mesh-ancestor
2134598|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2134599|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2134600|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
2134601|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134602|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134603|NCT03109015|Sunitinib|sunitinib|mesh-list
2134604|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134605|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2578182|NCT01641783|Paclitaxel|paclitaxel|mesh-list
2578183|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2578184|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2578185|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578186|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
2578187|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
2578188|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
2578189|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578190|NCT01641796|Paromomycin|paromomycin|mesh-list
2578191|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2578192|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578193|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2578194|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2578195|NCT01642030|Buprenorphine|buprenorphine|mesh-list
2578196|NCT01642030|Hydromorphone|hydromorphone|mesh-list
2578197|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2578198|NCT01642030|Narcotics|narcotics|mesh-ancestor
2578199|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2578200|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578201|NCT01642030|Analgesics|analgesics|mesh-ancestor
2134606|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2134607|NCT03109015|Growth Substances|growth substances|mesh-ancestor
2134608|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134609|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
2134610|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2578202|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
2578203|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578204|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2578205|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2578206|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2578207|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578208|NCT01642108|Incretins|incretins|mesh-ancestor
2578209|NCT01642108|Hormones|hormones|mesh-ancestor
2578210|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2578211|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2578212|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
2134611|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134612|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134613|NCT03110003|Bupivacaine|bupivacaine|mesh-list
2134614|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
2134615|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
2134616|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134617|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134618|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
2134619|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134620|NCT03110029|Efinaconazole|efinaconazole|mesh-list
2134621|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
2134622|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2134635|NCT03110562|Dexamethasone|dexamethasone|mesh-list
2134636|NCT03110562|Bortezomib|bortezomib|mesh-list
2134637|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134638|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
2134639|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
2134640|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134641|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134642|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2134643|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
2134644|NCT03110562|Hormones|hormones|mesh-ancestor
2134645|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2578213|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578214|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578215|NCT01642134|Aspirin|aspirin|mesh-list
2578216|NCT01642134|Clopidogrel|clopidogrel|mesh-list
2578217|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2578218|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2578219|NCT01642134|Analgesics|analgesics|mesh-ancestor
2578220|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
2134646|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2134647|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134648|NCT03111108|Grazoprevir|grazoprevir|mesh-list
2134649|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
2134650|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2134651|NCT03111316|Dinoprostone|dinoprostone|mesh-list
2134652|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
2134653|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2134654|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134655|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2134656|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2134657|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2134658|NCT03111381|Analgesics|analgesics|mesh-ancestor
2134659|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
2134660|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134661|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134662|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134663|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2134664|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2134665|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134666|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134667|NCT03111628|Omalizumab|omalizumab|mesh-list
2134668|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2134669|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2134670|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
2134679|NCT03112863|Vitamin A|vitamin a|mesh-list
2134680|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
2578221|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578222|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578223|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2578224|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2578225|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2578226|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2578227|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578228|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2578229|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2578230|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578231|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
2578232|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2578233|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2578234|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2578235|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
2578236|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578237|NCT01642186|Everolimus|everolimus|mesh-list
2578238|NCT01642186|Letrozole|letrozole|mesh-list
2578239|NCT01642186|Leuprolide|leuprolide|mesh-list
2578240|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578241|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2578242|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
2578243|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578244|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2578245|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2578246|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578247|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578248|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2578249|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
2578250|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2578251|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2578252|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
2578253|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2578254|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2578255|NCT01642433|Prazosin|prazosin|mesh-list
2578256|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2578257|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2578258|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2578259|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2578260|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
2578261|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578262|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578263|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578264|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
2578265|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2578266|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
2578267|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2578268|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578269|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2578270|NCT01642524|Dextrans|dextrans|mesh-list
2578271|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
2578272|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
2578273|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
2578274|NCT01642667|Saruplase|saruplase|mesh-list
2578275|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2578276|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2134681|NCT03112863|Vitamins|vitamins|mesh-ancestor
2134682|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
2419814|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2419815|NCT00805090|Itraconazole|itraconazole|mesh-list
2419816|NCT00805090|Diclofenac|diclofenac|mesh-list
2419817|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2419818|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419819|NCT00805090|Analgesics|analgesics|mesh-ancestor
2419820|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
2419821|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419822|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419823|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134683|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134684|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
2134685|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134686|NCT03112863|Protective Agents|protective agents|mesh-ancestor
2134687|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2134688|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134689|NCT03112993|Neostigmine|neostigmine|mesh-list
2134690|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2578277|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578278|NCT01642745|Mannitol|mannitol|mesh-list
2578279|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
2578280|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2578281|NCT01642745|Diuretics|diuretics|mesh-ancestor
2578282|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
2578283|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578284|NCT01642745|Miotics|miotics|mesh-ancestor
2578285|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
2578286|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578287|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2578288|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2578289|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
2134691|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134692|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134693|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
2134694|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134695|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134696|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2134697|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
2134698|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134699|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2134700|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
2134701|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2134702|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2134703|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
2134704|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2134705|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
2134706|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134707|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134708|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
2134709|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2134710|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
2134711|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134712|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134713|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
2134714|NCT03114969|Hormones|hormones|mesh-ancestor
2578290|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2578291|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2578292|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
2578293|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578294|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578295|NCT01642771|Docetaxel|docetaxel|mesh-list
2578296|NCT01642771|Fluorouracil|fluorouracil|mesh-list
2578297|NCT01642771|Capecitabine|capecitabine|mesh-list
2578298|NCT01642771|Epirubicin|epirubicin|mesh-list
2578299|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578300|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
2578301|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
2578302|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
2578303|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578304|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
2578305|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2578306|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2578307|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
2578308|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134715|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2134716|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
2134717|NCT03114995|Tirofiban|tirofiban|mesh-list
2134718|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2419824|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2419825|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2419826|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419827|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419828|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
2419829|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578309|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2578310|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2578311|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2578312|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578313|NCT01642862|Simvastatin|simvastatin|mesh-list
2578314|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2578315|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2578316|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
2578317|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134719|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2134720|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134721|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2134722|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2134723|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
2134724|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2134725|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134726|NCT03115112|Incretins|incretins|mesh-ancestor
2134727|NCT03115112|Hormones|hormones|mesh-ancestor
2134728|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2134729|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2134730|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
2134731|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134732|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134733|NCT03115177|Doxycycline|doxycycline|mesh-list
2134734|NCT03115177|Cefazolin|cefazolin|mesh-list
2134735|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2134736|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2134737|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
2134738|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2134739|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2134740|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
2134741|NCT03115801|Nivolumab|nivolumab|mesh-list
2134742|NCT03115801|Atezolizumab|atezolizumab|mesh-list
2134743|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
2134744|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2578318|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2578319|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2578320|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578321|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
2134745|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134746|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2134747|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134748|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134749|NCT03115827|Carbidopa|carbidopa|mesh-list
2134750|NCT03115827|Droxidopa|droxidopa|mesh-list
2134751|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2134752|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2134753|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
2134754|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134755|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134756|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134757|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2134758|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134759|NCT03116152|Paclitaxel|paclitaxel|mesh-list
2419830|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2419831|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2419832|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2419833|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
2419834|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2419835|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2419836|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
2419837|NCT00805116|Vitamins|vitamins|mesh-ancestor
2419838|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
2578322|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2578323|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578324|NCT01642940|Ticagrelor|ticagrelor|mesh-list
2578325|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2578326|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2578327|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2578328|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2578329|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2578330|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
2578331|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578332|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578333|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578334|NCT01642966|Ticagrelor|ticagrelor|mesh-list
2578335|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2578336|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2578337|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2578338|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2578339|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2578340|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
2578341|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578342|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578343|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134760|NCT03116152|Irinotecan|irinotecan|mesh-list
2134761|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2134762|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134763|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
2134764|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
2134765|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
2134766|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134767|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2134768|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2134769|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134770|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2134771|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
2134772|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2134773|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2134774|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2134775|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134776|NCT03117140|Dexamethasone|dexamethasone|mesh-list
2134777|NCT03117140|Clonidine|clonidine|mesh-list
2134778|NCT03117140|Buprenorphine|buprenorphine|mesh-list
2578344|NCT01642979|Cyclosporine|cyclosporine|mesh-list
2578345|NCT01642979|Levamisole|levamisole|mesh-list
2578346|NCT01642979|Cyclosporins|cyclosporins|mesh-list
2578347|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
2578348|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578349|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578350|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2134779|NCT03117140|Ropivacaine|ropivacaine|mesh-list
2134780|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134781|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
2134782|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
2134783|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134784|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134785|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2134786|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
2134787|NCT03117140|Hormones|hormones|mesh-ancestor
2134788|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2134789|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2134790|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134791|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
2134792|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
2134793|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134794|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
2134795|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2134796|NCT03117140|Narcotics|narcotics|mesh-ancestor
2134797|NCT03117140|Analgesics|analgesics|mesh-ancestor
2134798|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2134799|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2134800|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
2134801|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2134802|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2134803|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2134804|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
2134805|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134806|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134807|NCT03117361|Dexamethasone|dexamethasone|mesh-list
2134808|NCT03117361|Bortezomib|bortezomib|mesh-list
2134809|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134810|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
2134811|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
2134812|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134813|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134814|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2134815|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
2134816|NCT03117361|Hormones|hormones|mesh-ancestor
2578351|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
2578352|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578353|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
2578354|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578355|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
2578356|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2578357|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2578358|NCT01642979|Hormones|hormones|mesh-ancestor
2578359|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2578360|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2578361|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
2578362|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
2578363|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2578364|NCT01643031|Clopidogrel|clopidogrel|mesh-list
2578365|NCT01643031|Ticagrelor|ticagrelor|mesh-list
2578366|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2578367|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2134817|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2134818|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2134819|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134820|NCT03117517|Metformin|metformin|mesh-list
2134821|NCT03117517|Pioglitazone|pioglitazone|mesh-list
2134822|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2134823|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134824|NCT03117634|Aflibercept|aflibercept|mesh-list
2134825|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2134826|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2134827|NCT03117634|Growth Substances|growth substances|mesh-ancestor
2134828|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134829|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
2134830|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134831|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
2134832|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2134833|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
2134834|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2134835|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134836|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2134837|NCT03118466|Cytarabine|cytarabine|mesh-list
2134838|NCT03118466|Etoposide|etoposide|mesh-list
2134839|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
2134840|NCT03118466|Lenalidomide|lenalidomide|mesh-list
2134841|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2134842|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134843|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2134844|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2134845|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134846|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134847|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2134848|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
2134849|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
2134850|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578368|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2578369|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2578370|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
2578371|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578372|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578373|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578374|NCT01643070|Capecitabine|capecitabine|mesh-list
2578375|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
2578376|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2578377|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
2578378|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134851|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2578379|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578380|NCT01643083|Rifaximin|rifaximin|mesh-list
2578381|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2578382|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578383|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2578384|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
2578385|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
2578386|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2578387|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2578388|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578389|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
2578390|NCT01643135|Coagulants|coagulants|mesh-ancestor
2578391|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
2134852|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
2134853|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134854|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2134855|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2134856|NCT03118466|Growth Substances|growth substances|mesh-ancestor
2134857|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
2134858|NCT03118466|Analgesics|analgesics|mesh-ancestor
2134859|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
2134860|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134861|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2134862|NCT03118739|Febuxostat|febuxostat|mesh-list
2134863|NCT03118739|Verinurad|verinurad|mesh-list
2134864|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
2134865|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2134866|NCT03118765|Bromides|bromides|mesh-list
2134867|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2134868|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
2134869|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2134870|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
2134871|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134872|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134873|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2134874|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
2134875|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
2134876|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2134877|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
2134878|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134879|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134880|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
2134881|NCT03118843|Velpatasvir|velpatasvir|mesh-list
2134882|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
2134883|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2134884|NCT03118947|Pimavanserin|pimavanserin|mesh-list
2134885|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2134886|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2134887|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2134888|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2134889|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134890|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134891|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2134892|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2134893|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2134894|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
2134895|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134896|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134897|NCT03119168|Simethicone|simethicone|mesh-list
2134898|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
2134899|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134900|NCT03119168|Emollients|emollients|mesh-ancestor
2134901|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
2134902|NCT03119181|Lidocaine|lidocaine|mesh-list
2134903|NCT03119181|Epinephrine|epinephrine|mesh-list
2134904|NCT03119181|Racepinephrine|racepinephrine|mesh-list
2134905|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2134906|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
2134907|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
2134908|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
2134909|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134910|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134911|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
2578392|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2578393|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2578394|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2134912|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578395|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2134913|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2134914|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2134915|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2134916|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2134917|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134918|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2134919|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2134920|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
2134921|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134922|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2578396|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2578397|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2578398|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578399|NCT01643187|Vitamins|vitamins|mesh-list
2578400|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
2578401|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578402|NCT01643226|Riboflavin|riboflavin|mesh-list
2578403|NCT01643226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2578404|NCT01643226|Vitamin B Complex|vitamin b complex|mesh-ancestor
2578405|NCT01643226|Vitamins|vitamins|mesh-ancestor
2578406|NCT01643226|Micronutrients|micronutrients|mesh-ancestor
2578407|NCT01643226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578408|NCT01643226|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2134923|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2134924|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
2134925|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2134926|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
2134927|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
2134928|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
2134929|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2134930|NCT03119610|Oxytocin|oxytocin|mesh-list
2134931|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
2134932|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2134933|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134934|NCT03119701|Interferons|interferons|mesh-list
2134935|NCT03119701|Interferon-beta|interferon-beta|mesh-list
2134936|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
2578409|NCT01643226|Dermatologic Agents|dermatologic agents|mesh-ancestor
2578410|NCT01643252|Riboflavin|riboflavin|mesh-list
2578411|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2578412|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2578413|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
2578414|NCT01643252|Vitamins|vitamins|mesh-ancestor
2578415|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
2578416|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578417|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2578418|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
2578419|NCT01643265|Caseins|caseins|mesh-list
2578420|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
2578421|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
2578422|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578423|NCT01643278|Ipilimumab|ipilimumab|mesh-list
2578424|NCT01643278|Dasatinib|dasatinib|mesh-list
2578425|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2578426|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578427|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2578428|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578429|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2578430|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578431|NCT01643434|Clonidine|clonidine|mesh-list
2578432|NCT01643434|Spironolactone|spironolactone|mesh-list
2578433|NCT01643434|Analgesics|analgesics|mesh-ancestor
2578434|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
2578435|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578436|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578437|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2578438|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
2578439|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
2578440|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2578441|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2578442|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2578443|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
2578444|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134937|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578445|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578446|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2578447|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
2578448|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2578449|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2578450|NCT01643434|Diuretics|diuretics|mesh-ancestor
2578451|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
2578452|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
2578453|NCT01643447|Urinastatin|urinastatin|mesh-list
2578454|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2134938|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
2134939|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2134940|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
2134941|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134942|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2134943|NCT03119831|Ethanol|ethanol|mesh-list
2134944|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
2134945|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2134946|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2134947|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2134948|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134949|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134950|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
2134951|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
2134952|NCT03120351|Lidocaine|lidocaine|mesh-list
2134953|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
2134954|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
2134955|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2134956|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134957|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
2134958|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134959|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2134960|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2134961|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2134962|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2134963|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578455|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2578456|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
2578457|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578458|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578459|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134964|NCT03120520|Plecanatide|plecanatide|mesh-list
2134965|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2578473|NCT01643499|Leucovorin|leucovorin|mesh-list
2578474|NCT01643499|Fluorouracil|fluorouracil|mesh-list
2578475|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
2578476|NCT01643499|Irinotecan|irinotecan|mesh-list
2578477|NCT01643499|Calcium|calcium|mesh-list
2578478|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
2578479|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2578480|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578481|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
2578482|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578483|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2578484|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578485|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2578486|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
2578487|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2578488|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2578489|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578490|NCT01643499|Antidotes|antidotes|mesh-ancestor
2578491|NCT01643499|Protective Agents|protective agents|mesh-ancestor
2578492|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
2578493|NCT01643499|Vitamins|vitamins|mesh-ancestor
2578494|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
2578495|NCT01643603|Dasatinib|dasatinib|mesh-list
2134966|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
2134967|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134968|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2134969|NCT03121820|Memantine|memantine|mesh-list
2134970|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2134971|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2134972|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
2134973|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2134974|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2134975|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134976|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2134977|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2134978|NCT03122145|Capsaicin|capsaicin|mesh-list
2134979|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
2578496|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578497|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2578498|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578499|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578500|NCT01643629|Minoxidil|minoxidil|mesh-list
2578501|NCT01643629|Finasteride|finasteride|mesh-list
2578502|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2578503|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2578504|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578505|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578506|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
2578507|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2578508|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578509|NCT01643629|Urological Agents|urological agents|mesh-ancestor
2134980|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
2134981|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
2134982|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2134983|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134984|NCT03122457|C 1027|c 1027|mesh-list
2578510|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2578511|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
2578512|NCT01643759|Buprenorphine|buprenorphine|mesh-list
2578513|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2578514|NCT01643759|Narcotics|narcotics|mesh-ancestor
2578515|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2578516|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578517|NCT01643759|Analgesics|analgesics|mesh-ancestor
2578518|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
2578519|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578520|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2578521|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
2578522|NCT01643889|Domperidone|domperidone|mesh-list
2578523|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2578524|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578525|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2578526|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2578527|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578528|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578529|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578530|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578531|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
2578532|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
2134985|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2134986|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
2134987|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2134988|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134989|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
2134990|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2134991|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2134992|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
2134993|NCT03122587|Vitamins|vitamins|mesh-ancestor
2134994|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
2134995|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2134996|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2134997|NCT03122860|Lorecivivint|lorecivivint|mesh-list
2134998|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2134999|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2135000|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
2578533|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135001|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2578534|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2578535|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2578536|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
2578537|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578538|NCT01643941|Vaccines|vaccines|mesh-list
2578539|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
2578540|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578541|NCT01643980|Progesterone|progesterone|mesh-list
2578542|NCT01643980|Progestins|progestins|mesh-ancestor
2578543|NCT01643980|Hormones|hormones|mesh-ancestor
2578544|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2578545|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578546|NCT01644071|Dexetimide|dexetimide|mesh-list
2578547|NCT01644071|Citalopram|citalopram|mesh-list
2578548|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2578549|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2578550|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
2578551|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
2578552|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578553|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578554|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2578555|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2578556|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
2578557|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578558|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578559|NCT01644071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2578560|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2578561|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2135002|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2135003|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
2135004|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2135005|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135006|NCT03123471|Apremilast|apremilast|mesh-list
2135007|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2135008|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2135009|NCT03123471|Analgesics|analgesics|mesh-ancestor
2135010|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
2135011|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135012|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135013|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2135014|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2135015|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2135016|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2135017|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135018|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135019|NCT03123588|Anagrelide|anagrelide|mesh-list
2135020|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2135021|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2135022|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135023|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2135024|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2135025|NCT03123614|Prednisolone|prednisolone|mesh-list
2135026|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2135027|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
2135028|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2135029|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
2135030|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2135031|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
2135032|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2135033|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
2135034|NCT03123614|Hormones|hormones|mesh-ancestor
2135035|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135036|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135037|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2135038|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135039|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
2135040|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
2135041|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135042|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2135043|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2135044|NCT03123614|Protective Agents|protective agents|mesh-ancestor
2135045|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2135046|NCT03123848|Darunavir|darunavir|mesh-list
2135047|NCT03123848|Cobicistat|cobicistat|mesh-list
2135048|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2578562|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
2578563|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2578564|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
2578565|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2578566|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2578567|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
2578568|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
2578569|NCT01644110|Pomalidomide|pomalidomide|mesh-list
2578570|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
2578571|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578572|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2578573|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2578574|NCT01644110|Growth Substances|growth substances|mesh-ancestor
2135049|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2135050|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
2135051|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135052|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135053|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2135054|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2135055|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
2135056|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135057|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2135058|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2135059|NCT03123861|Gabapentin|gabapentin|mesh-list
2135060|NCT03123861|Analgesics|analgesics|mesh-ancestor
2135061|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
2135062|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135063|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135064|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
2135065|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2135066|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2135067|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135068|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2135069|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2135070|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2135071|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135072|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135073|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
2135074|NCT03124121|Golimumab|golimumab|mesh-list
2135075|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2135076|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2135077|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2135078|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
2135079|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135080|NCT03124199|Rifaximin|rifaximin|mesh-list
2135081|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2135082|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135083|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2135084|NCT03124407|Capsaicin|capsaicin|mesh-list
2135085|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
2135086|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
2135087|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
2135088|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135089|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135090|NCT03125395|Ivacaftor|ivacaftor|mesh-list
2135091|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2135092|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2135093|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135094|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2135095|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2135096|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135097|NCT03125902|Paclitaxel|paclitaxel|mesh-list
2135098|NCT03125902|Atezolizumab|atezolizumab|mesh-list
2135099|NCT03125902|Antibodies|antibodies|mesh-list
2135100|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2135101|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2135102|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135103|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
2135104|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
2135105|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
2135106|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135107|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
2135108|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135109|NCT03125941|Dexamethasone|dexamethasone|mesh-list
2135110|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2135111|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
2135112|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
2135113|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135114|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135115|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2135116|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
2135117|NCT03125941|Hormones|hormones|mesh-ancestor
2135118|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135119|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2135120|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135121|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2135122|NCT03126370|Emtricitabine|emtricitabine|mesh-list
2135123|NCT03126370|Tenofovir|tenofovir|mesh-list
2135124|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2135125|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
2135126|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2135127|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2135128|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135129|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135130|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
2578575|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
2578576|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578577|NCT01644253|Rituximab|rituximab|mesh-list
2578578|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
2578579|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2578580|NCT01644253|Idelalisib|idelalisib|mesh-list
2578581|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
2578582|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2578583|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578584|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
2578585|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578586|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2578587|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2578588|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
2578589|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578590|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578591|NCT01644773|Dasatinib|dasatinib|mesh-list
2578592|NCT01644773|Crizotinib|crizotinib|mesh-list
2578593|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578594|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2578595|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578596|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578597|NCT01644799|Lenalidomide|lenalidomide|mesh-list
2578598|NCT01644799|Idelalisib|idelalisib|mesh-list
2578599|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
2578600|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578601|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2578602|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2135131|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135132|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2135133|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2135134|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2135135|NCT03126539|Sulforaphane|sulforaphane|mesh-list
2135136|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2135137|NCT03126539|Protective Agents|protective agents|mesh-ancestor
2135138|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135139|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135140|NCT03126682|Bupropion|bupropion|mesh-list
2135141|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2135142|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
2135143|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2135144|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2135145|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2135146|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2135147|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135148|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
2135149|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135150|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135151|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2135152|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2135153|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135154|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2135155|NCT03126760|Hormones|hormones|mesh-ancestor
2578603|NCT01644799|Growth Substances|growth substances|mesh-ancestor
2578604|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
2578605|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578606|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578607|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578608|NCT01644825|Paclitaxel|paclitaxel|mesh-list
2578609|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2578610|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578611|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
2578612|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
2578613|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
2578614|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578615|NCT01644838|Promethazine|promethazine|mesh-list
2578616|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
2578617|NCT01644838|Scopolamine|scopolamine|mesh-list
2578618|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2578619|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
2578620|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
2135156|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135157|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135158|NCT03126786|Triamcinolone|triamcinolone|mesh-list
2135159|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2135160|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2135161|NCT03126786|Aflibercept|aflibercept|mesh-list
2135162|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2135163|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2135164|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
2135165|NCT03126786|Hormones|hormones|mesh-ancestor
2135166|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135167|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135168|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2135169|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
2135170|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135171|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135172|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2135173|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2135174|NCT03126786|Growth Substances|growth substances|mesh-ancestor
2578621|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578622|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578623|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2578624|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
2578625|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2578626|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
2578627|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578628|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578629|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2578630|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
2135175|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
2135176|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135177|NCT03127384|Lidocaine|lidocaine|mesh-list
2135178|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
2135179|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
2135180|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135181|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135182|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
2419839|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419845|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
2419846|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419847|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
2419848|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2419849|NCT00805233|Bromfenac|bromfenac|mesh-list
2419850|NCT00805233|Ranibizumab|ranibizumab|mesh-list
2419851|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2419852|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2419853|NCT00805233|Growth Substances|growth substances|mesh-ancestor
2419854|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578631|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
2578632|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2578633|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
2578634|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
2578635|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2578636|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2578637|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2578638|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2578639|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
2578640|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
2135183|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135184|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2135185|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2135186|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2135187|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2135188|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135189|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2135190|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135191|NCT03127943|Lidocaine|lidocaine|mesh-list
2135192|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
2135193|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
2135194|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2578641|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
2578642|NCT01644864|Ropivacaine|ropivacaine|mesh-list
2578643|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
2578644|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
2578645|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2578646|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578647|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
2578648|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578649|NCT01644955|Carboplatin|carboplatin|mesh-list
2578650|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135195|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135196|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
2135197|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135198|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2135199|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2135200|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2135201|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2135202|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135203|NCT03128008|Paclitaxel|paclitaxel|mesh-list
2135204|NCT03128008|Carboplatin|carboplatin|mesh-list
2135205|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2135206|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135207|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
2135208|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
2135209|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
2135210|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135211|NCT03129100|Ixekizumab|ixekizumab|mesh-list
2135212|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
2578651|NCT01644994|Cisplatin|cisplatin|mesh-list
2578652|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135213|NCT03129321|Econazole|econazole|mesh-list
2135214|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
2135215|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135216|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2135217|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2135218|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135219|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135220|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2135221|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
2135222|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135223|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135224|NCT03129945|Indomethacin|indomethacin|mesh-list
2135225|NCT03129945|Nifedipine|nifedipine|mesh-list
2135226|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2135227|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2135228|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135229|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2135230|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135231|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
2135232|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
2135233|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2135234|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2135235|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2135236|NCT03129945|Analgesics|analgesics|mesh-ancestor
2578653|NCT01645085|Mannitol|mannitol|mesh-list
2578654|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2578655|NCT01645085|Diuretics|diuretics|mesh-ancestor
2578656|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
2135237|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
2135238|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135239|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2135240|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2135241|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
2135242|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2135243|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135244|NCT03130738|Miconazole|miconazole|mesh-list
2135245|NCT03130738|Clotrimazole|clotrimazole|mesh-list
2135246|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
2135247|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135248|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2135249|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2135250|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135251|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135252|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2135253|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
2135254|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135255|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135256|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2135257|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2135258|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2135259|NCT03130959|Nivolumab|nivolumab|mesh-list
2135260|NCT03130959|Ipilimumab|ipilimumab|mesh-list
2135261|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2135262|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135263|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2135264|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135265|NCT03131219|Ravulizumab|ravulizumab|mesh-list
2135266|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2135267|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2135268|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
2135269|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135270|NCT03131453|CNP520|cnp520|mesh-list
2135271|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135272|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135273|NCT03131479|Licogliflozin|licogliflozin|mesh-list
2135274|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2135275|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135276|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2135277|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135278|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2135279|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
2135280|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135281|NCT03131687|Dulaglutide|dulaglutide|mesh-list
2135282|NCT03131687|Tirzepatide|tirzepatide|mesh-list
2135283|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2135284|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135285|NCT03131687|Incretins|incretins|mesh-ancestor
2135286|NCT03131687|Hormones|hormones|mesh-ancestor
2135287|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135288|NCT03131713|Acetaminophen|acetaminophen|mesh-list
2135289|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2135290|NCT03131713|Analgesics|analgesics|mesh-ancestor
2135291|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
2135292|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135293|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135294|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
2135295|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
2135296|NCT03131895|Lansoprazole|lansoprazole|mesh-list
2135297|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2135298|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2135299|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2135300|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135301|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135302|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
2135303|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135304|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2135305|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135306|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135307|NCT03132571|Naltrexone|naltrexone|mesh-list
2578657|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578658|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
2578659|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578660|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
2578661|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578662|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578663|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2578664|NCT01645228|Calcium|calcium|mesh-list
2578665|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2578666|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578667|NCT01645241|Ganirelix|ganirelix|mesh-list
2578668|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
2578669|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2578670|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135308|NCT03132571|Bupropion|bupropion|mesh-list
2135309|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2135310|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2135311|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578671|NCT01645254|Antimalarials|antimalarials|mesh-list
2578672|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2578673|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2578674|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578675|NCT01645384|Atorvastatin|atorvastatin|mesh-list
2578676|NCT01645384|Calcium|calcium|mesh-list
2578677|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2578678|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578679|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2578680|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2578681|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
2578682|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578683|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2578684|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2578685|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135312|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
2135313|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135314|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2578686|NCT01645410|Atorvastatin|atorvastatin|mesh-list
2578687|NCT01645410|Calcium|calcium|mesh-list
2578688|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2578689|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578690|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2578691|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2578692|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
2578693|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578694|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2578695|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2578696|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578697|NCT01645423|Atorvastatin|atorvastatin|mesh-list
2578698|NCT01645423|Calcium|calcium|mesh-list
2578699|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2578700|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578701|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2578702|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2578703|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
2578704|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578705|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2578706|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2578707|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578708|NCT01645449|Atorvastatin|atorvastatin|mesh-list
2578709|NCT01645449|Calcium|calcium|mesh-list
2578710|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2578711|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578712|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2135315|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
2135316|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2135317|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2135318|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2135319|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2135320|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135321|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
2135322|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135323|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2135324|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2135325|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135326|NCT03133481|Ropivacaine|ropivacaine|mesh-list
2135327|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
2135328|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
2135329|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135330|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135331|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
2135332|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135333|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2135334|NCT03134183|Misoprostol|misoprostol|mesh-list
2135335|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2135336|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
2135337|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2135338|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135339|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2135340|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2135341|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
2578713|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2578714|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
2578715|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135342|NCT03134703|Morphine|morphine|mesh-list
2135343|NCT03134703|Methadone|methadone|mesh-list
2135344|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2135345|NCT03134703|Narcotics|narcotics|mesh-ancestor
2135346|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135347|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135348|NCT03134703|Analgesics|analgesics|mesh-ancestor
2135349|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
2135350|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135351|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
2135352|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
2135353|NCT03135028|Cytarabine|cytarabine|mesh-list
2578716|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2578717|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2578718|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578719|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2578720|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
2578721|NCT01645475|Coagulants|coagulants|mesh-ancestor
2578722|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2578723|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
2578724|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578725|NCT01645748|Cisplatin|cisplatin|mesh-list
2578726|NCT01645748|Docetaxel|docetaxel|mesh-list
2578727|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578728|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
2578729|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
2135354|NCT03135028|Daunorubicin|daunorubicin|mesh-list
2135355|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2135356|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
2135357|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135358|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135359|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
2135360|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135361|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2135362|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
2135363|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135364|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2135365|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2135366|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2135367|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578730|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
2578731|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578732|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
2578733|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2578734|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2578735|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
2578736|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578737|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578738|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578739|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
2578740|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
2578741|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578742|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
2578743|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2578744|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
2578745|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
2578746|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2578747|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2578748|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578749|NCT01645800|Muramidase|muramidase|mesh-list
2578750|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578751|NCT01645826|Diltiazem|diltiazem|mesh-list
2578752|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2578753|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2578754|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2578755|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578756|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2578757|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578758|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
2578759|NCT01645839|Cytarabine|cytarabine|mesh-list
2578760|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2578761|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
2578762|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578763|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578764|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
2578765|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578766|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2578767|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
2578768|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578769|NCT01646034|Gemcitabine|gemcitabine|mesh-list
2578770|NCT01646034|Paclitaxel|paclitaxel|mesh-list
2578771|NCT01646034|Docetaxel|docetaxel|mesh-list
2578772|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
2578773|NCT01646034|Carboplatin|carboplatin|mesh-list
2578774|NCT01646034|Doxorubicin|doxorubicin|mesh-list
2578775|NCT01646034|Thiotepa|thiotepa|mesh-list
2578776|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2578777|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578778|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
2578779|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
2578780|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
2578781|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578782|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2578783|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
2578784|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578785|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2578786|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2578787|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
2578788|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2578789|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2578790|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
2578791|NCT01646034|Antiviral Agents|antiviral agents|mesh-ancestor
2578792|NCT01646034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135376|NCT03136068|Digoxin|digoxin|mesh-list
2135377|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2135378|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2135379|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135380|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135381|NCT03136068|Protective Agents|protective agents|mesh-ancestor
2135382|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135383|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
2135384|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2135385|NCT03136107|Protective Agents|protective agents|mesh-ancestor
2135386|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135387|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
2135388|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
2578793|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578794|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2578795|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2135389|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2135390|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
2135391|NCT03136198|Diuretics|diuretics|mesh-list
2135392|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
2578796|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2578797|NCT01646229|Polymyxins|polymyxins|mesh-list
2578798|NCT01646229|Polymyxin B|polymyxin b|mesh-list
2578799|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2578800|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578801|NCT01646281|Flecainide|flecainide|mesh-list
2578802|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2578803|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2578804|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2578805|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2578806|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578807|NCT01646294|Mirabegron|mirabegron|mesh-list
2578808|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2578809|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2578810|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2578811|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
2578812|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578813|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578814|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578815|NCT01646294|Urological Agents|urological agents|mesh-ancestor
2135393|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
2578816|NCT01646307|Atorvastatin|atorvastatin|mesh-list
2578817|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2578818|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2578819|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2578820|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
2578821|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135394|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135395|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2135396|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135397|NCT03136328|Edotreotide|edotreotide|mesh-list
2135398|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2135399|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135400|NCT03136484|Canagliflozin|canagliflozin|mesh-list
2135401|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2135402|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135403|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2135404|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135405|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2135406|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
2135407|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135408|NCT03137121|Olanzapine|olanzapine|mesh-list
2135409|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
2135410|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
2578822|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2578823|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2578824|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578825|NCT01646437|Aspirin|aspirin|mesh-list
2135411|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135412|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135413|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2135414|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2135415|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2135416|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135417|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2135418|NCT03137121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2578826|NCT01646437|Vitamin D|vitamin d|mesh-list
2578827|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
2578828|NCT01646437|Vitamins|vitamins|mesh-ancestor
2578829|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
2578830|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578831|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2578832|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2578833|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2578834|NCT01646437|Analgesics|analgesics|mesh-ancestor
2578835|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
2578836|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578837|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2578838|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2578839|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2578840|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2135419|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2135420|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2135421|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135422|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135423|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
2135424|NCT03137173|Vancomycin|vancomycin|mesh-list
2135425|NCT03137173|Aztreonam|aztreonam|mesh-list
2578841|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578842|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2578843|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2578844|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578845|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
2578846|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2578847|NCT01646515|Udenafil|udenafil|mesh-list
2578848|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2578849|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2578850|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578851|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578852|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
2578853|NCT01646554|Aflibercept|aflibercept|mesh-list
2578854|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578855|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2578856|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2135426|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
2135427|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2135428|NCT03137173|Cephalosporins|cephalosporins|mesh-list
2135429|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2135430|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135431|NCT03137303|Albuterol|albuterol|mesh-list
2135432|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2135433|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
2135434|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135435|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135436|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2135437|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
2135438|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
2135439|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2135440|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2578857|NCT01646554|Growth Substances|growth substances|mesh-ancestor
2578858|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578859|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
2578860|NCT01646567|Betamethasone|betamethasone|mesh-list
2578861|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
2578862|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2578863|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
2578864|NCT01646567|Calcipotriene|calcipotriene|mesh-list
2578865|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2578866|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2578867|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
2578868|NCT01646567|Hormones|hormones|mesh-ancestor
2578869|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135441|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2135442|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2135443|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
2135444|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135445|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135446|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
2135447|NCT03137784|Bromides|bromides|mesh-list
2135448|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
2135449|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2135450|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2135451|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2135452|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
2135453|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135454|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135455|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135456|NCT03137992|Bromides|bromides|mesh-list
2135457|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
2135458|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2135459|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
2135460|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135461|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135462|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2135463|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
2135464|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
2135465|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2135466|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
2135467|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135468|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578870|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578871|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2578872|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
2578873|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
2578874|NCT01646580|Ciclopirox|ciclopirox|mesh-list
2578875|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
2135469|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
2135470|NCT03138655|Vedolizumab|vedolizumab|mesh-list
2135471|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2135472|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
2135473|NCT03138967|Bromides|bromides|mesh-list
2135474|NCT03138967|Rocuronium|rocuronium|mesh-list
2135475|NCT03138967|Neostigmine|neostigmine|mesh-list
2135476|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
2135477|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2578876|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578877|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
2578878|NCT01646619|Analgesics|analgesics|mesh-ancestor
2578879|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
2578880|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578881|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578882|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
2578883|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2578884|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2578885|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
2135478|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2135479|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2135480|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135481|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135482|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2135483|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135484|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135485|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
2135486|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2578886|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2135487|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2135488|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
2135489|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2135490|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2135491|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2135492|NCT03139240|Oxycodone|oxycodone|mesh-list
2135493|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2135494|NCT03139240|Narcotics|narcotics|mesh-ancestor
2135495|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135496|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135497|NCT03139240|Analgesics|analgesics|mesh-ancestor
2135498|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
2135499|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135500|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
2135501|NCT03139279|Propofol|propofol|mesh-list
2135502|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2135503|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135504|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135505|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2135506|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
2135507|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
2135508|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2135509|NCT03139279|Analgesics|analgesics|mesh-ancestor
2135510|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
2135511|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419855|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
2419856|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419857|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2419858|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419859|NCT00805233|Analgesics|analgesics|mesh-ancestor
2419860|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
2419861|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419862|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419863|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2419864|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
2419865|NCT00805298|Epinephrine|epinephrine|mesh-list
2419866|NCT00805298|Racepinephrine|racepinephrine|mesh-list
2419867|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
2419868|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419869|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
2419870|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
2419871|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419872|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578887|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2578888|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578889|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2578890|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
2578891|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2578892|NCT01646684|Pasireotide|pasireotide|mesh-list
2578893|NCT01646684|Hormones|hormones|mesh-ancestor
2578894|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2578895|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578896|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
2578897|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2578898|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
2578899|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578900|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2578901|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2578902|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
2578903|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578904|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578905|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2578906|NCT01646775|Fentanyl|fentanyl|mesh-list
2578907|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2578908|NCT01646775|Narcotics|narcotics|mesh-ancestor
2578909|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2578910|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578911|NCT01646775|Analgesics|analgesics|mesh-ancestor
2578912|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
2578913|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578914|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2578915|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2578916|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
2578917|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
2578918|NCT01646788|Paclitaxel|paclitaxel|mesh-list
2578919|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2578920|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578921|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
2578922|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
2578923|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
2578924|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578925|NCT01646853|Fluorouracil|fluorouracil|mesh-list
2578926|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578927|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
2578928|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578929|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2578930|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2578931|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
2578932|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578933|NCT01647152|Ustekinumab|ustekinumab|mesh-list
2578934|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
2578935|NCT01647165|Dexamethasone|dexamethasone|mesh-list
2578936|NCT01647165|Lenalidomide|lenalidomide|mesh-list
2578937|NCT01647165|Bortezomib|bortezomib|mesh-list
2578938|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2578939|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
2578940|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
2578941|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578942|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578943|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2578944|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
2578945|NCT01647165|Hormones|hormones|mesh-ancestor
2578946|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135512|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2135513|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2135514|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2135515|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
2419873|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2419874|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
2419875|NCT00805298|Hormones|hormones|mesh-ancestor
2419876|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2419877|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2419878|NCT00805298|Protective Agents|protective agents|mesh-ancestor
2419879|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2419880|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2419881|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
2419882|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135516|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419883|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419884|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2419885|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2419886|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2419887|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
2419888|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
2135517|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135518|NCT03139604|Prednisone|prednisone|mesh-list
2135519|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
2135520|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2135521|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2135522|NCT03139604|Prednisolone|prednisolone|mesh-list
2135523|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
2135524|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2135525|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
2135526|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2135527|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
2135528|NCT03139604|Hormones|hormones|mesh-ancestor
2135529|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135530|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135531|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2135532|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135533|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
2135534|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
2135535|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135536|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2135537|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2135538|NCT03139604|Protective Agents|protective agents|mesh-ancestor
2135539|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
2135540|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2135541|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2135542|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135543|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
2135544|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
2135545|NCT03140631|Protamines|protamines|mesh-list
2135546|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
2135547|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135548|NCT03140631|Coagulants|coagulants|mesh-ancestor
2135549|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
2135550|NCT03140722|Hematinics|hematinics|mesh-ancestor
2135551|NCT03142451|Minocycline|minocycline|mesh-list
2135552|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2135553|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135554|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
2135555|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
2135556|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135557|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
2135558|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135559|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135560|NCT03143166|Telmisartan|telmisartan|mesh-list
2135561|NCT03143166|Dabigatran|dabigatran|mesh-list
2135562|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2135563|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2135564|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2184921|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2184922|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
2184923|NCT00002835|Hormones|hormones|mesh-ancestor
2419889|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
2419890|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2419891|NCT00805311|Aspirin|aspirin|mesh-list
2419892|NCT00805311|Losartan|losartan|mesh-list
2419893|NCT00805311|Amlodipine|amlodipine|mesh-list
2578947|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2578948|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578949|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
2578950|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2578951|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2578952|NCT01647165|Growth Substances|growth substances|mesh-ancestor
2578953|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
2578954|NCT01647256|Nikkomycin|nikkomycin|mesh-list
2578955|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
2578956|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184924|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2184925|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2184926|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2184927|NCT00002835|Analgesics|analgesics|mesh-ancestor
2135565|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135566|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
2135567|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2135568|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
2135569|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135570|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
2135571|NCT03143569|Heparin|heparin|mesh-list
2135572|NCT03143569|Calcium heparin|calcium heparin|mesh-list
2135573|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
2135574|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2135575|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2135576|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135577|NCT03144635|Grazoprevir|grazoprevir|mesh-list
2578957|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578958|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578959|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
2578960|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2578961|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578962|NCT01647412|Curcumin|curcumin|mesh-list
2578963|NCT01647412|Hormones|hormones|mesh-list
2578964|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2578965|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135578|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
2135579|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135580|NCT03144804|Lamivudine|lamivudine|mesh-list
2135581|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2135582|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2135583|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135584|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135585|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
2135586|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135587|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2135588|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2135589|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
2135590|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135591|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2135592|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135593|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135594|NCT03145207|Lidocaine|lidocaine|mesh-list
2135595|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
2135596|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
2135597|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135598|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135599|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
2135600|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135601|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2135602|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2135603|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2135604|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2578966|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2578967|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2578968|NCT01647412|Analgesics|analgesics|mesh-ancestor
2578969|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
2578970|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578971|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2578972|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2578973|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578974|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578975|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578976|NCT01647529|Ganciclovir|ganciclovir|mesh-list
2578977|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2578978|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
2578979|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2578980|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2578981|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2578982|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2578983|NCT01647555|Cetuximab|cetuximab|mesh-list
2578984|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2578985|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2578986|NCT01647633|Calcium|calcium|mesh-list
2135605|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135606|NCT03145259|Diclofenac|diclofenac|mesh-list
2135607|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
2135608|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2135609|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2135610|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2135611|NCT03145259|Analgesics|analgesics|mesh-ancestor
2135612|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
2135613|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135614|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135615|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2135616|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2135617|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2135618|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135619|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135620|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
2135621|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2135622|NCT03145766|Antibodies|antibodies|mesh-list
2135623|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
2135624|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135625|NCT03146403|Vaccines|vaccines|mesh-list
2135626|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
2135627|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135628|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
2135629|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
2135630|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135631|NCT03146806|Ketamine|ketamine|mesh-list
2135632|NCT03146806|Analgesics|analgesics|mesh-ancestor
2135633|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
2135634|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135635|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135636|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2135637|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2135638|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
2135639|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
2578987|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2578988|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2578989|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2578990|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2578991|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
2578992|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2578993|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
2578994|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2578995|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135640|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135641|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2135642|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2135643|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135644|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135645|NCT03147248|Infliximab|infliximab|mesh-list
2135646|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
2578996|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
2578997|NCT01647646|Hormones|hormones|mesh-ancestor
2578998|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2578999|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
2135647|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2135648|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2135649|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
2135650|NCT03148236|Vitamins|vitamins|mesh-ancestor
2135651|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
2135652|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135653|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
2135654|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135655|NCT03148236|Protective Agents|protective agents|mesh-ancestor
2135656|NCT03148756|Dalbavancin|dalbavancin|mesh-list
2135657|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2135658|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579000|NCT01647659|Trametinib|trametinib|mesh-list
2579001|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579002|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2579003|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579004|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579005|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2579006|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579007|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
2579008|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2579009|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2579010|NCT01647685|Prednisolone|prednisolone|mesh-list
2579011|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
2579012|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2579013|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
2579014|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2579015|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
2579016|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
2579017|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579018|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579019|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2579020|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
2579021|NCT01647685|Hormones|hormones|mesh-ancestor
2579022|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2579023|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2579024|NCT01647685|Protective Agents|protective agents|mesh-ancestor
2579025|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2579026|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579027|NCT01647828|Gemcitabine|gemcitabine|mesh-list
2579028|NCT01647828|Paclitaxel|paclitaxel|mesh-list
2579029|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2579030|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579031|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
2579032|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
2579033|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
2579034|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579035|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2579036|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
2579037|NCT01647828|Antiviral Agents|antiviral agents|mesh-ancestor
2579038|NCT01647828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579039|NCT01647828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579040|NCT01647828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2579041|NCT01647828|Immunologic Factors|immunologic factors|mesh-ancestor
2579042|NCT01647828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579043|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2579044|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2579045|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579046|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2579047|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
2579048|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579049|NCT01647893|Bivalirudin|bivalirudin|mesh-list
2579050|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
2579051|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2579052|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
2579053|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579054|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579055|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
2579056|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2579057|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2579058|NCT01647932|Diuretics|diuretics|mesh-ancestor
2579059|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
2579060|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135664|NCT03149055|Isavuconazole|isavuconazole|mesh-list
2135665|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
2135666|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579061|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2579062|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2579063|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579064|NCT01647984|Vitamins|vitamins|mesh-list
2579065|NCT01647984|Vitamin E|vitamin e|mesh-list
2579066|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
2135667|NCT03149848|Rifabutin|rifabutin|mesh-list
2135668|NCT03149848|Cabotegravir|cabotegravir|mesh-list
2135669|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2135670|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135671|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2135672|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
2135673|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2135674|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2135675|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135676|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135677|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2135678|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2135679|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
2135680|NCT03149887|Bupivacaine|bupivacaine|mesh-list
2135681|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
2135682|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
2135683|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135684|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135685|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
2135686|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135687|NCT03149991|Ketamine|ketamine|mesh-list
2135688|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
2135689|NCT03149991|Analgesics|analgesics|mesh-ancestor
2135690|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
2135691|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579067|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
2579068|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579069|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
2579070|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579071|NCT01647984|Protective Agents|protective agents|mesh-ancestor
2579072|NCT01648010|Mitomycins|mitomycins|mesh-list
2579073|NCT01648010|Mitomycin|mitomycin|mesh-list
2579074|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2579075|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579076|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
2579077|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579078|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2135692|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135693|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2135694|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2135695|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
2135696|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
2419894|NCT00805311|Atorvastatin|atorvastatin|mesh-list
2419895|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2419896|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419897|NCT00805311|Analgesics|analgesics|mesh-ancestor
2419898|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
2419899|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419900|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419901|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419902|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2579079|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579080|NCT01648036|Heparin|heparin|mesh-list
2579081|NCT01648036|Calcium heparin|calcium heparin|mesh-list
2579082|NCT01648036|Dalteparin|dalteparin|mesh-list
2579083|NCT01648036|Tinzaparin|tinzaparin|mesh-list
2579084|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2579085|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
2579086|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2579087|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2579088|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579089|NCT01648127|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2579090|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2579091|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579092|NCT01648205|Ranolazine|ranolazine|mesh-list
2579093|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2579094|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2579095|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579096|NCT01648218|Insulin|insulin|mesh-list
2135697|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135698|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2135699|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2135700|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135701|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579097|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2579098|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
2579099|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
2579100|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
2579101|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
2579102|NCT01648218|Protamines|protamines|mesh-list
2579103|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2579104|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135702|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
2135703|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
2579105|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
2579106|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579107|NCT01648218|Coagulants|coagulants|mesh-ancestor
2135704|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
2135705|NCT03150056|Prednisone|prednisone|mesh-list
2135706|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2579108|NCT01648231|Losartan|losartan|mesh-list
2579109|NCT01648231|Amlodipine|amlodipine|mesh-list
2579110|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2579111|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2579112|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2579113|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579114|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2579115|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579116|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
2579117|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2579118|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2579119|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2579120|NCT01648257|Cabotegravir|cabotegravir|mesh-list
2579121|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2579122|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2579123|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579124|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579125|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2579126|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2579127|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
2579128|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579129|NCT01648465|Everolimus|everolimus|mesh-list
2579130|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579131|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2579132|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
2579133|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579134|NCT01648517|Gemcitabine|gemcitabine|mesh-list
2579135|NCT01648517|Carboplatin|carboplatin|mesh-list
2579136|NCT01648517|Docetaxel|docetaxel|mesh-list
2579137|NCT01648517|Vinorelbine|vinorelbine|mesh-list
2135707|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
2135708|NCT03150056|Hormones|hormones|mesh-ancestor
2135709|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135710|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135711|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2135712|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135713|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
2135714|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2135715|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135716|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2135717|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2135718|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135719|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135720|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135721|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2135722|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2135723|NCT03150589|Ranibizumab|ranibizumab|mesh-list
2135724|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2579138|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579139|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2579140|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
2579141|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579142|NCT01648517|Antiviral Agents|antiviral agents|mesh-ancestor
2579143|NCT01648517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135725|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2135726|NCT03150589|Growth Substances|growth substances|mesh-ancestor
2135727|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135728|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
2135729|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135730|NCT03150719|Ivacaftor|ivacaftor|mesh-list
2135731|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2135732|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2135733|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135734|NCT03150875|Docetaxel|docetaxel|mesh-list
2135735|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579144|NCT01648517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579145|NCT01648517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2579146|NCT01648517|Immunologic Factors|immunologic factors|mesh-ancestor
2579147|NCT01648517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579148|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
2579149|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
2579150|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
2135736|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
2135737|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
2135738|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
2135739|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135740|NCT03151434|Hydromorphone|hydromorphone|mesh-list
2135741|NCT03151434|Bupivacaine|bupivacaine|mesh-list
2135742|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
2135743|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
2579151|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2579152|NCT01648556|Prednisone|prednisone|mesh-list
2579153|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2579154|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
2579155|NCT01648556|Hormones|hormones|mesh-ancestor
2579156|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2579157|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579158|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2579159|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579160|NCT01648595|Fentanyl|fentanyl|mesh-list
2579161|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2579162|NCT01648595|Narcotics|narcotics|mesh-ancestor
2579163|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2579164|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579165|NCT01648595|Analgesics|analgesics|mesh-ancestor
2579166|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
2579167|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135744|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135745|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135746|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
2135747|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135748|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2135749|NCT03151434|Narcotics|narcotics|mesh-ancestor
2135750|NCT03151434|Analgesics|analgesics|mesh-ancestor
2579168|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2579169|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2579170|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
2579171|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
2579172|NCT01648608|Exemestane|exemestane|mesh-list
2579173|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579174|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2579175|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2579176|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579177|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579178|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2579179|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
2579180|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2579181|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579182|NCT01648634|Nebivolol|nebivolol|mesh-list
2579183|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2579184|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
2579185|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2579186|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2579187|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2579188|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
2579189|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579190|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579191|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579192|NCT01648712|Heparin|heparin|mesh-list
2579193|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
2579194|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2579195|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2579196|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579197|NCT01648751|Estrogens|estrogens|mesh-list
2419903|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2419904|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2419905|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419906|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2419907|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2419908|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419909|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
2419910|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2419911|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2419912|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
2419913|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2419914|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2135751|NCT03151551|Adalimumab|adalimumab|mesh-list
2579198|NCT01648751|Hormones|hormones|mesh-ancestor
2579199|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2579200|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579201|NCT01648777|Bupivacaine|bupivacaine|mesh-list
2579202|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
2135752|NCT03151551|Ixekizumab|ixekizumab|mesh-list
2135753|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2135754|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2135755|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
2135756|NCT03152019|Tacrolimus|tacrolimus|mesh-list
2135757|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2135758|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
2135759|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135760|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2135761|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135762|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135763|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
2135764|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2135765|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135766|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2135767|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135768|NCT03152552|Empagliflozin|empagliflozin|mesh-list
2135769|NCT03152552|Licogliflozin|licogliflozin|mesh-list
2135770|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2135771|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135772|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2135773|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135774|NCT03152591|Licogliflozin|licogliflozin|mesh-list
2579203|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
2579204|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2579205|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579206|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
2579207|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579208|NCT01648829|Atorvastatin|atorvastatin|mesh-list
2579209|NCT01648829|Pitavastatin|pitavastatin|mesh-list
2579210|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2579211|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2579212|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
2579213|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579214|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2579215|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2579216|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579217|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2579218|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2135775|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2135776|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135777|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2135778|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135779|NCT03154333|Diacetylrhein|diacetylrhein|mesh-list
2135780|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2135781|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
2135782|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
2135783|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2135784|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2135785|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135786|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135787|NCT03154476|Urological Agents|urological agents|mesh-ancestor
2135788|NCT03154658|Ropivacaine|ropivacaine|mesh-list
2135789|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
2135790|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
2135791|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135792|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135793|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
2135794|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135795|NCT03155178|Ethanol|ethanol|mesh-list
2579219|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135796|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
2135797|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2135798|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2135799|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135800|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135801|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135802|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
2579220|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
2579221|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2579222|NCT01649024|Tremelimumab|tremelimumab|mesh-list
2579223|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579224|NCT01649037|Terlipressin|terlipressin|mesh-list
2579225|NCT01649037|Epinephrine|epinephrine|mesh-list
2579226|NCT01649037|Racepinephrine|racepinephrine|mesh-list
2135803|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
2135804|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
2135805|NCT03157089|Afatinib|afatinib|mesh-list
2579227|NCT01649037|Norepinephrine|norepinephrine|mesh-list
2579228|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
2579229|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2579230|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2579231|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
2579232|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579233|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579234|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579235|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2579236|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2579237|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
2579238|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579239|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2579240|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
2579241|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
2579242|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
2579243|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2579244|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2579245|NCT01649245|Interferons|interferons|mesh-list
2579246|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579247|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
2135806|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2135807|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135808|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2135809|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135810|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135811|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
2135812|NCT03157583|Glycerol|glycerol|mesh-list
2135813|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2135814|NCT03157583|Protective Agents|protective agents|mesh-ancestor
2135815|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135816|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
2135817|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2135818|NCT03158116|Aztreonam|aztreonam|mesh-list
2135819|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2135820|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135821|NCT03158220|Vaccines|vaccines|mesh-list
2579248|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579249|NCT01649258|Granisetron|granisetron|mesh-list
2579250|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
2579251|NCT01649258|Aprepitant|aprepitant|mesh-list
2579252|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
2579253|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
2579254|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579255|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579256|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2579257|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2579258|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
2579259|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579260|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579261|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2579262|NCT01649284|Afatinib|afatinib|mesh-list
2579263|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579264|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2579265|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579266|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579267|NCT01649336|Paclitaxel|paclitaxel|mesh-list
2579268|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
2579269|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2579270|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579271|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
2579272|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
2579273|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579274|NCT01649466|Insulin|insulin|mesh-list
2135822|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
2579275|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2579276|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2579277|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135823|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135824|NCT03158272|Nivolumab|nivolumab|mesh-list
2135825|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2135826|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579278|NCT01649479|Antibodies|antibodies|mesh-list
2579279|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
2579280|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
2579281|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579282|NCT01649544|Amiodarone|amiodarone|mesh-list
2579283|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2579284|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
2579285|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2579286|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2579287|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135827|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2135828|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135829|NCT03158311|Fluticasone|fluticasone|mesh-list
2135830|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
2135831|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2135832|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2135833|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2135834|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
2135835|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135836|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135837|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2419915|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2419916|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2579288|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2579289|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2579290|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2419917|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2419918|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2579291|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579292|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2579293|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2579294|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2579295|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
2579296|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2579297|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579298|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2579299|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2135838|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
2135839|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
2135840|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2135841|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
2135842|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2135843|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
2135844|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135845|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135846|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2135847|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2135848|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2135849|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
2579300|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
2579301|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579302|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579303|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
2579304|NCT01649635|Prednisone|prednisone|mesh-list
2579305|NCT01649635|Sargramostim|sargramostim|mesh-list
2579306|NCT01649635|Lenograstim|lenograstim|mesh-list
2579307|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2579308|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
2579309|NCT01649635|Hormones|hormones|mesh-ancestor
2579310|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2579311|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579312|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2579313|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579314|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
2419919|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
2419920|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2419921|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2419922|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2579315|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2579316|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2579317|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579318|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2579319|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2579320|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579321|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579322|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2579323|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2579324|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
2579325|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
2579326|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2579327|NCT01649674|Cathartics|cathartics|mesh-ancestor
2579328|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2579329|NCT01649713|Vaccines|vaccines|mesh-list
2579330|NCT01649713|Immunologic Factors|immunologic factors|mesh-ancestor
2579331|NCT01649713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135863|NCT03159143|Docetaxel|docetaxel|mesh-list
2135864|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
2135865|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135866|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
2135867|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
2135868|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
2135869|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135870|NCT03159260|Allantoin|allantoin|mesh-list
2135871|NCT03159260|Dermatologic Agents|dermatologic agents|mesh-ancestor
2135872|NCT03160703|Fluorides|fluorides|mesh-list
2135873|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
2135874|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
2135875|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
2135876|NCT03160703|Protective Agents|protective agents|mesh-ancestor
2135877|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135878|NCT03160716|Lidocaine|lidocaine|mesh-list
2135879|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
2135880|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
2135881|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135882|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135883|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
2135884|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135885|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2135886|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2135887|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2135888|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2135889|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135890|NCT03161158|Diuretics|diuretics|mesh-list
2135891|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
2135892|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135893|NCT03161405|Itraconazole|itraconazole|mesh-list
2135894|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2135895|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579332|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2579333|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
2579334|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2579335|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2579336|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579337|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579338|NCT01649739|Urological Agents|urological agents|mesh-ancestor
2579339|NCT01649830|Temozolomide|temozolomide|mesh-list
2579340|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2579341|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
2579342|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579343|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579344|NCT01649895|Cycloserine|cycloserine|mesh-list
2579345|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2579346|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579347|NCT01649895|Renal Agents|renal agents|mesh-ancestor
2579348|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2579349|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
2579350|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2579351|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
2579352|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579353|NCT01649921|Interferons|interferons|mesh-list
2579354|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
2579355|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579356|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
2579357|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579358|NCT01649960|Sirolimus|sirolimus|mesh-list
2579359|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2579360|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579361|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2579362|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579363|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
2579364|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2579365|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
2579366|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579367|NCT01649999|Peficitinib|peficitinib|mesh-list
2579368|NCT01649999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579369|NCT01649999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579370|NCT01649999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2579371|NCT01649999|Immunologic Factors|immunologic factors|mesh-ancestor
2579372|NCT01649999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579373|NCT01650012|Eplerenone|eplerenone|mesh-list
2579374|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2579375|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
2579376|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2579377|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579378|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2579379|NCT01650012|Diuretics|diuretics|mesh-ancestor
2579380|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
2579381|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2579382|NCT01650090|Cisplatin|cisplatin|mesh-list
2579383|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579384|NCT01650129|Insulin|insulin|mesh-list
2579385|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2579386|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
2579387|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
2579388|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2579389|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579390|NCT01650181|Selenium|selenium|mesh-list
2579391|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
2579392|NCT01650181|Metformin|metformin|mesh-list
2135896|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
2135897|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2135898|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2135899|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2135900|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2135901|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
2135902|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135903|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135904|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2135905|NCT03161938|Dexamethasone|dexamethasone|mesh-list
2135906|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2135907|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
2135908|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
2135909|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135910|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135911|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2135912|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
2135913|NCT03161938|Hormones|hormones|mesh-ancestor
2135914|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135915|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2579393|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2579394|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579395|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
2579396|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579397|NCT01650181|Protective Agents|protective agents|mesh-ancestor
2579398|NCT01650181|Trace Elements|trace elements|mesh-ancestor
2579399|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
2579400|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
2579401|NCT01650181|Vitamins|vitamins|mesh-ancestor
2579402|NCT01650272|Minoxidil|minoxidil|mesh-list
2579403|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2579404|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2579405|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
2579406|NCT01650376|Paclitaxel|paclitaxel|mesh-list
2579407|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2579408|NCT01650376|Carboplatin|carboplatin|mesh-list
2579409|NCT01650376|Olaparib|olaparib|mesh-list
2579410|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2579411|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579412|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
2579413|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
2579414|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
2579415|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579416|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2579417|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579418|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
2579419|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2579420|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
2579421|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579422|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
2579423|NCT01650415|Hematinics|hematinics|mesh-ancestor
2579424|NCT01650428|Bevacizumab|bevacizumab|mesh-list
2579425|NCT01650428|Fluorouracil|fluorouracil|mesh-list
2579426|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
2579427|NCT01650428|Irinotecan|irinotecan|mesh-list
2579428|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2579429|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579430|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2579431|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2579432|NCT01650428|Growth Substances|growth substances|mesh-ancestor
2579433|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579434|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
2579435|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
2579436|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579437|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2579438|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2579439|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
2579440|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2579441|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2579442|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579443|NCT01650441|Beclomethasone|beclomethasone|mesh-list
2579444|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
2579445|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2579446|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
2579447|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579448|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579449|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2579450|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
2579451|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2579452|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2579453|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2579454|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
2579455|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135916|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135917|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
2135918|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
2135919|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2135920|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
2579456|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579457|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2579458|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
2579459|NCT01650441|Hormones|hormones|mesh-ancestor
2579460|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2579461|NCT01650493|Listerine|listerine|mesh-list
2135921|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135922|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135923|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2135924|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
2135925|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2135926|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2135927|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2135928|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
2579462|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
2579463|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
2579464|NCT01650493|Protective Agents|protective agents|mesh-ancestor
2135929|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135930|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135931|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2135932|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2135933|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2135934|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
2135935|NCT03163303|Nicotine|nicotine|mesh-list
2135936|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2135937|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
2135938|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135939|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579465|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579466|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2579467|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579468|NCT01650506|Metformin|metformin|mesh-list
2579469|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2579470|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2579471|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579472|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579473|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2579474|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579475|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579476|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
2579477|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579478|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579479|NCT01650649|Lofexidine|lofexidine|mesh-list
2579480|NCT01650649|Clonidine|clonidine|mesh-list
2579481|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2579482|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2579483|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579484|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
2579485|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579486|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2579487|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2579488|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2579489|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
2579490|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135940|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2135941|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2135942|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
2135943|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135944|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135945|NCT03163472|Anesthetics|anesthetics|mesh-list
2135946|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
2135947|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135948|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579491|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579492|NCT01650649|Analgesics|analgesics|mesh-ancestor
2579493|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
2579494|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
2579495|NCT01650662|Cyclosporine|cyclosporine|mesh-list
2579496|NCT01650662|Cyclosporins|cyclosporins|mesh-list
2579497|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579498|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579499|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2579500|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
2579501|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579502|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
2579503|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579504|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
2579505|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2579506|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2579507|NCT01650701|Rituximab|rituximab|mesh-list
2579508|NCT01650701|Lenalidomide|lenalidomide|mesh-list
2579509|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2579510|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2579511|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579512|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
2579513|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579514|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2579515|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2579516|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2579517|NCT01650701|Growth Substances|growth substances|mesh-ancestor
2579518|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
2579519|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2579520|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
2579521|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579522|NCT01650727|Rituximab|rituximab|mesh-list
2579523|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2579524|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579525|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
2579526|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579527|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2579528|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2579529|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2579530|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2579531|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2579532|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579533|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579534|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579535|NCT01650740|Analgesics|analgesics|mesh-ancestor
2579536|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
2579537|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579538|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
2579539|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2579540|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
2579541|NCT01650792|Aspirin|aspirin|mesh-list
2579542|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2579543|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2579544|NCT01650792|Analgesics|analgesics|mesh-ancestor
2579545|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
2579546|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579547|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579548|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2579549|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2579550|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2579551|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2579552|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579553|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2579554|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2579555|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579556|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
2579557|NCT01650870|Lactulose|lactulose|mesh-list
2579558|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2579559|NCT01650883|Vitamin D|vitamin d|mesh-list
2579560|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
2579561|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
2579562|NCT01650883|Vitamins|vitamins|mesh-list
2579563|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
2579564|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579565|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2579566|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2579567|NCT01650961|Palonosetron|palonosetron|mesh-list
2579568|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
2579569|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
2579570|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579571|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135949|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
2135950|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135958|NCT03165955|Paclitaxel|paclitaxel|mesh-list
2135959|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2135960|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135961|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
2135962|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
2579572|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2579573|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2579574|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2579575|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
2579576|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579577|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579578|NCT01651130|Carbetocin|carbetocin|mesh-list
2579579|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
2135963|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
2135964|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2135965|NCT03165981|Vaccines|vaccines|mesh-list
2135966|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2135967|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
2135968|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135969|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
2135970|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2579580|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2579581|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579582|NCT01651156|Tolvaptan|tolvaptan|mesh-list
2579583|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2579584|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579585|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
2579586|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579587|NCT01651169|Methylphenidate|methylphenidate|mesh-list
2579588|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2579589|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579590|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2579591|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2579592|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2579593|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579594|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
2579595|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579596|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
2579597|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2579598|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2579599|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579600|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
2579601|NCT01651182|Coagulants|coagulants|mesh-ancestor
2579602|NCT01651312|Mirabegron|mirabegron|mesh-list
2579603|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2135971|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135972|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
2135973|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2135974|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2135975|NCT03167411|Exenatide|exenatide|mesh-list
2135976|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
2135977|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2135978|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135979|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2135980|NCT03167411|Incretins|incretins|mesh-ancestor
2135981|NCT03167411|Hormones|hormones|mesh-ancestor
2135982|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2135983|NCT03168022|Amitriptyline|amitriptyline|mesh-list
2135984|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
2135985|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2135986|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
2135987|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2135988|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2135989|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2135990|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2135991|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2135992|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2135993|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2135994|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2135995|NCT03168022|Analgesics|analgesics|mesh-ancestor
2135996|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
2579604|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2579605|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2579606|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
2579607|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579608|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579609|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579610|NCT01651312|Urological Agents|urological agents|mesh-ancestor
2579611|NCT01651325|Isavuconazole|isavuconazole|mesh-list
2579612|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
2579613|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
2579614|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
2579615|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2579616|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2579617|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2135997|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2135998|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2579618|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579619|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579620|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
2579621|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579622|NCT01651364|Cabergoline|cabergoline|mesh-list
2579623|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2579624|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2135999|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2136000|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136001|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
2136002|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136003|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
2136004|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2136005|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136006|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2136007|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136008|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
2579625|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
2579626|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
2579627|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579628|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579629|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579630|NCT01651377|Pramipexole|pramipexole|mesh-list
2579631|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
2579632|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579633|NCT01651377|Protective Agents|protective agents|mesh-ancestor
2579634|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579635|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2579636|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2579637|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
2579638|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
2579639|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579640|NCT01651390|Sirolimus|sirolimus|mesh-list
2579641|NCT01651390|Paclitaxel|paclitaxel|mesh-list
2579642|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2579643|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579644|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
2579645|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
2579646|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
2579647|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579648|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2579649|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579650|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2579651|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
2579652|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2579653|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
2579654|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579655|NCT01651416|Lumefantrine|lumefantrine|mesh-list
2136009|NCT03168308|Neostigmine|neostigmine|mesh-list
2136010|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2136011|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136012|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136013|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
2136014|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136015|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136016|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2136017|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
2136018|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136019|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2136020|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2136021|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2136022|NCT03168841|Efinaconazole|efinaconazole|mesh-list
2136023|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
2136024|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136025|NCT03168919|Temozolomide|temozolomide|mesh-list
2136026|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2136027|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
2136028|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136029|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136030|NCT03169244|Bupropion|bupropion|mesh-list
2136031|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2136032|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
2136033|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2579656|NCT01651416|Artemether|artemether|mesh-list
2419923|NCT00805324|Desloratadine|desloratadine|mesh-list
2419924|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2419925|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
2419926|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419927|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136034|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2136035|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2136036|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2136037|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136038|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
2136039|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136040|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136041|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2136042|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2136043|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136044|NCT03170219|Furosemide|furosemide|mesh-list
2136045|NCT03170219|Diuretics|diuretics|mesh-ancestor
2136046|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
2136047|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136048|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2579657|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
2579658|NCT01651416|Piperaquine|piperaquine|mesh-list
2579659|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
2579660|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2579661|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2579662|NCT01651416|Amodiaquine|amodiaquine|mesh-list
2579663|NCT01651416|Artenimol|artenimol|mesh-list
2579664|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
2579665|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2579666|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2136049|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2136050|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136051|NCT03170271|Benralizumab|benralizumab|mesh-list
2136052|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2136053|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
2136054|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
2136055|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2136056|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136057|NCT03170661|Rocuronium|rocuronium|mesh-list
2136058|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2136059|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2136060|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2136061|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136062|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136085|NCT03172325|Folic Acid|folic acid|mesh-list
2136086|NCT03172325|Prednisolone|prednisolone|mesh-list
2136087|NCT03172325|Adalimumab|adalimumab|mesh-list
2136088|NCT03172325|Methotrexate|methotrexate|mesh-list
2136089|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2136090|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
2136091|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2419928|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579667|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136092|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136093|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2136094|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
2136095|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136096|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136097|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
2136098|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136099|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2136100|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2136101|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
2136102|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2136103|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2136104|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2136105|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
2136106|NCT03172325|Hormones|hormones|mesh-ancestor
2136107|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2136108|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2136109|NCT03172325|Hematinics|hematinics|mesh-ancestor
2136110|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
2136111|NCT03172325|Vitamins|vitamins|mesh-ancestor
2136112|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
2136113|NCT03172494|Insulin|insulin|mesh-list
2136114|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2136115|NCT03172494|Liraglutide|liraglutide|mesh-list
2136116|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
2136117|NCT03172494|Xultophy|xultophy|mesh-list
2136118|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2136119|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136120|NCT03172494|Incretins|incretins|mesh-ancestor
2136121|NCT03172494|Hormones|hormones|mesh-ancestor
2136122|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2136123|NCT03172780|Diclofenac|diclofenac|mesh-list
2136124|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2136125|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2136126|NCT03172780|Analgesics|analgesics|mesh-ancestor
2136127|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
2136128|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136129|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136130|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2136131|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2136132|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2136133|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136134|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136135|NCT03173170|Itraconazole|itraconazole|mesh-list
2136136|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
2136137|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136138|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2136139|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2136140|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579668|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2579669|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579670|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579671|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2579672|NCT01651416|Renal Agents|renal agents|mesh-ancestor
2579673|NCT01651481|Montelukast|montelukast|mesh-list
2579674|NCT01651481|Levocetirizine|levocetirizine|mesh-list
2579675|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2579676|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
2579677|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2579678|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
2579679|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2579680|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579681|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2579682|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2579683|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579684|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2579685|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2579686|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
2579687|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
2579688|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579689|NCT01651520|Flumazenil|flumazenil|mesh-list
2579690|NCT01651520|Antidotes|antidotes|mesh-ancestor
2579691|NCT01651520|Protective Agents|protective agents|mesh-ancestor
2579692|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136141|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136142|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2136143|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
2136144|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2136145|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136146|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2136147|NCT03173560|Everolimus|everolimus|mesh-list
2136148|NCT03173560|Lenvatinib|lenvatinib|mesh-list
2136149|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136150|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2136151|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
2136152|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136153|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2136154|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136155|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136156|NCT03174132|Lidocaine|lidocaine|mesh-list
2136157|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
2136158|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
2136159|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
2136160|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2136161|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136162|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
2136163|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136164|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2136165|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2136166|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2136167|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2136168|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136169|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2136170|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
2136171|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
2136172|NCT03174132|Protective Agents|protective agents|mesh-ancestor
2136173|NCT03174158|Nicotine|nicotine|mesh-list
2136174|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2136175|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
2136176|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136177|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136178|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2136179|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2136180|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
2136181|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136182|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136183|NCT03174366|Denosumab|denosumab|mesh-list
2136184|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2136185|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136186|NCT03175120|Insulin|insulin|mesh-list
2136187|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2136188|NCT03175120|Liraglutide|liraglutide|mesh-list
2136189|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
2136190|NCT03175120|Xultophy|xultophy|mesh-list
2136191|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2136192|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136193|NCT03175120|Incretins|incretins|mesh-ancestor
2136194|NCT03175120|Hormones|hormones|mesh-ancestor
2136195|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2579693|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
2579694|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
2579695|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136196|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
2136197|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2136198|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136199|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2136200|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136201|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136202|NCT03176238|Everolimus|everolimus|mesh-list
2136203|NCT03176238|Exemestane|exemestane|mesh-list
2136204|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136205|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2136206|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
2136207|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136208|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2136209|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2136210|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136211|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419929|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2419930|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2419931|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
2419932|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
2419933|NCT00805350|SR 46349B|sr 46349b|mesh-list
2419934|NCT00805350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2419935|NCT00805350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2136212|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2136213|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
2579696|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579697|NCT01651572|Rocuronium|rocuronium|mesh-list
2579698|NCT01651572|Cisatracurium|cisatracurium|mesh-list
2579699|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2579700|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2579701|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2579702|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579703|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579704|NCT01651585|Valacyclovir|valacyclovir|mesh-list
2579705|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
2579706|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579707|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2579708|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
2579709|NCT01651715|Antibodies|antibodies|mesh-list
2579710|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
2579711|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579712|NCT01651728|Simvastatin|simvastatin|mesh-list
2579713|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2579714|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2579715|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
2579716|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579717|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2579718|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2579719|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579720|NCT01651754|Vaccines|vaccines|mesh-list
2579721|NCT01651754|Immunologic Factors|immunologic factors|mesh-ancestor
2579722|NCT01651754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579723|NCT01651871|Cetirizine|cetirizine|mesh-list
2579724|NCT01651871|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2579725|NCT01651871|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2579726|NCT01651871|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2579727|NCT01651871|Histamine Antagonists|histamine antagonists|mesh-ancestor
2579728|NCT01651871|Histamine Agents|histamine agents|mesh-ancestor
2579729|NCT01651871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579730|NCT01651871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579731|NCT01651871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579732|NCT01651923|Heparin|heparin|mesh-list
2579733|NCT01651923|Calcium heparin|calcium heparin|mesh-list
2579734|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
2579735|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2579736|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2579737|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579738|NCT01651962|Fentanyl|fentanyl|mesh-list
2579739|NCT01651962|Terbutaline|terbutaline|mesh-list
2579740|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2579741|NCT01651962|Narcotics|narcotics|mesh-ancestor
2579742|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2579743|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579744|NCT01651962|Analgesics|analgesics|mesh-ancestor
2579745|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
2579746|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579747|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2579748|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2136214|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2136215|NCT03176459|Bupivacaine|bupivacaine|mesh-list
2136216|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
2136217|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
2136218|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2136219|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136220|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
2136221|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136222|NCT03176784|Nicotine|nicotine|mesh-list
2136223|NCT03176784|Varenicline|varenicline|mesh-list
2136224|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2136225|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
2419936|NCT00805350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136226|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136227|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136228|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2136229|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2136230|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
2136231|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136232|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136233|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
2136234|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2579749|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
2579750|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
2579751|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2579752|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
2579753|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2579754|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
2579755|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
2579756|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
2579757|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2579758|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2579759|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2579760|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2579761|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
2579762|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579763|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579764|NCT01651988|Propofol|propofol|mesh-list
2579765|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2579766|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2579767|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579768|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2579769|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
2579770|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
2579771|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
2579772|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
2579773|NCT01652014|Fludarabine|fludarabine|mesh-list
2579774|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
2579775|NCT01652014|Tacrolimus|tacrolimus|mesh-list
2579776|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2579777|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
2579778|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579779|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2579780|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2579781|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
2136235|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
2136236|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136237|NCT03177395|Expectorants|expectorants|mesh-ancestor
2136238|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
2136239|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2419937|NCT00805350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2419938|NCT00805350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2419939|NCT00805350|Serotonin Agents|serotonin agents|mesh-ancestor
2419940|NCT00805350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2419941|NCT00805350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419942|NCT00805519|Chloroquine|chloroquine|mesh-list
2419943|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2419944|NCT00805519|Prednisolone|prednisolone|mesh-list
2419945|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2419946|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
2419947|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2419948|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
2419949|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2419950|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
2419951|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2419952|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
2419953|NCT00805519|Hormones|hormones|mesh-ancestor
2419954|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2419955|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419956|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2419957|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419958|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
2419959|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
2419960|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2419961|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2419962|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2419963|NCT00805519|Protective Agents|protective agents|mesh-ancestor
2419964|NCT00805519|Amebicides|amebicides|mesh-ancestor
2419965|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2136240|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
2136241|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136242|NCT03177395|Protective Agents|protective agents|mesh-ancestor
2136243|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136244|NCT03177395|Antidotes|antidotes|mesh-ancestor
2136245|NCT03177798|Icatibant|icatibant|mesh-list
2136246|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2136247|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2136248|NCT03177798|Analgesics|analgesics|mesh-ancestor
2136249|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
2136250|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136251|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136252|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2136253|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2136254|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
2136255|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
2136256|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136257|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2136258|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2136259|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
2136260|NCT03178487|Upadacitinib|upadacitinib|mesh-list
2136261|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2136262|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2136263|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136264|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136265|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2136266|NCT03178851|Atezolizumab|atezolizumab|mesh-list
2136267|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2136268|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136269|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
2136270|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136271|NCT03178942|Permethrin|permethrin|mesh-list
2136272|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136273|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136274|NCT03179345|Pregabalin|pregabalin|mesh-list
2136275|NCT03179345|Gabapentin|gabapentin|mesh-list
2136276|NCT03179345|Analgesics|analgesics|mesh-ancestor
2136277|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
2136278|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136279|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136280|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
2136281|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2136282|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2136283|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136284|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2136285|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2136286|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2136287|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2136288|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2136289|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2136290|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2136291|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136292|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
2136293|NCT03179410|Avelumab|avelumab|mesh-list
2136294|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2136295|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136296|NCT03179787|Aripiprazole|aripiprazole|mesh-list
2136297|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
2136298|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2136299|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2136300|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2136301|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2136302|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136303|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
2136304|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
2136305|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136306|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136307|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2136308|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2136309|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
2136310|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2136311|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2419966|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2136312|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2136313|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2136314|NCT03179891|Diazepam|diazepam|mesh-list
2136315|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2136316|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
2136317|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
2136318|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
2136319|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136320|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136321|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2136322|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2136323|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2136324|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2136325|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2136326|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2136327|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2136328|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2136329|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2136330|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
2136331|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
2136332|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
2136333|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
2136334|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136335|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136336|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
2136337|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2136338|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136339|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2136340|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136341|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
2136342|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
2136343|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579782|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579783|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579784|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2579785|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2579786|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
2579787|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2579788|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579789|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2136344|NCT03181009|Omalizumab|omalizumab|mesh-list
2136345|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2136346|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2136347|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
2136348|NCT03181308|Nivolumab|nivolumab|mesh-list
2136349|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2136350|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136351|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2136352|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136353|NCT03181451|Ferric maltol|ferric maltol|mesh-list
2136354|NCT03181451|Hematinics|hematinics|mesh-ancestor
2136365|NCT03181932|Vancomycin|vancomycin|mesh-list
2136366|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2136367|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579790|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2579791|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
2579792|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2579793|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579794|NCT01652092|Vidarabine|vidarabine|mesh-list
2579795|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
2579796|NCT01652092|Melphalan|melphalan|mesh-list
2579797|NCT01652092|Busulfan|busulfan|mesh-list
2579798|NCT01652092|Fludarabine|fludarabine|mesh-list
2579799|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
2579800|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
2136368|NCT03182920|Lasmiditan|lasmiditan|mesh-list
2136369|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2136370|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
2579801|NCT01652092|Mesna|mesna|mesh-list
2579802|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2579803|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
2579804|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579805|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2579806|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2579807|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
2579808|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579809|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579810|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2579811|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2579812|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
2579813|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
2579814|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579815|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2579816|NCT01652092|Protective Agents|protective agents|mesh-ancestor
2579817|NCT01652118|Clarithromycin|clarithromycin|mesh-list
2579818|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2579819|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579820|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2579821|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579822|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579823|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2579824|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2579825|NCT01652157|Pancrelipase|pancrelipase|mesh-list
2579826|NCT01652157|Pancreatin|pancreatin|mesh-list
2136371|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136372|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136373|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136374|NCT03183908|Vaccines|vaccines|mesh-list
2136375|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
2136376|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136377|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
2136378|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2579827|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2579828|NCT01652183|Acetaminophen|acetaminophen|mesh-list
2579829|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2579830|NCT01652183|Analgesics|analgesics|mesh-ancestor
2579831|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
2579832|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579833|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579834|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
2579835|NCT01652196|Leucovorin|leucovorin|mesh-list
2579836|NCT01652196|Fluorouracil|fluorouracil|mesh-list
2579837|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
2579838|NCT01652196|Aflibercept|aflibercept|mesh-list
2579839|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
2579840|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2579841|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
2579842|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579843|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2579844|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579845|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2579846|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
2579847|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579848|NCT01652196|Antidotes|antidotes|mesh-ancestor
2579849|NCT01652196|Protective Agents|protective agents|mesh-ancestor
2579850|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
2579851|NCT01652196|Vitamins|vitamins|mesh-ancestor
2579852|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
2579853|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2579854|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2579855|NCT01652196|Growth Substances|growth substances|mesh-ancestor
2579856|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
2579857|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2579858|NCT01652313|Rasagiline|rasagiline|mesh-list
2579859|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2579860|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579861|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579862|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2136379|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136380|NCT03184987|Albuterol|albuterol|mesh-list
2136381|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2136382|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
2136383|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579863|NCT01652313|Protective Agents|protective agents|mesh-ancestor
2136384|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136385|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2136386|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
2136387|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
2136388|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2136389|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2136390|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2136391|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2136392|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
2136393|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136394|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136395|NCT03185065|Amantadine|amantadine|mesh-list
2136396|NCT03185065|Methylphenidate|methylphenidate|mesh-list
2136397|NCT03185065|Modafinil|modafinil|mesh-list
2136398|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2136399|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136400|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2136401|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2136402|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2136403|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136404|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
2136405|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136406|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2136407|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2136408|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2136409|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2136410|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2136411|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
2136412|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136413|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2136414|NCT03185065|Analgesics|analgesics|mesh-ancestor
2136415|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
2136416|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136417|NCT03185546|Nicotine|nicotine|mesh-list
2136418|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2136419|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
2136420|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136421|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136422|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2136423|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2136424|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
2136425|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136426|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136427|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
2136428|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2136429|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2136430|NCT03186261|Fluorides|fluorides|mesh-list
2136431|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
2136432|NCT03186261|Protective Agents|protective agents|mesh-ancestor
2136433|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136434|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2136435|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136436|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
2136437|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
2136438|NCT03187197|Dabigatran|dabigatran|mesh-list
2136439|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
2136440|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2136441|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
2136442|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136443|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136444|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
2136445|NCT03187262|Daratumumab|daratumumab|mesh-list
2136446|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136447|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
2136448|NCT03187301|Apomorphine|apomorphine|mesh-list
2136449|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2136450|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579864|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579865|NCT01652326|Diazepam|diazepam|mesh-list
2579866|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2579867|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
2579868|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
2579869|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
2579870|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136451|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2136452|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2136453|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136454|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136455|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136456|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136457|NCT03187301|Emetics|emetics|mesh-ancestor
2136458|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
2136459|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136460|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2136461|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
2136462|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
2136463|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136464|NCT03187678|Selexipag|selexipag|mesh-list
2136465|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2136466|NCT03187730|Nicotine|nicotine|mesh-list
2136467|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2136468|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
2136469|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136470|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136471|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2136472|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2136473|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
2136474|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136475|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136476|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
2136477|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2136478|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
2136479|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136480|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2136481|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2136482|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
2136483|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136484|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136485|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2136486|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
2136487|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2136488|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
2136489|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136490|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136491|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2136492|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
2136493|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
2136494|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2136495|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
2136496|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136497|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579871|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579872|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2579873|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2579874|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2579875|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2579876|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2579877|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2136498|NCT03188185|Naltrexone|naltrexone|mesh-list
2136499|NCT03188185|Buprenorphine|buprenorphine|mesh-list
2136500|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2136501|NCT03188185|Narcotics|narcotics|mesh-ancestor
2579878|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2579879|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2579880|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2579881|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
2579882|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
2579883|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
2579884|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
2579885|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579886|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579887|NCT01652339|Amlodipine|amlodipine|mesh-list
2579888|NCT01652339|Valsartan|valsartan|mesh-list
2579889|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
2579890|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2136502|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2136503|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136504|NCT03188185|Analgesics|analgesics|mesh-ancestor
2136505|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
2136506|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579891|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2579892|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2579893|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579894|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2579895|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579896|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
2579897|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2579898|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2579899|NCT01652378|Lidocaine|lidocaine|mesh-list
2579900|NCT01652378|Ondansetron|ondansetron|mesh-list
2579901|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
2579902|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
2579903|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2579904|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579905|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
2579906|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579907|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2579908|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2579909|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2579910|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2579911|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579912|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
2579913|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
2579914|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2579915|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
2579916|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
2579917|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2579918|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
2579919|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579920|NCT01652378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2579921|NCT01652378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2579922|NCT01652378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2579923|NCT01652378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2579924|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
2579925|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2579926|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2579927|NCT01652417|Prednisolone|prednisolone|mesh-list
2579928|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
2579929|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2579930|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
2579931|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2579932|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
2579933|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
2579934|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579935|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579936|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2579937|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
2579938|NCT01652417|Hormones|hormones|mesh-ancestor
2579939|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2579940|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2579941|NCT01652417|Protective Agents|protective agents|mesh-ancestor
2579942|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2579943|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579944|NCT01652482|Leucovorin|leucovorin|mesh-list
2579945|NCT01652482|Fluorouracil|fluorouracil|mesh-list
2579946|NCT01652482|Irinotecan|irinotecan|mesh-list
2579947|NCT01652482|Cetuximab|cetuximab|mesh-list
2136507|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2136508|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2136509|NCT03189446|Paclitaxel|paclitaxel|mesh-list
2136510|NCT03189446|Carboplatin|carboplatin|mesh-list
2136511|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2136512|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136513|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
2136514|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
2136515|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
2136516|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136517|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
2136518|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136519|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2136520|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136521|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136522|NCT03189589|Nemiralisib|nemiralisib|mesh-list
2136523|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2579948|NCT01652482|Antimetabolites|antimetabolites|mesh-ancestor
2579949|NCT01652482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579950|NCT01652482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2579951|NCT01652482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579952|NCT01652482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2579953|NCT01652482|Immunologic Factors|immunologic factors|mesh-ancestor
2579954|NCT01652482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579955|NCT01652482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2579956|NCT01652482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2579957|NCT01652482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2579958|NCT01652482|Antidotes|antidotes|mesh-ancestor
2579959|NCT01652482|Protective Agents|protective agents|mesh-ancestor
2579960|NCT01652482|Vitamin B Complex|vitamin b complex|mesh-ancestor
2579961|NCT01652482|Vitamins|vitamins|mesh-ancestor
2579962|NCT01652482|Micronutrients|micronutrients|mesh-ancestor
2579963|NCT01652482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2579964|NCT01652534|Amantadine|amantadine|mesh-list
2579965|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2579966|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2579967|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
2579968|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2579969|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
2579970|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2579971|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2579972|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579973|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2579974|NCT01652534|Analgesics|analgesics|mesh-ancestor
2579975|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
2579976|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2579977|NCT01652547|Pasireotide|pasireotide|mesh-list
2579978|NCT01652547|Somatostatin|somatostatin|mesh-list
2579979|NCT01652547|Hormones|hormones|mesh-ancestor
2579980|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2579981|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579982|NCT01652560|Bevacizumab|bevacizumab|mesh-list
2579983|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2579984|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2579985|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2579986|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2579987|NCT01652560|Growth Substances|growth substances|mesh-ancestor
2579988|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579989|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
2579990|NCT01652586|Midazolam|midazolam|mesh-list
2579991|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
2579992|NCT01652586|Remifentanil|remifentanil|mesh-list
2579993|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2579994|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2579995|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2579996|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2579997|NCT01652586|Analgesics|analgesics|mesh-ancestor
2579998|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
2579999|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580000|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2580001|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2580002|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2580003|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
2580004|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580005|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580006|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2580007|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2580008|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2580009|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2580010|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2580011|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
2580012|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
2580013|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
2580014|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
2580015|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2580016|NCT01652586|Narcotics|narcotics|mesh-ancestor
2580017|NCT01652599|Dexamethasone|dexamethasone|mesh-list
2580018|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2580019|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
2580020|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
2580021|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580022|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580023|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2580024|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
2580025|NCT01652599|Hormones|hormones|mesh-ancestor
2580026|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2580027|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2580028|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580029|NCT01652638|Heparin|heparin|mesh-list
2580030|NCT01652638|Calcium heparin|calcium heparin|mesh-list
2580031|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
2580032|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2580033|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2580034|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580035|NCT01652781|Azacitidine|azacitidine|mesh-list
2580036|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2580037|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
2580038|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580039|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580040|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580041|NCT01652794|Gemcitabine|gemcitabine|mesh-list
2580042|NCT01652794|Carboplatin|carboplatin|mesh-list
2580043|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580044|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2580045|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
2136524|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136525|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136529|NCT03190005|Clopidogrel|clopidogrel|mesh-list
2136530|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2136531|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2136532|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2136533|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2136534|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
2136535|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136536|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136537|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136538|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
2136539|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2136540|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136541|NCT03190369|Hylan|hylan|mesh-list
2136542|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
2136543|NCT03190369|Protective Agents|protective agents|mesh-ancestor
2136544|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136545|NCT03191396|Liraglutide|liraglutide|mesh-list
2136546|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2136547|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136548|NCT03191396|Incretins|incretins|mesh-ancestor
2136549|NCT03191396|Hormones|hormones|mesh-ancestor
2136550|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2136551|NCT03192306|Ethanol|ethanol|mesh-list
2136552|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2580046|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580047|NCT01652794|Antiviral Agents|antiviral agents|mesh-ancestor
2580048|NCT01652794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580049|NCT01652794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580050|NCT01652794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2580051|NCT01652794|Immunologic Factors|immunologic factors|mesh-ancestor
2580052|NCT01652794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580053|NCT01652820|Gemcitabine|gemcitabine|mesh-list
2580054|NCT01652820|Carboplatin|carboplatin|mesh-list
2580055|NCT01652820|Docetaxel|docetaxel|mesh-list
2580056|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580057|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2580058|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
2580059|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136553|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136554|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2136555|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136556|NCT03192488|Cetirizine|cetirizine|mesh-list
2580060|NCT01652820|Antiviral Agents|antiviral agents|mesh-ancestor
2580061|NCT01652820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580062|NCT01652820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580063|NCT01652820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2580064|NCT01652820|Immunologic Factors|immunologic factors|mesh-ancestor
2580065|NCT01652820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580066|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
2136557|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2580067|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
2580068|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
2580069|NCT01652859|Amphotericin B|amphotericin b|mesh-list
2580070|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2580071|NCT01652859|Amebicides|amebicides|mesh-ancestor
2580072|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2580073|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2136558|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2136559|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2136560|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
2136561|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
2136562|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136563|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136564|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136565|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2136566|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
2136567|NCT03192826|Dipivefrin|dipivefrin|mesh-list
2136568|NCT03192826|Brinzolamide|brinzolamide|mesh-list
2136569|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2136570|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2136571|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2136572|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2136573|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
2136574|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136575|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136576|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136577|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2136578|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2136579|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2136580|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136581|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2136582|NCT03193047|Evolocumab|evolocumab|mesh-list
2136583|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2136584|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2136585|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
2136586|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136587|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2136588|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136589|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2136590|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136591|NCT03194373|Carboplatin|carboplatin|mesh-list
2136592|NCT03194373|Palbociclib|palbociclib|mesh-list
2136593|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136594|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2136595|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136596|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136597|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
2136598|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2136599|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136600|NCT03196349|Warfarin|warfarin|mesh-list
2136601|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
2136602|NCT03196349|Apixaban|apixaban|mesh-list
2136603|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
2136604|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2136605|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
2136606|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2136607|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
2580074|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580075|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2580076|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
2580077|NCT01652898|Esmolol|esmolol|mesh-list
2580078|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2580079|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2580080|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2580081|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
2580082|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136608|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136609|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136610|NCT03196505|Bupivacaine|bupivacaine|mesh-list
2136611|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
2136612|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
2136613|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2136614|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136615|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
2136616|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580083|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136617|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2136618|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2580084|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580085|NCT01652924|Anesthetics|anesthetics|mesh-list
2580086|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2580087|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580088|NCT01653015|Vaccines|vaccines|mesh-list
2580089|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
2580090|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136619|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136620|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
2136621|NCT03197025|Aldesleukin|aldesleukin|mesh-list
2136622|NCT03197025|Interleukin-2|interleukin-2|mesh-list
2136623|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136624|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2136625|NCT03197025|Analgesics|analgesics|mesh-ancestor
2136626|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
2136627|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136628|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136629|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2136630|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2136631|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
2580091|NCT01653041|Everolimus|everolimus|mesh-list
2580092|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580093|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2580094|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
2580095|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580096|NCT01653067|Cytarabine|cytarabine|mesh-list
2580097|NCT01653067|Sirolimus|sirolimus|mesh-list
2136632|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136633|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
2580098|NCT01653067|Dexamethasone|dexamethasone|mesh-list
2580099|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
2580100|NCT01653067|Rituximab|rituximab|mesh-list
2580101|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2580102|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
2580103|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
2580104|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580105|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580106|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2580107|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
2580108|NCT01653067|Hormones|hormones|mesh-ancestor
2580109|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2580110|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2580111|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580112|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580113|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2580114|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
2580115|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2580116|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2580117|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
2580118|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
2580119|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580120|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2580121|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2580122|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2580123|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
2580124|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2580125|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2580126|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2580127|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
2136634|NCT03197324|Digoxin|digoxin|mesh-list
2136635|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2136636|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2136637|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136638|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136639|NCT03197324|Protective Agents|protective agents|mesh-ancestor
2136640|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136641|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2136642|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
2136643|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2136644|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136645|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
2136646|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2136647|NCT03197883|Protective Agents|protective agents|mesh-ancestor
2136648|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580128|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580129|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2580130|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2136649|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
2580131|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580132|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
2580133|NCT01653171|Simethicone|simethicone|mesh-list
2580134|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2580135|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
2580136|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580137|NCT01653171|Expectorants|expectorants|mesh-ancestor
2580138|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
2580139|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2580140|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
2580141|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580142|NCT01653171|Protective Agents|protective agents|mesh-ancestor
2580143|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580144|NCT01653171|Antidotes|antidotes|mesh-ancestor
2580145|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
2580146|NCT01653171|Emollients|emollients|mesh-ancestor
2580147|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
2580148|NCT01653223|Simvastatin|simvastatin|mesh-list
2580149|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2580150|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2580151|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
2580152|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580153|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2580154|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2580155|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580156|NCT01653236|Ribavirin|ribavirin|mesh-list
2580157|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2580158|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
2580159|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580160|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
2580161|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580162|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
2580163|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580164|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2580165|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580166|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580167|NCT01653457|Memantine|memantine|mesh-list
2580168|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2580169|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2580170|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
2580171|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580172|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580173|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580174|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2580175|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2580176|NCT01653470|Leucovorin|leucovorin|mesh-list
2580177|NCT01653470|Paclitaxel|paclitaxel|mesh-list
2580178|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2580179|NCT01653470|Carboplatin|carboplatin|mesh-list
2580180|NCT01653470|Fluorouracil|fluorouracil|mesh-list
2136672|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2136673|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2580181|NCT01653470|Irinotecan|irinotecan|mesh-list
2580182|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2580183|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580184|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
2580185|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
2580186|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
2580187|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136674|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
2136675|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
2136676|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2136677|NCT03198221|Citric Acid|citric acid|mesh-list
2136678|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
2136679|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2136680|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
2136681|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
2136682|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136683|NCT03198221|Cathartics|cathartics|mesh-ancestor
2136684|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2136685|NCT03198221|Antacids|antacids|mesh-ancestor
2136686|NCT03198221|Laxatives|laxatives|mesh-ancestor
2136687|NCT03198507|Amoxicillin|amoxicillin|mesh-list
2136688|NCT03198507|Rifabutin|rifabutin|mesh-list
2580188|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
2580189|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2580190|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2580191|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
2580192|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580193|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2580194|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2580195|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580196|NCT01653470|Antidotes|antidotes|mesh-ancestor
2580197|NCT01653470|Protective Agents|protective agents|mesh-ancestor
2580198|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
2580199|NCT01653470|Vitamins|vitamins|mesh-ancestor
2580200|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
2580201|NCT01653522|Doxycycline|doxycycline|mesh-list
2580202|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2580203|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580204|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
2580205|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2580206|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2580207|NCT01653561|Apatinib|apatinib|mesh-list
2580208|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580209|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2580210|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580211|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580212|NCT01653639|Factor VIII|factor viii|mesh-list
2580213|NCT01653639|Coagulants|coagulants|mesh-ancestor
2580214|NCT01653665|Sargramostim|sargramostim|mesh-list
2136689|NCT03198507|Omeprazole|omeprazole|mesh-list
2136690|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2136691|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136692|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2136693|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2136694|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2136695|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136696|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136697|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2136698|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
2136699|NCT03198767|Licogliflozin|licogliflozin|mesh-list
2136700|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
2136701|NCT03198767|Psyllium|psyllium|mesh-list
2580215|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
2580216|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580217|NCT01653678|Vitamin D|vitamin d|mesh-list
2580218|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
2580219|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
2580220|NCT01653678|Vitamins|vitamins|mesh-list
2580221|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
2580222|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580223|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2580224|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2580225|NCT01653717|Vidarabine|vidarabine|mesh-list
2580226|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
2580227|NCT01653717|Fludarabine|fludarabine|mesh-list
2136702|NCT03198767|Calcium|calcium|mesh-list
2580228|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
2580229|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2580230|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
2580231|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136703|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2136704|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136705|NCT03198767|Antacids|antacids|mesh-ancestor
2136706|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580232|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2580233|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2580234|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
2580235|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580236|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580237|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2580238|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2580239|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
2136707|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2136708|NCT03198767|Cathartics|cathartics|mesh-ancestor
2136709|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2580240|NCT01653717|Antiviral Agents|antiviral agents|mesh-ancestor
2580241|NCT01653717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580242|NCT01653925|Dutasteride|dutasteride|mesh-list
2580243|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2580244|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2580245|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580246|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580247|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
2580248|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2580249|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580250|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2580251|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
2580252|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2580253|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2580254|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136710|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2136711|NCT03198871|Acetaminophen|acetaminophen|mesh-list
2136712|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2136713|NCT03198871|Analgesics|analgesics|mesh-ancestor
2136714|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
2136715|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136716|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136717|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
2136718|NCT03198884|Darunavir|darunavir|mesh-list
2136719|NCT03198884|Dolutegravir|dolutegravir|mesh-list
2136720|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2136721|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2580255|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2580256|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2580257|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580258|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580259|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580260|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2580261|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
2580262|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2580263|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580264|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2580265|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2580266|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2580267|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2580268|NCT01654081|Irinotecan|irinotecan|mesh-list
2580269|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2580270|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2580271|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580272|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580273|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580274|NCT01654120|Liraglutide|liraglutide|mesh-list
2580275|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2580276|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580277|NCT01654120|Incretins|incretins|mesh-ancestor
2580278|NCT01654120|Hormones|hormones|mesh-ancestor
2580279|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2580280|NCT01654146|Paclitaxel|paclitaxel|mesh-list
2580281|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2136722|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
2136723|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136724|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136725|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2580282|NCT01654146|Carboplatin|carboplatin|mesh-list
2580283|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2580284|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580285|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
2580286|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
2580287|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
2580288|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580289|NCT01654185|Letrozole|letrozole|mesh-list
2580290|NCT01654185|Exemestane|exemestane|mesh-list
2580291|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2580292|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580293|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2580294|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580295|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580296|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2580297|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
2580298|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2580299|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580300|NCT01654211|Ritonavir|ritonavir|mesh-list
2580301|NCT01654211|Lactams|lactams|mesh-list
2580302|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2580303|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2580304|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
2136726|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2136727|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
2136728|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136729|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2136730|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2136731|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2136732|NCT03199911|Erythromycin|erythromycin|mesh-list
2136733|NCT03199911|Bacitracin|bacitracin|mesh-list
2136734|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136735|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2136736|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2136737|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136738|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136739|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2136740|NCT03199963|Tamoxifen|tamoxifen|mesh-list
2136741|NCT03199963|Afimoxifene|afimoxifene|mesh-list
2136742|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2136743|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
2136744|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2136745|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136746|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2136747|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580305|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580306|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580307|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2580308|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2580309|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
2580310|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580311|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2580312|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2580313|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2580314|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
2580315|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2580316|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2580317|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580318|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2580319|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580320|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580321|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2580322|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
2580323|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2580324|NCT01654497|HU 211|hu 211|mesh-list
2580325|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2580326|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
2136748|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2136749|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2136750|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2136751|NCT03200860|Empagliflozin|empagliflozin|mesh-list
2136752|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2136753|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580327|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
2580328|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580329|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580330|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2580331|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2136754|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2136755|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136756|NCT03201211|Vaccines|vaccines|mesh-list
2136757|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
2136758|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136759|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2136760|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
2136761|NCT03201419|Coagulants|coagulants|mesh-ancestor
2136762|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2136763|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
2136764|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136765|NCT03201562|Tropicamide|tropicamide|mesh-list
2136766|NCT03201562|Aceclidine|aceclidine|mesh-list
2136767|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
2580332|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2580333|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580334|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580335|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2580336|NCT01654497|Protective Agents|protective agents|mesh-ancestor
2580337|NCT01654562|Simvastatin|simvastatin|mesh-list
2580338|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2580339|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2580340|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
2580341|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136768|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
2136769|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136770|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136771|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2136772|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2136773|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
2136774|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136775|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136776|NCT03201562|Miotics|miotics|mesh-ancestor
2136777|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2580342|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2580343|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2580344|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580345|NCT01654575|Methotrexate|methotrexate|mesh-list
2580346|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2580347|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
2580348|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2580349|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580350|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2580351|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
2580352|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580353|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580354|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
2580355|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580356|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2580357|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2580358|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
2580359|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2580360|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2580361|NCT01654640|Metformin|metformin|mesh-list
2580362|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2580363|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580364|NCT01654692|Ipilimumab|ipilimumab|mesh-list
2580365|NCT01654692|Fotemustine|fotemustine|mesh-list
2580366|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2580367|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580368|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2580369|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580370|NCT01654705|Pantoprazole|pantoprazole|mesh-list
2580371|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2580372|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2580373|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2580374|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580375|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580376|NCT01654718|Pantoprazole|pantoprazole|mesh-list
2419967|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419968|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
2419969|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2419970|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2419971|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2419972|NCT00805519|Analgesics|analgesics|mesh-ancestor
2419973|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
2419974|NCT00805519|Filaricides|filaricides|mesh-ancestor
2419975|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
2419976|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
2419977|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
2419978|NCT00805558|Metronidazole|metronidazole|mesh-list
2419979|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
2419980|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2419981|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2419982|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2419983|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2419984|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2419985|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2419986|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2419987|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2419988|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2419989|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
2419990|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2419991|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2419992|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2419993|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2419994|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2419995|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2419996|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2580377|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2580378|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2580379|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2580380|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580381|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580382|NCT01654731|Bezafibrate|bezafibrate|mesh-list
2580383|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2136800|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
2136801|NCT03202134|Anesthetics|anesthetics|mesh-list
2136802|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2136803|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136804|NCT03202134|Narcotics|narcotics|mesh-ancestor
2136805|NCT03202134|Analgesics|analgesics|mesh-ancestor
2136806|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
2136807|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136808|NCT03202511|Tenofovir|tenofovir|mesh-list
2136809|NCT03202511|Emtricitabine|emtricitabine|mesh-list
2136810|NCT03202511|Probenecid|probenecid|mesh-list
2580384|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
2580385|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580386|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2580387|NCT01654809|Vaccines|vaccines|mesh-list
2580388|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
2580389|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136811|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
2419997|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2419998|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2419999|NCT00805584|Desloratadine|desloratadine|mesh-list
2420000|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2420001|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
2420002|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420003|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420004|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420005|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2420006|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2420007|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
2420008|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
2420009|NCT00805649|Dexamethasone|dexamethasone|mesh-list
2420010|NCT00805649|Bevacizumab|bevacizumab|mesh-list
2420011|NCT00805649|Temazepam|temazepam|mesh-list
2420012|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2420013|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136812|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136813|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2136814|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2136815|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136816|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136817|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2136818|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2136819|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
2136820|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
2136821|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2580390|NCT01654939|Rifaximin|rifaximin|mesh-list
2580391|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2580392|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580393|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2580394|NCT01654965|Topotecan|topotecan|mesh-list
2580395|NCT01654965|Lenograstim|lenograstim|mesh-list
2580396|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2580397|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
2580398|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580399|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2580400|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2580401|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580402|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580403|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580404|NCT01655004|Exemestane|exemestane|mesh-list
2580405|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580406|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2580407|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2580408|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580409|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580410|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2580411|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
2580412|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2580413|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580414|NCT01655056|Darexaban|darexaban|mesh-list
2580415|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2580416|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
2580417|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2580418|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
2580419|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580420|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580421|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
2580422|NCT01655082|Nicotine|nicotine|mesh-list
2580423|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2580424|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
2580425|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580426|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580427|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2580428|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2580429|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
2580430|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580431|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580432|NCT01655095|Prucalopride|prucalopride|mesh-list
2580433|NCT01655095|Bisacodyl|bisacodyl|mesh-list
2580434|NCT01655095|Laxatives|laxatives|mesh-ancestor
2580435|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2580436|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2580437|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2136822|NCT03202511|Renal Agents|renal agents|mesh-ancestor
2580438|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
2580439|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580440|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580441|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580442|NCT01655095|Cathartics|cathartics|mesh-ancestor
2580443|NCT01655108|Minoxidil|minoxidil|mesh-list
2580444|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2580445|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
2580446|NCT01655147|Rifampin|rifampin|mesh-list
2580447|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
2136823|NCT03202550|Oxycodone|oxycodone|mesh-list
2136824|NCT03202550|Lorazepam|lorazepam|mesh-list
2136825|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2136826|NCT03202550|Narcotics|narcotics|mesh-ancestor
2136827|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2136828|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136829|NCT03202550|Analgesics|analgesics|mesh-ancestor
2136830|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
2136831|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136832|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
2136833|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
2136834|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
2136835|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2580448|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580449|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2580450|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580451|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580452|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
2580453|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2136836|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2136837|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2136838|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2136839|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2136840|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
2136841|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
2136842|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136843|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136844|NCT03203447|Triamcinolone|triamcinolone|mesh-list
2136845|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2136846|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2136847|NCT03203447|Bevacizumab|bevacizumab|mesh-list
2136848|NCT03203447|Ranibizumab|ranibizumab|mesh-list
2136849|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2136850|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2136851|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136852|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2136853|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2136854|NCT03203447|Growth Substances|growth substances|mesh-ancestor
2136855|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136856|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
2136857|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2136858|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
2580454|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580455|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2580456|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2580457|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
2580458|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2580459|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580460|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
2580461|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2580462|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2580463|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2580464|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2580465|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2580466|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2580467|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2580468|NCT01655199|Albuterol|albuterol|mesh-list
2580469|NCT01655199|Ipratropium|ipratropium|mesh-list
2580470|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2580471|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
2580472|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136859|NCT03203447|Hormones|hormones|mesh-ancestor
2136860|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2136861|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2136862|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
2136863|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580473|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580474|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2580475|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
2580476|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
2580477|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2580478|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2580479|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2580480|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2580481|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
2580482|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580483|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580484|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2580485|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
2580486|NCT01655212|Valganciclovir|valganciclovir|mesh-list
2580487|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
2580488|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136864|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136865|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
2136866|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2136867|NCT03203681|Testosterone|testosterone|mesh-list
2136868|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
2136869|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
2136870|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2136871|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136872|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
2580518|NCT01655303|Propranolol|propranolol|mesh-list
2580519|NCT01655303|Metoprolol|metoprolol|mesh-list
2580520|NCT01655303|Verapamil|verapamil|mesh-list
2580521|NCT01655303|Diltiazem|diltiazem|mesh-list
2580522|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2580523|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2580524|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
2580525|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580526|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580527|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580528|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2580529|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2580530|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
2580531|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
2580532|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
2580533|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580534|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2580535|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2580536|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2580537|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2580538|NCT01655316|Verapamil|verapamil|mesh-list
2580539|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2580540|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2580541|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2580542|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136873|NCT03203681|Hormones|hormones|mesh-ancestor
2136874|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2136875|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580543|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2580544|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580545|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
2580546|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
2580547|NCT01655524|Aminophylline|aminophylline|mesh-list
2580548|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2580549|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
2580550|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580551|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580552|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2580553|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
2580554|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2580555|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2580556|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580557|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580558|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2580559|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2580560|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
2580561|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580562|NCT01655524|Protective Agents|protective agents|mesh-ancestor
2580563|NCT01655628|Gemcitabine|gemcitabine|mesh-list
2580564|NCT01655628|Cisplatin|cisplatin|mesh-list
2580565|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580566|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2580567|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
2580568|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580569|NCT01655628|Antiviral Agents|antiviral agents|mesh-ancestor
2580570|NCT01655628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580571|NCT01655628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580572|NCT01655628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2580573|NCT01655628|Immunologic Factors|immunologic factors|mesh-ancestor
2580574|NCT01655628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580575|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
2580576|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2580577|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2580578|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580579|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
2580580|NCT01655641|Coagulants|coagulants|mesh-ancestor
2580581|NCT01655706|Aripiprazole|aripiprazole|mesh-list
2580582|NCT01655706|Citalopram|citalopram|mesh-list
2580583|NCT01655706|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2580584|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2580585|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2580586|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580587|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580588|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
2580589|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580590|NCT01655706|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2580591|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
2580592|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2580593|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2580594|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2580595|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2580596|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
2580597|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
2580598|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2580599|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2580600|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2580601|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2580602|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2580603|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2136876|NCT03203681|Androgens|androgens|mesh-ancestor
2136877|NCT03204279|Palonosetron|palonosetron|mesh-list
2136878|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
2136879|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
2580604|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2580605|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2580606|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580607|NCT01655758|Timolol|timolol|mesh-list
2580608|NCT01655758|Bimatoprost|bimatoprost|mesh-list
2580609|NCT01655758|Travoprost|travoprost|mesh-list
2580610|NCT01655758|Dorzolamide|dorzolamide|mesh-list
2580611|NCT01655758|Latanoprost|latanoprost|mesh-list
2580612|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2580613|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2580614|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
2580615|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580616|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580617|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580618|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2580619|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2580620|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2580621|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2580622|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2580623|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580624|NCT01655810|Vitamin D|vitamin d|mesh-list
2580625|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
2136880|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136881|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136882|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2580626|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
2580627|NCT01655810|Vitamins|vitamins|mesh-list
2580628|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
2580629|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
2580630|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580631|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2580632|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2580633|NCT01655810|Antacids|antacids|mesh-ancestor
2580634|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580635|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2580636|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
2580637|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2580638|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2580639|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2580640|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2580641|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580642|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
2580643|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580644|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580645|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2580646|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580647|NCT01655875|Plerixafor|plerixafor|mesh-list
2580648|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2580649|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2580650|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
2580651|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580652|NCT01655888|Tremelimumab|tremelimumab|mesh-list
2580653|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580654|NCT01655914|Flumazenil|flumazenil|mesh-list
2580655|NCT01655914|Antidotes|antidotes|mesh-ancestor
2580656|NCT01655914|Protective Agents|protective agents|mesh-ancestor
2580657|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580658|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
2580659|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
2580660|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580661|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580662|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
2580663|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2580664|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2580665|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580666|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
2580667|NCT01655927|Coagulants|coagulants|mesh-ancestor
2580668|NCT01655966|Vitamin D|vitamin d|mesh-list
2136883|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2136884|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2136885|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
2136886|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136887|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580669|NCT01655966|Interferons|interferons|mesh-list
2580670|NCT01655966|Ribavirin|ribavirin|mesh-list
2580671|NCT01655966|Vitamins|vitamins|mesh-ancestor
2580672|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
2580673|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580674|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2580675|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580676|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
2580677|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580678|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
2580679|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580680|NCT01655992|Capecitabine|capecitabine|mesh-list
2580681|NCT01655992|Tegafur|tegafur|mesh-list
2580682|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2580683|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
2580684|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580685|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580686|NCT01656005|Beclomethasone|beclomethasone|mesh-list
2580687|NCT01656005|Carvedilol|carvedilol|mesh-list
2580688|NCT01656005|Bisoprolol|bisoprolol|mesh-list
2580689|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
2580690|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
2580691|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2580692|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
2580693|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580694|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580695|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2580696|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
2580697|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2580698|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2580699|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2580700|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
2580701|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580702|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580703|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
2580704|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2580705|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
2580706|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2580707|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2580708|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2580709|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
2580710|NCT01656005|Protective Agents|protective agents|mesh-ancestor
2580711|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2580712|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2580713|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2580714|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
2580715|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2580716|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2580717|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
2580718|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2580719|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2580720|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
2580721|NCT01656005|Hormones|hormones|mesh-ancestor
2580722|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2580723|NCT01656018|Rilpivirine|rilpivirine|mesh-list
2580724|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2580725|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2580726|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580727|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136888|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
2136889|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136890|NCT03205150|Licogliflozin|licogliflozin|mesh-list
2136891|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2136892|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136893|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2136894|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136895|NCT03205163|Factor VIII|factor viii|mesh-list
2136896|NCT03205163|Coagulants|coagulants|mesh-ancestor
2136897|NCT03205358|Vaccines|vaccines|mesh-list
2136898|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
2136899|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136900|NCT03205566|Lamivudine|lamivudine|mesh-list
2136901|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
2136902|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2136903|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2136904|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136905|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136906|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
2136907|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136908|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2136909|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2136910|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2136911|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2136912|NCT03206073|Durvalumab|durvalumab|mesh-list
2136913|NCT03206073|Tremelimumab|tremelimumab|mesh-list
2136914|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2136915|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136916|NCT03206788|Losartan|losartan|mesh-list
2136917|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2136918|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2136919|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2136920|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2136921|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136922|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
2136923|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136924|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2136925|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136926|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136927|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
2136928|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136929|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2136930|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2136931|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136932|NCT03207243|Fluticasone|fluticasone|mesh-list
2136933|NCT03207243|Xhance|xhance|mesh-list
2136934|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2580728|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
2580729|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580730|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2580731|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2580732|NCT01656057|Acetaminophen|acetaminophen|mesh-list
2580733|NCT01656057|Metformin|metformin|mesh-list
2580734|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
2136935|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2136936|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2136937|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
2136938|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136939|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580735|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2580736|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2580737|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580738|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2580739|NCT01656057|Analgesics|analgesics|mesh-ancestor
2580740|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
2580741|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580742|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
2580743|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2580744|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2580745|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
2580746|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580747|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2580748|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2580749|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2580750|NCT01656070|Vitamin D|vitamin d|mesh-list
2580751|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
2580752|NCT01656070|Vitamins|vitamins|mesh-ancestor
2580753|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
2136940|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2136941|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
2136942|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
2136943|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2136944|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2136945|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2136946|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2136947|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
2136948|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2136949|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2136950|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2136951|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
2136952|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2136953|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2136954|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
2580754|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580755|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2580756|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2580757|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2580758|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2420014|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2420015|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2420016|NCT00805649|Growth Substances|growth substances|mesh-ancestor
2420017|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420018|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
2420019|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2420020|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
2420021|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
2136955|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2136956|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2136957|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2136958|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2136959|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136960|NCT03207750|Vaccines|vaccines|mesh-list
2136961|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2136962|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
2580759|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2580760|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
2580761|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580762|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580763|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2136963|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136964|NCT03208933|Pirfenidone|pirfenidone|mesh-list
2136965|NCT03208933|Analgesics|analgesics|mesh-ancestor
2136966|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
2136967|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2136968|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136969|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2136970|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2136971|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2136972|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2136973|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136974|NCT03209492|Leuprolide|leuprolide|mesh-list
2136975|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2136976|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
2136977|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2136978|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136979|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2136980|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136981|NCT03209518|Leuprolide|leuprolide|mesh-list
2136982|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2136983|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
2136984|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2580764|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2580765|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
2580766|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580767|NCT01656122|Abacavir|abacavir|mesh-list
2580768|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2580769|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2580770|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580771|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580772|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
2580773|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580774|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2580775|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2136985|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136986|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2136987|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2136988|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
2136989|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
2136990|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
2136991|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2136992|NCT03209570|Protective Agents|protective agents|mesh-ancestor
2136993|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2136994|NCT03210259|Adalimumab|adalimumab|mesh-list
2136995|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2136996|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2136997|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2136998|NCT03210376|Neostigmine|neostigmine|mesh-list
2136999|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2137000|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137001|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137002|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
2137003|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137004|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137005|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2580776|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
2580777|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2580778|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2580779|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580780|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
2137006|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
2137007|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137008|NCT03211117|Docetaxel|docetaxel|mesh-list
2137009|NCT03211117|Doxorubicin|doxorubicin|mesh-list
2137010|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2137011|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
2137012|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137013|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
2137014|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
2137015|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
2137016|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137017|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2137018|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2137019|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2137020|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137021|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2137022|NCT03211156|Amoxicillin|amoxicillin|mesh-list
2137023|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2137024|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580781|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2580782|NCT01656226|Protective Agents|protective agents|mesh-ancestor
2580783|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580784|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
2580785|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
2580786|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2580787|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
2580788|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2580789|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
2580790|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580791|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580792|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
2580793|NCT01656343|Abatacept|abatacept|mesh-list
2580794|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2580795|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2580796|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580797|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580798|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2580799|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
2580800|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580801|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2580802|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580803|NCT01656512|Vitamin D|vitamin d|mesh-list
2580804|NCT01656512|Diphosphonates|diphosphonates|mesh-list
2580805|NCT01656512|Calcium|calcium|mesh-list
2580806|NCT01656512|Vitamins|vitamins|mesh-ancestor
2580807|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
2580808|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580809|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2580810|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2580811|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2580812|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
2580813|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580814|NCT01656538|Paclitaxel|paclitaxel|mesh-list
2580815|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2137025|NCT03211234|Ranibizumab|ranibizumab|mesh-list
2137026|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2137027|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2137028|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2137029|NCT03211234|Growth Substances|growth substances|mesh-ancestor
2137030|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137031|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
2580816|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580817|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
2580818|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
2580819|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
2137032|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580820|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580821|NCT01656551|Gemcitabine|gemcitabine|mesh-list
2580822|NCT01656551|Pemetrexed|pemetrexed|mesh-list
2580823|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580824|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2580825|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
2580826|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580827|NCT01656551|Antiviral Agents|antiviral agents|mesh-ancestor
2580828|NCT01656551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580829|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580830|NCT01656551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2580831|NCT01656551|Immunologic Factors|immunologic factors|mesh-ancestor
2580832|NCT01656551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580833|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2580834|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2580835|NCT01656616|Antidotes|antidotes|mesh-list
2580836|NCT01656616|Protective Agents|protective agents|mesh-ancestor
2420022|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420023|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2420024|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
2420025|NCT00805649|Hormones|hormones|mesh-ancestor
2420026|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2420027|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2420028|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2420029|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2420030|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2420031|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2420032|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2420033|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
2580837|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580838|NCT01656642|Atezolizumab|atezolizumab|mesh-list
2580839|NCT01656642|Vemurafenib|vemurafenib|mesh-list
2580840|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580841|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2580842|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580843|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420034|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
2420035|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420036|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420037|NCT00805662|Oxytocin|oxytocin|mesh-list
2420038|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
2420039|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2580844|NCT01656668|Theobromine|theobromine|mesh-list
2580845|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2580846|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
2580847|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580848|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580849|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2580850|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
2580851|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
2580852|NCT01656720|Methoxamine|methoxamine|mesh-list
2580853|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
2580854|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
2580855|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580856|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580857|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2580858|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2580859|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2580860|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2580861|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
2580862|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580863|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580864|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
2580865|NCT01656798|Citric Acid|citric acid|mesh-list
2580866|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
2580867|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
2580868|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2580869|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
2580870|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
2580871|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580872|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
2580873|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2580874|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2580875|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420040|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420041|NCT00805701|Dutasteride|dutasteride|mesh-list
2580876|NCT01656798|Urological Agents|urological agents|mesh-ancestor
2580877|NCT01656811|Albuterol|albuterol|mesh-list
2580878|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2580879|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
2580880|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137033|NCT03211858|Insulin|insulin|mesh-list
2137034|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2137035|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
2137036|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
2137037|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
2137038|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2137039|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2137040|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137041|NCT03213457|Norethindrone|norethindrone|mesh-list
2137042|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
2137043|NCT03213457|Estradiol|estradiol|mesh-list
2137044|NCT03213457|Estrogens|estrogens|mesh-ancestor
2137045|NCT03213457|Hormones|hormones|mesh-ancestor
2137046|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2137047|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137048|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2137049|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
2137050|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2137051|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2137052|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2137053|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2137054|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2137055|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2137056|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137057|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2137058|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137059|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580881|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580882|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2580883|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
2580884|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
2580885|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2580886|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2580887|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2580888|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2580889|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
2580890|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580891|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580892|NCT01656980|Carmustine|carmustine|mesh-list
2580893|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2580894|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
2580895|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580896|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580897|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
2580898|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
2580899|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
2580900|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580901|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580902|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2580903|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2580904|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
2137060|NCT03214367|Insulin|insulin|mesh-list
2137061|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2137062|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
2137063|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
2137064|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2137065|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137066|NCT03214380|Insulin|insulin|mesh-list
2137067|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2137068|NCT03214380|Metformin|metformin|mesh-list
2137069|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
2137070|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
2137071|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2137072|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2137073|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137074|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137075|NCT03215706|Paclitaxel|paclitaxel|mesh-list
2137076|NCT03215706|Carboplatin|carboplatin|mesh-list
2137077|NCT03215706|Nivolumab|nivolumab|mesh-list
2580905|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
2137078|NCT03215706|Pemetrexed|pemetrexed|mesh-list
2137079|NCT03215706|Ipilimumab|ipilimumab|mesh-list
2137080|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2580906|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580907|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580908|NCT01657071|Aspirin|aspirin|mesh-list
2580909|NCT01657071|Clopidogrel|clopidogrel|mesh-list
2580910|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2580911|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2137081|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137082|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
2137083|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
2137084|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
2137085|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137086|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2137087|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2137088|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137089|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2137090|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2580912|NCT01657071|Analgesics|analgesics|mesh-ancestor
2580913|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
2580914|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580915|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580916|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2580917|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2580918|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2580919|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2580920|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580921|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2137091|NCT03216226|Glucagon|glucagon|mesh-list
2137092|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2137093|NCT03216226|Hormones|hormones|mesh-ancestor
2137094|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2137095|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137096|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2137097|NCT03216902|Latanoprost|latanoprost|mesh-list
2137098|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2137099|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
2580922|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2580923|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580924|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
2580925|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2580926|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2580927|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2580928|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
2580929|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580930|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
2580931|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2580932|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580933|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2580934|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2580935|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
2580936|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580937|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580938|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580939|NCT01657201|Voriconazole|voriconazole|mesh-list
2580940|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
2580941|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580942|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2580943|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2580944|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2580945|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580946|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2580947|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
2580948|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2580949|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580950|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2580951|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2580952|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2137100|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2137101|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
2137102|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580953|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2580954|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2580955|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2420042|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2420043|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2420044|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420045|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420046|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
2420047|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2420048|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580956|NCT01657240|Analgesics|analgesics|mesh-ancestor
2580957|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
2580958|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580959|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580960|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2580961|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2580962|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2580963|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2580964|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2580965|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
2580966|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
2580967|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580968|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580969|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2580970|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580971|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2580972|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2580973|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2580974|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
2580975|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580976|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2580977|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2580978|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
2580979|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2580980|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2580981|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
2580982|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
2580983|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2580984|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2580985|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2580986|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2580987|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2137103|NCT03216954|Expectorants|expectorants|mesh-ancestor
2137104|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
2137105|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2137106|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
2137107|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137108|NCT03216954|Protective Agents|protective agents|mesh-ancestor
2137109|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137110|NCT03216954|Antidotes|antidotes|mesh-ancestor
2580988|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2580989|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
2580990|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2580991|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2580992|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2580993|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2580994|NCT01657448|Methenamine|methenamine|mesh-list
2580995|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
2580996|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
2580997|NCT01657448|Methylene Blue|methylene blue|mesh-list
2580998|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2580999|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581000|NCT01657448|Renal Agents|renal agents|mesh-ancestor
2581001|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2137111|NCT03218592|Tenofovir|tenofovir|mesh-list
2137112|NCT03218592|Emtricitabine|emtricitabine|mesh-list
2137113|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2137114|NCT03218592|Maraviroc|maraviroc|mesh-list
2137115|NCT03218592|Dolutegravir|dolutegravir|mesh-list
2137116|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
2420049|NCT00805805|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2420050|NCT00805805|Chelating Agents|chelating agents|mesh-ancestor
2420051|NCT00805805|Sequestering Agents|sequestering agents|mesh-ancestor
2420052|NCT00805805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420053|NCT00805805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420054|NCT00805805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2581002|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581003|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581004|NCT01657487|Fluticasone|fluticasone|mesh-list
2581005|NCT01657487|Xhance|xhance|mesh-list
2581006|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2581007|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2581008|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2581009|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2581010|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
2581011|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581012|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581013|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2581014|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
2581015|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
2581016|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2581017|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2581018|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2581019|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2581020|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
2581021|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581022|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581023|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
2581024|NCT01657487|Hormones|hormones|mesh-ancestor
2581025|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581026|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
2581027|NCT01657500|Gentamicins|gentamicins|mesh-list
2581028|NCT01657500|Dextrans|dextrans|mesh-list
2581029|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2581030|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2581031|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581032|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2137117|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137118|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2137119|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2137120|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137121|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137122|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2137123|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2137124|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2137125|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2137126|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2137127|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2137128|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2137129|NCT03219294|Bromides|bromides|mesh-list
2581033|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581034|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581035|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
2581036|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
2581037|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
2581038|NCT01657513|Adalimumab|adalimumab|mesh-list
2581039|NCT01657513|Etanercept|etanercept|mesh-list
2581040|NCT01657513|Infliximab|infliximab|mesh-list
2137130|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
2137131|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
2581041|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2581042|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2581043|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2581044|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2581045|NCT01657513|Analgesics|analgesics|mesh-ancestor
2581046|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
2581047|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581048|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581049|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581050|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2581051|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
2581052|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
2581053|NCT01657578|Omeprazole|omeprazole|mesh-list
2581054|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2581055|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581056|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2581057|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581058|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581059|NCT01657591|Vemurafenib|vemurafenib|mesh-list
2581060|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581061|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2581062|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137132|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2137133|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2137134|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2137135|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137136|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137137|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2137138|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2137139|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
2137140|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581063|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581064|NCT01657656|Vitamin D|vitamin d|mesh-list
2581065|NCT01657656|Vitamins|vitamins|mesh-ancestor
2581066|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
2581067|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581068|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2581069|NCT01657669|Aflibercept|aflibercept|mesh-list
2581070|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2581071|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2581072|NCT01657669|Growth Substances|growth substances|mesh-ancestor
2581073|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581074|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
2581075|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581076|NCT01657682|Crenolanib|crenolanib|mesh-list
2581077|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137141|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137142|NCT03219723|Amoxicillin|amoxicillin|mesh-list
2137143|NCT03219723|Metronidazole|metronidazole|mesh-list
2137144|NCT03219723|Clarithromycin|clarithromycin|mesh-list
2137145|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2137146|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137147|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2137148|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2581078|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2581079|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
2581080|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
2581081|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581082|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581083|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2581084|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2581085|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
2581086|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581087|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581088|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
2581089|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2581090|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2581091|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581092|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2581093|NCT01657812|Analgesics|analgesics|mesh-ancestor
2581094|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
2581095|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581096|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2581097|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2581098|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2581099|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
2581100|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581101|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581102|NCT01657825|Isavuconazole|isavuconazole|mesh-list
2581103|NCT01657825|Warfarin|warfarin|mesh-list
2581104|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
2581105|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
2581106|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581107|NCT01657838|Ketoconazole|ketoconazole|mesh-list
2581108|NCT01657838|Isavuconazole|isavuconazole|mesh-list
2581109|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
2581110|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581111|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2581112|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2581113|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581114|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581115|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2581116|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
2581117|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581118|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137149|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2137150|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137151|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581119|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2581120|NCT01657851|Tamsulosin|tamsulosin|mesh-list
2581121|NCT01657851|Dutasteride|dutasteride|mesh-list
2581122|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2581123|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2581124|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2581125|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
2581126|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581127|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581128|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581129|NCT01657851|Urological Agents|urological agents|mesh-ancestor
2581130|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2581131|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2581132|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581133|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
2581134|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581135|NCT01657864|Lamotrigine|lamotrigine|mesh-list
2581136|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
2137152|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2137153|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2137154|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
2137155|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2137156|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137157|NCT03219866|Budesonide|budesonide|mesh-list
2137158|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
2137159|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2137160|NCT03219866|Ipratropium|ipratropium|mesh-list
2137161|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2137162|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2137163|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
2137164|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137165|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137166|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2137167|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
2137168|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
2581137|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2581138|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2581139|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581140|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2581141|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581142|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2581143|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2581144|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2581145|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2581146|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2581147|NCT01657890|Isavuconazole|isavuconazole|mesh-list
2581148|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
2581149|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581150|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2137169|NCT03219866|Hormones|hormones|mesh-ancestor
2137170|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2137171|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
2137172|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2137173|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
2137174|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137175|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137176|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
2137184|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
2137185|NCT03220958|Promethazine|promethazine|mesh-list
2137186|NCT03220958|Metoclopramide|metoclopramide|mesh-list
2137187|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2137188|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2137189|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2137190|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581151|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2581152|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
2581153|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581154|NCT01657929|Antacids|antacids|mesh-ancestor
2581155|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581156|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581157|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2581158|NCT01657955|Chlorambucil|chlorambucil|mesh-list
2581159|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2581160|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
2581161|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581162|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581163|NCT01657981|Darexaban|darexaban|mesh-list
2581164|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2581165|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
2581166|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2581167|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
2581168|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581169|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581170|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
2581171|NCT01658007|Sirolimus|sirolimus|mesh-list
2581172|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2581173|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581174|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2581175|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581176|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
2581177|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2581178|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
2581179|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581180|NCT01658033|Leucovorin|leucovorin|mesh-list
2581181|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
2581182|NCT01658033|Bevacizumab|bevacizumab|mesh-list
2581183|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581184|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2581185|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2581186|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2581187|NCT01658033|Growth Substances|growth substances|mesh-ancestor
2581188|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581189|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
2581190|NCT01658033|Antidotes|antidotes|mesh-ancestor
2581191|NCT01658033|Protective Agents|protective agents|mesh-ancestor
2581192|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
2581193|NCT01658033|Vitamins|vitamins|mesh-ancestor
2581194|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
2581195|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
2581196|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2581197|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2581198|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581199|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
2581200|NCT01658124|Coagulants|coagulants|mesh-ancestor
2581201|NCT01658176|Exemestane|exemestane|mesh-list
2581202|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581203|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2581204|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2581205|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581206|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581207|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2581208|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
2581209|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581210|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137191|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
2137192|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
2137193|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
2137194|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137195|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
2137196|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
2137197|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2137198|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2137199|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
2581211|NCT01658202|Nicotine|nicotine|mesh-list
2581212|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2581213|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
2581214|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581215|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581216|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2137200|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
2581217|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2137201|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137202|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137203|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2581218|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
2581219|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137204|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
2137205|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
2137206|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2137207|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2137208|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
2137209|NCT03221764|Amiodarone|amiodarone|mesh-list
2137210|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2137211|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
2137212|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2137213|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2137214|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581220|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581221|NCT01658215|Nicotine|nicotine|mesh-list
2581222|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2581223|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
2581224|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581225|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581226|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2137215|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2137216|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2137217|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2137218|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137219|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2137220|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2137221|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2137222|NCT03222349|Diazepam|diazepam|mesh-list
2137223|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2137224|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
2137225|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
2137226|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
2137227|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137228|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137229|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2137230|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2137231|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2137232|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2137233|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2581227|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2581228|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
2581229|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581230|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581231|NCT01658241|Panobinostat|panobinostat|mesh-list
2581232|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581233|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2581234|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581235|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581236|NCT01658319|Fludarabine|fludarabine|mesh-list
2581237|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
2581238|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581239|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2137234|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2137235|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2137236|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2581240|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
2581241|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581242|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2581243|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
2581244|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581245|NCT01658358|Doxorubicin|doxorubicin|mesh-list
2581246|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2581247|NCT01658358|Lapatinib|lapatinib|mesh-list
2581248|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2581249|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581250|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2581251|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2581252|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581253|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581254|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2137237|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2581255|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
2581256|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2581257|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2581258|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581259|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
2581260|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2137238|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
2137239|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
2137240|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
2137241|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
2137242|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137243|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137244|NCT03223272|Reserpine|reserpine|mesh-list
2137245|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2137246|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2137247|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2137248|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2137249|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137250|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2137251|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2137252|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2137253|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2137254|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581261|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
2581262|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581263|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
2581264|NCT01658449|Protective Agents|protective agents|mesh-ancestor
2581265|NCT01658462|Docetaxel|docetaxel|mesh-list
2581266|NCT01658462|Nintedanib|nintedanib|mesh-list
2581267|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581268|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
2137255|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
2137256|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137257|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
2581269|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
2581270|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
2581271|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581272|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2581273|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581274|NCT01658501|Metformin|metformin|mesh-list
2581275|NCT01658501|Liraglutide|liraglutide|mesh-list
2581276|NCT01658501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2581277|NCT01658501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581278|NCT01658501|Incretins|incretins|mesh-ancestor
2581279|NCT01658501|Hormones|hormones|mesh-ancestor
2581280|NCT01658501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581281|NCT01658527|Bicalutamide|bicalutamide|mesh-list
2581282|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
2581283|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
2581284|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581285|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581286|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581287|NCT01658553|Trametinib|trametinib|mesh-list
2581288|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581289|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2581290|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581291|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581292|NCT01658774|Ascorbic Acid|ascorbic acid|mesh-list
2581293|NCT01658774|Albendazole|albendazole|mesh-list
2581294|NCT01658774|Vitamins|vitamins|mesh-ancestor
2581295|NCT01658774|Micronutrients|micronutrients|mesh-ancestor
2581296|NCT01658774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581297|NCT01658774|Antioxidants|antioxidants|mesh-ancestor
2581298|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581299|NCT01658774|Protective Agents|protective agents|mesh-ancestor
2137258|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2137259|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
2137260|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137261|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
2137262|NCT03223909|Protective Agents|protective agents|mesh-ancestor
2137263|NCT03224182|Apaziquone|apaziquone|mesh-list
2137264|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137265|NCT03224351|Ivacaftor|ivacaftor|mesh-list
2137266|NCT03224351|VX-659|vx-659|mesh-list
2137267|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2581300|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
2581301|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2137268|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2137269|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137270|NCT03224403|Acetaminophen|acetaminophen|mesh-list
2137271|NCT03224403|Ibuprofen|ibuprofen|mesh-list
2137272|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2137273|NCT03224403|Analgesics|analgesics|mesh-ancestor
2137274|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
2137275|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137276|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137277|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
2137278|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2137279|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2137280|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2137281|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2137282|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137283|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137284|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2137285|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2137286|NCT03225313|Bupivacaine|bupivacaine|mesh-list
2137287|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2137288|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
2137289|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
2137290|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2137291|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137292|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
2137293|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137294|NCT03226223|Methamphetamine|methamphetamine|mesh-list
2137295|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2137296|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137297|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
2137298|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
2137299|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137300|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
2137301|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137302|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137303|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
2137304|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2137305|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2137306|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2137307|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2137308|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
2137309|NCT03226249|Doxorubicin|doxorubicin|mesh-list
2137310|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2137311|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
2137312|NCT03226249|Dacarbazine|dacarbazine|mesh-list
2137313|NCT03226249|Vinblastine|vinblastine|mesh-list
2137314|NCT03226249|Imidazole|imidazole|mesh-list
2137315|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2137316|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2137317|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137318|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2137319|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2137320|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137321|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137322|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2581302|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581303|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
2581304|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2581305|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2581306|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
2581307|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
2581308|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
2581309|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581310|NCT01658826|Valacyclovir|valacyclovir|mesh-list
2581311|NCT01658826|Pritelivir|pritelivir|mesh-list
2581312|NCT01658826|Antiviral Agents|antiviral agents|mesh-ancestor
2581313|NCT01658826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581314|NCT01658826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581315|NCT01658826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581316|NCT01658852|Metronidazole|metronidazole|mesh-list
2581317|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581318|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2581319|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2581320|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2581321|NCT01658878|Nivolumab|nivolumab|mesh-list
2581322|NCT01658878|Ipilimumab|ipilimumab|mesh-list
2581323|NCT01658878|Sorafenib|sorafenib|mesh-list
2581324|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2581325|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581326|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2581327|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581328|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2581329|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420055|NCT00805805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2420056|NCT00805805|Growth Substances|growth substances|mesh-ancestor
2420057|NCT00805805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420058|NCT00805805|Growth Inhibitors|growth inhibitors|mesh-ancestor
2420059|NCT00805805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420060|NCT00805857|Tipranavir|tipranavir|mesh-list
2581330|NCT01658891|Beclomethasone|beclomethasone|mesh-list
2581331|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
2581332|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2581333|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
2137323|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2137324|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
2137325|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2137326|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2137327|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
2137328|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
2137329|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
2137330|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
2137331|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
2137332|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137333|NCT03226275|Amlodipine|amlodipine|mesh-list
2137334|NCT03226275|Bisoprolol|bisoprolol|mesh-list
2137335|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2137336|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2137337|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2137338|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137339|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2137340|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137341|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
2137342|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
2137343|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
2137344|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137345|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2137346|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2137347|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2137348|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
2137349|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137350|NCT03226457|Empagliflozin|empagliflozin|mesh-list
2137351|NCT03226457|Furosemide|furosemide|mesh-list
2137352|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2137353|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137354|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2137355|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137356|NCT03226457|Diuretics|diuretics|mesh-ancestor
2137357|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
2137358|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2420061|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2420062|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2420063|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
2420064|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420065|NCT00806169|Triamcinolone|triamcinolone|mesh-list
2420066|NCT00806169|Bevacizumab|bevacizumab|mesh-list
2420067|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2420068|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420069|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2420070|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2420071|NCT00806169|Growth Substances|growth substances|mesh-ancestor
2420072|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420073|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
2420074|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2420075|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
2420076|NCT00806169|Hormones|hormones|mesh-ancestor
2420077|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2420078|NCT00806247|Tapentadol|tapentadol|mesh-list
2420079|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2420080|NCT00806247|Narcotics|narcotics|mesh-ancestor
2420081|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2581334|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581335|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581336|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2581337|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
2581338|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2581339|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2581340|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2581341|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
2581342|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581343|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581344|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2581345|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
2581346|NCT01658891|Hormones|hormones|mesh-ancestor
2137359|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2137360|NCT03226691|Plerixafor|plerixafor|mesh-list
2137361|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2137362|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2137363|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
2137364|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137365|NCT03226899|Colchicine|colchicine|mesh-list
2581347|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581348|NCT01659008|Estradiol|estradiol|mesh-list
2581349|NCT01659008|Estrogens|estrogens|mesh-ancestor
2581350|NCT01659008|Hormones|hormones|mesh-ancestor
2581351|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581352|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581353|NCT01659047|Idelalisib|idelalisib|mesh-list
2581354|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581355|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581356|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581357|NCT01659086|Vaccines|vaccines|mesh-list
2581358|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
2581359|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581360|NCT01659099|Prednisone|prednisone|mesh-list
2581361|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
2137366|NCT03226899|Allopurinol|allopurinol|mesh-list
2137367|NCT03226899|Febuxostat|febuxostat|mesh-list
2137368|NCT03226899|Lesinurad|lesinurad|mesh-list
2137369|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
2137370|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2137371|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
2137372|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
2137373|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
2137374|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137375|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137376|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
2581362|NCT01659099|Rituximab|rituximab|mesh-list
2581363|NCT01659099|Doxorubicin|doxorubicin|mesh-list
2137377|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137378|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2137379|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
2137380|NCT03226899|Protective Agents|protective agents|mesh-ancestor
2137381|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137382|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
2137383|NCT03226899|Renal Agents|renal agents|mesh-ancestor
2137384|NCT03228017|Aspirin|aspirin|mesh-list
2137385|NCT03228017|Atorvastatin|atorvastatin|mesh-list
2137386|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2137387|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2137388|NCT03228017|Analgesics|analgesics|mesh-ancestor
2137389|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
2137390|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137391|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137392|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2137393|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2137394|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2137395|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2137396|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137397|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2137398|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2137399|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581364|NCT01659099|Vincristine|vincristine|mesh-list
2581365|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
2581366|NCT01659099|Bleomycin|bleomycin|mesh-list
2137400|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
2137401|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2137402|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2581367|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2581368|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
2581369|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581370|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2581371|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2581372|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
2581373|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581374|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581375|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2581376|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2581377|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2581378|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2581379|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2581380|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581381|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2581382|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
2581383|NCT01659099|Hormones|hormones|mesh-ancestor
2581384|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581385|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2581386|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2581387|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
2581388|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
2581389|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
2581390|NCT01659151|Aldesleukin|aldesleukin|mesh-list
2581391|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
2581392|NCT01659151|Fludarabine|fludarabine|mesh-list
2581393|NCT01659151|Interleukin-2|interleukin-2|mesh-list
2581394|NCT01659151|Vemurafenib|vemurafenib|mesh-list
2581395|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2581396|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2581397|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
2581398|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581399|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2581400|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2581401|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
2581402|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581403|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581404|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2581405|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2581406|NCT01659151|Analgesics|analgesics|mesh-ancestor
2581407|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
2581408|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581409|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2581410|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2581411|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
2581412|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581413|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2581414|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
2581415|NCT01659190|Antacids|antacids|mesh-ancestor
2137403|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
2137404|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2137405|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2137410|NCT03228914|Phenylephrine|phenylephrine|mesh-list
2137411|NCT03228914|Epinephrine|epinephrine|mesh-list
2137412|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
2137413|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2137414|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2137415|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
2137416|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137417|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137418|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137419|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2137420|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2137421|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
2581416|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581417|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581418|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
2581419|NCT01659242|Methotrexate|methotrexate|mesh-list
2581420|NCT01659242|Leflunomide|leflunomide|mesh-list
2581421|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2581422|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
2581423|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2137422|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137423|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2137424|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
2137425|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
2137426|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
2137427|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2137428|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
2137429|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2137430|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2137431|NCT03228914|Protective Agents|protective agents|mesh-ancestor
2137432|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
2137433|NCT03229486|Neostigmine|neostigmine|mesh-list
2137434|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2137435|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137436|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137437|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
2137438|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137439|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137440|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2137441|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
2137442|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137443|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2137444|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2137445|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2137446|NCT03229759|Octenidine|octenidine|mesh-list
2137447|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137448|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2137449|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2137450|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137451|NCT03230864|Olanzapine|olanzapine|mesh-list
2137452|NCT03230864|Risperidone|risperidone|mesh-list
2137453|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2137454|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
2137455|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137456|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137457|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137458|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2137459|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2137460|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2137461|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2137462|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2581424|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581425|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2581426|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
2581427|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581428|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581429|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
2581430|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581431|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2581432|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2581433|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
2581434|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2581435|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2137463|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
2137464|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
2137465|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
2137466|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137467|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2137468|NCT03230864|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2137469|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2137470|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2137471|NCT03231228|Cefazolin|cefazolin|mesh-list
2137472|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2137473|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581436|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581437|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2581438|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2581439|NCT01659242|Analgesics|analgesics|mesh-ancestor
2581440|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
2581441|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581442|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2581443|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581444|NCT01659281|Artesunate|artesunate|mesh-list
2581445|NCT01659281|Mefloquine|mefloquine|mesh-list
2581446|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
2137474|NCT03231371|Adenosine|adenosine|mesh-list
2137475|NCT03231371|Analgesics|analgesics|mesh-ancestor
2581447|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2581448|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2581449|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581450|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581451|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
2581452|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
2581453|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2581454|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
2581455|NCT01659307|Aspirin|aspirin|mesh-list
2581456|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2581457|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2581458|NCT01659307|Analgesics|analgesics|mesh-ancestor
2581459|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
2581460|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581461|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581462|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2581463|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2581464|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2581465|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2581466|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581467|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2581468|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2581469|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581470|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
2581471|NCT01659346|Carvedilol|carvedilol|mesh-list
2581472|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2581473|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2581474|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
2581475|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581476|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581477|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581478|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2581479|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
2581480|NCT01659346|Protective Agents|protective agents|mesh-ancestor
2581481|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2581482|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2581483|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2581484|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
2581485|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2581486|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2581487|NCT01659359|Lidocaine|lidocaine|mesh-list
2581488|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
2581489|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
2581490|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2581491|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581492|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
2581493|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581494|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2581495|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2581496|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2581497|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2581498|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581499|NCT01659372|Naproxen|naproxen|mesh-list
2581500|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2581501|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2581502|NCT01659372|Analgesics|analgesics|mesh-ancestor
2581503|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
2581504|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581505|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581506|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2581507|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2581508|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
2581509|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2581510|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581511|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581512|NCT01659437|Clarithromycin|clarithromycin|mesh-list
2581513|NCT01659437|Streptomycin|streptomycin|mesh-list
2581514|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2581515|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581516|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2581517|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581518|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581519|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2581520|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2581521|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
2581522|NCT01659476|Miotics|miotics|mesh-ancestor
2581523|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
2581524|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581525|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581526|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2581527|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2581528|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
2581529|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2581530|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2581531|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
2581532|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581533|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581534|NCT01659515|Arbekacin|arbekacin|mesh-list
2137476|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
2137477|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137478|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137479|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2137480|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
2137481|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2137482|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
2137483|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
2137484|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137485|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137486|NCT03231709|Alogliptin|alogliptin|mesh-list
2137487|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2137488|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137489|NCT03231709|Incretins|incretins|mesh-ancestor
2137490|NCT03231709|Hormones|hormones|mesh-ancestor
2137491|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2137492|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2137493|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
2137494|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137495|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137496|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2137497|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
2581535|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581557|NCT01659619|Erythromycin|erythromycin|mesh-list
2581558|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
2581559|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2581560|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
2581561|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2581562|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581563|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581564|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2581565|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581566|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581567|NCT01659658|Thalidomide|thalidomide|mesh-list
2581568|NCT01659658|Dexamethasone|dexamethasone|mesh-list
2581569|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
2581570|NCT01659658|Melphalan|melphalan|mesh-list
2581571|NCT01659658|Lenalidomide|lenalidomide|mesh-list
2581572|NCT01659658|Ixazomib|ixazomib|mesh-list
2581573|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2581574|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
2581575|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581576|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2581577|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2581578|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
2581579|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581580|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581581|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2581582|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2581583|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
2581584|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
2581585|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581586|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581587|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
2581588|NCT01659658|Hormones|hormones|mesh-ancestor
2581589|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581590|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2581591|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2581592|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2581593|NCT01659658|Growth Substances|growth substances|mesh-ancestor
2137498|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2137499|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
2137500|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2137501|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137502|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2137503|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2137504|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137505|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
2137506|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2137507|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2137508|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
2137509|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
2137510|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137511|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137512|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2137513|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
2137514|NCT03232749|Hormones|hormones|mesh-ancestor
2137515|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2137516|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2137517|NCT03232749|Protective Agents|protective agents|mesh-ancestor
2137518|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
2137519|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2137520|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137521|NCT03233217|Vaccines|vaccines|mesh-list
2137522|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
2137523|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137524|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2137525|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2137526|NCT03233438|Dalbavancin|dalbavancin|mesh-list
2137527|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2581594|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
2581595|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
2581596|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2581597|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581598|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
2581599|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581600|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
2581601|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2581602|NCT01659684|Antibodies|antibodies|mesh-list
2581603|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
2581604|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2581605|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
2581606|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581607|NCT01659775|Ondansetron|ondansetron|mesh-list
2581608|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
2581609|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
2581610|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581611|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581612|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581613|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
2581614|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
2581615|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2581616|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
2581617|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581618|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581619|NCT01659775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2581620|NCT01659775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2581621|NCT01659775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2581622|NCT01659775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2581623|NCT01659775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2581624|NCT01659788|Ubiquinone|ubiquinone|mesh-list
2581625|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
2581626|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
2581627|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581628|NCT01659788|Vitamins|vitamins|mesh-ancestor
2581629|NCT01659827|Bupivacaine|bupivacaine|mesh-list
2581630|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
2137528|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137529|NCT03233737|Anesthetics|anesthetics|mesh-list
2137530|NCT03233737|Tetracaine|tetracaine|mesh-list
2137531|NCT03233737|Benzocaine|benzocaine|mesh-list
2137532|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2137533|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137534|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
2137535|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
2137536|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137537|NCT03234036|Ritonavir|ritonavir|mesh-list
2137538|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
2137539|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2137540|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2137541|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
2137542|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137543|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137544|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2137545|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2581631|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
2581632|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2581633|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581634|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
2137546|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
2137547|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137548|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2137549|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2137550|NCT03234374|Bupivacaine|bupivacaine|mesh-list
2137551|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
2137552|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
2137553|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2137554|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137555|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
2137556|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137557|NCT03235050|Liraglutide|liraglutide|mesh-list
2137558|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2137559|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137560|NCT03235050|Incretins|incretins|mesh-ancestor
2137561|NCT03235050|Hormones|hormones|mesh-ancestor
2137562|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2137563|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
2137564|NCT03235154|Velpatasvir|velpatasvir|mesh-list
2137565|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
2137566|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137567|NCT03236168|Ivermectin|ivermectin|mesh-list
2137568|NCT03236168|Permethrin|permethrin|mesh-list
2137569|NCT03236168|Malathion|malathion|mesh-list
2581635|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581636|NCT01659892|Montelukast|montelukast|mesh-list
2581637|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2581638|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
2581639|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2137570|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2137571|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581640|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
2581641|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581642|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581643|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2581644|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2581645|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581646|NCT01659905|Montelukast|montelukast|mesh-list
2581647|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2581648|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
2581649|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2137572|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137573|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581650|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
2581651|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581652|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581653|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2581654|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2581655|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581656|NCT01659918|Montelukast|montelukast|mesh-list
2581657|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2581658|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
2581659|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2581660|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
2581661|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581662|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581663|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2581664|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2581665|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581666|NCT01659931|Montelukast|montelukast|mesh-list
2581667|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2581668|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
2581669|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2581670|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
2581671|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581672|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581673|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2581674|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2581675|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581676|NCT01659944|Metoprolol|metoprolol|mesh-list
2581677|NCT01659944|Eliglustat|eliglustat|mesh-list
2581678|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2581679|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2581680|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
2581681|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
2581682|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581683|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581684|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2581685|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2581686|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2581687|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
2581688|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581689|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137574|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2137575|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
2137576|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137577|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137578|NCT03236311|Adenosine|adenosine|mesh-list
2137579|NCT03236311|Regadenoson|regadenoson|mesh-list
2137580|NCT03236311|Analgesics|analgesics|mesh-ancestor
2137581|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
2581690|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581691|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2581692|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
2581693|NCT01660295|Certoparin|certoparin|mesh-list
2581694|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
2581695|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2581696|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2581697|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581698|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2137582|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137583|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137584|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2137585|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
2137586|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2137587|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
2137588|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
2137589|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581699|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
2581700|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
2581701|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581702|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581703|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2581704|NCT01660295|Analgesics|analgesics|mesh-ancestor
2581705|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
2137590|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137591|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2137592|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
2137593|NCT03236506|Grazoprevir|grazoprevir|mesh-list
2137594|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
2137595|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137596|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2137597|NCT03237065|Hematinics|hematinics|mesh-ancestor
2137598|NCT03237481|Bupivacaine|bupivacaine|mesh-list
2137599|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
2137600|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
2137601|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2137602|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137603|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
2137604|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137605|NCT03238352|Listerine|listerine|mesh-list
2137606|NCT03238352|Fluorides|fluorides|mesh-list
2137607|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
2137608|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
2137609|NCT03238352|Protective Agents|protective agents|mesh-ancestor
2137610|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137611|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2137612|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137613|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2137614|NCT03238911|Hematinics|hematinics|mesh-ancestor
2137615|NCT03238924|Oxytocin|oxytocin|mesh-list
2137616|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
2137617|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2137618|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137619|NCT03239106|Apremilast|apremilast|mesh-list
2137620|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2137621|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2137622|NCT03239106|Analgesics|analgesics|mesh-ancestor
2137623|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
2137624|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137625|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137626|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2137627|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2137628|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2137629|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2137630|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137631|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581706|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581707|NCT01660373|Tirofiban|tirofiban|mesh-list
2581708|NCT01660373|Ticagrelor|ticagrelor|mesh-list
2581709|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2581710|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2581711|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2581712|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2581713|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
2581714|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581715|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581716|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581717|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2581718|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2581719|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2581720|NCT01660386|Glimepiride|glimepiride|mesh-list
2581721|NCT01660386|Saxagliptin|saxagliptin|mesh-list
2581722|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2581723|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581724|NCT01660386|Incretins|incretins|mesh-ancestor
2581725|NCT01660386|Hormones|hormones|mesh-ancestor
2581726|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581727|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2581728|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
2581729|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581730|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137632|NCT03239483|Dapivirine|dapivirine|mesh-list
2137633|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2137634|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2137635|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
2137636|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137637|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2137638|NCT03239522|Glycine|glycine|mesh-list
2137639|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
2137640|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581731|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2581732|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2581733|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
2581734|NCT01660399|Docetaxel|docetaxel|mesh-list
2581735|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581736|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
2581737|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
2581738|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
2581739|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581740|NCT01660477|Ritonavir|ritonavir|mesh-list
2581741|NCT01660477|Lopinavir|lopinavir|mesh-list
2581742|NCT01660477|Isavuconazole|isavuconazole|mesh-list
2581743|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2581744|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2581745|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
2581746|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581747|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581748|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2581749|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2581750|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
2581751|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581752|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2581753|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2581754|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
2581755|NCT01660542|Docetaxel|docetaxel|mesh-list
2581756|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581757|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
2581758|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
2581759|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
2581760|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581761|NCT01660594|Calcium|calcium|mesh-list
2581762|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2581763|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581764|NCT01660620|Betaxolol|betaxolol|mesh-list
2581765|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2581766|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
2581767|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
2581768|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581769|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581770|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2581771|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2581772|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2581773|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
2581774|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581775|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581776|NCT01660633|Melphalan|melphalan|mesh-list
2581777|NCT01660633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2581778|NCT01660633|Alkylating Agents|alkylating agents|mesh-ancestor
2581779|NCT01660633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581780|NCT01660633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581781|NCT01660633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2581782|NCT01660633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2581783|NCT01660633|Immunologic Factors|immunologic factors|mesh-ancestor
2581784|NCT01660633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581785|NCT01660750|Dexamethasone|dexamethasone|mesh-list
2581786|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
2581787|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2581788|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
2581789|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581790|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2581791|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2581792|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
2581793|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581794|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581795|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2581796|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2581797|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
2581798|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
2581799|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581800|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581801|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
2581802|NCT01660750|Hormones|hormones|mesh-ancestor
2581803|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581804|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2581805|NCT01660854|Proguanil|proguanil|mesh-list
2137641|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137642|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137643|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2137644|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2137645|NCT03240081|Estradiol|estradiol|mesh-list
2137646|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2137647|NCT03240081|Estrogens|estrogens|mesh-ancestor
2137648|NCT03240081|Hormones|hormones|mesh-ancestor
2137649|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2137650|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137651|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2137652|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
2137653|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2137654|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2137655|NCT03240133|Berotralstat|berotralstat|mesh-list
2137656|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137657|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137658|NCT03240575|Fluticasone|fluticasone|mesh-list
2137659|NCT03240575|Xhance|xhance|mesh-list
2137660|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
2581806|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2581807|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
2581808|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2581809|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2581810|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581811|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
2420082|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420083|NCT00806247|Analgesics|analgesics|mesh-ancestor
2420084|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
2420085|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420086|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2137661|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2137662|NCT03240575|Olodaterol|olodaterol|mesh-list
2137663|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2137664|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2137665|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
2137666|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137667|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137668|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2137669|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
2137670|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
2137671|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2137672|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
2137673|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2137674|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
2137675|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137676|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137677|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2137678|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2137679|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2137680|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
2137681|NCT03241030|Acetaminophen|acetaminophen|mesh-list
2137682|NCT03241030|Ibuprofen|ibuprofen|mesh-list
2137683|NCT03241030|Sucralfate|sucralfate|mesh-list
2137684|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2137685|NCT03241030|Analgesics|analgesics|mesh-ancestor
2137686|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
2137687|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137688|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137689|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
2137690|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2137691|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2420087|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2420088|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2420089|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420090|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
2420091|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420092|NCT00806299|Loperamide|loperamide|mesh-list
2420093|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
2420094|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2420095|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2420096|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
2420097|NCT00806468|Coagulants|coagulants|mesh-ancestor
2420098|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2420099|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
2581812|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581813|NCT01660867|Dexamethasone|dexamethasone|mesh-list
2581814|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2581815|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
2581816|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
2581817|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581818|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581819|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581820|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
2581821|NCT01660867|Hormones|hormones|mesh-ancestor
2581822|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581823|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2137692|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2137693|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2137694|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137695|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137696|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2137697|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2137698|NCT03241485|Morphine|morphine|mesh-list
2137699|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2137700|NCT03241485|Narcotics|narcotics|mesh-ancestor
2137701|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2137702|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137703|NCT03241485|Analgesics|analgesics|mesh-ancestor
2581824|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581825|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2581826|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2581827|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2581828|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
2581829|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137704|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
2137705|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137706|NCT03241810|Fulvestrant|fulvestrant|mesh-list
2137707|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2137708|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137709|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2137710|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2137711|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
2137712|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581830|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2581831|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2581832|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137713|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137714|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
2137715|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2137716|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137717|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2137718|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2137719|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137720|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2137721|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137722|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2137723|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2137724|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137725|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2137726|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137727|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
2137728|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2137729|NCT03242408|Testosterone|testosterone|mesh-list
2137730|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
2137731|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
2137732|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2137733|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137734|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
2137735|NCT03242408|Hormones|hormones|mesh-ancestor
2581833|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2581834|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2581835|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2581836|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
2581837|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581838|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2137736|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2137737|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137738|NCT03242408|Androgens|androgens|mesh-ancestor
2137739|NCT03242434|Mannitol|mannitol|mesh-list
2137740|NCT03242434|Lactulose|lactulose|mesh-list
2137741|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2137742|NCT03242434|Diuretics|diuretics|mesh-ancestor
2137743|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
2137744|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137745|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2137746|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
2137747|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2137748|NCT03242590|Testosterone|testosterone|mesh-list
2137749|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
2137750|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
2137751|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2581853|NCT01660997|Dexamethasone|dexamethasone|mesh-list
2581854|NCT01660997|Ixazomib|ixazomib|mesh-list
2581855|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2581856|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
2581857|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
2581858|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581859|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581860|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581861|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
2581862|NCT01660997|Hormones|hormones|mesh-ancestor
2581863|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581864|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2581865|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581866|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
2581867|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581868|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581869|NCT01661101|Omeprazole|omeprazole|mesh-list
2581870|NCT01661101|Dabigatran|dabigatran|mesh-list
2581871|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2581872|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581873|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2581874|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581875|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581876|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
2581877|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2581878|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
2581879|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
2581880|NCT01661166|Fesoterodine|fesoterodine|mesh-list
2581881|NCT01661166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2581882|NCT01661166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2581883|NCT01661166|Cholinergic Agents|cholinergic agents|mesh-ancestor
2581884|NCT01661166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581885|NCT01661166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581886|NCT01661166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581887|NCT01661166|Urological Agents|urological agents|mesh-ancestor
2581888|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2581889|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
2581890|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2581891|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2581892|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
2581893|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581894|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581895|NCT01661257|Infliximab|infliximab|mesh-list
2581896|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
2581897|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581898|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2581899|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
2581900|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2581901|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2581902|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581903|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
2581904|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2581905|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
2581906|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
2581907|NCT01661309|Vitamins|vitamins|mesh-ancestor
2581908|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
2581909|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581910|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
2581911|NCT01661322|Aspirin|aspirin|mesh-list
2581912|NCT01661322|Clopidogrel|clopidogrel|mesh-list
2581913|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2581914|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2581915|NCT01661322|Analgesics|analgesics|mesh-ancestor
2581916|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
2581917|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581918|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581919|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2581920|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2581921|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2581922|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2581923|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581924|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2581925|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2581926|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581927|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
2581928|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2581929|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2581930|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2581931|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
2581932|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581933|NCT01661335|Dexamethasone|dexamethasone|mesh-list
2581934|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
2581935|NCT01661335|Ondansetron|ondansetron|mesh-list
2581936|NCT01661335|Aprepitant|aprepitant|mesh-list
2581937|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
2581938|NCT01661335|BB 1101|bb 1101|mesh-list
2581939|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2581940|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
2581941|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
2581942|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2581943|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581944|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2581945|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
2581946|NCT01661335|Hormones|hormones|mesh-ancestor
2581947|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2581948|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2581949|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2581950|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
2581951|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2581952|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581953|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
2581954|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
2581955|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2581956|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
2581957|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2581958|NCT01661335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2581959|NCT01661335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2581960|NCT01661335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2581961|NCT01661335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2581962|NCT01661335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2581963|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2581964|NCT01661400|Thalidomide|thalidomide|mesh-list
2581965|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
2581966|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2581967|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
2581968|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581969|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2581970|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2581971|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
2581972|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581973|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137752|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137753|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
2137754|NCT03242590|Hormones|hormones|mesh-ancestor
2137755|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2137756|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137757|NCT03242590|Androgens|androgens|mesh-ancestor
2137758|NCT03242759|Pirfenidone|pirfenidone|mesh-list
2137759|NCT03242759|Nintedanib|nintedanib|mesh-list
2137760|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137761|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2137762|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137763|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137764|NCT03242759|Analgesics|analgesics|mesh-ancestor
2137765|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
2137766|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137767|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137768|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2137769|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2137770|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2137771|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2581974|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2581975|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
2581976|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2581977|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2581978|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2581979|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2581980|NCT01661400|Growth Substances|growth substances|mesh-ancestor
2581981|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
2581982|NCT01661439|Heparin|heparin|mesh-list
2581983|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2581984|NCT01661439|Tinzaparin|tinzaparin|mesh-list
2581985|NCT01661439|Dalteparin|dalteparin|mesh-list
2581986|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
2581987|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2581988|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2581989|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581990|NCT01661530|Vitamin E|vitamin e|mesh-list
2581991|NCT01661530|Vitamins|vitamins|mesh-ancestor
2581992|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
2581993|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2581994|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
2581995|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2581996|NCT01661530|Protective Agents|protective agents|mesh-ancestor
2581997|NCT01661556|Miconazole|miconazole|mesh-list
2581998|NCT01661556|Hydroquinone|hydroquinone|mesh-list
2581999|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
2582000|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582001|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2582002|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2582003|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582004|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582005|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2582006|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
2582007|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2582008|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582009|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2582010|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2582011|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
2582012|NCT01661556|Protective Agents|protective agents|mesh-ancestor
2582013|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2582014|NCT01661634|Ularitide|ularitide|mesh-list
2582015|NCT01661634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2582016|NCT01661634|Autonomic Agents|autonomic agents|mesh-ancestor
2582017|NCT01661634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582018|NCT01661634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582019|NCT01661634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2582020|NCT01661634|Respiratory System Agents|respiratory system agents|mesh-ancestor
2582021|NCT01661634|Diuretics|diuretics|mesh-ancestor
2582022|NCT01661634|Natriuretic Agents|natriuretic agents|mesh-ancestor
2582023|NCT01661647|Anesthetics|anesthetics|mesh-list
2582024|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2582025|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582026|NCT01661751|Vaccines|vaccines|mesh-list
2582027|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
2582028|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137772|NCT03243630|Menthol|menthol|mesh-list
2582029|NCT01661777|Diuretics|diuretics|mesh-list
2582030|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
2582031|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2137773|NCT03243630|Nicotine|nicotine|mesh-list
2137774|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2137775|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
2137776|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137777|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137778|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2137779|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2137780|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
2137781|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137782|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137783|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
2137784|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
2137785|NCT03244618|Fluorides|fluorides|mesh-list
2137786|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
2137787|NCT03244618|Protective Agents|protective agents|mesh-ancestor
2137788|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137789|NCT03245398|Mebendazole|mebendazole|mesh-list
2137790|NCT03245398|Piperazine|piperazine|mesh-list
2137791|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
2137792|NCT03245398|DMP 777|dmp 777|mesh-list
2137793|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
2137794|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
2137795|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2137796|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137797|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
2582032|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
2582033|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582034|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
2582035|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582036|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582037|NCT01661855|Riluzole|riluzole|mesh-list
2582038|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
2582039|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2582040|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2582041|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582042|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582043|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582044|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2582045|NCT01661855|Protective Agents|protective agents|mesh-ancestor
2582046|NCT01661868|Olaparib|olaparib|mesh-list
2582047|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2582048|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582049|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582050|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582051|NCT01661985|Azithromycin|azithromycin|mesh-list
2582052|NCT01661985|Doxycycline|doxycycline|mesh-list
2582053|NCT01661985|Lymecycline|lymecycline|mesh-list
2582054|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2582055|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582056|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
2582057|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2582058|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2582059|NCT01662037|Bosentan|bosentan|mesh-list
2137798|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
2137799|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
2137800|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137801|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137802|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582060|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2582061|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2582062|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582063|NCT01662050|Cytarabine|cytarabine|mesh-list
2582064|NCT01662050|Rituximab|rituximab|mesh-list
2582065|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2582066|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2582067|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582068|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
2137803|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
2137804|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2137805|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
2137806|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582069|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582070|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2582071|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2137807|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
2137808|NCT03245463|Protective Agents|protective agents|mesh-ancestor
2582072|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
2582073|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582074|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
2582075|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582076|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2582077|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2137809|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
2137810|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2137811|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137812|NCT03245762|Oxytocin|oxytocin|mesh-list
2582078|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
2582079|NCT01662089|Zinc|zinc|mesh-list
2582080|NCT01662089|Trace Elements|trace elements|mesh-ancestor
2582081|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
2582082|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582083|NCT01662128|Capecitabine|capecitabine|mesh-list
2582084|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2582085|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
2582086|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582087|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582088|NCT01662180|Hormones|hormones|mesh-list
2582089|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2582090|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2582091|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582092|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
2582093|NCT01662193|Vitamin D|vitamin d|mesh-list
2582094|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
2137813|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
2137814|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2137815|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137816|NCT03246152|Bevacizumab|bevacizumab|mesh-list
2137817|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2137818|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137819|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2137820|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2137821|NCT03246152|Growth Substances|growth substances|mesh-ancestor
2137822|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137823|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
2137824|NCT03246724|Midazolam|midazolam|mesh-list
2137825|NCT03246724|Triazolam|triazolam|mesh-list
2137826|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2137827|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2137828|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2137829|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137830|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2137831|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2582095|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
2582096|NCT01662193|Vitamins|vitamins|mesh-list
2582097|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
2582098|NCT01662193|Calcium|calcium|mesh-list
2582099|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
2582100|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582101|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2582102|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2582103|NCT01662193|Antacids|antacids|mesh-ancestor
2582104|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582105|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2582106|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
2582107|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2582108|NCT01662401|Bupivacaine|bupivacaine|mesh-list
2582109|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
2582110|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
2582111|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2582112|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582113|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
2582114|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582115|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
2582116|NCT01662466|Testosterone|testosterone|mesh-list
2582117|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
2582118|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
2582119|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2582120|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2582121|NCT01662466|Androgens|androgens|mesh-ancestor
2582122|NCT01662466|Hormones|hormones|mesh-ancestor
2137832|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2137833|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2137834|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
2137835|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
2137836|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
2137837|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
2137838|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582123|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2582124|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582125|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2582126|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582127|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
2582128|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2582129|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
2582130|NCT01662518|Dexamethasone|dexamethasone|mesh-list
2582131|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2582132|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
2582133|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
2582134|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582135|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582136|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2582137|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
2582138|NCT01662518|Hormones|hormones|mesh-ancestor
2582139|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2582140|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2582141|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582142|NCT01662622|Sevoflurane|sevoflurane|mesh-list
2582143|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2582144|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2582145|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
2582146|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
2582147|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2582148|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582149|NCT01662674|Metformin|metformin|mesh-list
2582150|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2582151|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582152|NCT01662687|Granisetron|granisetron|mesh-list
2582153|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
2582154|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
2582155|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582156|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582157|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2582158|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2582159|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
2582160|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582161|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582162|NCT01662700|Artesunate|artesunate|mesh-list
2582163|NCT01662700|Chloroquine|chloroquine|mesh-list
2582164|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
2582165|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2582166|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2582167|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582168|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582169|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
2582170|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
2582171|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2582172|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
2582173|NCT01662700|Amebicides|amebicides|mesh-ancestor
2582174|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2582175|NCT01662804|Interleukin-2|interleukin-2|mesh-list
2582176|NCT01662804|Antibodies|antibodies|mesh-list
2582177|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2582178|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
2137839|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137840|NCT03247673|Bevacizumab|bevacizumab|mesh-list
2137841|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2137842|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137843|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2137844|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2137845|NCT03247673|Growth Substances|growth substances|mesh-ancestor
2137846|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582179|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582180|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582181|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2582182|NCT01662804|Analgesics|analgesics|mesh-ancestor
2582183|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
2582184|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582185|NCT01662869|Leucovorin|leucovorin|mesh-list
2582186|NCT01662869|Folic Acid|folic acid|mesh-list
2582187|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
2582188|NCT01662869|Fluorouracil|fluorouracil|mesh-list
2582189|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
2582190|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582191|NCT01662869|Antidotes|antidotes|mesh-ancestor
2582192|NCT01662869|Protective Agents|protective agents|mesh-ancestor
2582193|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582194|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
2582195|NCT01662869|Vitamins|vitamins|mesh-ancestor
2582196|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
2582197|NCT01662869|Hematinics|hematinics|mesh-ancestor
2582198|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
2582199|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582200|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2582201|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2582202|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
2582203|NCT01662921|Insulin|insulin|mesh-list
2582204|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2582205|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
2582206|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
2582207|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
2582208|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2582209|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582210|NCT01663038|Aspirin|aspirin|mesh-list
2582211|NCT01663038|Clopidogrel|clopidogrel|mesh-list
2582212|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2582213|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2582214|NCT01663038|Analgesics|analgesics|mesh-ancestor
2582215|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
2582216|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582217|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582218|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2582219|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2582220|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2582221|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2582222|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582223|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2582224|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2582225|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582226|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
2582227|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2582228|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2582229|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2582230|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
2582231|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582232|NCT01663077|Clozapine|clozapine|mesh-list
2582233|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2582234|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
2582235|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582236|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582237|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582238|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2582239|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2137847|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
2137848|NCT03247738|Cangrelor|cangrelor|mesh-list
2137849|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2137850|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2137851|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2137852|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2137853|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
2137854|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137855|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137856|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137857|NCT03247790|Lasmiditan|lasmiditan|mesh-list
2137858|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2137859|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
2137860|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137861|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137862|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137863|NCT03248947|Buprenorphine|buprenorphine|mesh-list
2582240|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2582241|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2582242|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
2582243|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
2582244|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2582245|NCT01663090|Hematinics|hematinics|mesh-ancestor
2582246|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2582247|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2582248|NCT01663168|Rifabutin|rifabutin|mesh-list
2582249|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2582250|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582251|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2582252|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
2582253|NCT01663441|Oprelvekin|oprelvekin|mesh-list
2582254|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582255|NCT01663558|Imiquimod|imiquimod|mesh-list
2582256|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2582257|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
2582258|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582259|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582260|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
2582261|NCT01663662|Tolvaptan|tolvaptan|mesh-list
2582262|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2582263|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137864|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2137865|NCT03248947|Naloxone|naloxone|mesh-list
2137866|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2137867|NCT03248947|Narcotics|narcotics|mesh-ancestor
2137868|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2137869|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137870|NCT03248947|Analgesics|analgesics|mesh-ancestor
2137871|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
2137872|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137873|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2137874|NCT03249272|Adenosine|adenosine|mesh-list
2137875|NCT03249272|Regadenoson|regadenoson|mesh-list
2137876|NCT03249272|Analgesics|analgesics|mesh-ancestor
2137877|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
2137878|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137879|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137880|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2137881|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
2137882|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2137883|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
2582264|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
2582265|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582266|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2582267|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2582268|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582269|NCT01663805|Everolimus|everolimus|mesh-list
2582270|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582271|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2582272|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
2137884|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
2137885|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137886|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137887|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2137888|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2137889|NCT03249909|Laxatives|laxatives|mesh-ancestor
2137890|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2582273|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582274|NCT01663961|Digoxin|digoxin|mesh-list
2582275|NCT01663961|Mirabegron|mirabegron|mesh-list
2582276|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2582277|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2582278|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582279|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582280|NCT01663961|Protective Agents|protective agents|mesh-ancestor
2582281|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582282|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2582283|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2582284|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2137891|NCT03249935|Azithromycin|azithromycin|mesh-list
2137892|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2137893|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137894|NCT03250182|Budesonide|budesonide|mesh-list
2137895|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
2137896|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
2137897|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2137898|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2137899|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
2582285|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
2137900|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137901|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137902|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2137903|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
2137904|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
2137905|NCT03250182|Hormones|hormones|mesh-ancestor
2137906|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2137907|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2137908|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2137909|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2137910|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
2137911|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137912|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137913|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2137914|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2137915|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2137916|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
2137917|NCT03251482|Apixaban|apixaban|mesh-list
2137918|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2137919|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
2137920|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2137921|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
2137922|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137923|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582286|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582287|NCT01663961|Urological Agents|urological agents|mesh-ancestor
2582288|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
2582289|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2582290|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2582291|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2582292|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2582293|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582294|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
2582295|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582296|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582297|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2582298|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582299|NCT01664065|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2582300|NCT01664065|Cephalosporins|cephalosporins|mesh-list
2582301|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2582302|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582303|NCT01664182|Bevacizumab|bevacizumab|mesh-list
2582304|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2582305|NCT01664182|Sunitinib|sunitinib|mesh-list
2582306|NCT01664182|Trebananib|trebananib|mesh-list
2582307|NCT01664182|Sorafenib|sorafenib|mesh-list
2582308|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
2582309|NCT01664182|Antibodies|antibodies|mesh-list
2582310|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
2582311|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2582312|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
2582313|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582314|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2582315|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2582316|NCT01664182|Growth Substances|growth substances|mesh-ancestor
2582317|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582318|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
2582319|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
2582320|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2582321|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582322|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582323|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
2582324|NCT01664195|Hematinics|hematinics|mesh-ancestor
2582325|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
2582326|NCT01664221|Hematinics|hematinics|mesh-ancestor
2582327|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
2582328|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2582329|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
2582330|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582331|NCT01664260|Expectorants|expectorants|mesh-ancestor
2582332|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
2582333|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2137924|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
2137925|NCT03251963|Enoxaparin|enoxaparin|mesh-list
2582334|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
2582335|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582336|NCT01664260|Protective Agents|protective agents|mesh-ancestor
2582337|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582338|NCT01664260|Antidotes|antidotes|mesh-ancestor
2137926|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
2137927|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
2137928|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2137929|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2137930|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137931|NCT03252015|Lasmiditan|lasmiditan|mesh-list
2137932|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2582339|NCT01664507|Epinephrine|epinephrine|mesh-list
2582340|NCT01664507|Racepinephrine|racepinephrine|mesh-list
2582341|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
2582342|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2582343|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2582344|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
2582345|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137933|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
2137934|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2137935|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137936|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137937|NCT03252353|Octreotide|octreotide|mesh-list
2137938|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2137939|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2137940|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137941|NCT03253094|Fluconazole|fluconazole|mesh-list
2137942|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
2137943|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
2137944|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2137945|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2137946|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2137947|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137948|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137949|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2137950|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
2582346|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582347|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582348|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2582349|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2582350|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
2582351|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582352|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2582353|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
2582354|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
2582355|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
2582356|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2582357|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
2582358|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2582359|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2582360|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582361|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2582362|NCT01664520|Analgesics|analgesics|mesh-ancestor
2582363|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
2582364|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582365|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2582366|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2582367|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2582368|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
2582369|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582370|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582371|NCT01664650|Genistein|genistein|mesh-list
2582372|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2582373|NCT01664650|Protective Agents|protective agents|mesh-ancestor
2582374|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582375|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582376|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2582377|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582378|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137951|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2137952|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137953|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2137954|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2137955|NCT03254108|Tolvaptan|tolvaptan|mesh-list
2137956|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2137957|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137958|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
2137959|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137960|NCT03254134|Warfarin|warfarin|mesh-list
2137961|NCT03254134|Dabigatran|dabigatran|mesh-list
2137962|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
2137963|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
2137964|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2137965|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
2137966|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137967|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137968|NCT03254147|Warfarin|warfarin|mesh-list
2137969|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
2137970|NCT03254147|Dabigatran|dabigatran|mesh-list
2137971|NCT03254147|Apixaban|apixaban|mesh-list
2582379|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
2582380|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2582381|NCT01664650|Estrogens|estrogens|mesh-ancestor
2582382|NCT01664650|Hormones|hormones|mesh-ancestor
2582383|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2582384|NCT01664676|Liraglutide|liraglutide|mesh-list
2582385|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2582386|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582387|NCT01664676|Incretins|incretins|mesh-ancestor
2582388|NCT01664676|Hormones|hormones|mesh-ancestor
2582389|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2582390|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
2582391|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
2582392|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582393|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2582394|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582395|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582396|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
2582397|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2582398|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582399|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2582400|NCT01664728|Hormones|hormones|mesh-ancestor
2582401|NCT01664754|Carboplatin|carboplatin|mesh-list
2582402|NCT01664754|Pemetrexed|pemetrexed|mesh-list
2582403|NCT01664754|Exemestane|exemestane|mesh-list
2582404|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582405|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582406|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582407|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2582408|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2582409|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2582410|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2582411|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2582412|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
2582413|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2582414|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582415|NCT01664819|Antioxidants|antioxidants|mesh-list
2582416|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582417|NCT01664819|Protective Agents|protective agents|mesh-ancestor
2582418|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582419|NCT01664845|Metformin|metformin|mesh-list
2582420|NCT01664845|Ribavirin|ribavirin|mesh-list
2582421|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2582422|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582423|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
2137972|NCT03254147|Edoxaban|edoxaban|mesh-list
2137973|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
2137974|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2137975|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
2137976|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2137977|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
2137978|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2137979|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2137980|NCT03254459|Morphine|morphine|mesh-list
2137981|NCT03254459|Oxycodone|oxycodone|mesh-list
2137982|NCT03254459|Buprenorphine|buprenorphine|mesh-list
2137983|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2137984|NCT03254459|Narcotics|narcotics|mesh-ancestor
2137985|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2137986|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137987|NCT03254459|Analgesics|analgesics|mesh-ancestor
2582424|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582425|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
2582426|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582427|NCT01664871|Fluorides|fluorides|mesh-list
2582428|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
2582429|NCT01664871|Protective Agents|protective agents|mesh-ancestor
2582430|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582431|NCT01664910|Rituximab|rituximab|mesh-list
2582432|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2582433|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2582434|NCT01664910|Methotrexate|methotrexate|mesh-list
2582435|NCT01664910|Fludarabine|fludarabine|mesh-list
2582436|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
2582437|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2582438|NCT01664910|Antibodies|antibodies|mesh-list
2582439|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
2582440|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2582441|NCT01664910|Tacrolimus|tacrolimus|mesh-list
2582442|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
2582443|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2582444|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
2582445|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582446|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2137988|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
2137989|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2137990|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2137991|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2137992|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
2137993|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2137994|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
2137995|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2137996|NCT03255824|Fentanyl|fentanyl|mesh-list
2137997|NCT03255824|Midazolam|midazolam|mesh-list
2137998|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
2137999|NCT03255824|Propofol|propofol|mesh-list
2138000|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2138001|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138002|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138003|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2138004|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
2138005|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
2138006|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2138007|NCT03255824|Analgesics|analgesics|mesh-ancestor
2138008|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
2138009|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138010|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2138011|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2420100|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420101|NCT00806481|Sevelamer|sevelamer|mesh-list
2420102|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
2420103|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
2420104|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420105|NCT00806611|Ethanol|ethanol|mesh-list
2420106|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2420107|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420108|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2420109|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420110|NCT00806663|Sunitinib|sunitinib|mesh-list
2582447|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2582448|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2582449|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
2582450|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2582451|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2582452|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
2582453|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582454|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
2582455|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582456|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2582457|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2582458|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2582459|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2138012|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2138013|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
2138014|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138015|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138016|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2138017|NCT03255824|Narcotics|narcotics|mesh-ancestor
2582460|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2582461|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
2582462|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2582463|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2582464|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2582465|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582466|NCT01665066|Nicotine|nicotine|mesh-list
2582467|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2582468|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
2582469|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582470|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582471|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2582472|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2582473|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
2582474|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582475|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582476|NCT01665079|Propofol|propofol|mesh-list
2582477|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2582478|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2582479|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582480|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2582481|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
2582482|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
2582483|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
2582484|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2582485|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2138018|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2138019|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2138020|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2138021|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2138022|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
2138023|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
2138024|NCT03256136|Carboplatin|carboplatin|mesh-list
2138025|NCT03256136|Nivolumab|nivolumab|mesh-list
2138026|NCT03256136|Pemetrexed|pemetrexed|mesh-list
2138027|NCT03256136|Ipilimumab|ipilimumab|mesh-list
2138028|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138029|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2138030|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2138031|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138032|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138033|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2138034|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2138035|NCT03256162|Midazolam|midazolam|mesh-list
2138036|NCT03256162|Ketamine|ketamine|mesh-list
2138037|NCT03256162|Analgesics|analgesics|mesh-ancestor
2138038|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
2138039|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138040|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138041|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2138042|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2138043|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
2138044|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
2138045|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138046|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2138047|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2582486|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582487|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
2582488|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
2582489|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582490|NCT01665209|Morphine|morphine|mesh-list
2582491|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2582492|NCT01665209|Narcotics|narcotics|mesh-ancestor
2582493|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138048|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138049|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138050|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2138051|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2138052|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2138053|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2138054|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2138055|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
2138056|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
2138057|NCT03256253|Pregabalin|pregabalin|mesh-list
2138058|NCT03256253|Analgesics|analgesics|mesh-ancestor
2138059|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
2582494|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582495|NCT01665209|Analgesics|analgesics|mesh-ancestor
2582496|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
2582497|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582498|NCT01665222|Morphine|morphine|mesh-list
2582499|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2582500|NCT01665222|Narcotics|narcotics|mesh-ancestor
2582501|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2582502|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138060|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138061|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138062|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
2138063|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2138064|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2138065|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138066|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2138067|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2138068|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2138069|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138070|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2138075|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
2138076|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2138077|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2138078|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2138079|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
2138080|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138081|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138082|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138083|NCT03256695|Albuterol|albuterol|mesh-list
2138084|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2138085|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
2138086|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138087|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138088|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2138089|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
2138090|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
2138091|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2582503|NCT01665222|Analgesics|analgesics|mesh-ancestor
2582504|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
2582505|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582506|NCT01665235|Aspirin|aspirin|mesh-list
2582507|NCT01665235|Amlodipine|amlodipine|mesh-list
2582508|NCT01665235|Clopidogrel|clopidogrel|mesh-list
2582509|NCT01665235|Atorvastatin|atorvastatin|mesh-list
2582510|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2582511|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2582512|NCT01665235|Analgesics|analgesics|mesh-ancestor
2582513|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
2582514|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582515|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582516|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2582517|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2582518|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2582519|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2582520|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582521|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2582522|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2582523|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582524|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
2582525|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2582526|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2582527|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
2582528|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2582529|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2582530|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2582531|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2582532|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2582533|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
2582534|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138092|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2138093|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2582535|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2582536|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2582537|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2582538|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2582539|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
2582540|NCT01665248|Listerine|listerine|mesh-list
2582541|NCT01665248|Fluorides|fluorides|mesh-list
2582542|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
2582543|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
2582544|NCT01665248|Protective Agents|protective agents|mesh-ancestor
2582545|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582546|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2582547|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582548|NCT01665274|Capecitabine|capecitabine|mesh-list
2582549|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
2138094|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2138095|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
2138096|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138097|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138098|NCT03256799|Ivacaftor|ivacaftor|mesh-list
2138099|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2138100|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2138101|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138102|NCT03257202|Clindamycin|clindamycin|mesh-list
2138103|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
2138104|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
2138105|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2138106|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2138107|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138108|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2138109|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138110|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138111|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
2138112|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2138113|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2138114|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138115|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2138116|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
2138117|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138118|NCT03257631|Thalidomide|thalidomide|mesh-list
2138119|NCT03257631|Pomalidomide|pomalidomide|mesh-list
2138120|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
2138121|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138122|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2138123|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2138124|NCT03257631|Growth Substances|growth substances|mesh-ancestor
2138125|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
2138126|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138127|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2138128|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
2138129|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2582550|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2582551|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
2582552|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582553|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582554|NCT01665378|Folic Acid|folic acid|mesh-list
2582555|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
2582556|NCT01665378|Micronutrients|micronutrients|mesh-list
2582557|NCT01665378|Trace Elements|trace elements|mesh-list
2582558|NCT01665378|Hematinics|hematinics|mesh-ancestor
2582559|NCT01665378|Vitamins|vitamins|mesh-ancestor
2582560|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582561|NCT01665391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2582562|NCT01665391|Immunologic Factors|immunologic factors|mesh-ancestor
2582563|NCT01665391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582564|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
2582565|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2582566|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2582567|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2582568|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582569|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2582570|NCT01665404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2582571|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2582572|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2582573|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582574|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582575|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
2582576|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2138130|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138131|NCT03257813|Timolol|timolol|mesh-list
2138132|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2138133|NCT03257813|Dorzolamide|dorzolamide|mesh-list
2138134|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2138135|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2138136|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
2138137|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582577|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
2582578|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2582579|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2582580|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582581|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2582582|NCT01665417|Docetaxel|docetaxel|mesh-list
2582583|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582584|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
2582585|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
2582586|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
2582587|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138138|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138139|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138140|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2138141|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2138142|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2138143|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2138144|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2138145|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2138146|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138147|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
2138148|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
2138149|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138150|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138151|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138152|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
2138153|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
2138154|NCT03257995|Maleic acid|maleic acid|mesh-list
2138155|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582588|NCT01665469|Lycopene|lycopene|mesh-list
2582589|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2582590|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
2582591|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582592|NCT01665469|Protective Agents|protective agents|mesh-ancestor
2582593|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582594|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2582595|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2582596|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582597|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
2582598|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2582599|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2582600|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582601|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2582602|NCT01665586|Analgesics|analgesics|mesh-ancestor
2582603|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
2582604|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582605|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2582606|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2582607|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2582608|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
2582609|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582610|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582611|NCT01665638|Canagliflozin|canagliflozin|mesh-list
2582612|NCT01665638|Somatostatin|somatostatin|mesh-list
2582613|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2582614|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582615|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2582616|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582617|NCT01665638|Hormones|hormones|mesh-ancestor
2582618|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2582619|NCT01665677|Atorvastatin|atorvastatin|mesh-list
2582620|NCT01665677|Calcium|calcium|mesh-list
2138156|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138157|NCT03258645|Dabigatran|dabigatran|mesh-list
2138158|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
2138159|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2138160|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
2138161|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138162|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138163|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
2138164|NCT03258710|Tenofovir|tenofovir|mesh-list
2138165|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
2138166|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582621|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2582622|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582623|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2582624|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2582625|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
2582626|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582627|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2582628|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2582629|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582630|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2582631|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2582632|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582633|NCT01665742|Tocopherols|tocopherols|mesh-list
2582634|NCT01665742|Vitamin E|vitamin e|mesh-list
2582635|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
2582636|NCT01665742|Lycopene|lycopene|mesh-list
2582637|NCT01665742|Vitamins|vitamins|mesh-ancestor
2582638|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
2582639|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582640|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
2582641|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582642|NCT01665742|Protective Agents|protective agents|mesh-ancestor
2582643|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2582644|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2582645|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2582646|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582647|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
2582648|NCT01665781|Hematinics|hematinics|mesh-ancestor
2582668|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2582669|NCT01665846|Hematinics|hematinics|mesh-ancestor
2582670|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2582671|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2582672|NCT01666041|Fenofibrate|fenofibrate|mesh-list
2582673|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2582674|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
2582675|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582676|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2582677|NCT01666067|Simvastatin|simvastatin|mesh-list
2582678|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2582679|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2582680|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2582681|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
2582682|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582683|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2138167|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2138168|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2138169|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138170|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138171|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2138172|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2138173|NCT03258762|Leucovorin|leucovorin|mesh-list
2138174|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
2138175|NCT03258762|Calcium|calcium|mesh-list
2138176|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
2582684|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2582685|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582686|NCT01666080|Fludarabine|fludarabine|mesh-list
2582687|NCT01666080|Busulfan|busulfan|mesh-list
2420111|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420112|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2420113|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2420114|NCT00806663|Growth Substances|growth substances|mesh-ancestor
2420115|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420116|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
2420117|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2420118|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420119|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420120|NCT00806741|Phenylephrine|phenylephrine|mesh-list
2420121|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
2420122|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2582688|NCT01666080|Levetiracetam|levetiracetam|mesh-list
2582689|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582690|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582691|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2582692|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
2582693|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582694|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
2582695|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2582696|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2582697|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
2582698|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
2582699|NCT01666171|Metformin|metformin|mesh-list
2582700|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2582701|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582702|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2582703|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2582704|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2138177|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2138178|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138179|NCT03258762|Antidotes|antidotes|mesh-ancestor
2138180|NCT03258762|Protective Agents|protective agents|mesh-ancestor
2138181|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
2582705|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2582706|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
2582707|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582708|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2582709|NCT01666223|Cathartics|cathartics|mesh-ancestor
2582710|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2582711|NCT01666236|Triamcinolone|triamcinolone|mesh-list
2582712|NCT01666236|Ranibizumab|ranibizumab|mesh-list
2582713|NCT01666236|Verteporfin|verteporfin|mesh-list
2582714|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2582715|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2582716|NCT01666236|Growth Substances|growth substances|mesh-ancestor
2582717|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582718|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
2582719|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582720|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2582721|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
2582722|NCT01666236|Hormones|hormones|mesh-ancestor
2582723|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2582724|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2582725|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
2582726|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
2582727|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2582728|NCT01666249|Antibodies|antibodies|mesh-list
2582729|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
2582730|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582731|NCT01666262|Vaccines|vaccines|mesh-list
2582732|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
2138182|NCT03258762|Vitamins|vitamins|mesh-ancestor
2138183|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
2582733|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582734|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
2582735|NCT01666301|Hematinics|hematinics|mesh-ancestor
2582736|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2582737|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2582738|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582739|NCT01666379|Fentanyl|fentanyl|mesh-list
2582740|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2582741|NCT01666379|Narcotics|narcotics|mesh-ancestor
2582742|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2582743|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582744|NCT01666379|Analgesics|analgesics|mesh-ancestor
2138184|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
2138185|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2138186|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2138187|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138188|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2138189|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138190|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138191|NCT03259425|Nivolumab|nivolumab|mesh-list
2138192|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2138193|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582745|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
2582746|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582747|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2582748|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2582749|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
2582750|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
2138194|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2138195|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138196|NCT03259490|Metformin|metformin|mesh-list
2138197|NCT03259490|Empagliflozin|empagliflozin|mesh-list
2138198|NCT03259490|Linagliptin|linagliptin|mesh-list
2138199|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2138200|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138201|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2138202|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138203|NCT03259490|Incretins|incretins|mesh-ancestor
2138204|NCT03259490|Hormones|hormones|mesh-ancestor
2138205|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2582751|NCT01666418|Paclitaxel|paclitaxel|mesh-list
2582752|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2582753|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582754|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
2582755|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
2582756|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
2582757|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582758|NCT01666431|Lapatinib|lapatinib|mesh-list
2582759|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582760|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2582761|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582762|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582763|NCT01666522|Vitamin D|vitamin d|mesh-list
2582764|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
2582765|NCT01666522|Vitamins|vitamins|mesh-ancestor
2582766|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
2582767|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582768|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2582769|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2582770|NCT01666535|Vaccines|vaccines|mesh-list
2582771|NCT01666535|Immunologic Factors|immunologic factors|mesh-ancestor
2582772|NCT01666535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582773|NCT01666587|Ibuprofen|ibuprofen|mesh-list
2582774|NCT01666587|Antioxidants|antioxidants|mesh-list
2582775|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
2582776|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2582777|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2138206|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2138207|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
2138208|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138209|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
2138210|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
2138211|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2184928|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
2582778|NCT01666587|Analgesics|analgesics|mesh-ancestor
2582779|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
2582780|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582781|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582782|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2582783|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2582784|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2582785|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582786|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582787|NCT01666587|Protective Agents|protective agents|mesh-ancestor
2582788|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
2582789|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2582790|NCT01666600|Nintedanib|nintedanib|mesh-list
2582791|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582792|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2582793|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582794|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582795|NCT01666665|Metformin|metformin|mesh-list
2582796|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2582797|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582798|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
2582799|NCT01666678|Promethazine|promethazine|mesh-list
2582800|NCT01666678|Naproxen|naproxen|mesh-list
2138212|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138213|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138214|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
2138215|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
2138216|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
2138217|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2138218|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138219|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2138220|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2138221|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582801|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2582802|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2582803|NCT01666678|Analgesics|analgesics|mesh-ancestor
2582804|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
2582805|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582806|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582807|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2582808|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2582809|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
2582810|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2582811|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582812|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582813|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2582814|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2582815|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138222|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2138223|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2138224|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2138225|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138226|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
2138227|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138228|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2138229|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
2138230|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138231|NCT03260868|Insulin|insulin|mesh-list
2138232|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2138233|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
2138234|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
2138235|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
2138236|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2138237|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138238|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
2138239|NCT03260894|Sunitinib|sunitinib|mesh-list
2582816|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
2582817|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
2582818|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
2582819|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
2582820|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2582821|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2582822|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
2582823|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
2138240|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2138241|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138242|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2138243|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2138244|NCT03260894|Growth Substances|growth substances|mesh-ancestor
2138245|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138246|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
2582824|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2582825|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2582826|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
2582827|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
2582828|NCT01666691|CKD732|ckd732|mesh-list
2582829|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2582830|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2582831|NCT01666691|Growth Substances|growth substances|mesh-ancestor
2582832|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582833|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
2582834|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582835|NCT01666743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2582836|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2582837|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582838|NCT01666756|Sorafenib|sorafenib|mesh-list
2582839|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582840|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2582841|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582842|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582843|NCT01666769|Micafungin|micafungin|mesh-list
2582844|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
2582845|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582846|NCT01666925|Vaccines|vaccines|mesh-list
2582847|NCT01666925|Immunologic Factors|immunologic factors|mesh-ancestor
2582848|NCT01666925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582849|NCT01666977|Carboplatin|carboplatin|mesh-list
2582850|NCT01666977|Pemetrexed|pemetrexed|mesh-list
2582851|NCT01666977|Trebananib|trebananib|mesh-list
2582852|NCT01666977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582853|NCT01666977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582854|NCT01666977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582855|NCT01666977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2138247|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2138248|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138249|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138250|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
2138251|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2138252|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2138253|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2138254|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2138255|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582856|NCT01666977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2582857|NCT01666977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2582858|NCT01666977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2582859|NCT01666977|Growth Substances|growth substances|mesh-ancestor
2582860|NCT01666977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582861|NCT01666977|Growth Inhibitors|growth inhibitors|mesh-ancestor
2582862|NCT01667081|Grazoprevir|grazoprevir|mesh-list
2582863|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
2582864|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582865|NCT01667094|Meropenem|meropenem|mesh-list
2582866|NCT01667094|Tazobactam|tazobactam|mesh-list
2582867|NCT01667094|Piperacillin|piperacillin|mesh-list
2582868|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
2582869|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
2582870|NCT01667094|Ceftazidime|ceftazidime|mesh-list
2582871|NCT01667094|Cefepime|cefepime|mesh-list
2582872|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2582873|NCT01667094|Ticarcillin|ticarcillin|mesh-list
2582874|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
2582875|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2582876|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582877|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2582878|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582879|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582880|NCT01667120|Ketorolac|ketorolac|mesh-list
2582881|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2582882|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2582883|NCT01667120|Analgesics|analgesics|mesh-ancestor
2582884|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
2582885|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582886|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582887|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2582888|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2582889|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2582890|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582891|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582892|NCT01667133|Ponatinib|ponatinib|mesh-list
2582893|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582894|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2420123|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2420124|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
2420125|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
2420126|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420127|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420128|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
2420129|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2420130|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
2138256|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
2138257|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138258|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138259|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2138260|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138261|NCT03261336|Vitamin D|vitamin d|mesh-list
2138262|NCT03261336|Calcitriol|calcitriol|mesh-list
2138263|NCT03261336|Ketoconazole|ketoconazole|mesh-list
2138264|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
2582895|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582896|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582897|NCT01667211|Paclitaxel|paclitaxel|mesh-list
2582898|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2582899|NCT01667211|Nedaplatin|nedaplatin|mesh-list
2582900|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2582901|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582902|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
2582903|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
2582904|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
2582905|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582906|NCT01667263|Tretinoin|tretinoin|mesh-list
2582907|NCT01667263|Danazol|danazol|mesh-list
2582908|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582909|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
2582910|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
2582911|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2582912|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
2582913|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2582914|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582915|NCT01667315|Bupivacaine|bupivacaine|mesh-list
2582916|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
2582917|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
2582918|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138265|NCT03261336|Vitamins|vitamins|mesh-ancestor
2138266|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
2138267|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138268|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2138269|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2138270|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2138271|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
2138272|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138273|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2138274|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2138275|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138276|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138277|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2138278|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
2138279|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2138280|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2138281|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2138282|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2138283|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2138284|NCT03261999|Leuprolide|leuprolide|mesh-list
2138285|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2138286|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
2138287|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2138288|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138289|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2138290|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138291|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2138292|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2138293|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
2138294|NCT03262038|Ondansetron|ondansetron|mesh-list
2138295|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
2138296|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
2138297|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138298|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138299|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2138300|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
2138301|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
2138302|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2138303|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
2138304|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138305|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138306|NCT03262038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2138307|NCT03262038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2138308|NCT03262038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138309|NCT03262038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2138310|NCT03262038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2138311|NCT03262233|Nicotine|nicotine|mesh-list
2138312|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2138313|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
2138314|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138315|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138316|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2138317|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2582919|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582920|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
2582921|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582922|NCT01667445|Morphine|morphine|mesh-list
2582923|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2582924|NCT01667445|Narcotics|narcotics|mesh-ancestor
2582925|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2582926|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582927|NCT01667445|Analgesics|analgesics|mesh-ancestor
2582928|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
2582929|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582930|NCT01667484|Adderall|adderall|mesh-list
2582931|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2582932|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582933|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
2582934|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2582935|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2582936|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582937|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
2582938|NCT01667523|Capsaicin|capsaicin|mesh-list
2582939|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
2582940|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
2582941|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
2582942|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2582943|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582944|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2582945|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582946|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2582947|NCT01667523|Protective Agents|protective agents|mesh-ancestor
2582948|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2582949|NCT01667575|Amoxicillin|amoxicillin|mesh-list
2582950|NCT01667575|Clarithromycin|clarithromycin|mesh-list
2582951|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2582952|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
2582953|NCT01667575|Esomeprazole|esomeprazole|mesh-list
2582954|NCT01667575|Bismuth|bismuth|mesh-list
2582955|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2582956|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582957|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582958|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
2582959|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2582960|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2582961|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582962|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2582963|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2582964|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2582965|NCT01667575|Antacids|antacids|mesh-ancestor
2582966|NCT01667575|Diuretics|diuretics|mesh-ancestor
2582967|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
2582968|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2582969|NCT01667575|Expectorants|expectorants|mesh-ancestor
2582970|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
2582971|NCT01667614|Losartan|losartan|mesh-list
2582972|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2582973|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2582974|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2582975|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2582976|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582977|NCT01667692|Azithromycin|azithromycin|mesh-list
2582978|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2582979|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582980|NCT01667718|Amoxicillin|amoxicillin|mesh-list
2582981|NCT01667718|Levofloxacin|levofloxacin|mesh-list
2582982|NCT01667718|Ofloxacin|ofloxacin|mesh-list
2582983|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
2582984|NCT01667718|Lansoprazole|lansoprazole|mesh-list
2582985|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
2582986|NCT01667718|Bismuth|bismuth|mesh-list
2582987|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2582988|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2582989|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2582990|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2582991|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2582992|NCT01667718|Renal Agents|renal agents|mesh-ancestor
2582993|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2582994|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2582995|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2582996|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2582997|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2582998|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2582999|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2583000|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2138318|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
2138319|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138320|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138321|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2138322|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2138323|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138324|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
2138325|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2583001|NCT01667718|Antacids|antacids|mesh-ancestor
2583002|NCT01667718|Diuretics|diuretics|mesh-ancestor
2583003|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
2583004|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583005|NCT01667718|Expectorants|expectorants|mesh-ancestor
2583006|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
2583007|NCT01667744|Citalopram|citalopram|mesh-list
2583008|NCT01667744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2583009|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2583010|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2583011|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583012|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583013|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
2583014|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583015|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2583016|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
2583017|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2583018|NCT01667874|Gentamicins|gentamicins|mesh-list
2583019|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2138326|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583020|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583021|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2583022|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583023|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583024|NCT01668043|UB-421|ub-421|mesh-list
2583025|NCT01668043|Antibodies|antibodies|mesh-list
2583026|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
2583027|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583028|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2583029|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
2583030|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583031|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2583032|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2583033|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583034|NCT01668069|Ondansetron|ondansetron|mesh-list
2583035|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
2583036|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
2583037|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583038|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583039|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583040|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
2583041|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
2583042|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2583043|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
2138327|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2138328|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
2138329|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2138330|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138331|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138332|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138333|NCT03263442|Thiamine|thiamine|mesh-list
2138334|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
2138335|NCT03263442|Vitamins|vitamins|mesh-ancestor
2138336|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
2138337|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138338|NCT03264066|Atezolizumab|atezolizumab|mesh-list
2138339|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2138340|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583044|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583045|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583046|NCT01668069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2583047|NCT01668069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2583048|NCT01668069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583049|NCT01668069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2583050|NCT01668069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2583051|NCT01668121|Budesonide|budesonide|mesh-list
2583052|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
2583053|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2583054|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2583055|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2583056|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
2583057|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138341|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
2138342|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138343|NCT03264157|Vaccines|vaccines|mesh-list
2138344|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
2138345|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138346|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2138347|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2138348|NCT03266419|Rocuronium|rocuronium|mesh-list
2138349|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2138350|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2138351|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2138352|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138353|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138354|NCT03267576|Metformin|metformin|mesh-list
2138355|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2138356|NCT03267576|Canagliflozin|canagliflozin|mesh-list
2138357|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2138358|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138359|NCT03267576|Incretins|incretins|mesh-ancestor
2138360|NCT03267576|Hormones|hormones|mesh-ancestor
2138361|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2138362|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2138363|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
2138364|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138365|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138366|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2138367|NCT03267940|Atezolizumab|atezolizumab|mesh-list
2138368|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184929|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2583058|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583059|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2583060|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
2583061|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
2138377|NCT03268941|Metoclopramide|metoclopramide|mesh-list
2138378|NCT03268941|Maleic acid|maleic acid|mesh-list
2138379|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138380|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138381|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
2138382|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
2138383|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138384|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138385|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2138386|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2138387|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2138388|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
2138389|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138390|NCT03269435|Metoclopramide|metoclopramide|mesh-list
2138391|NCT03269435|Bupivacaine|bupivacaine|mesh-list
2138392|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
2138393|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
2138394|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138395|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138396|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
2138397|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138398|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
2138399|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
2138400|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2138401|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2138402|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2138403|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
2138404|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138405|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138406|NCT03269552|Rituximab|rituximab|mesh-list
2138407|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2138408|NCT03269552|Antibodies|antibodies|mesh-list
2138409|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
2138410|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2138411|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
2138412|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138413|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138414|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2138415|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2138416|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2583062|NCT01668121|Hormones|hormones|mesh-ancestor
2583063|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2583064|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2583065|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2583066|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2583067|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
2583068|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583069|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583070|NCT01668433|Primaquine|primaquine|mesh-list
2583071|NCT01668433|Methylene Blue|methylene blue|mesh-list
2583072|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
2583073|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2583074|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2583075|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583076|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583077|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583078|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
2583079|NCT01668446|Estradiol|estradiol|mesh-list
2583080|NCT01668446|Estrogens|estrogens|mesh-ancestor
2583081|NCT01668446|Hormones|hormones|mesh-ancestor
2583082|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2583083|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583084|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
2583085|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2583086|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2583087|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583088|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583089|NCT01668446|Urological Agents|urological agents|mesh-ancestor
2583090|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2583091|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583092|NCT01668498|Doxycycline|doxycycline|mesh-list
2583093|NCT01668498|Erythromycin|erythromycin|mesh-list
2138417|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2583094|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
2583095|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2583096|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
2583097|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2583098|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583099|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
2583100|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2583101|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2583102|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583103|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2583104|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583105|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583106|NCT01668550|AZD-0424|azd-0424|mesh-list
2583107|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2138418|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
2138419|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138420|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2138421|NCT03270332|Albuterol|albuterol|mesh-list
2138422|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2138423|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
2138424|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138425|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138426|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2138427|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
2138428|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
2138429|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2184930|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
2583108|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583109|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583110|NCT01668615|Tretinoin|tretinoin|mesh-list
2583111|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583112|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
2583113|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
2583114|NCT01668680|Celecoxib|celecoxib|mesh-list
2583115|NCT01668680|Capecitabine|capecitabine|mesh-list
2583116|NCT01668680|Methotrexate|methotrexate|mesh-list
2583117|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2583118|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
2583119|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583120|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583121|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2583122|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
2583123|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2583124|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583125|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
2583126|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583127|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2583128|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2583129|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
2583130|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2583131|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2583132|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2583133|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2583134|NCT01668680|Analgesics|analgesics|mesh-ancestor
2583135|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
2583136|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583137|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2583138|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2583139|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2583140|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2583141|NCT01668849|Fentanyl|fentanyl|mesh-list
2583142|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2583143|NCT01668849|Narcotics|narcotics|mesh-ancestor
2583144|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583145|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583146|NCT01668849|Analgesics|analgesics|mesh-ancestor
2583147|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
2583148|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583149|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2583150|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2583151|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
2583152|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
2583153|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2583154|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2138430|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2138431|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2138432|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2138433|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
2138434|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138435|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138436|NCT03270514|Bupivacaine|bupivacaine|mesh-list
2138437|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
2138438|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
2138439|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138440|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138441|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
2138442|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138443|NCT03270644|Propranolol|propranolol|mesh-list
2138444|NCT03270644|Lasmiditan|lasmiditan|mesh-list
2138445|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2138446|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2138447|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
2583155|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2583156|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2583157|NCT01668901|Aspirin|aspirin|mesh-list
2583158|NCT01668901|Warfarin|warfarin|mesh-list
2583159|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2583160|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2583161|NCT01668901|Analgesics|analgesics|mesh-ancestor
2583162|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
2583163|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583164|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583165|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2583166|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2583167|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2583168|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2583169|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583170|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2583171|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2583172|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583173|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
2583174|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
2583175|NCT01668927|Amoxicillin|amoxicillin|mesh-list
2583176|NCT01668927|Metronidazole|metronidazole|mesh-list
2138448|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138449|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138450|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138451|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2138452|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2138453|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
2138454|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2138455|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
2583177|NCT01668927|Tetracycline|tetracycline|mesh-list
2583178|NCT01668927|Furazolidone|furazolidone|mesh-list
2583179|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
2583180|NCT01668927|Lansoprazole|lansoprazole|mesh-list
2583181|NCT01668927|Bismuth|bismuth|mesh-list
2583182|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2583183|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583184|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2583185|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583186|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2583187|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2583188|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2583189|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583190|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583191|NCT01668927|Antacids|antacids|mesh-ancestor
2583192|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2583193|NCT01668927|Diuretics|diuretics|mesh-ancestor
2583194|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
2583195|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184931|NCT00002836|Thiotepa|thiotepa|mesh-list
2583196|NCT01668927|Expectorants|expectorants|mesh-ancestor
2583197|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
2138465|NCT03271528|Lacosamide|lacosamide|mesh-list
2138466|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
2138467|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2138468|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2138469|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2138470|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138471|NCT03272139|Bupivacaine|bupivacaine|mesh-list
2138472|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
2138473|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
2138474|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138475|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138476|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
2138477|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138478|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
2138479|NCT03273153|Atezolizumab|atezolizumab|mesh-list
2138480|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2138481|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138482|NCT03273257|Riociguat|riociguat|mesh-list
2138483|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
2138484|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138485|NCT03273387|Trimetazidine|trimetazidine|mesh-list
2138486|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
2138487|NCT03273946|Fluticasone|fluticasone|mesh-list
2138488|NCT03273946|Xhance|xhance|mesh-list
2583198|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2583199|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2583200|NCT01668927|Renal Agents|renal agents|mesh-ancestor
2583201|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2583202|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2583203|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
2583204|NCT01669044|Propofol|propofol|mesh-list
2583205|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2138489|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2138490|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2138491|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
2138492|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138493|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138494|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2138495|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
2138496|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
2138497|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2138498|NCT03274076|Tofacitinib|tofacitinib|mesh-list
2138499|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2138500|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138501|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138502|NCT03274453|Ketamine|ketamine|mesh-list
2138503|NCT03274453|Analgesics|analgesics|mesh-ancestor
2138504|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
2138505|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138506|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138507|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2138508|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2138509|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
2138510|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
2138511|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583206|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583207|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583208|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2583209|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
2583210|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
2583211|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2583212|NCT01669044|Analgesics|analgesics|mesh-ancestor
2583213|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
2583214|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583215|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2583216|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2583217|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2583218|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
2583219|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583220|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583221|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
2138512|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2138513|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2583222|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2583223|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583224|NCT01669135|Anesthetics|anesthetics|mesh-list
2583225|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583226|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583227|NCT01669213|Ondansetron|ondansetron|mesh-list
2583228|NCT01669213|Ramosetron|ramosetron|mesh-list
2583229|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
2583230|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
2583231|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583232|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583233|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583234|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
2583235|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
2583236|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2583237|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
2583238|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583239|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583240|NCT01669213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2583241|NCT01669213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2583242|NCT01669213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583243|NCT01669213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2583244|NCT01669213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2583245|NCT01669226|Taxane|taxane|mesh-list
2583246|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583247|NCT01669239|Doxorubicin|doxorubicin|mesh-list
2583248|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2583249|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2583250|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583251|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2583252|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2583253|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583254|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583255|NCT01669291|Leuprolide|leuprolide|mesh-list
2583256|NCT01669291|Cetrorelix|cetrorelix|mesh-list
2583257|NCT01669291|Menotropins|menotropins|mesh-list
2583258|NCT01669291|Ganirelix|ganirelix|mesh-list
2583259|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2583260|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
2583261|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2583262|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583263|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2583264|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583265|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
2583266|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2583267|NCT01669304|Verapamil|verapamil|mesh-list
2583268|NCT01669304|Sertraline|sertraline|mesh-list
2583269|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
2583270|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2583271|NCT01669304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2583272|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2583273|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2583274|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583275|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583276|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
2583277|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583278|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2583279|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2583280|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2583281|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
2583282|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
2583283|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
2583284|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2583285|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583286|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583287|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
2583288|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2583289|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583290|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138514|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138515|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138516|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2138517|NCT03274466|Laxatives|laxatives|mesh-ancestor
2138518|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583291|NCT01669447|Ranibizumab|ranibizumab|mesh-list
2138519|NCT03274804|Maraviroc|maraviroc|mesh-list
2583292|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2583293|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2583294|NCT01669447|Growth Substances|growth substances|mesh-ancestor
2583295|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583296|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
2583297|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583298|NCT01669499|Dexamethasone|dexamethasone|mesh-list
2583299|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
2583300|NCT01669499|BB 1101|bb 1101|mesh-list
2583301|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2583302|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
2583303|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
2583304|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583305|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583306|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583307|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
2583308|NCT01669499|Hormones|hormones|mesh-ancestor
2583309|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2583310|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2583311|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583312|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
2583313|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583314|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583315|NCT01669707|Endostar protein|endostar protein|mesh-list
2583316|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2583317|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2583318|NCT01669707|Growth Substances|growth substances|mesh-ancestor
2583319|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583320|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
2583321|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583322|NCT01669824|Aspirin|aspirin|mesh-list
2583323|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2583324|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2583325|NCT01669824|Analgesics|analgesics|mesh-ancestor
2583326|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
2583327|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583328|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583329|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2583330|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2583331|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2583332|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2583333|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583334|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2583335|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2583336|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583337|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
2583338|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2583339|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
2583340|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2583341|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2583342|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583343|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
2583344|NCT01669967|Promethazine|promethazine|mesh-list
2583345|NCT01669967|Lidocaine|lidocaine|mesh-list
2583346|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
2583347|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
2583348|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583349|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583350|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
2583351|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583352|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2583353|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2583354|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2583355|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2583356|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583357|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2583358|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2583359|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
2583360|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
2583361|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583362|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2583363|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
2583364|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
2583365|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583366|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2583367|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
2583368|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
2583369|NCT01669980|Vancomycin|vancomycin|mesh-list
2583370|NCT01669980|Ceftriaxone|ceftriaxone|mesh-list
2583371|NCT01669980|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2583372|NCT01669980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2583373|NCT01669980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583374|NCT01670071|Risperidone|risperidone|mesh-list
2583375|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2583376|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2583377|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
2583378|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583379|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583380|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583381|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2583382|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2583383|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583384|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2583385|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2583386|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
2583387|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2583388|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2583389|NCT01670084|Leucovorin|leucovorin|mesh-list
2583390|NCT01670084|Cytarabine|cytarabine|mesh-list
2583391|NCT01670084|Dexamethasone|dexamethasone|mesh-list
2583392|NCT01670084|Prednisone|prednisone|mesh-list
2583393|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
2583394|NCT01670084|Rituximab|rituximab|mesh-list
2583395|NCT01670084|Doxorubicin|doxorubicin|mesh-list
2583396|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2583397|NCT01670084|Methotrexate|methotrexate|mesh-list
2583398|NCT01670084|Vincristine|vincristine|mesh-list
2583399|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
2583400|NCT01670084|Mesna|mesna|mesh-list
2583401|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2583402|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
2583403|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583404|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2138520|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
2138521|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2138522|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138523|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2138524|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2138525|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138526|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2138527|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2138528|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
2138529|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138530|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2138531|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2138532|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138533|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
2138534|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
2138535|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2138536|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2138537|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138538|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138539|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138540|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2138541|NCT03276026|Neostigmine|neostigmine|mesh-list
2138542|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2138543|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138544|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138545|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
2138546|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138547|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138548|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2138549|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
2138550|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138551|NCT03276078|Bromides|bromides|mesh-list
2138552|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
2138553|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2138554|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
2138555|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583405|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2583406|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
2583407|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583408|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583409|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2138556|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138557|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2138558|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
2138559|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2138560|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2138561|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2138562|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
2138563|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138564|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138565|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
2138566|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2138567|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
2138568|NCT03276975|Coagulants|coagulants|mesh-ancestor
2138569|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
2138570|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2138571|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138572|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2138573|NCT03278106|Trifluridine|trifluridine|mesh-list
2138574|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
2138575|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138576|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
2138577|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138578|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2138579|NCT03278886|Naltrexone|naltrexone|mesh-list
2138580|NCT03278886|Nalmefene|nalmefene|mesh-list
2138581|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2138582|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2138583|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138584|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
2138585|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138586|NCT03279237|Leucovorin|leucovorin|mesh-list
2138587|NCT03279237|Paclitaxel|paclitaxel|mesh-list
2138588|NCT03279237|Carboplatin|carboplatin|mesh-list
2138589|NCT03279237|Fluorouracil|fluorouracil|mesh-list
2138590|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
2138591|NCT03279237|Irinotecan|irinotecan|mesh-list
2583410|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2583411|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
2583412|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
2138592|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2138593|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138594|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
2138595|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
2138596|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
2138597|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138598|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
2138599|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2138600|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2138601|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
2138602|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138603|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2138604|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2138605|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138606|NCT03279237|Antidotes|antidotes|mesh-ancestor
2138607|NCT03279237|Protective Agents|protective agents|mesh-ancestor
2138608|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
2138609|NCT03279237|Vitamins|vitamins|mesh-ancestor
2138610|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
2138611|NCT03279731|Liraglutide|liraglutide|mesh-list
2138612|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2138613|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138614|NCT03279731|Incretins|incretins|mesh-ancestor
2138615|NCT03279731|Hormones|hormones|mesh-ancestor
2138616|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2138617|NCT03280537|Omalizumab|omalizumab|mesh-list
2138618|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2138619|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2138620|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
2138621|NCT03280550|Omalizumab|omalizumab|mesh-list
2138622|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2138623|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2138624|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
2138625|NCT03281200|Nintedanib|nintedanib|mesh-list
2138626|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
2138627|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
2138628|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138629|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138630|NCT03281304|Tofacitinib|tofacitinib|mesh-list
2138631|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2583413|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583414|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583415|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
2583416|NCT01670084|Hormones|hormones|mesh-ancestor
2583417|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2583418|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2138632|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138633|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583419|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2583420|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2583421|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2583422|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2583423|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583424|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2583425|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
2583426|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2583427|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2583428|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
2583429|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
2583430|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2583431|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2583432|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
2583433|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583434|NCT01670084|Antidotes|antidotes|mesh-ancestor
2583435|NCT01670084|Protective Agents|protective agents|mesh-ancestor
2583436|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
2583437|NCT01670084|Vitamins|vitamins|mesh-ancestor
2583438|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
2583439|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2583440|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
2138645|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
2138646|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
2138647|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2138648|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2138649|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
2138650|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138651|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138652|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138653|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138654|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2138655|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138656|NCT03282240|Vaccines|vaccines|mesh-list
2138657|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
2138658|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138659|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
2138660|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138661|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2138662|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
2138663|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
2138664|NCT03282357|Protective Agents|protective agents|mesh-ancestor
2138665|NCT03282591|Serlopitant|serlopitant|mesh-list
2138666|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2138667|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138668|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138669|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583441|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
2583442|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
2583443|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
2583444|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
2583445|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2184932|NCT00002836|Carmustine|carmustine|mesh-list
2583446|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2583447|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583448|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583449|NCT01670136|Urological Agents|urological agents|mesh-ancestor
2583450|NCT01670149|Rifaximin|rifaximin|mesh-list
2420131|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
2420132|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2420133|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2420134|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2420135|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
2420136|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583451|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2583452|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583453|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583454|NCT01670162|Aflibercept|aflibercept|mesh-list
2583455|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2583456|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2583457|NCT01670162|Growth Substances|growth substances|mesh-ancestor
2138673|NCT03283436|Bupivacaine|bupivacaine|mesh-list
2138674|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
2138675|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
2138676|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138677|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138678|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
2138679|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138680|NCT03283696|Doxorubicin|doxorubicin|mesh-list
2138681|NCT03283696|Ifosfamide|ifosfamide|mesh-list
2138682|NCT03283696|Olaratumab|olaratumab|mesh-list
2138683|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2138684|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138685|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2138686|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2138687|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138688|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583458|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583459|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
2583460|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583461|NCT01670175|Sirolimus|sirolimus|mesh-list
2583462|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
2583463|NCT01670175|Topotecan|topotecan|mesh-list
2583464|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2583465|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
2583466|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583467|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2583468|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2583469|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
2583470|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583471|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583472|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2583473|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2583474|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583475|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2583476|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
2583477|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2583478|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2583479|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583480|NCT01670240|Adalimumab|adalimumab|mesh-list
2583481|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2138689|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2138690|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
2138691|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
2138692|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2138693|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138694|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
2138695|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
2583482|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2583483|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
2583484|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
2420137|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420138|NCT00806741|Protective Agents|protective agents|mesh-ancestor
2420139|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420140|NCT00806754|Ciclesonide|ciclesonide|mesh-list
2420141|NCT00806754|Azelastine|azelastine|mesh-list
2420142|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
2420143|NCT00806754|Hormones|hormones|mesh-ancestor
2583485|NCT01670318|Chromium|chromium|mesh-list
2583486|NCT01670318|Everolimus|everolimus|mesh-list
2583487|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583488|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2583489|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
2583490|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583491|NCT01670318|Trace Elements|trace elements|mesh-ancestor
2583492|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
2583493|NCT01670370|Gemcitabine|gemcitabine|mesh-list
2583494|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
2583495|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138696|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138697|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
2138698|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138699|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138700|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
2138701|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138702|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138703|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
2138704|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2138705|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2138706|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138707|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2138708|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138709|NCT03285646|Fasinumab|fasinumab|mesh-list
2138710|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2138711|NCT03285646|Analgesics|analgesics|mesh-ancestor
2138712|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
2138713|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138714|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138715|NCT03285984|Listerine|listerine|mesh-list
2138716|NCT03285984|Fluorides|fluorides|mesh-list
2138717|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
2138718|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
2583496|NCT01670370|Immunologic Factors|immunologic factors|mesh-ancestor
2583497|NCT01670370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583498|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2583499|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
2583500|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583501|NCT01670370|Antiviral Agents|antiviral agents|mesh-ancestor
2583502|NCT01670370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583503|NCT01670370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583504|NCT01670370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2583514|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
2583515|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2583516|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583517|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2583518|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2583519|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583520|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583521|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583522|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2583523|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2583524|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2583525|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2583526|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2583527|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138719|NCT03285984|Protective Agents|protective agents|mesh-ancestor
2583534|NCT01670552|Naproxen|naproxen|mesh-list
2583535|NCT01670552|Nimesulide|nimesulide|mesh-list
2583536|NCT01670552|Esomeprazole|esomeprazole|mesh-list
2583537|NCT01670552|Pantoprazole|pantoprazole|mesh-list
2583538|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2583539|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583540|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2583541|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583542|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583543|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2583544|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2583545|NCT01670552|Analgesics|analgesics|mesh-ancestor
2583546|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
2583547|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583548|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583549|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2583550|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2583551|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
2583552|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2583553|NCT01670565|Belimumab|belimumab|mesh-list
2583554|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2583555|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
2583556|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583557|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
2583558|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2583559|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
2583560|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583561|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
2583562|NCT01670578|Protective Agents|protective agents|mesh-ancestor
2583563|NCT01670669|Prucalopride|prucalopride|mesh-list
2583564|NCT01670669|Laxatives|laxatives|mesh-ancestor
2583565|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583566|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2583567|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2583568|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
2583569|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583570|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583571|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583572|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2583573|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2583574|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2583575|NCT01670773|Analgesics|analgesics|mesh-ancestor
2583576|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
2583577|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583578|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583579|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2583580|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2583581|NCT01670799|Ketorolac|ketorolac|mesh-list
2583582|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2583583|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2583584|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2583585|NCT01670799|Analgesics|analgesics|mesh-ancestor
2138720|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138721|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2138722|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138723|NCT03286218|Alprazolam|alprazolam|mesh-list
2138724|NCT03286218|Lasmiditan|lasmiditan|mesh-list
2138725|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2138726|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138727|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138728|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2138729|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2138730|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2138731|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
2138732|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
2138733|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138734|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138735|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2138736|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
2138737|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
2138738|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2138739|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138740|NCT03286829|Metoprolol|metoprolol|mesh-list
2138741|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2138742|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2138743|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
2138744|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
2583586|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
2583587|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583588|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583589|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2583590|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2583591|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2583592|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583593|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138745|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138746|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138747|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2138748|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2138749|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2138750|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
2138751|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138752|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138753|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
2138754|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2138755|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138756|NCT03287089|Renal Agents|renal agents|mesh-ancestor
2138757|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2138758|NCT03287219|Methylene Blue|methylene blue|mesh-list
2138759|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138760|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138761|NCT03287310|Albuterol|albuterol|mesh-list
2138762|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2138763|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
2138764|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138765|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138766|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2138767|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
2138768|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
2138769|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2138770|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2138771|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2138772|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2138773|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
2138774|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138775|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138776|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2138777|NCT03287635|Hormones|hormones|mesh-ancestor
2138778|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2138779|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138780|NCT03287674|Vidarabine|vidarabine|mesh-list
2138781|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
2138782|NCT03287674|Nivolumab|nivolumab|mesh-list
2138783|NCT03287674|Fludarabine|fludarabine|mesh-list
2138784|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
2138785|NCT03287674|Ipilimumab|ipilimumab|mesh-list
2138786|NCT03287674|Interleukin-2|interleukin-2|mesh-list
2138787|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2138788|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
2138789|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138790|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2138791|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2138792|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
2138793|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138794|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138795|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2138796|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2138797|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2138798|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2138799|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
2138800|NCT03287674|Antiviral Agents|antiviral agents|mesh-ancestor
2138801|NCT03287674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138802|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2138803|NCT03287674|Analgesics|analgesics|mesh-ancestor
2138804|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
2138805|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138806|NCT03287791|Azelaic acid|azelaic acid|mesh-list
2138807|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
2138808|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2138809|NCT03287791|Protective Agents|protective agents|mesh-ancestor
2138810|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138811|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
2138812|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138813|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
2138814|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
2138815|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138816|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138817|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138818|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
2138819|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
2138825|NCT03288987|Leucovorin|leucovorin|mesh-list
2138826|NCT03288987|Bevacizumab|bevacizumab|mesh-list
2138827|NCT03288987|Fluorouracil|fluorouracil|mesh-list
2138828|NCT03288987|Irinotecan|irinotecan|mesh-list
2138829|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2138830|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583594|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
2583595|NCT01670812|Rituximab|rituximab|mesh-list
2583596|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2583597|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583598|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
2583599|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583600|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2583601|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2138831|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2138832|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2138833|NCT03288987|Growth Substances|growth substances|mesh-ancestor
2138834|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138835|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
2138836|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
2138837|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138838|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2138839|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2138840|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
2138841|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2138842|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2583602|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
2583603|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
2583604|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583605|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583606|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
2583607|NCT01670812|Hormones|hormones|mesh-ancestor
2583608|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2583609|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2583610|NCT01670812|Protective Agents|protective agents|mesh-ancestor
2138843|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138844|NCT03288987|Antidotes|antidotes|mesh-ancestor
2138845|NCT03288987|Protective Agents|protective agents|mesh-ancestor
2138846|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
2138847|NCT03288987|Vitamins|vitamins|mesh-ancestor
2138848|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
2138849|NCT03289208|Edaravone|edaravone|mesh-list
2138850|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2138851|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
2138852|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138853|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2583611|NCT01670877|Trastuzumab|trastuzumab|mesh-list
2583612|NCT01670877|Fulvestrant|fulvestrant|mesh-list
2583613|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2583614|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583615|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2583616|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2583617|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2583618|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
2583619|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2583620|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583621|NCT01670890|Cisplatin|cisplatin|mesh-list
2583622|NCT01670890|Temozolomide|temozolomide|mesh-list
2583623|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138854|NCT03289208|Protective Agents|protective agents|mesh-ancestor
2138855|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138856|NCT03289234|Edaravone|edaravone|mesh-list
2138857|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2138858|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
2138859|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138860|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2138861|NCT03289234|Protective Agents|protective agents|mesh-ancestor
2138862|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138863|NCT03289533|Avelumab|avelumab|mesh-list
2138864|NCT03289533|Axitinib|axitinib|mesh-list
2138865|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2138866|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138867|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2583624|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2583625|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
2583626|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583627|NCT01670929|Progesterone|progesterone|mesh-list
2583628|NCT01670929|Progestins|progestins|mesh-ancestor
2583629|NCT01670929|Hormones|hormones|mesh-ancestor
2583630|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2583631|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583632|NCT01670955|Folic Acid|folic acid|mesh-list
2583633|NCT01670955|Hematinics|hematinics|mesh-ancestor
2583634|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
2583635|NCT01670955|Vitamins|vitamins|mesh-ancestor
2583636|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
2583637|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583638|NCT01671384|Valproic Acid|valproic acid|mesh-list
2583639|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
2138868|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138869|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138870|NCT03289676|Nicotine|nicotine|mesh-list
2138871|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2138872|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
2138873|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138874|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138875|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2138876|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2138877|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
2138878|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138879|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138880|NCT03289858|Bupivacaine|bupivacaine|mesh-list
2138881|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
2138882|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
2138883|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583640|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583641|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583642|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
2583643|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583644|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583645|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
2583646|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2583647|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583648|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2583649|NCT01671410|Morphine|morphine|mesh-list
2583650|NCT01671410|Buprenorphine|buprenorphine|mesh-list
2583651|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2583652|NCT01671410|Narcotics|narcotics|mesh-ancestor
2138884|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138885|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
2138886|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138887|NCT03290027|Tazarotene|tazarotene|mesh-list
2138888|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
2138889|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
2138890|NCT03290378|Tramadol|tramadol|mesh-list
2138891|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2138892|NCT03290378|Narcotics|narcotics|mesh-ancestor
2138893|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138894|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138895|NCT03290378|Analgesics|analgesics|mesh-ancestor
2583653|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583654|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583655|NCT01671410|Analgesics|analgesics|mesh-ancestor
2583656|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
2583657|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138896|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
2138897|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583658|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2583659|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
2583660|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138898|NCT03291080|Tretinoin|tretinoin|mesh-list
2138899|NCT03291080|Isotretinoin|isotretinoin|mesh-list
2138900|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138901|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
2138902|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
2138903|NCT03291197|Bupivacaine|bupivacaine|mesh-list
2138904|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
2138905|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
2138906|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138907|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138908|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
2138909|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138910|NCT03291288|Tolbutamide|tolbutamide|mesh-list
2138911|NCT03291288|Midazolam|midazolam|mesh-list
2138912|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2138913|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2138914|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138915|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583661|NCT01671709|Montelukast|montelukast|mesh-list
2583662|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2583663|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
2583664|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2583665|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
2583666|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2583667|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583668|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2583669|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2583670|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583671|NCT01671722|Montelukast|montelukast|mesh-list
2583672|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2583673|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
2583674|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2583675|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
2583676|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2583677|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583678|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2583679|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2583680|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583681|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
2583682|NCT01671774|Interleukin-2|interleukin-2|mesh-list
2583683|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583684|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2583685|NCT01671774|Analgesics|analgesics|mesh-ancestor
2583686|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
2583687|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583688|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583689|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2583690|NCT01671787|Tenofovir|tenofovir|mesh-list
2583691|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
2583692|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583693|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2583694|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2583695|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583696|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138916|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2138917|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2138918|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2138919|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2138920|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
2138921|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
2138922|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
2138923|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
2138924|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138925|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138926|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2138927|NCT03292016|Apomorphine|apomorphine|mesh-list
2583697|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2583698|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2583699|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
2138928|NCT03292016|Emetics|emetics|mesh-ancestor
2138929|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138930|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
2138931|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138932|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583700|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2583701|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2583702|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2583703|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583704|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
2583705|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583706|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583707|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2583708|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
2583709|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2583710|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583711|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
2583712|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583713|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
2583714|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2583715|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
2583716|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2583717|NCT01671891|Capecitabine|capecitabine|mesh-list
2583718|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
2583719|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2583720|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
2583721|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583722|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583723|NCT01671904|Rituximab|rituximab|mesh-list
2583724|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
2583725|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2583726|NCT01671904|Venetoclax|venetoclax|mesh-list
2583727|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2583728|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583729|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
2583730|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138933|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
2138934|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
2138935|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2138936|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138937|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
2138938|NCT03292640|Tazarotene|tazarotene|mesh-list
2138939|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
2138940|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
2138941|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
2138942|NCT03292640|Vitamins|vitamins|mesh-ancestor
2138943|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
2138944|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583731|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2583732|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2583733|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
2583734|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583735|NCT01671982|Tenofovir|tenofovir|mesh-list
2583736|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
2583737|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583738|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2583739|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2583740|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583741|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583742|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2583743|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2583744|NCT01672047|Vitamin D|vitamin d|mesh-list
2583745|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
2583746|NCT01672047|Vitamins|vitamins|mesh-ancestor
2583747|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
2583748|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138945|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2138946|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2138947|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583749|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2583750|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2583751|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
2583752|NCT01672086|Antacids|antacids|mesh-ancestor
2583753|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583754|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583755|NCT01672112|Oxycodone|oxycodone|mesh-list
2583756|NCT01672112|Codeine|codeine|mesh-list
2583757|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2583758|NCT01672112|Narcotics|narcotics|mesh-ancestor
2583759|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583760|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583761|NCT01672112|Analgesics|analgesics|mesh-ancestor
2583762|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
2583763|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583764|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
2583765|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
2583766|NCT01672151|Sirolimus|sirolimus|mesh-list
2583767|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2583768|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583769|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2583770|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583771|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
2583772|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2583773|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
2583774|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583775|NCT01672229|Bortezomib|bortezomib|mesh-list
2583776|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583777|NCT01672255|Fluoxetine|fluoxetine|mesh-list
2583778|NCT01672255|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2583779|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2583780|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2583781|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583782|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583783|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
2583784|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583785|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2583786|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
2583787|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2583788|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2583789|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2583790|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583791|NCT01672307|Minoxidil|minoxidil|mesh-list
2583792|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2583793|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
2583794|NCT01672346|Adenosine|adenosine|mesh-list
2583795|NCT01672346|Analgesics|analgesics|mesh-ancestor
2583796|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
2583797|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583798|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583799|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2583800|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
2583801|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2583802|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
2583803|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
2583804|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583805|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583806|NCT01672359|Choline|choline|mesh-list
2583807|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
2583808|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2583809|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
2583810|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583811|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583812|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2583813|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
2583814|NCT01672450|Ipilimumab|ipilimumab|mesh-list
2583815|NCT01672450|Interleukin-2|interleukin-2|mesh-list
2583816|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2583817|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583818|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2583819|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583820|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2583821|NCT01672450|Analgesics|analgesics|mesh-ancestor
2583822|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
2583823|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583824|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583825|NCT01672476|Valsartan|valsartan|mesh-list
2583826|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2583827|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2583828|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2583829|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583830|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2583831|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
2583832|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2583833|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2583834|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2583835|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583836|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583837|NCT01672580|Vitamins|vitamins|mesh-list
2583838|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
2583839|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583840|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2583841|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2583842|NCT01672606|Rocuronium|rocuronium|mesh-list
2583843|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2583844|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2583845|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2583846|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583847|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583848|NCT01672671|Paclitaxel|paclitaxel|mesh-list
2583849|NCT01672671|Doxorubicin|doxorubicin|mesh-list
2583850|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2583851|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583852|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
2583853|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
2583854|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
2583855|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583856|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2583857|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2583858|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2583859|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583860|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
2583861|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2583862|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583863|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2583864|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583865|NCT01672814|Riboflavin|riboflavin|mesh-list
2583866|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2583867|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2583868|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
2583869|NCT01672814|Vitamins|vitamins|mesh-ancestor
2583870|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
2583871|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583872|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2583873|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
2583874|NCT01673087|Dexamethasone|dexamethasone|mesh-list
2583875|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2583876|NCT01673087|Cosyntropin|cosyntropin|mesh-list
2583877|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
2583878|NCT01673087|Metyrapone|metyrapone|mesh-list
2583879|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2583880|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
2583881|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
2583882|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583883|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583884|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2583885|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
2583886|NCT01673087|Hormones|hormones|mesh-ancestor
2583887|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2583888|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2583889|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583890|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
2583891|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583892|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583893|NCT01673204|Calcitriol|calcitriol|mesh-list
2583894|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2583895|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583896|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2583897|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2583898|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583899|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2583900|NCT01673204|Vitamins|vitamins|mesh-ancestor
2583901|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
2583902|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2583903|NCT01673217|Doxorubicin|doxorubicin|mesh-list
2583904|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2583905|NCT01673217|Decitabine|decitabine|mesh-list
2583906|NCT01673217|Azacitidine|azacitidine|mesh-list
2583907|NCT01673217|Vaccines|vaccines|mesh-list
2583908|NCT01673217|Sargramostim|sargramostim|mesh-list
2583909|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
2583910|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
2583911|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583912|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2583913|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583914|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2583915|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2583916|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138948|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2138949|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138950|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2583917|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583918|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2583919|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
2583920|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2583921|NCT01673308|Lenalidomide|lenalidomide|mesh-list
2583922|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
2583923|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583924|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2583925|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2583926|NCT01673308|Growth Substances|growth substances|mesh-ancestor
2583927|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
2583928|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583929|NCT01673399|Atosiban|atosiban|mesh-list
2583930|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
2583931|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2583932|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138951|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2138952|NCT03293485|Imipenem|imipenem|mesh-list
2138953|NCT03293485|Relebactam|relebactam|mesh-list
2138954|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
2138955|NCT03293485|Cilastatin|cilastatin|mesh-list
2138956|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2138957|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2138958|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
2138959|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2138960|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2138961|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2583933|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
2583934|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2583935|NCT01673542|Lidocaine|lidocaine|mesh-list
2583936|NCT01673542|Prilocaine|prilocaine|mesh-list
2583937|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2583938|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
2583939|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
2583940|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2583941|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583942|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
2583943|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583944|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2583945|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2583946|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2583947|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2138962|NCT03293654|Bevacizumab|bevacizumab|mesh-list
2138963|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2138964|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2138965|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2138966|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2138967|NCT03293654|Growth Substances|growth substances|mesh-ancestor
2138968|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138969|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
2138977|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2138978|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2138979|NCT03294538|Estradiol|estradiol|mesh-list
2138980|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2138981|NCT03294538|Estrogens|estrogens|mesh-ancestor
2138982|NCT03294538|Hormones|hormones|mesh-ancestor
2184933|NCT00002836|Cisplatin|cisplatin|mesh-list
2138983|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2138984|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138985|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2138986|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
2138987|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2138988|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2138989|NCT03295721|Bupivacaine|bupivacaine|mesh-list
2138990|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
2138991|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
2138992|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2138993|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2138994|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
2138995|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2138996|NCT03296072|Listerine|listerine|mesh-list
2138997|NCT03296072|Fluorides|fluorides|mesh-list
2138998|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
2138999|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
2139000|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
2139001|NCT03296072|Protective Agents|protective agents|mesh-ancestor
2139002|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139003|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2583948|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583949|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2583950|NCT01673659|Mometasone Furoate|mometasone furoate|mesh-list
2583951|NCT01673659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2583952|NCT01673659|Dermatologic Agents|dermatologic agents|mesh-ancestor
2583953|NCT01673659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2583954|NCT01673724|Pramipexole|pramipexole|mesh-list
2583955|NCT01673724|Bromocriptine|bromocriptine|mesh-list
2583956|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
2583957|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139004|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2139005|NCT03296163|Paclitaxel|paclitaxel|mesh-list
2139006|NCT03296163|Bevacizumab|bevacizumab|mesh-list
2139007|NCT03296163|Carboplatin|carboplatin|mesh-list
2139008|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2139009|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139010|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
2139011|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
2139012|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
2139013|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139014|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2583958|NCT01673724|Protective Agents|protective agents|mesh-ancestor
2583959|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583960|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2583961|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2583962|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
2583963|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
2583964|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583965|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
2583966|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2583967|NCT01673737|Vemurafenib|vemurafenib|mesh-list
2583968|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2583969|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2583970|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2583971|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583972|NCT01673997|Metoprolol|metoprolol|mesh-list
2583973|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2583974|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2583975|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
2583976|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
2583977|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139015|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2139016|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2139017|NCT03296163|Growth Substances|growth substances|mesh-ancestor
2139018|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139019|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
2139020|NCT03296345|Ketamine|ketamine|mesh-list
2583978|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583979|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2583980|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2583981|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2583982|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
2139021|NCT03296345|Analgesics|analgesics|mesh-ancestor
2139022|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
2583983|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583984|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583985|NCT01674127|Methyldopa|methyldopa|mesh-list
2583986|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2583987|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
2583988|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
2583989|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2583990|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2583991|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2583992|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2583993|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2583994|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
2583995|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2583996|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2583997|NCT01674140|Tamoxifen|tamoxifen|mesh-list
2583998|NCT01674140|Everolimus|everolimus|mesh-list
2583999|NCT01674140|Letrozole|letrozole|mesh-list
2584000|NCT01674140|Anastrozole|anastrozole|mesh-list
2584001|NCT01674140|Leuprolide|leuprolide|mesh-list
2584002|NCT01674140|Exemestane|exemestane|mesh-list
2584003|NCT01674140|Goserelin|goserelin|mesh-list
2584004|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584005|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584006|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2584007|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
2584008|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584009|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2584010|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2584011|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584012|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2584013|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
2139023|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139024|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139025|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2139026|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2139027|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
2139028|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
2139029|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139030|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2139031|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2139032|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139033|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139034|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2139035|NCT03296527|Hormones|hormones|mesh-ancestor
2139036|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2139037|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139038|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
2584014|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2584015|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2584016|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2584017|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2584018|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2584019|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2584020|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
2584021|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2584022|NCT01674166|Prucalopride|prucalopride|mesh-list
2584023|NCT01674166|Laxatives|laxatives|mesh-ancestor
2584024|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2584025|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2584026|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2584027|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
2584028|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584029|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584030|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584031|NCT01674192|Prucalopride|prucalopride|mesh-list
2584032|NCT01674192|Laxatives|laxatives|mesh-ancestor
2584033|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2584034|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2584035|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2584036|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
2584037|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584038|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584039|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139039|NCT03296800|Rifampin|rifampin|mesh-list
2139040|NCT03296800|Probenecid|probenecid|mesh-list
2139041|NCT03296800|Verapamil|verapamil|mesh-list
2139042|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2139043|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
2139044|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2139045|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2139046|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
2139047|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2139048|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139049|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584040|NCT01674205|Vaccines|vaccines|mesh-list
2584041|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
2584042|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584043|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
2584044|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2584045|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584046|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2584047|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2584048|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584049|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584050|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584051|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2139050|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2139051|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2139052|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2139053|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2139054|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2139055|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2139056|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2139057|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2139058|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139059|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2139060|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139061|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
2139062|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
2139063|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
2139064|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2139065|NCT03296800|Renal Agents|renal agents|mesh-ancestor
2139066|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2584052|NCT01674257|Fluorides|fluorides|mesh-list
2584053|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
2584054|NCT01674257|Protective Agents|protective agents|mesh-ancestor
2584055|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584056|NCT01674257|Hematinics|hematinics|mesh-ancestor
2584057|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2584058|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2584059|NCT01674270|Bicalutamide|bicalutamide|mesh-list
2584060|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
2584061|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
2584062|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2584063|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584064|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584065|NCT01674283|Glucagon|glucagon|mesh-list
2584066|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2139067|NCT03297021|Ondansetron|ondansetron|mesh-list
2139068|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
2139069|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
2139070|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139071|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139072|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2139073|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
2139074|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
2139075|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2139076|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
2139077|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139078|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139079|NCT03297021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2139080|NCT03297021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2139081|NCT03297021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139082|NCT03297021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2139083|NCT03297021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2139084|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2139085|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2139086|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2584067|NCT01674283|Hormones|hormones|mesh-ancestor
2584068|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2584069|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584070|NCT01674413|Adalimumab|adalimumab|mesh-list
2584071|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2584072|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2584073|NCT01674504|Montelukast|montelukast|mesh-list
2584074|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2584075|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
2584076|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2584077|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
2584078|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2584079|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420144|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2420145|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420146|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2420147|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2420148|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
2420149|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139087|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
2139088|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2139089|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139090|NCT03297216|Progestins|progestins|mesh-ancestor
2139091|NCT03297216|Hormones|hormones|mesh-ancestor
2139092|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
2139093|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
2139094|NCT03297398|Androgens|androgens|mesh-list
2139095|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2139096|NCT03297398|Hormones|hormones|mesh-ancestor
2139097|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2139098|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139099|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
2139100|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139101|NCT03297398|Protective Agents|protective agents|mesh-ancestor
2139102|NCT03297398|Vitamins|vitamins|mesh-ancestor
2139103|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
2139104|NCT03297398|Estrogens|estrogens|mesh-ancestor
2139105|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2139106|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139107|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
2139108|NCT03297944|Zolpidem|zolpidem|mesh-list
2139109|NCT03297944|Alprazolam|alprazolam|mesh-list
2139110|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2139111|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2139112|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139113|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139114|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2139115|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
2139116|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
2139117|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139118|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139119|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2139120|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2139121|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2139122|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
2139123|NCT03298113|Protective Agents|protective agents|mesh-list
2139124|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139125|NCT03298412|Blinatumomab|blinatumomab|mesh-list
2139126|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139127|NCT03298984|Cytarabine|cytarabine|mesh-list
2139128|NCT03298984|Daunorubicin|daunorubicin|mesh-list
2139129|NCT03298984|Alvocidib|alvocidib|mesh-list
2139130|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2139131|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
2139132|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139133|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139134|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
2139135|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2139136|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2139137|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
2139138|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420150|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2420151|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
2420152|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2420153|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139139|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2139140|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2139141|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2139142|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139143|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
2139144|NCT03298984|Growth Substances|growth substances|mesh-ancestor
2139145|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2139146|NCT03299049|Rilpivirine|rilpivirine|mesh-list
2139147|NCT03299049|Cabotegravir|cabotegravir|mesh-list
2584080|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2584081|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2584082|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584083|NCT01674517|Montelukast|montelukast|mesh-list
2584084|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2584085|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
2584086|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2584087|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
2584088|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2584089|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584090|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2584091|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2139148|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2139149|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2139150|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139151|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139152|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
2139153|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2139154|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2139155|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2139156|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2139157|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2139158|NCT03299244|Cinacalcet|cinacalcet|mesh-list
2139159|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2139160|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139161|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2139162|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
2139163|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2139164|NCT03300570|Dolcanatide|dolcanatide|mesh-list
2139165|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2139166|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
2139167|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139168|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2139169|NCT03300674|Lidocaine|lidocaine|mesh-list
2139170|NCT03300674|Hydromorphone|hydromorphone|mesh-list
2139171|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
2139172|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
2139173|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139174|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139175|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
2139176|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139177|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2139178|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2139179|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2139180|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139181|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139182|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2139183|NCT03300674|Narcotics|narcotics|mesh-ancestor
2139184|NCT03300674|Analgesics|analgesics|mesh-ancestor
2139185|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2584092|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584093|NCT01674530|Lubiprostone|lubiprostone|mesh-list
2584094|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2139186|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2139187|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2139188|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139189|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139190|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2139191|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139192|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139193|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
2139194|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139195|NCT03301649|Ivermectin|ivermectin|mesh-list
2139196|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2139197|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2139198|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
2139199|NCT03302234|Ipilimumab|ipilimumab|mesh-list
2139200|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2139201|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139202|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2139203|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139204|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
2139205|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2139206|NCT03302559|Vitamin A|vitamin a|mesh-list
2139207|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
2139208|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
2139209|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2139210|NCT03302559|Protective Agents|protective agents|mesh-ancestor
2139211|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139212|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
2139213|NCT03302559|Vitamins|vitamins|mesh-ancestor
2139214|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
2139215|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
2139216|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139217|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2139218|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139219|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
2139220|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2139221|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139222|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139223|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
2139224|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139225|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139226|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2139227|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
2139228|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139229|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2139230|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
2139231|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139232|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2139233|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
2139234|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139235|NCT03303196|Pancrelipase|pancrelipase|mesh-list
2139236|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2139237|NCT03303794|Bupivacaine|bupivacaine|mesh-list
2139238|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
2584095|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2584096|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584097|NCT01674556|Gemcitabine|gemcitabine|mesh-list
2584098|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2584099|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
2584100|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584101|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584102|NCT01674556|Antiviral Agents|antiviral agents|mesh-ancestor
2584103|NCT01674556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584104|NCT01674556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584105|NCT01674556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2584106|NCT01674556|Immunologic Factors|immunologic factors|mesh-ancestor
2584107|NCT01674556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584108|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
2584109|NCT01674686|Atorvastatin|atorvastatin|mesh-list
2584110|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2584111|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2584112|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
2584113|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584114|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2139239|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
2139240|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139241|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139242|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
2139243|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139244|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
2139245|NCT03303950|Busulfan|busulfan|mesh-list
2139246|NCT03303950|Fludarabine|fludarabine|mesh-list
2139247|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2139248|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
2139249|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584115|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2584116|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584117|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2584118|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2584119|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2584120|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2584121|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
2584122|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584123|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584124|NCT01674738|Bevacizumab|bevacizumab|mesh-list
2584125|NCT01674738|Pemetrexed|pemetrexed|mesh-list
2584126|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2584127|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584128|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2584129|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2584130|NCT01674738|Growth Substances|growth substances|mesh-ancestor
2584131|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584132|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
2584133|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584134|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584135|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2584136|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2584137|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
2584138|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2584139|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584140|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2584141|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584142|NCT01674842|Cisplatin|cisplatin|mesh-list
2584143|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584144|NCT01674855|Lenograstim|lenograstim|mesh-list
2584145|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2584146|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
2584147|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584148|NCT01674868|Fluoxetine|fluoxetine|mesh-list
2139250|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2139251|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2139252|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
2139253|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139254|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139255|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2139256|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
2139257|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2139258|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139259|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2139260|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
2139261|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2139262|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2139263|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139264|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139265|NCT03304054|Amifampridine|amifampridine|mesh-list
2139266|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2139267|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139268|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139269|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2139270|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139271|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139272|NCT03304626|Prednisone|prednisone|mesh-list
2139273|NCT03304626|Budesonide|budesonide|mesh-list
2139274|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2139275|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
2139276|NCT03304626|Hormones|hormones|mesh-ancestor
2139277|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2139278|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139279|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2139280|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139281|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2139282|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
2139283|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139284|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2139285|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
2139286|NCT03304873|Retapamulin|retapamulin|mesh-list
2139287|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2139288|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584149|NCT01674868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2584150|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2584151|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2584152|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584153|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584154|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
2584155|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584156|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2584157|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
2584158|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2139289|NCT03305081|Copper|copper|mesh-list
2139290|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
2139291|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2139292|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
2139293|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2139294|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139295|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2139296|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2139297|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2139298|NCT03305081|Trace Elements|trace elements|mesh-ancestor
2139299|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
2139300|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
2139301|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2139302|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
2139303|NCT03305159|Povidone|povidone|mesh-list
2139304|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2139305|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2139306|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
2139307|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
2139308|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
2139309|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
2139310|NCT03305575|Bupivacaine|bupivacaine|mesh-list
2139311|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
2139312|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
2139313|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
2139314|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139315|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584159|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2584160|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2584161|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584162|NCT01674933|Listerine|listerine|mesh-list
2584163|NCT01674933|Fluorides|fluorides|mesh-list
2584164|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
2584165|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
2584166|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
2584167|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
2584168|NCT01674933|Protective Agents|protective agents|mesh-ancestor
2584169|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584170|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2584171|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584172|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2584173|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
2584174|NCT01674946|Cathartics|cathartics|mesh-ancestor
2584175|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2584176|NCT01675024|Rotigotine|rotigotine|mesh-list
2584177|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
2584178|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
2584179|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139316|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
2139317|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139318|NCT03305666|Bupivacaine|bupivacaine|mesh-list
2139319|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
2139320|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
2139321|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139322|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139323|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
2139324|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139325|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
2139326|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2139327|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139328|NCT03306589|Molgramostim|molgramostim|mesh-list
2139329|NCT03306589|Sargramostim|sargramostim|mesh-list
2139330|NCT03306589|Cantharidin|cantharidin|mesh-list
2139331|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
2139332|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139333|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584180|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139334|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139335|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139336|NCT03307005|Zolpidem|zolpidem|mesh-list
2139337|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2139338|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2139339|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139340|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584181|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584182|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
2139341|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2139342|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
2139343|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
2139344|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139345|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139346|NCT03307174|Fentanyl|fentanyl|mesh-list
2139347|NCT03307174|Bupivacaine|bupivacaine|mesh-list
2139348|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
2139349|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
2139350|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139351|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139352|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
2139353|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139354|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2139355|NCT03307174|Narcotics|narcotics|mesh-ancestor
2139356|NCT03307174|Analgesics|analgesics|mesh-ancestor
2139357|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2139358|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2584183|NCT01675076|Apixaban|apixaban|mesh-list
2584184|NCT01675076|Dabigatran|dabigatran|mesh-list
2584185|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2584186|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
2584187|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2584188|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
2584189|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584190|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584191|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
2584192|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
2584193|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2584194|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584195|NCT01675115|Aspirin|aspirin|mesh-list
2584196|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2584197|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2584198|NCT01675115|Analgesics|analgesics|mesh-ancestor
2584199|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
2584200|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584201|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584202|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2584203|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2584204|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2584205|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2584206|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584207|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2584208|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2584209|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139359|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
2139360|NCT03307252|Metformin|metformin|mesh-list
2139361|NCT03307252|Rifampin|rifampin|mesh-list
2139362|NCT03307252|Probenecid|probenecid|mesh-list
2139363|NCT03307252|Digoxin|digoxin|mesh-list
2139364|NCT03307252|Verapamil|verapamil|mesh-list
2139365|NCT03307252|Furosemide|furosemide|mesh-list
2139366|NCT03307252|Cimetidine|cimetidine|mesh-list
2139367|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2139368|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2139369|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139370|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2139371|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2139372|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
2139373|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139374|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2584210|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
2584211|NCT01675206|Vitamin K|vitamin k|mesh-list
2584212|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
2584213|NCT01675206|Vitamins|vitamins|mesh-ancestor
2139375|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2139376|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139377|NCT03307252|Diuretics|diuretics|mesh-ancestor
2139378|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
2584214|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
2584215|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584216|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2584217|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2584218|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584219|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
2584220|NCT01675206|Coagulants|coagulants|mesh-ancestor
2584221|NCT01675219|Mitomycins|mitomycins|mesh-list
2584222|NCT01675219|Mitomycin|mitomycin|mesh-list
2584223|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2584224|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584225|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
2584226|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584227|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2584228|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584229|NCT01675310|Metformin|metformin|mesh-list
2584230|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2584231|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584232|NCT01675362|Selenium|selenium|mesh-list
2584233|NCT01675362|Losartan|losartan|mesh-list
2584234|NCT01675362|Verapamil|verapamil|mesh-list
2584235|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
2584236|NCT01675362|Calcium|calcium|mesh-list
2584237|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2584238|NCT01675362|Antioxidants|antioxidants|mesh-list
2584239|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2584240|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584241|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2584242|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2584243|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2584244|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584245|NCT01675362|Protective Agents|protective agents|mesh-ancestor
2584246|NCT01675362|Trace Elements|trace elements|mesh-ancestor
2584247|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
2584248|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2584249|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
2584250|NCT01675466|Anesthetics|anesthetics|mesh-list
2584251|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584252|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584253|NCT01675518|ASP7991|asp7991|mesh-list
2584254|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2584255|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
2584256|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2584257|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584258|NCT01675557|Vitamin D|vitamin d|mesh-list
2584259|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
2584260|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
2584261|NCT01675557|Vitamins|vitamins|mesh-list
2584262|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
2584263|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139379|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2139380|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139381|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2139382|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
2139383|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2139384|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2139385|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
2139386|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2139387|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2139388|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2139389|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2139390|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2184934|NCT00002836|Etoposide|etoposide|mesh-list
2584264|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2584265|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2584266|NCT01675609|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2584267|NCT01675609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2584268|NCT01675609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2584269|NCT01675609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2584270|NCT01675609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2584271|NCT01675609|Adrenergic Agents|adrenergic agents|mesh-ancestor
2584272|NCT01675609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584273|NCT01675609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584274|NCT01675609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139391|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2139392|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2139393|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2139394|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2139395|NCT03307252|Protective Agents|protective agents|mesh-ancestor
2139396|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2139397|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2584275|NCT01675648|Lofexidine|lofexidine|mesh-list
2584276|NCT01675648|Clonidine|clonidine|mesh-list
2584277|NCT01675648|Diazepam|diazepam|mesh-list
2584278|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2584279|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
2584280|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
2584281|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
2584282|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584283|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584284|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2584285|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2584286|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584287|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2584288|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2584289|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2584290|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2584291|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2584292|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2139398|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
2139399|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
2139400|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
2139401|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2139402|NCT03307252|Renal Agents|renal agents|mesh-ancestor
2139403|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2139404|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2584293|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
2584294|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
2584295|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
2584296|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
2584297|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584298|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584299|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2584300|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2584301|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
2584302|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2584303|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2584304|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2584305|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
2139405|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2139406|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
2139407|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
2139408|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139409|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2139410|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2139411|NCT03307785|Paclitaxel|paclitaxel|mesh-list
2139412|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2139413|NCT03307785|Bevacizumab|bevacizumab|mesh-list
2584306|NCT01675648|Analgesics|analgesics|mesh-ancestor
2584307|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
2584308|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
2139414|NCT03307785|Carboplatin|carboplatin|mesh-list
2139415|NCT03307785|Pemetrexed|pemetrexed|mesh-list
2139416|NCT03307785|Niraparib|niraparib|mesh-list
2584309|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
2584310|NCT01675804|Methylphenidate|methylphenidate|mesh-list
2584311|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2584312|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584313|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2584314|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2584315|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2584316|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584317|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
2584318|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584319|NCT01675895|Lidocaine|lidocaine|mesh-list
2584320|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
2584321|NCT01675895|Anesthetics|anesthetics|mesh-list
2584322|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
2584323|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584324|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139417|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2584325|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
2584326|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584327|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2584328|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2584329|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2584330|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2584331|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584332|NCT01675947|Sirolimus|sirolimus|mesh-list
2584333|NCT01675947|Lidocaine|lidocaine|mesh-list
2584334|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
2584335|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
2584336|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584337|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584338|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
2584339|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584340|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2584341|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2584342|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2584343|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2584344|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139418|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139419|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
2584345|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2584346|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584347|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2584348|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584349|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
2584350|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2584351|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
2584352|NCT01675973|Ranolazine|ranolazine|mesh-list
2584353|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2584354|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2584355|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584356|NCT01675986|Pregabalin|pregabalin|mesh-list
2584357|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
2584358|NCT01675986|Analgesics|analgesics|mesh-ancestor
2584359|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
2584360|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584361|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584362|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
2584363|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2584364|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2584365|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584366|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2584367|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2139420|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
2139421|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
2139422|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139423|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2139424|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2139425|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2139426|NCT03307785|Growth Substances|growth substances|mesh-ancestor
2584368|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2584369|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584370|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2584371|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
2584372|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
2584373|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2584374|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
2584375|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
2584376|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584377|NCT01675999|Leucovorin|leucovorin|mesh-list
2584378|NCT01675999|Cetuximab|cetuximab|mesh-list
2584379|NCT01675999|Fluorouracil|fluorouracil|mesh-list
2584380|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
2584381|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2584382|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584383|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
2584384|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584385|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2584386|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2584387|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
2584388|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139427|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139428|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
2139429|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139430|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2139431|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2139432|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2139433|NCT03308669|Topiramate|topiramate|mesh-list
2139434|NCT03308669|Lasmiditan|lasmiditan|mesh-list
2139435|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
2139436|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2584389|NCT01675999|Antidotes|antidotes|mesh-ancestor
2584390|NCT01675999|Protective Agents|protective agents|mesh-ancestor
2584391|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
2584392|NCT01675999|Vitamins|vitamins|mesh-ancestor
2584393|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
2584394|NCT01676233|Insulin|insulin|mesh-list
2584395|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2584396|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
2584397|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2584398|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584399|NCT01676246|Flupirtine|flupirtine|mesh-list
2584400|NCT01676246|Analgesics|analgesics|mesh-ancestor
2584401|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
2584402|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584403|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584404|NCT01676259|Gemcitabine|gemcitabine|mesh-list
2584405|NCT01676259|Paclitaxel|paclitaxel|mesh-list
2139437|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139438|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2139439|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
2139440|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584406|NCT01676259|Folfirinox|folfirinox|mesh-list
2584407|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2584408|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584409|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
2584410|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
2584411|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
2584412|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584413|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2584414|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
2584415|NCT01676259|Antiviral Agents|antiviral agents|mesh-ancestor
2584416|NCT01676259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584417|NCT01676259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584418|NCT01676259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2584419|NCT01676259|Immunologic Factors|immunologic factors|mesh-ancestor
2584420|NCT01676259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139441|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139442|NCT03308825|Vaccines|vaccines|mesh-list
2139443|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
2139444|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139445|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
2139446|NCT03308942|Niraparib|niraparib|mesh-list
2139447|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2139448|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139449|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2139450|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139451|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139452|NCT03309657|Tazobactam|tazobactam|mesh-list
2139453|NCT03309657|Ceftolozane|ceftolozane|mesh-list
2139454|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2139455|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2139456|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584421|NCT01676285|Metoprolol|metoprolol|mesh-list
2584422|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2584423|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2584424|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
2584425|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
2584426|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584427|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584428|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2584429|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2584430|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2584431|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
2584432|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584433|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584434|NCT01676363|Diflunisal|diflunisal|mesh-list
2584435|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2584436|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2584437|NCT01676363|Analgesics|analgesics|mesh-ancestor
2584438|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
2584439|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139457|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2139458|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139459|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139460|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2139461|NCT03309657|Renal Agents|renal agents|mesh-ancestor
2139462|NCT03309943|Propranolol|propranolol|mesh-list
2139463|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2139464|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2139465|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
2139466|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139467|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139468|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139469|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2139470|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2139471|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
2139472|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
2139473|NCT03310021|Apixaban|apixaban|mesh-list
2139474|NCT03310021|Edoxaban|edoxaban|mesh-list
2139475|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2139476|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
2139477|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2139478|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
2139479|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139480|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139481|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
2139482|NCT03310268|Listerine|listerine|mesh-list
2139483|NCT03310268|Fluorides|fluorides|mesh-list
2139484|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
2139485|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
2139486|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
2139487|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
2139488|NCT03310268|Protective Agents|protective agents|mesh-ancestor
2139489|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139490|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2139491|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2139492|NCT03310411|Sumatriptan|sumatriptan|mesh-list
2139493|NCT03310411|Lasmiditan|lasmiditan|mesh-list
2584440|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584441|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2584442|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2584443|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2139494|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2139495|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2139496|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2139497|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
2139498|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139499|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139500|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139501|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2139502|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2139503|NCT03310970|Lidocaine|lidocaine|mesh-list
2139504|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
2139505|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
2139506|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139507|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584444|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584445|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584446|NCT01676402|Vaccines|vaccines|mesh-list
2584447|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
2584448|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584449|NCT01676493|Codeine|codeine|mesh-list
2584450|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2584451|NCT01676493|Narcotics|narcotics|mesh-ancestor
2584452|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584453|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584454|NCT01676493|Analgesics|analgesics|mesh-ancestor
2584455|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
2584456|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584457|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
2584458|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
2584459|NCT01676506|Ranibizumab|ranibizumab|mesh-list
2584460|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2139508|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
2584461|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2584462|NCT01676506|Growth Substances|growth substances|mesh-ancestor
2584463|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584464|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
2584465|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584466|NCT01676558|Rituximab|rituximab|mesh-list
2584467|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2584468|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584469|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
2584470|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584471|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2584472|NCT01676571|Vortioxetine|vortioxetine|mesh-list
2584473|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
2584474|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2584475|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2584476|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2584477|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584478|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584479|NCT01676571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2584480|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2139509|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139510|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2139511|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2139512|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2139513|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139514|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139515|NCT03311646|Nicotine|nicotine|mesh-list
2139516|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2139517|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
2139518|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139519|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139520|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2139521|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2139522|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
2139523|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584481|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2584482|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584483|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584484|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
2584485|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2584486|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2584487|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2584488|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2584489|NCT01676597|Rifaximin|rifaximin|mesh-list
2584490|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
2584491|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2584492|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584493|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2584494|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2584495|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584496|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584497|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2584498|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2584499|NCT01676597|Protective Agents|protective agents|mesh-ancestor
2584500|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584501|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
2584502|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2584503|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
2668546|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668547|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2668548|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
2668549|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2668550|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668551|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2668552|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
2668553|NCT02142920|Gedatolisib|gedatolisib|mesh-list
2668554|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2668555|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668556|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139524|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139525|NCT03311724|Tirzepatide|tirzepatide|mesh-list
2139526|NCT03311724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2584504|NCT01676649|Paclitaxel|paclitaxel|mesh-list
2584505|NCT01676649|Carboplatin|carboplatin|mesh-list
2584506|NCT01676649|Ipilimumab|ipilimumab|mesh-list
2584507|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2584508|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584509|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
2584510|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
2584511|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
2584512|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584513|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2584514|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2584515|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
2584516|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2584517|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584518|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2584519|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
2139527|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139528|NCT03311724|Incretins|incretins|mesh-ancestor
2139529|NCT03311724|Hormones|hormones|mesh-ancestor
2139530|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2139531|NCT03311841|Rifampin|rifampin|mesh-list
2139532|NCT03311841|Midazolam|midazolam|mesh-list
2139533|NCT03311841|Dabigatran|dabigatran|mesh-list
2139534|NCT03311841|Atorvastatin|atorvastatin|mesh-list
2139535|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2139536|NCT03311841|Pitavastatin|pitavastatin|mesh-list
2139537|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2139538|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2139539|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2139540|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
2139541|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139542|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2139543|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2139544|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139545|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2139546|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2139547|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139548|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139549|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2139550|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2139551|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2139552|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2139553|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
2139554|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
2139555|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
2139556|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
2139557|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139558|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
2139559|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2139560|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
2139561|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
2139562|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2139563|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
2139564|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2584520|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
2584521|NCT01676844|Protective Agents|protective agents|mesh-ancestor
2584522|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584523|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2584524|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
2584525|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584526|NCT01676987|Budesonide|budesonide|mesh-list
2139565|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2139566|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
2139567|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2139568|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2139569|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2139570|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2139571|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2584527|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
2584528|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2584529|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2584530|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
2584531|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584532|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584533|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2139572|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2584534|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
2584535|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
2584536|NCT01676987|Hormones|hormones|mesh-ancestor
2584537|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2584538|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2584539|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2584540|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2584541|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
2584542|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584543|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584544|NCT01677039|Ethanol|ethanol|mesh-list
2584545|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2584546|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584547|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584548|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584549|NCT01677065|Oxycodone|oxycodone|mesh-list
2584550|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2584551|NCT01677065|Narcotics|narcotics|mesh-ancestor
2584552|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584553|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584554|NCT01677065|Analgesics|analgesics|mesh-ancestor
2584555|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
2584556|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584557|NCT01677104|Liraglutide|liraglutide|mesh-list
2584558|NCT01677104|Exenatide|exenatide|mesh-list
2584559|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2584560|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2584561|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584562|NCT01677104|Incretins|incretins|mesh-ancestor
2584563|NCT01677104|Hormones|hormones|mesh-ancestor
2584564|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2584565|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2584566|NCT01677143|Bupivacaine|bupivacaine|mesh-list
2139573|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2139574|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
2139575|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
2139576|NCT03312023|Ledipasvir|ledipasvir|mesh-list
2139577|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
2139578|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2139579|NCT03312114|Avelumab|avelumab|mesh-list
2139580|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2139581|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139582|NCT03312517|Suvorexant|suvorexant|mesh-list
2139583|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2139584|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2139585|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139586|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139587|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2139588|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139589|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139590|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2139591|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
2139592|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139593|NCT03313076|Vitamin D|vitamin d|mesh-list
2139594|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
2139595|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
2139596|NCT03313076|Vitamins|vitamins|mesh-list
2139597|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
2584567|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
2584568|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
2584569|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584570|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584571|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
2584572|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584573|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2584574|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
2584575|NCT01677247|Glimepiride|glimepiride|mesh-list
2584576|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2584577|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2584578|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584579|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2584580|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
2584581|NCT01677260|Metformin|metformin|mesh-list
2139598|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139599|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2584582|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2139600|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2139601|NCT03314662|Vaccines|vaccines|mesh-list
2139602|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
2139603|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
2139604|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139605|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2139606|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
2139607|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2139608|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
2139609|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2139610|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
2139611|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139612|NCT03315559|Nemiralisib|nemiralisib|mesh-list
2139613|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2139614|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139615|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139616|NCT03315780|Dulaglutide|dulaglutide|mesh-list
2139617|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2139618|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139619|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2139620|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2139621|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2139622|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139623|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139624|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139625|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139626|NCT03315793|Analgesics|analgesics|mesh-ancestor
2139627|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
2139628|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139629|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
2139630|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2139631|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
2139632|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
2584583|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584584|NCT01677273|Caseins|caseins|mesh-list
2584585|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
2139633|NCT03316131|Febuxostat|febuxostat|mesh-list
2139634|NCT03316131|Verinurad|verinurad|mesh-list
2139635|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2139636|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139637|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2139638|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139639|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
2139640|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2139641|NCT03316378|Ropivacaine|ropivacaine|mesh-list
2139642|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
2139643|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
2139644|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139645|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139646|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
2139647|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139648|NCT03316807|Vaccines|vaccines|mesh-list
2139649|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
2139650|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139651|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
2139652|NCT03316976|Lansoprazole|lansoprazole|mesh-list
2139653|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2139654|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2139655|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2139656|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139657|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139658|NCT03318315|Vaccines|vaccines|mesh-list
2139659|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
2139660|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139661|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
2139662|NCT03318861|Fludarabine|fludarabine|mesh-list
2139663|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2139664|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
2139665|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139666|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2139667|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2139668|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
2139669|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139670|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584586|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
2584587|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584588|NCT01677338|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2584589|NCT01677338|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2584590|NCT01677338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584591|NCT01677351|Clonidine|clonidine|mesh-list
2584592|NCT01677351|Analgesics|analgesics|mesh-ancestor
2584593|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
2584594|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584595|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584596|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2584597|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
2584598|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
2584599|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2584600|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2584601|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2584602|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
2584603|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584604|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584605|NCT01677364|Oxytocin|oxytocin|mesh-list
2584606|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
2584607|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2584608|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584609|NCT01677390|Everolimus|everolimus|mesh-list
2584610|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584611|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2584612|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
2584613|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584614|NCT01677403|Tobramycin|tobramycin|mesh-list
2584615|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2584616|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584617|NCT01677442|Anesthetics|anesthetics|mesh-list
2584618|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584619|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139671|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2139672|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
2139673|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2139674|NCT03319277|Narcotics|narcotics|mesh-ancestor
2139675|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139676|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139677|NCT03319277|Analgesics|analgesics|mesh-ancestor
2139678|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
2584620|NCT01677468|Doxorubicin|doxorubicin|mesh-list
2584621|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2584622|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
2584623|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2584624|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584625|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2584626|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2584627|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584628|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584629|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
2584630|NCT01677468|Coagulants|coagulants|mesh-ancestor
2584631|NCT01677546|Insulin|insulin|mesh-list
2584632|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2584633|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2584634|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584635|NCT01677559|Paclitaxel|paclitaxel|mesh-list
2584636|NCT01677559|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2584637|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2584638|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584639|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
2584640|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
2584641|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
2584642|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584643|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
2584644|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
2584645|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584646|NCT01677598|Ustekinumab|ustekinumab|mesh-list
2584647|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
2584648|NCT01677611|Resveratrol|resveratrol|mesh-list
2584649|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
2584650|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584651|NCT01677611|Protective Agents|protective agents|mesh-ancestor
2139679|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584652|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584653|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139680|NCT03319719|Lidocaine|lidocaine|mesh-list
2139681|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
2139682|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
2139683|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
2139684|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139685|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139686|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
2139687|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139688|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2139689|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2139690|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2139691|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139692|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139693|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2139694|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
2139695|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
2139696|NCT03319719|Protective Agents|protective agents|mesh-ancestor
2139697|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
2139698|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2139699|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2139700|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
2139701|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139702|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
2139703|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2139704|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139705|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139706|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2139707|NCT03320057|Mifepristone|mifepristone|mesh-list
2139708|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2139709|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
2139710|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2139711|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139712|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2139713|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2139714|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2139715|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
2139716|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2139717|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2139718|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
2139719|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2139720|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
2584654|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2584655|NCT01677650|Methadone|methadone|mesh-list
2584656|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2584657|NCT01677650|Narcotics|narcotics|mesh-ancestor
2584658|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584659|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584660|NCT01677650|Analgesics|analgesics|mesh-ancestor
2584661|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
2584662|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584663|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
2584664|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
2584665|NCT01677702|Lactoferrin|lactoferrin|mesh-list
2584666|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584667|NCT01677754|Memantine|memantine|mesh-list
2584668|NCT01677754|Rivastigmine|rivastigmine|mesh-list
2584669|NCT01677754|Donepezil|donepezil|mesh-list
2584670|NCT01677754|Galantamine|galantamine|mesh-list
2584671|NCT01677754|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2584672|NCT01677754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584673|NCT01677754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584674|NCT01677754|Cholinergic Agents|cholinergic agents|mesh-ancestor
2584675|NCT01677754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584676|NCT01677754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584677|NCT01677754|Nootropic Agents|nootropic agents|mesh-ancestor
2584678|NCT01677754|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2584679|NCT01677754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2584680|NCT01677754|Dopamine Agents|dopamine agents|mesh-ancestor
2584681|NCT01677754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2584682|NCT01677754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2584683|NCT01677754|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2584684|NCT01677754|Autonomic Agents|autonomic agents|mesh-ancestor
2584685|NCT01677754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584686|NCT01677754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2584687|NCT01677754|Protective Agents|protective agents|mesh-ancestor
2584688|NCT01677884|Bevacizumab|bevacizumab|mesh-list
2584689|NCT01677884|Capecitabine|capecitabine|mesh-list
2584690|NCT01677884|Irinotecan|irinotecan|mesh-list
2584691|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2584692|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584693|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2584694|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2584695|NCT01677884|Growth Substances|growth substances|mesh-ancestor
2584696|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584697|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
2584698|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2584699|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
2584700|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584701|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2584702|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2584703|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584704|NCT01677897|Metformin|metformin|mesh-list
2584705|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2584706|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584707|NCT01677923|Metformin|metformin|mesh-list
2584708|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2139721|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2139722|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2139723|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2139724|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2139725|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139726|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
2139727|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2139728|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2139729|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2139730|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139731|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139732|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
2139733|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139734|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139735|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2139736|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139737|NCT03320941|Licogliflozin|licogliflozin|mesh-list
2139738|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2139739|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139740|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2139741|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139742|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2139743|NCT03321006|Citalopram|citalopram|mesh-list
2139744|NCT03321006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2139745|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2139746|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139747|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139748|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139749|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
2139750|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139751|NCT03321006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2139752|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
2139753|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2584709|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584710|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
2584711|NCT01677949|Etoposide|etoposide|mesh-list
2584712|NCT01677949|Clofarabine|clofarabine|mesh-list
2584713|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2584714|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
2584715|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139754|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139755|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2139756|NCT03321006|Analgesics|analgesics|mesh-ancestor
2139757|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
2139758|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
2139759|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
2139760|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2139761|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139762|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139763|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
2139764|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584716|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2139765|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139766|NCT03321396|Calcium|calcium|mesh-list
2139767|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2139768|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139769|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2139770|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2139771|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
2584717|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2584718|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
2584719|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584720|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584721|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2584722|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2584723|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2584724|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2584725|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584726|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2584727|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
2139778|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
2139779|NCT03322657|Neostigmine|neostigmine|mesh-list
2139780|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2139781|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139782|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139783|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
2584728|NCT01677962|Poly ICLC|poly iclc|mesh-list
2584729|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
2584730|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
2584731|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139784|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139785|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139786|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2139787|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
2139788|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139789|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2139790|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2139791|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2139792|NCT03323164|Timolol|timolol|mesh-list
2139793|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2139794|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2139795|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2139796|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
2139797|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139798|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139799|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139800|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2139801|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2584732|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2584733|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2584734|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584735|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584736|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2584737|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2584738|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584739|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
2584740|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584741|NCT01678027|Clarithromycin|clarithromycin|mesh-list
2584742|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2584743|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584744|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2584745|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584746|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668557|NCT02143050|Metformin|metformin|mesh-list
2139802|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2139803|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2139804|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2139805|NCT03323801|Tretinoin|tretinoin|mesh-list
2139806|NCT03323801|Isotretinoin|isotretinoin|mesh-list
2139807|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139808|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
2139809|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
2139810|NCT03324451|Insulin|insulin|mesh-list
2139811|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2139812|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139813|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2139814|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2139815|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2139816|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139817|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139818|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
2139819|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139820|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139821|NCT03325556|Pimavanserin|pimavanserin|mesh-list
2139822|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2139823|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2139824|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2139825|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2139826|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139827|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139828|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2139829|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2139830|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2139831|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
2139832|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139833|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139834|NCT03325816|Nivolumab|nivolumab|mesh-list
2139835|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2139836|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2139837|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139838|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2139839|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139840|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2139841|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
2139842|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2139843|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2139844|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2139845|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139846|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584747|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2584748|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2139847|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
2139848|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139849|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139850|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2139851|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139852|NCT03326999|Bupivacaine|bupivacaine|mesh-list
2139853|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
2139854|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
2139855|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139856|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139857|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
2139858|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139859|NCT03327051|Omeprazole|omeprazole|mesh-list
2139860|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2139861|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2139862|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2139863|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139864|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139865|NCT03328325|Vaccines|vaccines|mesh-list
2139866|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
2139867|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139868|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
2584749|NCT01678053|Omeprazole|omeprazole|mesh-list
2584750|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
2584751|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2584752|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2584753|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2584754|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2584755|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2584756|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584757|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
2584758|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584759|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584760|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2584761|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2584762|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584763|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2584764|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584765|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
2584766|NCT01678079|Calcium|calcium|mesh-list
2584767|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2139869|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
2139870|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
2139871|NCT03328832|Thrombin|thrombin|mesh-list
2139872|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2139873|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2139874|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584768|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584769|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2584770|NCT01678092|Omalizumab|omalizumab|mesh-list
2584771|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2584772|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2584773|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
2584774|NCT01678235|Insulin|insulin|mesh-list
2584775|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2584776|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
2139875|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
2139876|NCT03328832|Coagulants|coagulants|mesh-ancestor
2584777|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
2584778|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2584779|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584780|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
2584781|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2584782|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584783|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2584784|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584785|NCT01678352|Imiquimod|imiquimod|mesh-list
2584786|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2584787|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
2139877|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2139878|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
2139879|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2584788|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584789|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584790|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
2584791|NCT01678365|Metronidazole|metronidazole|mesh-list
2584792|NCT01678365|Gentamicins|gentamicins|mesh-list
2584793|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
2584794|NCT01678365|Ampicillin|ampicillin|mesh-list
2584795|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584796|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2584797|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2584798|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2584799|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2584800|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584801|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584802|NCT01678404|Rituximab|rituximab|mesh-list
2584803|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2584804|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584805|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
2584806|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584807|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2584808|NCT01678417|Rituximab|rituximab|mesh-list
2584809|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2584810|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584811|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
2584812|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584813|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2584814|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2139880|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
2139881|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139882|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
2139883|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
2139884|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2139885|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2139886|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2139887|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2584815|NCT01678430|Chlorambucil|chlorambucil|mesh-list
2584816|NCT01678430|Ofatumumab|ofatumumab|mesh-list
2584817|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2584818|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
2584819|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584820|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584821|NCT01678495|Plasminogen|plasminogen|mesh-list
2584822|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2584823|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2584824|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2584825|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584826|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
2584827|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584828|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2584829|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584830|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584831|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
2584832|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2584833|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584834|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2139888|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139889|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139890|NCT03328897|Omalizumab|omalizumab|mesh-list
2139891|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2139892|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2139893|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
2139894|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
2139895|NCT03329196|Hematinics|hematinics|mesh-ancestor
2139896|NCT03329209|Vedolizumab|vedolizumab|mesh-list
2139897|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2139898|NCT03329573|Paroxetine|paroxetine|mesh-list
2139899|NCT03329573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2139900|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2139901|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2139902|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139903|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139904|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
2139905|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139906|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2139907|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
2584835|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
2584836|NCT01678586|Gabapentin|gabapentin|mesh-list
2584837|NCT01678586|Analgesics|analgesics|mesh-ancestor
2584838|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
2584839|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584840|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584841|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
2584842|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2584843|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2584844|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584845|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2584846|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2584847|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2584848|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584849|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584850|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
2584851|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2584852|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2584853|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
2584854|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
2584855|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
2584856|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
2584857|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2584858|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2584859|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
2584860|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
2584861|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2584862|NCT01678599|Benzonidazole|benzonidazole|mesh-list
2584863|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2584864|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
2584865|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584866|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2584867|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2584868|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2584869|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584870|NCT01678612|Copper|copper|mesh-list
2584871|NCT01678612|Trace Elements|trace elements|mesh-ancestor
2584872|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
2584873|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584874|NCT01678664|Doxorubicin|doxorubicin|mesh-list
2584875|NCT01678664|Everolimus|everolimus|mesh-list
2584876|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2584877|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584878|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2584879|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2584880|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584881|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584882|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2139908|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2139909|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2139910|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2139911|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139912|NCT03329846|Nivolumab|nivolumab|mesh-list
2139913|NCT03329846|Linrodostat|linrodostat|mesh-list
2139914|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2139915|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139916|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2139917|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139918|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139919|NCT03329911|Paclitaxel|paclitaxel|mesh-list
2139920|NCT03329911|Carboplatin|carboplatin|mesh-list
2139921|NCT03329911|Bevacizumab|bevacizumab|mesh-list
2139922|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2139923|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139924|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
2139925|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
2139926|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
2139927|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139928|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2139929|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2139930|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2139931|NCT03329911|Growth Substances|growth substances|mesh-ancestor
2139932|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139933|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
2139934|NCT03329937|Niraparib|niraparib|mesh-list
2139935|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2139936|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139937|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139938|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2139939|NCT03330236|Anesthetics|anesthetics|mesh-list
2139940|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2139941|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139942|NCT03330457|Betrixaban|betrixaban|mesh-list
2139943|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2139944|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
2139945|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2139946|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
2139947|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139948|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584883|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
2584884|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584885|NCT01678677|Vaccines|vaccines|mesh-list
2584886|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
2584887|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584888|NCT01678690|Gemcitabine|gemcitabine|mesh-list
2584889|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2139949|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
2139950|NCT03331315|Celecoxib|celecoxib|mesh-list
2139951|NCT03331315|Ketorolac|ketorolac|mesh-list
2139952|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2139953|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2139954|NCT03331315|Analgesics|analgesics|mesh-ancestor
2139955|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
2584890|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
2584891|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584892|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584893|NCT01678690|Antiviral Agents|antiviral agents|mesh-ancestor
2584894|NCT01678690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584895|NCT01678690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2584896|NCT01678690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2584897|NCT01678690|Immunologic Factors|immunologic factors|mesh-ancestor
2584898|NCT01678690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584899|NCT01678703|Misoprostol|misoprostol|mesh-list
2139956|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139957|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139958|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2139959|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2139960|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2139961|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2139962|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2139963|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139964|NCT03331666|Evolocumab|evolocumab|mesh-list
2139965|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2139966|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2139967|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
2139968|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139969|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2139970|NCT03331835|Brodalumab|brodalumab|mesh-list
2139971|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
2139972|NCT03331965|Metoclopramide|metoclopramide|mesh-list
2139973|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
2139974|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
2139975|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2139976|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139977|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2139978|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2139979|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2139980|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
2139981|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2139982|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139983|NCT03332212|Empagliflozin|empagliflozin|mesh-list
2139984|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2584900|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2584901|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
2584902|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2584903|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584904|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2584905|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2584906|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
2584907|NCT01678716|Micronutrients|micronutrients|mesh-list
2584908|NCT01678716|Trace Elements|trace elements|mesh-list
2584909|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584910|NCT01678937|Cyclosporine|cyclosporine|mesh-list
2139985|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2139986|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2139987|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139991|NCT03332771|Metformin|metformin|mesh-list
2139992|NCT03332771|Glimepiride|glimepiride|mesh-list
2139993|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2139994|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2139995|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2139996|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2139997|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2139998|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
2139999|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2140000|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140001|NCT03333109|Erenumab|erenumab|mesh-list
2140002|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2140003|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140004|NCT03333109|Analgesics|analgesics|mesh-ancestor
2140005|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
2140006|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584911|NCT01678937|Sirolimus|sirolimus|mesh-list
2584912|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
2584913|NCT01678937|Tacrolimus|tacrolimus|mesh-list
2584914|NCT01678937|Cyclosporins|cyclosporins|mesh-list
2584915|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2584916|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
2584917|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584918|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2140007|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140008|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
2584919|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140009|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140010|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140011|NCT03334721|Gabapentin|gabapentin|mesh-list
2140012|NCT03334721|Analgesics|analgesics|mesh-ancestor
2140013|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
2140014|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140015|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140016|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
2140017|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2140018|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2140019|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140020|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2584920|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584921|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
2584922|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2584923|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
2584924|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2584925|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2584926|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584927|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2584928|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
2584929|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2584930|NCT01678963|Squalamine|squalamine|mesh-list
2584931|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2584932|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140021|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2140022|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2140023|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584933|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2584934|NCT01678963|Protective Agents|protective agents|mesh-ancestor
2584935|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584936|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584937|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2584938|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2584939|NCT01678963|Growth Substances|growth substances|mesh-ancestor
2584940|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
2584941|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
2584942|NCT01679041|Fludarabine|fludarabine|mesh-list
2420154|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420155|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2420156|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2420157|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
2420158|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
2420159|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420160|NCT00806767|Fludarabine|fludarabine|mesh-list
2420161|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
2584943|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
2584944|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2584945|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
2584946|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584947|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2584948|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2584949|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
2584950|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140024|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140025|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
2140026|NCT03334734|Isoniazid|isoniazid|mesh-list
2140027|NCT03334734|Macozinone|macozinone|mesh-list
2140028|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
2140029|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2140030|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140031|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2140032|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2140033|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
2140034|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140035|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2140036|NCT03334747|Lumefantrine|lumefantrine|mesh-list
2140037|NCT03334747|Artemether|artemether|mesh-list
2140038|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2140039|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
2140040|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2140041|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2584951|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140042|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420162|NCT00806767|Busulfan|busulfan|mesh-list
2584952|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2584953|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2584954|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
2584955|NCT01679080|Teriparatide|teriparatide|mesh-list
2584956|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2584957|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584958|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2584959|NCT01679093|Dexamethasone|dexamethasone|mesh-list
2584960|NCT01679093|Droperidol|droperidol|mesh-list
2584961|NCT01679093|Ondansetron|ondansetron|mesh-list
2584962|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2584963|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
2584964|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
2584965|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584966|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584967|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2584968|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
2584969|NCT01679093|Hormones|hormones|mesh-ancestor
2584970|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2584971|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2584972|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2584973|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
2584974|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
2584975|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2140043|NCT03334903|Gabapentin|gabapentin|mesh-list
2140044|NCT03334903|Analgesics|analgesics|mesh-ancestor
2140045|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
2140046|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584976|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
2584977|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2584978|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2584979|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2584980|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2584981|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584982|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2584983|NCT01679093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2140047|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140048|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
2140049|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2140050|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2140051|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140052|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2140053|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2140054|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2140055|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140056|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140057|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
2140058|NCT03336450|Midazolam|midazolam|mesh-list
2584984|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2584985|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2584986|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2584987|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
2584988|NCT01679106|Fentanyl|fentanyl|mesh-list
2584989|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2584990|NCT01679106|Narcotics|narcotics|mesh-ancestor
2140059|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2140060|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2140061|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140062|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140063|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2140064|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2140065|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2584991|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2584992|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2584993|NCT01679106|Analgesics|analgesics|mesh-ancestor
2584994|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
2584995|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2584996|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2584997|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2584998|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
2584999|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
2585000|NCT01679119|Gemcitabine|gemcitabine|mesh-list
2585001|NCT01679119|Prednisolone|prednisolone|mesh-list
2585002|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
2585003|NCT01679119|Rituximab|rituximab|mesh-list
2585004|NCT01679119|Vincristine|vincristine|mesh-list
2585005|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2140066|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2140067|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
2140068|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
2140069|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
2140070|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
2140071|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585006|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2585007|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
2585008|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585009|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2585010|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2585011|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
2585012|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585013|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585014|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2585015|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2585016|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2585017|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
2585018|NCT01679119|Antiviral Agents|antiviral agents|mesh-ancestor
2585019|NCT01679119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585020|NCT01679119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585021|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2585022|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
2585023|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
2585024|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
2585025|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2585026|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
2140072|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140073|NCT03336502|Posaconazole|posaconazole|mesh-list
2140074|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
2140075|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140076|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2140077|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2140078|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2140079|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2140080|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2140081|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140082|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140083|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2140084|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
2140085|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2140086|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140087|NCT03336645|Midazolam|midazolam|mesh-list
2140088|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2140089|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2140090|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140091|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140092|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2140093|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2140094|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2140095|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2140096|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
2140097|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
2140098|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
2140099|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
2140100|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140101|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140102|NCT03336853|Hybenx|hybenx|mesh-list
2585027|NCT01679119|Hormones|hormones|mesh-ancestor
2585028|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2585029|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2585030|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2585031|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
2585032|NCT01679327|Leucovorin|leucovorin|mesh-list
2585033|NCT01679327|Bevacizumab|bevacizumab|mesh-list
2585034|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
2585035|NCT01679327|Calcium|calcium|mesh-list
2585036|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
2585037|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2585038|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585039|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2140103|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
2140104|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
2140105|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140106|NCT03337152|Chloroquine|chloroquine|mesh-list
2140107|NCT03337152|Primaquine|primaquine|mesh-list
2585040|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2585041|NCT01679327|Growth Substances|growth substances|mesh-ancestor
2140108|NCT03337152|Amebicides|amebicides|mesh-ancestor
2140109|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2140110|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2140111|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140112|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
2140113|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2140114|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2140115|NCT03337308|Ezetimibe|ezetimibe|mesh-list
2140116|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2140117|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2140118|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
2140119|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140120|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2140121|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140122|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140123|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140124|NCT03337477|Insulin|insulin|mesh-list
2140125|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2140126|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140127|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140128|NCT03337490|Ivermectin|ivermectin|mesh-list
2140129|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2140130|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585042|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585043|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
2585044|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2585045|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2585046|NCT01679327|Antidotes|antidotes|mesh-ancestor
2585047|NCT01679327|Protective Agents|protective agents|mesh-ancestor
2585048|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
2585049|NCT01679327|Vitamins|vitamins|mesh-ancestor
2585050|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
2585051|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
2140131|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
2140132|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140133|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140134|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
2140135|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140136|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140137|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
2140138|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
2585052|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585053|NCT01679392|Ropivacaine|ropivacaine|mesh-list
2585054|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
2585055|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
2585056|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585057|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585058|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
2585059|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585060|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2585061|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2585062|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2585063|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2585064|NCT01679574|Metformin|metformin|mesh-list
2585065|NCT01679574|Letrozole|letrozole|mesh-list
2585066|NCT01679574|Clomiphene|clomiphene|mesh-list
2585067|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2585068|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585069|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585070|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2585071|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2585072|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585073|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585074|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2585075|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
2585076|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2585077|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2585078|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
2585079|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2585080|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2585081|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2140139|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
2140140|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585082|NCT01679639|Rifampin|rifampin|mesh-list
2140141|NCT03338400|Dexamethasone|dexamethasone|mesh-list
2140142|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2140143|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
2140144|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
2140145|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140146|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140147|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2140148|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
2140149|NCT03338400|Hormones|hormones|mesh-ancestor
2140150|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2140151|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2140152|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140153|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
2140154|NCT03338569|Vitamins|vitamins|mesh-ancestor
2140155|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
2140156|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140157|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
2140158|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140159|NCT03338569|Protective Agents|protective agents|mesh-ancestor
2140160|NCT03338803|Linagliptin|linagliptin|mesh-list
2140161|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140162|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140163|NCT03338803|Incretins|incretins|mesh-ancestor
2140164|NCT03338803|Hormones|hormones|mesh-ancestor
2140165|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2140166|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2140167|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
2140168|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140169|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140170|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
2140171|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2140172|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140173|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140174|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140175|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2140176|NCT03338998|Siponimod|siponimod|mesh-list
2140177|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2140178|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140179|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2140180|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
2140181|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140182|NCT03339297|Defibrotide|defibrotide|mesh-list
2140183|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2140184|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2140185|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140186|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2140187|NCT03339453|Glucagon|glucagon|mesh-list
2140188|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2140189|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2140190|NCT03339453|Hormones|hormones|mesh-ancestor
2140191|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2585083|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2585084|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
2585085|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2585086|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585087|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
2585088|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2585089|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585090|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585091|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2585092|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2585093|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2585094|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2585095|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2585096|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2585097|NCT01679652|Nebivolol|nebivolol|mesh-list
2585098|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2140192|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140193|NCT03339453|Incretins|incretins|mesh-ancestor
2140194|NCT03339583|Zopiclone|zopiclone|mesh-list
2140195|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2140196|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2420163|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
2585099|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
2585100|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2585101|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2585102|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2585103|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
2585104|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585105|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585106|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585107|NCT01679691|Anesthetics|anesthetics|mesh-list
2585108|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585109|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585110|NCT01679743|Trastuzumab|trastuzumab|mesh-list
2585111|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2585112|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585113|NCT01679795|Tibolone|tibolone|mesh-list
2585114|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
2140197|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140198|NCT03339726|Phenylephrine|phenylephrine|mesh-list
2140199|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
2140200|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2140201|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
2140202|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
2140203|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140204|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140205|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
2140206|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2140207|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
2140208|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
2585115|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
2585116|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2585117|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585118|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2585119|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2585120|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585121|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2585122|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
2585123|NCT01679795|Hormones|hormones|mesh-ancestor
2585124|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
2585125|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
2585126|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585127|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2585128|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585129|NCT01679899|Vildagliptin|vildagliptin|mesh-list
2585130|NCT01679899|Gliclazide|gliclazide|mesh-list
2140209|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2140210|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2140211|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2140212|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
2140213|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140214|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140215|NCT03339726|Protective Agents|protective agents|mesh-ancestor
2140216|NCT03340350|Minocycline|minocycline|mesh-list
2585131|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2585132|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585133|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2585134|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
2585135|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585136|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585137|NCT01679951|Methotrexate|methotrexate|mesh-list
2585138|NCT01679951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2585139|NCT01679951|Abortifacient Agents|abortifacient agents|mesh-ancestor
2585140|NCT01679951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2585141|NCT01679951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585142|NCT01679951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2140217|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2140218|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140219|NCT03340961|Doxycycline|doxycycline|mesh-list
2140220|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2140221|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140222|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
2140223|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2140224|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2585143|NCT01679951|Antimetabolites|antimetabolites|mesh-ancestor
2140225|NCT03341273|Azithromycin|azithromycin|mesh-list
2140226|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2140227|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140228|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
2140229|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140230|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140231|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
2140232|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140233|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140234|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
2140235|NCT03341910|Tazarotene|tazarotene|mesh-list
2140236|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
2140237|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
2140238|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
2140239|NCT03341910|Vitamins|vitamins|mesh-ancestor
2140240|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
2140241|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140242|NCT03342001|Calcitonin|calcitonin|mesh-list
2140243|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
2140244|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2140245|NCT03342001|Katacalcin|katacalcin|mesh-list
2140246|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2140247|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140248|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2140249|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
2140250|NCT03342404|Luspatercept|luspatercept|mesh-list
2140251|NCT03342404|Hematinics|hematinics|mesh-ancestor
2140252|NCT03342690|Eplerenone|eplerenone|mesh-list
2140253|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2140254|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
2140255|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2140256|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140257|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2420164|NCT00806767|Antibodies|antibodies|mesh-list
2420165|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
2420166|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2420167|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2420168|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140258|NCT03342690|Diuretics|diuretics|mesh-ancestor
2140259|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
2140260|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2140261|NCT03342963|Aripiprazole|aripiprazole|mesh-list
2140262|NCT03342963|Sertraline|sertraline|mesh-list
2140263|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
2140264|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2140265|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2140266|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2140267|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140268|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140269|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
2140270|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
2140271|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140272|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140273|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2140274|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2140275|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
2140276|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2140277|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2140278|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2140279|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2140280|NCT03342963|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2140281|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2140282|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2140283|NCT03343067|Norethindrone|norethindrone|mesh-list
2140284|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
2140285|NCT03343067|Estradiol|estradiol|mesh-list
2140286|NCT03343067|Estrogens|estrogens|mesh-ancestor
2140287|NCT03343067|Hormones|hormones|mesh-ancestor
2140288|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2140289|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140290|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2140291|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
2140292|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2140293|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2140294|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2140295|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2140296|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2140297|NCT03343080|Lidocaine|lidocaine|mesh-list
2585144|NCT01679951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585145|NCT01679951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585146|NCT01679951|Dermatologic Agents|dermatologic agents|mesh-ancestor
2585147|NCT01679951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585148|NCT01679951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2585149|NCT01679951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2585150|NCT01679951|Immunologic Factors|immunologic factors|mesh-ancestor
2585151|NCT01679951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2585152|NCT01679951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2585153|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
2585154|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2585155|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2585156|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
2585157|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585158|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2585159|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2585160|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585161|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585162|NCT01680042|Phenytoin|phenytoin|mesh-list
2585163|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
2585164|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2585165|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2585166|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2585167|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585168|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2585169|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2585170|NCT01680081|Adenosine|adenosine|mesh-list
2585171|NCT01680081|Analgesics|analgesics|mesh-ancestor
2585172|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
2585173|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585174|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585175|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2585176|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
2585177|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2585178|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
2585179|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
2585180|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585181|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585182|NCT01680094|Panobinostat|panobinostat|mesh-list
2140298|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
2140299|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
2140300|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140301|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140302|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
2140303|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140304|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2140305|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2140306|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2140307|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2140308|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140309|NCT03343639|Serlopitant|serlopitant|mesh-list
2140310|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2140311|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140312|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140313|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140314|NCT03344172|Gemcitabine|gemcitabine|mesh-list
2140315|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
2585183|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585184|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2585185|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585186|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585187|NCT01680107|Cycloserine|cycloserine|mesh-list
2585188|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2585189|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585190|NCT01680107|Renal Agents|renal agents|mesh-ancestor
2585191|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2585192|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
2585193|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2585194|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
2140316|NCT03344172|Paclitaxel|paclitaxel|mesh-list
2140317|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2140318|NCT03344172|Avelumab|avelumab|mesh-list
2585195|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585196|NCT01680120|Anesthetics|anesthetics|mesh-list
2585197|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585198|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585199|NCT01680146|Caseins|caseins|mesh-list
2585200|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
2585201|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
2585202|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585203|NCT01680185|Insulin|insulin|mesh-list
2585204|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2585205|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
2585206|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
2585207|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
2585208|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
2585209|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
2585210|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2585211|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585212|NCT01680198|Vitamin D|vitamin d|mesh-list
2585213|NCT01680198|Vitamins|vitamins|mesh-ancestor
2585214|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
2585215|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585216|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2585217|NCT01680250|Sirolimus|sirolimus|mesh-list
2585218|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2585219|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585220|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2585221|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585222|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
2585223|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2585224|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
2585225|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585226|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2585227|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2585228|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2585229|NCT01680263|Analgesics|analgesics|mesh-ancestor
2585230|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
2585231|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585232|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585233|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2585234|NCT01680406|Chloroquine|chloroquine|mesh-list
2585235|NCT01680406|Lumefantrine|lumefantrine|mesh-list
2585236|NCT01680406|Artemether|artemether|mesh-list
2585237|NCT01680406|Primaquine|primaquine|mesh-list
2585238|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2585239|NCT01680406|Amebicides|amebicides|mesh-ancestor
2585240|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2585241|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2585242|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585243|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
2585244|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2585245|NCT01680471|Midazolam|midazolam|mesh-list
2140319|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2140320|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140321|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
2140322|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
2140323|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
2140324|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140325|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2140326|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
2140327|NCT03344172|Antiviral Agents|antiviral agents|mesh-ancestor
2140328|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140329|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140330|NCT03344172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2140331|NCT03344172|Immunologic Factors|immunologic factors|mesh-ancestor
2140332|NCT03344172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140333|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
2140334|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2140335|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2140336|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2140337|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2140338|NCT03344510|Anesthetics|anesthetics|mesh-list
2140339|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140340|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585246|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2585247|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2585248|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585249|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585250|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2585251|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2585252|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2585253|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2585254|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
2585255|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
2585256|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
2585257|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
2585258|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585259|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585260|NCT01680536|Maraviroc|maraviroc|mesh-list
2585261|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2585262|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2585263|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140341|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2140342|NCT03344861|Trioxsalen|trioxsalen|mesh-list
2140343|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140344|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
2140345|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2140346|NCT03345407|Albuterol|albuterol|mesh-list
2140347|NCT03345407|Nemiralisib|nemiralisib|mesh-list
2140348|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2140349|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
2140350|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140351|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140352|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2140353|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
2140354|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
2140355|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2140356|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2140357|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2140358|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2140359|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
2140360|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140361|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140362|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2140363|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140364|NCT03345979|Aripiprazole|aripiprazole|mesh-list
2585264|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2585265|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2585266|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
2585267|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585268|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2585269|NCT01680679|Vaccines|vaccines|mesh-list
2585270|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
2585271|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585272|NCT01680718|Vasopressins|vasopressins|mesh-list
2585273|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
2585274|NCT01680718|Oxytocin|oxytocin|mesh-list
2140365|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2140366|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
2140367|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
2140368|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2140369|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2140370|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2140371|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140372|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140373|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
2140374|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
2140375|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140376|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140377|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2140378|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2585275|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
2585276|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2585277|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585278|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
2585279|NCT01680718|Coagulants|coagulants|mesh-ancestor
2585280|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2585281|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2585282|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
2585283|NCT01680796|Dexamethasone|dexamethasone|mesh-list
2585284|NCT01680796|Bortezomib|bortezomib|mesh-list
2585285|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2585286|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
2140379|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
2585287|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
2585288|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585289|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585290|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2585291|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
2585292|NCT01680796|Hormones|hormones|mesh-ancestor
2585293|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2585294|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2585295|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585296|NCT01680913|Anesthetics|anesthetics|mesh-list
2585297|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585298|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585299|NCT01680939|Ibuprofen|ibuprofen|mesh-list
2585300|NCT01680939|Morphine|morphine|mesh-list
2585301|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2585302|NCT01680939|Narcotics|narcotics|mesh-ancestor
2585303|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585304|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585305|NCT01680939|Analgesics|analgesics|mesh-ancestor
2585306|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
2585307|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585308|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2585309|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2585310|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2585311|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2585312|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2585313|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585314|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585315|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
2585316|NCT01680952|Sirolimus|sirolimus|mesh-list
2585317|NCT01680952|Tacrolimus|tacrolimus|mesh-list
2585318|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2585319|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
2585320|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585321|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2585322|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585323|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585324|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2585325|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585326|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2585327|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
2585328|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2585329|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585330|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
2585331|NCT01681134|Tacrolimus|tacrolimus|mesh-list
2585332|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2585333|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
2585334|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585335|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2585336|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585337|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585338|NCT01681264|Guanfacine|guanfacine|mesh-list
2585339|NCT01681264|Morphine|morphine|mesh-list
2585340|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2585341|NCT01681264|Narcotics|narcotics|mesh-ancestor
2585342|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585343|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585344|NCT01681264|Analgesics|analgesics|mesh-ancestor
2585345|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
2585346|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585347|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2585348|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2585349|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2585350|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2585351|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
2585352|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585353|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585354|NCT01681446|Interferons|interferons|mesh-list
2585355|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
2585356|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585357|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
2585358|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585359|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
2585360|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585361|NCT01681537|Cytarabine|cytarabine|mesh-list
2585362|NCT01681537|Etoposide|etoposide|mesh-list
2585363|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
2585364|NCT01681537|Lenalidomide|lenalidomide|mesh-list
2585365|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2585366|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585367|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2585368|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2585369|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585370|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585371|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2585372|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
2585373|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
2140380|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2140381|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2140382|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2140383|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2140384|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
2140385|NCT03346057|Rocuronium|rocuronium|mesh-list
2140386|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
2140387|NCT03346057|Neostigmine|neostigmine|mesh-list
2140388|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2140389|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2140390|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2140391|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140392|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140393|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2140394|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140395|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140396|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
2140397|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140398|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2140399|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
2140400|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2140401|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2140402|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2140403|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2140404|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
2140405|NCT03346070|Rocuronium|rocuronium|mesh-list
2140406|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
2140407|NCT03346070|Neostigmine|neostigmine|mesh-list
2140408|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2140409|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2140410|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2140411|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140412|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140413|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2140414|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140415|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140416|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
2585374|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585375|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2585376|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
2585377|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585378|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2585379|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2585380|NCT01681537|Growth Substances|growth substances|mesh-ancestor
2585381|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
2585382|NCT01681537|Analgesics|analgesics|mesh-ancestor
2585383|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
2585384|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585385|NCT01681550|Incretins|incretins|mesh-list
2585386|NCT01681550|Hormones|hormones|mesh-ancestor
2585387|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2585388|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585389|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
2585390|NCT01681563|Ofatumumab|ofatumumab|mesh-list
2585391|NCT01681563|Pentostatin|pentostatin|mesh-list
2140417|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140418|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2140419|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
2140420|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2140421|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2140422|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2140423|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2140424|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2140425|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
2140426|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140427|NCT03348683|Propranolol|propranolol|mesh-list
2140428|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2585392|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2585393|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
2585394|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140429|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2140430|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
2140431|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140432|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140433|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140434|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2140435|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2140436|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
2140437|NCT03349060|Abrocitinib|abrocitinib|mesh-list
2140438|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2140439|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140440|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140441|NCT03349333|Folic Acid|folic acid|mesh-list
2140442|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
2140443|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
2140444|NCT03349333|Vitamins|vitamins|mesh-ancestor
2140445|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
2140446|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140447|NCT03349333|Hematinics|hematinics|mesh-ancestor
2140448|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
2140449|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2140450|NCT03349710|Nivolumab|nivolumab|mesh-list
2140451|NCT03349710|Cetuximab|cetuximab|mesh-list
2140452|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140453|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2140454|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2140455|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140456|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2140457|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
2585395|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2585396|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2585397|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
2585398|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585399|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585400|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2585401|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2585402|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585403|NCT01681667|Ibuprofen|ibuprofen|mesh-list
2585404|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2585405|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2585406|NCT01681667|Analgesics|analgesics|mesh-ancestor
2585407|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
2585408|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585409|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585410|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2585411|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2585412|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2585413|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585414|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585415|NCT01681680|Metformin|metformin|mesh-list
2585416|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2585417|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585418|NCT01681693|Metformin|metformin|mesh-list
2585419|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2585420|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585421|NCT01681875|Nicotine|nicotine|mesh-list
2585422|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2585423|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
2585424|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585425|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585426|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2585427|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2585428|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
2585429|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585430|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585431|NCT01681966|Ropivacaine|ropivacaine|mesh-list
2585432|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2585433|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
2585434|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
2585435|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585436|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585437|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
2585438|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585439|NCT01681979|Fluticasone|fluticasone|mesh-list
2585440|NCT01681979|Xhance|xhance|mesh-list
2585441|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2585442|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2585443|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2585444|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
2585445|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585446|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585447|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2585448|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
2585449|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
2585450|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2585451|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2585452|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2585453|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2585454|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
2585455|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585456|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585457|NCT01682109|Valacyclovir|valacyclovir|mesh-list
2585458|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
2585459|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585460|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2585461|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2585462|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2585463|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585464|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585465|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2585466|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2585467|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2585468|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
2585469|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585470|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585471|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2585472|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2585473|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
2585474|NCT01682187|Lomustine|lomustine|mesh-list
2140458|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
2140468|NCT03351231|Nivolumab|nivolumab|mesh-list
2140469|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2140470|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140471|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2140472|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140473|NCT03351478|Empagliflozin|empagliflozin|mesh-list
2140474|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2140475|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2140476|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140477|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140478|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140479|NCT03351608|Atropine|atropine|mesh-list
2585475|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2585476|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
2585477|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585478|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585479|NCT01682343|Calcium|calcium|mesh-list
2585480|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2585481|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585482|NCT01682408|Mannitol|mannitol|mesh-list
2585483|NCT01682408|Ranitidine|ranitidine|mesh-list
2585484|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2585485|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2585486|NCT01682408|Diuretics|diuretics|mesh-ancestor
2585487|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
2585488|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585489|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2585490|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2585491|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2585492|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
2585493|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
2585494|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585495|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585496|NCT01682421|Dexamethasone|dexamethasone|mesh-list
2585497|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
2585498|NCT01682421|BB 1101|bb 1101|mesh-list
2585499|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585500|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585501|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2585502|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
2585503|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
2585504|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585505|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2585506|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
2585507|NCT01682421|Hormones|hormones|mesh-ancestor
2585508|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2585509|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2585510|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585511|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
2585512|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585513|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
2585514|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
2585515|NCT01682499|Calcium|calcium|mesh-list
2585516|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2585517|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585518|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2585519|NCT01682499|Analgesics|analgesics|mesh-ancestor
2585520|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
2585521|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585522|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
2585523|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585524|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2585525|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
2585526|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2585527|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2585528|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585529|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
2585530|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2585531|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
2585532|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2585533|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2585534|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2585535|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585536|NCT01682577|Perindopril|perindopril|mesh-list
2585537|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2585538|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
2585539|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585540|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585541|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2585542|NCT01682616|Rituximab|rituximab|mesh-list
2585543|NCT01682616|Venetoclax|venetoclax|mesh-list
2585544|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2585545|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585546|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
2585547|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585548|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2585549|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
2585550|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2585551|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2585552|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585553|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
2585554|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585555|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585556|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2585557|NCT01682746|Trioxsalen|trioxsalen|mesh-list
2585558|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585559|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
2585560|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2585561|NCT01682772|Olaparib|olaparib|mesh-list
2585562|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2585563|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140480|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
2140481|NCT03351608|Neostigmine|neostigmine|mesh-list
2140482|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2140483|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2140484|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2140485|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
2140486|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140487|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140488|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2140489|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
2140490|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
2140491|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
2140492|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2140493|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2140494|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
2140495|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140496|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140497|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2585564|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585565|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585566|NCT01682902|Insulin|insulin|mesh-list
2585567|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2585568|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
2585569|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
2585570|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2585571|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2585572|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585573|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
2585574|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2585575|NCT01682941|Estrogens|estrogens|mesh-ancestor
2585576|NCT01682941|Hormones|hormones|mesh-ancestor
2585577|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2585578|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585579|NCT01683006|Rocuronium|rocuronium|mesh-list
2585580|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2585581|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2585582|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2585583|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585584|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585585|NCT01683032|Methylphenidate|methylphenidate|mesh-list
2585586|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2585587|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585588|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2585589|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2585590|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2585591|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585592|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
2585593|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585594|NCT01683084|Telmisartan|telmisartan|mesh-list
2585595|NCT01683084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2585596|NCT01683084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2585597|NCT01683084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2585598|NCT01683084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585599|NCT01683149|Sorafenib|sorafenib|mesh-list
2585600|NCT01683149|Topotecan|topotecan|mesh-list
2585601|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
2140498|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140499|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2140500|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
2140501|NCT03351933|Antibodies|antibodies|mesh-list
2140502|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
2140503|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2140504|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2140505|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
2140506|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140507|NCT03352323|Phenylephrine|phenylephrine|mesh-list
2140508|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
2140509|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2140510|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2140511|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
2140512|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140513|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140514|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140515|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
2140516|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
2140517|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140518|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
2420169|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2420170|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
2420171|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420172|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2420173|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
2420174|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420175|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
2420176|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2420177|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2420178|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
2420179|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2420180|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2420181|NCT00806871|Prednisolone|prednisolone|mesh-list
2420182|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
2420183|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2585602|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140519|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2140520|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
2140521|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2140522|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
2140523|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2140524|NCT03352323|Protective Agents|protective agents|mesh-ancestor
2140525|NCT03352414|Alvimopan|alvimopan|mesh-list
2140526|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2140527|NCT03353740|Edetic Acid|edetic acid|mesh-list
2140528|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
2140529|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
2140530|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140531|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
2140532|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2585603|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2585604|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585605|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585606|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2585607|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2585608|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2585609|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2585610|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2585611|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2585612|NCT01683175|Cisplatin|cisplatin|mesh-list
2585613|NCT01683175|Vinorelbine|vinorelbine|mesh-list
2585614|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585615|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2585616|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585617|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585618|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2585619|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
2585620|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
2585621|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
2585622|NCT01683188|Vemurafenib|vemurafenib|mesh-list
2585623|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585624|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2585625|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585626|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585627|NCT01683253|Dopamine|dopamine|mesh-list
2585628|NCT01683253|Levodopa|levodopa|mesh-list
2585629|NCT01683253|Carbidopa|carbidopa|mesh-list
2585630|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
2585631|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2585632|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2585633|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
2585634|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585635|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585636|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585637|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2585638|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585639|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2585640|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
2585641|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
2585642|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585643|NCT01683253|Protective Agents|protective agents|mesh-ancestor
2585644|NCT01683292|Apomorphine|apomorphine|mesh-list
2585645|NCT01683292|Emetics|emetics|mesh-ancestor
2585646|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585647|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
2585648|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585649|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2585650|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
2585651|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
2585652|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585653|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585654|NCT01683552|Fexofenadine|fexofenadine|mesh-list
2585655|NCT01683552|Prednisone|prednisone|mesh-list
2585656|NCT01683552|Aprepitant|aprepitant|mesh-list
2585657|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2585658|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
2585659|NCT01683552|Hormones|hormones|mesh-ancestor
2585660|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2585661|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585662|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2585663|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585664|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
2585665|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
2585666|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585667|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2585668|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2585669|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585670|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585671|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2585672|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2585673|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2585674|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
2585675|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
2585676|NCT01683656|Niacin|niacin|mesh-list
2585677|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2585678|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
2585679|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585680|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2585681|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
2585682|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
2585683|NCT01683656|Vitamins|vitamins|mesh-ancestor
2585684|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
2585685|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585686|NCT01683682|Carboplatin|carboplatin|mesh-list
2585687|NCT01683682|Vinorelbine|vinorelbine|mesh-list
2585688|NCT01683682|Nintedanib|nintedanib|mesh-list
2585689|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585690|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2585691|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
2585692|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
2585693|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
2585694|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585695|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2585696|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585697|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
2585698|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2585699|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2585700|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585701|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
2585702|NCT01683747|Coagulants|coagulants|mesh-ancestor
2585703|NCT01683760|Fluconazole|fluconazole|mesh-list
2585704|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
2585705|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585706|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2585707|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2585708|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585709|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668558|NCT02143050|Trametinib|trametinib|mesh-list
2585710|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2585711|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
2585712|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2585713|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585714|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2585715|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2585716|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2585717|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
2585718|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585719|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
2585720|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2585721|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2585722|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585723|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
2585724|NCT01683955|Coagulants|coagulants|mesh-ancestor
2585725|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
2585726|NCT01684059|Astringents|astringents|mesh-ancestor
2585727|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585728|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
2585729|NCT01684072|Vaccines|vaccines|mesh-list
2140544|NCT03354429|Ticagrelor|ticagrelor|mesh-list
2140545|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2140546|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2140547|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2140548|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2140549|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
2140550|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140551|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140552|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140553|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
2140554|NCT03354598|Probenecid|probenecid|mesh-list
2140555|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2140556|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140557|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2585730|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
2585731|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585732|NCT01684085|Lorazepam|lorazepam|mesh-list
2585733|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
2585734|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
2585735|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
2585736|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585737|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585738|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2585739|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2585740|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585741|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2585742|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2585743|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2585744|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
2585745|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
2585746|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585747|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585748|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
2585749|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2140558|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2140559|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140560|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140561|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140562|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2140563|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2140564|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
2140565|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
2140566|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2140567|NCT03354598|Renal Agents|renal agents|mesh-ancestor
2140568|NCT03355326|Glycerol|glycerol|mesh-list
2140569|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2140570|NCT03355326|Protective Agents|protective agents|mesh-ancestor
2140571|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140572|NCT03355820|Antibodies|antibodies|mesh-list
2140573|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
2140574|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140575|NCT03357341|Albuterol|albuterol|mesh-list
2140576|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2140577|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
2585750|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585751|NCT01684111|Vinorelbine|vinorelbine|mesh-list
2585752|NCT01684111|Nintedanib|nintedanib|mesh-list
2585753|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2585754|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585755|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
2585756|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
2585757|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
2585758|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585759|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2585760|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585761|NCT01684241|Vaccines|vaccines|mesh-list
2585762|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
2585763|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585764|NCT01684306|Modafinil|modafinil|mesh-list
2585765|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2585766|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585767|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2585768|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2585769|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2585770|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585771|NCT01684319|Caseins|caseins|mesh-list
2585772|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
2585773|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
2585774|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585775|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
2585776|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2585777|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2585778|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585779|NCT01684397|Bevacizumab|bevacizumab|mesh-list
2585780|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2585781|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
2585782|NCT01684397|Antibodies|antibodies|mesh-list
2585783|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
2585784|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2585785|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
2585786|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585787|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2585788|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2585789|NCT01684397|Growth Substances|growth substances|mesh-ancestor
2585790|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585791|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
2585792|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
2585793|NCT01684449|Gemcitabine|gemcitabine|mesh-list
2585794|NCT01684449|Sirolimus|sirolimus|mesh-list
2585795|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2585796|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
2585797|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585798|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585799|NCT01684449|Antiviral Agents|antiviral agents|mesh-ancestor
2585800|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585801|NCT01684449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585802|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2585803|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
2585804|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585805|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2585806|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2585807|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
2585808|NCT01684657|Asenapine|asenapine|mesh-list
2585809|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2585810|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2585811|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585812|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585813|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2585814|NCT01684683|Theophylline|theophylline|mesh-list
2585815|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2585816|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
2585817|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585818|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585819|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2585820|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
2585821|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2585822|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585823|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585824|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
2585825|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2585826|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2585827|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
2585828|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585829|NCT01684774|Bupivacaine|bupivacaine|mesh-list
2585830|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
2585831|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
2585832|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585833|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585834|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
2585835|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585836|NCT01684787|Ribavirin|ribavirin|mesh-list
2585837|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2585838|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
2585839|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
2585840|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585841|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
2585842|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585843|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
2585844|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585845|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2585846|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
2585847|NCT01684800|Coagulants|coagulants|mesh-ancestor
2585848|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2585849|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
2585850|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585851|NCT01684813|Clopidogrel|clopidogrel|mesh-list
2585852|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2585853|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2585854|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2585855|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2585856|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2585857|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
2585858|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585859|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585860|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585861|NCT01684865|Rituximab|rituximab|mesh-list
2585862|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2585863|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585864|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
2585865|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140578|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140579|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585866|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2585867|NCT01684969|Haloperidol|haloperidol|mesh-list
2585868|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
2140580|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2140581|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
2140582|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
2140583|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2420184|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
2420185|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2420186|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
2420187|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
2420188|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420189|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420190|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2420191|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
2420192|NCT00806871|Hormones|hormones|mesh-ancestor
2420193|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2420194|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2420195|NCT00806871|Protective Agents|protective agents|mesh-ancestor
2420196|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2420197|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420198|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
2420199|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2420200|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420201|NCT00806910|Conivaptan|conivaptan|mesh-list
2420202|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2420203|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420204|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
2420205|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420206|NCT00806923|Gemcitabine|gemcitabine|mesh-list
2420207|NCT00806923|Bevacizumab|bevacizumab|mesh-list
2585869|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
2585870|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
2585871|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585872|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585873|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2585874|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2585875|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2140584|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2140585|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2140586|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2140587|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
2140588|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140589|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140590|NCT03357393|Midazolam|midazolam|mesh-list
2140591|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
2140592|NCT03357393|Scopolamine|scopolamine|mesh-list
2140593|NCT03357393|Morphine|morphine|mesh-list
2140594|NCT03357393|Propofol|propofol|mesh-list
2140595|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2140596|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2140597|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140598|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140599|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2140600|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
2140601|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
2140602|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2140603|NCT03357393|Narcotics|narcotics|mesh-ancestor
2140604|NCT03357393|Analgesics|analgesics|mesh-ancestor
2585876|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2585877|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2585878|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2585879|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
2585880|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585881|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585882|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2585883|NCT01684982|Sirolimus|sirolimus|mesh-list
2585884|NCT01684982|Everolimus|everolimus|mesh-list
2585885|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585886|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2585887|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
2585888|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585889|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2585890|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585891|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2585892|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
2585893|NCT01684995|Nicotine|nicotine|mesh-list
2585894|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2585895|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
2585896|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140605|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
2140606|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585897|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585898|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2585899|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2585900|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
2585901|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585902|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585903|NCT01685125|Prednisone|prednisone|mesh-list
2585904|NCT01685125|Dasatinib|dasatinib|mesh-list
2585905|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
2585906|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2585907|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
2140607|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2140608|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2140609|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2140610|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2140611|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
2140612|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
2140613|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140614|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140615|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2140616|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2140617|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
2140618|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
2585908|NCT01685125|Hormones|hormones|mesh-ancestor
2585909|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2585910|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585911|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2585912|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585913|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2585914|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585915|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585916|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2585917|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
2585918|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2585919|NCT01685255|Tamoxifen|tamoxifen|mesh-list
2585920|NCT01685255|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2585921|NCT01685255|Hormone Antagonists|hormone antagonists|mesh-ancestor
2585922|NCT01685255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2585923|NCT01685255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585924|NCT01685255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2585925|NCT01685255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585926|NCT01685255|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2585927|NCT01685255|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2585928|NCT01685255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2585929|NCT01685268|Prednisone|prednisone|mesh-list
2585930|NCT01685268|Prednisolone|prednisolone|mesh-list
2585931|NCT01685268|Abiraterone Acetate|abiraterone acetate|mesh-list
2585932|NCT01685268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2585933|NCT01685268|Glucocorticoids|glucocorticoids|mesh-ancestor
2585934|NCT01685268|Hormones|hormones|mesh-ancestor
2585935|NCT01685268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2140619|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
2140620|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2140621|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
2585936|NCT01685268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585937|NCT01685268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2585938|NCT01685268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585939|NCT01685268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2585940|NCT01685268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585941|NCT01685268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585942|NCT01685268|Hormone Antagonists|hormone antagonists|mesh-ancestor
2585943|NCT01685268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2585944|NCT01685281|Metadoxine|metadoxine|mesh-list
2585945|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2585946|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
2585947|NCT01685333|Hematinics|hematinics|mesh-ancestor
2585948|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
2585949|NCT01685359|Hematinics|hematinics|mesh-ancestor
2585950|NCT01685398|Timolol|timolol|mesh-list
2585951|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2585952|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2585953|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2140622|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
2140623|NCT03357614|Amoxicillin|amoxicillin|mesh-list
2140624|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
2140625|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
2140626|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
2140627|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2140628|NCT03357614|Ertapenem|ertapenem|mesh-list
2140629|NCT03357614|Lactams|lactams|mesh-list
2140630|NCT03357614|Probenecid|probenecid|mesh-list
2140631|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2140632|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140633|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2140634|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2140635|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140636|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140637|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140638|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2140639|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2140640|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2140641|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
2585954|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2585955|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
2585956|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2585957|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585958|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585959|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2585960|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2585961|NCT01685424|Etoricoxib|etoricoxib|mesh-list
2585962|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2140642|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
2140643|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2140644|NCT03357614|Renal Agents|renal agents|mesh-ancestor
2140645|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
2140646|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
2585963|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2585964|NCT01685424|Analgesics|analgesics|mesh-ancestor
2585965|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
2585966|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2585967|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585968|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2585969|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2585970|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2585971|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2140649|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
2140650|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2140651|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
2140652|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140653|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140654|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2140655|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
2140656|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
2140657|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2140658|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
2140659|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140660|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140661|NCT03358472|Carboplatin|carboplatin|mesh-list
2140662|NCT03358472|Fluorouracil|fluorouracil|mesh-list
2140663|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
2140664|NCT03358472|Cetuximab|cetuximab|mesh-list
2140665|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140666|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
2140667|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140668|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2140669|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2140670|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
2140671|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140672|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2140673|NCT03358576|Amoxicillin|amoxicillin|mesh-list
2140674|NCT03358576|Metronidazole|metronidazole|mesh-list
2585972|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585973|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585974|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
2585975|NCT01685489|Docetaxel|docetaxel|mesh-list
2585976|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2585977|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
2585978|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
2585979|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
2585980|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2585981|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2585982|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
2585983|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585984|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2585985|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
2585986|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585987|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
2140675|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
2140676|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
2140677|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
2140678|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2140679|NCT03358576|Ertapenem|ertapenem|mesh-list
2140680|NCT03358576|Lactams|lactams|mesh-list
2140681|NCT03358576|Probenecid|probenecid|mesh-list
2140682|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2140683|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2585988|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2585989|NCT01685489|Protective Agents|protective agents|mesh-ancestor
2585990|NCT01685502|Acarbose|acarbose|mesh-list
2585991|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2585992|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2585993|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140684|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2140685|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2140686|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2140687|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2585994|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2585995|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2585996|NCT01685515|Decitabine|decitabine|mesh-list
2585997|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
2585998|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2585999|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
2586000|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586001|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586002|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586003|NCT01685658|Acetaminophen|acetaminophen|mesh-list
2586004|NCT01685658|Ketoprofen|ketoprofen|mesh-list
2586005|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2586006|NCT01685658|Analgesics|analgesics|mesh-ancestor
2140688|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140689|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140690|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140691|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2140692|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2140693|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2140694|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
2140695|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
2140696|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2140697|NCT03358576|Renal Agents|renal agents|mesh-ancestor
2140698|NCT03359395|Alfentanil|alfentanil|mesh-list
2140699|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2140700|NCT03359395|Narcotics|narcotics|mesh-ancestor
2140701|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140702|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140703|NCT03359395|Analgesics|analgesics|mesh-ancestor
2140704|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
2140705|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140706|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2140707|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
2140708|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
2140709|NCT03359473|GSK2881078|gsk2881078|mesh-list
2140710|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
2140711|NCT03359473|Hormones|hormones|mesh-ancestor
2140712|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2140713|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140714|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2140715|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140716|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140717|NCT03359590|Incretins|incretins|mesh-ancestor
2140718|NCT03359590|Hormones|hormones|mesh-ancestor
2140719|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2140720|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2140721|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
2140722|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140723|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140724|NCT03359850|Niraparib|niraparib|mesh-list
2140725|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2140726|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140727|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140728|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140729|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
2140730|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140731|NCT03361176|Triamcinolone|triamcinolone|mesh-list
2140732|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2140733|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2140734|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
2140735|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2140736|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2140737|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
2140738|NCT03361176|Hormones|hormones|mesh-ancestor
2140739|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2140740|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140741|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2140742|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
2140743|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184935|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2586007|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
2586008|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586009|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586010|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
2586011|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2586012|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2586013|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2420208|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2420209|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420210|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2420211|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2420212|NCT00806923|Growth Substances|growth substances|mesh-ancestor
2420213|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420214|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
2420215|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2420216|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
2420217|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420218|NCT00806923|Antiviral Agents|antiviral agents|mesh-ancestor
2420219|NCT00806923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420220|NCT00806923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420221|NCT00806923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2420222|NCT00806923|Immunologic Factors|immunologic factors|mesh-ancestor
2420223|NCT00806936|Insulin|insulin|mesh-list
2420224|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2420225|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2586014|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2586015|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586016|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586017|NCT01685762|Metformin|metformin|mesh-list
2586018|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2586019|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586020|NCT01685814|Lenalidomide|lenalidomide|mesh-list
2586021|NCT01685814|Bortezomib|bortezomib|mesh-list
2586022|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
2586023|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586024|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2586025|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2140744|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140745|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2140746|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2140747|NCT03361605|Propofol|propofol|mesh-list
2140748|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2140749|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140750|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140751|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2140752|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
2140753|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
2140757|NCT03363776|Nivolumab|nivolumab|mesh-list
2140758|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2140759|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140760|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2140761|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140762|NCT03363906|Dulaglutide|dulaglutide|mesh-list
2140763|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2140764|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140765|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140766|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
2140767|NCT03364036|Cladribine|cladribine|mesh-list
2140768|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586026|NCT01685814|Growth Substances|growth substances|mesh-ancestor
2586027|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
2586028|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586029|NCT01685827|Eflornithine|eflornithine|mesh-list
2586030|NCT01685827|Nifurtimox|nifurtimox|mesh-list
2586031|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586032|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2586033|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2586034|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2586035|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586036|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2586037|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586038|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586039|NCT01685853|Bisacodyl|bisacodyl|mesh-list
2140769|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2140770|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
2140771|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140772|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
2586040|NCT01685853|Cathartics|cathartics|mesh-ancestor
2586041|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2586042|NCT01685853|Laxatives|laxatives|mesh-ancestor
2586043|NCT01685892|Venetoclax|venetoclax|mesh-list
2586044|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
2586045|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586046|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2586047|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2140773|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2140774|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140775|NCT03364309|Ixekizumab|ixekizumab|mesh-list
2140776|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
2140777|NCT03364608|Albuterol|albuterol|mesh-list
2140778|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2140779|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
2140780|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140781|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140782|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2140783|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
2140784|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
2140785|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2140786|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2140787|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2140788|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2140789|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
2140790|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140791|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140792|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
2140793|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2140794|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
2140795|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
2140796|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140797|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140798|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2140799|NCT03365011|Analgesics|analgesics|mesh-ancestor
2140800|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
2140801|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586048|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2586049|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2586050|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586051|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586052|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2586053|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2586054|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2586055|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
2586056|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2586057|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586058|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2586059|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2586060|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
2586061|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
2586062|NCT01685970|Cathartics|cathartics|mesh-ancestor
2586063|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2586064|NCT01686009|Ketamine|ketamine|mesh-list
2586065|NCT01686009|Analgesics|analgesics|mesh-ancestor
2586066|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
2586067|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586068|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586069|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2586070|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2586071|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
2586072|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
2586073|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140806|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2140807|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140808|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
2140809|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2140810|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140811|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2140812|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2140813|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586074|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2668559|NCT02143050|Dabrafenib|dabrafenib|mesh-list
2586075|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2586076|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2586077|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586078|NCT01686126|Metformin|metformin|mesh-list
2586079|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
2586080|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2586081|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586082|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2586083|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
2586084|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2586085|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2586086|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2586087|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2586088|NCT01686217|Niacinamide|niacinamide|mesh-list
2586089|NCT01686217|Peficitinib|peficitinib|mesh-list
2586090|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140814|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140815|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140816|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2140817|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2140818|NCT03366298|Epinephrine|epinephrine|mesh-list
2140819|NCT03366298|Racepinephrine|racepinephrine|mesh-list
2140820|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
2140821|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2140822|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2140823|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
2140824|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140825|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140826|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140827|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2140828|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2140829|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
2140830|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140831|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2140832|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
2140833|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
2140834|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
2140835|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2140836|NCT03367793|Metronidazole|metronidazole|mesh-list
2140837|NCT03367793|Methamphetamine|methamphetamine|mesh-list
2140838|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2586091|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586092|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2586093|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
2586094|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586095|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
2586096|NCT01686217|Vitamins|vitamins|mesh-ancestor
2586097|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
2586098|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
2586099|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2586100|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586101|NCT01686321|Rituximab|rituximab|mesh-list
2586102|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2586103|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2586104|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586105|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
2586106|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586107|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2586108|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2586109|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
2586110|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586111|NCT01686347|Ropivacaine|ropivacaine|mesh-list
2586112|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
2586113|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
2586114|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586115|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586116|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
2586117|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586118|NCT01686386|Dexamethasone|dexamethasone|mesh-list
2586119|NCT01686386|Lenalidomide|lenalidomide|mesh-list
2586120|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2586121|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2586122|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
2586123|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
2668560|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140839|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140840|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
2140841|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
2140842|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140843|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
2140844|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140845|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140846|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
2140847|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2140848|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2140849|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2140850|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2140851|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140852|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2140853|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2140854|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2140855|NCT03368235|Prednisolone|prednisolone|mesh-list
2140856|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2140857|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
2140858|NCT03368235|Hormones|hormones|mesh-ancestor
2140859|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2140860|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586124|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586125|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586126|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2586127|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
2586128|NCT01686386|Hormones|hormones|mesh-ancestor
2586129|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2586130|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2586131|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586132|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
2586133|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2586134|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2586135|NCT01686386|Growth Substances|growth substances|mesh-ancestor
2586136|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
2586137|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2586138|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
2586139|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586140|NCT01686464|Valacyclovir|valacyclovir|mesh-list
2586141|NCT01686464|Prednisone|prednisone|mesh-list
2586142|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2586143|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
2586144|NCT01686464|Hormones|hormones|mesh-ancestor
2586145|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2140861|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2140862|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140863|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
2140864|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2140865|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140866|NCT03368859|Leucovorin|leucovorin|mesh-list
2140867|NCT03368859|Bevacizumab|bevacizumab|mesh-list
2140868|NCT03368859|Fluorouracil|fluorouracil|mesh-list
2140869|NCT03368859|Irinotecan|irinotecan|mesh-list
2140870|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2140871|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140872|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2140873|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2140874|NCT03368859|Growth Substances|growth substances|mesh-ancestor
2140875|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140876|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
2140877|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
2140878|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140879|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2140880|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2140881|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
2140882|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2586146|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586147|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2586148|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586149|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
2586150|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586151|NCT01686529|Bevacizumab|bevacizumab|mesh-list
2586152|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2586153|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586154|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2586155|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2586156|NCT01686529|Growth Substances|growth substances|mesh-ancestor
2586157|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586158|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
2586159|NCT01686555|Venetoclax|venetoclax|mesh-list
2586160|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586161|NCT01686594|Methoxsalen|methoxsalen|mesh-list
2586162|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2586163|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
2140883|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2140884|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140885|NCT03368859|Antidotes|antidotes|mesh-ancestor
2140886|NCT03368859|Protective Agents|protective agents|mesh-ancestor
2140887|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
2140888|NCT03368859|Vitamins|vitamins|mesh-ancestor
2140889|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
2140890|NCT03369704|Omalizumab|omalizumab|mesh-list
2140891|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2586164|NCT01686607|Itraconazole|itraconazole|mesh-list
2586165|NCT01686607|Fluconazole|fluconazole|mesh-list
2586166|NCT01686607|Voriconazole|voriconazole|mesh-list
2586167|NCT01686607|Amphotericin B|amphotericin b|mesh-list
2586168|NCT01686607|Caspofungin|caspofungin|mesh-list
2586169|NCT01686607|Micafungin|micafungin|mesh-list
2586170|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
2586171|NCT01686607|Clotrimazole|clotrimazole|mesh-list
2586172|NCT01686607|Miconazole|miconazole|mesh-list
2586173|NCT01686607|Anidulafungin|anidulafungin|mesh-list
2586174|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586175|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2586176|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2586177|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586178|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586179|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2586180|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
2586181|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2586182|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586183|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2586184|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2586185|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2586186|NCT01686607|Amebicides|amebicides|mesh-ancestor
2586187|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2586188|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2586189|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2140892|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2140893|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
2140894|NCT03369951|Minocycline|minocycline|mesh-list
2140895|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2140896|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140897|NCT03370289|Vaccines|vaccines|mesh-list
2586190|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2586191|NCT01686620|Insulin Lispro|insulin lispro|mesh-list
2586192|NCT01686620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2586193|NCT01686620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586194|NCT01686711|Pioglitazone|pioglitazone|mesh-list
2586195|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2586196|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586197|NCT01686789|Interferons|interferons|mesh-list
2586198|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
2586199|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
2586200|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2586201|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586202|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
2586203|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586204|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
2586205|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586206|NCT01686802|Ibuprofen|ibuprofen|mesh-list
2586207|NCT01686802|Morphine|morphine|mesh-list
2140898|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
2140899|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140900|NCT03370770|Afatinib|afatinib|mesh-list
2140901|NCT03370770|Osimertinib|osimertinib|mesh-list
2140902|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140903|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2140904|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2140905|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586208|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2586209|NCT01686802|Narcotics|narcotics|mesh-ancestor
2140906|NCT03371381|Nivolumab|nivolumab|mesh-list
2140907|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2140908|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586210|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586211|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586212|NCT01686802|Analgesics|analgesics|mesh-ancestor
2586213|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
2586214|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586215|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2586216|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2586217|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2586218|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2586219|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2586220|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586221|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586222|NCT01687049|Red yeast rice|red yeast rice|mesh-list
2586223|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2586224|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2140909|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2140910|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140911|NCT03371459|Albuterol|albuterol|mesh-list
2140912|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2140913|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
2140914|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140915|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140916|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2140917|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
2140918|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
2140919|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2140920|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2140921|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2140922|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2140923|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
2140924|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140925|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140926|NCT03371836|Clobazam|clobazam|mesh-list
2140927|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
2140928|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2140929|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2140930|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140931|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140932|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2140933|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2140934|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
2140935|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
2140936|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140937|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140938|NCT03372083|Deferasirox|deferasirox|mesh-list
2140939|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2140940|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
2140941|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
2140942|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140943|NCT03372382|Acetaminophen|acetaminophen|mesh-list
2140944|NCT03372382|Ibuprofen|ibuprofen|mesh-list
2140945|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2140946|NCT03372382|Analgesics|analgesics|mesh-ancestor
2140947|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
2586225|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2586226|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
2586227|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586228|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586229|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2586230|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
2586231|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2586232|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
2140948|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140949|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140950|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
2140951|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2140952|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2140953|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2140954|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2140955|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184936|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
2586233|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
2586234|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586235|NCT01687127|Folic Acid|folic acid|mesh-list
2586236|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
2586237|NCT01687127|Calcium|calcium|mesh-list
2140956|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140957|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2140958|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2140959|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2140960|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140961|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140962|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2140963|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2140964|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586238|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2586239|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586240|NCT01687127|Hematinics|hematinics|mesh-ancestor
2586241|NCT01687127|Vitamins|vitamins|mesh-ancestor
2586242|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
2586243|NCT01687140|Cycloserine|cycloserine|mesh-list
2586244|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2586245|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586246|NCT01687140|Renal Agents|renal agents|mesh-ancestor
2586247|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2586248|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
2586249|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2586250|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
2586251|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586252|NCT01687205|Tenofovir|tenofovir|mesh-list
2586253|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
2586254|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586255|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2586256|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2586257|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586258|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140965|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
2140966|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2140967|NCT03373591|Bupivacaine|bupivacaine|mesh-list
2140968|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
2140969|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
2140970|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2140971|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140972|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
2140973|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2140974|NCT03374176|Amoxicillin|amoxicillin|mesh-list
2140975|NCT03374176|Metronidazole|metronidazole|mesh-list
2140976|NCT03374176|Clindamycin|clindamycin|mesh-list
2140977|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
2140978|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
2140979|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2140980|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140981|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2140982|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2140983|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2140984|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420226|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420227|NCT00806962|Vaccines|vaccines|mesh-list
2420228|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
2420229|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420230|NCT00807053|Ciclesonide|ciclesonide|mesh-list
2420231|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
2420232|NCT00807053|Hormones|hormones|mesh-ancestor
2420233|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2420234|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420235|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2420236|NCT00807066|Gefitinib|gefitinib|mesh-list
2420237|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420238|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2420239|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420240|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420241|NCT00807079|Carboplatin|carboplatin|mesh-list
2420242|NCT00807079|Topotecan|topotecan|mesh-list
2420243|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420244|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2420245|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2586259|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2586260|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2586261|NCT01687348|Lidocaine|lidocaine|mesh-list
2586262|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
2586263|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
2586264|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586265|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586266|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
2586267|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586268|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2586269|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2586270|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2140985|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140986|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
2140987|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2140988|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2140989|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
2140990|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2140991|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2140992|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2140993|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586271|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2586272|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586273|NCT01687374|Hormones|hormones|mesh-list
2586274|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
2586275|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2586276|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2140994|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2140995|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
2140996|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2140997|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2140998|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
2140999|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2141000|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
2141001|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
2141002|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586277|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2586278|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2586279|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2586280|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2586281|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2586282|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2586283|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
2586284|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2586285|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586286|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586287|NCT01687439|Vinorelbine|vinorelbine|mesh-list
2586288|NCT01687439|Endostar protein|endostar protein|mesh-list
2586289|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586290|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2586291|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
2141003|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141004|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2141005|NCT03375294|Analgesics|analgesics|mesh-ancestor
2141006|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
2141007|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141008|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
2141009|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2141010|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2141011|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141012|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
2586292|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
2586293|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
2586294|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586295|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2586296|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2586297|NCT01687439|Growth Substances|growth substances|mesh-ancestor
2586298|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586299|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
2586300|NCT01687491|Enoxaparin|enoxaparin|mesh-list
2586301|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
2586302|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2586303|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2586304|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586305|NCT01687517|Vaccines|vaccines|mesh-list
2586306|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
2586307|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586308|NCT01687582|Liraglutide|liraglutide|mesh-list
2586309|NCT01687582|Exenatide|exenatide|mesh-list
2586310|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2586311|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586312|NCT01687582|Incretins|incretins|mesh-ancestor
2586313|NCT01687582|Hormones|hormones|mesh-ancestor
2586314|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2586315|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2586316|NCT01687699|Spironolactone|spironolactone|mesh-list
2586317|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2586318|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
2586319|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2586320|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586321|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2586322|NCT01687699|Diuretics|diuretics|mesh-ancestor
2586323|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
2586324|NCT01687751|Midazolam|midazolam|mesh-list
2586325|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
2586326|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2586327|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586328|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586329|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2586330|NCT01687751|Analgesics|analgesics|mesh-ancestor
2586331|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
2586332|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586333|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2586334|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2586335|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2586336|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
2586337|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2586338|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586339|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2586340|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2586341|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2586342|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2586343|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2586344|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
2586345|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
2586346|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
2586347|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
2586348|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
2586349|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2586350|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586351|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586352|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2586353|NCT01687868|Analgesics|analgesics|mesh-ancestor
2586354|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
2586355|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586356|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2586357|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2586358|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2586359|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
2586360|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2586361|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586362|NCT01687894|Vasopressins|vasopressins|mesh-list
2586363|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
2586364|NCT01687894|Propofol|propofol|mesh-list
2586365|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
2586366|NCT01687894|Sevoflurane|sevoflurane|mesh-list
2586367|NCT01687894|Anesthetics|anesthetics|mesh-list
2586368|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
2586369|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2586370|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141013|NCT03376061|Coagulants|coagulants|mesh-ancestor
2141014|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
2141015|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2141016|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
2141017|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586371|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586372|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2586373|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2586374|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
2586375|NCT01687894|Coagulants|coagulants|mesh-ancestor
2586376|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2586377|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2586378|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
2586379|NCT01687985|Laxatives|laxatives|mesh-list
2586380|NCT01687985|Cathartics|cathartics|mesh-list
2586381|NCT01687985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2586382|NCT01688024|Mitomycins|mitomycins|mesh-list
2141018|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141019|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2141020|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
2141021|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
2141022|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2141023|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
2141024|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141025|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141026|NCT03377556|Talazoparib|talazoparib|mesh-list
2141027|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2141028|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141029|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141030|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141031|NCT03378076|Triamcinolone|triamcinolone|mesh-list
2141032|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2141033|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2141034|NCT03378076|FX006|fx006|mesh-list
2141035|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2141036|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141037|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
2141038|NCT03378076|Hormones|hormones|mesh-ancestor
2586383|NCT01688024|Mitomycin|mitomycin|mesh-list
2586384|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2586385|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586386|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
2586387|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586388|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2586389|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586401|NCT01688089|Levodopa|levodopa|mesh-list
2586402|NCT01688089|Carbidopa|carbidopa|mesh-list
2586403|NCT01688089|Entacapone|entacapone|mesh-list
2586404|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2586405|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2586406|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
2586407|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2586408|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586409|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586410|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2586411|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586412|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2586413|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
2586414|NCT01688154|Procyanidin|procyanidin|mesh-list
2586415|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
2586416|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586417|NCT01688154|Protective Agents|protective agents|mesh-ancestor
2586418|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586419|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2586420|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2586421|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586422|NCT01688206|Atezolizumab|atezolizumab|mesh-list
2586423|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586424|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
2586425|NCT01688349|Hormones|hormones|mesh-ancestor
2586426|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2586427|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586428|NCT01688362|Dexamethasone|dexamethasone|mesh-list
2586429|NCT01688362|Bupivacaine|bupivacaine|mesh-list
2586430|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2586431|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
2586432|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
2586433|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586434|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141039|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141040|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141041|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2141042|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
2141043|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141044|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141045|NCT03378635|Glucagon|glucagon|mesh-list
2141046|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2141047|NCT03378635|Hormones|hormones|mesh-ancestor
2141048|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141049|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141050|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
2141051|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2141052|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141053|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141054|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2141055|NCT03378973|Analgesics|analgesics|mesh-ancestor
2141056|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
2141057|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141058|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2586435|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2586436|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
2586437|NCT01688362|Hormones|hormones|mesh-ancestor
2586438|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2586439|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2586440|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586441|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
2586442|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
2586443|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586444|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
2586445|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2586446|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2586447|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2586448|NCT01688401|Melphalan|melphalan|mesh-list
2586449|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2586450|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
2586451|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586452|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586453|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2586454|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2586455|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
2586456|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586457|NCT01688492|Ipilimumab|ipilimumab|mesh-list
2586458|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2586459|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141059|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2141060|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2141061|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
2141062|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141063|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141064|NCT03379506|Grazoprevir|grazoprevir|mesh-list
2141065|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
2141066|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2141067|NCT03380026|Triamcinolone|triamcinolone|mesh-list
2141068|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2141069|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2141070|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
2141071|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2141072|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141073|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
2141074|NCT03380026|Hormones|hormones|mesh-ancestor
2141075|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141076|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141077|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2141078|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
2141079|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184937|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586460|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2586461|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586462|NCT01688518|Lidocaine|lidocaine|mesh-list
2586463|NCT01688518|Tetracaine|tetracaine|mesh-list
2586464|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
2586465|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
2586466|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586467|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586468|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
2586469|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586470|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2586471|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2586472|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2586473|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2586474|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586475|NCT01688544|Benzimidazole|benzimidazole|mesh-list
2586476|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
2586477|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2586478|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586479|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
2586480|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2586481|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2586482|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2586483|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2586484|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586485|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2586486|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586487|NCT01688570|Analgesics|analgesics|mesh-ancestor
2141080|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141081|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
2141082|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2141083|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141084|NCT03380091|Vitamin D|vitamin d|mesh-list
2141085|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
2141086|NCT03380091|Metformin|metformin|mesh-list
2141087|NCT03380091|Vitamins|vitamins|mesh-ancestor
2141088|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
2141089|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141090|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2586488|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
2586489|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586490|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
2586491|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2586492|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
2586493|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
2586494|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
2586495|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2586496|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2586497|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
2586498|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
2586499|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2586500|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
2586501|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2586502|NCT01688583|Fentanyl|fentanyl|mesh-list
2586503|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2586504|NCT01688583|Narcotics|narcotics|mesh-ancestor
2586505|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586506|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586507|NCT01688583|Analgesics|analgesics|mesh-ancestor
2586508|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
2586509|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586510|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2586511|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2586512|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
2141091|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2141092|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2141093|NCT03380390|Phenylephrine|phenylephrine|mesh-list
2141094|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
2141095|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2141096|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2141097|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
2141098|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141099|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141100|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141101|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
2141102|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
2141103|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141104|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
2586513|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
2586514|NCT01688648|Lidocaine|lidocaine|mesh-list
2586515|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
2586516|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
2586517|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
2586518|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586519|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586520|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
2586521|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586522|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2586523|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2586524|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2586525|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2586526|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586527|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2586528|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2586529|NCT01688648|Analgesics|analgesics|mesh-ancestor
2586530|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2586531|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2586532|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2586533|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
2586534|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2586535|NCT01688700|Paclitaxel|paclitaxel|mesh-list
2586536|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
2586537|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2586538|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586539|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
2586540|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
2586541|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
2586542|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586543|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2586544|NCT01688791|Paclitaxel|paclitaxel|mesh-list
2586545|NCT01688791|Carboplatin|carboplatin|mesh-list
2586546|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2586547|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586548|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
2586549|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
2586550|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
2586551|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586552|NCT01688934|Naproxen|naproxen|mesh-list
2586553|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2586554|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2586555|NCT01688934|Analgesics|analgesics|mesh-ancestor
2586556|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
2586557|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586558|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586559|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2586560|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2586561|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
2586562|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2586563|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586564|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586565|NCT01688947|Pregabalin|pregabalin|mesh-list
2586566|NCT01688947|Analgesics|analgesics|mesh-ancestor
2586567|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
2586568|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586569|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586570|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
2586571|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2586572|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2586573|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586574|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2586575|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2586576|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2586577|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586578|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2586579|NCT01688960|Aflibercept|aflibercept|mesh-list
2586580|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2586581|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2586582|NCT01688960|Growth Substances|growth substances|mesh-ancestor
2586583|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141105|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2586584|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
2586585|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586586|NCT01689051|Glucagon|glucagon|mesh-list
2586587|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2586588|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2586589|NCT01689051|Hormones|hormones|mesh-ancestor
2586590|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2586591|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586592|NCT01689051|Incretins|incretins|mesh-ancestor
2586593|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
2586594|NCT01689090|Citric Acid|citric acid|mesh-list
2586595|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
2586596|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2586597|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
2586598|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2586599|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
2586600|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
2586601|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586602|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2586603|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2586604|NCT01689090|Analgesics|analgesics|mesh-ancestor
2586605|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
2586606|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586607|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586608|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2586609|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2586610|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586611|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
2141106|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
2141107|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2141108|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
2141109|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2141110|NCT03380390|Protective Agents|protective agents|mesh-ancestor
2141111|NCT03380429|Albuterol|albuterol|mesh-list
2141112|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2141113|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
2141114|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141115|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141116|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2141117|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
2141118|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
2141119|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2141120|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2141121|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2141122|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2141123|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
2141124|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2586612|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2586613|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2586614|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586615|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2586616|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2586617|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586618|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586619|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586620|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2586621|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
2586622|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2586623|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586624|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2586625|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2586626|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2586627|NCT01689129|Insulin|insulin|mesh-list
2586628|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2586629|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
2586630|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2586631|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586632|NCT01689142|Insulin|insulin|mesh-list
2586633|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2586634|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
2586635|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2586636|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586637|NCT01689194|Cisplatin|cisplatin|mesh-list
2586638|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586639|NCT01689246|Methylene Blue|methylene blue|mesh-list
2586640|NCT01689246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141125|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141126|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
2141127|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2141128|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
2141129|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141130|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
2586641|NCT01689246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586642|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
2586643|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2586644|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
2586645|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2586646|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2586647|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586648|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2586649|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586650|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2586651|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586652|NCT01689285|Valacyclovir|valacyclovir|mesh-list
2586653|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
2141131|NCT03381248|Protective Agents|protective agents|mesh-ancestor
2141132|NCT03381742|Clopidogrel|clopidogrel|mesh-list
2141133|NCT03381742|Ticagrelor|ticagrelor|mesh-list
2141134|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2141135|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2141136|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2141137|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2141138|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
2141139|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141140|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141141|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141142|NCT03382262|Triamcinolone|triamcinolone|mesh-list
2141143|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2141144|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2141145|NCT03382262|FX006|fx006|mesh-list
2141146|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2141147|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141148|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
2141149|NCT03382262|Hormones|hormones|mesh-ancestor
2141150|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141151|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141152|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2141153|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
2141154|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586654|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586655|NCT01689298|Oxytocin|oxytocin|mesh-list
2586656|NCT01689298|Carbetocin|carbetocin|mesh-list
2586657|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
2586658|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2586659|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586660|NCT01689311|Alprostadil|alprostadil|mesh-list
2586661|NCT01689311|Misoprostol|misoprostol|mesh-list
2586662|NCT01689311|Oxytocin|oxytocin|mesh-list
2586663|NCT01689311|Ergonovine|ergonovine|mesh-list
2586664|NCT01689311|Dinoprost|dinoprost|mesh-list
2586665|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
2586666|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
2586667|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2586668|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586669|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2586670|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
2586671|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2586672|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2586673|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2586674|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
2586675|NCT01689311|Urological Agents|urological agents|mesh-ancestor
2586676|NCT01689558|Endostatins|endostatins|mesh-list
2586677|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586678|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2586679|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2586680|NCT01689558|Growth Substances|growth substances|mesh-ancestor
2586681|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586682|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
2586683|NCT01689597|Morphine|morphine|mesh-list
2586684|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2141155|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586685|NCT01689597|Narcotics|narcotics|mesh-ancestor
2141156|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2586686|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586687|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586688|NCT01689597|Analgesics|analgesics|mesh-ancestor
2586689|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
2586690|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586691|NCT01689623|Simeprevir|simeprevir|mesh-list
2586692|NCT01689623|Atorvastatin|atorvastatin|mesh-list
2586693|NCT01689623|Simvastatin|simvastatin|mesh-list
2586694|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2586695|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2586696|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
2586697|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586698|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2586699|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2141157|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2141158|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
2141159|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141160|NCT03382418|Antacids|antacids|mesh-ancestor
2141161|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141162|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2141163|NCT03382821|Dexamethasone|dexamethasone|mesh-list
2141164|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
2141165|NCT03382821|Triamcinolone|triamcinolone|mesh-list
2141166|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2141167|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2141168|NCT03382821|Lidocaine|lidocaine|mesh-list
2141169|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2141170|NCT03382821|BB 1101|bb 1101|mesh-list
2141171|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2586700|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586701|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
2586702|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586703|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
2586704|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
2586705|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2586706|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586707|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
2586708|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2586709|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586710|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
2586711|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2586712|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586713|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
2586714|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2586715|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586716|NCT01689753|Citric Acid|citric acid|mesh-list
2586717|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
2586718|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
2586719|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2586720|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
2586721|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
2586722|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586723|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
2586724|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2586725|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586726|NCT01689870|Ipilimumab|ipilimumab|mesh-list
2141172|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141173|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
2141174|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
2141175|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141176|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420246|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420247|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420248|NCT00807118|Fesoterodine|fesoterodine|mesh-list
2420249|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2420250|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2586727|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2586728|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586729|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2586730|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420251|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
2420252|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141177|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2141178|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
2141179|NCT03382821|Hormones|hormones|mesh-ancestor
2141180|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141181|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2141182|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141183|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
2141184|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141185|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141186|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
2141187|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
2141188|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141189|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
2141190|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2141191|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2141192|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2141193|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2141194|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2141195|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
2586731|NCT01689896|Testosterone|testosterone|mesh-list
2586732|NCT01689896|Androgens|androgens|mesh-ancestor
2586733|NCT01689896|Hormones|hormones|mesh-ancestor
2586734|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2586735|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586736|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2586737|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2586738|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
2586739|NCT01689987|Sirolimus|sirolimus|mesh-list
2586740|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
2586741|NCT01689987|Dexamethasone|dexamethasone|mesh-list
2586742|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
2586743|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
2586744|NCT01689987|Ichthammol|ichthammol|mesh-list
2586745|NCT01689987|BB 1101|bb 1101|mesh-list
2586746|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2586747|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
2586748|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586749|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2586750|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2586751|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
2586752|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586753|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586754|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2586755|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2586756|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
2586757|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
2586758|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586759|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2586760|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
2586761|NCT01689987|Hormones|hormones|mesh-ancestor
2586762|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2586763|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2586764|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2586765|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586766|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2586767|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
2586768|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
2586769|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2586770|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2586771|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586772|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
2586773|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
2586774|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
2586775|NCT01690039|Furosemide|furosemide|mesh-list
2586776|NCT01690039|Diuretics|diuretics|mesh-ancestor
2586777|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
2586778|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586779|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2586780|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2668561|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586781|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586782|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2586783|NCT01690091|Metformin|metformin|mesh-list
2586784|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2586785|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586786|NCT01690104|Rifampin|rifampin|mesh-list
2586787|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2586788|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
2586789|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2586790|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586791|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
2586792|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2586793|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586794|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586795|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2420253|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420254|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420255|NCT00807118|Urological Agents|urological agents|mesh-ancestor
2420256|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
2420257|NCT00807196|Rituximab|rituximab|mesh-list
2420258|NCT00807196|Fludarabine|fludarabine|mesh-list
2420259|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2420260|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
2420261|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420262|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2420263|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2420264|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
2420265|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420266|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420267|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2420268|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2420269|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2420270|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2420271|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420272|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2420273|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2586796|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2586797|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2586798|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2586799|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2586800|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2586801|NCT01690221|Diltiazem|diltiazem|mesh-list
2586802|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2586803|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2586804|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2586805|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586806|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2586807|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586808|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
2586809|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2586810|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
2586811|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586812|NCT01690286|Ketoconazole|ketoconazole|mesh-list
2586813|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
2586814|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586815|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2586816|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2586817|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586818|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586819|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2586820|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
2586821|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2586822|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141213|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
2141214|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2141215|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141216|NCT03382912|Nivolumab|nivolumab|mesh-list
2141217|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2141218|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141219|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2141220|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141221|NCT03383198|Bupivacaine|bupivacaine|mesh-list
2586823|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2586824|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
2586825|NCT01690325|Bevacizumab|bevacizumab|mesh-list
2586826|NCT01690325|Docetaxel|docetaxel|mesh-list
2586827|NCT01690325|Trastuzumab|trastuzumab|mesh-list
2586828|NCT01690325|Epirubicin|epirubicin|mesh-list
2586829|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2586830|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
2586831|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141222|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
2141223|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
2141224|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141225|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141226|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
2141227|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141228|NCT03383523|Praziquantel|praziquantel|mesh-list
2141229|NCT03383523|Emodepside|emodepside|mesh-list
2141230|NCT03383523|Toltrazuril|toltrazuril|mesh-list
2141231|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
2141232|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2141233|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2141234|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
2141235|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2141236|NCT03383588|Epinephrine|epinephrine|mesh-list
2141237|NCT03383588|Fentanyl|fentanyl|mesh-list
2141238|NCT03383588|Morphine|morphine|mesh-list
2141239|NCT03383588|Bupivacaine|bupivacaine|mesh-list
2141240|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
2141241|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
2141242|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141243|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141244|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
2141245|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141246|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2141247|NCT03383588|Narcotics|narcotics|mesh-ancestor
2141248|NCT03383588|Analgesics|analgesics|mesh-ancestor
2141249|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2141250|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2141251|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
2141252|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2141253|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2141254|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
2586832|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2586833|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2586834|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
2586835|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586836|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586837|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2586838|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2586839|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2586840|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2586841|NCT01690325|Growth Substances|growth substances|mesh-ancestor
2586842|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
2586843|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
2586844|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
2586845|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
2586846|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2586847|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2141255|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141256|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141257|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2141258|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2141259|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
2141260|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2141261|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
2141262|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
2141263|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
2141264|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2141265|NCT03383614|Emodepside|emodepside|mesh-list
2141266|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2141267|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586848|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2586849|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586850|NCT01690338|Bromides|bromides|mesh-list
2586851|NCT01690338|Rocuronium|rocuronium|mesh-list
2586852|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
2586853|NCT01690338|Cisatracurium|cisatracurium|mesh-list
2586854|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
2586855|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2586856|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2586857|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2586858|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141268|NCT03383692|Ritonavir|ritonavir|mesh-list
2141269|NCT03383692|Itraconazole|itraconazole|mesh-list
2141270|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2141271|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2141272|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
2141273|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141274|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141275|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2141276|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2141277|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
2141278|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2141279|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2141280|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2141281|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
2141282|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2141283|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2141284|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
2141285|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141286|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141287|NCT03383783|Listerine|listerine|mesh-list
2586859|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586860|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2586861|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2586862|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
2586863|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2586864|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586865|NCT01690364|Anesthetics|anesthetics|mesh-list
2586866|NCT01690364|Cisatracurium|cisatracurium|mesh-list
2586867|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
2586868|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586869|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586870|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2141288|NCT03383783|Fluorides|fluorides|mesh-list
2141289|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
2141290|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
2141291|NCT03383783|Protective Agents|protective agents|mesh-ancestor
2586871|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2586872|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586873|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2586874|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2586875|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2586876|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
2141292|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141293|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2141294|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2141295|NCT03384316|Vaccines|vaccines|mesh-list
2141296|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
2141297|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141298|NCT03384329|Resveratrol|resveratrol|mesh-list
2141299|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
2141300|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586877|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2586878|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586879|NCT01690403|Rifapentine|rifapentine|mesh-list
2586880|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2586881|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
2586882|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2141301|NCT03384329|Protective Agents|protective agents|mesh-ancestor
2586883|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586884|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
2586885|NCT01690468|Carboplatin|carboplatin|mesh-list
2586886|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586887|NCT01690507|Cytarabine|cytarabine|mesh-list
2586888|NCT01690507|Decitabine|decitabine|mesh-list
2586889|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
2586890|NCT01690507|Sargramostim|sargramostim|mesh-list
2586891|NCT01690507|Lenograstim|lenograstim|mesh-list
2586892|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2586893|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
2586894|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586895|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586896|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
2586897|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586898|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2586899|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
2586900|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586901|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586902|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2586903|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2586904|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
2586905|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2586906|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2586907|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586908|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2586909|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2586910|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586911|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586912|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586913|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2586914|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
2586915|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2586916|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586917|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2586918|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2586919|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2586920|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
2586921|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2586922|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586923|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2586924|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2586925|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586926|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586927|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586928|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2586929|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2586930|NCT01690572|Paclitaxel|paclitaxel|mesh-list
2141302|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141303|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141304|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2141305|NCT03384693|Defibrotide|defibrotide|mesh-list
2141306|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2141307|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2141308|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141309|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2141310|NCT03384940|Trastuzumab|trastuzumab|mesh-list
2141311|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2586931|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
2586932|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2586933|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586934|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
2586935|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
2586936|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
2586937|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586938|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2586939|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
2586940|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586941|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
2586942|NCT01690572|Protective Agents|protective agents|mesh-ancestor
2586943|NCT01690598|Topotecan|topotecan|mesh-list
2586944|NCT01690598|Veliparib|veliparib|mesh-list
2586945|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2586946|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2586947|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586948|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586949|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586950|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2586951|NCT01690637|Oseltamivir|oseltamivir|mesh-list
2586952|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
2586953|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2586954|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586955|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586956|NCT01690702|Paclitaxel|paclitaxel|mesh-list
2586957|NCT01690702|Docetaxel|docetaxel|mesh-list
2586958|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
2586959|NCT01690702|Epirubicin|epirubicin|mesh-list
2586960|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2586961|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2586962|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
2586963|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
2586964|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
2586965|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586966|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2586967|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
2586968|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586969|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2586970|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2586971|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
2586972|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2586973|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2586974|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2586975|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2586976|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2586977|NCT01690767|Lidocaine|lidocaine|mesh-list
2586978|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
2586979|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
2586980|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586981|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586982|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
2586983|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586984|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2586985|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2586986|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2586987|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2586988|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2586989|NCT01690780|Ibuprofen|ibuprofen|mesh-list
2586990|NCT01690780|Morphine|morphine|mesh-list
2586991|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2586992|NCT01690780|Narcotics|narcotics|mesh-ancestor
2586993|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2586994|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2586995|NCT01690780|Analgesics|analgesics|mesh-ancestor
2586996|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
2586997|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2586998|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2586999|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2587000|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2587001|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2587002|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2587003|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141312|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141313|NCT03386032|Desonide|desonide|mesh-list
2141314|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141315|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2141316|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2141317|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141318|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2141319|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141320|NCT03386448|Scopolamine|scopolamine|mesh-list
2141321|NCT03386448|Naltrexone|naltrexone|mesh-list
2141322|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2141323|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2141324|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2141325|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141326|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
2141327|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587004|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587005|NCT01690832|Fenoldopam|fenoldopam|mesh-list
2587006|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2587007|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
2587008|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
2587009|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
2587010|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587011|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587012|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587013|NCT01690871|Dactolisib|dactolisib|mesh-list
2587014|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587015|NCT01690884|Adenosine|adenosine|mesh-list
2587016|NCT01690884|Analgesics|analgesics|mesh-ancestor
2587017|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
2587018|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587019|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587020|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2587021|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
2587022|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2587023|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
2141328|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2141329|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
2141330|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
2141331|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2141332|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
2141333|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2141334|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
2141335|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141336|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141337|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2141338|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
2141339|NCT03386474|Aflibercept|aflibercept|mesh-list
2141340|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2141341|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2141342|NCT03386474|Growth Substances|growth substances|mesh-ancestor
2141343|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141344|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
2141345|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141346|NCT03387020|Everolimus|everolimus|mesh-list
2141347|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141348|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2141349|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
2141350|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141351|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
2141352|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2141353|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2141354|NCT03387046|Prednisolone|prednisolone|mesh-list
2587024|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
2587025|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587026|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587027|NCT01690962|Vitamins|vitamins|mesh-list
2587028|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
2587029|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
2587030|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
2587031|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
2587032|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587033|NCT01690962|Hematinics|hematinics|mesh-ancestor
2587034|NCT01690975|Benzonatate|benzonatate|mesh-list
2587035|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
2587036|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
2587037|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
2587038|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2141355|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
2141356|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2141357|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
2141358|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141359|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
2141360|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
2141361|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141362|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141363|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2141364|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
2141365|NCT03387046|Hormones|hormones|mesh-ancestor
2141366|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587039|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2587040|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587041|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2587042|NCT01691001|Analgesics|analgesics|mesh-ancestor
2587043|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
2587044|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587045|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2587046|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2587047|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2587048|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
2587049|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587050|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587051|NCT01691053|Spironolactone|spironolactone|mesh-list
2587052|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2587053|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
2587054|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587055|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587056|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2587057|NCT01691053|Diuretics|diuretics|mesh-ancestor
2587058|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
2141367|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2141368|NCT03387046|Protective Agents|protective agents|mesh-ancestor
2141369|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2141370|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141371|NCT03387462|Tenofovir|tenofovir|mesh-list
2141372|NCT03387462|Emtricitabine|emtricitabine|mesh-list
2141373|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
2141374|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2141375|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2141376|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2141377|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141378|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141379|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2141380|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2141381|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
2141382|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2141383|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587059|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
2587060|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
2587061|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2587062|NCT01691365|Vitamins|vitamins|mesh-list
2587063|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
2587064|NCT01691365|Antioxidants|antioxidants|mesh-list
2587065|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
2587066|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587067|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587068|NCT01691365|Protective Agents|protective agents|mesh-ancestor
2587069|NCT01691404|Quercetin|quercetin|mesh-list
2587070|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
2587071|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587072|NCT01691404|Protective Agents|protective agents|mesh-ancestor
2587073|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587074|NCT01691456|Montelukast|montelukast|mesh-list
2587075|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2587076|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
2587077|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2587078|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
2587079|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587080|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141384|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2141385|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141386|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
2141387|NCT03388008|Prednisone|prednisone|mesh-list
2141388|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
2141389|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2141390|NCT03388008|Abatacept|abatacept|mesh-list
2587081|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2587082|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2587083|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587084|NCT01691469|Montelukast|montelukast|mesh-list
2141391|NCT03388008|Tacrolimus|tacrolimus|mesh-list
2141392|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
2141393|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141394|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
2141395|NCT03388008|Hormones|hormones|mesh-ancestor
2141396|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587085|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2587086|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
2587087|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2587088|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
2587089|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587090|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587091|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2587092|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2587093|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141397|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141398|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2141399|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141400|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2141401|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
2141402|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2141403|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141404|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141405|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2141406|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2141407|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
2141408|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2141409|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2141410|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
2141411|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
2141412|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141413|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2141414|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2141415|NCT03388008|Protective Agents|protective agents|mesh-ancestor
2141416|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2141417|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2141418|NCT03388164|Dexetimide|dexetimide|mesh-list
2141419|NCT03388164|Citalopram|citalopram|mesh-list
2587094|NCT01691495|PENTA|penta|mesh-list
2587095|NCT01691495|Fondaparinux|fondaparinux|mesh-list
2587096|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2587097|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
2587098|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2587099|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
2587100|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587101|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587102|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
2587103|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2587104|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2587105|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
2587106|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2587107|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2587108|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2141420|NCT03388164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2141421|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2141422|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2587109|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2587110|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587111|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
2587112|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587113|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587114|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2587115|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587116|NCT01691677|Beclomethasone|beclomethasone|mesh-list
2587117|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2587118|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
2587119|NCT01691677|Hormones|hormones|mesh-ancestor
2587120|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587121|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587122|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2587123|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
2587124|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2587125|NCT01691742|Laxatives|laxatives|mesh-list
2141423|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141424|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141425|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
2141426|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141427|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2587126|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2587127|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2587128|NCT01691807|Ofatumumab|ofatumumab|mesh-list
2587129|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2587130|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
2587131|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587132|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587133|NCT01691846|Metformin|metformin|mesh-list
2587134|NCT01691846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2587135|NCT01691846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587136|NCT01691872|Ezogabine|ezogabine|mesh-list
2587137|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
2587138|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2587139|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141428|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
2141429|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2141430|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2141431|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2141432|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
2141433|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
2141434|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141435|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2141436|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2141437|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
2141438|NCT03388268|Vancomycin|vancomycin|mesh-list
2141439|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2141440|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2141441|NCT03389308|Diacetylrhein|diacetylrhein|mesh-list
2141442|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141443|NCT03389555|Vitamins|vitamins|mesh-list
2141444|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
2141445|NCT03389555|Thiamine|thiamine|mesh-list
2141446|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
2141447|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
2141448|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141449|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141450|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
2141451|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141452|NCT03389555|Protective Agents|protective agents|mesh-ancestor
2141453|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
2141454|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2141455|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
2141456|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141457|NCT03390166|Vaccines|vaccines|mesh-list
2141458|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
2141459|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141460|NCT03390426|Anesthetics|anesthetics|mesh-list
2141461|NCT03390426|Mepivacaine|mepivacaine|mesh-list
2141462|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
2141463|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141464|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141465|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
2141466|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141467|NCT03391765|Tilavonemab|tilavonemab|mesh-list
2141468|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
2141469|NCT03393000|Vitamin A|vitamin a|mesh-list
2141470|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
2141471|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
2141472|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141473|NCT03393000|Protective Agents|protective agents|mesh-ancestor
2141474|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141475|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2141476|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141477|NCT03393000|Vitamins|vitamins|mesh-ancestor
2141478|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
2141479|NCT03393208|Metformin|metformin|mesh-list
2141480|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2141481|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141482|NCT03393494|Adapalene|adapalene|mesh-list
2141483|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2141484|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
2141485|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2141486|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2141487|NCT03393494|Analgesics|analgesics|mesh-ancestor
2141488|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
2141489|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141490|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141491|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141492|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2141493|NCT03393754|Vaccines|vaccines|mesh-list
2141494|NCT03393754|Immunologic Factors|immunologic factors|mesh-ancestor
2141495|NCT03393754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141496|NCT03394885|Paclitaxel|paclitaxel|mesh-list
2587140|NCT01691937|Sufentanil|sufentanil|mesh-list
2587141|NCT01691937|Ropivacaine|ropivacaine|mesh-list
2587142|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
2587143|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
2587144|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2587145|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587146|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
2587147|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587148|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2587149|NCT01691937|Narcotics|narcotics|mesh-ancestor
2587150|NCT01691937|Analgesics|analgesics|mesh-ancestor
2587151|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2587152|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2587153|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
2587154|NCT01691976|Estrogens|estrogens|mesh-list
2587155|NCT01691976|Hormones|hormones|mesh-ancestor
2587156|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587157|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587158|NCT01692132|Prucalopride|prucalopride|mesh-list
2587159|NCT01692132|Laxatives|laxatives|mesh-ancestor
2587160|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2587161|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2587162|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2587163|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
2587164|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587165|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587166|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587167|NCT01692158|Heparin|heparin|mesh-list
2587168|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2587169|NCT01692158|Tinzaparin|tinzaparin|mesh-list
2587170|NCT01692158|Dalteparin|dalteparin|mesh-list
2587171|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
2587172|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2587173|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2587174|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587175|NCT01692171|Heparin|heparin|mesh-list
2587176|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2587177|NCT01692171|Tinzaparin|tinzaparin|mesh-list
2587178|NCT01692171|Dalteparin|dalteparin|mesh-list
2587179|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
2587180|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2587181|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2587182|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587183|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
2587184|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2587185|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2587186|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587187|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2587188|NCT01692210|Analgesics|analgesics|mesh-ancestor
2587189|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
2587190|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587191|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2587192|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2587193|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2587194|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
2587195|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587196|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587197|NCT01692457|Golimumab|golimumab|mesh-list
2587198|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2587199|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2587200|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2587201|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
2587202|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587203|NCT01692483|Prednisone|prednisone|mesh-list
2587204|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
2587205|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2587206|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
2587207|NCT01692483|Hormones|hormones|mesh-ancestor
2587208|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587209|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587210|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2587211|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141497|NCT03394885|Bevacizumab|bevacizumab|mesh-list
2141498|NCT03394885|Carboplatin|carboplatin|mesh-list
2141499|NCT03394885|Atezolizumab|atezolizumab|mesh-list
2587212|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2587213|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587214|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587215|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
2587216|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2587217|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2587218|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2587219|NCT01692678|Dacarbazine|dacarbazine|mesh-list
2587220|NCT01692678|Trabectedin|trabectedin|mesh-list
2587221|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2587222|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
2587223|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587224|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587225|NCT01692704|Gemcitabine|gemcitabine|mesh-list
2587226|NCT01692704|Floxuridine|floxuridine|mesh-list
2587227|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587228|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2587229|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
2587230|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587231|NCT01692704|Antiviral Agents|antiviral agents|mesh-ancestor
2587232|NCT01692704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587233|NCT01692704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587234|NCT01692704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2587235|NCT01692704|Immunologic Factors|immunologic factors|mesh-ancestor
2587236|NCT01692704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587237|NCT01692717|Losartan|losartan|mesh-list
2587238|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2587239|NCT01692717|Atorvastatin|atorvastatin|mesh-list
2587240|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2587241|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2587242|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
2587243|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587244|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2141500|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2141501|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141502|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
2141503|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
2141504|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
2141505|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141506|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2141507|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2141508|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2141509|NCT03394885|Growth Substances|growth substances|mesh-ancestor
2141510|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141511|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
2141512|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2141513|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2141514|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2141515|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2587245|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2587246|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587247|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2587248|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2587249|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2587250|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2587251|NCT01692717|Diuretics|diuretics|mesh-ancestor
2587252|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
2587253|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587254|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2587255|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2587256|NCT01692808|Vitamin D|vitamin d|mesh-list
2587257|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
2587258|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
2587259|NCT01692808|Vitamins|vitamins|mesh-list
2587260|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
2587261|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587262|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2587263|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2587264|NCT01692834|Cyclosporine|cyclosporine|mesh-list
2587265|NCT01692834|Cyclosporins|cyclosporins|mesh-list
2587266|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587267|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587268|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2587269|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
2587270|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587271|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
2587272|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587273|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
2587274|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2587275|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2587276|NCT01692886|Vaccines|vaccines|mesh-list
2587277|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2587278|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
2587279|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587280|NCT01692925|Factor VIII|factor viii|mesh-list
2587281|NCT01692925|Coagulants|coagulants|mesh-ancestor
2587282|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
2587283|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2587284|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
2587285|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587286|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587287|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2587288|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
2587289|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
2587290|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2587291|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
2587292|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587293|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587294|NCT01693081|Apomorphine|apomorphine|mesh-list
2587295|NCT01693081|Emetics|emetics|mesh-ancestor
2587296|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587297|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
2587298|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587299|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2587300|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
2141516|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141517|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141518|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141519|NCT03395353|Analgesics|analgesics|mesh-ancestor
2141520|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
2141521|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141522|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
2141523|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2141524|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
2141525|NCT03395808|Tramadol|tramadol|mesh-list
2141526|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2141527|NCT03395808|Narcotics|narcotics|mesh-ancestor
2587301|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
2587302|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587303|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587304|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
2587305|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
2587306|NCT01693159|Coagulants|coagulants|mesh-ancestor
2587307|NCT01693276|Gemcitabine|gemcitabine|mesh-list
2587308|NCT01693276|Paclitaxel|paclitaxel|mesh-list
2587309|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2587310|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2587311|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587312|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
2587313|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
2587314|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
2587315|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587316|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2587317|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
2587318|NCT01693276|Antiviral Agents|antiviral agents|mesh-ancestor
2587319|NCT01693276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587320|NCT01693276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587321|NCT01693276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2587322|NCT01693276|Immunologic Factors|immunologic factors|mesh-ancestor
2141528|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141529|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141530|NCT03395808|Analgesics|analgesics|mesh-ancestor
2141531|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
2141532|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141533|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
2587323|NCT01693276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587324|NCT01693289|Metformin|metformin|mesh-list
2587325|NCT01693289|Letrozole|letrozole|mesh-list
2587326|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2587327|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587328|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587329|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2587330|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2587331|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587332|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587333|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2587334|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
2587335|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587336|NCT01693302|Insulin|insulin|mesh-list
2587337|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2587338|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2587339|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587340|NCT01693328|Fentanyl|fentanyl|mesh-list
2587341|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2587342|NCT01693328|Narcotics|narcotics|mesh-ancestor
2587343|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2587344|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587345|NCT01693328|Analgesics|analgesics|mesh-ancestor
2587346|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
2587347|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587348|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2587349|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2587350|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
2587351|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
2587352|NCT01693380|Vaccines|vaccines|mesh-list
2587353|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
2587354|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587355|NCT01693393|Cyclosporine|cyclosporine|mesh-list
2587356|NCT01693393|Cyclosporins|cyclosporins|mesh-list
2587357|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587358|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587359|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2587360|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
2587361|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587362|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
2587363|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587364|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
2587365|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2587366|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2587367|NCT01693419|Gemcitabine|gemcitabine|mesh-list
2587368|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2587369|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2587370|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
2587371|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587372|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587373|NCT01693419|Antiviral Agents|antiviral agents|mesh-ancestor
2587374|NCT01693419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587375|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587376|NCT01693419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2587377|NCT01693419|Immunologic Factors|immunologic factors|mesh-ancestor
2587378|NCT01693419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587379|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2587380|NCT01693432|Docetaxel|docetaxel|mesh-list
2587381|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587382|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
2587383|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
2587384|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
2587385|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587386|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
2587387|NCT01693445|Irinotecan|irinotecan|mesh-list
2587388|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587389|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2587390|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2587391|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587392|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587393|NCT01693601|Panobinostat|panobinostat|mesh-list
2587394|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587395|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2587396|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587397|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587398|NCT01693640|Abatacept|abatacept|mesh-list
2587399|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2587400|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587401|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587402|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2587403|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
2587404|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587405|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2587406|NCT01693679|Lamivudine|lamivudine|mesh-list
2587407|NCT01693679|Adefovir|adefovir|mesh-list
2587408|NCT01693679|Telbivudine|telbivudine|mesh-list
2587409|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2587410|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2587411|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587412|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587413|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
2141534|NCT03395886|Remifentanil|remifentanil|mesh-list
2141535|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2141536|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141537|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141538|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2587414|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587415|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2587416|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2587417|NCT01693718|Fluorouracil|fluorouracil|mesh-list
2587418|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
2587419|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587420|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
2587421|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587422|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2587423|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2587424|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
2587425|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587426|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
2587427|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141539|NCT03395886|Analgesics|analgesics|mesh-ancestor
2141540|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
2141541|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141542|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2141543|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2141544|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2141545|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
2141546|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141547|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141548|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2141549|NCT03395886|Narcotics|narcotics|mesh-ancestor
2141550|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
2141551|NCT03395990|Procaine|procaine|mesh-list
2141552|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
2141553|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
2141554|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141555|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141556|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
2141557|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141558|NCT03396952|Aspirin|aspirin|mesh-list
2141559|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
2141560|NCT03396952|Ipilimumab|ipilimumab|mesh-list
2587428|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2587434|NCT01693809|Caffeine|caffeine|mesh-list
2587435|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2587436|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587437|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2587438|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587439|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587440|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2587441|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2587442|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
2587443|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587444|NCT01693822|Axitinib|axitinib|mesh-list
2141561|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2141562|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141563|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2141564|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2141565|NCT03396952|Analgesics|analgesics|mesh-ancestor
2587445|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587446|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2587447|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587448|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141566|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
2141567|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141568|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141569|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141570|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2141571|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2141572|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2141573|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184938|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2587456|NCT01694017|Tenofovir|tenofovir|mesh-list
2587457|NCT01694017|Zidovudine|zidovudine|mesh-list
2587458|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
2587459|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587460|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2587461|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2587462|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587463|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587464|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2587465|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2587466|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
2587475|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2587476|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
2587477|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2587478|NCT01694134|Prednisolone|prednisolone|mesh-list
2587479|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
2587480|NCT01694134|Lidocaine|lidocaine|mesh-list
2587481|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2587482|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
2587483|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
2587484|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
2587485|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2587486|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587487|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
2587488|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587489|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2420274|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2420275|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420276|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
2420277|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420278|NCT00807261|Gemcitabine|gemcitabine|mesh-list
2420279|NCT00807261|Docetaxel|docetaxel|mesh-list
2420280|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2420281|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
2420282|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420283|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420284|NCT00807261|Antiviral Agents|antiviral agents|mesh-ancestor
2420285|NCT00807261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420286|NCT00807261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420287|NCT00807261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2420288|NCT00807261|Immunologic Factors|immunologic factors|mesh-ancestor
2420289|NCT00807261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420290|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
2420291|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
2420292|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
2420293|NCT00807326|Simethicone|simethicone|mesh-list
2420294|NCT00807326|Loperamide|loperamide|mesh-list
2587490|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2587491|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2587492|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2587493|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587494|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2587495|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
2587496|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
2587497|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2587498|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
2587499|NCT01694134|Hormones|hormones|mesh-ancestor
2587500|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587501|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2587502|NCT01694134|Protective Agents|protective agents|mesh-ancestor
2587503|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2587504|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587505|NCT01694212|Diclofenac|diclofenac|mesh-list
2587506|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2587507|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2587508|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2587509|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2587510|NCT01694212|Analgesics|analgesics|mesh-ancestor
2587511|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
2587512|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587513|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587514|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2587515|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2587516|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2587517|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587518|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587519|NCT01694264|Entecavir|entecavir|mesh-list
2587520|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
2587521|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587522|NCT01694277|Sunitinib|sunitinib|mesh-list
2587523|NCT01694277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587524|NCT01694277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2587525|NCT01694277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2587526|NCT01694277|Growth Substances|growth substances|mesh-ancestor
2587527|NCT01694277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587528|NCT01694277|Growth Inhibitors|growth inhibitors|mesh-ancestor
2587529|NCT01694277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2587530|NCT01694277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141574|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2141575|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2141576|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141577|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
2141578|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2141579|NCT03397394|Rucaparib|rucaparib|mesh-list
2141580|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2141581|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141582|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141583|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141584|NCT03398278|Oxycodone|oxycodone|mesh-list
2141585|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2141586|NCT03398278|Narcotics|narcotics|mesh-ancestor
2141587|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141588|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141589|NCT03398278|Analgesics|analgesics|mesh-ancestor
2141590|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
2141591|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141592|NCT03398330|Oxycodone|oxycodone|mesh-list
2587531|NCT01694277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587532|NCT01694355|Vitamin D|vitamin d|mesh-list
2587533|NCT01694355|Vitamins|vitamins|mesh-ancestor
2587534|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
2587535|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587536|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2587537|NCT01694407|Tenofovir|tenofovir|mesh-list
2587538|NCT01694407|Emtricitabine|emtricitabine|mesh-list
2587539|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
2587540|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587541|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2587542|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2587543|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587544|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587545|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2587546|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2587547|NCT01694459|Heparin|heparin|mesh-list
2587548|NCT01694459|Calcium heparin|calcium heparin|mesh-list
2587549|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
2587550|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2587551|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2587552|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587553|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2587554|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
2587555|NCT01694498|Coagulants|coagulants|mesh-ancestor
2587556|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2587557|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
2587558|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587559|NCT01694576|Paclitaxel|paclitaxel|mesh-list
2587560|NCT01694576|Nedaplatin|nedaplatin|mesh-list
2587561|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2141593|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2141594|NCT03398330|Narcotics|narcotics|mesh-ancestor
2141595|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141596|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141597|NCT03398330|Analgesics|analgesics|mesh-ancestor
2141598|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
2141599|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141600|NCT03398356|Metformin|metformin|mesh-list
2141601|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2141602|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141603|NCT03398421|Itraconazole|itraconazole|mesh-list
2141604|NCT03398421|Nemiralisib|nemiralisib|mesh-list
2141605|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
2141606|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2141607|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2141608|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2141609|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141610|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141611|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2141612|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
2141613|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141614|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141615|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2141616|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2141617|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
2141618|NCT03400033|Hematinics|hematinics|mesh-ancestor
2141619|NCT03400475|Simvastatin|simvastatin|mesh-list
2141620|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2141621|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2141622|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
2141623|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141624|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2420295|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
2587562|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587563|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
2587564|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
2587565|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
2587566|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587567|NCT01694693|Abatacept|abatacept|mesh-list
2420296|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2420297|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
2420298|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420299|NCT00807326|Emollients|emollients|mesh-ancestor
2420300|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
2420301|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
2420302|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2420303|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2420304|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
2420305|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420306|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2420307|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2420308|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420309|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420310|NCT00807521|Dexamethasone|dexamethasone|mesh-list
2420311|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2420312|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
2420313|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
2420314|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587568|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2587569|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141625|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2141626|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141627|NCT03400852|Cosyntropin|cosyntropin|mesh-list
2141628|NCT03400852|Hormones|hormones|mesh-ancestor
2141629|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141630|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141631|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
2141632|NCT03401229|Benralizumab|benralizumab|mesh-list
2141633|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141634|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
2141635|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2141636|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2141637|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
2141638|NCT03401450|Bupivacaine|bupivacaine|mesh-list
2141639|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
2141640|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
2141641|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141642|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141643|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
2141644|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141645|NCT03402243|Menthol|menthol|mesh-list
2141646|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
2141647|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
2141648|NCT03403036|Brodalumab|brodalumab|mesh-list
2141649|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
2141650|NCT03403374|Evolocumab|evolocumab|mesh-list
2141651|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2141652|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2141653|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
2141654|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141655|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2141656|NCT03403504|Oxycodone|oxycodone|mesh-list
2141657|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2141658|NCT03403504|Narcotics|narcotics|mesh-ancestor
2141659|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141660|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141661|NCT03403504|Analgesics|analgesics|mesh-ancestor
2587570|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587571|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2587572|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
2587573|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587574|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2587575|NCT01694732|Varenicline|varenicline|mesh-list
2587576|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2587577|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2587578|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
2587579|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587580|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587581|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587582|NCT01694797|Metoprolol|metoprolol|mesh-list
2587583|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2587584|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2587585|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
2587586|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
2587587|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587588|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587589|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2587590|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2587591|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2587592|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
2587593|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587594|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587595|NCT01695005|Prednisone|prednisone|mesh-list
2587596|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2587597|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
2587598|NCT01695005|Hormones|hormones|mesh-ancestor
2587599|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587600|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587601|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2587602|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587603|NCT01695057|Vorinostat|vorinostat|mesh-list
2587604|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587605|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2587606|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668562|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141662|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
2587607|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587608|NCT01695070|Melatonin|melatonin|mesh-list
2587609|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
2587610|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587611|NCT01695070|Protective Agents|protective agents|mesh-ancestor
2587612|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587613|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2587614|NCT01695109|Liraglutide|liraglutide|mesh-list
2587615|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2587616|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587617|NCT01695109|Incretins|incretins|mesh-ancestor
2587618|NCT01695109|Hormones|hormones|mesh-ancestor
2587619|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587620|NCT01695122|Valproic Acid|valproic acid|mesh-list
2587621|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
2587622|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587623|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587624|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
2587625|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141663|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141664|NCT03403517|Dexamethasone|dexamethasone|mesh-list
2141665|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
2141666|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2141667|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2141668|NCT03403517|Prednisolone|prednisolone|mesh-list
2141669|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
2141670|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2141671|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
2141672|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141673|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
2141674|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
2141675|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141676|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141677|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2141678|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
2141679|NCT03403517|Hormones|hormones|mesh-ancestor
2141680|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141681|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2141682|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141683|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2141684|NCT03403517|Protective Agents|protective agents|mesh-ancestor
2141685|NCT03403712|Dexamethasone|dexamethasone|mesh-list
2141686|NCT03403712|Palonosetron|palonosetron|mesh-list
2141687|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141688|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
2141689|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
2141690|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141691|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141692|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2141693|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
2587626|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587627|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
2587628|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2587629|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2587630|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2587631|NCT01695148|Carotenoids|carotenoids|mesh-list
2587632|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
2587633|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587634|NCT01695148|Protective Agents|protective agents|mesh-ancestor
2587635|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587636|NCT01695174|Rifaximin|rifaximin|mesh-list
2587637|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2141694|NCT03403712|Hormones|hormones|mesh-ancestor
2141695|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141696|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2141697|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141698|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2141699|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2141700|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
2141701|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141702|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141703|NCT03404206|Ibuprofen|ibuprofen|mesh-list
2141704|NCT03404206|Naproxen|naproxen|mesh-list
2141705|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2141706|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2587638|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587639|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2587640|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
2587641|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
2587642|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587643|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587644|NCT01695226|Celecoxib|celecoxib|mesh-list
2587645|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2587646|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2587647|NCT01695226|Analgesics|analgesics|mesh-ancestor
2587648|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
2587649|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587650|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587651|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2587652|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2587653|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2587654|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2587655|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587656|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587657|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
2587658|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
2587659|NCT01695317|Vitamins|vitamins|mesh-ancestor
2587660|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
2587661|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587662|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
2587663|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
2587664|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
2587665|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
2141707|NCT03404206|Analgesics|analgesics|mesh-ancestor
2141708|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
2141709|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141710|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141711|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141712|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2141713|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2141714|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141715|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141716|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
2141717|NCT03404648|Choline|choline|mesh-list
2141718|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
2141719|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2141720|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
2141721|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141722|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2141723|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2141724|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
2141725|NCT03404843|Fasudil|fasudil|mesh-list
2141726|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2141727|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2141728|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141729|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2141730|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141731|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
2141732|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2141733|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141734|NCT03405259|Fluorides|fluorides|mesh-list
2141735|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
2141736|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
2141737|NCT03405259|Protective Agents|protective agents|mesh-ancestor
2587666|NCT01695356|Avobenzone|avobenzone|mesh-list
2587667|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
2587668|NCT01695356|Benzophenone|benzophenone|mesh-list
2587669|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2587670|NCT01695356|Protective Agents|protective agents|mesh-ancestor
2141738|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141741|NCT03405818|Tavaborole|tavaborole|mesh-list
2141742|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
2141743|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2141744|NCT03406260|Lasmiditan|lasmiditan|mesh-list
2141745|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2141746|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
2141747|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141748|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587671|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587672|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
2587673|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2587674|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
2587675|NCT01695460|Vitamins|vitamins|mesh-list
2587676|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
2587677|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587678|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2587679|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2587680|NCT01695707|Pioglitazone|pioglitazone|mesh-list
2587681|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2587682|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587683|NCT01695733|Vaccines|vaccines|mesh-list
2420315|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420316|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2420317|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
2420318|NCT00807521|Hormones|hormones|mesh-ancestor
2420319|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2420320|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2420321|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420322|NCT00807534|Bromides|bromides|mesh-list
2420323|NCT00807534|Ipratropium|ipratropium|mesh-list
2420324|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
2420325|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2420326|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
2420327|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420328|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420329|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2420330|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
2420331|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2587684|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
2587685|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587686|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
2587687|NCT01695759|Hematinics|hematinics|mesh-ancestor
2587688|NCT01695798|Vaccines|vaccines|mesh-list
2587689|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
2587690|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587691|NCT01695824|Warfarin|warfarin|mesh-list
2587692|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
2587693|NCT01695850|Sennosides|sennosides|mesh-list
2587694|NCT01695850|Laxatives|laxatives|mesh-ancestor
2587695|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2587696|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
2587697|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2587698|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
2587699|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2587700|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587701|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2587702|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2587703|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2587704|NCT01696110|Heparin|heparin|mesh-list
2587705|NCT01696110|Calcium heparin|calcium heparin|mesh-list
2587706|NCT01696110|Tirofiban|tirofiban|mesh-list
2587707|NCT01696110|Bivalirudin|bivalirudin|mesh-list
2587708|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
2587709|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2587710|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2587711|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587712|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
2587713|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2587714|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
2587715|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587716|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2587717|NCT01696240|Udenafil|udenafil|mesh-list
2587718|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2587719|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2587720|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587721|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587722|NCT01696370|Trimetazidine|trimetazidine|mesh-list
2587723|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
2587724|NCT01696383|Timolol|timolol|mesh-list
2587725|NCT01696383|Travoprost|travoprost|mesh-list
2587726|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2587727|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2587728|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
2587729|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587730|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587731|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587732|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2587733|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2587734|NCT01696409|Vitamin D|vitamin d|mesh-list
2587735|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
2587736|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
2587737|NCT01696409|Vitamins|vitamins|mesh-list
2587738|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
2587739|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587740|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2587741|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2587742|NCT01696422|Vaccines|vaccines|mesh-list
2587743|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
2587744|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587745|NCT01696435|Vitamin D|vitamin d|mesh-list
2587746|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
2587747|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
2587748|NCT01696435|Vitamins|vitamins|mesh-list
2587749|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
2587750|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587751|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2587752|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2587753|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
2587754|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
2587755|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587756|NCT01696448|Protective Agents|protective agents|mesh-ancestor
2587757|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587758|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
2587759|NCT01696448|Vitamins|vitamins|mesh-ancestor
2587760|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
2587761|NCT01696461|Plerixafor|plerixafor|mesh-list
2587762|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2587763|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2587764|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
2587765|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587766|NCT01696474|Bortezomib|bortezomib|mesh-list
2587767|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587768|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
2587769|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2587770|NCT01696500|Antibodies|antibodies|mesh-list
2587771|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
2587772|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2587773|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
2587774|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587775|NCT01696526|Vitamin D|vitamin d|mesh-list
2587776|NCT01696526|Vitamins|vitamins|mesh-ancestor
2587777|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
2587778|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587779|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2587780|NCT01696552|Cimetidine|cimetidine|mesh-list
2587781|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2587782|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2587783|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2587784|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
2587785|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
2587786|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587787|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587788|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587789|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2587790|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2587791|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587792|NCT01696617|Aripiprazole|aripiprazole|mesh-list
2587793|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
2587794|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2587795|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2587796|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2587797|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2587798|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587799|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
2587800|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
2587801|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587802|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587803|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2587804|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2587805|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
2587806|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2587807|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2587808|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2587809|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2587810|NCT01696630|Desflurane|desflurane|mesh-list
2587811|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2587812|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
2587813|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
2587814|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2587815|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587816|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2141749|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141750|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
2141751|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2141752|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141753|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
2141754|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2141755|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141756|NCT03407430|Pregabalin|pregabalin|mesh-list
2587817|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
2587818|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587819|NCT01696734|Domperidone|domperidone|mesh-list
2587820|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
2587821|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
2587822|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587823|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587824|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2141757|NCT03407430|Analgesics|analgesics|mesh-ancestor
2141758|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
2141759|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141760|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141761|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
2141762|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2141763|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2141764|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141765|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2141766|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2141767|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2141768|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141769|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2141770|NCT03407625|Misoprostol|misoprostol|mesh-list
2141771|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2141772|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
2141773|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2141774|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141775|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2141776|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2141777|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
2141778|NCT03408483|Epinephrine|epinephrine|mesh-list
2141779|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
2141780|NCT03408483|Bupivacaine|bupivacaine|mesh-list
2141781|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
2141782|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
2141783|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141784|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141785|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
2141786|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141787|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2141788|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2141789|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
2141790|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141791|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141792|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2141793|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2141794|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
2141795|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2141796|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
2141797|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
2141798|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
2141799|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2587825|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2587826|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
2587827|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587828|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587829|NCT01696799|Econazole|econazole|mesh-list
2587830|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
2587831|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587832|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2587833|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2141800|NCT03408483|Narcotics|narcotics|mesh-ancestor
2141801|NCT03408483|Analgesics|analgesics|mesh-ancestor
2141802|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
2141803|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
2141804|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
2141805|NCT03408639|Vitamins|vitamins|mesh-ancestor
2141806|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
2141807|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587834|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587835|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587836|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2587837|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
2141808|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
2141809|NCT03408639|Hematinics|hematinics|mesh-ancestor
2141810|NCT03408730|Vaccines|vaccines|mesh-list
2141811|NCT03408730|Immunologic Factors|immunologic factors|mesh-ancestor
2141812|NCT03408730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141813|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
2141814|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2141815|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2141816|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141817|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2141818|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141819|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2141820|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
2141821|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2141822|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2141823|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
2141824|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
2141825|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2141826|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
2141827|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2141828|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
2141829|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141830|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141831|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
2587838|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587839|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587840|NCT01696825|Diazepam|diazepam|mesh-list
2587841|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2587842|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
2587843|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
2141832|NCT03414359|Lidocaine|lidocaine|mesh-list
2141833|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
2141834|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
2141835|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
2141836|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141837|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141838|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
2141839|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141840|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2141841|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2141842|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2141843|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2420332|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
2420333|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420334|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420335|NCT00807547|Vaccines|vaccines|mesh-list
2420336|NCT00807547|Immunologic Factors|immunologic factors|mesh-ancestor
2420337|NCT00807547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420338|NCT00807612|Paclitaxel|paclitaxel|mesh-list
2420339|NCT00807612|Carboplatin|carboplatin|mesh-list
2420340|NCT00807612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2420341|NCT00807612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2420342|NCT00807612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420343|NCT00807612|Tubulin Modulators|tubulin modulators|mesh-ancestor
2420344|NCT00807612|Antimitotic Agents|antimitotic agents|mesh-ancestor
2420345|NCT00807612|Mitosis Modulators|mitosis modulators|mesh-ancestor
2420346|NCT00807612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420347|NCT00807612|Immunologic Factors|immunologic factors|mesh-ancestor
2420348|NCT00807612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420349|NCT00807625|Copper|copper|mesh-list
2420350|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2420351|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
2420352|NCT00807625|Trace Elements|trace elements|mesh-ancestor
2420353|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
2587844|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
2587845|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587846|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587847|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2587848|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2587849|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2587850|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2587851|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2587852|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2587853|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2587854|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2587855|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2587856|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
2141844|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141845|NCT03415178|Atorvastatin|atorvastatin|mesh-list
2141846|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2141847|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2141848|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2141849|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
2141850|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141851|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2141852|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2141853|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141854|NCT03415243|Acetaminophen|acetaminophen|mesh-list
2141855|NCT03415243|Phenylephrine|phenylephrine|mesh-list
2141856|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
2141857|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
2141858|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2141859|NCT03415243|Analgesics|analgesics|mesh-ancestor
2141860|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
2141861|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587857|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
2587858|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
2587859|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
2141862|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141863|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
2141864|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2141865|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
2141866|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
2141867|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
2141868|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2141869|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
2141870|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
2141871|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2141872|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2141873|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2141874|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
2141875|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141876|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141877|NCT03415243|Protective Agents|protective agents|mesh-ancestor
2141878|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
2141879|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2141880|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2141881|NCT03415581|Oxycodone|oxycodone|mesh-list
2141882|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2141883|NCT03415581|Narcotics|narcotics|mesh-ancestor
2141884|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2141885|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141886|NCT03415581|Analgesics|analgesics|mesh-ancestor
2141887|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
2141888|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141889|NCT03416127|Metformin|metformin|mesh-list
2141890|NCT03416127|Propolis|propolis|mesh-list
2141891|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2141892|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141893|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587860|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587861|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587862|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
2587863|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
2587864|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587865|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2587866|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587867|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2587868|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
2587869|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587870|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2587871|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587872|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2587873|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
2587874|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2587875|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2587876|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587877|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587878|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
2587879|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587880|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2587881|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2587882|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2587883|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2587884|NCT01697059|Amoxicillin|amoxicillin|mesh-list
2587885|NCT01697059|Piperacillin|piperacillin|mesh-list
2587886|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2587887|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2587888|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587889|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2587890|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587891|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587892|NCT01697072|Cisplatin|cisplatin|mesh-list
2587893|NCT01697072|Capecitabine|capecitabine|mesh-list
2587894|NCT01697072|Epirubicin|epirubicin|mesh-list
2587895|NCT01697072|Rilotumumab|rilotumumab|mesh-list
2587896|NCT01697072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587897|NCT01697072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2587898|NCT01697072|Antimetabolites|antimetabolites|mesh-ancestor
2141910|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
2141911|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
2141912|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141913|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2141914|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141915|NCT03418571|Gontivimab|gontivimab|mesh-list
2141916|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
2141917|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2141918|NCT03418714|Salvinorin A|salvinorin a|mesh-list
2141919|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
2141920|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141921|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2141922|NCT03419403|Temozolomide|temozolomide|mesh-list
2141923|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2141924|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2141925|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2141926|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
2141927|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587899|NCT01697072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587900|NCT01697072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2587901|NCT01697072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2587902|NCT01697072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2587903|NCT01697072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587904|NCT01697072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2587905|NCT01697098|Dexamethasone|dexamethasone|mesh-list
2587906|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
2587907|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
2587908|NCT01697098|BB 1101|bb 1101|mesh-list
2587909|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2587910|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
2587911|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
2420354|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420355|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2420356|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
2420357|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2420358|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2420359|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2420360|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2420361|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420362|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2420363|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2420364|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2420365|NCT00807690|Tacrolimus|tacrolimus|mesh-list
2420366|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2420367|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
2420368|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420369|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2420370|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420371|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420372|NCT00807755|Carboplatin|carboplatin|mesh-list
2420373|NCT00807755|Etoposide|etoposide|mesh-list
2420374|NCT00807755|Everolimus|everolimus|mesh-list
2420375|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420376|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2420377|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2420378|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2420379|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420380|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420381|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2420382|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
2420383|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420384|NCT00807807|Folic Acid|folic acid|mesh-list
2420385|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
2420386|NCT00807807|Hematinics|hematinics|mesh-ancestor
2141928|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2141929|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2141930|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
2141931|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
2141932|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2141933|NCT03421210|Nicotine|nicotine|mesh-list
2141934|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2141935|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
2141936|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141937|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141938|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2587912|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2587913|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587914|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2587915|NCT01697098|Hormones|hormones|mesh-ancestor
2587916|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2587917|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2587918|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587919|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
2587920|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587921|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587922|NCT01697111|Dienogest|dienogest|mesh-list
2587923|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2587924|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
2587925|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2587926|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587927|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2587928|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2587929|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2587930|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2587931|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
2587932|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141939|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2141940|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
2141941|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2141942|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141943|NCT03421379|Glucagon|glucagon|mesh-list
2587933|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2587934|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587935|NCT01697150|Pancrelipase|pancrelipase|mesh-list
2587936|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2587937|NCT01697228|Vitamin D|vitamin d|mesh-list
2141944|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2141945|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2141946|NCT03421379|Hormones|hormones|mesh-ancestor
2141947|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141948|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141949|NCT03421379|Incretins|incretins|mesh-ancestor
2141950|NCT03421730|Budesonide|budesonide|mesh-list
2141951|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141952|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2141953|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
2141954|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2141955|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587938|NCT01697228|Vitamins|vitamins|mesh-ancestor
2587939|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
2587940|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587941|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2587942|NCT01697267|Rituximab|rituximab|mesh-list
2587943|NCT01697267|Azathioprine|azathioprine|mesh-list
2587944|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2587945|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587946|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
2587947|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587948|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2587949|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
2587950|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587951|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2587952|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2587953|NCT01697280|Vaccines|vaccines|mesh-list
2587954|NCT01697280|Immunologic Factors|immunologic factors|mesh-ancestor
2587955|NCT01697280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587956|NCT01697293|Paclitaxel|paclitaxel|mesh-list
2587957|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
2587958|NCT01697293|Doxorubicin|doxorubicin|mesh-list
2587959|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2587960|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2587961|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2587962|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587963|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
2587964|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
2587965|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
2587966|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587967|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2587968|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
2587969|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587970|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2587971|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2587972|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
2587973|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2587974|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2587975|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2587976|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2587977|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2587978|NCT01697306|Gemcitabine|gemcitabine|mesh-list
2587979|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
2587980|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2587981|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
2587982|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587983|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2587984|NCT01697306|Antiviral Agents|antiviral agents|mesh-ancestor
2587985|NCT01697306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2587986|NCT01697306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2141956|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2141957|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
2141958|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
2141959|NCT03421730|Hormones|hormones|mesh-ancestor
2141960|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141961|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
2141962|NCT03422159|Thiamine|thiamine|mesh-list
2141963|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
2587987|NCT01697306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2587988|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
2587989|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587990|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2587991|NCT01697410|Terlipressin|terlipressin|mesh-list
2587992|NCT01697410|Norepinephrine|norepinephrine|mesh-list
2141964|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2141965|NCT03422159|Vitamins|vitamins|mesh-ancestor
2141966|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
2141967|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141968|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2141969|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
2141970|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141971|NCT03422159|Protective Agents|protective agents|mesh-ancestor
2141972|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
2141973|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
2141974|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2141975|NCT03424044|Glucagon|glucagon|mesh-list
2141976|NCT03424044|Pancrelipase|pancrelipase|mesh-list
2141977|NCT03424044|Pancreatin|pancreatin|mesh-list
2141978|NCT03424044|Hormones|hormones|mesh-list
2141979|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2141980|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141981|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2141982|NCT03424239|Vitamin D|vitamin d|mesh-list
2141983|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
2141984|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
2141985|NCT03424239|Vitamins|vitamins|mesh-list
2141986|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
2141987|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141988|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2141989|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2141990|NCT03424681|Modafinil|modafinil|mesh-list
2141991|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2141992|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2141993|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2141994|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2141995|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2141996|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2141997|NCT03425097|Fexofenadine|fexofenadine|mesh-list
2141998|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2141999|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2142000|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2142001|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
2142002|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
2142003|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142004|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142005|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142006|NCT03425253|Lidocaine|lidocaine|mesh-list
2142007|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
2142008|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
2142009|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142010|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142011|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
2587993|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2587994|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2587995|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
2587996|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2587997|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2587998|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2587999|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
2588000|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
2588001|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588002|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2588003|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2588004|NCT01697436|Ribavirin|ribavirin|mesh-list
2588005|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
2588006|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588007|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
2588008|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588009|NCT01697566|Metformin|metformin|mesh-list
2588010|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2588011|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588012|NCT01697605|Infigratinib|infigratinib|mesh-list
2588013|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588014|NCT01697618|Insulin|insulin|mesh-list
2588015|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2588016|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
2588017|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
2588018|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2588019|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2588020|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588021|NCT01697631|Insulin|insulin|mesh-list
2588022|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2588023|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
2588024|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
2588025|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2588026|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
2142012|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142013|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2142014|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2142015|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2142016|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2142017|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142018|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
2588027|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2588028|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2588029|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588030|NCT01697657|Insulin|insulin|mesh-list
2588031|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2588032|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
2588033|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
2588034|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
2588035|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
2588036|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
2588037|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2588038|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588039|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2588040|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2588041|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
2588042|NCT01697722|Beclomethasone|beclomethasone|mesh-list
2588043|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588044|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
2588045|NCT01697722|Hormones|hormones|mesh-ancestor
2588046|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2588047|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588048|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2588049|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
2588050|NCT01697735|Atorvastatin|atorvastatin|mesh-list
2588051|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2588052|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2588053|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2588054|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
2588055|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588056|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2588057|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2588058|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588059|NCT01697787|Artesunate|artesunate|mesh-list
2588060|NCT01697787|Lumefantrine|lumefantrine|mesh-list
2588061|NCT01697787|Artemether|artemether|mesh-list
2588062|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2588063|NCT01697787|Amodiaquine|amodiaquine|mesh-list
2588064|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
2588065|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2588066|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2588067|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588068|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588069|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
2588070|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
2588071|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2588072|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
2142019|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2142020|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142021|NCT03425396|Renal Agents|renal agents|mesh-ancestor
2142022|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2142023|NCT03426228|Progesterone|progesterone|mesh-list
2142024|NCT03426228|Estrogens|estrogens|mesh-list
2142025|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142026|NCT03426228|Hormones|hormones|mesh-ancestor
2142027|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2142028|NCT03426228|Progestins|progestins|mesh-ancestor
2142029|NCT03426995|Cantharidin|cantharidin|mesh-list
2142030|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142031|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588073|NCT01697826|Clindamycin|clindamycin|mesh-list
2142032|NCT03427619|Picibanil|picibanil|mesh-list
2588074|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
2588075|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
2142033|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142034|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
2142035|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
2588076|NCT01697826|Clotrimazole|clotrimazole|mesh-list
2588077|NCT01697826|Miconazole|miconazole|mesh-list
2588078|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2588079|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588080|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2588081|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588082|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588083|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2588084|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
2588085|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2588086|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2588087|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2588088|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
2588089|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2588090|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588091|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2588092|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2588093|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2588094|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2588095|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2588096|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588097|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588098|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2588099|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2588100|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588101|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
2588102|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2588103|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2588104|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2588105|NCT01698164|Estradiol|estradiol|mesh-list
2588106|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2588107|NCT01698164|Progesterone|progesterone|mesh-list
2588108|NCT01698164|Estrogens|estrogens|mesh-ancestor
2588109|NCT01698164|Hormones|hormones|mesh-ancestor
2588110|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2588111|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588112|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2588113|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
2588114|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2588115|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2588116|NCT01698164|Progestins|progestins|mesh-ancestor
2588117|NCT01698177|Vaccines|vaccines|mesh-list
2588118|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
2588119|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588120|NCT01698203|Ropivacaine|ropivacaine|mesh-list
2588121|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
2588122|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
2588123|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2588124|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588125|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
2588126|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588127|NCT01698281|Dexamethasone|dexamethasone|mesh-list
2588128|NCT01698281|Doxorubicin|doxorubicin|mesh-list
2588129|NCT01698281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588130|NCT01698281|Antiemetics|antiemetics|mesh-ancestor
2588131|NCT01698281|Autonomic Agents|autonomic agents|mesh-ancestor
2588132|NCT01698281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142036|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142037|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142038|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142039|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
2142040|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
2142041|NCT03428230|Acetaminophen|acetaminophen|mesh-list
2142042|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
2142043|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2142044|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2142045|NCT03428230|Analgesics|analgesics|mesh-ancestor
2142046|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
2142047|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142048|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588133|NCT01698281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142049|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
2142050|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
2142051|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
2142052|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142053|NCT03428360|Diazepam|diazepam|mesh-list
2142054|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2142055|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
2142056|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
2142057|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
2142058|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142059|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142060|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2142061|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2142062|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142063|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2142064|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2142065|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2142066|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2142067|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2142068|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2142069|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
2142070|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
2588134|NCT01698281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2588135|NCT01698281|Glucocorticoids|glucocorticoids|mesh-ancestor
2588136|NCT01698281|Hormones|hormones|mesh-ancestor
2588137|NCT01698281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2588138|NCT01698281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2588139|NCT01698281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588140|NCT01698281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2588141|NCT01698281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2588142|NCT01698281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2588143|NCT01698281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588144|NCT01698281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588145|NCT01698476|Vitamin D|vitamin d|mesh-list
2588146|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
2588147|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2588148|NCT01698476|Vitamins|vitamins|mesh-ancestor
2588149|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
2588150|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588151|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2588152|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2588153|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588154|NCT01698541|Tacrolimus|tacrolimus|mesh-list
2588155|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2142071|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
2142072|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
2142073|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142074|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142075|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
2142076|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2142077|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2142078|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142079|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
2142080|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142081|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142082|NCT03430050|Progesterone|progesterone|mesh-list
2142083|NCT03430050|Progestins|progestins|mesh-ancestor
2142084|NCT03430050|Hormones|hormones|mesh-ancestor
2142085|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2142086|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142087|NCT03430856|Insulin|insulin|mesh-list
2142088|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2142089|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
2142090|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2142091|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142092|NCT03430986|Lidocaine|lidocaine|mesh-list
2142093|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
2142094|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
2588156|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
2588157|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588158|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2588159|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588160|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588161|NCT01698567|Antithrombins|antithrombins|mesh-list
2142095|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142096|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588162|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
2588163|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2588164|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
2588165|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588166|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588167|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
2588168|NCT01698593|Epinephrine|epinephrine|mesh-list
2588169|NCT01698593|Bupivacaine|bupivacaine|mesh-list
2588170|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
2588171|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
2588172|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2588173|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588174|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
2588175|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588176|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2142097|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
2142098|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142099|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2142100|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2142101|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2142102|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2142103|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142104|NCT03431337|Amoxicillin|amoxicillin|mesh-list
2142105|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2142106|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142107|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2142108|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
2142109|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142110|NCT03432858|Vancomycin|vancomycin|mesh-list
2142111|NCT03432858|Cefazolin|cefazolin|mesh-list
2142112|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2142113|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142114|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
2142115|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2588177|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2588178|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
2588179|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2588180|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588181|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2588182|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2588183|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
2588184|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2588185|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
2588186|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
2588187|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
2588188|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2588189|NCT01698645|Fentanyl|fentanyl|mesh-list
2588190|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2588191|NCT01698645|Narcotics|narcotics|mesh-ancestor
2588192|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2588193|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588194|NCT01698645|Analgesics|analgesics|mesh-ancestor
2588195|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
2588196|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588197|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2588198|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2588199|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
2588200|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
2588201|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
2588202|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2588203|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588204|NCT01698723|Ribavirin|ribavirin|mesh-list
2588205|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
2588206|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588207|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
2588208|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588209|NCT01698749|Dexamethasone|dexamethasone|mesh-list
2588210|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588211|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
2588212|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
2588213|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588214|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588215|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2588216|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
2588217|NCT01698749|Hormones|hormones|mesh-ancestor
2588218|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2588219|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2588220|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588221|NCT01698788|Dexamethasone|dexamethasone|mesh-list
2588222|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
2588223|NCT01698788|BB 1101|bb 1101|mesh-list
2588224|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588225|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
2588226|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
2588227|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588228|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588229|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2588230|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
2588231|NCT01698788|Hormones|hormones|mesh-ancestor
2588232|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2588233|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2588234|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588235|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
2588236|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588237|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588238|NCT01698840|Vitamin D|vitamin d|mesh-list
2588239|NCT01698840|Vitamins|vitamins|mesh-ancestor
2588240|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
2588241|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142116|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142117|NCT03433703|Lenvatinib|lenvatinib|mesh-list
2142118|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142119|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2142120|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142121|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142122|NCT03433755|Evolocumab|evolocumab|mesh-list
2588242|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2588243|NCT01698918|Ethanol|ethanol|mesh-list
2588244|NCT01698918|Dexamethasone|dexamethasone|mesh-list
2588245|NCT01698918|Dexamethasone acetate|dexamethasone acetate|mesh-list
2588246|NCT01698918|Everolimus|everolimus|mesh-list
2588247|NCT01698918|Letrozole|letrozole|mesh-list
2588248|NCT01698918|Exemestane|exemestane|mesh-list
2588249|NCT01698918|BB 1101|bb 1101|mesh-list
2588250|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588251|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
2588252|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
2588253|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588254|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588255|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2588256|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
2588257|NCT01698918|Hormones|hormones|mesh-ancestor
2588258|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2588259|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2588260|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588261|NCT01698918|Protease Inhibitors|protease inhibitors|mesh-ancestor
2588262|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588263|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588264|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2588265|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
2588266|NCT01698918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2588267|NCT01698918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588268|NCT01698918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2588269|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2588270|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2588271|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2588272|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
2588273|NCT01698931|Glyburide|glyburide|mesh-list
2588274|NCT01698931|Repaglinide|repaglinide|mesh-list
2588275|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2588276|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588277|NCT01699113|Rabeprazole|rabeprazole|mesh-list
2588278|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2588279|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2588280|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2588281|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588282|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588283|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2588284|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2588285|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2588286|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
2588287|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588288|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2588289|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2588290|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588291|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
2588292|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2588293|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
2588294|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588295|NCT01699204|Expectorants|expectorants|mesh-ancestor
2588296|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
2588297|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2588298|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
2588299|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588300|NCT01699204|Protective Agents|protective agents|mesh-ancestor
2588301|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588302|NCT01699204|Antidotes|antidotes|mesh-ancestor
2588303|NCT01699282|Antivitamins K|antivitamins k|mesh-list
2588304|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
2588305|NCT01699347|Picibanil|picibanil|mesh-list
2588306|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588307|NCT01699360|Cyclosporine|cyclosporine|mesh-list
2588308|NCT01699360|Sirolimus|sirolimus|mesh-list
2588309|NCT01699360|Tacrolimus|tacrolimus|mesh-list
2588310|NCT01699360|Cyclosporins|cyclosporins|mesh-list
2588311|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2588312|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
2588313|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588314|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2588315|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588316|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588317|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
2588318|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588319|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
2588320|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2588321|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2588322|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2588323|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588324|NCT01699412|Dexamethasone|dexamethasone|mesh-list
2588325|NCT01699412|Clobetasol|clobetasol|mesh-list
2588326|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588327|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
2588328|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
2588329|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588330|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588331|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2588332|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
2142123|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2142124|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2142125|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
2588333|NCT01699412|Hormones|hormones|mesh-ancestor
2588334|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2588335|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2588336|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588337|NCT01699438|Mesalamine|mesalamine|mesh-list
2588338|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2588339|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2588340|NCT01699438|Analgesics|analgesics|mesh-ancestor
2588341|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
2588342|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588343|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588344|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588345|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2588346|NCT01699464|Timolol|timolol|mesh-list
2588347|NCT01699464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2588348|NCT01699464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2588349|NCT01699464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2588350|NCT01699464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2588351|NCT01699464|Adrenergic Agents|adrenergic agents|mesh-ancestor
2588352|NCT01699464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2588353|NCT01699464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588354|NCT01699464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588355|NCT01699464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2588356|NCT01699464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2142126|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142127|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2142128|NCT03434119|Insulin|insulin|mesh-list
2142129|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2588357|NCT01699490|Valsartan|valsartan|mesh-list
2588358|NCT01699490|Fluoxetine|fluoxetine|mesh-list
2588359|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2588360|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2588361|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2142130|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
2142131|NCT03434119|Lixisenatide|lixisenatide|mesh-list
2142132|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2142133|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142147|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2142148|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2142149|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2142150|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142151|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
2142152|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2142153|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
2142154|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
2142155|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142156|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142157|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2142158|NCT03435055|Analgesics|analgesics|mesh-ancestor
2142159|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
2142160|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142161|NCT03435185|Lidocaine|lidocaine|mesh-list
2142162|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
2142163|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
2142164|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142165|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142166|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
2142167|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588362|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588363|NCT01699490|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2588364|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2588365|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2588366|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2588367|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
2588368|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588369|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2588370|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
2588371|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2588372|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2588373|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2588374|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588375|NCT01699594|Mannitol|mannitol|mesh-list
2588376|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
2588377|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2588378|NCT01699594|Diuretics|diuretics|mesh-ancestor
2588379|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
2588380|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588381|NCT01699594|Miotics|miotics|mesh-ancestor
2588382|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
2588383|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588384|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2588385|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2588386|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
2588387|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2588388|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2588389|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
2588390|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2588391|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142168|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2142169|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2142170|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2588392|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2588393|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
2142171|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2142172|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142173|NCT03435614|Analgesics|analgesics|mesh-list
2142174|NCT03435614|Narcotics|narcotics|mesh-list
2142175|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142176|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142177|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
2142178|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142179|NCT03435692|Acetaminophen|acetaminophen|mesh-list
2142180|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
2142181|NCT03435692|Promethazine|promethazine|mesh-list
2142182|NCT03435692|Fentanyl|fentanyl|mesh-list
2142183|NCT03435692|Morphine|morphine|mesh-list
2142184|NCT03435692|Oxycodone|oxycodone|mesh-list
2142185|NCT03435692|Lorazepam|lorazepam|mesh-list
2142186|NCT03435692|Ondansetron|ondansetron|mesh-list
2142187|NCT03435692|Ropivacaine|ropivacaine|mesh-list
2142188|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2142189|NCT03435692|Narcotics|narcotics|mesh-ancestor
2142190|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142191|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142192|NCT03435692|Analgesics|analgesics|mesh-ancestor
2142193|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
2142194|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588394|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588395|NCT01699711|Protective Agents|protective agents|mesh-ancestor
2142195|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
2142196|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
2142197|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2142198|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2142199|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
2142200|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2142201|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
2142202|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
2142203|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
2142204|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2142205|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
2142206|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
2142207|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2142208|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
2588396|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588397|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2588398|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2588399|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588400|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2588401|NCT01699724|Sertraline|sertraline|mesh-list
2588402|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
2588403|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2588404|NCT01699724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2588405|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2588406|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2588407|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588408|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2588409|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
2588410|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588411|NCT01699737|Glimepiride|glimepiride|mesh-list
2588412|NCT01699737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2588413|NCT01699737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2588414|NCT01699737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588415|NCT01699737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2588416|NCT01699737|Immunologic Factors|immunologic factors|mesh-ancestor
2588417|NCT01699776|Digoxin|digoxin|mesh-list
2588418|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2588419|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2588420|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588421|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588422|NCT01699776|Protective Agents|protective agents|mesh-ancestor
2588423|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588424|NCT01699802|Anesthetics|anesthetics|mesh-list
2588425|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2588426|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142209|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142210|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142211|NCT03435692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2142212|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2588427|NCT01699828|Buspirone|buspirone|mesh-list
2142213|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2142214|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2142215|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2142216|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2142217|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2142218|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
2142219|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
2142220|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2142221|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
2142222|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
2142223|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
2142224|NCT03436420|Calcium|calcium|mesh-list
2142225|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2142226|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142227|NCT03437044|Clopidogrel|clopidogrel|mesh-list
2142228|NCT03437044|Ticagrelor|ticagrelor|mesh-list
2142229|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2142230|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2142231|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2142232|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2142233|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
2142234|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142235|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142236|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142237|NCT03437447|Praziquantel|praziquantel|mesh-list
2142238|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
2142239|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2142240|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142241|NCT03437564|Vortioxetine|vortioxetine|mesh-list
2142242|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
2142243|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2142244|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2142245|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2142246|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2588428|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2588429|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2588430|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2588431|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588432|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2588433|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2588434|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
2588435|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2588436|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588437|NCT01699854|Capsaicin|capsaicin|mesh-list
2588438|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
2588439|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
2588440|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
2588441|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588442|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588443|NCT01699919|Lidocaine|lidocaine|mesh-list
2588444|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
2588445|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
2588446|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2588447|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588448|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
2588449|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588450|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2588451|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2588452|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2588453|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2588454|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588455|NCT01699932|Metformin|metformin|mesh-list
2588456|NCT01699932|Glimepiride|glimepiride|mesh-list
2588457|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2588458|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588459|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2588460|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2588461|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
2588462|NCT01699997|Oxytocin|oxytocin|mesh-list
2588463|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
2588464|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2142247|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142248|NCT03437564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2142249|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2588465|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588466|NCT01700010|Paclitaxel|paclitaxel|mesh-list
2588467|NCT01700010|Lapatinib|lapatinib|mesh-list
2588468|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2588469|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588470|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
2588471|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
2588472|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
2142250|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2142251|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142252|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142253|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
2142254|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2142255|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2142256|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2142257|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2142258|NCT03437577|Tacrolimus|tacrolimus|mesh-list
2142259|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2142260|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
2142261|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142262|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2142263|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142264|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142265|NCT03438006|Vaccines|vaccines|mesh-list
2142266|NCT03438006|Immunologic Factors|immunologic factors|mesh-ancestor
2142267|NCT03438006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142268|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
2588473|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588474|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2588475|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588476|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
2588477|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2588478|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2588479|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2588480|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588481|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2142269|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2142270|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
2142271|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142272|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
2142273|NCT03438266|Protective Agents|protective agents|mesh-ancestor
2142274|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
2142275|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2142276|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142277|NCT03439072|Glucagon|glucagon|mesh-list
2142278|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2142279|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2142280|NCT03439072|Hormones|hormones|mesh-ancestor
2142281|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2142282|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142283|NCT03439072|Incretins|incretins|mesh-ancestor
2142284|NCT03439124|Cephalosporins|cephalosporins|mesh-list
2142285|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
2142286|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2142287|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2142288|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588482|NCT01700270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2588483|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2588484|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2588485|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588486|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2588487|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
2588488|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2588489|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
2588490|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2588491|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2588492|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588493|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2588494|NCT01700322|Clopidogrel|clopidogrel|mesh-list
2588495|NCT01700322|Ticagrelor|ticagrelor|mesh-list
2588496|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2588497|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2142289|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
2142290|NCT03439137|Hematinics|hematinics|mesh-ancestor
2142294|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2142295|NCT03440229|Laxatives|laxatives|mesh-ancestor
2588498|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2588499|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2588500|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2588501|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
2588502|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2588503|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588504|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588505|NCT01700400|Bevacizumab|bevacizumab|mesh-list
2588506|NCT01700400|Carboplatin|carboplatin|mesh-list
2588507|NCT01700400|Pemetrexed|pemetrexed|mesh-list
2588508|NCT01700400|Everolimus|everolimus|mesh-list
2588509|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2588510|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588511|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2588512|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2588513|NCT01700400|Growth Substances|growth substances|mesh-ancestor
2588514|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588515|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
2588516|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588517|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588518|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2588519|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2588520|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2588521|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
2588522|NCT01700413|Idarubicin|idarubicin|mesh-list
2588523|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2588524|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588525|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2588526|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2588527|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588528|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588529|NCT01700426|Vitamins|vitamins|mesh-list
2588530|NCT01700426|Vitamin E|vitamin e|mesh-list
2588531|NCT01700426|Tocopherols|tocopherols|mesh-list
2588532|NCT01700426|Tocotrienols|tocotrienols|mesh-list
2588533|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
2588534|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
2588535|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588536|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
2588537|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588538|NCT01700426|Protective Agents|protective agents|mesh-ancestor
2588539|NCT01700478|Vasopressins|vasopressins|mesh-list
2588540|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
2588541|NCT01700478|Misoprostol|misoprostol|mesh-list
2588542|NCT01700478|Diuretics|diuretics|mesh-list
2588543|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588544|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2588545|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
2588546|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2588547|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2588548|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2588549|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
2588550|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
2588551|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
2588552|NCT01700478|Coagulants|coagulants|mesh-ancestor
2588553|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2588554|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2588555|NCT01700491|Ropivacaine|ropivacaine|mesh-list
2588556|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
2588557|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
2588558|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2588559|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588560|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
2588561|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588562|NCT01700504|Gentamicins|gentamicins|mesh-list
2588563|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2142296|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2142297|NCT03440411|Dexamethasone|dexamethasone|mesh-list
2142298|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
2142299|NCT03440411|Pomalidomide|pomalidomide|mesh-list
2142300|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2588564|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142301|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
2142302|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142303|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2142304|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2142305|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
2142306|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142307|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142308|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2142309|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142310|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
2142311|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
2142312|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142313|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2142314|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
2142315|NCT03440411|Hormones|hormones|mesh-ancestor
2142316|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2142317|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2142318|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2142319|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2142320|NCT03440411|Growth Substances|growth substances|mesh-ancestor
2142321|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
2142322|NCT03440424|Lemborexant|lemborexant|mesh-list
2142323|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2142324|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142325|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142326|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2142327|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2142328|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142329|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142330|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
2142331|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2142332|NCT03441269|Ibuprofen|ibuprofen|mesh-list
2142333|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2142334|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2142335|NCT03441269|Analgesics|analgesics|mesh-ancestor
2588565|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2588566|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588567|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588568|NCT01700569|Leucovorin|leucovorin|mesh-list
2588569|NCT01700569|Folic Acid|folic acid|mesh-list
2588570|NCT01700569|Temozolomide|temozolomide|mesh-list
2588571|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
2588572|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588573|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2588574|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
2588575|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588576|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588577|NCT01700569|Antidotes|antidotes|mesh-ancestor
2588578|NCT01700569|Protective Agents|protective agents|mesh-ancestor
2588579|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
2588580|NCT01700569|Vitamins|vitamins|mesh-ancestor
2588581|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
2588582|NCT01700569|Hematinics|hematinics|mesh-ancestor
2588583|NCT01700608|Plerixafor|plerixafor|mesh-list
2588584|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2588585|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2588586|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
2588587|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588588|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2588589|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2588590|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588591|NCT01700790|Ritonavir|ritonavir|mesh-list
2588592|NCT01700790|Lopinavir|lopinavir|mesh-list
2588593|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2588594|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2588595|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
2588596|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588597|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588598|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2588599|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2588600|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
2588601|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588602|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2588603|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2588604|NCT01700803|Iodine|iodine|mesh-list
2588605|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
2588606|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
2142336|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
2142337|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142338|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142339|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142340|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2142341|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2142342|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142343|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142344|NCT03441581|Eluxadoline|eluxadoline|mesh-list
2142345|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2142346|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
2142347|NCT03441633|Apixaban|apixaban|mesh-list
2142348|NCT03441633|Dabigatran|dabigatran|mesh-list
2142349|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2142350|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
2142351|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2142352|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
2142353|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142354|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142355|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
2142356|NCT03441789|Betamethasone|betamethasone|mesh-list
2142357|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
2588607|NCT01700803|Povidone|povidone|mesh-list
2588608|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2588609|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588610|NCT01700803|Trace Elements|trace elements|mesh-ancestor
2588611|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
2588612|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588613|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
2588614|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
2588615|NCT01700881|Vitamin E|vitamin e|mesh-list
2588616|NCT01700881|Vitamins|vitamins|mesh-ancestor
2588617|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
2588618|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588619|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
2588620|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588621|NCT01700881|Protective Agents|protective agents|mesh-ancestor
2588622|NCT01700946|Cytarabine|cytarabine|mesh-list
2588623|NCT01700946|Aldesleukin|aldesleukin|mesh-list
2588624|NCT01700946|Dexamethasone|dexamethasone|mesh-list
2588625|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
2588626|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2588627|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2588628|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2588629|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
2588630|NCT01700946|Rituximab|rituximab|mesh-list
2588631|NCT01700946|Methotrexate|methotrexate|mesh-list
2588632|NCT01700946|Etoposide|etoposide|mesh-list
2588633|NCT01700946|Vincristine|vincristine|mesh-list
2588634|NCT01700946|Interleukin-2|interleukin-2|mesh-list
2588635|NCT01700946|Asparaginase|asparaginase|mesh-list
2588636|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
2588637|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
2588638|NCT01700946|Clofarabine|clofarabine|mesh-list
2588639|NCT01700946|Vinblastine|vinblastine|mesh-list
2588640|NCT01700946|Pegaspargase|pegaspargase|mesh-list
2588641|NCT01700946|Teniposide|teniposide|mesh-list
2588642|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2588643|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
2588644|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588645|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2588646|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2588647|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
2588648|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588649|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588650|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2588651|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588652|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
2142358|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2142359|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
2142360|NCT03441789|Calcipotriene|calcipotriene|mesh-list
2142361|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2142362|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142363|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
2588653|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
2588654|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588655|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2588656|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
2588657|NCT01700946|Hormones|hormones|mesh-ancestor
2668563|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2142364|NCT03441789|Hormones|hormones|mesh-ancestor
2142365|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2142366|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142367|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2142368|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
2142369|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
2142370|NCT03442569|Nivolumab|nivolumab|mesh-list
2142371|NCT03442569|Ipilimumab|ipilimumab|mesh-list
2142372|NCT03442569|Panitumumab|panitumumab|mesh-list
2142373|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2142374|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142375|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2142376|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142377|NCT03443063|Lemborexant|lemborexant|mesh-list
2142378|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2142379|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142380|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588658|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2588659|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2588660|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2588661|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2588662|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
2588663|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2588664|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2588665|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
2588666|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
2588667|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588668|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2588669|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2588670|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2588671|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2588672|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2588673|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
2588674|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588675|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
2588676|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
2588677|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
2588678|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2588679|NCT01700946|Analgesics|analgesics|mesh-ancestor
2588680|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
2588681|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2142381|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2142382|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2142383|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142384|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142385|NCT03444155|Folic Acid|folic acid|mesh-list
2142386|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
2142387|NCT03444155|Vitamins|vitamins|mesh-ancestor
2142388|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
2142389|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142390|NCT03444155|Hematinics|hematinics|mesh-ancestor
2142391|NCT03444584|Metformin|metformin|mesh-list
2142392|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2142393|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142394|NCT03444766|Nivolumab|nivolumab|mesh-list
2142395|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2142396|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142397|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2142398|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142399|NCT03445195|Imipenem|imipenem|mesh-list
2142400|NCT03445195|Sulbactam|sulbactam|mesh-list
2142401|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
2142402|NCT03445195|Cilastatin|cilastatin|mesh-list
2142403|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2142404|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142405|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
2142406|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142407|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142408|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2142409|NCT03445390|Acetaminophen|acetaminophen|mesh-list
2142410|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2142411|NCT03445390|Analgesics|analgesics|mesh-ancestor
2142412|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
2420387|NCT00807807|Vitamins|vitamins|mesh-ancestor
2420388|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
2142413|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142414|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142415|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
2142430|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2142431|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2142432|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142433|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2142434|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2142435|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2142436|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142437|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
2142438|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142439|NCT03447249|Ivacaftor|ivacaftor|mesh-list
2142440|NCT03447249|VX-659|vx-659|mesh-list
2142441|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2142442|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2142443|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142444|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
2142445|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2142446|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142447|NCT03447353|Acetaminophen|acetaminophen|mesh-list
2142448|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2142449|NCT03447353|Hydrocodone|hydrocodone|mesh-list
2142450|NCT03447353|Alprazolam|alprazolam|mesh-list
2142451|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2588682|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2588683|NCT01701076|Dexamethasone|dexamethasone|mesh-list
2588684|NCT01701076|Lenalidomide|lenalidomide|mesh-list
2588685|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2588686|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588687|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
2588688|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
2142452|NCT03447353|Analgesics|analgesics|mesh-ancestor
2142453|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
2142454|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142455|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142456|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
2142457|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2142458|NCT03447353|Narcotics|narcotics|mesh-ancestor
2142459|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142460|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
2142461|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
2142462|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2142463|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2142464|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2142465|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2142466|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
2142467|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
2142468|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142469|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142470|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2142471|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142472|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2142473|NCT03447821|Rifamycins|rifamycins|mesh-list
2142474|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
2142475|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2142476|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142477|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2588689|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588690|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588691|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2142478|NCT03448068|Ketamine|ketamine|mesh-list
2588692|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
2420389|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420390|NCT00807859|Paclitaxel|paclitaxel|mesh-list
2420391|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2420392|NCT00807859|Capecitabine|capecitabine|mesh-list
2420393|NCT00807859|Trastuzumab|trastuzumab|mesh-list
2420394|NCT00807859|Lapatinib|lapatinib|mesh-list
2420395|NCT00807859|Trebananib|trebananib|mesh-list
2420396|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2420397|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420398|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
2420399|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
2420400|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
2420401|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420402|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2420403|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
2142479|NCT03448068|Analgesics|analgesics|mesh-ancestor
2142480|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
2142481|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142482|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142483|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2142484|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2142485|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
2142486|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
2142487|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142488|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2142489|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2142490|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142491|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142492|NCT03448406|Empagliflozin|empagliflozin|mesh-list
2588693|NCT01701076|Hormones|hormones|mesh-ancestor
2588694|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2588695|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2588696|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588697|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588698|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
2588699|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2588700|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2588701|NCT01701076|Growth Substances|growth substances|mesh-ancestor
2588702|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
2588703|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2588704|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
2588705|NCT01701089|Selegiline|selegiline|mesh-list
2588706|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
2588707|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2588708|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2588709|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2588710|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2588711|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588712|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588713|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2588714|NCT01701089|Protective Agents|protective agents|mesh-ancestor
2588715|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588716|NCT01701180|Oxytocin|oxytocin|mesh-list
2588717|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
2142493|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2142494|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142495|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2142496|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142497|NCT03448419|Empagliflozin|empagliflozin|mesh-list
2142498|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2142499|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142500|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2420404|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2588718|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2588719|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588720|NCT01701219|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2588721|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2588722|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588723|NCT01701232|Rituximab|rituximab|mesh-list
2588724|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2588725|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588726|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
2588727|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142501|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142502|NCT03448536|Acetaminophen|acetaminophen|mesh-list
2142503|NCT03448536|Naproxen|naproxen|mesh-list
2142504|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2142505|NCT03448536|Analgesics|analgesics|mesh-ancestor
2142506|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
2142507|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142508|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142509|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
2142510|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2142511|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142512|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2142513|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
2142514|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2142515|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142516|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142517|NCT03449433|Insulin|insulin|mesh-list
2142518|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2142519|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
2142520|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
2588728|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2588729|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2588730|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2142521|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2142522|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
2142523|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2588731|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588732|NCT01701297|Renal Agents|renal agents|mesh-ancestor
2588733|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2588734|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
2588735|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2588736|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2588737|NCT01701323|Cytarabine|cytarabine|mesh-list
2588738|NCT01701323|Fludarabine|fludarabine|mesh-list
2588739|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
2142524|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142525|NCT03449446|Firsocostat|firsocostat|mesh-list
2142526|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142527|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588740|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588741|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2588742|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
2588743|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588744|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2588745|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
2588746|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588747|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
2142528|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
2142529|NCT03449758|Chloroquine|chloroquine|mesh-list
2142530|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
2142531|NCT03449758|Methotrexate|methotrexate|mesh-list
2142532|NCT03449758|Azathioprine|azathioprine|mesh-list
2142533|NCT03449758|Leflunomide|leflunomide|mesh-list
2142534|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2142535|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
2142536|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2142537|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142538|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2142539|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
2142540|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142541|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142542|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
2142543|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142544|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2142545|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2142546|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
2142547|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2142548|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2142549|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
2142550|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2142551|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2142552|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142553|NCT03449758|Amebicides|amebicides|mesh-ancestor
2142554|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2142555|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2142556|NCT03449758|Analgesics|analgesics|mesh-ancestor
2668564|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588748|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588749|NCT01701336|Cloricromen|cloricromen|mesh-list
2588750|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2588751|NCT01701349|Paclitaxel|paclitaxel|mesh-list
2588752|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
2588753|NCT01701349|Combretastatin|combretastatin|mesh-list
2588754|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2588755|NCT01701349|Carboplatin|carboplatin|mesh-list
2588756|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2588757|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588758|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
2588759|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
2588760|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
2588761|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142557|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
2142558|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142559|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142560|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2142561|NCT03450083|Benralizumab|benralizumab|mesh-list
2142562|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2142563|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
2142564|NCT03451773|Gemcitabine|gemcitabine|mesh-list
2142565|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2142566|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
2142567|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142568|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588762|NCT01701453|Clopidogrel|clopidogrel|mesh-list
2588763|NCT01701453|Ticagrelor|ticagrelor|mesh-list
2588764|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2588765|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2588766|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2588767|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2588768|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2588769|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
2588770|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2588771|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588772|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588773|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2588774|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2588775|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588776|NCT01701479|Aldesleukin|aldesleukin|mesh-list
2588777|NCT01701479|Interleukin-2|interleukin-2|mesh-list
2588778|NCT01701479|Dinutuximab|dinutuximab|mesh-list
2588779|NCT01701479|Isotretinoin|isotretinoin|mesh-list
2588780|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588781|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2588782|NCT01701479|Analgesics|analgesics|mesh-ancestor
2588783|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
2588784|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588785|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588786|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2588787|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2588788|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
2588789|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588790|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
2588791|NCT01701518|Dexamethasone|dexamethasone|mesh-list
2588792|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588793|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
2588794|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
2588795|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588796|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588797|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2588798|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
2588799|NCT01701518|Hormones|hormones|mesh-ancestor
2588800|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2588801|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2588802|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588803|NCT01701583|Omalizumab|omalizumab|mesh-list
2588804|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2588805|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2588806|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
2588807|NCT01701739|Digoxin|digoxin|mesh-list
2142569|NCT03451773|Antiviral Agents|antiviral agents|mesh-ancestor
2142570|NCT03451773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142571|NCT03451773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142572|NCT03451773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2588808|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2588809|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2588810|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588811|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588812|NCT01701739|Protective Agents|protective agents|mesh-ancestor
2588813|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588814|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
2588815|NCT01701778|Sevoflurane|sevoflurane|mesh-list
2588816|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
2588817|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2588818|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2588819|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588820|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2588821|NCT01701778|Analgesics|analgesics|mesh-ancestor
2588822|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
2588823|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588824|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2588825|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2588826|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2588827|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
2588828|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142573|NCT03451773|Immunologic Factors|immunologic factors|mesh-ancestor
2142574|NCT03451773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142575|NCT03452189|Vancomycin|vancomycin|mesh-list
2142576|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2142577|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142578|NCT03452527|Aflibercept|aflibercept|mesh-list
2142579|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
2142580|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2142581|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2142582|NCT03452527|Growth Substances|growth substances|mesh-ancestor
2588829|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588830|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2588831|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2588832|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
2588833|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
2588834|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
2588835|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
2588836|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
2588837|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
2588838|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588839|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588840|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2588841|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
2588842|NCT01701856|Interferons|interferons|mesh-list
2588843|NCT01701856|Interferon-beta|interferon-beta|mesh-list
2588844|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
2588845|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588846|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
2588847|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588848|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
2588849|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588850|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2588851|NCT01701882|Tenofovir|tenofovir|mesh-list
2588852|NCT01701882|Emtricitabine|emtricitabine|mesh-list
2142583|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142584|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
2142585|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142586|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
2142587|NCT03453060|Thrombin|thrombin|mesh-list
2142588|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
2142589|NCT03453060|Coagulants|coagulants|mesh-ancestor
2142590|NCT03453151|Anesthetics|anesthetics|mesh-list
2142591|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
2142592|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142593|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142594|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
2142595|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142596|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
2142597|NCT03454048|Piperaquine|piperaquine|mesh-list
2142598|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
2588853|NCT01701882|Rilpivirine|rilpivirine|mesh-list
2588854|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
2588855|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588856|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2588857|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2588858|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142599|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2142600|NCT03454048|Atovaquone|atovaquone|mesh-list
2142601|NCT03454048|Proguanil|proguanil|mesh-list
2142602|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2142603|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
2142604|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2142605|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2142606|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142607|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2142608|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142609|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142610|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2142611|NCT03454048|Renal Agents|renal agents|mesh-ancestor
2142612|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
2588859|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588860|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2588861|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2588862|NCT01701921|Pregabalin|pregabalin|mesh-list
2588863|NCT01701921|Analgesics|analgesics|mesh-ancestor
2588864|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
2588865|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588866|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588867|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
2588868|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2588869|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2588870|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588871|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2588872|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2588873|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2588874|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2588875|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2588876|NCT01702038|Rituximab|rituximab|mesh-list
2588877|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2588878|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588879|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
2588880|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588881|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2588882|NCT01702090|Ritonavir|ritonavir|mesh-list
2588883|NCT01702090|Darunavir|darunavir|mesh-list
2588884|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2588885|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2588886|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
2588887|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588888|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588889|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2588890|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2588891|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
2588892|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588893|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2588894|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2588895|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
2588896|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588897|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
2588898|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2588899|NCT01702129|Doxorubicin|doxorubicin|mesh-list
2588900|NCT01702129|Cetuximab|cetuximab|mesh-list
2142613|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
2142614|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2142615|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
2142616|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142617|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142618|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2142619|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
2142620|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2142621|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
2142622|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142623|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2588901|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2588902|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588903|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2588904|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2588905|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588906|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588907|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2588908|NCT01702181|Tacrolimus|tacrolimus|mesh-list
2588909|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2588910|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
2142624|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2142625|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
2142626|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
2142627|NCT03455218|Protective Agents|protective agents|mesh-ancestor
2142628|NCT03456700|Sirolimus|sirolimus|mesh-list
2142629|NCT03456700|Auranofin|auranofin|mesh-list
2142630|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2588911|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588912|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2588913|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588914|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588915|NCT01702207|Tacrolimus|tacrolimus|mesh-list
2588916|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2588917|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
2588918|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588919|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2142631|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142632|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2142633|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142634|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
2142635|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2142636|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
2142637|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142638|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2588920|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588921|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588922|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
2588923|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2588924|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588925|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2588926|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2588927|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588928|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588929|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588930|NCT01702389|Remifentanil|remifentanil|mesh-list
2588931|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2588932|NCT01702389|Narcotics|narcotics|mesh-ancestor
2588933|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2588934|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588935|NCT01702389|Analgesics|analgesics|mesh-ancestor
2588936|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
2588937|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588938|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
2588939|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2588940|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588941|NCT01702506|Antacids|antacids|mesh-list
2588942|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588943|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2588944|NCT01702610|Temozolomide|temozolomide|mesh-list
2588945|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2588946|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
2588947|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588948|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2588949|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
2588950|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
2588951|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2588952|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2142639|NCT03456960|Aspirin|aspirin|mesh-list
2142640|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2142641|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2142642|NCT03456960|Analgesics|analgesics|mesh-ancestor
2142643|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
2142644|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142645|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142646|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142647|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2142648|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2142649|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2142650|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142651|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2142652|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2142653|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142654|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
2142655|NCT03457636|Doxycycline|doxycycline|mesh-list
2142656|NCT03457636|Adapalene|adapalene|mesh-list
2588953|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2588954|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588955|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2588956|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2588957|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
2588958|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2420405|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2420406|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420407|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2420408|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2420409|NCT00807859|Growth Substances|growth substances|mesh-ancestor
2420410|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420411|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
2420412|NCT00807872|Antibodies|antibodies|mesh-list
2420413|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2420414|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
2420415|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588959|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2588960|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588961|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
2588962|NCT01702636|Coagulants|coagulants|mesh-ancestor
2588963|NCT01702649|Biapenem|biapenem|mesh-list
2588964|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2588965|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
2588966|NCT01702688|Giapreza|giapreza|mesh-list
2588967|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
2588968|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2588969|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2588970|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
2588971|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2588972|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588973|NCT01702701|Fluticasone|fluticasone|mesh-list
2588974|NCT01702701|Montelukast|montelukast|mesh-list
2588975|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588976|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2588977|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
2588978|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2588979|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2588980|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2588981|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
2588982|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
2588983|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2588984|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2142657|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
2142658|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2142659|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2142660|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142661|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
2142662|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2142663|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2142664|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
2142665|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2142666|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2142667|NCT03457636|Analgesics|analgesics|mesh-ancestor
2142668|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
2142669|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142670|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142671|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2588985|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
2588986|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2588987|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2588988|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2588989|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588990|NCT01702714|Gemcitabine|gemcitabine|mesh-list
2588991|NCT01702714|Paclitaxel|paclitaxel|mesh-list
2588992|NCT01702714|Carboplatin|carboplatin|mesh-list
2588993|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2588994|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142672|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2142673|NCT03457727|Omeprazole|omeprazole|mesh-list
2142674|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2142675|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2142676|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2142677|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142678|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588995|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
2588996|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
2588997|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
2588998|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2588999|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2589000|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
2589001|NCT01702714|Antiviral Agents|antiviral agents|mesh-ancestor
2589002|NCT01702714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589003|NCT01702714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589004|NCT01702714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2589005|NCT01702714|Immunologic Factors|immunologic factors|mesh-ancestor
2589006|NCT01702714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589007|NCT01702831|Lenalidomide|lenalidomide|mesh-list
2589008|NCT01702831|Melphalan|melphalan|mesh-list
2589009|NCT01702831|Busulfan|busulfan|mesh-list
2589010|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
2589011|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589012|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2589013|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2589014|NCT01702831|Growth Substances|growth substances|mesh-ancestor
2589015|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
2589016|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589017|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2589018|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
2589019|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589020|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2589021|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2589022|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2589023|NCT01702857|Vaccines|vaccines|mesh-list
2589024|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
2589025|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
2589026|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589027|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2589028|NCT01702857|Antacids|antacids|mesh-ancestor
2589029|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589030|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2589031|NCT01702974|Vitamin D|vitamin d|mesh-list
2589032|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
2589033|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2589034|NCT01702974|Vitamins|vitamins|mesh-ancestor
2589035|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
2589036|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589037|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2589038|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2142679|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2142680|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
2142681|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2142682|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2142683|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
2142684|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142685|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142686|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
2142687|NCT03459612|Promethazine|promethazine|mesh-list
2142688|NCT03459612|Lasmiditan|lasmiditan|mesh-list
2142689|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2142690|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2142691|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142692|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142693|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
2142694|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
2142695|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
2142696|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589039|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589040|NCT01703104|Folic Acid|folic acid|mesh-list
2589041|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
2589042|NCT01703104|Proguanil|proguanil|mesh-list
2589043|NCT01703104|Hematinics|hematinics|mesh-ancestor
2589044|NCT01703104|Vitamins|vitamins|mesh-ancestor
2589045|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
2589046|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589047|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
2589048|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2589049|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2589050|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589051|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
2589052|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589053|NCT01703130|Ropivacaine|ropivacaine|mesh-list
2589054|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
2142697|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
2142698|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
2142699|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2142700|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2142701|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
2142702|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
2142703|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142704|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142705|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2142706|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
2142707|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
2142708|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2142709|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
2142710|NCT03459794|Ivermectin|ivermectin|mesh-list
2142711|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2142712|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142713|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2142714|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142715|NCT03460990|Ivacaftor|ivacaftor|mesh-list
2142716|NCT03460990|VX-659|vx-659|mesh-list
2142717|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2142718|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2142719|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142720|NCT03462680|Niacin|niacin|mesh-list
2142721|NCT03462680|Vitamins|vitamins|mesh-ancestor
2142722|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
2142723|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142724|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
2142725|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2142726|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
2142727|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142728|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2142729|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
2142730|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
2142731|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2142732|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142733|NCT03463512|Racecadotril|racecadotril|mesh-list
2142734|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
2142735|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2142736|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
2142737|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142738|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589055|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
2589056|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589057|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589058|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
2589059|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589060|NCT01703234|Ramipril|ramipril|mesh-list
2589061|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2589062|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
2589063|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589064|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589065|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2589066|NCT01703312|Omalizumab|omalizumab|mesh-list
2589067|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2589068|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2589069|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
2589070|NCT01703325|Triamcinolone|triamcinolone|mesh-list
2589071|NCT01703325|Clobetasol|clobetasol|mesh-list
2589072|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2589073|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
2589074|NCT01703325|Hormones|hormones|mesh-ancestor
2589075|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2589076|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589077|NCT01703351|Fentanyl|fentanyl|mesh-list
2589078|NCT01703351|Ropivacaine|ropivacaine|mesh-list
2589079|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
2589080|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
2589081|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589082|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589083|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
2589084|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142739|NCT03463889|Edetic Acid|edetic acid|mesh-list
2142740|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2142741|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2142742|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589085|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2142743|NCT03463889|Anticoagulants|anticoagulants|mesh-ancestor
2142744|NCT03463889|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2142745|NCT03463889|Chelating Agents|chelating agents|mesh-ancestor
2142746|NCT03463889|Sequestering Agents|sequestering agents|mesh-ancestor
2142747|NCT03463915|Triamcinolone|triamcinolone|mesh-list
2142748|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2142749|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2142750|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2142751|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142752|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
2142753|NCT03463915|Hormones|hormones|mesh-ancestor
2142754|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2142755|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589086|NCT01703351|Narcotics|narcotics|mesh-ancestor
2589087|NCT01703351|Analgesics|analgesics|mesh-ancestor
2589088|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2142756|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2142757|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
2142758|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142759|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142760|NCT03464383|Citalopram|citalopram|mesh-list
2142761|NCT03464383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2142762|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2142763|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2142764|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142765|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142766|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
2142767|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142768|NCT03464383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2142769|NCT03464383|Antidepressive Agents|antidepressive agents|mesh-ancestor
2142770|NCT03464383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2142771|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
2589089|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2589090|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
2589091|NCT01703364|Lenalidomide|lenalidomide|mesh-list
2589092|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
2589093|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589094|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2589095|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2589096|NCT01703364|Growth Substances|growth substances|mesh-ancestor
2142772|NCT03465436|Lasmiditan|lasmiditan|mesh-list
2142773|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2142774|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142775|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2142776|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2142777|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142778|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142779|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142780|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142781|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2142782|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
2589097|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
2589098|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589099|NCT01703390|Cetuximab|cetuximab|mesh-list
2589100|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2589101|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589102|NCT01703455|Sorafenib|sorafenib|mesh-list
2142783|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142784|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
2142785|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2142786|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142787|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2142788|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2142789|NCT03467217|Losartan|losartan|mesh-list
2142790|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2142791|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2142792|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2142793|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2142794|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142795|NCT03467685|Anesthetics|anesthetics|mesh-list
2142796|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142797|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142798|NCT03467763|Metformin|metformin|mesh-list
2589103|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589104|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2589105|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589106|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589107|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
2589108|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
2589109|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2589110|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2589111|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2589112|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589113|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2589114|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2589115|NCT01703559|Phentolamine|phentolamine|mesh-list
2589116|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2589117|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2589118|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2589119|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2589120|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
2142799|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2142800|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142801|NCT03467945|Metformin|metformin|mesh-list
2142802|NCT03467945|Gliclazide|gliclazide|mesh-list
2142803|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2142804|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142805|NCT03467971|Metformin|metformin|mesh-list
2589121|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589122|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589123|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589124|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2589125|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
2589126|NCT01703624|Bromides|bromides|mesh-list
2589127|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
2589128|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2589129|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2589130|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2589131|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
2589132|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589133|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589134|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589135|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2589136|NCT01703637|Vildagliptin|vildagliptin|mesh-list
2589137|NCT01703637|Saxagliptin|saxagliptin|mesh-list
2589138|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2589139|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589140|NCT01703637|Incretins|incretins|mesh-ancestor
2589141|NCT01703637|Hormones|hormones|mesh-ancestor
2589142|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2589143|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2589144|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
2589145|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589146|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589147|NCT01703728|Menotropins|menotropins|mesh-list
2589148|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2589149|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
2589150|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2589151|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589152|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
2589153|NCT01703754|Ifosfamide|ifosfamide|mesh-list
2589154|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2589155|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
2589156|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589157|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589158|NCT01703910|Gemcitabine|gemcitabine|mesh-list
2589159|NCT01703910|Paclitaxel|paclitaxel|mesh-list
2589160|NCT01703910|Etoposide|etoposide|mesh-list
2589161|NCT01703910|Vinorelbine|vinorelbine|mesh-list
2589162|NCT01703910|Docetaxel|docetaxel|mesh-list
2589163|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2589164|NCT01703910|Cisplatin|cisplatin|mesh-list
2589165|NCT01703910|Doxorubicin|doxorubicin|mesh-list
2589166|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2589167|NCT01703910|Fluorouracil|fluorouracil|mesh-list
2589168|NCT01703910|Capecitabine|capecitabine|mesh-list
2589169|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
2589170|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
2142806|NCT03467971|Gliclazide|gliclazide|mesh-list
2589171|NCT01703910|Irinotecan|irinotecan|mesh-list
2589172|NCT01703910|Pemetrexed|pemetrexed|mesh-list
2589173|NCT01703910|Cetuximab|cetuximab|mesh-list
2589174|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2589175|NCT01703910|Sorafenib|sorafenib|mesh-list
2589176|NCT01703910|Topotecan|topotecan|mesh-list
2589177|NCT01703910|Dasatinib|dasatinib|mesh-list
2589178|NCT01703910|Mitomycins|mitomycins|mesh-list
2589179|NCT01703910|Mitomycin|mitomycin|mesh-list
2589180|NCT01703910|Raltitrexed|raltitrexed|mesh-list
2589181|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2142807|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2142808|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142809|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
2142810|NCT03468075|Gemcitabine|gemcitabine|mesh-list
2142811|NCT03468075|Vitamins|vitamins|mesh-ancestor
2589182|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589183|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
2589184|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
2589185|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
2589186|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589187|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2589188|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
2589189|NCT01703910|Antiviral Agents|antiviral agents|mesh-ancestor
2589190|NCT01703910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589191|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589192|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2589193|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
2589194|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589195|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2589196|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2589197|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2589198|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2589199|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2589200|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2589201|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2589202|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2589203|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
2142812|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
2142813|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142814|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2142815|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
2142816|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142817|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2142818|NCT03468075|Antiviral Agents|antiviral agents|mesh-ancestor
2142819|NCT03468075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2142820|NCT03468075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142821|NCT03468075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2142822|NCT03468075|Immunologic Factors|immunologic factors|mesh-ancestor
2142823|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
2142824|NCT03468075|Protective Agents|protective agents|mesh-ancestor
2142825|NCT03468543|Memantine|memantine|mesh-list
2142826|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2142827|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2142828|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
2142829|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142830|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142831|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142832|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2142833|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2142834|NCT03468920|Acetaminophen|acetaminophen|mesh-list
2142835|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2142836|NCT03468920|Analgesics|analgesics|mesh-ancestor
2142837|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
2142838|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142839|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142840|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
2142841|NCT03468933|Plasminogen|plasminogen|mesh-list
2142842|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2142843|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2142844|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2142845|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142846|NCT03469336|Betamethasone|betamethasone|mesh-list
2142847|NCT03469336|Calcipotriene|calcipotriene|mesh-list
2142848|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142849|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
2142850|NCT03469336|Hormones|hormones|mesh-ancestor
2589216|NCT01704027|Androgens|androgens|mesh-list
2589217|NCT01704027|Hormones|hormones|mesh-ancestor
2589218|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2589219|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589220|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
2589221|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2589222|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589223|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589224|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2589225|NCT01704092|Analgesics|analgesics|mesh-ancestor
2589226|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
2589227|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589228|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2589229|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2589230|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2589231|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
2589232|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589233|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589234|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2589235|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2589236|NCT01704339|Capsaicin|capsaicin|mesh-list
2589237|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
2589238|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
2589239|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
2589240|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589241|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589242|NCT01704365|Vaccines|vaccines|mesh-list
2589243|NCT01704365|Immunologic Factors|immunologic factors|mesh-ancestor
2589244|NCT01704365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589245|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
2589246|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
2589247|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2589248|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589249|NCT01704417|Insulin|insulin|mesh-list
2589250|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2142851|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2142852|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142853|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2142854|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
2142855|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
2142856|NCT03469349|Actovegin|actovegin|mesh-list
2142857|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2142858|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142859|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2142860|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2142861|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
2142862|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142863|NCT03469349|Protective Agents|protective agents|mesh-ancestor
2142864|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2142865|NCT03471871|Lemborexant|lemborexant|mesh-list
2142866|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2142867|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142868|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142869|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2142870|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2142871|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142872|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142873|NCT03472287|Diacetylrhein|diacetylrhein|mesh-list
2142874|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142875|NCT03472326|GS-9131|gs-9131|mesh-list
2142876|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142877|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142878|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2142879|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2142880|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
2589251|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
2589252|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2142881|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589253|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589254|NCT01704469|Anesthetics|anesthetics|mesh-list
2589255|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
2589256|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589257|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589258|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
2589259|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589260|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
2589261|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2589262|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
2589263|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589264|NCT01704482|Expectorants|expectorants|mesh-ancestor
2142882|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2142883|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2142884|NCT03472469|Acetaminophen|acetaminophen|mesh-list
2142885|NCT03472469|Ketorolac|ketorolac|mesh-list
2142886|NCT03472469|Naproxen|naproxen|mesh-list
2142887|NCT03472469|Celecoxib|celecoxib|mesh-list
2142888|NCT03472469|Lidocaine|lidocaine|mesh-list
2142889|NCT03472469|Pregabalin|pregabalin|mesh-list
2142890|NCT03472469|Gabapentin|gabapentin|mesh-list
2142891|NCT03472469|Tramadol|tramadol|mesh-list
2142892|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
2142893|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
2142894|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142895|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142896|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
2142897|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142898|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2142899|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2142900|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2142901|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2142902|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142903|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2142904|NCT03472469|Analgesics|analgesics|mesh-ancestor
2142905|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
2142906|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
2142907|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2142908|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2142909|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2589265|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
2589266|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2589267|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
2589268|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589269|NCT01704482|Protective Agents|protective agents|mesh-ancestor
2589270|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589271|NCT01704482|Antidotes|antidotes|mesh-ancestor
2589272|NCT01704508|Lumefantrine|lumefantrine|mesh-list
2589273|NCT01704508|Artemether|artemether|mesh-list
2589274|NCT01704508|Piperaquine|piperaquine|mesh-list
2589275|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2589276|NCT01704508|Artenimol|artenimol|mesh-list
2589277|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
2589278|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2589279|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2589280|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589281|NCT01704534|Ustekinumab|ustekinumab|mesh-list
2589282|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
2589283|NCT01704612|Ropivacaine|ropivacaine|mesh-list
2589284|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
2589285|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
2589286|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589287|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589288|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
2589289|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142910|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2142911|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2142912|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2142913|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2142914|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142915|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
2589290|NCT01704638|Digoxin|digoxin|mesh-list
2589291|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
2589292|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2142916|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2142917|NCT03472469|Narcotics|narcotics|mesh-ancestor
2184939|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2589293|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2589294|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589295|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589296|NCT01704638|Protective Agents|protective agents|mesh-ancestor
2589297|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589298|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2589299|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2589300|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589301|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2589302|NCT01704638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2589303|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2589304|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2589305|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589306|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
2589307|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2589308|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
2589309|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2589310|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2589311|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2589312|NCT01704690|Paclitaxel|paclitaxel|mesh-list
2589313|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2589314|NCT01704690|Cisplatin|cisplatin|mesh-list
2589315|NCT01704690|Fluorouracil|fluorouracil|mesh-list
2589316|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2589317|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589318|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
2589319|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
2589320|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
2589321|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589322|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
2589323|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2589324|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2589325|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
2589326|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589327|NCT01704703|Panitumumab|panitumumab|mesh-list
2589328|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2589329|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589330|NCT01704716|Aldesleukin|aldesleukin|mesh-list
2589331|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
2589332|NCT01704716|Melphalan|melphalan|mesh-list
2589333|NCT01704716|Busulfan|busulfan|mesh-list
2589334|NCT01704716|Carboplatin|carboplatin|mesh-list
2589335|NCT01704716|Doxorubicin|doxorubicin|mesh-list
2589336|NCT01704716|Etoposide|etoposide|mesh-list
2589337|NCT01704716|Vincristine|vincristine|mesh-list
2589338|NCT01704716|Interleukin-2|interleukin-2|mesh-list
2589339|NCT01704716|Dinutuximab|dinutuximab|mesh-list
2589340|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2589341|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
2589342|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589343|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2142918|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2142919|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142920|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2142921|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2142922|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142923|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
2142924|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2142925|NCT03472521|Gabapentin|gabapentin|mesh-list
2142926|NCT03472521|Analgesics|analgesics|mesh-ancestor
2142927|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
2142928|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142929|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142930|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
2142931|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2142932|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2142933|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2142934|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2142935|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2142936|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2142937|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2142938|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142939|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
2142940|NCT03472534|Diacetylrhein|diacetylrhein|mesh-list
2142941|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142942|NCT03472547|Diacetylrhein|diacetylrhein|mesh-list
2142943|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2589344|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2589345|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
2589346|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589347|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589348|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2589349|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2589350|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2589351|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2589352|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589353|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2589354|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
2589355|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
2589356|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
2589357|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2589358|NCT01704716|Analgesics|analgesics|mesh-ancestor
2589359|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
2589360|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589361|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2589362|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2589363|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
2142944|NCT03472885|Eculizumab|eculizumab|mesh-list
2142945|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2142946|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2142947|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
2142948|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142949|NCT03473184|Diacetylrhein|diacetylrhein|mesh-list
2142950|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142951|NCT03473197|Diacetylrhein|diacetylrhein|mesh-list
2142952|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2142953|NCT03473665|Celecoxib|celecoxib|mesh-list
2142954|NCT03473665|Diclofenac|diclofenac|mesh-list
2142955|NCT03473665|Indomethacin|indomethacin|mesh-list
2142956|NCT03473665|Meloxicam|meloxicam|mesh-list
2142957|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2142958|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2589364|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589365|NCT01704794|Folic Acid|folic acid|mesh-list
2589366|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
2589367|NCT01704794|Proguanil|proguanil|mesh-list
2589368|NCT01704794|Hematinics|hematinics|mesh-ancestor
2142959|NCT03473665|Analgesics|analgesics|mesh-ancestor
2142960|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
2142961|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589369|NCT01704794|Vitamins|vitamins|mesh-ancestor
2589370|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
2589371|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589372|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
2589373|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2589374|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2589375|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589376|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
2589377|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589378|NCT01704859|Vitamin D|vitamin d|mesh-list
2589379|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
2589380|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
2589381|NCT01704859|Vitamins|vitamins|mesh-list
2589382|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
2589383|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589384|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2589385|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2589386|NCT01704872|Dinutuximab|dinutuximab|mesh-list
2589387|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589388|NCT01704898|Efavirenz|efavirenz|mesh-list
2589389|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2589390|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2589391|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589392|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589393|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
2589394|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589395|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2589396|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2589397|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2589398|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2589399|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2142962|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142963|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2589400|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2589401|NCT01705002|Bevacizumab|bevacizumab|mesh-list
2589402|NCT01705002|Capecitabine|capecitabine|mesh-list
2589403|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2589404|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589405|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2589406|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2589407|NCT01705002|Growth Substances|growth substances|mesh-ancestor
2589408|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589409|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
2589410|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2589411|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
2589412|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589413|NCT01705041|Liver Extracts|liver extracts|mesh-list
2589414|NCT01705041|Hematinics|hematinics|mesh-ancestor
2589415|NCT01705158|Carboplatin|carboplatin|mesh-list
2589416|NCT01705158|Doxorubicin|doxorubicin|mesh-list
2589417|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2589418|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589419|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2589420|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2589421|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2589422|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589423|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589424|NCT01705184|Bevacizumab|bevacizumab|mesh-list
2589425|NCT01705184|Pemetrexed|pemetrexed|mesh-list
2589426|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2589427|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589428|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2589429|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2589430|NCT01705184|Growth Substances|growth substances|mesh-ancestor
2589431|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589432|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
2589433|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589434|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589435|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2589436|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2142964|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2142965|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2142966|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2142967|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2142968|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2142969|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
2142970|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
2142971|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2142972|NCT03473977|Benralizumab|benralizumab|mesh-list
2142973|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2142974|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
2142975|NCT03474081|Albuterol|albuterol|mesh-list
2142976|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
2142977|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2142978|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
2142979|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2142980|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2142981|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2142982|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
2142983|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
2142984|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2142985|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
2142986|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589437|NCT01705223|Vaccines|vaccines|mesh-list
2589438|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
2589439|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589440|NCT01705249|Norethindrone|norethindrone|mesh-list
2589441|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
2589442|NCT01705249|Estradiol|estradiol|mesh-list
2589443|NCT01705249|Estrogens|estrogens|mesh-ancestor
2589444|NCT01705249|Hormones|hormones|mesh-ancestor
2589445|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2589446|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589447|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2589448|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
2589449|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2589450|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2142987|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589451|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2589452|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2589453|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2589454|NCT01705314|Vitamin D|vitamin d|mesh-list
2589455|NCT01705314|Vitamins|vitamins|mesh-ancestor
2589456|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
2589457|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589458|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2589459|NCT01705340|Trastuzumab|trastuzumab|mesh-list
2589460|NCT01705340|Lapatinib|lapatinib|mesh-list
2589461|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2589462|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589463|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2589464|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589465|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589466|NCT01705379|Lactitol|lactitol|mesh-list
2589467|NCT01705379|Cathartics|cathartics|mesh-ancestor
2589468|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2589469|NCT01705392|Bevacizumab|bevacizumab|mesh-list
2589470|NCT01705392|Dacarbazine|dacarbazine|mesh-list
2589471|NCT01705392|Propranolol|propranolol|mesh-list
2589472|NCT01705392|Enalapril|enalapril|mesh-list
2589473|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2589474|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589475|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2589476|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2589477|NCT01705392|Growth Substances|growth substances|mesh-ancestor
2589478|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589479|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
2589480|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2589481|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2589482|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
2589483|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589484|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589485|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2589486|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2589487|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
2589488|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2589489|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
2589490|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2589491|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
2142988|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
2142989|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2142990|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2142991|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2142992|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2142993|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
2589492|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589493|NCT01705457|Vitamin A|vitamin a|mesh-list
2589494|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
2589495|NCT01705457|Vitamins|vitamins|mesh-ancestor
2589496|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
2589497|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589498|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
2589499|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589500|NCT01705457|Protective Agents|protective agents|mesh-ancestor
2589501|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2589502|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589503|NCT01705470|Furosemide|furosemide|mesh-list
2589504|NCT01705470|Diuretics|diuretics|mesh-ancestor
2589505|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
2589506|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589507|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2589508|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2589509|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589510|NCT01705483|Paclitaxel|paclitaxel|mesh-list
2589511|NCT01705483|Docetaxel|docetaxel|mesh-list
2589512|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2143004|NCT03476798|Bevacizumab|bevacizumab|mesh-list
2589513|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589514|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
2589515|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
2589516|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
2589517|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589518|NCT01705639|Melatonin|melatonin|mesh-list
2589519|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
2589520|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589521|NCT01705639|Protective Agents|protective agents|mesh-ancestor
2589522|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589523|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589524|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
2589525|NCT01705743|Sevoflurane|sevoflurane|mesh-list
2589526|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2589527|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2589528|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
2589529|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
2143005|NCT03476798|Rucaparib|rucaparib|mesh-list
2143006|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2143007|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143008|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2143009|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2143010|NCT03476798|Growth Substances|growth substances|mesh-ancestor
2143011|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143012|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
2143013|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2143014|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143015|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143016|NCT03478163|Clindamycin|clindamycin|mesh-list
2143017|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
2143018|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
2143019|NCT03478163|Cefazolin|cefazolin|mesh-list
2143020|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2143021|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143022|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2143023|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143024|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143025|NCT03478254|Vaccines|vaccines|mesh-list
2143026|NCT03478254|Immunologic Factors|immunologic factors|mesh-ancestor
2143027|NCT03478254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143028|NCT03478683|Budesonide|budesonide|mesh-list
2143029|NCT03478683|Albuterol|albuterol|mesh-list
2143030|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
2143031|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
2143032|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2143033|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2143034|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2143035|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
2143036|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143037|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143038|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2589530|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589531|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589532|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2589533|NCT01705743|Analgesics|analgesics|mesh-ancestor
2589534|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
2589535|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589536|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2589537|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2589538|NCT01705769|Micronutrients|micronutrients|mesh-list
2589539|NCT01705769|Trace Elements|trace elements|mesh-list
2589540|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589541|NCT01705795|Antibodies|antibodies|mesh-list
2589542|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
2589543|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589544|NCT01705808|Protein C|protein c|mesh-list
2589545|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
2589546|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2589547|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2143039|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
2143040|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
2143041|NCT03478683|Hormones|hormones|mesh-ancestor
2143042|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2143043|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2589548|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143044|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2143045|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2143046|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
2143047|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143048|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143049|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
2143050|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2143051|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
2143052|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
2143053|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2143054|NCT03478696|Budesonide|budesonide|mesh-list
2143055|NCT03478696|Albuterol|albuterol|mesh-list
2143056|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
2143057|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
2143058|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2143059|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2143060|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2143061|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
2143062|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143063|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143064|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2143065|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
2589549|NCT01705938|Dolcanatide|dolcanatide|mesh-list
2589550|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2589551|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
2589552|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589553|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2589554|NCT01705951|Nicotine|nicotine|mesh-list
2589555|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2589556|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
2143066|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
2143067|NCT03478696|Hormones|hormones|mesh-ancestor
2143068|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2143069|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2143070|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2143071|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2143072|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
2143073|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143074|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143075|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
2143076|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2143077|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
2143078|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
2143079|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2143080|NCT03478930|Omalizumab|omalizumab|mesh-list
2143081|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2143082|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2143083|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
2589557|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589558|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589559|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2589560|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2589561|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
2589562|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589563|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589564|NCT01706055|Interferons|interferons|mesh-list
2589565|NCT01706055|Interferon-beta|interferon-beta|mesh-list
2589566|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
2589567|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589568|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
2589569|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589570|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
2589571|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589572|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2589573|NCT01706120|Paclitaxel|paclitaxel|mesh-list
2589574|NCT01706120|Bevacizumab|bevacizumab|mesh-list
2589575|NCT01706120|Carboplatin|carboplatin|mesh-list
2589576|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2589577|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589578|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
2589579|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
2589580|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
2589581|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143088|NCT03478969|Insulin|insulin|mesh-list
2143089|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2143090|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143091|NCT03478982|Alprazolam|alprazolam|mesh-list
2143092|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2143093|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143094|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589582|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2589583|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2589584|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2589585|NCT01706120|Growth Substances|growth substances|mesh-ancestor
2589586|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589587|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
2589588|NCT01706172|Lidocaine|lidocaine|mesh-list
2589589|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
2589590|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
2589591|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589592|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589593|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
2589594|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589595|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2589596|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2589597|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2589598|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2589599|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589600|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
2589601|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2589602|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589603|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2589604|NCT01706354|Anesthetics|anesthetics|mesh-list
2589605|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
2589606|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589607|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589608|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
2589609|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589610|NCT01706367|Vaccines|vaccines|mesh-list
2589611|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
2589612|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589613|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
2589614|NCT01706471|Everolimus|everolimus|mesh-list
2589615|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589616|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2589617|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
2589618|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143095|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2143096|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2589619|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2589620|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2589621|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
2589622|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2589623|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589624|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589625|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589626|NCT01706510|Clopidogrel|clopidogrel|mesh-list
2589627|NCT01706510|Ticagrelor|ticagrelor|mesh-list
2589628|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2589629|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2589630|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2589631|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2589632|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
2589633|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589634|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589635|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589636|NCT01706562|Itraconazole|itraconazole|mesh-list
2589637|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
2589638|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589639|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2589640|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2589641|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143097|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2143098|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
2589642|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589643|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2589644|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
2589645|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2589646|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589647|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2589648|NCT01706627|Melatonin|melatonin|mesh-list
2589649|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
2589650|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589651|NCT01706627|Protective Agents|protective agents|mesh-ancestor
2589652|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143099|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
2143100|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143101|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143102|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
2143103|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
2143104|NCT03479216|Bupivacaine|bupivacaine|mesh-list
2143105|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
2143106|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
2143107|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143108|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143109|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
2143110|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143111|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2589653|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589654|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
2589655|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2589656|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589657|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2589658|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2589659|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589660|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589661|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589662|NCT01706692|Cyclosporine|cyclosporine|mesh-list
2589663|NCT01706692|Adalimumab|adalimumab|mesh-list
2589664|NCT01706692|Etanercept|etanercept|mesh-list
2589665|NCT01706692|Methotrexate|methotrexate|mesh-list
2589666|NCT01706692|Infliximab|infliximab|mesh-list
2589667|NCT01706692|Ustekinumab|ustekinumab|mesh-list
2589668|NCT01706692|Cyclosporins|cyclosporins|mesh-list
2143112|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2143113|NCT03479216|Analgesics|analgesics|mesh-ancestor
2143114|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2143115|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2143116|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2143117|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
2143118|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143119|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143120|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2143121|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
2143122|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2143123|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2143124|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2143125|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
2143126|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2143127|NCT03480009|Oxycodone|oxycodone|mesh-list
2143128|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
2143129|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2143130|NCT03480009|Narcotics|narcotics|mesh-ancestor
2143131|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589669|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2589670|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
2589671|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2589672|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589673|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2589674|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
2589675|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589676|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589677|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
2589678|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589679|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2589680|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2143132|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589681|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
2589682|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2589683|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2589684|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
2589685|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589686|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2589687|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2143133|NCT03480009|Analgesics|analgesics|mesh-ancestor
2143134|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
2143135|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143136|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
2143137|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
2143138|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2143139|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2143140|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143141|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143142|NCT03480022|Liraglutide|liraglutide|mesh-list
2143143|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2143144|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143145|NCT03480022|Incretins|incretins|mesh-ancestor
2143146|NCT03480022|Hormones|hormones|mesh-ancestor
2143147|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2143148|NCT03480243|Erythromycin|erythromycin|mesh-list
2143149|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
2143150|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2143151|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
2143152|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2143153|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143154|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2143155|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2589688|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2589689|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2589690|NCT01706692|Analgesics|analgesics|mesh-ancestor
2589691|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
2589692|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589693|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2589694|NCT01706874|Listerine|listerine|mesh-list
2589695|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2589696|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143156|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143157|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143158|NCT03480750|Carboplatin|carboplatin|mesh-list
2143159|NCT03480750|Doxorubicin|doxorubicin|mesh-list
2143160|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2143161|NCT03480750|Trientine|trientine|mesh-list
2143162|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143163|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2143164|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2143165|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2143166|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143167|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143168|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
2143169|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
2143170|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2589697|NCT01706887|Amiloride|amiloride|mesh-list
2589698|NCT01706887|Diuretics|diuretics|mesh-ancestor
2143171|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
2143172|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143173|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2143174|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
2143175|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143176|NCT03480932|Interferons|interferons|mesh-list
2143177|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
2143178|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
2143179|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2143180|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
2143181|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143182|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
2143183|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143184|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
2143185|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143186|NCT03481725|Coal Tar|coal tar|mesh-list
2143187|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
2143188|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
2143189|NCT03481816|Vaccines|vaccines|mesh-list
2143190|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
2184940|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
2589699|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
2589700|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589701|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2589702|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2589703|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2589704|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589705|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2589706|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2589707|NCT01706939|Carboplatin|carboplatin|mesh-list
2589708|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589709|NCT01707082|Midazolam|midazolam|mesh-list
2589710|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2589711|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2589712|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589713|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589714|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2589715|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2589716|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2589717|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2589718|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
2589719|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
2589720|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
2589721|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
2589722|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589723|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589724|NCT01707134|Insulin|insulin|mesh-list
2589725|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2589726|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
2589727|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
2589728|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
2589729|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
2589730|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2589731|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589732|NCT01707160|Insulin|insulin|mesh-list
2589733|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2143191|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143192|NCT03482011|Mirikizumab|mirikizumab|mesh-list
2143193|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2143194|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2143195|NCT03482011|Analgesics|analgesics|mesh-ancestor
2143196|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
2143197|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143198|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143199|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2143200|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2143201|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2143202|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2143203|NCT03482583|Nicotine|nicotine|mesh-list
2420416|NCT00807950|Simvastatin|simvastatin|mesh-list
2420417|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2420418|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2420419|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
2420420|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420421|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2420422|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2420423|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420424|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
2420425|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2420426|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420427|NCT00808002|Tenofovir|tenofovir|mesh-list
2420428|NCT00808002|Emtricitabine|emtricitabine|mesh-list
2143204|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2143205|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
2143206|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143207|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143208|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2143209|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2143210|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
2143211|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589734|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
2589735|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
2589736|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2589737|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2143212|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420429|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
2589738|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589739|NCT01707199|Artesunate|artesunate|mesh-list
2589740|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
2589741|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
2589742|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2589743|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
2589744|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2589745|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2589746|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589747|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589748|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
2589749|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
2589750|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2589751|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
2589752|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2589753|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589754|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589755|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2589756|NCT01707199|Renal Agents|renal agents|mesh-ancestor
2589757|NCT01707251|Ibuprofen|ibuprofen|mesh-list
2589758|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2589759|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2589760|NCT01707251|Analgesics|analgesics|mesh-ancestor
2589761|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
2589762|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589763|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589764|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2589765|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2589766|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2589767|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589768|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589769|NCT01707316|Canagliflozin|canagliflozin|mesh-list
2589770|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2143213|NCT03482882|Pimavanserin|pimavanserin|mesh-list
2143214|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2143215|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2143216|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2143217|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2143218|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143219|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143220|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2143221|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2143222|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2143223|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
2143224|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143225|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143226|NCT03482973|Bupivacaine|bupivacaine|mesh-list
2143227|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
2143228|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
2143229|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143230|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143231|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
2143232|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143233|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2143234|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
2143235|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143236|NCT03485222|Empagliflozin|empagliflozin|mesh-list
2143237|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2143238|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143239|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2143240|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420430|NCT00808002|Maraviroc|maraviroc|mesh-list
2420431|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
2420432|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420433|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2420434|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2420435|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420436|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420437|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2420438|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2420439|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2420440|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2420441|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2420442|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2420443|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2589771|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589772|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2589773|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589774|NCT01707342|Simeprevir|simeprevir|mesh-list
2589775|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
2589776|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589777|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
2589778|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589779|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589780|NCT01707394|Apixaban|apixaban|mesh-list
2589781|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2589782|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
2589783|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2589784|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
2589785|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589786|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589787|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
2589788|NCT01707407|Ketoconazole|ketoconazole|mesh-list
2143252|NCT03485911|Berotralstat|berotralstat|mesh-list
2143253|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143254|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143255|NCT03485950|Meropenem|meropenem|mesh-list
2143256|NCT03485950|Tazobactam|tazobactam|mesh-list
2143257|NCT03485950|Piperacillin|piperacillin|mesh-list
2143258|NCT03485950|Cefepime|cefepime|mesh-list
2143259|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2143260|NCT03485950|Ceftolozane|ceftolozane|mesh-list
2143261|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2143262|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143263|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2143264|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143265|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143266|NCT03485976|Ixekizumab|ixekizumab|mesh-list
2143267|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
2143268|NCT03486392|Liraglutide|liraglutide|mesh-list
2143269|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2143270|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143271|NCT03486392|Incretins|incretins|mesh-ancestor
2143272|NCT03486392|Hormones|hormones|mesh-ancestor
2143273|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2143274|NCT03486834|Vaccines|vaccines|mesh-list
2589789|NCT01707407|Pomalidomide|pomalidomide|mesh-list
2589790|NCT01707407|Carbamazepine|carbamazepine|mesh-list
2589791|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
2589792|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
2589793|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589794|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2589795|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2589796|NCT01707407|Growth Substances|growth substances|mesh-ancestor
2589797|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
2143275|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
2143276|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143277|NCT03487276|Vilobelimab|vilobelimab|mesh-list
2143278|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2143279|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2143280|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
2143281|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143282|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2143283|NCT03487549|Cantharidin|cantharidin|mesh-list
2143284|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143285|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589798|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589799|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
2143286|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
2143287|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
2589800|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143288|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143289|NCT03488108|Minoxidil|minoxidil|mesh-list
2143290|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2143291|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
2143292|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
2143293|NCT03488225|Leucovorin|leucovorin|mesh-list
2143294|NCT03488225|Folic Acid|folic acid|mesh-list
2143295|NCT03488225|Cytarabine|cytarabine|mesh-list
2143296|NCT03488225|Dexamethasone|dexamethasone|mesh-list
2143297|NCT03488225|Prednisone|prednisone|mesh-list
2589801|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2589802|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2589803|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589804|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589805|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2589806|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
2589807|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2589808|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2589809|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
2589810|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
2589811|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2589812|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589813|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2589814|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2143298|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
2143299|NCT03488225|Cortisone|cortisone|mesh-list
2143300|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
2143301|NCT03488225|Rituximab|rituximab|mesh-list
2143302|NCT03488225|Doxorubicin|doxorubicin|mesh-list
2143303|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2143304|NCT03488225|Methotrexate|methotrexate|mesh-list
2143305|NCT03488225|Vincristine|vincristine|mesh-list
2143306|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
2143307|NCT03488225|Ofatumumab|ofatumumab|mesh-list
2143308|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2143309|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2143310|NCT03488225|Antibodies|antibodies|mesh-list
2143311|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
2143312|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2143313|NCT03488225|BB 1101|bb 1101|mesh-list
2143314|NCT03488225|Calcium|calcium|mesh-list
2143315|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
2143316|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2143317|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
2143318|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143319|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2143320|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2143321|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
2143322|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143323|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143324|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2143325|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2143326|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
2143327|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
2143328|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143329|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2143330|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
2143331|NCT03488225|Hormones|hormones|mesh-ancestor
2143332|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2143333|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2589815|NCT01707407|Analgesics|analgesics|mesh-ancestor
2589816|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
2589817|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589818|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2589819|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2143334|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2143335|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2143336|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2143337|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143338|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2143339|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2143340|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2143341|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
2143342|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2143343|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2143344|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
2143345|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
2143346|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2143347|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2143348|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
2143349|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143350|NCT03488225|Antidotes|antidotes|mesh-ancestor
2143351|NCT03488225|Protective Agents|protective agents|mesh-ancestor
2143352|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
2143353|NCT03488225|Vitamins|vitamins|mesh-ancestor
2143354|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
2143355|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2143356|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
2143357|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
2143358|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
2143359|NCT03488225|Hematinics|hematinics|mesh-ancestor
2143360|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
2143361|NCT03489304|Zaleplon|zaleplon|mesh-list
2143362|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
2143363|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2143364|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143365|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143366|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
2143367|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
2143368|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143369|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143370|NCT03489551|Haloperidol|haloperidol|mesh-list
2143371|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
2143372|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
2143373|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143374|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143375|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2143376|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2143377|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2143378|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143379|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2143380|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2143381|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
2143382|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143383|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143384|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2143385|NCT03489850|Ibudilast|ibudilast|mesh-list
2143386|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2143387|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
2143388|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143389|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143390|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2143391|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
2143392|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2143393|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143394|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143395|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2143396|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
2143397|NCT03489863|Ticagrelor|ticagrelor|mesh-list
2143398|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2143399|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2143400|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2143401|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2143402|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2143403|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
2143404|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143405|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143406|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143407|NCT03490942|Glucagon|glucagon|mesh-list
2143408|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2143409|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2143410|NCT03490942|Hormones|hormones|mesh-ancestor
2589820|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2589821|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2589822|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2589823|NCT01707407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2589824|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2589825|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589826|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
2589827|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2589828|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
2589829|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2589830|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2589831|NCT01707537|Vaccines|vaccines|mesh-list
2589832|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
2589833|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589834|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
2589835|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
2589836|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589837|NCT01707615|Protective Agents|protective agents|mesh-ancestor
2589838|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589839|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2589840|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2589841|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589842|NCT01707628|Vaccines|vaccines|mesh-list
2589843|NCT01707628|Immunologic Factors|immunologic factors|mesh-ancestor
2589844|NCT01707628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589845|NCT01707732|Enoxaparin|enoxaparin|mesh-list
2589846|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
2589847|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2589848|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2589849|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589850|NCT01707745|Bevacizumab|bevacizumab|mesh-list
2589851|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2589852|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589853|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2589854|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2589855|NCT01707745|Growth Substances|growth substances|mesh-ancestor
2589856|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589857|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
2589858|NCT01707823|Aspirin|aspirin|mesh-list
2589859|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2589860|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2589861|NCT01707823|Analgesics|analgesics|mesh-ancestor
2589862|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
2589863|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143411|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2143412|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143413|NCT03490942|Incretins|incretins|mesh-ancestor
2143414|NCT03492099|Buprenorphine|buprenorphine|mesh-list
2143415|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2143416|NCT03492099|Narcotics|narcotics|mesh-ancestor
2143417|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143418|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143419|NCT03492099|Analgesics|analgesics|mesh-ancestor
2143420|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
2143421|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143422|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2143423|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2143424|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2143425|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2143426|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
2143427|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143428|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143429|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143430|NCT03492281|Urological Agents|urological agents|mesh-ancestor
2143431|NCT03493386|Glycine|glycine|mesh-list
2143432|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
2143433|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143434|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143435|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143436|NCT03493542|Vaccines|vaccines|mesh-list
2143437|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
2143438|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143439|NCT03493698|Midazolam|midazolam|mesh-list
2143440|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2143441|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2143442|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143443|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143444|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2143445|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2143446|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2143447|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2589864|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589865|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2589866|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2589867|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2143448|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
2143449|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
2143450|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
2143451|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
2143452|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143453|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143454|NCT03493828|Bupivacaine|bupivacaine|mesh-list
2589868|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2589869|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589870|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2589871|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2589872|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589873|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
2589874|NCT01707849|Everolimus|everolimus|mesh-list
2589875|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2589876|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2589877|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
2589878|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589879|NCT01707940|Ketoconazole|ketoconazole|mesh-list
2589880|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
2143455|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
2143456|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
2143457|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143458|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143459|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
2143460|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143461|NCT03493854|Paclitaxel|paclitaxel|mesh-list
2143462|NCT03493854|Docetaxel|docetaxel|mesh-list
2143463|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
2143464|NCT03493854|Doxorubicin|doxorubicin|mesh-list
2143465|NCT03493854|Trastuzumab|trastuzumab|mesh-list
2143466|NCT03493854|Pertuzumab|pertuzumab|mesh-list
2143467|NCT03493854|Hormones|hormones|mesh-list
2143468|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2143469|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143470|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
2143471|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
2589881|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589882|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2589883|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2589884|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589885|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143472|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
2143473|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143474|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2143475|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
2143476|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143477|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2143478|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2143479|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
2143480|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2143481|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2143482|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2589886|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2589887|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
2589888|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2589889|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589890|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2589891|NCT01707953|Midodrine|midodrine|mesh-list
2589892|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
2589893|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
2589894|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589895|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143483|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2143484|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143485|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2420444|NCT00808054|Lidocaine|lidocaine|mesh-list
2420445|NCT00808054|Prilocaine|prilocaine|mesh-list
2420446|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
2420447|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
2420448|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2420449|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420450|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
2420451|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420452|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2143486|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2143487|NCT03494816|Axitinib|axitinib|mesh-list
2143488|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143489|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2143490|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143491|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143492|NCT03494985|Muramidase|muramidase|mesh-list
2143493|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143494|NCT03495102|Dulaglutide|dulaglutide|mesh-list
2143495|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2143496|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143497|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
2143498|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2143499|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143500|NCT03496324|Ibuprofen|ibuprofen|mesh-list
2143501|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2143502|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2143503|NCT03496324|Analgesics|analgesics|mesh-ancestor
2143504|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
2589896|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2589897|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2589898|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2589899|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2589900|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
2589901|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589902|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589903|NCT01708005|Vitamin D|vitamin d|mesh-list
2589904|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
2589905|NCT01708005|Vitamins|vitamins|mesh-ancestor
2589906|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
2589907|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589908|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2589909|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2589910|NCT01708044|Pramlintide|pramlintide|mesh-list
2589911|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2589912|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589913|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
2589914|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2589915|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2589916|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589917|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
2589918|NCT01708239|Coagulants|coagulants|mesh-ancestor
2589919|NCT01708330|Lidocaine|lidocaine|mesh-list
2589920|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
2589921|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
2589922|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589923|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143505|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143506|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143507|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2143508|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2143509|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2143510|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143511|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143512|NCT03496467|Nepafenac|nepafenac|mesh-list
2143513|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2143514|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2589924|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
2589925|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589926|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2589927|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2589928|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2589929|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2589930|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589931|NCT01708369|Aspirin|aspirin|mesh-list
2589932|NCT01708369|Ethanol|ethanol|mesh-list
2589933|NCT01708369|Oseltamivir|oseltamivir|mesh-list
2589934|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2589935|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2589936|NCT01708369|Analgesics|analgesics|mesh-ancestor
2589937|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
2589938|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589939|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143515|NCT03496467|Analgesics|analgesics|mesh-ancestor
2143516|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
2143517|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143518|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589940|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2589941|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2589942|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2589943|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2589944|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589945|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2589946|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2589947|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2589948|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
2589949|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2589950|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2589951|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589952|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
2589953|NCT01708447|Lidocaine|lidocaine|mesh-list
2589954|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
2589955|NCT01708447|Anesthetics|anesthetics|mesh-list
2589956|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589957|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589958|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
2589959|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589960|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2589961|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2589962|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2143519|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2143520|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2143521|NCT03496545|Acetaminophen|acetaminophen|mesh-list
2143522|NCT03496545|Bromocriptine|bromocriptine|mesh-list
2143523|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2143524|NCT03496545|Analgesics|analgesics|mesh-ancestor
2143525|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
2143526|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143527|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143528|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
2143529|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2143530|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2143531|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
2143532|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2143533|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
2143534|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
2143535|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143536|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143537|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2143538|NCT03496974|Antibodies|antibodies|mesh-list
2143539|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
2589963|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2589964|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589965|NCT01708616|Risperidone|risperidone|mesh-list
2589966|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2589967|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
2589968|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589969|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589970|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589971|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2589972|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2589973|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2589974|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2589975|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2589976|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
2589977|NCT01708642|Epinephrine|epinephrine|mesh-list
2589978|NCT01708642|Racepinephrine|racepinephrine|mesh-list
2589979|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
2589980|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2589981|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2589982|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
2589983|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2589984|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2589985|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2589986|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2589987|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2589988|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
2589989|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2589990|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2589991|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
2589992|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
2589993|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
2589994|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2143540|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2143541|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
2143542|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143543|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143544|NCT03497039|Diclofenac|diclofenac|mesh-list
2143545|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2143546|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2143547|NCT03497039|Analgesics|analgesics|mesh-ancestor
2589995|NCT01708707|Morphine|morphine|mesh-list
2589996|NCT01708707|Buprenorphine|buprenorphine|mesh-list
2589997|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2589998|NCT01708707|Narcotics|narcotics|mesh-ancestor
2589999|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2590000|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143548|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
2143549|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143550|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420453|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2590001|NCT01708707|Analgesics|analgesics|mesh-ancestor
2590002|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
2590003|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590004|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2590005|NCT01708720|Vaccines|vaccines|mesh-list
2590006|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
2590007|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590008|NCT01708798|Eplerenone|eplerenone|mesh-list
2590009|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2590010|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
2590011|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2590012|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590013|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2590014|NCT01708798|Diuretics|diuretics|mesh-ancestor
2590015|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
2590016|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2590017|NCT01708837|Propofol|propofol|mesh-list
2590018|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2590019|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2590020|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590021|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2590022|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
2590023|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
2590024|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
2590025|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2590026|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
2590027|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2590028|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
2590029|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590030|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590031|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
2590032|NCT01708876|Artesunate|artesunate|mesh-list
2590033|NCT01708876|Chloroquine|chloroquine|mesh-list
2420454|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2420455|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2420456|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590034|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2590035|NCT01708876|Primaquine|primaquine|mesh-list
2590036|NCT01708876|Mefloquine|mefloquine|mesh-list
2590037|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
2590038|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2590039|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2420457|NCT00808145|Gemcitabine|gemcitabine|mesh-list
2420458|NCT00808145|Cisplatin|cisplatin|mesh-list
2420459|NCT00808145|Sorafenib|sorafenib|mesh-list
2420460|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420461|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2420462|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
2420463|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420464|NCT00808145|Antiviral Agents|antiviral agents|mesh-ancestor
2420465|NCT00808145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420466|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420467|NCT00808145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2420468|NCT00808145|Immunologic Factors|immunologic factors|mesh-ancestor
2143551|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2143552|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2143553|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2143554|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143555|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143556|NCT03497429|Niraparib|niraparib|mesh-list
2143557|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2143558|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143559|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143560|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143561|NCT03497845|Vaccines|vaccines|mesh-list
2143562|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
2143563|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143564|NCT03498196|Avelumab|avelumab|mesh-list
2590040|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2590041|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590042|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
2590043|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
2590044|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2590045|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
2590046|NCT01708876|Amebicides|amebicides|mesh-ancestor
2590047|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2590048|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2590049|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2590050|NCT01708876|Analgesics|analgesics|mesh-ancestor
2590051|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
2143565|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2143566|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143567|NCT03499353|Talazoparib|talazoparib|mesh-list
2143568|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2143569|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143570|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143571|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143572|NCT03499873|Nepafenac|nepafenac|mesh-list
2143573|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2143574|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2143575|NCT03499873|Analgesics|analgesics|mesh-ancestor
2143576|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
2590052|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590053|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590054|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2590055|NCT01708876|Filaricides|filaricides|mesh-ancestor
2590056|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
2590057|NCT01708993|Docetaxel|docetaxel|mesh-list
2590058|NCT01708993|Pemetrexed|pemetrexed|mesh-list
2143577|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143578|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143579|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2143580|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2143581|NCT03500211|Lidocaine|lidocaine|mesh-list
2143582|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
2143583|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
2143584|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143585|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143586|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
2143587|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143588|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2143589|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2590059|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590060|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
2590061|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
2590062|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
2590063|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590064|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590065|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2590066|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2590067|NCT01709019|Vaccines|vaccines|mesh-list
2590068|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
2590069|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590070|NCT01709071|Vaccines|vaccines|mesh-list
2590071|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
2590072|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143590|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2590073|NCT01709123|Chromium|chromium|mesh-list
2590074|NCT01709123|Trace Elements|trace elements|mesh-ancestor
2590075|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
2143591|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2143592|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143593|NCT03500289|Midazolam|midazolam|mesh-list
2143594|NCT03500289|Ketamine|ketamine|mesh-list
2143595|NCT03500289|Analgesics|analgesics|mesh-ancestor
2143596|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
2143597|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143598|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143599|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2143600|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2143601|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
2143602|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
2143603|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143604|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2143605|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2143606|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143607|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143608|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2143609|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2143610|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2143611|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2143612|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2143613|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
2143614|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
2143615|NCT03500302|Evolocumab|evolocumab|mesh-list
2143616|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2143617|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2143618|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
2590076|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590077|NCT01709214|Oxycodone|oxycodone|mesh-list
2590078|NCT01709214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2590079|NCT01709214|Narcotics|narcotics|mesh-ancestor
2590080|NCT01709214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2590081|NCT01709214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590082|NCT01709214|Analgesics|analgesics|mesh-ancestor
2590083|NCT01709214|Sensory System Agents|sensory system agents|mesh-ancestor
2590084|NCT01709214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590085|NCT01709292|Vemurafenib|vemurafenib|mesh-list
2590086|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590087|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2143619|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143620|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2143621|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2143622|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2143623|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2143624|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143625|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
2143626|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143627|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143628|NCT03501277|Pioglitazone|pioglitazone|mesh-list
2143629|NCT03501277|Alogliptin|alogliptin|mesh-list
2143630|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2143631|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143632|NCT03501277|Incretins|incretins|mesh-ancestor
2143633|NCT03501277|Hormones|hormones|mesh-ancestor
2143634|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2143635|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2143636|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
2143637|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143638|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143639|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2143640|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
2143641|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143642|NCT03502070|Tobramycin|tobramycin|mesh-list
2590088|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590089|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590090|NCT01709370|Letrozole|letrozole|mesh-list
2590091|NCT01709370|Palbociclib|palbociclib|mesh-list
2590092|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590093|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2590094|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2590095|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143643|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2143644|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143645|NCT03502616|Tofacitinib|tofacitinib|mesh-list
2143646|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2143647|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143648|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143649|NCT03502681|Avelumab|avelumab|mesh-list
2143650|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2590096|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590097|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2590098|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
2590099|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2590100|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590101|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2590102|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
2420469|NCT00808145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420470|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2420471|NCT00808171|Lidocaine|lidocaine|mesh-list
2420472|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
2420473|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
2420474|NCT00808171|Prilocaine|prilocaine|mesh-list
2590103|NCT01709630|Analgesics|analgesics|mesh-ancestor
2590104|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
2143651|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143652|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
2143653|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2143654|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
2143655|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
2143656|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143657|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143658|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2143659|NCT03502915|Analgesics|analgesics|mesh-ancestor
2143660|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
2143661|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143662|NCT03503292|Ondansetron|ondansetron|mesh-list
2143663|NCT03503292|Granisetron|granisetron|mesh-list
2143664|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
2143665|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
2143666|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143667|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143668|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2143669|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
2143670|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
2143671|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2143672|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
2143673|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143674|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143675|NCT03503292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2143676|NCT03503292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2143677|NCT03503292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143678|NCT03503292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2143679|NCT03503292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2143680|NCT03503578|Ketamine|ketamine|mesh-list
2143681|NCT03503578|Sevoflurane|sevoflurane|mesh-list
2143682|NCT03503578|Analgesics|analgesics|mesh-ancestor
2143683|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
2143684|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143685|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143686|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2143687|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2143688|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
2143689|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
2143690|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143691|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2143692|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2143693|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143694|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143695|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2143696|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2143697|NCT03505021|Simendan|simendan|mesh-list
2143698|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2143699|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
2143700|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2143701|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2143702|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420475|NCT00808171|Anesthetics|anesthetics|mesh-list
2420476|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2420477|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590105|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590106|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590107|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
2590108|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2590109|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2590110|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
2590111|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2590112|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2420478|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
2420479|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420480|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2420481|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2420482|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2420483|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2420484|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420485|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2420486|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
2420487|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2420488|NCT00808171|Analgesics|analgesics|mesh-ancestor
2420489|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
2420490|NCT00808184|Midazolam|midazolam|mesh-list
2420491|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2590113|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590114|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2590115|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
2590116|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2590117|NCT01709656|Celecoxib|celecoxib|mesh-list
2143703|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143704|NCT03505021|Protective Agents|protective agents|mesh-ancestor
2143705|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590118|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2590119|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2590120|NCT01709656|Analgesics|analgesics|mesh-ancestor
2590121|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
2590122|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590123|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590124|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2590125|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2590126|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2590127|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2590128|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590129|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590130|NCT01709682|Amiodarone|amiodarone|mesh-list
2590131|NCT01709682|Sotalol|sotalol|mesh-list
2590132|NCT01709682|Flecainide|flecainide|mesh-list
2590133|NCT01709682|Propafenone|propafenone|mesh-list
2590134|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2590135|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
2590136|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2590137|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2590138|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143706|NCT03506347|Vancomycin|vancomycin|mesh-list
2143707|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2143708|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143709|NCT03506724|Labetalol|labetalol|mesh-list
2143710|NCT03506724|Nifedipine|nifedipine|mesh-list
2143711|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2143712|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2143713|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143714|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2143715|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143716|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
2143717|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
2143718|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2143719|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2143720|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2143721|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
2143722|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143723|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2143724|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
2143725|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
2143726|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143727|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2143728|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2143729|NCT03508830|Bupivacaine|bupivacaine|mesh-list
2590139|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2590140|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2143730|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
2143731|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
2143732|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143733|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143734|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
2143735|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143736|NCT03509350|Vitamins|vitamins|mesh-list
2143737|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
2143738|NCT03509350|Thiamine|thiamine|mesh-list
2143739|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
2143740|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2143741|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2143742|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2143743|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
2143744|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143745|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2143746|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
2143747|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143748|NCT03509350|Protective Agents|protective agents|mesh-ancestor
2143749|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
2590141|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2590142|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590143|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2590144|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2590145|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2590146|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2590147|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2590148|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
2590149|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2590150|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590151|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
2590152|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
2143750|NCT03509675|Ibuprofen|ibuprofen|mesh-list
2143751|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2143752|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2143753|NCT03509675|Analgesics|analgesics|mesh-ancestor
2143754|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
2143755|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143756|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143757|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2143758|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2143759|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2143760|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143761|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143762|NCT03509766|Histamine|histamine|mesh-list
2143763|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
2143764|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
2143765|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143766|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590153|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590154|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2590155|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
2590156|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590157|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590158|NCT01709760|Methotrexate|methotrexate|mesh-list
2590159|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2590160|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
2590161|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2590162|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590163|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2590164|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
2590165|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590166|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590167|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
2590168|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590169|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2590170|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2590171|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
2590172|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2590173|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2590174|NCT01709825|Sulfalene|sulfalene|mesh-list
2590175|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2590176|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2590177|NCT01709825|Renal Agents|renal agents|mesh-ancestor
2590178|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
2590179|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2590180|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2590181|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
2590182|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2590183|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590184|NCT01709942|Cetrorelix|cetrorelix|mesh-list
2590185|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2590186|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
2590187|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2590188|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590189|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
2590190|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2590191|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2590192|NCT01709955|Cathartics|cathartics|mesh-ancestor
2590193|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2590194|NCT01709994|Aspirin|aspirin|mesh-list
2590195|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2590196|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2590197|NCT01709994|Analgesics|analgesics|mesh-ancestor
2590198|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
2590199|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590200|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590201|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2590202|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2590203|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2590204|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2590205|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590206|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2590207|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2590208|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590209|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
2590210|NCT01710007|Atorvastatin|atorvastatin|mesh-list
2590211|NCT01710007|Pitavastatin|pitavastatin|mesh-list
2590212|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2590213|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2590214|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
2590215|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590216|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2590217|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2590218|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590219|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
2590220|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
2590221|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2590222|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590223|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590224|NCT01710072|Aspirin|aspirin|mesh-list
2590225|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2590226|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2590227|NCT01710072|Analgesics|analgesics|mesh-ancestor
2590228|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
2590229|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590230|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590231|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2143767|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143768|NCT03509883|Apixaban|apixaban|mesh-list
2143769|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2143770|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
2143771|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2143772|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
2143773|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143774|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143775|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
2143776|NCT03510455|Infigratinib|infigratinib|mesh-list
2590232|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2590233|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2590234|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2590235|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590236|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2143777|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590237|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2590238|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590239|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
2590240|NCT01710163|Aripiprazole|aripiprazole|mesh-list
2590241|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
2590242|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2590243|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2590244|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2590245|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2590246|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590247|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
2590248|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
2590249|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2590250|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590251|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2590252|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2590253|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
2590254|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2590255|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2590256|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2143778|NCT03510481|Lumefantrine|lumefantrine|mesh-list
2143779|NCT03510481|Artemether|artemether|mesh-list
2143780|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
2143781|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2143782|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2143783|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143784|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
2143785|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2143786|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143787|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2143788|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2143789|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143790|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143791|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143792|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
2143793|NCT03510715|Niacin|niacin|mesh-list
2143794|NCT03510715|Niacinamide|niacinamide|mesh-list
2143795|NCT03510715|Atorvastatin|atorvastatin|mesh-list
2143796|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2143797|NCT03510715|Simvastatin|simvastatin|mesh-list
2143798|NCT03510715|Ezetimibe|ezetimibe|mesh-list
2143799|NCT03510715|Pravastatin|pravastatin|mesh-list
2143800|NCT03510715|Lovastatin|lovastatin|mesh-list
2143801|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
2143802|NCT03510715|Fenofibrate|fenofibrate|mesh-list
2590257|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2590258|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
2590259|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2590260|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
2590261|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2590262|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2590263|NCT01710228|Prednisolone|prednisolone|mesh-list
2590264|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
2590265|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2590266|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
2590267|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2590268|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
2590269|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
2590270|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590271|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590272|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2590273|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
2143803|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2143804|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2143805|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
2143806|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143807|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2143808|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2143809|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143810|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
2143811|NCT03510715|Vitamins|vitamins|mesh-ancestor
2590274|NCT01710228|Hormones|hormones|mesh-ancestor
2590275|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2590276|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2590277|NCT01710228|Protective Agents|protective agents|mesh-ancestor
2143812|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
2143813|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590278|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2143814|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
2143815|NCT03510910|Acetaminophen|acetaminophen|mesh-list
2143816|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2143817|NCT03510910|Analgesics|analgesics|mesh-ancestor
2143818|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
2143819|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143820|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143821|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
2590279|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590280|NCT01710384|Betamethasone|betamethasone|mesh-list
2590281|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2590282|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
2590283|NCT01710384|Hormones|hormones|mesh-ancestor
2590284|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2590285|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590286|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2590287|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
2143822|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2143823|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2143824|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2143825|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
2143826|NCT03511521|Insulin|insulin|mesh-list
2143827|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2143828|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
2143829|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
2143830|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
2143831|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
2143832|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2143833|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143834|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
2143835|NCT03512210|Velpatasvir|velpatasvir|mesh-list
2143836|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
2143837|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143838|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2143839|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
2143840|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143841|NCT03512353|Dexamethasone|dexamethasone|mesh-list
2143842|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2143843|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
2590288|NCT01710462|Domperidone|domperidone|mesh-list
2590289|NCT01710462|Pantoprazole|pantoprazole|mesh-list
2590290|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2590291|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2590292|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2590293|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590294|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590295|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
2590296|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
2590297|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590298|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590299|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2590300|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
2590301|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2590302|NCT01710488|Levofloxacin|levofloxacin|mesh-list
2590303|NCT01710488|Ofloxacin|ofloxacin|mesh-list
2590304|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
2590305|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2590306|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2590307|NCT01710488|Renal Agents|renal agents|mesh-ancestor
2590308|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2590309|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2590310|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2590311|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590312|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590313|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590314|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2590315|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2590316|NCT01710540|Metformin|metformin|mesh-list
2590317|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2590318|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590319|NCT01710553|Metformin|metformin|mesh-list
2590320|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2590321|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590322|NCT01710566|Misoprostol|misoprostol|mesh-list
2590323|NCT01710566|Oxytocin|oxytocin|mesh-list
2590324|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
2143844|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
2590325|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2590326|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590327|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2590328|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
2590329|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2590330|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2590331|NCT01710592|Docetaxel|docetaxel|mesh-list
2590332|NCT01710592|Capecitabine|capecitabine|mesh-list
2590333|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
2590334|NCT01710592|Epirubicin|epirubicin|mesh-list
2143845|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143846|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143847|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2143848|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
2143849|NCT03512353|Hormones|hormones|mesh-ancestor
2143850|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2143851|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2143852|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143853|NCT03513757|Lidocaine|lidocaine|mesh-list
2143854|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
2143855|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
2143856|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
2143857|NCT03513757|Propofol|propofol|mesh-list
2143858|NCT03513757|Sevoflurane|sevoflurane|mesh-list
2143859|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
2143860|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
2143861|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143862|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143863|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
2143864|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143865|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2143866|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2143867|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2143868|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2143869|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143870|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2143871|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2143872|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
2143873|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2143874|NCT03513757|Analgesics|analgesics|mesh-ancestor
2143875|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2143876|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2143877|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2143878|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
2143879|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2143880|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2143881|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2143882|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2143883|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2143884|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2590335|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590336|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
2590337|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
2590338|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
2590339|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590340|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2590341|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
2590342|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2590343|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2590344|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2590345|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590346|NCT01710631|Eszopiclone|eszopiclone|mesh-list
2590347|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2590348|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2590349|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590350|NCT01710670|Ethanol|ethanol|mesh-list
2590351|NCT01710670|Brivaracetam|brivaracetam|mesh-list
2590352|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2590353|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143885|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
2143886|NCT03514277|Bupivacaine|bupivacaine|mesh-list
2143887|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
2143888|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
2143889|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143890|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590354|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143891|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
2590355|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590356|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
2143892|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143893|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
2143894|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2143895|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143896|NCT03515941|Leucovorin|leucovorin|mesh-list
2143897|NCT03515941|Fluorouracil|fluorouracil|mesh-list
2143898|NCT03515941|Capecitabine|capecitabine|mesh-list
2143899|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
2143900|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
2143901|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143902|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2143903|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143904|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2143905|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
2143906|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143907|NCT03515941|Antidotes|antidotes|mesh-ancestor
2143908|NCT03515941|Protective Agents|protective agents|mesh-ancestor
2143909|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
2143910|NCT03515941|Vitamins|vitamins|mesh-ancestor
2143911|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
2143935|NCT03518125|Vaccines|vaccines|mesh-list
2590357|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2420492|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2420493|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2420494|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420495|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2420496|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2420497|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2420498|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2420499|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
2420500|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
2420501|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
2420502|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
2420503|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420504|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420505|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2420506|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2420507|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
2143936|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
2143937|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143938|NCT03519204|Lidocaine|lidocaine|mesh-list
2143939|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
2143940|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
2143941|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2143942|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143943|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
2143944|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143945|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2143946|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2420508|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420509|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2590358|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2590359|NCT01710696|Estradiol|estradiol|mesh-list
2590360|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2590361|NCT01710696|Estrogens|estrogens|mesh-ancestor
2590362|NCT01710696|Hormones|hormones|mesh-ancestor
2590363|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2590364|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590365|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2590366|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
2590367|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2590368|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2590369|NCT01710722|Ephedrine|ephedrine|mesh-list
2590370|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
2590371|NCT01710722|Caffeine|caffeine|mesh-list
2590372|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2590373|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590374|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2590375|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590376|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590377|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2590378|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2590379|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
2590380|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2590381|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
2590382|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
2590383|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590384|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2590385|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
2590386|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2590387|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2590388|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
2590389|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
2590390|NCT01710748|Everolimus|everolimus|mesh-list
2590391|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590392|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2590393|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
2590394|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590395|NCT01710761|Caffeine|caffeine|mesh-list
2590396|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2590397|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590398|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2590399|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590400|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590401|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2590402|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2590403|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
2590404|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2590405|NCT01710904|Oxycodone|oxycodone|mesh-list
2590406|NCT01710904|Naloxone|naloxone|mesh-list
2590407|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2590408|NCT01710904|Narcotics|narcotics|mesh-ancestor
2590409|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2590410|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590411|NCT01710904|Analgesics|analgesics|mesh-ancestor
2590412|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
2143947|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2143948|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2143949|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143950|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
2143951|NCT03519243|Hematinics|hematinics|mesh-ancestor
2590413|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590414|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2590415|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
2590416|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2590417|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143952|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
2143953|NCT03519516|Levofloxacin|levofloxacin|mesh-list
2143954|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2143955|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2143956|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2143957|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2143958|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2143959|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2143960|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143961|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2143962|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143963|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2143964|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2143965|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2590418|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590419|NCT01711021|Amphetamine|amphetamine|mesh-list
2590420|NCT01711021|Dextroamphetamine|dextroamphetamine|mesh-list
2590421|NCT01711021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2590422|NCT01711021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590423|NCT01711021|Sympathomimetics|sympathomimetics|mesh-ancestor
2590424|NCT01711021|Autonomic Agents|autonomic agents|mesh-ancestor
2590425|NCT01711021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590426|NCT01711021|Dopamine Agents|dopamine agents|mesh-ancestor
2590427|NCT01711021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2590428|NCT01711021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590429|NCT01711021|Adrenergic Agents|adrenergic agents|mesh-ancestor
2590430|NCT01711021|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2590431|NCT01711021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2590432|NCT01711021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2590433|NCT01711021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2590434|NCT01711060|Oxytocin|oxytocin|mesh-list
2590435|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
2590436|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2590437|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590438|NCT01711073|Plerixafor|plerixafor|mesh-list
2590439|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2590440|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2590441|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
2590442|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2590443|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
2590444|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2590445|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
2590446|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590447|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590448|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2590449|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
2590450|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2590451|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2590452|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2590453|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
2143966|NCT03519516|Renal Agents|renal agents|mesh-ancestor
2143967|NCT03519854|Bromides|bromides|mesh-list
2143968|NCT03519854|Rocuronium|rocuronium|mesh-list
2143969|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
2143970|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2143971|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2143972|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2143973|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143974|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143975|NCT03519867|Bromides|bromides|mesh-list
2143976|NCT03519867|Rocuronium|rocuronium|mesh-list
2143977|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
2143978|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2143979|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2143980|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2143981|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143982|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143983|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
2143984|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
2143985|NCT03520348|Vitamins|vitamins|mesh-ancestor
2143986|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
2143987|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590454|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2590455|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590456|NCT01711112|Docetaxel|docetaxel|mesh-list
2143988|NCT03520920|Rituximab|rituximab|mesh-list
2143989|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
2143990|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2143991|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2143992|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
2143993|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2143994|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2143995|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2143996|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2143997|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590457|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590458|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
2590459|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
2590460|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
2590461|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590462|NCT01711125|Baclofen|baclofen|mesh-list
2590463|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2590464|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590465|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2590466|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2143998|NCT03521141|Nicotine|nicotine|mesh-list
2143999|NCT03521141|Varenicline|varenicline|mesh-list
2144000|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2144001|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
2144002|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144003|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144004|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2144005|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2144006|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
2144007|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144008|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144009|NCT03521193|Aspirin|aspirin|mesh-list
2144010|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2144011|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2144012|NCT03521193|Analgesics|analgesics|mesh-ancestor
2144013|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
2144014|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144015|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590467|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2590468|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
2590469|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
2590470|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2590471|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144016|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2144017|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2144018|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2144019|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2144020|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590472|NCT01711229|Acetaminophen|acetaminophen|mesh-list
2590473|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2590474|NCT01711229|Analgesics|analgesics|mesh-ancestor
2590475|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
2590476|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590477|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590478|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
2590479|NCT01711242|Capecitabine|capecitabine|mesh-list
2590480|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
2590481|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2590482|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
2590483|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590484|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590485|NCT01711320|Omeprazole|omeprazole|mesh-list
2590486|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2590487|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2590488|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2590489|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590490|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590491|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
2590492|NCT01711437|Simethicone|simethicone|mesh-list
2590493|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
2590494|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
2590495|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2590496|NCT01711437|Citric Acid|citric acid|mesh-list
2590497|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
2590498|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2590499|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
2590500|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2590501|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
2590502|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
2590503|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590504|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
2590505|NCT01711437|Protective Agents|protective agents|mesh-ancestor
2590506|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590507|NCT01711437|Vitamins|vitamins|mesh-ancestor
2590508|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
2590509|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
2590510|NCT01711437|Emollients|emollients|mesh-ancestor
2590511|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
2590512|NCT01711437|Cathartics|cathartics|mesh-ancestor
2590513|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2590514|NCT01711437|Antacids|antacids|mesh-ancestor
2590515|NCT01711437|Laxatives|laxatives|mesh-ancestor
2144021|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2144022|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2144023|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144024|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
2144025|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
2144026|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2144027|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
2144028|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144029|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
2144030|NCT03521505|Propofol|propofol|mesh-list
2144031|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2144032|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144033|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590516|NCT01711463|Fluticasone|fluticasone|mesh-list
2590517|NCT01711463|Xhance|xhance|mesh-list
2590518|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2590519|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2590520|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
2590521|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590522|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590523|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2590524|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
2590525|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
2590526|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2590527|NCT01711476|Complement Factor H|complement factor h|mesh-list
2590528|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2590529|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2590530|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
2144034|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2144035|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
2144036|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
2144037|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2144038|NCT03521505|Analgesics|analgesics|mesh-ancestor
2144039|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
2144040|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144041|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2144042|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2144043|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2144044|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
2144045|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144046|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590531|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590532|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
2590533|NCT01711489|Isavuconazole|isavuconazole|mesh-list
2590534|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2590535|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590536|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2590537|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
2590538|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2590539|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2590540|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590541|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590542|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
2590543|NCT01711515|Cisplatin|cisplatin|mesh-list
2590544|NCT01711515|Ipilimumab|ipilimumab|mesh-list
2420510|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2420511|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420512|NCT00808223|Alefacept|alefacept|mesh-list
2420513|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
2420514|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
2420515|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420516|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
2420517|NCT00808275|Calcium|calcium|mesh-list
2420518|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2420519|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420520|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2420521|NCT00808288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2420522|NCT00808288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2420523|NCT00808288|Autonomic Agents|autonomic agents|mesh-ancestor
2590545|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590546|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2590547|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2590548|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590549|NCT01711528|Dexamethasone|dexamethasone|mesh-list
2590550|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
2590551|NCT01711528|Bortezomib|bortezomib|mesh-list
2590552|NCT01711528|Ichthammol|ichthammol|mesh-list
2590553|NCT01711528|BB 1101|bb 1101|mesh-list
2590554|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2590555|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
2590556|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
2590557|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590558|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590559|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2590560|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
2590561|NCT01711528|Hormones|hormones|mesh-ancestor
2590562|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2590563|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2590564|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590565|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
2590566|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590567|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590568|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
2590569|NCT01711554|Vitamin A|vitamin a|mesh-list
2590570|NCT01711554|Lenalidomide|lenalidomide|mesh-list
2590571|NCT01711554|Tretinoin|tretinoin|mesh-list
2590572|NCT01711554|Dinutuximab|dinutuximab|mesh-list
2590573|NCT01711554|Isotretinoin|isotretinoin|mesh-list
2590574|NCT01711554|Vitamins|vitamins|mesh-ancestor
2590575|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
2590576|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590577|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
2590578|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2590579|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2590580|NCT01711554|Growth Substances|growth substances|mesh-ancestor
2590581|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
2590582|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590583|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
2590584|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
2590585|NCT01711567|Tenofovir|tenofovir|mesh-list
2590586|NCT01711567|Entecavir|entecavir|mesh-list
2590587|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
2590588|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2590589|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2590590|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2590591|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590592|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590593|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2590594|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2590595|NCT01711632|Vemurafenib|vemurafenib|mesh-list
2590596|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590597|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2590598|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590599|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590600|NCT01711671|Dexamethasone|dexamethasone|mesh-list
2590601|NCT01711671|Lenalidomide|lenalidomide|mesh-list
2590602|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2590603|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
2590604|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
2590605|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590606|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590607|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2590608|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
2590609|NCT01711671|Hormones|hormones|mesh-ancestor
2590610|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2590611|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2590612|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590613|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
2590614|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2590615|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2590616|NCT01711671|Growth Substances|growth substances|mesh-ancestor
2590617|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
2590618|NCT01711697|Paclitaxel|paclitaxel|mesh-list
2590619|NCT01711697|Carboplatin|carboplatin|mesh-list
2590620|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2590621|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590622|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
2590623|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
2590624|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
2590625|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144047|NCT03521635|Pramipexole|pramipexole|mesh-list
2590626|NCT01711723|Darapladib|darapladib|mesh-list
2590627|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2590628|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590629|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590630|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2590631|NCT01711749|Calcium|calcium|mesh-list
2144048|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
2144049|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144050|NCT03521635|Protective Agents|protective agents|mesh-ancestor
2590632|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2590633|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590634|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2144051|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144052|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2144053|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2590635|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2590636|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
2590637|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590638|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2590639|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2144054|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
2144055|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
2144056|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144057|NCT03521791|Bromfenac|bromfenac|mesh-list
2144058|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2144059|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2144060|NCT03521791|Analgesics|analgesics|mesh-ancestor
2144061|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
2144062|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590640|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590641|NCT01711814|Peficitinib|peficitinib|mesh-list
2590642|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590643|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590644|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2590645|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
2590646|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590647|NCT01711827|Isavuconazole|isavuconazole|mesh-list
2590648|NCT01711827|Prednisone|prednisone|mesh-list
2590649|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2590650|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
2590651|NCT01711827|Hormones|hormones|mesh-ancestor
2590652|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2590653|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590654|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2590655|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590656|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
2144063|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144064|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2144065|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2144066|NCT03521817|Ethanol|ethanol|mesh-list
2144067|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2144068|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2144069|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144070|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144071|NCT03522441|Clindamycin|clindamycin|mesh-list
2144072|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
2590657|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2590658|NCT01711905|Vitamin D|vitamin d|mesh-list
2590659|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
2590660|NCT01711905|Vitamins|vitamins|mesh-ancestor
2590661|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
2590662|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590663|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2590664|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2590665|NCT01711931|Everolimus|everolimus|mesh-list
2590666|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590667|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2590668|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
2590669|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590670|NCT01711957|Liver Extracts|liver extracts|mesh-list
2590671|NCT01711957|Hematinics|hematinics|mesh-ancestor
2590672|NCT01711970|Paclitaxel|paclitaxel|mesh-list
2590673|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2590674|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590675|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
2590676|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
2590677|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
2590678|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590679|NCT01712100|Irbesartan|irbesartan|mesh-list
2590680|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2590681|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2590682|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2144073|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
2144074|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2144075|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2144076|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2144077|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144078|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144079|NCT03522506|Modafinil|modafinil|mesh-list
2144080|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2590683|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590684|NCT01712113|Irbesartan|irbesartan|mesh-list
2590685|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2590686|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2590687|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2590688|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590689|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2590690|NCT01712126|Irbesartan|irbesartan|mesh-list
2590691|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2590692|NCT01712126|Diuretics|diuretics|mesh-ancestor
2590693|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
2590694|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590695|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2590696|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2590697|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590698|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2590699|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2590700|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2590701|NCT01712139|Irbesartan|irbesartan|mesh-list
2590702|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2590703|NCT01712139|Diuretics|diuretics|mesh-ancestor
2590704|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
2590705|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590706|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2590707|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2590708|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590709|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2590710|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2590711|NCT01712217|Crizotinib|crizotinib|mesh-list
2590712|NCT01712217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590713|NCT01712217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2590714|NCT01712217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590715|NCT01712217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420524|NCT00808288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420525|NCT00808288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420526|NCT00808288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2420527|NCT00808288|Respiratory System Agents|respiratory system agents|mesh-ancestor
2420528|NCT00808288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2144081|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144082|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2144083|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2144084|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2144085|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144086|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2144087|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
2420529|NCT00808288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2420530|NCT00808288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2420531|NCT00808288|Adrenergic Agents|adrenergic agents|mesh-ancestor
2420532|NCT00808288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420533|NCT00808288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420534|NCT00808314|Dipyridamole|dipyridamole|mesh-list
2420535|NCT00808314|Regadenoson|regadenoson|mesh-list
2420536|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2420537|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420538|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590716|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
2590717|NCT01712295|Salicylates|salicylates|mesh-list
2590718|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2590719|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2590720|NCT01712295|Analgesics|analgesics|mesh-ancestor
2590721|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
2590722|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590723|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590724|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2590725|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2590726|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2590727|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590728|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590729|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2590730|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
2590731|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
2590732|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
2590733|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2590734|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
2590735|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2590736|NCT01712321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2590737|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2590738|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2590739|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590740|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144088|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2144089|NCT03523988|Acetaminophen|acetaminophen|mesh-list
2144090|NCT03523988|Ibuprofen|ibuprofen|mesh-list
2144091|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2144092|NCT03523988|Analgesics|analgesics|mesh-ancestor
2144093|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
2144094|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144095|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144096|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
2144097|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2144098|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2144099|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2144100|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2144101|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144102|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144103|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2144104|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2144105|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
2144106|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2144107|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
2590741|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
2590742|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590743|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2590744|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2590745|NCT01712347|Bevacizumab|bevacizumab|mesh-list
2590746|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2590747|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590748|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2590749|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2590750|NCT01712347|Growth Substances|growth substances|mesh-ancestor
2590751|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590752|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
2590753|NCT01712451|Fluticasone|fluticasone|mesh-list
2590754|NCT01712451|Xhance|xhance|mesh-list
2420539|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2420540|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
2420541|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2420542|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2420543|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
2420544|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
2420545|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420546|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420547|NCT00808327|Fentanyl|fentanyl|mesh-list
2420548|NCT00808327|Bupivacaine|bupivacaine|mesh-list
2590755|NCT01712451|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2590756|NCT01712451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2590757|NCT01712451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2590758|NCT01712451|Autonomic Agents|autonomic agents|mesh-ancestor
2590759|NCT01712451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420549|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
2590760|NCT01712451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590761|NCT01712451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2590762|NCT01712451|Respiratory System Agents|respiratory system agents|mesh-ancestor
2590763|NCT01712451|Dermatologic Agents|dermatologic agents|mesh-ancestor
2590764|NCT01712451|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2590765|NCT01712451|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2590766|NCT01712451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2590767|NCT01712451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2590768|NCT01712451|Adrenergic Agents|adrenergic agents|mesh-ancestor
2590769|NCT01712451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2590770|NCT01712451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590771|NCT01712464|Oxytocin|oxytocin|mesh-list
2590772|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
2590773|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2590774|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590775|NCT01712477|Midazolam|midazolam|mesh-list
2590776|NCT01712477|Propofol|propofol|mesh-list
2590777|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2590778|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144108|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144109|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
2144110|NCT03524157|Protective Agents|protective agents|mesh-ancestor
2144111|NCT03524339|Tamsulosin|tamsulosin|mesh-list
2144112|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2144113|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2144114|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2144115|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
2144116|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144117|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590779|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590780|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2590781|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
2590782|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
2590783|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2590784|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2590785|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2590786|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2590787|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
2590788|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
2590789|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2590790|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590791|NCT01712568|Ropinirole|ropinirole|mesh-list
2590792|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2590793|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2590794|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
2590795|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
2590796|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2590797|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590798|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590807|NCT01712646|Oxytocin|oxytocin|mesh-list
2590808|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
2590809|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2590810|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590811|NCT01712763|Goserelin|goserelin|mesh-list
2590812|NCT01712763|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2590813|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2590814|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590815|NCT01712763|Luteolytic Agents|luteolytic agents|mesh-ancestor
2590816|NCT01712763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2590817|NCT01712763|Contraceptive Agents|contraceptive agents|mesh-ancestor
2590818|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2590819|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590820|NCT01712763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2144118|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144119|NCT03524339|Urological Agents|urological agents|mesh-ancestor
2144120|NCT03525119|Vaccines|vaccines|mesh-list
2144121|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
2144122|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144123|NCT03525444|Ivacaftor|ivacaftor|mesh-list
2144124|NCT03525444|Elexacaftor|elexacaftor|mesh-list
2144125|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2144126|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2144127|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144128|NCT03525548|Ivacaftor|ivacaftor|mesh-list
2144129|NCT03525548|Elexacaftor|elexacaftor|mesh-list
2590839|NCT01712815|Clevudine|clevudine|mesh-list
2590840|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
2590841|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2590842|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
2590843|NCT01712828|Promethazine|promethazine|mesh-list
2590844|NCT01712828|Sirolimus|sirolimus|mesh-list
2590845|NCT01712828|Quinidine|quinidine|mesh-list
2590846|NCT01712828|Lenalidomide|lenalidomide|mesh-list
2590847|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
2590848|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590849|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2590850|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2590851|NCT01712828|Growth Substances|growth substances|mesh-ancestor
2590852|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
2590853|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590854|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2590855|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2590856|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2590857|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
2590858|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2590859|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2590860|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2590861|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2590862|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
2590863|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
2590864|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
2590865|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590866|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
2590867|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
2590868|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2590869|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2590870|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
2590871|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
2590872|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2590873|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590874|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2590875|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
2590876|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
2590877|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2590878|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2590879|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
2590880|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2590881|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
2590882|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2590883|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2144130|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2144131|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2144132|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144133|NCT03525834|Everolimus|everolimus|mesh-list
2144134|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144135|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2590884|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144136|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
2144137|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144138|NCT03527173|Vaccines|vaccines|mesh-list
2144139|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
2144140|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144141|NCT03527745|Albendazole|albendazole|mesh-list
2144142|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
2590885|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2590886|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2590887|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
2144143|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2144144|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2144145|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
2144146|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2590888|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2590889|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2590890|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2590891|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2590892|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2590893|NCT01712893|Goserelin|goserelin|mesh-list
2590894|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2590895|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590896|NCT01712919|Paclitaxel|paclitaxel|mesh-list
2590897|NCT01712919|Cetuximab|cetuximab|mesh-list
2590898|NCT01712919|Nedaplatin|nedaplatin|mesh-list
2590899|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2590900|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590901|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
2590902|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
2590903|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
2590904|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590905|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2590906|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
2590907|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2590908|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590909|NCT01712997|Bosentan|bosentan|mesh-list
2590910|NCT01712997|Iloprost|iloprost|mesh-list
2590911|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2590912|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2590913|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590914|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2590915|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
2590916|NCT01713049|Alovudine|alovudine|mesh-list
2590917|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
2590918|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2590919|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
2590920|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
2590921|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
2144147|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2144148|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
2144149|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
2144150|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
2144151|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144152|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590922|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2590923|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590924|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
2590925|NCT01713101|Coagulants|coagulants|mesh-ancestor
2590926|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
2590927|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2590928|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2590929|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590930|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2590931|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2590932|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2590933|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590934|NCT01713127|Remifentanil|remifentanil|mesh-list
2590935|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2590936|NCT01713127|Narcotics|narcotics|mesh-ancestor
2590937|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2590938|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590939|NCT01713127|Analgesics|analgesics|mesh-ancestor
2590940|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
2590941|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590942|NCT01713153|Misoprostol|misoprostol|mesh-list
2590943|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2590944|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
2590945|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2590946|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590947|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2590948|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2590949|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
2590950|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
2590951|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2590952|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2590953|NCT01713179|Ambroxol|ambroxol|mesh-list
2590954|NCT01713179|Expectorants|expectorants|mesh-ancestor
2590955|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
2590956|NCT01713218|Gemcitabine|gemcitabine|mesh-list
2590957|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2590958|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
2590959|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590960|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590961|NCT01713218|Antiviral Agents|antiviral agents|mesh-ancestor
2590962|NCT01713218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2590963|NCT01713218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590964|NCT01713218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2144153|NCT03528174|Pancrelipase|pancrelipase|mesh-list
2144154|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2144155|NCT03528369|Capsaicin|capsaicin|mesh-list
2144156|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
2144157|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
2144158|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
2144159|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590965|NCT01713218|Immunologic Factors|immunologic factors|mesh-ancestor
2590966|NCT01713218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590967|NCT01713231|Vitamin D|vitamin d|mesh-list
2590968|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
2590969|NCT01713231|Vitamins|vitamins|mesh-list
2590970|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
2590971|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590972|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2590973|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2590974|NCT01713309|Lenograstim|lenograstim|mesh-list
2590975|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2590976|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
2590977|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590978|NCT01713361|Enoxaparin|enoxaparin|mesh-list
2590979|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
2590980|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2590981|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2590982|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590983|NCT01713387|Gemcitabine|gemcitabine|mesh-list
2590984|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2590985|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
2590986|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2590987|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2590988|NCT01713387|Antiviral Agents|antiviral agents|mesh-ancestor
2590989|NCT01713387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2590990|NCT01713387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2590991|NCT01713387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2590992|NCT01713387|Immunologic Factors|immunologic factors|mesh-ancestor
2590993|NCT01713387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2590994|NCT01713426|Pregabalin|pregabalin|mesh-list
2590995|NCT01713426|Capsaicin|capsaicin|mesh-list
2590996|NCT01713426|Analgesics|analgesics|mesh-ancestor
2590997|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
2590998|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2590999|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591000|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
2591001|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2591002|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2591003|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591004|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2591005|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2591006|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2144160|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144161|NCT03528512|Fentanyl|fentanyl|mesh-list
2144162|NCT03528512|Midazolam|midazolam|mesh-list
2144163|NCT03528512|Ketamine|ketamine|mesh-list
2144164|NCT03528512|Analgesics|analgesics|mesh-ancestor
2144165|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
2144166|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591007|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2591008|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2591009|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
2591010|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
2591011|NCT01713556|Propranolol|propranolol|mesh-list
2591012|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2591013|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2420550|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
2420551|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2420552|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420553|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
2420554|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420555|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2420556|NCT00808327|Narcotics|narcotics|mesh-ancestor
2420557|NCT00808327|Analgesics|analgesics|mesh-ancestor
2420558|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2420559|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2420560|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
2420561|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
2144167|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144168|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2144169|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2144170|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
2144171|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
2144172|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144173|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2144174|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2144175|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144176|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144177|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2144178|NCT03528512|Narcotics|narcotics|mesh-ancestor
2144179|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2144180|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2591014|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
2591015|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2591016|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591017|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591018|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2591019|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2591020|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
2591021|NCT01713647|Losartan|losartan|mesh-list
2591022|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2591023|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2591024|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2591025|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2591026|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591027|NCT01713725|Omalizumab|omalizumab|mesh-list
2591028|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2591029|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2591030|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
2591031|NCT01713738|Rituximab|rituximab|mesh-list
2591032|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2591033|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591034|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
2591035|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591036|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2591037|NCT01713777|Lamotrigine|lamotrigine|mesh-list
2591038|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
2591039|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2591040|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2591041|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591042|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2591043|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591044|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2591045|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2591046|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2591047|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2591048|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2591049|NCT01713803|Buprenorphine|buprenorphine|mesh-list
2591050|NCT01713803|Naloxone|naloxone|mesh-list
2591051|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2591052|NCT01713803|Narcotics|narcotics|mesh-ancestor
2591053|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144181|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2144182|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2591054|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591055|NCT01713803|Analgesics|analgesics|mesh-ancestor
2591056|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
2591057|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591058|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2591059|NCT01713920|Amlodipine|amlodipine|mesh-list
2591060|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2591061|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2591062|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2591063|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591064|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2591065|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591066|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
2591067|NCT01713972|Dabrafenib|dabrafenib|mesh-list
2591068|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591069|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2591070|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144183|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2144184|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
2144185|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
2144186|NCT03528551|Factor VIII|factor viii|mesh-list
2144187|NCT03528551|Coagulants|coagulants|mesh-ancestor
2144188|NCT03528577|Albuterol|albuterol|mesh-list
2144189|NCT03528577|Procaterol|procaterol|mesh-list
2144190|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2144191|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
2144192|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144193|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144194|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2144195|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
2144196|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
2144197|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2144198|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2144199|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2144200|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2591071|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591072|NCT01714011|Aripiprazole|aripiprazole|mesh-list
2591073|NCT01714011|Ziprasidone|ziprasidone|mesh-list
2591074|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
2591075|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2591076|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2591077|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2591078|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2591079|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591080|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
2591081|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
2591082|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2591083|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591084|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2591085|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2591086|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
2591087|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2591088|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2591089|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2591090|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2591091|NCT01714037|Gemcitabine|gemcitabine|mesh-list
2591092|NCT01714037|Docetaxel|docetaxel|mesh-list
2591093|NCT01714037|Pemetrexed|pemetrexed|mesh-list
2591094|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591095|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2591096|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
2591097|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591098|NCT01714037|Antiviral Agents|antiviral agents|mesh-ancestor
2591099|NCT01714037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591100|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591101|NCT01714037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2591102|NCT01714037|Immunologic Factors|immunologic factors|mesh-ancestor
2591103|NCT01714037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591104|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
2144201|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
2144202|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144203|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144204|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
2591105|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
2591106|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
2591107|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2591108|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2591109|NCT01714089|Interferons|interferons|mesh-list
2591110|NCT01714089|Interferon-beta|interferon-beta|mesh-list
2591111|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
2591112|NCT01714089|RNS60|rns60|mesh-list
2591113|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591114|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
2591115|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591116|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
2591117|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591118|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2591119|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2591120|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2591121|NCT01714089|Analgesics|analgesics|mesh-ancestor
2591122|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
2591123|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591124|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2591125|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2591126|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2591127|NCT01714102|Resveratrol|resveratrol|mesh-list
2144213|NCT03530631|Adderall|adderall|mesh-list
2144214|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2144215|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144216|NCT03530995|Itraconazole|itraconazole|mesh-list
2144217|NCT03530995|Rifampin|rifampin|mesh-list
2144218|NCT03530995|Omeprazole|omeprazole|mesh-list
2144219|NCT03530995|Rabeprazole|rabeprazole|mesh-list
2591128|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
2591129|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591130|NCT01714102|Protective Agents|protective agents|mesh-ancestor
2591131|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591132|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591133|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2591134|NCT01714115|Aflibercept|aflibercept|mesh-list
2591135|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2591136|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2591137|NCT01714115|Growth Substances|growth substances|mesh-ancestor
2144220|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2144221|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2144222|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2144223|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144224|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144225|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
2144226|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2144227|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2144228|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2144229|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2144230|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
2144231|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2591138|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591139|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
2591140|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591141|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2591142|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2591143|NCT01714128|Estradiol|estradiol|mesh-list
2591144|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2591145|NCT01714128|Estrogens|estrogens|mesh-ancestor
2591146|NCT01714128|Hormones|hormones|mesh-ancestor
2591147|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2591148|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591149|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2591150|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
2591151|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2591152|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2591153|NCT01714154|Ritonavir|ritonavir|mesh-list
2591154|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2591155|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2591156|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
2591157|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591158|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591159|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2591160|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2591161|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
2591162|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591163|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2591164|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2591165|NCT01714193|Canagliflozin|canagliflozin|mesh-list
2591166|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
2591167|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
2591168|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2591169|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591170|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2591171|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591172|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2591173|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2591174|NCT01714206|Canagliflozin|canagliflozin|mesh-list
2591175|NCT01714206|Digoxin|digoxin|mesh-list
2591176|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2591177|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2591178|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591179|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591180|NCT01714206|Protective Agents|protective agents|mesh-ancestor
2591181|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591182|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2591183|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2591184|NCT01714297|Dalteparin|dalteparin|mesh-list
2591185|NCT01714297|Tinzaparin|tinzaparin|mesh-list
2591186|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2591187|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
2591188|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2591189|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2591190|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591191|NCT01714388|Remifentanil|remifentanil|mesh-list
2591192|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2591193|NCT01714388|Narcotics|narcotics|mesh-ancestor
2591194|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2591195|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591196|NCT01714388|Analgesics|analgesics|mesh-ancestor
2591197|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
2591198|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591199|NCT01714401|Albuterol|albuterol|mesh-list
2591200|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2591201|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
2591202|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591203|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591204|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2144232|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144233|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2144234|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2144235|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
2144236|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2144237|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
2144238|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2144239|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2144240|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2144241|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2144242|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2420562|NCT00808366|Clotrimazole|clotrimazole|mesh-list
2420563|NCT00808366|Miconazole|miconazole|mesh-list
2420564|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
2420565|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420566|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2420567|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2420568|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2420569|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420570|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420571|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2420572|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
2420573|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2591205|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
2591206|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
2591207|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2591208|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2591209|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2591210|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2591211|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
2591212|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2591213|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144243|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2144244|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2144245|NCT03531840|Olaparib|olaparib|mesh-list
2144246|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2144247|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144248|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144249|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144250|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2144251|NCT03531905|Ezetimibe|ezetimibe|mesh-list
2144252|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2144253|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2144254|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
2144255|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144256|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2144257|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144258|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2144259|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144265|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
2144266|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2144267|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144268|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
2144269|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
2144270|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
2144271|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
2144272|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
2591214|NCT01714414|Lamivudine|lamivudine|mesh-list
2591215|NCT01714414|Zidovudine|zidovudine|mesh-list
2591216|NCT01714414|Efavirenz|efavirenz|mesh-list
2591217|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2591218|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2591219|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591220|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591221|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
2591222|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591223|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2591224|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2591225|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
2591226|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2144273|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144274|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2144275|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2144276|NCT03535194|Mirikizumab|mirikizumab|mesh-list
2144277|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2144278|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2144279|NCT03535194|Analgesics|analgesics|mesh-ancestor
2144280|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
2144281|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144282|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144283|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2144284|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2144285|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2144286|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2144287|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2144288|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2144289|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2144290|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
2144291|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144292|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2144293|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
2591227|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2591228|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2591229|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2591230|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2591231|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2591232|NCT01714427|Dexamethasone|dexamethasone|mesh-list
2591233|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2591234|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
2591235|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
2591236|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591237|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591238|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2591239|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
2591240|NCT01714427|Hormones|hormones|mesh-ancestor
2591241|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2591242|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2144294|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144295|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144296|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2144297|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2144298|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2144299|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
2144300|NCT03537274|Interferons|interferons|mesh-list
2144301|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
2144302|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
2144303|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2144304|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144305|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
2144306|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2144307|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
2144308|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144309|NCT03537404|Ritonavir|ritonavir|mesh-list
2144310|NCT03537404|Tenofovir|tenofovir|mesh-list
2144311|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
2144312|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2144313|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2144314|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
2591243|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591244|NCT01714557|Tazobactam|tazobactam|mesh-list
2591245|NCT01714557|Piperacillin|piperacillin|mesh-list
2591246|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2591247|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2591248|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591249|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2591250|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591251|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591252|NCT01714570|Tazobactam|tazobactam|mesh-list
2591253|NCT01714570|Piperacillin|piperacillin|mesh-list
2591254|NCT01714570|Imipenem|imipenem|mesh-list
2591255|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2591256|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2591257|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591258|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2591259|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591260|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591261|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2591262|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591263|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2591264|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
2591265|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2591266|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
2591267|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2591268|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591269|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2591270|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2591271|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591272|NCT01714739|Nivolumab|nivolumab|mesh-list
2591273|NCT01714739|Ipilimumab|ipilimumab|mesh-list
2591274|NCT01714739|Immunoglobulins|immunoglobulins|mesh-list
2591275|NCT01714739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2591276|NCT01714739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591277|NCT01714739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2591278|NCT01714739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144315|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591279|NCT01714739|Immunologic Factors|immunologic factors|mesh-ancestor
2591280|NCT01714739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591281|NCT01714765|Everolimus|everolimus|mesh-list
2591282|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591283|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2591284|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
2591285|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591286|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
2591287|NCT01714817|Prednisone|prednisone|mesh-list
2591288|NCT01714817|Abatacept|abatacept|mesh-list
2591289|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2591290|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
2591291|NCT01714817|Hormones|hormones|mesh-ancestor
2591292|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2591293|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591294|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2591295|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591296|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2591297|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2591298|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
2591299|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2591300|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591301|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591302|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591303|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2591304|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2591305|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
2591306|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2591307|NCT01714843|Linaclotide|linaclotide|mesh-list
2591308|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2144316|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144317|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2144318|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2144319|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
2144320|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2144321|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2144322|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2144323|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2591309|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
2591310|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591311|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2591312|NCT01714856|Ropinirole|ropinirole|mesh-list
2591313|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2591314|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2591315|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
2591316|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
2591317|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2591318|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591319|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591320|NCT01714895|Insulin|insulin|mesh-list
2591321|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2591322|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2591323|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591324|NCT01714908|Etoposide|etoposide|mesh-list
2591325|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2591326|NCT01714908|Cisplatin|cisplatin|mesh-list
2591327|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2591328|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591329|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2591330|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2591331|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591332|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591333|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2591334|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2591335|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2591336|NCT01715077|Ipilimumab|ipilimumab|mesh-list
2591337|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2591338|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591339|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2591340|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591341|NCT01715090|Insulin|insulin|mesh-list
2591342|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2591343|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591344|NCT01715142|Gemcitabine|gemcitabine|mesh-list
2591345|NCT01715142|Paclitaxel|paclitaxel|mesh-list
2591346|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2591347|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2591348|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591349|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
2591350|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
2591351|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
2591352|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591353|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2591354|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
2591355|NCT01715142|Antiviral Agents|antiviral agents|mesh-ancestor
2591356|NCT01715142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591357|NCT01715142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591358|NCT01715142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2591359|NCT01715142|Immunologic Factors|immunologic factors|mesh-ancestor
2591360|NCT01715142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591361|NCT01715168|Doxorubicin|doxorubicin|mesh-list
2591362|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2591363|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2591364|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144324|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2144325|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2144326|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2144327|NCT03537651|Ivacaftor|ivacaftor|mesh-list
2144328|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2591365|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2591366|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2591367|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591368|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591369|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
2591370|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
2591371|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
2591372|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591373|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2591374|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591375|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591376|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
2144329|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2144330|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144331|NCT03538431|Buspirone|buspirone|mesh-list
2144332|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2144333|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2144334|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144335|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144336|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2144337|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2144338|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
2144339|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144340|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144341|NCT03538808|Varenicline|varenicline|mesh-list
2144342|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2144343|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2144344|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
2144345|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144346|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144347|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144348|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
2144349|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2144350|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
2144351|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144352|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2144353|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2144354|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2144355|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144356|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
2144357|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2591377|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2591378|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591379|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2591380|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
2591381|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2591382|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
2591383|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144358|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144359|NCT03540030|Acetaminophen|acetaminophen|mesh-list
2144360|NCT03540030|Celecoxib|celecoxib|mesh-list
2144361|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2144362|NCT03540030|Lidocaine|lidocaine|mesh-list
2144363|NCT03540030|Gabapentin|gabapentin|mesh-list
2591384|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591385|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2591386|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
2591387|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
2591388|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2591389|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
2591390|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2591391|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591392|NCT01715363|Leucovorin|leucovorin|mesh-list
2591393|NCT01715363|Folic Acid|folic acid|mesh-list
2591394|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
2591395|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
2591396|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591397|NCT01715363|Antidotes|antidotes|mesh-ancestor
2591398|NCT01715363|Protective Agents|protective agents|mesh-ancestor
2591399|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591400|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
2591401|NCT01715363|Vitamins|vitamins|mesh-ancestor
2591402|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
2591403|NCT01715363|Hematinics|hematinics|mesh-ancestor
2591404|NCT01715441|Irinotecan|irinotecan|mesh-list
2591405|NCT01715441|Sorafenib|sorafenib|mesh-list
2591406|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2591407|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2591408|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591409|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591410|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591411|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2591412|NCT01715493|Muramidase|muramidase|mesh-list
2591413|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591414|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2591415|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
2591416|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2591417|NCT01715519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2144364|NCT03540030|Propofol|propofol|mesh-list
2144365|NCT03540030|Sevoflurane|sevoflurane|mesh-list
2144366|NCT03540030|Desflurane|desflurane|mesh-list
2144367|NCT03540030|Rocuronium|rocuronium|mesh-list
2144368|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
2144369|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
2144370|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
2144371|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144372|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144373|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
2144374|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144375|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2144376|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2144377|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2144378|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2144379|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144380|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2144381|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2144382|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
2591418|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2591419|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2591420|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591421|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2591422|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
2591423|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591424|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2591425|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2591426|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
2144383|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2144384|NCT03540030|Analgesics|analgesics|mesh-ancestor
2144385|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
2144386|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2144387|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2144388|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2144389|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2591427|NCT01715584|Sevoflurane|sevoflurane|mesh-list
2591428|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2591429|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2591430|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
2144390|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2144391|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2144392|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2144393|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144394|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
2144395|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2144396|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2144397|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2144398|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2144399|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2144400|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144401|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
2144402|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2144403|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2144404|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2591431|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
2591432|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2591433|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591434|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2591435|NCT01715584|Analgesics|analgesics|mesh-ancestor
2591436|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
2591437|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591438|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
2591439|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
2591440|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591441|NCT01715597|Protective Agents|protective agents|mesh-ancestor
2591442|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591443|NCT01715597|Vitamins|vitamins|mesh-ancestor
2591444|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
2591445|NCT01715610|Clindamycin|clindamycin|mesh-list
2591446|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
2591447|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
2591448|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2591449|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2591450|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591451|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2591452|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591453|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591454|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2591455|NCT01715636|Tenofovir|tenofovir|mesh-list
2591456|NCT01715636|Emtricitabine|emtricitabine|mesh-list
2591457|NCT01715636|Rilpivirine|rilpivirine|mesh-list
2591458|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
2591459|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591460|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2591461|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2591462|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591463|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591464|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2591465|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2591466|NCT01715688|Lidocaine|lidocaine|mesh-list
2591467|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
2591468|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
2591469|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2591470|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591471|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
2591472|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591473|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2591474|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2591475|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2144405|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2144406|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2144407|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
2144408|NCT03540160|Serlopitant|serlopitant|mesh-list
2144409|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2144410|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144411|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144412|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144413|NCT03541044|Nicotine|nicotine|mesh-list
2144414|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2144415|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
2144416|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144417|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144418|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2144419|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2144420|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
2591476|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2591477|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591478|NCT01715701|Iodine|iodine|mesh-list
2591479|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2591480|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591481|NCT01715701|Trace Elements|trace elements|mesh-ancestor
2591482|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
2591483|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591484|NCT01715714|Atorvastatin|atorvastatin|mesh-list
2591485|NCT01715714|Simvastatin|simvastatin|mesh-list
2591486|NCT01715714|Pravastatin|pravastatin|mesh-list
2591487|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2591488|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2591489|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
2591490|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591491|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2591492|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2591493|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591494|NCT01715909|Oseltamivir|oseltamivir|mesh-list
2591495|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
2591496|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591497|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591498|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591499|NCT01715922|Fluconazole|fluconazole|mesh-list
2591500|NCT01715922|Flucytosine|flucytosine|mesh-list
2591501|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
2591502|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591503|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2591504|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2591505|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591506|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591507|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2591508|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
2591509|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2591510|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591511|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2591512|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2591513|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
2591514|NCT01715935|Everolimus|everolimus|mesh-list
2591515|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591516|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2591517|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
2591518|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591519|NCT01715974|Lenograstim|lenograstim|mesh-list
2591520|NCT01715974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2591521|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
2591522|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591523|NCT01715987|Tenofovir|tenofovir|mesh-list
2591524|NCT01715987|Entecavir|entecavir|mesh-list
2591525|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
2591526|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591527|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2591528|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2591529|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591530|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591531|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2591532|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2591533|NCT01716260|Chloroquine|chloroquine|mesh-list
2591534|NCT01716260|Primaquine|primaquine|mesh-list
2591535|NCT01716260|Amebicides|amebicides|mesh-ancestor
2591536|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2591537|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2591538|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591539|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
2591540|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2591541|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2591542|NCT01716273|Laxatives|laxatives|mesh-ancestor
2591543|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2591544|NCT01716312|Omalizumab|omalizumab|mesh-list
2591545|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2591546|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2591547|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
2144421|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2591548|NCT01716338|Glyburide|glyburide|mesh-list
2144422|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144423|NCT03541356|Carbidopa|carbidopa|mesh-list
2144424|NCT03541356|Levodopa|levodopa|mesh-list
2144425|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
2144426|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2144427|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2144428|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
2144429|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144430|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144431|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144432|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2144433|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144434|NCT03541941|Bupivacaine|bupivacaine|mesh-list
2144435|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
2144436|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
2144437|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144438|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144439|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
2144440|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144441|NCT03541980|Acetaminophen|acetaminophen|mesh-list
2144442|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2591549|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2591550|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591551|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2144443|NCT03541980|Analgesics|analgesics|mesh-ancestor
2144444|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
2144445|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144446|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144447|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
2144448|NCT03542266|Azacitidine|azacitidine|mesh-list
2591552|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2591553|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2591554|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2591555|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591556|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2591557|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591558|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2591559|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
2591560|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2591561|NCT01716416|Cetuximab|cetuximab|mesh-list
2591562|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2591563|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591564|NCT01716442|Rituximab|rituximab|mesh-list
2591565|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2591566|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591567|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
2144449|NCT03542266|Cc-486|cc-486|mesh-list
2144450|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2144451|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
2144452|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144453|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144454|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144455|NCT03543137|Nicotine|nicotine|mesh-list
2144456|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2144457|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
2144458|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144459|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144460|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2144461|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2591568|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591569|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2591570|NCT01716572|Erythromycin|erythromycin|mesh-list
2591571|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
2591572|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2591573|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
2591574|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2591575|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2144462|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
2144463|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144464|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591576|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2591577|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2591578|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144465|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2144466|NCT03545165|177Lu-PSMA-617|177lu-psma-617|mesh-list
2144467|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2144468|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144469|NCT03545503|Ketamine|ketamine|mesh-list
2144470|NCT03545503|Etomidate|etomidate|mesh-list
2144471|NCT03545503|Analgesics|analgesics|mesh-ancestor
2144472|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
2591579|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591580|NCT01716611|Tolvaptan|tolvaptan|mesh-list
2591581|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2591582|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591583|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
2591584|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591585|NCT01716624|Oxybutynin|oxybutynin|mesh-list
2591586|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
2591587|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2591588|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2591589|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2591590|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2591591|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591592|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
2591593|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2591594|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591595|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2591596|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591597|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
2591598|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
2591599|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2591600|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2591601|NCT01716624|Urological Agents|urological agents|mesh-ancestor
2591602|NCT01716637|Etanercept|etanercept|mesh-list
2591603|NCT01716637|Curcumin|curcumin|mesh-list
2591604|NCT01716637|Resveratrol|resveratrol|mesh-list
2591605|NCT01716637|Quercetin|quercetin|mesh-list
2591606|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2591607|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2591608|NCT01716637|Analgesics|analgesics|mesh-ancestor
2591609|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
2591610|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591611|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144473|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144474|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144475|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2144476|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2144477|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
2144478|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
2144479|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144480|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2144481|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2144482|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144483|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144484|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2144485|NCT03545893|Ibuprofen|ibuprofen|mesh-list
2144486|NCT03545893|Oxycodone|oxycodone|mesh-list
2144487|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2144488|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2144489|NCT03545893|Analgesics|analgesics|mesh-ancestor
2144490|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
2144491|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144492|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591612|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2591613|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2591614|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2591615|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2591616|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
2591617|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144493|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2144494|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2144495|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2144496|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144497|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144498|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2144499|NCT03545893|Narcotics|narcotics|mesh-ancestor
2591618|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144500|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144501|NCT03546192|Vaccines|vaccines|mesh-list
2144502|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
2144503|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144504|NCT03546621|Tenofovir|tenofovir|mesh-list
2144505|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
2144506|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2144507|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2144508|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2591619|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591620|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
2591621|NCT01716637|Protective Agents|protective agents|mesh-ancestor
2591622|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2591623|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
2591624|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2591625|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
2591626|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591627|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2591628|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2591629|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
2591630|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591631|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591632|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2591633|NCT01716767|Analgesics|analgesics|mesh-list
2591634|NCT01716767|Menthol|menthol|mesh-list
2591635|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
2591636|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591637|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591638|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
2591639|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
2591640|NCT01716806|Nivolumab|nivolumab|mesh-list
2591641|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2591642|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2591643|NCT01716806|Dacarbazine|dacarbazine|mesh-list
2591644|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2591645|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591646|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2591647|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591648|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2591649|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
2591650|NCT01716858|Sulforaphane|sulforaphane|mesh-list
2591651|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2591652|NCT01716858|Protective Agents|protective agents|mesh-ancestor
2591653|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591654|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591655|NCT01716949|Fluorouracil|fluorouracil|mesh-list
2591656|NCT01716949|Capecitabine|capecitabine|mesh-list
2591657|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
2591658|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
2591659|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591660|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2591661|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591662|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2591663|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
2591664|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591665|NCT01717027|Oxycodone|oxycodone|mesh-list
2591666|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2591667|NCT01717027|Narcotics|narcotics|mesh-ancestor
2591668|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2591669|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591670|NCT01717027|Analgesics|analgesics|mesh-ancestor
2591671|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
2591672|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591673|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
2591674|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2591675|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591676|NCT01717118|Vaccines|vaccines|mesh-list
2591677|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
2591678|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591679|NCT01717157|Fentanyl|fentanyl|mesh-list
2591680|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2591681|NCT01717157|Narcotics|narcotics|mesh-ancestor
2591682|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2591683|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144509|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591684|NCT01717157|Analgesics|analgesics|mesh-ancestor
2144510|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144511|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2144512|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2144513|NCT03546816|Serlopitant|serlopitant|mesh-list
2144514|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2144515|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144516|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144517|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144518|NCT03547154|Interferons|interferons|mesh-list
2144519|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
2144520|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
2144521|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2144522|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144523|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
2144524|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2144525|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
2144526|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144527|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2144528|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
2144529|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144530|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2144531|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2144532|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144533|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2144534|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
2144535|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144536|NCT03551730|Enoxaparin|enoxaparin|mesh-list
2144537|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
2144538|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
2144539|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2144540|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2144541|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144542|NCT03551743|Edoxaban|edoxaban|mesh-list
2144543|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2144544|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
2144545|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2591685|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
2591686|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591687|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2591688|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2591689|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
2591690|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
2591691|NCT01717222|Lidocaine|lidocaine|mesh-list
2591692|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
2591693|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
2591694|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2591695|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591696|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
2591697|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591698|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2591699|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2144546|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
2144547|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144548|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144549|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
2144550|NCT03552523|Pancrelipase|pancrelipase|mesh-list
2144551|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2144552|NCT03552549|Interferons|interferons|mesh-list
2144553|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
2144554|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
2144555|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2144556|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144557|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
2144558|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591700|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2591701|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2591702|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591703|NCT01717235|Ropinirole|ropinirole|mesh-list
2591704|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2591705|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2591706|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
2591707|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
2144559|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
2144560|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144561|NCT03553758|Ketamine|ketamine|mesh-list
2591708|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2591709|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591710|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591711|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
2591712|NCT01717300|Anacetrapib|anacetrapib|mesh-list
2591713|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2591714|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2591715|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
2591716|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591717|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2591718|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591719|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2591720|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591721|NCT01717404|Mexiletine|mexiletine|mesh-list
2591722|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2591723|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2591724|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2591725|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2591726|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591735|NCT01717599|Diclofenac|diclofenac|mesh-list
2591736|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2591737|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2591738|NCT01717599|Analgesics|analgesics|mesh-ancestor
2591739|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
2591740|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591741|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591742|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2591743|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2591744|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2591745|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591746|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591747|NCT01717612|Thrombin|thrombin|mesh-list
2591748|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
2591749|NCT01717612|Coagulants|coagulants|mesh-ancestor
2591750|NCT01717625|Montelukast|montelukast|mesh-list
2591751|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2591752|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
2591753|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2591754|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
2591755|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2591756|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591757|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2591758|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2591759|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591760|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
2591761|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2591762|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2591763|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591764|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
2591765|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
2591766|NCT01717729|Iodine|iodine|mesh-list
2591767|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2591768|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591769|NCT01717729|Trace Elements|trace elements|mesh-ancestor
2591770|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
2591771|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591772|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2591773|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420574|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420575|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2420576|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2420577|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
2420578|NCT00808392|Vaccines|vaccines|mesh-list
2420579|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
2420580|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420581|NCT00808418|Docetaxel|docetaxel|mesh-list
2420582|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420583|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
2420584|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
2420585|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
2420586|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420587|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2420588|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2420589|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2420590|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
2420591|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420592|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2591774|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2591775|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591776|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591777|NCT01717846|Abatacept|abatacept|mesh-list
2591778|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2591779|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591780|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591781|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2144562|NCT03553758|Analgesics|analgesics|mesh-ancestor
2144563|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
2144564|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144565|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144566|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2144567|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2144568|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
2144569|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
2144570|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144571|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2144572|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2144573|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144574|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144575|NCT03553940|Vaccines|vaccines|mesh-list
2144576|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
2144577|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144578|NCT03554005|Acetaminophen|acetaminophen|mesh-list
2144579|NCT03554005|Interferons|interferons|mesh-list
2144580|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
2144581|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
2144582|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2144583|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144584|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
2144585|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2144586|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2144587|NCT03554005|Analgesics|analgesics|mesh-ancestor
2144588|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
2144589|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144590|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144591|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
2144592|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
2144593|NCT03554018|Acetaminophen|acetaminophen|mesh-list
2144594|NCT03554018|Ibuprofen|ibuprofen|mesh-list
2144595|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2591782|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
2591783|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591784|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2591785|NCT01717911|Metformin|metformin|mesh-list
2591786|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2591787|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
2591788|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2591789|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591790|NCT01717911|Incretins|incretins|mesh-ancestor
2591791|NCT01717911|Hormones|hormones|mesh-ancestor
2591792|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2591793|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2591794|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
2591795|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591796|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591797|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2591798|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2591799|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
2591800|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591801|NCT01717950|Antacids|antacids|mesh-ancestor
2591802|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591803|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2144596|NCT03554018|Analgesics|analgesics|mesh-ancestor
2144597|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
2144598|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591804|NCT01717963|Naltrexone|naltrexone|mesh-list
2591805|NCT01717963|Buprenorphine|buprenorphine|mesh-list
2591806|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2591807|NCT01717963|Naloxone|naloxone|mesh-list
2591808|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2591809|NCT01717963|Narcotics|narcotics|mesh-ancestor
2591810|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2591811|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144599|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144600|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
2144601|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2144602|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2144603|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2144604|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2144605|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144606|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144607|NCT03554486|Insulin|insulin|mesh-list
2144608|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2144609|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
2144610|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
2144611|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2591812|NCT01717963|Analgesics|analgesics|mesh-ancestor
2591813|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
2591814|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591815|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2591816|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2591817|NCT01718054|Chloroquine|chloroquine|mesh-list
2591818|NCT01718054|Amebicides|amebicides|mesh-ancestor
2591819|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2591820|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2591821|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591822|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
2591823|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2591824|NCT01718093|Metformin|metformin|mesh-list
2591825|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2591826|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2591827|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591828|NCT01718093|Incretins|incretins|mesh-ancestor
2591829|NCT01718093|Hormones|hormones|mesh-ancestor
2591830|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2591831|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2591832|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
2591833|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591834|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591835|NCT01718145|Ribavirin|ribavirin|mesh-list
2591836|NCT01718145|Asunaprevir|asunaprevir|mesh-list
2591837|NCT01718145|Antimetabolites|antimetabolites|mesh-ancestor
2591838|NCT01718145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591839|NCT01718145|Antiviral Agents|antiviral agents|mesh-ancestor
2591840|NCT01718145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591841|NCT01718145|Protease Inhibitors|protease inhibitors|mesh-ancestor
2144612|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2144613|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144614|NCT03554772|Celecoxib|celecoxib|mesh-list
2144615|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2144616|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2591842|NCT01718145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591843|NCT01718158|Ribavirin|ribavirin|mesh-list
2591844|NCT01718158|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2591845|NCT01718158|Antimetabolites|antimetabolites|mesh-ancestor
2591846|NCT01718158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591847|NCT01718158|Antiviral Agents|antiviral agents|mesh-ancestor
2591848|NCT01718158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591849|NCT01718223|Temoporfin|temoporfin|mesh-list
2591850|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591851|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2591852|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
2591853|NCT01718236|Rocuronium|rocuronium|mesh-list
2591854|NCT01718236|Succinylcholine|succinylcholine|mesh-list
2591855|NCT01718236|Neostigmine|neostigmine|mesh-list
2591856|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2591857|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2591858|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2591859|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591860|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591861|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2144617|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2144618|NCT03554772|Analgesics|analgesics|mesh-ancestor
2144619|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
2144620|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144621|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144622|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2144623|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2144624|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2144625|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2144626|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144627|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144628|NCT03555305|Insulin|insulin|mesh-list
2144629|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2144630|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
2144631|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2144632|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591862|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591863|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591864|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
2591865|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2591866|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2591867|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
2591868|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2144633|NCT03555565|Metformin|metformin|mesh-list
2144634|NCT03555565|Alogliptin|alogliptin|mesh-list
2144635|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2144636|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144637|NCT03555565|Incretins|incretins|mesh-ancestor
2144638|NCT03555565|Hormones|hormones|mesh-ancestor
2144639|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2144640|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2144641|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
2591869|NCT01718288|Aspirin|aspirin|mesh-list
2591870|NCT01718288|Iloprost|iloprost|mesh-list
2591871|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2591872|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2591873|NCT01718288|Analgesics|analgesics|mesh-ancestor
2591874|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
2591875|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591876|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591877|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2591878|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2591879|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2591880|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2591881|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591882|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2591883|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2591884|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591885|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
2591886|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
2591887|NCT01718301|Ribavirin|ribavirin|mesh-list
2144642|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144643|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144644|NCT03555890|Cetirizine|cetirizine|mesh-list
2144645|NCT03555890|Levocetirizine|levocetirizine|mesh-list
2144646|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2144647|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2144648|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
2144649|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
2144650|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144651|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144652|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144653|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2144654|NCT03556761|Furosemide|furosemide|mesh-list
2144655|NCT03556761|Diuretics|diuretics|mesh-ancestor
2144656|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
2144657|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144658|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2144659|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2144660|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144661|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
2591888|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2591889|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2591890|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
2591891|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591892|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
2144662|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2144663|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
2144664|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
2144665|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144666|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144667|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144668|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2144669|NCT03557333|Analgesics|analgesics|mesh-ancestor
2144670|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
2591893|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591894|NCT01718314|Lidocaine|lidocaine|mesh-list
2591895|NCT01718314|Misoprostol|misoprostol|mesh-list
2591896|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
2144671|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144672|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
2144673|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2144674|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144675|NCT03557931|Olanzapine|olanzapine|mesh-list
2144676|NCT03557931|Risperidone|risperidone|mesh-list
2144677|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2144678|NCT03557931|Aripiprazole|aripiprazole|mesh-list
2144679|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2144680|NCT03557931|Ziprasidone|ziprasidone|mesh-list
2144681|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2144682|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
2144683|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2144684|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
2144685|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144686|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144687|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144688|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2144689|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2144690|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144691|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2144692|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2144693|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
2144694|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
2144695|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
2144696|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144697|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2144698|NCT03557931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2144699|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2144700|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2144701|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
2144702|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
2144703|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2144704|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2144705|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2144706|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2144707|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2144708|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2144709|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2144710|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
2144711|NCT03558555|Acetaminophen|acetaminophen|mesh-list
2144712|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2144713|NCT03558555|Analgesics|analgesics|mesh-ancestor
2144714|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
2144715|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144716|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144717|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
2144718|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2144719|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
2144720|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144721|NCT03559062|Ivacaftor|ivacaftor|mesh-list
2144722|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2144723|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2144724|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144725|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
2144726|NCT03559179|Narcotics|narcotics|mesh-ancestor
2144727|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144728|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144729|NCT03559179|Analgesics|analgesics|mesh-ancestor
2144730|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
2591897|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
2591898|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144731|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144732|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
2144733|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2144734|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
2144735|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2144736|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
2591899|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591900|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
2591901|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591902|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2591903|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2591904|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2591905|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2591906|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591907|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2591908|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
2591909|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2144737|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144738|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144739|NCT03560739|Ofatumumab|ofatumumab|mesh-list
2144740|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2144741|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144742|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
2144743|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591910|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2591911|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2591912|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
2591913|NCT01718327|Sunitinib|sunitinib|mesh-list
2591914|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591915|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2591916|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2591917|NCT01718327|Growth Substances|growth substances|mesh-ancestor
2591918|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591919|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
2591920|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2591921|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591922|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591923|NCT01718340|Metformin|metformin|mesh-list
2591924|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2591925|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591926|NCT01718366|Vitamin D|vitamin d|mesh-list
2591927|NCT01718366|Azacitidine|azacitidine|mesh-list
2591928|NCT01718366|Deferasirox|deferasirox|mesh-list
2591929|NCT01718366|Vitamins|vitamins|mesh-ancestor
2591930|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
2591931|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591932|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2591933|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2591934|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
2144744|NCT03562377|Vaccines|vaccines|mesh-list
2144745|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
2144746|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144747|NCT03562481|Lidocaine|lidocaine|mesh-list
2144748|NCT03562481|Epinephrine|epinephrine|mesh-list
2144749|NCT03562481|Racepinephrine|racepinephrine|mesh-list
2144750|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
2144751|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
2144752|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
2144753|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144754|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591935|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591936|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591937|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591938|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2144755|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
2144756|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144757|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2144758|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2144759|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2144760|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2144761|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144762|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2144763|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2144764|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
2591939|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
2591940|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
2591941|NCT01718379|Lenalidomide|lenalidomide|mesh-list
2591942|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
2591943|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591944|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2591945|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2591946|NCT01718379|Growth Substances|growth substances|mesh-ancestor
2591947|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
2591948|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144765|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144766|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2144767|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2144768|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
2591949|NCT01718496|Morphine|morphine|mesh-list
2591950|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2591951|NCT01718496|Narcotics|narcotics|mesh-ancestor
2591952|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2591953|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591954|NCT01718496|Analgesics|analgesics|mesh-ancestor
2591955|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
2591956|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144769|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2144770|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
2144771|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
2591957|NCT01718587|Lamivudine|lamivudine|mesh-list
2591958|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
2591959|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2591960|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2591961|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2591962|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591963|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591964|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2591965|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2591966|NCT01718613|Vasopressins|vasopressins|mesh-list
2591967|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
2591968|NCT01718613|Norepinephrine|norepinephrine|mesh-list
2591969|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2591970|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2591971|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
2591972|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2591973|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591974|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591975|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
2591976|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
2591977|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2591978|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2591979|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
2591980|NCT01718613|Coagulants|coagulants|mesh-ancestor
2591981|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2591982|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
2591983|NCT01718626|Docetaxel|docetaxel|mesh-list
2591984|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2591985|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
2591986|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
2591987|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
2591988|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591989|NCT01718652|Canagliflozin|canagliflozin|mesh-list
2591990|NCT01718652|Cyclosporine|cyclosporine|mesh-list
2591991|NCT01718652|Cyclosporins|cyclosporins|mesh-list
2591992|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144772|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
2144773|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2144774|NCT03562988|Vitamins|vitamins|mesh-list
2144775|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
2144776|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
2144777|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144778|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
2591993|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2591994|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2591995|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
2591996|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2591997|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
2591998|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2591999|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
2144779|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592000|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2592001|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2420593|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2420594|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420595|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
2420596|NCT00808704|Hematinics|hematinics|mesh-ancestor
2420597|NCT00808717|Atorvastatin|atorvastatin|mesh-list
2420598|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2420599|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2420600|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
2420601|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420602|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2420603|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2420604|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420605|NCT00808743|Celecoxib|celecoxib|mesh-list
2420606|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2592002|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2592003|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2592004|NCT01718678|Melatonin|melatonin|mesh-list
2592005|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
2592006|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592007|NCT01718678|Protective Agents|protective agents|mesh-ancestor
2592008|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592009|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2592010|NCT01718717|Morphine|morphine|mesh-list
2592011|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2592012|NCT01718717|Narcotics|narcotics|mesh-ancestor
2592013|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2592014|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592015|NCT01718717|Analgesics|analgesics|mesh-ancestor
2592016|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
2592017|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592033|NCT01718808|Capecitabine|capecitabine|mesh-list
2592034|NCT01718808|Cetuximab|cetuximab|mesh-list
2592035|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2592036|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
2592037|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592038|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592039|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2592040|NCT01718834|Vaccines|vaccines|mesh-list
2592041|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
2592042|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592043|NCT01718873|Leucovorin|leucovorin|mesh-list
2592044|NCT01718873|Folic Acid|folic acid|mesh-list
2592045|NCT01718873|Bevacizumab|bevacizumab|mesh-list
2592046|NCT01718873|Fluorouracil|fluorouracil|mesh-list
2592047|NCT01718873|Capecitabine|capecitabine|mesh-list
2592048|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
2592049|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
2592050|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2592051|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592052|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2592053|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2592054|NCT01718873|Growth Substances|growth substances|mesh-ancestor
2592055|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144780|NCT03562988|Protective Agents|protective agents|mesh-ancestor
2144781|NCT03563716|Atezolizumab|atezolizumab|mesh-list
2144782|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144783|NCT03565211|Progesterone|progesterone|mesh-list
2144784|NCT03565211|Progestins|progestins|mesh-ancestor
2144785|NCT03565211|Hormones|hormones|mesh-ancestor
2592056|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
2592057|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
2592058|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592059|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2144786|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2144787|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144788|NCT03565666|Insulin|insulin|mesh-list
2144789|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2592060|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2592061|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
2592062|NCT01718873|Antidotes|antidotes|mesh-ancestor
2592063|NCT01718873|Protective Agents|protective agents|mesh-ancestor
2592064|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
2592065|NCT01718873|Vitamins|vitamins|mesh-ancestor
2592066|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
2592067|NCT01718873|Hematinics|hematinics|mesh-ancestor
2592068|NCT01718899|Lenalidomide|lenalidomide|mesh-list
2592069|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
2592070|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592071|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2592072|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2592073|NCT01718899|Growth Substances|growth substances|mesh-ancestor
2592074|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
2592075|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592076|NCT01718912|Metronidazole|metronidazole|mesh-list
2592077|NCT01718912|Nystatin|nystatin|mesh-list
2144790|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
2144791|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
2144792|NCT03565666|Pancrelipase|pancrelipase|mesh-list
2144793|NCT03565666|Pancreatin|pancreatin|mesh-list
2144794|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2144795|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144796|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2144797|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2144798|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2144799|NCT03566485|Atezolizumab|atezolizumab|mesh-list
2144800|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144801|NCT03566810|Metformin|metformin|mesh-list
2144802|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2144803|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144804|NCT03566979|Naproxen|naproxen|mesh-list
2144805|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2144806|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2144807|NCT03566979|Analgesics|analgesics|mesh-ancestor
2144808|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
2144809|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144810|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144811|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2144812|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2592078|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592079|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2592080|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2592081|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2592082|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
2592083|NCT01718912|Ionophores|ionophores|mesh-ancestor
2592084|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2592085|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592086|NCT01718951|Pamidronate|pamidronate|mesh-list
2592087|NCT01718951|Golimumab|golimumab|mesh-list
2592088|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2592089|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2592090|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2592091|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
2592092|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592093|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2592094|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
2592095|NCT01718964|Mannitol|mannitol|mesh-list
2592096|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2592097|NCT01718964|Diuretics|diuretics|mesh-ancestor
2592098|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
2592099|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592100|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2592101|NCT01719016|Adenosine|adenosine|mesh-list
2592102|NCT01719016|Analgesics|analgesics|mesh-ancestor
2592103|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
2592104|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592105|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592106|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2592107|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
2592108|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2592109|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
2592110|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
2592111|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592112|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592113|NCT01719042|Ondansetron|ondansetron|mesh-list
2592114|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
2592115|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
2592116|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592117|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592118|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2592119|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
2592120|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
2592121|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2592122|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
2592123|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592124|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144813|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
2144814|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2144815|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144816|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144817|NCT03567382|Tenofovir|tenofovir|mesh-list
2144818|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
2592125|NCT01719042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2592126|NCT01719042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2592127|NCT01719042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2592128|NCT01719042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2592129|NCT01719042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2592130|NCT01719133|Histamine|histamine|mesh-list
2592131|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
2592132|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
2592133|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
2592134|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592135|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144819|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2144820|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2144821|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2144822|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144823|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144824|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2144825|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2592136|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592137|NCT01719159|Rituximab|rituximab|mesh-list
2592138|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2592139|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592140|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
2592141|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592142|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2592143|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
2592144|NCT01719185|Phentermine|phentermine|mesh-list
2592145|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2592146|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592147|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
2592148|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2592149|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
2592150|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
2592151|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592152|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
2592153|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592154|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592155|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
2592156|NCT01719185|Vitamins|vitamins|mesh-ancestor
2592157|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
2592158|NCT01719237|Ropivacaine|ropivacaine|mesh-list
2592159|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
2592160|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
2592161|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
2592162|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144826|NCT03567616|Dexamethasone|dexamethasone|mesh-list
2144827|NCT03567616|Venetoclax|venetoclax|mesh-list
2144828|NCT03567616|Pomalidomide|pomalidomide|mesh-list
2144829|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2144830|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
2144831|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
2144832|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144833|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592163|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144834|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2592164|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
2592165|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592166|NCT01719302|Gemcitabine|gemcitabine|mesh-list
2592167|NCT01719302|Docetaxel|docetaxel|mesh-list
2592168|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2592169|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
2592170|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592171|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592172|NCT01719302|Antiviral Agents|antiviral agents|mesh-ancestor
2592173|NCT01719302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592174|NCT01719302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592175|NCT01719302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2592176|NCT01719302|Immunologic Factors|immunologic factors|mesh-ancestor
2592177|NCT01719302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592178|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
2592179|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
2592180|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
2592181|NCT01719419|Orlistat|orlistat|mesh-list
2592182|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592183|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592184|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2592185|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2592186|NCT01719588|Tapentadol|tapentadol|mesh-list
2592187|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2592188|NCT01719588|Narcotics|narcotics|mesh-ancestor
2592189|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2592190|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592191|NCT01719588|Analgesics|analgesics|mesh-ancestor
2592192|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
2592193|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592194|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2592195|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2592196|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2592197|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592198|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
2144835|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
2144836|NCT03567616|Hormones|hormones|mesh-ancestor
2144837|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2144838|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2144839|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144840|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
2144841|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2144842|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2144843|NCT03567616|Growth Substances|growth substances|mesh-ancestor
2144844|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
2144845|NCT03568500|Olanzapine|olanzapine|mesh-list
2144846|NCT03568500|Risperidone|risperidone|mesh-list
2144847|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2144848|NCT03568500|Aripiprazole|aripiprazole|mesh-list
2144849|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2144850|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
2144851|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144852|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144853|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144854|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2144855|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2592199|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592200|NCT01719601|Tapentadol|tapentadol|mesh-list
2592201|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2592202|NCT01719601|Narcotics|narcotics|mesh-ancestor
2592203|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2592204|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592205|NCT01719601|Analgesics|analgesics|mesh-ancestor
2592206|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
2592207|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592208|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2592209|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2592210|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2592211|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592212|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
2592213|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592214|NCT01719614|Metformin|metformin|mesh-list
2592215|NCT01719614|Rilpivirine|rilpivirine|mesh-list
2592216|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2592217|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592218|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2592219|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2144856|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2144857|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2144858|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2144859|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
2144860|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
2144861|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
2144862|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144863|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2144864|NCT03568500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2144865|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2144866|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2144867|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
2144868|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
2144869|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2144870|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2144871|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2144872|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2144873|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
2144874|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2144875|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2144876|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
2592220|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592221|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592222|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
2592223|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592224|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2592225|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2592226|NCT01719627|Maraviroc|maraviroc|mesh-list
2592227|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2144877|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2144878|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2144879|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144880|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
2144881|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144882|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144883|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2144884|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592228|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2592229|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592230|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2592231|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2592232|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
2592233|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592234|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2592235|NCT01719640|Insulin|insulin|mesh-list
2592236|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2592237|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592238|NCT01719692|Rituximab|rituximab|mesh-list
2592239|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2592240|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592241|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
2592242|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592243|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2592244|NCT01719705|Pregabalin|pregabalin|mesh-list
2144885|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
2144886|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
2144887|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2592245|NCT01719705|Analgesics|analgesics|mesh-ancestor
2592246|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
2592247|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592248|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592249|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
2592250|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2592251|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2592252|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592253|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2592254|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2592255|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2592256|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2592257|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2592258|NCT01719770|Rocuronium|rocuronium|mesh-list
2592259|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2592260|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2144888|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2144889|NCT03570476|Olaparib|olaparib|mesh-list
2144890|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2144891|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144892|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144893|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144894|NCT03570554|Acetaminophen|acetaminophen|mesh-list
2144895|NCT03570554|Celecoxib|celecoxib|mesh-list
2144896|NCT03570554|Naproxen|naproxen|mesh-list
2144897|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2592261|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2592262|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592263|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592264|NCT01719835|Gemcitabine|gemcitabine|mesh-list
2592265|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
2592266|NCT01719835|Prednisolone|prednisolone|mesh-list
2592267|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
2592268|NCT01719835|Doxorubicin|doxorubicin|mesh-list
2592269|NCT01719835|Vincristine|vincristine|mesh-list
2592270|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2592271|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
2592272|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592273|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2592274|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2592275|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
2592276|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420607|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2420608|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2420609|NCT00808743|Analgesics|analgesics|mesh-ancestor
2420610|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
2420611|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420612|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420613|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2420614|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2420615|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2420616|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2420617|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420618|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592277|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592278|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2592279|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2592280|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
2592281|NCT01719835|Antiviral Agents|antiviral agents|mesh-ancestor
2592282|NCT01719835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592283|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592284|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2592285|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2592286|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2592287|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2592288|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
2592289|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
2592290|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
2592291|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2592292|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
2144898|NCT03570554|Analgesics|analgesics|mesh-ancestor
2144899|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
2144900|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144901|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144902|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
2144903|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2144904|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2144905|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2144906|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2144907|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2144908|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144909|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144910|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
2144911|NCT03570697|Evolocumab|evolocumab|mesh-list
2144912|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2144913|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2144914|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
2144915|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592293|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
2592294|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592295|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2592296|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
2592297|NCT01719835|Hormones|hormones|mesh-ancestor
2592298|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592299|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2592300|NCT01719835|Protective Agents|protective agents|mesh-ancestor
2592301|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2592302|NCT01719926|Indomethacin|indomethacin|mesh-list
2592303|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2592304|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2592305|NCT01719926|Analgesics|analgesics|mesh-ancestor
2592306|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
2592307|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592308|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592309|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2592310|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2592311|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
2592312|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
2592313|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2592314|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2592315|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592316|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592317|NCT01719952|Oxytocin|oxytocin|mesh-list
2592318|NCT01719952|Carbetocin|carbetocin|mesh-list
2592319|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
2592320|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2592321|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144916|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2144917|NCT03571516|Teduglutide|teduglutide|mesh-list
2144918|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2144919|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2144920|NCT03571516|Protective Agents|protective agents|mesh-ancestor
2592322|NCT01719978|Epinephrine|epinephrine|mesh-list
2592323|NCT01719978|Racepinephrine|racepinephrine|mesh-list
2592324|NCT01719978|Mepivacaine|mepivacaine|mesh-list
2592325|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
2592326|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2592327|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2592328|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
2592329|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592330|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592331|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592332|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2592333|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2592334|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
2592335|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592336|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2592337|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
2592338|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
2592339|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
2592340|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2592341|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
2592342|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
2592343|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2592344|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
2592345|NCT01720030|Simendan|simendan|mesh-list
2592346|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2592347|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
2592348|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2592349|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2592350|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592351|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592352|NCT01720030|Protective Agents|protective agents|mesh-ancestor
2592353|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592354|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2592355|NCT01720056|Verapamil|verapamil|mesh-list
2592356|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2592357|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
2592358|NCT01720056|Hormones|hormones|mesh-ancestor
2592359|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592360|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592361|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2592362|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
2592363|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144921|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592364|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2592365|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2144922|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2144923|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
2144924|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144925|NCT03571724|Menthol|menthol|mesh-list
2144926|NCT03571724|Nicotine|nicotine|mesh-list
2144927|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2144928|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
2144929|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144930|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144931|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2144932|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2144933|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
2144934|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144935|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144936|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
2144937|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
2144938|NCT03572478|Nivolumab|nivolumab|mesh-list
2144939|NCT03572478|Rucaparib|rucaparib|mesh-list
2144940|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2144941|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144942|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2144943|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144944|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2144945|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144946|NCT03572972|Warfarin|warfarin|mesh-list
2144947|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
2144948|NCT03572972|Dabigatran|dabigatran|mesh-list
2144949|NCT03572972|Apixaban|apixaban|mesh-list
2144950|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
2144951|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2144952|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
2144953|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2144954|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
2144955|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592366|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2592367|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2592368|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
2592369|NCT01720095|Niacin|niacin|mesh-list
2592370|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
2592371|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2592372|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
2592373|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592374|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2592375|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
2592376|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
2592377|NCT01720095|Vitamins|vitamins|mesh-ancestor
2592378|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
2592379|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592380|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
2592381|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2592382|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
2592383|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2592384|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
2592385|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592386|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592387|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
2592388|NCT01720212|Mirabegron|mirabegron|mesh-list
2592389|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2592390|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2592391|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2592392|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
2592393|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592394|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592395|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592396|NCT01720212|Urological Agents|urological agents|mesh-ancestor
2592397|NCT01720238|Lamivudine|lamivudine|mesh-list
2592398|NCT01720238|Adefovir|adefovir|mesh-list
2592399|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2592400|NCT01720238|Entecavir|entecavir|mesh-list
2592401|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2592402|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2592403|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592404|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592405|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
2592406|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2144956|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592407|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2144957|NCT03573323|Ixekizumab|ixekizumab|mesh-list
2144958|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
2144959|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
2144960|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2144961|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
2144962|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2144963|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144964|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2144965|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
2144966|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2144967|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2144968|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2592408|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2592409|NCT01720290|Metformin|metformin|mesh-list
2592410|NCT01720290|Repaglinide|repaglinide|mesh-list
2592411|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2592412|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592413|NCT01720303|Insulin|insulin|mesh-list
2592414|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2592415|NCT01720303|Repaglinide|repaglinide|mesh-list
2592416|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
2592417|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
2592418|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
2592419|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2592420|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592421|NCT01720394|Dinoprostone|dinoprostone|mesh-list
2592422|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
2592423|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2592424|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592425|NCT01720407|Imiquimod|imiquimod|mesh-list
2592426|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2592427|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
2592428|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592429|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144969|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
2144970|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2144971|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144972|NCT03573908|Linaclotide|linaclotide|mesh-list
2144973|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2592430|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
2592431|NCT01720459|Resveratrol|resveratrol|mesh-list
2592432|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
2144974|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
2144975|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592433|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592434|NCT01720459|Protective Agents|protective agents|mesh-ancestor
2592435|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592436|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144976|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2144977|NCT03574818|Gemcitabine|gemcitabine|mesh-list
2144978|NCT03574818|Necitumumab|necitumumab|mesh-list
2144979|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2144980|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2144981|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
2144982|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144983|NCT03574818|Antiviral Agents|antiviral agents|mesh-ancestor
2144984|NCT03574818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2144985|NCT03574818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2144986|NCT03574818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2144987|NCT03574818|Immunologic Factors|immunologic factors|mesh-ancestor
2144988|NCT03574818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144989|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2592437|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2592438|NCT01720485|Prednisolone|prednisolone|mesh-list
2592439|NCT01720485|Betamethasone|betamethasone|mesh-list
2592440|NCT01720485|Desloratadine|desloratadine|mesh-list
2592441|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
2592442|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2592443|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
2592444|NCT01720485|Hormones|hormones|mesh-ancestor
2592445|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592446|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592447|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2592448|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592449|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2592450|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
2144990|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2144991|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2144992|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2144993|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
2144994|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592451|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2592452|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
2592453|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592454|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592455|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2592456|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2592457|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
2592458|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
2592459|NCT01720498|Remifentanil|remifentanil|mesh-list
2592460|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2592461|NCT01720498|Narcotics|narcotics|mesh-ancestor
2592462|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2420619|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2420620|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2420621|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
2420622|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2420623|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
2592463|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592464|NCT01720498|Analgesics|analgesics|mesh-ancestor
2592465|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
2592466|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592467|NCT01720537|Bococizumab|bococizumab|mesh-list
2592468|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2592469|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2592470|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2592471|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
2592472|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592473|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2592474|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
2592475|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592476|NCT01720563|Leucovorin|leucovorin|mesh-list
2592477|NCT01720563|Tegafur|tegafur|mesh-list
2592478|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592479|NCT01720563|Antidotes|antidotes|mesh-ancestor
2592480|NCT01720563|Protective Agents|protective agents|mesh-ancestor
2592481|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592482|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
2592483|NCT01720563|Vitamins|vitamins|mesh-ancestor
2592484|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
2144995|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2144996|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2144997|NCT03575702|Urological Agents|urological agents|mesh-ancestor
2144998|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
2144999|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2145000|NCT03575806|Estrogens|estrogens|mesh-ancestor
2145001|NCT03575806|Hormones|hormones|mesh-ancestor
2592485|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2592486|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
2592487|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592488|NCT01720615|Remifentanil|remifentanil|mesh-list
2592489|NCT01720615|Propofol|propofol|mesh-list
2592490|NCT01720615|Sevoflurane|sevoflurane|mesh-list
2592491|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2592492|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2592493|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592494|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2592495|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
2592496|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
2145002|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2145003|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145004|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2145005|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145006|NCT03575871|Abrocitinib|abrocitinib|mesh-list
2145007|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2145008|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420624|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420625|NCT00808795|Expectorants|expectorants|mesh-ancestor
2420626|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
2420627|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2420628|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
2420629|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592497|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2592498|NCT01720615|Narcotics|narcotics|mesh-ancestor
2592499|NCT01720615|Analgesics|analgesics|mesh-ancestor
2592500|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
2592501|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145009|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145010|NCT03576066|Tenofovir|tenofovir|mesh-list
2145011|NCT03576066|Entecavir|entecavir|mesh-list
2145012|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
2145013|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145014|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2145015|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2145016|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145017|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145018|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2145019|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2145020|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2145021|NCT03576716|Calcifediol|calcifediol|mesh-list
2145022|NCT03576716|Vitamins|vitamins|mesh-ancestor
2145023|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
2145024|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592502|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2592503|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2592504|NCT01720628|Angiogenin|angiogenin|mesh-list
2592505|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2592506|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2592507|NCT01720628|Growth Substances|growth substances|mesh-ancestor
2592508|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592509|NCT01720719|Vitamin E|vitamin e|mesh-list
2592510|NCT01720719|Atorvastatin|atorvastatin|mesh-list
2592511|NCT01720719|Vitamins|vitamins|mesh-ancestor
2592512|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
2592513|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592514|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2592515|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2592516|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
2592517|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592518|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2592519|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2592520|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592521|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
2592522|NCT01720719|Protective Agents|protective agents|mesh-ancestor
2592523|NCT01720836|Poly ICLC|poly iclc|mesh-list
2592524|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
2592525|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
2592526|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145025|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2145026|NCT03577171|Entecavir|entecavir|mesh-list
2145027|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
2145028|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145029|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
2145030|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2145031|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145032|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2145033|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2145034|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592527|NCT01720875|Dexamethasone|dexamethasone|mesh-list
2592528|NCT01720875|Bortezomib|bortezomib|mesh-list
2592529|NCT01720875|Vorinostat|vorinostat|mesh-list
2592530|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2592531|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
2592532|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
2592533|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592534|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145035|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145036|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145037|NCT03577730|Caffeine|caffeine|mesh-list
2145038|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
2145039|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145040|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2145041|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145042|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2145043|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145044|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2592535|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2592536|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
2592537|NCT01720875|Hormones|hormones|mesh-ancestor
2592538|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592539|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2592540|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592541|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2592542|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592543|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592544|NCT01720940|Vancomycin|vancomycin|mesh-list
2592545|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2592546|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592547|NCT01721031|Tramadol|tramadol|mesh-list
2592548|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2592549|NCT01721031|Narcotics|narcotics|mesh-ancestor
2592550|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2592551|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592552|NCT01721031|Analgesics|analgesics|mesh-ancestor
2592553|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
2592554|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592555|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
2592556|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2592557|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2592558|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592559|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2592560|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2592561|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592562|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592563|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592564|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2592565|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
2592566|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2145045|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2145046|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
2145047|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145048|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
2145049|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2145050|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
2145051|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2145052|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
2592567|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592568|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2592569|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2592570|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2592571|NCT01721291|Albuterol|albuterol|mesh-list
2592572|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2592573|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
2592574|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592575|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592576|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2592577|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
2592578|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
2592579|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2592580|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2592581|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2592582|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2592583|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
2592584|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592585|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592586|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2592587|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2592588|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592589|NCT01721382|Incretins|incretins|mesh-ancestor
2592590|NCT01721382|Hormones|hormones|mesh-ancestor
2592591|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592592|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2592593|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
2592594|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592595|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145053|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145054|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145055|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
2145056|NCT03579719|Itraconazole|itraconazole|mesh-list
2145057|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
2145058|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145059|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2592596|NCT01721434|Simendan|simendan|mesh-list
2592597|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2592598|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
2592599|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2592600|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2592601|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592602|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592603|NCT01721434|Protective Agents|protective agents|mesh-ancestor
2592604|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592605|NCT01721525|Ribavirin|ribavirin|mesh-list
2592606|NCT01721525|Paclitaxel|paclitaxel|mesh-list
2592607|NCT01721525|Carboplatin|carboplatin|mesh-list
2592608|NCT01721525|Afatinib|afatinib|mesh-list
2592609|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2592610|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592611|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
2592612|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
2592613|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
2592614|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592615|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
2592616|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
2592617|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592618|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2145060|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2145061|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145062|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145063|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2145064|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
2592619|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592620|NCT01721616|Azithromycin|azithromycin|mesh-list
2592621|NCT01721616|Cefazolin|cefazolin|mesh-list
2592622|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2592623|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592624|NCT01721655|Spironolactone|spironolactone|mesh-list
2592625|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2592626|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
2592627|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592628|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592629|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2592630|NCT01721655|Diuretics|diuretics|mesh-ancestor
2592631|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
2592632|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2592633|NCT01721694|Azithromycin|azithromycin|mesh-list
2592634|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2592635|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592636|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2592637|NCT01721707|Latanoprost|latanoprost|mesh-list
2145065|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2145066|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145067|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2145068|NCT03579940|Lasmiditan|lasmiditan|mesh-list
2145069|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2592638|NCT01721707|Brinzolamide|brinzolamide|mesh-list
2592639|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2592640|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2592641|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2592642|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592643|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592644|NCT01721733|Ubiquinone|ubiquinone|mesh-list
2592645|NCT01721733|Micronutrients|micronutrients|mesh-ancestor
2592646|NCT01721733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592647|NCT01721798|Copper|copper|mesh-list
2592648|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
2592649|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2592650|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
2592651|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2592652|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592653|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2592654|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2592655|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2145070|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
2145071|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145072|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145073|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592656|NCT01721798|Trace Elements|trace elements|mesh-ancestor
2592657|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
2592658|NCT01721915|Vitamin D|vitamin d|mesh-list
2592659|NCT01721915|Vitamins|vitamins|mesh-ancestor
2592660|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
2592661|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592662|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2592663|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
2145074|NCT03580343|Tofacitinib|tofacitinib|mesh-list
2145075|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2145076|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145077|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145078|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
2145079|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2145080|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
2145081|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145082|NCT03581084|Expectorants|expectorants|mesh-ancestor
2145083|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
2592664|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2592665|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592666|NCT01722110|Indomethacin|indomethacin|mesh-list
2592667|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2592668|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2592669|NCT01722110|Analgesics|analgesics|mesh-ancestor
2592670|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
2592671|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592672|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592673|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2592674|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2592675|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
2592676|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
2592677|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2592678|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2592679|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592680|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592681|NCT01722201|Risperidone|risperidone|mesh-list
2592682|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2592683|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
2592684|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592685|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592686|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592687|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2592688|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2592689|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2592690|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2592691|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2592692|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
2592693|NCT01722214|Adalimumab|adalimumab|mesh-list
2592694|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2592695|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2592696|NCT01722227|Liraglutide|liraglutide|mesh-list
2592697|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2145084|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2145085|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
2145086|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592698|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592699|NCT01722227|Incretins|incretins|mesh-ancestor
2592700|NCT01722227|Hormones|hormones|mesh-ancestor
2592701|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592702|NCT01722240|Liraglutide|liraglutide|mesh-list
2592703|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2592704|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592705|NCT01722240|Incretins|incretins|mesh-ancestor
2592706|NCT01722240|Hormones|hormones|mesh-ancestor
2592707|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592708|NCT01722305|Dexamethasone|dexamethasone|mesh-list
2592709|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
2592710|NCT01722305|Pomalidomide|pomalidomide|mesh-list
2592711|NCT01722305|Ichthammol|ichthammol|mesh-list
2592712|NCT01722305|BB 1101|bb 1101|mesh-list
2592713|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2592714|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
2592715|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
2592716|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592717|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592718|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2592719|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
2145087|NCT03581084|Protective Agents|protective agents|mesh-ancestor
2592720|NCT01722305|Hormones|hormones|mesh-ancestor
2592721|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592722|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2592723|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592724|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
2592725|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592726|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592727|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
2592728|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2592729|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2145088|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145089|NCT03581084|Antidotes|antidotes|mesh-ancestor
2145090|NCT03582215|Salicylates|salicylates|mesh-list
2145091|NCT03582215|Avobenzone|avobenzone|mesh-list
2145092|NCT03582215|Homosalate|homosalate|mesh-list
2145093|NCT03582215|Oxybenzone|oxybenzone|mesh-list
2145094|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
2145095|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
2145096|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
2145097|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2145098|NCT03582215|Protective Agents|protective agents|mesh-ancestor
2145099|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145100|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
2145101|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2145102|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2145103|NCT03582215|Analgesics|analgesics|mesh-ancestor
2145104|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
2145105|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145106|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2145107|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2145108|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2145109|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145110|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145111|NCT03582553|Naringenin|naringenin|mesh-list
2145112|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2145113|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2145114|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2145115|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
2145116|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2145117|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145118|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2145119|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2145120|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2145121|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
2145122|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145123|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145124|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145125|NCT03583372|Urological Agents|urological agents|mesh-ancestor
2145126|NCT03583385|Metformin|metformin|mesh-list
2145127|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2145128|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145129|NCT03584009|Venetoclax|venetoclax|mesh-list
2145130|NCT03584009|Fulvestrant|fulvestrant|mesh-list
2145131|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145132|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2145133|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2145134|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2145135|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
2145136|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2145137|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145138|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
2145139|NCT03585504|Etonogestrel|etonogestrel|mesh-list
2145140|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2145141|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145142|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2420630|NCT00808795|Protective Agents|protective agents|mesh-ancestor
2420631|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420632|NCT00808795|Antidotes|antidotes|mesh-ancestor
2420633|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
2420634|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
2420635|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2420636|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2420637|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420638|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592730|NCT01722305|Growth Substances|growth substances|mesh-ancestor
2592731|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
2592732|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
2592733|NCT01722396|Vitamin D|vitamin d|mesh-list
2592734|NCT01722396|Vitamins|vitamins|mesh-ancestor
2592735|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
2145143|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2145144|NCT03585712|Norgestrel|norgestrel|mesh-list
2145145|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2145146|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2145147|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2145148|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
2145149|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2592736|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592737|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2592738|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
2592739|NCT01722409|Sevoflurane|sevoflurane|mesh-list
2592740|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2592741|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2592742|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592743|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2592744|NCT01722409|Analgesics|analgesics|mesh-ancestor
2592745|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
2592746|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592747|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2592748|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2592749|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2592750|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
2592751|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592752|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592753|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2592754|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2592755|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
2592756|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
2592757|NCT01722448|Choline|choline|mesh-list
2592758|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
2145150|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145151|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2145152|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2592759|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2592760|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
2592761|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592762|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2592763|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2592764|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
2592765|NCT01722513|Alprostadil|alprostadil|mesh-list
2592766|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2592767|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
2592768|NCT01722513|Urological Agents|urological agents|mesh-ancestor
2592769|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
2592770|NCT01722539|Piperaquine|piperaquine|mesh-list
2592771|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
2592772|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2592773|NCT01722539|Albendazole|albendazole|mesh-list
2592774|NCT01722539|Praziquantel|praziquantel|mesh-list
2592775|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
2592776|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2592777|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2592778|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592779|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2592780|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592781|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592782|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2592783|NCT01722539|Renal Agents|renal agents|mesh-ancestor
2145153|NCT03586544|Albuterol|albuterol|mesh-list
2145154|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2145155|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
2592784|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
2592785|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
2592786|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2592787|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
2592788|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
2592789|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
2592790|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592791|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
2592792|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2592793|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2592794|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592795|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592796|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420639|NCT00808912|Urological Agents|urological agents|mesh-ancestor
2420640|NCT00808951|Artesunate|artesunate|mesh-list
2420641|NCT00808951|Lumefantrine|lumefantrine|mesh-list
2420642|NCT00808951|Artemether|artemether|mesh-list
2420643|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2420644|NCT00808951|Amodiaquine|amodiaquine|mesh-list
2420645|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
2420646|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2420647|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2420648|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420649|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420650|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
2420651|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
2420652|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2420653|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
2420654|NCT00808977|Mesalamine|mesalamine|mesh-list
2420655|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2420656|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2420657|NCT00808977|Analgesics|analgesics|mesh-ancestor
2420658|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
2420659|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592797|NCT01722630|Dopamine|dopamine|mesh-list
2592798|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2592799|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
2592800|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
2592801|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592802|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592803|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
2592804|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145156|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145157|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145158|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2145159|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
2145160|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
2145161|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2592805|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592806|NCT01722630|Protective Agents|protective agents|mesh-ancestor
2592807|NCT01722656|Aflibercept|aflibercept|mesh-list
2592808|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2592809|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2592810|NCT01722656|Growth Substances|growth substances|mesh-ancestor
2592811|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592812|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
2592813|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592814|NCT01722708|Metronidazole|metronidazole|mesh-list
2592815|NCT01722708|Clindamycin|clindamycin|mesh-list
2592816|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
2592817|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
2592818|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592819|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2592820|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2592821|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2592822|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2592823|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592824|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592825|NCT01722799|Paclitaxel|paclitaxel|mesh-list
2592826|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2592827|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592828|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
2145162|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2145163|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2145164|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2145165|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
2145166|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145167|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145168|NCT03586726|Rifampin|rifampin|mesh-list
2145169|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2145170|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
2592829|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
2592830|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
2420660|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592831|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592832|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
2145171|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2145172|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145173|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
2145174|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2145175|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145176|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145177|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2145178|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2145179|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2145180|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2145181|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2145182|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2145183|NCT03587207|Vaccines|vaccines|mesh-list
2145184|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
2145185|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145186|NCT03587428|Zinc|zinc|mesh-list
2145187|NCT03587428|Trace Elements|trace elements|mesh-ancestor
2145188|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
2145189|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145190|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2592833|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
2592834|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
2592835|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592836|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2592837|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2592838|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
2592839|NCT01722942|Amiodarone|amiodarone|mesh-list
2592840|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2592841|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
2592842|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2592843|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2592844|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592845|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2592846|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2592847|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2592848|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592849|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2592850|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2592851|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2592852|NCT01722968|Paclitaxel|paclitaxel|mesh-list
2592853|NCT01722968|Bevacizumab|bevacizumab|mesh-list
2592854|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2592855|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592856|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
2592857|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
2592858|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
2592859|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592860|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2592861|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2592862|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2145191|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2145192|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2145193|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2145194|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145195|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145196|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145197|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2145198|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
2145199|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2592863|NCT01722968|Growth Substances|growth substances|mesh-ancestor
2592864|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592865|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
2592866|NCT01723059|Amoxicillin|amoxicillin|mesh-list
2592867|NCT01723059|Metronidazole|metronidazole|mesh-list
2592868|NCT01723059|Clarithromycin|clarithromycin|mesh-list
2592869|NCT01723059|Omeprazole|omeprazole|mesh-list
2592870|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2592871|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592872|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2592873|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2592874|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2592875|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2592876|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2592877|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592878|NCT01723059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592879|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2592880|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2145200|NCT03588806|Oxycodone|oxycodone|mesh-list
2145201|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2145202|NCT03588806|Narcotics|narcotics|mesh-ancestor
2145203|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145204|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145205|NCT03588806|Analgesics|analgesics|mesh-ancestor
2145206|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
2145207|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145208|NCT03588910|Acetaminophen|acetaminophen|mesh-list
2592881|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2592882|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
2592883|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
2592884|NCT01723150|Ertapenem|ertapenem|mesh-list
2592885|NCT01723150|Trimethoprim|trimethoprim|mesh-list
2592886|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
2592887|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2592888|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592889|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2592890|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2145209|NCT03588910|Ibuprofen|ibuprofen|mesh-list
2145210|NCT03588910|Oxycodone|oxycodone|mesh-list
2145211|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2145212|NCT03588910|Analgesics|analgesics|mesh-ancestor
2145213|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
2145214|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145215|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145216|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
2145217|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2145218|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2145219|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2145220|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2145221|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145222|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145223|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2145224|NCT03588910|Narcotics|narcotics|mesh-ancestor
2145225|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145226|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
2145227|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2145228|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145229|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2145230|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
2145231|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145232|NCT03591068|Fluticasone|fluticasone|mesh-list
2145233|NCT03591068|Xhance|xhance|mesh-list
2145234|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2145235|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2145236|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
2145237|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145238|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145239|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2145240|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
2145241|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
2145242|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2145243|NCT03591146|Ropivacaine|ropivacaine|mesh-list
2145244|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
2145245|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
2145246|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145247|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145248|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
2145249|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145250|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2145251|NCT03591406|Hematinics|hematinics|mesh-ancestor
2145252|NCT03592121|Phenylephrine|phenylephrine|mesh-list
2145253|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2145254|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
2145255|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
2145256|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145257|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145258|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
2145259|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2145260|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
2145261|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
2592891|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592892|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592893|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592894|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2592895|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2592896|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2592897|NCT01723150|Renal Agents|renal agents|mesh-ancestor
2592898|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
2592899|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2592900|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2592901|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2592902|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2145262|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2145263|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2145264|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2145265|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
2145266|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145267|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145268|NCT03592121|Protective Agents|protective agents|mesh-ancestor
2145269|NCT03593538|Metformin|metformin|mesh-list
2145270|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2145271|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145272|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
2145273|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2145274|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2145275|NCT03593902|Prednisolone|prednisolone|mesh-list
2145276|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
2145277|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
2145278|NCT03593902|Rituximab|rituximab|mesh-list
2145279|NCT03593902|Fludarabine|fludarabine|mesh-list
2145280|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
2145281|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2145282|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2592903|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2145283|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
2145284|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2145285|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
2145286|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145287|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2145288|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2145289|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
2145290|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145291|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145292|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2145293|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2145294|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2145295|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
2145296|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
2145297|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145298|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2145299|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
2145300|NCT03593902|Hormones|hormones|mesh-ancestor
2145301|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592910|NCT01723371|Carvedilol|carvedilol|mesh-list
2592911|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2592912|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2592913|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
2592914|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2592915|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592916|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592917|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2592918|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
2592919|NCT01723371|Protective Agents|protective agents|mesh-ancestor
2592920|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2592921|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2592922|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2592923|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
2145302|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2145303|NCT03593902|Protective Agents|protective agents|mesh-ancestor
2145304|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2145305|NCT03594045|Apixaban|apixaban|mesh-list
2145306|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2145307|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
2145308|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2145309|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
2145310|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145311|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145312|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
2145313|NCT03595449|Lidocaine|lidocaine|mesh-list
2145314|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
2145315|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
2145316|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145317|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145318|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
2145319|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592924|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2592925|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2592926|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
2592927|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2592928|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2592929|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
2592930|NCT01723527|Buprenorphine|buprenorphine|mesh-list
2145320|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2145321|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2145322|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2145323|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2145324|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145325|NCT03595579|Bupropion|bupropion|mesh-list
2145326|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2145327|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
2145328|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2145329|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2145330|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2145331|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2145332|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145333|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
2145334|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145335|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145336|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2145337|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2145338|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145339|NCT03596723|Prednisolone|prednisolone|mesh-list
2145340|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2145341|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
2145342|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2145343|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
2145344|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2145345|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
2592931|NCT01723527|Methadone|methadone|mesh-list
2592932|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2592933|NCT01723527|Narcotics|narcotics|mesh-ancestor
2592934|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2592935|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592936|NCT01723527|Analgesics|analgesics|mesh-ancestor
2592937|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
2592938|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592939|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2145346|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2145347|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
2145348|NCT03596723|Hormones|hormones|mesh-ancestor
2145349|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592940|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
2592941|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
2592942|NCT01723553|Corticosterone|corticosterone|mesh-list
2592943|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2592944|NCT01723579|Estradiol|estradiol|mesh-list
2592945|NCT01723579|Estrogens|estrogens|mesh-ancestor
2592946|NCT01723579|Hormones|hormones|mesh-ancestor
2145350|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145351|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2145352|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145353|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
2592947|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592948|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592949|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
2592950|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2592951|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592952|NCT01723670|Flurbiprofen|flurbiprofen|mesh-list
2592953|NCT01723670|Analgesics|analgesics|mesh-ancestor
2592954|NCT01723670|Sensory System Agents|sensory system agents|mesh-ancestor
2592955|NCT01723670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2592956|NCT01723670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592957|NCT01723670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2592958|NCT01723670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2592959|NCT01723670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2592960|NCT01723670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2592961|NCT01723670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2592962|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592963|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592964|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2592965|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
2592966|NCT01723735|Ezetimibe|ezetimibe|mesh-list
2592967|NCT01723735|Fenofibrate|fenofibrate|mesh-list
2592968|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2592969|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2592970|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
2592971|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592972|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2592973|NCT01723748|Hormones|hormones|mesh-list
2592974|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592975|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592976|NCT01723774|Anastrozole|anastrozole|mesh-list
2592977|NCT01723774|Goserelin|goserelin|mesh-list
2592978|NCT01723774|Palbociclib|palbociclib|mesh-list
2592979|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2592980|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592981|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2592982|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2592983|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592984|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592985|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2592986|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
2592987|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2592988|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2592989|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2592990|NCT01723800|Carboplatin|carboplatin|mesh-list
2592991|NCT01723800|Pemetrexed|pemetrexed|mesh-list
2592992|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2592993|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2592994|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2592995|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2592996|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2145354|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
2145355|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145356|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2145357|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2145358|NCT03596723|Protective Agents|protective agents|mesh-ancestor
2145359|NCT03597009|Nivolumab|nivolumab|mesh-list
2145360|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2420661|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2420662|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2420663|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2420664|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2420665|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145361|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2145362|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145363|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2420666|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
2420667|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2420668|NCT00809029|Incretins|incretins|mesh-ancestor
2420669|NCT00809029|Hormones|hormones|mesh-ancestor
2420670|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2420671|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420672|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
2145364|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145365|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
2145366|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
2145367|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
2145368|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
2145369|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145370|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
2145371|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2145372|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2145373|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145374|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2145375|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
2145376|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145377|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2145378|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
2145379|NCT03597139|Cyclosporine|cyclosporine|mesh-list
2145380|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2145381|NCT03597139|Cyclosporins|cyclosporins|mesh-list
2145382|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145383|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145384|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2145385|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
2145386|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145387|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
2145388|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145389|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
2145390|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2145391|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2145392|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2145393|NCT03597347|Molgramostim|molgramostim|mesh-list
2145394|NCT03597347|Sargramostim|sargramostim|mesh-list
2145395|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145396|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
2145397|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145398|NCT03597529|Melatonin|melatonin|mesh-list
2145399|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
2145400|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145401|NCT03597529|Protective Agents|protective agents|mesh-ancestor
2145402|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145403|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145404|NCT03599089|Acetaminophen|acetaminophen|mesh-list
2145405|NCT03599089|Ketorolac|ketorolac|mesh-list
2145406|NCT03599089|Oxycodone|oxycodone|mesh-list
2145407|NCT03599089|Bupivacaine|bupivacaine|mesh-list
2145408|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
2145409|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
2145410|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145411|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145412|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
2145413|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145414|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2145415|NCT03599089|Analgesics|analgesics|mesh-ancestor
2145416|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
2145417|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2145418|NCT03599089|Narcotics|narcotics|mesh-ancestor
2593015|NCT01723852|Vitamin D|vitamin d|mesh-list
2593016|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
2145419|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2145420|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2593017|NCT01723852|Vitamins|vitamins|mesh-list
2593018|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
2593019|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593020|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2593021|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2593022|NCT01724086|Interferons|interferons|mesh-list
2593023|NCT01724086|Ritonavir|ritonavir|mesh-list
2593024|NCT01724086|Ribavirin|ribavirin|mesh-list
2593025|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
2593026|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
2145421|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2145422|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2145423|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145424|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145425|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
2145426|NCT03599193|Tazarotene|tazarotene|mesh-list
2145427|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
2145428|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
2145429|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
2145430|NCT03599193|Vitamins|vitamins|mesh-ancestor
2145431|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
2145432|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145433|NCT03599362|Nivolumab|nivolumab|mesh-list
2145434|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2145435|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145436|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2145437|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145438|NCT03600376|Dantrolene|dantrolene|mesh-list
2145439|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2145440|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145441|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2145442|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145443|NCT03600428|Vaccines|vaccines|mesh-list
2145444|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
2145445|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145446|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2145447|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
2145448|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
2593027|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2593028|NCT01724086|Simeprevir|simeprevir|mesh-list
2593029|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593030|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
2593031|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593032|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2593033|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2593034|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
2593035|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593036|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593037|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2593038|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2593039|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2145449|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145450|NCT03604341|Dronabinol|dronabinol|mesh-list
2593040|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2593041|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
2593042|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
2593043|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593044|NCT01724138|Deferasirox|deferasirox|mesh-list
2593045|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2593046|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
2593047|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
2593048|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593049|NCT01724190|Vitamin D|vitamin d|mesh-list
2593050|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
2593051|NCT01724190|Vitamins|vitamins|mesh-ancestor
2593052|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
2593053|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593054|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2593055|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2593056|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
2593057|NCT01724229|Clotrimazole|clotrimazole|mesh-list
2593058|NCT01724229|Miconazole|miconazole|mesh-list
2593059|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593060|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2593061|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2593062|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2593063|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145451|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
2145452|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145453|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2145454|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2145455|NCT03604341|Analgesics|analgesics|mesh-ancestor
2145456|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
2145457|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145458|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2145459|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2145460|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2593064|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593065|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2593066|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
2593067|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2593068|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593069|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2593070|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2593071|NCT01724268|Prednisolone|prednisolone|mesh-list
2593072|NCT01724268|Methotrexate|methotrexate|mesh-list
2593073|NCT01724268|Methamphetamine|methamphetamine|mesh-list
2593074|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2593075|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
2593076|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2593077|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593078|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2593079|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
2593080|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593081|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593082|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
2593083|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593084|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2593085|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2593086|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
2593087|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2593088|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2593089|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2593090|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
2593091|NCT01724268|Hormones|hormones|mesh-ancestor
2593092|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2593093|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2593094|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
2593095|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593096|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2593097|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
2593098|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
2593099|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2593100|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
2593101|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2593102|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2593103|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2593104|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2593105|NCT01724346|Chlorambucil|chlorambucil|mesh-list
2593106|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2593107|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
2593108|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593109|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593110|NCT01724372|Aripiprazole|aripiprazole|mesh-list
2593111|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
2593112|NCT01724372|Fluoxetine|fluoxetine|mesh-list
2593113|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
2593114|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2593115|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2593116|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2593117|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593118|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
2593119|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
2593120|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2593121|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593122|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2593123|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2593124|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
2593125|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2593126|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2593127|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2593128|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2593129|NCT01724372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2593130|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2593131|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2593132|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2593133|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2593134|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2593135|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593136|NCT01724385|Bevacizumab|bevacizumab|mesh-list
2593137|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2593138|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593139|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2593140|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2145461|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145462|NCT03604341|Hormones|hormones|mesh-ancestor
2145463|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2145464|NCT03605212|Febuxostat|febuxostat|mesh-list
2145465|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
2145466|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2145467|NCT03605914|Acetaminophen|acetaminophen|mesh-list
2145468|NCT03605914|Diclofenac|diclofenac|mesh-list
2593141|NCT01724385|Growth Substances|growth substances|mesh-ancestor
2593142|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593143|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
2593144|NCT01724424|Melatonin|melatonin|mesh-list
2593145|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
2593146|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145469|NCT03605914|Hydrocodone|hydrocodone|mesh-list
2145470|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2145471|NCT03605914|Analgesics|analgesics|mesh-ancestor
2145472|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
2145473|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145474|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145475|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
2145476|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2145477|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2145478|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2145479|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2145480|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145481|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145482|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2145483|NCT03605914|Narcotics|narcotics|mesh-ancestor
2145484|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145485|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
2145486|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
2145487|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
2145488|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
2145489|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145490|NCT03607539|Pemetrexed|pemetrexed|mesh-list
2145491|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145492|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145493|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145494|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2145495|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2145496|NCT03608488|Vitamin D|vitamin d|mesh-list
2145497|NCT03608488|Vitamins|vitamins|mesh-ancestor
2145498|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
2145499|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145500|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2145501|NCT03608774|Azithromycin|azithromycin|mesh-list
2145502|NCT03608774|Doxycycline|doxycycline|mesh-list
2145503|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2145504|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145505|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
2145506|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2145507|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2145508|NCT03608839|Dexamethasone|dexamethasone|mesh-list
2145509|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
2145510|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2145511|NCT03608839|BB 1101|bb 1101|mesh-list
2145512|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2145513|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
2145514|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
2145515|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593147|NCT01724424|Protective Agents|protective agents|mesh-ancestor
2593148|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593149|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2593150|NCT01724450|Carvedilol|carvedilol|mesh-list
2593151|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2593152|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2145516|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145517|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2145518|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
2145519|NCT03608839|Hormones|hormones|mesh-ancestor
2145520|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2145521|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2145522|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145523|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
2145524|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145525|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593153|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
2593154|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2593155|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593156|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593157|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2593158|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
2593159|NCT01724450|Protective Agents|protective agents|mesh-ancestor
2593160|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2593161|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2593162|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2593163|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
2593164|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2593165|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2145526|NCT03610399|Primaquine|primaquine|mesh-list
2145527|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
2145528|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2145529|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2145530|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145531|NCT03610464|Amphetamine|amphetamine|mesh-list
2145532|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2145533|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145534|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
2145535|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
2145536|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145537|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
2145538|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145539|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145540|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
2145541|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2145542|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2145543|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2145544|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2145545|NCT03610633|Oxytocin|oxytocin|mesh-list
2145546|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
2145547|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2145548|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145549|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
2145550|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2145551|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145552|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2145553|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2145554|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145555|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145556|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145557|NCT03614975|Vaccines|vaccines|mesh-list
2145558|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
2145559|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145560|NCT03615404|Molgramostim|molgramostim|mesh-list
2145561|NCT03615404|Sargramostim|sargramostim|mesh-list
2145562|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
2145563|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145564|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145565|NCT03615482|Vaccines|vaccines|mesh-list
2145566|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
2145567|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145568|NCT03615534|Niacin|niacin|mesh-list
2145569|NCT03615534|Fenofibrate|fenofibrate|mesh-list
2145570|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2145571|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
2593166|NCT01724554|Aflibercept|aflibercept|mesh-list
2593167|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2593168|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2593169|NCT01724554|Growth Substances|growth substances|mesh-ancestor
2593170|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593171|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
2593172|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593173|NCT01724606|Sorafenib|sorafenib|mesh-list
2593174|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593175|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2593176|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593177|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593178|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
2593179|NCT01724619|Androgens|androgens|mesh-ancestor
2593180|NCT01724619|Hormones|hormones|mesh-ancestor
2593181|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2593182|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593183|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
2593184|NCT01724658|Testosterone|testosterone|mesh-list
2593185|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
2593186|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
2593187|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2593188|NCT01724658|Androgens|androgens|mesh-ancestor
2593189|NCT01724658|Hormones|hormones|mesh-ancestor
2593190|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2593191|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593192|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2593193|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593194|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
2593195|NCT01724723|Entecavir|entecavir|mesh-list
2593196|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
2593197|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593198|NCT01724788|Furosemide|furosemide|mesh-list
2593199|NCT01724788|Diuretics|diuretics|mesh-ancestor
2593200|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
2593201|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593202|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2593203|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2593204|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593205|NCT01724814|Insulin|insulin|mesh-list
2593206|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2593207|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593208|NCT01724866|Cyclophosphamide|cyclophosphamide|mesh-list
2593209|NCT01724866|Docetaxel|docetaxel|mesh-list
2593210|NCT01724866|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2593211|NCT01724866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2593212|NCT01724866|Immunologic Factors|immunologic factors|mesh-ancestor
2593213|NCT01724866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593214|NCT01724866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2593215|NCT01724866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2593216|NCT01724866|Alkylating Agents|alkylating agents|mesh-ancestor
2593217|NCT01724866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593218|NCT01724866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593219|NCT01724866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2593220|NCT01724866|Tubulin Modulators|tubulin modulators|mesh-ancestor
2593221|NCT01724866|Antimitotic Agents|antimitotic agents|mesh-ancestor
2593222|NCT01724866|Mitosis Modulators|mitosis modulators|mesh-ancestor
2145572|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145573|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2145574|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
2145575|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
2145576|NCT03615534|Vitamins|vitamins|mesh-ancestor
2593228|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2593229|NCT01724892|Dexamethasone|dexamethasone|mesh-list
2593230|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2593231|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
2593232|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
2593233|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593234|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593235|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2145577|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
2145578|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145579|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2145580|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145581|NCT03615924|Ticagrelor|ticagrelor|mesh-list
2145582|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2145583|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2145584|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2145585|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2145586|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
2145587|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145588|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145589|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145590|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
2145591|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2145592|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145593|NCT03617523|Vaccines|vaccines|mesh-list
2145594|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
2145595|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145596|NCT03617861|Secretin|secretin|mesh-list
2145597|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2145598|NCT03617861|Hormones|hormones|mesh-ancestor
2145599|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2145600|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145601|NCT03617913|Cisplatin|cisplatin|mesh-list
2145602|NCT03617913|Fluorouracil|fluorouracil|mesh-list
2145603|NCT03617913|Mitomycins|mitomycins|mesh-list
2145604|NCT03617913|Mitomycin|mitomycin|mesh-list
2145605|NCT03617913|Avelumab|avelumab|mesh-list
2145606|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2145607|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593236|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
2593237|NCT01724892|Hormones|hormones|mesh-ancestor
2593238|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2593239|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2593240|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593241|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2593242|NCT01724918|Lacosamide|lacosamide|mesh-list
2593243|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
2593244|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2593245|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2593246|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2593247|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593248|NCT01724931|Aminopterin|aminopterin|mesh-list
2593249|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2593250|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593251|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593252|NCT01724983|Fentanyl|fentanyl|mesh-list
2593253|NCT01724983|Ketamine|ketamine|mesh-list
2593254|NCT01724983|Analgesics|analgesics|mesh-ancestor
2593255|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
2593256|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593257|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593258|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2593259|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2593260|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
2593261|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
2593262|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2593263|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2593264|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2593265|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2593266|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593267|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2593268|NCT01724983|Narcotics|narcotics|mesh-ancestor
2593269|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2593270|NCT01725009|Levetiracetam|levetiracetam|mesh-list
2593271|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
2593272|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
2593273|NCT01725048|Mirtazapine|mirtazapine|mesh-list
2593274|NCT01725048|Citalopram|citalopram|mesh-list
2593275|NCT01725048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2593276|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2593277|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2593278|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145608|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
2593279|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2593280|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
2593281|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593282|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2593283|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
2593284|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2593285|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2593286|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
2593287|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
2593288|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2145609|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145610|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2145611|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2593289|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2593290|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2593291|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2593292|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2593293|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2593294|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
2593295|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2593296|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2593297|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2593298|NCT01725087|Tapentadol|tapentadol|mesh-list
2593299|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2593300|NCT01725087|Narcotics|narcotics|mesh-ancestor
2593301|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2593302|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593303|NCT01725087|Analgesics|analgesics|mesh-ancestor
2593304|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
2593305|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593306|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2593307|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2593308|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2593309|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593310|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
2593311|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2593312|NCT01725100|Trametinib|trametinib|mesh-list
2593313|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2593314|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593315|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2593316|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593317|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593318|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2593319|NCT01725100|Protective Agents|protective agents|mesh-ancestor
2593320|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593321|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2593322|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
2593323|NCT01725113|Calcitriol|calcitriol|mesh-list
2593324|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2593325|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593326|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2593327|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2593328|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593329|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2593330|NCT01725113|Vitamins|vitamins|mesh-ancestor
2593331|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
2593332|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2593333|NCT01725152|Ganaxolone|ganaxolone|mesh-list
2593334|NCT01725152|Neurosteroids|neurosteroids|mesh-ancestor
2593335|NCT01725152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2593336|NCT01725152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593337|NCT01725152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593338|NCT01725152|GABA Modulators|gaba modulators|mesh-ancestor
2593339|NCT01725152|GABA Agents|gaba agents|mesh-ancestor
2593340|NCT01725204|Dasatinib|dasatinib|mesh-list
2593341|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593342|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2593343|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145612|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
2145613|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145614|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2145615|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
2145616|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2145617|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593344|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593345|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2593346|NCT01725230|Simvastatin|simvastatin|mesh-list
2593347|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2593348|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2593349|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
2593350|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593351|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2145618|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2145619|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
2145620|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2145621|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145622|NCT03618641|Nivolumab|nivolumab|mesh-list
2145623|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2145624|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145625|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2145626|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593352|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2593353|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593354|NCT01725243|Carbetocin|carbetocin|mesh-list
2593355|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
2593356|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2593357|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593358|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2593359|NCT01725360|Montelukast|montelukast|mesh-list
2593360|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2593361|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
2593362|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2593363|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
2593364|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2593365|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593366|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2593367|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2145627|NCT03618823|Acetaminophen|acetaminophen|mesh-list
2145628|NCT03618823|Ibuprofen|ibuprofen|mesh-list
2145629|NCT03618823|Oxycodone|oxycodone|mesh-list
2145630|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2145631|NCT03618823|Analgesics|analgesics|mesh-ancestor
2145632|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
2145633|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145634|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145635|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
2145636|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2145637|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2145638|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2145639|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2145640|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145641|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145642|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2145643|NCT03618823|Narcotics|narcotics|mesh-ancestor
2145644|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145645|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
2145646|NCT03619837|Velpatasvir|velpatasvir|mesh-list
2145647|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
2593368|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593369|NCT01725412|Thiamine|thiamine|mesh-list
2593370|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
2593371|NCT01725412|Vitamins|vitamins|mesh-ancestor
2593372|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
2145648|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
2145649|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145650|NCT03620162|Vaccines|vaccines|mesh-list
2145651|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
2145652|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145653|NCT03620708|Nicotine|nicotine|mesh-list
2145654|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2145655|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
2145656|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145657|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145658|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2145659|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2145660|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
2145661|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145662|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593373|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593374|NCT01725477|Methylene Blue|methylene blue|mesh-list
2593375|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593376|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593377|NCT01725490|Metformin|metformin|mesh-list
2593378|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2593379|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593380|NCT01725542|Ribavirin|ribavirin|mesh-list
2593381|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2593382|NCT01725542|Asunaprevir|asunaprevir|mesh-list
2593383|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
2593384|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593385|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
2593386|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593387|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
2593388|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593389|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
2145663|NCT03620890|Protamines|protamines|mesh-list
2145664|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
2145665|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145666|NCT03620890|Coagulants|coagulants|mesh-ancestor
2145667|NCT03621085|Ketamine|ketamine|mesh-list
2145668|NCT03621085|Analgesics|analgesics|mesh-ancestor
2145669|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
2145670|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145671|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145672|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2145673|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2145674|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
2145675|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
2145676|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145677|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2145678|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2145679|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145680|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145681|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2593390|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2593391|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593392|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
2593393|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
2593394|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
2593395|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
2593396|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
2593397|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593398|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
2593399|NCT01725607|Anesthetics|anesthetics|mesh-list
2593400|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2593401|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593402|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2593403|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2593404|NCT01725607|Analgesics|analgesics|mesh-ancestor
2593405|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
2593406|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593407|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2593408|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2593409|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2593410|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
2593411|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2593412|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593413|NCT01725620|Etanercept|etanercept|mesh-list
2593414|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2593415|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2593416|NCT01725620|Analgesics|analgesics|mesh-ancestor
2593417|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
2593418|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593419|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593420|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2593421|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2593422|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2593423|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2593424|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
2593425|NCT01725672|Metformin|metformin|mesh-list
2593426|NCT01725672|Glimepiride|glimepiride|mesh-list
2593427|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2593428|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145682|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2145683|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
2145684|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2145685|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145686|NCT03623373|Cytarabine|cytarabine|mesh-list
2145687|NCT03623373|Rituximab|rituximab|mesh-list
2145688|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2145689|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
2145690|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2145691|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145692|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
2145693|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145694|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2145695|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2145696|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
2145697|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145698|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
2145699|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145700|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2145701|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2145702|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
2145703|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
2145704|NCT03624946|Antibodies|antibodies|mesh-list
2145705|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
2145706|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2145707|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2145708|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
2593429|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2593430|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2593431|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
2593432|NCT01725776|Milrinone|milrinone|mesh-list
2593433|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2593434|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2593435|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
2593436|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2593437|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2593438|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593439|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593440|NCT01725776|Protective Agents|protective agents|mesh-ancestor
2593441|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593442|NCT01725802|Levodopa|levodopa|mesh-list
2593443|NCT01725802|Carbidopa|carbidopa|mesh-list
2593444|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2593445|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2593446|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
2593447|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2593448|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593449|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593450|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2593451|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593452|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2593453|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2593454|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593455|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
2593456|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2593457|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2593458|NCT01726075|Somatostatin|somatostatin|mesh-list
2593459|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2593460|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2593461|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2593462|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2593463|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2593464|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
2593465|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2593466|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593467|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593468|NCT01726075|Hormones|hormones|mesh-ancestor
2593469|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2593470|NCT01726088|Modafinil|modafinil|mesh-list
2593471|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2593472|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593473|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2593474|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2593475|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2145709|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
2145710|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145711|NCT03626415|Abrocitinib|abrocitinib|mesh-list
2145712|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2145713|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145714|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145715|NCT03626714|Tacrolimus|tacrolimus|mesh-list
2145716|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2145717|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
2145718|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145719|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2145720|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145721|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145722|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2145723|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2145724|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2145725|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145726|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145727|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2145728|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2145729|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2145730|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2145731|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
2145732|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145733|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145734|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2145735|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2145736|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
2145737|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2145738|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2145739|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
2593476|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593477|NCT01726192|Ropivacaine|ropivacaine|mesh-list
2593478|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
2593479|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
2593480|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2593481|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593482|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
2593483|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593484|NCT01726205|Pregabalin|pregabalin|mesh-list
2593485|NCT01726205|Ropivacaine|ropivacaine|mesh-list
2593486|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
2593487|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
2593488|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2593489|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593490|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
2593491|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593492|NCT01726205|Analgesics|analgesics|mesh-ancestor
2593493|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
2593494|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2593495|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2593496|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593497|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2593498|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2593499|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2593500|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2593501|NCT01726283|Riboflavin|riboflavin|mesh-list
2593502|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
2593503|NCT01726283|Vitamins|vitamins|mesh-ancestor
2593504|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
2593505|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593506|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2593507|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
2593508|NCT01726400|Interferons|interferons|mesh-list
2593509|NCT01726400|Ribavirin|ribavirin|mesh-list
2593510|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
2593511|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145740|NCT03627767|Abrocitinib|abrocitinib|mesh-list
2145741|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2145742|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145743|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145744|NCT03628417|Bleomycin|bleomycin|mesh-list
2145745|NCT03628417|Calcium|calcium|mesh-list
2145746|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2145747|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593512|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
2593513|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593514|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
2593515|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593516|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
2593517|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593546|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
2593547|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
2593548|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2593549|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2593550|NCT01726465|Prednisolone|prednisolone|mesh-list
2593551|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
2593552|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2593553|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
2145748|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2145749|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145750|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2145751|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
2145752|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145753|NCT03629054|Metformin|metformin|mesh-list
2145754|NCT03629054|Empagliflozin|empagliflozin|mesh-list
2145755|NCT03629054|Linagliptin|linagliptin|mesh-list
2145756|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2145757|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145758|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2145759|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145760|NCT03629054|Incretins|incretins|mesh-ancestor
2145761|NCT03629054|Hormones|hormones|mesh-ancestor
2145762|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2145763|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2145764|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
2145765|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145766|NCT03629184|Oseltamivir|oseltamivir|mesh-list
2593554|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2593555|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2593556|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
2593557|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
2593558|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593559|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593560|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2593561|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
2145767|NCT03629184|Baloxavir|baloxavir|mesh-list
2145768|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
2145769|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145770|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145771|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145772|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
2145773|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2593562|NCT01726465|Hormones|hormones|mesh-ancestor
2593563|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2593564|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2593565|NCT01726465|Protective Agents|protective agents|mesh-ancestor
2593566|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2593567|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593568|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
2593569|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593570|NCT01726465|Expectorants|expectorants|mesh-ancestor
2593571|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
2593572|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2593573|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
2593574|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593575|NCT01726465|Antidotes|antidotes|mesh-ancestor
2593576|NCT01726478|Oxytocin|oxytocin|mesh-list
2593577|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
2593578|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2593579|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593580|NCT01726530|Fentanyl|fentanyl|mesh-list
2593581|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2593582|NCT01726530|Narcotics|narcotics|mesh-ancestor
2145774|NCT03629249|Growth Substances|growth substances|mesh-ancestor
2145775|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145776|NCT03629925|Gemcitabine|gemcitabine|mesh-list
2145777|NCT03629925|Carboplatin|carboplatin|mesh-list
2593583|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2593584|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593585|NCT01726530|Analgesics|analgesics|mesh-ancestor
2593586|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
2593587|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593588|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2593589|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2593590|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
2593591|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
2145778|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145779|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2145780|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
2145781|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145782|NCT03629925|Antiviral Agents|antiviral agents|mesh-ancestor
2593592|NCT01726582|Leucovorin|leucovorin|mesh-list
2593593|NCT01726582|Gemcitabine|gemcitabine|mesh-list
2593594|NCT01726582|Paclitaxel|paclitaxel|mesh-list
2593595|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2593596|NCT01726582|Capecitabine|capecitabine|mesh-list
2593597|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
2593598|NCT01726582|Irinotecan|irinotecan|mesh-list
2593599|NCT01726582|Cisplatin|cisplatin|mesh-list
2593600|NCT01726582|Folfirinox|folfirinox|mesh-list
2593601|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2593602|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593603|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
2593604|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
2593605|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
2593606|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593607|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2593608|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
2593609|NCT01726582|Antiviral Agents|antiviral agents|mesh-ancestor
2593610|NCT01726582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593611|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593612|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2593613|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
2593614|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593615|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2593616|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2593617|NCT01726582|Antidotes|antidotes|mesh-ancestor
2593618|NCT01726582|Protective Agents|protective agents|mesh-ancestor
2145783|NCT03629925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145784|NCT03629925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145785|NCT03629925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2145786|NCT03629925|Immunologic Factors|immunologic factors|mesh-ancestor
2145787|NCT03629925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593619|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
2593620|NCT01726582|Vitamins|vitamins|mesh-ancestor
2593621|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
2593622|NCT01726686|Ropivacaine|ropivacaine|mesh-list
2593623|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
2593624|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
2593625|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2593626|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593627|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
2593628|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593629|NCT01726725|Desflurane|desflurane|mesh-list
2593630|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2593631|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
2593632|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
2593633|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2593634|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593635|NCT01726764|Metformin|metformin|mesh-list
2593636|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2145788|NCT03630198|Lidocaine|lidocaine|mesh-list
2145789|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
2145790|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
2145791|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145792|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145793|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
2593637|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593638|NCT01726777|Vitamin D|vitamin d|mesh-list
2593639|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
2593640|NCT01726777|Vitamins|vitamins|mesh-list
2593641|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
2593642|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593643|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2593644|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2593645|NCT01726816|Probucol|probucol|mesh-list
2593646|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2593647|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2593648|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
2593649|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593650|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2593651|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
2593652|NCT01726816|Protective Agents|protective agents|mesh-ancestor
2593653|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593654|NCT01726829|Pancrelipase|pancrelipase|mesh-list
2593655|NCT01726829|Pancreatin|pancreatin|mesh-list
2593656|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2593657|NCT01726920|Naproxen|naproxen|mesh-list
2593658|NCT01726920|Naratriptan|naratriptan|mesh-list
2420673|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420674|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
2420675|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420676|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593659|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2593660|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2593661|NCT01726920|Analgesics|analgesics|mesh-ancestor
2593662|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
2593663|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593664|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593665|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2593666|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2593667|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
2593668|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2593669|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593670|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593671|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2593672|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2593673|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2593674|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
2593675|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2593676|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2420677|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2420678|NCT00809068|Tibolone|tibolone|mesh-list
2420679|NCT00809068|Fenofibrate|fenofibrate|mesh-list
2420680|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2420681|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
2420682|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420683|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2420684|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
2420685|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
2420686|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2420687|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420688|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2420689|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2420690|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420691|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2420692|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
2420693|NCT00809068|Hormones|hormones|mesh-ancestor
2420694|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2593677|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
2593678|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2593679|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
2593680|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593681|NCT01726946|Ribavirin|ribavirin|mesh-list
2593682|NCT01726946|Antimetabolites|antimetabolites|mesh-ancestor
2593683|NCT01726946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593684|NCT01726946|Antiviral Agents|antiviral agents|mesh-ancestor
2593685|NCT01726946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593686|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2593687|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
2593688|NCT01727050|Coagulants|coagulants|mesh-ancestor
2593689|NCT01727193|Azathioprine|azathioprine|mesh-list
2593690|NCT01727193|Leflunomide|leflunomide|mesh-list
2593691|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
2593692|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593693|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2593694|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593695|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2593696|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
2593697|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593698|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2593699|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593700|NCT01727271|Interferons|interferons|mesh-list
2593701|NCT01727271|Tenofovir|tenofovir|mesh-list
2593702|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
2593703|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
2593704|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2593705|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593706|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
2593707|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593708|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2593709|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2593710|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593711|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593712|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2593713|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2593714|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
2593715|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593716|NCT01727401|PENTA|penta|mesh-list
2593717|NCT01727401|Fondaparinux|fondaparinux|mesh-list
2593718|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2593719|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
2593720|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2593721|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
2593722|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593723|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593724|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
2593725|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2593726|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2593727|NCT01727427|Aspirin|aspirin|mesh-list
2593728|NCT01727427|Vitamin K|vitamin k|mesh-list
2593729|NCT01727427|Heparin|heparin|mesh-list
2593730|NCT01727427|Enoxaparin|enoxaparin|mesh-list
2593731|NCT01727427|Dalteparin|dalteparin|mesh-list
2593732|NCT01727427|Tinzaparin|tinzaparin|mesh-list
2593733|NCT01727427|PENTA|penta|mesh-list
2593734|NCT01727427|Nadroparin|nadroparin|mesh-list
2593735|NCT01727427|Warfarin|warfarin|mesh-list
2593736|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
2593737|NCT01727427|Dabigatran|dabigatran|mesh-list
2593738|NCT01727427|Apixaban|apixaban|mesh-list
2593739|NCT01727427|Fondaparinux|fondaparinux|mesh-list
2145794|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145795|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2145796|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2145797|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2145798|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2145799|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145800|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
2145801|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2145802|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2145803|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145804|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
2145805|NCT03631355|Coagulants|coagulants|mesh-ancestor
2145806|NCT03631433|Acetaminophen|acetaminophen|mesh-list
2145807|NCT03631433|Ibuprofen|ibuprofen|mesh-list
2593740|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
2593741|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
2593742|NCT01727427|Bemiparin|bemiparin|mesh-list
2593743|NCT01727427|Vitamins|vitamins|mesh-ancestor
2593744|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
2145808|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2593745|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593746|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2593747|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2593748|NCT01727427|Analgesics|analgesics|mesh-ancestor
2593749|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
2593750|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593751|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2593752|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2593753|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2593754|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2593755|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593756|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2593757|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2593758|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593759|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
2593760|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
2593761|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2593762|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
2593763|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2593764|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
2593765|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2593766|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
2593767|NCT01727427|Coagulants|coagulants|mesh-ancestor
2593768|NCT01727453|Warfarin|warfarin|mesh-list
2593769|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
2593770|NCT01727531|Chloroquine|chloroquine|mesh-list
2593771|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2593772|NCT01727531|Amebicides|amebicides|mesh-ancestor
2593773|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2593774|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2593775|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593776|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
2593777|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2593778|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2593779|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2593780|NCT01727531|Analgesics|analgesics|mesh-ancestor
2593781|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
2593782|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593783|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593784|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2593785|NCT01727531|Filaricides|filaricides|mesh-ancestor
2593786|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
2593787|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
2593788|NCT01727557|Anesthetics|anesthetics|mesh-list
2593789|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2593790|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593791|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2593792|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2593793|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593794|NCT01727778|Antibodies|antibodies|mesh-list
2593795|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
2593796|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
2593797|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420695|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2420696|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420697|NCT00809172|Cyclosporine|cyclosporine|mesh-list
2420698|NCT00809172|Methotrexate|methotrexate|mesh-list
2420699|NCT00809172|Cyclosporins|cyclosporins|mesh-list
2420700|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2420701|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
2420702|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2420703|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420704|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2420705|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
2420706|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420707|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420708|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
2420709|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420710|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2420711|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2420712|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
2420713|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2593798|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
2593799|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2145809|NCT03631433|Analgesics|analgesics|mesh-ancestor
2145810|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
2593800|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2593801|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593802|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
2593803|NCT01727843|Coagulants|coagulants|mesh-ancestor
2593804|NCT01727869|Cetuximab|cetuximab|mesh-list
2593805|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2593806|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2593807|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593808|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2593809|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593810|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593811|NCT01727973|Doxycycline|doxycycline|mesh-list
2593812|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2593813|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593814|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
2593815|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2593816|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2593817|NCT01728025|Ranolazine|ranolazine|mesh-list
2593818|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2593819|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2593820|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593821|NCT01728051|Melphalan|melphalan|mesh-list
2593822|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2593823|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
2593824|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593825|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593826|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2593827|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2593828|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
2593829|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593830|NCT01728064|Ubiquinone|ubiquinone|mesh-list
2593831|NCT01728064|Micronutrients|micronutrients|mesh-ancestor
2593832|NCT01728064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593833|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
2593834|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2593835|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593836|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
2593837|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2593838|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593839|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2593840|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593841|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593842|NCT01728259|Dexamethasone|dexamethasone|mesh-list
2593843|NCT01728259|Bortezomib|bortezomib|mesh-list
2593844|NCT01728259|Pomalidomide|pomalidomide|mesh-list
2593845|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2593846|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
2593847|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
2593848|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593849|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145811|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145812|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145813|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
2145814|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2145815|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2145816|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2593850|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2593851|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
2593852|NCT01728259|Hormones|hormones|mesh-ancestor
2593853|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2593854|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2593855|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593856|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
2593857|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2593858|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2593859|NCT01728259|Growth Substances|growth substances|mesh-ancestor
2593860|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
2593861|NCT01728272|Metoprolol|metoprolol|mesh-list
2593862|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2593863|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2145817|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2145818|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145819|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145820|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
2145821|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2593864|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
2593865|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
2593866|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2593867|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593868|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2593869|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2145822|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
2145823|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145824|NCT03632109|Gentamicins|gentamicins|mesh-list
2145825|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2145826|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145827|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2145828|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145829|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145830|NCT03633331|Letrozole|letrozole|mesh-list
2145831|NCT03633331|Fulvestrant|fulvestrant|mesh-list
2145832|NCT03633331|Palbociclib|palbociclib|mesh-list
2145833|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145834|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2145835|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2145836|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145837|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145838|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2145839|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
2145840|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2593870|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2593871|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
2593872|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145841|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145842|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2145843|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2145844|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2145845|NCT03633344|Silicon|silicon|mesh-list
2145846|NCT03633344|Trace Elements|trace elements|mesh-ancestor
2145847|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
2145848|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145849|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
2145850|NCT03633448|Guaifenesin|guaifenesin|mesh-list
2593873|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593874|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2593875|NCT01728363|Rifampin|rifampin|mesh-list
2593876|NCT01728363|Clindamycin|clindamycin|mesh-list
2593877|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
2593878|NCT01728363|Ticarcillin|ticarcillin|mesh-list
2593879|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
2593880|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593881|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2593882|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
2593883|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
2593884|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2593885|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593886|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593887|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2593888|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2593889|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2593890|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2593891|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2145851|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2145852|NCT03633448|Expectorants|expectorants|mesh-ancestor
2145853|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
2145854|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2145855|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2145856|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
2145857|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145858|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145859|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145860|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
2145861|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2145862|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
2145863|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
2145864|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145865|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
2145866|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2145867|NCT03633487|Guaifenesin|guaifenesin|mesh-list
2145868|NCT03633487|Expectorants|expectorants|mesh-ancestor
2145869|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
2145870|NCT03633526|Ivacaftor|ivacaftor|mesh-list
2145871|NCT03633526|VX-659|vx-659|mesh-list
2145872|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2145873|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2145874|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145875|NCT03634800|Nivolumab|nivolumab|mesh-list
2145876|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2145877|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145878|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2593892|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2593893|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2593894|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2593895|NCT01728441|Paclitaxel|paclitaxel|mesh-list
2593896|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2593897|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2593898|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145879|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145880|NCT03635957|Folic Acid|folic acid|mesh-list
2145881|NCT03635957|Methotrexate|methotrexate|mesh-list
2145882|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2145883|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
2145884|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2145885|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145886|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2145887|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
2145888|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145889|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145890|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
2145891|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145892|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2145893|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2145894|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
2593899|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
2593900|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
2593901|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
2593902|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593903|NCT01728480|Cisplatin|cisplatin|mesh-list
2593904|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593905|NCT01728571|Vitamin D|vitamin d|mesh-list
2593906|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
2593907|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
2593908|NCT01728571|Vitamins|vitamins|mesh-list
2593909|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
2593910|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593911|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2593912|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2593913|NCT01728740|Metformin|metformin|mesh-list
2593914|NCT01728740|Acarbose|acarbose|mesh-list
2593915|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2593916|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593917|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2593918|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593919|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593920|NCT01728753|Favipiravir|favipiravir|mesh-list
2593921|NCT01728753|Antiviral Agents|antiviral agents|mesh-ancestor
2593922|NCT01728753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593923|NCT01728818|Gemcitabine|gemcitabine|mesh-list
2593924|NCT01728818|Afatinib|afatinib|mesh-list
2593925|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2593926|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
2593927|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593928|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593929|NCT01728818|Antiviral Agents|antiviral agents|mesh-ancestor
2593930|NCT01728818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593931|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593932|NCT01728818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2593933|NCT01728818|Immunologic Factors|immunologic factors|mesh-ancestor
2593934|NCT01728818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593935|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2593936|NCT01728909|Oxytocin|oxytocin|mesh-list
2593937|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
2593938|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2593939|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145895|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2145896|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2145897|NCT03635957|Hematinics|hematinics|mesh-ancestor
2145898|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
2145899|NCT03635957|Vitamins|vitamins|mesh-ancestor
2145900|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
2593940|NCT01728922|Vitamin D|vitamin d|mesh-list
2593941|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
2593942|NCT01728922|Vitamins|vitamins|mesh-list
2593943|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
2593944|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593945|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2593946|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2593947|NCT01728935|Tenofovir|tenofovir|mesh-list
2593948|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
2593949|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593950|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2593951|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2593952|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593953|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593954|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2593955|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2593956|NCT01728948|Sorafenib|sorafenib|mesh-list
2593957|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593958|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2593959|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593960|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593961|NCT01728961|Lumefantrine|lumefantrine|mesh-list
2593962|NCT01728961|Artemether|artemether|mesh-list
2593963|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2593964|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
2593965|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2593966|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2593967|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593968|NCT01728974|Anesthetics|anesthetics|mesh-list
2145901|NCT03636061|Varenicline|varenicline|mesh-list
2145902|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2145903|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2145904|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
2593969|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2593970|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593971|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
2593972|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2593973|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593974|NCT01728987|Vitamins|vitamins|mesh-ancestor
2593975|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
2593976|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2593977|NCT01729104|Rituximab|rituximab|mesh-list
2593978|NCT01729104|Lenalidomide|lenalidomide|mesh-list
2593979|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2593980|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593981|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
2593982|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2593983|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2593984|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2593985|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2593986|NCT01729104|Growth Substances|growth substances|mesh-ancestor
2593987|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
2593988|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
2593989|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2593990|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2593991|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2593992|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2593993|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2593994|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2593995|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2593996|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2145905|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145906|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145907|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145908|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2145909|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2145910|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
2145911|NCT03638635|Bupivacaine|bupivacaine|mesh-list
2145912|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
2145913|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
2145914|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145915|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145916|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
2145917|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145918|NCT03638908|Fluoxetine|fluoxetine|mesh-list
2145919|NCT03638908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2145920|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2145921|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2145922|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145923|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2145924|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
2145925|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145926|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2145927|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
2145928|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2593997|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2593998|NCT01729260|Mebendazole|mebendazole|mesh-list
2593999|NCT01729260|Piperazine|piperazine|mesh-list
2594000|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
2594001|NCT01729260|DMP 777|dmp 777|mesh-list
2594002|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
2594003|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
2594004|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2594005|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594006|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
2594007|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
2594008|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
2594009|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594010|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594011|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594012|NCT01729403|Metformin|metformin|mesh-list
2594013|NCT01729403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2594014|NCT01729403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594015|NCT01729468|Aspirin|aspirin|mesh-list
2594016|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2594017|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2594018|NCT01729468|Analgesics|analgesics|mesh-ancestor
2594019|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
2594020|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594021|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594022|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2594023|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2594024|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2594025|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2594026|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594027|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2145929|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2145930|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2145931|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2145932|NCT03639675|Aflibercept|aflibercept|mesh-list
2145933|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2145934|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2145935|NCT03639675|Growth Substances|growth substances|mesh-ancestor
2145936|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145937|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
2145938|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145939|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2145940|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2145941|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2145942|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2145943|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145944|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
2145945|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2594028|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2594029|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594030|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
2594031|NCT01729481|Leucovorin|leucovorin|mesh-list
2594032|NCT01729481|Folic Acid|folic acid|mesh-list
2594033|NCT01729481|Gemcitabine|gemcitabine|mesh-list
2594034|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
2594035|NCT01729481|Irinotecan|irinotecan|mesh-list
2594036|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
2594037|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2594038|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
2594039|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594040|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594041|NCT01729481|Antiviral Agents|antiviral agents|mesh-ancestor
2594042|NCT01729481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145946|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145947|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2145948|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2145949|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
2145950|NCT03639779|Antidotes|antidotes|mesh-ancestor
2594043|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594044|NCT01729481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2594045|NCT01729481|Immunologic Factors|immunologic factors|mesh-ancestor
2594046|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594047|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2594048|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2594049|NCT01729481|Antidotes|antidotes|mesh-ancestor
2594050|NCT01729481|Protective Agents|protective agents|mesh-ancestor
2594051|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
2594052|NCT01729481|Vitamins|vitamins|mesh-ancestor
2594053|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
2594054|NCT01729481|Hematinics|hematinics|mesh-ancestor
2594055|NCT01729663|Interferons|interferons|mesh-list
2594056|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
2145951|NCT03639779|Protective Agents|protective agents|mesh-ancestor
2145952|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145953|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
2145954|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145955|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
2145956|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2145957|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145958|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
2145959|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
2145960|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
2594057|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
2594058|NCT01729663|Molgramostim|molgramostim|mesh-list
2594059|NCT01729663|Sargramostim|sargramostim|mesh-list
2594060|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
2594061|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594062|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
2594063|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594064|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
2594065|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594066|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2594067|NCT01729767|Acyclovir|acyclovir|mesh-list
2594068|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
2594069|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594070|NCT01729806|Rituximab|rituximab|mesh-list
2594071|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2594072|NCT01729806|Ipilimumab|ipilimumab|mesh-list
2145961|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2145962|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2145963|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
2145964|NCT03641508|Dexamethasone|dexamethasone|mesh-list
2145965|NCT03641508|Triamcinolone|triamcinolone|mesh-list
2145966|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2145967|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
2145968|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
2145969|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594073|NCT01729806|Antibodies|antibodies|mesh-list
2594074|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
2594075|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2594076|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
2594077|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594078|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594079|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2594080|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2594081|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594082|NCT01729897|Fentanyl|fentanyl|mesh-list
2594083|NCT01729897|Propofol|propofol|mesh-list
2594084|NCT01729897|Etomidate|etomidate|mesh-list
2594085|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2594086|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594087|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594088|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2145970|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145971|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2145972|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
2145973|NCT03641508|Hormones|hormones|mesh-ancestor
2594089|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
2594090|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
2594091|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2594092|NCT01729897|Narcotics|narcotics|mesh-ancestor
2594093|NCT01729897|Analgesics|analgesics|mesh-ancestor
2145974|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2145975|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2145976|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2145977|NCT03642262|Guaifenesin|guaifenesin|mesh-list
2145978|NCT03642262|Expectorants|expectorants|mesh-ancestor
2594094|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
2594095|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594096|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2594097|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
2594098|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2594099|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594100|NCT01730027|Montelukast|montelukast|mesh-list
2145979|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
2145980|NCT03642457|Bupivacaine|bupivacaine|mesh-list
2145981|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
2145982|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
2145983|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145984|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145985|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
2145986|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594101|NCT01730027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2594102|NCT01730027|Respiratory System Agents|respiratory system agents|mesh-ancestor
2594103|NCT01730027|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2594104|NCT01730027|Hormone Antagonists|hormone antagonists|mesh-ancestor
2594105|NCT01730027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2594106|NCT01730027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594107|NCT01730027|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2594108|NCT01730027|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2594109|NCT01730027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594110|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2594111|NCT01730157|Ipilimumab|ipilimumab|mesh-list
2594112|NCT01730157|Antibodies|antibodies|mesh-list
2594113|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
2594114|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2594115|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
2594116|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594117|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594118|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2594119|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594120|NCT01730209|Everolimus|everolimus|mesh-list
2594121|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594122|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2594123|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
2594124|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594125|NCT01730222|Gemcitabine|gemcitabine|mesh-list
2594126|NCT01730222|Paclitaxel|paclitaxel|mesh-list
2594127|NCT01730222|Capecitabine|capecitabine|mesh-list
2594128|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2594129|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594130|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
2594131|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
2594132|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
2594133|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594134|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2594135|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
2594136|NCT01730222|Antiviral Agents|antiviral agents|mesh-ancestor
2594137|NCT01730222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594138|NCT01730222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594139|NCT01730222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2594140|NCT01730222|Immunologic Factors|immunologic factors|mesh-ancestor
2145987|NCT03642717|Empagliflozin|empagliflozin|mesh-list
2145988|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2145989|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2145990|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2145991|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2145992|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
2145993|NCT03642873|Hydrocodone|hydrocodone|mesh-list
2145994|NCT03642873|Guaifenesin|guaifenesin|mesh-list
2145995|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2145996|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2145997|NCT03642873|Narcotics|narcotics|mesh-ancestor
2145998|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2145999|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146000|NCT03642873|Analgesics|analgesics|mesh-ancestor
2594141|NCT01730222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594142|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
2594143|NCT01730287|Calcium|calcium|mesh-list
2594144|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2594145|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594146|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2594147|NCT01730313|Pyridoxine|pyridoxine|mesh-list
2146001|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
2146002|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146003|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
2146004|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
2146005|NCT03642873|Expectorants|expectorants|mesh-ancestor
2146006|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2146007|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2146008|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
2146009|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146010|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146011|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
2146012|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2146013|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
2146014|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
2146015|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
2146016|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2146017|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
2146018|NCT03643575|Guaifenesin|guaifenesin|mesh-list
2146019|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2146020|NCT03643575|Expectorants|expectorants|mesh-ancestor
2146021|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
2146022|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2146023|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2146024|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
2146025|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2594148|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
2594149|NCT01730313|Phenytoin|phenytoin|mesh-list
2594150|NCT01730313|Valproic Acid|valproic acid|mesh-list
2594151|NCT01730313|Vitamins|vitamins|mesh-ancestor
2594152|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
2594153|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594154|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
2594155|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
2594156|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594157|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594158|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
2594159|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2594160|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
2594161|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2594162|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594163|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2594164|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2594165|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2594166|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2594167|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2594168|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2594169|NCT01730326|Acetaminophen|acetaminophen|mesh-list
2594170|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2594171|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2594172|NCT01730326|Analgesics|analgesics|mesh-ancestor
2594173|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
2594174|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594175|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594176|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
2594177|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2594178|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2146026|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146027|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146028|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
2146029|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2146030|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
2146031|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
2146032|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146033|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
2146034|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2146035|NCT03643952|Daptomycin|daptomycin|mesh-list
2146036|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2146037|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594179|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2594180|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2594181|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594182|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594183|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594184|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2594185|NCT01730495|Etanercept|etanercept|mesh-list
2594186|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2594187|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2594188|NCT01730495|Analgesics|analgesics|mesh-ancestor
2594189|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
2594190|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594191|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594192|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2594193|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2146038|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
2146039|NCT03644095|Guaifenesin|guaifenesin|mesh-list
2146040|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2146041|NCT03644095|Expectorants|expectorants|mesh-ancestor
2146042|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
2146043|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2146044|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2146045|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
2146046|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146047|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146048|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146049|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
2146050|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2146051|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
2146052|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
2146053|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146054|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
2146055|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2146056|NCT03644108|Guaifenesin|guaifenesin|mesh-list
2146057|NCT03644108|Expectorants|expectorants|mesh-ancestor
2146058|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
2146059|NCT03644212|Vitamin D|vitamin d|mesh-list
2146060|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
2146061|NCT03644212|Vitamins|vitamins|mesh-list
2146062|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
2146063|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146064|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2146065|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2146088|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
2146089|NCT03647709|Narcotics|narcotics|mesh-ancestor
2146090|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146091|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146092|NCT03647709|Analgesics|analgesics|mesh-ancestor
2146093|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
2146094|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146095|NCT03649477|Carbetocin|carbetocin|mesh-list
2146096|NCT03649477|Oxytocin|oxytocin|mesh-list
2146097|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
2146098|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2146099|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594194|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2594195|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2594196|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
2594197|NCT01730508|Interferons|interferons|mesh-list
2594198|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
2594199|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146100|NCT03649750|Guaifenesin|guaifenesin|mesh-list
2146101|NCT03649750|Expectorants|expectorants|mesh-ancestor
2146102|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
2146103|NCT03650387|Lidocaine|lidocaine|mesh-list
2146104|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
2146105|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
2146106|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146107|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146108|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
2146109|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146110|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2146111|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2146112|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2146113|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2146114|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146115|NCT03652610|Vaccines|vaccines|mesh-list
2594200|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
2594201|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594202|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
2594203|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594204|NCT01730612|Histamine|histamine|mesh-list
2594205|NCT01730612|Glycine|glycine|mesh-list
2594206|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
2594207|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
2594208|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2594209|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594210|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594211|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
2594212|NCT01730638|Histamine|histamine|mesh-list
2594213|NCT01730638|Glycine|glycine|mesh-list
2594214|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
2594215|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
2594216|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2594217|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594218|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594219|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
2594220|NCT01730664|Ertapenem|ertapenem|mesh-list
2594221|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2594222|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594223|NCT01730677|Vinorelbine|vinorelbine|mesh-list
2594224|NCT01730677|Lapatinib|lapatinib|mesh-list
2594225|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2594226|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594227|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
2594228|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
2594229|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
2594230|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594231|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2594232|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594233|NCT01730833|Paclitaxel|paclitaxel|mesh-list
2594234|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2594235|NCT01730833|Trastuzumab|trastuzumab|mesh-list
2594236|NCT01730833|Pertuzumab|pertuzumab|mesh-list
2594237|NCT01730833|Antibodies|antibodies|mesh-list
2594238|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
2594239|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2146116|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
2146117|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146118|NCT03652818|Acetaminophen|acetaminophen|mesh-list
2146119|NCT03652818|Pregabalin|pregabalin|mesh-list
2146120|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2146121|NCT03652818|Analgesics|analgesics|mesh-ancestor
2146122|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
2146123|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146124|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146125|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
2146126|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
2146127|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2146128|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2594240|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594241|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
2594242|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
2146129|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146130|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2146131|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2146132|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2146133|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146134|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2146135|NCT03653026|Upadacitinib|upadacitinib|mesh-list
2146136|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2146137|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2146138|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146139|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146140|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2146141|NCT03653416|Bupivacaine|bupivacaine|mesh-list
2146142|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
2146143|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
2146144|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146145|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146146|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
2146147|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146148|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
2146149|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2146150|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2146151|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146152|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
2146153|NCT03653429|Coagulants|coagulants|mesh-ancestor
2146154|NCT03654326|Naproxen|naproxen|mesh-list
2146155|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2594243|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
2594244|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594245|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
2594246|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594247|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2594248|NCT01730937|Sorafenib|sorafenib|mesh-list
2594249|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594250|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2594251|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594252|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594253|NCT01730976|Vitamin D|vitamin d|mesh-list
2594254|NCT01730976|Vitamins|vitamins|mesh-list
2594255|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
2594256|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594257|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2594258|NCT01731067|Fexofenadine|fexofenadine|mesh-list
2594259|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
2594260|NCT01731067|Midazolam|midazolam|mesh-list
2146156|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2146157|NCT03654326|Analgesics|analgesics|mesh-ancestor
2146158|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
2146159|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146160|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146161|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2146162|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2146163|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
2146164|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2146165|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146166|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146167|NCT03654417|Lidocaine|lidocaine|mesh-list
2146168|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
2146169|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
2146170|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146171|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146172|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
2594261|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
2594262|NCT01731067|Caffeine|caffeine|mesh-list
2594263|NCT01731067|Bupropion|bupropion|mesh-list
2594264|NCT01731067|Omeprazole|omeprazole|mesh-list
2594265|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2594266|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2594267|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594268|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594269|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2594270|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2594271|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2594272|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2594273|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
2594274|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
2146173|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146174|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2146175|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2594275|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
2594276|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
2594277|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2594278|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594279|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2594280|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2594281|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2594282|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594283|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2146176|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2146177|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2146178|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146179|NCT03655080|Paclitaxel|paclitaxel|mesh-list
2146180|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2146181|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2146182|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146183|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
2146184|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
2146185|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
2146186|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146187|NCT03655301|Metformin|metformin|mesh-list
2146188|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2146189|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146190|NCT03655444|Nivolumab|nivolumab|mesh-list
2146191|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2146192|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146193|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2146194|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146195|NCT03657095|Beraprost|beraprost|mesh-list
2146196|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2146197|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
2146198|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
2594284|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2594285|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2594286|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2594287|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
2594288|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2594289|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
2594290|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2594291|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2594292|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2594293|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
2594294|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2594295|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2594296|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
2594297|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
2594298|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2594299|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2594300|NCT01731067|Analgesics|analgesics|mesh-ancestor
2594301|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
2594302|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594303|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2594304|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2594305|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2594306|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2594307|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2594308|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2594309|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2594310|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2146199|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2146200|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146201|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2146202|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2146203|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146204|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594311|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
2594312|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
2146205|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146206|NCT03657407|Glycerol|glycerol|mesh-list
2146207|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2146208|NCT03657407|Protective Agents|protective agents|mesh-ancestor
2146209|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146210|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2146211|NCT03658876|Hematinics|hematinics|mesh-ancestor
2146212|NCT03660241|Abrocitinib|abrocitinib|mesh-list
2146213|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2146214|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146215|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146216|NCT03660839|Artefenomel|artefenomel|mesh-list
2146217|NCT03660839|Ferroquine|ferroquine|mesh-list
2146218|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
2146219|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2146220|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2146221|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146222|NCT03661346|Labetalol|labetalol|mesh-list
2146223|NCT03661346|Esmolol|esmolol|mesh-list
2146224|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2146225|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2146226|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2146227|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
2146228|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146229|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146230|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146231|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2146232|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
2146233|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
2146234|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146235|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2146236|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2146237|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
2146238|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2146239|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
2146240|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146241|NCT03661983|Aripiprazole|aripiprazole|mesh-list
2146242|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
2146243|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2146244|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2146245|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2146246|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146247|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146248|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
2146249|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
2146250|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146251|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146252|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2146253|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2146254|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
2146255|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2146256|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2146257|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2146258|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2146259|NCT03662074|Gemcitabine|gemcitabine|mesh-list
2146260|NCT03662074|Nivolumab|nivolumab|mesh-list
2146261|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2146262|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
2146263|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146264|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146265|NCT03662074|Antiviral Agents|antiviral agents|mesh-ancestor
2146266|NCT03662074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146267|NCT03662074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594313|NCT01731132|Copper|copper|mesh-list
2594314|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
2594315|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2594316|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
2594317|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2594318|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594319|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2594320|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2594321|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2594322|NCT01731132|Trace Elements|trace elements|mesh-ancestor
2594323|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
2594324|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
2594325|NCT01731158|Bevacizumab|bevacizumab|mesh-list
2594326|NCT01731158|Sunitinib|sunitinib|mesh-list
2594327|NCT01731158|Everolimus|everolimus|mesh-list
2594328|NCT01731158|Sorafenib|sorafenib|mesh-list
2594329|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2594330|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594331|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2594332|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2594333|NCT01731158|Growth Substances|growth substances|mesh-ancestor
2594334|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594335|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
2594336|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2594337|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
2594338|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2594339|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594340|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594341|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
2594342|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594343|NCT01731184|Midazolam|midazolam|mesh-list
2594344|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2594345|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2594346|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594347|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594348|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2594349|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2594350|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2594351|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2594352|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
2594353|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
2594354|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
2594355|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
2594356|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420714|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2420715|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
2420716|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420717|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2420718|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2420719|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
2420720|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2420721|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
2420722|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420723|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
2420724|NCT00809198|Protective Agents|protective agents|mesh-ancestor
2420725|NCT00809198|Laxatives|laxatives|mesh-ancestor
2594357|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594358|NCT01731236|Aspirin|aspirin|mesh-list
2594359|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2594360|NCT01731236|Vancomycin|vancomycin|mesh-list
2594361|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
2594362|NCT01731236|Neomycin|neomycin|mesh-list
2594363|NCT01731236|Choline|choline|mesh-list
2146268|NCT03662074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2146269|NCT03662074|Immunologic Factors|immunologic factors|mesh-ancestor
2146270|NCT03662074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146271|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2146272|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2420726|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2594364|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2594365|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2594366|NCT01731236|Analgesics|analgesics|mesh-ancestor
2594367|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
2594368|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594369|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594370|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2594371|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2594372|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2594373|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2594374|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594375|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2594376|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2594377|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594378|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
2594379|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594380|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2594381|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2594382|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594383|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2594384|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2594385|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
2594386|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2594387|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
2594388|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2594389|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2594390|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
2594391|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2594392|NCT01731275|Quetmolimab|quetmolimab|mesh-list
2594393|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2594394|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2594395|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
2594396|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594397|NCT01731301|Ribavirin|ribavirin|mesh-list
2594398|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
2594399|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594400|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
2594401|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594402|NCT01731327|Tofacitinib|tofacitinib|mesh-list
2594403|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2594404|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594405|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594406|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
2594407|NCT01731340|Calcium|calcium|mesh-list
2594408|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2594409|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594410|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2594411|NCT01731431|Glyburide|glyburide|mesh-list
2594412|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2594413|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594414|NCT01731444|Phenylephrine|phenylephrine|mesh-list
2594415|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
2594416|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2146273|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
2146274|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2146275|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146276|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2146277|NCT03662789|Hematinics|hematinics|mesh-ancestor
2146278|NCT03663101|Lidocaine|lidocaine|mesh-list
2146279|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
2146280|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2594417|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
2594418|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
2594419|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594420|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594421|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
2594422|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2594423|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
2594424|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
2594425|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2594426|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2594427|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2594428|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
2594429|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2594430|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594431|NCT01731444|Protective Agents|protective agents|mesh-ancestor
2594432|NCT01731457|Etanercept|etanercept|mesh-list
2594433|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2594434|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2594435|NCT01731457|Analgesics|analgesics|mesh-ancestor
2594436|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
2594437|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594438|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594439|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2594440|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2594441|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2594442|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2594443|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
2594444|NCT01731561|Rituximab|rituximab|mesh-list
2594445|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2594446|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594447|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
2594448|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594449|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2594450|NCT01731574|Dapivirine|dapivirine|mesh-list
2146281|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2146282|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
2146283|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
2594451|NCT01731574|Miconazole|miconazole|mesh-list
2594452|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2146284|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146285|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146286|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
2146287|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146288|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2146289|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2146290|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2146291|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2146292|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594453|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2594454|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
2594455|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594456|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
2594457|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2594458|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2594459|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594460|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594461|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2594462|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
2594463|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2594464|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594465|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2594466|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2146293|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2146294|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
2146295|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146296|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2146297|NCT03663283|Bupivacaine|bupivacaine|mesh-list
2146298|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
2146299|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
2146300|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146301|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146302|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
2146303|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146304|NCT03663582|Teduglutide|teduglutide|mesh-list
2146305|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2146306|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2146307|NCT03663582|Protective Agents|protective agents|mesh-ancestor
2146308|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146309|NCT03664544|Edaravone|edaravone|mesh-list
2146310|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2146311|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
2146312|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146313|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2146314|NCT03664544|Protective Agents|protective agents|mesh-ancestor
2146315|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146316|NCT03665155|Daratumumab|daratumumab|mesh-list
2146317|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146318|NCT03666663|Lidocaine|lidocaine|mesh-list
2146319|NCT03666663|Bupivacaine|bupivacaine|mesh-list
2146320|NCT03666663|Ropivacaine|ropivacaine|mesh-list
2420727|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
2420728|NCT00809237|Gefitinib|gefitinib|mesh-list
2420729|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
2420730|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2420731|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2420732|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420733|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420734|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420735|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2420736|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420737|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2420738|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
2420739|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2420740|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420741|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2420742|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2420743|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420744|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420745|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420746|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
2420747|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2420748|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2146321|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
2146322|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
2146323|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146324|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146325|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
2146326|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146327|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2146328|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2146329|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2146330|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2146331|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146332|NCT03667053|Glucagon|glucagon|mesh-list
2146333|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2146334|NCT03667053|Hormones|hormones|mesh-ancestor
2146335|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2146336|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146337|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
2146338|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2146339|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2146340|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
2146341|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146342|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2146343|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2146344|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146345|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594467|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
2594468|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2594469|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
2594470|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594471|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2594472|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2594473|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
2594474|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594475|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594476|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2594477|NCT01731652|Imiquimod|imiquimod|mesh-list
2594478|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2594479|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
2594480|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594481|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594482|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
2594483|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
2594484|NCT01731756|Salicylates|salicylates|mesh-list
2594485|NCT01731756|Petrolatum|petrolatum|mesh-list
2594486|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594487|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
2594488|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
2594489|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
2594490|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2594491|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2594492|NCT01731756|Analgesics|analgesics|mesh-ancestor
2594493|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
2146346|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2146347|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
2146348|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146349|NCT03669081|Ketorolac|ketorolac|mesh-list
2146350|NCT03669081|Pregabalin|pregabalin|mesh-list
2594494|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594495|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594496|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2594497|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2594498|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2594499|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594500|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594501|NCT01731756|Emollients|emollients|mesh-ancestor
2594502|NCT01731782|Bupivacaine|bupivacaine|mesh-list
2594503|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
2594504|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
2594505|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594506|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594507|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
2594508|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594509|NCT01731795|Dexamethasone|dexamethasone|mesh-list
2594510|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
2594511|NCT01731795|BB 1101|bb 1101|mesh-list
2146351|NCT03669081|Analgesics|analgesics|mesh-ancestor
2146352|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
2146353|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146354|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146355|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
2146356|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2146357|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2594512|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2594513|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
2594514|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
2594515|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594516|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594517|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2594518|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
2594519|NCT01731795|Hormones|hormones|mesh-ancestor
2594520|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2594521|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2594522|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594523|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
2594524|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594525|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594526|NCT01731899|S 20098|s 20098|mesh-list
2594527|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2594528|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594529|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594530|NCT01731925|Sunitinib|sunitinib|mesh-list
2594531|NCT01731925|Lanreotide|lanreotide|mesh-list
2594532|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594533|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2594534|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2594535|NCT01731925|Growth Substances|growth substances|mesh-ancestor
2594536|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594537|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
2594538|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2594539|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594540|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594541|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
2594542|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2594543|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2594544|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
2594545|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2594546|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
2594547|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2594548|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594549|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2594550|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2594551|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594552|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2594553|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
2594554|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2594555|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
2594556|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2594557|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594558|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2594559|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2594560|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594561|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
2594562|NCT01732146|Hematinics|hematinics|mesh-ancestor
2594563|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2594564|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
2594565|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594566|NCT01732224|Tenofovir|tenofovir|mesh-list
2594567|NCT01732224|Telbivudine|telbivudine|mesh-list
2594568|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
2594569|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594570|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2594571|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2594572|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594573|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594574|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2594575|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2594576|NCT01732250|Meropenem|meropenem|mesh-list
2594577|NCT01732250|Colistin|colistin|mesh-list
2594578|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2594579|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146358|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146359|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2146360|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2146361|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2146362|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146363|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2146364|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2146365|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2146366|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2146367|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2146368|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2146369|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146370|NCT03669861|Abatacept|abatacept|mesh-list
2146371|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2146372|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146373|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146374|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2146375|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
2146376|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146377|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2146378|NCT03670030|Sirolimus|sirolimus|mesh-list
2146379|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2594580|NCT01732276|Gefitinib|gefitinib|mesh-list
2594581|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594582|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2594583|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594584|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594585|NCT01732328|Vitamin D|vitamin d|mesh-list
2594586|NCT01732328|Calcium|calcium|mesh-list
2594587|NCT01732328|Vitamins|vitamins|mesh-ancestor
2594588|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
2594589|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594590|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2594591|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2594592|NCT01732367|Tenofovir|tenofovir|mesh-list
2594593|NCT01732367|Lamivudine|lamivudine|mesh-list
2594594|NCT01732367|Adefovir|adefovir|mesh-list
2594595|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
2594596|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594597|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2594598|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2594599|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594600|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594601|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2594602|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2594603|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
2594604|NCT01732380|Raltitrexed|raltitrexed|mesh-list
2594605|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594606|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2594607|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
2594608|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594609|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2594610|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594611|NCT01732393|Quercetin|quercetin|mesh-list
2594612|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
2146380|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146381|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2146382|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146383|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
2146384|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2146385|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
2146386|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594613|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594614|NCT01732393|Protective Agents|protective agents|mesh-ancestor
2594615|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594616|NCT01732666|Remifentanil|remifentanil|mesh-list
2594617|NCT01732666|Nefopam|nefopam|mesh-list
2594618|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2594619|NCT01732666|Narcotics|narcotics|mesh-ancestor
2594620|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594621|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594622|NCT01732666|Analgesics|analgesics|mesh-ancestor
2594623|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
2594624|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594625|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2594626|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2594627|NCT01732744|Eusol|eusol|mesh-list
2594628|NCT01732744|Castor Oil|castor oil|mesh-list
2594629|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2594630|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
2594631|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594632|NCT01732744|Cathartics|cathartics|mesh-ancestor
2594633|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2594634|NCT01732861|Lenalidomide|lenalidomide|mesh-list
2594635|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
2594636|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594637|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2594638|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2594639|NCT01732861|Growth Substances|growth substances|mesh-ancestor
2594640|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
2594641|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594642|NCT01733017|Lycopene|lycopene|mesh-list
2594643|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2594644|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
2594645|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146387|NCT03670160|Clonidine|clonidine|mesh-list
2146388|NCT03670160|Phenobarbital|phenobarbital|mesh-list
2146389|NCT03670160|Analgesics|analgesics|mesh-ancestor
2146390|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
2594646|NCT01733017|Protective Agents|protective agents|mesh-ancestor
2594647|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594648|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2594649|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2594650|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594651|NCT01733030|Cycloserine|cycloserine|mesh-list
2594652|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2594653|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146391|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146392|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146393|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2146394|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
2146395|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
2146396|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2594654|NCT01733030|Renal Agents|renal agents|mesh-ancestor
2594655|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2146397|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2146398|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2146399|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
2146400|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146401|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146402|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
2146403|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2146404|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146405|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2146406|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2146407|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
2146408|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
2146409|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2146410|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2146411|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2146412|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
2594656|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
2594657|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2594658|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
2146413|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
2146414|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2146415|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146416|NCT03670810|Lasmiditan|lasmiditan|mesh-list
2146417|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2146418|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
2146419|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146420|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146421|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146422|NCT03672006|Heparin|heparin|mesh-list
2146423|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2146424|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
2146425|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2146426|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2146427|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146428|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2146429|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2146430|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
2594659|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594660|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
2594661|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2594662|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594663|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594664|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2594665|NCT01733043|Analgesics|analgesics|mesh-ancestor
2594666|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
2594667|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594668|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2594669|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2594670|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2594671|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
2594672|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2594673|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594674|NCT01733095|Ambrisentan|ambrisentan|mesh-list
2594675|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2594676|NCT01733108|Canagliflozin|canagliflozin|mesh-list
2594677|NCT01733108|Glyburide|glyburide|mesh-list
2594678|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2594679|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594680|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2594681|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594682|NCT01733134|Tolvaptan|tolvaptan|mesh-list
2594683|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2594684|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594685|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
2594686|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594687|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
2594688|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2594689|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2594690|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2594691|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2594692|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594693|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
2594694|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2594695|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594696|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2594697|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594698|NCT01733342|Anesthetics|anesthetics|mesh-list
2594699|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594700|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594701|NCT01733394|Lamotrigine|lamotrigine|mesh-list
2594702|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
2594703|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2594704|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2594705|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594706|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2594707|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594708|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2594709|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2594710|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594711|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2594712|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2594713|NCT01733459|Metformin|metformin|mesh-list
2594714|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2594715|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594716|NCT01733485|Aspirin|aspirin|mesh-list
2594717|NCT01733485|Indomethacin|indomethacin|mesh-list
2594718|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2146431|NCT03673670|Olodaterol|olodaterol|mesh-list
2146432|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2146433|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
2146434|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146435|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146436|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2146437|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
2146438|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
2146439|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2594719|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2594720|NCT01733485|Analgesics|analgesics|mesh-ancestor
2594721|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
2146440|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
2146441|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146442|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146447|NCT03674177|Vaccines|vaccines|mesh-list
2146448|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
2146449|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146450|NCT03674970|Nicotine|nicotine|mesh-list
2146451|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2146452|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
2146453|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146454|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146455|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2146456|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2146457|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
2146458|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146459|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146460|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2146461|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2146462|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146463|NCT03675581|Nintedanib|nintedanib|mesh-list
2146464|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2146465|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2146466|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146467|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2146468|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146469|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146470|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2146471|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
2146472|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2146473|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146474|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2146475|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2146476|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2146477|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2146478|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2146479|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2146480|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2594722|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594723|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594724|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2594725|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2594726|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2594727|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2594728|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594729|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2594730|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2594731|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594732|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
2594733|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
2594734|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
2594735|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2594736|NCT01733589|Etoposide|etoposide|mesh-list
2594737|NCT01733589|Cisplatin|cisplatin|mesh-list
2594738|NCT01733589|Endostatins|endostatins|mesh-list
2594739|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2594740|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594741|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2594742|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2594743|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594744|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594745|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2594746|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2594747|NCT01733589|Growth Substances|growth substances|mesh-ancestor
2594748|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594749|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
2594750|NCT01733693|Buprenorphine|buprenorphine|mesh-list
2594751|NCT01733693|Methadone|methadone|mesh-list
2594752|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2594753|NCT01733693|Narcotics|narcotics|mesh-ancestor
2594754|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594755|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594756|NCT01733693|Analgesics|analgesics|mesh-ancestor
2594757|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
2594758|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594759|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2594760|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
2594761|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
2594762|NCT01733706|Nicotine|nicotine|mesh-list
2594763|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2594764|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
2594765|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594766|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146481|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2146482|NCT03676725|Lidocaine|lidocaine|mesh-list
2146483|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
2146484|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
2146485|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594767|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2594768|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2594769|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
2594770|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2594771|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594772|NCT01733823|Nimorazole|nimorazole|mesh-list
2594773|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2594774|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2594775|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2594776|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594777|NCT01733836|Metformin|metformin|mesh-list
2146486|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146487|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
2146488|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146489|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2146490|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2146491|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2146492|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2146493|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146494|NCT03677401|Serlopitant|serlopitant|mesh-list
2146495|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2146496|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146497|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146498|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594778|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2594779|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594780|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2594781|NCT01733888|Immunoconjugates|immunoconjugates|mesh-list
2594782|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2594783|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594784|NCT01733888|Immunologic Factors|immunologic factors|mesh-ancestor
2146499|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
2146500|NCT03678870|Narcotics|narcotics|mesh-ancestor
2146501|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594785|NCT01733888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594786|NCT01733966|Amoxicillin|amoxicillin|mesh-list
2594787|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
2594788|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
2594789|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2594790|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
2594791|NCT01733966|Secnidazole|secnidazole|mesh-list
2594792|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2594793|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594794|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594795|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594796|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2594797|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2594798|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2594799|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2594800|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2594801|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594802|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2594803|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2594804|NCT01733979|Iron|iron|mesh-list
2594805|NCT01733979|Trace Elements|trace elements|mesh-ancestor
2594806|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
2594807|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594808|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2594809|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2594810|NCT01734044|Dexamethasone|dexamethasone|mesh-list
2594811|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
2594812|NCT01734044|BB 1101|bb 1101|mesh-list
2594813|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2594814|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
2594815|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
2594816|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594817|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594818|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2594819|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
2594820|NCT01734044|Hormones|hormones|mesh-ancestor
2594821|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2594822|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2594823|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594824|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
2594825|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594826|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594827|NCT01734057|Dexamethasone|dexamethasone|mesh-list
2594828|NCT01734057|Rituximab|rituximab|mesh-list
2594829|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2594830|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
2594831|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
2594832|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594833|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594834|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2594835|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
2594836|NCT01734057|Hormones|hormones|mesh-ancestor
2594837|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2594838|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2594839|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594840|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2594841|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
2594842|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2594843|NCT01734096|Candesartan|candesartan|mesh-list
2594844|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
2594845|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2594846|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2594847|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2594848|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146502|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146503|NCT03678870|Analgesics|analgesics|mesh-ancestor
2146504|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
2146505|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146506|NCT03679975|Riluzole|riluzole|mesh-list
2146507|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
2146508|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2146509|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2146510|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146511|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146512|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146513|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2146514|NCT03679975|Protective Agents|protective agents|mesh-ancestor
2146515|NCT03680521|Nivolumab|nivolumab|mesh-list
2146516|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2146517|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146518|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2146519|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594849|NCT01734252|Argatroban|argatroban|mesh-list
2594850|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
2594851|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2594852|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
2594853|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594854|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594855|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
2594856|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2594857|NCT01734304|Vaccines|vaccines|mesh-list
2594858|NCT01734304|Immunologic Factors|immunologic factors|mesh-ancestor
2594859|NCT01734304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594860|NCT01734330|Nicotine|nicotine|mesh-list
2594861|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2594862|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
2594863|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594864|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594865|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2146520|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
2146521|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2146522|NCT03681093|Growth Substances|growth substances|mesh-ancestor
2146523|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146524|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
2146525|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2146526|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146527|NCT03682302|Bupivacaine|bupivacaine|mesh-list
2146528|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
2146529|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
2146530|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146531|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146532|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
2146533|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146534|NCT03682705|Upadacitinib|upadacitinib|mesh-list
2146535|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2146536|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2146537|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146538|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146539|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2146540|NCT03684044|Baloxavir|baloxavir|mesh-list
2146541|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
2146542|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146543|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146544|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146545|NCT03684265|Meloxicam|meloxicam|mesh-list
2146546|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2146547|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2146548|NCT03684265|Analgesics|analgesics|mesh-ancestor
2594866|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2594867|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
2594868|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2594869|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594870|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2594871|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
2594872|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2594873|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
2594874|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594875|NCT01734408|Antacids|antacids|mesh-ancestor
2594876|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594877|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2594878|NCT01734473|Caseins|caseins|mesh-list
2594879|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
2594880|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
2594881|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594882|NCT01734564|Poly I-C|poly i-c|mesh-list
2594883|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2594884|NCT01734564|Poly ICLC|poly iclc|mesh-list
2594885|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
2594886|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
2594887|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594888|NCT01734564|Laxatives|laxatives|mesh-ancestor
2594889|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2594890|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
2594891|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594892|NCT01734694|Vancomycin|vancomycin|mesh-list
2594893|NCT01734694|Linezolid|linezolid|mesh-list
2594894|NCT01734694|Daptomycin|daptomycin|mesh-list
2594895|NCT01734694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2594896|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2594897|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594898|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2594899|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2594900|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594901|NCT01734798|Gemcitabine|gemcitabine|mesh-list
2594902|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594903|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2594904|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
2594905|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594906|NCT01734798|Antiviral Agents|antiviral agents|mesh-ancestor
2594907|NCT01734798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594908|NCT01734798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146549|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
2146550|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594909|NCT01734798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2594910|NCT01734798|Immunologic Factors|immunologic factors|mesh-ancestor
2594911|NCT01734798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594912|NCT01734824|Denosumab|denosumab|mesh-list
2594913|NCT01734824|Teriparatide|teriparatide|mesh-list
2594914|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
2594915|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2594916|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594917|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2594918|NCT01734915|Iproplatin|iproplatin|mesh-list
2594919|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594920|NCT01734928|Thalidomide|thalidomide|mesh-list
2594921|NCT01734928|Dexamethasone|dexamethasone|mesh-list
2594922|NCT01734928|Bortezomib|bortezomib|mesh-list
2594923|NCT01734928|Pomalidomide|pomalidomide|mesh-list
2594924|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2594925|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
2594926|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
2594927|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594928|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594929|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2594930|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
2594931|NCT01734928|Hormones|hormones|mesh-ancestor
2594932|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2594933|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2594934|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594935|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
2594936|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2146551|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146552|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2146553|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2594937|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2594938|NCT01734928|Growth Substances|growth substances|mesh-ancestor
2594939|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
2594940|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2594941|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
2146554|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2146555|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2146556|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146557|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146558|NCT03684642|Metformin|metformin|mesh-list
2594942|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2594943|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2594944|NCT01734954|Midazolam|midazolam|mesh-list
2594945|NCT01734954|Analgesics|analgesics|mesh-list
2594946|NCT01734954|Anesthetics|anesthetics|mesh-list
2594947|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
2594948|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
2594949|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594950|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594951|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2594952|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2594953|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2594954|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2594955|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2594956|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2594957|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
2594958|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
2594959|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
2594960|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2594961|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594962|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
2594963|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594964|NCT01735006|Vaccines|vaccines|mesh-list
2594965|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
2594966|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594967|NCT01735019|Remifentanil|remifentanil|mesh-list
2594968|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2594969|NCT01735019|Narcotics|narcotics|mesh-ancestor
2146559|NCT03684642|Dulaglutide|dulaglutide|mesh-list
2146560|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
2146561|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2146562|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146563|NCT03685344|Durvalumab|durvalumab|mesh-list
2594970|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2594971|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594972|NCT01735019|Analgesics|analgesics|mesh-ancestor
2594973|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
2146564|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
2594974|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2594975|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
2594976|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2594977|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
2594978|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594979|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
2594980|NCT01735058|Protective Agents|protective agents|mesh-ancestor
2594981|NCT01735071|Bevacizumab|bevacizumab|mesh-list
2594982|NCT01735071|Carboplatin|carboplatin|mesh-list
2594983|NCT01735071|Trabectedin|trabectedin|mesh-list
2594984|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2594985|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2594986|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2594987|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2594988|NCT01735071|Growth Substances|growth substances|mesh-ancestor
2594989|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2594990|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
2594991|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2594992|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
2594993|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2594994|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2594995|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
2594996|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146565|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2146566|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2146567|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146568|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
2146569|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146570|NCT03685396|Hemostatics|hemostatics|mesh-list
2146571|NCT03685396|Coagulants|coagulants|mesh-ancestor
2146572|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2146573|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2146574|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146575|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2146576|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2146577|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2146578|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2146579|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146580|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
2594997|NCT01735097|Vitamin E|vitamin e|mesh-list
2594998|NCT01735097|Vitamins|vitamins|mesh-ancestor
2594999|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
2595000|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595001|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
2595002|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595003|NCT01735097|Protective Agents|protective agents|mesh-ancestor
2595004|NCT01735123|Caseins|caseins|mesh-list
2595005|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
2595006|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
2595007|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595008|NCT01735227|Omeprazole|omeprazole|mesh-list
2146581|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146582|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146583|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2146584|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146585|NCT03687827|Insulin|insulin|mesh-list
2146586|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2146587|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
2146588|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2146589|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146595|NCT03691779|Ivacaftor|ivacaftor|mesh-list
2146596|NCT03691779|Elexacaftor|elexacaftor|mesh-list
2146597|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2146598|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2595009|NCT01735227|Pantoprazole|pantoprazole|mesh-list
2595010|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2595011|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2595012|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2595013|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595014|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595015|NCT01735240|Ketoconazole|ketoconazole|mesh-list
2595016|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
2595017|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2595018|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2146599|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146600|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2146601|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2146602|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146603|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
2146604|NCT03691948|Narcotics|narcotics|mesh-ancestor
2146605|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146606|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146607|NCT03691948|Analgesics|analgesics|mesh-ancestor
2146608|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
2146609|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146610|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
2146611|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2146612|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
2146613|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146614|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146615|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2146616|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
2146617|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
2146618|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2146619|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
2146620|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146621|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146622|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
2146623|NCT03693950|Hematinics|hematinics|mesh-ancestor
2146624|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
2146625|NCT03693989|Difluprednate|difluprednate|mesh-list
2146626|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
2146627|NCT03693989|Hormones|hormones|mesh-ancestor
2146628|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2146629|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146630|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2146631|NCT03695094|Lamotrigine|lamotrigine|mesh-list
2146632|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
2146633|NCT03695094|Levetiracetam|levetiracetam|mesh-list
2146634|NCT03695094|Brivaracetam|brivaracetam|mesh-list
2146635|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
2146636|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
2146637|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2146638|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2146639|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146640|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2146641|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146642|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2146643|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2146644|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146645|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2146646|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2146647|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2146648|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2146649|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2146650|NCT03695367|Acetaminophen|acetaminophen|mesh-list
2146651|NCT03695367|Ibuprofen|ibuprofen|mesh-list
2146652|NCT03695367|Ketorolac|ketorolac|mesh-list
2146653|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2146654|NCT03695367|Analgesics|analgesics|mesh-ancestor
2146655|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
2146656|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146657|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146658|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
2146659|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2146660|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2146661|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2146662|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2146663|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146664|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146665|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
2146666|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
2146667|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2146668|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146669|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2146670|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2146671|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2595019|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2595020|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595021|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595022|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2595023|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
2595024|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2595025|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595026|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2595027|NCT01735318|Lisinopril|lisinopril|mesh-list
2595028|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2595029|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
2595030|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146672|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2146673|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146674|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146675|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146676|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
2146677|NCT03696758|Metoprolol|metoprolol|mesh-list
2146678|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
2146679|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
2146680|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2146681|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2146682|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146683|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146684|NCT03696758|Urological Agents|urological agents|mesh-ancestor
2146685|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2146686|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2146687|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
2146688|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
2595031|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595032|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2595033|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2595034|NCT01735318|Protective Agents|protective agents|mesh-ancestor
2595035|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595036|NCT01735344|Lisinopril|lisinopril|mesh-list
2595037|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2595038|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
2595039|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595040|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595041|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2595042|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2595043|NCT01735344|Protective Agents|protective agents|mesh-ancestor
2595044|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595045|NCT01735370|Etodolac|etodolac|mesh-list
2595046|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2595047|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2595048|NCT01735370|Analgesics|analgesics|mesh-ancestor
2595049|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
2595050|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595051|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595052|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2595053|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2595054|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2595055|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2595056|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595057|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595058|NCT01735383|Etodolac|etodolac|mesh-list
2595059|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2595060|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2595061|NCT01735383|Analgesics|analgesics|mesh-ancestor
2595062|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
2595063|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595064|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595065|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2595066|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2595067|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2595068|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2595069|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595070|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595071|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
2595072|NCT01735461|Calcium|calcium|mesh-list
2595073|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2146689|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146690|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146691|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2146692|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2146693|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2146694|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
2146695|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146696|NCT03697252|Xanomeline|xanomeline|mesh-list
2146697|NCT03697252|Trospium chloride|trospium chloride|mesh-list
2146698|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
2146699|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
2146700|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146701|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146702|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2146703|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2146704|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
2146705|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595074|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595075|NCT01735461|Antacids|antacids|mesh-ancestor
2595076|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595077|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2595078|NCT01735487|Nicotine|nicotine|mesh-list
2146706|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146707|NCT03697252|Urological Agents|urological agents|mesh-ancestor
2146708|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2595079|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2595080|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
2595081|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595082|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595083|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2595084|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2595085|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
2595086|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595087|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595088|NCT01735669|Remifentanil|remifentanil|mesh-list
2595089|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
2595090|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2595091|NCT01735669|Narcotics|narcotics|mesh-ancestor
2146709|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2146710|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2146711|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2146712|NCT03697993|Levofloxacin|levofloxacin|mesh-list
2146713|NCT03697993|Ofloxacin|ofloxacin|mesh-list
2146714|NCT03697993|Fosfomycin|fosfomycin|mesh-list
2146715|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2146716|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146717|NCT03697993|Renal Agents|renal agents|mesh-ancestor
2146718|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2146719|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2146720|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2146721|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146722|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146723|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146724|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2146725|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2146726|NCT03698279|Vaccines|vaccines|mesh-list
2595092|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2595093|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595094|NCT01735669|Analgesics|analgesics|mesh-ancestor
2595095|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
2595096|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595097|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2595098|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
2595099|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
2595100|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2595101|NCT01735747|Vincristine|vincristine|mesh-list
2595102|NCT01735747|Temozolomide|temozolomide|mesh-list
2595103|NCT01735747|Nedaplatin|nedaplatin|mesh-list
2595104|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2595105|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595106|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
2146727|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
2146728|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146729|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
2146730|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2595107|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
2595108|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
2595109|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595110|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2595111|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
2595112|NCT01735825|Paclitaxel|paclitaxel|mesh-list
2595113|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2595114|NCT01735825|Everolimus|everolimus|mesh-list
2595115|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2595116|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595117|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
2595118|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
2595119|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
2595120|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595121|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2595122|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
2595123|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595124|NCT01735864|Indirubin|indirubin|mesh-list
2595125|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2595126|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595127|NCT01735890|Amlodipine|amlodipine|mesh-list
2595128|NCT01735890|Valsartan|valsartan|mesh-list
2595129|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
2595130|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2595131|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2595132|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2595133|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595134|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2595135|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595136|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
2595137|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2595138|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2595139|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
2595140|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
2595141|NCT01736020|Ketamine|ketamine|mesh-list
2595142|NCT01736020|Propofol|propofol|mesh-list
2595143|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2595144|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2595145|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595146|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2595147|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
2595148|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
2595149|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2595150|NCT01736020|Analgesics|analgesics|mesh-ancestor
2595151|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
2595152|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595153|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2595154|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2595155|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2595156|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
2595157|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595158|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146731|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146732|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2146733|NCT03700892|Protective Agents|protective agents|mesh-ancestor
2146734|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146735|NCT03701061|Vaccines|vaccines|mesh-list
2146736|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
2146737|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146738|NCT03701074|Acetaminophen|acetaminophen|mesh-list
2146739|NCT03701074|Ibuprofen|ibuprofen|mesh-list
2146740|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2146741|NCT03701074|Analgesics|analgesics|mesh-ancestor
2146742|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
2146743|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146744|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146745|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
2146746|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2146747|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2146748|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2146749|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2146750|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146751|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146752|NCT03704376|Clonidine|clonidine|mesh-list
2146753|NCT03704376|Ropivacaine|ropivacaine|mesh-list
2146754|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
2595159|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2595160|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2595161|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2595162|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2595163|NCT01736033|Tamsulosin|tamsulosin|mesh-list
2595164|NCT01736033|Finasteride|finasteride|mesh-list
2146755|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
2146756|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146757|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146758|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
2146759|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146760|NCT03704376|Analgesics|analgesics|mesh-ancestor
2146761|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2146762|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
2146763|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
2146764|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2146765|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2146766|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2146767|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
2146768|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146769|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146770|NCT03704467|Carboplatin|carboplatin|mesh-list
2146771|NCT03704467|Avelumab|avelumab|mesh-list
2146772|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146773|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2146774|NCT03705273|Dexamethasone|dexamethasone|mesh-list
2595165|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2595166|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2595167|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2595168|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
2146775|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
2146776|NCT03705273|BB 1101|bb 1101|mesh-list
2146777|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2146778|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
2146779|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
2146780|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146781|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146782|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2146783|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
2146784|NCT03705273|Hormones|hormones|mesh-ancestor
2146785|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2146786|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2146787|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146788|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
2146789|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146790|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146791|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
2146792|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2146793|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
2146794|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2146795|NCT03706313|Bupivacaine|bupivacaine|mesh-list
2146796|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
2146797|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
2146798|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146799|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146800|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
2146801|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146802|NCT03708211|Esomeprazole|esomeprazole|mesh-list
2146803|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2146804|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2146805|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2146806|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146807|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146808|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
2146809|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
2146810|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2146811|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2146812|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
2146813|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146814|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146815|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146816|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146817|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2146818|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146819|NCT03710161|Vitamin D|vitamin d|mesh-list
2146820|NCT03710161|Vitamins|vitamins|mesh-ancestor
2146821|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
2146822|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146823|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2146824|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
2146825|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2146826|NCT03710590|Nicotine|nicotine|mesh-list
2146827|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2146828|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
2146829|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146830|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595169|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595170|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595171|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595172|NCT01736033|Urological Agents|urological agents|mesh-ancestor
2595173|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2595174|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2595175|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595176|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
2595177|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2595178|NCT01736150|Sevelamer|sevelamer|mesh-list
2595179|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
2595180|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
2595181|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595182|NCT01736163|Hormones|hormones|mesh-list
2595183|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2595184|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595185|NCT01736371|Propofol|propofol|mesh-list
2595186|NCT01736371|Sevoflurane|sevoflurane|mesh-list
2595187|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
2595188|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2595189|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595190|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2595191|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2595192|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
2595193|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2595194|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2595195|NCT01736410|Trastuzumab|trastuzumab|mesh-list
2595196|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595197|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2595198|NCT01736423|Ramosetron|ramosetron|mesh-list
2595199|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
2595200|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
2595201|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595202|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595203|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2595204|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2595205|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
2595206|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595207|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595208|NCT01736449|Bevacizumab|bevacizumab|mesh-list
2595209|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2595210|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146831|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2146832|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2146833|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
2146834|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146835|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146836|NCT03710889|Abaloparatide|abaloparatide|mesh-list
2146837|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2146838|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146839|NCT03711578|Tenalisib|tenalisib|mesh-list
2146840|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
2146841|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146842|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146843|NCT03712280|Rifaximin|rifaximin|mesh-list
2146844|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
2146845|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2146846|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146847|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2146848|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2146849|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
2146850|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146851|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146852|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2146853|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2146854|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2146855|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146856|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146857|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2146858|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2146859|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146860|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
2146861|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146862|NCT03712917|Topiramate|topiramate|mesh-list
2146863|NCT03712917|Flunarizine|flunarizine|mesh-list
2146864|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
2146865|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2146866|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146867|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2146868|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2146869|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146870|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2146871|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2595211|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2595212|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2595213|NCT01736449|Growth Substances|growth substances|mesh-ancestor
2595214|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595215|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
2595216|NCT01736488|Atenolol|atenolol|mesh-list
2595217|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2595218|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2595219|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
2595220|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
2595221|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595222|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595223|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2595224|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2595225|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2595226|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
2595227|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595228|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595229|NCT01736514|Allopurinol|allopurinol|mesh-list
2595230|NCT01736514|Febuxostat|febuxostat|mesh-list
2595231|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
2595232|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595233|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595234|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
2595235|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2595236|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2595237|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
2595238|NCT01736514|Protective Agents|protective agents|mesh-ancestor
2146872|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
2146873|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
2146874|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146875|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
2146876|NCT03714022|Abatacept|abatacept|mesh-list
2146877|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2146878|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595239|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595240|NCT01736670|Triamcinolone|triamcinolone|mesh-list
2595241|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2595242|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2595243|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2146879|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146880|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2146881|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
2146882|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146883|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2146884|NCT03714672|Diclofenac|diclofenac|mesh-list
2146885|NCT03714672|Tramadol|tramadol|mesh-list
2595244|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2595245|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
2595246|NCT01736670|Hormones|hormones|mesh-ancestor
2595247|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2595248|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595249|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2595250|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
2595251|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146886|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2146887|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2146888|NCT03714672|Analgesics|analgesics|mesh-ancestor
2146889|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
2146890|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146891|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146892|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2146893|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2146894|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2146895|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146896|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146897|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2146898|NCT03714672|Narcotics|narcotics|mesh-ancestor
2146899|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146900|NCT03714919|Acetaminophen|acetaminophen|mesh-list
2146901|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
2146902|NCT03714919|Ketamine|ketamine|mesh-list
2146903|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
2146904|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2420749|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420750|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
2420751|NCT00809393|Coagulants|coagulants|mesh-ancestor
2420752|NCT00809536|Metformin|metformin|mesh-list
2420753|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2420754|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420755|NCT00809549|Lenograstim|lenograstim|mesh-list
2420756|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2420757|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
2420758|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420759|NCT00809627|Caffeine|caffeine|mesh-list
2420760|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2420761|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420762|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2595252|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595253|NCT01736761|Ritonavir|ritonavir|mesh-list
2595254|NCT01736761|Darunavir|darunavir|mesh-list
2595255|NCT01736761|Rilpivirine|rilpivirine|mesh-list
2595256|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2595257|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2595258|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
2595259|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595260|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595261|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2595262|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2595263|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
2595264|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2595265|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2595266|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2595267|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2595268|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2595269|NCT01736800|Temozolomide|temozolomide|mesh-list
2595270|NCT01736800|Topotecan|topotecan|mesh-list
2595271|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2595272|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
2595273|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595274|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595275|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2595276|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2146905|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146906|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146907|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2146908|NCT03714919|Analgesics|analgesics|mesh-ancestor
2146909|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
2146910|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146911|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2146912|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2146913|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2146914|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
2146915|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146916|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146917|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2146918|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2146919|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
2146920|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
2420763|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420764|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420765|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2420766|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2146921|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2146922|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2146923|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
2146924|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
2146925|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
2146926|NCT03716024|Linezolid|linezolid|mesh-list
2146927|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2146928|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2595277|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595278|NCT01736813|Maraviroc|maraviroc|mesh-list
2595279|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2595280|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2595281|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595282|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2595283|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2595284|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
2595285|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2595286|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2595287|NCT01736878|Sorafenib|sorafenib|mesh-list
2595288|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595289|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2595290|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595291|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595292|NCT01736891|Rasagiline|rasagiline|mesh-list
2595293|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2595294|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595295|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595296|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2595297|NCT01736891|Protective Agents|protective agents|mesh-ancestor
2595298|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146929|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2146930|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146931|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146932|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
2146933|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
2146934|NCT03716076|Carbetocin|carbetocin|mesh-list
2146935|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
2146936|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2146937|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146938|NCT03717012|Nintedanib|nintedanib|mesh-list
2146939|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146940|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2595299|NCT01737008|Cisplatin|cisplatin|mesh-list
2595300|NCT01737008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595301|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
2595302|NCT01737073|Narcotics|narcotics|mesh-ancestor
2595303|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2595304|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595305|NCT01737073|Analgesics|analgesics|mesh-ancestor
2595306|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
2595307|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595308|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
2595309|NCT01737086|Astringents|astringents|mesh-ancestor
2595310|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595311|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
2595312|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
2595313|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2595314|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420767|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
2420768|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420769|NCT00809692|Histamine|histamine|mesh-list
2420770|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
2420771|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
2420772|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
2420773|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420774|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420775|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420776|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2420777|NCT00809705|Incretins|incretins|mesh-ancestor
2420778|NCT00809705|Hormones|hormones|mesh-ancestor
2420779|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2146941|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146942|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146943|NCT03717051|Nicotine|nicotine|mesh-list
2146944|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2146945|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
2146946|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146947|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146948|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2146949|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2146950|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
2146951|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595315|NCT01737177|Rituximab|rituximab|mesh-list
2595316|NCT01737177|Lenalidomide|lenalidomide|mesh-list
2595317|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2595318|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2595319|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595320|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
2595321|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595322|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2595323|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2595324|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2595325|NCT01737177|Growth Substances|growth substances|mesh-ancestor
2595326|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
2595327|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2595328|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
2595329|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595330|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
2595331|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595332|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
2595333|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2595334|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2595335|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595336|NCT01737203|Urological Agents|urological agents|mesh-ancestor
2595337|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
2595338|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2595339|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595340|NCT01737294|Capsaicin|capsaicin|mesh-list
2595341|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
2595342|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
2595343|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
2595344|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595345|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595346|NCT01737307|Fluorides|fluorides|mesh-list
2595347|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
2595348|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
2595349|NCT01737307|Protective Agents|protective agents|mesh-ancestor
2595350|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595351|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2146952|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146953|NCT03717064|Pitavastatin|pitavastatin|mesh-list
2146954|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2146955|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2146956|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2146957|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
2146958|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146959|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146960|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2146961|NCT03717155|Gemcitabine|gemcitabine|mesh-list
2146962|NCT03717155|Carboplatin|carboplatin|mesh-list
2146963|NCT03717155|Cetuximab|cetuximab|mesh-list
2146964|NCT03717155|Avelumab|avelumab|mesh-list
2146965|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2146966|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2146967|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
2595352|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2595353|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2595354|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
2595355|NCT01737346|Lomustine|lomustine|mesh-list
2595356|NCT01737346|Procarbazine|procarbazine|mesh-list
2595357|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2595358|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
2595359|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595360|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595361|NCT01737359|Tenofovir|tenofovir|mesh-list
2595362|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
2595363|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146968|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595364|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2595365|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2595366|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595367|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595368|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2595369|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2595370|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
2595371|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2595372|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2595373|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
2595374|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595375|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595376|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595377|NCT01737411|Urological Agents|urological agents|mesh-ancestor
2595378|NCT01737541|Fluoxetine|fluoxetine|mesh-list
2595379|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2595380|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2595381|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2595382|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595383|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595384|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
2595385|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595386|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2595387|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
2595388|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2595389|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2595390|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2595391|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595392|NCT01737671|Leucovorin|leucovorin|mesh-list
2595393|NCT01737671|Methotrexate|methotrexate|mesh-list
2595394|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2595395|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
2595396|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2595397|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595398|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2595399|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
2595400|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595401|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595402|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
2595403|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595404|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2595405|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2595406|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
2595407|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2595408|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2595409|NCT01737671|Antidotes|antidotes|mesh-ancestor
2595410|NCT01737671|Protective Agents|protective agents|mesh-ancestor
2595411|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
2595412|NCT01737671|Vitamins|vitamins|mesh-ancestor
2595413|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
2595414|NCT01737892|Epinephrine|epinephrine|mesh-list
2595415|NCT01737892|Racepinephrine|racepinephrine|mesh-list
2595416|NCT01737892|Epinephryl borate|epinephryl borate|mesh-list
2595417|NCT01737892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2595418|NCT01737892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2595419|NCT01737892|Adrenergic Agents|adrenergic agents|mesh-ancestor
2595420|NCT01737892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595421|NCT01737892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595422|NCT01737892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595423|NCT01737892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2595424|NCT01737892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2595425|NCT01737892|Autonomic Agents|autonomic agents|mesh-ancestor
2595426|NCT01737892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595427|NCT01737892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2595428|NCT01737892|Respiratory System Agents|respiratory system agents|mesh-ancestor
2595429|NCT01737892|Mydriatics|mydriatics|mesh-ancestor
2595430|NCT01737892|Sympathomimetics|sympathomimetics|mesh-ancestor
2595431|NCT01737892|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2595432|NCT01737905|Epinephrine|epinephrine|mesh-list
2595433|NCT01737905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2595434|NCT01737905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2595435|NCT01737905|Adrenergic Agents|adrenergic agents|mesh-ancestor
2595436|NCT01737905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2146969|NCT03717155|Antiviral Agents|antiviral agents|mesh-ancestor
2146970|NCT03717155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146971|NCT03717155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146972|NCT03717155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2146973|NCT03717155|Immunologic Factors|immunologic factors|mesh-ancestor
2146974|NCT03717155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146975|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2146976|NCT03717506|Clindamycin|clindamycin|mesh-list
2146977|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
2146978|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
2146979|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2146980|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146981|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2146982|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2146983|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146984|NCT03719586|Remdesivir|remdesivir|mesh-list
2146985|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
2146986|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2146987|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
2146988|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2146989|NCT03720119|Lidocaine|lidocaine|mesh-list
2146990|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
2146991|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
2146992|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2146993|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2146994|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
2146995|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2146996|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2146997|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2146998|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2595437|NCT01737905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595438|NCT01737905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595439|NCT01737905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2595440|NCT01737905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2146999|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2147000|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147001|NCT03720470|Abrocitinib|abrocitinib|mesh-list
2147002|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2147003|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147004|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147005|NCT03720847|Estradiol|estradiol|mesh-list
2147006|NCT03720847|Progesterone|progesterone|mesh-list
2147007|NCT03720847|Estrogens|estrogens|mesh-ancestor
2147008|NCT03720847|Hormones|hormones|mesh-ancestor
2147009|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2147010|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147011|NCT03720847|Progestins|progestins|mesh-ancestor
2147012|NCT03721172|Apremilast|apremilast|mesh-list
2147013|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2147014|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2147015|NCT03721172|Analgesics|analgesics|mesh-ancestor
2147016|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
2147017|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147018|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147019|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2595441|NCT01737905|Autonomic Agents|autonomic agents|mesh-ancestor
2595442|NCT01737905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595443|NCT01737905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2595444|NCT01737905|Respiratory System Agents|respiratory system agents|mesh-ancestor
2595445|NCT01737905|Mydriatics|mydriatics|mesh-ancestor
2595446|NCT01737905|Sympathomimetics|sympathomimetics|mesh-ancestor
2595447|NCT01737905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2595448|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
2595449|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2595450|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2595451|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
2595452|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595453|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595454|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595455|NCT01737918|Urological Agents|urological agents|mesh-ancestor
2595456|NCT01738035|Budesonide|budesonide|mesh-list
2595457|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2595458|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2595459|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
2595460|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595461|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595462|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2595463|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
2595464|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
2147020|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147021|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2147022|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2147023|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147024|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147025|NCT03722238|Ibuprofen|ibuprofen|mesh-list
2147026|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2147027|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2147028|NCT03722238|Analgesics|analgesics|mesh-ancestor
2147029|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
2147030|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147031|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147032|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147033|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2595465|NCT01738035|Hormones|hormones|mesh-ancestor
2595466|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2595467|NCT01738087|Fluticasone|fluticasone|mesh-list
2595468|NCT01738087|Xhance|xhance|mesh-list
2595469|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
2595470|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2595471|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2595472|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
2595473|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595474|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595475|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2595476|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
2595477|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
2595478|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2595479|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2595480|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2595481|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2595482|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
2595483|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595484|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595485|NCT01738100|Morphine|morphine|mesh-list
2595486|NCT01738100|Clopidogrel|clopidogrel|mesh-list
2595487|NCT01738100|Ticagrelor|ticagrelor|mesh-list
2595488|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2595489|NCT01738100|Narcotics|narcotics|mesh-ancestor
2595490|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2595491|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595492|NCT01738100|Analgesics|analgesics|mesh-ancestor
2595493|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
2595494|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595495|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2595496|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2595497|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2595498|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2595499|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
2595500|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595501|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595502|NCT01738139|Ipilimumab|ipilimumab|mesh-list
2595503|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
2595504|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2595505|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595506|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2595507|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595508|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2595509|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595510|NCT01738178|Caffeine|caffeine|mesh-list
2595511|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2595512|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595513|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2595514|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595515|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595516|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2595517|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2595518|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
2595519|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595520|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
2595521|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2595522|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
2595523|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595524|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
2595525|NCT01738243|Protective Agents|protective agents|mesh-ancestor
2595526|NCT01738282|Baclofen|baclofen|mesh-list
2595527|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2595528|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147034|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2147035|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147036|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147037|NCT03722524|Amlodipine|amlodipine|mesh-list
2147038|NCT03722524|Perindopril|perindopril|mesh-list
2147039|NCT03722524|Indapamide|indapamide|mesh-list
2147040|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
2147041|NCT03722524|Diuretics|diuretics|mesh-list
2147042|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2147043|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2147044|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2147045|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2147046|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595529|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2595530|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595531|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2595532|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
2595533|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
2595534|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595535|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420780|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420781|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
2420782|NCT00809718|Rifapentine|rifapentine|mesh-list
2420783|NCT00809718|Rifampin|rifampin|mesh-list
2420784|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2420785|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2420786|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
2420787|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420788|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2420789|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2420790|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420791|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420792|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2420793|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
2420794|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2420795|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
2147047|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2147048|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147049|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
2147050|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
2147051|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
2147052|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147053|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2147054|NCT03722576|Calcium|calcium|mesh-list
2147055|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2147056|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147057|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
2147058|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2147059|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2147060|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2147061|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
2147062|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595536|NCT01738295|Donepezil|donepezil|mesh-list
2595537|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2595538|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595539|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595540|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
2595541|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595542|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595543|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
2595544|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
2595545|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595546|NCT01738373|Plerixafor|plerixafor|mesh-list
2595547|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2147063|NCT03746002|Metolazone|metolazone|mesh-list
2147064|NCT03746002|Furosemide|furosemide|mesh-list
2595548|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2595549|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
2595550|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2595551|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
2595552|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
2595553|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595554|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595555|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595556|NCT01738451|Dabrafenib|dabrafenib|mesh-list
2420796|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2420797|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2420798|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2420799|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2420800|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2595557|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595558|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2595559|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595560|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595561|NCT01738542|Bosentan|bosentan|mesh-list
2595562|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
2595563|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2595564|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595565|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2595566|NCT01738607|Psyllium|psyllium|mesh-list
2595567|NCT01738607|Laxatives|laxatives|mesh-ancestor
2595568|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2595569|NCT01738607|Cathartics|cathartics|mesh-ancestor
2595570|NCT01738724|Goserelin|goserelin|mesh-list
2595571|NCT01738724|Dienogest|dienogest|mesh-list
2595572|NCT01738724|Desogestrel|desogestrel|mesh-list
2595573|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2595574|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595575|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2595576|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
2595577|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2595578|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595579|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2595580|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2595581|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2595582|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2595583|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
2595584|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2595585|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2595586|NCT01738724|Progestins|progestins|mesh-ancestor
2595587|NCT01738724|Hormones|hormones|mesh-ancestor
2595588|NCT01738763|Inositol|inositol|mesh-list
2147065|NCT03746002|Diuretics|diuretics|mesh-ancestor
2147066|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
2147067|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147068|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2147069|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2147070|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147071|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2147072|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2147073|NCT03789292|Adalimumab|adalimumab|mesh-list
2420801|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2420802|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2420803|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
2420804|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2420805|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420806|NCT00809744|Vitamins|vitamins|mesh-ancestor
2420807|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
2420808|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2420809|NCT00809796|Pentamidine|pentamidine|mesh-list
2420810|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
2420811|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420812|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2420813|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2420814|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2420815|NCT00809874|Caseins|caseins|mesh-list
2420816|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
2420817|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
2420818|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595589|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
2595590|NCT01738763|Vitamins|vitamins|mesh-ancestor
2595591|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
2595592|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595593|NCT01738802|Micronutrients|micronutrients|mesh-list
2595594|NCT01738802|Trace Elements|trace elements|mesh-list
2595595|NCT01738802|Antioxidants|antioxidants|mesh-list
2595596|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595597|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595598|NCT01738802|Protective Agents|protective agents|mesh-ancestor
2595599|NCT01738815|Valproic Acid|valproic acid|mesh-list
2595600|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
2595601|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595602|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595603|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
2595604|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595605|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595606|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
2595607|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2595608|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2595609|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2595610|NCT01738867|Naltrexone|naltrexone|mesh-list
2595611|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2595612|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2595613|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595614|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
2595615|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595616|NCT01738893|Gabapentin|gabapentin|mesh-list
2595617|NCT01738893|Analgesics|analgesics|mesh-ancestor
2595618|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
2595619|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595620|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595621|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
2595622|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2595623|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2595624|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2595625|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2595626|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2595627|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2595628|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595629|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595630|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
2595631|NCT01738945|Amlodipine|amlodipine|mesh-list
2595632|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2595633|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2595634|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2595635|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595636|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2595637|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595638|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
2595639|NCT01739049|Liraglutide|liraglutide|mesh-list
2595640|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2595641|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595642|NCT01739049|Incretins|incretins|mesh-ancestor
2595643|NCT01739049|Hormones|hormones|mesh-ancestor
2595644|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2147074|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147075|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147076|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
2147077|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
2147078|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
2147079|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147080|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147081|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
2147082|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147083|NCT03812224|Erenumab|erenumab|mesh-list
2147084|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2147085|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595645|NCT01739127|Risperidone|risperidone|mesh-list
2595646|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2595647|NCT01739127|Aripiprazole|aripiprazole|mesh-list
2595648|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2595649|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
2595650|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595651|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595652|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595653|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2147086|NCT03812224|Analgesics|analgesics|mesh-ancestor
2147087|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
2147088|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147089|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147090|NCT03817853|Prednisone|prednisone|mesh-list
2147091|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
2147092|NCT03817853|Prednisolone|prednisolone|mesh-list
2147093|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
2595654|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2595655|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2595656|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2595657|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2595658|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
2595659|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
2595660|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
2595661|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2595662|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2595663|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2595664|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2595665|NCT01739192|Bupropion|bupropion|mesh-list
2147094|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2147095|NCT03817853|Doxorubicin|doxorubicin|mesh-list
2147096|NCT03817853|Vincristine|vincristine|mesh-list
2147097|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
2147098|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2147099|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
2147100|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147101|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147102|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2147103|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
2147104|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147105|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2147106|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2147107|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2147108|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2147109|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2147110|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147111|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147112|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
2147113|NCT03817853|Hormones|hormones|mesh-ancestor
2147114|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2147115|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2147116|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2147117|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
2147118|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
2147119|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
2147120|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
2595666|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2595667|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
2595668|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2595669|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2595670|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2595671|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2595672|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595673|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
2595674|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595675|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595676|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2147121|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
2147122|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147123|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2147124|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2147125|NCT03817853|Protective Agents|protective agents|mesh-ancestor
2147126|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2595677|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2595678|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595679|NCT01739218|Paclitaxel|paclitaxel|mesh-list
2595680|NCT01739218|Bevacizumab|bevacizumab|mesh-list
2595681|NCT01739218|Carboplatin|carboplatin|mesh-list
2595682|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2595683|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595684|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
2595685|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
2595686|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
2595687|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595688|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2595689|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2595690|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2595691|NCT01739218|Growth Substances|growth substances|mesh-ancestor
2595692|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595693|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
2147135|NCT03828422|Calcium|calcium|mesh-list
2147136|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2147137|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595694|NCT01739413|Anesthetics|anesthetics|mesh-list
2595695|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2595696|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595697|NCT01739439|Gemcitabine|gemcitabine|mesh-list
2147138|NCT03829618|Lidocaine|lidocaine|mesh-list
2147139|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
2147140|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
2147141|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147142|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147143|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
2147144|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147145|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2147146|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2147147|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2147148|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2147149|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147150|NCT03830333|Metronidazole|metronidazole|mesh-list
2147151|NCT03830333|Meropenem|meropenem|mesh-list
2147152|NCT03830333|Tazobactam|tazobactam|mesh-list
2147153|NCT03830333|Ceftolozane|ceftolozane|mesh-list
2147154|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2147155|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147156|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2147157|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2147158|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2147159|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2147160|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147161|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147162|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2147163|NCT03830333|Renal Agents|renal agents|mesh-ancestor
2147164|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
2147165|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
2595698|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2595699|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
2595700|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595701|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595702|NCT01739439|Antiviral Agents|antiviral agents|mesh-ancestor
2595703|NCT01739439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2595704|NCT01739439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595705|NCT01739439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2595706|NCT01739439|Immunologic Factors|immunologic factors|mesh-ancestor
2595707|NCT01739439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595708|NCT01739504|Anesthetics|anesthetics|mesh-list
2595709|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2595710|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595711|NCT01739556|Aspirin|aspirin|mesh-list
2595712|NCT01739556|Ticagrelor|ticagrelor|mesh-list
2595713|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2595714|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2595715|NCT01739556|Analgesics|analgesics|mesh-ancestor
2595716|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
2595717|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595718|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595719|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2595720|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147166|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147167|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
2147168|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2595721|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2595722|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2595723|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595724|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2595725|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2595726|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595727|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
2595728|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2595729|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2595730|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2595731|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
2595732|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595733|NCT01739582|Enclomiphene|enclomiphene|mesh-list
2595734|NCT01739582|Clomiphene|clomiphene|mesh-list
2595735|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
2595736|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2595737|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
2595738|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2595739|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595740|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2595741|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
2595742|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2595743|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2595744|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2595745|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
2595746|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
2595747|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2595748|NCT01739673|Riboflavin|riboflavin|mesh-list
2595749|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
2595750|NCT01739673|Vitamins|vitamins|mesh-ancestor
2595751|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
2595752|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595753|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2595754|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
2595755|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
2595756|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
2595757|NCT01739855|Calcium|calcium|mesh-list
2595758|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2595759|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595760|NCT01739855|Antacids|antacids|mesh-ancestor
2595761|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595762|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2595763|NCT01739855|Vitamins|vitamins|mesh-ancestor
2595764|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
2595765|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2595766|NCT01739894|Paclitaxel|paclitaxel|mesh-list
2595767|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2595768|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595769|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
2595770|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
2595771|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
2595772|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595773|NCT01739907|Vitamin D|vitamin d|mesh-list
2595774|NCT01739907|Vitamins|vitamins|mesh-ancestor
2595775|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
2595776|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595777|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2595778|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
2595779|NCT01739920|Povidone|povidone|mesh-list
2595780|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
2420819|NCT00809887|Micafungin|micafungin|mesh-list
2420820|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
2420821|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420822|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
2420823|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2420824|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420825|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2420826|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2420827|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420828|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420829|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420830|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2420831|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2147169|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147170|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
2147171|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147172|NCT03862755|Heparin|heparin|mesh-list
2147173|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2147174|NCT03862755|Tinzaparin|tinzaparin|mesh-list
2147175|NCT03862755|Dalteparin|dalteparin|mesh-list
2595781|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
2595782|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2595783|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2595784|NCT01739985|Dexamethasone|dexamethasone|mesh-list
2595785|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
2595786|NCT01739985|Droperidol|droperidol|mesh-list
2595787|NCT01739985|Ondansetron|ondansetron|mesh-list
2595788|NCT01739985|BB 1101|bb 1101|mesh-list
2595789|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2595790|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
2595791|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
2147176|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
2147177|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2147178|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2147179|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595792|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595793|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595794|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2147191|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
2147192|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2147193|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147194|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2147195|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147196|NCT03885596|Acetaminophen|acetaminophen|mesh-list
2595795|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
2595796|NCT01739985|Hormones|hormones|mesh-ancestor
2595797|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2595798|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2595799|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595800|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
2595801|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595802|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595803|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
2595804|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
2595805|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2595806|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
2595807|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595808|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2595809|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2595810|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2595811|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2595812|NCT01739985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2595813|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2595814|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2595815|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2147197|NCT03885596|Celecoxib|celecoxib|mesh-list
2147198|NCT03885596|Ketorolac|ketorolac|mesh-list
2147199|NCT03885596|Lidocaine|lidocaine|mesh-list
2147200|NCT03885596|Fentanyl|fentanyl|mesh-list
2147201|NCT03885596|Bupivacaine|bupivacaine|mesh-list
2147202|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
2147203|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
2147204|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147205|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147206|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
2147207|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147208|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2147209|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2147210|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2147211|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2147212|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147213|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2147214|NCT03885596|Narcotics|narcotics|mesh-ancestor
2147215|NCT03885596|Analgesics|analgesics|mesh-ancestor
2147216|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2147217|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2147218|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
2147219|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2147220|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
2147221|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2147222|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147223|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147224|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2147225|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2595816|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
2595817|NCT01740245|Biguanides|biguanides|mesh-list
2595818|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
2595819|NCT01740245|Polihexanide|polihexanide|mesh-list
2595820|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2147226|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147227|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2147228|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2595821|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2595822|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
2595823|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2595824|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595825|NCT01740271|Epirubicin|epirubicin|mesh-list
2595826|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2595827|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595828|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2595829|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2595830|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595831|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595832|NCT01740336|Paclitaxel|paclitaxel|mesh-list
2595833|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2595834|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595835|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
2595836|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
2595837|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
2595838|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595839|NCT01740453|Ropivacaine|ropivacaine|mesh-list
2595840|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
2147229|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2147230|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
2147231|NCT03889158|Vaccines|vaccines|mesh-list
2147232|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
2147233|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147234|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
2147235|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147236|NCT03889158|Protective Agents|protective agents|mesh-ancestor
2420832|NCT00809939|Progesterone|progesterone|mesh-list
2420833|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2420834|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2420835|NCT00809939|Progestins|progestins|mesh-ancestor
2420836|NCT00809939|Hormones|hormones|mesh-ancestor
2147237|NCT03889158|Vitamins|vitamins|mesh-ancestor
2147238|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
2147248|NCT03897348|Lacosamide|lacosamide|mesh-list
2147249|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
2147250|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2147251|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2420837|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2420838|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420839|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2420840|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
2420841|NCT00810017|Etoposide|etoposide|mesh-list
2420842|NCT00810017|Trastuzumab|trastuzumab|mesh-list
2147252|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2420843|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2420844|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420845|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2420846|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2420847|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420848|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420849|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2420850|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2420851|NCT00810030|Hematinics|hematinics|mesh-ancestor
2420852|NCT00810121|Ketoprofen|ketoprofen|mesh-list
2595841|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
2147253|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147254|NCT03907033|Bupivacaine|bupivacaine|mesh-list
2147255|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
2147256|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
2147257|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147258|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595842|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2595843|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595844|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
2595845|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595846|NCT01740492|Ketamine|ketamine|mesh-list
2595847|NCT01740492|Analgesics|analgesics|mesh-ancestor
2595848|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
2595849|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595850|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595851|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2595852|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2595853|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
2595854|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
2595855|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2595856|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2595857|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2595858|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595859|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595860|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
2595861|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
2595862|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595863|NCT01740518|Protective Agents|protective agents|mesh-ancestor
2595864|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595865|NCT01740518|Vitamins|vitamins|mesh-ancestor
2147259|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
2147260|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147261|NCT03920215|Varenicline|varenicline|mesh-list
2147262|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2147263|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2147264|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
2147265|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147266|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147267|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147268|NCT03921151|Mirtazapine|mirtazapine|mesh-list
2147269|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
2147270|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2147271|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2147272|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
2147273|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
2595866|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
2147274|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147275|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147276|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147277|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2147278|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2147279|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147280|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2147281|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2147282|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2147283|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
2147284|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2595891|NCT01740648|Fluorouracil|fluorouracil|mesh-list
2595892|NCT01740648|Trametinib|trametinib|mesh-list
2595893|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
2595894|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420853|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2420854|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2420855|NCT00810121|Analgesics|analgesics|mesh-ancestor
2420856|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
2420857|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420858|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420859|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2420860|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2420861|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2420862|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420863|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420864|NCT00810316|Clonazepam|clonazepam|mesh-list
2420865|NCT00810316|Alprazolam|alprazolam|mesh-list
2420866|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2420867|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2420868|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420869|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2420870|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2147285|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2147286|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
2147287|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2147288|NCT03927911|Bupivacaine|bupivacaine|mesh-list
2147289|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
2147290|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
2420871|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2420872|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
2420873|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
2420874|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420875|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420876|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
2420877|NCT00810381|Nitroprusside|nitroprusside|mesh-list
2420878|NCT00810381|Isosorbide|isosorbide|mesh-list
2420879|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2420880|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2420881|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
2420882|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
2420883|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2420884|NCT00810381|Diuretics|diuretics|mesh-ancestor
2420885|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
2420886|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420887|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2420888|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420889|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2595895|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2595896|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595897|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2595898|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
2595899|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595900|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2595901|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595902|NCT01740921|Aspirin|aspirin|mesh-list
2595903|NCT01740921|Liraglutide|liraglutide|mesh-list
2595904|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2147291|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147292|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147293|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
2595905|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2595906|NCT01740921|Analgesics|analgesics|mesh-ancestor
2595907|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
2595908|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595909|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595910|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2595911|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2595912|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2595913|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2595914|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595915|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2595916|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2595917|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2595918|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
2147294|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147295|NCT03938857|Fentanyl|fentanyl|mesh-list
2147296|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
2595919|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2595920|NCT01740921|Incretins|incretins|mesh-ancestor
2595921|NCT01740921|Hormones|hormones|mesh-ancestor
2595922|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2595923|NCT01740947|Amphotericin B|amphotericin b|mesh-list
2595924|NCT01740947|Tobramycin|tobramycin|mesh-list
2595925|NCT01740947|Colistin|colistin|mesh-list
2595926|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2595927|NCT01740947|Amebicides|amebicides|mesh-ancestor
2595928|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2595929|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2595930|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2595931|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2595932|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
2595933|NCT01740960|Dronabinol|dronabinol|mesh-list
2595934|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
2147297|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2147298|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147299|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595935|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595936|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2595937|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2595938|NCT01740960|Analgesics|analgesics|mesh-ancestor
2595939|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
2595940|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595941|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2595942|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2595943|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595944|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595945|NCT01740960|Hormones|hormones|mesh-ancestor
2595946|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2595947|NCT01741038|Cetuximab|cetuximab|mesh-list
2595948|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2595949|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595950|NCT01741077|Folic Acid|folic acid|mesh-list
2595951|NCT01741077|Hematinics|hematinics|mesh-ancestor
2595952|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
2595953|NCT01741077|Vitamins|vitamins|mesh-ancestor
2595954|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
2595955|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595966|NCT01741142|Citalopram|citalopram|mesh-list
2595967|NCT01741142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2595968|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2595969|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2595970|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595971|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2595972|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
2595973|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595974|NCT01741142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2595975|NCT01741142|Antidepressive Agents|antidepressive agents|mesh-ancestor
2595976|NCT01741142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2595977|NCT01741155|Docetaxel|docetaxel|mesh-list
2595978|NCT01741155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2595979|NCT01741155|Tubulin Modulators|tubulin modulators|mesh-ancestor
2595980|NCT01741155|Antimitotic Agents|antimitotic agents|mesh-ancestor
2595981|NCT01741155|Mitosis Modulators|mitosis modulators|mesh-ancestor
2595982|NCT01741155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2595983|NCT01741181|Vitamin D|vitamin d|mesh-list
2595984|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
2595985|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
2595986|NCT01741181|Vitamins|vitamins|mesh-list
2595987|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
2595988|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595989|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2595990|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2595991|NCT01741285|Fluticasone|fluticasone|mesh-list
2595992|NCT01741285|Beclomethasone|beclomethasone|mesh-list
2595993|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2595994|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2595995|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
2595996|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2595997|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2595998|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2595999|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
2596000|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
2596001|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2596002|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
2596003|NCT01741285|Hormones|hormones|mesh-ancestor
2596004|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2596005|NCT01741324|Vitamin D|vitamin d|mesh-list
2596006|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
2596007|NCT01741324|Vitamins|vitamins|mesh-list
2596008|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
2596009|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596010|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2596011|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2596012|NCT01741376|Progesterone|progesterone|mesh-list
2596013|NCT01741376|Progestins|progestins|mesh-ancestor
2596014|NCT01741376|Hormones|hormones|mesh-ancestor
2596015|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2596016|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596017|NCT01741389|Melatonin|melatonin|mesh-list
2596018|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
2596019|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596020|NCT01741389|Protective Agents|protective agents|mesh-ancestor
2596021|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420890|NCT00810446|Rifabutin|rifabutin|mesh-list
2420891|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2420892|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420893|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2147300|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2147301|NCT03938857|Analgesics|analgesics|mesh-ancestor
2147302|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
2147303|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147304|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2147305|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2147306|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2147307|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
2147308|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147309|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147310|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2147311|NCT03938857|Narcotics|narcotics|mesh-ancestor
2147312|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2147313|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2147314|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
2147315|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
2147316|NCT03945981|Lamivudine|lamivudine|mesh-list
2147317|NCT03945981|Dolutegravir|dolutegravir|mesh-list
2420894|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
2420895|NCT00810524|Lamivudine|lamivudine|mesh-list
2420896|NCT00810524|Adefovir|adefovir|mesh-list
2420897|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2420898|NCT00810524|Telbivudine|telbivudine|mesh-list
2596022|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596023|NCT01741493|Upadacitinib|upadacitinib|mesh-list
2596024|NCT01741493|Tofacitinib|tofacitinib|mesh-list
2596025|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2596026|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596027|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147318|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2147319|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2147320|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147321|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147322|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
2147323|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147324|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2147325|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2147326|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2147327|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2147328|NCT03950674|Folic Acid|folic acid|mesh-list
2147329|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
2147330|NCT03950674|Hydroxocobalamin|hydroxocobalamin|mesh-list
2147331|NCT03950674|Dexamethasone|dexamethasone|mesh-list
2147332|NCT03950674|Carboplatin|carboplatin|mesh-list
2147333|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
2147334|NCT03950674|Pemetrexed|pemetrexed|mesh-list
2147335|NCT03950674|Vitamins|vitamins|mesh-ancestor
2147336|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
2596028|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2596029|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2596030|NCT01741506|Dalteparin|dalteparin|mesh-list
2596031|NCT01741506|Tinzaparin|tinzaparin|mesh-list
2596032|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2596033|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
2596034|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2596035|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2596036|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596037|NCT01741519|Landiolol|landiolol|mesh-list
2596038|NCT01741519|Esmolol|esmolol|mesh-list
2596039|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2596040|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2596041|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2596042|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
2596043|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596044|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596045|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596046|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2596047|NCT01741558|Riboflavin|riboflavin|mesh-list
2596048|NCT01741558|Methotrexate|methotrexate|mesh-list
2596049|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2596050|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
2596051|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2596052|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596053|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2596054|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
2596055|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596056|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596057|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
2596058|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596059|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2147337|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147338|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2147339|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147340|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
2147341|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
2147342|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147343|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2147344|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
2147345|NCT03950674|Hormones|hormones|mesh-ancestor
2147346|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2147347|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2147348|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2147349|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147350|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147351|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2147352|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2147353|NCT03950674|Hematinics|hematinics|mesh-ancestor
2147354|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
2147355|NCT03954834|Tirzepatide|tirzepatide|mesh-list
2147356|NCT03954834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2147357|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147358|NCT03954834|Incretins|incretins|mesh-ancestor
2147359|NCT03954834|Hormones|hormones|mesh-ancestor
2596060|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2596061|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
2596062|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2596063|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2596064|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
2596065|NCT01741558|Vitamins|vitamins|mesh-ancestor
2596066|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
2596067|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2596068|NCT01741623|Bisoprolol|bisoprolol|mesh-list
2596069|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2596070|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
2596071|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
2596072|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596073|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596074|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2596075|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2596076|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2596077|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
2596078|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596079|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596080|NCT01741649|Povidone|povidone|mesh-list
2596081|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
2596082|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
2596083|NCT01741753|Prednisone|prednisone|mesh-list
2596084|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2420899|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2420900|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2420901|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420902|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420903|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
2420904|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420905|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2420906|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2420907|NCT00810563|Bupivacaine|bupivacaine|mesh-list
2420908|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
2420909|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
2420910|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2420911|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420912|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
2420913|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420914|NCT00810589|Insulin|insulin|mesh-list
2420915|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2420916|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
2420917|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
2420918|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2147360|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2147361|NCT03958071|Pirfenidone|pirfenidone|mesh-list
2147362|NCT03958071|Nintedanib|nintedanib|mesh-list
2147363|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2147364|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2147365|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147366|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147367|NCT03958071|Analgesics|analgesics|mesh-ancestor
2147368|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
2147369|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147370|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147371|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2147372|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2147373|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147374|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147375|NCT03968159|Pimavanserin|pimavanserin|mesh-list
2147376|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2596085|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
2596086|NCT01741753|Hormones|hormones|mesh-ancestor
2596087|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2596088|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596089|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2596090|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596091|NCT01741831|Darunavir|darunavir|mesh-list
2596092|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2596093|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2596094|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
2596095|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596096|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596097|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2596098|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2596099|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
2596100|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2596101|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
2596102|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2596103|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596104|NCT01742247|Palmidrol|palmidrol|mesh-list
2596105|NCT01742247|Analgesics|analgesics|mesh-ancestor
2147377|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2147378|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2147379|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2147380|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147381|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147382|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2147383|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2147384|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2147385|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
2596106|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
2596107|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596108|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596109|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2596110|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2596111|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2596112|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2596113|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
2596114|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2596115|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2596116|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2596117|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596118|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596119|NCT01742247|Hormones|hormones|mesh-ancestor
2596120|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2596121|NCT01742273|Vitamin K|vitamin k|mesh-list
2596122|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
2596123|NCT01742273|Vitamins|vitamins|mesh-ancestor
2596124|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
2596125|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596126|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2596127|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2596128|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596129|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
2596130|NCT01742273|Coagulants|coagulants|mesh-ancestor
2596131|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
2596132|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596133|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2596134|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596135|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596136|NCT01742338|Prednisone|prednisone|mesh-list
2596137|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
2147386|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147387|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147388|NCT03970824|Adalimumab|adalimumab|mesh-list
2147389|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147390|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147391|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
2147392|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2147393|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2147394|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
2147395|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147396|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147397|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147398|NCT03979807|Bromides|bromides|mesh-list
2147399|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
2147400|NCT03979807|Olodaterol|olodaterol|mesh-list
2147401|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2147402|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
2147403|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147404|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147405|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2147406|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
2147407|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
2147408|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2147409|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
2147410|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147411|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147412|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
2147413|NCT03982069|Vaccines|vaccines|mesh-list
2147414|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
2147415|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596138|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2596139|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2596140|NCT01742338|Prednisolone|prednisolone|mesh-list
2596141|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
2596142|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2596143|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
2147416|NCT04005859|Lidocaine|lidocaine|mesh-list
2147417|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
2147418|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
2147419|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147420|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147421|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
2147422|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147423|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2147424|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2147425|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2147426|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2147427|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147428|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
2147429|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
2147430|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147431|NCT04011592|Ketamine|ketamine|mesh-list
2147432|NCT04011592|Analgesics|analgesics|mesh-ancestor
2147433|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
2147434|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147435|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147436|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2147437|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2147438|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
2147439|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
2147440|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596144|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2596145|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
2596146|NCT01742338|Hormones|hormones|mesh-ancestor
2596147|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2596148|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596149|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2596150|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596151|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
2596152|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
2596153|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596154|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2596155|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2596156|NCT01742338|Protective Agents|protective agents|mesh-ancestor
2596157|NCT01742390|Risperidone|risperidone|mesh-list
2596158|NCT01742390|Aripiprazole|aripiprazole|mesh-list
2596159|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2596160|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2596161|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
2596162|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596163|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596164|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596165|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2596166|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2596167|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596168|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2596169|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2596170|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
2596171|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
2596172|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
2596173|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2596174|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2596175|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2596176|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2596177|NCT01742429|Amoxicillin|amoxicillin|mesh-list
2596178|NCT01742429|Metronidazole|metronidazole|mesh-list
2596179|NCT01742429|Levofloxacin|levofloxacin|mesh-list
2596180|NCT01742429|Ofloxacin|ofloxacin|mesh-list
2596181|NCT01742429|Tetracycline|tetracycline|mesh-list
2147441|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2147442|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2147443|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596182|NCT01742429|Bismuth|bismuth|mesh-list
2596183|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2596184|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2596185|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2596186|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2596187|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2596188|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2596189|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2147444|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147445|NCT04032327|Bupivacaine|bupivacaine|mesh-list
2596190|NCT01742429|Renal Agents|renal agents|mesh-ancestor
2596191|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2596192|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2596193|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596194|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596195|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596196|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2596197|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2596198|NCT01742429|Antacids|antacids|mesh-ancestor
2147446|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
2147447|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
2147448|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596199|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2596200|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2596201|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
2596202|NCT01742533|Hormones|hormones|mesh-list
2596203|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2596204|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596205|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
2596206|NCT01742624|Tacrolimus|tacrolimus|mesh-list
2596207|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2596208|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
2596209|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596210|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2596211|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596212|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596213|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2596214|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596215|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2596216|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
2596217|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2596218|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2596219|NCT01742637|Adapalene|adapalene|mesh-list
2596220|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2596221|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
2596222|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2596223|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2596224|NCT01742637|Analgesics|analgesics|mesh-ancestor
2147449|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147450|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
2147451|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147452|NCT04036292|Varenicline|varenicline|mesh-list
2596225|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
2596226|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596227|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596228|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2596229|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2596230|NCT01742663|Diclofenac|diclofenac|mesh-list
2596231|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2596232|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2596233|NCT01742663|Analgesics|analgesics|mesh-ancestor
2596234|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
2596235|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596236|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596237|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2596238|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2596239|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2596240|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596241|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596242|NCT01742676|Tacrolimus|tacrolimus|mesh-list
2596243|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2596244|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
2596245|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596246|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2596247|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596248|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596249|NCT01742689|Indomethacin|indomethacin|mesh-list
2596250|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2596251|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2596252|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2596253|NCT01742689|Analgesics|analgesics|mesh-ancestor
2596254|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
2596255|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596256|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596257|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2596258|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2596259|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
2596260|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
2596261|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2596262|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2596263|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596264|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596265|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
2596266|NCT01742689|Coagulants|coagulants|mesh-ancestor
2596267|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2596268|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
2596269|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
2596270|NCT01742702|Bisoprolol|bisoprolol|mesh-list
2596271|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
2596272|NCT01742702|Albuterol|albuterol|mesh-list
2596273|NCT01742702|Caseins|caseins|mesh-list
2596274|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2596275|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
2596276|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596277|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147453|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2147454|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2147455|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
2147456|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147457|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147458|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147459|NCT04042077|Vancomycin|vancomycin|mesh-list
2147460|NCT04042077|Tazobactam|tazobactam|mesh-list
2147461|NCT04042077|Linezolid|linezolid|mesh-list
2147462|NCT04042077|Piperacillin|piperacillin|mesh-list
2147463|NCT04042077|Tigecycline|tigecycline|mesh-list
2147464|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2147465|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2147466|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147467|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2147468|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147469|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147470|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2147471|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
2147472|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2147473|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147474|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2147475|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2147476|NCT04052204|Avelumab|avelumab|mesh-list
2147477|NCT04052204|Talazoparib|talazoparib|mesh-list
2147478|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2147479|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2147480|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2147481|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596278|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2596279|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
2596280|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
2596281|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2596282|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2596283|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2596284|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2596285|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
2596286|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596287|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596288|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
2596289|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
2596290|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
2596291|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2596292|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
2596293|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2596294|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2596295|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2596296|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2596297|NCT01742767|Pemetrexed|pemetrexed|mesh-list
2596298|NCT01742767|Cisplatin|cisplatin|mesh-list
2596299|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596300|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596301|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596302|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2596303|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2596304|NCT01742793|Lenalidomide|lenalidomide|mesh-list
2596305|NCT01742793|Romidepsin|romidepsin|mesh-list
2596306|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
2596307|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596308|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2596309|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2596310|NCT01742793|Growth Substances|growth substances|mesh-ancestor
2596311|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
2596312|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596313|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2596314|NCT01742845|Ropivacaine|ropivacaine|mesh-list
2596315|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
2596316|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
2596317|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596318|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596319|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
2147482|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147483|NCT04067011|Doxycycline|doxycycline|mesh-list
2147484|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
2147485|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2147486|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147487|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
2147488|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2147489|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2147490|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2596320|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596321|NCT01742988|Rituximab|rituximab|mesh-list
2596322|NCT01742988|Venetoclax|venetoclax|mesh-list
2596323|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2596324|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596325|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
2596326|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596327|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2596328|NCT01743014|Ramipril|ramipril|mesh-list
2596329|NCT01743014|Clopidogrel|clopidogrel|mesh-list
2596330|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2596331|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2596332|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2596333|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2596334|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
2596335|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596336|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596337|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596338|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2596339|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
2596340|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596341|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2596342|NCT01743066|Vitamin E|vitamin e|mesh-list
2596343|NCT01743066|Vitamins|vitamins|mesh-ancestor
2596344|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
2596345|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596346|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
2596347|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596348|NCT01743066|Protective Agents|protective agents|mesh-ancestor
2596349|NCT01743079|Lamivudine|lamivudine|mesh-list
2596350|NCT01743079|Telbivudine|telbivudine|mesh-list
2596351|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2596352|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2147491|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2596353|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596354|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596355|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
2596356|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2596357|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2596358|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2596359|NCT01743118|Calcipotriene|calcipotriene|mesh-list
2596360|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
2596361|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
2596362|NCT01743144|Analgesics|analgesics|mesh-ancestor
2596363|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
2596364|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596365|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596366|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
2596367|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596368|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2596369|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
2596370|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2596371|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2596372|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596373|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2596374|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
2596375|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2596376|NCT01743157|Bevacizumab|bevacizumab|mesh-list
2596377|NCT01743157|Ipilimumab|ipilimumab|mesh-list
2596378|NCT01743157|Interleukin-2|interleukin-2|mesh-list
2596379|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2596380|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596381|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2147492|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147493|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147494|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2147495|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2147496|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2147497|NCT04085341|Sunitinib|sunitinib|mesh-list
2147498|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2147499|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2147500|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2147501|NCT04085341|Growth Substances|growth substances|mesh-ancestor
2147502|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147503|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
2147504|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2147505|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147506|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147507|NCT04094870|Sertraline|sertraline|mesh-list
2596382|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2596383|NCT01743157|Growth Substances|growth substances|mesh-ancestor
2596384|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596385|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
2596386|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2596387|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596388|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2596389|NCT01743157|Analgesics|analgesics|mesh-ancestor
2596390|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
2596391|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596392|NCT01743235|Buspirone|buspirone|mesh-list
2596393|NCT01743235|Testosterone|testosterone|mesh-list
2596394|NCT01743235|Androgens|androgens|mesh-ancestor
2596395|NCT01743235|Hormones|hormones|mesh-ancestor
2596396|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2596397|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596398|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2596399|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2596400|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596401|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2596402|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2596403|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
2596404|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596405|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596406|NCT01743300|Sunitinib|sunitinib|mesh-list
2596407|NCT01743300|Midazolam|midazolam|mesh-list
2596408|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2596409|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2596410|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596411|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596412|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2596413|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2596414|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2596415|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2147508|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
2147509|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2147510|NCT04094870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2147511|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2147512|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2147513|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147514|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147515|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
2147516|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147517|NCT04103515|Cimetidine|cimetidine|mesh-list
2147518|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2147519|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2147520|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2147521|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
2147522|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
2147523|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147524|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147525|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147526|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2147527|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2147528|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147529|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
2147530|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2147531|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
2147532|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147533|NCT04123405|Expectorants|expectorants|mesh-ancestor
2147534|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
2147535|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2147536|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
2147537|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147538|NCT04123405|Protective Agents|protective agents|mesh-ancestor
2147539|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147540|NCT04123405|Antidotes|antidotes|mesh-ancestor
2147541|NCT04138758|Bromides|bromides|mesh-list
2596416|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
2596417|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
2596418|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
2596419|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
2596420|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596421|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596422|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596423|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2596424|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2596425|NCT01743300|Growth Substances|growth substances|mesh-ancestor
2596426|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
2596427|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2596428|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596429|NCT01743326|Anesthetics|anesthetics|mesh-list
2596430|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596431|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596432|NCT01743365|Afatinib|afatinib|mesh-list
2596433|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596434|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2596435|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596436|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596437|NCT01743378|Ropivacaine|ropivacaine|mesh-list
2596438|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
2596439|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
2147542|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
2147543|NCT04138758|Olodaterol|olodaterol|mesh-list
2147544|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2147545|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
2147546|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147547|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147548|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2147549|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
2147550|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
2147551|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2147552|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
2147553|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147554|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147555|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
2596440|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596441|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596442|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
2596443|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596444|NCT01743456|Anesthetics|anesthetics|mesh-list
2596445|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596446|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596447|NCT01743508|Misoprostol|misoprostol|mesh-list
2596448|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2147556|NCT04147715|Dolutegravir|dolutegravir|mesh-list
2147557|NCT04147715|Midazolam|midazolam|mesh-list
2147558|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2147559|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2147560|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147561|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147562|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2147563|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2147564|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2147565|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2147566|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
2147567|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
2596449|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
2596450|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2596451|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596452|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2596453|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2147568|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
2147569|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
2147570|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147571|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147572|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2147573|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2147574|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147575|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2596454|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
2596455|NCT01743651|Baclofen|baclofen|mesh-list
2596456|NCT01743651|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2596457|NCT01743651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596458|NCT01743651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2596459|NCT01743651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596460|NCT01743651|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2596461|NCT01743651|GABA Agonists|gaba agonists|mesh-ancestor
2596462|NCT01743651|GABA Agents|gaba agents|mesh-ancestor
2596463|NCT01743651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596464|NCT01743651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596465|NCT01743690|Nystatin|nystatin|mesh-list
2596466|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2596467|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2596468|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
2596469|NCT01743690|Hormones|hormones|mesh-ancestor
2596470|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2596471|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596472|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2596473|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2596474|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
2596475|NCT01743690|Ionophores|ionophores|mesh-ancestor
2596476|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2596477|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596478|NCT01743742|Vitamins|vitamins|mesh-list
2596479|NCT01743742|Ascorbic Acid|ascorbic acid|mesh-list
2596480|NCT01743742|Vitamin E|vitamin e|mesh-list
2596481|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
2596482|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596483|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
2596484|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596485|NCT01743742|Protective Agents|protective agents|mesh-ancestor
2596486|NCT01743755|Dexamethasone|dexamethasone|mesh-list
2596487|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2596488|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
2596489|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
2147576|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2147577|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
2147578|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147579|NCT04160091|FX006|fx006|mesh-list
2147580|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147581|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
2147582|NCT04160091|Hormones|hormones|mesh-ancestor
2147583|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2596490|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596491|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596492|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2596493|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
2596494|NCT01743755|Hormones|hormones|mesh-ancestor
2596495|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2596496|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2147584|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147585|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2147586|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
2147587|NCT04164758|Pimavanserin|pimavanserin|mesh-list
2147588|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2147589|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
2147590|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2147591|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2596497|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596498|NCT01743794|Ropivacaine|ropivacaine|mesh-list
2596499|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
2596500|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
2596501|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596502|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596503|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
2147592|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2147593|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147594|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147595|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2147596|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2147597|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2147598|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2596504|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596505|NCT01743820|Piperaquine|piperaquine|mesh-list
2596506|NCT01743820|Primaquine|primaquine|mesh-list
2596507|NCT01743820|Artenimol|artenimol|mesh-list
2596508|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
2596509|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2596510|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2596511|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2596512|NCT01743885|Propranolol|propranolol|mesh-list
2596513|NCT01743885|Acebutolol|acebutolol|mesh-list
2596514|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2596515|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2596516|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
2147599|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
2147600|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147601|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147602|NCT04165031|Docetaxel|docetaxel|mesh-list
2147603|NCT04165031|Cetuximab|cetuximab|mesh-list
2147604|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2147605|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2147606|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
2147607|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
2147608|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
2147609|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147610|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2147611|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2147612|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147613|NCT04171414|Adalimumab|adalimumab|mesh-list
2147614|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147615|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147616|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
2147617|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2147618|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147619|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2147620|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2147621|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596517|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596518|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596519|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596520|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2596521|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2596522|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
2596523|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
2596524|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
2596525|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147622|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596526|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2596527|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
2596528|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2596529|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
2596530|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2596531|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
2596532|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596533|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596534|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
2596535|NCT01743911|Tadalafil|tadalafil|mesh-list
2147623|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2147624|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
2147625|NCT04184297|Olodaterol|olodaterol|mesh-list
2147626|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2147627|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
2147628|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147629|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147630|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2147631|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
2147632|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
2147633|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2147634|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
2147635|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147636|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147637|NCT04189848|Dulaglutide|dulaglutide|mesh-list
2147638|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2147639|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147640|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
2147641|NCT04211909|Velpatasvir|velpatasvir|mesh-list
2147642|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
2147643|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147644|NCT04218110|Ethanol|ethanol|mesh-list
2147645|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
2147646|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2147647|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2147648|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147649|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147650|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147651|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
2147652|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
2147653|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2147654|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2147655|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
2147656|NCT04223843|Olodaterol|olodaterol|mesh-list
2147657|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2147658|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
2147659|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147660|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147661|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2596536|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
2596537|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2596538|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2596539|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596540|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596541|NCT01743911|Urological Agents|urological agents|mesh-ancestor
2596542|NCT01743950|Bevacizumab|bevacizumab|mesh-list
2596543|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2596544|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596545|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2147662|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
2147663|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
2147664|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2147665|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
2147666|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147667|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147668|NCT04229303|Voriconazole|voriconazole|mesh-list
2147669|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
2147670|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147671|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2147672|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2147673|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147674|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147675|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2147676|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
2147677|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2147678|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147679|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2147680|NCT04256603|Gabapentin|gabapentin|mesh-list
2147681|NCT04256603|Analgesics|analgesics|mesh-ancestor
2147682|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
2147683|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147684|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147685|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
2147686|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2147687|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2147688|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147689|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2147690|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2147691|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2147692|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147693|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147694|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
2147695|NCT04290494|Plasminogen|plasminogen|mesh-list
2147696|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2147697|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2147698|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147699|NCT04303156|Islatravir|islatravir|mesh-list
2147700|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
2147701|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147702|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147703|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147704|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2147705|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2147706|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2147707|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2147708|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2147709|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
2147710|NCT04323852|Vitamin D|vitamin d|mesh-list
2147711|NCT04323852|Vitamins|vitamins|mesh-ancestor
2147712|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
2147713|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147714|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2147715|NCT04327843|Haloperidol|haloperidol|mesh-list
2147716|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
2147717|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
2147718|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
2147719|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147720|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147721|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2596546|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2596547|NCT01743950|Growth Substances|growth substances|mesh-ancestor
2596548|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596549|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
2596550|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
2596551|NCT01744106|Ephedrine|ephedrine|mesh-list
2596552|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2596553|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
2596554|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596555|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596556|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2596557|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
2596558|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
2596559|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2596560|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2596561|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
2596562|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
2596563|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147722|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2147723|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2147724|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147725|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2147726|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2147727|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
2147728|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147729|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596564|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596565|NCT01744184|Midazolam|midazolam|mesh-list
2596566|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
2147730|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2147731|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
2596567|NCT01744184|Entonox|entonox|mesh-list
2596568|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2596569|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2596570|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596571|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596572|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2596573|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2596574|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2596575|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2596576|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
2596577|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
2596578|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
2596579|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
2596580|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596581|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596582|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2596583|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2596584|NCT01744184|Analgesics|analgesics|mesh-ancestor
2596585|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
2596586|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596587|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2596588|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2596589|NCT01744236|Liraglutide|liraglutide|mesh-list
2596590|NCT01744236|Exenatide|exenatide|mesh-list
2596591|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2596592|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596593|NCT01744236|Incretins|incretins|mesh-ancestor
2596594|NCT01744236|Hormones|hormones|mesh-ancestor
2596595|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2596596|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2596597|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
2596598|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596599|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596600|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2596601|NCT01744249|Axitinib|axitinib|mesh-list
2596602|NCT01744249|Octreotide|octreotide|mesh-list
2596603|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596604|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2596605|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596606|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596607|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2596608|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2596609|NCT01744262|Anesthetics|anesthetics|mesh-list
2596610|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596611|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147732|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
2147733|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2147734|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2147735|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147736|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147737|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147738|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147739|NCT04347954|Iodine|iodine|mesh-list
2147740|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
2147741|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
2147742|NCT04347954|Povidone|povidone|mesh-list
2147743|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2147744|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147745|NCT04347954|Trace Elements|trace elements|mesh-ancestor
2147746|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
2147747|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147748|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
2147749|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
2147750|NCT04358068|Azithromycin|azithromycin|mesh-list
2147751|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
2147752|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2147753|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147754|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
2147755|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2147756|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2147757|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147758|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147759|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147760|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
2147761|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2147762|NCT04373421|Benzydamine|benzydamine|mesh-list
2147763|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2147764|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147765|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
2147766|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
2147767|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147768|NCT04398732|Etanercept|etanercept|mesh-list
2147769|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2147770|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2147771|NCT04398732|Analgesics|analgesics|mesh-ancestor
2147772|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
2147773|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147774|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147775|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147776|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147777|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2147778|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2147779|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
2147780|NCT04401293|Heparin|heparin|mesh-list
2147781|NCT04401293|Enoxaparin|enoxaparin|mesh-list
2147782|NCT04401293|Calcium heparin|calcium heparin|mesh-list
2147783|NCT04401293|Dalteparin|dalteparin|mesh-list
2147784|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
2147785|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
2147786|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2147787|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2147788|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147789|NCT04420572|Betamethasone|betamethasone|mesh-list
2147790|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147791|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
2147792|NCT04420572|Hormones|hormones|mesh-ancestor
2147793|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2147794|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147795|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2147796|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
2147797|NCT04428411|Etanercept|etanercept|mesh-list
2147798|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2596612|NCT01744288|Clopidogrel|clopidogrel|mesh-list
2596613|NCT01744288|Ticagrelor|ticagrelor|mesh-list
2596614|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2596615|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2147799|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2147800|NCT04428411|Analgesics|analgesics|mesh-ancestor
2147801|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
2147802|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147803|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147804|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147805|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147806|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2147807|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2147808|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
2147809|NCT04492475|Interferons|interferons|mesh-list
2147810|NCT04492475|Interferon-beta|interferon-beta|mesh-list
2147811|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
2147812|NCT04492475|Remdesivir|remdesivir|mesh-list
2147813|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2147814|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
2147815|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147816|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
2147817|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147818|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2147819|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
2596616|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2596617|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2596618|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
2596619|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596620|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596621|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596622|NCT01744314|Indomethacin|indomethacin|mesh-list
2147820|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147821|NCT04495283|Acetaminophen|acetaminophen|mesh-list
2147822|NCT04495283|Pregabalin|pregabalin|mesh-list
2147823|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2147824|NCT04495283|Analgesics|analgesics|mesh-ancestor
2147825|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
2147826|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596623|NCT01744314|Pantoprazole|pantoprazole|mesh-list
2596624|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2147827|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147828|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
2147829|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
2147830|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2147831|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2147832|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147833|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2596625|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2596626|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2596627|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596628|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596629|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2147834|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2147835|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2147836|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147837|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2147838|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
2147839|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2147840|NCT04501640|Mirabegron|mirabegron|mesh-list
2147841|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2147842|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2147843|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2147844|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
2147845|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147846|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147847|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147848|NCT04501640|Urological Agents|urological agents|mesh-ancestor
2147849|NCT04501952|Remdesivir|remdesivir|mesh-list
2596630|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2596631|NCT01744314|Analgesics|analgesics|mesh-ancestor
2596632|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
2147850|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
2147851|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147852|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
2147853|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147854|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
2147855|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2147856|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
2147857|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2147858|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
2596633|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596634|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596635|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2596636|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2596637|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
2596638|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
2596639|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2596640|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2596641|NCT01744366|Goserelin|goserelin|mesh-list
2596642|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2596643|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596644|NCT01744379|Lesinurad|lesinurad|mesh-list
2596645|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
2596646|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2596647|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
2596648|NCT01744379|Renal Agents|renal agents|mesh-ancestor
2596649|NCT01744444|Gabapentin|gabapentin|mesh-list
2596650|NCT01744444|Memantine|memantine|mesh-list
2596651|NCT01744444|Analgesics|analgesics|mesh-ancestor
2596652|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
2596653|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596654|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596655|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
2596656|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2596657|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2596658|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596659|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2596660|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2596661|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2596662|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596663|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596664|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
2596665|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2147859|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147860|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147861|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
2147862|NCT04507763|Etanercept|etanercept|mesh-list
2147863|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2147864|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2147865|NCT04507763|Analgesics|analgesics|mesh-ancestor
2147866|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
2147867|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147868|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596666|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2596667|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
2596668|NCT01744470|Tacrolimus|tacrolimus|mesh-list
2596669|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2596670|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
2596671|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596672|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2596673|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596674|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596675|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2596676|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
2596677|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596678|NCT01744587|Protective Agents|protective agents|mesh-ancestor
2596679|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596680|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2596681|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2596682|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596683|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2147869|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147870|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147871|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2147872|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2596684|NCT01744626|Rituximab|rituximab|mesh-list
2596685|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2596686|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596687|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
2596688|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596689|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2596690|NCT01744652|Dasatinib|dasatinib|mesh-list
2596691|NCT01744652|Crizotinib|crizotinib|mesh-list
2596692|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596693|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2596694|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596695|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596696|NCT01744678|Immunoconjugates|immunoconjugates|mesh-list
2596697|NCT01744678|Immunologic Factors|immunologic factors|mesh-ancestor
2596698|NCT01744678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596699|NCT01744756|Bevacizumab|bevacizumab|mesh-list
2596700|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2596701|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596702|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2596703|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2596704|NCT01744756|Growth Substances|growth substances|mesh-ancestor
2596705|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596706|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
2596707|NCT01744873|Bisoprolol|bisoprolol|mesh-list
2596708|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2596709|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
2596710|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
2596711|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596712|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596713|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2596714|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2596715|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2596716|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
2596717|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596718|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596719|NCT01744886|Benzocaine|benzocaine|mesh-list
2596720|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
2596721|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
2596722|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596723|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596724|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
2596725|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596726|NCT01744912|Lenalidomide|lenalidomide|mesh-list
2596727|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
2596728|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596729|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2596730|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2596731|NCT01744912|Growth Substances|growth substances|mesh-ancestor
2147873|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
2147874|NCT04537234|Vaccines|vaccines|mesh-list
2147875|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
2147876|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147877|NCT04854707|Menotropins|menotropins|mesh-list
2147878|NCT04854707|Hormones|hormones|mesh-list
2147879|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2147880|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2147881|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147882|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2596732|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
2596733|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596734|NCT01744964|Apomorphine|apomorphine|mesh-list
2596735|NCT01744964|Emetics|emetics|mesh-ancestor
2596736|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596737|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
2596738|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596739|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2596740|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
2596741|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
2596742|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596743|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596744|NCT01745081|Mannitol|mannitol|mesh-list
2596745|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2596746|NCT01745081|Diuretics|diuretics|mesh-ancestor
2596747|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
2596748|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596749|NCT01745159|Tacrolimus|tacrolimus|mesh-list
2147883|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
2147884|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2147885|NCT04926233|Bromides|bromides|mesh-list
2147886|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
2147887|NCT04926233|Olodaterol|olodaterol|mesh-list
2147888|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2147889|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
2147890|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596750|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2596751|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
2596752|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596753|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2596754|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596755|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596756|NCT01745263|Vitamin D|vitamin d|mesh-list
2596757|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
2596758|NCT01745263|Vitamins|vitamins|mesh-ancestor
2596759|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
2596760|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596761|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2147891|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147892|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2147893|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
2147894|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
2147895|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2147896|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
2147897|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147898|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147899|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
2420919|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420920|NCT00810680|Valproic Acid|valproic acid|mesh-list
2420921|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
2420922|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420923|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420924|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
2420925|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2420926|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420927|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
2420928|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2420929|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596762|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2596763|NCT01745302|Gefitinib|gefitinib|mesh-list
2596764|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596765|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2596766|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596767|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596768|NCT01745328|Amoxicillin|amoxicillin|mesh-list
2596769|NCT01745328|Levofloxacin|levofloxacin|mesh-list
2147900|NCT04943159|Afamelanotide|afamelanotide|mesh-list
2147901|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
2147902|NCT04525157|Afamelanotide|afamelanotide|mesh-list
2147903|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
2147904|NCT04523831|Doxycycline|doxycycline|mesh-list
2147905|NCT04523831|Ivermectin|ivermectin|mesh-list
2147906|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2147907|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2147908|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
2147909|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2147910|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2147911|NCT04511520|Trimetazidine|trimetazidine|mesh-list
2147912|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
2147913|NCT04507776|Etanercept|etanercept|mesh-list
2147914|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2147915|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2147916|NCT04507776|Analgesics|analgesics|mesh-ancestor
2147917|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
2147918|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147919|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147920|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2147921|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147922|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2147923|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2596770|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2596771|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2596772|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2596773|NCT01745328|Renal Agents|renal agents|mesh-ancestor
2596774|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2596775|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2596776|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596777|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596778|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596779|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2596780|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2596781|NCT01745549|Insulin|insulin|mesh-list
2596782|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2596783|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2596784|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596785|NCT01745562|Alprazolam|alprazolam|mesh-list
2596786|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2596787|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596788|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596789|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2596790|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2596791|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2596792|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
2596793|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
2596794|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596795|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596796|NCT01745575|Alprazolam|alprazolam|mesh-list
2596797|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2596798|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2596799|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596800|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2596801|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2596802|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2596803|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
2596804|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
2596805|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596806|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147924|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
2147925|NCT04495374|Pregabalin|pregabalin|mesh-list
2147926|NCT04495374|Analgesics|analgesics|mesh-ancestor
2147927|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
2147928|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147929|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147930|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
2147931|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2147932|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2147933|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147934|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2147935|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2147936|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2147937|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147938|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2147939|NCT04495712|Spironolactone|spironolactone|mesh-list
2147940|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2147941|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
2147942|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2147943|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147944|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2147945|NCT04495712|Diuretics|diuretics|mesh-ancestor
2147946|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
2596833|NCT01745601|Dexetimide|dexetimide|mesh-list
2596834|NCT01745601|Citalopram|citalopram|mesh-list
2596835|NCT01745601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2596836|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2596837|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2596838|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596839|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596840|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
2596841|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596842|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2596843|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
2596844|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2596845|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2596846|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2596847|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
2596848|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
2596849|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596850|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2596851|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2596852|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
2596853|NCT01745614|Nimesulide|nimesulide|mesh-list
2596854|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2596855|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2596856|NCT01745614|Analgesics|analgesics|mesh-ancestor
2596857|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
2596858|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596859|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596860|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2596861|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2596862|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2596863|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596864|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596865|NCT01745640|Dexamethasone|dexamethasone|mesh-list
2596866|NCT01745640|Pomalidomide|pomalidomide|mesh-list
2596867|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2596868|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
2596869|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
2596870|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147947|NCT04490499|Vaccines|vaccines|mesh-list
2147948|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
2147949|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147950|NCT04490239|Heparin|heparin|mesh-list
2596871|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596872|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2596873|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
2596874|NCT01745640|Hormones|hormones|mesh-ancestor
2596875|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2596876|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2596877|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596878|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
2596879|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2596880|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2596881|NCT01745640|Growth Substances|growth substances|mesh-ancestor
2596882|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
2596883|NCT01745666|Epinephrine|epinephrine|mesh-list
2596884|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2596885|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2596886|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
2596887|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596888|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596889|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596890|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2596891|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2596892|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
2596893|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596894|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2596895|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
2596896|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
2596897|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
2596898|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2596899|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
2596900|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2596901|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2596902|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2596903|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2596904|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2596905|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596906|NCT01745757|Paclitaxel|paclitaxel|mesh-list
2596907|NCT01745757|Bevacizumab|bevacizumab|mesh-list
2596908|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2596909|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596910|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
2596911|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
2147951|NCT04490239|Calcium heparin|calcium heparin|mesh-list
2147952|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
2147953|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2147954|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2147955|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147956|NCT04467424|Lidocaine|lidocaine|mesh-list
2147957|NCT04467424|Ketamine|ketamine|mesh-list
2596912|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
2596913|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596914|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2596915|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2596916|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2147958|NCT04467424|Propofol|propofol|mesh-list
2147959|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
2147960|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
2147961|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147962|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147963|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
2147964|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147965|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2147966|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2147967|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2147968|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2147969|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147970|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2147971|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2147972|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
2596917|NCT01745757|Growth Substances|growth substances|mesh-ancestor
2596918|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596919|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
2596920|NCT01745770|Mesalamine|mesalamine|mesh-list
2596921|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2596922|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2147973|NCT04467424|Analgesics|analgesics|mesh-ancestor
2147974|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2147975|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2147976|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2147977|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2147978|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
2147979|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2147980|NCT04448561|Morphine|morphine|mesh-list
2147981|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2147982|NCT04448561|Narcotics|narcotics|mesh-ancestor
2596923|NCT01745770|Analgesics|analgesics|mesh-ancestor
2596924|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
2596925|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2596926|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596927|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2596928|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2596929|NCT01745835|Bisacodyl|bisacodyl|mesh-list
2596930|NCT01745835|Cathartics|cathartics|mesh-ancestor
2596931|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2596932|NCT01745835|Laxatives|laxatives|mesh-ancestor
2596933|NCT01745965|Trastuzumab|trastuzumab|mesh-list
2596934|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2596935|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596936|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
2147983|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2147984|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2147985|NCT04448561|Analgesics|analgesics|mesh-ancestor
2147986|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
2147987|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2147988|NCT04459585|Dabigatran|dabigatran|mesh-list
2147989|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
2147990|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2147991|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
2147992|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2147993|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2147994|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
2147995|NCT04456634|Lumefantrine|lumefantrine|mesh-list
2147996|NCT04456634|Artemether|artemether|mesh-list
2147997|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2147998|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
2147999|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2148000|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148001|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148002|NCT04439214|Nivolumab|nivolumab|mesh-list
2148003|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2148004|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148005|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2148006|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148007|NCT04439279|Trametinib|trametinib|mesh-list
2148008|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2148009|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148010|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2148011|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148012|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148013|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2148014|NCT04439279|Protective Agents|protective agents|mesh-ancestor
2148015|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148016|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2148017|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
2596937|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
2420930|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2420931|NCT00810706|Exemestane|exemestane|mesh-list
2420932|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420933|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2420934|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2420935|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420936|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420937|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2420938|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
2420939|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2420940|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420941|NCT00810732|Nifedipine|nifedipine|mesh-list
2420942|NCT00810732|Sitaxsentan|sitaxsentan|mesh-list
2596938|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2596939|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2596940|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
2596941|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
2596942|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2596943|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2596944|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2596945|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2596946|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596947|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596948|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2596949|NCT01746199|Renal Agents|renal agents|mesh-ancestor
2148031|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
2148032|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
2148033|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2148034|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148035|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148036|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148037|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148038|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148039|NCT04428502|Etanercept|etanercept|mesh-list
2148040|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2148041|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2148042|NCT04428502|Analgesics|analgesics|mesh-ancestor
2148043|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
2148044|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148045|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148046|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2596950|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2596951|NCT01746238|Bevacizumab|bevacizumab|mesh-list
2596952|NCT01746238|Doxorubicin|doxorubicin|mesh-list
2596953|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2148047|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148048|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2148049|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2148050|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
2148051|NCT04428424|Etanercept|etanercept|mesh-list
2148052|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2148053|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2148054|NCT04428424|Analgesics|analgesics|mesh-ancestor
2148055|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
2148056|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148057|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148058|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148059|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148060|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2148061|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2148062|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
2148063|NCT04428359|Vitamin D|vitamin d|mesh-list
2148064|NCT04428359|Vitamins|vitamins|mesh-ancestor
2148065|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
2148066|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148067|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2148068|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
2148069|NCT04410159|Listerine|listerine|mesh-list
2148070|NCT04410159|Povidone|povidone|mesh-list
2148071|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
2148072|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
2148073|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2148074|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148075|NCT04425850|Ivermectin|ivermectin|mesh-list
2148076|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148077|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2596954|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596955|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2148078|NCT04425863|Aspirin|aspirin|mesh-list
2148079|NCT04425863|Ivermectin|ivermectin|mesh-list
2596956|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2596957|NCT01746238|Growth Substances|growth substances|mesh-ancestor
2596958|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596959|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
2596960|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2596961|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2596962|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2596963|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596964|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596965|NCT01746251|Afatinib|afatinib|mesh-list
2596966|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596967|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2596968|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596969|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596970|NCT01746277|Docetaxel|docetaxel|mesh-list
2596971|NCT01746277|Pemetrexed|pemetrexed|mesh-list
2596972|NCT01746277|Gefitinib|gefitinib|mesh-list
2596973|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596974|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
2596975|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
2596976|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
2596977|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596978|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2596979|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2596980|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2596981|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2596982|NCT01746485|Treprostinil|treprostinil|mesh-list
2596983|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2596984|NCT01746563|Ranibizumab|ranibizumab|mesh-list
2596985|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2596986|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2596987|NCT01746563|Growth Substances|growth substances|mesh-ancestor
2596988|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596989|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
2596990|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2596991|NCT01746602|Timolol|timolol|mesh-list
2596992|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2596993|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2596994|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
2596995|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2596996|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2596997|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2596998|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2596999|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2597000|NCT01746641|Remifentanil|remifentanil|mesh-list
2597001|NCT01746641|Propofol|propofol|mesh-list
2597002|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2597003|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2597004|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597005|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2597006|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
2597007|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
2597008|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2597009|NCT01746641|Narcotics|narcotics|mesh-ancestor
2597010|NCT01746641|Analgesics|analgesics|mesh-ancestor
2597011|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
2597012|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597013|NCT01746680|Methotrexate|methotrexate|mesh-list
2148080|NCT04425863|Dexamethasone|dexamethasone|mesh-list
2148081|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
2148082|NCT04425863|Enoxaparin|enoxaparin|mesh-list
2148083|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2148084|NCT04425863|BB 1101|bb 1101|mesh-list
2148085|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148086|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
2148087|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
2148088|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148089|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148090|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2148091|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
2148092|NCT04425863|Hormones|hormones|mesh-ancestor
2148093|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2597014|NCT01746680|Tacrolimus|tacrolimus|mesh-list
2597015|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2597016|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
2597017|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2597018|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597019|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2597020|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
2597021|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597022|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597023|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
2597024|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597025|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2597026|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2597027|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
2597028|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2597029|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2597030|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2597031|NCT01746719|Etodolac|etodolac|mesh-list
2597032|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2597033|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2597034|NCT01746719|Analgesics|analgesics|mesh-ancestor
2597035|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
2597036|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597037|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597038|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2597039|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2597040|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2597041|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2597042|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597043|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597044|NCT01746771|Paclitaxel|paclitaxel|mesh-list
2597045|NCT01746771|Trastuzumab|trastuzumab|mesh-list
2597046|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2597047|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597048|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
2597049|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
2597050|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
2597051|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597052|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2597053|NCT01746823|Cyclosporine|cyclosporine|mesh-list
2597054|NCT01746823|Cyclosporins|cyclosporins|mesh-list
2597055|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597056|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597057|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2597058|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
2597059|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597060|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
2597061|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2597062|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
2597063|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2597064|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2148094|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2148095|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148096|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
2148097|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148098|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148099|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2148100|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2148101|NCT04425863|Analgesics|analgesics|mesh-ancestor
2148102|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
2148103|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148104|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2148105|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2148106|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2148107|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2148108|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
2148109|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
2148110|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148111|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148112|NCT04425746|Afamelanotide|afamelanotide|mesh-list
2148113|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
2597076|NCT01746875|Aflibercept|aflibercept|mesh-list
2597077|NCT01746875|Verteporfin|verteporfin|mesh-list
2597078|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2597079|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2597080|NCT01746875|Growth Substances|growth substances|mesh-ancestor
2597081|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597082|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
2597083|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597084|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2597085|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
2597086|NCT01746992|Prednisone|prednisone|mesh-list
2597087|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
2597088|NCT01746992|Ifosfamide|ifosfamide|mesh-list
2597089|NCT01746992|Doxorubicin|doxorubicin|mesh-list
2597090|NCT01746992|Methotrexate|methotrexate|mesh-list
2597091|NCT01746992|Etoposide|etoposide|mesh-list
2597092|NCT01746992|Vincristine|vincristine|mesh-list
2597093|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
2597094|NCT01746992|Pirarubicin|pirarubicin|mesh-list
2597095|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2597096|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
2597097|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597098|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2597099|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2597100|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
2597101|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597102|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597103|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2597104|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2597105|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2597106|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2597107|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597108|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148114|NCT04422561|Ivermectin|ivermectin|mesh-list
2148115|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148116|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148117|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
2148118|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2148119|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2148120|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
2597109|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
2597110|NCT01746992|Hormones|hormones|mesh-ancestor
2597111|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2597112|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2597113|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2597114|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
2597115|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2597116|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2597117|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
2597118|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
2597119|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2597120|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2420943|NCT00810732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2420944|NCT00810732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2420945|NCT00810732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420946|NCT00810732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2420947|NCT00810732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420948|NCT00810732|Vasodilator Agents|vasodilator agents|mesh-ancestor
2420949|NCT00810732|Tocolytic Agents|tocolytic agents|mesh-ancestor
2420950|NCT00810732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2420951|NCT00810732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2420952|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2420953|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
2420954|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2420955|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
2420956|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420957|NCT00810849|Prednisolone|prednisolone|mesh-list
2420958|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2420959|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
2420960|NCT00810849|Hormones|hormones|mesh-ancestor
2420961|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2420962|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597121|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2597122|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
2597123|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
2597124|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
2597125|NCT01747044|Milnacipran|milnacipran|mesh-list
2597126|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
2597127|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2597128|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2597129|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2597130|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597131|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597132|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597133|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2597134|NCT01747044|Analgesics|analgesics|mesh-ancestor
2597135|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
2597136|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597137|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
2597138|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2597139|NCT01747083|Metformin|metformin|mesh-list
2597140|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2597141|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597142|NCT01747135|Betadex|betadex|mesh-list
2597143|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
2597144|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597145|NCT01747148|Radavirsen|radavirsen|mesh-list
2597146|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
2597147|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2597148|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
2597149|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2597150|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2597151|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597152|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
2597153|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597154|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597155|NCT01747174|Adenosine|adenosine|mesh-list
2597156|NCT01747174|Nitroprusside|nitroprusside|mesh-list
2597157|NCT01747174|Analgesics|analgesics|mesh-ancestor
2597158|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
2597159|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597160|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597161|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2597162|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
2597163|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2597164|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
2597165|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
2597166|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597167|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597168|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2597169|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2597170|NCT01747226|Fluorides|fluorides|mesh-list
2597171|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
2597172|NCT01747226|Protective Agents|protective agents|mesh-ancestor
2597173|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597174|NCT01747252|Resveratrol|resveratrol|mesh-list
2597175|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
2597176|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597177|NCT01747252|Protective Agents|protective agents|mesh-ancestor
2597178|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597179|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597180|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2420963|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2420964|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2420965|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
2148121|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148122|NCT04407507|Ivermectin|ivermectin|mesh-list
2148123|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148124|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148125|NCT04406194|Favipiravir|favipiravir|mesh-list
2420966|NCT00810862|Lactitol|lactitol|mesh-list
2420967|NCT00810862|Cathartics|cathartics|mesh-ancestor
2420968|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2420969|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2420970|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2420971|NCT00810862|Analgesics|analgesics|mesh-ancestor
2420972|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
2597181|NCT01747278|Trimethoprim|trimethoprim|mesh-list
2597182|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
2597183|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2597184|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2597185|NCT01747278|Renal Agents|renal agents|mesh-ancestor
2597186|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
2597187|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2597188|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2597189|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2597190|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597191|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597192|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2597193|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2597194|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2597195|NCT01747564|Mirabegron|mirabegron|mesh-list
2148126|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
2148127|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148128|NCT04403399|Varenicline|varenicline|mesh-list
2148129|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2148130|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2148131|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
2148132|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148133|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148134|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148135|NCT04401579|Remdesivir|remdesivir|mesh-list
2148136|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
2148137|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148138|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
2148139|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148140|NCT04400682|Favipiravir|favipiravir|mesh-list
2597196|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2597197|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2597198|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2597199|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
2597200|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597201|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597202|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597203|NCT01747564|Urological Agents|urological agents|mesh-ancestor
2597204|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
2597205|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2597206|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2597207|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
2597208|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597209|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597210|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597211|NCT01747577|Urological Agents|urological agents|mesh-ancestor
2148141|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
2148142|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148143|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
2148144|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2148145|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148146|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
2148147|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
2597212|NCT01747590|Zolpidem|zolpidem|mesh-list
2597213|NCT01747590|Alprazolam|alprazolam|mesh-list
2148148|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148149|NCT04399122|Acetaminophen|acetaminophen|mesh-list
2420973|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420974|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420975|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2420976|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2420977|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
2420978|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2420979|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
2420980|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2420981|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2420982|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420983|NCT00810914|Bupivacaine|bupivacaine|mesh-list
2420984|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
2420985|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
2420986|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2420987|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420988|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
2420989|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2420990|NCT00810940|Mannitol|mannitol|mesh-list
2420991|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2597214|NCT01747590|Caffeine|caffeine|mesh-list
2597215|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2597216|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597217|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2597218|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597219|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597220|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2597221|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2597222|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
2597223|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597224|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2597225|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2597226|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2597227|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2597228|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
2597229|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
2597230|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2597231|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2597232|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2597233|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
2597234|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
2597235|NCT01747616|Chitosan|chitosan|mesh-list
2597236|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2597237|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2597238|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2597239|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
2597240|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2597241|NCT01747616|Expectorants|expectorants|mesh-ancestor
2597242|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
2597243|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2597244|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
2597245|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597246|NCT01747616|Protective Agents|protective agents|mesh-ancestor
2597247|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597248|NCT01747616|Antidotes|antidotes|mesh-ancestor
2597249|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2597250|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2597251|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
2597252|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2597253|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
2597254|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
2597255|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
2597256|NCT01747616|Coagulants|coagulants|mesh-ancestor
2597257|NCT01747642|Sorafenib|sorafenib|mesh-list
2597258|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597259|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2597260|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597261|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597262|NCT01747668|Tocopherols|tocopherols|mesh-list
2597263|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
2148150|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2148151|NCT04399122|Oxycodone|oxycodone|mesh-list
2148152|NCT04399122|Codeine|codeine|mesh-list
2148153|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2148154|NCT04399122|Analgesics|analgesics|mesh-ancestor
2148155|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
2148156|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148157|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148158|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
2148159|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2148160|NCT04399122|Narcotics|narcotics|mesh-ancestor
2148161|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148162|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
2148163|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
2148164|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2148165|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148166|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148167|NCT04397445|Ranitidine|ranitidine|mesh-list
2148168|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2148169|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2597264|NCT01747668|Vitamin E|vitamin e|mesh-list
2597265|NCT01747668|Vitamins|vitamins|mesh-ancestor
2597266|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
2597267|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597268|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
2597269|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148170|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2597270|NCT01747668|Protective Agents|protective agents|mesh-ancestor
2597271|NCT01747707|Docetaxel|docetaxel|mesh-list
2597272|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597273|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
2597274|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
2597275|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
2597276|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597277|NCT01747720|Vitamin D|vitamin d|mesh-list
2597278|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
2597279|NCT01747720|Vitamins|vitamins|mesh-ancestor
2597280|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
2597281|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597282|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2597283|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2597284|NCT01747746|Enoxaparin|enoxaparin|mesh-list
2597285|NCT01747746|Warfarin|warfarin|mesh-list
2597286|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
2597287|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
2597288|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2597289|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
2597290|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2597291|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
2597292|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597293|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597294|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2597295|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2597296|NCT01747798|Auranofin|auranofin|mesh-list
2597297|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2597298|NCT01747993|Tamsulosin|tamsulosin|mesh-list
2597299|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2597300|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2597301|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2597302|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
2148171|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2148172|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
2148173|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
2148174|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148175|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148176|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148177|NCT04396639|Factor VIII|factor viii|mesh-list
2148178|NCT04396639|Coagulants|coagulants|mesh-ancestor
2597303|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597304|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597305|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597306|NCT01747993|Urological Agents|urological agents|mesh-ancestor
2597307|NCT01748019|Namitecan|namitecan|mesh-list
2597308|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2597309|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597310|NCT01748084|Rituximab|rituximab|mesh-list
2597311|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2597312|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597313|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
2597314|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597315|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2597316|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2597317|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
2597318|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2597319|NCT01748123|Diuretics|diuretics|mesh-ancestor
2597320|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
2148179|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
2148180|NCT04393493|Furosemide|furosemide|mesh-list
2148181|NCT04393493|Spironolactone|spironolactone|mesh-list
2148182|NCT04393493|Diuretics|diuretics|mesh-ancestor
2148183|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
2148184|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148185|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2148186|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2148187|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148188|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2597321|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597322|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2597323|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2597324|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148189|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
2148190|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2148191|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2148192|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2148193|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2148194|NCT04392362|Adenosine|adenosine|mesh-list
2148195|NCT04392362|Analgesics|analgesics|mesh-ancestor
2597330|NCT01748175|Triamcinolone|triamcinolone|mesh-list
2597331|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2148196|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
2148197|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148198|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148199|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2148200|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
2148201|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2148202|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
2148203|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
2148204|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148205|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148206|NCT04392141|Colchicine|colchicine|mesh-list
2148207|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
2148208|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148209|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
2148210|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
2148211|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
2148212|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2420992|NCT00810940|Diuretics|diuretics|mesh-ancestor
2420993|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
2597332|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2597333|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2597334|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2597335|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
2597336|NCT01748175|Hormones|hormones|mesh-ancestor
2597337|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2597338|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597339|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2597340|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
2597341|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597342|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597343|NCT01748253|Amlodipine|amlodipine|mesh-list
2597344|NCT01748253|Telmisartan|telmisartan|mesh-list
2597345|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2597346|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2597347|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2597348|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2597349|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597350|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2597351|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597352|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
2597353|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2597354|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2597355|NCT01748279|Atorvastatin|atorvastatin|mesh-list
2597356|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
2597357|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2597358|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2597359|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
2597360|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597361|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2597362|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2597363|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597364|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2597365|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
2597366|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597367|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420994|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2420995|NCT00810953|Pentamidine|pentamidine|mesh-list
2420996|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
2420997|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2420998|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2420999|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2421000|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2421001|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
2421002|NCT00811005|Methoxsalen|methoxsalen|mesh-list
2421003|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2421004|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
2421005|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2421006|NCT00811031|Prednisone|prednisone|mesh-list
2421007|NCT00811031|Docetaxel|docetaxel|mesh-list
2421008|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421009|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
2148213|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148214|NCT04391842|Diclofenac|diclofenac|mesh-list
2148215|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2148216|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2148217|NCT04391842|Analgesics|analgesics|mesh-ancestor
2148218|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
2148219|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148220|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148221|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148222|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148223|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2148224|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148225|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148226|NCT04390022|Ivermectin|ivermectin|mesh-list
2148227|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2597368|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2597369|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
2597370|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2597371|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2597372|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2597373|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
2597374|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597375|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2597376|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2597377|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2597378|NCT01748318|Renal Agents|renal agents|mesh-ancestor
2597379|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2597380|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
2597381|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2597382|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2597383|NCT01748344|Cetirizine|cetirizine|mesh-list
2148228|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148229|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
2148230|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148231|NCT04374500|Verapamil|verapamil|mesh-list
2148232|NCT04374500|Nitroprusside|nitroprusside|mesh-list
2148233|NCT04374500|Acetylcholine|acetylcholine|mesh-list
2148234|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
2597384|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2597385|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2597386|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2597387|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
2597388|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
2597389|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597390|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597391|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597392|NCT01748370|Vitamin D|vitamin d|mesh-list
2597393|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
2597394|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
2597395|NCT01748370|Vitamins|vitamins|mesh-list
2597396|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
2597397|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597398|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2597399|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2597400|NCT01748396|Calcitriol|calcitriol|mesh-list
2597401|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
2597402|NCT01748396|Calcium|calcium|mesh-list
2597403|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2597404|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597405|NCT01748396|Antacids|antacids|mesh-ancestor
2597406|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597407|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2597408|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2597409|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2597410|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2597411|NCT01748396|Vitamins|vitamins|mesh-ancestor
2597412|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
2148235|NCT04374500|Bradykinin|bradykinin|mesh-list
2421010|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
2597413|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2597414|NCT01748422|Capsaicin|capsaicin|mesh-list
2597415|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
2597416|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
2597417|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
2597418|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597419|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597420|NCT01748435|Capsaicin|capsaicin|mesh-list
2597421|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
2597422|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
2597423|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
2597424|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597425|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597426|NCT01748448|Vitamin D|vitamin d|mesh-list
2597427|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
2597428|NCT01748448|Vitamins|vitamins|mesh-ancestor
2597429|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
2597430|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597431|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2597432|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2597433|NCT01748487|Dexamethasone|dexamethasone|mesh-list
2597434|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
2597435|NCT01748487|BB 1101|bb 1101|mesh-list
2597436|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2597437|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
2597438|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
2597439|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597440|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597441|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2597442|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
2597443|NCT01748487|Hormones|hormones|mesh-ancestor
2148236|NCT04374500|Substance P|substance p|mesh-list
2148237|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2597444|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2597445|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2597446|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597447|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
2597448|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597449|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597450|NCT01748500|Pantoprazole|pantoprazole|mesh-list
2597451|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2597452|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2597453|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2597454|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597455|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597456|NCT01748526|Canagliflozin|canagliflozin|mesh-list
2597457|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2597458|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597459|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2148238|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2148239|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2148240|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148241|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2148242|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148243|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2148244|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2148245|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2597460|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597461|NCT01748539|Brodalumab|brodalumab|mesh-list
2597462|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
2148246|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
2148247|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148248|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
2148249|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
2148250|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
2148251|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148252|NCT04370548|Clindamycin|clindamycin|mesh-list
2148253|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
2148254|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
2148255|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2148256|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148257|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2148258|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148259|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597463|NCT01748630|Fentanyl|fentanyl|mesh-list
2597464|NCT01748630|Midazolam|midazolam|mesh-list
2148260|NCT04368429|Vaccines|vaccines|mesh-list
2148261|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
2148262|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148263|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2148264|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
2597465|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
2597466|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2597467|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2597468|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597469|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2597470|NCT01748630|Analgesics|analgesics|mesh-ancestor
2597471|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
2597472|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597473|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2597474|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2597475|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2597476|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
2597477|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597478|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597479|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2597480|NCT01748630|Narcotics|narcotics|mesh-ancestor
2597481|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2597482|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2597483|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
2597484|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
2597485|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2597486|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2597487|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2597488|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
2597489|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
2148265|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148266|NCT04358991|Ceftazidime|ceftazidime|mesh-list
2148267|NCT04358991|Avibactam|avibactam|mesh-list
2148268|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
2148269|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2148270|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148271|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2148272|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148273|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148274|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
2148275|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
2597490|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
2597491|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
2597492|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597493|NCT01748669|Protective Agents|protective agents|mesh-ancestor
2597494|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597495|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2597496|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597497|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2597498|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597499|NCT01748721|Antibodies|antibodies|mesh-list
2597500|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2597501|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
2597502|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148276|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2148277|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148278|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148279|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148280|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148281|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148282|NCT04352660|Mitomycins|mitomycins|mesh-list
2148283|NCT04352660|Mitomycin|mitomycin|mesh-list
2148284|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2148285|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148286|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
2148287|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148288|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2148289|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148290|NCT04349917|Methylphenidate|methylphenidate|mesh-list
2148291|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2148292|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148293|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2148294|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2148295|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2148296|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597503|NCT01748773|Capecitabine|capecitabine|mesh-list
2597504|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
2597505|NCT01748773|Trastuzumab|trastuzumab|mesh-list
2597506|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2597507|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
2597508|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597509|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597510|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2597511|NCT01748838|Mannitol|mannitol|mesh-list
2597512|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2597513|NCT01748838|Diuretics|diuretics|mesh-ancestor
2597514|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
2597515|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597516|NCT01748929|Albendazole|albendazole|mesh-list
2597517|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
2597518|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2597519|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2597520|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
2597521|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2597522|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2597523|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
2597524|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
2597525|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
2597526|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597527|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597528|NCT01749072|Vinorelbine|vinorelbine|mesh-list
2148297|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
2148298|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148302|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
2148303|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148304|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
2148305|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
2597529|NCT01749072|Ifosfamide|ifosfamide|mesh-list
2597530|NCT01749072|Gefitinib|gefitinib|mesh-list
2597531|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2597532|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597533|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
2597534|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
2597535|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
2597536|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597537|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2597538|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
2597539|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2597540|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597541|NCT01749085|Ketoconazole|ketoconazole|mesh-list
2148306|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2148307|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148308|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148309|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421011|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
2421012|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421013|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148310|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148311|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148312|NCT04343222|Bromfenac|bromfenac|mesh-list
2148313|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
2148314|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2148315|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2597542|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
2148316|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2421014|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
2421015|NCT00811031|Hormones|hormones|mesh-ancestor
2421016|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421017|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421018|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2421019|NCT00811083|Succimer|succimer|mesh-list
2421020|NCT00811083|Antidotes|antidotes|mesh-ancestor
2421021|NCT00811083|Protective Agents|protective agents|mesh-ancestor
2421022|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421023|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
2421024|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
2421025|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421026|NCT00811096|Chloroquine|chloroquine|mesh-list
2421027|NCT00811096|Tinidazole|tinidazole|mesh-list
2597543|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2597544|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2597545|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2597546|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597547|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597548|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2597549|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
2597550|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2597551|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597552|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2597553|NCT01749098|Ketamine|ketamine|mesh-list
2597554|NCT01749098|Analgesics|analgesics|mesh-ancestor
2597555|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
2597556|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597557|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597558|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2597559|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2597560|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
2597561|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
2597562|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2597563|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2597564|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2597565|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597566|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597567|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
2597568|NCT01749111|Methotrexate|methotrexate|mesh-list
2597569|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2597570|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2597571|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
2597572|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597573|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2597574|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2597575|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
2597576|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597577|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597578|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2597579|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2597580|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
2597581|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2597582|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2597583|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
2597584|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
2597585|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597586|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2597587|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2597588|NCT01749150|Ritonavir|ritonavir|mesh-list
2597589|NCT01749150|Ribavirin|ribavirin|mesh-list
2597590|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2597591|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
2597592|NCT01749150|Lactams|lactams|mesh-list
2597593|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2597594|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2597595|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
2597596|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597597|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597598|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2597599|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2148317|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2148318|NCT04343222|Analgesics|analgesics|mesh-ancestor
2148319|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
2148320|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148321|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148322|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148323|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148324|NCT04343092|Ivermectin|ivermectin|mesh-list
2148325|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148326|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148327|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
2148328|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2148329|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2148330|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148331|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148332|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2148333|NCT04342663|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2597600|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
2597601|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2597602|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2597603|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2597604|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
2597605|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
2597606|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597607|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2597608|NCT01749228|Etodolac|etodolac|mesh-list
2597609|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2597610|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2597611|NCT01749228|Analgesics|analgesics|mesh-ancestor
2597612|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
2597613|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597614|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597615|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2597616|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2597617|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2597618|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2597619|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597620|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597621|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2597622|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2597623|NCT01749319|Baclofen|baclofen|mesh-list
2597624|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2597625|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597626|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2597627|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597628|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2597629|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
2597630|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
2597631|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148334|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2148335|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2148336|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148337|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148338|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
2148339|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2148340|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
2148341|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2148342|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2148343|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148344|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2148345|NCT04342130|Morphine|morphine|mesh-list
2148346|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2148347|NCT04342130|Narcotics|narcotics|mesh-ancestor
2148348|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148349|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148350|NCT04342130|Analgesics|analgesics|mesh-ancestor
2148351|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
2148352|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148353|NCT04340557|Losartan|losartan|mesh-list
2148354|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2148355|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2148356|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2421028|NCT00811096|Amebicides|amebicides|mesh-ancestor
2421029|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2421030|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2421031|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421032|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
2421033|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421034|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
2421035|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421036|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2421037|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2421038|NCT00811122|Corticosterone|corticosterone|mesh-list
2421039|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2421040|NCT00811200|Triamcinolone|triamcinolone|mesh-list
2421041|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2421042|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2421043|NCT00811200|Ranibizumab|ranibizumab|mesh-list
2421044|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2421045|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2421046|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2597632|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597633|NCT01749371|Vitamins|vitamins|mesh-list
2597634|NCT01749371|Vitamin E|vitamin e|mesh-list
2597635|NCT01749371|Tocopherols|tocopherols|mesh-list
2597636|NCT01749371|Tocotrienols|tocotrienols|mesh-list
2597637|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
2597638|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
2597639|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597640|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
2597641|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597642|NCT01749371|Protective Agents|protective agents|mesh-ancestor
2597643|NCT01749384|Bevacizumab|bevacizumab|mesh-list
2597644|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2597645|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
2597646|NCT01749384|Antibodies|antibodies|mesh-list
2597647|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
2597648|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2597649|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
2597650|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597651|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2597652|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2597653|NCT01749384|Growth Substances|growth substances|mesh-ancestor
2597654|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597655|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
2597656|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
2597657|NCT01749397|Fluorouracil|fluorouracil|mesh-list
2597658|NCT01749397|Floxuridine|floxuridine|mesh-list
2597659|NCT01749397|Veliparib|veliparib|mesh-list
2597660|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
2597661|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
2597662|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597663|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2597664|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597665|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2597666|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
2597667|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597668|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2597669|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597670|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
2148357|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2148358|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148359|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2148360|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
2148361|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148362|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148363|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
2148364|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2148365|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2148366|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148367|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
2148368|NCT04338074|Coagulants|coagulants|mesh-ancestor
2148369|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
2148370|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2148371|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148372|NCT04335552|Azithromycin|azithromycin|mesh-list
2148373|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
2148374|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2148375|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148376|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
2148377|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2597671|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2597672|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2597673|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2597674|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2597675|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597676|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
2597677|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597678|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597679|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2597680|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597681|NCT01749475|Midazolam|midazolam|mesh-list
2597682|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2597683|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2597684|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2597685|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597686|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2597687|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2597688|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2597689|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2597690|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
2597691|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
2597692|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
2597693|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
2597694|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597695|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597696|NCT01749514|Luspatercept|luspatercept|mesh-list
2597697|NCT01749514|Hematinics|hematinics|mesh-ancestor
2597698|NCT01749540|Luspatercept|luspatercept|mesh-list
2597699|NCT01749540|Hematinics|hematinics|mesh-ancestor
2597700|NCT01749566|Maraviroc|maraviroc|mesh-list
2597701|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2597702|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2597703|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597704|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2597705|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2597706|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
2597707|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2597708|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2597709|NCT01749579|Fentanyl|fentanyl|mesh-list
2597710|NCT01749579|Midazolam|midazolam|mesh-list
2597711|NCT01749579|Propofol|propofol|mesh-list
2597712|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2597713|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2597714|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597715|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2597716|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
2597717|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
2597718|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2597719|NCT01749579|Narcotics|narcotics|mesh-ancestor
2597720|NCT01749579|Analgesics|analgesics|mesh-ancestor
2597721|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
2597722|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597723|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2597724|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2597725|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2597726|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2597727|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
2597728|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
2597729|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597730|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597731|NCT01749969|Dexamethasone|dexamethasone|mesh-list
2597732|NCT01749969|Lenalidomide|lenalidomide|mesh-list
2597733|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2597734|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
2597735|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
2597736|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597737|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597738|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2597739|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
2421047|NCT00811200|Growth Substances|growth substances|mesh-ancestor
2421048|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421049|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
2421050|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421051|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2421052|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
2421053|NCT00811200|Hormones|hormones|mesh-ancestor
2421054|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421055|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2421056|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
2421057|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421058|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421059|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2597740|NCT01749969|Hormones|hormones|mesh-ancestor
2597741|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2597742|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2597743|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597744|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
2597745|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2597746|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2597747|NCT01749969|Growth Substances|growth substances|mesh-ancestor
2597748|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
2597749|NCT01750060|Fentanyl|fentanyl|mesh-list
2597750|NCT01750060|Naltrexone|naltrexone|mesh-list
2597751|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2597752|NCT01750060|Narcotics|narcotics|mesh-ancestor
2597753|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2597754|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597755|NCT01750060|Analgesics|analgesics|mesh-ancestor
2597756|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
2597757|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148378|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148379|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148380|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148381|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148382|NCT04334876|Antibodies|antibodies|mesh-list
2148383|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
2148384|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
2148385|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148386|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
2148387|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
2148388|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2148389|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148390|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148391|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148392|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148393|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148394|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
2148395|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
2597758|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2597759|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2597760|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
2597761|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
2597762|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2597763|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2597764|NCT01750073|Paclitaxel|paclitaxel|mesh-list
2597765|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
2597766|NCT01750073|Doxorubicin|doxorubicin|mesh-list
2597767|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2597768|NCT01750073|Trastuzumab|trastuzumab|mesh-list
2597769|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2597770|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2597771|NCT01750073|Antibodies|antibodies|mesh-list
2597772|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
2597773|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2597774|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2597775|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597776|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
2597777|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
2597778|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
2597779|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597780|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2597781|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
2597782|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597783|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2597784|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2597785|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
2597786|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2597787|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2597788|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2597789|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2597790|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597791|NCT01750099|Lidocaine|lidocaine|mesh-list
2597792|NCT01750099|Epinephrine|epinephrine|mesh-list
2597793|NCT01750099|Fentanyl|fentanyl|mesh-list
2597794|NCT01750099|Bupivacaine|bupivacaine|mesh-list
2597795|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
2597796|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
2597797|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2597798|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597799|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
2597800|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597801|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2597802|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2597803|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2597804|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2597805|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148396|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2597806|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2597807|NCT01750099|Narcotics|narcotics|mesh-ancestor
2597808|NCT01750099|Analgesics|analgesics|mesh-ancestor
2597809|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2148397|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148398|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148399|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148400|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148401|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148402|NCT04322968|Ketorolac|ketorolac|mesh-list
2148403|NCT04322968|Ketamine|ketamine|mesh-list
2148404|NCT04322968|Analgesics|analgesics|mesh-ancestor
2148405|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
2148406|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148407|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148408|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2148409|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2148410|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
2148411|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
2148412|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148413|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2148414|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2148415|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148416|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597810|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2597811|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
2597812|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2597813|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2597814|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
2597815|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597816|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2597817|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2597818|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
2597819|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2597820|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
2148417|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2148418|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2148419|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148420|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148421|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2148422|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148423|NCT04332107|Azithromycin|azithromycin|mesh-list
2148424|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2148425|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148426|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
2148427|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2148428|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2597821|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
2597822|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
2597823|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2597824|NCT01750359|Curcumin|curcumin|mesh-list
2597825|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2148429|NCT04323592|Prednisolone|prednisolone|mesh-list
2148430|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
2148431|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2148432|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
2148433|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148434|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
2148435|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
2148436|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148437|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148438|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2148439|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
2148440|NCT04323592|Hormones|hormones|mesh-ancestor
2148441|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2148442|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2148443|NCT04323592|Protective Agents|protective agents|mesh-ancestor
2148444|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2148445|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148446|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
2148447|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
2148448|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2148449|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148450|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148451|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148452|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148453|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148454|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
2148455|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
2148456|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2597826|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2597827|NCT01750359|Analgesics|analgesics|mesh-ancestor
2597828|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
2597829|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597830|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597831|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2597832|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2597833|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597834|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597835|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597836|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2597837|NCT01750385|Cephalosporins|cephalosporins|mesh-list
2597838|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2597839|NCT01750437|Esomeprazole|esomeprazole|mesh-list
2597840|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2597841|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2597842|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2597843|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597844|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597845|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2597846|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
2597847|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2597848|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
2597849|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2597850|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597851|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2148457|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148458|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148459|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148460|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148461|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148462|NCT04322526|Naltrexone|naltrexone|mesh-list
2148463|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2148464|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2148465|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148466|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
2148467|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148468|NCT04322682|Colchicine|colchicine|mesh-list
2148469|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
2148470|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148471|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
2148472|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
2148473|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
2148474|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148475|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148476|NCT04322396|Azithromycin|azithromycin|mesh-list
2148477|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
2148478|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2148479|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148480|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
2148481|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2148482|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148483|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148484|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148485|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148486|NCT04318535|Griseofulvin|griseofulvin|mesh-list
2148487|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
2148488|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148489|NCT04314037|Praziquantel|praziquantel|mesh-list
2148490|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
2148491|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148492|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148493|NCT04310085|Lumefantrine|lumefantrine|mesh-list
2597852|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2597853|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2597854|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2597855|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2597856|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597857|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2597858|NCT01750541|Valproic Acid|valproic acid|mesh-list
2597859|NCT01750541|Haloperidol|haloperidol|mesh-list
2597860|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
2597861|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
2597862|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
2597863|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597864|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148494|NCT04310085|Artemether|artemether|mesh-list
2148495|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2148496|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
2148497|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2597865|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2597866|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2597867|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2597868|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2597869|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2597870|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2597871|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
2597872|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597873|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597874|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2597875|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
2597876|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597877|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
2597878|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
2597882|NCT01750580|Ipilimumab|ipilimumab|mesh-list
2597883|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2597884|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597885|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2597886|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597887|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
2597888|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2597889|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2597890|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597891|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
2597892|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2597893|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597894|NCT01750723|Acetazolamide|acetazolamide|mesh-list
2597895|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
2597896|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2597897|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597898|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597899|NCT01750723|Diuretics|diuretics|mesh-ancestor
2597900|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
2597901|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597902|NCT01750762|Lenalidomide|lenalidomide|mesh-list
2148498|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148499|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148500|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
2148501|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
2148502|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2148503|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2148504|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148505|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148506|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148507|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148508|NCT04307940|Acetaminophen|acetaminophen|mesh-list
2148509|NCT04307940|Naproxen|naproxen|mesh-list
2148510|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2148511|NCT04307940|Hydrocodone|hydrocodone|mesh-list
2597903|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
2597904|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597905|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2597906|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2597907|NCT01750762|Growth Substances|growth substances|mesh-ancestor
2597908|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
2597909|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597910|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
2597911|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2597912|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
2597913|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2597914|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
2597915|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597916|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597917|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
2597918|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
2597919|NCT01750801|Propolis|propolis|mesh-list
2597920|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2597921|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2597922|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
2597923|NCT01750866|Prednisone|prednisone|mesh-list
2597924|NCT01750866|Sargramostim|sargramostim|mesh-list
2148512|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2148513|NCT04307940|Analgesics|analgesics|mesh-ancestor
2148514|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
2597925|NCT01750866|Lenograstim|lenograstim|mesh-list
2597926|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2597927|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
2597928|NCT01750866|Hormones|hormones|mesh-ancestor
2597929|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2597930|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597931|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2597932|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597933|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
2597934|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2597935|NCT01750983|Lenalidomide|lenalidomide|mesh-list
2597936|NCT01750983|Ipilimumab|ipilimumab|mesh-list
2597937|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
2597938|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597939|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2597940|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2597941|NCT01750983|Growth Substances|growth substances|mesh-ancestor
2597942|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
2597943|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597944|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2597945|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2597946|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597947|NCT01751009|Vitamins|vitamins|mesh-list
2597948|NCT01751009|Vitamin A|vitamin a|mesh-list
2597949|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
2597950|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
2597951|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597952|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
2597953|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597954|NCT01751009|Protective Agents|protective agents|mesh-ancestor
2597955|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2597956|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2597957|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2597958|NCT01751074|Darapladib|darapladib|mesh-list
2597959|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2597960|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2597961|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
2597962|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597963|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2597964|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2597965|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597966|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2597967|NCT01751126|Cyclosporine|cyclosporine|mesh-list
2597968|NCT01751126|Cyclosporins|cyclosporins|mesh-list
2597969|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597970|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597971|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2597972|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
2597973|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597974|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
2597975|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2597976|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
2597977|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2597978|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2597979|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
2597980|NCT01751204|Calcium|calcium|mesh-list
2597981|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2597982|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2597983|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2597984|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
2597985|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597986|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597987|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2597988|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2597989|NCT01751295|Atorvastatin|atorvastatin|mesh-list
2597990|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2597991|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2148515|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2597992|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
2597993|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2597994|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2148516|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148517|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
2148518|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2148519|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148520|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2148521|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
2148522|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2597995|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2597996|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2597997|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2597998|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2597999|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598000|NCT01751321|Incretins|incretins|mesh-ancestor
2598001|NCT01751321|Hormones|hormones|mesh-ancestor
2598002|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2598003|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2598004|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
2598005|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598006|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598007|NCT01751347|Lidocaine|lidocaine|mesh-list
2598008|NCT01751347|Bupivacaine|bupivacaine|mesh-list
2598009|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
2598010|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
2598011|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598012|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598013|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
2598014|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598015|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2598016|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2598017|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2598018|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2598019|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598020|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
2598021|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2598022|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2598023|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2598024|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598025|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
2598026|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598027|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148523|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148524|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148525|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2148526|NCT04307940|Narcotics|narcotics|mesh-ancestor
2148527|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148528|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
2598028|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2598029|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598030|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
2598031|NCT01751425|Dasatinib|dasatinib|mesh-list
2598032|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
2598033|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598034|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2598035|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598036|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598037|NCT01751763|Sorafenib|sorafenib|mesh-list
2598038|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598039|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2598040|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598041|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598042|NCT01751828|Sertraline|sertraline|mesh-list
2598043|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
2598044|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2598045|NCT01751828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2598046|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2598047|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2598048|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598049|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598050|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
2598051|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598052|NCT01751854|Citalopram|citalopram|mesh-list
2598053|NCT01751854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2148529|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
2148530|NCT04297631|Tobramycin|tobramycin|mesh-list
2598054|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2598055|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2598056|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598057|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598058|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
2598059|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598060|NCT01751854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2598061|NCT01751854|Antidepressive Agents|antidepressive agents|mesh-ancestor
2598062|NCT01751854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2598063|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
2598064|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598065|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2598066|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598067|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598068|NCT01751984|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2598069|NCT01751984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2598070|NCT01751984|Antimetabolites|antimetabolites|mesh-ancestor
2598071|NCT01751984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598072|NCT01751984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2598073|NCT01751984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598074|NCT01751984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2598075|NCT01751984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598076|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
2598077|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598078|NCT01752075|Lenalidomide|lenalidomide|mesh-list
2598079|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
2148531|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2148532|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148533|NCT04297241|Isosorbide|isosorbide|mesh-list
2148534|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2148535|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2148536|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2598080|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598081|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2598082|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2598083|NCT01752075|Growth Substances|growth substances|mesh-ancestor
2598084|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
2598085|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598086|NCT01752153|Silymarin|silymarin|mesh-list
2598087|NCT01752153|Deferoxamine|deferoxamine|mesh-list
2598088|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
2598089|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598090|NCT01752153|Protective Agents|protective agents|mesh-ancestor
2148537|NCT04297241|Diuretics|diuretics|mesh-ancestor
2148538|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
2148539|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148540|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
2148541|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2148542|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148543|NCT04292535|Insulin|insulin|mesh-list
2148544|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2148545|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
2148546|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
2148547|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2148548|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2148549|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148550|NCT04292171|Gabapentin|gabapentin|mesh-list
2148551|NCT04292171|Analgesics|analgesics|mesh-ancestor
2148552|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
2148553|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148554|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598091|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598092|NCT01752153|Siderophores|siderophores|mesh-ancestor
2598093|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2598094|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
2598095|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
2598096|NCT01752205|Paclitaxel|paclitaxel|mesh-list
2598097|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2598098|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2598099|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598100|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
2148555|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
2148556|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2148557|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2148558|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148559|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2148560|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2148561|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2148562|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148563|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148564|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
2148565|NCT04292899|Remdesivir|remdesivir|mesh-list
2148566|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
2148567|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148568|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
2148569|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148570|NCT04292730|Remdesivir|remdesivir|mesh-list
2148571|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
2148572|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148573|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
2148574|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148575|NCT04290676|Dexamethasone|dexamethasone|mesh-list
2148576|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
2148577|NCT04290676|BB 1101|bb 1101|mesh-list
2148578|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148579|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
2148580|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
2148581|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148582|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148583|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2148584|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
2148585|NCT04290676|Hormones|hormones|mesh-ancestor
2148586|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2148587|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2148588|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148589|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
2148590|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148591|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148592|NCT04290039|Atropine|atropine|mesh-list
2148593|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2598101|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
2598102|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
2598103|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598104|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2598105|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598106|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
2598107|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2598108|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2598109|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598110|NCT01752244|Vitamins|vitamins|mesh-ancestor
2598111|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
2598112|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
2598113|NCT01752270|Cyproterone|cyproterone|mesh-list
2598114|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
2598115|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
2598116|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
2598117|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2598118|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598119|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598120|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2598121|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
2598122|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2598123|NCT01752322|Lidocaine|lidocaine|mesh-list
2598124|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
2598125|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
2598126|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598127|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598128|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
2598129|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598130|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2598131|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2598132|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2598133|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2598134|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148594|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2148595|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2148596|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2148597|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2148598|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
2148599|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148600|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148601|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2148602|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
2148603|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
2148604|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
2148605|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2148606|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2148607|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
2148608|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148609|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148610|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
2148611|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2148612|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148613|NCT04280705|Remdesivir|remdesivir|mesh-list
2148614|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
2148615|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148616|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
2148617|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148618|NCT04284930|Bupivacaine|bupivacaine|mesh-list
2148619|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
2148620|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
2148621|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148622|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148623|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
2148624|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148625|NCT04283773|Antibodies|antibodies|mesh-list
2148626|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
2148627|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2148628|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
2148629|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598146|NCT01752517|Vinorelbine|vinorelbine|mesh-list
2598147|NCT01752517|Ifosfamide|ifosfamide|mesh-list
2598148|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2598149|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598150|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
2598151|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
2598152|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
2598153|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148630|NCT04277936|Levetiracetam|levetiracetam|mesh-list
2148631|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
2148632|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
2148633|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2148634|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
2148635|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
2148636|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148637|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148638|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
2148639|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148640|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2148641|NCT04272775|Dexamethasone|dexamethasone|mesh-list
2148642|NCT04272775|Lenalidomide|lenalidomide|mesh-list
2148643|NCT04272775|Ixazomib|ixazomib|mesh-list
2598154|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2598155|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
2598156|NCT01752543|Conivaptan|conivaptan|mesh-list
2598157|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2598158|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598159|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
2598160|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598161|NCT01752686|Carboplatin|carboplatin|mesh-list
2148644|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148645|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
2148646|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
2598162|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598163|NCT01752699|Methadone|methadone|mesh-list
2148647|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148648|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148649|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2148650|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
2148651|NCT04272775|Hormones|hormones|mesh-ancestor
2148652|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2148653|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2148654|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148655|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
2148656|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2148657|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2148658|NCT04272775|Growth Substances|growth substances|mesh-ancestor
2148659|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
2148660|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
2148661|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148662|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148663|NCT04267770|Insulin|insulin|mesh-list
2148664|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2148665|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2148666|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148667|NCT04251884|Ropivacaine|ropivacaine|mesh-list
2148668|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
2148669|NCT04251884|Anesthetics|anesthetics|mesh-list
2148670|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148671|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598164|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2598165|NCT01752699|Narcotics|narcotics|mesh-ancestor
2598166|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598167|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598168|NCT01752699|Analgesics|analgesics|mesh-ancestor
2598169|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
2598170|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598171|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
2598172|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
2598173|NCT01752790|Azathioprine|azathioprine|mesh-list
2598174|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2598175|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
2598176|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598177|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2598178|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598179|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2598180|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
2598181|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598182|NCT01752881|Vaccines|vaccines|mesh-list
2598183|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
2598184|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598185|NCT01752959|Remifentanil|remifentanil|mesh-list
2598186|NCT01752959|Esmolol|esmolol|mesh-list
2598187|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2598188|NCT01752959|Narcotics|narcotics|mesh-ancestor
2598189|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598190|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598191|NCT01752959|Analgesics|analgesics|mesh-ancestor
2598192|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
2598193|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598194|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2598195|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2598196|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2598197|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
2598198|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598199|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598200|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
2598201|NCT01752998|Narcotics|narcotics|mesh-ancestor
2598202|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598203|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598204|NCT01752998|Analgesics|analgesics|mesh-ancestor
2598205|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
2598206|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598207|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2598208|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2598209|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
2598210|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598211|NCT01753102|Estradiol|estradiol|mesh-list
2598212|NCT01753102|Estrogens|estrogens|mesh-ancestor
2598213|NCT01753102|Hormones|hormones|mesh-ancestor
2598214|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2598215|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598216|NCT01753128|Imipramine|imipramine|mesh-list
2598217|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2598218|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
2598219|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2598220|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2598221|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2598222|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2598223|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148672|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
2148673|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148674|NCT04249336|Listerine|listerine|mesh-list
2148675|NCT04249336|Calcium|calcium|mesh-list
2148676|NCT04249336|Fluorides|fluorides|mesh-list
2148677|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
2148678|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2598224|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
2598225|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598226|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598227|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2598228|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
2148679|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148680|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
2148681|NCT04249336|Protective Agents|protective agents|mesh-ancestor
2148682|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2148683|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148684|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
2148685|NCT04249310|Olodaterol|olodaterol|mesh-list
2148686|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2148687|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
2148688|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148689|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148690|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2148691|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
2148692|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
2148693|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2148694|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
2148695|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148696|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148697|NCT04238650|Bevacizumab|bevacizumab|mesh-list
2148698|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2148699|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148700|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2148701|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2148702|NCT04238650|Growth Substances|growth substances|mesh-ancestor
2148703|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148704|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
2148705|NCT04238663|Bevacizumab|bevacizumab|mesh-list
2148706|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2598229|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2598230|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2598231|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2598232|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2598233|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598234|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
2598235|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598236|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598237|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2598238|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598239|NCT01753375|Vitamin D|vitamin d|mesh-list
2598240|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
2148707|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148708|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2148709|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2148710|NCT04238663|Growth Substances|growth substances|mesh-ancestor
2148711|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148712|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
2148713|NCT04203225|Lidocaine|lidocaine|mesh-list
2148714|NCT04203225|Epinephrine|epinephrine|mesh-list
2148715|NCT04203225|Tetracaine|tetracaine|mesh-list
2148716|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
2148717|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
2148718|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148719|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148720|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
2598241|NCT01753375|Vitamins|vitamins|mesh-ancestor
2598242|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
2598243|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598244|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2598245|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2598246|NCT01753453|Plerixafor|plerixafor|mesh-list
2598247|NCT01753453|Sargramostim|sargramostim|mesh-list
2598248|NCT01753453|Lenograstim|lenograstim|mesh-list
2598249|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
2148721|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148722|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2148723|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2148724|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2148725|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2148726|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148727|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2148728|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2148729|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
2148730|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148731|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2598250|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598251|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2598252|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2598253|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2598254|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
2598255|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598256|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2598257|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2598258|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
2148732|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2148733|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
2148734|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2148735|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
2148736|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
2148737|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
2148738|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2148739|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
2148740|NCT04222699|Mupirocin|mupirocin|mesh-list
2148741|NCT04222699|Calcium|calcium|mesh-list
2148742|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2148743|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148744|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2598259|NCT01753752|Chitosan|chitosan|mesh-list
2598260|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2598261|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2598262|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2598263|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
2598264|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598265|NCT01753752|Expectorants|expectorants|mesh-ancestor
2598266|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
2598267|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2598268|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
2598269|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148745|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148746|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
2148747|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2148748|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2148749|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421060|NCT00811226|Olmesartan|olmesartan|mesh-list
2421061|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2421062|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2421063|NCT00811226|Diuretics|diuretics|mesh-ancestor
2421064|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
2421065|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421066|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2421067|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2421068|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421069|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2421070|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2421071|NCT00811239|Antivenins|antivenins|mesh-list
2421072|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
2421073|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598270|NCT01753752|Protective Agents|protective agents|mesh-ancestor
2598271|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598272|NCT01753752|Antidotes|antidotes|mesh-ancestor
2598273|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2598274|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2598275|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
2598276|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2598277|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
2598278|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
2598279|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
2598280|NCT01753752|Coagulants|coagulants|mesh-ancestor
2148750|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148751|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
2148752|NCT04218799|Mupirocin|mupirocin|mesh-list
2598281|NCT01753882|Citalopram|citalopram|mesh-list
2598282|NCT01753882|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2598283|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2598284|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2598285|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598286|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598287|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
2598288|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598289|NCT01753882|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2598290|NCT01753882|Antidepressive Agents|antidepressive agents|mesh-ancestor
2598291|NCT01753882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2598292|NCT01754116|Cabotegravir|cabotegravir|mesh-list
2598293|NCT01754116|Midazolam|midazolam|mesh-list
2598294|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2598295|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2598296|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598297|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598298|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2598299|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2598300|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2598301|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2598302|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
2598303|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
2598304|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
2598305|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
2598306|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598307|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598308|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2598309|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2598310|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598311|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2598312|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2148753|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2148754|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148755|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
2148756|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2148757|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2148758|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148759|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148760|NCT04204057|Tenalisib|tenalisib|mesh-list
2148761|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
2148762|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148763|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148764|NCT04207840|Epinephrine|epinephrine|mesh-list
2148765|NCT04207840|Racepinephrine|racepinephrine|mesh-list
2148766|NCT04207840|Albuterol|albuterol|mesh-list
2148767|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
2148768|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2148769|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2148770|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
2148771|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148772|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148773|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148774|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2148775|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2148776|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
2148777|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148778|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2598313|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
2598314|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598315|NCT01754181|Insulin|insulin|mesh-list
2598316|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2148779|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
2148780|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
2148781|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
2148782|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2598317|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598318|NCT01754220|Montelukast|montelukast|mesh-list
2598319|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2598320|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
2598321|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2598322|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
2598323|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2598324|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598325|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2598326|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2598327|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598328|NCT01754285|Octreotide|octreotide|mesh-list
2598329|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2598330|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2598331|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598332|NCT01754324|Methadone|methadone|mesh-list
2598333|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2598334|NCT01754324|Narcotics|narcotics|mesh-ancestor
2598335|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598336|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598337|NCT01754324|Analgesics|analgesics|mesh-ancestor
2598338|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
2598339|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598340|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
2598341|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
2598342|NCT01754649|Misoprostol|misoprostol|mesh-list
2598343|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2598344|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
2598345|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2598346|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598347|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2598348|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2598349|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
2598350|NCT01754701|Iron|iron|mesh-list
2598351|NCT01754701|Trace Elements|trace elements|mesh-ancestor
2598352|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
2598353|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598354|NCT01754792|Inositol|inositol|mesh-list
2598355|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
2598356|NCT01754792|Vitamins|vitamins|mesh-ancestor
2598357|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
2148783|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
2148784|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2148785|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2148786|NCT04198948|Gliclazide|gliclazide|mesh-list
2148787|NCT04198948|Omeprazole|omeprazole|mesh-list
2148788|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2148789|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2148790|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2148791|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148792|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148793|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2148794|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148795|NCT04204200|Vitamins|vitamins|mesh-list
2148796|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
2598358|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598359|NCT01754805|Methotrexate|methotrexate|mesh-list
2598360|NCT01754805|Peficitinib|peficitinib|mesh-list
2598361|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2598362|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
2598363|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2598364|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598365|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2598366|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
2598367|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598368|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598369|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
2148797|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
2148798|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148799|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
2148800|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598370|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598371|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2598372|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2598373|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
2598374|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2598375|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2598376|NCT01754831|Fluorides|fluorides|mesh-list
2598377|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
2598378|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
2598379|NCT01754831|Protective Agents|protective agents|mesh-ancestor
2598380|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598381|NCT01754844|AZD7624|azd7624|mesh-list
2598382|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2598383|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598384|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598385|NCT01754857|Rituximab|rituximab|mesh-list
2598386|NCT01754857|Lenalidomide|lenalidomide|mesh-list
2148801|NCT04204200|Protective Agents|protective agents|mesh-ancestor
2148802|NCT04194151|Propofol|propofol|mesh-list
2148803|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2148804|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148805|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148806|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2148807|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
2148808|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
2148809|NCT04186806|Muramidase|muramidase|mesh-list
2148810|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148811|NCT04184999|Dexamethasone|dexamethasone|mesh-list
2148812|NCT04184999|Prednisolone|prednisolone|mesh-list
2148813|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2148814|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
2148815|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2148816|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
2148817|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2148818|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
2148819|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148820|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
2148821|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
2148822|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148823|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148824|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2148825|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
2148826|NCT04184999|Hormones|hormones|mesh-ancestor
2148827|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2148828|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2148829|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148830|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2148831|NCT04184999|Protective Agents|protective agents|mesh-ancestor
2148832|NCT04184271|Fluorides|fluorides|mesh-list
2148833|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
2148834|NCT04184271|Protective Agents|protective agents|mesh-ancestor
2148835|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148836|NCT04179461|Vitamin D|vitamin d|mesh-list
2148837|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
2148838|NCT04179461|Fluticasone|fluticasone|mesh-list
2148839|NCT04179461|Xhance|xhance|mesh-list
2598387|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2598388|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2598389|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598390|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
2598391|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598392|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2598393|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2148840|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
2148841|NCT04179461|Cetirizine|cetirizine|mesh-list
2148842|NCT04179461|Loratadine|loratadine|mesh-list
2148843|NCT04179461|Azithromycin|azithromycin|mesh-list
2148844|NCT04179461|Budesonide|budesonide|mesh-list
2148845|NCT04179461|Beclomethasone|beclomethasone|mesh-list
2148846|NCT04179461|Emollients|emollients|mesh-list
2148847|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
2598394|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2598395|NCT01754857|Growth Substances|growth substances|mesh-ancestor
2598396|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
2598397|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2598398|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
2148848|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
2148849|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2148850|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2148851|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
2598399|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598400|NCT01754870|Rituximab|rituximab|mesh-list
2598401|NCT01754870|Lenalidomide|lenalidomide|mesh-list
2598402|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2598403|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2598404|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598405|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
2598406|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421074|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
2421075|NCT00811291|Folic Acid|folic acid|mesh-list
2421076|NCT00811291|Calcium|calcium|mesh-list
2421077|NCT00811291|Vitamins|vitamins|mesh-ancestor
2421078|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
2421079|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421080|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2421081|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2421082|NCT00811291|Hematinics|hematinics|mesh-ancestor
2421083|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
2421084|NCT00811330|Atorvastatin|atorvastatin|mesh-list
2421085|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2421086|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2421087|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
2148852|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2148853|NCT04179461|Vitamins|vitamins|mesh-ancestor
2148854|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
2148855|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148856|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2148857|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2148858|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2148859|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
2148860|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148861|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2148862|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
2148863|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
2148864|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2148865|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2148866|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
2148867|NCT04179461|Hormones|hormones|mesh-ancestor
2148868|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2148869|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2148870|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148871|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2148872|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2148873|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2148874|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
2148875|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148876|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148877|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
2148878|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2148879|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
2148880|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2148881|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
2148882|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
2148883|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
2148884|NCT04179474|Erenumab|erenumab|mesh-list
2148885|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2148886|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148887|NCT04179474|Analgesics|analgesics|mesh-ancestor
2148888|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
2148889|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148890|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148891|NCT04177862|Fentanyl|fentanyl|mesh-list
2148892|NCT04177862|Sufentanil|sufentanil|mesh-list
2148893|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2148894|NCT04177862|Narcotics|narcotics|mesh-ancestor
2148895|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148896|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148897|NCT04177862|Analgesics|analgesics|mesh-ancestor
2148898|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
2598407|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2598408|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2598409|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2598410|NCT01754870|Growth Substances|growth substances|mesh-ancestor
2598411|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
2421088|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598412|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2148899|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148900|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2148901|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2148902|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
2148903|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
2148904|NCT04175262|Sunitinib|sunitinib|mesh-list
2148905|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148906|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2148907|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2148908|NCT04175262|Growth Substances|growth substances|mesh-ancestor
2148909|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148910|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
2598413|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
2598414|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598415|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
2598416|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
2598417|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2598418|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598419|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598420|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
2598421|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2598422|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598423|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598424|NCT01754961|Vitamin D|vitamin d|mesh-list
2148911|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2148912|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148913|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148921|NCT04173429|Nadroparin|nadroparin|mesh-list
2148922|NCT04173429|Warfarin|warfarin|mesh-list
2148923|NCT04173429|Calcium|calcium|mesh-list
2598425|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
2598426|NCT01754961|Vitamins|vitamins|mesh-list
2598427|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
2148924|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2148925|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148926|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
2148927|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2148928|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2148929|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148930|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2148931|NCT04169061|Hormones|hormones|mesh-ancestor
2148932|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2148933|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148934|NCT04157738|Insulin|insulin|mesh-list
2148935|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2148936|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
2148937|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
2598428|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598429|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2598430|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2598431|NCT01754974|Ribavirin|ribavirin|mesh-list
2598432|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2598433|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
2598434|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598435|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
2598436|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598437|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
2598438|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
2598439|NCT01755078|Calcium|calcium|mesh-list
2598440|NCT01755078|Sevelamer|sevelamer|mesh-list
2598441|NCT01755078|Calcium acetate|calcium acetate|mesh-list
2598442|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2598443|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598444|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2598445|NCT01755078|Antacids|antacids|mesh-ancestor
2148938|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2148939|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598446|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598447|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2598448|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
2148940|NCT04156646|Esomeprazole|esomeprazole|mesh-list
2148941|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2148942|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2148943|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2598449|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
2598450|NCT01755117|Ropivacaine|ropivacaine|mesh-list
2598451|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
2598452|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
2598453|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598454|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598455|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
2598456|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598457|NCT01755182|Somatostatin|somatostatin|mesh-list
2598458|NCT01755182|Hormones|hormones|mesh-ancestor
2598459|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2598460|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598461|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
2598462|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2598463|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598464|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2598465|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2598466|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598467|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598468|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598469|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2598470|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2598471|NCT01755299|Caffeine|caffeine|mesh-list
2598472|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2598473|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598474|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2598475|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598476|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598477|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2598478|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2598479|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
2598480|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598481|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
2598482|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2598483|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2598484|NCT01755338|Prednisolone|prednisolone|mesh-list
2598485|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
2598486|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2598487|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
2598488|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2598489|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
2598490|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
2598491|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598492|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598493|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2598494|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
2598495|NCT01755338|Hormones|hormones|mesh-ancestor
2598496|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2598497|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2598498|NCT01755338|Protective Agents|protective agents|mesh-ancestor
2598499|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2598500|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598501|NCT01755377|Benzonidazole|benzonidazole|mesh-list
2598502|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2598503|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
2598504|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598505|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2598506|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2148944|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2148945|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148946|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
2148947|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2148948|NCT04169113|Narcotics|narcotics|mesh-ancestor
2148949|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148950|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148951|NCT04169113|Analgesics|analgesics|mesh-ancestor
2598507|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2598508|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598509|NCT01755403|Benzonidazole|benzonidazole|mesh-list
2598510|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2598511|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
2598512|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598513|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2598514|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2598515|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2598516|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598517|NCT01755468|Insulin|insulin|mesh-list
2598518|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2598519|NCT01755468|Metformin|metformin|mesh-list
2598520|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
2598521|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
2148952|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
2148953|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148954|NCT04160975|Vaccines|vaccines|mesh-list
2148955|NCT04160975|Immunologic Factors|immunologic factors|mesh-ancestor
2148956|NCT04160975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148957|NCT04167189|Lidocaine|lidocaine|mesh-list
2148958|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
2148959|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
2148960|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2148961|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148962|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
2148963|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2148964|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2148965|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2148966|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2148967|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2148968|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2148969|NCT04162795|Loratadine|loratadine|mesh-list
2148970|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
2148971|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
2598522|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2598523|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598524|NCT01755494|Metformin|metformin|mesh-list
2598525|NCT01755494|Saxagliptin|saxagliptin|mesh-list
2598526|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2598527|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598528|NCT01755494|Incretins|incretins|mesh-ancestor
2598529|NCT01755494|Hormones|hormones|mesh-ancestor
2598530|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2598531|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2598532|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
2598533|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598534|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598535|NCT01755520|Aspirin|aspirin|mesh-list
2148972|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2148973|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2148974|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2148975|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
2148976|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
2148977|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2148978|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598536|NCT01755520|Ticagrelor|ticagrelor|mesh-list
2598537|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2598538|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2598539|NCT01755520|Analgesics|analgesics|mesh-ancestor
2598540|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
2598541|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598542|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598543|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2598544|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2598545|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2598546|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2598547|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598548|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2598549|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2598550|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598551|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
2598552|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2598553|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2598554|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2598555|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
2148979|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148980|NCT04161144|Sirolimus|sirolimus|mesh-list
2148981|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2148982|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148983|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2598556|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598557|NCT01755559|Artesunate|artesunate|mesh-list
2598558|NCT01755559|Lumefantrine|lumefantrine|mesh-list
2598559|NCT01755559|Artemether|artemether|mesh-list
2598560|NCT01755559|Piperaquine|piperaquine|mesh-list
2598561|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2598562|NCT01755559|Amodiaquine|amodiaquine|mesh-list
2598563|NCT01755559|Artenimol|artenimol|mesh-list
2598564|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
2598565|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2598566|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2598567|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598568|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148984|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2148985|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
2148986|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2148987|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
2148988|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598569|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
2598570|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
2598571|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2598572|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
2598573|NCT01755572|Liraglutide|liraglutide|mesh-list
2598574|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2598575|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598576|NCT01755572|Incretins|incretins|mesh-ancestor
2598577|NCT01755572|Hormones|hormones|mesh-ancestor
2598578|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2598579|NCT01755611|Minocycline|minocycline|mesh-list
2598580|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2598581|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598582|NCT01755663|Metoprolol|metoprolol|mesh-list
2598583|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2598584|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2598585|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
2598586|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
2598587|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598588|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598589|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2598590|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2598591|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2598592|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
2598593|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598594|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598595|NCT01755676|Orlistat|orlistat|mesh-list
2598596|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598597|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598598|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2598599|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2148989|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2148990|NCT04150861|Hormones|hormones|mesh-ancestor
2148991|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2148992|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2148993|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2148994|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148995|NCT04150224|Macozinone|macozinone|mesh-list
2148996|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
2148997|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2148998|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2148999|NCT04149405|Diphosphonates|diphosphonates|mesh-list
2149000|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2149001|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149002|NCT04141930|Baloxavir|baloxavir|mesh-list
2149003|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
2149004|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149005|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149006|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149007|NCT04142242|Vaccines|vaccines|mesh-list
2149008|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
2149009|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149010|NCT04139018|Timolol|timolol|mesh-list
2598600|NCT01755728|Acetaminophen|acetaminophen|mesh-list
2598601|NCT01755728|Ibuprofen|ibuprofen|mesh-list
2598602|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2598603|NCT01755728|Analgesics|analgesics|mesh-ancestor
2598604|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
2598605|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598606|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598607|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
2598608|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2598609|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2598610|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2598611|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2598612|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598613|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598614|NCT01755845|Paclitaxel|paclitaxel|mesh-list
2598615|NCT01755845|Cisplatin|cisplatin|mesh-list
2598616|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2598617|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598618|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
2598619|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
2598620|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
2598621|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598622|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2598623|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2598624|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598625|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2598626|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
2598627|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598628|NCT01755897|Paclitaxel|paclitaxel|mesh-list
2598629|NCT01755897|Cisplatin|cisplatin|mesh-list
2598630|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2149011|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2149012|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2149013|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
2149014|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149015|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149016|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149017|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2149018|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2149019|NCT04131556|Maribavir|maribavir|mesh-list
2149020|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
2598631|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598632|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
2598633|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
2598634|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
2598635|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598636|NCT01755923|Docetaxel|docetaxel|mesh-list
2598637|NCT01755923|Gefitinib|gefitinib|mesh-list
2598638|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598639|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
2598640|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
2598641|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
2598642|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598643|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2598644|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598655|NCT01756040|Lactulose|lactulose|mesh-list
2598656|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2598657|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2598658|NCT01756105|Insulin|insulin|mesh-list
2598659|NCT01756105|Metformin|metformin|mesh-list
2598660|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
2598661|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
2149021|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149022|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
2149023|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2149024|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149025|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2598662|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
2598663|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2598664|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598665|NCT01756118|Dactolisib|dactolisib|mesh-list
2598666|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598667|NCT01756131|Cabotegravir|cabotegravir|mesh-list
2598668|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2598669|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2598670|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598671|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598672|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2598673|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2598674|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
2598675|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598676|NCT01756170|Paclitaxel|paclitaxel|mesh-list
2598677|NCT01756170|Cisplatin|cisplatin|mesh-list
2598678|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2598679|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598680|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
2598681|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
2598682|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
2598683|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598684|NCT01756183|Paclitaxel|paclitaxel|mesh-list
2598685|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2598686|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598687|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
2598688|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
2598689|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
2598690|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598691|NCT01756248|Aflibercept|aflibercept|mesh-list
2598692|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2598693|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2598694|NCT01756248|Growth Substances|growth substances|mesh-ancestor
2598695|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598696|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
2598697|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598698|NCT01756261|Aflibercept|aflibercept|mesh-list
2598699|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2598700|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2598701|NCT01756261|Growth Substances|growth substances|mesh-ancestor
2598702|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598703|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
2598704|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598705|NCT01756339|Moxifloxacin|moxifloxacin|mesh-list
2598706|NCT01756339|Solithromycin|solithromycin|mesh-list
2598707|NCT01756339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2598708|NCT01756339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598709|NCT01756339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2598710|NCT01756339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2598711|NCT01756339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598712|NCT01756339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598713|NCT01756339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598714|NCT01756404|Canagliflozin|canagliflozin|mesh-list
2598715|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2598716|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598717|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2598718|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598719|NCT01756417|Metformin|metformin|mesh-list
2598720|NCT01756417|Canagliflozin|canagliflozin|mesh-list
2598721|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2598722|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598723|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2598724|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598725|NCT01756430|Carvedilol|carvedilol|mesh-list
2598726|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2598727|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2598728|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
2598729|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598730|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598731|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598732|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2598733|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
2598734|NCT01756430|Protective Agents|protective agents|mesh-ancestor
2598735|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2598736|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2149026|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2149027|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2149028|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149029|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
2149030|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149031|NCT04137627|Melatonin|melatonin|mesh-list
2149032|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
2149033|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149034|NCT04137627|Protective Agents|protective agents|mesh-ancestor
2149035|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149036|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598737|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2598738|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
2598739|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2598740|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2598741|NCT01756443|Lidocaine|lidocaine|mesh-list
2598742|NCT01756443|Epinephrine|epinephrine|mesh-list
2598743|NCT01756443|Racepinephrine|racepinephrine|mesh-list
2598744|NCT01756443|Bupivacaine|bupivacaine|mesh-list
2598745|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
2598746|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
2598747|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
2598748|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598749|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598750|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
2598751|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598752|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2598753|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2598754|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2598755|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2598756|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598757|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2598758|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2598759|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
2598760|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598761|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2598762|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2598763|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
2598764|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2598765|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
2598766|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
2598767|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
2598768|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2598769|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
2598770|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2598771|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2598772|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598773|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2598774|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2598775|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598776|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598777|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598778|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2598779|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
2598780|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2598781|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598782|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2598783|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2598784|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2598785|NCT01756508|Eculizumab|eculizumab|mesh-list
2598786|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2598787|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2598788|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
2598789|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598790|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
2598791|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2598792|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598793|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2598794|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2598795|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598796|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598797|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598798|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
2149037|NCT04136145|Belimumab|belimumab|mesh-list
2149038|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2149039|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
2149040|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149041|NCT04132336|Naproxen|naproxen|mesh-list
2149042|NCT04132336|Caffeine|caffeine|mesh-list
2149043|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2149044|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149045|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2149046|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149047|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149048|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2149049|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2149050|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
2149051|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149052|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2149053|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2149054|NCT04132336|Analgesics|analgesics|mesh-ancestor
2149055|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
2149056|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149057|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2149058|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2149059|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
2149060|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2149061|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2149062|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2149063|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2149064|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
2149065|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2149066|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149067|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2149068|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2149069|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2149070|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2149071|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2149072|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2149073|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2149074|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2149075|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
2149076|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2149077|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149078|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2149079|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2149080|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149081|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149082|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149083|NCT04123665|Fluorides|fluorides|mesh-list
2149084|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
2149085|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
2149086|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
2149087|NCT04123665|Protective Agents|protective agents|mesh-ancestor
2149088|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149089|NCT04121078|Rifampin|rifampin|mesh-list
2149090|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2149091|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
2149092|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2598799|NCT01756547|Diuretics|diuretics|mesh-ancestor
2598800|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
2598801|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598802|NCT01756547|Expectorants|expectorants|mesh-ancestor
2598803|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
2598804|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
2598805|NCT01756612|Hematinics|hematinics|mesh-ancestor
2598806|NCT01756638|Prednisolone|prednisolone|mesh-list
2598807|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2598808|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
2598809|NCT01756638|Hormones|hormones|mesh-ancestor
2598810|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2598811|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598812|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2598813|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598814|NCT01756651|Fentanyl|fentanyl|mesh-list
2598815|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2598816|NCT01756651|Narcotics|narcotics|mesh-ancestor
2598817|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598818|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598819|NCT01756651|Analgesics|analgesics|mesh-ancestor
2598820|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
2598821|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598822|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2598823|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2598824|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
2598825|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
2598826|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
2598827|NCT01756664|Petrolatum|petrolatum|mesh-list
2598828|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2598829|NCT01756664|Protective Agents|protective agents|mesh-ancestor
2598830|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598831|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
2598832|NCT01756664|Emollients|emollients|mesh-ancestor
2598833|NCT01756768|Palbociclib|palbociclib|mesh-list
2598834|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598835|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2598836|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598837|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598838|NCT01756781|Palbociclib|palbociclib|mesh-list
2598839|NCT01756781|Midazolam|midazolam|mesh-list
2598840|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2598841|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2598842|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598843|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598844|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2598845|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2598846|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2598847|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2598848|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
2598849|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
2598850|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
2598851|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
2598852|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598853|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598854|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598855|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2598856|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598857|NCT01756924|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2598858|NCT01756924|Vancomycin|vancomycin|mesh-list
2598859|NCT01756924|Ciprofloxacin|ciprofloxacin|mesh-list
2598860|NCT01756924|Levofloxacin|levofloxacin|mesh-list
2598861|NCT01756924|Rifampin|rifampin|mesh-list
2598862|NCT01756924|Cefazolin|cefazolin|mesh-list
2598863|NCT01756924|Ceftriaxone|ceftriaxone|mesh-list
2598864|NCT01756924|Linezolid|linezolid|mesh-list
2598865|NCT01756924|Daptomycin|daptomycin|mesh-list
2598866|NCT01756924|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2598867|NCT01756924|Oxacillin|oxacillin|mesh-list
2598868|NCT01756924|Nafcillin|nafcillin|mesh-list
2598869|NCT01756924|Fusidic Acid|fusidic acid|mesh-list
2598870|NCT01756924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598871|NCT01756924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2598872|NCT01756924|Antitubercular Agents|antitubercular agents|mesh-ancestor
2598873|NCT01756924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2598874|NCT01756924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2598875|NCT01756924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598876|NCT01756924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598877|NCT01756924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149093|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149094|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
2149095|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2149096|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149097|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149098|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2598878|NCT01756924|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2598879|NCT01756924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2598880|NCT01756924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2598881|NCT01756924|Renal Agents|renal agents|mesh-ancestor
2598882|NCT01756924|Leprostatic Agents|leprostatic agents|mesh-ancestor
2598883|NCT01756924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2598884|NCT01756924|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2598885|NCT01756924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2598886|NCT01756924|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2598887|NCT01756924|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2598888|NCT01756924|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2598889|NCT01756924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2598890|NCT01756924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2598891|NCT01756924|Antimalarials|antimalarials|mesh-ancestor
2149099|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2149100|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2149101|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2149102|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2149103|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2598892|NCT01756924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2598893|NCT01756924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2598894|NCT01756989|Thalidomide|thalidomide|mesh-list
2598895|NCT01756989|Celecoxib|celecoxib|mesh-list
2598896|NCT01756989|Etoposide|etoposide|mesh-list
2598897|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
2598898|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2598899|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598900|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2598901|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2598902|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598903|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598904|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2598905|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2598906|NCT01756989|Analgesics|analgesics|mesh-ancestor
2598907|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
2598908|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2598909|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598910|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2598911|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2598912|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2598913|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2598914|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2598915|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
2598916|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
2598917|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2598918|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598919|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2598920|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2598921|NCT01756989|Growth Substances|growth substances|mesh-ancestor
2598922|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
2598923|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
2598924|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2598925|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2598926|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2598927|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
2149104|NCT04117607|Rezafungin|rezafungin|mesh-list
2149105|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
2149106|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149107|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
2598928|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598929|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598930|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598931|NCT01757106|Sevoflurane|sevoflurane|mesh-list
2598932|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2598933|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2598934|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
2598935|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
2598936|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2598937|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598938|NCT01757236|Vancomycin|vancomycin|mesh-list
2598939|NCT01757236|Rifampin|rifampin|mesh-list
2598940|NCT01757236|Clindamycin|clindamycin|mesh-list
2598941|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
2598942|NCT01757236|Linezolid|linezolid|mesh-list
2598943|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2598944|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
2598945|NCT01757236|Trimethoprim|trimethoprim|mesh-list
2598946|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
2598947|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2598948|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2598949|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2598950|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
2598951|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
2598952|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2598953|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2598954|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2598955|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2598956|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2598957|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2598958|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2598959|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2598960|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2598961|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2598962|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2598963|NCT01757236|Renal Agents|renal agents|mesh-ancestor
2598964|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
2598965|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2598966|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2598967|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2598968|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2598969|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2598970|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2598971|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
2598972|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2598973|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2598974|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
2598975|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2598976|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2598977|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598978|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2598979|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2598980|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2598981|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2598982|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2598983|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2149108|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2149109|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
2149110|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149111|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
2149112|NCT04115358|Protective Agents|protective agents|mesh-ancestor
2149113|NCT04114058|Bupivacaine|bupivacaine|mesh-list
2149114|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
2149115|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
2149116|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149117|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149118|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
2149119|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149120|NCT04112160|Ketorolac|ketorolac|mesh-list
2149121|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2149122|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2149123|NCT04112160|Analgesics|analgesics|mesh-ancestor
2149124|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
2149125|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149126|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149127|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2149128|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2149129|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2149130|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149131|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149132|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
2149133|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
2149134|NCT04112069|Pancrelipase|pancrelipase|mesh-list
2149135|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2149136|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149137|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2149138|NCT04109222|Vaccines|vaccines|mesh-list
2149139|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
2149140|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149141|NCT04105972|Ivacaftor|ivacaftor|mesh-list
2149142|NCT04105972|Elexacaftor|elexacaftor|mesh-list
2149143|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2149144|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2149145|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149146|NCT04102956|Kallikreins|kallikreins|mesh-list
2149147|NCT04102956|Coagulants|coagulants|mesh-ancestor
2149148|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
2598984|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2598985|NCT01757262|Clopidogrel|clopidogrel|mesh-list
2598986|NCT01757262|Ticagrelor|ticagrelor|mesh-list
2598987|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2598988|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2598989|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2598990|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2598991|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
2598992|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2598993|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149149|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
2149150|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2149151|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149152|NCT04102345|Zolpidem|zolpidem|mesh-list
2149153|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2149154|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2149155|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149156|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149157|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2149158|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
2149159|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
2149160|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149161|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149162|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2149163|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2149164|NCT04089982|Varenicline|varenicline|mesh-list
2149165|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2598994|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2598995|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
2598996|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2598997|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2598998|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
2598999|NCT01757418|Antibodies|antibodies|mesh-list
2599000|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
2599001|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2599002|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2599003|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
2599004|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599005|NCT01757431|Eculizumab|eculizumab|mesh-list
2599006|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2599007|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2599008|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
2599009|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599010|NCT01757457|Abciximab|abciximab|mesh-list
2599011|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
2599012|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2599013|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
2599014|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2599015|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599016|NCT01757587|Insulin|insulin|mesh-list
2599017|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2599018|NCT01757587|Metformin|metformin|mesh-list
2599019|NCT01757587|Vildagliptin|vildagliptin|mesh-list
2599020|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2599021|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599022|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2599023|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
2599024|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599025|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599026|NCT01757626|Molgramostim|molgramostim|mesh-list
2599027|NCT01757626|Sargramostim|sargramostim|mesh-list
2599028|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
2599029|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599030|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599031|NCT01757639|Ipilimumab|ipilimumab|mesh-list
2599032|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2599033|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599034|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2599035|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599036|NCT01757756|Midazolam|midazolam|mesh-list
2599037|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2599038|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2599039|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599040|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599041|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2149166|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2149167|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
2149168|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149169|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149170|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149171|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
2149172|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2149173|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149174|NCT04098575|Empagliflozin|empagliflozin|mesh-list
2149175|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2149176|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149177|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2149178|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149191|NCT04094883|Vaccines|vaccines|mesh-list
2149192|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
2149193|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149194|NCT04084769|Vaccines|vaccines|mesh-list
2149195|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
2149196|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149197|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2149198|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2149199|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2149200|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2149201|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149202|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
2149203|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149204|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149205|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2149206|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149207|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
2149208|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2149209|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
2599042|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2599043|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2599044|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2599045|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
2599046|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
2599047|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
2599048|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
2599049|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2599050|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599051|NCT01757769|Silodosin|silodosin|mesh-list
2599052|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2599053|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2599054|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2599055|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
2599056|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2599057|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599058|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599059|NCT01757769|Urological Agents|urological agents|mesh-ancestor
2599060|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
2599061|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
2599062|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2599063|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2599064|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599065|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599066|NCT01757782|Urological Agents|urological agents|mesh-ancestor
2599067|NCT01757795|Otaplimastat|otaplimastat|mesh-list
2599068|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2599069|NCT01757795|Protective Agents|protective agents|mesh-ancestor
2599070|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599071|NCT01757808|Ranolazine|ranolazine|mesh-list
2599072|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2599073|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2599074|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599075|NCT01757860|Vitamin D|vitamin d|mesh-list
2599076|NCT01757860|Vitamins|vitamins|mesh-ancestor
2599077|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
2149210|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149211|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
2149212|NCT04081610|Protective Agents|protective agents|mesh-ancestor
2149213|NCT04081324|Lasmiditan|lasmiditan|mesh-list
2149214|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2149215|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
2599078|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599079|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2599080|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
2599081|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2599082|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2599083|NCT01757899|Prednisolone|prednisolone|mesh-list
2599084|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
2599085|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2599086|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
2599087|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2599088|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
2599089|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
2599090|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599091|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599092|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2599093|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
2599094|NCT01757899|Hormones|hormones|mesh-ancestor
2599095|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2599096|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2599097|NCT01757899|Protective Agents|protective agents|mesh-ancestor
2599098|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2599099|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599100|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
2599101|NCT01758029|Testosterone|testosterone|mesh-list
2599102|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
2599103|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
2599104|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2599105|NCT01758029|Androgens|androgens|mesh-ancestor
2599106|NCT01758029|Hormones|hormones|mesh-ancestor
2599107|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2599108|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599109|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2599110|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599111|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
2599112|NCT01758081|Vitamin D|vitamin d|mesh-list
2599113|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
2599114|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
2599115|NCT01758081|Vitamins|vitamins|mesh-list
2599116|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
2599117|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599118|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2599119|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2599120|NCT01758094|Testosterone|testosterone|mesh-list
2599121|NCT01758094|Androgens|androgens|mesh-ancestor
2599122|NCT01758094|Hormones|hormones|mesh-ancestor
2599123|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2599124|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149216|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149217|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149218|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149219|NCT04076787|Sunitinib|sunitinib|mesh-list
2149220|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149221|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2421089|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2421090|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2421091|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421092|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
2421093|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2421094|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2421095|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2421096|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
2421097|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421098|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2599125|NCT01758107|Cyclosporine|cyclosporine|mesh-list
2599126|NCT01758107|Cyclosporins|cyclosporins|mesh-list
2599127|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599128|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599129|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2599130|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
2599131|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599132|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
2599133|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599134|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
2599135|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2599136|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2599137|NCT01758120|Prednisone|prednisone|mesh-list
2599138|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
2599139|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2599140|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
2599141|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599142|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2599143|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2599144|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
2599145|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149222|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2149223|NCT04076787|Growth Substances|growth substances|mesh-ancestor
2149224|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149225|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
2149226|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2149227|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149228|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149231|NCT04042324|Heparin|heparin|mesh-list
2599146|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599147|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2599148|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2599149|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
2599150|NCT01758120|Hormones|hormones|mesh-ancestor
2599151|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2599152|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2599153|NCT01758146|Tamoxifen|tamoxifen|mesh-list
2599154|NCT01758146|Letrozole|letrozole|mesh-list
2599155|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599156|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2599157|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2599158|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599159|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599160|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2599161|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
2599162|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2599163|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599164|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2599165|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2599166|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2599167|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2599168|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2599169|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
2599170|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
2599171|NCT01758185|Vaccines|vaccines|mesh-list
2599172|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
2599173|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599174|NCT01758198|Methotrexate|methotrexate|mesh-list
2599175|NCT01758198|Abatacept|abatacept|mesh-list
2599176|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2599177|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
2599178|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2599179|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599180|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2599181|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
2149232|NCT04042324|Calcium heparin|calcium heparin|mesh-list
2149233|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
2149234|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149235|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2149236|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2149237|NCT04070287|Antibodies|antibodies|mesh-list
2149238|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
2599182|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599183|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599184|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
2599185|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599186|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2599187|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2599188|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
2599189|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2599190|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2421099|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2421100|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421101|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2421102|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421103|NCT00811369|Fulvestrant|fulvestrant|mesh-list
2421104|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2421105|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421106|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2599191|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2599192|NCT01758263|Metoprolol|metoprolol|mesh-list
2599193|NCT01758263|Nebivolol|nebivolol|mesh-list
2599194|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2599195|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2599196|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
2599197|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
2599198|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599199|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599200|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2599201|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2599202|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2599203|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
2599204|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2599205|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599206|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
2599207|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2599208|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2599209|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2599222|NCT01758367|Decitabine|decitabine|mesh-list
2599223|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2599224|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
2599225|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599226|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599227|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149239|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
2149240|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599228|NCT01758380|Metformin|metformin|mesh-list
2599229|NCT01758380|Vildagliptin|vildagliptin|mesh-list
2599230|NCT01758380|Gliclazide|gliclazide|mesh-list
2599231|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2599232|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599233|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2599234|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
2599235|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599236|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599237|NCT01758393|Prednisone|prednisone|mesh-list
2599238|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2599239|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
2599240|NCT01758393|Hormones|hormones|mesh-ancestor
2599241|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2599242|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599243|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2599244|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599245|NCT01758458|Interferons|interferons|mesh-list
2599246|NCT01758458|Aldesleukin|aldesleukin|mesh-list
2599247|NCT01758458|Interferon-beta|interferon-beta|mesh-list
2599248|NCT01758458|Interleukin-2|interleukin-2|mesh-list
2599249|NCT01758458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599250|NCT01758458|Antiviral Agents|antiviral agents|mesh-ancestor
2599251|NCT01758458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599252|NCT01758458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2599253|NCT01758458|Analgesics|analgesics|mesh-ancestor
2599254|NCT01758458|Sensory System Agents|sensory system agents|mesh-ancestor
2599255|NCT01758458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599256|NCT01758458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599257|NCT01758458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2599258|NCT01758458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2599259|NCT01758458|Immunologic Factors|immunologic factors|mesh-ancestor
2599260|NCT01758471|Acarbose|acarbose|mesh-list
2599261|NCT01758471|Glipizide|glipizide|mesh-list
2599262|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2599263|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599264|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599265|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2599266|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599267|NCT01758627|Icodextrin|icodextrin|mesh-list
2599268|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
2599269|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2599270|NCT01758640|Warfarin|warfarin|mesh-list
2599271|NCT01758640|Phenindione|phenindione|mesh-list
2599272|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
2599273|NCT01758666|Leucovorin|leucovorin|mesh-list
2599274|NCT01758666|Methotrexate|methotrexate|mesh-list
2599275|NCT01758666|Calcium|calcium|mesh-list
2599276|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
2599277|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2599278|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599279|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2599280|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
2599281|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2599282|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2599283|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
2599284|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149253|NCT04050722|Listerine|listerine|mesh-list
2149254|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
2149255|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
2149256|NCT04050722|Protective Agents|protective agents|mesh-ancestor
2149257|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149258|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2149259|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599285|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599286|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
2599287|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599288|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2599289|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2599290|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
2599291|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2599292|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2599293|NCT01758666|Antidotes|antidotes|mesh-ancestor
2149260|NCT04069221|Cobicistat|cobicistat|mesh-list
2149261|NCT04069221|Artefenomel|artefenomel|mesh-list
2149262|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2149263|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2149264|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
2149265|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149266|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2599294|NCT01758666|Protective Agents|protective agents|mesh-ancestor
2599295|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
2599296|NCT01758666|Vitamins|vitamins|mesh-ancestor
2599297|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
2599298|NCT01758744|Treprostinil|treprostinil|mesh-list
2599299|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2599300|NCT01758809|Bupivacaine|bupivacaine|mesh-list
2599301|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
2599302|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
2599303|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599304|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599305|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
2599306|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599307|NCT01758835|Calpastatin|calpastatin|mesh-list
2599308|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2599309|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
2599310|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599311|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149267|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2149268|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149269|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149270|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
2149271|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2149272|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2599312|NCT01758861|Anesthetics|anesthetics|mesh-list
2599313|NCT01758861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599314|NCT01758861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599315|NCT01758913|Ibuprofen|ibuprofen|mesh-list
2599316|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2599317|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2599318|NCT01758913|Analgesics|analgesics|mesh-ancestor
2599319|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
2599320|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599321|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599322|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2599323|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2599324|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2599325|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599326|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599327|NCT01758978|Hydrocodone|hydrocodone|mesh-list
2599328|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2599329|NCT01758978|Narcotics|narcotics|mesh-ancestor
2599330|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599331|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599332|NCT01758978|Analgesics|analgesics|mesh-ancestor
2599333|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
2599334|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599335|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
2599336|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
2599337|NCT01759030|Rituximab|rituximab|mesh-list
2599338|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2599339|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599340|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
2599341|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599342|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2599343|NCT01759108|Rebamipide|rebamipide|mesh-list
2599344|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2599345|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2599346|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
2599347|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599348|NCT01759108|Protective Agents|protective agents|mesh-ancestor
2599349|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599350|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599351|NCT01759238|Bevacizumab|bevacizumab|mesh-list
2149281|NCT04066647|Dexamethasone|dexamethasone|mesh-list
2149282|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2149283|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
2149284|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
2149285|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149286|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149287|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2149288|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
2149289|NCT04066647|Hormones|hormones|mesh-ancestor
2149290|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2149291|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2149292|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149293|NCT04066426|Acetaminophen|acetaminophen|mesh-list
2149294|NCT04066426|Dexamethasone|dexamethasone|mesh-list
2149295|NCT04066426|Naproxen|naproxen|mesh-list
2149296|NCT04066426|Codeine|codeine|mesh-list
2149297|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2149298|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
2149299|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
2149300|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149301|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149302|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2149303|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
2149304|NCT04066426|Hormones|hormones|mesh-ancestor
2149305|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2149306|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2149307|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149308|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2149309|NCT04066426|Analgesics|analgesics|mesh-ancestor
2149310|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
2149311|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
2149312|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2149313|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2149314|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
2599352|NCT01759238|Capecitabine|capecitabine|mesh-list
2599353|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2599354|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599355|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2599356|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2599357|NCT01759238|Growth Substances|growth substances|mesh-ancestor
2599358|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599359|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
2599360|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2599361|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
2599362|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599363|NCT01759394|Maleic acid|maleic acid|mesh-list
2599364|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599365|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599366|NCT01759459|Lidocaine|lidocaine|mesh-list
2149315|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2149316|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599367|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
2599368|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
2599369|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599370|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599371|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
2599372|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599373|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2599374|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2599375|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2149317|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149318|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2149319|NCT04066426|Narcotics|narcotics|mesh-ancestor
2149320|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149321|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
2149322|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
2149323|NCT04060654|Buprenorphine|buprenorphine|mesh-list
2149324|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2149325|NCT04060654|Narcotics|narcotics|mesh-ancestor
2149326|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149327|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149328|NCT04060654|Analgesics|analgesics|mesh-ancestor
2149329|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
2149330|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599376|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2599377|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599378|NCT01759485|Vitamin D|vitamin d|mesh-list
2599379|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
2599380|NCT01759485|Vitamins|vitamins|mesh-ancestor
2599381|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
2599382|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149331|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2149332|NCT04058353|Ivacaftor|ivacaftor|mesh-list
2599383|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2599384|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2599385|NCT01759524|Lidocaine|lidocaine|mesh-list
2599386|NCT01759524|Clonidine|clonidine|mesh-list
2599387|NCT01759524|Bupivacaine|bupivacaine|mesh-list
2599388|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
2599389|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
2599390|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599391|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599392|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
2599393|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149333|NCT04058353|Elexacaftor|elexacaftor|mesh-list
2149334|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2149335|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2149336|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149337|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
2149338|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2149339|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2149340|NCT04051684|Ropivacaine|ropivacaine|mesh-list
2149341|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
2149342|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
2149343|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599394|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2599395|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2599396|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2599397|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2599398|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599399|NCT01759524|Analgesics|analgesics|mesh-ancestor
2599400|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2599401|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
2599402|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
2599403|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2599404|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2599405|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2599406|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
2599407|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2599408|NCT01759576|Canagliflozin|canagliflozin|mesh-list
2599409|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2599410|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599411|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2599412|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599413|NCT01759589|Remifentanil|remifentanil|mesh-list
2599414|NCT01759589|Propofol|propofol|mesh-list
2149344|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149345|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
2599415|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
2599416|NCT01759589|Sevoflurane|sevoflurane|mesh-list
2599417|NCT01759589|Anesthetics|anesthetics|mesh-list
2599418|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2599419|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599420|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149346|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149347|NCT04045964|Nicotine|nicotine|mesh-list
2149348|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2149349|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
2149350|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149351|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149352|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2149353|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2149354|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
2149355|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149356|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599421|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
2599422|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2599423|NCT01759589|Narcotics|narcotics|mesh-ancestor
2599424|NCT01759589|Analgesics|analgesics|mesh-ancestor
2599425|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
2599426|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599427|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2599428|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2599429|NCT01759706|Dexamethasone|dexamethasone|mesh-list
2599430|NCT01759706|Sufentanil|sufentanil|mesh-list
2599431|NCT01759706|Diazepam|diazepam|mesh-list
2599432|NCT01759706|Ondansetron|ondansetron|mesh-list
2599433|NCT01759706|Anesthetics|anesthetics|mesh-list
2599434|NCT01759706|Ropivacaine|ropivacaine|mesh-list
2599435|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2599436|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
2599437|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
2599438|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599439|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599440|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2599441|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
2149366|NCT04054193|Dexamethasone|dexamethasone|mesh-list
2149367|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
2149368|NCT04054193|Aprepitant|aprepitant|mesh-list
2149369|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
2149370|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2149371|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
2149372|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
2149373|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149374|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149375|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2149376|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
2149377|NCT04054193|Hormones|hormones|mesh-ancestor
2149378|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2149379|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2149380|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149381|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2149382|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149383|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599442|NCT01759706|Hormones|hormones|mesh-ancestor
2599443|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2599444|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2599445|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599446|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599447|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
2599448|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
2149384|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2149385|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
2149386|NCT04053270|Afamelanotide|afamelanotide|mesh-list
2149387|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
2149388|NCT04049552|Sirolimus|sirolimus|mesh-list
2149389|NCT04049552|Petrolatum|petrolatum|mesh-list
2149390|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2149391|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149392|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2599449|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2599450|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
2599451|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2599452|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599453|NCT01759706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2599454|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2599455|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2599456|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2599457|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2599458|NCT01759706|Narcotics|narcotics|mesh-ancestor
2149393|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149394|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
2149395|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2149396|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
2149397|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149398|NCT04049552|Emollients|emollients|mesh-ancestor
2149399|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
2149400|NCT04050865|Dexamethasone|dexamethasone|mesh-list
2149401|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2599459|NCT01759706|Analgesics|analgesics|mesh-ancestor
2599460|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
2599461|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2599462|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2599463|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
2599464|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
2149402|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
2599465|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
2599466|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2599467|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2599468|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2599469|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
2599470|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
2599471|NCT01759719|Chromium|chromium|mesh-list
2599472|NCT01759719|Trace Elements|trace elements|mesh-ancestor
2599473|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
2599474|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599475|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
2599476|NCT01759732|Fludarabine|fludarabine|mesh-list
2599477|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2599478|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2599479|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
2599480|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599481|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2599482|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2599483|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
2599484|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599485|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599486|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2599487|NCT01759771|Vitamin D|vitamin d|mesh-list
2599488|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
2599489|NCT01759771|Vitamins|vitamins|mesh-ancestor
2599490|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
2599491|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599492|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2599493|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2599494|NCT01759810|Vaccines|vaccines|mesh-list
2599495|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
2599496|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149403|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
2149404|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149405|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149406|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2599505|NCT01759875|Ritonavir|ritonavir|mesh-list
2599506|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2599507|NCT01759875|Rabeprazole|rabeprazole|mesh-list
2599508|NCT01759875|Betaine|betaine|mesh-list
2599509|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2599510|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2599511|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
2599512|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599513|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599514|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2599515|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2599516|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
2599517|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599518|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2599519|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2599520|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2599521|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2599522|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2599523|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
2599524|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2599525|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
2599526|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2599527|NCT01759940|Ropivacaine|ropivacaine|mesh-list
2599528|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
2599529|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
2599530|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599531|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599532|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
2599533|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599534|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2599535|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
2599536|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599537|NCT01760018|Desflurane|desflurane|mesh-list
2599538|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2149407|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
2149408|NCT04050865|Hormones|hormones|mesh-ancestor
2149409|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2149410|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2149411|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149412|NCT04050371|Tenofovir|tenofovir|mesh-list
2149413|NCT04050371|Emtricitabine|emtricitabine|mesh-list
2149414|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
2599539|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
2599540|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
2599541|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599542|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599543|NCT01760096|Cyclosporine|cyclosporine|mesh-list
2149415|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149416|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2149417|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2149418|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149419|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149420|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2149421|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2149422|NCT04048681|Cocaine|cocaine|mesh-list
2149423|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
2149424|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
2149425|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149426|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149427|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
2149428|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149429|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2149430|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2149431|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2149432|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2149433|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149434|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
2149435|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149436|NCT04041453|Ivermectin|ivermectin|mesh-list
2599544|NCT01760096|Levamisole|levamisole|mesh-list
2599545|NCT01760096|Cyclosporins|cyclosporins|mesh-list
2599546|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
2599547|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599548|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599549|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2599550|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
2599551|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599552|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
2599553|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599554|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
2599555|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2599556|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2599557|NCT01760096|Hormones|hormones|mesh-ancestor
2599558|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2599559|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2599560|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
2599561|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
2599562|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2599563|NCT01760109|Piperacillin|piperacillin|mesh-list
2599564|NCT01760109|Sulbactam|sulbactam|mesh-list
2599565|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2599566|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599567|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2599568|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599569|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599570|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2599571|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
2599572|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599573|NCT01760148|Interferons|interferons|mesh-list
2599574|NCT01760148|Ribavirin|ribavirin|mesh-list
2149437|NCT04041453|Albendazole|albendazole|mesh-list
2149438|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2149439|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149440|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
2149441|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
2149442|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2149443|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2599575|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
2599576|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
2599577|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599578|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
2149444|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
2149445|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
2149446|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
2149447|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149448|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149449|NCT04041219|Tacrolimus|tacrolimus|mesh-list
2149450|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2149451|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
2149452|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149453|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2149454|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149455|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149456|NCT04039867|Gemcitabine|gemcitabine|mesh-list
2149457|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
2149458|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2149459|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
2149460|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149461|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149462|NCT04039867|Antiviral Agents|antiviral agents|mesh-ancestor
2149463|NCT04039867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149464|NCT04039867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149465|NCT04039867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2149466|NCT04039867|Immunologic Factors|immunologic factors|mesh-ancestor
2149467|NCT04039867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149468|NCT04039412|Levofloxacin|levofloxacin|mesh-list
2149469|NCT04039412|Ofloxacin|ofloxacin|mesh-list
2149470|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2149471|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149472|NCT04039412|Renal Agents|renal agents|mesh-ancestor
2599579|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599580|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
2599581|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599582|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
2599583|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599584|NCT01760161|Ropivacaine|ropivacaine|mesh-list
2599585|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
2599586|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
2599587|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599588|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599589|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
2599590|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599591|NCT01760174|Bupivacaine|bupivacaine|mesh-list
2599592|NCT01760174|Ropivacaine|ropivacaine|mesh-list
2599593|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
2599594|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
2599595|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599596|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599597|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
2599598|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599599|NCT01760226|Prednisone|prednisone|mesh-list
2599600|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
2599601|NCT01760226|Rituximab|rituximab|mesh-list
2599602|NCT01760226|Doxorubicin|doxorubicin|mesh-list
2599603|NCT01760226|Methotrexate|methotrexate|mesh-list
2599604|NCT01760226|Etoposide|etoposide|mesh-list
2599605|NCT01760226|Vincristine|vincristine|mesh-list
2599606|NCT01760226|Sargramostim|sargramostim|mesh-list
2599607|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2599608|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
2599609|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599610|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2599611|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2599612|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
2599613|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599614|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599615|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2599616|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2599617|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2599618|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2599619|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2599620|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599621|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2599622|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
2599623|NCT01760226|Hormones|hormones|mesh-ancestor
2599624|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2149473|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2149474|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2149475|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2149476|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149477|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149478|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149479|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2149480|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2149481|NCT04024228|Vaccines|vaccines|mesh-list
2149482|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
2149483|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
2149484|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149485|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
2149486|NCT04036110|Vitamins|vitamins|mesh-list
2149487|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
2149488|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
2149489|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149490|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
2149491|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149492|NCT04036110|Protective Agents|protective agents|mesh-ancestor
2149493|NCT04024501|Verinurad|verinurad|mesh-list
2149494|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
2149495|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2149496|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
2149497|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2149498|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
2149499|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149500|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149501|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
2149502|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149503|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
2149504|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2149505|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
2149506|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149507|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149508|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
2149509|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149510|NCT04031885|Paclitaxel|paclitaxel|mesh-list
2149511|NCT04031885|Docetaxel|docetaxel|mesh-list
2149512|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2149513|NCT04031885|Capecitabine|capecitabine|mesh-list
2149514|NCT04031885|Fulvestrant|fulvestrant|mesh-list
2149515|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2149516|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149517|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
2149518|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
2149519|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
2149520|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149521|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2149522|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
2149523|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2149524|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2149525|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2149526|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
2149527|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2149528|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149529|NCT04029584|Rifampin|rifampin|mesh-list
2149530|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2149531|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
2149532|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2149533|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149534|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
2149535|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2149536|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149537|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149538|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2149539|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2149540|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2149541|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2149542|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2149543|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2149544|NCT04028960|Insulin|insulin|mesh-list
2599625|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2599626|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2599627|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
2421107|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2421108|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
2421109|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421110|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599628|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2599629|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2599630|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
2599631|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
2599632|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2599633|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2599634|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2599635|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
2599636|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
2599637|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
2599638|NCT01760252|Capecitabine|capecitabine|mesh-list
2599639|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
2599640|NCT01760252|Irinotecan|irinotecan|mesh-list
2599641|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2599642|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
2599643|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599644|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599645|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2599646|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2599647|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599648|NCT01760278|Cetrorelix|cetrorelix|mesh-list
2599649|NCT01760278|Hormones|hormones|mesh-list
2599650|NCT01760278|Progesterone|progesterone|mesh-list
2599651|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2599652|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2599653|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599654|NCT01760278|Progestins|progestins|mesh-ancestor
2599655|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2599656|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
2149545|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2149546|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2149547|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149548|NCT04023695|Lidocaine|lidocaine|mesh-list
2149549|NCT04023695|Epinephrine|epinephrine|mesh-list
2149550|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
2149551|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
2149552|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149553|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149554|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
2149555|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149556|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2599657|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2599658|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
2599659|NCT01760330|Acetaminophen|acetaminophen|mesh-list
2599660|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2599661|NCT01760330|Analgesics|analgesics|mesh-ancestor
2599662|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
2599663|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599664|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599665|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
2599666|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
2599667|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
2599668|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2599669|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2599670|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599671|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421111|NCT00811408|Cidofovir|cidofovir|mesh-list
2421112|NCT00811408|Carboplatin|carboplatin|mesh-list
2421113|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421114|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
2421115|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421116|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421117|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421118|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
2421119|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
2421120|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2421121|NCT00811421|Mefloquine|mefloquine|mesh-list
2421122|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
2421123|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2421124|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2421125|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421126|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2421127|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149557|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2149558|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2149559|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2149560|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149561|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2149562|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2149563|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
2599672|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599673|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2599674|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
2599675|NCT01760460|Anacetrapib|anacetrapib|mesh-list
2599676|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2599677|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2599678|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
2599679|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599680|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2599681|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599682|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2599683|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599684|NCT01760564|Miglustat|miglustat|mesh-list
2599685|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599686|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599687|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2599688|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2599689|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
2599690|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599691|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2599692|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2599693|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599694|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
2599695|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2599696|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2599697|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
2599698|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2599699|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2599700|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599701|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
2149564|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149565|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2149566|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2599702|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2599703|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599704|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2599705|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599706|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2599707|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
2599708|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
2599709|NCT01760577|Protective Agents|protective agents|mesh-ancestor
2599710|NCT01760642|Rifampin|rifampin|mesh-list
2599711|NCT01760642|Ketoconazole|ketoconazole|mesh-list
2599712|NCT01760642|Midazolam|midazolam|mesh-list
2599713|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2599714|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2599715|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599716|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599717|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2599718|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2599719|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2599720|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2599721|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
2599722|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
2599723|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
2599724|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
2599725|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2599726|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599727|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2599728|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
2599729|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2599730|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599731|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
2599732|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2599733|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599734|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2599735|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2599736|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2599737|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2599738|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2599739|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2599740|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
2599741|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2599742|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2599743|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2599744|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
2599745|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2599746|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2599747|NCT01760655|Vidarabine|vidarabine|mesh-list
2599748|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
2599749|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
2599750|NCT01760655|Thiotepa|thiotepa|mesh-list
2599751|NCT01760655|Fludarabine|fludarabine|mesh-list
2599752|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
2599753|NCT01760655|Tacrolimus|tacrolimus|mesh-list
2599754|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2599755|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
2599756|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599757|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2599758|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2599759|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
2599760|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599761|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599762|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2599763|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2599764|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
2599765|NCT01760655|Antiviral Agents|antiviral agents|mesh-ancestor
2599766|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599767|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2599768|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599769|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2599770|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2599771|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
2599772|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2599773|NCT01760694|Leucovorin|leucovorin|mesh-list
2599774|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
2599775|NCT01760694|Irinotecan|irinotecan|mesh-list
2599776|NCT01760694|Folfirinox|folfirinox|mesh-list
2599777|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599778|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2599779|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2599780|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599781|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599782|NCT01760694|Antidotes|antidotes|mesh-ancestor
2599783|NCT01760694|Protective Agents|protective agents|mesh-ancestor
2599784|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599785|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
2599786|NCT01760694|Vitamins|vitamins|mesh-ancestor
2599787|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
2599788|NCT01760746|Bevacizumab|bevacizumab|mesh-list
2599789|NCT01760746|Ranibizumab|ranibizumab|mesh-list
2149567|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
2149568|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2149569|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
2149570|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
2149571|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
2149572|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2149573|NCT04018664|Nalbuphine|nalbuphine|mesh-list
2149574|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2149575|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2149576|NCT04018664|Narcotics|narcotics|mesh-ancestor
2149577|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149578|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149579|NCT04018664|Analgesics|analgesics|mesh-ancestor
2149580|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
2149581|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149582|NCT04027803|Eculizumab|eculizumab|mesh-list
2149583|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2599790|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2149584|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2149585|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
2599791|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599792|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2599793|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2599794|NCT01760746|Growth Substances|growth substances|mesh-ancestor
2599795|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599796|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
2599797|NCT01760798|Teriparatide|teriparatide|mesh-list
2599798|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2599799|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599800|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2599801|NCT01760811|Cetuximab|cetuximab|mesh-list
2599802|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2599803|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599804|NCT01760824|Amoxicillin|amoxicillin|mesh-list
2599805|NCT01760824|Metronidazole|metronidazole|mesh-list
2599806|NCT01760824|Clarithromycin|clarithromycin|mesh-list
2599807|NCT01760824|Tetracycline|tetracycline|mesh-list
2599808|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
2599809|NCT01760824|Esomeprazole|esomeprazole|mesh-list
2599810|NCT01760824|Bismuth|bismuth|mesh-list
2599811|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2599812|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599813|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2599814|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2599815|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2599816|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2599817|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2599818|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599819|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599820|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2599821|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2599822|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2599823|NCT01760824|Antacids|antacids|mesh-ancestor
2149586|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149587|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
2149588|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2149589|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149590|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
2149591|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
2149592|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2149593|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
2149594|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149595|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149596|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2149597|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
2149598|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
2149599|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2599824|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2599825|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599826|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
2599827|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2599828|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599829|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599830|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2599831|NCT01760967|Analgesics|analgesics|mesh-ancestor
2599832|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
2599833|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599834|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2599835|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2599836|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2599837|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
2599838|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2599839|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599840|NCT01760980|Exemestane|exemestane|mesh-list
2599841|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599842|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2599843|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2599844|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599845|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599846|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2599847|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
2599848|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2599849|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599850|NCT01761071|Diclofenac|diclofenac|mesh-list
2599851|NCT01761071|Ketorolac|ketorolac|mesh-list
2599852|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2599853|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2599854|NCT01761071|Analgesics|analgesics|mesh-ancestor
2149600|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
2149601|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149602|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149603|NCT04009577|Lemborexant|lemborexant|mesh-list
2149604|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2149605|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149606|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149607|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2149608|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2149609|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149610|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149611|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
2149612|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
2149613|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149614|NCT03995680|Mebendazole|mebendazole|mesh-list
2149615|NCT03995680|Piperazine|piperazine|mesh-list
2149616|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
2149617|NCT03995680|DMP 777|dmp 777|mesh-list
2149618|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
2149619|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
2149620|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2149621|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149622|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
2149623|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
2149624|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
2149625|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599855|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
2599856|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599857|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599858|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2599859|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2599860|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2149626|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149627|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149628|NCT04005404|Ropivacaine|ropivacaine|mesh-list
2149629|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
2149630|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
2599861|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599862|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599863|NCT01761110|Buprenorphine|buprenorphine|mesh-list
2599864|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2599865|NCT01761110|Narcotics|narcotics|mesh-ancestor
2599866|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599867|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599868|NCT01761110|Analgesics|analgesics|mesh-ancestor
2599869|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
2599870|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599871|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2599872|NCT01761136|Vaccines|vaccines|mesh-list
2599873|NCT01761136|Immunologic Factors|immunologic factors|mesh-ancestor
2599874|NCT01761136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599875|NCT01761149|Remifentanil|remifentanil|mesh-list
2599876|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2599877|NCT01761149|Narcotics|narcotics|mesh-ancestor
2599878|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599879|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599880|NCT01761149|Analgesics|analgesics|mesh-ancestor
2599881|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
2599882|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599883|NCT01761201|Levofloxacin|levofloxacin|mesh-list
2599884|NCT01761201|Ofloxacin|ofloxacin|mesh-list
2599885|NCT01761201|Isoniazid|isoniazid|mesh-list
2599886|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2599887|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599888|NCT01761201|Renal Agents|renal agents|mesh-ancestor
2599889|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2599890|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2599891|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2599892|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599893|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599894|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599895|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2599896|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2599897|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
2149631|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2599898|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2599899|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2599900|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
2599901|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2599902|NCT01761214|Amoxicillin|amoxicillin|mesh-list
2599903|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
2599904|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
2599905|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
2599906|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2599907|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
2599908|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2599909|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599910|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2599911|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2599912|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599913|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599914|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599915|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2599916|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2599917|NCT01761318|Liraglutide|liraglutide|mesh-list
2599918|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2599919|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599920|NCT01761318|Incretins|incretins|mesh-ancestor
2599921|NCT01761318|Hormones|hormones|mesh-ancestor
2599922|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2599923|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
2599924|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2599925|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
2599926|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599927|NCT01761487|Gentamicins|gentamicins|mesh-list
2599928|NCT01761487|Polymyxins|polymyxins|mesh-list
2599929|NCT01761487|Colistin|colistin|mesh-list
2599930|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2599931|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2599932|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2599933|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599934|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599935|NCT01761513|Esomeprazole|esomeprazole|mesh-list
2599936|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2599937|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2599938|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2599939|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599940|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599941|NCT01761526|Rotigotine|rotigotine|mesh-list
2599942|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
2599943|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
2599944|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2599945|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599946|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599947|NCT01761552|Atropine|atropine|mesh-list
2149632|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149633|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
2149634|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149635|NCT03993288|Iron|iron|mesh-list
2149636|NCT03993288|Trace Elements|trace elements|mesh-ancestor
2149637|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
2149638|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149639|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
2149640|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2149641|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149642|NCT03978832|Risperidone|risperidone|mesh-list
2149643|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2149644|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
2149645|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149646|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149647|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149648|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2149649|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2149650|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149651|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2149652|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2149653|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
2149654|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2599948|NCT01761552|Neostigmine|neostigmine|mesh-list
2599949|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2599950|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2599951|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2599952|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
2599953|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599954|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599955|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2599956|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
2599957|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
2599958|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
2599959|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2599960|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2599961|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
2599962|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2599963|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599964|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2599965|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599966|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2599967|NCT01761656|Atorvastatin|atorvastatin|mesh-list
2599968|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2599969|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2599970|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
2599971|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599972|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2599973|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2599974|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599975|NCT01761669|Vitamin D|vitamin d|mesh-list
2599976|NCT01761669|Vitamins|vitamins|mesh-ancestor
2599977|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
2599978|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599979|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2599980|NCT01761877|Sulindac|sulindac|mesh-list
2599981|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2599982|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2599983|NCT01761877|Analgesics|analgesics|mesh-ancestor
2599984|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
2599985|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2599986|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2599987|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2599988|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2599989|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2599990|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2599991|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2599992|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2599998|NCT01761916|Clonidine|clonidine|mesh-list
2599999|NCT01761916|Captopril|captopril|mesh-list
2600000|NCT01761916|Analgesics|analgesics|mesh-ancestor
2600001|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
2600002|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600003|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600004|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2600005|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
2600006|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
2600007|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2600008|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2600009|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2600010|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
2600011|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600012|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600013|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2600014|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
2600015|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600016|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
2600017|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2149655|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
2149656|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
2149657|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
2149658|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2149659|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149660|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2600018|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600019|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600020|NCT01761994|Nafamostat|nafamostat|mesh-list
2600021|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2600022|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2600023|NCT01761994|Analgesics|analgesics|mesh-ancestor
2600024|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
2600025|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600026|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600027|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2600028|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2149661|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2149662|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2149663|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2149664|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2149665|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2149666|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2149667|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149668|NCT04004481|Morphine|morphine|mesh-list
2149669|NCT04004481|Tramadol|tramadol|mesh-list
2149670|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2149671|NCT04004481|Narcotics|narcotics|mesh-ancestor
2149672|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149673|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149674|NCT04004481|Analgesics|analgesics|mesh-ancestor
2149675|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
2149676|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149677|NCT03997851|Acetaminophen|acetaminophen|mesh-list
2600029|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
2600030|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
2600031|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600032|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600033|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2600034|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2600035|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2600036|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2600037|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
2600038|NCT01762046|Metformin|metformin|mesh-list
2600039|NCT01762046|Glipizide|glipizide|mesh-list
2600040|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2600041|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600042|NCT01762150|Gemcitabine|gemcitabine|mesh-list
2600043|NCT01762150|Sorafenib|sorafenib|mesh-list
2600044|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600045|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2600046|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
2600047|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600048|NCT01762150|Antiviral Agents|antiviral agents|mesh-ancestor
2600049|NCT01762150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600050|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600051|NCT01762150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2600052|NCT01762150|Immunologic Factors|immunologic factors|mesh-ancestor
2600053|NCT01762150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600054|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2600055|NCT01762163|Aspirin|aspirin|mesh-list
2600056|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2600057|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2600058|NCT01762163|Analgesics|analgesics|mesh-ancestor
2600059|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
2600060|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600061|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600062|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2600063|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2600064|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2600065|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2600066|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600067|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2600068|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2600069|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600070|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
2149678|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2149679|NCT03997851|Analgesics|analgesics|mesh-ancestor
2149680|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
2149681|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149682|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149683|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
2149684|NCT03996694|Oxycodone|oxycodone|mesh-list
2149685|NCT03996694|Buprenorphine|buprenorphine|mesh-list
2149686|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2149687|NCT03996694|Narcotics|narcotics|mesh-ancestor
2149688|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149689|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149690|NCT03996694|Analgesics|analgesics|mesh-ancestor
2600071|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
2600072|NCT01762202|Fludarabine|fludarabine|mesh-list
2600073|NCT01762202|Ofatumumab|ofatumumab|mesh-list
2600074|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2600075|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
2600076|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600077|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2600078|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2600079|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
2600080|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600081|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600082|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2600083|NCT01762306|Folic Acid|folic acid|mesh-list
2600084|NCT01762306|Diclofenac|diclofenac|mesh-list
2600085|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2600086|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2600087|NCT01762306|Analgesics|analgesics|mesh-ancestor
2600088|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
2600089|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600090|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600091|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2600092|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2600093|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2600094|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600095|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600096|NCT01762306|Hematinics|hematinics|mesh-ancestor
2600097|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
2600098|NCT01762306|Vitamins|vitamins|mesh-ancestor
2600099|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
2600100|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
2600101|NCT01762319|Pyridoxal|pyridoxal|mesh-list
2600102|NCT01762319|Pyridoxine|pyridoxine|mesh-list
2600103|NCT01762319|Misoprostol|misoprostol|mesh-list
2600104|NCT01762319|Vitamins|vitamins|mesh-ancestor
2600105|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
2600106|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600107|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2600108|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
2600109|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2600110|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2600111|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2600112|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
2600113|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
2600114|NCT01762332|Remifentanil|remifentanil|mesh-list
2600115|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2600116|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2600117|NCT01762332|Narcotics|narcotics|mesh-ancestor
2600118|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2600119|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600120|NCT01762332|Analgesics|analgesics|mesh-ancestor
2600121|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
2600122|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600123|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2600124|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
2600125|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600126|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600127|NCT01762436|Atenolol|atenolol|mesh-list
2600128|NCT01762436|Bisoprolol|bisoprolol|mesh-list
2149691|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
2149692|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149693|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2149694|NCT03988907|Midazolam|midazolam|mesh-list
2149695|NCT03988907|Risdiplam|risdiplam|mesh-list
2149696|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2149697|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2149698|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2600129|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2149699|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149700|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2600130|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2600131|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
2600132|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
2600133|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600134|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600135|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2600136|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2600137|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2600138|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
2600139|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600140|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600141|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
2600142|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
2600143|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2600144|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2600145|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600146|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600147|NCT01762475|Urological Agents|urological agents|mesh-ancestor
2600148|NCT01762514|Amifostine|amifostine|mesh-list
2600149|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2600150|NCT01762514|Protective Agents|protective agents|mesh-ancestor
2600151|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600152|NCT01762540|Prednisolone|prednisolone|mesh-list
2600153|NCT01762540|Calcium|calcium|mesh-list
2149701|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2149702|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2149703|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2149704|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
2149705|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
2149706|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
2149707|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
2149708|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149709|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149710|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2149711|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149712|NCT03988088|Lasmiditan|lasmiditan|mesh-list
2149713|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2149714|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
2149715|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149716|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600154|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
2600155|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2600156|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600157|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2600158|NCT01762540|Hormones|hormones|mesh-ancestor
2600159|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2600160|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2600161|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600162|NCT01762644|Cyclosporine|cyclosporine|mesh-list
2600163|NCT01762644|Omeprazole|omeprazole|mesh-list
2600164|NCT01762644|Cyclosporins|cyclosporins|mesh-list
2600165|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600166|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600167|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2600168|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
2600169|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600170|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
2600171|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600172|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
2600173|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2600174|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2600175|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2600176|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2600177|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2600178|NCT01762657|Cyclosporine|cyclosporine|mesh-list
2600179|NCT01762657|Lansoprazole|lansoprazole|mesh-list
2600180|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
2600181|NCT01762657|Cyclosporins|cyclosporins|mesh-list
2600182|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600183|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600184|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2600185|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
2600186|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600187|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
2600188|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600189|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
2600190|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2600191|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2600192|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2149717|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149718|NCT03980522|Rilonacept|rilonacept|mesh-list
2149719|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2149720|NCT03999684|Tretinoin|tretinoin|mesh-list
2149721|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149722|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
2149723|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
2149724|NCT03993392|Buprenorphine|buprenorphine|mesh-list
2149725|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2149726|NCT03993392|Narcotics|narcotics|mesh-ancestor
2149727|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149728|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149729|NCT03993392|Analgesics|analgesics|mesh-ancestor
2149730|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
2600193|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2600194|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2600195|NCT01762670|Metronidazole|metronidazole|mesh-list
2600196|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600197|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2600198|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2600199|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2600200|NCT01762787|Aspirin|aspirin|mesh-list
2600201|NCT01762787|Prednisolone|prednisolone|mesh-list
2600202|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2600203|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
2600204|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2600205|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
2600206|NCT01762787|Cantharidin|cantharidin|mesh-list
2600207|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2600208|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
2600209|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2600210|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2600211|NCT01762787|Analgesics|analgesics|mesh-ancestor
2600212|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
2600213|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600214|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600215|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2600216|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2600217|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2600218|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2600219|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600220|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2600221|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2600222|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600223|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
2600224|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
2600225|NCT01762787|Hormones|hormones|mesh-ancestor
2600226|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2600227|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2600228|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600229|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
2600230|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
2600231|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2600232|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2600233|NCT01762787|Protective Agents|protective agents|mesh-ancestor
2600234|NCT01762826|Inositol|inositol|mesh-list
2600235|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
2600236|NCT01762826|Vitamins|vitamins|mesh-ancestor
2600237|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
2600238|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600239|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
2600240|NCT01762839|Oritavancin|oritavancin|mesh-list
2600241|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2600242|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600243|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2600244|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2600245|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600246|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600247|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600248|NCT01762852|Belimumab|belimumab|mesh-list
2600249|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2600250|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
2149731|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149732|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2149733|NCT03989427|Listerine|listerine|mesh-list
2149734|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
2600251|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600252|NCT01762878|Nemiralisib|nemiralisib|mesh-list
2600253|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2600254|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600255|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600256|NCT01762891|Acetaminophen|acetaminophen|mesh-list
2600257|NCT01762891|Celecoxib|celecoxib|mesh-list
2600258|NCT01762891|Rofecoxib|rofecoxib|mesh-list
2600259|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2600260|NCT01762891|Analgesics|analgesics|mesh-ancestor
2600261|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
2600262|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600263|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600264|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
2600265|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2600266|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2600267|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2600268|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2600269|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2600270|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600271|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600272|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
2600273|NCT01762995|Dolutegravir|dolutegravir|mesh-list
2600274|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
2600275|NCT01762995|Calcium|calcium|mesh-list
2600276|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2600277|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600278|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2600279|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2600280|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600281|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600282|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2600283|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2149735|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
2149736|NCT03989427|Protective Agents|protective agents|mesh-ancestor
2149737|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600284|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
2600285|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600286|NCT01762995|Antacids|antacids|mesh-ancestor
2600287|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2600288|NCT01762995|Trace Elements|trace elements|mesh-ancestor
2600289|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
2600290|NCT01763021|Rifampin|rifampin|mesh-list
2600291|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2600292|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
2600293|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2600294|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600295|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
2600296|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2600297|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600298|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600299|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2600300|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2600301|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2600302|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2600303|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2600304|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2600305|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
2600306|NCT01763281|Hormones|hormones|mesh-ancestor
2600307|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2600308|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600309|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2600310|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600311|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2600312|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600313|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600314|NCT01763424|Calcitriol|calcitriol|mesh-list
2600315|NCT01763424|Niacinamide|niacinamide|mesh-list
2149738|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2149739|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149740|NCT03981822|Cantharidin|cantharidin|mesh-list
2149741|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149742|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149743|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
2149744|NCT03992482|Antibodies|antibodies|mesh-list
2600316|NCT01763424|Niacin|niacin|mesh-list
2149745|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
2149746|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2149747|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2149748|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
2149749|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149750|NCT03993119|Anticoagulants|anticoagulants|mesh-list
2149751|NCT03988803|Memantine|memantine|mesh-list
2149752|NCT03988803|BI 425809|bi 425809|mesh-list
2149753|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2149754|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2149755|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
2149756|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149757|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600317|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
2600318|NCT01763424|Calcipotriene|calcipotriene|mesh-list
2600319|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
2600320|NCT01763424|Vitamins|vitamins|mesh-ancestor
2600321|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
2600322|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600323|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2600324|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
2600325|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600326|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2600327|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
2600328|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
2600329|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2600330|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2600331|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2600332|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2600333|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2600334|NCT01763437|Tetracycline|tetracycline|mesh-list
2600335|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2600336|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600337|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2600338|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600339|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600340|NCT01763450|Bevacizumab|bevacizumab|mesh-list
2600341|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2600342|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600343|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2600344|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2600345|NCT01763450|Growth Substances|growth substances|mesh-ancestor
2600346|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600347|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
2600348|NCT01763463|Fluticasone|fluticasone|mesh-list
2600349|NCT01763463|Xhance|xhance|mesh-list
2600350|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2600351|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2600352|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
2600353|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2600354|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
2600355|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600356|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600357|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2600358|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
2600359|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
2600360|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2600361|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2600362|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2600363|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2600364|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
2600365|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600366|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600367|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
2600368|NCT01763463|Hormones|hormones|mesh-ancestor
2600369|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2600370|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
2600371|NCT01763476|Paclitaxel|paclitaxel|mesh-list
2600372|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2600373|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600374|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
2600375|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
2149758|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149759|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2149760|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2149761|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
2149762|NCT03987191|Insulin|insulin|mesh-list
2149763|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
2149764|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2149765|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2149766|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149767|NCT03988842|Heparin|heparin|mesh-list
2149768|NCT03988842|Calcium heparin|calcium heparin|mesh-list
2149769|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2600376|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
2600377|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600378|NCT01763541|Anastrozole|anastrozole|mesh-list
2600379|NCT01763541|Leuprolide|leuprolide|mesh-list
2600380|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2600381|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600382|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2600383|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2600384|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600385|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600386|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2600387|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
2600388|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2600389|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600390|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2600391|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
2600392|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2600393|NCT01763580|Prednisolone|prednisolone|mesh-list
2600394|NCT01763580|Tacrolimus|tacrolimus|mesh-list
2600395|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2600396|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
2600397|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600398|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2600399|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600400|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600401|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2600402|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
2600403|NCT01763580|Hormones|hormones|mesh-ancestor
2600404|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2600405|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2600406|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600407|NCT01763658|Dexamethasone|dexamethasone|mesh-list
2600408|NCT01763658|Prednisolone|prednisolone|mesh-list
2600409|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2600410|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
2600411|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2600412|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
2600413|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2149770|NCT03988842|Plasminogen|plasminogen|mesh-list
2149771|NCT03988842|Apixaban|apixaban|mesh-list
2149772|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
2149773|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2149774|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2149775|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149776|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2149777|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
2149778|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2149779|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
2149780|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149781|NCT03981861|Metformin|metformin|mesh-list
2149782|NCT03981861|Spironolactone|spironolactone|mesh-list
2149783|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2149784|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149785|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2149786|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
2149787|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2149788|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2149789|NCT03981861|Diuretics|diuretics|mesh-ancestor
2149790|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
2149791|NCT03987074|Firsocostat|firsocostat|mesh-list
2149792|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149793|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149794|NCT03979820|Phenelzine|phenelzine|mesh-list
2149795|NCT03979820|Tyramine|tyramine|mesh-list
2149796|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
2149797|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2149798|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2600414|NCT01763658|Antioxidants|antioxidants|mesh-list
2600415|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2600416|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
2600417|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
2600418|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600419|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600420|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2600421|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
2600422|NCT01763658|Hormones|hormones|mesh-ancestor
2149799|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149800|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149801|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
2149802|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
2149803|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149804|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149805|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2149806|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2149807|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2149808|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
2149809|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149810|NCT03972137|Nicotine|nicotine|mesh-list
2600423|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2600424|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2600425|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600426|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600427|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2600428|NCT01763658|Protective Agents|protective agents|mesh-ancestor
2600429|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
2600430|NCT01763671|Paclitaxel|paclitaxel|mesh-list
2600431|NCT01763671|Docetaxel|docetaxel|mesh-list
2600432|NCT01763671|Bevacizumab|bevacizumab|mesh-list
2600433|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2600434|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600435|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
2600436|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
2149811|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2149812|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
2149813|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149814|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149815|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2149816|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2149817|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
2149818|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149819|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149820|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
2149821|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
2149822|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149823|NCT03984838|Dolutegravir|dolutegravir|mesh-list
2149824|NCT03984838|Rilpivirine|rilpivirine|mesh-list
2600437|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
2600438|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600439|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2600440|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2600441|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2600442|NCT01763671|Growth Substances|growth substances|mesh-ancestor
2600443|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600444|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
2600445|NCT01763710|Paclitaxel|paclitaxel|mesh-list
2600446|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2600447|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2600448|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600449|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
2600450|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
2600451|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
2600452|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600453|NCT01763749|Clopidogrel|clopidogrel|mesh-list
2600454|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2600455|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2600456|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2600457|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2600458|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
2600459|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600460|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600461|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600462|NCT01763788|Gemcitabine|gemcitabine|mesh-list
2600463|NCT01763788|Necitumumab|necitumumab|mesh-list
2149825|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2149826|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2149827|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149828|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149829|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2149830|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2149831|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
2149832|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149833|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2149834|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2149835|NCT03983941|Ropivacaine|ropivacaine|mesh-list
2149836|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
2600464|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600465|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2600466|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
2600467|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600468|NCT01763788|Antiviral Agents|antiviral agents|mesh-ancestor
2600469|NCT01763788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600470|NCT01763788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600471|NCT01763788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2600472|NCT01763788|Immunologic Factors|immunologic factors|mesh-ancestor
2600473|NCT01763788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149837|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
2149838|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149839|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149840|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
2149841|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149842|NCT03976752|Tenofovir|tenofovir|mesh-list
2600474|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2600475|NCT01764087|Paclitaxel|paclitaxel|mesh-list
2149843|NCT03976752|Emtricitabine|emtricitabine|mesh-list
2149844|NCT03976752|Cobicistat|cobicistat|mesh-list
2149845|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
2149846|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2149847|NCT03976752|Elvitegravir|elvitegravir|mesh-list
2149848|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
2149849|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149850|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2149851|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2149852|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149853|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149854|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2149855|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2149856|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2149857|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2149858|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2149859|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2149860|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2149861|NCT03976466|Calcium|calcium|mesh-list
2600476|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
2600477|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2600478|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600479|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
2600480|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
2600481|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
2600482|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600483|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600484|NCT01764126|Vaccines|vaccines|mesh-list
2600485|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
2600486|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600487|NCT01764139|Vitamin D|vitamin d|mesh-list
2600488|NCT01764139|Vitamins|vitamins|mesh-ancestor
2600489|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
2600490|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600491|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2600492|NCT01764178|Valsartan|valsartan|mesh-list
2600493|NCT01764178|Pitavastatin|pitavastatin|mesh-list
2600494|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2600495|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2600496|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2600497|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600498|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2600499|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2600500|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2600501|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
2600502|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600503|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2600504|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2600505|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2600506|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600507|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2600508|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
2600509|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2600510|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
2600511|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2600512|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600513|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2600514|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2600515|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600516|NCT01764295|Olmesartan|olmesartan|mesh-list
2600517|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2600518|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2600519|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2600520|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
2600521|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600522|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2600523|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2600524|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600525|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2600526|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2600527|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2600528|NCT01764451|Simvastatin|simvastatin|mesh-list
2600529|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2600530|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2600531|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
2600532|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600533|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2600534|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2600535|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600536|NCT01764555|Acetaminophen|acetaminophen|mesh-list
2600537|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2600538|NCT01764555|Analgesics|analgesics|mesh-ancestor
2600539|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
2600540|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600541|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600542|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
2600543|NCT01764581|Tacrolimus|tacrolimus|mesh-list
2600544|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2600545|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
2600546|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600547|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2600548|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600549|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149862|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2149863|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149864|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149865|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
2149866|NCT03979066|Atezolizumab|atezolizumab|mesh-list
2149867|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149868|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
2149869|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2149870|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149871|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2600550|NCT01764672|Methylphenidate|methylphenidate|mesh-list
2600551|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2600552|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600553|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2600554|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2600555|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2600556|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600557|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
2600558|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600559|NCT01764750|Vancomycin|vancomycin|mesh-list
2600560|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2600561|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600562|NCT01764828|Gemcitabine|gemcitabine|mesh-list
2149872|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
2149873|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149874|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
2149875|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2149876|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
2149877|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2149878|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
2149879|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149880|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
2149881|NCT03967444|Protective Agents|protective agents|mesh-ancestor
2149882|NCT03966365|Timolol|timolol|mesh-list
2149883|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2149884|NCT03966365|Dorzolamide|dorzolamide|mesh-list
2600563|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2600564|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
2600565|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600566|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600567|NCT01764828|Antiviral Agents|antiviral agents|mesh-ancestor
2600568|NCT01764828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600569|NCT01764828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600570|NCT01764828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2600571|NCT01764828|Immunologic Factors|immunologic factors|mesh-ancestor
2600572|NCT01764828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600573|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2600574|NCT01764867|Dexetimide|dexetimide|mesh-list
2600575|NCT01764867|Mirtazapine|mirtazapine|mesh-list
2600576|NCT01764867|Trazodone|trazodone|mesh-list
2600577|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
2600578|NCT01764867|Citalopram|citalopram|mesh-list
2600579|NCT01764867|Bupropion|bupropion|mesh-list
2600580|NCT01764867|Fluoxetine|fluoxetine|mesh-list
2600581|NCT01764867|Paroxetine|paroxetine|mesh-list
2600582|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2600583|NCT01764867|Sertraline|sertraline|mesh-list
2600584|NCT01764867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2600585|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2600586|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2600587|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600588|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600589|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
2600590|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600591|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2600592|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
2600593|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2600594|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2600595|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2600596|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
2600597|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
2600598|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600599|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2600600|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2600601|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
2600602|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2600603|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
2600604|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2600605|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2600606|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600607|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2149885|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2149886|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2149887|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
2149888|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149889|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149890|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600608|NCT01764867|Analgesics|analgesics|mesh-ancestor
2600609|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
2600610|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2600611|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
2600612|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
2600613|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2600614|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2600615|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2600616|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2600617|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2149891|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2149892|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2149893|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2149894|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2149895|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2149896|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2149897|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149898|NCT03965351|Probenecid|probenecid|mesh-list
2600618|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2600619|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
2600620|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2600621|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2600622|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2600623|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2600624|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2600625|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
2149899|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
2149900|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
2149901|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2149902|NCT03965351|Renal Agents|renal agents|mesh-ancestor
2149903|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
2149904|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2149905|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
2149906|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149907|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149908|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2149909|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
2149910|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
2149911|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2149912|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
2149913|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149914|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149915|NCT03965052|Travoprost|travoprost|mesh-list
2149916|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2149917|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2149918|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2600626|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2600627|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2600628|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
2600629|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600630|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600631|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600632|NCT01764893|Urological Agents|urological agents|mesh-ancestor
2600633|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
2600634|NCT01765010|Calcitriol|calcitriol|mesh-list
2600635|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
2600636|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2600637|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2600638|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600639|NCT01765010|Vitamins|vitamins|mesh-ancestor
2600640|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
2600641|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2600642|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2600643|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2600644|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600645|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2600646|NCT01765023|Metformin|metformin|mesh-list
2600647|NCT01765023|Atorvastatin|atorvastatin|mesh-list
2600648|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2600649|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600650|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2600651|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2600652|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
2600653|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149919|NCT03965039|Fluorides|fluorides|mesh-list
2149920|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
2149921|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
2149922|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
2149923|NCT03965039|Protective Agents|protective agents|mesh-ancestor
2149924|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149925|NCT03963401|PF-06700841|pf-06700841|mesh-list
2149926|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2149927|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149928|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149929|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
2149930|NCT03962634|Tetracaine|tetracaine|mesh-list
2149931|NCT03962634|Carticaine|carticaine|mesh-list
2600654|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2600655|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2600656|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600657|NCT01765088|Temozolomide|temozolomide|mesh-list
2600658|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2600659|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
2600660|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600661|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600669|NCT01765218|Topiramate|topiramate|mesh-list
2600670|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
2600671|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2600672|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600673|NCT01765231|Entecavir|entecavir|mesh-list
2600674|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
2600675|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600676|NCT01765257|Rasagiline|rasagiline|mesh-list
2600677|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2600678|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600679|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600680|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2600681|NCT01765257|Protective Agents|protective agents|mesh-ancestor
2600682|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600683|NCT01765296|Celecoxib|celecoxib|mesh-list
2600684|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2600685|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2600686|NCT01765296|Analgesics|analgesics|mesh-ancestor
2600687|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
2600688|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600689|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600690|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2600691|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2600692|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2600693|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2600694|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600695|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600696|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
2600697|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2600698|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2600699|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600700|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
2600701|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600702|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600703|NCT01765374|Rituximab|rituximab|mesh-list
2600704|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2600705|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600706|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
2600707|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600708|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2600709|NCT01765400|Clopidogrel|clopidogrel|mesh-list
2600710|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2600711|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2600712|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2600713|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2600714|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2600715|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
2600716|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600717|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600718|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600719|NCT01765452|Clopidogrel|clopidogrel|mesh-list
2600720|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2600721|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2600722|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2149932|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
2149933|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
2600723|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2600724|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
2600725|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600726|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600727|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600728|NCT01765556|Ketoconazole|ketoconazole|mesh-list
2600729|NCT01765556|Vemurafenib|vemurafenib|mesh-list
2600730|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
2600731|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600732|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2600733|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2600734|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600735|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600736|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2600737|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
2600738|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2600739|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600740|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2600741|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600742|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2600743|NCT01765608|Zonisamide|zonisamide|mesh-list
2600744|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
2600745|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2600746|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2600747|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600748|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2600749|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600750|NCT01765738|Minocycline|minocycline|mesh-list
2600751|NCT01765738|Rifampin|rifampin|mesh-list
2600752|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2600753|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600754|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2600755|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
2600756|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
2600757|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2600758|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600759|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600760|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2600761|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2600762|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2600763|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2600764|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2600765|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2600766|NCT01765790|Antibodies|antibodies|mesh-list
2600767|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
2600768|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
2149934|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2149935|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149936|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
2149937|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149938|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2149939|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2149940|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
2149941|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149942|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149943|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
2149944|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
2149945|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
2149946|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2149947|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
2149948|NCT03962738|Lasmiditan|lasmiditan|mesh-list
2149949|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2149950|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
2149951|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149952|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149953|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149954|NCT03946124|Fesoterodine|fesoterodine|mesh-list
2600769|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600770|NCT01765829|Droperidol|droperidol|mesh-list
2600771|NCT01765829|Haloperidol|haloperidol|mesh-list
2600772|NCT01765829|Pimozide|pimozide|mesh-list
2600773|NCT01765829|Olanzapine|olanzapine|mesh-list
2149955|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2600774|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
2600775|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
2600776|NCT01765829|Risperidone|risperidone|mesh-list
2600777|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2600778|NCT01765829|Aripiprazole|aripiprazole|mesh-list
2600779|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2600780|NCT01765829|Ziprasidone|ziprasidone|mesh-list
2600781|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
2600782|NCT01765829|Clozapine|clozapine|mesh-list
2600783|NCT01765829|Asenapine|asenapine|mesh-list
2600784|NCT01765829|Amisulpride|amisulpride|mesh-list
2600785|NCT01765829|Perphenazine|perphenazine|mesh-list
2600786|NCT01765829|Sertindole|sertindole|mesh-list
2600787|NCT01765829|Sulpiride|sulpiride|mesh-list
2600788|NCT01765829|Clopenthixol|clopenthixol|mesh-list
2600789|NCT01765829|Clothiapine|clothiapine|mesh-list
2600790|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2600791|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
2600792|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600793|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600794|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600795|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2600796|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2600797|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2600798|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2600799|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
2600800|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
2600801|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
2600802|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600803|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2600804|NCT01765829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2600805|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2600806|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2600807|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
2600808|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
2149956|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2149957|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
2149958|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149959|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149960|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149961|NCT03946124|Urological Agents|urological agents|mesh-ancestor
2149962|NCT03961308|Vedolizumab|vedolizumab|mesh-list
2149963|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2600809|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2600810|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2600811|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2600812|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2600813|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2600814|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
2600815|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
2600816|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2600817|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2600818|NCT01765842|Rituximab|rituximab|mesh-list
2600819|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2600820|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600821|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
2600822|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600823|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2600824|NCT01765855|Betrixaban|betrixaban|mesh-list
2600825|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2600826|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
2600827|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2600828|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
2600829|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600830|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600831|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
2600832|NCT01765868|Betrixaban|betrixaban|mesh-list
2600833|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2600834|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
2600835|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2600836|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
2600837|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600838|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600839|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
2600840|NCT01765881|Misoprostol|misoprostol|mesh-list
2600841|NCT01765881|Dinoprostone|dinoprostone|mesh-list
2600842|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2600843|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
2149964|NCT03961295|Vedolizumab|vedolizumab|mesh-list
2149965|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2149966|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2600844|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2600845|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600846|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2600847|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2600848|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
2600849|NCT01765946|Metformin|metformin|mesh-list
2600850|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2600851|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600852|NCT01766063|Interferons|interferons|mesh-list
2600853|NCT01766063|Interferon-beta|interferon-beta|mesh-list
2600854|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
2600855|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600856|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
2600857|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2149967|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2149968|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2149969|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2149970|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149971|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
2149972|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149973|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149974|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2149975|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149976|NCT03954444|Phenylephrine|phenylephrine|mesh-list
2149977|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
2600858|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
2600859|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600860|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2600861|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
2600862|NCT01766089|Remifentanil|remifentanil|mesh-list
2600863|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2600864|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2600865|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600866|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2600867|NCT01766089|Analgesics|analgesics|mesh-ancestor
2600868|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
2600869|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600870|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2600871|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2600872|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2600873|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
2600874|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600875|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600876|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2600877|NCT01766089|Narcotics|narcotics|mesh-ancestor
2600878|NCT01766128|Zonisamide|zonisamide|mesh-list
2600879|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
2600880|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2600881|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2600882|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600883|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2600884|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600885|NCT01766154|Tirofiban|tirofiban|mesh-list
2149978|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2149979|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2149980|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
2149981|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2149982|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2149983|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2149984|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
2149985|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
2149986|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2149987|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
2149988|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2149989|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
2149990|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2149991|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
2149992|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2149993|NCT03954444|Protective Agents|protective agents|mesh-ancestor
2149994|NCT03953820|Diazepam|diazepam|mesh-list
2149995|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2600886|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2600887|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2600888|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600889|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2600890|NCT01766180|Resveratrol|resveratrol|mesh-list
2600891|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
2600892|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600893|NCT01766180|Protective Agents|protective agents|mesh-ancestor
2600894|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600895|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2149996|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
2149997|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
2149998|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
2149999|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150000|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150001|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2150002|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2150003|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150004|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2150005|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2150006|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2600896|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2600897|NCT01766258|Carbidopa|carbidopa|mesh-list
2600898|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2600899|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2600900|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
2600901|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2600902|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600903|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600904|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2600905|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600906|NCT01766323|Modafinil|modafinil|mesh-list
2600907|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2600908|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600909|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2600910|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2600911|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2150007|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2150008|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2150009|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2150010|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
2150011|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
2150012|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
2150013|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
2150014|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150015|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150016|NCT03961100|Entrectinib|entrectinib|mesh-list
2600912|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600913|NCT01766375|Cyclosporine|cyclosporine|mesh-list
2600914|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
2600915|NCT01766375|Methotrexate|methotrexate|mesh-list
2600916|NCT01766375|Cyclosporins|cyclosporins|mesh-list
2150017|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2150018|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150019|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150020|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2150021|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
2150022|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150023|NCT03960658|Ketamine|ketamine|mesh-list
2150024|NCT03960658|Analgesics|analgesics|mesh-ancestor
2150025|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
2150026|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150027|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150028|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2150029|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2150030|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
2150031|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
2150032|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150033|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2150034|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2150035|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150036|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150037|NCT03959332|Baloxavir|baloxavir|mesh-list
2150038|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
2150039|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150040|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150041|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150042|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
2150043|NCT03958656|Fludarabine|fludarabine|mesh-list
2150044|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2150045|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
2150046|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150047|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2150048|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2150049|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
2150050|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150051|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150052|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2150053|NCT03954743|Vaccines|vaccines|mesh-list
2150054|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
2150055|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150056|NCT03951805|Insulin|insulin|mesh-list
2150057|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2150058|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
2150059|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2150060|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150061|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2150062|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
2150063|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150064|NCT03949621|Vedolizumab|vedolizumab|mesh-list
2150065|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2150066|NCT03949244|Latanoprost|latanoprost|mesh-list
2150067|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2150068|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2150069|NCT03948581|Vedolizumab|vedolizumab|mesh-list
2150070|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2150071|NCT03948386|Bupivacaine|bupivacaine|mesh-list
2150072|NCT03948386|Mepivacaine|mepivacaine|mesh-list
2150073|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
2150074|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
2150075|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150076|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150077|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
2150078|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150079|NCT03943095|Fluorides|fluorides|mesh-list
2150080|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
2150081|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
2150082|NCT03943095|Protective Agents|protective agents|mesh-ancestor
2150083|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150084|NCT03942042|Ixekizumab|ixekizumab|mesh-list
2150085|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
2150086|NCT03923530|Eplerenone|eplerenone|mesh-list
2150087|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2150088|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
2150089|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150090|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150091|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2150092|NCT03923530|Diuretics|diuretics|mesh-ancestor
2150093|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
2150094|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2150095|NCT03914417|Imiquimod|imiquimod|mesh-list
2150096|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2150097|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
2150098|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150099|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150100|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
2150101|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
2150102|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2150103|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
2150104|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150105|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150106|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2150107|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
2600917|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2600918|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
2600919|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2600920|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600921|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2600922|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
2600923|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600924|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600925|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
2421128|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421129|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2421130|NCT00811421|Renal Agents|renal agents|mesh-ancestor
2421131|NCT00811447|Docetaxel|docetaxel|mesh-list
2421132|NCT00811447|Fluorouracil|fluorouracil|mesh-list
2421133|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421134|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
2421135|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
2421136|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
2421137|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421138|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
2421139|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2150108|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
2150109|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2150110|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
2150111|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150112|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150113|NCT03936387|Ropivacaine|ropivacaine|mesh-list
2600926|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600927|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2600928|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2600929|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
2600930|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2600931|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2600932|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
2600933|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600934|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2600935|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2600936|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2600937|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
2600938|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2600939|NCT01766414|Complement C1s|complement c1s|mesh-list
2600940|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2600941|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
2600942|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
2600943|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600944|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2600945|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2600946|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
2600947|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2600948|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600949|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2600950|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
2600951|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2600952|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600953|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600954|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600955|NCT01766583|Lenalidomide|lenalidomide|mesh-list
2600956|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
2600957|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600958|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2600959|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2600960|NCT01766583|Growth Substances|growth substances|mesh-ancestor
2600961|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
2600962|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2600963|NCT01766609|Triamcinolone|triamcinolone|mesh-list
2600964|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2600965|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2600966|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2600967|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2600968|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
2600969|NCT01766609|Hormones|hormones|mesh-ancestor
2600970|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2600971|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600972|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2600973|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
2600974|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2600975|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2600976|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
2600977|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
2600978|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
2600979|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600980|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2600981|NCT01766843|Charcoal|charcoal|mesh-list
2600982|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2150114|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
2150115|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
2150116|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150117|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150118|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
2150119|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150120|NCT03935399|Oxytocin|oxytocin|mesh-list
2150121|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
2150122|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2150123|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600983|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
2600984|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2600985|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600986|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2600987|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
2600988|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
2600989|NCT01766843|Hormones|hormones|mesh-ancestor
2600990|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150138|NCT03928327|Itraconazole|itraconazole|mesh-list
2150139|NCT03928327|Rifampin|rifampin|mesh-list
2150140|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
2150141|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2600991|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
2600992|NCT01766843|Antidotes|antidotes|mesh-ancestor
2600993|NCT01766843|Protective Agents|protective agents|mesh-ancestor
2600994|NCT01766960|Morphine|morphine|mesh-list
2600995|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2600996|NCT01766960|Narcotics|narcotics|mesh-ancestor
2600997|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2600998|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2600999|NCT01766960|Analgesics|analgesics|mesh-ancestor
2601000|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
2601001|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601002|NCT01767025|Oxytocin|oxytocin|mesh-list
2601003|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
2601004|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2601005|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601006|NCT01767090|Leuprolide|leuprolide|mesh-list
2601007|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2601008|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
2601009|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2601010|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601011|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2601012|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601013|NCT01767129|Quinidine|quinidine|mesh-list
2601014|NCT01767129|Dextromethorphan|dextromethorphan|mesh-list
2601015|NCT01767129|Antitussive Agents|antitussive agents|mesh-ancestor
2601016|NCT01767129|Respiratory System Agents|respiratory system agents|mesh-ancestor
2601017|NCT01767129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2601018|NCT01767129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2601019|NCT01767129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601020|NCT01767129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601021|NCT01767129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601022|NCT01767129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2601023|NCT01767129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2601024|NCT01767129|Adrenergic Agents|adrenergic agents|mesh-ancestor
2601025|NCT01767129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2601026|NCT01767129|Antimalarials|antimalarials|mesh-ancestor
2601027|NCT01767129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2150142|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2150143|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2150144|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150145|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150146|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2150147|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
2150148|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150149|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150150|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2150151|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2150152|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
2150153|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2150154|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
2150155|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2150156|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2150157|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2150158|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2150159|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2150160|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2150161|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2150162|NCT03933774|Tretinoin|tretinoin|mesh-list
2150163|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150164|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
2150165|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
2150166|NCT03912259|Emollients|emollients|mesh-list
2150167|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
2150168|NCT03933618|Anastrozole|anastrozole|mesh-list
2150169|NCT03933618|Clomiphene|clomiphene|mesh-list
2150170|NCT03933618|Enclomiphene|enclomiphene|mesh-list
2150171|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
2150172|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150173|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2150174|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150175|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2150176|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2150177|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150178|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2150179|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
2150180|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2601028|NCT01767129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2601029|NCT01767129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601030|NCT01767129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601031|NCT01767129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2601032|NCT01767129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2601033|NCT01767129|Cholinergic Agents|cholinergic agents|mesh-ancestor
2601034|NCT01767129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2601035|NCT01767129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2601036|NCT01767129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2601037|NCT01767129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2601038|NCT01767129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2601039|NCT01767259|Valsartan|valsartan|mesh-list
2601040|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2601041|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2601042|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2601043|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2601044|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601045|NCT01767259|Diuretics|diuretics|mesh-ancestor
2601046|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
2601047|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150181|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150182|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2150183|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
2150184|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2150185|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2150186|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2150187|NCT03927105|Nivolumab|nivolumab|mesh-list
2150188|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2150189|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150190|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2150191|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150192|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
2150193|NCT03923933|Bumetanide|bumetanide|mesh-list
2601048|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2601049|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2601050|NCT01767272|Fexofenadine|fexofenadine|mesh-list
2601051|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2601052|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2601053|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2601054|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
2601055|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
2601056|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601057|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601058|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601059|NCT01767298|Valsartan|valsartan|mesh-list
2601060|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2601061|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2601062|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2601063|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2601064|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601065|NCT01767298|Diuretics|diuretics|mesh-ancestor
2601066|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
2601067|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601068|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2601069|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2601070|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
2601071|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
2601072|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2601073|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
2601074|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601075|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601076|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601077|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2601078|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601079|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
2601080|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2601081|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2601082|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
2601083|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601084|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601085|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2601086|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601087|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2601088|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
2601089|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601090|NCT01767428|Acetaminophen|acetaminophen|mesh-list
2601091|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2601092|NCT01767428|Analgesics|analgesics|mesh-ancestor
2601093|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
2601094|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150194|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2150195|NCT03923933|Diuretics|diuretics|mesh-ancestor
2150196|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
2150197|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150198|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2150199|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2150200|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150201|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2150202|NCT03909295|Valsartan|valsartan|mesh-list
2150203|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2150204|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2150205|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2150206|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2150207|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150208|NCT03930264|Azathioprine|azathioprine|mesh-list
2150209|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
2150210|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150211|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2150212|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150213|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2150214|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
2150215|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150216|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2150217|NCT03929367|Oxytocin|oxytocin|mesh-list
2150218|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
2150219|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2601095|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601096|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
2601097|NCT01767454|Ipilimumab|ipilimumab|mesh-list
2601098|NCT01767454|Trametinib|trametinib|mesh-list
2601099|NCT01767454|Dabrafenib|dabrafenib|mesh-list
2601100|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2601101|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601102|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2601103|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601104|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2601105|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601106|NCT01767532|Cephalexin|cephalexin|mesh-list
2601107|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2601108|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601109|NCT01767545|Dexamethasone|dexamethasone|mesh-list
2601110|NCT01767545|Bevacizumab|bevacizumab|mesh-list
2601111|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2601112|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150220|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150221|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2150222|NCT03928522|Vancomycin|vancomycin|mesh-list
2150223|NCT03928522|Tobramycin|tobramycin|mesh-list
2150224|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150225|NCT03910439|Avelumab|avelumab|mesh-list
2150226|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2150227|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150228|NCT03927950|Citalopram|citalopram|mesh-list
2150229|NCT03927950|Bupropion|bupropion|mesh-list
2150230|NCT03927950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2150231|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2150232|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2150233|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150234|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150235|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
2150236|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150237|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2150238|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
2150239|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2150240|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2150241|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
2150242|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2150243|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2601113|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2601114|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2601115|NCT01767545|Growth Substances|growth substances|mesh-ancestor
2601116|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601117|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
2601118|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2601119|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
2601120|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
2601121|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601122|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2601123|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
2601124|NCT01767545|Hormones|hormones|mesh-ancestor
2601125|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2601126|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2601127|NCT01767571|Cephalexin|cephalexin|mesh-list
2601128|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2601129|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601130|NCT01767584|Cephalexin|cephalexin|mesh-list
2601131|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2601132|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601133|NCT01767610|Infliximab|infliximab|mesh-list
2601134|NCT01767610|Fenofibrate|fenofibrate|mesh-list
2601135|NCT01767610|Pitavastatin|pitavastatin|mesh-list
2601136|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2601137|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
2601138|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601139|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2601140|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2601141|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2601142|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601143|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
2601144|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2601145|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2150244|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601146|NCT01767623|Vemurafenib|vemurafenib|mesh-list
2601147|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601148|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2601149|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601150|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601151|NCT01767675|Carboplatin|carboplatin|mesh-list
2601152|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601153|NCT01767714|Plerixafor|plerixafor|mesh-list
2601154|NCT01767714|Lenograstim|lenograstim|mesh-list
2601155|NCT01767714|Sargramostim|sargramostim|mesh-list
2601156|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2601157|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
2601158|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601159|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2601160|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2601161|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
2601162|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601163|NCT01767896|Vaccines|vaccines|mesh-list
2601164|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
2601165|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601166|NCT01768039|Vitamin D|vitamin d|mesh-list
2601167|NCT01768039|Vitamins|vitamins|mesh-ancestor
2601168|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
2601169|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601170|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2601171|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2601172|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2601173|NCT01768078|Betamethasone|betamethasone|mesh-list
2601174|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601175|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
2601176|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2601177|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
2601178|NCT01768078|Hormones|hormones|mesh-ancestor
2601179|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2601180|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601181|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2601182|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
2601183|NCT01768182|Leucovorin|leucovorin|mesh-list
2601184|NCT01768182|Folic Acid|folic acid|mesh-list
2601185|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
2601186|NCT01768182|Antidotes|antidotes|mesh-ancestor
2601187|NCT01768182|Protective Agents|protective agents|mesh-ancestor
2601188|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601189|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
2150245|NCT03927781|Pregabalin|pregabalin|mesh-list
2150246|NCT03927781|Analgesics|analgesics|mesh-ancestor
2150247|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
2150248|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150249|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150250|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
2150251|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2601190|NCT01768182|Vitamins|vitamins|mesh-ancestor
2601191|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
2601192|NCT01768182|Hematinics|hematinics|mesh-ancestor
2601193|NCT01768195|Entecavir|entecavir|mesh-list
2601194|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
2601195|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601196|NCT01768208|Saxagliptin|saxagliptin|mesh-list
2601197|NCT01768208|Incretins|incretins|mesh-ancestor
2601198|NCT01768208|Hormones|hormones|mesh-ancestor
2601199|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2601200|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601201|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2601202|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
2601203|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601204|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601205|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2601206|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2601207|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2601208|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601209|NCT01768260|Aspirin|aspirin|mesh-list
2601210|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2150252|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2601211|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2601212|NCT01768260|Analgesics|analgesics|mesh-ancestor
2601213|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
2601214|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601215|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601216|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2601217|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2601218|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2601219|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2601220|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601221|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2601222|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2601223|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601224|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
2601225|NCT01768273|Midazolam|midazolam|mesh-list
2601226|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2601227|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2601228|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2601229|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601230|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2601231|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2601232|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2601233|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2601234|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
2601235|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
2601236|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
2601237|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
2601238|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601239|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601240|NCT01768299|Misoprostol|misoprostol|mesh-list
2601241|NCT01768299|Mifepristone|mifepristone|mesh-list
2601242|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2601243|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
2601244|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2601245|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601246|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2601247|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2601248|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
2601249|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2601250|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2601251|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2601252|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2601253|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
2601254|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2601255|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2601256|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
2601257|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2601258|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
2601259|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2601260|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2150253|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150254|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2150255|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2150256|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2150257|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150258|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2150259|NCT03905811|Terazosin|terazosin|mesh-list
2601261|NCT01768312|Cyclosporine|cyclosporine|mesh-list
2601262|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2601263|NCT01768312|Cyclosporins|cyclosporins|mesh-list
2601264|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601265|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601266|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2601267|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
2601268|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601269|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
2601270|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601271|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
2601272|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2601273|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2601274|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2601275|NCT01768338|Ofatumumab|ofatumumab|mesh-list
2601276|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601277|NCT01768351|Calcitriol|calcitriol|mesh-list
2601278|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2601279|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601280|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2601281|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2601282|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601283|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2601284|NCT01768351|Vitamins|vitamins|mesh-ancestor
2601285|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
2150260|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2150261|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2150262|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2150263|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
2150264|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150265|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150266|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150267|NCT03905811|Urological Agents|urological agents|mesh-ancestor
2150268|NCT03895307|Anesthetics|anesthetics|mesh-list
2150269|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
2150270|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150271|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150272|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
2150273|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150279|NCT03905642|Amikacin|amikacin|mesh-list
2150280|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2150281|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150282|NCT03892889|Aripiprazole|aripiprazole|mesh-list
2150283|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
2150284|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2150285|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2150286|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2150287|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150288|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150289|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
2150290|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
2150291|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150292|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150293|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2150294|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2150295|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
2150296|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2601286|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2601287|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2601288|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2601289|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601290|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2601291|NCT01768364|Renal Agents|renal agents|mesh-ancestor
2601292|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
2601293|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2601294|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2601295|NCT01768377|Lidocaine|lidocaine|mesh-list
2601296|NCT01768377|Fentanyl|fentanyl|mesh-list
2601297|NCT01768377|Midazolam|midazolam|mesh-list
2601298|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
2150297|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2150298|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2150299|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2150300|NCT03921723|Dolutegravir|dolutegravir|mesh-list
2150301|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2150302|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2150303|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150304|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601299|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
2601300|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2601301|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601302|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
2601303|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601304|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2150305|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2150306|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2150307|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
2150308|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150309|NCT03921190|Anesthetics|anesthetics|mesh-list
2150310|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2601305|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2601306|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2601307|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2601308|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601309|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2601310|NCT01768377|Narcotics|narcotics|mesh-ancestor
2601311|NCT01768377|Analgesics|analgesics|mesh-ancestor
2601312|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2601313|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2601314|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
2601315|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2601316|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2601317|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2601318|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2601319|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
2601320|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
2601321|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601322|NCT01768390|Fluorides|fluorides|mesh-list
2601323|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
2601324|NCT01768390|Protective Agents|protective agents|mesh-ancestor
2601325|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601326|NCT01768455|Glimepiride|glimepiride|mesh-list
2601327|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2601328|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2601329|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601330|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2601331|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
2601332|NCT01768481|Atorvastatin|atorvastatin|mesh-list
2601333|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2601334|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2601335|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
2150311|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150312|NCT03920865|Risdiplam|risdiplam|mesh-list
2150313|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2150314|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601336|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601337|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2601338|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2601339|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601340|NCT01768507|Resveratrol|resveratrol|mesh-list
2601341|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
2601342|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601343|NCT01768507|Protective Agents|protective agents|mesh-ancestor
2601344|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601345|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601346|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2601347|NCT01768663|Itraconazole|itraconazole|mesh-list
2601348|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
2601349|NCT01768663|Rifampin|rifampin|mesh-list
2601350|NCT01768663|Ivacaftor|ivacaftor|mesh-list
2601351|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
2601352|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601353|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2601354|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2601355|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601356|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601357|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2601358|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
2601359|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421140|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2421141|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
2601360|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601361|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2601362|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2601363|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2601364|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2601365|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601366|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2421142|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421143|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2421144|NCT00811460|Incretins|incretins|mesh-ancestor
2421145|NCT00811460|Hormones|hormones|mesh-ancestor
2421146|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421147|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421148|NCT00811486|Spironolactone|spironolactone|mesh-list
2421149|NCT00811486|Conivaptan|conivaptan|mesh-list
2150315|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150316|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2150317|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2150318|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2150319|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150320|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150321|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2601367|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2601368|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
2601369|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
2601370|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2601371|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2601372|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2601373|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2601374|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2601375|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2601376|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2601377|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2601378|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2601379|NCT01768741|Liver Extracts|liver extracts|mesh-list
2601380|NCT01768741|Hematinics|hematinics|mesh-ancestor
2601381|NCT01768767|Ketamine|ketamine|mesh-list
2601382|NCT01768767|Analgesics|analgesics|mesh-ancestor
2601383|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
2601384|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601385|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601386|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2601387|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2601388|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
2601389|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
2601390|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2601391|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2601392|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2601393|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601394|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601395|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
2601396|NCT01768780|Bupivacaine|bupivacaine|mesh-list
2601397|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2601398|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
2601399|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
2601400|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2601401|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601402|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
2601403|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601404|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2601405|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2601406|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
2601407|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601408|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601409|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
2601410|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2601411|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
2601412|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601413|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601414|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2601415|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
2601416|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2601417|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
2601418|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601419|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150322|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2150323|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2150324|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2150325|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
2150326|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150327|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150328|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2150329|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2150330|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
2150331|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2150332|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2150333|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
2601420|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2601421|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
2601422|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
2601423|NCT01768884|Protective Agents|protective agents|mesh-ancestor
2601424|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
2601425|NCT01768897|Cytarabine|cytarabine|mesh-list
2601426|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
2601427|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2601428|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
2601429|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601430|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601431|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
2601432|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601433|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2601434|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
2421150|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2421151|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
2421152|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421153|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601435|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601436|NCT01768897|Analgesics|analgesics|mesh-ancestor
2601437|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
2601438|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601439|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2601440|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2601441|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601442|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
2601443|NCT01768897|Protective Agents|protective agents|mesh-ancestor
2601444|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
2601445|NCT01768897|Vitamins|vitamins|mesh-ancestor
2601446|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
2601447|NCT01768975|Dapansutrile|dapansutrile|mesh-list
2601448|NCT01768975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2601449|NCT01768988|Pregabalin|pregabalin|mesh-list
2601450|NCT01768988|Analgesics|analgesics|mesh-ancestor
2601451|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
2601452|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601453|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601454|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
2601455|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2601456|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2601457|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601458|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2601459|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2601460|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2150334|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
2150335|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
2150336|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150337|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421154|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2421155|NCT00811486|Diuretics|diuretics|mesh-ancestor
2421156|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
2421157|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2421158|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421159|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2421160|NCT00811603|Cefazolin|cefazolin|mesh-list
2421161|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421162|NCT00811681|Pioglitazone|pioglitazone|mesh-list
2421163|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2421164|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421165|NCT00811746|Eszopiclone|eszopiclone|mesh-list
2421166|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2421167|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2421168|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421169|NCT00811759|Temozolomide|temozolomide|mesh-list
2421170|NCT00811759|Sorafenib|sorafenib|mesh-list
2421171|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2421172|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
2421173|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421174|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421175|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2421176|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421177|NCT00811785|Copper|copper|mesh-list
2421178|NCT00811785|Trace Elements|trace elements|mesh-ancestor
2421179|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
2150338|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150339|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
2150340|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
2150341|NCT03911843|Vitamin D|vitamin d|mesh-list
2150342|NCT03911843|Vitamins|vitamins|mesh-ancestor
2150343|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
2150344|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150345|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2150346|NCT03896633|Brinzolamide|brinzolamide|mesh-list
2150347|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2150348|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150349|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150350|NCT03894813|Metronidazole|metronidazole|mesh-list
2150351|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150352|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2150353|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2150354|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2150355|NCT03906448|Temozolomide|temozolomide|mesh-list
2150356|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2150357|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
2150358|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150359|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150360|NCT03909763|Danazol|danazol|mesh-list
2150361|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2150362|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
2150363|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150364|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150365|NCT03903822|PF-06700841|pf-06700841|mesh-list
2150366|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2150367|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150368|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150369|NCT03905096|Donepezil|donepezil|mesh-list
2150370|NCT03905096|BI 425809|bi 425809|mesh-list
2150371|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2150372|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150373|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150374|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
2150375|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150376|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150377|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
2150378|NCT03894969|Vaccines|vaccines|mesh-list
2150379|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
2150380|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150381|NCT03892707|Folic Acid|folic acid|mesh-list
2150382|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
2150383|NCT03892707|Celecoxib|celecoxib|mesh-list
2150384|NCT03892707|Etoricoxib|etoricoxib|mesh-list
2150385|NCT03892707|Meloxicam|meloxicam|mesh-list
2150386|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2150387|NCT03892707|Nimesulide|nimesulide|mesh-list
2150388|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2601461|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2601462|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2601463|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2601464|NCT01769027|Azithromycin|azithromycin|mesh-list
2601465|NCT01769027|Penicillins|penicillins|mesh-list
2601466|NCT01769027|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2601467|NCT01769027|Sertraline|sertraline|mesh-list
2601468|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2601469|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601470|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
2601471|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2601472|NCT01769027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2601473|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2601474|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2601475|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601476|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601477|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
2601478|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601479|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
2601480|NCT01769040|Rifaximin|rifaximin|mesh-list
2601481|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2601482|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601483|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2150389|NCT03892707|Benphothiamine|benphothiamine|mesh-list
2150390|NCT03892707|Vitamins|vitamins|mesh-ancestor
2150391|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
2601484|NCT01769066|Pemetrexed|pemetrexed|mesh-list
2601485|NCT01769066|Gefitinib|gefitinib|mesh-list
2601486|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601487|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601488|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601489|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2601490|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2601491|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2601492|NCT01769079|Isosorbide|isosorbide|mesh-list
2601493|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2601494|NCT01769079|Diuretics|diuretics|mesh-ancestor
2601495|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
2150392|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150393|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2150394|NCT03892707|Analgesics|analgesics|mesh-ancestor
2150395|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
2150396|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150397|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2150398|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2150399|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2601496|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601497|NCT01769118|Caffeine|caffeine|mesh-list
2601498|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2601499|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601500|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2601501|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601502|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601503|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2150400|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150401|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150402|NCT03892707|Hematinics|hematinics|mesh-ancestor
2150403|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2150404|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
2150405|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
2150406|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
2150407|NCT03890367|Vaccines|vaccines|mesh-list
2150408|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
2150409|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150410|NCT03889444|Dexamethasone|dexamethasone|mesh-list
2150411|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2150412|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
2150413|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
2150414|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150415|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150416|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2150417|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
2150418|NCT03889444|Hormones|hormones|mesh-ancestor
2150419|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150420|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2150421|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150422|NCT03888755|Icatibant|icatibant|mesh-list
2150423|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2150424|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2150425|NCT03888755|Analgesics|analgesics|mesh-ancestor
2150426|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
2150427|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150428|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150429|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2150430|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2150431|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
2150432|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
2150433|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150434|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2150435|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2150436|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
2150437|NCT03888365|Treprostinil|treprostinil|mesh-list
2601504|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2601505|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
2601506|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601507|NCT01769183|Squalamine|squalamine|mesh-list
2601508|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2601509|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2601510|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2601511|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150438|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2601512|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2601513|NCT01769183|Protective Agents|protective agents|mesh-ancestor
2601514|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601515|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601516|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2601517|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2601518|NCT01769183|Growth Substances|growth substances|mesh-ancestor
2601519|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
2601520|NCT01769235|Clindamycin|clindamycin|mesh-list
2601521|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
2150439|NCT03887442|Paclitaxel|paclitaxel|mesh-list
2150440|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2150441|NCT03887442|Cetuximab|cetuximab|mesh-list
2150442|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2150443|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150444|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
2150445|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
2150446|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
2150447|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601522|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
2601523|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2601524|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2601525|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601526|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2601527|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601528|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601529|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
2601530|NCT01769482|Udenafil|udenafil|mesh-list
2150448|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2150449|NCT03873987|Oritavancin|oritavancin|mesh-list
2150450|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2150451|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150452|NCT03887299|Disinfectants|disinfectants|mesh-list
2150453|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150454|NCT03886701|Isoniazid|isoniazid|mesh-list
2150455|NCT03886701|Rifapentine|rifapentine|mesh-list
2150456|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
2150457|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2150458|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150459|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2150460|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2150461|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
2150462|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150463|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2150464|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2150465|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
2150466|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2150467|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
2150468|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150469|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
2150470|NCT03885154|Valproic Acid|valproic acid|mesh-list
2150471|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
2150472|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601531|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2601532|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2601533|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601534|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601535|NCT01769625|Vitamin D|vitamin d|mesh-list
2601536|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
2601537|NCT01769625|Celecoxib|celecoxib|mesh-list
2150473|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150474|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
2150475|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150476|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150477|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
2150478|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2150479|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2601538|NCT01769625|Vitamins|vitamins|mesh-ancestor
2601539|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
2601540|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601541|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2601542|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2601543|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2601544|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2601545|NCT01769625|Analgesics|analgesics|mesh-ancestor
2150480|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2150481|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2150482|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
2150483|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
2150484|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2150485|NCT03885154|Analgesics|analgesics|mesh-ancestor
2150486|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
2150487|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150488|NCT03883386|Loratadine|loratadine|mesh-list
2150489|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
2150490|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
2601546|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
2601547|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601548|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2601549|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2601550|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2601551|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2601552|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601553|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601554|NCT01769651|Methadone|methadone|mesh-list
2601555|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2601556|NCT01769651|Narcotics|narcotics|mesh-ancestor
2601557|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2601558|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601559|NCT01769651|Analgesics|analgesics|mesh-ancestor
2601560|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
2601561|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601562|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
2601563|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
2150491|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2150492|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2150493|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2150494|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
2150495|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
2150496|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150497|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150498|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150499|NCT03882424|Bevacizumab|bevacizumab|mesh-list
2150500|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2150501|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601564|NCT01769664|Clindamycin|clindamycin|mesh-list
2601565|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
2601566|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
2601567|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2601568|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2601569|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601570|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2601571|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601572|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601573|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
2601574|NCT01769677|Hydrocodone|hydrocodone|mesh-list
2601575|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2601576|NCT01769677|Narcotics|narcotics|mesh-ancestor
2150502|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2150503|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2150504|NCT03882424|Growth Substances|growth substances|mesh-ancestor
2150505|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150506|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
2150507|NCT03882047|Fluticasone|fluticasone|mesh-list
2150508|NCT03882047|Xhance|xhance|mesh-list
2150509|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
2150510|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2601577|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2601578|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601579|NCT01769677|Analgesics|analgesics|mesh-ancestor
2601580|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
2601581|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601582|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
2601583|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
2601584|NCT01769703|Dabigatran|dabigatran|mesh-list
2601585|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
2601586|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2601587|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
2601588|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601589|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150511|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2150512|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
2150513|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150514|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150515|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2150516|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
2150517|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
2150518|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2150519|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
2150520|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2150521|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
2150522|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150523|NCT03881163|Expectorants|expectorants|mesh-ancestor
2601590|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
2601591|NCT01769768|Bupropion|bupropion|mesh-list
2601592|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2601593|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
2601594|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2601595|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2601596|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2150524|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
2150525|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2150526|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
2150527|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150528|NCT03881163|Protective Agents|protective agents|mesh-ancestor
2150529|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150530|NCT03881163|Antidotes|antidotes|mesh-ancestor
2150531|NCT03881059|Ustekinumab|ustekinumab|mesh-list
2150532|NCT03881059|BMS-986165|bms-986165|mesh-list
2150533|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
2150534|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2150535|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150536|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150537|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
2150538|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2150539|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2150540|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2150541|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
2150542|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150543|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150544|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150545|NCT03875664|Bupivacaine|bupivacaine|mesh-list
2150546|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
2150547|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
2150548|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150549|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150550|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
2150551|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150552|NCT03848871|Betamethasone|betamethasone|mesh-list
2601597|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2601598|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601599|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
2601600|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601601|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601602|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2601603|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2601604|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601605|NCT01769781|Anastrozole|anastrozole|mesh-list
2601606|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2601607|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150553|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
2150554|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2150555|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
2150556|NCT03848871|Calcipotriene|calcipotriene|mesh-list
2150557|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2150558|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2150559|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
2150560|NCT03848871|Hormones|hormones|mesh-ancestor
2150561|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150562|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150563|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2150564|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
2601608|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2601609|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2601610|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150565|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
2150566|NCT03848403|Ixekizumab|ixekizumab|mesh-list
2150567|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
2150568|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2150569|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2150570|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
2150571|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150572|NCT03879603|Antacids|antacids|mesh-ancestor
2150573|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601611|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601612|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2601613|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
2601614|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2601615|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601616|NCT01769820|Dexamethasone|dexamethasone|mesh-list
2601617|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2601618|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
2601619|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
2601620|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601621|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601622|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2150574|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2150575|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
2150576|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
2150577|NCT03879772|Beclomethasone|beclomethasone|mesh-list
2150578|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150579|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2601623|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
2601624|NCT01769820|Hormones|hormones|mesh-ancestor
2601625|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150580|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
2150581|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2601626|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2601627|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601628|NCT01769833|Interferons|interferons|mesh-list
2601629|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
2601630|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
2601631|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2601632|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601633|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
2601634|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601635|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
2601636|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601637|NCT01769898|Budesonide|budesonide|mesh-list
2601638|NCT01769898|Theophylline|theophylline|mesh-list
2601639|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
2601640|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2601641|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2150582|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
2150583|NCT03879772|Hormones|hormones|mesh-ancestor
2150584|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150585|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150586|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2150587|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
2150588|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
2150589|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2150590|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
2150591|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
2150592|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150593|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
2150594|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2150595|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150596|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2150597|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150598|NCT03866434|Anagrelide|anagrelide|mesh-list
2150599|NCT03866434|Omeprazole|omeprazole|mesh-list
2150600|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2150601|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2601642|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
2601643|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601644|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601645|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2601646|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
2601647|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
2601648|NCT01769898|Hormones|hormones|mesh-ancestor
2668565|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150602|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2150603|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150604|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150605|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2601649|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2601650|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2601651|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2601652|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2601653|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
2601654|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601655|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601656|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2601657|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601658|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
2601659|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2601660|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2601661|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
2601662|NCT01769911|Cytarabine|cytarabine|mesh-list
2601663|NCT01769911|Etoposide|etoposide|mesh-list
2601664|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
2601665|NCT01769911|Melphalan|melphalan|mesh-list
2601666|NCT01769911|Carmustine|carmustine|mesh-list
2601667|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2601668|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2601669|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601670|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2150606|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2150607|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2150608|NCT03855059|Dexamethasone|dexamethasone|mesh-list
2150609|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
2150610|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2150611|NCT03855059|BB 1101|bb 1101|mesh-list
2150612|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2150613|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
2150614|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
2150615|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150616|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150617|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2150618|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
2150619|NCT03855059|Hormones|hormones|mesh-ancestor
2150620|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150621|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2150622|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150623|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
2150624|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150625|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150626|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
2150627|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2150628|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2150629|NCT03852537|Prednisolone|prednisolone|mesh-list
2601671|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2601672|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601673|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601674|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2601675|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
2601676|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
2601677|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601678|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2601679|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
2601680|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601681|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2601682|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
2601683|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2601684|NCT01769950|Choline|choline|mesh-list
2601685|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
2601686|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2601687|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
2601688|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601689|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2601690|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2601691|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
2601692|NCT01770041|Acetaminophen|acetaminophen|mesh-list
2601693|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2601694|NCT01770041|Analgesics|analgesics|mesh-ancestor
2601695|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
2601696|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601697|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601698|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
2601699|NCT01770080|Peppermint oil|peppermint oil|mesh-list
2601700|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2601701|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
2601702|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
2601703|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601704|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601705|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2601706|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
2601707|NCT01770106|Denosumab|denosumab|mesh-list
2601708|NCT01770106|Alendronate|alendronate|mesh-list
2601709|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2601710|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601711|NCT01770119|Vaccines|vaccines|mesh-list
2601712|NCT01770119|Immunologic Factors|immunologic factors|mesh-ancestor
2601713|NCT01770119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601714|NCT01770132|Gemcitabine|gemcitabine|mesh-list
2601715|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2601716|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
2601717|NCT01770132|Trioxsalen|trioxsalen|mesh-list
2601718|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2601719|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
2601720|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601721|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601722|NCT01770132|Antiviral Agents|antiviral agents|mesh-ancestor
2601723|NCT01770132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601724|NCT01770132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601725|NCT01770132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2601726|NCT01770132|Immunologic Factors|immunologic factors|mesh-ancestor
2601727|NCT01770132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601728|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
2601729|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2601730|NCT01770171|Paclitaxel|paclitaxel|mesh-list
2601731|NCT01770171|Bevacizumab|bevacizumab|mesh-list
2601732|NCT01770171|Carboplatin|carboplatin|mesh-list
2601733|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2601734|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601735|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
2601736|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
2601737|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
2601738|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601739|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2601740|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2601741|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2601742|NCT01770171|Growth Substances|growth substances|mesh-ancestor
2601743|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601744|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
2601745|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2601746|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2150630|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
2150631|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2150632|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
2150633|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2150634|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
2150635|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
2150636|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601747|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2601748|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601749|NCT01770210|Atorvastatin|atorvastatin|mesh-list
2601750|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2601751|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2601752|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
2601753|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601754|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2601755|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2601756|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601757|NCT01770223|Ribavirin|ribavirin|mesh-list
2601758|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2601759|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
2601760|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601761|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
2601762|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601763|NCT01770236|Acetaminophen|acetaminophen|mesh-list
2601764|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2601765|NCT01770236|Analgesics|analgesics|mesh-ancestor
2668566|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
2601766|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
2601767|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601768|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601769|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
2601770|NCT01770301|Paclitaxel|paclitaxel|mesh-list
2601771|NCT01770301|Bevacizumab|bevacizumab|mesh-list
2601772|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2150637|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150638|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2150639|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
2150640|NCT03852537|Hormones|hormones|mesh-ancestor
2150641|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150642|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2150643|NCT03852537|Protective Agents|protective agents|mesh-ancestor
2150644|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2150645|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150646|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
2150647|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
2150648|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150649|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2150650|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
2150651|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601773|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601774|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
2601775|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
2601776|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
2601777|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601778|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2601779|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2601780|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2601781|NCT01770301|Growth Substances|growth substances|mesh-ancestor
2601782|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601783|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
2601784|NCT01770444|Cytarabine|cytarabine|mesh-list
2601785|NCT01770444|Thioguanine|thioguanine|mesh-list
2150652|NCT03873116|Berotralstat|berotralstat|mesh-list
2150653|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150654|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150655|NCT03872843|Ibuprofen|ibuprofen|mesh-list
2150656|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2150657|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2150658|NCT03872843|Analgesics|analgesics|mesh-ancestor
2150659|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
2150660|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150661|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601786|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2601787|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
2601788|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601789|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601790|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
2601791|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601792|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2601793|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
2601794|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601795|NCT01770470|Chitosan|chitosan|mesh-list
2601796|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2601797|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2601798|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
2601799|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601800|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2601801|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
2601802|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
2601803|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
2601804|NCT01770470|Coagulants|coagulants|mesh-ancestor
2601805|NCT01770496|Vaccines|vaccines|mesh-list
2601806|NCT01770496|Immunologic Factors|immunologic factors|mesh-ancestor
2150662|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2150663|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2150664|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2150665|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150666|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150667|NCT03861338|Buprenorphine|buprenorphine|mesh-list
2150668|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2601807|NCT01770496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601808|NCT01770600|Risperidone|risperidone|mesh-list
2601809|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2150669|NCT03861338|Narcotics|narcotics|mesh-ancestor
2150670|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150671|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150672|NCT03861338|Analgesics|analgesics|mesh-ancestor
2150673|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
2150674|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150675|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2150676|NCT03848416|Ixekizumab|ixekizumab|mesh-list
2150677|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
2150678|NCT03853551|Osimertinib|osimertinib|mesh-list
2150679|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150680|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2150681|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150682|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150683|NCT03869450|Lidocaine|lidocaine|mesh-list
2150684|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
2150685|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
2150686|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
2601810|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
2601811|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601812|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601813|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601814|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2601815|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2601816|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2601817|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2150687|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150688|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150689|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
2150690|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150691|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2150692|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2150693|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2150694|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2150695|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150696|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2150697|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
2150698|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
2150699|NCT03869450|Protective Agents|protective agents|mesh-ancestor
2150700|NCT03859960|Insulin|insulin|mesh-list
2150701|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2150702|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2150703|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150704|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
2150705|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2601818|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2601819|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
2601820|NCT01770769|Cloxacillin|cloxacillin|mesh-list
2601821|NCT01770769|Cephalothin|cephalothin|mesh-list
2601822|NCT01770769|Dalteparin|dalteparin|mesh-list
2601823|NCT01770769|Tinzaparin|tinzaparin|mesh-list
2601824|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2601825|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
2601826|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2601827|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2601828|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601829|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2150706|NCT03868059|Testosterone|testosterone|mesh-list
2150707|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
2150708|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
2150709|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2150710|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150711|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
2150712|NCT03868059|Hormones|hormones|mesh-ancestor
2150713|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150714|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601830|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601831|NCT01770795|Gemcitabine|gemcitabine|mesh-list
2601832|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2150715|NCT03868059|Androgens|androgens|mesh-ancestor
2150716|NCT03850444|Paclitaxel|paclitaxel|mesh-list
2150717|NCT03850444|Carboplatin|carboplatin|mesh-list
2150718|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
2150719|NCT03850444|Pemetrexed|pemetrexed|mesh-list
2150720|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2150721|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601833|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
2150722|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
2150723|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
2150724|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
2150725|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150726|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2150727|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150728|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2150729|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2150730|NCT03865407|Allopurinol|allopurinol|mesh-list
2150731|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
2150732|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150733|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150734|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
2601834|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601835|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601836|NCT01770795|Antiviral Agents|antiviral agents|mesh-ancestor
2601837|NCT01770795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601838|NCT01770795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601839|NCT01770795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2601840|NCT01770795|Immunologic Factors|immunologic factors|mesh-ancestor
2601841|NCT01770795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601842|NCT01770899|Montelukast|montelukast|mesh-list
2601843|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2150735|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2150736|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2150737|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
2150738|NCT03865407|Protective Agents|protective agents|mesh-ancestor
2150739|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150740|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2150741|NCT03857230|Hormones|hormones|mesh-ancestor
2150742|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150743|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150744|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
2150745|NCT03855189|Beclomethasone|beclomethasone|mesh-list
2150746|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2150747|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
2150748|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2150749|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
2150750|NCT03855189|Hormones|hormones|mesh-ancestor
2150751|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150752|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150753|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2150754|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
2150755|NCT03847610|Penicillins|penicillins|mesh-list
2150756|NCT03847610|Penicillin V|penicillin v|mesh-list
2150757|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2150758|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150759|NCT03850093|Bisoprolol|bisoprolol|mesh-list
2150760|NCT03850093|Gabapentin|gabapentin|mesh-list
2150761|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150762|NCT03850093|Analgesics|analgesics|mesh-ancestor
2150763|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
2150764|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150765|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
2150766|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2150767|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2150768|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150769|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2150770|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2150771|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2150772|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150773|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150774|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
2150775|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2150776|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
2601844|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
2601845|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2601846|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
2601847|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2601848|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601849|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2601850|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2601851|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150777|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
2601852|NCT01770964|Pregabalin|pregabalin|mesh-list
2601853|NCT01770964|Analgesics|analgesics|mesh-ancestor
2601854|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
2601855|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601856|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601857|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
2601858|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2601859|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2601860|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601861|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2601862|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2601863|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2601864|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2601865|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2601866|NCT01771081|Ranibizumab|ranibizumab|mesh-list
2601867|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2601868|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2601869|NCT01771081|Growth Substances|growth substances|mesh-ancestor
2601870|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601871|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
2601872|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150778|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2150779|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2150780|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2150781|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
2150782|NCT03847389|Clobetasol|clobetasol|mesh-list
2150783|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2601898|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
2601899|NCT01771146|Irinotecan|irinotecan|mesh-list
2601900|NCT01771146|Folfirinox|folfirinox|mesh-list
2601901|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601902|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2601903|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2601904|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601905|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601906|NCT01771185|Metformin|metformin|mesh-list
2601907|NCT01771185|Gliclazide|gliclazide|mesh-list
2601908|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2601909|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601910|NCT01771198|Simvastatin|simvastatin|mesh-list
2601911|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2601912|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2601913|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
2601914|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601915|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2601916|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2601917|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601918|NCT01771289|Docetaxel|docetaxel|mesh-list
2601919|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601920|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
2601921|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
2601922|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
2150784|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
2150785|NCT03847389|Hormones|hormones|mesh-ancestor
2150786|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2150787|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150788|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2150789|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150790|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
2150791|NCT03855228|Loratadine|loratadine|mesh-list
2150792|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2150793|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
2150794|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2150795|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
2150796|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2150797|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2150798|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
2150799|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
2150800|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150801|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150802|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150803|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
2150804|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2150805|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2150806|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2150807|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2150808|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150809|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
2150810|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150811|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150812|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2150813|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150814|NCT03857750|Rocuronium|rocuronium|mesh-list
2150815|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2150816|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2150817|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2150818|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150819|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150820|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
2150821|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2150822|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
2150823|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2150824|NCT03860753|Pioglitazone|pioglitazone|mesh-list
2150825|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2150826|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150827|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2150828|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2150829|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
2150830|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2150831|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2150832|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150833|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
2150834|NCT03856164|Coagulants|coagulants|mesh-ancestor
2150835|NCT03849690|Esomeprazole|esomeprazole|mesh-list
2150836|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2150837|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2150838|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2150839|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150840|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150841|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
2601923|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601924|NCT01771302|Calcium|calcium|mesh-list
2601925|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2601926|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601927|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
2601928|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2601929|NCT01771328|Cortisone|cortisone|mesh-list
2601930|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2601931|NCT01771406|Nebivolol|nebivolol|mesh-list
2601932|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2601933|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
2601934|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2601935|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2601936|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2601937|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
2150842|NCT03846219|Calcium|calcium|mesh-list
2150843|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2150844|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150845|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2150846|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2150847|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2150848|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
2150849|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
2150850|NCT03840811|Cefixime|cefixime|mesh-list
2150851|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2150852|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150853|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2150854|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2150855|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150856|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150857|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150858|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2150859|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2150860|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
2150861|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2150862|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2150863|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150864|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
2150865|NCT03825939|Coagulants|coagulants|mesh-ancestor
2150866|NCT03841331|Serlopitant|serlopitant|mesh-list
2150867|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2150868|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150869|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150870|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150871|NCT03840278|Pancrelipase|pancrelipase|mesh-list
2601938|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601939|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601940|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601941|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2601942|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2601943|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2601944|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2601945|NCT01771458|Tamoxifen|tamoxifen|mesh-list
2601946|NCT01771458|Trastuzumab|trastuzumab|mesh-list
2601947|NCT01771458|Everolimus|everolimus|mesh-list
2601948|NCT01771458|Sorafenib|sorafenib|mesh-list
2601949|NCT01771458|Letrozole|letrozole|mesh-list
2601950|NCT01771458|Dasatinib|dasatinib|mesh-list
2150872|NCT03840278|Pancreatin|pancreatin|mesh-list
2150873|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2150874|NCT03839355|Warfarin|warfarin|mesh-list
2150875|NCT03839355|Apixaban|apixaban|mesh-list
2150876|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
2601951|NCT01771458|Lapatinib|lapatinib|mesh-list
2601952|NCT01771458|Vemurafenib|vemurafenib|mesh-list
2601953|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2601954|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601955|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2601956|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
2601957|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601958|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2601959|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601960|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601961|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2601962|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2601963|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2601964|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
2601965|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2601966|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2601967|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2601968|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2601969|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2150877|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2150878|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
2150879|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2150880|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
2150881|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150882|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150883|NCT03838874|Bupivacaine|bupivacaine|mesh-list
2150884|NCT03838874|Mepivacaine|mepivacaine|mesh-list
2150885|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
2150886|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
2601970|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2150887|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150888|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150889|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
2150890|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150891|NCT03822078|Denosumab|denosumab|mesh-list
2150892|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2150893|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150894|NCT03811951|Insulin|insulin|mesh-list
2150895|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2150896|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150897|NCT03810235|Lidocaine|lidocaine|mesh-list
2150898|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
2150899|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
2150900|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150901|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150902|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
2150903|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150904|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2150905|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2150906|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2150907|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2150908|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150909|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
2150910|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2601971|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2601972|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2601973|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601974|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
2601975|NCT01771822|Ibuprofen|ibuprofen|mesh-list
2601976|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2601977|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2601978|NCT01771822|Analgesics|analgesics|mesh-ancestor
2601979|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
2601980|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2601981|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2601982|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2601983|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2601984|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2601985|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2601986|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601987|NCT01771874|Bupropion|bupropion|mesh-list
2601988|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2601989|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2601990|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
2601991|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2601992|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2601993|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2601994|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2601995|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2601996|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
2601997|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2601998|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150911|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2150912|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150913|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
2150914|NCT03806556|Coagulants|coagulants|mesh-ancestor
2150915|NCT03836664|Timolol|timolol|mesh-list
2150916|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2150917|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2150918|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2150919|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2150920|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
2150921|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150922|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150923|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150924|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2150925|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2150926|NCT03823391|Adalimumab|adalimumab|mesh-list
2150927|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2150928|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2150929|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
2150930|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2150931|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2150932|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150933|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2150934|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2150935|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150936|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150937|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2150938|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2150939|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
2150940|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2150941|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150942|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2150943|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2150944|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2150945|NCT03836729|Tenofovir|tenofovir|mesh-list
2150946|NCT03836729|Emtricitabine|emtricitabine|mesh-list
2150947|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
2421180|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421181|NCT00811837|Midazolam|midazolam|mesh-list
2421182|NCT00811837|Remifentanil|remifentanil|mesh-list
2421183|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2421184|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2421185|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2421186|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421187|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2421188|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2421189|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2421190|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2421191|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
2421192|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
2421193|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
2421194|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
2421195|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2421196|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421197|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2421198|NCT00811837|Narcotics|narcotics|mesh-ancestor
2421199|NCT00811837|Analgesics|analgesics|mesh-ancestor
2421200|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
2421201|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421202|NCT00811876|Leuprolide|leuprolide|mesh-list
2421203|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2421204|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
2421205|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2421206|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421207|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2421208|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421209|NCT00811915|Sirolimus|sirolimus|mesh-list
2421210|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2421211|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421212|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2150948|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150949|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2150950|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2150951|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421213|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2601999|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2602000|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2602001|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602002|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
2602003|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
2602004|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2602005|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
2602006|NCT01771978|Diltiazem|diltiazem|mesh-list
2602007|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2602008|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2602009|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2602010|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602011|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2602012|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602013|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
2602017|NCT01772056|Fluticasone|fluticasone|mesh-list
2602018|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2602019|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2602020|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
2602021|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602022|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602023|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2602024|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
2150952|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150953|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2150954|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2150955|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2150956|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
2150957|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150963|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
2150964|NCT03801148|Lansoprazole|lansoprazole|mesh-list
2150965|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2150966|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2150967|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2150968|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150969|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150970|NCT03831854|Lamotrigine|lamotrigine|mesh-list
2150971|NCT03831854|Ketamine|ketamine|mesh-list
2150972|NCT03831854|Analgesics|analgesics|mesh-ancestor
2150973|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
2602025|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
2602026|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2602027|NCT01772212|Terbinafine|terbinafine|mesh-list
2602028|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
2602029|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602030|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602031|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602032|NCT01772238|Amoxicillin|amoxicillin|mesh-list
2602033|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2602034|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
2602035|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
2602036|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2602037|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602038|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2602039|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602040|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421214|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
2421215|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2421216|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
2421217|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421218|NCT00811967|Ribavirin|ribavirin|mesh-list
2421219|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2421220|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
2421221|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
2421222|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602041|NCT01772251|Insulin|insulin|mesh-list
2602042|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2602043|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602044|NCT01772290|Itraconazole|itraconazole|mesh-list
2602045|NCT01772290|Fluconazole|fluconazole|mesh-list
2602046|NCT01772290|Rabeprazole|rabeprazole|mesh-list
2602047|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
2602048|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602049|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2602050|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2602051|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602052|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602053|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2602054|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
2602055|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2602056|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602057|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2602058|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2602059|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2602060|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2421223|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
2602061|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2602062|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2150974|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2150975|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2150976|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2150977|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2150978|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
2150979|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
2150980|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2150981|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2150982|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2150983|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2150984|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2150985|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
2150986|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2602063|NCT01772381|Dexamethasone|dexamethasone|mesh-list
2602064|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2602065|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
2602066|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
2602067|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602068|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602069|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2602070|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
2602071|NCT01772381|Hormones|hormones|mesh-ancestor
2602072|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2602073|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2602074|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602075|NCT01772420|Lenalidomide|lenalidomide|mesh-list
2150987|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2150988|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2150989|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2150990|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2150991|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2150992|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2150993|NCT03824912|Ketoconazole|ketoconazole|mesh-list
2150994|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
2150995|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2150996|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2150997|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2150998|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2150999|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151000|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2151001|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
2151002|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151003|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151004|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2151005|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
2151006|NCT03822884|Hematinics|hematinics|mesh-ancestor
2151007|NCT03806270|Midazolam|midazolam|mesh-list
2151008|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
2151009|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2151010|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2602076|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
2602077|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602078|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2602079|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2151011|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151012|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151013|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2151014|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2151015|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2151016|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2151017|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
2151018|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
2151019|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
2151020|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
2151021|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151022|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151023|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
2151024|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
2151025|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2151026|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
2151027|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
2151028|NCT03830892|Nicotine|nicotine|mesh-list
2602080|NCT01772420|Growth Substances|growth substances|mesh-ancestor
2602081|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
2602082|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602083|NCT01772563|Itraconazole|itraconazole|mesh-list
2602084|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
2602085|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602086|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2602087|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2602088|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602089|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602090|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2602091|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
2602092|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2602093|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151029|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2151030|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
2151031|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151032|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151033|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2151034|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2151035|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
2151036|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151037|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151038|NCT03823378|Upadacitinib|upadacitinib|mesh-list
2151039|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2151040|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2151041|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151042|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151043|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2151044|NCT03830281|Insulin|insulin|mesh-list
2151045|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2151046|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
2151047|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2151048|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151049|NCT03818815|Amoxicillin|amoxicillin|mesh-list
2151050|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
2151051|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
2151052|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2151053|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2151054|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151055|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2151056|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151057|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151058|NCT03828539|Topiramate|topiramate|mesh-list
2151059|NCT03828539|Erenumab|erenumab|mesh-list
2151060|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2151061|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
2151062|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2151063|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151064|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2151065|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602094|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2602095|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
2602096|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
2602097|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
2602098|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
2602099|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2602100|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602101|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2602102|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2602103|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602104|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602105|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602106|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2602107|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2602108|NCT01772641|Varenicline|varenicline|mesh-list
2602109|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2602110|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2602111|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
2602112|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602113|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602114|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151066|NCT03828539|Analgesics|analgesics|mesh-ancestor
2151067|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
2151068|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151069|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
2151070|NCT03824704|Nivolumab|nivolumab|mesh-list
2151071|NCT03824704|Rucaparib|rucaparib|mesh-list
2151072|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2151073|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151074|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2151075|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151076|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2151077|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151078|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
2151079|NCT03827473|Prednisone|prednisone|mesh-list
2151080|NCT03827473|Cortisone|cortisone|mesh-list
2602115|NCT01772797|Ceritinib|ceritinib|mesh-list
2602116|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602117|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2602118|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602119|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602120|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
2602121|NCT01772836|Biapenem|biapenem|mesh-list
2602122|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602123|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602124|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2602125|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151081|NCT03827473|Docetaxel|docetaxel|mesh-list
2151082|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
2151083|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
2151084|NCT03827473|Hormones|hormones|mesh-list
2151085|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2151086|NCT03827473|Androgens|androgens|mesh-list
2151087|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
2151088|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151089|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
2602126|NCT01772940|Ritonavir|ritonavir|mesh-list
2602127|NCT01772940|Lopinavir|lopinavir|mesh-list
2602128|NCT01772940|Tenofovir|tenofovir|mesh-list
2602129|NCT01772940|Lamivudine|lamivudine|mesh-list
2602130|NCT01772940|Zidovudine|zidovudine|mesh-list
2602131|NCT01772940|Emtricitabine|emtricitabine|mesh-list
2602132|NCT01772940|Nevirapine|nevirapine|mesh-list
2602133|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2602134|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2602135|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
2602136|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602137|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602138|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2602139|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2602140|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
2602141|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602142|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2602143|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2602144|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2602145|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2602146|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
2602147|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2602148|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2602149|NCT01772953|Treosulfan|treosulfan|mesh-list
2602150|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2602151|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
2602152|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602153|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602154|NCT01772979|Trabectedin|trabectedin|mesh-list
2602155|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2151090|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
2151091|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
2151092|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151093|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2151094|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
2421224|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421225|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
2421226|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421227|NCT00811980|Vancomycin|vancomycin|mesh-list
2421228|NCT00811980|Linezolid|linezolid|mesh-list
2421229|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2421230|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421231|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2602156|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
2602157|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602158|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151095|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151096|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151097|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2151098|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2151099|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151100|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
2151101|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2151102|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
2151103|NCT03827473|Protective Agents|protective agents|mesh-ancestor
2151104|NCT03827473|Vitamins|vitamins|mesh-ancestor
2151105|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
2151106|NCT03827473|Estrogens|estrogens|mesh-ancestor
2151107|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
2151108|NCT03812328|Enoxaparin|enoxaparin|mesh-list
2151109|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
2151110|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2151111|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2151112|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151113|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2151114|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2151115|NCT03822182|Dexamethasone|dexamethasone|mesh-list
2151116|NCT03822182|Bupivacaine|bupivacaine|mesh-list
2151117|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2151118|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
2151119|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
2602159|NCT01773005|Acetaminophen|acetaminophen|mesh-list
2602160|NCT01773005|Ibuprofen|ibuprofen|mesh-list
2602161|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2602162|NCT01773005|Analgesics|analgesics|mesh-ancestor
2602163|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
2602164|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602165|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602166|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
2602167|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2602168|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2602169|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2602170|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2602171|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602172|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602173|NCT01773044|Lidocaine|lidocaine|mesh-list
2602174|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
2602175|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
2602176|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2602177|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602178|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
2602179|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602180|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2602181|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2602182|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2602183|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2602184|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602185|NCT01773083|Heparin|heparin|mesh-list
2602186|NCT01773083|Calcium heparin|calcium heparin|mesh-list
2602187|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
2602188|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2602189|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2602190|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602191|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
2602192|NCT01773096|Bisacodyl|bisacodyl|mesh-list
2602193|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2602194|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
2602195|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2602196|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2602197|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602198|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
2602199|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602200|NCT01773096|Cathartics|cathartics|mesh-ancestor
2602201|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2602202|NCT01773096|Laxatives|laxatives|mesh-ancestor
2602203|NCT01773096|Antacids|antacids|mesh-ancestor
2668567|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2151120|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151121|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602204|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151122|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151123|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
2151124|NCT03822182|Hormones|hormones|mesh-ancestor
2151125|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151126|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2151127|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151128|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
2151129|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
2151130|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151131|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
2151132|NCT03822416|Nicotine|nicotine|mesh-list
2151133|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2151134|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
2151135|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602205|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
2602206|NCT01773174|Dabigatran|dabigatran|mesh-list
2602207|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
2602208|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2602209|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
2602210|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602211|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602212|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
2602217|NCT01773395|Methotrexate|methotrexate|mesh-list
2602218|NCT01773395|Fludarabine|fludarabine|mesh-list
2602219|NCT01773395|Busulfan|busulfan|mesh-list
2602220|NCT01773395|Tacrolimus|tacrolimus|mesh-list
2602221|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2602222|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
2602223|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2602224|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602225|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2602226|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
2602227|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602228|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602229|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
2602230|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602231|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2602232|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2602233|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
2602234|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2602235|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2602236|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2602237|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
2151136|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151137|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2151138|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2151139|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
2151140|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151141|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151142|NCT03806231|Dinoprostone|dinoprostone|mesh-list
2151143|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
2151144|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2151145|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151146|NCT03822377|Ticagrelor|ticagrelor|mesh-list
2151147|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2151148|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2151149|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2151150|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2151151|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
2151152|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151153|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151154|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602238|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2602239|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2602240|NCT01773408|Cytarabine|cytarabine|mesh-list
2602241|NCT01773408|Daunorubicin|daunorubicin|mesh-list
2602242|NCT01773408|Idarubicin|idarubicin|mesh-list
2602243|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2602244|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
2668568|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2602245|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602246|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602247|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
2602248|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602249|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2602250|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
2602251|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602252|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2602253|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2602254|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2602255|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602256|NCT01773460|Everolimus|everolimus|mesh-list
2602257|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602258|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2602259|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
2602260|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602261|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2602262|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2602263|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2602264|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
2602265|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602266|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2151155|NCT03820388|Propofol|propofol|mesh-list
2151156|NCT03820388|Etomidate|etomidate|mesh-list
2151157|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2151158|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151159|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151160|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2151161|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
2151162|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
2151163|NCT03809182|Fentanyl|fentanyl|mesh-list
2151164|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
2151165|NCT03809182|Morphine|morphine|mesh-list
2151166|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2151167|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151168|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151169|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2151170|NCT03809182|Analgesics|analgesics|mesh-ancestor
2151171|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
2151172|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151173|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2151174|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2151175|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2151176|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
2151177|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151178|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151179|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2602267|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2602268|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602269|NCT01773538|Rifaximin|rifaximin|mesh-list
2602270|NCT01773538|Lactulose|lactulose|mesh-list
2602271|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2602272|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602273|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151180|NCT03809182|Narcotics|narcotics|mesh-ancestor
2151181|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2151182|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2151183|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
2151184|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
2151185|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
2151186|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2602274|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
2602275|NCT01773616|Prednisolone|prednisolone|mesh-list
2602276|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2602277|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
2602278|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2602279|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
2602280|NCT01773616|Rituximab|rituximab|mesh-list
2602281|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2602282|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
2602283|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2602284|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602285|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
2602286|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602287|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2602288|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2151187|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602289|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2602290|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
2602291|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2602292|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602293|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602294|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602295|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2602296|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
2602297|NCT01773616|Hormones|hormones|mesh-ancestor
2602298|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2602299|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2602300|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
2602301|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
2602302|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602303|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2602304|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2602305|NCT01773616|Protective Agents|protective agents|mesh-ancestor
2602306|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
2602307|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2602308|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
2602309|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602310|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2602311|NCT01773707|Abatacept|abatacept|mesh-list
2602312|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2602313|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602314|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602315|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2602316|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
2151188|NCT03805672|Enoxaparin|enoxaparin|mesh-list
2151189|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
2151190|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
2151191|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2151192|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2151193|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151194|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2151195|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2151196|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151197|NCT03802994|Vaccines|vaccines|mesh-list
2151198|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2151199|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
2151200|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151201|NCT03809611|Choline|choline|mesh-list
2151202|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
2602317|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602318|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2151203|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2151204|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
2151205|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151206|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151207|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2151208|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
2151209|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2151210|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2151211|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
2151212|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151213|NCT03807245|Antacids|antacids|mesh-ancestor
2151214|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151215|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151216|NCT03802916|Deferiprone|deferiprone|mesh-list
2151217|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2151218|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
2151219|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
2421232|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421233|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421234|NCT00811993|Gemcitabine|gemcitabine|mesh-list
2421235|NCT00811993|Etoposide|etoposide|mesh-list
2421236|NCT00811993|Docetaxel|docetaxel|mesh-list
2421237|NCT00811993|Bevacizumab|bevacizumab|mesh-list
2421238|NCT00811993|Carboplatin|carboplatin|mesh-list
2421239|NCT00811993|Capecitabine|capecitabine|mesh-list
2421240|NCT00811993|Trastuzumab|trastuzumab|mesh-list
2421241|NCT00811993|Irinotecan|irinotecan|mesh-list
2421242|NCT00811993|Cetuximab|cetuximab|mesh-list
2421243|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2421244|NCT00811993|Temozolomide|temozolomide|mesh-list
2421245|NCT00811993|Sorafenib|sorafenib|mesh-list
2421246|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2151220|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151221|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
2151222|NCT03805386|Narcotics|narcotics|mesh-ancestor
2151223|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151224|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151225|NCT03805386|Analgesics|analgesics|mesh-ancestor
2151226|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
2602319|NCT01773772|Progesterone|progesterone|mesh-list
2602320|NCT01773772|Progestins|progestins|mesh-ancestor
2602321|NCT01773772|Hormones|hormones|mesh-ancestor
2602322|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2602323|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602324|NCT01773785|Docetaxel|docetaxel|mesh-list
2602325|NCT01773785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602326|NCT01773785|Tubulin Modulators|tubulin modulators|mesh-ancestor
2602327|NCT01773785|Antimitotic Agents|antimitotic agents|mesh-ancestor
2602328|NCT01773785|Mitosis Modulators|mitosis modulators|mesh-ancestor
2151227|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151228|NCT03803475|Edetic Acid|edetic acid|mesh-list
2151229|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
2151230|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
2151231|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151232|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
2151233|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2151234|NCT03802227|Oxycodone|oxycodone|mesh-list
2151235|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2151236|NCT03802227|Narcotics|narcotics|mesh-ancestor
2151237|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151238|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151239|NCT03802227|Analgesics|analgesics|mesh-ancestor
2151240|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
2151241|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151242|NCT03802864|Bupivacaine|bupivacaine|mesh-list
2151243|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
2151244|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
2151245|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151246|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151247|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
2151248|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602329|NCT01773785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602330|NCT01773798|Insulin|insulin|mesh-list
2602331|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2151249|NCT03801265|Ropivacaine|ropivacaine|mesh-list
2151250|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
2151251|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
2151252|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151253|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151254|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
2151255|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151256|NCT03801928|Infliximab|infliximab|mesh-list
2151257|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
2151258|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151259|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2151260|NCT03800173|Galidesivir|galidesivir|mesh-list
2151261|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
2151262|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151263|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
2151264|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2602332|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
2602333|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
2602334|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2602335|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2602336|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602337|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2602338|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602339|NCT01773837|Methylphenidate|methylphenidate|mesh-list
2151265|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151266|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151267|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2151268|NCT03799783|Analgesics|analgesics|mesh-ancestor
2151269|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
2151270|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151271|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2151272|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2151273|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2151274|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
2151275|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151276|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151277|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
2151278|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
2151279|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2602340|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2602341|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602342|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2602343|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2602344|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2602345|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151280|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2151281|NCT03797872|Prednisolone|prednisolone|mesh-list
2151282|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
2151283|NCT03797872|Triamcinolone|triamcinolone|mesh-list
2151284|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2151285|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2151286|NCT03797872|Methotrexate|methotrexate|mesh-list
2151287|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2151288|NCT03797872|Leflunomide|leflunomide|mesh-list
2151289|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2602346|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
2602347|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602348|NCT01773876|Micafungin|micafungin|mesh-list
2602349|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
2602350|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602351|NCT01773928|Vaccines|vaccines|mesh-list
2602352|NCT01773928|Immunologic Factors|immunologic factors|mesh-ancestor
2151290|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
2151291|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2151292|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
2602353|NCT01773928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602354|NCT01774370|Dabigatran|dabigatran|mesh-list
2602355|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
2602356|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2602357|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
2602358|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602359|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602360|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
2602361|NCT01774396|Lidocaine|lidocaine|mesh-list
2151293|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2151294|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151295|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2151296|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
2151297|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151298|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151299|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
2151300|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151301|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2151302|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2151303|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
2151304|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2151305|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2151306|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2151307|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
2151308|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
2151309|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151310|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151311|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
2151312|NCT03797872|Hormones|hormones|mesh-ancestor
2151313|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151314|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2151315|NCT03797872|Protective Agents|protective agents|mesh-ancestor
2151316|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2151317|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151318|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2151319|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2151320|NCT03797872|Analgesics|analgesics|mesh-ancestor
2151321|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
2151322|NCT03799484|Lidocaine|lidocaine|mesh-list
2151323|NCT03799484|Prilocaine|prilocaine|mesh-list
2151324|NCT03799484|Petrolatum|petrolatum|mesh-list
2151325|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
2151326|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2151327|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2151328|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
2151329|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
2602362|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
2602363|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
2602364|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2602365|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602366|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
2602367|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602368|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2602369|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2602370|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2602371|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2602372|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602373|NCT01774474|Dexamethasone|dexamethasone|mesh-list
2602374|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
2602375|NCT01774474|Triamcinolone|triamcinolone|mesh-list
2602376|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2602377|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2602378|NCT01774474|Bromfenac|bromfenac|mesh-list
2602379|NCT01774474|Bevacizumab|bevacizumab|mesh-list
2602380|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2602381|NCT01774474|BB 1101|bb 1101|mesh-list
2602382|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2602383|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2602384|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602385|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2602386|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2602387|NCT01774474|Growth Substances|growth substances|mesh-ancestor
2602388|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602389|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
2602390|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2602391|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
2602392|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
2602393|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602394|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2602395|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
2602396|NCT01774474|Hormones|hormones|mesh-ancestor
2602397|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2602398|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2602399|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
2602400|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151330|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151331|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151332|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
2151333|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151334|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2151335|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2602401|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602402|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2602403|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2151336|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2151337|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2151338|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151339|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2151340|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
2151341|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151342|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2151343|NCT03799484|Emollients|emollients|mesh-ancestor
2151344|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
2151345|NCT03796728|Lidocaine|lidocaine|mesh-list
2151346|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
2151347|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
2151348|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151349|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151350|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
2151351|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151352|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2151353|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2151354|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2151355|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2151356|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151357|NCT03796260|Entrectinib|entrectinib|mesh-list
2151358|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2151359|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602404|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
2602405|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2602406|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2602407|NCT01774474|Analgesics|analgesics|mesh-ancestor
2602408|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
2602409|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2602410|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
2602411|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2602412|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602413|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602414|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2602415|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2602416|NCT01774487|Protective Agents|protective agents|mesh-ancestor
2602417|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602418|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
2602419|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2602420|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
2602421|NCT01774565|Insulin|insulin|mesh-list
2602422|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2602423|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2602424|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602425|NCT01774578|Gemcitabine|gemcitabine|mesh-list
2602426|NCT01774578|Docetaxel|docetaxel|mesh-list
2602427|NCT01774578|Pemetrexed|pemetrexed|mesh-list
2602428|NCT01774578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2602429|NCT01774578|Antimetabolites|antimetabolites|mesh-ancestor
2602430|NCT01774578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602431|NCT01774578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602432|NCT01774578|Antiviral Agents|antiviral agents|mesh-ancestor
2602433|NCT01774578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602434|NCT01774578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602435|NCT01774578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2602436|NCT01774578|Immunologic Factors|immunologic factors|mesh-ancestor
2602437|NCT01774578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602438|NCT01774578|Tubulin Modulators|tubulin modulators|mesh-ancestor
2151360|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151361|NCT03780959|Etanercept|etanercept|mesh-list
2151362|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2151363|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2151364|NCT03780959|Analgesics|analgesics|mesh-ancestor
2151365|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
2151366|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151367|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151368|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2151369|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2151370|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2602439|NCT01774578|Antimitotic Agents|antimitotic agents|mesh-ancestor
2602440|NCT01774578|Mitosis Modulators|mitosis modulators|mesh-ancestor
2602441|NCT01774578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2602442|NCT01774578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2602443|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
2602444|NCT01774812|Vitamin D|vitamin d|mesh-list
2602445|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
2151371|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2151372|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
2151373|NCT03796182|Metformin|metformin|mesh-list
2151374|NCT03796182|Abrocitinib|abrocitinib|mesh-list
2151375|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2151376|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151377|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2151378|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151379|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151380|NCT03796013|Entrectinib|entrectinib|mesh-list
2151381|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2151382|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602446|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2602447|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2602448|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602449|NCT01774812|Vitamins|vitamins|mesh-ancestor
2602450|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
2602451|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2602452|NCT01774838|Clopidogrel|clopidogrel|mesh-list
2602453|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2151383|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151384|NCT03796676|Abrocitinib|abrocitinib|mesh-list
2151385|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2602454|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2602455|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2151386|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151387|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151388|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
2151389|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2151390|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151391|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151392|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2151393|NCT03793751|Analgesics|analgesics|mesh-ancestor
2151394|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
2151395|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151396|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2151397|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2151398|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2151399|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
2151400|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151401|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151402|NCT03793556|Omeprazole|omeprazole|mesh-list
2151403|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2151404|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151405|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2151406|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151407|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602456|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2602457|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2602458|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
2602459|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602460|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602461|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602462|NCT01774864|Udenafil|udenafil|mesh-list
2602463|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2602464|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2602465|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602466|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602467|NCT01774877|Leflunomide|leflunomide|mesh-list
2602468|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602469|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602470|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2602471|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
2602472|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602473|NCT01775098|Allopurinol|allopurinol|mesh-list
2602474|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
2602475|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602476|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602477|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
2602478|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2602479|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2602480|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
2602481|NCT01775098|Protective Agents|protective agents|mesh-ancestor
2602482|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602483|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2602484|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
2602485|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602486|NCT01775397|Vancomycin|vancomycin|mesh-list
2602487|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
2602488|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2602489|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602490|NCT01775475|Prednisone|prednisone|mesh-list
2602491|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
2602492|NCT01775475|Lomustine|lomustine|mesh-list
2602493|NCT01775475|Doxorubicin|doxorubicin|mesh-list
2602494|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2602495|NCT01775475|Etoposide|etoposide|mesh-list
2602496|NCT01775475|Vincristine|vincristine|mesh-list
2602497|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
2602498|NCT01775475|Procarbazine|procarbazine|mesh-list
2602499|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2602500|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
2602501|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602502|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2602503|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2602504|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
2602505|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602506|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602507|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2602508|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2602509|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2602510|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2602511|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602512|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2602513|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
2602514|NCT01775475|Hormones|hormones|mesh-ancestor
2602515|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2602516|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2602517|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2151416|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2151417|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2421247|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421248|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
2421249|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
2421250|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
2421251|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421252|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2421253|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2421254|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2421255|NCT00811993|Growth Substances|growth substances|mesh-ancestor
2421256|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421257|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
2421258|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2421259|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
2421260|NCT00811993|Antiviral Agents|antiviral agents|mesh-ancestor
2421261|NCT00811993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421262|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421263|NCT00811993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2421264|NCT00811993|Immunologic Factors|immunologic factors|mesh-ancestor
2151418|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2151419|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2151420|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2151421|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2151422|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2151423|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
2151424|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602518|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
2602519|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
2602520|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
2602521|NCT01775540|Dexamethasone|dexamethasone|mesh-list
2602522|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
2602523|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2151425|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151426|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151427|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
2151428|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
2151429|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
2151430|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151431|NCT03792672|Ketamine|ketamine|mesh-list
2151432|NCT03792672|Analgesics|analgesics|mesh-ancestor
2151433|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
2602524|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
2602525|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
2602526|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602527|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602528|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2602529|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
2602530|NCT01775540|Hormones|hormones|mesh-ancestor
2602531|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2602532|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2602533|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602534|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2602535|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2602536|NCT01775579|Metformin|metformin|mesh-list
2151434|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151435|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151436|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2151437|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2151438|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
2151439|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
2151440|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151441|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2151442|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2151443|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151444|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151445|NCT03792191|Fentanyl|fentanyl|mesh-list
2151446|NCT03792191|Bupivacaine|bupivacaine|mesh-list
2151447|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
2151448|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
2151449|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151450|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151451|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
2151452|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151453|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2151454|NCT03792191|Narcotics|narcotics|mesh-ancestor
2151455|NCT03792191|Analgesics|analgesics|mesh-ancestor
2151456|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2151457|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2151458|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
2151459|NCT03789175|Niacinamide|niacinamide|mesh-list
2151460|NCT03789175|Niacin|niacin|mesh-list
2151461|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
2151462|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
2151463|NCT03789175|Vitamins|vitamins|mesh-ancestor
2151464|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
2151465|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151466|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2151467|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
2151468|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151469|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2602537|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2602538|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2602539|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602540|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2602541|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2602542|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
2602543|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602544|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2602545|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2602546|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602547|NCT01775618|Factor VIII|factor viii|mesh-list
2602548|NCT01775618|Coagulants|coagulants|mesh-ancestor
2602549|NCT01775631|Rituximab|rituximab|mesh-list
2602550|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2602551|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602552|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
2602553|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602554|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2602555|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
2602556|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2602557|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602558|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2602559|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2602560|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602561|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602562|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602566|NCT01775839|Aspirin|aspirin|mesh-list
2151470|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
2151471|NCT03783702|Acetaminophen|acetaminophen|mesh-list
2151472|NCT03783702|Ibuprofen|ibuprofen|mesh-list
2602567|NCT01775839|Digoxin|digoxin|mesh-list
2602568|NCT01775839|Clopidogrel|clopidogrel|mesh-list
2602569|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2602570|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2602571|NCT01775839|Analgesics|analgesics|mesh-ancestor
2602572|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
2602573|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151473|NCT03783702|Oxycodone|oxycodone|mesh-list
2602574|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602575|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2602576|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2602577|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2602578|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2602579|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602580|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2602581|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2602582|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151474|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2151475|NCT03783702|Analgesics|analgesics|mesh-ancestor
2151476|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
2151477|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151478|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151479|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
2151480|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2151481|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2151482|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2151483|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2602583|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
2602584|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2602585|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2602586|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2602587|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
2602588|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602589|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2602590|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2602591|NCT01775839|Protective Agents|protective agents|mesh-ancestor
2602592|NCT01775891|Flecainide|flecainide|mesh-list
2602593|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2151484|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151485|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151486|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2151487|NCT03783702|Narcotics|narcotics|mesh-ancestor
2151488|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151489|NCT03781479|Amifampridine|amifampridine|mesh-list
2151490|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2151491|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151492|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151493|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2151494|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2151495|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151496|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
2151497|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
2151498|NCT03783039|Coagulants|coagulants|mesh-ancestor
2151499|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2151500|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
2151501|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2151502|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
2151503|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151504|NCT03783130|Antacids|antacids|mesh-ancestor
2151505|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151506|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2602594|NCT01775891|Propafenone|propafenone|mesh-list
2602595|NCT01775891|Pilsicainide|pilsicainide|mesh-list
2602596|NCT01775891|Lidocaine|lidocaine|mesh-list
2602597|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2602598|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2602599|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2602600|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602601|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
2602602|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
2602603|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2602604|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602605|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
2602606|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602607|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
2602608|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2602609|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2602610|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
2602611|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2602612|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2602613|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2602614|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
2151507|NCT03773796|Nabilone|nabilone|mesh-list
2151508|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
2151509|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
2151510|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151511|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151512|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151513|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2151514|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2151515|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151516|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2151517|NCT03782233|Bromides|bromides|mesh-list
2151518|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2151519|NCT03782233|Rocuronium|rocuronium|mesh-list
2602615|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2602616|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602617|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2602618|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2602619|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2602620|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2602621|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602622|NCT01776320|Alprostadil|alprostadil|mesh-list
2602623|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2602624|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
2602625|NCT01776320|Urological Agents|urological agents|mesh-ancestor
2602626|NCT01776437|Talazoparib|talazoparib|mesh-list
2602627|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2602628|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602629|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602630|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602631|NCT01776515|Acetaminophen|acetaminophen|mesh-list
2602632|NCT01776515|Tramadol|tramadol|mesh-list
2151520|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
2151521|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2151522|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2151523|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2151524|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151525|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151526|NCT03781375|Etanercept|etanercept|mesh-list
2151527|NCT03781375|Methotrexate|methotrexate|mesh-list
2151528|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2151529|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
2602633|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2602634|NCT01776515|Analgesics|analgesics|mesh-ancestor
2602635|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
2602636|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602637|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602638|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
2602639|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2151530|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2151531|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151532|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2151533|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
2151534|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151535|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602640|NCT01776515|Narcotics|narcotics|mesh-ancestor
2602641|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2602642|NCT01776567|Everolimus|everolimus|mesh-list
2602643|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602644|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2602645|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
2602646|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602647|NCT01776606|Botulinum Toxins|botulinum toxins|mesh-list
2602648|NCT01776606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2602649|NCT01776606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2602650|NCT01776606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2602651|NCT01776606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2602652|NCT01776606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602653|NCT01776606|Cholinergic Agents|cholinergic agents|mesh-ancestor
2602654|NCT01776606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602655|NCT01776606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151536|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
2151537|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151538|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2151539|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2151540|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
2602656|NCT01776606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2602657|NCT01776606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602658|NCT01776671|Gabapentin|gabapentin|mesh-list
2602659|NCT01776671|Analgesics|analgesics|mesh-ancestor
2602660|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
2602661|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602662|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602663|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
2602664|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2602665|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2602666|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2602667|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2602668|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2602669|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2602670|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602671|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602672|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
2602673|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2602674|NCT01776684|Gefitinib|gefitinib|mesh-list
2602675|NCT01776684|Afatinib|afatinib|mesh-list
2602676|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602677|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2602678|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602679|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151541|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2151542|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2151543|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2151544|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2151545|NCT03781375|Analgesics|analgesics|mesh-ancestor
2151546|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
2151547|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602680|NCT01776788|Insulin|insulin|mesh-list
2602681|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2602682|NCT01776788|Exenatide|exenatide|mesh-list
2602683|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
2602684|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2602685|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602686|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2602687|NCT01776788|Incretins|incretins|mesh-ancestor
2602688|NCT01776788|Hormones|hormones|mesh-ancestor
2602689|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2602700|NCT01776853|Levan|levan|mesh-list
2602701|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602702|NCT01776970|Nabiximols|nabiximols|mesh-list
2602703|NCT01776970|Analgesics|analgesics|mesh-ancestor
2602704|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
2602705|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602706|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602707|NCT01777087|Capsaicin|capsaicin|mesh-list
2602708|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
2602709|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
2602710|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
2602711|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602712|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602713|NCT01777100|Sufentanil|sufentanil|mesh-list
2602714|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2151548|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2151549|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151550|NCT03780010|Paclitaxel|paclitaxel|mesh-list
2602715|NCT01777100|Narcotics|narcotics|mesh-ancestor
2602716|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2602717|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602718|NCT01777100|Analgesics|analgesics|mesh-ancestor
2602719|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
2602720|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602721|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2602722|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2151551|NCT03780010|Carboplatin|carboplatin|mesh-list
2151552|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2151553|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151554|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
2151555|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
2151556|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
2151557|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151558|NCT03774576|Itraconazole|itraconazole|mesh-list
2602723|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
2602724|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
2602725|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2602726|NCT01777464|Histamine|histamine|mesh-list
2602727|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
2602728|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
2151559|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
2151560|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151561|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2151562|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2151563|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151564|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151565|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2602729|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602730|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602731|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151566|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
2151567|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151568|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151569|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2151570|NCT03772041|Tolvaptan|tolvaptan|mesh-list
2151571|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2151572|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151573|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
2151574|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151575|NCT03774745|Mifepristone|mifepristone|mesh-list
2602732|NCT01777477|Gemcitabine|gemcitabine|mesh-list
2602733|NCT01777477|Chloroquine|chloroquine|mesh-list
2602734|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2602735|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
2602736|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602737|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602738|NCT01777477|Antiviral Agents|antiviral agents|mesh-ancestor
2602739|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602740|NCT01777477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602741|NCT01777477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2602742|NCT01777477|Immunologic Factors|immunologic factors|mesh-ancestor
2602743|NCT01777477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602744|NCT01777477|Amebicides|amebicides|mesh-ancestor
2602745|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2602746|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2602747|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
2151576|NCT03774745|Progesterone|progesterone|mesh-list
2151577|NCT03774745|Progestins|progestins|mesh-ancestor
2151578|NCT03774745|Hormones|hormones|mesh-ancestor
2151579|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151580|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151581|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2151582|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
2151583|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2151584|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2151585|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2151586|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2151587|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
2602748|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2602749|NCT01777503|Clopidogrel|clopidogrel|mesh-list
2602750|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2602751|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2602752|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2602753|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2602754|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2602755|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
2602756|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602757|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151588|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2151589|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2151590|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
2151591|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
2151592|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2151593|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2151594|NCT03771560|Leucovorin|leucovorin|mesh-list
2151595|NCT03771560|Folic Acid|folic acid|mesh-list
2151596|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
2151597|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151598|NCT03771560|Antidotes|antidotes|mesh-ancestor
2602758|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602759|NCT01777555|Levodopa|levodopa|mesh-list
2602760|NCT01777555|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2602761|NCT01777555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2602762|NCT01777555|Dopamine Agents|dopamine agents|mesh-ancestor
2602763|NCT01777555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602764|NCT01777555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602765|NCT01777555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602766|NCT01777685|Sulpiride|sulpiride|mesh-list
2602767|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2602768|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2602769|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2602770|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602771|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2602772|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2602773|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
2602774|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602775|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602776|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2602777|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
2602778|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2602779|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2602780|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602781|NCT01777737|Renal Agents|renal agents|mesh-ancestor
2602782|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2602783|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
2602784|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2602785|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2602786|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
2602787|NCT01777867|Miotics|miotics|mesh-ancestor
2602788|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
2151599|NCT03771560|Protective Agents|protective agents|mesh-ancestor
2151600|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
2151601|NCT03771560|Vitamins|vitamins|mesh-ancestor
2151602|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
2151603|NCT03771560|Hematinics|hematinics|mesh-ancestor
2151604|NCT03770091|Allantoin|allantoin|mesh-list
2151605|NCT03770091|Dermatologic Agents|dermatologic agents|mesh-ancestor
2151606|NCT03769896|Nabilone|nabilone|mesh-list
2151607|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
2151608|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
2151609|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151610|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151611|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2602789|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602790|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602791|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2602792|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2602793|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
2602794|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2151612|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2151613|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2151614|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151615|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2151616|NCT03768726|Ziprasidone|ziprasidone|mesh-list
2151617|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2151618|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
2151619|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151620|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151621|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151622|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2151623|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2151624|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151625|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2151626|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2151627|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
2602795|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2602796|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
2602797|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602798|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602799|NCT01777919|Copper|copper|mesh-list
2602800|NCT01777919|Temozolomide|temozolomide|mesh-list
2602801|NCT01777919|Disulfiram|disulfiram|mesh-list
2602802|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2602803|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
2602804|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602805|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602806|NCT01777919|Trace Elements|trace elements|mesh-ancestor
2602807|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
2602808|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602809|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2602810|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2602811|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602812|NCT01778075|Acetaminophen|acetaminophen|mesh-list
2602813|NCT01778075|Tramadol|tramadol|mesh-list
2602814|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2602815|NCT01778075|Analgesics|analgesics|mesh-ancestor
2602816|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
2602817|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602818|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602819|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
2602820|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2602821|NCT01778075|Narcotics|narcotics|mesh-ancestor
2602822|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2602823|NCT01778101|Lansoprazole|lansoprazole|mesh-list
2151628|NCT03767738|Aflibercept|aflibercept|mesh-list
2151629|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2151630|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2151631|NCT03767738|Growth Substances|growth substances|mesh-ancestor
2151632|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151633|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
2602824|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
2602825|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2602826|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2602827|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2602828|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602829|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602830|NCT01778114|Vitamin D|vitamin d|mesh-list
2602831|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
2151634|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151635|NCT03767062|Topiramate|topiramate|mesh-list
2151636|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
2151637|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2151638|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151639|NCT03765502|Glucagon|glucagon|mesh-list
2151640|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2151641|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151642|NCT03765502|Hormones|hormones|mesh-ancestor
2151643|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151644|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151645|NCT03765502|Incretins|incretins|mesh-ancestor
2151646|NCT03765138|Pramipexole|pramipexole|mesh-list
2151647|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
2151648|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151649|NCT03765138|Protective Agents|protective agents|mesh-ancestor
2151650|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151651|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2151652|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2151653|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
2151654|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
2151655|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151656|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
2151657|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
2151658|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151659|NCT03763929|Protective Agents|protective agents|mesh-ancestor
2151660|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151661|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2151662|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151663|NCT03763175|Lovastatin|lovastatin|mesh-list
2151664|NCT03763175|L 647318|l 647318|mesh-list
2151665|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
2151666|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2151667|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2151668|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
2602832|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
2602833|NCT01778114|Vitamins|vitamins|mesh-list
2602834|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
2602835|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602836|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2602837|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2602838|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
2602839|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
2602840|NCT01778192|Citric Acid|citric acid|mesh-list
2151669|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151670|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2151671|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2151672|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151673|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
2151674|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2602841|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
2602842|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
2602843|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2602844|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
2602845|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
2602846|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602847|NCT01778192|Cathartics|cathartics|mesh-ancestor
2602848|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2602849|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
2602850|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
2602851|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602852|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
2602853|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602854|NCT01778244|Metformin|metformin|mesh-list
2602855|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2602856|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602857|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
2602858|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2602859|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
2602860|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2602861|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
2602862|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602863|NCT01778309|Expectorants|expectorants|mesh-ancestor
2602864|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
2602865|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2602866|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
2602867|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602868|NCT01778309|Protective Agents|protective agents|mesh-ancestor
2602869|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602870|NCT01778309|Antidotes|antidotes|mesh-ancestor
2602871|NCT01778400|Ethanol|ethanol|mesh-list
2602872|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2602873|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602874|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2602875|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602876|NCT01778413|Tenofovir|tenofovir|mesh-list
2602877|NCT01778413|Emtricitabine|emtricitabine|mesh-list
2602878|NCT01778413|Efavirenz|efavirenz|mesh-list
2602879|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2602880|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
2602881|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602882|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2602883|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2602884|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602885|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602886|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2602887|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2602888|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2602889|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2602890|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2602891|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2602892|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2602893|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2602894|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
2602895|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602896|NCT01778686|Pindolol|pindolol|mesh-list
2602897|NCT01778686|Citalopram|citalopram|mesh-list
2602898|NCT01778686|Tryptophan|tryptophan|mesh-list
2602899|NCT01778686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2602900|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2151675|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151676|NCT03760250|Imiquimod|imiquimod|mesh-list
2151677|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2151678|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
2151679|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151680|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151681|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
2151682|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
2151683|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2151684|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151685|NCT03759600|Niraparib|niraparib|mesh-list
2602901|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2602902|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602903|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602904|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
2602905|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602906|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2602907|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
2602908|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2602909|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2602910|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2602911|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
2602912|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2602913|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2602914|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
2602915|NCT01778803|Paclitaxel|paclitaxel|mesh-list
2602916|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2602917|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602918|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
2602919|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
2602920|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
2602921|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602922|NCT01778842|Clopidogrel|clopidogrel|mesh-list
2602923|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2602924|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2602925|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2602926|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2602927|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2602928|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
2602929|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602930|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151686|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2151687|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151688|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151689|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151690|NCT03759587|Niraparib|niraparib|mesh-list
2151691|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2151692|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151693|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151694|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151695|NCT03758365|Triamcinolone|triamcinolone|mesh-list
2602931|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602932|NCT01778946|Nicotine|nicotine|mesh-list
2602933|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2602934|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
2602935|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2602936|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602937|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2602938|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2602939|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
2602940|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2602941|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602942|NCT01779050|Paclitaxel|paclitaxel|mesh-list
2602943|NCT01779050|Docetaxel|docetaxel|mesh-list
2602944|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
2602945|NCT01779050|Carboplatin|carboplatin|mesh-list
2602946|NCT01779050|Doxorubicin|doxorubicin|mesh-list
2602947|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2602948|NCT01779050|Fluorouracil|fluorouracil|mesh-list
2602949|NCT01779050|Trastuzumab|trastuzumab|mesh-list
2602950|NCT01779050|Epirubicin|epirubicin|mesh-list
2602951|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2602952|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602953|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
2602954|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
2151696|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2151697|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2151698|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
2602955|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
2602956|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602957|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2602958|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
2602959|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602960|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2602961|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2602962|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
2602963|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2602964|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2602965|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2602966|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2602967|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602968|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
2602969|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2602970|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2602971|NCT01779089|Minocycline|minocycline|mesh-list
2602972|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2602973|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2602974|NCT01779206|Paclitaxel|paclitaxel|mesh-list
2602975|NCT01779206|Docetaxel|docetaxel|mesh-list
2602976|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
2602977|NCT01779206|Epirubicin|epirubicin|mesh-list
2602978|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2602979|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2602980|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
2602981|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
2602982|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
2602983|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2602984|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2602985|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
2602986|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2602987|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2602988|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2602989|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
2602990|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2602991|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2602992|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2602993|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2602994|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2602995|NCT01779232|Danazol|danazol|mesh-list
2602996|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2602997|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
2602998|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2602999|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603000|NCT01779245|Calcium|calcium|mesh-list
2603001|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2603002|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603003|NCT01779258|Desonide|desonide|mesh-list
2603004|NCT01779258|Glycerol|glycerol|mesh-list
2603005|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2603006|NCT01779258|Protective Agents|protective agents|mesh-ancestor
2603007|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603008|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2603009|NCT01779271|Loxoprofen|loxoprofen|mesh-list
2603010|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2603011|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2603012|NCT01779271|Analgesics|analgesics|mesh-ancestor
2603013|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
2603014|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603015|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151699|NCT03758365|Betamethasone|betamethasone|mesh-list
2151700|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
2151701|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2603016|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2603017|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2603018|NCT01779284|Timolol|timolol|mesh-list
2603019|NCT01779284|Travoprost|travoprost|mesh-list
2603020|NCT01779284|Latanoprost|latanoprost|mesh-list
2603021|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2603022|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2603023|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
2151702|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
2603024|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603025|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603026|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603027|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2603028|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2603029|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2603030|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2603031|NCT01779362|Metformin|metformin|mesh-list
2603032|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
2603033|NCT01779362|Liraglutide|liraglutide|mesh-list
2603034|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2603035|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603036|NCT01779362|Incretins|incretins|mesh-ancestor
2603037|NCT01779362|Hormones|hormones|mesh-ancestor
2603038|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2603039|NCT01779401|Aspirin|aspirin|mesh-list
2603040|NCT01779401|Cilostazol|cilostazol|mesh-list
2603041|NCT01779401|Clopidogrel|clopidogrel|mesh-list
2603042|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2603043|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2603044|NCT01779401|Analgesics|analgesics|mesh-ancestor
2603045|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
2603046|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603047|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603048|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2603049|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2603050|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2421265|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2421266|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2421267|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2421268|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2603051|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2603052|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603053|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2151703|NCT03758365|Clobetasol|clobetasol|mesh-list
2151704|NCT03758365|Desonide|desonide|mesh-list
2151705|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
2151706|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2151707|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2151708|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2151709|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
2151710|NCT03758365|Hormones|hormones|mesh-ancestor
2151711|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151712|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151713|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2151714|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
2151715|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151716|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151717|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2151718|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
2151719|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
2151720|NCT03757234|Levofloxacin|levofloxacin|mesh-list
2603054|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2603055|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603056|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
2603057|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2603058|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2603059|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2603060|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
2603061|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603062|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2603063|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
2603064|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2603065|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
2603066|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
2603067|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2603068|NCT01779401|Protective Agents|protective agents|mesh-ancestor
2151721|NCT03757234|Ofloxacin|ofloxacin|mesh-list
2421269|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2421270|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
2421271|NCT00812019|Vaccines|vaccines|mesh-list
2421272|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
2421273|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
2421274|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421275|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2603069|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2603070|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2603071|NCT01779453|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2603072|NCT01779453|Atorvastatin|atorvastatin|mesh-list
2603073|NCT01779453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2603074|NCT01779453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2603075|NCT01779453|Antimetabolites|antimetabolites|mesh-ancestor
2603076|NCT01779453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151722|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2151723|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151724|NCT03757234|Renal Agents|renal agents|mesh-ancestor
2151725|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2151726|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2151727|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2151728|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603077|NCT01779453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2603078|NCT01779453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2603079|NCT01779453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603080|NCT01779453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2603081|NCT01779453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151729|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151730|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151731|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2151732|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2151733|NCT03756883|Fluticasone|fluticasone|mesh-list
2151734|NCT03756883|Xhance|xhance|mesh-list
2151735|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2151736|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2151737|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2151738|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2151739|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
2151740|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151741|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151742|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2151743|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
2151744|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
2151745|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2151746|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2151747|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2151748|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2151749|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
2151750|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151751|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151752|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
2151753|NCT03756883|Hormones|hormones|mesh-ancestor
2151754|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151755|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
2151756|NCT03756129|Ketamine|ketamine|mesh-list
2151757|NCT03756129|Analgesics|analgesics|mesh-ancestor
2151758|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
2151759|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151760|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151761|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2603082|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2603083|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
2603084|NCT01779466|Coagulants|coagulants|mesh-ancestor
2603085|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2603086|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
2603087|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603088|NCT01779479|Paclitaxel|paclitaxel|mesh-list
2603089|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2603090|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603091|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
2603092|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
2603093|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
2603094|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603095|NCT01779492|Oxycodone|oxycodone|mesh-list
2603096|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2603097|NCT01779492|Narcotics|narcotics|mesh-ancestor
2603098|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2603099|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603100|NCT01779492|Analgesics|analgesics|mesh-ancestor
2603101|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
2151762|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2151763|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
2151764|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
2151765|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151766|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2151767|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2151768|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151769|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603102|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603103|NCT01779518|Interferons|interferons|mesh-list
2603104|NCT01779518|Ribavirin|ribavirin|mesh-list
2603105|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
2603106|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603107|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
2603108|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603109|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
2603110|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603111|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
2603112|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2603113|NCT01779596|Bosentan|bosentan|mesh-list
2603114|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2603115|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2603116|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603117|NCT01779609|Bosentan|bosentan|mesh-list
2603118|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2603119|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2603120|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603121|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
2603122|NCT01779687|Atorvastatin|atorvastatin|mesh-list
2603123|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2603124|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2603125|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
2603126|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603127|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2603128|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2603129|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603130|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2603131|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2151770|NCT03756038|Lorazepam|lorazepam|mesh-list
2151771|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
2151772|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
2151773|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
2151774|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151775|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151776|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151777|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2151778|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151779|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2151780|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2151781|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2151782|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
2151783|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
2151784|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151785|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151786|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
2151787|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2151788|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
2151789|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2151790|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151791|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2151792|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2603132|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
2603133|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603134|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2603135|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2603136|NCT01779830|Zolpidem|zolpidem|mesh-list
2603137|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2603138|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2603139|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2603140|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603141|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2603142|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
2603143|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
2603144|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603145|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603146|NCT01779843|Cytarabine|cytarabine|mesh-list
2603147|NCT01779843|Idarubicin|idarubicin|mesh-list
2603148|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2603149|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
2603150|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603151|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603152|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
2603153|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603154|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2603155|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
2603156|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603157|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2603158|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2603159|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2603160|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603161|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
2603162|NCT01779882|Busulfan|busulfan|mesh-list
2603163|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2603164|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
2603165|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603166|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2603167|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2603168|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
2603169|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603170|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603171|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2603172|NCT01779908|Vitamin D|vitamin d|mesh-list
2603173|NCT01779908|Vitamins|vitamins|mesh-ancestor
2603174|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
2603175|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603176|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2603177|NCT01779921|Thrombin|thrombin|mesh-list
2603178|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
2603179|NCT01779921|Coagulants|coagulants|mesh-ancestor
2603180|NCT01779947|Estradiol|estradiol|mesh-list
2603181|NCT01779947|Estrogens|estrogens|mesh-ancestor
2603182|NCT01779947|Hormones|hormones|mesh-ancestor
2603183|NCT01779947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2603184|NCT01779947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603185|NCT01780051|Metformin|metformin|mesh-list
2603186|NCT01780051|Repaglinide|repaglinide|mesh-list
2603187|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2603188|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603189|NCT01780181|Gemcitabine|gemcitabine|mesh-list
2603190|NCT01780181|Docetaxel|docetaxel|mesh-list
2603191|NCT01780181|Vinorelbine|vinorelbine|mesh-list
2603192|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2603193|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
2603194|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603195|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603196|NCT01780181|Antiviral Agents|antiviral agents|mesh-ancestor
2603197|NCT01780181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603198|NCT01780181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603199|NCT01780181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2603200|NCT01780181|Immunologic Factors|immunologic factors|mesh-ancestor
2603201|NCT01780181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151793|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2151794|NCT03753113|Minoxidil|minoxidil|mesh-list
2151795|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2151796|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
2151797|NCT03751657|Insulin|insulin|mesh-list
2151798|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2151799|NCT03751657|Metformin|metformin|mesh-list
2151800|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
2151801|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2151802|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2151803|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151804|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
2151805|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151806|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603202|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
2603203|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
2151807|NCT03747497|Linezolid|linezolid|mesh-list
2151808|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2603204|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
2603205|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2603206|NCT01780233|Fentanyl|fentanyl|mesh-list
2151809|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151810|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2151811|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151812|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151813|NCT03743038|Minocycline|minocycline|mesh-list
2151814|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2151815|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151816|NCT03742154|Varenicline|varenicline|mesh-list
2603207|NCT01780233|Naltrexone|naltrexone|mesh-list
2603208|NCT01780233|Citric Acid|citric acid|mesh-list
2603209|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
2603210|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2603211|NCT01780233|Narcotics|narcotics|mesh-ancestor
2603212|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2603213|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603214|NCT01780233|Analgesics|analgesics|mesh-ancestor
2603215|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
2603216|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603217|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2603218|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2603219|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
2151817|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2151818|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2151819|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
2151820|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151821|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151822|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151823|NCT03740659|Levofloxacin|levofloxacin|mesh-list
2151824|NCT03740659|Ofloxacin|ofloxacin|mesh-list
2151825|NCT03740659|Dexamethasone|dexamethasone|mesh-list
2151826|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
2151827|NCT03740659|BB 1101|bb 1101|mesh-list
2151828|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2151829|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
2151830|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
2151831|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151832|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151833|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151834|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
2151835|NCT03740659|Hormones|hormones|mesh-ancestor
2151836|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151837|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2151838|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151839|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
2151840|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151841|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151842|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2151843|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151844|NCT03740659|Renal Agents|renal agents|mesh-ancestor
2151845|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2151846|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2151847|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2151848|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2151849|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2603220|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
2603221|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
2603222|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2603223|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
2603224|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
2603225|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603226|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2603227|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2603228|NCT01780259|Triazolam|triazolam|mesh-list
2603229|NCT01780259|Esketamine|esketamine|mesh-list
2603230|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
2603231|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2603232|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2603233|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2603234|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2603235|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2603236|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603237|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
2603238|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
2603239|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603240|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603241|NCT01780311|Sotalol|sotalol|mesh-list
2603242|NCT01780311|Flecainide|flecainide|mesh-list
2603243|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2603244|NCT01780311|Propafenone|propafenone|mesh-list
2603245|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2603246|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2603247|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
2603248|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603249|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603250|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603251|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
2603252|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
2603253|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603254|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2603255|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2603256|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2603257|NCT01780428|Acetaminophen|acetaminophen|mesh-list
2603258|NCT01780428|Promethazine|promethazine|mesh-list
2603259|NCT01780428|Diphenhydramine|diphenhydramine|mesh-list
2603260|NCT01780428|Hydrocodone|hydrocodone|mesh-list
2603261|NCT01780428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2603262|NCT01780428|Analgesics|analgesics|mesh-ancestor
2603263|NCT01780428|Sensory System Agents|sensory system agents|mesh-ancestor
2603264|NCT01780428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151867|NCT03739528|Levofloxacin|levofloxacin|mesh-list
2151868|NCT03739528|Ofloxacin|ofloxacin|mesh-list
2151869|NCT03739528|Tobramycin|tobramycin|mesh-list
2151870|NCT03739528|Dexamethasone|dexamethasone|mesh-list
2151871|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
2603265|NCT01780428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603266|NCT01780428|Antipyretics|antipyretics|mesh-ancestor
2603267|NCT01780428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2603268|NCT01780428|Narcotics|narcotics|mesh-ancestor
2603269|NCT01780428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2603270|NCT01780428|Antitussive Agents|antitussive agents|mesh-ancestor
2603271|NCT01780428|Respiratory System Agents|respiratory system agents|mesh-ancestor
2603272|NCT01780428|Antipruritics|antipruritics|mesh-ancestor
2603273|NCT01780428|Dermatologic Agents|dermatologic agents|mesh-ancestor
2603274|NCT01780428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2603275|NCT01780428|Histamine Antagonists|histamine antagonists|mesh-ancestor
2603276|NCT01780428|Histamine Agents|histamine agents|mesh-ancestor
2603277|NCT01780428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603278|NCT01780428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603279|NCT01780428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2603280|NCT01780428|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2603281|NCT01780428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2603282|NCT01780428|Anesthetics, Local|anesthetics, local|mesh-ancestor
2603283|NCT01780428|Anesthetics|anesthetics|mesh-ancestor
2603284|NCT01780428|Antiemetics|antiemetics|mesh-ancestor
2603285|NCT01780428|Autonomic Agents|autonomic agents|mesh-ancestor
2421276|NCT00812032|Aspirin|aspirin|mesh-list
2421277|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2421278|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2421279|NCT00812032|Analgesics|analgesics|mesh-ancestor
2421280|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
2421281|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151872|NCT03739528|BB 1101|bb 1101|mesh-list
2421282|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421283|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2421284|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421285|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2421286|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2151873|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2151874|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
2151875|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
2151876|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151877|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151878|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151879|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
2151880|NCT03739528|Hormones|hormones|mesh-ancestor
2151881|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151882|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2151883|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151884|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
2603286|NCT01780428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2603287|NCT01780467|Dopamine|dopamine|mesh-list
2603288|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2603289|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
2603290|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
2603291|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603292|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603293|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
2603294|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603295|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603296|NCT01780467|Protective Agents|protective agents|mesh-ancestor
2603297|NCT01780519|Lorazepam|lorazepam|mesh-list
2603298|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
2603299|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
2603300|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
2603301|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603302|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603303|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2603304|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2603305|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2603306|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2603307|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2603308|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2603309|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
2603310|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
2603311|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603312|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603313|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2603314|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2603315|NCT01780558|Hormones|hormones|mesh-list
2603316|NCT01780558|Estradiol|estradiol|mesh-list
2603317|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2603318|NCT01780558|Progesterone|progesterone|mesh-list
2603319|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151885|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151886|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151887|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2151888|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151889|NCT03739528|Renal Agents|renal agents|mesh-ancestor
2151890|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2151891|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2151892|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2151893|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2151894|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2151895|NCT03738865|Glucagon|glucagon|mesh-list
2151896|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2151897|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2151898|NCT03738865|Hormones|hormones|mesh-ancestor
2603320|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603321|NCT01780558|Estrogens|estrogens|mesh-ancestor
2603322|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2603323|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
2603324|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2603325|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2603326|NCT01780558|Progestins|progestins|mesh-ancestor
2603327|NCT01780610|Letrozole|letrozole|mesh-list
2603328|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2603329|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2603330|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2603331|NCT01780610|Hormones|hormones|mesh-list
2603332|NCT01780610|Estradiol|estradiol|mesh-list
2603333|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2603334|NCT01780610|Progesterone|progesterone|mesh-list
2603335|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151899|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2151900|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151901|NCT03738865|Incretins|incretins|mesh-ancestor
2151902|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2151903|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2151904|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2151905|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2151906|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151907|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
2151908|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151909|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603336|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603337|NCT01780610|Estrogens|estrogens|mesh-ancestor
2603338|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2603339|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
2603340|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2603341|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2603342|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603343|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2603344|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2603345|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603346|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603347|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2603348|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
2603349|NCT01780610|Progestins|progestins|mesh-ancestor
2603350|NCT01780740|Atorvastatin|atorvastatin|mesh-list
2603351|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2603352|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2603353|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
2603354|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603355|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2603356|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2603357|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603358|NCT01780753|Primaquine|primaquine|mesh-list
2603359|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
2603360|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2603361|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2603362|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603363|NCT01780844|Mycophenolic Acid|mycophenolic acid|mesh-list
2603364|NCT01780844|Prednisone|prednisone|mesh-list
2603365|NCT01780844|Tacrolimus|tacrolimus|mesh-list
2603366|NCT01780844|Basiliximab|basiliximab|mesh-list
2603367|NCT01780844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2603368|NCT01780844|Glucocorticoids|glucocorticoids|mesh-ancestor
2603369|NCT01780844|Hormones|hormones|mesh-ancestor
2603370|NCT01780844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2603371|NCT01780844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603372|NCT01780844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2603373|NCT01780844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603374|NCT01780844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2603375|NCT01780844|Immunologic Factors|immunologic factors|mesh-ancestor
2603376|NCT01780844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2603377|NCT01780844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603378|NCT01780844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603379|NCT01780844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2603380|NCT01780844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2603381|NCT01780844|Antitubercular Agents|antitubercular agents|mesh-ancestor
2603382|NCT01780844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2603383|NCT01780844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603384|NCT01780883|Melatonin|melatonin|mesh-list
2603385|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
2603386|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603387|NCT01780883|Protective Agents|protective agents|mesh-ancestor
2603388|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603389|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2603390|NCT01780909|Paromomycin|paromomycin|mesh-list
2603391|NCT01780909|Domperidone|domperidone|mesh-list
2603392|NCT01780909|Loperamide|loperamide|mesh-list
2603393|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
2603394|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
2603395|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
2603396|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603397|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603398|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2603399|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2603400|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
2603401|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603402|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603403|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2603404|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603405|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2603406|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2603407|NCT01780948|Everolimus|everolimus|mesh-list
2603408|NCT01780948|Atorvastatin|atorvastatin|mesh-list
2603409|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2603410|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2603411|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
2603412|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603413|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2603414|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2603415|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603416|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603417|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2603418|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
2603419|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603420|NCT01781052|Iloprost|iloprost|mesh-list
2603421|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2603422|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
2603423|NCT01781273|Ethanol|ethanol|mesh-list
2603424|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2603425|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603426|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2603427|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603428|NCT01781377|Metoclopramide|metoclopramide|mesh-list
2603429|NCT01781377|Propofol|propofol|mesh-list
2603430|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2603431|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2603432|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151910|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2151911|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151912|NCT03736785|Insulin|insulin|mesh-list
2151913|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2151914|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151915|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
2151916|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
2151917|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151918|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
2151919|NCT03734601|Tacrolimus|tacrolimus|mesh-list
2151920|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2151921|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2151922|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
2151923|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151924|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2151925|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151926|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151927|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2151928|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151929|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2151930|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
2151931|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2151932|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151933|NCT03733899|Anesthetics|anesthetics|mesh-list
2151934|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2151935|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151936|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
2151937|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
2151938|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2151939|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2151940|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603433|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2603434|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
2603435|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
2603436|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
2603437|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
2603438|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603439|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2603440|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2603441|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2603442|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
2603443|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603444|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603445|NCT01781442|Sirolimus|sirolimus|mesh-list
2603446|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2603447|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603448|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2603449|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603450|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
2603451|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2151941|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151942|NCT03733470|Urological Agents|urological agents|mesh-ancestor
2151943|NCT03732248|Sirolimus|sirolimus|mesh-list
2151944|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2151945|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2151946|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2151947|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2151948|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
2151949|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2151950|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
2151951|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603452|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
2603453|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603454|NCT01781507|Cetirizine|cetirizine|mesh-list
2603455|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2603456|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2603457|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2603458|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
2603459|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
2603460|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603461|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603462|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603463|NCT01781663|Petrolatum|petrolatum|mesh-list
2603464|NCT01781663|Emollients|emollients|mesh-ancestor
2603465|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
2603466|NCT01781702|Celecoxib|celecoxib|mesh-list
2603467|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2603468|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2603469|NCT01781702|Analgesics|analgesics|mesh-ancestor
2603470|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
2603471|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603472|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603473|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2603474|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2603475|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2603476|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2603477|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603478|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603479|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2603480|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
2603481|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603482|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
2603483|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
2603484|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603485|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603486|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603487|NCT01781897|Mosapride|mosapride|mesh-list
2603488|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2603489|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2603490|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
2603491|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603492|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603493|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603494|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2603495|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2151952|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2151953|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
2151954|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151955|NCT03730961|Furosemide|furosemide|mesh-list
2151956|NCT03730961|Diuretics|diuretics|mesh-ancestor
2151957|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
2151958|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151959|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2151960|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2603496|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
2603497|NCT01781936|Hormones|hormones|mesh-ancestor
2151961|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151962|NCT03730116|Bisoprolol|bisoprolol|mesh-list
2151963|NCT03730116|Perindopril|perindopril|mesh-list
2151964|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2151965|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
2151966|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
2603498|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2603499|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603500|NCT01781988|Gemcitabine|gemcitabine|mesh-list
2603501|NCT01781988|Carboplatin|carboplatin|mesh-list
2603502|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603503|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2603504|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
2603505|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603506|NCT01781988|Antiviral Agents|antiviral agents|mesh-ancestor
2603507|NCT01781988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603508|NCT01781988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151967|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2151968|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151969|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2151970|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2151971|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2151972|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
2151973|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151974|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151975|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2151976|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
2151977|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151978|NCT03726996|Desipramine|desipramine|mesh-list
2151979|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2151980|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
2151981|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2603509|NCT01781988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2603510|NCT01781988|Immunologic Factors|immunologic factors|mesh-ancestor
2603511|NCT01781988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603512|NCT01782001|Vitamins|vitamins|mesh-list
2603513|NCT01782001|Vitamin A|vitamin a|mesh-list
2603514|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
2603515|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
2603516|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603517|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
2603518|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603519|NCT01782001|Protective Agents|protective agents|mesh-ancestor
2603520|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2603521|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603522|NCT01782261|Liraglutide|liraglutide|mesh-list
2603523|NCT01782261|Saxagliptin|saxagliptin|mesh-list
2603524|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2151982|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2151983|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2151984|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2151985|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2151986|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2151987|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
2151988|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2151989|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151990|NCT03725085|Guaifenesin|guaifenesin|mesh-list
2151991|NCT03725085|Expectorants|expectorants|mesh-ancestor
2151992|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
2151993|NCT03724981|Dulaglutide|dulaglutide|mesh-list
2151994|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2151995|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2151996|NCT03724968|Nivolumab|nivolumab|mesh-list
2151997|NCT03724968|Ipilimumab|ipilimumab|mesh-list
2151998|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2151999|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152000|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2152001|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603525|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603526|NCT01782261|Incretins|incretins|mesh-ancestor
2603527|NCT01782261|Hormones|hormones|mesh-ancestor
2603528|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2603529|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2603530|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
2603531|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603532|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603533|NCT01782274|Vaccines|vaccines|mesh-list
2603534|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
2603535|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603536|NCT01782287|Vaccines|vaccines|mesh-list
2603537|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
2603538|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603539|NCT01782300|Vaccines|vaccines|mesh-list
2603540|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
2603541|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603542|NCT01782352|Vitamin D|vitamin d|mesh-list
2603543|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
2603544|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
2603545|NCT01782352|Vitamins|vitamins|mesh-list
2603546|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
2603547|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603548|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2603549|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2603550|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
2603551|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2603552|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603553|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
2603554|NCT01782443|Aflibercept|aflibercept|mesh-list
2603555|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2603556|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2603557|NCT01782443|Growth Substances|growth substances|mesh-ancestor
2603558|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603559|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
2603560|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152002|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
2152003|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
2152004|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603561|NCT01782508|Interferons|interferons|mesh-list
2603562|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
2603563|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603564|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
2603565|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603566|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2603567|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603568|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603569|NCT01782560|Omeprazole|omeprazole|mesh-list
2603570|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2603571|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2603572|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2603573|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603574|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603575|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
2152005|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152006|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152007|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2152008|NCT03723980|Propolis|propolis|mesh-list
2152009|NCT03723980|Calcium|calcium|mesh-list
2152010|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2152011|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152012|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152013|NCT03723447|Dexamethasone|dexamethasone|mesh-list
2152014|NCT03723447|Epinephrine|epinephrine|mesh-list
2152015|NCT03723447|Bupivacaine|bupivacaine|mesh-list
2152016|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2152017|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
2152018|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
2152019|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152020|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152021|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2152022|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
2152023|NCT03723447|Hormones|hormones|mesh-ancestor
2152024|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2152025|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2603576|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2603577|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2603578|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603579|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
2603580|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
2603581|NCT01782599|Nicotine|nicotine|mesh-list
2603582|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2603583|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
2152026|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152027|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
2152028|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
2152029|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152030|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
2152031|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2152032|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2152033|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
2152034|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152035|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152036|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2152037|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2152038|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2603584|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603585|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603586|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2603587|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2603588|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
2603589|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603590|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603591|NCT01782612|Analgesics|analgesics|mesh-list
2603592|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
2152039|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
2152040|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
2152041|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
2152042|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2152043|NCT03718143|Adavosertib|adavosertib|mesh-list
2152044|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152045|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152046|NCT03709576|Azacitidine|azacitidine|mesh-list
2152047|NCT03709576|Pevonedistat|pevonedistat|mesh-list
2152048|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2152049|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
2152050|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152051|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152052|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152053|NCT03701295|Azacitidine|azacitidine|mesh-list
2152054|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2152055|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
2152056|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152057|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152058|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152059|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
2152060|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2152061|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2152062|NCT03694821|Prednisolone|prednisolone|mesh-list
2152063|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
2152064|NCT03694821|Ketorolac|ketorolac|mesh-list
2152065|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2152066|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2152067|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
2152068|NCT03694821|Hylan|hylan|mesh-list
2152069|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2152070|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
2152071|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
2152072|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152073|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152074|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2152075|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
2152076|NCT03694821|Hormones|hormones|mesh-ancestor
2152077|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2152078|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2152079|NCT03694821|Protective Agents|protective agents|mesh-ancestor
2152080|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2152081|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152082|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2152083|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2152084|NCT03694821|Analgesics|analgesics|mesh-ancestor
2603593|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603594|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603595|NCT01782651|Capecitabine|capecitabine|mesh-list
2603596|NCT01782651|Lapatinib|lapatinib|mesh-list
2603597|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2152085|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
2152086|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2152087|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2603598|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
2603599|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603600|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603601|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2603602|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603603|NCT01782729|Tacrolimus|tacrolimus|mesh-list
2603604|NCT01782729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2603605|NCT01782729|Immunologic Factors|immunologic factors|mesh-ancestor
2603606|NCT01782729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603607|NCT01782729|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2603608|NCT01782729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603609|NCT01782729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603610|NCT01782781|Epinephrine|epinephrine|mesh-list
2603611|NCT01782781|Ropivacaine|ropivacaine|mesh-list
2603612|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
2603613|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
2603614|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2603615|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603616|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
2152088|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152089|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152090|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
2152091|NCT03682367|Gabapentin|gabapentin|mesh-list
2603617|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603618|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2603619|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2603620|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
2603621|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603622|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603623|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2603624|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2603625|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
2603626|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2603627|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
2603628|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
2603629|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
2603630|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2603631|NCT01782846|Codeine|codeine|mesh-list
2603632|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2603633|NCT01782846|Narcotics|narcotics|mesh-ancestor
2603634|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2603635|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603636|NCT01782846|Analgesics|analgesics|mesh-ancestor
2603637|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
2603638|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603639|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
2603640|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
2603641|NCT01782911|Resveratrol|resveratrol|mesh-list
2603642|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
2603643|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603644|NCT01782911|Protective Agents|protective agents|mesh-ancestor
2603645|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603646|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603647|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2603648|NCT01782924|Brodalumab|brodalumab|mesh-list
2603649|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
2603650|NCT01782937|Brodalumab|brodalumab|mesh-list
2603651|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
2152092|NCT03682367|Analgesics|analgesics|mesh-ancestor
2152093|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
2152094|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152095|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152096|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
2152097|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2152098|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2152099|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152100|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2152101|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2152102|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2152103|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152104|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152105|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
2152106|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
2152107|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2603652|NCT01782950|Rifampin|rifampin|mesh-list
2603653|NCT01782950|Isoniazid|isoniazid|mesh-list
2603654|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
2603655|NCT01782950|Ethambutol|ethambutol|mesh-list
2603656|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2152108|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
2152109|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152110|NCT03680911|Expectorants|expectorants|mesh-ancestor
2152111|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
2152112|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2152113|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
2152114|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152115|NCT03680911|Protective Agents|protective agents|mesh-ancestor
2152116|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152117|NCT03680911|Antidotes|antidotes|mesh-ancestor
2152118|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2152119|NCT03656692|Hormones|hormones|mesh-ancestor
2152120|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2152121|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152122|NCT03643159|Aripiprazole|aripiprazole|mesh-list
2152123|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
2152124|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
2152125|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2152126|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2152127|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152128|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152129|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
2152130|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
2152131|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152132|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152133|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2152134|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2152135|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
2152136|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2152137|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2152138|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2152139|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2152140|NCT03630120|Sorafenib|sorafenib|mesh-list
2152141|NCT03630120|Lenvatinib|lenvatinib|mesh-list
2152142|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152143|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2152144|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152145|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152146|NCT03615508|Phenylephrine|phenylephrine|mesh-list
2152147|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
2152148|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2152149|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
2152150|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
2603657|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
2603658|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2603659|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603660|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
2603661|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2603662|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152151|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152152|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152153|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
2152154|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2152155|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
2152156|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
2603663|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603664|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2603665|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2603666|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2603667|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2603668|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2603669|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2603670|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2603671|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2603672|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
2603673|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2603674|NCT01782976|Bevacizumab|bevacizumab|mesh-list
2603675|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2603676|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603677|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2152157|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2603678|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2603679|NCT01782976|Growth Substances|growth substances|mesh-ancestor
2603680|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603681|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
2603682|NCT01782989|Doxycycline|doxycycline|mesh-list
2603683|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2603684|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603685|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
2603686|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2603687|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2603688|NCT01783002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2603689|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
2603690|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2603691|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152158|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2152159|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2152160|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
2152161|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152162|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152163|NCT03615508|Protective Agents|protective agents|mesh-ancestor
2152164|NCT03615144|Fludarabine|fludarabine|mesh-list
2152165|NCT03615144|Melphalan|melphalan|mesh-list
2152166|NCT03615144|Thiotepa|thiotepa|mesh-list
2152167|NCT03615144|Clofarabine|clofarabine|mesh-list
2152168|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
2152169|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2152170|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152171|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2152172|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
2152173|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152174|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2152175|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
2152176|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152177|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2152178|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
2152179|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2152180|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
2152181|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152182|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
2152183|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2152184|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2152185|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152186|NCT03598140|Urological Agents|urological agents|mesh-ancestor
2152187|NCT03591458|Amitriptyline|amitriptyline|mesh-list
2152188|NCT03591458|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2152189|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2152190|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
2603692|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
2603693|NCT01783106|Doxycycline|doxycycline|mesh-list
2603694|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
2603695|NCT01783106|Budesonide|budesonide|mesh-list
2603696|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2603697|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2603698|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
2603699|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603700|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603701|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2603702|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
2603703|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
2603704|NCT01783106|Hormones|hormones|mesh-ancestor
2603705|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2603706|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
2603707|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2152191|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2152192|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2152193|NCT03591458|Analgesics|analgesics|mesh-ancestor
2152194|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
2152195|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152196|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152197|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2152198|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2152199|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2152200|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603708|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2603709|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152201|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
2152202|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152203|NCT03591458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2603710|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603711|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603712|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2603713|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2603714|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2603715|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2603716|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603717|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2603718|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2603719|NCT01783197|Paclitaxel|paclitaxel|mesh-list
2603720|NCT01783197|Carboplatin|carboplatin|mesh-list
2603721|NCT01783197|Pemetrexed|pemetrexed|mesh-list
2603722|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2603723|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603724|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
2603725|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
2603726|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
2603727|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603728|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603729|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2152204|NCT03591458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2152205|NCT03591458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152206|NCT03590743|Apixaban|apixaban|mesh-list
2152207|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2152208|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
2152209|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2152210|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
2152211|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152212|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152213|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
2152214|NCT03580382|Trametinib|trametinib|mesh-list
2152215|NCT03580382|Antibodies|antibodies|mesh-list
2152216|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
2152217|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152218|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152219|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2152220|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152221|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152222|NCT03565328|Niacinamide|niacinamide|mesh-list
2152223|NCT03565328|Niacin|niacin|mesh-list
2152224|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
2152225|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
2152226|NCT03565328|Vitamins|vitamins|mesh-ancestor
2152227|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
2603730|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2603731|NCT01783340|Azithromycin|azithromycin|mesh-list
2603732|NCT01783340|Vaccines|vaccines|mesh-list
2603733|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2603734|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603735|NCT01783340|Immunologic Factors|immunologic factors|mesh-ancestor
2603736|NCT01783340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603737|NCT01783379|Micafungin|micafungin|mesh-list
2603738|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
2603739|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603740|NCT01783431|Poly ICLC|poly iclc|mesh-list
2603741|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
2603742|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
2603743|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152228|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152229|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2603770|NCT01783587|Docetaxel|docetaxel|mesh-list
2603771|NCT01783587|Afatinib|afatinib|mesh-list
2603772|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603773|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
2603774|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
2603775|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
2603776|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603777|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2152230|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
2152231|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152232|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2152233|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
2152234|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
2152235|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
2152236|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152237|NCT03538015|Carvedilol|carvedilol|mesh-list
2152238|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2152239|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2152240|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
2152241|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152242|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152243|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152244|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2152245|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
2152246|NCT03538015|Protective Agents|protective agents|mesh-ancestor
2152247|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2152248|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2152249|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2152250|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
2152251|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2152252|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2152253|NCT03509207|Vorinostat|vorinostat|mesh-list
2152254|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152255|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2152256|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152257|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603778|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603779|NCT01783717|Exenatide|exenatide|mesh-list
2603780|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2603781|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603782|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2603783|NCT01783717|Incretins|incretins|mesh-ancestor
2603784|NCT01783717|Hormones|hormones|mesh-ancestor
2603785|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2603786|NCT01783756|Capecitabine|capecitabine|mesh-list
2603787|NCT01783756|Everolimus|everolimus|mesh-list
2603788|NCT01783756|Lapatinib|lapatinib|mesh-list
2603789|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2603790|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
2603791|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603792|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603793|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2603794|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
2603795|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603796|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2603797|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603798|NCT01783834|Pemetrexed|pemetrexed|mesh-list
2603799|NCT01783834|Gefitinib|gefitinib|mesh-list
2603800|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603801|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603802|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603803|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2603804|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2603805|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2603806|NCT01783925|Aflibercept|aflibercept|mesh-list
2603807|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2603808|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2603809|NCT01783925|Growth Substances|growth substances|mesh-ancestor
2603810|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603811|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
2603812|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603813|NCT01783951|Cisplatin|cisplatin|mesh-list
2603814|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603815|NCT01783964|Cytarabine|cytarabine|mesh-list
2603816|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2603817|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
2603818|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603819|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603820|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
2603821|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603822|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2603823|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
2603824|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152258|NCT03490916|Acetazolamide|acetazolamide|mesh-list
2152259|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
2152260|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2152261|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152262|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152263|NCT03490916|Diuretics|diuretics|mesh-ancestor
2152264|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
2603825|NCT01783977|Vaccines|vaccines|mesh-list
2603826|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
2603827|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603828|NCT01784107|Ifosfamide|ifosfamide|mesh-list
2603829|NCT01784107|Belotecan|belotecan|mesh-list
2152265|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152266|NCT03477903|Metoclopramide|metoclopramide|mesh-list
2152267|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
2152268|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
2152269|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152270|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152271|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2152272|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2603830|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2603831|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
2603832|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603833|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603834|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2603835|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2603836|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603837|NCT01784120|Doxorubicin|doxorubicin|mesh-list
2603838|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2603839|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603840|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2603841|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2603842|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603843|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603844|NCT01784159|Aspirin|aspirin|mesh-list
2603845|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2603846|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2603847|NCT01784159|Analgesics|analgesics|mesh-ancestor
2603848|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
2603849|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603850|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603851|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2603852|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2603853|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2603854|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2603855|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603856|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2603857|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2603858|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603859|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
2603860|NCT01784250|Propranolol|propranolol|mesh-list
2603861|NCT01784250|Clonidine|clonidine|mesh-list
2603862|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2603863|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2603864|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
2152273|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2152274|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
2603865|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2603866|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603867|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603868|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2603869|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2603870|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
2603871|NCT01784250|Analgesics|analgesics|mesh-ancestor
2603872|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
2603873|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152275|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152276|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152277|NCT03469258|Pancrelipase|pancrelipase|mesh-list
2152278|NCT03469258|Pancreatin|pancreatin|mesh-list
2152279|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2152280|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
2152281|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2152282|NCT03465891|Atezolizumab|atezolizumab|mesh-list
2152283|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152284|NCT03465735|Heparin|heparin|mesh-list
2603874|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
2603875|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
2603876|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2603877|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2603878|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2603879|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
2603880|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2603881|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2603882|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
2603883|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152285|NCT03465735|Enoxaparin|enoxaparin|mesh-list
2152286|NCT03465735|Dalteparin|dalteparin|mesh-list
2152287|NCT03465735|Warfarin|warfarin|mesh-list
2152288|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
2152289|NCT03465735|Dabigatran|dabigatran|mesh-list
2152290|NCT03465735|Apixaban|apixaban|mesh-list
2152291|NCT03465735|Edoxaban|edoxaban|mesh-list
2152292|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
2152293|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2152294|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2152295|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152296|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2152297|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
2152298|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2152299|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
2152300|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152301|NCT03457818|Denosumab|denosumab|mesh-list
2152302|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2152303|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152304|NCT03455556|Atezolizumab|atezolizumab|mesh-list
2603884|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2603885|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2603886|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603887|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603888|NCT01784315|Chloroquine|chloroquine|mesh-list
2603889|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2603890|NCT01784315|Primaquine|primaquine|mesh-list
2603891|NCT01784315|Artemisinins|artemisinins|mesh-list
2603892|NCT01784315|Artemisinin|artemisinin|mesh-list
2603893|NCT01784315|Amebicides|amebicides|mesh-ancestor
2603894|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2603895|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2603896|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603897|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
2603898|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2603899|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2603900|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2603901|NCT01784315|Analgesics|analgesics|mesh-ancestor
2603902|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
2603903|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2603904|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603905|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2603906|NCT01784315|Filaricides|filaricides|mesh-ancestor
2603907|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
2603908|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
2152305|NCT03455556|Maytansine|maytansine|mesh-list
2152306|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2152307|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603909|NCT01784380|Metformin|metformin|mesh-list
2603910|NCT01784380|Clomiphene|clomiphene|mesh-list
2603911|NCT01784380|Enclomiphene|enclomiphene|mesh-list
2603912|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
2603913|NCT01784380|Menotropins|menotropins|mesh-list
2603914|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
2603915|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2603916|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603917|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2603918|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
2603919|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2603920|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2603921|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
2603922|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2603923|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2603924|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2603925|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
2603926|NCT01784445|Ceftazidime|ceftazidime|mesh-list
2603927|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2603928|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603929|NCT01784536|Oritavancin|oritavancin|mesh-list
2603930|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2603931|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603932|NCT01784549|Gemcitabine|gemcitabine|mesh-list
2603933|NCT01784549|Docetaxel|docetaxel|mesh-list
2603934|NCT01784549|Pemetrexed|pemetrexed|mesh-list
2603935|NCT01784549|Vinorelbine|vinorelbine|mesh-list
2603936|NCT01784549|Gefitinib|gefitinib|mesh-list
2603937|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603938|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2603939|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
2603940|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603941|NCT01784549|Antiviral Agents|antiviral agents|mesh-ancestor
2603942|NCT01784549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2603943|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603944|NCT01784549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2603945|NCT01784549|Immunologic Factors|immunologic factors|mesh-ancestor
2603946|NCT01784549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603947|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
2603948|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
2152308|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
2152309|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603949|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
2603950|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2603951|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2603952|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2603953|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2603954|NCT01784562|Riociguat|riociguat|mesh-list
2603955|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
2603956|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603957|NCT01784640|Pemetrexed|pemetrexed|mesh-list
2603958|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603959|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603960|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603961|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2603962|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2603963|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2603964|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603965|NCT01784874|Vaccines|vaccines|mesh-list
2603966|NCT01784874|Immunologic Factors|immunologic factors|mesh-ancestor
2603967|NCT01784874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603968|NCT01784900|Catumaxomab|catumaxomab|mesh-list
2603969|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2603970|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2603971|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
2603972|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603973|NCT01784913|Sargramostim|sargramostim|mesh-list
2603974|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
2603975|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603976|NCT01784978|Everolimus|everolimus|mesh-list
2603977|NCT01784978|Sunitinib|sunitinib|mesh-list
2603978|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2603979|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2603980|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
2603981|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603982|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2603983|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2603984|NCT01784978|Growth Substances|growth substances|mesh-ancestor
2603985|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
2603986|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2152310|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2152311|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
2152312|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
2152313|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
2152314|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152315|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
2152316|NCT03447639|Povidone|povidone|mesh-list
2152317|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
2152318|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
2152319|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2152320|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152321|NCT03426137|Ketorolac|ketorolac|mesh-list
2152322|NCT03426137|Oxycodone|oxycodone|mesh-list
2152323|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2603987|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2603988|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2603989|NCT01785004|Vitamin D|vitamin d|mesh-list
2603990|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
2603991|NCT01785004|Vitamins|vitamins|mesh-ancestor
2603992|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
2603993|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2603994|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2603995|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2603996|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
2603997|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2603998|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
2603999|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
2604000|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604001|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604002|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2604003|NCT01785030|Analgesics|analgesics|mesh-ancestor
2604004|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
2604005|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604006|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2604007|NCT01785043|Liraglutide|liraglutide|mesh-list
2604008|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2604009|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604010|NCT01785043|Incretins|incretins|mesh-ancestor
2604011|NCT01785043|Hormones|hormones|mesh-ancestor
2604012|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604013|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2152324|NCT03426137|Narcotics|narcotics|mesh-ancestor
2152325|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604014|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
2604015|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604016|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604017|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2604018|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
2604019|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604020|NCT01785108|Vitamin D|vitamin d|mesh-list
2604021|NCT01785108|Ibuprofen|ibuprofen|mesh-list
2604022|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
2604023|NCT01785108|Vitamins|vitamins|mesh-ancestor
2604024|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
2604025|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604026|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2604027|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2604028|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2604029|NCT01785108|Analgesics|analgesics|mesh-ancestor
2604030|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
2604031|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604032|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2604033|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2604034|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2604035|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604036|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604037|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2604038|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
2152326|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152327|NCT03426137|Analgesics|analgesics|mesh-ancestor
2152328|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
2152329|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152330|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2152331|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2152332|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2152333|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2604039|NCT01785290|Haloperidol|haloperidol|mesh-list
2604040|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
2604041|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
2604042|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
2604043|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604044|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604045|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2604046|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2604047|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2604048|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604049|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2604050|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2604051|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
2604052|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604053|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604054|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2604055|NCT01785420|Trastuzumab|trastuzumab|mesh-list
2604056|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2604057|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604058|NCT01785433|Tiotropium Bromide|tiotropium bromide|mesh-list
2152334|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2152335|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152336|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604059|NCT01785433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2604060|NCT01785433|Autonomic Agents|autonomic agents|mesh-ancestor
2604061|NCT01785433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604062|NCT01785433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604063|NCT01785433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2152337|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
2152338|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2152339|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2152340|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152341|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
2152342|NCT03425799|Coagulants|coagulants|mesh-ancestor
2152343|NCT03382925|Triamcinolone|triamcinolone|mesh-list
2152344|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2152345|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2604064|NCT01785433|Respiratory System Agents|respiratory system agents|mesh-ancestor
2604065|NCT01785433|Parasympatholytics|parasympatholytics|mesh-ancestor
2604066|NCT01785433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2604067|NCT01785433|Cholinergic Agents|cholinergic agents|mesh-ancestor
2604068|NCT01785433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604069|NCT01785433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604070|NCT01785446|Sufentanil|sufentanil|mesh-list
2604071|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
2604072|NCT01785446|Dsuvia|dsuvia|mesh-list
2604073|NCT01785446|Atracurium|atracurium|mesh-list
2604074|NCT01785446|Cisatracurium|cisatracurium|mesh-list
2604075|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2604076|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604077|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604078|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2604079|NCT01785446|Analgesics|analgesics|mesh-ancestor
2604080|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
2604081|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604082|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2604083|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2604084|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2604085|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
2604086|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604087|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604088|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2604089|NCT01785446|Narcotics|narcotics|mesh-ancestor
2604090|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2604091|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2604092|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
2604093|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
2604094|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2604095|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2604096|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2604097|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2604098|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2604099|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
2604100|NCT01785589|Adenosine|adenosine|mesh-list
2152346|NCT03382925|Lidocaine|lidocaine|mesh-list
2152347|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2604101|NCT01785589|Analgesics|analgesics|mesh-ancestor
2604102|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
2604103|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604104|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604105|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2604106|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
2604107|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2604108|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
2604109|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
2604110|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604111|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604112|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2604113|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
2604114|NCT01785641|Gentamicins|gentamicins|mesh-list
2604115|NCT01785641|Cefazolin|cefazolin|mesh-list
2604116|NCT01785641|Ceftazidime|ceftazidime|mesh-list
2604117|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2604118|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604119|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
2604120|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2604121|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2604122|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604123|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604124|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604125|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2604126|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2604127|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2604128|NCT01785693|Clonidine|clonidine|mesh-list
2604129|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
2604130|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
2604131|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
2604132|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604133|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604134|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
2604135|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604136|NCT01785693|Analgesics|analgesics|mesh-ancestor
2604137|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2604138|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
2604139|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
2604140|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2604141|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2604142|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2604143|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
2604144|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604145|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604146|NCT01785771|Exenatide|exenatide|mesh-list
2604147|NCT01785771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2604148|NCT01785771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604149|NCT01785771|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2604150|NCT01785771|Incretins|incretins|mesh-ancestor
2604151|NCT01785771|Hormones|hormones|mesh-ancestor
2604152|NCT01785771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604153|NCT01785797|Silicon|silicon|mesh-list
2604154|NCT01785797|Trace Elements|trace elements|mesh-ancestor
2604155|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
2604156|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604157|NCT01785836|Dapsone|dapsone|mesh-list
2604158|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604159|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
2604160|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2604161|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2604162|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2604163|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604164|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604165|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
2604166|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2604167|NCT01785862|Ibuprofen|ibuprofen|mesh-list
2604168|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2604169|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2604170|NCT01785862|Analgesics|analgesics|mesh-ancestor
2604171|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
2604172|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604173|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604174|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2604175|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2152348|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
2604176|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2604177|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152349|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
2152350|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152351|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152352|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
2152353|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152354|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2152355|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2152356|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2152357|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2152358|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152359|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2152360|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
2152361|NCT03382925|Hormones|hormones|mesh-ancestor
2152362|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2152363|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2152364|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
2152365|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152366|NCT03370536|Ibutilide|ibutilide|mesh-list
2604178|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604179|NCT01785979|Chloroquine|chloroquine|mesh-list
2604180|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2604181|NCT01785979|Prednisone|prednisone|mesh-list
2604182|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2604183|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
2604184|NCT01785979|Hormones|hormones|mesh-ancestor
2604185|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604186|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604187|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2604188|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604189|NCT01785979|Amebicides|amebicides|mesh-ancestor
2604190|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2604191|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2604192|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604193|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
2604194|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2604195|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2604196|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2604197|NCT01785979|Analgesics|analgesics|mesh-ancestor
2604198|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
2604199|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604200|NCT01785979|Filaricides|filaricides|mesh-ancestor
2604201|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
2604202|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
2604203|NCT01786018|Cyclosporine|cyclosporine|mesh-list
2421287|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421288|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2421289|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2421290|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604204|NCT01786018|Methotrexate|methotrexate|mesh-list
2604205|NCT01786018|Busulfan|busulfan|mesh-list
2604206|NCT01786018|Thiotepa|thiotepa|mesh-list
2604207|NCT01786018|Cyclosporins|cyclosporins|mesh-list
2604208|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2604209|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
2604210|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2604211|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152367|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2152368|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
2421291|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
2421292|NCT00812123|Cyclosporine|cyclosporine|mesh-list
2421293|NCT00812123|Sirolimus|sirolimus|mesh-list
2421294|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
2421295|NCT00812123|Prednisone|prednisone|mesh-list
2421296|NCT00812123|Cyclosporins|cyclosporins|mesh-list
2421297|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2421298|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
2421299|NCT00812123|Hormones|hormones|mesh-ancestor
2604212|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2604213|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
2604214|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604215|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604216|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
2604217|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604218|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2604219|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2604220|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
2604221|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2152369|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2152370|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2152371|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
2152372|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2152373|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152374|NCT03360903|Caffeine|caffeine|mesh-list
2152375|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2152376|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152377|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2152378|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152379|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152380|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2152381|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2152382|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
2152383|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152384|NCT03359174|Tretinoin|tretinoin|mesh-list
2152385|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152386|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
2152387|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
2152388|NCT03348904|Gemcitabine|gemcitabine|mesh-list
2152389|NCT03348904|Paclitaxel|paclitaxel|mesh-list
2152390|NCT03348904|Carboplatin|carboplatin|mesh-list
2152391|NCT03348904|Nivolumab|nivolumab|mesh-list
2152392|NCT03348904|Pemetrexed|pemetrexed|mesh-list
2152393|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2152394|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152395|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
2152396|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
2152397|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
2152398|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152399|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2152400|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
2604222|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2604223|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
2604224|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604225|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2604226|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
2604227|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2152401|NCT03348904|Antiviral Agents|antiviral agents|mesh-ancestor
2152402|NCT03348904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152403|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152404|NCT03348904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2152405|NCT03348904|Immunologic Factors|immunologic factors|mesh-ancestor
2152406|NCT03348904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152407|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2152408|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2152409|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2152410|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2152411|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
2152412|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2152413|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
2152414|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
2152415|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2152416|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
2152417|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604228|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2604229|NCT01786070|Budesonide|budesonide|mesh-list
2604230|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2152418|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2152419|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2152420|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
2152421|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152422|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152423|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2152424|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2152425|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
2152426|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
2152427|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604231|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2604232|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
2604233|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152428|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2152429|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
2152430|NCT03342638|Hormones|hormones|mesh-ancestor
2421300|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421301|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604234|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604235|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2604236|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
2604237|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
2604238|NCT01786070|Hormones|hormones|mesh-ancestor
2604239|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2152431|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2152432|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2152433|NCT03342638|Protective Agents|protective agents|mesh-ancestor
2152434|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2152435|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2152436|NCT03342157|Sennosides|sennosides|mesh-list
2152437|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
2152438|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2152439|NCT03342157|Laxatives|laxatives|mesh-ancestor
2152440|NCT03339401|Brincidofovir|brincidofovir|mesh-list
2152441|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
2152442|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152443|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2604240|NCT01786200|Aspirin|aspirin|mesh-list
2604241|NCT01786200|Ibuprofen|ibuprofen|mesh-list
2604242|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2604243|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2604244|NCT01786200|Analgesics|analgesics|mesh-ancestor
2604245|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
2604246|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604247|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604248|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2604249|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2604250|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2604251|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2604252|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604253|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2604254|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2604255|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604256|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
2604257|NCT01786226|Mifepristone|mifepristone|mesh-list
2604258|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2604259|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
2604260|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2604261|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604262|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2604263|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2604264|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2604265|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
2604266|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2604267|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2604268|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
2604269|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604270|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
2604271|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2604272|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2604273|NCT01786382|Midazolam|midazolam|mesh-list
2604274|NCT01786382|Omeprazole|omeprazole|mesh-list
2152444|NCT03333746|Nivolumab|nivolumab|mesh-list
2152445|NCT03333746|Lenalidomide|lenalidomide|mesh-list
2421302|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2421303|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421304|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421305|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421306|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2421307|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
2421308|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
2421309|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421310|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
2421311|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421312|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2421313|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2421314|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2421315|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
2421316|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2421317|NCT00812175|Sorafenib|sorafenib|mesh-list
2152446|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2152447|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152448|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2152449|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152450|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
2152451|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152452|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2152453|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2152454|NCT03333746|Growth Substances|growth substances|mesh-ancestor
2152455|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
2152456|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
2152457|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2152458|NCT03325114|Diuretics|diuretics|mesh-ancestor
2152459|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
2152460|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152461|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2604275|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2604276|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2604277|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604278|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604279|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2604280|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2604281|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2604282|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2604283|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
2604284|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
2604285|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
2604286|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
2604287|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604288|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604289|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2604290|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2604291|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2604292|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604293|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
2604294|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2152462|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2152463|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152464|NCT03305055|Fentanyl|fentanyl|mesh-list
2604295|NCT01786434|Fentanyl|fentanyl|mesh-list
2604296|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2604297|NCT01786434|Narcotics|narcotics|mesh-ancestor
2604298|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604299|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604300|NCT01786434|Analgesics|analgesics|mesh-ancestor
2604301|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
2604302|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604303|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2604304|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2604305|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
2604306|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
2152465|NCT03305055|Ketamine|ketamine|mesh-list
2152466|NCT03305055|Analgesics|analgesics|mesh-ancestor
2152467|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
2152468|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152469|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152470|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2152471|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2152472|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
2152473|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
2152474|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152475|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2152476|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2152477|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152478|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152479|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2152480|NCT03305055|Narcotics|narcotics|mesh-ancestor
2152481|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2152482|NCT03302247|Gemcitabine|gemcitabine|mesh-list
2152483|NCT03302247|Nivolumab|nivolumab|mesh-list
2152484|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2152485|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
2152486|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152487|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152488|NCT03302247|Antiviral Agents|antiviral agents|mesh-ancestor
2604307|NCT01786538|Leucovorin|leucovorin|mesh-list
2604308|NCT01786538|Fluorouracil|fluorouracil|mesh-list
2604309|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
2604310|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
2604311|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604312|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2604313|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604314|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2604315|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
2604316|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604317|NCT01786538|Antidotes|antidotes|mesh-ancestor
2604318|NCT01786538|Protective Agents|protective agents|mesh-ancestor
2604319|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
2604320|NCT01786538|Vitamins|vitamins|mesh-ancestor
2604321|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
2604322|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
2604323|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2604324|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
2604325|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604326|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604327|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2604328|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
2604329|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2604330|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2604331|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2604332|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
2604333|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604334|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604335|NCT01786655|Epinephrine|epinephrine|mesh-list
2604336|NCT01786655|Bupivacaine|bupivacaine|mesh-list
2604337|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
2604338|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
2604339|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
2604340|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604341|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604342|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
2604343|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604344|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2604345|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2604346|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
2604347|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604348|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604349|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2604350|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2604351|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
2604352|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2604353|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
2604354|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
2604355|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
2604356|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2604357|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2604358|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2604359|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2604360|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2604361|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2604362|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2604363|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
2604364|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2152489|NCT03302247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152490|NCT03302247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152491|NCT03302247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2152492|NCT03302247|Immunologic Factors|immunologic factors|mesh-ancestor
2152493|NCT03302247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604365|NCT01787123|Protective Agents|protective agents|mesh-ancestor
2604366|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604367|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
2604368|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
2604369|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
2604370|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
2604371|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2604372|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2604373|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604374|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604375|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604376|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
2604377|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2604378|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2152494|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2152495|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2152496|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
2152497|NCT03277183|Hematinics|hematinics|mesh-ancestor
2152498|NCT03248141|Factor VIII|factor viii|mesh-list
2152499|NCT03248141|Coagulants|coagulants|mesh-ancestor
2152500|NCT03251326|Propranolol|propranolol|mesh-list
2152501|NCT03251326|Nabilone|nabilone|mesh-list
2152502|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2152503|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2152504|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
2152505|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152506|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152507|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152508|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2152509|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2152510|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
2152511|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
2152512|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
2152513|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152514|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2152515|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2152516|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2152517|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152518|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2152519|NCT03219372|Pravastatin|pravastatin|mesh-list
2152520|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2152521|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2152522|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
2152523|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152524|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2604379|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2604380|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2604381|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604382|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
2604383|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604384|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604385|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2604386|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604387|NCT01787357|Canagliflozin|canagliflozin|mesh-list
2604388|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
2604389|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2604390|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604391|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2604392|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2604393|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604394|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604395|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604396|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604397|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2604398|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2604399|NCT01787396|Metformin|metformin|mesh-list
2604400|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2604401|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604402|NCT01787409|Vitamin D|vitamin d|mesh-list
2604403|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
2604404|NCT01787409|Vitamins|vitamins|mesh-ancestor
2604405|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
2604406|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604407|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2604408|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2604409|NCT01787474|Cytarabine|cytarabine|mesh-list
2152525|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2152526|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152527|NCT03217175|Glucagon|glucagon|mesh-list
2152528|NCT03217175|Pancrelipase|pancrelipase|mesh-list
2152529|NCT03217175|Pancreatin|pancreatin|mesh-list
2152530|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152531|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2604410|NCT01787474|Fludarabine|fludarabine|mesh-list
2604411|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
2604412|NCT01787474|Lenograstim|lenograstim|mesh-list
2604413|NCT01787474|Sargramostim|sargramostim|mesh-list
2604414|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604415|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2152532|NCT03217175|Hormones|hormones|mesh-ancestor
2604416|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
2604417|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604418|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2604419|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
2604420|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604421|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2604422|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
2604423|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604424|NCT01787487|Azacitidine|azacitidine|mesh-list
2604425|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2604426|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
2152533|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2152534|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2152535|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2152536|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152537|NCT03232892|Trametinib|trametinib|mesh-list
2152538|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152539|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2152540|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152541|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152542|NCT03169530|Ethanol|ethanol|mesh-list
2152543|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2152544|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152545|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152546|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152547|NCT03189433|Dantrolene|dantrolene|mesh-list
2152548|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2152549|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152550|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2152551|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152552|NCT03172026|Maraviroc|maraviroc|mesh-list
2152553|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2152554|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2152555|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152556|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2152557|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2152558|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
2152559|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152560|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2152561|NCT03161964|Propranolol|propranolol|mesh-list
2152562|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2152563|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2152564|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
2152565|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152566|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152567|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152568|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2152569|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2152570|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
2152571|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2152572|NCT03150160|Travoprost|travoprost|mesh-list
2152573|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2152574|NCT03150160|Brinzolamide|brinzolamide|mesh-list
2152575|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2152576|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2152577|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2152578|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2152579|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2152580|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
2604427|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604428|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604429|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604430|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2604431|NCT01787500|Cetuximab|cetuximab|mesh-list
2604432|NCT01787500|Irinotecan|irinotecan|mesh-list
2604433|NCT01787500|Camptothecin|camptothecin|mesh-list
2604434|NCT01787500|Vemurafenib|vemurafenib|mesh-list
2604435|NCT01787500|Antibodies|antibodies|mesh-list
2152581|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152582|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152583|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152584|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2604436|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
2604437|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2604438|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
2604439|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604440|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604441|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2604442|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2604443|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604444|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152585|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152586|NCT03109418|Ketamine|ketamine|mesh-list
2152587|NCT03109418|Analgesics|analgesics|mesh-ancestor
2152588|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
2152589|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152590|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152591|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2152592|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2604445|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2604446|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2604447|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
2604448|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2604449|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
2604450|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604451|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
2604452|NCT01787630|Protective Agents|protective agents|mesh-ancestor
2604453|NCT01787669|Dexamethasone|dexamethasone|mesh-list
2604454|NCT01787669|Bevacizumab|bevacizumab|mesh-list
2604455|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2604456|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604457|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2604458|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2604459|NCT01787669|Growth Substances|growth substances|mesh-ancestor
2604460|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604461|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
2604462|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2604463|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
2604464|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
2604465|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604466|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2604467|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
2604468|NCT01787669|Hormones|hormones|mesh-ancestor
2604469|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604470|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2604471|NCT01788007|Imiquimod|imiquimod|mesh-list
2152593|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
2152594|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
2152595|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152596|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2152597|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2152598|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152599|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152600|NCT03120676|Atezolizumab|atezolizumab|mesh-list
2152601|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152602|NCT03109873|Metformin|metformin|mesh-list
2604472|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2604473|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
2604474|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604475|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604476|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
2604477|NCT01788020|Dexamethasone|dexamethasone|mesh-list
2604478|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
2604479|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
2604480|NCT01788020|Rituximab|rituximab|mesh-list
2604481|NCT01788020|Bortezomib|bortezomib|mesh-list
2604482|NCT01788020|BB 1101|bb 1101|mesh-list
2604483|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2604484|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
2604485|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604486|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2604487|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2152603|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2152604|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152605|NCT03113071|Decitabine|decitabine|mesh-list
2152606|NCT03113071|Digoxin|digoxin|mesh-list
2152607|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2152608|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
2604488|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
2604489|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604490|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604491|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2604492|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2152609|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152610|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152611|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152612|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2152613|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2152614|NCT03113071|Protective Agents|protective agents|mesh-ancestor
2152615|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152616|NCT03110900|Lorazepam|lorazepam|mesh-list
2152617|NCT03110900|Haloperidol|haloperidol|mesh-list
2152618|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
2152619|NCT03110900|Loxapine|loxapine|mesh-list
2152620|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
2152621|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
2152622|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152623|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152624|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2152625|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2152626|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2152627|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152628|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2604493|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
2604494|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
2604495|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604496|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2604497|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
2604498|NCT01788020|Hormones|hormones|mesh-ancestor
2604499|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604500|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2604501|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
2604502|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604503|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2604504|NCT01788072|Oxytocin|oxytocin|mesh-list
2604505|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
2604506|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2604507|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604508|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
2604509|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2604510|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152629|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2152630|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
2152631|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152632|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152633|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2152634|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
2152635|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2152636|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2152637|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
2152638|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
2152639|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
2604511|NCT01788189|Lenalidomide|lenalidomide|mesh-list
2604512|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
2604513|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604514|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2604515|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2604516|NCT01788189|Growth Substances|growth substances|mesh-ancestor
2604517|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
2604518|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604519|NCT01788254|Talinolol|talinolol|mesh-list
2604520|NCT01788254|Torsemide|torsemide|mesh-list
2604521|NCT01788254|Midazolam|midazolam|mesh-list
2604522|NCT01788254|Codeine|codeine|mesh-list
2604523|NCT01788254|Pravastatin|pravastatin|mesh-list
2604524|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2604525|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2604526|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604527|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604528|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2604529|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2604530|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2604531|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2604532|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
2152640|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2152641|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2604533|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
2604534|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
2604535|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
2152642|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2152643|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2152644|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152645|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
2152646|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152647|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152648|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2152649|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152650|NCT03065933|Clonidine|clonidine|mesh-list
2152651|NCT03065933|Analgesics|analgesics|mesh-ancestor
2152652|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
2152653|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152654|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152655|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2152656|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
2152657|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
2152658|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2152659|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2604536|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604537|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604538|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2604539|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2604540|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
2604541|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2604542|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2604543|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604544|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2152660|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2152661|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
2152662|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152663|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152664|NCT03070002|Denosumab|denosumab|mesh-list
2152665|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2152666|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152667|NCT03050398|Letrozole|letrozole|mesh-list
2604545|NCT01788254|Narcotics|narcotics|mesh-ancestor
2604546|NCT01788254|Analgesics|analgesics|mesh-ancestor
2604547|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
2604548|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604549|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
2604550|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
2604551|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2604552|NCT01788254|Diuretics|diuretics|mesh-ancestor
2604553|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
2604554|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2604555|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2604556|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2604557|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2604558|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
2604559|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2604560|NCT01788280|Bevacizumab|bevacizumab|mesh-list
2604561|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2604562|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604563|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2604564|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2604565|NCT01788280|Growth Substances|growth substances|mesh-ancestor
2604566|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604567|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
2604568|NCT01788332|Olaparib|olaparib|mesh-list
2604569|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2604570|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604571|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604572|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604573|NCT01788371|Lamivudine|lamivudine|mesh-list
2604574|NCT01788371|Telbivudine|telbivudine|mesh-list
2604575|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2604576|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2152668|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152669|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2152670|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2152671|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604577|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152672|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152673|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2152674|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
2152675|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2152676|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152677|NCT03042780|Folfirinox|folfirinox|mesh-list
2152678|NCT03042780|Lenograstim|lenograstim|mesh-list
2152679|NCT03042780|Sargramostim|sargramostim|mesh-list
2152680|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2152681|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
2152682|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152683|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152684|NCT03029832|Atezolizumab|atezolizumab|mesh-list
2152685|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152686|NCT03031340|Pregabalin|pregabalin|mesh-list
2604578|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604579|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
2604580|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604581|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2604582|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2604583|NCT01788384|Clindamycin|clindamycin|mesh-list
2604584|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
2604585|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
2604586|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2604587|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2604588|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604589|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2604590|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604591|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604592|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
2604593|NCT01788462|Tesamorelin|tesamorelin|mesh-list
2604594|NCT01788462|Growth Substances|growth substances|mesh-ancestor
2604595|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152687|NCT03031340|Analgesics|analgesics|mesh-ancestor
2152688|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
2152689|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152690|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152691|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
2152692|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2152693|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2152694|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152695|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2152696|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2152697|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2152698|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152699|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2152700|NCT03007719|Fluorides|fluorides|mesh-list
2152701|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
2152702|NCT03007719|Protective Agents|protective agents|mesh-ancestor
2152703|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152704|NCT03010423|Nicorandil|nicorandil|mesh-list
2152705|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2152706|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2604596|NCT01788501|Cyclosporine|cyclosporine|mesh-list
2604597|NCT01788501|Methotrexate|methotrexate|mesh-list
2604598|NCT01788501|Tacrolimus|tacrolimus|mesh-list
2604599|NCT01788501|Cyclosporins|cyclosporins|mesh-list
2604600|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2604601|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
2604602|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2604603|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604604|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2604605|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
2604606|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604607|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604608|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
2604609|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604610|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2604611|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2604612|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
2604613|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2604614|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2604615|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2604616|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
2604617|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152707|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
2604618|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2604619|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2604620|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2604621|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2604622|NCT01788605|Ramosetron|ramosetron|mesh-list
2604623|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
2604624|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
2604625|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604626|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604627|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2604628|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2604629|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
2604630|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604631|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152708|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
2152709|NCT03010423|Vitamins|vitamins|mesh-ancestor
2152710|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
2152711|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152712|NCT02985801|Pancrelipase|pancrelipase|mesh-list
2152713|NCT02985801|Pancreatin|pancreatin|mesh-list
2152714|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2152715|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
2152716|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2152717|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2152718|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2152719|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2152720|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152721|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
2152722|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152723|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152724|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2604632|NCT01788670|Ethanol|ethanol|mesh-list
2604633|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2604634|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604635|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604636|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152725|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152726|NCT02994251|Gemcitabine|gemcitabine|mesh-list
2152727|NCT02994251|Doxorubicin|doxorubicin|mesh-list
2152728|NCT02994251|Mitomycins|mitomycins|mesh-list
2152729|NCT02994251|Mitomycin|mitomycin|mesh-list
2152730|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152731|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2152732|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
2152733|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152734|NCT02994251|Antiviral Agents|antiviral agents|mesh-ancestor
2152735|NCT02994251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152736|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152737|NCT02994251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2152738|NCT02994251|Immunologic Factors|immunologic factors|mesh-ancestor
2604637|NCT01788722|Dienogest|dienogest|mesh-list
2604638|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2604639|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
2604640|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2604641|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604642|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2604643|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2604644|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2604645|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2604646|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
2604647|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604648|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2604649|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604650|NCT01788774|Risperidone|risperidone|mesh-list
2604651|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2604652|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
2604653|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604654|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604655|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604656|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2604657|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2152739|NCT02994251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152740|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2152741|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2604658|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604659|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2604660|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2604661|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
2604662|NCT01788969|Citalopram|citalopram|mesh-list
2604663|NCT01788969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2604664|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2604665|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2604666|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604667|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604668|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
2604669|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604670|NCT01788969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2604671|NCT01788969|Antidepressive Agents|antidepressive agents|mesh-ancestor
2604672|NCT01788969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2604673|NCT01788982|Nintedanib|nintedanib|mesh-list
2604674|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152742|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2152743|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
2604675|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2604676|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604677|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604678|NCT01789086|Liraglutide|liraglutide|mesh-list
2604679|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2152744|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2152745|NCT02971839|Ivacaftor|ivacaftor|mesh-list
2152746|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2152747|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2152748|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152749|NCT02985840|Dexamethasone|dexamethasone|mesh-list
2152750|NCT02985840|Ondansetron|ondansetron|mesh-list
2152751|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2152752|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
2152753|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
2152754|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152755|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152756|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2152757|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
2604680|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604681|NCT01789086|Incretins|incretins|mesh-ancestor
2604682|NCT01789086|Hormones|hormones|mesh-ancestor
2604683|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604684|NCT01789099|Sargramostim|sargramostim|mesh-list
2152758|NCT02985840|Hormones|hormones|mesh-ancestor
2152759|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2152760|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2152761|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152762|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
2152763|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
2152764|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2152765|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
2152766|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152767|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152768|NCT02985840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2152769|NCT02985840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2152770|NCT02985840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152771|NCT02985840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2152772|NCT02985840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2152773|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2152774|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
2152775|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2152776|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152777|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
2152778|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152779|NCT02974803|Trametinib|trametinib|mesh-list
2152780|NCT02974803|Dabrafenib|dabrafenib|mesh-list
2152781|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152782|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2152783|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152784|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152785|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
2152786|NCT02974686|Everolimus|everolimus|mesh-list
2152787|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152788|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2152789|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
2152790|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152791|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2152792|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2152793|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
2152794|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2152795|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152796|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152797|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604685|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
2604686|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604687|NCT01789125|Nicotine|nicotine|mesh-list
2604688|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2604689|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
2604690|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604691|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604692|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2604693|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2604694|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
2604695|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604696|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604697|NCT01789216|Ketorolac|ketorolac|mesh-list
2604698|NCT01789216|Meloxicam|meloxicam|mesh-list
2604699|NCT01789216|Pregabalin|pregabalin|mesh-list
2604700|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2604701|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2604702|NCT01789216|Analgesics|analgesics|mesh-ancestor
2604703|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
2152798|NCT02956005|Tacrolimus|tacrolimus|mesh-list
2152799|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2152800|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
2152801|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152802|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2152803|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152804|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152805|NCT02966184|Albuterol|albuterol|mesh-list
2152806|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2152807|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
2152808|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152809|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152810|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2152811|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
2152812|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
2152813|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2152814|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2152815|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2152816|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2152817|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
2152818|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152819|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152820|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2152821|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2152822|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2152823|NCT02954159|Vedolizumab|vedolizumab|mesh-list
2152824|NCT02954159|Tacrolimus|tacrolimus|mesh-list
2152825|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2152826|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
2152827|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152828|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2152829|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152830|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152831|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2152832|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
2152833|NCT02947022|Zinc|zinc|mesh-list
2152834|NCT02947022|Edetic Acid|edetic acid|mesh-list
2152835|NCT02947022|Calcium|calcium|mesh-list
2604704|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604705|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604706|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2604707|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2604708|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2152836|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
2152837|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2152838|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604709|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604710|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604711|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
2604712|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2604713|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2604714|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2604715|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2604716|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2604717|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604718|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2604719|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2604720|NCT01789242|Dexamethasone|dexamethasone|mesh-list
2604721|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2604722|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
2604723|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
2604724|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604725|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604726|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2152839|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2152840|NCT02947022|Trace Elements|trace elements|mesh-ancestor
2152841|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
2152842|NCT02947022|Antidotes|antidotes|mesh-ancestor
2152843|NCT02947022|Protective Agents|protective agents|mesh-ancestor
2152844|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
2152845|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
2152846|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152847|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2152848|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
2152849|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2152850|NCT02936999|Vitamin D|vitamin d|mesh-list
2152851|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
2152852|NCT02936999|Vitamins|vitamins|mesh-ancestor
2152853|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
2152854|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152855|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2152856|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2152857|NCT02950480|Zafirlukast|zafirlukast|mesh-list
2152858|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2152859|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
2152860|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2152861|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
2152862|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2152863|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152864|NCT02936206|Tamoxifen|tamoxifen|mesh-list
2152865|NCT02936206|Fulvestrant|fulvestrant|mesh-list
2152866|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2152867|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
2152868|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2152869|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152870|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2152871|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152872|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2152873|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2152874|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2152875|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2152876|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
2152877|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
2152878|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2152879|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152880|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152881|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
2152882|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
2152883|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
2152884|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2152885|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2152886|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152887|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
2152888|NCT02908516|Coagulants|coagulants|mesh-ancestor
2152889|NCT02920450|Paclitaxel|paclitaxel|mesh-list
2152890|NCT02920450|Carboplatin|carboplatin|mesh-list
2152891|NCT02920450|Gedatolisib|gedatolisib|mesh-list
2152892|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2152893|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152894|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
2152895|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
2152896|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
2152897|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604727|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
2604728|NCT01789242|Hormones|hormones|mesh-ancestor
2604729|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604730|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2604731|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604732|NCT01789294|Mesalamine|mesalamine|mesh-list
2604733|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2604734|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2604735|NCT01789294|Analgesics|analgesics|mesh-ancestor
2604736|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
2604737|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604738|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604739|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2604740|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2604741|NCT01789333|Riboflavin|riboflavin|mesh-list
2604742|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2604743|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2604744|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
2604745|NCT01789333|Vitamins|vitamins|mesh-ancestor
2604746|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
2604747|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604748|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2604749|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
2604750|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
2604751|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2604752|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604753|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604754|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2604755|NCT01789385|Analgesics|analgesics|mesh-ancestor
2604756|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
2604757|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604758|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2604759|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2604760|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2604761|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
2604762|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604763|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604764|NCT01789437|Dexamethasone|dexamethasone|mesh-list
2604765|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2604766|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
2604767|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
2604768|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604769|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604770|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2604771|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
2604772|NCT01789437|Hormones|hormones|mesh-ancestor
2604773|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604774|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2604775|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604776|NCT01789619|Tacrolimus|tacrolimus|mesh-list
2604777|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2604778|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
2604779|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152898|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2152899|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152900|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2152901|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2152902|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
2152903|NCT02920177|Hormones|hormones|mesh-ancestor
2152904|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2152905|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152906|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2152907|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
2152908|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2152909|NCT02926638|Rilotumumab|rilotumumab|mesh-list
2152910|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2152911|NCT02926638|Antibodies|antibodies|mesh-list
2152912|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
2152913|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2152914|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
2152915|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152916|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152917|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2604780|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2604781|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152918|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2152919|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152920|NCT02920242|Rifaximin|rifaximin|mesh-list
2152921|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2152922|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2152923|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2152924|NCT02892500|Betamethasone|betamethasone|mesh-list
2152925|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
2152926|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2152927|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
2152928|NCT02892500|Bupivacaine|bupivacaine|mesh-list
2152929|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2152930|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
2604782|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604783|NCT01789710|Bupropion|bupropion|mesh-list
2604784|NCT01789710|Nicotine|nicotine|mesh-list
2604785|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2604786|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
2604787|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604788|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604789|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2604790|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2604791|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
2604792|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604793|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604794|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2604795|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
2604796|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2604797|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2604798|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2604799|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2604800|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
2604801|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2604802|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2604803|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604804|NCT01789723|Leucovorin|leucovorin|mesh-list
2604805|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
2604806|NCT01789723|Antidotes|antidotes|mesh-ancestor
2604807|NCT01789723|Protective Agents|protective agents|mesh-ancestor
2604808|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604809|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
2604810|NCT01789723|Vitamins|vitamins|mesh-ancestor
2152931|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
2152932|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152933|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152934|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
2152935|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2152936|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2152937|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
2152938|NCT02892500|Hormones|hormones|mesh-ancestor
2152939|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2152940|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2152941|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
2152942|NCT02899728|Cisplatin|cisplatin|mesh-list
2152943|NCT02899728|Carboplatin|carboplatin|mesh-list
2152944|NCT02899728|Etoposide|etoposide|mesh-list
2152945|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
2152946|NCT02899728|Olaparib|olaparib|mesh-list
2152947|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
2152948|NCT02899728|Cediranib|cediranib|mesh-list
2152949|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2152950|NCT02899728|Maleic acid|maleic acid|mesh-list
2152951|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152952|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2152953|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2152954|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2152955|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604811|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
2604812|NCT01789736|Travoprost|travoprost|mesh-list
2604813|NCT01789736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2604814|NCT01789736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2604815|NCT01789736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2604816|NCT01789827|Interleukin-2|interleukin-2|mesh-list
2604817|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604818|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2604819|NCT01789827|Analgesics|analgesics|mesh-ancestor
2604820|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
2604821|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604822|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604823|NCT01789879|Efavirenz|efavirenz|mesh-list
2604824|NCT01789879|Nevirapine|nevirapine|mesh-list
2152956|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152957|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
2152958|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
2152959|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
2152960|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
2152961|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
2152962|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2152963|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
2152964|NCT02875067|Lenalidomide|lenalidomide|mesh-list
2152965|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2152966|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152967|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
2152968|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152969|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2152970|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2152971|NCT02875067|Growth Substances|growth substances|mesh-ancestor
2152972|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
2152973|NCT02868892|Pemetrexed|pemetrexed|mesh-list
2152974|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152975|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604825|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
2604826|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2604827|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2604828|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604829|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604830|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
2152976|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152977|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2152978|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2152979|NCT02826161|Paclitaxel|paclitaxel|mesh-list
2152980|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2152981|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152982|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
2152983|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
2152984|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
2152985|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2152986|NCT02828124|Nivolumab|nivolumab|mesh-list
2152987|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2152988|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2152989|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2152990|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604831|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604832|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2604833|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2604834|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2604835|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2604836|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2604837|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2604838|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2604839|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
2604840|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2604841|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604842|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2604843|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2604844|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2604845|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2604846|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2604847|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
2604848|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2604849|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2604850|NCT01789892|Prednisolone|prednisolone|mesh-list
2604851|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
2604852|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2604853|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
2604854|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2604855|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2604856|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
2604857|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
2152991|NCT02826551|Bupivacaine|bupivacaine|mesh-list
2152992|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
2604858|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604859|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152993|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
2152994|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2152995|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2152996|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
2152997|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604860|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2604861|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
2604862|NCT01789892|Hormones|hormones|mesh-ancestor
2604863|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604864|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2604865|NCT01789892|Protective Agents|protective agents|mesh-ancestor
2604866|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2604867|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604868|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2604869|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604870|NCT01789957|Exenatide|exenatide|mesh-list
2604871|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2604872|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604873|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2604874|NCT01789957|Incretins|incretins|mesh-ancestor
2604875|NCT01789957|Hormones|hormones|mesh-ancestor
2152998|NCT02819804|Nivolumab|nivolumab|mesh-list
2152999|NCT02819804|Dasatinib|dasatinib|mesh-list
2153000|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2153001|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153002|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2153003|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153004|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2153005|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604876|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604877|NCT01790009|Acetaminophen|acetaminophen|mesh-list
2604878|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2604879|NCT01790009|Analgesics|analgesics|mesh-ancestor
2604880|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
2604881|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604882|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604883|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
2604884|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
2153006|NCT02806960|Glucagon|glucagon|mesh-list
2153007|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2153008|NCT02806960|Hormones|hormones|mesh-ancestor
2153009|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153010|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153011|NCT02815397|Metformin|metformin|mesh-list
2153012|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2153013|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153014|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
2153015|NCT02802592|Hematinics|hematinics|mesh-ancestor
2604885|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2604886|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2604887|NCT01790022|Prednisolone|prednisolone|mesh-list
2604888|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
2604889|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2604890|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
2604891|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2604892|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
2604893|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
2604894|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604895|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604896|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2604897|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
2604898|NCT01790022|Hormones|hormones|mesh-ancestor
2604899|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604900|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2604901|NCT01790022|Protective Agents|protective agents|mesh-ancestor
2604902|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2604903|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2604904|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
2604905|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2604906|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604907|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2604908|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2604909|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153016|NCT02774148|Acetaminophen|acetaminophen|mesh-list
2604910|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604911|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153017|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2153018|NCT02774148|Analgesics|analgesics|mesh-ancestor
2153019|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
2153020|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153021|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604912|NCT01790100|Ribavirin|ribavirin|mesh-list
2604913|NCT01790100|Antimetabolites|antimetabolites|mesh-ancestor
2604914|NCT01790100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153022|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
2153023|NCT02773576|Risperidone|risperidone|mesh-list
2153024|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2153025|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
2153026|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2153027|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153028|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153029|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2153030|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2604915|NCT01790100|Antiviral Agents|antiviral agents|mesh-ancestor
2604916|NCT01790100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604917|NCT01790139|Simethicone|simethicone|mesh-list
2604918|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
2604919|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153031|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153032|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2153033|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2153034|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
2153035|NCT02730793|Aztreonam|aztreonam|mesh-list
2153036|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2153037|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153038|NCT02744352|Ropivacaine|ropivacaine|mesh-list
2153039|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
2153040|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
2153041|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153042|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153043|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
2153044|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153045|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
2153046|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2604920|NCT01790139|Emollients|emollients|mesh-ancestor
2604921|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
2604922|NCT01790165|Terbinafine|terbinafine|mesh-list
2604923|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
2604924|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604925|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2604926|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604927|NCT01790282|Estradiol|estradiol|mesh-list
2604928|NCT01790282|Progesterone|progesterone|mesh-list
2604929|NCT01790282|Estrogens|estrogens|mesh-ancestor
2604930|NCT01790282|Hormones|hormones|mesh-ancestor
2604931|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604932|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604933|NCT01790282|Progestins|progestins|mesh-ancestor
2604934|NCT01790308|Liraglutide|liraglutide|mesh-list
2604935|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2604936|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604937|NCT01790308|Incretins|incretins|mesh-ancestor
2604938|NCT01790308|Hormones|hormones|mesh-ancestor
2604939|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604940|NCT01790464|Lidocaine|lidocaine|mesh-list
2604941|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
2604942|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
2604943|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604944|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604945|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
2604946|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604947|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2604948|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2153047|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
2153048|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
2153049|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153050|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153051|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2604949|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2604950|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2604951|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604952|NCT01790529|Metronidazole|metronidazole|mesh-list
2604953|NCT01790529|Cefuroxime|cefuroxime|mesh-list
2604954|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
2604955|NCT01790529|Anesthetics|anesthetics|mesh-list
2604956|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604957|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604958|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2604959|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2604960|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2604961|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2604962|NCT01790542|Iron|iron|mesh-list
2604963|NCT01790542|Trace Elements|trace elements|mesh-ancestor
2604964|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
2604965|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604966|NCT01790555|Diazepam|diazepam|mesh-list
2604967|NCT01790555|Dronabinol|dronabinol|mesh-list
2604968|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2604969|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
2604970|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
2604971|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
2604972|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2604973|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2604974|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2604975|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2604976|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2604977|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2604978|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2604979|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2604980|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2604981|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2604982|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2604983|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
2604984|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
2604985|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
2604986|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
2604987|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2604988|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2604989|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
2604990|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2604991|NCT01790555|Analgesics|analgesics|mesh-ancestor
2604992|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
2604993|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2604994|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2604995|NCT01790555|Hormones|hormones|mesh-ancestor
2604996|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2604997|NCT01790672|Ethanol|ethanol|mesh-list
2604998|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2604999|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2605000|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605001|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605002|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
2605003|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2605004|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
2605005|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605006|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2605007|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2605008|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
2153052|NCT02757521|Analgesics|analgesics|mesh-ancestor
2153053|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
2153054|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153055|NCT02758132|Denosumab|denosumab|mesh-list
2153056|NCT02758132|Prednisone|prednisone|mesh-list
2153057|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2153058|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
2153059|NCT02758132|Hormones|hormones|mesh-ancestor
2153060|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153061|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153062|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2153063|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153064|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2153065|NCT02734940|Lidocaine|lidocaine|mesh-list
2153066|NCT02734940|Fentanyl|fentanyl|mesh-list
2153067|NCT02734940|Ketamine|ketamine|mesh-list
2153068|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
2153069|NCT02734940|Morphine|morphine|mesh-list
2605009|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605010|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605011|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2605012|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2605013|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2605014|NCT01790893|Aflibercept|aflibercept|mesh-list
2605015|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2605016|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2605017|NCT01790893|Growth Substances|growth substances|mesh-ancestor
2605018|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605019|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
2605020|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605021|NCT01790971|Morphine|morphine|mesh-list
2605022|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2605023|NCT01790971|Narcotics|narcotics|mesh-ancestor
2605024|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605025|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605026|NCT01790971|Analgesics|analgesics|mesh-ancestor
2605027|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
2605028|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605029|NCT01790997|Aspirin|aspirin|mesh-list
2605030|NCT01790997|Clopidogrel|clopidogrel|mesh-list
2605031|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2605032|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2605033|NCT01790997|Analgesics|analgesics|mesh-ancestor
2605034|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
2605035|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605036|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605037|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2605038|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2605039|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2605040|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2605041|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605042|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2605043|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2605044|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605045|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
2605046|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2605047|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2605048|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2605049|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
2605050|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605051|NCT01791088|Sirolimus|sirolimus|mesh-list
2605052|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2153070|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
2153071|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
2153072|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153073|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153074|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
2153075|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605053|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2605054|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2605055|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605056|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
2605057|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2605058|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
2605059|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605060|NCT01791114|Propranolol|propranolol|mesh-list
2605061|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2605062|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2605063|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
2605064|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2153076|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2153077|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2153078|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2153079|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2153080|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153081|NCT02734940|Analgesics|analgesics|mesh-ancestor
2153082|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2153083|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2153084|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
2153085|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2153086|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2153087|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605065|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605066|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153088|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2153089|NCT02734940|Narcotics|narcotics|mesh-ancestor
2153090|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2153091|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2153092|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2153093|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2153094|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2153095|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2153096|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
2153097|NCT02749617|Apixaban|apixaban|mesh-list
2153098|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2153099|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
2153100|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2153101|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
2153102|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153103|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153104|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
2153105|NCT02749227|Pasireotide|pasireotide|mesh-list
2153106|NCT02749227|Hormones|hormones|mesh-ancestor
2153107|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153108|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153109|NCT02746263|Acetaminophen|acetaminophen|mesh-list
2153110|NCT02746263|Morphine|morphine|mesh-list
2153111|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2153112|NCT02746263|Narcotics|narcotics|mesh-ancestor
2153113|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153114|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153115|NCT02746263|Analgesics|analgesics|mesh-ancestor
2153116|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
2153117|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153118|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2153119|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
2153120|NCT02721277|SMOFlipid|smoflipid|mesh-list
2153121|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2605067|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2605068|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2605069|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
2605070|NCT01791166|Antibodies|antibodies|mesh-list
2605071|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
2605072|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605073|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2605074|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2605075|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605076|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2605077|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
2605078|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605079|NCT01791231|Canagliflozin|canagliflozin|mesh-list
2605080|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2605081|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605082|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2605083|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605084|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
2605085|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2605086|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605087|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605088|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2605089|NCT01791296|Analgesics|analgesics|mesh-ancestor
2605090|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
2605091|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605092|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2605093|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2153122|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2153123|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2153124|NCT02732327|Vancomycin|vancomycin|mesh-list
2153125|NCT02732327|Meropenem|meropenem|mesh-list
2605094|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2605095|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
2605096|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605097|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605098|NCT01791309|Panitumumab|panitumumab|mesh-list
2605099|NCT01791309|Vemurafenib|vemurafenib|mesh-list
2605100|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2605101|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153126|NCT02732327|Tazobactam|tazobactam|mesh-list
2153127|NCT02732327|Linezolid|linezolid|mesh-list
2605102|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2605103|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605104|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605105|NCT01791374|Rilotumumab|rilotumumab|mesh-list
2605106|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2605107|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2605108|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605109|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
2605110|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605111|NCT01791400|Sumatriptan|sumatriptan|mesh-list
2605112|NCT01791400|Metoclopramide|metoclopramide|mesh-list
2605113|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
2605114|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
2605115|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153128|NCT02732327|Piperacillin|piperacillin|mesh-list
2153129|NCT02732327|Cefepime|cefepime|mesh-list
2153130|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2153131|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2153132|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153133|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2153134|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153135|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153136|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2153137|NCT02726399|Capecitabine|capecitabine|mesh-list
2153138|NCT02726399|Trastuzumab|trastuzumab|mesh-list
2153139|NCT02726399|Ramucirumab|ramucirumab|mesh-list
2153140|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153141|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2605116|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605117|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2605118|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2605119|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2605120|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
2605121|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605122|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605123|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2605124|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2605125|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2605126|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
2605127|NCT01791439|Lidocaine|lidocaine|mesh-list
2605128|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
2605129|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
2605130|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605131|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605132|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
2605133|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605134|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2605135|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2605136|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2605137|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2605138|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605139|NCT01791478|Letrozole|letrozole|mesh-list
2605140|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
2605141|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605142|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2605143|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2605144|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605145|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605146|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2605147|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
2605148|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605149|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605150|NCT01791608|Zinc|zinc|mesh-list
2605151|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
2605152|NCT01791608|Trace Elements|trace elements|mesh-ancestor
2605153|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
2605154|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605155|NCT01791608|Astringents|astringents|mesh-ancestor
2605156|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
2605157|NCT01791647|Inositol|inositol|mesh-list
2605158|NCT01791647|Metformin|metformin|mesh-list
2605159|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2605160|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605161|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
2605162|NCT01791647|Vitamins|vitamins|mesh-ancestor
2153142|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
2605163|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
2605164|NCT01791699|Moxonidine|moxonidine|mesh-list
2605165|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2605166|NCT01791751|Clomiphene|clomiphene|mesh-list
2605167|NCT01791751|Enclomiphene|enclomiphene|mesh-list
2605168|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
2605169|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2605170|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
2605171|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605172|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605173|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2605174|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
2605175|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2605176|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2605177|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2605178|NCT01791816|Phenylephrine|phenylephrine|mesh-list
2605179|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
2605180|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2605181|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2605182|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
2605183|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
2605184|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605185|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605186|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
2605187|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2605188|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
2605189|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
2605190|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2605191|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2605192|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2605193|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
2605194|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605195|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605196|NCT01791816|Protective Agents|protective agents|mesh-ancestor
2605197|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605198|NCT01791868|Valproic Acid|valproic acid|mesh-list
2605199|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
2605200|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605201|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605202|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
2605203|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605204|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605205|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
2605206|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2605207|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605208|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2605209|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
2605210|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2605211|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2605212|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2153143|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153144|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2153145|NCT02720510|Dexamethasone|dexamethasone|mesh-list
2153146|NCT02720510|Lenalidomide|lenalidomide|mesh-list
2153147|NCT02720510|Bortezomib|bortezomib|mesh-list
2605213|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2605214|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605215|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
2605216|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605217|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605218|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2605219|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605220|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
2605221|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2605222|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2605223|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2605224|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2605225|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605226|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
2605227|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605228|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605229|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2605230|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605231|NCT01791985|Letrozole|letrozole|mesh-list
2605232|NCT01791985|Anastrozole|anastrozole|mesh-list
2153148|NCT02720510|Panobinostat|panobinostat|mesh-list
2153149|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2153150|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
2153151|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
2605233|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605234|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2605235|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2153152|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153153|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153154|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2153155|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
2153156|NCT02720510|Hormones|hormones|mesh-ancestor
2153157|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153158|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2153159|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153160|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
2153161|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2153162|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2153163|NCT02720510|Growth Substances|growth substances|mesh-ancestor
2153164|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
2153165|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2153166|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153167|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153168|NCT02717949|Ribavirin|ribavirin|mesh-list
2153169|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
2153170|NCT02717949|Ledipasvir|ledipasvir|mesh-list
2153171|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
2153172|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153173|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
2153174|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153175|NCT02717130|Aripiprazole|aripiprazole|mesh-list
2153176|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
2153177|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2153178|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2605236|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605237|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605238|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2605239|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
2605240|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605241|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605242|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2605243|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
2605244|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2605245|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2605246|NCT01792037|Prednisolone|prednisolone|mesh-list
2605247|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
2605248|NCT01792037|Midazolam|midazolam|mesh-list
2605249|NCT01792037|Etomidate|etomidate|mesh-list
2605250|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2605251|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
2605252|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2605253|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2605254|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605255|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605256|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2605257|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2605258|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2605259|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2605260|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
2605261|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
2605262|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
2605263|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
2605264|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605265|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605266|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2605267|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
2605268|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
2605269|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605270|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2605271|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
2605272|NCT01792037|Hormones|hormones|mesh-ancestor
2605273|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153179|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2153180|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153181|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153182|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
2153183|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
2153184|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2153185|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153186|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2605274|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2605275|NCT01792037|Protective Agents|protective agents|mesh-ancestor
2605276|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2605277|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605278|NCT01792050|Paclitaxel|paclitaxel|mesh-list
2605279|NCT01792050|Docetaxel|docetaxel|mesh-list
2605280|NCT01792050|Tryptophan|tryptophan|mesh-list
2605281|NCT01792050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2605282|NCT01792050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605283|NCT01792050|Tubulin Modulators|tubulin modulators|mesh-ancestor
2605284|NCT01792050|Antimitotic Agents|antimitotic agents|mesh-ancestor
2605285|NCT01792050|Mitosis Modulators|mitosis modulators|mesh-ancestor
2605286|NCT01792050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605287|NCT01792050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2605288|NCT01792050|Antidepressive Agents|antidepressive agents|mesh-ancestor
2605289|NCT01792050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2605290|NCT01792063|Sevoflurane|sevoflurane|mesh-list
2605291|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2605292|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2605293|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
2605294|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
2605295|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605296|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605297|NCT01792102|Dexamethasone|dexamethasone|mesh-list
2605298|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2605299|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
2605300|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
2605301|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605302|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605303|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2605304|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
2605305|NCT01792102|Hormones|hormones|mesh-ancestor
2605306|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605307|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2605308|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605309|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
2605310|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2605311|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605312|NCT01792375|Dinoprostone|dinoprostone|mesh-list
2605313|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
2605314|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2605315|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605316|NCT01792388|Vitamin D|vitamin d|mesh-list
2605317|NCT01792388|Vitamins|vitamins|mesh-ancestor
2605318|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
2605319|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605320|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2605321|NCT01792505|Imiquimod|imiquimod|mesh-list
2605322|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2153187|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2153188|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
2153189|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2153190|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2153191|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2153192|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2153193|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
2153194|NCT02709083|Dasatinib|dasatinib|mesh-list
2605323|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
2605324|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605325|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605326|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
2605327|NCT01792557|Phenol|phenol|mesh-list
2605328|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2605329|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2605330|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
2605331|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2605332|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2605333|NCT01792570|Darunavir|darunavir|mesh-list
2605334|NCT01792570|Rilpivirine|rilpivirine|mesh-list
2605335|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2605336|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2605337|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
2153195|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153196|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2153197|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153198|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153199|NCT02693171|Dinutuximab|dinutuximab|mesh-list
2153200|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153201|NCT02696226|Aspirin|aspirin|mesh-list
2153202|NCT02696226|Warfarin|warfarin|mesh-list
2153203|NCT02696226|Clopidogrel|clopidogrel|mesh-list
2605338|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605339|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605340|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2605341|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2605342|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
2605343|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2605344|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2605345|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2153204|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2153205|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2153206|NCT02696226|Analgesics|analgesics|mesh-ancestor
2153207|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
2153208|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153209|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153210|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2153211|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2153212|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2153213|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2153214|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153215|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2153216|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2153217|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153218|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
2153219|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2153220|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2153221|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2153222|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
2153223|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2153224|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
2153225|NCT02706691|Infigratinib|infigratinib|mesh-list
2153226|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153227|NCT02708849|Lamotrigine|lamotrigine|mesh-list
2153228|NCT02708849|Ketamine|ketamine|mesh-list
2153229|NCT02708849|Analgesics|analgesics|mesh-ancestor
2153230|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
2153231|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153232|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153233|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2153234|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2153235|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
2153236|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
2153237|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153238|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2153239|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2153240|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2153241|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153242|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
2153243|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2153244|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2153245|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2153246|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2153247|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2153248|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2153249|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2421318|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421319|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2421320|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421321|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421322|NCT00812214|Eszopiclone|eszopiclone|mesh-list
2421323|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2421324|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153250|NCT02693717|Pemetrexed|pemetrexed|mesh-list
2153251|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153252|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153253|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153254|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2153255|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2153256|NCT02693002|Norethindrone|norethindrone|mesh-list
2153257|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
2153258|NCT02693002|Estradiol|estradiol|mesh-list
2153259|NCT02693002|Estrogens|estrogens|mesh-ancestor
2153260|NCT02693002|Hormones|hormones|mesh-ancestor
2153261|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153262|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153263|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2153264|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
2153265|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2153266|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2153267|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2153268|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2605367|NCT01792700|Amoxicillin|amoxicillin|mesh-list
2605368|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
2605369|NCT01792700|Metronidazole|metronidazole|mesh-list
2605370|NCT01792700|Tetracycline|tetracycline|mesh-list
2605371|NCT01792700|Esomeprazole|esomeprazole|mesh-list
2605372|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2605373|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2605374|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2153269|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2153270|NCT02689518|Aflibercept|aflibercept|mesh-list
2153271|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2153272|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2153273|NCT02689518|Growth Substances|growth substances|mesh-ancestor
2153274|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153275|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
2153276|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153277|NCT02687165|Cycloserine|cycloserine|mesh-list
2153278|NCT02687165|Milnacipran|milnacipran|mesh-list
2605375|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2605376|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605377|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605378|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605379|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2605380|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2605381|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2605382|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2605383|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2605384|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2605385|NCT01792713|Sertaconazole|sertaconazole|mesh-list
2153279|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
2153280|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2153281|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153282|NCT02687165|Renal Agents|renal agents|mesh-ancestor
2153283|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2153284|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
2153285|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2153286|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
2153287|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605386|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
2605387|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2605388|NCT01792804|Vancomycin|vancomycin|mesh-list
2605389|NCT01792804|Clindamycin|clindamycin|mesh-list
2605390|NCT01792804|Cefazolin|cefazolin|mesh-list
2605391|NCT01792804|Linezolid|linezolid|mesh-list
2605392|NCT01792804|Daptomycin|daptomycin|mesh-list
2605393|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2605394|NCT01792804|Floxacillin|floxacillin|mesh-list
2153288|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2153289|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2605395|NCT01792804|Cloxacillin|cloxacillin|mesh-list
2605396|NCT01792804|Trimethoprim|trimethoprim|mesh-list
2605397|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
2605398|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2605399|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2605400|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2605401|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605402|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605403|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2605404|NCT01792804|Renal Agents|renal agents|mesh-ancestor
2605405|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
2605406|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2605407|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2605408|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2605409|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2605410|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2605411|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2605412|NCT01792934|Bevacizumab|bevacizumab|mesh-list
2605413|NCT01792934|Irinotecan|irinotecan|mesh-list
2153290|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2153291|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2153292|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153293|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2153294|NCT02687165|Analgesics|analgesics|mesh-ancestor
2153295|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
2153296|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153297|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
2153298|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2153299|NCT02679560|Bupivacaine|bupivacaine|mesh-list
2153300|NCT02679560|Ropivacaine|ropivacaine|mesh-list
2153301|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
2153302|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
2153303|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153304|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605414|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2605415|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605416|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2605417|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2605418|NCT01792934|Growth Substances|growth substances|mesh-ancestor
2605419|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605420|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
2605421|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2605422|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2605423|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605424|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605425|NCT01793038|Clomiphene|clomiphene|mesh-list
2605426|NCT01793038|Enclomiphene|enclomiphene|mesh-list
2605427|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
2605428|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2605429|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605430|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2605431|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
2605432|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605433|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605434|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2605435|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
2605436|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2605437|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2605438|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2605439|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2605440|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605441|NCT01793077|Leuprolide|leuprolide|mesh-list
2605442|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2605443|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
2605444|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2153305|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
2153306|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153307|NCT02674204|Atorvastatin|atorvastatin|mesh-list
2153308|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2153309|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2153310|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
2153311|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153312|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2605445|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605446|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2605447|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605448|NCT01793259|Methotrexate|methotrexate|mesh-list
2605449|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2605450|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
2605451|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2605452|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605453|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2605454|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
2605455|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605456|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605457|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
2605458|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605459|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2605460|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2605461|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
2605462|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2605463|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2605464|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
2605465|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2605466|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605467|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605468|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2605469|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2605470|NCT01793272|Protective Agents|protective agents|mesh-ancestor
2605471|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605472|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
2605473|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2605474|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
2605475|NCT01793350|Benphothiamine|benphothiamine|mesh-list
2605476|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2605477|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
2605478|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605479|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
2605480|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
2605481|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605482|NCT01793480|Methadone|methadone|mesh-list
2605483|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2605484|NCT01793480|Narcotics|narcotics|mesh-ancestor
2605485|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605486|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605487|NCT01793480|Analgesics|analgesics|mesh-ancestor
2605488|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
2605489|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605490|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
2605491|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
2605492|NCT01793519|Adalimumab|adalimumab|mesh-list
2605493|NCT01793519|Etanercept|etanercept|mesh-list
2605494|NCT01793519|Infliximab|infliximab|mesh-list
2605495|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2153313|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2153314|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153315|NCT02671461|Aspirin|aspirin|mesh-list
2153316|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2153317|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2153318|NCT02671461|Analgesics|analgesics|mesh-ancestor
2153319|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
2153320|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153321|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153322|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2153323|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2153324|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2153325|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2153326|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153327|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2605496|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2605497|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2605498|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2605499|NCT01793519|Analgesics|analgesics|mesh-ancestor
2605500|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
2605501|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605502|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605503|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2605504|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2605505|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
2605506|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
2605507|NCT01793636|Everolimus|everolimus|mesh-list
2153328|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2153329|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153330|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
2153331|NCT02663752|Deferasirox|deferasirox|mesh-list
2153332|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2153333|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
2153334|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
2153335|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153336|NCT02658357|Risperidone|risperidone|mesh-list
2153337|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2153338|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
2153339|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2153340|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153341|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153342|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2153343|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2153344|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153345|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2153346|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2153347|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
2153348|NCT02658877|Omalizumab|omalizumab|mesh-list
2153349|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2153350|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2153351|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
2153352|NCT02654639|Bevacizumab|bevacizumab|mesh-list
2605508|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605509|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2605510|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
2605511|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605512|NCT01793753|Propofol|propofol|mesh-list
2605513|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2605514|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605515|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605516|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2605517|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
2605518|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
2605519|NCT01793870|Carvedilol|carvedilol|mesh-list
2605520|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2605521|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2605522|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
2605523|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605524|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605525|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605526|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2605527|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
2605528|NCT01793870|Protective Agents|protective agents|mesh-ancestor
2605529|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2605530|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2605531|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2605532|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
2605533|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2605534|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2605535|NCT01793948|Metformin|metformin|mesh-list
2605536|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2605537|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605538|NCT01794078|Ambrisentan|ambrisentan|mesh-list
2605539|NCT01794078|Aminophylline|aminophylline|mesh-list
2605540|NCT01794078|Theophylline|theophylline|mesh-list
2605541|NCT01794078|Ethylene|ethylene|mesh-list
2605542|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2605543|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
2605544|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605545|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153353|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2605546|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2605547|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
2605548|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2605549|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605550|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605551|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
2605552|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2605553|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2605554|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
2605555|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605556|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2605557|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2605558|NCT01794078|Protective Agents|protective agents|mesh-ancestor
2605559|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2605560|NCT01794078|Growth Substances|growth substances|mesh-ancestor
2605561|NCT01794091|Eplerenone|eplerenone|mesh-list
2605562|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2605563|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
2605564|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605565|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605566|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2605567|NCT01794091|Diuretics|diuretics|mesh-ancestor
2605568|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
2605569|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2605570|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2605571|NCT01794143|Liraglutide|liraglutide|mesh-list
2605572|NCT01794143|Glimepiride|glimepiride|mesh-list
2605573|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2605574|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2605575|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605576|NCT01794143|Incretins|incretins|mesh-ancestor
2605577|NCT01794143|Hormones|hormones|mesh-ancestor
2605578|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605579|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
2605580|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153354|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153355|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2153356|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2153357|NCT02654639|Growth Substances|growth substances|mesh-ancestor
2153358|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153359|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
2153360|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
2153361|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153362|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
2153363|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153364|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153365|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2153366|NCT02634606|Tocotrienols|tocotrienols|mesh-list
2153367|NCT02634606|Vitamin E|vitamin e|mesh-list
2153368|NCT02634606|Tocopherols|tocopherols|mesh-list
2153369|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
2153370|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153371|NCT02634606|Protective Agents|protective agents|mesh-ancestor
2153372|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153373|NCT02634606|Vitamins|vitamins|mesh-ancestor
2153374|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
2153375|NCT02634827|Decitabine|decitabine|mesh-list
2153376|NCT02634827|Midostaurin|midostaurin|mesh-list
2153377|NCT02634827|Staurosporine|staurosporine|mesh-list
2153378|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2153379|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
2153380|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153381|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153382|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153383|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2605581|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605582|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2605583|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2605584|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
2605585|NCT01794169|Cytarabine|cytarabine|mesh-list
2605586|NCT01794169|Azacitidine|azacitidine|mesh-list
2605587|NCT01794169|Daunorubicin|daunorubicin|mesh-list
2605588|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2605589|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
2605590|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605591|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605592|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
2605593|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2605594|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2153384|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2153385|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2153386|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153387|NCT02638129|Naltrexone|naltrexone|mesh-list
2153388|NCT02638129|Bupropion|bupropion|mesh-list
2153389|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2153390|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2153391|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153392|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
2153393|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605595|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
2605596|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153394|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2153395|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
2153396|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2153397|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2153398|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2153399|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2153400|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153401|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
2153402|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2153403|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2153404|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2153405|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153406|NCT02623959|Doxycycline|doxycycline|mesh-list
2153407|NCT02623959|Fentanyl|fentanyl|mesh-list
2153408|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2153409|NCT02623959|Narcotics|narcotics|mesh-ancestor
2153410|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153411|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153412|NCT02623959|Analgesics|analgesics|mesh-ancestor
2153413|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
2153414|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153415|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2153416|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2153417|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
2153418|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
2153419|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2153420|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153421|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
2153422|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2153423|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2153424|NCT02631148|Melatonin|melatonin|mesh-list
2153425|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
2605597|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605598|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2605599|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2605600|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2605601|NCT01794182|Glyburide|glyburide|mesh-list
2605602|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2605603|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605604|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2605605|NCT01794208|Hormones|hormones|mesh-ancestor
2605606|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605607|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605608|NCT01794247|Lidocaine|lidocaine|mesh-list
2605609|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
2605610|NCT01794247|Fentanyl|fentanyl|mesh-list
2605611|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
2605612|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
2605613|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153426|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153427|NCT02631148|Protective Agents|protective agents|mesh-ancestor
2153428|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605614|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605615|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
2605616|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605617|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2605618|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2605619|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2153429|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153430|NCT02630472|Quinine|quinine|mesh-list
2153431|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
2153432|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2153433|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2153434|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2605620|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2605621|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605622|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2605623|NCT01794247|Narcotics|narcotics|mesh-ancestor
2605624|NCT01794247|Analgesics|analgesics|mesh-ancestor
2605625|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2605626|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2605627|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
2605628|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
2605629|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2605630|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2605631|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
2605632|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2605633|NCT01794273|Phenylephrine|phenylephrine|mesh-list
2605634|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
2605635|NCT01794273|Ephedrine|ephedrine|mesh-list
2605636|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2605637|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
2605638|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
2605639|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605640|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605641|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
2605642|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2605643|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
2605644|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
2605645|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2153435|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2153436|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153437|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2153438|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153439|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2153440|NCT02630472|Analgesics|analgesics|mesh-ancestor
2153441|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
2153442|NCT02626520|Gemcitabine|gemcitabine|mesh-list
2153443|NCT02626520|Paclitaxel|paclitaxel|mesh-list
2153444|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2605646|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2605647|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2605648|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
2605649|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605650|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605651|NCT01794273|Protective Agents|protective agents|mesh-ancestor
2605652|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2605653|NCT01794351|Resveratrol|resveratrol|mesh-list
2605654|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
2605655|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605656|NCT01794351|Protective Agents|protective agents|mesh-ancestor
2605657|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605658|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605659|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2605660|NCT01794429|Exenatide|exenatide|mesh-list
2605661|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2605662|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605663|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2153445|NCT02626520|Fluorouracil|fluorouracil|mesh-list
2153446|NCT02626520|Irinotecan|irinotecan|mesh-list
2153447|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2153448|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153449|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
2153450|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
2153451|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
2421325|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421326|NCT00812240|Imatinib Mesylate|imatinib mesylate|mesh-list
2421327|NCT00812240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421328|NCT00812240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2421329|NCT00812240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421330|NCT00812240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421331|NCT00812266|Carboplatin|carboplatin|mesh-list
2421332|NCT00812266|Etoposide|etoposide|mesh-list
2421333|NCT00812266|Topotecan|topotecan|mesh-list
2421334|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605664|NCT01794429|Incretins|incretins|mesh-ancestor
2605665|NCT01794429|Hormones|hormones|mesh-ancestor
2605666|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605667|NCT01794507|Dexamethasone|dexamethasone|mesh-list
2605668|NCT01794507|Bortezomib|bortezomib|mesh-list
2605669|NCT01794507|Venetoclax|venetoclax|mesh-list
2605670|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2605671|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
2153452|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153453|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2153454|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
2153455|NCT02626520|Antiviral Agents|antiviral agents|mesh-ancestor
2153456|NCT02626520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153457|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153458|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2153459|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
2153460|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153461|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2153462|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2153463|NCT02614898|Eculizumab|eculizumab|mesh-list
2153464|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2153465|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2153466|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
2153467|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605672|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
2605673|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605674|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605675|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2605676|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
2605677|NCT01794507|Hormones|hormones|mesh-ancestor
2605678|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605679|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2605680|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605681|NCT01794533|Lidocaine|lidocaine|mesh-list
2605682|NCT01794533|Epinephrine|epinephrine|mesh-list
2605683|NCT01794533|Racepinephrine|racepinephrine|mesh-list
2605684|NCT01794533|Fentanyl|fentanyl|mesh-list
2605685|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
2605686|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
2605687|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
2605688|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605689|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605690|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
2605691|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605692|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2605693|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2605694|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2605695|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2605696|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605697|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2605698|NCT01794533|Narcotics|narcotics|mesh-ancestor
2605699|NCT01794533|Analgesics|analgesics|mesh-ancestor
2605700|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2605701|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2605702|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
2605703|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2605704|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2605705|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
2605706|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605707|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2605708|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2605709|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
2605710|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2153468|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
2153469|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2153470|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153471|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2153472|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153473|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2153474|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
2153475|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2153476|NCT02619812|Antibodies|antibodies|mesh-list
2153477|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
2153478|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605711|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
2605712|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
2605713|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
2605714|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2605715|NCT01794572|Melphalan|melphalan|mesh-list
2605716|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2605717|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
2605718|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605719|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605720|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2605721|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2605722|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
2605723|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605724|NCT01794767|Heparin|heparin|mesh-list
2605725|NCT01794767|Calcium heparin|calcium heparin|mesh-list
2605726|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
2605727|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2605728|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2605729|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605730|NCT01794793|Cabergoline|cabergoline|mesh-list
2605731|NCT01794793|Pasireotide|pasireotide|mesh-list
2605732|NCT01794793|Somatostatin|somatostatin|mesh-list
2605733|NCT01794793|Hormones|hormones|mesh-ancestor
2153479|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2153480|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2153481|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
2153482|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153483|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2153484|NCT02614586|Ondansetron|ondansetron|mesh-list
2605734|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605735|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153485|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
2153486|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
2153487|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153488|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605736|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2605737|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2605738|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
2605739|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
2605740|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605741|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605742|NCT01794897|Valacyclovir|valacyclovir|mesh-list
2605743|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
2605744|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2605745|NCT01794975|Ketamine|ketamine|mesh-list
2605746|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2605747|NCT01794975|Analgesics|analgesics|mesh-ancestor
2605748|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
2605749|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605750|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605751|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2605752|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2605753|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
2605754|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
2153489|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2153490|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
2153491|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
2153492|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2153493|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
2153494|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605755|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605756|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2605757|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2605758|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605759|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605760|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2605761|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2605762|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2605763|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
2605764|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
2605765|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605766|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
2605767|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
2605768|NCT01795131|Vitamins|vitamins|mesh-ancestor
2605769|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
2605770|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605771|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
2605772|NCT01795131|Hematinics|hematinics|mesh-ancestor
2605773|NCT01795144|Glucagon|glucagon|mesh-list
2605774|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2605775|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2605776|NCT01795144|Hormones|hormones|mesh-ancestor
2605777|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605778|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605779|NCT01795144|Incretins|incretins|mesh-ancestor
2605780|NCT01795170|Pyridoxine|pyridoxine|mesh-list
2605781|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
2605782|NCT01795170|Vitamins|vitamins|mesh-ancestor
2605783|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
2605784|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605785|NCT01795183|Amisulpride|amisulpride|mesh-list
2605786|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2605787|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2605788|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605789|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605790|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2605791|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2605792|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
2605793|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605794|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605795|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2605796|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
2605797|NCT01795209|Ranibizumab|ranibizumab|mesh-list
2605798|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2153495|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153496|NCT02614586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2153497|NCT02614586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2153498|NCT02614586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153499|NCT02614586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2605799|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2605800|NCT01795209|Growth Substances|growth substances|mesh-ancestor
2605801|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605802|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
2605803|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605804|NCT01795222|Midazolam|midazolam|mesh-list
2605805|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2605806|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2605807|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605808|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605809|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2605810|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2153500|NCT02614586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2153501|NCT02606279|Valsartan|valsartan|mesh-list
2153502|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2153503|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2153504|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2153505|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153506|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
2153507|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2153508|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
2153509|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153510|NCT02605824|Expectorants|expectorants|mesh-ancestor
2153511|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
2153512|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2153513|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
2605811|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2605812|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2605813|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
2605814|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
2605815|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
2605816|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
2605817|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605818|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605819|NCT01795235|Atenolol|atenolol|mesh-list
2605820|NCT01795235|Glucagon|glucagon|mesh-list
2605821|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2605822|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2605823|NCT01795235|Hormones|hormones|mesh-ancestor
2605824|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605825|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605826|NCT01795235|Incretins|incretins|mesh-ancestor
2605827|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2605828|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2605829|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
2605830|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
2605831|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605832|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2605833|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2605834|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2605835|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
2605836|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605837|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605838|NCT01795248|Liraglutide|liraglutide|mesh-list
2605839|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2605840|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605841|NCT01795248|Incretins|incretins|mesh-ancestor
2605842|NCT01795248|Hormones|hormones|mesh-ancestor
2605843|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605844|NCT01795287|Anesthetics|anesthetics|mesh-list
2605845|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2605846|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605847|NCT01795313|Imiquimod|imiquimod|mesh-list
2605848|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2605849|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
2605850|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605851|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605852|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
2605853|NCT01795430|Etoposide|etoposide|mesh-list
2605854|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
2605855|NCT01795430|Melphalan|melphalan|mesh-list
2605856|NCT01795430|Busulfan|busulfan|mesh-list
2605857|NCT01795430|Topotecan|topotecan|mesh-list
2605858|NCT01795430|Ifosfamide|ifosfamide|mesh-list
2605859|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2605860|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605861|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2605862|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2605863|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605864|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605865|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2605866|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
2605867|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2605868|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2605869|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
2605870|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605871|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2605874|NCT01795599|Mifepristone|mifepristone|mesh-list
2605875|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2605876|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
2605877|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2153514|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153515|NCT02605824|Protective Agents|protective agents|mesh-ancestor
2153516|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153517|NCT02605824|Antidotes|antidotes|mesh-ancestor
2153518|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
2153519|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
2153520|NCT02598622|Vitamins|vitamins|mesh-ancestor
2153521|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
2153522|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153523|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
2153524|NCT02589145|Pyridoxine|pyridoxine|mesh-list
2153525|NCT02589145|Gemcitabine|gemcitabine|mesh-list
2153526|NCT02589145|Dexamethasone|dexamethasone|mesh-list
2153527|NCT02589145|Rituximab|rituximab|mesh-list
2153528|NCT02589145|Lenalidomide|lenalidomide|mesh-list
2153529|NCT02589145|Melphalan|melphalan|mesh-list
2153530|NCT02589145|Busulfan|busulfan|mesh-list
2153531|NCT02589145|Vorinostat|vorinostat|mesh-list
2153532|NCT02589145|Enoxaparin|enoxaparin|mesh-list
2153533|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2153534|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
2153535|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
2153536|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153537|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153538|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2605878|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605879|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2605880|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2605881|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2605882|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
2153539|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
2153540|NCT02589145|Hormones|hormones|mesh-ancestor
2153541|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153542|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2153543|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153544|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2153545|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
2153546|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2153547|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2153548|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
2153549|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153550|NCT02589145|Antiviral Agents|antiviral agents|mesh-ancestor
2153551|NCT02589145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153552|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153553|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2153554|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2153555|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2153556|NCT02589145|Growth Substances|growth substances|mesh-ancestor
2605883|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2605884|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2605885|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
2605886|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605887|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
2605888|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2605889|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2605890|NCT01795664|Fluticasone|fluticasone|mesh-list
2605891|NCT01795664|Xhance|xhance|mesh-list
2605892|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2605893|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2605894|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2605895|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2605896|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
2605897|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2605898|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605899|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2605900|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
2605901|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
2605902|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2605903|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2605904|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2605905|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2605906|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
2605907|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605908|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605909|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
2605910|NCT01795664|Hormones|hormones|mesh-ancestor
2605911|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605912|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
2605913|NCT01795703|Prednisolone|prednisolone|mesh-list
2605914|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2605915|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
2605916|NCT01795703|Hormones|hormones|mesh-ancestor
2605917|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2605918|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605919|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2605920|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605921|NCT01795794|Omeprazole|omeprazole|mesh-list
2605922|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2605923|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2605924|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2605925|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605926|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605927|NCT01795820|Ticagrelor|ticagrelor|mesh-list
2153557|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
2153558|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2153559|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
2153560|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2153561|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
2153562|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2153563|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2153564|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2153565|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
2153566|NCT02589145|Vitamins|vitamins|mesh-ancestor
2153567|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
2605928|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2605929|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2605930|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2605931|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2605932|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
2605933|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605934|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605935|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605936|NCT01795911|Interferons|interferons|mesh-list
2605937|NCT01795911|Ribavirin|ribavirin|mesh-list
2605938|NCT01795911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605939|NCT01795911|Antiviral Agents|antiviral agents|mesh-ancestor
2605940|NCT01795911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2605941|NCT01795911|Antimetabolites|antimetabolites|mesh-ancestor
2605942|NCT01795911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605943|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
2605944|NCT01795976|Fludarabine|fludarabine|mesh-list
2605945|NCT01795976|Interleukin-2|interleukin-2|mesh-list
2605946|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2605947|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
2605948|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605949|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2605950|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2605951|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
2605952|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605953|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605954|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2605955|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2605956|NCT01795976|Analgesics|analgesics|mesh-ancestor
2605957|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
2605958|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153568|NCT02582749|Bicalutamide|bicalutamide|mesh-list
2153569|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2153570|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
2153571|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
2153572|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153573|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153574|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605959|NCT01796002|Romidepsin|romidepsin|mesh-list
2605960|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2605961|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153575|NCT02593682|Suvorexant|suvorexant|mesh-list
2153576|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2153577|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2153578|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153579|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153580|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2153581|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2153582|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153583|NCT02587650|Ceritinib|ceritinib|mesh-list
2153584|NCT02587650|Entrectinib|entrectinib|mesh-list
2153585|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153586|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2153587|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153588|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153589|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
2153590|NCT02569957|Topotecan|topotecan|mesh-list
2605962|NCT01796028|Metformin|metformin|mesh-list
2605963|NCT01796028|Docetaxel|docetaxel|mesh-list
2605964|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2605965|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605966|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2605967|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
2153591|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2153592|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2153593|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2153594|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153595|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153596|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153597|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
2153598|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153599|NCT02569957|Expectorants|expectorants|mesh-ancestor
2153600|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
2605968|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
2605969|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
2153601|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2153602|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
2153603|NCT02569957|Protective Agents|protective agents|mesh-ancestor
2153604|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153605|NCT02569957|Antidotes|antidotes|mesh-ancestor
2153606|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
2153607|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
2153608|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
2153609|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2153610|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2605970|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605971|NCT01796093|Digoxin|digoxin|mesh-list
2605972|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2605973|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2605974|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2605975|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2605976|NCT01796093|Protective Agents|protective agents|mesh-ancestor
2605977|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605978|NCT01796106|Fluorides|fluorides|mesh-list
2605979|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
2605980|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
2605981|NCT01796106|Protective Agents|protective agents|mesh-ancestor
2605982|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605983|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2605984|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
2605985|NCT01796132|Citalopram|citalopram|mesh-list
2605986|NCT01796132|Fluoxetine|fluoxetine|mesh-list
2605987|NCT01796132|Paroxetine|paroxetine|mesh-list
2605988|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2605989|NCT01796132|Sertraline|sertraline|mesh-list
2605990|NCT01796132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2605991|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2605992|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2605993|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153611|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
2153612|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
2153613|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605994|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2605995|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
2605996|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2605997|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2605998|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
2605999|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2606000|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606001|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2606002|NCT01796132|Analgesics|analgesics|mesh-ancestor
2606003|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
2606004|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
2606005|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2606006|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2606007|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606008|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2606009|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2606010|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2606011|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2606012|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2153614|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153615|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153616|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2153617|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
2153618|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2153619|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2153620|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2153621|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153622|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2153623|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
2153624|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153625|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2153626|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2153627|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153628|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
2153629|NCT02549716|Acetaminophen|acetaminophen|mesh-list
2153630|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2153631|NCT02549716|Analgesics|analgesics|mesh-ancestor
2153632|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
2153633|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153634|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153635|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
2153636|NCT02531308|Metformin|metformin|mesh-list
2153637|NCT02531308|Prednisone|prednisone|mesh-list
2606013|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2606014|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606015|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2606016|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153638|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
2153639|NCT02531308|Rituximab|rituximab|mesh-list
2153640|NCT02531308|Doxorubicin|doxorubicin|mesh-list
2153641|NCT02531308|Vincristine|vincristine|mesh-list
2153642|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606017|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606018|NCT01796366|Insulin|insulin|mesh-list
2606019|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2606020|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
2606021|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2606022|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606023|NCT01796405|Clofarabine|clofarabine|mesh-list
2606024|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2606025|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
2606026|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606027|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606028|NCT01796418|Beraprost|beraprost|mesh-list
2606029|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2606030|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
2606031|NCT01796444|Hormones|hormones|mesh-list
2606032|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2606033|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606034|NCT01796483|Clonidine|clonidine|mesh-list
2606035|NCT01796483|Analgesics|analgesics|mesh-ancestor
2606036|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
2606037|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606038|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606039|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2606040|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
2606041|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
2606042|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2606043|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2153643|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
2153644|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153645|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2153646|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2153647|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
2153648|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153649|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153650|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2153651|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2153652|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2153653|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2153654|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2153655|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2153656|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153657|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2153658|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
2606044|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2606045|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
2606046|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2606047|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606048|NCT01796522|Nifedipine|nifedipine|mesh-list
2606049|NCT01796522|Progesterone|progesterone|mesh-list
2153659|NCT02531308|Hormones|hormones|mesh-ancestor
2153660|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153661|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2153662|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2153663|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
2153664|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
2153665|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
2606050|NCT01796522|Progestins|progestins|mesh-ancestor
2606051|NCT01796522|Hormones|hormones|mesh-ancestor
2606052|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153666|NCT02534038|Quinidine|quinidine|mesh-list
2153667|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
2606053|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606054|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2606055|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2606056|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606057|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2606058|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
2606059|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
2606060|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2606061|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2153668|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
2153669|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
2153670|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2153671|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2153672|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2153673|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153674|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153675|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2153676|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2153677|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
2153678|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2153679|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
2153680|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2153681|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2153682|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153683|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153684|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2153685|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2153686|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
2153687|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2153688|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2153689|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2153690|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2153691|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2153692|NCT02520726|Sertraline|sertraline|mesh-list
2153693|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
2153694|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2153695|NCT02520726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2153696|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2153697|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2153698|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153699|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2153700|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
2153701|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153702|NCT02518750|Cytarabine|cytarabine|mesh-list
2153703|NCT02518750|Dexamethasone|dexamethasone|mesh-list
2153704|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
2153705|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
2153706|NCT02518750|Methotrexate|methotrexate|mesh-list
2153707|NCT02518750|Etoposide|etoposide|mesh-list
2153708|NCT02518750|Vincristine|vincristine|mesh-list
2153709|NCT02518750|Bortezomib|bortezomib|mesh-list
2153710|NCT02518750|Asparaginase|asparaginase|mesh-list
2153711|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
2153712|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
2606062|NCT01796613|Desogestrel|desogestrel|mesh-list
2606063|NCT01796613|Etonogestrel|etonogestrel|mesh-list
2606064|NCT01796613|NuvaRing|nuvaring|mesh-list
2606065|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2606066|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2606067|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2606068|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
2606069|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2606070|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606071|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2606072|NCT01796613|Estrogens|estrogens|mesh-ancestor
2606073|NCT01796613|Hormones|hormones|mesh-ancestor
2606074|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2606075|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2606076|NCT01796613|Progestins|progestins|mesh-ancestor
2606077|NCT01796730|Bambuterol|bambuterol|mesh-list
2606078|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2606079|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
2606080|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606081|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606082|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2153713|NCT02518750|Clofarabine|clofarabine|mesh-list
2153714|NCT02518750|Panobinostat|panobinostat|mesh-list
2153715|NCT02518750|Pegaspargase|pegaspargase|mesh-list
2153716|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2153717|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
2153718|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153719|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2153720|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2153721|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
2153722|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153723|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153724|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2153725|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2153726|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
2153727|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
2153728|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153729|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2153730|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
2153731|NCT02518750|Hormones|hormones|mesh-ancestor
2153732|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153733|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2153734|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2153735|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
2153736|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2153737|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2153738|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
2153739|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
2153740|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606083|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
2606084|NCT01796782|Capecitabine|capecitabine|mesh-list
2606085|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2606086|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
2606087|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606088|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606089|NCT01796808|Lidocaine|lidocaine|mesh-list
2606090|NCT01796808|Epinephrine|epinephrine|mesh-list
2606091|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
2153741|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2153742|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2153743|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2153744|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2153745|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2153746|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
2153747|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606092|NCT01796808|Anesthetics|anesthetics|mesh-list
2606093|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2606094|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606095|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
2606096|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606097|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2606098|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2606099|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2606100|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2606101|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606102|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2606103|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2606104|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
2606105|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2606106|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2606107|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2606108|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
2606109|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2606110|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
2606111|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
2606112|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
2606113|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2606114|NCT01796899|Brivaracetam|brivaracetam|mesh-list
2606115|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
2606116|NCT01796938|Lacosamide|lacosamide|mesh-list
2606117|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
2606118|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2606119|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2606120|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2606121|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606122|NCT01796951|Aspirin|aspirin|mesh-list
2606123|NCT01796951|Celecoxib|celecoxib|mesh-list
2153748|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
2153749|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
2153750|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
2153751|NCT02518750|Analgesics|analgesics|mesh-ancestor
2153752|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
2153753|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2153754|NCT02515851|Bupivacaine|bupivacaine|mesh-list
2153755|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
2153756|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
2153757|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153758|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153759|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
2153760|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606124|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2606125|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2606126|NCT01796951|Analgesics|analgesics|mesh-ancestor
2606127|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
2606128|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606129|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606130|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2606131|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2606132|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2606133|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2606134|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606135|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2606136|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2606137|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606138|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
2606139|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2606140|NCT01797107|Azithromycin|azithromycin|mesh-list
2606141|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2606142|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606143|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2606144|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2153761|NCT02506985|Warfarin|warfarin|mesh-list
2153762|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
2153763|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
2153764|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2153765|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
2153766|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2153767|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
2153768|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153769|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606145|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606146|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
2606147|NCT01797198|Repaglinide|repaglinide|mesh-list
2606148|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
2606149|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2606150|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606151|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2606152|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
2606153|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606154|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2153770|NCT02514252|Fentanyl|fentanyl|mesh-list
2153771|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2153772|NCT02514252|Narcotics|narcotics|mesh-ancestor
2153773|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153774|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153775|NCT02514252|Analgesics|analgesics|mesh-ancestor
2153776|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
2153777|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153778|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2153779|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2153780|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
2153781|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
2153782|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
2153783|NCT02501759|Antidotes|antidotes|mesh-ancestor
2153784|NCT02501759|Protective Agents|protective agents|mesh-ancestor
2153785|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153786|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
2153787|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
2153788|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153789|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2153790|NCT02487277|Gemcitabine|gemcitabine|mesh-list
2153791|NCT02487277|Paclitaxel|paclitaxel|mesh-list
2606155|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2153792|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2153793|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153794|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
2153795|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
2153796|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
2153797|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153798|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2153799|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
2153800|NCT02487277|Antiviral Agents|antiviral agents|mesh-ancestor
2153801|NCT02487277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153802|NCT02487277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153803|NCT02487277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2153804|NCT02487277|Immunologic Factors|immunologic factors|mesh-ancestor
2153805|NCT02487277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153806|NCT02499887|Prednisone|prednisone|mesh-list
2153807|NCT02499887|Albuterol|albuterol|mesh-list
2153808|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2153809|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
2153810|NCT02499887|Hormones|hormones|mesh-ancestor
2153811|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153812|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153813|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2153814|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153815|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2153816|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
2153817|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153818|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2153819|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
2153820|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
2153821|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2153822|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2153823|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2153824|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2153825|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
2153826|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2153827|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606156|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2606157|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606158|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
2606159|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2606160|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2606161|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606162|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
2606163|NCT01797289|Coagulants|coagulants|mesh-ancestor
2606164|NCT01797315|Sirolimus|sirolimus|mesh-list
2606165|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2606166|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606167|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2606168|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606169|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
2606170|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606171|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
2606172|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606173|NCT01797341|Tacrolimus|tacrolimus|mesh-list
2606174|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606175|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
2606176|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421335|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2421336|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2421337|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2421338|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421339|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421340|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2421341|NCT00812292|Rilpivirine|rilpivirine|mesh-list
2421342|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2421343|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2421344|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421345|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421346|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
2421347|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421348|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2421349|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2421350|NCT00812318|Cabotegravir|cabotegravir|mesh-list
2421351|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2606177|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2606178|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606179|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606180|NCT01797523|Metformin|metformin|mesh-list
2606181|NCT01797523|Everolimus|everolimus|mesh-list
2606182|NCT01797523|Letrozole|letrozole|mesh-list
2606183|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2606184|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606185|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153828|NCT02504099|Ritonavir|ritonavir|mesh-list
2153829|NCT02504099|Ribavirin|ribavirin|mesh-list
2153830|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2153831|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2153832|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
2153833|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153834|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153835|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2153836|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2153837|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
2153838|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153839|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2153840|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2153841|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
2153842|NCT02500901|Niraparib|niraparib|mesh-list
2153843|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2606186|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606187|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
2606188|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2606189|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2606190|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606191|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606192|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2606193|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
2606194|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2606195|NCT01797601|Insulin|insulin|mesh-list
2606196|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2606197|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2606198|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606199|NCT01797666|Pioglitazone|pioglitazone|mesh-list
2606200|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2606201|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606202|NCT01797718|Letrozole|letrozole|mesh-list
2606203|NCT01797718|Testosterone|testosterone|mesh-list
2606204|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606205|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2606206|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2606207|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606208|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606209|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2606210|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
2606211|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2606212|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606213|NCT01797718|Androgens|androgens|mesh-ancestor
2606214|NCT01797718|Hormones|hormones|mesh-ancestor
2606215|NCT01797757|Orlistat|orlistat|mesh-list
2606216|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606217|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606218|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2606219|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2606220|NCT01797796|Capsaicin|capsaicin|mesh-list
2606221|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
2606222|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
2606223|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
2606224|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606225|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153844|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153845|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153846|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153847|NCT02496039|Quinidine|quinidine|mesh-list
2153848|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
2153849|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
2153850|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
2153851|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2153852|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2153853|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2606226|NCT01797848|Ribavirin|ribavirin|mesh-list
2606227|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2606228|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
2606229|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606230|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
2606231|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606232|NCT01797900|Paclitaxel|paclitaxel|mesh-list
2606233|NCT01797900|Cisplatin|cisplatin|mesh-list
2606234|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2606235|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606236|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
2606237|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
2606238|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
2606239|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606240|NCT01797913|Gemcitabine|gemcitabine|mesh-list
2606241|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2606242|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
2606243|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606244|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606245|NCT01797913|Antiviral Agents|antiviral agents|mesh-ancestor
2606246|NCT01797913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606247|NCT01797913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606248|NCT01797913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606249|NCT01797913|Immunologic Factors|immunologic factors|mesh-ancestor
2606250|NCT01797913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606251|NCT01797926|Losartan|losartan|mesh-list
2606252|NCT01797926|Amlodipine|amlodipine|mesh-list
2606253|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2606254|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2606255|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2606256|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606257|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2606258|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606259|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
2606260|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2606261|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2606262|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2606263|NCT01797978|Methylene Blue|methylene blue|mesh-list
2606264|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153854|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153855|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153856|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2153857|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2153858|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
2153859|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2153860|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
2153861|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2153862|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2153863|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153864|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153865|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2153866|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2153867|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
2606265|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606266|NCT01797991|Dexamethasone|dexamethasone|mesh-list
2606267|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
2606268|NCT01797991|BB 1101|bb 1101|mesh-list
2606269|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2606270|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
2606271|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
2606272|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606273|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606274|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2606275|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
2606276|NCT01797991|Hormones|hormones|mesh-ancestor
2606277|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2606278|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2606279|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606280|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
2606281|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606282|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606283|NCT01798017|Misoprostol|misoprostol|mesh-list
2606284|NCT01798017|Mifepristone|mifepristone|mesh-list
2606285|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2606286|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
2153868|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2153869|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2153870|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2153871|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2153872|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2153873|NCT02492295|Propofol|propofol|mesh-list
2153874|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2153875|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2606287|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2606288|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606289|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2606290|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2606291|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
2606292|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2606293|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2606294|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2606295|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2153876|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153877|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2153878|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
2153879|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
2153880|NCT02473445|Cysteamine|cysteamine|mesh-list
2153881|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2153882|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153883|NCT02491411|Dexamethasone|dexamethasone|mesh-list
2153884|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
2153885|NCT02491411|Ichthammol|ichthammol|mesh-list
2153886|NCT02491411|BB 1101|bb 1101|mesh-list
2153887|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2153888|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
2153889|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
2153890|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153891|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153892|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2153893|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
2153894|NCT02491411|Hormones|hormones|mesh-ancestor
2606296|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
2606297|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2606298|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2606299|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
2606300|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2606301|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
2606302|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2606303|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2606304|NCT01798030|Vitamin D|vitamin d|mesh-list
2606305|NCT01798030|Vitamins|vitamins|mesh-ancestor
2606306|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
2606307|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606308|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2606309|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2606310|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606311|NCT01798251|Capecitabine|capecitabine|mesh-list
2606312|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
2606313|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2606314|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
2606315|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606316|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606317|NCT01798277|Amiodarone|amiodarone|mesh-list
2606318|NCT01798277|Sotalol|sotalol|mesh-list
2606319|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2606320|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
2606321|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2606322|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2606323|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153895|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153896|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2153897|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153898|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
2153899|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153900|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153901|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
2153902|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2153903|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2606324|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2606325|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2606326|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2606327|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606328|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2606329|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2606330|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2606331|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2606332|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2606333|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
2606334|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2606335|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606336|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
2153904|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2153905|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2153906|NCT02468583|Triamcinolone|triamcinolone|mesh-list
2153907|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2153908|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2153909|NCT02468583|FX006|fx006|mesh-list
2153910|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2606337|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
2606338|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606339|NCT01798446|Axitinib|axitinib|mesh-list
2606340|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606341|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2606342|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606343|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153911|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2153912|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
2153913|NCT02468583|Hormones|hormones|mesh-ancestor
2153914|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153915|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153916|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2153917|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
2153918|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153919|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153920|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2153921|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153922|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2153923|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153924|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153925|NCT02469415|Azacitidine|azacitidine|mesh-list
2153926|NCT02469415|Decitabine|decitabine|mesh-list
2153927|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2153928|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
2153929|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153930|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153931|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153932|NCT02434146|Phenylephrine|phenylephrine|mesh-list
2153933|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
2153934|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2153935|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
2153936|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
2606344|NCT01798459|Methylphenidate|methylphenidate|mesh-list
2606345|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2606346|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606347|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2606348|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2153937|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153938|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153939|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
2153940|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2153941|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
2153942|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
2153943|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2153944|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2153945|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2153946|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
2153947|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2153948|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153949|NCT02434146|Protective Agents|protective agents|mesh-ancestor
2153950|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
2153951|NCT02447887|Ixazomib|ixazomib|mesh-list
2153952|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606349|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2606350|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606351|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
2606352|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2606353|NCT01798472|Cimetidine|cimetidine|mesh-list
2606354|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2606355|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2606356|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2606357|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
2606358|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
2606359|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2606360|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606361|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606362|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2606363|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2606364|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606365|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
2606366|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2606367|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
2606368|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606369|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
2606370|NCT01798498|Protective Agents|protective agents|mesh-ancestor
2606371|NCT01798537|Vancomycin|vancomycin|mesh-list
2606372|NCT01798537|Colistin|colistin|mesh-list
2606373|NCT01798537|Nystatin|nystatin|mesh-list
2606374|NCT01798537|Neomycin|neomycin|mesh-list
2606375|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2606376|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606377|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
2606378|NCT01798537|Ionophores|ionophores|mesh-ancestor
2606379|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2606380|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606381|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2606382|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606383|NCT01798576|Interferons|interferons|mesh-list
2606384|NCT01798576|Ribavirin|ribavirin|mesh-list
2606385|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
2606386|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
2606387|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2606388|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606389|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
2606390|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606391|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
2606392|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606393|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
2606394|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606395|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2606396|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2606397|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2606398|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
2606399|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606400|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2606401|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2606402|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606403|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
2606404|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606405|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2606406|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606407|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606408|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
2606409|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2606410|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606411|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2606412|NCT01798680|Vitamin D|vitamin d|mesh-list
2606413|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
2606414|NCT01798680|Vitamins|vitamins|mesh-ancestor
2606415|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
2606416|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606417|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2606418|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2606419|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2606420|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2606421|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
2606422|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2606423|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2606424|NCT01798836|Estradiol|estradiol|mesh-list
2153953|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
2153954|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2153955|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153956|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
2153957|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153958|NCT02439970|Valganciclovir|valganciclovir|mesh-list
2153959|NCT02439970|Brincidofovir|brincidofovir|mesh-list
2153960|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
2153961|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153962|NCT02439957|Valganciclovir|valganciclovir|mesh-list
2153963|NCT02439957|Brincidofovir|brincidofovir|mesh-list
2153964|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
2153965|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153966|NCT02436265|Dexamethasone|dexamethasone|mesh-list
2153967|NCT02436265|Ropivacaine|ropivacaine|mesh-list
2153968|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2153969|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
2153970|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
2153971|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606425|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2421352|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2421353|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421354|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421355|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2421356|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2421357|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
2421358|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421359|NCT00812344|Ketoconazole|ketoconazole|mesh-list
2421360|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
2421361|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421362|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2421363|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2421364|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421365|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2153972|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153973|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2153974|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
2153975|NCT02436265|Hormones|hormones|mesh-ancestor
2606426|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2606427|NCT01798836|Estrogens|estrogens|mesh-ancestor
2606428|NCT01798836|Hormones|hormones|mesh-ancestor
2606429|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2606430|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606431|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2606432|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
2606433|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2606434|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2606435|NCT01798875|Metformin|metformin|mesh-list
2606436|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
2606437|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
2606438|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2606439|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606440|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2606441|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2606442|NCT01798901|Decitabine|decitabine|mesh-list
2606443|NCT01798901|Azacitidine|azacitidine|mesh-list
2606444|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2606445|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2606446|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
2606447|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606448|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606449|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606450|NCT01798914|Insulin|insulin|mesh-list
2153976|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2153977|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2153978|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153979|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
2153980|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
2153981|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2153982|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
2153983|NCT02429583|Vaccines|vaccines|mesh-list
2153984|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
2153985|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153986|NCT02417870|Aldesleukin|aldesleukin|mesh-list
2606451|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2606452|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153987|NCT02417870|Interleukin-2|interleukin-2|mesh-list
2153988|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2153989|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2153990|NCT02417870|Analgesics|analgesics|mesh-ancestor
2153991|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
2153992|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2153993|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2153994|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2153995|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2153996|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
2153997|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2153998|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2153999|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
2154000|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154001|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
2154002|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606453|NCT01798940|Pioglitazone|pioglitazone|mesh-list
2606454|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2606455|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606456|NCT01798979|Midazolam|midazolam|mesh-list
2606457|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2606458|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2606459|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2606460|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606461|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2606462|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2606463|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2606464|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2606465|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
2606466|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
2606467|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
2606468|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
2606469|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154003|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2154004|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
2154005|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154006|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
2154007|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154008|NCT02413047|Methotrexate|methotrexate|mesh-list
2154009|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
2154010|NCT02413047|Azathioprine|azathioprine|mesh-list
2154011|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2154012|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
2154013|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2154014|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154015|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2154016|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
2154017|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154018|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154019|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
2154020|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154021|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2154022|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606470|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606471|NCT01799005|Micronutrients|micronutrients|mesh-list
2606472|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606473|NCT01799057|Metformin|metformin|mesh-list
2606474|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2606475|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606476|NCT01799083|Decitabine|decitabine|mesh-list
2606477|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2606478|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
2606479|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606480|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606481|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606482|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
2606483|NCT01799109|Albuterol|albuterol|mesh-list
2606484|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2606485|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
2606486|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606487|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606488|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2606489|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
2606490|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
2606491|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2606492|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2606493|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2606494|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2154023|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
2154024|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2154025|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2154026|NCT02422303|Ketamine|ketamine|mesh-list
2154027|NCT02422303|Analgesics|analgesics|mesh-ancestor
2154028|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
2154029|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154030|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154031|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2606495|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
2606496|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2606497|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606498|NCT01799109|Analgesics|analgesics|mesh-ancestor
2606499|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
2606500|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
2606501|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2606502|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2606503|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
2606504|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2606505|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2606506|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2606507|NCT01799161|Theophylline|theophylline|mesh-list
2606508|NCT01799161|Vaccines|vaccines|mesh-list
2606509|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
2606510|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606511|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2606512|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
2606513|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606514|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2606515|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
2606516|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2606517|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606518|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606519|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
2606520|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2606521|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2606522|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
2606523|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2606524|NCT01799317|Vitamin D|vitamin d|mesh-list
2606525|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
2606526|NCT01799317|Vitamins|vitamins|mesh-ancestor
2606527|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
2606528|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606529|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2606530|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2606531|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2154032|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2154033|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
2154034|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
2154035|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2154036|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2154037|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2154038|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154039|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606532|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
2606533|NCT01799356|Metronidazole|metronidazole|mesh-list
2606534|NCT01799356|Ofloxacin|ofloxacin|mesh-list
2606535|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2606536|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606537|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
2606538|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2606539|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2606540|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606541|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606542|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606543|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2606544|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2606545|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2606546|NCT01799356|Renal Agents|renal agents|mesh-ancestor
2606547|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2606548|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2606549|NCT01799460|Cyclosporine|cyclosporine|mesh-list
2606550|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
2606551|NCT01799460|Tacrolimus|tacrolimus|mesh-list
2606552|NCT01799460|Cyclosporins|cyclosporins|mesh-list
2606553|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2606554|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
2606555|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
2606556|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606557|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2606558|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2606559|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
2606560|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606561|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606562|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2606563|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2606564|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606565|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
2606566|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606567|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
2606568|NCT01799460|Hormones|hormones|mesh-ancestor
2606569|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2606570|NCT01799486|Adefovir|adefovir|mesh-list
2606571|NCT01799486|Telbivudine|telbivudine|mesh-list
2606572|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
2606573|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606574|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2606575|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2606576|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606577|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606578|NCT01799603|Simeprevir|simeprevir|mesh-list
2606579|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
2606580|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606581|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
2606582|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606583|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606584|NCT01799616|Pamidronate|pamidronate|mesh-list
2606585|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2606586|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606587|NCT01799629|Glycerol|glycerol|mesh-list
2606588|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2606589|NCT01799629|Protective Agents|protective agents|mesh-ancestor
2606590|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606591|NCT01799798|Denosumab|denosumab|mesh-list
2606592|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2606593|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606594|NCT01799850|Pioglitazone|pioglitazone|mesh-list
2606595|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2606596|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606597|NCT01799863|Ketorolac|ketorolac|mesh-list
2154040|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2154041|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2154042|NCT02410551|Vidarabine|vidarabine|mesh-list
2606598|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2606599|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2606600|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
2606601|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2606602|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2154043|NCT02410551|Fludarabine|fludarabine|mesh-list
2154044|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
2154045|NCT02410551|Busulfan|busulfan|mesh-list
2154046|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154047|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2154048|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
2154049|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154050|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154051|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
2154052|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154053|NCT02410551|Antiviral Agents|antiviral agents|mesh-ancestor
2154054|NCT02410551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2154055|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
2154056|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2154057|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2154058|NCT02411643|Calcipotriene|calcipotriene|mesh-list
2606603|NCT01799863|Analgesics|analgesics|mesh-ancestor
2606604|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
2606605|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606606|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606607|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2606608|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2606609|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2606610|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606611|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606612|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2606613|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2606614|NCT01799863|Laxatives|laxatives|mesh-ancestor
2606615|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2606616|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
2606617|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2606618|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2606619|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
2606620|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2606621|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606622|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606623|NCT01799902|Urological Agents|urological agents|mesh-ancestor
2606624|NCT01799954|Vaccines|vaccines|mesh-list
2606625|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
2606626|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606627|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
2606628|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2606629|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
2606630|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2606631|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
2606632|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606633|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606634|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
2606635|NCT01800019|Nicotine|nicotine|mesh-list
2606636|NCT01800019|Varenicline|varenicline|mesh-list
2606637|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2606638|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
2606639|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606640|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606641|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2606642|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2606643|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
2606644|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2606645|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154059|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
2154060|NCT02409355|Gemcitabine|gemcitabine|mesh-list
2154061|NCT02409355|Carboplatin|carboplatin|mesh-list
2154062|NCT02409355|Atezolizumab|atezolizumab|mesh-list
2154063|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154064|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2154065|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
2606646|NCT01800097|Modafinil|modafinil|mesh-list
2606647|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2606648|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606649|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2606650|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2606651|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2606652|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606653|NCT01800227|Metformin|metformin|mesh-list
2606654|NCT01800227|Pioglitazone|pioglitazone|mesh-list
2606655|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2606656|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606657|NCT01800240|Metformin|metformin|mesh-list
2606658|NCT01800240|Pioglitazone|pioglitazone|mesh-list
2606659|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2606660|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606661|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
2606662|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606663|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
2606664|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2154066|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154067|NCT02409355|Antiviral Agents|antiviral agents|mesh-ancestor
2154068|NCT02409355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2154069|NCT02409355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154070|NCT02409355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154071|NCT02409355|Immunologic Factors|immunologic factors|mesh-ancestor
2154072|NCT02409355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154073|NCT02392377|Leucovorin|leucovorin|mesh-list
2154074|NCT02392377|Paclitaxel|paclitaxel|mesh-list
2154075|NCT02392377|Carboplatin|carboplatin|mesh-list
2154076|NCT02392377|Fluorouracil|fluorouracil|mesh-list
2154077|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
2154078|NCT02392377|Calcium|calcium|mesh-list
2154079|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
2606665|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2606666|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606667|NCT01800292|Urological Agents|urological agents|mesh-ancestor
2606668|NCT01800357|Aspirin|aspirin|mesh-list
2606669|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
2606670|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2606671|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2606672|NCT01800357|Analgesics|analgesics|mesh-ancestor
2606673|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
2606674|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606675|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606676|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2606677|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2606678|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2606679|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2606680|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606681|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2606682|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2606683|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606684|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
2606685|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2606686|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
2606687|NCT01800396|Caseins|caseins|mesh-list
2606688|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
2154080|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2154081|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154082|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
2154083|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
2154084|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
2154085|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154086|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2154087|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154088|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
2154089|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2154090|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154091|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
2154092|NCT02392377|Antidotes|antidotes|mesh-ancestor
2154093|NCT02392377|Protective Agents|protective agents|mesh-ancestor
2606689|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
2606690|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606691|NCT01800422|Progesterone|progesterone|mesh-list
2606692|NCT01800422|Progestins|progestins|mesh-ancestor
2606693|NCT01800422|Hormones|hormones|mesh-ancestor
2606694|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2606695|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606696|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
2606697|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
2606698|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2606699|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2606700|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606701|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
2606702|NCT01800435|Coagulants|coagulants|mesh-ancestor
2606703|NCT01800487|Silymarin|silymarin|mesh-list
2606704|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
2606705|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154094|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
2154095|NCT02392377|Vitamins|vitamins|mesh-ancestor
2154096|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
2154097|NCT02394665|Temozolomide|temozolomide|mesh-list
2154098|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2154099|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
2154100|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154101|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154102|NCT02389712|Lamotrigine|lamotrigine|mesh-list
2154103|NCT02389712|Fluoxetine|fluoxetine|mesh-list
2154104|NCT02389712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2154105|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2154106|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2154107|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606706|NCT01800487|Protective Agents|protective agents|mesh-ancestor
2606707|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606708|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
2606709|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2606710|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
2154108|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154109|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
2154110|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154111|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2154112|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
2154113|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2154114|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2154115|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2154116|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154117|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
2154118|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2154119|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2154120|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2154121|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2154122|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2154123|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2606711|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606712|NCT01800526|Expectorants|expectorants|mesh-ancestor
2606713|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
2606714|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2606715|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
2606716|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606717|NCT01800526|Protective Agents|protective agents|mesh-ancestor
2606718|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606719|NCT01800526|Antidotes|antidotes|mesh-ancestor
2606720|NCT01800630|Gemcitabine|gemcitabine|mesh-list
2606721|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2606722|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
2606723|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606724|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606725|NCT01800630|Antiviral Agents|antiviral agents|mesh-ancestor
2606726|NCT01800630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606727|NCT01800630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606728|NCT01800630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606729|NCT01800630|Immunologic Factors|immunologic factors|mesh-ancestor
2606730|NCT01800630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606731|NCT01800643|Busulfan|busulfan|mesh-list
2606732|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
2154124|NCT02390362|Rituximab|rituximab|mesh-list
2154125|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2154126|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606733|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606734|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606735|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
2606736|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606737|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2606738|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606739|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2606740|NCT01800695|Temozolomide|temozolomide|mesh-list
2606741|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2606742|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
2606743|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606744|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606745|NCT01800708|Prednisolone|prednisolone|mesh-list
2606746|NCT01800708|Triamcinolone|triamcinolone|mesh-list
2606747|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2606748|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2606749|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2606750|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2606751|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
2606752|NCT01800708|Hormones|hormones|mesh-ancestor
2606753|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2154127|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
2154128|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154129|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2154130|NCT02383433|Gemcitabine|gemcitabine|mesh-list
2154131|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2154132|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
2154133|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154134|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154135|NCT02383433|Antiviral Agents|antiviral agents|mesh-ancestor
2154136|NCT02383433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606754|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606755|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2606756|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606757|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606758|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
2606759|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606760|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606761|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2606762|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606763|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
2606764|NCT01800799|Celecoxib|celecoxib|mesh-list
2606765|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2606766|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2606767|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2606768|NCT01800799|Analgesics|analgesics|mesh-ancestor
2154137|NCT02383433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154138|NCT02383433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154139|NCT02383433|Immunologic Factors|immunologic factors|mesh-ancestor
2154140|NCT02383433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154141|NCT02382588|Ganciclovir|ganciclovir|mesh-list
2154142|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
2154143|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2154144|NCT02379390|Prednisone|prednisone|mesh-list
2154145|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
2154146|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2154147|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
2154148|NCT02379390|Hormones|hormones|mesh-ancestor
2154149|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2154150|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154151|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2154152|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154153|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2154154|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154155|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154156|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
2606769|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
2606770|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606771|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606772|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2606773|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2606774|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2606775|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606776|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606777|NCT01800825|Clindamycin|clindamycin|mesh-list
2606778|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
2606779|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
2606780|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2606781|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606782|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2606783|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606784|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606785|NCT01800942|Azithromycin|azithromycin|mesh-list
2606786|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2606787|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606788|NCT01801046|Cytarabine|cytarabine|mesh-list
2606789|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
2606790|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2606791|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
2606792|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606793|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606794|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
2606795|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606796|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606797|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
2606798|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606799|NCT01801046|Analgesics|analgesics|mesh-ancestor
2606800|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
2606801|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606802|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2606803|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2606804|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606805|NCT01801072|Levetiracetam|levetiracetam|mesh-list
2606806|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
2606807|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
2606808|NCT01801137|Everolimus|everolimus|mesh-list
2606809|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606810|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606811|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
2606812|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606813|NCT01801163|Sorafenib|sorafenib|mesh-list
2606814|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606815|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2606816|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606817|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606818|NCT01801189|Pregabalin|pregabalin|mesh-list
2606819|NCT01801189|Analgesics|analgesics|mesh-ancestor
2606820|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
2606821|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606822|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606823|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
2606824|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2154157|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2154158|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2154159|NCT02373865|Glimepiride|glimepiride|mesh-list
2154160|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2154161|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154162|NCT02373865|Incretins|incretins|mesh-ancestor
2154163|NCT02373865|Hormones|hormones|mesh-ancestor
2154164|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2606825|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2606826|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606827|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2606828|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2606829|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2606830|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2606831|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2606832|NCT01801228|Eplerenone|eplerenone|mesh-list
2606833|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2606834|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
2606835|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2606836|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606837|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2606838|NCT01801228|Diuretics|diuretics|mesh-ancestor
2606839|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
2606840|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2606841|NCT01801410|Misoprostol|misoprostol|mesh-list
2606842|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2606843|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
2606844|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2606845|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606846|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2606847|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2606848|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
2606849|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
2606850|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606851|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
2606852|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606853|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606854|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2606855|NCT01801644|Gemcitabine|gemcitabine|mesh-list
2606856|NCT01801644|Cisplatin|cisplatin|mesh-list
2606857|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606858|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2606859|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
2606860|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606861|NCT01801644|Antiviral Agents|antiviral agents|mesh-ancestor
2606862|NCT01801644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606863|NCT01801644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606864|NCT01801644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606865|NCT01801644|Immunologic Factors|immunologic factors|mesh-ancestor
2606866|NCT01801644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606867|NCT01801774|Triamcinolone|triamcinolone|mesh-list
2606868|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2606869|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2606870|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2606871|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2606872|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
2606873|NCT01801774|Hormones|hormones|mesh-ancestor
2606874|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2606875|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606876|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606877|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
2154165|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2154166|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
2154167|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154168|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154169|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2154170|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154171|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
2154172|NCT02369744|Tamsulosin|tamsulosin|mesh-list
2154173|NCT02369744|Silodosin|silodosin|mesh-list
2154174|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2154175|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2154176|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2154177|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
2154178|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154179|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154180|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154181|NCT02369744|Urological Agents|urological agents|mesh-ancestor
2154182|NCT02379585|Paclitaxel|paclitaxel|mesh-list
2154183|NCT02379585|Docetaxel|docetaxel|mesh-list
2154184|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
2154185|NCT02379585|Doxorubicin|doxorubicin|mesh-list
2154186|NCT02379585|Trastuzumab|trastuzumab|mesh-list
2154187|NCT02379585|Pertuzumab|pertuzumab|mesh-list
2154188|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2154189|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154190|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
2154191|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
2154192|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
2154193|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154194|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154195|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
2154196|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154197|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2154198|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2154199|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
2154200|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2154201|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2154202|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2154203|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2154204|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154205|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2154206|NCT02370888|Lenalidomide|lenalidomide|mesh-list
2154207|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
2154208|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154209|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2154210|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2154211|NCT02370888|Growth Substances|growth substances|mesh-ancestor
2154212|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
2154213|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154214|NCT02367170|Midazolam|midazolam|mesh-list
2154215|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2154216|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2154217|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2154218|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154219|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2154220|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2154221|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2154222|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2154223|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
2154224|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
2154225|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
2154226|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
2154227|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154228|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154229|NCT02365233|Insulin|insulin|mesh-list
2154230|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2154231|NCT02365233|Pioglitazone|pioglitazone|mesh-list
2154232|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2154233|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
2606878|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606879|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606880|NCT01801904|Panitumumab|panitumumab|mesh-list
2154234|NCT02365233|Saxagliptin|saxagliptin|mesh-list
2154235|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2154236|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2154237|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606881|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2606882|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154238|NCT02365233|Incretins|incretins|mesh-ancestor
2154239|NCT02365233|Hormones|hormones|mesh-ancestor
2154240|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2154241|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
2154242|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154243|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154244|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
2154245|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154246|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
2154247|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154248|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2154249|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2154250|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
2154251|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154252|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154253|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2154254|NCT02353468|Dexamethasone|dexamethasone|mesh-list
2154255|NCT02353468|Lenalidomide|lenalidomide|mesh-list
2154256|NCT02353468|Bortezomib|bortezomib|mesh-list
2606898|NCT01802255|Midazolam|midazolam|mesh-list
2606899|NCT01802255|Sevoflurane|sevoflurane|mesh-list
2606900|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2606901|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2606902|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2606903|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606904|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2606905|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2606906|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2606907|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2606908|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
2154257|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2154258|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
2154259|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
2154260|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154261|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154262|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2154263|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
2154264|NCT02353468|Hormones|hormones|mesh-ancestor
2154265|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2154266|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2154267|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154268|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
2154269|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2154270|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2154271|NCT02353468|Growth Substances|growth substances|mesh-ancestor
2154272|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
2154273|NCT02360059|Metformin|metformin|mesh-list
2606909|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
2606910|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
2606911|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
2606912|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2606913|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606914|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2606915|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2606916|NCT01802268|Sirolimus|sirolimus|mesh-list
2606917|NCT01802268|Tacrolimus|tacrolimus|mesh-list
2606918|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606919|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
2606920|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606921|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2606922|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606923|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606924|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2606925|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606926|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2606927|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606928|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
2606929|NCT01802450|Dasatinib|dasatinib|mesh-list
2606930|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606931|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2606932|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606933|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606934|NCT01802476|Palbociclib|palbociclib|mesh-list
2606935|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606936|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2606937|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606938|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606939|NCT01802489|Amiloride|amiloride|mesh-list
2606940|NCT01802489|Diuretics|diuretics|mesh-ancestor
2606941|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
2606942|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606943|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2606944|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2606945|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2606946|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606947|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2421366|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2421367|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
2421368|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421369|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421370|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2421371|NCT00812370|Bivalirudin|bivalirudin|mesh-list
2421372|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
2421373|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2421374|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
2421375|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421376|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421377|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
2421378|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
2421379|NCT00812396|Testosterone|testosterone|mesh-list
2421380|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
2421381|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
2606948|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2606949|NCT01802502|Rifampin|rifampin|mesh-list
2606950|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2606951|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
2606952|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2606953|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2606954|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
2606955|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2606956|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606957|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154274|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2154275|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154276|NCT02345460|Leucovorin|leucovorin|mesh-list
2154277|NCT02345460|Fluorouracil|fluorouracil|mesh-list
2154278|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
2154279|NCT02345460|Irinotecan|irinotecan|mesh-list
2154280|NCT02345460|Calcium|calcium|mesh-list
2154281|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
2154282|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2606958|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2606959|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2606960|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2606961|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2606962|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2606963|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2606964|NCT01802593|Methotrexate|methotrexate|mesh-list
2606965|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
2606966|NCT01802593|Azathioprine|azathioprine|mesh-list
2606967|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2606968|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
2154283|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154284|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
2154285|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154286|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2154287|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154288|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154289|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
2154290|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2154291|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2606969|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2606970|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606971|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2606972|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
2606973|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606974|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2606975|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
2606976|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2606977|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2606978|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2606979|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
2606980|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2606981|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2606982|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
2606983|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2606984|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
2606985|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2606986|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2606987|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2606988|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
2606989|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2606990|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
2606991|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2606992|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2606993|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2606994|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
2606995|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
2606996|NCT01802619|Protective Agents|protective agents|mesh-ancestor
2606997|NCT01802645|Leucovorin|leucovorin|mesh-list
2606998|NCT01802645|Folic Acid|folic acid|mesh-list
2606999|NCT01802645|Bevacizumab|bevacizumab|mesh-list
2607000|NCT01802645|Cetuximab|cetuximab|mesh-list
2154292|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154293|NCT02345460|Antidotes|antidotes|mesh-ancestor
2154294|NCT02345460|Protective Agents|protective agents|mesh-ancestor
2154295|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
2154296|NCT02345460|Vitamins|vitamins|mesh-ancestor
2154297|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
2154298|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
2154299|NCT02351063|Diuretics|diuretics|mesh-list
2154300|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2154301|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
2154302|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2154303|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
2154304|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154305|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154306|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
2154307|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154308|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2154309|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
2154310|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2154311|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2154312|NCT02345772|Docetaxel|docetaxel|mesh-list
2154313|NCT02345772|Trastuzumab|trastuzumab|mesh-list
2154314|NCT02345772|Fulvestrant|fulvestrant|mesh-list
2154315|NCT02345772|Pertuzumab|pertuzumab|mesh-list
2154316|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154317|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
2154318|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
2154319|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
2154320|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154321|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2154322|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2154323|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2154324|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2607001|NCT01802645|Fluorouracil|fluorouracil|mesh-list
2607002|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
2607003|NCT01802645|Irinotecan|irinotecan|mesh-list
2607004|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
2607005|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2607006|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607007|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2607008|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2607009|NCT01802645|Growth Substances|growth substances|mesh-ancestor
2607010|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607011|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
2607012|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
2607013|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607014|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2607015|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607016|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
2607017|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2607018|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2607019|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607020|NCT01802645|Antidotes|antidotes|mesh-ancestor
2607021|NCT01802645|Protective Agents|protective agents|mesh-ancestor
2607022|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
2607023|NCT01802645|Vitamins|vitamins|mesh-ancestor
2607024|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
2607025|NCT01802645|Hematinics|hematinics|mesh-ancestor
2607026|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
2154325|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
2154326|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2154327|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154328|NCT02353572|Dexamethasone|dexamethasone|mesh-list
2154329|NCT02353572|Bortezomib|bortezomib|mesh-list
2154330|NCT02353572|Melphalan|melphalan|mesh-list
2154331|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2154332|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
2154333|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
2154334|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154335|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154336|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2154337|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
2154338|NCT02353572|Hormones|hormones|mesh-ancestor
2154339|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2607027|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2607028|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607029|NCT01802684|Aflibercept|aflibercept|mesh-list
2607030|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2607031|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2607032|NCT01802684|Growth Substances|growth substances|mesh-ancestor
2607033|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607034|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
2607035|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607036|NCT01802723|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2607037|NCT01802723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2607038|NCT01802723|Autonomic Agents|autonomic agents|mesh-ancestor
2607039|NCT01802723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607040|NCT01802723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607041|NCT01802723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2607042|NCT01802723|Respiratory System Agents|respiratory system agents|mesh-ancestor
2607043|NCT01802723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2607044|NCT01802723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2607045|NCT01802723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2607046|NCT01802723|Adrenergic Agents|adrenergic agents|mesh-ancestor
2607047|NCT01802723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607048|NCT01802723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607049|NCT01802749|Gemcitabine|gemcitabine|mesh-list
2607050|NCT01802749|Paclitaxel|paclitaxel|mesh-list
2607051|NCT01802749|Bevacizumab|bevacizumab|mesh-list
2607052|NCT01802749|Carboplatin|carboplatin|mesh-list
2607053|NCT01802749|Doxorubicin|doxorubicin|mesh-list
2607054|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2607055|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2607056|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607057|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
2607058|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
2607059|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
2607060|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607061|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2607062|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2607063|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2607064|NCT01802749|Growth Substances|growth substances|mesh-ancestor
2607065|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607066|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
2607067|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2607068|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
2607069|NCT01802749|Antiviral Agents|antiviral agents|mesh-ancestor
2607070|NCT01802749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607071|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607072|NCT01802749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607073|NCT01802749|Immunologic Factors|immunologic factors|mesh-ancestor
2607074|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2607075|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2607076|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2607077|NCT01802814|Epratuzumab|epratuzumab|mesh-list
2607078|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2607079|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607080|NCT01802892|Plerixafor|plerixafor|mesh-list
2607081|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2607082|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2607083|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
2607084|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607085|NCT01802918|Ritonavir|ritonavir|mesh-list
2607086|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
2154340|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2154341|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154342|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2154343|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
2154344|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154345|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2154346|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154347|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
2154348|NCT02343263|Bupivacaine|bupivacaine|mesh-list
2607087|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2607088|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2607089|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
2607090|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607091|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607092|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2607093|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2607094|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
2607095|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607096|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2607097|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2607098|NCT01802931|Ketoconazole|ketoconazole|mesh-list
2607099|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
2607100|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607101|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2607102|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2154349|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2154350|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
2154351|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
2154352|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2154353|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154354|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
2154355|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154356|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
2607103|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607104|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607105|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2607106|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
2607107|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2607108|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607109|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2607110|NCT01802944|Insulin|insulin|mesh-list
2607111|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2154357|NCT02343263|Coagulants|coagulants|mesh-ancestor
2154358|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2154359|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
2154360|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154361|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
2154362|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154363|NCT02341495|Vitamin D|vitamin d|mesh-list
2154364|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
2154365|NCT02341495|Azacitidine|azacitidine|mesh-list
2607112|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607113|NCT01802970|Paclitaxel|paclitaxel|mesh-list
2607114|NCT01802970|Vinorelbine|vinorelbine|mesh-list
2607115|NCT01802970|Capecitabine|capecitabine|mesh-list
2607116|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2607117|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2607118|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607119|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
2607120|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
2607121|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
2607122|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607123|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2607124|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
2607125|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2607126|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
2607127|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2607128|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
2607129|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154366|NCT02341495|Deferasirox|deferasirox|mesh-list
2154367|NCT02341495|Vitamins|vitamins|mesh-ancestor
2154368|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
2154369|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154370|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2154371|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2154372|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
2154373|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607130|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607131|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2607132|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
2607133|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2607134|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2607135|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2607136|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
2607137|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607138|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607139|NCT01803152|Gemcitabine|gemcitabine|mesh-list
2607140|NCT01803152|Imiquimod|imiquimod|mesh-list
2607141|NCT01803152|Vaccines|vaccines|mesh-list
2607142|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
2607143|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607144|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2607145|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
2607146|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607147|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154374|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154375|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154376|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2154377|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2154378|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
2154379|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
2154380|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
2154381|NCT02318901|Trastuzumab|trastuzumab|mesh-list
2154382|NCT02318901|Cetuximab|cetuximab|mesh-list
2154383|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2154384|NCT02318901|Maytansine|maytansine|mesh-list
2154385|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2154386|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154387|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2154388|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
2154389|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
2154390|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
2154391|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154392|NCT02317276|Triamcinolone|triamcinolone|mesh-list
2154393|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2154394|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2154395|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2607148|NCT01803152|Antiviral Agents|antiviral agents|mesh-ancestor
2607149|NCT01803152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607150|NCT01803152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607151|NCT01803152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607152|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2607153|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
2607154|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
2607155|NCT01803191|Fosfomycin|fosfomycin|mesh-list
2607156|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2154396|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2607157|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607158|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2607159|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2607160|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607161|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607162|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607163|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2607164|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2607165|NCT01803321|Rilonacept|rilonacept|mesh-list
2607166|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2607167|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2607168|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
2607169|NCT01803347|Coagulants|coagulants|mesh-ancestor
2607170|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
2607171|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2607172|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607173|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2607174|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2607175|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607176|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607177|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607178|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2607179|NCT01803503|Docetaxel|docetaxel|mesh-list
2607180|NCT01803503|Sunitinib|sunitinib|mesh-list
2607181|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607182|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
2607183|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
2607184|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
2607185|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607186|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2607187|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2607188|NCT01803503|Growth Substances|growth substances|mesh-ancestor
2607189|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607190|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
2607191|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2607192|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154397|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
2154398|NCT02317276|Hormones|hormones|mesh-ancestor
2154399|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2154400|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154401|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154402|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
2154403|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154404|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154405|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
2154406|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
2154407|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
2607193|NCT01803555|Budesonide|budesonide|mesh-list
2607194|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
2607195|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2607196|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2607197|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2607198|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
2607199|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607200|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607201|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2607202|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
2154408|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2154409|NCT02299206|Protective Agents|protective agents|mesh-ancestor
2154410|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154411|NCT02302859|Nicotine|nicotine|mesh-list
2154412|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2154413|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
2154414|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154415|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154416|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2154417|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2154418|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
2154419|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154420|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154421|NCT02297230|Paclitaxel|paclitaxel|mesh-list
2154422|NCT02297230|Capecitabine|capecitabine|mesh-list
2154423|NCT02297230|Trastuzumab|trastuzumab|mesh-list
2154424|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2154425|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607203|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
2154426|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
2154427|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
2154428|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
2154429|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154430|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2154431|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
2154432|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2154433|NCT02284906|Pioglitazone|pioglitazone|mesh-list
2607204|NCT01803555|Hormones|hormones|mesh-ancestor
2607205|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2607206|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2607207|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2607208|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2607209|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
2607210|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607211|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607212|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
2607213|NCT01803594|Niacin|niacin|mesh-list
2607214|NCT01803594|Niacinamide|niacinamide|mesh-list
2607215|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
2607216|NCT01803594|Vitamins|vitamins|mesh-ancestor
2607217|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
2607218|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607219|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2607220|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
2607221|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607222|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2607223|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
2607224|NCT01803659|Vitamin A|vitamin a|mesh-list
2607225|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
2607226|NCT01803659|Carotenoids|carotenoids|mesh-list
2607227|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
2607228|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607229|NCT01803659|Protective Agents|protective agents|mesh-ancestor
2607230|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607231|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2607232|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607233|NCT01803659|Vitamins|vitamins|mesh-ancestor
2607234|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
2607235|NCT01803763|Omalizumab|omalizumab|mesh-list
2607236|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2607237|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2607238|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
2607239|NCT01803828|Tadalafil|tadalafil|mesh-list
2607240|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
2607241|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2607242|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2607243|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607244|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607245|NCT01803828|Urological Agents|urological agents|mesh-ancestor
2607246|NCT01804127|Rituximab|rituximab|mesh-list
2607247|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2607248|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607249|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
2607250|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607251|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2607252|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
2607253|NCT01804205|Analgesics|analgesics|mesh-ancestor
2607254|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
2607255|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607256|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607257|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
2607258|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2607259|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2154434|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2154435|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154436|NCT02282332|Ticagrelor|ticagrelor|mesh-list
2607260|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
2607261|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2607262|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2607263|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607264|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2607265|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
2607266|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2607267|NCT01804218|Nadolol|nadolol|mesh-list
2154437|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2154438|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2154439|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2154440|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2154441|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
2154442|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154443|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154444|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154445|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2154446|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2154447|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154448|NCT02276560|Gemcitabine|gemcitabine|mesh-list
2154449|NCT02276560|Paclitaxel|paclitaxel|mesh-list
2154450|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2154451|NCT02276560|Cisplatin|cisplatin|mesh-list
2154452|NCT02276560|Pemetrexed|pemetrexed|mesh-list
2154453|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2154454|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154455|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
2154456|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
2154457|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
2154458|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154459|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2154460|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
2154461|NCT02276560|Antiviral Agents|antiviral agents|mesh-ancestor
2154462|NCT02276560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2154463|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607268|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2607269|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2607270|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
2607271|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607272|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607273|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607274|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2607275|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2607276|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
2607277|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
2607278|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607279|NCT01804244|Rilpivirine|rilpivirine|mesh-list
2607280|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2607281|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2607282|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607283|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607284|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
2607285|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607286|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2607287|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2607288|NCT01804335|Trifarotene|trifarotene|mesh-list
2607289|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
2607290|NCT01804361|Cyclosporine|cyclosporine|mesh-list
2607291|NCT01804361|Cyclosporins|cyclosporins|mesh-list
2421382|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2421383|NCT00812396|Androgens|androgens|mesh-ancestor
2154464|NCT02276560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154465|NCT02276560|Immunologic Factors|immunologic factors|mesh-ancestor
2154466|NCT02276560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154467|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2154468|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2154469|NCT02280252|Paclitaxel|paclitaxel|mesh-list
2154470|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2154471|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154472|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
2154473|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
2154474|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
2154475|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154476|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
2154477|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
2154478|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2154479|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
2421384|NCT00812396|Hormones|hormones|mesh-ancestor
2421385|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421386|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421387|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2421388|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154480|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154481|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607292|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607293|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607294|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607295|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
2607296|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607297|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
2607298|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607299|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
2154482|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2154483|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
2154484|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
2154485|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2607300|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2607301|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2607302|NCT01804374|Everolimus|everolimus|mesh-list
2607303|NCT01804374|Sorafenib|sorafenib|mesh-list
2607304|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607305|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607306|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
2607307|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607308|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2607309|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154486|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
2154487|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154488|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154489|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2154490|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2154491|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2154492|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
2154493|NCT02273752|Everolimus|everolimus|mesh-list
2154494|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154495|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607310|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607311|NCT01804387|Lamivudine|lamivudine|mesh-list
2607312|NCT01804387|Adefovir|adefovir|mesh-list
2607313|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2607314|NCT01804387|Telbivudine|telbivudine|mesh-list
2607315|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2607316|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2607317|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607318|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607319|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
2607320|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607321|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2607322|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2607323|NCT01804400|Montelukast|montelukast|mesh-list
2607324|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2607325|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
2607326|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2607327|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
2607328|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2607329|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607330|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2607331|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2607332|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607333|NCT01804413|Insulin|insulin|mesh-list
2607334|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2607335|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2607336|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607337|NCT01804543|Ranolazine|ranolazine|mesh-list
2607338|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2607339|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2607340|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607341|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
2154496|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
2154497|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154498|NCT02271594|Insulin|insulin|mesh-list
2154499|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2154500|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154501|NCT02263365|Loperamide|loperamide|mesh-list
2154502|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
2607342|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2607343|NCT01804595|Protective Agents|protective agents|mesh-ancestor
2607344|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607345|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
2607346|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
2607347|NCT01804634|Melphalan|melphalan|mesh-list
2607348|NCT01804634|Fludarabine|fludarabine|mesh-list
2607349|NCT01804634|Tacrolimus|tacrolimus|mesh-list
2607350|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607351|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
2154503|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2154504|NCT02266797|Dexamethasone|dexamethasone|mesh-list
2154505|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2154506|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
2154507|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
2607352|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607353|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2607354|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2607355|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
2607356|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607357|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607358|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2607359|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2607360|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607361|NCT01804712|Rituximab|rituximab|mesh-list
2607362|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2607363|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607364|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
2607365|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607366|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2607367|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2607368|NCT01804777|Amiloride|amiloride|mesh-list
2607369|NCT01804777|Diuretics|diuretics|mesh-ancestor
2154508|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154509|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154510|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2154511|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
2154512|NCT02266797|Hormones|hormones|mesh-ancestor
2154513|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2154514|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2154515|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154516|NCT02253394|Ambrisentan|ambrisentan|mesh-list
2607370|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
2607371|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607372|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2607373|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2607374|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2607375|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607376|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2607377|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2607378|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2607379|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2607380|NCT01804790|Capecitabine|capecitabine|mesh-list
2607381|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2607382|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
2607383|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607384|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607385|NCT01804829|Immunoglobulins|immunoglobulins|mesh-list
2607386|NCT01804829|Antibodies|antibodies|mesh-list
2607387|NCT01804829|gamma-Globulins|gamma-globulins|mesh-list
2607388|NCT01804829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2607389|NCT01804829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2607390|NCT01804829|Immunoglobulin G|immunoglobulin g|mesh-list
2607391|NCT01804829|Immunologic Factors|immunologic factors|mesh-ancestor
2607392|NCT01804829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607393|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
2607394|NCT01804985|Dasatinib|dasatinib|mesh-list
2607395|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154517|NCT02253394|Spironolactone|spironolactone|mesh-list
2154518|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2154519|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
2421389|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
2421390|NCT00812422|Ibuprofen|ibuprofen|mesh-list
2421391|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2421392|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2421393|NCT00812422|Analgesics|analgesics|mesh-ancestor
2421394|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
2421395|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607396|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2607397|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607398|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154520|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2154521|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154522|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2154523|NCT02253394|Diuretics|diuretics|mesh-ancestor
2154524|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
2154525|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2154526|NCT02241551|Gemcitabine|gemcitabine|mesh-list
2154527|NCT02241551|Paclitaxel|paclitaxel|mesh-list
2154528|NCT02241551|Fluorouracil|fluorouracil|mesh-list
2154529|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
2154530|NCT02241551|Irinotecan|irinotecan|mesh-list
2154531|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2154532|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154533|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
2154534|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
2154535|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
2154536|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154537|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2154538|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
2154539|NCT02241551|Antiviral Agents|antiviral agents|mesh-ancestor
2154540|NCT02241551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2154541|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154542|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154543|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
2154544|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154545|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2154546|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2154547|NCT02232880|Abatacept|abatacept|mesh-list
2154548|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2607399|NCT01805115|Misoprostol|misoprostol|mesh-list
2607400|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2154549|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154550|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154551|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154552|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
2154553|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154554|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2154555|NCT02239627|Clonidine|clonidine|mesh-list
2154556|NCT02239627|Analgesics|analgesics|mesh-ancestor
2154557|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
2154558|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154559|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154560|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2154561|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
2154562|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
2154563|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2154564|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2154565|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2154566|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
2154567|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154568|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154569|NCT02244944|Ezetimibe|ezetimibe|mesh-list
2154570|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2154571|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2607401|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
2607402|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2607403|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607404|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2607405|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2607406|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
2607407|NCT01805232|Artesunate|artesunate|mesh-list
2607408|NCT01805232|Quinine|quinine|mesh-list
2607409|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
2607410|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2607411|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2607412|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607413|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607414|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
2607415|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
2607416|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2154572|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
2607417|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
2607418|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2154573|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154574|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2154575|NCT02241187|Cetuximab|cetuximab|mesh-list
2154576|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2154577|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154578|NCT02239926|Ranolazine|ranolazine|mesh-list
2154579|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2154580|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2154581|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607419|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607420|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2607421|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607422|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2607423|NCT01805232|Analgesics|analgesics|mesh-ancestor
2607424|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
2607425|NCT01805258|Efavirenz|efavirenz|mesh-list
2607426|NCT01805258|Nevirapine|nevirapine|mesh-list
2607427|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2607428|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2607429|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607430|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607431|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
2607432|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607433|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2607434|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2607435|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2607436|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2607437|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2607438|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2154582|NCT02234011|Ketamine|ketamine|mesh-list
2154583|NCT02234011|Analgesics|analgesics|mesh-ancestor
2154584|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
2154585|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154586|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154587|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2154588|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2154589|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
2154590|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
2154591|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2154592|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2607439|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2607440|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2607441|NCT01805271|Everolimus|everolimus|mesh-list
2607442|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607443|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607444|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
2607445|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607446|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
2607447|NCT01805310|Cathartics|cathartics|mesh-ancestor
2607448|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2607449|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2607450|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607451|NCT01805453|Losartan|losartan|mesh-list
2607452|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2607453|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2607454|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2607455|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2154593|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2154594|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154595|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154596|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
2154597|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2607456|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607457|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
2607458|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2607459|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
2154598|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2154599|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154600|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
2154601|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
2154602|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2154603|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
2154604|NCT02224599|Imiquimod|imiquimod|mesh-list
2154605|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607460|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2607461|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
2607462|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607463|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607464|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
2607465|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
2607466|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2607467|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
2607468|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2607469|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
2607470|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607471|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607472|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
2607473|NCT01805570|Ticagrelor|ticagrelor|mesh-list
2607474|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2607475|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2607476|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2607477|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2607478|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2607479|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
2607480|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607481|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607482|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607483|NCT01805596|Clopidogrel|clopidogrel|mesh-list
2154606|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
2154607|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154608|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2154609|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2154610|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
2154611|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154612|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154613|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2154614|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2154615|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
2154616|NCT02200328|Metronidazole|metronidazole|mesh-list
2154617|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2154618|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2154619|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2154620|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2154621|NCT02181790|Acitretin|acitretin|mesh-list
2154622|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
2154623|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
2154624|NCT02177266|Colchicine|colchicine|mesh-list
2154625|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
2154626|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2154627|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
2154628|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
2607484|NCT01805596|Ticagrelor|ticagrelor|mesh-list
2607485|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2607486|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2607487|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2607488|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2607489|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
2607490|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607491|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607492|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607493|NCT01805700|Caffeine|caffeine|mesh-list
2607494|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2607495|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607496|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2607497|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607498|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421396|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421397|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2421398|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421399|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2421400|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421401|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421402|NCT00812435|Eptifibatide|eptifibatide|mesh-list
2421403|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2421404|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2421405|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
2421406|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154629|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
2154630|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154631|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154632|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2607499|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2607500|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2607501|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
2607502|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607503|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
2607504|NCT01805726|Alfentanil|alfentanil|mesh-list
2607505|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2607506|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2607507|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607508|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2607509|NCT01805726|Analgesics|analgesics|mesh-ancestor
2607510|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
2607511|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607512|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2607513|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2607514|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2607515|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
2607516|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607517|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607518|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2607519|NCT01805726|Narcotics|narcotics|mesh-ancestor
2607520|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2607521|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
2607522|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
2607523|NCT01805804|Valsartan|valsartan|mesh-list
2154633|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2154634|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154635|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2154636|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2154637|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2154638|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154639|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
2154640|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154641|NCT02177773|Octreotide|octreotide|mesh-list
2154642|NCT02177773|Edotreotide|edotreotide|mesh-list
2154643|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2154644|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2154645|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154646|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2607524|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2607525|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2607526|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2607527|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607528|NCT01805817|Copper|copper|mesh-list
2607529|NCT01805817|Drospirenone|drospirenone|mesh-list
2607530|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
2607531|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2607532|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2607533|NCT01805817|Estradiol|estradiol|mesh-list
2607534|NCT01805817|Estrogens|estrogens|mesh-ancestor
2154647|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154648|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
2154649|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
2154650|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2154651|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2154652|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154653|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154654|NCT02162979|Urological Agents|urological agents|mesh-ancestor
2154655|NCT02169830|Topiramate|topiramate|mesh-list
2154656|NCT02169830|Nortriptyline|nortriptyline|mesh-list
2154657|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
2154658|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2154659|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607535|NCT01805817|Hormones|hormones|mesh-ancestor
2607536|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2607537|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607538|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2607539|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
2607540|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2607541|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2154660|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2154661|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
2154662|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2154663|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2154664|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2154665|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2154666|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154667|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
2154668|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154669|NCT02159040|Azacitidine|azacitidine|mesh-list
2154670|NCT02159040|Deferasirox|deferasirox|mesh-list
2154671|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2154672|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
2154673|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154674|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154675|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154676|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2154677|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
2154678|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
2154679|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
2154680|NCT02168270|Temozolomide|temozolomide|mesh-list
2154681|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2154682|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
2154683|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154684|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154685|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
2154686|NCT02168270|Protective Agents|protective agents|mesh-ancestor
2154687|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154688|NCT02168270|Vitamins|vitamins|mesh-ancestor
2154689|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
2154690|NCT02157116|Docetaxel|docetaxel|mesh-list
2154691|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154692|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
2154693|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
2154694|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
2154695|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607542|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2607543|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2607544|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2607545|NCT01805817|Trace Elements|trace elements|mesh-ancestor
2607546|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
2607547|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2607548|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
2607549|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2607550|NCT01805817|Diuretics|diuretics|mesh-ancestor
2607551|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
2607552|NCT01805856|Cefazolin|cefazolin|mesh-list
2607553|NCT01805856|Piperacillin|piperacillin|mesh-list
2607554|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2607555|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607556|NCT01805908|Pertuzumab|pertuzumab|mesh-list
2607557|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2607558|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607559|NCT01805999|Psyllium|psyllium|mesh-list
2607560|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
2607561|NCT01805999|Cathartics|cathartics|mesh-ancestor
2607562|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2607563|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
2607564|NCT01806090|Clopidogrel|clopidogrel|mesh-list
2154696|NCT02152670|Raclopride|raclopride|mesh-list
2154697|NCT02152670|Methylphenidate|methylphenidate|mesh-list
2154698|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
2154699|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2154700|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154701|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2154702|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2154703|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2154704|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154705|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
2154706|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154707|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2154708|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2154709|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2154710|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2607565|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2607566|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2154711|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2154712|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154713|NCT02137096|Carboplatin|carboplatin|mesh-list
2154714|NCT02137096|Etoposide|etoposide|mesh-list
2154715|NCT02137096|Ifosfamide|ifosfamide|mesh-list
2154716|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
2154717|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154718|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2154719|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2154720|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2154721|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154722|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154723|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2154724|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
2154725|NCT02147834|Ranolazine|ranolazine|mesh-list
2154726|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2154727|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2154728|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154729|NCT02144155|Oxytocin|oxytocin|mesh-list
2154730|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
2607567|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2607568|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2607569|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
2607570|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607571|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607572|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607573|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
2607574|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2607575|NCT01806116|Decitabine|decitabine|mesh-list
2607576|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2607577|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
2607578|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607579|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607580|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607581|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
2607582|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
2607583|NCT01806272|Vitamins|vitamins|mesh-ancestor
2607584|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
2607585|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607586|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
2607587|NCT01806272|Hematinics|hematinics|mesh-ancestor
2607588|NCT01806311|Amlodipine|amlodipine|mesh-list
2607589|NCT01806311|Candesartan|candesartan|mesh-list
2607590|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2607591|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2607592|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2607593|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607594|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2154731|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2154732|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154733|NCT02140788|Metformin|metformin|mesh-list
2154734|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2154735|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154736|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
2154737|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2154738|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
2154739|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
2154740|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2607595|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607596|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
2607597|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2607598|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2607599|NCT01806324|Losartan|losartan|mesh-list
2607600|NCT01806324|Atorvastatin|atorvastatin|mesh-list
2607601|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2607602|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2607603|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
2154741|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154742|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2154743|NCT02145169|Analgesics|analgesics|mesh-ancestor
2154744|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
2154745|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154746|NCT02130622|Promethazine|promethazine|mesh-list
2154747|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
2154748|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
2607604|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154749|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
2154750|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2154751|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
2154752|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
2154753|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154754|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154755|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154756|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2421407|NCT00812448|Protective Agents|protective agents|mesh-ancestor
2607605|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2607606|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2607607|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607608|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2607609|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2607610|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2607611|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2607612|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
2607613|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2607614|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607615|NCT01806363|Telmisartan|telmisartan|mesh-list
2607616|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
2607617|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2607618|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2607619|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2607620|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607621|NCT01806363|Diuretics|diuretics|mesh-ancestor
2607622|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
2607623|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607624|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2607625|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2607626|NCT01806376|Maleic acid|maleic acid|mesh-list
2607627|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607628|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607629|NCT01806415|Imidazole|imidazole|mesh-list
2607630|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607631|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607632|NCT01806454|Calcium|calcium|mesh-list
2607633|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2607634|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607635|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2607636|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
2607637|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607638|NCT01806753|Midazolam|midazolam|mesh-list
2607639|NCT01806753|Propofol|propofol|mesh-list
2607640|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2607641|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2607642|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607643|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2607644|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
2607645|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
2607646|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2607647|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2607648|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2607649|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2607650|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
2607651|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
2607652|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607653|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607654|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
2607655|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
2607656|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
2607657|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2607658|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607659|NCT01806792|Vitamins|vitamins|mesh-ancestor
2607660|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
2421408|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421409|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2421410|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2421411|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421412|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2421413|NCT00812513|Becaplermin|becaplermin|mesh-list
2421414|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
2421415|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2421416|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2607661|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2607662|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2607663|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2607664|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154757|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2154758|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2154759|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2154760|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
2154761|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
2154762|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
2154763|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154764|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
2607665|NCT01806805|Zonisamide|zonisamide|mesh-list
2607666|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
2607667|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2607668|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2607669|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607670|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2607671|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607672|NCT01806948|Ramosetron|ramosetron|mesh-list
2607673|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
2154765|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
2154766|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2154767|NCT02133534|Atorvastatin|atorvastatin|mesh-list
2154768|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2154769|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2154770|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
2154771|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154772|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2154773|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2154774|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154775|NCT02134912|Pemetrexed|pemetrexed|mesh-list
2154776|NCT02134912|Crizotinib|crizotinib|mesh-list
2154777|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607674|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
2607675|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607676|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607677|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2607678|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2607679|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
2607680|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607681|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607682|NCT01807078|Ezetimibe|ezetimibe|mesh-list
2154778|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154779|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154780|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2154781|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2154782|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2154783|NCT02131155|Afatinib|afatinib|mesh-list
2154784|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607683|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2607684|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2607685|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
2607686|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607687|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2607688|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2607689|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2607690|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154785|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2154786|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154787|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154788|NCT02117050|Interferons|interferons|mesh-list
2154789|NCT02117050|Interferon-beta|interferon-beta|mesh-list
2154790|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
2154791|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154792|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
2154793|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2154794|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
2154795|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154796|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2154797|NCT02110069|Sirolimus|sirolimus|mesh-list
2154798|NCT02110069|Vincristine|vincristine|mesh-list
2154799|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2154800|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154801|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
2154802|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
2154803|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
2154804|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154805|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2154806|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2154807|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2154808|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
2154809|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154810|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
2154811|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154812|NCT02105116|Cytarabine|cytarabine|mesh-list
2154813|NCT02105116|Fludarabine|fludarabine|mesh-list
2154814|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
2154815|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154816|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2154817|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
2154818|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154819|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154820|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
2154821|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154822|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
2154823|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2154824|NCT02094352|Ketamine|ketamine|mesh-list
2154825|NCT02094352|Analgesics|analgesics|mesh-ancestor
2154826|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
2154827|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154828|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154829|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2154830|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2154831|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
2154832|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
2154833|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2154834|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2154835|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2154836|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2421417|NCT00812513|Growth Substances|growth substances|mesh-ancestor
2421418|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421419|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
2421420|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2421421|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421422|NCT00812578|Vitamins|vitamins|mesh-ancestor
2421423|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
2421424|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2421425|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
2421426|NCT00812669|Rituximab|rituximab|mesh-list
2421427|NCT00812669|Fludarabine|fludarabine|mesh-list
2421428|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
2421429|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2421430|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
2421431|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421432|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421433|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2421434|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
2607715|NCT01807286|Dexamethasone|dexamethasone|mesh-list
2607716|NCT01807286|Melphalan|melphalan|mesh-list
2607717|NCT01807286|Pomalidomide|pomalidomide|mesh-list
2607718|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2607719|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
2607720|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
2154837|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154838|NCT02096042|Azacitidine|azacitidine|mesh-list
2154839|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2154840|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2154841|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
2154842|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154843|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154844|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154845|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2154846|NCT02088957|Phenytoin|phenytoin|mesh-list
2154847|NCT02088957|Brivaracetam|brivaracetam|mesh-list
2154848|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2154849|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
2154850|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2154851|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2154852|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2154853|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154854|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2154855|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2154856|NCT02075411|Bupivacaine|bupivacaine|mesh-list
2154857|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
2154858|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
2154859|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2154860|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154861|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
2154862|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154863|NCT02074904|Topiramate|topiramate|mesh-list
2154864|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
2154865|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2154866|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154867|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
2154868|NCT02081183|Prednisone|prednisone|mesh-list
2154869|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
2154870|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154871|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
2154872|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154873|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2154874|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2154875|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
2154876|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154877|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154878|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2154879|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2154880|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
2154881|NCT02081183|Hormones|hormones|mesh-ancestor
2154882|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2154883|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2154884|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2154885|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2154886|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
2154887|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2154888|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2154889|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607721|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607722|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607723|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2607724|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
2607725|NCT01807286|Hormones|hormones|mesh-ancestor
2607726|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2607727|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2607728|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607729|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2607730|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
2607731|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607732|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2607733|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607734|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
2607735|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2607736|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2607737|NCT01807286|Growth Substances|growth substances|mesh-ancestor
2607738|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
2607739|NCT01807325|Pancrelipase|pancrelipase|mesh-list
2607740|NCT01807325|Pancreatin|pancreatin|mesh-list
2607741|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2607742|NCT01807377|Midazolam|midazolam|mesh-list
2607743|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2607744|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2154890|NCT02075021|Paclitaxel|paclitaxel|mesh-list
2154891|NCT02075021|Lenalidomide|lenalidomide|mesh-list
2154892|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2154893|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154894|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
2607745|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2607746|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607747|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2607748|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2607749|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2607750|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2607751|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
2607752|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
2607753|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
2607754|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
2607755|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607756|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607757|NCT01807429|Midazolam|midazolam|mesh-list
2607758|NCT01807429|Morphine|morphine|mesh-list
2607759|NCT01807429|Ketamine|ketamine|mesh-list
2607760|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2154895|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
2154896|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
2154897|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154898|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
2154899|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154900|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2154901|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2154902|NCT02075021|Growth Substances|growth substances|mesh-ancestor
2154903|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
2154904|NCT02057237|Mitotane|mitotane|mesh-list
2154905|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2154906|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154907|NCT02058537|Bethanechol|bethanechol|mesh-list
2154908|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2154909|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
2154910|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154911|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154912|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2154913|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2154914|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
2154915|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154916|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154917|NCT02038153|Lenalidomide|lenalidomide|mesh-list
2154918|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
2154919|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154920|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2154921|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2154922|NCT02038153|Growth Substances|growth substances|mesh-ancestor
2154923|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
2154924|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154925|NCT02044302|Morphine|morphine|mesh-list
2154926|NCT02044302|Narcotics|narcotics|mesh-list
2154927|NCT02044302|Analgesics|analgesics|mesh-list
2154928|NCT02044302|Bupivacaine|bupivacaine|mesh-list
2154929|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
2154930|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
2154931|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
2154932|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2154933|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154934|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
2154935|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154936|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2154937|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2154938|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2607761|NCT01807429|Narcotics|narcotics|mesh-ancestor
2607762|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2607763|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607764|NCT01807429|Analgesics|analgesics|mesh-ancestor
2607765|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
2607766|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607767|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2607768|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2607769|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
2607770|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
2154939|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154940|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
2154941|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2154942|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2154943|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2154944|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154945|NCT02048904|Incretins|incretins|mesh-ancestor
2154946|NCT02048904|Hormones|hormones|mesh-ancestor
2154947|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2154948|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2154949|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
2154950|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607771|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2607772|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2607773|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607774|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607775|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2607776|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2607777|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2607778|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2607779|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2607780|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
2607781|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
2607782|NCT01807494|Cimetidine|cimetidine|mesh-list
2607783|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2607784|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2607785|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2607786|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
2607787|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
2607788|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607789|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607790|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607791|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2607792|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2607793|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607794|NCT01807546|ON 01910|on 01910|mesh-list
2607795|NCT01807546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607796|NCT01807546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2607797|NCT01807546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607798|NCT01807546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154951|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154952|NCT02044822|Rituximab|rituximab|mesh-list
2154953|NCT02044822|Idelalisib|idelalisib|mesh-list
2154954|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2154955|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154956|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
2154957|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154958|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2154959|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154960|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607799|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
2607800|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
2607801|NCT01807611|Melphalan|melphalan|mesh-list
2607802|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
2607803|NCT01807611|Thiotepa|thiotepa|mesh-list
2607804|NCT01807611|Fludarabine|fludarabine|mesh-list
2607805|NCT01807611|Lenograstim|lenograstim|mesh-list
2607806|NCT01807611|Sargramostim|sargramostim|mesh-list
2607807|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607808|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
2607809|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607810|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2607811|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2607812|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
2607813|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607814|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607815|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2607816|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2607817|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2607818|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2607819|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
2154961|NCT02043860|Melphalan|melphalan|mesh-list
2154962|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
2154963|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154964|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2154965|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
2154966|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154967|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2154968|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2154969|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2154970|NCT02030015|Miglustat|miglustat|mesh-list
2154971|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154972|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154973|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2154974|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2154975|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
2154976|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2154977|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2154978|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2154979|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154980|NCT02015663|Tobramycin|tobramycin|mesh-list
2154981|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2154982|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2154983|NCT02029846|Metformin|metformin|mesh-list
2154984|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2154985|NCT02029846|Incretins|incretins|mesh-list
2154986|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2154987|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2154988|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
2154989|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2154990|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2154991|NCT02029846|Hormones|hormones|mesh-ancestor
2154992|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2154993|NCT02027272|Dexamethasone|dexamethasone|mesh-list
2607820|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2607821|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607822|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607823|NCT01807741|Asenapine|asenapine|mesh-list
2607824|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2607825|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2607826|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2607827|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607828|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2607829|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
2154994|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
2154995|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2154996|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
2154997|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
2154998|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2154999|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155000|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2607830|NCT01807767|Everolimus|everolimus|mesh-list
2607831|NCT01807767|Tacrolimus|tacrolimus|mesh-list
2607832|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607833|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
2607834|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607835|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2607836|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607837|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607838|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607839|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2607840|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2607841|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
2607842|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2607843|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607844|NCT01807832|Capsaicin|capsaicin|mesh-list
2607845|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
2607846|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
2607847|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
2607848|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607849|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155001|NCT02027272|Hormones|hormones|mesh-ancestor
2607850|NCT01807910|Choline|choline|mesh-list
2607851|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
2607852|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2607853|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
2607854|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607855|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2607856|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2607857|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
2607858|NCT01807962|Lidocaine|lidocaine|mesh-list
2607859|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
2607860|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
2607861|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2607862|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607863|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
2607864|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607865|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2607866|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2607867|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2607868|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2607869|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607870|NCT01808014|Nefopam|nefopam|mesh-list
2607871|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2607872|NCT01808014|Analgesics|analgesics|mesh-ancestor
2607873|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
2607874|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607875|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607876|NCT01808131|Lesinurad|lesinurad|mesh-list
2607877|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
2607878|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2607879|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
2607880|NCT01808131|Renal Agents|renal agents|mesh-ancestor
2607881|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
2607882|NCT01808300|Pregabalin|pregabalin|mesh-list
2607883|NCT01808300|Analgesics|analgesics|mesh-ancestor
2607884|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
2607885|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607886|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155002|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155003|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2155004|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155005|NCT02017379|Erythromycin|erythromycin|mesh-list
2155006|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
2155007|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2155008|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
2155009|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2155010|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155011|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2155012|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2155013|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155014|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155015|NCT02008370|Bupivacaine|bupivacaine|mesh-list
2155016|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
2155017|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
2155018|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155019|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155020|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
2155021|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155022|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2155023|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2155024|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155025|NCT02015910|Incretins|incretins|mesh-ancestor
2155026|NCT02015910|Hormones|hormones|mesh-ancestor
2155027|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155028|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2155029|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
2155030|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155031|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607887|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
2607888|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2155032|NCT01986751|Clonidine|clonidine|mesh-list
2155033|NCT01986751|Ropivacaine|ropivacaine|mesh-list
2155034|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
2155035|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
2155036|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155037|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155038|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
2155039|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155040|NCT01986751|Analgesics|analgesics|mesh-ancestor
2155041|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2155042|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
2155043|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
2155044|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2155045|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2155046|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2155047|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
2155048|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2155049|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155050|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
2155051|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155052|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
2155053|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2155054|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2155055|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155056|NCT01996852|Urological Agents|urological agents|mesh-ancestor
2155057|NCT01997567|Ropivacaine|ropivacaine|mesh-list
2155058|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
2155059|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
2155060|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155061|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155062|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
2155063|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155064|NCT01977729|Sertraline|sertraline|mesh-list
2155065|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
2155066|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2607889|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2607890|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607891|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2607892|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2607893|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2607894|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2607895|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2607896|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
2607897|NCT01808300|Protective Agents|protective agents|mesh-ancestor
2155067|NCT01977729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2155068|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2155069|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2155070|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155071|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2155072|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
2155073|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155074|NCT01973062|Rituximab|rituximab|mesh-list
2607898|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
2607899|NCT01808300|Vitamins|vitamins|mesh-ancestor
2607900|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
2607901|NCT01808456|Vaccines|vaccines|mesh-list
2607902|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
2607903|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607904|NCT01808469|Antibodies|antibodies|mesh-list
2607905|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2607906|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
2607907|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155075|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2155076|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2155077|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155078|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
2155079|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155080|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2155081|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2155082|NCT01984268|Hormones|hormones|mesh-ancestor
2155083|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155084|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155085|NCT01974284|Ethanol|ethanol|mesh-list
2155086|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2607908|NCT01808495|Mitomycins|mitomycins|mesh-list
2607909|NCT01808495|Mitomycin|mitomycin|mesh-list
2607910|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2607911|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607912|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
2607913|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607914|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2155087|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155088|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155089|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155090|NCT01971853|Analgesics|analgesics|mesh-list
2155091|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
2155092|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155093|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155094|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
2155095|NCT01980875|Idelalisib|idelalisib|mesh-list
2155096|NCT01980875|Chlorambucil|chlorambucil|mesh-list
2155097|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2155098|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155099|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155100|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155101|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2155102|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
2155103|NCT01980342|Efavirenz|efavirenz|mesh-list
2155104|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2155105|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2155106|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155107|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155108|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
2607915|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607916|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
2607917|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2607918|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
2607919|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607920|NCT01808521|Expectorants|expectorants|mesh-ancestor
2607921|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
2607922|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2607923|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
2607924|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607925|NCT01808521|Protective Agents|protective agents|mesh-ancestor
2607926|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607927|NCT01808521|Antidotes|antidotes|mesh-ancestor
2607928|NCT01808586|Dexamethasone|dexamethasone|mesh-list
2607929|NCT01808586|Betamethasone|betamethasone|mesh-list
2607930|NCT01808586|Lidocaine|lidocaine|mesh-list
2607931|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2607932|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
2607933|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
2607934|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607935|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155109|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155110|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2155111|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2155112|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2155113|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2155114|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2155115|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2155116|NCT01978535|Iron|iron|mesh-list
2155117|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2155118|NCT01978535|Trace Elements|trace elements|mesh-ancestor
2155119|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
2155120|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155121|NCT01978535|Hematinics|hematinics|mesh-ancestor
2155122|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2155123|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2155124|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155125|NCT01970462|Incretins|incretins|mesh-ancestor
2155126|NCT01970462|Hormones|hormones|mesh-ancestor
2155127|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155128|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2155129|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
2155130|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155131|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155132|NCT01969565|Dexamethasone|dexamethasone|mesh-list
2607936|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2607937|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
2607938|NCT01808586|Hormones|hormones|mesh-ancestor
2607939|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2607940|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2607941|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607942|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
2607943|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
2155133|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2155134|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
2155135|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
2155136|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155137|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155138|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2155139|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
2155140|NCT01969565|Hormones|hormones|mesh-ancestor
2155141|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155142|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2155143|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607944|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2607945|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
2607946|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2607947|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2607948|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2607949|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2607950|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607951|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2607952|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
2607953|NCT01808599|Rituximab|rituximab|mesh-list
2607954|NCT01808599|Chlorambucil|chlorambucil|mesh-list
2607955|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2607956|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607957|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
2607958|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607959|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2607960|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2155144|NCT01962974|Golimumab|golimumab|mesh-list
2155145|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2155146|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2155147|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155148|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
2155149|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155150|NCT01951378|Albuterol|albuterol|mesh-list
2155151|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2155152|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
2155153|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155154|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155155|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2155156|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
2155157|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
2155158|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2155159|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2155160|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2155161|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2155162|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
2155163|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2155164|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155165|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2607961|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
2607962|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607963|NCT01808638|Gemcitabine|gemcitabine|mesh-list
2607964|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2607965|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
2607966|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607967|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2607968|NCT01808638|Antiviral Agents|antiviral agents|mesh-ancestor
2607969|NCT01808638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2607970|NCT01808638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2607971|NCT01808638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607972|NCT01808638|Immunologic Factors|immunologic factors|mesh-ancestor
2607973|NCT01808638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607974|NCT01808768|Alcaftadine|alcaftadine|mesh-list
2607975|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2607976|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
2607977|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
2607978|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2607979|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2607980|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155166|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2155167|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2155168|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
2155169|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2155170|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607988|NCT01808898|Bupivacaine|bupivacaine|mesh-list
2155171|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2155172|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2155173|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2155174|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2155175|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2155176|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2155177|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2155178|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2155179|NCT01935947|Gemcitabine|gemcitabine|mesh-list
2155180|NCT01935947|Azacitidine|azacitidine|mesh-list
2155181|NCT01935947|Docetaxel|docetaxel|mesh-list
2155182|NCT01935947|Irinotecan|irinotecan|mesh-list
2155183|NCT01935947|Pemetrexed|pemetrexed|mesh-list
2155184|NCT01935947|Camptothecin|camptothecin|mesh-list
2155185|NCT01935947|Entinostat|entinostat|mesh-list
2607989|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
2607990|NCT01808898|Mepivacaine|mepivacaine|mesh-list
2607991|NCT01808898|Anesthetics|anesthetics|mesh-list
2607992|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2607993|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2607994|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
2155186|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2155187|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2155188|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
2155189|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155190|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155191|NCT01935947|Antiviral Agents|antiviral agents|mesh-ancestor
2607995|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2607996|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
2607997|NCT01808911|Rituximab|rituximab|mesh-list
2607998|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2607999|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
2608000|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608001|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2608002|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2608003|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
2608004|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608005|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608006|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2608007|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2608008|NCT01809041|Remifentanil|remifentanil|mesh-list
2608009|NCT01809041|Propofol|propofol|mesh-list
2608010|NCT01809041|Sevoflurane|sevoflurane|mesh-list
2608011|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2608012|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608013|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608014|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2608015|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
2608016|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
2608017|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2608018|NCT01809041|Narcotics|narcotics|mesh-ancestor
2608019|NCT01809041|Analgesics|analgesics|mesh-ancestor
2608020|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
2608021|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608022|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2608023|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2608024|NCT01809158|Minocycline|minocycline|mesh-list
2608025|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2608026|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155192|NCT01935947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155193|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155194|NCT01935947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155195|NCT01935947|Immunologic Factors|immunologic factors|mesh-ancestor
2155196|NCT01935947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155197|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
2608027|NCT01809171|Vitamin D|vitamin d|mesh-list
2608028|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
2608029|NCT01809171|Vitamins|vitamins|mesh-ancestor
2608030|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
2608031|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608032|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2608033|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2608034|NCT01809184|Insulin|insulin|mesh-list
2608035|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2608036|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
2608037|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2608038|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608039|NCT01809301|Niacin|niacin|mesh-list
2608040|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
2608041|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2608042|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
2608043|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608044|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2608045|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
2608046|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
2608047|NCT01809301|Vitamins|vitamins|mesh-ancestor
2608048|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
2608049|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608050|NCT01809340|Minocycline|minocycline|mesh-list
2608051|NCT01809340|Ketamine|ketamine|mesh-list
2608052|NCT01809340|Analgesics|analgesics|mesh-ancestor
2608053|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
2608054|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608055|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608056|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2155198|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
2155199|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
2155200|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2155201|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2155202|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2155203|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2155204|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2155205|NCT01938716|Gemcitabine|gemcitabine|mesh-list
2155206|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2155207|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
2155208|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155209|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155210|NCT01938716|Antiviral Agents|antiviral agents|mesh-ancestor
2155211|NCT01938716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155212|NCT01938716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155213|NCT01938716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155214|NCT01938716|Immunologic Factors|immunologic factors|mesh-ancestor
2155215|NCT01938716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155216|NCT01936974|Gemcitabine|gemcitabine|mesh-list
2155217|NCT01936974|Bevacizumab|bevacizumab|mesh-list
2155218|NCT01936974|Carboplatin|carboplatin|mesh-list
2155219|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
2155220|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2155221|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155222|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2155223|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2421435|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421436|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421437|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2421438|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2421439|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2421440|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
2608057|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2608058|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
2608059|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
2608060|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608061|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2608062|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2608063|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608064|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608065|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2421441|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2421442|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2421443|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
2421444|NCT00812760|Levodopa|levodopa|mesh-list
2421445|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2608066|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608067|NCT01809379|Cisplatin|cisplatin|mesh-list
2608068|NCT01809379|Doxorubicin|doxorubicin|mesh-list
2608069|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608070|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2608071|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2608072|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2608073|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608074|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608075|NCT01809392|Decitabine|decitabine|mesh-list
2608076|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2608077|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
2608078|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155224|NCT01936974|Growth Substances|growth substances|mesh-ancestor
2155225|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155226|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
2155227|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2155228|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
2155229|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155230|NCT01936974|Antiviral Agents|antiviral agents|mesh-ancestor
2155231|NCT01936974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155232|NCT01936974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155233|NCT01936974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155234|NCT01936974|Immunologic Factors|immunologic factors|mesh-ancestor
2608079|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608080|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608081|NCT01809444|Doxycycline|doxycycline|mesh-list
2155235|NCT01938833|Paclitaxel|paclitaxel|mesh-list
2155236|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2155237|NCT01938833|Romidepsin|romidepsin|mesh-list
2155238|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2155239|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155240|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
2155241|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
2155242|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
2155243|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608082|NCT01809444|Prednisone|prednisone|mesh-list
2608083|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2608084|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
2608085|NCT01809444|Hormones|hormones|mesh-ancestor
2608086|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2608087|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608088|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2608089|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608090|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2608091|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608092|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
2608093|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2608094|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2608095|NCT01809626|Zolpidem|zolpidem|mesh-list
2608096|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2608097|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2608098|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608099|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155244|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2155245|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2155246|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2155247|NCT01928082|Estradiol|estradiol|mesh-list
2155248|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2155249|NCT01928082|Estrogens|estrogens|mesh-ancestor
2155250|NCT01928082|Hormones|hormones|mesh-ancestor
2155251|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155252|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155253|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2155254|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
2155255|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2155256|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2155257|NCT01928615|Trastuzumab|trastuzumab|mesh-list
2155258|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2155259|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2155260|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608100|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2608101|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
2608102|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
2608103|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608104|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608105|NCT01809691|Bicalutamide|bicalutamide|mesh-list
2608106|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
2608107|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
2608108|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155261|NCT01910389|Tadalafil|tadalafil|mesh-list
2155262|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
2155263|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2155264|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2155265|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155266|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608109|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608110|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608111|NCT01809743|Adenosine|adenosine|mesh-list
2608112|NCT01809743|Regadenoson|regadenoson|mesh-list
2608113|NCT01809743|Analgesics|analgesics|mesh-ancestor
2608114|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
2608115|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608116|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608117|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2608118|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
2608119|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2608120|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
2608121|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
2608122|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608123|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608124|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2608125|NCT01809808|Hormones|hormones|mesh-list
2608126|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2608127|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608128|NCT01809847|Ofatumumab|ofatumumab|mesh-list
2608129|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608130|NCT01809860|Sirolimus|sirolimus|mesh-list
2608131|NCT01809860|Isavuconazole|isavuconazole|mesh-list
2608132|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2608133|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608134|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2608135|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608136|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
2608137|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2608138|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
2608139|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608140|NCT01809886|Neostigmine|neostigmine|mesh-list
2608141|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2608142|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608143|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608144|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
2608145|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608146|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608147|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2608148|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
2155267|NCT01910389|Urological Agents|urological agents|mesh-ancestor
2155268|NCT01916590|Bupivacaine|bupivacaine|mesh-list
2155269|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
2155270|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
2155271|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155272|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155273|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
2155274|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155275|NCT01913327|Risperidone|risperidone|mesh-list
2155276|NCT01913327|Aripiprazole|aripiprazole|mesh-list
2155277|NCT01913327|Modafinil|modafinil|mesh-list
2155278|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2155279|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
2155280|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2155281|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155282|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155283|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2155284|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2155285|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155286|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2155287|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2155288|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
2155289|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
2155290|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
2608149|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421446|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2421447|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
2421448|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2421449|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421450|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421451|NCT00812786|Cyclosporine|cyclosporine|mesh-list
2421452|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
2421453|NCT00812786|Everolimus|everolimus|mesh-list
2421454|NCT00812786|Tacrolimus|tacrolimus|mesh-list
2421455|NCT00812786|Cyclosporins|cyclosporins|mesh-list
2421456|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2421457|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
2421458|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421459|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2421460|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421461|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608150|NCT01809925|Psyllium|psyllium|mesh-list
2608151|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
2608152|NCT01809925|Cathartics|cathartics|mesh-ancestor
2608153|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2608154|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
2608155|NCT01810185|Naltrexone|naltrexone|mesh-list
2608156|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2608157|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2155291|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2155292|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2155293|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2155294|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2155295|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2155296|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2155297|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2155298|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2155299|NCT01901224|Metformin|metformin|mesh-list
2155300|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2608158|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608159|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
2608160|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608161|NCT01810237|Dabigatran|dabigatran|mesh-list
2608162|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
2608163|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2608164|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
2608165|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608166|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155301|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155302|NCT01910441|Metformin|metformin|mesh-list
2155303|NCT01910441|Glimepiride|glimepiride|mesh-list
2155304|NCT01910441|Vildagliptin|vildagliptin|mesh-list
2155305|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2155306|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155307|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2155308|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2608167|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
2608168|NCT01810315|Estradiol|estradiol|mesh-list
2608169|NCT01810315|Estrogens|estrogens|mesh-ancestor
2608170|NCT01810315|Hormones|hormones|mesh-ancestor
2608171|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2608172|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608173|NCT01810354|Cefazolin|cefazolin|mesh-list
2608174|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2608175|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608176|NCT01810367|Gemcitabine|gemcitabine|mesh-list
2608177|NCT01810367|Cisplatin|cisplatin|mesh-list
2608178|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155309|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
2155310|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2155311|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
2155312|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155313|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155314|NCT01902966|Propranolol|propranolol|mesh-list
2155315|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2155316|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2155317|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
2155318|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2155319|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155320|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155321|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2155322|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2155323|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
2155324|NCT01901679|Celecoxib|celecoxib|mesh-list
2155325|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2155326|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2155327|NCT01901679|Analgesics|analgesics|mesh-ancestor
2155328|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
2155329|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155330|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155331|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2155332|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2155333|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2155334|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2155335|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155336|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155337|NCT01900730|Valproic Acid|valproic acid|mesh-list
2155338|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
2155339|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155340|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155341|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
2608179|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2608180|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
2608181|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608182|NCT01810367|Antiviral Agents|antiviral agents|mesh-ancestor
2608183|NCT01810367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608184|NCT01810367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608185|NCT01810367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2608186|NCT01810367|Immunologic Factors|immunologic factors|mesh-ancestor
2608187|NCT01810367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608188|NCT01810393|Trastuzumab|trastuzumab|mesh-list
2608189|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2608190|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608191|NCT01810458|Acetaminophen|acetaminophen|mesh-list
2608192|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2608193|NCT01810458|Lidocaine|lidocaine|mesh-list
2155342|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2155343|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155344|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
2155345|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2155346|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608194|NCT01810458|Fentanyl|fentanyl|mesh-list
2608195|NCT01810458|Midazolam|midazolam|mesh-list
2608196|NCT01810458|Oxycodone|oxycodone|mesh-list
2608197|NCT01810458|Lorazepam|lorazepam|mesh-list
2608198|NCT01810458|Ondansetron|ondansetron|mesh-list
2608199|NCT01810458|Liver Extracts|liver extracts|mesh-list
2608200|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
2608201|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
2608202|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608203|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608204|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
2608205|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608206|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2608207|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2608208|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2608209|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2608210|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608211|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2608212|NCT01810458|Narcotics|narcotics|mesh-ancestor
2608213|NCT01810458|Analgesics|analgesics|mesh-ancestor
2608214|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2608215|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2608216|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
2608217|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2608218|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2608219|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2608220|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2608221|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
2608222|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
2608223|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608224|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2608225|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
2608226|NCT01810458|Hematinics|hematinics|mesh-ancestor
2608227|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
2608228|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
2608229|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2155347|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2155348|NCT01877564|Metformin|metformin|mesh-list
2155349|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2155350|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155351|NCT01890694|Tolvaptan|tolvaptan|mesh-list
2155352|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2155353|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608230|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
2608231|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
2608232|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2608233|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
2608234|NCT01810458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2608235|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
2608236|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2608237|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2608238|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2608239|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2608240|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2608241|NCT01810575|Alprostadil|alprostadil|mesh-list
2608242|NCT01810575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2608243|NCT01810575|Vasodilator Agents|vasodilator agents|mesh-ancestor
2608244|NCT01810575|Urological Agents|urological agents|mesh-ancestor
2608245|NCT01810588|Vidarabine|vidarabine|mesh-list
2608246|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
2608247|NCT01810588|Rituximab|rituximab|mesh-list
2608248|NCT01810588|Fludarabine|fludarabine|mesh-list
2608249|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
2608250|NCT01810588|Melphalan|melphalan|mesh-list
2608251|NCT01810588|Tacrolimus|tacrolimus|mesh-list
2608252|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2608253|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
2608254|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2608255|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608256|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
2608257|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608258|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2608259|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2608260|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
2608261|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608262|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2608263|NCT01810588|Antiviral Agents|antiviral agents|mesh-ancestor
2608264|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608265|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2608266|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608267|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2608268|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2608269|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
2608270|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2608271|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2608272|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
2608273|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2608274|NCT01810601|Progesterone|progesterone|mesh-list
2608275|NCT01810601|Progestins|progestins|mesh-ancestor
2608276|NCT01810601|Hormones|hormones|mesh-ancestor
2608277|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2608278|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608279|NCT01810640|Liver Extracts|liver extracts|mesh-list
2608280|NCT01810640|Hematinics|hematinics|mesh-ancestor
2155354|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
2155355|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155356|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
2155357|NCT01890577|Hematinics|hematinics|mesh-ancestor
2155358|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
2155359|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2155360|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
2155361|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155362|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
2155363|NCT01895959|Protective Agents|protective agents|mesh-ancestor
2608281|NCT01810705|Asparaginase|asparaginase|mesh-list
2608282|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608283|NCT01810731|Vaccines|vaccines|mesh-list
2608284|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
2608285|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608286|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2155364|NCT01889420|Everolimus|everolimus|mesh-list
2608287|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608288|NCT01810796|Ranolazine|ranolazine|mesh-list
2608289|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2155365|NCT01889420|Pomalidomide|pomalidomide|mesh-list
2155366|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155367|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155368|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
2155369|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155370|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2608290|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2608291|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608292|NCT01810809|Hylan|hylan|mesh-list
2608293|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
2608294|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
2608295|NCT01810809|Protective Agents|protective agents|mesh-ancestor
2608296|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608297|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2608298|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
2608299|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
2608300|NCT01810848|Hylan|hylan|mesh-list
2608301|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2608302|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
2608303|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608304|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
2155371|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2155372|NCT01889420|Growth Substances|growth substances|mesh-ancestor
2155373|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
2155374|NCT01881984|Glycerol|glycerol|mesh-list
2155375|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2155376|NCT01881984|Protective Agents|protective agents|mesh-ancestor
2155377|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155378|NCT01893359|Riboflavin|riboflavin|mesh-list
2155379|NCT01893359|Dextrans|dextrans|mesh-list
2155380|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2155381|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2155382|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
2155383|NCT01893359|Vitamins|vitamins|mesh-ancestor
2155384|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
2155385|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155386|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2155387|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
2155388|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
2608305|NCT01810848|Protective Agents|protective agents|mesh-ancestor
2608306|NCT01810887|Ritonavir|ritonavir|mesh-list
2608307|NCT01810887|Darunavir|darunavir|mesh-list
2608308|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2608309|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2608310|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
2608311|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608312|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608313|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2608314|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2608315|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
2608316|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608317|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2608318|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2608319|NCT01810926|Cyclosporine|cyclosporine|mesh-list
2608320|NCT01810926|Rituximab|rituximab|mesh-list
2608321|NCT01810926|Methotrexate|methotrexate|mesh-list
2608322|NCT01810926|Fludarabine|fludarabine|mesh-list
2608323|NCT01810926|Thiotepa|thiotepa|mesh-list
2608324|NCT01810926|Treosulfan|treosulfan|mesh-list
2608325|NCT01810926|Antibodies|antibodies|mesh-list
2608326|NCT01810926|Cyclosporins|cyclosporins|mesh-list
2608327|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
2608328|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608329|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2608330|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608331|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2608332|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2608333|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
2608334|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2608335|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2608336|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
2608337|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608338|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
2608339|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155389|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
2155390|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
2155391|NCT01887288|Capecitabine|capecitabine|mesh-list
2608340|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2608341|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2608342|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2608343|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
2608344|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608345|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2608346|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2608347|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
2608348|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2608349|NCT01811056|Mifepristone|mifepristone|mesh-list
2608350|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2608351|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
2608352|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2608353|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608354|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2608355|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2608356|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2155392|NCT01887288|Digoxin|digoxin|mesh-list
2155393|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2155394|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
2155395|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155396|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155397|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2155398|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2155399|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155400|NCT01887288|Protective Agents|protective agents|mesh-ancestor
2155401|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155402|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
2155403|NCT01878786|Everolimus|everolimus|mesh-list
2155404|NCT01878786|Tacrolimus|tacrolimus|mesh-list
2155405|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155406|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
2155407|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155408|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2155409|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155410|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155411|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155412|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2155413|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2155414|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
2155415|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2155416|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155417|NCT01861717|Lanreotide|lanreotide|mesh-list
2155418|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155419|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
2155420|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
2155421|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
2155422|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155423|NCT01860040|Gemcitabine|gemcitabine|mesh-list
2155424|NCT01860040|Pemetrexed|pemetrexed|mesh-list
2155425|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155426|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2155427|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
2155428|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155429|NCT01860040|Antiviral Agents|antiviral agents|mesh-ancestor
2155430|NCT01860040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155431|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155432|NCT01860040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155433|NCT01860040|Immunologic Factors|immunologic factors|mesh-ancestor
2155434|NCT01860040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155435|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2155436|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2155437|NCT01851174|Gemcitabine|gemcitabine|mesh-list
2155438|NCT01851174|Paclitaxel|paclitaxel|mesh-list
2155439|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2155440|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155441|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
2155442|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
2155443|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
2155444|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155445|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2155446|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
2155447|NCT01851174|Antiviral Agents|antiviral agents|mesh-ancestor
2155448|NCT01851174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155449|NCT01851174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155450|NCT01851174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2608357|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
2608358|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2608359|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2608360|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
2608361|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2608362|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
2608363|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2608364|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2608365|NCT01811160|Melatonin|melatonin|mesh-list
2608366|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
2155451|NCT01851174|Immunologic Factors|immunologic factors|mesh-ancestor
2155452|NCT01851174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155453|NCT01846182|Pregabalin|pregabalin|mesh-list
2155454|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2155455|NCT01846182|Analgesics|analgesics|mesh-ancestor
2155456|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
2155457|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155458|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155459|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
2155460|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2155461|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2155462|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155463|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2155464|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2155465|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2155466|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155467|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2155468|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2608367|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608368|NCT01811160|Protective Agents|protective agents|mesh-ancestor
2608369|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608370|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608371|NCT01811251|Dexamethasone|dexamethasone|mesh-list
2608372|NCT01811251|Pregabalin|pregabalin|mesh-list
2608373|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2608374|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
2608375|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
2608376|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608377|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608378|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2608379|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
2608380|NCT01811251|Hormones|hormones|mesh-ancestor
2608381|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155469|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2155470|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2155471|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
2155472|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
2155473|NCT01844206|Morphine|morphine|mesh-list
2155474|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2608382|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2608383|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608384|NCT01811251|Analgesics|analgesics|mesh-ancestor
2608385|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
2608386|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
2608387|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2608388|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2608389|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155475|NCT01844206|Narcotics|narcotics|mesh-ancestor
2155476|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155477|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155478|NCT01844206|Analgesics|analgesics|mesh-ancestor
2155479|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
2155480|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421462|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
2421463|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421464|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
2421465|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421466|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421467|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2421468|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2421469|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
2421470|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2421471|NCT00812825|Prednisolone|prednisolone|mesh-list
2421472|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2155481|NCT01856322|Sulindac|sulindac|mesh-list
2155482|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2155483|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2155484|NCT01856322|Analgesics|analgesics|mesh-ancestor
2155485|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
2155486|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155487|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155488|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2155489|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2155490|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155491|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2155492|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155493|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155494|NCT01853176|Bupivacaine|bupivacaine|mesh-list
2155495|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
2155496|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
2155497|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155498|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155499|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
2155500|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155501|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2155502|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155503|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2155504|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155505|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155506|NCT01856361|Ramipril|ramipril|mesh-list
2155507|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2155508|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
2155509|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155510|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155511|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2155512|NCT01853982|Tazobactam|tazobactam|mesh-list
2155513|NCT01853982|Piperacillin|piperacillin|mesh-list
2155514|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2155515|NCT01853982|Ceftolozane|ceftolozane|mesh-list
2155516|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2155517|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2155518|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155519|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2155520|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155521|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155522|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2155523|NCT01853982|Renal Agents|renal agents|mesh-ancestor
2155524|NCT01841931|Buprenorphine|buprenorphine|mesh-list
2155525|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2155526|NCT01841931|Naloxone|naloxone|mesh-list
2155527|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2155528|NCT01841931|Narcotics|narcotics|mesh-ancestor
2421473|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
2421474|NCT00812825|Hormones|hormones|mesh-ancestor
2608390|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2608391|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2608392|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2608393|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608394|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2608395|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
2608396|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608397|NCT01811381|Curcumin|curcumin|mesh-list
2608398|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2608399|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2608400|NCT01811381|Analgesics|analgesics|mesh-ancestor
2608401|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
2608402|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608403|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608404|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2608405|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2608406|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608407|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421475|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421476|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421477|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2421478|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421479|NCT00812851|Dronabinol|dronabinol|mesh-list
2421480|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
2155529|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155530|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608408|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608409|NCT01811459|Haloperidol|haloperidol|mesh-list
2608410|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2608411|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
2608412|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
2608413|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2608414|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2608415|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2608416|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608417|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608418|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
2608419|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
2608420|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608421|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2155531|NCT01841931|Analgesics|analgesics|mesh-ancestor
2155532|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
2155533|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155534|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2155535|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2608422|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2608423|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
2608424|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608425|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608426|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2608427|NCT01811498|Bevacizumab|bevacizumab|mesh-list
2608428|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2608429|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608430|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2608431|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2608432|NCT01811498|Growth Substances|growth substances|mesh-ancestor
2608433|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608434|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
2608438|NCT01811615|Ethanol|ethanol|mesh-list
2608439|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2608440|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608441|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608442|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155536|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
2155537|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155538|NCT01821963|Interferons|interferons|mesh-list
2155539|NCT01821963|Ribavirin|ribavirin|mesh-list
2155540|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
2155541|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
2155542|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2155543|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155544|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
2155545|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155546|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
2155547|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155548|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
2155549|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155550|NCT01821898|Budesonide|budesonide|mesh-list
2155551|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2155552|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2155553|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
2155554|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155555|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155556|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2155557|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
2155558|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
2155559|NCT01821898|Hormones|hormones|mesh-ancestor
2155560|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155561|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
2155562|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155563|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
2155564|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2155565|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2155566|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155567|NCT01830790|Urological Agents|urological agents|mesh-ancestor
2608443|NCT01811667|Sirolimus|sirolimus|mesh-list
2608444|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2608445|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608446|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2608447|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608448|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
2608449|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2608450|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
2608451|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608452|NCT01811810|Androgens|androgens|mesh-list
2608453|NCT01811810|Hormones|hormones|mesh-ancestor
2608454|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2608455|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608456|NCT01811836|Zinc|zinc|mesh-list
2608457|NCT01811836|Trace Elements|trace elements|mesh-ancestor
2608458|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
2608459|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608460|NCT01811849|Insulin|insulin|mesh-list
2608461|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2608462|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
2608463|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2608464|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608465|NCT01812018|Gemcitabine|gemcitabine|mesh-list
2608466|NCT01812018|Docetaxel|docetaxel|mesh-list
2608467|NCT01812018|Endostar protein|endostar protein|mesh-list
2608468|NCT01812018|Endostatins|endostatins|mesh-list
2608469|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2608470|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
2155568|NCT01829477|Glimepiride|glimepiride|mesh-list
2155569|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2155570|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2155571|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155572|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155573|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
2155574|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2155575|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2155576|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2155577|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2608471|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608472|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608473|NCT01812018|Antiviral Agents|antiviral agents|mesh-ancestor
2608474|NCT01812018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608475|NCT01812018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608476|NCT01812018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155578|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155579|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2155580|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155581|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
2155582|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2155583|NCT01821859|Bevacizumab|bevacizumab|mesh-list
2155584|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2155585|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2155586|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155587|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2155588|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2155589|NCT01821859|Growth Substances|growth substances|mesh-ancestor
2155590|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155591|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
2155592|NCT01810302|Nicardipine|nicardipine|mesh-list
2608477|NCT01812018|Immunologic Factors|immunologic factors|mesh-ancestor
2608478|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608479|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
2608480|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
2608481|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
2608482|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2608483|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2608484|NCT01812018|Growth Substances|growth substances|mesh-ancestor
2608485|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
2608486|NCT01812096|Bortezomib|bortezomib|mesh-list
2608487|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608488|NCT01812122|Glimepiride|glimepiride|mesh-list
2608489|NCT01812122|Vildagliptin|vildagliptin|mesh-list
2608490|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2608491|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2608492|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608493|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2608494|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
2421481|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155593|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2155594|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2155595|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2155596|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155597|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2155598|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155599|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
2155600|NCT01804166|Golimumab|golimumab|mesh-list
2155601|NCT01804166|Infliximab|infliximab|mesh-list
2608495|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2608496|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
2608497|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608498|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608499|NCT01812135|Vaccines|vaccines|mesh-list
2608500|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
2608501|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608502|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
2608503|NCT01812200|Dabigatran|dabigatran|mesh-list
2608504|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
2608505|NCT01812200|Ticagrelor|ticagrelor|mesh-list
2608506|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2608507|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2608508|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2608509|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2608510|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
2608511|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608512|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155602|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
2155603|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2155604|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2155605|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2155606|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2155607|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155608|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
2155609|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155610|NCT01783015|Etanercept|etanercept|mesh-list
2155611|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2155612|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2155613|NCT01783015|Analgesics|analgesics|mesh-ancestor
2155614|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
2155615|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155616|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421482|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2421483|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2421484|NCT00812851|Analgesics|analgesics|mesh-ancestor
2421485|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
2421486|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421487|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2421488|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2421489|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2421490|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421491|NCT00812851|Hormones|hormones|mesh-ancestor
2421492|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421493|NCT00812864|Capecitabine|capecitabine|mesh-list
2421494|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2421495|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
2421496|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421497|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421498|NCT00812994|Citalopram|citalopram|mesh-list
2421499|NCT00812994|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2421500|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2421501|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2421502|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421503|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2421504|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
2421505|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421506|NCT00812994|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2421507|NCT00812994|Antidepressive Agents|antidepressive agents|mesh-ancestor
2421508|NCT00812994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2421509|NCT00813059|Bevacizumab|bevacizumab|mesh-list
2608513|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608514|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2608515|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
2608516|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2155617|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2155618|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2155619|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2155620|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155621|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
2155622|NCT01800162|Methotrexate|methotrexate|mesh-list
2155623|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2155624|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
2155625|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2155626|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155627|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2155628|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
2155629|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155630|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155631|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
2155632|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155633|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2155634|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155635|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
2608517|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
2608518|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608519|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
2608520|NCT01812239|Progesterone|progesterone|mesh-list
2608521|NCT01812239|Progestins|progestins|mesh-list
2608522|NCT01812239|Hormones|hormones|mesh-ancestor
2608523|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2608524|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608525|NCT01812252|Azacitidine|azacitidine|mesh-list
2608526|NCT01812252|Decitabine|decitabine|mesh-list
2608527|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2608528|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
2608529|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608530|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608531|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608532|NCT01812330|Clopidogrel|clopidogrel|mesh-list
2608533|NCT01812330|Ticagrelor|ticagrelor|mesh-list
2608534|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2608535|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2608536|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2608537|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2608538|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
2608539|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608540|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608541|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608542|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
2608543|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2608544|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
2608545|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
2608546|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608547|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608548|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2155636|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2155637|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2155638|NCT01797380|Citalopram|citalopram|mesh-list
2155639|NCT01797380|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2155640|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2155641|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2155642|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155643|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2155644|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
2155645|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155646|NCT01797380|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2155647|NCT01797380|Antidepressive Agents|antidepressive agents|mesh-ancestor
2155648|NCT01797380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2155649|NCT01781026|Vemurafenib|vemurafenib|mesh-list
2155650|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155651|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2155652|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608549|NCT01812356|Analgesics|analgesics|mesh-ancestor
2608550|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
2608551|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608552|NCT01812369|Gemcitabine|gemcitabine|mesh-list
2608553|NCT01812369|Doxorubicin|doxorubicin|mesh-list
2608554|NCT01812369|Vinblastine|vinblastine|mesh-list
2608555|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2608556|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
2608557|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608558|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155653|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155654|NCT01788475|Dexamethasone|dexamethasone|mesh-list
2155655|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
2155656|NCT01788475|BB 1101|bb 1101|mesh-list
2155657|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2155658|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
2608559|NCT01812369|Antiviral Agents|antiviral agents|mesh-ancestor
2608560|NCT01812369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608561|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608562|NCT01812369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2608563|NCT01812369|Immunologic Factors|immunologic factors|mesh-ancestor
2608564|NCT01812369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155659|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
2155660|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155661|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155662|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2155663|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
2155664|NCT01788475|Hormones|hormones|mesh-ancestor
2155665|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155666|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2155667|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155668|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
2155669|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155670|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155671|NCT01784991|Morphine|morphine|mesh-list
2155672|NCT01784991|Hydromorphone|hydromorphone|mesh-list
2155673|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2155674|NCT01784991|Narcotics|narcotics|mesh-ancestor
2155675|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155676|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155677|NCT01784991|Analgesics|analgesics|mesh-ancestor
2155678|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
2155679|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155680|NCT01777854|Omeprazole|omeprazole|mesh-list
2155681|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2155682|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2155683|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2155684|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155685|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155686|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2155687|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2155688|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155689|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2155690|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2155691|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2155692|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155693|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
2155694|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2155695|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
2155696|NCT01772719|Simvastatin|simvastatin|mesh-list
2155697|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2608565|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2608566|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2608567|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2608568|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2608569|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
2608570|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
2608571|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
2608572|NCT01812382|Retapamulin|retapamulin|mesh-list
2608573|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2608574|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608575|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
2608576|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
2608577|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2608578|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2608579|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608580|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608581|NCT01812434|Urological Agents|urological agents|mesh-ancestor
2608582|NCT01812538|Diclofenac|diclofenac|mesh-list
2608583|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2608584|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2608585|NCT01812538|Analgesics|analgesics|mesh-ancestor
2608586|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
2608587|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608588|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608589|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2608590|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2608591|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2608592|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608593|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608594|NCT01812551|Alendronate|alendronate|mesh-list
2608595|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2608596|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608597|NCT01812603|Nabiximols|nabiximols|mesh-list
2608598|NCT01812603|Analgesics|analgesics|mesh-ancestor
2608599|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
2608600|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608601|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608602|NCT01812616|Nabiximols|nabiximols|mesh-list
2608603|NCT01812616|Analgesics|analgesics|mesh-ancestor
2608604|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
2608605|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608606|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608607|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
2608608|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2155698|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2155699|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
2155700|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155701|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2155702|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2155703|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155704|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2155705|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155706|NCT01764997|Adalimumab|adalimumab|mesh-list
2155707|NCT01764997|Etanercept|etanercept|mesh-list
2155708|NCT01764997|Methotrexate|methotrexate|mesh-list
2421510|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2421511|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421512|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2421513|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2155709|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2155710|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
2155711|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2155712|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155713|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2155714|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
2155715|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155716|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608609|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2608610|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
2608611|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608612|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608613|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608614|NCT01812720|Dexamethasone|dexamethasone|mesh-list
2608615|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2608616|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
2608617|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
2608618|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608619|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608620|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2608621|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
2608622|NCT01812720|Hormones|hormones|mesh-ancestor
2421514|NCT00813059|Growth Substances|growth substances|mesh-ancestor
2421515|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421516|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
2421517|NCT00813072|Docetaxel|docetaxel|mesh-list
2421518|NCT00813072|Irinotecan|irinotecan|mesh-list
2421519|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421520|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
2608623|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155717|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
2155718|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155719|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2155720|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155721|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
2155722|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2155723|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2155724|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2155725|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2155726|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2155727|NCT01764997|Analgesics|analgesics|mesh-ancestor
2155728|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
2155729|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155730|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2155731|NCT01769443|Bortezomib|bortezomib|mesh-list
2155732|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155733|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2155734|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2155735|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155736|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2608624|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2608625|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608626|NCT01812889|TOL-463|tol-463|mesh-list
2608627|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608628|NCT01812928|Diclofenac|diclofenac|mesh-list
2608629|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2608630|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2608631|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2608632|NCT01812928|Analgesics|analgesics|mesh-ancestor
2608633|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
2608634|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608635|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608636|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2608637|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2155737|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2155738|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2155739|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155740|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
2155741|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2155742|NCT01749826|Morphine|morphine|mesh-list
2155743|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2608638|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608639|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608640|NCT01812954|Cyclosporine|cyclosporine|mesh-list
2608641|NCT01812954|Adalimumab|adalimumab|mesh-list
2608642|NCT01812954|Etanercept|etanercept|mesh-list
2608643|NCT01812954|Methotrexate|methotrexate|mesh-list
2608644|NCT01812954|Infliximab|infliximab|mesh-list
2608645|NCT01812954|Ustekinumab|ustekinumab|mesh-list
2608646|NCT01812954|Acitretin|acitretin|mesh-list
2608647|NCT01812954|Cyclosporins|cyclosporins|mesh-list
2608648|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2608649|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
2608650|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2608651|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608652|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2155744|NCT01749826|Narcotics|narcotics|mesh-ancestor
2608653|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
2608654|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608655|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608656|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
2608657|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608658|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2608659|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2608660|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
2608661|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2608662|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2608663|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
2608664|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608665|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2608666|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2608667|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2608668|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2608669|NCT01812954|Analgesics|analgesics|mesh-ancestor
2608670|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
2608671|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608672|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2608673|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
2608674|NCT01812967|Caseins|caseins|mesh-list
2608675|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
2608676|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
2608677|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608678|NCT01813162|Tenofovir|tenofovir|mesh-list
2608679|NCT01813162|Metronidazole|metronidazole|mesh-list
2608680|NCT01813162|Terconazole|terconazole|mesh-list
2608681|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
2608682|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
2608683|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608684|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2155745|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155746|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155747|NCT01749826|Analgesics|analgesics|mesh-ancestor
2155748|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
2155749|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155750|NCT01756586|Dexamethasone|dexamethasone|mesh-list
2155751|NCT01756586|Bupivacaine|bupivacaine|mesh-list
2155752|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2155753|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
2155754|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
2155755|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155756|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155757|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2155758|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
2155759|NCT01756586|Hormones|hormones|mesh-ancestor
2155760|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155761|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2155762|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155763|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
2155764|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
2155765|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155766|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
2155767|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
2155768|NCT01754987|Sorafenib|sorafenib|mesh-list
2155769|NCT01754987|Vitamins|vitamins|mesh-ancestor
2155770|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
2155771|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155772|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155773|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2155774|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155775|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155776|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
2155777|NCT01754987|Protective Agents|protective agents|mesh-ancestor
2155778|NCT01756560|Bupivacaine|bupivacaine|mesh-list
2155779|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
2155780|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
2155781|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155782|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155783|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
2155784|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155785|NCT01756573|Bupivacaine|bupivacaine|mesh-list
2155786|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
2155787|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
2155788|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2155789|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155790|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
2155791|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155792|NCT01745913|Fludarabine|fludarabine|mesh-list
2155793|NCT01745913|Melphalan|melphalan|mesh-list
2155794|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
2155795|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155796|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155797|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155798|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
2155799|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155800|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2155801|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
2155802|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2155803|NCT01752023|Gemcitabine|gemcitabine|mesh-list
2155804|NCT01752023|Itraconazole|itraconazole|mesh-list
2155805|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
2155806|NCT01752023|Cisplatin|cisplatin|mesh-list
2608685|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2608686|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608687|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608688|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2608689|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2608690|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2608691|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2608692|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2608693|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2608694|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608695|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
2608696|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
2608697|NCT01813201|Testosterone|testosterone|mesh-list
2608698|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
2608699|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
2155807|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155808|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2155809|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
2155810|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155811|NCT01752023|Antiviral Agents|antiviral agents|mesh-ancestor
2155812|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155813|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155814|NCT01752023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155815|NCT01752023|Immunologic Factors|immunologic factors|mesh-ancestor
2155816|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155817|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
2155818|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2155819|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2155820|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2155821|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
2155822|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155823|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2155824|NCT01740154|Sunitinib|sunitinib|mesh-list
2155825|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155826|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2155827|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2155828|NCT01740154|Growth Substances|growth substances|mesh-ancestor
2155829|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155830|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
2155831|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2155832|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155833|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155834|NCT01748162|Fluticasone|fluticasone|mesh-list
2155835|NCT01748162|Prednisolone|prednisolone|mesh-list
2155836|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2155837|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2155838|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
2155839|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155840|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608700|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2608701|NCT01813201|Androgens|androgens|mesh-ancestor
2608702|NCT01813201|Hormones|hormones|mesh-ancestor
2608703|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2608704|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608705|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2608706|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608707|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
2608708|NCT01813227|Dexamethasone|dexamethasone|mesh-list
2608709|NCT01813227|Rituximab|rituximab|mesh-list
2608710|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2608711|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
2608712|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
2608713|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608714|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608715|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2608716|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
2608717|NCT01813227|Hormones|hormones|mesh-ancestor
2608718|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2608719|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2608720|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608721|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2608722|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
2608723|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2608724|NCT01813240|Minocycline|minocycline|mesh-list
2608725|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2608726|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608727|NCT01813253|Irinotecan|irinotecan|mesh-list
2608728|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
2608729|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2608730|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2608731|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608732|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608733|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608734|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2608735|NCT01813318|Acamprosate|acamprosate|mesh-list
2608736|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2608737|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
2608738|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2608739|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155841|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2155842|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
2155843|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
2608740|NCT01813461|Isavuconazole|isavuconazole|mesh-list
2608741|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
2608742|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608743|NCT01813487|Entecavir|entecavir|mesh-list
2608744|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
2608745|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608746|NCT01813513|Simeprevir|simeprevir|mesh-list
2608747|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
2608748|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608749|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
2608750|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608751|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608752|NCT01813552|Ritonavir|ritonavir|mesh-list
2155844|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2155845|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
2155846|NCT01748162|Hormones|hormones|mesh-ancestor
2155847|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155848|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2155849|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155850|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2155851|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2155852|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155853|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2155854|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2155855|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2155856|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155857|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
2155858|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2155859|NCT01732926|Rituximab|rituximab|mesh-list
2155860|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2155861|NCT01732926|Idelalisib|idelalisib|mesh-list
2155862|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2155863|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155864|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
2155865|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155866|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2155867|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2155868|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
2155869|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155870|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155871|NCT01732913|Rituximab|rituximab|mesh-list
2155872|NCT01732913|Idelalisib|idelalisib|mesh-list
2155873|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2155874|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608753|NCT01813552|Omeprazole|omeprazole|mesh-list
2608754|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2608755|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2608756|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
2608757|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608758|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608759|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2608760|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2608761|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
2608762|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608763|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2608764|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2608765|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2155875|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
2155876|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155877|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2155878|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155879|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155880|NCT01716052|Ibuprofen|ibuprofen|mesh-list
2155881|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2608766|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2608767|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2608768|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
2608769|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2608770|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
2608771|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608772|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
2608773|NCT01813565|Protective Agents|protective agents|mesh-ancestor
2608774|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2608775|NCT01813591|Hormones|hormones|mesh-ancestor
2608776|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2608777|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608778|NCT01813604|Vaccines|vaccines|mesh-list
2608779|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
2608780|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608781|NCT01813617|Prednisone|prednisone|mesh-list
2608782|NCT01813617|Methotrexate|methotrexate|mesh-list
2608783|NCT01813617|Azathioprine|azathioprine|mesh-list
2608784|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2608785|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2608786|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
2608787|NCT01813617|Hormones|hormones|mesh-ancestor
2608788|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2608789|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608790|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2608791|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608792|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2608793|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
2608794|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2608795|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2608796|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
2608797|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608798|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
2608799|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608800|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2608801|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
2608802|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2608803|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2608804|NCT01813643|Risperidone|risperidone|mesh-list
2608805|NCT01813643|Aripiprazole|aripiprazole|mesh-list
2608806|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2608807|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
2608808|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608809|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608810|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608811|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2608812|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2608813|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608814|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2608815|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2608816|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
2608817|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
2608818|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
2608819|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2155882|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2155883|NCT01716052|Analgesics|analgesics|mesh-ancestor
2155884|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
2155885|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155886|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155887|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2155888|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2155889|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2155890|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155891|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155892|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2155893|NCT01718444|Clomiphene|clomiphene|mesh-list
2155894|NCT01718444|Enclomiphene|enclomiphene|mesh-list
2155895|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
2155896|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
2155897|NCT01718444|Progestins|progestins|mesh-list
2155898|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2155899|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
2155900|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155901|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155902|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2608820|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2608821|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2155903|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
2155904|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2155905|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2608822|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2608823|NCT01813656|Aripiprazole|aripiprazole|mesh-list
2608824|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
2608825|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2608826|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2608827|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2608828|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608829|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608830|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
2608831|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
2608832|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608833|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608834|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2608835|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2608836|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
2608837|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2608838|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2608839|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2608840|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2608841|NCT01813773|Aflibercept|aflibercept|mesh-list
2608842|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2608843|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2608844|NCT01813773|Growth Substances|growth substances|mesh-ancestor
2608845|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608846|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
2608847|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608848|NCT01813812|Rebamipide|rebamipide|mesh-list
2608849|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2608850|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2608851|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
2608852|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608853|NCT01813812|Protective Agents|protective agents|mesh-ancestor
2608854|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608855|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608859|NCT01813955|Papaverine|papaverine|mesh-list
2608860|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2608861|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608862|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608863|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
2608864|NCT01813955|Urological Agents|urological agents|mesh-ancestor
2608865|NCT01813981|Caffeine|caffeine|mesh-list
2608866|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2608867|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608868|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2155906|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2155907|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2155908|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2155909|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2155910|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
2155911|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2155912|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2155913|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2155914|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2155915|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155916|NCT01718444|Hormones|hormones|mesh-ancestor
2155917|NCT01712854|Budesonide|budesonide|mesh-list
2155918|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2155919|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2608869|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608870|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608871|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2608872|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2608873|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
2608874|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2155920|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2155921|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
2155922|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155923|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155924|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2155925|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
2155926|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
2155927|NCT01712854|Hormones|hormones|mesh-ancestor
2155928|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2155929|NCT01717482|Metformin|metformin|mesh-list
2155930|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2155931|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155932|NCT01702896|Interleukin-2|interleukin-2|mesh-list
2155933|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155934|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2155935|NCT01702896|Analgesics|analgesics|mesh-ancestor
2155936|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
2155937|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155938|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155939|NCT01709136|Sirolimus|sirolimus|mesh-list
2155940|NCT01709136|Tacrolimus|tacrolimus|mesh-list
2155941|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2155942|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
2155943|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155944|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2155945|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155946|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155947|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2155948|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2155949|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2155950|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155951|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
2155952|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
2155953|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2155954|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
2155955|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155956|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155957|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2155958|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
2608875|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2608876|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2608877|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2608878|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
2608879|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608880|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608881|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2608882|NCT01814059|Sirolimus|sirolimus|mesh-list
2608883|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2608884|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608885|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2608886|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608887|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
2608888|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2608889|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
2608890|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608891|NCT01814085|Citalopram|citalopram|mesh-list
2608892|NCT01814085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2608893|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2608894|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2608895|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608896|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608897|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
2608898|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608899|NCT01814085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2608900|NCT01814085|Antidepressive Agents|antidepressive agents|mesh-ancestor
2608901|NCT01814085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2608902|NCT01814098|Citalopram|citalopram|mesh-list
2155959|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
2608903|NCT01814098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2608904|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2608905|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2608906|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608907|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608908|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
2608909|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608910|NCT01814098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2608911|NCT01814098|Antidepressive Agents|antidepressive agents|mesh-ancestor
2155960|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2155961|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
2155962|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608912|NCT01814098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2608913|NCT01814163|Paclitaxel|paclitaxel|mesh-list
2608914|NCT01814163|Bevacizumab|bevacizumab|mesh-list
2608915|NCT01814163|Carboplatin|carboplatin|mesh-list
2608916|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2608917|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608918|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
2608919|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
2608920|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
2608921|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608922|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2608923|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2608924|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2608925|NCT01814163|Growth Substances|growth substances|mesh-ancestor
2608926|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608927|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
2608928|NCT01814189|Promethazine|promethazine|mesh-list
2608929|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
2608930|NCT01814189|Sumatriptan|sumatriptan|mesh-list
2608931|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2608932|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2608933|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2608934|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
2608935|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608936|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608937|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608938|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
2608939|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
2608940|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2608941|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
2608942|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
2608943|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2608944|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2608945|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2608946|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608947|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
2608948|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
2608949|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
2155963|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155964|NCT01705106|Celecoxib|celecoxib|mesh-list
2155965|NCT01705106|Capecitabine|capecitabine|mesh-list
2155966|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2155967|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
2155968|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155969|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421521|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
2421522|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
2421523|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421524|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2421525|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2421526|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421527|NCT00813137|Endostar protein|endostar protein|mesh-list
2421528|NCT00813137|Endostatins|endostatins|mesh-list
2421529|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2421530|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2421531|NCT00813137|Growth Substances|growth substances|mesh-ancestor
2421532|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421533|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
2421534|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421535|NCT00813163|Irinotecan|irinotecan|mesh-list
2421536|NCT00813163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2608950|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608951|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
2608952|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
2608953|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2608954|NCT01814319|Probenecid|probenecid|mesh-list
2608955|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
2608956|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
2608957|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2608958|NCT01814319|Renal Agents|renal agents|mesh-ancestor
2608959|NCT01814410|Ethanol|ethanol|mesh-list
2608960|NCT01814410|Nicotine|nicotine|mesh-list
2608961|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2608962|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
2608963|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608964|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608965|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2608966|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2608967|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
2608968|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2608969|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608970|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2608971|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608972|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2608973|NCT01814423|Chloroquine|chloroquine|mesh-list
2608974|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2608975|NCT01814423|Amebicides|amebicides|mesh-ancestor
2608976|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2608977|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2608978|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2608979|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
2608980|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2608981|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2608982|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2608983|NCT01814423|Analgesics|analgesics|mesh-ancestor
2608984|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
2608985|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2608986|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2608987|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2608988|NCT01814423|Filaricides|filaricides|mesh-ancestor
2608989|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
2608990|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
2608991|NCT01814449|Letrozole|letrozole|mesh-list
2608992|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2608993|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2608994|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2608995|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2608996|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2608997|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2608998|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
2608999|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609000|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609001|NCT01814475|Vidarabine|vidarabine|mesh-list
2609002|NCT01814475|Fludarabine|fludarabine|mesh-list
2609003|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
2609004|NCT01814475|Busulfan|busulfan|mesh-list
2609005|NCT01814475|Thiotepa|thiotepa|mesh-list
2609006|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609007|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2609008|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
2609009|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609010|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2609011|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
2609012|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609013|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
2609014|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609015|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
2609016|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2155970|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2155971|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2155972|NCT01705106|Analgesics|analgesics|mesh-ancestor
2155973|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
2155974|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155975|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155976|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2609017|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2609018|NCT01814501|Leucovorin|leucovorin|mesh-list
2609019|NCT01814501|Fluorouracil|fluorouracil|mesh-list
2609020|NCT01814501|Irinotecan|irinotecan|mesh-list
2609021|NCT01814501|Panitumumab|panitumumab|mesh-list
2609022|NCT01814501|Calcium|calcium|mesh-list
2609023|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
2609024|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2609025|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609026|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
2609027|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609028|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2609029|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609030|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2609031|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
2609032|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2609033|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2609034|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155977|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2155978|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2155979|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2609035|NCT01814501|Antidotes|antidotes|mesh-ancestor
2609036|NCT01814501|Protective Agents|protective agents|mesh-ancestor
2609037|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
2609038|NCT01814501|Vitamins|vitamins|mesh-ancestor
2609039|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
2609040|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2609041|NCT01814514|Timolol|timolol|mesh-list
2609042|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2609043|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2609044|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
2609045|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609046|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609047|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609048|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2609049|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2609050|NCT01814618|Budesonide|budesonide|mesh-list
2609051|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2609052|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2609053|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
2609054|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609055|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609056|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2609057|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
2609058|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
2609059|NCT01814618|Hormones|hormones|mesh-ancestor
2609060|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609061|NCT01814657|Lidocaine|lidocaine|mesh-list
2609062|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
2609063|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
2609064|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2609065|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609066|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
2609067|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609068|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2609069|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2155980|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155981|NCT01702909|Interleukin-2|interleukin-2|mesh-list
2155982|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2155983|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2609070|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2609071|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2609072|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609073|NCT01814683|Primaquine|primaquine|mesh-list
2609074|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
2609075|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2609076|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2609077|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609078|NCT01814709|Itraconazole|itraconazole|mesh-list
2609079|NCT01814709|Rifampin|rifampin|mesh-list
2609080|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
2609081|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609082|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2609083|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2609084|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609085|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609086|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2609087|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
2155984|NCT01702909|Analgesics|analgesics|mesh-ancestor
2155985|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
2155986|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2155987|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2155988|NCT01701622|Febuxostat|febuxostat|mesh-list
2155989|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
2155990|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2155991|NCT01697800|Tadalafil|tadalafil|mesh-list
2155992|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
2155993|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2155994|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2155995|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2155996|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2155997|NCT01697800|Urological Agents|urological agents|mesh-ancestor
2155998|NCT01692691|Dacarbazine|dacarbazine|mesh-list
2155999|NCT01692691|Carmustine|carmustine|mesh-list
2156000|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2156001|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
2609088|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609089|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609090|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2609091|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2609092|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
2609093|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2609094|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
2609095|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2609096|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2609097|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2609098|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2609099|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2609100|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2609101|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2609102|NCT01814826|Azacitidine|azacitidine|mesh-list
2609103|NCT01814826|Pevonedistat|pevonedistat|mesh-list
2609104|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2609105|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
2609106|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609107|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609108|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609109|NCT01814865|Prednisone|prednisone|mesh-list
2609110|NCT01814865|Anastrozole|anastrozole|mesh-list
2609111|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
2609112|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2609113|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2609114|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
2609115|NCT01814865|Hormones|hormones|mesh-ancestor
2156002|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156003|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156004|NCT01691079|Bromides|bromides|mesh-list
2156005|NCT01691079|Ipratropium|ipratropium|mesh-list
2156006|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
2156007|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2156008|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
2156009|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156010|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156011|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2156012|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
2156013|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2156014|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
2156015|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2156016|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156017|NCT01689974|Ipilimumab|ipilimumab|mesh-list
2156018|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2156019|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156020|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2156021|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156022|NCT01663285|Gemcitabine|gemcitabine|mesh-list
2156023|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156024|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2156025|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
2156026|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156027|NCT01663285|Antiviral Agents|antiviral agents|mesh-ancestor
2156028|NCT01663285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2156029|NCT01663285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156030|NCT01663285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2156031|NCT01663285|Immunologic Factors|immunologic factors|mesh-ancestor
2156032|NCT01663285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156033|NCT01683864|Cisplatin|cisplatin|mesh-list
2156034|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156035|NCT01673061|Lidocaine|lidocaine|mesh-list
2156036|NCT01673061|Epinephrine|epinephrine|mesh-list
2156037|NCT01673061|Norflurane|norflurane|mesh-list
2156038|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
2156039|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
2156040|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156041|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156042|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
2156043|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156044|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2156045|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2156046|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2156047|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2156048|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156049|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2156050|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2156051|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
2156052|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609116|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609117|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609118|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2609119|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609120|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2609121|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609122|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609123|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2609124|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
2609125|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2609126|NCT01814891|Vitamin A|vitamin a|mesh-list
2609127|NCT01814891|Vitamins|vitamins|mesh-ancestor
2156053|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2156054|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2156055|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
2156056|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2156057|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
2156058|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
2156059|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
2156060|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2609128|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
2609129|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609130|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
2609131|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2609132|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
2609133|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2609134|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609135|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
2609136|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
2609137|NCT01815021|Calcium|calcium|mesh-list
2609138|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2609139|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609140|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2609141|NCT01815021|Antacids|antacids|mesh-ancestor
2609142|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609143|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2609144|NCT01815047|Vitamin D|vitamin d|mesh-list
2156061|NCT01675960|Gabapentin|gabapentin|mesh-list
2156062|NCT01675960|Analgesics|analgesics|mesh-ancestor
2156063|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
2156064|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156065|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156066|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
2156067|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2156068|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2156069|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156070|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2156071|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2156072|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2609145|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
2156073|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609146|NCT01815047|Vitamins|vitamins|mesh-ancestor
2609147|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
2609148|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609149|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2609150|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2609151|NCT01815073|Vaccines|vaccines|mesh-list
2609152|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
2609153|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609154|NCT01815125|Ondansetron|ondansetron|mesh-list
2609155|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
2609156|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
2609157|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609158|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609159|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2609160|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
2609161|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
2609162|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2609163|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
2609164|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609165|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609166|NCT01815125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2609167|NCT01815125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2609168|NCT01815125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2609169|NCT01815125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2609170|NCT01815125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2156074|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156075|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
2156076|NCT01668147|Ritonavir|ritonavir|mesh-list
2156077|NCT01668147|Efavirenz|efavirenz|mesh-list
2156078|NCT01668147|Loperamide|loperamide|mesh-list
2156079|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
2156080|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2156081|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2156082|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
2156083|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156084|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156085|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2156086|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2156087|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
2156088|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2156089|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2156090|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2156091|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2156092|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2156093|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2156094|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2609171|NCT01815203|Caffeine|caffeine|mesh-list
2609172|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2609173|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609174|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2609175|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609176|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609177|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2609178|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2609179|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
2609180|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609181|NCT01815242|Gemcitabine|gemcitabine|mesh-list
2609182|NCT01815242|Paclitaxel|paclitaxel|mesh-list
2609183|NCT01815242|Carboplatin|carboplatin|mesh-list
2609184|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2609185|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609186|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
2156095|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2156096|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2156097|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2156098|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2156099|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2156100|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
2156101|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156102|NCT01662102|Rituximab|rituximab|mesh-list
2609187|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
2609188|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
2609189|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609190|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2609191|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
2609192|NCT01815242|Antiviral Agents|antiviral agents|mesh-ancestor
2609193|NCT01815242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609194|NCT01815242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609195|NCT01815242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2609196|NCT01815242|Immunologic Factors|immunologic factors|mesh-ancestor
2609197|NCT01815242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609198|NCT01815255|Tenofovir|tenofovir|mesh-list
2609199|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
2609200|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609201|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2609202|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2609203|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609204|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609205|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2609206|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2609207|NCT01815268|Vaccines|vaccines|mesh-list
2609208|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
2609209|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609210|NCT01815294|Doxorubicin|doxorubicin|mesh-list
2609211|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2609212|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2609213|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609214|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2609215|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2609216|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609217|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609218|NCT01815307|Gemcitabine|gemcitabine|mesh-list
2609219|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2609220|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
2609221|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609222|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609223|NCT01815307|Antiviral Agents|antiviral agents|mesh-ancestor
2609224|NCT01815307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609225|NCT01815307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609226|NCT01815307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2609227|NCT01815307|Immunologic Factors|immunologic factors|mesh-ancestor
2609228|NCT01815307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609229|NCT01815359|Leucovorin|leucovorin|mesh-list
2609230|NCT01815359|Mitomycins|mitomycins|mesh-list
2609231|NCT01815359|Mitomycin|mitomycin|mesh-list
2609232|NCT01815359|Antidotes|antidotes|mesh-ancestor
2609233|NCT01815359|Protective Agents|protective agents|mesh-ancestor
2609234|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609235|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
2609236|NCT01815359|Vitamins|vitamins|mesh-ancestor
2609237|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
2609238|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2609239|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609240|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
2156103|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2156104|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156105|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
2609241|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609242|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2609243|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609244|NCT01815437|Vitamin D|vitamin d|mesh-list
2609245|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
2609246|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
2609247|NCT01815437|Vitamins|vitamins|mesh-list
2609248|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
2421537|NCT00813163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2421538|NCT00813163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421539|NCT00813163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609249|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609250|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2609251|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2609252|NCT01815528|Catumaxomab|catumaxomab|mesh-list
2609253|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2156106|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421540|NCT00813163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421541|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2421542|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
2421543|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421544|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2421545|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2609254|NCT01815541|Teicoplanin|teicoplanin|mesh-list
2156107|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2156108|NCT01659554|Cisplatin|cisplatin|mesh-list
2156109|NCT01659554|Doxorubicin|doxorubicin|mesh-list
2156110|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2156111|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156112|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2156113|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2156114|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2156115|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156116|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156117|NCT01658813|Interferons|interferons|mesh-list
2156118|NCT01658813|Fluorouracil|fluorouracil|mesh-list
2156119|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
2156120|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156121|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2156122|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156123|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2156124|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
2156125|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156126|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
2156127|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2156128|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2156129|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
2156130|NCT01649505|Coagulants|coagulants|mesh-ancestor
2156131|NCT01642732|Everolimus|everolimus|mesh-list
2156132|NCT01642732|Leuprolide|leuprolide|mesh-list
2156133|NCT01642732|Bicalutamide|bicalutamide|mesh-list
2609255|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2609256|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609257|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2609258|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2609259|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2609260|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2609261|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156134|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156135|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2156136|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
2156137|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156138|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2156139|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
2156140|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2156141|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2156142|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
2156143|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
2156144|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2156145|NCT01645709|Verapamil|verapamil|mesh-list
2156146|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2156147|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2156148|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2421546|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421547|NCT00813228|Incretins|incretins|mesh-ancestor
2421548|NCT00813228|Hormones|hormones|mesh-ancestor
2421549|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421550|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2421551|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
2421552|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421553|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421554|NCT00813241|Celecoxib|celecoxib|mesh-list
2421555|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2421556|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2421557|NCT00813241|Analgesics|analgesics|mesh-ancestor
2421558|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
2421559|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421560|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421561|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2421562|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421563|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2421564|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2421565|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421566|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156149|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156150|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2156151|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156152|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
2156153|NCT01648270|Buprenorphine|buprenorphine|mesh-list
2156154|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2156155|NCT01648270|Narcotics|narcotics|mesh-ancestor
2156156|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156157|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156158|NCT01648270|Analgesics|analgesics|mesh-ancestor
2156159|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
2156160|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156161|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2156162|NCT01633814|Estradiol|estradiol|mesh-list
2156163|NCT01633814|Estrogens|estrogens|mesh-ancestor
2156164|NCT01633814|Hormones|hormones|mesh-ancestor
2156165|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2156166|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156167|NCT01636466|Everolimus|everolimus|mesh-list
2156168|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156169|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2156170|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
2156171|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156172|NCT01629329|Aspirin|aspirin|mesh-list
2156173|NCT01629329|Acetaminophen|acetaminophen|mesh-list
2156174|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
2156175|NCT01629329|Caffeine|caffeine|mesh-list
2156176|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2156177|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2156178|NCT01629329|Analgesics|analgesics|mesh-ancestor
2156179|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
2156180|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156181|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156182|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2609262|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609263|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
2609264|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609265|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2609266|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2609267|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
2609268|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2156183|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2156184|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2156185|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2609269|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609270|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2609271|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
2156186|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156187|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2156188|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2156189|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156190|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
2156191|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2156192|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2156193|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2156194|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2156195|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
2609272|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2609273|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
2609274|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609275|NCT01815892|Furosemide|furosemide|mesh-list
2609276|NCT01815892|Diuretics|diuretics|mesh-ancestor
2609277|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
2609278|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609279|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2609280|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2609281|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609282|NCT01815944|Ropivacaine|ropivacaine|mesh-list
2609283|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
2609284|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
2609285|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2609286|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609287|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
2156196|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2156197|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
2609288|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609289|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2609290|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609291|NCT01816035|Trastuzumab|trastuzumab|mesh-list
2609292|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2609293|NCT01816035|Maytansine|maytansine|mesh-list
2609294|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
2609295|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2609296|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609297|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2609298|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
2609299|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
2609300|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
2609301|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609302|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
2609303|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609304|NCT01816139|Estradiol|estradiol|mesh-list
2609305|NCT01816139|Estrogens|estrogens|mesh-ancestor
2609306|NCT01816139|Hormones|hormones|mesh-ancestor
2609307|NCT01816139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609308|NCT01816139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609314|NCT01816191|Diltiazem|diltiazem|mesh-list
2609315|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2609316|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2609317|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2609318|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609319|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2609320|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609321|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
2609322|NCT01816321|Ganirelix|ganirelix|mesh-list
2609323|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
2609324|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609325|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609326|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
2609327|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2609328|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2609329|NCT01816334|Prednisolone|prednisolone|mesh-list
2609330|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
2609331|NCT01816334|Ketoprofen|ketoprofen|mesh-list
2609332|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2609333|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
2609334|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2609335|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
2609336|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
2609337|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609338|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609339|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2609340|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
2609341|NCT01816334|Hormones|hormones|mesh-ancestor
2609342|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609343|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2609344|NCT01816334|Protective Agents|protective agents|mesh-ancestor
2609345|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2609346|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609347|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2609348|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2609349|NCT01816334|Analgesics|analgesics|mesh-ancestor
2609350|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
2609351|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2609352|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2609353|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609354|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609355|NCT01816412|Paclitaxel|paclitaxel|mesh-list
2609356|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2609357|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609358|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
2609359|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
2609360|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
2609361|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609362|NCT01816490|Silybin|silybin|mesh-list
2609363|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2156198|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
2156199|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2156200|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2156201|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2156202|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156203|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2156204|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2156205|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
2156206|NCT01632020|Metformin|metformin|mesh-list
2156207|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2156208|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156209|NCT01608906|Heparin|heparin|mesh-list
2156210|NCT01608906|Calcium heparin|calcium heparin|mesh-list
2156211|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
2156212|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2156213|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2156214|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156215|NCT01621737|Oxytocin|oxytocin|mesh-list
2156216|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
2156217|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2156218|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156219|NCT01614067|Ganirelix|ganirelix|mesh-list
2156220|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
2156221|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2156222|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156223|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2609364|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609365|NCT01816490|Protective Agents|protective agents|mesh-ancestor
2609366|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609367|NCT01816529|Diltiazem|diltiazem|mesh-list
2609368|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2609369|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2609370|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2609371|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609372|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2609373|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609374|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
2609375|NCT01816555|Vitamin D|vitamin d|mesh-list
2609376|NCT01816555|Vitamins|vitamins|mesh-ancestor
2609377|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
2609378|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609379|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2609380|NCT01816581|Morphine|morphine|mesh-list
2609381|NCT01816581|Naloxone|naloxone|mesh-list
2609382|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2156224|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2156225|NCT01607320|Clomiphene|clomiphene|mesh-list
2156226|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
2156227|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2156228|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
2156229|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2156230|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156231|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2156232|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
2156233|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2156234|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2156235|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2156236|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2156237|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2156238|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
2156239|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2156240|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2156241|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2156242|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156243|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2156244|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2156245|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2156246|NCT01609231|Irinotecan|irinotecan|mesh-list
2156247|NCT01609231|Cetuximab|cetuximab|mesh-list
2156248|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2156249|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2156250|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609383|NCT01816581|Narcotics|narcotics|mesh-ancestor
2609384|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156251|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156252|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156253|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2156254|NCT01602198|Rivastigmine|rivastigmine|mesh-list
2156255|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2156256|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156257|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156258|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
2156259|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2156260|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156261|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2609385|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609386|NCT01816581|Analgesics|analgesics|mesh-ancestor
2609387|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
2609388|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609389|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2609390|NCT01816620|Dexamethasone|dexamethasone|mesh-list
2609391|NCT01816620|Lenalidomide|lenalidomide|mesh-list
2609392|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2156262|NCT01602198|Protective Agents|protective agents|mesh-ancestor
2156263|NCT01606150|Lidocaine|lidocaine|mesh-list
2156264|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
2156265|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
2609393|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
2609394|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
2156266|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156267|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156268|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
2156269|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156270|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2156271|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2156272|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2156273|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2156274|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156275|NCT01605370|Metoprolol|metoprolol|mesh-list
2156276|NCT01605370|Nebivolol|nebivolol|mesh-list
2156277|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2156278|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2156279|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
2609395|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609396|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609397|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2609398|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
2609399|NCT01816620|Hormones|hormones|mesh-ancestor
2609400|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609401|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2609402|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609403|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
2609404|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2609405|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2609406|NCT01816620|Growth Substances|growth substances|mesh-ancestor
2609407|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
2609408|NCT01816646|Cidofovir|cidofovir|mesh-list
2609409|NCT01816646|Probenecid|probenecid|mesh-list
2609410|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
2609411|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
2609412|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2609413|NCT01816646|Renal Agents|renal agents|mesh-ancestor
2609414|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
2609415|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609416|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609417|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609418|NCT01816659|Metformin|metformin|mesh-list
2609419|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2609420|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609421|NCT01816789|Buserelin|buserelin|mesh-list
2609422|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2609423|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
2609424|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2609425|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609426|NCT01816958|Ketamine|ketamine|mesh-list
2609427|NCT01816958|Analgesics|analgesics|mesh-ancestor
2609428|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
2609429|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609430|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609431|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2156280|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
2156281|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156282|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609432|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2609433|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
2609434|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
2609435|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2609436|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2609437|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2609438|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609439|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609440|NCT01816971|Dexamethasone|dexamethasone|mesh-list
2609441|NCT01816971|Lenalidomide|lenalidomide|mesh-list
2609442|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2609443|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
2609444|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
2609445|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609446|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609447|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2609448|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
2609449|NCT01816971|Hormones|hormones|mesh-ancestor
2609450|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609451|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2609452|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609453|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
2609454|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2609455|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2609456|NCT01816971|Growth Substances|growth substances|mesh-ancestor
2609457|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
2609458|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2609459|NCT01816997|Pravastatin|pravastatin|mesh-list
2609460|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2609461|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2609462|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
2609463|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609464|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2609465|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2609466|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609467|NCT01817023|Cisplatin|cisplatin|mesh-list
2609468|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156283|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2156284|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2156285|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2156286|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
2156287|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609469|NCT01817036|Vitamin D|vitamin d|mesh-list
2609470|NCT01817036|Vitamins|vitamins|mesh-ancestor
2609471|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
2156288|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156289|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
2156290|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2156291|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2156292|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2156293|NCT01605617|Fesoterodine|fesoterodine|mesh-list
2156294|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2156295|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2609472|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609473|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2609474|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
2609475|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2609476|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2609477|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2609478|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2609486|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
2609487|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2609488|NCT01817257|Heparin|heparin|mesh-list
2609489|NCT01817257|Enoxaparin|enoxaparin|mesh-list
2156296|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
2156297|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2156298|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156299|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156300|NCT01605617|Urological Agents|urological agents|mesh-ancestor
2156301|NCT01606709|Leuprolide|leuprolide|mesh-list
2156302|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2156303|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
2156304|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2156305|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156306|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2156307|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156308|NCT01603121|Lisofylline|lisofylline|mesh-list
2156309|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2156310|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
2156311|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156312|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2156313|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2156314|NCT01603121|Analgesics|analgesics|mesh-ancestor
2156315|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
2156316|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156317|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2156318|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2156319|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2156320|NCT01602016|Leucovorin|leucovorin|mesh-list
2156321|NCT01602016|Folic Acid|folic acid|mesh-list
2156322|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
2156323|NCT01602016|Antidotes|antidotes|mesh-ancestor
2156324|NCT01602016|Protective Agents|protective agents|mesh-ancestor
2156325|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156326|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
2609490|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2609491|NCT01817257|Tinzaparin|tinzaparin|mesh-list
2609492|NCT01817257|Dalteparin|dalteparin|mesh-list
2609493|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
2609494|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2609495|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2609496|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609497|NCT01817283|Triptolide|triptolide|mesh-list
2609498|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2609499|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609500|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2609501|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
2609502|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2609503|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2609504|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
2609505|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2609506|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
2609507|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609508|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609509|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
2609510|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
2609511|NCT01817322|Prednisolone|prednisolone|mesh-list
2609512|NCT01817322|Deflazacort|deflazacort|mesh-list
2609513|NCT01817322|Basiliximab|basiliximab|mesh-list
2609514|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2609515|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
2609516|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
2609517|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609518|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609519|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2609520|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
2609521|NCT01817322|Hormones|hormones|mesh-ancestor
2609522|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609523|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2609524|NCT01817322|Protective Agents|protective agents|mesh-ancestor
2609525|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2609526|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609527|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2156327|NCT01602016|Vitamins|vitamins|mesh-ancestor
2156328|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
2156329|NCT01602016|Hematinics|hematinics|mesh-ancestor
2156330|NCT01603394|Pregabalin|pregabalin|mesh-list
2156331|NCT01603394|Analgesics|analgesics|mesh-ancestor
2156332|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
2156333|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156334|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156335|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
2156336|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2156337|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2156338|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156339|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2156340|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2156341|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2156342|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156343|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2156344|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2156345|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156346|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2156347|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156348|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156349|NCT01598025|Fludarabine|fludarabine|mesh-list
2156350|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
2156351|NCT01598025|Melphalan|melphalan|mesh-list
2156352|NCT01598025|Thiotepa|thiotepa|mesh-list
2156353|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2156354|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156355|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2156356|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
2156357|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156358|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2156359|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
2156360|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156361|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2156362|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
2156363|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2156364|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
2156365|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
2421567|NCT00813332|Docetaxel|docetaxel|mesh-list
2421568|NCT00813332|Endostar protein|endostar protein|mesh-list
2609528|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2609529|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
2609530|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2609531|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609532|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156366|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156367|NCT01587963|Protective Agents|protective agents|mesh-ancestor
2156368|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156369|NCT01587963|Vitamins|vitamins|mesh-ancestor
2156370|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
2156371|NCT01591096|Plasminogen|plasminogen|mesh-list
2156372|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2156373|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2156374|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2156375|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156376|NCT01576575|Rifampin|rifampin|mesh-list
2421569|NCT00813332|Endostatins|endostatins|mesh-list
2421570|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421571|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
2421572|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
2421573|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
2421574|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421575|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2421576|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2421577|NCT00813332|Growth Substances|growth substances|mesh-ancestor
2421578|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421579|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
2421580|NCT00813410|Insulin|insulin|mesh-list
2421581|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2421582|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421583|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
2421584|NCT00813423|Sunitinib|sunitinib|mesh-list
2421585|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421586|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2421587|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2421588|NCT00813423|Growth Substances|growth substances|mesh-ancestor
2421589|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421590|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
2421591|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2421592|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421593|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609533|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609534|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2609535|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
2609536|NCT01817348|Lidocaine|lidocaine|mesh-list
2609537|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
2609538|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
2609539|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2609540|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609541|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
2609542|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609543|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2156377|NCT01576575|Ketoconazole|ketoconazole|mesh-list
2156378|NCT01576575|Buprenorphine|buprenorphine|mesh-list
2156379|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2156380|NCT01576575|Narcotics|narcotics|mesh-ancestor
2156381|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156382|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156383|NCT01576575|Analgesics|analgesics|mesh-ancestor
2156384|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
2156385|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156386|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2156387|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2156388|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
2156389|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2156390|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2156391|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
2156392|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2156393|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156394|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156395|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2156396|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2156397|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2156398|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2156399|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2609544|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2609545|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2609546|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2609547|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609548|NCT01817400|Aspirin|aspirin|mesh-list
2609549|NCT01817400|Pioglitazone|pioglitazone|mesh-list
2609550|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2609551|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2609552|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2609553|NCT01817400|Analgesics|analgesics|mesh-ancestor
2609554|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
2609555|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609556|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609557|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2609558|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2609559|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2609560|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2609561|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609562|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2609563|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2609564|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609565|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
2609566|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2609567|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2609568|NCT01817426|Infliximab|infliximab|mesh-list
2609569|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
2609570|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2609571|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2609572|NCT01817439|Amiodarone|amiodarone|mesh-list
2609573|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2609574|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
2609575|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2609576|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2609577|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609578|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2609579|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2609580|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2609581|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609582|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2609583|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2609584|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2609585|NCT01817452|Paclitaxel|paclitaxel|mesh-list
2609586|NCT01817452|Trastuzumab|trastuzumab|mesh-list
2609587|NCT01817452|Pertuzumab|pertuzumab|mesh-list
2609588|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2609589|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609590|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
2609591|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
2609592|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
2609593|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609594|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2609595|NCT01817699|Vitamin D|vitamin d|mesh-list
2609596|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
2609597|NCT01817699|Vitamins|vitamins|mesh-ancestor
2609598|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
2609599|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609600|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2609601|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2609602|NCT01817803|Metolazone|metolazone|mesh-list
2609603|NCT01817803|Furosemide|furosemide|mesh-list
2609604|NCT01817803|Spironolactone|spironolactone|mesh-list
2609605|NCT01817803|Diuretics|diuretics|mesh-ancestor
2609606|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
2609607|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609608|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2609609|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2609610|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609611|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2609612|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
2609613|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609614|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2609615|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2609616|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2609617|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2156400|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2156401|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
2156402|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2156403|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2156404|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2156405|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
2156406|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2156407|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2156408|NCT01583647|Niacin|niacin|mesh-list
2156409|NCT01583647|Niacinamide|niacinamide|mesh-list
2156410|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
2156411|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2156412|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
2156413|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156414|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2156415|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
2156416|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
2156417|NCT01583647|Vitamins|vitamins|mesh-ancestor
2609618|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2609619|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2609620|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609621|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609622|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2609623|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2609624|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609625|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
2609626|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609627|NCT01817829|Acetaminophen|acetaminophen|mesh-list
2609628|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2609629|NCT01817829|Analgesics|analgesics|mesh-ancestor
2609630|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
2609631|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609632|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609633|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
2609634|NCT01817868|Factor VIII|factor viii|mesh-list
2609635|NCT01817868|Coagulants|coagulants|mesh-ancestor
2609636|NCT01817894|Eflornithine|eflornithine|mesh-list
2609637|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609638|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2609639|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2156418|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
2156419|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156420|NCT01575028|Bupivacaine|bupivacaine|mesh-list
2156421|NCT01575028|Ropivacaine|ropivacaine|mesh-list
2156422|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
2156423|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
2156424|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156425|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156426|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
2156427|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156428|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
2156429|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
2156430|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2156431|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
2156432|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156433|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2156434|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2156435|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
2156436|NCT01570634|Loperamide|loperamide|mesh-list
2156437|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
2156438|NCT01570634|Calcium|calcium|mesh-list
2156439|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2156440|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156441|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2156442|NCT01566370|Zonisamide|zonisamide|mesh-list
2156443|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
2156444|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2156445|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2156446|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609640|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2609641|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609642|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2609643|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609644|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609645|NCT01817972|Azathioprine|azathioprine|mesh-list
2609646|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
2609647|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
2609648|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609649|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2609650|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609651|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2609652|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
2609653|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609654|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2609655|NCT01817985|Velpatasvir|velpatasvir|mesh-list
2609656|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
2609657|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609658|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2609659|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
2609660|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609661|NCT01818076|Botulinum Toxins|botulinum toxins|mesh-list
2609662|NCT01818076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2609663|NCT01818076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2609664|NCT01818076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2609665|NCT01818076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2609666|NCT01818076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609667|NCT01818076|Cholinergic Agents|cholinergic agents|mesh-ancestor
2609668|NCT01818076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609669|NCT01818076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609670|NCT01818076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2609671|NCT01818076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609672|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2609673|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
2609674|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2609675|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2609676|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609677|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2609678|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609679|NCT01818375|Anesthetics|anesthetics|mesh-list
2609680|NCT01818375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156447|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2609681|NCT01818375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609682|NCT01818648|Exenatide|exenatide|mesh-list
2609683|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2609684|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609685|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2609686|NCT01818648|Incretins|incretins|mesh-ancestor
2156448|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156449|NCT01561989|Vitamin D|vitamin d|mesh-list
2156450|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
2156451|NCT01561989|Vaccines|vaccines|mesh-list
2156452|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
2156453|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156454|NCT01561989|Vitamins|vitamins|mesh-ancestor
2156455|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
2156456|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2156457|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2609687|NCT01818648|Hormones|hormones|mesh-ancestor
2609688|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609689|NCT01818713|Doxorubicin|doxorubicin|mesh-list
2609690|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2609691|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2609692|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609693|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2609694|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2609695|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609696|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609697|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
2609698|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
2609699|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609700|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
2609701|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609702|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609703|NCT01818856|Ritonavir|ritonavir|mesh-list
2609704|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2609705|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2609706|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2609707|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
2609708|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609709|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609710|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2609711|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2609712|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
2609713|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609714|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2156458|NCT01560507|Bupropion|bupropion|mesh-list
2156459|NCT01560507|Nicotine|nicotine|mesh-list
2609715|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2609716|NCT01818869|Adenosine|adenosine|mesh-list
2609717|NCT01818869|Analgesics|analgesics|mesh-ancestor
2156460|NCT01560507|Varenicline|varenicline|mesh-list
2156461|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2156462|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
2156463|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156464|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156465|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2156466|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2156467|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
2156468|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2156469|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156470|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2156471|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
2156472|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2156473|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2156474|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2156475|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2156476|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
2156477|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2156478|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2156479|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156480|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
2156481|NCT01555489|Vitamins|vitamins|mesh-ancestor
2156482|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
2609718|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
2609719|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156483|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609720|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609721|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2609722|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
2609723|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2609724|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
2609725|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
2609726|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609727|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609728|NCT01818908|Prednisone|prednisone|mesh-list
2609729|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
2609730|NCT01818908|Doxorubicin|doxorubicin|mesh-list
2609731|NCT01818908|Etoposide|etoposide|mesh-list
2609732|NCT01818908|Vincristine|vincristine|mesh-list
2609733|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2609734|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
2609735|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609736|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2609737|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2609738|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
2609739|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609740|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609741|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2609742|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2609743|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2609744|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2609745|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609746|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2609747|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
2609748|NCT01818908|Hormones|hormones|mesh-ancestor
2609749|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609750|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2609751|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2609752|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
2609753|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
2156484|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
2156485|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156486|NCT01555489|Protective Agents|protective agents|mesh-ancestor
2156487|NCT01549977|Febuxostat|febuxostat|mesh-list
2156488|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
2156489|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2156490|NCT01558492|Paclitaxel|paclitaxel|mesh-list
2156491|NCT01558492|Carboplatin|carboplatin|mesh-list
2156492|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2156493|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156494|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
2156495|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
2156496|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
2156497|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156498|NCT01555073|Celecoxib|celecoxib|mesh-list
2156499|NCT01555073|Pregabalin|pregabalin|mesh-list
2156500|NCT01555073|Analgesics|analgesics|mesh-ancestor
2609754|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
2609755|NCT01818921|CKD732|ckd732|mesh-list
2609756|NCT01818921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2609757|NCT01818921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2609758|NCT01818921|Growth Substances|growth substances|mesh-ancestor
2609759|NCT01818921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609760|NCT01818921|Growth Inhibitors|growth inhibitors|mesh-ancestor
2609761|NCT01818921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421594|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
2421595|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2421596|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2421597|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421598|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421599|NCT00813436|Oxytocin|oxytocin|mesh-list
2421600|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
2421601|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2421602|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421603|NCT00813449|Dacarbazine|dacarbazine|mesh-list
2421604|NCT00813449|Endostar protein|endostar protein|mesh-list
2421605|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2421606|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
2421607|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421608|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421609|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2421610|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2156501|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
2156502|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609762|NCT01818973|Bevacizumab|bevacizumab|mesh-list
2609763|NCT01818973|Capecitabine|capecitabine|mesh-list
2609764|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
2609765|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2609766|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609767|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2609768|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2609769|NCT01818973|Growth Substances|growth substances|mesh-ancestor
2609770|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156503|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156504|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
2156505|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2156506|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2156507|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156508|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2156509|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2156510|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2156511|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2609771|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
2609772|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2156512|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2156513|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2156514|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2156515|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2156516|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2156517|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2156518|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2609773|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
2609774|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609775|NCT01819012|Isoflurane|isoflurane|mesh-list
2609776|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2609777|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
2609778|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
2609779|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156519|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156520|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2156521|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2156522|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
2156523|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
2156524|NCT01550510|Irinotecan|irinotecan|mesh-list
2156525|NCT01550510|Camptothecin|camptothecin|mesh-list
2156526|NCT01550510|Vitamins|vitamins|mesh-ancestor
2156527|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
2156528|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156529|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2156530|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2156531|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156532|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156533|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156534|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
2156535|NCT01550510|Protective Agents|protective agents|mesh-ancestor
2609780|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609781|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
2609782|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2609783|NCT01819064|Atropine|atropine|mesh-list
2609784|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2609785|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2609786|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2609787|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
2609788|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609789|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609790|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2609791|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
2609792|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
2609793|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
2609794|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2609795|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2609796|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
2609797|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609798|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609799|NCT01819155|Vaccines|vaccines|mesh-list
2609800|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
2609801|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609802|NCT01819220|Amlodipine|amlodipine|mesh-list
2156536|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2156537|NCT01547728|Antithrombins|antithrombins|mesh-list
2156538|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
2156539|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2156540|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
2156541|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156542|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156543|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
2156544|NCT01548651|Saxagliptin|saxagliptin|mesh-list
2609803|NCT01819220|Valsartan|valsartan|mesh-list
2609804|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2609805|NCT01819220|Telmisartan|telmisartan|mesh-list
2609806|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
2609807|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
2609808|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2609809|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2609810|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2609811|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156545|NCT01548651|Incretins|incretins|mesh-ancestor
2156546|NCT01548651|Hormones|hormones|mesh-ancestor
2156547|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2156548|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156549|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2156550|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
2156551|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156552|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156553|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2156554|NCT01545648|Denosumab|denosumab|mesh-list
2156555|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2156556|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156557|NCT01546883|Dabigatran|dabigatran|mesh-list
2156558|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
2156559|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2156560|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
2156561|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156562|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156563|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
2156564|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2156565|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
2156566|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156567|NCT01536015|Rotigotine|rotigotine|mesh-list
2156568|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
2156569|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
2609812|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2609813|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609814|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
2609815|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2609816|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2609817|NCT01819220|Diuretics|diuretics|mesh-ancestor
2609818|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
2609819|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2609820|NCT01819259|Nicotine|nicotine|mesh-list
2609821|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2609822|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
2609823|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609824|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609825|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2609826|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2609827|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
2156570|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2156571|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156572|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156573|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2156574|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2156575|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2156576|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
2156577|NCT01533753|Gabapentin|gabapentin|mesh-list
2609828|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2156578|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2156579|NCT01533753|Analgesics|analgesics|mesh-ancestor
2156580|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
2156581|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156582|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156583|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
2156584|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2156585|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2156586|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156587|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2156588|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2156589|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2156590|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2156591|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156592|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
2156593|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2156594|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2156595|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2156596|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2609829|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609830|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2609831|NCT01819285|Hormones|hormones|mesh-ancestor
2609832|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2609833|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609834|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
2609835|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609836|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2156597|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
2156598|NCT01534143|Sirolimus|sirolimus|mesh-list
2156599|NCT01534143|Fludarabine|fludarabine|mesh-list
2156600|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
2156601|NCT01534143|Bortezomib|bortezomib|mesh-list
2156602|NCT01534143|Busulfan|busulfan|mesh-list
2156603|NCT01534143|Tacrolimus|tacrolimus|mesh-list
2156604|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
2156605|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2156606|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
2156607|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156608|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2156609|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
2156610|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156611|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2156612|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
2156613|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156614|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2156615|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156616|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2156617|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2156618|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2156619|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
2156620|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
2156621|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2609837|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609838|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609839|NCT01819402|Pioglitazone|pioglitazone|mesh-list
2609840|NCT01819402|Glimepiride|glimepiride|mesh-list
2609841|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2609842|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609843|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2609844|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2609845|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
2609846|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2609847|NCT01819441|Perindopril|perindopril|mesh-list
2156622|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2156623|NCT01530880|Acetaminophen|acetaminophen|mesh-list
2156624|NCT01530880|Ibuprofen|ibuprofen|mesh-list
2156625|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2156626|NCT01530880|Analgesics|analgesics|mesh-ancestor
2156627|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
2156628|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156629|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156630|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
2156631|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2156632|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2156633|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2609848|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2609849|NCT01819441|Diuretics|diuretics|mesh-ancestor
2609850|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
2609851|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609852|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2609853|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2609854|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609855|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2609856|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
2609857|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609858|NCT01819610|Ketorolac|ketorolac|mesh-list
2609859|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2609860|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2609861|NCT01819610|Analgesics|analgesics|mesh-ancestor
2609862|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
2609863|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609864|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609865|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2609866|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2609867|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2609868|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609869|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609870|NCT01819649|Selenium|selenium|mesh-list
2609871|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
2609872|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609873|NCT01819649|Protective Agents|protective agents|mesh-ancestor
2609874|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609875|NCT01819649|Trace Elements|trace elements|mesh-ancestor
2609876|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
2609877|NCT01819701|Ubiquinone|ubiquinone|mesh-list
2609878|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
2609879|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
2609880|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609881|NCT01819701|Vitamins|vitamins|mesh-ancestor
2609882|NCT01819779|Amlodipine|amlodipine|mesh-list
2609883|NCT01819779|Valsartan|valsartan|mesh-list
2609884|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
2609885|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2609886|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2609887|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2609888|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609889|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2609890|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609891|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
2609892|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2609893|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2609894|NCT01819857|Ondansetron|ondansetron|mesh-list
2609895|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
2609896|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
2156634|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2156635|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156636|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156637|NCT01527942|Acetaminophen|acetaminophen|mesh-list
2156638|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2156639|NCT01527942|Analgesics|analgesics|mesh-ancestor
2156640|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
2609897|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609898|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609899|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2609900|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
2609901|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
2609902|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2609903|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
2609904|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609905|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156641|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609906|NCT01819857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2609907|NCT01819857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2609908|NCT01819857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2609909|NCT01819857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2609910|NCT01819857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2609911|NCT01819870|Carvedilol|carvedilol|mesh-list
2609912|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2609913|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2609914|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
2609915|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609916|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609917|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609918|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2609919|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
2609920|NCT01819870|Protective Agents|protective agents|mesh-ancestor
2609921|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2609922|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2609923|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2609924|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
2609925|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2609926|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2609927|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2609928|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2609929|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2609930|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2609931|NCT01820026|Amoxicillin|amoxicillin|mesh-list
2609932|NCT01820026|Azithromycin|azithromycin|mesh-list
2609933|NCT01820026|Vancomycin|vancomycin|mesh-list
2609934|NCT01820026|Imipenem|imipenem|mesh-list
2156642|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156643|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
2156644|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
2156645|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
2156646|NCT01532635|Tacrolimus|tacrolimus|mesh-list
2156647|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2156648|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
2156649|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156650|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2156651|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2609935|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2609936|NCT01820026|Cefotaxime|cefotaxime|mesh-list
2609937|NCT01820026|Cefoxitin|cefoxitin|mesh-list
2609938|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2609939|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2609940|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2609941|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609942|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609943|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
2609944|NCT01820091|Antidotes|antidotes|mesh-ancestor
2609945|NCT01820091|Protective Agents|protective agents|mesh-ancestor
2609946|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609947|NCT01820104|Lansoprazole|lansoprazole|mesh-list
2609948|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
2609949|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2609950|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2156652|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
2156653|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156654|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156655|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2156656|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2156657|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156658|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2156659|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2156660|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
2156661|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2156662|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2156663|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
2156664|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156665|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
2156666|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156667|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156668|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2156669|NCT01526408|Famciclovir|famciclovir|mesh-list
2156670|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
2156671|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2156672|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2156673|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156674|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156675|NCT01525927|Cisplatin|cisplatin|mesh-list
2156676|NCT01525927|Carboplatin|carboplatin|mesh-list
2156677|NCT01525927|Etoposide|etoposide|mesh-list
2156678|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156679|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2156680|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2156681|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2156682|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609951|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2609952|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609953|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156683|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609954|NCT01820143|Esomeprazole|esomeprazole|mesh-list
2609955|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2609956|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2609957|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2609958|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2609959|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609960|NCT01820299|Vitamin D|vitamin d|mesh-list
2609961|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
2609962|NCT01820299|Vitamins|vitamins|mesh-ancestor
2609963|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
2609964|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609965|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2609966|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2609967|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609968|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
2609969|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609970|NCT01820299|Protective Agents|protective agents|mesh-ancestor
2609971|NCT01820312|Paclitaxel|paclitaxel|mesh-list
2609972|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2609973|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609974|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
2609975|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
2609976|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
2156684|NCT01507233|Morphine|morphine|mesh-list
2156685|NCT01507233|Bupivacaine|bupivacaine|mesh-list
2156686|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
2156687|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
2156688|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156689|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156690|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
2156691|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156692|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2156693|NCT01507233|Narcotics|narcotics|mesh-ancestor
2156694|NCT01507233|Analgesics|analgesics|mesh-ancestor
2156695|NCT01500772|Ribavirin|ribavirin|mesh-list
2156696|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2156697|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
2156698|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156699|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
2156700|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2156701|NCT01517763|Immunoconjugates|immunoconjugates|mesh-list
2156702|NCT01517763|Immunologic Factors|immunologic factors|mesh-ancestor
2156703|NCT01517763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609977|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609978|NCT01820325|Paclitaxel|paclitaxel|mesh-list
2609979|NCT01820325|Carboplatin|carboplatin|mesh-list
2609980|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2609981|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2609982|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
2609983|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
2609984|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
2609985|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2609986|NCT01820442|Lofexidine|lofexidine|mesh-list
2609987|NCT01820442|Clonidine|clonidine|mesh-list
2609988|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2156704|NCT01507584|Bimatoprost|bimatoprost|mesh-list
2156705|NCT01507584|Brinzolamide|brinzolamide|mesh-list
2156706|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2156707|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2156708|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156709|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156710|NCT01510756|Sorafenib|sorafenib|mesh-list
2156711|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156712|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2156713|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156714|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156715|NCT01500109|Acetaminophen|acetaminophen|mesh-list
2609989|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2609990|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609991|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
2609992|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2609993|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2609994|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2609995|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2156716|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2156717|NCT01500109|Analgesics|analgesics|mesh-ancestor
2156718|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
2156719|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156720|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156721|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
2156722|NCT01509053|Aripiprazole|aripiprazole|mesh-list
2156723|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
2156724|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2156725|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2156726|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2156727|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156728|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2609996|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
2609997|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2609998|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156729|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
2156730|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
2156731|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2156732|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156733|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2156734|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2156735|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
2156736|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2156737|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2156738|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2156739|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2609999|NCT01820442|Analgesics|analgesics|mesh-ancestor
2610000|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
2610001|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
2610002|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
2610003|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2610004|NCT01820455|Mupirocin|mupirocin|mesh-list
2610005|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2610006|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610007|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
2610008|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
2610009|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2610010|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2610011|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610012|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610013|NCT01820624|Tretinoin|tretinoin|mesh-list
2610014|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
2610015|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
2610016|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2610017|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610018|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610019|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
2610020|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2610021|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2610022|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610023|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610024|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
2156740|NCT01495988|Bevacizumab|bevacizumab|mesh-list
2156741|NCT01495988|Vemurafenib|vemurafenib|mesh-list
2156742|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2156743|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610025|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
2610026|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
2610027|NCT01820767|Atorvastatin|atorvastatin|mesh-list
2610028|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2610029|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2156744|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2156745|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2156746|NCT01495988|Growth Substances|growth substances|mesh-ancestor
2421611|NCT00813449|Growth Substances|growth substances|mesh-ancestor
2421612|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421613|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
2421614|NCT00813475|Insulin|insulin|mesh-list
2421615|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2421616|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2421617|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421618|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2421619|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
2421620|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421621|NCT00813527|Fenofibrate|fenofibrate|mesh-list
2421622|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2610030|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
2610031|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610032|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2610033|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2610034|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610035|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2610036|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610037|NCT01820767|Vitamins|vitamins|mesh-ancestor
2610038|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
2156747|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156748|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
2156749|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2156750|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156751|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610039|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2610040|NCT01820793|Cefoxitin|cefoxitin|mesh-list
2610041|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2610042|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610043|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
2610044|NCT01820832|Calcitriol|calcitriol|mesh-list
2610045|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2610046|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610047|NCT01820832|Vitamins|vitamins|mesh-ancestor
2610048|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
2610049|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2610050|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2610051|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610052|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610053|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2610054|NCT01820858|Paclitaxel|paclitaxel|mesh-list
2610055|NCT01820858|Carboplatin|carboplatin|mesh-list
2610056|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2156752|NCT01483872|Tigecycline|tigecycline|mesh-list
2156753|NCT01483872|Heparin|heparin|mesh-list
2156754|NCT01483872|Calcium heparin|calcium heparin|mesh-list
2156755|NCT01483872|Anticoagulants|anticoagulants|mesh-list
2156756|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156757|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2156758|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2156759|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2156760|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2156761|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2156762|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156763|NCT01487499|Cisplatin|cisplatin|mesh-list
2156764|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156765|NCT01478113|Amphetamine|amphetamine|mesh-list
2156766|NCT01478113|Adderall|adderall|mesh-list
2156767|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
2156768|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2156769|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156770|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
2156771|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
2156772|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156773|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
2156774|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2156775|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156776|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
2610057|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610058|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
2610059|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
2610060|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
2610061|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610062|NCT01820897|Trimethoprim|trimethoprim|mesh-list
2610063|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2610064|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
2610065|NCT01820897|Fosfomycin|fosfomycin|mesh-list
2610066|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2610067|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610068|NCT01820897|Renal Agents|renal agents|mesh-ancestor
2610069|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
2610070|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2610071|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2610072|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2610073|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610074|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610075|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2610076|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2610077|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2610078|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2610079|NCT01820910|Doxycycline|doxycycline|mesh-list
2610080|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2610081|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610082|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
2156777|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2156778|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2156779|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2156780|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2156781|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
2156782|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2156783|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2156784|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2156785|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2156786|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610083|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2610084|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2610085|NCT01820962|Heparin|heparin|mesh-list
2610086|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
2610087|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610088|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2610089|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2610090|NCT01821001|Bromocriptine|bromocriptine|mesh-list
2610091|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2610092|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2610093|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
2610094|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2610095|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610096|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
2610097|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
2610098|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610099|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610100|NCT01821027|Canagliflozin|canagliflozin|mesh-list
2610101|NCT01821027|Simvastatin|simvastatin|mesh-list
2610102|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2610103|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2610104|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
2610105|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610106|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2610107|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2610108|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610109|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2610110|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2610111|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610112|NCT01821040|Prednisone|prednisone|mesh-list
2610113|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2610114|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
2610115|NCT01821040|Hormones|hormones|mesh-ancestor
2610116|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2610117|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610118|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2156787|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
2156788|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2156789|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156790|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2156791|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156792|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2156793|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2156794|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
2156795|NCT01473732|Everolimus|everolimus|mesh-list
2156796|NCT01473732|Tacrolimus|tacrolimus|mesh-list
2156797|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2156798|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
2156799|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156800|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2156801|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156802|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156803|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610119|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610120|NCT01821066|Tamoxifen|tamoxifen|mesh-list
2421623|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
2421624|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421625|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2421626|NCT00813566|Alovudine|alovudine|mesh-list
2421627|NCT00813566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2421628|NCT00813566|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2421629|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421630|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
2421631|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421632|NCT00813605|Conatumumab|conatumumab|mesh-list
2421633|NCT00813605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2421634|NCT00813605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421635|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2421636|NCT00813631|Laxatives|laxatives|mesh-ancestor
2156804|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2156805|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2156806|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
2156807|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2156808|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610121|NCT01821066|Palbociclib|palbociclib|mesh-list
2610122|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2610123|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
2610124|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2610125|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610126|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2610127|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610128|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2610129|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2610130|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2610131|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2610132|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610133|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610134|NCT01821170|Methylphenidate|methylphenidate|mesh-list
2610135|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2610136|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610137|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2610138|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2610139|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610140|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610141|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
2610142|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610143|NCT01821235|Gabapentin|gabapentin|mesh-list
2610144|NCT01821235|Analgesics|analgesics|mesh-ancestor
2610145|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
2610146|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610147|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610148|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
2610149|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2610150|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2610151|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2610152|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2610153|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2610154|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2610155|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610156|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610157|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
2610158|NCT01821248|Gemcitabine|gemcitabine|mesh-list
2610159|NCT01821248|Cisplatin|cisplatin|mesh-list
2610160|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610161|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2610162|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
2610163|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610164|NCT01821248|Antiviral Agents|antiviral agents|mesh-ancestor
2610165|NCT01821248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610166|NCT01821248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610167|NCT01821248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2610168|NCT01821248|Immunologic Factors|immunologic factors|mesh-ancestor
2610169|NCT01821248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610170|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
2610171|NCT01821261|Fluorides|fluorides|mesh-list
2610172|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
2610173|NCT01821261|Protective Agents|protective agents|mesh-ancestor
2421637|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2156809|NCT01472692|Febuxostat|febuxostat|mesh-list
2156810|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
2156811|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2610174|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610175|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2610176|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610177|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
2610178|NCT01821274|Diltiazem|diltiazem|mesh-list
2610179|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2610180|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2610181|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610182|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610183|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2610184|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610185|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
2610186|NCT01821404|Atorvastatin|atorvastatin|mesh-list
2610187|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2610188|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2610189|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
2610190|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610191|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2610192|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2610193|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610194|NCT01821430|Pregabalin|pregabalin|mesh-list
2610195|NCT01821430|Analgesics|analgesics|mesh-ancestor
2610196|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
2610197|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610198|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610199|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
2610200|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2610201|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610202|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610203|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2610204|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2610205|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2610206|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2610207|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2610208|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
2610209|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
2610210|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
2610211|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2610212|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2610213|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2610214|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610215|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610216|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
2610217|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610218|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610219|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2610220|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610221|NCT01821612|Leucovorin|leucovorin|mesh-list
2610222|NCT01821612|Gemcitabine|gemcitabine|mesh-list
2610223|NCT01821612|Fluorouracil|fluorouracil|mesh-list
2156812|NCT01465230|Lenalidomide|lenalidomide|mesh-list
2156813|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
2156814|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156815|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2156816|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2156817|NCT01465230|Growth Substances|growth substances|mesh-ancestor
2156818|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
2156819|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156820|NCT01464723|Ranibizumab|ranibizumab|mesh-list
2156821|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2610224|NCT01821612|Capecitabine|capecitabine|mesh-list
2610225|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
2610226|NCT01821612|Irinotecan|irinotecan|mesh-list
2610227|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2610228|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
2610229|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610230|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610231|NCT01821612|Antiviral Agents|antiviral agents|mesh-ancestor
2610232|NCT01821612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610233|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610234|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2156822|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2156823|NCT01464723|Growth Substances|growth substances|mesh-ancestor
2156824|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156825|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
2156826|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156827|NCT01446250|Ribavirin|ribavirin|mesh-list
2156828|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2156829|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
2156830|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156831|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
2156832|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2156833|NCT01457053|Torsemide|torsemide|mesh-list
2610235|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
2610236|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156834|NCT01457053|Furosemide|furosemide|mesh-list
2156835|NCT01457053|Bumetanide|bumetanide|mesh-list
2156836|NCT01457053|Diuretics|diuretics|mesh-list
2156837|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
2156838|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
2610237|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2610238|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2610239|NCT01821612|Antidotes|antidotes|mesh-ancestor
2610240|NCT01821612|Protective Agents|protective agents|mesh-ancestor
2610241|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
2610242|NCT01821612|Vitamins|vitamins|mesh-ancestor
2610243|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
2610244|NCT01821664|Heparin|heparin|mesh-list
2610245|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
2610246|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2610247|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2610248|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610249|NCT01821677|Danazol|danazol|mesh-list
2610250|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2610251|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
2156839|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156840|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2156841|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156842|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2156843|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2156844|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
2156845|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156846|NCT01451723|Protective Agents|protective agents|mesh-ancestor
2156847|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156848|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2156849|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2156850|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156851|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2156852|NCT01440595|Ribavirin|ribavirin|mesh-list
2156853|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2156854|NCT01440595|Grazoprevir|grazoprevir|mesh-list
2156855|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
2156856|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156857|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
2156858|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2156859|NCT01443923|Interferons|interferons|mesh-list
2156860|NCT01443923|Ribavirin|ribavirin|mesh-list
2156861|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
2156862|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
2156863|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2156864|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156865|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
2156866|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2156867|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
2156868|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156869|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
2156870|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156871|NCT01439347|Vincristine|vincristine|mesh-list
2156872|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2156873|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156874|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
2156875|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
2156876|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
2156877|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156878|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
2156879|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2156880|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156881|NCT01434745|Simvastatin|simvastatin|mesh-list
2610252|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2156882|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2156883|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2156884|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
2156885|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156886|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2156887|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2156888|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156889|NCT01415986|Temoporfin|temoporfin|mesh-list
2156890|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156891|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2156892|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
2156893|NCT01410799|Hormones|hormones|mesh-list
2610253|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610264|NCT01821703|Spironolactone|spironolactone|mesh-list
2610265|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2610266|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
2610267|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2610268|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610269|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2610270|NCT01821703|Diuretics|diuretics|mesh-ancestor
2610271|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
2610272|NCT01821781|Fludarabine|fludarabine|mesh-list
2610273|NCT01821781|Melphalan|melphalan|mesh-list
2610274|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
2610275|NCT01821781|Thiotepa|thiotepa|mesh-list
2610276|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610277|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610278|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2610279|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
2610280|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610281|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2610282|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
2610283|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2610284|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2610285|NCT01821833|Paclitaxel|paclitaxel|mesh-list
2610286|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2610287|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610288|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
2610289|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
2156894|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
2156895|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2156896|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156897|NCT01426113|Timolol|timolol|mesh-list
2156898|NCT01426113|Bimatoprost|bimatoprost|mesh-list
2156899|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2156900|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2156901|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2156902|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2156903|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
2156904|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2156905|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156906|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156907|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2610290|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
2610291|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610292|NCT01821846|Liraglutide|liraglutide|mesh-list
2610293|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2610294|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610295|NCT01821846|Incretins|incretins|mesh-ancestor
2610296|NCT01821846|Hormones|hormones|mesh-ancestor
2610297|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2610298|NCT01821872|Acetaminophen|acetaminophen|mesh-list
2610299|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2610300|NCT01821872|Analgesics|analgesics|mesh-ancestor
2610301|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
2156908|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2156909|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
2156910|NCT01420965|Antibodies|antibodies|mesh-list
2156911|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
2156912|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2156913|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
2610302|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610303|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610304|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
2156914|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156915|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2156916|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2156917|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
2156918|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156919|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156920|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2156921|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
2156922|NCT01406860|Promethazine|promethazine|mesh-list
2156923|NCT01406860|Droperidol|droperidol|mesh-list
2156924|NCT01406860|Metoclopramide|metoclopramide|mesh-list
2156925|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2156926|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2156927|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156928|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156929|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
2156930|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
2156931|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
2156932|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156933|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
2156934|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
2156935|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2156936|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2156937|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
2156938|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
2156939|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2156940|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156941|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2156942|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
2156943|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
2156944|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2156945|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2156946|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
2156947|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2156948|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2156949|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2156950|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2156951|NCT01401049|Lidocaine|lidocaine|mesh-list
2156952|NCT01401049|Propofol|propofol|mesh-list
2156953|NCT01401049|Fospropofol|fospropofol|mesh-list
2156954|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
2156955|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
2156956|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2156957|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156958|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
2156959|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2156960|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2421638|NCT00813696|Gemcitabine|gemcitabine|mesh-list
2421639|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421640|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2421641|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
2421642|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421643|NCT00813696|Antiviral Agents|antiviral agents|mesh-ancestor
2421644|NCT00813696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421645|NCT00813696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421646|NCT00813696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2421647|NCT00813696|Immunologic Factors|immunologic factors|mesh-ancestor
2421648|NCT00813696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421649|NCT00813722|Losartan|losartan|mesh-list
2421650|NCT00813722|Atenolol|atenolol|mesh-list
2421651|NCT00813722|Amlodipine|amlodipine|mesh-list
2421652|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2421653|NCT00813722|Calcium|calcium|mesh-list
2421654|NCT00813722|Diuretics|diuretics|mesh-list
2421655|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2421656|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2421657|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610305|NCT01821989|Lactoferrin|lactoferrin|mesh-list
2610306|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610307|NCT01822015|Cytarabine|cytarabine|mesh-list
2610308|NCT01822015|Sirolimus|sirolimus|mesh-list
2610309|NCT01822015|Idarubicin|idarubicin|mesh-list
2610310|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2610311|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
2610312|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610313|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610314|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
2610315|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610316|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2610317|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
2156961|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2156962|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2156963|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2156964|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156965|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2156966|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2156967|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
2156968|NCT01408641|Topiramate|topiramate|mesh-list
2156969|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
2156970|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2156971|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156972|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
2156973|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
2156974|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2156975|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2156976|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156977|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2156978|NCT01409031|Urological Agents|urological agents|mesh-ancestor
2156979|NCT01402531|Bevacizumab|bevacizumab|mesh-list
2156980|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2156981|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2156982|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2156983|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2610318|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610319|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2610320|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2610321|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
2610322|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2610323|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2610324|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2156984|NCT01402531|Growth Substances|growth substances|mesh-ancestor
2156985|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2156986|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
2156994|NCT01397552|Dexamethasone|dexamethasone|mesh-list
2156995|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
2156996|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2156997|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2156998|NCT01397552|Prednisolone|prednisolone|mesh-list
2156999|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
2157000|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2157001|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
2610325|NCT01822028|Miglustat|miglustat|mesh-list
2610326|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
2610327|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610328|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610329|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2610330|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2610331|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
2610332|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610333|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2157002|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2157003|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
2157004|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
2157005|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2157006|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610334|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2610335|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157007|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2157008|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
2157009|NCT01397552|Hormones|hormones|mesh-ancestor
2157010|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157011|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2157012|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157013|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2157014|NCT01397552|Protective Agents|protective agents|mesh-ancestor
2157015|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2610336|NCT01822080|Dienogest|dienogest|mesh-list
2610337|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2610338|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
2610339|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2610340|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610341|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2610342|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2610343|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2610344|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2610345|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
2610346|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2610347|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2610348|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610349|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
2610350|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2610351|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610352|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610353|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
2610354|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610355|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610356|NCT01822275|Temozolomide|temozolomide|mesh-list
2610357|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2610358|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
2610359|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610360|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157016|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
2157017|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157018|NCT01397695|Bevacizumab|bevacizumab|mesh-list
2157019|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2610361|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2610362|NCT01822288|Tibolone|tibolone|mesh-list
2610363|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
2610364|NCT01822288|Estradiol|estradiol|mesh-list
2610365|NCT01822288|Estrogens|estrogens|mesh-ancestor
2610366|NCT01822288|Hormones|hormones|mesh-ancestor
2610367|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2610368|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610369|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2610370|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
2610371|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2610372|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2610373|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2610374|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2610375|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2610376|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2610377|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2610378|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610379|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
2610380|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
2610381|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2610382|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2610383|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
2610384|NCT01822314|Paclitaxel|paclitaxel|mesh-list
2610385|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2610386|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2610387|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610388|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
2610389|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
2610390|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
2610391|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610392|NCT01822405|Tocopherols|tocopherols|mesh-list
2610393|NCT01822405|Vitamin E|vitamin e|mesh-list
2610394|NCT01822405|Tocotrienols|tocotrienols|mesh-list
2610395|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
2157020|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157021|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2157022|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2157023|NCT01397695|Growth Substances|growth substances|mesh-ancestor
2157024|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610396|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
2610397|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2610398|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610399|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610400|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2610401|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2610402|NCT01822405|Protective Agents|protective agents|mesh-ancestor
2610403|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610404|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
2610405|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2610406|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
2610407|NCT01822405|Vitamins|vitamins|mesh-ancestor
2610408|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
2610409|NCT01822418|S 20098|s 20098|mesh-list
2610410|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2157025|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
2157033|NCT01390181|Losartan|losartan|mesh-list
2157034|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2157035|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2157036|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2157037|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2610411|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2610412|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610413|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2610414|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610415|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610416|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610417|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2610418|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
2610419|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2610420|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610421|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2610422|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
2157038|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157039|NCT01394211|Anastrozole|anastrozole|mesh-list
2157040|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2610423|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2610424|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610425|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610426|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610427|NCT01822509|Nivolumab|nivolumab|mesh-list
2610428|NCT01822509|Ipilimumab|ipilimumab|mesh-list
2610429|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2610430|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610431|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2610432|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610433|NCT01822600|Omeprazole|omeprazole|mesh-list
2610434|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2610435|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2610436|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2610437|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610438|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610439|NCT01822613|Paclitaxel|paclitaxel|mesh-list
2610440|NCT01822613|Docetaxel|docetaxel|mesh-list
2610441|NCT01822613|Irinotecan|irinotecan|mesh-list
2610442|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2610443|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610444|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
2610445|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
2610446|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
2610447|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610448|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2157041|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157042|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2610449|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2610450|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610451|NCT01822639|Amlodipine|amlodipine|mesh-list
2610452|NCT01822639|Enalapril|enalapril|mesh-list
2610453|NCT01822639|Enalaprilat|enalaprilat|mesh-list
2610454|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2610455|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2610456|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610457|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610458|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2610459|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610460|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
2610461|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610462|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2610463|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
2157043|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2157044|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157045|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157046|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2157047|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
2157048|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157049|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157050|NCT01388920|Tesamorelin|tesamorelin|mesh-list
2157051|NCT01388920|Growth Substances|growth substances|mesh-ancestor
2157052|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157053|NCT01377441|Ibuprofen|ibuprofen|mesh-list
2157054|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2157055|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2157056|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2157057|NCT01377441|Analgesics|analgesics|mesh-ancestor
2610480|NCT01822730|Risperidone|risperidone|mesh-list
2610481|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2610482|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2610483|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
2610484|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610485|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610486|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610487|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2610488|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2610489|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2610490|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2610491|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2610492|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
2610493|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2610494|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2610495|NCT01822808|Hydralazine|hydralazine|mesh-list
2610496|NCT01822808|Isosorbide|isosorbide|mesh-list
2157058|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
2157059|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2157060|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157061|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2157062|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2157063|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157064|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157065|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
2157066|NCT01383447|Entinostat|entinostat|mesh-list
2610497|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2610498|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2610499|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2610500|NCT01822808|Diuretics|diuretics|mesh-ancestor
2610501|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
2610502|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610503|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
2610504|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2610505|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610506|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2610507|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2610508|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
2610509|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2610510|NCT01822860|Diuretics|diuretics|mesh-ancestor
2610511|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
2610512|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610513|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2610514|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610515|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610516|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
2157067|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2157068|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157069|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2157070|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157071|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610517|NCT01822951|Donepezil|donepezil|mesh-list
2610518|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2610519|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610520|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610521|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
2610522|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610523|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610524|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
2610525|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2610526|NCT01822951|Protective Agents|protective agents|mesh-ancestor
2610527|NCT01822977|Omeprazole|omeprazole|mesh-list
2610528|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2610529|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2610530|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2610531|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610532|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610533|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
2610534|NCT01823029|Hematinics|hematinics|mesh-ancestor
2610535|NCT01823042|Azathioprine|azathioprine|mesh-list
2610536|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
2610537|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610538|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2610539|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610540|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2610541|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
2610542|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610543|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2610544|NCT01823081|Bevacizumab|bevacizumab|mesh-list
2610545|NCT01823081|Fasudil|fasudil|mesh-list
2610546|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2610547|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157072|NCT01372618|Pasireotide|pasireotide|mesh-list
2157073|NCT01372618|Hormones|hormones|mesh-ancestor
2157074|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157075|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157076|NCT01385280|Exemestane|exemestane|mesh-list
2157077|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2157078|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2157079|NCT01385280|Estradiol|estradiol|mesh-list
2157080|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2157081|NCT01385280|Estrogens|estrogens|mesh-ancestor
2157082|NCT01385280|Hormones|hormones|mesh-ancestor
2157083|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157084|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157085|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2610548|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2610549|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2610550|NCT01823081|Growth Substances|growth substances|mesh-ancestor
2610551|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610552|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
2610553|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2610554|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610555|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610556|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2610557|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
2610558|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2610559|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610560|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2610561|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2610562|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2610563|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
2610564|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610565|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2610566|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2610567|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610568|NCT01823159|Ezogabine|ezogabine|mesh-list
2610569|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
2610570|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610571|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610572|NCT01823172|Methylene Blue|methylene blue|mesh-list
2610573|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610574|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610575|NCT01823185|Clopidogrel|clopidogrel|mesh-list
2610576|NCT01823185|Ticagrelor|ticagrelor|mesh-list
2610577|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2610578|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2610579|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2610580|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2610581|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2610582|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
2610583|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610584|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610585|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610586|NCT01823198|Aldesleukin|aldesleukin|mesh-list
2610587|NCT01823198|Fludarabine|fludarabine|mesh-list
2610588|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
2610589|NCT01823198|Busulfan|busulfan|mesh-list
2157086|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
2157087|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2157088|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2157089|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157090|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2157091|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2157092|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157093|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157094|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2157095|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
2157096|NCT01379274|Lenalidomide|lenalidomide|mesh-list
2157097|NCT01379274|Azacitidine|azacitidine|mesh-list
2157098|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
2157099|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157100|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2157101|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2157102|NCT01379274|Growth Substances|growth substances|mesh-ancestor
2157103|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
2157104|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157105|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157106|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
2610590|NCT01823198|Interleukin-2|interleukin-2|mesh-list
2610591|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610592|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2610593|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
2610594|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610595|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2610596|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
2610597|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610598|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
2610599|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2610600|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2610601|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2610602|NCT01823198|Analgesics|analgesics|mesh-ancestor
2610603|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
2610604|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610605|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2610606|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2610607|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
2157107|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157108|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157109|NCT01379469|Carbamazepine|carbamazepine|mesh-list
2157110|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
2157111|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
2157112|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2157113|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2157114|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157115|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2157116|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2157117|NCT01379469|Analgesics|analgesics|mesh-ancestor
2157118|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
2157119|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2157120|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2157121|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2157122|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157123|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2157124|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2157125|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
2157126|NCT01369641|Cisplatin|cisplatin|mesh-list
2157127|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157128|NCT01369641|Antidotes|antidotes|mesh-ancestor
2157129|NCT01369641|Protective Agents|protective agents|mesh-ancestor
2157130|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157131|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
2157132|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157133|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
2157134|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2157135|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157136|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
2157137|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
2157138|NCT01359254|Vidarabine|vidarabine|mesh-list
2157139|NCT01359254|Fludarabine|fludarabine|mesh-list
2157140|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
2157141|NCT01359254|Melphalan|melphalan|mesh-list
2157142|NCT01359254|Busulfan|busulfan|mesh-list
2157143|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2157144|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157145|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157146|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
2157147|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157148|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157149|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
2157150|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157151|NCT01359254|Antiviral Agents|antiviral agents|mesh-ancestor
2157152|NCT01359254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610608|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610609|NCT01823393|Heparin|heparin|mesh-list
2610610|NCT01823393|Calcium heparin|calcium heparin|mesh-list
2610611|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
2610612|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2610613|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2610614|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610615|NCT01823523|Clindamycin|clindamycin|mesh-list
2610616|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
2610617|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
2610618|NCT01823523|Cefazolin|cefazolin|mesh-list
2610619|NCT01823523|Cephalexin|cephalexin|mesh-list
2610620|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2610621|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610622|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2610623|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610624|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610625|NCT01823744|Micronutrients|micronutrients|mesh-list
2610626|NCT01823744|Trace Elements|trace elements|mesh-list
2610627|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610628|NCT01823770|Rotigotine|rotigotine|mesh-list
2610629|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
2610630|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
2157153|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2157154|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
2157155|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2157156|NCT01347632|Metronidazole|metronidazole|mesh-list
2157157|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157158|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2157159|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2610631|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610632|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610633|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610634|NCT01823809|Adenosine|adenosine|mesh-list
2610635|NCT01823809|Analgesics|analgesics|mesh-ancestor
2610636|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
2610637|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610638|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610639|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2610640|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
2610641|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2610642|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
2610643|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
2610644|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610645|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610646|NCT01823848|Mineral Oil|mineral oil|mesh-list
2610647|NCT01823848|Emollients|emollients|mesh-ancestor
2610648|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
2610649|NCT01823965|Ranibizumab|ranibizumab|mesh-list
2610650|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2610651|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2610652|NCT01823965|Growth Substances|growth substances|mesh-ancestor
2610653|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610654|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
2610655|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610656|NCT01824043|Ranibizumab|ranibizumab|mesh-list
2610657|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2610658|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2610659|NCT01824043|Growth Substances|growth substances|mesh-ancestor
2610660|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610661|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
2610662|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610663|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2157160|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2157161|NCT01350232|Cytarabine|cytarabine|mesh-list
2157162|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
2157163|NCT01350232|Rituximab|rituximab|mesh-list
2157164|NCT01350232|Fludarabine|fludarabine|mesh-list
2157165|NCT01350232|Bortezomib|bortezomib|mesh-list
2157166|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157167|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
2157168|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157169|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2157170|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2610664|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2610665|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610666|NCT01824199|Omeprazole|omeprazole|mesh-list
2610667|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2610668|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2610669|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2610670|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157171|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
2157172|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157173|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157174|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2157175|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2157176|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157177|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
2157178|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
2157179|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157180|NCT01352416|Ranolazine|ranolazine|mesh-list
2157181|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2610671|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610672|NCT01824225|Aflibercept|aflibercept|mesh-list
2610673|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2610674|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2610675|NCT01824225|Growth Substances|growth substances|mesh-ancestor
2610676|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610677|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
2610678|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157182|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2157183|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157184|NCT01350258|Vidarabine|vidarabine|mesh-list
2157185|NCT01350258|Fludarabine|fludarabine|mesh-list
2157186|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
2157187|NCT01350258|Melphalan|melphalan|mesh-list
2157188|NCT01350258|Thiotepa|thiotepa|mesh-list
2610679|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
2610680|NCT01824238|Anacetrapib|anacetrapib|mesh-list
2610681|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2610682|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2610683|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
2610684|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157189|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157190|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157191|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
2157192|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157193|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157194|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
2157195|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157196|NCT01350258|Antiviral Agents|antiviral agents|mesh-ancestor
2157197|NCT01350258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157198|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2157199|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
2157200|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2157201|NCT01349595|Bortezomib|bortezomib|mesh-list
2157202|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157203|NCT01340573|Interferons|interferons|mesh-list
2157204|NCT01340573|Ribavirin|ribavirin|mesh-list
2157205|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2157206|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157207|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
2157208|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157209|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
2610685|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2610686|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610687|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2610688|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610689|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
2610690|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2610691|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
2610692|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2610693|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
2610694|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610695|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2610696|NCT01824264|Licogliflozin|licogliflozin|mesh-list
2610697|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2610698|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610699|NCT01824264|Incretins|incretins|mesh-ancestor
2610700|NCT01824264|Hormones|hormones|mesh-ancestor
2610701|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2610702|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2610703|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
2610704|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610705|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610706|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2610707|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
2610708|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2610709|NCT01824420|Oxybutynin|oxybutynin|mesh-list
2610710|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2610711|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2610712|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
2610713|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610714|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610715|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610716|NCT01824420|Urological Agents|urological agents|mesh-ancestor
2610717|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
2610718|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
2610719|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610720|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2610721|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610722|NCT01824420|Renal Agents|renal agents|mesh-ancestor
2610723|NCT01824433|Fluoxetine|fluoxetine|mesh-list
2610724|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2610725|NCT01824433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2610726|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2421658|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2421659|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2421660|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2421661|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421662|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
2421663|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2421664|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2610727|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610728|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610729|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610730|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
2610731|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610732|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2610733|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
2610734|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2610735|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2610736|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2610737|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610738|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2610739|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
2610740|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610741|NCT01824524|Hydromorphone|hydromorphone|mesh-list
2610742|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2610743|NCT01824524|Narcotics|narcotics|mesh-ancestor
2610744|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2610745|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610746|NCT01824524|Analgesics|analgesics|mesh-ancestor
2610747|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
2610748|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610749|NCT01824537|Vaccines|vaccines|mesh-list
2610750|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
2610751|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610752|NCT01824615|Sunitinib|sunitinib|mesh-list
2610753|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610754|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2610755|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2610756|NCT01824615|Growth Substances|growth substances|mesh-ancestor
2610757|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610758|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
2610759|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2610760|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610761|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610762|NCT01824758|Lidocaine|lidocaine|mesh-list
2610763|NCT01824758|Rocuronium|rocuronium|mesh-list
2610764|NCT01824758|Esmolol|esmolol|mesh-list
2610765|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
2610766|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
2610767|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2610768|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610769|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
2610770|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610771|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2610772|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2610773|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2610774|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610775|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610776|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2610777|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2610778|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2610779|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2157210|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157211|NCT01335997|Niacin|niacin|mesh-list
2157212|NCT01335997|Niacinamide|niacinamide|mesh-list
2157213|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
2157214|NCT01335997|Simvastatin|simvastatin|mesh-list
2157215|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2157216|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2157217|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
2421665|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2421666|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
2421667|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2421668|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
2421669|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
2421670|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421671|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2421672|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2421673|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
2421674|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2421675|NCT00813735|Dexetimide|dexetimide|mesh-list
2421676|NCT00813735|Eszopiclone|eszopiclone|mesh-list
2421677|NCT00813735|Citalopram|citalopram|mesh-list
2610780|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2610781|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2610782|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
2610783|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610784|NCT01824836|Anastrozole|anastrozole|mesh-list
2610785|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2610786|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610787|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2610788|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2610789|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610790|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610791|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2610792|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
2610793|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2610794|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610803|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
2610804|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2610805|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2610806|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2610807|NCT01824992|Interferons|interferons|mesh-list
2610808|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157218|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157219|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2157220|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2157221|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157222|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
2157223|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
2157224|NCT01335997|Vitamins|vitamins|mesh-ancestor
2157225|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
2157226|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157227|NCT01340885|Rivastigmine|rivastigmine|mesh-list
2157228|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2157229|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2157230|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2157231|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610809|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
2610810|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610811|NCT01825031|Azithromycin|azithromycin|mesh-list
2610812|NCT01825031|Isoniazid|isoniazid|mesh-list
2610813|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
2610814|NCT01825031|Fluconazole|fluconazole|mesh-list
2610815|NCT01825031|Albendazole|albendazole|mesh-list
2610816|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2610817|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157232|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157233|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
2157234|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610818|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2610819|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2610820|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
2610821|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2610822|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2610823|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610824|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610825|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
2610826|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2610827|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2610828|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2610829|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
2610830|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2610831|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610832|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2610833|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2610834|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
2610835|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2157235|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157236|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2157237|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157238|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
2157239|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2157240|NCT01340885|Protective Agents|protective agents|mesh-ancestor
2157241|NCT01334606|Insulin|insulin|mesh-list
2157242|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2157243|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157244|NCT01326923|Cetuximab|cetuximab|mesh-list
2157245|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2157246|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157247|NCT01332799|Allopurinol|allopurinol|mesh-list
2157248|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
2157249|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157250|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157251|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
2610836|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2610837|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
2610838|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2610839|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
2610840|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2610841|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
2610842|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2610843|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2610844|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
2610845|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
2610846|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
2610847|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157252|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2157253|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2157254|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
2157255|NCT01332799|Protective Agents|protective agents|mesh-ancestor
2157256|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157257|NCT01329549|Carboplatin|carboplatin|mesh-list
2157258|NCT01329549|Nintedanib|nintedanib|mesh-list
2157259|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157260|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2157261|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157262|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157263|NCT01326845|Deferasirox|deferasirox|mesh-list
2157264|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2157265|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
2157266|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
2157267|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157273|NCT01320683|Leucovorin|leucovorin|mesh-list
2157274|NCT01320683|Bevacizumab|bevacizumab|mesh-list
2157275|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2157276|NCT01320683|Fluorouracil|fluorouracil|mesh-list
2157277|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
2157278|NCT01320683|Irinotecan|irinotecan|mesh-list
2157279|NCT01320683|Antibodies|antibodies|mesh-list
2157280|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
2157281|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2157282|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
2157283|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157284|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2610848|NCT01825044|Cyclosporine|cyclosporine|mesh-list
2610849|NCT01825044|Cyclosporins|cyclosporins|mesh-list
2610850|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610851|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610852|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2610853|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
2610854|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610855|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
2610856|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610857|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
2610858|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2610859|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2610860|NCT01825083|Ketamine|ketamine|mesh-list
2157285|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2157286|NCT01320683|Growth Substances|growth substances|mesh-ancestor
2610861|NCT01825083|Analgesics|analgesics|mesh-ancestor
2610862|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
2610863|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610864|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610865|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2610866|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2610867|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
2610868|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
2610869|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2610870|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2610871|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2610872|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2157287|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157288|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
2157289|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
2157290|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
2157291|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157292|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157293|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157294|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2157295|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2157296|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157297|NCT01320683|Antidotes|antidotes|mesh-ancestor
2157298|NCT01320683|Protective Agents|protective agents|mesh-ancestor
2157299|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
2157300|NCT01320683|Vitamins|vitamins|mesh-ancestor
2157301|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
2157302|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
2157303|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
2157304|NCT01313273|Lanreotide|lanreotide|mesh-list
2157305|NCT01313273|Androgens|androgens|mesh-list
2157306|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2610873|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610874|NCT01825109|Vaccines|vaccines|mesh-list
2610875|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
2610876|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610877|NCT01825395|Amifampridine|amifampridine|mesh-list
2610878|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2610879|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610880|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610881|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2610882|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2610883|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610884|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2610885|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610886|NCT01825447|Naltrexone|naltrexone|mesh-list
2610887|NCT01825447|Oxycodone|oxycodone|mesh-list
2610888|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2610889|NCT01825447|Narcotics|narcotics|mesh-ancestor
2610890|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2610891|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610892|NCT01825447|Analgesics|analgesics|mesh-ancestor
2610893|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
2610894|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610895|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2610896|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2610897|NCT01825473|Erythromycin|erythromycin|mesh-list
2610898|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
2610899|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2610900|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
2610901|NCT01825473|Phenobarbital|phenobarbital|mesh-list
2610902|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2610903|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610904|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2610905|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2610906|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610907|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610908|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
2610909|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2610910|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2610911|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610912|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2610913|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2610914|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610915|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
2610916|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
2610917|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2610918|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2610919|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2610920|NCT01825551|Sargramostim|sargramostim|mesh-list
2610921|NCT01825551|Lenograstim|lenograstim|mesh-list
2610922|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
2610923|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610924|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2610925|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
2610926|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2610927|NCT01825603|Gemcitabine|gemcitabine|mesh-list
2610928|NCT01825603|Cisplatin|cisplatin|mesh-list
2610929|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2610930|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2610931|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
2610932|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610933|NCT01825603|Antiviral Agents|antiviral agents|mesh-ancestor
2610934|NCT01825603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2610935|NCT01825603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610936|NCT01825603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2610937|NCT01825603|Immunologic Factors|immunologic factors|mesh-ancestor
2157307|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2157308|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
2157309|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
2157310|NCT01313273|Hormones|hormones|mesh-ancestor
2157311|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157312|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157313|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
2157314|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157315|NCT01313273|Protective Agents|protective agents|mesh-ancestor
2157316|NCT01313273|Vitamins|vitamins|mesh-ancestor
2157317|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
2157318|NCT01313273|Estrogens|estrogens|mesh-ancestor
2157319|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2157320|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157321|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
2157322|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
2610938|NCT01825603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610939|NCT01825616|Vitamin D|vitamin d|mesh-list
2610940|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
2610941|NCT01825616|Vitamins|vitamins|mesh-ancestor
2610942|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
2610943|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610944|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2610945|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2610946|NCT01825720|Insulin|insulin|mesh-list
2610947|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2610948|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610949|NCT01825733|Palonosetron|palonosetron|mesh-list
2610950|NCT01825733|Ramosetron|ramosetron|mesh-list
2610951|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
2610952|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
2610953|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610954|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610955|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2610956|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2610957|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2610958|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
2610959|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610960|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610961|NCT01825850|Irbesartan|irbesartan|mesh-list
2610962|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2610963|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2610964|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2610965|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610966|NCT01825863|Ropivacaine|ropivacaine|mesh-list
2610967|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
2610968|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
2157323|NCT01321008|Prednisone|prednisone|mesh-list
2157324|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
2157325|NCT01321008|Doxorubicin|doxorubicin|mesh-list
2157326|NCT01321008|Vincristine|vincristine|mesh-list
2157327|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157328|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
2610969|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2610970|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157329|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157330|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2157331|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2610971|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
2610972|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2610973|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2610974|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2610975|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610976|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2610977|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2610978|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2157332|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
2157333|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157334|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157335|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2157336|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2157337|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2157338|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2157339|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157340|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2157341|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
2610979|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2610980|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2610981|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2610982|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2610983|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2610984|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
2610985|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2610986|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610987|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2610988|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2610989|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
2157342|NCT01321008|Hormones|hormones|mesh-ancestor
2157343|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157344|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2610990|NCT01825980|Ritonavir|ritonavir|mesh-list
2610991|NCT01825980|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2610992|NCT01825980|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2610993|NCT01825980|Protease Inhibitors|protease inhibitors|mesh-ancestor
2610994|NCT01825980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2610995|NCT01825980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2610996|NCT01825980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2610997|NCT01825980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2610998|NCT01825980|Antiviral Agents|antiviral agents|mesh-ancestor
2610999|NCT01825980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611000|NCT01825980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2611001|NCT01825980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2611002|NCT01825993|Morphine|morphine|mesh-list
2611003|NCT01825993|Bupivacaine|bupivacaine|mesh-list
2611004|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
2611005|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
2611006|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2611007|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611008|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
2157345|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2157346|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
2157347|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
2157348|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
2611009|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611010|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2611011|NCT01825993|Narcotics|narcotics|mesh-ancestor
2611012|NCT01825993|Analgesics|analgesics|mesh-ancestor
2611013|NCT01826149|Propofol|propofol|mesh-list
2611014|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2611015|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2611016|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611017|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2611018|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
2611019|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
2611020|NCT01826175|Clopidogrel|clopidogrel|mesh-list
2611021|NCT01826175|Ticagrelor|ticagrelor|mesh-list
2611022|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2611023|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2611024|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2611025|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2157349|NCT01310803|Valrubicin|valrubicin|mesh-list
2157350|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157351|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2157352|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2157353|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157354|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157355|NCT01309581|Ketamine|ketamine|mesh-list
2157356|NCT01309581|Methohexital|methohexital|mesh-list
2157357|NCT01309581|Analgesics|analgesics|mesh-ancestor
2157358|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
2157359|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2157360|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157361|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2157362|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2611026|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
2611027|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2421678|NCT00813735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2421679|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2421680|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2421681|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421682|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2421683|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
2421684|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421685|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2421686|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
2157363|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
2157364|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
2157365|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2157366|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2157367|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2611028|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611029|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611030|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2611031|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
2611032|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
2611033|NCT01826279|Resveratrol|resveratrol|mesh-list
2611034|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
2157368|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2157369|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157370|NCT01315873|Bortezomib|bortezomib|mesh-list
2157371|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2157372|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157373|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2157374|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
2157375|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157376|NCT01313923|Sirolimus|sirolimus|mesh-list
2157377|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2421687|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2421688|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2421689|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2421690|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
2421691|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
2421692|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421693|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2421694|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2421695|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
2421696|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2421697|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2421698|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
2611035|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611036|NCT01826279|Protective Agents|protective agents|mesh-ancestor
2611037|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611038|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611039|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2611040|NCT01826396|Irinotecan|irinotecan|mesh-list
2611041|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2611042|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2611043|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611044|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611045|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611046|NCT01826526|Taurolidine|taurolidine|mesh-list
2611047|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611048|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2611049|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611050|NCT01826747|Progesterone|progesterone|mesh-list
2611051|NCT01826747|Progestins|progestins|mesh-ancestor
2611052|NCT01826747|Hormones|hormones|mesh-ancestor
2611053|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2611054|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611055|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
2157378|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157379|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2157380|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157381|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
2157382|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157383|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
2157384|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157385|NCT01313416|Gemcitabine|gemcitabine|mesh-list
2157386|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157387|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
2157388|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157389|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157390|NCT01313416|Antiviral Agents|antiviral agents|mesh-ancestor
2157391|NCT01313416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157392|NCT01313416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157393|NCT01313416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157394|NCT01313416|Immunologic Factors|immunologic factors|mesh-ancestor
2157395|NCT01313416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157396|NCT01303003|Dexamethasone|dexamethasone|mesh-list
2157397|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2157398|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
2157399|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
2157400|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2157401|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157402|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2157403|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
2157404|NCT01303003|Hormones|hormones|mesh-ancestor
2157405|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157406|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2157407|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157408|NCT01302444|Tadalafil|tadalafil|mesh-list
2157409|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
2157410|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2157411|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2157412|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157413|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157414|NCT01302444|Urological Agents|urological agents|mesh-ancestor
2157415|NCT01301963|Plerixafor|plerixafor|mesh-list
2157416|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2157417|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2157418|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
2157419|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157420|NCT01292070|Histamine|histamine|mesh-list
2157421|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
2157422|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
2157423|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2157424|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157425|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157426|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
2157427|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2611056|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611057|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611058|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
2611059|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611060|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611061|NCT01826838|Dasatinib|dasatinib|mesh-list
2611062|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611063|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2611064|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611065|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611066|NCT01826864|Sargramostim|sargramostim|mesh-list
2611067|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
2157428|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
2157429|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157430|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2157431|NCT01290718|Capecitabine|capecitabine|mesh-list
2157432|NCT01290718|Trastuzumab|trastuzumab|mesh-list
2157433|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2611068|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157434|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
2157435|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157436|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157437|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2157438|NCT01293123|Tenofovir|tenofovir|mesh-list
2157439|NCT01293123|Emtricitabine|emtricitabine|mesh-list
2157440|NCT01293123|Efavirenz|efavirenz|mesh-list
2157441|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
2157442|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
2157443|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157444|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2157445|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2157446|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157447|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157448|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2157449|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2157450|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2157451|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2157452|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2157453|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2157454|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2157455|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2157456|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2611069|NCT01826916|Ecallantide|ecallantide|mesh-list
2611070|NCT01826916|Analgesics|analgesics|mesh-ancestor
2611071|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
2611072|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611073|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611074|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2611075|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2611076|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2611077|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2611078|NCT01827007|Polygeline|polygeline|mesh-list
2611079|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
2611080|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
2611081|NCT01827020|Lidocaine|lidocaine|mesh-list
2611082|NCT01827020|Ketamine|ketamine|mesh-list
2611083|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
2611084|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
2611085|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2611086|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611087|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
2611088|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611089|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2611090|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2611091|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2611092|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2611093|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611094|NCT01827020|Analgesics|analgesics|mesh-ancestor
2611095|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2611096|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2611097|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
2611098|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2611099|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2611100|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2611101|NCT01827059|Bosentan|bosentan|mesh-list
2611102|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2611103|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2611104|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611105|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
2611106|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
2611107|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157457|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2157458|NCT01280643|Leucovorin|leucovorin|mesh-list
2157459|NCT01280643|Bevacizumab|bevacizumab|mesh-list
2157460|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2157461|NCT01280643|Cetuximab|cetuximab|mesh-list
2157462|NCT01280643|Fluorouracil|fluorouracil|mesh-list
2157463|NCT01280643|Capecitabine|capecitabine|mesh-list
2611108|NCT01827111|Paclitaxel|paclitaxel|mesh-list
2611109|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2611110|NCT01827111|Ipilimumab|ipilimumab|mesh-list
2611111|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2157464|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
2611112|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611113|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
2157465|NCT01280643|Irinotecan|irinotecan|mesh-list
2157466|NCT01280643|Antibodies|antibodies|mesh-list
2157467|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
2157468|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2157469|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
2157470|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157471|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2157472|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2157473|NCT01280643|Growth Substances|growth substances|mesh-ancestor
2157474|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157475|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
2157476|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
2157477|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
2157478|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157479|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157480|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157481|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2157482|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2157483|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157484|NCT01280643|Antidotes|antidotes|mesh-ancestor
2157485|NCT01280643|Protective Agents|protective agents|mesh-ancestor
2157486|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
2157487|NCT01280643|Vitamins|vitamins|mesh-ancestor
2157488|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
2157489|NCT01281124|Azacitidine|azacitidine|mesh-list
2157490|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157491|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
2611114|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
2611115|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
2611116|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611117|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2611118|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2611119|NCT01827124|Oxytocin|oxytocin|mesh-list
2611120|NCT01827124|Carbetocin|carbetocin|mesh-list
2611121|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
2611122|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2611123|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157492|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157493|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157494|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157495|NCT01272141|Everolimus|everolimus|mesh-list
2157496|NCT01272141|Lapatinib|lapatinib|mesh-list
2157497|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157498|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157499|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
2157500|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157501|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2157502|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157503|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157504|NCT01282216|Vaccines|vaccines|mesh-list
2157505|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2611124|NCT01827137|Lenalidomide|lenalidomide|mesh-list
2611125|NCT01827137|Molgramostim|molgramostim|mesh-list
2611126|NCT01827137|Sargramostim|sargramostim|mesh-list
2611127|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
2611128|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611129|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2611130|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2611131|NCT01827137|Growth Substances|growth substances|mesh-ancestor
2611132|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
2611133|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611134|NCT01827202|Candesartan|candesartan|mesh-list
2611135|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2611136|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2611137|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2611138|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611139|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
2611140|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
2611141|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611142|NCT01827280|Vildagliptin|vildagliptin|mesh-list
2157506|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
2157507|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157508|NCT01284504|Celecoxib|celecoxib|mesh-list
2157509|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2611143|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2611144|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611145|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2611146|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
2611147|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611148|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611149|NCT01827293|Promethazine|promethazine|mesh-list
2611150|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
2611151|NCT01827293|Lorazepam|lorazepam|mesh-list
2611152|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
2611153|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
2611154|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
2611155|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611156|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611157|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2611158|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2611159|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2611160|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2611161|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2611162|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2611163|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
2611164|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
2611165|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2611166|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611167|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
2611168|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
2611169|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2611170|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
2611171|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
2611172|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2611173|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2611174|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
2611175|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
2611176|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
2157510|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2157511|NCT01284504|Analgesics|analgesics|mesh-ancestor
2157512|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
2157513|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2157514|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157515|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2157516|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2157517|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2157518|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2157519|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157520|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157521|NCT01269034|Insulin|insulin|mesh-list
2157522|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2157523|NCT01269034|Exenatide|exenatide|mesh-list
2157524|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
2157525|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
2157526|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
2157527|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2157528|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157529|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2157530|NCT01269034|Incretins|incretins|mesh-ancestor
2157531|NCT01269034|Hormones|hormones|mesh-ancestor
2157532|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157533|NCT01274533|Lenalidomide|lenalidomide|mesh-list
2157534|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
2157535|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157536|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2157537|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2157538|NCT01274533|Growth Substances|growth substances|mesh-ancestor
2157539|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
2157540|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157541|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
2157542|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
2157543|NCT01279616|Busulfan|busulfan|mesh-list
2157544|NCT01279616|Rituximab|rituximab|mesh-list
2157545|NCT01279616|Fludarabine|fludarabine|mesh-list
2157546|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
2157547|NCT01279616|Tacrolimus|tacrolimus|mesh-list
2157548|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
2157549|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157550|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
2157551|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157552|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2157553|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2611177|NCT01827345|Vitamin D|vitamin d|mesh-list
2611178|NCT01827345|Vitamins|vitamins|mesh-ancestor
2611179|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
2611180|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611181|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2611182|NCT01827384|Carboplatin|carboplatin|mesh-list
2611183|NCT01827384|Everolimus|everolimus|mesh-list
2611184|NCT01827384|Temozolomide|temozolomide|mesh-list
2611185|NCT01827384|Trametinib|trametinib|mesh-list
2611186|NCT01827384|Veliparib|veliparib|mesh-list
2611187|NCT01827384|Adavosertib|adavosertib|mesh-list
2611188|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611189|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2611190|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
2611191|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611192|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2611193|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
2611194|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611195|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2611196|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611197|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2611198|NCT01827397|Vaccines|vaccines|mesh-list
2611199|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
2611200|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611201|NCT01827540|Dolutegravir|dolutegravir|mesh-list
2611202|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
2611203|NCT01827540|Midazolam|midazolam|mesh-list
2157554|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
2157555|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157556|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611204|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2611205|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2611206|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2611207|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611208|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2611209|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2611210|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2611211|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2611212|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
2611213|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
2611214|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
2611215|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
2611216|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2611217|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611218|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2611219|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2611220|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611221|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2611222|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2611223|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
2611224|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611225|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2157557|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2157558|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2157559|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157560|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
2157561|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2157562|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157563|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2157564|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2157565|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
2157566|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2157567|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611226|NCT01827553|Gemcitabine|gemcitabine|mesh-list
2611227|NCT01827553|Folfirinox|folfirinox|mesh-list
2611228|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2611229|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
2611230|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157568|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2157569|NCT01276054|Methylene Blue|methylene blue|mesh-list
2157570|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2157571|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157572|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157573|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2157574|NCT01264965|Acetaminophen|acetaminophen|mesh-list
2611231|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611232|NCT01827553|Antiviral Agents|antiviral agents|mesh-ancestor
2611233|NCT01827553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611234|NCT01827553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157575|NCT01264965|Oxycodone|oxycodone|mesh-list
2157576|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2157577|NCT01264965|Analgesics|analgesics|mesh-ancestor
2157578|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
2157579|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2157580|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157581|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
2157582|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2157583|NCT01264965|Narcotics|narcotics|mesh-ancestor
2611235|NCT01827553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2611236|NCT01827553|Immunologic Factors|immunologic factors|mesh-ancestor
2611237|NCT01827553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611238|NCT01827618|Sirolimus|sirolimus|mesh-list
2611239|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2611240|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611241|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2611242|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611243|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
2611244|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2611245|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
2611246|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611247|NCT01827722|Dexamethasone|dexamethasone|mesh-list
2611248|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
2611249|NCT01827722|Ranibizumab|ranibizumab|mesh-list
2611250|NCT01827722|BB 1101|bb 1101|mesh-list
2611251|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2611252|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
2611253|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
2611254|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611255|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611256|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2611257|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
2611258|NCT01827722|Hormones|hormones|mesh-ancestor
2611259|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2611260|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2611261|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611262|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
2611263|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611264|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611265|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2611266|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2611267|NCT01827722|Growth Substances|growth substances|mesh-ancestor
2611268|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
2611269|NCT01827735|Aldesleukin|aldesleukin|mesh-list
2611270|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611271|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2611272|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2611273|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
2611274|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611275|NCT01827865|Etodolac|etodolac|mesh-list
2611276|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2611277|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2611278|NCT01827865|Analgesics|analgesics|mesh-ancestor
2611279|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
2157584|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2157585|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
2157586|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2157587|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2157588|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
2611280|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611281|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611282|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2611283|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2611284|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2611285|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2611286|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611287|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611288|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2611289|NCT01827878|Lisinopril|lisinopril|mesh-list
2611290|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
2611291|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2157589|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
2157590|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2157591|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157592|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
2611292|NCT01827878|Diuretics|diuretics|mesh-ancestor
2611293|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
2611294|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611295|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2611296|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2611297|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611298|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2611299|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
2611300|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611301|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2611302|NCT01827878|Protective Agents|protective agents|mesh-ancestor
2611303|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2611304|NCT01828125|Glucagon|glucagon|mesh-list
2611305|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2611306|NCT01828125|Hormones|hormones|mesh-ancestor
2611307|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2611308|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157593|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2157594|NCT01273064|Interferons|interferons|mesh-list
2157595|NCT01273064|Ribavirin|ribavirin|mesh-list
2157596|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157597|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
2157598|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157599|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
2157600|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157601|NCT01274559|Niacin|niacin|mesh-list
2611309|NCT01828203|Minocycline|minocycline|mesh-list
2611310|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2611311|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611312|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
2611313|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2611314|NCT01828294|Antibodies|antibodies|mesh-list
2611315|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
2611316|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611317|NCT01828346|Azacitidine|azacitidine|mesh-list
2611318|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2611319|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
2611320|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611321|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611322|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611323|NCT01828359|Losartan|losartan|mesh-list
2611324|NCT01828359|Amlodipine|amlodipine|mesh-list
2611325|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2611326|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2611327|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2611328|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611329|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2611330|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611331|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
2611332|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2611333|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2611334|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2611335|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
2611336|NCT01828385|Analgesics|analgesics|mesh-ancestor
2611337|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
2611338|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611339|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611340|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
2611341|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2611342|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2157602|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2157603|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
2157604|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157605|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2157606|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
2157607|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
2157608|NCT01274559|Vitamins|vitamins|mesh-ancestor
2157609|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
2157610|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157611|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
2157612|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2157613|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2157614|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2157615|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157616|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
2157617|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2611343|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
2611344|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2611345|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2611346|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611347|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2611348|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
2611349|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2611350|NCT01828437|Pyridoxine|pyridoxine|mesh-list
2611351|NCT01828437|Prednisolone|prednisolone|mesh-list
2611352|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2611353|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
2611354|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2611355|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
2611356|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2611357|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
2611358|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2611359|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
2611360|NCT01828437|Hormones|hormones|mesh-ancestor
2611361|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2611362|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611363|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2611364|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611365|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
2611366|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
2611367|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611368|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2611369|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2611370|NCT01828437|Protective Agents|protective agents|mesh-ancestor
2611371|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
2611372|NCT01828437|Vitamins|vitamins|mesh-ancestor
2611373|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
2611374|NCT01828463|Nitisinone|nitisinone|mesh-list
2611375|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611376|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611377|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
2611378|NCT01828489|Analgesics|analgesics|mesh-ancestor
2611379|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
2611380|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611381|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611382|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611383|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2611384|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2611385|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611386|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611387|NCT01828606|Monensin|monensin|mesh-list
2611388|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
2611389|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611390|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2611391|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2611392|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
2611393|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
2611394|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
2611395|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611396|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611397|NCT01828606|Ionophores|ionophores|mesh-ancestor
2611398|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2611399|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
2611400|NCT01828697|Enoxaparin|enoxaparin|mesh-list
2611401|NCT01828697|Dalteparin|dalteparin|mesh-list
2611402|NCT01828697|Tinzaparin|tinzaparin|mesh-list
2611403|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2611404|NCT01828697|Nadroparin|nadroparin|mesh-list
2611405|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
2611406|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
2611407|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2611408|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2611409|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611410|NCT01828710|Folic Acid|folic acid|mesh-list
2611411|NCT01828710|Inositol|inositol|mesh-list
2611412|NCT01828710|Hematinics|hematinics|mesh-ancestor
2611413|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
2611414|NCT01828710|Vitamins|vitamins|mesh-ancestor
2611415|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
2611416|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611417|NCT01828736|Gemcitabine|gemcitabine|mesh-list
2611418|NCT01828736|Cisplatin|cisplatin|mesh-list
2611419|NCT01828736|Carboplatin|carboplatin|mesh-list
2611420|NCT01828736|Trastuzumab|trastuzumab|mesh-list
2611421|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157618|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157619|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2157620|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2157621|NCT01267825|Bupivacaine|bupivacaine|mesh-list
2157622|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
2611422|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2611423|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
2611424|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611425|NCT01828736|Antiviral Agents|antiviral agents|mesh-ancestor
2611426|NCT01828736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611427|NCT01828736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611428|NCT01828736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2611429|NCT01828736|Immunologic Factors|immunologic factors|mesh-ancestor
2611430|NCT01828736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611431|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2611432|NCT01828788|Ropivacaine|ropivacaine|mesh-list
2611433|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
2611434|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
2611435|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2611436|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611437|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
2611438|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611439|NCT01828840|Fentanyl|fentanyl|mesh-list
2611440|NCT01828840|Morphine|morphine|mesh-list
2611441|NCT01828840|Methadone|methadone|mesh-list
2611442|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2611443|NCT01828840|Narcotics|narcotics|mesh-ancestor
2611444|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2611445|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611446|NCT01828840|Analgesics|analgesics|mesh-ancestor
2611447|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
2611448|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611449|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2611450|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2611451|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
2611452|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
2611453|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
2611454|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
2611455|NCT01828879|Tacrolimus|tacrolimus|mesh-list
2611456|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2611457|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
2611458|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611459|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2611460|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611461|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611462|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2611463|NCT01828892|Vancomycin|vancomycin|mesh-list
2611464|NCT01828892|Meropenem|meropenem|mesh-list
2611465|NCT01828892|Ceftazidime|ceftazidime|mesh-list
2611466|NCT01828892|Cefotaxime|cefotaxime|mesh-list
2611467|NCT01828892|Cefoxitin|cefoxitin|mesh-list
2611468|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611469|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
2611470|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2611471|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611472|NCT01829178|Cisplatin|cisplatin|mesh-list
2611473|NCT01829178|Docetaxel|docetaxel|mesh-list
2611474|NCT01829178|Fluorouracil|fluorouracil|mesh-list
2611475|NCT01829178|Silymarin|silymarin|mesh-list
2611476|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611477|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
2611478|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
2611479|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
2611480|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611481|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
2611482|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2611483|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2611484|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
2611485|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611486|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
2611487|NCT01829178|Protective Agents|protective agents|mesh-ancestor
2611488|NCT01829334|Listerine|listerine|mesh-list
2611489|NCT01829334|Fluorides|fluorides|mesh-list
2611490|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
2611491|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
2611492|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
2611493|NCT01829334|Protective Agents|protective agents|mesh-ancestor
2611494|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611495|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2611496|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611497|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
2611498|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2611499|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
2611500|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611501|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
2611502|NCT01829451|Protective Agents|protective agents|mesh-ancestor
2611503|NCT01829529|Amoxicillin|amoxicillin|mesh-list
2611504|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2611505|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157623|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
2157624|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2157625|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157626|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
2157627|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611520|NCT01829659|Ticagrelor|ticagrelor|mesh-list
2611521|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2611522|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2611523|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2611524|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2611525|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
2611526|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2611527|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611528|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611529|NCT01829685|Entecavir|entecavir|mesh-list
2611530|NCT01829685|Adefovir|adefovir|mesh-list
2611531|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
2611532|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611533|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2611534|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2611535|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611536|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611537|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2611538|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2611539|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2611540|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
2611541|NCT01829711|Protective Agents|protective agents|mesh-list
2611542|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611543|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157628|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2157629|NCT01264679|Hematinics|hematinics|mesh-ancestor
2157630|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2157631|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2157632|NCT01259284|Atorvastatin|atorvastatin|mesh-list
2611544|NCT01829802|Ritonavir|ritonavir|mesh-list
2611545|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2611546|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
2611547|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2611548|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2611549|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
2611550|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611551|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611552|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2611553|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2611554|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
2611555|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611556|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2611557|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2611558|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2611559|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2611560|NCT01829841|Sunitinib|sunitinib|mesh-list
2157633|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2611561|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157634|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2157635|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
2157636|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157637|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2157638|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2157639|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157640|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
2157641|NCT01263028|Vitamin D|vitamin d|mesh-list
2157642|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2157643|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611562|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2611563|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2611564|NCT01829841|Growth Substances|growth substances|mesh-ancestor
2611565|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611566|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
2611567|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2611568|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611569|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611570|NCT01829893|Tamsulosin|tamsulosin|mesh-list
2611571|NCT01829893|Finasteride|finasteride|mesh-list
2611572|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2611573|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2611574|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2611575|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
2611576|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2611577|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611578|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611579|NCT01829893|Urological Agents|urological agents|mesh-ancestor
2611580|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2611581|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2611582|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611583|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
2611584|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2611585|NCT01829958|Prednisone|prednisone|mesh-list
2611586|NCT01829958|Rituximab|rituximab|mesh-list
2611587|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2157644|NCT01263028|Vitamins|vitamins|mesh-ancestor
2157645|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
2157646|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2157647|NCT01253668|Antibodies|antibodies|mesh-list
2157648|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2157649|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
2157650|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157651|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
2157652|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2157653|NCT01259024|Estrogens|estrogens|mesh-ancestor
2157654|NCT01259024|Hormones|hormones|mesh-ancestor
2421699|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2421700|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
2421701|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421702|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421703|NCT00813891|Ranibizumab|ranibizumab|mesh-list
2421704|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2421705|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2421706|NCT00813891|Growth Substances|growth substances|mesh-ancestor
2421707|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421708|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
2421709|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421710|NCT00813956|Gemcitabine|gemcitabine|mesh-list
2421711|NCT00813956|Carboplatin|carboplatin|mesh-list
2421712|NCT00813956|Iniparib|iniparib|mesh-list
2421713|NCT00813956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421714|NCT00813956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2421715|NCT00813956|Antimetabolites|antimetabolites|mesh-ancestor
2421716|NCT00813956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421717|NCT00813956|Antiviral Agents|antiviral agents|mesh-ancestor
2421718|NCT00813956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421719|NCT00813956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421720|NCT00813956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2421721|NCT00813956|Immunologic Factors|immunologic factors|mesh-ancestor
2421722|NCT00813956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421723|NCT00813956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2421724|NCT00814008|Insulin|insulin|mesh-list
2611588|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611589|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
2611590|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611591|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2611592|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2611593|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
2611594|NCT01829958|Hormones|hormones|mesh-ancestor
2611595|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2611596|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2611597|NCT01830101|Temozolomide|temozolomide|mesh-list
2611598|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2611599|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
2611600|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611601|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611602|NCT01830153|Everolimus|everolimus|mesh-list
2611603|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611604|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2611605|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
2611606|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611607|NCT01830218|Anesthetics|anesthetics|mesh-list
2157655|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157656|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157657|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2157658|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157659|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
2157660|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157661|NCT01246011|Warfarin|warfarin|mesh-list
2157662|NCT01246011|Argatroban|argatroban|mesh-list
2157663|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
2157664|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
2157665|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2157666|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
2157667|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611608|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2611609|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611610|NCT01830244|Paclitaxel|paclitaxel|mesh-list
2611611|NCT01830244|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2611612|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2611613|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611614|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
2611615|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
2611616|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
2611617|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611618|NCT01830270|Paclitaxel|paclitaxel|mesh-list
2611619|NCT01830270|Epirubicin|epirubicin|mesh-list
2611620|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2611621|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611622|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
2611623|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
2611624|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
2611625|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611626|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2611627|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2611628|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2611629|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157668|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157669|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2157670|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
2157671|NCT01244620|Tadalafil|tadalafil|mesh-list
2157672|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
2157673|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
2157674|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2157675|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2157676|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157677|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157678|NCT01244620|Urological Agents|urological agents|mesh-ancestor
2157679|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2157680|NCT01240304|Gemcitabine|gemcitabine|mesh-list
2157681|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157682|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
2157683|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157684|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157685|NCT01240304|Antiviral Agents|antiviral agents|mesh-ancestor
2157686|NCT01240304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157687|NCT01240304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157688|NCT01240304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157689|NCT01240304|Immunologic Factors|immunologic factors|mesh-ancestor
2157690|NCT01240304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157691|NCT01230788|Rituximab|rituximab|mesh-list
2157692|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2157693|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157694|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
2157695|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157696|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2157697|NCT01231750|Capsaicin|capsaicin|mesh-list
2611630|NCT01830296|Morphine|morphine|mesh-list
2611631|NCT01830296|Remifentanil|remifentanil|mesh-list
2611632|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2611633|NCT01830296|Narcotics|narcotics|mesh-ancestor
2611634|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2611635|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611636|NCT01830296|Analgesics|analgesics|mesh-ancestor
2611637|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
2611638|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611639|NCT01830322|Gemcitabine|gemcitabine|mesh-list
2611640|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2611641|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
2611642|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611643|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611644|NCT01830322|Antiviral Agents|antiviral agents|mesh-ancestor
2611645|NCT01830322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611646|NCT01830322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611647|NCT01830322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2611648|NCT01830322|Immunologic Factors|immunologic factors|mesh-ancestor
2611649|NCT01830322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611650|NCT01830335|Indomethacin|indomethacin|mesh-list
2611651|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2611652|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2611653|NCT01830335|Analgesics|analgesics|mesh-ancestor
2611654|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
2611655|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611656|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611657|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2611658|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2611659|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
2611660|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
2611661|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2611662|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2611663|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611664|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611665|NCT01830361|Midostaurin|midostaurin|mesh-list
2611666|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611667|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2611668|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611669|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611670|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2611671|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
2611672|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2611673|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2611674|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2611675|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611676|NCT01830465|Rituximab|rituximab|mesh-list
2611677|NCT01830465|Bortezomib|bortezomib|mesh-list
2611678|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2611679|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611680|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
2611681|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611682|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2611683|NCT01830478|Rituximab|rituximab|mesh-list
2611684|NCT01830478|Lenalidomide|lenalidomide|mesh-list
2611685|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2611686|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611687|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
2611688|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611689|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2611690|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2611691|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2611692|NCT01830478|Growth Substances|growth substances|mesh-ancestor
2611693|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
2611694|NCT01830491|Aspirin|aspirin|mesh-list
2611695|NCT01830491|Clopidogrel|clopidogrel|mesh-list
2611696|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2611697|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2611698|NCT01830491|Analgesics|analgesics|mesh-ancestor
2611699|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
2611700|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611701|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611702|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2611703|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2611704|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2611705|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2611706|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611707|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2611708|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2611709|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611710|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
2611711|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2611712|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2611713|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2611714|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
2611715|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2611716|NCT01830517|Losartan|losartan|mesh-list
2611717|NCT01830517|Amlodipine|amlodipine|mesh-list
2611718|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2611719|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2611720|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2611721|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611722|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2611723|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611724|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
2611725|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2611726|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2611727|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2611728|NCT01830530|Telmisartan|telmisartan|mesh-list
2611729|NCT01830530|Nifedipine|nifedipine|mesh-list
2611730|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2611731|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2611732|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2611733|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611734|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2611735|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2611736|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2611737|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611738|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
2611739|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
2611740|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2611741|NCT01830556|Cetuximab|cetuximab|mesh-list
2611742|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2611743|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611744|NCT01830777|Cytarabine|cytarabine|mesh-list
2611745|NCT01830777|Etoposide|etoposide|mesh-list
2611746|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
2611747|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2611748|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2611749|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611750|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2611751|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2611752|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611753|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611754|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2611755|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
2611756|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
2611757|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611758|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2611759|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
2611760|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611761|NCT01830777|Analgesics|analgesics|mesh-ancestor
2611762|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
2611763|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611764|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2611765|NCT01830829|Tamsulosin|tamsulosin|mesh-list
2611766|NCT01830829|Dutasteride|dutasteride|mesh-list
2157698|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
2157699|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
2611767|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2611768|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2611769|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2611770|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
2611771|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2611772|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611773|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611774|NCT01830829|Urological Agents|urological agents|mesh-ancestor
2611775|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2611776|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2611777|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611778|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
2611779|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2611780|NCT01830868|Zonisamide|zonisamide|mesh-list
2611781|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
2611782|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2611783|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2611784|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611785|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2611786|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611787|NCT01830907|Vitamins|vitamins|mesh-list
2611788|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
2611789|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611790|NCT01830946|Caseins|caseins|mesh-list
2611791|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
2611792|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
2611793|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611794|NCT01831011|Aspirin|aspirin|mesh-list
2611795|NCT01831011|Cinepazide|cinepazide|mesh-list
2611796|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
2611797|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2611798|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2611799|NCT01831011|Analgesics|analgesics|mesh-ancestor
2157700|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
2157701|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2157702|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157703|NCT01230307|Vitamin D|vitamin d|mesh-list
2157704|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
2157705|NCT01230307|Vitamins|vitamins|mesh-ancestor
2157706|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
2157707|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157708|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2157709|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2157710|NCT01222871|Triamcinolone|triamcinolone|mesh-list
2157711|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2157712|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
2157713|NCT01222871|Hormones|hormones|mesh-ancestor
2157714|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157715|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157716|NCT01219673|Minocycline|minocycline|mesh-list
2157717|NCT01219673|Modafinil|modafinil|mesh-list
2157718|NCT01219673|Bupropion|bupropion|mesh-list
2157719|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2157720|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
2157721|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2157722|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2157723|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2157724|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2157725|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157726|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
2157727|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2157728|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157729|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2421725|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2421726|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421727|NCT00814021|Sunitinib|sunitinib|mesh-list
2421728|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421729|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2421730|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2421731|NCT00814021|Growth Substances|growth substances|mesh-ancestor
2421732|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421733|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
2421734|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2611800|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
2611801|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611802|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611803|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2611804|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2611805|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2611806|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2611807|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611808|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2611809|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2611810|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611811|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
2611812|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
2611813|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2611814|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
2611815|NCT01831050|Vaccines|vaccines|mesh-list
2611816|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
2611817|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611818|NCT01831193|Curcumin|curcumin|mesh-list
2611819|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2157730|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2157731|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157732|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2157733|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157734|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2157735|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2157736|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2157737|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2157738|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2157739|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2157740|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2157741|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2157742|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157743|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2157744|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157745|NCT01223001|Analgesics|analgesics|mesh-ancestor
2157746|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
2157747|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2157748|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
2157749|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2157750|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
2157751|NCT01217060|Dexamethasone|dexamethasone|mesh-list
2157752|NCT01217060|Docetaxel|docetaxel|mesh-list
2157753|NCT01217060|Fluorouracil|fluorouracil|mesh-list
2157754|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2157755|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
2157756|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
2157757|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2157758|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157759|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2157760|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
2157761|NCT01217060|Hormones|hormones|mesh-ancestor
2157762|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157763|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2611820|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2611821|NCT01831193|Analgesics|analgesics|mesh-ancestor
2611822|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
2611823|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611824|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611825|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2611826|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2611827|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611828|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611829|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157764|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157765|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
2611830|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2611831|NCT01831323|Rifaximin|rifaximin|mesh-list
2611832|NCT01831323|Mesalamine|mesalamine|mesh-list
2611833|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2611834|NCT01831323|Psyllium|psyllium|mesh-list
2611835|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611836|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2611837|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2157766|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
2157767|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
2157768|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157769|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
2157770|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157771|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157772|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
2157773|NCT01206101|Liraglutide|liraglutide|mesh-list
2157774|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2157775|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157776|NCT01206101|Incretins|incretins|mesh-ancestor
2157777|NCT01206101|Hormones|hormones|mesh-ancestor
2157778|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157779|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
2157780|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2157781|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2157782|NCT01216631|Prednisolone|prednisolone|mesh-list
2611838|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2611839|NCT01831323|Analgesics|analgesics|mesh-ancestor
2611840|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
2611841|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611842|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611843|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2611844|NCT01831323|Cathartics|cathartics|mesh-ancestor
2611845|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
2611846|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2611847|NCT01831479|Olmesartan|olmesartan|mesh-list
2611848|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2611849|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2611850|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2611851|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2611852|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
2611853|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611854|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2611855|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2611856|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611857|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2611858|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2611859|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2611860|NCT01831505|Prednisolone|prednisolone|mesh-list
2611861|NCT01831505|Rituximab|rituximab|mesh-list
2611862|NCT01831505|Doxorubicin|doxorubicin|mesh-list
2611863|NCT01831505|Vincristine|vincristine|mesh-list
2611864|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2611865|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2611866|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611867|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
2611868|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611869|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2611870|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2611871|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2611872|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2611873|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611874|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611875|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2611876|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
2611877|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
2611878|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
2611879|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2611880|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
2611881|NCT01831505|Hormones|hormones|mesh-ancestor
2611882|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2611883|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2611884|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2611885|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
2611886|NCT01831622|Methylphenidate|methylphenidate|mesh-list
2611887|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2611888|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611889|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2611890|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2611891|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2611892|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611893|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
2157783|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
2611894|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2611895|NCT01831661|Metformin|metformin|mesh-list
2611896|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2611897|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611898|NCT01831674|Metformin|metformin|mesh-list
2611899|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2611900|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611901|NCT01831687|Etodolac|etodolac|mesh-list
2611902|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2611903|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2611904|NCT01831687|Analgesics|analgesics|mesh-ancestor
2611905|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
2611906|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611907|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611908|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2611909|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2611910|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2157784|NCT01216631|Infliximab|infliximab|mesh-list
2157785|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2157786|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
2157787|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2157788|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
2157789|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
2157790|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2157791|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157792|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2157793|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
2157794|NCT01216631|Hormones|hormones|mesh-ancestor
2157795|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157796|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2157797|NCT01216631|Protective Agents|protective agents|mesh-ancestor
2157798|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2157799|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157800|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
2157801|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2157802|NCT01211756|Oxytocin|oxytocin|mesh-list
2157803|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
2157804|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2157805|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157806|NCT01209520|Paclitaxel|paclitaxel|mesh-list
2157807|NCT01209520|Vinorelbine|vinorelbine|mesh-list
2157808|NCT01209520|Docetaxel|docetaxel|mesh-list
2157809|NCT01209520|Cisplatin|cisplatin|mesh-list
2157810|NCT01209520|Carboplatin|carboplatin|mesh-list
2157811|NCT01209520|Pemetrexed|pemetrexed|mesh-list
2157812|NCT01209520|Azacitidine|azacitidine|mesh-list
2157813|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2157814|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157815|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
2157816|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
2157817|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
2157818|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157819|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157820|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2157821|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2157822|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157823|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
2157824|NCT01207726|Azacitidine|azacitidine|mesh-list
2157825|NCT01207726|Entinostat|entinostat|mesh-list
2157826|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2157827|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157828|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
2157829|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157830|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157831|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157832|NCT01206296|Gemcitabine|gemcitabine|mesh-list
2157833|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157834|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
2157835|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157836|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157837|NCT01206296|Antiviral Agents|antiviral agents|mesh-ancestor
2157838|NCT01206296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157839|NCT01206296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157840|NCT01206296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157841|NCT01206296|Immunologic Factors|immunologic factors|mesh-ancestor
2157842|NCT01206296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611911|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2157843|NCT01207102|Paclitaxel|paclitaxel|mesh-list
2157844|NCT01207102|Carboplatin|carboplatin|mesh-list
2157845|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2157846|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2157847|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157848|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
2157849|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
2611912|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611913|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611914|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2611915|NCT01831700|Lisinopril|lisinopril|mesh-list
2611916|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
2611917|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2611918|NCT01831700|Diuretics|diuretics|mesh-ancestor
2611919|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
2611920|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157850|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
2157851|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157852|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
2157853|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2157854|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157855|NCT01202110|Propranolol|propranolol|mesh-list
2157856|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2157857|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2157858|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
2157859|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2157860|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611921|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2611922|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2611923|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611924|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2611925|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
2611926|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611927|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2611928|NCT01831700|Protective Agents|protective agents|mesh-ancestor
2611929|NCT01831947|Ranibizumab|ranibizumab|mesh-list
2611930|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2611931|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2611932|NCT01831947|Growth Substances|growth substances|mesh-ancestor
2611933|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611934|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
2611935|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611936|NCT01832051|Trastuzumab|trastuzumab|mesh-list
2611937|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2611938|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2611939|NCT01832129|Vitamins|vitamins|mesh-list
2611940|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
2611941|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
2611942|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
2611943|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
2611944|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611945|NCT01832129|Hematinics|hematinics|mesh-ancestor
2611946|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
2421735|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421736|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421737|NCT00814047|Yohimbine|yohimbine|mesh-list
2421738|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
2421739|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
2421740|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421741|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421742|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2421743|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2421744|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2421745|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
2421746|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2421747|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421748|NCT00814047|Urological Agents|urological agents|mesh-ancestor
2421749|NCT00814086|Paclitaxel|paclitaxel|mesh-list
2421750|NCT00814086|Cisplatin|cisplatin|mesh-list
2421751|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2421752|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421753|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
2421754|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
2421755|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
2611947|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2611948|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2611949|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2611950|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611951|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2611952|NCT01832285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2611953|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2611954|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2611955|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611956|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2611957|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
2611958|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2611959|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
2611960|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2611961|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2611962|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611963|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2611964|NCT01832311|Ketorolac|ketorolac|mesh-list
2611965|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2611966|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2611967|NCT01832311|Analgesics|analgesics|mesh-ancestor
2611968|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
2611969|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2611970|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2611971|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2611972|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2611973|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2611974|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611975|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157861|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157862|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2157863|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2157864|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
2157865|NCT01206439|Nebivolol|nebivolol|mesh-list
2157866|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2157867|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
2157868|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2157869|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2611976|NCT01832350|Quinidine|quinidine|mesh-list
2611977|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
2611978|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
2611979|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
2611980|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2611981|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2157870|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2157871|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
2157872|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2157873|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157874|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157875|NCT01200602|Megestrol|megestrol|mesh-list
2157876|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
2157877|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2157878|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2157879|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2157880|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
2157881|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2157882|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157883|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2157884|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2157885|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2157886|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157887|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
2157888|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2157889|NCT01198548|Vitamin D|vitamin d|mesh-list
2157890|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
2157891|NCT01198548|Leucovorin|leucovorin|mesh-list
2157892|NCT01198548|Bevacizumab|bevacizumab|mesh-list
2157893|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2157894|NCT01198548|Fluorouracil|fluorouracil|mesh-list
2611982|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2611983|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2611984|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157895|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
2157896|NCT01198548|Antibodies|antibodies|mesh-list
2611985|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2611986|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2611987|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
2611988|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2611989|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
2611990|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2611991|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2611992|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2611993|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2611994|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2611995|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2611996|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
2611997|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2611998|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2157897|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
2157898|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2157899|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
2157900|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157901|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2157902|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2611999|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2612000|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2612001|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2612002|NCT01832363|Xenon|xenon|mesh-list
2612003|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2612004|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
2612005|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
2612006|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612007|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612008|NCT01832415|Bevacizumab|bevacizumab|mesh-list
2612009|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2612010|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612011|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2612012|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2612013|NCT01832415|Growth Substances|growth substances|mesh-ancestor
2157903|NCT01198548|Growth Substances|growth substances|mesh-ancestor
2157904|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157905|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
2157906|NCT01198548|Vitamins|vitamins|mesh-ancestor
2157907|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
2157908|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
2612014|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612015|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
2612016|NCT01832467|Cetuximab|cetuximab|mesh-list
2612017|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2612018|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612019|NCT01832558|Eplerenone|eplerenone|mesh-list
2612020|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2612021|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
2612022|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2612023|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612024|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2612025|NCT01832558|Diuretics|diuretics|mesh-ancestor
2612026|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
2612027|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2612028|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2612029|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2612030|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2612031|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612032|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612033|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
2612034|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612035|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2612036|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2612037|NCT01832623|Vitamin D|vitamin d|mesh-list
2612038|NCT01832623|Vitamins|vitamins|mesh-ancestor
2612039|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
2612040|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612041|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2612042|NCT01832662|Caffeine|caffeine|mesh-list
2612043|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2612044|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612045|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2612046|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612047|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612048|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2612049|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2612050|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
2612051|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612052|NCT01832675|Bupivacaine|bupivacaine|mesh-list
2612053|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
2612054|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
2612055|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612056|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612057|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
2612058|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612059|NCT01832870|Ipilimumab|ipilimumab|mesh-list
2612060|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2612061|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612062|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2612063|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612064|NCT01832896|Ecallantide|ecallantide|mesh-list
2612065|NCT01832896|Analgesics|analgesics|mesh-ancestor
2612066|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
2612067|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612068|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612069|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2612070|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2612071|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2612072|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2612073|NCT01832922|Rituximab|rituximab|mesh-list
2612074|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2612075|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2612076|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612077|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
2612078|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612079|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2612080|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2612081|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
2612082|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612083|NCT01832935|Insulin|insulin|mesh-list
2612084|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2157909|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2157910|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2157911|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
2157912|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157913|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157914|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157915|NCT01198548|Antidotes|antidotes|mesh-ancestor
2157916|NCT01198548|Protective Agents|protective agents|mesh-ancestor
2157917|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
2157918|NCT01194908|Tamoxifen|tamoxifen|mesh-list
2157919|NCT01194908|Decitabine|decitabine|mesh-list
2157920|NCT01194908|Panobinostat|panobinostat|mesh-list
2157921|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157922|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
2157923|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157924|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157925|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612085|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
2612086|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
2612087|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
2612088|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
2612089|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2612090|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612091|NCT01832948|Leucovorin|leucovorin|mesh-list
2612092|NCT01832948|Folic Acid|folic acid|mesh-list
2612093|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
2612094|NCT01832948|Endostar protein|endostar protein|mesh-list
2612095|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
2612096|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612097|NCT01832948|Antidotes|antidotes|mesh-ancestor
2612098|NCT01832948|Protective Agents|protective agents|mesh-ancestor
2157926|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2157927|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
2157928|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157929|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612099|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612100|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
2157930|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2157931|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2157932|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2157933|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2157934|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2157935|NCT01194856|Ritonavir|ritonavir|mesh-list
2157936|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2157937|NCT01194856|Efavirenz|efavirenz|mesh-list
2157938|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2157939|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2157940|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
2157941|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157942|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612101|NCT01832948|Vitamins|vitamins|mesh-ancestor
2612102|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
2612103|NCT01832948|Hematinics|hematinics|mesh-ancestor
2612104|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2612105|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2157943|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2157944|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2157945|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
2157946|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2157947|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2612106|NCT01832948|Growth Substances|growth substances|mesh-ancestor
2612107|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
2612108|NCT01832987|Trimethoprim|trimethoprim|mesh-list
2612109|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2612110|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
2612111|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2612112|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612113|NCT01832987|Renal Agents|renal agents|mesh-ancestor
2612114|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
2612115|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2612116|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2612117|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2612118|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612119|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612120|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2612121|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2612122|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2612123|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2612124|NCT01833221|Lidocaine|lidocaine|mesh-list
2612125|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
2612126|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
2612127|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612128|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612129|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
2612130|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612131|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2612132|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2612133|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2612134|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2612135|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612136|NCT01833299|Sorafenib|sorafenib|mesh-list
2612137|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
2612138|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612139|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2612140|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612141|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612142|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2612143|NCT01833299|Estrogens|estrogens|mesh-ancestor
2612144|NCT01833299|Hormones|hormones|mesh-ancestor
2612145|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2612146|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612147|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2612148|NCT01833312|Meperidine|meperidine|mesh-list
2612149|NCT01833312|Buspirone|buspirone|mesh-list
2612150|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2612151|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2157948|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2157949|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2157950|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2612152|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612153|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157951|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2157952|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2157953|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2157954|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2157955|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2157956|NCT01194427|Tamoxifen|tamoxifen|mesh-list
2157957|NCT01194427|Vorinostat|vorinostat|mesh-list
2157958|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2157959|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
2157960|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2157961|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157962|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2157963|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157964|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2157965|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2157966|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2157967|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2157968|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157969|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157970|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2612154|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2612155|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2612156|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
2612157|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612158|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612159|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2612160|NCT01833312|Narcotics|narcotics|mesh-ancestor
2612161|NCT01833312|Analgesics|analgesics|mesh-ancestor
2612162|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
2612163|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612164|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2612165|NCT01833351|Vitamins|vitamins|mesh-list
2612166|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
2612167|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
2612168|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612169|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
2612170|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612171|NCT01833351|Protective Agents|protective agents|mesh-ancestor
2612172|NCT01833559|Insulin|insulin|mesh-list
2612173|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2612174|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
2612175|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2612176|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612177|NCT01833572|Gefitinib|gefitinib|mesh-list
2612178|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612179|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2612180|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612181|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612182|NCT01833611|Entecavir|entecavir|mesh-list
2612183|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
2612184|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612185|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
2612186|NCT01833663|Estrogens|estrogens|mesh-list
2612187|NCT01833663|Hormones|hormones|mesh-ancestor
2157971|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157972|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2157973|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2157974|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157975|NCT01182610|Paclitaxel|paclitaxel|mesh-list
2157976|NCT01182610|Carboplatin|carboplatin|mesh-list
2157977|NCT01182610|Fluorouracil|fluorouracil|mesh-list
2157978|NCT01182610|Panitumumab|panitumumab|mesh-list
2157979|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2157980|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2157981|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
2157982|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
2157983|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
2421756|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421757|NCT00814125|Tamoxifen|tamoxifen|mesh-list
2421758|NCT00814125|Anastrozole|anastrozole|mesh-list
2421759|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2421760|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
2421761|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421762|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612188|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2612189|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612190|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2157984|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157985|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
2157986|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2157987|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2157988|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
2157989|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157990|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2157991|NCT01189071|Darifenacin|darifenacin|mesh-list
2157992|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2157993|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2157994|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
2157995|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612191|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2612192|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
2612193|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612194|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612195|NCT01833663|Urological Agents|urological agents|mesh-ancestor
2612196|NCT01833676|Sevoflurane|sevoflurane|mesh-list
2612197|NCT01833676|Desflurane|desflurane|mesh-list
2612198|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2612199|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2612200|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
2612201|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
2612202|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612203|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612204|NCT01833715|Morphine|morphine|mesh-list
2612205|NCT01833715|Methadone|methadone|mesh-list
2612206|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2612207|NCT01833715|Narcotics|narcotics|mesh-ancestor
2612208|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612209|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612210|NCT01833715|Analgesics|analgesics|mesh-ancestor
2157996|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2157997|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2157998|NCT01189071|Urological Agents|urological agents|mesh-ancestor
2157999|NCT01183416|Tretinoin|tretinoin|mesh-list
2158000|NCT01183416|Isotretinoin|isotretinoin|mesh-list
2158001|NCT01183416|Antibodies|antibodies|mesh-list
2612211|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
2612212|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612213|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
2612214|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
2612215|NCT01833728|Acetaminophen|acetaminophen|mesh-list
2612216|NCT01833728|Propacetamol|propacetamol|mesh-list
2612217|NCT01833728|Nefopam|nefopam|mesh-list
2612218|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2612219|NCT01833728|Analgesics|analgesics|mesh-ancestor
2612220|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
2612221|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612222|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612223|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2612224|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2612225|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2612226|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
2612227|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
2158002|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2158003|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
2158004|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158005|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158006|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
2158007|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
2158008|NCT01183221|Oxytocin|oxytocin|mesh-list
2158009|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
2158010|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2158011|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158012|NCT01190306|Riboflavin|riboflavin|mesh-list
2158013|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
2158014|NCT01190306|Vitamins|vitamins|mesh-ancestor
2158015|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
2158016|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158017|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2158018|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
2158019|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2612228|NCT01833767|Interleukin-2|interleukin-2|mesh-list
2158020|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
2158021|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2158022|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2158023|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
2158024|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158025|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158026|NCT01181921|Galantamine|galantamine|mesh-list
2158027|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2158028|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158029|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158030|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
2158031|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158032|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158033|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2158034|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
2158035|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158036|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
2158037|NCT01188798|Methotrexate|methotrexate|mesh-list
2158038|NCT01188798|Pentostatin|pentostatin|mesh-list
2421763|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2612229|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2612230|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
2612231|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612232|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2612233|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2612234|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
2612235|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612236|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612237|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2612238|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2612239|NCT01833767|Analgesics|analgesics|mesh-ancestor
2612240|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
2612241|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612242|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
2612243|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2612244|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
2421764|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421765|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2421766|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2421767|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2421768|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2421769|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2612245|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2612246|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612247|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2612248|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2612249|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2612250|NCT01833819|Lidocaine|lidocaine|mesh-list
2612251|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
2612252|NCT01833819|Remifentanil|remifentanil|mesh-list
2612253|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
2612254|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
2612255|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612256|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612257|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
2612258|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612259|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2612260|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2612261|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2612262|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2612263|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612264|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2612265|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2612266|NCT01833819|Analgesics|analgesics|mesh-ancestor
2612267|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2612268|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2612269|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2612270|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
2612271|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612272|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2612273|NCT01833819|Narcotics|narcotics|mesh-ancestor
2612274|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2612275|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2612276|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612277|NCT01834014|Bevacizumab|bevacizumab|mesh-list
2612278|NCT01834014|Cetuximab|cetuximab|mesh-list
2612279|NCT01834014|Fluorouracil|fluorouracil|mesh-list
2612280|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
2612281|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2612282|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612283|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2612284|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2612285|NCT01834014|Growth Substances|growth substances|mesh-ancestor
2612286|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612287|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
2612288|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
2612289|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612290|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2612291|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2612292|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
2612293|NCT01834170|Gemcitabine|gemcitabine|mesh-list
2612294|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2612295|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
2612296|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612297|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612298|NCT01834170|Antiviral Agents|antiviral agents|mesh-ancestor
2612299|NCT01834170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612300|NCT01834170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612301|NCT01834170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2612302|NCT01834170|Immunologic Factors|immunologic factors|mesh-ancestor
2612303|NCT01834170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612304|NCT01834183|Gemcitabine|gemcitabine|mesh-list
2612305|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2612306|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
2612307|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612308|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612309|NCT01834183|Antiviral Agents|antiviral agents|mesh-ancestor
2612310|NCT01834183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612311|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612312|NCT01834183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2612313|NCT01834183|Immunologic Factors|immunologic factors|mesh-ancestor
2612314|NCT01834183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612315|NCT01834209|Prednisone|prednisone|mesh-list
2612316|NCT01834209|Prednisolone|prednisolone|mesh-list
2612317|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
2612318|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2612319|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
2612320|NCT01834209|Hormones|hormones|mesh-ancestor
2612321|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2612322|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612323|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2612324|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612325|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2612326|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612327|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158039|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2158040|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
2158041|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2158042|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158043|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2158044|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
2158045|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158046|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158047|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
2158048|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158049|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2158050|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2158051|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
2158052|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2158053|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2158054|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2158055|NCT01183884|Tretinoin|tretinoin|mesh-list
2158056|NCT01183884|Isotretinoin|isotretinoin|mesh-list
2158057|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158058|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
2158059|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
2158060|NCT01183429|Tretinoin|tretinoin|mesh-list
2158061|NCT01183429|Isotretinoin|isotretinoin|mesh-list
2158062|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612328|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
2612329|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2612330|NCT01834235|Gemcitabine|gemcitabine|mesh-list
2612331|NCT01834235|Paclitaxel|paclitaxel|mesh-list
2612332|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2612333|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612334|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
2612335|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
2612336|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
2612337|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612338|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2612339|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
2612340|NCT01834235|Antiviral Agents|antiviral agents|mesh-ancestor
2612341|NCT01834235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158063|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
2158064|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
2158065|NCT01166178|Vitamin D|vitamin d|mesh-list
2158066|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
2158067|NCT01166178|Calcium|calcium|mesh-list
2158068|NCT01166178|Vitamins|vitamins|mesh-ancestor
2612342|NCT01834235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612343|NCT01834235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2612344|NCT01834235|Immunologic Factors|immunologic factors|mesh-ancestor
2612345|NCT01834235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612346|NCT01834248|Poly I-C|poly i-c|mesh-list
2612347|NCT01834248|Decitabine|decitabine|mesh-list
2612348|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2612349|NCT01834248|Poly ICLC|poly iclc|mesh-list
2612350|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2612351|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
2612352|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612353|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612354|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612355|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
2612356|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
2612357|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612358|NCT01834248|Laxatives|laxatives|mesh-ancestor
2612359|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2158069|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
2158070|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158071|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2158072|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2158073|NCT01169753|Modafinil|modafinil|mesh-list
2612360|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
2612361|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612362|NCT01834508|Entecavir|entecavir|mesh-list
2612363|NCT01834508|Adefovir|adefovir|mesh-list
2612364|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
2612365|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612366|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2158074|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2158075|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158076|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2158077|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2612367|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2612368|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612369|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612370|NCT01834547|Methylphenidate|methylphenidate|mesh-list
2612371|NCT01834547|Caffeine|caffeine|mesh-list
2612372|NCT01834547|Modafinil|modafinil|mesh-list
2612373|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2612374|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612375|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2612376|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2612377|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2158078|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2158079|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158080|NCT01169610|Varenicline|varenicline|mesh-list
2158081|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2158082|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2158083|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
2158084|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158085|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158086|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158087|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
2612378|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612379|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
2612380|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612381|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2612382|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612383|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2612384|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2612385|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
2612386|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2612387|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2612388|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2612389|NCT01834768|Eplerenone|eplerenone|mesh-list
2612390|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2612391|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
2158088|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2158089|NCT01155388|Hematinics|hematinics|mesh-ancestor
2158090|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2158091|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2158092|NCT01155388|Trace Elements|trace elements|mesh-ancestor
2158093|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
2158094|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158095|NCT01163084|Leuprolide|leuprolide|mesh-list
2158096|NCT01163084|Goserelin|goserelin|mesh-list
2158097|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2158098|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
2158099|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2158100|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158101|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2158102|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158103|NCT01166724|Sirolimus|sirolimus|mesh-list
2158104|NCT01166724|Tacrolimus|tacrolimus|mesh-list
2158105|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2158106|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
2158107|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158108|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2158109|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158110|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612392|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2612393|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612394|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2612395|NCT01834768|Diuretics|diuretics|mesh-ancestor
2612396|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
2612397|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2612398|NCT01834820|Dexamethasone|dexamethasone|mesh-list
2612399|NCT01834820|Epinephrine|epinephrine|mesh-list
2612400|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2612401|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
2612402|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
2612403|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612404|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612405|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2612406|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
2612407|NCT01834820|Hormones|hormones|mesh-ancestor
2612408|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2612409|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2158111|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2158112|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158113|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2158114|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158115|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
2158116|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
2158117|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2158118|NCT01155375|Hematinics|hematinics|mesh-ancestor
2158119|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2158120|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2158121|NCT01155375|Trace Elements|trace elements|mesh-ancestor
2158122|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
2158123|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158124|NCT01157533|Vancomycin|vancomycin|mesh-list
2612410|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612411|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2612412|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2612413|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
2612414|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158125|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2158126|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612415|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612416|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2612417|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2612418|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2612419|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
2612420|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
2612421|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
2612422|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2612423|NCT01834885|Fluticasone|fluticasone|mesh-list
2612424|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2612425|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2612426|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2612427|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2612428|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
2612429|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612430|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612431|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2612432|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
2612433|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
2612434|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2612435|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2612436|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2612437|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2612438|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
2612439|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612440|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612441|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
2612442|NCT01834885|Hormones|hormones|mesh-ancestor
2612443|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2612444|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
2612445|NCT01834898|Oxycodone|oxycodone|mesh-list
2612446|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2612447|NCT01834898|Narcotics|narcotics|mesh-ancestor
2612448|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612449|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612450|NCT01834898|Analgesics|analgesics|mesh-ancestor
2612451|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
2612452|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612453|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
2612454|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2612455|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2612456|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2612457|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612458|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
2612459|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612460|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612461|NCT01834963|Interferons|interferons|mesh-list
2612462|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
2612463|NCT01834963|Cisplatin|cisplatin|mesh-list
2612464|NCT01834963|Fluorouracil|fluorouracil|mesh-list
2612465|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612466|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
2612467|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612468|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2612469|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2612470|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
2612471|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612472|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
2612473|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612474|NCT01834989|Mitogens|mitogens|mesh-list
2612475|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
2612476|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158127|NCT01162304|Oxycodone|oxycodone|mesh-list
2158128|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2158129|NCT01162304|Narcotics|narcotics|mesh-ancestor
2158130|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2158131|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158132|NCT01162304|Analgesics|analgesics|mesh-ancestor
2158133|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
2158134|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158135|NCT01151904|Timolol|timolol|mesh-list
2158136|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2158137|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2158138|NCT01151904|Latanoprost|latanoprost|mesh-list
2612501|NCT01835067|Ranibizumab|ranibizumab|mesh-list
2612502|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2612503|NCT01835067|Plasminogen|plasminogen|mesh-list
2612504|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2612505|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2612506|NCT01835067|Growth Substances|growth substances|mesh-ancestor
2612507|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612508|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
2612509|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612510|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2612511|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2612512|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612513|NCT01835184|Vemurafenib|vemurafenib|mesh-list
2612514|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612515|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2612516|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612517|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612518|NCT01835197|Abrocitinib|abrocitinib|mesh-list
2612519|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2612520|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612521|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612522|NCT01835236|Paclitaxel|paclitaxel|mesh-list
2612523|NCT01835236|Vinorelbine|vinorelbine|mesh-list
2612524|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2612525|NCT01835236|Trastuzumab|trastuzumab|mesh-list
2612526|NCT01835236|Pertuzumab|pertuzumab|mesh-list
2158139|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2158140|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2158141|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2158142|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
2158143|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158144|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158145|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158146|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2158147|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2158148|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2158149|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2158150|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2158151|NCT01155518|Clomiphene|clomiphene|mesh-list
2158152|NCT01155518|Testosterone|testosterone|mesh-list
2158153|NCT01155518|Androgens|androgens|mesh-ancestor
2158154|NCT01155518|Hormones|hormones|mesh-ancestor
2158155|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2158156|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158157|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2612527|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2612528|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612529|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
2612530|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
2612531|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
2612532|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612533|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2612534|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
2612535|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612536|NCT01835314|Stiripentol|stiripentol|mesh-list
2612537|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
2612538|NCT01835340|Anesthetics|anesthetics|mesh-list
2612539|NCT01835340|Propofol|propofol|mesh-list
2612540|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612541|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612542|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2612543|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2612544|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
2612545|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2612546|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2158158|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
2158159|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2158160|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
2158161|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2158162|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2158163|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2158164|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
2158165|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2612547|NCT01835418|Amlodipine|amlodipine|mesh-list
2612548|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2612549|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2612550|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2612551|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612552|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2612553|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612554|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
2612555|NCT01835561|Thalidomide|thalidomide|mesh-list
2158166|NCT01147393|Epratuzumab|epratuzumab|mesh-list
2158167|NCT01147393|Veltuzumab|veltuzumab|mesh-list
2158168|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
2158169|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2158170|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158171|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
2158172|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
2158173|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158174|NCT01147042|Interferons|interferons|mesh-list
2158175|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
2158176|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158177|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
2158178|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158179|NCT01139996|Clonidine|clonidine|mesh-list
2612556|NCT01835561|Pomalidomide|pomalidomide|mesh-list
2612557|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
2612558|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612559|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2612560|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2612561|NCT01835561|Growth Substances|growth substances|mesh-ancestor
2612562|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
2612563|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612564|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2612565|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
2612566|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2612567|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612568|NCT01835639|Vitamin D|vitamin d|mesh-list
2612569|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
2158180|NCT01139996|Analgesics|analgesics|mesh-ancestor
2158181|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
2158182|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158183|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158184|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2158185|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
2158186|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
2158187|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2158188|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2158189|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2158190|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
2158191|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612570|NCT01835639|Vitamins|vitamins|mesh-ancestor
2612571|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
2612572|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612573|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2612574|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2612575|NCT01835665|Nimodipine|nimodipine|mesh-list
2612576|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2612577|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2612578|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2612579|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612580|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2612581|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612582|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
2612583|NCT01835678|Linagliptin|linagliptin|mesh-list
2612584|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2612585|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612586|NCT01835678|Incretins|incretins|mesh-ancestor
2612587|NCT01835678|Hormones|hormones|mesh-ancestor
2612588|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2612589|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2612590|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
2612591|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158192|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158193|NCT01142128|Esomeprazole|esomeprazole|mesh-list
2158194|NCT01142128|Pancrelipase|pancrelipase|mesh-list
2158195|NCT01142128|Pancreatin|pancreatin|mesh-list
2158196|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2158197|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2158198|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2158199|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158200|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158201|NCT01131884|Alendronate|alendronate|mesh-list
2158202|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2158203|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158204|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2158205|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
2158206|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2158207|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2158208|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2158209|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2158210|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158211|NCT01126879|Genistein|genistein|mesh-list
2158212|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2158213|NCT01126879|Protective Agents|protective agents|mesh-ancestor
2158214|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158215|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158216|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2158217|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158218|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158219|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
2158220|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2158221|NCT01126879|Estrogens|estrogens|mesh-ancestor
2158222|NCT01126879|Hormones|hormones|mesh-ancestor
2158223|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2158224|NCT01139125|Cysteamine|cysteamine|mesh-list
2158225|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2158226|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158227|NCT01133639|Ketorolac|ketorolac|mesh-list
2158228|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2612592|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612593|NCT01835691|Vitamin D|vitamin d|mesh-list
2612594|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
2612595|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
2612596|NCT01835691|Vitamins|vitamins|mesh-list
2612597|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
2612598|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612599|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2158229|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2158230|NCT01133639|Analgesics|analgesics|mesh-ancestor
2158231|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
2158232|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158233|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158234|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2158235|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421770|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421771|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421772|NCT00814216|Fluticasone|fluticasone|mesh-list
2421773|NCT00814216|Xhance|xhance|mesh-list
2421774|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2421775|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2421776|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
2421777|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612600|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2612601|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2612602|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158236|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2158237|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158238|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158239|NCT01126801|Estradiol|estradiol|mesh-list
2158240|NCT01126801|Estrogens|estrogens|mesh-ancestor
2158241|NCT01126801|Hormones|hormones|mesh-ancestor
2158242|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2158243|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158244|NCT01126957|Fentanyl|fentanyl|mesh-list
2158245|NCT01126957|Ketamine|ketamine|mesh-list
2158246|NCT01126957|Propofol|propofol|mesh-list
2158247|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2158248|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2158249|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158250|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2158251|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
2158252|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
2158253|NCT01126957|Analgesics|analgesics|mesh-ancestor
2158254|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
2158255|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158256|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2158257|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2612603|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2612604|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612605|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612606|NCT01836016|Fluticasone|fluticasone|mesh-list
2612607|NCT01836016|Xhance|xhance|mesh-list
2612608|NCT01836016|Albuterol|albuterol|mesh-list
2612609|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
2612610|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2612611|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2612612|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2612613|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2612614|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
2612615|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612616|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612617|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2612618|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
2612619|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
2612620|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2612621|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2612622|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2612623|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2612624|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
2612625|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612626|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612627|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
2612628|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2612629|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
2612630|NCT01836016|Hormones|hormones|mesh-ancestor
2612631|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2612632|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
2612633|NCT01836094|Methylene Blue|methylene blue|mesh-list
2612634|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612635|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612636|NCT01836120|Docetaxel|docetaxel|mesh-list
2612637|NCT01836120|Raltitrexed|raltitrexed|mesh-list
2612638|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612639|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
2612640|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
2612641|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
2612642|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612643|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2612644|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
2612645|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2612646|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612647|NCT01836224|Terlipressin|terlipressin|mesh-list
2612648|NCT01836224|Norepinephrine|norepinephrine|mesh-list
2612649|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2612650|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2612651|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2612652|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2612653|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
2158258|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2158259|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158260|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158261|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2158262|NCT01126957|Narcotics|narcotics|mesh-ancestor
2158263|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2158264|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
2158265|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158266|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158267|NCT01122511|Dexamethasone|dexamethasone|mesh-list
2158268|NCT01122511|Ranibizumab|ranibizumab|mesh-list
2158269|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2158270|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
2158271|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
2158272|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158273|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158274|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2158275|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
2158276|NCT01122511|Hormones|hormones|mesh-ancestor
2158277|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2158278|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2158279|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158280|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2158281|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2158282|NCT01122511|Growth Substances|growth substances|mesh-ancestor
2158283|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
2158284|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
2158285|NCT01118013|Methotrexate|methotrexate|mesh-list
2158286|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
2158287|NCT01118013|Fludarabine|fludarabine|mesh-list
2158288|NCT01118013|Busulfan|busulfan|mesh-list
2612654|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612655|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612656|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612657|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
2612658|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
2612659|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612660|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
2612661|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2612662|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
2612663|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612664|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2612665|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2612666|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
2612667|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612668|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612669|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2158289|NCT01118013|Tacrolimus|tacrolimus|mesh-list
2158290|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2158291|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2158292|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
2612670|NCT01836328|Methadone|methadone|mesh-list
2612671|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2612672|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2612673|NCT01836328|Narcotics|narcotics|mesh-ancestor
2612674|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612675|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612676|NCT01836328|Analgesics|analgesics|mesh-ancestor
2612677|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
2612678|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612679|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
2612680|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
2612681|NCT01836341|Carboplatin|carboplatin|mesh-list
2612682|NCT01836341|Pemetrexed|pemetrexed|mesh-list
2612683|NCT01836341|Afatinib|afatinib|mesh-list
2612684|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612685|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158293|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2158294|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158295|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2158296|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
2158297|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612686|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612687|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2158298|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158299|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
2612688|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2612689|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2612690|NCT01836406|Ketorolac|ketorolac|mesh-list
2612691|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2612692|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2612693|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2612694|NCT01836406|Analgesics|analgesics|mesh-ancestor
2612695|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
2612696|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612697|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158300|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158301|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2158302|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2158303|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
2158304|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2158305|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2158306|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2158307|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2158308|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2158309|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
2612698|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2612699|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2612700|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2612701|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612702|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158310|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2158311|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158312|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
2158313|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2158314|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2158315|NCT01122381|Ethosuximide|ethosuximide|mesh-list
2158316|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
2158317|NCT01116232|Sirolimus|sirolimus|mesh-list
2158318|NCT01116232|Rituximab|rituximab|mesh-list
2158319|NCT01116232|Tacrolimus|tacrolimus|mesh-list
2158320|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2158321|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2158322|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158323|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
2158324|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158325|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2158326|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2158327|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2158328|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158329|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158330|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2158331|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158332|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2158333|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
2158334|NCT01108666|Nelfinavir|nelfinavir|mesh-list
2158335|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2158336|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2158337|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
2158338|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158339|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612703|NCT01836432|Leucovorin|leucovorin|mesh-list
2612704|NCT01836432|Gemcitabine|gemcitabine|mesh-list
2158340|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2158341|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2612705|NCT01836432|Paclitaxel|paclitaxel|mesh-list
2612706|NCT01836432|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2612707|NCT01836432|Fluorouracil|fluorouracil|mesh-list
2612708|NCT01836432|Capecitabine|capecitabine|mesh-list
2612709|NCT01836432|Oxaliplatin|oxaliplatin|mesh-list
2612710|NCT01836432|Irinotecan|irinotecan|mesh-list
2612711|NCT01836432|Folfirinox|folfirinox|mesh-list
2612712|NCT01836432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2612713|NCT01836432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612714|NCT01836432|Tubulin Modulators|tubulin modulators|mesh-ancestor
2612715|NCT01836432|Antimitotic Agents|antimitotic agents|mesh-ancestor
2612716|NCT01836432|Mitosis Modulators|mitosis modulators|mesh-ancestor
2612717|NCT01836432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612718|NCT01836432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2612719|NCT01836432|Antimetabolites|antimetabolites|mesh-ancestor
2612720|NCT01836432|Antiviral Agents|antiviral agents|mesh-ancestor
2612721|NCT01836432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612722|NCT01836432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612723|NCT01836432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2612724|NCT01836432|Immunologic Factors|immunologic factors|mesh-ancestor
2612725|NCT01836432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612726|NCT01836432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2612727|NCT01836432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2612728|NCT01836432|Antidotes|antidotes|mesh-ancestor
2612729|NCT01836432|Protective Agents|protective agents|mesh-ancestor
2612730|NCT01836432|Vitamin B Complex|vitamin b complex|mesh-ancestor
2612731|NCT01836432|Vitamins|vitamins|mesh-ancestor
2612732|NCT01836432|Micronutrients|micronutrients|mesh-ancestor
2612733|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2612734|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2612735|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612736|NCT01836536|Bevacizumab|bevacizumab|mesh-list
2612737|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2612738|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612739|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2612740|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2612741|NCT01836536|Growth Substances|growth substances|mesh-ancestor
2612742|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612743|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
2612744|NCT01836575|Carboplatin|carboplatin|mesh-list
2612745|NCT01836575|Pemetrexed|pemetrexed|mesh-list
2612746|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612747|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612748|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612749|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2612750|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2612751|NCT01836614|Lidocaine|lidocaine|mesh-list
2612752|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
2612753|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
2612754|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612755|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612756|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
2612757|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612758|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2612759|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2612760|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2612761|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2612762|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612763|NCT01836653|Bevacizumab|bevacizumab|mesh-list
2612764|NCT01836653|Cetuximab|cetuximab|mesh-list
2612765|NCT01836653|Fluorouracil|fluorouracil|mesh-list
2612766|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
2612767|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2612768|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612769|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2612770|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2612771|NCT01836653|Growth Substances|growth substances|mesh-ancestor
2612772|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612773|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
2612774|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
2158342|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
2158343|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158344|NCT01115244|Dapsone|dapsone|mesh-list
2612775|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612776|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2612777|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2612778|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
2612779|NCT01836679|Paclitaxel|paclitaxel|mesh-list
2612780|NCT01836679|Carboplatin|carboplatin|mesh-list
2612781|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2612782|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612783|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
2612784|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
2158345|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158346|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
2158347|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2158348|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2158349|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2158350|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158351|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158352|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
2158353|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2612785|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
2158354|NCT01106534|Aspirin|aspirin|mesh-list
2158355|NCT01106534|Everolimus|everolimus|mesh-list
2158356|NCT01106534|Clopidogrel|clopidogrel|mesh-list
2158357|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2158358|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2158359|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2158360|NCT01106534|Analgesics|analgesics|mesh-ancestor
2158361|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
2158362|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158363|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158364|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2158365|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2158366|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2158367|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2158368|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158369|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2158370|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2612786|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612787|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
2612788|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2612789|NCT01836900|Hemostatics|hemostatics|mesh-list
2612790|NCT01836900|Coagulants|coagulants|mesh-ancestor
2612791|NCT01837043|Cyclosporine|cyclosporine|mesh-list
2612792|NCT01837043|Abatacept|abatacept|mesh-list
2612793|NCT01837043|Tacrolimus|tacrolimus|mesh-list
2612794|NCT01837043|Cyclosporins|cyclosporins|mesh-list
2612795|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2612796|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2612797|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
2612798|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612799|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612800|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612801|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
2612802|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612803|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
2612804|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2612805|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2612806|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612807|NCT01837108|Eplerenone|eplerenone|mesh-list
2612808|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2612809|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
2612810|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2612811|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612812|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2612813|NCT01837108|Diuretics|diuretics|mesh-ancestor
2612814|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
2612815|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2612816|NCT01837199|Amoxicillin|amoxicillin|mesh-list
2612817|NCT01837199|Metronidazole|metronidazole|mesh-list
2612818|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2612819|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612820|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2612821|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2612822|NCT01837251|Bevacizumab|bevacizumab|mesh-list
2612823|NCT01837251|Carboplatin|carboplatin|mesh-list
2612824|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2612825|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612826|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2612827|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2612828|NCT01837251|Growth Substances|growth substances|mesh-ancestor
2612829|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612830|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
2612831|NCT01837277|Efavirenz|efavirenz|mesh-list
2612832|NCT01837277|Dolutegravir|dolutegravir|mesh-list
2612833|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2612834|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2612835|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158371|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158372|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
2158373|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158374|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2158375|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
2158376|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2158377|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2612836|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612837|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
2158378|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2158379|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
2158380|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158381|NCT01100658|Methylphenidate|methylphenidate|mesh-list
2158382|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2158383|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158384|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2158385|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2158386|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2158387|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158388|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
2612838|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2612839|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2612840|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2612841|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2612842|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2612843|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2612844|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2612845|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2612846|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2612847|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2612848|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2612849|NCT01837290|Midazolam|midazolam|mesh-list
2612850|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
2612851|NCT01837290|Bupivacaine|bupivacaine|mesh-list
2612852|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
2612853|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
2612854|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612855|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612856|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
2612857|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158389|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158390|NCT01103180|Citalopram|citalopram|mesh-list
2158391|NCT01103180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2158392|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2158393|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2612858|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2612859|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2612860|NCT01837290|Analgesics|analgesics|mesh-ancestor
2612861|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2612862|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2612863|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2612864|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
2612865|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612866|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612867|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2612868|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2612869|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2612870|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2612871|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2612872|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
2612873|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
2612874|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
2612875|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2612876|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
2612877|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
2612878|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612879|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612880|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2612881|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2612882|NCT01837329|Growth Substances|growth substances|mesh-ancestor
2612883|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612884|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
2612885|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612886|NCT01837394|Acetaminophen|acetaminophen|mesh-list
2612887|NCT01837394|Morphine|morphine|mesh-list
2612888|NCT01837394|Ondansetron|ondansetron|mesh-list
2612889|NCT01837394|Metoclopramide|metoclopramide|mesh-list
2612890|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2612891|NCT01837394|Narcotics|narcotics|mesh-ancestor
2612892|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612893|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612894|NCT01837394|Analgesics|analgesics|mesh-ancestor
2158394|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158395|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158396|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
2158397|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158398|NCT01103180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2158399|NCT01103180|Antidepressive Agents|antidepressive agents|mesh-ancestor
2158400|NCT01103180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2158401|NCT01090141|Micafungin|micafungin|mesh-list
2158402|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
2158403|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158404|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2158405|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
2158406|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158407|NCT01094561|Secretin|secretin|mesh-list
2158408|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2158409|NCT01094561|Hormones|hormones|mesh-ancestor
2158410|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2158411|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158412|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2158413|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
2158414|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158415|NCT01078844|Memantine|memantine|mesh-list
2158416|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2158417|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2158418|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
2158419|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158420|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158421|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158422|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2158423|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2158424|NCT01085643|Lubiprostone|lubiprostone|mesh-list
2158425|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2158426|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2158427|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158428|NCT01080768|Amlodipine|amlodipine|mesh-list
2158429|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2158430|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2158431|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2158432|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158433|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2158434|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158435|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
2158436|NCT01074502|Apremilast|apremilast|mesh-list
2158437|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2158438|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2158439|NCT01074502|Analgesics|analgesics|mesh-ancestor
2158440|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
2158441|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158442|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158443|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2612895|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
2612896|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612897|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2612898|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
2612899|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
2612900|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
2612901|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2612902|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
2612903|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
2612904|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2612905|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
2612906|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612907|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612908|NCT01837394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2612909|NCT01837394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2612910|NCT01837394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2612911|NCT01837394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2612912|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2612913|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2612914|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
2612915|NCT01837433|Prednisone|prednisone|mesh-list
2612916|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
2612917|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2612918|NCT01837433|Hormones|hormones|mesh-ancestor
2612919|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2612920|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612921|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2612922|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612923|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
2612924|NCT01837446|Promethazine|promethazine|mesh-list
2612925|NCT01837446|Lidocaine|lidocaine|mesh-list
2612926|NCT01837446|Morphine|morphine|mesh-list
2612927|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2158444|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2158445|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2612928|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
2612929|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
2612930|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
2612931|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2612932|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612933|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
2612934|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612935|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2612936|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2612937|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2158446|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2158447|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158448|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158449|NCT01074437|Prednisolone|prednisolone|mesh-list
2158450|NCT01074437|Propranolol|propranolol|mesh-list
2158451|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2158452|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
2158453|NCT01074437|Hormones|hormones|mesh-ancestor
2158454|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2158455|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158456|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2158457|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158458|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2158459|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2158460|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
2158461|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158462|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158463|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2158464|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2158465|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
2158466|NCT01072526|Cyclosporine|cyclosporine|mesh-list
2158467|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
2158468|NCT01072526|Cyclosporins|cyclosporins|mesh-list
2158469|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158470|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158471|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2158472|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
2158473|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158474|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
2158475|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158476|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
2158477|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2158478|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2158479|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2158480|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2158481|NCT01071993|Atorvastatin|atorvastatin|mesh-list
2158482|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2158483|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2612938|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2612939|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612940|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2612941|NCT01837446|Narcotics|narcotics|mesh-ancestor
2612942|NCT01837446|Analgesics|analgesics|mesh-ancestor
2612943|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2612944|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2158484|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
2158485|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158486|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2158487|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2158488|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158489|NCT01065051|Riociguat|riociguat|mesh-list
2158490|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
2158491|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158492|NCT01058642|Pregabalin|pregabalin|mesh-list
2421778|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421779|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2421780|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
2421781|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
2421782|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2421783|NCT00814229|Vaccines|vaccines|mesh-list
2421784|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
2421785|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
2421786|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421787|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2421788|NCT00814268|Aspirin|aspirin|mesh-list
2421789|NCT00814268|Clopidogrel|clopidogrel|mesh-list
2612945|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
2612946|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
2612947|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2612948|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2612949|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
2612950|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
2612951|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612952|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2612953|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
2612954|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
2612955|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2612956|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
2612957|NCT01837446|Antacids|antacids|mesh-ancestor
2612958|NCT01837498|Neostigmine|neostigmine|mesh-list
2612959|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2612960|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612961|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612962|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
2612963|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2612964|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612965|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2612966|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
2612967|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612968|NCT01837576|Calcipotriene|calcipotriene|mesh-list
2612969|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
2612970|NCT01837628|Lidocaine|lidocaine|mesh-list
2612971|NCT01837628|Mineral Oil|mineral oil|mesh-list
2612972|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
2612973|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
2612974|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2158493|NCT01058642|Analgesics|analgesics|mesh-ancestor
2158494|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
2158495|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158496|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158497|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
2158498|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2158499|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2158500|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158501|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2158502|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2158503|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2158504|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2158505|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2158506|NCT01065818|Telbivudine|telbivudine|mesh-list
2158507|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
2158508|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158509|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2158510|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158511|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158512|NCT01051921|Interferons|interferons|mesh-list
2158513|NCT01051921|Ribavirin|ribavirin|mesh-list
2158514|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158515|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
2158516|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158517|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
2158518|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158519|NCT01048125|Nitroprusside|nitroprusside|mesh-list
2158520|NCT01048125|Phenylephrine|phenylephrine|mesh-list
2158521|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
2612975|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2612976|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
2612977|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612978|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2612979|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2612980|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2612981|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2612982|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612983|NCT01837628|Emollients|emollients|mesh-ancestor
2612984|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
2612985|NCT01837667|Docetaxel|docetaxel|mesh-list
2612986|NCT01837667|LB100|lb100|mesh-list
2612987|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2612988|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
2612989|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
2612990|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
2612991|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2612992|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2612993|NCT01837810|Ibuprofen|ibuprofen|mesh-list
2612994|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2612995|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2612996|NCT01837810|Analgesics|analgesics|mesh-ancestor
2612997|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
2612998|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2612999|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613000|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2613001|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2613002|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2613003|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613004|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613005|NCT01837862|Mebendazole|mebendazole|mesh-list
2613006|NCT01837862|Piperazine|piperazine|mesh-list
2613007|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
2613008|NCT01837862|Bevacizumab|bevacizumab|mesh-list
2158522|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2158523|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
2158524|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
2158525|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158526|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158527|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
2158528|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2158529|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
2158530|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
2158531|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2158532|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2421790|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2421791|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2421792|NCT00814268|Analgesics|analgesics|mesh-ancestor
2421793|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
2421794|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421795|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421796|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2421797|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421798|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2421799|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2421800|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613009|NCT01837862|Carboplatin|carboplatin|mesh-list
2613010|NCT01837862|Irinotecan|irinotecan|mesh-list
2613011|NCT01837862|Vincristine|vincristine|mesh-list
2613012|NCT01837862|Temozolomide|temozolomide|mesh-list
2613013|NCT01837862|DMP 777|dmp 777|mesh-list
2613014|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2613015|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613016|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2613017|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2613018|NCT01837862|Growth Substances|growth substances|mesh-ancestor
2613019|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613020|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
2613021|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2613022|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2613023|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613024|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613025|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2613026|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
2613027|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
2613028|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
2613029|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2613030|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
2613031|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
2613032|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
2613033|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2613034|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158533|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2158534|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
2613035|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
2613036|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
2613037|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2613038|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
2613039|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613040|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613041|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2613042|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
2158535|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158536|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158537|NCT01048125|Protective Agents|protective agents|mesh-ancestor
2158538|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2158539|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
2158540|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2158541|NCT01058369|Deferasirox|deferasirox|mesh-list
2158542|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2158543|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
2158544|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
2158545|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158546|NCT01048723|Everolimus|everolimus|mesh-list
2158547|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158548|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2158549|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
2158550|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158551|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
2158552|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2158553|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158554|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2158555|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
2158556|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2613043|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
2613044|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2613045|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
2613046|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613047|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613048|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2613049|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2613050|NCT01837992|Primaquine|primaquine|mesh-list
2613051|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
2613052|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2613053|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2613054|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613055|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
2613056|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2613057|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613058|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
2613059|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2613060|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2613061|NCT01838174|Prednisolone|prednisolone|mesh-list
2613062|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
2613063|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2613064|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
2613065|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2613066|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
2613067|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
2613068|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613069|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613070|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2613071|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
2613072|NCT01838174|Hormones|hormones|mesh-ancestor
2613073|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2613074|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2613075|NCT01838174|Protective Agents|protective agents|mesh-ancestor
2613076|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2613077|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158557|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158558|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158559|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158560|NCT01038752|Suramin|suramin|mesh-list
2158561|NCT01038752|Carboplatin|carboplatin|mesh-list
2613085|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
2613086|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2613087|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
2613088|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613089|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
2613090|NCT01838252|Protective Agents|protective agents|mesh-ancestor
2613091|NCT01838330|Psyllium|psyllium|mesh-list
2613092|NCT01838330|Cathartics|cathartics|mesh-ancestor
2613093|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2613094|NCT01838395|Cytarabine|cytarabine|mesh-list
2613095|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2613096|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
2613097|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613098|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613099|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
2613100|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613101|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2613102|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
2613103|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613104|NCT01838434|Lenalidomide|lenalidomide|mesh-list
2613105|NCT01838434|Idelalisib|idelalisib|mesh-list
2613106|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
2613107|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613108|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2613109|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2613110|NCT01838434|Growth Substances|growth substances|mesh-ancestor
2613111|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
2613112|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613113|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613114|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613115|NCT01838460|Lobeline|lobeline|mesh-list
2613116|NCT01838460|Nicotine|nicotine|mesh-list
2613117|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2613118|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
2158562|NCT01038752|Docetaxel|docetaxel|mesh-list
2158563|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158564|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
2158565|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
2158566|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
2613119|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613120|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613121|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2613122|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2613123|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
2613124|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613125|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613126|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
2613127|NCT01838473|Lobeline|lobeline|mesh-list
2613128|NCT01838473|Nicotine|nicotine|mesh-list
2613129|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2613130|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
2613131|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158567|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158568|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
2158569|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
2158570|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2158571|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158572|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2158573|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2158574|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2158575|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2158576|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2158577|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2158578|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158579|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158580|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158581|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
2158582|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2158583|NCT01045694|Triamcinolone|triamcinolone|mesh-list
2158584|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2613132|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613133|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2613134|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2158585|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2158586|NCT01045694|Lidocaine|lidocaine|mesh-list
2158587|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
2158588|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2158589|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2158590|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2158591|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
2158592|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
2158593|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2158594|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613135|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
2613136|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613137|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613138|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
2613139|NCT01838538|Paclitaxel|paclitaxel|mesh-list
2613140|NCT01838538|Bevacizumab|bevacizumab|mesh-list
2613141|NCT01838538|Carboplatin|carboplatin|mesh-list
2613142|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2613143|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613144|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
2613145|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
2613146|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
2613147|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613148|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2613149|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2613150|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2613151|NCT01838538|Growth Substances|growth substances|mesh-ancestor
2613152|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613153|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
2613154|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2613155|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
2613156|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2613157|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
2613158|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613159|NCT01838707|Fentanyl|fentanyl|mesh-list
2613160|NCT01838707|Morphine|morphine|mesh-list
2613161|NCT01838707|Bupivacaine|bupivacaine|mesh-list
2613162|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
2613163|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
2613164|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613165|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613166|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
2613167|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613168|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2613169|NCT01838707|Narcotics|narcotics|mesh-ancestor
2613170|NCT01838707|Analgesics|analgesics|mesh-ancestor
2613171|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2613172|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2613173|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
2613174|NCT01838772|Interferons|interferons|mesh-list
2613175|NCT01838772|Ribavirin|ribavirin|mesh-list
2613176|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613177|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
2613178|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613179|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
2613180|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613181|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2613182|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2158595|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
2158596|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158597|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2158598|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2158599|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2613183|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2613184|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2613185|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613186|NCT01838902|Primaquine|primaquine|mesh-list
2613187|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
2613188|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2613189|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2613190|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613191|NCT01838928|Bupivacaine|bupivacaine|mesh-list
2613192|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
2613193|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
2613194|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2158600|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2613195|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613196|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
2613197|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613198|NCT01838993|Lidocaine|lidocaine|mesh-list
2613199|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
2613200|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
2613201|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613202|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613203|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
2613204|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613205|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2613206|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2613207|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2613208|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2613209|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613210|NCT01839032|Vinorelbine|vinorelbine|mesh-list
2613211|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613212|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2613213|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
2613214|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
2613215|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
2613216|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613217|NCT01839084|Isoflurane|isoflurane|mesh-list
2613218|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2613219|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
2613220|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
2613221|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613222|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613223|NCT01839097|Prednisone|prednisone|mesh-list
2613224|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
2613225|NCT01839097|Doxorubicin|doxorubicin|mesh-list
2613226|NCT01839097|Vincristine|vincristine|mesh-list
2613227|NCT01839097|Belinostat|belinostat|mesh-list
2613228|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2613229|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
2613230|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613231|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2613232|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2158601|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158602|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2158603|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
2158604|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158605|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2158606|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2158607|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
2158608|NCT01045694|Hormones|hormones|mesh-ancestor
2158609|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2158610|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2158611|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
2158612|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158613|NCT01035944|Chitosan|chitosan|mesh-list
2158614|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2158615|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2158616|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
2158617|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158618|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2158619|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
2158620|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
2158621|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
2158622|NCT01035944|Coagulants|coagulants|mesh-ancestor
2158623|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
2158624|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158625|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2158626|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158627|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158628|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2158629|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2158630|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2158631|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2613233|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
2613234|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613235|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158632|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158633|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158634|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158635|NCT01035073|Analgesics|analgesics|mesh-ancestor
2158636|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
2158637|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158638|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
2158639|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2158640|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
2158641|NCT01031550|Propofol|propofol|mesh-list
2158642|NCT01031550|Isoflurane|isoflurane|mesh-list
2158643|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2158644|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2158645|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158646|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2158647|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
2158648|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
2158649|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2158650|NCT01025271|Daptomycin|daptomycin|mesh-list
2158651|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2158652|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158653|NCT01022398|Vitamin D|vitamin d|mesh-list
2158654|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
2158655|NCT01022398|Vitamins|vitamins|mesh-ancestor
2158656|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
2158657|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158658|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2158659|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2158660|NCT01019980|Acetaminophen|acetaminophen|mesh-list
2158661|NCT01019980|Diclofenac|diclofenac|mesh-list
2158662|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2158663|NCT01019980|Analgesics|analgesics|mesh-ancestor
2158664|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
2158665|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158666|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158667|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
2158668|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2158669|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2158670|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2158671|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2158672|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613236|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2613237|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2613238|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2613239|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2613240|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613241|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2613242|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
2613243|NCT01839097|Hormones|hormones|mesh-ancestor
2613244|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2613245|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2613246|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2613247|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
2613248|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
2613249|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
2613250|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2613251|NCT01839149|Oxytocin|oxytocin|mesh-list
2613252|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
2613253|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2613254|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613255|NCT01839175|Vaccines|vaccines|mesh-list
2613256|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2158673|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158674|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
2158675|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2158676|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2158677|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
2158678|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158679|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2158680|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2158681|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
2158682|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2158683|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158684|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2158685|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2158686|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2158687|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158688|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
2158689|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158690|NCT01020903|Aprepitant|aprepitant|mesh-list
2613257|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
2613258|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613259|NCT01839240|Cytarabine|cytarabine|mesh-list
2613260|NCT01839240|Azacitidine|azacitidine|mesh-list
2613261|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
2613262|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2613263|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
2613264|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613265|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613266|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
2613267|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613268|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2613269|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
2613270|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613271|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158691|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
2158692|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
2158693|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158694|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158695|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2158696|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2158697|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158698|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158699|NCT01023620|Pioglitazone|pioglitazone|mesh-list
2158700|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2158701|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158702|NCT01018810|Interleukin-23|interleukin-23|mesh-list
2158703|NCT01018810|Antibodies|antibodies|mesh-list
2158704|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
2158705|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
2158706|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158707|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2158708|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2158709|NCT01018810|Growth Substances|growth substances|mesh-ancestor
2158710|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
2158711|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158712|NCT01016561|Cisplatin|cisplatin|mesh-list
2158713|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158714|NCT01016847|Montelukast|montelukast|mesh-list
2158715|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2158716|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
2158717|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2158718|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
2158719|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2158720|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158721|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2158722|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2158723|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158724|NCT01014767|Leucovorin|leucovorin|mesh-list
2158725|NCT01014767|Dactinomycin|dactinomycin|mesh-list
2158726|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
2158727|NCT01014767|Temozolomide|temozolomide|mesh-list
2158728|NCT01014767|Cisplatin|cisplatin|mesh-list
2613272|NCT01839240|Analgesics|analgesics|mesh-ancestor
2613273|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
2613274|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613275|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2158729|NCT01014767|Carboplatin|carboplatin|mesh-list
2158730|NCT01014767|Doxorubicin|doxorubicin|mesh-list
2158731|NCT01014767|Methotrexate|methotrexate|mesh-list
2158732|NCT01014767|Irinotecan|irinotecan|mesh-list
2158733|NCT01014767|Etoposide|etoposide|mesh-list
2158734|NCT01014767|Vincristine|vincristine|mesh-list
2158735|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2158736|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
2158737|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158738|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2158739|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2158740|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
2613276|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2158741|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158742|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613277|NCT01839253|Atenolol|atenolol|mesh-list
2158743|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2158744|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2158745|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2158746|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2158747|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613278|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2613279|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2613280|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2613281|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
2613282|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
2613283|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613284|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613285|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2613286|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2613287|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2613288|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
2613289|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158748|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2158749|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
2158750|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2158751|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2158752|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
2613290|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613291|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
2613292|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613293|NCT01839344|Acarbose|acarbose|mesh-list
2613294|NCT01839344|Quercetin|quercetin|mesh-list
2613295|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2613296|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613297|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613298|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2613299|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613300|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
2158753|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
2158754|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2158755|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2158756|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2158757|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2158758|NCT01014767|Antidotes|antidotes|mesh-ancestor
2158759|NCT01014767|Protective Agents|protective agents|mesh-ancestor
2158760|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
2158761|NCT01014767|Vitamins|vitamins|mesh-ancestor
2158762|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
2158763|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
2158764|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
2158765|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
2158766|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2158767|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158768|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2158769|NCT01013701|Fluticasone|fluticasone|mesh-list
2158770|NCT01013701|Xhance|xhance|mesh-list
2158771|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2158772|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2158773|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
2158774|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158775|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421801|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2421802|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2421803|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421804|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
2421805|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2421806|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2421807|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2421808|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
2421809|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2421810|NCT00814281|Montelukast|montelukast|mesh-list
2421811|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2421812|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
2421813|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2421814|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
2421815|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421816|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421817|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2158776|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2613301|NCT01839344|Protective Agents|protective agents|mesh-ancestor
2613302|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
2613303|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2613304|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
2613305|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2613306|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
2613307|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613308|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613309|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
2613310|NCT01839370|Pramlintide|pramlintide|mesh-list
2613311|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2613312|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613313|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
2613314|NCT01839383|Calcium|calcium|mesh-list
2158777|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
2158778|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
2158779|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2158780|NCT01009931|Dexamethasone|dexamethasone|mesh-list
2158781|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
2158782|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
2158783|NCT01009931|Choline|choline|mesh-list
2158784|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2158785|NCT01009931|BB 1101|bb 1101|mesh-list
2158786|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2158787|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
2158788|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
2158789|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158790|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158791|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2158792|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
2158793|NCT01009931|Hormones|hormones|mesh-ancestor
2158794|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2158795|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2158796|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158797|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
2158798|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158799|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158800|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
2158801|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2613315|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2613316|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613317|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2613318|NCT01839500|Trastuzumab|trastuzumab|mesh-list
2613319|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2613320|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613321|NCT01839552|Fentanyl|fentanyl|mesh-list
2613322|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2613323|NCT01839552|Narcotics|narcotics|mesh-ancestor
2613324|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613325|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613326|NCT01839552|Analgesics|analgesics|mesh-ancestor
2613327|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
2613328|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613329|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2613330|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2613331|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
2613332|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
2613333|NCT01839578|Heparin|heparin|mesh-list
2613334|NCT01839578|Calcium heparin|calcium heparin|mesh-list
2613335|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
2613336|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613337|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2613338|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2613339|NCT01839630|Sorafenib|sorafenib|mesh-list
2613340|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613341|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2613342|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613343|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613344|NCT01839643|Meloxicam|meloxicam|mesh-list
2613345|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2613346|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2613347|NCT01839643|Analgesics|analgesics|mesh-ancestor
2613348|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
2613349|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158802|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
2613350|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613351|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2613352|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2613353|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2158803|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2158804|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
2158805|NCT01009931|Analgesics|analgesics|mesh-ancestor
2158806|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
2158807|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2158808|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2158809|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2158810|NCT01006018|Pioglitazone|pioglitazone|mesh-list
2158811|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2158812|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2158813|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158814|NCT01006018|Incretins|incretins|mesh-ancestor
2158815|NCT01006018|Hormones|hormones|mesh-ancestor
2158816|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2158817|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2158818|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
2158819|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158820|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158821|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
2158822|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2613354|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2613355|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613356|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613357|NCT01839734|Lubiprostone|lubiprostone|mesh-list
2613358|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2613359|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2613360|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613361|NCT01839773|Paclitaxel|paclitaxel|mesh-list
2613362|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2613363|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2613364|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613365|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
2613366|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
2613367|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
2613368|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613369|NCT01839812|Cosyntropin|cosyntropin|mesh-list
2613370|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2613371|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2613372|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
2158823|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613373|NCT01839812|Hormones|hormones|mesh-ancestor
2613374|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2613375|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613376|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613377|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613378|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
2613379|NCT01839851|Hormones|hormones|mesh-ancestor
2613380|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2613381|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613382|NCT01839890|Paclitaxel|paclitaxel|mesh-list
2613383|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2613384|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613385|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
2613386|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
2613387|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
2613388|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613389|NCT01839929|Tacrolimus|tacrolimus|mesh-list
2613390|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2613391|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
2613392|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613393|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2613394|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613395|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613396|NCT01839955|Quinacrine|quinacrine|mesh-list
2613397|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2613398|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613399|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2613400|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613401|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613402|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
2158824|NCT01005914|Cytarabine|cytarabine|mesh-list
2158825|NCT01005914|Dexamethasone|dexamethasone|mesh-list
2158826|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
2158827|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2158828|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2158829|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
2158830|NCT01005914|Doxorubicin|doxorubicin|mesh-list
2158831|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2158832|NCT01005914|Methotrexate|methotrexate|mesh-list
2158833|NCT01005914|Vincristine|vincristine|mesh-list
2158834|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
2613403|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2613404|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
2613405|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2613406|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613407|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
2613408|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2613409|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
2613410|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2613411|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2613412|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
2613413|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
2613414|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613415|NCT01839981|Protective Agents|protective agents|mesh-ancestor
2613416|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613417|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
2613418|NCT01839981|Vitamins|vitamins|mesh-ancestor
2613419|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
2613420|NCT01839994|Androgens|androgens|mesh-list
2613421|NCT01839994|Hormones|hormones|mesh-ancestor
2613422|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2613423|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613424|NCT01840007|Metformin|metformin|mesh-list
2613425|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2613426|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613427|NCT01840046|Interleukin-2|interleukin-2|mesh-list
2613428|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613429|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2613430|NCT01840046|Analgesics|analgesics|mesh-ancestor
2613431|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
2613432|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613433|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613434|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
2613435|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2613436|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2613437|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2613438|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2613439|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
2613440|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2613441|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613442|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613443|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2613444|NCT01840254|Analgesics|analgesics|mesh-ancestor
2613445|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
2613446|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613447|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2613448|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2613449|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2613450|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
2613451|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613452|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613453|NCT01840384|Micronutrients|micronutrients|mesh-list
2613454|NCT01840384|Trace Elements|trace elements|mesh-list
2613455|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613456|NCT01840423|Levodopa|levodopa|mesh-list
2613457|NCT01840423|Carbidopa|carbidopa|mesh-list
2613458|NCT01840423|Entacapone|entacapone|mesh-list
2613459|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2613460|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2613461|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
2613462|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613463|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158835|NCT01005914|Asparaginase|asparaginase|mesh-list
2158836|NCT01005914|Pegaspargase|pegaspargase|mesh-list
2158837|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2613464|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613465|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2613466|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613467|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2613468|NCT01840449|Lanreotide|lanreotide|mesh-list
2613469|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613470|NCT01840566|Cytarabine|cytarabine|mesh-list
2613471|NCT01840566|Etoposide|etoposide|mesh-list
2613472|NCT01840566|Melphalan|melphalan|mesh-list
2613473|NCT01840566|Carmustine|carmustine|mesh-list
2613474|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2613475|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613476|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2613477|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2613478|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613479|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613480|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2613481|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
2613482|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
2613483|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613484|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2613485|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
2613486|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613487|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2613488|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
2613489|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2613490|NCT01840592|Doxorubicin|doxorubicin|mesh-list
2613491|NCT01840592|Sorafenib|sorafenib|mesh-list
2613492|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2613493|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613494|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2613495|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2613496|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613497|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613498|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2613499|NCT01840683|Heparin|heparin|mesh-list
2613500|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
2613501|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2613502|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2613503|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613504|NCT01840696|Regadenoson|regadenoson|mesh-list
2613505|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2613506|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2613507|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
2613508|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
2613509|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613510|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613511|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613512|NCT01840774|Ketamine|ketamine|mesh-list
2613513|NCT01840774|Analgesics|analgesics|mesh-list
2613514|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
2613515|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613516|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613517|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2613518|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2613519|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
2613520|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
2613521|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613522|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2613523|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2613524|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613525|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613526|NCT01840800|Ropivacaine|ropivacaine|mesh-list
2613527|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
2613528|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
2613529|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613530|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613531|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
2613532|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613533|NCT01840813|Misoprostol|misoprostol|mesh-list
2613534|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2613535|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
2613536|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2613537|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613538|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2613539|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2613540|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
2613541|NCT01841008|Tacrolimus|tacrolimus|mesh-list
2613542|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2613543|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
2613544|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613545|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2613546|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613547|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613548|NCT01841099|Mesalamine|mesalamine|mesh-list
2613549|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2613550|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2613551|NCT01841099|Analgesics|analgesics|mesh-ancestor
2613552|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
2613553|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613554|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613555|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2613556|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2613557|NCT01841112|BI 409306|bi 409306|mesh-list
2613558|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2613559|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158838|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
2158839|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158840|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2158841|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2158842|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
2613560|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613561|NCT01841125|Citalopram|citalopram|mesh-list
2613562|NCT01841125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2613563|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2613564|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2613565|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613566|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613567|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
2613568|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613569|NCT01841125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2613570|NCT01841125|Antidepressive Agents|antidepressive agents|mesh-ancestor
2613571|NCT01841125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2613572|NCT01841164|Montelukast|montelukast|mesh-list
2613573|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2613574|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
2613575|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2613576|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
2613577|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2613578|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613579|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2613580|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2613581|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158843|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158844|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158845|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2158846|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2158847|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
2158848|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
2158849|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158850|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2158851|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
2158852|NCT01005914|Hormones|hormones|mesh-ancestor
2158853|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2158854|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2158855|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2158856|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2158857|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2158858|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158859|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2158860|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
2158861|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2158862|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2158863|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
2158864|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
2158865|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2158866|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2158867|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
2158868|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158869|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2158870|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
2158871|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
2158872|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
2158873|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2158874|NCT01005914|Protective Agents|protective agents|mesh-ancestor
2613592|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
2613593|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
2613594|NCT01841242|Povidone|povidone|mesh-list
2613595|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2613596|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613597|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
2613598|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
2613599|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
2613600|NCT01841294|Lidocaine|lidocaine|mesh-list
2613601|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
2613602|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
2613603|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613604|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613605|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
2613606|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613607|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2613608|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2613609|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2613610|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2613611|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613612|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
2613613|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
2613614|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
2613615|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613616|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2613617|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2613618|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
2613619|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2613620|NCT01841320|Methadone|methadone|mesh-list
2613621|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2613622|NCT01841320|Narcotics|narcotics|mesh-ancestor
2613623|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613624|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613625|NCT01841320|Analgesics|analgesics|mesh-ancestor
2613626|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
2613627|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613628|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
2613629|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
2613630|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
2613631|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613632|NCT01841359|Pramlintide|pramlintide|mesh-list
2613633|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2613634|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613635|NCT01841411|Metronidazole|metronidazole|mesh-list
2613636|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
2613637|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2613638|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613639|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2613640|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2613641|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2613642|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
2613643|NCT01841411|Expectorants|expectorants|mesh-ancestor
2613644|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
2613645|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2613646|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
2613647|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613648|NCT01841411|Protective Agents|protective agents|mesh-ancestor
2613649|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613650|NCT01841411|Antidotes|antidotes|mesh-ancestor
2613651|NCT01841424|Benzocaine|benzocaine|mesh-list
2613652|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
2613653|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
2613654|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613655|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613656|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
2613657|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613658|NCT01841463|Vemurafenib|vemurafenib|mesh-list
2613659|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613660|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2613661|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613662|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613663|NCT01841502|Paroxetine|paroxetine|mesh-list
2613664|NCT01841502|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2613665|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2613666|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2613667|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613668|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613669|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
2613670|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613671|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2613672|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
2613673|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2613674|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2613675|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2613676|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613677|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2613678|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
2613679|NCT01841515|Coagulants|coagulants|mesh-ancestor
2613680|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2613681|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
2613682|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613683|NCT01841658|Folic Acid|folic acid|mesh-list
2613684|NCT01841658|Hematinics|hematinics|mesh-ancestor
2613685|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
2613686|NCT01841658|Vitamins|vitamins|mesh-ancestor
2613687|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
2613688|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613689|NCT01841684|Anacetrapib|anacetrapib|mesh-list
2613690|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2613691|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2613692|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
2613693|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613694|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2613695|NCT01841775|Interferons|interferons|mesh-list
2613696|NCT01841775|Ribavirin|ribavirin|mesh-list
2613697|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613698|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
2158875|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2158876|NCT00996333|Gemcitabine|gemcitabine|mesh-list
2158877|NCT00996333|Capecitabine|capecitabine|mesh-list
2158878|NCT00996333|Docetaxel|docetaxel|mesh-list
2158879|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2613699|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613700|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
2613701|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613702|NCT01841827|Cilostazol|cilostazol|mesh-list
2613703|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2613704|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
2613705|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613706|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613707|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2613708|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
2158880|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
2158881|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158882|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158883|NCT00996333|Antiviral Agents|antiviral agents|mesh-ancestor
2158884|NCT00996333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2158885|NCT00996333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158886|NCT00996333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2158887|NCT00996333|Immunologic Factors|immunologic factors|mesh-ancestor
2158888|NCT00996333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158889|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
2158890|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
2158891|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
2158892|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
2158893|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
2158894|NCT00998738|Calcium|calcium|mesh-list
2158895|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2158896|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158897|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2158898|NCT00998738|Analgesics|analgesics|mesh-ancestor
2158899|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
2158900|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158901|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
2158902|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2158903|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2158904|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
2158905|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2158906|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2613709|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2613710|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2613711|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613712|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2613713|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
2613714|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2613715|NCT01841827|Protective Agents|protective agents|mesh-ancestor
2613716|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2613717|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2158907|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158908|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
2158909|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2158910|NCT00996502|Prednisone|prednisone|mesh-list
2613718|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613719|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2613720|NCT01842035|Regadenoson|regadenoson|mesh-list
2613721|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2613722|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2613723|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
2613724|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
2613725|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613726|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613727|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613728|NCT01842074|Bortezomib|bortezomib|mesh-list
2613729|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613730|NCT01842087|Iproplatin|iproplatin|mesh-list
2613731|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613732|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2613733|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613734|NCT01842113|Rifaximin|rifaximin|mesh-list
2613735|NCT01842113|Lactulose|lactulose|mesh-list
2613736|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2613737|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613738|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2613739|NCT01842139|Poly I-C|poly i-c|mesh-list
2613740|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2613741|NCT01842139|Poly ICLC|poly iclc|mesh-list
2613742|NCT01842139|Basiliximab|basiliximab|mesh-list
2613743|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
2613744|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
2613745|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613746|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2613747|NCT01842139|Laxatives|laxatives|mesh-ancestor
2613748|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2613749|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
2613750|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613751|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2613752|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2158911|NCT00996502|Bevacizumab|bevacizumab|mesh-list
2158912|NCT00996502|Docetaxel|docetaxel|mesh-list
2158913|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2158914|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2158915|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158916|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2613753|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613754|NCT01842230|Niacin|niacin|mesh-list
2613755|NCT01842230|Amlodipine|amlodipine|mesh-list
2613756|NCT01842230|Telmisartan|telmisartan|mesh-list
2613757|NCT01842230|Atorvastatin|atorvastatin|mesh-list
2613758|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2613759|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2613760|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
2613761|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613762|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2613763|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2613764|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613765|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2613766|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2613767|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2613768|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2613769|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613770|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
2613771|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2613772|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2613773|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
2613774|NCT01842230|Vitamins|vitamins|mesh-ancestor
2613775|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
2613776|NCT01842256|Amlodipine|amlodipine|mesh-list
2613777|NCT01842256|Telmisartan|telmisartan|mesh-list
2613778|NCT01842256|Atorvastatin|atorvastatin|mesh-list
2613779|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2613780|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2613781|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
2613782|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421818|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2421819|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421820|NCT00814294|Insulin|insulin|mesh-list
2421821|NCT00814294|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2421822|NCT00814294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2421823|NCT00814294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421824|NCT00814359|Benzydamine|benzydamine|mesh-list
2421825|NCT00814359|Sucralfate|sucralfate|mesh-list
2421826|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2421827|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2421828|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2421829|NCT00814372|Metformin|metformin|mesh-list
2421830|NCT00814372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2421831|NCT00814372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421832|NCT00814515|Cyclosporine|cyclosporine|mesh-list
2421833|NCT00814515|Cyclosporins|cyclosporins|mesh-list
2421834|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421835|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421836|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2421837|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
2421838|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421839|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
2421840|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421841|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
2421842|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421843|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2158917|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2158918|NCT00996502|Growth Substances|growth substances|mesh-ancestor
2158919|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158920|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
2158921|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
2158922|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
2158923|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
2158924|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158925|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2158926|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
2158927|NCT00996502|Hormones|hormones|mesh-ancestor
2158928|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2158929|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2158930|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2158931|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158932|NCT00997386|Melphalan|melphalan|mesh-list
2158933|NCT00997386|Busulfan|busulfan|mesh-list
2158934|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
2158935|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2158936|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
2158937|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158938|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613783|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2613784|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2613785|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613786|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2613787|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2613788|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2421844|NCT00814528|Imiquimod|imiquimod|mesh-list
2613789|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2613790|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613791|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
2613792|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2613793|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2613794|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
2613795|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2613796|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613797|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2613798|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
2613799|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2158939|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2158940|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2158941|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
2158942|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158943|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2158944|NCT00985738|Dutasteride|dutasteride|mesh-list
2158945|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2613800|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613801|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613802|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158946|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2158947|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158948|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613805|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
2613806|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613807|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2613808|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613809|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613810|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
2613811|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2613812|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613813|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2613814|NCT01842373|Lidocaine|lidocaine|mesh-list
2613815|NCT01842373|Tetracaine|tetracaine|mesh-list
2613816|NCT01842373|Benzocaine|benzocaine|mesh-list
2158949|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
2158950|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2158951|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158952|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2158953|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2158954|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2158955|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
2158956|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158957|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2158958|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2158959|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158960|NCT00989937|Oxytocin|oxytocin|mesh-list
2158961|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
2158962|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2158963|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613817|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
2613818|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
2613819|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613820|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613821|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
2613822|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613823|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2613824|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2613825|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2613826|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2613827|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158964|NCT00986947|Rituximab|rituximab|mesh-list
2158965|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2158966|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2158967|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
2158968|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158969|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2158970|NCT00982995|Palonosetron|palonosetron|mesh-list
2158971|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
2158972|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
2158973|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2158974|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158975|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2158976|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2158977|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2158978|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
2158979|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2158980|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158981|NCT00984490|Metformin|metformin|mesh-list
2158982|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2158983|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158984|NCT00986310|Fluoxetine|fluoxetine|mesh-list
2158985|NCT00986310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2158986|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2158987|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2158988|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2158989|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613841|NCT01842516|Delpazolid|delpazolid|mesh-list
2613842|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
2613843|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2613844|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613845|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2613846|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613847|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613848|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
2613849|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2613850|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2158990|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
2158991|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2158992|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2158993|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
2158994|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2158995|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2158996|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2158997|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2158998|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2158999|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2159000|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159001|NCT00983645|Cyclosporine|cyclosporine|mesh-list
2159002|NCT00983645|Tacrolimus|tacrolimus|mesh-list
2159003|NCT00983645|Cyclosporins|cyclosporins|mesh-list
2159004|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159005|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
2159006|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159007|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2159008|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159009|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159010|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
2159011|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159012|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
2159013|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2159014|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2159015|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2159016|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2159017|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
2159018|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159019|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2613851|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613852|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
2613853|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613854|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613855|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
2613856|NCT01842672|Clofarabine|clofarabine|mesh-list
2613857|NCT01842672|Analgesics|analgesics|mesh-ancestor
2613858|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
2613859|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613860|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159020|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2159021|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159022|NCT00979550|Imiquimod|imiquimod|mesh-list
2159023|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2159024|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
2159025|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159026|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159027|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
2159028|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
2159029|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2159030|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159031|NCT00981370|Deferasirox|deferasirox|mesh-list
2159032|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2159033|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
2159034|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
2159035|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159036|NCT00975611|Amantadine|amantadine|mesh-list
2159037|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2159038|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2159039|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
2159040|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159041|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
2159042|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159043|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159044|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159045|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2159046|NCT00975611|Analgesics|analgesics|mesh-ancestor
2159047|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
2159048|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159049|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2159050|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2159051|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2159052|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
2159053|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159054|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2159055|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2159056|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159057|NCT00979810|Alovudine|alovudine|mesh-list
2159058|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
2159059|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613861|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613862|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2613863|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2613864|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613865|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613866|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2613867|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
2613868|NCT01842893|Fentanyl|fentanyl|mesh-list
2613869|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2613870|NCT01842893|Narcotics|narcotics|mesh-ancestor
2613871|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2159060|NCT00974922|Vitamin D|vitamin d|mesh-list
2159061|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
2159062|NCT00974922|Vitamins|vitamins|mesh-ancestor
2159063|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
2159064|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159065|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2159066|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2159067|NCT00976339|Vitamin D|vitamin d|mesh-list
2159068|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
2159069|NCT00976339|Vitamins|vitamins|mesh-ancestor
2159070|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
2613872|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613873|NCT01842893|Analgesics|analgesics|mesh-ancestor
2613874|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
2613875|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613876|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2613877|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2613878|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
2613879|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
2613880|NCT01842932|Bromides|bromides|mesh-list
2613881|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2613882|NCT01842932|Cimetropium|cimetropium|mesh-list
2613883|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
2613884|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
2613885|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2613886|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613887|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613888|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
2613889|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
2613890|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613891|NCT01843010|Parecoxib|parecoxib|mesh-list
2613892|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2613893|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2613894|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613895|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613896|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2613897|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2613898|NCT01843010|Analgesics|analgesics|mesh-ancestor
2613899|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
2613900|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613901|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613902|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2613903|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2613904|NCT01843075|Liraglutide|liraglutide|mesh-list
2613905|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2613906|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613907|NCT01843075|Incretins|incretins|mesh-ancestor
2613908|NCT01843075|Hormones|hormones|mesh-ancestor
2613909|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2613910|NCT01843088|Mannitol|mannitol|mesh-list
2613911|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2613912|NCT01843088|Diuretics|diuretics|mesh-ancestor
2613913|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
2613914|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613915|NCT01843127|Exenatide|exenatide|mesh-list
2613916|NCT01843127|Ranolazine|ranolazine|mesh-list
2613917|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2613918|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613919|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2613920|NCT01843127|Incretins|incretins|mesh-ancestor
2613921|NCT01843127|Hormones|hormones|mesh-ancestor
2613922|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2613923|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2613924|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2613925|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613926|NCT01843153|Ropivacaine|ropivacaine|mesh-list
2613927|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
2613928|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
2613929|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613930|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613931|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
2613932|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613933|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2613934|NCT01843166|Estrogens|estrogens|mesh-ancestor
2613935|NCT01843166|Hormones|hormones|mesh-ancestor
2613936|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2613937|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613938|NCT01843179|Cytarabine|cytarabine|mesh-list
2613939|NCT01843179|Sulindac|sulindac|mesh-list
2613940|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2613941|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
2613942|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613943|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2613944|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
2613945|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613946|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2613947|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
2613948|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613949|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2613950|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2613951|NCT01843179|Analgesics|analgesics|mesh-ancestor
2613952|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
2159071|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159072|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2159073|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2159074|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2159075|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2159076|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
2159077|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159078|NCT00957827|Cephalexin|cephalexin|mesh-list
2159079|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2159080|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159081|NCT00953329|Alefacept|alefacept|mesh-list
2159082|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
2159083|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
2159084|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159085|NCT00965055|Atorvastatin|atorvastatin|mesh-list
2159086|NCT00965055|Ezetimibe|ezetimibe|mesh-list
2159087|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2159088|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2159089|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
2159090|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159091|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2159092|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2159093|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159094|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
2159095|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
2159096|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159097|NCT00962429|Protective Agents|protective agents|mesh-ancestor
2159098|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159099|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
2159100|NCT00962429|Vitamins|vitamins|mesh-ancestor
2159101|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
2159102|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2159103|NCT00966654|Incretins|incretins|mesh-ancestor
2159104|NCT00966654|Hormones|hormones|mesh-ancestor
2159105|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159106|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613953|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613954|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2613955|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2613956|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2613957|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2613958|NCT01843257|Ethanol|ethanol|mesh-list
2613959|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2613960|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2613961|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613962|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613963|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
2159122|NCT00954187|Pregabalin|pregabalin|mesh-list
2159123|NCT00954187|Gabapentin|gabapentin|mesh-list
2159124|NCT00954187|Analgesics|analgesics|mesh-ancestor
2159125|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
2159126|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159127|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159128|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
2159129|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2159130|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2159131|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159132|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2159133|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2159134|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2159135|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2159136|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2159137|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2159138|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2159139|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159140|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
2159141|NCT00953615|Thalidomide|thalidomide|mesh-list
2159142|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159143|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
2159144|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159145|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
2159146|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2159147|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159148|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2159149|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2159150|NCT00953615|Growth Substances|growth substances|mesh-ancestor
2159151|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
2159152|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159153|NCT00947284|Nalbuphine|nalbuphine|mesh-list
2159154|NCT00947284|Naloxone|naloxone|mesh-list
2159155|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2159156|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159157|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
2159158|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159159|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2159160|NCT00947284|Narcotics|narcotics|mesh-ancestor
2159161|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2159162|NCT00947284|Analgesics|analgesics|mesh-ancestor
2159163|NCT00957034|Testosterone|testosterone|mesh-list
2159164|NCT00957034|Androgens|androgens|mesh-ancestor
2159165|NCT00957034|Hormones|hormones|mesh-ancestor
2613964|NCT01843296|Fentanyl|fentanyl|mesh-list
2613965|NCT01843296|Bupivacaine|bupivacaine|mesh-list
2613966|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
2613967|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
2613968|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2613969|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613970|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
2613971|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2613972|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2613973|NCT01843296|Narcotics|narcotics|mesh-ancestor
2613974|NCT01843296|Analgesics|analgesics|mesh-ancestor
2613975|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2613976|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2613977|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
2613978|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2613979|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
2613980|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2613981|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2613982|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2613983|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2613984|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
2613985|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2613986|NCT01843309|Spironolactone|spironolactone|mesh-list
2613987|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2613988|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
2159166|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159167|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159168|NCT00949988|Rituximab|rituximab|mesh-list
2159169|NCT00949988|Dasatinib|dasatinib|mesh-list
2159170|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2159171|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159172|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
2159173|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613989|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2613990|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613991|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2613992|NCT01843309|Diuretics|diuretics|mesh-ancestor
2613993|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
2613994|NCT01843439|Pyridoxine|pyridoxine|mesh-list
2613995|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
2613996|NCT01843439|Vitamins|vitamins|mesh-ancestor
2613997|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
2613998|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2613999|NCT01843452|Capecitabine|capecitabine|mesh-list
2159174|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2614000|NCT01843452|Mitomycins|mitomycins|mesh-list
2614001|NCT01843452|Mitomycin|mitomycin|mesh-list
2614002|NCT01843452|Panitumumab|panitumumab|mesh-list
2614003|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2614004|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
2614005|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614006|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614007|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2614008|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
2614009|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2614010|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614011|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2614012|NCT01843530|Cortisone|cortisone|mesh-list
2614013|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2614014|NCT01843556|Donepezil|donepezil|mesh-list
2614015|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2614016|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614017|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614018|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
2614019|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614020|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614021|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
2614022|NCT01843647|Cisplatin|cisplatin|mesh-list
2614023|NCT01843647|Vinorelbine|vinorelbine|mesh-list
2614024|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614025|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2614026|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
2614027|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
2614028|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
2614029|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614030|NCT01843699|Topiramate|topiramate|mesh-list
2614031|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
2614032|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2614033|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614034|NCT01843725|Capecitabine|capecitabine|mesh-list
2614035|NCT01843725|Aflibercept|aflibercept|mesh-list
2614036|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2614037|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
2614038|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614039|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614040|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2614041|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2614042|NCT01843725|Growth Substances|growth substances|mesh-ancestor
2614043|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614044|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
2614045|NCT01843738|Vemurafenib|vemurafenib|mesh-list
2614046|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614047|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2614048|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614049|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614050|NCT01843829|Paclitaxel|paclitaxel|mesh-list
2614051|NCT01843829|Carboplatin|carboplatin|mesh-list
2614052|NCT01843829|Capecitabine|capecitabine|mesh-list
2159175|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2159176|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159177|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159178|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
2159179|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2159180|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
2159181|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159182|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159183|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2159184|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
2159185|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2159186|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
2614053|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
2614054|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2614055|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614056|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
2614057|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
2614058|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
2614059|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614060|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2614061|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
2614062|NCT01843868|Prednisolone|prednisolone|mesh-list
2614063|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
2614064|NCT01843868|Doxorubicin|doxorubicin|mesh-list
2159187|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159188|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159189|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2159190|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
2614065|NCT01843868|Vincristine|vincristine|mesh-list
2614066|NCT01843868|Lorazepam|lorazepam|mesh-list
2614067|NCT01843868|Ondansetron|ondansetron|mesh-list
2614068|NCT01843868|Aprepitant|aprepitant|mesh-list
2614069|NCT01843868|Palonosetron|palonosetron|mesh-list
2614070|NCT01843868|Metoclopramide|metoclopramide|mesh-list
2614071|NCT01843868|Granisetron|granisetron|mesh-list
2614072|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
2614073|NCT01843868|Tropisetron|tropisetron|mesh-list
2614074|NCT01843868|Antiemetics|antiemetics|mesh-list
2614075|NCT01843868|Emetics|emetics|mesh-list
2614076|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2614077|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
2614078|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614079|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2614080|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2614081|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
2614082|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614083|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614084|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2614085|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2614086|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2614087|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2614088|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614089|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2614090|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
2614091|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
2614092|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
2614093|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2614094|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
2614095|NCT01843868|Hormones|hormones|mesh-ancestor
2614096|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2614097|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2614098|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
2614099|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614100|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2614101|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
2614102|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
2614103|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2614104|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
2614105|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614106|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2614107|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2614108|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2614109|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2614110|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2614111|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2159191|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
2159192|NCT00948194|Protective Agents|protective agents|mesh-ancestor
2159193|NCT00946985|Risperidone|risperidone|mesh-list
2159194|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2159195|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2159196|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
2159197|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159198|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159199|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159200|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2159201|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2159202|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2159203|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2159204|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2159205|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
2159206|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2159207|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2159208|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2159209|NCT00950690|Latanoprost|latanoprost|mesh-list
2159210|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2159211|NCT00941928|Vidarabine|vidarabine|mesh-list
2159212|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
2614112|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2614113|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2614114|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2614115|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
2159213|NCT00941928|Fludarabine|fludarabine|mesh-list
2159214|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
2159215|NCT00941928|Interleukin-2|interleukin-2|mesh-list
2159216|NCT00941928|Epratuzumab|epratuzumab|mesh-list
2159217|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159218|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
2159219|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159220|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2159221|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2159222|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
2159223|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159224|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159225|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2159226|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2159227|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
2159228|NCT00941928|Antiviral Agents|antiviral agents|mesh-ancestor
2159229|NCT00941928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159230|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2159231|NCT00941928|Analgesics|analgesics|mesh-ancestor
2159232|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
2159233|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159234|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2159235|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
2159236|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159237|NCT00947791|Midazolam|midazolam|mesh-list
2614116|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
2614117|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2614118|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
2159238|NCT00947791|Ketamine|ketamine|mesh-list
2159239|NCT00947791|Analgesics|analgesics|mesh-ancestor
2159240|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
2159241|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159242|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159243|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2159244|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2159245|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
2159246|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
2159247|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2159248|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2159249|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2159250|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159251|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614119|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
2614120|NCT01843998|Sirolimus|sirolimus|mesh-list
2614121|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2614122|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614123|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2614124|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614125|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
2614126|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2614127|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
2614128|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614129|NCT01844024|Misoprostol|misoprostol|mesh-list
2159252|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2159253|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2159254|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2159255|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2614130|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2614131|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
2614132|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2614133|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614134|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2614135|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2614136|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
2614137|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
2614138|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614139|NCT01844141|Ethanol|ethanol|mesh-list
2614140|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
2614141|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2614142|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2614143|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614144|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2614145|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614146|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
2614147|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
2614148|NCT01844323|Palbociclib|palbociclib|mesh-list
2614149|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159256|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2159257|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
2159258|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
2159259|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2159260|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2159261|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159262|NCT00947011|Incretins|incretins|mesh-ancestor
2159263|NCT00947011|Hormones|hormones|mesh-ancestor
2159264|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159265|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2159266|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
2159267|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614150|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2614151|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614152|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159268|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159269|NCT00936598|Zolpidem|zolpidem|mesh-list
2614153|NCT01844401|Albuterol|albuterol|mesh-list
2614154|NCT01844401|Procaterol|procaterol|mesh-list
2614155|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2614156|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
2614157|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614158|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614159|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2614160|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
2614161|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
2614162|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2614163|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2614164|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2614165|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2614166|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
2614167|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614168|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614169|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
2614170|NCT01844427|Memantine|memantine|mesh-list
2614171|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2614172|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2614173|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
2614174|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614175|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614176|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159270|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2159271|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2159272|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2159273|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159274|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2159275|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
2159276|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
2159277|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159278|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159279|NCT00920309|Sirolimus|sirolimus|mesh-list
2159280|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2159281|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159282|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2159283|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159284|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
2159285|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159286|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
2159287|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159288|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
2159289|NCT00934791|Sirolimus|sirolimus|mesh-list
2614177|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2614178|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2614179|NCT01844622|Domperidone|domperidone|mesh-list
2614180|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
2614181|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
2614182|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614183|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614184|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2614185|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2614186|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
2614187|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159290|NCT00934791|Prednisone|prednisone|mesh-list
2159291|NCT00934791|Tacrolimus|tacrolimus|mesh-list
2614188|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614189|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
2614190|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
2614191|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614192|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2614193|NCT01844648|Tropicamide|tropicamide|mesh-list
2614194|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
2614195|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
2614196|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614197|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614198|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2614199|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2159292|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2159293|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
2159294|NCT00934791|Hormones|hormones|mesh-ancestor
2159295|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159296|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159297|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2159298|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159299|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159300|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
2159301|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2159302|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614200|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
2614201|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614202|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614203|NCT01844674|Vemurafenib|vemurafenib|mesh-list
2614204|NCT01844674|Tizanidine|tizanidine|mesh-list
2614205|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614206|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2614207|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614208|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614209|NCT01844674|Analgesics|analgesics|mesh-ancestor
2614210|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
2614211|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614212|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614213|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
2614214|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2614215|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2614216|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
2614217|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
2614218|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2614219|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2614220|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2614221|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
2614222|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614223|NCT01844791|Gemcitabine|gemcitabine|mesh-list
2614224|NCT01844791|Pentamidine|pentamidine|mesh-list
2614225|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2159303|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159304|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2159305|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2159306|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
2159307|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2159308|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159309|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
2159310|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2159311|NCT00932152|Bevacizumab|bevacizumab|mesh-list
2159312|NCT00932152|Fulvestrant|fulvestrant|mesh-list
2159313|NCT00932152|Anastrozole|anastrozole|mesh-list
2159314|NCT00932152|Analgesics|analgesics|mesh-list
2159315|NCT00932152|Antiemetics|antiemetics|mesh-list
2159316|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2159317|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159318|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2159319|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2159320|NCT00932152|Growth Substances|growth substances|mesh-ancestor
2159321|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159322|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
2159323|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159324|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2159325|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2159326|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2614226|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
2614227|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614228|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614229|NCT01844791|Antiviral Agents|antiviral agents|mesh-ancestor
2614230|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614231|NCT01844791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614232|NCT01844791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2614233|NCT01844791|Immunologic Factors|immunologic factors|mesh-ancestor
2614234|NCT01844791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614235|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
2614236|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2614237|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2614238|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2614239|NCT01844804|Infliximab|infliximab|mesh-list
2614240|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
2614241|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2614242|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2614243|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
2614244|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2614245|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614246|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2614247|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614248|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614249|NCT01844947|Sorafenib|sorafenib|mesh-list
2614250|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614251|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2614252|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159327|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
2159328|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159329|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2159330|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2159331|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159332|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159333|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
2159334|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159335|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
2159336|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2159337|NCT00924807|Sorafenib|sorafenib|mesh-list
2614253|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614254|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
2614255|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2614256|NCT01845038|Timolol|timolol|mesh-list
2614257|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2614258|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2159338|NCT00924807|Leuprolide|leuprolide|mesh-list
2159339|NCT00924807|Bicalutamide|bicalutamide|mesh-list
2159340|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159341|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2159342|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159343|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159344|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2159345|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
2159346|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2159347|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159348|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2159349|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
2159350|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
2159351|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159352|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
2159353|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159354|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
2159355|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159356|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2159357|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2159358|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
2159359|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159360|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614259|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
2614260|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614261|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614262|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614263|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2614264|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2614265|NCT01845064|Kallikreins|kallikreins|mesh-list
2614266|NCT01845064|Coagulants|coagulants|mesh-ancestor
2614267|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
2614268|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
2614269|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2614270|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614271|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
2614272|NCT01845090|Calcium|calcium|mesh-list
2614273|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2614274|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614275|NCT01845090|Antacids|antacids|mesh-ancestor
2614276|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614277|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2614278|NCT01845142|Vitamin D|vitamin d|mesh-list
2614279|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
2614280|NCT01845142|Vitamins|vitamins|mesh-ancestor
2614281|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
2614282|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614283|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2614284|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2614285|NCT01845194|Metoprolol|metoprolol|mesh-list
2614286|NCT01845194|Talinolol|talinolol|mesh-list
2614287|NCT01845194|Torsemide|torsemide|mesh-list
2614288|NCT01845194|Midazolam|midazolam|mesh-list
2614289|NCT01845194|Codeine|codeine|mesh-list
2614290|NCT01845194|Caffeine|caffeine|mesh-list
2614291|NCT01845194|Pravastatin|pravastatin|mesh-list
2614292|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2614293|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2614294|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2614295|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614296|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2614297|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2614298|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2614299|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2614300|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
2614301|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
2614302|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
2614303|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
2614304|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159361|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2159362|NCT00926575|Beclomethasone|beclomethasone|mesh-list
2159363|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2159364|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
2159365|NCT00926575|Hormones|hormones|mesh-ancestor
2159366|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159367|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159368|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2159369|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
2159370|NCT00911053|Melatonin|melatonin|mesh-list
2159371|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
2159372|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159373|NCT00911053|Protective Agents|protective agents|mesh-ancestor
2159374|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614305|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614306|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2614307|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2614308|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614309|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2614310|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2159375|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2159376|NCT00918463|Dasatinib|dasatinib|mesh-list
2159377|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159378|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2159379|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159380|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159381|NCT00913692|Glycine|glycine|mesh-list
2159382|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
2159383|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159384|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159385|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159386|NCT00918645|Calcium|calcium|mesh-list
2614311|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
2614312|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2614313|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2614314|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
2614315|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
2614316|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614317|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2159387|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2159388|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159389|NCT00907218|Varenicline|varenicline|mesh-list
2159390|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2159391|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2159392|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
2159393|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159394|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159395|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159396|NCT00906035|Aspirin|aspirin|mesh-list
2159397|NCT00906035|Dipyridamole|dipyridamole|mesh-list
2159398|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2159399|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2159400|NCT00906035|Analgesics|analgesics|mesh-ancestor
2159401|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
2159402|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159403|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159404|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2159405|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2614318|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2614319|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2614320|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
2614321|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2614322|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2614323|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
2614324|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2614325|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2614326|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2614327|NCT01845194|Narcotics|narcotics|mesh-ancestor
2614328|NCT01845194|Analgesics|analgesics|mesh-ancestor
2614329|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
2159406|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2159407|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2159408|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159409|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2159410|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2159411|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159412|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
2159413|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2159414|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
2159415|NCT00904423|Vitamin D|vitamin d|mesh-list
2159416|NCT00904423|Vitamins|vitamins|mesh-ancestor
2159417|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
2159418|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159419|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2159420|NCT00903396|Palonosetron|palonosetron|mesh-list
2159421|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
2159422|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
2159423|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159424|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159425|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2159426|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2159427|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2159428|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
2159429|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159430|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159431|NCT00894790|Celecoxib|celecoxib|mesh-list
2159432|NCT00894790|Diclofenac|diclofenac|mesh-list
2159433|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2614330|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
2614331|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
2614332|NCT01845194|Diuretics|diuretics|mesh-ancestor
2614333|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
2614334|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2614335|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2614336|NCT01845246|Colistin|colistin|mesh-list
2614337|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2614338|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614339|NCT01845259|Liraglutide|liraglutide|mesh-list
2614340|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2614341|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614342|NCT01845259|Incretins|incretins|mesh-ancestor
2614343|NCT01845259|Hormones|hormones|mesh-ancestor
2614344|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2614345|NCT01845272|Amlodipine|amlodipine|mesh-list
2614346|NCT01845272|Candesartan|candesartan|mesh-list
2159434|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2159435|NCT00894790|Analgesics|analgesics|mesh-ancestor
2159436|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
2159437|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159438|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159439|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2159440|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2159441|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2159442|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2159443|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159444|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159445|NCT00902668|Lovastatin|lovastatin|mesh-list
2159446|NCT00902668|L 647318|l 647318|mesh-list
2159447|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
2159448|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2159449|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2159450|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
2159451|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159452|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2159453|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2159454|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159455|NCT00881205|Rivastigmine|rivastigmine|mesh-list
2159456|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2159457|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159458|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159459|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
2159460|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159461|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159462|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2159463|NCT00881205|Protective Agents|protective agents|mesh-ancestor
2159464|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
2159465|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2159466|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
2159467|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159468|NCT00896025|Expectorants|expectorants|mesh-ancestor
2159469|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
2159470|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2159471|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
2159472|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614347|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
2614348|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2614349|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2614350|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2614351|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614352|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2159473|NCT00896025|Protective Agents|protective agents|mesh-ancestor
2159474|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159475|NCT00896025|Antidotes|antidotes|mesh-ancestor
2159476|NCT00903006|Dasatinib|dasatinib|mesh-list
2159477|NCT00903006|Fulvestrant|fulvestrant|mesh-list
2159478|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614353|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614354|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
2614355|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2614356|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2614357|NCT01845298|Rifampin|rifampin|mesh-list
2614358|NCT01845298|Rifamycins|rifamycins|mesh-list
2614359|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2614360|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
2614361|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2614362|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614363|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
2614364|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2614365|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614366|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614367|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2614368|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2614369|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2614370|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2614371|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2614372|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2614373|NCT01845337|Capecitabine|capecitabine|mesh-list
2614374|NCT01845337|Tegafur|tegafur|mesh-list
2159479|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2614375|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2614376|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
2614377|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614378|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614379|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
2614380|NCT01845363|Cefazolin|cefazolin|mesh-list
2614381|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2614382|NCT01845376|Anesthetics|anesthetics|mesh-list
2614383|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2614384|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614385|NCT01845428|Pravastatin|pravastatin|mesh-list
2614386|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2614387|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2614388|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
2614389|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614390|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2614391|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2614392|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614393|NCT01845441|Fentanyl|fentanyl|mesh-list
2614394|NCT01845441|Midazolam|midazolam|mesh-list
2614395|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
2614396|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2614397|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2614398|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614399|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2614400|NCT01845441|Analgesics|analgesics|mesh-ancestor
2614401|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
2614402|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614403|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2614404|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2614405|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2614406|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
2614407|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614408|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614409|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2614410|NCT01845441|Narcotics|narcotics|mesh-ancestor
2614411|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2614412|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2614413|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
2614414|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
2614415|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2614416|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2614417|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2614418|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
2614419|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
2614420|NCT01845493|Sulforaphane|sulforaphane|mesh-list
2159480|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159481|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159482|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2159483|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2159484|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2159485|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
2159486|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159487|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159488|NCT00887315|Cisplatin|cisplatin|mesh-list
2159489|NCT00887315|Docetaxel|docetaxel|mesh-list
2159490|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159491|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
2614421|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2614422|NCT01845493|Protective Agents|protective agents|mesh-ancestor
2614423|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614424|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614425|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2614426|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
2614427|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
2614428|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2614429|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614430|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
2614431|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614432|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2614433|NCT01845558|Wobenzym|wobenzym|mesh-list
2614434|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2614435|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
2614436|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614437|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
2614438|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2614439|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
2614440|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2614441|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
2614442|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614443|NCT01845610|Manganese|manganese|mesh-list
2614444|NCT01845610|Trace Elements|trace elements|mesh-ancestor
2614445|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
2614446|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159492|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
2159493|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
2159494|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159495|NCT00891904|Cetuximab|cetuximab|mesh-list
2159496|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2159497|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159498|NCT00889421|Apremilast|apremilast|mesh-list
2159499|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2159500|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2159501|NCT00889421|Analgesics|analgesics|mesh-ancestor
2159502|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
2159503|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159504|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159505|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2159506|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2159507|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2159508|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2159509|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159510|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159511|NCT00875394|Metformin|metformin|mesh-list
2159512|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2159513|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2159514|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159515|NCT00875394|Incretins|incretins|mesh-ancestor
2159516|NCT00875394|Hormones|hormones|mesh-ancestor
2159517|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159518|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2159519|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
2159520|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159521|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159522|NCT00882310|Gemcitabine|gemcitabine|mesh-list
2159523|NCT00882310|Capecitabine|capecitabine|mesh-list
2159524|NCT00882310|Docetaxel|docetaxel|mesh-list
2159525|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2159526|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
2159527|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159528|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159529|NCT00882310|Antiviral Agents|antiviral agents|mesh-ancestor
2159530|NCT00882310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159531|NCT00882310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159532|NCT00882310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159533|NCT00882310|Immunologic Factors|immunologic factors|mesh-ancestor
2614447|NCT01845649|Estradiol|estradiol|mesh-list
2614448|NCT01845649|Estrogens|estrogens|mesh-ancestor
2614449|NCT01845649|Hormones|hormones|mesh-ancestor
2614450|NCT01845649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2614451|NCT01845649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614452|NCT01845675|Temozolomide|temozolomide|mesh-list
2614453|NCT01845675|Dacarbazine|dacarbazine|mesh-list
2614454|NCT01845675|Endostatins|endostatins|mesh-list
2614455|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2614456|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
2614457|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614458|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614459|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2614460|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2614461|NCT01845675|Growth Substances|growth substances|mesh-ancestor
2614462|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614463|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
2614464|NCT01845688|Losartan|losartan|mesh-list
2614465|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2614466|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2614467|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2614468|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2614469|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614470|NCT01845701|Artesunate|artesunate|mesh-list
2614471|NCT01845701|Lumefantrine|lumefantrine|mesh-list
2614472|NCT01845701|Artemether|artemether|mesh-list
2614473|NCT01845701|Piperaquine|piperaquine|mesh-list
2614474|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2614475|NCT01845701|Amodiaquine|amodiaquine|mesh-list
2614476|NCT01845701|Artenimol|artenimol|mesh-list
2614477|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
2614478|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2614479|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2614480|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614481|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614482|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
2614483|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
2614484|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2614485|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
2614486|NCT01845727|Amphotericin B|amphotericin b|mesh-list
2614487|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2614488|NCT01845727|Amebicides|amebicides|mesh-ancestor
2614489|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2614490|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2614491|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614492|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2614493|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
2614494|NCT01845805|Gemcitabine|gemcitabine|mesh-list
2614495|NCT01845805|Azacitidine|azacitidine|mesh-list
2614496|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2614497|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
2614498|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614499|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614500|NCT01845805|Antiviral Agents|antiviral agents|mesh-ancestor
2614501|NCT01845805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614502|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614503|NCT01845805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2614504|NCT01845805|Immunologic Factors|immunologic factors|mesh-ancestor
2614505|NCT01845805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614506|NCT01845844|Ranibizumab|ranibizumab|mesh-list
2614507|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2614508|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2614509|NCT01845844|Growth Substances|growth substances|mesh-ancestor
2614510|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614511|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
2614512|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614513|NCT01846026|Vitamin D|vitamin d|mesh-list
2614514|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
2614515|NCT01846026|Vitamins|vitamins|mesh-ancestor
2614516|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
2614517|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614518|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2614519|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2614520|NCT01846117|Vitamin D|vitamin d|mesh-list
2614521|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
2614522|NCT01846117|Vitamins|vitamins|mesh-ancestor
2614523|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
2614524|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614525|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2614526|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
2614527|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2614528|NCT01846117|Estrogens|estrogens|mesh-ancestor
2614529|NCT01846117|Hormones|hormones|mesh-ancestor
2614530|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2614531|NCT01846143|Poly ICLC|poly iclc|mesh-list
2614532|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
2614533|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614534|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
2614535|NCT01846273|Ranibizumab|ranibizumab|mesh-list
2614536|NCT01846273|Verteporfin|verteporfin|mesh-list
2614537|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2614538|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2614539|NCT01846273|Growth Substances|growth substances|mesh-ancestor
2614540|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614541|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
2614542|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614543|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2614544|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
2614545|NCT01846325|Vitamin E|vitamin e|mesh-list
2614546|NCT01846325|Vitamins|vitamins|mesh-ancestor
2614547|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
2614548|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614549|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
2614550|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159534|NCT00882310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159535|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
2159536|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
2159537|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
2159538|NCT00880542|Sorafenib|sorafenib|mesh-list
2614551|NCT01846325|Protective Agents|protective agents|mesh-ancestor
2614552|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
2614553|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2614554|NCT01846364|Protective Agents|protective agents|mesh-ancestor
2614555|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614556|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614557|NCT01846390|Gemcitabine|gemcitabine|mesh-list
2614558|NCT01846390|Dexamethasone|dexamethasone|mesh-list
2614559|NCT01846390|Romidepsin|romidepsin|mesh-list
2614560|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614561|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2614562|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
2159539|NCT00880542|Ifosfamide|ifosfamide|mesh-list
2159540|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159541|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2159542|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159543|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159544|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2159545|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
2159546|NCT00879619|Prednisone|prednisone|mesh-list
2159547|NCT00879619|Cortisone|cortisone|mesh-list
2159548|NCT00879619|Docetaxel|docetaxel|mesh-list
2159549|NCT00879619|Sunitinib|sunitinib|mesh-list
2159550|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159551|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
2159552|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
2159553|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
2159554|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159555|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2159556|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
2159557|NCT00879619|Hormones|hormones|mesh-ancestor
2159558|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159559|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159560|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2159561|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2159562|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2159563|NCT00879619|Growth Substances|growth substances|mesh-ancestor
2159564|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
2159565|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2159566|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159567|NCT00874939|Donepezil|donepezil|mesh-list
2159568|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2159569|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159570|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614563|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
2614564|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614565|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614566|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2614567|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
2614568|NCT01846390|Hormones|hormones|mesh-ancestor
2614569|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2614570|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2614571|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2614572|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
2614573|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614574|NCT01846390|Antiviral Agents|antiviral agents|mesh-ancestor
2614575|NCT01846390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614576|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614577|NCT01846390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2614578|NCT01846390|Immunologic Factors|immunologic factors|mesh-ancestor
2614579|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2614580|NCT01846481|Cocaine|cocaine|mesh-list
2614581|NCT01846481|Anesthetics, Local|anesthetics, local|mesh-ancestor
2614582|NCT01846481|Anesthetics|anesthetics|mesh-ancestor
2614583|NCT01846481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2614584|NCT01846481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614585|NCT01846481|Sensory System Agents|sensory system agents|mesh-ancestor
2614586|NCT01846481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614587|NCT01846481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2159571|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
2614588|NCT01846481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2614589|NCT01846481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2614590|NCT01846481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2614591|NCT01846481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614592|NCT01846481|Dopamine Agents|dopamine agents|mesh-ancestor
2614593|NCT01846481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614594|NCT01846559|Clopidogrel|clopidogrel|mesh-list
2614595|NCT01846559|Ticagrelor|ticagrelor|mesh-list
2614596|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2614597|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2614598|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2614599|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2614600|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
2614601|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614602|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614603|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614604|NCT01846650|Capecitabine|capecitabine|mesh-list
2614605|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2614606|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
2614607|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614608|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614613|NCT01846806|Rifaximin|rifaximin|mesh-list
2614614|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2614615|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614616|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2614617|NCT01846832|Interferons|interferons|mesh-list
2614618|NCT01846832|Ribavirin|ribavirin|mesh-list
2614619|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
2614620|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
2614621|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2614622|NCT01846832|Simeprevir|simeprevir|mesh-list
2614623|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614624|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
2614625|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614626|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
2614627|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614628|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
2614629|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614630|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
2614631|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614632|NCT01846962|Fluticasone|fluticasone|mesh-list
2614633|NCT01846962|Budesonide|budesonide|mesh-list
2614634|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2614635|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2614636|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
2614637|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614638|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614639|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2614640|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
2159572|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159573|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159574|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
2159575|NCT00877071|Doxorubicin|doxorubicin|mesh-list
2159576|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2159577|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159578|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2159579|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2159580|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159581|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159582|NCT00878969|Valsartan|valsartan|mesh-list
2159583|NCT00878969|Ramipril|ramipril|mesh-list
2614641|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
2614642|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2614643|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
2159584|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2159585|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2159586|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2159587|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2159588|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159589|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
2159590|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159591|NCT00869414|Insulin|insulin|mesh-list
2159592|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2159593|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
2159594|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2159595|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159596|NCT00863512|Gemcitabine|gemcitabine|mesh-list
2614644|NCT01846962|Hormones|hormones|mesh-ancestor
2614645|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2614646|NCT01846975|Abatacept|abatacept|mesh-list
2614647|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2614648|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614649|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614650|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2614651|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
2614652|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614653|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2614654|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2614655|NCT01847144|Gliclazide|gliclazide|mesh-list
2614656|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2614657|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2614658|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614659|NCT01847144|Incretins|incretins|mesh-ancestor
2614660|NCT01847144|Hormones|hormones|mesh-ancestor
2614661|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2614662|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
2614663|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614664|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614665|NCT01847157|Anesthetics|anesthetics|mesh-list
2614666|NCT01847157|Prilocaine|prilocaine|mesh-list
2614667|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2614668|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614669|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
2614670|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
2614671|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614672|NCT01847235|Temozolomide|temozolomide|mesh-list
2614673|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2614674|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
2614675|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614676|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614677|NCT01847326|Paclitaxel|paclitaxel|mesh-list
2614678|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2614679|NCT01847326|Carboplatin|carboplatin|mesh-list
2614680|NCT01847326|Fluorouracil|fluorouracil|mesh-list
2614681|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
2614682|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2614683|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614684|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
2614685|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
2614686|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
2614687|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614688|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
2614689|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2614690|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2614691|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
2614692|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614693|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
2614694|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614695|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2614696|NCT01847339|Bupivacaine|bupivacaine|mesh-list
2614697|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
2614698|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
2614699|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2614700|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614701|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
2159597|NCT00863512|Docetaxel|docetaxel|mesh-list
2159598|NCT00863512|Pemetrexed|pemetrexed|mesh-list
2159599|NCT00863512|Vinorelbine|vinorelbine|mesh-list
2159600|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159601|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2159602|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
2159603|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159604|NCT00863512|Antiviral Agents|antiviral agents|mesh-ancestor
2159605|NCT00863512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159606|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159607|NCT00863512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159608|NCT00863512|Immunologic Factors|immunologic factors|mesh-ancestor
2159609|NCT00863512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159610|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
2159611|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
2159612|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
2159613|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2159614|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2159615|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2159616|NCT00868998|Gemcitabine|gemcitabine|mesh-list
2159617|NCT00868998|Capecitabine|capecitabine|mesh-list
2159618|NCT00868998|Docetaxel|docetaxel|mesh-list
2159619|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2159620|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
2159621|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159622|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159623|NCT00868998|Antiviral Agents|antiviral agents|mesh-ancestor
2159624|NCT00868998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159625|NCT00868998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159626|NCT00868998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159627|NCT00868998|Immunologic Factors|immunologic factors|mesh-ancestor
2159628|NCT00868998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159629|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
2159630|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
2159631|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
2159632|NCT00869258|Gemcitabine|gemcitabine|mesh-list
2159633|NCT00869258|Capecitabine|capecitabine|mesh-list
2159634|NCT00869258|Docetaxel|docetaxel|mesh-list
2159635|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2159636|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
2159637|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159638|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159639|NCT00869258|Antiviral Agents|antiviral agents|mesh-ancestor
2159640|NCT00869258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159641|NCT00869258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159642|NCT00869258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2614702|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614703|NCT01847404|Aspirin|aspirin|mesh-list
2614704|NCT01847404|Pantoprazole|pantoprazole|mesh-list
2614705|NCT01847404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2614706|NCT01847404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2614707|NCT01847404|Analgesics|analgesics|mesh-ancestor
2614708|NCT01847404|Sensory System Agents|sensory system agents|mesh-ancestor
2614709|NCT01847404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614710|NCT01847404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614711|NCT01847404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2614712|NCT01847404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2614713|NCT01847404|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2614714|NCT01847404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2614715|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614716|NCT01847404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2614717|NCT01847404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2614718|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614719|NCT01847404|Antipyretics|antipyretics|mesh-ancestor
2614720|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2614721|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2614722|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2614723|NCT01847417|Pantoprazole|pantoprazole|mesh-list
2614724|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2614725|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2614726|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2614727|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614728|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614729|NCT01847456|Insulin|insulin|mesh-list
2614730|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2614731|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2614732|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614733|NCT01847495|Irinotecan|irinotecan|mesh-list
2614734|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2614735|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2614736|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614737|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614738|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614739|NCT01847521|Quercetin|quercetin|mesh-list
2614740|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
2614741|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614742|NCT01847521|Protective Agents|protective agents|mesh-ancestor
2614743|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159643|NCT00869258|Immunologic Factors|immunologic factors|mesh-ancestor
2614744|NCT01847573|Halofuginone|halofuginone|mesh-list
2614745|NCT01847573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614746|NCT01847573|Coccidiostats|coccidiostats|mesh-ancestor
2159644|NCT00869258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159645|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
2159646|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
2159647|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
2159648|NCT00853229|Pregabalin|pregabalin|mesh-list
2159649|NCT00853229|Analgesics|analgesics|mesh-ancestor
2159650|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
2159651|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159652|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159653|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
2159654|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2159655|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2159656|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159657|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2159658|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2159659|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2159660|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2159661|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2159662|NCT00860158|Dasatinib|dasatinib|mesh-list
2159663|NCT00860158|Leuprolide|leuprolide|mesh-list
2614747|NCT01847573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2614748|NCT01847573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2614749|NCT01847573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614750|NCT01847573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2614751|NCT01847573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614752|NCT01847573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614753|NCT01847573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2614754|NCT01847573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2614755|NCT01847573|Growth Substances|growth substances|mesh-ancestor
2614756|NCT01847573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614757|NCT01847573|Growth Inhibitors|growth inhibitors|mesh-ancestor
2614758|NCT01847599|Capecitabine|capecitabine|mesh-list
2614759|NCT01847599|Lapatinib|lapatinib|mesh-list
2614760|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2614761|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
2614762|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614763|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614764|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2614765|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614766|NCT01847612|Methylene Blue|methylene blue|mesh-list
2614767|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614768|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614769|NCT01847664|Rifamycins|rifamycins|mesh-list
2614770|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
2614771|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2614772|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614773|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2614774|NCT01847677|Paclitaxel|paclitaxel|mesh-list
2614775|NCT01847677|Bevacizumab|bevacizumab|mesh-list
2614776|NCT01847677|Carboplatin|carboplatin|mesh-list
2614777|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2614778|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614779|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
2614780|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
2614781|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
2614782|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614783|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2614784|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2614785|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2614786|NCT01847677|Growth Substances|growth substances|mesh-ancestor
2614787|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614788|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
2614789|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
2614790|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2614791|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
2614792|NCT01847768|Miotics|miotics|mesh-ancestor
2614793|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
2614794|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614795|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614796|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2614797|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2614798|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
2614799|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2614800|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2614801|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
2614802|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614803|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614804|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2614805|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
2614806|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614807|NCT01847872|Vaccines|vaccines|mesh-list
2159664|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159665|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2159666|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159667|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159668|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2159669|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
2159670|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2159671|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159672|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2159673|NCT00843986|Conivaptan|conivaptan|mesh-list
2159674|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2159675|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159676|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
2159677|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159678|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
2159679|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2159680|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2159681|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2159682|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2159683|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159684|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
2159685|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159686|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159687|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2159688|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614808|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
2614809|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614810|NCT01847976|Doxycycline|doxycycline|mesh-list
2614811|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2614812|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614813|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
2614814|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2614815|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2614816|NCT01848106|Bivalirudin|bivalirudin|mesh-list
2614817|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
2614818|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2614819|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
2614820|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614821|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614822|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
2614823|NCT01848119|Gabapentin|gabapentin|mesh-list
2614824|NCT01848119|Analgesics|analgesics|mesh-ancestor
2614825|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
2614826|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614827|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614828|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
2614829|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2159689|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
2159690|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2159691|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2159692|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
2159693|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2159694|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
2159695|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159696|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
2159697|NCT00852241|Protective Agents|protective agents|mesh-ancestor
2159698|NCT00851552|Rituximab|rituximab|mesh-list
2159699|NCT00851552|Doxorubicin|doxorubicin|mesh-list
2159700|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2159701|NCT00851552|Bortezomib|bortezomib|mesh-list
2159702|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2159703|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159704|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
2159705|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614830|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2614831|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2614832|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2614833|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2614834|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2614835|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614836|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614837|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
2614838|NCT01848132|Prednisone|prednisone|mesh-list
2614839|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
2614840|NCT01848132|Rituximab|rituximab|mesh-list
2614841|NCT01848132|Doxorubicin|doxorubicin|mesh-list
2614842|NCT01848132|Vincristine|vincristine|mesh-list
2614843|NCT01848132|Bortezomib|bortezomib|mesh-list
2614844|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2614845|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
2614846|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159706|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2159707|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2159708|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2614847|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2614848|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2614849|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
2614850|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614851|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614852|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2614853|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2614854|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2614855|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2614856|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2614857|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614858|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2614859|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
2614860|NCT01848132|Hormones|hormones|mesh-ancestor
2614861|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2614862|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2614863|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2614864|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
2614865|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
2614866|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
2614867|NCT01848197|Paclitaxel|paclitaxel|mesh-list
2614868|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2614869|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614870|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
2614871|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
2614872|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
2614873|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614874|NCT01848236|Vitamin D|vitamin d|mesh-list
2614875|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
2614876|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
2614877|NCT01848236|Vitamins|vitamins|mesh-list
2614878|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
2614879|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614880|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2614881|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2614882|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2614883|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
2614884|NCT01848301|Acetylcholine|acetylcholine|mesh-list
2614885|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
2614886|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2614887|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
2614888|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614889|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159709|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2159710|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159711|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159712|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
2159713|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2614890|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614891|NCT01848340|Cabotegravir|cabotegravir|mesh-list
2614892|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2614893|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2614894|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614895|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614896|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2614897|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2614898|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
2614899|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614900|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2614901|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614902|NCT01848613|Vinorelbine|vinorelbine|mesh-list
2614903|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2614904|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614905|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
2614906|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
2159714|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2159715|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2159716|NCT00850720|Vasopressins|vasopressins|mesh-list
2159717|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159718|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
2159719|NCT00850720|Coagulants|coagulants|mesh-ancestor
2159720|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2159721|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2159722|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
2159723|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2159724|NCT00851591|Psyllium|psyllium|mesh-list
2614907|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
2614908|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614909|NCT01848639|Spironolactone|spironolactone|mesh-list
2614910|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2614911|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
2614912|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2614913|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614914|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2614915|NCT01848639|Diuretics|diuretics|mesh-ancestor
2614916|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
2614917|NCT01848652|Doxorubicin|doxorubicin|mesh-list
2614918|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2614919|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614920|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2614921|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2614922|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614923|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614924|NCT01848665|Indomethacin|indomethacin|mesh-list
2614925|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2614926|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2614927|NCT01848665|Analgesics|analgesics|mesh-ancestor
2614928|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
2614929|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614930|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159725|NCT00851591|Cathartics|cathartics|mesh-ancestor
2159726|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2159727|NCT00843310|Dexamethasone|dexamethasone|mesh-list
2159728|NCT00843310|Lenalidomide|lenalidomide|mesh-list
2159729|NCT00843310|Melphalan|melphalan|mesh-list
2159730|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2159731|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
2159732|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
2159733|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159734|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159735|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2159736|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
2159737|NCT00843310|Hormones|hormones|mesh-ancestor
2159738|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159739|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2159740|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159741|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
2159742|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2159743|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2159744|NCT00843310|Growth Substances|growth substances|mesh-ancestor
2159745|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
2159746|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2159747|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
2159748|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159749|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2614931|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2614932|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2614933|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
2614934|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
2614935|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2614936|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2614937|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614938|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614939|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
2614940|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
2614941|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614942|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
2614943|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614944|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614945|NCT01848743|Tenofovir|tenofovir|mesh-list
2614946|NCT01848743|Lamivudine|lamivudine|mesh-list
2159750|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159751|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2159752|NCT00847002|Laxatives|laxatives|mesh-ancestor
2159753|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2159754|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
2159755|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
2159756|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
2159757|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159758|NCT00843830|Vaccines|vaccines|mesh-list
2159759|NCT00843830|Immunologic Factors|immunologic factors|mesh-ancestor
2159760|NCT00843830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159761|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2159762|NCT00835679|Cetuximab|cetuximab|mesh-list
2159763|NCT00835679|Dasatinib|dasatinib|mesh-list
2159764|NCT00835679|Antibodies|antibodies|mesh-list
2159765|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
2614947|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
2614948|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614949|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2614950|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2614951|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614952|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614953|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2614954|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2614955|NCT01848769|Beclomethasone|beclomethasone|mesh-list
2614956|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
2614957|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2159766|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2159767|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
2159768|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159769|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159770|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2159771|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159772|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159773|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2159774|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159775|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2159776|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159777|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159778|NCT00832520|Mirtazapine|mirtazapine|mesh-list
2159779|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
2159780|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2159781|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2159782|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
2159783|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
2159784|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159785|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159786|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614958|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
2614959|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2614960|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614961|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2614962|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
2614963|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2614964|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2614965|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2614966|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
2614967|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2614968|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614969|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2614970|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
2614971|NCT01848769|Hormones|hormones|mesh-ancestor
2159787|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2614972|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2614973|NCT01848808|Wobenzym|wobenzym|mesh-list
2614974|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2159788|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2159789|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2159790|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2159791|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2159792|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2159793|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
2159794|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2159795|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2159796|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
2159797|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2159798|NCT00833859|Gemcitabine|gemcitabine|mesh-list
2159799|NCT00833859|Capecitabine|capecitabine|mesh-list
2614975|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
2614976|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614977|NCT01848873|Amlodipine|amlodipine|mesh-list
2614978|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2159800|NCT00833859|Docetaxel|docetaxel|mesh-list
2159801|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2159802|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
2159803|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159804|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614979|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2614980|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2614981|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614982|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2614983|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2614984|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
2614985|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
2614986|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2614987|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
2614988|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2614989|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2614990|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2614991|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
2614992|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2614993|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
2614994|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2614995|NCT01849016|Expectorants|expectorants|mesh-ancestor
2614996|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
2614997|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2614998|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
2614999|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615000|NCT01849016|Protective Agents|protective agents|mesh-ancestor
2615001|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615002|NCT01849016|Antidotes|antidotes|mesh-ancestor
2615003|NCT01849042|Donepezil|donepezil|mesh-list
2615004|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2615005|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615006|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615007|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
2615008|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615009|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615010|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
2615011|NCT01849094|Milrinone|milrinone|mesh-list
2615012|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2615013|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2615014|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
2615015|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2615016|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2615017|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615018|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615019|NCT01849094|Protective Agents|protective agents|mesh-ancestor
2615020|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615021|NCT01849146|Temozolomide|temozolomide|mesh-list
2615022|NCT01849146|Adavosertib|adavosertib|mesh-list
2615023|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2615024|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
2615025|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615026|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615027|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615028|NCT01849211|Rocuronium|rocuronium|mesh-list
2615029|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2615030|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2159805|NCT00833859|Antiviral Agents|antiviral agents|mesh-ancestor
2615031|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2159806|NCT00833859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159807|NCT00833859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159808|NCT00833859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159809|NCT00833859|Immunologic Factors|immunologic factors|mesh-ancestor
2159810|NCT00833859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159811|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
2159812|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
2159813|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
2159814|NCT00840827|Cyclosporine|cyclosporine|mesh-list
2159815|NCT00840827|Lenalidomide|lenalidomide|mesh-list
2159816|NCT00840827|Cyclosporins|cyclosporins|mesh-list
2159817|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159818|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159819|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159820|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
2159821|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159822|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
2159823|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159824|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
2615032|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615033|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615034|NCT01849406|Budesonide|budesonide|mesh-list
2615035|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2615036|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2615037|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
2615038|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615039|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615040|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2159825|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2159826|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2159827|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2159828|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2159829|NCT00840827|Growth Substances|growth substances|mesh-ancestor
2159830|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
2159831|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159832|NCT00832572|Ranolazine|ranolazine|mesh-list
2159833|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2159834|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2159835|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159836|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2159837|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2159838|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159839|NCT00832624|Incretins|incretins|mesh-ancestor
2159840|NCT00832624|Hormones|hormones|mesh-ancestor
2615041|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
2615042|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
2615043|NCT01849406|Hormones|hormones|mesh-ancestor
2615044|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2615045|NCT01849640|Piperaquine|piperaquine|mesh-list
2615046|NCT01849640|Primaquine|primaquine|mesh-list
2615047|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
2615048|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2615049|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2615050|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615051|NCT01849666|Vemurafenib|vemurafenib|mesh-list
2615052|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
2615053|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615054|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2615055|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615056|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159841|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159842|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2159843|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
2159844|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159845|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159846|NCT00832299|Leucovorin|leucovorin|mesh-list
2159847|NCT00832299|Fluorouracil|fluorouracil|mesh-list
2159848|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
2159849|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
2615057|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
2615058|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
2615059|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2159850|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615060|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2615061|NCT01849783|Thalidomide|thalidomide|mesh-list
2615062|NCT01849783|Dexamethasone|dexamethasone|mesh-list
2615063|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
2615064|NCT01849783|Melphalan|melphalan|mesh-list
2615065|NCT01849783|Doxorubicin|doxorubicin|mesh-list
2615066|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2615067|NCT01849783|Etoposide|etoposide|mesh-list
2615068|NCT01849783|Bortezomib|bortezomib|mesh-list
2615069|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
2615070|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2615071|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
2615072|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615073|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2615074|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2615075|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
2615076|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615077|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615078|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2615079|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2615080|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
2615081|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
2615082|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615083|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2615084|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
2615085|NCT01849783|Hormones|hormones|mesh-ancestor
2615086|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2615087|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2615088|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2615089|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2615090|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2615091|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615092|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2615093|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
2615094|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2615095|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615096|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2615097|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2615098|NCT01849783|Growth Substances|growth substances|mesh-ancestor
2615099|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
2615100|NCT01849835|Menthol|menthol|mesh-list
2615101|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
2615102|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
2615103|NCT01849861|Methimazole|methimazole|mesh-list
2615104|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
2615105|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
2615106|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2615107|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615108|NCT01849926|Amdinocillin|amdinocillin|mesh-list
2615109|NCT01849926|Ibuprofen|ibuprofen|mesh-list
2615110|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2615111|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2615112|NCT01849926|Analgesics|analgesics|mesh-ancestor
2615113|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
2615114|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615115|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615116|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2615117|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2615118|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2615119|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615120|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615121|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2615122|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615123|NCT01849926|Renal Agents|renal agents|mesh-ancestor
2615124|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2615125|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2615126|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
2615127|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615128|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
2615129|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2615130|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2615131|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615132|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2615133|NCT01850017|Analgesics|analgesics|mesh-ancestor
2615134|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
2615135|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615136|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2615137|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2159851|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2159852|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159853|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159854|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
2159855|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159856|NCT00832299|Antidotes|antidotes|mesh-ancestor
2159857|NCT00832299|Protective Agents|protective agents|mesh-ancestor
2159858|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
2159859|NCT00832299|Vitamins|vitamins|mesh-ancestor
2159860|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
2159861|NCT00836355|Minocycline|minocycline|mesh-list
2159862|NCT00836355|Enoxaparin|enoxaparin|mesh-list
2159863|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
2159864|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2159865|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2159866|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159867|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2159868|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615138|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2615139|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
2615140|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615141|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615142|NCT01850095|Azelaic acid|azelaic acid|mesh-list
2615143|NCT01850095|Estradiol|estradiol|mesh-list
2159869|NCT00816777|Irinotecan|irinotecan|mesh-list
2159870|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2159871|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2159872|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159873|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159874|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159875|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
2159876|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2159877|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
2159878|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159879|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159880|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2159881|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
2159882|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2159883|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
2159884|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159885|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2159886|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2159887|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
2615144|NCT01850095|Estrogens|estrogens|mesh-ancestor
2615145|NCT01850095|Hormones|hormones|mesh-ancestor
2615146|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2615147|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615148|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615149|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
2159888|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
2159889|NCT00823095|Protective Agents|protective agents|mesh-ancestor
2159890|NCT00827567|Everolimus|everolimus|mesh-list
2159891|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159892|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159893|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
2159894|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159895|NCT00815633|Alefacept|alefacept|mesh-list
2159896|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
2159897|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
2159898|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159899|NCT00825227|Modafinil|modafinil|mesh-list
2159900|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2159901|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159902|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2159903|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2159904|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2159905|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159906|NCT00822679|Eszopiclone|eszopiclone|mesh-list
2159907|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2159908|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2159909|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159910|NCT00809458|Vitamin E|vitamin e|mesh-list
2159911|NCT00809458|Tocopherols|tocopherols|mesh-list
2159912|NCT00809458|Tocotrienols|tocotrienols|mesh-list
2159913|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
2615171|NCT01850121|Infliximab|infliximab|mesh-list
2615172|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
2615173|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2615174|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2615175|NCT01850147|Sunitinib|sunitinib|mesh-list
2615176|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615177|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2615178|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2615179|NCT01850147|Growth Substances|growth substances|mesh-ancestor
2615180|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615181|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
2615182|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2615183|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615184|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615185|NCT01850160|Valsartan|valsartan|mesh-list
2615186|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
2615187|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
2615188|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
2615189|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2615190|NCT01850160|Diuretics|diuretics|mesh-list
2615191|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
2615192|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2615193|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615194|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
2615195|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615196|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2615197|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2615198|NCT01850251|Vitamin D|vitamin d|mesh-list
2615199|NCT01850251|Vitamins|vitamins|mesh-ancestor
2615200|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
2615201|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615202|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2615203|NCT01850277|Amiodarone|amiodarone|mesh-list
2615204|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2615205|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
2615206|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2615207|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2615208|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615209|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2615210|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2159914|NCT00809458|Vitamins|vitamins|mesh-ancestor
2159915|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
2159916|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159917|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
2159918|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159919|NCT00809458|Protective Agents|protective agents|mesh-ancestor
2159920|NCT00807365|Hormones|hormones|mesh-list
2159921|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
2159922|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159923|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159924|NCT00814333|Thrombin|thrombin|mesh-list
2159925|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
2159926|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
2159927|NCT00814333|Coagulants|coagulants|mesh-ancestor
2159928|NCT00809341|Prednisone|prednisone|mesh-list
2615211|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2615212|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615213|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2615214|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2615215|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2615216|NCT01850303|Gemcitabine|gemcitabine|mesh-list
2615217|NCT01850303|Pemetrexed|pemetrexed|mesh-list
2615218|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2615219|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
2615220|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615221|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615222|NCT01850303|Antiviral Agents|antiviral agents|mesh-ancestor
2615223|NCT01850303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615224|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615225|NCT01850303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2615226|NCT01850303|Immunologic Factors|immunologic factors|mesh-ancestor
2615227|NCT01850303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615228|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2615229|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2615230|NCT01850355|Buspirone|buspirone|mesh-list
2615231|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2615232|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2615233|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2615234|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159929|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
2159930|NCT00809341|Ifosfamide|ifosfamide|mesh-list
2159931|NCT00809341|Rituximab|rituximab|mesh-list
2159932|NCT00809341|Carboplatin|carboplatin|mesh-list
2159933|NCT00809341|Doxorubicin|doxorubicin|mesh-list
2615235|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2615236|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2615237|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
2615238|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615239|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615240|NCT01850511|Phenylephrine|phenylephrine|mesh-list
2615241|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
2615242|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2615243|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2615244|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
2615245|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615246|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615247|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615248|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
2615249|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
2615250|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615251|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
2615252|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2615253|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
2615254|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2615255|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
2615256|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2615257|NCT01850511|Protective Agents|protective agents|mesh-ancestor
2615258|NCT01850628|Paclitaxel|paclitaxel|mesh-list
2615259|NCT01850628|Trastuzumab|trastuzumab|mesh-list
2615260|NCT01850628|Pertuzumab|pertuzumab|mesh-list
2421845|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2421846|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
2421847|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421848|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421849|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
2421850|NCT00814541|Dexamethasone|dexamethasone|mesh-list
2421851|NCT00814541|Doxorubicin|doxorubicin|mesh-list
2421852|NCT00814541|Bortezomib|bortezomib|mesh-list
2421853|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2421854|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
2421855|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
2421856|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421857|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421858|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2421859|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
2421860|NCT00814541|Hormones|hormones|mesh-ancestor
2159934|NCT00809341|Etoposide|etoposide|mesh-list
2159935|NCT00809341|Vincristine|vincristine|mesh-list
2159936|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159937|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
2159938|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615261|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2615262|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159939|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2159940|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2159941|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
2159942|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159943|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159944|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2159945|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2159946|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2159947|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2159948|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2159949|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159950|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2615263|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
2615264|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
2615265|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
2615266|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615267|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2615268|NCT01850680|Folic Acid|folic acid|mesh-list
2615269|NCT01850680|Methotrexate|methotrexate|mesh-list
2615270|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2615271|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
2615272|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2615273|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159951|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
2159952|NCT00809341|Hormones|hormones|mesh-ancestor
2159953|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2159954|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2159955|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2615274|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2615275|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
2615276|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615277|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615278|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
2615279|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615280|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2615281|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2615282|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
2615283|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2615284|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2615285|NCT01850680|Hematinics|hematinics|mesh-ancestor
2615286|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
2615287|NCT01850680|Vitamins|vitamins|mesh-ancestor
2615288|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
2159956|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
2159957|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
2159958|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
2159959|NCT00803283|Morphine|morphine|mesh-list
2159960|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2159961|NCT00803283|Narcotics|narcotics|mesh-ancestor
2159962|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2159963|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159964|NCT00803283|Analgesics|analgesics|mesh-ancestor
2159965|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
2159966|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2159967|NCT00811590|Everolimus|everolimus|mesh-list
2159968|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159969|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159970|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
2159971|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2159972|NCT00808899|Sirolimus|sirolimus|mesh-list
2159973|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
2159974|NCT00808899|Doxorubicin|doxorubicin|mesh-list
2159975|NCT00808899|Irinotecan|irinotecan|mesh-list
2159976|NCT00808899|Etoposide|etoposide|mesh-list
2159977|NCT00808899|Topotecan|topotecan|mesh-list
2159978|NCT00808899|Tretinoin|tretinoin|mesh-list
2159979|NCT00808899|Isotretinoin|isotretinoin|mesh-list
2159980|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2159981|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
2159982|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615295|NCT01850940|Tolvaptan|tolvaptan|mesh-list
2615296|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2615297|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615298|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
2615299|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615300|NCT01850953|Varenicline|varenicline|mesh-list
2615301|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2615302|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2615303|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
2615304|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615305|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615306|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615307|NCT01850979|Tacrolimus|tacrolimus|mesh-list
2615308|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2615309|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
2615310|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615311|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2615312|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615313|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615314|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
2615315|NCT01851005|Remifentanil|remifentanil|mesh-list
2615316|NCT01851005|Anesthetics|anesthetics|mesh-list
2615317|NCT01851005|Propofol|propofol|mesh-list
2615318|NCT01851005|Sevoflurane|sevoflurane|mesh-list
2615319|NCT01851005|Rocuronium|rocuronium|mesh-list
2615320|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2615321|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615322|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2615323|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2615324|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
2615325|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2615326|NCT01851005|Analgesics|analgesics|mesh-ancestor
2615327|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
2615328|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615329|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2615330|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2615331|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2615332|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
2615333|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615334|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615335|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2615336|NCT01851005|Narcotics|narcotics|mesh-ancestor
2615337|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2615338|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2615339|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2615340|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2615341|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2615342|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
2615343|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2615344|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
2615345|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615346|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615347|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615348|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2615349|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2615350|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615351|NCT01851265|Olaparib|olaparib|mesh-list
2615352|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2615353|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615354|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615355|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615356|NCT01851278|Triamcinolone|triamcinolone|mesh-list
2615357|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2615358|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2615359|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2615360|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2615361|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
2615362|NCT01851278|Hormones|hormones|mesh-ancestor
2615363|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2615364|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615365|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2615366|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
2615367|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615368|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615369|NCT01851408|Sirolimus|sirolimus|mesh-list
2615370|NCT01851408|Sorafenib|sorafenib|mesh-list
2615371|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615372|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2615373|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615374|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615375|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2615376|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615377|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2615378|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
2615379|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2615380|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
2615381|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615382|NCT01851473|Quinine|quinine|mesh-list
2159983|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2159984|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2159985|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
2159986|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2159987|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2159988|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2159989|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2159990|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2159991|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2159992|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2159993|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2159994|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2159995|NCT00808899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2159996|NCT00808899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2159997|NCT00808899|Antifungal Agents|antifungal agents|mesh-ancestor
2159998|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
2159999|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
2160000|NCT00808769|Omeprazole|omeprazole|mesh-list
2160001|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
2160002|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2160003|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2615383|NCT01851473|Acetazolamide|acetazolamide|mesh-list
2615384|NCT01851473|Cocaine|cocaine|mesh-list
2615385|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
2615386|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2615387|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615388|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615389|NCT01851473|Diuretics|diuretics|mesh-ancestor
2615390|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
2615391|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615392|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
2615393|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
2615394|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2615395|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
2615396|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615397|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2615398|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2615399|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2160004|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2160005|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160006|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160007|NCT00803179|Hormones|hormones|mesh-list
2160008|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160009|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160010|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
2160011|NCT00801931|Melphalan|melphalan|mesh-list
2160012|NCT00801931|Busulfan|busulfan|mesh-list
2160013|NCT00801931|Thiotepa|thiotepa|mesh-list
2160014|NCT00801931|Fludarabine|fludarabine|mesh-list
2160015|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
2160016|NCT00801931|Phenytoin|phenytoin|mesh-list
2160017|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
2160018|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
2160019|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2160020|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2160021|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
2160022|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160023|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2160024|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2160025|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
2160026|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160027|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615400|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2615401|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
2615402|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615403|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
2615404|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2615405|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2615406|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615407|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2615408|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2615409|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2615410|NCT01851473|Analgesics|analgesics|mesh-ancestor
2615411|NCT01851486|Clonidine|clonidine|mesh-list
2615412|NCT01851486|Naloxone|naloxone|mesh-list
2615413|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2615414|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615415|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
2615416|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615417|NCT01851486|Analgesics|analgesics|mesh-ancestor
2160028|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2160029|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2160030|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
2160031|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2160032|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2615418|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2615419|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
2615420|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
2615421|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2615422|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2615423|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2615424|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
2615425|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615426|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615427|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2615428|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2615429|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615430|NCT01851551|Rituximab|rituximab|mesh-list
2615431|NCT01851551|Vincristine|vincristine|mesh-list
2615432|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2615433|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615434|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
2615435|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615436|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2615437|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2615438|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
2615439|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
2615440|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
2615441|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615442|NCT01851642|Albuterol|albuterol|mesh-list
2615443|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2615444|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
2615445|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615446|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615447|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2615448|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
2615449|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
2615450|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2615451|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2615452|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2615453|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2615454|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
2615455|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615456|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615457|NCT01851681|Amoxicillin|amoxicillin|mesh-list
2615458|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2160033|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2160034|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2160035|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2160036|NCT00793520|Milnacipran|milnacipran|mesh-list
2160037|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
2160038|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2160039|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2160040|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2615459|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615460|NCT01851733|Doxorubicin|doxorubicin|mesh-list
2160041|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615461|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2615462|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615463|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2615464|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2615465|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615466|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615467|NCT01851759|Cinepazide|cinepazide|mesh-list
2421861|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421862|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2421863|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421864|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2421865|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2421866|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2421867|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421868|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421869|NCT00814593|Carmustine|carmustine|mesh-list
2421870|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2421871|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
2421872|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421873|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421874|NCT00814606|Ribavirin|ribavirin|mesh-list
2421875|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2421876|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
2421877|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421878|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
2615468|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
2615469|NCT01851824|Vemurafenib|vemurafenib|mesh-list
2615470|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
2615471|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615472|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2615473|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615474|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615475|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
2615476|NCT01851850|Opicapone|opicapone|mesh-list
2160042|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160043|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615477|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2615478|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615479|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615480|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2615481|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2615482|NCT01851941|Leucovorin|leucovorin|mesh-list
2615483|NCT01851941|Folic Acid|folic acid|mesh-list
2615484|NCT01851941|Fluorouracil|fluorouracil|mesh-list
2615485|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
2615486|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
2615487|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
2615488|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615489|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2615490|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615491|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2615492|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
2615493|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615494|NCT01851941|Antidotes|antidotes|mesh-ancestor
2615495|NCT01851941|Protective Agents|protective agents|mesh-ancestor
2615496|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
2615497|NCT01851941|Vitamins|vitamins|mesh-ancestor
2615498|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
2615499|NCT01851941|Hematinics|hematinics|mesh-ancestor
2615500|NCT01851954|Clarithromycin|clarithromycin|mesh-list
2615501|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2615502|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615503|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2615504|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615505|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615506|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2615507|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2615508|NCT01851980|Furosemide|furosemide|mesh-list
2615509|NCT01851980|Diuretics|diuretics|mesh-ancestor
2615510|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
2615511|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615512|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2615513|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2615514|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615515|NCT01851993|Ondansetron|ondansetron|mesh-list
2615516|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
2615517|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
2615518|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615519|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615520|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2615521|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
2615522|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
2615523|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2160044|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2160045|NCT00793520|Analgesics|analgesics|mesh-ancestor
2160046|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
2160047|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160048|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
2160049|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2160050|NCT00806390|Metoprolol|metoprolol|mesh-list
2160051|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2160052|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2160053|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
2160054|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
2160055|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615524|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
2615525|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615526|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615527|NCT01851993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2615528|NCT01851993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2615529|NCT01851993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2615530|NCT01851993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2615531|NCT01851993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2615532|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
2615533|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2615534|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2615535|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615536|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
2615537|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
2615538|NCT01852266|Vaccines|vaccines|mesh-list
2615539|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
2615540|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615541|NCT01852318|Fexofenadine|fexofenadine|mesh-list
2615542|NCT01852318|Pregabalin|pregabalin|mesh-list
2615543|NCT01852318|Analgesics|analgesics|mesh-ancestor
2615544|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
2615545|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615546|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615547|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
2615548|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2615549|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2615550|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615551|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2615552|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2615553|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2615554|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2615555|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2615556|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2615557|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2615558|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2615559|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
2615560|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
2615561|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615562|NCT01852409|Bevacizumab|bevacizumab|mesh-list
2615563|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2615564|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615565|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2160056|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160057|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2160058|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2160059|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2615566|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2615567|NCT01852409|Growth Substances|growth substances|mesh-ancestor
2615568|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615569|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
2615570|NCT01852461|Poractant alfa|poractant alfa|mesh-list
2615571|NCT01852461|Beractant|beractant|mesh-list
2615572|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2615573|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
2615574|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
2615575|NCT01852539|Propofol|propofol|mesh-list
2615576|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2615577|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2615578|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615579|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2615580|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
2615581|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
2615582|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2615583|NCT01852539|Analgesics|analgesics|mesh-ancestor
2615584|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
2615585|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615586|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2615587|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2615588|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2615589|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
2615590|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615591|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615592|NCT01852565|Diltiazem|diltiazem|mesh-list
2615593|NCT01852565|Darapladib|darapladib|mesh-list
2615594|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2615595|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2615596|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2615597|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615598|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2615599|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615600|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
2615601|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2615602|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615603|NCT01852604|Interferons|interferons|mesh-list
2615604|NCT01852604|Ritonavir|ritonavir|mesh-list
2615605|NCT01852604|Ribavirin|ribavirin|mesh-list
2615606|NCT01852604|Simeprevir|simeprevir|mesh-list
2160060|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
2160061|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160062|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160063|NCT00795236|Melatonin|melatonin|mesh-list
2160064|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
2160065|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615607|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615608|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
2615609|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615610|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2615611|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2615612|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
2615613|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615614|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615615|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2615616|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2615617|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2615618|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2615619|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
2615620|NCT01852630|Imipenem|imipenem|mesh-list
2615621|NCT01852630|Cefepime|cefepime|mesh-list
2615622|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2615623|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615624|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
2615625|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
2615626|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2615627|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2615628|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615629|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2615630|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
2160066|NCT00795236|Protective Agents|protective agents|mesh-ancestor
2160067|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160068|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160069|NCT00799773|Rituximab|rituximab|mesh-list
2160070|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2615631|NCT01852890|Gemcitabine|gemcitabine|mesh-list
2615632|NCT01852890|Vitamins|vitamins|mesh-ancestor
2615633|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
2615634|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615635|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2615636|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
2615637|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615638|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615639|NCT01852890|Antiviral Agents|antiviral agents|mesh-ancestor
2615640|NCT01852890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615641|NCT01852890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615642|NCT01852890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2615643|NCT01852890|Immunologic Factors|immunologic factors|mesh-ancestor
2615644|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
2615645|NCT01852890|Protective Agents|protective agents|mesh-ancestor
2615646|NCT01852903|Vitamins|vitamins|mesh-list
2615647|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
2615648|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
2615649|NCT01852903|Calcium|calcium|mesh-list
2615650|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
2615651|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615652|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2615653|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
2615654|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615655|NCT01852903|Protective Agents|protective agents|mesh-ancestor
2615656|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
2615657|NCT01852994|Testosterone|testosterone|mesh-list
2615658|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
2615659|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
2615660|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2615661|NCT01852994|Androgens|androgens|mesh-ancestor
2615662|NCT01852994|Hormones|hormones|mesh-ancestor
2615663|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2615664|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615665|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2615666|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615667|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
2615668|NCT01853111|Aldesleukin|aldesleukin|mesh-list
2615669|NCT01853111|Interleukin-2|interleukin-2|mesh-list
2615670|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615671|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2615672|NCT01853111|Analgesics|analgesics|mesh-ancestor
2615673|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
2615674|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615675|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615676|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2615677|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2615678|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
2615679|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615680|NCT01853306|Veliparib|veliparib|mesh-list
2615681|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2615682|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615683|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615684|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615685|NCT01853423|Sirolimus|sirolimus|mesh-list
2615686|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2615687|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615688|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2615689|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615690|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
2615691|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2615692|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
2615693|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615694|NCT01853449|Fentanyl|fentanyl|mesh-list
2615695|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2615696|NCT01853449|Narcotics|narcotics|mesh-ancestor
2615697|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2615698|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615699|NCT01853449|Analgesics|analgesics|mesh-ancestor
2160071|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615700|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
2615701|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615702|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2615703|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2615704|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
2615705|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
2615706|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
2615707|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
2615708|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2615709|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2615710|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615711|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615712|NCT01853540|Urological Agents|urological agents|mesh-ancestor
2615713|NCT01853566|Hormones|hormones|mesh-list
2615714|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160072|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
2615715|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615727|NCT01853709|Bisacodyl|bisacodyl|mesh-list
2615728|NCT01853709|Cathartics|cathartics|mesh-ancestor
2615729|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2615730|NCT01853709|Laxatives|laxatives|mesh-ancestor
2160073|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160074|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2160075|NCT00790452|Aspirin|aspirin|mesh-list
2160076|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2160077|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2160078|NCT00790452|Analgesics|analgesics|mesh-ancestor
2160079|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
2160080|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160081|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160082|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2160083|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2615742|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
2615743|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2615744|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2615745|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
2615746|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615747|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615748|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2615749|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
2615750|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2615751|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2615752|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2615753|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
2615754|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615755|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615756|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
2615757|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2615758|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
2615759|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2615760|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
2615761|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615762|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615763|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
2615764|NCT01853813|Bevacizumab|bevacizumab|mesh-list
2615765|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2615766|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615767|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2615768|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2615769|NCT01853813|Growth Substances|growth substances|mesh-ancestor
2615770|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615771|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
2615772|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
2615773|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
2615774|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615775|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615776|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615777|NCT01853956|Alprazolam|alprazolam|mesh-list
2615778|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2615779|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2615780|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615781|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2615782|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2615783|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2615784|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
2615785|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
2615786|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160084|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2160085|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2160086|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160087|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2160088|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2160089|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160090|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
2160091|NCT00795665|Bevacizumab|bevacizumab|mesh-list
2160092|NCT00795665|Carmustine|carmustine|mesh-list
2615787|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615788|NCT01854021|Anesthetics|anesthetics|mesh-list
2615789|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2615790|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615791|NCT01854073|Scopolamine|scopolamine|mesh-list
2615792|NCT01854073|Bromides|bromides|mesh-list
2615793|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2615794|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
2160093|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2160094|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160095|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2160096|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2160097|NCT00795665|Growth Substances|growth substances|mesh-ancestor
2160098|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160099|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
2160100|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2160101|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
2160102|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160103|NCT00787917|Omalizumab|omalizumab|mesh-list
2160104|NCT00787917|Itraconazole|itraconazole|mesh-list
2160105|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
2160106|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615795|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2615796|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
2615797|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
2615798|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615799|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615800|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2615801|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
2615802|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2615803|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
2615804|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615805|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160107|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2160108|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2160109|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160110|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160111|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2160112|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
2160113|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160114|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160115|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2160116|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2160117|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2160118|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
2160119|NCT00798590|Glucagon|glucagon|mesh-list
2160120|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2160121|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2160122|NCT00798590|Hormones|hormones|mesh-ancestor
2615806|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2615807|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
2615808|NCT01854086|Diphosphonates|diphosphonates|mesh-list
2615809|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2160123|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160124|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615810|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615811|NCT01854203|Gemcitabine|gemcitabine|mesh-list
2615812|NCT01854203|Cisplatin|cisplatin|mesh-list
2615813|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615814|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2615815|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
2615816|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615817|NCT01854203|Antiviral Agents|antiviral agents|mesh-ancestor
2615818|NCT01854203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615819|NCT01854203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615820|NCT01854203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2615821|NCT01854203|Immunologic Factors|immunologic factors|mesh-ancestor
2615822|NCT01854203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615823|NCT01854216|Rotigotine|rotigotine|mesh-list
2615824|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
2615825|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
2615826|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615827|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615828|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615829|NCT01854255|Cisplatin|cisplatin|mesh-list
2615830|NCT01854255|Doxorubicin|doxorubicin|mesh-list
2615831|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2615832|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615833|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2615834|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2615835|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2615836|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615837|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615838|NCT01854411|Analgesics|analgesics|mesh-list
2615839|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
2615840|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615841|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615842|NCT01854463|Vitamin D|vitamin d|mesh-list
2615843|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
2615844|NCT01854463|Vitamins|vitamins|mesh-ancestor
2615845|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
2160125|NCT00798590|Incretins|incretins|mesh-ancestor
2160126|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
2160127|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
2160128|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
2160129|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2160130|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2160131|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160132|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160133|NCT00796510|Urological Agents|urological agents|mesh-ancestor
2160134|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2160135|NCT00796861|Sunitinib|sunitinib|mesh-list
2160136|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160137|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2615846|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615847|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2615848|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2615849|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
2615850|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2615851|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2615852|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615853|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
2615854|NCT01854476|Coagulants|coagulants|mesh-ancestor
2615855|NCT01854489|Rifampin|rifampin|mesh-list
2615856|NCT01854489|Buprenorphine|buprenorphine|mesh-list
2615857|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2615858|NCT01854489|Narcotics|narcotics|mesh-ancestor
2160138|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2160139|NCT00796861|Growth Substances|growth substances|mesh-ancestor
2160140|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160141|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
2160142|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2160143|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160144|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160145|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
2160146|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2160147|NCT00791076|Hormones|hormones|mesh-ancestor
2160148|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160149|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160150|NCT00790478|Melatonin|melatonin|mesh-list
2160151|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
2615859|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2615860|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615861|NCT01854489|Analgesics|analgesics|mesh-ancestor
2615862|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
2615863|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421879|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421880|NCT00814619|Capecitabine|capecitabine|mesh-list
2421881|NCT00814619|Panitumumab|panitumumab|mesh-list
2421882|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2421883|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
2421884|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421885|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421886|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2421887|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2615864|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2615865|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2615866|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
2615867|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2615868|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615869|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
2615870|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2615871|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615872|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615873|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2615874|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2615875|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2615876|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2615877|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2615878|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2615879|NCT01854502|Fluorides|fluorides|mesh-list
2615880|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
2615881|NCT01854502|Protective Agents|protective agents|mesh-ancestor
2615882|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615883|NCT01854515|Dexamethasone|dexamethasone|mesh-list
2160152|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160153|NCT00790478|Protective Agents|protective agents|mesh-ancestor
2160154|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160155|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160156|NCT00796107|Letrozole|letrozole|mesh-list
2160157|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160158|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2160159|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2160160|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160161|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160162|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2615884|NCT01854515|Budesonide|budesonide|mesh-list
2615885|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
2615886|NCT01854515|BB 1101|bb 1101|mesh-list
2615887|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2615888|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
2615889|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
2615890|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2615891|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615892|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2615893|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
2615894|NCT01854515|Hormones|hormones|mesh-ancestor
2615895|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2615896|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2615897|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615898|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2615899|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2615900|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
2615901|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
2160163|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
2160164|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421888|NCT00814723|Ezetimibe|ezetimibe|mesh-list
2615902|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615903|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615904|NCT01854606|Everolimus|everolimus|mesh-list
2615905|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615906|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2615907|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
2615908|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615909|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
2615910|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2615911|NCT01854684|Temoporfin|temoporfin|mesh-list
2615912|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615913|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2615914|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
2615915|NCT01854723|Insulin|insulin|mesh-list
2615916|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2615917|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
2615918|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
2615919|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
2615920|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
2615921|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2615922|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615923|NCT01854749|Cisplatin|cisplatin|mesh-list
2615924|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615925|NCT01854762|Ritonavir|ritonavir|mesh-list
2615926|NCT01854762|Lopinavir|lopinavir|mesh-list
2615927|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
2615928|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2615929|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2615930|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
2615931|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615932|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615933|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2615934|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2615935|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
2615936|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160165|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160166|NCT00791336|Nelfinavir|nelfinavir|mesh-list
2160167|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2160168|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2160169|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
2160170|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160171|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160172|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2160173|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2160174|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
2160175|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160176|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
2160177|NCT00786682|Docetaxel|docetaxel|mesh-list
2160178|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160179|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
2160180|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
2160181|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
2160182|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160183|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
2160184|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2160185|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2160186|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160187|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160188|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2160189|NCT00791843|Hormones|hormones|mesh-list
2160190|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
2160191|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160192|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160193|NCT00774306|Phenytoin|phenytoin|mesh-list
2160194|NCT00774306|Levetiracetam|levetiracetam|mesh-list
2160195|NCT00774306|Valproic Acid|valproic acid|mesh-list
2160196|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
2615937|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2615938|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2615939|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2615940|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2615941|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
2615942|NCT01854814|Losartan|losartan|mesh-list
2615943|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2615944|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2615945|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2160197|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
2160198|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160199|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160200|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
2160201|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615946|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
2615947|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2615948|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2615949|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615950|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615951|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2615952|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2615953|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2615954|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2615955|NCT01854970|Esomeprazole|esomeprazole|mesh-list
2615956|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2615957|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2615958|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2615959|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615960|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615961|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
2615962|NCT01855009|Vitamin D|vitamin d|mesh-list
2615963|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
2615964|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
2160202|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160203|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
2160204|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2615965|NCT01855009|Calcium|calcium|mesh-list
2615966|NCT01855009|Vitamins|vitamins|mesh-ancestor
2615967|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
2615968|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615969|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2615970|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2615971|NCT01855009|Antacids|antacids|mesh-ancestor
2160205|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160206|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2160207|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2160208|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2160209|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2160210|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2160211|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2160212|NCT00771602|Rituximab|rituximab|mesh-list
2160213|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
2160214|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2160215|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160216|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
2160217|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160218|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2160219|NCT00779038|Fentanyl|fentanyl|mesh-list
2160220|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2160221|NCT00779038|Narcotics|narcotics|mesh-ancestor
2160222|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160223|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160224|NCT00779038|Analgesics|analgesics|mesh-ancestor
2160225|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
2160226|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160227|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2160228|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2160229|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
2160230|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
2160231|NCT00780455|Interferons|interferons|mesh-list
2160232|NCT00780455|Interferon-beta|interferon-beta|mesh-list
2160233|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
2160234|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160235|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
2160236|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160237|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
2160238|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160239|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2160240|NCT00771316|Meropenem|meropenem|mesh-list
2160241|NCT00771316|Ertapenem|ertapenem|mesh-list
2160242|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2160243|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160244|NCT00780481|Bradykinin|bradykinin|mesh-list
2160245|NCT00780481|Kininogens|kininogens|mesh-list
2160246|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
2160247|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2160248|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
2160249|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615972|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615973|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2615974|NCT01855061|Midazolam|midazolam|mesh-list
2615975|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2615976|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2160250|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160251|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2160252|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
2160253|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2160254|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160255|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2160256|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2160257|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2160258|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160259|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
2160260|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615977|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2615978|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2615979|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2615980|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2615981|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2615982|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2615983|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
2615984|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
2615985|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
2615986|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
2615987|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2615988|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615989|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
2615990|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2615991|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
2615992|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2615993|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
2615994|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2615995|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2615996|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
2615997|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
2615998|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2615999|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
2616000|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2616001|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
2616002|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616003|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616004|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
2616005|NCT01855256|Oxybutynin|oxybutynin|mesh-list
2616006|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
2160261|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
2160262|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2160263|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2160264|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
2160265|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2160266|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160267|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2160268|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2160269|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2160270|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2616007|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
2616008|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616009|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616010|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2616011|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2616012|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
2616013|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616014|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616015|NCT01855256|Urological Agents|urological agents|mesh-ancestor
2616016|NCT01855321|Vitamin D|vitamin d|mesh-list
2616017|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
2616018|NCT01855321|Vitamins|vitamins|mesh-ancestor
2616019|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
2616020|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616021|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2616022|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2616023|NCT01855334|Spironolactone|spironolactone|mesh-list
2616024|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2616025|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
2616026|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2616027|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616028|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2616029|NCT01855334|Diuretics|diuretics|mesh-ancestor
2616030|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
2616031|NCT01855386|Liver Extracts|liver extracts|mesh-list
2160271|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160272|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2616032|NCT01855386|Hematinics|hematinics|mesh-ancestor
2616033|NCT01855451|Cetuximab|cetuximab|mesh-list
2616034|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616035|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2616036|NCT01855490|Exenatide|exenatide|mesh-list
2616037|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2160273|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2160274|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160275|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160276|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160277|NCT00755261|Bevacizumab|bevacizumab|mesh-list
2616038|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616039|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2616040|NCT01855490|Incretins|incretins|mesh-ancestor
2616041|NCT01855490|Hormones|hormones|mesh-ancestor
2616042|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2616043|NCT01855516|Heparin|heparin|mesh-list
2616044|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
2616045|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2616046|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2616047|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616048|NCT01855529|Ropivacaine|ropivacaine|mesh-list
2616049|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
2616050|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
2616051|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616052|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616053|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
2616054|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616055|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
2616056|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2616057|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2616058|NCT01855555|Propofol|propofol|mesh-list
2616059|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2616060|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616061|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616062|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2616063|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
2616064|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
2616065|NCT01855568|Methotrexate|methotrexate|mesh-list
2616066|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2616067|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
2616068|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2616069|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616070|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2616071|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
2616072|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616073|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616074|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
2616075|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616076|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2616077|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2616078|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
2616079|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2616080|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2616081|NCT01855581|Ketamine|ketamine|mesh-list
2616082|NCT01855581|Propofol|propofol|mesh-list
2616083|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2616084|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616085|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616086|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2616087|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
2616088|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
2616089|NCT01855581|Analgesics|analgesics|mesh-ancestor
2616090|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
2616091|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616092|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2616093|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2616094|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2616095|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616096|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616097|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
2616098|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
2616099|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2616100|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616101|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616102|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
2616103|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2616104|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616105|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616106|NCT01855607|Menthol|menthol|mesh-list
2616107|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
2616108|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
2616109|NCT01855711|Alosetron|alosetron|mesh-list
2616110|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2616111|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2616112|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
2616113|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616114|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616115|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160278|NCT00755261|Doxorubicin|doxorubicin|mesh-list
2160279|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2160280|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160281|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2160282|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2160283|NCT00755261|Growth Substances|growth substances|mesh-ancestor
2160284|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160285|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
2160286|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2616116|NCT01855724|Gemcitabine|gemcitabine|mesh-list
2616117|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2616118|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
2160287|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2160288|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2160289|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160290|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160291|NCT00766636|Gemcitabine|gemcitabine|mesh-list
2160292|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2160293|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2160294|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
2160295|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160296|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160297|NCT00766636|Antiviral Agents|antiviral agents|mesh-ancestor
2160298|NCT00766636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160299|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160300|NCT00766636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2160301|NCT00766636|Immunologic Factors|immunologic factors|mesh-ancestor
2160302|NCT00766636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160303|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2160304|NCT00768248|Ropivacaine|ropivacaine|mesh-list
2160305|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
2616119|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616120|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616121|NCT01855724|Antiviral Agents|antiviral agents|mesh-ancestor
2616122|NCT01855724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160306|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
2160307|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160308|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160309|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
2160310|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160311|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
2160312|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
2160313|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2160314|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2160315|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160316|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160317|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160318|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2160319|NCT00764699|Mecasermin|mecasermin|mesh-list
2160320|NCT00764699|Growth Substances|growth substances|mesh-ancestor
2160321|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160322|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
2160323|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2160324|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2160325|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
2160326|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160327|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160328|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160329|NCT00759577|Urological Agents|urological agents|mesh-ancestor
2616123|NCT01855724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616124|NCT01855724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2616125|NCT01855724|Immunologic Factors|immunologic factors|mesh-ancestor
2616126|NCT01855724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616127|NCT01855737|Warfarin|warfarin|mesh-list
2616128|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
2616129|NCT01855763|Insulin|insulin|mesh-list
2616130|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2616131|NCT01855763|Metformin|metformin|mesh-list
2616132|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2616133|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616134|NCT01855867|Tenofovir|tenofovir|mesh-list
2616135|NCT01855867|Emtricitabine|emtricitabine|mesh-list
2616136|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
2616137|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2616138|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2616139|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2616140|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616141|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616142|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2616143|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2616144|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2616145|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
2616146|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616147|NCT01855971|Protective Agents|protective agents|mesh-ancestor
2616148|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616149|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2616150|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2616151|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160330|NCT00763009|Dipyridamole|dipyridamole|mesh-list
2160331|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2160332|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160333|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160334|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2160335|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
2160336|NCT00760461|Domperidone|domperidone|mesh-list
2160337|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
2160338|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
2160339|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160340|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160341|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2160342|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2160343|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
2160344|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160345|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160346|NCT00749658|Bupropion|bupropion|mesh-list
2160347|NCT00749658|Varenicline|varenicline|mesh-list
2160348|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2160349|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
2160350|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2160351|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2160352|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2160353|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2160354|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160355|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
2160356|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160357|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160358|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2160359|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2616152|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2616153|NCT01855984|Tocotrienols|tocotrienols|mesh-list
2616154|NCT01855984|Vitamin E|vitamin e|mesh-list
2616155|NCT01855984|Tocopherols|tocopherols|mesh-list
2616156|NCT01855984|Tocovid|tocovid|mesh-list
2616157|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
2616158|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616159|NCT01855984|Protective Agents|protective agents|mesh-ancestor
2616160|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616161|NCT01855984|Vitamins|vitamins|mesh-ancestor
2616162|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
2616163|NCT01856023|Aldesleukin|aldesleukin|mesh-list
2616164|NCT01856023|Ipilimumab|ipilimumab|mesh-list
2616165|NCT01856023|Interleukin-2|interleukin-2|mesh-list
2616166|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2616167|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616168|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2616169|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616170|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2616171|NCT01856023|Analgesics|analgesics|mesh-ancestor
2616172|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
2616173|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616174|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616175|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2160360|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160361|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2160362|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2160363|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
2160364|NCT00754793|Dexetimide|dexetimide|mesh-list
2160365|NCT00754793|Citalopram|citalopram|mesh-list
2160366|NCT00754793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2616176|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2616177|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
2616178|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2616179|NCT01856062|Dexamethasone|dexamethasone|mesh-list
2616180|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2616181|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
2616182|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
2616183|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616184|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616185|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2616186|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
2616187|NCT01856062|Hormones|hormones|mesh-ancestor
2616188|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2616189|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2616190|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616191|NCT01856101|Dactolisib|dactolisib|mesh-list
2616192|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616193|NCT01856127|Sertraline|sertraline|mesh-list
2616194|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2616195|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
2616196|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2616197|NCT01856127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2616198|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2616199|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2616200|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616201|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616202|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
2616203|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160367|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2160368|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2160369|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160370|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616204|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2616205|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2616206|NCT01856166|Sufentanil|sufentanil|mesh-list
2616207|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
2616208|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
2616209|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
2616210|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616211|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616212|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
2616213|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616214|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2616215|NCT01856166|Narcotics|narcotics|mesh-ancestor
2616216|NCT01856166|Analgesics|analgesics|mesh-ancestor
2616217|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2616218|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2616219|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
2616220|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
2160371|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
2160372|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160373|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2160374|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
2160375|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2160376|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2160377|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2616221|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2616222|NCT01856205|Antibodies|antibodies|mesh-list
2616223|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
2616224|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2616225|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
2616226|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160378|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
2160379|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
2160380|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160381|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2160382|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2160383|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
2160384|NCT00754052|Donepezil|donepezil|mesh-list
2160385|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2160386|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160387|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160388|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
2160389|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616227|NCT01856348|Vitamin D|vitamin d|mesh-list
2616228|NCT01856348|Vitamins|vitamins|mesh-ancestor
2616229|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
2616230|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616231|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2160390|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160391|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
2160392|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2160393|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160394|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2160395|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160396|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160397|NCT00752986|Fulvestrant|fulvestrant|mesh-list
2616232|NCT01856374|Sirolimus|sirolimus|mesh-list
2616233|NCT01856374|Everolimus|everolimus|mesh-list
2616234|NCT01856374|Atorvastatin|atorvastatin|mesh-list
2616235|NCT01856374|Pravastatin|pravastatin|mesh-list
2616236|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2616237|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2616238|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
2616239|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616240|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2616241|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2616242|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160398|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2160399|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160400|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2160401|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2160402|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
2160403|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160404|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160405|NCT00746239|Dexetimide|dexetimide|mesh-list
2160406|NCT00746239|Citalopram|citalopram|mesh-list
2160407|NCT00746239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2160408|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2160409|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2160410|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160411|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160412|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
2160413|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160414|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2160415|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
2160416|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2160417|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2160418|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2160419|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
2616243|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616244|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2616245|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
2616246|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616247|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2616248|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2616249|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2616250|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
2616251|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
2616252|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
2616253|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616254|NCT01856517|Clonidine|clonidine|mesh-list
2616255|NCT01856517|Analgesics|analgesics|mesh-ancestor
2616256|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
2616257|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160420|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
2616258|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616259|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2616260|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
2616261|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
2616262|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2616263|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2616264|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2616265|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
2616266|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616267|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616268|NCT01856556|Glycine|glycine|mesh-list
2616269|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
2616270|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616271|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616272|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616273|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2616274|NCT01856621|Charcoal|charcoal|mesh-list
2616275|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2616276|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
2616277|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616278|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616279|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2616280|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
2160421|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160422|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2160423|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2160424|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
2160425|NCT00754013|Donepezil|donepezil|mesh-list
2160426|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2160427|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160428|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160429|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
2160430|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160431|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160432|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
2616281|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
2616282|NCT01856621|Hormones|hormones|mesh-ancestor
2616283|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2616284|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
2616285|NCT01856621|Antidotes|antidotes|mesh-ancestor
2616286|NCT01856621|Protective Agents|protective agents|mesh-ancestor
2616287|NCT01856738|Rivastigmine|rivastigmine|mesh-list
2616288|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2616289|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160433|NCT00751933|Vaccines|vaccines|mesh-list
2160434|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
2160435|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160436|NCT00746603|Simvastatin|simvastatin|mesh-list
2160437|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2160438|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2160439|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
2160440|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160441|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2160442|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2160443|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160444|NCT00739050|Simvastatin|simvastatin|mesh-list
2160445|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2160446|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2160447|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
2160448|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160449|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2421889|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2421890|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2421891|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
2421892|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421893|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2421894|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
2421895|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
2421896|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2421897|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2421898|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421899|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421900|NCT00814736|Urological Agents|urological agents|mesh-ancestor
2421901|NCT00814762|Vaccines|vaccines|mesh-list
2421902|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
2616290|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616291|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
2160450|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2160451|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160452|NCT00736385|Metformin|metformin|mesh-list
2160453|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2160454|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160455|NCT00738972|Valsartan|valsartan|mesh-list
2160456|NCT00738972|Simvastatin|simvastatin|mesh-list
2160457|NCT00738972|Ezetimibe|ezetimibe|mesh-list
2160458|NCT00738972|Pravastatin|pravastatin|mesh-list
2160459|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2160460|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2160461|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
2616292|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616293|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616294|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2616295|NCT01856738|Protective Agents|protective agents|mesh-ancestor
2616296|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
2616297|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2616298|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
2616299|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616300|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2616301|NCT01856946|Vitamin D|vitamin d|mesh-list
2616302|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
2616303|NCT01856946|Vitamins|vitamins|mesh-ancestor
2616304|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
2616305|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616306|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2616307|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2160462|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160463|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2160464|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2160465|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160466|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2160467|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2160468|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2160469|NCT00743197|Aspirin|aspirin|mesh-list
2160470|NCT00743197|Lisinopril|lisinopril|mesh-list
2160471|NCT00743197|Simvastatin|simvastatin|mesh-list
2160472|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2160473|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2160474|NCT00743197|Analgesics|analgesics|mesh-ancestor
2160475|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
2160476|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160477|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160478|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2160479|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2616308|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
2616309|NCT01856959|Albuterol|albuterol|mesh-list
2616310|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2616311|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
2616312|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616313|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616314|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2616315|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
2616316|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
2616317|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2616318|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2616319|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2616320|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2616321|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
2616322|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616323|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616324|NCT01856959|Analgesics|analgesics|mesh-ancestor
2616325|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
2616326|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
2616327|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616328|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2616329|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
2616330|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2616331|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2616332|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2616333|NCT01856985|Misoprostol|misoprostol|mesh-list
2616334|NCT01856985|Mifepristone|mifepristone|mesh-list
2160480|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2616335|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2616336|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
2616337|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2616338|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616339|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2616340|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2616341|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
2616342|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2616343|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2616344|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2616345|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2616346|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
2616347|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2616348|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2616349|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
2616350|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2616351|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
2616352|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2616353|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2616354|NCT01856998|Propofol|propofol|mesh-list
2616355|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2160481|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2160482|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160483|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2160484|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2160485|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160486|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
2160487|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2160488|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2160489|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
2160490|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2160491|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2160492|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2160493|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
2160494|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2616356|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616357|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616358|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2616359|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
2616360|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
2616361|NCT01857011|Iron|iron|mesh-list
2616362|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2616363|NCT01857011|Teferrol|teferrol|mesh-list
2616364|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
2616365|NCT01857011|Trace Elements|trace elements|mesh-ancestor
2616366|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
2616367|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616368|NCT01857011|Hematinics|hematinics|mesh-ancestor
2616369|NCT01857024|Sevelamer|sevelamer|mesh-list
2616370|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
2616371|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
2616372|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616373|NCT01857115|Dexamethasone|dexamethasone|mesh-list
2616374|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
2616375|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2616376|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
2616377|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616378|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2616379|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2616380|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
2616381|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616382|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616383|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2616384|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2616385|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
2616386|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
2616387|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616388|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2616389|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
2616390|NCT01857115|Hormones|hormones|mesh-ancestor
2616391|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2616392|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2616393|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
2616394|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2616395|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616396|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616397|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2616398|NCT01857141|Analgesics|analgesics|mesh-ancestor
2616399|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
2616400|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616401|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2616402|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2616403|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2616404|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
2616405|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616406|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616407|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
2616408|NCT01857154|Vitamin D|vitamin d|mesh-list
2616409|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
2616410|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
2616411|NCT01857154|Calcium|calcium|mesh-list
2616412|NCT01857154|Vitamins|vitamins|mesh-ancestor
2616413|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
2616414|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616415|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2616416|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2616417|NCT01857154|Antacids|antacids|mesh-ancestor
2616418|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616419|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2616420|NCT01857193|Everolimus|everolimus|mesh-list
2616421|NCT01857193|Exemestane|exemestane|mesh-list
2616422|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616423|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2160495|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2160496|NCT00743197|Protective Agents|protective agents|mesh-ancestor
2160497|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2160498|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160499|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2160500|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160501|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160502|NCT00739882|Antibodies|antibodies|mesh-list
2616424|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
2616425|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616426|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2616427|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2616428|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616429|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616430|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2616431|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
2616432|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160503|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2160504|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
2160505|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160506|NCT00731770|Fluticasone|fluticasone|mesh-list
2160507|NCT00731770|Xhance|xhance|mesh-list
2160508|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2160509|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2160510|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2160511|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2160512|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
2160513|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160514|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616433|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
2616434|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2616435|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2616436|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2616437|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
2616438|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160515|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2160516|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
2160517|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
2160518|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2160519|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2160520|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2160521|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2160522|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
2160523|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160524|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160525|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
2616439|NCT01857349|Ethanol|ethanol|mesh-list
2616440|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
2616441|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2616442|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2616443|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2616444|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616445|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616446|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
2616447|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
2616448|NCT01857375|Insulin|insulin|mesh-list
2616449|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2616450|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616451|NCT01857453|Etoposide|etoposide|mesh-list
2616452|NCT01857453|Carboplatin|carboplatin|mesh-list
2616453|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2616454|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616455|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2616456|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2616457|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616458|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616459|NCT01857479|Amphotericin B|amphotericin b|mesh-list
2616460|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2160526|NCT00731770|Hormones|hormones|mesh-ancestor
2160527|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160528|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
2160529|NCT00729365|Ramipril|ramipril|mesh-list
2160530|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2160531|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
2160532|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160533|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160534|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2160535|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
2160536|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2160537|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2160538|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2160539|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2160540|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160541|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
2160542|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160543|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160544|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2160545|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160546|NCT00726180|Trastuzumab|trastuzumab|mesh-list
2160547|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2616461|NCT01857479|Budesonide|budesonide|mesh-list
2616462|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2616463|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2616464|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
2616465|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616466|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616467|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2616468|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
2616469|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
2616470|NCT01857479|Hormones|hormones|mesh-ancestor
2616471|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2616472|NCT01857479|Amebicides|amebicides|mesh-ancestor
2616473|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2616474|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2616475|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2616476|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2616477|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
2616478|NCT01857544|Aflibercept|aflibercept|mesh-list
2616479|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2616480|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2616481|NCT01857544|Growth Substances|growth substances|mesh-ancestor
2616482|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616483|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
2616484|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616485|NCT01857596|Trazodone|trazodone|mesh-list
2616486|NCT01857596|Bupropion|bupropion|mesh-list
2616487|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2616488|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
2616489|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2616490|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2616491|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2616492|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2616493|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616494|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
2616495|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616496|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616497|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2616498|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2616499|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616500|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2616501|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2616502|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616503|NCT01857596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2616504|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
2616505|NCT01857609|Metformin|metformin|mesh-list
2616506|NCT01857609|Rabeprazole|rabeprazole|mesh-list
2616507|NCT01857609|Pantoprazole|pantoprazole|mesh-list
2616508|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2616509|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616510|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2616511|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2616512|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2160548|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160549|NCT00724282|Eszopiclone|eszopiclone|mesh-list
2160550|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2160551|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160552|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616513|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616514|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616515|NCT01857726|Doxorubicin|doxorubicin|mesh-list
2616516|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616517|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2616518|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2160553|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
2160554|NCT00728845|Paclitaxel|paclitaxel|mesh-list
2160555|NCT00728845|Bevacizumab|bevacizumab|mesh-list
2160556|NCT00728845|Carboplatin|carboplatin|mesh-list
2616519|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2616520|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616521|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616522|NCT01857752|Temozolomide|temozolomide|mesh-list
2616523|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2616524|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
2616525|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616526|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616527|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2616528|NCT01857804|Amoxicillin|amoxicillin|mesh-list
2616529|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
2616530|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2160557|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2160558|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160559|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
2160560|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
2160561|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
2160562|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160563|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2160564|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2160565|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2160566|NCT00728845|Growth Substances|growth substances|mesh-ancestor
2160567|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160568|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
2160569|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
2160570|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2160571|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2160572|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160573|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160574|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2160575|NCT00726830|Morphine|morphine|mesh-list
2160576|NCT00726830|Oxycodone|oxycodone|mesh-list
2160577|NCT00726830|Methadone|methadone|mesh-list
2160578|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2160579|NCT00726830|Narcotics|narcotics|mesh-ancestor
2160580|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616531|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160581|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160582|NCT00726830|Analgesics|analgesics|mesh-ancestor
2616532|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2160583|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
2160584|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160585|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
2160586|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
2160587|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
2160588|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160589|NCT00729560|Flutamide|flutamide|mesh-list
2160590|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
2160591|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
2160592|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160593|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160594|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2160595|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160596|NCT00716807|Nalbuphine|nalbuphine|mesh-list
2160597|NCT00716807|Naloxone|naloxone|mesh-list
2160598|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2160599|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160600|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
2160601|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616533|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
2616534|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
2616535|NCT01857817|Etodolac|etodolac|mesh-list
2616536|NCT01857817|Propranolol|propranolol|mesh-list
2616537|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2616538|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2160602|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2160603|NCT00716807|Narcotics|narcotics|mesh-ancestor
2160604|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160605|NCT00716807|Analgesics|analgesics|mesh-ancestor
2160606|NCT00714948|Gemcitabine|gemcitabine|mesh-list
2160607|NCT00714948|Sorafenib|sorafenib|mesh-list
2160608|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160609|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2616539|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
2616540|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616541|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616542|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616543|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2616544|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2616545|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
2616546|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2616547|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2616548|NCT01857817|Analgesics|analgesics|mesh-ancestor
2616549|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
2616550|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616551|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2616552|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2616553|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2616554|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2616555|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616556|NCT01857843|Everolimus|everolimus|mesh-list
2616557|NCT01857843|Simvastatin|simvastatin|mesh-list
2616558|NCT01857843|Ezetimibe|ezetimibe|mesh-list
2616559|NCT01857843|Pravastatin|pravastatin|mesh-list
2616560|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616561|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2616562|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
2421903|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421904|NCT00814866|Adalimumab|adalimumab|mesh-list
2421905|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2421906|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421907|NCT00814905|Clindamycin|clindamycin|mesh-list
2421908|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
2421909|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
2421910|NCT00814905|Gentamicins|gentamicins|mesh-list
2421911|NCT00814905|Ampicillin|ampicillin|mesh-list
2421912|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2421913|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421914|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2421915|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421916|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616563|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616564|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2616565|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2616566|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
2616567|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421917|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2160610|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
2616568|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2616569|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2616570|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616571|NCT01857856|Eplerenone|eplerenone|mesh-list
2616572|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2616573|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
2616574|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2616575|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616576|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2616577|NCT01857856|Diuretics|diuretics|mesh-ancestor
2616578|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
2616579|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2616580|NCT01857895|Exenatide|exenatide|mesh-list
2616581|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2616582|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616583|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2616584|NCT01857895|Incretins|incretins|mesh-ancestor
2616585|NCT01857895|Hormones|hormones|mesh-ancestor
2616586|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2616587|NCT01857921|Trimetazidine|trimetazidine|mesh-list
2616588|NCT01857921|Atorvastatin|atorvastatin|mesh-list
2160611|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160612|NCT00714948|Antiviral Agents|antiviral agents|mesh-ancestor
2160613|NCT00714948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160614|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160615|NCT00714948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2160616|NCT00714948|Immunologic Factors|immunologic factors|mesh-ancestor
2160617|NCT00714948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160618|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2160619|NCT00720343|Choline|choline|mesh-list
2616589|NCT01857921|Pravastatin|pravastatin|mesh-list
2616590|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2616591|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2616592|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
2616593|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616594|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2616595|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2616596|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616597|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
2160620|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
2160621|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2160622|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
2160623|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160624|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2160625|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2160626|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
2160627|NCT00719914|Eptifibatide|eptifibatide|mesh-list
2160628|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2160629|NCT00718640|Dexamethasone|dexamethasone|mesh-list
2160630|NCT00718640|Bortezomib|bortezomib|mesh-list
2160631|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2160632|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
2160633|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
2160634|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160635|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160636|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2160637|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
2160638|NCT00718640|Hormones|hormones|mesh-ancestor
2160639|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160640|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2160641|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160642|NCT00720083|Cisplatin|cisplatin|mesh-list
2160643|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160644|NCT00717275|Temozolomide|temozolomide|mesh-list
2160645|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2160646|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
2160647|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160648|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160649|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
2160650|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2160651|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2160652|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2160653|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2160654|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160655|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
2160656|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160657|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160658|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2160659|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160660|NCT00706797|Etanercept|etanercept|mesh-list
2160661|NCT00706797|Methotrexate|methotrexate|mesh-list
2160662|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2160663|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
2160664|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2160665|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160666|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2160667|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
2160668|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160669|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160670|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
2160671|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616646|NCT01857999|Losartan|losartan|mesh-list
2616647|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2616648|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2616649|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2616650|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2616651|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616652|NCT01858025|Fluorouracil|fluorouracil|mesh-list
2616653|NCT01858025|Mitomycins|mitomycins|mesh-list
2616654|NCT01858025|Mitomycin|mitomycin|mesh-list
2616655|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
2616656|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616657|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2616658|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616659|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2616660|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
2616661|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616662|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2616663|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
2616664|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2616665|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616666|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
2616667|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2616668|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616669|NCT01858051|Vitamins|vitamins|mesh-ancestor
2616670|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
2616671|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2616672|NCT01858077|Everolimus|everolimus|mesh-list
2616673|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616674|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2616675|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
2616676|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616677|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
2616678|NCT01858090|Promethazine|promethazine|mesh-list
2616679|NCT01858090|Diclofenac|diclofenac|mesh-list
2616680|NCT01858090|Atropine|atropine|mesh-list
2616681|NCT01858090|Ephedrine|ephedrine|mesh-list
2616682|NCT01858090|Fentanyl|fentanyl|mesh-list
2616683|NCT01858090|Sufentanil|sufentanil|mesh-list
2616684|NCT01858090|Meperidine|meperidine|mesh-list
2160672|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2160673|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2160674|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
2160675|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2160676|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2160677|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2160678|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2160679|NCT00706797|Analgesics|analgesics|mesh-ancestor
2160680|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
2160681|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160682|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2160683|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2160684|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2160685|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
2160686|NCT00713596|Coagulants|coagulants|mesh-ancestor
2160687|NCT00703885|Alprazolam|alprazolam|mesh-list
2160688|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2160689|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160690|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616685|NCT01858090|Metoclopramide|metoclopramide|mesh-list
2616686|NCT01858090|Propofol|propofol|mesh-list
2616687|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
2616688|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2616689|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616690|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616691|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2616692|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
2616693|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
2616694|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2616695|NCT01858090|Narcotics|narcotics|mesh-ancestor
2616696|NCT01858090|Analgesics|analgesics|mesh-ancestor
2616697|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
2616698|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616699|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2616700|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2616701|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2616702|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2616703|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2616704|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2616705|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616706|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616707|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2160691|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2160692|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2160693|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2160694|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
2160695|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
2160696|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160697|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160698|NCT00713258|Alendronate|alendronate|mesh-list
2616708|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2616709|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
2616710|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2616711|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
2616712|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
2616713|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
2616714|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2616715|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2160699|NCT00713258|Hormones|hormones|mesh-list
2160700|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
2160701|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160702|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160703|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2160704|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2160705|NCT00707161|Cisplatin|cisplatin|mesh-list
2160706|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160707|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
2160708|NCT00704496|Ephedrine|ephedrine|mesh-list
2160709|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2160710|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
2160711|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160712|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616716|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
2616717|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2616718|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2616719|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
2616720|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
2616721|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2616722|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2616723|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
2616724|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
2616725|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2616726|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
2616727|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
2616728|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2616729|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2616730|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
2616731|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2616732|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
2616733|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2616734|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
2616735|NCT01858155|Melatonin|melatonin|mesh-list
2616736|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
2616737|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616738|NCT01858155|Protective Agents|protective agents|mesh-ancestor
2616739|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616740|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616741|NCT01858168|Irinotecan|irinotecan|mesh-list
2616742|NCT01858168|Temozolomide|temozolomide|mesh-list
2616743|NCT01858168|Olaparib|olaparib|mesh-list
2616744|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2616745|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2616746|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616747|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616748|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616749|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2616750|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
2616751|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2616752|NCT01858207|Doxorubicin|doxorubicin|mesh-list
2616753|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2616754|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616755|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2616756|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2616757|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616758|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616759|NCT01858311|Tocotrienols|tocotrienols|mesh-list
2616760|NCT01858311|Vitamin E|vitamin e|mesh-list
2616761|NCT01858311|Tocopherols|tocopherols|mesh-list
2616762|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
2616763|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616764|NCT01858311|Protective Agents|protective agents|mesh-ancestor
2616765|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616766|NCT01858311|Vitamins|vitamins|mesh-ancestor
2616767|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
2616768|NCT01858402|Acetaminophen|acetaminophen|mesh-list
2616769|NCT01858402|Dipyrone|dipyrone|mesh-list
2616770|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2160713|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2616771|NCT01858402|Analgesics|analgesics|mesh-ancestor
2616772|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
2616773|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616774|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616775|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
2160714|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
2160715|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
2160716|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2160717|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2160718|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
2160719|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
2160720|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160721|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160722|NCT00708916|Apremilast|apremilast|mesh-list
2160723|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2160724|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2616776|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2616777|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2616778|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2616779|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
2616780|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616781|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2616782|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616783|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616784|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
2616785|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160725|NCT00708916|Analgesics|analgesics|mesh-ancestor
2160726|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
2160727|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160728|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160729|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2160730|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2160731|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2160732|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2160733|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160734|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160735|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2616786|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616787|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2616788|NCT01858571|Thalidomide|thalidomide|mesh-list
2616789|NCT01858571|Celecoxib|celecoxib|mesh-list
2616790|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
2616791|NCT01858571|Etoposide|etoposide|mesh-list
2616792|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2616793|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
2616794|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616795|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2616796|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2616797|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
2616798|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616799|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616800|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2616801|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2616802|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2616803|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2616804|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616805|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2160736|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2160737|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160738|NCT00699842|Lenalidomide|lenalidomide|mesh-list
2160739|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
2616806|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2616807|NCT01858571|Analgesics|analgesics|mesh-ancestor
2616808|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
2616809|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2616810|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2616811|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2616812|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2616813|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
2616814|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2616815|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2616816|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2616817|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2616818|NCT01858571|Growth Substances|growth substances|mesh-ancestor
2616819|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
2616820|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2616821|NCT01858610|Irbesartan|irbesartan|mesh-list
2616822|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2616823|NCT01858610|Diuretics|diuretics|mesh-ancestor
2616824|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
2616825|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160740|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160741|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2160742|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2160743|NCT00699842|Growth Substances|growth substances|mesh-ancestor
2160744|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
2160745|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160746|NCT00702962|Carboplatin|carboplatin|mesh-list
2160747|NCT00702962|Etoposide|etoposide|mesh-list
2160748|NCT00702962|Vorinostat|vorinostat|mesh-list
2160749|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160750|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2160751|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2160752|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2160753|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160754|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160755|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2160756|NCT00703534|Lesogaberan|lesogaberan|mesh-list
2616826|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2616827|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2616828|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616829|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2616830|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2421918|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2421919|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
2421920|NCT00814944|Sirolimus|sirolimus|mesh-list
2421921|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2616831|NCT01858623|Losartan|losartan|mesh-list
2616832|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2616833|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2616834|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2616835|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2616836|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2616837|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616838|NCT01858623|Diuretics|diuretics|mesh-ancestor
2616839|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
2616840|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616841|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2616842|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2616843|NCT01858649|Bevacizumab|bevacizumab|mesh-list
2616844|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
2616845|NCT01858649|Irinotecan|irinotecan|mesh-list
2616846|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2616847|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616848|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2616849|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2616850|NCT01858649|Growth Substances|growth substances|mesh-ancestor
2616851|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616852|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
2616853|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2616854|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2616855|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616856|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616857|NCT01858662|Leucovorin|leucovorin|mesh-list
2616858|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
2616859|NCT01858662|Irinotecan|irinotecan|mesh-list
2616860|NCT01858662|Cetuximab|cetuximab|mesh-list
2616861|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616862|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2421922|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2421923|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2421924|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421925|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
2421926|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2421927|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
2421928|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421929|NCT00815022|Fentanyl|fentanyl|mesh-list
2421930|NCT00815022|Morphine|morphine|mesh-list
2421931|NCT00815022|Bupivacaine|bupivacaine|mesh-list
2160757|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2160758|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2160759|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
2160760|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
2160761|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160762|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160763|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160764|NCT00698009|Vidarabine|vidarabine|mesh-list
2160765|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
2160766|NCT00698009|Fludarabine|fludarabine|mesh-list
2160767|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
2160768|NCT00698009|Interleukin-2|interleukin-2|mesh-list
2160769|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2160770|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
2160771|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160772|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2160773|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2160774|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
2160775|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160776|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160777|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2160778|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2160779|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
2160780|NCT00698009|Antiviral Agents|antiviral agents|mesh-ancestor
2160781|NCT00698009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160782|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2160783|NCT00698009|Analgesics|analgesics|mesh-ancestor
2160784|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
2160785|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160786|NCT00703339|Treprostinil|treprostinil|mesh-list
2160787|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2616863|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2616864|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616865|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616866|NCT01858662|Antidotes|antidotes|mesh-ancestor
2616867|NCT01858662|Protective Agents|protective agents|mesh-ancestor
2616868|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616869|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
2616870|NCT01858662|Vitamins|vitamins|mesh-ancestor
2160788|NCT00691444|Melatonin|melatonin|mesh-list
2160789|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
2160790|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160791|NCT00691444|Protective Agents|protective agents|mesh-ancestor
2160792|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160793|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160794|NCT00691652|Rituximab|rituximab|mesh-list
2160795|NCT00691652|Clofarabine|clofarabine|mesh-list
2160796|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2160797|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160798|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
2160799|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616871|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
2616872|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2160800|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2160801|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2160802|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
2160803|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160804|NCT00686972|Glucagon|glucagon|mesh-list
2160805|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2160806|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2160807|NCT00686972|Hormones|hormones|mesh-ancestor
2160808|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2616897|NCT01858792|Belimumab|belimumab|mesh-list
2616898|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2616899|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
2616900|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616901|NCT01858831|Atovaquone|atovaquone|mesh-list
2616902|NCT01858831|Proguanil|proguanil|mesh-list
2160809|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160810|NCT00686972|Incretins|incretins|mesh-ancestor
2160811|NCT00693017|Zonisamide|zonisamide|mesh-list
2160812|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
2160813|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2160814|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2616903|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2616904|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2616905|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
2616906|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2616907|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2616908|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616909|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616910|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
2616911|NCT01858870|Lacosamide|lacosamide|mesh-list
2616912|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
2616913|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2616914|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2616915|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2616916|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616917|NCT01858883|Gemcitabine|gemcitabine|mesh-list
2616918|NCT01858883|Paclitaxel|paclitaxel|mesh-list
2616919|NCT01858883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2616920|NCT01858883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616921|NCT01858883|Tubulin Modulators|tubulin modulators|mesh-ancestor
2616922|NCT01858883|Antimitotic Agents|antimitotic agents|mesh-ancestor
2160815|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160816|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2160817|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160818|NCT00691574|Melatonin|melatonin|mesh-list
2160819|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
2160820|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160821|NCT00691574|Protective Agents|protective agents|mesh-ancestor
2160822|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160823|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160824|NCT00692094|Melatonin|melatonin|mesh-list
2160825|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
2160826|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160827|NCT00692094|Protective Agents|protective agents|mesh-ancestor
2616923|NCT01858883|Mitosis Modulators|mitosis modulators|mesh-ancestor
2616924|NCT01858883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616925|NCT01858883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2616926|NCT01858883|Antimetabolites|antimetabolites|mesh-ancestor
2616927|NCT01858883|Antiviral Agents|antiviral agents|mesh-ancestor
2616928|NCT01858883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2616929|NCT01858883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2616930|NCT01858883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2616931|NCT01858883|Immunologic Factors|immunologic factors|mesh-ancestor
2616932|NCT01858883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616933|NCT01858896|Glucagon|glucagon|mesh-list
2421932|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
2421933|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
2421934|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2421935|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421936|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
2421937|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421938|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2421939|NCT00815022|Narcotics|narcotics|mesh-ancestor
2421940|NCT00815022|Analgesics|analgesics|mesh-ancestor
2160828|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160829|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160830|NCT00692003|Zonisamide|zonisamide|mesh-list
2160831|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
2160832|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2160833|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2160834|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160835|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2160836|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160837|NCT00678288|Interferons|interferons|mesh-list
2160838|NCT00678288|Sorafenib|sorafenib|mesh-list
2160839|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160840|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
2160841|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160842|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2160843|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160844|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160845|NCT00676026|Zolpidem|zolpidem|mesh-list
2160846|NCT00676026|Fluoxetine|fluoxetine|mesh-list
2160847|NCT00676026|Progesterone|progesterone|mesh-list
2160848|NCT00676026|Progestins|progestins|mesh-ancestor
2160849|NCT00676026|Hormones|hormones|mesh-ancestor
2160850|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160851|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160852|NCT00676026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2160853|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2160854|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2160855|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160856|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160857|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
2160858|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2160859|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
2160860|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2160861|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2160862|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2160863|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160864|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2160865|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2160866|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160867|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2160868|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
2160869|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
2160870|NCT00689052|Pramipexole|pramipexole|mesh-list
2160871|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
2160872|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160873|NCT00689052|Protective Agents|protective agents|mesh-ancestor
2160874|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160875|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2160876|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2616934|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2616935|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2616936|NCT01858896|Hormones|hormones|mesh-ancestor
2616937|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2616938|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616939|NCT01858896|Incretins|incretins|mesh-ancestor
2616940|NCT01858909|Melatonin|melatonin|mesh-list
2616941|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
2616942|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616943|NCT01858909|Protective Agents|protective agents|mesh-ancestor
2616944|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160877|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
2616945|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160878|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
2160879|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160880|NCT00678574|Fluoxetine|fluoxetine|mesh-list
2160881|NCT00678574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2160882|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2160883|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2160884|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2616986|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2616987|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
2616988|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2616989|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2616990|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2616991|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2616992|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2616993|NCT01858961|Interferons|interferons|mesh-list
2616994|NCT01858961|Ribavirin|ribavirin|mesh-list
2616995|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2616996|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
2616997|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2616998|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
2616999|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617000|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2160885|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160886|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
2160887|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160888|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2160889|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
2160890|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2160891|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2160892|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2160893|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160894|NCT00683917|Leuprolide|leuprolide|mesh-list
2160895|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2160896|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
2160897|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2160898|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160899|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2160900|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160901|NCT00688935|Melatonin|melatonin|mesh-list
2160902|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
2160903|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160904|NCT00688935|Protective Agents|protective agents|mesh-ancestor
2160905|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160906|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160907|NCT00685880|Betamethasone|betamethasone|mesh-list
2160908|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
2160909|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2160910|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
2160911|NCT00685880|Hormones|hormones|mesh-ancestor
2617001|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617002|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2617003|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617004|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617005|NCT01859234|Bevacizumab|bevacizumab|mesh-list
2617006|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
2617007|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2617008|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617009|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2617010|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2617011|NCT01859234|Growth Substances|growth substances|mesh-ancestor
2617012|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160912|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160913|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160914|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2617013|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
2617014|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2617015|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617016|NCT01859377|Ibuprofen|ibuprofen|mesh-list
2617017|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2617018|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2617019|NCT01859377|Analgesics|analgesics|mesh-ancestor
2617020|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
2617021|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617022|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617023|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2617024|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2617025|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2617026|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617027|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617028|NCT01859455|Atorvastatin|atorvastatin|mesh-list
2617029|NCT01859455|Simvastatin|simvastatin|mesh-list
2617030|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2617031|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2617032|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
2617033|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617034|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2617035|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2617036|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617037|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
2617038|NCT01859468|Calcium|calcium|mesh-list
2617039|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2160915|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
2160916|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2160917|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
2160918|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2160919|NCT00681044|Melphalan|melphalan|mesh-list
2160920|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
2160921|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160922|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2160923|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
2160924|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160925|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160926|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2160927|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2160928|NCT00684255|Fludarabine|fludarabine|mesh-list
2160929|NCT00684255|Busulfan|busulfan|mesh-list
2160930|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
2160931|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160932|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617040|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617041|NCT01859468|Antacids|antacids|mesh-ancestor
2617042|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617043|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2617044|NCT01859481|Eletriptan|eletriptan|mesh-list
2617045|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2617046|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
2617047|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617048|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160933|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2160934|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
2160935|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617049|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617050|NCT01859585|Ketorolac|ketorolac|mesh-list
2617051|NCT01859585|Parecoxib|parecoxib|mesh-list
2617052|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2617053|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2617054|NCT01859585|Analgesics|analgesics|mesh-ancestor
2617055|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
2617056|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617057|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617058|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2617059|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2617060|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2617061|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617062|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617063|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2617064|NCT01859624|Albuterol|albuterol|mesh-list
2617065|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2617066|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
2617067|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617068|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617069|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2617070|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
2617071|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
2617072|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2617073|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2617074|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2617075|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2617076|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
2617077|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617078|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617079|NCT01859728|Gemcitabine|gemcitabine|mesh-list
2617080|NCT01859728|Cisplatin|cisplatin|mesh-list
2617081|NCT01859728|Irinotecan|irinotecan|mesh-list
2617082|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617083|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2617084|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
2617085|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617086|NCT01859728|Antiviral Agents|antiviral agents|mesh-ancestor
2617087|NCT01859728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617088|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617089|NCT01859728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2617090|NCT01859728|Immunologic Factors|immunologic factors|mesh-ancestor
2617091|NCT01859728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617092|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2617093|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2617094|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
2617095|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2617096|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2617097|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
2617098|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617099|NCT01859819|Cytarabine|cytarabine|mesh-list
2617100|NCT01859819|Rituximab|rituximab|mesh-list
2617101|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2617102|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617103|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
2617104|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617105|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2617106|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2617107|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
2617108|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617109|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
2617110|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617111|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2617112|NCT01859858|Curcumin|curcumin|mesh-list
2617113|NCT01859858|Irinotecan|irinotecan|mesh-list
2617114|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2617115|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2617116|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617117|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617118|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160936|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
2160937|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2160938|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2160939|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2617119|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2617120|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2617121|NCT01859858|Analgesics|analgesics|mesh-ancestor
2617122|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
2617123|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617124|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617125|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2617126|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2617127|NCT01859962|Ribavirin|ribavirin|mesh-list
2617128|NCT01859962|Antimetabolites|antimetabolites|mesh-ancestor
2617129|NCT01859962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617130|NCT01859962|Antiviral Agents|antiviral agents|mesh-ancestor
2617131|NCT01859962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617132|NCT01860014|Poractant alfa|poractant alfa|mesh-list
2160940|NCT00683787|Docetaxel|docetaxel|mesh-list
2160941|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2160942|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
2160943|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
2160944|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
2160945|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160946|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
2160947|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2160948|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160949|NCT00678041|Renal Agents|renal agents|mesh-ancestor
2160950|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2160951|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2160952|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
2160953|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2160954|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2160955|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2160956|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2160957|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160958|NCT00669461|Lubiprostone|lubiprostone|mesh-list
2160959|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2160960|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2160961|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160962|NCT00673309|Insulin|insulin|mesh-list
2617133|NCT01860014|Beractant|beractant|mesh-list
2617134|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2617135|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
2617136|NCT01860066|Fluticasone|fluticasone|mesh-list
2617137|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2617138|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2617139|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2617140|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2617141|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
2617142|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617143|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617144|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2617145|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
2617146|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
2617147|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2617148|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2617149|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2617150|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2617151|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
2617152|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617153|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617154|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
2617155|NCT01860066|Hormones|hormones|mesh-ancestor
2617156|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2617157|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
2617158|NCT01860105|Clopidogrel|clopidogrel|mesh-list
2617159|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2617160|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2617161|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2617162|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2617163|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
2617164|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617165|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617166|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617167|NCT01860144|Bevacizumab|bevacizumab|mesh-list
2160963|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2160964|NCT00673309|Itraconazole|itraconazole|mesh-list
2160965|NCT00673309|Propranolol|propranolol|mesh-list
2160966|NCT00673309|Hormones|hormones|mesh-list
2160967|NCT00673309|Oxandrolone|oxandrolone|mesh-list
2160968|NCT00673309|Nandrolone|nandrolone|mesh-list
2160969|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2160970|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160971|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2160972|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160973|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2160974|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2160975|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
2160976|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617168|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2617169|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617170|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2617171|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2617172|NCT01860144|Growth Substances|growth substances|mesh-ancestor
2617173|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617174|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
2617175|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
2617176|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2617177|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617178|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2617179|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
2617180|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2160977|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2160978|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2160979|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
2160980|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
2160981|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2160982|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2160983|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2160984|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2160985|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2160986|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
2160987|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2160988|NCT00673309|Androgens|androgens|mesh-ancestor
2160989|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
2160990|NCT00673595|Varenicline|varenicline|mesh-list
2160991|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2617181|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617182|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617183|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617184|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2617185|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2617186|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617187|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617188|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2617189|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2617190|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617191|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
2160992|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2160993|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
2160994|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2160995|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2160996|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2160997|NCT00673361|Temozolomide|temozolomide|mesh-list
2160998|NCT00673361|Sorafenib|sorafenib|mesh-list
2160999|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2161000|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
2161001|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161002|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161003|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2161004|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161005|NCT00668785|Ranibizumab|ranibizumab|mesh-list
2161006|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2617192|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617193|NCT01860235|Anesthetics|anesthetics|mesh-list
2161007|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2161008|NCT00668785|Growth Substances|growth substances|mesh-ancestor
2161009|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161010|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
2161011|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161012|NCT00673179|Leucovorin|leucovorin|mesh-list
2617194|NCT01860235|Benzocaine|benzocaine|mesh-list
2617195|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
2617196|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2617197|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617198|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
2617199|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617200|NCT01860300|Amoxicillin|amoxicillin|mesh-list
2617201|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
2617202|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
2617203|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2617204|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2617205|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617206|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2617207|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617208|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617209|NCT01860391|Fluorides|fluorides|mesh-list
2617210|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
2617211|NCT01860391|Protective Agents|protective agents|mesh-ancestor
2617212|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617213|NCT01860417|Mepivacaine|mepivacaine|mesh-list
2617214|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
2161013|NCT00673179|Gemcitabine|gemcitabine|mesh-list
2161014|NCT00673179|Doxorubicin|doxorubicin|mesh-list
2161015|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2161016|NCT00673179|Methotrexate|methotrexate|mesh-list
2161017|NCT00673179|Ifosfamide|ifosfamide|mesh-list
2617215|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
2617216|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2617217|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617218|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
2617219|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617225|NCT01860469|Vancomycin|vancomycin|mesh-list
2617226|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2161018|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
2161019|NCT00673179|Razoxane|razoxane|mesh-list
2161020|NCT00673179|Sargramostim|sargramostim|mesh-list
2161021|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161022|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2161023|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
2161024|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161025|NCT00673179|Antiviral Agents|antiviral agents|mesh-ancestor
2617227|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617228|NCT01860482|Rabeprazole|rabeprazole|mesh-list
2617229|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2617230|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2617231|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2617232|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617233|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617234|NCT01860508|Carboplatin|carboplatin|mesh-list
2161026|NCT00673179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161027|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161028|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2161029|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
2161030|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161031|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2161032|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2161033|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2161034|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2617235|NCT01860508|Pemetrexed|pemetrexed|mesh-list
2617236|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617237|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617238|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617239|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2617240|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2617241|NCT01860625|Donepezil|donepezil|mesh-list
2617242|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2617243|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617244|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617245|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
2617246|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2161035|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
2617247|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617248|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
2617249|NCT01860638|Bevacizumab|bevacizumab|mesh-list
2617250|NCT01860638|Temozolomide|temozolomide|mesh-list
2617251|NCT01860638|Lomustine|lomustine|mesh-list
2161036|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2161037|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
2161038|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2161039|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2161040|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2161041|NCT00673179|Antidotes|antidotes|mesh-ancestor
2161042|NCT00673179|Protective Agents|protective agents|mesh-ancestor
2161043|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
2161044|NCT00673179|Vitamins|vitamins|mesh-ancestor
2161045|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
2161046|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2161047|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
2161048|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2617252|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2617253|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617254|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2617255|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2617256|NCT01860638|Growth Substances|growth substances|mesh-ancestor
2617257|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617258|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
2617259|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2617260|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
2617261|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161049|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
2161050|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
2161051|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2161052|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
2161053|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2161054|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2161055|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2161056|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2161057|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161058|NCT00660348|Morphine|morphine|mesh-list
2161059|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2161060|NCT00660348|Narcotics|narcotics|mesh-ancestor
2161061|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2161062|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617262|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
2617263|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2617264|NCT01860690|Methotrexate|methotrexate|mesh-list
2617265|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2617266|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
2617267|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2617268|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617269|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2617270|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
2617271|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617272|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161063|NCT00660348|Analgesics|analgesics|mesh-ancestor
2161064|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
2161065|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161066|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
2161067|NCT00664066|Hematinics|hematinics|mesh-ancestor
2161068|NCT00667017|Immunotoxins|immunotoxins|mesh-list
2161069|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
2161070|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161071|NCT00665444|Aripiprazole|aripiprazole|mesh-list
2161072|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
2161073|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2161074|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2161075|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2617273|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
2617274|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617275|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2617276|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2617277|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
2617278|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2617279|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2617280|NCT01860716|Melatonin|melatonin|mesh-list
2161076|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2161077|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161078|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
2617281|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
2617282|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617283|NCT01860716|Protective Agents|protective agents|mesh-ancestor
2617284|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617285|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2617286|NCT01860729|Anacetrapib|anacetrapib|mesh-list
2617287|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2617288|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2617289|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
2617290|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161079|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
2161080|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2161081|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161082|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2161083|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2161084|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
2161085|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2161086|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2161087|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2161088|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2161089|NCT00656916|Fluticasone|fluticasone|mesh-list
2161090|NCT00656916|Xhance|xhance|mesh-list
2161091|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2161092|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2161093|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
2161094|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161095|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161096|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2161097|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
2161098|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
2161099|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2161100|NCT00660595|Risperidone|risperidone|mesh-list
2161101|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2161102|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2161103|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
2161104|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617291|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2617292|NCT01860742|Interferons|interferons|mesh-list
2617293|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
2617294|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
2617295|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2617296|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617297|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
2617298|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617299|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
2161105|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161106|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617300|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617301|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2617302|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617303|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2617304|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2617305|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2617306|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2617307|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617308|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2617309|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2617310|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2617311|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
2617312|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617313|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617314|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2617315|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2617316|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
2617317|NCT01860833|Ibuprofen|ibuprofen|mesh-list
2617318|NCT01860833|Celecoxib|celecoxib|mesh-list
2617319|NCT01860833|Diclofenac|diclofenac|mesh-list
2617320|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2617321|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2617322|NCT01860833|Analgesics|analgesics|mesh-ancestor
2617323|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
2617324|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617325|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617326|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2617327|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2617328|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2617329|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161107|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2161108|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2161109|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2161110|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2161111|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2161112|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
2161113|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
2161114|NCT00661466|Bupivacaine|bupivacaine|mesh-list
2161115|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
2161116|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
2161117|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2161118|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161119|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
2161120|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161121|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2161122|NCT00646282|Vitamins|vitamins|mesh-ancestor
2161123|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
2161124|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161125|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2161126|NCT00657553|Bortezomib|bortezomib|mesh-list
2161127|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161128|NCT00655057|Citalopram|citalopram|mesh-list
2617330|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617331|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2617332|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2161129|NCT00655057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2161130|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2161131|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2161132|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161133|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2161134|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
2161135|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161136|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2161137|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
2161138|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2161139|NCT00648895|Metoprolol|metoprolol|mesh-list
2161140|NCT00648895|Nebivolol|nebivolol|mesh-list
2161141|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2161142|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2161143|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
2161144|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
2161145|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161146|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161147|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2161148|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2161149|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2617333|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617334|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617345|NCT01861015|Vasopressins|vasopressins|mesh-list
2617346|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
2617347|NCT01861015|Epinephrine|epinephrine|mesh-list
2617348|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2617349|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2617350|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
2161150|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
2161151|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2161152|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161153|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
2161154|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2161155|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2161156|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2617351|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617352|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617353|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617354|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2617355|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2617356|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
2617357|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617358|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2617359|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
2617360|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
2617361|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
2617362|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2617363|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
2617364|NCT01861015|Coagulants|coagulants|mesh-ancestor
2617365|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2617366|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
2617367|NCT01861041|Bupivacaine|bupivacaine|mesh-list
2617368|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
2617369|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
2617370|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2617371|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617372|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
2617373|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161157|NCT00647426|Carboplatin|carboplatin|mesh-list
2161158|NCT00647426|Docetaxel|docetaxel|mesh-list
2161159|NCT00647426|Sorafenib|sorafenib|mesh-list
2161160|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161161|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
2161162|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
2161163|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
2161164|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161165|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2617399|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
2617400|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2617401|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
2617402|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2617403|NCT01861223|Afatinib|afatinib|mesh-list
2617404|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
2617405|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617406|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2617407|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617408|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617409|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2161166|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161167|NCT00637806|Megestrol|megestrol|mesh-list
2161168|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
2161169|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2161170|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2161171|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2161172|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
2617419|NCT01861340|Dexamethasone|dexamethasone|mesh-list
2617420|NCT01861340|Lenalidomide|lenalidomide|mesh-list
2617421|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2617422|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
2617423|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
2617424|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617425|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617426|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2617427|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
2617428|NCT01861340|Hormones|hormones|mesh-ancestor
2617429|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2617430|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2617431|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617432|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
2617433|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2617434|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2617435|NCT01861340|Growth Substances|growth substances|mesh-ancestor
2617436|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
2617437|NCT01861496|Cisplatin|cisplatin|mesh-list
2617438|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617439|NCT01861535|Imiquimod|imiquimod|mesh-list
2617440|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2617441|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
2617442|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617443|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617444|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
2617445|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
2617446|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2617447|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
2617448|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617449|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2617450|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2617451|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
2617452|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617453|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617454|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2617455|NCT01861626|Isotretinoin|isotretinoin|mesh-list
2617456|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
2617457|NCT01861847|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2617458|NCT01861847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2617459|NCT01861847|Immunologic Factors|immunologic factors|mesh-ancestor
2617460|NCT01861847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617461|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
2617462|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
2617463|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617464|NCT01861951|Doxorubicin|doxorubicin|mesh-list
2617465|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2617466|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617467|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2617468|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2617469|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617470|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617471|NCT01861990|Valproic Acid|valproic acid|mesh-list
2617472|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
2617473|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617474|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617475|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
2617476|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617477|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617478|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
2617479|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2617480|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2617481|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2617482|NCT01862003|Leucovorin|leucovorin|mesh-list
2617483|NCT01862003|Folic Acid|folic acid|mesh-list
2617484|NCT01862003|Fluorouracil|fluorouracil|mesh-list
2617485|NCT01862003|Irinotecan|irinotecan|mesh-list
2617486|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
2617487|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
2617488|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617489|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2161173|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2161174|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161175|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2161176|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2161177|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2161178|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617490|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617491|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2617492|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
2617493|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617494|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2617495|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2617496|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617497|NCT01862003|Antidotes|antidotes|mesh-ancestor
2617498|NCT01862003|Protective Agents|protective agents|mesh-ancestor
2617499|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
2617500|NCT01862003|Vitamins|vitamins|mesh-ancestor
2617501|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
2617502|NCT01862003|Hematinics|hematinics|mesh-ancestor
2617503|NCT01862081|Paclitaxel|paclitaxel|mesh-list
2617504|NCT01862081|Docetaxel|docetaxel|mesh-list
2617505|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2617506|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617507|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
2617508|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
2617509|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
2617510|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617511|NCT01862120|Interleukin-2|interleukin-2|mesh-list
2617512|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617513|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2617514|NCT01862120|Analgesics|analgesics|mesh-ancestor
2617515|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
2617516|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617517|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617518|NCT01862224|Methotrexate|methotrexate|mesh-list
2617519|NCT01862224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2617520|NCT01862224|Abortifacient Agents|abortifacient agents|mesh-ancestor
2617521|NCT01862224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2617522|NCT01862224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161179|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
2161180|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2161181|NCT00652457|Memantine|memantine|mesh-list
2161182|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2161183|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2161184|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
2161185|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2161186|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161187|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161188|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2161189|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2161190|NCT00642603|Bevacizumab|bevacizumab|mesh-list
2161191|NCT00642603|Capecitabine|capecitabine|mesh-list
2161192|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
2161193|NCT00642603|Irinotecan|irinotecan|mesh-list
2161194|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2161195|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161196|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2161197|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2161198|NCT00642603|Growth Substances|growth substances|mesh-ancestor
2161199|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161200|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
2161201|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2161202|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
2161203|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161204|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2161205|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2161206|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161207|NCT00629798|Fludarabine|fludarabine|mesh-list
2161208|NCT00629798|Melphalan|melphalan|mesh-list
2161209|NCT00629798|Busulfan|busulfan|mesh-list
2161210|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2161211|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161212|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161213|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2161214|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
2617523|NCT01862224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2617524|NCT01862224|Antimetabolites|antimetabolites|mesh-ancestor
2617525|NCT01862224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617526|NCT01862224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161215|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161216|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2161217|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
2161218|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2161219|NCT00637728|Megestrol|megestrol|mesh-list
2161220|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
2161221|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2161222|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2161223|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2161224|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
2161225|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2161226|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161227|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2161228|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2161229|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2617527|NCT01862224|Dermatologic Agents|dermatologic agents|mesh-ancestor
2617528|NCT01862224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617529|NCT01862224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2617530|NCT01862224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2617531|NCT01862224|Immunologic Factors|immunologic factors|mesh-ancestor
2617532|NCT01862224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2617533|NCT01862224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2617534|NCT01862263|Vildagliptin|vildagliptin|mesh-list
2617535|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2617536|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617537|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2617538|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
2617539|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617540|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617541|NCT01862302|Haloperidol|haloperidol|mesh-list
2617542|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
2617543|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
2617544|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
2617545|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617546|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617547|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2617548|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2617549|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2617550|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2161230|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161231|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
2161232|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2161233|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
2161234|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2161235|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161236|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
2161237|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2161238|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
2161239|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617551|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2617552|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2617553|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
2617554|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617555|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161240|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
2161241|NCT00642382|Protective Agents|protective agents|mesh-ancestor
2161242|NCT00637416|Lansoprazole|lansoprazole|mesh-list
2161243|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
2161244|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2161245|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2161246|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2161247|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161248|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161249|NCT00638222|Carvedilol|carvedilol|mesh-list
2161250|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2161251|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2161252|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
2161253|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2161254|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161255|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617556|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2617557|NCT01862315|Gemcitabine|gemcitabine|mesh-list
2617558|NCT01862315|Dexamethasone|dexamethasone|mesh-list
2617559|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
2617560|NCT01862315|Floxuridine|floxuridine|mesh-list
2617561|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2161256|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2161257|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
2161258|NCT00638222|Protective Agents|protective agents|mesh-ancestor
2617562|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
2617563|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
2617564|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617565|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617566|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2617567|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
2617568|NCT01862315|Hormones|hormones|mesh-ancestor
2617569|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2617570|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2617571|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617572|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2617573|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
2617574|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617575|NCT01862315|Antiviral Agents|antiviral agents|mesh-ancestor
2617576|NCT01862315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617577|NCT01862315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617578|NCT01862315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2617579|NCT01862315|Immunologic Factors|immunologic factors|mesh-ancestor
2617580|NCT01862354|Anesthetics|anesthetics|mesh-list
2617581|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2617582|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617583|NCT01862497|Carvedilol|carvedilol|mesh-list
2161259|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2161260|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2161261|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2161262|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
2161263|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2161264|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2161265|NCT00634322|Leucovorin|leucovorin|mesh-list
2161266|NCT00634322|Antidotes|antidotes|mesh-ancestor
2161267|NCT00634322|Protective Agents|protective agents|mesh-ancestor
2161268|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161269|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
2161270|NCT00634322|Vitamins|vitamins|mesh-ancestor
2161271|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
2617584|NCT01862497|Prazosin|prazosin|mesh-list
2617585|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2617586|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2617587|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
2617588|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617589|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617590|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617591|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2617592|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
2617593|NCT01862497|Protective Agents|protective agents|mesh-ancestor
2617594|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2617595|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2617596|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2617597|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
2617598|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2617599|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2617600|NCT01862523|Capsaicin|capsaicin|mesh-list
2617601|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
2617602|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
2617603|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
2617604|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617605|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617606|NCT01862835|Anastrozole|anastrozole|mesh-list
2617607|NCT01862835|Testosterone|testosterone|mesh-list
2617608|NCT01862835|Estrogens|estrogens|mesh-list
2617609|NCT01862835|Androgens|androgens|mesh-ancestor
2617610|NCT01862835|Hormones|hormones|mesh-ancestor
2617611|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2161272|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
2161273|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
2617612|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617613|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2617614|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161274|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161275|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
2161276|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161277|NCT00631137|Testosterone|testosterone|mesh-list
2161278|NCT00631137|Androgens|androgens|mesh-ancestor
2161279|NCT00631137|Hormones|hormones|mesh-ancestor
2161280|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2161281|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161282|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2161283|NCT00634972|Ketorolac|ketorolac|mesh-list
2161284|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2161285|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2161286|NCT00634972|Analgesics|analgesics|mesh-ancestor
2161287|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
2161288|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617615|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2617616|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2617617|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617618|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617619|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2617620|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
2617621|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
2161289|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161290|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2161291|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2161292|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2161293|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161294|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161295|NCT00633061|Enoxaparin|enoxaparin|mesh-list
2161296|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
2161297|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2161298|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2161299|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161300|NCT00626444|Ascorbic Acid|ascorbic acid|mesh-list
2161301|NCT00626444|Vitamins|vitamins|mesh-ancestor
2161302|NCT00626444|Micronutrients|micronutrients|mesh-ancestor
2161303|NCT00626444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161304|NCT00626444|Antioxidants|antioxidants|mesh-ancestor
2617622|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2617623|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617624|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2617625|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2617626|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617627|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617628|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617629|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
2617630|NCT01862926|Rituximab|rituximab|mesh-list
2617631|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2617632|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
2617633|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617634|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2617635|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2617636|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
2617637|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617638|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617639|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2617640|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2617641|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
2617642|NCT01862978|Heparin|heparin|mesh-list
2617643|NCT01862978|Nadroparin|nadroparin|mesh-list
2617644|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
2617645|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2617646|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2617647|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617648|NCT01863004|Bortezomib|bortezomib|mesh-list
2617649|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617650|NCT01863069|Interferons|interferons|mesh-list
2617651|NCT01863069|Interferon-beta|interferon-beta|mesh-list
2617652|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
2617653|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617654|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
2617655|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617656|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
2161305|NCT00626444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161306|NCT00626444|Protective Agents|protective agents|mesh-ancestor
2617657|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161307|NCT00634010|Morphine|morphine|mesh-list
2161308|NCT00634010|Methadone|methadone|mesh-list
2161309|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2161310|NCT00634010|Narcotics|narcotics|mesh-ancestor
2161311|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2161312|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161313|NCT00634010|Analgesics|analgesics|mesh-ancestor
2161314|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
2161315|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161316|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
2161317|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
2161318|NCT00623974|Teriparatide|teriparatide|mesh-list
2161319|NCT00623974|Calcitriol|calcitriol|mesh-list
2161320|NCT00623974|Calcium|calcium|mesh-list
2161321|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
2161322|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2161323|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161324|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2161325|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2161326|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2161327|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617658|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2617659|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2617660|NCT01863147|Acarbose|acarbose|mesh-list
2617661|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2617662|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617663|NCT01863147|Incretins|incretins|mesh-ancestor
2617664|NCT01863147|Hormones|hormones|mesh-ancestor
2617665|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2617666|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2617667|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
2617668|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617669|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617670|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2617671|NCT01863173|Metoprolol|metoprolol|mesh-list
2617672|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2161328|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2161329|NCT00623974|Vitamins|vitamins|mesh-ancestor
2161330|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
2161331|NCT00624650|Phenylephrine|phenylephrine|mesh-list
2161332|NCT00624650|Dobutamine|dobutamine|mesh-list
2161333|NCT00624650|Furosemide|furosemide|mesh-list
2161334|NCT00624650|Vasopressins|vasopressins|mesh-list
2161335|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
2161336|NCT00624650|Epinephrine|epinephrine|mesh-list
2617673|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2617674|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
2617675|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
2617676|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617677|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617678|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2617679|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2617680|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2617681|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
2617682|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617683|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617684|NCT01863199|Ranibizumab|ranibizumab|mesh-list
2617685|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2617686|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2617687|NCT01863199|Growth Substances|growth substances|mesh-ancestor
2617688|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617689|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
2617690|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617691|NCT01863225|Atorvastatin|atorvastatin|mesh-list
2161337|NCT00624650|Racepinephrine|racepinephrine|mesh-list
2161338|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
2161339|NCT00624650|Norepinephrine|norepinephrine|mesh-list
2161340|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2161341|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
2161342|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2161343|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2161344|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
2617692|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2617693|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2161345|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2161346|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161347|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617694|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2617695|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
2617696|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617697|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2617698|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2617699|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617700|NCT01863238|Ivacaftor|ivacaftor|mesh-list
2617701|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2617702|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2617703|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617704|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2617705|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2617706|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2617707|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2617708|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617709|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
2617710|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617711|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617712|NCT01863277|Melatonin|melatonin|mesh-list
2617713|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
2617714|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617715|NCT01863277|Protective Agents|protective agents|mesh-ancestor
2617716|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617717|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2617718|NCT01863355|Fentanyl|fentanyl|mesh-list
2617719|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2617720|NCT01863355|Narcotics|narcotics|mesh-ancestor
2617721|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2617722|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617723|NCT01863355|Analgesics|analgesics|mesh-ancestor
2617724|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
2617725|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617726|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2617727|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2617728|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
2617729|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
2617730|NCT01863407|Metronidazole|metronidazole|mesh-list
2617731|NCT01863407|Dexamethasone|dexamethasone|mesh-list
2617732|NCT01863407|Allantoin|allantoin|mesh-list
2617733|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2617734|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
2617735|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
2617736|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617737|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617738|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2617739|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
2617740|NCT01863407|Hormones|hormones|mesh-ancestor
2617741|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2617742|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2617743|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617744|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617745|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2617746|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2617747|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2617748|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
2617749|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2617750|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2617751|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617752|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2617753|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2617754|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2617755|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617756|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
2617757|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617758|NCT01863485|Vorolanib|vorolanib|mesh-list
2617759|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2617760|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617761|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617762|NCT01863511|Tolvaptan|tolvaptan|mesh-list
2617763|NCT01863511|Diuretics|diuretics|mesh-list
2617764|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
2617765|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
2617766|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617767|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2617768|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617769|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2161348|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2161349|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2161350|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
2161351|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161352|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2161353|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
2161354|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
2161355|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
2161356|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2161357|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
2161358|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2161359|NCT00624650|Protective Agents|protective agents|mesh-ancestor
2161360|NCT00624650|Diuretics|diuretics|mesh-ancestor
2161361|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
2161362|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2161363|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2161364|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
2161365|NCT00624650|Coagulants|coagulants|mesh-ancestor
2617796|NCT01863589|Adefovir|adefovir|mesh-list
2617797|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
2617798|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617799|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2617800|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2617801|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617802|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617803|NCT01863602|Lamotrigine|lamotrigine|mesh-list
2617804|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
2617805|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2617806|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2617807|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617808|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2617809|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617810|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2617811|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2617812|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2617813|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2617814|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2617815|NCT01863615|Isotretinoin|isotretinoin|mesh-list
2617816|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
2617817|NCT01863641|Calcitriol|calcitriol|mesh-list
2617818|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2617819|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161366|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2161367|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2161368|NCT00626561|Paclitaxel|paclitaxel|mesh-list
2161369|NCT00626561|Bevacizumab|bevacizumab|mesh-list
2161370|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2161371|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161372|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
2161373|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
2161374|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
2161375|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161376|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2161377|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2161378|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2161379|NCT00626561|Growth Substances|growth substances|mesh-ancestor
2617820|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2617821|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2617822|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617823|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2617824|NCT01863641|Vitamins|vitamins|mesh-ancestor
2617825|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
2161380|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161381|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
2161382|NCT00613730|Gemcitabine|gemcitabine|mesh-list
2161383|NCT00613730|Panitumumab|panitumumab|mesh-list
2161384|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2161385|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
2161386|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161387|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161388|NCT00613730|Antiviral Agents|antiviral agents|mesh-ancestor
2161389|NCT00613730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161390|NCT00613730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161391|NCT00613730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2161392|NCT00613730|Immunologic Factors|immunologic factors|mesh-ancestor
2161393|NCT00613730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161394|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2617826|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2617827|NCT01863654|Montelukast|montelukast|mesh-list
2617828|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2617829|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
2617830|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2617831|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
2617832|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2617833|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617834|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2617835|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2617836|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617837|NCT01863706|Misoprostol|misoprostol|mesh-list
2617838|NCT01863706|Oxytocin|oxytocin|mesh-list
2617839|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
2617840|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2617841|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617842|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2617843|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
2617844|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2617845|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2617846|NCT01863719|Colistin|colistin|mesh-list
2617847|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2617848|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617849|NCT01863810|Pregabalin|pregabalin|mesh-list
2617850|NCT01863810|Analgesics|analgesics|mesh-ancestor
2617851|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
2617852|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161395|NCT00625586|Gemcitabine|gemcitabine|mesh-list
2161396|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2161397|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
2161398|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161399|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161400|NCT00625586|Antiviral Agents|antiviral agents|mesh-ancestor
2161401|NCT00625586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161402|NCT00625586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161403|NCT00625586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2161404|NCT00625586|Immunologic Factors|immunologic factors|mesh-ancestor
2161405|NCT00625586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161406|NCT00625703|Linezolid|linezolid|mesh-list
2161407|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2161408|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161409|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2161410|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617853|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617854|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
2617855|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2617856|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2617857|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617858|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2617859|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2617860|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2617861|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2617862|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2617863|NCT01863823|Amoxicillin|amoxicillin|mesh-list
2617864|NCT01863823|Tetracycline|tetracycline|mesh-list
2617865|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2617866|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2617867|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2617868|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617869|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617870|NCT01863888|Teriflunomide|teriflunomide|mesh-list
2617871|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
2617872|NCT01863888|Charcoal|charcoal|mesh-list
2617873|NCT01863888|Antidotes|antidotes|mesh-ancestor
2617874|NCT01863888|Protective Agents|protective agents|mesh-ancestor
2161411|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161412|NCT00625742|Ibuprofen|ibuprofen|mesh-list
2161413|NCT00625742|Atenolol|atenolol|mesh-list
2161414|NCT00625742|Melatonin|melatonin|mesh-list
2161415|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2161416|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2161417|NCT00625742|Analgesics|analgesics|mesh-ancestor
2161418|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
2161419|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161420|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617875|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617876|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2617877|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2617878|NCT01863888|Analgesics|analgesics|mesh-ancestor
2617879|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
2617880|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617881|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2617882|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2617883|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2617884|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
2617885|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2617886|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2617887|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
2617888|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617889|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2617890|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2617891|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2617892|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2617893|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
2617894|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617895|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2617896|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2617897|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161421|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2161422|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2161423|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2161424|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161425|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161426|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
2161427|NCT00625742|Protective Agents|protective agents|mesh-ancestor
2161428|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2161429|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2161430|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2161431|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
2161432|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
2161433|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2161434|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2161435|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2161436|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
2161437|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2161438|NCT00619242|Sorafenib|sorafenib|mesh-list
2161439|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161440|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2161441|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161442|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161443|NCT00616577|Ropivacaine|ropivacaine|mesh-list
2161444|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
2161445|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
2161446|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2161447|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161448|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
2617928|NCT01864057|Thiamine|thiamine|mesh-list
2617929|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
2617930|NCT01864057|Vitamins|vitamins|mesh-ancestor
2617931|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
2617932|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617933|NCT01864070|Everolimus|everolimus|mesh-list
2617934|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161449|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161450|NCT00616759|Propofol|propofol|mesh-list
2161451|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2161452|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2161453|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161454|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2161455|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
2161456|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
2161457|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
2161458|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2161459|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161460|NCT00616343|Zonisamide|zonisamide|mesh-list
2161461|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
2161462|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2161463|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2161464|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161465|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2161466|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161467|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
2161468|NCT00612677|Pemetrexed|pemetrexed|mesh-list
2161469|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161470|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161471|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161472|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2161473|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2161474|NCT00616603|Dexamethasone|dexamethasone|mesh-list
2161475|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
2161476|NCT00616603|Ropivacaine|ropivacaine|mesh-list
2161477|NCT00616603|BB 1101|bb 1101|mesh-list
2617935|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2617936|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
2617937|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617938|NCT01864083|Fluorides|fluorides|mesh-list
2617939|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
2617940|NCT01864083|Protective Agents|protective agents|mesh-ancestor
2617941|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617942|NCT01864096|Metformin|metformin|mesh-list
2617943|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2617944|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617945|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
2617946|NCT01864109|Temozolomide|temozolomide|mesh-list
2617947|NCT01864109|Ifosfamide|ifosfamide|mesh-list
2617948|NCT01864109|Doxorubicin|doxorubicin|mesh-list
2617949|NCT01864109|Etoposide|etoposide|mesh-list
2617950|NCT01864109|Irinotecan|irinotecan|mesh-list
2617951|NCT01864109|Vincristine|vincristine|mesh-list
2617952|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
2617953|NCT01864109|Razoxane|razoxane|mesh-list
2617954|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2617955|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
2617956|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617957|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2617958|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2617959|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
2617960|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617961|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2617962|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2617963|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2161478|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2161479|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
2161480|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
2161481|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161482|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161483|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2161484|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
2161485|NCT00616603|Hormones|hormones|mesh-ancestor
2161486|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2161487|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2161488|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161489|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
2617964|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2617965|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2617966|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2617967|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2617968|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2617969|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
2617970|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
2617971|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
2617972|NCT01864109|Protective Agents|protective agents|mesh-ancestor
2617973|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2617974|NCT01864161|Iron|iron|mesh-list
2617975|NCT01864161|Trace Elements|trace elements|mesh-ancestor
2617976|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
2617977|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617978|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
2617979|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2617980|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2617981|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161490|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161491|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161492|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
2161493|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
2161494|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2161495|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
2161496|NCT00610532|Probenecid|probenecid|mesh-list
2161497|NCT00610532|Phenytoin|phenytoin|mesh-list
2161498|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
2161499|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2161500|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2161501|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2161502|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161503|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2161504|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2161505|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
2161506|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
2161507|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2617982|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2617983|NCT01864187|Analgesics|analgesics|mesh-ancestor
2617984|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
2617985|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617986|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2617987|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2617988|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2617989|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
2617990|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2617991|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2617992|NCT01864213|Tetracaine|tetracaine|mesh-list
2617993|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
2617994|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
2617995|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2617996|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2617997|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
2617998|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2617999|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
2618000|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
2161508|NCT00610532|Renal Agents|renal agents|mesh-ancestor
2161509|NCT00609765|Dexamethasone|dexamethasone|mesh-list
2161510|NCT00609765|Bevacizumab|bevacizumab|mesh-list
2161511|NCT00609765|Doxorubicin|doxorubicin|mesh-list
2161512|NCT00609765|Fluorouracil|fluorouracil|mesh-list
2161513|NCT00609765|Streptozocin|streptozocin|mesh-list
2161514|NCT00609765|Ondansetron|ondansetron|mesh-list
2618001|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
2618002|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2618003|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
2161515|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2161516|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161517|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2161518|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2161519|NCT00609765|Growth Substances|growth substances|mesh-ancestor
2161520|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161521|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
2161522|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2161523|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
2161524|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
2161525|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161526|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2161527|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
2618004|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618005|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2618006|NCT01864551|Lamotrigine|lamotrigine|mesh-list
2618007|NCT01864551|Olanzapine|olanzapine|mesh-list
2618008|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
2618009|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
2618010|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618011|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618012|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2618013|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2618014|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2618015|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618016|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2618017|NCT01864551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2618018|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2618019|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2161528|NCT00609765|Hormones|hormones|mesh-ancestor
2161529|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2161530|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2618020|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618021|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2618022|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
2618023|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
2618024|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2618025|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2618026|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2618027|NCT01864616|Vitamin D|vitamin d|mesh-list
2618028|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
2618029|NCT01864616|Vitamins|vitamins|mesh-ancestor
2618030|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
2618031|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618032|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2161531|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2161532|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2161533|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2618033|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2618034|NCT01864655|Saracatinib|saracatinib|mesh-list
2618035|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618036|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618037|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618038|NCT01864681|Metformin|metformin|mesh-list
2618039|NCT01864681|Gefitinib|gefitinib|mesh-list
2618040|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2618041|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618042|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618043|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2618044|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618045|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618046|NCT01864746|Palbociclib|palbociclib|mesh-list
2161534|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161535|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161536|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
2161537|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2161538|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2161539|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
2161540|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
2161541|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
2161542|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2161543|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
2161544|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2161545|NCT00609765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2161546|NCT00609765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2161547|NCT00609765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2161548|NCT00609765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2161549|NCT00609765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2161550|NCT00608465|Ramipril|ramipril|mesh-list
2161551|NCT00608465|Eplerenone|eplerenone|mesh-list
2618047|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618048|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2618049|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618050|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618051|NCT01864772|Cetuximab|cetuximab|mesh-list
2618052|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2618053|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618054|NCT01864798|Denosumab|denosumab|mesh-list
2618055|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2618056|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618057|NCT01864824|Vitamins|vitamins|mesh-list
2618058|NCT01864824|Folic Acid|folic acid|mesh-list
2618059|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
2618060|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
2618061|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
2618062|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
2618063|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618064|NCT01864824|Hematinics|hematinics|mesh-ancestor
2618065|NCT01864863|Bosentan|bosentan|mesh-list
2618066|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2618067|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2618068|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618069|NCT01864915|Prucalopride|prucalopride|mesh-list
2618070|NCT01864915|Laxatives|laxatives|mesh-ancestor
2618071|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2618072|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2618073|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2618074|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
2618075|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2618076|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618077|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618078|NCT01865110|Prednisone|prednisone|mesh-list
2618079|NCT01865110|Rituximab|rituximab|mesh-list
2618080|NCT01865110|Lenalidomide|lenalidomide|mesh-list
2618081|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
2618082|NCT01865110|Vincristine|vincristine|mesh-list
2618083|NCT01865110|Doxorubicin|doxorubicin|mesh-list
2618084|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2618085|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618086|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
2618087|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618088|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2618089|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2618090|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2618091|NCT01865110|Growth Substances|growth substances|mesh-ancestor
2618092|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
2618093|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2161552|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2161553|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
2161554|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161555|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161556|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2161557|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2161558|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
2161559|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2161560|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161561|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2161562|NCT00608465|Diuretics|diuretics|mesh-ancestor
2161563|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
2161564|NCT00608777|Betamethasone|betamethasone|mesh-list
2161565|NCT00608777|Calcipotriene|calcipotriene|mesh-list
2161566|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2161567|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
2161568|NCT00608777|Hormones|hormones|mesh-ancestor
2161569|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2161570|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161571|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2161572|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
2161573|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
2161574|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2161575|NCT00601848|Trioxsalen|trioxsalen|mesh-list
2161576|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161577|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
2161578|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2161579|NCT00607477|Minoxidil|minoxidil|mesh-list
2161580|NCT00607477|Hydralazine|hydralazine|mesh-list
2618094|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2618095|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
2618096|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618097|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2618098|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2618099|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
2618100|NCT01865110|Hormones|hormones|mesh-ancestor
2618101|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2618102|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2618103|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2618104|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
2618105|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
2618106|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
2161581|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2161582|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
2161583|NCT00595920|Vaccines|vaccines|mesh-list
2161584|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
2161585|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161586|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
2161587|NCT00596947|Prednisone|prednisone|mesh-list
2161588|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
2161589|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2161590|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2161591|NCT00596947|Prednisolone|prednisolone|mesh-list
2161592|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
2161593|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2161594|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
2161595|NCT00596947|Tacrolimus|tacrolimus|mesh-list
2161596|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
2161597|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2161598|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2161599|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
2161600|NCT00596947|Hormones|hormones|mesh-ancestor
2161601|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2618107|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2618108|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2618109|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2618110|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618111|NCT01865175|Iron|iron|mesh-list
2618112|NCT01865175|Trace Elements|trace elements|mesh-ancestor
2618113|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
2618114|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618115|NCT01865188|Amlodipine|amlodipine|mesh-list
2618116|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2161602|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161603|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2161604|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161605|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2161606|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
2618117|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2618118|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2618119|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2618120|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618121|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2618122|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618123|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
2618124|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2618125|NCT01865201|Mannitol|mannitol|mesh-list
2618126|NCT01865201|Edaravone|edaravone|mesh-list
2618127|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2618128|NCT01865201|Diuretics|diuretics|mesh-ancestor
2618129|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
2618130|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618131|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2618132|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
2618133|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618134|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2618135|NCT01865201|Protective Agents|protective agents|mesh-ancestor
2618136|NCT01865279|Insulin|insulin|mesh-list
2618137|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2618138|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
2618139|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
2618140|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
2618141|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
2618142|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2618143|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618144|NCT01865292|Insulin|insulin|mesh-list
2618145|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2618146|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
2618147|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2618148|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618149|NCT01865305|Insulin|insulin|mesh-list
2618150|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2618151|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
2618152|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
2618153|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2618154|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
2618155|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2618156|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
2618157|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2618158|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618159|NCT01865318|Insulin|insulin|mesh-list
2618160|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2618161|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618162|NCT01865331|Insulin|insulin|mesh-list
2618163|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2618164|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
2618165|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
2618166|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2618167|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618168|NCT01865500|Prednisolone|prednisolone|mesh-list
2618169|NCT01865500|Budesonide|budesonide|mesh-list
2618170|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2618171|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
2618172|NCT01865500|Hormones|hormones|mesh-ancestor
2618173|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2618174|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618175|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2618176|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618177|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
2618178|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618179|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2618180|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2618181|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
2618182|NCT01865630|Etanercept|etanercept|mesh-list
2618183|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2618184|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2618185|NCT01865630|Analgesics|analgesics|mesh-ancestor
2618186|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
2618187|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618188|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618189|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2618190|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2618191|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2618192|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2618193|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
2618194|NCT01865669|Oxytocin|oxytocin|mesh-list
2618195|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
2618196|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2618197|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618198|NCT01865721|Entonox|entonox|mesh-list
2618199|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2618200|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
2618201|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618202|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618203|NCT01865760|Octreotide|octreotide|mesh-list
2618204|NCT01865760|Somatostatin|somatostatin|mesh-list
2618205|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2618206|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2618207|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618208|NCT01865760|Hormones|hormones|mesh-ancestor
2618209|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2618210|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618211|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
2618212|NCT01865916|Bisacodyl|bisacodyl|mesh-list
2618213|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
2618214|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618215|NCT01865916|Protective Agents|protective agents|mesh-ancestor
2618216|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618217|NCT01865916|Vitamins|vitamins|mesh-ancestor
2618218|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
2618219|NCT01865916|Cathartics|cathartics|mesh-ancestor
2618220|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2618221|NCT01865916|Laxatives|laxatives|mesh-ancestor
2618222|NCT01865968|Vaccines|vaccines|mesh-list
2618223|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
2618224|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618225|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2618226|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
2618227|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618228|NCT01866059|Methamphetamine|methamphetamine|mesh-list
2618229|NCT01866059|Calcium|calcium|mesh-list
2618230|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2618231|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618232|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2618233|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
2618234|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
2618235|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618236|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
2161607|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2161608|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161609|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161610|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2161611|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2161612|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
2161613|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2161614|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161615|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
2161616|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
2161617|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161618|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2161619|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2161620|NCT00596947|Protective Agents|protective agents|mesh-ancestor
2161621|NCT00584012|Docetaxel|docetaxel|mesh-list
2161622|NCT00584012|Lovastatin|lovastatin|mesh-list
2161623|NCT00584012|L 647318|l 647318|mesh-list
2161624|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
2161625|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161626|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
2161627|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
2161628|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
2161629|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161630|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2161631|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2161632|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
2161633|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2618237|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2618238|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618239|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
2161634|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2161635|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161636|NCT00599131|Docetaxel|docetaxel|mesh-list
2161637|NCT00599131|Fluorouracil|fluorouracil|mesh-list
2161638|NCT00599131|Cetuximab|cetuximab|mesh-list
2161639|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161640|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
2161641|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
2618240|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2618241|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2618242|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2618243|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2618244|NCT01866111|Cenobamate|cenobamate|mesh-list
2618245|NCT01866111|Anticonvulsants|anticonvulsants|mesh-ancestor
2618246|NCT01866241|Misoprostol|misoprostol|mesh-list
2618247|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2618248|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
2618249|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2618250|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618251|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2618252|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2618253|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
2618254|NCT01866254|Morphine|morphine|mesh-list
2618255|NCT01866254|Hydromorphone|hydromorphone|mesh-list
2618256|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2618257|NCT01866254|Narcotics|narcotics|mesh-ancestor
2618258|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618259|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618260|NCT01866254|Analgesics|analgesics|mesh-ancestor
2618261|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
2618262|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618263|NCT01866267|Maraviroc|maraviroc|mesh-list
2618264|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2618265|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2618266|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618267|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2618268|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2618269|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
2618270|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618271|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2618272|NCT01866397|Cidofovir|cidofovir|mesh-list
2618273|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
2618274|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618275|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618276|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618277|NCT01866488|Misoprostol|misoprostol|mesh-list
2618278|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2618279|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
2618280|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2618281|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618282|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2618283|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2161642|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
2161643|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161644|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
2161645|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2161646|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2161647|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
2161648|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161649|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2618284|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
2618285|NCT01866514|Lidocaine|lidocaine|mesh-list
2618286|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
2618287|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
2618288|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618289|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618290|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
2618291|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618292|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2618293|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2618294|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2618295|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2618296|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618297|NCT01866553|Interferons|interferons|mesh-list
2161650|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
2618298|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
2618299|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
2618300|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2618301|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618302|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
2618303|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618304|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
2618305|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618306|NCT01866605|Midazolam|midazolam|mesh-list
2618307|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2618308|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2618309|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618310|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618311|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2618312|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2618313|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2618314|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2618315|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
2618316|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
2618317|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
2618318|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
2618319|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2618320|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618321|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
2618322|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2618323|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
2618324|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618325|NCT01866644|Expectorants|expectorants|mesh-ancestor
2618326|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
2618327|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2618328|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
2161651|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
2161652|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2161653|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
2161654|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161655|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161656|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
2161657|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161658|NCT00589550|Interferons|interferons|mesh-list
2161659|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
2161660|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
2161661|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2161662|NCT00589550|Sorafenib|sorafenib|mesh-list
2161663|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161664|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
2161665|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161666|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2161667|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161668|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161669|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
2161670|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161671|NCT00577772|Rifaximin|rifaximin|mesh-list
2161672|NCT00577772|Lactulose|lactulose|mesh-list
2161673|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2161674|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161675|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2161676|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2161677|NCT00592007|Fulvestrant|fulvestrant|mesh-list
2161678|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161679|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2161680|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161681|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161682|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2161683|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2161684|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2161685|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
2161686|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2161687|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618329|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618330|NCT01866644|Protective Agents|protective agents|mesh-ancestor
2618331|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618332|NCT01866644|Antidotes|antidotes|mesh-ancestor
2618333|NCT01866657|Phenylephrine|phenylephrine|mesh-list
2618334|NCT01866657|Dopamine|dopamine|mesh-list
2618335|NCT01866657|Ephedrine|ephedrine|mesh-list
2618336|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2618337|NCT01866657|Propofol|propofol|mesh-list
2618338|NCT01866657|Sevoflurane|sevoflurane|mesh-list
2618339|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
2618340|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618341|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618342|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2618343|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2618344|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
2618345|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2618346|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2618347|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2618348|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
2618349|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
2618350|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618351|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
2618352|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
2618353|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
2618354|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2618355|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2618356|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2618357|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
2618358|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2618359|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618360|NCT01866657|Protective Agents|protective agents|mesh-ancestor
2618361|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
2618362|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2618363|NCT01866930|Interferons|interferons|mesh-list
2618364|NCT01866930|Ribavirin|ribavirin|mesh-list
2618365|NCT01866930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618366|NCT01866930|Antiviral Agents|antiviral agents|mesh-ancestor
2618367|NCT01866930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618368|NCT01866930|Antimetabolites|antimetabolites|mesh-ancestor
2618369|NCT01866930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161688|NCT00595582|Curcumin|curcumin|mesh-list
2161689|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2161690|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2161691|NCT00595582|Analgesics|analgesics|mesh-ancestor
2161692|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
2161693|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618370|NCT01867138|Vancomycin|vancomycin|mesh-list
2618371|NCT01867138|Cefazolin|cefazolin|mesh-list
2618372|NCT01867138|Amikacin|amikacin|mesh-list
2618373|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2618374|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618375|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2618376|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2618377|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2618378|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2618379|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618380|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2618381|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618382|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2618383|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
2618384|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2618385|NCT01867268|Acetazolamide|acetazolamide|mesh-list
2618386|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
2618387|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2618388|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618389|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618390|NCT01867268|Diuretics|diuretics|mesh-ancestor
2618391|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
2618392|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618393|NCT01867281|Aspirin|aspirin|mesh-list
2618394|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2618395|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2618396|NCT01867281|Analgesics|analgesics|mesh-ancestor
2618397|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
2618398|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618399|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618400|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2618401|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2618402|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2618403|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2618404|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618405|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2618406|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2618407|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618408|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
2618409|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
2618410|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2618411|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2618412|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
2618413|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618414|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2618415|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2618416|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618417|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618418|NCT01867333|Metronidazole|metronidazole|mesh-list
2618419|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618420|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2618421|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2618422|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2618423|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2618424|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2618425|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
2618426|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618427|NCT01867463|Antacids|antacids|mesh-ancestor
2618428|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618429|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2161694|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161695|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2161696|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2161697|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161698|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161699|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161700|NCT00588146|Interferons|interferons|mesh-list
2161701|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
2161702|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
2161703|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2161704|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161705|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
2161706|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161707|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
2161708|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161709|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2161710|NCT00590538|Genistein|genistein|mesh-list
2618430|NCT01867502|Metformin|metformin|mesh-list
2618431|NCT01867502|Vildagliptin|vildagliptin|mesh-list
2618432|NCT01867502|Glyburide|glyburide|mesh-list
2618433|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2618434|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618435|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2618436|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
2618437|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618438|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618439|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
2618440|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2618441|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618442|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
2618443|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2618444|NCT01867645|Antibodies|antibodies|mesh-list
2618445|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
2618446|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2618447|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
2618448|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618449|NCT01867697|Leucovorin|leucovorin|mesh-list
2618450|NCT01867697|Folic Acid|folic acid|mesh-list
2618451|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
2618452|NCT01867697|Irinotecan|irinotecan|mesh-list
2618453|NCT01867697|Cetuximab|cetuximab|mesh-list
2618454|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
2618455|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
2618456|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618457|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618458|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2618459|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2161711|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161712|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2161713|NCT00590538|Protective Agents|protective agents|mesh-ancestor
2161714|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161715|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2618460|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618461|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618462|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2618463|NCT01867697|Antidotes|antidotes|mesh-ancestor
2161716|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2421941|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2618464|NCT01867697|Protective Agents|protective agents|mesh-ancestor
2618465|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
2618466|NCT01867697|Vitamins|vitamins|mesh-ancestor
2618467|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
2618468|NCT01867697|Hematinics|hematinics|mesh-ancestor
2618469|NCT01867697|Antacids|antacids|mesh-ancestor
2618470|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2618471|NCT01867775|Mirtazapine|mirtazapine|mesh-list
2618472|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
2618473|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2618474|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2618475|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
2618476|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
2618477|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2618478|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618479|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618480|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2618481|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2618482|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618483|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2618484|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2618485|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2618486|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
2618487|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2618488|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2618489|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
2618490|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2618491|NCT01867866|Trifluridine|trifluridine|mesh-list
2618492|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
2618493|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618494|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
2618495|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618496|NCT01867892|Leucovorin|leucovorin|mesh-list
2618497|NCT01867892|Gemcitabine|gemcitabine|mesh-list
2618498|NCT01867892|Fluorouracil|fluorouracil|mesh-list
2618499|NCT01867892|Irinotecan|irinotecan|mesh-list
2618500|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
2618501|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2618502|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
2618503|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618504|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618505|NCT01867892|Antiviral Agents|antiviral agents|mesh-ancestor
2618506|NCT01867892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618507|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618508|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2618509|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
2618510|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618511|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2618512|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2618513|NCT01867892|Antidotes|antidotes|mesh-ancestor
2618514|NCT01867892|Protective Agents|protective agents|mesh-ancestor
2618515|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
2618516|NCT01867892|Vitamins|vitamins|mesh-ancestor
2618517|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
2618518|NCT01867957|Vaccines|vaccines|mesh-list
2618519|NCT01867957|Immunologic Factors|immunologic factors|mesh-ancestor
2421942|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2421943|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
2421944|NCT00815048|Atropine|atropine|mesh-list
2421945|NCT00815048|Fentanyl|fentanyl|mesh-list
2421946|NCT00815048|Remifentanil|remifentanil|mesh-list
2421947|NCT00815048|Succinylcholine|succinylcholine|mesh-list
2421948|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2421949|NCT00815048|Narcotics|narcotics|mesh-ancestor
2421950|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2421951|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421952|NCT00815048|Analgesics|analgesics|mesh-ancestor
2421953|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
2421954|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421955|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2421956|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2421957|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
2421958|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
2421959|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2421960|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2421961|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
2618520|NCT01867957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618521|NCT01868048|Nabiximols|nabiximols|mesh-list
2618522|NCT01868048|Analgesics|analgesics|mesh-ancestor
2618523|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
2618524|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618525|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618526|NCT01868113|Fluticasone|fluticasone|mesh-list
2618527|NCT01868113|Xhance|xhance|mesh-list
2618528|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2618529|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2618530|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
2618531|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618532|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618533|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2618534|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
2618535|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
2618536|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2618537|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2618538|NCT01868126|Latanoprost|latanoprost|mesh-list
2618539|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2618540|NCT01868191|Thiamine|thiamine|mesh-list
2618541|NCT01868191|Benphothiamine|benphothiamine|mesh-list
2618542|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2618543|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
2618544|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618545|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
2618546|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
2161717|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161718|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
2161719|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2161720|NCT00590538|Estrogens|estrogens|mesh-ancestor
2161721|NCT00590538|Hormones|hormones|mesh-ancestor
2161722|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2161723|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
2161724|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161725|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2161726|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161727|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161728|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
2161729|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
2161730|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2161731|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161732|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161733|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
2161734|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2161735|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618547|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618548|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
2618549|NCT01868191|Vitamins|vitamins|mesh-ancestor
2618550|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
2618551|NCT01868269|Dexamethasone|dexamethasone|mesh-list
2618552|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
2618553|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
2618554|NCT01868269|Rituximab|rituximab|mesh-list
2618555|NCT01868269|BB 1101|bb 1101|mesh-list
2618556|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2618557|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
2618558|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618559|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2618560|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2618561|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
2618562|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618563|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618564|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2618565|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2618566|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
2618567|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
2618568|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618569|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2618570|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
2618571|NCT01868269|Hormones|hormones|mesh-ancestor
2618572|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2618573|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2618574|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
2618575|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618576|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2618577|NCT01868360|Aflibercept|aflibercept|mesh-list
2618578|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2618579|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2618580|NCT01868360|Growth Substances|growth substances|mesh-ancestor
2618581|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618582|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
2618583|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618584|NCT01868438|Artesunate|artesunate|mesh-list
2618585|NCT01868438|Pyronaridine|pyronaridine|mesh-list
2618586|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
2618587|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2161736|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161737|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
2161738|NCT00586716|Antibodies|antibodies|mesh-list
2161739|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
2161740|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2161741|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2161742|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
2161743|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161744|NCT00588471|Simvastatin|simvastatin|mesh-list
2161745|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2161746|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2161747|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
2161748|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161749|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2161750|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2161751|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161752|NCT00590135|Atorvastatin|atorvastatin|mesh-list
2161753|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2161754|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2161755|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
2161756|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161757|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2161758|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2161759|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161760|NCT00582036|Insulin|insulin|mesh-list
2161761|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2161762|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2161763|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618588|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2618589|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618590|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618591|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
2618592|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
2618593|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2618594|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
2618595|NCT01868451|Doxorubicin|doxorubicin|mesh-list
2618596|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2618597|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2618598|NCT01868451|Dacarbazine|dacarbazine|mesh-list
2618599|NCT01868451|Vinblastine|vinblastine|mesh-list
2618600|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2618601|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618602|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2618603|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2618604|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618605|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618606|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2618607|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2618608|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
2618609|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2161764|NCT00585585|Betahistine|betahistine|mesh-list
2161765|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
2161766|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
2161767|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
2161768|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2161769|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161770|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161771|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2161772|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
2161773|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161774|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2618610|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
2618611|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
2618612|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
2618613|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
2618614|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2618615|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
2618616|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161775|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161776|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161777|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
2161778|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161779|NCT00579254|Amlodipine|amlodipine|mesh-list
2161780|NCT00579254|Atorvastatin|atorvastatin|mesh-list
2161781|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2161782|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2161783|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
2161784|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618617|NCT01868529|Insulin|insulin|mesh-list
2618618|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2618619|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
2618620|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2618621|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618622|NCT01868555|Insulin|insulin|mesh-list
2618623|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2618624|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
2618625|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
2618626|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2618627|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2618628|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618629|NCT01868568|Insulin|insulin|mesh-list
2161785|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2161786|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2161787|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161788|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2161789|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2161790|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2161791|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2161792|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161793|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
2161794|NCT00585611|Atorvastatin|atorvastatin|mesh-list
2161795|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2161796|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2161797|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
2161798|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161799|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2161800|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2161801|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161802|NCT00572260|Daptomycin|daptomycin|mesh-list
2161803|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2161804|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161805|NCT00571194|Pravastatin|pravastatin|mesh-list
2161806|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2161807|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2161808|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
2161809|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161810|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2161811|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2161812|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161813|NCT00584935|Rituximab|rituximab|mesh-list
2161814|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2161815|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161816|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
2161817|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161818|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2161819|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
2161820|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2161821|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2618630|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2618631|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
2618632|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
2618633|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2618634|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
2618635|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2618636|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2618637|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618638|NCT01868581|Insulin|insulin|mesh-list
2161822|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618639|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2618640|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
2161823|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2161824|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161825|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2161826|NCT00573391|Thalidomide|thalidomide|mesh-list
2161827|NCT00573391|Dexamethasone|dexamethasone|mesh-list
2161828|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
2161829|NCT00573391|Melphalan|melphalan|mesh-list
2161830|NCT00573391|Bortezomib|bortezomib|mesh-list
2161831|NCT00573391|BB 1101|bb 1101|mesh-list
2161832|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2161833|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
2618641|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
2618642|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2618643|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618644|NCT01868750|Calcitriol|calcitriol|mesh-list
2618645|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2618646|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618647|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2618648|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2618649|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618650|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2618651|NCT01868750|Vitamins|vitamins|mesh-ancestor
2618652|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
2618653|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2618654|NCT01868802|Ketamine|ketamine|mesh-list
2618655|NCT01868802|Analgesics|analgesics|mesh-ancestor
2618656|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
2618657|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618658|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618659|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2618660|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2618661|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
2618662|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
2618663|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618664|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2618665|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2618666|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2618667|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618668|NCT01868880|Bisoprolol|bisoprolol|mesh-list
2618669|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2618670|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2618671|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
2161834|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
2161835|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161836|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161837|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2161838|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
2161839|NCT00573391|Hormones|hormones|mesh-ancestor
2161840|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2161841|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2161842|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161843|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
2161844|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161845|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161846|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2161847|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
2161848|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2161849|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2161850|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
2161851|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
2161852|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2161853|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161854|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2161855|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2161856|NCT00573391|Growth Substances|growth substances|mesh-ancestor
2161857|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
2161858|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2161859|NCT00570258|Fulvestrant|fulvestrant|mesh-list
2161860|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161861|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2161862|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161863|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618672|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2161864|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2161865|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2161866|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2161867|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
2161868|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2161869|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161870|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
2618673|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618674|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618675|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2618676|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
2618677|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
2618678|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618679|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2618680|NCT01868906|Temozolomide|temozolomide|mesh-list
2618681|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2618682|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
2618683|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618684|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618685|NCT01868945|Vitamin D|vitamin d|mesh-list
2618686|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
2618687|NCT01868945|Calcifediol|calcifediol|mesh-list
2618688|NCT01868945|Vitamins|vitamins|mesh-ancestor
2618689|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
2618690|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618691|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2618692|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2618693|NCT01868984|Paclitaxel|paclitaxel|mesh-list
2618694|NCT01868984|Heparin|heparin|mesh-list
2618695|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2618696|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618697|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
2618698|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
2618699|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
2618700|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618701|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
2618702|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2618703|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2618704|NCT01869010|Tenofovir|tenofovir|mesh-list
2618705|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
2618706|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618707|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2618708|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2618709|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618710|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618711|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2618712|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2618713|NCT01869023|Gemcitabine|gemcitabine|mesh-list
2618714|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618715|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2618716|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
2618717|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618718|NCT01869023|Antiviral Agents|antiviral agents|mesh-ancestor
2618719|NCT01869023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618720|NCT01869023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618721|NCT01869023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2618722|NCT01869023|Immunologic Factors|immunologic factors|mesh-ancestor
2618723|NCT01869023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618724|NCT01869036|Morphine|morphine|mesh-list
2618725|NCT01869036|Anesthetics|anesthetics|mesh-list
2618726|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618727|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618728|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2618729|NCT01869036|Narcotics|narcotics|mesh-ancestor
2618730|NCT01869036|Analgesics|analgesics|mesh-ancestor
2618731|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
2618732|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618733|NCT01869205|Ivermectin|ivermectin|mesh-list
2618734|NCT01869205|Abamectin|abamectin|mesh-list
2618735|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2161871|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161872|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
2161873|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161874|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161875|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2161876|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
2618736|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618737|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
2618738|NCT01869257|Triclosan|triclosan|mesh-list
2618739|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2618740|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618741|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2618742|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2161877|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161878|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
2161879|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161880|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161881|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2161882|NCT00574080|Cytarabine|cytarabine|mesh-list
2161883|NCT00574080|Thalidomide|thalidomide|mesh-list
2161884|NCT00574080|Dexamethasone|dexamethasone|mesh-list
2161885|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
2161886|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
2161887|NCT00574080|Melphalan|melphalan|mesh-list
2161888|NCT00574080|Carmustine|carmustine|mesh-list
2618743|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
2618744|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618745|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2618746|NCT01869309|Ticagrelor|ticagrelor|mesh-list
2618747|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2618748|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2618749|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2618750|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2618751|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2618752|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
2618753|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2618754|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618755|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161889|NCT00574080|Cisplatin|cisplatin|mesh-list
2161890|NCT00574080|Etoposide|etoposide|mesh-list
2161891|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
2161892|NCT00574080|Doxorubicin|doxorubicin|mesh-list
2161893|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2161894|NCT00574080|Bortezomib|bortezomib|mesh-list
2161895|NCT00574080|BB 1101|bb 1101|mesh-list
2161896|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2161897|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
2161898|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161899|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2161900|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2161901|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
2161902|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161903|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161904|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2161905|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2161906|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
2161907|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
2161908|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161909|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2161910|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
2161911|NCT00574080|Hormones|hormones|mesh-ancestor
2161912|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2161913|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2161914|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
2161915|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161916|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2161917|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2161918|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2161919|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2161920|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
2161921|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
2161922|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161923|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2161924|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
2161925|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2161926|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2161927|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2618771|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
2618772|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2618773|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2618774|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618775|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
2618776|NCT01869413|Coagulants|coagulants|mesh-ancestor
2618777|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
2618778|NCT01869491|Antacids|antacids|mesh-ancestor
2618779|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161928|NCT00574080|Growth Substances|growth substances|mesh-ancestor
2161929|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
2161930|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
2161931|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2161932|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
2161933|NCT00558558|Hormones|hormones|mesh-ancestor
2161934|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2161935|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161936|NCT00577356|Docetaxel|docetaxel|mesh-list
2161937|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161938|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
2618780|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2618781|NCT01869556|Oxytocin|oxytocin|mesh-list
2618782|NCT01869556|Ergonovine|ergonovine|mesh-list
2618783|NCT01869556|Carboprost|carboprost|mesh-list
2618784|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
2618785|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2618786|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618787|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2618788|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
2618789|NCT01869569|Pregabalin|pregabalin|mesh-list
2618790|NCT01869569|Analgesics|analgesics|mesh-ancestor
2618791|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
2618792|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618793|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618794|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
2618795|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2618796|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2618797|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618798|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2618799|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2618800|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2618801|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618802|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2161939|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
2161940|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
2161941|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161942|NCT00573937|Morphine|morphine|mesh-list
2161943|NCT00573937|Methadone|methadone|mesh-list
2161944|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2161945|NCT00573937|Narcotics|narcotics|mesh-ancestor
2618803|NCT01869621|Metformin|metformin|mesh-list
2618804|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2618805|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618806|NCT01869673|Anesthetics|anesthetics|mesh-list
2618807|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618808|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618809|NCT01869751|Prucalopride|prucalopride|mesh-list
2618810|NCT01869751|Laxatives|laxatives|mesh-ancestor
2618811|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2618812|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2618813|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2618814|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
2618815|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2161946|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618816|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618817|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618818|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
2618819|NCT01869803|Calicheamicins|calicheamicins|mesh-list
2618820|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2618821|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618822|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2618838|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
2618839|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2618840|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2618841|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618842|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2618843|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2618844|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
2618845|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2618846|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618847|NCT01869907|Minocycline|minocycline|mesh-list
2618848|NCT01869907|Amitriptyline|amitriptyline|mesh-list
2618849|NCT01869907|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2618850|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2618851|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618852|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2618853|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
2618854|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2618855|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2618856|NCT01869907|Analgesics|analgesics|mesh-ancestor
2618857|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
2618858|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618859|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618860|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2618861|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2618862|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2618863|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618864|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
2618865|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2618866|NCT01869907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2618867|NCT01869907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2618868|NCT01869907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618869|NCT01869946|Ropivacaine|ropivacaine|mesh-list
2618870|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
2618871|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
2618872|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618873|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618874|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
2618875|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618876|NCT01870011|Anesthetics|anesthetics|mesh-list
2618877|NCT01870011|Propofol|propofol|mesh-list
2618878|NCT01870011|Desflurane|desflurane|mesh-list
2618879|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2161947|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161948|NCT00573937|Analgesics|analgesics|mesh-ancestor
2161949|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
2161950|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2161951|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
2161952|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
2161953|NCT00571922|Acamprosate|acamprosate|mesh-list
2161954|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2161955|NCT00569868|Bortezomib|bortezomib|mesh-list
2161956|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161957|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
2161958|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2161959|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161960|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2161961|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
2161962|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2161963|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618880|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618881|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2618882|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2618883|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
2618884|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2618885|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
2618886|NCT01870024|Lorazepam|lorazepam|mesh-list
2618887|NCT01870024|Clonazepam|clonazepam|mesh-list
2618888|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
2618889|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
2618890|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
2618891|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618892|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618893|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2618894|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2618895|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618896|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2618897|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2618898|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2161964|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161965|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161966|NCT00570531|Paclitaxel|paclitaxel|mesh-list
2161967|NCT00570531|Bevacizumab|bevacizumab|mesh-list
2161968|NCT00570531|Fluorouracil|fluorouracil|mesh-list
2161969|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2161970|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161971|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
2618899|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
2618900|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
2618901|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2618902|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618903|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2618904|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2618905|NCT01870050|Dapsone|dapsone|mesh-list
2618906|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618907|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
2618908|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2618909|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2618910|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2618911|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618912|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618913|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
2618914|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2618915|NCT01870115|Vitamin D|vitamin d|mesh-list
2618916|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
2618917|NCT01870115|Melatonin|melatonin|mesh-list
2618918|NCT01870115|Vitamins|vitamins|mesh-ancestor
2618919|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
2618920|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618921|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2618922|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618923|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2161972|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
2161973|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
2161974|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161975|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2161976|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2161977|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2161978|NCT00570531|Growth Substances|growth substances|mesh-ancestor
2161979|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161980|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
2161981|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
2161982|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2161983|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2161984|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
2618924|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
2618925|NCT01870115|Protective Agents|protective agents|mesh-ancestor
2161985|NCT00561912|Interferons|interferons|mesh-list
2618926|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618927|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
2618928|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
2618929|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
2618930|NCT01870128|Methotrexate|methotrexate|mesh-list
2618931|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2618932|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
2618933|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2618934|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618935|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2618936|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
2618937|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618938|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618939|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
2618940|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618941|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2618942|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2618943|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
2618944|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2618945|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2618946|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2618947|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
2618948|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
2618949|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618950|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2618951|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
2618952|NCT01870128|Hormones|hormones|mesh-ancestor
2618953|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2618954|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2618955|NCT01870128|Protective Agents|protective agents|mesh-ancestor
2618956|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
2618957|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2618958|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2618959|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618960|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2161986|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
2161987|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
2161988|NCT00561912|Decitabine|decitabine|mesh-list
2161989|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2161990|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
2161991|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2161992|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
2161993|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2161994|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2161995|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
2161996|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2161997|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2161998|NCT00561795|Paclitaxel|paclitaxel|mesh-list
2161999|NCT00561795|Carboplatin|carboplatin|mesh-list
2162000|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2162001|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162002|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
2162003|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
2162004|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
2162005|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162006|NCT00564876|Dasatinib|dasatinib|mesh-list
2162007|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162008|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2162009|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162010|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162011|NCT00558870|Morphine|morphine|mesh-list
2162012|NCT00558870|Methadone|methadone|mesh-list
2162013|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2618961|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2618962|NCT01870128|Analgesics|analgesics|mesh-ancestor
2618963|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
2618964|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2618965|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2618966|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2618967|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2618968|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2618969|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618970|NCT01870219|Ketamine|ketamine|mesh-list
2618971|NCT01870219|Sevoflurane|sevoflurane|mesh-list
2618972|NCT01870219|Anesthetics|anesthetics|mesh-list
2162014|NCT00558870|Narcotics|narcotics|mesh-ancestor
2162015|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618973|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
2618974|NCT01870219|Analgesics|analgesics|mesh-ancestor
2618975|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
2618976|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2618977|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618978|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2618979|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
2618980|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2618981|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2618982|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2618983|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2618984|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2618985|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2618986|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2618987|NCT01870284|Adalimumab|adalimumab|mesh-list
2618988|NCT01870284|Ixekizumab|ixekizumab|mesh-list
2618989|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2618990|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2618991|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
2618992|NCT01870427|Aflibercept|aflibercept|mesh-list
2618993|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2618994|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2618995|NCT01870427|Growth Substances|growth substances|mesh-ancestor
2618996|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2618997|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
2162016|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162017|NCT00558870|Analgesics|analgesics|mesh-ancestor
2162018|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
2162019|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162020|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
2162021|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
2162022|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
2162023|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
2162024|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2162025|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2162026|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162027|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2162028|NCT00521924|Cyclosporine|cyclosporine|mesh-list
2162029|NCT00521924|Chloroquine|chloroquine|mesh-list
2162030|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
2162031|NCT00521924|Methotrexate|methotrexate|mesh-list
2162032|NCT00521924|Infliximab|infliximab|mesh-list
2162033|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
2162034|NCT00521924|Cyclosporins|cyclosporins|mesh-list
2162035|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2618998|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2618999|NCT01870440|Dexamethasone|dexamethasone|mesh-list
2619000|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
2619001|NCT01870440|BB 1101|bb 1101|mesh-list
2162036|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
2162037|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2162038|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162039|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162040|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
2162041|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162042|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162043|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
2162044|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162045|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2162046|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162047|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
2162048|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2162049|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
2162050|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162051|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2619002|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2619003|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
2619004|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
2162052|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2162053|NCT00521924|Amebicides|amebicides|mesh-ancestor
2162054|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2162055|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2162056|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
2162057|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2162058|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2162059|NCT00521924|Analgesics|analgesics|mesh-ancestor
2162060|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
2162061|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162062|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2162063|NCT00548886|Epinephrine|epinephrine|mesh-list
2619005|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619006|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619007|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2619008|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
2619009|NCT01870440|Hormones|hormones|mesh-ancestor
2619010|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2619011|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2619012|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619013|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
2619014|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619015|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619016|NCT01870466|Cilostazol|cilostazol|mesh-list
2162064|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2162065|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2162066|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
2162067|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2162068|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162069|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162070|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2162071|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2162072|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
2619017|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2619018|NCT01870466|Simvastatin|simvastatin|mesh-list
2619019|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2619020|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2619021|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
2162073|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162074|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2162075|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
2162076|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
2162077|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
2162078|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2162079|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
2162080|NCT00539838|Prednisone|prednisone|mesh-list
2162081|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
2162082|NCT00539838|Methotrexate|methotrexate|mesh-list
2162083|NCT00539838|Azathioprine|azathioprine|mesh-list
2162084|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2162085|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
2162086|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2162087|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
2162088|NCT00539838|Hormones|hormones|mesh-ancestor
2162089|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2162090|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619022|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619023|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2619024|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2619025|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619026|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2619027|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
2162091|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2162092|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162093|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2162094|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
2162095|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2162096|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162097|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
2162098|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162099|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
2162100|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162101|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2162102|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
2162103|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2162104|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2162105|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2162106|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2162107|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
2162108|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2162109|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162110|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
2162111|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
2162112|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162113|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2162114|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2162115|NCT00539838|Protective Agents|protective agents|mesh-ancestor
2162116|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2162117|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2162118|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2162119|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2162120|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162121|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
2162122|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2162123|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162124|NCT00542542|Fentanyl|fentanyl|mesh-list
2162125|NCT00542542|Midazolam|midazolam|mesh-list
2162126|NCT00542542|Propofol|propofol|mesh-list
2162127|NCT00542542|Ropivacaine|ropivacaine|mesh-list
2162128|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2162129|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2162130|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162131|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2162132|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
2162133|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
2162134|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
2162135|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
2162136|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162137|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2162138|NCT00542542|Narcotics|narcotics|mesh-ancestor
2162139|NCT00542542|Analgesics|analgesics|mesh-ancestor
2162140|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2162141|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2162142|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2162143|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2162144|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
2162145|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
2162146|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2619028|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619029|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619030|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2619031|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
2619032|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2619033|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2619034|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2619035|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
2619036|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2619037|NCT01870466|Protective Agents|protective agents|mesh-ancestor
2619038|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2162147|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162148|NCT00547300|Metoprolol|metoprolol|mesh-list
2162149|NCT00547300|Nebivolol|nebivolol|mesh-list
2162150|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2162151|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2162152|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
2162153|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
2162154|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162155|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162156|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2162157|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2162158|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2162159|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
2162160|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2421962|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2421963|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
2421964|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
2421965|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
2421966|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2421967|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2421968|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
2421969|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2421970|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2421971|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2421972|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2421973|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2421974|NCT00815204|Dexamethasone|dexamethasone|mesh-list
2421975|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2619039|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2619040|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2619041|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2619042|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2619043|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619044|NCT01870505|Letrozole|letrozole|mesh-list
2619045|NCT01870505|Exemestane|exemestane|mesh-list
2619046|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619047|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2619048|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2619049|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619050|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619051|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2619052|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
2619053|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2619054|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619055|NCT01870635|Ondansetron|ondansetron|mesh-list
2619056|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
2619057|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
2619058|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619059|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619060|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2619061|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
2619062|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
2619063|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2619064|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
2619065|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2162161|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162162|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
2162163|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2162164|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2162165|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2162166|NCT00539617|Leucovorin|leucovorin|mesh-list
2162167|NCT00539617|Fluorouracil|fluorouracil|mesh-list
2162168|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
2162169|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2162170|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
2162171|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162172|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162173|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162174|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162175|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
2619066|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619067|NCT01870635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2619068|NCT01870635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2619069|NCT01870635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619070|NCT01870635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2619071|NCT01870635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2162176|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162177|NCT00539617|Antidotes|antidotes|mesh-ancestor
2162178|NCT00539617|Protective Agents|protective agents|mesh-ancestor
2162179|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
2162180|NCT00539617|Vitamins|vitamins|mesh-ancestor
2162181|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
2162182|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2162183|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162184|NCT00546455|Fenretinide|fenretinide|mesh-list
2162185|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162186|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2162187|NCT00546455|Protective Agents|protective agents|mesh-ancestor
2162188|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619072|NCT01870648|Ondansetron|ondansetron|mesh-list
2619073|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
2619074|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
2619075|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619076|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619077|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2619078|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
2619079|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
2619080|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2619081|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
2619082|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2619083|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619084|NCT01870648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2162189|NCT00538980|Dasatinib|dasatinib|mesh-list
2619085|NCT01870648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2619086|NCT01870648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619087|NCT01870648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2619088|NCT01870648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2619089|NCT01870674|Prucalopride|prucalopride|mesh-list
2619090|NCT01870674|YH12852|yh12852|mesh-list
2619091|NCT01870674|Laxatives|laxatives|mesh-ancestor
2619092|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2619093|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2619094|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2619095|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
2619096|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2619097|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619098|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619099|NCT01870804|Atorvastatin|atorvastatin|mesh-list
2619100|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2619101|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2619102|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2619103|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
2619104|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619105|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2619106|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2619107|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619108|NCT01870895|Ramosetron|ramosetron|mesh-list
2619109|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
2619110|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
2619111|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619112|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619113|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2619114|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2619115|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
2619116|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2619117|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619118|NCT01870908|Tacrolimus|tacrolimus|mesh-list
2619119|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2619120|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
2619121|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619122|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2619123|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619124|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619125|NCT01870986|Adalimumab|adalimumab|mesh-list
2619126|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2619127|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2619128|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
2619129|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2619130|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619131|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619132|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2619133|NCT01871129|Analgesics|analgesics|mesh-ancestor
2619134|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
2619135|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619136|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2619137|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2619138|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2619139|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
2619140|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2619141|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619142|NCT01871311|Cetuximab|cetuximab|mesh-list
2619143|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2619144|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619145|NCT01871363|Capecitabine|capecitabine|mesh-list
2619146|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162190|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162191|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2162192|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162193|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162194|NCT00535262|Selegiline|selegiline|mesh-list
2162195|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
2162196|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2162197|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2162198|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2162199|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2162200|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162201|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619147|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2619148|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
2619149|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619150|NCT01871376|Aflibercept|aflibercept|mesh-list
2619151|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2619152|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2619153|NCT01871376|Growth Substances|growth substances|mesh-ancestor
2619154|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619155|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
2619156|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619157|NCT01871415|Metformin|metformin|mesh-list
2619158|NCT01871415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2619159|NCT01871415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619160|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
2619161|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2619162|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619163|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619164|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2619165|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2619166|NCT01871454|Protective Agents|protective agents|mesh-ancestor
2619167|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619168|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
2619169|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2619170|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
2619171|NCT01871467|Sargramostim|sargramostim|mesh-list
2619172|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
2619173|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619174|NCT01871480|Gefitinib|gefitinib|mesh-list
2619175|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619176|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2619177|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619178|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619179|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
2619180|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2619181|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162202|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2162203|NCT00535262|Protective Agents|protective agents|mesh-ancestor
2162204|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162205|NCT00536978|Cytarabine|cytarabine|mesh-list
2162206|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
2162207|NCT00536978|Melphalan|melphalan|mesh-list
2162208|NCT00536978|Carmustine|carmustine|mesh-list
2162209|NCT00536978|Rituximab|rituximab|mesh-list
2162210|NCT00536978|Methotrexate|methotrexate|mesh-list
2162211|NCT00536978|Fludarabine|fludarabine|mesh-list
2162212|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
2162213|NCT00536978|Etoposide|etoposide|mesh-list
2162214|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
2162215|NCT00536978|Tacrolimus|tacrolimus|mesh-list
2162216|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162217|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
2162218|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162219|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2162220|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2162221|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
2162222|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162223|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162224|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2162225|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2162226|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2162227|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
2162228|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2619182|NCT01871571|Leucovorin|leucovorin|mesh-list
2619183|NCT01871571|Bevacizumab|bevacizumab|mesh-list
2619184|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2619185|NCT01871571|Fluorouracil|fluorouracil|mesh-list
2619186|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
2619187|NCT01871571|Antibodies|antibodies|mesh-list
2619188|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
2619189|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2619190|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
2619191|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619192|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2619193|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2619194|NCT01871571|Growth Substances|growth substances|mesh-ancestor
2619195|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619196|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
2162229|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162230|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
2162231|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
2162232|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162233|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2162234|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2162235|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
2162236|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162237|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2162238|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2162239|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2162240|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2162241|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2162242|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2162243|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
2162244|NCT00529282|Vancomycin|vancomycin|mesh-list
2162245|NCT00529282|Cefepime|cefepime|mesh-list
2162246|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
2162247|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2162248|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2619197|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
2619198|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
2619199|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619200|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2619201|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162249|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162250|NCT00524134|Carvedilol|carvedilol|mesh-list
2162251|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2162252|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2162253|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
2162254|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2162255|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162256|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619202|NCT01871571|Antidotes|antidotes|mesh-ancestor
2619203|NCT01871571|Protective Agents|protective agents|mesh-ancestor
2619204|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
2619205|NCT01871571|Vitamins|vitamins|mesh-ancestor
2619206|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
2619207|NCT01871649|Golimumab|golimumab|mesh-list
2619208|NCT01871649|Methotrexate|methotrexate|mesh-list
2619209|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2619210|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
2619211|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2619212|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619213|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2619214|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
2619215|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619216|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619217|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
2619218|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619219|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2619220|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2619221|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
2619222|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2619223|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2619224|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2619225|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2619226|NCT01871662|Interferons|interferons|mesh-list
2619227|NCT01871662|Ribavirin|ribavirin|mesh-list
2619228|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
2619229|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
2619230|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2619231|NCT01871662|Silybin|silybin|mesh-list
2619232|NCT01871662|Silymarin|silymarin|mesh-list
2619233|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619234|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
2619235|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619236|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
2619237|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619238|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
2619239|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619240|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
2619241|NCT01871662|Protective Agents|protective agents|mesh-ancestor
2619242|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2619243|NCT01871675|Rituximab|rituximab|mesh-list
2619244|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2619245|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2619246|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619247|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
2619248|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619249|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2619250|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2619251|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
2619252|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619253|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
2619254|NCT01871701|Dexetimide|dexetimide|mesh-list
2619255|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2619256|NCT01871701|Citalopram|citalopram|mesh-list
2619257|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2619258|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2619259|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619260|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2619261|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2619262|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619263|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619264|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619265|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2619266|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
2619267|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2619268|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619269|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2619270|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2619271|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2619272|NCT01871701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2619273|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2619274|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2619275|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2619276|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
2619277|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2619278|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
2619279|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2619280|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2619281|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2619282|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
2619283|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
2619284|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619285|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2619286|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2619287|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
2619288|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2619289|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2619290|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619291|NCT01871740|Folic Acid|folic acid|mesh-list
2619292|NCT01871740|Enalapril|enalapril|mesh-list
2619293|NCT01871740|Enalaprilat|enalaprilat|mesh-list
2619294|NCT01871740|Maleic acid|maleic acid|mesh-list
2619295|NCT01871740|Hematinics|hematinics|mesh-ancestor
2619296|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
2619297|NCT01871740|Vitamins|vitamins|mesh-ancestor
2619298|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
2619299|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619300|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619301|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619302|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2619303|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
2619304|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2619305|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
2619306|NCT01871766|Dactinomycin|dactinomycin|mesh-list
2619307|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
2619308|NCT01871766|Ifosfamide|ifosfamide|mesh-list
2619309|NCT01871766|Bevacizumab|bevacizumab|mesh-list
2619310|NCT01871766|Doxorubicin|doxorubicin|mesh-list
2619311|NCT01871766|Etoposide|etoposide|mesh-list
2619312|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
2619313|NCT01871766|Irinotecan|irinotecan|mesh-list
2619314|NCT01871766|Vincristine|vincristine|mesh-list
2619315|NCT01871766|Sorafenib|sorafenib|mesh-list
2619316|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
2162257|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2162258|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
2162259|NCT00524134|Protective Agents|protective agents|mesh-ancestor
2162260|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2162261|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2162262|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2162263|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
2162264|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2619317|NCT01871766|Razoxane|razoxane|mesh-list
2619318|NCT01871766|Mitogens|mitogens|mesh-list
2619319|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2619320|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
2619321|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619322|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2619323|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2619324|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
2619325|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619326|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619327|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2619328|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2619329|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2619330|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2619331|NCT01871766|Growth Substances|growth substances|mesh-ancestor
2619332|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
2162265|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2162266|NCT00517699|Cytarabine|cytarabine|mesh-list
2162267|NCT00517699|Rituximab|rituximab|mesh-list
2162268|NCT00517699|Methotrexate|methotrexate|mesh-list
2162269|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2162270|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619333|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2619334|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2619335|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2619336|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619337|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2619338|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2619339|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
2619340|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
2619341|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
2619342|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2619343|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2619344|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619345|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2619346|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2162271|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
2162272|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162273|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2162274|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2162275|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
2162276|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2162277|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162278|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
2162279|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162280|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
2162281|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162282|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2162283|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162284|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2162285|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
2162286|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162287|NCT00528437|Carboplatin|carboplatin|mesh-list
2162288|NCT00528437|Temozolomide|temozolomide|mesh-list
2162289|NCT00528437|Thiotepa|thiotepa|mesh-list
2162290|NCT00528437|Tretinoin|tretinoin|mesh-list
2162291|NCT00528437|Isotretinoin|isotretinoin|mesh-list
2162292|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162293|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2162294|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
2162295|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162296|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2162297|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162298|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
2162299|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162300|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
2162301|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
2162302|NCT00527982|Celecoxib|celecoxib|mesh-list
2162303|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2162304|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2162305|NCT00527982|Analgesics|analgesics|mesh-ancestor
2162306|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
2162307|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162308|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619347|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2162309|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2619348|NCT01871766|Protective Agents|protective agents|mesh-ancestor
2619349|NCT01871792|Pitavastatin|pitavastatin|mesh-list
2619350|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2619351|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2619352|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2619353|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
2619354|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619355|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619356|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2619357|NCT01871844|Octreotide|octreotide|mesh-list
2619358|NCT01871844|Somatostatin|somatostatin|mesh-list
2619359|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2619360|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2619361|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619362|NCT01871844|Hormones|hormones|mesh-ancestor
2619363|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2619364|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619365|NCT01871857|Epinephrine|epinephrine|mesh-list
2619366|NCT01871857|Racepinephrine|racepinephrine|mesh-list
2619367|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
2619368|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2619369|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2619370|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
2619371|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2619372|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619373|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619374|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2619375|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2619376|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
2619377|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619378|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2619379|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
2619380|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
2619381|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
2619382|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2619383|NCT01871922|Atropine|atropine|mesh-list
2619384|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2619385|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2619386|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2619387|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
2619388|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619389|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619390|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2619391|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
2619392|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
2619393|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
2619394|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2619395|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2619396|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
2619397|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2619398|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619399|NCT01871935|Sufentanil|sufentanil|mesh-list
2619400|NCT01871935|Remifentanil|remifentanil|mesh-list
2619401|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2619402|NCT01871935|Narcotics|narcotics|mesh-ancestor
2619403|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619404|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619405|NCT01871935|Analgesics|analgesics|mesh-ancestor
2619406|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
2619407|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619408|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2619409|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2619410|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
2619411|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
2619412|NCT01871961|Methotrexate|methotrexate|mesh-list
2162310|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2162311|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2162312|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2162313|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162314|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619413|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2619414|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
2619415|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2162315|NCT00524459|Docetaxel|docetaxel|mesh-list
2619416|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162316|NCT00524459|Doxorubicin|doxorubicin|mesh-list
2162317|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2162318|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162319|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
2162320|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
2162321|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
2162322|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162323|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2619417|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2619418|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
2619419|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619420|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619421|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
2619422|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619423|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2619424|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162324|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2162325|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2162326|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162327|NCT00517361|Bevacizumab|bevacizumab|mesh-list
2162328|NCT00517361|Carboplatin|carboplatin|mesh-list
2162329|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2162330|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162331|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2162332|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2619425|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
2619426|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2619427|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2619428|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2619429|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
2619430|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2619431|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2619432|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2619433|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619434|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619435|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2619436|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
2619437|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2619438|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2619439|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2619440|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619441|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619442|NCT01872013|ASP7991|asp7991|mesh-list
2619443|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2619444|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
2619445|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2619446|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619447|NCT01872026|ASP7991|asp7991|mesh-list
2619448|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2162333|NCT00517361|Growth Substances|growth substances|mesh-ancestor
2162334|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162335|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
2162336|NCT00523939|Cytarabine|cytarabine|mesh-list
2162337|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162338|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
2162339|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162340|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162341|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
2619449|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
2619450|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2619451|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619452|NCT01872039|Nicardipine|nicardipine|mesh-list
2619453|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2619454|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2619455|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2619456|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619457|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2619458|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619459|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
2619460|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
2619461|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
2619462|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
2619463|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162342|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162343|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162344|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
2162345|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162346|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
2162347|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162348|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2162349|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162350|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162351|NCT00523809|Vidarabine|vidarabine|mesh-list
2162352|NCT00523809|Bevacizumab|bevacizumab|mesh-list
2162353|NCT00523809|Fludarabine|fludarabine|mesh-list
2162354|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
2162355|NCT00523809|Melphalan|melphalan|mesh-list
2162356|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
2162357|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2162358|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2162359|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162360|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2162361|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2162362|NCT00523809|Growth Substances|growth substances|mesh-ancestor
2162363|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162364|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
2162365|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162366|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
2162367|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162368|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162369|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
2162370|NCT00523809|Antiviral Agents|antiviral agents|mesh-ancestor
2162371|NCT00523809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162372|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2162373|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
2162374|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2162375|NCT00522301|Sorafenib|sorafenib|mesh-list
2162376|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162377|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2162378|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162379|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162380|NCT00517192|Ritonavir|ritonavir|mesh-list
2162381|NCT00517192|Darunavir|darunavir|mesh-list
2162382|NCT00517192|Tipranavir|tipranavir|mesh-list
2162383|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2162384|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2619464|NCT01872351|Protective Agents|protective agents|mesh-ancestor
2619465|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619466|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
2619467|NCT01872351|Vitamins|vitamins|mesh-ancestor
2619468|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
2619469|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
2619470|NCT01872403|Paclitaxel|paclitaxel|mesh-list
2619471|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2619472|NCT01872403|Carboplatin|carboplatin|mesh-list
2619473|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2619474|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619475|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
2619476|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
2619477|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
2619478|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619479|NCT01872416|Doxorubicin|doxorubicin|mesh-list
2619480|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2619481|NCT01872416|Ifosfamide|ifosfamide|mesh-list
2619482|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2619483|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619484|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2619485|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2162385|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
2162386|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162387|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162388|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2162389|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2162390|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
2162391|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162392|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2619486|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619487|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619488|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2619489|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
2619490|NCT01872442|Interferons|interferons|mesh-list
2619491|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
2162393|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2162394|NCT00503581|Megestrol|megestrol|mesh-list
2162395|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
2162396|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2162397|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2162398|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2162399|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
2162400|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2162401|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162402|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2619492|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
2619493|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2619494|NCT01872442|Dasatinib|dasatinib|mesh-list
2619495|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619496|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
2619497|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619498|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
2619499|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619500|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2619501|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619502|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619503|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
2619504|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
2619505|NCT01872494|Pentazocine|pentazocine|mesh-list
2619506|NCT01872494|Palonosetron|palonosetron|mesh-list
2619507|NCT01872494|Ropivacaine|ropivacaine|mesh-list
2619508|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
2619509|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
2619510|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619511|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619512|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
2619513|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619514|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
2619515|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
2619516|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2619517|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2619518|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2619519|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
2619520|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2619521|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619522|NCT01872494|Analgesics|analgesics|mesh-ancestor
2162403|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2162404|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2162405|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162406|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
2162407|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2162408|NCT00509600|Etanercept|etanercept|mesh-list
2162409|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2162410|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2162411|NCT00509600|Analgesics|analgesics|mesh-ancestor
2162412|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
2162413|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162414|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162415|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2162416|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2421976|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
2421977|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
2421978|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2421979|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421980|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2421981|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
2421982|NCT00815204|Hormones|hormones|mesh-ancestor
2421983|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2421984|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2421985|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2421986|NCT00815256|Riboflavin|riboflavin|mesh-list
2421987|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
2421988|NCT00815256|Vitamins|vitamins|mesh-ancestor
2421989|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
2421990|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2421991|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2421992|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
2619523|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2619524|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2619525|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2162417|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2162418|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162419|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
2162420|NCT00515112|Testosterone|testosterone|mesh-list
2162421|NCT00515112|Androgens|androgens|mesh-ancestor
2619526|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2619527|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2619528|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619529|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2619530|NCT01872494|Narcotics|narcotics|mesh-ancestor
2619531|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2619532|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2619533|NCT01872546|Adalimumab|adalimumab|mesh-list
2162422|NCT00515112|Hormones|hormones|mesh-ancestor
2162423|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2162424|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162425|NCT00508872|Leucovorin|leucovorin|mesh-list
2162426|NCT00508872|Bevacizumab|bevacizumab|mesh-list
2162427|NCT00508872|Fluorouracil|fluorouracil|mesh-list
2162428|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
2162429|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2162430|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619534|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2619535|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2619536|NCT01872702|Piperaquine|piperaquine|mesh-list
2619537|NCT01872702|Primaquine|primaquine|mesh-list
2619538|NCT01872702|Artenimol|artenimol|mesh-list
2619539|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
2619540|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2619541|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2619542|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619543|NCT01872728|Anesthetics|anesthetics|mesh-list
2619544|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619545|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619546|NCT01872754|Remifentanil|remifentanil|mesh-list
2619547|NCT01872754|Propofol|propofol|mesh-list
2619548|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2619549|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619550|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619551|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2619552|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
2619553|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
2619554|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2619555|NCT01872754|Narcotics|narcotics|mesh-ancestor
2619556|NCT01872754|Analgesics|analgesics|mesh-ancestor
2619557|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
2619558|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619559|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
2162431|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2162432|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2162433|NCT00508872|Growth Substances|growth substances|mesh-ancestor
2162434|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162435|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
2162436|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
2162437|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162438|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162439|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2619560|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2619561|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619562|NCT01872832|Verinurad|verinurad|mesh-list
2619563|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
2619564|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2619565|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2619566|NCT01872845|Pravastatin|pravastatin|mesh-list
2619567|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2619568|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2619569|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
2619570|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162440|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
2162441|NCT00508872|Antidotes|antidotes|mesh-ancestor
2619571|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2619572|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2619573|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619574|NCT01872858|Aspirin|aspirin|mesh-list
2619575|NCT01872858|Cilostazol|cilostazol|mesh-list
2619576|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2162442|NCT00508872|Protective Agents|protective agents|mesh-ancestor
2162443|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
2162444|NCT00508872|Vitamins|vitamins|mesh-ancestor
2162445|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
2162446|NCT00506064|Melatonin|melatonin|mesh-list
2162447|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
2162448|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162449|NCT00506064|Protective Agents|protective agents|mesh-ancestor
2619577|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2619578|NCT01872858|Analgesics|analgesics|mesh-ancestor
2619579|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
2619580|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619581|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619582|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2619583|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2619584|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2619585|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2619586|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619587|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2619588|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2619589|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619590|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
2619591|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2619592|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
2619593|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2162450|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162451|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2162452|NCT00503880|Cytarabine|cytarabine|mesh-list
2162453|NCT00503880|Clofarabine|clofarabine|mesh-list
2162454|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
2162455|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162456|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162457|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
2162458|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162459|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162460|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
2162461|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619594|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
2619595|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
2619596|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2619597|NCT01872858|Protective Agents|protective agents|mesh-ancestor
2619598|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2619599|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2619600|NCT01872871|Acetaminophen|acetaminophen|mesh-list
2619601|NCT01872871|Anesthetics|anesthetics|mesh-list
2619602|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
2162462|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162463|NCT00501228|Lenograstim|lenograstim|mesh-list
2162464|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2619603|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2619604|NCT01872871|Analgesics|analgesics|mesh-ancestor
2619605|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
2619606|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619607|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619608|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
2619609|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619610|NCT01872884|Remifentanil|remifentanil|mesh-list
2619611|NCT01872884|Sevoflurane|sevoflurane|mesh-list
2619612|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2619613|NCT01872884|Narcotics|narcotics|mesh-ancestor
2619614|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619615|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619616|NCT01872884|Analgesics|analgesics|mesh-ancestor
2619617|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
2619618|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619619|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2619620|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2619621|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
2619622|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
2619623|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
2619624|NCT01872897|Antacids|antacids|mesh-ancestor
2619625|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619626|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2162465|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
2162466|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619627|NCT01872923|Bleomycin|bleomycin|mesh-list
2619628|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2162467|NCT00496782|Maraviroc|maraviroc|mesh-list
2162468|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2162469|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2162470|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162471|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2162472|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2162473|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
2162474|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162475|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2162476|NCT00506909|Oxytocin|oxytocin|mesh-list
2619629|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619630|NCT01872936|Ribavirin|ribavirin|mesh-list
2619631|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
2619632|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619633|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
2619634|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619635|NCT01872962|Gemcitabine|gemcitabine|mesh-list
2619636|NCT01872962|Cisplatin|cisplatin|mesh-list
2619637|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162477|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
2162478|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2619638|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2619639|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
2619640|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619641|NCT01872962|Antiviral Agents|antiviral agents|mesh-ancestor
2619642|NCT01872962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619643|NCT01872962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619644|NCT01872962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2619645|NCT01872962|Immunologic Factors|immunologic factors|mesh-ancestor
2619646|NCT01872962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619647|NCT01872988|Tenofovir|tenofovir|mesh-list
2619648|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
2619649|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619650|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2619651|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2619652|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619653|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619654|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2619655|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2619656|NCT01873001|Pioglitazone|pioglitazone|mesh-list
2619657|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
2619658|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2619659|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619660|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619661|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2619662|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162479|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162480|NCT00487578|Naratriptan|naratriptan|mesh-list
2162481|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2162482|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2162483|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2162484|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
2162485|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2162486|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162487|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619663|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619664|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
2619665|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2619666|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2619667|NCT01873027|Sirolimus|sirolimus|mesh-list
2619668|NCT01873027|Umirolimus|umirolimus|mesh-list
2619669|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2619670|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2619671|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
2619672|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619673|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2619674|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619675|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2619676|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619677|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
2619678|NCT01873079|Esomeprazole|esomeprazole|mesh-list
2619679|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2619680|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2619681|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2162488|NCT00503009|Fluticasone|fluticasone|mesh-list
2162489|NCT00503009|Xhance|xhance|mesh-list
2162490|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2162491|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2162492|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2162493|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
2162494|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162495|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162496|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2162497|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
2162498|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
2162499|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2162500|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2162501|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2162502|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2162503|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
2162504|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2162505|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162506|NCT00500045|Niacin|niacin|mesh-list
2162507|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
2162508|NCT00500045|Niacinamide|niacinamide|mesh-list
2162509|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2162510|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
2162511|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162512|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2162513|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
2162514|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
2162515|NCT00500045|Vitamins|vitamins|mesh-ancestor
2162516|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
2162517|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162518|NCT00499590|Ranibizumab|ranibizumab|mesh-list
2162519|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2162520|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2162521|NCT00499590|Growth Substances|growth substances|mesh-ancestor
2619682|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619683|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619684|NCT01873131|Timolol|timolol|mesh-list
2619685|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2619686|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2619687|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
2619688|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2619689|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619690|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619691|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2619692|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2619693|NCT01873144|Epinephrine|epinephrine|mesh-list
2619694|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2619695|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2619696|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2619697|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
2619698|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2619699|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619700|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619701|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2619702|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2619703|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
2619704|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619705|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2619706|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
2619707|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
2619708|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
2619709|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2162522|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162523|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
2162524|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162525|NCT00501345|Aspirin|aspirin|mesh-list
2162526|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2162527|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2619710|NCT01873157|Bortezomib|bortezomib|mesh-list
2619711|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619712|NCT01873222|Sirolimus|sirolimus|mesh-list
2619713|NCT01873222|Umirolimus|umirolimus|mesh-list
2619714|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2619715|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162528|NCT00501345|Analgesics|analgesics|mesh-ancestor
2619716|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
2162529|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
2162530|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162531|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162532|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2162533|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2162534|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2162535|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2162536|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162537|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2162538|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2162539|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162540|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
2162541|NCT00496756|Sorafenib|sorafenib|mesh-list
2162542|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162543|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2619717|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619718|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2619719|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619720|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2619721|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619722|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
2619723|NCT01873313|Ropivacaine|ropivacaine|mesh-list
2619724|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
2619725|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
2619726|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619727|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619728|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
2619729|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619730|NCT01873326|Paclitaxel|paclitaxel|mesh-list
2619731|NCT01873326|Etoposide|etoposide|mesh-list
2619732|NCT01873326|Ifosfamide|ifosfamide|mesh-list
2619733|NCT01873326|Bleomycin|bleomycin|mesh-list
2619734|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2619735|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619736|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
2619737|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
2619738|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
2619739|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619740|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2619741|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2619742|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619743|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2619744|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
2619745|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2619746|NCT01873339|Midazolam|midazolam|mesh-list
2619747|NCT01873339|Darapladib|darapladib|mesh-list
2619748|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2162544|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162545|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162546|NCT00495716|Acyclovir|acyclovir|mesh-list
2162547|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
2162548|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162549|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
2619749|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2619750|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619751|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619752|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2619753|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2619754|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2619755|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2619756|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
2619757|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
2619758|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
2619759|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
2619760|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2619761|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619762|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2619763|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619764|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2619765|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
2619766|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2619767|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
2619768|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2619769|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619770|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2619771|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2619772|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619773|NCT01873430|Melatonin|melatonin|mesh-list
2619774|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
2619775|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619776|NCT01873430|Protective Agents|protective agents|mesh-ancestor
2619777|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619778|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619779|NCT01873443|Folic Acid|folic acid|mesh-list
2619780|NCT01873443|Rituximab|rituximab|mesh-list
2619781|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2619782|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619783|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
2619784|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619785|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2619786|NCT01873443|Hematinics|hematinics|mesh-ancestor
2619787|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
2619788|NCT01873443|Vitamins|vitamins|mesh-ancestor
2619789|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
2619790|NCT01873573|Triamcinolone|triamcinolone|mesh-list
2619791|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2619792|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
2619793|NCT01873573|Hormones|hormones|mesh-ancestor
2619794|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2619795|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619796|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
2619797|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2619798|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619799|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2619800|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2619801|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619802|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619803|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619804|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2619805|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2619806|NCT01873703|Azacitidine|azacitidine|mesh-list
2619807|NCT01873703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2619808|NCT01873703|Antimetabolites|antimetabolites|mesh-ancestor
2619809|NCT01873703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619810|NCT01873703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619811|NCT01873703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619812|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
2619813|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
2619814|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2619815|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2619816|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619817|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
2619818|NCT01873768|Coagulants|coagulants|mesh-ancestor
2619819|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
2619820|NCT01873807|Etoposide|etoposide|mesh-list
2619821|NCT01873807|Idarubicin|idarubicin|mesh-list
2619822|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2619823|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
2619824|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619825|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2619826|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2619827|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
2619828|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619829|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619830|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2619831|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2619832|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2619833|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2619834|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619835|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2619836|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
2619837|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
2619838|NCT01873820|Calcium|calcium|mesh-list
2619839|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2619840|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619841|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
2619842|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619843|NCT01873820|Protective Agents|protective agents|mesh-ancestor
2619844|NCT01873820|Vitamins|vitamins|mesh-ancestor
2619845|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
2619846|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
2619847|NCT01873833|Capecitabine|capecitabine|mesh-list
2619848|NCT01873833|Trastuzumab|trastuzumab|mesh-list
2619849|NCT01873833|Lapatinib|lapatinib|mesh-list
2619850|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2619851|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
2619852|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619853|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2619854|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2619855|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
2619856|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619857|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619858|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2619859|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2619860|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
2619861|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2619862|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2619863|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619864|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
2619865|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
2619866|NCT01874002|Sirolimus|sirolimus|mesh-list
2619867|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2619868|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619869|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2619870|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619871|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
2619872|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2619873|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
2619874|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619875|NCT01874028|Trientine|trientine|mesh-list
2619876|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
2619877|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
2619878|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619879|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
2619880|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619881|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
2619882|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
2619883|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
2619884|NCT01874080|Metformin|metformin|mesh-list
2619885|NCT01874080|Saxagliptin|saxagliptin|mesh-list
2619886|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2619887|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619888|NCT01874080|Incretins|incretins|mesh-ancestor
2619889|NCT01874080|Hormones|hormones|mesh-ancestor
2619890|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2619891|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2619892|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
2619893|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619894|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619895|NCT01874171|Cetuximab|cetuximab|mesh-list
2619896|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619897|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2619898|NCT01874236|Bupivacaine|bupivacaine|mesh-list
2619899|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
2619900|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
2619901|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619902|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619903|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
2619904|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619905|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
2619906|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2619907|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619908|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2619909|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2619910|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619911|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619912|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619913|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
2619914|NCT01874470|Diuretics|diuretics|mesh-list
2619915|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
2619916|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619917|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
2162550|NCT00500890|Carboplatin|carboplatin|mesh-list
2162551|NCT00500890|Etoposide|etoposide|mesh-list
2162552|NCT00500890|Vincristine|vincristine|mesh-list
2162553|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162554|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
2162555|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619918|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2619919|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2619920|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2619921|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2619922|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619923|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619924|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619925|NCT01874574|Triamcinolone|triamcinolone|mesh-list
2619926|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2619927|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2619928|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2619929|NCT01874574|Hylan|hylan|mesh-list
2619930|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2619931|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
2619932|NCT01874574|Hormones|hormones|mesh-ancestor
2619933|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2619934|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619935|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2619936|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
2619937|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619938|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619939|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
2619940|NCT01874574|Protective Agents|protective agents|mesh-ancestor
2619941|NCT01874626|Ibuprofen|ibuprofen|mesh-list
2619942|NCT01874626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2619943|NCT01874626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2619944|NCT01874626|Analgesics|analgesics|mesh-ancestor
2619945|NCT01874626|Sensory System Agents|sensory system agents|mesh-ancestor
2619946|NCT01874626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2619947|NCT01874626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619948|NCT01874626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2619949|NCT01874626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2619950|NCT01874626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2619951|NCT01874626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619952|NCT01874626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619953|NCT01874639|Hemostatics|hemostatics|mesh-list
2619954|NCT01874639|Coagulants|coagulants|mesh-ancestor
2619955|NCT01874678|Cisplatin|cisplatin|mesh-list
2619956|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619957|NCT01874717|Midazolam|midazolam|mesh-list
2619958|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2619959|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2619960|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619961|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619962|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2619963|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2619964|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2619965|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2619966|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
2619967|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
2619968|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
2619969|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
2619970|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2619971|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619972|NCT01874730|Anesthetics|anesthetics|mesh-list
2619973|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619974|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619975|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2619976|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2619977|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2619978|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
2619979|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2619980|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2619981|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2619982|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2619983|NCT01874847|Melatonin|melatonin|mesh-list
2619984|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
2619985|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162556|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2162557|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2162558|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
2162559|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162560|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2619986|NCT01874847|Protective Agents|protective agents|mesh-ancestor
2619987|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2619988|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2619989|NCT01874860|Doxycycline|doxycycline|mesh-list
2619990|NCT01874860|Clindamycin|clindamycin|mesh-list
2619991|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
2619992|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
2619993|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
2619994|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
2619995|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2619996|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2619997|NCT01874860|Prednisolone|prednisolone|mesh-list
2619998|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
2619999|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
2620000|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2162561|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2162562|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2162563|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2620001|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
2620002|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620003|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2620004|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620005|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
2620006|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2620007|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2620008|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
2620009|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
2620010|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620011|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620012|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2620013|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
2620014|NCT01874860|Hormones|hormones|mesh-ancestor
2620015|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2620016|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2162564|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2162565|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162566|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
2162567|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
2162568|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
2162569|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2162570|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162571|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2162572|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162573|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620017|NCT01874860|Protective Agents|protective agents|mesh-ancestor
2620018|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2620019|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620020|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2620021|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620022|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620023|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2620024|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
2620025|NCT01874964|Methadone|methadone|mesh-list
2620026|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2620027|NCT01874964|Narcotics|narcotics|mesh-ancestor
2620028|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2620029|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162574|NCT00493025|Paclitaxel|paclitaxel|mesh-list
2162575|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2162576|NCT00493025|Cisplatin|cisplatin|mesh-list
2162577|NCT00493025|Gefitinib|gefitinib|mesh-list
2162578|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2162579|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162580|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
2162581|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
2162582|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
2162583|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162584|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2162585|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620030|NCT01874964|Analgesics|analgesics|mesh-ancestor
2620031|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
2620032|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620033|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
2620034|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
2620035|NCT01875107|Insulin|insulin|mesh-list
2162586|NCT00491400|Atorvastatin|atorvastatin|mesh-list
2620036|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2620037|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620038|NCT01875172|Bupropion|bupropion|mesh-list
2620039|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2620040|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
2620041|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2620042|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2620043|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2620044|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2620045|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620046|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
2620047|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2620048|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620049|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2620050|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2620051|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620052|NCT01875185|Aspirin|aspirin|mesh-list
2620053|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2620054|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2620055|NCT01875185|Analgesics|analgesics|mesh-ancestor
2620056|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
2620057|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620058|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620059|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620060|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2620061|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2620062|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2620063|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620064|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2620065|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2620066|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620067|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
2620068|NCT01875224|Abatacept|abatacept|mesh-list
2620069|NCT01875224|Tacrolimus|tacrolimus|mesh-list
2620070|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2620071|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
2620072|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620073|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2620074|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620075|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620076|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2620077|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620078|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2620079|NCT01875263|Levofloxacin|levofloxacin|mesh-list
2620080|NCT01875263|Ofloxacin|ofloxacin|mesh-list
2620081|NCT01875263|Cloxacillin|cloxacillin|mesh-list
2620082|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2620083|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620084|NCT01875263|Renal Agents|renal agents|mesh-ancestor
2620085|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2620086|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2620087|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2620088|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620089|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620090|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620091|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2620092|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2620093|NCT01875653|Molgramostim|molgramostim|mesh-list
2620094|NCT01875653|Sargramostim|sargramostim|mesh-list
2620095|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
2620096|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162587|NCT00491400|Fenofibrate|fenofibrate|mesh-list
2162588|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2162589|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2162590|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
2162591|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162592|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2162593|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2162594|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162595|NCT00490776|Panobinostat|panobinostat|mesh-list
2162596|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162597|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2162598|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162599|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620097|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620098|NCT01875666|Trastuzumab|trastuzumab|mesh-list
2620099|NCT01875666|Pertuzumab|pertuzumab|mesh-list
2620100|NCT01875666|Lapatinib|lapatinib|mesh-list
2620101|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2620102|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620103|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2162600|NCT00487162|Insulin|insulin|mesh-list
2162601|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2162602|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162603|NCT00491387|Metoprolol|metoprolol|mesh-list
2162604|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2162605|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2620104|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620105|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620106|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
2620107|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620108|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2620109|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620110|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620111|NCT01875757|Vitamin D|vitamin d|mesh-list
2620112|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
2620113|NCT01875757|Vitamins|vitamins|mesh-ancestor
2620114|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
2620115|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620116|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2620117|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2620118|NCT01875822|Curcumin|curcumin|mesh-list
2620119|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2620120|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2620121|NCT01875822|Analgesics|analgesics|mesh-ancestor
2620122|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
2620123|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620124|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620125|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620126|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2620127|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620128|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620129|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620130|NCT01875926|Gontivimab|gontivimab|mesh-list
2620131|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
2620132|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620133|NCT01875952|Isoniazid|isoniazid|mesh-list
2620134|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
2620135|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2620136|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620137|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2620138|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2620139|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
2620140|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620141|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2620142|NCT01876004|Methotrexate|methotrexate|mesh-list
2620143|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2620144|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
2620145|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2620146|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620147|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2620148|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
2620149|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620150|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620151|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
2620152|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620153|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2620154|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2620155|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
2620156|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2620157|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2620158|NCT01876108|Amoxicillin|amoxicillin|mesh-list
2620159|NCT01876108|Azithromycin|azithromycin|mesh-list
2620160|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
2620161|NCT01876108|Omeprazole|omeprazole|mesh-list
2620162|NCT01876108|Bismuth|bismuth|mesh-list
2620163|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2620164|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620165|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2620166|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2162606|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
2620167|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2620168|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620169|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620170|NCT01876108|Antacids|antacids|mesh-ancestor
2620171|NCT01876121|Celecoxib|celecoxib|mesh-list
2620172|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2620173|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2620174|NCT01876121|Analgesics|analgesics|mesh-ancestor
2620175|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
2620176|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620177|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620178|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620179|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2620180|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2620181|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2620182|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620183|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620184|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
2620185|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2620186|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2620187|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
2620188|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2620189|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620190|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620191|NCT01876186|Urological Agents|urological agents|mesh-ancestor
2620192|NCT01876290|Dexamethasone|dexamethasone|mesh-list
2620193|NCT01876290|Ondansetron|ondansetron|mesh-list
2620194|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620195|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
2620196|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
2620197|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620198|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620199|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2620200|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
2620201|NCT01876290|Hormones|hormones|mesh-ancestor
2162607|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
2162608|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162609|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162610|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2162611|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2162612|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2162613|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
2162614|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2162615|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162616|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
2162617|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162618|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
2162619|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
2162620|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2162621|NCT00483119|Antibodies|antibodies|mesh-list
2162622|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
2162623|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2162624|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162625|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
2162626|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162627|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2162628|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2162629|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
2421993|NCT00815269|Sevoflurane|sevoflurane|mesh-list
2421994|NCT00815269|Desflurane|desflurane|mesh-list
2421995|NCT00815269|Isoflurane|isoflurane|mesh-list
2421996|NCT00815269|Halothane|halothane|mesh-list
2421997|NCT00815269|Enflurane|enflurane|mesh-list
2421998|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2421999|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2422000|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
2422001|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
2422002|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2422003|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422004|NCT00815282|Vaccines|vaccines|mesh-list
2422005|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
2422006|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422007|NCT00815373|Timolol|timolol|mesh-list
2422008|NCT00815373|Dorzolamide|dorzolamide|mesh-list
2422009|NCT00815373|Latanoprost|latanoprost|mesh-list
2422010|NCT00815373|Maleic acid|maleic acid|mesh-list
2422011|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2162630|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162631|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162632|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2162633|NCT00487461|Simvastatin|simvastatin|mesh-list
2162634|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2162635|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2162636|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
2162637|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162638|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2162639|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2162640|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162641|NCT00484718|Celecoxib|celecoxib|mesh-list
2162642|NCT00484718|Oxycodone|oxycodone|mesh-list
2162643|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2620202|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2620203|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2620204|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620205|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
2620206|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
2620207|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2620208|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
2620209|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2620210|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620211|NCT01876290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2620212|NCT01876290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2620213|NCT01876290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2162644|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2162645|NCT00484718|Analgesics|analgesics|mesh-ancestor
2162646|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
2162647|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620214|NCT01876290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2620215|NCT01876290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2620216|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
2620217|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2620218|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620219|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2620220|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2620221|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620222|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620223|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620224|NCT01876355|Clonidine|clonidine|mesh-list
2620225|NCT01876355|Analgesics|analgesics|mesh-ancestor
2620226|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
2620227|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620228|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620229|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2620230|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
2620231|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
2620232|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2620233|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2620234|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2620235|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
2620236|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2620237|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620238|NCT01876433|Mirabegron|mirabegron|mesh-list
2620239|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2620240|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2620241|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2620242|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
2620243|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2620244|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620245|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620246|NCT01876433|Urological Agents|urological agents|mesh-ancestor
2620247|NCT01876550|Mupirocin|mupirocin|mesh-list
2620248|NCT01876550|Calcium|calcium|mesh-list
2620249|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2620250|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620251|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2620252|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620253|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2620254|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620255|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620256|NCT01876563|Vitamin D|vitamin d|mesh-list
2620257|NCT01876563|Vitamins|vitamins|mesh-ancestor
2162648|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162649|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2162650|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2162651|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2162652|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2162653|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162654|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162655|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2162656|NCT00484718|Narcotics|narcotics|mesh-ancestor
2162657|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2162658|NCT00474188|Dexamethasone|dexamethasone|mesh-list
2162659|NCT00474188|Lenalidomide|lenalidomide|mesh-list
2162660|NCT00474188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2162661|NCT00474188|Antiemetics|antiemetics|mesh-ancestor
2162662|NCT00474188|Autonomic Agents|autonomic agents|mesh-ancestor
2162663|NCT00474188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162664|NCT00474188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162665|NCT00474188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2162666|NCT00474188|Glucocorticoids|glucocorticoids|mesh-ancestor
2162667|NCT00474188|Hormones|hormones|mesh-ancestor
2162668|NCT00474188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2162669|NCT00474188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2162670|NCT00474188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162671|NCT00474188|Immunologic Factors|immunologic factors|mesh-ancestor
2162672|NCT00474188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2162673|NCT00474188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2162674|NCT00474188|Growth Substances|growth substances|mesh-ancestor
2162675|NCT00474188|Growth Inhibitors|growth inhibitors|mesh-ancestor
2162676|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2162677|NCT00479258|Insulin|insulin|mesh-list
2162678|NCT00479258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2162679|NCT00479258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2162680|NCT00479258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162681|NCT00470067|Carboplatin|carboplatin|mesh-list
2162682|NCT00470067|Doxorubicin|doxorubicin|mesh-list
2162683|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2162684|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162685|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2162686|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2162687|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2162688|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162689|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162690|NCT00476827|Gemcitabine|gemcitabine|mesh-list
2162691|NCT00476827|Paclitaxel|paclitaxel|mesh-list
2162692|NCT00476827|Vinorelbine|vinorelbine|mesh-list
2162693|NCT00476827|Docetaxel|docetaxel|mesh-list
2162694|NCT00476827|Bevacizumab|bevacizumab|mesh-list
2162695|NCT00476827|Irinotecan|irinotecan|mesh-list
2162696|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2162697|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162698|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
2162699|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
2162700|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
2162701|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162702|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2162703|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2162704|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2162705|NCT00476827|Growth Substances|growth substances|mesh-ancestor
2162706|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162707|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
2162708|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162709|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
2162710|NCT00476827|Antiviral Agents|antiviral agents|mesh-ancestor
2162711|NCT00476827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162712|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162713|NCT00476827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162714|NCT00476827|Immunologic Factors|immunologic factors|mesh-ancestor
2162715|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2620258|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
2620259|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620260|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2620261|NCT01876615|Diclofenac|diclofenac|mesh-list
2620262|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2620263|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2620264|NCT01876615|Analgesics|analgesics|mesh-ancestor
2620265|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
2620266|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620267|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620268|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620269|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2620270|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2620271|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620272|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620273|NCT01876628|Clindamycin|clindamycin|mesh-list
2620274|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
2620275|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
2620276|NCT01876628|Floxacillin|floxacillin|mesh-list
2620277|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2620278|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620279|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2620280|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620281|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620282|NCT01876641|Decitabine|decitabine|mesh-list
2620283|NCT01876641|Vemurafenib|vemurafenib|mesh-list
2620284|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2620285|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
2620286|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620287|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620288|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620289|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2620290|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2620291|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620292|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2620293|NCT01876797|Ticagrelor|ticagrelor|mesh-list
2620294|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2620295|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2620296|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2620297|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2620298|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2620299|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
2620300|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2620301|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620302|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620303|NCT01876849|Exenatide|exenatide|mesh-list
2620304|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2620305|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620306|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2620307|NCT01876849|Incretins|incretins|mesh-ancestor
2162716|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2162717|NCT00475657|Pemetrexed|pemetrexed|mesh-list
2162718|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162719|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162720|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620308|NCT01876849|Hormones|hormones|mesh-ancestor
2620309|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2620310|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2620311|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
2620312|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620313|NCT01876966|Ritonavir|ritonavir|mesh-list
2620314|NCT01876966|Darunavir|darunavir|mesh-list
2620315|NCT01876966|Lumefantrine|lumefantrine|mesh-list
2620316|NCT01876966|Artemether|artemether|mesh-list
2620317|NCT01876966|Etravirine|etravirine|mesh-list
2620318|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2162721|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2162722|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2162723|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2162724|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2162725|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
2162726|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162727|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
2162728|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
2162729|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2162730|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2162731|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2162732|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162733|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2162734|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2162735|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
2620319|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2162736|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2162737|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
2162738|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2162739|NCT00459121|Paclitaxel|paclitaxel|mesh-list
2162740|NCT00459121|Carboplatin|carboplatin|mesh-list
2162741|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2162742|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620320|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2620321|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
2620322|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620323|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620324|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2620325|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2620326|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
2620327|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620328|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2620329|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2620330|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
2620331|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2620332|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2162743|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
2162744|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
2162745|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
2162746|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162747|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
2162748|NCT00450333|Hematinics|hematinics|mesh-ancestor
2162749|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
2162750|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2162751|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2162752|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162753|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2162754|NCT00455143|Analgesics|analgesics|mesh-ancestor
2162755|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
2620333|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2620334|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2620335|NCT01877122|Ibuprofen|ibuprofen|mesh-list
2620336|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2620337|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2620338|NCT01877122|Analgesics|analgesics|mesh-ancestor
2620339|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
2620340|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620341|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620342|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620343|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2620344|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2620345|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620346|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620347|NCT01877226|Tapentadol|tapentadol|mesh-list
2620348|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2620349|NCT01877226|Narcotics|narcotics|mesh-ancestor
2620350|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2620351|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620352|NCT01877226|Analgesics|analgesics|mesh-ancestor
2620353|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
2620354|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620355|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2620356|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2620357|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2620358|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620359|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
2620360|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2620361|NCT01877356|Anesthetics|anesthetics|mesh-list
2162756|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162757|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2162758|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2620362|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2620363|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620364|NCT01877395|Vaccines|vaccines|mesh-list
2620365|NCT01877395|Immunologic Factors|immunologic factors|mesh-ancestor
2620366|NCT01877395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620367|NCT01877512|Hormones|hormones|mesh-list
2620368|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2162759|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2620369|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620370|NCT01877577|Vitamin D|vitamin d|mesh-list
2620371|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
2620372|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
2620373|NCT01877577|Vitamins|vitamins|mesh-list
2620374|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
2620375|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620376|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2620377|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2620378|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
2620379|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
2620380|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620381|NCT01877590|Protective Agents|protective agents|mesh-ancestor
2620382|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620383|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
2620384|NCT01877590|Vitamins|vitamins|mesh-ancestor
2620385|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
2620386|NCT01877746|Prednisone|prednisone|mesh-list
2620387|NCT01877746|Azathioprine|azathioprine|mesh-list
2620388|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620389|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
2620390|NCT01877746|Hormones|hormones|mesh-ancestor
2620391|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2620392|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620393|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2620394|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620395|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
2620396|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620397|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2620398|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2620399|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
2620400|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2620401|NCT01877811|Agerafenib|agerafenib|mesh-list
2162760|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
2162761|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2162762|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162763|NCT00456989|Docetaxel|docetaxel|mesh-list
2162764|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162765|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
2162766|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
2162767|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
2162768|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162769|NCT00448682|Leucovorin|leucovorin|mesh-list
2162770|NCT00448682|Docetaxel|docetaxel|mesh-list
2162771|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
2162772|NCT00448682|Floxuridine|floxuridine|mesh-list
2162773|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
2162774|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162775|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
2162776|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
2620402|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2620403|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620404|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620405|NCT01877837|Vidarabine|vidarabine|mesh-list
2620406|NCT01877837|Fludarabine|fludarabine|mesh-list
2620407|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
2620408|NCT01877837|Melphalan|melphalan|mesh-list
2620409|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
2620410|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620411|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2620412|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
2620413|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620414|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2620415|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
2620416|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620417|NCT01877837|Antiviral Agents|antiviral agents|mesh-ancestor
2162777|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
2162778|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162779|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162780|NCT00448682|Antidotes|antidotes|mesh-ancestor
2162781|NCT00448682|Protective Agents|protective agents|mesh-ancestor
2162782|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
2162783|NCT00448682|Vitamins|vitamins|mesh-ancestor
2620418|NCT01877837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162784|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
2162785|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2620419|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2620420|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
2620421|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2620422|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2620423|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
2620424|NCT01877889|Canagliflozin|canagliflozin|mesh-list
2620425|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2620426|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620427|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2620428|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620429|NCT01877954|Fluticasone|fluticasone|mesh-list
2620430|NCT01877954|Xhance|xhance|mesh-list
2620431|NCT01877954|Beclomethasone|beclomethasone|mesh-list
2620432|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620433|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2620434|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
2620435|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620436|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620437|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2620438|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
2620439|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
2620440|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2620441|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
2620442|NCT01877954|Hormones|hormones|mesh-ancestor
2620443|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2620444|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2620445|NCT01878136|Plasminogen|plasminogen|mesh-list
2620446|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2620447|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2620448|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620449|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
2620450|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2620451|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
2620452|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620453|NCT01878201|Valsartan|valsartan|mesh-list
2620454|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2620455|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2620456|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2620457|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162786|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
2162787|NCT00454571|Leuprolide|leuprolide|mesh-list
2162788|NCT00454571|Goserelin|goserelin|mesh-list
2162789|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2162790|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
2162791|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2162792|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162793|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2162794|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162795|NCT00452361|Cyclosporine|cyclosporine|mesh-list
2162796|NCT00452361|Sirolimus|sirolimus|mesh-list
2162797|NCT00452361|Tacrolimus|tacrolimus|mesh-list
2162798|NCT00452361|Cyclosporins|cyclosporins|mesh-list
2162799|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2162800|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162801|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
2162802|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162803|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162804|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162805|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
2162806|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162807|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
2162808|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2162809|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2162810|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2162811|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162812|NCT00447603|Losartan|losartan|mesh-list
2162813|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2162814|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2162815|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2162816|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2162817|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2162818|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162819|NCT00447603|Diuretics|diuretics|mesh-ancestor
2162820|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
2162821|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162822|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2620458|NCT01878227|Fenofibrate|fenofibrate|mesh-list
2620459|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2620460|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
2620461|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620462|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2620463|NCT01878318|Methotrexate|methotrexate|mesh-list
2620464|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2620465|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
2620466|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2620467|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620468|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2620469|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
2620470|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620471|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620472|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
2620473|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620474|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2620475|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2620476|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
2620477|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2620478|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2620479|NCT01878357|Piperaquine|piperaquine|mesh-list
2620480|NCT01878357|Primaquine|primaquine|mesh-list
2620481|NCT01878357|Artenimol|artenimol|mesh-list
2620482|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
2620483|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2620484|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2620485|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620486|NCT01878422|Leucovorin|leucovorin|mesh-list
2620487|NCT01878422|Bevacizumab|bevacizumab|mesh-list
2620488|NCT01878422|Cetuximab|cetuximab|mesh-list
2620489|NCT01878422|Fluorouracil|fluorouracil|mesh-list
2620490|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
2620491|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2620492|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620493|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2620494|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2620495|NCT01878422|Growth Substances|growth substances|mesh-ancestor
2620496|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620497|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
2620498|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
2620499|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620500|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2620501|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2620502|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
2620503|NCT01878422|Antidotes|antidotes|mesh-ancestor
2620504|NCT01878422|Protective Agents|protective agents|mesh-ancestor
2620505|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
2620506|NCT01878422|Vitamins|vitamins|mesh-ancestor
2620507|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
2620508|NCT01878513|Risperidone|risperidone|mesh-list
2620509|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2620510|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
2620511|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2620512|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620513|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620514|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2620515|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2620516|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2620517|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2620518|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2620519|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
2620520|NCT01878539|Anticoagulants|anticoagulants|mesh-list
2620521|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2620522|NCT01878578|Phenytoin|phenytoin|mesh-list
2620523|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
2620524|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2162823|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2162824|NCT00447421|Pemetrexed|pemetrexed|mesh-list
2162825|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162826|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162827|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162828|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2162829|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2620525|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2620526|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2620527|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620528|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2620529|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2162830|NCT00441272|Pioglitazone|pioglitazone|mesh-list
2162831|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2162832|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162833|NCT00440271|Ritonavir|ritonavir|mesh-list
2162834|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
2162835|NCT00440271|Maraviroc|maraviroc|mesh-list
2162836|NCT00440271|Tipranavir|tipranavir|mesh-list
2162837|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
2162838|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2162839|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2162840|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2162841|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
2162842|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162843|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162844|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2162845|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2162846|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
2162847|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162848|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2162849|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2162850|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2162851|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2162852|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2162853|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2162854|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2162855|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2162856|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2162857|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162858|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
2162859|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2162860|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
2162861|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2162862|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
2162863|NCT00429026|Melphalan|melphalan|mesh-list
2162864|NCT00429026|Fludarabine|fludarabine|mesh-list
2162865|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162866|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
2162867|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162868|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2162869|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2162870|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
2162871|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162872|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162873|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2162874|NCT00428207|Insulin|insulin|mesh-list
2162875|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2162876|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
2162877|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
2162878|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2162879|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
2162880|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2162881|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162882|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2162883|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162884|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
2422012|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2422013|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
2422014|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422015|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422016|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422017|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2422018|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2422019|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422020|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2162885|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2162886|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620554|NCT01878643|Vancomycin|vancomycin|mesh-list
2620555|NCT01878643|Gentamicins|gentamicins|mesh-list
2620556|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2620557|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162887|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2162888|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
2162889|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2162890|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162891|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162892|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162893|NCT00430027|Capecitabine|capecitabine|mesh-list
2162894|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
2162895|NCT00430027|Cetuximab|cetuximab|mesh-list
2162896|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162897|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
2162898|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162899|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620558|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2620559|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620560|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620573|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
2620574|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2620575|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
2620576|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620577|NCT01878695|Expectorants|expectorants|mesh-ancestor
2620578|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
2620579|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2620580|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
2620581|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620582|NCT01878695|Protective Agents|protective agents|mesh-ancestor
2620583|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620584|NCT01878695|Antidotes|antidotes|mesh-ancestor
2620585|NCT01878708|Dexamethasone|dexamethasone|mesh-list
2620586|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
2620587|NCT01878708|Asparaginase|asparaginase|mesh-list
2620588|NCT01878708|Pegaspargase|pegaspargase|mesh-list
2620589|NCT01878708|BB 1101|bb 1101|mesh-list
2620590|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620591|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
2620592|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
2620593|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620594|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620595|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2620596|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
2620597|NCT01878708|Hormones|hormones|mesh-ancestor
2620598|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2620599|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2620600|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620601|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
2620602|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620603|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620604|NCT01878734|Micronutrients|micronutrients|mesh-list
2620605|NCT01878734|Trace Elements|trace elements|mesh-list
2620606|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620607|NCT01878864|Lidocaine|lidocaine|mesh-list
2620608|NCT01878864|Bupivacaine|bupivacaine|mesh-list
2620609|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
2620610|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
2620611|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2620612|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620613|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
2620614|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620615|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2620616|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2620617|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2620618|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2620619|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620620|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
2620621|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
2620622|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620623|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2620624|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2620625|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
2620626|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2620627|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620628|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2620629|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
2620630|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2620631|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620632|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2620633|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2620634|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620635|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620636|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620637|NCT01879033|Insulin|insulin|mesh-list
2620638|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2620639|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620640|NCT01879085|Gemcitabine|gemcitabine|mesh-list
2620641|NCT01879085|Docetaxel|docetaxel|mesh-list
2620642|NCT01879085|Vorinostat|vorinostat|mesh-list
2620643|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2620644|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
2620645|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620646|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620647|NCT01879085|Antiviral Agents|antiviral agents|mesh-ancestor
2620648|NCT01879085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620649|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620650|NCT01879085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2620651|NCT01879085|Immunologic Factors|immunologic factors|mesh-ancestor
2620652|NCT01879085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620653|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
2620654|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
2620655|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
2620656|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2620657|NCT01879202|Methylphenidate|methylphenidate|mesh-list
2620658|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2620659|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620660|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2620661|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2620662|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2620663|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620664|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
2620665|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2620666|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2620667|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2620668|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620669|NCT01879228|Incretins|incretins|mesh-ancestor
2620670|NCT01879228|Hormones|hormones|mesh-ancestor
2620671|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2620672|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2620673|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
2620674|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162900|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2162901|NCT00429858|Gemcitabine|gemcitabine|mesh-list
2162902|NCT00429858|Tegafur|tegafur|mesh-list
2620675|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620676|NCT01879241|Rasagiline|rasagiline|mesh-list
2620677|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2620678|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620679|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620680|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2620681|NCT01879241|Protective Agents|protective agents|mesh-ancestor
2620682|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620683|NCT01879293|Metformin|metformin|mesh-list
2620684|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2620685|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620686|NCT01879358|Sirolimus|sirolimus|mesh-list
2620687|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2620688|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162903|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162904|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
2162905|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162906|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620689|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2620690|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620691|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
2620692|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2620693|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
2620694|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620695|NCT01879423|Lamotrigine|lamotrigine|mesh-list
2620696|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
2620697|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2620698|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2620699|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620700|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2620701|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620702|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2620703|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2620704|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2620705|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2620706|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2620707|NCT01879488|Edetic Acid|edetic acid|mesh-list
2620708|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
2620709|NCT01879488|Antidotes|antidotes|mesh-ancestor
2620710|NCT01879488|Protective Agents|protective agents|mesh-ancestor
2620711|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620712|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
2620713|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
2162907|NCT00429858|Antiviral Agents|antiviral agents|mesh-ancestor
2162908|NCT00429858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2162909|NCT00429858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162910|NCT00429858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162911|NCT00429858|Immunologic Factors|immunologic factors|mesh-ancestor
2162912|NCT00429858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162913|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
2162914|NCT00425438|Prednisolone|prednisolone|mesh-list
2162915|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
2162916|NCT00425438|Azathioprine|azathioprine|mesh-list
2162917|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162918|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
2162919|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162920|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2162921|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2162922|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
2162923|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162924|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162925|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2620714|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620715|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2620716|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
2620717|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2620718|NCT01879514|Prednisone|prednisone|mesh-list
2162926|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2162927|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2162928|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
2162929|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2162930|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620719|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620720|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
2620721|NCT01879514|Hormones|hormones|mesh-ancestor
2620722|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2620723|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620724|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2620725|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620726|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2620727|NCT01879527|Amiloride|amiloride|mesh-list
2620728|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
2620729|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2620730|NCT01879527|Diuretics|diuretics|mesh-ancestor
2620731|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
2620732|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620733|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2620734|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2620735|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620736|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2620737|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2162931|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162932|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2162933|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
2620738|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2620739|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2620740|NCT01879605|Bisacodyl|bisacodyl|mesh-list
2620741|NCT01879605|Sorbitol|sorbitol|mesh-list
2620742|NCT01879605|Cathartics|cathartics|mesh-ancestor
2620743|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2620744|NCT01879605|Laxatives|laxatives|mesh-ancestor
2620745|NCT01879748|Rasagiline|rasagiline|mesh-list
2620746|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2620747|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620748|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620749|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2620750|NCT01879748|Protective Agents|protective agents|mesh-ancestor
2620751|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620752|NCT01879917|Liraglutide|liraglutide|mesh-list
2620753|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2620754|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620755|NCT01879917|Incretins|incretins|mesh-ancestor
2162934|NCT00425438|Hormones|hormones|mesh-ancestor
2162935|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2162936|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2162937|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
2162938|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162939|NCT00421954|Ziprasidone|ziprasidone|mesh-list
2162940|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2162941|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
2162942|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2620756|NCT01879917|Hormones|hormones|mesh-ancestor
2620757|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2620758|NCT01879930|Doxycycline|doxycycline|mesh-list
2620759|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2620760|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620761|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
2620762|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2620763|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2620764|NCT01880112|Cefazolin|cefazolin|mesh-list
2620765|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2620766|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620767|NCT01880125|Acetaminophen|acetaminophen|mesh-list
2620768|NCT01880125|Tramadol|tramadol|mesh-list
2620769|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2620770|NCT01880125|Analgesics|analgesics|mesh-ancestor
2620771|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
2620772|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620773|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162943|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162944|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162945|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2162946|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2620774|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
2620775|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2620776|NCT01880125|Narcotics|narcotics|mesh-ancestor
2620777|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2620778|NCT01880138|Anesthetics|anesthetics|mesh-list
2620779|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2620780|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620781|NCT01880216|Enoxaparin|enoxaparin|mesh-list
2620782|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
2620783|NCT01880216|Bemiparin|bemiparin|mesh-list
2620784|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
2620785|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2620786|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2620787|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620788|NCT01880307|Prednisolone|prednisolone|mesh-list
2620789|NCT01880307|Azathioprine|azathioprine|mesh-list
2620790|NCT01880307|Infliximab|infliximab|mesh-list
2620791|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620792|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
2620793|NCT01880307|Hormones|hormones|mesh-ancestor
2620794|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2620795|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620796|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2620797|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620798|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2620799|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
2620800|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2620801|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
2620802|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620803|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2620804|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2620805|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
2620806|NCT01880346|Vitamin D|vitamin d|mesh-list
2620807|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
2620808|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
2620809|NCT01880346|Vitamins|vitamins|mesh-list
2620810|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
2620811|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620812|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2620813|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2620814|NCT01880359|Nimorazole|nimorazole|mesh-list
2620815|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2620816|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2620817|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2620818|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620819|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
2620820|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
2620821|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620822|NCT01880372|Protective Agents|protective agents|mesh-ancestor
2620823|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620824|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
2620825|NCT01880372|Vitamins|vitamins|mesh-ancestor
2620826|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
2620827|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
2620828|NCT01880385|Bevacizumab|bevacizumab|mesh-list
2620829|NCT01880385|Docetaxel|docetaxel|mesh-list
2620830|NCT01880385|Fluorouracil|fluorouracil|mesh-list
2620831|NCT01880385|Trastuzumab|trastuzumab|mesh-list
2620832|NCT01880385|Epirubicin|epirubicin|mesh-list
2620833|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2620834|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
2162947|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2162948|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2162949|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2162950|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
2162951|NCT00422942|Rituximab|rituximab|mesh-list
2162952|NCT00422942|Methotrexate|methotrexate|mesh-list
2162953|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2162954|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162955|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
2162956|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162957|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2162958|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2162959|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
2620835|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620836|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2620837|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2620838|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
2620839|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620840|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2162960|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2620841|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2620842|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2620843|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2620844|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2620845|NCT01880385|Growth Substances|growth substances|mesh-ancestor
2620846|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
2620847|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
2620848|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
2620849|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
2620850|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
2620851|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2620852|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2620853|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2620854|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2620855|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620856|NCT01880463|Vitamin D|vitamin d|mesh-list
2620857|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
2620858|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
2620859|NCT01880463|Vitamins|vitamins|mesh-list
2620860|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
2620861|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620862|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2620863|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2620864|NCT01880541|Anesthetics|anesthetics|mesh-list
2620865|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2620866|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620876|NCT01880619|Tamsulosin|tamsulosin|mesh-list
2620877|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
2620878|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2620879|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2620880|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2620881|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
2620882|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2620883|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620884|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620885|NCT01880619|Urological Agents|urological agents|mesh-ancestor
2620886|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2620887|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2620888|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
2620889|NCT01880658|Capecitabine|capecitabine|mesh-list
2620890|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2620891|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
2620892|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620893|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620894|NCT01880749|Everolimus|everolimus|mesh-list
2162961|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2162962|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
2162963|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162964|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
2620895|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2620896|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2620897|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
2620898|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620899|NCT01880775|Bupivacaine|bupivacaine|mesh-list
2620900|NCT01880775|Prilocaine|prilocaine|mesh-list
2620901|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
2620902|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
2620903|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2620904|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620905|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
2620906|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620907|NCT01880931|Remifentanil|remifentanil|mesh-list
2620908|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2620909|NCT01880931|Narcotics|narcotics|mesh-ancestor
2620910|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2620911|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620912|NCT01880931|Analgesics|analgesics|mesh-ancestor
2620913|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
2620914|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2620915|NCT01880957|Lamotrigine|lamotrigine|mesh-list
2620916|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
2620917|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
2162965|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2162966|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2162967|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2162968|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2162969|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
2162970|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2162971|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2162972|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162973|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2162974|NCT00409344|Analgesics|analgesics|mesh-ancestor
2162975|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
2162976|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162977|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2162978|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2162979|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2162980|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
2162981|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2162982|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162983|NCT00414453|Lidocaine|lidocaine|mesh-list
2162984|NCT00414453|Oxycodone|oxycodone|mesh-list
2162985|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
2162986|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
2162987|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2162988|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2162989|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
2162990|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2162991|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2162992|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2620918|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2620919|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620920|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620921|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
2620922|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2620923|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2620924|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620925|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
2620926|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2620927|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2620928|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2620929|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2620930|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2620931|NCT01881074|Listerine|listerine|mesh-list
2620932|NCT01881074|Triclosan|triclosan|mesh-list
2162993|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2162994|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2162995|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2162996|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2162997|NCT00414453|Narcotics|narcotics|mesh-ancestor
2162998|NCT00414453|Analgesics|analgesics|mesh-ancestor
2162999|NCT00417248|Etoposide|etoposide|mesh-list
2163000|NCT00417248|Sorafenib|sorafenib|mesh-list
2163001|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163002|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2163003|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2163004|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2163005|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163006|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163007|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2163008|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
2163009|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2163010|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2163011|NCT00418145|Prednisolone|prednisolone|mesh-list
2163012|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
2620933|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
2620934|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
2620935|NCT01881074|Protective Agents|protective agents|mesh-ancestor
2620936|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620937|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2620938|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620939|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2163013|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2163014|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
2163015|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2163016|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
2163017|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
2163018|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163019|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163020|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2163021|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
2163022|NCT00418145|Hormones|hormones|mesh-ancestor
2163023|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2620940|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2620941|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
2620942|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163024|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2163025|NCT00418145|Protective Agents|protective agents|mesh-ancestor
2163026|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2620943|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2620944|NCT01881100|Listerine|listerine|mesh-list
2620945|NCT01881100|Fluorides|fluorides|mesh-list
2620946|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
2620947|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
2620948|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
2620949|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
2620950|NCT01881100|Protective Agents|protective agents|mesh-ancestor
2620951|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620952|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2620953|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2620954|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
2620955|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
2620956|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620957|NCT01881347|Resveratrol|resveratrol|mesh-list
2163027|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163028|NCT00409331|Amifostine|amifostine|mesh-list
2163029|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2163030|NCT00409331|Protective Agents|protective agents|mesh-ancestor
2163031|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163032|NCT00391430|Sertraline|sertraline|mesh-list
2163033|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
2163034|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2163035|NCT00391430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2163036|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2163037|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2163038|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163039|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163040|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
2163041|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163042|NCT00384293|Niacin|niacin|mesh-list
2163043|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2163044|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
2163045|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163046|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2163047|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
2163048|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
2620958|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
2620959|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620960|NCT01881347|Protective Agents|protective agents|mesh-ancestor
2620961|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620962|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2620963|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2620964|NCT01881464|Adalimumab|adalimumab|mesh-list
2620965|NCT01881464|Infliximab|infliximab|mesh-list
2620966|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2620967|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2620968|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
2620969|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2620970|NCT01881503|HBOC 201|hboc 201|mesh-list
2620971|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
2620972|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
2620973|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2620974|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2620975|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620976|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
2620977|NCT01881568|Coagulants|coagulants|mesh-ancestor
2620978|NCT01881763|Ketamine|ketamine|mesh-list
2620979|NCT01881763|Methohexital|methohexital|mesh-list
2620980|NCT01881763|Analgesics|analgesics|mesh-ancestor
2620981|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
2620982|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163049|NCT00384293|Vitamins|vitamins|mesh-ancestor
2163050|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
2163051|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163052|NCT00374543|Ziprasidone|ziprasidone|mesh-list
2163053|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2163054|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
2163055|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163056|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163057|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163058|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2163059|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2163060|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2163061|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2163062|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2163063|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
2163064|NCT00377455|Bosentan|bosentan|mesh-list
2163065|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2620983|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620984|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2620985|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2620986|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
2620987|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
2620988|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2620989|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2620990|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2620991|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2620992|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620993|NCT01881919|Quercetin|quercetin|mesh-list
2620994|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
2620995|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2620996|NCT01881919|Protective Agents|protective agents|mesh-ancestor
2620997|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2620998|NCT01881971|Calcium|calcium|mesh-list
2620999|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2621000|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621001|NCT01881997|Fentanyl|fentanyl|mesh-list
2621002|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2621003|NCT01881997|Narcotics|narcotics|mesh-ancestor
2621004|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621005|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621006|NCT01881997|Analgesics|analgesics|mesh-ancestor
2621007|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
2621008|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621009|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2621010|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2621011|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
2621012|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
2621013|NCT01882010|Sargramostim|sargramostim|mesh-list
2621014|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
2621015|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621016|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2621017|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
2621018|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
2621019|NCT01882127|Dexamethasone|dexamethasone|mesh-list
2621020|NCT01882127|Tretinoin|tretinoin|mesh-list
2621021|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2621022|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
2621023|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
2621024|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621025|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621026|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2621027|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
2621028|NCT01882127|Hormones|hormones|mesh-ancestor
2621029|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2621030|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2621031|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621032|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
2621033|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
2621034|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
2621035|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
2621036|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
2163066|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2621037|NCT01882179|Hormones|hormones|mesh-ancestor
2668569|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621038|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2621039|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621040|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
2621041|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2621042|NCT01882179|Diuretics|diuretics|mesh-ancestor
2621043|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
2621044|NCT01882296|Pantoprazole|pantoprazole|mesh-list
2621045|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2621046|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2621047|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2621048|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621049|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621050|NCT01882322|Tacrolimus|tacrolimus|mesh-list
2621051|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2621052|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
2621053|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621054|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2621055|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621056|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621057|NCT01882361|Naltrexone|naltrexone|mesh-list
2621058|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2621059|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2163067|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163068|NCT00369265|Lansoprazole|lansoprazole|mesh-list
2163069|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
2163070|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2163071|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2163072|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2163073|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163074|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163075|NCT00364689|Rifaximin|rifaximin|mesh-list
2163076|NCT00364689|Lactulose|lactulose|mesh-list
2163077|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2163078|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2163079|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2163080|NCT00352118|Docetaxel|docetaxel|mesh-list
2163081|NCT00352118|Fluorouracil|fluorouracil|mesh-list
2163082|NCT00352118|Lenograstim|lenograstim|mesh-list
2163083|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621060|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621061|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
2621062|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621063|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2621064|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2621065|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
2621066|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2621067|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2621068|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
2621069|NCT01882400|Alendronate|alendronate|mesh-list
2621070|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
2621071|NCT01882400|Diphosphonates|diphosphonates|mesh-list
2621072|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2621073|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621074|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2621075|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2621076|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621077|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2621078|NCT01882530|Acetaminophen|acetaminophen|mesh-list
2621079|NCT01882530|Ketoprofen|ketoprofen|mesh-list
2621080|NCT01882530|Morphine|morphine|mesh-list
2621081|NCT01882530|Nefopam|nefopam|mesh-list
2621082|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2621083|NCT01882530|Narcotics|narcotics|mesh-ancestor
2621084|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621085|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621086|NCT01882530|Analgesics|analgesics|mesh-ancestor
2621087|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
2621088|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621089|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2621090|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
2621091|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2621092|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2621093|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2621094|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2163084|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
2621095|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668570|NCT02143219|Leucovorin|leucovorin|mesh-list
2621096|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621097|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
2621098|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2621099|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2621100|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2621101|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2621102|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621103|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
2621104|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621105|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621106|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2621107|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621108|NCT01882660|Decitabine|decitabine|mesh-list
2621109|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2621110|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
2621111|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621112|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621113|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621114|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2621117|NCT01883011|Piracetam|piracetam|mesh-list
2621118|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2621119|NCT01883011|Protective Agents|protective agents|mesh-ancestor
2621120|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621121|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
2621122|NCT01883024|Insulin|insulin|mesh-list
2621123|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2621124|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621125|NCT01883102|Capsaicin|capsaicin|mesh-list
2621126|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
2621127|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
2621128|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
2621129|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621130|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621131|NCT01883167|Febuxostat|febuxostat|mesh-list
2621132|NCT01883167|Verinurad|verinurad|mesh-list
2621133|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
2621134|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2621135|NCT01883193|Micronutrients|micronutrients|mesh-list
2621136|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621137|NCT01883232|Lidocaine|lidocaine|mesh-list
2621138|NCT01883232|Epinephrine|epinephrine|mesh-list
2621139|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
2621140|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
2621141|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621142|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621143|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
2621144|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621145|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2621146|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2621147|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2621148|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2621149|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621150|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2621151|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2621152|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
2621153|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621154|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2621155|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2621156|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
2621157|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2621158|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
2621159|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
2621160|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
2621161|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2621162|NCT01883297|Aldesleukin|aldesleukin|mesh-list
2621163|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
2621164|NCT01883297|Interleukin-2|interleukin-2|mesh-list
2621165|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2621166|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
2621167|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621168|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2621169|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2621170|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
2621171|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621172|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621173|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2621174|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2621175|NCT01883297|Analgesics|analgesics|mesh-ancestor
2621176|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
2621177|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621178|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2621179|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2621180|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
2621181|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621182|NCT01883323|Aldesleukin|aldesleukin|mesh-list
2621183|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
2621184|NCT01883323|Fludarabine|fludarabine|mesh-list
2621185|NCT01883323|Interleukin-2|interleukin-2|mesh-list
2621186|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2621187|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
2621188|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621189|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2621190|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2621191|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
2621192|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621193|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621194|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2621195|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2621196|NCT01883323|Analgesics|analgesics|mesh-ancestor
2621197|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
2621198|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621199|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2621200|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2621201|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
2621202|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621203|NCT01883505|Levodopa|levodopa|mesh-list
2163085|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
2163086|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
2163087|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163088|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
2163089|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2163090|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163091|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
2163092|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163093|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2163094|NCT00368654|Methotrexate|methotrexate|mesh-list
2163095|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2163096|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
2163097|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2163098|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163099|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2163100|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
2163101|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163102|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163103|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
2163104|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163105|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2163106|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163107|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
2163108|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2163109|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2163110|NCT00356421|Insulin|insulin|mesh-list
2163111|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2163112|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
2163113|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2621204|NCT01883505|Carbidopa|carbidopa|mesh-list
2621205|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2621206|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2621207|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
2621208|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621209|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621210|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621211|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2621212|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621213|NCT01883518|Vaccines|vaccines|mesh-list
2621214|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
2621215|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621216|NCT01883531|Mannitol|mannitol|mesh-list
2621217|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2621218|NCT01883531|Diuretics|diuretics|mesh-ancestor
2621219|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
2621220|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621221|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
2621222|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2621223|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621224|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
2621225|NCT01883869|Ticagrelor|ticagrelor|mesh-list
2621226|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2621227|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2621228|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2621229|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2621230|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
2621231|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163114|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163115|NCT00356187|Propranolol|propranolol|mesh-list
2163116|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2163117|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2163118|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
2163119|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163120|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163121|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163122|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2163123|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2163124|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
2163125|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
2163126|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163127|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
2163128|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163129|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163130|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2163131|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2163132|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
2163133|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163134|NCT00319839|Paclitaxel|paclitaxel|mesh-list
2163135|NCT00319839|Cetuximab|cetuximab|mesh-list
2163136|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2163137|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2163138|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163139|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
2163140|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
2163141|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
2163142|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163143|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2163144|NCT00344019|Atorvastatin|atorvastatin|mesh-list
2163145|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2163146|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2163147|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
2163148|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163149|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2163150|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2163151|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163152|NCT00338455|Dobutamine|dobutamine|mesh-list
2163153|NCT00338455|Milrinone|milrinone|mesh-list
2163154|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2163155|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2163156|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
2163157|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
2163158|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163159|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163160|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2163161|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2163162|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2163163|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
2163164|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163165|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163166|NCT00338455|Protective Agents|protective agents|mesh-ancestor
2163167|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
2163168|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2163169|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
2163170|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2163171|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2163172|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163173|NCT00329108|Olanzapine|olanzapine|mesh-list
2163174|NCT00329108|Ziprasidone|ziprasidone|mesh-list
2163175|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
2163176|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
2163177|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163178|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163179|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2163180|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2163181|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2163182|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2163183|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2163184|NCT00329108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2163185|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2163186|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2163187|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163188|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163189|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
2163190|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2163191|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2163192|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
2163193|NCT00325572|Ascorbic Acid|ascorbic acid|mesh-list
2163194|NCT00325572|Vitamins|vitamins|mesh-ancestor
2163195|NCT00325572|Micronutrients|micronutrients|mesh-ancestor
2163196|NCT00325572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621232|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621233|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621234|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
2621235|NCT01883882|Narcotics|narcotics|mesh-ancestor
2621236|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621237|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621238|NCT01883882|Analgesics|analgesics|mesh-ancestor
2621239|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
2621240|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621241|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
2163197|NCT00325572|Antioxidants|antioxidants|mesh-ancestor
2163198|NCT00325572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163199|NCT00325572|Protective Agents|protective agents|mesh-ancestor
2163200|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
2163201|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2163202|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163203|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2163204|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2163205|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2163206|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
2163207|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163208|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163209|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621242|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2621243|NCT01883921|Antibodies|antibodies|mesh-list
2621244|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
2621245|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621246|NCT01884038|Treprostinil|treprostinil|mesh-list
2621247|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2621248|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2621249|NCT01884116|Capsaicin|capsaicin|mesh-list
2621250|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
2621251|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
2621252|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
2621253|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621254|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621255|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2621256|NCT01884116|Analgesics|analgesics|mesh-ancestor
2621257|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2621258|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2621259|NCT01884259|Docetaxel|docetaxel|mesh-list
2621260|NCT01884259|Fluorouracil|fluorouracil|mesh-list
2621261|NCT01884259|Cetuximab|cetuximab|mesh-list
2621262|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621263|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
2621264|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
2621265|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
2621266|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621267|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
2621268|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2621269|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2621270|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
2621271|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621272|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2621273|NCT01884272|Naproxen|naproxen|mesh-list
2163210|NCT00323635|Urological Agents|urological agents|mesh-ancestor
2163211|NCT00329732|Lidocaine|lidocaine|mesh-list
2621274|NCT01884272|Indomethacin|indomethacin|mesh-list
2621275|NCT01884272|Lesinurad|lesinurad|mesh-list
2621276|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2621277|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2621278|NCT01884272|Analgesics|analgesics|mesh-ancestor
2621279|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
2621280|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621281|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621282|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2621283|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2621284|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
2621285|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2621286|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621287|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621288|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
2621289|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2621290|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
2621291|NCT01884272|Renal Agents|renal agents|mesh-ancestor
2621292|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
2621293|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621294|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2621295|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621296|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621297|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
2621298|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2621299|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621300|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2621301|NCT01884298|Lidocaine|lidocaine|mesh-list
2621302|NCT01884298|Remifentanil|remifentanil|mesh-list
2621303|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
2621304|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
2621305|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621306|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621307|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
2621308|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163212|NCT00329732|Bupivacaine|bupivacaine|mesh-list
2163213|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
2163214|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
2163215|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2163216|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163217|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
2163218|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163219|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2163220|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2163221|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2163222|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2163223|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163224|NCT00314353|Bevacizumab|bevacizumab|mesh-list
2163225|NCT00314353|Capecitabine|capecitabine|mesh-list
2163226|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
2163227|NCT00314353|Irinotecan|irinotecan|mesh-list
2163228|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2163229|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163230|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2163231|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2163232|NCT00314353|Growth Substances|growth substances|mesh-ancestor
2163233|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163234|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
2163235|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2163236|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
2163237|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163238|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2163239|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2163240|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163241|NCT00314327|Risperidone|risperidone|mesh-list
2163242|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2163243|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
2163244|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163245|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163246|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163247|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2621309|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2621310|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2621311|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2621312|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2621313|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621314|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2621315|NCT01884298|Narcotics|narcotics|mesh-ancestor
2621316|NCT01884298|Analgesics|analgesics|mesh-ancestor
2621317|NCT01884402|Ribavirin|ribavirin|mesh-list
2621318|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2621319|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
2621320|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621321|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
2621322|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621323|NCT01884415|Vaccines|vaccines|mesh-list
2621324|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
2621325|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621326|NCT01884428|Gemcitabine|gemcitabine|mesh-list
2163248|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2163249|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2163250|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2163251|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2163252|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
2163253|NCT00308113|Ubiquinone|ubiquinone|mesh-list
2163254|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
2163255|NCT00308113|Prednisone|prednisone|mesh-list
2163256|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2163257|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
2163258|NCT00308113|Hormones|hormones|mesh-ancestor
2621327|NCT01884428|Prednisolone|prednisolone|mesh-list
2621328|NCT01884428|Vinorelbine|vinorelbine|mesh-list
2621329|NCT01884428|Ifosfamide|ifosfamide|mesh-list
2621330|NCT01884428|Panobinostat|panobinostat|mesh-list
2621331|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2621332|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
2621333|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621334|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163259|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2163260|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163261|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2163262|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163263|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
2163264|NCT00308113|Vitamins|vitamins|mesh-ancestor
2163265|NCT00305643|Celecoxib|celecoxib|mesh-list
2163266|NCT00305643|Capecitabine|capecitabine|mesh-list
2163267|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2163268|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
2163269|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163270|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163271|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2163272|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2163273|NCT00305643|Analgesics|analgesics|mesh-ancestor
2163274|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
2621335|NCT01884428|Antiviral Agents|antiviral agents|mesh-ancestor
2621336|NCT01884428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621337|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163275|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163276|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163277|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2163278|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2163279|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2163280|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2163281|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163282|NCT00298740|Insulin|insulin|mesh-list
2163283|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2163284|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163285|NCT00301080|Cycloserine|cycloserine|mesh-list
2163286|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2621338|NCT01884428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2621339|NCT01884428|Immunologic Factors|immunologic factors|mesh-ancestor
2621340|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621341|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2621342|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
2621343|NCT01884428|Hormones|hormones|mesh-ancestor
2621344|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2621345|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2621346|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2163287|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621347|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
2621348|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
2621349|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
2621350|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2621351|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
2621352|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2163288|NCT00301080|Renal Agents|renal agents|mesh-ancestor
2163289|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2163290|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
2163291|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2163292|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
2163293|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163294|NCT00299195|Sulindac|sulindac|mesh-list
2163295|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2163296|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2163297|NCT00299195|Analgesics|analgesics|mesh-ancestor
2163298|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
2163299|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163300|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163301|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2163302|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2163303|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163304|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2163305|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163306|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163307|NCT00290407|Rituximab|rituximab|mesh-list
2621353|NCT01884441|Gemcitabine|gemcitabine|mesh-list
2621354|NCT01884441|Vinorelbine|vinorelbine|mesh-list
2621355|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2621356|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2621357|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
2621358|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621359|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621360|NCT01884441|Antiviral Agents|antiviral agents|mesh-ancestor
2621361|NCT01884441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621362|NCT01884441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621363|NCT01884441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2621364|NCT01884441|Immunologic Factors|immunologic factors|mesh-ancestor
2163308|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2163309|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163310|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
2163311|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621365|NCT01884441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621366|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2621367|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
2621368|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
2621369|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
2621370|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2621371|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
2621372|NCT01884467|Gentamicins|gentamicins|mesh-list
2621373|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2621374|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621375|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2621376|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621377|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621378|NCT01884506|Iron|iron|mesh-list
2621379|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
2621380|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2621381|NCT01884506|Trace Elements|trace elements|mesh-ancestor
2621382|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
2621383|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621384|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
2621385|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621386|NCT01884506|Protective Agents|protective agents|mesh-ancestor
2621387|NCT01884506|Vitamins|vitamins|mesh-ancestor
2621388|NCT01884558|Metformin|metformin|mesh-list
2163312|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2163313|NCT00268463|Capecitabine|capecitabine|mesh-list
2163314|NCT00268463|Floxuridine|floxuridine|mesh-list
2163315|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
2163316|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2163317|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
2163318|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163319|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163320|NCT00276419|Diclofenac|diclofenac|mesh-list
2163321|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2621389|NCT01884558|Isavuconazole|isavuconazole|mesh-list
2621390|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2621391|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621392|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
2621393|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621394|NCT01884623|Methotrexate|methotrexate|mesh-list
2621395|NCT01884623|Cetuximab|cetuximab|mesh-list
2621396|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2621397|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
2621398|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2621399|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621400|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2621401|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
2621402|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163322|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2163323|NCT00276419|Analgesics|analgesics|mesh-ancestor
2163324|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
2163325|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163326|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621403|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621404|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
2621405|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621406|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2621407|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2621408|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
2621409|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2621410|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2621411|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2621412|NCT01884636|Isavuconazole|isavuconazole|mesh-list
2621413|NCT01884636|Methotrexate|methotrexate|mesh-list
2621414|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2621415|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
2621416|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2163327|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2163328|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2163329|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2163330|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163331|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163332|NCT00279409|Aripiprazole|aripiprazole|mesh-list
2163333|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
2163334|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2163335|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2621417|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621418|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2621419|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
2621420|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621421|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621422|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
2621423|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621424|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2621425|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2621426|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
2621427|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2621428|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2621429|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
2621430|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621431|NCT01884740|Bevacizumab|bevacizumab|mesh-list
2621432|NCT01884740|Cetuximab|cetuximab|mesh-list
2621433|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2621434|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163336|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2163337|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2163338|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163339|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
2163340|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
2163341|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163342|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163343|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2163344|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2163345|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
2163346|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2163347|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2163348|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2621435|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2163349|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2163350|NCT00281879|Cytarabine|cytarabine|mesh-list
2163351|NCT00281879|Cyclosporine|cyclosporine|mesh-list
2163352|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
2163353|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
2163354|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
2163355|NCT00281879|Melphalan|melphalan|mesh-list
2163356|NCT00281879|Busulfan|busulfan|mesh-list
2621436|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2621437|NCT01884740|Growth Substances|growth substances|mesh-ancestor
2621438|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621439|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
2621440|NCT01884857|Metoprolol|metoprolol|mesh-list
2621441|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2621442|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2621443|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
2621444|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
2621445|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621446|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621447|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2621448|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2621449|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2621450|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
2621451|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621452|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621453|NCT01884896|Metoprolol|metoprolol|mesh-list
2621454|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2621455|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2621456|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
2621457|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
2621458|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621459|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621460|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2621461|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2621462|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2163357|NCT00281879|Carmustine|carmustine|mesh-list
2163358|NCT00281879|Methotrexate|methotrexate|mesh-list
2163359|NCT00281879|Fludarabine|fludarabine|mesh-list
2163360|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
2163361|NCT00281879|Etoposide|etoposide|mesh-list
2163362|NCT00281879|Tacrolimus|tacrolimus|mesh-list
2163363|NCT00281879|Cyclosporins|cyclosporins|mesh-list
2163364|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2163365|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163366|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
2163367|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163368|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2163369|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2163370|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
2163371|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163372|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163373|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2163374|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2163375|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
2163376|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2621463|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
2621464|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621465|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621466|NCT01884909|Metoprolol|metoprolol|mesh-list
2621467|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2621468|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2621469|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
2621470|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
2621471|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621472|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621473|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2621474|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2621475|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2621476|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
2621477|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621478|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621479|NCT01884922|Vinblastine|vinblastine|mesh-list
2621480|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2163377|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2163378|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
2163379|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
2163380|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163381|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2163382|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2163383|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2163384|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2163385|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2163386|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
2163387|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2163388|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2163389|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
2163390|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2163391|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2163392|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
2163393|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2163394|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2163395|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
2163396|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
2621481|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621482|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
2621483|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
2621484|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
2621485|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163397|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163398|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2163399|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
2163400|NCT00281879|Hormones|hormones|mesh-ancestor
2163401|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2163402|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2163403|NCT00281879|Protective Agents|protective agents|mesh-ancestor
2163404|NCT00271011|Irinotecan|irinotecan|mesh-list
2163405|NCT00271011|Cetuximab|cetuximab|mesh-list
2163406|NCT00271011|Mitomycins|mitomycins|mesh-list
2163407|NCT00271011|Mitomycin|mitomycin|mesh-list
2163408|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2163409|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2163410|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163411|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163412|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163413|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2163414|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2163415|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
2163416|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2621486|NCT01884935|Natalizumab|natalizumab|mesh-list
2621487|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
2621488|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621489|NCT01885013|Metformin|metformin|mesh-list
2621490|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
2621491|NCT01885013|Doxorubicin|doxorubicin|mesh-list
2621492|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2621493|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
2621494|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621495|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2621496|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2621497|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
2621498|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621499|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621500|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2621501|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2621502|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2621503|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2621504|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2621505|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621506|NCT01885091|Kinetin|kinetin|mesh-list
2621507|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2621508|NCT01885091|Growth Substances|growth substances|mesh-ancestor
2621509|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621510|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
2621511|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
2621512|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
2621513|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621514|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621515|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2621516|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2621517|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
2621518|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
2621519|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621520|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621521|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
2621522|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2621523|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
2621524|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621525|NCT01885338|Expectorants|expectorants|mesh-ancestor
2621526|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
2621527|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2621528|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
2621529|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621530|NCT01885338|Protective Agents|protective agents|mesh-ancestor
2621531|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621532|NCT01885338|Antidotes|antidotes|mesh-ancestor
2621533|NCT01885364|Remifentanil|remifentanil|mesh-list
2621534|NCT01885364|Propofol|propofol|mesh-list
2621535|NCT01885364|Esmolol|esmolol|mesh-list
2621536|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2621537|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621538|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621539|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2163417|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2163418|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
2163419|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163420|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2163421|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
2163422|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163423|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163424|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2163425|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2163426|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2163427|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
2163428|NCT00256295|Gemcitabine|gemcitabine|mesh-list
2163429|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
2163430|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2163431|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
2163432|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163433|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621540|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
2621541|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
2621542|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2621543|NCT01885364|Narcotics|narcotics|mesh-ancestor
2621544|NCT01885364|Analgesics|analgesics|mesh-ancestor
2621545|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
2621546|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621547|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2163434|NCT00256295|Antiviral Agents|antiviral agents|mesh-ancestor
2163435|NCT00256295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2163436|NCT00256295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163437|NCT00256295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163438|NCT00256295|Immunologic Factors|immunologic factors|mesh-ancestor
2163439|NCT00256295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163440|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
2163441|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163442|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2163443|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163444|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163445|NCT00268450|Gemcitabine|gemcitabine|mesh-list
2163446|NCT00268450|Paclitaxel|paclitaxel|mesh-list
2163447|NCT00268450|Bevacizumab|bevacizumab|mesh-list
2163448|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2621548|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2621549|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2621550|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
2621551|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621552|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621553|NCT01885481|Dexamethasone|dexamethasone|mesh-list
2621554|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
2621555|NCT01885481|Betamethasone|betamethasone|mesh-list
2621556|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
2621557|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2621558|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
2621559|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2621560|NCT01885481|BB 1101|bb 1101|mesh-list
2621561|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2621562|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
2621563|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
2163449|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163450|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
2621564|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621565|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621566|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2163451|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
2163452|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
2163453|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163454|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2163455|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2163456|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2163457|NCT00268450|Growth Substances|growth substances|mesh-ancestor
2621567|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
2621568|NCT01885481|Hormones|hormones|mesh-ancestor
2621569|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2621570|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2621571|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621572|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
2621573|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621574|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621575|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2621576|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
2621577|NCT01885585|Apixaban|apixaban|mesh-list
2621578|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2621579|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
2163458|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163459|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
2163460|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2163461|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
2163462|NCT00268450|Antiviral Agents|antiviral agents|mesh-ancestor
2163463|NCT00268450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2163464|NCT00268450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163465|NCT00268450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163466|NCT00268450|Immunologic Factors|immunologic factors|mesh-ancestor
2163467|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
2163468|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
2163469|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163470|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2621580|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2621581|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
2621582|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621583|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621584|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
2621585|NCT01885598|Apixaban|apixaban|mesh-list
2621586|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2621587|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
2163471|NCT00250718|Levofloxacin|levofloxacin|mesh-list
2163472|NCT00250718|Ofloxacin|ofloxacin|mesh-list
2163473|NCT00250718|Dexamethasone|dexamethasone|mesh-list
2163474|NCT00250718|Rituximab|rituximab|mesh-list
2163475|NCT00250718|Etoposide|etoposide|mesh-list
2163476|NCT00250718|Vincristine|vincristine|mesh-list
2163477|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2163478|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
2163479|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
2163480|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163481|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163482|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2163483|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
2163484|NCT00250718|Hormones|hormones|mesh-ancestor
2163485|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2163486|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2163487|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163488|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2163489|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
2163490|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2163491|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2163492|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2163493|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2163494|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163495|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163496|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
2163497|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
2163498|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
2163499|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2668571|NCT02143219|Folic Acid|folic acid|mesh-list
2621588|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2621589|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
2621590|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621591|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621592|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
2621593|NCT01885689|Sirolimus|sirolimus|mesh-list
2621594|NCT01885689|Melphalan|melphalan|mesh-list
2621595|NCT01885689|Clofarabine|clofarabine|mesh-list
2621596|NCT01885689|Tacrolimus|tacrolimus|mesh-list
2621597|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2621598|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
2621599|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621600|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2621601|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621602|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621603|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2621604|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621605|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2621606|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621607|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
2621608|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2621609|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
2621610|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2621611|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2621612|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
2621613|NCT01885702|Vaccines|vaccines|mesh-list
2621614|NCT01885702|Immunologic Factors|immunologic factors|mesh-ancestor
2621615|NCT01885702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621616|NCT01885715|Neostigmine|neostigmine|mesh-list
2621617|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2621618|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163500|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2163501|NCT00250718|Renal Agents|renal agents|mesh-ancestor
2163502|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2163503|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2163504|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2163505|NCT00218036|Dexetimide|dexetimide|mesh-list
2163506|NCT00218036|Modafinil|modafinil|mesh-list
2163507|NCT00218036|Citalopram|citalopram|mesh-list
2163508|NCT00218036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2163509|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2163510|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2163511|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163512|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163513|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
2163514|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163515|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2163516|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
2163517|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2163518|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2163519|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2163520|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
2163521|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
2163522|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163523|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2163524|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2163525|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
2163526|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2621619|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621620|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
2621621|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621622|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621623|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2621624|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
2621625|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621626|NCT01885988|Nebivolol|nebivolol|mesh-list
2621627|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2163527|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2163528|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2163529|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2163530|NCT00240227|Prazosin|prazosin|mesh-list
2163531|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2163532|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2163533|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2163534|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2163535|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
2163536|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163537|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163538|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163539|NCT00206375|Hormones|hormones|mesh-list
2163540|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2163541|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163542|NCT00229931|Triamcinolone|triamcinolone|mesh-list
2163543|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2163544|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2163545|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2163546|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2163547|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
2163548|NCT00229931|Hormones|hormones|mesh-ancestor
2163549|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2163550|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163551|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163552|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
2163553|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163554|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163555|NCT00209131|Tamsulosin|tamsulosin|mesh-list
2163556|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2163557|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2163558|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2163559|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
2163560|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163561|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163562|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163563|NCT00209131|Urological Agents|urological agents|mesh-ancestor
2163564|NCT00233090|Modafinil|modafinil|mesh-list
2163565|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2163566|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163567|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2163568|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2163569|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2163570|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163571|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
2163572|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2163573|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163574|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163575|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2621628|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
2621629|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2621630|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2163576|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2163577|NCT00205049|Protective Agents|protective agents|mesh-ancestor
2163578|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163579|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
2163580|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2163581|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
2163582|NCT00209027|Aripiprazole|aripiprazole|mesh-list
2163583|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
2163584|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2163585|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2163586|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2163587|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2163588|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163589|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
2163590|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
2163591|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163592|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163593|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2163594|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2163595|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
2163596|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2163597|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2163598|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2163599|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2163600|NCT00182637|Bortezomib|bortezomib|mesh-list
2163601|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163602|NCT00176488|Vinorelbine|vinorelbine|mesh-list
2163603|NCT00176488|Epirubicin|epirubicin|mesh-list
2163604|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2163605|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163606|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
2163607|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
2163608|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
2163609|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163610|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2163611|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2163612|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2163613|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163614|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
2163615|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2163616|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163617|NCT00183963|Tamoxifen|tamoxifen|mesh-list
2163618|NCT00183963|Fulvestrant|fulvestrant|mesh-list
2163619|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2163620|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
2163621|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2163622|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163623|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2163624|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163625|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2163626|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2163627|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2163628|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2163629|NCT00162773|Omalizumab|omalizumab|mesh-list
2163630|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2163631|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2163632|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
2163633|NCT00176631|Docetaxel|docetaxel|mesh-list
2163634|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163635|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
2621631|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2621632|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
2621633|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621634|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621635|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621636|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
2621637|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2621638|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
2621639|NCT01886001|Povidone|povidone|mesh-list
2621640|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2621641|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621642|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
2621643|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
2621644|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
2163636|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
2163637|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
2163638|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163639|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
2163640|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2163641|NCT00177970|Antibodies|antibodies|mesh-list
2163642|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
2163643|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
2163644|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2163645|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
2163646|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163647|NCT00177866|Celecoxib|celecoxib|mesh-list
2163648|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2163649|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2163650|NCT00177866|Analgesics|analgesics|mesh-ancestor
2163651|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
2163652|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163653|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163654|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2163655|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2163656|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2163657|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2163658|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163659|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163660|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
2163661|NCT00165503|Pemetrexed|pemetrexed|mesh-list
2163662|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163663|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621645|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
2621646|NCT01886014|Oxytocin|oxytocin|mesh-list
2621647|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
2621648|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2163664|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163665|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2163666|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2163667|NCT00165503|Antidotes|antidotes|mesh-ancestor
2163668|NCT00165503|Protective Agents|protective agents|mesh-ancestor
2163669|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163670|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
2621649|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621650|NCT01886053|Ertapenem|ertapenem|mesh-list
2621651|NCT01886053|beta-Lactams|beta-lactams|mesh-list
2621652|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2621653|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621654|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
2621655|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2621656|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621657|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621658|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2621659|NCT01886079|Analgesics|analgesics|mesh-ancestor
2621660|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
2621661|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621662|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2621663|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2621664|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2621665|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
2621666|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621667|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621668|NCT01886196|Ibuprofen|ibuprofen|mesh-list
2621669|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2621670|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2621671|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2621672|NCT01886196|Analgesics|analgesics|mesh-ancestor
2621673|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
2621674|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621675|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621676|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2621677|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2621678|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621679|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163671|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
2163672|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2163673|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2163674|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
2163675|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
2163676|NCT00160563|Levocetirizine|levocetirizine|mesh-list
2163677|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2163678|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2163679|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
2163680|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
2163681|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163682|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163683|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163684|NCT00142519|Morphine|morphine|mesh-list
2163685|NCT00142519|Methadone|methadone|mesh-list
2163686|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2163687|NCT00142519|Narcotics|narcotics|mesh-ancestor
2163688|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2163689|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163690|NCT00142519|Analgesics|analgesics|mesh-ancestor
2163691|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
2163692|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163693|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
2163694|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
2163695|NCT00145704|Vitamin D|vitamin d|mesh-list
2163696|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
2163697|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
2163698|NCT00145704|Diphosphonates|diphosphonates|mesh-list
2163699|NCT00145704|Vitamins|vitamins|mesh-list
2163700|NCT00145704|Calcium|calcium|mesh-list
2163701|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
2163702|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163703|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2163704|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2163705|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2621680|NCT01886209|Prednisone|prednisone|mesh-list
2621681|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
2621682|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2621683|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2621684|NCT01886209|Prednisolone|prednisolone|mesh-list
2163706|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2163707|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163708|NCT00113386|Docetaxel|docetaxel|mesh-list
2163709|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163710|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
2621685|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
2621686|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2621687|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
2621688|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2621689|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
2621690|NCT01886209|Hormones|hormones|mesh-ancestor
2621691|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2621692|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621693|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2621694|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621695|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
2621696|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
2621697|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621698|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2621699|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2621700|NCT01886209|Protective Agents|protective agents|mesh-ancestor
2621701|NCT01886248|Antithrombins|antithrombins|mesh-list
2621702|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
2621703|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2621704|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
2621705|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621706|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621707|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
2621708|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
2621709|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
2621710|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
2163711|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
2163712|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
2163713|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163714|NCT00138151|Interferons|interferons|mesh-list
2163715|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
2163716|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
2163717|NCT00138151|Paclitaxel|paclitaxel|mesh-list
2163718|NCT00138151|Isotretinoin|isotretinoin|mesh-list
2163719|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2621711|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621712|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621713|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
2621714|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621715|NCT01886365|Insulin|insulin|mesh-list
2621716|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2621717|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621718|NCT01886404|Efavirenz|efavirenz|mesh-list
2621719|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2621720|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2163720|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163721|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
2163722|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
2163723|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
2163724|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163725|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
2163726|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2163727|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
2163728|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163729|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
2621721|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621722|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621723|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
2621724|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621725|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2621726|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2621727|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2621728|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2621729|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2621730|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2621731|NCT01886443|Tocopherols|tocopherols|mesh-list
2621732|NCT01886443|Vitamin E|vitamin e|mesh-list
2621733|NCT01886443|alpha-Tocopherol|alpha-tocopherol|mesh-list
2621734|NCT01886443|Infliximab|infliximab|mesh-list
2621735|NCT01886443|Epoprostenol|epoprostenol|mesh-list
2621736|NCT01886443|Tezosentan|tezosentan|mesh-list
2621737|NCT01886443|Melatonin|melatonin|mesh-list
2621738|NCT01886443|Antithrombins|antithrombins|mesh-list
2621739|NCT01886443|Antithrombin III|antithrombin iii|mesh-list
2621740|NCT01886443|Epoetin Alfa|epoetin alfa|mesh-list
2621741|NCT01886443|Dermatologic Agents|dermatologic agents|mesh-ancestor
2621742|NCT01886443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2621743|NCT01886443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2621744|NCT01886443|Antioxidants|antioxidants|mesh-ancestor
2621745|NCT01886443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621746|NCT01886443|Protective Agents|protective agents|mesh-ancestor
2621747|NCT01886443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621748|NCT01886443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621749|NCT01886443|Hematinics|hematinics|mesh-ancestor
2621750|NCT01886443|Vitamins|vitamins|mesh-ancestor
2621751|NCT01886443|Micronutrients|micronutrients|mesh-ancestor
2621752|NCT01886443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2621753|NCT01886443|Protease Inhibitors|protease inhibitors|mesh-ancestor
2621754|NCT01886443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621755|NCT01886443|Anticoagulants|anticoagulants|mesh-ancestor
2621756|NCT01886443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2621757|NCT01886443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2621758|NCT01886443|Vasodilator Agents|vasodilator agents|mesh-ancestor
2621759|NCT01886534|Diuretics|diuretics|mesh-list
2621760|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
2621761|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621762|NCT01886560|Doxycycline|doxycycline|mesh-list
2621763|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2621764|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621765|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
2621766|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2621767|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2621768|NCT01886573|Azacitidine|azacitidine|mesh-list
2621769|NCT01886573|Entinostat|entinostat|mesh-list
2621770|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2621771|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2621772|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
2621773|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621774|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621775|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621776|NCT01886599|Asunaprevir|asunaprevir|mesh-list
2621777|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
2621778|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621779|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621780|NCT01886638|Abacavir|abacavir|mesh-list
2621781|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2621782|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2621783|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621784|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621785|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
2621786|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621787|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2621788|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2621789|NCT01886664|Sevoflurane|sevoflurane|mesh-list
2621790|NCT01886664|Desflurane|desflurane|mesh-list
2621791|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2621792|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2621793|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
2621794|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
2621795|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621796|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621797|NCT01886768|Anesthetics|anesthetics|mesh-list
2621798|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621799|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621800|NCT01886794|Estrogens|estrogens|mesh-list
2621801|NCT01886794|Hormones|hormones|mesh-ancestor
2621802|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2621803|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621812|NCT01887119|Eplerenone|eplerenone|mesh-list
2621813|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2621814|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
2621815|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2621816|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621817|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2621818|NCT01887119|Diuretics|diuretics|mesh-ancestor
2621819|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
2621820|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2621821|NCT01887158|Bisacodyl|bisacodyl|mesh-list
2621822|NCT01887158|Cathartics|cathartics|mesh-ancestor
2163730|NCT00129974|Gemcitabine|gemcitabine|mesh-list
2163731|NCT00129974|Pemetrexed|pemetrexed|mesh-list
2163732|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2163733|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
2163734|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163735|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163736|NCT00129974|Antiviral Agents|antiviral agents|mesh-ancestor
2163737|NCT00129974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2163738|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163739|NCT00129974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163740|NCT00129974|Immunologic Factors|immunologic factors|mesh-ancestor
2163741|NCT00129974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163742|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2163743|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2163744|NCT00126659|Sorafenib|sorafenib|mesh-list
2163745|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163746|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2163747|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163748|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163749|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
2163750|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
2163751|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2163752|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2163753|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163754|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163755|NCT00133679|Urological Agents|urological agents|mesh-ancestor
2163756|NCT00113399|Paclitaxel|paclitaxel|mesh-list
2163757|NCT00113399|Docetaxel|docetaxel|mesh-list
2163758|NCT00113399|Fluorouracil|fluorouracil|mesh-list
2163759|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2163760|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163761|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
2163762|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
2163763|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
2163764|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163765|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
2163766|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2163767|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163768|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
2163769|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163770|NCT00118053|Carboplatin|carboplatin|mesh-list
2163771|NCT00118053|Docetaxel|docetaxel|mesh-list
2163772|NCT00118053|Trastuzumab|trastuzumab|mesh-list
2163773|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163774|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
2621823|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2621824|NCT01887158|Laxatives|laxatives|mesh-ancestor
2621825|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
2621826|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2621827|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621828|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621829|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2163775|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
2163776|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
2163777|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163778|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2163779|NCT00107614|Rituximab|rituximab|mesh-list
2163780|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2163781|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163782|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
2621830|NCT01887184|Analgesics|analgesics|mesh-ancestor
2621831|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
2621832|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621833|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2621834|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2621835|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2621836|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
2621837|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621838|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621839|NCT01887197|Mannitol|mannitol|mesh-list
2621840|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2621841|NCT01887197|Diuretics|diuretics|mesh-ancestor
2621842|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
2621843|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621844|NCT01887223|Timolol|timolol|mesh-list
2621845|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2621846|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2621847|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2621848|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2621849|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2621850|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
2621851|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621852|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621853|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621854|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2621855|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2621856|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2621857|NCT01887249|Metronidazole|metronidazole|mesh-list
2621858|NCT01887249|Clarithromycin|clarithromycin|mesh-list
2621859|NCT01887249|Esomeprazole|esomeprazole|mesh-list
2621860|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621861|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2621862|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2621863|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2621864|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2621865|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2621866|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2621867|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621868|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621869|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2621870|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2621871|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2621872|NCT01887275|Interferons|interferons|mesh-list
2621873|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621874|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
2621875|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621876|NCT01887301|Nabiximols|nabiximols|mesh-list
2621877|NCT01887301|Analgesics|analgesics|mesh-ancestor
2621878|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
2621879|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621880|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621881|NCT01887340|Carboplatin|carboplatin|mesh-list
2621882|NCT01887340|Etoposide|etoposide|mesh-list
2621883|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621884|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2621885|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2621886|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2621887|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621888|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621889|NCT01887379|Furosemide|furosemide|mesh-list
2621890|NCT01887379|Diuretics|diuretics|mesh-ancestor
2163783|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163784|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2163785|NCT00107315|Bevacizumab|bevacizumab|mesh-list
2163786|NCT00107315|Capecitabine|capecitabine|mesh-list
2621891|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
2621892|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621893|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2621894|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2621895|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621896|NCT01887405|Epinephrine|epinephrine|mesh-list
2621897|NCT01887405|Racepinephrine|racepinephrine|mesh-list
2621898|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
2621899|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2621900|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2621901|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
2621902|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621903|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621904|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163787|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2163788|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163789|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2163790|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2163791|NCT00107315|Growth Substances|growth substances|mesh-ancestor
2163792|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163793|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
2163794|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2163795|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
2163796|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163797|NCT00108433|Vancomycin|vancomycin|mesh-list
2163798|NCT00108433|Cefazolin|cefazolin|mesh-list
2163799|NCT00108433|Linezolid|linezolid|mesh-list
2163800|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2163801|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2163802|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2163803|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163804|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163805|NCT00113919|Busulfan|busulfan|mesh-list
2163806|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
2163807|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163808|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163809|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
2621905|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2621906|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2621907|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
2621908|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621909|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2621910|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
2621911|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
2621912|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
2621913|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2621914|NCT01887457|Voriconazole|voriconazole|mesh-list
2621915|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
2621916|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2621917|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2621918|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2621919|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621920|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621921|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2621922|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
2621923|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2621924|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621925|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2621926|NCT01887522|Vinblastine|vinblastine|mesh-list
2621927|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2163810|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163811|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2163812|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163813|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2163814|NCT00108342|Nicotine|nicotine|mesh-list
2163815|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2163816|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
2163817|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163818|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621928|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621929|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
2621930|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
2621931|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
2621932|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621933|NCT01887561|Dasatinib|dasatinib|mesh-list
2621934|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621935|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2163819|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2163820|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2163821|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
2163822|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163823|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163824|NCT00100828|Irinotecan|irinotecan|mesh-list
2621936|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621937|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621938|NCT01887613|Gabapentin|gabapentin|mesh-list
2621939|NCT01887613|Analgesics|analgesics|mesh-ancestor
2621940|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
2621941|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621942|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621943|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
2621944|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2621945|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2621946|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621947|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2621948|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2621949|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2621950|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163825|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2163826|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2163827|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621951|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621952|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
2621953|NCT01887626|Ticagrelor|ticagrelor|mesh-list
2621954|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2621955|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2621956|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2621957|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2621958|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
2621959|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621960|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621961|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621962|NCT01887691|Eszopiclone|eszopiclone|mesh-list
2621963|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2163828|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163829|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163830|NCT00104728|Gefitinib|gefitinib|mesh-list
2163831|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163832|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2163833|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163834|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163835|NCT00089414|Drospirenone|drospirenone|mesh-list
2163836|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2163837|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2163838|NCT00089414|Estradiol|estradiol|mesh-list
2163839|NCT00089414|Progesterone|progesterone|mesh-list
2163840|NCT00089414|Estrogens|estrogens|mesh-ancestor
2163841|NCT00089414|Hormones|hormones|mesh-ancestor
2163842|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2163843|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163844|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2163845|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
2163846|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2163847|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2163848|NCT00089414|Progestins|progestins|mesh-ancestor
2163849|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2163850|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2163851|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2163852|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
2163853|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2163854|NCT00089414|Diuretics|diuretics|mesh-ancestor
2163855|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
2163856|NCT00083915|Thalidomide|thalidomide|mesh-list
2163857|NCT00083915|Dexamethasone|dexamethasone|mesh-list
2163858|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
2163859|NCT00083915|Melphalan|melphalan|mesh-list
2163860|NCT00083915|Cisplatin|cisplatin|mesh-list
2163861|NCT00083915|Doxorubicin|doxorubicin|mesh-list
2163862|NCT00083915|Etoposide|etoposide|mesh-list
2163863|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2163864|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163865|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
2163866|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163867|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2163868|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2163869|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
2163870|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163871|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163872|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2163873|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2163874|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
2621964|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2621965|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621966|NCT01887704|Aspirin|aspirin|mesh-list
2621967|NCT01887704|Sirolimus|sirolimus|mesh-list
2621968|NCT01887704|Paclitaxel|paclitaxel|mesh-list
2621969|NCT01887704|Everolimus|everolimus|mesh-list
2163875|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
2163876|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163877|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2163878|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
2163879|NCT00083915|Hormones|hormones|mesh-ancestor
2163880|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2163881|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2163882|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2163883|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2163884|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2163885|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163886|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2163887|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
2163888|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2163889|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2163890|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2163891|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2163892|NCT00083915|Growth Substances|growth substances|mesh-ancestor
2163893|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
2163894|NCT00090870|Interferons|interferons|mesh-list
2621970|NCT01887704|Clopidogrel|clopidogrel|mesh-list
2621971|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2621972|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621973|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
2621974|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
2621975|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
2621976|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2621977|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2621978|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2621979|NCT01887704|Analgesics|analgesics|mesh-ancestor
2621980|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
2621981|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2621982|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2621983|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2163895|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
2163896|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
2163897|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2163898|NCT00090870|Thalidomide|thalidomide|mesh-list
2163899|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2621984|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2621985|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2621986|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2621987|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2621988|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2621989|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2621990|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
2621991|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2621992|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
2621993|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2621994|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2621995|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2621996|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
2621997|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2621998|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2621999|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622000|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2622001|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
2622002|NCT01887743|Pantoprazole|pantoprazole|mesh-list
2622003|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2622004|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2622005|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2622006|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622007|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622008|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2622009|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622010|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2622011|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622012|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163900|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
2622013|NCT01887821|Chloroquine|chloroquine|mesh-list
2622014|NCT01887821|Piperaquine|piperaquine|mesh-list
2622015|NCT01887821|Artenimol|artenimol|mesh-list
2622016|NCT01887821|Amebicides|amebicides|mesh-ancestor
2622017|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2622018|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2622019|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622020|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
2622021|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2622022|NCT01887847|Nicotine|nicotine|mesh-list
2622023|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2622024|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
2622025|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622026|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622027|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2622028|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2622029|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
2622030|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622031|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622032|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
2622033|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2622034|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
2622035|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622036|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
2622037|NCT01887873|Protective Agents|protective agents|mesh-ancestor
2622038|NCT01887886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2622039|NCT01887886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622040|NCT01887886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2622041|NCT01887886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622042|NCT01887886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622043|NCT01887951|Tramadol|tramadol|mesh-list
2622044|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2622045|NCT01887951|Narcotics|narcotics|mesh-ancestor
2622046|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622047|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622048|NCT01887951|Analgesics|analgesics|mesh-ancestor
2622049|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
2622050|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163901|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2163902|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
2163903|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163904|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163905|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
2163906|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2163907|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2163908|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2622051|NCT01888042|Everolimus|everolimus|mesh-list
2622052|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622053|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2622054|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
2622055|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622056|NCT01888107|Risperidone|risperidone|mesh-list
2622057|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2622058|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
2622059|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622060|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622061|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622062|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2622063|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2622064|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622065|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2622066|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2622067|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
2622068|NCT01888120|Ziconotide|ziconotide|mesh-list
2622069|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2622070|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2622071|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622072|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2622073|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622074|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2622075|NCT01888120|Protective Agents|protective agents|mesh-ancestor
2622076|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2622077|NCT01888120|Analgesics|analgesics|mesh-ancestor
2622078|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
2622079|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622080|NCT01888224|Isotretinoin|isotretinoin|mesh-list
2622081|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
2622082|NCT01888250|Lamotrigine|lamotrigine|mesh-list
2622083|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
2622084|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2622085|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2622086|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622087|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2622088|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622089|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2163909|NCT00090870|Growth Substances|growth substances|mesh-ancestor
2163910|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
2163911|NCT00088972|Celecoxib|celecoxib|mesh-list
2163912|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2163913|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2163914|NCT00088972|Analgesics|analgesics|mesh-ancestor
2163915|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
2163916|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163917|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163918|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2622090|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2622091|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622092|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2622093|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2622094|NCT01888263|Lamotrigine|lamotrigine|mesh-list
2622095|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
2622096|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2622097|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2622098|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622099|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2622100|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163919|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2163920|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2163921|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2163922|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163923|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163924|NCT00088829|Paclitaxel|paclitaxel|mesh-list
2163925|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2163926|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2163927|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163928|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
2163929|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
2163930|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
2163931|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163932|NCT00089128|Gemcitabine|gemcitabine|mesh-list
2163933|NCT00089128|Irinotecan|irinotecan|mesh-list
2163934|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2163935|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
2163936|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163937|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163938|NCT00089128|Antiviral Agents|antiviral agents|mesh-ancestor
2163939|NCT00089128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2163940|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622101|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2622102|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2622103|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622104|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2622105|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2622106|NCT01888289|Isotretinoin|isotretinoin|mesh-list
2622107|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
2622108|NCT01888302|Gemcitabine|gemcitabine|mesh-list
2622109|NCT01888302|Sirolimus|sirolimus|mesh-list
2622110|NCT01888302|Cisplatin|cisplatin|mesh-list
2622111|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622112|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2622113|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
2622114|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622115|NCT01888302|Antiviral Agents|antiviral agents|mesh-ancestor
2622116|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622117|NCT01888302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622118|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2622119|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
2622120|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622121|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2622122|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2163941|NCT00089128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163942|NCT00089128|Immunologic Factors|immunologic factors|mesh-ancestor
2163943|NCT00089128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622123|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
2622124|NCT01888328|Isotretinoin|isotretinoin|mesh-list
2622125|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
2622126|NCT01888341|Isotretinoin|isotretinoin|mesh-list
2622127|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
2622128|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2622129|NCT01888354|Hormones|hormones|mesh-ancestor
2622130|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2622131|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622132|NCT01888393|Ivacaftor|ivacaftor|mesh-list
2622133|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2622134|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2622135|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622136|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
2622137|NCT01888445|Hematinics|hematinics|mesh-ancestor
2622138|NCT01888458|Micafungin|micafungin|mesh-list
2622139|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
2163944|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2163945|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2163946|NCT00075608|Melphalan|melphalan|mesh-list
2163947|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
2163948|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622140|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622141|NCT01888536|Pregabalin|pregabalin|mesh-list
2622142|NCT01888536|Alprostadil|alprostadil|mesh-list
2622143|NCT01888536|Analgesics|analgesics|mesh-ancestor
2622144|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
2622145|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622146|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622147|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
2622148|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2622149|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2622150|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622151|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2622152|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2622153|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2622154|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622155|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2622156|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2622157|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
2622158|NCT01888536|Urological Agents|urological agents|mesh-ancestor
2622159|NCT01888562|Ponatinib|ponatinib|mesh-list
2622160|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622161|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2622162|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622163|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622164|NCT01888575|Aspirin|aspirin|mesh-list
2622165|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2622166|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2622167|NCT01888575|Analgesics|analgesics|mesh-ancestor
2622168|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
2622169|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622170|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622171|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2622172|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2622173|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2622174|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2622175|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622176|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2163949|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2163950|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
2163951|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622177|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2622178|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622179|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
2622180|NCT01888718|Fexofenadine|fexofenadine|mesh-list
2622181|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2622182|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2622183|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2622184|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
2622185|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
2668572|NCT02143219|Irinotecan|irinotecan|mesh-list
2163952|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163953|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2163954|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163955|NCT00074724|Dobutamine|dobutamine|mesh-list
2163956|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2163957|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
2163958|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
2163959|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2163960|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163961|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2163962|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2163963|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2163964|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
2163965|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2163966|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163967|NCT00074724|Protective Agents|protective agents|mesh-ancestor
2163968|NCT00085631|Cisplatin|cisplatin|mesh-list
2163969|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163970|NCT00062751|Sirolimus|sirolimus|mesh-list
2163971|NCT00062751|Letrozole|letrozole|mesh-list
2163972|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163973|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2163974|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2163975|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163976|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2163977|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2163978|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
2163979|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2163980|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2163981|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2163982|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2163983|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2163984|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
2163985|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2163986|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
2163987|NCT00066807|Tamoxifen|tamoxifen|mesh-list
2163988|NCT00066807|Epirubicin|epirubicin|mesh-list
2163989|NCT00066807|Exemestane|exemestane|mesh-list
2163990|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2163991|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2163992|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2163993|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2163994|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2163995|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2163996|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622186|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622187|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622188|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622189|NCT01888731|Lamotrigine|lamotrigine|mesh-list
2622190|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
2622191|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2622192|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2622193|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622194|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2622195|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622196|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2622197|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2163997|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2163998|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
2163999|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2164000|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164001|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2164002|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2164003|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2164004|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2164005|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2164006|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2164007|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
2164008|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2164009|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
2164010|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2164011|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2164012|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
2622198|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622199|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2622200|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2622201|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2622202|NCT01888744|Cetrorelix|cetrorelix|mesh-list
2622203|NCT01888744|Progesterone|progesterone|mesh-list
2622204|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2622205|NCT01888744|Ganirelix|ganirelix|mesh-list
2622206|NCT01888744|Progestins|progestins|mesh-ancestor
2622207|NCT01888744|Hormones|hormones|mesh-ancestor
2622208|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2622209|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622210|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2622211|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2622212|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
2622213|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
2622214|NCT01888757|Lamotrigine|lamotrigine|mesh-list
2622215|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
2622216|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2622217|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2622218|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622219|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2622220|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622221|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2622222|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2622223|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622224|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2622225|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2622226|NCT01888796|Linagliptin|linagliptin|mesh-list
2622227|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2622228|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622229|NCT01888796|Incretins|incretins|mesh-ancestor
2622230|NCT01888796|Hormones|hormones|mesh-ancestor
2622231|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2622232|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2622233|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
2622234|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622235|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622236|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
2622237|NCT01888822|Ampicillin|ampicillin|mesh-list
2622238|NCT01888822|Sulbactam|sulbactam|mesh-list
2622239|NCT01888822|Sultamicillin|sultamicillin|mesh-list
2622240|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2622241|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622242|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2622243|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2622244|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622245|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622246|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622247|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2622248|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2622249|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2622250|NCT01888835|Mirtazapine|mirtazapine|mesh-list
2622251|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
2622252|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2622253|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2622254|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
2622255|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
2622256|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622257|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622258|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622259|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2622260|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2622261|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622262|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2622263|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2622264|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2622265|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
2622266|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2622267|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2622268|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
2622269|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2622270|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
2622271|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
2622272|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622273|NCT01888861|Protective Agents|protective agents|mesh-ancestor
2622274|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622275|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
2622276|NCT01888861|Vitamins|vitamins|mesh-ancestor
2622277|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
2622278|NCT01888978|Leucovorin|leucovorin|mesh-list
2622279|NCT01888978|Gemcitabine|gemcitabine|mesh-list
2622280|NCT01888978|Fluorouracil|fluorouracil|mesh-list
2622281|NCT01888978|Docetaxel|docetaxel|mesh-list
2622282|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
2622283|NCT01888978|Irinotecan|irinotecan|mesh-list
2622284|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
2622285|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2622286|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
2622287|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622288|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622289|NCT01888978|Antiviral Agents|antiviral agents|mesh-ancestor
2622290|NCT01888978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622291|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622292|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2622293|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
2622294|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622295|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
2622296|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
2622297|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
2622298|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2622299|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2622300|NCT01888978|Antidotes|antidotes|mesh-ancestor
2622301|NCT01888978|Protective Agents|protective agents|mesh-ancestor
2622302|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
2622303|NCT01888978|Vitamins|vitamins|mesh-ancestor
2622304|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
2622305|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
2622306|NCT01889004|Propofol|propofol|mesh-list
2622307|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2622308|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622309|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622310|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2622311|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
2622312|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
2164013|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
2164014|NCT00058188|Calcium|calcium|mesh-list
2164015|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2164016|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164017|NCT00058188|Vitamins|vitamins|mesh-ancestor
2164018|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
2164019|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2164020|NCT00014560|Antibodies|antibodies|mesh-list
2164021|NCT00014560|Sargramostim|sargramostim|mesh-list
2164022|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2164023|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
2164024|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164025|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
2164026|NCT00038142|Doxorubicin|doxorubicin|mesh-list
2164027|NCT00038142|Vincristine|vincristine|mesh-list
2164028|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
2622313|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2622314|NCT01889004|Analgesics|analgesics|mesh-ancestor
2622315|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
2622316|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622317|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2622318|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2622319|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2622320|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
2622321|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622322|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622323|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
2622324|NCT01889056|Hematinics|hematinics|mesh-ancestor
2622325|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2622326|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2622327|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622328|NCT01889134|Alendronate|alendronate|mesh-list
2622329|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2164029|NCT00038142|Razoxane|razoxane|mesh-list
2164030|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2622330|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622331|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
2622332|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2622333|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
2622334|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2622335|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2622336|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622337|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2622338|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622339|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2622340|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622343|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2622344|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622345|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2164031|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
2164032|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164033|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2164034|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2164035|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
2164036|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164037|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164038|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2164039|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2164040|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2164041|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2164042|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164043|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2164044|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
2164045|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
2164046|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
2164047|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2164048|NCT00038142|Protective Agents|protective agents|mesh-ancestor
2164049|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
2164050|NCT00020722|Ifosfamide|ifosfamide|mesh-list
2164051|NCT00020722|Thiotepa|thiotepa|mesh-list
2164052|NCT00020722|Carboplatin|carboplatin|mesh-list
2164053|NCT00020722|Etoposide|etoposide|mesh-list
2622346|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622347|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622348|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
2622349|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2622350|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622351|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
2622352|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622353|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
2622354|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2622355|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622356|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
2622357|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622358|NCT01889368|Protective Agents|protective agents|mesh-ancestor
2622359|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622360|NCT01889407|Idarubicin|idarubicin|mesh-list
2164054|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
2164055|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2164056|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
2164057|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164058|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2164059|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2164060|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
2164061|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164062|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164063|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2164064|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2164065|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2164066|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2622361|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2622362|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622363|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2622364|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2622365|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622366|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622367|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2622368|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
2164067|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164068|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2622369|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622370|NCT01889446|Calcium|calcium|mesh-list
2622371|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2622372|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622373|NCT01889498|Acetazolamide|acetazolamide|mesh-list
2622374|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
2622375|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2622376|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622377|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622378|NCT01889498|Diuretics|diuretics|mesh-ancestor
2622379|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
2622380|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622381|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
2622382|NCT01889576|Antacids|antacids|mesh-ancestor
2622383|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622384|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2622385|NCT01889680|Leucovorin|leucovorin|mesh-list
2622386|NCT01889680|Fluorouracil|fluorouracil|mesh-list
2622387|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
2622388|NCT01889680|Aflibercept|aflibercept|mesh-list
2622389|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
2164069|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2164070|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
2164071|NCT00006478|Sargramostim|sargramostim|mesh-list
2164072|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2164073|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
2164074|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164075|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2164076|NCT00019747|Thalidomide|thalidomide|mesh-list
2164077|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2164078|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
2164079|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164080|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
2164081|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2164082|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2164083|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2164084|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2164085|NCT00019747|Growth Substances|growth substances|mesh-ancestor
2164086|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
2164087|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164088|NCT00006916|Bleomycin|bleomycin|mesh-list
2164089|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2164090|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164091|NCT00003726|Lepirudin|lepirudin|mesh-list
2164092|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
2164093|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2164094|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
2164095|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164096|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164097|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
2164098|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2164099|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2164100|NCT04051996|Decitabine|decitabine|mesh-list
2164101|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2164102|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
2164103|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164104|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164105|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164106|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2164107|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2164108|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
2164109|NCT02126878|Hormones|hormones|mesh-ancestor
2164110|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2164111|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164112|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2164113|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
2164114|NCT02595996|Propranolol|propranolol|mesh-list
2164115|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2164116|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2164117|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
2622390|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
2622391|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622392|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2622393|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622394|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2164118|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622395|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
2164119|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622396|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622397|NCT01889680|Antidotes|antidotes|mesh-ancestor
2622398|NCT01889680|Protective Agents|protective agents|mesh-ancestor
2622399|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
2164120|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164121|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2164122|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2164123|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
2164124|NCT02009384|Ipilimumab|ipilimumab|mesh-list
2622400|NCT01889680|Vitamins|vitamins|mesh-ancestor
2622401|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
2622402|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2622403|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2622404|NCT01889680|Growth Substances|growth substances|mesh-ancestor
2622405|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
2622406|NCT01889758|Tacrolimus|tacrolimus|mesh-list
2622407|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2622408|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
2622409|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622410|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2622411|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622412|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622413|NCT01889771|Nicotine|nicotine|mesh-list
2622414|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2622415|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
2622416|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622417|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622418|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2622419|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2622420|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
2622421|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622422|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622423|NCT01889810|Vitamin D|vitamin d|mesh-list
2622424|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
2622425|NCT01889810|Vitamins|vitamins|mesh-ancestor
2622426|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
2622427|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622428|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2622429|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2622430|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2622431|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2622432|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
2622433|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622434|NCT01889914|Insulin|insulin|mesh-list
2622435|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2622436|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2622437|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622438|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
2622439|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
2622440|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2622441|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2622442|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622443|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622444|NCT01889966|Urological Agents|urological agents|mesh-ancestor
2622445|NCT01889979|Tramadol|tramadol|mesh-list
2622446|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2622447|NCT01889979|Narcotics|narcotics|mesh-ancestor
2622448|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164125|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2164126|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164127|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2164128|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164129|NCT04558125|Heparin|heparin|mesh-list
2164130|NCT04558125|Calcium heparin|calcium heparin|mesh-list
2164131|NCT04558125|Enoxaparin|enoxaparin|mesh-list
2164132|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2164133|NCT04558125|Tinzaparin|tinzaparin|mesh-list
2164134|NCT04558125|Dalteparin|dalteparin|mesh-list
2164135|NCT04558125|Tenecteplase|tenecteplase|mesh-list
2164136|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
2164137|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
2164138|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2164139|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2164140|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622449|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622450|NCT01889979|Analgesics|analgesics|mesh-ancestor
2164141|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
2164142|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
2164143|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2164144|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2164145|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2164146|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164147|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164148|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2164149|NCT00521885|Enoxaparin|enoxaparin|mesh-list
2622451|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
2622452|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622453|NCT01889992|Sirolimus|sirolimus|mesh-list
2622454|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2622455|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622456|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2622457|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622458|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
2622459|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2622460|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
2622461|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622462|NCT01890005|Aspirin|aspirin|mesh-list
2622463|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2622464|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2622465|NCT01890005|Analgesics|analgesics|mesh-ancestor
2622466|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
2164150|NCT00521885|Fondaparinux|fondaparinux|mesh-list
2164151|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
2164152|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2164153|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2164154|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164155|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2164156|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
2164157|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2164158|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
2164159|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622467|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622468|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622469|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2622470|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2622471|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2622472|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2622473|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622474|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2622475|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2622476|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622477|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
2164173|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
2164174|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2164175|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2164176|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164177|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
2164178|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2164179|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164180|NCT00479167|Bortezomib|bortezomib|mesh-list
2164181|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
2622478|NCT01890200|Ribavirin|ribavirin|mesh-list
2622479|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2622480|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
2622481|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622482|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
2622483|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622484|NCT01890408|Ropivacaine|ropivacaine|mesh-list
2622485|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
2164182|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164183|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
2164184|NCT02212574|Lomustine|lomustine|mesh-list
2164185|NCT02212574|Vincristine|vincristine|mesh-list
2164186|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2164187|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
2164188|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164189|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2164190|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2164191|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
2164192|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164193|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164194|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2622486|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
2622487|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622488|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164195|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2164196|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
2164197|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
2164198|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
2164199|NCT04422210|Carboplatin|carboplatin|mesh-list
2164200|NCT04422210|Etoposide|etoposide|mesh-list
2164201|NCT04422210|Atezolizumab|atezolizumab|mesh-list
2164202|NCT04422210|Venetoclax|venetoclax|mesh-list
2164203|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164204|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2164205|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2164206|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2622489|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
2622490|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622491|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
2622492|NCT01890538|Piracetam|piracetam|mesh-list
2622493|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2622494|NCT01890538|Protective Agents|protective agents|mesh-ancestor
2622495|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622496|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
2622497|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
2622498|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
2622499|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622500|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2622501|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2622502|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
2622503|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
2622504|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622505|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622506|NCT01890629|Metformin|metformin|mesh-list
2622507|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2622508|NCT01890629|Glimepiride|glimepiride|mesh-list
2622509|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2622510|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622511|NCT01890629|Incretins|incretins|mesh-ancestor
2622512|NCT01890629|Hormones|hormones|mesh-ancestor
2622513|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2622514|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2622515|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
2622516|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622517|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622518|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2622519|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2622520|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
2164207|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164208|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164209|NCT04298918|Trastuzumab|trastuzumab|mesh-list
2164210|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2164211|NCT04298918|Venetoclax|venetoclax|mesh-list
2164212|NCT04298918|Maytansine|maytansine|mesh-list
2164213|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2164214|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164215|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2164216|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
2622521|NCT01890772|Vitamin D|vitamin d|mesh-list
2622522|NCT01890772|Ribavirin|ribavirin|mesh-list
2622523|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2622524|NCT01890772|Vitamins|vitamins|mesh-ancestor
2622525|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
2164217|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
2164218|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
2668573|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
2622526|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622527|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2622528|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
2622529|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622530|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
2164219|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164220|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
2164221|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2164222|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164223|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
2164224|NCT00955929|Alprostadil|alprostadil|mesh-list
2164225|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
2164226|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2164227|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2164228|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164229|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164230|NCT00955929|Urological Agents|urological agents|mesh-ancestor
2164231|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2164232|NCT00402883|Folic Acid|folic acid|mesh-list
2164233|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
2164234|NCT00402883|Hydroxocobalamin|hydroxocobalamin|mesh-list
2164235|NCT00402883|Bevacizumab|bevacizumab|mesh-list
2164236|NCT00402883|Carboplatin|carboplatin|mesh-list
2164237|NCT00402883|Pemetrexed|pemetrexed|mesh-list
2164238|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2164239|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164240|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2164241|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2164242|NCT00402883|Growth Substances|growth substances|mesh-ancestor
2164243|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164244|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
2164245|NCT00402883|Vitamins|vitamins|mesh-ancestor
2164246|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
2164247|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164248|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622531|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622532|NCT01890863|Fluticasone|fluticasone|mesh-list
2622533|NCT01890863|Xhance|xhance|mesh-list
2622534|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2164249|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2164250|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2164251|NCT00402883|Hematinics|hematinics|mesh-ancestor
2164252|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
2164253|NCT02934503|Carboplatin|carboplatin|mesh-list
2164254|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
2622535|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2622536|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2622537|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2622538|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
2622539|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622540|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622541|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2622542|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
2622543|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
2622544|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2622545|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2622546|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2622547|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2622548|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
2622549|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622550|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622551|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
2622552|NCT01890863|Hormones|hormones|mesh-ancestor
2622553|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2622554|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
2622555|NCT01890889|Ezetimibe|ezetimibe|mesh-list
2622556|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2164255|NCT02934503|Etoposide|etoposide|mesh-list
2164256|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164257|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2164258|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2164259|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2164260|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2164261|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164262|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622557|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2622558|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
2622559|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622560|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2622561|NCT01890902|Ketoprofen|ketoprofen|mesh-list
2622562|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2622563|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2622564|NCT01890902|Analgesics|analgesics|mesh-ancestor
2622565|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
2622566|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164263|NCT02137252|Naltrexone|naltrexone|mesh-list
2164264|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2164265|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164266|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164267|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
2164268|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164269|NCT01294670|Etoposide|etoposide|mesh-list
2164270|NCT01294670|Vorinostat|vorinostat|mesh-list
2164271|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2164272|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164273|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2164274|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2164275|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164276|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164277|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2164278|NCT03095287|Factor VIII|factor viii|mesh-list
2164279|NCT03095287|Coagulants|coagulants|mesh-ancestor
2164280|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2164281|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184856|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2622567|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622568|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2622569|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2622570|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2622571|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622572|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622573|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2622574|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2622575|NCT01890993|Liraglutide|liraglutide|mesh-list
2622576|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2622577|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622578|NCT01890993|Incretins|incretins|mesh-ancestor
2622579|NCT01890993|Hormones|hormones|mesh-ancestor
2622580|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2622581|NCT01891019|Thalidomide|thalidomide|mesh-list
2622582|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2622583|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
2622584|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622585|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
2622586|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2622587|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622588|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2622589|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2622590|NCT01891019|Growth Substances|growth substances|mesh-ancestor
2622591|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
2184857|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2184858|NCT00002833|Protective Agents|protective agents|mesh-ancestor
2184859|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2184860|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2184861|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184862|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184863|NCT00002835|Leucovorin|leucovorin|mesh-list
2622592|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622593|NCT01891084|Acetaminophen|acetaminophen|mesh-list
2622594|NCT01891084|Ibuprofen|ibuprofen|mesh-list
2622595|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2622596|NCT01891084|Analgesics|analgesics|mesh-ancestor
2622597|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
2622598|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622599|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622600|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
2622601|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2622602|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2622603|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2622604|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2164282|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
2164283|NCT00000105|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2164284|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2164285|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
2164286|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164287|NCT00000114|Vitamins|vitamins|mesh-list
2164288|NCT00000114|Vitamin E|vitamin e|mesh-list
2164289|NCT00000114|Vitamin A|vitamin a|mesh-list
2164290|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
2164291|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164292|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
2622605|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622606|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622607|NCT01891175|Anesthetics|anesthetics|mesh-list
2622608|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622609|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164293|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164294|NCT00000114|Protective Agents|protective agents|mesh-ancestor
2164295|NCT00000115|Acetazolamide|acetazolamide|mesh-list
2164296|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
2164297|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2164298|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164299|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164300|NCT00000115|Diuretics|diuretics|mesh-ancestor
2164301|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
2164302|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164303|NCT00000116|Vitamin A|vitamin a|mesh-list
2164304|NCT00000116|Vitamins|vitamins|mesh-ancestor
2164305|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
2164306|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164307|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
2164308|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2164309|NCT00000117|Antibodies|antibodies|mesh-list
2164310|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
2164311|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164312|NCT00000119|Heparin|heparin|mesh-list
2164313|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
2164314|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2164315|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2164316|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164317|NCT00000120|Erythromycin|erythromycin|mesh-list
2164318|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
2164319|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2164320|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
2622610|NCT01891201|Oxytocin|oxytocin|mesh-list
2622611|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
2622612|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2622613|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622614|NCT01891227|Capecitabine|capecitabine|mesh-list
2164321|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
2164322|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2164323|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2164324|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2164325|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2164326|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164327|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164328|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2164329|NCT00000122|Fluorouracil|fluorouracil|mesh-list
2622615|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2622616|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2622617|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
2622618|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622619|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622620|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2622621|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
2622622|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
2622623|NCT01891292|Enalapril|enalapril|mesh-list
2622624|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2622625|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
2622626|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622627|NCT01891292|Expectorants|expectorants|mesh-ancestor
2622628|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
2622629|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2622630|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
2622631|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164330|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
2184864|NCT00002835|Interferons|interferons|mesh-list
2622632|NCT01891292|Protective Agents|protective agents|mesh-ancestor
2164331|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164332|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2164333|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164334|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2164335|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
2164336|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164337|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2164338|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
2164339|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2164340|NCT00000123|Protective Agents|protective agents|mesh-ancestor
2164341|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164342|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2164343|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622633|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622634|NCT01891292|Antidotes|antidotes|mesh-ancestor
2622635|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2622636|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
2622637|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622638|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2622639|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
2622640|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2622641|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
2622642|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622643|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
2622644|NCT01891396|Protective Agents|protective agents|mesh-ancestor
2622645|NCT01891435|Acetaminophen|acetaminophen|mesh-list
2622646|NCT01891435|Diclofenac|diclofenac|mesh-list
2622647|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2622648|NCT01891435|Analgesics|analgesics|mesh-ancestor
2622649|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
2622650|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164344|NCT00000132|Betaxolol|betaxolol|mesh-list
2164345|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2164346|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
2164347|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
2164348|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164349|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164350|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2164351|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2164352|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2164353|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
2164354|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2164355|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164356|NCT00000138|Acyclovir|acyclovir|mesh-list
2164357|NCT00000138|Prednisolone|prednisolone|mesh-list
2164358|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2164359|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
2164360|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2164361|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
2622651|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622652|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
2622653|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2622654|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2622655|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2622656|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2622657|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622658|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622659|NCT01891461|Hemostatics|hemostatics|mesh-list
2622660|NCT01891461|Coagulants|coagulants|mesh-ancestor
2622661|NCT01891487|Bimatoprost|bimatoprost|mesh-list
2622662|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2622663|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
2622664|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2622665|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
2622666|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622667|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164362|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2164363|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
2164364|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2164365|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
2164366|NCT00000138|Hormones|hormones|mesh-ancestor
2164367|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2622668|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2622669|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
2622670|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2622671|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
2164368|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164369|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2164370|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164371|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
2164372|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
2164373|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164374|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2164375|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2164376|NCT00000138|Protective Agents|protective agents|mesh-ancestor
2622672|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622673|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622674|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2622675|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
2622676|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
2622677|NCT01891500|Protective Agents|protective agents|mesh-ancestor
2622678|NCT01891513|Losartan|losartan|mesh-list
2622679|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2622680|NCT01891513|Perindopril|perindopril|mesh-list
2622681|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2622682|NCT01891513|Diuretics|diuretics|mesh-list
2622683|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
2622684|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2622685|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2622686|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2622687|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2622688|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622689|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
2622690|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622691|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2622692|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
2622693|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622694|NCT01891526|Tretinoin|tretinoin|mesh-list
2622695|NCT01891526|Alitretinoin|alitretinoin|mesh-list
2622696|NCT01891526|Isotretinoin|isotretinoin|mesh-list
2622697|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622698|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
2622699|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
2622700|NCT01891643|Dexamethasone|dexamethasone|mesh-list
2622701|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
2622702|NCT01891643|Lenalidomide|lenalidomide|mesh-list
2622703|NCT01891643|Elotuzumab|elotuzumab|mesh-list
2622704|NCT01891643|BB 1101|bb 1101|mesh-list
2622705|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2164377|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
2164378|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2164379|NCT00000139|Acyclovir|acyclovir|mesh-list
2164380|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
2622706|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
2622707|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
2622708|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622709|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622710|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2622711|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
2622712|NCT01891643|Hormones|hormones|mesh-ancestor
2622713|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2622714|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2622715|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622716|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
2622717|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622718|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622719|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
2622720|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2622721|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2622722|NCT01891643|Growth Substances|growth substances|mesh-ancestor
2622723|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
2164381|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2164382|NCT00000145|Zinc|zinc|mesh-list
2164383|NCT00000145|Antioxidants|antioxidants|mesh-list
2164384|NCT00000145|Trace Elements|trace elements|mesh-ancestor
2164385|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
2164386|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164387|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164388|NCT00000145|Protective Agents|protective agents|mesh-ancestor
2164389|NCT00000146|Prednisone|prednisone|mesh-list
2164390|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
2164391|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2164392|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2422021|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2164393|NCT00000146|Prednisolone|prednisolone|mesh-list
2164394|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
2164395|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2164396|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
2164397|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2164398|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
2164399|NCT00000146|Hormones|hormones|mesh-ancestor
2164400|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2622724|NCT01891708|Bevacizumab|bevacizumab|mesh-list
2622725|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2622726|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622727|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2622728|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2622729|NCT01891708|Growth Substances|growth substances|mesh-ancestor
2622730|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622731|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
2622732|NCT01891747|Ascorbic Acid|ascorbic acid|mesh-list
2622733|NCT01891747|Bevacizumab|bevacizumab|mesh-list
2622734|NCT01891747|Temozolomide|temozolomide|mesh-list
2622735|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2622736|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622737|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2622738|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2622739|NCT01891747|Growth Substances|growth substances|mesh-ancestor
2622740|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622741|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
2622742|NCT01891747|Vitamins|vitamins|mesh-ancestor
2622743|NCT01891747|Micronutrients|micronutrients|mesh-ancestor
2622744|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2622745|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
2622746|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622747|NCT01891747|Antioxidants|antioxidants|mesh-ancestor
2622748|NCT01891747|Protective Agents|protective agents|mesh-ancestor
2622749|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
2622750|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2622751|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
2622752|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
2622753|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622754|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622755|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2622756|NCT01891812|Analgesics|analgesics|mesh-ancestor
2622757|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
2622758|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622759|NCT01891851|Ritonavir|ritonavir|mesh-list
2622760|NCT01891851|Simeprevir|simeprevir|mesh-list
2622761|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2164401|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164402|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2164403|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164404|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
2164405|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
2164406|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164407|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2164408|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2164409|NCT00000146|Protective Agents|protective agents|mesh-ancestor
2164410|NCT00000147|Prednisone|prednisone|mesh-list
2164411|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
2164412|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2164413|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2164414|NCT00000147|Prednisolone|prednisolone|mesh-list
2164415|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
2164416|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2164417|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
2164418|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2164419|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
2164420|NCT00000147|Hormones|hormones|mesh-ancestor
2164421|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2422022|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2422023|NCT00815399|Metformin|metformin|mesh-list
2422024|NCT00815399|Pioglitazone|pioglitazone|mesh-list
2422025|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2422026|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422027|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
2422028|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422029|NCT00815503|Ropivacaine|ropivacaine|mesh-list
2422030|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
2422031|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
2622762|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2622763|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
2622764|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622765|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622766|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2622767|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2622768|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
2622769|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622770|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2622771|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2622772|NCT01891916|Caseins|caseins|mesh-list
2622773|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
2622774|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
2622775|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622776|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
2622777|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622778|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
2622779|NCT01892098|Astringents|astringents|mesh-ancestor
2622780|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622781|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
2622782|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
2622783|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2622784|NCT01892150|Protective Agents|protective agents|mesh-ancestor
2622785|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622786|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
2164422|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164423|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2164424|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2164425|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
2164426|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
2164427|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164428|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2164429|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2164430|NCT00000147|Protective Agents|protective agents|mesh-ancestor
2164431|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2164432|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2622787|NCT01892176|Ubiquinone|ubiquinone|mesh-list
2622788|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
2622789|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
2622790|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622791|NCT01892176|Vitamins|vitamins|mesh-ancestor
2622792|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2622793|NCT01892241|Entecavir|entecavir|mesh-list
2622794|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
2622795|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622796|NCT01892254|Metformin|metformin|mesh-list
2622797|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2622798|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622799|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
2622800|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2622801|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622802|NCT01892332|Lidocaine|lidocaine|mesh-list
2622803|NCT01892332|Fentanyl|fentanyl|mesh-list
2622804|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
2622805|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
2622806|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164433|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
2164434|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2164435|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164436|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164437|NCT00000151|Aspirin|aspirin|mesh-list
2164438|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2164439|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2164440|NCT00000151|Analgesics|analgesics|mesh-ancestor
2164441|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
2164442|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164443|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622807|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622808|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
2622809|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622810|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2622811|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2622812|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2622813|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2622814|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622815|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2622816|NCT01892332|Narcotics|narcotics|mesh-ancestor
2164444|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2164445|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2164446|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2164447|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2164448|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164449|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2164450|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2164451|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164452|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
2164453|NCT00000152|Aspirin|aspirin|mesh-list
2164454|NCT00000152|Beta Carotene|beta carotene|mesh-list
2164455|NCT00000152|Carotenoids|carotenoids|mesh-list
2164456|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2164457|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2164458|NCT00000152|Analgesics|analgesics|mesh-ancestor
2164459|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
2164460|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164461|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164462|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2164463|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2164464|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2164465|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2164466|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164467|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2164468|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2164469|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164470|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
2164471|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
2164472|NCT00000152|Protective Agents|protective agents|mesh-ancestor
2164473|NCT00000152|Provitamins|provitamins|mesh-ancestor
2622817|NCT01892332|Analgesics|analgesics|mesh-ancestor
2622818|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2622819|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2622820|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
2622821|NCT01892371|Cytarabine|cytarabine|mesh-list
2622822|NCT01892371|Azacitidine|azacitidine|mesh-list
2622823|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2622824|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
2622825|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622826|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622827|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
2622828|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622829|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2622830|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
2622831|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622832|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622833|NCT01892384|BI 409306|bi 409306|mesh-list
2622834|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2622835|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622836|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622837|NCT01892488|Sultamicillin|sultamicillin|mesh-list
2622838|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
2622839|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2622840|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622841|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622842|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622843|NCT01892527|Cetuximab|cetuximab|mesh-list
2622844|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2622845|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622846|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2622847|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
2622848|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622849|NCT01892631|Vaccines|vaccines|mesh-list
2622850|NCT01892631|Immunologic Factors|immunologic factors|mesh-ancestor
2622851|NCT01892631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622852|NCT01892644|Deferasirox|deferasirox|mesh-list
2622853|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2622854|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
2622855|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
2622856|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622857|NCT01892683|Propofol|propofol|mesh-list
2622858|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
2622859|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622860|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164474|NCT00000152|Vitamins|vitamins|mesh-ancestor
2164475|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
2164476|NCT00000157|Aspirin|aspirin|mesh-list
2164477|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2164478|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2164479|NCT00000157|Analgesics|analgesics|mesh-ancestor
2164480|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
2164481|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164482|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164483|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2164484|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2164485|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2164486|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2164487|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164488|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2164489|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2164490|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164491|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
2164492|NCT00000160|Xenon|xenon|mesh-list
2164493|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2164494|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
2164495|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
2164496|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164497|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164498|NCT00000161|Aspirin|aspirin|mesh-list
2164499|NCT00000161|Vitamins|vitamins|mesh-list
2164500|NCT00000161|Ascorbic Acid|ascorbic acid|mesh-list
2164501|NCT00000161|Vitamin E|vitamin e|mesh-list
2164502|NCT00000161|Beta Carotene|beta carotene|mesh-list
2164503|NCT00000161|Carotenoids|carotenoids|mesh-list
2164504|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
2164505|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164506|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2164507|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2164508|NCT00000161|Analgesics|analgesics|mesh-ancestor
2164509|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
2164510|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164511|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2164512|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2164513|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2164514|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2164515|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164516|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2164517|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2164518|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164519|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
2164520|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
2164521|NCT00000161|Protective Agents|protective agents|mesh-ancestor
2164522|NCT00000161|Provitamins|provitamins|mesh-ancestor
2164523|NCT00000170|Atropine|atropine|mesh-list
2622861|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2622862|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2622863|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
2622864|NCT01892748|Vitamin D|vitamin d|mesh-list
2622865|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
2622866|NCT01892748|Vitamins|vitamins|mesh-ancestor
2622867|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
2622868|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622869|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2622870|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2622871|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
2164524|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2164525|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2164526|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2164527|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
2164528|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164529|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164530|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2164531|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
2164532|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
2164533|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
2164534|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2164535|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2164536|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
2164537|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622872|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2164538|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164539|NCT00000171|Melatonin|melatonin|mesh-list
2164540|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
2164541|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164542|NCT00000171|Protective Agents|protective agents|mesh-ancestor
2164543|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622873|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2622874|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
2622875|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622876|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622877|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2622878|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
2622879|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2622880|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2622881|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2622882|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
2622883|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622884|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622885|NCT01892813|Bupropion|bupropion|mesh-list
2622886|NCT01892813|Nicotine|nicotine|mesh-list
2622887|NCT01892813|Varenicline|varenicline|mesh-list
2622888|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2622889|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
2622890|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622891|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622892|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2622893|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2622894|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
2622895|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622896|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622897|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2622898|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
2622899|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2622900|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2622901|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2622902|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2622903|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
2622904|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2622905|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2622906|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622907|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
2622908|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2622909|NCT01892995|Ketamine|ketamine|mesh-list
2622910|NCT01892995|Analgesics|analgesics|mesh-ancestor
2164544|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164545|NCT00000172|Galantamine|galantamine|mesh-list
2164546|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2164547|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164548|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164549|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
2164550|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2164551|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164552|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2164553|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
2164554|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164555|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
2622911|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
2622912|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622913|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622914|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2622915|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2164556|NCT00000173|Vitamin E|vitamin e|mesh-list
2164557|NCT00000173|Donepezil|donepezil|mesh-list
2164558|NCT00000173|Vitamins|vitamins|mesh-ancestor
2164559|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
2164560|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164561|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2164562|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164563|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164564|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
2164565|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2164566|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
2622916|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
2622917|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
2622918|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622919|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2622920|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2164567|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
2164568|NCT00000173|Protective Agents|protective agents|mesh-ancestor
2164569|NCT00000174|Rivastigmine|rivastigmine|mesh-list
2164570|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2164571|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164572|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164573|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
2164574|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2164575|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164576|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2164577|NCT00000174|Protective Agents|protective agents|mesh-ancestor
2164578|NCT00000175|Testosterone|testosterone|mesh-list
2164579|NCT00000175|Estrogens|estrogens|mesh-list
2164580|NCT00000175|Androgens|androgens|mesh-ancestor
2164581|NCT00000175|Hormones|hormones|mesh-ancestor
2622921|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622922|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622923|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
2622924|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2622925|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
2622926|NCT01893060|Povidone|povidone|mesh-list
2622927|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2622928|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2164582|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2164583|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164584|NCT00000176|Progesterone|progesterone|mesh-list
2164585|NCT00000176|Estrogens|estrogens|mesh-list
2164586|NCT00000176|Progestins|progestins|mesh-ancestor
2164587|NCT00000176|Hormones|hormones|mesh-ancestor
2164588|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2164589|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164590|NCT00000177|Estrogens|estrogens|mesh-list
2164591|NCT00000177|Hormones|hormones|mesh-ancestor
2164592|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2164593|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164594|NCT00000178|Prednisone|prednisone|mesh-list
2164595|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2164596|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
2164597|NCT00000178|Hormones|hormones|mesh-ancestor
2164598|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2164599|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164600|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2164601|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622929|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
2622930|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
2622931|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
2622932|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
2622933|NCT01893099|Sorafenib|sorafenib|mesh-list
2622934|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622935|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2622936|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622937|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622938|NCT01893177|Vaccines|vaccines|mesh-list
2622939|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
2622940|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622941|NCT01893190|Nimodipine|nimodipine|mesh-list
2622942|NCT01893190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2622943|NCT01893190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2622944|NCT01893190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2622945|NCT01893190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622946|NCT01893190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2622947|NCT01893190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622948|NCT01893190|Vasodilator Agents|vasodilator agents|mesh-ancestor
2622949|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
2622950|NCT01893229|Valproic Acid|valproic acid|mesh-list
2622951|NCT01893229|Olanzapine|olanzapine|mesh-list
2164602|NCT00000179|Haloperidol|haloperidol|mesh-list
2164603|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
2164604|NCT00000179|Trazodone|trazodone|mesh-list
2164605|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
2164606|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
2164607|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164608|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164609|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2622952|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2622953|NCT01893229|Ziprasidone|ziprasidone|mesh-list
2622954|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
2622955|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
2622956|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
2622957|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2622958|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622959|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2622960|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2622961|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2622962|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2622963|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2622964|NCT01893229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2622965|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2622966|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2622967|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622968|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622969|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
2622970|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
2622971|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622972|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
2622973|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2622974|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2622975|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
2622976|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
2622977|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
2622978|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2622979|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2622980|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2622981|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2622982|NCT01893294|Gemcitabine|gemcitabine|mesh-list
2622983|NCT01893294|Fluorouracil|fluorouracil|mesh-list
2622984|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2622985|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
2622986|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622987|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622988|NCT01893294|Antiviral Agents|antiviral agents|mesh-ancestor
2164610|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2164611|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2164612|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164613|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2164614|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2164615|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
2164616|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2622989|NCT01893294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2622990|NCT01893294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2622991|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2622992|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
2622993|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2622994|NCT01893320|Decitabine|decitabine|mesh-list
2622995|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2622996|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
2622997|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2622998|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2622999|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623000|NCT01893385|Vitamin D|vitamin d|mesh-list
2623001|NCT01893385|Vitamins|vitamins|mesh-ancestor
2623002|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
2623003|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623004|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2623005|NCT01893424|Dronabinol|dronabinol|mesh-list
2623006|NCT01893424|Nabiximols|nabiximols|mesh-list
2623007|NCT01893424|Cannabidiol|cannabidiol|mesh-list
2623008|NCT01893424|Piperine|piperine|mesh-list
2623009|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
2623010|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
2623011|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623012|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2623013|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2623014|NCT01893424|Analgesics|analgesics|mesh-ancestor
2623015|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
2623016|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623017|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2623018|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2623019|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623020|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623021|NCT01893424|Hormones|hormones|mesh-ancestor
2623022|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623023|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2623024|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623025|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
2623026|NCT01893450|Bromocriptine|bromocriptine|mesh-list
2164617|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164618|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2164619|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2623027|NCT01893450|Methimazole|methimazole|mesh-list
2623028|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2623029|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623030|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623031|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2623032|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2623033|NCT01893450|Protective Agents|protective agents|mesh-ancestor
2623034|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623035|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
2623036|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2623037|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
2623038|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2623039|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2623040|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
2623041|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623042|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
2623043|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
2623044|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623045|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
2623046|NCT01893541|Propranolol|propranolol|mesh-list
2623047|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2623048|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2623049|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
2623050|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623051|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623052|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623053|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2623054|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2623055|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
2623056|NCT01893658|Omalizumab|omalizumab|mesh-list
2623057|NCT01893658|Prednisone|prednisone|mesh-list
2623058|NCT01893658|Prednisolone|prednisolone|mesh-list
2623059|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2623060|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
2623061|NCT01893658|Hormones|hormones|mesh-ancestor
2623062|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623063|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623064|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2623065|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623066|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2623067|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2623068|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
2623069|NCT01893723|Remifentanil|remifentanil|mesh-list
2623070|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2623071|NCT01893723|Narcotics|narcotics|mesh-ancestor
2623072|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623073|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623074|NCT01893723|Analgesics|analgesics|mesh-ancestor
2623075|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
2623076|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623077|NCT01893788|Eplerenone|eplerenone|mesh-list
2623078|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2623079|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
2623080|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623081|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623082|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2164620|NCT00000179|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2164621|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2164622|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2164623|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
2164624|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2164625|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
2164626|NCT00000187|Ritanserin|ritanserin|mesh-list
2164627|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2164628|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
2164629|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2164630|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164631|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164632|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2164633|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2164634|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164635|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2164636|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2164637|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2164638|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
2164639|NCT00000188|Selegiline|selegiline|mesh-list
2623083|NCT01893788|Diuretics|diuretics|mesh-ancestor
2623084|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
2623085|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2623086|NCT01893996|Adalimumab|adalimumab|mesh-list
2623087|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2623088|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2623089|NCT01894035|Iloprost|iloprost|mesh-list
2623090|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2623091|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
2623092|NCT01894048|Beclomethasone|beclomethasone|mesh-list
2623093|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2623094|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
2623095|NCT01894048|Hormones|hormones|mesh-ancestor
2623096|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623097|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623098|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2623099|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
2623100|NCT01894061|Bevacizumab|bevacizumab|mesh-list
2623101|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2623102|NCT01894061|Antibodies|antibodies|mesh-list
2623103|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
2623104|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2164640|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
2164641|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2164642|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2164643|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2164644|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2164645|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164646|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164647|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2164648|NCT00000188|Protective Agents|protective agents|mesh-ancestor
2164649|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164650|NCT00000189|Gepirone|gepirone|mesh-list
2164651|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
2164652|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2164653|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2164654|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2164655|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164656|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164657|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2164658|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
2164659|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2164660|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164661|NCT00000191|Carbamazepine|carbamazepine|mesh-list
2164662|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
2164663|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
2164664|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2164665|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164666|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164667|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2164668|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2164669|NCT00000191|Analgesics|analgesics|mesh-ancestor
2164670|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
2164671|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164672|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2164673|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2164674|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164675|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2164676|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2164677|NCT00000192|Lamotrigine|lamotrigine|mesh-list
2164678|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
2164679|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2164680|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2623105|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623106|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2623107|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2623108|NCT01894061|Growth Substances|growth substances|mesh-ancestor
2668574|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
2623109|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623110|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
2623111|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
2623112|NCT01894269|Lamivudine|lamivudine|mesh-list
2623113|NCT01894269|Entecavir|entecavir|mesh-list
2164681|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164682|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2164683|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164684|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2164685|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2164686|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164687|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2164688|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2164689|NCT00000194|Cycloserine|cycloserine|mesh-list
2164690|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2164691|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2164692|NCT00000194|Renal Agents|renal agents|mesh-ancestor
2164693|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2164694|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
2164695|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2164696|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
2164697|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164698|NCT00000195|Naltrexone|naltrexone|mesh-list
2164699|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2164700|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164701|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164702|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
2164703|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164704|NCT00000196|Naltrexone|naltrexone|mesh-list
2164705|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2164706|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164707|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164708|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
2164709|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164710|NCT00000197|Propranolol|propranolol|mesh-list
2623114|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2623115|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2623116|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623117|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623118|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
2623119|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623120|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2623121|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2623122|NCT01894295|Vitamin D|vitamin d|mesh-list
2623123|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2623124|NCT01894295|Vitamins|vitamins|mesh-ancestor
2623125|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
2623126|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623127|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2623128|NCT01894308|Testosterone|testosterone|mesh-list
2623129|NCT01894308|Androgens|androgens|mesh-ancestor
2164711|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2164712|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2164713|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
2164714|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2164715|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164716|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164717|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2164718|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2164719|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
2164720|NCT00000198|Piracetam|piracetam|mesh-list
2164721|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2164722|NCT00000198|Protective Agents|protective agents|mesh-ancestor
2164723|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164724|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
2164725|NCT00000199|Piracetam|piracetam|mesh-list
2164726|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2164727|NCT00000199|Protective Agents|protective agents|mesh-ancestor
2164728|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164729|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
2164730|NCT00000200|Methadone|methadone|mesh-list
2164731|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164732|NCT00000200|Narcotics|narcotics|mesh-ancestor
2164733|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164734|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623130|NCT01894308|Hormones|hormones|mesh-ancestor
2623131|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623132|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623133|NCT01894334|Edaravone|edaravone|mesh-list
2623134|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
2623135|NCT01894334|Urinastatin|urinastatin|mesh-list
2623136|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2623137|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2623138|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623139|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
2623140|NCT01894334|Coagulants|coagulants|mesh-ancestor
2623141|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2623142|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
2623143|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2623144|NCT01894334|Protective Agents|protective agents|mesh-ancestor
2623145|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623146|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2623147|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2623148|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
2623149|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623150|NCT01894360|Belimumab|belimumab|mesh-list
2623151|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2164735|NCT00000200|Analgesics|analgesics|mesh-ancestor
2164736|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
2164737|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164738|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
2164739|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
2164740|NCT00000201|Selegiline|selegiline|mesh-list
2164741|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
2164742|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2164743|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2164744|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2164745|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2164746|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164747|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164748|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2164749|NCT00000201|Protective Agents|protective agents|mesh-ancestor
2164750|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164751|NCT00000202|Buprenorphine|buprenorphine|mesh-list
2623152|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
2623153|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623154|NCT01894412|Etanercept|etanercept|mesh-list
2623155|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2623156|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2623157|NCT01894412|Analgesics|analgesics|mesh-ancestor
2164752|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164753|NCT00000202|Narcotics|narcotics|mesh-ancestor
2164754|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164755|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164756|NCT00000202|Analgesics|analgesics|mesh-ancestor
2164757|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
2164758|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164759|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164760|NCT00000203|Buprenorphine|buprenorphine|mesh-list
2164761|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164762|NCT00000203|Narcotics|narcotics|mesh-ancestor
2164763|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164764|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164765|NCT00000203|Analgesics|analgesics|mesh-ancestor
2164766|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
2164767|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164768|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164769|NCT00000204|Buprenorphine|buprenorphine|mesh-list
2164770|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164771|NCT00000204|Narcotics|narcotics|mesh-ancestor
2164772|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623158|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
2623159|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623160|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623161|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2623162|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2623163|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2623164|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2623165|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
2164773|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164774|NCT00000204|Analgesics|analgesics|mesh-ancestor
2164775|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
2623166|NCT01894451|Bevacizumab|bevacizumab|mesh-list
2623167|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
2623168|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2623169|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623170|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2623171|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2623172|NCT01894451|Growth Substances|growth substances|mesh-ancestor
2623173|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623174|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
2623175|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2623176|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623177|NCT01894633|Chloroquine|chloroquine|mesh-list
2623178|NCT01894633|Amebicides|amebicides|mesh-ancestor
2623179|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2164776|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164777|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164778|NCT00000205|Buprenorphine|buprenorphine|mesh-list
2164779|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164780|NCT00000205|Narcotics|narcotics|mesh-ancestor
2164781|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623180|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2623181|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623182|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
2623183|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2623184|NCT01894685|Mesalamine|mesalamine|mesh-list
2623185|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2623186|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2623187|NCT01894685|Analgesics|analgesics|mesh-ancestor
2623188|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
2623189|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623190|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623191|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2623192|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2623193|NCT01894711|Trastuzumab|trastuzumab|mesh-list
2623194|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2623195|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623196|NCT01894789|Clopidogrel|clopidogrel|mesh-list
2623197|NCT01894789|Ticagrelor|ticagrelor|mesh-list
2623198|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2623199|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2623200|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2623201|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2623202|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
2623203|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623204|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623205|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623206|NCT01894815|Dexetimide|dexetimide|mesh-list
2623207|NCT01894815|Citalopram|citalopram|mesh-list
2623208|NCT01894815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2623209|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2623210|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2623211|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623212|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623213|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
2623214|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623215|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2623216|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
2623217|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2623218|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2623219|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2623220|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
2623221|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
2623222|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623223|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2623224|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2623225|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
2623226|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
2623227|NCT01894867|Antacids|antacids|mesh-ancestor
2623228|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623229|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2623230|NCT01895010|Tropisetron|tropisetron|mesh-list
2623231|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
2623232|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
2623233|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164782|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164783|NCT00000205|Analgesics|analgesics|mesh-ancestor
2164784|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
2164785|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164786|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164787|NCT00000206|Buprenorphine|buprenorphine|mesh-list
2164788|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164789|NCT00000206|Narcotics|narcotics|mesh-ancestor
2164790|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164791|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164792|NCT00000206|Analgesics|analgesics|mesh-ancestor
2164793|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
2164794|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164795|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164796|NCT00000207|Buprenorphine|buprenorphine|mesh-list
2164797|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164798|NCT00000207|Narcotics|narcotics|mesh-ancestor
2164799|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164800|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164801|NCT00000207|Analgesics|analgesics|mesh-ancestor
2164802|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
2164803|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164804|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164805|NCT00000208|Buprenorphine|buprenorphine|mesh-list
2164806|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164807|NCT00000208|Narcotics|narcotics|mesh-ancestor
2164808|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164809|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164810|NCT00000208|Analgesics|analgesics|mesh-ancestor
2164811|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
2164812|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164813|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164814|NCT00000209|Buprenorphine|buprenorphine|mesh-list
2164815|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164816|NCT00000209|Narcotics|narcotics|mesh-ancestor
2164817|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164818|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164819|NCT00000209|Analgesics|analgesics|mesh-ancestor
2164820|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
2164821|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164822|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164823|NCT00000210|Buprenorphine|buprenorphine|mesh-list
2164824|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164825|NCT00000210|Narcotics|narcotics|mesh-ancestor
2623234|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623235|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2623236|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2623237|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2623238|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
2623239|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623240|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623241|NCT01895023|Midazolam|midazolam|mesh-list
2623242|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
2623243|NCT01895023|GABA Modulators|gaba modulators|mesh-list
2623244|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2623245|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623246|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623247|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2623248|NCT01895023|Analgesics|analgesics|mesh-ancestor
2623249|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
2623250|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623251|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2623252|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2623253|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2623254|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
2623255|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623256|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623257|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2623258|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2623259|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2623260|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2623261|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2623262|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
2623263|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
2623264|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
2623265|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
2623266|NCT01895049|Prednisone|prednisone|mesh-list
2164826|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164827|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623267|NCT01895049|Everolimus|everolimus|mesh-list
2623268|NCT01895049|Tacrolimus|tacrolimus|mesh-list
2623269|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
2623270|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2623271|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2623272|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
2623273|NCT01895049|Hormones|hormones|mesh-ancestor
2623274|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623275|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623276|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2623277|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623278|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2623279|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
2623280|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2623281|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623282|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623283|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2623284|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2623285|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
2623286|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2623287|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623288|NCT01895075|Budesonide|budesonide|mesh-list
2623289|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2623290|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2623291|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
2164828|NCT00000210|Analgesics|analgesics|mesh-ancestor
2164829|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
2164830|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164831|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164832|NCT00000211|Buprenorphine|buprenorphine|mesh-list
2164833|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2623292|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623293|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623294|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2623295|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
2623296|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
2623297|NCT01895075|Hormones|hormones|mesh-ancestor
2623298|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623299|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2623300|NCT01895205|Hematinics|hematinics|mesh-ancestor
2623301|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2164834|NCT00000211|Narcotics|narcotics|mesh-ancestor
2164835|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164836|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164837|NCT00000211|Analgesics|analgesics|mesh-ancestor
2164838|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
2623302|NCT01895218|Hematinics|hematinics|mesh-ancestor
2623303|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2164839|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164840|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164841|NCT00000212|Desipramine|desipramine|mesh-list
2164842|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2164843|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
2164844|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2164845|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164846|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164847|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2164848|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2164849|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2164850|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
2164851|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2164852|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164853|NCT00000213|Fluoxetine|fluoxetine|mesh-list
2164854|NCT00000213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2164855|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2164856|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2623304|NCT01895231|Hematinics|hematinics|mesh-ancestor
2623305|NCT01895257|Leucovorin|leucovorin|mesh-list
2623306|NCT01895257|Fluorouracil|fluorouracil|mesh-list
2623307|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
2623308|NCT01895257|Antidotes|antidotes|mesh-ancestor
2623309|NCT01895257|Protective Agents|protective agents|mesh-ancestor
2623310|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623311|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
2623312|NCT01895257|Vitamins|vitamins|mesh-ancestor
2623313|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
2623314|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
2623315|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623316|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2623317|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623318|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2623319|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
2623320|NCT01895296|Pasireotide|pasireotide|mesh-list
2623321|NCT01895296|Hormones|hormones|mesh-ancestor
2623322|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623323|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623324|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
2623325|NCT01895348|Remifentanil|remifentanil|mesh-list
2623326|NCT01895348|Propofol|propofol|mesh-list
2623327|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2623328|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623329|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623330|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2623331|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
2623332|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
2623333|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2623334|NCT01895348|Analgesics|analgesics|mesh-ancestor
2623335|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
2623336|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623337|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2623338|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2623339|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2623340|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
2623341|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623342|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623343|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2623344|NCT01895348|Narcotics|narcotics|mesh-ancestor
2623345|NCT01895400|Cilostazol|cilostazol|mesh-list
2623346|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2623347|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
2623348|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623349|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623350|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2623351|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
2623352|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2623353|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2623354|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623355|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2623356|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
2623357|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2623358|NCT01895400|Protective Agents|protective agents|mesh-ancestor
2623359|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2623360|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2623361|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623362|NCT01895569|Metformin|metformin|mesh-list
2623363|NCT01895569|Pioglitazone|pioglitazone|mesh-list
2623364|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2164857|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164858|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2164859|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
2164860|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164861|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2164862|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
2164863|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2164864|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2164865|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2164866|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164867|NCT00000214|Buprenorphine|buprenorphine|mesh-list
2164868|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164869|NCT00000214|Narcotics|narcotics|mesh-ancestor
2164870|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164871|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164872|NCT00000214|Analgesics|analgesics|mesh-ancestor
2623365|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2623366|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623367|NCT01895569|Incretins|incretins|mesh-ancestor
2623368|NCT01895569|Hormones|hormones|mesh-ancestor
2623369|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623370|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2623371|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
2623372|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2164873|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
2164874|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164875|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164876|NCT00000215|Pergolide|pergolide|mesh-list
2164877|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
2164878|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
2164879|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2164880|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164881|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164882|NCT00000216|Buprenorphine|buprenorphine|mesh-list
2164883|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164884|NCT00000216|Narcotics|narcotics|mesh-ancestor
2164885|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164886|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164887|NCT00000216|Analgesics|analgesics|mesh-ancestor
2164888|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
2164889|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164890|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164891|NCT00000217|Carbamazepine|carbamazepine|mesh-list
2164892|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
2164893|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
2164894|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2164895|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164896|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164897|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2164898|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2164899|NCT00000217|Analgesics|analgesics|mesh-ancestor
2164900|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
2164901|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164902|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2164903|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2164904|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164905|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2164906|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2164907|NCT00000218|Carbamazepine|carbamazepine|mesh-list
2164908|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
2164909|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
2164910|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2164911|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164912|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164913|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2164914|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2164915|NCT00000218|Analgesics|analgesics|mesh-ancestor
2164916|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
2164917|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164918|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2623373|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623374|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
2623375|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
2623376|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623377|NCT01895621|Protective Agents|protective agents|mesh-ancestor
2623378|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623379|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
2623380|NCT01895621|Vitamins|vitamins|mesh-ancestor
2623381|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
2623382|NCT01895764|Adalimumab|adalimumab|mesh-list
2164919|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2164920|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2164921|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2164922|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2164923|NCT00000219|Buprenorphine|buprenorphine|mesh-list
2164924|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2623383|NCT01895764|Methotrexate|methotrexate|mesh-list
2623384|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2623385|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
2623386|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2623387|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623388|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2623389|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
2623390|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623391|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623392|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
2164925|NCT00000219|Narcotics|narcotics|mesh-ancestor
2164926|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2184865|NCT00002835|Cytarabine|cytarabine|mesh-list
2623393|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623394|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2623395|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2623396|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
2623397|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2623398|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2623399|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2623400|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2623401|NCT01895829|Hematinics|hematinics|mesh-ancestor
2623402|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2623403|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2623404|NCT01895881|Estradiol|estradiol|mesh-list
2623405|NCT01895881|Estrogens|estrogens|mesh-ancestor
2623406|NCT01895881|Hormones|hormones|mesh-ancestor
2623407|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623408|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623409|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
2623410|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2623411|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623412|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2623413|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
2623414|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2623415|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623416|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623417|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623418|NCT01895998|Albuterol|albuterol|mesh-list
2623419|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2623420|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
2623421|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623422|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623423|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2623424|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
2623425|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
2623426|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2623427|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2623428|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2623429|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2623430|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
2623431|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623432|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623433|NCT01896011|Teriparatide|teriparatide|mesh-list
2623434|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2623435|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623436|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2623437|NCT01896180|Latanoprost|latanoprost|mesh-list
2623438|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2623439|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2623440|NCT01896245|Sevoflurane|sevoflurane|mesh-list
2623441|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2623442|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2623443|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
2623444|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
2623445|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623446|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623447|NCT01896284|Aflibercept|aflibercept|mesh-list
2623448|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2623449|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2623450|NCT01896284|Growth Substances|growth substances|mesh-ancestor
2623451|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164927|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164928|NCT00000219|Analgesics|analgesics|mesh-ancestor
2623452|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
2623453|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623454|NCT01896323|Ketoconazole|ketoconazole|mesh-list
2623455|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
2623456|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623457|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2623458|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2623459|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623460|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623461|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2623462|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
2623463|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623464|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164929|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
2164930|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164931|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164932|NCT00000220|Buprenorphine|buprenorphine|mesh-list
2164933|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164934|NCT00000220|Narcotics|narcotics|mesh-ancestor
2164935|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164936|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164937|NCT00000220|Analgesics|analgesics|mesh-ancestor
2164938|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
2164939|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164940|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164941|NCT00000221|Buprenorphine|buprenorphine|mesh-list
2164942|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164943|NCT00000221|Narcotics|narcotics|mesh-ancestor
2164944|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164945|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164946|NCT00000221|Analgesics|analgesics|mesh-ancestor
2164947|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
2164948|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164949|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164950|NCT00000222|Buprenorphine|buprenorphine|mesh-list
2164951|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164952|NCT00000222|Narcotics|narcotics|mesh-ancestor
2623465|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2623466|NCT01896336|Zolpidem|zolpidem|mesh-list
2623467|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2623468|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2623469|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623470|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623471|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2623472|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
2623473|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
2623474|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623475|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623476|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2623477|NCT01896349|Amitriptyline|amitriptyline|mesh-list
2623478|NCT01896349|Risperidone|risperidone|mesh-list
2623479|NCT01896349|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2623480|NCT01896349|Sulpiride|sulpiride|mesh-list
2623481|NCT01896349|Mirtazapine|mirtazapine|mesh-list
2623482|NCT01896349|Trazodone|trazodone|mesh-list
2623483|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
2623484|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
2623485|NCT01896349|Citalopram|citalopram|mesh-list
2623486|NCT01896349|Bupropion|bupropion|mesh-list
2623487|NCT01896349|Sertraline|sertraline|mesh-list
2623488|NCT01896349|Fluoxetine|fluoxetine|mesh-list
2623489|NCT01896349|Paroxetine|paroxetine|mesh-list
2623490|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2623491|NCT01896349|Nortriptyline|nortriptyline|mesh-list
2623492|NCT01896349|Imipramine|imipramine|mesh-list
2623493|NCT01896349|Clomipramine|clomipramine|mesh-list
2623494|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
2623495|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2623496|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
2623497|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623498|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623499|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623500|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2623501|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2164953|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164954|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164955|NCT00000222|Analgesics|analgesics|mesh-ancestor
2164956|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
2164957|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164958|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164959|NCT00000223|Buprenorphine|buprenorphine|mesh-list
2164960|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164961|NCT00000223|Narcotics|narcotics|mesh-ancestor
2164962|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164963|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164964|NCT00000223|Analgesics|analgesics|mesh-ancestor
2164965|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
2164966|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164967|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2623502|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623503|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2623504|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2623505|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
2623506|NCT01896349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2623507|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2164968|NCT00000224|Buprenorphine|buprenorphine|mesh-list
2164969|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164970|NCT00000224|Narcotics|narcotics|mesh-ancestor
2164971|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164972|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164973|NCT00000224|Analgesics|analgesics|mesh-ancestor
2164974|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
2164975|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164976|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164977|NCT00000225|Buprenorphine|buprenorphine|mesh-list
2164978|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164979|NCT00000225|Narcotics|narcotics|mesh-ancestor
2164980|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164981|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164982|NCT00000225|Analgesics|analgesics|mesh-ancestor
2164983|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
2164984|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164985|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164986|NCT00000226|Buprenorphine|buprenorphine|mesh-list
2164987|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2623508|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2623509|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2623510|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623511|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2623512|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2623513|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2623514|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623515|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2623516|NCT01896349|Analgesics|analgesics|mesh-ancestor
2623517|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
2623518|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2623519|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
2623520|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
2623521|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2623522|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2623523|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2623524|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2623525|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
2623526|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2623527|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2623528|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2623529|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2623530|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2623531|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2623532|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2164988|NCT00000226|Narcotics|narcotics|mesh-ancestor
2164989|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164990|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2164991|NCT00000226|Analgesics|analgesics|mesh-ancestor
2623533|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2623534|NCT01896388|Ifenprodil|ifenprodil|mesh-list
2623535|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2623536|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2623537|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
2623538|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623539|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623540|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623541|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
2623542|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2164992|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
2164993|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2164994|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2164995|NCT00000227|Buprenorphine|buprenorphine|mesh-list
2164996|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2164997|NCT00000227|Narcotics|narcotics|mesh-ancestor
2623543|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2623544|NCT01896440|Ondansetron|ondansetron|mesh-list
2623545|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
2164998|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2164999|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165000|NCT00000227|Analgesics|analgesics|mesh-ancestor
2165001|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
2165002|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165003|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165004|NCT00000228|Buprenorphine|buprenorphine|mesh-list
2165005|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165006|NCT00000228|Narcotics|narcotics|mesh-ancestor
2165007|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165008|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165009|NCT00000228|Analgesics|analgesics|mesh-ancestor
2165010|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
2623546|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
2623547|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623548|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623549|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2623550|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
2623551|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
2623552|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2623553|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
2623554|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623555|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623556|NCT01896440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2623557|NCT01896440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2623558|NCT01896440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623559|NCT01896440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2623560|NCT01896440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2623561|NCT01896518|Nicotine|nicotine|mesh-list
2623562|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2623563|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
2623564|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623565|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623566|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2623567|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2623568|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
2623569|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623570|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623571|NCT01896531|Leucovorin|leucovorin|mesh-list
2623572|NCT01896531|Fluorouracil|fluorouracil|mesh-list
2623573|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
2623574|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
2623575|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623576|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2623577|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623578|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2623579|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
2623580|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623581|NCT01896531|Antidotes|antidotes|mesh-ancestor
2623582|NCT01896531|Protective Agents|protective agents|mesh-ancestor
2623583|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
2623584|NCT01896531|Vitamins|vitamins|mesh-ancestor
2623585|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
2165011|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165012|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165013|NCT00000229|Buprenorphine|buprenorphine|mesh-list
2165014|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165015|NCT00000229|Narcotics|narcotics|mesh-ancestor
2623586|NCT01896609|Interferons|interferons|mesh-list
2623587|NCT01896609|Ribavirin|ribavirin|mesh-list
2623588|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
2623589|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
2623590|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2623591|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
2623592|NCT01896609|Complement Factor H|complement factor h|mesh-list
2623593|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623594|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
2623595|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623596|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
2623597|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623598|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
2623599|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623600|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2623601|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2623602|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2165016|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623603|NCT01896622|Ritonavir|ritonavir|mesh-list
2623604|NCT01896622|Cobicistat|cobicistat|mesh-list
2623605|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2623606|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2165017|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165018|NCT00000229|Analgesics|analgesics|mesh-ancestor
2165019|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
2623607|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
2623608|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623609|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623610|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2623611|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2623612|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
2623613|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623614|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2623615|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2623616|NCT01896661|Amlodipine|amlodipine|mesh-list
2623617|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
2165020|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165021|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165022|NCT00000230|Buprenorphine|buprenorphine|mesh-list
2165023|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165024|NCT00000230|Narcotics|narcotics|mesh-ancestor
2165025|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165026|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623618|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
2623619|NCT01896661|Amiloride|amiloride|mesh-list
2623620|NCT01896661|Calcium|calcium|mesh-list
2623621|NCT01896661|Diuretics|diuretics|mesh-list
2623622|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2623623|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623624|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2165027|NCT00000230|Analgesics|analgesics|mesh-ancestor
2165028|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
2165029|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165030|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165031|NCT00000231|Buprenorphine|buprenorphine|mesh-list
2165032|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165033|NCT00000231|Narcotics|narcotics|mesh-ancestor
2165034|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165035|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165036|NCT00000231|Analgesics|analgesics|mesh-ancestor
2165037|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
2165038|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165039|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165040|NCT00000232|Buprenorphine|buprenorphine|mesh-list
2165041|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165042|NCT00000232|Narcotics|narcotics|mesh-ancestor
2165043|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165044|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165045|NCT00000232|Analgesics|analgesics|mesh-ancestor
2165046|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
2165047|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165048|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165049|NCT00000233|Buprenorphine|buprenorphine|mesh-list
2165050|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165051|NCT00000233|Narcotics|narcotics|mesh-ancestor
2165052|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165053|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165054|NCT00000233|Analgesics|analgesics|mesh-ancestor
2165055|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
2165056|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165057|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165058|NCT00000234|Buprenorphine|buprenorphine|mesh-list
2165059|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165060|NCT00000234|Narcotics|narcotics|mesh-ancestor
2165061|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165062|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165063|NCT00000234|Analgesics|analgesics|mesh-ancestor
2165064|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
2623625|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2623626|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623627|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
2623628|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
2623629|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2623630|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2623631|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2623632|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2165065|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165066|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2623633|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2623634|NCT01896739|Vaccines|vaccines|mesh-list
2623635|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
2623636|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623637|NCT01896960|Fentanyl|fentanyl|mesh-list
2623638|NCT01896960|Bupivacaine|bupivacaine|mesh-list
2623639|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
2623640|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
2623641|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623642|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623643|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
2623644|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165067|NCT00000235|Buprenorphine|buprenorphine|mesh-list
2165068|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165069|NCT00000235|Narcotics|narcotics|mesh-ancestor
2165070|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165071|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165072|NCT00000235|Analgesics|analgesics|mesh-ancestor
2165073|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
2165074|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165075|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165076|NCT00000236|Buprenorphine|buprenorphine|mesh-list
2165077|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2165078|NCT00000236|Naloxone|naloxone|mesh-list
2165079|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165080|NCT00000236|Narcotics|narcotics|mesh-ancestor
2165081|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165082|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165083|NCT00000236|Analgesics|analgesics|mesh-ancestor
2165084|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
2165085|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165086|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165087|NCT00000237|Buprenorphine|buprenorphine|mesh-list
2165088|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165089|NCT00000237|Narcotics|narcotics|mesh-ancestor
2165090|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165091|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165092|NCT00000237|Analgesics|analgesics|mesh-ancestor
2623645|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2623646|NCT01896960|Narcotics|narcotics|mesh-ancestor
2623647|NCT01896960|Analgesics|analgesics|mesh-ancestor
2623648|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2623649|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2623650|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
2623651|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2623652|NCT01897012|Romidepsin|romidepsin|mesh-list
2623653|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623654|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2623655|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2165093|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
2165094|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165095|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165096|NCT00000238|Buprenorphine|buprenorphine|mesh-list
2165097|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165098|NCT00000238|Narcotics|narcotics|mesh-ancestor
2165099|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165100|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165101|NCT00000238|Analgesics|analgesics|mesh-ancestor
2165102|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
2165103|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165104|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165105|NCT00000239|Buprenorphine|buprenorphine|mesh-list
2165106|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165107|NCT00000239|Narcotics|narcotics|mesh-ancestor
2165108|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165109|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623656|NCT01897038|Sorafenib|sorafenib|mesh-list
2623657|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623658|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2623659|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623660|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165110|NCT00000239|Analgesics|analgesics|mesh-ancestor
2165111|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
2165112|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165113|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165114|NCT00000240|Buprenorphine|buprenorphine|mesh-list
2165115|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2623661|NCT01897051|Rifaximin|rifaximin|mesh-list
2623662|NCT01897051|Propranolol|propranolol|mesh-list
2623663|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2623664|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2623665|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
2623666|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623667|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623668|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623669|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2623670|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2623671|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
2623672|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2623673|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623674|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2623675|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
2623676|NCT01897116|Vemurafenib|vemurafenib|mesh-list
2623677|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
2165116|NCT00000240|Narcotics|narcotics|mesh-ancestor
2165117|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165118|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623678|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2623679|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2623680|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623681|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623682|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623683|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2623684|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623685|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2623686|NCT01897324|Hormones|hormones|mesh-list
2623687|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623688|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623689|NCT01897337|Aprepitant|aprepitant|mesh-list
2623690|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
2623691|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
2623692|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623693|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623694|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2623695|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2623696|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623697|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623698|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
2623699|NCT01897428|Salicylates|salicylates|mesh-list
2623700|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2623701|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2623702|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2623703|NCT01897428|Analgesics|analgesics|mesh-ancestor
2623704|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
2623705|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623706|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623707|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2623708|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2623709|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2623710|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623711|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165119|NCT00000240|Analgesics|analgesics|mesh-ancestor
2165120|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
2165121|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165122|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165123|NCT00000241|Flupenthixol|flupenthixol|mesh-list
2165124|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
2165125|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2165126|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2165127|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165128|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165129|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165130|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2165131|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
2165132|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165133|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165134|NCT00000242|Carbamazepine|carbamazepine|mesh-list
2165135|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
2165136|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
2165137|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2165138|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165139|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623712|NCT01897441|Paclitaxel|paclitaxel|mesh-list
2165140|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165141|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165142|NCT00000242|Analgesics|analgesics|mesh-ancestor
2165143|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
2165144|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165145|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2165146|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165147|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165148|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2165149|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2165150|NCT00000243|Buprenorphine|buprenorphine|mesh-list
2623713|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
2623714|NCT01897441|Doxorubicin|doxorubicin|mesh-list
2623715|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2623716|NCT01897441|Trastuzumab|trastuzumab|mesh-list
2623717|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2623718|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2623719|NCT01897441|Antibodies|antibodies|mesh-list
2623720|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
2623721|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2623722|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2623723|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623724|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
2623725|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
2623726|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
2623727|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623728|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2623729|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
2623730|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623731|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2623732|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2623733|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
2623734|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2623735|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2623736|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2623737|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2623738|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623739|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
2623740|NCT01897454|Leucovorin|leucovorin|mesh-list
2623741|NCT01897454|Folic Acid|folic acid|mesh-list
2623742|NCT01897454|Gemcitabine|gemcitabine|mesh-list
2623743|NCT01897454|Fluorouracil|fluorouracil|mesh-list
2623744|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
2623745|NCT01897454|Irinotecan|irinotecan|mesh-list
2623746|NCT01897454|Camptothecin|camptothecin|mesh-list
2623747|NCT01897454|Calcium|calcium|mesh-list
2165151|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165152|NCT00000243|Narcotics|narcotics|mesh-ancestor
2165153|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165154|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165155|NCT00000243|Analgesics|analgesics|mesh-ancestor
2165156|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
2165157|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165158|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165159|NCT00000244|Dynorphins|dynorphins|mesh-list
2165160|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165161|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165162|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165163|NCT00000245|Desipramine|desipramine|mesh-list
2165164|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2165165|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
2165166|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165167|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2165168|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165169|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2165170|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165171|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165172|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
2165173|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165174|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165175|NCT00000246|Flumazenil|flumazenil|mesh-list
2165176|NCT00000246|Antidotes|antidotes|mesh-ancestor
2165177|NCT00000246|Protective Agents|protective agents|mesh-ancestor
2623748|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
2623749|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2623750|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
2623751|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623752|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623753|NCT01897454|Antiviral Agents|antiviral agents|mesh-ancestor
2623754|NCT01897454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623755|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623756|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2623757|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
2623758|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623759|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2623760|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2623761|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2623762|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2623763|NCT01897454|Antidotes|antidotes|mesh-ancestor
2623764|NCT01897454|Protective Agents|protective agents|mesh-ancestor
2623765|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
2623766|NCT01897454|Vitamins|vitamins|mesh-ancestor
2623767|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
2623768|NCT01897454|Hematinics|hematinics|mesh-ancestor
2623769|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2623770|NCT01897480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2623771|NCT01897480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623772|NCT01897480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2623773|NCT01897480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623774|NCT01897480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623775|NCT01897636|Vaccines|vaccines|mesh-list
2623776|NCT01897636|Immunologic Factors|immunologic factors|mesh-ancestor
2623777|NCT01897636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623778|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
2623779|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
2623780|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2623781|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2623782|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623783|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623784|NCT01897740|Urological Agents|urological agents|mesh-ancestor
2623785|NCT01897753|Hormones|hormones|mesh-list
2623786|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623787|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623788|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
2623789|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623790|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623791|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2623792|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623793|NCT01897844|Somatostatin|somatostatin|mesh-list
2623794|NCT01897844|Hormones|hormones|mesh-ancestor
2623795|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2623796|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623797|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
2623798|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2623799|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623800|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
2623801|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
2623802|NCT01898039|Vaccines|vaccines|mesh-list
2623803|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
2623804|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623805|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2623806|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2623807|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2623808|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
2623809|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623810|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623811|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2623812|NCT01898052|Anesthetics|anesthetics|mesh-list
2623813|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
2623814|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623815|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623816|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
2623817|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
2623818|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623819|NCT01898065|Misonidazole|misonidazole|mesh-list
2623820|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623821|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2623822|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2623823|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623824|NCT01898104|Capecitabine|capecitabine|mesh-list
2623825|NCT01898104|Valproic Acid|valproic acid|mesh-list
2623826|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2623827|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
2623828|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623829|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623830|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
2623831|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623832|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
2623833|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623834|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623835|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
2623836|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2623837|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623838|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2623839|NCT01898117|Paclitaxel|paclitaxel|mesh-list
2623840|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2623841|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
2623842|NCT01898117|Carboplatin|carboplatin|mesh-list
2623843|NCT01898117|Atezolizumab|atezolizumab|mesh-list
2623844|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2623845|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2623846|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623847|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
2623848|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
2623849|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
2623850|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623851|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2623852|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
2623853|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623854|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2623855|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2165178|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165179|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
2165180|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
2165181|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165182|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165183|NCT00000248|Pergolide|pergolide|mesh-list
2165184|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
2165185|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
2165186|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165187|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623856|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
2623857|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2623858|NCT01898169|Nicotine|nicotine|mesh-list
2623859|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2623860|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
2623861|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623862|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623863|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2623864|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2623865|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
2623866|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623867|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623868|NCT01898182|Kinetin|kinetin|mesh-list
2623869|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2623870|NCT01898182|Growth Substances|growth substances|mesh-ancestor
2623871|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623872|NCT01898221|Ethanol|ethanol|mesh-list
2623873|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2623874|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623875|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623876|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165188|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623893|NCT01898338|Daptomycin|daptomycin|mesh-list
2623894|NCT01898338|Fosfomycin|fosfomycin|mesh-list
2623895|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2623896|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623897|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
2623898|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
2623899|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2623900|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623901|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2623902|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
2623903|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2623904|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623905|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623906|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623907|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2623908|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2623909|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2623910|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
2623911|NCT01898494|Carboplatin|carboplatin|mesh-list
2623912|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623913|NCT01898507|Nicotine|nicotine|mesh-list
2623914|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2623915|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
2623916|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623917|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623918|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2623919|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2623920|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
2623921|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623922|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623923|NCT01898520|Nabiximols|nabiximols|mesh-list
2623924|NCT01898520|Analgesics|analgesics|mesh-ancestor
2623925|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
2623926|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623927|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623928|NCT01898585|Vemurafenib|vemurafenib|mesh-list
2623929|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2623930|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2623931|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623932|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623933|NCT01898624|Mirabegron|mirabegron|mesh-list
2623934|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2165189|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
2165190|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165191|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
2165192|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
2165193|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165194|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165195|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165196|NCT00000249|Analgesics|analgesics|mesh-ancestor
2165197|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
2165198|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165199|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
2165200|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165201|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
2165202|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
2165203|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165204|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623935|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2623936|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2623937|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
2623938|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2623939|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623940|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623941|NCT01898624|Urological Agents|urological agents|mesh-ancestor
2623942|NCT01898676|Valproic Acid|valproic acid|mesh-list
2623943|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
2623944|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2623945|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2623946|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
2623947|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165205|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2623948|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623949|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
2623950|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2623951|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623952|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2623953|NCT01898728|Iodine|iodine|mesh-list
2165206|NCT00000250|Analgesics|analgesics|mesh-ancestor
2165207|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
2165208|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165209|NCT00000251|Isoflurane|isoflurane|mesh-list
2165210|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165211|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
2165212|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
2165213|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165214|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165215|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
2165216|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165217|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
2623954|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
2623955|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
2623956|NCT01898728|Povidone|povidone|mesh-list
2623957|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2623958|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2623959|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2623960|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2623961|NCT01898728|Trace Elements|trace elements|mesh-ancestor
2623962|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
2623963|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623964|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
2623965|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
2623991|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
2623992|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2623993|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2623994|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2623995|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2623996|NCT01898819|Analgesics|analgesics|mesh-ancestor
2623997|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
2623998|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2623999|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2624000|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2624001|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2624002|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
2624003|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624004|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624005|NCT01898897|Anesthetics|anesthetics|mesh-list
2624006|NCT01898897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624007|NCT01898897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624008|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2624009|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2624010|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2624011|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
2624012|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624013|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2624014|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2624015|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624016|NCT01899066|Carboplatin|carboplatin|mesh-list
2624017|NCT01899066|Etoposide|etoposide|mesh-list
2624018|NCT01899066|Vincristine|vincristine|mesh-list
2624019|NCT01899066|Ranibizumab|ranibizumab|mesh-list
2624020|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624021|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2624022|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2624023|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2624024|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624025|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624026|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
2624027|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
2624028|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
2624029|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2624030|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2624031|NCT01899066|Growth Substances|growth substances|mesh-ancestor
2624032|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624033|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
2624034|NCT01899105|Ivacaftor|ivacaftor|mesh-list
2624035|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2624036|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2624037|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624038|NCT01899118|Capecitabine|capecitabine|mesh-list
2624039|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
2624040|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
2624041|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2624042|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
2624043|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624044|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624045|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2624046|NCT01899170|Carfentanil|carfentanil|mesh-list
2624047|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2624048|NCT01899170|Narcotics|narcotics|mesh-ancestor
2624049|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624050|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624051|NCT01899170|Analgesics|analgesics|mesh-ancestor
2624052|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
2624053|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624054|NCT01899248|Sevoflurane|sevoflurane|mesh-list
2624055|NCT01899248|Desflurane|desflurane|mesh-list
2624056|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2624057|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2624058|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
2624059|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
2624060|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624061|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624062|NCT01899326|Desipramine|desipramine|mesh-list
2624063|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624064|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2624065|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
2624066|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2624067|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624068|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624069|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2624070|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2624071|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2624072|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
2165218|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
2165219|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165220|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165221|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165222|NCT00000252|Analgesics|analgesics|mesh-ancestor
2165223|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
2165224|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165225|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
2165226|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165227|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
2165228|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
2165229|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165230|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624073|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624074|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2624075|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2165231|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165232|NCT00000253|Analgesics|analgesics|mesh-ancestor
2165233|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
2165234|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165235|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
2165236|NCT00000254|Isoflurane|isoflurane|mesh-list
2165237|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165238|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
2165239|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
2165240|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165241|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165242|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165243|NCT00000254|Analgesics|analgesics|mesh-ancestor
2165244|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
2165245|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165246|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
2165247|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165248|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
2165249|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
2165250|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165251|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165252|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165253|NCT00000255|Analgesics|analgesics|mesh-ancestor
2165254|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
2165255|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624076|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624077|NCT01899430|Metformin|metformin|mesh-list
2624078|NCT01899430|Liraglutide|liraglutide|mesh-list
2624079|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2624080|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624081|NCT01899430|Incretins|incretins|mesh-ancestor
2624082|NCT01899430|Hormones|hormones|mesh-ancestor
2624083|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2624084|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
2624085|NCT01899521|Astringents|astringents|mesh-ancestor
2624086|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624087|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
2624088|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2165256|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
2165257|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165258|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
2165259|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
2165260|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165261|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165262|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165263|NCT00000256|Analgesics|analgesics|mesh-ancestor
2165264|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
2165265|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165266|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
2165267|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165268|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
2165269|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
2165270|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624089|NCT01899690|Clindamycin|clindamycin|mesh-list
2624090|NCT01899690|Cephalexin|cephalexin|mesh-list
2624091|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624092|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2624093|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624094|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624095|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2624096|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2624097|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2624098|NCT01899755|Adalimumab|adalimumab|mesh-list
2624099|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2624100|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2624101|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2624102|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2624103|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624104|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
2624105|NCT01899794|Oxybutynin|oxybutynin|mesh-list
2624106|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
2624107|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
2624108|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624109|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165271|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165272|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2624110|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2624111|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2624112|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
2624113|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624114|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624115|NCT01899794|Urological Agents|urological agents|mesh-ancestor
2624116|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2624117|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624118|NCT01899794|Renal Agents|renal agents|mesh-ancestor
2624119|NCT01899820|Lumefantrine|lumefantrine|mesh-list
2624120|NCT01899820|Artemether|artemether|mesh-list
2624121|NCT01899820|Piperaquine|piperaquine|mesh-list
2624122|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2624123|NCT01899820|Artenimol|artenimol|mesh-list
2624124|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
2624125|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2624126|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2624127|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624128|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2624129|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2624130|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624131|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
2624132|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
2624133|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2624134|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
2624135|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2624136|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624137|NCT01899846|Progestins|progestins|mesh-ancestor
2624138|NCT01899846|Hormones|hormones|mesh-ancestor
2624139|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
2624145|NCT01900015|Efavirenz|efavirenz|mesh-list
2624146|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
2624147|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2624148|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2624149|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624150|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624151|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
2624152|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624153|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2624154|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2624155|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2624156|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2624157|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2624158|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2624159|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2624160|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2624161|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2624162|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2624163|NCT01900028|Itraconazole|itraconazole|mesh-list
2624164|NCT01900028|Olaparib|olaparib|mesh-list
2624165|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2624166|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2165273|NCT00000257|Analgesics|analgesics|mesh-ancestor
2165274|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
2165275|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624167|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624168|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624169|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
2624170|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624171|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2624172|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2624173|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2624174|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
2624175|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2165276|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
2165277|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165278|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
2624176|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624177|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2624178|NCT01900041|Minoxidil|minoxidil|mesh-list
2165279|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
2165280|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165281|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165282|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165283|NCT00000258|Analgesics|analgesics|mesh-ancestor
2165284|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
2165285|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165286|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
2165287|NCT00000259|Sevoflurane|sevoflurane|mesh-list
2165288|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2165289|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165290|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
2165291|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
2165292|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165293|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165294|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165295|NCT00000259|Analgesics|analgesics|mesh-ancestor
2165296|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
2165297|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165298|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
2165299|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165300|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
2165301|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
2165302|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165303|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165304|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165305|NCT00000260|Analgesics|analgesics|mesh-ancestor
2165306|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
2165307|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165308|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
2165309|NCT00000261|Sevoflurane|sevoflurane|mesh-list
2165310|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2165311|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165312|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
2165313|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
2165314|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165315|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165316|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165317|NCT00000261|Analgesics|analgesics|mesh-ancestor
2165318|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
2165319|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165320|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
2165321|NCT00000262|Sevoflurane|sevoflurane|mesh-list
2165322|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2165323|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165324|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
2165325|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
2165326|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165327|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165328|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165329|NCT00000262|Analgesics|analgesics|mesh-ancestor
2165330|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
2165331|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165332|NCT00000263|Ethanol|ethanol|mesh-list
2165333|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
2165334|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2165335|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2165336|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165337|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165338|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165339|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
2165340|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
2165341|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165342|NCT00000263|Analgesics|analgesics|mesh-ancestor
2165343|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
2165344|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165345|NCT00000264|Ethanol|ethanol|mesh-list
2165346|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
2165347|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2165348|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2165349|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165350|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165351|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2165352|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
2165353|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
2165354|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165355|NCT00000264|Analgesics|analgesics|mesh-ancestor
2165356|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
2165357|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165358|NCT00000266|Flupenthixol|flupenthixol|mesh-list
2165359|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
2165360|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2165361|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2165362|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165363|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165364|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165365|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2165366|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
2165367|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165368|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165369|NCT00000267|Risperidone|risperidone|mesh-list
2165370|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2165371|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
2165372|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165373|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165374|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165375|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2165376|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2165377|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165378|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165379|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2165380|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
2165381|NCT00000268|Bupropion|bupropion|mesh-list
2165382|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2165383|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
2165384|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165385|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2165386|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165387|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165388|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624179|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2624180|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
2624181|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2624182|NCT01900093|Hormones|hormones|mesh-ancestor
2624183|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2624184|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624185|NCT01900106|Ritonavir|ritonavir|mesh-list
2624186|NCT01900106|Darunavir|darunavir|mesh-list
2624187|NCT01900106|Lamivudine|lamivudine|mesh-list
2624188|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
2624189|NCT01900106|Abacavir|abacavir|mesh-list
2624190|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
2624191|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2624192|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2624193|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
2624194|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624195|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624196|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2624197|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2624198|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
2624199|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624200|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2624201|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2624202|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2624203|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2624204|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2624205|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2624206|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
2165389|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
2165390|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165391|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165392|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2165393|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2165394|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2165395|NCT00000269|Pergolide|pergolide|mesh-list
2165396|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
2165397|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
2165398|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165399|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165400|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624207|NCT01900158|Gemcitabine|gemcitabine|mesh-list
2624208|NCT01900158|Cisplatin|cisplatin|mesh-list
2624209|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624210|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2624211|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
2624212|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624213|NCT01900158|Antiviral Agents|antiviral agents|mesh-ancestor
2624214|NCT01900158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624215|NCT01900158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624216|NCT01900158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2165401|NCT00000270|Cocaine|cocaine|mesh-list
2165402|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
2165403|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
2165404|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165405|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165406|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
2165407|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165408|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2165409|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2165410|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165411|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165412|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165413|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
2165414|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165415|NCT00000271|Desipramine|desipramine|mesh-list
2165416|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2165417|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
2165418|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165419|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2165420|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165421|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2165422|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165423|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165424|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
2165425|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165426|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165427|NCT00000273|Fentanyl|fentanyl|mesh-list
2165428|NCT00000273|Morphine|morphine|mesh-list
2165429|NCT00000273|Oxycodone|oxycodone|mesh-list
2165430|NCT00000273|Buprenorphine|buprenorphine|mesh-list
2165431|NCT00000273|Methadone|methadone|mesh-list
2165432|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165433|NCT00000273|Narcotics|narcotics|mesh-ancestor
2624217|NCT01900158|Immunologic Factors|immunologic factors|mesh-ancestor
2624218|NCT01900158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165434|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165435|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165436|NCT00000273|Analgesics|analgesics|mesh-ancestor
2624219|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2624220|NCT01900197|Hematinics|hematinics|mesh-ancestor
2624221|NCT01900301|Scopolamine|scopolamine|mesh-list
2624222|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2624223|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2624224|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
2624225|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
2624226|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624227|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624228|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2624229|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
2624230|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2624231|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
2624232|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624233|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624234|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2624235|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
2624236|NCT01900327|Gemcitabine|gemcitabine|mesh-list
2624237|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2624238|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
2624239|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624240|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624241|NCT01900327|Antiviral Agents|antiviral agents|mesh-ancestor
2624242|NCT01900327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2165437|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
2165438|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165439|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2165440|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2624243|NCT01900327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624244|NCT01900327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2624245|NCT01900327|Immunologic Factors|immunologic factors|mesh-ancestor
2624246|NCT01900327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624247|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
2624248|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2624249|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624250|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624251|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2624252|NCT01900405|Analgesics|analgesics|mesh-ancestor
2624253|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
2624254|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624255|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2624256|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2165441|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
2165442|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
2165443|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165444|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
2165445|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
2165446|NCT00000274|Flupenthixol|flupenthixol|mesh-list
2165447|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
2165448|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2165449|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2165450|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165451|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165452|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165453|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2165454|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
2165455|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165456|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165457|NCT00000275|Flupenthixol|flupenthixol|mesh-list
2624257|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2624258|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
2624259|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624260|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624261|NCT01900496|Rituximab|rituximab|mesh-list
2624262|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2624263|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2624264|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624265|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
2624266|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624267|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2624268|NCT01900509|Dexamethasone|dexamethasone|mesh-list
2624269|NCT01900509|Etoposide|etoposide|mesh-list
2624270|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
2624271|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2624272|NCT01900509|Clofarabine|clofarabine|mesh-list
2624273|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2624274|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
2624275|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
2624276|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624277|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624278|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2624279|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
2624280|NCT01900509|Hormones|hormones|mesh-ancestor
2624281|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2624282|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2624283|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624284|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2624285|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2624286|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2624287|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624288|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624289|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2624290|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
2624291|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2624292|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
2624293|NCT01900587|Tapentadol|tapentadol|mesh-list
2624294|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2624295|NCT01900587|Narcotics|narcotics|mesh-ancestor
2624296|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624297|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624298|NCT01900587|Analgesics|analgesics|mesh-ancestor
2624299|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
2165458|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
2165459|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2165460|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2165461|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165462|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165463|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165464|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2165465|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
2165466|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165467|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165468|NCT00000276|Bupropion|bupropion|mesh-list
2165469|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2165470|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
2165471|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165472|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2165473|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165474|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165475|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165476|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
2165477|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165478|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165479|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2165480|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2165481|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2165482|NCT00000277|Mazindol|mazindol|mesh-list
2165483|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2165484|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165485|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2165486|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165487|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165488|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165489|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
2165490|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165491|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2165492|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
2165493|NCT00000278|Disulfiram|disulfiram|mesh-list
2165494|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2165495|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2165496|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2165497|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165498|NCT00000279|Clonidine|clonidine|mesh-list
2165499|NCT00000279|Analgesics|analgesics|mesh-ancestor
2165500|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
2165501|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165502|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165503|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2165504|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
2165505|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
2165506|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2165507|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2165508|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2165509|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
2165510|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165511|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165512|NCT00000280|Nimodipine|nimodipine|mesh-list
2165513|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2165514|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2165515|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165516|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165517|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2165518|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165519|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
2165520|NCT00000281|Amantadine|amantadine|mesh-list
2165521|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2165522|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2165523|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
2165524|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2165525|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
2165526|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165527|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165528|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165529|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165530|NCT00000281|Analgesics|analgesics|mesh-ancestor
2165531|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
2165532|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165533|NCT00000282|Pemoline|pemoline|mesh-list
2165534|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2165535|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165536|NCT00000285|Phenytoin|phenytoin|mesh-list
2165537|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
2165538|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2165539|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2624300|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624301|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2624302|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2624303|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2624304|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624305|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
2624306|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624307|NCT01900639|Aspirin|aspirin|mesh-list
2165540|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165541|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165542|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2165543|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2165544|NCT00000286|Nefazodone|nefazodone|mesh-list
2165545|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2165546|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165547|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165548|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165549|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165550|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165551|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2165552|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
2165553|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165554|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2165555|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2165556|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
2165557|NCT00000289|Ondansetron|ondansetron|mesh-list
2165558|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
2165559|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
2165560|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165561|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165562|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2165563|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
2165564|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
2624308|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2624309|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2624310|NCT01900639|Analgesics|analgesics|mesh-ancestor
2624311|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
2624312|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624313|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624314|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2624315|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2624316|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2624317|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2624318|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624319|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2624320|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2624321|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624322|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
2624323|NCT01900717|Leucovorin|leucovorin|mesh-list
2624324|NCT01900717|Bevacizumab|bevacizumab|mesh-list
2624325|NCT01900717|Fluorouracil|fluorouracil|mesh-list
2624326|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
2624327|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2624328|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624329|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2624330|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2624331|NCT01900717|Growth Substances|growth substances|mesh-ancestor
2624332|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624333|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
2624334|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
2165565|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2165566|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
2165567|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624335|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624336|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2624337|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2624338|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
2624339|NCT01900717|Antidotes|antidotes|mesh-ancestor
2624340|NCT01900717|Protective Agents|protective agents|mesh-ancestor
2624341|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
2165568|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165569|NCT00000289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2165570|NCT00000289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2624342|NCT01900717|Vitamins|vitamins|mesh-ancestor
2624343|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
2624344|NCT01900795|Ibuprofen|ibuprofen|mesh-list
2624345|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2624346|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2624347|NCT01900795|Analgesics|analgesics|mesh-ancestor
2624348|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
2624349|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624350|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624351|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2624352|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2624353|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2624354|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624355|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624356|NCT01900847|Morphine|morphine|mesh-list
2624357|NCT01900847|Ketamine|ketamine|mesh-list
2624358|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2624359|NCT01900847|Narcotics|narcotics|mesh-ancestor
2624360|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624361|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624362|NCT01900847|Analgesics|analgesics|mesh-ancestor
2624363|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
2624364|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165571|NCT00000289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165572|NCT00000289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165573|NCT00000289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2165574|NCT00000290|Cocaine|cocaine|mesh-list
2165575|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
2165576|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
2624365|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2624366|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2624367|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
2624368|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
2624369|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2624370|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2624371|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624372|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624373|NCT01900860|Vitamin D|vitamin d|mesh-list
2624374|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
2624375|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
2624376|NCT01900860|Vitamins|vitamins|mesh-list
2624377|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
2624378|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624379|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2624380|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2624381|NCT01900886|Ribavirin|ribavirin|mesh-list
2624382|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2624383|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
2165577|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165578|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165579|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
2165580|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165581|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2165582|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2165583|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165584|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2184866|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
2624384|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624385|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
2624386|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624387|NCT01900938|Midazolam|midazolam|mesh-list
2624388|NCT01900938|Propofol|propofol|mesh-list
2624389|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2624390|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624391|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624392|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2624393|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
2624394|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
2624395|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2624396|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2624397|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2624398|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2624399|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
2624400|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
2624401|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624402|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624403|NCT01900951|Temozolomide|temozolomide|mesh-list
2624404|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2624405|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
2624406|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624407|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624408|NCT01901003|Lorazepam|lorazepam|mesh-list
2624409|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
2422032|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2422033|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422034|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
2422035|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422036|NCT00815542|Dinoprostone|dinoprostone|mesh-list
2422037|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
2422038|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2422039|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422040|NCT00815568|Vidarabine|vidarabine|mesh-list
2422041|NCT00815568|Fludarabine|fludarabine|mesh-list
2624410|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
2624411|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
2624412|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624413|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624414|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2624415|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2624416|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624417|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2165585|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165586|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
2165587|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165588|NCT00000291|Labetalol|labetalol|mesh-list
2165589|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2165590|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2165591|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
2165592|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165593|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165594|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165595|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2165596|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
2165597|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
2624418|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2624419|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2624420|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
2624421|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
2624422|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624423|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624424|NCT01901120|Mirabegron|mirabegron|mesh-list
2624425|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2624426|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2624427|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2624428|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
2624429|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624430|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624431|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624432|NCT01901120|Urological Agents|urological agents|mesh-ancestor
2624433|NCT01901172|Posaconazole|posaconazole|mesh-list
2624434|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
2165598|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165599|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2165600|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2165601|NCT00000292|Cocaine|cocaine|mesh-list
2165602|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
2165603|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
2165604|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165605|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624435|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624436|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2624437|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2624438|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2624439|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2624440|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2624441|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624442|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624443|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2624444|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
2624445|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2624446|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165606|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
2165607|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165608|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2165609|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2165610|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165611|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165612|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165613|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
2165614|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165615|NCT00000293|Nefazodone|nefazodone|mesh-list
2165616|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2165617|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165618|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165619|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165620|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165621|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165622|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2165623|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
2165624|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2624447|NCT01901198|Interferons|interferons|mesh-list
2624448|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
2624449|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
2624450|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624451|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
2624452|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624453|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
2624454|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624455|NCT01901276|Omeprazole|omeprazole|mesh-list
2624456|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2624457|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2624458|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2624459|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624460|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624461|NCT01901380|Caseins|caseins|mesh-list
2624462|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
2624463|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
2624464|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624465|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
2624466|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2624467|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624468|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624469|NCT01901471|Cyclosporine|cyclosporine|mesh-list
2624470|NCT01901471|Cyclosporins|cyclosporins|mesh-list
2624471|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624472|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624473|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2624474|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
2624475|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624476|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
2165625|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2165626|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2165627|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
2165628|NCT00000294|Carvedilol|carvedilol|mesh-list
2165629|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2624477|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624478|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
2624479|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2624480|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2624481|NCT01901484|Praziquantel|praziquantel|mesh-list
2624482|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
2624483|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2624484|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624485|NCT01901549|Metoprolol|metoprolol|mesh-list
2624486|NCT01901549|Lisinopril|lisinopril|mesh-list
2624487|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2165630|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2165631|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
2165632|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165633|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165634|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165635|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2165636|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
2165637|NCT00000294|Protective Agents|protective agents|mesh-ancestor
2165638|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2184867|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
2624488|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2624489|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
2624490|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
2624491|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624492|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624493|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2624494|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2624495|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2624496|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
2624497|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624498|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624499|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2624500|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
2624501|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624502|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2624503|NCT01901549|Protective Agents|protective agents|mesh-ancestor
2624504|NCT01901601|Anesthetics|anesthetics|mesh-list
2624505|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624506|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624507|NCT01901640|Udenafil|udenafil|mesh-list
2624508|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2624509|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2624510|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624511|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624512|NCT01901666|Hormones|hormones|mesh-list
2624513|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2624514|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624515|NCT01901692|Sorafenib|sorafenib|mesh-list
2624516|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624517|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2624518|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624519|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624520|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2624521|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2624522|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624523|NCT01901861|Incretins|incretins|mesh-ancestor
2624524|NCT01901861|Hormones|hormones|mesh-ancestor
2624525|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2624526|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2624527|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
2624528|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624529|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624530|NCT01902017|Ketotifen|ketotifen|mesh-list
2624531|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
2624532|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
2624533|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2624534|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
2624535|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
2624536|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624537|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624538|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624539|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2624540|NCT01902108|Clonidine|clonidine|mesh-list
2624541|NCT01902108|Bupivacaine|bupivacaine|mesh-list
2624542|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
2624543|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
2624544|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624545|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624546|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
2624547|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624548|NCT01902108|Analgesics|analgesics|mesh-ancestor
2624549|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2624550|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
2624551|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
2624552|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2624553|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2624554|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2624555|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
2624556|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624557|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165639|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165640|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2165641|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
2165642|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2165643|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2165644|NCT00000295|Progesterone|progesterone|mesh-list
2165645|NCT00000295|Progestins|progestins|mesh-ancestor
2165646|NCT00000295|Hormones|hormones|mesh-ancestor
2165647|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2165648|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165649|NCT00000297|Labetalol|labetalol|mesh-list
2165650|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2165651|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2165652|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
2165653|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165654|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165655|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165656|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2165657|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
2165658|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
2165659|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165660|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2165661|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2165662|NCT00000298|Buprenorphine|buprenorphine|mesh-list
2165663|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2624558|NCT01902121|Insulin|insulin|mesh-list
2624559|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2624560|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2624561|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624562|NCT01902160|Sirolimus|sirolimus|mesh-list
2624563|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2624564|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2624565|NCT01902160|Antibodies|antibodies|mesh-list
2624566|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
2165664|NCT00000298|Naloxone|naloxone|mesh-list
2165665|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165666|NCT00000298|Narcotics|narcotics|mesh-ancestor
2165667|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165668|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165669|NCT00000298|Analgesics|analgesics|mesh-ancestor
2165670|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
2165671|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165672|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165673|NCT00000299|Buprenorphine|buprenorphine|mesh-list
2165674|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165675|NCT00000299|Narcotics|narcotics|mesh-ancestor
2165676|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165677|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165678|NCT00000299|Analgesics|analgesics|mesh-ancestor
2165679|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
2165680|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165681|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165682|NCT00000301|Amantadine|amantadine|mesh-list
2165683|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2165684|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2165685|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
2165686|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2165687|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
2165688|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165689|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165690|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165691|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2165692|NCT00000301|Analgesics|analgesics|mesh-ancestor
2165693|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
2165694|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165695|NCT00000302|Buprenorphine|buprenorphine|mesh-list
2165696|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2624567|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2624568|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
2624569|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
2624570|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624571|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624572|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2624573|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624574|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2624575|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
2624576|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2624577|NCT01902186|Ritonavir|ritonavir|mesh-list
2624578|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2624579|NCT01902186|Tenofovir|tenofovir|mesh-list
2624580|NCT01902186|Emtricitabine|emtricitabine|mesh-list
2624581|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
2624582|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2624583|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2624584|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
2624585|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624586|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624587|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2624588|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2624589|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
2624590|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624591|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2624592|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2624593|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2624594|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2624595|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2624596|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2624597|NCT01902225|Doxorubicin|doxorubicin|mesh-list
2624598|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2624599|NCT01902225|Romidepsin|romidepsin|mesh-list
2624600|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2624601|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624602|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2624603|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2624604|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2165697|NCT00000302|Narcotics|narcotics|mesh-ancestor
2165698|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165699|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165700|NCT00000302|Analgesics|analgesics|mesh-ancestor
2165701|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
2165702|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165703|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165704|NCT00000303|Baclofen|baclofen|mesh-list
2165705|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2165706|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165707|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2165708|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165709|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2165710|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
2165711|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
2165712|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165713|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165714|NCT00000304|Amphetamine|amphetamine|mesh-list
2165715|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
2165716|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2165717|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165718|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
2624605|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624606|NCT01902238|Ethanol|ethanol|mesh-list
2624607|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
2624608|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2624609|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624610|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624611|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624612|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624615|NCT01902342|Oseltamivir|oseltamivir|mesh-list
2624616|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
2624617|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624618|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2165719|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
2624619|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624620|NCT01902381|Thioctic Acid|thioctic acid|mesh-list
2165720|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165721|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
2165722|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165723|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165724|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
2165725|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2165726|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2624621|NCT01902381|Antioxidants|antioxidants|mesh-ancestor
2624622|NCT01902381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624623|NCT01902381|Protective Agents|protective agents|mesh-ancestor
2624624|NCT01902381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624625|NCT01902381|Vitamin B Complex|vitamin b complex|mesh-ancestor
2624626|NCT01902381|Vitamins|vitamins|mesh-ancestor
2624627|NCT01902381|Micronutrients|micronutrients|mesh-ancestor
2624628|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
2624629|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2624630|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2624631|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624632|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
2624633|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
2624634|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
2624635|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2624636|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624637|NCT01902498|Aspirin|aspirin|mesh-list
2624638|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2624639|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2624640|NCT01902498|Analgesics|analgesics|mesh-ancestor
2624641|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
2165727|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165728|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2165729|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
2165730|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2165731|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165732|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2165733|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165734|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165735|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165736|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
2165737|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165738|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
2165739|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2165740|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624642|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624643|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624644|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2624645|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2624646|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2624647|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2165741|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2165742|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165743|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165744|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624648|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624649|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2624650|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2624651|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624652|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
2624653|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
2165745|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
2165746|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624654|NCT01902511|Lenograstim|lenograstim|mesh-list
2624655|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2624656|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
2624657|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624658|NCT01902511|Hematinics|hematinics|mesh-ancestor
2624659|NCT01902524|Fentanyl|fentanyl|mesh-list
2624660|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2624661|NCT01902524|Narcotics|narcotics|mesh-ancestor
2624662|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624663|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165747|NCT00000307|Naltrexone|naltrexone|mesh-list
2165748|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2624664|NCT01902524|Analgesics|analgesics|mesh-ancestor
2624665|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
2624666|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624667|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2624668|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2624669|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
2624670|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
2624671|NCT01902537|Prucalopride|prucalopride|mesh-list
2624672|NCT01902537|Laxatives|laxatives|mesh-ancestor
2624673|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2624674|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2624675|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2624676|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
2165749|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165750|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165751|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
2165752|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165753|NCT00000308|Amphetamine|amphetamine|mesh-list
2165754|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
2165755|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2165756|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165757|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
2165758|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
2165759|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165760|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
2165761|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165762|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624677|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624678|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165763|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
2165764|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2165765|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165766|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165767|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2165768|NCT00000309|Risperidone|risperidone|mesh-list
2165769|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2165770|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
2165771|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165772|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624679|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624680|NCT01902550|Metoprolol|metoprolol|mesh-list
2624681|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2624682|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2624683|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
2624684|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
2624685|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624686|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624687|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2624688|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2624689|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2624690|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
2624691|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624692|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624693|NCT01902641|Rocuronium|rocuronium|mesh-list
2624694|NCT01902641|Succinylcholine|succinylcholine|mesh-list
2624695|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2624696|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2624697|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2624698|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624699|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624700|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2624701|NCT01902771|Imiquimod|imiquimod|mesh-list
2624702|NCT01902771|Vaccines|vaccines|mesh-list
2624703|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
2624704|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624705|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2624706|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624707|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
2624708|NCT01902810|Propranolol|propranolol|mesh-list
2624709|NCT01902810|Metoprolol|metoprolol|mesh-list
2624710|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2624711|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2624712|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
2624713|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624714|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165773|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165774|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2165775|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2165776|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165777|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165778|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2165779|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
2165780|NCT00000310|Risperidone|risperidone|mesh-list
2165781|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2165782|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
2165783|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165784|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165785|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165786|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2165787|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2165788|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165789|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165790|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2165791|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
2165792|NCT00000311|Buprenorphine|buprenorphine|mesh-list
2165793|NCT00000311|Methadone|methadone|mesh-list
2165794|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165795|NCT00000311|Narcotics|narcotics|mesh-ancestor
2165796|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165797|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165798|NCT00000311|Analgesics|analgesics|mesh-ancestor
2165799|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
2165800|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165801|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165802|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
2165803|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
2165804|NCT00000313|Fenfluramine|fenfluramine|mesh-list
2165805|NCT00000313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2165806|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2624715|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624716|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2624717|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2624718|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
2624719|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
2624720|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
2624721|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624722|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2624723|NCT01902862|Rituximab|rituximab|mesh-list
2624724|NCT01902862|Bortezomib|bortezomib|mesh-list
2624725|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2624726|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624727|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
2624728|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624729|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2624730|NCT01902875|Paclitaxel|paclitaxel|mesh-list
2624731|NCT01902875|Cisplatin|cisplatin|mesh-list
2624732|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2624733|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624734|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
2624735|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
2624736|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
2624737|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624738|NCT01903018|Cisplatin|cisplatin|mesh-list
2624739|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624740|NCT01903057|Azithromycin|azithromycin|mesh-list
2624741|NCT01903057|Ivermectin|ivermectin|mesh-list
2624742|NCT01903057|Albendazole|albendazole|mesh-list
2624743|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2624744|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624745|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2624746|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
2624747|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
2624748|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2624749|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2165807|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422042|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
2422043|NCT00815568|Busulfan|busulfan|mesh-list
2422044|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422045|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2422046|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
2422047|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422048|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2165808|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165809|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165810|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
2165811|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165812|NCT00000315|Cocaine|cocaine|mesh-list
2165813|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
2165814|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
2165815|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165816|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165817|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
2165818|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165819|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2165820|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2165821|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165822|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165823|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165824|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
2165825|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624750|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
2624751|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
2624752|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
2624753|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624754|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624755|NCT01903070|Linagliptin|linagliptin|mesh-list
2624756|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2624757|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624758|NCT01903070|Incretins|incretins|mesh-ancestor
2624759|NCT01903070|Hormones|hormones|mesh-ancestor
2624760|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2624761|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2624762|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
2624763|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624764|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624765|NCT01903083|Gemcitabine|gemcitabine|mesh-list
2624766|NCT01903083|Tadalafil|tadalafil|mesh-list
2624767|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2624768|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
2624769|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624770|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624771|NCT01903083|Antiviral Agents|antiviral agents|mesh-ancestor
2624772|NCT01903083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624773|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624774|NCT01903083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2624775|NCT01903083|Immunologic Factors|immunologic factors|mesh-ancestor
2624776|NCT01903083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624777|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
2624778|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2624779|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2165826|NCT00000316|Cocaine|cocaine|mesh-list
2165827|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
2165828|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
2165829|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165830|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165831|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
2165832|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165833|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2165834|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2165835|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165836|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165837|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165838|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
2165839|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165840|NCT00000317|Risperidone|risperidone|mesh-list
2165841|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2165842|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
2165843|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165844|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165845|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165846|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2624780|NCT01903083|Urological Agents|urological agents|mesh-ancestor
2624781|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
2624782|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2624783|NCT01903109|Cevimeline|cevimeline|mesh-list
2624784|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2624785|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
2624786|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624787|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624788|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2624789|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2624790|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
2165847|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2165848|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165849|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165850|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2624791|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624792|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624793|NCT01903122|Cevimeline|cevimeline|mesh-list
2624794|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2624795|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
2624796|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624797|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624798|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2624799|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2624800|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
2165851|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
2165852|NCT00000318|Buprenorphine|buprenorphine|mesh-list
2624801|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624802|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624803|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2624804|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
2624805|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2624806|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2624807|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2624808|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624809|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624810|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2624811|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
2624812|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624813|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2624814|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
2624815|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2624816|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
2624817|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624818|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
2624819|NCT01903330|Bevacizumab|bevacizumab|mesh-list
2624820|NCT01903330|Sargramostim|sargramostim|mesh-list
2624821|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2624822|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
2624823|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624824|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2624825|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2624826|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
2624827|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624828|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624829|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2624830|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2624831|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2624832|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2624833|NCT01903330|Growth Substances|growth substances|mesh-ancestor
2624834|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
2624835|NCT01903421|Fentanyl|fentanyl|mesh-list
2624836|NCT01903421|Bupivacaine|bupivacaine|mesh-list
2165853|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165854|NCT00000318|Narcotics|narcotics|mesh-ancestor
2165855|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165856|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165857|NCT00000318|Analgesics|analgesics|mesh-ancestor
2165858|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
2165859|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165860|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165861|NCT00000319|Buprenorphine|buprenorphine|mesh-list
2624837|NCT01903421|Anesthetics|anesthetics|mesh-list
2624838|NCT01903421|Propofol|propofol|mesh-list
2624839|NCT01903421|Sevoflurane|sevoflurane|mesh-list
2624840|NCT01903421|Isoflurane|isoflurane|mesh-list
2624841|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
2624842|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624843|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624844|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
2624845|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624846|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2624847|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2624848|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
2624849|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2624850|NCT01903421|Narcotics|narcotics|mesh-ancestor
2624851|NCT01903421|Analgesics|analgesics|mesh-ancestor
2165862|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165863|NCT00000319|Narcotics|narcotics|mesh-ancestor
2165864|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165865|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165866|NCT00000319|Analgesics|analgesics|mesh-ancestor
2165867|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
2624852|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2624853|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2624854|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2624855|NCT01903473|Sirolimus|sirolimus|mesh-list
2624856|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2624857|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624858|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2624859|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624860|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
2624861|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2624862|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
2624863|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624864|NCT01903681|Melatonin|melatonin|mesh-list
2624865|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
2624866|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624867|NCT01903681|Protective Agents|protective agents|mesh-ancestor
2624868|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624869|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624870|NCT01903694|Sorafenib|sorafenib|mesh-list
2624871|NCT01903694|Pravastatin|pravastatin|mesh-list
2165868|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165869|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165870|NCT00000320|Buprenorphine|buprenorphine|mesh-list
2165871|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165872|NCT00000320|Narcotics|narcotics|mesh-ancestor
2165873|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165874|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165875|NCT00000320|Analgesics|analgesics|mesh-ancestor
2165876|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
2165877|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165878|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165879|NCT00000321|Desipramine|desipramine|mesh-list
2165880|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2624872|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624873|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2624874|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624875|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624876|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2624877|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2624878|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
2624879|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2624880|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2624881|NCT01903785|Albuterol|albuterol|mesh-list
2624882|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2624883|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
2624884|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624885|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165881|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
2165882|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165883|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2165884|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165885|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2165886|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2624886|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2624887|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
2624888|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
2624889|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2624890|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2624891|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2624892|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2624893|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
2624894|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624895|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624896|NCT01903824|Modafinil|modafinil|mesh-list
2624897|NCT01903824|Donepezil|donepezil|mesh-list
2624898|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2624899|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624900|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624901|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
2624902|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2624903|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624904|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
2624905|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2624906|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2165887|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165888|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
2165889|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165890|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165891|NCT00000324|Tryptophan|tryptophan|mesh-list
2165892|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2165893|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
2165894|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165895|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2165896|NCT00000325|Hormones|hormones|mesh-ancestor
2165897|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2165898|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165899|NCT00000326|Heroin|heroin|mesh-list
2165900|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165901|NCT00000326|Narcotics|narcotics|mesh-ancestor
2165902|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165903|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165904|NCT00000326|Analgesics|analgesics|mesh-ancestor
2624907|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2624908|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2624909|NCT01903954|Ribavirin|ribavirin|mesh-list
2165905|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
2165906|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165907|NCT00000327|Heroin|heroin|mesh-list
2165908|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165909|NCT00000327|Narcotics|narcotics|mesh-ancestor
2165910|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165911|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165912|NCT00000327|Analgesics|analgesics|mesh-ancestor
2165913|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
2165914|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165915|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
2165916|NCT00000328|Narcotics|narcotics|mesh-ancestor
2165917|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165918|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165919|NCT00000328|Analgesics|analgesics|mesh-ancestor
2165920|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
2165921|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165922|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
2165923|NCT00000329|Narcotics|narcotics|mesh-ancestor
2165924|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165925|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165926|NCT00000329|Analgesics|analgesics|mesh-ancestor
2165927|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
2165928|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422049|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
2422050|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422051|NCT00815568|Antiviral Agents|antiviral agents|mesh-ancestor
2422052|NCT00815568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624910|NCT01903954|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2165929|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
2165930|NCT00000330|Narcotics|narcotics|mesh-ancestor
2165931|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165932|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422053|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
2422054|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2422055|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2422056|NCT00815594|Bevacizumab|bevacizumab|mesh-list
2422057|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2422058|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422059|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2422060|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2422061|NCT00815594|Growth Substances|growth substances|mesh-ancestor
2422062|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624911|NCT01903954|Antimetabolites|antimetabolites|mesh-ancestor
2624912|NCT01903954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624913|NCT01903954|Antiviral Agents|antiviral agents|mesh-ancestor
2624914|NCT01903954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624915|NCT01904032|Vitamin D|vitamin d|mesh-list
2624916|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
2624917|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
2624918|NCT01904032|Vitamins|vitamins|mesh-list
2624919|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
2624920|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624921|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2624922|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2624923|NCT01904045|Tacrolimus|tacrolimus|mesh-list
2624924|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2624925|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
2624926|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624927|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2624928|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624929|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624930|NCT01904097|Pregabalin|pregabalin|mesh-list
2624931|NCT01904097|Analgesics|analgesics|mesh-ancestor
2624932|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
2624933|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2624934|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624935|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
2624936|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2624937|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2624938|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624939|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2624940|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2624941|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2624942|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2624943|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2624944|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
2624945|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
2624946|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
2624947|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2624948|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165933|NCT00000330|Analgesics|analgesics|mesh-ancestor
2165934|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
2165935|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165936|NCT00000332|Nimodipine|nimodipine|mesh-list
2165937|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2165938|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2165939|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165940|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165941|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2165942|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165943|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
2165944|NCT00000333|Benztropine|benztropine|mesh-list
2165945|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2165946|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2165947|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
2165948|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
2165949|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165950|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165951|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2165952|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2165953|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
2165954|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2165955|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165956|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2624949|NCT01904110|Vitamins|vitamins|mesh-ancestor
2624950|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
2624951|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2624952|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2165957|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2165958|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2165959|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
2165960|NCT00000334|Buprenorphine|buprenorphine|mesh-list
2165961|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165962|NCT00000334|Narcotics|narcotics|mesh-ancestor
2165963|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165964|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624953|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2624954|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624955|NCT01904123|Tyrphostins|tyrphostins|mesh-list
2624956|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624957|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624958|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624959|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
2624960|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
2624961|NCT01904136|Melphalan|melphalan|mesh-list
2624962|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
2624963|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2624964|NCT01904136|Fludarabine|fludarabine|mesh-list
2624965|NCT01904136|Tacrolimus|tacrolimus|mesh-list
2624966|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2624967|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
2624968|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624969|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2624970|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2624971|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
2624972|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165965|NCT00000334|Analgesics|analgesics|mesh-ancestor
2165966|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
2165967|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165968|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2165969|NCT00000335|Morphine|morphine|mesh-list
2165970|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2165971|NCT00000335|Narcotics|narcotics|mesh-ancestor
2165972|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2165973|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165974|NCT00000335|Analgesics|analgesics|mesh-ancestor
2165975|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
2624973|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624974|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2165976|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2165977|NCT00000336|Selegiline|selegiline|mesh-list
2165978|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
2165979|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165980|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2165981|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2165982|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2165983|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2165984|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165985|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2624975|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2624976|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624977|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2624978|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2624979|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
2624980|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2624981|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624982|NCT01904162|Finafloxacin|finafloxacin|mesh-list
2624983|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2624984|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2624985|NCT01904162|Renal Agents|renal agents|mesh-ancestor
2624986|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2624987|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2624988|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2624989|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2624990|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624991|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2624992|NCT01904214|Siponimod|siponimod|mesh-list
2624993|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2624994|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2624995|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2624996|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
2624997|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2624998|NCT01904253|Topotecan|topotecan|mesh-list
2624999|NCT01904253|Amrubicin|amrubicin|mesh-list
2625000|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2625001|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2625002|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625003|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625004|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2165986|NCT00000336|Protective Agents|protective agents|mesh-ancestor
2165987|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165988|NCT00000337|Selegiline|selegiline|mesh-list
2165989|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
2165990|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2165991|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2165992|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2165993|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2165994|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2165995|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2165996|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2165997|NCT00000337|Protective Agents|protective agents|mesh-ancestor
2165998|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2165999|NCT00000338|Lisuride|lisuride|mesh-list
2166000|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2166001|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2166002|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2166003|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
2166004|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166005|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166006|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166007|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
2166008|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
2166009|NCT00000339|Risperidone|risperidone|mesh-list
2166010|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2625005|NCT01904357|Cefazolin|cefazolin|mesh-list
2625006|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2625007|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625008|NCT01904409|Rifaximin|rifaximin|mesh-list
2625009|NCT01904409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2625010|NCT01904409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625011|NCT01904409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2625012|NCT01904487|Tiagabine|tiagabine|mesh-list
2625013|NCT01904487|Flumazenil|flumazenil|mesh-list
2625014|NCT01904487|Antidotes|antidotes|mesh-ancestor
2625015|NCT01904487|Protective Agents|protective agents|mesh-ancestor
2625016|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625017|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
2625018|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
2625019|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625020|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625021|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
2625022|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
2625023|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2625024|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2625025|NCT01904500|Cefazolin|cefazolin|mesh-list
2625026|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2625027|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625028|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2625029|NCT01904539|Cathartics|cathartics|mesh-ancestor
2625030|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2625031|NCT01904591|Vitamin E|vitamin e|mesh-list
2625032|NCT01904591|Selenium|selenium|mesh-list
2625033|NCT01904591|Vitamins|vitamins|mesh-ancestor
2625034|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
2625035|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625036|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
2625037|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625038|NCT01904591|Protective Agents|protective agents|mesh-ancestor
2625039|NCT01904591|Trace Elements|trace elements|mesh-ancestor
2625040|NCT01904643|Cytarabine|cytarabine|mesh-list
2625041|NCT01904643|Etoposide|etoposide|mesh-list
2625042|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
2625043|NCT01904643|Lenalidomide|lenalidomide|mesh-list
2625044|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
2625045|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2625046|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625047|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2625048|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2625049|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625050|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625051|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2625052|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
2625053|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
2625054|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625055|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2625056|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
2625057|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625058|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2625059|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2166011|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
2166012|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166013|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166014|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166015|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2166016|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2166017|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166018|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166019|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2166020|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
2166021|NCT00000340|Pemoline|pemoline|mesh-list
2166022|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2166023|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166024|NCT00000341|Buprenorphine|buprenorphine|mesh-list
2166025|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2166026|NCT00000341|Narcotics|narcotics|mesh-ancestor
2625060|NCT01904643|Growth Substances|growth substances|mesh-ancestor
2625061|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
2625062|NCT01904643|Analgesics|analgesics|mesh-ancestor
2625063|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
2625064|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625065|NCT01904682|ON 01910|on 01910|mesh-list
2625066|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625067|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2625068|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625069|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625070|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
2625071|NCT01904695|Diuretics|diuretics|mesh-list
2625072|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2625073|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
2625074|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
2625075|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625076|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
2625077|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625078|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625079|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2625080|NCT01904734|Clomiphene|clomiphene|mesh-list
2625081|NCT01904734|Enclomiphene|enclomiphene|mesh-list
2625082|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
2625083|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2625084|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
2625085|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2625086|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625087|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2625088|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
2625089|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2625090|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2625091|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2625092|NCT01904747|Palbociclib|palbociclib|mesh-list
2625093|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625094|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2625095|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625096|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625097|NCT01904786|Melatonin|melatonin|mesh-list
2625098|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
2625099|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625100|NCT01904786|Protective Agents|protective agents|mesh-ancestor
2625101|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625102|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2625103|NCT01904981|Atenolol|atenolol|mesh-list
2625104|NCT01904981|Valsartan|valsartan|mesh-list
2625105|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2625106|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2625107|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2625108|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2625109|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625110|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2625111|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
2625112|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
2625113|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625114|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625115|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2625116|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2166027|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166028|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166029|NCT00000341|Analgesics|analgesics|mesh-ancestor
2166030|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
2166031|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166032|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2625117|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
2625118|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625119|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2625120|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
2625121|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625125|NCT01905059|Lamivudine|lamivudine|mesh-list
2625126|NCT01905059|Lopinavir|lopinavir|mesh-list
2625127|NCT01905059|Darunavir|darunavir|mesh-list
2625128|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2625129|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
2625130|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2625131|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2625132|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625133|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625134|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
2625135|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625136|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2625137|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2625138|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2625139|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2625140|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2625141|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
2625142|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2625143|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2625144|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2625145|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2625146|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625147|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
2625148|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625149|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625150|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2625151|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625152|NCT01905150|Leucovorin|leucovorin|mesh-list
2625153|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
2625154|NCT01905150|Gemcitabine|gemcitabine|mesh-list
2625155|NCT01905150|Fluorouracil|fluorouracil|mesh-list
2625156|NCT01905150|Docetaxel|docetaxel|mesh-list
2625157|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
2625158|NCT01905150|Irinotecan|irinotecan|mesh-list
2625159|NCT01905150|Mitomycins|mitomycins|mesh-list
2625160|NCT01905150|Mitomycin|mitomycin|mesh-list
2625161|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
2625162|NCT01905150|Vitamins|vitamins|mesh-ancestor
2166033|NCT00000342|Risperidone|risperidone|mesh-list
2166034|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2166035|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
2166036|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166037|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166038|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166039|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2166040|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2166041|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166042|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166043|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2166044|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
2166045|NCT00000344|Buprenorphine|buprenorphine|mesh-list
2166046|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2166047|NCT00000344|Naloxone|naloxone|mesh-list
2166048|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2166049|NCT00000344|Narcotics|narcotics|mesh-ancestor
2166050|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166051|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166052|NCT00000344|Analgesics|analgesics|mesh-ancestor
2166053|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
2625163|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
2625164|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625165|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2625166|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
2625167|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625168|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625169|NCT01905150|Antiviral Agents|antiviral agents|mesh-ancestor
2625170|NCT01905150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625171|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625172|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2625173|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
2625174|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
2625175|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
2625176|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
2166054|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166055|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166056|NCT00000345|Lofexidine|lofexidine|mesh-list
2166057|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2166058|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166059|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166060|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
2166061|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166062|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2166063|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2625177|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2625178|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2625179|NCT01905150|Antidotes|antidotes|mesh-ancestor
2625180|NCT01905150|Protective Agents|protective agents|mesh-ancestor
2625181|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
2625182|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
2625183|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2625184|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
2625185|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2625186|NCT01905215|Vaccines|vaccines|mesh-list
2625187|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
2625188|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166064|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2166065|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
2166066|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166067|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166068|NCT00000347|Risperidone|risperidone|mesh-list
2166069|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2166070|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
2166071|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166072|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166073|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166074|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2166075|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2166076|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166077|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166078|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2166079|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
2166080|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
2166081|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
2166082|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
2166083|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625189|NCT01905371|Amphetamine|amphetamine|mesh-list
2625190|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
2625191|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2625192|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625193|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
2625194|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
2166084|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166085|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166086|NCT00000349|Flupenthixol|flupenthixol|mesh-list
2166087|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
2166088|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2166089|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2166090|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166091|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166092|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166093|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2166094|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
2166095|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166096|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625195|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625196|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
2625197|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625198|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625199|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
2625200|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2625201|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2625202|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2625203|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2625204|NCT01905436|Ivermectin|ivermectin|mesh-list
2625205|NCT01905436|Albendazole|albendazole|mesh-list
2625206|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2625207|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625208|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
2625209|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
2625210|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2625211|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2625212|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
2625213|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
2625214|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
2625215|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625216|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625217|NCT01905501|Anesthetics|anesthetics|mesh-list
2625218|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2625219|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625220|NCT01905566|Clopidogrel|clopidogrel|mesh-list
2625221|NCT01905566|Ticagrelor|ticagrelor|mesh-list
2625222|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2625223|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2625224|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2625225|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2625226|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
2625227|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625228|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625229|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625230|NCT01905618|Nicotine|nicotine|mesh-list
2625231|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2166097|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
2166098|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
2166099|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
2166100|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2625232|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
2625233|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625234|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625235|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2625236|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2625237|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
2625238|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625239|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625240|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
2625241|NCT01905631|Promethazine|promethazine|mesh-list
2625242|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2625243|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2625244|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2625245|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625246|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
2625247|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
2625248|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
2625249|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625250|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
2625251|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
2625252|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2625253|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2625254|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
2625255|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
2625256|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625257|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625258|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2625259|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
2625260|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
2625261|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
2625262|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2625263|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
2625264|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625265|NCT01905696|Expectorants|expectorants|mesh-ancestor
2625266|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
2625267|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2625268|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
2625269|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625270|NCT01905696|Protective Agents|protective agents|mesh-ancestor
2166101|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2166102|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166103|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166104|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166105|NCT00000353|Buprenorphine|buprenorphine|mesh-list
2166106|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2166107|NCT00000353|Naloxone|naloxone|mesh-list
2166108|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2166109|NCT00000353|Narcotics|narcotics|mesh-ancestor
2166110|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166111|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166112|NCT00000353|Analgesics|analgesics|mesh-ancestor
2166113|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
2166114|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166115|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166116|NCT00000354|Lofexidine|lofexidine|mesh-list
2166117|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2166118|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166119|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166120|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
2166121|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166122|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2166123|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2166124|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2166125|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
2166126|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166127|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166128|NCT00000355|Buprenorphine|buprenorphine|mesh-list
2166129|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2625271|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625272|NCT01905696|Antidotes|antidotes|mesh-ancestor
2625273|NCT01905774|Deferasirox|deferasirox|mesh-list
2625274|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2625275|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
2625276|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
2625277|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625278|NCT01905904|Sevoflurane|sevoflurane|mesh-list
2625279|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2625280|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2625281|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
2625282|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
2625283|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2625284|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625285|NCT01906073|Fentanyl|fentanyl|mesh-list
2625286|NCT01906073|Morphine|morphine|mesh-list
2625287|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2625288|NCT01906073|Narcotics|narcotics|mesh-ancestor
2625289|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2625290|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625291|NCT01906073|Analgesics|analgesics|mesh-ancestor
2625292|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
2625293|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625294|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2625295|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2625296|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
2625297|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
2625298|NCT01906125|Palbociclib|palbociclib|mesh-list
2625299|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625300|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2625301|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625302|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625303|NCT01906216|Sorafenib|sorafenib|mesh-list
2625304|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625305|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2625306|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625307|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625308|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
2166130|NCT00000355|Narcotics|narcotics|mesh-ancestor
2166131|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166132|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166133|NCT00000355|Analgesics|analgesics|mesh-ancestor
2166134|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
2166135|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166136|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2625309|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2625310|NCT01906242|Eusol|eusol|mesh-list
2625311|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2625312|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625313|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
2166137|NCT00000357|Buprenorphine|buprenorphine|mesh-list
2166138|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2166139|NCT00000357|Narcotics|narcotics|mesh-ancestor
2166140|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166141|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166142|NCT00000357|Analgesics|analgesics|mesh-ancestor
2625314|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2625315|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625316|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
2625317|NCT01906307|Giapreza|giapreza|mesh-list
2625318|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2625319|NCT01906411|Dopamine|dopamine|mesh-list
2625320|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2625321|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
2625322|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
2625323|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625324|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166143|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
2166144|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166145|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166146|NCT00000358|Lofexidine|lofexidine|mesh-list
2166147|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2166148|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166149|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166150|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
2625325|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
2625326|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625327|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625328|NCT01906411|Protective Agents|protective agents|mesh-ancestor
2625329|NCT01906450|Azithromycin|azithromycin|mesh-list
2625330|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2625331|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625332|NCT01906528|Mivacurium|mivacurium|mesh-list
2625333|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2625334|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2625335|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2625336|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625337|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625338|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2625339|NCT01906580|Entecavir|entecavir|mesh-list
2625340|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
2625341|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625342|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
2625343|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
2625344|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625345|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2625346|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625347|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2625348|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
2625349|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625350|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2625351|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625352|NCT01906749|Colchicine|colchicine|mesh-list
2625353|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
2625354|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2625355|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
2625356|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
2625357|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
2625358|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625359|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625360|NCT01906762|Acetaminophen|acetaminophen|mesh-list
2625361|NCT01906762|Morphine|morphine|mesh-list
2625362|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2625363|NCT01906762|Narcotics|narcotics|mesh-ancestor
2166151|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166152|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2166153|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2166154|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2166155|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
2166156|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166157|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625364|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2625365|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166158|NCT00000361|Methotrexate|methotrexate|mesh-list
2166159|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2166160|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
2166161|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2166162|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166163|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2166164|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
2166165|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166166|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2166167|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
2166168|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166169|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2625366|NCT01906762|Analgesics|analgesics|mesh-ancestor
2625367|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
2625368|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625369|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2625370|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
2625371|NCT01906788|Lumefantrine|lumefantrine|mesh-list
2625372|NCT01906788|Artemether|artemether|mesh-list
2625373|NCT01906788|Primaquine|primaquine|mesh-list
2625374|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2625375|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
2166170|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2166171|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
2166172|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2166173|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2166174|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
2166175|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2166176|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
2166177|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166178|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166179|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166180|NCT00000368|Paroxetine|paroxetine|mesh-list
2166181|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2166182|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166183|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166184|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166185|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166186|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
2166187|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166188|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2166189|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166190|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166191|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2166192|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2166193|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166194|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
2166195|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
2625376|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2625377|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2625378|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625379|NCT01906801|Diacetylrhein|diacetylrhein|mesh-list
2625380|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2625381|NCT01906814|Carboplatin|carboplatin|mesh-list
2625382|NCT01906814|Etoposide|etoposide|mesh-list
2625383|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
2625384|NCT01906814|Vincristine|vincristine|mesh-list
2625385|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625386|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2625387|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2625388|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2625389|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625390|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625391|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
2625392|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
2625393|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
2625394|NCT01906853|Vaccines|vaccines|mesh-list
2625395|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
2625396|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
2625397|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625398|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2625399|NCT01906879|Bismuth|bismuth|mesh-list
2625400|NCT01906879|Antacids|antacids|mesh-ancestor
2625401|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625402|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2625403|NCT01906944|Triamcinolone|triamcinolone|mesh-list
2166196|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166197|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166198|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166199|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
2166200|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2166201|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166202|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166203|NCT00000372|Cycloserine|cycloserine|mesh-list
2166204|NCT00000372|Clozapine|clozapine|mesh-list
2166205|NCT00000372|Glycine|glycine|mesh-list
2166206|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2166207|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625404|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2625405|NCT01906944|Bupivacaine|bupivacaine|mesh-list
2625406|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
2625407|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
2625408|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2625409|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625410|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
2625411|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625412|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2625413|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
2625414|NCT01906944|Hormones|hormones|mesh-ancestor
2625415|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2625416|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2625417|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
2625418|NCT01907009|Melphalan|melphalan|mesh-list
2625419|NCT01907009|Lenograstim|lenograstim|mesh-list
2625420|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2625421|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
2625422|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625423|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625424|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2625425|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2625426|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
2166208|NCT00000372|Renal Agents|renal agents|mesh-ancestor
2166209|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2166210|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
2166211|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2166212|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
2166213|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166214|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2166215|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
2166216|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166217|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166218|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2166219|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2166220|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166221|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166222|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
2166223|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
2166224|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
2166225|NCT00000373|Olanzapine|olanzapine|mesh-list
2166226|NCT00000373|Fluoxetine|fluoxetine|mesh-list
2166227|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
2166228|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
2166229|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166230|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166231|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2625427|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625428|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2625429|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
2625430|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2625431|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
2625432|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2625433|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
2625434|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625435|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625436|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
2625437|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
2625438|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2625439|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
2625440|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625441|NCT01907061|Expectorants|expectorants|mesh-ancestor
2166232|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2166233|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2625442|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
2166234|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166235|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166236|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2166237|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2625443|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2625444|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
2625445|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625446|NCT01907061|Protective Agents|protective agents|mesh-ancestor
2625447|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625448|NCT01907061|Antidotes|antidotes|mesh-ancestor
2625449|NCT01907165|Copper|copper|mesh-list
2625450|NCT01907165|Temozolomide|temozolomide|mesh-list
2625451|NCT01907165|Disulfiram|disulfiram|mesh-list
2625452|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2625453|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
2625454|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625455|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625456|NCT01907165|Trace Elements|trace elements|mesh-ancestor
2625457|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
2625458|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625459|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2625460|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2625461|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625462|NCT01907191|Bupivacaine|bupivacaine|mesh-list
2625463|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
2625464|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
2625465|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2625466|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625467|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
2625468|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625469|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
2625470|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2625471|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2625472|NCT01907204|Prednisolone|prednisolone|mesh-list
2625473|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
2625474|NCT01907204|Budesonide|budesonide|mesh-list
2625475|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2625476|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
2625477|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2625478|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
2625479|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
2625480|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625481|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625482|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2625483|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
2625484|NCT01907204|Hormones|hormones|mesh-ancestor
2625485|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2625486|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2625487|NCT01907204|Protective Agents|protective agents|mesh-ancestor
2625488|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2625489|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625490|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2625491|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2625492|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
2625493|NCT01907230|Entecavir|entecavir|mesh-list
2166238|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166239|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166240|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166241|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
2166242|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2166243|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166244|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2625494|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
2625495|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625496|NCT01907308|Docetaxel|docetaxel|mesh-list
2625497|NCT01907308|Trebananib|trebananib|mesh-list
2625498|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625499|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
2625500|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
2625501|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
2625502|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625503|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2625504|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2625505|NCT01907308|Growth Substances|growth substances|mesh-ancestor
2625506|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625507|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
2625508|NCT01907373|Probenecid|probenecid|mesh-list
2625509|NCT01907373|Olmesartan|olmesartan|mesh-list
2625510|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2625511|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2625512|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2625513|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2625514|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625515|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
2625516|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
2625517|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2166245|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2166246|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166247|NCT00000374|Olanzapine|olanzapine|mesh-list
2166248|NCT00000374|Risperidone|risperidone|mesh-list
2166249|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2625518|NCT01907373|Renal Agents|renal agents|mesh-ancestor
2625519|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
2625520|NCT01907529|Docetaxel|docetaxel|mesh-list
2625521|NCT01907529|Epirubicin|epirubicin|mesh-list
2625522|NCT01907529|Endostar protein|endostar protein|mesh-list
2625523|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2625524|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
2625525|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625526|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2166250|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
2166251|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166252|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166253|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166254|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2166255|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2166256|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166257|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166258|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2166259|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
2166260|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
2166261|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
2166262|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166263|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2166264|NCT00000374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2166265|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2625527|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2625528|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
2625529|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625530|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625531|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2625532|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
2625533|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
2625534|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
2625535|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2625536|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2625537|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2625538|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625539|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2625540|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2625541|NCT01907529|Growth Substances|growth substances|mesh-ancestor
2625542|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
2625543|NCT01907594|Cycloserine|cycloserine|mesh-list
2625544|NCT01907594|Nicotine|nicotine|mesh-list
2625545|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2625546|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
2625547|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625548|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625549|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2625550|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2625551|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
2625552|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625553|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625554|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2625555|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625556|NCT01907594|Renal Agents|renal agents|mesh-ancestor
2625557|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2625558|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
2625559|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2625560|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
2625561|NCT01907633|Domperidone|domperidone|mesh-list
2625562|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
2625563|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
2625564|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625565|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625566|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2625567|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2625568|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
2625569|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625570|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625571|NCT01907685|Docetaxel|docetaxel|mesh-list
2625572|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625573|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
2625574|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
2625575|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
2625576|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625577|NCT01907724|Simeprevir|simeprevir|mesh-list
2625578|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
2625579|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625580|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
2625581|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625582|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625583|NCT01907776|Arbekacin|arbekacin|mesh-list
2625584|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2625585|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625586|NCT01907802|Dabrafenib|dabrafenib|mesh-list
2625587|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625588|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2625589|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625590|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625591|NCT01907867|Finafloxacin|finafloxacin|mesh-list
2625592|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2625593|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625594|NCT01907867|Renal Agents|renal agents|mesh-ancestor
2625595|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2625596|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2625597|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2625598|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625599|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625600|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625601|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
2625602|NCT01907880|Pamidronate|pamidronate|mesh-list
2625603|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2625604|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625605|NCT01907984|Diclofenac|diclofenac|mesh-list
2625606|NCT01907984|Midazolam|midazolam|mesh-list
2625607|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2625608|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2625609|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2625610|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625611|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2625612|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2625613|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2625614|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2625615|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
2625616|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
2625617|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
2625618|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
2625619|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625620|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625621|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2625622|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2625623|NCT01907984|Analgesics|analgesics|mesh-ancestor
2625624|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
2625625|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625626|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2625627|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2625628|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2625629|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625630|NCT01907997|Lidocaine|lidocaine|mesh-list
2625631|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
2625632|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
2625633|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2625634|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625635|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
2625636|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625637|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2166266|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166267|NCT00000375|Nortriptyline|nortriptyline|mesh-list
2166268|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166269|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166270|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166271|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166272|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2166273|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2166274|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166275|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166276|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
2166277|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166278|NCT00000376|Desipramine|desipramine|mesh-list
2166279|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2166280|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166281|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166282|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166283|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166284|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2166285|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166286|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166287|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
2166288|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166289|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166290|NCT00000377|Nortriptyline|nortriptyline|mesh-list
2166291|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2166292|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166293|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2625638|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2625639|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2625640|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2625641|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625642|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2625643|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2625644|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
2625645|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625646|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625647|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2625648|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
2625649|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
2625650|NCT01908075|Hormones|hormones|mesh-ancestor
2625651|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2625652|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
2625653|NCT01908114|Vaccines|vaccines|mesh-list
2625654|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
2625655|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625656|NCT01908257|Lesinurad|lesinurad|mesh-list
2625657|NCT01908257|Ranitidine|ranitidine|mesh-list
2625658|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2625659|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2625660|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2625661|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2625662|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
2625663|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
2625664|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625665|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625666|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625667|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
2625668|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2625669|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
2625670|NCT01908257|Renal Agents|renal agents|mesh-ancestor
2625671|NCT01908283|Vaccines|vaccines|mesh-list
2625672|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
2625673|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625674|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2625675|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
2625676|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
2625677|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2625678|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2625679|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2625680|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2625681|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625682|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2625683|NCT01908296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2625684|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2625685|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2625686|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625687|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625688|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
2625689|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2625690|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2625691|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2625692|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625693|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2625694|NCT01908322|Sorafenib|sorafenib|mesh-list
2625695|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625696|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2625697|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625698|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625699|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2625700|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
2625701|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
2625702|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625703|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
2625704|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625705|NCT01908348|Erythritol|erythritol|mesh-list
2625706|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
2625707|NCT01908387|Azacitidine|azacitidine|mesh-list
2625708|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2625709|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
2625710|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625711|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625712|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625713|NCT01908452|Pyridoxine|pyridoxine|mesh-list
2625714|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
2625715|NCT01908452|Vitamins|vitamins|mesh-ancestor
2625716|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
2625717|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625718|NCT01908465|Ebastine|ebastine|mesh-list
2625719|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2625720|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
2625721|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
2625722|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625723|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625724|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625725|NCT01908478|Gemcitabine|gemcitabine|mesh-list
2625726|NCT01908478|Veliparib|veliparib|mesh-list
2625727|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2625728|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
2625729|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625730|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625731|NCT01908478|Antiviral Agents|antiviral agents|mesh-ancestor
2625732|NCT01908478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625733|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625734|NCT01908478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2625735|NCT01908478|Immunologic Factors|immunologic factors|mesh-ancestor
2625736|NCT01908478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625737|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2625738|NCT01908556|Letrozole|letrozole|mesh-list
2625739|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625740|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2625741|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2625742|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625743|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625744|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2625745|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
2625746|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2625747|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625748|NCT01908621|Cytarabine|cytarabine|mesh-list
2625749|NCT01908621|Lenograstim|lenograstim|mesh-list
2625750|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2625751|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
2625752|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166294|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2166295|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166296|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166297|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625753|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2625754|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
2625755|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625756|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625757|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
2625758|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625759|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2625760|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2166298|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
2166299|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166300|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166301|NCT00000379|Fluoxetine|fluoxetine|mesh-list
2166302|NCT00000379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2166303|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166304|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166305|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166306|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166307|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
2166308|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625761|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
2625762|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625763|NCT01908738|Lidocaine|lidocaine|mesh-list
2625764|NCT01908738|Anesthetics, Local|anesthetics, local|mesh-ancestor
2625765|NCT01908738|Anesthetics|anesthetics|mesh-ancestor
2625766|NCT01908738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2625767|NCT01908738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625768|NCT01908738|Sensory System Agents|sensory system agents|mesh-ancestor
2625769|NCT01908738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625770|NCT01908738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2625771|NCT01908738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2625772|NCT01908738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2625773|NCT01908738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2625774|NCT01908738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625775|NCT01908777|Cytarabine|cytarabine|mesh-list
2625776|NCT01908777|Etoposide|etoposide|mesh-list
2625777|NCT01908777|Melphalan|melphalan|mesh-list
2625778|NCT01908777|Carmustine|carmustine|mesh-list
2625779|NCT01908777|Romidepsin|romidepsin|mesh-list
2625780|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2625781|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625782|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2625783|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2625784|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625785|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625786|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2625787|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
2625788|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
2625789|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625790|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2625791|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
2625792|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625793|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2625794|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
2625795|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2625796|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2625797|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
2625798|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2625799|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625800|NCT01909037|Curcumin|curcumin|mesh-list
2625801|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2625802|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2625803|NCT01909037|Analgesics|analgesics|mesh-ancestor
2625804|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
2625805|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625806|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625807|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2625808|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2625809|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625810|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625811|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625812|NCT01909063|Vitamin D|vitamin d|mesh-list
2625813|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
2625814|NCT01909063|Vitamins|vitamins|mesh-list
2625815|NCT01909063|Vitamin E|vitamin e|mesh-list
2625816|NCT01909063|Vitamin A|vitamin a|mesh-list
2625817|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
2625818|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625819|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2625820|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2625821|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
2625822|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625823|NCT01909063|Protective Agents|protective agents|mesh-ancestor
2625824|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
2625825|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
2625826|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
2625827|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2625828|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625829|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
2625830|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625831|NCT01909115|Vitamin D|vitamin d|mesh-list
2625832|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
2625833|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
2625834|NCT01909115|Vitamins|vitamins|mesh-list
2625835|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
2625836|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625837|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2625838|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2625839|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
2625840|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
2625841|NCT01909219|Cathartics|cathartics|mesh-ancestor
2625842|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2625843|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2625844|NCT01909245|Gastrins|gastrins|mesh-list
2166309|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2166310|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166311|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166312|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2166313|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2166314|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166315|NCT00000381|Fluoxetine|fluoxetine|mesh-list
2166316|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2166317|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166318|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166319|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166320|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166321|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
2166322|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625845|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
2625846|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166323|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2166324|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166325|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166326|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2166327|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2166328|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166329|NCT00000384|Sertraline|sertraline|mesh-list
2166330|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166331|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166332|NCT00000384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2166333|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166334|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2625847|NCT01909245|Hormones|hormones|mesh-ancestor
2625848|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2625849|NCT01909427|Methotrexate|methotrexate|mesh-list
2625850|NCT01909427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2625851|NCT01909427|Abortifacient Agents|abortifacient agents|mesh-ancestor
2625852|NCT01909427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2625853|NCT01909427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625854|NCT01909427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2625855|NCT01909427|Antimetabolites|antimetabolites|mesh-ancestor
2625856|NCT01909427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625857|NCT01909427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625858|NCT01909427|Dermatologic Agents|dermatologic agents|mesh-ancestor
2625859|NCT01909427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625860|NCT01909427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2625861|NCT01909427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2625862|NCT01909427|Immunologic Factors|immunologic factors|mesh-ancestor
2625863|NCT01909427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2625864|NCT01909427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2625865|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
2625866|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
2625867|NCT01909557|Vitamins|vitamins|mesh-ancestor
2625868|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
2625869|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625870|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
2625871|NCT01909622|Vitamin D|vitamin d|mesh-list
2625872|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
2625873|NCT01909622|Vitamins|vitamins|mesh-list
2625874|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
2625875|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625876|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2625877|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2625878|NCT01909661|Caseins|caseins|mesh-list
2625879|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
2625880|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
2625881|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625882|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
2625883|NCT01909752|Imiquimod|imiquimod|mesh-list
2625884|NCT01909752|Vaccines|vaccines|mesh-list
2625885|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
2625886|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625887|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2625888|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2625889|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2625890|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
2625891|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625892|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625893|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2625894|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2625895|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
2625896|NCT01909830|Gemcitabine|gemcitabine|mesh-list
2625897|NCT01909830|Pemetrexed|pemetrexed|mesh-list
2625898|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2625899|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
2625900|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625901|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625902|NCT01909830|Antiviral Agents|antiviral agents|mesh-ancestor
2625903|NCT01909830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625904|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625905|NCT01909830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2625906|NCT01909830|Immunologic Factors|immunologic factors|mesh-ancestor
2625907|NCT01909830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625908|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2625909|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2625910|NCT01909843|Gontivimab|gontivimab|mesh-list
2625911|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
2625912|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625913|NCT01909856|Dexamethasone|dexamethasone|mesh-list
2625914|NCT01909856|Palonosetron|palonosetron|mesh-list
2625915|NCT01909856|Granisetron|granisetron|mesh-list
2625916|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625917|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2625918|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
2625919|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
2625920|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625921|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625922|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2625923|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
2625924|NCT01909856|Hormones|hormones|mesh-ancestor
2625925|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2625926|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2625927|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2166335|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166336|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166337|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
2625928|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2625929|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
2625930|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625931|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625932|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2625933|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2625934|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625935|NCT01910077|Tacrolimus|tacrolimus|mesh-list
2625936|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2625937|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
2625938|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625939|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2625940|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625941|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625942|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
2625943|NCT01910090|Famotidine|famotidine|mesh-list
2625944|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2625945|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2625946|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2625947|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
2625948|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
2625949|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2625950|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625951|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625952|NCT01910090|Analgesics|analgesics|mesh-ancestor
2625953|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
2625954|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625955|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2625956|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2625957|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2625958|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2625959|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2625960|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625961|NCT01910142|Vitamin K|vitamin k|mesh-list
2625962|NCT01910142|Calcium|calcium|mesh-list
2625963|NCT01910142|Vitamins|vitamins|mesh-ancestor
2625964|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
2625965|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625966|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2625967|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2625968|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2625969|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2625970|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
2625971|NCT01910142|Coagulants|coagulants|mesh-ancestor
2625972|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
2625973|NCT01910155|Dexamethasone|dexamethasone|mesh-list
2625974|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2625975|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
2625976|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
2625977|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2625978|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625979|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2625980|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
2625981|NCT01910155|Hormones|hormones|mesh-ancestor
2625982|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2625983|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2625984|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2625985|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2625986|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2625987|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2625988|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2625989|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2625990|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166338|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166339|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
2166340|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166341|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166342|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166343|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166344|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
2166345|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2625991|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2625992|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2625993|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
2625994|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2625995|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625996|NCT01910246|Metformin|metformin|mesh-list
2625997|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2625998|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2625999|NCT01910259|Amiloride|amiloride|mesh-list
2626000|NCT01910259|Riluzole|riluzole|mesh-list
2626001|NCT01910259|Fluoxetine|fluoxetine|mesh-list
2626002|NCT01910259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2166346|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166347|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166348|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
2166349|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2626003|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2626004|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626005|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626006|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626007|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
2626008|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626009|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2626010|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
2626011|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2626012|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2626013|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2626014|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626015|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
2626016|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2626017|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2626018|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2626019|NCT01910259|Protective Agents|protective agents|mesh-ancestor
2626020|NCT01910259|Diuretics|diuretics|mesh-ancestor
2626021|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
2626022|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2626023|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2626024|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2626025|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2626026|NCT01910285|Sufentanil|sufentanil|mesh-list
2626027|NCT01910285|Dsuvia|dsuvia|mesh-list
2626028|NCT01910285|Remifentanil|remifentanil|mesh-list
2626029|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2626030|NCT01910285|Narcotics|narcotics|mesh-ancestor
2626031|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2626032|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626033|NCT01910285|Analgesics|analgesics|mesh-ancestor
2626034|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
2626035|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626036|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2626037|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2626038|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
2626039|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
2626040|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
2626041|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2626042|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2626043|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2626044|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626045|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626046|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
2626047|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626048|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626049|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2626050|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626051|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
2626052|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2626053|NCT01910415|Ivacaftor|ivacaftor|mesh-list
2626054|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2626055|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626056|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2626057|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2626058|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626059|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626060|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626061|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2626062|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
2626063|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2626064|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626065|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2626066|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2626067|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2626068|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2166350|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2166351|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166352|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166353|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2626069|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626070|NCT01910428|Asparaginase|asparaginase|mesh-list
2626071|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626072|NCT01910480|Ketoconazole|ketoconazole|mesh-list
2626073|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
2626074|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626075|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2626076|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2626077|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626078|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626079|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2626080|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
2626081|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2626082|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626083|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2626084|NCT01910506|Verinurad|verinurad|mesh-list
2626085|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
2626086|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2626087|NCT01910532|Clevidipine|clevidipine|mesh-list
2166354|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2166355|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166356|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166357|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166358|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166359|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
2166360|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2166361|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166362|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2166363|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2166364|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166365|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2166366|NCT00000390|Imipramine|imipramine|mesh-list
2166367|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2166368|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166369|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166370|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2166371|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166372|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166373|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166374|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
2166375|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166376|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166377|NCT00000395|Folic Acid|folic acid|mesh-list
2166378|NCT00000395|Leucovorin|leucovorin|mesh-list
2166379|NCT00000395|Methotrexate|methotrexate|mesh-list
2166380|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
2166381|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2626088|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2626089|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626090|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626091|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2626092|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626093|NCT01910545|OTS167|ots167|mesh-list
2626094|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2626095|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626096|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626097|NCT01910610|Bevacizumab|bevacizumab|mesh-list
2626098|NCT01910610|Cetuximab|cetuximab|mesh-list
2626099|NCT01910610|Panitumumab|panitumumab|mesh-list
2626100|NCT01910610|Irinotecan|irinotecan|mesh-list
2626101|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2626102|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626103|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2626104|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2626105|NCT01910610|Growth Substances|growth substances|mesh-ancestor
2626106|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626107|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
2626108|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2626109|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2626110|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626111|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626112|NCT01910766|Ubiquinone|ubiquinone|mesh-list
2626113|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
2626114|NCT01910766|Clomiphene|clomiphene|mesh-list
2166382|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
2166383|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2166384|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166385|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2166386|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
2166387|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166388|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2166389|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
2166390|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166391|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2166392|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2166393|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
2166394|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2166395|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2166396|NCT00000395|Hematinics|hematinics|mesh-ancestor
2166397|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
2166398|NCT00000395|Vitamins|vitamins|mesh-ancestor
2166399|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
2166400|NCT00000395|Antidotes|antidotes|mesh-ancestor
2166401|NCT00000395|Protective Agents|protective agents|mesh-ancestor
2166402|NCT00000399|Hormones|hormones|mesh-list
2166403|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2166404|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166405|NCT00000400|Alendronate|alendronate|mesh-list
2166406|NCT00000400|Teriparatide|teriparatide|mesh-list
2626115|NCT01910766|Enclomiphene|enclomiphene|mesh-list
2626116|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
2626117|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2626118|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
2626119|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2626120|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626121|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2626122|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
2626123|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2626124|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2626125|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2626126|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
2166407|NCT00000400|Hormones|hormones|mesh-list
2166408|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
2166409|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2626127|NCT01910766|Vitamins|vitamins|mesh-ancestor
2626128|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
2626129|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2626130|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
2626131|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626132|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2626133|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2626134|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
2626135|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626136|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626137|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2626138|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
2626139|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2626140|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
2626141|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626142|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2626143|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2626144|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
2626145|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626146|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626147|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2626148|NCT01910883|Finafloxacin|finafloxacin|mesh-list
2626149|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
2626150|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2626151|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2626152|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626153|NCT01910883|Renal Agents|renal agents|mesh-ancestor
2626154|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2626155|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2626156|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2626157|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626158|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166410|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626159|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626160|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2626161|NCT01910987|Dexamethasone|dexamethasone|mesh-list
2626162|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
2626163|NCT01910987|Bortezomib|bortezomib|mesh-list
2626164|NCT01910987|BB 1101|bb 1101|mesh-list
2626165|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2626166|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
2626167|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
2626168|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626169|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626170|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2626171|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
2626172|NCT01910987|Hormones|hormones|mesh-ancestor
2626173|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2626174|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2626175|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626176|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
2626177|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626178|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626179|NCT01911195|Isoflurane|isoflurane|mesh-list
2626180|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2626181|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
2626182|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
2626183|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2626184|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626185|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
2626186|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2626187|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
2626188|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626189|NCT01911247|Metformin|metformin|mesh-list
2626190|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2626191|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626192|NCT01911299|Choline|choline|mesh-list
2626193|NCT01911299|Glycerol|glycerol|mesh-list
2626194|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
2626195|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2626196|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
2626197|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626198|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2626199|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2626200|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
2626201|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2626202|NCT01911299|Protective Agents|protective agents|mesh-ancestor
2626203|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626204|NCT01911325|Docetaxel|docetaxel|mesh-list
2626205|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626206|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
2626207|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
2626208|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
2626209|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626210|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
2626211|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2626212|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
2626213|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626214|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166411|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2166412|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2166413|NCT00000402|Calcium|calcium|mesh-list
2166414|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2166415|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166416|NCT00000403|Doxycycline|doxycycline|mesh-list
2166417|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2166418|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2166419|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
2166420|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2626215|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2626216|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
2626217|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
2626218|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2626219|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
2626220|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626221|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626222|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
2626223|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2626224|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2166421|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2166422|NCT00000412|Alendronate|alendronate|mesh-list
2166423|NCT00000412|Calcitriol|calcitriol|mesh-list
2166424|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2166425|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166426|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2166427|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2166428|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166429|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166430|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2166431|NCT00000412|Vitamins|vitamins|mesh-ancestor
2166432|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
2166433|NCT00000415|Calcium|calcium|mesh-list
2626225|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2626226|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626227|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626228|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
2626229|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626230|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626231|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2626232|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626233|NCT01911455|Acamprosate|acamprosate|mesh-list
2626234|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2626235|NCT01911468|Metformin|metformin|mesh-list
2626236|NCT01911468|Liraglutide|liraglutide|mesh-list
2626237|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2626238|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2626239|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626240|NCT01911468|Incretins|incretins|mesh-ancestor
2626241|NCT01911468|Hormones|hormones|mesh-ancestor
2626242|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2626243|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
2626244|NCT01911494|Methyldopa|methyldopa|mesh-list
2626245|NCT01911494|Analgesics|analgesics|mesh-ancestor
2626246|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
2626247|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626248|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626249|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
2626250|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2626251|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2626252|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
2626253|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2626254|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626255|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626256|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2626257|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
2626258|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2626259|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2626260|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
2626261|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
2626262|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2626263|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2626264|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2626265|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
2626266|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626267|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2626268|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626269|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2626270|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626271|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166434|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2166435|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166436|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2166437|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2166438|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2166439|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
2166440|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2166441|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166442|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2166443|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2166444|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2166445|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2166446|NCT00000419|Estrogens|estrogens|mesh-ancestor
2626272|NCT01911598|Paclitaxel|paclitaxel|mesh-list
2166447|NCT00000419|Hormones|hormones|mesh-ancestor
2166448|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2166449|NCT00000420|Norinyl|norinyl|mesh-list
2166450|NCT00000420|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2166451|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2166452|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2166453|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2166454|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
2166455|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2166456|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166457|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2166458|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2166459|NCT00000420|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2166460|NCT00000420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2166461|NCT00000421|Prednisone|prednisone|mesh-list
2166462|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2166463|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
2166464|NCT00000421|Hormones|hormones|mesh-ancestor
2166465|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2166466|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166467|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2626273|NCT01911598|Carboplatin|carboplatin|mesh-list
2626274|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2626275|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626276|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
2626277|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
2626278|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
2626279|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626280|NCT01911624|Enoxaparin|enoxaparin|mesh-list
2626281|NCT01911624|Dabigatran|dabigatran|mesh-list
2626282|NCT01911624|Argatroban|argatroban|mesh-list
2626283|NCT01911624|Thrombin|thrombin|mesh-list
2626284|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
2626285|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2626286|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2626287|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626288|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
2626289|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2626290|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
2626291|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626292|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
2626293|NCT01911624|Coagulants|coagulants|mesh-ancestor
2626294|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2626295|NCT01911728|Pioglitazone|pioglitazone|mesh-list
2626296|NCT01911728|Midazolam|midazolam|mesh-list
2626297|NCT01911728|Omeprazole|omeprazole|mesh-list
2626298|NCT01911728|Warfarin|warfarin|mesh-list
2626299|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2626300|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2626301|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2626302|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626303|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2626304|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2626305|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2626306|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2626307|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
2626308|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
2626309|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
2626310|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
2626311|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626312|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626313|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2626314|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
2422063|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
2422064|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
2422065|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
2422066|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2422067|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2422068|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422069|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422070|NCT00815646|Urological Agents|urological agents|mesh-ancestor
2422071|NCT00815841|Methylphenidate|methylphenidate|mesh-list
2422072|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2422073|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626315|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2166468|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2166469|NCT00000425|Acetaminophen|acetaminophen|mesh-list
2166470|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2166471|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2166472|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2166473|NCT00000425|Analgesics|analgesics|mesh-ancestor
2166474|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
2166475|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166476|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166477|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
2166478|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2166479|NCT00000426|Calcium|calcium|mesh-list
2166480|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2626316|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2626317|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2626318|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626319|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2626320|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
2626321|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2626322|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
2626323|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626324|NCT01911949|Epinephrine|epinephrine|mesh-list
2626325|NCT01911949|Bupivacaine|bupivacaine|mesh-list
2626326|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
2626327|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
2626328|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2626329|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626330|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
2626331|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626332|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2626333|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2626334|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
2626335|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626336|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626337|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2626338|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2626339|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
2626340|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2626341|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
2626342|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
2626343|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
2626344|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2626345|NCT01911975|Lacosamide|lacosamide|mesh-list
2626346|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
2626347|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2626348|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2626349|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626350|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626351|NCT01912053|Gemcitabine|gemcitabine|mesh-list
2626352|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626353|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2626354|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
2626355|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626356|NCT01912053|Antiviral Agents|antiviral agents|mesh-ancestor
2626357|NCT01912053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626358|NCT01912053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626359|NCT01912053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2626360|NCT01912053|Immunologic Factors|immunologic factors|mesh-ancestor
2626361|NCT01912053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626362|NCT01912066|Aceclofenac|aceclofenac|mesh-list
2626363|NCT01912066|Misoprostol|misoprostol|mesh-list
2626364|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2626365|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
2626366|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2626367|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626368|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2626369|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2626370|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
2626371|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2626372|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2166481|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166482|NCT00000427|Alendronate|alendronate|mesh-list
2166483|NCT00000427|Hormones|hormones|mesh-list
2166484|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
2166485|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2626373|NCT01912066|Analgesics|analgesics|mesh-ancestor
2626374|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
2626375|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626376|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2626377|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2626378|NCT01912118|Remifentanil|remifentanil|mesh-list
2626379|NCT01912118|Propofol|propofol|mesh-list
2626380|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2626381|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2626382|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626383|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2626384|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
2626385|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
2166486|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166487|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2166488|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2166489|NCT00000428|Amitriptyline|amitriptyline|mesh-list
2166490|NCT00000428|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2166491|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2166492|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166493|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166494|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2166495|NCT00000428|Analgesics|analgesics|mesh-ancestor
2166496|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
2166497|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166498|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166499|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2166500|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2626386|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2626387|NCT01912118|Narcotics|narcotics|mesh-ancestor
2626388|NCT01912118|Analgesics|analgesics|mesh-ancestor
2626389|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
2626390|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626391|NCT01912378|Oxytocin|oxytocin|mesh-list
2626392|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
2626393|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2166501|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166502|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166503|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
2166504|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166505|NCT00000428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2166506|NCT00000428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2166507|NCT00000428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166508|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
2166509|NCT00000429|Calcium|calcium|mesh-list
2166510|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2166511|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166512|NCT00000429|Antacids|antacids|mesh-ancestor
2166513|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626394|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626395|NCT01912391|Selegiline|selegiline|mesh-list
2626396|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
2626397|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2626398|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2626399|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2626400|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2626401|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626402|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626403|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2626404|NCT01912391|Protective Agents|protective agents|mesh-ancestor
2626405|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626406|NCT01912443|Bevacizumab|bevacizumab|mesh-list
2626407|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2626408|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626409|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2626410|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2626411|NCT01912443|Growth Substances|growth substances|mesh-ancestor
2626412|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626413|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
2626414|NCT01912534|Valsartan|valsartan|mesh-list
2626415|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2626416|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2626417|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2626418|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166514|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2166515|NCT00000430|Alendronate|alendronate|mesh-list
2166516|NCT00000430|Estrogens|estrogens|mesh-list
2166517|NCT00000430|Progestins|progestins|mesh-list
2166518|NCT00000430|Hormones|hormones|mesh-ancestor
2166519|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2626419|NCT01912573|Naloxone|naloxone|mesh-list
2626420|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2626421|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626422|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
2626423|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166520|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166521|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2166522|NCT00000437|Naltrexone|naltrexone|mesh-list
2166523|NCT00000437|Nicotine|nicotine|mesh-list
2166524|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2626424|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
2626425|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
2626426|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2626427|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2626428|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626429|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626430|NCT01912586|Urological Agents|urological agents|mesh-ancestor
2626431|NCT01912625|Paclitaxel|paclitaxel|mesh-list
2626432|NCT01912625|Carboplatin|carboplatin|mesh-list
2626433|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2626434|NCT01912625|Trametinib|trametinib|mesh-list
2626435|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2626436|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626437|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
2626438|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
2626439|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
2626440|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626441|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2626442|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626443|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
2626444|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2626445|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
2626446|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626447|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
2626448|NCT01912638|Protective Agents|protective agents|mesh-ancestor
2626449|NCT01912651|Cephalexin|cephalexin|mesh-list
2626450|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2626451|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626452|NCT01912677|Labetalol|labetalol|mesh-list
2626453|NCT01912677|Methyldopa|methyldopa|mesh-list
2626454|NCT01912677|Nifedipine|nifedipine|mesh-list
2626455|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2626456|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626457|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626458|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2166525|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
2166526|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166527|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166528|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2166529|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2626459|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626460|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
2626461|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
2626462|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2626463|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2626464|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2626465|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
2626466|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626467|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2626468|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
2626469|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
2626470|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626471|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2626472|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2626473|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
2626474|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2626475|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2626476|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2626477|NCT01912755|Lidocaine|lidocaine|mesh-list
2626478|NCT01912755|Epinephrine|epinephrine|mesh-list
2166530|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
2626479|NCT01912755|Racepinephrine|racepinephrine|mesh-list
2626480|NCT01912755|Carticaine|carticaine|mesh-list
2626481|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
2626482|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
2626483|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
2626484|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2626485|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626486|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
2626487|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626488|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2626489|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2626490|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2626491|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626492|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626493|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2626494|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2626495|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
2626496|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626497|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2626498|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2626499|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
2626500|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2626501|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
2626502|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
2626503|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
2626504|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2626505|NCT01912820|Quercetin|quercetin|mesh-list
2626506|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
2626507|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626508|NCT01912820|Protective Agents|protective agents|mesh-ancestor
2626509|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626510|NCT01912898|Vitamin D|vitamin d|mesh-list
2626511|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
2626512|NCT01912898|Vitamins|vitamins|mesh-list
2166531|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166532|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166533|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2166534|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166535|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
2166536|NCT00000438|Naltrexone|naltrexone|mesh-list
2166537|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2166538|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166539|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166540|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
2166541|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166542|NCT00000439|Valproic Acid|valproic acid|mesh-list
2166543|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
2166544|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166545|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166546|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
2166547|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166548|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166549|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
2166550|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2166551|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166552|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166553|NCT00000440|Naltrexone|naltrexone|mesh-list
2166554|NCT00000440|Sertraline|sertraline|mesh-list
2166555|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2166556|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166557|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166558|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
2166559|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166560|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166561|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166562|NCT00000440|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2166563|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166564|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166565|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166566|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626513|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
2626514|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626515|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2166567|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
2626516|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2166568|NCT00000441|Carbamazepine|carbamazepine|mesh-list
2166569|NCT00000441|Lorazepam|lorazepam|mesh-list
2166570|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
2166571|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
2166572|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
2166573|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166574|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166575|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2166576|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2166577|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166578|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2166579|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2166580|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166581|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
2166582|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
2166583|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166584|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166585|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
2166586|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2166587|NCT00000441|Analgesics|analgesics|mesh-ancestor
2166588|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
2166589|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2166590|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166591|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2166592|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2166593|NCT00000442|Naltrexone|naltrexone|mesh-list
2166594|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2166595|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166596|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166597|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
2166598|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166599|NCT00000443|Ondansetron|ondansetron|mesh-list
2166600|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
2166601|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
2166602|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166603|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166604|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2166605|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
2166606|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
2166607|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2166608|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
2166609|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166610|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166611|NCT00000443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2166612|NCT00000443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2166613|NCT00000443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2166614|NCT00000443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166615|NCT00000443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2166616|NCT00000444|Nicotine|nicotine|mesh-list
2166617|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2166618|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
2166619|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626517|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2626518|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2626519|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
2626520|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2626521|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
2626522|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2626523|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626524|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2626525|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2626526|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626527|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626528|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626529|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626530|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2626531|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2626532|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
2626533|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626534|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2626535|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626536|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626537|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
2166620|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626538|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2626539|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626540|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2626541|NCT01913054|Fentanyl|fentanyl|mesh-list
2626542|NCT01913054|Propofol|propofol|mesh-list
2626543|NCT01913054|Etomidate|etomidate|mesh-list
2626544|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2626545|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2626546|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626547|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2626548|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
2626549|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
2626550|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2626551|NCT01913054|Narcotics|narcotics|mesh-ancestor
2626552|NCT01913054|Analgesics|analgesics|mesh-ancestor
2626553|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
2626554|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626555|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2626556|NCT01913106|Valacyclovir|valacyclovir|mesh-list
2166621|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2166622|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2166623|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
2166624|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166625|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626557|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
2626558|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626559|NCT01913119|Romidepsin|romidepsin|mesh-list
2626560|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2626561|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626562|NCT01913158|Hydrocortisone|hydrocortisone|mesh-list
2626563|NCT01913158|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2626564|NCT01913158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2626565|NCT01913379|Itraconazole|itraconazole|mesh-list
2626566|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
2626567|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
2626568|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626569|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2626570|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2626571|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626572|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626573|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2626574|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
2626575|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2626576|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626577|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2626578|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2626579|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
2626580|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2626581|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2626582|NCT01913431|Entecavir|entecavir|mesh-list
2626583|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
2626584|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626585|NCT01913444|Antithrombins|antithrombins|mesh-list
2422074|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2422075|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2422076|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422077|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422078|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
2422079|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422080|NCT00815854|Folic Acid|folic acid|mesh-list
2626586|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
2626587|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2626588|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
2626589|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626590|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626591|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
2626592|NCT01913691|Ipilimumab|ipilimumab|mesh-list
2626593|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2626594|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2166626|NCT00000445|Naltrexone|naltrexone|mesh-list
2166627|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2166628|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2626595|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2422081|NCT00815854|Hematinics|hematinics|mesh-ancestor
2626596|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626597|NCT01913730|Dexamethasone|dexamethasone|mesh-list
2626598|NCT01913730|Bortezomib|bortezomib|mesh-list
2626599|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2626600|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
2626601|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
2626602|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626603|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626604|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2626605|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
2626606|NCT01913730|Hormones|hormones|mesh-ancestor
2626607|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2626608|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2626609|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626610|NCT01913808|Iron|iron|mesh-list
2626611|NCT01913808|Glycine|glycine|mesh-list
2626612|NCT01913808|Trace Elements|trace elements|mesh-ancestor
2626613|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
2626614|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626615|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
2626616|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626617|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626618|NCT01913834|Teriparatide|teriparatide|mesh-list
2626619|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2626620|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626621|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2626622|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
2626623|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
2626624|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2626625|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2626626|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626627|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626628|NCT01913847|Urological Agents|urological agents|mesh-ancestor
2626629|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2626630|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626631|NCT01913951|Azacitidine|azacitidine|mesh-list
2626632|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2626633|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
2626634|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626635|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626636|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626637|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
2626638|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
2626639|NCT01913964|Vitamins|vitamins|mesh-ancestor
2626640|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
2626641|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626642|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
2626643|NCT01913990|Dexamethasone|dexamethasone|mesh-list
2626644|NCT01913990|Ondansetron|ondansetron|mesh-list
2626645|NCT01913990|Aprepitant|aprepitant|mesh-list
2626646|NCT01913990|Antiemetics|antiemetics|mesh-list
2626647|NCT01913990|Emetics|emetics|mesh-list
2626648|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2626649|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
2626650|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626651|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626652|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2626653|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
2626654|NCT01913990|Hormones|hormones|mesh-ancestor
2626655|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2166629|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166630|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
2166631|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166632|NCT00000446|Sertraline|sertraline|mesh-list
2626656|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2626657|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626658|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
2626659|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
2626660|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2626661|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
2626662|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626663|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626664|NCT01913990|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2626665|NCT01913990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2626666|NCT01913990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2626667|NCT01913990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2626668|NCT01913990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2626669|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2626670|NCT01914042|Morphine|morphine|mesh-list
2626671|NCT01914042|Milnacipran|milnacipran|mesh-list
2626672|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
2166633|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166634|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166635|NCT00000446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2166636|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166637|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166638|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626673|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2626674|NCT01914042|Narcotics|narcotics|mesh-ancestor
2166639|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166640|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
2166641|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166642|NCT00000447|Naltrexone|naltrexone|mesh-list
2166643|NCT00000447|Nicotine|nicotine|mesh-list
2166644|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2166645|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
2166646|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166647|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166648|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2626675|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2626676|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626677|NCT01914042|Analgesics|analgesics|mesh-ancestor
2626678|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
2626679|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626680|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2626681|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2626682|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626683|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626684|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626685|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2166649|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2166650|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
2166651|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166652|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166653|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2166654|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166655|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
2166656|NCT00000448|Naltrexone|naltrexone|mesh-list
2626686|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
2626687|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2626688|NCT01914081|Resveratrol|resveratrol|mesh-list
2626689|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
2626690|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626691|NCT01914081|Protective Agents|protective agents|mesh-ancestor
2626692|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626693|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626694|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2626695|NCT01914133|Acarbose|acarbose|mesh-list
2626696|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
2166657|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2166658|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166659|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166660|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
2166661|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166662|NCT00000449|Naltrexone|naltrexone|mesh-list
2166663|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2166664|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166665|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626697|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626698|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166666|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
2166667|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166668|NCT00000450|Naltrexone|naltrexone|mesh-list
2166669|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2626699|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2626700|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626701|NCT01914146|Insulin|insulin|mesh-list
2626702|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2626703|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2626704|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626705|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
2166670|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166671|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166672|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
2166673|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166674|NCT00000451|Naltrexone|naltrexone|mesh-list
2166675|NCT00000451|Sertraline|sertraline|mesh-list
2626706|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2626707|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2626708|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626709|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
2626710|NCT01914211|Coagulants|coagulants|mesh-ancestor
2626711|NCT01914237|Castor Oil|castor oil|mesh-list
2166676|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2166677|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166678|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166679|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
2166680|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166681|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166682|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166683|NCT00000451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2166684|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166685|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166686|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166687|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166688|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
2166689|NCT00000452|Naltrexone|naltrexone|mesh-list
2166690|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2166691|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166692|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166693|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
2626712|NCT01914237|Cathartics|cathartics|mesh-ancestor
2626713|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2626714|NCT01914250|Analgesics|analgesics|mesh-list
2626715|NCT01914250|Tetracaine|tetracaine|mesh-list
2626716|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
2626717|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626718|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626719|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
2626720|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
2626721|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2626722|NCT01914367|Vaccines|vaccines|mesh-list
2626723|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
2626724|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626725|NCT01914380|Aflibercept|aflibercept|mesh-list
2626726|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2626727|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2626728|NCT01914380|Growth Substances|growth substances|mesh-ancestor
2626729|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166694|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166695|NCT00000454|Nicotine|nicotine|mesh-list
2166696|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2166697|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
2166698|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166699|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166700|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2166701|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2166702|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
2166703|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166704|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166705|NCT00000455|Naltrexone|naltrexone|mesh-list
2166706|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2166707|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166708|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166709|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
2166710|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166711|NCT00000456|Naltrexone|naltrexone|mesh-list
2166712|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2166713|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2166714|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626730|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
2626731|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626732|NCT01914419|Oxytocin|oxytocin|mesh-list
2626733|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
2626734|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2626735|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626736|NCT01914432|Telmisartan|telmisartan|mesh-list
2626737|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2626738|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2166715|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
2626739|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2626740|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
2626741|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626742|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2626743|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2626744|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626745|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2626746|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2626747|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2626748|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2626749|NCT01914562|Cathartics|cathartics|mesh-ancestor
2626750|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2166716|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166717|NCT00000457|Bupropion|bupropion|mesh-list
2166718|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2166719|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
2626751|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
2626752|NCT01914627|Salicylates|salicylates|mesh-list
2626753|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626754|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
2626755|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
2626756|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
2626757|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2166720|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166721|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2166722|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166723|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166724|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166725|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
2166726|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166727|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166728|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2166729|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2166730|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166731|NCT00000458|Sertraline|sertraline|mesh-list
2166732|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166733|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166734|NCT00000458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2166735|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2166736|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166737|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166738|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166739|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
2626758|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2626759|NCT01914627|Analgesics|analgesics|mesh-ancestor
2626760|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
2166740|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166741|NCT00000461|Niacin|niacin|mesh-list
2166742|NCT00000461|Pravastatin|pravastatin|mesh-list
2166743|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
2166744|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
2166745|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2166746|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
2166747|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166748|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2166749|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
2166750|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
2166751|NCT00000461|Vitamins|vitamins|mesh-ancestor
2166752|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
2166753|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166754|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2184868|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2626761|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626762|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626763|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2626764|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2626765|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2626766|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626767|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626768|NCT01914692|Somatostatin|somatostatin|mesh-list
2626769|NCT01914692|Hormones|hormones|mesh-ancestor
2626770|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2166755|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2166756|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166757|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2166758|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2626771|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626772|NCT01914718|Rituximab|rituximab|mesh-list
2626773|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2626774|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626775|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
2626776|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626777|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2626778|NCT01914744|Lamivudine|lamivudine|mesh-list
2626779|NCT01914744|Entecavir|entecavir|mesh-list
2626780|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2626781|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2626782|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626783|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626784|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
2626785|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626786|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2626787|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2626788|NCT01914770|Belimumab|belimumab|mesh-list
2626789|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2626790|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
2626791|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626792|NCT01914822|Methylphenidate|methylphenidate|mesh-list
2626793|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2626794|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626795|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2626796|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2626797|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626798|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626799|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
2626800|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626801|NCT01914900|Docetaxel|docetaxel|mesh-list
2626802|NCT01914900|Fluorouracil|fluorouracil|mesh-list
2626803|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626804|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
2626805|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
2626806|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
2626807|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626808|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
2626809|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2626810|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2626811|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
2626812|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626813|NCT01914939|Oxytocin|oxytocin|mesh-list
2626814|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
2626815|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2626816|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626817|NCT01914965|Bupropion|bupropion|mesh-list
2626818|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2626819|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
2626820|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2626821|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2166759|NCT00000463|Warfarin|warfarin|mesh-list
2166760|NCT00000463|Lovastatin|lovastatin|mesh-list
2166761|NCT00000463|L 647318|l 647318|mesh-list
2166762|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
2166763|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
2166764|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
2166765|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2166766|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2166767|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
2166768|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166769|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2422082|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
2422083|NCT00815854|Vitamins|vitamins|mesh-ancestor
2422084|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
2422085|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422086|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
2422087|NCT00815867|Hematinics|hematinics|mesh-ancestor
2422088|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
2422089|NCT00815893|Propofol|propofol|mesh-list
2422090|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2422091|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2626822|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2626823|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626824|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626825|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
2626826|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626827|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626828|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2626829|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2626830|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626831|NCT01915069|Cilostazol|cilostazol|mesh-list
2626832|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2626833|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
2626834|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626835|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626836|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2626837|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
2626838|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2626839|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2626840|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626841|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2626842|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
2626843|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2626844|NCT01915069|Protective Agents|protective agents|mesh-ancestor
2626845|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2626846|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2626847|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626848|NCT01915082|Azithromycin|azithromycin|mesh-list
2626849|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2626850|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2166770|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2166771|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166772|NCT00000464|Quinidine|quinidine|mesh-list
2166773|NCT00000464|Amiodarone|amiodarone|mesh-list
2166774|NCT00000464|Sotalol|sotalol|mesh-list
2166775|NCT00000464|Propafenone|propafenone|mesh-list
2166776|NCT00000464|Mexiletine|mexiletine|mesh-list
2166777|NCT00000464|Procainamide|procainamide|mesh-list
2166778|NCT00000464|Imipramine|imipramine|mesh-list
2166779|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2166780|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
2166781|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2166782|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166783|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166784|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2166785|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2166786|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2166787|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166788|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2166789|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2166790|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2166791|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2166792|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2166793|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
2166794|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166795|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166796|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
2626851|NCT01915134|Gemcitabine|gemcitabine|mesh-list
2626852|NCT01915134|Cisplatin|cisplatin|mesh-list
2626853|NCT01915134|Endostatins|endostatins|mesh-list
2626854|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626855|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2626856|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
2626857|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626858|NCT01915134|Antiviral Agents|antiviral agents|mesh-ancestor
2626859|NCT01915134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626860|NCT01915134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626861|NCT01915134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2166797|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
2166798|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166799|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2166800|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
2166801|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2166802|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2166803|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2626862|NCT01915134|Immunologic Factors|immunologic factors|mesh-ancestor
2626863|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626864|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2626865|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2626866|NCT01915134|Growth Substances|growth substances|mesh-ancestor
2626867|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
2626868|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2626869|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2626870|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
2626871|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626872|NCT01915264|Metformin|metformin|mesh-list
2626873|NCT01915264|Acarbose|acarbose|mesh-list
2626874|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2626875|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626876|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2626877|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626878|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626879|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
2626880|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2626881|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2626882|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626883|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2626884|NCT01915277|Analgesics|analgesics|mesh-ancestor
2626885|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
2626886|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626887|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2626888|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2626889|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2626890|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
2626891|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626892|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626893|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
2626894|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2626895|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2626896|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2626897|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626898|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626899|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
2626900|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626901|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626902|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2626903|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626904|NCT01915472|Irinotecan|irinotecan|mesh-list
2626905|NCT01915472|Labetuzumab|labetuzumab|mesh-list
2626906|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
2626907|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
2626908|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626909|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2626910|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2626911|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626912|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166804|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2166805|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
2166806|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2166807|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2166808|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2166809|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2166810|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2166811|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
2166812|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2166813|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2166814|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
2166815|NCT00000466|Progesterone|progesterone|mesh-list
2166816|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2166817|NCT00000466|Estrogens|estrogens|mesh-list
2166818|NCT00000466|Progestins|progestins|mesh-ancestor
2166819|NCT00000466|Hormones|hormones|mesh-ancestor
2166820|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2166821|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166822|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2166823|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2166824|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2166825|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
2166826|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2626913|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626914|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2626915|NCT01915537|Infliximab|infliximab|mesh-list
2626916|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
2626917|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2626918|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2626919|NCT01915550|Insulin|insulin|mesh-list
2626920|NCT01915550|Metformin|metformin|mesh-list
2626921|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2626922|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
2626923|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2626924|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626925|NCT01915602|Sorafenib|sorafenib|mesh-list
2626926|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626927|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2626928|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626929|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626930|NCT01915758|Clindamycin|clindamycin|mesh-list
2626931|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
2626932|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
2626933|NCT01915758|Tretinoin|tretinoin|mesh-list
2626934|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2626935|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2626936|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2626937|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626938|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626939|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2626940|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
2626941|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
2626942|NCT01915810|Nicotine|nicotine|mesh-list
2626943|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2166827|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2166828|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2166829|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2166830|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2166831|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2166832|NCT00000468|Plasminogen|plasminogen|mesh-list
2166833|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2166834|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2166835|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2166836|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166837|NCT00000469|Aspirin|aspirin|mesh-list
2626944|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
2626945|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2626946|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626947|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2626948|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2626949|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
2626950|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2626951|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626952|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2626953|NCT01915901|Bismuth|bismuth|mesh-list
2626954|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2626955|NCT01915901|Antacids|antacids|mesh-ancestor
2626956|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626957|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2626958|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
2626959|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2626960|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
2626961|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626962|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
2626963|NCT01915979|Betamethasone|betamethasone|mesh-list
2626964|NCT01915979|Mitogens|mitogens|mesh-list
2626965|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
2626966|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626967|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2626968|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
2626969|NCT01915979|Hormones|hormones|mesh-ancestor
2626970|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2626971|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626972|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2626973|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
2626974|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2626975|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2626976|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626977|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2626978|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2626979|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626980|NCT01916174|Insulin|insulin|mesh-list
2626981|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2626982|NCT01916174|Liraglutide|liraglutide|mesh-list
2626983|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
2626984|NCT01916174|Xultophy|xultophy|mesh-list
2626985|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2626986|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2626987|NCT01916174|Incretins|incretins|mesh-ancestor
2626988|NCT01916174|Hormones|hormones|mesh-ancestor
2626989|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2626990|NCT01916187|Imetelstat|imetelstat|mesh-list
2626991|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
2626992|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2626993|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2626994|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2626995|NCT01916200|Paroxetine|paroxetine|mesh-list
2626996|NCT01916200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2626997|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2626998|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2626999|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627000|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627001|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
2627002|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166838|NCT00000469|Lovastatin|lovastatin|mesh-list
2166839|NCT00000469|L 647318|l 647318|mesh-list
2166840|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
2627003|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2627004|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
2627005|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2627006|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2627007|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2627008|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627009|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
2627010|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2627011|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
2627012|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627013|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
2627014|NCT01916213|Protective Agents|protective agents|mesh-ancestor
2627015|NCT01916252|Dexamethasone|dexamethasone|mesh-list
2627016|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
2627017|NCT01916252|Lenalidomide|lenalidomide|mesh-list
2627018|NCT01916252|Bortezomib|bortezomib|mesh-list
2627019|NCT01916252|Melphalan|melphalan|mesh-list
2627020|NCT01916252|Busulfan|busulfan|mesh-list
2627021|NCT01916252|BB 1101|bb 1101|mesh-list
2627022|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2166841|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2166842|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2166843|NCT00000469|Analgesics|analgesics|mesh-ancestor
2166844|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
2166845|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166846|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166847|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2627023|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
2627024|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
2627025|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627026|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166848|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2166849|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2166850|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2166851|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627027|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2627028|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
2627029|NCT01916252|Hormones|hormones|mesh-ancestor
2627030|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2627031|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2627032|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627033|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
2627034|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2627035|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2627036|NCT01916252|Growth Substances|growth substances|mesh-ancestor
2627037|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
2627038|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2166852|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2166853|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2166854|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166855|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
2166856|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2166857|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2166858|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
2166859|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2166860|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2166861|NCT00000472|Heparin|heparin|mesh-list
2166862|NCT00000472|Plasminogen|plasminogen|mesh-list
2166863|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2166864|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
2627039|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
2627040|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627041|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2627042|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2627043|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
2627044|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627045|NCT01916265|Glucagon|glucagon|mesh-list
2627046|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2627047|NCT01916265|Hormones|hormones|mesh-ancestor
2627048|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2627049|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627050|NCT01916278|Lidocaine|lidocaine|mesh-list
2627051|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
2627052|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
2627053|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627054|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627055|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
2627056|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627057|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2627058|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2627059|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2627060|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2627061|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627062|NCT01916317|Lidocaine|lidocaine|mesh-list
2627063|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
2627064|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
2627065|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627066|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627067|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
2627068|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627069|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2627070|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2627071|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2627072|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2627073|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627074|NCT01916382|Nitisinone|nitisinone|mesh-list
2627075|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627076|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627077|NCT01916395|Sumatriptan|sumatriptan|mesh-list
2627078|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2627079|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2627080|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2627081|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
2627082|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627083|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627084|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627085|NCT01916408|Wobenzym|wobenzym|mesh-list
2627086|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2627087|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
2627088|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627089|NCT01916447|Bevacizumab|bevacizumab|mesh-list
2627090|NCT01916447|Irinotecan|irinotecan|mesh-list
2627091|NCT01916447|Camptothecin|camptothecin|mesh-list
2627092|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2627093|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627094|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2627095|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2627096|NCT01916447|Growth Substances|growth substances|mesh-ancestor
2627097|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627098|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
2166865|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2627099|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2627100|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2627101|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627102|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627103|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2627104|NCT01916577|Plerixafor|plerixafor|mesh-list
2627105|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2627106|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2627107|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
2627108|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2627109|NCT01916642|Lidocaine|lidocaine|mesh-list
2627110|NCT01916642|Etomidate|etomidate|mesh-list
2627111|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
2627112|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
2627113|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627114|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627115|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
2627116|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627117|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2627118|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2627119|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2627120|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2627121|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627122|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2627123|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2627124|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
2627125|NCT01916707|Enoxaparin|enoxaparin|mesh-list
2627126|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
2627127|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2627128|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2627129|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627130|NCT01916733|Insulin|insulin|mesh-list
2627131|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2627132|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627133|NCT01916785|Dasatinib|dasatinib|mesh-list
2627134|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627135|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2627136|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166866|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2166867|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166868|NCT00000477|Lovastatin|lovastatin|mesh-list
2166869|NCT00000477|L 647318|l 647318|mesh-list
2166870|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
2166871|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2166872|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2166873|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
2166874|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166875|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2166876|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2166877|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166878|NCT00000478|Atenolol|atenolol|mesh-list
2627137|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627138|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2627139|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2627140|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2627141|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2627142|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2627143|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2627144|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627145|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2627146|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627147|NCT01916863|Canagliflozin|canagliflozin|mesh-list
2627148|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2627149|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2627150|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627151|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2627152|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627153|NCT01916902|Ticagrelor|ticagrelor|mesh-list
2627154|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2166879|NCT00000478|Diltiazem|diltiazem|mesh-list
2627155|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2627156|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2627157|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2627158|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
2627159|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627160|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627161|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627162|NCT01916915|Tramadol|tramadol|mesh-list
2627163|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
2627164|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2166880|NCT00000478|Nifedipine|nifedipine|mesh-list
2166881|NCT00000478|Isosorbide|isosorbide|mesh-list
2166882|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2166883|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2166884|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2166885|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166886|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166887|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2166888|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166889|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
2166890|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
2166891|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2166892|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2627165|NCT01916915|Narcotics|narcotics|mesh-ancestor
2627166|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627167|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627168|NCT01916915|Analgesics|analgesics|mesh-ancestor
2627169|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
2627170|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627171|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
2627172|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
2627173|NCT01916954|Lumefantrine|lumefantrine|mesh-list
2627174|NCT01916954|Artemether|artemether|mesh-list
2627175|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2627176|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
2627177|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2627178|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2627179|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2627180|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
2627181|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2627182|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2627183|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627184|NCT01917032|Folic Acid|folic acid|mesh-list
2627185|NCT01917032|Vitamin A|vitamin a|mesh-list
2627186|NCT01917032|Micronutrients|micronutrients|mesh-list
2627187|NCT01917032|Trace Elements|trace elements|mesh-list
2627188|NCT01917032|Tretinoin|tretinoin|mesh-list
2627189|NCT01917032|Vitamins|vitamins|mesh-ancestor
2627190|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627191|NCT01917032|Hematinics|hematinics|mesh-ancestor
2627192|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
2627193|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627194|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
2627195|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
2627196|NCT01917045|Sufentanil|sufentanil|mesh-list
2627197|NCT01917045|Morphine|morphine|mesh-list
2627198|NCT01917045|Dsuvia|dsuvia|mesh-list
2627199|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2627200|NCT01917045|Narcotics|narcotics|mesh-ancestor
2627201|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627202|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627203|NCT01917045|Analgesics|analgesics|mesh-ancestor
2627204|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
2627205|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627206|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2627207|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2627208|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
2627209|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
2627210|NCT01917058|Abatacept|abatacept|mesh-list
2627211|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2627212|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166893|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2166894|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
2166895|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
2166896|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627213|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627214|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2627215|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
2627216|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627217|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2627218|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
2627219|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2627220|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627221|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627222|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2627223|NCT01917097|Analgesics|analgesics|mesh-ancestor
2627224|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
2166897|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2166898|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2166899|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2166900|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
2166901|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627225|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627226|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2627227|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2627228|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2627229|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
2627230|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166902|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2166903|NCT00000478|Diuretics|diuretics|mesh-ancestor
2166904|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
2166905|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2166906|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2166907|NCT00000482|Niacin|niacin|mesh-list
2166908|NCT00000482|Clofibrate|clofibrate|mesh-list
2166909|NCT00000482|Estrogens|estrogens|mesh-list
2166910|NCT00000482|Hormones|hormones|mesh-ancestor
2166911|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2166912|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166913|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2166914|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
2166915|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166916|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2166917|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
2166918|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
2166919|NCT00000482|Vitamins|vitamins|mesh-ancestor
2166920|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
2166921|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2166922|NCT00000483|Niacin|niacin|mesh-list
2166923|NCT00000483|Clofibrate|clofibrate|mesh-list
2166924|NCT00000483|Estrogens|estrogens|mesh-list
2166925|NCT00000483|Hormones|hormones|mesh-ancestor
2166926|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2166927|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166928|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2166929|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
2166930|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166931|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2166932|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
2166933|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
2166934|NCT00000483|Vitamins|vitamins|mesh-ancestor
2166935|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
2166936|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2166937|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
2166938|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2166939|NCT00000484|Diuretics|diuretics|mesh-ancestor
2166940|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
2627231|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627232|NCT01917149|Metoprolol|metoprolol|mesh-list
2627233|NCT01917149|Valsartan|valsartan|mesh-list
2627234|NCT01917149|Benazepril|benazepril|mesh-list
2627235|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2627236|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2627237|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2627238|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627239|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2627240|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
2627241|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
2627242|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166941|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166942|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2166943|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2166944|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166945|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
2166946|NCT00000485|Diuretics|diuretics|mesh-list
2166947|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
2166948|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166949|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
2166950|NCT00000487|Diuretics|diuretics|mesh-list
2166951|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
2166952|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166953|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
2166954|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2166955|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2166956|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
2166957|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166958|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2166959|NCT00000491|Aspirin|aspirin|mesh-list
2166960|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2166961|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2166962|NCT00000491|Analgesics|analgesics|mesh-ancestor
2166963|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
2166964|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2166965|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166966|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2166967|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2166968|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2166969|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2166970|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166971|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2166972|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2166973|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2166974|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
2166975|NCT00000492|Propranolol|propranolol|mesh-list
2166976|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2166977|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2166978|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
2166979|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2166980|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166981|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166982|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2627243|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627244|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2627245|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2627246|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2166983|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2166984|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
2166985|NCT00000493|Propranolol|propranolol|mesh-list
2166986|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2166987|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2166988|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
2166989|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422092|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627247|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
2627248|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422093|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2422094|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
2422095|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
2422096|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2422097|NCT00815893|Analgesics|analgesics|mesh-ancestor
2422098|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
2422099|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422100|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2422101|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2422102|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2422103|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
2422104|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422105|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422106|NCT00815945|Carboplatin|carboplatin|mesh-list
2422107|NCT00815945|Doxorubicin|doxorubicin|mesh-list
2422108|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422109|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2422110|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2422111|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2422112|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422113|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422114|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
2422115|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
2166990|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2166991|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2166992|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2166993|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2166994|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
2166995|NCT00000494|Indomethacin|indomethacin|mesh-list
2166996|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2166997|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2166998|NCT00000494|Analgesics|analgesics|mesh-ancestor
2166999|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
2167000|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167001|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167002|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2167003|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2167004|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
2167005|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
2167006|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2167007|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2167008|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167009|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167010|NCT00000496|Aspirin|aspirin|mesh-list
2167011|NCT00000496|Dipyridamole|dipyridamole|mesh-list
2167012|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2167013|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2167014|NCT00000496|Analgesics|analgesics|mesh-ancestor
2167015|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
2167016|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167017|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167018|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2167019|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2627249|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2627250|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
2627251|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627252|NCT01917279|Docetaxel|docetaxel|mesh-list
2627253|NCT01917279|Capecitabine|capecitabine|mesh-list
2627254|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627255|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
2627256|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
2627257|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
2627258|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627259|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2627260|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
2627261|NCT01917318|Iloperidone|iloperidone|mesh-list
2627262|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2627263|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2627264|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627265|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627266|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2627267|NCT01917331|Beclomethasone|beclomethasone|mesh-list
2627268|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
2627269|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
2627270|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2627271|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
2627272|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627273|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627274|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2167020|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2167021|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2167022|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167023|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2167024|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2167025|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167026|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
2167027|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2167028|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167029|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
2167030|NCT00000499|Metoprolol|metoprolol|mesh-list
2167031|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
2167032|NCT00000499|Hydralazine|hydralazine|mesh-list
2167033|NCT00000499|Reserpine|reserpine|mesh-list
2167034|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2167035|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2167036|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
2167037|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
2167038|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167039|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627275|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
2627276|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2627277|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2627278|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2627279|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
2627280|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627281|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627282|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2167040|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2167041|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2167042|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2167043|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
2167044|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2167045|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167046|NCT00000499|Diuretics|diuretics|mesh-ancestor
2167047|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
2167048|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2167049|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2167050|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167051|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2167052|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2167053|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2167054|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2627283|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2627284|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2627285|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
2627286|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2627287|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
2627288|NCT01917331|Hormones|hormones|mesh-ancestor
2627289|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2627290|NCT01917383|Timolol|timolol|mesh-list
2167055|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2167056|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2167057|NCT00000500|Aspirin|aspirin|mesh-list
2167058|NCT00000500|Carotenoids|carotenoids|mesh-list
2167059|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2167060|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2167061|NCT00000500|Analgesics|analgesics|mesh-ancestor
2167062|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
2627291|NCT01917383|Latanoprost|latanoprost|mesh-list
2627292|NCT01917383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2627293|NCT01917383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2627294|NCT01917383|Adrenergic Agents|adrenergic agents|mesh-ancestor
2627295|NCT01917383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627296|NCT01917383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627297|NCT01917383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627298|NCT01917383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2627299|NCT01917383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2627300|NCT01917383|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2627301|NCT01917383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2627302|NCT01917448|Morphine|morphine|mesh-list
2627303|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2627304|NCT01917448|Narcotics|narcotics|mesh-ancestor
2627305|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627306|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627307|NCT01917448|Analgesics|analgesics|mesh-ancestor
2627308|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
2627309|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627310|NCT01917552|Capecitabine|capecitabine|mesh-list
2627311|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2627312|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
2627313|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627314|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627315|NCT01917578|Paclitaxel|paclitaxel|mesh-list
2627316|NCT01917578|Docetaxel|docetaxel|mesh-list
2627317|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2627318|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
2627319|NCT01917578|Carboplatin|carboplatin|mesh-list
2627320|NCT01917578|Doxorubicin|doxorubicin|mesh-list
2627321|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2627322|NCT01917578|Fluorouracil|fluorouracil|mesh-list
2627323|NCT01917578|Trastuzumab|trastuzumab|mesh-list
2627324|NCT01917578|Epirubicin|epirubicin|mesh-list
2627325|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2627326|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627327|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
2627328|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
2627329|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
2627330|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627331|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2627332|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
2627333|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627334|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2627335|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2627336|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
2627337|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2627338|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2627339|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2627340|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2627341|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627342|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
2627343|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2627344|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2627345|NCT01917617|Gemcitabine|gemcitabine|mesh-list
2627346|NCT01917617|Cisplatin|cisplatin|mesh-list
2627347|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2627348|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627349|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2627350|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
2627351|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627352|NCT01917617|Antiviral Agents|antiviral agents|mesh-ancestor
2627353|NCT01917617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2627354|NCT01917617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627355|NCT01917617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2627356|NCT01917617|Immunologic Factors|immunologic factors|mesh-ancestor
2627357|NCT01917617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627358|NCT01917708|Abatacept|abatacept|mesh-list
2627359|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2627360|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627361|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627362|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2627363|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
2627364|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627365|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2627366|NCT01917721|Doxycycline|doxycycline|mesh-list
2627367|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2627368|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2627369|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
2627370|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2627371|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2627372|NCT01917799|Aspirin|aspirin|mesh-list
2627373|NCT01917799|Heparin|heparin|mesh-list
2627374|NCT01917799|Enoxaparin|enoxaparin|mesh-list
2627375|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2627376|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2627377|NCT01917799|Analgesics|analgesics|mesh-ancestor
2627378|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
2627379|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627380|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627381|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2627382|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2627383|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2627384|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2627385|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627386|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2627387|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2627388|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627389|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
2627390|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
2627391|NCT01917877|Dexamethasone|dexamethasone|mesh-list
2627392|NCT01917877|Bevacizumab|bevacizumab|mesh-list
2627393|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2627394|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627395|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2627396|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2627397|NCT01917877|Growth Substances|growth substances|mesh-ancestor
2627398|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627399|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
2627400|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2627401|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
2627402|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
2627403|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167063|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627404|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2627405|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
2627406|NCT01917877|Hormones|hormones|mesh-ancestor
2627407|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2627408|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2627409|NCT01917890|Curcumin|curcumin|mesh-list
2627410|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2627411|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2627412|NCT01917890|Analgesics|analgesics|mesh-ancestor
2627413|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
2627414|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627415|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627416|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2627417|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2627418|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627419|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627420|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627421|NCT01918098|Oxycodone|oxycodone|mesh-list
2627422|NCT01918098|Naloxone|naloxone|mesh-list
2627423|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2627424|NCT01918098|Narcotics|narcotics|mesh-ancestor
2627425|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627426|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627427|NCT01918098|Analgesics|analgesics|mesh-ancestor
2627428|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
2627429|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627430|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2627431|NCT01918111|Adenosine|adenosine|mesh-list
2627432|NCT01918111|Analgesics|analgesics|mesh-ancestor
2627433|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
2627434|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627435|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627436|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2627437|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
2627438|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2627439|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
2627440|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
2627441|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627442|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627443|NCT01918124|Paclitaxel|paclitaxel|mesh-list
2627444|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
2627445|NCT01918124|Cisplatin|cisplatin|mesh-list
2627446|NCT01918124|Carboplatin|carboplatin|mesh-list
2627447|NCT01918124|Doxorubicin|doxorubicin|mesh-list
2627448|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2627449|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627450|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
2627451|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
2627452|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
2627453|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627454|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2627455|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
2627456|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627457|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2627458|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2627459|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
2627460|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2627461|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2627462|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2627463|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2627464|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627465|NCT01918150|Cobalt|cobalt|mesh-list
2627466|NCT01918150|Chromium|chromium|mesh-list
2627467|NCT01918150|Trace Elements|trace elements|mesh-ancestor
2627468|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
2627469|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627470|NCT01918176|Palbociclib|palbociclib|mesh-list
2627471|NCT01918176|Rabeprazole|rabeprazole|mesh-list
2627472|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627473|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2627474|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627475|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627476|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2627477|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2627478|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2627479|NCT01918241|Lenograstim|lenograstim|mesh-list
2627480|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2627481|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
2627482|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627483|NCT01918254|Paclitaxel|paclitaxel|mesh-list
2627484|NCT01918254|Pertuzumab|pertuzumab|mesh-list
2627485|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2627486|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627487|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
2627488|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
2627489|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
2627490|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627491|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2627492|NCT01918358|Valsartan|valsartan|mesh-list
2627493|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2627494|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2627495|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2627496|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
2627497|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627498|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2627499|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2627500|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627501|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2627502|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2627503|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2627504|NCT01918384|Arbekacin|arbekacin|mesh-list
2627505|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2627506|NCT01918397|Levofloxacin|levofloxacin|mesh-list
2627507|NCT01918397|Ofloxacin|ofloxacin|mesh-list
2627508|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2627509|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2627510|NCT01918397|Renal Agents|renal agents|mesh-ancestor
2627511|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2627512|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2627513|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2627514|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627515|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627516|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627517|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2627518|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2627519|NCT01918475|Carbetocin|carbetocin|mesh-list
2627520|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
2627521|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2627522|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627523|NCT01918488|Amiloride|amiloride|mesh-list
2627524|NCT01918488|Triamterene|triamterene|mesh-list
2167064|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167065|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2167066|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2167067|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2167068|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2167069|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167070|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2167071|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2167072|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167073|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
2167074|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
2167075|NCT00000500|Protective Agents|protective agents|mesh-ancestor
2627525|NCT01918488|Diuretics|diuretics|mesh-ancestor
2627526|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
2627527|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627528|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2627529|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2627530|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2627531|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627532|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2167076|NCT00000503|Streptokinase|streptokinase|mesh-list
2167077|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
2167078|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167079|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2167080|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2167081|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167082|NCT00000504|Flecainide|flecainide|mesh-list
2167083|NCT00000504|Moricizine|moricizine|mesh-list
2167084|NCT00000504|Encainide|encainide|mesh-list
2167085|NCT00000504|Imipramine|imipramine|mesh-list
2167086|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2167087|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2167088|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2167089|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2167090|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167091|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2167092|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
2167093|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2167094|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2167095|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2167096|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
2167097|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2167098|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167099|NCT00000505|Plasminogen|plasminogen|mesh-list
2167100|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2167101|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2167102|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2167103|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167104|NCT00000506|Phentermine|phentermine|mesh-list
2167105|NCT00000506|Fenfluramine|fenfluramine|mesh-list
2167106|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2627533|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2627534|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
2627535|NCT01918514|Analgesics|analgesics|mesh-ancestor
2627536|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
2627537|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627538|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627539|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
2627540|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627541|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2627542|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
2627543|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2627544|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2627545|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627546|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2627547|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
2627548|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2627549|NCT01918527|Capecitabine|capecitabine|mesh-list
2627550|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
2627551|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2627552|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
2627553|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627554|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627555|NCT01918631|Tenofovir|tenofovir|mesh-list
2627556|NCT01918631|Entecavir|entecavir|mesh-list
2167107|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167108|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
2167109|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2167110|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
2167111|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
2167112|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167113|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
2167114|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2167115|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167116|NCT00000506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2167117|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2167118|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2167119|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
2167120|NCT00000507|Streptokinase|streptokinase|mesh-list
2167121|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2167122|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2167123|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167124|NCT00000510|Aspirin|aspirin|mesh-list
2167125|NCT00000510|Dipyridamole|dipyridamole|mesh-list
2167126|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2167127|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2167128|NCT00000510|Analgesics|analgesics|mesh-ancestor
2167129|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
2167130|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167131|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167132|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2627557|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
2627558|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2627559|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2627560|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2627561|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627562|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627563|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2627564|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2627565|NCT01918644|Capecitabine|capecitabine|mesh-list
2627566|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2627567|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
2627568|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627569|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627570|NCT01918709|Valsartan|valsartan|mesh-list
2627571|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2627572|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2627573|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2627574|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
2627575|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627576|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2627577|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2627578|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627579|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2627580|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2627581|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2627582|NCT01918813|Vancomycin|vancomycin|mesh-list
2627583|NCT01918813|Mupirocin|mupirocin|mesh-list
2627584|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2167133|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2167134|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2167135|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2167136|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167137|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2167138|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2167139|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167140|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
2167141|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2627585|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2627586|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2627587|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627588|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627589|NCT01918852|Bevacizumab|bevacizumab|mesh-list
2627590|NCT01918852|Capecitabine|capecitabine|mesh-list
2167142|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167143|NCT00000512|Niacin|niacin|mesh-list
2167144|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
2167145|NCT00000512|Lovastatin|lovastatin|mesh-list
2167146|NCT00000512|L 647318|l 647318|mesh-list
2167147|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
2167148|NCT00000512|Colestipol|colestipol|mesh-list
2167149|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2167150|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
2167151|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167152|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2167153|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167154|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
2167155|NCT00000512|Vitamins|vitamins|mesh-ancestor
2167156|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
2167157|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167158|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2167159|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2167160|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167161|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
2167162|NCT00000513|Atenolol|atenolol|mesh-list
2167163|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
2167164|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2167165|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2167166|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
2167167|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
2167168|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167169|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167170|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2167171|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2167172|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2167173|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
2167174|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2184869|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2167175|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167176|NCT00000513|Diuretics|diuretics|mesh-ancestor
2627591|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2627592|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627593|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2627594|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2627595|NCT01918852|Growth Substances|growth substances|mesh-ancestor
2627596|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627597|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
2627598|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2627599|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
2627600|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627601|NCT01918865|Metformin|metformin|mesh-list
2627602|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2627603|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627604|NCT01918878|Aflibercept|aflibercept|mesh-list
2627605|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2627606|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2627607|NCT01918878|Growth Substances|growth substances|mesh-ancestor
2627608|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627609|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
2627610|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627611|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
2627612|NCT01918904|Antidotes|antidotes|mesh-ancestor
2167177|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
2167178|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2167179|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2167180|NCT00000514|Atenolol|atenolol|mesh-list
2167181|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
2167182|NCT00000514|Reserpine|reserpine|mesh-list
2167183|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2167184|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2167185|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
2167186|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
2167187|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167188|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167189|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2167190|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2167191|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2167192|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
2167193|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627613|NCT01918904|Protective Agents|protective agents|mesh-ancestor
2627614|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627615|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
2627616|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627617|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
2627618|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2627619|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2627620|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
2627621|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
2627622|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
2627623|NCT01918917|Morphine|morphine|mesh-list
2627624|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
2627625|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2627626|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2167194|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167195|NCT00000514|Diuretics|diuretics|mesh-ancestor
2167196|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
2167197|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2167198|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2167199|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2167200|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2167201|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2167202|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2627627|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627628|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2627629|NCT01918917|Analgesics|analgesics|mesh-ancestor
2627630|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
2627631|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627632|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2627633|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2627634|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2627635|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
2627636|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2184870|NCT00002835|Prednisolone|prednisolone|mesh-list
2167203|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2627637|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627638|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2627639|NCT01918917|Narcotics|narcotics|mesh-ancestor
2627640|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
2627641|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
2627642|NCT01918995|Regadenoson|regadenoson|mesh-list
2627643|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2627644|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2627645|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
2627646|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
2627647|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627648|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627649|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627650|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2627651|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
2627652|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2167204|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2167205|NCT00000516|Enalapril|enalapril|mesh-list
2167206|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2167207|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
2167208|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167209|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167210|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2167211|NCT00000517|Warfarin|warfarin|mesh-list
2167212|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
2167213|NCT00000518|Quinidine|quinidine|mesh-list
2167214|NCT00000518|Sotalol|sotalol|mesh-list
2167215|NCT00000518|Mexiletine|mexiletine|mesh-list
2167216|NCT00000518|Procainamide|procainamide|mesh-list
2167217|NCT00000518|Imipramine|imipramine|mesh-list
2167218|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2167219|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2167220|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
2167221|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2167222|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167223|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167224|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2167225|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
2627653|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2627654|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2627655|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627656|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627657|NCT01919047|Mirabegron|mirabegron|mesh-list
2627658|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2627659|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2627660|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2627661|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
2627662|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627663|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627664|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627665|NCT01919047|Urological Agents|urological agents|mesh-ancestor
2627666|NCT01919086|Dexamethasone|dexamethasone|mesh-list
2627667|NCT01919086|Lenalidomide|lenalidomide|mesh-list
2627668|NCT01919086|Bortezomib|bortezomib|mesh-list
2627669|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2627670|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
2627671|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
2627672|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627673|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167226|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
2167227|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167228|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2167229|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
2167230|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2167231|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2167232|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2167233|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2167234|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2167235|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
2167236|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2167237|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2167238|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2167239|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167240|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2184871|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
2627674|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2627675|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
2627676|NCT01919086|Hormones|hormones|mesh-ancestor
2627677|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2627678|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2627679|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627680|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
2627681|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2627682|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2627683|NCT01919086|Growth Substances|growth substances|mesh-ancestor
2627684|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
2627685|NCT01919203|Remifentanil|remifentanil|mesh-list
2627686|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2627687|NCT01919203|Narcotics|narcotics|mesh-ancestor
2627688|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627689|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627690|NCT01919203|Analgesics|analgesics|mesh-ancestor
2627691|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
2627692|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627693|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
2167241|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2167242|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
2167243|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2167244|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2167245|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2167246|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2167247|NCT00000520|Aspirin|aspirin|mesh-list
2167248|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
2167249|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2167250|NCT00000520|Antibodies|antibodies|mesh-list
2167251|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
2167252|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2167253|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2167254|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2167255|NCT00000520|Analgesics|analgesics|mesh-ancestor
2167256|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
2167257|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167258|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167259|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2167260|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2167261|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2167262|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2167263|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167264|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2167265|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2167266|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167267|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
2167268|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
2167269|NCT00000522|Acebutolol|acebutolol|mesh-list
2167270|NCT00000522|Amlodipine|amlodipine|mesh-list
2167271|NCT00000522|Enalapril|enalapril|mesh-list
2167272|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
2167273|NCT00000522|Doxazosin|doxazosin|mesh-list
2167274|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2167275|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2167276|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2167277|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167278|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2167279|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627694|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
2627695|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
2627696|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
2627697|NCT01919255|Citric Acid|citric acid|mesh-list
2627698|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
2627699|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2627700|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
2627701|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
2627702|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627703|NCT01919255|Cathartics|cathartics|mesh-ancestor
2167280|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167281|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2167282|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
2627704|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2627705|NCT01919255|Antacids|antacids|mesh-ancestor
2627706|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
2627707|NCT01919294|Testosterone|testosterone|mesh-list
2627708|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
2167283|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627709|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
2627710|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2627711|NCT01919294|Androgens|androgens|mesh-ancestor
2627712|NCT01919294|Hormones|hormones|mesh-ancestor
2627713|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2627714|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627715|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2627716|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627717|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
2627718|NCT01919346|Eculizumab|eculizumab|mesh-list
2627719|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2627720|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2627721|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
2627722|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627723|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
2627724|NCT01919424|Miotics|miotics|mesh-ancestor
2627725|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
2627726|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167284|NCT00000522|Diuretics|diuretics|mesh-ancestor
2167285|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
2167286|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2167287|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2167288|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2167289|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2167290|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
2167291|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2167292|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2167293|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
2167294|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
2167295|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167296|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2167297|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2167298|NCT00000524|Cyclosporine|cyclosporine|mesh-list
2167299|NCT00000524|Prednisone|prednisone|mesh-list
2167300|NCT00000524|Cyclosporins|cyclosporins|mesh-list
2167301|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2167302|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
2167303|NCT00000524|Hormones|hormones|mesh-ancestor
2167304|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2627727|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627728|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2627729|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2627730|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
2627731|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2627732|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2627733|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
2167305|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167306|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2627734|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627735|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627736|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
2627737|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2627738|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
2627739|NCT01919593|Povidone|povidone|mesh-list
2627740|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2627741|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2627742|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
2627743|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
2627744|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
2627745|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
2627746|NCT01919619|Lenalidomide|lenalidomide|mesh-list
2627747|NCT01919619|Ipilimumab|ipilimumab|mesh-list
2627748|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
2627749|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627750|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2627751|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2627752|NCT01919619|Growth Substances|growth substances|mesh-ancestor
2627753|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
2627754|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167307|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167308|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167309|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167310|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2627755|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2627756|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2167311|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
2167312|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
2167313|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2167314|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
2167315|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2167316|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2167317|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2167318|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
2167319|NCT00000525|Triamterene|triamterene|mesh-list
2167320|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2167321|NCT00000525|Diuretics|diuretics|mesh-ancestor
2167322|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
2167323|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167324|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2167325|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2167326|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167327|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2167328|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2167329|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2167330|NCT00000526|Flecainide|flecainide|mesh-list
2167331|NCT00000526|Moricizine|moricizine|mesh-list
2167332|NCT00000526|Encainide|encainide|mesh-list
2167333|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2167334|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2167335|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2167336|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2167337|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167338|NCT00000527|Aspirin|aspirin|mesh-list
2167339|NCT00000527|Dipyridamole|dipyridamole|mesh-list
2167340|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2167341|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2167342|NCT00000527|Analgesics|analgesics|mesh-ancestor
2167343|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
2167344|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627757|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627758|NCT01919788|Insulin|insulin|mesh-list
2627759|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2627760|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627761|NCT01919879|Cetuximab|cetuximab|mesh-list
2627762|NCT01919879|Afatinib|afatinib|mesh-list
2627763|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2627764|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627765|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2627766|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627767|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627768|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
2627769|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
2627770|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2627771|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627772|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627773|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
2627774|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2627775|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2167345|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167346|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2167347|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2167348|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2167349|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2167350|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167351|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2167352|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2167353|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167354|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
2167355|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2167356|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
2422116|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422117|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2422118|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422119|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2422120|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
2167357|NCT00000529|Tamoxifen|tamoxifen|mesh-list
2167358|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2422121|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422122|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2627776|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627777|NCT01919905|Vitamin D|vitamin d|mesh-list
2627778|NCT01919905|Vitamins|vitamins|mesh-ancestor
2627779|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
2627780|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627781|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2627782|NCT01919918|Adenosine|adenosine|mesh-list
2627783|NCT01919918|Analgesics|analgesics|mesh-ancestor
2627784|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
2627785|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627786|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627787|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2627788|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
2627789|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2627790|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
2627791|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
2627792|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627793|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627794|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
2627795|NCT01920022|Mifepristone|mifepristone|mesh-list
2627796|NCT01920022|Etonogestrel|etonogestrel|mesh-list
2627797|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2627798|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627799|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2627800|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
2627801|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2627802|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2627803|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2627804|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2627805|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2627806|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
2627807|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2627808|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
2627809|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2627810|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2627811|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
2627812|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
2627813|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
2627814|NCT01920113|Remifentanil|remifentanil|mesh-list
2627815|NCT01920113|Propofol|propofol|mesh-list
2167359|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
2167360|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167361|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167362|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2167363|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167364|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2167365|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2167366|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2627816|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2627817|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627818|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627819|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2627820|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
2627821|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
2627822|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2627823|NCT01920113|Analgesics|analgesics|mesh-ancestor
2627824|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
2627825|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627826|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2627827|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2627828|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2627829|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
2627830|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627831|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627832|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2627833|NCT01920113|Narcotics|narcotics|mesh-ancestor
2627834|NCT01920191|Poly ICLC|poly iclc|mesh-list
2627835|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
2627836|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
2627837|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627838|NCT01920204|Midostaurin|midostaurin|mesh-list
2627839|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627840|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2627841|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627842|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627843|NCT01920269|Mitomycins|mitomycins|mesh-list
2627844|NCT01920269|Mitomycin|mitomycin|mesh-list
2627845|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2167367|NCT00000530|Nifedipine|nifedipine|mesh-list
2167368|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2167369|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2167370|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167371|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2167372|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167373|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167374|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
2167375|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2627846|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627847|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
2627848|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627849|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2627850|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627851|NCT01920334|Zolpidem|zolpidem|mesh-list
2627852|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2627853|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2627854|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627855|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627856|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2627857|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
2627858|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
2627859|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627860|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627861|NCT01920386|Acetaminophen|acetaminophen|mesh-list
2627862|NCT01920386|Tramadol|tramadol|mesh-list
2627863|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2627864|NCT01920386|Analgesics|analgesics|mesh-ancestor
2627865|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
2627866|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627867|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627868|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
2627869|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2627870|NCT01920386|Narcotics|narcotics|mesh-ancestor
2627871|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627872|NCT01920503|Doxorubicin|doxorubicin|mesh-list
2627873|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2627874|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627875|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2627876|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2627877|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627878|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627879|NCT01920516|Melphalan|melphalan|mesh-list
2627880|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2627881|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
2627882|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627883|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627884|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2627885|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2627886|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
2627887|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627888|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
2627889|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2627890|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2627891|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627892|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2627893|NCT01920542|Analgesics|analgesics|mesh-ancestor
2627894|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
2627895|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627896|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2627897|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2627898|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2627899|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
2167376|NCT00000531|Amiodarone|amiodarone|mesh-list
2167377|NCT00000531|Sotalol|sotalol|mesh-list
2167378|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2167379|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167380|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2167381|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2184872|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
2627900|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2627901|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627902|NCT01920737|Leucovorin|leucovorin|mesh-list
2627903|NCT01920737|Cytarabine|cytarabine|mesh-list
2627904|NCT01920737|Dexamethasone|dexamethasone|mesh-list
2627905|NCT01920737|Prednisone|prednisone|mesh-list
2627906|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
2627907|NCT01920737|Methotrexate|methotrexate|mesh-list
2627908|NCT01920737|Vincristine|vincristine|mesh-list
2627909|NCT01920737|Daunorubicin|daunorubicin|mesh-list
2627910|NCT01920737|Asparaginase|asparaginase|mesh-list
2627911|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
2167382|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167383|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2627912|NCT01920737|Pegaspargase|pegaspargase|mesh-list
2627913|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2627914|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
2627915|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627916|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2627917|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2627918|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
2627919|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167384|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2167385|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2167386|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627920|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627921|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2627922|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2627923|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
2627924|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
2627925|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627926|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2627927|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
2627928|NCT01920737|Hormones|hormones|mesh-ancestor
2627929|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2627930|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2627931|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2627932|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
2627933|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2627934|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2627935|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
2627936|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
2627937|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627938|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2627939|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2627940|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
2627941|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2627942|NCT01920737|Antidotes|antidotes|mesh-ancestor
2627943|NCT01920737|Protective Agents|protective agents|mesh-ancestor
2167387|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2167388|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2167389|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2167390|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2167391|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2167392|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
2167393|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2167394|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167395|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
2167396|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
2167397|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167398|NCT00000534|Calcium|calcium|mesh-list
2167399|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2167400|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167401|NCT00000539|Vitamins|vitamins|mesh-list
2167402|NCT00000539|Vitamin E|vitamin e|mesh-list
2167403|NCT00000539|Beta Carotene|beta carotene|mesh-list
2167404|NCT00000539|Warfarin|warfarin|mesh-list
2167405|NCT00000539|Pravastatin|pravastatin|mesh-list
2167406|NCT00000539|Carotenoids|carotenoids|mesh-list
2167407|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
2167408|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167409|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
2167410|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
2167411|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167412|NCT00000539|Protective Agents|protective agents|mesh-ancestor
2167413|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2627944|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
2627945|NCT01920737|Vitamins|vitamins|mesh-ancestor
2627946|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
2627947|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2627948|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
2627949|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
2627950|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
2627951|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2627952|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2627953|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2627954|NCT01920919|Dexamethasone|dexamethasone|mesh-list
2627955|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2627956|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
2627957|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
2627958|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627959|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627960|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2167414|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
2167415|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2167416|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2167417|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2167418|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167419|NCT00000539|Provitamins|provitamins|mesh-ancestor
2167420|NCT00000541|Vitamins|vitamins|mesh-list
2167421|NCT00000541|Folic Acid|folic acid|mesh-list
2167422|NCT00000541|Vitamin E|vitamin e|mesh-list
2167423|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
2167424|NCT00000541|Hydroxocobalamin|hydroxocobalamin|mesh-list
2167425|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
2167426|NCT00000541|Pyridoxal|pyridoxal|mesh-list
2167427|NCT00000541|Pyridoxine|pyridoxine|mesh-list
2167428|NCT00000541|Beta Carotene|beta carotene|mesh-list
2627961|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
2627962|NCT01920919|Hormones|hormones|mesh-ancestor
2627963|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2627964|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2627965|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627966|NCT01920932|Prednisone|prednisone|mesh-list
2627967|NCT01920932|Prednisolone|prednisolone|mesh-list
2627968|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
2627969|NCT01920932|Dacarbazine|dacarbazine|mesh-list
2627970|NCT01920932|Doxorubicin|doxorubicin|mesh-list
2627971|NCT01920932|Etoposide|etoposide|mesh-list
2627972|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2627973|NCT01920932|Imidazole|imidazole|mesh-list
2627974|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2627975|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
2167429|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
2167430|NCT00000541|Carotenoids|carotenoids|mesh-list
2167431|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
2167432|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167433|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
2167434|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167435|NCT00000541|Protective Agents|protective agents|mesh-ancestor
2167436|NCT00000541|Hematinics|hematinics|mesh-ancestor
2167437|NCT00000541|Provitamins|provitamins|mesh-ancestor
2167438|NCT00000542|Amlodipine|amlodipine|mesh-list
2167439|NCT00000542|Lisinopril|lisinopril|mesh-list
2167440|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
2167441|NCT00000542|Doxazosin|doxazosin|mesh-list
2167442|NCT00000542|Pravastatin|pravastatin|mesh-list
2167443|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2167444|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2167445|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2627976|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627977|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2627978|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2167446|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2167447|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167448|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2167449|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167450|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167451|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2167452|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2167453|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
2167454|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2167455|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2167456|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167457|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
2627979|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
2627980|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2627981|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2627982|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2627983|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2627984|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2627985|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2627986|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2627987|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2627988|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
2627989|NCT01920932|Hormones|hormones|mesh-ancestor
2627990|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2627991|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2627992|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2627993|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2627994|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2627995|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2627996|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2627997|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2627998|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2627999|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2628000|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2628001|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628002|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
2167458|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2167459|NCT00000542|Protective Agents|protective agents|mesh-ancestor
2167460|NCT00000542|Diuretics|diuretics|mesh-ancestor
2167461|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
2167462|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2167463|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2167464|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2167465|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2167466|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
2167467|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2167468|NCT00000543|Calcium|calcium|mesh-list
2167469|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2167470|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167471|NCT00000547|Enalapril|enalapril|mesh-list
2167472|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2167473|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
2167474|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167475|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167476|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2167477|NCT00000549|Hormones|hormones|mesh-list
2167478|NCT00000549|Estrogens|estrogens|mesh-list
2167479|NCT00000549|Progestins|progestins|mesh-list
2167480|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167481|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628003|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628004|NCT01920984|Bevacizumab|bevacizumab|mesh-list
2628005|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2628006|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628007|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2628008|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2628009|NCT01920984|Growth Substances|growth substances|mesh-ancestor
2628010|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628011|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
2628012|NCT01921010|Niacin|niacin|mesh-list
2628013|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
2628014|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2628015|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
2628016|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628017|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2628018|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
2628019|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
2628020|NCT01921010|Vitamins|vitamins|mesh-ancestor
2628021|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
2628022|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628023|NCT01921192|Folic Acid|folic acid|mesh-list
2628024|NCT01921192|Hematinics|hematinics|mesh-ancestor
2628025|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
2628026|NCT01921192|Vitamins|vitamins|mesh-ancestor
2628027|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
2628028|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628029|NCT01921218|Cyclosporine|cyclosporine|mesh-list
2167482|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
2628030|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
2628031|NCT01921218|Prednisone|prednisone|mesh-list
2628032|NCT01921218|Abatacept|abatacept|mesh-list
2628033|NCT01921218|Tacrolimus|tacrolimus|mesh-list
2628034|NCT01921218|Cyclosporins|cyclosporins|mesh-list
2628035|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2628036|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2628037|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
2628038|NCT01921218|Hormones|hormones|mesh-ancestor
2628039|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628040|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628041|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2628042|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628043|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2628044|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
2628045|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628046|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628047|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
2628048|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628049|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
2628050|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2628051|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2628052|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2628053|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
2167483|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2167484|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167485|NCT00000553|Niacin|niacin|mesh-list
2167486|NCT00000553|Simvastatin|simvastatin|mesh-list
2167487|NCT00000553|Antioxidants|antioxidants|mesh-list
2167488|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2167489|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2167490|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
2167491|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167492|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2628054|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2628055|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2628056|NCT01921231|Bupivacaine|bupivacaine|mesh-list
2628057|NCT01921231|Prilocaine|prilocaine|mesh-list
2628058|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
2628059|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
2628060|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2628061|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628062|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
2628063|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167493|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2167494|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628067|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
2628068|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
2628069|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2628070|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2628071|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628072|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2628073|NCT01921361|Analgesics|analgesics|mesh-ancestor
2628074|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
2628075|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628076|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2628077|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2628078|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2628079|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
2628080|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628081|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628082|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
2628083|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
2628084|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
2628085|NCT01921374|Interferons|interferons|mesh-list
2628086|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
2628087|NCT01921374|Interleukin-2|interleukin-2|mesh-list
2628088|NCT01921374|Interleukin-4|interleukin-4|mesh-list
2167495|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167496|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
2167497|NCT00000553|Vitamins|vitamins|mesh-ancestor
2628089|NCT01921374|Dinoprostone|dinoprostone|mesh-list
2628090|NCT01921374|Hormones|hormones|mesh-list
2628091|NCT01921374|Estradiol|estradiol|mesh-list
2628092|NCT01921374|Testosterone|testosterone|mesh-list
2628093|NCT01921374|Progesterone|progesterone|mesh-list
2628094|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2628095|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2628096|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2628097|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
2628098|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2628099|NCT01921374|Antibodies|antibodies|mesh-list
2628100|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
2628101|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
2628102|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
2628103|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
2628104|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
2628105|NCT01921374|Uric Acid|uric acid|mesh-list
2628106|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167498|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
2167499|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167500|NCT00000553|Protective Agents|protective agents|mesh-ancestor
2167501|NCT00000554|Dobutamine|dobutamine|mesh-list
2167502|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2167503|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
2167504|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
2628107|NCT01921374|Vitamins|vitamins|mesh-ancestor
2628108|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
2628109|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628110|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
2628111|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628112|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628113|NCT01921374|Estrogens|estrogens|mesh-ancestor
2628114|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2628115|NCT01921374|Androgens|androgens|mesh-ancestor
2628116|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
2628117|NCT01921374|Progestins|progestins|mesh-ancestor
2628118|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2628119|NCT01921374|Analgesics|analgesics|mesh-ancestor
2628120|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
2628121|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167505|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167506|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167507|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2167508|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2167509|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2167510|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
2167511|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2167512|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167513|NCT00000554|Protective Agents|protective agents|mesh-ancestor
2167514|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
2167515|NCT00000555|Vitamin E|vitamin e|mesh-list
2167516|NCT00000555|Hormones|hormones|mesh-list
2167517|NCT00000555|Progesterone|progesterone|mesh-list
2167518|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2167519|NCT00000555|Estrogens|estrogens|mesh-list
2167520|NCT00000555|Vitamins|vitamins|mesh-ancestor
2628122|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
2628123|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628124|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628125|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
2628126|NCT01921374|Protective Agents|protective agents|mesh-ancestor
2628127|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
2628128|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2628129|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2628130|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
2628131|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
2628132|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628133|NCT01921426|Protective Agents|protective agents|mesh-ancestor
2628134|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628135|NCT01921582|Methylphenidate|methylphenidate|mesh-list
2628136|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2628137|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628138|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2628139|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2628140|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2628141|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628142|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
2628143|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628144|NCT01921647|Amoxicillin|amoxicillin|mesh-list
2628145|NCT01921647|Clarithromycin|clarithromycin|mesh-list
2628146|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2628147|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2167521|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
2628148|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2628149|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628150|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628151|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2628152|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2628153|NCT01921673|Docetaxel|docetaxel|mesh-list
2628154|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628155|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
2628156|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
2628157|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
2628158|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628159|NCT01921738|Azithromycin|azithromycin|mesh-list
2628160|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2628161|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628162|NCT01921790|Gemcitabine|gemcitabine|mesh-list
2628163|NCT01921790|Dexamethasone|dexamethasone|mesh-list
2628164|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
2628165|NCT01921790|Bevacizumab|bevacizumab|mesh-list
2628166|NCT01921790|Pegaspargase|pegaspargase|mesh-list
2628167|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2628168|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
2628169|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
2167522|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167523|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167524|NCT00000555|Progestins|progestins|mesh-ancestor
2167525|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
2167526|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167527|NCT00000555|Protective Agents|protective agents|mesh-ancestor
2167528|NCT00000556|Quinidine|quinidine|mesh-list
2167529|NCT00000556|Digoxin|digoxin|mesh-list
2167530|NCT00000556|Amiodarone|amiodarone|mesh-list
2167531|NCT00000556|Verapamil|verapamil|mesh-list
2167532|NCT00000556|Sotalol|sotalol|mesh-list
2167533|NCT00000556|Flecainide|flecainide|mesh-list
2167534|NCT00000556|Propafenone|propafenone|mesh-list
2167535|NCT00000556|Procainamide|procainamide|mesh-list
2167536|NCT00000556|Moricizine|moricizine|mesh-list
2628170|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628171|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628172|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2628173|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
2628174|NCT01921790|Hormones|hormones|mesh-ancestor
2628175|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167537|NCT00000556|Disopyramide|disopyramide|mesh-list
2167538|NCT00000556|Diltiazem|diltiazem|mesh-list
2167539|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2167540|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
2628176|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2628177|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628178|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2628179|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
2628180|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628181|NCT01921790|Antiviral Agents|antiviral agents|mesh-ancestor
2628182|NCT01921790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628183|NCT01921790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628184|NCT01921790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2167541|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2167542|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2167543|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167544|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167545|NCT00000556|Protective Agents|protective agents|mesh-ancestor
2628185|NCT01921790|Immunologic Factors|immunologic factors|mesh-ancestor
2628186|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2628187|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2628188|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2628189|NCT01921790|Growth Substances|growth substances|mesh-ancestor
2628190|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
2628191|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
2628192|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2628193|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
2628194|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
2628195|NCT01921868|Vitamins|vitamins|mesh-ancestor
2628196|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
2628197|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628198|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
2628199|NCT01921920|Omeprazole|omeprazole|mesh-list
2628200|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2167546|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628201|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2628202|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2628203|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628204|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628205|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2628206|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2628207|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2628208|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
2628209|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628210|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2628211|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2628212|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628213|NCT01921972|Memantine|memantine|mesh-list
2628214|NCT01921972|Galantamine|galantamine|mesh-list
2628215|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2628216|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2628217|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
2628218|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628219|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628220|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628221|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2628222|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2628223|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2628224|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628225|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
2628226|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2628227|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
2628228|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628229|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
2628230|NCT01921985|Terlipressin|terlipressin|mesh-list
2628231|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2628232|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2628233|NCT01922141|Amlodipine|amlodipine|mesh-list
2628234|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2628235|NCT01922141|Ramipril|ramipril|mesh-list
2628236|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2167547|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167548|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2167549|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2167550|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2167551|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2167552|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2167553|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2167554|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2628237|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2628238|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2628239|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628240|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2628241|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628242|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
2628243|NCT01922141|Diuretics|diuretics|mesh-ancestor
2628244|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
2628245|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2628246|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2628247|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
2628248|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628249|NCT01922154|Ranibizumab|ranibizumab|mesh-list
2628250|NCT01922154|Mitomycin|mitomycin|mesh-list
2628251|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2628252|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2628253|NCT01922154|Growth Substances|growth substances|mesh-ancestor
2628254|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628255|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
2167555|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2167556|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2167557|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2628256|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628257|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
2628258|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628259|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2628260|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2628261|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628262|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2628263|NCT01922193|Hormones|hormones|mesh-ancestor
2628264|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628265|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167558|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2167559|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2628266|NCT01922375|Naftopidil|naftopidil|mesh-list
2628267|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2628268|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2628269|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
2628270|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628271|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628272|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628273|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2628274|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2628275|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2628276|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2628277|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2628278|NCT01922427|RNS60|rns60|mesh-list
2628279|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2628280|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2628281|NCT01922427|Analgesics|analgesics|mesh-ancestor
2628282|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
2628283|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628284|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628285|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2628286|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2167560|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2167561|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
2167562|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
2167563|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167564|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2167565|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2167566|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
2167567|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2167568|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2167569|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2167570|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2167571|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2628287|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2628288|NCT01922440|Parathyroid Hormone|parathyroid hormone|mesh-list
2167572|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
2167573|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2167574|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2167575|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167576|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
2167577|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2167578|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
2167579|NCT00000559|Hormones|hormones|mesh-list
2167580|NCT00000559|Estradiol|estradiol|mesh-list
2167581|NCT00000559|Estrogens|estrogens|mesh-list
2167582|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167583|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167584|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2167585|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
2628289|NCT01922440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2628290|NCT01922440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628291|NCT01922466|Loxoprofen|loxoprofen|mesh-list
2628292|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2628293|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2628294|NCT01922466|Analgesics|analgesics|mesh-ancestor
2167586|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2167587|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2167588|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2167589|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2167590|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2167591|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2167592|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2167593|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167594|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
2167595|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2167596|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2184873|NCT00002835|Melphalan|melphalan|mesh-list
2167597|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167598|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167599|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2167600|NCT00000563|Dexamethasone|dexamethasone|mesh-list
2167601|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2167602|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
2167603|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
2167604|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167605|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167606|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2167607|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
2167608|NCT00000563|Hormones|hormones|mesh-ancestor
2167609|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167610|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2167611|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167612|NCT00000568|Ipratropium|ipratropium|mesh-list
2167613|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2167614|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
2167615|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167616|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167617|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2167618|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
2167619|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2167620|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
2167621|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2167622|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167623|NCT00000569|Triamcinolone|triamcinolone|mesh-list
2167624|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2167625|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
2167626|NCT00000569|Hormones|hormones|mesh-ancestor
2167627|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167628|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167629|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2167630|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
2167631|NCT00000574|Ibuprofen|ibuprofen|mesh-list
2167632|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2167633|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2167634|NCT00000574|Analgesics|analgesics|mesh-ancestor
2167635|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
2167636|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167637|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167638|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2167639|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2167640|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2167641|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167642|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628295|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
2628296|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628297|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628298|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2628299|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2628300|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2628301|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628302|NCT01922596|Ropivacaine|ropivacaine|mesh-list
2167643|NCT00000576|Beclomethasone|beclomethasone|mesh-list
2167644|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2167645|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
2167646|NCT00000576|Hormones|hormones|mesh-ancestor
2167647|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167648|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167649|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2167650|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
2167651|NCT00000577|Colchicine|colchicine|mesh-list
2167652|NCT00000577|Albuterol|albuterol|mesh-list
2167653|NCT00000577|Hormones|hormones|mesh-list
2167654|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
2167655|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
2167656|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167657|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167658|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2167659|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
2167660|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167661|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2628303|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
2628304|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
2628305|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2628306|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628307|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
2628308|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628309|NCT01922687|Amlodipine|amlodipine|mesh-list
2628310|NCT01922687|Atorvastatin|atorvastatin|mesh-list
2628311|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2628312|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2628313|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
2628314|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628315|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2628316|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2628317|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628318|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2628319|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2628320|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2628321|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2628322|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628323|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
2628324|NCT01922713|Vitamin A|vitamin a|mesh-list
2628325|NCT01922713|Beta Carotene|beta carotene|mesh-list
2628326|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
2628327|NCT01922713|Vitamins|vitamins|mesh-ancestor
2628328|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
2628329|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628330|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
2628331|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628332|NCT01922713|Protective Agents|protective agents|mesh-ancestor
2628333|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2628334|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628335|NCT01922713|Provitamins|provitamins|mesh-ancestor
2628336|NCT01922765|Amoxicillin|amoxicillin|mesh-list
2628337|NCT01922765|Metronidazole|metronidazole|mesh-list
2628338|NCT01922765|Clarithromycin|clarithromycin|mesh-list
2628339|NCT01922765|Rabeprazole|rabeprazole|mesh-list
2628340|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2628341|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628342|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2628343|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2628344|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2628345|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628346|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628347|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2628348|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2628349|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2628350|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2628351|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2628352|NCT01922804|Vitamins|vitamins|mesh-list
2628353|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
2628354|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628355|NCT01922817|Saxagliptin|saxagliptin|mesh-list
2628356|NCT01922817|Incretins|incretins|mesh-ancestor
2628357|NCT01922817|Hormones|hormones|mesh-ancestor
2628358|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628359|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628360|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2628361|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
2628362|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628363|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167662|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
2167663|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
2167664|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2167665|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2167666|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2167667|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2167668|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167669|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
2167670|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2167671|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
2628364|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2628365|NCT01922843|Calcitriol|calcitriol|mesh-list
2628366|NCT01922843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2628367|NCT01922843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628368|NCT01922843|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2628369|NCT01922843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2628370|NCT01922843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628371|NCT01922843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2628372|NCT01922843|Vitamins|vitamins|mesh-ancestor
2628373|NCT01922843|Micronutrients|micronutrients|mesh-ancestor
2628374|NCT01922843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2628375|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
2628376|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2628377|NCT01922921|Trastuzumab|trastuzumab|mesh-list
2628378|NCT01922921|Pertuzumab|pertuzumab|mesh-list
2628379|NCT01922921|Antibodies|antibodies|mesh-list
2628380|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
2628381|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2628382|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
2628383|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628384|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628385|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2628386|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2628387|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
2628388|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628389|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
2628390|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2628391|NCT01922921|Protective Agents|protective agents|mesh-ancestor
2628392|NCT01922999|Melatonin|melatonin|mesh-list
2628393|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
2628394|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628395|NCT01922999|Protective Agents|protective agents|mesh-ancestor
2628396|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628397|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2628398|NCT01923012|Vitamin K|vitamin k|mesh-list
2628399|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
2628400|NCT01923012|Vitamins|vitamins|mesh-ancestor
2628401|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
2628402|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628403|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2628404|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2628405|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628406|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
2628407|NCT01923012|Coagulants|coagulants|mesh-ancestor
2628408|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
2628409|NCT01923064|Polidocanol|polidocanol|mesh-list
2628410|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628411|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2628412|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2628413|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2628414|NCT01923077|Simvastatin|simvastatin|mesh-list
2628415|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2628416|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2628417|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
2628418|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628419|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2628420|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2628421|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628422|NCT01923090|Finasteride|finasteride|mesh-list
2628423|NCT01923090|Dutasteride|dutasteride|mesh-list
2628424|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2628425|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2628426|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167672|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
2167673|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
2167674|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167675|NCT00000578|Beclomethasone|beclomethasone|mesh-list
2167676|NCT00000578|Theophylline|theophylline|mesh-list
2167677|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2167678|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
2167679|NCT00000578|Hormones|hormones|mesh-ancestor
2167680|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167681|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167682|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2167683|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
2167684|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2167685|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
2167686|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167687|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2628427|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628428|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
2668575|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2167688|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167689|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628429|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628430|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628431|NCT01923090|Urological Agents|urological agents|mesh-ancestor
2628432|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2628433|NCT01923194|Hormones|hormones|mesh-ancestor
2628434|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628435|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628436|NCT01923259|Donepezil|donepezil|mesh-list
2628437|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2628438|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628439|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628440|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
2628441|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628442|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628443|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
2628444|NCT01923298|Estradiol|estradiol|mesh-list
2628445|NCT01923298|Estrogens|estrogens|mesh-ancestor
2628446|NCT01923298|Hormones|hormones|mesh-ancestor
2628447|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628448|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628449|NCT01923337|Irinotecan|irinotecan|mesh-list
2628450|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2628451|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2628452|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628453|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628454|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628455|NCT01923376|Lactulose|lactulose|mesh-list
2628456|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2628457|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2628458|NCT01923376|Laxatives|laxatives|mesh-ancestor
2628459|NCT01923454|Acetazolamide|acetazolamide|mesh-list
2167690|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167691|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2167692|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2167693|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
2628460|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
2628461|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2628462|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628463|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628464|NCT01923454|Diuretics|diuretics|mesh-ancestor
2628465|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
2628466|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628467|NCT01923545|Lenograstim|lenograstim|mesh-list
2628468|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2628469|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
2628470|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628471|NCT01923558|Donepezil|donepezil|mesh-list
2628472|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2167694|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2167695|NCT00000579|Ketoconazole|ketoconazole|mesh-list
2167696|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
2167697|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2167698|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2167699|NCT00000579|Prednisolone|prednisolone|mesh-list
2167700|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
2167701|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2167702|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
2167703|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2628473|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628474|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628475|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
2628476|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628477|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628478|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
2628479|NCT01923584|Ubiquinone|ubiquinone|mesh-list
2628480|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
2628481|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628482|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2628483|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
2628484|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628485|NCT01923597|Protective Agents|protective agents|mesh-ancestor
2628486|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167704|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
2628487|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2628488|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2628489|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628490|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2628491|NCT01923623|Ropivacaine|ropivacaine|mesh-list
2628492|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
2167705|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
2167706|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167707|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167708|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2167709|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
2167710|NCT00000579|Hormones|hormones|mesh-ancestor
2167711|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167712|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2167713|NCT00000579|Protective Agents|protective agents|mesh-ancestor
2167714|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2167715|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628493|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
2628494|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2628495|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628496|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
2628497|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628498|NCT01923649|Lanreotide|lanreotide|mesh-list
2167716|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
2167717|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2167718|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2167719|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2167720|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167721|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167722|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2167723|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
2167724|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2167725|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
2167726|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2167727|NCT00000580|Antibodies|antibodies|mesh-list
2167728|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
2167729|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2167730|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
2167731|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167732|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
2167733|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2628499|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628500|NCT01923818|Aspirin|aspirin|mesh-list
2628501|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
2628502|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2628503|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2628504|NCT01923818|Analgesics|analgesics|mesh-ancestor
2628505|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
2628506|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628507|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628508|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2628509|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2628510|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2628511|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2628512|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628513|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2628514|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2167734|NCT00000584|Antibodies|antibodies|mesh-list
2167735|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
2167736|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167737|NCT00000585|Penicillins|penicillins|mesh-list
2167738|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2167739|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2167740|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
2167741|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628515|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628516|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
2628517|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2628518|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
2628519|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2628520|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
2628521|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
2628522|NCT01923831|Dexamethasone|dexamethasone|mesh-list
2167742|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
2628523|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
2628524|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2422123|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422124|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2422125|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
2422126|NCT00816127|Coagulants|coagulants|mesh-ancestor
2422127|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2422128|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
2422129|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422130|NCT00816140|Clarithromycin|clarithromycin|mesh-list
2422131|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2422132|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422133|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2167743|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167744|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167745|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2167746|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
2628525|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
2628526|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
2628527|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2167747|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2167748|NCT00000590|Antibodies|antibodies|mesh-list
2167749|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
2167750|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167751|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
2167752|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2167753|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2167754|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
2167755|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167756|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2167757|NCT00000595|Deferoxamine|deferoxamine|mesh-list
2167758|NCT00000595|Siderophores|siderophores|mesh-ancestor
2167759|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2167760|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
2167761|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
2167762|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167763|NCT00000596|Dapsone|dapsone|mesh-list
2167764|NCT00000596|Prednisone|prednisone|mesh-list
2167765|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
2167766|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2628528|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628529|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2628530|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
2628531|NCT01923831|Hormones|hormones|mesh-ancestor
2628532|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628533|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2628534|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628535|NCT01923831|Analgesics|analgesics|mesh-ancestor
2167767|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
2167768|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167769|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2167770|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2167771|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
2167772|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167773|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167774|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2167775|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2167776|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
2167777|NCT00000596|Hormones|hormones|mesh-ancestor
2167778|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167779|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2167780|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2167781|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
2167782|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2167783|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2167784|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2167785|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628536|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
2628537|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
2167786|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
2167787|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2167788|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
2167789|NCT00000597|Nandrolone|nandrolone|mesh-list
2167790|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
2167791|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2167792|NCT00000597|Androgens|androgens|mesh-ancestor
2167793|NCT00000597|Hormones|hormones|mesh-ancestor
2184874|NCT00002835|Ifosfamide|ifosfamide|mesh-list
2184875|NCT00002835|Carmustine|carmustine|mesh-list
2422134|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167794|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167795|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167796|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
2167797|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2167798|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
2167799|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2167800|NCT00000599|Niacin|niacin|mesh-list
2167801|NCT00000599|Colestipol|colestipol|mesh-list
2167802|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2167803|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
2167804|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167805|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2167806|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167807|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
2628538|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2628539|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2628540|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
2628541|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2628542|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2628543|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628544|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2628545|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
2628546|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2628547|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2628548|NCT01923844|Beractant|beractant|mesh-list
2628549|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
2628550|NCT01923857|Enclomiphene|enclomiphene|mesh-list
2628551|NCT01923857|Clomiphene|clomiphene|mesh-list
2628552|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
2628553|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2628554|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
2628555|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628556|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628557|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2628558|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
2167808|NCT00000599|Vitamins|vitamins|mesh-ancestor
2167809|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
2167810|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167811|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
2167812|NCT00000600|Vitamins|vitamins|mesh-list
2167813|NCT00000600|Ascorbic Acid|ascorbic acid|mesh-list
2167814|NCT00000600|Vitamin E|vitamin e|mesh-list
2167815|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
2167816|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167817|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
2628559|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2628560|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2628561|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2628562|NCT01923870|Enclomiphene|enclomiphene|mesh-list
2628563|NCT01923870|Clomiphene|clomiphene|mesh-list
2628564|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
2628565|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2628566|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
2628567|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628568|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628569|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2167818|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167819|NCT00000600|Protective Agents|protective agents|mesh-ancestor
2167820|NCT00000601|Hormones|hormones|mesh-list
2167821|NCT00000601|Progesterone|progesterone|mesh-list
2167822|NCT00000601|Estrogens|estrogens|mesh-list
2167823|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167824|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167825|NCT00000601|Progestins|progestins|mesh-ancestor
2167826|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
2167827|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167828|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
2167829|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628570|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
2628571|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2628572|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2628573|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2628574|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2167830|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184876|NCT00002835|Cisplatin|cisplatin|mesh-list
2628575|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2628576|NCT01923935|Melphalan|melphalan|mesh-list
2628577|NCT01923935|Busulfan|busulfan|mesh-list
2628578|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2628579|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
2628580|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628581|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628582|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2628583|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2628584|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
2628585|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628586|NCT01923948|Pregabalin|pregabalin|mesh-list
2628587|NCT01923948|Analgesics|analgesics|mesh-ancestor
2628588|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
2628589|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628590|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628591|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
2628592|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2628593|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2628594|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628595|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2628596|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2628597|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2628598|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2628599|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2628600|NCT01923974|Melatonin|melatonin|mesh-list
2628601|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
2628602|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628603|NCT01923974|Protective Agents|protective agents|mesh-ancestor
2628604|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628605|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2628606|NCT01923987|Cetuximab|cetuximab|mesh-list
2628607|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2628608|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628609|NCT01924000|Minoxidil|minoxidil|mesh-list
2628610|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2628611|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167831|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2167832|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2167833|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
2167834|NCT00000605|Hormones|hormones|mesh-list
2167835|NCT00000605|Estrogens|estrogens|mesh-list
2167836|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167837|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167838|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2167839|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2167840|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2167841|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
2167842|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2167843|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2167844|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2167845|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2167846|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2167847|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167848|NCT00000609|Amiodarone|amiodarone|mesh-list
2628612|NCT01924013|Vitamin D|vitamin d|mesh-list
2628613|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
2628614|NCT01924013|Vitamins|vitamins|mesh-ancestor
2628615|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
2628616|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628617|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2628618|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2628619|NCT01924052|Calcitonin|calcitonin|mesh-list
2628620|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2628621|NCT01924052|Katacalcin|katacalcin|mesh-list
2628622|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2628623|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628624|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2628625|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
2628626|NCT01924065|Anticoagulants|anticoagulants|mesh-list
2628627|NCT01924078|Capecitabine|capecitabine|mesh-list
2628628|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2628629|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2628630|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
2628631|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628632|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628633|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2628634|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628635|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2628636|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
2628637|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628638|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628639|NCT01924091|Dapivirine|dapivirine|mesh-list
2628640|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2628641|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2628642|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
2628643|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628644|NCT01924104|Aspirin|aspirin|mesh-list
2628645|NCT01924104|Heparin|heparin|mesh-list
2628646|NCT01924104|Calcium heparin|calcium heparin|mesh-list
2628647|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2628648|NCT01924104|Tinzaparin|tinzaparin|mesh-list
2628649|NCT01924104|Dalteparin|dalteparin|mesh-list
2628650|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2628651|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2628652|NCT01924104|Analgesics|analgesics|mesh-ancestor
2628653|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
2628654|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628655|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628656|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2628657|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2628658|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2628659|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2167849|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2167850|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167851|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2167852|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2167853|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167854|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2167855|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2167856|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2628660|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628661|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2628662|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2628663|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167857|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167858|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2167859|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2167860|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2167861|NCT00000611|Vitamin D|vitamin d|mesh-list
2167862|NCT00000611|Calcium|calcium|mesh-list
2167863|NCT00000611|Hormones|hormones|mesh-list
2167864|NCT00000611|Estrogens|estrogens|mesh-list
2167865|NCT00000611|Progestins|progestins|mesh-list
2167866|NCT00000611|Vitamins|vitamins|mesh-ancestor
2167867|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
2167868|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167869|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2167870|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2167871|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167872|NCT00000612|Estrogens|estrogens|mesh-list
2167873|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2167874|NCT00000612|Hormones|hormones|mesh-ancestor
2167875|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167876|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167877|NCT00000613|Genistein|genistein|mesh-list
2167878|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2167879|NCT00000613|Protective Agents|protective agents|mesh-ancestor
2167880|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167881|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167882|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2628664|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
2628665|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
2628666|NCT01924234|Morphine|morphine|mesh-list
2628667|NCT01924234|Remifentanil|remifentanil|mesh-list
2628668|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2628669|NCT01924234|Narcotics|narcotics|mesh-ancestor
2628670|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2628671|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628672|NCT01924234|Analgesics|analgesics|mesh-ancestor
2628673|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
2628674|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628675|NCT01924260|Gemcitabine|gemcitabine|mesh-list
2628676|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2167883|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167884|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167885|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
2167886|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2167887|NCT00000613|Estrogens|estrogens|mesh-ancestor
2167888|NCT00000613|Hormones|hormones|mesh-ancestor
2167889|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167890|NCT00000614|Warfarin|warfarin|mesh-list
2628677|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
2628678|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628679|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628680|NCT01924260|Antiviral Agents|antiviral agents|mesh-ancestor
2628681|NCT01924260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628682|NCT01924260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628683|NCT01924260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2628684|NCT01924260|Immunologic Factors|immunologic factors|mesh-ancestor
2628685|NCT01924260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628686|NCT01924273|Talaporfin|talaporfin|mesh-list
2628687|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628688|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2628689|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
2628690|NCT01924286|Prednisone|prednisone|mesh-list
2628691|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2628692|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
2628693|NCT01924286|Hormones|hormones|mesh-ancestor
2628694|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628695|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167891|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
2167892|NCT00000617|Azithromycin|azithromycin|mesh-list
2167893|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2167894|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2167895|NCT00000621|Tretinoin|tretinoin|mesh-list
2167896|NCT00000621|Isotretinoin|isotretinoin|mesh-list
2167897|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167898|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
2167899|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
2628696|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2628697|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628698|NCT01924325|Aspirin|aspirin|mesh-list
2628699|NCT01924325|Apixaban|apixaban|mesh-list
2628700|NCT01924325|Clopidogrel|clopidogrel|mesh-list
2628701|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2628702|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2628703|NCT01924325|Analgesics|analgesics|mesh-ancestor
2628704|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
2628705|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628706|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628707|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2628708|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2628709|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2628710|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2628711|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628712|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2628713|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2628714|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628715|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
2628716|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2628717|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2628718|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2628719|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
2628720|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628721|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2628722|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
2628723|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2628724|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
2628725|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
2628726|NCT01924468|Haloperidol|haloperidol|mesh-list
2628727|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
2628728|NCT01924468|Methylphenidate|methylphenidate|mesh-list
2167900|NCT00000623|Decitabine|decitabine|mesh-list
2167901|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
2628729|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2628730|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628731|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2167902|NCT00000623|Deferiprone|deferiprone|mesh-list
2167903|NCT00000623|Deferoxamine|deferoxamine|mesh-list
2167904|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
2167905|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2167906|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2167907|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167908|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167909|NCT00000623|Urological Agents|urological agents|mesh-ancestor
2167910|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2167911|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
2167912|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167913|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2167914|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
2167915|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
2167916|NCT00000623|Siderophores|siderophores|mesh-ancestor
2167917|NCT00000625|Zidovudine|zidovudine|mesh-list
2167918|NCT00000625|Didanosine|didanosine|mesh-list
2167919|NCT00000625|Zalcitabine|zalcitabine|mesh-list
2167920|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
2167921|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167922|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2167923|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2167924|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167925|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
2167926|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2167927|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2167928|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2167929|NCT00000626|Doxorubicin|doxorubicin|mesh-list
2167930|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2167931|NCT00000626|Bleomycin|bleomycin|mesh-list
2167932|NCT00000626|Dacarbazine|dacarbazine|mesh-list
2628732|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2628733|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2628734|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628735|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
2628736|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628737|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
2628738|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
2628739|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628740|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2628741|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2628742|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2628743|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2628744|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2628745|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2628746|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2628747|NCT01924481|Theobromine|theobromine|mesh-list
2628748|NCT01924481|Caffeine|caffeine|mesh-list
2628749|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2628750|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628751|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2628752|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628753|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628754|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2628755|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2628756|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
2628757|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628758|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2628759|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
2628760|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628761|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2628762|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
2628763|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
2628764|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2628765|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
2628766|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2628767|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2628768|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2628769|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2628770|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628771|NCT01924624|Thalidomide|thalidomide|mesh-list
2628772|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2628773|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
2628774|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167933|NCT00000626|Vinblastine|vinblastine|mesh-list
2167934|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2628775|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
2628776|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2628777|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628778|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2628779|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2628780|NCT01924624|Growth Substances|growth substances|mesh-ancestor
2628781|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
2628782|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628783|NCT01924637|Insulin|insulin|mesh-list
2628784|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2628785|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
2628786|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
2628787|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2628788|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2628789|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628790|NCT01924676|Oxycodone|oxycodone|mesh-list
2628791|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2628792|NCT01924676|Narcotics|narcotics|mesh-ancestor
2628793|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2628794|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628795|NCT01924676|Analgesics|analgesics|mesh-ancestor
2628796|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
2628797|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628798|NCT01924819|Leucovorin|leucovorin|mesh-list
2628799|NCT01924819|Cisplatin|cisplatin|mesh-list
2628800|NCT01924819|Docetaxel|docetaxel|mesh-list
2628801|NCT01924819|Fluorouracil|fluorouracil|mesh-list
2628802|NCT01924819|Capecitabine|capecitabine|mesh-list
2628803|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
2628804|NCT01924819|Epirubicin|epirubicin|mesh-list
2628805|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628806|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
2628807|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
2628808|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
2628809|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628810|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
2628811|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2628812|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2628813|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
2628814|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628815|NCT01924819|Antidotes|antidotes|mesh-ancestor
2628816|NCT01924819|Protective Agents|protective agents|mesh-ancestor
2628817|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
2628818|NCT01924819|Vitamins|vitamins|mesh-ancestor
2628819|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
2628820|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2628821|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2628822|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2628823|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628824|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2628825|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
2628826|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2628827|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
2628828|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628829|NCT01924910|Vitamin D|vitamin d|mesh-list
2628830|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
2167935|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167936|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2167937|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2167938|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167939|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167940|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2167941|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
2167942|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2167943|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
2167944|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
2167945|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
2167946|NCT00000627|Fluconazole|fluconazole|mesh-list
2167947|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
2167948|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2167949|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2167950|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2167951|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628831|NCT01924910|Vitamins|vitamins|mesh-ancestor
2628832|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
2628833|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628834|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2628835|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2628836|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2628837|NCT01925027|Sirolimus|sirolimus|mesh-list
2628838|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2628839|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628840|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2628841|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628842|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
2167952|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167953|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2167954|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
2167955|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2167956|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167957|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2628843|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2628844|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
2628845|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628846|NCT01925066|Vancomycin|vancomycin|mesh-list
2628847|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2628848|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628849|NCT01925092|Mifepristone|mifepristone|mesh-list
2167958|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2167959|NCT00000628|Zidovudine|zidovudine|mesh-list
2167960|NCT00000628|L-697661|l-697661|mesh-list
2167961|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
2628850|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2628851|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
2628852|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2628853|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628854|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2628855|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2628856|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2628857|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
2628858|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2628859|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2628860|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
2628861|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628862|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
2628863|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2628864|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2628865|NCT01925131|Prednisone|prednisone|mesh-list
2628866|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
2628867|NCT01925131|Vincristine|vincristine|mesh-list
2628868|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2628869|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2628870|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
2628871|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628872|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2628873|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2628874|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
2628875|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628876|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628877|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2628878|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2628879|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
2628880|NCT01925131|Hormones|hormones|mesh-ancestor
2628881|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628882|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2628883|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2628884|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
2628885|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
2628886|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
2628887|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2628888|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2628889|NCT01925287|Curcumin|curcumin|mesh-list
2628890|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2628891|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2628892|NCT01925287|Analgesics|analgesics|mesh-ancestor
2628893|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
2628894|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628895|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628896|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2628897|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2628898|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2167962|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167963|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2167964|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2167965|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628899|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628900|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628901|NCT01925300|Bisoprolol|bisoprolol|mesh-list
2628902|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2628903|NCT01925300|Calcium|calcium|mesh-list
2628904|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2628905|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628906|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2628907|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2628908|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
2628909|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628910|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2628911|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2628912|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628913|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2628914|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
2628915|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
2628916|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628917|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2628918|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2628919|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2628920|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
2628921|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628922|NCT01925352|Mitogens|mitogens|mesh-list
2628923|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
2628924|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628925|NCT01925378|Nelfinavir|nelfinavir|mesh-list
2628926|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2628927|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2628928|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
2628929|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628930|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628931|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2628932|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2628933|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
2628934|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628935|NCT01925456|Fesoterodine|fesoterodine|mesh-list
2628936|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2628937|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2628938|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
2628939|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628940|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628941|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628942|NCT01925456|Urological Agents|urological agents|mesh-ancestor
2628943|NCT01925547|Curcumin|curcumin|mesh-list
2628944|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2628945|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2628946|NCT01925547|Analgesics|analgesics|mesh-ancestor
2628947|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
2628948|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628949|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628950|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2628951|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2167966|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
2167967|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2167968|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2167969|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2167970|NCT00000629|Zidovudine|zidovudine|mesh-list
2167971|NCT00000629|Valproic Acid|valproic acid|mesh-list
2167972|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
2167973|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628952|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2628953|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628954|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628955|NCT01925638|Ketoconazole|ketoconazole|mesh-list
2628956|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
2628957|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628958|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2628959|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2184877|NCT00002835|Methotrexate|methotrexate|mesh-list
2167974|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2167975|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2167976|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628960|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628961|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2628962|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2628963|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
2628964|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2628965|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628966|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2628967|NCT01925729|Phenylephrine|phenylephrine|mesh-list
2628968|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
2167977|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
2167978|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628969|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
2628970|NCT01925729|Ephedrine|ephedrine|mesh-list
2628971|NCT01925729|Histamine|histamine|mesh-list
2628972|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2628973|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
2628974|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2628975|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628976|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2628977|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
2628978|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
2628979|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2628980|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2628981|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
2628982|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
2628983|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2628984|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167979|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2167980|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2167981|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
2167982|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
2167983|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2167984|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2167985|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
2167986|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2167987|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2167988|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2167989|NCT00000633|Vaccines|vaccines|mesh-list
2167990|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
2167991|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2628985|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
2628986|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
2628987|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2167992|NCT00000634|Nevirapine|nevirapine|mesh-list
2167993|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2167994|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2167995|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2167996|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2167997|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
2167998|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2628988|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2628989|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2628990|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
2628991|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2628992|NCT01925729|Protective Agents|protective agents|mesh-ancestor
2628993|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
2167999|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168000|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168001|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2168002|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2168003|NCT00000635|Trifluridine|trifluridine|mesh-list
2168004|NCT00000635|Polymyxins|polymyxins|mesh-list
2168005|NCT00000635|Bacitracin|bacitracin|mesh-list
2168006|NCT00000635|Polymyxin B|polymyxin b|mesh-list
2168007|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
2168008|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168009|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
2168010|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168011|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2168012|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2168013|NCT00000636|Pyridoxine|pyridoxine|mesh-list
2168014|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
2168015|NCT00000636|Rifampin|rifampin|mesh-list
2168016|NCT00000636|Isoniazid|isoniazid|mesh-list
2168017|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
2168018|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2168019|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
2168020|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2168021|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168022|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
2168023|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168024|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628994|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2628995|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
2628996|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2628997|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
2628998|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2628999|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629000|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
2629001|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2629002|NCT01925820|Entecavir|entecavir|mesh-list
2629003|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
2629004|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629005|NCT01925859|Dexamethasone|dexamethasone|mesh-list
2629006|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
2629007|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2629008|NCT01925859|BB 1101|bb 1101|mesh-list
2629009|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2629010|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
2629011|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
2629012|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629013|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629014|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2629015|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
2629016|NCT01925859|Hormones|hormones|mesh-ancestor
2629017|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2629018|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2629019|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629020|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
2629021|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629022|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168025|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168026|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2168027|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2168028|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2168029|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2168030|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2168031|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2168032|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2168033|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2168034|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
2168035|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2168036|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
2168037|NCT00000636|Vitamins|vitamins|mesh-ancestor
2168038|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
2168039|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168040|NCT00000637|Zidovudine|zidovudine|mesh-list
2168041|NCT00000637|Didanosine|didanosine|mesh-list
2168042|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
2168043|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168044|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168045|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168046|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168047|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
2168048|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168049|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168050|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2629023|NCT01925898|Midazolam|midazolam|mesh-list
2629024|NCT01925898|Ketamine|ketamine|mesh-list
2629025|NCT01925898|Analgesics|analgesics|mesh-ancestor
2629026|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
2629027|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629028|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629029|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2629030|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2629031|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
2629032|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
2629033|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2168051|NCT00000638|Pyridoxine|pyridoxine|mesh-list
2629034|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2168052|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
2168053|NCT00000638|Rifampin|rifampin|mesh-list
2629035|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2629036|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629037|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629038|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2629039|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2629040|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2629041|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2629042|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2629043|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
2629044|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
2629045|NCT01925911|Midazolam|midazolam|mesh-list
2629046|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2629047|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2629048|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2629049|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629050|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2629051|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2629052|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2629053|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2629054|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
2629055|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
2629056|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
2629057|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
2629058|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629059|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629060|NCT01925937|Ubiquinone|ubiquinone|mesh-list
2629061|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
2629062|NCT01925937|Atorvastatin|atorvastatin|mesh-list
2629063|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2629064|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2629065|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
2629066|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629067|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2629068|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2629069|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629070|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
2629071|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629072|NCT01925937|Vitamins|vitamins|mesh-ancestor
2629073|NCT01926041|Varenicline|varenicline|mesh-list
2629074|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2629075|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2629076|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
2629077|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629078|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629079|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629080|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
2629081|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
2629082|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629083|NCT01926132|Protective Agents|protective agents|mesh-ancestor
2629084|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168054|NCT00000638|Isoniazid|isoniazid|mesh-list
2168055|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
2168056|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2168057|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
2168058|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2168059|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168060|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
2168061|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168062|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168063|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168064|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2168065|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2168066|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2168067|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2168068|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2168069|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2168070|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2168071|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2168072|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
2168073|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2168074|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
2168075|NCT00000638|Vitamins|vitamins|mesh-ancestor
2629085|NCT01926132|Vitamins|vitamins|mesh-ancestor
2629086|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
2629087|NCT01926158|Denosumab|denosumab|mesh-list
2629088|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2629089|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629090|NCT01926197|Leucovorin|leucovorin|mesh-list
2168076|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
2168077|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168078|NCT00000639|Itraconazole|itraconazole|mesh-list
2168079|NCT00000639|Fluconazole|fluconazole|mesh-list
2168080|NCT00000639|Amphotericin B|amphotericin b|mesh-list
2168081|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2168082|NCT00000639|Flucytosine|flucytosine|mesh-list
2168083|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
2168084|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168085|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2168086|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2168087|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168088|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168089|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2168090|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
2168091|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2168092|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168093|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2629091|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
2629092|NCT01926197|Irinotecan|irinotecan|mesh-list
2629093|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629094|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2629095|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2168094|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2168095|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2168096|NCT00000639|Amebicides|amebicides|mesh-ancestor
2168097|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2168098|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2168099|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2168100|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
2168101|NCT00000640|Clindamycin|clindamycin|mesh-list
2168102|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
2168103|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
2168104|NCT00000640|Dapsone|dapsone|mesh-list
2168105|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2168106|NCT00000640|Primaquine|primaquine|mesh-list
2168107|NCT00000640|Trimethoprim|trimethoprim|mesh-list
2629096|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629097|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629098|NCT01926197|Antidotes|antidotes|mesh-ancestor
2629099|NCT01926197|Protective Agents|protective agents|mesh-ancestor
2629100|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629101|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
2629102|NCT01926197|Vitamins|vitamins|mesh-ancestor
2629103|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
2629104|NCT01926210|Letrozole|letrozole|mesh-list
2629105|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168108|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
2168109|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2168110|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168111|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2168112|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168113|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168114|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
2168115|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2168116|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2168117|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2168118|NCT00000640|Renal Agents|renal agents|mesh-ancestor
2168119|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2168120|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2168121|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2168122|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2168123|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
2168124|NCT00000641|Azithromycin|azithromycin|mesh-list
2168125|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
2168126|NCT00000641|Rifampin|rifampin|mesh-list
2168127|NCT00000641|Amikacin|amikacin|mesh-list
2168128|NCT00000641|Ethambutol|ethambutol|mesh-list
2168129|NCT00000641|Clofazimine|clofazimine|mesh-list
2168130|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2168131|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184878|NCT00002835|Etoposide|etoposide|mesh-list
2629106|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2629107|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2629108|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629109|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629110|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2629111|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
2629112|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2629113|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629114|NCT01926236|Leucovorin|leucovorin|mesh-list
2629115|NCT01926236|Folic Acid|folic acid|mesh-list
2629116|NCT01926236|Fluorouracil|fluorouracil|mesh-list
2629117|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
2629118|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
2629119|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
2629120|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629121|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2629122|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629123|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2629124|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
2629125|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629126|NCT01926236|Antidotes|antidotes|mesh-ancestor
2629127|NCT01926236|Protective Agents|protective agents|mesh-ancestor
2629128|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
2629129|NCT01926236|Vitamins|vitamins|mesh-ancestor
2629130|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
2629131|NCT01926236|Hematinics|hematinics|mesh-ancestor
2629132|NCT01926288|Entecavir|entecavir|mesh-list
2629133|NCT01926288|Maleic acid|maleic acid|mesh-list
2629134|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629135|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629136|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
2629137|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168132|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2168133|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2168134|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168135|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168136|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168137|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2168138|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2168139|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2168140|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
2168141|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
2168142|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168143|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2168144|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2168145|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2629138|NCT01926379|Isoniazid|isoniazid|mesh-list
2629139|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
2629140|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2629141|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629142|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2629143|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2629144|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
2629145|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629146|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2629147|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
2629148|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2629149|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2629150|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629151|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2629152|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2629153|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
2629154|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2629155|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
2629156|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629157|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2629158|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629159|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629160|NCT01926587|Azacitidine|azacitidine|mesh-list
2629161|NCT01926587|ON 01910|on 01910|mesh-list
2168146|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2168147|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2168148|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2168149|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2168150|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
2629162|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2629163|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
2629164|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629165|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168151|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
2168152|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168153|NCT00000643|Leucovorin|leucovorin|mesh-list
2168154|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
2168155|NCT00000643|Calcium|calcium|mesh-list
2629166|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629167|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2629168|NCT01926639|Rituximab|rituximab|mesh-list
2629169|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2629170|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629171|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
2629172|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629173|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2168156|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
2168157|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2168158|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168159|NCT00000643|Antidotes|antidotes|mesh-ancestor
2629174|NCT01926652|Amlodipine|amlodipine|mesh-list
2629175|NCT01926652|Candesartan|candesartan|mesh-list
2629176|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
2629177|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2629178|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2168160|NCT00000643|Protective Agents|protective agents|mesh-ancestor
2168161|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
2168162|NCT00000643|Vitamins|vitamins|mesh-ancestor
2168163|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
2168164|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
2168165|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2168166|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2168167|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168168|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2168169|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168170|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168171|NCT00000644|Clarithromycin|clarithromycin|mesh-list
2168172|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2168173|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629179|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2629180|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629181|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2629182|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629183|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
2629184|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2629185|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2629186|NCT01926665|Dexamethasone|dexamethasone|mesh-list
2629187|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2629188|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
2629189|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
2629190|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629191|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629192|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2629193|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
2629194|NCT01926665|Hormones|hormones|mesh-ancestor
2629195|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2629196|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2629197|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629198|NCT01926769|Metformin|metformin|mesh-list
2629199|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2629200|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629201|NCT01926821|Sizofiran|sizofiran|mesh-list
2629202|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2629203|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
2629204|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629205|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2629206|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629207|NCT01926847|Riociguat|riociguat|mesh-list
2629208|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
2629209|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629210|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2629211|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
2629212|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629213|NCT01926899|Bortezomib|bortezomib|mesh-list
2168174|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2168175|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168176|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168177|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2168178|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2168179|NCT00000645|Hypericin|hypericin|mesh-list
2168180|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
2168181|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2168182|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168183|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
2168184|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168185|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168186|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629214|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629215|NCT01927029|Progesterone|progesterone|mesh-list
2629216|NCT01927029|Progestins|progestins|mesh-ancestor
2629217|NCT01927029|Hormones|hormones|mesh-ancestor
2629218|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2629219|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629220|NCT01927068|Paclitaxel|paclitaxel|mesh-list
2629221|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2629222|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629223|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
2629224|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
2629225|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
2629226|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629227|NCT01927198|Verinurad|verinurad|mesh-list
2629228|NCT01927198|Gout Suppressants|gout suppressants|mesh-ancestor
2629229|NCT01927198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2629230|NCT01927224|Nifurtimox|nifurtimox|mesh-list
2629231|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2629232|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2629233|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2629234|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629235|NCT01927263|Infliximab|infliximab|mesh-list
2629236|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
2629237|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2629238|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2629239|NCT01927315|Fenofibrate|fenofibrate|mesh-list
2629240|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2629241|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
2629242|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629243|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2629244|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2168187|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2168188|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
2168189|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168190|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
2168191|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2168192|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629245|NCT01927328|Hematinics|hematinics|mesh-ancestor
2629246|NCT01927406|Timolol|timolol|mesh-list
2629247|NCT01927406|Bimatoprost|bimatoprost|mesh-list
2629248|NCT01927406|Travoprost|travoprost|mesh-list
2629249|NCT01927406|Latanoprost|latanoprost|mesh-list
2629250|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2629251|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2629252|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
2629253|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629254|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629255|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629256|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2629257|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2629258|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2629259|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2629260|NCT01927484|Methotrexate|methotrexate|mesh-list
2629261|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2629262|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
2629263|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2629264|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629265|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2168193|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168194|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2168195|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2168196|NCT00000646|Protective Agents|protective agents|mesh-ancestor
2629266|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
2629267|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629268|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629269|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
2629270|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629271|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2629272|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2629273|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
2168197|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168198|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
2629274|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2629275|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2629276|NCT01927588|Prednisone|prednisone|mesh-list
2629277|NCT01927588|Everolimus|everolimus|mesh-list
2629278|NCT01927588|Tacrolimus|tacrolimus|mesh-list
2629279|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2629280|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
2629281|NCT01927588|Hormones|hormones|mesh-ancestor
2629282|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2629283|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629284|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2629285|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629286|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2629287|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
2629288|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2629289|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629290|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629291|NCT01927640|Cocaine|cocaine|mesh-list
2629292|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
2629293|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2629294|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2629295|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629296|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2629297|NCT01927640|Analgesics|analgesics|mesh-ancestor
2629298|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
2629299|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629300|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2629301|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2629302|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2629303|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
2629304|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629305|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629306|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
2629307|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
2629308|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2629309|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2629310|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2629311|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2629312|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
2629313|NCT01927679|Vitamin E|vitamin e|mesh-list
2629314|NCT01927679|Antioxidants|antioxidants|mesh-list
2629315|NCT01927679|Vitamins|vitamins|mesh-ancestor
2168199|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2168200|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
2168201|NCT00000647|Interferons|interferons|mesh-list
2168202|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
2168203|NCT00000647|Zidovudine|zidovudine|mesh-list
2168204|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
2168205|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168206|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
2168207|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168208|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
2168209|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168210|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
2629316|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
2629317|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629318|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629319|NCT01927679|Protective Agents|protective agents|mesh-ancestor
2629320|NCT01927744|Docetaxel|docetaxel|mesh-list
2629321|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2629322|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629323|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
2629324|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
2629325|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
2629326|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629327|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2629328|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168211|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168212|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2629329|NCT01927835|Vaccines|vaccines|mesh-list
2629330|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
2629331|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629332|NCT01927874|Bupivacaine|bupivacaine|mesh-list
2629333|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
2629334|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
2629335|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2629336|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629337|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
2629338|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629339|NCT01927913|Deferasirox|deferasirox|mesh-list
2629340|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2629341|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
2629342|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
2629343|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629344|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
2629345|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2629346|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
2629347|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629348|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629349|NCT01928043|Curcumin|curcumin|mesh-list
2629350|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2629351|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2629352|NCT01928043|Analgesics|analgesics|mesh-ancestor
2629353|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
2629354|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629355|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629356|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2629357|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2629358|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629359|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629360|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168213|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168214|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168215|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2629361|NCT01928056|Montelukast|montelukast|mesh-list
2629362|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2629363|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
2168216|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168217|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
2168218|NCT00000648|Penicillins|penicillins|mesh-list
2168219|NCT00000648|Penicillin G|penicillin g|mesh-list
2168220|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2168221|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
2168222|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2168223|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168224|NCT00000649|Zidovudine|zidovudine|mesh-list
2168225|NCT00000649|Nevirapine|nevirapine|mesh-list
2168226|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
2168227|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629364|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2629365|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
2629366|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2168228|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168229|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168230|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168231|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
2168232|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168233|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2629367|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629368|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2629369|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2629370|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629371|NCT01928069|Montelukast|montelukast|mesh-list
2629372|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2629373|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
2629374|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2629375|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
2629376|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2629377|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629378|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2168234|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168235|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2168236|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2168237|NCT00000650|Ditiocarb|ditiocarb|mesh-list
2168238|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2168239|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
2629379|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2629380|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629381|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
2629382|NCT01928134|Calcium|calcium|mesh-list
2629383|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2629384|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629385|NCT01928134|Antacids|antacids|mesh-ancestor
2629386|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629387|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2629388|NCT01928160|Carboplatin|carboplatin|mesh-list
2629389|NCT01928160|Pemetrexed|pemetrexed|mesh-list
2629390|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2629391|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629392|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629393|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629394|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2629395|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2629396|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2629397|NCT01928316|Mizolastine|mizolastine|mesh-list
2629398|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2629399|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2629400|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
2629401|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
2629402|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629403|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629404|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168240|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168241|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
2168242|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629405|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2629406|NCT01928407|Darunavir|darunavir|mesh-list
2629407|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2629408|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2629409|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
2629410|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629411|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629412|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2629413|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2629414|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
2629415|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629416|NCT01928459|Infigratinib|infigratinib|mesh-list
2629417|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629418|NCT01928498|Paclitaxel|paclitaxel|mesh-list
2629419|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2629420|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629421|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
2629422|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
2629423|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
2629424|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629425|NCT01928511|Interferons|interferons|mesh-list
2629426|NCT01928511|Tenofovir|tenofovir|mesh-list
2629427|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
2629428|NCT01928511|Lamivudine|lamivudine|mesh-list
2629429|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
2629430|NCT01928511|Entecavir|entecavir|mesh-list
2629431|NCT01928511|Adefovir|adefovir|mesh-list
2629432|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2629433|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629434|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
2629435|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629436|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2629437|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2629438|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629439|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629440|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2629441|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2629442|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
2629443|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629444|NCT01928537|ON 01910|on 01910|mesh-list
2629445|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629446|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2629447|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629448|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629449|NCT01928563|Udenafil|udenafil|mesh-list
2629450|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2629451|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2629452|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629453|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629454|NCT01928576|Nivolumab|nivolumab|mesh-list
2629455|NCT01928576|Azacitidine|azacitidine|mesh-list
2629456|NCT01928576|Entinostat|entinostat|mesh-list
2629457|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2629458|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629459|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2629460|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629461|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2629462|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
2629463|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629464|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2629465|NCT01928628|Valsartan|valsartan|mesh-list
2629466|NCT01928628|Lercanidipine|lercanidipine|mesh-list
2168243|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
2168244|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
2168245|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168246|NCT00000651|Zidovudine|zidovudine|mesh-list
2168247|NCT00000651|Zalcitabine|zalcitabine|mesh-list
2168248|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
2168249|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168250|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168251|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168252|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168253|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
2168254|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168255|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168256|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168257|NCT00000652|Zidovudine|zidovudine|mesh-list
2168258|NCT00000652|Didanosine|didanosine|mesh-list
2168259|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
2168260|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168261|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168262|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168263|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168264|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
2168265|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168266|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168267|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168268|NCT00000653|Zalcitabine|zalcitabine|mesh-list
2168269|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
2168270|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168271|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168272|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168273|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168274|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
2168275|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168276|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168277|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168278|NCT00000654|Fialuridine|fialuridine|mesh-list
2168279|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
2168280|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168281|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168282|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168283|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168284|NCT00000655|Trimethoprim|trimethoprim|mesh-list
2168285|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2168286|NCT00000655|Atovaquone|atovaquone|mesh-list
2168287|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
2168288|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2168289|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168290|NCT00000655|Renal Agents|renal agents|mesh-ancestor
2168291|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
2168292|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2168293|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2168294|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2168295|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168296|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168297|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2629467|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2629468|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2629469|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2168298|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2168299|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2168300|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2168301|NCT00000656|Zidovudine|zidovudine|mesh-list
2168302|NCT00000656|Didanosine|didanosine|mesh-list
2168303|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
2168304|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168305|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168306|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2629470|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629471|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2629472|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2629473|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2629474|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629475|NCT01928823|Cycloserine|cycloserine|mesh-list
2629476|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2629477|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629478|NCT01928823|Renal Agents|renal agents|mesh-ancestor
2629479|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2629480|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
2629481|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2629482|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
2629483|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629484|NCT01928875|Anesthetics|anesthetics|mesh-list
2629485|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2629486|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629487|NCT01928888|Famotidine|famotidine|mesh-list
2629488|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
2629489|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2629490|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2629491|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2629492|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
2629493|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
2629494|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629495|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629496|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629497|NCT01928888|Antacids|antacids|mesh-ancestor
2168307|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168308|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
2168309|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168310|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168311|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168312|NCT00000657|Zidovudine|zidovudine|mesh-list
2168313|NCT00000657|Didanosine|didanosine|mesh-list
2168314|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
2168315|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168316|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168317|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168318|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168319|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
2168320|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168321|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168322|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168323|NCT00000658|Leucovorin|leucovorin|mesh-list
2168324|NCT00000658|Cytarabine|cytarabine|mesh-list
2629498|NCT01928901|Thymol|thymol|mesh-list
2629499|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629500|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2629501|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
2629502|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
2629503|NCT01928914|Tafenoquine|tafenoquine|mesh-list
2629504|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2629505|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168325|NCT00000658|Dexamethasone|dexamethasone|mesh-list
2168326|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
2168327|NCT00000658|Doxorubicin|doxorubicin|mesh-list
2168328|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2168329|NCT00000658|Methotrexate|methotrexate|mesh-list
2168330|NCT00000658|Vincristine|vincristine|mesh-list
2168331|NCT00000658|Bleomycin|bleomycin|mesh-list
2168332|NCT00000658|Allopurinol|allopurinol|mesh-list
2168333|NCT00000658|Sargramostim|sargramostim|mesh-list
2168334|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
2168335|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2168336|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
2168337|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168338|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2168339|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2629506|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2629507|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2629508|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629509|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629510|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629511|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
2629512|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2629513|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2629514|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2629515|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2629516|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2629517|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
2629518|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629519|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2629520|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2629521|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629522|NCT01929096|Edaravone|edaravone|mesh-list
2629523|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2629524|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
2629525|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629526|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2629527|NCT01929096|Protective Agents|protective agents|mesh-ancestor
2629528|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629529|NCT01929161|Oxytocin|oxytocin|mesh-list
2629530|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
2629531|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2629532|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629533|NCT01929187|Amorolfine|amorolfine|mesh-list
2629534|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
2629535|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629536|NCT01929213|Bosentan|bosentan|mesh-list
2629537|NCT01929213|Udenafil|udenafil|mesh-list
2629538|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2629539|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2629540|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629541|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2629542|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2629543|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629544|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
2629545|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
2629546|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2629547|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2168340|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
2168341|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168342|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629548|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629549|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2168343|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2168344|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2168345|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
2168346|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
2168347|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2168348|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2168349|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
2168350|NCT00000658|Hormones|hormones|mesh-ancestor
2168351|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2168352|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2168353|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2168354|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2168355|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2168356|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629550|NCT01929252|Analgesics|analgesics|mesh-ancestor
2629551|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
2629552|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629553|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2629554|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2629555|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2629556|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
2629557|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629558|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629559|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
2629560|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
2629561|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2629562|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2629563|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
2629564|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629565|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629566|NCT01929278|Clindamycin|clindamycin|mesh-list
2629567|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
2629568|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
2629569|NCT01929278|Tretinoin|tretinoin|mesh-list
2629570|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2629571|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629572|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2629573|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629574|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629575|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629576|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
2629577|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
2629578|NCT01929330|Dutasteride|dutasteride|mesh-list
2629579|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2629580|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2629581|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629582|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629583|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
2629584|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2629585|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629586|NCT01929382|Interferons|interferons|mesh-list
2629587|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
2629588|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629589|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
2629590|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629591|NCT01929421|Gemcitabine|gemcitabine|mesh-list
2629592|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2629593|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
2629594|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629595|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629596|NCT01929421|Antiviral Agents|antiviral agents|mesh-ancestor
2629597|NCT01929421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629598|NCT01929421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629599|NCT01929421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2629600|NCT01929421|Immunologic Factors|immunologic factors|mesh-ancestor
2629601|NCT01929421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629602|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
2629603|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629604|NCT01929512|Metformin|metformin|mesh-list
2629605|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2629606|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2629607|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629608|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2629609|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2629610|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
2629611|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629612|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2629613|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2629614|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629615|NCT01929577|Peficitinib|peficitinib|mesh-list
2629616|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629617|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629618|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2629619|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
2629620|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629621|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2629622|NCT01929590|Laxatives|laxatives|mesh-ancestor
2168357|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2168358|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
2168359|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2168360|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2168361|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
2168362|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
2168363|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2629623|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2629624|NCT01929603|Rifampin|rifampin|mesh-list
2629625|NCT01929603|Olaparib|olaparib|mesh-list
2629626|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2629627|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629628|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629629|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168364|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168365|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
2168366|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168367|NCT00000658|Antidotes|antidotes|mesh-ancestor
2168368|NCT00000658|Protective Agents|protective agents|mesh-ancestor
2168369|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
2168370|NCT00000658|Vitamins|vitamins|mesh-ancestor
2168371|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
2168372|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2168373|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
2168374|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
2168375|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
2168376|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
2168377|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2168378|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
2168379|NCT00000659|Zidovudine|zidovudine|mesh-list
2168380|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
2168381|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168382|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168383|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168384|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168385|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
2168386|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168387|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168388|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168389|NCT00000660|Etoposide|etoposide|mesh-list
2168390|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2629630|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2629631|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
2629632|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2629633|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629634|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
2629635|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2629636|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2629637|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2629638|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2629639|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2629640|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2629641|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2629642|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2629643|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629644|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
2629645|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
2629646|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629647|NCT01929668|Protective Agents|protective agents|mesh-ancestor
2629648|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629649|NCT01929668|Vitamins|vitamins|mesh-ancestor
2629650|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
2629651|NCT01929746|Daclizumab|daclizumab|mesh-list
2629652|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2629653|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
2629654|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629655|NCT01929798|Pancrelipase|pancrelipase|mesh-list
2629656|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2629657|NCT01929811|Metformin|metformin|mesh-list
2629658|NCT01929811|Docetaxel|docetaxel|mesh-list
2629659|NCT01929811|Epirubicin|epirubicin|mesh-list
2629660|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2629661|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629662|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629663|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
2168391|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168392|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2168393|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2168394|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168395|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168396|NCT00000661|Zidovudine|zidovudine|mesh-list
2629664|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
2629665|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
2629666|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629667|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2629668|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2168397|NCT00000661|Oxazepam|oxazepam|mesh-list
2168398|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
2168399|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168400|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168401|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168402|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168403|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
2168404|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168405|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168406|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168407|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2168408|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2168409|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168410|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2168411|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2168412|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2168413|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
2168414|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
2168415|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2168416|NCT00000662|Zidovudine|zidovudine|mesh-list
2168417|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
2629669|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2629670|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629671|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
2629672|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2629673|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
2629674|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629675|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629676|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2629677|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
2629678|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2629679|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
2629680|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629681|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629682|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2629683|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
2629684|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
2629685|NCT01929824|Protective Agents|protective agents|mesh-ancestor
2629686|NCT01929915|Fentanyl|fentanyl|mesh-list
2629687|NCT01929915|Morphine|morphine|mesh-list
2629688|NCT01929915|Bupivacaine|bupivacaine|mesh-list
2629689|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
2629690|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
2629691|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2629692|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629693|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
2629694|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629695|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2629696|NCT01929915|Narcotics|narcotics|mesh-ancestor
2629697|NCT01929915|Analgesics|analgesics|mesh-ancestor
2629698|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2629699|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2629700|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
2629701|NCT01929941|Gemcitabine|gemcitabine|mesh-list
2629702|NCT01929941|Paclitaxel|paclitaxel|mesh-list
2629703|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2629704|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629705|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
2629706|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
2629707|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
2629708|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629709|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2629710|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
2629711|NCT01929941|Antiviral Agents|antiviral agents|mesh-ancestor
2629712|NCT01929941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629713|NCT01929941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629714|NCT01929941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2629715|NCT01929941|Immunologic Factors|immunologic factors|mesh-ancestor
2629716|NCT01929941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629717|NCT01930019|Thiopental|thiopental|mesh-list
2168418|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168419|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2629718|NCT01930019|Etomidate|etomidate|mesh-list
2629719|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
2629720|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2629721|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629722|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2629723|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2629724|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
2629725|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
2629726|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
2629727|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
2629728|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629729|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629730|NCT01930201|Anesthetics|anesthetics|mesh-list
2629731|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2629732|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629733|NCT01930292|Paclitaxel|paclitaxel|mesh-list
2629734|NCT01930292|Carboplatin|carboplatin|mesh-list
2629735|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2629736|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629737|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
2629738|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
2629739|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
2629740|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629741|NCT01930318|Parecoxib|parecoxib|mesh-list
2629742|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2629743|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2629744|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629745|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629746|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2629747|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2629748|NCT01930318|Analgesics|analgesics|mesh-ancestor
2629749|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
2629750|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629751|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629752|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2168420|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168421|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168422|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
2168423|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168424|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2629753|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2629754|NCT01930331|Piperaquine|piperaquine|mesh-list
2629755|NCT01930331|Artenimol|artenimol|mesh-list
2629756|NCT01930331|Artemisinins|artemisinins|mesh-list
2629757|NCT01930331|Artemisinin|artemisinin|mesh-list
2629758|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
2629759|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2629760|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2629761|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629762|NCT01930357|Vaccines|vaccines|mesh-list
2629763|NCT01930357|Immunologic Factors|immunologic factors|mesh-ancestor
2629764|NCT01930357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629765|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2629766|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
2629767|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
2629768|NCT01930396|Heparin|heparin|mesh-list
2629769|NCT01930396|Calcium heparin|calcium heparin|mesh-list
2629770|NCT01930396|Tinzaparin|tinzaparin|mesh-list
2629771|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2629772|NCT01930396|Dalteparin|dalteparin|mesh-list
2629773|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
2629774|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2629775|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2629776|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629777|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
2629778|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629779|NCT01930552|Leucovorin|leucovorin|mesh-list
2629780|NCT01930552|Fluorouracil|fluorouracil|mesh-list
2629781|NCT01930552|Irinotecan|irinotecan|mesh-list
2629782|NCT01930552|Aflibercept|aflibercept|mesh-list
2629783|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
2168425|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168426|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
2629784|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629785|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2629786|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629787|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2629788|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
2629789|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629790|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2629791|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2629792|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629793|NCT01930552|Antidotes|antidotes|mesh-ancestor
2629794|NCT01930552|Protective Agents|protective agents|mesh-ancestor
2629795|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
2629796|NCT01930552|Vitamins|vitamins|mesh-ancestor
2629797|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
2629798|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2629799|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2629800|NCT01930552|Growth Substances|growth substances|mesh-ancestor
2629801|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
2629802|NCT01930591|Clopidogrel|clopidogrel|mesh-list
2629803|NCT01930591|Ticagrelor|ticagrelor|mesh-list
2629804|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2629805|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2168427|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
2168428|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168429|NCT00000664|Zidovudine|zidovudine|mesh-list
2168430|NCT00000664|Interleukin-2|interleukin-2|mesh-list
2168431|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
2168432|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168433|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2629806|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2629807|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2629808|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
2629809|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629810|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629811|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629812|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
2629813|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2629814|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2629815|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2629816|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629817|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629818|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2629819|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2629820|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168434|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168435|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168436|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
2168437|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168438|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168439|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168440|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168441|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2168442|NCT00000664|Analgesics|analgesics|mesh-ancestor
2168443|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
2168444|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2168445|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168446|NCT00000665|Ganciclovir|ganciclovir|mesh-list
2168447|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2168448|NCT00000665|Foscarnet|foscarnet|mesh-list
2168449|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2168450|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
2168451|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168452|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168453|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168454|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168455|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168456|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
2168457|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
2168458|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2168459|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2168460|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168461|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2168462|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168463|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168464|NCT00000668|Ganciclovir|ganciclovir|mesh-list
2168465|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2168466|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
2168467|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168468|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168469|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168470|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168471|NCT00000669|Didanosine|didanosine|mesh-list
2629821|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
2629822|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629823|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2629824|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2168472|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
2168473|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168474|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168475|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168476|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168477|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
2168478|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168479|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168480|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168481|NCT00000670|Zidovudine|zidovudine|mesh-list
2629825|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2629826|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2629827|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629828|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2629829|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
2629830|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2629831|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
2629832|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629833|NCT01930734|Dobutamine|dobutamine|mesh-list
2629834|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2629835|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
2629836|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
2629837|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629838|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629839|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2629840|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2629841|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2629842|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
2629843|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629844|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629845|NCT01930734|Protective Agents|protective agents|mesh-ancestor
2629846|NCT01930773|Clopidogrel|clopidogrel|mesh-list
2629847|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2629848|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2629849|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2629850|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2629851|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
2629852|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629853|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629854|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629855|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
2629856|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2629857|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2629858|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2168482|NCT00000670|Probenecid|probenecid|mesh-list
2168483|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
2168484|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168485|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168486|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168487|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168488|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
2168489|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168490|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168491|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168492|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
2168493|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
2168494|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2168495|NCT00000670|Renal Agents|renal agents|mesh-ancestor
2168496|NCT00000671|Zidovudine|zidovudine|mesh-list
2168497|NCT00000671|Didanosine|didanosine|mesh-list
2168498|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
2629859|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2629860|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629861|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
2629862|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629863|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629864|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2629865|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629866|NCT01930812|Listerine|listerine|mesh-list
2629867|NCT01930812|Fluorides|fluorides|mesh-list
2629868|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
2629869|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
2168499|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168500|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2184879|NCT00002835|Vincristine|vincristine|mesh-list
2168501|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168502|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168503|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
2168504|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168505|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168506|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2629870|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
2629871|NCT01930812|Protective Agents|protective agents|mesh-ancestor
2629872|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629873|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2629874|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629875|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2629876|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629877|NCT01930864|Metformin|metformin|mesh-list
2629878|NCT01930864|Irinotecan|irinotecan|mesh-list
2629879|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2629880|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629881|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2629882|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2629883|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629884|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629885|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629886|NCT01930877|Lidocaine|lidocaine|mesh-list
2629887|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
2629888|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
2629889|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2629890|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629891|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
2629892|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629893|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2629894|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2629895|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2629896|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2629897|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629898|NCT01930916|Anticoagulants|anticoagulants|mesh-list
2629899|NCT01930916|Antibodies|antibodies|mesh-list
2629900|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
2629901|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
2629902|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
2629903|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629904|NCT01930955|Amoxicillin|amoxicillin|mesh-list
2629905|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2629906|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629907|NCT01931033|Oxytocin|oxytocin|mesh-list
2629908|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
2629909|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2629910|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629911|NCT01931085|Triclabendazole|triclabendazole|mesh-list
2629912|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2629913|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
2629914|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2629915|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629916|NCT01931098|Topotecan|topotecan|mesh-list
2629917|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2629918|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2168507|NCT00000672|Didanosine|didanosine|mesh-list
2168508|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
2168509|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168510|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168511|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168512|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168513|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
2168514|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168515|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168516|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168517|NCT00000673|Ganciclovir|ganciclovir|mesh-list
2168518|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2168519|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
2168520|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2629919|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629920|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629921|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629922|NCT01931137|Insulin|insulin|mesh-list
2629923|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2168521|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2629924|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629925|NCT01931189|Infliximab|infliximab|mesh-list
2629926|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
2629927|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2629928|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2629929|NCT01931215|Clonidine|clonidine|mesh-list
2629930|NCT01931215|Morphine|morphine|mesh-list
2629931|NCT01931215|Ropivacaine|ropivacaine|mesh-list
2629932|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
2629933|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2629934|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629935|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2629936|NCT01931215|Narcotics|narcotics|mesh-ancestor
2629937|NCT01931215|Analgesics|analgesics|mesh-ancestor
2629938|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
2629939|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629940|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
2629941|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2629942|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
2629943|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
2629944|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2629945|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2629946|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2168522|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168523|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168524|NCT00000674|Leucovorin|leucovorin|mesh-list
2168525|NCT00000674|Clindamycin|clindamycin|mesh-list
2168526|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
2168527|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
2168528|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
2168529|NCT00000674|Calcium|calcium|mesh-list
2168530|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
2168531|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2168532|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168533|NCT00000674|Antidotes|antidotes|mesh-ancestor
2168534|NCT00000674|Protective Agents|protective agents|mesh-ancestor
2168535|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
2168536|NCT00000674|Vitamins|vitamins|mesh-ancestor
2168537|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
2168538|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2168539|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168540|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2168541|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168542|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168543|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
2168544|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2168545|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2168546|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2168547|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
2168548|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
2168549|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168550|NCT00000676|Fluconazole|fluconazole|mesh-list
2168551|NCT00000676|Clotrimazole|clotrimazole|mesh-list
2168552|NCT00000676|Miconazole|miconazole|mesh-list
2168553|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
2168554|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168555|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2168556|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2168557|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168558|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168559|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2168560|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
2168561|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2168562|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168563|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2168564|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2629947|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
2629948|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629949|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629950|NCT01931293|Folic Acid|folic acid|mesh-list
2629951|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
2629952|NCT01931293|Vitamins|vitamins|mesh-ancestor
2629953|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
2629954|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629955|NCT01931293|Hematinics|hematinics|mesh-ancestor
2629956|NCT01931306|Afatinib|afatinib|mesh-list
2629957|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2629958|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2629959|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629960|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629961|NCT01931319|Baclofen|baclofen|mesh-list
2629962|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2629963|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168565|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2168566|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2168567|NCT00000677|Sch 39304|sch 39304|mesh-list
2168568|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
2168569|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168570|NCT00000678|Zidovudine|zidovudine|mesh-list
2629964|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2629965|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2629966|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2168571|NCT00000678|Zalcitabine|zalcitabine|mesh-list
2168572|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
2168573|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168574|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168575|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168576|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168577|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
2168578|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168579|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168580|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168581|NCT00000679|Zidovudine|zidovudine|mesh-list
2168582|NCT00000679|Zalcitabine|zalcitabine|mesh-list
2168583|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
2168584|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168585|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168586|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168587|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629967|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
2629968|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
2629969|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2629970|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2629971|NCT01931332|Heroin|heroin|mesh-list
2629972|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2629973|NCT01931332|Narcotics|narcotics|mesh-ancestor
2629974|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2629975|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168588|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
2168589|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168590|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168591|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168592|NCT00000680|Zidovudine|zidovudine|mesh-list
2168593|NCT00000680|Aldesleukin|aldesleukin|mesh-list
2168594|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
2168595|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168596|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168597|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2629976|NCT01931332|Analgesics|analgesics|mesh-ancestor
2629977|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
2629978|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2168598|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168599|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
2168600|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168601|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168602|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168603|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168604|NCT00000681|Zidovudine|zidovudine|mesh-list
2168605|NCT00000681|Doxorubicin|doxorubicin|mesh-list
2168606|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2168607|NCT00000681|Bleomycin|bleomycin|mesh-list
2168608|NCT00000681|Vincristine|vincristine|mesh-list
2168609|NCT00000681|Sargramostim|sargramostim|mesh-list
2168610|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2168611|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168612|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2168613|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2168614|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168615|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168616|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2168617|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
2168618|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
2168619|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
2168620|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
2629979|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2629980|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2629981|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629982|NCT01931410|Misoprostol|misoprostol|mesh-list
2629983|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2629984|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
2629985|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2629986|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629987|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2629988|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2629989|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
2629990|NCT01931501|Montelukast|montelukast|mesh-list
2629991|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2629992|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
2168621|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168622|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168623|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
2168624|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168625|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168626|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168627|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
2168628|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168629|NCT00000682|Zidovudine|zidovudine|mesh-list
2168630|NCT00000682|Zalcitabine|zalcitabine|mesh-list
2168631|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
2168632|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168633|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168634|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168635|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2629993|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2629994|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
2629995|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2629996|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2629997|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2168636|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
2168637|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168638|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168639|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168640|NCT00000684|Dextrans|dextrans|mesh-list
2168641|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
2168642|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
2629998|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2629999|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630000|NCT01931514|Montelukast|montelukast|mesh-list
2630001|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2630002|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
2630003|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2630004|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
2630005|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2630006|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630007|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2168643|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
2168644|NCT00000685|Zidovudine|zidovudine|mesh-list
2168645|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
2168646|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168647|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2630008|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2630009|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630010|NCT01931592|Gentamicins|gentamicins|mesh-list
2630011|NCT01931592|Colistin|colistin|mesh-list
2630012|NCT01931592|Fosfomycin|fosfomycin|mesh-list
2630013|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2630014|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630015|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2630016|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168648|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168649|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168650|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
2168651|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168652|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168653|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168654|NCT00000686|Stavudine|stavudine|mesh-list
2168655|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
2168656|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168657|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2630017|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630018|NCT01931657|Mifepristone|mifepristone|mesh-list
2630019|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
2630020|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2630021|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
2630022|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2630023|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630024|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2630025|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2630026|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2630027|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
2630028|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2630029|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2630030|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
2630031|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2630032|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
2630033|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2630034|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2630035|NCT01931683|Remifentanil|remifentanil|mesh-list
2630036|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2630037|NCT01931683|Narcotics|narcotics|mesh-ancestor
2630038|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630039|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630040|NCT01931683|Analgesics|analgesics|mesh-ancestor
2630041|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
2630042|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630043|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
2630044|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
2630045|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630046|NCT01931787|Protective Agents|protective agents|mesh-ancestor
2630047|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630048|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
2630049|NCT01931787|Vitamins|vitamins|mesh-ancestor
2630050|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
2630051|NCT01931982|Liraglutide|liraglutide|mesh-list
2630052|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2630053|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630054|NCT01931982|Incretins|incretins|mesh-ancestor
2168658|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168659|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168660|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
2168661|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630055|NCT01931982|Hormones|hormones|mesh-ancestor
2630056|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2630057|NCT01932151|Terlipressin|terlipressin|mesh-list
2630058|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2630059|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2630060|NCT01932177|Everolimus|everolimus|mesh-list
2630061|NCT01932177|Sorafenib|sorafenib|mesh-list
2630062|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630063|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2630064|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
2630065|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630066|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2630067|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630068|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630069|NCT01932203|Aspirin|aspirin|mesh-list
2630070|NCT01932203|Cilostazol|cilostazol|mesh-list
2630071|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2630072|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2630073|NCT01932203|Analgesics|analgesics|mesh-ancestor
2630074|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
2630075|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630076|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630077|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2630078|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2630079|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2630080|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2630081|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630082|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2630083|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2630084|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630085|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
2630086|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2630087|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
2630088|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2630089|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
2630090|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
2630091|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2630092|NCT01932203|Protective Agents|protective agents|mesh-ancestor
2630093|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2630094|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2630095|NCT01932229|Afatinib|afatinib|mesh-list
2630096|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630097|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2630098|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630099|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630100|NCT01932268|Rifampin|rifampin|mesh-list
2630101|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2630102|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
2630103|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2630104|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630105|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
2630106|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2630107|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630108|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630109|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2630110|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2630111|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2168662|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168663|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168664|NCT00000687|Interferons|interferons|mesh-list
2168665|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
2168666|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
2168667|NCT00000687|Zidovudine|zidovudine|mesh-list
2168668|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168669|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
2168670|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168671|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
2168672|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168673|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
2168674|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168675|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168676|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168677|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168678|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168679|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168680|NCT00000688|Ganciclovir|ganciclovir|mesh-list
2168681|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2168682|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
2168683|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168684|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168685|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168686|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168687|NCT00000689|Leucovorin|leucovorin|mesh-list
2168688|NCT00000689|Cytarabine|cytarabine|mesh-list
2168689|NCT00000689|Dexamethasone|dexamethasone|mesh-list
2168690|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
2168691|NCT00000689|Doxorubicin|doxorubicin|mesh-list
2168692|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2168693|NCT00000689|Methotrexate|methotrexate|mesh-list
2168694|NCT00000689|Vincristine|vincristine|mesh-list
2168695|NCT00000689|Bleomycin|bleomycin|mesh-list
2168696|NCT00000689|Sargramostim|sargramostim|mesh-list
2168697|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
2168698|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2168699|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
2168700|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168701|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2168702|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2168703|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
2168704|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168705|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168706|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2168707|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2168708|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
2168709|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
2168710|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2168711|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2168712|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
2168713|NCT00000689|Hormones|hormones|mesh-ancestor
2184880|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
2630112|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2630113|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2630114|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2630115|NCT01932320|Ketoconazole|ketoconazole|mesh-list
2630116|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
2630117|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630118|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2630119|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2630120|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630121|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630122|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2630123|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
2630124|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2630125|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630126|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2630127|NCT01932372|Etanercept|etanercept|mesh-list
2630128|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
2630129|NCT01932372|Tofacitinib|tofacitinib|mesh-list
2630130|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2630131|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2630132|NCT01932372|Analgesics|analgesics|mesh-ancestor
2630133|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
2630134|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630135|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168714|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2168715|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2168716|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2168717|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2630136|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2630137|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2630138|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2630139|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
2168718|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2168719|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168720|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2168721|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
2168722|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2168723|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2168724|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
2168725|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
2168726|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2168727|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168728|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
2168729|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168730|NCT00000689|Antidotes|antidotes|mesh-ancestor
2630140|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2630141|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630142|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630143|NCT01932385|Sorafenib|sorafenib|mesh-list
2630144|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630145|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2630146|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630147|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630148|NCT01932424|Propofol|propofol|mesh-list
2630149|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2630150|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630151|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630152|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2630153|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
2630154|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
2630155|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
2630156|NCT01932502|Clobazam|clobazam|mesh-list
2630157|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
2630158|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2630159|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2168731|NCT00000689|Protective Agents|protective agents|mesh-ancestor
2168732|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
2168733|NCT00000689|Vitamins|vitamins|mesh-ancestor
2168734|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
2168735|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2168736|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
2168737|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
2168738|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
2168739|NCT00000690|Dextrans|dextrans|mesh-list
2168740|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
2168741|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
2168742|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
2168743|NCT00000691|Foscarnet|foscarnet|mesh-list
2168744|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2168745|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
2168746|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168747|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168748|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168749|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168750|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168751|NCT00000692|Miglustat|miglustat|mesh-list
2630160|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630161|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630162|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2630163|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2630164|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
2630165|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
2630166|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2630167|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630168|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2630169|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2630170|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2630171|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630172|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630173|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2630174|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2630175|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2630176|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2630177|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
2630178|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2630179|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630180|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2630181|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2630182|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
2630183|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2630184|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2630185|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
2168752|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168753|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168754|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168755|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168756|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
2168757|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168758|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2168759|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2168760|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168761|NCT00000693|Zidovudine|zidovudine|mesh-list
2168762|NCT00000693|Acyclovir|acyclovir|mesh-list
2168763|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
2630186|NCT01932554|Ibuprofen|ibuprofen|mesh-list
2630187|NCT01932554|Fentanyl|fentanyl|mesh-list
2630188|NCT01932554|Morphine|morphine|mesh-list
2630189|NCT01932554|Hydromorphone|hydromorphone|mesh-list
2630190|NCT01932554|Narcotics|narcotics|mesh-list
2630191|NCT01932554|Abciximab|abciximab|mesh-list
2630192|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2630193|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630194|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630195|NCT01932554|Analgesics|analgesics|mesh-ancestor
2630196|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
2630197|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630198|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2630199|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2630200|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
2630201|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
2422135|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422136|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2422137|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2422138|NCT00816205|Nifedipine|nifedipine|mesh-list
2422139|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2422140|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422141|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630202|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2168764|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630203|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2630204|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2630205|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2630206|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2630207|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630208|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630209|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
2630210|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2630211|NCT01932580|Docetaxel|docetaxel|mesh-list
2630212|NCT01932580|Fluorouracil|fluorouracil|mesh-list
2630213|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
2630214|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630215|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
2630216|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
2630217|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
2630218|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630219|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
2630220|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2630221|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2630222|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
2630223|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630224|NCT01932918|Ketorolac|ketorolac|mesh-list
2630225|NCT01932918|Morphine|morphine|mesh-list
2630226|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2630227|NCT01932918|Narcotics|narcotics|mesh-ancestor
2630228|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630229|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630230|NCT01932918|Analgesics|analgesics|mesh-ancestor
2630231|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
2630232|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630233|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2168765|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168766|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168767|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168768|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
2168769|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168770|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168771|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168772|NCT00000694|Interferons|interferons|mesh-list
2168773|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
2168774|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
2168775|NCT00000694|Zidovudine|zidovudine|mesh-list
2168776|NCT00000694|Sargramostim|sargramostim|mesh-list
2168777|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168778|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
2168779|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168780|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
2168781|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630234|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2630235|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2630236|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2630237|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2630238|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630239|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630240|NCT01932931|Vitamin D|vitamin d|mesh-list
2630241|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
2630242|NCT01932931|Vitamins|vitamins|mesh-ancestor
2630243|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
2630244|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630245|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2630246|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2630247|NCT01933022|Leuprolide|leuprolide|mesh-list
2630248|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2630249|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
2630250|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2630251|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630252|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2630253|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630254|NCT01933061|Paclitaxel|paclitaxel|mesh-list
2630255|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2630256|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2630257|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630258|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
2630259|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
2168782|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
2168783|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630260|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
2630261|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630262|NCT01933152|Ranibizumab|ranibizumab|mesh-list
2630263|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2630264|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2630265|NCT01933152|Growth Substances|growth substances|mesh-ancestor
2630266|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630267|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
2630268|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630269|NCT01933347|Gefitinib|gefitinib|mesh-list
2630270|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630271|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2630272|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630273|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630274|NCT01933360|Misoprostol|misoprostol|mesh-list
2630275|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2630276|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
2630277|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2630278|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630279|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2630280|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2630281|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
2630282|NCT01933412|Vaccines|vaccines|mesh-list
2630283|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
2630284|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630285|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
2630286|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2630287|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630288|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2630289|NCT01933503|Cathartics|cathartics|mesh-ancestor
2630290|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2630291|NCT01933516|Rituximab|rituximab|mesh-list
2630292|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2630293|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630294|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
2630295|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630296|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2630297|NCT01933542|Morphine|morphine|mesh-list
2630298|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
2630299|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2630300|NCT01933542|Narcotics|narcotics|mesh-ancestor
2630301|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630302|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630303|NCT01933542|Analgesics|analgesics|mesh-ancestor
2630304|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
2630305|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630306|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2630307|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2630308|NCT01933568|Cisplatin|cisplatin|mesh-list
2630309|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630310|NCT01933698|Amoxicillin|amoxicillin|mesh-list
2630311|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2630312|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630313|NCT01933711|Rituximab|rituximab|mesh-list
2630314|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2630315|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630316|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
2630317|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630318|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2630319|NCT01933724|Prednisone|prednisone|mesh-list
2168784|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168785|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168786|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168787|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168788|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168789|NCT00000695|Interferons|interferons|mesh-list
2168790|NCT00000695|Zidovudine|zidovudine|mesh-list
2168791|NCT00000695|Interferon-beta|interferon-beta|mesh-list
2168792|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
2168793|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168794|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
2168795|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168796|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
2168797|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168798|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168799|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168800|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168801|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2630320|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
2630321|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2630322|NCT01933724|Hormones|hormones|mesh-ancestor
2630323|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2630324|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630325|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2630326|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630327|NCT01933815|Bevacizumab|bevacizumab|mesh-list
2168802|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168803|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
2168804|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168805|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2168806|NCT00000696|Interferons|interferons|mesh-list
2168807|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
2630328|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2630329|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630330|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2630331|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2630332|NCT01933815|Growth Substances|growth substances|mesh-ancestor
2630333|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630334|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
2630335|NCT01933906|Interferons|interferons|mesh-list
2630336|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
2630337|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
2630338|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2630339|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630340|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
2630341|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630342|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
2630343|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630344|NCT01933945|Sorafenib|sorafenib|mesh-list
2630345|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630346|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2630347|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630348|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630349|NCT01933971|Lenograstim|lenograstim|mesh-list
2630350|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2630351|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
2630352|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630353|NCT01933997|Pyridoxine|pyridoxine|mesh-list
2630354|NCT01933997|Metadoxine|metadoxine|mesh-list
2630355|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2630356|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
2630357|NCT01933997|Vitamins|vitamins|mesh-ancestor
2630358|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
2630359|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630360|NCT01934023|Varenicline|varenicline|mesh-list
2168808|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
2168809|NCT00000696|Zidovudine|zidovudine|mesh-list
2168810|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168811|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
2168812|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168813|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
2168814|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168815|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
2168816|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168817|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168818|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168819|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168820|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168821|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168822|NCT00000697|Foscarnet|foscarnet|mesh-list
2168823|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2168824|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
2168825|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168826|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168827|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168828|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168829|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168830|NCT00000698|Ganciclovir|ganciclovir|mesh-list
2630361|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2630362|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2630363|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
2630364|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2168831|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2168832|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
2168833|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630365|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630366|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630367|NCT01934049|Anesthetics|anesthetics|mesh-list
2630368|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2168834|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168835|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168836|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168837|NCT00000699|Ribavirin|ribavirin|mesh-list
2168838|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
2168839|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
2168840|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168841|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
2168842|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168843|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2168844|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
2168845|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630369|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630370|NCT01934088|Fentanyl|fentanyl|mesh-list
2630371|NCT01934088|Midazolam|midazolam|mesh-list
2630372|NCT01934088|Propofol|propofol|mesh-list
2630373|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2630374|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630375|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630376|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2630377|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
2630378|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
2630379|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2630380|NCT01934088|Narcotics|narcotics|mesh-ancestor
2630381|NCT01934088|Analgesics|analgesics|mesh-ancestor
2630382|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
2630383|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630384|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2630385|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2630386|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2630387|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2630388|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
2630389|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
2630390|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2630391|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630392|NCT01934127|Vaccines|vaccines|mesh-list
2630393|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
2168846|NCT00000700|Zidovudine|zidovudine|mesh-list
2168847|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
2168848|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168849|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168850|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168851|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168852|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
2168853|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168854|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168855|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2630394|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630395|NCT01934166|Nalmefene|nalmefene|mesh-list
2630396|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2630397|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630398|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
2630399|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630400|NCT01934361|Carboplatin|carboplatin|mesh-list
2630401|NCT01934361|Lomustine|lomustine|mesh-list
2630402|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630403|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2630404|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
2630405|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630406|NCT01934452|Sunitinib|sunitinib|mesh-list
2630407|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630408|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2630409|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2630410|NCT01934452|Growth Substances|growth substances|mesh-ancestor
2630411|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630412|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
2630413|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2630414|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630415|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630416|NCT01934569|Losartan|losartan|mesh-list
2630417|NCT01934569|Midazolam|midazolam|mesh-list
2630418|NCT01934569|Caffeine|caffeine|mesh-list
2168856|NCT00000701|Zidovudine|zidovudine|mesh-list
2168857|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
2168858|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168859|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168860|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168861|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168862|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
2168863|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168864|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168865|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168866|NCT00000702|Zidovudine|zidovudine|mesh-list
2168867|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
2168868|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168869|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168870|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168871|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168872|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
2168873|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168874|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168875|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168876|NCT00000703|Leucovorin|leucovorin|mesh-list
2168877|NCT00000703|Cytarabine|cytarabine|mesh-list
2168878|NCT00000703|Zidovudine|zidovudine|mesh-list
2168879|NCT00000703|Dexamethasone|dexamethasone|mesh-list
2630419|NCT01934569|Omeprazole|omeprazole|mesh-list
2630420|NCT01934569|Pravastatin|pravastatin|mesh-list
2630421|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2630422|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2630423|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630424|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630425|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2630426|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2630427|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2630428|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2630429|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
2630430|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
2630431|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
2630432|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
2630433|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2630434|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630435|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2630436|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2630437|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2168880|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
2168881|NCT00000703|Doxorubicin|doxorubicin|mesh-list
2168882|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2168883|NCT00000703|Methotrexate|methotrexate|mesh-list
2168884|NCT00000703|Vincristine|vincristine|mesh-list
2168885|NCT00000703|Bleomycin|bleomycin|mesh-list
2168886|NCT00000703|Allopurinol|allopurinol|mesh-list
2168887|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
2168888|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2168889|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
2168890|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168891|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2168892|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2168893|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
2168894|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168895|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2168896|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2630438|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2630439|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2630440|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2630441|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2630442|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630443|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2630444|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2630445|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2630446|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2630447|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
2630448|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2630449|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2630450|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
2630451|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2168897|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2168898|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
2168899|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
2168900|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2168901|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2168902|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
2168903|NCT00000703|Hormones|hormones|mesh-ancestor
2168904|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2168905|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2168906|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2168907|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2630452|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2630453|NCT01934634|Gemcitabine|gemcitabine|mesh-list
2630454|NCT01934634|Paclitaxel|paclitaxel|mesh-list
2630455|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2630456|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630457|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
2630458|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
2630459|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
2630460|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630461|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2630462|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
2630463|NCT01934634|Antiviral Agents|antiviral agents|mesh-ancestor
2630464|NCT01934634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630465|NCT01934634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630466|NCT01934634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2630467|NCT01934634|Immunologic Factors|immunologic factors|mesh-ancestor
2630468|NCT01934634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630469|NCT01934712|Insulin|insulin|mesh-list
2630470|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2630471|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
2630472|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
2630473|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2630474|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2630475|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630476|NCT01934777|Vitamin E|vitamin e|mesh-list
2168908|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2168909|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630477|NCT01934777|Choline|choline|mesh-list
2630478|NCT01934777|Vitamins|vitamins|mesh-ancestor
2630479|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
2630480|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630481|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
2630482|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630483|NCT01934777|Protective Agents|protective agents|mesh-ancestor
2630484|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
2630485|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2168910|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2168911|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
2168912|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2168913|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2168914|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
2168915|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
2630486|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
2630487|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2630488|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2630489|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
2630490|NCT01934816|Liraglutide|liraglutide|mesh-list
2630491|NCT01934816|Exenatide|exenatide|mesh-list
2630492|NCT01934816|Glucagon|glucagon|mesh-list
2630493|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2630494|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2630495|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630496|NCT01934816|Incretins|incretins|mesh-ancestor
2630497|NCT01934816|Hormones|hormones|mesh-ancestor
2630498|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2630499|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2630500|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2630501|NCT01934829|Sorafenib|sorafenib|mesh-list
2630502|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630503|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2630504|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630505|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630506|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2630507|NCT01934933|Celecoxib|celecoxib|mesh-list
2630508|NCT01934933|Etanercept|etanercept|mesh-list
2630509|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2630510|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2630511|NCT01934933|Analgesics|analgesics|mesh-ancestor
2630512|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
2630513|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630514|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630515|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2630516|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2630517|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2630518|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2630519|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630520|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630521|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2630522|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2630523|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
2630524|NCT01935063|Lidocaine|lidocaine|mesh-list
2630525|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
2168916|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2168917|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168918|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
2168919|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168920|NCT00000703|Antidotes|antidotes|mesh-ancestor
2168921|NCT00000703|Protective Agents|protective agents|mesh-ancestor
2168922|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
2168923|NCT00000703|Vitamins|vitamins|mesh-ancestor
2168924|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
2168925|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2168926|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
2168927|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
2168928|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
2168929|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168930|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168931|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168932|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
2168933|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2168934|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
2168935|NCT00000704|Zalcitabine|zalcitabine|mesh-list
2168936|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
2168937|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168938|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168939|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168940|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168941|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
2168942|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168943|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168944|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2168945|NCT00000705|Zidovudine|zidovudine|mesh-list
2168946|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
2168947|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168948|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2630526|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
2630527|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630528|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630529|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
2630530|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630531|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2630532|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2630533|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2630534|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2630535|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630536|NCT01935089|Interferons|interferons|mesh-list
2630537|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
2630538|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
2630539|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2630540|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630541|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
2630542|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630543|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
2630544|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630545|NCT01935115|Ketamine|ketamine|mesh-list
2630546|NCT01935115|Propofol|propofol|mesh-list
2630547|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2630548|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630549|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630550|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2630551|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
2630552|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
2630553|NCT01935115|Analgesics|analgesics|mesh-ancestor
2168949|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2630554|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
2630555|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630556|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2630557|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2630558|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2630559|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2630560|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630561|NCT01935128|Everolimus|everolimus|mesh-list
2630562|NCT01935128|Tacrolimus|tacrolimus|mesh-list
2630563|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2630564|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
2630565|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630566|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2630567|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630568|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630569|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630570|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
2630571|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2630572|NCT01935141|Growth Substances|growth substances|mesh-ancestor
2630573|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630574|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
2630575|NCT01935193|Analgesics|analgesics|mesh-ancestor
2630576|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
2630577|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2168950|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168951|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
2168952|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168953|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168954|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2630578|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630579|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2630580|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2630581|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2630582|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2630583|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2630584|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2630585|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630586|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630587|NCT01935206|Naloxone|naloxone|mesh-list
2630588|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2630589|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630590|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
2630591|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630592|NCT01935310|Imiquimod|imiquimod|mesh-list
2630593|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2630594|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
2630595|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630596|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630597|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
2630598|NCT01935336|Ponatinib|ponatinib|mesh-list
2630599|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630600|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2630601|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630602|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630606|NCT01935492|Paclitaxel|paclitaxel|mesh-list
2630607|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2630608|NCT01935492|Bevacizumab|bevacizumab|mesh-list
2630609|NCT01935492|Doxorubicin|doxorubicin|mesh-list
2630610|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2630611|NCT01935492|Capecitabine|capecitabine|mesh-list
2630612|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2630613|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630614|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
2630615|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
2630616|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
2630617|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630618|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2630619|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2630620|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2630621|NCT01935492|Growth Substances|growth substances|mesh-ancestor
2630622|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630623|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
2168955|NCT00000706|Zidovudine|zidovudine|mesh-list
2168956|NCT00000706|Quinine|quinine|mesh-list
2630624|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2630625|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2630626|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2630627|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630628|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2630629|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
2630630|NCT01935505|Bupropion|bupropion|mesh-list
2630631|NCT01935505|Nicotine|nicotine|mesh-list
2630632|NCT01935505|Varenicline|varenicline|mesh-list
2630633|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2630634|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
2630635|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630636|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630637|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2630638|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2630639|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
2630640|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2630641|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630642|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2630643|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
2630644|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2630645|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2630646|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2630647|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2630648|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
2630649|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2630650|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2630651|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630652|NCT01935518|Fasudil|fasudil|mesh-list
2630653|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2630654|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2630655|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630656|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2630657|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630658|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
2630659|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2630660|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630661|NCT01935531|Diclofenac|diclofenac|mesh-list
2630662|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
2630663|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2630664|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2630665|NCT01935531|Analgesics|analgesics|mesh-ancestor
2630666|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
2630667|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630668|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630669|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2630670|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2168957|NCT00000706|Probenecid|probenecid|mesh-list
2168958|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
2168959|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168960|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2168961|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2168962|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168963|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
2168964|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168965|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2168966|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2630671|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2630672|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630673|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630674|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2630675|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
2630676|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
2630677|NCT01935531|Protective Agents|protective agents|mesh-ancestor
2630678|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
2630679|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2630680|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2630681|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630682|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
2630683|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2630684|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630685|NCT01935557|Heparin|heparin|mesh-list
2630686|NCT01935557|Calcium heparin|calcium heparin|mesh-list
2630687|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
2630688|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2630689|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2630690|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630691|NCT01935596|Ropivacaine|ropivacaine|mesh-list
2630692|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
2630693|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
2630694|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
2630695|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630696|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630697|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
2630698|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630699|NCT01935648|Ropivacaine|ropivacaine|mesh-list
2630700|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
2630701|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
2630702|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2168967|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
2168968|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2168969|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2168970|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2168971|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2168972|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2630703|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630704|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
2630705|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630706|NCT01935674|Ritonavir|ritonavir|mesh-list
2630707|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2630708|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2630709|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2630710|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
2630711|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630712|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168973|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2168974|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2168975|NCT00000706|Analgesics|analgesics|mesh-ancestor
2168976|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
2168977|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
2168978|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
2168979|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2168980|NCT00000706|Renal Agents|renal agents|mesh-ancestor
2168981|NCT00000707|Pentamidine|pentamidine|mesh-list
2168982|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
2168983|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168984|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2168985|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2168986|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2630713|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2630714|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2630715|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
2630716|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630717|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2630718|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2630719|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2630720|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2630721|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
2630722|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2630723|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2630724|NCT01935713|Nicotine|nicotine|mesh-list
2630725|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2630726|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
2168987|NCT00000708|Fluconazole|fluconazole|mesh-list
2168988|NCT00000708|Amphotericin B|amphotericin b|mesh-list
2168989|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2168990|NCT00000708|Flucytosine|flucytosine|mesh-list
2168991|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
2168992|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2168993|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2168994|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2168995|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2168996|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2168997|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2168998|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
2168999|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2630727|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630728|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169000|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169001|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2169002|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2169003|NCT00000708|Amebicides|amebicides|mesh-ancestor
2169004|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169005|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169006|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169007|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
2630729|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2630730|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2630731|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
2630732|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2630733|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630734|NCT01935778|Docetaxel|docetaxel|mesh-list
2630735|NCT01935778|Capecitabine|capecitabine|mesh-list
2630736|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
2630737|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630738|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
2169008|NCT00000709|Zidovudine|zidovudine|mesh-list
2169009|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
2169010|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169011|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169012|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169013|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169014|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
2169015|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169016|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169017|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169018|NCT00000710|Didanosine|didanosine|mesh-list
2169019|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
2169020|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169021|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169022|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169023|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169024|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
2169025|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169026|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169027|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169028|NCT00000711|Zidovudine|zidovudine|mesh-list
2169029|NCT00000711|Sargramostim|sargramostim|mesh-list
2169030|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
2169031|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169032|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169033|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169034|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169035|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
2169036|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169037|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2630739|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
2630740|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
2630741|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630742|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2630743|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
2630744|NCT01935804|Metformin|metformin|mesh-list
2630745|NCT01935804|Pioglitazone|pioglitazone|mesh-list
2630746|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2630747|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630748|NCT01935817|Vitamin E|vitamin e|mesh-list
2630749|NCT01935817|Silybin|silybin|mesh-list
2630750|NCT01935817|Vitamins|vitamins|mesh-ancestor
2630751|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
2630752|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630753|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
2630754|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630755|NCT01935817|Protective Agents|protective agents|mesh-ancestor
2630756|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2630757|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630758|NCT01935830|Ritonavir|ritonavir|mesh-list
2630759|NCT01935830|Efavirenz|efavirenz|mesh-list
2630760|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2630761|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2630762|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
2630763|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630764|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630765|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2630766|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2630767|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
2169038|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169039|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
2169040|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169041|NCT00000712|Zidovudine|zidovudine|mesh-list
2169042|NCT00000712|Acyclovir|acyclovir|mesh-list
2169043|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
2169044|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169045|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169046|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2630768|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630769|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2630770|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2630771|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2630772|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2630773|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2630774|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2630775|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2630776|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2630777|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2630778|NCT01935869|Petrolatum|petrolatum|mesh-list
2630779|NCT01935869|Emollients|emollients|mesh-ancestor
2630780|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
2630781|NCT01935882|Lumefantrine|lumefantrine|mesh-list
2630782|NCT01935882|Artemether|artemether|mesh-list
2630783|NCT01935882|Primaquine|primaquine|mesh-list
2630784|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2630785|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
2630786|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2630787|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2630788|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630789|NCT01935908|Levetiracetam|levetiracetam|mesh-list
2630790|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
2630791|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
2630803|NCT01935973|Trametinib|trametinib|mesh-list
2630804|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630805|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2630806|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630807|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630808|NCT01936012|Lisinopril|lisinopril|mesh-list
2630809|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2630810|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
2630811|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630812|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630813|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2630814|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2630815|NCT01936012|Protective Agents|protective agents|mesh-ancestor
2630816|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630817|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2630818|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
2630819|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2630820|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630821|NCT01936025|Incretins|incretins|mesh-ancestor
2630822|NCT01936025|Hormones|hormones|mesh-ancestor
2630823|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2630824|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2630825|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
2630826|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630827|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630828|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
2630829|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
2630830|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2630831|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2630832|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2169047|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169048|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
2169049|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630833|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
2630834|NCT01936064|Epirubicin|epirubicin|mesh-list
2630835|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2630836|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
2630837|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630838|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2630839|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2630840|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
2630841|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630842|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630843|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2630844|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2630845|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2630846|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2630847|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630848|NCT01936090|Bortezomib|bortezomib|mesh-list
2630849|NCT01936090|Melphalan|melphalan|mesh-list
2422142|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2422143|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422144|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
2422145|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
2422146|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2630850|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630851|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2630852|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
2630853|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630854|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2630855|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2630856|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
2630857|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630858|NCT01936103|Atorvastatin|atorvastatin|mesh-list
2630859|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2630860|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2630861|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
2630862|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630863|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2630864|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2630865|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630866|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
2630867|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
2630868|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2630869|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
2630870|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630871|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2630872|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2169050|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169051|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169052|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2169053|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
2169054|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169055|NCT00000714|Leucovorin|leucovorin|mesh-list
2169056|NCT00000714|Trimetrexate|trimetrexate|mesh-list
2169057|NCT00000714|Calcium|calcium|mesh-list
2169058|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
2169059|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2169060|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169061|NCT00000714|Antidotes|antidotes|mesh-ancestor
2169062|NCT00000714|Protective Agents|protective agents|mesh-ancestor
2169063|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
2169064|NCT00000714|Vitamins|vitamins|mesh-ancestor
2169065|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
2169066|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
2169067|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422147|NCT00816218|Pioglitazone|pioglitazone|mesh-list
2422148|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2422149|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422150|NCT00816244|Atorvastatin|atorvastatin|mesh-list
2422151|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2422152|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2422153|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
2422154|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422155|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2422156|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2422157|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630873|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
2630874|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2630875|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630876|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630877|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2630878|NCT01936233|Aspirin|aspirin|mesh-list
2630879|NCT01936233|Lamivudine|lamivudine|mesh-list
2630880|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2630881|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2630882|NCT01936233|Analgesics|analgesics|mesh-ancestor
2630883|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
2630884|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630885|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630886|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2630887|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2630888|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2630889|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2630890|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630891|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2630892|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2630893|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630894|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
2630895|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2630896|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2630897|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
2630898|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2630899|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2630900|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2630901|NCT01936285|Colchicine|colchicine|mesh-list
2630902|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
2630903|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2630904|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
2630905|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
2630906|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
2630907|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630908|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2630909|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
2630910|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
2630911|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2630912|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2630913|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630914|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630915|NCT01936350|Urological Agents|urological agents|mesh-ancestor
2630924|NCT01936532|Dexamethasone|dexamethasone|mesh-list
2630925|NCT01936532|Lenalidomide|lenalidomide|mesh-list
2630926|NCT01936532|Ixazomib|ixazomib|mesh-list
2630927|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2630928|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
2630929|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
2630930|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630931|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630932|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2630933|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
2630934|NCT01936532|Hormones|hormones|mesh-ancestor
2630935|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2630936|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2630937|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169068|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2169069|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
2169070|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169071|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169072|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2169073|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169074|NCT00000715|Trimethoprim|trimethoprim|mesh-list
2169075|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2169076|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
2169077|NCT00000715|Pentamidine|pentamidine|mesh-list
2630938|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
2630939|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2630940|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2630941|NCT01936532|Growth Substances|growth substances|mesh-ancestor
2630942|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
2630943|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
2630944|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630945|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630946|NCT01936545|Propofol|propofol|mesh-list
2630947|NCT01936545|Desflurane|desflurane|mesh-list
2630948|NCT01936545|Liver Extracts|liver extracts|mesh-list
2630949|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2630950|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630951|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630952|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2630953|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
2630954|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
2630955|NCT01936545|Hematinics|hematinics|mesh-ancestor
2630956|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2630957|NCT01936636|Fentanyl|fentanyl|mesh-list
2630958|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2630959|NCT01936636|Narcotics|narcotics|mesh-ancestor
2630960|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2630961|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630962|NCT01936636|Analgesics|analgesics|mesh-ancestor
2630963|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
2630964|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630965|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2169078|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2169079|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169080|NCT00000715|Renal Agents|renal agents|mesh-ancestor
2169081|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
2169082|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169083|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169084|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2169085|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2630966|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2630967|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
2630968|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
2630969|NCT01936688|Etanercept|etanercept|mesh-list
2630970|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2630971|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2630972|NCT01936688|Analgesics|analgesics|mesh-ancestor
2630973|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
2630974|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2630975|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2630976|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2630977|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2630978|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2630979|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2630980|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
2630981|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2630982|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2630983|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2630984|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
2630985|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2630986|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2630987|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2630988|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169086|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169087|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2169088|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2169089|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2169090|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
2169091|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2169092|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169093|NCT00000716|Zidovudine|zidovudine|mesh-list
2169094|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
2169095|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169096|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169097|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169098|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169099|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
2631005|NCT01936961|Antibodies|antibodies|mesh-list
2631006|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
2631007|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631008|NCT01937013|Oxytocin|oxytocin|mesh-list
2631009|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
2631010|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2631011|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631012|NCT01937078|Famotidine|famotidine|mesh-list
2631013|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2631014|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2631015|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2631016|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
2631017|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
2631018|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631019|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631020|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169100|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169101|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169102|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169103|NCT00000717|Clindamycin|clindamycin|mesh-list
2169104|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
2169105|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
2169106|NCT00000717|Primaquine|primaquine|mesh-list
2169107|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169108|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631021|NCT01937104|Remifentanil|remifentanil|mesh-list
2631022|NCT01937104|Desflurane|desflurane|mesh-list
2631023|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2631024|NCT01937104|Narcotics|narcotics|mesh-ancestor
2631025|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631026|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631027|NCT01937104|Analgesics|analgesics|mesh-ancestor
2631028|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
2631029|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631030|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2631031|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
2631032|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
2631033|NCT01937156|Granisetron|granisetron|mesh-list
2631034|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
2631035|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
2631036|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631037|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169109|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2169110|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169111|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169112|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
2169113|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169114|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169115|NCT00000718|Zidovudine|zidovudine|mesh-list
2169116|NCT00000718|Zalcitabine|zalcitabine|mesh-list
2169117|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
2169118|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169119|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169120|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169121|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169122|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
2169123|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169124|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169125|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169126|NCT00000719|Zidovudine|zidovudine|mesh-list
2169127|NCT00000719|Zalcitabine|zalcitabine|mesh-list
2169128|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
2169129|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184881|NCT00002835|Idarubicin|idarubicin|mesh-list
2631038|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2631039|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2169130|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169131|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169132|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631040|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
2631041|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631042|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631043|NCT01937169|Levodopa|levodopa|mesh-list
2631044|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2631045|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2631046|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
2169133|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
2169134|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169135|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169136|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169137|NCT00000720|Zidovudine|zidovudine|mesh-list
2169138|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
2169139|NCT00000720|Antibodies|antibodies|mesh-list
2169140|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
2169141|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169142|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169143|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169144|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169145|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
2169146|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169147|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169148|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169149|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
2169150|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169151|NCT00000722|Pentamidine|pentamidine|mesh-list
2631047|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631048|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169152|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
2169153|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169154|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169155|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169156|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2169157|NCT00000723|Leucovorin|leucovorin|mesh-list
2169158|NCT00000723|Zidovudine|zidovudine|mesh-list
2169159|NCT00000723|Dexamethasone|dexamethasone|mesh-list
2169160|NCT00000723|Methotrexate|methotrexate|mesh-list
2169161|NCT00000723|Calcium|calcium|mesh-list
2169162|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
2169163|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2169164|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
2631049|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631050|NCT01937182|Citalopram|citalopram|mesh-list
2631051|NCT01937182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2631052|NCT01937182|Serotonin|serotonin|mesh-list
2631053|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2631054|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2631055|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631056|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631057|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
2631058|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631059|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2631060|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
2631061|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2169165|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
2169166|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2169167|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169168|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2169169|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
2169170|NCT00000723|Hormones|hormones|mesh-ancestor
2169171|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2169172|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2631062|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2631063|NCT01937234|Metoclopramide|metoclopramide|mesh-list
2631064|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
2631065|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
2631066|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631067|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631068|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2631069|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2169173|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169174|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2169175|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2169176|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
2169177|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2169178|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2169179|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
2169180|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169181|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
2631070|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2631071|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
2631072|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631073|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631074|NCT01937325|Ivacaftor|ivacaftor|mesh-list
2631075|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2631076|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2631077|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631078|NCT01937338|AZD7624|azd7624|mesh-list
2631079|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2631080|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631081|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631082|NCT01937442|Thalidomide|thalidomide|mesh-list
2631083|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2631084|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
2631085|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631086|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
2631087|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2631088|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631089|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2631090|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2631091|NCT01937442|Growth Substances|growth substances|mesh-ancestor
2631092|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
2631093|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631101|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
2631102|NCT01937494|Histamine|histamine|mesh-list
2631103|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
2631104|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
2631105|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631106|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631107|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631108|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
2631109|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
2631110|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631111|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
2631112|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2169182|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169183|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2169184|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2631113|NCT01937611|Midazolam|midazolam|mesh-list
2631114|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
2631115|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2631116|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631117|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631118|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2631119|NCT01937611|Analgesics|analgesics|mesh-ancestor
2631120|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
2631121|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631122|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2631123|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2631124|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2631125|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
2631126|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631127|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631128|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2631129|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2631130|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2631131|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2631132|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2631133|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
2631134|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
2631135|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
2631136|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
2169185|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
2169186|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2169187|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169188|NCT00000723|Antidotes|antidotes|mesh-ancestor
2169189|NCT00000723|Protective Agents|protective agents|mesh-ancestor
2169190|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
2169191|NCT00000723|Vitamins|vitamins|mesh-ancestor
2169192|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
2169193|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169194|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
2169195|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631137|NCT01937650|Metronidazole|metronidazole|mesh-list
2631138|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631139|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2631140|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2631141|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2631142|NCT01937728|Interferons|interferons|mesh-list
2631143|NCT01937728|Ribavirin|ribavirin|mesh-list
2631144|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
2169196|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169197|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169198|NCT00000724|Leucovorin|leucovorin|mesh-list
2169199|NCT00000724|Trimetrexate|trimetrexate|mesh-list
2169200|NCT00000724|Calcium|calcium|mesh-list
2169201|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
2169202|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2169203|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169204|NCT00000724|Antidotes|antidotes|mesh-ancestor
2169205|NCT00000724|Protective Agents|protective agents|mesh-ancestor
2169206|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
2169207|NCT00000724|Vitamins|vitamins|mesh-ancestor
2169208|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
2169209|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
2169210|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169211|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2169212|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
2169213|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631145|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
2631146|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2631147|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631148|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
2631149|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169214|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169215|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2169216|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169217|NCT00000725|Interferons|interferons|mesh-list
2169218|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
2169219|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
2169220|NCT00000725|Zidovudine|zidovudine|mesh-list
2169221|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169222|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
2169223|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169224|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
2169225|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169226|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
2169227|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169228|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169229|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169230|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169231|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169232|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169233|NCT00000726|Foscarnet|foscarnet|mesh-list
2169234|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2169235|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
2169236|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169237|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2631150|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
2631151|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631152|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
2631153|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631154|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
2631155|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2169238|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169239|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169240|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169241|NCT00000727|Zidovudine|zidovudine|mesh-list
2631156|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
2631157|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631158|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631159|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2631160|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
2631161|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2631162|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
2631163|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631164|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631165|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2631166|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
2631167|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
2631168|NCT01937754|Protective Agents|protective agents|mesh-ancestor
2631169|NCT01937767|Fentanyl|fentanyl|mesh-list
2631170|NCT01937767|Remifentanil|remifentanil|mesh-list
2631171|NCT01937767|Propofol|propofol|mesh-list
2631172|NCT01937767|Sevoflurane|sevoflurane|mesh-list
2631173|NCT01937767|Rocuronium|rocuronium|mesh-list
2631174|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2631175|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631176|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631177|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2631178|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
2631179|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
2631180|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2631181|NCT01937767|Narcotics|narcotics|mesh-ancestor
2631182|NCT01937767|Analgesics|analgesics|mesh-ancestor
2631183|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
2631184|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631185|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2631186|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2631187|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2631188|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2631189|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2631190|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2631191|NCT01937806|Tenofovir|tenofovir|mesh-list
2631192|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
2631193|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631194|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2631195|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2631196|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631197|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631198|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2631199|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2631200|NCT01937832|Ertapenem|ertapenem|mesh-list
2631201|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2631202|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631203|NCT01938092|Diazepam|diazepam|mesh-list
2631204|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2631205|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
2631206|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
2631207|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
2631208|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631209|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631210|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2631211|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2631212|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631213|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2631214|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2631215|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2631216|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2631217|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2631218|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2631219|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
2631220|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
2631221|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
2631222|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
2169242|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
2169243|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
2169244|NCT00000727|Trimethoprim|trimethoprim|mesh-list
2169245|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
2169246|NCT00000727|Pentamidine|pentamidine|mesh-list
2169247|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2169248|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
2169249|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631223|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631224|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631225|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
2631226|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2631227|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631228|NCT01938144|Acetaminophen|acetaminophen|mesh-list
2631229|NCT01938144|Ibuprofen|ibuprofen|mesh-list
2631230|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2631231|NCT01938144|Analgesics|analgesics|mesh-ancestor
2631232|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
2631233|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631234|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631235|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
2631236|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2631237|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2631238|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2631239|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2631240|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631241|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631242|NCT01938183|Metronidazole|metronidazole|mesh-list
2631243|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169250|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169251|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169252|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169253|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
2169254|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169255|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169256|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169257|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
2169258|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169259|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169260|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2169261|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2631244|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2631245|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2631246|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2631247|NCT01938235|Exenatide|exenatide|mesh-list
2631248|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2631249|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631250|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2631251|NCT01938235|Incretins|incretins|mesh-ancestor
2631252|NCT01938235|Hormones|hormones|mesh-ancestor
2631253|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2631254|NCT01938248|Aspirin|aspirin|mesh-list
2631255|NCT01938248|Apixaban|apixaban|mesh-list
2169262|NCT00000727|Renal Agents|renal agents|mesh-ancestor
2169263|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2169264|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2169265|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2169266|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
2169267|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2169268|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169269|NCT00000728|Zidovudine|zidovudine|mesh-list
2169270|NCT00000728|Aldesleukin|aldesleukin|mesh-list
2169271|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
2169272|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169273|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169274|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169275|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169276|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
2169277|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169278|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169279|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169280|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169281|NCT00000729|Foscarnet|foscarnet|mesh-list
2169282|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2169283|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
2169284|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169285|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169286|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169287|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169288|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169289|NCT00000730|Leucovorin|leucovorin|mesh-list
2169290|NCT00000730|Trimethoprim|trimethoprim|mesh-list
2169291|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2169292|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
2169293|NCT00000730|Pentamidine|pentamidine|mesh-list
2169294|NCT00000730|Trimetrexate|trimetrexate|mesh-list
2631256|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2631257|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2631258|NCT01938248|Analgesics|analgesics|mesh-ancestor
2169295|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
2169296|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
2169297|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631259|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
2631260|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631261|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631262|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2631263|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2631264|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2631265|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2631266|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631267|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2631268|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2631269|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631270|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
2631271|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2631272|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
2631273|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2631274|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
2631275|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
2631276|NCT01938261|Acetaminophen|acetaminophen|mesh-list
2631277|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2631278|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2631279|NCT01938261|Analgesics|analgesics|mesh-ancestor
2631280|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
2631281|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631282|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631283|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
2169298|NCT00000730|Antidotes|antidotes|mesh-ancestor
2169299|NCT00000730|Protective Agents|protective agents|mesh-ancestor
2169300|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
2169301|NCT00000730|Vitamins|vitamins|mesh-ancestor
2169302|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
2169303|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2169304|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
2169305|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
2169306|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2169307|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2169308|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
2169309|NCT00000730|Hormones|hormones|mesh-ancestor
2169310|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2631284|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
2631285|NCT01938300|Analgesics|analgesics|mesh-ancestor
2631286|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
2631287|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631288|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631289|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
2631290|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631291|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2631292|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
2631293|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2631294|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2631295|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631296|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2631297|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
2631298|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2631299|NCT01938417|Tobramycin|tobramycin|mesh-list
2169311|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2169312|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169313|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2169314|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169315|NCT00000730|Renal Agents|renal agents|mesh-ancestor
2169316|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
2169317|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169318|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169319|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2169320|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169321|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169322|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2169323|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2169324|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2169325|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
2169326|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2169327|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169328|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2169329|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
2631300|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169330|NCT00000731|Acetaminophen|acetaminophen|mesh-list
2169331|NCT00000731|Zidovudine|zidovudine|mesh-list
2169332|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2169333|NCT00000731|Analgesics|analgesics|mesh-ancestor
2169334|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
2169335|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2169336|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169337|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
2169338|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
2169339|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169340|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169341|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169342|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169343|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
2169344|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169345|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169346|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169347|NCT00000732|Zidovudine|zidovudine|mesh-list
2631301|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631302|NCT01938443|Trametinib|trametinib|mesh-list
2631303|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631304|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2631305|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631306|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169348|NCT00000732|Trimethoprim|trimethoprim|mesh-list
2169349|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
2169350|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2169351|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
2169352|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169353|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169354|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169355|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631307|NCT01938456|Docetaxel|docetaxel|mesh-list
2631308|NCT01938456|Trametinib|trametinib|mesh-list
2631309|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631310|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
2631311|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
2631312|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
2631313|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631314|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2631315|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631316|NCT01938508|Minocycline|minocycline|mesh-list
2631317|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2631318|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631319|NCT01938547|Clevidipine|clevidipine|mesh-list
2631320|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2631321|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2631322|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631323|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2631324|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631325|NCT01938612|Durvalumab|durvalumab|mesh-list
2169356|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
2169357|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169358|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169359|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169360|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2169361|NCT00000732|Renal Agents|renal agents|mesh-ancestor
2169362|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
2169363|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169364|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169365|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2169366|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2169367|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2169368|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2169369|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169370|NCT00000733|Ribavirin|ribavirin|mesh-list
2169371|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
2169372|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169373|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
2631326|NCT01938612|Tremelimumab|tremelimumab|mesh-list
2631327|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2631328|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631329|NCT01938729|Gemcitabine|gemcitabine|mesh-list
2169374|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631330|NCT01938729|Dexamethasone|dexamethasone|mesh-list
2169375|NCT00000734|Zidovudine|zidovudine|mesh-list
2169376|NCT00000734|Trimethoprim|trimethoprim|mesh-list
2169377|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
2169378|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2169379|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
2169380|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169381|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169382|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169383|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169384|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
2169385|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169386|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169387|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169388|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2169389|NCT00000734|Renal Agents|renal agents|mesh-ancestor
2169390|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
2169391|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169392|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169393|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2631331|NCT01938729|Floxuridine|floxuridine|mesh-list
2631332|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2631333|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
2631334|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
2631335|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631336|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631337|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2631338|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
2631339|NCT01938729|Hormones|hormones|mesh-ancestor
2631340|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2631341|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2631342|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631343|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2631344|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
2631345|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631346|NCT01938729|Antiviral Agents|antiviral agents|mesh-ancestor
2631347|NCT01938729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631348|NCT01938729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631349|NCT01938729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2631350|NCT01938729|Immunologic Factors|immunologic factors|mesh-ancestor
2631351|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
2631352|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
2631353|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
2631354|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631355|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631356|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
2631357|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631358|NCT01938781|Entecavir|entecavir|mesh-list
2631359|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
2631360|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631361|NCT01938820|Entecavir|entecavir|mesh-list
2631362|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
2631363|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631364|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2631365|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
2631366|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2631367|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2631368|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2631369|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631370|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631371|NCT01938872|Paclitaxel|paclitaxel|mesh-list
2631372|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2631373|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631374|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
2631375|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
2631376|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
2631377|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631378|NCT01938911|Oxytocin|oxytocin|mesh-list
2631379|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
2631380|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2631381|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631382|NCT01939054|Docetaxel|docetaxel|mesh-list
2631383|NCT01939054|Capecitabine|capecitabine|mesh-list
2631384|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
2631385|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169394|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2631386|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
2631387|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
2631388|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
2631389|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631390|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2631391|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
2631392|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2631393|NCT01939093|Thiamine|thiamine|mesh-list
2631394|NCT01939093|Cinnarizine|cinnarizine|mesh-list
2631395|NCT01939093|Diazepam|diazepam|mesh-list
2631396|NCT01939093|Vitamins|vitamins|mesh-ancestor
2631397|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
2631398|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631399|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
2631400|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2631401|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
2631402|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
2631403|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
2631404|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631405|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2631406|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2631407|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631408|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2631409|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2631410|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2631411|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2631412|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2631413|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2631414|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
2631415|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
2631416|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
2631417|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
2631418|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631419|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631420|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2631421|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2631422|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2631423|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2631424|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
2631425|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
2631426|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
2631427|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
2631428|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631429|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2631430|NCT01939327|Rituximab|rituximab|mesh-list
2631431|NCT01939327|Lenalidomide|lenalidomide|mesh-list
2631432|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2631433|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631434|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
2631435|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631436|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2631437|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2631438|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2631439|NCT01939327|Growth Substances|growth substances|mesh-ancestor
2169395|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2169396|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2169397|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169398|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2169399|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
2169400|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169401|NCT00000736|Zidovudine|zidovudine|mesh-list
2169402|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
2169403|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169404|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169405|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169406|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169407|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
2169408|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169409|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169410|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169411|NCT00000737|Megestrol|megestrol|mesh-list
2169412|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
2169413|NCT00000737|Dronabinol|dronabinol|mesh-list
2169414|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
2169415|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169416|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2169417|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2169418|NCT00000737|Analgesics|analgesics|mesh-ancestor
2169419|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
2631440|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
2631441|NCT01939379|Acetaminophen|acetaminophen|mesh-list
2631442|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2631443|NCT01939379|Morphine|morphine|mesh-list
2631444|NCT01939379|Oxycodone|oxycodone|mesh-list
2631445|NCT01939379|Analgesics|analgesics|mesh-list
2631446|NCT01939379|Ropivacaine|ropivacaine|mesh-list
2631447|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2631448|NCT01939379|Narcotics|narcotics|mesh-ancestor
2631449|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631450|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631451|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
2631452|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631453|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
2169420|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2169421|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2169422|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2169423|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2169424|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169425|NCT00000737|Hormones|hormones|mesh-ancestor
2169426|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2169427|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2631454|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
2631455|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2631456|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2631457|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2631458|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2631459|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
2631460|NCT01939418|Gemcitabine|gemcitabine|mesh-list
2631461|NCT01939418|Everolimus|everolimus|mesh-list
2631462|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169428|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2169429|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2169430|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
2169431|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2169432|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2169433|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2169434|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2169435|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169436|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
2169437|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2169438|NCT00000738|Zidovudine|zidovudine|mesh-list
2169439|NCT00000738|Nimodipine|nimodipine|mesh-list
2169440|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
2169441|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169442|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169443|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169444|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169445|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
2169446|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169447|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169448|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169449|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2169450|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2169451|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422158|NCT00816283|Dasatinib|dasatinib|mesh-list
2422159|NCT00816283|Vorinostat|vorinostat|mesh-list
2631463|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2631464|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
2631465|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631466|NCT01939418|Antiviral Agents|antiviral agents|mesh-ancestor
2631467|NCT01939418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631468|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631469|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2631470|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
2631471|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422160|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422161|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2422162|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422163|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422164|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2422165|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2422166|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2422167|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422168|NCT00816413|Cyclosporine|cyclosporine|mesh-list
2422169|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
2631472|NCT01939444|Naloxone|naloxone|mesh-list
2631473|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2631474|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631475|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
2631476|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631477|NCT01939457|Misoprostol|misoprostol|mesh-list
2631478|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2631479|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
2631480|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2631481|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631482|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2631483|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2631484|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
2631485|NCT01939483|Irinotecan|irinotecan|mesh-list
2631486|NCT01939483|Camptothecin|camptothecin|mesh-list
2631487|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2631488|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2631489|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631490|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631491|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631492|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2631493|NCT01939509|Atenolol|atenolol|mesh-list
2631494|NCT01939509|Bisoprolol|bisoprolol|mesh-list
2631495|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2631496|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2631497|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
2631498|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
2631499|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631500|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631501|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2631502|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2631503|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2631504|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
2631505|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631506|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631507|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2631508|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
2631509|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631510|NCT01939561|Lamotrigine|lamotrigine|mesh-list
2631511|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
2631512|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2631513|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2631514|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631515|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2631516|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631517|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2631518|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2631519|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631520|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2631521|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2631522|NCT01939574|Bevacizumab|bevacizumab|mesh-list
2631523|NCT01939574|Temozolomide|temozolomide|mesh-list
2631524|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2631525|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631526|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2631527|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2631528|NCT01939574|Growth Substances|growth substances|mesh-ancestor
2631529|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631530|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
2422170|NCT00816413|Pentostatin|pentostatin|mesh-list
2422171|NCT00816413|Cyclosporins|cyclosporins|mesh-list
2422172|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422173|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422174|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2422175|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
2422176|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422177|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
2422178|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422179|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
2422180|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2422181|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2422182|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2631531|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2631532|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
2631533|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631534|NCT01939639|Oxytocin|oxytocin|mesh-list
2631535|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
2631536|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2631537|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631538|NCT01939691|Prednisolone|prednisolone|mesh-list
2631539|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2631540|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
2631541|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2631542|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
2631543|NCT01939691|Nepafenac|nepafenac|mesh-list
2631544|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2631545|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
2631546|NCT01939691|Difluprednate|difluprednate|mesh-list
2631547|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2631548|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
2631549|NCT01939691|Hormones|hormones|mesh-ancestor
2631550|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2631551|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631552|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2631553|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631554|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
2631555|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
2631556|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631557|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2631558|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2631559|NCT01939691|Protective Agents|protective agents|mesh-ancestor
2631560|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2631561|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2631562|NCT01939691|Analgesics|analgesics|mesh-ancestor
2631563|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
2631564|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2631565|NCT01939730|Rituximab|rituximab|mesh-list
2631566|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2631567|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631568|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
2631569|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631570|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2631571|NCT01939743|Diclofenac|diclofenac|mesh-list
2631572|NCT01939743|Lidocaine|lidocaine|mesh-list
2631573|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
2631574|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
2631575|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631576|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631577|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
2631578|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631579|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2631580|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2631581|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2631582|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2631583|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631584|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2631585|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2631586|NCT01939743|Analgesics|analgesics|mesh-ancestor
2631587|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2631588|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2631589|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2631590|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631591|NCT01939834|Insulin|insulin|mesh-list
2631592|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2631593|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631594|NCT01939886|Artesunate|artesunate|mesh-list
2631595|NCT01939886|Lumefantrine|lumefantrine|mesh-list
2631596|NCT01939886|Artemether|artemether|mesh-list
2631597|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2631598|NCT01939886|Mefloquine|mefloquine|mesh-list
2631599|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
2631600|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2631601|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2631602|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631603|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631604|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
2631605|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
2631606|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2631607|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
2631608|NCT01939912|Adenosine|adenosine|mesh-list
2631609|NCT01939912|Analgesics|analgesics|mesh-ancestor
2631610|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
2631611|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631612|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631613|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2631614|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
2631615|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2631616|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
2631617|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
2631618|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631619|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631620|NCT01939990|Nebivolol|nebivolol|mesh-list
2631621|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2631622|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
2631623|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2631624|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2631625|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2631626|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
2631627|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631628|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631629|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631630|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2631631|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631632|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631633|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631634|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2631643|NCT01940172|Conatumumab|conatumumab|mesh-list
2631644|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2631645|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631646|NCT01940224|Pregabalin|pregabalin|mesh-list
2631647|NCT01940224|Morphine|morphine|mesh-list
2631648|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2631649|NCT01940224|Narcotics|narcotics|mesh-ancestor
2631650|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631651|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631652|NCT01940224|Analgesics|analgesics|mesh-ancestor
2631653|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
2631654|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631655|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
2631656|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2631657|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2631658|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631659|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2631660|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2631661|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2631662|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2631663|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
2631664|NCT01940250|Analgesics|analgesics|mesh-ancestor
2631665|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
2631666|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631667|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631668|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
2631669|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631670|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2631671|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
2631672|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2631673|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2631674|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631675|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2631676|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
2631677|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2169452|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2169453|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169454|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
2169455|NCT00000739|Dapsone|dapsone|mesh-list
2631678|NCT01940393|Cetirizine|cetirizine|mesh-list
2631679|NCT01940393|Fexofenadine|fexofenadine|mesh-list
2631680|NCT01940393|Desloratadine|desloratadine|mesh-list
2631681|NCT01940393|Ebastine|ebastine|mesh-list
2631682|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2631683|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2631684|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2631685|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
2631686|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
2169456|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169457|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
2169458|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169459|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169460|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2169461|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631687|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631688|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631689|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631690|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2631691|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
2169462|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169463|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
2169464|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169465|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
2169466|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2169467|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2169468|NCT00000741|Prednisolone|prednisolone|mesh-list
2169469|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
2169470|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2631692|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
2631693|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2631694|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2631695|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631696|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
2631697|NCT01940419|Coagulants|coagulants|mesh-ancestor
2631698|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
2631699|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2631700|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2631701|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631702|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
2631703|NCT01940536|Coagulants|coagulants|mesh-ancestor
2631704|NCT01940601|Lenograstim|lenograstim|mesh-list
2631705|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2631706|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
2631707|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631708|NCT01940627|Ubiquinone|ubiquinone|mesh-list
2631709|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
2631710|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
2631711|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631712|NCT01940627|Vitamins|vitamins|mesh-ancestor
2631713|NCT01940653|Estradiol|estradiol|mesh-list
2631714|NCT01940653|Progesterone|progesterone|mesh-list
2631715|NCT01940653|Estrogens|estrogens|mesh-ancestor
2631716|NCT01940653|Hormones|hormones|mesh-ancestor
2169471|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
2169472|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2169473|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
2169474|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
2169475|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2169476|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169477|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2169478|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
2169479|NCT00000741|Hormones|hormones|mesh-ancestor
2169480|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2169481|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2169482|NCT00000741|Protective Agents|protective agents|mesh-ancestor
2631717|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2631718|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631719|NCT01940653|Progestins|progestins|mesh-ancestor
2631720|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
2631721|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2631722|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2631723|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631724|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
2631725|NCT01940692|Coagulants|coagulants|mesh-ancestor
2631726|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
2631727|NCT01940718|Testosterone|testosterone|mesh-list
2631728|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
2631729|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
2631730|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2631731|NCT01940718|Androgens|androgens|mesh-ancestor
2631732|NCT01940718|Hormones|hormones|mesh-ancestor
2631733|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2631734|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631735|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2631736|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631737|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
2631738|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2631739|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2631740|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169483|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2169484|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169485|NCT00000742|Zidovudine|zidovudine|mesh-list
2169486|NCT00000742|Didanosine|didanosine|mesh-list
2169487|NCT00000742|Atevirdine|atevirdine|mesh-list
2169488|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
2169489|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169490|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169491|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169492|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169493|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
2169494|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169495|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169496|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169497|NCT00000743|Zidovudine|zidovudine|mesh-list
2169498|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
2169499|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631751|NCT01940952|Donepezil|donepezil|mesh-list
2631752|NCT01940952|Udenafil|udenafil|mesh-list
2631753|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2631754|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631755|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631756|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
2631757|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631758|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631759|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
2631760|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2631761|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2631762|NCT01940965|Lixisenatide|lixisenatide|mesh-list
2631763|NCT01940965|Biguanides|biguanides|mesh-list
2631764|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2631765|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631766|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
2631767|NCT01940978|Methylphenidate|methylphenidate|mesh-list
2631768|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2631769|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631770|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2631771|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2631772|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2631773|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631774|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
2631775|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631776|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
2631777|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
2631778|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2631779|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2631780|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
2631781|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
2631782|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2631783|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
2169500|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2631784|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2631785|NCT01940991|Botulinum Toxins|botulinum toxins|mesh-list
2631786|NCT01940991|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2169501|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169502|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169503|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
2169504|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169505|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169506|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169507|NCT00000744|Fluconazole|fluconazole|mesh-list
2631787|NCT01940991|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2631788|NCT01940991|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2631789|NCT01940991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2631790|NCT01940991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631791|NCT01940991|Cholinergic Agents|cholinergic agents|mesh-ancestor
2631792|NCT01940991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631793|NCT01940991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169508|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
2169509|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169510|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2169511|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2169512|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169513|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169514|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2169515|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
2169516|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2169517|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169518|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2169519|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2169520|NCT00000745|Vaccines|vaccines|mesh-list
2169521|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
2169522|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631794|NCT01940991|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2631795|NCT01940991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631796|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2631797|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2631798|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631799|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2631800|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
2631801|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631802|NCT01941056|Vaccines|vaccines|mesh-list
2631803|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
2631804|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631805|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
2631806|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2631807|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2631808|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
2631809|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
2631810|NCT01941134|Estradiol|estradiol|mesh-list
2631811|NCT01941134|Estrogens|estrogens|mesh-ancestor
2631812|NCT01941134|Hormones|hormones|mesh-ancestor
2631813|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2631814|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631815|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2631816|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2631817|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2631818|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2631819|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2631820|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2631821|NCT01941173|Leucovorin|leucovorin|mesh-list
2631822|NCT01941173|Fluorouracil|fluorouracil|mesh-list
2631823|NCT01941173|Irinotecan|irinotecan|mesh-list
2631824|NCT01941173|Aflibercept|aflibercept|mesh-list
2631825|NCT01941173|Calcium|calcium|mesh-list
2631826|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
2631827|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
2631828|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2631829|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631830|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
2631831|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631832|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2631833|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631834|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2631835|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
2631836|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2169523|NCT00000747|Nevirapine|nevirapine|mesh-list
2169524|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169525|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169526|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169527|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169528|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
2169529|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169530|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169531|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169532|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2169533|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2169534|NCT00000748|Trimethoprim|trimethoprim|mesh-list
2169535|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2169536|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
2169537|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2169538|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169539|NCT00000748|Renal Agents|renal agents|mesh-ancestor
2169540|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
2169541|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169542|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169543|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2169544|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169545|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169546|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2169547|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2169548|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2169549|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2631837|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2631838|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631839|NCT01941173|Antidotes|antidotes|mesh-ancestor
2631840|NCT01941173|Protective Agents|protective agents|mesh-ancestor
2631841|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
2631842|NCT01941173|Vitamins|vitamins|mesh-ancestor
2631843|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
2631844|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2169550|NCT00000750|Zidovudine|zidovudine|mesh-list
2169551|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
2169552|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169553|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169554|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169555|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169556|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
2169557|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169558|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2631845|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2631846|NCT01941173|Growth Substances|growth substances|mesh-ancestor
2631847|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
2631848|NCT01941199|Metformin|metformin|mesh-list
2631849|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2631850|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631851|NCT01941225|Iloprost|iloprost|mesh-list
2631852|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2631853|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
2631854|NCT01941264|Lumefantrine|lumefantrine|mesh-list
2631855|NCT01941264|Artemether|artemether|mesh-list
2631856|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2631857|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
2631858|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2631859|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2631860|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631861|NCT01941316|Irinotecan|irinotecan|mesh-list
2631862|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2631863|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2631864|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631865|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631866|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631867|NCT01941329|Ranibizumab|ranibizumab|mesh-list
2631868|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2631869|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2631870|NCT01941329|Growth Substances|growth substances|mesh-ancestor
2631871|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631872|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
2631873|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631874|NCT01941407|Bevacizumab|bevacizumab|mesh-list
2631875|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2631876|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169559|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169560|NCT00000751|Zidovudine|zidovudine|mesh-list
2169561|NCT00000751|Immune Sera|immune sera|mesh-list
2169562|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
2169563|NCT00000751|Antibodies|antibodies|mesh-list
2169564|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
2169565|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169566|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169567|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169568|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169569|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
2169570|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169571|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169572|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169573|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
2169574|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169575|NCT00000752|Cefuroxime|cefuroxime|mesh-list
2169576|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
2169577|NCT00000752|Beclomethasone|beclomethasone|mesh-list
2169578|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
2169579|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
2169580|NCT00000752|Ephedrine|ephedrine|mesh-list
2169581|NCT00000752|Guaifenesin|guaifenesin|mesh-list
2169582|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2169583|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2169584|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
2169585|NCT00000752|Hormones|hormones|mesh-ancestor
2169586|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2169587|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169588|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2169589|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
2169590|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2169591|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
2169592|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2169593|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
2169594|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2169595|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2169596|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
2169597|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
2169598|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2169599|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169600|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169601|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169602|NCT00000752|Expectorants|expectorants|mesh-ancestor
2169603|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2169604|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2169605|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
2169606|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2169607|NCT00000753|Zidovudine|zidovudine|mesh-list
2169608|NCT00000753|Didanosine|didanosine|mesh-list
2169609|NCT00000753|Zalcitabine|zalcitabine|mesh-list
2169610|NCT00000753|Atevirdine|atevirdine|mesh-list
2169611|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
2169612|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169613|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169614|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169615|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631877|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2631878|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2631879|NCT01941407|Growth Substances|growth substances|mesh-ancestor
2631880|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631881|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
2631890|NCT01941524|Poractant alfa|poractant alfa|mesh-list
2631891|NCT01941524|Beractant|beractant|mesh-list
2631892|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2631893|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
2631894|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2631895|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
2631896|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631897|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
2631898|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2631899|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2631900|NCT01941589|Prednisolone|prednisolone|mesh-list
2631901|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
2631902|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
2631903|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2631904|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2631905|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2631906|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2631907|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
2631908|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2631909|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
2631910|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
2631911|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2631912|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631913|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2631914|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
2631915|NCT01941589|Hormones|hormones|mesh-ancestor
2631916|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2631917|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2631918|NCT01941589|Protective Agents|protective agents|mesh-ancestor
2631919|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2631920|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631921|NCT01941602|Enoxaparin|enoxaparin|mesh-list
2631922|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
2631923|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2631924|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2631925|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631926|NCT01941641|Capecitabine|capecitabine|mesh-list
2631927|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2631928|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
2631929|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631930|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631931|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
2631932|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
2631933|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2631934|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2631935|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631936|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631937|NCT01941732|Urological Agents|urological agents|mesh-ancestor
2631938|NCT01941758|Vaccines|vaccines|mesh-list
2169616|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
2169617|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169618|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169619|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169620|NCT00000754|Interferons|interferons|mesh-list
2169621|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
2169622|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
2169623|NCT00000754|Zidovudine|zidovudine|mesh-list
2169624|NCT00000754|Zalcitabine|zalcitabine|mesh-list
2169625|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169626|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
2169627|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169628|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
2169629|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631939|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
2631940|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631941|NCT01941771|Capecitabine|capecitabine|mesh-list
2631942|NCT01941771|Vinorelbine|vinorelbine|mesh-list
2631943|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2631944|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
2631945|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631946|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631947|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2631948|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
2631949|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
2631950|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
2631951|NCT01941810|Lactoferrin|lactoferrin|mesh-list
2631952|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2631953|NCT01941836|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2631954|NCT01941836|Ezetimibe|ezetimibe|mesh-list
2631955|NCT01941836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2631956|NCT01941836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2169630|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
2169631|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169632|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169633|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169634|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169635|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169636|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169637|NCT00000755|Zidovudine|zidovudine|mesh-list
2169638|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
2169639|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169640|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169641|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169642|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169643|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
2169644|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169645|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169646|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169647|NCT00000758|Fluorouracil|fluorouracil|mesh-list
2169648|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
2169649|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169650|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2169651|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169652|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2631957|NCT01941836|Antimetabolites|antimetabolites|mesh-ancestor
2631958|NCT01941836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631959|NCT01941836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2631960|NCT01941836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2631961|NCT01941836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2631962|NCT01941836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631963|NCT01941875|Progesterone|progesterone|mesh-list
2631964|NCT01941875|Progestins|progestins|mesh-ancestor
2631965|NCT01941875|Hormones|hormones|mesh-ancestor
2631966|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2631967|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631968|NCT01941888|Midazolam|midazolam|mesh-list
2631969|NCT01941888|Propofol|propofol|mesh-list
2631970|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2631971|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2631972|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631973|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2631974|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
2631975|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
2631976|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2631977|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2631978|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2631979|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2631980|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
2631981|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
2631982|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2631983|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2631984|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
2631985|NCT01941901|Bleomycin|bleomycin|mesh-list
2631986|NCT01941901|Calcium|calcium|mesh-list
2631987|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2631988|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631989|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2631990|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2631991|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2631992|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
2631993|NCT01941914|Calcium|calcium|mesh-list
2631994|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2631995|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2631996|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2631997|NCT01941953|Metformin|metformin|mesh-list
2631998|NCT01941953|Fluorouracil|fluorouracil|mesh-list
2631999|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2632000|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632001|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
2632002|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632003|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2632004|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632005|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2632006|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
2632007|NCT01941966|Capecitabine|capecitabine|mesh-list
2632008|NCT01941966|Mitomycins|mitomycins|mesh-list
2169653|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
2632009|NCT01941966|Mitomycin|mitomycin|mesh-list
2632010|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2169654|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169655|NCT00000760|Zidovudine|zidovudine|mesh-list
2169656|NCT00000760|Didanosine|didanosine|mesh-list
2169657|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
2169658|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169659|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169660|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169661|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169662|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
2169663|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169664|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2632011|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
2632012|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632013|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632014|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2632015|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
2632016|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2632017|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632018|NCT01941979|Leucovorin|leucovorin|mesh-list
2632019|NCT01941979|Capecitabine|capecitabine|mesh-list
2632020|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
2632021|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2632022|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
2632023|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632024|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632025|NCT01941979|Antidotes|antidotes|mesh-ancestor
2632026|NCT01941979|Protective Agents|protective agents|mesh-ancestor
2632027|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632028|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
2422183|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422184|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2422185|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
2422186|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2422187|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2422188|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
2422189|NCT00816426|Rifampin|rifampin|mesh-list
2422190|NCT00816426|Isoniazid|isoniazid|mesh-list
2422191|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
2422192|NCT00816426|Kanamycin|kanamycin|mesh-list
2422193|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2422194|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422195|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2422196|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2169665|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169666|NCT00000761|Interferons|interferons|mesh-list
2169667|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
2169668|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169669|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
2169670|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169671|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
2169672|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2169673|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169674|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2169675|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2169676|NCT00000763|Growth Substances|growth substances|mesh-ancestor
2422197|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632029|NCT01941979|Vitamins|vitamins|mesh-ancestor
2632030|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
2632031|NCT01942070|Everolimus|everolimus|mesh-list
2632032|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632033|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2632034|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
2632035|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632036|NCT01942109|Torsemide|torsemide|mesh-list
2632037|NCT01942109|Furosemide|furosemide|mesh-list
2632038|NCT01942109|Diuretics|diuretics|mesh-ancestor
2632039|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
2632040|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632041|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2632042|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2632043|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632044|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2169677|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169678|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
2169679|NCT00000764|Interferons|interferons|mesh-list
2169680|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
2169681|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
2169682|NCT00000764|Isotretinoin|isotretinoin|mesh-list
2169683|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169684|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
2169685|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169686|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
2169687|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169688|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
2169689|NCT00000765|Zidovudine|zidovudine|mesh-list
2169690|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
2169691|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169692|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2632057|NCT01942174|Methotrexate|methotrexate|mesh-list
2632058|NCT01942174|Vaccines|vaccines|mesh-list
2632059|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2632060|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2632061|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
2632062|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2632063|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632064|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2632065|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
2632066|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632067|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632068|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
2632069|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632070|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2632071|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2632072|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
2632073|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2632074|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2632075|NCT01942187|Aripiprazole|aripiprazole|mesh-list
2632076|NCT01942187|Bupropion|bupropion|mesh-list
2632077|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2632078|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
2632079|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2632080|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2632081|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2632082|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2632083|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632084|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
2632085|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632086|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632087|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2632088|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2632089|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632090|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2632091|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2632092|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632093|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
2632094|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2632095|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2632096|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
2632097|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2632098|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2632099|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2632100|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2632101|NCT01942291|Niacin|niacin|mesh-list
2632102|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
2632103|NCT01942291|Vitamins|vitamins|mesh-ancestor
2632104|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
2632105|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632106|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
2169693|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169694|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169695|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
2169696|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169697|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169698|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169699|NCT00000766|Ganciclovir|ganciclovir|mesh-list
2169700|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2169701|NCT00000766|Foscarnet|foscarnet|mesh-list
2169702|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2632107|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2632108|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
2632109|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632110|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2632111|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
2632112|NCT01942304|Calcium|calcium|mesh-list
2632113|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2632114|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632115|NCT01942343|Droperidol|droperidol|mesh-list
2632116|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2632117|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
2632118|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
2632119|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632120|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632121|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2632122|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2632123|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2632124|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632125|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2632126|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2632127|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2632128|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
2632129|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632130|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632131|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2169703|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
2169704|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169705|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169706|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169707|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169708|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169709|NCT00000767|Vaccines|vaccines|mesh-list
2169710|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
2169711|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169712|NCT00000768|Ganciclovir|ganciclovir|mesh-list
2169713|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2169714|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
2169715|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169716|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169717|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169718|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169719|NCT00000769|Interleukin-4|interleukin-4|mesh-list
2169720|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2632132|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
2632133|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2632134|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
2632135|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2632136|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632137|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2169721|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
2169722|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169723|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169724|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2169725|NCT00000770|Zidovudine|zidovudine|mesh-list
2169726|NCT00000770|Nevirapine|nevirapine|mesh-list
2169727|NCT00000770|Didanosine|didanosine|mesh-list
2169728|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
2169729|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169730|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169731|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169732|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169733|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
2169734|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169735|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169736|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169737|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2632138|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2632139|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632140|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2632141|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2632142|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2169738|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2169739|NCT00000771|Paromomycin|paromomycin|mesh-list
2169740|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169741|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169742|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169743|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169744|NCT00000772|Ribavirin|ribavirin|mesh-list
2169745|NCT00000772|Didanosine|didanosine|mesh-list
2169746|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
2169747|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169748|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
2169749|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169750|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169751|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169752|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169753|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169754|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169755|NCT00000773|Atovaquone|atovaquone|mesh-list
2169756|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169757|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
2169758|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169759|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169760|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169761|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169762|NCT00000776|Fluconazole|fluconazole|mesh-list
2169763|NCT00000776|Amphotericin B|amphotericin b|mesh-list
2169764|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2169765|NCT00000776|Flucytosine|flucytosine|mesh-list
2169766|NCT00000776|Dexamethasone|dexamethasone|mesh-list
2169767|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2169768|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
2169769|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
2169770|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2169771|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169772|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2169773|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
2169774|NCT00000776|Hormones|hormones|mesh-ancestor
2632143|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632144|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632145|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2632146|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2632147|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2632148|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
2632149|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632150|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632151|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2632152|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2632153|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
2632154|NCT01942447|Vancomycin|vancomycin|mesh-list
2632155|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2632156|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632157|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2632158|NCT01942460|Hematinics|hematinics|mesh-ancestor
2632159|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2632160|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2632161|NCT01942551|Tadalafil|tadalafil|mesh-list
2632162|NCT01942551|Dutasteride|dutasteride|mesh-list
2632163|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
2632164|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2632165|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2632166|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632167|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632168|NCT01942551|Urological Agents|urological agents|mesh-ancestor
2632169|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2632170|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2632171|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
2632172|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2632173|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632174|NCT01942577|Protective Agents|protective agents|mesh-list
2632175|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632176|NCT01942681|Propiverine|propiverine|mesh-list
2169775|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2169776|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2169777|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632177|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
2632178|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
2632179|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632180|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632181|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2632182|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2632183|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
2632184|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632185|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632186|NCT01942681|Urological Agents|urological agents|mesh-ancestor
2632187|NCT01942889|Antioxidants|antioxidants|mesh-list
2632188|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632189|NCT01942889|Protective Agents|protective agents|mesh-ancestor
2632190|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632191|NCT01943019|Linagliptin|linagliptin|mesh-list
2169778|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
2169779|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169780|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2169781|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2169782|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169783|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169784|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2169785|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
2169786|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2169787|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2169788|NCT00000776|Amebicides|amebicides|mesh-ancestor
2169789|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169790|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169791|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169792|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
2632192|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2632193|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632194|NCT01943019|Incretins|incretins|mesh-ancestor
2632195|NCT01943019|Hormones|hormones|mesh-ancestor
2632196|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2632197|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2632198|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
2632199|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632200|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632201|NCT01943058|Megestrol|megestrol|mesh-list
2632202|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
2632203|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
2169793|NCT00000778|Pyridoxine|pyridoxine|mesh-list
2169794|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
2169795|NCT00000778|Levofloxacin|levofloxacin|mesh-list
2169796|NCT00000778|Ofloxacin|ofloxacin|mesh-list
2169797|NCT00000778|Isoniazid|isoniazid|mesh-list
2169798|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2169799|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169800|NCT00000778|Renal Agents|renal agents|mesh-ancestor
2169801|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169802|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2169803|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2169804|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169805|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632204|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2632205|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
2632206|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2632207|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632208|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2632209|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2632210|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2632211|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2632212|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2632213|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632214|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
2632215|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2632216|NCT01943136|Mupirocin|mupirocin|mesh-list
2632217|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2632218|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632219|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2632220|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169806|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169807|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2169808|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2169809|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
2169810|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2169811|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2169812|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
2169813|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2169814|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
2169815|NCT00000778|Vitamins|vitamins|mesh-ancestor
2169816|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
2169817|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169818|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2169819|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2169820|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
2169821|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169822|NCT00000779|Antacids|antacids|mesh-ancestor
2169823|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169824|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2169825|NCT00000781|Zidovudine|zidovudine|mesh-list
2169826|NCT00000781|Nevirapine|nevirapine|mesh-list
2169827|NCT00000781|Didanosine|didanosine|mesh-list
2632221|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632222|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
2632223|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2632224|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
2632225|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632226|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2632227|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2632228|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
2632229|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632230|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169828|NCT00000781|Zalcitabine|zalcitabine|mesh-list
2169829|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
2169830|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169831|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169832|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169833|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169834|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
2169835|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169836|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169837|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169838|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2169839|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2169840|NCT00000782|Vaccines|vaccines|mesh-list
2169841|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
2169842|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632231|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2632232|NCT01943240|Ropivacaine|ropivacaine|mesh-list
2632233|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
2632234|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
2632235|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632236|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632237|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
2632238|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632239|NCT01943305|Vaccines|vaccines|mesh-list
2632240|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
2632241|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632242|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2632243|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2632244|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2632245|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2632246|NCT01943422|Interferons|interferons|mesh-list
2632247|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
2632248|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
2632249|NCT01943422|Vemurafenib|vemurafenib|mesh-list
2632250|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632251|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
2632252|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632253|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
2632254|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632255|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2632256|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169843|NCT00000788|Fluconazole|fluconazole|mesh-list
2169844|NCT00000788|Methadone|methadone|mesh-list
2169845|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2632257|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632258|NCT01943487|Verapamil|verapamil|mesh-list
2632259|NCT01943487|Tamsulosin|tamsulosin|mesh-list
2632260|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
2632261|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2632262|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2632263|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2632264|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
2632265|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632266|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632267|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632268|NCT01943487|Urological Agents|urological agents|mesh-ancestor
2632269|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2632270|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2632271|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
2632272|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2632273|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2632274|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2632275|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2632276|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
2632277|NCT01943526|Natalizumab|natalizumab|mesh-list
2632278|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
2632279|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169846|NCT00000788|Narcotics|narcotics|mesh-ancestor
2169847|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2169848|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169849|NCT00000788|Analgesics|analgesics|mesh-ancestor
2169850|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
2169851|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2169852|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
2169853|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
2169854|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
2169855|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169856|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2169857|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2169858|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169859|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169860|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2169861|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
2169862|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2169863|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2169864|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2169865|NCT00000789|Zidovudine|zidovudine|mesh-list
2169866|NCT00000789|Stavudine|stavudine|mesh-list
2169867|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
2169868|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169869|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169870|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2169871|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169872|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
2169873|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169874|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169875|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169876|NCT00000790|Thalidomide|thalidomide|mesh-list
2169877|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2169878|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
2632280|NCT01943617|Entecavir|entecavir|mesh-list
2632281|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
2632282|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632283|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
2632284|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2632285|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
2632286|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632287|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632288|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2632289|NCT01943630|Protective Agents|protective agents|mesh-ancestor
2632290|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2632291|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2632292|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632293|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632294|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
2632295|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632296|NCT01943760|Tramadol|tramadol|mesh-list
2169879|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169880|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
2169881|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169882|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169883|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2169884|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2169885|NCT00000790|Growth Substances|growth substances|mesh-ancestor
2169886|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
2169887|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169888|NCT00000791|Zidovudine|zidovudine|mesh-list
2169889|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
2169890|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169891|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2169892|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2632297|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2632298|NCT01943760|Narcotics|narcotics|mesh-ancestor
2632299|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632300|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632301|NCT01943760|Analgesics|analgesics|mesh-ancestor
2632302|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
2632303|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632304|NCT01943786|Cetuximab|cetuximab|mesh-list
2632305|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2632306|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632307|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2632308|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2632309|NCT01943812|Estradiol|estradiol|mesh-list
2632310|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2632311|NCT01943812|Progesterone|progesterone|mesh-list
2632312|NCT01943812|Estrogens|estrogens|mesh-ancestor
2632313|NCT01943812|Hormones|hormones|mesh-ancestor
2632314|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2632315|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632316|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2632317|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
2632318|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2632319|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2632320|NCT01943812|Progestins|progestins|mesh-ancestor
2632321|NCT01943877|Propolis|propolis|mesh-list
2632322|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632323|NCT01943942|Montelukast|montelukast|mesh-list
2632324|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2632325|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
2632326|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2632327|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
2632328|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2632329|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632330|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2632331|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2632332|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632333|NCT01943994|Psilocybin|psilocybin|mesh-list
2632334|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
2632335|NCT01943994|Nicotine|nicotine|mesh-list
2632336|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2632337|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
2632338|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632339|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632340|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2632341|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2632342|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
2632343|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632344|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632345|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
2632346|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2632347|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2632348|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
2632349|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2632350|NCT01944033|Terbutaline|terbutaline|mesh-list
2632351|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2632352|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
2632353|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632354|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632355|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2632356|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
2632357|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
2169893|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169894|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
2169895|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169896|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2169897|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2169898|NCT00000792|Hypericin|hypericin|mesh-list
2169899|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
2169900|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2169901|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169902|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
2632358|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
2632359|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2632360|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2632361|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2632362|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2632363|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
2632364|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632365|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632366|NCT01944085|Acetaminophen|acetaminophen|mesh-list
2632367|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
2632368|NCT01944085|Ibuprofen|ibuprofen|mesh-list
2632369|NCT01944085|Vitamins|vitamins|mesh-ancestor
2632370|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
2632371|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632372|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2632373|NCT01944085|Analgesics|analgesics|mesh-ancestor
2632374|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
2632375|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632376|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
2632377|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2632378|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2632379|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2632380|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2632381|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632382|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632383|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
2632384|NCT01944085|Protective Agents|protective agents|mesh-ancestor
2632385|NCT01944176|Simvastatin|simvastatin|mesh-list
2632386|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2632387|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2632388|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
2632389|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632390|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2632391|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2632392|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632393|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2632394|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
2632395|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2632396|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2632397|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632398|NCT01944215|Caffeine|caffeine|mesh-list
2632399|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2632400|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632401|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2632402|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632403|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632404|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2632405|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2632406|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
2632407|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632408|NCT01944384|Spironolactone|spironolactone|mesh-list
2632409|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2632410|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
2632411|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2632412|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632413|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2632414|NCT01944384|Diuretics|diuretics|mesh-ancestor
2632415|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
2632416|NCT01944410|Mitogens|mitogens|mesh-list
2632417|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
2632418|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632419|NCT01944436|Rivastigmine|rivastigmine|mesh-list
2632420|NCT01944436|Donepezil|donepezil|mesh-list
2632421|NCT01944436|Galantamine|galantamine|mesh-list
2632422|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
2184882|NCT00002835|Bleomycin|bleomycin|mesh-list
2169903|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632423|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632424|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632425|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
2632426|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632427|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632428|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
2632429|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2632430|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
2632431|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632432|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2169904|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169905|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169906|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2169907|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
2169908|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169909|NCT00000793|Mexiletine|mexiletine|mesh-list
2169910|NCT00000793|Amitriptyline|amitriptyline|mesh-list
2632433|NCT01944436|Protective Agents|protective agents|mesh-ancestor
2632434|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
2632435|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2632436|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632437|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2632438|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632439|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
2632440|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2632441|NCT01944683|Midazolam|midazolam|mesh-list
2632442|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2632443|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2632444|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632445|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169911|NCT00000793|Benztropine|benztropine|mesh-list
2169912|NCT00000793|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2169913|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2169914|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
2169915|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2169916|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2169917|NCT00000793|Analgesics|analgesics|mesh-ancestor
2169918|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
2169919|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2169920|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169921|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2169922|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2169923|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2169924|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169925|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
2169926|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2169927|NCT00000793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2169928|NCT00000793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2169929|NCT00000793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2169930|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2632446|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2632447|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2632448|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2632449|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2632450|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
2632451|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
2632452|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
2632453|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
2632454|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632455|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632456|NCT01944735|Mannitol|mannitol|mesh-list
2632457|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2632458|NCT01944735|Diuretics|diuretics|mesh-ancestor
2632459|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
2632460|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632461|NCT01944800|Ticagrelor|ticagrelor|mesh-list
2632462|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2632463|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2632464|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2632465|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2632466|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2632467|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
2632468|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632469|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632470|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632471|NCT01944852|Icodextrin|icodextrin|mesh-list
2632472|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
2632473|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2632474|NCT01945021|Crizotinib|crizotinib|mesh-list
2632475|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632476|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2632477|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632478|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632479|NCT01945047|Midazolam|midazolam|mesh-list
2169931|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2169932|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2169933|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2169934|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2169935|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
2169936|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
2169937|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2169938|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2169939|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
2169940|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2169941|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
2169942|NCT00000794|Leucovorin|leucovorin|mesh-list
2169943|NCT00000794|Clarithromycin|clarithromycin|mesh-list
2169944|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
2169945|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
2169946|NCT00000794|Atovaquone|atovaquone|mesh-list
2169947|NCT00000794|Calcium|calcium|mesh-list
2169948|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
2169949|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2169950|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632480|NCT01945047|Ketamine|ketamine|mesh-list
2632481|NCT01945047|Analgesics|analgesics|mesh-ancestor
2632482|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
2632483|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632484|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632485|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2632486|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2632487|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
2632488|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
2632489|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632490|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2632491|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2632492|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632493|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632494|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2632495|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2632496|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2632497|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2632498|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2632499|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
2632500|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
2632501|NCT01945099|Insulin|insulin|mesh-list
2632502|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2632503|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632504|NCT01945268|Vaccines|vaccines|mesh-list
2632505|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
2632506|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632507|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
2632508|NCT01945437|Analgesics|analgesics|mesh-ancestor
2632509|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
2632510|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632511|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632512|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
2632513|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632514|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2632515|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
2632516|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2632517|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2632518|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632519|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2632520|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
2632521|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2632522|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2632523|NCT01945450|Clindamycin|clindamycin|mesh-list
2169951|NCT00000794|Antidotes|antidotes|mesh-ancestor
2169952|NCT00000794|Protective Agents|protective agents|mesh-ancestor
2169953|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
2169954|NCT00000794|Vitamins|vitamins|mesh-ancestor
2169955|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
2169956|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169957|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2169958|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2169959|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169960|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169961|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2632524|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
2632525|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
2632526|NCT01945450|Gentamicins|gentamicins|mesh-list
2632527|NCT01945450|Ampicillin|ampicillin|mesh-list
2632528|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632529|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2632530|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632531|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169962|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2169963|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
2169964|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2169965|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2169966|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2169967|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
2169968|NCT00000796|Pyridoxine|pyridoxine|mesh-list
2169969|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
2169970|NCT00000796|Levofloxacin|levofloxacin|mesh-list
2169971|NCT00000796|Cycloserine|cycloserine|mesh-list
2169972|NCT00000796|Rifampin|rifampin|mesh-list
2169973|NCT00000796|Isoniazid|isoniazid|mesh-list
2169974|NCT00000796|Amikacin|amikacin|mesh-list
2169975|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
2632532|NCT01945476|Midazolam|midazolam|mesh-list
2632533|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2632534|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2632535|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632536|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2169976|NCT00000796|Ethambutol|ethambutol|mesh-list
2169977|NCT00000796|Clofazimine|clofazimine|mesh-list
2169978|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
2169979|NCT00000796|Streptomycin|streptomycin|mesh-list
2169980|NCT00000796|Ethionamide|ethionamide|mesh-list
2169981|NCT00000796|Capreomycin|capreomycin|mesh-list
2169982|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2169983|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632537|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2632538|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2632539|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2632540|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2632541|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
2632542|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
2632543|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
2632544|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
2632545|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632546|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632547|NCT01945528|Lidocaine|lidocaine|mesh-list
2632548|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
2632549|NCT01945528|Anesthetics|anesthetics|mesh-list
2632550|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632551|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632552|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
2632553|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632554|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2632555|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2632556|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2632557|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2169984|NCT00000796|Renal Agents|renal agents|mesh-ancestor
2169985|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2169986|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2169987|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2169988|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2169989|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2169990|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2169991|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2169992|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2169993|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2169994|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
2169995|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
2169996|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2632558|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632559|NCT01945554|Bupivacaine|bupivacaine|mesh-list
2632560|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
2632561|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
2632562|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2169997|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2169998|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2169999|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2170000|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2170001|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2170002|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2170003|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2170004|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2170005|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
2170006|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2170007|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
2170008|NCT00000796|Vitamins|vitamins|mesh-ancestor
2170009|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
2170010|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170011|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2170012|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2170013|NCT00000799|Cidofovir|cidofovir|mesh-list
2170014|NCT00000799|Probenecid|probenecid|mesh-list
2170015|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
2170016|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
2170017|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2170018|NCT00000799|Renal Agents|renal agents|mesh-ancestor
2170019|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
2170020|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170021|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170022|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170023|NCT00000800|Zidovudine|zidovudine|mesh-list
2170024|NCT00000800|Methadone|methadone|mesh-list
2170025|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
2170026|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170027|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170028|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170029|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170030|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
2170031|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170032|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170033|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170034|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2170035|NCT00000800|Narcotics|narcotics|mesh-ancestor
2170036|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2170037|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170038|NCT00000800|Analgesics|analgesics|mesh-ancestor
2170039|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
2170040|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632563|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632564|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
2632565|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632566|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
2632567|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2632568|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2632569|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2632570|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2632571|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632572|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
2632573|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632574|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632575|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2632576|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632577|NCT01945736|Methadone|methadone|mesh-list
2632578|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2632579|NCT01945736|Narcotics|narcotics|mesh-ancestor
2632580|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632581|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632582|NCT01945736|Analgesics|analgesics|mesh-ancestor
2632583|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
2632584|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632585|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
2632586|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
2632587|NCT01945788|Teriparatide|teriparatide|mesh-list
2632588|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2632589|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632590|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2632591|NCT01945801|Furosemide|furosemide|mesh-list
2632592|NCT01945801|Spironolactone|spironolactone|mesh-list
2632593|NCT01945801|Diuretics|diuretics|mesh-ancestor
2632594|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
2632595|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632596|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2632597|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2632598|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632599|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2632600|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
2170041|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
2170042|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
2170043|NCT00000801|Cytarabine|cytarabine|mesh-list
2170044|NCT00000801|Dexamethasone|dexamethasone|mesh-list
2170045|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
2170046|NCT00000801|Doxorubicin|doxorubicin|mesh-list
2170047|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2170048|NCT00000801|Vincristine|vincristine|mesh-list
2170049|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2632601|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2632602|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2632603|NCT01945840|Hormones|hormones|mesh-list
2632604|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2632605|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632606|NCT01945879|Heparin|heparin|mesh-list
2632607|NCT01945879|Enoxaparin|enoxaparin|mesh-list
2632608|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2632609|NCT01945879|Tinzaparin|tinzaparin|mesh-list
2632610|NCT01945879|Dalteparin|dalteparin|mesh-list
2632611|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
2632612|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2632613|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2632614|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632615|NCT01945892|Dexamethasone|dexamethasone|mesh-list
2632616|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2632617|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
2632618|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
2632619|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632620|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632621|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2632622|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
2632623|NCT01945892|Hormones|hormones|mesh-ancestor
2632624|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2632625|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2632626|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632627|NCT01945957|Oxytocin|oxytocin|mesh-list
2632628|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
2632629|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2632630|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632631|NCT01945983|Norepinephrine|norepinephrine|mesh-list
2632632|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2632633|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2632634|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
2632635|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632636|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632637|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632638|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
2632639|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
2632640|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632641|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2632642|NCT01946009|Cidofovir|cidofovir|mesh-list
2632643|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
2632644|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632645|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632646|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632647|NCT01946035|Doxazosin|doxazosin|mesh-list
2632648|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2632649|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2632650|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2632651|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2632652|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
2632653|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2170050|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
2184883|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
2632654|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632655|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632656|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
2632657|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632658|NCT01946074|Paclitaxel|paclitaxel|mesh-list
2632659|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2632660|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632661|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
2632662|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
2632663|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
2632664|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632665|NCT01946256|Amoxicillin|amoxicillin|mesh-list
2632666|NCT01946256|Erythromycin|erythromycin|mesh-list
2632667|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
2632668|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2632669|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
2632670|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2632671|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632672|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2632673|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2632674|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632675|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632676|NCT01946295|Famotidine|famotidine|mesh-list
2632677|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2632678|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2632679|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2632680|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
2632681|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
2632682|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632683|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632684|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632685|NCT01946373|Vidarabine|vidarabine|mesh-list
2632686|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
2632687|NCT01946373|Fludarabine|fludarabine|mesh-list
2632688|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
2632689|NCT01946373|Interleukin-2|interleukin-2|mesh-list
2632690|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2632691|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
2632692|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632693|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2632694|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2632695|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
2632696|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632697|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632698|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2632699|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2632700|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
2632701|NCT01946373|Antiviral Agents|antiviral agents|mesh-ancestor
2632702|NCT01946373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632703|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2632704|NCT01946373|Analgesics|analgesics|mesh-ancestor
2632705|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
2632706|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632707|NCT01946386|Betamethasone|betamethasone|mesh-list
2632708|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
2632709|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2632710|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
2632711|NCT01946386|Clobetasol|clobetasol|mesh-list
2632712|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2632713|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2632714|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
2632715|NCT01946386|Hormones|hormones|mesh-ancestor
2632716|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2632717|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632718|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2632719|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
2632720|NCT01946399|Dexamethasone|dexamethasone|mesh-list
2632721|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2632722|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
2632723|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
2632724|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632725|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632726|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2632727|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
2632728|NCT01946399|Hormones|hormones|mesh-ancestor
2668576|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2170051|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170052|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2170053|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2170054|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
2170055|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170056|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170057|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2170058|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2170059|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
2170060|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
2170061|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632729|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2632730|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2632731|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632732|NCT01946477|Dexamethasone|dexamethasone|mesh-list
2632733|NCT01946477|Pomalidomide|pomalidomide|mesh-list
2632734|NCT01946477|Daratumumab|daratumumab|mesh-list
2632735|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2632736|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
2632737|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
2632738|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2170062|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2170063|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
2170064|NCT00000801|Hormones|hormones|mesh-ancestor
2170065|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2170066|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2170067|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2170068|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2170069|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2170070|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170071|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2170072|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
2170073|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
2170074|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170075|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2170076|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
2170077|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
2170078|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
2170079|NCT00000802|Dapsone|dapsone|mesh-list
2170080|NCT00000802|Atovaquone|atovaquone|mesh-list
2170081|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170082|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
2170083|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2170084|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2170085|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2170086|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170087|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170088|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
2170089|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2170090|NCT00000803|Zidovudine|zidovudine|mesh-list
2170091|NCT00000803|Didanosine|didanosine|mesh-list
2170092|NCT00000803|Delavirdine|delavirdine|mesh-list
2170093|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
2170094|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170095|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170096|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170097|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170098|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
2170099|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170100|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170101|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170102|NCT00000804|Indinavir|indinavir|mesh-list
2632739|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632740|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2632741|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
2170103|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170104|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170105|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170106|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170107|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170108|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170109|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170110|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
2170111|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632742|NCT01946477|Hormones|hormones|mesh-ancestor
2170112|NCT00000805|Ganciclovir|ganciclovir|mesh-list
2668577|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632743|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2632744|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2632745|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632746|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
2632747|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2632748|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2632749|NCT01946477|Growth Substances|growth substances|mesh-ancestor
2632750|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
2632751|NCT01946555|Fentanyl|fentanyl|mesh-list
2632752|NCT01946555|Morphine|morphine|mesh-list
2632753|NCT01946555|Oxycodone|oxycodone|mesh-list
2632754|NCT01946555|Buprenorphine|buprenorphine|mesh-list
2632755|NCT01946555|Methadone|methadone|mesh-list
2632756|NCT01946555|Hydromorphone|hydromorphone|mesh-list
2632757|NCT01946555|Tapentadol|tapentadol|mesh-list
2632758|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2632759|NCT01946555|Narcotics|narcotics|mesh-ancestor
2632760|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632761|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632762|NCT01946555|Analgesics|analgesics|mesh-ancestor
2632763|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
2632764|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632765|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2632766|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2632767|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
2632768|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
2632769|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2632770|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
2632771|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
2632772|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2632773|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2632774|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2632775|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632776|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
2632777|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632778|NCT01946568|Dalbavancin|dalbavancin|mesh-list
2170113|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2170114|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
2170115|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170116|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170117|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170118|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170119|NCT00000807|Etoposide|etoposide|mesh-list
2170120|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2170121|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170122|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2170123|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2170124|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170125|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170126|NCT00000808|Nevirapine|nevirapine|mesh-list
2170127|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170128|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170129|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170130|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170131|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
2170132|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170133|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170134|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2632779|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2632780|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632781|NCT01946594|Acetaminophen|acetaminophen|mesh-list
2632782|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2632783|NCT01946594|Analgesics|analgesics|mesh-ancestor
2632784|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
2632785|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632786|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632787|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
2632788|NCT01946607|Citalopram|citalopram|mesh-list
2632789|NCT01946607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2632790|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2632791|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2632792|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632793|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632794|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
2632795|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632796|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2632797|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
2632798|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2632799|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
2632800|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2632801|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
2632802|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632803|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632804|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2632805|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
2632806|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2632807|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2632808|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2632809|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
2632810|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632811|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632812|NCT01946711|Budesonide|budesonide|mesh-list
2632813|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2632814|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2632815|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
2632816|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632817|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632818|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2632819|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
2632820|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
2632821|NCT01946711|Hormones|hormones|mesh-ancestor
2632822|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2632823|NCT01946815|Atorvastatin|atorvastatin|mesh-list
2632824|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2632825|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2632826|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
2632827|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632828|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2632829|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2632830|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632831|NCT01946906|Rifaximin|rifaximin|mesh-list
2632832|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2632833|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632834|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2632835|NCT01946971|Lansoprazole|lansoprazole|mesh-list
2632836|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
2632837|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2632838|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2632839|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2170135|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2170136|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2632840|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632841|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632842|NCT01946984|Diclofenac|diclofenac|mesh-list
2632843|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
2632844|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2632845|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2632846|NCT01946984|Analgesics|analgesics|mesh-ancestor
2632847|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
2632848|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632849|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632850|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2632851|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2632852|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2632853|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632854|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632855|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2632856|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
2632857|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632858|NCT01947023|Lapatinib|lapatinib|mesh-list
2632859|NCT01947023|Dabrafenib|dabrafenib|mesh-list
2632860|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632861|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2632862|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632863|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632864|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
2632865|NCT01947062|Cisplatin|cisplatin|mesh-list
2632866|NCT01947062|Etoposide|etoposide|mesh-list
2632867|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
2170137|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2170138|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2170139|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
2170140|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170141|NCT00000809|Antacids|antacids|mesh-ancestor
2170142|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170143|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2170144|NCT00000810|Zidovudine|zidovudine|mesh-list
2170145|NCT00000810|Didanosine|didanosine|mesh-list
2170146|NCT00000810|Delavirdine|delavirdine|mesh-list
2170147|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
2170148|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170149|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170150|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170151|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170152|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
2170153|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170154|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170155|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170156|NCT00000811|Azithromycin|azithromycin|mesh-list
2170157|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2170158|NCT00000811|Trimethoprim|trimethoprim|mesh-list
2170159|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
2170160|NCT00000811|Atovaquone|atovaquone|mesh-list
2170161|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2170162|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170163|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2170164|NCT00000811|Renal Agents|renal agents|mesh-ancestor
2170165|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
2170166|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2170167|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2170168|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2170169|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170170|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170171|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2170172|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2632868|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2632869|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
2632870|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632871|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2632872|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2632873|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
2632874|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632875|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632876|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2632877|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2632878|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2632879|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2632880|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632881|NCT01947114|Ketamine|ketamine|mesh-list
2632882|NCT01947114|Remifentanil|remifentanil|mesh-list
2632883|NCT01947114|Propofol|propofol|mesh-list
2632884|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2632885|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632886|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632887|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2632888|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
2632889|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
2632890|NCT01947114|Analgesics|analgesics|mesh-ancestor
2632891|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
2632892|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632893|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2632894|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2632895|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2632896|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632897|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632898|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2632899|NCT01947114|Narcotics|narcotics|mesh-ancestor
2632900|NCT01947140|Romidepsin|romidepsin|mesh-list
2632901|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2632902|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632903|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
2632904|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2632905|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170173|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2632906|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
2632907|NCT01947205|Acetaminophen|acetaminophen|mesh-list
2632908|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2632909|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2632910|NCT01947205|Analgesics|analgesics|mesh-ancestor
2632911|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
2170174|NCT00000812|Thalidomide|thalidomide|mesh-list
2170175|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2170176|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
2170177|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170178|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
2632912|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632913|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632914|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
2632915|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2632916|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2632917|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2632918|NCT01947309|Lenalidomide|lenalidomide|mesh-list
2632919|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
2632920|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632921|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2632922|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2632923|NCT01947309|Growth Substances|growth substances|mesh-ancestor
2632924|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
2632925|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632926|NCT01947465|Vaccines|vaccines|mesh-list
2632927|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
2632928|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632929|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
2632930|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2632931|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632932|NCT01947608|Ceritinib|ceritinib|mesh-list
2632933|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2632934|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2632935|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632936|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632937|NCT01947660|Anesthetics|anesthetics|mesh-list
2632938|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2632939|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632940|NCT01947699|Glyburide|glyburide|mesh-list
2632941|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2632942|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632943|NCT01947777|Rifampin|rifampin|mesh-list
2632944|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2632945|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
2632946|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2632947|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2632948|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
2632949|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2632950|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2632951|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632952|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2632953|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2632954|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2632955|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2632956|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2632957|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2632958|NCT01947790|Metformin|metformin|mesh-list
2632959|NCT01947790|Pioglitazone|pioglitazone|mesh-list
2632960|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2632961|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632962|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2632963|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2632964|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2632965|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2170179|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2170180|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170181|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2170182|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2170183|NCT00000812|Growth Substances|growth substances|mesh-ancestor
2170184|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
2170185|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170186|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
2170187|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2170188|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
2632966|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632967|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2632968|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2632969|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2632970|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
2632971|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2632972|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632973|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2632974|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2632975|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
2632976|NCT01947920|Tramadol|tramadol|mesh-list
2632977|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2632978|NCT01947920|Narcotics|narcotics|mesh-ancestor
2632979|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2170189|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170190|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2170191|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170192|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
2170193|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170194|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
2170195|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2170196|NCT00000813|Protective Agents|protective agents|mesh-ancestor
2170197|NCT00000814|Zidovudine|zidovudine|mesh-list
2170198|NCT00000814|Nevirapine|nevirapine|mesh-list
2170199|NCT00000814|Didanosine|didanosine|mesh-list
2170200|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
2170201|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2632980|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632981|NCT01947920|Analgesics|analgesics|mesh-ancestor
2632982|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
2632983|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632984|NCT01947933|Mirikizumab|mirikizumab|mesh-list
2632985|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2632986|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2632987|NCT01947933|Analgesics|analgesics|mesh-ancestor
2632988|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
2632989|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2632990|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2632991|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2632992|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2632993|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2632994|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2632995|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
2632996|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2632997|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
2632998|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2632999|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
2633000|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633001|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633002|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
2633003|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
2633004|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2633005|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
2633006|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2633007|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
2633008|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633009|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633010|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
2633011|NCT01947998|Warfarin|warfarin|mesh-list
2633012|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
2633013|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2633014|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
2633015|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2633016|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
2633017|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2633018|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
2633019|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633020|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633021|NCT01948011|Racecadotril|racecadotril|mesh-list
2633022|NCT01948011|Thiorphan|thiorphan|mesh-list
2633023|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
2633024|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2633025|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
2633026|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633027|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633028|NCT01948024|Asenapine|asenapine|mesh-list
2633029|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2633030|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2633031|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633032|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633033|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2633034|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
2633035|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2633036|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
2633037|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
2633038|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633039|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633040|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2633041|NCT01948115|Analgesics|analgesics|mesh-ancestor
2633042|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
2633043|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633044|NCT01948128|Vitamin D|vitamin d|mesh-list
2633045|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
2170202|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170203|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170204|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170205|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
2170206|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170207|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170208|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170209|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2170210|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2170211|NCT00000816|Trimethoprim|trimethoprim|mesh-list
2170212|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2170213|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
2170214|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2170215|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170216|NCT00000816|Renal Agents|renal agents|mesh-ancestor
2170217|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
2170218|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2170219|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2170220|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2170221|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170222|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170223|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2170224|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2170225|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2170226|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2170227|NCT00000817|Amitriptyline|amitriptyline|mesh-list
2170228|NCT00000817|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2170229|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2170230|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
2170231|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2170232|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2170233|NCT00000817|Analgesics|analgesics|mesh-ancestor
2633046|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
2633047|NCT01948128|Vitamins|vitamins|mesh-list
2633048|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
2633049|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633050|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2633051|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2633052|NCT01948232|Perindopril|perindopril|mesh-list
2633053|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2633054|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
2633055|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633056|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633057|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2633058|NCT01948245|Taurolidine|taurolidine|mesh-list
2633059|NCT01948245|Heparin|heparin|mesh-list
2633060|NCT01948245|Calcium heparin|calcium heparin|mesh-list
2633061|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
2633062|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633063|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2633064|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2633065|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633066|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2633067|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633068|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
2633069|NCT01948336|Ketamine|ketamine|mesh-list
2633070|NCT01948336|Propofol|propofol|mesh-list
2633071|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2633072|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633073|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633074|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2633075|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
2633076|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
2633077|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2633078|NCT01948336|Analgesics|analgesics|mesh-ancestor
2633079|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
2633080|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633081|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2633082|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2633083|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2633084|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
2170234|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
2170235|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2170236|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170237|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2170238|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2170239|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2170240|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170241|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
2170242|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633085|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633086|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633087|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2633088|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2633089|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2633090|NCT01948362|Sulforaphane|sulforaphane|mesh-list
2633091|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2633092|NCT01948362|Protective Agents|protective agents|mesh-ancestor
2633093|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633094|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633095|NCT01948401|Prednisolone|prednisolone|mesh-list
2633096|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2633097|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
2633098|NCT01948401|Hormones|hormones|mesh-ancestor
2633099|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2633100|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633101|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2633102|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633103|NCT01948505|Acetaminophen|acetaminophen|mesh-list
2633104|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2633105|NCT01948505|Analgesics|analgesics|mesh-ancestor
2633106|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
2633107|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633108|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633109|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
2633110|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
2170243|NCT00000817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2170244|NCT00000817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2170245|NCT00000817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633111|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2633112|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
2633113|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633114|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
2633115|NCT01948583|Protective Agents|protective agents|mesh-ancestor
2633116|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2633117|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2633118|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2633119|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
2633120|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633121|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2633122|NCT01948765|Propofol|propofol|mesh-list
2170246|NCT00000818|Zidovudine|zidovudine|mesh-list
2170247|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
2170248|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170249|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170250|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170251|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170252|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
2170253|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170254|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170255|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170256|NCT00000819|Prednisone|prednisone|mesh-list
2633123|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2422198|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422199|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422200|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2422201|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
2422202|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
2633124|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633125|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633126|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2633127|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
2633128|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
2633129|NCT01948804|Letrozole|letrozole|mesh-list
2633130|NCT01948804|Clomiphene|clomiphene|mesh-list
2633131|NCT01948804|Cetrorelix|cetrorelix|mesh-list
2633132|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2633133|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633134|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2633135|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2633136|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633137|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633138|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2633139|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
2633140|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2633141|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633142|NCT01948804|Hormones|hormones|mesh-ancestor
2633143|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2633144|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
2633145|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2633146|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2633147|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2633148|NCT01948817|Deferasirox|deferasirox|mesh-list
2633149|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2170257|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2170258|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
2170259|NCT00000819|Hormones|hormones|mesh-ancestor
2170260|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2170261|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633150|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
2633151|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
2633152|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633153|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2633154|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2633155|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2633156|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2633157|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633158|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633159|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633160|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
2633161|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2633162|NCT01948921|Meperidine|meperidine|mesh-list
2633163|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2633164|NCT01948921|Narcotics|narcotics|mesh-ancestor
2633165|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633166|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633167|NCT01948921|Analgesics|analgesics|mesh-ancestor
2633168|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
2633169|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633170|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2633171|NCT01948960|Everolimus|everolimus|mesh-list
2633172|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633173|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2633174|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
2633175|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633176|NCT01948999|Anesthetics|anesthetics|mesh-list
2633177|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633178|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633179|NCT01949038|Alprazolam|alprazolam|mesh-list
2170262|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2422203|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2422204|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2422205|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2422206|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2422207|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2170263|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170264|NCT00000820|Aldesleukin|aldesleukin|mesh-list
2170265|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170266|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170267|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170268|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
2170269|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170270|NCT00000821|Aldesleukin|aldesleukin|mesh-list
2170271|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170272|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170273|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170274|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
2170275|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170276|NCT00000822|Ritonavir|ritonavir|mesh-list
2170277|NCT00000822|Stavudine|stavudine|mesh-list
2170278|NCT00000822|Didanosine|didanosine|mesh-list
2170279|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2633180|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2633181|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633182|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633183|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2633184|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2633185|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2633186|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
2170280|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170281|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170282|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633187|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
2633188|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633189|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633190|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
2633191|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633192|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
2633193|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
2633194|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
2633195|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
2633196|NCT01949129|Busulfan|busulfan|mesh-list
2633197|NCT01949129|Thiotepa|thiotepa|mesh-list
2633198|NCT01949129|Treosulfan|treosulfan|mesh-list
2633199|NCT01949129|Fludarabine|fludarabine|mesh-list
2633200|NCT01949129|Etoposide|etoposide|mesh-list
2633201|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
2633202|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2633203|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
2633204|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2633205|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
2633206|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633207|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2633208|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2633209|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
2633210|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633211|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170283|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170284|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170285|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170286|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
2170287|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170288|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2170289|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2170290|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
2170291|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170292|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170293|NCT00000823|Zidovudine|zidovudine|mesh-list
2170294|NCT00000823|Didanosine|didanosine|mesh-list
2170295|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
2170296|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170297|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170298|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170299|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170300|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
2170301|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170302|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170303|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170304|NCT00000825|Aldesleukin|aldesleukin|mesh-list
2170305|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170306|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170307|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170308|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
2633212|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2170309|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170310|NCT00000826|Clarithromycin|clarithromycin|mesh-list
2170311|NCT00000826|Dapsone|dapsone|mesh-list
2170312|NCT00000826|Rifabutin|rifabutin|mesh-list
2170313|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2170314|NCT00000826|Fluconazole|fluconazole|mesh-list
2170315|NCT00000826|Trimethoprim|trimethoprim|mesh-list
2170316|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
2170317|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2633213|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2633214|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2633215|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2633216|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633217|NCT01949168|Ribavirin|ribavirin|mesh-list
2633218|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2633219|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
2633220|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633221|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
2633222|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633223|NCT01949233|Doxycycline|doxycycline|mesh-list
2633224|NCT01949233|Irbesartan|irbesartan|mesh-list
2633225|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2633226|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633227|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
2633228|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2633229|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2633230|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2633231|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2633232|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2633233|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633234|NCT01949363|Cefixime|cefixime|mesh-list
2633235|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2633236|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633237|NCT01949454|Fluorometholone|fluorometholone|mesh-list
2633238|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2633239|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
2633240|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2633241|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2633242|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
2633243|NCT01949454|Hormones|hormones|mesh-ancestor
2633244|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2633245|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633246|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2633247|NCT01949519|Lycopene|lycopene|mesh-list
2633248|NCT01949519|Docetaxel|docetaxel|mesh-list
2633249|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633250|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
2633251|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
2633252|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
2633253|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633254|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2633255|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
2633256|NCT01949519|Protective Agents|protective agents|mesh-ancestor
2633257|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170318|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170319|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2170320|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170321|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170322|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2170323|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2170324|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
2170325|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2170326|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2170327|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
2170328|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2170329|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170330|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2170331|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2170332|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2170333|NCT00000826|Renal Agents|renal agents|mesh-ancestor
2170334|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
2633258|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2633259|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2633260|NCT01949571|Mirtazapine|mirtazapine|mesh-list
2633261|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
2633262|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2633263|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2633264|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
2633265|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
2633266|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633267|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633268|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633269|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2633270|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2633271|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633272|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2633273|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2633274|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2170335|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2170336|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2170337|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2170338|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2170339|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2170340|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
2170341|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2170342|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
2633275|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
2633276|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2633277|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2633278|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
2633279|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2633280|NCT01949675|Vaccines|vaccines|mesh-list
2633281|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
2633282|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633283|NCT01949714|Epinephrine|epinephrine|mesh-list
2633284|NCT01949714|Racepinephrine|racepinephrine|mesh-list
2633285|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
2633286|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2633287|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2633288|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
2633289|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633290|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633291|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633292|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2633293|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2633294|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
2633295|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633296|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2633297|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
2633298|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
2170343|NCT00000827|Immune Sera|immune sera|mesh-list
2633299|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
2633300|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2633301|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2633302|NCT01949766|Glycerol|glycerol|mesh-list
2633303|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2633304|NCT01949766|Protective Agents|protective agents|mesh-ancestor
2633305|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633306|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633307|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
2633308|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2633309|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
2633310|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633311|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
2633312|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633313|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633314|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2633315|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
2633316|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633317|NCT01949818|Prednisone|prednisone|mesh-list
2633318|NCT01949818|Prednisolone|prednisolone|mesh-list
2633319|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
2633320|NCT01949818|Doxorubicin|doxorubicin|mesh-list
2633321|NCT01949818|Vincristine|vincristine|mesh-list
2633322|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2633323|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
2633324|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633325|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2633326|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2633327|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
2633328|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633329|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633330|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2633331|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2633332|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2633333|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2633334|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633335|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2633336|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
2633337|NCT01949818|Hormones|hormones|mesh-ancestor
2633338|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2633339|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2633340|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2633341|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
2633342|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
2633343|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
2633344|NCT01949857|Vaccines|vaccines|mesh-list
2633345|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
2633346|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633347|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
2633348|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2633349|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
2633350|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633351|NCT01949935|Mupirocin|mupirocin|mesh-list
2633352|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2633353|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633354|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2633355|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633356|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633357|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2633358|NCT01949948|Tenecteplase|tenecteplase|mesh-list
2633359|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2633360|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2633361|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633362|NCT01950000|Fentanyl|fentanyl|mesh-list
2633363|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2633364|NCT01950000|Narcotics|narcotics|mesh-ancestor
2633365|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633366|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633367|NCT01950000|Analgesics|analgesics|mesh-ancestor
2633368|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
2633369|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633370|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2633371|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2633372|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
2633373|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
2633374|NCT01950182|Tamoxifen|tamoxifen|mesh-list
2633375|NCT01950182|Gemcitabine|gemcitabine|mesh-list
2633376|NCT01950182|Capecitabine|capecitabine|mesh-list
2633377|NCT01950182|Trastuzumab|trastuzumab|mesh-list
2633378|NCT01950182|Vinorelbine|vinorelbine|mesh-list
2633379|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2633380|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2633381|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
2633382|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633383|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633384|NCT01950182|Antiviral Agents|antiviral agents|mesh-ancestor
2633385|NCT01950182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633386|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633387|NCT01950182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2633388|NCT01950182|Immunologic Factors|immunologic factors|mesh-ancestor
2633389|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633390|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2633391|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2633392|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
2633393|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
2633394|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
2633395|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2633396|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
2633397|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2633398|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2633399|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2633400|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2633401|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2633402|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2633403|NCT01950195|Ipilimumab|ipilimumab|mesh-list
2633404|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2633405|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633406|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2633407|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170344|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
2170345|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170346|NCT00000829|Vaccines|vaccines|mesh-list
2170347|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2170348|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
2170349|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170350|NCT00000831|Lamivudine|lamivudine|mesh-list
2633425|NCT01950403|Linaclotide|linaclotide|mesh-list
2633426|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2633427|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
2633428|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633429|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2633430|NCT01950416|Clopidogrel|clopidogrel|mesh-list
2633431|NCT01950416|Ticagrelor|ticagrelor|mesh-list
2633432|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2633433|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2633434|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2633435|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2633436|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
2633437|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633438|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633439|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633440|NCT01950481|Ceritinib|ceritinib|mesh-list
2633441|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633442|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2170351|NCT00000831|Zidovudine|zidovudine|mesh-list
2170352|NCT00000831|Stavudine|stavudine|mesh-list
2170353|NCT00000831|Didanosine|didanosine|mesh-list
2170354|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170355|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170356|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170357|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170358|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
2170359|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170360|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170361|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170362|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
2170363|NCT00000833|Ribavirin|ribavirin|mesh-list
2170364|NCT00000833|Didanosine|didanosine|mesh-list
2170365|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
2170366|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170367|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
2170368|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170369|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170370|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170371|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170372|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170373|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170374|NCT00000834|Lamivudine|lamivudine|mesh-list
2170375|NCT00000834|Zidovudine|zidovudine|mesh-list
2170376|NCT00000834|Methotrexate|methotrexate|mesh-list
2170377|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2170378|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
2170379|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2170380|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633443|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633444|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633445|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
2633446|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2633447|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633448|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
2633449|NCT01950507|Fluconazole|fluconazole|mesh-list
2633450|NCT01950507|Voriconazole|voriconazole|mesh-list
2633451|NCT01950507|Micafungin|micafungin|mesh-list
2633452|NCT01950507|Budesonide|budesonide|mesh-list
2633453|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2633454|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2633455|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
2633456|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633457|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633458|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2633459|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
2633460|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
2633461|NCT01950507|Hormones|hormones|mesh-ancestor
2633462|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2633463|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
2633464|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633465|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2633466|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2633467|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633468|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633469|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2633470|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
2633471|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2633472|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2633473|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2633474|NCT01950520|Topiramate|topiramate|mesh-list
2633475|NCT01950520|Phentermine|phentermine|mesh-list
2633476|NCT01950520|Propranolol|propranolol|mesh-list
2633477|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
2633478|NCT01950520|Pindolol|pindolol|mesh-list
2633479|NCT01950520|Naltrexone|naltrexone|mesh-list
2633480|NCT01950520|Caffeine|caffeine|mesh-list
2170381|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2170382|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
2170383|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170384|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170385|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
2170386|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170387|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2170388|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2170389|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
2170390|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2170391|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2633481|NCT01950520|Dantrolene|dantrolene|mesh-list
2633482|NCT01950520|Mirabegron|mirabegron|mesh-list
2633483|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2633484|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2633485|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633486|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
2633487|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633488|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2633489|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2633490|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633491|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633492|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2633493|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2633494|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
2633495|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633496|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2633497|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2170392|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170393|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
2170394|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170395|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170396|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170397|NCT00000838|Lamivudine|lamivudine|mesh-list
2170398|NCT00000838|Zidovudine|zidovudine|mesh-list
2170399|NCT00000838|Stavudine|stavudine|mesh-list
2170400|NCT00000838|Didanosine|didanosine|mesh-list
2633498|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
2633499|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2633500|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2633501|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
2633502|NCT01950520|Analgesics|analgesics|mesh-ancestor
2633503|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
2633504|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633505|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
2633506|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2633507|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2633508|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2633509|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
2633510|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2633511|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2633512|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2633513|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2633514|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2633515|NCT01950520|Urological Agents|urological agents|mesh-ancestor
2633516|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
2633517|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2633518|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
2633519|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
2633520|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2633521|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
2633522|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2633523|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2633524|NCT01950546|Fluorides|fluorides|mesh-list
2633525|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
2633526|NCT01950546|Protective Agents|protective agents|mesh-ancestor
2633527|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633528|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
2633529|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633530|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
2633531|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633532|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633533|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2633534|NCT01950611|Bortezomib|bortezomib|mesh-list
2633535|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633536|NCT01950689|Nimorazole|nimorazole|mesh-list
2633537|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2633538|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2633539|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2633540|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633541|NCT01950793|Triamcinolone|triamcinolone|mesh-list
2633542|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2633543|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2633544|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
2633545|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2633546|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2633547|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
2633548|NCT01950793|Hormones|hormones|mesh-ancestor
2633549|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2633550|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633551|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2633552|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
2633553|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633554|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633555|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2633556|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
2633557|NCT01950793|Protective Agents|protective agents|mesh-ancestor
2633558|NCT01950884|Ezetimibe|ezetimibe|mesh-list
2633559|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2633560|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2633561|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
2633562|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633563|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2633564|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
2633565|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633566|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
2633567|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2633568|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2633569|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633570|NCT01950923|Urological Agents|urological agents|mesh-ancestor
2633571|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2633572|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
2633573|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
2633574|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2633575|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2633576|NCT01951027|Lenograstim|lenograstim|mesh-list
2633577|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2633578|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
2633579|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633580|NCT01951053|Citalopram|citalopram|mesh-list
2633581|NCT01951053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2633582|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2633583|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2633584|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633585|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633586|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
2633587|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633588|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2633589|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
2633590|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2633591|NCT01951079|Digoxin|digoxin|mesh-list
2633592|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2633593|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2633594|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633595|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633596|NCT01951079|Protective Agents|protective agents|mesh-ancestor
2633597|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633598|NCT01951144|Lorazepam|lorazepam|mesh-list
2633599|NCT01951144|PF-06372865|pf-06372865|mesh-list
2633600|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
2633601|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
2633602|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
2633603|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633604|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633605|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2633606|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2633607|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633608|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2633609|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2633610|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2633611|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
2170401|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170402|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170403|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170404|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170405|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
2170406|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170407|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170408|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170409|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
2170410|NCT00000839|Didanosine|didanosine|mesh-list
2170411|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
2170412|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170413|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170414|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170415|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170416|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
2170417|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170418|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170419|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170420|NCT00000841|Lamivudine|lamivudine|mesh-list
2170421|NCT00000841|Zidovudine|zidovudine|mesh-list
2170422|NCT00000841|Stavudine|stavudine|mesh-list
2170423|NCT00000841|Indinavir|indinavir|mesh-list
2170424|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170425|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170426|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170427|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170428|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
2170429|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170430|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170431|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170432|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
2170433|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170434|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2633612|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
2633613|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633614|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633615|NCT01951209|Rifaximin|rifaximin|mesh-list
2170435|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170436|NCT00000842|Mitogens|mitogens|mesh-list
2170437|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
2170438|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170439|NCT00000843|Adefovir|adefovir|mesh-list
2170440|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2170441|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
2633616|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2633617|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633618|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2633619|NCT01951274|Serlopitant|serlopitant|mesh-list
2633620|NCT01951274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2633621|NCT01951274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633622|NCT01951274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633623|NCT01951274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633624|NCT01951404|Allopurinol|allopurinol|mesh-list
2633625|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
2633626|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633627|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633628|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
2633629|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2633630|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2633631|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
2633632|NCT01951404|Protective Agents|protective agents|mesh-ancestor
2633633|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633634|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2633635|NCT01951430|Cephalosporins|cephalosporins|mesh-list
2633636|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2633637|NCT01951430|Itraconazole|itraconazole|mesh-list
2633638|NCT01951430|Fluconazole|fluconazole|mesh-list
2633639|NCT01951430|Posaconazole|posaconazole|mesh-list
2633640|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
2633641|NCT01951430|Clotrimazole|clotrimazole|mesh-list
2633642|NCT01951430|Miconazole|miconazole|mesh-list
2633643|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633644|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2633645|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2633646|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633647|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633648|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2633649|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
2633650|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2633651|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633652|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2633653|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2633654|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2633655|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2633656|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2633657|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2633658|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2633659|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2633660|NCT01951430|Renal Agents|renal agents|mesh-ancestor
2633661|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
2633670|NCT01951482|Bevacizumab|bevacizumab|mesh-list
2633671|NCT01951482|Cisplatin|cisplatin|mesh-list
2633672|NCT01951482|Pemetrexed|pemetrexed|mesh-list
2633673|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2633674|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633675|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2633676|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2633677|NCT01951482|Growth Substances|growth substances|mesh-ancestor
2633678|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633679|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
2633680|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633681|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633682|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2633683|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2633684|NCT01951508|Methylphenidate|methylphenidate|mesh-list
2633685|NCT01951508|Modafinil|modafinil|mesh-list
2422208|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2422209|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2170442|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170443|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170444|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170445|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170446|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170447|NCT00000844|Interferons|interferons|mesh-list
2170448|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
2170449|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170450|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
2633686|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2633687|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633688|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2633689|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2633690|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2633691|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170451|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170452|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
2170453|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170454|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
2170455|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2170456|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
2170457|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170458|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2170459|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170460|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
2170461|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170462|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
2170463|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2170464|NCT00000847|Protective Agents|protective agents|mesh-ancestor
2170465|NCT00000848|Indinavir|indinavir|mesh-list
2170466|NCT00000848|Saquinavir|saquinavir|mesh-list
2170467|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170468|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170469|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170470|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170471|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170472|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170473|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2633692|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
2633693|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633694|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2633695|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2633696|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2633697|NCT01951560|Valproic Acid|valproic acid|mesh-list
2633698|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
2633699|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633700|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633701|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
2633702|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633703|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633704|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
2633705|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2633706|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633707|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2633708|NCT01951599|Osimertinib|osimertinib|mesh-list
2633709|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633710|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2633711|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633712|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633713|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2633714|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
2633715|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633716|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2170474|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
2422210|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2422211|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2422212|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
2422213|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2422214|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2422215|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
2422216|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2422217|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2633717|NCT01951677|Antacids|antacids|mesh-ancestor
2633718|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633719|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2633720|NCT01951729|Atropine|atropine|mesh-list
2633721|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2633722|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2633723|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2633724|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
2633725|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633726|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633727|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2633728|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
2633729|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
2633730|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
2633731|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2633732|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2633733|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
2633734|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633735|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633736|NCT01951846|Nintedanib|nintedanib|mesh-list
2633737|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633738|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2633739|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633740|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633741|NCT01951872|Caffeine|caffeine|mesh-list
2633742|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2633743|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633744|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2633745|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633746|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633747|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2633748|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2633749|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
2633750|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633751|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
2633752|NCT01951885|Methotrexate|methotrexate|mesh-list
2633753|NCT01951885|Tacrolimus|tacrolimus|mesh-list
2633754|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2633755|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
2633756|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2633757|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633758|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2633759|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
2633760|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633761|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633762|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
2633763|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633764|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2633765|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2633766|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
2633767|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2633768|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2633769|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2633770|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2633771|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2633772|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
2633773|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2633774|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633775|NCT01951898|Montelukast|montelukast|mesh-list
2633776|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2170475|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170476|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2170477|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2170478|NCT00000849|Aldesleukin|aldesleukin|mesh-list
2170479|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170480|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2633777|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
2633778|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2633779|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
2633780|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2633781|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633782|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2633783|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2633784|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633785|NCT01951911|Ketamine|ketamine|mesh-list
2633786|NCT01951911|Analgesics|analgesics|mesh-ancestor
2633787|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
2633788|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633789|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633790|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2633791|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2633792|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
2633793|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
2633794|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633795|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2633796|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2633797|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633798|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170481|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170482|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
2170483|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170484|NCT00000850|Indinavir|indinavir|mesh-list
2170485|NCT00000850|Sargramostim|sargramostim|mesh-list
2633799|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
2633800|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2633801|NCT01951924|Antibodies|antibodies|mesh-list
2633802|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
2633803|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
2633804|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633813|NCT01952314|Naftopidil|naftopidil|mesh-list
2633814|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2633815|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2633816|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
2633817|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633818|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633819|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633820|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2633821|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2633822|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2633823|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2633824|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2633825|NCT01952561|Dapivirine|dapivirine|mesh-list
2633826|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2633827|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2633828|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
2633829|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2633830|NCT01952626|Ondansetron|ondansetron|mesh-list
2633831|NCT01952626|Palonosetron|palonosetron|mesh-list
2633832|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
2633833|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
2633834|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633835|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633836|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2633837|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
2633838|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
2633839|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2633840|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
2633841|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633842|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633843|NCT01952626|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2633844|NCT01952626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2633845|NCT01952626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633846|NCT01952626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2633847|NCT01952626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2633848|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2633849|NCT01952652|Naproxen|naproxen|mesh-list
2633850|NCT01952652|Codeine|codeine|mesh-list
2633851|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2633852|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2170486|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
2633853|NCT01952652|Analgesics|analgesics|mesh-ancestor
2633854|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
2633855|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633856|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633857|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2633858|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2170487|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170488|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170489|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170490|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170491|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170492|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170493|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170494|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170495|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
2170496|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170497|NCT00000851|Stavudine|stavudine|mesh-list
2170498|NCT00000851|Didanosine|didanosine|mesh-list
2633859|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
2633860|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2633861|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170499|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
2170500|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170501|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170502|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170503|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170504|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
2170505|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170506|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170507|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170508|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
2170509|NCT00000854|Nandrolone|nandrolone|mesh-list
2170510|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
2170511|NCT00000854|Androgens|androgens|mesh-ancestor
2170512|NCT00000854|Hormones|hormones|mesh-ancestor
2170513|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2170514|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170515|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
2170516|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2170517|NCT00000855|Zidovudine|zidovudine|mesh-list
2170518|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
2170519|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170520|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170521|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170522|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170523|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
2170524|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170525|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170526|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170527|NCT00000856|Ganciclovir|ganciclovir|mesh-list
2170528|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2170529|NCT00000856|Foscarnet|foscarnet|mesh-list
2170530|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2170531|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
2170532|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170533|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170534|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170535|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170536|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2633862|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633863|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2633864|NCT01952652|Narcotics|narcotics|mesh-ancestor
2633865|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633866|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
2633867|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
2633868|NCT01952756|Cilostazol|cilostazol|mesh-list
2633869|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2633870|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
2633871|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633872|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633873|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2633874|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
2633875|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2633876|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2633877|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170537|NCT00000857|Interleukin-12|interleukin-12|mesh-list
2170538|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2170539|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
2170540|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170541|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2170542|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2170543|NCT00000857|Growth Substances|growth substances|mesh-ancestor
2633878|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2633879|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
2633880|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2633881|NCT01952756|Protective Agents|protective agents|mesh-ancestor
2633882|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2633883|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2633884|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633885|NCT01952769|Pidilizumab|pidilizumab|mesh-list
2633886|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2633887|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633888|NCT01952782|Naloxone|naloxone|mesh-list
2633889|NCT01952782|Hormones|hormones|mesh-list
2633890|NCT01952782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2633891|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633892|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2633893|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
2633894|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633895|NCT01952886|Ondansetron|ondansetron|mesh-list
2633896|NCT01952886|Granisetron|granisetron|mesh-list
2633897|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
2633898|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
2633899|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633900|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633901|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2633902|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
2633903|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
2633904|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2633905|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
2633906|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633907|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633908|NCT01952886|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2633909|NCT01952886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2633910|NCT01952886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633911|NCT01952886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2633912|NCT01952886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2633913|NCT01952951|Fluorouracil|fluorouracil|mesh-list
2633914|NCT01952951|Capecitabine|capecitabine|mesh-list
2633915|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
2633916|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
2633917|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633918|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2633919|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633920|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2633921|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
2633922|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170544|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
2170545|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170546|NCT00000859|Ritonavir|ritonavir|mesh-list
2170547|NCT00000859|Nelfinavir|nelfinavir|mesh-list
2170548|NCT00000859|Indinavir|indinavir|mesh-list
2170549|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170550|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2633923|NCT01952990|Phenylephrine|phenylephrine|mesh-list
2633924|NCT01952990|Oxymetazoline|oxymetazoline|mesh-list
2633925|NCT01952990|Tetracaine|tetracaine|mesh-list
2633926|NCT01952990|Anesthetics, Local|anesthetics, local|mesh-ancestor
2633927|NCT01952990|Anesthetics|anesthetics|mesh-ancestor
2633928|NCT01952990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2633929|NCT01952990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633930|NCT01952990|Sensory System Agents|sensory system agents|mesh-ancestor
2633931|NCT01952990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2633932|NCT01952990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2633933|NCT01952990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2633934|NCT01952990|Adrenergic Agents|adrenergic agents|mesh-ancestor
2633935|NCT01952990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2633936|NCT01952990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633937|NCT01952990|Sympathomimetics|sympathomimetics|mesh-ancestor
2633938|NCT01952990|Autonomic Agents|autonomic agents|mesh-ancestor
2633939|NCT01952990|Nasal Decongestants|nasal decongestants|mesh-ancestor
2170551|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
2633940|NCT01952990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2633941|NCT01952990|Respiratory System Agents|respiratory system agents|mesh-ancestor
2633942|NCT01952990|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2633943|NCT01952990|Mydriatics|mydriatics|mesh-ancestor
2633944|NCT01952990|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2633945|NCT01952990|Protective Agents|protective agents|mesh-ancestor
2633946|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
2633947|NCT01953107|Trace Elements|trace elements|mesh-ancestor
2633948|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
2633949|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633950|NCT01953120|Abatacept|abatacept|mesh-list
2633951|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2633952|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633953|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633954|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2633955|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
2633956|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633957|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2633958|NCT01953172|Tocotrienols|tocotrienols|mesh-list
2633959|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
2633960|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
2633961|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633962|NCT01953172|Protective Agents|protective agents|mesh-ancestor
2633963|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633964|NCT01953172|Vitamins|vitamins|mesh-ancestor
2633965|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
2633966|NCT01953367|Tobramycin|tobramycin|mesh-list
2633967|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2633968|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170552|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170553|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633969|NCT01953406|Fluorouracil|fluorouracil|mesh-list
2633970|NCT01953406|Mitomycins|mitomycins|mesh-list
2633971|NCT01953406|Mitomycin|mitomycin|mesh-list
2633972|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
2633973|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633974|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2633975|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633976|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2633977|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
2633978|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2633979|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2633980|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
2633981|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2633982|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633983|NCT01953419|Pemetrexed|pemetrexed|mesh-list
2633984|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633985|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2633986|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633987|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2633988|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2633989|NCT01953445|Paclitaxel|paclitaxel|mesh-list
2633990|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2633991|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2633992|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
2633993|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
2633994|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
2633995|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2633996|NCT01953510|Vaccines|vaccines|mesh-list
2633997|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2633998|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
2633999|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634000|NCT01953536|Folic Acid|folic acid|mesh-list
2634001|NCT01953536|Paclitaxel|paclitaxel|mesh-list
2634002|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2634003|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2634004|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634005|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
2634006|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
2634007|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
2634008|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634009|NCT01953536|Hematinics|hematinics|mesh-ancestor
2634010|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
2634011|NCT01953536|Vitamins|vitamins|mesh-ancestor
2634012|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
2634013|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634014|NCT01953588|Fulvestrant|fulvestrant|mesh-list
2634015|NCT01953588|Anastrozole|anastrozole|mesh-list
2634016|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2634017|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634018|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2634019|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2634020|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
2634021|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2634022|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634023|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2634024|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2634025|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634026|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634027|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
2634028|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2634029|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
2634030|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2634031|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170554|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170555|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170556|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
2170557|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170558|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2170559|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2170560|NCT00000861|Indinavir|indinavir|mesh-list
2170561|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170562|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170563|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170564|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170565|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170566|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170567|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170568|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
2170569|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170570|NCT00000862|Zidovudine|zidovudine|mesh-list
2170571|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
2170572|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634032|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2634033|NCT01953731|Rifampin|rifampin|mesh-list
2634034|NCT01953731|Palbociclib|palbociclib|mesh-list
2634035|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634036|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2634037|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634038|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634039|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2634040|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
2634041|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2634042|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634043|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
2634044|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2634045|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2634046|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2634047|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2634048|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2634049|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2634050|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2634051|NCT01953744|Fluconazole|fluconazole|mesh-list
2634052|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2634053|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
2634054|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634055|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2634056|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2634057|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634058|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634059|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2634060|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
2634061|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2634062|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634063|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2634064|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2170573|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2634065|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2634066|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2634067|NCT01953757|Vitamins|vitamins|mesh-list
2634068|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
2170574|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170575|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170576|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
2170577|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170578|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170579|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170580|NCT00000864|Zidovudine|zidovudine|mesh-list
2170581|NCT00000864|Abacavir|abacavir|mesh-list
2634069|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
2634070|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
2634071|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
2634072|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634073|NCT01953757|Hematinics|hematinics|mesh-ancestor
2634074|NCT01953770|Cytarabine|cytarabine|mesh-list
2634075|NCT01953770|Prednisone|prednisone|mesh-list
2634076|NCT01953770|Methotrexate|methotrexate|mesh-list
2634077|NCT01953770|Daunorubicin|daunorubicin|mesh-list
2634078|NCT01953770|Asparaginase|asparaginase|mesh-list
2634079|NCT01953770|Pegaspargase|pegaspargase|mesh-list
2634080|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2634081|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
2634082|NCT01953770|Hormones|hormones|mesh-ancestor
2634083|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2634084|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634085|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2634086|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634087|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2634088|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
2634089|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2634090|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2634091|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
2634092|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634093|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
2634094|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634095|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2634096|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2634097|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
2634098|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2634099|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2634100|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
2634101|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634102|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2634103|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2634104|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2634105|NCT01953796|Clomiphene|clomiphene|mesh-list
2634106|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2634107|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
2634108|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2634109|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634110|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2634111|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
2634112|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2634113|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2634114|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2634115|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2634116|NCT01953835|Simvastatin|simvastatin|mesh-list
2634117|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2634118|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2634119|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
2634120|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634121|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2634122|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2634123|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634124|NCT01953848|Tamsulosin|tamsulosin|mesh-list
2634125|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
2634126|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2634127|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2634128|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2634129|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
2170582|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
2170583|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170584|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2634130|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634131|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634132|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634133|NCT01953848|Urological Agents|urological agents|mesh-ancestor
2634134|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2634135|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2634136|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
2634137|NCT01953887|Tamsulosin|tamsulosin|mesh-list
2634138|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
2634139|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2634140|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2634141|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2634142|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
2634143|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634144|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634145|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634146|NCT01953887|Urological Agents|urological agents|mesh-ancestor
2634147|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2634148|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2634149|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
2634150|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
2634151|NCT01953900|Fludarabine|fludarabine|mesh-list
2634152|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2634153|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
2634154|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634155|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2634156|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2634157|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
2634158|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634159|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634160|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2634161|NCT01953952|Cisplatin|cisplatin|mesh-list
2634162|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634163|NCT01953978|Acetaminophen|acetaminophen|mesh-list
2170585|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170586|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170587|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
2634164|NCT01953978|Dexamethasone|dexamethasone|mesh-list
2634165|NCT01953978|Ibuprofen|ibuprofen|mesh-list
2634166|NCT01953978|Morphine|morphine|mesh-list
2634167|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2634168|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
2634169|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
2634170|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634171|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634172|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2634173|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
2634174|NCT01953978|Hormones|hormones|mesh-ancestor
2634175|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2634176|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2634177|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634178|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2634179|NCT01953978|Narcotics|narcotics|mesh-ancestor
2634180|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2634181|NCT01953978|Analgesics|analgesics|mesh-ancestor
2634182|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
2634183|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2634184|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2634185|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2634186|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2634187|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634188|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170588|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170589|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170590|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170591|NCT00000865|Lamivudine|lamivudine|mesh-list
2170592|NCT00000865|Zidovudine|zidovudine|mesh-list
2170593|NCT00000865|Abacavir|abacavir|mesh-list
2634189|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
2634190|NCT01954030|Bevacizumab|bevacizumab|mesh-list
2634191|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
2170594|NCT00000865|Stavudine|stavudine|mesh-list
2170595|NCT00000865|Didanosine|didanosine|mesh-list
2170596|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170597|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170598|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634192|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2634193|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634194|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2634195|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2634196|NCT01954030|Growth Substances|growth substances|mesh-ancestor
2634197|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634198|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
2634199|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2634200|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2634201|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634202|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2634203|NCT01954043|Rifampin|rifampin|mesh-list
2634204|NCT01954043|Dabrafenib|dabrafenib|mesh-list
2634205|NCT01954043|Rabeprazole|rabeprazole|mesh-list
2634206|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2170599|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170600|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
2170601|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170602|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170603|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170604|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
2170605|NCT00000867|Memantine|memantine|mesh-list
2170606|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2170607|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2170608|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
2170609|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2170610|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170611|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170612|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2170613|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2170614|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2170615|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2170616|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
2170617|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170618|NCT00000868|Antacids|antacids|mesh-ancestor
2170619|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170620|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2170621|NCT00000869|Nevirapine|nevirapine|mesh-list
2170622|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170623|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170624|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170625|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170626|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
2170627|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170628|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2634207|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2634208|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2634209|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634210|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634211|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2634212|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
2634213|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2170629|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170630|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2170631|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2170632|NCT00000870|Lamivudine|lamivudine|mesh-list
2170633|NCT00000870|Zidovudine|zidovudine|mesh-list
2170634|NCT00000870|Stavudine|stavudine|mesh-list
2170635|NCT00000870|Didanosine|didanosine|mesh-list
2170636|NCT00000870|Aldesleukin|aldesleukin|mesh-list
2170637|NCT00000870|Indinavir|indinavir|mesh-list
2634214|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634215|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
2634216|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2634217|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2634218|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2634219|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2634220|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2634221|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2634222|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2634223|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634224|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2634225|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
2634226|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2634227|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
2634228|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634229|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
2634230|NCT01954108|Protective Agents|protective agents|mesh-ancestor
2634231|NCT01954186|Oxytocin|oxytocin|mesh-list
2634232|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
2634233|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2634234|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634235|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
2634236|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2634237|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
2634238|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2634239|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
2634240|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634241|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634242|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
2634243|NCT01954290|Mannitol|mannitol|mesh-list
2634244|NCT01954290|Conivaptan|conivaptan|mesh-list
2634245|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2634246|NCT01954290|Diuretics|diuretics|mesh-ancestor
2634247|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
2170638|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170639|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170640|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170641|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170642|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
2170643|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170644|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170645|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170646|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
2170647|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170648|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170649|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170650|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170651|NCT00000872|Lamivudine|lamivudine|mesh-list
2170652|NCT00000872|Zidovudine|zidovudine|mesh-list
2170653|NCT00000872|Nevirapine|nevirapine|mesh-list
2170654|NCT00000872|Abacavir|abacavir|mesh-list
2170655|NCT00000872|Stavudine|stavudine|mesh-list
2170656|NCT00000872|Nelfinavir|nelfinavir|mesh-list
2170657|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170658|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2634248|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634249|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2634250|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634251|NCT01954355|Paclitaxel|paclitaxel|mesh-list
2634252|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2634253|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634254|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
2634255|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
2634256|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
2634257|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634258|NCT01954368|Sufentanil|sufentanil|mesh-list
2634259|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2634260|NCT01954368|Narcotics|narcotics|mesh-ancestor
2634261|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2634262|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634263|NCT01954368|Analgesics|analgesics|mesh-ancestor
2634264|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
2634265|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634266|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2634267|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2634268|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
2634269|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
2170659|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170660|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170661|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
2170662|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170663|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170664|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170665|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
2170666|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2170667|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2170668|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2634270|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
2634271|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
2634272|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2634273|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2634274|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634275|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634276|NCT01954524|Urological Agents|urological agents|mesh-ancestor
2634277|NCT01954693|Everolimus|everolimus|mesh-list
2634278|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634279|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2634280|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
2634281|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634282|NCT01954732|Metformin|metformin|mesh-list
2634283|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2170669|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170670|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170671|NCT00000875|Acetaminophen|acetaminophen|mesh-list
2170672|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
2170673|NCT00000875|Promethazine|promethazine|mesh-list
2634284|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634285|NCT01954784|Cyclosporine|cyclosporine|mesh-list
2634286|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
2634287|NCT01954784|Fludarabine|fludarabine|mesh-list
2634288|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
2634289|NCT01954784|Lenalidomide|lenalidomide|mesh-list
2634290|NCT01954784|Bortezomib|bortezomib|mesh-list
2634291|NCT01954784|Cyclosporins|cyclosporins|mesh-list
2634292|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634293|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2634294|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
2634295|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634296|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2634297|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
2170674|NCT00000875|Lamivudine|lamivudine|mesh-list
2170675|NCT00000875|Zidovudine|zidovudine|mesh-list
2170676|NCT00000875|Aldesleukin|aldesleukin|mesh-list
2170677|NCT00000875|Indinavir|indinavir|mesh-list
2170678|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2170679|NCT00000875|Analgesics|analgesics|mesh-ancestor
2170680|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
2170681|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2170682|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170683|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
2170684|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2634298|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634299|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634300|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
2634301|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634302|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
2634303|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2634304|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2634305|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2634306|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2634307|NCT01954784|Growth Substances|growth substances|mesh-ancestor
2634308|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
2634309|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2170685|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170686|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170687|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170688|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
2170689|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170690|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170691|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170692|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
2170693|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170694|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2170695|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2170696|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2170697|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
2634310|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2634311|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
2634312|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2634313|NCT01954914|Plerixafor|plerixafor|mesh-list
2634314|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2634315|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2634316|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
2634317|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634318|NCT01954966|Progesterone|progesterone|mesh-list
2170698|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
2170699|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
2634319|NCT01954966|Progestins|progestins|mesh-ancestor
2634320|NCT01954966|Hormones|hormones|mesh-ancestor
2634321|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2634322|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634331|NCT01954992|Fluorouracil|fluorouracil|mesh-list
2634332|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
2634333|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634334|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2634335|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634336|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2634337|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
2634338|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634339|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
2634340|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
2634341|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634342|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
2170700|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
2170701|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2170702|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2170703|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
2170704|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
2170705|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2170706|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2170707|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
2170708|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
2634343|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634344|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634345|NCT01955070|Ketamine|ketamine|mesh-list
2634346|NCT01955070|Analgesics|analgesics|mesh-ancestor
2634347|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
2634348|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634349|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634350|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2634351|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2634352|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
2634353|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
2634354|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2634355|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2170709|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170710|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170711|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170712|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
2170713|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
2170714|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170715|NCT00000877|Indinavir|indinavir|mesh-list
2170716|NCT00000877|Rifabutin|rifabutin|mesh-list
2170717|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2634356|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2634357|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634358|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634359|NCT01955135|Ketamine|ketamine|mesh-list
2634360|NCT01955135|Propofol|propofol|mesh-list
2634361|NCT01955135|Sevoflurane|sevoflurane|mesh-list
2634362|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2634363|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2634364|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634365|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2634366|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
2634367|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
2634368|NCT01955135|Analgesics|analgesics|mesh-ancestor
2634369|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
2634370|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634371|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2634372|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2634373|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2634374|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2170718|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170719|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170720|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170721|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170722|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170723|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170724|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
2170725|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170726|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2634375|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634376|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2634377|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2634378|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
2634379|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2634380|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2634381|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634382|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
2634383|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634384|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634385|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
2634386|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2634387|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2634388|NCT01955187|Prednisolone|prednisolone|mesh-list
2634389|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
2170727|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2170728|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
2170729|NCT00000878|Lamivudine|lamivudine|mesh-list
2634390|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
2634391|NCT01955187|Rituximab|rituximab|mesh-list
2634392|NCT01955187|Tacrolimus|tacrolimus|mesh-list
2634393|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2634394|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
2634395|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2634396|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
2634397|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634398|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2634399|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2634400|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
2634401|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634402|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634403|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2634404|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2634405|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2634406|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634407|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2634408|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
2634409|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
2634410|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634411|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2634412|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
2634413|NCT01955187|Hormones|hormones|mesh-ancestor
2634414|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2634415|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2634416|NCT01955187|Protective Agents|protective agents|mesh-ancestor
2634417|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2634418|NCT01955200|Cilostazol|cilostazol|mesh-list
2634419|NCT01955200|Clopidogrel|clopidogrel|mesh-list
2634420|NCT01955200|Ticagrelor|ticagrelor|mesh-list
2634421|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2634422|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2634423|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2634424|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2634425|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
2634426|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634427|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634428|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634429|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2634430|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
2634431|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634432|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2634433|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
2634434|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2634435|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2634436|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
2634437|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2634438|NCT01955200|Protective Agents|protective agents|mesh-ancestor
2634439|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2170730|NCT00000878|Zidovudine|zidovudine|mesh-list
2634440|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2634441|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634442|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
2634443|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2634444|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634445|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
2634446|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634447|NCT01955252|Azithromycin|azithromycin|mesh-list
2634448|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2634449|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634450|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
2634451|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2634452|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634453|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
2634454|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
2634455|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
2634456|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634457|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634458|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634459|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2634460|NCT01955421|Gefitinib|gefitinib|mesh-list
2634461|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634462|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2634463|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634464|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634465|NCT01955460|Aldesleukin|aldesleukin|mesh-list
2634466|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
2634467|NCT01955460|Fludarabine|fludarabine|mesh-list
2634468|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
2634469|NCT01955460|Interleukin-2|interleukin-2|mesh-list
2170731|NCT00000878|Stavudine|stavudine|mesh-list
2170732|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170733|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170734|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170735|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170736|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
2170737|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170738|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170739|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2634470|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2634471|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
2634472|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634473|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2634474|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2634475|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
2634476|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634477|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634478|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2634479|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2634480|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
2634481|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2634482|NCT01955460|Analgesics|analgesics|mesh-ancestor
2634483|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
2634484|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634485|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2634486|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2634487|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
2634488|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170740|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
2170741|NCT00000880|Cyclosporine|cyclosporine|mesh-list
2170742|NCT00000880|Cyclosporins|cyclosporins|mesh-list
2170743|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170744|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170745|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2170746|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
2170747|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170748|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
2170749|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170750|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
2170751|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2634497|NCT01955512|Clopidogrel|clopidogrel|mesh-list
2634498|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2634499|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2634500|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2634501|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2634502|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
2634503|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634504|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634505|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634506|NCT01955577|Vitamin D|vitamin d|mesh-list
2634507|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
2634508|NCT01955577|Vitamins|vitamins|mesh-ancestor
2634509|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
2634510|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170752|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2170753|NCT00000881|Cidofovir|cidofovir|mesh-list
2170754|NCT00000881|Probenecid|probenecid|mesh-list
2170755|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
2170756|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
2170757|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2170758|NCT00000881|Renal Agents|renal agents|mesh-ancestor
2170759|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
2170760|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634511|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2634512|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2634513|NCT01955642|Clopidogrel|clopidogrel|mesh-list
2634514|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2634515|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2634516|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2634517|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2634518|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
2634519|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634520|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634521|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634522|NCT01955655|Baclofen|baclofen|mesh-list
2634523|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2634524|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634525|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2634526|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634527|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2634528|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
2634529|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
2634530|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634531|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634532|NCT01955694|Eplerenone|eplerenone|mesh-list
2634533|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2634534|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
2634535|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2634536|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634537|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2634538|NCT01955694|Diuretics|diuretics|mesh-ancestor
2634539|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
2634540|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2634541|NCT01955759|Amiodarone|amiodarone|mesh-list
2634542|NCT01955759|Bisoprolol|bisoprolol|mesh-list
2634543|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2634544|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2634545|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2634546|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2170761|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170762|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170763|NCT00000882|Lamivudine|lamivudine|mesh-list
2170764|NCT00000882|Zidovudine|zidovudine|mesh-list
2170765|NCT00000882|Stavudine|stavudine|mesh-list
2170766|NCT00000882|Delavirdine|delavirdine|mesh-list
2170767|NCT00000882|Indinavir|indinavir|mesh-list
2170768|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170769|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170770|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170771|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170772|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
2170773|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170774|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2634547|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
2634548|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634549|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2634550|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2634551|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634552|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2634553|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
2634554|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2634555|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2634556|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2634557|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2634558|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2634559|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2634560|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2634561|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2634562|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2634563|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
2634564|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634565|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634566|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2634567|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
2634568|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
2634569|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634570|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2634571|NCT01955824|Lidocaine|lidocaine|mesh-list
2634572|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
2634573|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
2634574|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2634575|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634576|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
2634577|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422218|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2422219|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422220|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422221|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
2422222|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422223|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422224|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2422225|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2170775|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170776|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
2170777|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170778|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170779|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170780|NCT00000883|Azithromycin|azithromycin|mesh-list
2170781|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2170782|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170783|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
2170784|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2170785|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
2170786|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170787|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2170788|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170789|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
2170790|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170791|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
2170792|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2170793|NCT00000884|Protective Agents|protective agents|mesh-ancestor
2170794|NCT00000885|Lamivudine|lamivudine|mesh-list
2170795|NCT00000885|Zidovudine|zidovudine|mesh-list
2170796|NCT00000885|Efavirenz|efavirenz|mesh-list
2170797|NCT00000885|Abacavir|abacavir|mesh-list
2170798|NCT00000885|Stavudine|stavudine|mesh-list
2170799|NCT00000885|Didanosine|didanosine|mesh-list
2634578|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2634579|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2634580|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2634581|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2634582|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634583|NCT01955967|Lidocaine|lidocaine|mesh-list
2634584|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
2634585|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
2170800|NCT00000885|Adefovir|adefovir|mesh-list
2170801|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2170802|NCT00000885|Nelfinavir|nelfinavir|mesh-list
2634586|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2634587|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634588|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
2634589|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634590|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2634591|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2634592|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2634593|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2634594|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634595|NCT01955980|Budesonide|budesonide|mesh-list
2634596|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2634597|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2634598|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
2634599|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634600|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634601|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2634602|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
2634603|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
2634604|NCT01955980|Hormones|hormones|mesh-ancestor
2634605|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2634606|NCT01956006|Milrinone|milrinone|mesh-list
2634607|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2634608|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2634609|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
2634610|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2634611|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2634612|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634613|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634614|NCT01956006|Protective Agents|protective agents|mesh-ancestor
2634615|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634616|NCT01956201|Atorvastatin|atorvastatin|mesh-list
2634617|NCT01956201|Fenofibrate|fenofibrate|mesh-list
2634618|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2634619|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2170803|NCT00000885|Indinavir|indinavir|mesh-list
2170804|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170805|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170806|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170807|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170808|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
2170809|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170810|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170811|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170812|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
2170813|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2170814|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2170815|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2170816|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2170817|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2170818|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2170819|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170820|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170821|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170822|NCT00000887|Lamivudine|lamivudine|mesh-list
2170823|NCT00000887|Zidovudine|zidovudine|mesh-list
2170824|NCT00000887|Nelfinavir|nelfinavir|mesh-list
2170825|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2422226|NCT00816543|Docetaxel|docetaxel|mesh-list
2422227|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
2422228|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422229|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
2422230|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
2422231|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
2422232|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422233|NCT00816634|Paclitaxel|paclitaxel|mesh-list
2422234|NCT00816634|Capecitabine|capecitabine|mesh-list
2422235|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2422236|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422237|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
2422238|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
2422239|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
2422240|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422241|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2170826|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170827|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170828|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170829|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
2170830|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170831|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170832|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170833|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
2170834|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170835|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170836|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
2634620|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
2634621|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634622|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2634623|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2634624|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634625|NCT01956305|Metformin|metformin|mesh-list
2634626|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2634627|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634628|NCT01956474|Riboflavin|riboflavin|mesh-list
2634629|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
2634630|NCT01956474|Vitamins|vitamins|mesh-ancestor
2634631|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
2634632|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634633|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2634634|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
2634635|NCT01956487|Propafenone|propafenone|mesh-list
2634636|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2634637|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2634638|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2634639|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2634640|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634641|NCT01956591|Oxybutynin|oxybutynin|mesh-list
2634642|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
2634643|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
2634644|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634645|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634646|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2634647|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2634648|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
2170837|NCT00000888|Ritonavir|ritonavir|mesh-list
2170838|NCT00000888|Lamivudine|lamivudine|mesh-list
2170839|NCT00000888|Zidovudine|zidovudine|mesh-list
2170840|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170841|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170842|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170843|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170844|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170845|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170846|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170847|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
2170848|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170849|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2634649|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634650|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634651|NCT01956591|Urological Agents|urological agents|mesh-ancestor
2634652|NCT01956604|Clonidine|clonidine|mesh-list
2634653|NCT01956604|Analgesics|analgesics|mesh-ancestor
2634654|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
2634655|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634656|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634657|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2634658|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
2634659|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
2634660|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2634661|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2634662|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2634663|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
2634664|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634665|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634666|NCT01956695|Rituximab|rituximab|mesh-list
2634667|NCT01956695|Lenalidomide|lenalidomide|mesh-list
2634668|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2634669|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170850|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2634670|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
2634671|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634672|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2634673|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2634674|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2634675|NCT01956695|Growth Substances|growth substances|mesh-ancestor
2634676|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
2634677|NCT01956734|Temozolomide|temozolomide|mesh-list
2634678|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2634679|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
2634680|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634681|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634682|NCT01956786|Amlodipine|amlodipine|mesh-list
2634683|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2634684|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2634685|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2634686|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634687|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2634688|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634689|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
2634690|NCT01956812|Gemcitabine|gemcitabine|mesh-list
2634691|NCT01956812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2634692|NCT01956812|Antimetabolites|antimetabolites|mesh-ancestor
2634693|NCT01956812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634694|NCT01956812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634695|NCT01956812|Antiviral Agents|antiviral agents|mesh-ancestor
2170851|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170852|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170853|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
2170854|NCT00000889|Aldesleukin|aldesleukin|mesh-list
2170855|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170856|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170857|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170858|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
2170859|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634696|NCT01956812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634697|NCT01956812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634698|NCT01956812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2634699|NCT01956812|Immunologic Factors|immunologic factors|mesh-ancestor
2634700|NCT01956812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634701|NCT01956864|Vitamin D|vitamin d|mesh-list
2634702|NCT01956864|Vitamins|vitamins|mesh-ancestor
2634703|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
2634704|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634705|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2634706|NCT01956929|Metformin|metformin|mesh-list
2634707|NCT01956929|Lactulose|lactulose|mesh-list
2634708|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2634709|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634710|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2634711|NCT01956955|Heparin|heparin|mesh-list
2634712|NCT01956955|Enoxaparin|enoxaparin|mesh-list
2634713|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2634714|NCT01956955|Calcium heparin|calcium heparin|mesh-list
2634715|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
2634716|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2634717|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2634718|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634719|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
2634720|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
2634721|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2634722|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2634723|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634724|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2634725|NCT01956981|Analgesics|analgesics|mesh-ancestor
2634726|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
2634727|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634728|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2634729|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2634730|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2634731|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
2170860|NCT00000891|Ritonavir|ritonavir|mesh-list
2170861|NCT00000891|Saquinavir|saquinavir|mesh-list
2170862|NCT00000891|Lamivudine|lamivudine|mesh-list
2170863|NCT00000891|Zidovudine|zidovudine|mesh-list
2170864|NCT00000891|Stavudine|stavudine|mesh-list
2170865|NCT00000891|Didanosine|didanosine|mesh-list
2634732|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634733|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634734|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
2634735|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2634736|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
2634737|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2634738|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2634739|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2634740|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
2634741|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2634742|NCT01957007|Docetaxel|docetaxel|mesh-list
2634743|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634744|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
2634745|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
2634746|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
2634747|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634748|NCT01957046|Laxatives|laxatives|mesh-list
2634749|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2634750|NCT01957189|Tamsulosin|tamsulosin|mesh-list
2634751|NCT01957189|Dutasteride|dutasteride|mesh-list
2634752|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2634753|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2634754|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2634755|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
2634756|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634757|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634758|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634759|NCT01957189|Urological Agents|urological agents|mesh-ancestor
2634760|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2634761|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2634762|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634763|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
2634764|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2634765|NCT01957293|Albuterol|albuterol|mesh-list
2634766|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2634767|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
2634768|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634769|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634770|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2634771|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
2634772|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
2634773|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2634774|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2634775|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2634776|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2634777|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
2634778|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634779|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634780|NCT01957319|Vitamin E|vitamin e|mesh-list
2634781|NCT01957319|Silybin|silybin|mesh-list
2634782|NCT01957319|Vitamins|vitamins|mesh-ancestor
2634783|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
2634784|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634785|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
2634786|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634787|NCT01957319|Protective Agents|protective agents|mesh-ancestor
2634788|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2634789|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634793|NCT01957436|Docetaxel|docetaxel|mesh-list
2634794|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
2634795|NCT01957436|Androgens|androgens|mesh-list
2634796|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634797|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
2634798|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
2634799|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
2170866|NCT00000891|Delavirdine|delavirdine|mesh-list
2170867|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170868|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170869|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170870|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170871|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634800|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634801|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2634802|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634803|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
2634804|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2634805|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634806|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2634807|NCT01957436|Hormones|hormones|mesh-ancestor
2170872|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170873|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170874|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
2170875|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170876|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2170877|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2170878|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170879|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170880|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
2170881|NCT00000892|Ritonavir|ritonavir|mesh-list
2170882|NCT00000892|Nelfinavir|nelfinavir|mesh-list
2170883|NCT00000892|Saquinavir|saquinavir|mesh-list
2170884|NCT00000892|Delavirdine|delavirdine|mesh-list
2634808|NCT01957449|Propranolol|propranolol|mesh-list
2634809|NCT01957449|Metoprolol|metoprolol|mesh-list
2634810|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2634811|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2634812|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
2634813|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634814|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634815|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634816|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2634817|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2634818|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
2634819|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
2634820|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
2170885|NCT00000892|Adefovir|adefovir|mesh-list
2170886|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2170887|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170888|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170889|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170890|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170891|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170892|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170893|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170894|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
2634821|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634822|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2634823|NCT01957540|Ticagrelor|ticagrelor|mesh-list
2634824|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2634825|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2634826|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2170895|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170896|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2170897|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2170898|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170899|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170900|NCT00000893|Efavirenz|efavirenz|mesh-list
2170901|NCT00000893|Nelfinavir|nelfinavir|mesh-list
2170902|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170903|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170904|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170905|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170906|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
2170907|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170908|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2170909|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2170910|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2170911|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2170912|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2634827|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2634828|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2634829|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
2634830|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2170913|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2170914|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2634831|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634832|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634833|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
2634834|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2634835|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2634836|NCT01957631|Prednisolone|prednisolone|mesh-list
2634837|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
2634838|NCT01957631|Bupivacaine|bupivacaine|mesh-list
2634839|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2634840|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
2634841|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
2634842|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
2634843|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2634844|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634845|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
2634846|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634847|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2634848|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
2634849|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
2634850|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2634851|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
2634852|NCT01957631|Hormones|hormones|mesh-ancestor
2170915|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170916|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170917|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170918|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170919|NCT00000894|Ganciclovir|ganciclovir|mesh-list
2170920|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2170921|NCT00000894|Cidofovir|cidofovir|mesh-list
2170922|NCT00000894|Probenecid|probenecid|mesh-list
2170923|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
2170924|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170925|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170926|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170927|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170928|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
2170929|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
2170930|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2170931|NCT00000894|Renal Agents|renal agents|mesh-ancestor
2170932|NCT00000895|Azithromycin|azithromycin|mesh-list
2170933|NCT00000895|Nevirapine|nevirapine|mesh-list
2170934|NCT00000895|Nelfinavir|nelfinavir|mesh-list
2170935|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2170936|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170937|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2634853|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2634854|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2634855|NCT01957631|Protective Agents|protective agents|mesh-ancestor
2634856|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2634857|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634858|NCT01957839|Cabergoline|cabergoline|mesh-list
2634859|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2634860|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2634861|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
2634862|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
2634863|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634864|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170938|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170939|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170940|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170941|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
2170942|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170943|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170944|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2170945|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2634865|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634866|NCT01957852|Thrombin|thrombin|mesh-list
2634867|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
2634868|NCT01957852|Coagulants|coagulants|mesh-ancestor
2634869|NCT01957943|SMOFlipid|smoflipid|mesh-list
2634870|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2634871|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2634872|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2170946|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170947|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170948|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170949|NCT00000896|Lamivudine|lamivudine|mesh-list
2170950|NCT00000896|Zidovudine|zidovudine|mesh-list
2170951|NCT00000896|Nevirapine|nevirapine|mesh-list
2170952|NCT00000896|Stavudine|stavudine|mesh-list
2170953|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2170954|NCT00000896|Indinavir|indinavir|mesh-list
2170955|NCT00000896|Interleukin-12|interleukin-12|mesh-list
2170956|NCT00000896|Sargramostim|sargramostim|mesh-list
2170957|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2170958|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170959|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170960|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170961|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
2170962|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170963|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170964|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2634873|NCT01957956|Temozolomide|temozolomide|mesh-list
2634874|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2634875|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
2634876|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634877|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634878|NCT01957995|Docetaxel|docetaxel|mesh-list
2634879|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634880|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
2634881|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
2634882|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
2634883|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634884|NCT01958138|Propofol|propofol|mesh-list
2634885|NCT01958138|Isoflurane|isoflurane|mesh-list
2634886|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2634887|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2634888|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634889|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2634890|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
2634891|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
2634892|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2634893|NCT01958190|Sirolimus|sirolimus|mesh-list
2634894|NCT01958190|Tacrolimus|tacrolimus|mesh-list
2634895|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2634896|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
2634897|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634898|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2634899|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634900|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634901|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2634902|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634903|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2634904|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634905|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
2170965|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
2170966|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
2170967|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2170968|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2170969|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2170970|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2170971|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170972|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170973|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170974|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2170975|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2170976|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2634906|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2634907|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2634908|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2634909|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2634910|NCT01958372|Etoposide|etoposide|mesh-list
2634911|NCT01958372|Pemetrexed|pemetrexed|mesh-list
2634912|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634913|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2634914|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2170977|NCT00000896|Growth Substances|growth substances|mesh-ancestor
2170978|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
2170979|NCT00000897|Zidovudine|zidovudine|mesh-list
2170980|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
2170981|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170982|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2634915|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2634916|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634917|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634918|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2634919|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2634920|NCT01958580|Gemcitabine|gemcitabine|mesh-list
2634921|NCT01958580|Docetaxel|docetaxel|mesh-list
2634922|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2634923|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
2634924|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634925|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2634926|NCT01958580|Antiviral Agents|antiviral agents|mesh-ancestor
2634927|NCT01958580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634928|NCT01958580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2634929|NCT01958580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2634930|NCT01958580|Immunologic Factors|immunologic factors|mesh-ancestor
2634931|NCT01958580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634932|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
2634933|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
2634934|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
2634935|NCT01958684|Copper|copper|mesh-list
2634936|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
2634937|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2634938|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
2422242|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
2422243|NCT00816660|Factor VIII|factor viii|mesh-list
2422244|NCT00816660|Coagulants|coagulants|mesh-ancestor
2422245|NCT00816673|Melatonin|melatonin|mesh-list
2422246|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
2422247|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422248|NCT00816673|Protective Agents|protective agents|mesh-ancestor
2422249|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422250|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2422251|NCT00816699|Anesthetics|anesthetics|mesh-list
2422252|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2422253|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422254|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
2422255|NCT00816712|Testosterone|testosterone|mesh-list
2422256|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
2422257|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
2422258|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2422259|NCT00816712|Androgens|androgens|mesh-ancestor
2422260|NCT00816712|Hormones|hormones|mesh-ancestor
2422261|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2422262|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634939|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2634940|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634941|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2634942|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2634943|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2634944|NCT01958684|Trace Elements|trace elements|mesh-ancestor
2634945|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
2634946|NCT01958775|Glucagon|glucagon|mesh-list
2634947|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2634948|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2634949|NCT01958775|Hormones|hormones|mesh-ancestor
2634950|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2634951|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634952|NCT01958775|Incretins|incretins|mesh-ancestor
2634953|NCT01958814|Albuterol|albuterol|mesh-list
2634954|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2634955|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
2634956|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634957|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634958|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2634959|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
2634960|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
2634961|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2634962|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2634963|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2634964|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2634965|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
2634966|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634967|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634968|NCT01958866|Acetaminophen|acetaminophen|mesh-list
2634969|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2634970|NCT01958866|Analgesics|analgesics|mesh-ancestor
2634971|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
2634972|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634973|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634974|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
2634975|NCT01958905|Lumefantrine|lumefantrine|mesh-list
2634976|NCT01958905|Artemether|artemether|mesh-list
2634977|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2634978|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
2634979|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2634980|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2634981|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2634982|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
2634983|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2634984|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
2634985|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2634986|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2634987|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2634988|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
2634989|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2634990|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
2634991|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2634992|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2634993|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2634994|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
2634995|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
2634996|NCT01958944|Protective Agents|protective agents|mesh-ancestor
2634997|NCT01958996|Idarubicin|idarubicin|mesh-list
2634998|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2634999|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635000|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2635001|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2635002|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635003|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635004|NCT01959022|Doxazosin|doxazosin|mesh-list
2635005|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2635006|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2635007|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2170983|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2170984|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635008|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2635009|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
2635010|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635011|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635012|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635013|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
2635014|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
2635015|NCT01959061|Raltitrexed|raltitrexed|mesh-list
2635016|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635017|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2635018|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
2635019|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635020|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2635021|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635022|NCT01959074|Aceclofenac|aceclofenac|mesh-list
2635023|NCT01959074|Naftopidil|naftopidil|mesh-list
2635024|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2170985|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
2170986|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2170987|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170988|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170989|NCT00000898|Ritonavir|ritonavir|mesh-list
2170990|NCT00000898|Nelfinavir|nelfinavir|mesh-list
2170991|NCT00000898|Saquinavir|saquinavir|mesh-list
2170992|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2170993|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2170994|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
2170995|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2170996|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2170997|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2170998|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2170999|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
2171000|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2635025|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2635026|NCT01959074|Analgesics|analgesics|mesh-ancestor
2171001|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171002|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171003|NCT00000899|Lamivudine|lamivudine|mesh-list
2171004|NCT00000899|Stavudine|stavudine|mesh-list
2171005|NCT00000899|Nelfinavir|nelfinavir|mesh-list
2171006|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
2635027|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
2635028|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635029|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171007|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2171008|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
2171009|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171010|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2171011|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2171012|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
2171013|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171014|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171015|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2171016|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171017|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171018|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171019|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
2171020|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171021|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171022|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171023|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
2171024|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171025|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171026|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171027|NCT00000901|Lamivudine|lamivudine|mesh-list
2171028|NCT00000901|Stavudine|stavudine|mesh-list
2171029|NCT00000901|Indinavir|indinavir|mesh-list
2635030|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2635031|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2635032|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2635033|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2635034|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
2635035|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635036|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635037|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2635038|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2635039|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2635040|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2635041|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2635042|NCT01959100|Azithromycin|azithromycin|mesh-list
2635043|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2635044|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2635045|NCT01959152|Imidacloprid|imidacloprid|mesh-list
2635046|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
2635047|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635048|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635049|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635050|NCT01959191|Aspirin|aspirin|mesh-list
2635051|NCT01959191|Clopidogrel|clopidogrel|mesh-list
2635052|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2635053|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2171030|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171031|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171032|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171033|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171034|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
2171035|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171036|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171037|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171038|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
2171039|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171040|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171041|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171042|NCT00000902|Ritonavir|ritonavir|mesh-list
2171043|NCT00000902|Nelfinavir|nelfinavir|mesh-list
2171044|NCT00000902|Lamivudine|lamivudine|mesh-list
2171045|NCT00000902|Zidovudine|zidovudine|mesh-list
2171046|NCT00000902|Nevirapine|nevirapine|mesh-list
2171047|NCT00000902|Stavudine|stavudine|mesh-list
2171048|NCT00000902|Didanosine|didanosine|mesh-list
2171049|NCT00000902|Zalcitabine|zalcitabine|mesh-list
2171050|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171051|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171052|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171053|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171054|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171055|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171056|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171057|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
2171058|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171059|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171060|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171061|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171062|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171063|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
2171064|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2171065|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2171066|NCT00000903|Lamivudine|lamivudine|mesh-list
2171067|NCT00000903|Zidovudine|zidovudine|mesh-list
2171068|NCT00000903|Efavirenz|efavirenz|mesh-list
2171069|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2635054|NCT01959191|Analgesics|analgesics|mesh-ancestor
2635055|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
2635056|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635057|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635058|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2635059|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2635060|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2635061|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2635062|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635063|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2635064|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2635065|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635066|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
2635067|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2635068|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2635069|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2635070|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
2635071|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635072|NCT01959204|Oxycodone|oxycodone|mesh-list
2635073|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2635074|NCT01959204|Narcotics|narcotics|mesh-ancestor
2635075|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635076|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635077|NCT01959204|Analgesics|analgesics|mesh-ancestor
2635078|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
2635079|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635080|NCT01959282|Niacinamide|niacinamide|mesh-list
2635081|NCT01959282|Peficitinib|peficitinib|mesh-list
2635082|NCT01959282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635083|NCT01959282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635084|NCT01959282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2635085|NCT01959282|Immunologic Factors|immunologic factors|mesh-ancestor
2635086|NCT01959282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635087|NCT01959282|Vitamin B Complex|vitamin b complex|mesh-ancestor
2635088|NCT01959282|Vitamins|vitamins|mesh-ancestor
2635089|NCT01959282|Micronutrients|micronutrients|mesh-ancestor
2635090|NCT01959386|Trastuzumab|trastuzumab|mesh-list
2171070|NCT00000903|Nelfinavir|nelfinavir|mesh-list
2171071|NCT00000903|Indinavir|indinavir|mesh-list
2171072|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171073|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171074|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171075|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171076|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
2171077|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171078|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171079|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171080|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
2171081|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2171082|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171083|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2171084|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2171085|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2171086|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2171087|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171088|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171089|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171090|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
2171091|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2171092|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
2171093|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171094|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2171095|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171096|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
2171097|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171098|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
2171099|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2171100|NCT00000904|Protective Agents|protective agents|mesh-ancestor
2171101|NCT00000906|Ritonavir|ritonavir|mesh-list
2171102|NCT00000906|Saquinavir|saquinavir|mesh-list
2171103|NCT00000906|Methadone|methadone|mesh-list
2171104|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2635091|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2635092|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635093|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2635094|NCT01959399|Peficitinib|peficitinib|mesh-list
2635095|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2635096|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2635097|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
2635098|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635099|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2635100|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2635101|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635102|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2635103|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
2635104|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635105|NCT01959438|Selenious Acid|selenious acid|mesh-list
2635106|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
2635107|NCT01959438|Trace Elements|trace elements|mesh-ancestor
2635108|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
2171105|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171106|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171107|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171108|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171109|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171110|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171111|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
2171112|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171113|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171114|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171115|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2635109|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635110|NCT01959451|Clopidogrel|clopidogrel|mesh-list
2635111|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2635112|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2635113|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2635114|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2635115|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2635116|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
2635117|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635118|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171116|NCT00000906|Narcotics|narcotics|mesh-ancestor
2171117|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2171118|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171119|NCT00000906|Analgesics|analgesics|mesh-ancestor
2171120|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
2171121|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2171122|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
2171123|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
2171124|NCT00000909|Aldesleukin|aldesleukin|mesh-list
2171125|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171126|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171127|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171128|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
2171129|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171130|NCT00000912|Efavirenz|efavirenz|mesh-list
2171131|NCT00000912|Abacavir|abacavir|mesh-list
2171132|NCT00000912|Adefovir|adefovir|mesh-list
2171133|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2171134|NCT00000912|Nelfinavir|nelfinavir|mesh-list
2171135|NCT00000912|Indinavir|indinavir|mesh-list
2171136|NCT00000912|Saquinavir|saquinavir|mesh-list
2171137|NCT00000912|Amprenavir|amprenavir|mesh-list
2635119|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635120|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
2635121|NCT01959477|Busulfan|busulfan|mesh-list
2635122|NCT01959477|Etoposide|etoposide|mesh-list
2635123|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
2635124|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2635125|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
2635126|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635127|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2635128|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2635129|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
2635130|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635131|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635132|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2635133|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2635134|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2635135|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2635136|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635137|NCT01959633|Interferons|interferons|mesh-list
2635138|NCT01959633|Vemurafenib|vemurafenib|mesh-list
2635139|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635140|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
2171138|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171139|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171140|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635141|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2635142|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2635143|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635144|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635145|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
2635146|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2171141|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171142|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
2171143|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171144|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2635147|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
2635148|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635149|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635150|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2635151|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
2635152|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2171145|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171146|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2171147|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2171148|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2171149|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2171150|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171151|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171152|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171153|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171154|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171155|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171156|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2171157|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
2171158|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2635153|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
2635154|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635155|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635156|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2635157|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
2635158|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
2635159|NCT01959828|Protective Agents|protective agents|mesh-ancestor
2635160|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2635161|NCT01959854|Laxatives|laxatives|mesh-ancestor
2635162|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2635163|NCT01960010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2635164|NCT01960010|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2635165|NCT01960023|Cetuximab|cetuximab|mesh-list
2635166|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2635167|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635168|NCT01960049|Ropivacaine|ropivacaine|mesh-list
2635169|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
2635170|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
2635171|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2171159|NCT00000913|Ritonavir|ritonavir|mesh-list
2171160|NCT00000913|Nelfinavir|nelfinavir|mesh-list
2171161|NCT00000913|Saquinavir|saquinavir|mesh-list
2171162|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171163|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171164|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171165|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171166|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635172|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635173|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
2635174|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635175|NCT01960153|Tadalafil|tadalafil|mesh-list
2635176|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
2635177|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2635178|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2635179|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635180|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635181|NCT01960153|Urological Agents|urological agents|mesh-ancestor
2171167|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171168|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171169|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
2171170|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171171|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171172|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171173|NCT00000914|Ritonavir|ritonavir|mesh-list
2171174|NCT00000914|Nelfinavir|nelfinavir|mesh-list
2635182|NCT01960179|Lixisenatide|lixisenatide|mesh-list
2635183|NCT01960179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2635184|NCT01960179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635185|NCT01960205|Metformin|metformin|mesh-list
2635186|NCT01960205|Saxagliptin|saxagliptin|mesh-list
2635187|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2635188|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635189|NCT01960205|Incretins|incretins|mesh-ancestor
2635190|NCT01960205|Hormones|hormones|mesh-ancestor
2635191|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2635192|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2635193|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
2635194|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635195|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635196|NCT01960283|Methotrexate|methotrexate|mesh-list
2635197|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2635198|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
2635199|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2635200|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635201|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2635202|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
2635203|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635204|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635205|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
2171175|NCT00000914|Indinavir|indinavir|mesh-list
2171176|NCT00000914|Efavirenz|efavirenz|mesh-list
2171177|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171178|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171179|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171180|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171181|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171182|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171183|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171184|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
2171185|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171186|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171187|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171188|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171189|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171190|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2171191|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2171192|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2171193|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2171194|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2171195|NCT00000916|Lamivudine|lamivudine|mesh-list
2171196|NCT00000916|Zidovudine|zidovudine|mesh-list
2171197|NCT00000916|Stavudine|stavudine|mesh-list
2171198|NCT00000916|Didanosine|didanosine|mesh-list
2171199|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2635206|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635207|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2635208|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2635209|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
2635210|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2635211|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2635212|NCT01960426|Adalimumab|adalimumab|mesh-list
2635213|NCT01960426|Infliximab|infliximab|mesh-list
2635214|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2635215|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2171200|NCT00000916|Indinavir|indinavir|mesh-list
2171201|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
2171202|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171203|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171204|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171205|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171206|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
2171207|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171208|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171209|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171210|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
2171211|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171212|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
2171213|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171214|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171215|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171216|NCT00000918|Ritonavir|ritonavir|mesh-list
2171217|NCT00000918|Indinavir|indinavir|mesh-list
2171218|NCT00000918|Saquinavir|saquinavir|mesh-list
2171219|NCT00000918|Amprenavir|amprenavir|mesh-list
2171220|NCT00000918|Lamivudine|lamivudine|mesh-list
2171221|NCT00000918|Zidovudine|zidovudine|mesh-list
2171222|NCT00000918|Stavudine|stavudine|mesh-list
2171223|NCT00000918|Didanosine|didanosine|mesh-list
2171224|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2171225|NCT00000918|Efavirenz|efavirenz|mesh-list
2171226|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171227|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171228|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171229|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171230|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171231|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171232|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171233|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
2171234|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171235|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171236|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171237|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2635216|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
2635217|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2635218|NCT01960543|Fentanyl|fentanyl|mesh-list
2635219|NCT01960543|Bupivacaine|bupivacaine|mesh-list
2635220|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
2635221|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
2635222|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
2635223|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635224|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635225|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
2635226|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635227|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2635228|NCT01960543|Narcotics|narcotics|mesh-ancestor
2635229|NCT01960543|Analgesics|analgesics|mesh-ancestor
2635230|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2635231|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2635232|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
2635233|NCT01960569|Hirudins|hirudins|mesh-list
2635234|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
2635235|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2635236|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
2635237|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635238|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635239|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
2635240|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2635241|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2635242|NCT01960595|Fentanyl|fentanyl|mesh-list
2635243|NCT01960595|Bupivacaine|bupivacaine|mesh-list
2635244|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
2171238|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2635245|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
2635246|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2171239|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
2171240|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2171241|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2171242|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2171243|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2171244|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2171245|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2171246|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
2171247|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2171248|NCT00000919|Ritonavir|ritonavir|mesh-list
2171249|NCT00000919|Nelfinavir|nelfinavir|mesh-list
2635247|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635248|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
2635249|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635250|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2635251|NCT01960595|Narcotics|narcotics|mesh-ancestor
2635252|NCT01960595|Analgesics|analgesics|mesh-ancestor
2635253|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2635254|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2635255|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
2635256|NCT01960647|Paclitaxel|paclitaxel|mesh-list
2635257|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2635258|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635259|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
2635260|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
2635261|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
2171250|NCT00000919|Indinavir|indinavir|mesh-list
2171251|NCT00000919|Amprenavir|amprenavir|mesh-list
2171252|NCT00000919|Lamivudine|lamivudine|mesh-list
2171253|NCT00000919|Zidovudine|zidovudine|mesh-list
2171254|NCT00000919|Abacavir|abacavir|mesh-list
2171255|NCT00000919|Stavudine|stavudine|mesh-list
2171256|NCT00000919|Didanosine|didanosine|mesh-list
2171257|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2171258|NCT00000919|Efavirenz|efavirenz|mesh-list
2171259|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
2171260|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171261|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171262|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171263|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171264|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171265|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171266|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171267|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
2171268|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171269|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171270|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171271|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171272|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171273|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
2171274|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2171275|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2171276|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2635262|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635263|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2635264|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2635265|NCT01960829|Everolimus|everolimus|mesh-list
2635266|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635267|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2171277|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2171278|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2171279|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171280|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
2171281|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2171282|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
2171283|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2171284|NCT00000920|Ritonavir|ritonavir|mesh-list
2171285|NCT00000920|Saquinavir|saquinavir|mesh-list
2171286|NCT00000920|Lamivudine|lamivudine|mesh-list
2171287|NCT00000920|Zidovudine|zidovudine|mesh-list
2635268|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
2635269|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635270|NCT01961063|Busulfan|busulfan|mesh-list
2635271|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
2635272|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171288|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171289|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2635273|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2635274|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
2635275|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635276|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2635277|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635278|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2635279|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2635280|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2635281|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2635282|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
2635283|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2635284|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
2635285|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635286|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635287|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
2635288|NCT01961154|Hormones|hormones|mesh-ancestor
2635289|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2635290|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
2635291|NCT01961180|Citalopram|citalopram|mesh-list
2635292|NCT01961180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2635293|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2635294|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2635295|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635296|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635297|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
2635298|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635299|NCT01961180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2635300|NCT01961180|Antidepressive Agents|antidepressive agents|mesh-ancestor
2635301|NCT01961180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2635302|NCT01961193|Silicon|silicon|mesh-list
2171290|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171291|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171292|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171293|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171294|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171295|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
2171296|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171297|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171298|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171299|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171300|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171301|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
2171302|NCT00000921|Prednisone|prednisone|mesh-list
2171303|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2171304|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
2635303|NCT01961193|Trace Elements|trace elements|mesh-ancestor
2635304|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
2635305|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635306|NCT01961219|Anesthetics|anesthetics|mesh-list
2635307|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635308|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635309|NCT01961336|Testosterone|testosterone|mesh-list
2635310|NCT01961336|Androgens|androgens|mesh-ancestor
2635311|NCT01961336|Hormones|hormones|mesh-ancestor
2635312|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2635313|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635314|NCT01961388|Metformin|metformin|mesh-list
2635315|NCT01961388|Acarbose|acarbose|mesh-list
2635316|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2635317|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635318|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2635319|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635320|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635321|NCT01961414|Aflibercept|aflibercept|mesh-list
2635322|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2635323|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2635324|NCT01961414|Growth Substances|growth substances|mesh-ancestor
2635325|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635326|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
2635327|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635328|NCT01961453|Isosorbide|isosorbide|mesh-list
2635329|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2635330|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2171305|NCT00000921|Hormones|hormones|mesh-ancestor
2635331|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2635332|NCT01961453|Diuretics|diuretics|mesh-ancestor
2635333|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
2635334|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635335|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
2635336|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2635337|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635338|NCT01961635|Cimetidine|cimetidine|mesh-list
2635339|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2635340|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2635341|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2635342|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
2635343|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
2635344|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635345|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635346|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635347|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2635348|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2635349|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635350|NCT01961739|Lidocaine|lidocaine|mesh-list
2635351|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
2635352|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
2635353|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635354|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635355|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
2635356|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635357|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2635358|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2635359|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2635360|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2635361|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635362|NCT01961752|Triamcinolone|triamcinolone|mesh-list
2635363|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2635364|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2635365|NCT01961752|Bupivacaine|bupivacaine|mesh-list
2635366|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2635367|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
2635368|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
2635369|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635370|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635371|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
2635372|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635373|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2635374|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
2635375|NCT01961752|Hormones|hormones|mesh-ancestor
2635376|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2635377|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2635378|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
2635379|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635380|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635381|NCT01961830|Arbekacin|arbekacin|mesh-list
2635382|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2635383|NCT01961843|Prednisone|prednisone|mesh-list
2635384|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
2635385|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2635386|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
2635387|NCT01961843|Hormones|hormones|mesh-ancestor
2635388|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2635389|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635390|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2635391|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635392|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2635393|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635394|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635395|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
2635396|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2635397|NCT01961856|Clopidogrel|clopidogrel|mesh-list
2635398|NCT01961856|Ticagrelor|ticagrelor|mesh-list
2635399|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2635400|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2635401|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2635402|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2635403|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
2635404|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635405|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635406|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635407|NCT01961947|Vaccines|vaccines|mesh-list
2635408|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
2635409|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635410|NCT01962116|Heparin|heparin|mesh-list
2635411|NCT01962116|Calcium heparin|calcium heparin|mesh-list
2635412|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
2635413|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635414|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2635415|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2635416|NCT01962181|Methylphenidate|methylphenidate|mesh-list
2635417|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2635418|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635419|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2635420|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2171306|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2171307|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171308|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2171309|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171310|NCT00000922|Lamivudine|lamivudine|mesh-list
2171311|NCT00000922|Efavirenz|efavirenz|mesh-list
2171312|NCT00000922|Nevirapine|nevirapine|mesh-list
2171313|NCT00000922|Abacavir|abacavir|mesh-list
2171314|NCT00000922|Stavudine|stavudine|mesh-list
2171315|NCT00000922|Didanosine|didanosine|mesh-list
2171316|NCT00000922|Nelfinavir|nelfinavir|mesh-list
2171317|NCT00000922|Indinavir|indinavir|mesh-list
2171318|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171319|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171320|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171321|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171322|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
2171323|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171324|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171325|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171326|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2171327|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171328|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2171329|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2171330|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2171331|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2171332|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
2171333|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171334|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171335|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
2635421|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2635422|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635423|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
2635424|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635425|NCT01962246|Capecitabine|capecitabine|mesh-list
2635426|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
2635427|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2635428|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
2635429|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635430|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635431|NCT01962285|Propofol|propofol|mesh-list
2635432|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2635433|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635434|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635435|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2635436|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
2635437|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
2171336|NCT00000923|Lamivudine|lamivudine|mesh-list
2171337|NCT00000923|Zidovudine|zidovudine|mesh-list
2171338|NCT00000923|Stavudine|stavudine|mesh-list
2171339|NCT00000923|Didanosine|didanosine|mesh-list
2635438|NCT01962363|Tocotrienols|tocotrienols|mesh-list
2635439|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
2635440|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
2635441|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635442|NCT01962363|Protective Agents|protective agents|mesh-ancestor
2635443|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171340|NCT00000923|Aldesleukin|aldesleukin|mesh-list
2171341|NCT00000923|Indinavir|indinavir|mesh-list
2171342|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171343|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171344|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171345|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171346|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
2171347|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171348|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171349|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171350|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
2171351|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171352|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171353|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171354|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171355|NCT00000924|Ritonavir|ritonavir|mesh-list
2171356|NCT00000924|Nelfinavir|nelfinavir|mesh-list
2171357|NCT00000924|Nevirapine|nevirapine|mesh-list
2171358|NCT00000924|Stavudine|stavudine|mesh-list
2171359|NCT00000924|Didanosine|didanosine|mesh-list
2171360|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171361|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171362|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
2635444|NCT01962363|Vitamins|vitamins|mesh-ancestor
2635445|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
2635446|NCT01962376|Bevacizumab|bevacizumab|mesh-list
2635447|NCT01962376|Capecitabine|capecitabine|mesh-list
2635448|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
2635449|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2635450|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635451|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2635452|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2635453|NCT01962376|Growth Substances|growth substances|mesh-ancestor
2635454|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635455|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
2635456|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2635457|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
2635458|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635459|NCT01962415|Fludarabine|fludarabine|mesh-list
2635460|NCT01962415|Melphalan|melphalan|mesh-list
2635461|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
2635462|NCT01962415|Thiotepa|thiotepa|mesh-list
2635463|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
2635464|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635465|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635466|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2171363|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171364|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171365|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171366|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171367|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
2171368|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171369|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171370|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2635467|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
2635468|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635469|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2635470|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
2635471|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2635472|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2635473|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
2635474|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635475|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2635476|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
2635477|NCT01962454|Testosterone|testosterone|mesh-list
2635478|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
2635479|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
2635480|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2171371|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171372|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171373|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2171374|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2171375|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
2171376|NCT00000926|Nonoxynol|nonoxynol|mesh-list
2171377|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2171378|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2171379|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635481|NCT01962454|Androgens|androgens|mesh-ancestor
2635482|NCT01962454|Hormones|hormones|mesh-ancestor
2635483|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2635484|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635485|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2635486|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635487|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
2635488|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
2635489|NCT01962571|Hematinics|hematinics|mesh-ancestor
2635490|NCT01962636|Cyclosporine|cyclosporine|mesh-list
2635491|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
2635492|NCT01962636|Fludarabine|fludarabine|mesh-list
2635493|NCT01962636|Cyclosporins|cyclosporins|mesh-list
2635494|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2635495|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
2635496|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635497|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2635498|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2635499|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
2635500|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635501|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635502|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2635503|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635504|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
2635505|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2635506|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
2635507|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2635520|NCT01962831|Dinoprostone|dinoprostone|mesh-list
2635521|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
2635522|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2635523|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635524|NCT01962948|Paclitaxel|paclitaxel|mesh-list
2635525|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2635526|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635527|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
2635528|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
2635529|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
2635530|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635531|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2635532|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
2635533|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2635534|NCT01963039|Protective Agents|protective agents|mesh-ancestor
2635535|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635536|NCT01963182|Irinotecan|irinotecan|mesh-list
2635537|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2635538|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2635539|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635540|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635541|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635542|NCT01963208|Ganaxolone|ganaxolone|mesh-list
2635543|NCT01963208|Neurosteroids|neurosteroids|mesh-ancestor
2635544|NCT01963208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635545|NCT01963208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635546|NCT01963208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635547|NCT01963208|GABA Modulators|gaba modulators|mesh-ancestor
2171380|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2171381|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
2171382|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2171383|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2171384|NCT00000929|Nonoxynol|nonoxynol|mesh-list
2171385|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2171386|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2171387|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171388|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2171389|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
2635548|NCT01963208|GABA Agents|gaba agents|mesh-ancestor
2171390|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2171391|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2171392|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
2171393|NCT00000935|Antibodies|antibodies|mesh-list
2171394|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
2171395|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2171396|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2171397|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
2171398|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171399|NCT00000936|Cyclosporine|cyclosporine|mesh-list
2171400|NCT00000936|Cyclosporins|cyclosporins|mesh-list
2171401|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171402|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171403|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2171404|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
2171405|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171406|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
2171407|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171408|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
2635549|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2635550|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2635551|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635552|NCT01963299|Clonidine|clonidine|mesh-list
2635553|NCT01963299|Ropivacaine|ropivacaine|mesh-list
2635554|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
2635555|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
2635556|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635557|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635558|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
2635559|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635560|NCT01963299|Analgesics|analgesics|mesh-ancestor
2635561|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2635562|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
2635563|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
2635564|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2635565|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2635566|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2635567|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
2171409|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2171410|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2171411|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2171412|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171413|NCT00000938|Doxycycline|doxycycline|mesh-list
2171414|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
2171415|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2171416|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171417|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
2635568|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635569|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635570|NCT01963325|Paclitaxel|paclitaxel|mesh-list
2635571|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2635572|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2635573|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635574|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
2635575|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
2635576|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
2635577|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635578|NCT01963390|Testosterone|testosterone|mesh-list
2635579|NCT01963390|Androgens|androgens|mesh-ancestor
2635580|NCT01963390|Hormones|hormones|mesh-ancestor
2635581|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2635582|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635583|NCT01963416|Micronutrients|micronutrients|mesh-list
2635584|NCT01963416|Trace Elements|trace elements|mesh-list
2635585|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635586|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2635587|NCT01963442|Lactams|lactams|mesh-list
2635588|NCT01963442|beta-Lactams|beta-lactams|mesh-list
2635589|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2635590|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2635591|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2635592|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635593|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635594|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
2171418|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2171419|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2171420|NCT00000939|Efavirenz|efavirenz|mesh-list
2171421|NCT00000939|Stavudine|stavudine|mesh-list
2171422|NCT00000939|Didanosine|didanosine|mesh-list
2171423|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
2171424|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171425|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171426|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171427|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171428|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
2171429|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171430|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2171431|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171432|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2171433|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2171434|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2171435|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2171436|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171437|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
2171438|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
2171439|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171440|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171441|NCT00000940|Ritonavir|ritonavir|mesh-list
2635595|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635596|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635597|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2635598|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2635599|NCT01963546|Analgesics|analgesics|mesh-ancestor
2635600|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
2635601|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635602|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2635603|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2635604|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2635605|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
2171442|NCT00000940|Amprenavir|amprenavir|mesh-list
2171443|NCT00000940|Lamivudine|lamivudine|mesh-list
2171444|NCT00000940|Abacavir|abacavir|mesh-list
2171445|NCT00000940|Stavudine|stavudine|mesh-list
2171446|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171447|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171448|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171449|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171450|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635606|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635607|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635608|NCT01963559|Lidocaine|lidocaine|mesh-list
2635609|NCT01963559|Prilocaine|prilocaine|mesh-list
2635610|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2635611|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
2171451|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171452|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171453|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
2171454|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171455|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171456|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171457|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171458|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171459|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
2635612|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
2635613|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635614|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635615|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
2635616|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635617|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2635618|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2635619|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2635620|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2635621|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635622|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2635623|NCT01963663|Metformin|metformin|mesh-list
2635624|NCT01963663|Pioglitazone|pioglitazone|mesh-list
2635625|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2635626|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635627|NCT01963702|Capecitabine|capecitabine|mesh-list
2635628|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
2635629|NCT01963702|Docetaxel|docetaxel|mesh-list
2171460|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2635630|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2635631|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
2635632|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635633|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635634|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
2635635|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
2635636|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
2171461|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
2171462|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2171463|NCT00000941|Ritonavir|ritonavir|mesh-list
2171464|NCT00000941|Nelfinavir|nelfinavir|mesh-list
2171465|NCT00000941|Saquinavir|saquinavir|mesh-list
2171466|NCT00000941|Atorvastatin|atorvastatin|mesh-list
2171467|NCT00000941|Simvastatin|simvastatin|mesh-list
2171468|NCT00000941|Pravastatin|pravastatin|mesh-list
2171469|NCT00000941|Calcium|calcium|mesh-list
2171470|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2171471|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171472|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2171473|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2171474|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
2171475|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171476|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2171477|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2171478|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171479|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171480|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171481|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171482|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171483|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2635645|NCT01963741|Histamine|histamine|mesh-list
2635646|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
2635647|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
2635648|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635649|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635650|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635651|NCT01963754|Epinephrine|epinephrine|mesh-list
2635652|NCT01963754|Racepinephrine|racepinephrine|mesh-list
2171484|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
2171485|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171486|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171487|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171488|NCT00000942|Nevirapine|nevirapine|mesh-list
2171489|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171490|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171491|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635653|NCT01963754|Anesthetics|anesthetics|mesh-list
2635654|NCT01963754|Carticaine|carticaine|mesh-list
2635655|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
2635656|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635657|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635658|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2635659|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2635660|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
2635661|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635662|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635663|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2635664|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2635665|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
2635666|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635667|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2635668|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
2635669|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
2635670|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
2635671|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2635672|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
2635673|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
2171492|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635674|NCT01963832|Fluoxetine|fluoxetine|mesh-list
2635675|NCT01963832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2635676|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2635677|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2635678|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635679|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635680|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
2635681|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635682|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2635683|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
2635684|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2635685|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2635686|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2635687|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635688|NCT01963910|Mannitol|mannitol|mesh-list
2635689|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2171493|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
2171494|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171495|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171496|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171497|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2171498|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2171499|NCT00000943|Vaccines|vaccines|mesh-list
2171500|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
2171501|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635690|NCT01963910|Diuretics|diuretics|mesh-ancestor
2635691|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
2635692|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635693|NCT01963962|Copper|copper|mesh-list
2635694|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
2635695|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2635696|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
2635697|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2635698|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635699|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2635700|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2635701|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2635702|NCT01963962|Trace Elements|trace elements|mesh-ancestor
2635703|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
2635704|NCT01964001|Vitamins|vitamins|mesh-list
2635705|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
2635706|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
2635707|NCT01964001|Pyridoxal|pyridoxal|mesh-list
2635708|NCT01964001|Pyridoxine|pyridoxine|mesh-list
2635709|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
2635710|NCT01964001|Ubiquinone|ubiquinone|mesh-list
2635711|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
2635712|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635713|NCT01964027|Irinotecan|irinotecan|mesh-list
2635714|NCT01964027|Epirubicin|epirubicin|mesh-list
2635715|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2635716|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2635717|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635718|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635719|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635720|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2635721|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2635722|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
2635723|NCT01964040|Bupivacaine|bupivacaine|mesh-list
2635724|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
2635725|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
2635726|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635727|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635728|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
2635729|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635730|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2635731|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2635732|NCT01964040|Analgesics|analgesics|mesh-ancestor
2635733|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2635734|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2635735|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2635736|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
2635737|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635738|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171502|NCT00000944|Lamivudine|lamivudine|mesh-list
2171503|NCT00000944|Zidovudine|zidovudine|mesh-list
2635739|NCT01964079|Losartan|losartan|mesh-list
2635740|NCT01964079|Amlodipine|amlodipine|mesh-list
2635741|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2171504|NCT00000944|Indinavir|indinavir|mesh-list
2171505|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171506|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171507|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171508|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171509|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
2171510|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171511|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2635742|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2635743|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2635744|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635745|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2635746|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635747|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
2635748|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2635749|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2635750|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2635751|NCT01964157|Ceritinib|ceritinib|mesh-list
2635752|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635753|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2635754|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635755|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635756|NCT01964170|Goserelin|goserelin|mesh-list
2635757|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2635758|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635759|NCT01964183|Mirabegron|mirabegron|mesh-list
2635760|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2635761|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2635762|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2635763|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2635764|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
2635765|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635766|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635767|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635768|NCT01964183|Urological Agents|urological agents|mesh-ancestor
2635769|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2635770|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2635771|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
2635772|NCT01964248|Lidocaine|lidocaine|mesh-list
2635773|NCT01964248|Prilocaine|prilocaine|mesh-list
2635774|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2635775|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
2635776|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
2635777|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2171512|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171513|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
2171514|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171515|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171516|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171517|NCT00000945|Cidofovir|cidofovir|mesh-list
2171518|NCT00000945|Probenecid|probenecid|mesh-list
2171519|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
2171520|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
2171521|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2171522|NCT00000945|Renal Agents|renal agents|mesh-ancestor
2171523|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
2171524|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171525|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171526|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171527|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
2171528|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2171529|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
2171530|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171531|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2171532|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171533|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
2171534|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171535|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
2171536|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2171537|NCT00000946|Protective Agents|protective agents|mesh-ancestor
2171538|NCT00000947|Azithromycin|azithromycin|mesh-list
2171539|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2171540|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171541|NCT00000948|Aldesleukin|aldesleukin|mesh-list
2171542|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171543|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2635778|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635779|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
2635780|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635781|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2635782|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2635783|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2635784|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2635785|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635786|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2635787|NCT01964287|Leucovorin|leucovorin|mesh-list
2635788|NCT01964287|Gemcitabine|gemcitabine|mesh-list
2635789|NCT01964287|Paclitaxel|paclitaxel|mesh-list
2635790|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
2635791|NCT01964287|Irinotecan|irinotecan|mesh-list
2635792|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2635793|NCT01964287|Folfirinox|folfirinox|mesh-list
2635794|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2635795|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635796|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
2635797|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
2635798|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
2635799|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635800|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2635801|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
2171544|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171545|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
2171546|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171547|NCT00000949|Aldesleukin|aldesleukin|mesh-list
2171548|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171549|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171550|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171551|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
2171552|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171553|NCT00000950|Pyridoxine|pyridoxine|mesh-list
2171554|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
2171555|NCT00000950|Rifampin|rifampin|mesh-list
2171556|NCT00000950|Isoniazid|isoniazid|mesh-list
2171557|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
2171558|NCT00000950|Ethambutol|ethambutol|mesh-list
2171559|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2171560|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
2171561|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2171562|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171563|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
2171564|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171565|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171566|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171567|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2171568|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2171569|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2171570|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2171571|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2171572|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2171573|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2171574|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2171575|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
2171576|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2171577|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
2171578|NCT00000950|Vitamins|vitamins|mesh-ancestor
2171579|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
2171580|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171581|NCT00000951|Fluconazole|fluconazole|mesh-list
2635802|NCT01964287|Antiviral Agents|antiviral agents|mesh-ancestor
2635803|NCT01964287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2635804|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635805|NCT01964287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2635806|NCT01964287|Immunologic Factors|immunologic factors|mesh-ancestor
2635807|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635808|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2635809|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2635810|NCT01964287|Antidotes|antidotes|mesh-ancestor
2635811|NCT01964287|Protective Agents|protective agents|mesh-ancestor
2635812|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
2635813|NCT01964287|Vitamins|vitamins|mesh-ancestor
2171582|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
2635814|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
2635815|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
2635816|NCT01964365|Fenofibrate|fenofibrate|mesh-list
2171583|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171584|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2171585|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171586|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171587|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171588|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2171589|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
2171590|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2171591|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171592|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2171593|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2171594|NCT00000952|Ritonavir|ritonavir|mesh-list
2635817|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2635818|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2635819|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
2635820|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635821|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2635822|NCT01964391|Paclitaxel|paclitaxel|mesh-list
2635823|NCT01964391|Docetaxel|docetaxel|mesh-list
2635824|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
2635825|NCT01964391|Carboplatin|carboplatin|mesh-list
2635826|NCT01964391|Doxorubicin|doxorubicin|mesh-list
2635827|NCT01964391|Trastuzumab|trastuzumab|mesh-list
2635828|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2635829|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635830|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
2635831|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
2635832|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
2635833|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635834|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2635835|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
2635836|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635837|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2635838|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2635839|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
2635840|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2635841|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2635842|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2635843|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2635844|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635845|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2635846|NCT01964404|Dronabinol|dronabinol|mesh-list
2635847|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
2635848|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635849|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2635850|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2635851|NCT01964404|Analgesics|analgesics|mesh-ancestor
2635852|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
2635853|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635854|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2171595|NCT00000952|Lamivudine|lamivudine|mesh-list
2171596|NCT00000952|Zidovudine|zidovudine|mesh-list
2171597|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2171598|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2171599|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
2171600|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171601|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171602|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171603|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171604|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
2171605|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171606|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171607|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171608|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2635855|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2635856|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635857|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635858|NCT01964404|Hormones|hormones|mesh-ancestor
2635859|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2635860|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2635861|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2635862|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2635863|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
2635864|NCT01964534|Gemcitabine|gemcitabine|mesh-list
2635865|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2635866|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2635867|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
2635868|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635869|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635870|NCT01964534|Antiviral Agents|antiviral agents|mesh-ancestor
2635871|NCT01964534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2635872|NCT01964534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635873|NCT01964534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2635874|NCT01964534|Immunologic Factors|immunologic factors|mesh-ancestor
2635875|NCT01964534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171609|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171610|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
2171611|NCT00000953|Acyclovir|acyclovir|mesh-list
2171612|NCT00000953|Sorivudine|sorivudine|mesh-list
2171613|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
2171614|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171615|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171616|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171617|NCT00000954|Didanosine|didanosine|mesh-list
2171618|NCT00000954|Zalcitabine|zalcitabine|mesh-list
2171619|NCT00000954|Doxorubicin|doxorubicin|mesh-list
2171620|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2171621|NCT00000954|Bleomycin|bleomycin|mesh-list
2171622|NCT00000954|Vincristine|vincristine|mesh-list
2171623|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2171624|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171625|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2171626|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2171627|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171628|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171629|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2171630|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
2171631|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
2171632|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
2171633|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
2171634|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171635|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171636|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
2171637|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171638|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171639|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171640|NCT00000959|Pyridoxine|pyridoxine|mesh-list
2171641|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
2171642|NCT00000959|Isoniazid|isoniazid|mesh-list
2171643|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
2171644|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2171645|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171646|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2635882|NCT01964573|Rotigotine|rotigotine|mesh-list
2635883|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
2635884|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
2635885|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635886|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635887|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635888|NCT01964586|Lidocaine|lidocaine|mesh-list
2635889|NCT01964586|Epinephrine|epinephrine|mesh-list
2635890|NCT01964586|Racepinephrine|racepinephrine|mesh-list
2635891|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
2635892|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
2635893|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
2635894|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
2635895|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635896|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635897|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
2635898|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635899|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2635900|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2635901|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2635902|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2635903|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171647|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2171648|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
2171649|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171650|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2171651|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
2171652|NCT00000959|Vitamins|vitamins|mesh-ancestor
2635904|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2635905|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2635906|NCT01964586|Analgesics|analgesics|mesh-ancestor
2635907|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2635908|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2635909|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2635910|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
2635911|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635912|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2635913|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2635914|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
2635915|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2635916|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
2635917|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
2635918|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
2635919|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2635920|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
2635921|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635922|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635923|NCT01964781|Epinephrine|epinephrine|mesh-list
2635924|NCT01964781|Racepinephrine|racepinephrine|mesh-list
2635925|NCT01964781|Bupivacaine|bupivacaine|mesh-list
2635926|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
2635927|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
2635928|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
2635929|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
2635930|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635931|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635932|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
2635933|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635934|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2635935|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2635936|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635937|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
2635938|NCT01964781|Coagulants|coagulants|mesh-ancestor
2635939|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2635940|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2635941|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
2635942|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2635943|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2635944|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2635945|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
2171653|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
2171654|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171655|NCT00000960|Zidovudine|zidovudine|mesh-list
2171656|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
2171657|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171658|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171659|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171660|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171661|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
2171662|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171663|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171664|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171665|NCT00000961|Zidovudine|zidovudine|mesh-list
2171666|NCT00000961|Immune Sera|immune sera|mesh-list
2171667|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
2171668|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171669|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171670|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2635946|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2635947|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
2635948|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
2635949|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
2635950|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2171671|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635961|NCT01964846|Curcumin|curcumin|mesh-list
2635962|NCT01964846|Resveratrol|resveratrol|mesh-list
2635963|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2635964|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2635965|NCT01964846|Analgesics|analgesics|mesh-ancestor
2635966|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
2635967|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635968|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635969|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2635970|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2635971|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635972|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635973|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2635974|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
2635975|NCT01964846|Protective Agents|protective agents|mesh-ancestor
2635976|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2635977|NCT01964911|Ropivacaine|ropivacaine|mesh-list
2635978|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
2635979|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
2635980|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2635981|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635982|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
2635983|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2635984|NCT01964989|Vaccines|vaccines|mesh-list
2635985|NCT01964989|Immunologic Factors|immunologic factors|mesh-ancestor
2635986|NCT01964989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635987|NCT01965041|Aflibercept|aflibercept|mesh-list
2635988|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2635989|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2635990|NCT01965041|Growth Substances|growth substances|mesh-ancestor
2635991|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2635992|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
2635993|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635994|NCT01965080|Exemestane|exemestane|mesh-list
2635995|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2635996|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2635997|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2635998|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2635999|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636000|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2636001|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
2636002|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2636003|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636004|NCT01965132|Adalimumab|adalimumab|mesh-list
2636005|NCT01965132|Etanercept|etanercept|mesh-list
2636006|NCT01965132|Golimumab|golimumab|mesh-list
2636007|NCT01965132|Abatacept|abatacept|mesh-list
2636008|NCT01965132|Infliximab|infliximab|mesh-list
2636009|NCT01965132|Ustekinumab|ustekinumab|mesh-list
2636010|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636011|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
2636012|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171672|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
2171673|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171674|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171675|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171676|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
2171677|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171678|NCT00000962|Nevirapine|nevirapine|mesh-list
2171679|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171680|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171681|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171682|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171683|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
2171684|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171685|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171686|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171687|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2636013|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2636014|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2636015|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2636016|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2636017|NCT01965132|Analgesics|analgesics|mesh-ancestor
2636018|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
2636019|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636020|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2636021|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2636022|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
2636023|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2636024|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636025|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2636026|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2636027|NCT01965275|Gefitinib|gefitinib|mesh-list
2636028|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636029|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2636030|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636031|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636032|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
2636033|NCT01965301|Promethazine|promethazine|mesh-list
2636034|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2636035|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2636036|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636037|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636038|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
2636039|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
2636040|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
2636041|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636042|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
2636043|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
2636044|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2636045|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2636046|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
2636047|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
2636048|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636049|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636050|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2636051|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
2636052|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
2636053|NCT01965353|Dexamethasone|dexamethasone|mesh-list
2636054|NCT01965353|Lenalidomide|lenalidomide|mesh-list
2636055|NCT01965353|Bortezomib|bortezomib|mesh-list
2636056|NCT01965353|Panobinostat|panobinostat|mesh-list
2636057|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2636058|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
2636059|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
2636060|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636061|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636062|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2636063|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
2636064|NCT01965353|Hormones|hormones|mesh-ancestor
2636065|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2636066|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2636067|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636068|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
2636069|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2636070|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2636071|NCT01965353|Growth Substances|growth substances|mesh-ancestor
2636072|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
2636073|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2636074|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636075|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636076|NCT01965405|Bupropion|bupropion|mesh-list
2636077|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2636078|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
2636079|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2636080|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2636081|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2636082|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2636083|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636084|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
2636085|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636086|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636087|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2636088|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2636089|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636090|NCT01965522|Vitamin D|vitamin d|mesh-list
2636091|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
2636092|NCT01965522|Vitamins|vitamins|mesh-list
2636093|NCT01965522|Melatonin|melatonin|mesh-list
2636094|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
2636095|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636096|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2636097|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2636098|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
2636099|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636100|NCT01965522|Protective Agents|protective agents|mesh-ancestor
2636101|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636102|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
2636103|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2636104|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
2636105|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2636106|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636107|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2636108|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2636109|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2636110|NCT01965626|Oseltamivir|oseltamivir|mesh-list
2636111|NCT01965626|Dexamethasone|dexamethasone|mesh-list
2171688|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2171689|NCT00000963|Didanosine|didanosine|mesh-list
2171690|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
2171691|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171692|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171693|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171694|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171695|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
2171696|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171697|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171698|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2636112|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2636113|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
2636114|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
2636115|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636116|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636117|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2636118|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
2636119|NCT01965626|Hormones|hormones|mesh-ancestor
2636120|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2636121|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2636122|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636123|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
2636124|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2636125|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636126|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636127|NCT01965704|Ondansetron|ondansetron|mesh-list
2636128|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
2636129|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
2636130|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636131|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636132|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2636133|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
2636134|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
2636135|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2636136|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
2636137|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636138|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636139|NCT01965704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2636140|NCT01965704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2636141|NCT01965704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636142|NCT01965704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2636143|NCT01965704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2636144|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
2636145|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2636146|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2636147|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636148|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
2636149|NCT01965730|Coagulants|coagulants|mesh-ancestor
2636150|NCT01965925|Modafinil|modafinil|mesh-list
2636151|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2636152|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171699|NCT00000964|Foscarnet|foscarnet|mesh-list
2636153|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2636154|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2636155|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2636156|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636157|NCT01965977|Bortezomib|bortezomib|mesh-list
2636158|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636159|NCT01966055|Solithromycin|solithromycin|mesh-list
2636160|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2636161|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171700|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2171701|NCT00000964|Ranitidine|ranitidine|mesh-list
2171702|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2171703|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2171704|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2636162|NCT01966133|Doxorubicin|doxorubicin|mesh-list
2636163|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2636164|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
2636165|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2636166|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636167|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2636168|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2636169|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636170|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636171|NCT01966172|Acetaminophen|acetaminophen|mesh-list
2636172|NCT01966172|Ibuprofen|ibuprofen|mesh-list
2636173|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2636174|NCT01966172|Morphine|morphine|mesh-list
2636175|NCT01966172|Gabapentin|gabapentin|mesh-list
2636176|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2636177|NCT01966172|Narcotics|narcotics|mesh-ancestor
2636178|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636179|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636180|NCT01966172|Analgesics|analgesics|mesh-ancestor
2636181|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
2636182|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636183|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2636184|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2636185|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2636186|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2636187|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636188|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636189|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
2636190|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
2636191|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2636192|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2636193|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2636194|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2636195|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2636196|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636197|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
2636198|NCT01966263|Epinephrine|epinephrine|mesh-list
2636199|NCT01966263|Racepinephrine|racepinephrine|mesh-list
2636200|NCT01966263|Ropivacaine|ropivacaine|mesh-list
2636201|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
2636202|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
2636203|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
2636204|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636205|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636206|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
2636207|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636208|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2636209|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2636210|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
2636211|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636212|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636213|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2636214|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2636215|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
2636216|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2636217|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
2636218|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
2636219|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
2636220|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2636221|NCT01966276|Methylphenidate|methylphenidate|mesh-list
2636222|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2636223|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636224|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2171705|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2171706|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
2636225|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2636226|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2636227|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636228|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
2636229|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636230|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
2636231|NCT01966289|Guadecitabine|guadecitabine|mesh-list
2636232|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
2636233|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636234|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2636235|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2636236|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2636237|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
2636238|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636239|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636240|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2636241|NCT01966302|Beraprost|beraprost|mesh-list
2636242|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2636243|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
2636244|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2636245|NCT01966341|Laxatives|laxatives|mesh-list
2171707|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
2171708|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2171709|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171710|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171711|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
2171712|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171713|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2636246|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
2636247|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2636248|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2636249|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
2636250|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636251|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636281|NCT01966484|Succinylcholine|succinylcholine|mesh-list
2636282|NCT01966484|Mivacurium|mivacurium|mesh-list
2636283|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2636284|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2636285|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2636286|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636287|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636288|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2636289|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2636290|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
2171714|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171715|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171716|NCT00000965|Zidovudine|zidovudine|mesh-list
2171717|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
2171718|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171719|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171720|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2636291|NCT01966575|Progestins|progestins|mesh-list
2636292|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2636293|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2636294|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2636295|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
2636296|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2636297|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636298|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2636299|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2636300|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2636301|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2636302|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636303|NCT01966575|Hormones|hormones|mesh-ancestor
2636304|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2636305|NCT01966627|Liver Extracts|liver extracts|mesh-list
2636306|NCT01966627|Hematinics|hematinics|mesh-ancestor
2636307|NCT01966653|Fosfomycin|fosfomycin|mesh-list
2636308|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
2636309|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2636310|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171721|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171722|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
2171723|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171724|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171725|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171726|NCT00000966|Leucovorin|leucovorin|mesh-list
2171727|NCT00000966|Azithromycin|azithromycin|mesh-list
2171728|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
2171729|NCT00000966|Calcium|calcium|mesh-list
2171730|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
2171731|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2171732|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171733|NCT00000966|Antidotes|antidotes|mesh-ancestor
2171734|NCT00000966|Protective Agents|protective agents|mesh-ancestor
2171735|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
2171736|NCT00000966|Vitamins|vitamins|mesh-ancestor
2171737|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
2171738|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2171739|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171740|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
2171741|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2636311|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2636312|NCT01966653|Renal Agents|renal agents|mesh-ancestor
2636313|NCT01966692|Fluticasone|fluticasone|mesh-list
2636314|NCT01966692|Xhance|xhance|mesh-list
2636315|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2636316|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2636317|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
2636318|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636319|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636320|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2636321|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
2636322|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
2636323|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2636324|NCT01966783|Budesonide|budesonide|mesh-list
2636325|NCT01966783|Mesalamine|mesalamine|mesh-list
2636326|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2636327|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2636328|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
2636329|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636330|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636331|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2636332|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
2636333|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
2636334|NCT01966783|Hormones|hormones|mesh-ancestor
2636335|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2636336|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2636337|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2171742|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2171743|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2636338|NCT01966783|Analgesics|analgesics|mesh-ancestor
2636339|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
2636340|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2636341|NCT01966822|Ritonavir|ritonavir|mesh-list
2636342|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2636343|NCT01966822|Dolutegravir|dolutegravir|mesh-list
2636344|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
2636345|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2636346|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636347|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636348|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2636349|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2636350|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
2636351|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2636352|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2636353|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2636354|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2636355|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2636356|NCT01966913|Bevacizumab|bevacizumab|mesh-list
2636357|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2636358|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636359|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2636360|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2636361|NCT01966913|Growth Substances|growth substances|mesh-ancestor
2636362|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636363|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
2636364|NCT01967017|Lidocaine|lidocaine|mesh-list
2636365|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
2636366|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
2636367|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636368|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636369|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
2636370|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636371|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2636372|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2636373|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2636374|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2636375|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636376|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2636377|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636378|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2636379|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636380|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636381|NCT01967199|Paclitaxel|paclitaxel|mesh-list
2636382|NCT01967199|Everolimus|everolimus|mesh-list
2171744|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171745|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171746|NCT00000967|Interferons|interferons|mesh-list
2171747|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
2171748|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
2171749|NCT00000967|Zidovudine|zidovudine|mesh-list
2171750|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171751|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
2171752|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171753|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
2171754|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171755|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
2171756|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171757|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171758|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171759|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171760|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171761|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171762|NCT00000969|Didanosine|didanosine|mesh-list
2171763|NCT00000969|Zalcitabine|zalcitabine|mesh-list
2171764|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
2636383|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2636384|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636385|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
2636386|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
2171765|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171766|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171767|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171768|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171769|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
2171770|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171771|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171772|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171773|NCT00000970|Ganciclovir|ganciclovir|mesh-list
2171774|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2171775|NCT00000970|Foscarnet|foscarnet|mesh-list
2171776|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2171777|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
2171778|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171779|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171780|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171781|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171782|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171783|NCT00000971|Zidovudine|zidovudine|mesh-list
2171784|NCT00000971|Didanosine|didanosine|mesh-list
2171785|NCT00000971|Clarithromycin|clarithromycin|mesh-list
2171786|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
2171787|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171788|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171789|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171790|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171791|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
2171792|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171793|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171794|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171795|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2171796|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2171797|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171798|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171799|NCT00000973|Leucovorin|leucovorin|mesh-list
2171800|NCT00000973|Zidovudine|zidovudine|mesh-list
2171801|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
2171802|NCT00000973|Calcium|calcium|mesh-list
2171803|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
2171804|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2171805|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171806|NCT00000973|Antidotes|antidotes|mesh-ancestor
2171807|NCT00000973|Protective Agents|protective agents|mesh-ancestor
2171808|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
2171809|NCT00000973|Vitamins|vitamins|mesh-ancestor
2171810|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
2171811|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
2171812|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636387|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
2636388|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636389|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2636390|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
2636391|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636392|NCT01967238|Vaccines|vaccines|mesh-list
2636393|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
2636394|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636395|NCT01967251|Udenafil|udenafil|mesh-list
2636396|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2636397|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2636398|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636399|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636400|NCT01967264|Udenafil|udenafil|mesh-list
2636401|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2636402|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2636403|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636404|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636405|NCT01967368|Vaccines|vaccines|mesh-list
2636406|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
2636407|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636408|NCT01967381|Methamphetamine|methamphetamine|mesh-list
2636409|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2636410|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636411|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
2636412|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
2636413|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636414|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
2636415|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636416|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636417|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
2636418|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2636419|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2171813|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171814|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171815|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171816|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
2171817|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171818|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171819|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171820|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
2171821|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2171822|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2171823|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2171824|NCT00000974|Pentamidine|pentamidine|mesh-list
2171825|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
2171826|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171827|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2171828|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2171829|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2171830|NCT00000975|Itraconazole|itraconazole|mesh-list
2171831|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
2171832|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171833|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2171834|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2171835|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171836|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171837|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2171838|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
2636420|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2636421|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2636422|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
2636423|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2636424|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636425|NCT01967459|Vitamins|vitamins|mesh-ancestor
2636426|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
2636427|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2636428|NCT01967472|Artesunate|artesunate|mesh-list
2636429|NCT01967472|Lumefantrine|lumefantrine|mesh-list
2636430|NCT01967472|Artemether|artemether|mesh-list
2636431|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2636432|NCT01967472|Amodiaquine|amodiaquine|mesh-list
2636433|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
2636434|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2636435|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2636436|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2636437|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636438|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
2636439|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
2171839|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2171840|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171841|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171842|NCT00000976|Zidovudine|zidovudine|mesh-list
2171843|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
2171844|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
2171845|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636440|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2636441|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
2636442|NCT01967498|Montelukast|montelukast|mesh-list
2636443|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2636444|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
2636445|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2636446|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
2636447|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2636448|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636449|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2636450|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2636451|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636452|NCT01967524|Ropivacaine|ropivacaine|mesh-list
2636453|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2636454|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
2636455|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2636456|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
2636457|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
2636458|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636459|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636460|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
2636461|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636462|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2636463|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2636464|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636465|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
2636466|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636467|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2636468|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2636469|NCT01967758|Amoxicillin|amoxicillin|mesh-list
2636470|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2636471|NCT01967758|Trimethoprim|trimethoprim|mesh-list
2636472|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
2636473|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2636474|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2636475|NCT01967758|Renal Agents|renal agents|mesh-ancestor
2636476|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
2636477|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2636478|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2636479|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2636480|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636481|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636482|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2636483|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2636484|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2636485|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2636486|NCT01967810|Bevacizumab|bevacizumab|mesh-list
2636487|NCT01967810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2636488|NCT01967810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636489|NCT01967810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2171846|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171847|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171848|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171849|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
2171850|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171851|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171852|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171853|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
2636490|NCT01967810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2636491|NCT01967810|Growth Substances|growth substances|mesh-ancestor
2636492|NCT01967810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636493|NCT01967810|Growth Inhibitors|growth inhibitors|mesh-ancestor
2636494|NCT01967823|Aldesleukin|aldesleukin|mesh-list
2636495|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
2636496|NCT01967823|Fludarabine|fludarabine|mesh-list
2636497|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2636498|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
2636499|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636500|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2636501|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2636502|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
2636503|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636504|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636505|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2636506|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2636507|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2636508|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
2636509|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2636510|NCT01967875|Docetaxel|docetaxel|mesh-list
2636511|NCT01967875|Capecitabine|capecitabine|mesh-list
2636512|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636513|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
2636514|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
2636515|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
2636516|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636517|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2636518|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
2636519|NCT01967927|Imidazole|imidazole|mesh-list
2636520|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636521|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636522|NCT01967979|Itraconazole|itraconazole|mesh-list
2636523|NCT01967979|Fluoxetine|fluoxetine|mesh-list
2636524|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
2636525|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2636526|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2171854|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636527|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2636528|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636529|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636530|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2636531|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
2636532|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2636533|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636534|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2636535|NCT01967979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2636536|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2636537|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2636538|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636539|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
2636540|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2636541|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
2636542|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2636543|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2636544|NCT01968005|Etodolac|etodolac|mesh-list
2636545|NCT01968005|Lidocaine|lidocaine|mesh-list
2636546|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
2636547|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
2636548|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636549|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636550|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
2636551|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636552|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2636553|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2636554|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2636555|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2636556|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636557|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2636558|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2636559|NCT01968005|Analgesics|analgesics|mesh-ancestor
2636560|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2636561|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2636562|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2171855|NCT00000978|Zidovudine|zidovudine|mesh-list
2171856|NCT00000978|Zalcitabine|zalcitabine|mesh-list
2171857|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
2171858|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171859|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171860|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2636563|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2636564|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636565|NCT01968018|Acetaminophen|acetaminophen|mesh-list
2636566|NCT01968018|Tramadol|tramadol|mesh-list
2636567|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2636568|NCT01968018|Analgesics|analgesics|mesh-ancestor
2636569|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
2636570|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636571|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636572|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
2636573|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2636574|NCT01968018|Narcotics|narcotics|mesh-ancestor
2636575|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636576|NCT01968044|Linagliptin|linagliptin|mesh-list
2636577|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2636578|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636579|NCT01968044|Incretins|incretins|mesh-ancestor
2636580|NCT01968044|Hormones|hormones|mesh-ancestor
2636581|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2636582|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2171861|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171862|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
2171863|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171864|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171865|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171866|NCT00000979|Zidovudine|zidovudine|mesh-list
2171867|NCT00000979|Didanosine|didanosine|mesh-list
2171868|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
2171869|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171870|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171871|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171872|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636583|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
2636584|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636585|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636586|NCT01968083|Vaccines|vaccines|mesh-list
2636587|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
2636588|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636589|NCT01968109|Nivolumab|nivolumab|mesh-list
2636590|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2636591|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636592|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2636593|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636594|NCT01968161|Asenapine|asenapine|mesh-list
2636595|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2636596|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2636597|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636598|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636599|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2636600|NCT01968200|Enalapril|enalapril|mesh-list
2636601|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2636602|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
2636603|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636604|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636605|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2636606|NCT01968239|Ranibizumab|ranibizumab|mesh-list
2636607|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2636608|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2636609|NCT01968239|Growth Substances|growth substances|mesh-ancestor
2636610|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636611|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
2636612|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636613|NCT01968395|Caspofungin|caspofungin|mesh-list
2636614|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
2636615|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2636616|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636617|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636618|NCT01968460|Pramipexole|pramipexole|mesh-list
2636619|NCT01968460|Rasagiline|rasagiline|mesh-list
2636620|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
2636621|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636622|NCT01968460|Protective Agents|protective agents|mesh-ancestor
2636623|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636624|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2636625|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2636626|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
2636627|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
2636628|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636629|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2636630|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636631|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2636632|NCT01968486|Ranibizumab|ranibizumab|mesh-list
2636633|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2636634|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2636635|NCT01968486|Growth Substances|growth substances|mesh-ancestor
2636636|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636637|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
2636638|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636639|NCT01968564|Curcumin|curcumin|mesh-list
2636640|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2636641|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2636642|NCT01968564|Analgesics|analgesics|mesh-ancestor
2636643|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
2636644|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636645|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636646|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2636647|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2636648|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636649|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636650|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636651|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2636652|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2636653|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2636654|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
2636655|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636656|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2636657|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2636658|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636659|NCT01968590|Vitamin D|vitamin d|mesh-list
2636660|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
2636661|NCT01968590|Vitamins|vitamins|mesh-ancestor
2636662|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
2636663|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636664|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2636665|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2636666|NCT01968616|Ranibizumab|ranibizumab|mesh-list
2636667|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2636668|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2636669|NCT01968616|Growth Substances|growth substances|mesh-ancestor
2636670|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636671|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
2636672|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636673|NCT01968655|Factor VIII|factor viii|mesh-list
2636674|NCT01968655|Coagulants|coagulants|mesh-ancestor
2636675|NCT01968733|Moxifloxacin|moxifloxacin|mesh-list
2636676|NCT01968733|Solithromycin|solithromycin|mesh-list
2636677|NCT01968733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2422263|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2422264|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422265|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
2171873|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
2171874|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171875|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171876|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171877|NCT00000980|Spiramycin|spiramycin|mesh-list
2171878|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2171879|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171880|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
2171881|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2171882|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2171883|NCT00000981|Fiacitabine|fiacitabine|mesh-list
2171884|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171885|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
2171886|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171887|NCT00000982|Zidovudine|zidovudine|mesh-list
2171888|NCT00000982|Didanosine|didanosine|mesh-list
2171889|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
2171890|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171891|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171892|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2636678|NCT01968733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2636679|NCT01968733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2636680|NCT01968733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2636681|NCT01968733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636682|NCT01968733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636683|NCT01968733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636684|NCT01968759|Ramipril|ramipril|mesh-list
2636685|NCT01968759|Irbesartan|irbesartan|mesh-list
2636686|NCT01968759|Sevelamer|sevelamer|mesh-list
2636687|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2636688|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
2636689|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636690|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636691|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2171893|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171894|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
2171895|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171896|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171897|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171898|NCT00000983|Zidovudine|zidovudine|mesh-list
2171899|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
2171900|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636692|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2636693|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2636694|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
2171901|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2422266|NCT00816790|Tazobactam|tazobactam|mesh-list
2422267|NCT00816790|Piperacillin|piperacillin|mesh-list
2422268|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2422269|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2422270|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422271|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2422272|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171902|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2636695|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
2636696|NCT01968798|Aspirin|aspirin|mesh-list
2636697|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2636698|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2636699|NCT01968798|Analgesics|analgesics|mesh-ancestor
2636700|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
2636701|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636702|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636703|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2636704|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2636705|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2636706|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2636707|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636708|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2636709|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2636710|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636711|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
2636712|NCT01968850|Vitamin D|vitamin d|mesh-list
2636713|NCT01968850|Alendronate|alendronate|mesh-list
2636714|NCT01968850|Vitamins|vitamins|mesh-ancestor
2636715|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
2636716|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636717|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2636718|NCT01968915|Paclitaxel|paclitaxel|mesh-list
2171903|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171904|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
2171905|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171906|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171907|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171908|NCT00000985|Acyclovir|acyclovir|mesh-list
2171909|NCT00000985|Foscarnet|foscarnet|mesh-list
2171910|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2171911|NCT00000985|Vidarabine|vidarabine|mesh-list
2171912|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
2171913|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171914|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171915|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171916|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171917|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171918|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
2171919|NCT00000986|Zidovudine|zidovudine|mesh-list
2636719|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2636720|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171920|NCT00000986|Aldesleukin|aldesleukin|mesh-list
2171921|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
2171922|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171923|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171924|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171925|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171926|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
2171927|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2636721|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
2636722|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
2636723|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
2636724|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636725|NCT01969006|Bupivacaine|bupivacaine|mesh-list
2636726|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
2636727|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
2636728|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636729|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636730|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
2636731|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636732|NCT01969019|Prednisone|prednisone|mesh-list
2636733|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
2636734|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2636735|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2636736|NCT01969019|Prednisolone|prednisolone|mesh-list
2636737|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
2636738|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2636739|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
2636740|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2636741|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
2636742|NCT01969019|Hormones|hormones|mesh-ancestor
2171928|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171929|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2636743|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2636744|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636745|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2636746|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636747|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
2636748|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
2636749|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636750|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2636751|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2636752|NCT01969019|Protective Agents|protective agents|mesh-ancestor
2636753|NCT01969032|Paclitaxel|paclitaxel|mesh-list
2636754|NCT01969032|Doxorubicin|doxorubicin|mesh-list
2636755|NCT01969032|Capecitabine|capecitabine|mesh-list
2171930|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171931|NCT00000987|Zidovudine|zidovudine|mesh-list
2171932|NCT00000987|Doxorubicin|doxorubicin|mesh-list
2171933|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2171934|NCT00000987|Bleomycin|bleomycin|mesh-list
2171935|NCT00000987|Vincristine|vincristine|mesh-list
2171936|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2171937|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2171938|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2171939|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2171940|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171941|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171942|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2171943|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
2171944|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
2171945|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
2171946|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
2636756|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
2636757|NCT01969032|Carboplatin|carboplatin|mesh-list
2636758|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2636759|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636760|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
2636761|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
2636762|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
2636763|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636764|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2636765|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2636766|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2636767|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636768|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2636769|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
2636770|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2636771|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
2636772|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636773|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2636774|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2636775|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
2636776|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2636777|NCT01969071|Simendan|simendan|mesh-list
2636778|NCT01969071|Dobutamine|dobutamine|mesh-list
2636779|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2636780|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
2636781|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2636782|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2636783|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636784|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636785|NCT01969071|Protective Agents|protective agents|mesh-ancestor
2636786|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636787|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
2636788|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
2636789|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636790|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2636791|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2636792|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2636793|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
2636794|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636795|NCT01969149|Insulin|insulin|mesh-list
2636796|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2171947|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171948|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171949|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
2636797|NCT01969149|Exenatide|exenatide|mesh-list
2636798|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
2636799|NCT01969149|Incretins|incretins|mesh-list
2636800|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2636801|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636802|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2636803|NCT01969149|Hormones|hormones|mesh-ancestor
2636804|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2636805|NCT01969227|Ketamine|ketamine|mesh-list
2636806|NCT01969227|Analgesics|analgesics|mesh-ancestor
2636807|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
2636808|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636809|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636810|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2636811|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2636812|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
2636813|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
2636814|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636815|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2636816|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2636817|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636818|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636819|NCT01969318|Metformin|metformin|mesh-list
2636820|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2636821|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636822|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2636823|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2636824|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636825|NCT01969357|Incretins|incretins|mesh-ancestor
2636826|NCT01969357|Hormones|hormones|mesh-ancestor
2171950|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171951|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171952|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171953|NCT00000988|Stavudine|stavudine|mesh-list
2171954|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
2171955|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171956|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171957|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171958|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171959|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
2171960|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171961|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2636827|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2636828|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2636829|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
2636830|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636831|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636832|NCT01969578|Paclitaxel|paclitaxel|mesh-list
2636833|NCT01969578|Carboplatin|carboplatin|mesh-list
2636834|NCT01969578|Doxorubicin|doxorubicin|mesh-list
2636835|NCT01969578|Bicalutamide|bicalutamide|mesh-list
2636836|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2636837|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2636838|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636839|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
2171962|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171963|NCT00000989|Zidovudine|zidovudine|mesh-list
2171964|NCT00000989|Ganciclovir|ganciclovir|mesh-list
2171965|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2171966|NCT00000989|Sargramostim|sargramostim|mesh-list
2171967|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
2171968|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171969|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171970|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171971|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171972|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
2171973|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171974|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171975|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2636840|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
2636841|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
2171976|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
2171977|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2171978|NCT00000990|Zidovudine|zidovudine|mesh-list
2171979|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
2171980|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171981|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171982|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171983|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636842|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636843|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2636844|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2636845|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2636846|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636847|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
2636848|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
2636849|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2636850|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636851|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
2636852|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2636853|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
2636854|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2636855|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2636856|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2636857|NCT01969617|Naltrexone|naltrexone|mesh-list
2636858|NCT01969617|Nalmefene|nalmefene|mesh-list
2636859|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2636860|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636861|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
2636862|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636863|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2636867|NCT01969656|Calcitriol|calcitriol|mesh-list
2636868|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2636869|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636870|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2636871|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2636872|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636873|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2636874|NCT01969656|Vitamins|vitamins|mesh-ancestor
2636875|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
2636876|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2636877|NCT01969669|Ketoconazole|ketoconazole|mesh-list
2636878|NCT01969669|Venetoclax|venetoclax|mesh-list
2636879|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636880|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
2636881|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2636882|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2636883|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2636884|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636885|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636886|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2636887|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
2636888|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2636889|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636890|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2171984|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
2171985|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2171986|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2171987|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2171988|NCT00000991|Zidovudine|zidovudine|mesh-list
2171989|NCT00000991|Trimethoprim|trimethoprim|mesh-list
2171990|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
2171991|NCT00000991|Dapsone|dapsone|mesh-list
2171992|NCT00000991|Pentamidine|pentamidine|mesh-list
2171993|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2171994|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
2171995|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2171996|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2171997|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2171998|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2171999|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
2172000|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172001|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172002|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172003|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2172004|NCT00000991|Renal Agents|renal agents|mesh-ancestor
2172005|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
2172006|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2172007|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2172008|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2172009|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2172010|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2172011|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172012|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
2172013|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2172014|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
2172015|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2172016|NCT00000992|Itraconazole|itraconazole|mesh-list
2172017|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
2172018|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172019|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2172020|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172021|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636891|NCT01969682|Rifampin|rifampin|mesh-list
2636892|NCT01969682|Venetoclax|venetoclax|mesh-list
2636893|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636894|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2636895|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
2636896|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2636897|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2636898|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
2636899|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2636900|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636901|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636902|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2636903|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2636904|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2636905|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2636906|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2636907|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2636908|NCT01969695|Venetoclax|venetoclax|mesh-list
2636909|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636910|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
2636911|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2636912|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2636913|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2636914|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2636915|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636916|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
2636917|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636918|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636919|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2636920|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636921|NCT01969838|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2636922|NCT01969838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2636923|NCT01969838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636924|NCT01969838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636925|NCT01969877|Cetuximab|cetuximab|mesh-list
2636926|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636927|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2636928|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
2636929|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2636930|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636931|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636932|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2636933|NCT01969903|Analgesics|analgesics|mesh-ancestor
2636934|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
2636935|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636936|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2636937|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2636938|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2636939|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
2636940|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636941|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636942|NCT01969942|Melphalan|melphalan|mesh-list
2636943|NCT01969942|Busulfan|busulfan|mesh-list
2636944|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2636945|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
2636946|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636947|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636948|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2636949|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2636950|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
2636951|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636952|NCT01969955|Paclitaxel|paclitaxel|mesh-list
2636953|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2636954|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2636955|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2636956|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
2636957|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
2636958|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
2636959|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636960|NCT01970046|Metformin|metformin|mesh-list
2636961|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2172022|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172023|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2172024|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
2172025|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2172026|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172027|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2172028|NCT00000993|Zidovudine|zidovudine|mesh-list
2172029|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
2172030|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172031|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172032|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172033|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172034|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
2172035|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172036|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2636962|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636963|NCT01970059|Metoprolol|metoprolol|mesh-list
2636964|NCT01970059|Carvedilol|carvedilol|mesh-list
2636965|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2636966|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2636967|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
2172037|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172038|NCT00000994|Zidovudine|zidovudine|mesh-list
2172039|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
2172040|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172041|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172042|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172043|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172044|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
2636968|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
2636969|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2636970|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636971|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2636972|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2636973|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2636974|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
2636975|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2636976|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2636977|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
2636978|NCT01970059|Protective Agents|protective agents|mesh-ancestor
2636979|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2636980|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2636981|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2636982|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
2636983|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2636984|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2636985|NCT01970072|Midazolam|midazolam|mesh-list
2636986|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2636987|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2636988|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2636989|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2636990|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2636991|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2636992|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2636993|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2636994|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
2636995|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
2636996|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
2636997|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
2636998|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2172045|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172046|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172047|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172048|NCT00000995|Zidovudine|zidovudine|mesh-list
2172049|NCT00000995|Ganciclovir|ganciclovir|mesh-list
2172050|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2172051|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
2172052|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172053|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172054|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172055|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2636999|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637000|NCT01970202|Enoxaparin|enoxaparin|mesh-list
2637001|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
2637002|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
2637003|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2637004|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2637005|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637006|NCT01970215|Atorvastatin|atorvastatin|mesh-list
2637007|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2637008|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2637009|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2637010|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
2637011|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637012|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2637013|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2637014|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637015|NCT01970228|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2637016|NCT01970228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637017|NCT01970228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2637018|NCT01970280|Enoxaparin|enoxaparin|mesh-list
2637019|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
2637020|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2637021|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2637022|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637023|NCT01970345|Mecasermin|mecasermin|mesh-list
2637024|NCT01970345|Growth Substances|growth substances|mesh-ancestor
2637025|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637026|NCT01970358|Poly ICLC|poly iclc|mesh-list
2637027|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
2637028|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
2637029|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172056|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
2172057|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172058|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172059|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172060|NCT00000996|Doxorubicin|doxorubicin|mesh-list
2172061|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2172062|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2172063|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172064|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2172065|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2172066|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172067|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172068|NCT00000997|Zalcitabine|zalcitabine|mesh-list
2172069|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
2172070|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172071|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172072|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172073|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172074|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
2172075|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172076|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2637041|NCT01970449|Vaccines|vaccines|mesh-list
2637042|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
2637043|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637044|NCT01970501|Metoprolol|metoprolol|mesh-list
2637045|NCT01970501|Bucindolol|bucindolol|mesh-list
2637046|NCT01970501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2637047|NCT01970501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2637048|NCT01970501|Sympatholytics|sympatholytics|mesh-ancestor
2637049|NCT01970501|Autonomic Agents|autonomic agents|mesh-ancestor
2637050|NCT01970501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637051|NCT01970501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637052|NCT01970501|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2637053|NCT01970501|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2637054|NCT01970501|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2637055|NCT01970501|Adrenergic Agents|adrenergic agents|mesh-ancestor
2637056|NCT01970501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2637057|NCT01970501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637058|NCT01970501|Sympathomimetics|sympathomimetics|mesh-ancestor
2637059|NCT01970501|Vasodilator Agents|vasodilator agents|mesh-ancestor
2637060|NCT01970501|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2637061|NCT01970501|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2637062|NCT01970553|Gemcitabine|gemcitabine|mesh-list
2637063|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2637064|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
2637065|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637066|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637067|NCT01970553|Antiviral Agents|antiviral agents|mesh-ancestor
2637068|NCT01970553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637069|NCT01970553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637070|NCT01970553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2172077|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172078|NCT00000998|Leucovorin|leucovorin|mesh-list
2172079|NCT00000998|Trimetrexate|trimetrexate|mesh-list
2172080|NCT00000998|Calcium|calcium|mesh-list
2172081|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
2172082|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2172083|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172084|NCT00000998|Antidotes|antidotes|mesh-ancestor
2172085|NCT00000998|Protective Agents|protective agents|mesh-ancestor
2172086|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
2172087|NCT00000998|Vitamins|vitamins|mesh-ancestor
2172088|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
2637071|NCT01970553|Immunologic Factors|immunologic factors|mesh-ancestor
2637072|NCT01970553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637073|NCT01970579|Paclitaxel|paclitaxel|mesh-list
2637074|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2637075|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637076|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
2637077|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
2637078|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
2637079|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637080|NCT01970722|Gemcitabine|gemcitabine|mesh-list
2637081|NCT01970722|Paclitaxel|paclitaxel|mesh-list
2637082|NCT01970722|Cisplatin|cisplatin|mesh-list
2637083|NCT01970722|Carboplatin|carboplatin|mesh-list
2637084|NCT01970722|Doxorubicin|doxorubicin|mesh-list
2637085|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2637086|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2637087|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2637088|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637089|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
2637090|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
2637091|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
2637092|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637093|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2637094|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
2637095|NCT01970722|Antiviral Agents|antiviral agents|mesh-ancestor
2637096|NCT01970722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637097|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637098|NCT01970722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2637099|NCT01970722|Immunologic Factors|immunologic factors|mesh-ancestor
2637100|NCT01970722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637101|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2637102|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2637103|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2637104|NCT01970748|Propranolol|propranolol|mesh-list
2637105|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2172089|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
2637106|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2637107|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
2637108|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2637109|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637110|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637111|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2637112|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2637113|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
2637114|NCT01970800|Hormones|hormones|mesh-list
2637115|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2637116|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637117|NCT01970904|Ribavirin|ribavirin|mesh-list
2637118|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2637119|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
2637120|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637121|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
2637122|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637123|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2637124|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2637125|NCT01971034|Metformin|metformin|mesh-list
2637126|NCT01971034|Paclitaxel|paclitaxel|mesh-list
2637127|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2637128|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637129|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
2637130|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
2637131|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
2637132|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637133|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2172090|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172091|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2172092|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
2172093|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172094|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172095|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2172096|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172097|NCT00000999|Zidovudine|zidovudine|mesh-list
2172098|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
2172099|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172100|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2637134|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637135|NCT01971047|Insulin|insulin|mesh-list
2637136|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
2637137|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2637138|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2172101|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172102|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172103|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
2172104|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172105|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172106|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172107|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2172108|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
2172109|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172110|NCT00001001|Zidovudine|zidovudine|mesh-list
2637139|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637140|NCT01971190|Aflibercept|aflibercept|mesh-list
2637141|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2637142|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2637143|NCT01971190|Growth Substances|growth substances|mesh-ancestor
2637144|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637145|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
2637146|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637147|NCT01971242|Exenatide|exenatide|mesh-list
2637148|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2637149|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637150|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2637151|NCT01971242|Incretins|incretins|mesh-ancestor
2637152|NCT01971242|Hormones|hormones|mesh-ancestor
2637153|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2637154|NCT01971268|Cimetidine|cimetidine|mesh-list
2637155|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2637156|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2637157|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2637158|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
2172111|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
2637159|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
2637160|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2637161|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637162|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637163|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2637164|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2637165|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637166|NCT01971281|Gemcitabine|gemcitabine|mesh-list
2637167|NCT01971281|Paclitaxel|paclitaxel|mesh-list
2637168|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2637169|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637170|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
2637171|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
2637172|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
2637173|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637174|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2637175|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
2637176|NCT01971281|Antiviral Agents|antiviral agents|mesh-ancestor
2637177|NCT01971281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172112|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172113|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172114|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172115|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172116|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
2172117|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172118|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172119|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172120|NCT00001002|Zidovudine|zidovudine|mesh-list
2172121|NCT00001002|Foscarnet|foscarnet|mesh-list
2172122|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2172123|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
2172124|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172125|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172126|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172127|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172128|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
2172129|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172130|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172131|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172132|NCT00001003|Zidovudine|zidovudine|mesh-list
2172133|NCT00001003|Pentamidine|pentamidine|mesh-list
2172134|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
2172135|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172136|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172137|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172138|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172139|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
2172140|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172141|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2637178|NCT01971281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637179|NCT01971281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2637180|NCT01971281|Immunologic Factors|immunologic factors|mesh-ancestor
2637181|NCT01971281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637182|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
2637183|NCT01971411|Vitamin D|vitamin d|mesh-list
2637184|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
2637185|NCT01971411|Vitamins|vitamins|mesh-list
2637186|NCT01971411|Calcium|calcium|mesh-list
2637187|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
2637188|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637189|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2637190|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2637191|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
2637192|NCT01971424|Antacids|antacids|mesh-ancestor
2637193|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637194|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2637195|NCT01971450|Iloprost|iloprost|mesh-list
2637196|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2637197|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
2637198|NCT01971489|Gemcitabine|gemcitabine|mesh-list
2637199|NCT01971489|Cisplatin|cisplatin|mesh-list
2637200|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637201|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2637202|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
2637203|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637204|NCT01971489|Antiviral Agents|antiviral agents|mesh-ancestor
2637205|NCT01971489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637206|NCT01971489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637207|NCT01971489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2637208|NCT01971489|Immunologic Factors|immunologic factors|mesh-ancestor
2637209|NCT01971489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637210|NCT01971515|Tamoxifen|tamoxifen|mesh-list
2637211|NCT01971515|Trastuzumab|trastuzumab|mesh-list
2637212|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2637213|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637214|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2637215|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
2172142|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172143|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
2172144|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2172145|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2172146|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2172147|NCT00001004|Interferons|interferons|mesh-list
2172148|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
2172149|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172150|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
2172151|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172152|NCT00001005|Zidovudine|zidovudine|mesh-list
2172153|NCT00001005|Aldesleukin|aldesleukin|mesh-list
2172154|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
2172155|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172156|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172157|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172158|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172159|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
2172160|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172161|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172162|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172163|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172164|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
2172165|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2637216|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2637217|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637218|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2637219|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2637220|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2637221|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2637222|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2637223|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2637224|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2637225|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
2637226|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637227|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2637228|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2637229|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637230|NCT01971632|Oxycodone|oxycodone|mesh-list
2637231|NCT01971632|Naloxone|naloxone|mesh-list
2637232|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2637233|NCT01971632|Narcotics|narcotics|mesh-ancestor
2637234|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2637235|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637236|NCT01971632|Analgesics|analgesics|mesh-ancestor
2637237|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
2637238|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637239|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2637240|NCT01971658|Thalidomide|thalidomide|mesh-list
2637241|NCT01971658|Dexamethasone|dexamethasone|mesh-list
2637242|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
2637243|NCT01971658|Bortezomib|bortezomib|mesh-list
2637244|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2637245|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
2637246|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637247|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2637248|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2637249|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
2637250|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637251|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637252|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2637253|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2637254|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
2637255|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
2637256|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637257|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2637258|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
2637259|NCT01971658|Hormones|hormones|mesh-ancestor
2637260|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2637261|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2637262|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
2637263|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2637264|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637265|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2637266|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2637267|NCT01971658|Growth Substances|growth substances|mesh-ancestor
2637268|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
2637269|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
2637270|NCT01971684|Sirolimus|sirolimus|mesh-list
2637271|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
2637272|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637273|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
2637274|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637275|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2637276|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2637277|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
2637278|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2637279|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637280|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637281|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637282|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
2637283|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2637284|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
2637285|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2637286|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2637287|NCT01971801|Vitamin D|vitamin d|mesh-list
2637288|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
2637289|NCT01971801|Vitamins|vitamins|mesh-ancestor
2637290|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
2637291|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637292|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2637293|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2637294|NCT01971814|Infliximab|infliximab|mesh-list
2637295|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
2637296|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2637297|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2637298|NCT01971918|Antibodies|antibodies|mesh-list
2637299|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
2637300|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637307|NCT01972035|Valacyclovir|valacyclovir|mesh-list
2637308|NCT01972035|Valganciclovir|valganciclovir|mesh-list
2637309|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
2637310|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637311|NCT01972113|Vitamins|vitamins|mesh-list
2637312|NCT01972113|Vitamin K|vitamin k|mesh-list
2637313|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
2172166|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
2172167|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172168|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172169|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2172170|NCT00001006|Protective Agents|protective agents|mesh-ancestor
2172171|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2637314|NCT01972113|Vitamin MK 7|vitamin mk 7|mesh-list
2637315|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
2637316|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637317|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2637318|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2637319|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637320|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
2637321|NCT01972113|Coagulants|coagulants|mesh-ancestor
2637322|NCT01972230|Remifentanil|remifentanil|mesh-list
2637323|NCT01972230|Sevoflurane|sevoflurane|mesh-list
2637324|NCT01972230|Propofol|propofol|mesh-list
2637325|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2637326|NCT01972230|Narcotics|narcotics|mesh-ancestor
2637327|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2637328|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637329|NCT01972230|Analgesics|analgesics|mesh-ancestor
2172172|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172173|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172174|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172175|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
2172176|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172177|NCT00001007|Zidovudine|zidovudine|mesh-list
2172178|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
2172179|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172180|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172181|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2637330|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
2637331|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637332|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2637333|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2637334|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
2637335|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
2637336|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2637337|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2637338|NCT01972269|Lidocaine|lidocaine|mesh-list
2637339|NCT01972269|Fentanyl|fentanyl|mesh-list
2637340|NCT01972269|Bupivacaine|bupivacaine|mesh-list
2637341|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
2637342|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
2637343|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2637344|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637345|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
2637346|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637347|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2637348|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2637349|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2637350|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2637351|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637352|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2637353|NCT01972269|Narcotics|narcotics|mesh-ancestor
2637354|NCT01972269|Analgesics|analgesics|mesh-ancestor
2637355|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2172182|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172183|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
2172184|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172185|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172186|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172187|NCT00001008|Zidovudine|zidovudine|mesh-list
2172188|NCT00001008|Methadone|methadone|mesh-list
2637356|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2637357|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
2637358|NCT01972347|Trametinib|trametinib|mesh-list
2637359|NCT01972347|Dabrafenib|dabrafenib|mesh-list
2637360|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637361|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2637362|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637363|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637364|NCT01972373|Bevacizumab|bevacizumab|mesh-list
2637365|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2637366|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637367|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2637368|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2637369|NCT01972373|Growth Substances|growth substances|mesh-ancestor
2637370|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637371|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
2637372|NCT01972490|Bevacizumab|bevacizumab|mesh-list
2637373|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2637374|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637375|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2637376|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2637377|NCT01972490|Growth Substances|growth substances|mesh-ancestor
2637378|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637379|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
2637380|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
2637381|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637382|NCT01972620|Bupivacaine|bupivacaine|mesh-list
2637383|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
2637384|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
2637385|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2637386|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637387|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
2637388|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637389|NCT01972711|Amisulpride|amisulpride|mesh-list
2637390|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2637391|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2637392|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2637393|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637394|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2637395|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2637396|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
2637397|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2637398|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637399|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2637400|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
2637401|NCT01972763|Ranibizumab|ranibizumab|mesh-list
2637402|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2637403|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2637404|NCT01972763|Growth Substances|growth substances|mesh-ancestor
2637405|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637406|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
2637407|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637408|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2637409|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
2637410|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
2637411|NCT01972854|Riboflavin|riboflavin|mesh-list
2637412|NCT01972854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2637413|NCT01972854|Vitamin B Complex|vitamin b complex|mesh-ancestor
2172189|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
2172190|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172191|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172192|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172193|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637414|NCT01972854|Vitamins|vitamins|mesh-ancestor
2637415|NCT01972854|Micronutrients|micronutrients|mesh-ancestor
2637416|NCT01972854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637417|NCT01972854|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2637418|NCT01972854|Dermatologic Agents|dermatologic agents|mesh-ancestor
2637419|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
2637420|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2637421|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172194|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
2172195|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172196|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172197|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172198|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2172199|NCT00001008|Narcotics|narcotics|mesh-ancestor
2172200|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2172201|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172202|NCT00001008|Analgesics|analgesics|mesh-ancestor
2172203|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
2172204|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2172205|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
2172206|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
2172207|NCT00001009|Dextrans|dextrans|mesh-list
2172208|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
2172209|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
2172210|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
2172211|NCT00001010|Zidovudine|zidovudine|mesh-list
2172212|NCT00001010|Acyclovir|acyclovir|mesh-list
2172213|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
2172214|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172215|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172216|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172217|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172218|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
2172219|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172220|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172221|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172222|NCT00001011|Zidovudine|zidovudine|mesh-list
2172223|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
2172224|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172225|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172226|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172227|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172228|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
2172229|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172230|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2637422|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2637423|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637424|NCT01972906|Ibuprofen|ibuprofen|mesh-list
2637425|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2637426|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2637427|NCT01972906|Analgesics|analgesics|mesh-ancestor
2637428|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
2637429|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637430|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637431|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2637432|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2637433|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2637434|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637435|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637436|NCT01972984|Anastrozole|anastrozole|mesh-list
2637437|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2637438|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637439|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2637440|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2637441|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637442|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637443|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2637444|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
2637445|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2637446|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172231|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172232|NCT00001013|Leucovorin|leucovorin|mesh-list
2172233|NCT00001013|Trimethoprim|trimethoprim|mesh-list
2172234|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2637447|NCT01973010|Ibuprofen|ibuprofen|mesh-list
2637448|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2637449|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2637450|NCT01973010|Analgesics|analgesics|mesh-ancestor
2637451|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
2637452|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637453|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172235|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
2172236|NCT00001013|Pentamidine|pentamidine|mesh-list
2172237|NCT00001013|Trimetrexate|trimetrexate|mesh-list
2172238|NCT00001013|Calcium|calcium|mesh-list
2172239|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
2637454|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2637455|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2637456|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2637457|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637458|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172240|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2172241|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172242|NCT00001013|Antidotes|antidotes|mesh-ancestor
2172243|NCT00001013|Protective Agents|protective agents|mesh-ancestor
2172244|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
2172245|NCT00001013|Vitamins|vitamins|mesh-ancestor
2172246|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
2172247|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2172248|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172249|NCT00001013|Renal Agents|renal agents|mesh-ancestor
2172250|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
2637459|NCT01973049|Ribavirin|ribavirin|mesh-list
2637460|NCT01973049|Asunaprevir|asunaprevir|mesh-list
2637461|NCT01973049|Antimetabolites|antimetabolites|mesh-ancestor
2637462|NCT01973049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637463|NCT01973049|Antiviral Agents|antiviral agents|mesh-ancestor
2637464|NCT01973049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637465|NCT01973049|Protease Inhibitors|protease inhibitors|mesh-ancestor
2637466|NCT01973049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637467|NCT01973101|Gemcitabine|gemcitabine|mesh-list
2637468|NCT01973101|Cisplatin|cisplatin|mesh-list
2637469|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637470|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2637471|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
2637472|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637473|NCT01973101|Antiviral Agents|antiviral agents|mesh-ancestor
2637474|NCT01973101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637475|NCT01973101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637476|NCT01973101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2172251|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2172252|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2637477|NCT01973101|Immunologic Factors|immunologic factors|mesh-ancestor
2637478|NCT01973101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637479|NCT01973114|Latanoprost|latanoprost|mesh-list
2637480|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2637481|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2637482|NCT01973140|Tolvaptan|tolvaptan|mesh-list
2637483|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2637484|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637485|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
2637486|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637487|NCT01973309|Paclitaxel|paclitaxel|mesh-list
2637488|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2637489|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637490|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
2637491|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
2637492|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
2637493|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637494|NCT01973322|Vaccines|vaccines|mesh-list
2637495|NCT01973322|Complement Factor H|complement factor h|mesh-list
2637496|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
2637497|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637498|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2637499|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2637500|NCT01973400|Tocotrienols|tocotrienols|mesh-list
2637501|NCT01973400|Vitamin E|vitamin e|mesh-list
2637502|NCT01973400|Tocopherols|tocopherols|mesh-list
2172253|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2172254|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172255|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172256|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2172257|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2172258|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172259|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
2172260|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2172261|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2172262|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2172263|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
2172264|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172265|NCT00001014|Leucovorin|leucovorin|mesh-list
2172266|NCT00001014|Trimethoprim|trimethoprim|mesh-list
2172267|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2172268|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
2172269|NCT00001014|Trimetrexate|trimetrexate|mesh-list
2172270|NCT00001014|Calcium|calcium|mesh-list
2172271|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
2637503|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
2637504|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637505|NCT01973400|Protective Agents|protective agents|mesh-ancestor
2422273|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422274|NCT00816816|Docetaxel|docetaxel|mesh-list
2422275|NCT00816816|Fluorouracil|fluorouracil|mesh-list
2422276|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422277|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
2422278|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
2422279|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
2422280|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422281|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
2422282|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2422283|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2422284|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
2422285|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422286|NCT00816855|Docetaxel|docetaxel|mesh-list
2422287|NCT00816855|Fluorouracil|fluorouracil|mesh-list
2422288|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422289|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
2422290|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
2422291|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
2422292|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637506|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637507|NCT01973400|Vitamins|vitamins|mesh-ancestor
2637508|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
2172272|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2172273|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172274|NCT00001014|Antidotes|antidotes|mesh-ancestor
2172275|NCT00001014|Protective Agents|protective agents|mesh-ancestor
2172276|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
2172277|NCT00001014|Vitamins|vitamins|mesh-ancestor
2172278|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
2637523|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2637524|NCT01973517|Hematinics|hematinics|mesh-ancestor
2637525|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2637526|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2637527|NCT01973660|Tamoxifen|tamoxifen|mesh-list
2637528|NCT01973660|Paclitaxel|paclitaxel|mesh-list
2637529|NCT01973660|Trastuzumab|trastuzumab|mesh-list
2637530|NCT01973660|Letrozole|letrozole|mesh-list
2637531|NCT01973660|Lapatinib|lapatinib|mesh-list
2637532|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2637533|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637534|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
2637535|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
2637536|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
2637537|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637538|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2637539|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2172279|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2172280|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172281|NCT00001014|Renal Agents|renal agents|mesh-ancestor
2172282|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
2172283|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2172284|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2172285|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2172286|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172287|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172288|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2172289|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2637540|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2637541|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637542|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2637543|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
2637544|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2637545|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637546|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2637547|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2637548|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2637549|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2637550|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2637551|NCT01973751|Budesonide|budesonide|mesh-list
2637552|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2637553|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2637554|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
2172290|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172291|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2172292|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
2172293|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2172294|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
2172295|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172296|NCT00001015|Ribavirin|ribavirin|mesh-list
2172297|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
2172298|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172299|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
2172300|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637555|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637556|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637557|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2637558|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
2637559|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
2637560|NCT01973751|Hormones|hormones|mesh-ancestor
2637561|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2637562|NCT01973790|Z 338|z 338|mesh-list
2637563|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2637564|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637565|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637566|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
2637567|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2637568|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637569|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2637570|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
2637571|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2637572|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2637573|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2637574|NCT01973816|Estradiol|estradiol|mesh-list
2637575|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2637576|NCT01973816|Cyproterone|cyproterone|mesh-list
2637577|NCT01973816|Estrogens|estrogens|mesh-ancestor
2637578|NCT01973816|Hormones|hormones|mesh-ancestor
2637579|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2637580|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637581|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2637582|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
2637583|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2637584|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2637585|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
2637586|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
2637587|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637588|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2637589|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
2637590|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2637591|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2637592|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
2637593|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2637594|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
2637595|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2637596|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637597|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2637598|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2637599|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637600|NCT01973855|Ribavirin|ribavirin|mesh-list
2637601|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
2637602|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637603|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
2172301|NCT00001016|Leucovorin|leucovorin|mesh-list
2172302|NCT00001016|Trimetrexate|trimetrexate|mesh-list
2172303|NCT00001016|Calcium|calcium|mesh-list
2637604|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637605|NCT01973868|Cetuximab|cetuximab|mesh-list
2637606|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2637607|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637608|NCT01973920|Insulin|insulin|mesh-list
2637609|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2637610|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637611|NCT01973933|Metformin|metformin|mesh-list
2637612|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
2637613|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2637614|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637615|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
2637616|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2637617|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2637618|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637619|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2637620|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637621|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637622|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
2637623|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2637624|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2172304|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
2172305|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2172306|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172307|NCT00001016|Antidotes|antidotes|mesh-ancestor
2172308|NCT00001016|Protective Agents|protective agents|mesh-ancestor
2172309|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
2172310|NCT00001016|Vitamins|vitamins|mesh-ancestor
2637625|NCT01974024|Prednisolone|prednisolone|mesh-list
2637626|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
2172311|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
2172312|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
2172313|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172314|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2172315|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
2172316|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172317|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172318|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2637627|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2637628|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
2637629|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2637630|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
2637631|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
2637632|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637633|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637634|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2637635|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
2637636|NCT01974024|Hormones|hormones|mesh-ancestor
2637637|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2172319|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172320|NCT00001017|Fluconazole|fluconazole|mesh-list
2172321|NCT00001017|Amphotericin B|amphotericin b|mesh-list
2172322|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2172323|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
2172324|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172325|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2172326|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172327|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172328|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172329|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2172330|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
2172331|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2172332|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172333|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2172334|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2637638|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2637639|NCT01974024|Protective Agents|protective agents|mesh-ancestor
2637640|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2637641|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637642|NCT01974037|Capsaicin|capsaicin|mesh-list
2637643|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
2637644|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
2637645|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
2637646|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2172335|NCT00001017|Amebicides|amebicides|mesh-ancestor
2172336|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2172337|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2172338|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2172339|NCT00001022|Zidovudine|zidovudine|mesh-list
2172340|NCT00001022|Didanosine|didanosine|mesh-list
2172341|NCT00001022|Zalcitabine|zalcitabine|mesh-list
2172342|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
2172343|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172344|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172345|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172346|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172347|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
2422293|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
2637647|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637648|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
2422294|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2422295|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2422296|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
2422297|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422298|NCT00816868|Capecitabine|capecitabine|mesh-list
2422299|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2422300|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2422301|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
2422302|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422303|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422304|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2422305|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422306|NCT00816894|Olanzapine|olanzapine|mesh-list
2422307|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
2422308|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
2637649|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2637650|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
2637651|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2637652|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637653|NCT01974167|Vitamins|vitamins|mesh-ancestor
2637654|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
2637655|NCT01974258|Vemurafenib|vemurafenib|mesh-list
2637656|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637657|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2637658|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637659|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637660|NCT01974297|Atorvastatin|atorvastatin|mesh-list
2637661|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
2637662|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2637663|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2637664|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
2637665|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637666|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2637667|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2637668|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637669|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2637670|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2637671|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2637672|NCT01974375|Fluconazole|fluconazole|mesh-list
2637673|NCT01974375|Micafungin|micafungin|mesh-list
2637674|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
2637675|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637676|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2637677|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2637678|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637679|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172348|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172349|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172350|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172351|NCT00001023|Azithromycin|azithromycin|mesh-list
2172352|NCT00001023|Clarithromycin|clarithromycin|mesh-list
2172353|NCT00001023|Rifabutin|rifabutin|mesh-list
2172354|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2172355|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172356|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2637680|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2637681|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
2637682|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2172357|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172358|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172359|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2172360|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172361|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2172362|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
2172363|NCT00001024|Zidovudine|zidovudine|mesh-list
2172364|NCT00001024|Didanosine|didanosine|mesh-list
2172365|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
2172366|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172367|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172368|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172369|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172370|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
2172371|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172372|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172373|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172374|NCT00001025|Zidovudine|zidovudine|mesh-list
2172375|NCT00001025|Didanosine|didanosine|mesh-list
2172376|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
2172377|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172378|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172379|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2637683|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637684|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2637685|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2637686|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
2637687|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2637688|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637689|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
2637719|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
2637720|NCT01974518|Rituximab|rituximab|mesh-list
2637721|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2637722|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
2637723|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637724|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2637725|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2637726|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
2637727|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637728|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637729|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2637730|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2637731|NCT01974609|Acetaminophen|acetaminophen|mesh-list
2172380|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172381|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
2172382|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172383|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172384|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172385|NCT00001027|Pentamidine|pentamidine|mesh-list
2172386|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
2172387|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637732|NCT01974609|Ibuprofen|ibuprofen|mesh-list
2637733|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2637734|NCT01974609|Hydrocodone|hydrocodone|mesh-list
2637735|NCT01974609|Narcotics|narcotics|mesh-list
2637736|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2637737|NCT01974609|Analgesics|analgesics|mesh-ancestor
2637738|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
2637739|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637740|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637741|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
2637742|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2637743|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2637744|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2637745|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2637746|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637747|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637748|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2637749|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2637750|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
2637751|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
2637752|NCT01974622|Verteporfin|verteporfin|mesh-list
2637753|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2637754|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
2637755|NCT01974648|Remifentanil|remifentanil|mesh-list
2637756|NCT01974648|Propofol|propofol|mesh-list
2637757|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2637758|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2172388|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2172389|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2172390|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2172391|NCT00001028|Dapsone|dapsone|mesh-list
2172392|NCT00001028|Pentamidine|pentamidine|mesh-list
2172393|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172394|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
2172395|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2637759|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637760|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2637761|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
2637762|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
2637763|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2637764|NCT01974648|Narcotics|narcotics|mesh-ancestor
2637765|NCT01974648|Analgesics|analgesics|mesh-ancestor
2637766|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
2637767|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637768|NCT01974843|Bupivacaine|bupivacaine|mesh-list
2637769|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
2637770|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
2637771|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
2637772|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2637773|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637774|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
2637775|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637776|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2637777|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2637778|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2637779|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2637780|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637781|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2637782|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637783|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
2637784|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2637785|NCT01975012|Rilpivirine|rilpivirine|mesh-list
2637786|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2637787|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2637788|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637789|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637790|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
2637791|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637792|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2637793|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2637794|NCT01975051|Miltefosine|miltefosine|mesh-list
2637795|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
2637796|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637797|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637798|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2637799|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2637800|NCT01975064|Propofol|propofol|mesh-list
2637801|NCT01975064|Sevoflurane|sevoflurane|mesh-list
2637802|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2637803|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2637804|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637805|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2637806|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
2637807|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
2637808|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2637809|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2637810|NCT01975129|Oxytocin|oxytocin|mesh-list
2637811|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
2637812|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2637813|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637814|NCT01975142|Trastuzumab|trastuzumab|mesh-list
2637815|NCT01975142|Maytansine|maytansine|mesh-list
2637816|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2637817|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172396|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2172397|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2172398|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172399|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172400|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
2172401|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2172402|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
2172403|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2172404|NCT00001029|Zidovudine|zidovudine|mesh-list
2172405|NCT00001029|Didanosine|didanosine|mesh-list
2637818|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2172406|NCT00001029|Zalcitabine|zalcitabine|mesh-list
2172407|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
2172408|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172409|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172410|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2637819|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
2637820|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
2637821|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
2637822|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637823|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2637824|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2637825|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2637826|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
2172411|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172412|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
2172413|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172414|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172415|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2637827|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637828|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2637829|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2637830|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637831|NCT01975259|Glucagon|glucagon|mesh-list
2637832|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
2637833|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2637834|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2637835|NCT01975259|Hormones|hormones|mesh-ancestor
2637836|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2637837|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172416|NCT00001030|Clarithromycin|clarithromycin|mesh-list
2172417|NCT00001030|Rifabutin|rifabutin|mesh-list
2172418|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2172419|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172420|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2172421|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172422|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172423|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2637838|NCT01975259|Incretins|incretins|mesh-ancestor
2637839|NCT01975272|Iron|iron|mesh-list
2637840|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
2637841|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
2172424|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172425|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2172426|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
2172427|NCT00001032|Zidovudine|zidovudine|mesh-list
2172428|NCT00001032|Zalcitabine|zalcitabine|mesh-list
2172429|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
2172430|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172431|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172432|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172433|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172434|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
2172435|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172436|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172437|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172438|NCT00001033|Pyridoxine|pyridoxine|mesh-list
2172439|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
2172440|NCT00001033|Levofloxacin|levofloxacin|mesh-list
2172441|NCT00001033|Rifampin|rifampin|mesh-list
2172442|NCT00001033|Isoniazid|isoniazid|mesh-list
2172443|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
2172444|NCT00001033|Ethambutol|ethambutol|mesh-list
2172445|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2172446|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637842|NCT01975272|Trace Elements|trace elements|mesh-ancestor
2637843|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
2637844|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637845|NCT01975272|Hematinics|hematinics|mesh-ancestor
2637846|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
2637847|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2637848|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2637849|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172447|NCT00001033|Renal Agents|renal agents|mesh-ancestor
2172448|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2637850|NCT01975363|Curcumin|curcumin|mesh-list
2637851|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2637852|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2637853|NCT01975363|Analgesics|analgesics|mesh-ancestor
2637854|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
2637855|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637856|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637857|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2637858|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2637859|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637860|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637861|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637862|NCT01975441|Ivermectin|ivermectin|mesh-list
2637863|NCT01975441|Albendazole|albendazole|mesh-list
2637864|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
2637865|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2637866|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637867|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
2637868|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
2637869|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2637870|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2637871|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
2637872|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
2637873|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
2637874|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637875|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637876|NCT01975441|Filaricides|filaricides|mesh-ancestor
2637877|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
2637878|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2637879|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637880|NCT01975454|Capecitabine|capecitabine|mesh-list
2637881|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
2637882|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2637883|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
2637884|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637885|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637886|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2637887|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2637888|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2637889|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2637890|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637891|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2637892|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637893|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
2637894|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2637895|NCT01975610|Spebrutinib|spebrutinib|mesh-list
2637896|NCT01975610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2637897|NCT01975610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637898|NCT01975610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637899|NCT01975662|Vancomycin|vancomycin|mesh-list
2637900|NCT01975662|Daptomycin|daptomycin|mesh-list
2637901|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2637902|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637903|NCT01975688|Nabiximols|nabiximols|mesh-list
2637904|NCT01975688|Analgesics|analgesics|mesh-ancestor
2637905|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
2637906|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637907|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637908|NCT01975714|Bimatoprost|bimatoprost|mesh-list
2637909|NCT01975714|Latanoprost|latanoprost|mesh-list
2637910|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2637911|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2637912|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2637913|NCT01975727|Dexamethasone|dexamethasone|mesh-list
2637914|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
2637915|NCT01975727|BB 1101|bb 1101|mesh-list
2637916|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2637917|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
2637918|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
2637919|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637920|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637921|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2637922|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
2637923|NCT01975727|Hormones|hormones|mesh-ancestor
2637924|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2637925|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2637926|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2637927|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
2172449|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2172450|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2172451|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172452|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172453|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172454|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2172455|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172456|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2172457|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
2172458|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
2172459|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172460|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2172461|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2172462|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2637928|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637929|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172463|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2172464|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2172465|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2172466|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2172467|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2637930|NCT01975753|Fentanyl|fentanyl|mesh-list
2637931|NCT01975753|Morphine|morphine|mesh-list
2637932|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2637933|NCT01975753|Narcotics|narcotics|mesh-ancestor
2637934|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2637935|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637936|NCT01975753|Analgesics|analgesics|mesh-ancestor
2637937|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
2637938|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2637939|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2637940|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2637941|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
2637942|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
2637943|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
2637944|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2637945|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
2637946|NCT01975805|Povidone|povidone|mesh-list
2637947|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2637948|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2637949|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
2637950|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
2637951|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
2637952|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
2637953|NCT01975818|Epoetin Alfa|epoetin alfa|mesh-list
2637954|NCT01975818|Hematinics|hematinics|mesh-ancestor
2172468|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
2172469|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2172470|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
2637955|NCT01975961|Telmisartan|telmisartan|mesh-list
2637956|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2637957|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2637958|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2637959|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
2637960|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637961|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2637962|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2637963|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2637964|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2637965|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2637966|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2172471|NCT00001033|Vitamins|vitamins|mesh-ancestor
2172472|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
2172473|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172474|NCT00001034|Ganciclovir|ganciclovir|mesh-list
2172475|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2172476|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
2422309|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422310|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422311|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2422312|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2422313|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2422314|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2422315|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2422316|NCT00816894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2422317|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2422318|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422319|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422320|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422321|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
2637981|NCT01976078|Midazolam|midazolam|mesh-list
2637982|NCT01976078|Esomeprazole|esomeprazole|mesh-list
2637983|NCT01976078|Ranitidine|ranitidine|mesh-list
2637984|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2637985|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2637986|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2637987|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2637988|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2637989|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2637990|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2637991|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2637992|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2637993|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
2637994|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
2637995|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
2637996|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
2637997|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2637998|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2637999|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2638000|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2638001|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2638002|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638003|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2638004|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
2638005|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
2638006|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
2638007|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638008|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2638009|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2172477|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172478|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172479|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638010|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638011|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638012|NCT01976169|Palbociclib|palbociclib|mesh-list
2638013|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2638014|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638015|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2638016|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638017|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638018|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2638019|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
2638020|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
2638021|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
2638022|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
2638023|NCT01976182|Methotrexate|methotrexate|mesh-list
2638024|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2638025|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
2638026|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638027|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2638028|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2638029|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
2638030|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638031|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638032|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2172480|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172481|NCT00001035|Interferons|interferons|mesh-list
2172482|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
2172483|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
2638033|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2638034|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
2638035|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2638036|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2638037|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
2638038|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
2638039|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638040|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2638041|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2638042|NCT01976195|Thalidomide|thalidomide|mesh-list
2638043|NCT01976195|Dexamethasone|dexamethasone|mesh-list
2638044|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2638045|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
2638046|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
2638047|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638048|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638049|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2638050|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
2638051|NCT01976195|Hormones|hormones|mesh-ancestor
2638052|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2638053|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2638054|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638055|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2638056|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
2638057|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
2638058|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2638059|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638060|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2638061|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2638062|NCT01976195|Growth Substances|growth substances|mesh-ancestor
2638063|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
2638064|NCT01976208|Omalizumab|omalizumab|mesh-list
2172484|NCT00001035|Zidovudine|zidovudine|mesh-list
2172485|NCT00001035|Didanosine|didanosine|mesh-list
2172486|NCT00001035|Zalcitabine|zalcitabine|mesh-list
2172487|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172488|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
2172489|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172490|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
2638065|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2638066|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2638067|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
2638068|NCT01976520|Vaccines|vaccines|mesh-list
2638069|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
2638070|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638071|NCT01976585|Poly ICLC|poly iclc|mesh-list
2638072|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
2638073|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
2638074|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638075|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
2638076|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2638077|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2172491|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172492|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
2172493|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172494|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172495|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172496|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172497|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172498|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172499|NCT00001036|Zidovudine|zidovudine|mesh-list
2172500|NCT00001036|Interleukin-2|interleukin-2|mesh-list
2172501|NCT00001036|Thymalfasin|thymalfasin|mesh-list
2172502|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
2172503|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172504|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172505|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172506|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172507|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
2172508|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638078|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2638079|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2638080|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638081|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
2638082|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638083|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638084|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2638085|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638086|NCT01976676|Folic Acid|folic acid|mesh-list
2638087|NCT01976676|Hematinics|hematinics|mesh-ancestor
2638088|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
2638089|NCT01976676|Vitamins|vitamins|mesh-ancestor
2638090|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
2638091|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638092|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
2638093|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2638094|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638095|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638096|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2638097|NCT01976754|Analgesics|analgesics|mesh-ancestor
2638098|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
2638099|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638100|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2638101|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2638102|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2638103|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
2638104|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638105|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638106|NCT01976780|Artesunate|artesunate|mesh-list
2638107|NCT01976780|Lumefantrine|lumefantrine|mesh-list
2638108|NCT01976780|Artemether|artemether|mesh-list
2638109|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2638110|NCT01976780|Mefloquine|mefloquine|mesh-list
2638111|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
2638112|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2638113|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2638114|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638115|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638116|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
2638117|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
2638118|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2638119|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
2638120|NCT01976923|Bevacizumab|bevacizumab|mesh-list
2638121|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2638122|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638123|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2638124|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2638125|NCT01976923|Growth Substances|growth substances|mesh-ancestor
2638126|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638127|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
2638128|NCT01976936|Lovastatin|lovastatin|mesh-list
2638129|NCT01976936|L 647318|l 647318|mesh-list
2638130|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
2638131|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2638132|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2638133|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
2638134|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638135|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2172509|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172510|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2638136|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2638137|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638138|NCT01977118|Streptokinase|streptokinase|mesh-list
2638139|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2638140|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2638141|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638142|NCT01977209|Gossypol|gossypol|mesh-list
2638143|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2638144|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
2638145|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2638146|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638147|NCT01977235|Irinotecan|irinotecan|mesh-list
2638148|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638149|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2638150|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2638151|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638152|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638153|NCT01977300|Valproic Acid|valproic acid|mesh-list
2638154|NCT01977300|Olanzapine|olanzapine|mesh-list
2638155|NCT01977300|Risperidone|risperidone|mesh-list
2638156|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
2638157|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2638158|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
2638159|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638160|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638161|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638162|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2638163|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2638164|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638165|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2638166|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2638167|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
2638168|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
2638169|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
2638170|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638171|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2638172|NCT01977300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2638173|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2638174|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2638175|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
2638176|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638177|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
2638178|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
2638179|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
2638180|NCT01977339|Bupivacaine|bupivacaine|mesh-list
2638181|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
2638182|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
2172511|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172512|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2172513|NCT00001036|Analgesics|analgesics|mesh-ancestor
2172514|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
2172515|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2172516|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172517|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2172518|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
2172519|NCT00001038|Valacyclovir|valacyclovir|mesh-list
2172520|NCT00001038|Acyclovir|acyclovir|mesh-list
2172521|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
2172522|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172523|NCT00001039|Clarithromycin|clarithromycin|mesh-list
2172524|NCT00001039|Ethambutol|ethambutol|mesh-list
2172525|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2172526|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172527|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2172528|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172529|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172530|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2172531|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172532|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
2172533|NCT00001040|Zidovudine|zidovudine|mesh-list
2638183|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638184|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638185|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
2638186|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638187|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2638188|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2638189|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2638190|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2638191|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2638192|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638193|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638194|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638195|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2638196|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
2638197|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2638198|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2638199|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2172534|NCT00001040|Zalcitabine|zalcitabine|mesh-list
2172535|NCT00001040|Saquinavir|saquinavir|mesh-list
2172536|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
2172537|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172538|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172539|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172540|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172541|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
2172542|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638200|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2638201|NCT01977417|Analgesics|analgesics|mesh-ancestor
2638202|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
2638203|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638204|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638205|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2638206|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2638207|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2638208|NCT01977430|Furosemide|furosemide|mesh-list
2638209|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2638210|NCT01977430|Diuretics|diuretics|mesh-ancestor
2638211|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
2638212|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638213|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2638214|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2638215|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638216|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2638217|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2638218|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2638219|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2638220|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
2638221|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638222|NCT01977989|Vancomycin|vancomycin|mesh-list
2638223|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2638224|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638225|NCT01978015|Timolol|timolol|mesh-list
2638226|NCT01978015|Bimatoprost|bimatoprost|mesh-list
2638227|NCT01978015|Travoprost|travoprost|mesh-list
2638228|NCT01978015|Dextrans|dextrans|mesh-list
2638229|NCT01978015|Latanoprost|latanoprost|mesh-list
2638230|NCT01978015|Maleic acid|maleic acid|mesh-list
2638231|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2638232|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2638233|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
2638234|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638235|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638236|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638237|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2172543|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172544|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172545|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2172546|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2172547|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
2172548|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2638238|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2638239|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638240|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2638241|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2638242|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
2638243|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
2638244|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
2638245|NCT01978041|Fluorides|fluorides|mesh-list
2638246|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
2638247|NCT01978041|Protective Agents|protective agents|mesh-ancestor
2638248|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638249|NCT01978301|Triamcinolone|triamcinolone|mesh-list
2638250|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2638251|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2638252|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2638253|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2638254|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
2638255|NCT01978301|Hormones|hormones|mesh-ancestor
2638256|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2638257|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638258|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2638259|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
2638260|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638261|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638262|NCT01978366|Halofuginone|halofuginone|mesh-list
2638263|NCT01978366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638264|NCT01978366|Coccidiostats|coccidiostats|mesh-ancestor
2638265|NCT01978366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2638266|NCT01978366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2638267|NCT01978366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172549|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172550|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2172551|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
2172552|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
2172553|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2638268|NCT01978366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2638269|NCT01978366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638270|NCT01978366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638271|NCT01978366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2638272|NCT01978366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2638273|NCT01978366|Growth Substances|growth substances|mesh-ancestor
2638274|NCT01978366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638275|NCT01978366|Growth Inhibitors|growth inhibitors|mesh-ancestor
2638276|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
2638277|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
2638278|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638279|NCT01978405|Protective Agents|protective agents|mesh-ancestor
2638280|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638281|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
2638282|NCT01978405|Vitamins|vitamins|mesh-ancestor
2638283|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
2638284|NCT01978418|Albuterol|albuterol|mesh-list
2638285|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2638286|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
2638287|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638288|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638289|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2638290|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
2638291|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
2638292|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2638293|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2638294|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2638295|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2638296|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
2638297|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638298|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638299|NCT01978431|Cocaine|cocaine|mesh-list
2172554|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
2172555|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172556|NCT00001042|Antacids|antacids|mesh-ancestor
2172557|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172558|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2172559|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2172560|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2172561|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
2172562|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172563|NCT00001044|Antacids|antacids|mesh-ancestor
2172564|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172565|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2172566|NCT00001045|Zidovudine|zidovudine|mesh-list
2172567|NCT00001045|Nevirapine|nevirapine|mesh-list
2172568|NCT00001045|Didanosine|didanosine|mesh-list
2172569|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
2172570|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172571|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172572|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172573|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172574|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
2172575|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172576|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172577|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2638300|NCT01978431|Methylphenidate|methylphenidate|mesh-list
2638301|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2638302|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638303|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2638304|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2638305|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2638306|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638307|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
2638308|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638309|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
2638310|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
2638311|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638312|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
2638313|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638314|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2638315|NCT01978457|Propranolol|propranolol|mesh-list
2638316|NCT01978457|Cocaine|cocaine|mesh-list
2638317|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2638318|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2638319|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
2638320|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638321|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638322|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638323|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2638324|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2638325|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
2638326|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
2638327|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
2638328|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638329|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
2638330|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638331|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2638332|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2638333|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2172578|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2172579|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2172580|NCT00001047|Clarithromycin|clarithromycin|mesh-list
2172581|NCT00001047|Ethambutol|ethambutol|mesh-list
2638334|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2638335|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
2638336|NCT01978483|Denosumab|denosumab|mesh-list
2638337|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2638338|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172582|NCT00001047|Rifabutin|rifabutin|mesh-list
2172583|NCT00001047|Clofazimine|clofazimine|mesh-list
2172584|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2172585|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172586|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2172587|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172588|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172589|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2172590|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172591|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
2172592|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2172593|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2172594|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
2172595|NCT00001048|Cytarabine|cytarabine|mesh-list
2172596|NCT00001048|Zidovudine|zidovudine|mesh-list
2172597|NCT00001048|Didanosine|didanosine|mesh-list
2172598|NCT00001048|Zalcitabine|zalcitabine|mesh-list
2172599|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
2172600|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172601|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2172602|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
2172603|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172604|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172605|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
2172606|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172607|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2172608|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2422322|NCT00816959|Bleomycin|bleomycin|mesh-list
2422323|NCT00816959|Dacarbazine|dacarbazine|mesh-list
2422324|NCT00816959|Vinblastine|vinblastine|mesh-list
2422325|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2422326|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422327|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422328|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2422329|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
2422330|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2422331|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
2422332|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
2422333|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
2422334|NCT00816972|Loratadine|loratadine|mesh-list
2422335|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
2422336|NCT00816972|Oxybutynin|oxybutynin|mesh-list
2422337|NCT00816972|Desloratadine|desloratadine|mesh-list
2422338|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
2422339|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
2422340|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638339|NCT01978496|Eletriptan|eletriptan|mesh-list
2638340|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2638341|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
2638342|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638343|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638344|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638345|NCT01978665|Prednisone|prednisone|mesh-list
2638346|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2638347|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
2638348|NCT01978665|Hormones|hormones|mesh-ancestor
2638349|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2638350|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638351|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2638352|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638353|NCT01978678|Budesonide|budesonide|mesh-list
2638354|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2638355|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2638356|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
2638357|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638358|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638359|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2638360|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
2638361|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
2638362|NCT01978678|Hormones|hormones|mesh-ancestor
2638363|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2638364|NCT01978704|Insulin|insulin|mesh-list
2638365|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2638366|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2638367|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638368|NCT01978717|Anesthetics|anesthetics|mesh-list
2638369|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638370|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638371|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
2638372|NCT01978782|Citalopram|citalopram|mesh-list
2638373|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2638374|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2638375|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
2638376|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638377|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2638378|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2638379|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638380|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638381|NCT01978782|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2638382|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2638383|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2638384|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638385|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
2638386|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638387|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2638388|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
2638389|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2638390|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
2638391|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
2638392|NCT01978873|Androgens|androgens|mesh-list
2638393|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2638394|NCT01978873|Hormones|hormones|mesh-ancestor
2172609|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172610|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172611|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172612|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172613|NCT00001049|Zidovudine|zidovudine|mesh-list
2172614|NCT00001049|Didanosine|didanosine|mesh-list
2172615|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
2638395|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2638396|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638397|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
2638398|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638399|NCT01978873|Protective Agents|protective agents|mesh-ancestor
2638400|NCT01978873|Vitamins|vitamins|mesh-ancestor
2638401|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
2638402|NCT01978873|Estrogens|estrogens|mesh-ancestor
2638403|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2638404|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638405|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
2638406|NCT01979211|Cetuximab|cetuximab|mesh-list
2638407|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2638408|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638409|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2638410|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2638411|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638412|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
2638413|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2638414|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
2638415|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2638416|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2638417|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2638418|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638419|NCT01979354|Morphine|morphine|mesh-list
2638420|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2638421|NCT01979354|Narcotics|narcotics|mesh-ancestor
2638422|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638423|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638424|NCT01979354|Analgesics|analgesics|mesh-ancestor
2638425|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
2638426|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638427|NCT01979406|Vaccines|vaccines|mesh-list
2638428|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
2638429|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638430|NCT01979510|Acetaminophen|acetaminophen|mesh-list
2638431|NCT01979510|Etoricoxib|etoricoxib|mesh-list
2638432|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2638433|NCT01979510|Analgesics|analgesics|mesh-ancestor
2638434|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
2638435|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638436|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638437|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
2638438|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2638439|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2638440|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2638441|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2638442|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2638443|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638444|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172616|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172617|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172618|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172619|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172620|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
2172621|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172622|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172623|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172624|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2172625|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2172626|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
2172627|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172628|NCT00001052|Antacids|antacids|mesh-ancestor
2172629|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172630|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2172631|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2172632|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2172633|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
2172634|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172635|NCT00001053|Antacids|antacids|mesh-ancestor
2172636|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172637|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2172638|NCT00001054|Valacyclovir|valacyclovir|mesh-list
2172639|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
2172640|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172641|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
2638504|NCT01979653|Midazolam|midazolam|mesh-list
2638505|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
2638506|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2638507|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638508|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638509|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2638510|NCT01979653|Analgesics|analgesics|mesh-ancestor
2638511|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
2172642|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2172643|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
2172644|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172645|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2172646|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172647|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
2172648|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172649|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
2172650|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2172651|NCT00001055|Protective Agents|protective agents|mesh-ancestor
2172652|NCT00001057|Zidovudine|zidovudine|mesh-list
2172653|NCT00001057|Didanosine|didanosine|mesh-list
2172654|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
2172655|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172656|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172657|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172658|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172659|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
2638512|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638513|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2638514|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2638515|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2638516|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
2638517|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638518|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638519|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2638520|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2638521|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2638522|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2638523|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2638524|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
2638525|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
2638526|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
2638527|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
2638528|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2638529|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2172660|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172661|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172662|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172663|NCT00001058|Ritonavir|ritonavir|mesh-list
2172664|NCT00001058|Indinavir|indinavir|mesh-list
2172665|NCT00001058|Clarithromycin|clarithromycin|mesh-list
2172666|NCT00001058|Ethambutol|ethambutol|mesh-list
2172667|NCT00001058|Rifabutin|rifabutin|mesh-list
2172668|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2172669|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2172670|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
2172671|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172672|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172673|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172674|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172675|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
2638530|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2638531|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638532|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638533|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2638534|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2638535|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2638536|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2638537|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
2638538|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638539|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638540|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2638541|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2638542|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
2638543|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2638544|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2638545|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
2638546|NCT01979796|Nicotine|nicotine|mesh-list
2638547|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2638548|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
2638549|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638550|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638551|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2638552|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2638553|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
2638554|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638555|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638556|NCT01979965|Ranolazine|ranolazine|mesh-list
2638557|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2638558|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2638559|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638560|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
2638561|NCT01980004|Diuretics|diuretics|mesh-ancestor
2638562|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
2638563|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638564|NCT01980004|Expectorants|expectorants|mesh-ancestor
2638565|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
2638566|NCT01980069|Neostigmine|neostigmine|mesh-list
2638567|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2638568|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638569|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638570|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
2638571|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638572|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172676|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172677|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2638573|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2638574|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
2638575|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638576|NCT01980082|Cefazolin|cefazolin|mesh-list
2638577|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2638578|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638579|NCT01980277|Paclitaxel|paclitaxel|mesh-list
2638580|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2638581|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638582|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
2638583|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
2638584|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
2638585|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638586|NCT01980303|Esketamine|esketamine|mesh-list
2638587|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
2638588|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2638589|NCT01980316|Heparin|heparin|mesh-list
2638590|NCT01980316|Calcium heparin|calcium heparin|mesh-list
2638591|NCT01980316|Argatroban|argatroban|mesh-list
2172678|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172679|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2172680|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2172681|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
2172682|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2172683|NCT00001059|Doxorubicin|doxorubicin|mesh-list
2172684|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2172685|NCT00001059|Bleomycin|bleomycin|mesh-list
2172686|NCT00001059|Vincristine|vincristine|mesh-list
2172687|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2172688|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172689|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2172690|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2172691|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638592|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
2638593|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2638594|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2638595|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638596|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
2638597|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2172692|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172693|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2172694|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
2172695|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
2172696|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
2172697|NCT00001061|Ganciclovir|ganciclovir|mesh-list
2172698|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2172699|NCT00001061|Foscarnet|foscarnet|mesh-list
2172700|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2172701|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
2172702|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172703|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2638598|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
2638599|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638600|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2638601|NCT01980329|Maraviroc|maraviroc|mesh-list
2638602|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2638603|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2638604|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638605|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2638606|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172704|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172705|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172706|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172707|NCT00001062|Ganciclovir|ganciclovir|mesh-list
2172708|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2172709|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
2172710|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172711|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172712|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172713|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172714|NCT00001063|Zidovudine|zidovudine|mesh-list
2172715|NCT00001063|Stavudine|stavudine|mesh-list
2172716|NCT00001063|Didanosine|didanosine|mesh-list
2172717|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
2172718|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172719|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172720|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2638607|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
2638608|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638609|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2638610|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
2638611|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2638612|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2638613|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638614|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
2172721|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172722|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
2172723|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172724|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172725|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172726|NCT00001065|Amphotericin B|amphotericin b|mesh-list
2172727|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2172728|NCT00001065|Amebicides|amebicides|mesh-ancestor
2172729|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2172730|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2638615|NCT01980355|Coagulants|coagulants|mesh-ancestor
2638616|NCT01980407|Leucovorin|leucovorin|mesh-list
2638617|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
2638618|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
2638619|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638620|NCT01980407|Antidotes|antidotes|mesh-ancestor
2638621|NCT01980407|Protective Agents|protective agents|mesh-ancestor
2638622|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638623|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
2638624|NCT01980407|Vitamins|vitamins|mesh-ancestor
2638625|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
2638626|NCT01980472|Paclitaxel|paclitaxel|mesh-list
2638627|NCT01980472|Bevacizumab|bevacizumab|mesh-list
2638628|NCT01980472|Carboplatin|carboplatin|mesh-list
2638629|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2638630|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638631|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
2638632|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
2638633|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
2638634|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638635|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2638636|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2638637|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2638638|NCT01980472|Growth Substances|growth substances|mesh-ancestor
2638639|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638640|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
2638641|NCT01980498|Fentanyl|fentanyl|mesh-list
2638642|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2638643|NCT01980498|Narcotics|narcotics|mesh-ancestor
2638644|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638645|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638646|NCT01980498|Analgesics|analgesics|mesh-ancestor
2638647|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
2638648|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638649|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2638650|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2638651|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
2638652|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
2638653|NCT01980550|Nicotine|nicotine|mesh-list
2638654|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2638655|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
2638656|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2172731|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172732|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2172733|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
2172734|NCT00001066|Lamivudine|lamivudine|mesh-list
2172735|NCT00001066|Zidovudine|zidovudine|mesh-list
2172736|NCT00001066|Didanosine|didanosine|mesh-list
2172737|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172738|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2638657|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638658|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2638659|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2638660|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
2638661|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638662|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638663|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2638664|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2172739|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172740|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638665|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
2172741|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
2172742|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172743|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172744|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172745|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
2172746|NCT00001067|Lamivudine|lamivudine|mesh-list
2172747|NCT00001067|Zidovudine|zidovudine|mesh-list
2172748|NCT00001067|Stavudine|stavudine|mesh-list
2172749|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172750|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172751|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172752|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172753|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
2172754|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172755|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2638666|NCT01980667|Cisplatin|cisplatin|mesh-list
2638667|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638668|NCT01980680|Estradiol|estradiol|mesh-list
2638669|NCT01980680|Progesterone|progesterone|mesh-list
2638670|NCT01980680|Estrogens|estrogens|mesh-ancestor
2638671|NCT01980680|Hormones|hormones|mesh-ancestor
2172756|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172757|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
2172758|NCT00001068|Lamivudine|lamivudine|mesh-list
2172759|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172760|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172761|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172762|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172763|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
2172764|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172765|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172766|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172767|NCT00001070|Ascorbic Acid|ascorbic acid|mesh-list
2172768|NCT00001070|Vitamins|vitamins|mesh-ancestor
2172769|NCT00001070|Micronutrients|micronutrients|mesh-ancestor
2172770|NCT00001070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172771|NCT00001070|Antioxidants|antioxidants|mesh-ancestor
2172772|NCT00001070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172773|NCT00001070|Protective Agents|protective agents|mesh-ancestor
2172774|NCT00001071|Lenograstim|lenograstim|mesh-list
2172775|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2172776|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
2638672|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2638673|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638674|NCT01980680|Progestins|progestins|mesh-ancestor
2638675|NCT01980745|Chloroquine|chloroquine|mesh-list
2638676|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2638677|NCT01980745|Amebicides|amebicides|mesh-ancestor
2638678|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2172777|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172778|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
2172779|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2172780|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
2172781|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172782|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2172783|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172784|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
2172785|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172786|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
2172787|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2172788|NCT00001072|Protective Agents|protective agents|mesh-ancestor
2172789|NCT00001073|Isotretinoin|isotretinoin|mesh-list
2172790|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
2172791|NCT00001074|Didanosine|didanosine|mesh-list
2172792|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
2172793|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172794|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
2172795|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172796|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172797|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172798|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
2172799|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172800|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
2172801|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172802|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172803|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172804|NCT00001075|Ritonavir|ritonavir|mesh-list
2172805|NCT00001075|Lamivudine|lamivudine|mesh-list
2638679|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2638680|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638681|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
2638682|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2638683|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2638684|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2638685|NCT01980745|Analgesics|analgesics|mesh-ancestor
2638686|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
2638687|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638688|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638689|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2638690|NCT01980745|Filaricides|filaricides|mesh-ancestor
2638691|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
2638692|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
2638693|NCT01980810|Paclitaxel|paclitaxel|mesh-list
2638694|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2638695|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2638696|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172806|NCT00001075|Zidovudine|zidovudine|mesh-list
2172807|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2638697|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
2638698|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
2638699|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
2638700|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638701|NCT01980823|Metformin|metformin|mesh-list
2638702|NCT01980823|Atorvastatin|atorvastatin|mesh-list
2638703|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2638704|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638705|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2638706|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2638707|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
2638708|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638709|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2638710|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2638711|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638712|NCT01980849|Nadroparin|nadroparin|mesh-list
2638713|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
2638714|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2638715|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2638716|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638717|NCT01980966|Oseltamivir|oseltamivir|mesh-list
2638718|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
2638719|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638720|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172808|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2172809|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
2172810|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172811|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172812|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172813|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172814|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
2172815|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172816|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2172817|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172818|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172819|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172820|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
2172821|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
2172822|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2172823|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
2172824|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172825|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2172826|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172827|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
2172828|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172829|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
2172830|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2172831|NCT00001076|Protective Agents|protective agents|mesh-ancestor
2172832|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
2638721|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638722|NCT01980979|Treprostinil|treprostinil|mesh-list
2638723|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2638724|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
2638725|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2172833|NCT00001079|Megestrol|megestrol|mesh-list
2172834|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
2172835|NCT00001079|Testosterone|testosterone|mesh-list
2172836|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
2172837|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
2172838|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2172839|NCT00001079|Androgens|androgens|mesh-ancestor
2172840|NCT00001079|Hormones|hormones|mesh-ancestor
2172841|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2172842|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172843|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2172844|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2172845|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
2172846|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2172847|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2172848|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2172849|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
2172850|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2172851|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2638726|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638727|NCT01981278|Tapentadol|tapentadol|mesh-list
2638728|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2638729|NCT01981278|Narcotics|narcotics|mesh-ancestor
2638730|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638731|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638732|NCT01981278|Analgesics|analgesics|mesh-ancestor
2638733|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
2638734|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2172852|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2172853|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
2172854|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2172855|NCT00001080|Lamivudine|lamivudine|mesh-list
2172856|NCT00001080|Vaccines|vaccines|mesh-list
2638735|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2638736|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2638737|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2638738|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638739|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
2638740|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638741|NCT01981291|Anesthetics|anesthetics|mesh-list
2638742|NCT01981291|Mepivacaine|mepivacaine|mesh-list
2638743|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
2638744|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638745|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638746|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
2638747|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638748|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
2638749|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2638750|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
2638751|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638752|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
2638753|NCT01981330|Protective Agents|protective agents|mesh-ancestor
2638754|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
2638755|NCT01981369|Propofol|propofol|mesh-list
2638756|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2638757|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638758|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638759|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2638760|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
2638761|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
2638762|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2638763|NCT01981369|Analgesics|analgesics|mesh-ancestor
2638764|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
2638765|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638766|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2638767|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2638768|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2638769|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
2638770|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638771|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172857|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2172858|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
2172859|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172860|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172861|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172862|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638772|NCT01981447|Lacosamide|lacosamide|mesh-list
2638773|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
2638774|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2638775|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2638776|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2638777|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638778|NCT01981460|Methylene Blue|methylene blue|mesh-list
2638779|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638780|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638781|NCT01981499|Cetirizine|cetirizine|mesh-list
2638782|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2638783|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2638784|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2638785|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
2638786|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
2638787|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638788|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638789|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638790|NCT01981525|Metformin|metformin|mesh-list
2638791|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2638792|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638793|NCT01981707|Choline|choline|mesh-list
2638794|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
2638795|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2638796|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
2638797|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638798|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2638799|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2638800|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
2638801|NCT01981746|Ropivacaine|ropivacaine|mesh-list
2638802|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
2638803|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
2638804|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638805|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638806|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
2638807|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638808|NCT01981811|Aripiprazole|aripiprazole|mesh-list
2638809|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
2638810|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2638811|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2638812|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2638813|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638814|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638815|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
2638816|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
2638817|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638818|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638819|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2638820|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2638821|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
2638822|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2638823|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2638824|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2638825|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2638826|NCT01981889|Prednisone|prednisone|mesh-list
2638827|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2638828|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
2638829|NCT01981889|Hormones|hormones|mesh-ancestor
2638830|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2638831|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638832|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2638833|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638834|NCT01981941|Gabapentin|gabapentin|mesh-list
2638835|NCT01981941|Analgesics|analgesics|mesh-ancestor
2638836|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
2638837|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638838|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638839|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
2638840|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2638841|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2638842|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638843|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2638844|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2638845|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2638846|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638847|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638848|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
2638849|NCT01982019|Hormones|hormones|mesh-list
2638850|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2172863|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172864|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
2172865|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172866|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172867|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172868|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
2172869|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2172870|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172871|NCT00001082|Adefovir|adefovir|mesh-list
2172872|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2172873|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
2172874|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172875|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172876|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172877|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172878|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172879|NCT00001083|Ritonavir|ritonavir|mesh-list
2172880|NCT00001083|Indinavir|indinavir|mesh-list
2172881|NCT00001083|Lamivudine|lamivudine|mesh-list
2172882|NCT00001083|Zidovudine|zidovudine|mesh-list
2172883|NCT00001083|Nevirapine|nevirapine|mesh-list
2172884|NCT00001083|Stavudine|stavudine|mesh-list
2172885|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2172886|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2172887|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
2172888|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172889|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172890|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172891|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172892|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
2172893|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638851|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638852|NCT01982071|Micafungin|micafungin|mesh-list
2638853|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
2638854|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638855|NCT01982097|Sorafenib|sorafenib|mesh-list
2638856|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638857|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2638858|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638859|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172894|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2172895|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172896|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172897|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172898|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
2172899|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2172900|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2172901|NCT00001084|Lamivudine|lamivudine|mesh-list
2172902|NCT00001084|Zidovudine|zidovudine|mesh-list
2172903|NCT00001084|Stavudine|stavudine|mesh-list
2172904|NCT00001084|Indinavir|indinavir|mesh-list
2172905|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172906|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172907|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172908|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172909|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
2172910|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172911|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172912|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172913|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
2172914|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2172915|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2172916|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
2172917|NCT00001085|Lamivudine|lamivudine|mesh-list
2172918|NCT00001085|Zidovudine|zidovudine|mesh-list
2172919|NCT00001085|Amprenavir|amprenavir|mesh-list
2172920|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172921|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172922|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172923|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172924|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
2172925|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172926|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2638860|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
2638861|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2638862|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638863|NCT01982201|Lesinurad|lesinurad|mesh-list
2638864|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
2638865|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2638866|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
2638867|NCT01982201|Renal Agents|renal agents|mesh-ancestor
2638868|NCT01982396|Lamivudine|lamivudine|mesh-list
2638869|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2638870|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2638871|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638872|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638873|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
2638874|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638875|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2638876|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2638877|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2638878|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2638879|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2638880|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
2638881|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638882|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2638883|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2638884|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638885|NCT01982578|Genistein|genistein|mesh-list
2638886|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2638887|NCT01982578|Protective Agents|protective agents|mesh-ancestor
2638888|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638889|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638890|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2638891|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638892|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638893|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
2638894|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2638895|NCT01982578|Estrogens|estrogens|mesh-ancestor
2638896|NCT01982578|Hormones|hormones|mesh-ancestor
2638897|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2638898|NCT01982734|Curcumin|curcumin|mesh-list
2638899|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2638900|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2638901|NCT01982734|Analgesics|analgesics|mesh-ancestor
2638902|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
2638903|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638904|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638905|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2638906|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2638907|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638908|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638909|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638910|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2638911|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
2638912|NCT01982760|Coagulants|coagulants|mesh-ancestor
2638913|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2638914|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
2638915|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638916|NCT01982799|Acetaminophen|acetaminophen|mesh-list
2638917|NCT01982799|Ibuprofen|ibuprofen|mesh-list
2638918|NCT01982799|Naproxen|naproxen|mesh-list
2638919|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2638920|NCT01982799|Hydrocodone|hydrocodone|mesh-list
2638921|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2638922|NCT01982799|Analgesics|analgesics|mesh-ancestor
2638923|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
2638924|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638925|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638926|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
2638927|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2638928|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2638929|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2172927|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172928|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
2172929|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2638930|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2638931|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638932|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638933|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
2638934|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2638935|NCT01982799|Narcotics|narcotics|mesh-ancestor
2638936|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638937|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
2638938|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
2172930|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
2172931|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2172932|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2172933|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2172934|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
2172935|NCT00001086|Efavirenz|efavirenz|mesh-list
2172936|NCT00001086|Abacavir|abacavir|mesh-list
2172937|NCT00001086|Indinavir|indinavir|mesh-list
2172938|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172939|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2172940|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172941|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172942|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
2172943|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172944|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2172945|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2638939|NCT01982864|Gentamicins|gentamicins|mesh-list
2638940|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2638941|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2638942|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2638943|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638944|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638945|NCT01982929|Epinephrine|epinephrine|mesh-list
2638946|NCT01982929|Bupivacaine|bupivacaine|mesh-list
2638947|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
2638948|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
2638949|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638950|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638951|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
2638952|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638953|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2638954|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2638955|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
2638956|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2638957|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638958|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2638959|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2638960|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
2638961|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2638962|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
2638963|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
2638964|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
2638965|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2638966|NCT01983124|Vemurafenib|vemurafenib|mesh-list
2638967|NCT01983124|Fotemustine|fotemustine|mesh-list
2638968|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2638969|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2638970|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2638971|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638972|NCT01983137|Oxycodone|oxycodone|mesh-list
2638973|NCT01983137|Naloxone|naloxone|mesh-list
2638974|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2638975|NCT01983137|Narcotics|narcotics|mesh-ancestor
2638976|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638977|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638978|NCT01983137|Analgesics|analgesics|mesh-ancestor
2638979|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
2638980|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2638981|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2172946|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2172947|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2172948|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2172949|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2172950|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172951|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172952|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2172953|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2638982|NCT01983306|Dolcanatide|dolcanatide|mesh-list
2638983|NCT01983306|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2638984|NCT01983306|Enzyme Activators|enzyme activators|mesh-ancestor
2638985|NCT01983306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2638986|NCT01983306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2638987|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2638988|NCT01983371|Hematinics|hematinics|mesh-ancestor
2638989|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2638990|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2638991|NCT01983384|Anesthetics|anesthetics|mesh-list
2638992|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2638993|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2638994|NCT01983449|Dexamethasone|dexamethasone|mesh-list
2638995|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
2638996|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2638997|NCT01983449|BB 1101|bb 1101|mesh-list
2638998|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2638999|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
2639000|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
2639001|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2172954|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
2172955|NCT00001087|Ritonavir|ritonavir|mesh-list
2172956|NCT00001087|Nelfinavir|nelfinavir|mesh-list
2172957|NCT00001087|Saquinavir|saquinavir|mesh-list
2172958|NCT00001087|Lamivudine|lamivudine|mesh-list
2172959|NCT00001087|Zidovudine|zidovudine|mesh-list
2172960|NCT00001087|Stavudine|stavudine|mesh-list
2172961|NCT00001087|Didanosine|didanosine|mesh-list
2639002|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639003|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2639004|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
2639005|NCT01983449|Hormones|hormones|mesh-ancestor
2639006|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639007|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2639008|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639009|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
2639010|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639011|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172962|NCT00001087|Zalcitabine|zalcitabine|mesh-list
2172963|NCT00001087|Efavirenz|efavirenz|mesh-list
2172964|NCT00001087|Adefovir|adefovir|mesh-list
2172965|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2172966|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2172967|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2172968|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
2172969|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2172970|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2172971|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2172972|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2172973|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
2639012|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2639013|NCT01983462|Clonidine|clonidine|mesh-list
2639014|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2639015|NCT01983462|Diuretics|diuretics|mesh-ancestor
2639016|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
2639017|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639018|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2639019|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2639020|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639021|NCT01983462|Analgesics|analgesics|mesh-ancestor
2639022|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
2639023|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639024|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
2639025|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
2639026|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2639027|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2639028|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2639029|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
2639030|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2639031|NCT01983475|Denosumab|denosumab|mesh-list
2639032|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2639033|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639034|NCT01983501|Tucatinib|tucatinib|mesh-list
2172974|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2172975|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2172976|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2172977|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2172978|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2639035|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639036|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639037|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2639038|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639039|NCT01983514|Oxytocin|oxytocin|mesh-list
2172979|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
2172980|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2172981|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2172982|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2172983|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2172984|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2172985|NCT00001088|Bupivacaine|bupivacaine|mesh-list
2172986|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
2172987|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
2172988|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2172989|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172990|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
2172991|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2172992|NCT00001090|Sargramostim|sargramostim|mesh-list
2172993|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
2172994|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2172995|NCT00001091|Ritonavir|ritonavir|mesh-list
2172996|NCT00001091|Nelfinavir|nelfinavir|mesh-list
2639040|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
2639041|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2639042|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639043|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
2639044|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2172997|NCT00001091|Lamivudine|lamivudine|mesh-list
2172998|NCT00001091|Nevirapine|nevirapine|mesh-list
2172999|NCT00001091|Stavudine|stavudine|mesh-list
2173000|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2173001|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2173002|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
2173003|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173004|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173005|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173006|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173007|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
2173008|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173009|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2173010|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2173011|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173012|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173013|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2173014|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2173015|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
2173016|NCT00001094|Lamivudine|lamivudine|mesh-list
2173017|NCT00001094|Zidovudine|zidovudine|mesh-list
2173018|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2173019|NCT00001094|Delavirdine|delavirdine|mesh-list
2173020|NCT00001094|Nelfinavir|nelfinavir|mesh-list
2173021|NCT00001094|Saquinavir|saquinavir|mesh-list
2173022|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173023|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173024|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173025|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173026|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
2173027|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173028|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173029|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173030|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
2173031|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2173032|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2173033|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
2173034|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2173035|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2173036|NCT00001095|Lamivudine|lamivudine|mesh-list
2173037|NCT00001095|Zidovudine|zidovudine|mesh-list
2173038|NCT00001095|Nevirapine|nevirapine|mesh-list
2173039|NCT00001095|Stavudine|stavudine|mesh-list
2173040|NCT00001095|Indinavir|indinavir|mesh-list
2173041|NCT00001095|Amprenavir|amprenavir|mesh-list
2173042|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173043|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173044|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184884|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2639045|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2639046|NCT01983527|Prednisolone|prednisolone|mesh-list
2639047|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
2639048|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2639049|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
2639050|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2639051|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
2639052|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
2639053|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639054|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639055|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2639056|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
2639057|NCT01983527|Hormones|hormones|mesh-ancestor
2639058|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173045|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173046|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
2173047|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173048|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173049|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173050|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
2173051|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2173052|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2173053|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2173054|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2173055|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
2173056|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2173057|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
2173058|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2173059|NCT00001100|Ganciclovir|ganciclovir|mesh-list
2173060|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2173061|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
2173062|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173063|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173064|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639059|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2639060|NCT01983527|Protective Agents|protective agents|mesh-ancestor
2639061|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2639062|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639063|NCT01983540|Vaccines|vaccines|mesh-list
2639064|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2639065|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
2639066|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639067|NCT01983579|Bevacizumab|bevacizumab|mesh-list
2639068|NCT01983579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2639069|NCT01983579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639070|NCT01983579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2639071|NCT01983579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2639072|NCT01983579|Growth Substances|growth substances|mesh-ancestor
2639073|NCT01983579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639074|NCT01983579|Growth Inhibitors|growth inhibitors|mesh-ancestor
2422341|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422342|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2422343|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2422344|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
2422345|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422346|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422347|NCT00816972|Urological Agents|urological agents|mesh-ancestor
2422348|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2639075|NCT01983657|Molgramostim|molgramostim|mesh-list
2639076|NCT01983657|Sargramostim|sargramostim|mesh-list
2639077|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
2639078|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639079|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639080|NCT01983722|Stiripentol|stiripentol|mesh-list
2173065|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173066|NCT00001101|Doxycycline|doxycycline|mesh-list
2173067|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
2173068|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2173069|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173070|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
2173071|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2173072|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2173073|NCT00001104|Zidovudine|zidovudine|mesh-list
2173074|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
2639081|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
2639082|NCT01983735|Niacin|niacin|mesh-list
2639083|NCT01983735|Amlodipine|amlodipine|mesh-list
2639084|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2639085|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2639086|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2639087|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639088|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2639089|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639090|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
2639091|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2173075|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173076|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173077|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173078|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173079|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
2173080|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173081|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173082|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173083|NCT00001105|Antibodies|antibodies|mesh-list
2173084|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2173085|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
2173086|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173087|NCT00001106|Zidovudine|zidovudine|mesh-list
2173088|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
2173089|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173090|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173091|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173092|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173093|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
2173094|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173095|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173096|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173097|NCT00001107|Fluconazole|fluconazole|mesh-list
2173098|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2173099|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
2173100|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173101|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2173102|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2173103|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173104|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173105|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2173106|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
2173107|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173108|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173109|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2173110|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2173111|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2173112|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2173113|NCT00001108|Ritonavir|ritonavir|mesh-list
2173114|NCT00001108|Nelfinavir|nelfinavir|mesh-list
2173115|NCT00001108|Saquinavir|saquinavir|mesh-list
2173116|NCT00001108|Lamivudine|lamivudine|mesh-list
2173117|NCT00001108|Nevirapine|nevirapine|mesh-list
2173118|NCT00001108|Stavudine|stavudine|mesh-list
2173119|NCT00001108|Didanosine|didanosine|mesh-list
2173120|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2173121|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2173122|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
2173123|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173124|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173125|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173126|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173127|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
2173128|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173129|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2173130|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2173131|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173132|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173133|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2173134|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2173135|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
2173136|NCT00001111|Zidovudine|zidovudine|mesh-list
2173137|NCT00001111|Nevirapine|nevirapine|mesh-list
2173138|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
2173139|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639092|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
2639093|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2639094|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
2639095|NCT01983735|Vitamins|vitamins|mesh-ancestor
2639096|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
2639097|NCT01983761|Vidarabine|vidarabine|mesh-list
2639098|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
2639099|NCT01983761|Fludarabine|fludarabine|mesh-list
2639100|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
2639101|NCT01983761|Melphalan|melphalan|mesh-list
2639102|NCT01983761|Busulfan|busulfan|mesh-list
2639103|NCT01983761|Clofarabine|clofarabine|mesh-list
2639104|NCT01983761|Tacrolimus|tacrolimus|mesh-list
2639105|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639106|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
2639107|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639108|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2639109|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
2639110|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639111|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2639112|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
2639113|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2639114|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2639115|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639116|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2639117|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2639118|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
2639119|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2639120|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2639121|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
2639122|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2639123|NCT01983774|Esomeprazole|esomeprazole|mesh-list
2639124|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2639125|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2639126|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2639127|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639128|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639129|NCT01983800|Midazolam|midazolam|mesh-list
2639130|NCT01983800|Propofol|propofol|mesh-list
2173140|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173141|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173142|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173143|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
2173144|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173145|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173146|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173147|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2173148|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2173149|NCT00001112|Interferons|interferons|mesh-list
2173150|NCT00001112|Zidovudine|zidovudine|mesh-list
2173151|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
2173152|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173153|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
2173154|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173155|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
2173156|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173157|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173158|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173159|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173160|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173161|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173162|NCT00001113|Interferons|interferons|mesh-list
2173163|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
2173164|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
2173165|NCT00001113|Zidovudine|zidovudine|mesh-list
2173166|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173167|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
2173168|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173169|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
2173170|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173171|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
2173172|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173173|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173174|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173175|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639131|NCT01983800|Isoflurane|isoflurane|mesh-list
2639132|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2639133|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2639134|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639135|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2639136|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
2639137|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
2639138|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2639139|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2173176|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173177|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173178|NCT00001114|Interferons|interferons|mesh-list
2173179|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
2173180|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
2173181|NCT00001114|Didanosine|didanosine|mesh-list
2173182|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173183|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
2173184|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173185|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
2173186|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173187|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
2173188|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173189|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173190|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173191|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173192|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173193|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173194|NCT00001115|Acyclovir|acyclovir|mesh-list
2173195|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
2173196|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173197|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
2173198|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2173199|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2173200|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173201|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173202|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173203|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
2173204|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173205|NCT00001119|Ritonavir|ritonavir|mesh-list
2173206|NCT00001119|Indinavir|indinavir|mesh-list
2173207|NCT00001119|Amprenavir|amprenavir|mesh-list
2173208|NCT00001119|Lamivudine|lamivudine|mesh-list
2173209|NCT00001119|Zidovudine|zidovudine|mesh-list
2173210|NCT00001119|Abacavir|abacavir|mesh-list
2173211|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2173212|NCT00001119|Efavirenz|efavirenz|mesh-list
2173213|NCT00001119|Vaccines|vaccines|mesh-list
2173214|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
2173215|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173216|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2173217|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2173218|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
2173219|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639140|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2639141|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2639142|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
2639143|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
2639144|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2639145|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639146|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2639147|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
2639148|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2639149|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
2639150|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639151|NCT01983943|Protective Agents|protective agents|mesh-ancestor
2639152|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639153|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2639154|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
2639155|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
2639156|NCT01984008|Citric Acid|citric acid|mesh-list
2639157|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
2639158|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
2639159|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2639160|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
2639161|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
2639162|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173220|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173221|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173222|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173223|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
2173224|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2639163|NCT01984008|Cathartics|cathartics|mesh-ancestor
2639164|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2639165|NCT01984008|Antacids|antacids|mesh-ancestor
2639166|NCT01984073|Niacin|niacin|mesh-list
2639167|NCT01984073|Niacinamide|niacinamide|mesh-list
2639168|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
2639169|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2639170|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
2639171|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639172|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2639173|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
2639174|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
2639175|NCT01984073|Vitamins|vitamins|mesh-ancestor
2639176|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
2639177|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639178|NCT01984086|Albuterol|albuterol|mesh-list
2639179|NCT01984086|Charcoal|charcoal|mesh-list
2639180|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2639181|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
2173225|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2173226|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2173227|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173228|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173229|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
2173230|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2173231|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2173232|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2173233|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2173234|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2639182|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639183|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639184|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2639185|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
2639186|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
2639187|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2639188|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2639189|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2173235|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2173236|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
2173237|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2173238|NCT00001122|Efavirenz|efavirenz|mesh-list
2173239|NCT00001122|Stavudine|stavudine|mesh-list
2173240|NCT00001122|Didanosine|didanosine|mesh-list
2173241|NCT00001122|Nelfinavir|nelfinavir|mesh-list
2173242|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173243|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173244|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173245|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173246|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
2173247|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173248|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2173249|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2173250|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2173251|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2173252|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2173253|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2173254|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
2173255|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173256|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173257|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2173258|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2173259|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
2173260|NCT00001123|Ribavirin|ribavirin|mesh-list
2173261|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
2173262|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173263|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
2173264|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173265|NCT00001126|Cidofovir|cidofovir|mesh-list
2173266|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
2173267|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173268|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173269|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173270|NCT00001128|Azithromycin|azithromycin|mesh-list
2173271|NCT00001128|Paromomycin|paromomycin|mesh-list
2173272|NCT00001128|Interleukin-12|interleukin-12|mesh-list
2173273|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2639190|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2639191|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
2639192|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2639193|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639194|NCT01984086|Antidotes|antidotes|mesh-ancestor
2173274|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173275|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2173276|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
2173277|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173278|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2639195|NCT01984086|Protective Agents|protective agents|mesh-ancestor
2639196|NCT01984099|Folic Acid|folic acid|mesh-list
2639197|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
2639198|NCT01984099|Methotrexate|methotrexate|mesh-list
2639199|NCT01984099|Vitamins|vitamins|mesh-ancestor
2639200|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
2639201|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639202|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2639203|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
2639204|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2639205|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2639206|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
2639207|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639208|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639209|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
2639210|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639211|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2639212|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2639213|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
2639214|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2639215|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2639216|NCT01984099|Hematinics|hematinics|mesh-ancestor
2639217|NCT01984138|Estradiol|estradiol|mesh-list
2639218|NCT01984138|Estrogens|estrogens|mesh-ancestor
2639219|NCT01984138|Hormones|hormones|mesh-ancestor
2173279|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2173280|NCT00001128|Growth Substances|growth substances|mesh-ancestor
2173281|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
2173282|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173283|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2173284|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2173285|NCT00001131|Aldesleukin|aldesleukin|mesh-list
2173286|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173287|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173288|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173289|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
2173290|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173291|NCT00001132|Abacavir|abacavir|mesh-list
2173292|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173293|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173294|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173295|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173296|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
2173297|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173298|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173299|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173300|NCT00001133|Ritonavir|ritonavir|mesh-list
2173301|NCT00001133|Indinavir|indinavir|mesh-list
2173302|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2173303|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2173304|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
2173305|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173306|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173307|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173308|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173309|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
2173310|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173311|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2173312|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2173313|NCT00001135|Nevirapine|nevirapine|mesh-list
2173314|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173315|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173316|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173317|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173318|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
2173319|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173320|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2639220|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639221|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639222|NCT01984177|Hormones|hormones|mesh-list
2639223|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2639224|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
2639225|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639226|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639227|NCT01984255|Ipilimumab|ipilimumab|mesh-list
2639228|NCT01984255|Bavituximab|bavituximab|mesh-list
2639229|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2639230|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639231|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2639232|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639233|NCT01984372|Insulin|insulin|mesh-list
2639234|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2639235|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639236|NCT01984463|Fentanyl|fentanyl|mesh-list
2639237|NCT01984463|Morphine|morphine|mesh-list
2639238|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2639239|NCT01984463|Narcotics|narcotics|mesh-ancestor
2639240|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2639241|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639242|NCT01984463|Analgesics|analgesics|mesh-ancestor
2639243|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
2639244|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639245|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2639246|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2639247|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
2173321|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173322|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2173323|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2173324|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2173325|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2173326|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2173327|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
2173328|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173329|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
2173330|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173331|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2639248|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
2639249|NCT01984567|Vitamin E|vitamin e|mesh-list
2639250|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
2639251|NCT01984567|Vitamins|vitamins|mesh-ancestor
2639252|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
2639253|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639254|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
2639255|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639256|NCT01984567|Protective Agents|protective agents|mesh-ancestor
2639257|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
2639258|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2639259|NCT01984606|Empagliflozin|empagliflozin|mesh-list
2639260|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2639261|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639262|NCT01984606|Incretins|incretins|mesh-ancestor
2639263|NCT01984606|Hormones|hormones|mesh-ancestor
2639264|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639265|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2639266|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
2639267|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173332|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2173333|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
2173334|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173335|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173336|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2173337|NCT00001165|Doxorubicin|doxorubicin|mesh-list
2173338|NCT00001165|Streptozocin|streptozocin|mesh-list
2173339|NCT00001165|Fluorouracil|fluorouracil|mesh-list
2173340|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2173341|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173342|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2173343|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2173344|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173345|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173346|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
2639268|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639269|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2639270|NCT01984749|Febuxostat|febuxostat|mesh-list
2639271|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
2639272|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2639273|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
2639274|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2639275|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2639276|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2639277|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2639278|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639279|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639280|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639281|NCT01984931|Medazepam|medazepam|mesh-list
2639282|NCT01984931|Metoclopramide|metoclopramide|mesh-list
2639283|NCT01984931|Bromazepam|bromazepam|mesh-list
2639284|NCT01984931|Simethicone|simethicone|mesh-list
2639285|NCT01984931|Trimebutine|trimebutine|mesh-list
2639286|NCT01984931|Mosapride|mosapride|mesh-list
2639287|NCT01984931|Maleic acid|maleic acid|mesh-list
2639288|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639289|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639290|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
2639291|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
2639292|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639293|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639294|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2639295|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2639296|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2639297|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
2639298|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2639299|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
2173347|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2173348|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173349|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
2173350|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173351|NCT00001180|Hormones|hormones|mesh-list
2173352|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2173353|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
2173354|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173355|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173356|NCT00001181|Testolactone|testolactone|mesh-list
2173357|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2173358|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173359|NCT00001190|Deslorelin|deslorelin|mesh-list
2173360|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173361|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173362|NCT00001191|Omeprazole|omeprazole|mesh-list
2173363|NCT00001191|Pantoprazole|pantoprazole|mesh-list
2173364|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2173365|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2173366|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2173367|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173368|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173369|NCT00001193|Melphalan|melphalan|mesh-list
2173370|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2173371|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
2173372|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173373|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173374|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2173375|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173376|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
2173377|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173378|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
2173379|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173380|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
2173381|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173382|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173383|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173384|NCT00001202|Testolactone|testolactone|mesh-list
2173385|NCT00001202|Spironolactone|spironolactone|mesh-list
2173386|NCT00001202|Deslorelin|deslorelin|mesh-list
2173387|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2173388|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
2184885|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
2173389|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173390|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173391|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2173392|NCT00001202|Diuretics|diuretics|mesh-ancestor
2173393|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
2173394|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173395|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173396|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2173397|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173398|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
2173399|NCT00001209|Ifosfamide|ifosfamide|mesh-list
2173400|NCT00001209|Vincristine|vincristine|mesh-list
2639300|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2639301|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
2639302|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
2639303|NCT01984931|Emollients|emollients|mesh-ancestor
2639304|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
2639305|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2639306|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2639307|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2173401|NCT00001209|Doxorubicin|doxorubicin|mesh-list
2173402|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2173403|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173404|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
2173405|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173406|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2173407|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2173408|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
2173409|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173410|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173411|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2173412|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2173413|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
2173414|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
2173415|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
2173416|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2173417|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2173418|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2173419|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173420|NCT00001212|Cyclosporine|cyclosporine|mesh-list
2173421|NCT00001212|Prednisone|prednisone|mesh-list
2173422|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
2173423|NCT00001212|Cyclosporins|cyclosporins|mesh-list
2173424|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173425|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
2173426|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173427|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2173428|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2173429|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
2173430|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173431|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173432|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2173433|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2173434|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
2173435|NCT00001212|Hormones|hormones|mesh-ancestor
2173436|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173437|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2173438|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173439|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
2173440|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173441|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
2173442|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2173443|NCT00001221|Hormones|hormones|mesh-list
2173444|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173445|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173446|NCT00001228|Interferons|interferons|mesh-list
2173447|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173448|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
2173449|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173450|NCT00001237|Molgramostim|molgramostim|mesh-list
2173451|NCT00001237|Sargramostim|sargramostim|mesh-list
2173452|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
2173453|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173454|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173455|NCT00001249|Antibodies|antibodies|mesh-list
2639308|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2639309|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
2639310|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
2639311|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
2639312|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2639313|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2639314|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2639315|NCT01985061|Busulfan|busulfan|mesh-list
2639316|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
2639317|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639318|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2639319|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
2639320|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639321|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2639322|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639323|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2639324|NCT01985087|Temozolomide|temozolomide|mesh-list
2639325|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2639326|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
2639327|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639328|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639329|NCT01985152|Choline|choline|mesh-list
2639330|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2639331|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2639332|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2639333|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173456|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
2173457|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173458|NCT00001251|Mafosfamide|mafosfamide|mesh-list
2173459|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2639334|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
2639335|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2639336|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
2639337|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2639338|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2173460|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
2173461|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173462|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173463|NCT00001256|Prednisone|prednisone|mesh-list
2173464|NCT00001256|Methotrexate|methotrexate|mesh-list
2173465|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2173466|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
2173467|NCT00001256|Hormones|hormones|mesh-ancestor
2173468|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173469|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173470|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2173471|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173472|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2173473|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
2173474|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2173475|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2173476|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
2173477|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173478|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
2173479|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173480|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2173481|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173482|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
2173483|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2173484|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173485|NCT00001259|Leuprolide|leuprolide|mesh-list
2173486|NCT00001259|Estradiol|estradiol|mesh-list
2173487|NCT00001259|Progesterone|progesterone|mesh-list
2173488|NCT00001259|Estrogens|estrogens|mesh-ancestor
2173489|NCT00001259|Hormones|hormones|mesh-ancestor
2173490|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173491|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173492|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2173493|NCT00001259|Progestins|progestins|mesh-ancestor
2173494|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2173495|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
2173496|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2173497|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173498|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
2173499|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2173500|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2639339|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
2639340|NCT01985256|Flucytosine|flucytosine|mesh-list
2639341|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
2639342|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2639343|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
2639344|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639345|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
2639346|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2639347|NCT01985373|Antibodies|antibodies|mesh-list
2639348|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
2639349|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2639350|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
2639351|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639352|NCT01985451|Temozolomide|temozolomide|mesh-list
2639353|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2639354|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
2639355|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639356|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639357|NCT01985477|Dexamethasone|dexamethasone|mesh-list
2639358|NCT01985477|Lenalidomide|lenalidomide|mesh-list
2639359|NCT01985477|Tretinoin|tretinoin|mesh-list
2639360|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2639361|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
2639362|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
2639363|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639364|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639365|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2173501|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
2173502|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173503|NCT00001266|Suramin|suramin|mesh-list
2173504|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
2173505|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
2173506|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2173507|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173508|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173509|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2173510|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2173511|NCT00001267|Zidovudine|zidovudine|mesh-list
2173512|NCT00001267|Didanosine|didanosine|mesh-list
2173513|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
2639366|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
2639367|NCT01985477|Hormones|hormones|mesh-ancestor
2639368|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639369|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2639370|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639371|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
2639372|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2639373|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2639374|NCT01985477|Growth Substances|growth substances|mesh-ancestor
2639375|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
2639376|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
2639377|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
2173514|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173515|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173516|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173517|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173518|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
2173519|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173520|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173521|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173522|NCT00001280|Itraconazole|itraconazole|mesh-list
2173523|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
2173524|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173525|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2173526|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2173527|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173528|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173529|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2173530|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
2173531|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173532|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173533|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2173534|NCT00001282|Zidovudine|zidovudine|mesh-list
2173535|NCT00001282|Interleukin-2|interleukin-2|mesh-list
2173536|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
2173537|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639378|NCT01985594|Nifedipine|nifedipine|mesh-list
2639379|NCT01985594|Progesterone|progesterone|mesh-list
2639380|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2639381|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2639382|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639383|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2639384|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639385|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
2639386|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
2639387|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2639388|NCT01985594|Progestins|progestins|mesh-ancestor
2639389|NCT01985594|Hormones|hormones|mesh-ancestor
2639390|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639391|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
2639392|NCT01985724|Docetaxel|docetaxel|mesh-list
2639393|NCT01985724|Epirubicin|epirubicin|mesh-list
2639394|NCT01985724|Fluorouracil|fluorouracil|mesh-list
2639395|NCT01985724|Mitogens|mitogens|mesh-list
2639396|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2639397|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
2639398|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639399|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2639400|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2639401|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
2173538|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173539|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173540|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173541|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
2173542|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173543|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173544|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173545|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173546|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2173547|NCT00001282|Analgesics|analgesics|mesh-ancestor
2173548|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
2173549|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2173550|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173551|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
2173552|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2173553|NCT00001287|Antibodies|antibodies|mesh-list
2173554|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
2173555|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2173556|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
2173557|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173558|NCT00001296|Interferons|interferons|mesh-list
2173559|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
2173560|NCT00001296|Melphalan|melphalan|mesh-list
2173561|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173562|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
2173563|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173564|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2173565|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
2173566|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173567|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2173568|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173569|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
2639402|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639403|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639404|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2639405|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
2639406|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
2639407|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
2639408|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2639409|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2639410|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2639411|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639412|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
2173570|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173571|NCT00001300|Doxorubicin|doxorubicin|mesh-list
2173572|NCT00001300|Ifosfamide|ifosfamide|mesh-list
2173573|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2173574|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173575|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2173576|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2173577|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639413|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2639414|NCT01985750|Cycloserine|cycloserine|mesh-list
2639415|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2639416|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2639417|NCT01985750|Renal Agents|renal agents|mesh-ancestor
2639418|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2639419|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
2639420|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2639421|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
2639422|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639423|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
2639424|NCT01985789|Promethazine|promethazine|mesh-list
2639425|NCT01985789|Cetirizine|cetirizine|mesh-list
2639426|NCT01985789|Desloratadine|desloratadine|mesh-list
2639427|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2639428|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2639429|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2639430|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639431|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
2173578|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173579|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2173580|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
2173581|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
2173582|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2173583|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
2173584|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2173585|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173586|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2173587|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
2173588|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2173589|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
2173590|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173591|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2173592|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2173593|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
2173594|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
2173595|NCT00001303|Protective Agents|protective agents|mesh-ancestor
2173596|NCT00001307|Capsaicin|capsaicin|mesh-list
2173597|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
2173598|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
2173599|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
2173600|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2173601|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173602|NCT00001311|Heparin|heparin|mesh-list
2173603|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
2173604|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2173605|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2173606|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173607|NCT00001317|Interferons|interferons|mesh-list
2173608|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
2173609|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173610|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
2173611|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173612|NCT00001318|Interferons|interferons|mesh-list
2173613|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
2173614|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173615|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
2173616|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173617|NCT00001322|Leuprolide|leuprolide|mesh-list
2173618|NCT00001322|Progesterone|progesterone|mesh-list
2173619|NCT00001322|Progestins|progestins|mesh-ancestor
2173620|NCT00001322|Hormones|hormones|mesh-ancestor
2173621|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173622|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173623|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2173624|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
2173625|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2173626|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2173627|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173628|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2173629|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2173630|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173631|NCT00001328|Ganciclovir|ganciclovir|mesh-list
2173632|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2173633|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
2173634|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173635|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173636|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639432|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
2173637|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173638|NCT00001332|Cisplatin|cisplatin|mesh-list
2173639|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173640|NCT00001333|Topotecan|topotecan|mesh-list
2173641|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2173642|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2173643|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173644|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173645|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173646|NCT00001335|Topotecan|topotecan|mesh-list
2173647|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2173648|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2173649|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173650|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173651|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173658|NCT00001339|Doxorubicin|doxorubicin|mesh-list
2173659|NCT00001339|Etoposide|etoposide|mesh-list
2173660|NCT00001339|Vincristine|vincristine|mesh-list
2173661|NCT00001339|Mitotane|mitotane|mesh-list
2173662|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2173663|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173664|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2173665|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2173666|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173667|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173668|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2173669|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
2173670|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
2173671|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
2173672|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2173673|NCT00001341|Raltitrexed|raltitrexed|mesh-list
2173674|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2173675|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
2173676|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173677|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173678|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2173679|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173680|NCT00001343|Oxandrolone|oxandrolone|mesh-list
2173681|NCT00001343|Androgens|androgens|mesh-ancestor
2173682|NCT00001343|Hormones|hormones|mesh-ancestor
2173683|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173684|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173685|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
2173686|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
2173687|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
2173688|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
2173689|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2173690|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2173691|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2173692|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173693|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173694|NCT00001354|Zidovudine|zidovudine|mesh-list
2173695|NCT00001354|Interleukin-2|interleukin-2|mesh-list
2173696|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
2173697|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173698|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173699|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173700|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173701|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
2173702|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173703|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173704|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173705|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173706|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2173707|NCT00001354|Analgesics|analgesics|mesh-ancestor
2173708|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
2173709|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2173710|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639433|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
2639434|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639435|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
2639436|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
2639437|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2639438|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2639439|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
2639440|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
2639441|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2639442|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639443|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2639444|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
2639445|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
2173711|NCT00001357|Interleukin-2|interleukin-2|mesh-list
2173712|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173713|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2173714|NCT00001357|Analgesics|analgesics|mesh-ancestor
2173715|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
2173716|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2173717|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173718|NCT00001359|Penicillins|penicillins|mesh-list
2173719|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2173720|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173721|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
2173722|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
2173723|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
2173724|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2173725|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2173726|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2173727|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173728|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173729|NCT00001378|Fenretinide|fenretinide|mesh-list
2173730|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173731|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2173732|NCT00001378|Protective Agents|protective agents|mesh-ancestor
2173733|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173743|NCT00001381|Suramin|suramin|mesh-list
2173744|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
2173745|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
2173746|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2173747|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173748|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173749|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2173750|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2173751|NCT00001383|Paclitaxel|paclitaxel|mesh-list
2173752|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2173753|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173754|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
2173755|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
2173756|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
2173757|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173758|NCT00001384|Paclitaxel|paclitaxel|mesh-list
2173759|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
2173760|NCT00001384|Doxorubicin|doxorubicin|mesh-list
2173761|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2173762|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2173763|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173764|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
2173765|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
2173766|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
2173767|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173768|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173769|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
2173770|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173771|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2173772|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2173773|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
2639446|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2639447|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2639448|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
2639449|NCT01985828|Androgens|androgens|mesh-list
2639450|NCT01985828|Hormones|hormones|mesh-ancestor
2639451|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173774|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2173775|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2173776|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2173777|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2173778|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173779|NCT00001387|Paclitaxel|paclitaxel|mesh-list
2173780|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2173781|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173782|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
2173783|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
2173784|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
2173785|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173786|NCT00001407|Interferons|interferons|mesh-list
2173787|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
2173788|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173789|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
2173790|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173791|NCT00001409|Interleukin-2|interleukin-2|mesh-list
2173792|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173793|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2173794|NCT00001409|Analgesics|analgesics|mesh-ancestor
2173795|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
2173796|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2173797|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173798|NCT00001421|Methimazole|methimazole|mesh-list
2173799|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
2173800|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
2173801|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173802|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173803|NCT00001422|Fludarabine|fludarabine|mesh-list
2173804|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173805|NCT00001426|Paclitaxel|paclitaxel|mesh-list
2173806|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
2173807|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2173808|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173809|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
2173810|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
2173811|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
2173812|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173813|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173814|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
2173815|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173816|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2173817|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2173818|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
2173819|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2173820|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
2173821|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173822|NCT00001428|Fluorouracil|fluorouracil|mesh-list
2173823|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
2173824|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173825|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2173826|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173827|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173828|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
2173829|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173830|NCT00001431|Gemcitabine|gemcitabine|mesh-list
2173831|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2173832|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
2173833|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173834|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173835|NCT00001431|Antiviral Agents|antiviral agents|mesh-ancestor
2173836|NCT00001431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173837|NCT00001431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173838|NCT00001431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173839|NCT00001431|Immunologic Factors|immunologic factors|mesh-ancestor
2173840|NCT00001431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173841|NCT00001436|Tamoxifen|tamoxifen|mesh-list
2173842|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2173843|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
2173844|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2173845|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173846|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2173847|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173848|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2173849|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2639452|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639453|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
2639454|NCT01985841|Docetaxel|docetaxel|mesh-list
2639455|NCT01985841|Fluorouracil|fluorouracil|mesh-list
2639456|NCT01985841|Epirubicin|epirubicin|mesh-list
2639457|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2639458|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
2639459|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639460|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2639461|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2173850|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2173851|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
2173852|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2173853|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173854|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173855|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2173856|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2173857|NCT00001437|Protective Agents|protective agents|mesh-ancestor
2173858|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173859|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
2173860|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2173861|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
2173862|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
2173863|NCT00001438|Tretinoin|tretinoin|mesh-list
2173864|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173865|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
2173866|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
2173867|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
2173868|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173869|NCT00001440|Interleukin-2|interleukin-2|mesh-list
2173870|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173871|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2173872|NCT00001440|Analgesics|analgesics|mesh-ancestor
2173873|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
2173874|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2173875|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173876|NCT00001442|Paclitaxel|paclitaxel|mesh-list
2173877|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2173878|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173879|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
2173880|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
2173881|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
2173882|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173883|NCT00001443|Indinavir|indinavir|mesh-list
2173884|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2173885|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2173886|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
2173887|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173888|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173889|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173890|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173891|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
2173892|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173893|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2173894|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173895|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2173896|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173897|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173898|NCT00001446|Thalidomide|thalidomide|mesh-list
2173899|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173900|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
2173901|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173902|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
2173903|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2173904|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173905|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2173906|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2173907|NCT00001446|Growth Substances|growth substances|mesh-ancestor
2173908|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
2173909|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173910|NCT00001449|Leucovorin|leucovorin|mesh-list
2173911|NCT00001449|Gemcitabine|gemcitabine|mesh-list
2173912|NCT00001449|Floxuridine|floxuridine|mesh-list
2173913|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2173914|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
2173915|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173916|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173917|NCT00001449|Antiviral Agents|antiviral agents|mesh-ancestor
2173918|NCT00001449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173919|NCT00001449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173920|NCT00001449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173921|NCT00001449|Immunologic Factors|immunologic factors|mesh-ancestor
2173922|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173923|NCT00001449|Antidotes|antidotes|mesh-ancestor
2173924|NCT00001449|Protective Agents|protective agents|mesh-ancestor
2173925|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
2173926|NCT00001449|Vitamins|vitamins|mesh-ancestor
2173927|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
2173928|NCT00001450|Paclitaxel|paclitaxel|mesh-list
2173929|NCT00001450|Cisplatin|cisplatin|mesh-list
2173930|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2173931|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173932|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
2173933|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
2173934|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
2173935|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173936|NCT00001457|Lamivudine|lamivudine|mesh-list
2173937|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2173938|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2173939|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2173940|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173941|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
2173942|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173943|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2173944|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2173945|NCT00001474|Interleukin-2|interleukin-2|mesh-list
2173946|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173947|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2173948|NCT00001474|Analgesics|analgesics|mesh-ancestor
2173949|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
2173950|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2173951|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173952|NCT00001475|Thalidomide|thalidomide|mesh-list
2173953|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2173954|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
2173955|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173956|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
2173957|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2173958|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2173959|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2173960|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2173961|NCT00001475|Growth Substances|growth substances|mesh-ancestor
2173962|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
2173963|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2173964|NCT00001482|Lamotrigine|lamotrigine|mesh-list
2173965|NCT00001482|Gabapentin|gabapentin|mesh-list
2173966|NCT00001482|Analgesics|analgesics|mesh-ancestor
2173967|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
2173968|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2173969|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173970|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
2173971|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2173972|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2173973|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2173974|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2173975|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2173976|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2173977|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2173978|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173979|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
2173980|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2173981|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2173982|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2173983|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2639462|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
2639463|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639464|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639465|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2639466|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
2639467|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
2639468|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
2639469|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
2639470|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2639471|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2639472|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2639473|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2639474|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639475|NCT01985854|Propofol|propofol|mesh-list
2639476|NCT01985854|Desflurane|desflurane|mesh-list
2639477|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2639478|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2639479|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639480|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2173984|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2173985|NCT00001483|Sertraline|sertraline|mesh-list
2173986|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2173987|NCT00001483|Bupropion|bupropion|mesh-list
2173988|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
2173989|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2173990|NCT00001483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2173991|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2173992|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2173993|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2173994|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2173995|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
2173996|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2173997|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2173998|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2173999|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2174000|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
2174001|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2174002|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2174003|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174004|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2174005|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2174006|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
2174007|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174008|NCT00001495|Irinotecan|irinotecan|mesh-list
2174009|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2174010|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2174011|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174012|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174013|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174014|NCT00001498|Leucovorin|leucovorin|mesh-list
2174015|NCT00001498|Paclitaxel|paclitaxel|mesh-list
2174016|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
2174017|NCT00001498|Doxorubicin|doxorubicin|mesh-list
2174018|NCT00001498|Fluorouracil|fluorouracil|mesh-list
2174019|NCT00001498|Methotrexate|methotrexate|mesh-list
2174020|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2174021|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174022|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
2174023|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
2174024|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
2174025|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174026|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174027|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
2174028|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174029|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174030|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2174031|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
2174032|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2174033|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2174034|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2174035|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2174036|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174037|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
2174038|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2174039|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2174040|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
2174041|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2174042|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
2174043|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2174044|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2174045|NCT00001498|Antidotes|antidotes|mesh-ancestor
2174046|NCT00001498|Protective Agents|protective agents|mesh-ancestor
2174047|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
2174048|NCT00001498|Vitamins|vitamins|mesh-ancestor
2174049|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
2174050|NCT00001499|Paclitaxel|paclitaxel|mesh-list
2174051|NCT00001499|Cisplatin|cisplatin|mesh-list
2174052|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2174053|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174054|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
2174055|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
2174056|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
2174057|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174058|NCT00001502|Carboplatin|carboplatin|mesh-list
2174059|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174060|NCT00001504|Tretinoin|tretinoin|mesh-list
2174061|NCT00001504|Alitretinoin|alitretinoin|mesh-list
2174062|NCT00001504|Isotretinoin|isotretinoin|mesh-list
2174063|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174064|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
2174065|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
2174066|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2174067|NCT00001507|Antibodies|antibodies|mesh-list
2174068|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
2174069|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2174070|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
2174071|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174072|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174073|NCT00001509|Tretinoin|tretinoin|mesh-list
2174074|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174075|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
2174076|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
2174077|NCT00001520|Neostigmine|neostigmine|mesh-list
2174078|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2174079|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174080|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174081|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
2174082|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2174083|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174084|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2174085|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
2174086|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174103|NCT00001524|Thalidomide|thalidomide|mesh-list
2174104|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174105|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
2174106|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174107|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
2174108|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2174109|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174110|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2174111|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2174112|NCT00001524|Growth Substances|growth substances|mesh-ancestor
2174113|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
2174114|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174115|NCT00001526|Daclizumab|daclizumab|mesh-list
2174116|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174117|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
2639481|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
2639482|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
2639483|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2639484|NCT01985893|Trastuzumab|trastuzumab|mesh-list
2639485|NCT01985893|Lapatinib|lapatinib|mesh-list
2639486|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2639487|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639488|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2639489|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639490|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174118|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174119|NCT00001533|Cyclosporine|cyclosporine|mesh-list
2174120|NCT00001533|Cyclosporins|cyclosporins|mesh-list
2174121|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174122|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174123|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174124|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
2174125|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174126|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
2174127|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174128|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
2174129|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174130|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2174131|NCT00001534|Losartan|losartan|mesh-list
2174132|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2174133|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2174134|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2174135|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2174136|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174137|NCT00001535|Interleukin-2|interleukin-2|mesh-list
2174138|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174139|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2174140|NCT00001535|Analgesics|analgesics|mesh-ancestor
2174141|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
2174142|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174143|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174144|NCT00001542|Fluconazole|fluconazole|mesh-list
2174145|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
2174146|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174147|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2174148|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2174149|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174150|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174151|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2174152|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
2174153|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2174154|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174155|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2174156|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2174157|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
2174158|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2174159|NCT00001561|Antibodies|antibodies|mesh-list
2174160|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2174161|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
2174162|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174163|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2174164|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174165|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
2174166|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174167|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
2174168|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174169|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
2174170|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2174171|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
2174172|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174173|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
2174174|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174175|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2174176|NCT00001569|Paclitaxel|paclitaxel|mesh-list
2174177|NCT00001569|Cisplatin|cisplatin|mesh-list
2174178|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2174179|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174180|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
2174181|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
2174182|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
2174183|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174184|NCT00001570|Vinblastine|vinblastine|mesh-list
2174185|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2174186|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174187|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
2174188|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
2174189|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
2174190|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174191|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
2174192|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2174193|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
2174194|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174195|NCT00001576|Leucovorin|leucovorin|mesh-list
2174196|NCT00001576|Melphalan|melphalan|mesh-list
2174197|NCT00001576|Floxuridine|floxuridine|mesh-list
2174198|NCT00001576|Antidotes|antidotes|mesh-ancestor
2174199|NCT00001576|Protective Agents|protective agents|mesh-ancestor
2174200|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174201|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
2174202|NCT00001576|Vitamins|vitamins|mesh-ancestor
2174203|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
2174204|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2174205|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
2174206|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174207|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174208|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2174209|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174210|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
2174211|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2174212|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
2174213|NCT00001577|Melphalan|melphalan|mesh-list
2174214|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2174215|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
2174216|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174217|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174218|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2174219|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174220|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
2174221|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174222|NCT00001579|Leucovorin|leucovorin|mesh-list
2174223|NCT00001579|Fluorouracil|fluorouracil|mesh-list
2174224|NCT00001579|Eniluracil|eniluracil|mesh-list
2174225|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
2174226|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174227|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2174228|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174229|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174230|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
2174231|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174232|NCT00001579|Antidotes|antidotes|mesh-ancestor
2174233|NCT00001579|Protective Agents|protective agents|mesh-ancestor
2174234|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
2174235|NCT00001579|Vitamins|vitamins|mesh-ancestor
2174236|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
2174237|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174238|NCT00001587|Melphalan|melphalan|mesh-list
2174239|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2174240|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
2174241|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174242|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174243|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2174244|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174245|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
2174246|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174247|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2174248|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2174249|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
2174250|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174251|NCT00001599|Thalidomide|thalidomide|mesh-list
2174252|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174253|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
2174254|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174255|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
2174256|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2174257|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174258|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2174259|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2174260|NCT00001599|Growth Substances|growth substances|mesh-ancestor
2174261|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
2174262|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174263|NCT00001624|Insulin|insulin|mesh-list
2174264|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2174265|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174266|NCT00001626|Cyclosporine|cyclosporine|mesh-list
2174267|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
2174268|NCT00001626|Cyclosporins|cyclosporins|mesh-list
2174269|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2174270|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174271|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
2174272|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174273|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174274|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2174275|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
2174276|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174277|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174278|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2174279|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174280|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
2174281|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174282|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
2639491|NCT01986036|Calcium|calcium|mesh-list
2639492|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2639493|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639494|NCT01986049|Bupivacaine|bupivacaine|mesh-list
2639495|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
2639496|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
2639497|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2639498|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639499|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
2639500|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174283|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2174284|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
2174285|NCT00001628|Giapreza|giapreza|mesh-list
2174286|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
2174287|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
2174288|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2174289|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2174290|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
2174291|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174292|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174293|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2174294|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
2174295|NCT00001629|Giapreza|giapreza|mesh-list
2174296|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
2174297|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
2174298|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2174299|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2174300|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
2174301|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174302|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174303|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2174304|NCT00001644|Lamivudine|lamivudine|mesh-list
2174305|NCT00001644|Zidovudine|zidovudine|mesh-list
2174306|NCT00001644|Nevirapine|nevirapine|mesh-list
2174307|NCT00001644|Indinavir|indinavir|mesh-list
2174308|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2174309|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2174310|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174311|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174312|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
2174313|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174314|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2174315|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2174316|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
2174317|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2174318|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2174319|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2174320|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2174321|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
2174322|NCT00001646|Voriconazole|voriconazole|mesh-list
2174323|NCT00001646|Amphotericin B|amphotericin b|mesh-list
2174324|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2174325|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
2174326|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174327|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2174328|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2174329|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174330|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174331|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2174332|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
2174333|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2174334|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174335|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2174336|NCT00001646|Amebicides|amebicides|mesh-ancestor
2174337|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2174338|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2174339|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2174340|NCT00001649|Valacyclovir|valacyclovir|mesh-list
2174341|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
2174342|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174343|NCT00001658|Amoxicillin|amoxicillin|mesh-list
2174344|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2174345|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174346|NCT00001666|Methamphetamine|methamphetamine|mesh-list
2174347|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2174348|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174349|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
2174350|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
2174351|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174352|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
2174353|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2174354|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174355|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
2174356|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2639516|NCT01986088|Sumatriptan|sumatriptan|mesh-list
2639517|NCT01986088|Eletriptan|eletriptan|mesh-list
2639518|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2639519|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2639520|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2639521|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
2639522|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2639523|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639524|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639525|NCT01986127|Adalimumab|adalimumab|mesh-list
2639526|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2639527|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2639528|NCT01986192|Warfarin|warfarin|mesh-list
2639529|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
2639530|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
2639531|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2639532|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
2639533|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2639534|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
2639535|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639536|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639537|NCT01986270|Sumatriptan|sumatriptan|mesh-list
2639538|NCT01986270|Eletriptan|eletriptan|mesh-list
2639539|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2639540|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2639541|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2639542|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
2639543|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2639544|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639545|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639546|NCT01986283|Oxycodone|oxycodone|mesh-list
2174357|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2174358|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2174359|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2174360|NCT00001669|Mecasermin|mecasermin|mesh-list
2174361|NCT00001669|Growth Substances|growth substances|mesh-ancestor
2174362|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174363|NCT00001676|Fludarabine|fludarabine|mesh-list
2174364|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174365|NCT00001677|Methotrexate|methotrexate|mesh-list
2174366|NCT00001677|Fludarabine|fludarabine|mesh-list
2174367|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2422349|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422350|NCT00816972|Renal Agents|renal agents|mesh-ancestor
2422351|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2422352|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2422353|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
2422354|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
2422355|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
2422356|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
2422357|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2422358|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2174368|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
2174369|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2174370|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174371|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2174372|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
2174373|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174374|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174375|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
2174376|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639547|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2639548|NCT01986283|Narcotics|narcotics|mesh-ancestor
2639549|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2639550|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639551|NCT01986283|Analgesics|analgesics|mesh-ancestor
2639552|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
2639553|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639554|NCT01986309|Lidocaine|lidocaine|mesh-list
2639555|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
2639556|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
2639557|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2639558|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639559|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
2639560|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639561|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2639562|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2639563|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2639564|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2639565|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639566|NCT01986322|Vaccines|vaccines|mesh-list
2639567|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
2639568|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639569|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
2639570|NCT01986426|Ipilimumab|ipilimumab|mesh-list
2639571|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2639572|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639573|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2639574|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639575|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2639576|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
2174377|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2174378|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174379|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
2174380|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174381|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2174382|NCT00001680|Thalidomide|thalidomide|mesh-list
2174383|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174384|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
2174385|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174386|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
2174387|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2422359|NCT00817011|Mirtazapine|mirtazapine|mesh-list
2639577|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2174388|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174389|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2174390|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2174391|NCT00001680|Growth Substances|growth substances|mesh-ancestor
2174392|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
2174393|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174394|NCT00001688|Ritonavir|ritonavir|mesh-list
2174395|NCT00001688|Nevirapine|nevirapine|mesh-list
2174396|NCT00001688|Stavudine|stavudine|mesh-list
2174397|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2174398|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2174399|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
2174400|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174401|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174402|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2174403|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2174404|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
2174405|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174406|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2174407|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2174408|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2639578|NCT01986465|Prednisolone|prednisolone|mesh-list
2639579|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
2639580|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2639581|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
2639582|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2639583|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
2639584|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
2639585|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639586|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639587|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2639588|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
2639589|NCT01986465|Hormones|hormones|mesh-ancestor
2639590|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639591|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2639592|NCT01986465|Protective Agents|protective agents|mesh-ancestor
2639593|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2639594|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639595|NCT01986556|Lesinurad|lesinurad|mesh-list
2639596|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
2639597|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2639598|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
2639599|NCT01986556|Renal Agents|renal agents|mesh-ancestor
2639600|NCT01986582|Phenylephrine|phenylephrine|mesh-list
2639601|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
2639602|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2639603|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2639604|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
2639605|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2639606|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639607|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639608|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
2639609|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
2639610|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639611|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
2639612|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2639613|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
2639614|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2639615|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
2639616|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2639617|NCT01986582|Protective Agents|protective agents|mesh-ancestor
2639618|NCT01986608|Lacosamide|lacosamide|mesh-list
2639619|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
2639620|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2639621|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2639622|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2639623|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639624|NCT01986660|Ibuprofen|ibuprofen|mesh-list
2639625|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2639626|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2639627|NCT01986660|Analgesics|analgesics|mesh-ancestor
2639628|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
2639629|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174409|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2174410|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2639630|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174411|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2174412|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
2174413|NCT00001689|Vincristine|vincristine|mesh-list
2174414|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2174415|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174416|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
2174417|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
2174418|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
2174419|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639631|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2639632|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2639633|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2639634|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639635|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639636|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
2639637|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
2639638|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2639639|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2639640|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174420|NCT00001693|Celecoxib|celecoxib|mesh-list
2174421|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2174422|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2174423|NCT00001693|Analgesics|analgesics|mesh-ancestor
2174424|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
2174425|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174426|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174427|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2174428|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174429|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2174430|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2174431|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174432|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174433|NCT00001696|Genistein|genistein|mesh-list
2174434|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2639641|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639642|NCT01986673|Urological Agents|urological agents|mesh-ancestor
2639643|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2639644|NCT01986764|Estradiol|estradiol|mesh-list
2639645|NCT01986764|Estrogens|estrogens|mesh-list
2639646|NCT01986764|Hormones|hormones|mesh-ancestor
2639647|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639648|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639649|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2639650|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2639651|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2639652|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2639653|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639654|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
2639655|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2639656|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2639657|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2639658|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639659|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2639660|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2639661|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2639662|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639663|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
2639664|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2639665|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
2639666|NCT01986894|Thalidomide|thalidomide|mesh-list
2639667|NCT01986894|Pomalidomide|pomalidomide|mesh-list
2639668|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2639669|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2639670|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2639671|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2639672|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174435|NCT00001696|Protective Agents|protective agents|mesh-ancestor
2174436|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174437|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174438|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2174439|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639673|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639674|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639675|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639676|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
2639677|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2639678|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2639679|NCT01986894|Growth Substances|growth substances|mesh-ancestor
2639680|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
2639681|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2639682|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
2639683|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
2639684|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2639685|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2639686|NCT01986998|Prednisolone|prednisolone|mesh-list
2639687|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
2639688|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2639689|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
2639690|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2639691|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
2639692|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
2639693|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639694|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639695|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2639696|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
2639697|NCT01986998|Hormones|hormones|mesh-ancestor
2639698|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639699|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2639700|NCT01986998|Protective Agents|protective agents|mesh-ancestor
2639701|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2639702|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639703|NCT01987076|Prednisone|prednisone|mesh-list
2639704|NCT01987076|Clobetasol|clobetasol|mesh-list
2639705|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2639706|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
2639707|NCT01987076|Hormones|hormones|mesh-ancestor
2639708|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639709|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639710|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2639711|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639712|NCT01987128|Ropivacaine|ropivacaine|mesh-list
2639713|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
2639714|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
2639715|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2639716|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639717|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
2639718|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639719|NCT01987154|Caseins|caseins|mesh-list
2639720|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
2639721|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
2639722|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639723|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2639724|NCT01987167|Hormones|hormones|mesh-ancestor
2639725|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639726|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639727|NCT01987297|Cytarabine|cytarabine|mesh-list
2639728|NCT01987297|Daunorubicin|daunorubicin|mesh-list
2639729|NCT01987297|Idarubicin|idarubicin|mesh-list
2639730|NCT01987297|Tretinoin|tretinoin|mesh-list
2639731|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
2639732|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2639733|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
2639734|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639735|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639736|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
2639737|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2639738|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2639739|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
2639740|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639741|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2639742|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2639743|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2639744|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639745|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
2639746|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
2639747|NCT01987310|Atorvastatin|atorvastatin|mesh-list
2639748|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2174440|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174441|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
2174442|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2174443|NCT00001696|Estrogens|estrogens|mesh-ancestor
2174444|NCT00001696|Hormones|hormones|mesh-ancestor
2174445|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2174446|NCT00001698|Ketorolac|ketorolac|mesh-list
2174447|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2174448|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2174449|NCT00001698|Analgesics|analgesics|mesh-ancestor
2174450|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
2174451|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174452|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174453|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2174454|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174455|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2174456|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174457|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174458|NCT00001713|Heparin|heparin|mesh-list
2174459|NCT00001713|Plasminogen|plasminogen|mesh-list
2174460|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2174461|NCT00001713|Warfarin|warfarin|mesh-list
2174462|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
2174463|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2174464|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2174465|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174466|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
2174467|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
2174468|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2174469|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
2174470|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174471|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174472|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2174473|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
2174474|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2174475|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
2174476|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174477|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2174478|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2174479|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
2174480|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
2174481|NCT00001716|Protective Agents|protective agents|mesh-ancestor
2174482|NCT00001720|Alendronate|alendronate|mesh-list
2174483|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2174484|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174485|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
2174486|NCT00001724|Analgesics|analgesics|mesh-ancestor
2174487|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
2174488|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174489|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174490|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2174491|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2174492|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2174493|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174494|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2174495|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174496|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174497|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
2174498|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
2174499|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
2174500|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2174501|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2174502|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2174503|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174504|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174505|NCT00001728|Alendronate|alendronate|mesh-list
2174506|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2174507|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174508|NCT00001729|Ribavirin|ribavirin|mesh-list
2174509|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
2174510|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174511|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
2174512|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174513|NCT00001731|Cyclosporine|cyclosporine|mesh-list
2174514|NCT00001731|Cyclosporins|cyclosporins|mesh-list
2174515|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174516|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174517|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174518|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
2174519|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174520|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
2174521|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174522|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
2174523|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2639749|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2639750|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
2639751|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639752|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2639753|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2639754|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639755|NCT01987323|Latanoprost|latanoprost|mesh-list
2639756|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2639757|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2639758|NCT01987375|Cetuximab|cetuximab|mesh-list
2639759|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2639760|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639761|NCT01987570|Allopurinol|allopurinol|mesh-list
2639762|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
2639763|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639764|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639765|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
2639766|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2639767|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2639768|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
2639769|NCT01987570|Protective Agents|protective agents|mesh-ancestor
2639770|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639771|NCT01987739|Zolpidem|zolpidem|mesh-list
2639772|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2639773|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2639774|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2639775|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639776|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2639777|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
2639778|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
2639779|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2639780|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639781|NCT01987804|Oxytocin|oxytocin|mesh-list
2639782|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
2639783|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2639784|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639785|NCT01988077|Ipilimumab|ipilimumab|mesh-list
2639786|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2639787|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639788|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2639789|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639790|NCT01988116|Calcitriol|calcitriol|mesh-list
2639791|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2639792|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639793|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2639794|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2639795|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639796|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2639797|NCT01988116|Vitamins|vitamins|mesh-ancestor
2639798|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
2639799|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2639800|NCT01988298|Acetaminophen|acetaminophen|mesh-list
2639801|NCT01988298|Ibuprofen|ibuprofen|mesh-list
2639802|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2639803|NCT01988298|Analgesics|analgesics|mesh-ancestor
2639804|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
2639805|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639806|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639807|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
2639808|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2639809|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2639810|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2639811|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2639812|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639813|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639814|NCT01988311|Psilocybin|psilocybin|mesh-list
2639815|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
2639816|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639817|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2639818|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
2639819|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2174524|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2174525|NCT00001736|Cysteamine|cysteamine|mesh-list
2174526|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2174527|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174528|NCT00001737|Cyclosporine|cyclosporine|mesh-list
2174529|NCT00001737|Cyclosporins|cyclosporins|mesh-list
2174530|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174531|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639820|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2639821|NCT01988506|Interleukin-2|interleukin-2|mesh-list
2639822|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639823|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2639824|NCT01988506|Analgesics|analgesics|mesh-ancestor
2639825|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
2639826|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639827|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639828|NCT01988545|Exenatide|exenatide|mesh-list
2639829|NCT01988545|Glucagon|glucagon|mesh-list
2639830|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2639831|NCT01988545|Incretins|incretins|mesh-ancestor
2639832|NCT01988545|Hormones|hormones|mesh-ancestor
2639833|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639834|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639835|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2639836|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2639837|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2639846|NCT01988610|Mifepristone|mifepristone|mesh-list
2639847|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2639848|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
2639849|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2639850|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174532|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174533|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
2174534|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174535|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
2174536|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174537|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
2174538|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174539|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2174540|NCT00001741|Losartan|losartan|mesh-list
2422360|NCT00817011|Trazodone|trazodone|mesh-list
2422361|NCT00817011|Bupropion|bupropion|mesh-list
2422362|NCT00817011|Fluoxetine|fluoxetine|mesh-list
2422363|NCT00817011|Paroxetine|paroxetine|mesh-list
2422364|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2422365|NCT00817011|Citalopram|citalopram|mesh-list
2422366|NCT00817011|Sertraline|sertraline|mesh-list
2422367|NCT00817011|Nortriptyline|nortriptyline|mesh-list
2422368|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2422369|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
2422370|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2422371|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2422372|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2422373|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422374|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422375|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
2422376|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422377|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422378|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2422379|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2422380|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639851|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2639852|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2639853|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2639854|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
2639855|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2639856|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2639857|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
2639858|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639859|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
2639860|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2639861|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2639862|NCT01988649|Oxytocin|oxytocin|mesh-list
2639863|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
2639864|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2639865|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639866|NCT01988831|Propranolol|propranolol|mesh-list
2639867|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2639868|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2639869|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
2639870|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2639871|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639872|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639873|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2639874|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2639875|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
2174541|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2174542|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2174543|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2174544|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2174545|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174546|NCT00001749|Cyclosporine|cyclosporine|mesh-list
2174547|NCT00001749|Cyclosporins|cyclosporins|mesh-list
2174548|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2174549|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174550|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174551|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174552|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
2174553|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174554|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
2174555|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174556|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
2174557|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174558|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2174559|NCT00001752|Estrogens|estrogens|mesh-list
2639891|NCT01988896|Atezolizumab|atezolizumab|mesh-list
2639892|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639893|NCT01988961|Golimumab|golimumab|mesh-list
2639894|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2639895|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2639896|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2639897|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
2639898|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639899|NCT01989000|Gemcitabine|gemcitabine|mesh-list
2639900|NCT01989000|Imidazole|imidazole|mesh-list
2639901|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2639902|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
2639903|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639904|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639905|NCT01989000|Antiviral Agents|antiviral agents|mesh-ancestor
2639906|NCT01989000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2639907|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639908|NCT01989000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2639909|NCT01989000|Immunologic Factors|immunologic factors|mesh-ancestor
2639910|NCT01989000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639911|NCT01989052|Lomustine|lomustine|mesh-list
2174560|NCT00001752|Hormones|hormones|mesh-ancestor
2174561|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2174562|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174563|NCT00001757|Voriconazole|voriconazole|mesh-list
2639912|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
2639913|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2639914|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
2639915|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639916|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639917|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2639918|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2639919|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2639920|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639921|NCT01989078|Losartan|losartan|mesh-list
2639922|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2639923|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2639924|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2639925|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2639926|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639927|NCT01989091|Heparin|heparin|mesh-list
2639928|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
2639929|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2639930|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2174564|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
2174565|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174566|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2639931|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639932|NCT01989312|Lidocaine|lidocaine|mesh-list
2639933|NCT01989312|Epinephrine|epinephrine|mesh-list
2639934|NCT01989312|Midazolam|midazolam|mesh-list
2639935|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
2639936|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
2639937|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
2639938|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2639939|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639940|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
2639941|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639942|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2639943|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2639944|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2639945|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2639946|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639947|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2639948|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2639949|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2639950|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2639951|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2639952|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2639953|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
2639954|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
2639955|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
2639956|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2639957|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2174567|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2174568|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174569|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174570|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2174571|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
2174572|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2174573|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174574|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2174575|NCT00001758|Efavirenz|efavirenz|mesh-list
2174576|NCT00001758|Abacavir|abacavir|mesh-list
2174577|NCT00001758|Amprenavir|amprenavir|mesh-list
2174578|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2174579|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2639958|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2639959|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
2639960|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2639961|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2639962|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
2639963|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2639964|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
2639965|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
2639966|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
2639967|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2639968|NCT01989325|Dexamethasone|dexamethasone|mesh-list
2639969|NCT01989325|Filanesib|filanesib|mesh-list
2639970|NCT01989325|Lenograstim|lenograstim|mesh-list
2639971|NCT01989325|Sargramostim|sargramostim|mesh-list
2639972|NCT01989325|Proteasome Inhibitors|proteasome inhibitors|mesh-list
2639973|NCT01989325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2639974|NCT01989325|Antiemetics|antiemetics|mesh-ancestor
2639975|NCT01989325|Autonomic Agents|autonomic agents|mesh-ancestor
2639976|NCT01989325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2639977|NCT01989325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2639978|NCT01989325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2639979|NCT01989325|Glucocorticoids|glucocorticoids|mesh-ancestor
2639980|NCT01989325|Hormones|hormones|mesh-ancestor
2639981|NCT01989325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2639982|NCT01989325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2174580|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174581|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174582|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
2174583|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174584|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2174585|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2174586|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2174587|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2174588|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2174589|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2639983|NCT01989325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2639984|NCT01989325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2639985|NCT01989325|Immunologic Factors|immunologic factors|mesh-ancestor
2639986|NCT01989325|Protease Inhibitors|protease inhibitors|mesh-ancestor
2639987|NCT01989325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2639988|NCT01989325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2639989|NCT01989325|Antimitotic Agents|antimitotic agents|mesh-ancestor
2639990|NCT01989325|Mitosis Modulators|mitosis modulators|mesh-ancestor
2639991|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
2639992|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2639993|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2639994|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2639995|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
2639996|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
2639997|NCT01989429|Vitamin D|vitamin d|mesh-list
2639998|NCT01989429|Vitamins|vitamins|mesh-ancestor
2639999|NCT01989429|Micronutrients|micronutrients|mesh-ancestor
2640000|NCT01989429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640001|NCT01989429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2640002|NCT01989507|Nicotine|nicotine|mesh-list
2640003|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2640004|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
2640005|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640006|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640007|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2174590|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2174591|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2174592|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2174593|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
2174594|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2640008|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2640009|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
2640010|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2640011|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640012|NCT01989559|Vaccines|vaccines|mesh-list
2640013|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
2640014|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640015|NCT01989598|Trametinib|trametinib|mesh-list
2640016|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640017|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2640018|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640019|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640020|NCT01989611|Tenofovir|tenofovir|mesh-list
2640021|NCT01989611|Emtricitabine|emtricitabine|mesh-list
2640022|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
2640023|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640024|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2640025|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2174595|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2174596|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2174597|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
2174598|NCT00001763|Interleukin-12|interleukin-12|mesh-list
2174599|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2640026|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640027|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640028|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2640029|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2640030|NCT01989663|Tenofovir|tenofovir|mesh-list
2640031|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
2640032|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640033|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2640034|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2640035|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640036|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640037|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2640038|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2640039|NCT01989676|Paclitaxel|paclitaxel|mesh-list
2640040|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2640041|NCT01989676|Trastuzumab|trastuzumab|mesh-list
2640042|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2640043|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640044|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
2640045|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
2640046|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
2640047|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640048|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2640049|NCT01989780|Paclitaxel|paclitaxel|mesh-list
2640050|NCT01989780|Bevacizumab|bevacizumab|mesh-list
2640051|NCT01989780|Letrozole|letrozole|mesh-list
2640052|NCT01989780|Fulvestrant|fulvestrant|mesh-list
2640053|NCT01989780|Anastrozole|anastrozole|mesh-list
2640054|NCT01989780|Exemestane|exemestane|mesh-list
2640055|NCT01989780|Goserelin|goserelin|mesh-list
2640056|NCT01989780|Leuprolide|leuprolide|mesh-list
2640057|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2640058|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2640059|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640060|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
2640061|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
2174600|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
2174601|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174602|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2174603|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2640062|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
2640063|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640064|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2640065|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2640066|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2640067|NCT01989780|Growth Substances|growth substances|mesh-ancestor
2640068|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640069|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
2640070|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2640071|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640072|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2640073|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
2640074|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2640075|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2640076|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2640077|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2640078|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
2640079|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2640080|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
2640081|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2640082|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
2640083|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2640084|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
2640085|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640086|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174604|NCT00001763|Growth Substances|growth substances|mesh-ancestor
2174605|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
2174606|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174607|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
2174608|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2174609|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174610|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2174611|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
2174612|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2174613|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640087|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
2640088|NCT01989884|IDN 5109|idn 5109|mesh-list
2640089|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640090|NCT01989897|Phenol|phenol|mesh-list
2640091|NCT01989897|Histamine|histamine|mesh-list
2640092|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
2640093|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
2640094|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2640095|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640096|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640097|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2640098|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640099|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
2640100|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2640101|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2640102|NCT01989923|Nicotine|nicotine|mesh-list
2640103|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2640104|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
2640105|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640106|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640107|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2640108|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2640109|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
2640110|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2640111|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640112|NCT01989936|Eletriptan|eletriptan|mesh-list
2640113|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2640114|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
2640115|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2640116|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640117|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174614|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174615|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174616|NCT00001766|Ritonavir|ritonavir|mesh-list
2174617|NCT00001766|Nelfinavir|nelfinavir|mesh-list
2174618|NCT00001766|Amprenavir|amprenavir|mesh-list
2174619|NCT00001766|Abacavir|abacavir|mesh-list
2174620|NCT00001766|Efavirenz|efavirenz|mesh-list
2174621|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2174622|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2174623|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
2174624|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640118|NCT01990079|Bupropion|bupropion|mesh-list
2640119|NCT01990079|Nicotine|nicotine|mesh-list
2640120|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2640121|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
2640122|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640123|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640124|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2640125|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2640126|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
2640127|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2640128|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640129|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2640130|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
2640131|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2640132|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2640133|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2640134|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2640135|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
2640136|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2640137|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2640138|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640139|NCT01990118|Cyclosporine|cyclosporine|mesh-list
2640140|NCT01990118|Cyclosporins|cyclosporins|mesh-list
2174625|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640141|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640142|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640143|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2640144|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
2640145|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640146|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
2640147|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640148|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
2640149|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2640150|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2174626|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2174627|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2174628|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
2174629|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174630|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2174631|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2174632|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2174633|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2174634|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2174635|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2174636|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2174637|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2174638|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2174639|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2640151|NCT01990144|Rituximab|rituximab|mesh-list
2640152|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2640153|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2640154|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640155|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
2640156|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640157|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2640158|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2640159|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
2640160|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640161|NCT01990196|Dasatinib|dasatinib|mesh-list
2640162|NCT01990196|Trametinib|trametinib|mesh-list
2640163|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640164|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2640165|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640166|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640167|NCT01990352|Doxorubicin|doxorubicin|mesh-list
2640168|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2640169|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2640170|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640171|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2640172|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2640173|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640174|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640175|NCT01990378|Rabeprazole|rabeprazole|mesh-list
2640176|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2640177|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2640178|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2640179|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640180|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640181|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
2640182|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2640183|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
2640184|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
2640185|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2640186|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640187|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2640188|NCT01990404|Analgesics|analgesics|mesh-ancestor
2640189|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
2640190|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640191|NCT01990443|Reslizumab|reslizumab|mesh-list
2640192|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2640193|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
2640194|NCT01990586|Rabeprazole|rabeprazole|mesh-list
2640195|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2640196|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2640197|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2640198|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640199|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174640|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
2174641|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2174642|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
2174643|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2174644|NCT00001768|Antibodies|antibodies|mesh-list
2174645|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
2174646|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2174647|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
2174648|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174649|NCT00001777|Sertraline|sertraline|mesh-list
2174650|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
2640200|NCT01990690|Antioxidants|antioxidants|mesh-list
2640201|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640202|NCT01990690|Protective Agents|protective agents|mesh-ancestor
2640203|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640204|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
2640205|NCT01990755|Olanzapine|olanzapine|mesh-list
2640206|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
2640207|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
2640208|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640209|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640210|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2640211|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2640212|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2640213|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2640214|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2640215|NCT01990755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2640216|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2640217|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2640218|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640219|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2640220|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
2640221|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
2640222|NCT01990781|Dexamethasone|dexamethasone|mesh-list
2640223|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
2640224|NCT01990781|Lidocaine|lidocaine|mesh-list
2640225|NCT01990781|BB 1101|bb 1101|mesh-list
2640226|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2640227|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
2640228|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
2640229|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640230|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640231|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2640232|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
2640233|NCT01990781|Hormones|hormones|mesh-ancestor
2640234|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2640235|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2640236|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640237|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
2640238|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640239|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640240|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
2640241|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
2640242|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2640243|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
2640244|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2640245|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2640246|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2640247|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2640248|NCT01990807|Idarubicin|idarubicin|mesh-list
2640249|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2640250|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640251|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2640252|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2640253|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640254|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640255|NCT01990872|Vitamin D|vitamin d|mesh-list
2640256|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
2640257|NCT01990872|Vitamins|vitamins|mesh-ancestor
2640258|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
2640259|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640260|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2640261|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2640262|NCT01990911|Diuretics|diuretics|mesh-list
2174651|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2174652|NCT00001777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2174653|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2174654|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2174655|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174656|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2174657|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
2174658|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640263|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
2640264|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640265|NCT01990937|Midazolam|midazolam|mesh-list
2640266|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2640267|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2640268|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2640269|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640270|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2174659|NCT00001784|Mexiletine|mexiletine|mesh-list
2174660|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2174661|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2174662|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2174663|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2174664|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640271|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2640272|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2640273|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2640274|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
2640275|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
2640276|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
2640277|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
2640278|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2640279|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640280|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2640281|NCT01991054|Vitamin D|vitamin d|mesh-list
2640282|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
2640283|NCT01991054|Vitamins|vitamins|mesh-ancestor
2640284|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
2640285|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640286|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2640287|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2640288|NCT01991119|Dronedarone|dronedarone|mesh-list
2640289|NCT01991119|Propafenone|propafenone|mesh-list
2640290|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2640291|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2640292|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2640293|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2640294|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640295|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
2640296|NCT01991145|Hematinics|hematinics|mesh-ancestor
2640297|NCT01991158|Gemcitabine|gemcitabine|mesh-list
2640298|NCT01991158|Dexamethasone|dexamethasone|mesh-list
2640299|NCT01991158|Methotrexate|methotrexate|mesh-list
2640300|NCT01991158|Pegaspargase|pegaspargase|mesh-list
2640301|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2640302|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
2640303|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
2640304|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640305|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640306|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2640307|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
2640308|NCT01991158|Hormones|hormones|mesh-ancestor
2640309|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2640310|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2640311|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640312|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2640313|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
2640314|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640315|NCT01991158|Antiviral Agents|antiviral agents|mesh-ancestor
2640316|NCT01991158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640317|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640318|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2640319|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
2640320|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2640321|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
2640322|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2640323|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
2640324|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2640325|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174665|NCT00001785|Interferons|interferons|mesh-list
2174666|NCT00001785|Interferon-beta|interferon-beta|mesh-list
2640326|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2640327|NCT01991275|Morphine|morphine|mesh-list
2640328|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2640329|NCT01991275|Narcotics|narcotics|mesh-ancestor
2640330|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2174667|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
2174668|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174669|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
2174670|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174671|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
2174672|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174673|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2174674|NCT00001790|Micafungin|micafungin|mesh-list
2174675|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
2174676|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174677|NCT00001805|Rituximab|rituximab|mesh-list
2174678|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2174679|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174680|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
2174681|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174682|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174683|NCT00001810|Voriconazole|voriconazole|mesh-list
2174684|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
2174685|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174686|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2174687|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2174688|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640331|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640332|NCT01991275|Analgesics|analgesics|mesh-ancestor
2640333|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
2640334|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640335|NCT01991288|Epinephrine|epinephrine|mesh-list
2640336|NCT01991288|Racepinephrine|racepinephrine|mesh-list
2640337|NCT01991288|Bupivacaine|bupivacaine|mesh-list
2174689|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174690|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2174691|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
2174692|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2174693|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174694|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2174695|NCT00001812|Nystatin|nystatin|mesh-list
2174696|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2174697|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174698|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
2174699|NCT00001812|Ionophores|ionophores|mesh-ancestor
2174700|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2174701|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174702|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
2174703|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174704|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
2174705|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174706|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174707|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2174708|NCT00001827|Aldesleukin|aldesleukin|mesh-list
2174709|NCT00001827|Sargramostim|sargramostim|mesh-list
2174710|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
2174711|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
2174712|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174713|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174714|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2174715|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2174716|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
2174717|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174718|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2174719|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
2640338|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
2640339|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
2640340|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
2640341|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
2640342|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2640343|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640344|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
2640345|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640346|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2640347|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2640348|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
2640349|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2640350|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640351|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2640352|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2640353|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
2640354|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2640355|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
2640356|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
2640357|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
2640358|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2640359|NCT01991327|Enclomiphene|enclomiphene|mesh-list
2640360|NCT01991327|Clomiphene|clomiphene|mesh-list
2640361|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
2640362|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2640363|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
2640364|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2640365|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640366|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2640367|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
2640368|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2640369|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2640370|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2640371|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
2640372|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640373|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2640374|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640375|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640376|NCT01991457|Fludarabine|fludarabine|mesh-list
2640377|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640378|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2640379|NCT01991561|Vaccines|vaccines|mesh-list
2640380|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
2640381|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640382|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2640383|NCT01991561|Antacids|antacids|mesh-ancestor
2640384|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640385|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2640386|NCT01991574|Calcium|calcium|mesh-list
2174720|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174721|NCT00001839|Cyclosporine|cyclosporine|mesh-list
2174722|NCT00001839|Cyclosporins|cyclosporins|mesh-list
2174723|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2174724|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174725|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174726|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174727|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
2174728|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174729|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
2174730|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174731|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
2174732|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174733|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2174734|NCT00001842|Dexamethasone|dexamethasone|mesh-list
2174735|NCT00001842|Sargramostim|sargramostim|mesh-list
2174736|NCT00001842|Lenograstim|lenograstim|mesh-list
2640387|NCT01991574|Calcium acetate|calcium acetate|mesh-list
2640388|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2640389|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640390|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
2640391|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
2640392|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640393|NCT01991587|Vaccines|vaccines|mesh-list
2640394|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
2640395|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640396|NCT01991626|Iron|iron|mesh-list
2640397|NCT01991626|Trace Elements|trace elements|mesh-list
2640398|NCT01991626|Micronutrients|micronutrients|mesh-list
2640399|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640400|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
2640401|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640402|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2174737|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2174738|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
2640403|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2640404|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640405|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640406|NCT01991834|Cefazolin|cefazolin|mesh-list
2640407|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2640408|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640409|NCT01991873|Leucovorin|leucovorin|mesh-list
2640410|NCT01991873|Folic Acid|folic acid|mesh-list
2640411|NCT01991873|Fluorouracil|fluorouracil|mesh-list
2640412|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
2640413|NCT01991873|Panitumumab|panitumumab|mesh-list
2640414|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
2640415|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
2640416|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640417|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2640418|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640419|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2640420|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
2640421|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640422|NCT01991873|Antidotes|antidotes|mesh-ancestor
2640423|NCT01991873|Protective Agents|protective agents|mesh-ancestor
2640424|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
2640425|NCT01991873|Vitamins|vitamins|mesh-ancestor
2640426|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
2640427|NCT01991873|Hematinics|hematinics|mesh-ancestor
2640428|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2640429|NCT01991951|Warfarin|warfarin|mesh-list
2640430|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
2640431|NCT01992133|Vitamin D|vitamin d|mesh-list
2640432|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
2640433|NCT01992133|Vitamins|vitamins|mesh-ancestor
2640434|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
2640435|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640436|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2640437|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2640438|NCT01992146|Naloxone|naloxone|mesh-list
2640439|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2640440|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640441|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
2640442|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174739|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
2174740|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174741|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174742|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2174743|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
2174744|NCT00001842|Hormones|hormones|mesh-ancestor
2174745|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2174746|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2640443|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
2640444|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2640445|NCT01992198|Metronidazole|metronidazole|mesh-list
2640446|NCT01992198|Meropenem|meropenem|mesh-list
2640447|NCT01992198|Cefoperazone|cefoperazone|mesh-list
2640448|NCT01992198|Sulperazone|sulperazone|mesh-list
2640449|NCT01992198|Somatostatin|somatostatin|mesh-list
2640450|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2640451|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640452|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
2640453|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
2640454|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2640455|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2640456|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2640457|NCT01992198|Hormones|hormones|mesh-ancestor
2640458|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2640459|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640460|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2640461|NCT01992198|Renal Agents|renal agents|mesh-ancestor
2640462|NCT01992211|Metformin|metformin|mesh-list
2640463|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2640464|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2640465|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640466|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2640467|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2640468|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
2640469|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640470|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2640471|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2640472|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640473|NCT01992263|Vitamin D|vitamin d|mesh-list
2640474|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
2640475|NCT01992263|Vitamins|vitamins|mesh-list
2640476|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
2640477|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640478|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2640479|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2640480|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
2640481|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2640482|NCT01992328|Antibodies|antibodies|mesh-list
2640483|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
2640484|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2640485|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
2640486|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
2640487|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640488|NCT01992341|Paclitaxel|paclitaxel|mesh-list
2640489|NCT01992341|Trebananib|trebananib|mesh-list
2640490|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2640491|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640492|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
2640493|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
2640494|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
2640495|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640496|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2640497|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2640498|NCT01992341|Growth Substances|growth substances|mesh-ancestor
2640499|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640500|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
2640501|NCT01992562|Ziconotide|ziconotide|mesh-list
2640502|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2640503|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2640504|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174747|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174748|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
2174749|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2174750|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2174751|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2174752|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
2174753|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2174754|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174755|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2174756|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2174757|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2174758|NCT00001854|Ribavirin|ribavirin|mesh-list
2174759|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
2174760|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174761|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
2174762|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174763|NCT00001860|Octreotide|octreotide|mesh-list
2174764|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2174765|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2174766|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640505|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2640506|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640507|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2640508|NCT01992562|Protective Agents|protective agents|mesh-ancestor
2640509|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2640510|NCT01992562|Analgesics|analgesics|mesh-ancestor
2640511|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
2640512|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640513|NCT01992588|Insulin|insulin|mesh-list
2640514|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2640515|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
2640516|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
2640517|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2640518|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2640519|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640520|NCT01992601|Telmisartan|telmisartan|mesh-list
2640521|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2640522|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2640523|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2640524|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
2640525|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640526|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2640527|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2640528|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640529|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2640530|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2640531|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2640532|NCT01992653|Prednisone|prednisone|mesh-list
2640533|NCT01992653|Prednisolone|prednisolone|mesh-list
2640534|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
2640535|NCT01992653|Rituximab|rituximab|mesh-list
2640536|NCT01992653|Doxorubicin|doxorubicin|mesh-list
2640537|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
2640538|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2640539|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
2640540|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640541|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2640542|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2640543|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
2640544|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640545|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640546|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2640547|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2640548|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2640549|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2640550|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2640551|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640552|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2640553|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
2640554|NCT01992653|Hormones|hormones|mesh-ancestor
2640555|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2640556|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2640557|NCT01992705|Fluorouracil|fluorouracil|mesh-list
2640558|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
2640559|NCT01992705|Irinotecan|irinotecan|mesh-list
2640560|NCT01992705|Folfirinox|folfirinox|mesh-list
2640561|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
2640562|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640563|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2640564|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640565|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2640566|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
2640567|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640568|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2640569|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2640570|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640571|NCT01992796|Telmisartan|telmisartan|mesh-list
2640572|NCT01992796|Candesartan|candesartan|mesh-list
2640573|NCT01992796|Olmesartan|olmesartan|mesh-list
2640574|NCT01992796|Irbesartan|irbesartan|mesh-list
2640575|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2640576|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2640577|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2640578|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640579|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
2640580|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2640581|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2640582|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640583|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
2640584|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
2640585|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640586|NCT01992900|Piperaquine|piperaquine|mesh-list
2640587|NCT01992900|Artenimol|artenimol|mesh-list
2640588|NCT01992900|Artemisinins|artemisinins|mesh-list
2640589|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
2640590|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2640591|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2640592|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640593|NCT01992952|Fulvestrant|fulvestrant|mesh-list
2640594|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2640595|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640596|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2640597|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2640598|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
2640599|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2640600|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640601|NCT01993134|Cefazolin|cefazolin|mesh-list
2640602|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2640603|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640604|NCT01993173|Vaccines|vaccines|mesh-list
2640605|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
2640606|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640607|NCT01993212|Enclomiphene|enclomiphene|mesh-list
2640608|NCT01993212|Testosterone|testosterone|mesh-list
2640609|NCT01993212|Androgens|androgens|mesh-ancestor
2640610|NCT01993212|Hormones|hormones|mesh-ancestor
2640611|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2640612|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174767|NCT00001862|Etanercept|etanercept|mesh-list
2174768|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2174769|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2174770|NCT00001862|Analgesics|analgesics|mesh-ancestor
2174771|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
2174772|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174773|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640613|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2640614|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
2640615|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2640616|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
2640617|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2640618|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2640619|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2640620|NCT01993225|Enclomiphene|enclomiphene|mesh-list
2640621|NCT01993225|Testosterone|testosterone|mesh-list
2640622|NCT01993225|Androgens|androgens|mesh-ancestor
2640623|NCT01993225|Hormones|hormones|mesh-ancestor
2640624|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2640625|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640626|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2640627|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
2640628|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2640629|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
2640630|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2640631|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2640632|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2640633|NCT01993251|Melatonin|melatonin|mesh-list
2640634|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
2640635|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640636|NCT01993251|Protective Agents|protective agents|mesh-ancestor
2640637|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640638|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2640639|NCT01993290|Ropivacaine|ropivacaine|mesh-list
2640640|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
2640641|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
2640642|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2640643|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640644|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
2640645|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640646|NCT01993459|Midazolam|midazolam|mesh-list
2640647|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2640648|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2640649|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2640650|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2640651|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640652|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2640653|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2640654|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2640655|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2640656|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
2640657|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
2640658|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
2640659|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
2640660|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2640661|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640662|NCT01993472|Andrographolide|andrographolide|mesh-list
2640663|NCT01993472|Capecitabine|capecitabine|mesh-list
2640664|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2640665|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
2174774|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2174775|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174776|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2174777|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174778|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
2174779|NCT00001863|Leflunomide|leflunomide|mesh-list
2174780|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174781|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640666|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640667|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640668|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2640669|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2640670|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2640671|NCT01993472|Analgesics|analgesics|mesh-ancestor
2640672|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
2640673|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640674|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640675|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2640676|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2640677|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2640678|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640679|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
2640680|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2640681|NCT01993537|Vitamin D|vitamin d|mesh-list
2640682|NCT01993537|Vitamins|vitamins|mesh-ancestor
2640683|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
2640684|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640685|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2640686|NCT01993589|Acetaminophen|acetaminophen|mesh-list
2640687|NCT01993589|Analgesics|analgesics|mesh-list
2174782|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174783|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
2174784|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174785|NCT00001864|Atropine|atropine|mesh-list
2174786|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2174787|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2174788|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2174789|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
2640688|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2640689|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
2640690|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640691|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640692|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
2640693|NCT01993641|Azacitidine|azacitidine|mesh-list
2640694|NCT01993641|Decitabine|decitabine|mesh-list
2640695|NCT01993641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2640696|NCT01993641|Antimetabolites|antimetabolites|mesh-ancestor
2640697|NCT01993641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640698|NCT01993641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640699|NCT01993641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640700|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
2640701|NCT01993680|Bromides|bromides|mesh-list
2640702|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2640703|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
2640704|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2640705|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640706|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640707|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
2640708|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2640709|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640710|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2640729|NCT01993771|Anesthetics|anesthetics|mesh-list
2640730|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2640731|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640732|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
2640733|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2640734|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640735|NCT01993810|Paclitaxel|paclitaxel|mesh-list
2640736|NCT01993810|Etoposide|etoposide|mesh-list
2640737|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
2640738|NCT01993810|Cisplatin|cisplatin|mesh-list
2640739|NCT01993810|Carboplatin|carboplatin|mesh-list
2640740|NCT01993810|Pemetrexed|pemetrexed|mesh-list
2640741|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2640742|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
2640743|NCT01993810|Durvalumab|durvalumab|mesh-list
2640744|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
2640745|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2640746|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
2640747|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2174790|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174791|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174792|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2640748|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640749|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
2640750|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
2640751|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
2640752|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640753|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2640754|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2640755|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640756|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2640757|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2640758|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2640759|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
2640760|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640761|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
2640762|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
2640763|NCT01993979|Gemcitabine|gemcitabine|mesh-list
2640764|NCT01993979|Cisplatin|cisplatin|mesh-list
2640765|NCT01993979|Carboplatin|carboplatin|mesh-list
2640766|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640767|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2640768|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
2640769|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640770|NCT01993979|Antiviral Agents|antiviral agents|mesh-ancestor
2640771|NCT01993979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640772|NCT01993979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640773|NCT01993979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2640774|NCT01993979|Immunologic Factors|immunologic factors|mesh-ancestor
2640775|NCT01993979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640776|NCT01994031|Paclitaxel|paclitaxel|mesh-list
2640777|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2174793|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
2174794|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
2174795|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
2174796|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2640778|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2640779|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640780|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
2640781|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
2640782|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
2640783|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640784|NCT01994070|Procainamide|procainamide|mesh-list
2640785|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2640786|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2640787|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2640788|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2640789|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640790|NCT01994096|Caspofungin|caspofungin|mesh-list
2640791|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
2640792|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640793|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640794|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640795|NCT01994265|Warfarin|warfarin|mesh-list
2640796|NCT01994265|Dabigatran|dabigatran|mesh-list
2640797|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
2640798|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
2640799|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2640800|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
2640801|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640802|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640803|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2640804|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
2640805|NCT01994330|Coagulants|coagulants|mesh-ancestor
2640806|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2640807|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
2640808|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640809|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
2640810|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2640811|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640812|NCT01994460|Linezolid|linezolid|mesh-list
2640813|NCT01994460|Ethambutol|ethambutol|mesh-list
2640814|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2640815|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640816|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2640817|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640818|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640819|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
2640820|NCT01994525|Vaccines|vaccines|mesh-list
2640821|NCT01994525|Immunologic Factors|immunologic factors|mesh-ancestor
2640822|NCT01994525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640823|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
2640824|NCT01994642|Dexamethasone|dexamethasone|mesh-list
2640825|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
2640826|NCT01994642|BB 1101|bb 1101|mesh-list
2640827|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2640828|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
2640829|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
2640830|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640831|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640832|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2640833|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
2640834|NCT01994642|Hormones|hormones|mesh-ancestor
2640835|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2640836|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2640837|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640838|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
2640839|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640840|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640841|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2640842|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640843|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2640844|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2640845|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2640846|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2640847|NCT01994668|Lorazepam|lorazepam|mesh-list
2640848|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
2640849|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
2640850|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
2640851|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640852|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640853|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2640854|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2640855|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2640856|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2640857|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2640858|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2640859|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
2640860|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
2640861|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2640862|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640863|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
2640864|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
2640865|NCT01994733|Calcium|calcium|mesh-list
2640866|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2640867|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640868|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2640869|NCT01994733|Antacids|antacids|mesh-ancestor
2640870|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640871|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2640872|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
2640873|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2640874|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2640875|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
2640876|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
2640877|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640878|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640879|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2640880|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
2640881|NCT01994759|Hormones|hormones|mesh-ancestor
2640882|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2640883|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2174797|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2174798|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
2174799|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2174800|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174801|NCT00001865|Daclizumab|daclizumab|mesh-list
2174802|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174803|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
2174804|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174805|NCT00001870|Acetylcholine|acetylcholine|mesh-list
2174806|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
2174807|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2174808|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
2174809|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2174810|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174811|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174812|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
2174813|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2174814|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174815|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174816|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2174817|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2174818|NCT00001877|Protective Agents|protective agents|mesh-ancestor
2174819|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174820|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
2174821|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2174822|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
2174823|NCT00001889|Dobutamine|dobutamine|mesh-list
2174824|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2174825|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
2174826|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
2174827|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174828|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422381|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2422382|NCT00817011|Analgesics|analgesics|mesh-ancestor
2640884|NCT01994759|Protective Agents|protective agents|mesh-ancestor
2640885|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
2640886|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2640887|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
2640888|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640889|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2640890|NCT01994941|Clopidogrel|clopidogrel|mesh-list
2640891|NCT01994941|Ticagrelor|ticagrelor|mesh-list
2640892|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2640893|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2640894|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2640895|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2640896|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
2640897|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2640898|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640899|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640900|NCT01994967|Bupivacaine|bupivacaine|mesh-list
2422383|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
2422384|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422385|NCT00817011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2422386|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
2422387|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2422388|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
2422389|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
2422390|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2422391|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2422392|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2422393|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2422394|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2422395|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2422396|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
2422397|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2640901|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
2640902|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
2640903|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
2640904|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2640905|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174829|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2174830|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2174831|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2174832|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
2174833|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2174834|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174835|NCT00001889|Protective Agents|protective agents|mesh-ancestor
2174836|NCT00001890|Estrogens|estrogens|mesh-list
2174837|NCT00001890|Hormones|hormones|mesh-ancestor
2174838|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2174839|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174840|NCT00001891|Dobutamine|dobutamine|mesh-list
2174841|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2174842|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
2174843|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
2174844|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174845|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174846|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2174847|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2174848|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2174849|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
2174850|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2640906|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
2640907|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174851|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174852|NCT00001891|Protective Agents|protective agents|mesh-ancestor
2174853|NCT00001893|Etanercept|etanercept|mesh-list
2174854|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2174855|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2174856|NCT00001893|Analgesics|analgesics|mesh-ancestor
2174857|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
2174858|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174859|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174860|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2174861|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174862|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2174863|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174864|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
2174865|NCT00001901|Etanercept|etanercept|mesh-list
2174866|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2174867|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2174868|NCT00001901|Analgesics|analgesics|mesh-ancestor
2174869|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
2174870|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174871|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174872|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2174873|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174874|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2174875|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174876|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
2174877|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
2174878|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2174879|NCT00001903|Antibodies|antibodies|mesh-list
2640908|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2640909|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2640910|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2640911|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
2640912|NCT01995006|Dipyrone|dipyrone|mesh-list
2640913|NCT01995006|Naproxen|naproxen|mesh-list
2640914|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2640915|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2640916|NCT01995006|Analgesics|analgesics|mesh-ancestor
2640917|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
2640918|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640919|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174880|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
2174881|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174882|NCT00001905|Interferons|interferons|mesh-list
2174883|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
2174884|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174885|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
2174886|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174887|NCT00001906|Interleukin-12|interleukin-12|mesh-list
2174888|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2174889|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2174890|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
2174891|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174892|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2174893|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2174894|NCT00001906|Growth Substances|growth substances|mesh-ancestor
2174895|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
2174896|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174897|NCT00001906|Antacids|antacids|mesh-ancestor
2640920|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2640921|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2640922|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
2640923|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2640924|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640925|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640926|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
2640927|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
2640928|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2640929|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2640930|NCT01995019|Prednisolone|prednisolone|mesh-list
2640931|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
2640932|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2640933|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
2640934|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2640935|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
2640936|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
2640937|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640938|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640939|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2640940|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
2640941|NCT01995019|Hormones|hormones|mesh-ancestor
2640942|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2640943|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2640944|NCT01995019|Protective Agents|protective agents|mesh-ancestor
2640945|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2640946|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640947|NCT01995032|Metformin|metformin|mesh-list
2640948|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2640949|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640950|NCT01995058|Prednisone|prednisone|mesh-list
2640951|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
2640952|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2640953|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
2640954|NCT01995058|Hormones|hormones|mesh-ancestor
2640955|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2640956|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640957|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2640958|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640959|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2640960|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640961|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640962|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
2640963|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2640964|NCT01995084|Imidazole|imidazole|mesh-list
2640965|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2640966|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2640967|NCT01995188|Bevacizumab|bevacizumab|mesh-list
2640968|NCT01995188|Carboplatin|carboplatin|mesh-list
2640969|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2640970|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640971|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2640972|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2640973|NCT01995188|Growth Substances|growth substances|mesh-ancestor
2640974|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640975|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
2640976|NCT01995214|Propofol|propofol|mesh-list
2640977|NCT01995214|Sevoflurane|sevoflurane|mesh-list
2640978|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2640979|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2640980|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640981|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2640982|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
2640983|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
2640984|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2640985|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2640986|NCT01995292|Anesthetics|anesthetics|mesh-list
2640987|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
2174898|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174899|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2174900|NCT00001911|Interleukin-12|interleukin-12|mesh-list
2174901|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2174902|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
2174903|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174904|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2174905|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2174906|NCT00001911|Growth Substances|growth substances|mesh-ancestor
2174907|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
2174908|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2640988|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2640989|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640990|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
2640991|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2640992|NCT01995331|Cyclosporine|cyclosporine|mesh-list
2640993|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
2640994|NCT01995331|Cyclosporins|cyclosporins|mesh-list
2640995|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2640996|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
2640997|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2640998|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2640999|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2641000|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
2641001|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641002|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641003|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2641004|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174909|NCT00001929|Eliprodil|eliprodil|mesh-list
2174910|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2174911|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2174912|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2174913|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174914|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174915|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2174916|NCT00001929|Protective Agents|protective agents|mesh-ancestor
2174917|NCT00001930|Amantadine|amantadine|mesh-list
2641005|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
2641006|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641007|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
2641008|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2641009|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
2641010|NCT01995344|Fludarabine|fludarabine|mesh-list
2641011|NCT01995344|Interleukin-2|interleukin-2|mesh-list
2641012|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2641013|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
2641014|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641015|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2641016|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2641017|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
2641018|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641019|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641020|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2174918|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2174919|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2174920|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
2174921|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641021|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2641022|NCT01995344|Analgesics|analgesics|mesh-ancestor
2641023|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
2641024|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641025|NCT01995370|Aspirin|aspirin|mesh-list
2641026|NCT01995370|Cilostazol|cilostazol|mesh-list
2174922|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
2174923|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2174924|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174925|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174926|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2174927|NCT00001930|Analgesics|analgesics|mesh-ancestor
2174928|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
2174929|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174930|NCT00001933|Nefiracetam|nefiracetam|mesh-list
2174931|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2174932|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2174933|NCT00001933|Protective Agents|protective agents|mesh-ancestor
2641027|NCT01995370|Clopidogrel|clopidogrel|mesh-list
2641028|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2641029|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2641030|NCT01995370|Analgesics|analgesics|mesh-ancestor
2641031|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
2641032|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641033|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641034|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2641035|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2641036|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2641037|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2641038|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641039|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2641040|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2641041|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641042|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
2641043|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2641044|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2641045|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2641046|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
2641047|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641048|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2641049|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
2641050|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2641051|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
2641052|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
2641053|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2641054|NCT01995370|Protective Agents|protective agents|mesh-ancestor
2641055|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2641056|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2641063|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2641064|NCT01995669|Lenalidomide|lenalidomide|mesh-list
2641065|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
2641066|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
2641067|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174934|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174935|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
2174936|NCT00001934|Daclizumab|daclizumab|mesh-list
2174937|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174938|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
2174939|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174940|NCT00001937|Fluconazole|fluconazole|mesh-list
2174941|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
2174942|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174943|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2174944|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2174945|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174946|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641068|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2641069|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2641070|NCT01995669|Growth Substances|growth substances|mesh-ancestor
2641071|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
2641072|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641073|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2641074|NCT01995695|Vaccines|vaccines|mesh-list
2641075|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
2641076|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641077|NCT01995734|Pasireotide|pasireotide|mesh-list
2641078|NCT01995734|Hormones|hormones|mesh-ancestor
2641079|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2641080|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641081|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2641082|NCT01995799|Hematinics|hematinics|mesh-ancestor
2641083|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2641084|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2641085|NCT01995890|Nepafenac|nepafenac|mesh-list
2641086|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2641087|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2641088|NCT01995890|Analgesics|analgesics|mesh-ancestor
2641089|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
2641090|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641091|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641092|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2641093|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2641094|NCT01996085|Amlodipine|amlodipine|mesh-list
2641095|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2641096|NCT01996085|Telmisartan|telmisartan|mesh-list
2174947|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2174948|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
2174949|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2641097|NCT01996085|Lisinopril|lisinopril|mesh-list
2641098|NCT01996085|Nebivolol|nebivolol|mesh-list
2641099|NCT01996085|Indapamide|indapamide|mesh-list
2641100|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2641101|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2641102|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2641103|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641104|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2641105|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641106|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
2641107|NCT01996085|Diuretics|diuretics|mesh-ancestor
2641108|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
2641109|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2641110|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2641111|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2641112|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2641113|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
2641114|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641115|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2641116|NCT01996085|Protective Agents|protective agents|mesh-ancestor
2641117|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2641118|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2641119|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2641120|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
2641121|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641122|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2641123|NCT01996150|Eusol|eusol|mesh-list
2641124|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
2641125|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641126|NCT01996189|Insulin|insulin|mesh-list
2641127|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2641128|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641129|NCT01996267|Paclitaxel|paclitaxel|mesh-list
2641130|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
2641131|NCT01996267|Carboplatin|carboplatin|mesh-list
2641132|NCT01996267|Fluorouracil|fluorouracil|mesh-list
2174950|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174951|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2174952|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2174953|NCT00001940|Voriconazole|voriconazole|mesh-list
2174954|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
2174955|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2174956|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2174957|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2174958|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174959|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174960|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2174961|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
2641133|NCT01996267|Trastuzumab|trastuzumab|mesh-list
2641134|NCT01996267|Pertuzumab|pertuzumab|mesh-list
2641135|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2641136|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641137|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
2641138|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
2641139|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
2641140|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641141|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2641142|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
2641143|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641144|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2641145|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2641146|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
2641147|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2641148|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
2641149|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2641150|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2641151|NCT01996293|Lamotrigine|lamotrigine|mesh-list
2641152|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
2641153|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2641154|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2641155|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641156|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2641157|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641158|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2641159|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2641160|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641161|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2641162|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2641163|NCT01996306|Leucovorin|leucovorin|mesh-list
2641164|NCT01996306|Bevacizumab|bevacizumab|mesh-list
2641165|NCT01996306|Fluorouracil|fluorouracil|mesh-list
2641166|NCT01996306|Capecitabine|capecitabine|mesh-list
2641167|NCT01996306|Irinotecan|irinotecan|mesh-list
2641168|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2641169|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641170|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2641171|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2641172|NCT01996306|Growth Substances|growth substances|mesh-ancestor
2641173|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641174|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
2641175|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
2641176|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641177|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2641178|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2641179|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
2641180|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2641181|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2641182|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641183|NCT01996306|Antidotes|antidotes|mesh-ancestor
2641184|NCT01996306|Protective Agents|protective agents|mesh-ancestor
2641185|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
2641186|NCT01996306|Vitamins|vitamins|mesh-ancestor
2641187|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
2641188|NCT01996358|Rocuronium|rocuronium|mesh-list
2641189|NCT01996358|Succinylcholine|succinylcholine|mesh-list
2641190|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2641191|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2641192|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2174962|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2174963|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174964|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2174965|NCT00001944|Vinorelbine|vinorelbine|mesh-list
2641193|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641194|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641195|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2641196|NCT01996384|Lidocaine|lidocaine|mesh-list
2641197|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
2641198|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
2641199|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641200|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641201|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
2641202|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641203|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2641204|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2641205|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2641206|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2641207|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641208|NCT01996423|Vitamin D|vitamin d|mesh-list
2641209|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
2641210|NCT01996423|Vitamins|vitamins|mesh-ancestor
2641211|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
2641212|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641213|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2641214|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2641241|NCT01996462|Dexetimide|dexetimide|mesh-list
2641242|NCT01996462|Citalopram|citalopram|mesh-list
2641243|NCT01996462|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2641244|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2641245|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2641246|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641247|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641248|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
2641249|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641250|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2641251|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
2641252|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2641253|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2641254|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2641255|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
2641256|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
2641257|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641258|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2641259|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2641260|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
2641261|NCT01996475|Dexetimide|dexetimide|mesh-list
2174966|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2174967|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2174968|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
2174969|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
2174970|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
2174971|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174972|NCT00001954|Etanercept|etanercept|mesh-list
2174973|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2174974|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2174975|NCT00001954|Analgesics|analgesics|mesh-ancestor
2174976|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
2174977|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174978|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174979|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2174980|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2174981|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2174982|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2174983|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
2174984|NCT00001955|Celecoxib|celecoxib|mesh-list
2174985|NCT00001955|Etanercept|etanercept|mesh-list
2174986|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2174987|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2174988|NCT00001955|Analgesics|analgesics|mesh-ancestor
2174989|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
2174990|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2174991|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2174992|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2174993|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2641262|NCT01996475|Citalopram|citalopram|mesh-list
2641263|NCT01996475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2641264|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2641265|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2641266|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641267|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641268|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
2641269|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641270|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2641271|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
2641272|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2641273|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2641274|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2641275|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
2641276|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
2641277|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641278|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2641279|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2641280|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
2641281|NCT01996488|Olanzapine|olanzapine|mesh-list
2641282|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
2641283|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
2641284|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641285|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641286|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2641287|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2641288|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2641289|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641290|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2641291|NCT01996488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2641292|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2641293|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2641294|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641295|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641296|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
2641297|NCT01996501|Olanzapine|olanzapine|mesh-list
2641298|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
2174994|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2174995|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2174996|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2174997|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2174998|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2174999|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2175000|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
2175001|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
2175002|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2175003|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
2175004|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175005|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175006|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175007|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
2175008|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2175009|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
2175010|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2175011|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175012|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2175013|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
2175014|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2175015|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
2175016|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175017|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2175018|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2175019|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
2175020|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
2175021|NCT00001963|Protective Agents|protective agents|mesh-ancestor
2175022|NCT00001964|Cyclosporine|cyclosporine|mesh-list
2175023|NCT00001964|Cyclosporins|cyclosporins|mesh-list
2175024|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175025|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175026|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2175027|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
2175028|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175029|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
2641299|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
2641300|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2175030|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175031|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
2175032|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2175033|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2641301|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641302|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2641303|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2641304|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2641305|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641306|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2641307|NCT01996501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2641308|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2641309|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2641310|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641311|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641312|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
2641313|NCT01996579|Lactoferrin|lactoferrin|mesh-list
2641314|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641315|NCT01996618|Ranolazine|ranolazine|mesh-list
2641316|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2641317|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2641318|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641319|NCT01996683|Deferiprone|deferiprone|mesh-list
2641320|NCT01996683|Deferoxamine|deferoxamine|mesh-list
2641321|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2641322|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
2641323|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
2641324|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641325|NCT01996683|Siderophores|siderophores|mesh-ancestor
2641326|NCT01996696|Metformin|metformin|mesh-list
2641327|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2641328|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641329|NCT01996735|Ticagrelor|ticagrelor|mesh-list
2641330|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2641331|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2641332|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2641333|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2641334|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
2641335|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641336|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641337|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641338|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
2641339|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2641340|NCT01996761|Protective Agents|protective agents|mesh-ancestor
2641341|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641342|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
2641343|NCT01996865|Rituximab|rituximab|mesh-list
2641344|NCT01996865|Lenalidomide|lenalidomide|mesh-list
2641345|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2641346|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641347|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
2641348|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641349|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2641350|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2641351|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2641352|NCT01996865|Growth Substances|growth substances|mesh-ancestor
2641353|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
2641354|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2641355|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
2175034|NCT00001965|Cyclosporine|cyclosporine|mesh-list
2175035|NCT00001965|Cyclosporins|cyclosporins|mesh-list
2175036|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175037|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175038|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2175039|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
2175040|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175041|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
2641356|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2641357|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641358|NCT01997099|Diazepam|diazepam|mesh-list
2641359|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2641360|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
2641361|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
2641362|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
2641363|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2175042|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175043|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
2175044|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2175045|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2175046|NCT00001968|Ritonavir|ritonavir|mesh-list
2175047|NCT00001968|Amprenavir|amprenavir|mesh-list
2175048|NCT00001968|Lamivudine|lamivudine|mesh-list
2641364|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641365|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2641366|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2641367|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641368|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2641369|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2641370|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2641371|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2641372|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2641373|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2641374|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
2641375|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
2641376|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
2641377|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
2641378|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641379|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641380|NCT01997112|Acetaminophen|acetaminophen|mesh-list
2641381|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2641382|NCT01997112|Analgesics|analgesics|mesh-ancestor
2641383|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
2641384|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641385|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641386|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
2641387|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2641388|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2641389|NCT01997164|Aflibercept|aflibercept|mesh-list
2175049|NCT00001968|Abacavir|abacavir|mesh-list
2175050|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2175051|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2175052|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
2175053|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175054|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175055|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175056|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175057|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
2641390|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2641391|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2641392|NCT01997164|Growth Substances|growth substances|mesh-ancestor
2641393|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641394|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
2641395|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641396|NCT01997190|Valacyclovir|valacyclovir|mesh-list
2641397|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
2641398|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641399|NCT01997203|Vitamin D|vitamin d|mesh-list
2641400|NCT01997203|Interferons|interferons|mesh-list
2641401|NCT01997203|Ribavirin|ribavirin|mesh-list
2641402|NCT01997203|Vitamins|vitamins|mesh-ancestor
2641403|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
2641404|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641405|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2641406|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641407|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
2641408|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641409|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
2641410|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641411|NCT01997255|Everolimus|everolimus|mesh-list
2641412|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641413|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2641414|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
2641415|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641416|NCT01997294|Atorvastatin|atorvastatin|mesh-list
2641417|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2641418|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2641419|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
2641420|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641421|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2641422|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2641423|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641424|NCT01997463|Albuterol|albuterol|mesh-list
2175058|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641425|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2641426|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
2641427|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641428|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641429|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2641430|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
2641431|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
2641432|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2641433|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2641434|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2641435|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2641436|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
2641437|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641438|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175059|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2175060|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2175061|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175062|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175063|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2175064|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
2175065|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175066|NCT00001989|Zidovudine|zidovudine|mesh-list
2175067|NCT00001989|Trichosanthin|trichosanthin|mesh-list
2175068|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
2175069|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175070|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175071|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175072|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175073|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
2175074|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175075|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175076|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175077|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2175078|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
2175079|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2175080|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641439|NCT01997580|Citalopram|citalopram|mesh-list
2641440|NCT01997580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2641441|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2641442|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2641443|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641444|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641445|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
2175081|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2175082|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2175083|NCT00001990|Atovaquone|atovaquone|mesh-list
2175084|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175085|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
2175086|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175087|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175088|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175089|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175090|NCT00001991|Atovaquone|atovaquone|mesh-list
2175091|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175092|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
2175093|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175094|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175095|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175096|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175097|NCT00001993|Miglustat|miglustat|mesh-list
2175098|NCT00001993|Zidovudine|zidovudine|mesh-list
2175099|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
2175100|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175101|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175102|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175103|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175104|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
2175105|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175106|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175107|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175108|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2175109|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2175110|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175111|NCT00001994|Atovaquone|atovaquone|mesh-list
2641446|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641447|NCT01997580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2641448|NCT01997580|Antidepressive Agents|antidepressive agents|mesh-ancestor
2175112|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175113|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
2175114|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175115|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175116|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175117|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641449|NCT01997580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2641450|NCT01997593|Ropivacaine|ropivacaine|mesh-list
2641451|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
2641452|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
2641453|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641454|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641455|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
2641456|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641457|NCT01997632|Vaccines|vaccines|mesh-list
2175118|NCT00001995|Rifabutin|rifabutin|mesh-list
2175119|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175120|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175121|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2175122|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
2175123|NCT00001996|Atovaquone|atovaquone|mesh-list
2175124|NCT00001996|Pentamidine|pentamidine|mesh-list
2175125|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175126|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
2175127|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175128|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175129|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175130|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175131|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
2175132|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2175133|NCT00001997|Zidovudine|zidovudine|mesh-list
2641458|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
2641459|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641460|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
2641461|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2641462|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2641463|NCT01997658|Prednisolone|prednisolone|mesh-list
2641464|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
2641465|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2641466|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
2641467|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2641468|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
2641469|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
2175134|NCT00001997|Didanosine|didanosine|mesh-list
2175135|NCT00001997|Interleukin-2|interleukin-2|mesh-list
2175136|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
2175137|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175138|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175139|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175140|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175141|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
2175142|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175143|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2641470|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641471|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641472|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2641473|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
2641474|NCT01997658|Hormones|hormones|mesh-ancestor
2641475|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2641476|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2641477|NCT01997658|Protective Agents|protective agents|mesh-ancestor
2641478|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2641479|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641480|NCT01997762|Resveratrol|resveratrol|mesh-list
2641481|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
2641482|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641483|NCT01997762|Protective Agents|protective agents|mesh-ancestor
2641484|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641485|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641486|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2641487|NCT01997775|Metformin|metformin|mesh-list
2641488|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2641489|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641490|NCT01997788|Morphine|morphine|mesh-list
2641491|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2641492|NCT01997788|Narcotics|narcotics|mesh-ancestor
2641493|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641494|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641495|NCT01997788|Analgesics|analgesics|mesh-ancestor
2641496|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
2641497|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641498|NCT01997801|Ketamine|ketamine|mesh-list
2641499|NCT01997801|Analgesics|analgesics|mesh-ancestor
2641500|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
2641501|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641502|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641503|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2641504|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2641505|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
2175144|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175145|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2175146|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2175147|NCT00001997|Analgesics|analgesics|mesh-ancestor
2175148|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
2175149|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2175150|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175151|NCT00001998|Nystatin|nystatin|mesh-list
2175152|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175153|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175154|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
2175155|NCT00001998|Ionophores|ionophores|mesh-ancestor
2175156|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2175157|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175158|NCT00001999|Ganciclovir|ganciclovir|mesh-list
2175159|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2641506|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
2641507|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641508|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2641509|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2641510|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641511|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641512|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
2641513|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
2175160|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
2175161|NCT00001999|Antibodies|antibodies|mesh-list
2175162|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
2175163|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175164|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175165|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175166|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175167|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
2175168|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175169|NCT00002000|Valacyclovir|valacyclovir|mesh-list
2175170|NCT00002000|Acyclovir|acyclovir|mesh-list
2175171|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
2175172|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175173|NCT00002001|Zidovudine|zidovudine|mesh-list
2175174|NCT00002001|Didanosine|didanosine|mesh-list
2175175|NCT00002001|Zalcitabine|zalcitabine|mesh-list
2175176|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
2175177|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175178|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175179|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175180|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175181|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
2641514|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641515|NCT01997840|Dexamethasone|dexamethasone|mesh-list
2641516|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
2175182|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175183|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175184|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175185|NCT00002002|Leucovorin|leucovorin|mesh-list
2175186|NCT00002002|Trimethoprim|trimethoprim|mesh-list
2175187|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
2175188|NCT00002002|Calcium|calcium|mesh-list
2175189|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
2175190|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2175191|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175192|NCT00002002|Antidotes|antidotes|mesh-ancestor
2175193|NCT00002002|Protective Agents|protective agents|mesh-ancestor
2175194|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
2175195|NCT00002002|Vitamins|vitamins|mesh-ancestor
2641517|NCT01997840|Pomalidomide|pomalidomide|mesh-list
2641518|NCT01997840|Ricolinostat|ricolinostat|mesh-list
2641519|NCT01997840|BB 1101|bb 1101|mesh-list
2641520|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2641521|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
2641522|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
2641523|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641524|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641525|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2641526|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
2641527|NCT01997840|Hormones|hormones|mesh-ancestor
2641528|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2641529|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2641530|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641531|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
2641532|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641533|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641534|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
2641535|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2641536|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2641537|NCT01997840|Growth Substances|growth substances|mesh-ancestor
2641538|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
2641539|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2641540|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2641541|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2641542|NCT01997944|Interferons|interferons|mesh-list
2641543|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
2641544|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
2641545|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2641546|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641547|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
2641548|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641549|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
2641550|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641551|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
2641552|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2641553|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2641554|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641555|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
2175196|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
2175197|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2175198|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641556|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641557|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641558|NCT01998035|Azacitidine|azacitidine|mesh-list
2641559|NCT01998035|Romidepsin|romidepsin|mesh-list
2641560|NCT01998035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2641561|NCT01998035|Antimetabolites|antimetabolites|mesh-ancestor
2641562|NCT01998035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641563|NCT01998035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641564|NCT01998035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641565|NCT01998035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2641566|NCT01998113|Insulin|insulin|mesh-list
2641567|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2641568|NCT01998113|Metformin|metformin|mesh-list
2641569|NCT01998113|Glyburide|glyburide|mesh-list
2641570|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2641571|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641572|NCT01998126|Nivolumab|nivolumab|mesh-list
2641573|NCT01998126|Ipilimumab|ipilimumab|mesh-list
2175199|NCT00002002|Renal Agents|renal agents|mesh-ancestor
2175200|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
2175201|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175202|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175203|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2175204|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175205|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175206|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2175207|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2175208|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2175209|NCT00002003|Etoposide|etoposide|mesh-list
2175210|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
2175211|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2175212|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641574|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2641575|NCT01998126|Crizotinib|crizotinib|mesh-list
2641576|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2641577|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641578|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2641579|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641580|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2641581|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641582|NCT01998165|Remifentanil|remifentanil|mesh-list
2641583|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2641584|NCT01998165|Narcotics|narcotics|mesh-ancestor
2641585|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641586|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175213|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2175214|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2175215|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175216|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175217|NCT00002003|Analgesics|analgesics|mesh-ancestor
2175218|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
2175219|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2175220|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175221|NCT00002006|Zidovudine|zidovudine|mesh-list
2175222|NCT00002006|Sargramostim|sargramostim|mesh-list
2175223|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
2175224|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175225|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175226|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175227|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175228|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
2641587|NCT01998165|Analgesics|analgesics|mesh-ancestor
2641588|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
2641589|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641590|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
2641591|NCT01998217|Remifentanil|remifentanil|mesh-list
2641592|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2641593|NCT01998217|Narcotics|narcotics|mesh-ancestor
2641594|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641595|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641596|NCT01998217|Analgesics|analgesics|mesh-ancestor
2641597|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
2641598|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641599|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2641600|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2641601|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2641602|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2175229|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175230|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175231|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175232|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
2175233|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175234|NCT00002007|Zidovudine|zidovudine|mesh-list
2175235|NCT00002007|Sargramostim|sargramostim|mesh-list
2175236|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
2175237|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175238|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175239|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175240|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641603|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2641604|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641605|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641606|NCT01998295|Lumefantrine|lumefantrine|mesh-list
2641607|NCT01998295|Artemether|artemether|mesh-list
2641608|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2641609|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
2641610|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2641611|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2641612|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641613|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
2641614|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2641615|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
2641616|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641617|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
2641618|NCT01998308|Protective Agents|protective agents|mesh-ancestor
2641619|NCT01998347|Paclitaxel|paclitaxel|mesh-list
2641620|NCT01998347|Fluorouracil|fluorouracil|mesh-list
2641621|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2641622|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641623|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
2641624|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
2641625|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
2641626|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641627|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
2641628|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2641629|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2641630|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
2641631|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641632|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2641633|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2641634|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641635|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
2641636|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
2641637|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641638|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2641639|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2641640|NCT01998503|Dexamethasone|dexamethasone|mesh-list
2641641|NCT01998503|Bortezomib|bortezomib|mesh-list
2641642|NCT01998503|Melphalan|melphalan|mesh-list
2641643|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2641644|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
2641645|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
2641646|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641647|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641648|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2641649|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
2641650|NCT01998503|Hormones|hormones|mesh-ancestor
2641651|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2641652|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2641653|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641654|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
2641655|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2641656|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
2641657|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641658|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2641659|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2641660|NCT01998529|Cisplatin|cisplatin|mesh-list
2641661|NCT01998529|Amifostine|amifostine|mesh-list
2641662|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641663|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2641664|NCT01998529|Protective Agents|protective agents|mesh-ancestor
2641665|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175241|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
2175242|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641666|NCT01998685|Fentanyl|fentanyl|mesh-list
2641667|NCT01998685|Midazolam|midazolam|mesh-list
2641668|NCT01998685|Remifentanil|remifentanil|mesh-list
2641669|NCT01998685|Propofol|propofol|mesh-list
2641670|NCT01998685|Sevoflurane|sevoflurane|mesh-list
2641671|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2641672|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641673|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175243|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175244|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175245|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
2175246|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175247|NCT00002008|Sargramostim|sargramostim|mesh-list
2175248|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
2641674|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2641675|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
2641676|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
2641677|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2641678|NCT01998685|Narcotics|narcotics|mesh-ancestor
2641679|NCT01998685|Analgesics|analgesics|mesh-ancestor
2641680|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
2641681|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641682|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2641683|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2641684|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2641685|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2641686|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
2641687|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
2641688|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641689|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641690|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2641691|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2641692|NCT01998698|Lidocaine|lidocaine|mesh-list
2641693|NCT01998698|Dipivefrin|dipivefrin|mesh-list
2641694|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
2641695|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2641696|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
2641697|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641698|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641699|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641700|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2641701|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
2641702|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
2641703|NCT01998698|Protective Agents|protective agents|mesh-ancestor
2641704|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
2641705|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
2641706|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641707|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
2641708|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641709|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2641710|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2641711|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2641712|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2641713|NCT01998763|Vitamin D|vitamin d|mesh-list
2641714|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
2641715|NCT01998763|Vitamins|vitamins|mesh-ancestor
2641716|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
2641717|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641718|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2641719|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2641720|NCT01998776|Misoprostol|misoprostol|mesh-list
2641721|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2641722|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
2175249|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175250|NCT00002009|Sargramostim|sargramostim|mesh-list
2175251|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
2175252|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175253|NCT00002010|Fluconazole|fluconazole|mesh-list
2175254|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
2175255|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641723|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2641724|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641725|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2641726|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2641727|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
2641728|NCT01998789|Everolimus|everolimus|mesh-list
2641729|NCT01998789|Tacrolimus|tacrolimus|mesh-list
2641730|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2641731|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
2641732|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641733|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2641734|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641735|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641736|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2175256|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2175257|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2175258|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175259|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175260|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2175261|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
2641737|NCT01998828|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2641738|NCT01998828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2641739|NCT01998828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641740|NCT01998828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641741|NCT01998971|Acetaminophen|acetaminophen|mesh-list
2641742|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
2641743|NCT01998971|Promethazine|promethazine|mesh-list
2641744|NCT01998971|Thalidomide|thalidomide|mesh-list
2641745|NCT01998971|Dexamethasone|dexamethasone|mesh-list
2641746|NCT01998971|Prednisone|prednisone|mesh-list
2641747|NCT01998971|Lenalidomide|lenalidomide|mesh-list
2641748|NCT01998971|Melphalan|melphalan|mesh-list
2641749|NCT01998971|Bortezomib|bortezomib|mesh-list
2641750|NCT01998971|Pomalidomide|pomalidomide|mesh-list
2641751|NCT01998971|Daratumumab|daratumumab|mesh-list
2641752|NCT01998971|Montelukast|montelukast|mesh-list
2641753|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2641754|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
2641755|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
2641756|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641757|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641758|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2641759|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
2641760|NCT01998971|Hormones|hormones|mesh-ancestor
2641761|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2641762|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2641763|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641764|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
2641765|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2641766|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2641767|NCT01998971|Growth Substances|growth substances|mesh-ancestor
2641768|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
2641769|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2641770|NCT01998971|Analgesics|analgesics|mesh-ancestor
2641771|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
2641772|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
2641773|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2175262|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2175263|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175264|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2175265|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2175266|NCT00002011|Methoxsalen|methoxsalen|mesh-list
2175267|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2175268|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
2175269|NCT00002012|Interferons|interferons|mesh-list
2175270|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
2175271|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2175272|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
2175273|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175274|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
2175275|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175276|NCT00002013|Zidovudine|zidovudine|mesh-list
2175277|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
2175278|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641774|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
2641775|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641776|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2641777|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2641778|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
2641779|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2641780|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641781|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2641782|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
2641783|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2641784|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
2641785|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2641786|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2175279|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175280|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175281|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175282|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
2175283|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175284|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175285|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175286|NCT00002014|Zidovudine|zidovudine|mesh-list
2175287|NCT00002014|Didanosine|didanosine|mesh-list
2175288|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
2175289|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175290|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175291|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175292|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175293|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
2175294|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175295|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175296|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175297|NCT00002015|Ganciclovir|ganciclovir|mesh-list
2175298|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2175299|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
2175300|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175301|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175302|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175303|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175304|NCT00002017|Interleukin-2|interleukin-2|mesh-list
2175305|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2175306|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2175307|NCT00002017|Analgesics|analgesics|mesh-ancestor
2175308|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
2175309|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2175310|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175311|NCT00002018|Interferons|interferons|mesh-list
2175312|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
2175313|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641787|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2641788|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2641789|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641790|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
2641791|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
2641792|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2641793|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
2422398|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2422399|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2422400|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2422401|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2422402|NCT00817037|Nifedipine|nifedipine|mesh-list
2422403|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
2422404|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2422405|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422406|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422407|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2422408|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641794|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
2641795|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641796|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2641797|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
2641798|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
2641799|NCT01999153|Ropivacaine|ropivacaine|mesh-list
2641800|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
2641801|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
2641802|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641803|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641804|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
2641805|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641824|NCT01999270|Bevacizumab|bevacizumab|mesh-list
2641825|NCT01999270|Irinotecan|irinotecan|mesh-list
2641826|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2175314|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
2175315|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175316|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
2175317|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175318|NCT00002019|Amphotericin B|amphotericin b|mesh-list
2175319|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2175320|NCT00002019|Amebicides|amebicides|mesh-ancestor
2175321|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2641827|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641828|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2641829|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2641830|NCT01999270|Growth Substances|growth substances|mesh-ancestor
2641831|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641832|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
2641833|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2641834|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2641835|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641836|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641837|NCT01999309|Simvastatin|simvastatin|mesh-list
2641838|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2641839|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2641840|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
2641841|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641842|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2641843|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2641844|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641845|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
2641846|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2641847|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641848|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2641849|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
2641850|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2641851|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175322|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175323|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175324|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175325|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
2175326|NCT00002020|Zidovudine|zidovudine|mesh-list
2175327|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
2175328|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175329|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2641852|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641853|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641854|NCT01999413|Cytarabine|cytarabine|mesh-list
2641855|NCT01999413|Daunorubicin|daunorubicin|mesh-list
2641856|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2641857|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
2641858|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641859|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641860|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
2641861|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2641862|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2641863|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
2641864|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641865|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2641866|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2641867|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2641868|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641869|NCT01999647|Ropivacaine|ropivacaine|mesh-list
2641870|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
2641871|NCT01999647|Anesthetics|anesthetics|mesh-list
2641872|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641873|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641874|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
2641875|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641876|NCT01999673|Docetaxel|docetaxel|mesh-list
2641877|NCT01999673|Bavituximab|bavituximab|mesh-list
2641878|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2641879|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641880|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
2641881|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
2641882|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
2641883|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641884|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2641885|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
2641886|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641887|NCT01999686|Metformin|metformin|mesh-list
2641888|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2641889|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641890|NCT01999738|Folic Acid|folic acid|mesh-list
2641891|NCT01999738|Hematinics|hematinics|mesh-ancestor
2641892|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
2641893|NCT01999738|Vitamins|vitamins|mesh-ancestor
2641894|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
2641895|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641896|NCT01999764|Retinol acetate|retinol acetate|mesh-list
2641897|NCT01999764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2641898|NCT01999764|Immunologic Factors|immunologic factors|mesh-ancestor
2641899|NCT01999764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641900|NCT01999764|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2641901|NCT01999764|Protective Agents|protective agents|mesh-ancestor
2641902|NCT01999764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641903|NCT01999829|Caffeine|caffeine|mesh-list
2641904|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641905|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2641906|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641907|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2641908|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175330|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175331|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175332|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
2175333|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175334|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175335|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175336|NCT00002021|Foscarnet|foscarnet|mesh-list
2641909|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2641910|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2641911|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
2641912|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641913|NCT01999842|Vaccines|vaccines|mesh-list
2641914|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
2641915|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641916|NCT01999907|Vitamin D|vitamin d|mesh-list
2641917|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
2641918|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
2641919|NCT01999907|Vitamins|vitamins|mesh-list
2641920|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
2641921|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641922|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2641923|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2641924|NCT01999933|Cisplatin|cisplatin|mesh-list
2641925|NCT01999933|Docetaxel|docetaxel|mesh-list
2641926|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641927|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
2641928|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
2641929|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
2641930|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641931|NCT02000089|Secretin|secretin|mesh-list
2641932|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2641933|NCT02000089|Hormones|hormones|mesh-ancestor
2641934|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2641935|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641936|NCT02000102|Aflibercept|aflibercept|mesh-list
2641937|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2641938|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2641939|NCT02000102|Growth Substances|growth substances|mesh-ancestor
2641940|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641941|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
2641942|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641943|NCT02000193|Fulvestrant|fulvestrant|mesh-list
2641944|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2641945|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641946|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2641947|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2641948|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
2641949|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2641950|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641951|NCT02000206|Ketamine|ketamine|mesh-list
2641952|NCT02000206|Alfentanil|alfentanil|mesh-list
2641953|NCT02000206|Propofol|propofol|mesh-list
2641954|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2641955|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2641956|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641957|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2641958|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
2641959|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
2641960|NCT02000206|Analgesics|analgesics|mesh-ancestor
2641961|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
2641962|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2175337|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2175338|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
2175339|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175340|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175341|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175342|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175343|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175344|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
2175345|NCT00002022|Hematinics|hematinics|mesh-ancestor
2175346|NCT00002023|Zidovudine|zidovudine|mesh-list
2175347|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
2641963|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2641964|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2641965|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2641966|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2641967|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641968|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2641969|NCT02000206|Narcotics|narcotics|mesh-ancestor
2641970|NCT02000336|Prednisolone|prednisolone|mesh-list
2641971|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2641972|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
2641973|NCT02000336|Hormones|hormones|mesh-ancestor
2641974|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2641975|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641976|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2641977|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2641978|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2641979|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2641980|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
2641981|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641982|NCT02000388|Ketorolac|ketorolac|mesh-list
2641983|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2641984|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2641985|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2641986|NCT02000388|Analgesics|analgesics|mesh-ancestor
2641987|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
2641988|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2641989|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2641990|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2641991|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2641992|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2641993|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2641994|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2641995|NCT02000401|Ketorolac|ketorolac|mesh-list
2641996|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2641997|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2641998|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2641999|NCT02000401|Analgesics|analgesics|mesh-ancestor
2642000|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
2642001|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642002|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642003|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2642004|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2642005|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2642006|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642007|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642008|NCT02000414|Daptomycin|daptomycin|mesh-list
2642009|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2642010|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642011|NCT02000596|Trastuzumab|trastuzumab|mesh-list
2642012|NCT02000596|Pertuzumab|pertuzumab|mesh-list
2642013|NCT02000596|Fulvestrant|fulvestrant|mesh-list
2642014|NCT02000596|Anastrozole|anastrozole|mesh-list
2175348|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175349|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175350|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175351|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175352|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
2175353|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175354|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175355|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175356|NCT00002024|Ganciclovir|ganciclovir|mesh-list
2642015|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2642016|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642017|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2642018|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2642019|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2642020|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
2642021|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2642022|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642023|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2642024|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2642025|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642026|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642027|NCT02000674|Rocuronium|rocuronium|mesh-list
2642028|NCT02000674|Succinylcholine|succinylcholine|mesh-list
2642029|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2642030|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2642031|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2642032|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642033|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642034|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2642035|NCT02000700|Canagliflozin|canagliflozin|mesh-list
2642036|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2642037|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642038|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2642039|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642040|NCT02000726|Citalopram|citalopram|mesh-list
2642041|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
2642042|NCT02000726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2642043|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2642044|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2642045|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175357|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2175358|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
2175359|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175360|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175361|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175362|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175363|NCT00002025|Ganciclovir|ganciclovir|mesh-list
2175364|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2175365|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
2175366|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642046|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2642047|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
2642048|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642049|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2642050|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2642051|NCT02000804|Darapladib|darapladib|mesh-list
2642052|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2642053|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642054|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642055|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
2642056|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642057|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175367|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175368|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175369|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175370|NCT00002026|Acyclovir|acyclovir|mesh-list
2175371|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
2175372|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175373|NCT00002027|Diclazuril|diclazuril|mesh-list
2175374|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
2642065|NCT02000947|Durvalumab|durvalumab|mesh-list
2642066|NCT02000947|Tremelimumab|tremelimumab|mesh-list
2642067|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2642068|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2642069|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642070|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
2642071|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642072|NCT02001012|Chloroquine|chloroquine|mesh-list
2642073|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2642074|NCT02001012|Lumefantrine|lumefantrine|mesh-list
2642075|NCT02001012|Artemether|artemether|mesh-list
2642076|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2642077|NCT02001012|Amebicides|amebicides|mesh-ancestor
2642078|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2642079|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2642080|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642081|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
2642082|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2175375|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175376|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175377|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175378|NCT00002028|Didanosine|didanosine|mesh-list
2175379|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
2175380|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175381|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175382|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175383|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175384|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
2175385|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175386|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175387|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175388|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2175389|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2175390|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2175391|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2175392|NCT00002030|Pentamidine|pentamidine|mesh-list
2175393|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
2175394|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175395|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175396|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175397|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2175398|NCT00002032|Rifabutin|rifabutin|mesh-list
2175399|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175400|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175401|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2175402|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
2642083|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2642084|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2642085|NCT02001012|Analgesics|analgesics|mesh-ancestor
2642086|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
2642087|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642088|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642089|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2642090|NCT02001012|Filaricides|filaricides|mesh-ancestor
2642091|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
2642092|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
2642093|NCT02001103|Memantine|memantine|mesh-list
2642094|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2175403|NCT00002033|Zidovudine|zidovudine|mesh-list
2175404|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
2175405|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175406|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175407|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175408|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175409|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
2175410|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175411|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2642095|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2642096|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
2642097|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2642098|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642099|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642100|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2642101|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2642102|NCT02001168|Docetaxel|docetaxel|mesh-list
2642103|NCT02001168|Pemetrexed|pemetrexed|mesh-list
2642104|NCT02001168|Cisplatin|cisplatin|mesh-list
2642105|NCT02001168|Endostatins|endostatins|mesh-list
2642106|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642107|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
2642108|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
2642109|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
2642110|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642111|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642112|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2175412|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175413|NCT00002034|Zidovudine|zidovudine|mesh-list
2175414|NCT00002034|Ganciclovir|ganciclovir|mesh-list
2175415|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2175416|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
2175417|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175418|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175419|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175420|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175421|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
2175422|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642113|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2642114|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2642115|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2642116|NCT02001168|Growth Substances|growth substances|mesh-ancestor
2642117|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642118|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
2642119|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
2642120|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2642121|NCT02001259|Lidocaine|lidocaine|mesh-list
2642122|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
2642123|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
2642124|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2642125|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642126|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
2642127|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642128|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2642129|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2642130|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2642131|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2642132|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642133|NCT02001272|Paclitaxel|paclitaxel|mesh-list
2642134|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2642135|NCT02001272|Carboplatin|carboplatin|mesh-list
2642136|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2642137|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642138|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
2642139|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
2642140|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
2642141|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642142|NCT02001285|Remifentanil|remifentanil|mesh-list
2642143|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2642144|NCT02001285|Narcotics|narcotics|mesh-ancestor
2642145|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2642146|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642147|NCT02001285|Analgesics|analgesics|mesh-ancestor
2642148|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
2642149|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642150|NCT02001298|Nitroprusside|nitroprusside|mesh-list
2175423|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175424|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175425|NCT00002035|Zidovudine|zidovudine|mesh-list
2175426|NCT00002035|Didanosine|didanosine|mesh-list
2175427|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
2175428|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175429|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175430|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175431|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175432|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
2175433|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175434|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175435|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175436|NCT00002036|Immune Sera|immune sera|mesh-list
2175437|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
2175438|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175439|NCT00002037|Trifluridine|trifluridine|mesh-list
2642151|NCT02001298|Remifentanil|remifentanil|mesh-list
2642152|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2642153|NCT02001298|Narcotics|narcotics|mesh-ancestor
2642154|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2642155|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642156|NCT02001298|Analgesics|analgesics|mesh-ancestor
2642157|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
2642158|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642159|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2642160|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
2642161|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2642162|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642163|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
2642164|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2642165|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2642166|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642167|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
2642168|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
2642169|NCT02001363|Liraglutide|liraglutide|mesh-list
2642170|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2175440|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
2642171|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642172|NCT02001363|Incretins|incretins|mesh-ancestor
2642173|NCT02001363|Hormones|hormones|mesh-ancestor
2642174|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2642175|NCT02001428|Piperaquine|piperaquine|mesh-list
2642176|NCT02001428|Artenimol|artenimol|mesh-list
2642177|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
2642178|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175441|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175442|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
2175443|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175444|NCT00002038|Fluconazole|fluconazole|mesh-list
2175445|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
2175446|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175447|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2175448|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2175449|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175450|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175451|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2175452|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
2175453|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2175454|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175455|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2175456|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2175457|NCT00002039|Foscarnet|foscarnet|mesh-list
2175458|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2175459|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
2175460|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175461|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175462|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175463|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175464|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175465|NCT00002040|Fluconazole|fluconazole|mesh-list
2175466|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
2642179|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2642180|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642181|NCT02001506|Docetaxel|docetaxel|mesh-list
2642182|NCT02001506|Epirubicin|epirubicin|mesh-list
2642183|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642184|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
2642185|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
2642186|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
2642187|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642188|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2642189|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2642190|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2642191|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642192|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
2642193|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642194|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2642195|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642196|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642197|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
2642198|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2642199|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642200|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2642201|NCT02001584|Memantine|memantine|mesh-list
2642202|NCT02001584|Baclofen|baclofen|mesh-list
2642203|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2642204|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2642205|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
2642206|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2642207|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642208|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642209|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2642210|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2642211|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2642212|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2642213|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642214|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2642215|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
2642216|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
2642220|NCT02001740|Lidocaine|lidocaine|mesh-list
2642221|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
2642222|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
2642223|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2642224|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642225|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
2642226|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642227|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2642228|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2642229|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2642230|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2642231|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642232|NCT02001818|Interferons|interferons|mesh-list
2642233|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
2642234|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
2642235|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2642236|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
2642237|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642238|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
2642239|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642240|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
2642241|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642242|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2642243|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642244|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642245|NCT02001857|Hemostatics|hemostatics|mesh-list
2642246|NCT02001857|Coagulants|coagulants|mesh-ancestor
2642247|NCT02001883|Policosanol|policosanol|mesh-list
2642248|NCT02001883|Atorvastatin|atorvastatin|mesh-list
2642249|NCT02001883|Simvastatin|simvastatin|mesh-list
2642250|NCT02001883|Red yeast rice|red yeast rice|mesh-list
2642251|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2642252|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2642253|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
2642254|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642255|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2642256|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2642257|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642258|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2642259|NCT02001896|Gemcitabine|gemcitabine|mesh-list
2642260|NCT02001896|Carboplatin|carboplatin|mesh-list
2642261|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2642262|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642263|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2642264|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
2642265|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642266|NCT02001896|Antiviral Agents|antiviral agents|mesh-ancestor
2642267|NCT02001896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642268|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642269|NCT02001896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2642270|NCT02001896|Immunologic Factors|immunologic factors|mesh-ancestor
2175467|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175468|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2175469|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2175470|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422409|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
2422410|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
2422411|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2422412|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2422413|NCT00817050|Fluticasone|fluticasone|mesh-list
2422414|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
2422415|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2422416|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2422417|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
2422418|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422419|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422420|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2422421|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
2422422|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
2422423|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2422424|NCT00817076|Desloratadine|desloratadine|mesh-list
2422425|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2422426|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
2642271|NCT02001896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642272|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2642273|NCT02001909|Neomycin|neomycin|mesh-list
2642274|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2642275|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642276|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2642277|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642278|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642279|NCT02001935|Theophylline|theophylline|mesh-list
2642280|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2642281|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
2642282|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642283|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642284|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2175471|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175472|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2175473|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
2642285|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
2642286|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2642287|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642288|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642289|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
2642290|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2642291|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2175474|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2175475|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175476|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2175477|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2175478|NCT00002041|Amphotericin B|amphotericin b|mesh-list
2175479|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2175480|NCT00002041|Amebicides|amebicides|mesh-ancestor
2175481|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175482|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175483|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175484|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175485|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
2175486|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
2175487|NCT00002042|Hematinics|hematinics|mesh-ancestor
2175488|NCT00002043|Dapsone|dapsone|mesh-list
2175489|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175490|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
2175491|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175492|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175493|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2175494|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175495|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175496|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
2175497|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175498|NCT00002044|Zidovudine|zidovudine|mesh-list
2175499|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
2175500|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175501|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2642292|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
2642293|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2642294|NCT02001948|Morphine|morphine|mesh-list
2642295|NCT02001948|Bupivacaine|bupivacaine|mesh-list
2642296|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
2642297|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
2642298|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2642299|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642300|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
2642301|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642302|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2642303|NCT02001948|Narcotics|narcotics|mesh-ancestor
2642304|NCT02001948|Analgesics|analgesics|mesh-ancestor
2642305|NCT02001974|Paclitaxel|paclitaxel|mesh-list
2642306|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2642307|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642308|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
2642309|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
2642310|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
2642311|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175502|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2642312|NCT02002000|Vitamin D|vitamin d|mesh-list
2642313|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
2642314|NCT02002000|Vitamins|vitamins|mesh-ancestor
2642315|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
2175503|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175504|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
2175505|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175506|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2642316|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642317|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2642318|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2642319|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
2642320|NCT02002039|Hematinics|hematinics|mesh-ancestor
2642321|NCT02002065|Vaccines|vaccines|mesh-list
2642322|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
2642323|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642324|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2642325|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
2175507|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175508|NCT00002045|Zidovudine|zidovudine|mesh-list
2175509|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
2175510|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175511|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175512|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175513|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175514|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
2175515|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642326|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2642327|NCT02002078|Prednisolone|prednisolone|mesh-list
2642328|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
2642329|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2642330|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
2642331|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2642332|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
2642333|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
2642334|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642335|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642336|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2642337|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
2642338|NCT02002078|Hormones|hormones|mesh-ancestor
2642339|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2642340|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2642341|NCT02002078|Protective Agents|protective agents|mesh-ancestor
2642342|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2642343|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642344|NCT02002156|Vaccines|vaccines|mesh-list
2642345|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2642346|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
2642347|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
2642348|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642349|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2642350|NCT02002195|Leucovorin|leucovorin|mesh-list
2642351|NCT02002195|Fluorouracil|fluorouracil|mesh-list
2642352|NCT02002195|Capecitabine|capecitabine|mesh-list
2642353|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
2642354|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
2642355|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642356|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2642357|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642358|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2642359|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
2642360|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642361|NCT02002195|Antidotes|antidotes|mesh-ancestor
2642362|NCT02002195|Protective Agents|protective agents|mesh-ancestor
2642363|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
2642364|NCT02002195|Vitamins|vitamins|mesh-ancestor
2642365|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
2175516|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175517|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175518|NCT00002046|Zidovudine|zidovudine|mesh-list
2175519|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
2175520|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175521|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175522|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175523|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175524|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
2642366|NCT02002247|Selenium|selenium|mesh-list
2642367|NCT02002247|Selenious Acid|selenious acid|mesh-list
2642368|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
2642369|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
2175525|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175526|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2642370|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642371|NCT02002247|Protective Agents|protective agents|mesh-ancestor
2642372|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642373|NCT02002247|Trace Elements|trace elements|mesh-ancestor
2642374|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
2642375|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
2642376|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2642377|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
2642378|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
2642379|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2642380|NCT02002260|Estradiol|estradiol|mesh-list
2642381|NCT02002260|Estrogens|estrogens|mesh-ancestor
2642382|NCT02002260|Hormones|hormones|mesh-ancestor
2642383|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2642384|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642385|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2642386|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2642387|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2642388|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2642389|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2642390|NCT02002286|Triptolide|triptolide|mesh-list
2642391|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2642392|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642393|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2642394|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
2642395|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2642396|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2642397|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
2642398|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2642399|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
2642400|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642401|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642402|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
2642403|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
2642404|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
2642405|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642406|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2642407|NCT02002325|Plasminogen|plasminogen|mesh-list
2642408|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2642409|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2642410|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642411|NCT02002377|Aflibercept|aflibercept|mesh-list
2642412|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2642413|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2642414|NCT02002377|Growth Substances|growth substances|mesh-ancestor
2642415|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642416|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
2642417|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642418|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2642419|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2642420|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642421|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2642422|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
2642423|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642424|NCT02002403|Danazol|danazol|mesh-list
2642425|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2642426|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
2642427|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2642428|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642429|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
2642430|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
2642431|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2642432|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642433|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
2642434|NCT02002598|Dexamethasone|dexamethasone|mesh-list
2642435|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
2642436|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2642437|NCT02002598|BB 1101|bb 1101|mesh-list
2642438|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2642439|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
2642440|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
2642441|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642442|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642443|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2642444|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
2642445|NCT02002598|Hormones|hormones|mesh-ancestor
2642446|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2642447|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2642448|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642449|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
2642450|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642451|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642452|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2642453|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
2642454|NCT02002611|Warfarin|warfarin|mesh-list
2642455|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
2642456|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
2642457|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2642458|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2642459|NCT02002663|Prednisolone|prednisolone|mesh-list
2642460|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
2642461|NCT02002663|Morphine|morphine|mesh-list
2642462|NCT02002663|Ropivacaine|ropivacaine|mesh-list
2642463|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2642464|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
2642465|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2642466|NCT02002663|Narcotics|narcotics|mesh-ancestor
2642467|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2642468|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642469|NCT02002663|Analgesics|analgesics|mesh-ancestor
2642470|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
2642471|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642472|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
2175527|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175528|NCT00002047|Zidovudine|zidovudine|mesh-list
2175529|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
2175530|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175531|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175532|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175533|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175534|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
2175535|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642473|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
2642474|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2642475|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
2642476|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
2642477|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2642478|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
2642479|NCT02002663|Hormones|hormones|mesh-ancestor
2642480|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2642481|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2642482|NCT02002663|Protective Agents|protective agents|mesh-ancestor
2642483|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2642484|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642485|NCT02002715|Budesonide|budesonide|mesh-list
2642486|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2642487|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2642488|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
2642489|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642490|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642491|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2642492|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
2642493|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
2642494|NCT02002715|Hormones|hormones|mesh-ancestor
2642495|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2642496|NCT02002741|Acetaminophen|acetaminophen|mesh-list
2642497|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2642498|NCT02002741|Analgesics|analgesics|mesh-ancestor
2175536|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175537|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175538|NCT00002048|Zidovudine|zidovudine|mesh-list
2642499|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
2642500|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642501|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642502|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
2642503|NCT02002754|Bambuterol|bambuterol|mesh-list
2175539|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
2642504|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2642505|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
2175540|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175541|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175542|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175543|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175544|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
2175545|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175546|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2642506|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642507|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642508|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2642509|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
2642510|NCT02002806|Ethanol|ethanol|mesh-list
2642511|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2175547|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175548|NCT00002049|Thymopentin|thymopentin|mesh-list
2175549|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2642512|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642513|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2642514|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642515|NCT02002819|Levetiracetam|levetiracetam|mesh-list
2642516|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
2642517|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
2642518|NCT02002858|Nicotine|nicotine|mesh-list
2642519|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2642520|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
2642521|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642522|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642523|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2642524|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2642525|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
2642526|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2642527|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642528|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
2642529|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2642530|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2642531|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642532|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
2642533|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2642534|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642535|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
2175550|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
2175551|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175552|NCT00002050|Thymopentin|thymopentin|mesh-list
2175553|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2175554|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
2175555|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175556|NCT00002051|Thymopentin|thymopentin|mesh-list
2175557|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2175558|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
2642536|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2642537|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2175559|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175560|NCT00002052|Amoxicillin|amoxicillin|mesh-list
2175561|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
2175562|NCT00002052|Ampicillin|ampicillin|mesh-list
2175563|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175564|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175565|NCT00002053|Pentamidine|pentamidine|mesh-list
2175566|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
2175567|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175568|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175569|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175570|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2175571|NCT00002054|Pentamidine|pentamidine|mesh-list
2175572|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
2175573|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175574|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175575|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2642538|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2642539|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2642540|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642541|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
2642542|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2175576|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2175577|NCT00002055|Pentamidine|pentamidine|mesh-list
2175578|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
2642543|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642544|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2642545|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642546|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
2642547|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2642548|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2642549|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642550|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
2642551|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2642552|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642553|NCT02003144|Eculizumab|eculizumab|mesh-list
2642554|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2642555|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2642556|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
2642557|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642558|NCT02003209|Carboplatin|carboplatin|mesh-list
2642559|NCT02003209|Docetaxel|docetaxel|mesh-list
2642560|NCT02003209|Trastuzumab|trastuzumab|mesh-list
2642561|NCT02003209|Goserelin|goserelin|mesh-list
2642562|NCT02003209|Pertuzumab|pertuzumab|mesh-list
2642563|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2642564|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2642565|NCT02003209|Antibodies|antibodies|mesh-list
2642566|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
2642567|NCT02003209|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2642568|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2642569|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
2642570|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642571|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642572|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
2642573|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
2642574|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
2642575|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642576|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2642577|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2642578|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642579|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2642580|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
2642581|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2642644|NCT02003313|Vaccines|vaccines|mesh-list
2175579|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175580|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175581|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175582|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2175583|NCT00002056|Pentamidine|pentamidine|mesh-list
2175584|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
2175585|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175586|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175587|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175588|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2175589|NCT00002057|Nystatin|nystatin|mesh-list
2175590|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175591|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175592|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
2175593|NCT00002057|Ionophores|ionophores|mesh-ancestor
2175594|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2175595|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175596|NCT00002058|Clofazimine|clofazimine|mesh-list
2642645|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
2642646|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642647|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2642648|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2642649|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642650|NCT02003495|Vaccines|vaccines|mesh-list
2642651|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
2642652|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642653|NCT02003664|Baclofen|baclofen|mesh-list
2642654|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2642655|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642656|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2642657|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642658|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2642659|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
2642660|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
2642661|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2642662|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642663|NCT02003677|Insulin|insulin|mesh-list
2642664|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2642665|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
2642666|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
2642667|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2642668|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2642669|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642670|NCT02003742|Tamsulosin|tamsulosin|mesh-list
2642671|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2642672|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2642673|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2642674|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
2642675|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2642676|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175597|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2175598|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
2642677|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642678|NCT02003742|Urological Agents|urological agents|mesh-ancestor
2642679|NCT02003768|Propofol|propofol|mesh-list
2642680|NCT02003768|Desflurane|desflurane|mesh-list
2642681|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2642682|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2642683|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642684|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2642685|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
2642686|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
2642687|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2642688|NCT02003885|Desflurane|desflurane|mesh-list
2642689|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2642690|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
2642691|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
2642692|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2642693|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642694|NCT02004067|Cyclosporine|cyclosporine|mesh-list
2642695|NCT02004067|Castor Oil|castor oil|mesh-list
2642696|NCT02004067|Cyclosporins|cyclosporins|mesh-list
2642697|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642698|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642699|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2642700|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
2642701|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642702|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
2642703|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642704|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
2642705|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2642706|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2642707|NCT02004067|Cathartics|cathartics|mesh-ancestor
2642708|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2175599|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175600|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175601|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
2175602|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2175603|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
2175604|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175605|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
2175606|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175607|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
2175608|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2175609|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
2175610|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175611|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
2175612|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175613|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
2175614|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2175615|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
2175616|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175617|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
2175618|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175619|NCT00002062|Spiramycin|spiramycin|mesh-list
2175620|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175621|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175622|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
2175623|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175624|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175625|NCT00002063|Zidovudine|zidovudine|mesh-list
2175626|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
2175627|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175628|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175629|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175630|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175631|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
2175632|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175633|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175634|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175635|NCT00002064|Clindamycin|clindamycin|mesh-list
2175636|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
2175637|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
2175638|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
2175639|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175640|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175641|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2175642|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642709|NCT02004171|Nicotine|nicotine|mesh-list
2642710|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2642711|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
2642712|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642713|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642714|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2642715|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2642716|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
2642717|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2642718|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642719|NCT02004184|Pemetrexed|pemetrexed|mesh-list
2642720|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642721|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642722|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642723|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2642724|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2642725|NCT02004197|Amoxicillin|amoxicillin|mesh-list
2642726|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
2642727|NCT02004197|Bismuth|bismuth|mesh-list
2642728|NCT02004197|Ranitidine|ranitidine|mesh-list
2642729|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2642730|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642731|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2642732|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642733|NCT02004197|Antacids|antacids|mesh-ancestor
2642734|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2642735|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2642736|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2642737|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
2642738|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
2175643|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175644|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
2175645|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175646|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2642739|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2642740|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175647|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2175648|NCT00002065|Disulfiram|disulfiram|mesh-list
2175649|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2175650|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2175651|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175652|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175653|NCT00002066|Thymopentin|thymopentin|mesh-list
2175654|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2175655|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
2175656|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175657|NCT00002067|Megestrol|megestrol|mesh-list
2175658|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
2175659|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2175660|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2175661|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2175662|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
2642763|NCT02004301|Diclofenac|diclofenac|mesh-list
2642764|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2642765|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2642766|NCT02004301|Analgesics|analgesics|mesh-ancestor
2642767|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
2642768|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642769|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642770|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2642771|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2642772|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2642773|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642774|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642775|NCT02004314|Chloroquine|chloroquine|mesh-list
2642776|NCT02004314|Amebicides|amebicides|mesh-ancestor
2642777|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2642778|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2642779|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642780|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
2642781|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2642782|NCT02004418|Choline|choline|mesh-list
2642783|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
2642784|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2642785|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
2642786|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642787|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2642788|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2175663|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2175664|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175665|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2175666|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2175667|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2175668|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2175669|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
2175670|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2175671|NCT00002068|Fluconazole|fluconazole|mesh-list
2175672|NCT00002068|Amphotericin B|amphotericin b|mesh-list
2642789|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
2642790|NCT02004509|Anticoagulants|anticoagulants|mesh-list
2642791|NCT02004574|Betamethasone|betamethasone|mesh-list
2642792|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
2642793|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2642794|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
2642795|NCT02004574|Calcipotriene|calcipotriene|mesh-list
2642796|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2642797|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2642798|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
2642799|NCT02004574|Hormones|hormones|mesh-ancestor
2642800|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2642801|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642802|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2642803|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
2642804|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
2642805|NCT02004652|Prucalopride|prucalopride|mesh-list
2642806|NCT02004652|Laxatives|laxatives|mesh-ancestor
2642807|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2642808|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2642809|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2642810|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
2642811|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2642812|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642813|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642814|NCT02004769|Docetaxel|docetaxel|mesh-list
2642815|NCT02004769|Capecitabine|capecitabine|mesh-list
2642816|NCT02004769|Trastuzumab|trastuzumab|mesh-list
2642817|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642818|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
2642819|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
2642820|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
2642821|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642822|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2642823|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
2642824|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2642825|NCT02004782|Prednisolone|prednisolone|mesh-list
2642826|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2642827|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
2642828|NCT02004782|Hormones|hormones|mesh-ancestor
2642829|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2175673|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2175674|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
2175675|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175676|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2175677|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2175678|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175679|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175680|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2642830|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642831|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2642832|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642833|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
2642834|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
2642835|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
2642836|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2642837|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642838|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
2642839|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642840|NCT02004860|Ciclopirox|ciclopirox|mesh-list
2642841|NCT02004860|Tacrolimus|tacrolimus|mesh-list
2642842|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2642843|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
2642844|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642845|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2642846|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642847|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642848|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
2642849|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642850|NCT02004899|Fentanyl|fentanyl|mesh-list
2642851|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2642852|NCT02004899|Narcotics|narcotics|mesh-ancestor
2642853|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2642854|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642855|NCT02004899|Analgesics|analgesics|mesh-ancestor
2642856|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
2642857|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642858|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2642859|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2642860|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
2642861|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
2642862|NCT02005068|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2642863|NCT02005068|Cephalosporins|cephalosporins|mesh-list
2642864|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2642865|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642866|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2642867|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2642868|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2642869|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2642870|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642871|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2642872|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642873|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2642874|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
2642875|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2642876|NCT02005120|Bevacizumab|bevacizumab|mesh-list
2642877|NCT02005120|Endostatins|endostatins|mesh-list
2642878|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2642879|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642880|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2642881|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2642882|NCT02005120|Growth Substances|growth substances|mesh-ancestor
2642883|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642884|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
2642885|NCT02005289|Lenalidomide|lenalidomide|mesh-list
2642886|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
2642887|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642888|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2642889|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2642890|NCT02005289|Growth Substances|growth substances|mesh-ancestor
2642891|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
2642892|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642893|NCT02005302|Vitamin D|vitamin d|mesh-list
2642894|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
2642895|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
2642896|NCT02005302|Vitamins|vitamins|mesh-list
2642897|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
2642898|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175681|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
2642899|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2642900|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2642901|NCT02005315|Gemcitabine|gemcitabine|mesh-list
2642902|NCT02005315|Paclitaxel|paclitaxel|mesh-list
2642903|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2642904|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642905|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
2642906|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
2642907|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
2642908|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642909|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2642910|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
2642911|NCT02005315|Antiviral Agents|antiviral agents|mesh-ancestor
2642912|NCT02005315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642913|NCT02005315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642914|NCT02005315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2642915|NCT02005315|Immunologic Factors|immunologic factors|mesh-ancestor
2642916|NCT02005315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642917|NCT02005419|Metformin|metformin|mesh-list
2642918|NCT02005419|Gemcitabine|gemcitabine|mesh-list
2642919|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2175682|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2175683|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175684|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2175685|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2175686|NCT00002068|Amebicides|amebicides|mesh-ancestor
2175687|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175688|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175689|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175690|NCT00002069|Ditiocarb|ditiocarb|mesh-list
2175691|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2175692|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
2175693|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175694|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
2175695|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175696|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
2175697|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
2175698|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642920|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
2642921|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642922|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642923|NCT02005419|Antiviral Agents|antiviral agents|mesh-ancestor
2642924|NCT02005419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642925|NCT02005419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642926|NCT02005419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2642927|NCT02005419|Immunologic Factors|immunologic factors|mesh-ancestor
2642928|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175699|NCT00002070|Ganciclovir|ganciclovir|mesh-list
2175700|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2175701|NCT00002070|Sargramostim|sargramostim|mesh-list
2175702|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
2175703|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175704|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
2175705|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175706|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2642929|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2642930|NCT02005523|RNS60|rns60|mesh-list
2642931|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2642932|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2642933|NCT02005523|Analgesics|analgesics|mesh-ancestor
2642934|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
2642935|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642936|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642937|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2642938|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2175707|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175708|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175709|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
2175710|NCT00002071|Hematinics|hematinics|mesh-ancestor
2175711|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
2175712|NCT00002072|Hematinics|hematinics|mesh-ancestor
2175713|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
2175714|NCT00002073|Hematinics|hematinics|mesh-ancestor
2642939|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2175715|NCT00002074|Fluconazole|fluconazole|mesh-list
2642940|NCT02005575|Dexamethasone|dexamethasone|mesh-list
2642941|NCT02005575|Bupivacaine|bupivacaine|mesh-list
2642942|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2175716|NCT00002074|Amphotericin B|amphotericin b|mesh-list
2175717|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2175718|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
2175719|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175720|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2175721|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2175722|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175723|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175724|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2175725|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
2175726|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2175727|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175728|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2175729|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2642943|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
2642944|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
2642945|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642946|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642947|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2642948|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
2642949|NCT02005575|Hormones|hormones|mesh-ancestor
2642950|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2642951|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2642952|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642953|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
2642954|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
2642955|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2642956|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
2642957|NCT02005588|Iron|iron|mesh-list
2642958|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
2642959|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
2642960|NCT02005588|Trace Elements|trace elements|mesh-ancestor
2642961|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
2642962|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642963|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
2642964|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
2642965|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175730|NCT00002074|Amebicides|amebicides|mesh-ancestor
2175731|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175732|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175733|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175734|NCT00002075|Fluconazole|fluconazole|mesh-list
2175735|NCT00002075|Amphotericin B|amphotericin b|mesh-list
2175736|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2175737|NCT00002075|Flucytosine|flucytosine|mesh-list
2175738|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
2175739|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642966|NCT02005653|Doxycycline|doxycycline|mesh-list
2642967|NCT02005653|Albendazole|albendazole|mesh-list
2642968|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
2642969|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2642970|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2642971|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
2642972|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2642973|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2642974|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
2642975|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
2642976|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2642977|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
2642978|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
2642979|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
2642980|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2642981|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2642982|NCT02005653|Filaricides|filaricides|mesh-ancestor
2642983|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
2642984|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2642985|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2642986|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
2642987|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2642988|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642989|NCT02005718|Vitamins|vitamins|mesh-ancestor
2642990|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
2642991|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2642992|NCT02005757|Mizoribine|mizoribine|mesh-list
2642993|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2642994|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2642995|NCT02005757|Analgesics|analgesics|mesh-ancestor
2642996|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
2642997|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2642998|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2642999|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2643000|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2643001|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2643002|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643003|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2643004|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643005|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
2643006|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2643007|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2643008|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643009|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643010|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2643011|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
2643012|NCT02005770|Propofol|propofol|mesh-list
2643013|NCT02005770|Sevoflurane|sevoflurane|mesh-list
2643014|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2643015|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643016|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643017|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2643018|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
2643019|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
2643020|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2643021|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2643022|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
2175740|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2175741|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2175742|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175743|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175744|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2175745|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
2175746|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2175747|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175748|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2175749|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2175750|NCT00002075|Amebicides|amebicides|mesh-ancestor
2175751|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2643023|NCT02005783|Docetaxel|docetaxel|mesh-list
2643024|NCT02005783|Epirubicin|epirubicin|mesh-list
2643025|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2643026|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
2643027|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643028|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2643029|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2643030|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
2643031|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643032|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643033|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2643034|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
2643035|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
2643036|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
2643037|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2643038|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2643039|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2643040|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643041|NCT02005822|Valganciclovir|valganciclovir|mesh-list
2643042|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
2643043|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643044|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2643045|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
2643046|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
2643047|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2643048|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2643049|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643050|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643051|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2643052|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643053|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2643054|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643055|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643056|NCT02006173|Lidocaine|lidocaine|mesh-list
2643057|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
2643058|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
2643059|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643060|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643061|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
2643062|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643063|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2643064|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2643065|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2643066|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2643067|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643068|NCT02006225|Plerixafor|plerixafor|mesh-list
2643069|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2643070|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2643071|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
2643072|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643073|NCT02006277|Crizotinib|crizotinib|mesh-list
2643074|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2643075|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643076|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2643077|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175752|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175753|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2643078|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643079|NCT02006355|Ropivacaine|ropivacaine|mesh-list
2643080|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
2643081|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
2643082|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643083|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643084|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
2643085|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643086|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2643087|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2643088|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2175754|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
2175755|NCT00002076|Fluconazole|fluconazole|mesh-list
2175756|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
2643089|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
2643090|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643091|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643092|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
2643093|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643094|NCT02006498|Silymarin|silymarin|mesh-list
2643095|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
2643096|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643097|NCT02006498|Protective Agents|protective agents|mesh-ancestor
2175757|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175758|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2175759|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2175760|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175761|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175762|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2175763|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
2643098|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643099|NCT02006589|Candesartan|candesartan|mesh-list
2643100|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
2643101|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2643102|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2643103|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2643104|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643105|NCT02006602|Candesartan|candesartan|mesh-list
2643106|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
2643107|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2643108|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2643109|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2643110|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643111|NCT02006745|Ribavirin|ribavirin|mesh-list
2643112|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
2643113|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643114|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
2643115|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643116|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2175764|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2175765|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175766|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2175767|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2175768|NCT00002077|Fluconazole|fluconazole|mesh-list
2175769|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
2175770|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175771|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2175772|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2175773|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175774|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175775|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2643117|NCT02006849|Hormones|hormones|mesh-ancestor
2643118|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2643119|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175776|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
2175777|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2175778|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175779|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2175780|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2643120|NCT02006914|Chromium|chromium|mesh-list
2643121|NCT02006914|Picolinic acid|picolinic acid|mesh-list
2643122|NCT02006914|Trace Elements|trace elements|mesh-ancestor
2643123|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
2643124|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643125|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2643126|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
2643127|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
2643128|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643129|NCT02006966|Lidocaine|lidocaine|mesh-list
2643130|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
2643131|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
2643132|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643133|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643134|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
2643135|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643136|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2643137|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2643138|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2643139|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2643140|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643141|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
2643142|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643143|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2643144|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2643145|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
2643146|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643147|NCT02007044|Rituximab|rituximab|mesh-list
2643148|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2643149|NCT02007044|Antibodies|antibodies|mesh-list
2643150|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
2175781|NCT00002078|Interferons|interferons|mesh-list
2175782|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
2175783|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2175784|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
2175785|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175786|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
2175787|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175788|NCT00002079|Miglustat|miglustat|mesh-list
2175789|NCT00002079|Zidovudine|zidovudine|mesh-list
2175790|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
2175791|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175792|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175793|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175794|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175795|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
2175796|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175797|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175798|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2643151|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2643152|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
2643153|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643154|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643155|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2643156|NCT02007122|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2643157|NCT02007122|Cephalosporins|cephalosporins|mesh-list
2643158|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2643159|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643160|NCT02007148|Docetaxel|docetaxel|mesh-list
2643161|NCT02007148|Capecitabine|capecitabine|mesh-list
2643162|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643163|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
2643164|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
2643165|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
2643166|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643167|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2643168|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
2643169|NCT02007161|Diclofenac|diclofenac|mesh-list
2643170|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2643171|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2643172|NCT02007161|Analgesics|analgesics|mesh-ancestor
2643173|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
2643174|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643175|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643176|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2643177|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2643178|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2643179|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643180|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643181|NCT02007174|Bevacizumab|bevacizumab|mesh-list
2643182|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2643183|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643184|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2643185|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2643186|NCT02007174|Growth Substances|growth substances|mesh-ancestor
2643187|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643188|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
2643189|NCT02007330|Lidocaine|lidocaine|mesh-list
2643190|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
2643191|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
2643192|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643193|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643194|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
2643195|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643196|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2643197|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2643198|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2643199|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2643200|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643201|NCT02007408|Lidocaine|lidocaine|mesh-list
2643202|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
2643203|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
2643204|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643205|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643206|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
2643207|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2175799|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2175800|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2175801|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175802|NCT00002080|Rifabutin|rifabutin|mesh-list
2175803|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175804|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175805|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2175806|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
2175807|NCT00002081|Zidovudine|zidovudine|mesh-list
2175808|NCT00002081|Zalcitabine|zalcitabine|mesh-list
2175809|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
2175810|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175811|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175812|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175813|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175814|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
2175815|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175816|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2643208|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2643209|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2643210|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2643211|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2643212|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643213|NCT02007447|Oxytocin|oxytocin|mesh-list
2643214|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
2643215|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2643216|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643217|NCT02007603|Amoxicillin|amoxicillin|mesh-list
2643218|NCT02007603|Ampicillin|ampicillin|mesh-list
2643219|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
2643220|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
2643221|NCT02007603|Sulbactam|sulbactam|mesh-list
2643222|NCT02007603|Sultamicillin|sultamicillin|mesh-list
2643223|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2643224|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643225|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643226|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643227|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2643228|NCT02007629|Riociguat|riociguat|mesh-list
2643229|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
2643230|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643231|NCT02007655|Apixaban|apixaban|mesh-list
2643232|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2643233|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
2643234|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2643235|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
2643236|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643237|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643238|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
2175817|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175818|NCT00002082|Azithromycin|azithromycin|mesh-list
2175819|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175820|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175821|NCT00002084|Valacyclovir|valacyclovir|mesh-list
2643239|NCT02007746|Liver Extracts|liver extracts|mesh-list
2643240|NCT02007746|Hematinics|hematinics|mesh-ancestor
2643241|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
2643242|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2643243|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643244|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643245|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2643246|NCT02007798|Analgesics|analgesics|mesh-ancestor
2643247|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
2643248|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643249|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2643250|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2643251|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2643252|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
2643253|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643254|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643255|NCT02007837|Aspirin|aspirin|mesh-list
2643256|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2643257|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2643258|NCT02007837|Analgesics|analgesics|mesh-ancestor
2643259|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
2643260|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643261|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643262|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2643263|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2643264|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2643265|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2643266|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643267|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2643268|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2643269|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643270|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
2643271|NCT02007850|Ropivacaine|ropivacaine|mesh-list
2643272|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
2643273|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
2643274|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643275|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643276|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
2643277|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643278|NCT02007915|Pamidronate|pamidronate|mesh-list
2643279|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2643280|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643281|NCT02007928|Olanzapine|olanzapine|mesh-list
2643282|NCT02007928|Risperidone|risperidone|mesh-list
2643283|NCT02007928|Aripiprazole|aripiprazole|mesh-list
2643284|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2643285|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
2643286|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643287|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643288|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643289|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2643290|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2643291|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643292|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2643293|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2175822|NCT00002084|Acyclovir|acyclovir|mesh-list
2175823|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
2175824|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643294|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
2643295|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
2643296|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
2643297|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643298|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2643299|NCT02007928|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2643300|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2643301|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2643302|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
2643303|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
2643304|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2643305|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2643306|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2643307|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2643308|NCT02008006|Cytarabine|cytarabine|mesh-list
2643309|NCT02008006|Etoposide|etoposide|mesh-list
2643310|NCT02008006|Melphalan|melphalan|mesh-list
2643311|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2643312|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2643313|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643314|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2643315|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2643316|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643317|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643318|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2643319|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
2643320|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
2643321|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643322|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2643323|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
2643324|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643325|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2643326|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
2643327|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2643328|NCT02008019|Everolimus|everolimus|mesh-list
2643329|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643330|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2643331|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
2643332|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643333|NCT02008123|Primidone|primidone|mesh-list
2643334|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
2643335|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
2643336|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
2643337|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643338|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643339|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643340|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
2175825|NCT00002085|Azithromycin|azithromycin|mesh-list
2175826|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175827|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175828|NCT00002086|Interferons|interferons|mesh-list
2175829|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
2175830|NCT00002086|Zidovudine|zidovudine|mesh-list
2175831|NCT00002086|Zalcitabine|zalcitabine|mesh-list
2175832|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2175833|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
2175834|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175835|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
2175836|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175837|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
2643341|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2643342|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2643343|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643344|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
2643345|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643346|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643347|NCT02008162|Bromides|bromides|mesh-list
2643348|NCT02008162|Albuterol|albuterol|mesh-list
2643349|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
2643350|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
2643351|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
2643352|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643353|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643354|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2643355|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
2643356|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
2643357|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2643358|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
2643359|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643360|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643361|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
2643362|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
2643363|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2643364|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2643365|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2643366|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2643367|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
2643368|NCT02008201|Vitamin D|vitamin d|mesh-list
2643369|NCT02008201|Vitamins|vitamins|mesh-ancestor
2643370|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
2643371|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643372|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2643373|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
2643374|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2643375|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643376|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643377|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2643378|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2643379|NCT02008214|Protective Agents|protective agents|mesh-ancestor
2643380|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643381|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
2643382|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2643383|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
2643384|NCT02008292|Physostigmine|physostigmine|mesh-list
2643385|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2643386|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643387|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643388|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
2643389|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643390|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643391|NCT02008292|Miotics|miotics|mesh-ancestor
2643392|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
2643393|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643394|NCT02008344|Favipiravir|favipiravir|mesh-list
2643395|NCT02008344|Antiviral Agents|antiviral agents|mesh-ancestor
2643396|NCT02008344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643397|NCT02008383|Panitumumab|panitumumab|mesh-list
2643398|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2643399|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643400|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
2643401|NCT02008422|Tegafur|tegafur|mesh-list
2643402|NCT02008422|Endostar protein|endostar protein|mesh-list
2643403|NCT02008422|Endostatins|endostatins|mesh-list
2643404|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643405|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2643406|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
2643407|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643408|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2643409|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2643410|NCT02008422|Growth Substances|growth substances|mesh-ancestor
2643411|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643412|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
2643413|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
2643414|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2643415|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2643416|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643417|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
2643418|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643419|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643420|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
2643421|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2643422|NCT02008578|Antibodies|antibodies|mesh-list
2643423|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
2643424|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643425|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
2643426|NCT02008721|Protective Agents|protective agents|mesh-ancestor
2643427|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643428|NCT02008734|Palbociclib|palbociclib|mesh-list
2643429|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643430|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2643431|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643432|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643433|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
2643434|NCT02008747|Analgesics|analgesics|mesh-ancestor
2643435|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
2643436|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643437|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643438|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
2643439|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643440|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2643441|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
2643442|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2643443|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2175838|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175839|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175840|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175841|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175842|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175843|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175844|NCT00002089|Azithromycin|azithromycin|mesh-list
2175845|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175846|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175847|NCT00002090|Azithromycin|azithromycin|mesh-list
2175848|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175849|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175850|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
2175851|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2175852|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175853|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175854|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2175855|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2175856|NCT00002091|Protective Agents|protective agents|mesh-ancestor
2175857|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175858|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
2175859|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2175860|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
2175861|NCT00002092|Cimetidine|cimetidine|mesh-list
2175862|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2175863|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2175864|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2175865|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
2175866|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
2643444|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643445|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2643446|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
2643447|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2643448|NCT02008786|Ramipril|ramipril|mesh-list
2643449|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2643450|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2643451|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2643452|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
2643453|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643454|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2643455|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2643456|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643457|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2643458|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
2643459|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2643460|NCT02008968|Allopurinol|allopurinol|mesh-list
2643461|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
2643462|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643463|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643464|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
2643465|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2643466|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2643467|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
2643468|NCT02008968|Protective Agents|protective agents|mesh-ancestor
2643469|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643470|NCT02008981|Aspirin|aspirin|mesh-list
2643471|NCT02008981|Turmeric extract|turmeric extract|mesh-list
2643472|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2643473|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2643474|NCT02008981|Analgesics|analgesics|mesh-ancestor
2643475|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
2643476|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643477|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643478|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2643479|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2643480|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2643481|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2175867|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2175868|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175869|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175870|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2175871|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2175872|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175873|NCT00002093|Doxorubicin|doxorubicin|mesh-list
2175874|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2175875|NCT00002093|Daunorubicin|daunorubicin|mesh-list
2175876|NCT00002093|Bleomycin|bleomycin|mesh-list
2175877|NCT00002093|Vincristine|vincristine|mesh-list
2175878|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2175879|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2175880|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2175881|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2175882|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175883|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175884|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2175885|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
2643482|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643483|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2643484|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2643485|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643486|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
2643487|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
2643488|NCT02008981|Protective Agents|protective agents|mesh-ancestor
2643489|NCT02009007|Phenylephrine|phenylephrine|mesh-list
2643490|NCT02009007|Dopamine|dopamine|mesh-list
2643491|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
2643492|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2643493|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
2643494|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
2643495|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643496|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643497|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
2643498|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2175886|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
2175887|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
2175888|NCT00002094|Atevirdine|atevirdine|mesh-list
2175889|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175890|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2643499|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
2643500|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
2643501|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2643502|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2643503|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2643504|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
2643505|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643506|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175891|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175892|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175893|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
2175894|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175895|NCT00002095|Ganciclovir|ganciclovir|mesh-list
2175896|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2175897|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
2175898|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175899|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2643507|NCT02009007|Protective Agents|protective agents|mesh-ancestor
2643508|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
2643509|NCT02009098|Cefuroxime|cefuroxime|mesh-list
2643510|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
2643511|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2643512|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643513|NCT02009189|Taurolidine|taurolidine|mesh-list
2643514|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643515|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2643516|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643517|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
2643518|NCT02009202|Cathartics|cathartics|mesh-ancestor
2643519|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2422427|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422428|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422429|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422430|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2422431|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2422432|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
2422433|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
2422434|NCT00817245|Amoxicillin|amoxicillin|mesh-list
2422435|NCT00817245|Metronidazole|metronidazole|mesh-list
2422436|NCT00817245|Omeprazole|omeprazole|mesh-list
2422437|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2422438|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643520|NCT02009215|Piperaquine|piperaquine|mesh-list
2643521|NCT02009215|Artenimol|artenimol|mesh-list
2643522|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
2643523|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2643524|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2643525|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643526|NCT02009280|Anesthetics|anesthetics|mesh-list
2643527|NCT02009280|Propofol|propofol|mesh-list
2643528|NCT02009280|Sevoflurane|sevoflurane|mesh-list
2643529|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643530|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643531|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2643532|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2643533|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
2643534|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2643535|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2643536|NCT02009306|Fentanyl|fentanyl|mesh-list
2643537|NCT02009306|Midazolam|midazolam|mesh-list
2643538|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2643539|NCT02009306|Narcotics|narcotics|mesh-ancestor
2643540|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643541|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643542|NCT02009306|Analgesics|analgesics|mesh-ancestor
2422439|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2422440|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2422441|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2422442|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2422443|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2422444|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422445|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422446|NCT00817258|Cisplatin|cisplatin|mesh-list
2422447|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422448|NCT00817271|Glucagon|glucagon|mesh-list
2422449|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2422450|NCT00817271|Hormones|hormones|mesh-ancestor
2422451|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2422452|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422453|NCT00817284|Bevacizumab|bevacizumab|mesh-list
2422454|NCT00817284|Irinotecan|irinotecan|mesh-list
2422455|NCT00817284|Temozolomide|temozolomide|mesh-list
2175900|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175901|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175902|NCT00002096|Zidovudine|zidovudine|mesh-list
2175903|NCT00002096|Didanosine|didanosine|mesh-list
2175904|NCT00002096|Ganciclovir|ganciclovir|mesh-list
2175905|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2175906|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
2643543|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
2643544|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643545|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2643546|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2643547|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
2643548|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
2643549|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2643550|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2643551|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2643552|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2643553|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
2643554|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
2643555|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643556|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643557|NCT02009410|Pancrelipase|pancrelipase|mesh-list
2643558|NCT02009410|Pancreatin|pancreatin|mesh-list
2643559|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2643560|NCT02009436|Azacitidine|azacitidine|mesh-list
2643561|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2643562|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
2643563|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643564|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643565|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643566|NCT02009449|Leucovorin|leucovorin|mesh-list
2643567|NCT02009449|Gemcitabine|gemcitabine|mesh-list
2643568|NCT02009449|Paclitaxel|paclitaxel|mesh-list
2643569|NCT02009449|Docetaxel|docetaxel|mesh-list
2643570|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2643571|NCT02009449|Carboplatin|carboplatin|mesh-list
2643572|NCT02009449|Fluorouracil|fluorouracil|mesh-list
2643573|NCT02009449|Capecitabine|capecitabine|mesh-list
2643574|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
2643575|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
2643576|NCT02009449|Nivolumab|nivolumab|mesh-list
2643577|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
2643578|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2643579|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643580|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
2643581|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
2643582|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
2643583|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643584|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2643585|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
2643586|NCT02009449|Antiviral Agents|antiviral agents|mesh-ancestor
2643587|NCT02009449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643588|NCT02009449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643589|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2643590|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
2643591|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643592|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2643593|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2643594|NCT02009449|Antidotes|antidotes|mesh-ancestor
2643595|NCT02009449|Protective Agents|protective agents|mesh-ancestor
2643596|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
2643597|NCT02009449|Vitamins|vitamins|mesh-ancestor
2643598|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
2643599|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2643600|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
2643601|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2643602|NCT02009462|Protective Agents|protective agents|mesh-ancestor
2643603|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643604|NCT02009488|Canagliflozin|canagliflozin|mesh-list
2643605|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2643606|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643607|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2643608|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643609|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
2643610|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
2643611|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2643612|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
2643613|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2643614|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2643615|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2175907|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175908|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175909|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175910|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175911|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
2175912|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175913|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2643616|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2643617|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643618|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
2643619|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643620|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643621|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2643622|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643623|NCT02009579|Nintedanib|nintedanib|mesh-list
2643624|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643625|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2643626|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643627|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643628|NCT02009592|Rifaximin|rifaximin|mesh-list
2643629|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2643630|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643631|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2643632|NCT02009618|Rifaximin|rifaximin|mesh-list
2643633|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2643634|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643635|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2643636|NCT02009631|Veliparib|veliparib|mesh-list
2643637|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2643638|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643639|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643640|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643641|NCT02009709|Riboflavin|riboflavin|mesh-list
2643642|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2643643|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2643644|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
2643645|NCT02009709|Vitamins|vitamins|mesh-ancestor
2643646|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
2643647|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643648|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2643649|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
2643650|NCT02009748|Vitamin D|vitamin d|mesh-list
2643651|NCT02009748|Vitamins|vitamins|mesh-ancestor
2643652|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
2643653|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643654|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2643655|NCT02009787|Vitamin D|vitamin d|mesh-list
2643656|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
2643657|NCT02009787|Vitamins|vitamins|mesh-ancestor
2643658|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
2643659|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643660|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2643661|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2643662|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2643663|NCT02009943|Hematinics|hematinics|mesh-ancestor
2643664|NCT02010164|Ubiquinone|ubiquinone|mesh-list
2643665|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
2643666|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
2643667|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643668|NCT02010164|Vitamins|vitamins|mesh-ancestor
2643669|NCT02010333|Benzyl Alcohol|benzyl alcohol|mesh-list
2643670|NCT02010333|Anesthetics, Local|anesthetics, local|mesh-ancestor
2643671|NCT02010333|Anesthetics|anesthetics|mesh-ancestor
2643672|NCT02010333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643673|NCT02010333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643674|NCT02010333|Sensory System Agents|sensory system agents|mesh-ancestor
2643675|NCT02010333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643676|NCT02010372|Vaccines|vaccines|mesh-list
2643677|NCT02010372|Immunologic Factors|immunologic factors|mesh-ancestor
2643678|NCT02010372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643679|NCT02010385|Octreotide|octreotide|mesh-list
2643680|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2643681|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2643682|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643683|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2643684|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2643685|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2643686|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
2643687|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643688|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643689|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
2643690|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2643691|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2643692|NCT02010593|Dapivirine|dapivirine|mesh-list
2643693|NCT02010593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2643694|NCT02010593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2643695|NCT02010593|Antiviral Agents|antiviral agents|mesh-ancestor
2175914|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175915|NCT00002097|Nystatin|nystatin|mesh-list
2175916|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175917|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175918|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
2175919|NCT00002097|Ionophores|ionophores|mesh-ancestor
2643696|NCT02010593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643697|NCT02010723|Polidocanol|polidocanol|mesh-list
2643698|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2643699|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2643700|NCT02010762|Vitamin D|vitamin d|mesh-list
2643701|NCT02010762|Vitamins|vitamins|mesh-ancestor
2643702|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
2643703|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643704|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2643705|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
2643706|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2643707|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2643708|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2643709|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2643710|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643711|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
2643712|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643713|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643714|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2643715|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643716|NCT02010827|Glucagon|glucagon|mesh-list
2643717|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2643718|NCT02010827|Hormones|hormones|mesh-ancestor
2643719|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2643720|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643721|NCT02010905|Losartan|losartan|mesh-list
2643722|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2643723|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2643724|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2643725|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2643726|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643727|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
2643728|NCT02010944|Mirabegron|mirabegron|mesh-list
2643729|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2643730|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2643731|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
2643732|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643733|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643734|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643735|NCT02010944|Urological Agents|urological agents|mesh-ancestor
2643736|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2643737|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2643738|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2643739|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
2643740|NCT02010957|Etomidate|etomidate|mesh-list
2643741|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2643742|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643743|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643744|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2643745|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
2643746|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
2643747|NCT02010970|Itraconazole|itraconazole|mesh-list
2643748|NCT02010970|Diltiazem|diltiazem|mesh-list
2643749|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
2643750|NCT02010970|Midazolam|midazolam|mesh-list
2643751|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2643752|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643753|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2643754|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2643755|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643756|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2643757|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2643758|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2643759|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2643760|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
2643761|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
2643762|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
2643763|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
2643764|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643765|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643766|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
2643767|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643768|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2643769|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2643770|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643771|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2643772|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
2643773|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2643774|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2643775|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2643776|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2643777|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
2643778|NCT02011126|Imetelstat|imetelstat|mesh-list
2643779|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
2643780|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643781|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643782|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2643783|NCT02011191|Biotin|biotin|mesh-list
2643784|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
2643785|NCT02011191|Vitamins|vitamins|mesh-ancestor
2643786|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
2643787|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643788|NCT02011321|Clevidipine|clevidipine|mesh-list
2643789|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2643790|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2643791|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643792|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2643793|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643794|NCT02011347|Ketamine|ketamine|mesh-list
2643795|NCT02011347|Analgesics|analgesics|mesh-ancestor
2643796|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
2643797|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643798|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643799|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2643800|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2643801|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
2643802|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
2643803|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643804|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2643805|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2643806|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643807|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643808|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
2643809|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2643810|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643811|NCT02011620|Isosorbide|isosorbide|mesh-list
2643812|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2643813|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2643814|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2643815|NCT02011620|Diuretics|diuretics|mesh-ancestor
2643816|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
2643817|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643818|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
2643819|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2643820|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643821|NCT02011633|Metformin|metformin|mesh-list
2643822|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2643823|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2643824|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643825|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2643826|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2643827|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
2643828|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643829|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2643830|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2643831|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643832|NCT02011659|Ramosetron|ramosetron|mesh-list
2643833|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
2643834|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
2643835|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643836|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643837|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2175920|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2175921|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175922|NCT00002098|Didanosine|didanosine|mesh-list
2175923|NCT00002098|Lentinan|lentinan|mesh-list
2175924|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
2175925|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175926|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175927|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175928|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175929|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
2175930|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175931|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175932|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175933|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2175934|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
2643838|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2643839|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
2643840|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643841|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643842|NCT02011737|Naftopidil|naftopidil|mesh-list
2643843|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2643844|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2643845|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
2643846|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643847|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643848|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643849|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2643850|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2643851|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2643852|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2643853|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2643854|NCT02011750|Valproic Acid|valproic acid|mesh-list
2175935|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175936|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2175937|NCT00002099|Didanosine|didanosine|mesh-list
2643855|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
2643856|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643857|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643858|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
2643859|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643860|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643861|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
2643862|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2643863|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643864|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2643865|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
2643866|NCT02011828|Vitamin D|vitamin d|mesh-list
2643867|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2643868|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643869|NCT02011828|Vitamins|vitamins|mesh-ancestor
2643870|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
2643871|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2643872|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
2643873|NCT02011841|Rifaximin|rifaximin|mesh-list
2643874|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2643875|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643876|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2643877|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2643878|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643879|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643880|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643881|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2643882|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2643883|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2643884|NCT02011880|Corylifolin|corylifolin|mesh-list
2643885|NCT02011880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2643886|NCT02011880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643887|NCT02011880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643888|NCT02011880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2643889|NCT02011880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2643890|NCT02011880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643891|NCT02011906|Vitamins|vitamins|mesh-list
2643892|NCT02011906|Vitamin E|vitamin e|mesh-list
2175938|NCT00002099|Lentinan|lentinan|mesh-list
2643893|NCT02011906|Tocopherols|tocopherols|mesh-list
2643894|NCT02011906|Tocotrienols|tocotrienols|mesh-list
2643895|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
2643896|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
2643897|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643898|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
2643899|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643900|NCT02011906|Protective Agents|protective agents|mesh-ancestor
2643901|NCT02011958|Amphotericin B|amphotericin b|mesh-list
2643902|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2643903|NCT02011958|Miltefosine|miltefosine|mesh-list
2643904|NCT02011958|Amebicides|amebicides|mesh-ancestor
2643905|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2643906|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2643907|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643908|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2643909|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
2643910|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643911|NCT02011971|Vinpocetine|vinpocetine|mesh-list
2643912|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2643913|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643914|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643915|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
2175939|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
2175940|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175941|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2175942|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2175943|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175944|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
2175945|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175946|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2175947|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2175948|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2175949|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
2175950|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175951|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2175952|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
2175953|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
2175954|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2175955|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2175956|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2643916|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2643917|NCT02011971|Protective Agents|protective agents|mesh-ancestor
2643918|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643919|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
2643920|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2643921|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2643922|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
2643923|NCT02012049|Risperidone|risperidone|mesh-list
2643924|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2643925|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
2643926|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643927|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643928|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643929|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2643930|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2643931|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2643932|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2643933|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2643934|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
2643935|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
2643936|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643937|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2643938|NCT02012075|Metoprolol|metoprolol|mesh-list
2643939|NCT02012075|Carvedilol|carvedilol|mesh-list
2643940|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2643941|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2643942|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
2643943|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
2643944|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2643945|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643946|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2643947|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2643948|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2643949|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
2643950|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643951|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175957|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
2175958|NCT00002101|Clarithromycin|clarithromycin|mesh-list
2175959|NCT00002101|Ethambutol|ethambutol|mesh-list
2175960|NCT00002101|Rifabutin|rifabutin|mesh-list
2175961|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2175962|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175963|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2175964|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175965|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175966|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2175967|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2643952|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
2643953|NCT02012075|Protective Agents|protective agents|mesh-ancestor
2643954|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2643955|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2643956|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2643957|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
2643958|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2643959|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2643960|NCT02012088|Prednisone|prednisone|mesh-list
2643961|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
2643962|NCT02012088|Rituximab|rituximab|mesh-list
2643963|NCT02012088|Doxorubicin|doxorubicin|mesh-list
2643964|NCT02012088|Vincristine|vincristine|mesh-list
2643965|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2643966|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
2643967|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2643968|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2643969|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2643970|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
2643971|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643972|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2643973|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2175968|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
2175969|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2175970|NCT00002102|Leucovorin|leucovorin|mesh-list
2643974|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2643975|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2643976|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2643977|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2643978|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2643979|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2643980|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
2643981|NCT02012088|Hormones|hormones|mesh-ancestor
2643982|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2643983|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2643984|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2643985|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
2643986|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
2643987|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
2643988|NCT02012114|Cysteamine|cysteamine|mesh-list
2643989|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2643990|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175971|NCT00002102|Trimetrexate|trimetrexate|mesh-list
2175972|NCT00002102|Calcium|calcium|mesh-list
2175973|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
2175974|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2175975|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175976|NCT00002102|Antidotes|antidotes|mesh-ancestor
2175977|NCT00002102|Protective Agents|protective agents|mesh-ancestor
2175978|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
2175979|NCT00002102|Vitamins|vitamins|mesh-ancestor
2175980|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
2175981|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
2175982|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2175983|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2175984|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
2175985|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2175986|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2175987|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2175988|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2175989|NCT00002103|Leucovorin|leucovorin|mesh-list
2175990|NCT00002103|Trimetrexate|trimetrexate|mesh-list
2175991|NCT00002103|Calcium|calcium|mesh-list
2175992|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
2643991|NCT02012140|Ticagrelor|ticagrelor|mesh-list
2175993|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2175994|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2175995|NCT00002103|Antidotes|antidotes|mesh-ancestor
2175996|NCT00002103|Protective Agents|protective agents|mesh-ancestor
2175997|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
2643992|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2643993|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2643994|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2643995|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2643996|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
2643997|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2643998|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2643999|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644000|NCT02012166|Insulin|insulin|mesh-list
2644001|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2644002|NCT02012166|Octreotide|octreotide|mesh-list
2644003|NCT02012166|Glucagon|glucagon|mesh-list
2644004|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2644005|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644006|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2644007|NCT02012166|Hormones|hormones|mesh-ancestor
2644008|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2644009|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2644010|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644011|NCT02012244|Fentanyl|fentanyl|mesh-list
2644012|NCT02012244|Anesthetics|anesthetics|mesh-list
2644013|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
2644014|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2644015|NCT02012244|Narcotics|narcotics|mesh-ancestor
2644016|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2644017|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644018|NCT02012244|Analgesics|analgesics|mesh-ancestor
2644019|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
2644020|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2175998|NCT00002103|Vitamins|vitamins|mesh-ancestor
2175999|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
2176000|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
2176001|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176002|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2176003|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
2176004|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176005|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176006|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2176007|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644021|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2644022|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2644023|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
2644024|NCT02012296|Mifepristone|mifepristone|mesh-list
2644025|NCT02012296|Androgens|androgens|mesh-list
2644026|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2644027|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
2644028|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2644029|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644030|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2644031|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2644032|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2644033|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
2644034|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2644035|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2644036|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
2644037|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2644038|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
2644039|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2644040|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2644041|NCT02012296|Hormones|hormones|mesh-ancestor
2644042|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2644043|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
2644044|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644045|NCT02012322|Ubiquinone|ubiquinone|mesh-list
2644046|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
2644047|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
2644048|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644049|NCT02012322|Vitamins|vitamins|mesh-ancestor
2644050|NCT02012335|Ketamine|ketamine|mesh-list
2644051|NCT02012335|Analgesics|analgesics|mesh-ancestor
2176008|NCT00002104|Thalidomide|thalidomide|mesh-list
2176009|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2176010|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
2176011|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176012|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
2176013|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176014|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176015|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2176016|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2176017|NCT00002104|Growth Substances|growth substances|mesh-ancestor
2176018|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
2176019|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644052|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
2644053|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644054|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644055|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2644056|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2644057|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
2644058|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
2644059|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2644060|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2644061|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2644062|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644063|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644064|NCT02012387|Omalizumab|omalizumab|mesh-list
2644065|NCT02012387|Vaccines|vaccines|mesh-list
2644066|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2644067|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
2644068|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644069|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2644070|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2644071|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
2644072|NCT02012465|Insulin|insulin|mesh-list
2644073|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
2644074|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2644075|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644076|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2644077|NCT02012517|Cefazolin|cefazolin|mesh-list
2644078|NCT02012517|Cephalexin|cephalexin|mesh-list
2644079|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2644080|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644081|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
2644082|NCT02012556|Tesamorelin|tesamorelin|mesh-list
2644083|NCT02012556|Growth Substances|growth substances|mesh-ancestor
2644084|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644085|NCT02012569|Hemostatics|hemostatics|mesh-list
2644086|NCT02012569|Coagulants|coagulants|mesh-ancestor
2644087|NCT02012595|Donepezil|donepezil|mesh-list
2644088|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2176020|NCT00002105|Doxorubicin|doxorubicin|mesh-list
2176021|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2176022|NCT00002105|Bleomycin|bleomycin|mesh-list
2176023|NCT00002105|Vincristine|vincristine|mesh-list
2176024|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2644089|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644090|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644091|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
2644092|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644093|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644094|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
2644095|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
2644096|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644097|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
2644098|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644099|NCT02012777|Propranolol|propranolol|mesh-list
2644100|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2644101|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2644102|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
2644103|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644104|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644105|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644106|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2644107|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2644108|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
2644109|NCT02012920|Seviteronel|seviteronel|mesh-list
2176025|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176026|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2644110|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644111|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2644112|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644113|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644114|NCT02012933|Amifampridine|amifampridine|mesh-list
2644115|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2644116|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644117|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644118|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2644119|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2644120|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644121|NCT02012946|Simendan|simendan|mesh-list
2644122|NCT02012946|Dobutamine|dobutamine|mesh-list
2644123|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2644124|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
2644125|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2644126|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2644127|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644128|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644129|NCT02012946|Protective Agents|protective agents|mesh-ancestor
2644130|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644131|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
2644132|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
2644133|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644134|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2644135|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2644136|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2644137|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
2644138|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2176027|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2176028|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176029|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176030|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2176031|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
2176032|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
2644139|NCT02012998|Vaccines|vaccines|mesh-list
2644140|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
2644141|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644142|NCT02013089|Everolimus|everolimus|mesh-list
2644143|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2644144|NCT02013089|Sorafenib|sorafenib|mesh-list
2644145|NCT02013089|Sunitinib|sunitinib|mesh-list
2644146|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
2644147|NCT02013089|Gefitinib|gefitinib|mesh-list
2176033|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
2176034|NCT00002106|Ranitidine|ranitidine|mesh-list
2176035|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2176036|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2176037|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2644148|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644149|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2644150|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
2644151|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644152|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2644153|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644154|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644155|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2644156|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2644157|NCT02013089|Growth Substances|growth substances|mesh-ancestor
2644158|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
2644159|NCT02013102|Decitabine|decitabine|mesh-list
2644160|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2644161|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
2644162|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644163|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644164|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644165|NCT02013115|Budesonide|budesonide|mesh-list
2644166|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2644167|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2644168|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
2644169|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644170|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176038|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2176039|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
2176040|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
2176041|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2176042|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176043|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176044|NCT00002107|Aldesleukin|aldesleukin|mesh-list
2176045|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176046|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176047|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176048|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
2176049|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644171|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2644172|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
2644173|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
2176050|NCT00002108|Lamivudine|lamivudine|mesh-list
2176051|NCT00002108|Zidovudine|zidovudine|mesh-list
2176052|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176053|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176054|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176055|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176056|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
2176057|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176058|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176059|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176060|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
2176061|NCT00002109|Zidovudine|zidovudine|mesh-list
2176062|NCT00002109|Stavudine|stavudine|mesh-list
2176063|NCT00002109|Didanosine|didanosine|mesh-list
2176064|NCT00002109|Zalcitabine|zalcitabine|mesh-list
2176065|NCT00002109|Thymopentin|thymopentin|mesh-list
2176066|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
2176067|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176068|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176069|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176070|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176071|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
2644174|NCT02013115|Hormones|hormones|mesh-ancestor
2644175|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2644176|NCT02013141|Telavancin|telavancin|mesh-list
2644177|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2644178|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644179|NCT02013154|Paclitaxel|paclitaxel|mesh-list
2644180|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
2644181|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2644182|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644183|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
2644184|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
2644185|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
2644186|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644187|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2644188|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2644189|NCT02013219|Atezolizumab|atezolizumab|mesh-list
2644190|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644191|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2644192|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644193|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644194|NCT02013232|Aripiprazole|aripiprazole|mesh-list
2644195|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
2644196|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2644197|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2644198|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2644199|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2644200|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644201|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
2176072|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176073|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176074|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176075|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2176076|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
2176077|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644202|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
2644203|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644204|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644205|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2644206|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2644207|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
2644208|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2644209|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2644210|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2176078|NCT00002110|Zidovudine|zidovudine|mesh-list
2176079|NCT00002110|Cysteamine|cysteamine|mesh-list
2176080|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
2176081|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176082|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176083|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176084|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176085|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
2644211|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2644212|NCT02013258|Oxytocin|oxytocin|mesh-list
2644213|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
2644214|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2644215|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644216|NCT02013271|Paclitaxel|paclitaxel|mesh-list
2644217|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2644218|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644219|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
2644220|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
2644221|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
2176086|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176087|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176088|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176089|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2176090|NCT00002111|Saquinavir|saquinavir|mesh-list
2176091|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176092|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176093|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176094|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644222|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644223|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
2644224|NCT02013336|Irinotecan|irinotecan|mesh-list
2644225|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2644226|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
2644227|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644228|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2644229|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2644230|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
2644231|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644232|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644233|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2644234|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2176095|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176096|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176097|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176098|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
2176099|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176100|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2176101|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176102|NCT00002112|Fluconazole|fluconazole|mesh-list
2176103|NCT00002112|Nystatin|nystatin|mesh-list
2176104|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
2176105|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176106|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2176107|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176108|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176109|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176110|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2176111|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
2176112|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2176113|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176114|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2176115|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2176116|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176117|NCT00002112|Ionophores|ionophores|mesh-ancestor
2176118|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2176119|NCT00002113|Fluconazole|fluconazole|mesh-list
2176120|NCT00002113|Flucytosine|flucytosine|mesh-list
2176121|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
2176122|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176123|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2644235|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2644236|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644237|NCT02013362|Folic Acid|folic acid|mesh-list
2644238|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
2644239|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
2644240|NCT02013362|Vitamins|vitamins|mesh-ancestor
2644241|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
2644242|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644243|NCT02013362|Hematinics|hematinics|mesh-ancestor
2644244|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
2644245|NCT02013427|Naproxen|naproxen|mesh-list
2644246|NCT02013427|Omeprazole|omeprazole|mesh-list
2644247|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2644248|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2644249|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2644250|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644251|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644252|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2644253|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2644254|NCT02013427|Analgesics|analgesics|mesh-ancestor
2644255|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
2644256|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644257|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644258|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2644259|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2644260|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
2644261|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2644262|NCT02013453|Paclitaxel|paclitaxel|mesh-list
2644263|NCT02013453|Carboplatin|carboplatin|mesh-list
2644264|NCT02013453|Fluorouracil|fluorouracil|mesh-list
2644265|NCT02013453|Pemetrexed|pemetrexed|mesh-list
2644266|NCT02013453|Omeprazole|omeprazole|mesh-list
2644267|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2644268|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644269|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
2176124|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176125|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176126|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176127|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2176128|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
2176129|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2176130|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176131|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2176132|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2644270|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
2644271|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
2644272|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644273|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
2644274|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2644275|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2644276|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
2644277|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644278|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644279|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2644280|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2644281|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2644282|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2644283|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2644284|NCT02013492|Propranolol|propranolol|mesh-list
2644285|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2644286|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2644287|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
2644288|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644289|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644290|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644291|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2644292|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2644293|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
2644294|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
2644295|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2644296|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2644297|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644298|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2644299|NCT02013570|Analgesics|analgesics|mesh-ancestor
2644300|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
2644301|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644302|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2644303|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2644304|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2644305|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
2644306|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644307|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644308|NCT02013648|Cytarabine|cytarabine|mesh-list
2644309|NCT02013648|Daunorubicin|daunorubicin|mesh-list
2644310|NCT02013648|Dasatinib|dasatinib|mesh-list
2644311|NCT02013648|Idarubicin|idarubicin|mesh-list
2644312|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2644313|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
2644314|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644315|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644316|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
2644317|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644318|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2644319|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
2644320|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644321|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2644322|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2644323|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2644324|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644325|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2644326|NCT02013700|Remestemcel-l|remestemcel-l|mesh-list
2644327|NCT02013700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2644328|NCT02013700|Antiviral Agents|antiviral agents|mesh-ancestor
2644329|NCT02013700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644330|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
2644331|NCT02013856|Procyanidin|procyanidin|mesh-list
2644332|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
2644333|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644334|NCT02013856|Protective Agents|protective agents|mesh-ancestor
2644335|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644336|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2644337|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2644338|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644339|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
2644340|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2644341|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644342|NCT02013960|Misoprostol|misoprostol|mesh-list
2644343|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2644344|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
2644345|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2644346|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644347|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2644348|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2644349|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
2644350|NCT02013986|Midazolam|midazolam|mesh-list
2644351|NCT02013986|Propofol|propofol|mesh-list
2644352|NCT02013986|Etomidate|etomidate|mesh-list
2644353|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2644354|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2644355|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644356|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2644357|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
2644358|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
2644359|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2644360|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2644361|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2644362|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2644363|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
2644364|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
2644365|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644366|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644367|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2644368|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2644369|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2644370|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2644371|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644372|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
2644373|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644374|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644375|NCT02014103|Tacrolimus|tacrolimus|mesh-list
2176133|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
2176134|NCT00002115|Adefovir|adefovir|mesh-list
2176135|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
2176136|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644376|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2644377|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
2644378|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644379|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2644380|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644381|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644382|NCT02014142|Latanoprost|latanoprost|mesh-list
2644383|NCT02014142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2644384|NCT02014142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2644385|NCT02014337|Mifepristone|mifepristone|mesh-list
2644386|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2644387|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
2176137|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176138|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176139|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176140|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176141|NCT00002116|Cidofovir|cidofovir|mesh-list
2176142|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
2176143|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176144|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176145|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176146|NCT00002117|Zidovudine|zidovudine|mesh-list
2176147|NCT00002117|Zalcitabine|zalcitabine|mesh-list
2176148|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
2644388|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2644389|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644390|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2644391|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2644392|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2644393|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
2644394|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2644395|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2644396|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
2644397|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2644398|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
2644399|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2644400|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2644401|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
2644402|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2644403|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
2644404|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644405|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
2644406|NCT02014428|Protective Agents|protective agents|mesh-ancestor
2644407|NCT02014454|Propranolol|propranolol|mesh-list
2644408|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2644409|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2644410|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2644411|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2644412|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
2644413|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2176149|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176150|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176151|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176152|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176153|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
2176154|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176155|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176156|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176157|NCT00002118|Zalcitabine|zalcitabine|mesh-list
2176158|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
2176159|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176160|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176161|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176162|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176163|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
2176164|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176165|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176166|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176167|NCT00002120|Leucovorin|leucovorin|mesh-list
2176168|NCT00002120|Trimethoprim|trimethoprim|mesh-list
2176169|NCT00002120|Dapsone|dapsone|mesh-list
2176170|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
2176171|NCT00002120|Trimetrexate|trimetrexate|mesh-list
2176172|NCT00002120|Calcium|calcium|mesh-list
2176173|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
2644414|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644415|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644416|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2644417|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2644418|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
2644419|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
2176174|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2176175|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176176|NCT00002120|Antidotes|antidotes|mesh-ancestor
2176177|NCT00002120|Protective Agents|protective agents|mesh-ancestor
2176178|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
2176179|NCT00002120|Vitamins|vitamins|mesh-ancestor
2176180|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
2176181|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2176182|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176183|NCT00002120|Renal Agents|renal agents|mesh-ancestor
2176184|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
2176185|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2176186|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2176187|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2176188|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176189|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176190|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2176191|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2176192|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176193|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
2176194|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176195|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
2176196|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2176197|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
2644420|NCT02014506|Fludarabine|fludarabine|mesh-list
2644421|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2644422|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2644423|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
2644424|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644425|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2644426|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2644427|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
2644428|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644429|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644430|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2644431|NCT02014532|Montelukast|montelukast|mesh-list
2644432|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
2644433|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2644434|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
2644435|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
2644436|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2644437|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644438|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2644439|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2644440|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644441|NCT02014545|Lucanthone|lucanthone|mesh-list
2644442|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
2644443|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2644444|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
2644445|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2644446|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644447|NCT02014558|Voriconazole|voriconazole|mesh-list
2644448|NCT02014558|Cephalexin|cephalexin|mesh-list
2644449|NCT02014558|Midazolam|midazolam|mesh-list
2644450|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2644451|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2644452|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2644453|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644454|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2644455|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2644456|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2644457|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2644458|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
2644459|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
2644460|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
2176198|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176199|NCT00002122|Azithromycin|azithromycin|mesh-list
2176200|NCT00002122|Rifabutin|rifabutin|mesh-list
2644461|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
2644462|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2176201|NCT00002122|Fluconazole|fluconazole|mesh-list
2176202|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176203|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644463|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644464|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
2644465|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176204|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
2176205|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2176206|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176207|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176208|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176209|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2176210|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
2176211|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2176212|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176213|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2176214|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2176215|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2176216|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
2176217|NCT00002123|Didanosine|didanosine|mesh-list
2176218|NCT00002123|Delavirdine|delavirdine|mesh-list
2176219|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
2176220|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176221|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176222|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176223|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176224|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
2644466|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2644467|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2644468|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644469|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2644470|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
2644471|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2644472|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2644473|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2644474|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
2176225|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176226|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2644475|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
2644476|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644477|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644478|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644479|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
2644480|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2644481|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644482|NCT02014649|Laninamivir|laninamivir|mesh-list
2644483|NCT02014649|Zanamivir|zanamivir|mesh-list
2644484|NCT02014649|Antiviral Agents|antiviral agents|mesh-ancestor
2644485|NCT02014649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644486|NCT02014649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644487|NCT02014649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644488|NCT02014714|Fentanyl|fentanyl|mesh-list
2644489|NCT02014714|Morphine|morphine|mesh-list
2644490|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2644491|NCT02014714|Narcotics|narcotics|mesh-ancestor
2644492|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2644493|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644494|NCT02014714|Analgesics|analgesics|mesh-ancestor
2644495|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
2644496|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644497|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2644498|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2644499|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
2644500|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
2644501|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2644502|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2644503|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
2644504|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644505|NCT02014727|Antacids|antacids|mesh-ancestor
2644506|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644507|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2644508|NCT02014753|Cobalt|cobalt|mesh-list
2644509|NCT02014753|Chromium|chromium|mesh-list
2644510|NCT02014753|Everolimus|everolimus|mesh-list
2644511|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644512|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2644513|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
2644514|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644515|NCT02014753|Trace Elements|trace elements|mesh-ancestor
2644516|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
2644517|NCT02014831|Cetuximab|cetuximab|mesh-list
2644518|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2644519|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644520|NCT02014922|Vitamin E|vitamin e|mesh-list
2644521|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
2644522|NCT02014922|Tocopherols|tocopherols|mesh-list
2176227|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176228|NCT00002124|Lamivudine|lamivudine|mesh-list
2176229|NCT00002124|Zidovudine|zidovudine|mesh-list
2176230|NCT00002124|Delavirdine|delavirdine|mesh-list
2176231|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176232|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176233|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176234|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176235|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
2176236|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176237|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176238|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176239|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
2176240|NCT00002125|Foscarnet|foscarnet|mesh-list
2176241|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2176242|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
2176243|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176244|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176245|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176246|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176247|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176248|NCT00002126|Lenograstim|lenograstim|mesh-list
2176249|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2176250|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
2176251|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176252|NCT00002127|Thalidomide|thalidomide|mesh-list
2176253|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2176254|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
2176255|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176256|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
2176257|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176258|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176259|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2176260|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2176261|NCT00002127|Growth Substances|growth substances|mesh-ancestor
2176262|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
2176263|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176264|NCT00002128|Adefovir|adefovir|mesh-list
2176265|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2176266|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
2644523|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2644524|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2644525|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
2644526|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2644527|NCT02014922|Laxatives|laxatives|mesh-ancestor
2644528|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2644529|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
2644530|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644531|NCT02014922|Protective Agents|protective agents|mesh-ancestor
2644532|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644533|NCT02014922|Vitamins|vitamins|mesh-ancestor
2644534|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
2644535|NCT02015117|Trametinib|trametinib|mesh-list
2644536|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644537|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2644538|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644539|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644540|NCT02015156|Trastuzumab|trastuzumab|mesh-list
2644541|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2644542|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644543|NCT02015169|Lapatinib|lapatinib|mesh-list
2644544|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644545|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2176267|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176268|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2644546|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644547|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644548|NCT02015182|Bupivacaine|bupivacaine|mesh-list
2644549|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
2644550|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
2644551|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2644552|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644553|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
2644554|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644555|NCT02015260|Citric Acid|citric acid|mesh-list
2644556|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
2644557|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2644558|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
2644559|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
2644560|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644561|NCT02015299|Linagliptin|linagliptin|mesh-list
2644562|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2644563|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2644564|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644565|NCT02015299|Incretins|incretins|mesh-ancestor
2644566|NCT02015299|Hormones|hormones|mesh-ancestor
2644567|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2644568|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
2644569|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644570|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644571|NCT02015312|Silicon|silicon|mesh-list
2644572|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2644573|NCT02015312|Mannitol|mannitol|mesh-list
2644574|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2176269|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176270|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176271|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176272|NCT00002129|Vesnarinone|vesnarinone|mesh-list
2176273|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2176274|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
2176275|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176276|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644575|NCT02015312|Diuretics|diuretics|mesh-ancestor
2644576|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
2644577|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644578|NCT02015312|Trace Elements|trace elements|mesh-ancestor
2644579|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
2644580|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
2644581|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644582|NCT02015312|Protective Agents|protective agents|mesh-ancestor
2644583|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2644584|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2644585|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644586|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2644595|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
2644596|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2644597|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
2644598|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644599|NCT02015403|Expectorants|expectorants|mesh-ancestor
2644600|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
2644601|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2644602|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
2644603|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644604|NCT02015403|Protective Agents|protective agents|mesh-ancestor
2644605|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644606|NCT02015403|Antidotes|antidotes|mesh-ancestor
2644607|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
2644608|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
2644609|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644610|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
2176277|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
2644611|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
2644612|NCT02015507|Ivacaftor|ivacaftor|mesh-list
2644613|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2644614|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644615|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2644616|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2644617|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644618|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644619|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644620|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2644621|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2644622|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2644623|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2644624|NCT02015559|Protective Agents|protective agents|mesh-list
2176278|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176279|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2176280|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2176281|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176282|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176283|NCT00002129|Protective Agents|protective agents|mesh-ancestor
2176284|NCT00002130|Vesnarinone|vesnarinone|mesh-list
2176285|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2176286|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
2176287|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644625|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644626|NCT02015598|Carbocysteine|carbocysteine|mesh-list
2644627|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2644628|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644629|NCT02015598|Expectorants|expectorants|mesh-ancestor
2644630|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
2644631|NCT02015611|Vitamin D|vitamin d|mesh-list
2644632|NCT02015611|Vitamins|vitamins|mesh-ancestor
2644633|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
2644634|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644635|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2644636|NCT02015650|Fluorouracil|fluorouracil|mesh-list
2644637|NCT02015650|Cetuximab|cetuximab|mesh-list
2176288|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176289|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
2176290|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176291|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2176292|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2176293|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176294|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176295|NCT00002130|Protective Agents|protective agents|mesh-ancestor
2176296|NCT00002131|Vesnarinone|vesnarinone|mesh-list
2176297|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2176298|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
2176299|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176300|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176301|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
2176302|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176303|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2644638|NCT02015650|Mitomycins|mitomycins|mesh-list
2644639|NCT02015650|Mitomycin|mitomycin|mesh-list
2644640|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
2644641|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644642|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2644643|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644644|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2644645|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
2644646|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644647|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2644648|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2644649|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
2644650|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2644651|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644652|NCT02015728|Etoposide|etoposide|mesh-list
2644653|NCT02015728|Everolimus|everolimus|mesh-list
2644654|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2644655|NCT02015728|Temozolomide|temozolomide|mesh-list
2644656|NCT02015728|Sorafenib|sorafenib|mesh-list
2644657|NCT02015728|Dasatinib|dasatinib|mesh-list
2644658|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2644659|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176304|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2644660|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2644661|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2644662|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176305|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176306|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176307|NCT00002131|Protective Agents|protective agents|mesh-ancestor
2176308|NCT00002132|Itraconazole|itraconazole|mesh-list
2176309|NCT00002132|Fluconazole|fluconazole|mesh-list
2644663|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644664|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2644665|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
2644666|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644667|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2644668|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2644669|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
2644670|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2644671|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644672|NCT02015923|Panitumumab|panitumumab|mesh-list
2644673|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2644674|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644675|NCT02015949|Methylphenidate|methylphenidate|mesh-list
2644676|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2644677|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644678|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2644679|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2644680|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2644681|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644682|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
2644683|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644684|NCT02015988|Simvastatin|simvastatin|mesh-list
2644685|NCT02015988|Fenofibrate|fenofibrate|mesh-list
2644686|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2644687|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2644688|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
2644689|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644690|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2644691|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2644692|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644693|NCT02016001|Fluorides|fluorides|mesh-list
2644694|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
2644695|NCT02016001|Protective Agents|protective agents|mesh-ancestor
2644696|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644697|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
2644698|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2644699|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644700|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2644701|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2644702|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644703|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644704|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644705|NCT02016196|Rifaximin|rifaximin|mesh-list
2644706|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2644707|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644708|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2644709|NCT02016209|Paclitaxel|paclitaxel|mesh-list
2644710|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2644711|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2644712|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644713|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
2644714|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
2644715|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
2644716|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644717|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
2644718|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2644719|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2644720|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2644721|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644722|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2644723|NCT02016261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2644724|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2644725|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2644726|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644727|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644728|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
2644729|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2176310|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
2644730|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
2644731|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2644732|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2644733|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644734|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2644735|NCT02016274|Paclitaxel|paclitaxel|mesh-list
2644736|NCT02016274|Cisplatin|cisplatin|mesh-list
2644737|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2644738|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644739|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
2644740|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
2644741|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
2644742|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644743|NCT02016287|Paclitaxel|paclitaxel|mesh-list
2644744|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2644745|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644746|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
2644747|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
2644748|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
2644749|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644750|NCT02016365|Doxycycline|doxycycline|mesh-list
2644751|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2644752|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2644753|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644754|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
2644755|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2644756|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2644757|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2644758|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2644759|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
2644760|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2644761|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2644762|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644763|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2176311|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176312|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2176313|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176314|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176315|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176316|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2176317|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
2176318|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2176319|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176320|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2176321|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2176322|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2176323|NCT00002133|Itraconazole|itraconazole|mesh-list
2176324|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
2644764|NCT02016391|Analgesics|analgesics|mesh-ancestor
2644765|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
2644766|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644767|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2644768|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2644769|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2644770|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
2644771|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644772|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644773|NCT02016417|Gemcitabine|gemcitabine|mesh-list
2644774|NCT02016417|Cisplatin|cisplatin|mesh-list
2644775|NCT02016417|Docetaxel|docetaxel|mesh-list
2644776|NCT02016417|Fluorouracil|fluorouracil|mesh-list
2644777|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644778|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2644779|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
2644780|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176325|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176326|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2176327|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176328|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176329|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176330|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2176331|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
2644781|NCT02016417|Antiviral Agents|antiviral agents|mesh-ancestor
2644782|NCT02016417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644783|NCT02016417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644784|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2644785|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
2644786|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644787|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
2644788|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
2644789|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
2644790|NCT02016443|Tizanidine|tizanidine|mesh-list
2644791|NCT02016443|Analgesics|analgesics|mesh-ancestor
2644792|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
2644793|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644794|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644795|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
2176332|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2176333|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176334|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2176335|NCT00002134|Ganciclovir|ganciclovir|mesh-list
2176336|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2176337|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
2176338|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176339|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176340|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176341|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176342|NCT00002135|Ganciclovir|ganciclovir|mesh-list
2176343|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2176344|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
2176345|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176346|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176347|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176348|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176349|NCT00002139|Azithromycin|azithromycin|mesh-list
2176350|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176351|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176352|NCT00002140|Azithromycin|azithromycin|mesh-list
2176353|NCT00002140|Clarithromycin|clarithromycin|mesh-list
2176354|NCT00002140|Ethambutol|ethambutol|mesh-list
2176355|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2644796|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2644797|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2644798|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
2644799|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
2644800|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2644801|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2644802|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2644803|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
2644804|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644805|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644806|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
2644807|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
2644808|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644809|NCT02016495|Protective Agents|protective agents|mesh-ancestor
2644810|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644811|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
2644812|NCT02016495|Vitamins|vitamins|mesh-ancestor
2644813|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
2644814|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2644815|NCT02016547|Abciximab|abciximab|mesh-list
2644816|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2644817|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2644818|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644819|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
2176356|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176357|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2176358|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176359|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644820|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2644821|NCT02016664|Ketamine|ketamine|mesh-list
2644822|NCT02016664|Analgesics|analgesics|mesh-ancestor
2644823|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
2644824|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644825|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644826|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2644827|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2644828|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
2644829|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
2644830|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2644831|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2644832|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2644833|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644834|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644835|NCT02016703|Erythritol|erythritol|mesh-list
2644836|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
2644837|NCT02016729|Trametinib|trametinib|mesh-list
2644838|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644839|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2644840|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644841|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176360|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2176361|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176362|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
2644842|NCT02016807|Sucralfate|sucralfate|mesh-list
2644843|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2644844|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2644845|NCT02016820|Omeprazole|omeprazole|mesh-list
2644846|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2644847|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2644848|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2644849|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644850|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644851|NCT02016846|Liraglutide|liraglutide|mesh-list
2644852|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2644853|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644854|NCT02016846|Incretins|incretins|mesh-ancestor
2644855|NCT02016846|Hormones|hormones|mesh-ancestor
2644856|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2644857|NCT02016976|Midazolam|midazolam|mesh-list
2644858|NCT02016976|Meperidine|meperidine|mesh-list
2644859|NCT02016976|Analgesics|analgesics|mesh-list
2644860|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
2644861|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644862|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644863|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2644864|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2644865|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2644866|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2644867|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2644868|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2644869|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2176363|NCT00002141|Abacavir|abacavir|mesh-list
2176364|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176365|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176366|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176367|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176368|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
2176369|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176370|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176371|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176372|NCT00002142|Cidofovir|cidofovir|mesh-list
2644870|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
2644871|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
2644872|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
2644873|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
2644874|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644875|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644876|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2176373|NCT00002142|Probenecid|probenecid|mesh-list
2176374|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
2176375|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
2176376|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2176377|NCT00002142|Renal Agents|renal agents|mesh-ancestor
2176378|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
2176379|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176380|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176381|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176382|NCT00002143|Acitretin|acitretin|mesh-list
2176383|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
2176384|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
2644877|NCT02016976|Narcotics|narcotics|mesh-ancestor
2644878|NCT02017119|Lactulose|lactulose|mesh-list
2644879|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2644880|NCT02017197|Warfarin|warfarin|mesh-list
2176385|NCT00002144|Foscarnet|foscarnet|mesh-list
2176386|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2644881|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
2644882|NCT02017314|Morphine|morphine|mesh-list
2644883|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2644884|NCT02017314|Narcotics|narcotics|mesh-ancestor
2644885|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2176387|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
2176388|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176389|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176390|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176391|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176392|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176393|NCT00002145|Foscarnet|foscarnet|mesh-list
2176394|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2176395|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
2644886|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644887|NCT02017314|Analgesics|analgesics|mesh-ancestor
2644888|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
2644889|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644890|NCT02017340|Nilvadipine|nilvadipine|mesh-list
2644891|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2644892|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2644893|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2644894|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644895|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2644896|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644897|NCT02017392|Lidocaine|lidocaine|mesh-list
2644898|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
2644899|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
2644900|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2644901|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644902|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
2176396|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176397|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176398|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176399|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176400|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176401|NCT00002146|Foscarnet|foscarnet|mesh-list
2176402|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2176403|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
2176404|NCT00002146|Analgesics|analgesics|mesh-ancestor
2176405|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
2176406|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2176407|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176408|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
2176409|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2176410|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2176411|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
2176412|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2176413|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2176414|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176415|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2176416|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
2176417|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2176418|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
2176419|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176420|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176421|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176422|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176423|NCT00002147|Doxorubicin|doxorubicin|mesh-list
2176424|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2176425|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2176426|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176427|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2176428|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2176429|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176430|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176431|NCT00002148|OPC 14117|opc 14117|mesh-list
2176432|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2176433|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
2176434|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644903|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644904|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2644905|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2644906|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2644907|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2644908|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644909|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
2644910|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2644911|NCT02017405|Antibodies|antibodies|mesh-list
2644912|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
2644913|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644914|NCT02017457|Azacitidine|azacitidine|mesh-list
2644915|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2644916|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
2644917|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644918|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644919|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644920|NCT02017561|Metformin|metformin|mesh-list
2644921|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2644922|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644923|NCT02017600|Fluorouracil|fluorouracil|mesh-list
2644924|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644925|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
2644926|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176435|NCT00002148|Protective Agents|protective agents|mesh-ancestor
2176436|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176437|NCT00002149|Amoxicillin|amoxicillin|mesh-list
2176438|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
2176439|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
2176440|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
2176441|NCT00002149|Ephedrine|ephedrine|mesh-list
2176442|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176443|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176444|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2176445|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176446|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176447|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2176448|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
2176449|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2176450|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176451|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2644927|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2644928|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2644929|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
2644930|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644931|NCT02017613|Tenalisib|tenalisib|mesh-list
2644932|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
2644933|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644934|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644935|NCT02017639|Simvastatin|simvastatin|mesh-list
2176452|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
2176453|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
2176454|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2644936|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2644937|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2176455|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2176456|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
2176457|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
2176458|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2176459|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
2176460|NCT00002154|Selegiline|selegiline|mesh-list
2176461|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
2644938|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
2644939|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644940|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2644941|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2644942|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644943|NCT02017704|Leucovorin|leucovorin|mesh-list
2644944|NCT02017704|Capecitabine|capecitabine|mesh-list
2644945|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
2644946|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2644947|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
2644948|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644949|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644950|NCT02017704|Antidotes|antidotes|mesh-ancestor
2176462|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2176463|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2176464|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2176465|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2176466|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176467|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176468|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2176469|NCT00002154|Protective Agents|protective agents|mesh-ancestor
2176470|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176471|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
2176472|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
2176473|NCT00002154|Vitamins|vitamins|mesh-ancestor
2176474|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
2176475|NCT00002155|Lamivudine|lamivudine|mesh-list
2176476|NCT00002155|Zidovudine|zidovudine|mesh-list
2176477|NCT00002155|Indinavir|indinavir|mesh-list
2176478|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176479|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176480|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176481|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644951|NCT02017704|Protective Agents|protective agents|mesh-ancestor
2644952|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644953|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
2644954|NCT02017704|Vitamins|vitamins|mesh-ancestor
2644955|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
2644956|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
2644957|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2644958|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644959|NCT02018055|Aspirin|aspirin|mesh-list
2644960|NCT02018055|Clopidogrel|clopidogrel|mesh-list
2644961|NCT02018055|Ticagrelor|ticagrelor|mesh-list
2644962|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2644963|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2644964|NCT02018055|Analgesics|analgesics|mesh-ancestor
2644965|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
2644966|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2644967|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2644968|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2644969|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2644970|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2644971|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2644972|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644973|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2644974|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2644975|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644976|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
2644977|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2644978|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2644979|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2644980|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
2644981|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2644982|NCT02018081|Levofloxacin|levofloxacin|mesh-list
2644983|NCT02018081|Ofloxacin|ofloxacin|mesh-list
2644984|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2644985|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2644986|NCT02018081|Renal Agents|renal agents|mesh-ancestor
2644987|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2644988|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2644989|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2644990|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2644991|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2644992|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2644993|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2644994|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2644995|NCT02018094|Iodine|iodine|mesh-list
2644996|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
2644997|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
2644998|NCT02018094|Metronidazole|metronidazole|mesh-list
2644999|NCT02018094|Clindamycin|clindamycin|mesh-list
2645000|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2645001|NCT02018094|Teicoplanin|teicoplanin|mesh-list
2645002|NCT02018094|Povidone|povidone|mesh-list
2176482|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
2176483|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176484|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176485|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176486|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
2176487|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176488|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2645003|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2645004|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645005|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
2645006|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2645007|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2176489|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176490|NCT00002156|Ganciclovir|ganciclovir|mesh-list
2176491|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2176492|NCT00002156|Fomivirsen|fomivirsen|mesh-list
2176493|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
2176494|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176495|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176496|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176497|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176498|NCT00002157|Thalidomide|thalidomide|mesh-list
2176499|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2176500|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
2176501|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645008|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2645009|NCT02018094|Trace Elements|trace elements|mesh-ancestor
2645010|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
2645011|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645012|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2645013|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645014|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645015|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
2645016|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
2645017|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2645018|NCT02018133|Vitamin D|vitamin d|mesh-list
2645019|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
2645020|NCT02018133|Vitamins|vitamins|mesh-ancestor
2645021|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
2645022|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645023|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2645024|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2645025|NCT02018159|Menotropins|menotropins|mesh-list
2645026|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2645027|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
2645028|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2645029|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645030|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
2645031|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
2645032|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
2645033|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645034|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645035|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
2645036|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645037|NCT02018263|Cocaine|cocaine|mesh-list
2645038|NCT02018263|Nicotine|nicotine|mesh-list
2645039|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2645040|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
2645041|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645042|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645043|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2645044|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2645045|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
2645046|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645047|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645048|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
2645049|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
2645050|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645051|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
2645052|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2645053|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2645054|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2645055|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2645056|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
2645057|NCT02018276|Lidocaine|lidocaine|mesh-list
2645058|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
2645059|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
2645060|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645061|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645062|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
2645063|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645064|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2645065|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2176502|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
2176503|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176504|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645066|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2645067|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2645068|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645069|NCT02018289|Triclosan|triclosan|mesh-list
2645070|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2645071|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645072|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2645073|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2645074|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
2645075|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645076|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2645077|NCT02018328|Curcumin|curcumin|mesh-list
2176505|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2176506|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2176507|NCT00002157|Growth Substances|growth substances|mesh-ancestor
2176508|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
2176509|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176510|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
2176511|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2176512|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176513|NCT00002159|Itraconazole|itraconazole|mesh-list
2176514|NCT00002159|Amphotericin B|amphotericin b|mesh-list
2176515|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2176516|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
2176517|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176518|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2176519|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176520|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176521|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176522|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2176523|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
2176524|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2645078|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2645079|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2645080|NCT02018328|Analgesics|analgesics|mesh-ancestor
2645081|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
2645082|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645083|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645084|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2645085|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2645086|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645087|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645088|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645089|NCT02018367|Proflavine|proflavine|mesh-list
2645090|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2645091|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645092|NCT02018419|Vaccines|vaccines|mesh-list
2645093|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
2645094|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645095|NCT02018523|Lenalidomide|lenalidomide|mesh-list
2645096|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
2645097|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645098|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2645099|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2645100|NCT02018523|Growth Substances|growth substances|mesh-ancestor
2645101|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
2645102|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645103|NCT02018536|Simeprevir|simeprevir|mesh-list
2645104|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
2645105|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645106|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
2645107|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645108|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645109|NCT02018588|Tryptophan|tryptophan|mesh-list
2645110|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2645111|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
2645112|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2645113|NCT02018601|Acetaminophen|acetaminophen|mesh-list
2645114|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2645115|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2645116|NCT02018601|Analgesics|analgesics|mesh-ancestor
2645117|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
2176525|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176526|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2176527|NCT00002159|Amebicides|amebicides|mesh-ancestor
2176528|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2176529|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2176530|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176531|NCT00002160|Ziconotide|ziconotide|mesh-list
2176532|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2176533|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2176534|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176535|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2176536|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176537|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2176538|NCT00002160|Protective Agents|protective agents|mesh-ancestor
2645118|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645119|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645120|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
2645121|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2645122|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2645123|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2645124|NCT02018731|Metformin|metformin|mesh-list
2645125|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2645126|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645127|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
2645128|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
2645129|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2645130|NCT02018757|Estrogens|estrogens|mesh-ancestor
2645131|NCT02018757|Hormones|hormones|mesh-ancestor
2645132|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2645133|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645134|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2645135|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645136|NCT02018783|Listerine|listerine|mesh-list
2645137|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
2645138|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
2645139|NCT02018783|Protective Agents|protective agents|mesh-ancestor
2645140|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645141|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2645142|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645143|NCT02018796|Misoprostol|misoprostol|mesh-list
2645144|NCT02018796|Mifepristone|mifepristone|mesh-list
2645145|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2645146|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
2645147|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2645148|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645149|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2645150|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2645151|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
2645152|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2645153|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2645154|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2645155|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2645156|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
2645157|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2645158|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2645159|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
2645160|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2645161|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
2645162|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2645163|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2645164|NCT02018861|Rituximab|rituximab|mesh-list
2176539|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2176540|NCT00002160|Analgesics|analgesics|mesh-ancestor
2176541|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
2176542|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2176543|NCT00002161|Adefovir|adefovir|mesh-list
2176544|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2176545|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
2176546|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176547|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176548|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176549|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176550|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176551|NCT00002162|Lamivudine|lamivudine|mesh-list
2645165|NCT02018861|Carboplatin|carboplatin|mesh-list
2645166|NCT02018861|Etoposide|etoposide|mesh-list
2645167|NCT02018861|Ifosfamide|ifosfamide|mesh-list
2645168|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2645169|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645170|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
2645171|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645172|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2645173|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2645174|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2645175|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2645176|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645177|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645178|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2645179|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
2645180|NCT02018874|Gemcitabine|gemcitabine|mesh-list
2645181|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2645182|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
2645183|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645184|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645185|NCT02018874|Antiviral Agents|antiviral agents|mesh-ancestor
2645186|NCT02018874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645187|NCT02018874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176552|NCT00002162|Zidovudine|zidovudine|mesh-list
2176553|NCT00002162|Stavudine|stavudine|mesh-list
2176554|NCT00002162|Didanosine|didanosine|mesh-list
2176555|NCT00002162|Zalcitabine|zalcitabine|mesh-list
2176556|NCT00002162|Saquinavir|saquinavir|mesh-list
2176557|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176558|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176559|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645188|NCT02018874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2645189|NCT02018874|Immunologic Factors|immunologic factors|mesh-ancestor
2645190|NCT02018874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645191|NCT02018926|Azacitidine|azacitidine|mesh-list
2645192|NCT02018926|Mocetinostat|mocetinostat|mesh-list
2645193|NCT02018926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2645194|NCT02018926|Antimetabolites|antimetabolites|mesh-ancestor
2645195|NCT02018926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645196|NCT02018926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645197|NCT02018926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645198|NCT02018926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2645199|NCT02018965|Vitamins|vitamins|mesh-list
2645200|NCT02018965|Niacin|niacin|mesh-list
2645201|NCT02018965|Niacinamide|niacinamide|mesh-list
2645202|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
2645203|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
2645204|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
2645205|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645206|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2645207|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
2645208|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645209|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2645210|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
2645211|NCT02018991|Everolimus|everolimus|mesh-list
2645212|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645213|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2645214|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
2645215|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645216|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
2645217|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2176560|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176561|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
2176562|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176563|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2645218|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2645219|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2645220|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2645221|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645222|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
2645223|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645224|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645225|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2645226|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645227|NCT02019056|Pyridoxine|pyridoxine|mesh-list
2645228|NCT02019056|Metadoxine|metadoxine|mesh-list
2645229|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2645230|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
2645231|NCT02019056|Vitamins|vitamins|mesh-ancestor
2176564|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176565|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
2176566|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176567|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176568|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176569|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2176570|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176571|NCT00002163|Abacavir|abacavir|mesh-list
2176572|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176573|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2645232|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
2645233|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645234|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
2645235|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2645236|NCT02019160|Fluorides|fluorides|mesh-list
2645237|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
2645238|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
2645239|NCT02019160|Protective Agents|protective agents|mesh-ancestor
2645240|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645241|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2645242|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645243|NCT02019186|Vitamins|vitamins|mesh-list
2645244|NCT02019186|Ascorbic Acid|ascorbic acid|mesh-list
2645245|NCT02019186|Vitamin E|vitamin e|mesh-list
2645246|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
2645247|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645248|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
2645249|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645250|NCT02019186|Protective Agents|protective agents|mesh-ancestor
2645251|NCT02019290|Midazolam|midazolam|mesh-list
2645252|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2645253|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2645254|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645255|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645256|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2645257|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2176574|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176575|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176576|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
2176577|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176578|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176579|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176580|NCT00002164|Nelfinavir|nelfinavir|mesh-list
2176581|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176582|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176583|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176584|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176585|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176586|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2645258|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2645259|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2645260|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
2645261|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
2645262|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
2645263|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
2645264|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645265|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645266|NCT02019329|Risperidone|risperidone|mesh-list
2645267|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2645268|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
2645269|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645270|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645271|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645272|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2645273|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2645274|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645275|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2645276|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2645277|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
2645278|NCT02019355|Fluorouracil|fluorouracil|mesh-list
2645279|NCT02019355|Calcipotriene|calcipotriene|mesh-list
2645280|NCT02019355|Petrolatum|petrolatum|mesh-list
2645281|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
2176587|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2645282|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645283|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2645284|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645285|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2645286|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
2645287|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645288|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
2645289|NCT02019355|Emollients|emollients|mesh-ancestor
2645290|NCT02019381|Vitamin D|vitamin d|mesh-list
2645291|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
2645292|NCT02019381|Vitamins|vitamins|mesh-list
2645293|NCT02019381|Calcium|calcium|mesh-list
2645294|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
2645295|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645296|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2645297|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2645298|NCT02019446|Terbinafine|terbinafine|mesh-list
2645299|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
2645300|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645301|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645302|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645303|NCT02019459|Nicotine|nicotine|mesh-list
2645304|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2645305|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
2645306|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645307|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645308|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2645309|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2645310|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
2645311|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645312|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645313|NCT02019485|Tapentadol|tapentadol|mesh-list
2645314|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2645315|NCT02019485|Narcotics|narcotics|mesh-ancestor
2645316|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645317|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645318|NCT02019485|Analgesics|analgesics|mesh-ancestor
2176588|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
2176589|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176590|NCT00002165|Nelfinavir|nelfinavir|mesh-list
2176591|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176592|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176593|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176594|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176595|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176596|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176597|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176598|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
2176599|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176600|NCT00002166|Nevirapine|nevirapine|mesh-list
2176601|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176602|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176603|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645319|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
2645320|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645321|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2645322|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2645323|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2645324|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645325|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
2645326|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645327|NCT02019524|Folic Acid|folic acid|mesh-list
2645328|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
2645329|NCT02019524|Molgramostim|molgramostim|mesh-list
2645330|NCT02019524|Vaccines|vaccines|mesh-list
2645331|NCT02019524|Sargramostim|sargramostim|mesh-list
2645332|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
2645333|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645334|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645335|NCT02019524|Hematinics|hematinics|mesh-ancestor
2645336|NCT02019524|Vitamins|vitamins|mesh-ancestor
2645337|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
2645338|NCT02019589|Progesterone|progesterone|mesh-list
2645339|NCT02019589|Progestins|progestins|mesh-ancestor
2176604|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176605|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
2176606|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645340|NCT02019589|Hormones|hormones|mesh-ancestor
2645341|NCT02019589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2645342|NCT02019589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645343|NCT02019784|Rifaximin|rifaximin|mesh-list
2645344|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2645345|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645346|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2645347|NCT02019797|Desflurane|desflurane|mesh-list
2645348|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2645349|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
2645350|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
2645351|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645352|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645353|NCT02019810|Dobutamine|dobutamine|mesh-list
2645354|NCT02019810|Norepinephrine|norepinephrine|mesh-list
2645355|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2645356|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2645357|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
2645358|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645359|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645360|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645361|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
2645362|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
2645363|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645364|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2645365|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2645366|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2645367|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2645368|NCT02019810|Protective Agents|protective agents|mesh-ancestor
2645369|NCT02019836|Vitamin D|vitamin d|mesh-list
2645370|NCT02019836|Vitamins|vitamins|mesh-ancestor
2645371|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
2645372|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645373|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2645374|NCT02019875|Clarithromycin|clarithromycin|mesh-list
2645375|NCT02019875|Rifampin|rifampin|mesh-list
2645376|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2645377|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645378|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2645379|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645380|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176607|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176608|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176609|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2176610|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2645381|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2645382|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2645383|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2645384|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
2645385|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
2645386|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2645387|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2645388|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2645389|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2645390|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2645391|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2645392|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2645393|NCT02020005|Nicotine|nicotine|mesh-list
2645394|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2645395|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
2645396|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645397|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645398|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2645399|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2645400|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
2645401|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645402|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645403|NCT02020070|Ipilimumab|ipilimumab|mesh-list
2645404|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2645405|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645406|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2645407|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645408|NCT02020122|Pregabalin|pregabalin|mesh-list
2645409|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2645410|NCT02020122|Analgesics|analgesics|mesh-ancestor
2645411|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
2645412|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645413|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645414|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
2645415|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2645416|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2645417|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645418|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2645419|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2645420|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2645421|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645422|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2645423|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2645424|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2645425|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645426|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
2645427|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
2645428|NCT02020161|Methotrexate|methotrexate|mesh-list
2645429|NCT02020161|Idarubicin|idarubicin|mesh-list
2645430|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2645431|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
2645432|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2645433|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645434|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2645435|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
2645436|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645437|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645438|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
2645439|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645440|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2645441|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2645442|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
2645443|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2645444|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2645445|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2176611|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
2176612|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2176613|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
2176614|NCT00002168|Lamivudine|lamivudine|mesh-list
2176615|NCT00002168|Zidovudine|zidovudine|mesh-list
2176616|NCT00002168|Stavudine|stavudine|mesh-list
2176617|NCT00002168|Didanosine|didanosine|mesh-list
2176618|NCT00002168|Indinavir|indinavir|mesh-list
2176619|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176620|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176621|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645446|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2645447|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2645448|NCT02020200|Methylphenidate|methylphenidate|mesh-list
2645449|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2645450|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645451|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2645452|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2645453|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2645454|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645455|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
2645456|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645457|NCT02020213|Posaconazole|posaconazole|mesh-list
2645458|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
2645459|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645460|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2645461|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2645462|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2645463|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2645464|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2645465|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645466|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645467|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2645468|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
2645469|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2645470|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645471|NCT02020330|Lumefantrine|lumefantrine|mesh-list
2645472|NCT02020330|Artemether|artemether|mesh-list
2176622|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176623|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
2176624|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176625|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176626|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176627|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
2176628|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176629|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176630|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176631|NCT00002169|Nelfinavir|nelfinavir|mesh-list
2176632|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176633|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176634|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176635|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176636|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176637|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176638|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176639|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
2176640|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645473|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2645474|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
2645475|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2645476|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2645477|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645478|NCT02020499|Lanreotide|lanreotide|mesh-list
2645479|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645480|NCT02020551|Lidocaine|lidocaine|mesh-list
2645481|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
2645482|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
2645483|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645484|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645485|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
2645486|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645487|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2645488|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2645489|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2645490|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2645491|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645492|NCT02020603|Epinephrine|epinephrine|mesh-list
2645493|NCT02020603|Racepinephrine|racepinephrine|mesh-list
2645494|NCT02020603|Hemostatics|hemostatics|mesh-list
2645495|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
2645496|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2645497|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2645498|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
2645499|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645500|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645501|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645502|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2645503|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2645504|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
2645505|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645506|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2645507|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
2645508|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
2645509|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
2645510|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2645511|NCT02020603|Coagulants|coagulants|mesh-ancestor
2645512|NCT02020629|Lixisenatide|lixisenatide|mesh-list
2645513|NCT02020629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2645514|NCT02020629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645515|NCT02020681|Fluorides|fluorides|mesh-list
2645516|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
2645517|NCT02020681|Protective Agents|protective agents|mesh-ancestor
2645518|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645519|NCT02020694|Vitamin D|vitamin d|mesh-list
2645520|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
2645521|NCT02020694|Vitamins|vitamins|mesh-list
2645522|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
2645523|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645524|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2645525|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2176641|NCT00002170|Nelfinavir|nelfinavir|mesh-list
2176642|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176643|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176644|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176645|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176646|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176647|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176648|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176649|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
2176650|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176651|NCT00002171|Nelfinavir|nelfinavir|mesh-list
2176652|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176653|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176654|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176655|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176656|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176657|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176658|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176659|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
2176660|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176661|NCT00002174|Thalidomide|thalidomide|mesh-list
2176662|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2176663|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
2176664|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176665|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
2176666|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176667|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176668|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2176669|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2176670|NCT00002174|Growth Substances|growth substances|mesh-ancestor
2176671|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
2645547|NCT02020720|Fluorides|fluorides|mesh-list
2645548|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
2645549|NCT02020720|Protective Agents|protective agents|mesh-ancestor
2645550|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645551|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
2645552|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2645553|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2645554|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2645555|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2645556|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645557|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
2645558|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2176672|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176673|NCT00002176|Stavudine|stavudine|mesh-list
2176674|NCT00002176|Didanosine|didanosine|mesh-list
2176675|NCT00002176|Nelfinavir|nelfinavir|mesh-list
2176676|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
2176677|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176678|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
2176679|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176680|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176681|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176682|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
2176683|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176684|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
2176685|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176686|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176687|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176688|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176689|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176690|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
2645559|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645560|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2645561|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645562|NCT02021006|Amoxicillin|amoxicillin|mesh-list
2645563|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
2645564|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
2645565|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2645566|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
2645567|NCT02021006|Cefixime|cefixime|mesh-list
2645568|NCT02021006|Trimethoprim|trimethoprim|mesh-list
2645569|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
2645570|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2645571|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645572|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2645573|NCT02021006|Renal Agents|renal agents|mesh-ancestor
2645574|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
2645575|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2645576|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2645577|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2645578|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645579|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645580|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2645581|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2645582|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2645583|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2645584|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2645585|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2645586|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
2645587|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2645588|NCT02021097|Estradiol|estradiol|mesh-list
2645589|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2645590|NCT02021097|Estrogens|estrogens|mesh-ancestor
2645591|NCT02021097|Hormones|hormones|mesh-ancestor
2645592|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2645593|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645594|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2645595|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
2645596|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2645597|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2645598|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2645599|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2645600|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2645601|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2645602|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2645603|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2645604|NCT02021123|Anidulafungin|anidulafungin|mesh-list
2645605|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
2645606|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645607|NCT02021201|Risperidone|risperidone|mesh-list
2645608|NCT02021201|Sertindole|sertindole|mesh-list
2645609|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2645610|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
2645611|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645612|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645613|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645614|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2645615|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2645616|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645617|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2645618|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2176691|NCT00002177|Stavudine|stavudine|mesh-list
2176692|NCT00002177|Didanosine|didanosine|mesh-list
2176693|NCT00002177|Nelfinavir|nelfinavir|mesh-list
2176694|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
2176695|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176696|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
2645619|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
2645620|NCT02021214|Methylphenidate|methylphenidate|mesh-list
2645621|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2645622|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645623|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2645624|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2645625|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2645626|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645627|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
2176697|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645628|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645629|NCT02021240|Dexamethasone|dexamethasone|mesh-list
2645630|NCT02021240|Ketamine|ketamine|mesh-list
2645631|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2645632|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
2645633|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
2645634|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645635|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645636|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2645637|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
2645638|NCT02021240|Hormones|hormones|mesh-ancestor
2645639|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2645640|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2645641|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645642|NCT02021240|Analgesics|analgesics|mesh-ancestor
2645643|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
2645644|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2645645|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2645646|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
2645647|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
2645648|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645649|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2645650|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2645651|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2176698|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176699|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176700|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
2176701|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176702|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
2176703|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176704|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176705|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176706|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176707|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176708|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176709|NCT00002178|Ritonavir|ritonavir|mesh-list
2176710|NCT00002178|Nelfinavir|nelfinavir|mesh-list
2176711|NCT00002178|Saquinavir|saquinavir|mesh-list
2176712|NCT00002178|Delavirdine|delavirdine|mesh-list
2176713|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176714|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176715|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
2645652|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645653|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
2645654|NCT02021409|Hematinics|hematinics|mesh-ancestor
2645655|NCT02021422|Fluorouracil|fluorouracil|mesh-list
2645656|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
2645657|NCT02021422|Irinotecan|irinotecan|mesh-list
2645658|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2645659|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
2645660|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645661|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2645662|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645663|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2645664|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
2645665|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645666|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2645667|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2645668|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645669|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2645670|NCT02021474|Phenol|phenol|mesh-list
2645671|NCT02021474|Histamine|histamine|mesh-list
2645672|NCT02021474|Histamine phosphate|histamine phosphate|mesh-list
2645673|NCT02021474|Histamine Agonists|histamine agonists|mesh-ancestor
2645674|NCT02021474|Histamine Agents|histamine agents|mesh-ancestor
2645675|NCT02021474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645676|NCT02021474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645677|NCT02021474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645678|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2645679|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645680|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
2645681|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2645682|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2176716|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645683|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2645684|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645685|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
2176717|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176718|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176719|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176720|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
2176721|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176722|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2176723|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176724|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176725|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176726|NCT00002179|Lamivudine|lamivudine|mesh-list
2176727|NCT00002179|Zidovudine|zidovudine|mesh-list
2176728|NCT00002179|Indinavir|indinavir|mesh-list
2176729|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176730|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176731|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176732|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176733|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
2176734|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176735|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176736|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176737|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
2176738|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176739|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176740|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176741|NCT00002180|Tenofovir|tenofovir|mesh-list
2176742|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
2176743|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176744|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176745|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176746|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645686|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2645687|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645688|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
2645689|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
2645690|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645691|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645692|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645693|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
2645694|NCT02021825|Analgesics|analgesics|mesh-ancestor
2645695|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
2645696|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645697|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645698|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645699|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2645700|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2645701|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645702|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645703|NCT02021851|Dexamethasone|dexamethasone|mesh-list
2645704|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
2645705|NCT02021851|Ondansetron|ondansetron|mesh-list
2645706|NCT02021851|Aprepitant|aprepitant|mesh-list
2645707|NCT02021851|BB 1101|bb 1101|mesh-list
2645708|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2645709|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
2645710|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
2645711|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645712|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645713|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2645714|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
2645715|NCT02021851|Hormones|hormones|mesh-ancestor
2645716|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2176747|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176748|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176749|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176750|NCT00002181|Cidofovir|cidofovir|mesh-list
2176751|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
2176752|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176753|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176754|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176755|NCT00002182|Megestrol|megestrol|mesh-list
2176756|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
2176757|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2176758|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2176759|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2176760|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
2645717|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2645718|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645719|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
2645720|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176761|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2176762|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176763|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2176764|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2176765|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2176766|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645721|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645722|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
2645723|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
2645724|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2645725|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
2645726|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645727|NCT02021851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2645728|NCT02021851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2645729|NCT02021851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2422456|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2422457|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422458|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2422459|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2422460|NCT00817284|Growth Substances|growth substances|mesh-ancestor
2422461|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422462|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
2422463|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2422464|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2176767|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
2176768|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2176769|NCT00002183|Lamivudine|lamivudine|mesh-list
2176770|NCT00002183|Zidovudine|zidovudine|mesh-list
2176771|NCT00002183|Abacavir|abacavir|mesh-list
2176772|NCT00002183|Amprenavir|amprenavir|mesh-list
2176773|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2645730|NCT02021851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2645731|NCT02021851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2645732|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2645733|NCT02021864|Vitamin D|vitamin d|mesh-list
2645734|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
2645735|NCT02021864|Vitamins|vitamins|mesh-ancestor
2645736|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
2645737|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645738|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2645739|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2645740|NCT02022059|Lidocaine|lidocaine|mesh-list
2645741|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
2645742|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
2422465|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422466|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422467|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2422468|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
2422469|NCT00817362|Trastuzumab|trastuzumab|mesh-list
2422470|NCT00817362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2422471|NCT00817362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422472|NCT00817375|Milnacipran|milnacipran|mesh-list
2422473|NCT00817375|Mirtazapine|mirtazapine|mesh-list
2422474|NCT00817375|Sertraline|sertraline|mesh-list
2422475|NCT00817375|Fluoxetine|fluoxetine|mesh-list
2422476|NCT00817375|Paroxetine|paroxetine|mesh-list
2422477|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2176774|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176775|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176776|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176777|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
2176778|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176779|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176780|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176781|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
2176782|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2176783|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
2176784|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176785|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2422478|NCT00817375|Nortriptyline|nortriptyline|mesh-list
2645743|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645744|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645745|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
2645746|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645747|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2645748|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2645749|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2645750|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2645751|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645752|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2645753|NCT02022163|Vaccines|vaccines|mesh-list
2645754|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
2645755|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645756|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2645757|NCT02022163|Antacids|antacids|mesh-ancestor
2645758|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645759|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2645760|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2645761|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2645762|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
2645763|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2645764|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
2645765|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2645766|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645767|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2645768|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2645769|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645770|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2645771|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
2645772|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2645773|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
2645774|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2645775|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645776|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2645777|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2176786|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176787|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176788|NCT00002184|Lamivudine|lamivudine|mesh-list
2176789|NCT00002184|Zidovudine|zidovudine|mesh-list
2176790|NCT00002184|Stavudine|stavudine|mesh-list
2176791|NCT00002184|Adefovir|adefovir|mesh-list
2176792|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2176793|NCT00002184|Nelfinavir|nelfinavir|mesh-list
2176794|NCT00002184|Saquinavir|saquinavir|mesh-list
2176795|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176796|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176797|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176798|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176799|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
2176800|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645778|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645779|NCT02022254|Metformin|metformin|mesh-list
2645780|NCT02022254|Warfarin|warfarin|mesh-list
2645781|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2645782|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645783|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
2645784|NCT02022280|Lansoprazole|lansoprazole|mesh-list
2645785|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
2645786|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2645787|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2645788|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2645789|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645790|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645791|NCT02022293|Atorvastatin|atorvastatin|mesh-list
2645792|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2645793|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2645794|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
2645795|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645796|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2645797|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2645798|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645799|NCT02022358|Leucovorin|leucovorin|mesh-list
2645800|NCT02022358|Folic Acid|folic acid|mesh-list
2645801|NCT02022358|Methotrexate|methotrexate|mesh-list
2645802|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
2645803|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2176801|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176802|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2645804|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
2645805|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2645806|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645807|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2645808|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
2645809|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645810|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645811|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
2645812|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645813|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2645814|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2645815|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
2645816|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2645817|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2645818|NCT02022358|Antidotes|antidotes|mesh-ancestor
2645819|NCT02022358|Protective Agents|protective agents|mesh-ancestor
2645820|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
2645821|NCT02022358|Vitamins|vitamins|mesh-ancestor
2645822|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
2645823|NCT02022358|Hematinics|hematinics|mesh-ancestor
2645824|NCT02022475|Vitamin D|vitamin d|mesh-list
2645825|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
2645826|NCT02022475|Vitamins|vitamins|mesh-ancestor
2645827|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
2645828|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645829|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2645830|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2645831|NCT02022488|Midazolam|midazolam|mesh-list
2645832|NCT02022488|Ketamine|ketamine|mesh-list
2645833|NCT02022488|Alfentanil|alfentanil|mesh-list
2645834|NCT02022488|Analgesics|analgesics|mesh-ancestor
2645835|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
2645836|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645837|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645838|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2645839|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2645840|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
2645841|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
2645842|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645843|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2645844|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2645845|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645846|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645847|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2645848|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2645849|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2645850|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2645851|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2645852|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
2645853|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
2645854|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2645855|NCT02022488|Narcotics|narcotics|mesh-ancestor
2645856|NCT02022527|Aspirin|aspirin|mesh-list
2645857|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
2645858|NCT02022527|Salicylates|salicylates|mesh-list
2645859|NCT02022527|Warfarin|warfarin|mesh-list
2645860|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2645861|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2645862|NCT02022527|Analgesics|analgesics|mesh-ancestor
2645863|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
2645864|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645865|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645866|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2645867|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2645868|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2645869|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2645870|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645871|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2645872|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2645873|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645874|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
2645875|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
2645876|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645877|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
2645878|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
2645879|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
2645880|NCT02022540|Ranibizumab|ranibizumab|mesh-list
2645881|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2176803|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
2176804|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176805|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176806|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176807|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2176808|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2645882|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2645883|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2645884|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2645885|NCT02022540|Growth Substances|growth substances|mesh-ancestor
2645886|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645887|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
2645888|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645889|NCT02022592|Midazolam|midazolam|mesh-list
2645890|NCT02022592|Lormetazepam|lormetazepam|mesh-list
2645891|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2645892|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2645893|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645894|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645895|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2645896|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2645897|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2645898|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2645899|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
2645900|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
2645901|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
2645902|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
2645903|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645904|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645905|NCT02022644|Irinotecan|irinotecan|mesh-list
2645906|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2645907|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2645908|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645909|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645910|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645911|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
2645912|NCT02022709|Sertraline|sertraline|mesh-list
2645913|NCT02022709|Fluoxetine|fluoxetine|mesh-list
2645914|NCT02022709|Paroxetine|paroxetine|mesh-list
2645915|NCT02022709|Citalopram|citalopram|mesh-list
2645916|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
2645917|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2645918|NCT02022709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2645919|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2645920|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2645921|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645922|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2645923|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
2645924|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645925|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2645926|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2645927|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2645928|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645929|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2645930|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2645931|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645932|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2645933|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2645934|NCT02022722|Triamcinolone|triamcinolone|mesh-list
2645935|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2645936|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2645937|NCT02022722|Bupivacaine|bupivacaine|mesh-list
2645938|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2645939|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
2645940|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
2645941|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2645942|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645943|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
2645944|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2645945|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2645946|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
2645947|NCT02022722|Hormones|hormones|mesh-ancestor
2645948|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2645949|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2645950|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
2176809|NCT00002185|Nelfinavir|nelfinavir|mesh-list
2176810|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176811|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176812|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176813|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176814|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176815|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176816|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176817|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
2176818|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176819|NCT00002186|Acyclovir|acyclovir|mesh-list
2176820|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
2176821|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176822|NCT00002187|Fomivirsen|fomivirsen|mesh-list
2176823|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
2176824|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176825|NCT00002188|Alitretinoin|alitretinoin|mesh-list
2176826|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176827|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
2176828|NCT00002189|Paclitaxel|paclitaxel|mesh-list
2176829|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2176830|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176831|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
2176832|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
2176833|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
2176834|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176835|NCT00002190|Lamivudine|lamivudine|mesh-list
2176836|NCT00002190|Zidovudine|zidovudine|mesh-list
2176837|NCT00002190|Saquinavir|saquinavir|mesh-list
2176838|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176839|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176840|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176841|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176842|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
2176843|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645951|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2645952|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645953|NCT02022761|Laninamivir|laninamivir|mesh-list
2645954|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
2645955|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645956|NCT02022852|Capecitabine|capecitabine|mesh-list
2645957|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2645958|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
2645959|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645960|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645961|NCT02022917|Bevacizumab|bevacizumab|mesh-list
2645962|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2645963|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645964|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2645965|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2645966|NCT02022917|Growth Substances|growth substances|mesh-ancestor
2645967|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645968|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
2645969|NCT02022930|Triamcinolone|triamcinolone|mesh-list
2645970|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2645971|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2176844|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176845|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176846|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
2176847|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176848|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176849|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176850|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2176851|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176852|NCT00002191|Albendazole|albendazole|mesh-list
2176853|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
2176854|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2176855|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176856|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
2176857|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2176858|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2176859|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
2176860|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
2176861|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
2645972|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2645973|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2176862|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645974|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
2645975|NCT02022930|Hormones|hormones|mesh-ancestor
2645976|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2645977|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2645978|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2645979|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
2645980|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176863|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2176864|NCT00002192|Azithromycin|azithromycin|mesh-list
2176865|NCT00002192|Clarithromycin|clarithromycin|mesh-list
2176866|NCT00002192|Ethambutol|ethambutol|mesh-list
2176867|NCT00002192|Rifapentine|rifapentine|mesh-list
2176868|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176869|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176870|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2176871|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176872|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176873|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2176874|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176875|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
2176876|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2645981|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645987|NCT02023021|Gemcitabine|gemcitabine|mesh-list
2645988|NCT02023021|Paclitaxel|paclitaxel|mesh-list
2645989|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2645990|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2645991|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
2645992|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
2645993|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
2645994|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2645995|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2645996|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
2645997|NCT02023021|Antiviral Agents|antiviral agents|mesh-ancestor
2645998|NCT02023021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2645999|NCT02023021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646000|NCT02023021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646001|NCT02023021|Immunologic Factors|immunologic factors|mesh-ancestor
2646002|NCT02023021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646003|NCT02023047|Nifedipine|nifedipine|mesh-list
2646004|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2646005|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2646006|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646007|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2646008|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646009|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
2646010|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
2176877|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
2176878|NCT00002193|Amprenavir|amprenavir|mesh-list
2176879|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2176880|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
2176881|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176882|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176883|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176884|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176885|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176886|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176887|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176888|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2646011|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2646012|NCT02023086|Tropicamide|tropicamide|mesh-list
2646013|NCT02023086|Mydriatics|mydriatics|mesh-list
2646014|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
2646015|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646016|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646017|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2646018|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2646019|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
2646020|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646021|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646022|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
2646023|NCT02023164|Promethazine|promethazine|mesh-list
2176889|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176890|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
2176891|NCT00002194|Clarithromycin|clarithromycin|mesh-list
2176892|NCT00002194|Erythromycin|erythromycin|mesh-list
2176893|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
2176894|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2176895|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
2176896|NCT00002194|Nevirapine|nevirapine|mesh-list
2176897|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176898|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176899|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2646024|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2646025|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2646026|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2646027|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646028|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
2646029|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
2176900|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176901|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176902|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2176903|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176904|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176905|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2646030|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
2646031|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646032|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
2646033|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
2646034|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2646035|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2646036|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
2176906|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
2176907|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176908|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176909|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2176910|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2176911|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2176912|NCT00002195|Lamivudine|lamivudine|mesh-list
2176913|NCT00002195|Zidovudine|zidovudine|mesh-list
2176914|NCT00002195|Amprenavir|amprenavir|mesh-list
2176915|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176916|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176917|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176918|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176919|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
2176920|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646037|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
2646038|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646039|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646040|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2646041|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
2646042|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
2646043|NCT02023359|Everolimus|everolimus|mesh-list
2646044|NCT02023359|Exemestane|exemestane|mesh-list
2646045|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646046|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646047|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
2646048|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646049|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2646050|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2646051|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646052|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646053|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2646054|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
2646055|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2646056|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
2646057|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
2646058|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2646059|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
2646060|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646061|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646062|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2646063|NCT02023450|Ritonavir|ritonavir|mesh-list
2176921|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2646064|NCT02023450|Saquinavir|saquinavir|mesh-list
2646065|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2646066|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2646067|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
2646068|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646069|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646070|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2646071|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2646072|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
2646073|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646074|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2646075|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2646076|NCT02023463|Leuprolide|leuprolide|mesh-list
2176922|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176923|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
2176924|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2176925|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
2176926|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2176927|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176928|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176929|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176930|NCT00002197|Abacavir|abacavir|mesh-list
2176931|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176932|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176933|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646077|NCT02023463|Goserelin|goserelin|mesh-list
2646078|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2646079|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
2646080|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2646081|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646082|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2646083|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646084|NCT02023554|Azithromycin|azithromycin|mesh-list
2646085|NCT02023554|Theophylline|theophylline|mesh-list
2646086|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2646087|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646088|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2646089|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
2646090|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646091|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646092|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2646093|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
2646094|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2646095|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646096|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646097|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
2646098|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2646099|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2646100|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
2646101|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646102|NCT02023567|Serotonin|serotonin|mesh-list
2646103|NCT02023567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2646104|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2646105|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
2646106|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646107|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646108|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646109|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2646110|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2646111|NCT02023593|Leucovorin|leucovorin|mesh-list
2646112|NCT02023593|Fluorouracil|fluorouracil|mesh-list
2646113|NCT02023593|Irinotecan|irinotecan|mesh-list
2646114|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
2646115|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646116|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2646117|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646118|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646119|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
2646120|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646121|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2646122|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2646123|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646124|NCT02023593|Antidotes|antidotes|mesh-ancestor
2646125|NCT02023593|Protective Agents|protective agents|mesh-ancestor
2646126|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
2646127|NCT02023593|Vitamins|vitamins|mesh-ancestor
2646128|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
2646129|NCT02023684|Lidocaine|lidocaine|mesh-list
2646130|NCT02023684|Ropivacaine|ropivacaine|mesh-list
2646131|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
2646132|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
2646133|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2646134|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646135|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
2646136|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646137|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2646138|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2646139|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2646140|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2646141|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646142|NCT02023710|Paclitaxel|paclitaxel|mesh-list
2646143|NCT02023710|Bevacizumab|bevacizumab|mesh-list
2646144|NCT02023710|Carboplatin|carboplatin|mesh-list
2646145|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2646146|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646147|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
2646148|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
2646149|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
2646150|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646151|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2646152|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2646153|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2646154|NCT02023710|Growth Substances|growth substances|mesh-ancestor
2646155|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646156|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
2646157|NCT02023840|Metronidazole|metronidazole|mesh-list
2646158|NCT02023840|Erythritol|erythritol|mesh-list
2646159|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646160|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2646161|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2646162|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2646163|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
2646164|NCT02023853|Metronidazole|metronidazole|mesh-list
2646165|NCT02023853|Erythritol|erythritol|mesh-list
2646166|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646167|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2646168|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2646169|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2646170|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
2646171|NCT02023892|Atorvastatin|atorvastatin|mesh-list
2646172|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2646173|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2646174|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
2646175|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646176|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2646177|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2646178|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646179|NCT02023931|Sulforaphane|sulforaphane|mesh-list
2646180|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2646181|NCT02023931|Protective Agents|protective agents|mesh-ancestor
2646182|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646183|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646187|NCT02024009|Gemcitabine|gemcitabine|mesh-list
2646188|NCT02024009|Nelfinavir|nelfinavir|mesh-list
2646189|NCT02024009|Paclitaxel|paclitaxel|mesh-list
2646190|NCT02024009|Capecitabine|capecitabine|mesh-list
2646191|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2646192|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646193|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
2646194|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
2646195|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
2646196|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646197|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2646198|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
2646199|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
2646200|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646201|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646202|NCT02024009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646203|NCT02024009|Immunologic Factors|immunologic factors|mesh-ancestor
2646204|NCT02024009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2176934|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646205|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2646206|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2646207|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
2646208|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2646209|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2646210|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
2646211|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
2646212|NCT02024022|Cathartics|cathartics|mesh-ancestor
2646213|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2176935|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
2176936|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176937|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176938|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176939|NCT00002198|Abacavir|abacavir|mesh-list
2176940|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176941|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176942|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176943|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176944|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
2176945|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176946|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176947|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176948|NCT00002199|Lamivudine|lamivudine|mesh-list
2176949|NCT00002199|Zidovudine|zidovudine|mesh-list
2176950|NCT00002199|Abacavir|abacavir|mesh-list
2176951|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2176952|NCT00002199|Indinavir|indinavir|mesh-list
2176953|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176954|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176955|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176956|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176957|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
2176958|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176959|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176960|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176961|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
2176962|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176963|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2646214|NCT02024152|Cetirizine|cetirizine|mesh-list
2646215|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2646216|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2176964|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176965|NCT00002200|Abacavir|abacavir|mesh-list
2176966|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2176967|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2176968|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176969|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176970|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
2176971|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176972|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176973|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2646217|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2646218|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
2646219|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
2646220|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646221|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646222|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646223|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
2646224|NCT02024217|Tegafur|tegafur|mesh-list
2646225|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646226|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2646227|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
2646228|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646229|NCT02024230|Warfarin|warfarin|mesh-list
2176974|NCT00002201|Ritonavir|ritonavir|mesh-list
2176975|NCT00002201|Nelfinavir|nelfinavir|mesh-list
2176976|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176977|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176978|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176979|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176980|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176981|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176982|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2646230|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
2646231|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
2646232|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2176983|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
2646233|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
2646234|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2646235|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
2646236|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646237|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646238|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
2646239|NCT02024256|Analgesics|analgesics|mesh-ancestor
2646240|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
2646241|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646242|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646243|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
2646244|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2646245|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2646246|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
2646247|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2646248|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2646249|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646250|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2646251|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
2646252|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2646253|NCT02024295|Choline|choline|mesh-list
2176984|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176985|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2176986|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2176987|NCT00002202|Indinavir|indinavir|mesh-list
2176988|NCT00002202|Amprenavir|amprenavir|mesh-list
2176989|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2176990|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2176991|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
2176992|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2176993|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2176994|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2176995|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2176996|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
2646254|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
2646255|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
2646256|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2646257|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
2646258|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646259|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2646260|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2646261|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
2646262|NCT02024308|Cytarabine|cytarabine|mesh-list
2646263|NCT02024308|Fludarabine|fludarabine|mesh-list
2646264|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646265|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2646266|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
2646267|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646268|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646269|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
2646270|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646271|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
2646272|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646273|NCT02024334|Leflunomide|leflunomide|mesh-list
2646274|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646275|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646276|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2176997|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2176998|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2176999|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
2177000|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2177001|NCT00002203|Lamivudine|lamivudine|mesh-list
2177002|NCT00002203|Zidovudine|zidovudine|mesh-list
2177003|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2177004|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177005|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177006|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177007|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177008|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
2177009|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177010|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2646277|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
2646278|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646279|NCT02024373|Atorvastatin|atorvastatin|mesh-list
2646280|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2646281|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2177011|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177012|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
2177013|NCT00002205|Abacavir|abacavir|mesh-list
2177014|NCT00002205|Amprenavir|amprenavir|mesh-list
2177015|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177016|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177017|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177018|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177019|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
2177020|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646282|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
2646283|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646284|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2646285|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2646286|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646287|NCT02024425|Antioxidants|antioxidants|mesh-list
2646288|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646289|NCT02024425|Protective Agents|protective agents|mesh-ancestor
2646290|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646291|NCT02024555|Azithromycin|azithromycin|mesh-list
2646292|NCT02024555|Levofloxacin|levofloxacin|mesh-list
2646293|NCT02024555|Ofloxacin|ofloxacin|mesh-list
2177021|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177022|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177023|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2177024|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
2177025|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2177026|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177027|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177028|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177029|NCT00002206|Adefovir|adefovir|mesh-list
2177030|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2177031|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
2177032|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177033|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177034|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177035|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177036|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646294|NCT02024555|Rifampin|rifampin|mesh-list
2646295|NCT02024555|Ethambutol|ethambutol|mesh-list
2646296|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2646297|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646298|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2646299|NCT02024555|Renal Agents|renal agents|mesh-ancestor
2646300|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2646301|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2646302|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646303|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646304|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646305|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2646306|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2646307|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2646308|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
2646309|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
2646310|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2646311|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2646312|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2646313|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2646314|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2646315|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2646316|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2646317|NCT02024568|Pregabalin|pregabalin|mesh-list
2646318|NCT02024568|Analgesics|analgesics|mesh-ancestor
2646319|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
2646320|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646321|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646322|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
2646323|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2646324|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2646325|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177037|NCT00002207|Stavudine|stavudine|mesh-list
2177038|NCT00002207|Didanosine|didanosine|mesh-list
2646326|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2646327|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2646328|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2646329|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2646330|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2646331|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
2646332|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2646333|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
2646334|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
2646335|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2422479|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
2422480|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2422481|NCT00817375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2646336|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646337|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2646338|NCT02024594|Analgesics|analgesics|mesh-ancestor
2646339|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
2646340|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646341|NCT02024633|Gemcitabine|gemcitabine|mesh-list
2646342|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2177039|NCT00002207|Antimetabolites|antimetabolites|mesh-ancestor
2177040|NCT00002207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177041|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177042|NCT00002207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177043|NCT00002207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177044|NCT00002207|Antiviral Agents|antiviral agents|mesh-ancestor
2177045|NCT00002207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177046|NCT00002207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177047|NCT00002207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177048|NCT00002208|Lamivudine|lamivudine|mesh-list
2177049|NCT00002208|Zidovudine|zidovudine|mesh-list
2177050|NCT00002208|Stavudine|stavudine|mesh-list
2177051|NCT00002208|Indinavir|indinavir|mesh-list
2177052|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177053|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177054|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177055|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177056|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
2177057|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177058|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177059|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177060|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
2177061|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177062|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177063|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177064|NCT00002210|Delavirdine|delavirdine|mesh-list
2177065|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177066|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177067|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177068|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177069|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
2177070|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177071|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177072|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177073|NCT00002211|Stavudine|stavudine|mesh-list
2177074|NCT00002211|Didanosine|didanosine|mesh-list
2177075|NCT00002211|Delavirdine|delavirdine|mesh-list
2177076|NCT00002211|Nelfinavir|nelfinavir|mesh-list
2422482|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2422483|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422484|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422485|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422486|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
2422487|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422488|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2422489|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2422490|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2422491|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422492|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2422493|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2422494|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
2422495|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
2422496|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2422497|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2177077|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
2177078|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177079|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177080|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177081|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177082|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
2177083|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646343|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
2646344|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646345|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646346|NCT02024633|Antiviral Agents|antiviral agents|mesh-ancestor
2646347|NCT02024633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646348|NCT02024633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646349|NCT02024633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646350|NCT02024633|Immunologic Factors|immunologic factors|mesh-ancestor
2646351|NCT02024633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646352|NCT02024659|Budesonide|budesonide|mesh-list
2646353|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2646354|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2646355|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
2646356|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646357|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646358|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2646359|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
2646360|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
2646361|NCT02024659|Hormones|hormones|mesh-ancestor
2646362|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2646363|NCT02024841|Docetaxel|docetaxel|mesh-list
2646364|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646365|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
2646366|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
2646367|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
2646368|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646369|NCT02024906|Caseins|caseins|mesh-list
2646370|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
2646371|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
2646372|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646373|NCT02024919|Diltiazem|diltiazem|mesh-list
2646374|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2646375|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2646376|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2646377|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646378|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2646379|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646380|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
2646381|NCT02024945|Propiverine|propiverine|mesh-list
2646382|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
2646383|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
2646384|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646385|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646386|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2646387|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2646388|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
2646389|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646390|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646391|NCT02024945|Urological Agents|urological agents|mesh-ancestor
2177084|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177085|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177086|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177087|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177088|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177089|NCT00002212|Bexarotene|bexarotene|mesh-list
2177090|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2177091|NCT00002213|Efavirenz|efavirenz|mesh-list
2177092|NCT00002213|Abacavir|abacavir|mesh-list
2177093|NCT00002213|Amprenavir|amprenavir|mesh-list
2177094|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177095|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177096|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177097|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177098|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
2177099|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177100|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2177101|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177102|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2177103|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2177104|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2177105|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2177106|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177107|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2646392|NCT02024984|Clomiphene|clomiphene|mesh-list
2646393|NCT02024984|Enclomiphene|enclomiphene|mesh-list
2646394|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
2646395|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2646396|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
2646397|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2646398|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646399|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2646400|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
2646401|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2646402|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2646403|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2646404|NCT02025010|Prednisone|prednisone|mesh-list
2646405|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
2646406|NCT02025010|Glucocorticoids|glucocorticoids|mesh-list
2646407|NCT02025010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2646408|NCT02025010|Hormones|hormones|mesh-ancestor
2646409|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2646410|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646411|NCT02025010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2646412|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646413|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2646414|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646415|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646416|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
2646417|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2646418|NCT02025023|Triamcinolone|triamcinolone|mesh-list
2646419|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2646420|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2646421|NCT02025023|Fluorouracil|fluorouracil|mesh-list
2646422|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2646423|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
2646424|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646425|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2646426|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646427|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646428|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
2646429|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646430|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2646431|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
2646432|NCT02025023|Hormones|hormones|mesh-ancestor
2646433|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2646434|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646435|NCT02025036|Capecitabine|capecitabine|mesh-list
2646436|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
2646437|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2646438|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
2646439|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646440|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646441|NCT02025140|Anesthetics|anesthetics|mesh-list
2646442|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2646443|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646444|NCT02025166|Acetaminophen|acetaminophen|mesh-list
2646445|NCT02025166|Lornoxicam|lornoxicam|mesh-list
2646446|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2646447|NCT02025166|Analgesics|analgesics|mesh-ancestor
2646448|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
2646449|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646450|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646451|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
2646452|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2646453|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2646454|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2646455|NCT02025192|Capecitabine|capecitabine|mesh-list
2177108|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2177109|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
2177110|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2177111|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2646456|NCT02025192|Trastuzumab|trastuzumab|mesh-list
2177112|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177113|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177114|NCT00002214|Capravirine|capravirine|mesh-list
2177115|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177116|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177117|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177118|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177119|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
2177120|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177121|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177122|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177123|NCT00002215|Nelfinavir|nelfinavir|mesh-list
2177124|NCT00002215|Emivirine|emivirine|mesh-list
2177125|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177126|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177127|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177128|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177129|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177130|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177131|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177132|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
2177133|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177134|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177135|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177136|NCT00002216|Lamivudine|lamivudine|mesh-list
2177137|NCT00002216|Zidovudine|zidovudine|mesh-list
2177138|NCT00002216|Abacavir|abacavir|mesh-list
2177139|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2177140|NCT00002216|Nelfinavir|nelfinavir|mesh-list
2177141|NCT00002216|Amprenavir|amprenavir|mesh-list
2177142|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177143|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177144|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177145|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177146|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
2177147|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177148|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177149|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177150|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
2646457|NCT02025192|Tucatinib|tucatinib|mesh-list
2646458|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2646459|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
2646460|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646461|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646462|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2646463|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2646464|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646465|NCT02025218|Gefitinib|gefitinib|mesh-list
2646466|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646467|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2646468|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646469|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646470|NCT02025348|Metoprolol|metoprolol|mesh-list
2646471|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2646472|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2646473|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
2646474|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
2646475|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646476|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646477|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2646478|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2646479|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2646480|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
2646481|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646482|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177151|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177152|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177153|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177154|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2177155|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
2177156|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2177157|NCT00002217|Lamivudine|lamivudine|mesh-list
2177158|NCT00002217|Zidovudine|zidovudine|mesh-list
2177159|NCT00002217|Abacavir|abacavir|mesh-list
2177160|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2646483|NCT02025361|Lidocaine|lidocaine|mesh-list
2646484|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
2646485|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
2646486|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2646487|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646488|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
2646489|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2177161|NCT00002217|Amprenavir|amprenavir|mesh-list
2177162|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177163|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177164|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177165|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177166|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
2177167|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177168|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177169|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2646490|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2646491|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2646492|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2646493|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2646494|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646495|NCT02025374|Bupivacaine|bupivacaine|mesh-list
2646496|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
2646497|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
2646498|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
2646499|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2646500|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646501|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
2646502|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646503|NCT02025465|Metoprolol|metoprolol|mesh-list
2646504|NCT02025465|Diltiazem|diltiazem|mesh-list
2646505|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2646506|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2646507|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
2646508|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
2646509|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646510|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646511|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2646512|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2646513|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2646514|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
2646515|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646516|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646517|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2646518|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2646519|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2646520|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
2646521|NCT02025491|Amphotericin B|amphotericin b|mesh-list
2646522|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2646523|NCT02025491|Amebicides|amebicides|mesh-ancestor
2646524|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2646525|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2646526|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646527|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2646528|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
2646529|NCT02025608|Pramipexole|pramipexole|mesh-list
2646530|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
2646531|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646532|NCT02025608|Protective Agents|protective agents|mesh-ancestor
2646533|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646534|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2646535|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2646536|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
2646537|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
2646538|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646539|NCT02025712|Everolimus|everolimus|mesh-list
2646540|NCT02025712|Exemestane|exemestane|mesh-list
2646541|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646542|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646543|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
2646544|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646545|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2646546|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2646547|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646548|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177170|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
2177171|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2177172|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
2177173|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2177174|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177175|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2646549|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2646550|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
2646551|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2646552|NCT02025803|Capecitabine|capecitabine|mesh-list
2646553|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2646554|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
2646555|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646556|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646557|NCT02025855|Methadone|methadone|mesh-list
2646558|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2646559|NCT02025855|Narcotics|narcotics|mesh-ancestor
2646560|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2646561|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646562|NCT02025855|Analgesics|analgesics|mesh-ancestor
2646563|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
2646564|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646565|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
2177176|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177177|NCT00002219|Nelfinavir|nelfinavir|mesh-list
2177178|NCT00002219|Adefovir|adefovir|mesh-list
2177179|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2177180|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177181|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177182|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177183|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177184|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177185|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177186|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177187|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
2177188|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177189|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177190|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177191|NCT00002220|Efavirenz|efavirenz|mesh-list
2177192|NCT00002220|Adefovir|adefovir|mesh-list
2177193|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2177194|NCT00002220|Indinavir|indinavir|mesh-list
2177195|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177196|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177197|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177198|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177199|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
2177200|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177201|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2177202|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177203|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2177204|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2177205|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2177206|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2177207|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177208|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177209|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177210|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2646566|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
2646567|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
2646568|NCT02025868|Darunavir|darunavir|mesh-list
2646569|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2646570|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2646571|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
2646572|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646573|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2646574|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2646575|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646576|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646577|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2646578|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2646579|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
2646580|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
2646581|NCT02025881|Thiotepa|thiotepa|mesh-list
2646582|NCT02025881|Carboplatin|carboplatin|mesh-list
2646583|NCT02025881|Etoposide|etoposide|mesh-list
2646584|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646585|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
2646586|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646587|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2646588|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2646589|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
2646590|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646591|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646592|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2646593|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2646594|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2646595|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2646596|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646597|NCT02025998|Ibudilast|ibudilast|mesh-list
2646598|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2646599|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
2646600|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646601|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646602|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2646603|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
2646604|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2646605|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646606|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646607|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2646608|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
2646609|NCT02026050|Dexamethasone|dexamethasone|mesh-list
2646610|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
2646611|NCT02026050|BB 1101|bb 1101|mesh-list
2646612|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2646613|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
2646614|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
2646615|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646616|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646617|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2646618|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
2177211|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177212|NCT00002222|Valganciclovir|valganciclovir|mesh-list
2177213|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
2177214|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177215|NCT00002223|Ritonavir|ritonavir|mesh-list
2177216|NCT00002223|Indinavir|indinavir|mesh-list
2177217|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177218|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177219|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177220|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177221|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177222|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2646619|NCT02026050|Hormones|hormones|mesh-ancestor
2646620|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2646621|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2646622|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646623|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
2646624|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646625|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646626|NCT02026219|Clopidogrel|clopidogrel|mesh-list
2646627|NCT02026219|Ticagrelor|ticagrelor|mesh-list
2646628|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2646629|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2646630|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2646631|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2646632|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
2646633|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646634|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646635|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646636|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
2646637|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
2646638|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2646639|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2646640|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646641|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646642|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646643|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2646644|NCT02026310|Metformin|metformin|mesh-list
2646645|NCT02026310|Glimepiride|glimepiride|mesh-list
2646646|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2646647|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646648|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2646649|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646650|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
2646651|NCT02026349|Favipiravir|favipiravir|mesh-list
2646652|NCT02026349|Antiviral Agents|antiviral agents|mesh-ancestor
2646653|NCT02026349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646654|NCT02026479|Dexamethasone|dexamethasone|mesh-list
2646655|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
2646656|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2646657|NCT02026479|BB 1101|bb 1101|mesh-list
2646658|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2646659|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
2646660|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
2646661|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646662|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646663|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2646664|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
2646665|NCT02026479|Hormones|hormones|mesh-ancestor
2646666|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2646667|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2646668|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646669|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
2646670|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646671|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177223|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177224|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
2177225|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177226|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2177227|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177228|NCT00002224|Stavudine|stavudine|mesh-list
2177229|NCT00002224|Didanosine|didanosine|mesh-list
2177230|NCT00002224|Nelfinavir|nelfinavir|mesh-list
2177231|NCT00002224|Antimetabolites|antimetabolites|mesh-ancestor
2177232|NCT00002224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177233|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177234|NCT00002224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177235|NCT00002224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177236|NCT00002224|Antiviral Agents|antiviral agents|mesh-ancestor
2177237|NCT00002224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177238|NCT00002224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177239|NCT00002224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177240|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177241|NCT00002224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177242|NCT00002224|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177243|NCT00002225|Efavirenz|efavirenz|mesh-list
2177244|NCT00002225|Stavudine|stavudine|mesh-list
2177245|NCT00002225|Didanosine|didanosine|mesh-list
2177246|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177247|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177248|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177249|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177250|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
2177251|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177252|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2177253|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177254|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2177255|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2177256|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2177257|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2646672|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
2646673|NCT02026492|Miotics|miotics|mesh-ancestor
2646674|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
2177258|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
2177259|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177260|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177261|NCT00002226|Semaxinib|semaxinib|mesh-list
2177262|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2177263|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2177264|NCT00002226|Growth Substances|growth substances|mesh-ancestor
2177265|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177266|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
2177267|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2177268|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2646675|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646676|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646677|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2646678|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2646679|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
2646680|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2646681|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2646682|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
2646683|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646684|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646685|NCT02026505|Bortezomib|bortezomib|mesh-list
2646686|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646687|NCT02026518|Vitamin D|vitamin d|mesh-list
2646688|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
2646689|NCT02026518|Vitamins|vitamins|mesh-ancestor
2177269|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177270|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177271|NCT00002227|Lamivudine|lamivudine|mesh-list
2177272|NCT00002227|Efavirenz|efavirenz|mesh-list
2177273|NCT00002227|Stavudine|stavudine|mesh-list
2177274|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177275|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177276|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177277|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177278|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
2646690|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
2646691|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646692|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2646693|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2646694|NCT02026583|Simvastatin|simvastatin|mesh-list
2646695|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2646696|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2646697|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
2646698|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646699|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2646700|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2646701|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646702|NCT02026765|Heparin|heparin|mesh-list
2646703|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
2646704|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2646705|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2646706|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646707|NCT02026778|Betahistine|betahistine|mesh-list
2646708|NCT02026778|Ondansetron|ondansetron|mesh-list
2646709|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
2646710|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
2646711|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646712|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646713|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2646714|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
2646715|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
2646716|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2646717|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
2646718|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646719|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646720|NCT02026778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2646721|NCT02026778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2646722|NCT02026778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2646723|NCT02026778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2646724|NCT02026778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2646725|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
2646726|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
2646727|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
2646728|NCT02026817|Metformin|metformin|mesh-list
2646729|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2646730|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2646731|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646732|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2646733|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2646734|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
2646735|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646736|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2646737|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2646738|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646739|NCT02026856|Selenious Acid|selenious acid|mesh-list
2646740|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
2646741|NCT02026856|Trace Elements|trace elements|mesh-ancestor
2646742|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
2646743|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646744|NCT02026869|Metformin|metformin|mesh-list
2646745|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2646746|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177279|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177280|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177281|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177282|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2177283|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177284|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2177285|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2177286|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2177287|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2177288|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
2177289|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
2177290|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2177291|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2177292|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646747|NCT02026921|Carboplatin|carboplatin|mesh-list
2646748|NCT02026921|Docetaxel|docetaxel|mesh-list
2646749|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646750|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
2646751|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
2646752|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
2646753|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646754|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
2646755|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
2646756|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646757|NCT02026973|Fulvestrant|fulvestrant|mesh-list
2646758|NCT02026973|Anastrozole|anastrozole|mesh-list
2646759|NCT02026973|Somatostatin|somatostatin|mesh-list
2646760|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2646761|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646762|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2646763|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2646764|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
2646765|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2646766|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646767|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2646768|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2646769|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646770|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646771|NCT02026973|Hormones|hormones|mesh-ancestor
2646772|NCT02027064|Interferons|interferons|mesh-list
2646773|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
2646774|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646775|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
2646776|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646777|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
2646778|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646779|NCT02027103|Metformin|metformin|mesh-list
2646780|NCT02027103|Pioglitazone|pioglitazone|mesh-list
2646781|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2646782|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646783|NCT02027220|Dexamethasone|dexamethasone|mesh-list
2646784|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
2646785|NCT02027220|Bortezomib|bortezomib|mesh-list
2646786|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646787|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
2177293|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177294|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177295|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
2177296|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177297|NCT00002229|Saquinavir|saquinavir|mesh-list
2177298|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177299|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177300|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177301|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177302|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177303|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177304|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177305|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
2177306|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177307|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2646788|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646789|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2177308|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177309|NCT00002230|Efavirenz|efavirenz|mesh-list
2177310|NCT00002230|Stavudine|stavudine|mesh-list
2177311|NCT00002230|Didanosine|didanosine|mesh-list
2177312|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
2177313|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177314|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177315|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177316|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177317|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
2177318|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177319|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2177320|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177321|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2177322|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2177323|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2646790|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2646791|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
2646792|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646793|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646794|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2646795|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2646796|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
2646797|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
2646798|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646799|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2646800|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
2646801|NCT02027220|Hormones|hormones|mesh-ancestor
2646802|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2646803|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2646804|NCT02027298|Abatacept|abatacept|mesh-list
2646805|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2646806|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646807|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646808|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646809|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
2646810|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646811|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2646812|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
2646813|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
2646814|NCT02027324|Povidone|povidone|mesh-list
2646815|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2646816|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646817|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
2646818|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
2646819|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
2646820|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
2646821|NCT02027337|Drospirenone|drospirenone|mesh-list
2646822|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2646823|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2646824|NCT02027337|Cyproterone|cyproterone|mesh-list
2646825|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
2646826|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2646827|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2646828|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2646829|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
2646830|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2646831|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646832|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2646833|NCT02027337|Estrogens|estrogens|mesh-ancestor
2646834|NCT02027337|Hormones|hormones|mesh-ancestor
2646835|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2646836|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2646837|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
2646838|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2646839|NCT02027337|Diuretics|diuretics|mesh-ancestor
2646840|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
2646841|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
2646842|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646843|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2177324|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2177325|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2177326|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
2177327|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
2646844|NCT02027363|Capecitabine|capecitabine|mesh-list
2646845|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2646846|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
2177328|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177329|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177330|NCT00002233|Lamivudine|lamivudine|mesh-list
2177331|NCT00002233|Abacavir|abacavir|mesh-list
2177332|NCT00002233|Indinavir|indinavir|mesh-list
2177333|NCT00002233|Amprenavir|amprenavir|mesh-list
2177334|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177335|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177336|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177337|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177338|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
2177339|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177340|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177341|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177342|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177343|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177344|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177345|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2177346|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
2646847|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646848|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646849|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
2646850|NCT02027454|Cabotegravir|cabotegravir|mesh-list
2646851|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2646852|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177347|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2177348|NCT00002234|Lamivudine|lamivudine|mesh-list
2177349|NCT00002234|Efavirenz|efavirenz|mesh-list
2177350|NCT00002234|Didanosine|didanosine|mesh-list
2177351|NCT00002234|Adefovir|adefovir|mesh-list
2177352|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2177353|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177354|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177355|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646853|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2646854|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2646855|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646856|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646857|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646858|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2646859|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2646860|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2646861|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2646862|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
2646863|NCT02027493|Interferons|interferons|mesh-list
2646864|NCT02027493|Ribavirin|ribavirin|mesh-list
2646865|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
2646866|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
2646867|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2646868|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646869|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
2646870|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646871|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
2646872|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646873|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
2646874|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646875|NCT02027532|Vancomycin|vancomycin|mesh-list
2646876|NCT02027532|Cefazolin|cefazolin|mesh-list
2646877|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2646878|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646879|NCT02027675|Micronutrients|micronutrients|mesh-list
2646880|NCT02027675|Trace Elements|trace elements|mesh-list
2646881|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646882|NCT02027753|Metformin|metformin|mesh-list
2646883|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
2646884|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2646885|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2646886|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646887|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
2646888|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177356|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177357|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
2177358|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646889|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646890|NCT02027792|Diclofenac|diclofenac|mesh-list
2646891|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2646892|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2646893|NCT02027792|Analgesics|analgesics|mesh-ancestor
2646894|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
2646895|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646896|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646897|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2646898|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2646899|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2646900|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646901|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646902|NCT02027870|Sirolimus|sirolimus|mesh-list
2646903|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2646904|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646905|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2646906|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646907|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
2646908|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646909|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
2646910|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646911|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
2646912|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
2646913|NCT02027922|Protective Agents|protective agents|mesh-ancestor
2646914|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646915|NCT02027935|Aldesleukin|aldesleukin|mesh-list
2646916|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
2646917|NCT02027935|Ipilimumab|ipilimumab|mesh-list
2646918|NCT02027935|Interleukin-2|interleukin-2|mesh-list
2646919|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2646920|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
2646921|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646922|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2646923|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2646924|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
2646925|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646926|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646927|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2646928|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2646929|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2646930|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2646931|NCT02027935|Analgesics|analgesics|mesh-ancestor
2646932|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
2646933|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2646934|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2646935|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2646936|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
2646937|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2646938|NCT02027961|Durvalumab|durvalumab|mesh-list
2646939|NCT02027961|Trametinib|trametinib|mesh-list
2646940|NCT02027961|Dabrafenib|dabrafenib|mesh-list
2646941|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2646942|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2646943|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2646944|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646945|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646946|NCT02027987|Valproic Acid|valproic acid|mesh-list
2177359|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177360|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177361|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2177362|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177363|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2177364|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2177365|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2177366|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2177367|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
2177368|NCT00002235|Efavirenz|efavirenz|mesh-list
2177369|NCT00002235|Nelfinavir|nelfinavir|mesh-list
2177370|NCT00002235|Indinavir|indinavir|mesh-list
2177371|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177372|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177373|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646947|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
2646948|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646949|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646950|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
2646951|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646952|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646953|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
2646954|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2646955|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2646956|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2646957|NCT02028026|Citalopram|citalopram|mesh-list
2646958|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2646959|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2646960|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2646961|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2646962|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646963|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2646964|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
2646965|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646966|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2646967|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
2646968|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2646969|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2646970|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2646971|NCT02028078|Insulin|insulin|mesh-list
2646972|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2646973|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2646974|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646975|NCT02028234|Omeprazole|omeprazole|mesh-list
2646976|NCT02028234|Pantoprazole|pantoprazole|mesh-list
2646977|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2646978|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2646979|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2646980|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2646981|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646982|NCT02028260|Modafinil|modafinil|mesh-list
2646983|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2646984|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2646985|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2646986|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2646987|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2646988|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2646989|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2646990|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2646991|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
2646992|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2646993|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2177374|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177375|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
2177376|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177377|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2177378|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177379|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2646994|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2646995|NCT02028338|Dapivirine|dapivirine|mesh-list
2646996|NCT02028338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177380|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2177381|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2177382|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2177383|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177384|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177385|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177386|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177387|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177388|NCT00002236|Zidovudine|zidovudine|mesh-list
2177389|NCT00002236|Delavirdine|delavirdine|mesh-list
2177390|NCT00002236|Indinavir|indinavir|mesh-list
2177391|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
2177392|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177393|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177394|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2646997|NCT02028338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2646998|NCT02028338|Antiviral Agents|antiviral agents|mesh-ancestor
2646999|NCT02028338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647000|NCT02028364|Everolimus|everolimus|mesh-list
2647001|NCT02028364|Exemestane|exemestane|mesh-list
2647002|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647003|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2177395|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177396|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
2177397|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177398|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177399|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177400|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177401|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177402|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177403|NCT00002238|Interferons|interferons|mesh-list
2177404|NCT00002238|Zidovudine|zidovudine|mesh-list
2177405|NCT00002238|Interferon-beta|interferon-beta|mesh-list
2177406|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
2177407|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2177408|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
2177409|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177410|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
2177411|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177412|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177413|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177414|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177415|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177416|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177417|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
2177418|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177419|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2177420|NCT00002239|Ritonavir|ritonavir|mesh-list
2177421|NCT00002239|Amprenavir|amprenavir|mesh-list
2177422|NCT00002239|Abacavir|abacavir|mesh-list
2177423|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
2177424|NCT00002239|Efavirenz|efavirenz|mesh-list
2177425|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177426|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177427|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
2647004|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
2647005|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647006|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2647007|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2647008|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647009|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647010|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2647011|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
2647012|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2647013|NCT02028403|BMS-936559|bms-936559|mesh-list
2647014|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2177428|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177429|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177430|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177431|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177432|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
2177433|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177434|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2177435|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177436|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177437|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177438|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2177439|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2177440|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2647015|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2647016|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647017|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
2647018|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647019|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
2647020|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
2647021|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647022|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2647023|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
2647024|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
2647025|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2647026|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2647027|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647028|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647029|NCT02028429|Urological Agents|urological agents|mesh-ancestor
2647030|NCT02028494|Capecitabine|capecitabine|mesh-list
2177441|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2177442|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2177443|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2647031|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2647032|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
2647033|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647034|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647035|NCT02028507|Capecitabine|capecitabine|mesh-list
2647036|NCT02028507|Fulvestrant|fulvestrant|mesh-list
2647037|NCT02028507|Palbociclib|palbociclib|mesh-list
2177444|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2177445|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2177446|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
2177447|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2177448|NCT00002240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2177449|NCT00002240|Nelfinavir|nelfinavir|mesh-list
2177450|NCT00002240|Stavudine|stavudine|mesh-list
2177451|NCT00002240|Didanosine|didanosine|mesh-list
2177452|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177453|NCT00002240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177454|NCT00002240|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177455|NCT00002240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177456|NCT00002240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177457|NCT00002240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177458|NCT00002240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177459|NCT00002240|Antiviral Agents|antiviral agents|mesh-ancestor
2177460|NCT00002240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177461|NCT00002240|Antimetabolites|antimetabolites|mesh-ancestor
2177462|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177463|NCT00002240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177464|NCT00002241|Ritonavir|ritonavir|mesh-list
2177465|NCT00002241|Indinavir|indinavir|mesh-list
2177466|NCT00002241|Lamivudine|lamivudine|mesh-list
2177467|NCT00002241|Stavudine|stavudine|mesh-list
2177468|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177469|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177470|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177471|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177472|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647038|NCT02028507|Exemestane|exemestane|mesh-list
2647039|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2647040|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
2647041|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647042|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647043|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2647044|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2647045|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2647046|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
2647047|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2647048|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647049|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2647050|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647051|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2647052|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2647053|NCT02028533|Oxytocin|oxytocin|mesh-list
2647054|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
2647055|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2647056|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647057|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
2647058|NCT02028598|Clomipramine|clomipramine|mesh-list
2647059|NCT02028598|Citric Acid|citric acid|mesh-list
2647060|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
2647061|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
2647062|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2647063|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
2647064|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
2647065|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647066|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
2647067|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2647068|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2647069|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647070|NCT02028598|Urological Agents|urological agents|mesh-ancestor
2647071|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2647072|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
2647073|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2647074|NCT02028598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2177473|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177474|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2647075|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2647076|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2647077|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647078|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
2647079|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647080|NCT02028663|Esomeprazole|esomeprazole|mesh-list
2647081|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2647082|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2647083|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2647084|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647085|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647086|NCT02028689|Metformin|metformin|mesh-list
2647087|NCT02028689|Lesinurad|lesinurad|mesh-list
2647088|NCT02028689|Furosemide|furosemide|mesh-list
2647089|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2647090|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647091|NCT02028689|Diuretics|diuretics|mesh-ancestor
2647092|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
2647093|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2647094|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2647095|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647096|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
2647097|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2647098|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
2647099|NCT02028689|Renal Agents|renal agents|mesh-ancestor
2647100|NCT02028806|Leucovorin|leucovorin|mesh-list
2647101|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
2647102|NCT02028806|Irinotecan|irinotecan|mesh-list
2647103|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647104|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2647105|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2647106|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647107|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647108|NCT02028806|Antidotes|antidotes|mesh-ancestor
2647109|NCT02028806|Protective Agents|protective agents|mesh-ancestor
2647110|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647111|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
2647112|NCT02028806|Vitamins|vitamins|mesh-ancestor
2647113|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
2647114|NCT02028819|Dolutegravir|dolutegravir|mesh-list
2647115|NCT02028819|Ibalizumab|ibalizumab|mesh-list
2647116|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2647117|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2647118|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177475|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
2177476|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177477|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2177478|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177479|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177480|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177481|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
2177482|NCT00002243|Calanolide A|calanolide a|mesh-list
2177483|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177484|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177485|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
2177486|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177487|NCT00002245|Lamivudine|lamivudine|mesh-list
2177488|NCT00002245|Abacavir|abacavir|mesh-list
2177489|NCT00002245|Amprenavir|amprenavir|mesh-list
2177490|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177491|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177492|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177493|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647119|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647120|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2647121|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2647122|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
2647123|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647124|NCT02028910|Ondansetron|ondansetron|mesh-list
2647125|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
2647126|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
2647127|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647128|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647129|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2647130|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
2647131|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
2647132|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2647133|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
2177494|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
2177495|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177496|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177497|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177498|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2177499|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
2177500|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2177501|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2177502|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2177503|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
2177504|NCT00002246|Stavudine|stavudine|mesh-list
2177505|NCT00002246|Antimetabolites|antimetabolites|mesh-ancestor
2177506|NCT00002246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177507|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177508|NCT00002246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177509|NCT00002246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647134|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647135|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647136|NCT02028910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2647137|NCT02028910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2647138|NCT02028910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2647139|NCT02028910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2647140|NCT02028910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2647141|NCT02028923|Morphine|morphine|mesh-list
2647142|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2647143|NCT02028923|Narcotics|narcotics|mesh-ancestor
2647144|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2647145|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647146|NCT02028923|Analgesics|analgesics|mesh-ancestor
2647147|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
2647148|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647149|NCT02028949|Idarubicin|idarubicin|mesh-list
2647150|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2647151|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647152|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2647153|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2647154|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647155|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647156|NCT02029001|Everolimus|everolimus|mesh-list
2647157|NCT02029001|Sorafenib|sorafenib|mesh-list
2647158|NCT02029001|Durvalumab|durvalumab|mesh-list
2647159|NCT02029001|Olaparib|olaparib|mesh-list
2647160|NCT02029001|Lapatinib|lapatinib|mesh-list
2647161|NCT02029001|Tremelimumab|tremelimumab|mesh-list
2647162|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647163|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2647164|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
2647165|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647166|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2647167|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647168|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647169|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2647170|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2647171|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
2647172|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2647173|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
2647174|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647175|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
2647176|NCT02029105|Protective Agents|protective agents|mesh-ancestor
2647177|NCT02029118|Aspirin|aspirin|mesh-list
2647178|NCT02029118|Metoprolol|metoprolol|mesh-list
2647179|NCT02029118|Ramipril|ramipril|mesh-list
2177510|NCT00002246|Antiviral Agents|antiviral agents|mesh-ancestor
2177511|NCT00002246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177512|NCT00002246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177513|NCT00002246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177514|NCT00002247|Ganciclovir|ganciclovir|mesh-list
2177515|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2177516|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
2177517|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177518|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177519|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177520|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647180|NCT02029118|Atorvastatin|atorvastatin|mesh-list
2647181|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2177521|NCT00002249|Levofloxacin|levofloxacin|mesh-list
2647182|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2647183|NCT02029118|Analgesics|analgesics|mesh-ancestor
2647184|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
2647185|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647186|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647187|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2647188|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2647189|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2177522|NCT00002249|Ofloxacin|ofloxacin|mesh-list
2177523|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2177524|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177525|NCT00002249|Renal Agents|renal agents|mesh-ancestor
2177526|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2177527|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2177528|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2177529|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177530|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177531|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2177532|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2177533|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177534|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
2177535|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
2647190|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2647191|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647192|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2647193|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2647194|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647195|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
2647196|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2647197|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2647198|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
2647199|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2647200|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2647201|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2647202|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2647203|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
2647204|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
2647205|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2647206|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2647207|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2647208|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
2647209|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647210|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2647211|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
2647212|NCT02029313|Montelukast|montelukast|mesh-list
2647213|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2647214|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
2177536|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177537|NCT00002251|Ganciclovir|ganciclovir|mesh-list
2177538|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2177539|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
2177540|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177541|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177542|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177543|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177544|NCT00002252|Octreotide|octreotide|mesh-list
2177545|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2177546|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2647215|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2647216|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
2647217|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2647218|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647219|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2647220|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2177547|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2177548|NCT00002253|Octreotide|octreotide|mesh-list
2177549|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2177550|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2177551|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2177552|NCT00002254|Alovudine|alovudine|mesh-list
2177553|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
2177554|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177555|NCT00002255|Zidovudine|zidovudine|mesh-list
2177556|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
2177557|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
2647221|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647222|NCT02029378|Eculizumab|eculizumab|mesh-list
2647223|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2647224|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2647225|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
2647226|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647229|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2647230|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2647231|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2647232|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647233|NCT02029482|Ponesimod|ponesimod|mesh-list
2647234|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2647235|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647236|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2647237|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
2647238|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647239|NCT02029534|Atorvastatin|atorvastatin|mesh-list
2647240|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2647241|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2647242|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
2647243|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647244|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2647245|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2647246|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647247|NCT02029573|Temozolomide|temozolomide|mesh-list
2647248|NCT02029573|Atorvastatin|atorvastatin|mesh-list
2647249|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2647250|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2647251|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
2647252|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647253|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2647254|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2647255|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647256|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2647257|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
2647258|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647259|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
2647260|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647261|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2647262|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2647263|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647264|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647265|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
2647266|NCT02029599|Acetaminophen|acetaminophen|mesh-list
2647267|NCT02029599|Methotrexate|methotrexate|mesh-list
2647268|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2647269|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
2647270|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2647271|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647272|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2647273|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
2647274|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647275|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647276|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
2647277|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647278|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2647279|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2647280|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
2647281|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2647282|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2647283|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2647284|NCT02029599|Analgesics|analgesics|mesh-ancestor
2177558|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177559|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177560|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177561|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177562|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
2647285|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
2177563|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177564|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2647286|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647287|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
2177565|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177566|NCT00002255|Hematinics|hematinics|mesh-ancestor
2177567|NCT00002256|Zalcitabine|zalcitabine|mesh-list
2177568|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
2177569|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177570|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177571|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177572|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177573|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
2177574|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177575|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177576|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177577|NCT00002257|Ganciclovir|ganciclovir|mesh-list
2177578|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2177579|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
2177580|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177581|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177582|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177583|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177584|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
2177585|NCT00002259|Analgesics|analgesics|mesh-ancestor
2177586|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
2177587|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2177588|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177589|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2177590|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2177591|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2177592|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177593|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177594|NCT00002260|Alovudine|alovudine|mesh-list
2177595|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
2177596|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177597|NCT00002261|Vaccines|vaccines|mesh-list
2177598|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
2177599|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177600|NCT00002263|Zidovudine|zidovudine|mesh-list
2177601|NCT00002263|Sargramostim|sargramostim|mesh-list
2177602|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
2647288|NCT02029612|Nicotine|nicotine|mesh-list
2647289|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2647290|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
2647291|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647292|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647293|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2422498|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2422499|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2422500|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2422501|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2422502|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
2422503|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2647294|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2647295|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
2647296|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647297|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647298|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2647299|NCT02029625|Ezetimibe|ezetimibe|mesh-list
2647300|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2647301|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2647302|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
2647303|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647304|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2647305|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2647306|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647307|NCT02029794|Acetic Acid|acetic acid|mesh-list
2647308|NCT02029794|Retinol acetate|retinol acetate|mesh-list
2647309|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2647310|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647311|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2177603|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177604|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177605|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2647312|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
2422504|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2647313|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647314|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2647315|NCT02029794|Protective Agents|protective agents|mesh-ancestor
2647316|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647317|NCT02029898|Remifentanil|remifentanil|mesh-list
2647318|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2647319|NCT02029898|Narcotics|narcotics|mesh-ancestor
2647320|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2647321|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647322|NCT02029898|Analgesics|analgesics|mesh-ancestor
2647323|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
2647324|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647325|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
2647326|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2647327|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647328|NCT02029937|Proflavine|proflavine|mesh-list
2177606|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177607|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
2177608|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177609|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177610|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177611|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
2647329|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2647330|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647331|NCT02029950|Cytarabine|cytarabine|mesh-list
2647332|NCT02029950|Etoposide|etoposide|mesh-list
2647333|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
2647334|NCT02029950|Daunorubicin|daunorubicin|mesh-list
2647335|NCT02029950|Idarubicin|idarubicin|mesh-list
2647336|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
2647337|NCT02029950|Pomalidomide|pomalidomide|mesh-list
2647338|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2647339|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647340|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2647341|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2647342|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177612|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177613|NCT00002265|Zalcitabine|zalcitabine|mesh-list
2177614|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
2177615|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177616|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177617|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177618|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177619|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
2177620|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177621|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177622|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177623|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
2177624|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2177625|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
2177626|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177627|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2177628|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2177629|NCT00002266|Protective Agents|protective agents|mesh-ancestor
2177630|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177631|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177632|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177633|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177634|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
2177635|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177636|NCT00002267|Rifabutin|rifabutin|mesh-list
2177637|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2177638|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177639|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2177640|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
2177641|NCT00002269|Zidovudine|zidovudine|mesh-list
2177642|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2647343|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647344|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2647345|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
2177643|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
2177644|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177645|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177646|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2647346|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
2647347|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647348|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2647349|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
2647350|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647351|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2647352|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2647353|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2647354|NCT02029950|Growth Substances|growth substances|mesh-ancestor
2647355|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
2647356|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
2647357|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
2647358|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
2647359|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
2647360|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
2647361|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2647362|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2647363|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
2647364|NCT02030028|Hormones|hormones|mesh-ancestor
2647365|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2647366|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647367|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647368|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647369|NCT02030054|Atorvastatin|atorvastatin|mesh-list
2647370|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2647371|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2647372|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2647373|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
2647374|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647375|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2647376|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2647377|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647378|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
2647379|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2647380|NCT02030314|Diuretics|diuretics|mesh-ancestor
2647381|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
2647382|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647383|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2647384|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2647385|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647386|NCT02030483|Dexamethasone|dexamethasone|mesh-list
2647387|NCT02030483|Lenalidomide|lenalidomide|mesh-list
2647388|NCT02030483|Palbociclib|palbociclib|mesh-list
2647389|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2647390|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
2647391|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
2647392|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647393|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647394|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2647395|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
2647396|NCT02030483|Hormones|hormones|mesh-ancestor
2647397|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2647398|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2647399|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647400|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
2647401|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2647402|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2647403|NCT02030483|Growth Substances|growth substances|mesh-ancestor
2647404|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
2647405|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2647406|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647407|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647408|NCT02030561|Trastuzumab|trastuzumab|mesh-list
2647409|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2647410|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647411|NCT02030639|ON 01910|on 01910|mesh-list
2647412|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2177647|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177648|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
2177649|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177650|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177651|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177652|NCT00002270|Interferons|interferons|mesh-list
2177653|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
2177654|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
2177655|NCT00002270|Zidovudine|zidovudine|mesh-list
2177656|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647413|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2647414|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647415|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647416|NCT02030678|Irinotecan|irinotecan|mesh-list
2647417|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2647418|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2647419|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647420|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647421|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647422|NCT02030717|Clonidine|clonidine|mesh-list
2647423|NCT02030717|Anesthetics|anesthetics|mesh-list
2647424|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2647425|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647426|NCT02030717|Analgesics|analgesics|mesh-ancestor
2647427|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
2647428|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647429|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2647430|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
2647431|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
2647432|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2647433|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2647434|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2647435|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
2647436|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647437|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647438|NCT02030860|Gemcitabine|gemcitabine|mesh-list
2647439|NCT02030860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2647440|NCT02030860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2647441|NCT02030860|Antimetabolites|antimetabolites|mesh-ancestor
2647442|NCT02030860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647443|NCT02030860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647444|NCT02030860|Antiviral Agents|antiviral agents|mesh-ancestor
2647445|NCT02030860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647446|NCT02030860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647447|NCT02030860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2647448|NCT02030860|Immunologic Factors|immunologic factors|mesh-ancestor
2647449|NCT02030860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647450|NCT02030912|Amoxicillin|amoxicillin|mesh-list
2647451|NCT02030912|Minocycline|minocycline|mesh-list
2647452|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2647453|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647454|NCT02030964|Eflornithine|eflornithine|mesh-list
2647455|NCT02030964|Celecoxib|celecoxib|mesh-list
2647456|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
2647457|NCT02030964|Topotecan|topotecan|mesh-list
2647458|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2647459|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
2647460|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647461|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2647462|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2647463|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
2647464|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647465|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647466|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2647467|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2647468|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2647469|NCT02030964|Analgesics|analgesics|mesh-ancestor
2647470|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
2647471|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647472|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2647473|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2647474|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2647475|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647476|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2647477|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2647478|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2647479|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2647480|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2647481|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647482|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2647483|NCT02030977|Resveratrol|resveratrol|mesh-list
2647484|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
2647485|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647486|NCT02030977|Protective Agents|protective agents|mesh-ancestor
2647487|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177657|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
2177658|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177659|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
2177660|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177661|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
2177662|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177663|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177664|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177665|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177666|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177667|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177668|NCT00002271|Alovudine|alovudine|mesh-list
2177669|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
2177670|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177671|NCT00002272|Foscarnet|foscarnet|mesh-list
2177672|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2177673|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
2177674|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177675|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177676|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177677|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177678|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177679|NCT00002273|Ganciclovir|ganciclovir|mesh-list
2177680|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2177681|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
2177682|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647488|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647489|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2647490|NCT02030990|Fluorometholone|fluorometholone|mesh-list
2647491|NCT02030990|Mitomycins|mitomycins|mesh-list
2647492|NCT02030990|Mitomycin|mitomycin|mesh-list
2647493|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2647494|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647495|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
2647496|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647497|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2647498|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647499|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2647500|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
2647501|NCT02030990|Hormones|hormones|mesh-ancestor
2647502|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2647503|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647504|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2647505|NCT02031016|Fentanyl|fentanyl|mesh-list
2647506|NCT02031016|Remifentanil|remifentanil|mesh-list
2647507|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2647508|NCT02031016|Narcotics|narcotics|mesh-ancestor
2647509|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2647510|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647511|NCT02031016|Analgesics|analgesics|mesh-ancestor
2647512|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
2647513|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647514|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2647515|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2647516|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
2647517|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
2647518|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2647519|NCT02031081|Prucalopride|prucalopride|mesh-list
2647520|NCT02031081|Laxatives|laxatives|mesh-ancestor
2647521|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2647522|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2647523|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2647524|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
2647525|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647526|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647527|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647528|NCT02031211|Etanercept|etanercept|mesh-list
2647529|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2647530|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2647531|NCT02031211|Analgesics|analgesics|mesh-ancestor
2647532|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
2647533|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647534|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647535|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2177683|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177684|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177685|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177686|NCT00002274|Didanosine|didanosine|mesh-list
2177687|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
2177688|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177689|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177690|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177691|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177692|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
2177693|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177694|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177695|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177696|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2177697|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2177698|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2177699|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2177700|NCT00002276|Zidovudine|zidovudine|mesh-list
2177701|NCT00002276|Ibuprofen|ibuprofen|mesh-list
2177702|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2647536|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2647537|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2647538|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2647539|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
2647542|NCT02031289|Folic Acid|folic acid|mesh-list
2647543|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
2647544|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
2647545|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
2647546|NCT02031289|Vitamins|vitamins|mesh-ancestor
2647547|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
2647548|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647549|NCT02031289|Hematinics|hematinics|mesh-ancestor
2647550|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
2647551|NCT02031367|Triamcinolone|triamcinolone|mesh-list
2647552|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2647553|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2647554|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2647555|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2647556|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
2647557|NCT02031367|Hormones|hormones|mesh-ancestor
2647558|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2647559|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647560|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2177703|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2177704|NCT00002276|Analgesics|analgesics|mesh-ancestor
2177705|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
2177706|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2177707|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177708|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2177709|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2177710|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2177711|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177712|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177713|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
2177714|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177715|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177716|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
2177717|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177718|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177719|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177720|NCT00002277|Fluconazole|fluconazole|mesh-list
2647561|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
2647562|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647563|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647564|NCT02031419|Rituximab|rituximab|mesh-list
2647565|NCT02031419|Spebrutinib|spebrutinib|mesh-list
2647566|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2647567|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647568|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
2647569|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647570|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2647571|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2647572|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647573|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647574|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
2647575|NCT02031510|Bupivacaine|bupivacaine|mesh-list
2647576|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
2647577|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
2647578|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2647579|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647580|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
2647581|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647582|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2647583|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2647584|NCT02031510|Analgesics|analgesics|mesh-ancestor
2647585|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2647586|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2647587|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2647588|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
2647589|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647590|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647591|NCT02031523|Analgesics|analgesics|mesh-list
2647592|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
2647593|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647594|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647595|NCT02031601|Carboplatin|carboplatin|mesh-list
2647596|NCT02031601|Docetaxel|docetaxel|mesh-list
2647597|NCT02031601|Pemetrexed|pemetrexed|mesh-list
2647598|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2647599|NCT02031601|Gefitinib|gefitinib|mesh-list
2647600|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647601|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
2647602|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
2647603|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
2647604|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647605|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647606|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2647607|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2647608|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2647609|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
2647610|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
2647611|NCT02031692|Calcium|calcium|mesh-list
2647612|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2647613|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647614|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2647615|NCT02031692|Vitamins|vitamins|mesh-ancestor
2647616|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
2647617|NCT02031692|Antacids|antacids|mesh-ancestor
2647618|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647619|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2647620|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2647621|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
2647622|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647623|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2647624|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647625|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2647626|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647627|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647628|NCT02031861|Nifedipine|nifedipine|mesh-list
2647629|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2647630|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2647631|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647632|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2647633|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647634|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
2647635|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
2647636|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2647637|NCT02031939|Capecitabine|capecitabine|mesh-list
2647638|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
2647639|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2647640|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
2647641|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647642|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647643|NCT02031965|Dexamethasone|dexamethasone|mesh-list
2647644|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2647645|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
2647646|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
2647647|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647648|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647649|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2177721|NCT00002277|Amphotericin B|amphotericin b|mesh-list
2177722|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2177723|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
2177724|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177725|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2647650|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
2647651|NCT02031965|Hormones|hormones|mesh-ancestor
2647652|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2647653|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2647654|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647655|NCT02031991|Bevacizumab|bevacizumab|mesh-list
2647656|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2647657|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647658|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2647659|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2647660|NCT02031991|Growth Substances|growth substances|mesh-ancestor
2647661|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647662|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
2647663|NCT02032043|Ivermectin|ivermectin|mesh-list
2177726|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177727|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177728|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177729|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2177730|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
2177731|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2647664|NCT02032043|Albendazole|albendazole|mesh-list
2647665|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2647666|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647667|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
2647668|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
2647669|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2647670|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2647671|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
2647672|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
2647673|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
2647674|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647675|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647676|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
2647677|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2647678|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
2647679|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2647680|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
2647681|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647682|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2177732|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177733|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2177734|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2177735|NCT00002277|Amebicides|amebicides|mesh-ancestor
2177736|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2177737|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2177738|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2177739|NCT00002278|Diclazuril|diclazuril|mesh-list
2647683|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2647684|NCT02032134|Protective Agents|protective agents|mesh-ancestor
2647685|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647686|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2647687|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
2647688|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647689|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
2647690|NCT02032186|Cathartics|cathartics|mesh-ancestor
2177740|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
2177741|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2177742|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2177743|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177744|NCT00002279|Zalcitabine|zalcitabine|mesh-list
2177745|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
2177746|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177747|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177748|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177749|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177750|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
2177751|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177752|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177753|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177754|NCT00002280|Didanosine|didanosine|mesh-list
2647691|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2647692|NCT02032277|Paclitaxel|paclitaxel|mesh-list
2647693|NCT02032277|Cyclophosphamide|cyclophosphamide|mesh-list
2647694|NCT02032277|Carboplatin|carboplatin|mesh-list
2647695|NCT02032277|Doxorubicin|doxorubicin|mesh-list
2647696|NCT02032277|Veliparib|veliparib|mesh-list
2647697|NCT02032277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2647698|NCT02032277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647699|NCT02032277|Tubulin Modulators|tubulin modulators|mesh-ancestor
2647700|NCT02032277|Antimitotic Agents|antimitotic agents|mesh-ancestor
2647701|NCT02032277|Mitosis Modulators|mitosis modulators|mesh-ancestor
2647702|NCT02032277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647703|NCT02032277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2647704|NCT02032277|Immunologic Factors|immunologic factors|mesh-ancestor
2647705|NCT02032277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647706|NCT02032277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2647707|NCT02032277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2647708|NCT02032277|Alkylating Agents|alkylating agents|mesh-ancestor
2647709|NCT02032277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2647710|NCT02032277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2647711|NCT02032277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2647712|NCT02032277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2647713|NCT02032277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647714|NCT02032277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2647715|NCT02032290|Clopidogrel|clopidogrel|mesh-list
2647716|NCT02032290|Ticagrelor|ticagrelor|mesh-list
2647717|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2647718|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2647719|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2647720|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2647721|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
2647722|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647723|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647724|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647725|NCT02032303|Ticagrelor|ticagrelor|mesh-list
2647726|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2647727|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2177755|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
2177756|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177757|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177758|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177759|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177760|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
2177761|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177762|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177763|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177764|NCT00002281|Zidovudine|zidovudine|mesh-list
2177765|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
2177766|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
2177767|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177768|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2647728|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2647729|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2647730|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2647731|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
2647732|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647733|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647734|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647735|NCT02032355|Anesthetics|anesthetics|mesh-list
2647736|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2647737|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647738|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
2647739|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2647740|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
2647741|NCT02032394|Povidone|povidone|mesh-list
2647742|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2647743|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647744|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
2647745|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
2647746|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
2647747|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
2647748|NCT02032654|Floxacillin|floxacillin|mesh-list
2647749|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2647750|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647751|NCT02032784|Octreotide|octreotide|mesh-list
2647752|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2647753|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2647754|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647755|NCT02032797|Progesterone|progesterone|mesh-list
2647756|NCT02032797|Progestins|progestins|mesh-ancestor
2647757|NCT02032797|Hormones|hormones|mesh-ancestor
2647758|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2647759|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647765|NCT02032836|Iloprost|iloprost|mesh-list
2647766|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2647767|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
2647768|NCT02032927|Acetaminophen|acetaminophen|mesh-list
2647769|NCT02032927|Oxycodone|oxycodone|mesh-list
2647770|NCT02032927|Codeine|codeine|mesh-list
2647771|NCT02032927|Naloxone|naloxone|mesh-list
2647772|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2647773|NCT02032927|Analgesics|analgesics|mesh-ancestor
2647774|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
2647775|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647776|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647777|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
2647778|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2647779|NCT02032927|Narcotics|narcotics|mesh-ancestor
2647780|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2647781|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2647782|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
2647783|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
2647784|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
2647785|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2647786|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2647787|NCT02033018|Aflibercept|aflibercept|mesh-list
2647788|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2647789|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2647790|NCT02033018|Growth Substances|growth substances|mesh-ancestor
2647791|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647792|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
2647793|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647794|NCT02033031|Bevacizumab|bevacizumab|mesh-list
2647795|NCT02033031|Ranibizumab|ranibizumab|mesh-list
2647796|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2647797|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647798|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2647799|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2647800|NCT02033031|Growth Substances|growth substances|mesh-ancestor
2647801|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647802|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
2647803|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
2177769|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177770|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177771|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
2177772|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177773|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177774|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177775|NCT00002281|Hematinics|hematinics|mesh-ancestor
2177776|NCT00002282|Fluconazole|fluconazole|mesh-list
2177777|NCT00002282|Clotrimazole|clotrimazole|mesh-list
2177778|NCT00002282|Miconazole|miconazole|mesh-list
2177779|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
2647804|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647805|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647806|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
2647807|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2647808|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647809|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
2647810|NCT02033239|Insulin|insulin|mesh-list
2647811|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2647812|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
2647813|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
2647814|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2647815|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2647816|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647817|NCT02033356|Lidocaine|lidocaine|mesh-list
2647818|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
2177780|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177781|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2177782|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177783|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177784|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177785|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2177786|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
2177787|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2177788|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177789|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2647819|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
2647820|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2647821|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647822|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
2177790|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2177791|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2177792|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2177793|NCT00002283|Trimethoprim|trimethoprim|mesh-list
2177794|NCT00002283|Dapsone|dapsone|mesh-list
2177795|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
2177796|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2177797|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177798|NCT00002283|Renal Agents|renal agents|mesh-ancestor
2177799|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
2177800|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2177801|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2177802|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2177803|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177804|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177805|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2177806|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2177807|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177808|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
2177809|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2177810|NCT00002284|Zidovudine|zidovudine|mesh-list
2177811|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
2177812|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177813|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2647823|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647824|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2647825|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2647826|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2647827|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2647828|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647829|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2647830|NCT02033408|Amoxicillin|amoxicillin|mesh-list
2647831|NCT02033408|Metronidazole|metronidazole|mesh-list
2647832|NCT02033408|Vancomycin|vancomycin|mesh-list
2647833|NCT02033408|Doxycycline|doxycycline|mesh-list
2647834|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
2647835|NCT02033408|Gentamicins|gentamicins|mesh-list
2647836|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647837|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2647838|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2647839|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
2647840|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2647841|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2647842|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647843|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647844|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647845|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2647846|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2647847|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2647848|NCT02033434|Ketamine|ketamine|mesh-list
2647849|NCT02033434|Analgesics|analgesics|mesh-ancestor
2647850|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
2647851|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647852|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647853|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2647854|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2647855|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
2647856|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
2647857|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2647858|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2647859|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2647860|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647861|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647862|NCT02033512|Hormones|hormones|mesh-list
2647863|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2647864|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647865|NCT02033538|Paclitaxel|paclitaxel|mesh-list
2177814|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177815|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177816|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
2177817|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177818|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177819|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177820|NCT00002285|Zidovudine|zidovudine|mesh-list
2177821|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
2647866|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2647867|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2647868|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647869|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
2647870|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
2647871|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
2647872|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647873|NCT02033551|Paclitaxel|paclitaxel|mesh-list
2647874|NCT02033551|Carboplatin|carboplatin|mesh-list
2647875|NCT02033551|Veliparib|veliparib|mesh-list
2177822|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177823|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177824|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177825|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177826|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
2177827|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177828|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177829|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2647876|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2647877|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647878|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
2647879|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
2647880|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
2647881|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647882|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2647883|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647884|NCT02033603|Ropivacaine|ropivacaine|mesh-list
2647885|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
2647886|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
2647887|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2647888|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647889|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
2647890|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647891|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2647892|NCT02033707|Scopolamine|scopolamine|mesh-list
2647893|NCT02033707|Hallucinogens|hallucinogens|mesh-list
2647894|NCT02033707|Nicotine|nicotine|mesh-list
2647895|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2647896|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
2647897|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647898|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647899|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2647900|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2647901|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
2647902|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647903|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647904|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2647905|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
2647906|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2647907|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
2647908|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2647909|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2647910|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2647911|NCT02033733|Cisatracurium|cisatracurium|mesh-list
2647912|NCT02033733|Atracurium|atracurium|mesh-list
2647913|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
2647914|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2647915|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647916|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647917|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2647918|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2647919|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2647920|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
2647921|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647922|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647923|NCT02033798|Tamsulosin|tamsulosin|mesh-list
2647924|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2647925|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2647926|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2647927|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
2647928|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647929|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647930|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647931|NCT02033798|Urological Agents|urological agents|mesh-ancestor
2647932|NCT02033941|Phenol|phenol|mesh-list
2647933|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2647934|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2647935|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
2647936|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2647937|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2647938|NCT02033967|Milrinone|milrinone|mesh-list
2647939|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
2647940|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2647941|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2647942|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2647943|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2647944|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647945|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647946|NCT02033967|Protective Agents|protective agents|mesh-ancestor
2647947|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647948|NCT02034071|Diazoxide|diazoxide|mesh-list
2647949|NCT02034071|Choline|choline|mesh-list
2647950|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
2647951|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2647952|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
2647953|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647954|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2647955|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2177830|NCT00002286|Zidovudine|zidovudine|mesh-list
2177831|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
2177832|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177833|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177834|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2647956|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
2647957|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2647958|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
2647959|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2647960|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2647961|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2647962|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2647963|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647970|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2647971|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2647972|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647973|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2647974|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2647975|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2647976|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647977|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
2647978|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647979|NCT02034253|Risperidone|risperidone|mesh-list
2647980|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2177835|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177836|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
2177837|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177838|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177839|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2647981|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
2647982|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2647983|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2647984|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2647985|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2647986|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2647987|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2647988|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2647989|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2647990|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
2647991|NCT02034292|Aspirin|aspirin|mesh-list
2647992|NCT02034292|Clopidogrel|clopidogrel|mesh-list
2647993|NCT02034292|APD791|apd791|mesh-list
2647994|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2647995|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2647996|NCT02034292|Analgesics|analgesics|mesh-ancestor
2647997|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
2647998|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2647999|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648000|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2648001|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2648002|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2648003|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2648004|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648005|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2648006|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2648007|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648008|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
2648009|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2648010|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2648011|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2648012|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
2648013|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648014|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2648015|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2648016|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
2648017|NCT02034331|Acetylcholine|acetylcholine|mesh-list
2648018|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648019|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
2177840|NCT00002287|Zidovudine|zidovudine|mesh-list
2177841|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
2177842|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177843|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177844|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177845|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177846|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
2177847|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177848|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177849|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177850|NCT00002288|Zidovudine|zidovudine|mesh-list
2177851|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
2177852|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177853|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177854|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177855|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177856|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
2177857|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177858|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177859|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177860|NCT00002289|Thymopentin|thymopentin|mesh-list
2177861|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2177862|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
2177863|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177864|NCT00002290|Zidovudine|zidovudine|mesh-list
2648020|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2648021|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
2648022|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648023|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648028|NCT02034500|Vaccines|vaccines|mesh-list
2648029|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
2648030|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648031|NCT02034604|Tamsulosin|tamsulosin|mesh-list
2648032|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2648033|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2648034|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2648035|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
2648036|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648037|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648038|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648039|NCT02034604|Urological Agents|urological agents|mesh-ancestor
2648040|NCT02034630|Busulfan|busulfan|mesh-list
2648041|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
2648042|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648043|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2648044|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
2648045|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648046|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2648047|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648048|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2648049|NCT02034838|Ritonavir|ritonavir|mesh-list
2648050|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2648051|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2648052|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2648053|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
2648054|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648055|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648056|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2648057|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2648058|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
2648059|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648060|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2648061|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2648062|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
2648063|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2648064|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
2648065|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648066|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
2648067|NCT02034890|Protective Agents|protective agents|mesh-ancestor
2648068|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
2648069|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2648070|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648071|NCT02034981|Crizotinib|crizotinib|mesh-list
2648072|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648073|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2648074|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648075|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648076|NCT02035020|Interferons|interferons|mesh-list
2648077|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
2177865|NCT00002290|Acyclovir|acyclovir|mesh-list
2177866|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
2177867|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177868|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177869|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177870|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177871|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
2177872|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177873|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2177874|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2177875|NCT00002291|Pentamidine|pentamidine|mesh-list
2177876|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
2177877|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177878|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2177879|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2177880|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2177881|NCT00002292|Pentamidine|pentamidine|mesh-list
2177882|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
2177883|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177884|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2177885|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2177886|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2177887|NCT00002293|Nystatin|nystatin|mesh-list
2177888|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2177889|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177890|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
2177891|NCT00002293|Ionophores|ionophores|mesh-ancestor
2177892|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2177893|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648078|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648079|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
2648080|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648081|NCT02035072|Gemcitabine|gemcitabine|mesh-list
2648082|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
2648083|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2648084|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
2648085|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648086|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648087|NCT02035072|Antiviral Agents|antiviral agents|mesh-ancestor
2648088|NCT02035072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648089|NCT02035072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648090|NCT02035072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2648091|NCT02035072|Immunologic Factors|immunologic factors|mesh-ancestor
2648092|NCT02035072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177894|NCT00002294|Fluconazole|fluconazole|mesh-list
2177895|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
2177896|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177897|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2177898|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177899|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177900|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177901|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2177902|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
2177903|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2177904|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177905|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2177906|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2177907|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
2177908|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2177909|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
2177910|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177911|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
2177912|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177913|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
2177914|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2177915|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
2177916|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177917|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
2177918|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177919|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
2177920|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2177921|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
2177922|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177923|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
2177924|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177925|NCT00002298|Ribavirin|ribavirin|mesh-list
2177926|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
2177927|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177928|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
2177929|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177930|NCT00002299|Interferons|interferons|mesh-list
2177931|NCT00002299|Interferon-beta|interferon-beta|mesh-list
2177932|NCT00002299|Ganciclovir|ganciclovir|mesh-list
2177933|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2177934|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
2177935|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2177936|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
2177937|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177938|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
2177939|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177940|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177941|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177942|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177943|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2177944|NCT00002300|Megestrol|megestrol|mesh-list
2177945|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
2177946|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2177947|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2177948|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2177949|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
2177950|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2177951|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177952|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2177953|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2177954|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2177955|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2177956|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
2177957|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2177958|NCT00002301|Foscarnet|foscarnet|mesh-list
2177959|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2177960|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
2177961|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177962|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2177963|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2177964|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177965|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177966|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
2177967|NCT00002302|Hematinics|hematinics|mesh-ancestor
2177968|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
2177969|NCT00002303|Hematinics|hematinics|mesh-ancestor
2177970|NCT00002304|Fluconazole|fluconazole|mesh-list
2177971|NCT00002304|Ketoconazole|ketoconazole|mesh-list
2177972|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
2177973|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177974|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2648108|NCT02035215|Atorvastatin|atorvastatin|mesh-list
2648109|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2648110|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2648111|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
2648112|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648113|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2648114|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2648115|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648116|NCT02035371|Insulin|insulin|mesh-list
2648117|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2648118|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
2177975|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177976|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177977|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177978|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2177979|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
2177980|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2177981|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177982|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2177983|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2177984|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2177985|NCT00002305|Fluconazole|fluconazole|mesh-list
2177986|NCT00002305|Amphotericin B|amphotericin b|mesh-list
2177987|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2177988|NCT00002305|Flucytosine|flucytosine|mesh-list
2177989|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
2177990|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2177991|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2177992|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2177993|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2177994|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2177995|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2177996|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
2648119|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
2648120|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2648121|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2648122|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648123|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
2177997|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2177998|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2177999|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2178000|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2648124|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2648125|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2648126|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2648127|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2648128|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648129|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
2648130|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648131|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648132|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2178001|NCT00002305|Amebicides|amebicides|mesh-ancestor
2178002|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2178003|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2178004|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2178005|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
2178006|NCT00002306|Fluconazole|fluconazole|mesh-list
2178007|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
2648133|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648134|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2648135|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2648136|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648137|NCT02035488|Tobramycin|tobramycin|mesh-list
2648138|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2648139|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648140|NCT02035527|Docetaxel|docetaxel|mesh-list
2648141|NCT02035527|Sorafenib|sorafenib|mesh-list
2648142|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648143|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
2648144|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
2648145|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
2648146|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648147|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2648148|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648149|NCT02035709|Hydromorphone|hydromorphone|mesh-list
2648150|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2648151|NCT02035709|Narcotics|narcotics|mesh-ancestor
2648152|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648153|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648154|NCT02035709|Analgesics|analgesics|mesh-ancestor
2648155|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
2178008|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178009|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2178010|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178011|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178012|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178013|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2178014|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
2178015|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2178016|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178017|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2178018|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2178019|NCT00002307|Zidovudine|zidovudine|mesh-list
2178020|NCT00002307|Stavudine|stavudine|mesh-list
2178021|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
2178022|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178023|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178024|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178025|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648156|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648157|NCT02035787|Metformin|metformin|mesh-list
2648158|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2648159|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648160|NCT02035800|Adalimumab|adalimumab|mesh-list
2648161|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2648162|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2648163|NCT02035891|Colchicine|colchicine|mesh-list
2648164|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
2648165|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2648166|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
2648167|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
2648168|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
2648169|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648170|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648171|NCT02035904|Morphine|morphine|mesh-list
2648172|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
2648173|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2648174|NCT02035904|Narcotics|narcotics|mesh-ancestor
2648175|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648176|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648177|NCT02035904|Analgesics|analgesics|mesh-ancestor
2648178|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
2648179|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648180|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
2648181|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
2648182|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
2648183|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2648184|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648185|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648186|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2648187|NCT02035930|Analgesics|analgesics|mesh-ancestor
2648188|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
2648189|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648190|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2648191|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2648192|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2648193|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
2648194|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648195|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648196|NCT02035943|Insulin|insulin|mesh-list
2648197|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2648198|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2648199|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648200|NCT02035956|Vaccines|vaccines|mesh-list
2648201|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
2648202|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648203|NCT02035982|Rivastigmine|rivastigmine|mesh-list
2648204|NCT02035982|Donepezil|donepezil|mesh-list
2648205|NCT02035982|Galantamine|galantamine|mesh-list
2648206|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
2648207|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648208|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648209|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
2648210|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648211|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648212|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
2648213|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2648214|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
2648215|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648216|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2648217|NCT02035982|Protective Agents|protective agents|mesh-ancestor
2648218|NCT02036008|Liver Extracts|liver extracts|mesh-list
2648219|NCT02036008|Hematinics|hematinics|mesh-ancestor
2648220|NCT02036060|Prednisone|prednisone|mesh-list
2648221|NCT02036060|Docetaxel|docetaxel|mesh-list
2648222|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648223|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
2648224|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
2648225|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
2648226|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648227|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2648228|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
2648229|NCT02036060|Hormones|hormones|mesh-ancestor
2648230|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2648231|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648232|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2648233|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
2648234|NCT02036073|Hematinics|hematinics|mesh-ancestor
2648235|NCT02036086|Vemurafenib|vemurafenib|mesh-list
2178026|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
2178027|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178028|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178029|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178030|NCT00002308|Stavudine|stavudine|mesh-list
2178031|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
2178032|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178033|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178034|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2648236|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648237|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2648238|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648239|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648240|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
2648241|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2648242|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2648243|NCT02036125|Prednisolone|prednisolone|mesh-list
2648244|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
2648245|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2648246|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
2648247|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2648248|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
2648249|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
2648250|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648251|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648252|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2648253|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
2648254|NCT02036125|Hormones|hormones|mesh-ancestor
2648255|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2648256|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2648257|NCT02036125|Protective Agents|protective agents|mesh-ancestor
2648258|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2648259|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648260|NCT02036151|Fluorides|fluorides|mesh-list
2648261|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
2648262|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
2648263|NCT02036151|Protective Agents|protective agents|mesh-ancestor
2648264|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648265|NCT02036164|Paclitaxel|paclitaxel|mesh-list
2648266|NCT02036164|Cisplatin|cisplatin|mesh-list
2178035|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178036|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
2178037|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178038|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178039|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178040|NCT00002309|Azithromycin|azithromycin|mesh-list
2178041|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2178042|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178043|NCT00002311|Wobenzym|wobenzym|mesh-list
2178044|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2178045|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
2178046|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178047|NCT00002312|Zidovudine|zidovudine|mesh-list
2178048|NCT00002312|Delavirdine|delavirdine|mesh-list
2178049|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
2178050|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178051|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178052|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2648267|NCT02036164|Carboplatin|carboplatin|mesh-list
2648268|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2648269|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648270|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
2648271|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
2648272|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
2648273|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648274|NCT02036229|Ivermectin|ivermectin|mesh-list
2648275|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2648276|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648277|NCT02036242|Sufentanil|sufentanil|mesh-list
2648278|NCT02036242|Ropivacaine|ropivacaine|mesh-list
2178053|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178054|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
2178055|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178056|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178057|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178058|NCT00002313|Didanosine|didanosine|mesh-list
2178059|NCT00002313|Nystatin|nystatin|mesh-list
2178060|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
2178061|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178062|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178063|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178064|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648279|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
2648280|NCT02036242|Anesthetics|anesthetics|mesh-list
2178065|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
2648281|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648282|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648283|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
2648284|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648285|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2648286|NCT02036242|Narcotics|narcotics|mesh-ancestor
2648287|NCT02036242|Analgesics|analgesics|mesh-ancestor
2648288|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2648289|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2648290|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
2648291|NCT02036255|Taurolidine|taurolidine|mesh-list
2648292|NCT02036255|Heparin|heparin|mesh-list
2648293|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
2648294|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2648295|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2648296|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648297|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648298|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2648299|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648300|NCT02036281|Substance P|substance p|mesh-list
2648301|NCT02036281|Neurokinin A|neurokinin a|mesh-list
2648302|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648303|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648304|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648305|NCT02036359|Docetaxel|docetaxel|mesh-list
2648306|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2648307|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648308|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
2648309|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
2648310|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
2648311|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648312|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2648313|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648314|NCT02036372|Insulin|insulin|mesh-list
2648315|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2648316|NCT02036372|Liraglutide|liraglutide|mesh-list
2648317|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2648318|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648319|NCT02036372|Incretins|incretins|mesh-ancestor
2648320|NCT02036372|Hormones|hormones|mesh-ancestor
2648321|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2648322|NCT02036437|Misoprostol|misoprostol|mesh-list
2648323|NCT02036437|Dinoprostone|dinoprostone|mesh-list
2648324|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2648325|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
2648326|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2648327|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648328|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2648329|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2648330|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
2648331|NCT02036463|Prednisone|prednisone|mesh-list
2648332|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2648333|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
2648334|NCT02036463|Hormones|hormones|mesh-ancestor
2648335|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2648336|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648337|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2648338|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648339|NCT02036489|Prednisone|prednisone|mesh-list
2648340|NCT02036489|Vincristine|vincristine|mesh-list
2648341|NCT02036489|Daunorubicin|daunorubicin|mesh-list
2648342|NCT02036489|Asparaginase|asparaginase|mesh-list
2648343|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
2648344|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2648345|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
2648346|NCT02036489|Hormones|hormones|mesh-ancestor
2648347|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2648348|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648349|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2648350|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648351|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2648352|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
2648353|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
2648354|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
2648355|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648356|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2648357|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2648358|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2648359|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648360|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
2648361|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2648362|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2648363|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
2648364|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2648365|NCT02036528|Doxycycline|doxycycline|mesh-list
2648366|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
2648367|NCT02036528|Gentamicins|gentamicins|mesh-list
2648368|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2648369|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648370|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
2648371|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2648372|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2648373|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2648374|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2648375|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648376|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648377|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648378|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2648379|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2648380|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2648381|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
2648382|NCT02036554|Everolimus|everolimus|mesh-list
2648383|NCT02036554|Tacrolimus|tacrolimus|mesh-list
2648384|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2648385|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
2648386|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648387|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2648388|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648389|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648390|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648391|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2648392|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2648393|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
2648394|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2648395|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648396|NCT02036697|Fentanyl|fentanyl|mesh-list
2648397|NCT02036697|Morphine|morphine|mesh-list
2648398|NCT02036697|Bupivacaine|bupivacaine|mesh-list
2648399|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
2648400|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
2648401|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648402|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648403|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
2648404|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648405|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2648406|NCT02036697|Narcotics|narcotics|mesh-ancestor
2648407|NCT02036697|Analgesics|analgesics|mesh-ancestor
2648408|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2648409|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2648410|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
2648411|NCT02036723|Bevacizumab|bevacizumab|mesh-list
2648412|NCT02036723|Ranibizumab|ranibizumab|mesh-list
2648413|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2648414|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648415|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2648416|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2648417|NCT02036723|Growth Substances|growth substances|mesh-ancestor
2648418|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648419|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
2648420|NCT02036736|Propofol|propofol|mesh-list
2648421|NCT02036736|Anesthetics|anesthetics|mesh-list
2648422|NCT02036736|Desflurane|desflurane|mesh-list
2648423|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2648424|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648425|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648426|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2648427|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
2648428|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2648429|NCT02036827|Bromides|bromides|mesh-list
2648430|NCT02036827|Rocuronium|rocuronium|mesh-list
2648431|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
2648432|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2648433|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2648434|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2648435|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648436|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648437|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2178066|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648438|NCT02036879|Norethindrone|norethindrone|mesh-list
2648439|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
2648440|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2648441|NCT02036879|Estradiol|estradiol|mesh-list
2648442|NCT02036879|Estrogens|estrogens|mesh-ancestor
2648443|NCT02036879|Hormones|hormones|mesh-ancestor
2648444|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2648445|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648446|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2648447|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
2648448|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2648449|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2648450|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2648451|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2648452|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2648453|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2648454|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2648455|NCT02036983|Anesthetics|anesthetics|mesh-list
2648456|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
2648457|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648458|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178067|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178068|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178069|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2178070|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
2178071|NCT00002313|Ionophores|ionophores|mesh-ancestor
2178072|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2178073|NCT00002315|Acyclovir|acyclovir|mesh-list
2178074|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
2178075|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
2178076|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648459|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
2648460|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648461|NCT02037009|Anesthetics|anesthetics|mesh-list
2648462|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648463|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648464|NCT02037035|Ketamine|ketamine|mesh-list
2648465|NCT02037035|Analgesics|analgesics|mesh-ancestor
2648466|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
2648467|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648468|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648469|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2648470|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2648471|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
2648472|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
2648473|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648474|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2648475|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2648476|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648477|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648478|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
2648479|NCT02037126|Promethazine|promethazine|mesh-list
2648480|NCT02037126|Psilocybin|psilocybin|mesh-list
2648481|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2648482|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2648483|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648484|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648485|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
2648486|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
2648487|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
2648488|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648489|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
2648490|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
2648491|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2648492|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2648493|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
2648494|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
2648495|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648496|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648497|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2648498|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
2648499|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
2648500|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
2178077|NCT00002316|Amphotericin B|amphotericin b|mesh-list
2178078|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2178079|NCT00002316|Amebicides|amebicides|mesh-ancestor
2178080|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2178081|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2178082|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648501|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2648502|NCT02037191|Methotrexate|methotrexate|mesh-list
2648503|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2648504|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
2648505|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2648506|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648507|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2648508|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
2648509|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648510|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648511|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
2648512|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648513|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2648514|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2648515|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
2648516|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2648517|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2648518|NCT02037399|Dexamethasone|dexamethasone|mesh-list
2648519|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2648520|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
2648521|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
2648522|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648523|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648524|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2648525|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
2648526|NCT02037399|Hormones|hormones|mesh-ancestor
2648527|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2648528|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2648529|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648530|NCT02037412|Clopidogrel|clopidogrel|mesh-list
2648531|NCT02037412|Ticagrelor|ticagrelor|mesh-list
2648532|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2648533|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2648534|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2648535|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2648536|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
2648537|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2178083|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2178084|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
2178085|NCT00002317|Leucovorin|leucovorin|mesh-list
2178086|NCT00002317|Trimetrexate|trimetrexate|mesh-list
2178087|NCT00002317|Calcium|calcium|mesh-list
2178088|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
2178089|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2178090|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178091|NCT00002317|Antidotes|antidotes|mesh-ancestor
2648538|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648539|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648540|NCT02037464|Capsaicin|capsaicin|mesh-list
2648541|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
2648542|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
2648543|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
2648544|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648545|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648546|NCT02037503|Ketamine|ketamine|mesh-list
2648547|NCT02037503|Analgesics|analgesics|mesh-ancestor
2648548|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
2648549|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648550|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648551|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2178092|NCT00002317|Protective Agents|protective agents|mesh-ancestor
2178093|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
2178094|NCT00002317|Vitamins|vitamins|mesh-ancestor
2178095|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
2178096|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
2178097|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178098|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2178099|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
2178100|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178101|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2178102|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2648552|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2648553|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
2648554|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
2178103|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178104|NCT00002318|Doxorubicin|doxorubicin|mesh-list
2178105|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2178106|NCT00002318|Bleomycin|bleomycin|mesh-list
2178107|NCT00002318|Vincristine|vincristine|mesh-list
2178108|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2178109|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2178110|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2178111|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2178112|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178113|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178114|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2178115|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
2178116|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
2178117|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
2648555|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648556|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2648557|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2648558|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648559|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648560|NCT02037516|Neostigmine|neostigmine|mesh-list
2648561|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2648562|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178118|NCT00002319|Doxorubicin|doxorubicin|mesh-list
2178119|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2178120|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2178121|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2178122|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2178123|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2178124|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178125|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178126|NCT00002320|Lamivudine|lamivudine|mesh-list
2648563|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648564|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
2648565|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648566|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648567|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2648568|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
2648569|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648570|NCT02037529|Paclitaxel|paclitaxel|mesh-list
2648571|NCT02037529|Halichondrin B|halichondrin b|mesh-list
2648572|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2648573|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2648574|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648575|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
2648576|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
2648577|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
2648578|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648579|NCT02037633|Fentanyl|fentanyl|mesh-list
2648580|NCT02037633|Ropivacaine|ropivacaine|mesh-list
2648581|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
2648582|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
2648583|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648584|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648585|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
2178127|NCT00002320|Zidovudine|zidovudine|mesh-list
2178128|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178129|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178130|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648586|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648587|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2648588|NCT02037633|Narcotics|narcotics|mesh-ancestor
2178131|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178132|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
2178133|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178134|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178135|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178136|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
2178137|NCT00002321|Aldesleukin|aldesleukin|mesh-list
2178138|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2178139|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178140|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178141|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
2178142|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178143|NCT00002322|Zidovudine|zidovudine|mesh-list
2648589|NCT02037633|Analgesics|analgesics|mesh-ancestor
2648590|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2648591|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2648592|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
2648593|NCT02037672|Metformin|metformin|mesh-list
2648594|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2648595|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648596|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
2648597|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
2648598|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
2648599|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648600|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648601|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
2648602|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648603|NCT02037724|Iron|iron|mesh-list
2648604|NCT02037724|Trace Elements|trace elements|mesh-ancestor
2648605|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
2648606|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648607|NCT02037737|Abatacept|abatacept|mesh-list
2648608|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2648609|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648610|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648611|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2648612|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
2648613|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648614|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2648615|NCT02037802|Fentanyl|fentanyl|mesh-list
2648616|NCT02037802|Meperidine|meperidine|mesh-list
2648617|NCT02037802|Bupivacaine|bupivacaine|mesh-list
2648618|NCT02037802|Propofol|propofol|mesh-list
2648619|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
2648620|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
2648621|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648622|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648623|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
2648624|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648625|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2648626|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2648627|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
2648628|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2648629|NCT02037802|Narcotics|narcotics|mesh-ancestor
2648630|NCT02037802|Analgesics|analgesics|mesh-ancestor
2648631|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2648632|NCT02037815|Mannitol|mannitol|mesh-list
2648633|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2648634|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2648635|NCT02037815|Diuretics|diuretics|mesh-ancestor
2648636|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
2648637|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178144|NCT00002322|Atevirdine|atevirdine|mesh-list
2178145|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
2178146|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178147|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178148|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178149|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178150|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
2178151|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178152|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178153|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178154|NCT00002323|Zidovudine|zidovudine|mesh-list
2648638|NCT02037919|Etonogestrel|etonogestrel|mesh-list
2648639|NCT02037919|Desogestrel|desogestrel|mesh-list
2648640|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2648641|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
2648642|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2648643|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648644|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2648645|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2648646|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2648647|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2648648|NCT02037919|Progestins|progestins|mesh-ancestor
2648649|NCT02037919|Hormones|hormones|mesh-ancestor
2648650|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2648651|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
2648652|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2178155|NCT00002323|Nevirapine|nevirapine|mesh-list
2178156|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
2648653|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648654|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
2648655|NCT02037997|Docetaxel|docetaxel|mesh-list
2648656|NCT02037997|Pemetrexed|pemetrexed|mesh-list
2648657|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2648658|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648659|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
2648660|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
2648661|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
2648662|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648663|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648664|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2648665|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2648666|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2648667|NCT02038062|Sevoflurane|sevoflurane|mesh-list
2648668|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2648669|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2648670|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
2648671|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
2648672|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2178157|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178158|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178159|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178160|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178161|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
2178162|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178163|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178164|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178165|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2178166|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2648673|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648674|NCT02038257|Petrolatum|petrolatum|mesh-list
2648675|NCT02038257|Emollients|emollients|mesh-ancestor
2648676|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
2648677|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2648678|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2648679|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
2648680|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
2648681|NCT02038335|Etonogestrel|etonogestrel|mesh-list
2648682|NCT02038335|Norethindrone|norethindrone|mesh-list
2648683|NCT02038335|Estradiol|estradiol|mesh-list
2648684|NCT02038335|Estrogens|estrogens|mesh-ancestor
2648685|NCT02038335|Hormones|hormones|mesh-ancestor
2648686|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2648687|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648688|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2648689|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
2648690|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2648691|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2178167|NCT00002324|Zidovudine|zidovudine|mesh-list
2178168|NCT00002324|Nevirapine|nevirapine|mesh-list
2178169|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
2178170|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178171|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178172|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178173|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178174|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
2178175|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178176|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178177|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178178|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2178179|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2178180|NCT00002325|Fluconazole|fluconazole|mesh-list
2178181|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
2648692|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2648693|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2648694|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2648695|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2648696|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2648697|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648698|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2648699|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
2648700|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2648701|NCT02038452|Prednisolone|prednisolone|mesh-list
2648702|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
2178182|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648703|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2648704|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
2648705|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2648706|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
2648707|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
2648708|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648709|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648710|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2648711|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
2648712|NCT02038452|Hormones|hormones|mesh-ancestor
2648713|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2648714|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2648715|NCT02038452|Protective Agents|protective agents|mesh-ancestor
2648716|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2648717|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648718|NCT02038491|Anesthetics|anesthetics|mesh-list
2648719|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648720|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648721|NCT02038621|Paclitaxel|paclitaxel|mesh-list
2648722|NCT02038621|Capecitabine|capecitabine|mesh-list
2648723|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
2648724|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2648725|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648726|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
2648727|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
2648728|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
2648729|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648730|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2648731|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
2648732|NCT02038634|Betamethasone|betamethasone|mesh-list
2648733|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2648734|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
2648735|NCT02038634|Hormones|hormones|mesh-ancestor
2648736|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2178183|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2178184|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178185|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178186|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178187|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2178188|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
2178189|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2178190|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178191|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2648737|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648738|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2648739|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
2648740|NCT02038699|TIC10 compound|tic10 compound|mesh-list
2648741|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648742|NCT02038777|Cytarabine|cytarabine|mesh-list
2648743|NCT02038777|Azacitidine|azacitidine|mesh-list
2648744|NCT02038777|Daunorubicin|daunorubicin|mesh-list
2648745|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2648746|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
2648747|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648748|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648749|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
2648750|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648751|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2648752|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
2648753|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648754|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648755|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2648756|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2648757|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2648758|NCT02038816|Azacitidine|azacitidine|mesh-list
2648759|NCT02038816|Deferasirox|deferasirox|mesh-list
2648760|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2648761|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
2648762|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648763|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648764|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648765|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2648766|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
2648767|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
2178192|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2178193|NCT00002326|Zidovudine|zidovudine|mesh-list
2178194|NCT00002326|Adefovir|adefovir|mesh-list
2178195|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
2178196|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178197|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178198|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178199|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178200|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
2178201|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178202|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178203|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178204|NCT00002327|Cidofovir|cidofovir|mesh-list
2178205|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
2178206|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178207|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178208|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178209|NCT00002328|Azithromycin|azithromycin|mesh-list
2178210|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2178211|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178212|NCT00002330|Ganciclovir|ganciclovir|mesh-list
2178213|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2178214|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
2178215|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178216|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178217|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178218|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178219|NCT00002331|Clarithromycin|clarithromycin|mesh-list
2178220|NCT00002331|Ethambutol|ethambutol|mesh-list
2178221|NCT00002331|Clofazimine|clofazimine|mesh-list
2178222|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2178223|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178224|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2178225|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178226|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178227|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2178228|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178229|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
2178230|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2178231|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
2178232|NCT00002332|Thymopentin|thymopentin|mesh-list
2178233|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2178234|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
2178235|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178236|NCT00002333|Saquinavir|saquinavir|mesh-list
2178237|NCT00002333|Zalcitabine|zalcitabine|mesh-list
2178238|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178239|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178240|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178241|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178242|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178243|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178244|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178245|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
2178246|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178247|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2178248|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178249|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
2178250|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2648768|NCT02038842|Vaccines|vaccines|mesh-list
2648769|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
2648770|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648771|NCT02038868|Tamsulosin|tamsulosin|mesh-list
2648772|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2648773|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2648774|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2648775|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
2648776|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648777|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648778|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648779|NCT02038868|Urological Agents|urological agents|mesh-ancestor
2648780|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
2648781|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2178251|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178252|NCT00002334|Zidovudine|zidovudine|mesh-list
2178253|NCT00002334|Zalcitabine|zalcitabine|mesh-list
2178254|NCT00002334|Saquinavir|saquinavir|mesh-list
2178255|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
2178256|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178257|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178258|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178259|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648782|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
2648783|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648784|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648785|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2648786|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
2648787|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
2648788|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2648789|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
2648790|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648791|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648792|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
2648793|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2648794|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
2648795|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648796|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648797|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2648798|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
2648799|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
2648800|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2648801|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
2648802|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648803|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648804|NCT02039063|Quetmolimab|quetmolimab|mesh-list
2648805|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2648806|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2648807|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
2648808|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648809|NCT02039323|Tenofovir|tenofovir|mesh-list
2648810|NCT02039323|Maraviroc|maraviroc|mesh-list
2648811|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
2648812|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648813|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2648814|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2648815|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648816|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648817|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2648818|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2648819|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2648820|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2648821|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2648822|NCT02039336|Docetaxel|docetaxel|mesh-list
2648823|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648824|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
2648825|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
2648826|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
2648827|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648828|NCT02039362|Tenofovir|tenofovir|mesh-list
2178260|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
2178261|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178262|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178263|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178264|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178265|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178266|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178267|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2648829|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
2648830|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648831|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2648832|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2648833|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648834|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648835|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2648836|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2648837|NCT02039453|Fentanyl|fentanyl|mesh-list
2648838|NCT02039453|Meperidine|meperidine|mesh-list
2178268|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178269|NCT00002335|Emtricitabine|emtricitabine|mesh-list
2178270|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
2648839|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2648840|NCT02039453|Narcotics|narcotics|mesh-ancestor
2648841|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648842|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648843|NCT02039453|Analgesics|analgesics|mesh-ancestor
2648844|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
2648845|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648846|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2648847|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2648848|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
2648849|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
2648850|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
2648851|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
2648852|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2648853|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648854|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648855|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
2648856|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2648857|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648858|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648859|NCT02039492|Spironolactone|spironolactone|mesh-list
2648860|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2648861|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
2648862|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2648863|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648864|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2648865|NCT02039492|Diuretics|diuretics|mesh-ancestor
2648866|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
2648867|NCT02039518|Gemcitabine|gemcitabine|mesh-list
2648868|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2648869|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
2648870|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648871|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648872|NCT02039518|Antiviral Agents|antiviral agents|mesh-ancestor
2648873|NCT02039518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648874|NCT02039518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648875|NCT02039518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2648876|NCT02039518|Immunologic Factors|immunologic factors|mesh-ancestor
2648877|NCT02039518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648878|NCT02039531|Mitogens|mitogens|mesh-list
2648879|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
2648880|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
2648881|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648882|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2648883|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
2648884|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648885|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
2648886|NCT02039531|Protective Agents|protective agents|mesh-ancestor
2648887|NCT02039661|Lidocaine|lidocaine|mesh-list
2648888|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
2648889|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
2648890|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2648891|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648892|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
2648893|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648894|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2648895|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2648896|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2648897|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2648898|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648899|NCT02039700|Lesinurad|lesinurad|mesh-list
2648900|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
2648901|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2648902|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
2648903|NCT02039700|Renal Agents|renal agents|mesh-ancestor
2648904|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2648905|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2648906|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2648907|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2648908|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2648909|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
2648910|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648911|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648912|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178271|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178272|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178273|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178274|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178275|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178276|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178277|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178278|NCT00002336|Clarithromycin|clarithromycin|mesh-list
2648913|NCT02039791|Paclitaxel|paclitaxel|mesh-list
2648914|NCT02039791|Carboplatin|carboplatin|mesh-list
2648915|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
2648916|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2648917|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648918|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
2648919|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
2648920|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
2178279|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2178280|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178281|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2178282|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178283|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178284|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2178285|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178286|NCT00002337|Vesnarinone|vesnarinone|mesh-list
2178287|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2178288|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
2178289|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178290|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2178291|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
2178292|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2648921|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648922|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2648923|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2648924|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
2648925|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2648926|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
2648927|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648928|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
2648929|NCT02039804|Protective Agents|protective agents|mesh-ancestor
2648930|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2648931|NCT02039869|Omeprazole|omeprazole|mesh-list
2648932|NCT02039869|Sucralfate|sucralfate|mesh-list
2648933|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2648934|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2648935|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2648936|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648937|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648938|NCT02039960|Bupropion|bupropion|mesh-list
2648939|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2648940|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
2648941|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2648942|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2648943|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2648944|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2648945|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648946|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
2178293|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2178294|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2178295|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178296|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178297|NCT00002337|Protective Agents|protective agents|mesh-ancestor
2178298|NCT00002339|Fluconazole|fluconazole|mesh-list
2648947|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2648948|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178299|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
2178300|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178301|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2178302|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178303|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178304|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178305|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2178306|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
2184886|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2648949|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2648950|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2648951|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648952|NCT02039999|Citric Acid|citric acid|mesh-list
2648953|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
2648954|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2648955|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
2648956|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2648957|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
2648958|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
2648959|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648960|NCT02040064|Gefitinib|gefitinib|mesh-list
2648961|NCT02040064|Tremelimumab|tremelimumab|mesh-list
2648962|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648963|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2648964|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2648965|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648966|NCT02040142|Mitomycins|mitomycins|mesh-list
2648967|NCT02040142|Mitomycin|mitomycin|mesh-list
2648968|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2648969|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648970|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
2648971|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648972|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2648973|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178307|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2178308|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178309|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2178310|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2178311|NCT00002340|Atovaquone|atovaquone|mesh-list
2178312|NCT00002340|Pentamidine|pentamidine|mesh-list
2178313|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178314|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
2178315|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2178316|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2178317|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178318|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178319|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
2178320|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2178321|NCT00002341|Itraconazole|itraconazole|mesh-list
2178322|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
2178323|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178324|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2178325|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178326|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178327|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178328|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2178329|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
2178330|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2178331|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178332|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2178333|NCT00002343|Ethambutol|ethambutol|mesh-list
2178334|NCT00002343|Rifabutin|rifabutin|mesh-list
2178335|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
2178336|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2178337|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178338|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2178339|NCT00002344|Azithromycin|azithromycin|mesh-list
2178340|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2178341|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178342|NCT00002345|Megestrol|megestrol|mesh-list
2178343|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
2178344|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2178345|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2178346|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2178347|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
2178348|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2178349|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178350|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2648974|NCT02040220|Aflibercept|aflibercept|mesh-list
2648975|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2648976|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2648977|NCT02040220|Growth Substances|growth substances|mesh-ancestor
2648978|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648979|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
2648980|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2648981|NCT02040246|Metformin|metformin|mesh-list
2648982|NCT02040246|Repaglinide|repaglinide|mesh-list
2648983|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2648984|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648985|NCT02040285|Metoclopramide|metoclopramide|mesh-list
2648986|NCT02040285|Bisacodyl|bisacodyl|mesh-list
2648987|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
2648988|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
2648989|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2648990|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2648991|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2648992|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2648993|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2648994|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
2648995|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2178351|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2178352|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2178353|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2178354|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
2178355|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2178356|NCT00002346|Adefovir|adefovir|mesh-list
2178357|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2648996|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2648997|NCT02040285|Cathartics|cathartics|mesh-ancestor
2648998|NCT02040285|Laxatives|laxatives|mesh-ancestor
2648999|NCT02040311|Topiramate|topiramate|mesh-list
2649000|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
2649001|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2649002|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649003|NCT02040350|Pralidoxime|pralidoxime|mesh-list
2649004|NCT02040350|Antidotes|antidotes|mesh-ancestor
2649005|NCT02040350|Protective Agents|protective agents|mesh-ancestor
2649006|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649007|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
2649008|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
2649009|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649010|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
2649011|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2649012|NCT02040376|Metformin|metformin|mesh-list
2649013|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2649014|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649015|NCT02040402|Vaccines|vaccines|mesh-list
2649016|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
2649017|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649018|NCT02040415|Eperisone|eperisone|mesh-list
2649019|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
2649020|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2649021|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2649022|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649023|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2649024|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649025|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2649026|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2649027|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649028|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
2649029|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
2649030|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
2649031|NCT02040441|Spironolactone|spironolactone|mesh-list
2649032|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2649033|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
2649034|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649035|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649036|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2649037|NCT02040441|Diuretics|diuretics|mesh-ancestor
2649038|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
2649039|NCT02040454|Paclitaxel|paclitaxel|mesh-list
2649040|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2649041|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649042|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
2649043|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
2649044|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
2649045|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649046|NCT02040571|Insulin|insulin|mesh-list
2649047|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2649048|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649049|NCT02040597|Beclomethasone|beclomethasone|mesh-list
2649050|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
2649051|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
2649052|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2649053|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
2649054|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649055|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649056|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2649057|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
2649058|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2649059|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2649060|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2649061|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
2649062|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2649063|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649064|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2649065|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2649066|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2649067|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
2649068|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2178358|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
2178359|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649069|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
2649070|NCT02040597|Hormones|hormones|mesh-ancestor
2649071|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649072|NCT02040636|Vaccines|vaccines|mesh-list
2649073|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
2649074|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649075|NCT02040649|Midazolam|midazolam|mesh-list
2649076|NCT02040649|Propofol|propofol|mesh-list
2649077|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2649078|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649079|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649080|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2649081|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
2649082|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
2649083|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2649084|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2649085|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2649086|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2649087|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
2649088|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
2649089|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2649090|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649091|NCT02040662|Morphine|morphine|mesh-list
2649092|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2649093|NCT02040662|Narcotics|narcotics|mesh-ancestor
2649094|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649095|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649096|NCT02040662|Analgesics|analgesics|mesh-ancestor
2649097|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
2649098|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649099|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
2649100|NCT02040818|Tigecycline|tigecycline|mesh-list
2649101|NCT02040818|Heparin|heparin|mesh-list
2649102|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2649103|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
2649104|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2649105|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2649106|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649107|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
2649108|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649109|NCT02040818|Expectorants|expectorants|mesh-ancestor
2649110|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
2649111|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2649112|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
2649113|NCT02040818|Protective Agents|protective agents|mesh-ancestor
2649114|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649115|NCT02040818|Antidotes|antidotes|mesh-ancestor
2649116|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2649117|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2178360|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2649118|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649119|NCT02040831|Vaccines|vaccines|mesh-list
2649120|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
2649121|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649122|NCT02040883|Olanzapine|olanzapine|mesh-list
2649123|NCT02040883|Risperidone|risperidone|mesh-list
2649124|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2649125|NCT02040883|Aripiprazole|aripiprazole|mesh-list
2649126|NCT02040883|Ziprasidone|ziprasidone|mesh-list
2649127|NCT02040883|Tandospirone|tandospirone|mesh-list
2649128|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2649129|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
2649130|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2649131|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649132|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649133|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2178361|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178362|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178363|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649134|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2649135|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649136|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2649137|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2649138|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
2649139|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
2649140|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
2649141|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649142|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2649143|NCT02040883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2649144|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2649145|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2649146|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
2649147|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
2649148|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2649149|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2649150|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2649151|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2649152|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2649153|NCT02040909|Propofol|propofol|mesh-list
2649154|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2649155|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649156|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649157|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2649158|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
2649159|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
2649160|NCT02040935|Trastuzumab|trastuzumab|mesh-list
2649161|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2649162|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649163|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
2649164|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2649165|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649166|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2649167|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2649168|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178364|NCT00002347|Zidovudine|zidovudine|mesh-list
2178365|NCT00002347|Nevirapine|nevirapine|mesh-list
2178366|NCT00002347|Zalcitabine|zalcitabine|mesh-list
2178367|NCT00002347|Saquinavir|saquinavir|mesh-list
2178368|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
2178369|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178370|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178371|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178372|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178373|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
2178374|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178375|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178376|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178377|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2178378|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2178379|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178380|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178381|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178382|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2178383|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2649169|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649170|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649171|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2649172|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2649173|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2649174|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
2178384|NCT00002348|Mitoguazone|mitoguazone|mesh-list
2178385|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2178386|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178387|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178388|NCT00002349|Stavudine|stavudine|mesh-list
2178389|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
2178390|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649175|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649176|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2649177|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2649178|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649179|NCT02041143|Caseins|caseins|mesh-list
2649180|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
2649181|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
2649182|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649183|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2649184|NCT02041234|Liraglutide|liraglutide|mesh-list
2649185|NCT02041234|Empagliflozin|empagliflozin|mesh-list
2649186|NCT02041234|Linagliptin|linagliptin|mesh-list
2649187|NCT02041234|Canagliflozin|canagliflozin|mesh-list
2649188|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2649189|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2649190|NCT02041234|Orlistat|orlistat|mesh-list
2649191|NCT02041234|Incretins|incretins|mesh-list
2649192|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2649193|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649194|NCT02041234|Hormones|hormones|mesh-ancestor
2649195|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649196|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
2649197|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649198|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649199|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2649200|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2649201|NCT02041273|Palbociclib|palbociclib|mesh-list
2649202|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649203|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2649204|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649205|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649206|NCT02041338|Paclitaxel|paclitaxel|mesh-list
2649207|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2649208|NCT02041338|Carboplatin|carboplatin|mesh-list
2649209|NCT02041338|Epirubicin|epirubicin|mesh-list
2649210|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2178391|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178392|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178393|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178394|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
2178395|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178396|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178397|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178398|NCT00002351|Indinavir|indinavir|mesh-list
2178399|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178400|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178401|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178402|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178403|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649211|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649212|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
2649213|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
2649214|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
2649215|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649216|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2649217|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2649218|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2649219|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649220|NCT02041351|Docetaxel|docetaxel|mesh-list
2649221|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649222|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
2649223|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
2649224|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
2649225|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649226|NCT02041455|Amitriptyline|amitriptyline|mesh-list
2649227|NCT02041455|Melatonin|melatonin|mesh-list
2649228|NCT02041455|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2178404|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178405|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178406|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
2178407|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178408|NCT00002352|Lobucavir|lobucavir|mesh-list
2178409|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178410|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178411|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178412|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178413|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
2178414|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178415|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178416|NCT00002354|Stavudine|stavudine|mesh-list
2178417|NCT00002354|Indinavir|indinavir|mesh-list
2178418|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
2178419|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178420|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178421|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178422|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178423|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
2178424|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178425|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178426|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178427|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178428|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178429|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178430|NCT00002355|Fomivirsen|fomivirsen|mesh-list
2178431|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
2178432|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178433|NCT00002356|Fomivirsen|fomivirsen|mesh-list
2178434|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
2178435|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178436|NCT00002357|Zidovudine|zidovudine|mesh-list
2178437|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
2178438|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178439|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178440|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178441|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178442|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
2178443|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178444|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178445|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178446|NCT00002358|Sorivudine|sorivudine|mesh-list
2178447|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
2178448|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178449|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178450|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178451|NCT00002360|Didanosine|didanosine|mesh-list
2649229|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
2649230|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649231|NCT02041455|Protective Agents|protective agents|mesh-ancestor
2178452|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
2178453|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178454|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178455|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178456|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178457|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
2178458|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178459|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178460|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178461|NCT00002361|Ritonavir|ritonavir|mesh-list
2178462|NCT00002361|Indinavir|indinavir|mesh-list
2649232|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649233|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649234|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2649235|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
2649236|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2649237|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2649238|NCT02041455|Analgesics|analgesics|mesh-ancestor
2649239|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
2649240|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649241|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2178463|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178464|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178465|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178466|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184887|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
2649242|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2649243|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2649244|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
2649245|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2178467|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178468|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178469|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178470|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
2178471|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178472|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2649246|NCT02041455|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2649247|NCT02041455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2649248|NCT02041481|Leucovorin|leucovorin|mesh-list
2649249|NCT02041481|Fluorouracil|fluorouracil|mesh-list
2649250|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
2649251|NCT02041481|Calcium|calcium|mesh-list
2649252|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
2649253|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2649254|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649255|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
2649256|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649257|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2649258|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649259|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2178473|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178474|NCT00002362|Emtricitabine|emtricitabine|mesh-list
2178475|NCT00002362|Efavirenz|efavirenz|mesh-list
2178476|NCT00002362|Abacavir|abacavir|mesh-list
2178477|NCT00002362|Stavudine|stavudine|mesh-list
2178478|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
2178479|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178480|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178481|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178482|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178483|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178484|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178485|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2649260|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
2649261|NCT02041481|Antidotes|antidotes|mesh-ancestor
2649262|NCT02041481|Protective Agents|protective agents|mesh-ancestor
2649263|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
2649264|NCT02041481|Vitamins|vitamins|mesh-ancestor
2649265|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
2649266|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2649267|NCT02041546|Poractant alfa|poractant alfa|mesh-list
2649268|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
2649269|NCT02041650|Ticagrelor|ticagrelor|mesh-list
2649270|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2649271|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2649272|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2649273|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2649274|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
2649275|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2649276|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649277|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649278|NCT02041767|Ertapenem|ertapenem|mesh-list
2649279|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2649280|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649281|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
2649282|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2649283|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649284|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2178486|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2178487|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178488|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2178489|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2178490|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2178491|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2178492|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
2178493|NCT00002364|Abacavir|abacavir|mesh-list
2178494|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178495|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178496|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649285|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
2649286|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178497|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178498|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
2178499|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178500|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178501|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178502|NCT00002366|Ritonavir|ritonavir|mesh-list
2178503|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178504|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178505|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178506|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178507|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178508|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178509|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178510|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
2178511|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178512|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2178513|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178514|NCT00002367|Lamivudine|lamivudine|mesh-list
2178515|NCT00002367|Zidovudine|zidovudine|mesh-list
2178516|NCT00002367|Saquinavir|saquinavir|mesh-list
2178517|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178518|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178519|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178520|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178521|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
2178522|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178523|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178524|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178525|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
2178526|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178527|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178528|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178529|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2178530|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178531|NCT00002368|Lamivudine|lamivudine|mesh-list
2178532|NCT00002368|Nevirapine|nevirapine|mesh-list
2178533|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178534|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178535|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178536|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178537|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
2178538|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649287|NCT02042170|Hormones|hormones|mesh-list
2649288|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649289|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649290|NCT02042196|Cetrorelix|cetrorelix|mesh-list
2649291|NCT02042196|Estradiol|estradiol|mesh-list
2649292|NCT02042196|Estrogens|estrogens|mesh-ancestor
2649293|NCT02042196|Hormones|hormones|mesh-ancestor
2649294|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649295|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649296|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2649297|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2649298|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
2649299|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
2649300|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
2649301|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649302|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
2649303|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649304|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178539|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178540|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178541|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2178542|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2178543|NCT00002369|Lamivudine|lamivudine|mesh-list
2178544|NCT00002369|Zidovudine|zidovudine|mesh-list
2178545|NCT00002369|Stavudine|stavudine|mesh-list
2178546|NCT00002369|Indinavir|indinavir|mesh-list
2178547|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2649305|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2649306|NCT02042287|Metronidazole|metronidazole|mesh-list
2649307|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649308|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2649309|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2649310|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2649311|NCT02042326|Sirolimus|sirolimus|mesh-list
2649312|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2649313|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649314|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2649315|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649316|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
2649317|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2649318|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
2649319|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649320|NCT02042378|Rucaparib|rucaparib|mesh-list
2649321|NCT02042378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2649322|NCT02042378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649323|NCT02042378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649324|NCT02042378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649325|NCT02042391|Cytarabine|cytarabine|mesh-list
2649326|NCT02042391|Prednisone|prednisone|mesh-list
2649327|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
2649328|NCT02042391|Rituximab|rituximab|mesh-list
2649329|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
2649330|NCT02042391|Doxorubicin|doxorubicin|mesh-list
2649331|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2649332|NCT02042391|Vincristine|vincristine|mesh-list
2649333|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2649334|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
2649335|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649336|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2649337|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2649338|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
2649339|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649340|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649341|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2649342|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2649343|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2649344|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
2649345|NCT02042391|Hormones|hormones|mesh-ancestor
2649346|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649347|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2649348|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2649349|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
2649350|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
2649351|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649352|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2649353|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2649354|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2649355|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649356|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2649357|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
2649358|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
2649359|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
2649360|NCT02042482|Ubiquinone|ubiquinone|mesh-list
2649361|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
2649362|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
2649363|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649364|NCT02042482|Vitamins|vitamins|mesh-ancestor
2649365|NCT02042495|Metformin|metformin|mesh-list
2649366|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2649367|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649368|NCT02042573|Sertraline|sertraline|mesh-list
2649369|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
2649370|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2649371|NCT02042573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2649372|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2178548|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178549|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178550|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178551|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
2649373|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2649374|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649375|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2649376|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
2649377|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649378|NCT02042599|Sevoflurane|sevoflurane|mesh-list
2649379|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2649380|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2649381|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
2649382|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
2649383|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649384|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649385|NCT02042612|Sevoflurane|sevoflurane|mesh-list
2649386|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2649387|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2649388|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
2649389|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
2649390|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649391|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649392|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2649393|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2649394|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649395|NCT02042664|Metformin|metformin|mesh-list
2649396|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2649397|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649398|NCT02042690|Dexamethasone|dexamethasone|mesh-list
2649399|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
2649400|NCT02042690|Methotrexate|methotrexate|mesh-list
2649401|NCT02042690|Epirubicin|epirubicin|mesh-list
2649402|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
2649403|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2649404|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
2649405|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649406|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2649407|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2649408|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
2649409|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649410|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649411|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2649412|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2649413|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
2649414|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
2649415|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649416|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2649417|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
2649418|NCT02042690|Hormones|hormones|mesh-ancestor
2649419|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649420|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2649421|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649422|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2649423|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
2649424|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2649425|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2649426|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
2649427|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
2649428|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2649429|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2649430|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2649431|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2649432|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2649433|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
2649434|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
2649435|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649436|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
2649437|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649438|NCT02042742|Protective Agents|protective agents|mesh-ancestor
2649439|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649440|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2649441|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2649442|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
2649443|NCT02042989|Vorinostat|vorinostat|mesh-list
2649444|NCT02042989|Ixazomib|ixazomib|mesh-list
2649445|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649446|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2649447|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649448|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649449|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
2649450|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2649451|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2649452|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649453|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2649454|NCT02043054|Liraglutide|liraglutide|mesh-list
2649455|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2178552|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649456|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649457|NCT02043054|Incretins|incretins|mesh-ancestor
2649458|NCT02043054|Hormones|hormones|mesh-ancestor
2649459|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649460|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2649461|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
2649462|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649463|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649464|NCT02043171|Vitamin D|vitamin d|mesh-list
2649465|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
2649466|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
2649467|NCT02043171|Vitamins|vitamins|mesh-list
2649468|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
2649469|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649470|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2649471|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2649472|NCT02043223|Vitamins|vitamins|mesh-list
2649473|NCT02043223|Vitamin A|vitamin a|mesh-list
2649474|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
2649475|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
2649476|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649477|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
2649478|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649479|NCT02043223|Protective Agents|protective agents|mesh-ancestor
2649480|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2649481|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649482|NCT02043288|Gemcitabine|gemcitabine|mesh-list
2178553|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178554|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178555|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
2178556|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178557|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178558|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178559|NCT00002370|Itraconazole|itraconazole|mesh-list
2178560|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
2178561|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178562|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2178563|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178564|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178565|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178566|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2178567|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
2178568|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649483|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2649484|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
2649485|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649486|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649487|NCT02043288|Antiviral Agents|antiviral agents|mesh-ancestor
2649488|NCT02043288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649489|NCT02043288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649490|NCT02043288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2649491|NCT02043288|Immunologic Factors|immunologic factors|mesh-ancestor
2649492|NCT02043288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649493|NCT02043314|Isoniazid|isoniazid|mesh-list
2649494|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
2178569|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178570|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2178571|NCT00002371|Lamivudine|lamivudine|mesh-list
2178572|NCT00002371|Zidovudine|zidovudine|mesh-list
2178573|NCT00002371|Stavudine|stavudine|mesh-list
2178574|NCT00002371|Indinavir|indinavir|mesh-list
2178575|NCT00002371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178576|NCT00002371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178577|NCT00002371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178578|NCT00002371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178579|NCT00002371|Antiviral Agents|antiviral agents|mesh-ancestor
2178580|NCT00002371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178581|NCT00002371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178582|NCT00002371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178583|NCT00002371|Antimetabolites|antimetabolites|mesh-ancestor
2178584|NCT00002371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178585|NCT00002371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178586|NCT00002371|Protease Inhibitors|protease inhibitors|mesh-ancestor
2649495|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2649496|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649497|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2649498|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2178587|NCT00002372|Nelfinavir|nelfinavir|mesh-list
2178588|NCT00002372|Indinavir|indinavir|mesh-list
2178589|NCT00002372|Saquinavir|saquinavir|mesh-list
2178590|NCT00002372|Amprenavir|amprenavir|mesh-list
2178591|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2649499|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
2649500|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649501|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2649502|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
2649503|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
2649504|NCT02043457|Hormones|hormones|mesh-list
2649505|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649506|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649507|NCT02043587|Leucovorin|leucovorin|mesh-list
2649508|NCT02043587|Cytarabine|cytarabine|mesh-list
2649509|NCT02043587|Prednisone|prednisone|mesh-list
2649510|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
2649511|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2178592|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178593|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178594|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178595|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178596|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178597|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178598|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
2178599|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178600|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2178601|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178602|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2178603|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
2178604|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2178605|NCT00002373|Maribavir|maribavir|mesh-list
2178606|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
2178607|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178608|NCT00002374|Ritonavir|ritonavir|mesh-list
2178609|NCT00002374|Nelfinavir|nelfinavir|mesh-list
2178610|NCT00002374|Saquinavir|saquinavir|mesh-list
2649512|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2649513|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2649514|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
2649515|NCT02043587|Rituximab|rituximab|mesh-list
2649516|NCT02043587|Methotrexate|methotrexate|mesh-list
2649517|NCT02043587|Etoposide|etoposide|mesh-list
2649518|NCT02043587|Vincristine|vincristine|mesh-list
2649519|NCT02043587|Daunorubicin|daunorubicin|mesh-list
2649520|NCT02043587|Asparaginase|asparaginase|mesh-list
2649521|NCT02043587|Dasatinib|dasatinib|mesh-list
2649522|NCT02043587|Pegaspargase|pegaspargase|mesh-list
2649523|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2649524|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
2649525|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649526|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2649527|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2649528|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
2649529|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649530|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649531|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2649532|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2649533|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2649534|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
2649535|NCT02043587|Hormones|hormones|mesh-ancestor
2649536|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649537|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2649538|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2649539|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
2178611|NCT00002374|Stavudine|stavudine|mesh-list
2178612|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178613|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178614|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178615|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178616|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178617|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178618|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2649540|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2178619|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
2178620|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178621|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2649541|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2649542|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
2649543|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
2649544|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649545|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2649546|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2649547|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2649548|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2649549|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2178622|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178623|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
2178624|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178625|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178626|NCT00002375|Nelfinavir|nelfinavir|mesh-list
2178627|NCT00002375|Indinavir|indinavir|mesh-list
2178628|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178629|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178630|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178631|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178632|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178633|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178634|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178635|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
2178636|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178637|NCT00002376|Lamivudine|lamivudine|mesh-list
2178638|NCT00002376|Zidovudine|zidovudine|mesh-list
2178639|NCT00002376|Stavudine|stavudine|mesh-list
2178640|NCT00002376|Didanosine|didanosine|mesh-list
2178641|NCT00002376|Indinavir|indinavir|mesh-list
2649550|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
2649551|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649552|NCT02043587|Antidotes|antidotes|mesh-ancestor
2649553|NCT02043587|Protective Agents|protective agents|mesh-ancestor
2649554|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
2649555|NCT02043587|Vitamins|vitamins|mesh-ancestor
2649556|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
2649557|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
2649558|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
2649559|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
2649560|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2649561|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2649562|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
2649563|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2649564|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649565|NCT02043717|Vitamin D|vitamin d|mesh-list
2649566|NCT02043717|Vitamins|vitamins|mesh-ancestor
2649567|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
2649568|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649569|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2649570|NCT02043730|Gemcitabine|gemcitabine|mesh-list
2649571|NCT02043730|Paclitaxel|paclitaxel|mesh-list
2649572|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2649573|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649574|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
2649575|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
2649576|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
2649577|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649578|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2649579|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
2649580|NCT02043730|Antiviral Agents|antiviral agents|mesh-ancestor
2649581|NCT02043730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649582|NCT02043730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649583|NCT02043730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2649584|NCT02043730|Immunologic Factors|immunologic factors|mesh-ancestor
2649585|NCT02043730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649586|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
2649587|NCT02043756|Analgesics|analgesics|mesh-ancestor
2649588|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
2649589|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649590|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649591|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649592|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2649593|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2649594|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649595|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649596|NCT02043821|Capecitabine|capecitabine|mesh-list
2178642|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2649597|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2649598|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
2178643|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178644|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178645|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649599|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649600|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649601|NCT02043886|Acarbose|acarbose|mesh-list
2649602|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2649603|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649604|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649605|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2649606|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649607|NCT02043912|Haloperidol|haloperidol|mesh-list
2649608|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
2649609|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
2649610|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
2649611|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649612|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649613|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2649614|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2649615|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2649616|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649617|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2649618|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2649619|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
2649620|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2649621|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649622|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2649623|NCT02043977|Propofol|propofol|mesh-list
2649624|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2649625|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649626|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649627|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2649628|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
2649629|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
2649630|NCT02044120|Irinotecan|irinotecan|mesh-list
2649631|NCT02044120|Temozolomide|temozolomide|mesh-list
2649632|NCT02044120|Niraparib|niraparib|mesh-list
2649633|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2649634|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2649635|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649636|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649637|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649638|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2649639|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
2649640|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2649641|NCT02044133|Vitamin D|vitamin d|mesh-list
2649642|NCT02044133|Vitamins|vitamins|mesh-ancestor
2649643|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
2649644|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649645|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2649646|NCT02044146|Clopidogrel|clopidogrel|mesh-list
2649647|NCT02044146|Ticagrelor|ticagrelor|mesh-list
2649648|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2649649|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2178646|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
2178647|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178648|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2649650|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2649651|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2649652|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2649653|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
2649654|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2649655|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649656|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649657|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
2649658|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2649659|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649660|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649661|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2649662|NCT02044224|Analgesics|analgesics|mesh-ancestor
2649663|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
2649664|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649665|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2178649|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2649666|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2649667|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2649668|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
2649669|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2649670|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649671|NCT02044250|Aspirin|aspirin|mesh-list
2649672|NCT02044250|Clopidogrel|clopidogrel|mesh-list
2649673|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2649674|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2649675|NCT02044250|Analgesics|analgesics|mesh-ancestor
2649676|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
2649677|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649678|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649679|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2649680|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2649681|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2649682|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2649683|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649684|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2649685|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2649686|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649687|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
2649688|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2649689|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2649690|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2649691|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
2649692|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2649693|NCT02044341|Benzocaine|benzocaine|mesh-list
2649694|NCT02044341|Glycerol|glycerol|mesh-list
2649695|NCT02044341|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2649696|NCT02044341|Protective Agents|protective agents|mesh-ancestor
2649697|NCT02044341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649698|NCT02044341|Anesthetics, Local|anesthetics, local|mesh-ancestor
2649699|NCT02044341|Anesthetics|anesthetics|mesh-ancestor
2649700|NCT02044341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649701|NCT02044341|Sensory System Agents|sensory system agents|mesh-ancestor
2649702|NCT02044341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649703|NCT02044354|Docetaxel|docetaxel|mesh-list
2649704|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649705|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
2178650|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
2178651|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178652|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178653|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178654|NCT00002377|Valganciclovir|valganciclovir|mesh-list
2178655|NCT00002377|Ganciclovir|ganciclovir|mesh-list
2178656|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2178657|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
2178658|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178659|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178660|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649706|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
2649707|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
2649708|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178661|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178662|NCT00002378|Ritonavir|ritonavir|mesh-list
2178663|NCT00002378|Nelfinavir|nelfinavir|mesh-list
2178664|NCT00002378|Saquinavir|saquinavir|mesh-list
2178665|NCT00002378|Lamivudine|lamivudine|mesh-list
2178666|NCT00002378|Zidovudine|zidovudine|mesh-list
2178667|NCT00002378|Stavudine|stavudine|mesh-list
2178668|NCT00002378|Delavirdine|delavirdine|mesh-list
2178669|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178670|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178671|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178672|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178673|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178674|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178675|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178676|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
2178677|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178678|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2178679|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178680|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2649709|NCT02044497|Oxycodone|oxycodone|mesh-list
2649710|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2649711|NCT02044497|Narcotics|narcotics|mesh-ancestor
2649712|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649713|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649714|NCT02044497|Analgesics|analgesics|mesh-ancestor
2649715|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
2649716|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649717|NCT02044549|Oxytocin|oxytocin|mesh-list
2649718|NCT02044549|Carbetocin|carbetocin|mesh-list
2649719|NCT02044549|Methylergonovine|methylergonovine|mesh-list
2178681|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178682|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
2178683|NCT00002379|Lamivudine|lamivudine|mesh-list
2178684|NCT00002379|Zidovudine|zidovudine|mesh-list
2178685|NCT00002379|Stavudine|stavudine|mesh-list
2178686|NCT00002379|Adefovir|adefovir|mesh-list
2178687|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2178688|NCT00002379|Indinavir|indinavir|mesh-list
2178689|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178690|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178691|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178692|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178693|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
2178694|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178695|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178696|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178697|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
2178698|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178699|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178700|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
2649720|NCT02044549|Syntometrine|syntometrine|mesh-list
2649721|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
2649722|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2649723|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649724|NCT02044601|Paclitaxel|paclitaxel|mesh-list
2649725|NCT02044601|Carboplatin|carboplatin|mesh-list
2649726|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2649727|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2649728|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649729|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
2649730|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
2649731|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
2649732|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649733|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2649734|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178701|NCT00002380|Nelfinavir|nelfinavir|mesh-list
2178702|NCT00002380|Saquinavir|saquinavir|mesh-list
2178703|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178704|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178705|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178706|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178707|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178708|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178709|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178710|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
2649735|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2649736|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2649737|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
2649738|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649739|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2649740|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649741|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2649742|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649743|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
2178711|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178712|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2178713|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178714|NCT00002381|Nevirapine|nevirapine|mesh-list
2178715|NCT00002381|Stavudine|stavudine|mesh-list
2178716|NCT00002381|Nelfinavir|nelfinavir|mesh-list
2178717|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178718|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178719|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178720|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178721|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
2178722|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178723|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178724|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178725|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2178726|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2178727|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
2178728|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2649744|NCT02044653|Hematinics|hematinics|mesh-ancestor
2649745|NCT02044809|Cannabidiol|cannabidiol|mesh-list
2649746|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
2649747|NCT02044952|Mesalamine|mesalamine|mesh-list
2649748|NCT02044952|Triptolide|triptolide|mesh-list
2649749|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2649750|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2649751|NCT02044952|Analgesics|analgesics|mesh-ancestor
2649752|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
2649753|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649754|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649755|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2649756|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2649757|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649758|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2649759|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2649760|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
2649761|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2649762|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2649763|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
2649764|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2649765|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
2649766|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649767|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2178729|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178730|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178731|NCT00002382|Saquinavir|saquinavir|mesh-list
2178732|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178733|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178734|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178735|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178736|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178737|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178738|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178739|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
2649768|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2649769|NCT02044965|Trimethoprim|trimethoprim|mesh-list
2649770|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
2649771|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649772|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2649773|NCT02044965|Renal Agents|renal agents|mesh-ancestor
2649774|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
2649775|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2649776|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2649777|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2649778|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649779|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649780|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2649781|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2649782|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2649783|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
2649784|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2649785|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649786|NCT02045017|Dexamethasone|dexamethasone|mesh-list
2178740|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178741|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2178742|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178743|NCT00002383|Saquinavir|saquinavir|mesh-list
2178744|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178745|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2649787|NCT02045017|Pomalidomide|pomalidomide|mesh-list
2649788|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2649789|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
2649790|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
2649791|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649792|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649793|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2649794|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
2649795|NCT02045017|Hormones|hormones|mesh-ancestor
2649796|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649797|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2649798|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2178746|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178747|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649799|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
2649800|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2649801|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2649802|NCT02045017|Growth Substances|growth substances|mesh-ancestor
2649803|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
2649804|NCT02045030|Aflibercept|aflibercept|mesh-list
2649805|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2649806|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2649807|NCT02045030|Growth Substances|growth substances|mesh-ancestor
2649808|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649809|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
2649810|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649811|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
2649812|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2649813|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
2649814|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649815|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2649816|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2649817|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2649818|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649819|NCT02045069|Ivermectin|ivermectin|mesh-list
2649820|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2649821|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649822|NCT02045290|Metformin|metformin|mesh-list
2649823|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2649824|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649825|NCT02045368|Methotrexate|methotrexate|mesh-list
2649826|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2649827|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
2649828|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2649829|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649830|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2649831|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
2649832|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649833|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649834|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
2649835|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649836|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2649837|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2649838|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
2649839|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2649840|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2649841|NCT02045589|Gemcitabine|gemcitabine|mesh-list
2649842|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2649843|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2649844|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
2649845|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649846|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649847|NCT02045589|Antiviral Agents|antiviral agents|mesh-ancestor
2649848|NCT02045589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649849|NCT02045589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649850|NCT02045589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2649851|NCT02045589|Immunologic Factors|immunologic factors|mesh-ancestor
2649852|NCT02045589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649853|NCT02045602|Gemcitabine|gemcitabine|mesh-list
2649854|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2649855|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2649856|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
2649857|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649858|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649859|NCT02045602|Antiviral Agents|antiviral agents|mesh-ancestor
2649860|NCT02045602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649861|NCT02045602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649862|NCT02045602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2649863|NCT02045602|Immunologic Factors|immunologic factors|mesh-ancestor
2649864|NCT02045602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649865|NCT02045667|Mexiletine|mexiletine|mesh-list
2649866|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2649867|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2649868|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2649869|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2649870|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649871|NCT02045693|Buprenorphine|buprenorphine|mesh-list
2649872|NCT02045693|Methadone|methadone|mesh-list
2649873|NCT02045693|Naloxone|naloxone|mesh-list
2649874|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2649875|NCT02045693|Narcotics|narcotics|mesh-ancestor
2649876|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649877|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649878|NCT02045693|Analgesics|analgesics|mesh-ancestor
2649879|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
2649880|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649881|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2649882|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
2649883|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
2649884|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
2178748|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178749|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178750|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178751|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
2178752|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178753|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2649885|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
2649886|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
2649887|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2649888|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649889|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
2649890|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649891|NCT02045849|Itraconazole|itraconazole|mesh-list
2649892|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
2649893|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649894|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2649895|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2649896|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649897|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178754|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178755|NCT00002384|Cidofovir|cidofovir|mesh-list
2178756|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
2178757|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178758|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178759|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178760|NCT00002386|Lamivudine|lamivudine|mesh-list
2178761|NCT00002386|Zidovudine|zidovudine|mesh-list
2178762|NCT00002386|Stavudine|stavudine|mesh-list
2178763|NCT00002386|Didanosine|didanosine|mesh-list
2178764|NCT00002386|Zalcitabine|zalcitabine|mesh-list
2178765|NCT00002386|Indinavir|indinavir|mesh-list
2178766|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178767|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178768|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178769|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178770|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
2649898|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2649899|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
2649900|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649901|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649902|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2649903|NCT02045914|Calcium|calcium|mesh-list
2649904|NCT02045914|Ionophores|ionophores|mesh-list
2649905|NCT02045914|Ionomycin|ionomycin|mesh-list
2649906|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
2649907|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2649908|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649909|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2649910|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649911|NCT02045940|GSK2881078|gsk2881078|mesh-list
2649912|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
2649913|NCT02045940|Hormones|hormones|mesh-ancestor
2649914|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2649915|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649916|NCT02045953|Albuterol|albuterol|mesh-list
2649917|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2649918|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
2649919|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2649920|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649921|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2649922|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
2178771|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649923|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
2649924|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2649925|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2649926|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2649927|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2649928|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
2178772|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178773|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178774|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
2178775|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178776|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178777|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178778|NCT00002387|Efavirenz|efavirenz|mesh-list
2178779|NCT00002387|Indinavir|indinavir|mesh-list
2178780|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178781|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178782|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649929|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2649930|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649931|NCT02045992|Caffeine|caffeine|mesh-list
2649932|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2649933|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649934|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2649935|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649936|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649937|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2649938|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2649939|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
2649940|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2649941|NCT02046044|Digoxin|digoxin|mesh-list
2649942|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2649943|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2649944|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649945|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649946|NCT02046044|Protective Agents|protective agents|mesh-ancestor
2649947|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649948|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
2649949|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2649950|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649951|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
2649952|NCT02046187|Temozolomide|temozolomide|mesh-list
2649953|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2649954|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
2649955|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649956|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649957|NCT02046304|Gemcitabine|gemcitabine|mesh-list
2649958|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2649959|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
2649960|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649961|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649962|NCT02046304|Antiviral Agents|antiviral agents|mesh-ancestor
2649963|NCT02046304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178783|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178784|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
2178785|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178786|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2178787|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178788|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2178789|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2649964|NCT02046304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649965|NCT02046304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2649966|NCT02046304|Immunologic Factors|immunologic factors|mesh-ancestor
2649967|NCT02046304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649968|NCT02046395|Amlodipine|amlodipine|mesh-list
2649969|NCT02046395|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2649970|NCT02046395|Hydralazine|hydralazine|mesh-list
2649971|NCT02046395|Terazosin|terazosin|mesh-list
2649972|NCT02046395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2649973|NCT02046395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2649974|NCT02046395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2649975|NCT02046395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649976|NCT02046395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2649977|NCT02046395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2649978|NCT02046395|Vasodilator Agents|vasodilator agents|mesh-ancestor
2649979|NCT02046395|Diuretics|diuretics|mesh-ancestor
2649980|NCT02046395|Natriuretic Agents|natriuretic agents|mesh-ancestor
2178790|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2178791|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2178792|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178793|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178794|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178795|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178796|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178797|NCT00002388|Abacavir|abacavir|mesh-list
2178798|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178799|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2649981|NCT02046395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2649982|NCT02046395|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2649983|NCT02046395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2649984|NCT02046395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2649985|NCT02046395|Adrenergic Agents|adrenergic agents|mesh-ancestor
2649986|NCT02046395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2649987|NCT02046395|Urological Agents|urological agents|mesh-ancestor
2649988|NCT02046421|Gemcitabine|gemcitabine|mesh-list
2649989|NCT02046421|Carboplatin|carboplatin|mesh-list
2649990|NCT02046421|Mifepristone|mifepristone|mesh-list
2649991|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2649992|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2649993|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
2649994|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2649995|NCT02046421|Antiviral Agents|antiviral agents|mesh-ancestor
2649996|NCT02046421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2649997|NCT02046421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2649998|NCT02046421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2649999|NCT02046421|Immunologic Factors|immunologic factors|mesh-ancestor
2650000|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650001|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2650002|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
2650003|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2650004|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2650005|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2650006|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2650007|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
2650008|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2650009|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2650010|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
2650011|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650012|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
2650013|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2650014|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2650015|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2650016|NCT02046434|Glycerol|glycerol|mesh-list
2650017|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2650018|NCT02046434|Protective Agents|protective agents|mesh-ancestor
2650019|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650020|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650021|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
2650022|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2650023|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2650024|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2650025|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2650026|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
2650027|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650028|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650029|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650030|NCT02046460|Aspirin|aspirin|mesh-list
2650031|NCT02046460|Vitamin K|vitamin k|mesh-list
2650032|NCT02046460|Warfarin|warfarin|mesh-list
2650033|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
2650034|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
2650035|NCT02046460|Vitamins|vitamins|mesh-ancestor
2650036|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
2650037|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650038|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
2650039|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2650040|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2650041|NCT02046460|Analgesics|analgesics|mesh-ancestor
2650042|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
2650043|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2178800|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178801|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178802|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
2178803|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178804|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178805|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178806|NCT00002389|Lamivudine|lamivudine|mesh-list
2178807|NCT00002389|Zidovudine|zidovudine|mesh-list
2178808|NCT00002389|Abacavir|abacavir|mesh-list
2178809|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178810|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178811|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178812|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178813|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
2178814|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178815|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178816|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178817|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
2178818|NCT00002390|Abacavir|abacavir|mesh-list
2178819|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178820|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178821|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178822|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178823|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
2178824|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178825|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178826|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2650044|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2650045|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2650046|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2650047|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2650048|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650049|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2650050|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2650051|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650052|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
2650053|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2650054|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
2650055|NCT02046460|Coagulants|coagulants|mesh-ancestor
2650056|NCT02046486|Ticagrelor|ticagrelor|mesh-list
2650057|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2650058|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2650059|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2650060|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2650061|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
2650062|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650063|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650064|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650065|NCT02046499|Oxytocin|oxytocin|mesh-list
2650066|NCT02046499|Ergonovine|ergonovine|mesh-list
2650067|NCT02046499|Syntometrine|syntometrine|mesh-list
2650068|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
2650069|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2178827|NCT00002391|Lamivudine|lamivudine|mesh-list
2178828|NCT00002391|Zidovudine|zidovudine|mesh-list
2178829|NCT00002391|Abacavir|abacavir|mesh-list
2650070|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650071|NCT02046538|Leucovorin|leucovorin|mesh-list
2650072|NCT02046538|Fluorouracil|fluorouracil|mesh-list
2650073|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
2650074|NCT02046538|Irinotecan|irinotecan|mesh-list
2650075|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
2650076|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650077|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2650078|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650079|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2650080|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
2650081|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650082|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2650083|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2650084|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650085|NCT02046538|Antidotes|antidotes|mesh-ancestor
2650086|NCT02046538|Protective Agents|protective agents|mesh-ancestor
2650087|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
2178830|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178831|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2650088|NCT02046538|Vitamins|vitamins|mesh-ancestor
2650089|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
2650090|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2650091|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2650092|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2650093|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2650094|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650095|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
2650096|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2178832|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650097|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650098|NCT02046577|Vitamin D|vitamin d|mesh-list
2650099|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
2650100|NCT02046577|Vitamins|vitamins|mesh-ancestor
2650101|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
2650102|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650103|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2650104|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2650105|NCT02046590|Propofol|propofol|mesh-list
2650106|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
2650107|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2650108|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650109|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2650110|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2650111|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
2650112|NCT02046629|Teriflunomide|teriflunomide|mesh-list
2650113|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
2650114|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2650115|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2650116|NCT02046629|Analgesics|analgesics|mesh-ancestor
2650117|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
2650118|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650119|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650120|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2650121|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2650122|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2650123|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
2650124|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2650125|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2650126|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
2650127|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650128|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2650129|NCT02046668|Spironolactone|spironolactone|mesh-list
2650130|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2650131|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
2650132|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650133|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650134|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2650135|NCT02046668|Diuretics|diuretics|mesh-ancestor
2650136|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
2650137|NCT02046694|Allopurinol|allopurinol|mesh-list
2650138|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
2650139|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650140|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650141|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
2650142|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2650143|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2650144|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
2650145|NCT02046694|Protective Agents|protective agents|mesh-ancestor
2650146|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650147|NCT02046720|Propofol|propofol|mesh-list
2650148|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2650149|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2650150|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650151|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2650152|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
2650153|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
2650154|NCT02046733|Nivolumab|nivolumab|mesh-list
2650155|NCT02046733|Ipilimumab|ipilimumab|mesh-list
2650156|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2650157|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650158|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2650159|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650160|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2650161|NCT02046850|Rifampin|rifampin|mesh-list
2650162|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2650163|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
2650164|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2650165|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650166|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
2650167|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2650168|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650169|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650170|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2650171|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2650172|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2650173|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2650174|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2650175|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2650176|NCT02046915|Dexamethasone|dexamethasone|mesh-list
2650177|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
2650178|NCT02046915|Pomalidomide|pomalidomide|mesh-list
2650179|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2650180|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
2650181|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650182|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2650183|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2650184|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
2650185|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650186|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650187|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2650188|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2650189|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
2650190|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
2178833|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178834|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
2178835|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178836|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178837|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178838|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
2178839|NCT00002392|Thalidomide|thalidomide|mesh-list
2178840|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2178841|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
2178842|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178843|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
2178844|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2650191|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650192|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2650193|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
2650194|NCT02046915|Hormones|hormones|mesh-ancestor
2650195|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650196|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2650197|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2650198|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2650199|NCT02046915|Growth Substances|growth substances|mesh-ancestor
2650200|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
2650201|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
2650202|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2178845|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178846|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2178847|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2178848|NCT00002392|Growth Substances|growth substances|mesh-ancestor
2178849|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
2178850|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2178851|NCT00002393|Efavirenz|efavirenz|mesh-list
2178852|NCT00002393|Indinavir|indinavir|mesh-list
2178853|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178854|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178855|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178856|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178857|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
2178858|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178859|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2178860|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178861|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2178862|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2178863|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2178864|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2650203|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
2650204|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2650205|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
2650206|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650207|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650208|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
2650209|NCT02047019|Candesartan|candesartan|mesh-list
2650210|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
2650211|NCT02047019|Nifedipine|nifedipine|mesh-list
2650212|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2650213|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2650214|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2650215|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650216|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2650217|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2178865|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178866|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178867|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178868|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178869|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178870|NCT00002394|Terbinafine|terbinafine|mesh-list
2178871|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
2178872|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178873|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178874|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178875|NCT00002395|Topotecan|topotecan|mesh-list
2178876|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2178877|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2178878|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650218|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2650219|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650220|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
2650221|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
2650222|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2650223|NCT02047136|Histamine|histamine|mesh-list
2650224|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
2650225|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
2650226|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650227|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650228|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650229|NCT02047149|Zileuton|zileuton|mesh-list
2650230|NCT02047149|Dasatinib|dasatinib|mesh-list
2650231|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
2650232|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650233|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2650234|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650235|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650236|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2650237|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2650238|NCT02047149|Analgesics|analgesics|mesh-ancestor
2650239|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
2650240|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650241|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650242|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2650243|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2650244|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2650245|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2650246|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
2650247|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650248|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
2650249|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2650250|NCT02047162|Bismuth|bismuth|mesh-list
2650251|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2650252|NCT02047162|Antacids|antacids|mesh-ancestor
2178879|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178880|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2178881|NCT00002396|Tenofovir|tenofovir|mesh-list
2178882|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
2178883|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178884|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178885|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178886|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178887|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178888|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178889|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178890|NCT00002397|Lamivudine|lamivudine|mesh-list
2178891|NCT00002397|Stavudine|stavudine|mesh-list
2650253|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650254|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2650255|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
2650256|NCT02047175|Niacin|niacin|mesh-list
2650257|NCT02047175|Amlodipine|amlodipine|mesh-list
2650258|NCT02047175|Telmisartan|telmisartan|mesh-list
2650259|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2650260|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2650261|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2650262|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2650263|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650264|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2650265|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650266|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
2650267|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2650268|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2650269|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
2650270|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2650271|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2650272|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650273|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2650274|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2650275|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
2650276|NCT02047175|Vitamins|vitamins|mesh-ancestor
2650277|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
2650278|NCT02047201|Docetaxel|docetaxel|mesh-list
2650279|NCT02047201|Fluorouracil|fluorouracil|mesh-list
2650280|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650281|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
2650282|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
2650283|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
2650284|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650285|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
2650286|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2650287|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2650288|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
2650289|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650290|NCT02047214|Bevacizumab|bevacizumab|mesh-list
2650291|NCT02047214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2650292|NCT02047214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650293|NCT02047214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2650294|NCT02047214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2650295|NCT02047214|Growth Substances|growth substances|mesh-ancestor
2650296|NCT02047214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650297|NCT02047214|Growth Inhibitors|growth inhibitors|mesh-ancestor
2650298|NCT02047292|Tacrine|tacrine|mesh-list
2650299|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2650300|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650301|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650302|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
2650303|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650304|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650305|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2650306|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
2650307|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650308|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
2650309|NCT02047422|Metolazone|metolazone|mesh-list
2650310|NCT02047422|Furosemide|furosemide|mesh-list
2650311|NCT02047422|Spironolactone|spironolactone|mesh-list
2650312|NCT02047422|Diuretics|diuretics|mesh-ancestor
2650313|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
2650314|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650315|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2178892|NCT00002397|Nelfinavir|nelfinavir|mesh-list
2178893|NCT00002397|Saquinavir|saquinavir|mesh-list
2178894|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178895|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178896|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178897|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178898|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
2178899|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178900|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178901|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178902|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
2178903|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2650316|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2650317|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650318|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2650319|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
2650320|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650321|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2650322|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2650323|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2650324|NCT02047474|Leucovorin|leucovorin|mesh-list
2650325|NCT02047474|Fluorouracil|fluorouracil|mesh-list
2650326|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
2650327|NCT02047474|Irinotecan|irinotecan|mesh-list
2650328|NCT02047474|Calcium|calcium|mesh-list
2650329|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
2650330|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2178904|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178905|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178906|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2178907|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178908|NCT00002398|Adefovir|adefovir|mesh-list
2178909|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2178910|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
2650331|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650332|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
2650333|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650334|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2650335|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650336|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2650337|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
2650338|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2650339|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2650340|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650341|NCT02047474|Antidotes|antidotes|mesh-ancestor
2650342|NCT02047474|Protective Agents|protective agents|mesh-ancestor
2650343|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
2650344|NCT02047474|Vitamins|vitamins|mesh-ancestor
2650345|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
2650346|NCT02047539|Aspirin|aspirin|mesh-list
2650347|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2650348|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2650349|NCT02047539|Analgesics|analgesics|mesh-ancestor
2650350|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
2650351|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650352|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650353|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2650354|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2650355|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2650356|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2650357|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650358|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2650359|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2650360|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650361|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
2650362|NCT02047552|Iron|iron|mesh-list
2650363|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2650364|NCT02047552|Oxandrolone|oxandrolone|mesh-list
2650365|NCT02047552|Trace Elements|trace elements|mesh-ancestor
2650366|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
2650367|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650368|NCT02047552|Hematinics|hematinics|mesh-ancestor
2650369|NCT02047552|Androgens|androgens|mesh-ancestor
2650370|NCT02047552|Hormones|hormones|mesh-ancestor
2650371|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650372|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
2650373|NCT02047565|Edoxaban|edoxaban|mesh-list
2650374|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2650375|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
2650376|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2650377|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
2650378|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650379|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650380|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
2650381|NCT02047578|Busulfan|busulfan|mesh-list
2650382|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
2650383|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650384|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2650385|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
2650386|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650387|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2650388|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650389|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2650390|NCT02047630|Latanoprost|latanoprost|mesh-list
2650391|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2650392|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2650393|NCT02047773|Meropenem|meropenem|mesh-list
2650394|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2650395|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650396|NCT02047799|Calcitriol|calcitriol|mesh-list
2650397|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2650398|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650399|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2650400|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2178911|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178912|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178913|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178914|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178915|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178916|NCT00002399|Fluconazole|fluconazole|mesh-list
2178917|NCT00002399|Posaconazole|posaconazole|mesh-list
2650401|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650402|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2650403|NCT02047799|Vitamins|vitamins|mesh-ancestor
2650404|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
2650405|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2650406|NCT02047838|Hormones|hormones|mesh-list
2650407|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2650408|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650409|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650410|NCT02048007|Azithromycin|azithromycin|mesh-list
2650411|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2650412|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178918|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
2178919|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178920|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2178921|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2178922|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178923|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178924|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2178925|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
2178926|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2178927|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650413|NCT02048020|Paclitaxel|paclitaxel|mesh-list
2650414|NCT02048020|Carboplatin|carboplatin|mesh-list
2650415|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2650416|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650417|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
2650418|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
2650419|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
2650420|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650421|NCT02048085|Clopidogrel|clopidogrel|mesh-list
2650422|NCT02048085|Ticagrelor|ticagrelor|mesh-list
2650423|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2650424|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2650425|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2650426|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2650427|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
2650428|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650429|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650430|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650431|NCT02048098|Misoprostol|misoprostol|mesh-list
2650432|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2650433|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
2650434|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2650435|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650436|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2650437|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2650438|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
2650439|NCT02048150|Antibodies|antibodies|mesh-list
2650440|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2178928|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2178929|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2650441|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
2650442|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650443|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
2650444|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2650445|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650446|NCT02048215|Ephedrine|ephedrine|mesh-list
2650447|NCT02048215|Caffeine|caffeine|mesh-list
2650448|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2650449|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650450|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2650451|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650452|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650453|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2650454|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2650455|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
2650456|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650457|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
2650458|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
2650459|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650460|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2650461|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
2650462|NCT02048228|Clopidogrel|clopidogrel|mesh-list
2650463|NCT02048228|Ticagrelor|ticagrelor|mesh-list
2650464|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2650465|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2650466|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2650467|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2650468|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
2650469|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650470|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650471|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650472|NCT02048293|Remifentanil|remifentanil|mesh-list
2178930|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2178931|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2178932|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2178933|NCT00002400|Lamivudine|lamivudine|mesh-list
2178934|NCT00002400|Zidovudine|zidovudine|mesh-list
2178935|NCT00002400|Delavirdine|delavirdine|mesh-list
2178936|NCT00002400|Indinavir|indinavir|mesh-list
2650473|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2650474|NCT02048293|Narcotics|narcotics|mesh-ancestor
2650475|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2650476|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650477|NCT02048293|Analgesics|analgesics|mesh-ancestor
2650478|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
2650479|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650480|NCT02048319|Ethanol|ethanol|mesh-list
2650481|NCT02048319|Pasireotide|pasireotide|mesh-list
2650482|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2650483|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650484|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2650485|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650486|NCT02048319|Hormones|hormones|mesh-ancestor
2650487|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650488|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2650489|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
2650490|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2650491|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2650492|NCT02048358|Prednisolone|prednisolone|mesh-list
2650493|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
2650494|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2650495|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
2650496|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2650497|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
2650498|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
2650499|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650500|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650501|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2650502|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
2650503|NCT02048358|Hormones|hormones|mesh-ancestor
2650504|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650505|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2650506|NCT02048358|Protective Agents|protective agents|mesh-ancestor
2650507|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2650508|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650509|NCT02048384|Metformin|metformin|mesh-list
2650510|NCT02048384|Sirolimus|sirolimus|mesh-list
2650511|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2650512|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650513|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2650514|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650515|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2650516|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650517|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
2650518|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2650519|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
2650520|NCT02048423|Ketamine|ketamine|mesh-list
2650521|NCT02048423|Analgesics|analgesics|mesh-ancestor
2650522|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
2650523|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650524|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650525|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2650526|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2650527|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
2650528|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
2650529|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2650530|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2650531|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2650532|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650533|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650534|NCT02048475|Desflurane|desflurane|mesh-list
2650535|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2650536|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
2650537|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
2650538|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2650539|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650540|NCT02048488|Belizatinib|belizatinib|mesh-list
2650541|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2650542|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650543|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650544|NCT02048540|Bevacizumab|bevacizumab|mesh-list
2650545|NCT02048540|Docetaxel|docetaxel|mesh-list
2650546|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
2650547|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2650548|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650549|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2650550|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2650551|NCT02048540|Growth Substances|growth substances|mesh-ancestor
2650552|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650553|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
2650554|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
2650555|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
2650556|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
2650557|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650558|NCT02048644|Beclomethasone|beclomethasone|mesh-list
2650559|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
2650560|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2178937|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178938|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178939|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178940|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178941|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
2178942|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178943|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178944|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178945|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
2178946|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178947|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178948|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178949|NCT00002401|Lamivudine|lamivudine|mesh-list
2178950|NCT00002401|Zidovudine|zidovudine|mesh-list
2178951|NCT00002401|Delavirdine|delavirdine|mesh-list
2178952|NCT00002401|Indinavir|indinavir|mesh-list
2178953|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2178954|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2178955|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178956|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178957|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
2650561|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
2650562|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650563|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650564|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2650565|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
2650566|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2650567|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2650568|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2650569|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
2650570|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650571|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650572|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2650573|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
2650574|NCT02048644|Hormones|hormones|mesh-ancestor
2650575|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650576|NCT02048683|Sevoflurane|sevoflurane|mesh-list
2650577|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2650578|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2650579|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
2650580|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
2650581|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2650582|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650583|NCT02048761|Metformin|metformin|mesh-list
2650584|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2650585|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650586|NCT02048800|Treosulfan|treosulfan|mesh-list
2650587|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2650588|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
2650589|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650590|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2178958|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178959|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178960|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178961|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
2178962|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178963|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178964|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178965|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2178966|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2178967|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
2178968|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2178969|NCT00002402|Antacids|antacids|mesh-ancestor
2178970|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178971|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2178972|NCT00002404|Valacyclovir|valacyclovir|mesh-list
2178973|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
2178974|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178975|NCT00002405|Amprenavir|amprenavir|mesh-list
2178976|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2650610|NCT02048852|Menthol|menthol|mesh-list
2650611|NCT02048852|Nicotine|nicotine|mesh-list
2650612|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2650613|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
2650614|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650615|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650616|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2650617|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2650618|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
2178977|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
2178978|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2178979|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178980|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178981|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2650619|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650620|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650621|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
2650622|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
2650623|NCT02048865|Apixaban|apixaban|mesh-list
2650624|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2650625|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
2650626|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2650627|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
2650628|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650629|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650630|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
2650631|NCT02048917|Bupropion|bupropion|mesh-list
2650632|NCT02048917|Varenicline|varenicline|mesh-list
2650633|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2650634|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
2650635|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2650636|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2650637|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2178982|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178983|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178984|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178985|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178986|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178987|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
2178988|NCT00002406|Indinavir|indinavir|mesh-list
2178989|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2178990|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2178991|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
2178992|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2178993|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2178994|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2178995|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2178996|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
2178997|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2178998|NCT00002407|Lamivudine|lamivudine|mesh-list
2178999|NCT00002407|Nevirapine|nevirapine|mesh-list
2179000|NCT00002407|Stavudine|stavudine|mesh-list
2179001|NCT00002407|Didanosine|didanosine|mesh-list
2179002|NCT00002407|Indinavir|indinavir|mesh-list
2179003|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179004|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179005|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179006|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179007|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
2179008|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179009|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179010|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179011|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2179012|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2179013|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
2179014|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179015|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179016|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179017|NCT00002409|Lamivudine|lamivudine|mesh-list
2650638|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2650639|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650640|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
2650641|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650642|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650643|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2650644|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2650645|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650646|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2650647|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2650648|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
2650649|NCT02048930|Budesonide|budesonide|mesh-list
2650650|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2650651|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2650652|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
2650653|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2179018|NCT00002409|Zidovudine|zidovudine|mesh-list
2179019|NCT00002409|Abacavir|abacavir|mesh-list
2650654|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650655|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2650656|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
2650657|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
2650658|NCT02048930|Hormones|hormones|mesh-ancestor
2650659|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650660|NCT02048943|Gemcitabine|gemcitabine|mesh-list
2650661|NCT02048943|Paclitaxel|paclitaxel|mesh-list
2650662|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2650663|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2650664|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179020|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2179021|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179022|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179023|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179024|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179025|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
2179026|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179027|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179028|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179029|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
2179030|NCT00002410|Lamivudine|lamivudine|mesh-list
2179031|NCT00002410|Zidovudine|zidovudine|mesh-list
2179032|NCT00002410|Indinavir|indinavir|mesh-list
2179033|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179034|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179035|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179036|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179037|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
2179038|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179039|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179040|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179041|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
2179042|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179043|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179044|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179045|NCT00002411|Lamivudine|lamivudine|mesh-list
2179046|NCT00002411|Zidovudine|zidovudine|mesh-list
2179047|NCT00002411|Stavudine|stavudine|mesh-list
2179048|NCT00002411|Didanosine|didanosine|mesh-list
2179049|NCT00002411|Nelfinavir|nelfinavir|mesh-list
2179050|NCT00002411|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179051|NCT00002411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179052|NCT00002411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179053|NCT00002411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179054|NCT00002411|Antiviral Agents|antiviral agents|mesh-ancestor
2179055|NCT00002411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179056|NCT00002411|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2422505|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2422506|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2422507|NCT00817375|Analgesics|analgesics|mesh-ancestor
2422508|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
2179057|NCT00002411|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2422509|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422510|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2422511|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2422512|NCT00817466|Epinephrine|epinephrine|mesh-list
2422513|NCT00817466|Racepinephrine|racepinephrine|mesh-list
2422514|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
2422515|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2422516|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2422517|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
2422518|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422519|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422520|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422521|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2422522|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2422523|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
2422524|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422525|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2422526|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
2422527|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
2422528|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
2422529|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2422530|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2650665|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
2650666|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
2650667|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
2179058|NCT00002411|Antimetabolites|antimetabolites|mesh-ancestor
2179059|NCT00002411|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179060|NCT00002411|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179061|NCT00002411|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179062|NCT00002412|Stavudine|stavudine|mesh-list
2179063|NCT00002412|Didanosine|didanosine|mesh-list
2179064|NCT00002412|Emivirine|emivirine|mesh-list
2179065|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
2179066|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179067|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
2179068|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179069|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179070|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179071|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
2179072|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179073|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
2179074|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179075|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179076|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179077|NCT00002413|Emivirine|emivirine|mesh-list
2650668|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650669|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2179078|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179079|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179080|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179081|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179082|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
2179083|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179084|NCT00002415|Tenofovir|tenofovir|mesh-list
2179085|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
2179086|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650670|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
2650671|NCT02048943|Antiviral Agents|antiviral agents|mesh-ancestor
2650672|NCT02048943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650673|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650674|NCT02048943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179087|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179088|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179089|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179090|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179091|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179092|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179093|NCT00002416|Lamivudine|lamivudine|mesh-list
2179094|NCT00002416|Emtricitabine|emtricitabine|mesh-list
2179095|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179096|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179097|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179098|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179099|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
2179100|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179101|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179102|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179103|NCT00002417|Amprenavir|amprenavir|mesh-list
2179104|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2179105|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
2179106|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2179107|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179108|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179109|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179110|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179111|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179112|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179113|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179114|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179115|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
2179116|NCT00002418|Nevirapine|nevirapine|mesh-list
2179117|NCT00002418|Stavudine|stavudine|mesh-list
2179118|NCT00002418|Didanosine|didanosine|mesh-list
2179119|NCT00002418|Emivirine|emivirine|mesh-list
2179120|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
2179121|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179122|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179123|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179124|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179125|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
2650675|NCT02048943|Immunologic Factors|immunologic factors|mesh-ancestor
2650676|NCT02048943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650677|NCT02048969|Flumazenil|flumazenil|mesh-list
2650678|NCT02048969|Antidotes|antidotes|mesh-ancestor
2650679|NCT02048969|Protective Agents|protective agents|mesh-ancestor
2650680|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650681|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
2650682|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
2650683|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650684|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650685|NCT02049034|Lixisenatide|lixisenatide|mesh-list
2650686|NCT02049034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2650687|NCT02049034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650688|NCT02049047|Everolimus|everolimus|mesh-list
2650689|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650690|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179126|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179127|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179128|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179129|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2179130|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2650691|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
2650692|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650693|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
2650694|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2650695|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2650696|NCT02049073|Prednisolone|prednisolone|mesh-list
2650697|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
2650698|NCT02049073|Zonisamide|zonisamide|mesh-list
2650699|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2650700|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
2650701|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2650702|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
2650703|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
2650704|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650705|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650706|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2650707|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
2650708|NCT02049073|Hormones|hormones|mesh-ancestor
2650709|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650710|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2650711|NCT02049073|Protective Agents|protective agents|mesh-ancestor
2650712|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2650713|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650714|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
2650715|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2650716|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2650717|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650718|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2650719|NCT02049138|Upadacitinib|upadacitinib|mesh-list
2650720|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2650721|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2650722|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179131|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179132|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
2179133|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
2179134|NCT00002419|Efavirenz|efavirenz|mesh-list
2179135|NCT00002419|Abacavir|abacavir|mesh-list
2179136|NCT00002419|Adefovir|adefovir|mesh-list
2179137|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2179138|NCT00002419|Amprenavir|amprenavir|mesh-list
2179139|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179140|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179141|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179142|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179143|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
2179144|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179145|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2179146|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2179147|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2179148|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2179149|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2179150|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2179151|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179152|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179153|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2179154|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
2179155|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2179156|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179157|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179158|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
2650723|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650724|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2650725|NCT02049190|Onapristone|onapristone|mesh-list
2650726|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650727|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2179159|NCT00002420|Stavudine|stavudine|mesh-list
2179160|NCT00002420|Didanosine|didanosine|mesh-list
2179161|NCT00002420|Delavirdine|delavirdine|mesh-list
2179162|NCT00002420|Emivirine|emivirine|mesh-list
2179163|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
2179164|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179165|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
2179166|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179167|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179168|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179169|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
2179170|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179171|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
2650728|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
2650729|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2650730|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650731|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
2650732|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650733|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
2650734|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
2650735|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650736|NCT02049229|Everolimus|everolimus|mesh-list
2650737|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650738|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2650739|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
2650740|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650741|NCT02049255|Bupivacaine|bupivacaine|mesh-list
2650742|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
2650743|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
2650744|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
2650745|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2650746|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650747|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
2650748|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650749|NCT02049268|Ethanol|ethanol|mesh-list
2650750|NCT02049268|Nicotine|nicotine|mesh-list
2650751|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2650752|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
2650753|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650754|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650755|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2650756|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2650757|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
2650758|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650759|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650760|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2650761|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650762|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2650763|NCT02049294|Omalizumab|omalizumab|mesh-list
2650764|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2650765|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2650766|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
2650767|NCT02049320|Remifentanil|remifentanil|mesh-list
2650768|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2650769|NCT02049320|Narcotics|narcotics|mesh-ancestor
2650770|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2650771|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650772|NCT02049320|Analgesics|analgesics|mesh-ancestor
2650773|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
2650774|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650775|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
2650776|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
2650777|NCT02049346|Hematinics|hematinics|mesh-ancestor
2179172|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650778|NCT02049411|Ketamine|ketamine|mesh-list
2650779|NCT02049411|Analgesics|analgesics|mesh-ancestor
2650780|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
2650781|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650782|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650783|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2650784|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2650785|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
2650786|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
2650787|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2650788|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2650789|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2650790|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650791|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650792|NCT02049515|Ofatumumab|ofatumumab|mesh-list
2650793|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650794|NCT02049541|Rituximab|rituximab|mesh-list
2650795|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2650796|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650797|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
2650798|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650799|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2650800|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
2650801|NCT02049580|Thiotepa|thiotepa|mesh-list
2650802|NCT02049580|Fludarabine|fludarabine|mesh-list
2650803|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2650804|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
2650805|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650806|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2650807|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2650808|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
2650809|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650810|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650811|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2650812|NCT02049593|Irinotecan|irinotecan|mesh-list
2650813|NCT02049593|Temozolomide|temozolomide|mesh-list
2650814|NCT02049593|Talazoparib|talazoparib|mesh-list
2650815|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2650816|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2650817|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2650818|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650819|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650820|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650821|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2650822|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
2650823|NCT02049606|Nabumetone|nabumetone|mesh-list
2650824|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2650825|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2650826|NCT02049606|Analgesics|analgesics|mesh-ancestor
2650827|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
2650828|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650829|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650830|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2650831|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2650832|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2650833|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2650834|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650835|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179173|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2422531|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2422532|NCT00817583|Docetaxel|docetaxel|mesh-list
2422533|NCT00817583|Fluorouracil|fluorouracil|mesh-list
2422534|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422535|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
2422536|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
2422537|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
2422538|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422539|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
2422540|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2422541|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2422542|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
2422543|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422544|NCT00817622|Vitamin E|vitamin e|mesh-list
2422545|NCT00817622|Vitamins|vitamins|mesh-ancestor
2422546|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
2650836|NCT02049671|Hormones|hormones|mesh-list
2650837|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2650838|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179174|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179175|NCT00002423|Lamivudine|lamivudine|mesh-list
2179176|NCT00002423|Abacavir|abacavir|mesh-list
2179177|NCT00002423|Nelfinavir|nelfinavir|mesh-list
2179178|NCT00002423|Indinavir|indinavir|mesh-list
2179179|NCT00002423|Amprenavir|amprenavir|mesh-list
2179180|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179181|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179182|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179183|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179184|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
2179185|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179186|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179187|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179188|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179189|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179190|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179191|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2179192|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
2179193|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2179194|NCT00002424|Lamivudine|lamivudine|mesh-list
2179195|NCT00002424|Stavudine|stavudine|mesh-list
2179196|NCT00002424|Indinavir|indinavir|mesh-list
2179197|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179198|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2650839|NCT02049736|Telbivudine|telbivudine|mesh-list
2650840|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
2650841|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650842|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2650843|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650844|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650845|NCT02049762|Aspirin|aspirin|mesh-list
2650846|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2650847|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2650848|NCT02049762|Analgesics|analgesics|mesh-ancestor
2650849|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
2650850|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650851|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650852|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2650853|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2650854|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2650855|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2650856|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650857|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2650858|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2650859|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650860|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
2650861|NCT02049801|Cytarabine|cytarabine|mesh-list
2650862|NCT02049801|Idarubicin|idarubicin|mesh-list
2650863|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2650864|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
2650865|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650866|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650867|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
2650868|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650869|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2650870|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
2650871|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650872|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2179199|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179200|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179201|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
2179202|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179203|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179204|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179205|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
2179206|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179207|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179208|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179209|NCT00002425|Saquinavir|saquinavir|mesh-list
2179210|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2650873|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2179211|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2650874|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2650875|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650876|NCT02049905|Gemcitabine|gemcitabine|mesh-list
2650877|NCT02049905|Docetaxel|docetaxel|mesh-list
2650878|NCT02049905|Doxorubicin|doxorubicin|mesh-list
2650879|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2179212|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179213|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179214|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179215|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179216|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179217|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
2179218|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650880|NCT02049905|Ifosfamide|ifosfamide|mesh-list
2650881|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
2650882|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2650883|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
2650884|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650885|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650886|NCT02049905|Antiviral Agents|antiviral agents|mesh-ancestor
2650887|NCT02049905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650888|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650889|NCT02049905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2650890|NCT02049905|Immunologic Factors|immunologic factors|mesh-ancestor
2650891|NCT02049905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650892|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
2650893|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
2650894|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
2650895|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2650896|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2650897|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2650898|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2650899|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
2650900|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
2650901|NCT02049970|Bupivacaine|bupivacaine|mesh-list
2179219|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2179220|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2179221|NCT00002426|Adefovir|adefovir|mesh-list
2179222|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2179223|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
2650902|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
2650903|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
2650904|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2650905|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650906|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
2650907|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650908|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2650909|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2650910|NCT02049970|Analgesics|analgesics|mesh-ancestor
2650911|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2650912|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2650913|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2650914|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
2650915|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650916|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650917|NCT02050009|Metformin|metformin|mesh-list
2650918|NCT02050009|Paclitaxel|paclitaxel|mesh-list
2650919|NCT02050009|Carboplatin|carboplatin|mesh-list
2650920|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2650921|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650922|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
2650923|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
2650924|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
2650925|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650926|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2650927|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650928|NCT02050074|Metformin|metformin|mesh-list
2650929|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2650930|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2650931|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650932|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2650933|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2650934|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
2650935|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179224|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650936|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2650937|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
2650938|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2650939|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
2650940|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
2650941|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2650942|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650943|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2650944|NCT02050152|Analgesics|analgesics|mesh-ancestor
2650945|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
2650946|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650947|NCT02050178|Gemcitabine|gemcitabine|mesh-list
2650948|NCT02050178|Paclitaxel|paclitaxel|mesh-list
2650949|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2179225|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179226|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179227|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179228|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179229|NCT00002427|Stavudine|stavudine|mesh-list
2179230|NCT00002427|Didanosine|didanosine|mesh-list
2179231|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
2179232|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179233|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
2179234|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650950|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650951|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
2650952|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
2650953|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
2650954|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650955|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2650956|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
2650957|NCT02050178|Antiviral Agents|antiviral agents|mesh-ancestor
2650958|NCT02050178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2650959|NCT02050178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179235|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179236|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179237|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
2179238|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179239|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
2179240|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179241|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179242|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179243|NCT00002428|Vaccines|vaccines|mesh-list
2179244|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
2650960|NCT02050178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2650961|NCT02050178|Immunologic Factors|immunologic factors|mesh-ancestor
2650962|NCT02050178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650963|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
2650964|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
2650965|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2650966|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2650967|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2650968|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650969|NCT02050360|Urological Agents|urological agents|mesh-ancestor
2650970|NCT02050529|Hydralazine|hydralazine|mesh-list
2650971|NCT02050529|Labetalol|labetalol|mesh-list
2650972|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2650973|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
2650974|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2650975|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2650976|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
2650977|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2650978|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650979|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650980|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
2650981|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
2650982|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2650983|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2650984|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2650985|NCT02050594|Ipilimumab|ipilimumab|mesh-list
2650986|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2650987|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2650988|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2650989|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650990|NCT02050672|Inositol|inositol|mesh-list
2179245|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650991|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
2650992|NCT02050672|Vitamins|vitamins|mesh-ancestor
2650993|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
2650994|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2650995|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
2179246|NCT00002429|Lamivudine|lamivudine|mesh-list
2179247|NCT00002429|Zidovudine|zidovudine|mesh-list
2179248|NCT00002429|Stavudine|stavudine|mesh-list
2179249|NCT00002429|Didanosine|didanosine|mesh-list
2179250|NCT00002429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2179251|NCT00002429|Nelfinavir|nelfinavir|mesh-list
2179252|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179253|NCT00002429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179254|NCT00002429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179255|NCT00002429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179256|NCT00002429|Antiviral Agents|antiviral agents|mesh-ancestor
2179257|NCT00002429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179258|NCT00002429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179259|NCT00002429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2650996|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2650997|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2650998|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
2650999|NCT02050802|Macitentan|macitentan|mesh-list
2651000|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2651001|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651002|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2651003|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2651004|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651005|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651006|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651007|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2651008|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2651009|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2651010|NCT02050828|Ranibizumab|ranibizumab|mesh-list
2651011|NCT02050828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2651012|NCT02050828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2651013|NCT02050828|Growth Substances|growth substances|mesh-ancestor
2651014|NCT02050828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651015|NCT02050828|Growth Inhibitors|growth inhibitors|mesh-ancestor
2651016|NCT02050828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651017|NCT02050893|Midazolam|midazolam|mesh-list
2651018|NCT02050893|Propofol|propofol|mesh-list
2651019|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2651020|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2651021|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651022|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2651023|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
2651024|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
2651025|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2651026|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2651027|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2651028|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2651029|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
2651030|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
2651031|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651032|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651033|NCT02050958|Ibuprofen|ibuprofen|mesh-list
2651034|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2651035|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2651036|NCT02050958|Analgesics|analgesics|mesh-ancestor
2651037|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
2651038|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651039|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651040|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2651041|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2651042|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2651043|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651044|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651045|NCT02051023|Fluorometholone|fluorometholone|mesh-list
2651046|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
2651047|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2651048|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2651049|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2651050|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
2651051|NCT02051023|Hormones|hormones|mesh-ancestor
2651052|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2651053|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651054|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2651055|NCT02051153|Modafinil|modafinil|mesh-list
2651056|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2651057|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651058|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2179260|NCT00002429|Antimetabolites|antimetabolites|mesh-ancestor
2179261|NCT00002429|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179262|NCT00002429|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179263|NCT00002429|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179264|NCT00002430|Lamivudine|lamivudine|mesh-list
2179265|NCT00002430|Stavudine|stavudine|mesh-list
2179266|NCT00002430|Nelfinavir|nelfinavir|mesh-list
2179267|NCT00002430|Indinavir|indinavir|mesh-list
2179268|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179269|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179270|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179271|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179272|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
2651059|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2651060|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2651061|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179273|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179274|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2651065|NCT02051231|Oxytocin|oxytocin|mesh-list
2651066|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
2651067|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2651068|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651078|NCT02051387|Cannabidiol|cannabidiol|mesh-list
2651079|NCT02051387|Olanzapine|olanzapine|mesh-list
2651080|NCT02051387|Risperidone|risperidone|mesh-list
2651081|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2651082|NCT02051387|Amisulpride|amisulpride|mesh-list
2651083|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2651084|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
2651085|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651086|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651087|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651088|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2651089|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2651090|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2651091|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2651092|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2651093|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
2651094|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
2651095|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
2651096|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651097|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2651098|NCT02051387|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2651099|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2651100|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2651101|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
2651102|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
2651103|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2651104|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2651105|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2651106|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2651107|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2651108|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651109|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651110|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179275|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2651111|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2651112|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
2651113|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2651114|NCT02051530|Tryptophan|tryptophan|mesh-list
2651115|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2651116|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
2651117|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2651118|NCT02051569|Tryptophan|tryptophan|mesh-list
2651119|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2651120|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
2651121|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2651122|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2651123|NCT02051738|Mebendazole|mebendazole|mesh-list
2179276|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
2179277|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179278|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179279|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179280|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
2179281|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2179282|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2179283|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179284|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
2179285|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
2179286|NCT00002432|Foscarnet|foscarnet|mesh-list
2179287|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2179288|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
2179289|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179290|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179291|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2651124|NCT02051738|Piperazine|piperazine|mesh-list
2651125|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
2651126|NCT02051738|DMP 777|dmp 777|mesh-list
2179292|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179293|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179294|NCT00002433|Interferons|interferons|mesh-list
2179295|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
2179296|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179297|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
2179298|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179299|NCT00002434|Leucovorin|leucovorin|mesh-list
2179300|NCT00002434|Trimetrexate|trimetrexate|mesh-list
2179301|NCT00002434|Calcium|calcium|mesh-list
2179302|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
2179303|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2179304|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179305|NCT00002434|Antidotes|antidotes|mesh-ancestor
2179306|NCT00002434|Protective Agents|protective agents|mesh-ancestor
2179307|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
2179308|NCT00002434|Vitamins|vitamins|mesh-ancestor
2179309|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
2179310|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
2179311|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179312|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2179313|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
2179314|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179315|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179316|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2179317|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179318|NCT00002435|Zidovudine|zidovudine|mesh-list
2179319|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
2179320|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179321|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2651127|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
2651128|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
2651129|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2651130|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651131|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
2651132|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
2651133|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
2651134|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651135|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651136|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651137|NCT02051751|Paclitaxel|paclitaxel|mesh-list
2651138|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2651139|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179322|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179323|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651140|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
2651141|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
2651142|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
2651143|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651144|NCT02051842|Metadoxine|metadoxine|mesh-list
2651145|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2651146|NCT02051868|Paclitaxel|paclitaxel|mesh-list
2651147|NCT02051868|Carboplatin|carboplatin|mesh-list
2651148|NCT02051868|Fluorouracil|fluorouracil|mesh-list
2651149|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2651150|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651151|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
2651152|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
2651153|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
2651154|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651155|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
2651156|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2651157|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2651158|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
2651159|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651160|NCT02051894|Dobutamine|dobutamine|mesh-list
2651161|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2651162|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
2651163|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
2651164|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651165|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651166|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2651167|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2651168|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2651169|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
2651170|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651171|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651172|NCT02051894|Protective Agents|protective agents|mesh-ancestor
2651173|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
2651174|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2179324|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
2179325|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179326|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179327|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179328|NCT00002436|Lamivudine|lamivudine|mesh-list
2179329|NCT00002436|Zidovudine|zidovudine|mesh-list
2179330|NCT00002436|Zalcitabine|zalcitabine|mesh-list
2651175|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2651176|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2651177|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651178|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
2651179|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651180|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651181|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2651182|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651183|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
2651184|NCT02051946|Diuretics|diuretics|mesh-ancestor
2651185|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
2651186|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651187|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651188|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651189|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
2651190|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
2651191|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2179331|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179332|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179333|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179334|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179335|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
2179336|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179337|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2651192|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2651193|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2651194|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2651195|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651196|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
2651197|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651198|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651199|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2651200|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651201|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2179338|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179339|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
2179340|NCT00002437|Cidofovir|cidofovir|mesh-list
2179341|NCT00002437|Probenecid|probenecid|mesh-list
2179342|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
2179343|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
2179344|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2179345|NCT00002437|Renal Agents|renal agents|mesh-ancestor
2179346|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
2179347|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179348|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179349|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179350|NCT00002438|Itraconazole|itraconazole|mesh-list
2179351|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
2179352|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179353|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2179354|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2179355|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179356|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179357|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2179358|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
2179359|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2179360|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179361|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2179362|NCT00002439|Alitretinoin|alitretinoin|mesh-list
2179363|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179364|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
2179365|NCT00002440|Ritonavir|ritonavir|mesh-list
2179366|NCT00002440|Nelfinavir|nelfinavir|mesh-list
2179367|NCT00002440|Indinavir|indinavir|mesh-list
2179368|NCT00002440|Saquinavir|saquinavir|mesh-list
2179369|NCT00002440|Amprenavir|amprenavir|mesh-list
2179370|NCT00002440|Abacavir|abacavir|mesh-list
2651202|NCT02052128|Onapristone|onapristone|mesh-list
2651203|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651204|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2651205|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
2651206|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2651207|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651208|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
2651209|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2651210|NCT02052154|Vaccines|vaccines|mesh-list
2651211|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
2651212|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651213|NCT02052167|Methotrexate|methotrexate|mesh-list
2651214|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2651215|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
2651216|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2651217|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651218|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2651219|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
2651220|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651221|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651222|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
2651223|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651224|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2651225|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2651226|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
2651227|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2651228|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2651229|NCT02052180|Bupivacaine|bupivacaine|mesh-list
2651230|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
2651231|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
2651232|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2651233|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651234|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
2651235|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651236|NCT02052193|Vemurafenib|vemurafenib|mesh-list
2651237|NCT02052193|Dabrafenib|dabrafenib|mesh-list
2651238|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651239|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2651240|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651241|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651242|NCT02052258|Oxytocin|oxytocin|mesh-list
2179371|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2651243|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
2651244|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2651245|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651246|NCT02052323|Artesunate|artesunate|mesh-list
2651247|NCT02052323|Mefloquine|mefloquine|mesh-list
2651248|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
2651249|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2651250|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2651251|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651252|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651253|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
2651254|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
2651255|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2651256|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
2651257|NCT02052336|Clarithromycin|clarithromycin|mesh-list
2651258|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2651259|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651260|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2651261|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651262|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651263|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2651264|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2651265|NCT02052388|Daptomycin|daptomycin|mesh-list
2651266|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2651267|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651268|NCT02052492|Vitamin D|vitamin d|mesh-list
2651269|NCT02052492|Vitamins|vitamins|mesh-ancestor
2651270|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
2651271|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651272|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2651273|NCT02052609|Brodalumab|brodalumab|mesh-list
2651274|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
2651275|NCT02052648|Bevacizumab|bevacizumab|mesh-list
2651276|NCT02052648|Temozolomide|temozolomide|mesh-list
2651277|NCT02052648|Tryptophan|tryptophan|mesh-list
2651278|NCT02052648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2651279|NCT02052648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651280|NCT02052648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2651281|NCT02052648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2651282|NCT02052648|Growth Substances|growth substances|mesh-ancestor
2651283|NCT02052648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651284|NCT02052648|Growth Inhibitors|growth inhibitors|mesh-ancestor
2651285|NCT02052648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2651286|NCT02052648|Alkylating Agents|alkylating agents|mesh-ancestor
2651287|NCT02052648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651288|NCT02052648|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2651289|NCT02052648|Antidepressive Agents|antidepressive agents|mesh-ancestor
2651290|NCT02052648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2651291|NCT02052687|Imiquimod|imiquimod|mesh-list
2651292|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2651293|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
2651294|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651295|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651296|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
2651297|NCT02052713|Tamsulosin|tamsulosin|mesh-list
2651298|NCT02052713|Dutasteride|dutasteride|mesh-list
2651299|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2651300|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2651301|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2651302|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
2651303|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651304|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651305|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651306|NCT02052713|Urological Agents|urological agents|mesh-ancestor
2651307|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2651308|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2651309|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651310|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
2651311|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2651312|NCT02052726|Vaccines|vaccines|mesh-list
2651313|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
2651314|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651315|NCT02052739|Brexanolone|brexanolone|mesh-list
2651316|NCT02052739|Neurosteroids|neurosteroids|mesh-ancestor
2651317|NCT02052739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651318|NCT02052739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651319|NCT02052739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651320|NCT02052739|GABA Modulators|gaba modulators|mesh-ancestor
2179372|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179373|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179374|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179375|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179376|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179377|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179378|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
2179379|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179380|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2179381|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2179382|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179383|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179384|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2179385|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
2179386|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2179387|NCT00002442|Lamivudine|lamivudine|mesh-list
2179388|NCT00002442|Stavudine|stavudine|mesh-list
2179389|NCT00002442|Nelfinavir|nelfinavir|mesh-list
2651321|NCT02052739|GABA Agents|gaba agents|mesh-ancestor
2651324|NCT02052908|Naproxen|naproxen|mesh-list
2651325|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2179390|NCT00002442|Indinavir|indinavir|mesh-list
2179391|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179392|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179393|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179394|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179395|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
2179396|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651326|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2651327|NCT02052908|Analgesics|analgesics|mesh-ancestor
2651328|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
2651329|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651330|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651331|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2651332|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2651333|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
2651334|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2651335|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651336|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651337|NCT02052934|Vaccines|vaccines|mesh-list
2651338|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
2651339|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651340|NCT02052973|Propolis|propolis|mesh-list
2651341|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2668578|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668579|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668580|NCT02143219|Antidotes|antidotes|mesh-ancestor
2668581|NCT02143219|Protective Agents|protective agents|mesh-ancestor
2668582|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668583|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
2668584|NCT02143219|Vitamins|vitamins|mesh-ancestor
2668585|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
2668586|NCT02143219|Hematinics|hematinics|mesh-ancestor
2668587|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2668588|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2668589|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2668590|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2668591|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668592|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668593|NCT02143362|Remifentanil|remifentanil|mesh-list
2668594|NCT02143362|Anesthetics|anesthetics|mesh-list
2668595|NCT02143362|Propofol|propofol|mesh-list
2668596|NCT02143362|Cisatracurium|cisatracurium|mesh-list
2668597|NCT02143362|Atracurium|atracurium|mesh-list
2668598|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2668599|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668600|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2668601|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2668602|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
2668603|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2668604|NCT02143362|Narcotics|narcotics|mesh-ancestor
2668605|NCT02143362|Analgesics|analgesics|mesh-ancestor
2668606|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
2668607|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651342|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
2651343|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2651344|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651345|NCT02053142|Acyclovir|acyclovir|mesh-list
2651346|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
2651347|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179397|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179398|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179399|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
2179400|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179401|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179402|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
2651358|NCT02053298|Timolol|timolol|mesh-list
2651359|NCT02053298|Dorzolamide|dorzolamide|mesh-list
2651360|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2651361|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2651362|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
2651363|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651364|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179403|NCT00002443|Zidovudine|zidovudine|mesh-list
2179404|NCT00002443|Indinavir|indinavir|mesh-list
2179405|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
2179406|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179407|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179408|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179409|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179410|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
2179411|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179412|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179413|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179414|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179415|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179416|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179417|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
2179418|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2179419|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651365|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651366|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2651367|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2651368|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2651369|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651370|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
2651371|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2651372|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2651373|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651374|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
2651375|NCT02053363|Coagulants|coagulants|mesh-ancestor
2651376|NCT02053402|Vitamin D|vitamin d|mesh-list
2651377|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
2651378|NCT02053402|Vitamins|vitamins|mesh-ancestor
2651379|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
2651380|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651381|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2651382|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2651383|NCT02053519|Vitamin D|vitamin d|mesh-list
2651384|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
2651385|NCT02053519|Vitamins|vitamins|mesh-ancestor
2651386|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
2651387|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651388|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2651389|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2651390|NCT02053558|Lidocaine|lidocaine|mesh-list
2651391|NCT02053558|Ropivacaine|ropivacaine|mesh-list
2651392|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
2651393|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
2651394|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2179420|NCT00002446|Fluconazole|fluconazole|mesh-list
2651395|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179421|NCT00002446|Posaconazole|posaconazole|mesh-list
2179422|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
2179423|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179424|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2179425|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2179426|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179427|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651396|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
2651397|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651398|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2651399|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2651400|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2651401|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2651402|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651403|NCT02053597|Paclitaxel|paclitaxel|mesh-list
2651404|NCT02053597|Doxorubicin|doxorubicin|mesh-list
2651405|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2651406|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651407|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
2651408|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
2651409|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
2651410|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651411|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2651412|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2651413|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2651414|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651415|NCT02053675|Vasopressins|vasopressins|mesh-list
2651416|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
2651417|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
2651418|NCT02053675|Coagulants|coagulants|mesh-ancestor
2651419|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2651420|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2651421|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
2179428|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2179429|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
2179430|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2179431|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179432|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2179433|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2179434|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2179435|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2179436|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2179437|NCT00002447|Ritonavir|ritonavir|mesh-list
2179438|NCT00002447|Saquinavir|saquinavir|mesh-list
2179439|NCT00002447|Efavirenz|efavirenz|mesh-list
2651422|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651423|NCT02053727|Abatacept|abatacept|mesh-list
2651424|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2651425|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651426|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651427|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2651428|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
2651429|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651430|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2651431|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
2651432|NCT02053766|Propofol|propofol|mesh-list
2651433|NCT02053766|Sevoflurane|sevoflurane|mesh-list
2651434|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2651435|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2651436|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651437|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2651438|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
2651439|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
2651440|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2651441|NCT02053766|Analgesics|analgesics|mesh-ancestor
2651442|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
2651443|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651444|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2651445|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2651446|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2651447|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
2651448|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651449|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179440|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2651450|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2651451|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2651452|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2651453|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
2651454|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2651455|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
2651456|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2651457|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651458|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2651459|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2651460|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651461|NCT02053818|Sufentanil|sufentanil|mesh-list
2651462|NCT02053818|Remifentanil|remifentanil|mesh-list
2651463|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2651464|NCT02053818|Narcotics|narcotics|mesh-ancestor
2651465|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2651466|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651467|NCT02053818|Analgesics|analgesics|mesh-ancestor
2651468|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
2651469|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651470|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2651471|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2651472|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
2651473|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
2651474|NCT02053857|Amoxicillin|amoxicillin|mesh-list
2651475|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2651476|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651477|NCT02053909|Aspirin|aspirin|mesh-list
2651478|NCT02053909|Ticagrelor|ticagrelor|mesh-list
2651479|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2651480|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2651481|NCT02053909|Analgesics|analgesics|mesh-ancestor
2651482|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
2651483|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651484|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651485|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2651486|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2651487|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2651488|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2651489|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651490|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2651491|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2651492|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651493|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
2651494|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2651495|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2651496|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2651497|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
2651498|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651499|NCT02053922|Misoprostol|misoprostol|mesh-list
2651500|NCT02053922|Oxytocin|oxytocin|mesh-list
2651501|NCT02053922|Carbetocin|carbetocin|mesh-list
2651502|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2651503|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
2651504|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2651505|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651506|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2651507|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2651508|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
2651509|NCT02053935|Dopamine|dopamine|mesh-list
2651510|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2651511|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
2651512|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
2651513|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651514|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651515|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
2651516|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651517|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651518|NCT02053935|Protective Agents|protective agents|mesh-ancestor
2651519|NCT02053974|Spironolactone|spironolactone|mesh-list
2651520|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2651521|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
2651522|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2651523|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651524|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2651525|NCT02053974|Diuretics|diuretics|mesh-ancestor
2179441|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179442|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179443|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179444|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179445|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179446|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179447|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
2179448|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179449|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2179450|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2179451|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179452|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179453|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2179454|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2179455|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2179456|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2179457|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2179458|NCT00002448|Ritonavir|ritonavir|mesh-list
2179459|NCT00002448|Saquinavir|saquinavir|mesh-list
2179460|NCT00002448|Efavirenz|efavirenz|mesh-list
2179461|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179462|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179463|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179464|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179465|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179466|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179467|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179468|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
2179469|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179470|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2179471|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2179472|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179473|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179474|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2179475|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2179476|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2651526|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
2651527|NCT02054000|Tirofiban|tirofiban|mesh-list
2651528|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2651529|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2651530|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651531|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2651532|NCT02054052|Bevacizumab|bevacizumab|mesh-list
2651533|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2651534|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651535|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2651536|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2651537|NCT02054052|Growth Substances|growth substances|mesh-ancestor
2651538|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651539|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
2651540|NCT02054078|Bevacizumab|bevacizumab|mesh-list
2651541|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2651542|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651543|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2651544|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2651545|NCT02054078|Growth Substances|growth substances|mesh-ancestor
2651546|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651547|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
2179477|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2179478|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2179479|NCT00002449|Aldesleukin|aldesleukin|mesh-list
2179480|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179481|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179482|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179483|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
2179484|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179485|NCT00002450|Tenofovir|tenofovir|mesh-list
2179486|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
2651568|NCT02054143|Sevoflurane|sevoflurane|mesh-list
2651569|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2651570|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2651571|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
2651572|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
2651573|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2651574|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651575|NCT02054182|Vitamin D|vitamin d|mesh-list
2651576|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
2651577|NCT02054182|Vitamins|vitamins|mesh-ancestor
2651578|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
2651579|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651580|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2651581|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2651582|NCT02054299|Thiamine|thiamine|mesh-list
2651583|NCT02054299|Proguanil|proguanil|mesh-list
2651584|NCT02054299|Sumatriptan|sumatriptan|mesh-list
2651585|NCT02054299|Amitriptyline|amitriptyline|mesh-list
2651586|NCT02054299|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2651587|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2651588|NCT02054299|Fenoterol|fenoterol|mesh-list
2651589|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2651590|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2651591|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2651592|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
2651593|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651594|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651595|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651596|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2651597|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
2651598|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2651599|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2651600|NCT02054299|Analgesics|analgesics|mesh-ancestor
2651601|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
2651602|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651603|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2651604|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2651605|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2651606|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
2651607|NCT02054299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2651608|NCT02054299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2651609|NCT02054299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2651610|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2651611|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
2651612|NCT02054299|Vitamins|vitamins|mesh-ancestor
2651613|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
2651614|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
2651615|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2651616|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2651617|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651618|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
2651619|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2651620|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
2651621|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2651622|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
2651623|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
2651624|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
2651625|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2651626|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2179487|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422547|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422548|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
2422549|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422550|NCT00817622|Protective Agents|protective agents|mesh-ancestor
2422551|NCT00817648|Risperidone|risperidone|mesh-list
2422552|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2422553|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2422554|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
2422555|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422556|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422557|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422558|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2422559|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2422560|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2422561|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2422562|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2422563|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
2422564|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
2422565|NCT00817661|Vitamin A|vitamin a|mesh-list
2422566|NCT00817661|Vitamins|vitamins|mesh-ancestor
2422567|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
2422568|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422569|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
2422570|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2422571|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422572|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2422573|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
2422574|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2422575|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422576|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422577|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422578|NCT00817713|Ivermectin|ivermectin|mesh-list
2422579|NCT00817713|Albendazole|albendazole|mesh-list
2422580|NCT00817713|Praziquantel|praziquantel|mesh-list
2422581|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2422582|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422583|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
2422584|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
2422585|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2422586|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2422587|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
2422588|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
2422589|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
2422590|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422591|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422592|NCT00817739|Leuprolide|leuprolide|mesh-list
2422593|NCT00817739|Flutamide|flutamide|mesh-list
2422594|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2422595|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
2422596|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2651627|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2651628|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2651629|NCT02054429|Insulin|insulin|mesh-list
2651630|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2651631|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2651632|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651633|NCT02054442|Methotrexate|methotrexate|mesh-list
2651634|NCT02054442|Cetuximab|cetuximab|mesh-list
2651635|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2179488|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179489|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2651636|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
2651637|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2651638|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651639|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2651640|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
2651641|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651642|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651643|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
2651644|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651645|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2651646|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2651647|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
2651648|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2651649|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2651650|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2651651|NCT02054468|Remifentanil|remifentanil|mesh-list
2651652|NCT02054468|Propofol|propofol|mesh-list
2651653|NCT02054468|Rocuronium|rocuronium|mesh-list
2651654|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2651655|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2651656|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651657|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2651658|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
2651659|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
2651660|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2651661|NCT02054468|Narcotics|narcotics|mesh-ancestor
2651662|NCT02054468|Analgesics|analgesics|mesh-ancestor
2651663|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
2651664|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651665|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2651666|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2651667|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2651668|NCT02054637|Lanreotide|lanreotide|mesh-list
2651669|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651670|NCT02054663|Clopidogrel|clopidogrel|mesh-list
2651671|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2651672|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2651673|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2651674|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2651675|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
2651676|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651677|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651678|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651679|NCT02054676|Ibuprofen|ibuprofen|mesh-list
2651680|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2651681|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2651682|NCT02054676|Analgesics|analgesics|mesh-ancestor
2651683|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
2651684|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651685|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179490|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179491|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179492|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179493|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179494|NCT00002451|Ritonavir|ritonavir|mesh-list
2179495|NCT00002451|Indinavir|indinavir|mesh-list
2179496|NCT00002451|Lamivudine|lamivudine|mesh-list
2179497|NCT00002451|Stavudine|stavudine|mesh-list
2179498|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179499|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179500|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179501|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179502|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179503|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179504|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179505|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
2651686|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2651687|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2651688|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2651689|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651690|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651691|NCT02054793|Itraconazole|itraconazole|mesh-list
2651692|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
2651693|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651694|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2651695|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2651696|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651697|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651698|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2651699|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
2651700|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2651701|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651702|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2651703|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
2651704|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2651705|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651706|NCT02054884|Paclitaxel|paclitaxel|mesh-list
2651707|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2179506|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651708|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2651709|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651710|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
2651711|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
2651712|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
2651713|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651714|NCT02054936|Warfarin|warfarin|mesh-list
2651715|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
2651716|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
2179507|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2179508|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2179509|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179510|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179511|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
2179512|NCT00002452|Indinavir|indinavir|mesh-list
2179513|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2179514|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2179515|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
2179516|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179517|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179518|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179519|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179520|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
2179521|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179522|NCT00002453|Tenofovir|tenofovir|mesh-list
2179523|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
2179524|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179525|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2179526|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179527|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179528|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651717|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2651718|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
2651719|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2651720|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
2651721|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651722|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651723|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
2651724|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2651725|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
2651726|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651727|NCT02054949|Expectorants|expectorants|mesh-ancestor
2651728|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
2651729|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2651730|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
2651731|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651732|NCT02054949|Protective Agents|protective agents|mesh-ancestor
2651733|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651734|NCT02054949|Antidotes|antidotes|mesh-ancestor
2651735|NCT02054975|Vitamin D|vitamin d|mesh-list
2651736|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
2651737|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
2651738|NCT02054975|Vitamins|vitamins|mesh-list
2651739|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
2651740|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651741|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2651742|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2651743|NCT02054988|Caffeine|caffeine|mesh-list
2651744|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2651745|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651746|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2651747|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651748|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651749|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2651750|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2651751|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
2651752|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651753|NCT02055014|Liraglutide|liraglutide|mesh-list
2651754|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2651755|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651756|NCT02055014|Incretins|incretins|mesh-ancestor
2651757|NCT02055014|Hormones|hormones|mesh-ancestor
2651758|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2651759|NCT02055079|Sirolimus|sirolimus|mesh-list
2651760|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2651761|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651762|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2651763|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651764|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
2651765|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2651766|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
2651767|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651768|NCT02055131|Aspirin|aspirin|mesh-list
2651769|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2651770|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2651771|NCT02055131|Analgesics|analgesics|mesh-ancestor
2179529|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2179530|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2179531|NCT00002456|Cyclosporine|cyclosporine|mesh-list
2179532|NCT00002456|Methotrexate|methotrexate|mesh-list
2179533|NCT00002456|Cyclosporins|cyclosporins|mesh-list
2179534|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2179535|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
2179536|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2179537|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179538|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2179539|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
2179540|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179541|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179542|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
2651772|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
2651773|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651774|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651775|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2651776|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2651777|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2651778|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2651779|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651780|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2651781|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2651782|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651783|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
2651784|NCT02055170|Finasteride|finasteride|mesh-list
2651785|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2651786|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2651787|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651788|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651789|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
2651790|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2179543|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179544|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2179545|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179546|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
2179547|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2179548|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179549|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
2179550|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179551|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2179552|NCT00002458|Antibodies|antibodies|mesh-list
2179553|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2651791|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651792|NCT02055170|Urological Agents|urological agents|mesh-ancestor
2651793|NCT02055183|Antitoxins|antitoxins|mesh-list
2651794|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
2651795|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
2651796|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651797|NCT02055196|Irinotecan|irinotecan|mesh-list
2651798|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2651799|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2651800|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651801|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651802|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651803|NCT02055274|Rotigotine|rotigotine|mesh-list
2651804|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
2651805|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
2651806|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651807|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651808|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651809|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2651810|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2651811|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2179554|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
2179555|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179556|NCT00002460|Tamoxifen|tamoxifen|mesh-list
2179557|NCT00002460|Goserelin|goserelin|mesh-list
2179558|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2179559|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
2179560|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2179561|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179562|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2179563|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179564|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2179565|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2179566|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2179567|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
2179568|NCT00002461|Carmustine|carmustine|mesh-list
2179569|NCT00002461|Etoposide|etoposide|mesh-list
2179570|NCT00002461|Sargramostim|sargramostim|mesh-list
2651812|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2651813|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651814|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651815|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651816|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
2179571|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179572|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
2179573|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179574|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2179575|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2179576|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
2179577|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179578|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179579|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2179580|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2179581|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2179582|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2179583|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179584|NCT00002462|Cobalt|cobalt|mesh-list
2179585|NCT00002462|Prednisone|prednisone|mesh-list
2651817|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2651818|NCT02055378|Atropine|atropine|mesh-list
2651819|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2651820|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2651821|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2651822|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
2651823|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651824|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651825|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2651826|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
2651827|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
2651828|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
2651829|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2651830|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2651831|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
2651832|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651833|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651834|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
2651835|NCT02055456|Nandrolone|nandrolone|mesh-list
2651836|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
2651837|NCT02055456|Androgens|androgens|mesh-ancestor
2651838|NCT02055456|Hormones|hormones|mesh-ancestor
2651839|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2651840|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651841|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
2651842|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2651843|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
2651844|NCT02055482|Hematinics|hematinics|mesh-ancestor
2651845|NCT02055586|Alovudine|alovudine|mesh-list
2651846|NCT02055586|Fluorides|fluorides|mesh-list
2651847|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
2651848|NCT02055586|Protective Agents|protective agents|mesh-ancestor
2651849|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651850|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
2179586|NCT00002462|Doxorubicin|doxorubicin|mesh-list
2651851|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651852|NCT02055664|Ropivacaine|ropivacaine|mesh-list
2179587|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2651853|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
2651854|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
2651855|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2651856|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651857|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
2651858|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651859|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
2651860|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2651861|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651862|NCT02055703|Itraconazole|itraconazole|mesh-list
2651863|NCT02055703|Rifampin|rifampin|mesh-list
2651864|NCT02055703|Digoxin|digoxin|mesh-list
2651865|NCT02055703|Donepezil|donepezil|mesh-list
2651866|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2651867|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651868|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651869|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
2651870|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651871|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651872|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
2651873|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
2651874|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651875|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2651876|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2651877|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2651878|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
2651879|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2651880|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2651881|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2651882|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
2651883|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2651884|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
2651885|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2651886|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2651887|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2651888|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2651889|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2651890|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2651891|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2651892|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2651893|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2651894|NCT02055703|Protective Agents|protective agents|mesh-ancestor
2651895|NCT02055716|Sulforaphane|sulforaphane|mesh-list
2651896|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2651897|NCT02055716|Protective Agents|protective agents|mesh-ancestor
2651898|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651899|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651900|NCT02055911|Ranibizumab|ranibizumab|mesh-list
2651901|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2651902|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2651903|NCT02055911|Growth Substances|growth substances|mesh-ancestor
2651904|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651905|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
2651906|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651907|NCT02055963|Minocycline|minocycline|mesh-list
2651908|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2651909|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651910|NCT02056041|Liver Extracts|liver extracts|mesh-list
2651911|NCT02056041|Hematinics|hematinics|mesh-ancestor
2651912|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
2651913|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2651914|NCT02056184|Adalimumab|adalimumab|mesh-list
2651915|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2651916|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2651917|NCT02056210|Plerixafor|plerixafor|mesh-list
2651918|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2651919|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2651920|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
2651921|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651922|NCT02056223|Acetaminophen|acetaminophen|mesh-list
2651923|NCT02056223|Ibuprofen|ibuprofen|mesh-list
2651924|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2651925|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2651926|NCT02056223|Analgesics|analgesics|mesh-ancestor
2179588|NCT00002462|Bleomycin|bleomycin|mesh-list
2651927|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
2651928|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651929|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651930|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2651931|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2651932|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2651933|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651934|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651935|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
2651936|NCT02056236|Midazolam|midazolam|mesh-list
2651937|NCT02056236|Levetiracetam|levetiracetam|mesh-list
2651938|NCT02056236|Valproic Acid|valproic acid|mesh-list
2651939|NCT02056236|Lorazepam|lorazepam|mesh-list
2651940|NCT02056236|Thiopental|thiopental|mesh-list
2651941|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
2651942|NCT02056236|Propofol|propofol|mesh-list
2651943|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2651944|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2651945|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651946|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2651947|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
2651948|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
2651949|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2651950|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2651951|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2651952|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2651953|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
2651954|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
2651955|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651956|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651957|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
2651958|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2651959|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
2651960|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
2651961|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
2651962|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651963|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2651964|NCT02056249|Norepinephrine|norepinephrine|mesh-list
2651965|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2651966|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2651967|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
2651968|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2651969|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651970|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651971|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
2651972|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
2179589|NCT00002462|Vincristine|vincristine|mesh-list
2179590|NCT00002462|Vinblastine|vinblastine|mesh-list
2179591|NCT00002462|Procarbazine|procarbazine|mesh-list
2179592|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
2179593|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2179594|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179595|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2179596|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2179597|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179598|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179599|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2179600|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
2179601|NCT00002462|Hormones|hormones|mesh-ancestor
2179602|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2651973|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2651974|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2651975|NCT02056353|Insulin|insulin|mesh-list
2651976|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2651977|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651978|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
2651979|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
2651980|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2651981|NCT02056366|Protective Agents|protective agents|mesh-ancestor
2651982|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651983|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
2651984|NCT02056366|Vitamins|vitamins|mesh-ancestor
2651985|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
2651986|NCT02056379|Dexamethasone|dexamethasone|mesh-list
2651987|NCT02056379|Budesonide|budesonide|mesh-list
2651988|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2651989|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
2651990|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
2651991|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2179603|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422597|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422598|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2422599|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422600|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
2422601|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
2422602|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2422603|NCT00817765|Ritonavir|ritonavir|mesh-list
2422604|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
2422605|NCT00817765|Posaconazole|posaconazole|mesh-list
2422606|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2422607|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2422608|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
2422609|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422610|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422611|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2422612|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2422613|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
2422614|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2651992|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2651993|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2651994|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
2651995|NCT02056379|Hormones|hormones|mesh-ancestor
2651996|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2651997|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2651998|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2651999|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2652000|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2652001|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
2652002|NCT02056405|Mosapride|mosapride|mesh-list
2652003|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2652004|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2652005|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
2652006|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2652007|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652008|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652009|NCT02056418|Prednisone|prednisone|mesh-list
2652010|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
2652011|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2652012|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
2652013|NCT02056418|Hormones|hormones|mesh-ancestor
2652014|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2652015|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652016|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2652017|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652018|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
2652019|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2652020|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2652021|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652022|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
2652023|NCT02056444|Coagulants|coagulants|mesh-ancestor
2652024|NCT02056587|Everolimus|everolimus|mesh-list
2652025|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652026|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2652027|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
2652028|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652029|NCT02056600|Metformin|metformin|mesh-list
2652030|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2652031|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652032|NCT02056665|Minocycline|minocycline|mesh-list
2652033|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2652034|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652035|NCT02056678|Acetaminophen|acetaminophen|mesh-list
2652036|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2652037|NCT02056678|Analgesics|analgesics|mesh-ancestor
2652038|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
2652039|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652040|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652041|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
2652042|NCT02056717|Dexamethasone|dexamethasone|mesh-list
2652043|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2652044|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
2652045|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
2652046|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652047|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652048|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2652049|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
2652050|NCT02056717|Hormones|hormones|mesh-ancestor
2652051|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2652052|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2652053|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652054|NCT02056730|Calcium|calcium|mesh-list
2652055|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2652056|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652057|NCT02056743|Fexofenadine|fexofenadine|mesh-list
2652058|NCT02056743|Losartan|losartan|mesh-list
2652059|NCT02056743|Midazolam|midazolam|mesh-list
2652060|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
2652061|NCT02056743|Caffeine|caffeine|mesh-list
2652062|NCT02056743|Omeprazole|omeprazole|mesh-list
2652063|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2652064|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2652065|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2652066|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652067|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2652068|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2652069|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2652070|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2652071|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
2652072|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
2652073|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
2652074|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
2179604|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2179605|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2179606|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
2179607|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
2179608|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
2652075|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2652076|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652077|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2652078|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2652079|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2652080|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2652081|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2652082|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2652083|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2652084|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652085|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2652086|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2652087|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2652088|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2652089|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
2652090|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
2652091|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
2652092|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2652093|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2652094|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2652095|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2652096|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2652097|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
2652098|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
2652099|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
2652100|NCT02056847|Pitavastatin|pitavastatin|mesh-list
2652101|NCT02056847|Calcium|calcium|mesh-list
2652102|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2652103|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652104|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2652105|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2652106|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2179609|NCT00002462|Trace Elements|trace elements|mesh-ancestor
2179610|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
2179611|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
2179612|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2179613|NCT00002463|Leucovorin|leucovorin|mesh-list
2652107|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2652108|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
2652109|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652110|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652111|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2652112|NCT02056899|Gabapentin|gabapentin|mesh-list
2652113|NCT02056899|Analgesics|analgesics|mesh-ancestor
2652114|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
2652115|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652116|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652117|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
2652118|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2652119|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2652120|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2652121|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2652122|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2652123|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2652124|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2652125|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652126|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
2652127|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2652128|NCT02056938|Basiliximab|basiliximab|mesh-list
2652129|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
2652130|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652131|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2652132|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
2652133|NCT02057003|Grazoprevir|grazoprevir|mesh-list
2652134|NCT02057003|Ledipasvir|ledipasvir|mesh-list
2652135|NCT02057003|Velpatasvir|velpatasvir|mesh-list
2652136|NCT02057003|Simeprevir|simeprevir|mesh-list
2652137|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
2652138|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652139|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
2652140|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652141|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652142|NCT02057094|Caseins|caseins|mesh-list
2652143|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
2652144|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
2652145|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652146|NCT02057107|Docetaxel|docetaxel|mesh-list
2179614|NCT00002463|Prednisone|prednisone|mesh-list
2179615|NCT00002463|Methotrexate|methotrexate|mesh-list
2179616|NCT00002463|Vincristine|vincristine|mesh-list
2179617|NCT00002463|Procarbazine|procarbazine|mesh-list
2179618|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
2179619|NCT00002463|Calcium|calcium|mesh-list
2179620|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
2179621|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2179622|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179623|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2179624|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
2179625|NCT00002463|Hormones|hormones|mesh-ancestor
2179626|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2179627|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2179628|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179629|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2652147|NCT02057107|Cetuximab|cetuximab|mesh-list
2652148|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652149|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
2652150|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
2652151|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
2652152|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652153|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2652154|NCT02057133|Tamoxifen|tamoxifen|mesh-list
2652155|NCT02057133|Trastuzumab|trastuzumab|mesh-list
2652156|NCT02057133|Pertuzumab|pertuzumab|mesh-list
2652157|NCT02057133|Everolimus|everolimus|mesh-list
2652158|NCT02057133|Letrozole|letrozole|mesh-list
2652159|NCT02057133|Fulvestrant|fulvestrant|mesh-list
2652160|NCT02057133|Anastrozole|anastrozole|mesh-list
2652161|NCT02057133|Exemestane|exemestane|mesh-list
2652162|NCT02057133|Loperamide|loperamide|mesh-list
2652163|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2652164|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652165|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2652166|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
2652167|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652168|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2652169|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2652170|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652171|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652172|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2652173|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
2179630|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
2652174|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2652175|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2652176|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2652177|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2652178|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2652179|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2652180|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
2652181|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2652182|NCT02057172|Liraglutide|liraglutide|mesh-list
2652183|NCT02057172|Exenatide|exenatide|mesh-list
2652184|NCT02057172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2179631|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2179632|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2179633|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
2652185|NCT02057172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652186|NCT02057172|Incretins|incretins|mesh-ancestor
2652187|NCT02057172|Hormones|hormones|mesh-ancestor
2652188|NCT02057172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2652189|NCT02057172|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2652190|NCT02057263|Alendronate|alendronate|mesh-list
2652191|NCT02057263|Diphosphonates|diphosphonates|mesh-list
2652192|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2652193|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652194|NCT02057289|Micafungin|micafungin|mesh-list
2652195|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
2652196|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652197|NCT02057315|Ketoprofen|ketoprofen|mesh-list
2652198|NCT02057315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2652199|NCT02057315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2652200|NCT02057315|Analgesics|analgesics|mesh-ancestor
2652201|NCT02057315|Sensory System Agents|sensory system agents|mesh-ancestor
2652202|NCT02057315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652203|NCT02057315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652204|NCT02057315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2652205|NCT02057315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652206|NCT02057315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2652207|NCT02057315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652208|NCT02057315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652209|NCT02057328|Telmisartan|telmisartan|mesh-list
2652210|NCT02057328|Nebivolol|nebivolol|mesh-list
2652211|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2179634|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179635|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
2179636|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179637|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2179638|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179639|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
2179640|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2179641|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179642|NCT00002463|Antidotes|antidotes|mesh-ancestor
2179643|NCT00002463|Protective Agents|protective agents|mesh-ancestor
2652212|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2652213|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2652214|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652215|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
2652216|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2652217|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2652218|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2652219|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
2652220|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2652221|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652222|NCT02057367|Bupivacaine|bupivacaine|mesh-list
2652223|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
2652224|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
2652225|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2652226|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652227|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
2652228|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652229|NCT02057380|Dexamethasone|dexamethasone|mesh-list
2652230|NCT02057380|Paclitaxel|paclitaxel|mesh-list
2652231|NCT02057380|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2652232|NCT02057380|Bortezomib|bortezomib|mesh-list
2652233|NCT02057380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2652234|NCT02057380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652235|NCT02057380|Tubulin Modulators|tubulin modulators|mesh-ancestor
2652236|NCT02057380|Antimitotic Agents|antimitotic agents|mesh-ancestor
2652237|NCT02057380|Mitosis Modulators|mitosis modulators|mesh-ancestor
2652238|NCT02057380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652239|NCT02057380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2652240|NCT02057380|Antiemetics|antiemetics|mesh-ancestor
2652241|NCT02057380|Autonomic Agents|autonomic agents|mesh-ancestor
2652242|NCT02057380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652243|NCT02057380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652244|NCT02057380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2652245|NCT02057380|Glucocorticoids|glucocorticoids|mesh-ancestor
2652246|NCT02057380|Hormones|hormones|mesh-ancestor
2652247|NCT02057380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2652248|NCT02057380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2652249|NCT02057380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2652250|NCT02057380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652251|NCT02057484|Tacrolimus|tacrolimus|mesh-list
2652252|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179644|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
2179645|NCT00002463|Vitamins|vitamins|mesh-ancestor
2179646|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
2179647|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2179648|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
2179649|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
2179650|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
2179651|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
2179652|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2179653|NCT00002465|Megestrol|megestrol|mesh-list
2179654|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
2179655|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2422615|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2422616|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2422617|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
2422618|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2422619|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2422620|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2422621|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2422622|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2422623|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
2422624|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2422625|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422626|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
2652253|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
2652254|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652255|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2652256|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652257|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652258|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
2652259|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
2652260|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
2652261|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2652262|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652263|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
2652264|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652265|NCT02057679|Amoxicillin|amoxicillin|mesh-list
2652266|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2652267|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652268|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
2652269|NCT02057770|Busulfan|busulfan|mesh-list
2652270|NCT02057770|Fludarabine|fludarabine|mesh-list
2652271|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
2652272|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2652273|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
2652274|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652275|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652276|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2652277|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
2652278|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652279|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652280|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2652281|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2652282|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
2652283|NCT02057796|Efavirenz|efavirenz|mesh-list
2652284|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2652285|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2652286|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2652287|NCT02057796|Rifampin|rifampin|mesh-list
2652288|NCT02057796|Isoniazid|isoniazid|mesh-list
2652289|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
2652290|NCT02057796|Ethambutol|ethambutol|mesh-list
2652291|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2652292|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2652293|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652294|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652295|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
2652296|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652297|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2652298|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2652299|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2652300|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2652301|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2652302|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2652303|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2652304|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2652305|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2652306|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
2179656|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2179657|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2179658|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
2179659|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2179660|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179661|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2179662|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2179663|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2179664|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179665|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
2179666|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2179667|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
2179668|NCT00002466|Ifosfamide|ifosfamide|mesh-list
2179669|NCT00002466|Doxorubicin|doxorubicin|mesh-list
2179670|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2179671|NCT00002466|Etoposide|etoposide|mesh-list
2179672|NCT00002466|Vincristine|vincristine|mesh-list
2179673|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179674|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
2179675|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179676|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2179677|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2179678|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
2179679|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179680|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179681|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2179682|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2179683|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2652307|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2652308|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
2652309|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2652310|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2652311|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2652312|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2652313|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2652314|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
2652315|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2652316|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2652317|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
2652318|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652319|NCT02057926|Tetracycline|tetracycline|mesh-list
2652320|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2652321|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652322|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2652323|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652324|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652325|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
2652326|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2652327|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2652328|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652329|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
2652330|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
2652331|NCT02058173|Chloroquine|chloroquine|mesh-list
2652332|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2652333|NCT02058173|Amebicides|amebicides|mesh-ancestor
2652334|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2652335|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2652336|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652337|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
2652338|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652339|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2652340|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2652341|NCT02058173|Analgesics|analgesics|mesh-ancestor
2652342|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
2652343|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652344|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652345|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2652346|NCT02058173|Filaricides|filaricides|mesh-ancestor
2652347|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
2652348|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
2652349|NCT02058186|Vitamin D|vitamin d|mesh-list
2652350|NCT02058186|Vitamins|vitamins|mesh-ancestor
2652351|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
2652352|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652353|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2652354|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
2652355|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2652356|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
2652357|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2652358|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
2652359|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652360|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652361|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
2652362|NCT02058212|Vitamin E|vitamin e|mesh-list
2652363|NCT02058212|Selenium|selenium|mesh-list
2652364|NCT02058212|Vitamins|vitamins|mesh-ancestor
2652365|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
2652366|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652367|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
2652368|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652369|NCT02058212|Protective Agents|protective agents|mesh-ancestor
2652370|NCT02058212|Trace Elements|trace elements|mesh-ancestor
2652371|NCT02058277|Aprepitant|aprepitant|mesh-list
2652372|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
2652373|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
2652374|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652375|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652376|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2652377|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2179684|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2179685|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179686|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2179687|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
2179688|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
2179689|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
2179690|NCT00002470|Interferons|interferons|mesh-list
2179691|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
2179692|NCT00002470|Fluorouracil|fluorouracil|mesh-list
2652378|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2652379|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652380|NCT02058303|Bupivacaine|bupivacaine|mesh-list
2652381|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
2652382|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
2652383|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2652384|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652385|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
2652386|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652387|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2652388|NCT02058420|Tocotrienols|tocotrienols|mesh-list
2652389|NCT02058420|Vitamin E|vitamin e|mesh-list
2652390|NCT02058420|Tocopherols|tocopherols|mesh-list
2652391|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
2652392|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652393|NCT02058420|Protective Agents|protective agents|mesh-ancestor
2652394|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652395|NCT02058420|Vitamins|vitamins|mesh-ancestor
2652396|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
2652397|NCT02058433|Paclitaxel|paclitaxel|mesh-list
2652398|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2179693|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
2652399|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2652400|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652401|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
2652402|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
2652403|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
2652404|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652405|NCT02058446|Amlodipine|amlodipine|mesh-list
2652406|NCT02058446|Valsartan|valsartan|mesh-list
2652407|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
2652408|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2652409|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2652410|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2652411|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652412|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2652413|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652414|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
2652415|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2652416|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2652417|NCT02058485|Midazolam|midazolam|mesh-list
2652418|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
2652419|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2652420|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2652421|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652422|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2652423|NCT02058485|Analgesics|analgesics|mesh-ancestor
2652424|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
2652425|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652426|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2652427|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2652428|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2652429|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
2652430|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2652431|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652432|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2652433|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2652434|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2652435|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2652436|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2652437|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
2652438|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
2652439|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
2652440|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
2652441|NCT02058576|Tamsulosin|tamsulosin|mesh-list
2652442|NCT02058576|Dutasteride|dutasteride|mesh-list
2652443|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2652444|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2652445|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2652446|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
2179694|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179695|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2179696|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179697|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179698|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
2652447|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2652448|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652449|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652450|NCT02058576|Urological Agents|urological agents|mesh-ancestor
2652451|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2652452|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2652453|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652454|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
2652455|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2652456|NCT02058641|Darapladib|darapladib|mesh-list
2652457|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
2652458|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652459|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652460|NCT02058667|Paclitaxel|paclitaxel|mesh-list
2652461|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2652462|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652463|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
2652464|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
2652465|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
2652466|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652467|NCT02058693|Amphetamine|amphetamine|mesh-list
2652468|NCT02058693|Adderall|adderall|mesh-list
2652469|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2652470|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652471|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
2652472|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
2652473|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652474|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
2652475|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2652476|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652477|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
2652478|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2652479|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2652480|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2652481|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2652482|NCT02058706|Leuprolide|leuprolide|mesh-list
2652483|NCT02058706|Goserelin|goserelin|mesh-list
2652484|NCT02058706|Bicalutamide|bicalutamide|mesh-list
2652485|NCT02058706|Androgens|androgens|mesh-list
2652486|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2652487|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
2652488|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2652489|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652490|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2652491|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652492|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
2652493|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
2652494|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2652495|NCT02058706|Hormones|hormones|mesh-ancestor
2652496|NCT02058823|Amlodipine|amlodipine|mesh-list
2652497|NCT02058823|Valsartan|valsartan|mesh-list
2652498|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2652499|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2652500|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2652501|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652502|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2652503|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652504|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
2652505|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2652506|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2652507|NCT02058875|Cyclosporine|cyclosporine|mesh-list
2652508|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
2652509|NCT02058875|Prednisone|prednisone|mesh-list
2179699|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179700|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
2179701|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179702|NCT00002471|Leucovorin|leucovorin|mesh-list
2179703|NCT00002471|Cytarabine|cytarabine|mesh-list
2179704|NCT00002471|Dexamethasone|dexamethasone|mesh-list
2179705|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
2652510|NCT02058875|Cyclosporins|cyclosporins|mesh-list
2652511|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2652512|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
2652513|NCT02058875|Hormones|hormones|mesh-ancestor
2652514|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2652515|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652516|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2652517|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652518|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652519|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652520|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2652521|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
2652522|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
2652523|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652524|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
2652525|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652526|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2652527|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2652528|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2652529|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
2652530|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2652531|NCT02058901|Sunitinib|sunitinib|mesh-list
2652532|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652533|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2652534|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2652535|NCT02058901|Growth Substances|growth substances|mesh-ancestor
2652536|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179706|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
2652537|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
2652538|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2652539|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652540|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652541|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2652542|NCT02058979|Cefazolin|cefazolin|mesh-list
2652543|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652544|NCT02059018|Diclofenac|diclofenac|mesh-list
2652545|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
2652546|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
2652547|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2652548|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2652549|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2179707|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2179708|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2179709|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2179710|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
2179711|NCT00002471|Thiotepa|thiotepa|mesh-list
2179712|NCT00002471|Methotrexate|methotrexate|mesh-list
2179713|NCT00002471|Etoposide|etoposide|mesh-list
2179714|NCT00002471|Vincristine|vincristine|mesh-list
2179715|NCT00002471|Daunorubicin|daunorubicin|mesh-list
2179716|NCT00002471|Asparaginase|asparaginase|mesh-list
2652550|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2652551|NCT02059018|Analgesics|analgesics|mesh-ancestor
2652552|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
2652553|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652554|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652555|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2652556|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652557|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652558|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652559|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
2652560|NCT02059031|Cabotegravir|cabotegravir|mesh-list
2652561|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2652562|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2652563|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652564|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652565|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2652566|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2652567|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
2652568|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652569|NCT02059330|Palbociclib|palbociclib|mesh-list
2652570|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652571|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2652572|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652573|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652574|NCT02059460|Terlipressin|terlipressin|mesh-list
2652575|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2652576|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2652577|NCT02059499|Fluorouracil|fluorouracil|mesh-list
2652578|NCT02059499|Imiquimod|imiquimod|mesh-list
2652579|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
2652580|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652581|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2652582|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652583|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2652584|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
2652585|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652586|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2652587|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
2652588|NCT02059564|Liraglutide|liraglutide|mesh-list
2652589|NCT02059564|Exenatide|exenatide|mesh-list
2652590|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2652591|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652592|NCT02059564|Incretins|incretins|mesh-ancestor
2652593|NCT02059564|Hormones|hormones|mesh-ancestor
2652594|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2652595|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2652596|NCT02059590|Isavuconazole|isavuconazole|mesh-list
2652597|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
2179717|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
2179718|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179719|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
2179720|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179721|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2179722|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2652598|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179723|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
2179724|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179725|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179726|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2179727|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2179728|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
2179729|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
2179730|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2179731|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2179732|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
2179733|NCT00002471|Hormones|hormones|mesh-ancestor
2179734|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2652599|NCT02059616|Amlodipine|amlodipine|mesh-list
2652600|NCT02059616|Candesartan|candesartan|mesh-list
2652601|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
2652602|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2652603|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2652604|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2652605|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652606|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2652607|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652608|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
2652609|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2652610|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2652611|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
2652612|NCT02059655|Bimatoprost|bimatoprost|mesh-list
2652613|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2652614|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2652615|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2652616|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2652617|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652618|NCT02059694|Lidocaine|lidocaine|mesh-list
2652619|NCT02059694|Epinephrine|epinephrine|mesh-list
2652620|NCT02059694|Racepinephrine|racepinephrine|mesh-list
2652621|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
2652622|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
2652623|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
2652624|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2652625|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652626|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
2652627|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652628|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2652629|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2652630|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2652631|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2652632|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652633|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2652634|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2652635|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
2652636|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2652637|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2652638|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2652639|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
2652640|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2652641|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
2652642|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
2652643|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
2652644|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2652645|NCT02059759|Aldesleukin|aldesleukin|mesh-list
2652646|NCT02059759|Interleukin-2|interleukin-2|mesh-list
2652647|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652648|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2652649|NCT02059759|Analgesics|analgesics|mesh-ancestor
2652650|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
2652651|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652652|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652653|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2652654|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2652655|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
2652656|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652657|NCT02059772|Ranibizumab|ranibizumab|mesh-list
2652658|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2652659|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2652660|NCT02059772|Growth Substances|growth substances|mesh-ancestor
2179735|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2652661|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652662|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
2652663|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652664|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
2652665|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2652666|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
2652667|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652668|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652669|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2652670|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
2652671|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652672|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652673|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2652674|NCT02059876|Paclitaxel|paclitaxel|mesh-list
2652675|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2652676|NCT02059876|Carboplatin|carboplatin|mesh-list
2652677|NCT02059876|Trastuzumab|trastuzumab|mesh-list
2652678|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2652679|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652680|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
2652681|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
2652682|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
2652683|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652684|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2652685|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
2652686|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2652687|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2652688|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652689|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
2652690|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
2652691|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652692|NCT02059915|Oxycodone|oxycodone|mesh-list
2652693|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2652694|NCT02059915|Narcotics|narcotics|mesh-ancestor
2652695|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2652696|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652697|NCT02059915|Analgesics|analgesics|mesh-ancestor
2652698|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
2652699|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652700|NCT02059967|Paclitaxel|paclitaxel|mesh-list
2652701|NCT02059967|Carboplatin|carboplatin|mesh-list
2652702|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2652703|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652704|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
2652705|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
2652706|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
2652707|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652708|NCT02060006|Meloxicam|meloxicam|mesh-list
2652709|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
2652710|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2652711|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2652712|NCT02060006|Analgesics|analgesics|mesh-ancestor
2652713|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
2652714|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652715|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652716|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2652717|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652718|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2652719|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652720|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652721|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
2652722|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2652723|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2652724|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2652725|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
2652726|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652727|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2652728|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2652729|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652730|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2652731|NCT02060032|Atorvastatin|atorvastatin|mesh-list
2652732|NCT02060032|Simvastatin|simvastatin|mesh-list
2652733|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2652734|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2652735|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
2652736|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652737|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2652738|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2652739|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652740|NCT02060149|Minocycline|minocycline|mesh-list
2652741|NCT02060149|Sulbactam|sulbactam|mesh-list
2652742|NCT02060149|Cefoperazone|cefoperazone|mesh-list
2652743|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2652744|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2652745|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179736|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2179737|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
2179738|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2179739|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2179740|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
2179741|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
2179742|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179743|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2179744|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179745|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2179746|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2179747|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2179748|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
2179749|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652746|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2652747|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652748|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652759|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
2652760|NCT02060201|Saxagliptin|saxagliptin|mesh-list
2652761|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2652762|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652763|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2652764|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652765|NCT02060201|Incretins|incretins|mesh-ancestor
2652766|NCT02060201|Hormones|hormones|mesh-ancestor
2652767|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2652768|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2652769|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
2652770|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652771|NCT02060253|Paclitaxel|paclitaxel|mesh-list
2652772|NCT02060253|Trastuzumab|trastuzumab|mesh-list
2652773|NCT02060253|Pertuzumab|pertuzumab|mesh-list
2652774|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2652775|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652776|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
2652777|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
2652778|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
2652779|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652780|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2652781|NCT02060279|Carotenoids|carotenoids|mesh-list
2652782|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
2652783|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652784|NCT02060279|Protective Agents|protective agents|mesh-ancestor
2652785|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652786|NCT02060305|Bevacizumab|bevacizumab|mesh-list
2652787|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2652788|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652789|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2652790|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2652791|NCT02060305|Growth Substances|growth substances|mesh-ancestor
2652792|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652793|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
2652794|NCT02060318|Infliximab|infliximab|mesh-list
2652795|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
2652796|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2652797|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652798|NCT02060396|Aspirin|aspirin|mesh-list
2652799|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2652800|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2652801|NCT02060396|Analgesics|analgesics|mesh-ancestor
2652802|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
2652803|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652804|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652805|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2652806|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652807|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2652808|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2652809|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652810|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2652811|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2652812|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652813|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
2652814|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
2179750|NCT00002471|Antidotes|antidotes|mesh-ancestor
2179751|NCT00002471|Protective Agents|protective agents|mesh-ancestor
2179752|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
2179753|NCT00002471|Vitamins|vitamins|mesh-ancestor
2179754|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
2179755|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
2179756|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
2179757|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
2179758|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2179759|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2179760|NCT00002472|Etoposide|etoposide|mesh-list
2179761|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179762|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2179763|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2179764|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2179765|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179766|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179767|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
2179768|NCT00002474|Carboplatin|carboplatin|mesh-list
2179769|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
2179770|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179771|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
2179772|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179773|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2179774|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2179775|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
2179776|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179777|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179778|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2179779|NCT00002474|Analgesics|analgesics|mesh-ancestor
2179780|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
2179781|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2179782|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2179783|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2179784|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179785|NCT00002475|Interferons|interferons|mesh-list
2652815|NCT02060487|Citric Acid|citric acid|mesh-list
2652816|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
2652817|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
2652818|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2652819|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
2652820|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
2652821|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652822|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
2652823|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2652824|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2652825|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652826|NCT02060487|Urological Agents|urological agents|mesh-ancestor
2652827|NCT02060552|Diacetylrhein|diacetylrhein|mesh-list
2652828|NCT02060552|Colchicine|colchicine|mesh-list
2652829|NCT02060552|Febuxostat|febuxostat|mesh-list
2652830|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
2652831|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652832|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
2652833|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
2652834|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
2652835|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652836|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652837|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2652838|NCT02060591|Bupivacaine|bupivacaine|mesh-list
2652839|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
2652840|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
2652841|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2652842|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652843|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
2652844|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652845|NCT02060604|Ketorolac|ketorolac|mesh-list
2179786|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
2179787|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
2179788|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
2179789|NCT00002475|Vaccines|vaccines|mesh-list
2179790|NCT00002475|Sargramostim|sargramostim|mesh-list
2179791|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
2179792|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179793|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179794|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2179795|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2179796|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
2179797|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179798|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179799|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2179800|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
2179801|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179802|NCT00002476|Leucovorin|leucovorin|mesh-list
2179803|NCT00002476|Cobalt|cobalt|mesh-list
2179804|NCT00002476|Fluorouracil|fluorouracil|mesh-list
2179805|NCT00002476|Methotrexate|methotrexate|mesh-list
2179806|NCT00002476|Vincristine|vincristine|mesh-list
2652846|NCT02060604|Ranibizumab|ranibizumab|mesh-list
2652847|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2652848|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2652849|NCT02060604|Growth Substances|growth substances|mesh-ancestor
2652850|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652851|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
2652852|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652853|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2652854|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2652855|NCT02060604|Analgesics|analgesics|mesh-ancestor
2652856|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
2652857|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652858|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2652859|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652860|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2652861|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652862|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652863|NCT02060656|Gemcitabine|gemcitabine|mesh-list
2652864|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
2652865|NCT02060656|Rituximab|rituximab|mesh-list
2652866|NCT02060656|Lenalidomide|lenalidomide|mesh-list
2652867|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652868|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2652869|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
2652870|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652871|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652872|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2652873|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
2652874|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652875|NCT02060656|Antiviral Agents|antiviral agents|mesh-ancestor
2652876|NCT02060656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652877|NCT02060656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652878|NCT02060656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2652879|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2652880|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2652881|NCT02060656|Growth Substances|growth substances|mesh-ancestor
2652882|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
2179807|NCT00002476|Bleomycin|bleomycin|mesh-list
2179808|NCT00002476|Calcium|calcium|mesh-list
2179809|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
2179810|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2179811|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179812|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
2179813|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179814|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2179815|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179816|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179817|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
2179818|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2179819|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
2179820|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2179821|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
2179822|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179823|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2179824|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652883|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2652884|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
2652885|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
2652886|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652887|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2652888|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
2652889|NCT02060656|Hormones|hormones|mesh-ancestor
2652890|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2652891|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2652892|NCT02060656|Protective Agents|protective agents|mesh-ancestor
2652893|NCT02060669|Capecitabine|capecitabine|mesh-list
2179825|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179826|NCT00002476|Antidotes|antidotes|mesh-ancestor
2179827|NCT00002476|Protective Agents|protective agents|mesh-ancestor
2179828|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
2179829|NCT00002476|Vitamins|vitamins|mesh-ancestor
2179830|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
2179831|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2179832|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
2652894|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2652895|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
2652896|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652897|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652898|NCT02060734|Lidocaine|lidocaine|mesh-list
2652899|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
2652900|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
2652901|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2652902|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652903|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
2652904|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652905|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2652906|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2652907|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2652908|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2179833|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
2179834|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
2179835|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2179836|NCT00002476|Trace Elements|trace elements|mesh-ancestor
2179837|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
2179838|NCT00002477|Carboplatin|carboplatin|mesh-list
2179839|NCT00002477|Doxorubicin|doxorubicin|mesh-list
2179840|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2179841|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179842|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
2179843|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179844|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2179845|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2179846|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
2179847|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179848|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179849|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2179850|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2179851|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2652909|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652910|NCT02060786|Clopidogrel|clopidogrel|mesh-list
2652911|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2652912|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2652913|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2652914|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2652915|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
2652916|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2652917|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652918|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652919|NCT02060851|Iron|iron|mesh-list
2179852|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2652920|NCT02060851|Trace Elements|trace elements|mesh-ancestor
2652921|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
2652922|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652923|NCT02060916|PAZ320|paz320|mesh-list
2652924|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2652925|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652926|NCT02060929|Esketamine|esketamine|mesh-list
2652927|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
2652928|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2652929|NCT02060955|Bevacizumab|bevacizumab|mesh-list
2652930|NCT02060955|Irinotecan|irinotecan|mesh-list
2652931|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2652932|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652933|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2652934|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2652935|NCT02060955|Growth Substances|growth substances|mesh-ancestor
2652936|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652937|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
2652938|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2652939|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2652940|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2652941|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652942|NCT02061007|Misonidazole|misonidazole|mesh-list
2652943|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2652944|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2652945|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2652946|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2652947|NCT02061124|Sevelamer|sevelamer|mesh-list
2652948|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
2652949|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
2652950|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652951|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2652952|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2652953|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652954|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2652955|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
2652956|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652957|NCT02061267|Niacin|niacin|mesh-list
2652958|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
2652959|NCT02061267|Vitamins|vitamins|mesh-ancestor
2652960|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
2652961|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652962|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
2652963|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2652964|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
2652965|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652966|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2652967|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
2652968|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
2652969|NCT02061293|Promethazine|promethazine|mesh-list
2652970|NCT02061293|Psilocybin|psilocybin|mesh-list
2652971|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2652972|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2652973|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2652974|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652975|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
2652976|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
2652977|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
2652978|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2652979|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
2652980|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
2652981|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2652982|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2652983|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
2652984|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
2652985|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2652986|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2652987|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2652988|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
2652989|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
2652990|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
2652991|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2652992|NCT02061449|Romidepsin|romidepsin|mesh-list
2652993|NCT02061449|Poly ICLC|poly iclc|mesh-list
2652994|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
2652995|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
2652996|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2652997|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2652998|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179853|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179854|NCT00002478|Etoposide|etoposide|mesh-list
2179855|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2179856|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179857|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2179858|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2179859|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179860|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179861|NCT00002479|Tretinoin|tretinoin|mesh-list
2179862|NCT00002479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179863|NCT00002479|Keratolytic Agents|keratolytic agents|mesh-ancestor
2179864|NCT00002479|Dermatologic Agents|dermatologic agents|mesh-ancestor
2179865|NCT00002481|Cytarabine|cytarabine|mesh-list
2179866|NCT00002481|Dexamethasone|dexamethasone|mesh-list
2179867|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
2179868|NCT00002481|Etoposide|etoposide|mesh-list
2179869|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179870|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
2179871|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179872|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2652999|NCT02061475|Lidocaine|lidocaine|mesh-list
2653000|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
2653001|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
2653002|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653003|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653004|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
2653005|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653006|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2653007|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2653008|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2653009|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2653010|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653020|NCT02061631|Dexamethasone|dexamethasone|mesh-list
2653021|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
2653022|NCT02061631|Docetaxel|docetaxel|mesh-list
2653023|NCT02061631|BB 1101|bb 1101|mesh-list
2653024|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653025|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2653026|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
2653027|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
2653028|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653029|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653030|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2653031|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
2653032|NCT02061631|Hormones|hormones|mesh-ancestor
2653033|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2653034|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2653035|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
2653036|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653037|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653038|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
2653039|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
2653040|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
2653041|NCT02061644|Anesthetics|anesthetics|mesh-list
2653042|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653043|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653044|NCT02061657|Misoprostol|misoprostol|mesh-list
2653045|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2179873|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2179874|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
2179875|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179876|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179877|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2179878|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2653046|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
2179879|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
2179880|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
2653047|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2653048|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653049|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2653050|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2653051|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
2653052|NCT02061761|Nivolumab|nivolumab|mesh-list
2653053|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2653054|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653055|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2653056|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653057|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
2653058|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2653059|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
2653060|NCT02061800|Melphalan|melphalan|mesh-list
2653061|NCT02061800|Busulfan|busulfan|mesh-list
2653062|NCT02061800|Thiotepa|thiotepa|mesh-list
2653063|NCT02061800|Fludarabine|fludarabine|mesh-list
2653064|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
2653065|NCT02061800|Tacrolimus|tacrolimus|mesh-list
2653066|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2653067|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
2653068|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653069|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2653070|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2653071|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
2653072|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653073|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653074|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2653075|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2653076|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653077|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2653078|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
2653079|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
2653080|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653081|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2653082|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
2653083|NCT02061800|Hormones|hormones|mesh-ancestor
2653084|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2653085|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2653086|NCT02061800|Protective Agents|protective agents|mesh-ancestor
2653087|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2653088|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2653089|NCT02061878|Bexarotene|bexarotene|mesh-list
2653090|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653091|NCT02061917|Lobeline|lobeline|mesh-list
2653092|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2653093|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
2653094|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653095|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653096|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2653097|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2653098|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
2653099|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422627|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2422628|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
2422629|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2422630|NCT00817895|Cisplatin|cisplatin|mesh-list
2422631|NCT00817895|Fluorouracil|fluorouracil|mesh-list
2422632|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422633|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
2422634|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422635|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2422636|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2422637|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
2422638|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422639|NCT00817934|Bisacodyl|bisacodyl|mesh-list
2653100|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653101|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
2653102|NCT02062034|Vitamins|vitamins|mesh-list
2653103|NCT02062034|Vitamin E|vitamin e|mesh-list
2653104|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
2653105|NCT02062034|Ubiquinone|ubiquinone|mesh-list
2653106|NCT02062034|Antioxidants|antioxidants|mesh-list
2653107|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
2653108|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653109|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653110|NCT02062034|Protective Agents|protective agents|mesh-ancestor
2653111|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
2179881|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2179882|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2179883|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
2179884|NCT00002481|Hormones|hormones|mesh-ancestor
2179885|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2179886|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2179887|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2179888|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2179889|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2179890|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653112|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2653113|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653114|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
2653115|NCT02062112|Laxatives|laxatives|mesh-list
2653116|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2653117|NCT02062190|Resveratrol|resveratrol|mesh-list
2653118|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
2653119|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653120|NCT02062190|Protective Agents|protective agents|mesh-ancestor
2653121|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653122|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653123|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2653124|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
2653125|NCT02062203|Glycine|glycine|mesh-list
2653126|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2653127|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653128|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2653129|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2653130|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653131|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653132|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653133|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653134|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
2653135|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2653136|NCT02062255|Aspirin|aspirin|mesh-list
2653137|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2653138|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2653139|NCT02062255|Analgesics|analgesics|mesh-ancestor
2653140|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
2653141|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653142|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653143|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2653144|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2653145|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2653146|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2653147|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653148|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2653149|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2653150|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653151|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
2653152|NCT02062281|Vaccines|vaccines|mesh-list
2653153|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2653154|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
2653155|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653156|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
2653157|NCT02062333|Esmolol|esmolol|mesh-list
2653158|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2653159|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653160|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179891|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2179892|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
2179893|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
2653161|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2653162|NCT02062333|Analgesics|analgesics|mesh-ancestor
2653163|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
2653164|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653165|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2653166|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2653167|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2653168|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
2653169|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2653170|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653171|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2653172|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2653173|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2653174|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
2653175|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2653176|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2653177|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653178|NCT02062489|Tamoxifen|tamoxifen|mesh-list
2653179|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2653180|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
2653181|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2653182|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653183|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2653184|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653185|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2653186|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2653187|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2653188|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
2653189|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653190|NCT02062892|Sirolimus|sirolimus|mesh-list
2653191|NCT02062892|Everolimus|everolimus|mesh-list
2653192|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653193|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2653194|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
2653195|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653196|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2653197|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653198|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2653199|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
2653200|NCT02062944|Sirolimus|sirolimus|mesh-list
2653201|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2653202|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2653203|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653204|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2653205|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653206|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
2653207|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
2653208|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653209|NCT02062983|Trastuzumab|trastuzumab|mesh-list
2653210|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2179894|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179895|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
2179896|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
2179897|NCT00002482|Antibodies|antibodies|mesh-list
2179898|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179899|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
2179900|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179901|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2179902|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2179903|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
2179904|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653211|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653212|NCT02062996|Phenylephrine|phenylephrine|mesh-list
2653213|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
2653214|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2653215|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2653216|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
2653217|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2653218|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653219|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653220|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
2653221|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
2653222|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653223|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
2653224|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2653225|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
2653226|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2653227|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
2653228|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2653229|NCT02062996|Protective Agents|protective agents|mesh-ancestor
2653230|NCT02063022|Dactinomycin|dactinomycin|mesh-list
2653231|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
2653232|NCT02063022|Melphalan|melphalan|mesh-list
2653233|NCT02063022|Busulfan|busulfan|mesh-list
2653234|NCT02063022|Ifosfamide|ifosfamide|mesh-list
2653235|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
2653236|NCT02063022|Doxorubicin|doxorubicin|mesh-list
2179905|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653237|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2653238|NCT02063022|Etoposide|etoposide|mesh-list
2179906|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2179907|NCT00002487|Methotrexate|methotrexate|mesh-list
2179908|NCT00002487|Dipyridamole|dipyridamole|mesh-list
2179909|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2653239|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
2653240|NCT02063022|Vincristine|vincristine|mesh-list
2653241|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2653242|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
2653243|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653244|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2653245|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2653246|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
2653247|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653248|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653249|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2653250|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2653251|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2653252|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2653253|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653254|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2653255|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
2653256|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
2653257|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
2653258|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2653259|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653260|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2653261|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2653262|NCT02063100|Losartan|losartan|mesh-list
2653263|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2653264|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2653265|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2653266|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2653267|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653268|NCT02063139|Fluticasone|fluticasone|mesh-list
2653269|NCT02063139|Beclomethasone|beclomethasone|mesh-list
2653270|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2653271|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2653272|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
2653273|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653274|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653275|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2653276|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
2653277|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
2653278|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2653279|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
2653280|NCT02063139|Hormones|hormones|mesh-ancestor
2653281|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2653282|NCT02063269|Rivastigmine|rivastigmine|mesh-list
2653283|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2653284|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653285|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653286|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
2179910|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
2179911|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2179912|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179913|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2179914|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
2179915|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179916|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179917|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
2179918|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179919|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2179920|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179921|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
2179922|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2179923|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179924|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2179925|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2179926|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
2179927|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
2179928|NCT00002488|Etoposide|etoposide|mesh-list
2179929|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179930|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
2179931|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179932|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2179933|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2179934|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
2179935|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179936|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179937|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2179938|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2179939|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2179940|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2179941|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179942|NCT00002489|Leucovorin|leucovorin|mesh-list
2653287|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2653288|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653289|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2653290|NCT02063269|Protective Agents|protective agents|mesh-ancestor
2653291|NCT02063295|CKD732|ckd732|mesh-list
2653292|NCT02063295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2653293|NCT02063295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2653294|NCT02063295|Growth Substances|growth substances|mesh-ancestor
2653295|NCT02063295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653296|NCT02063295|Growth Inhibitors|growth inhibitors|mesh-ancestor
2653297|NCT02063295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653298|NCT02063334|Vitamin D|vitamin d|mesh-list
2653299|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
2653300|NCT02063334|Vitamins|vitamins|mesh-ancestor
2653301|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
2653302|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653303|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2653304|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2653305|NCT02063360|Ritonavir|ritonavir|mesh-list
2653306|NCT02063360|Darunavir|darunavir|mesh-list
2653307|NCT02063360|Fostemsavir|fostemsavir|mesh-list
2653308|NCT02063360|Etravirine|etravirine|mesh-list
2653309|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2653310|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2653311|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
2653312|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653313|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653314|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2653315|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2653316|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
2653317|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653318|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2653319|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2653320|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2653321|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2653322|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2653323|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2653324|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
2653325|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2653326|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
2653327|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653328|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
2653329|NCT02063373|Protective Agents|protective agents|mesh-ancestor
2653330|NCT02063425|Fluoxetine|fluoxetine|mesh-list
2653331|NCT02063425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2653332|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2653333|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2653334|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653335|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2653336|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
2653337|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653338|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2653339|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
2653340|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2653341|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2653342|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2653343|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653344|NCT02063529|Leucovorin|leucovorin|mesh-list
2653345|NCT02063529|Fluorouracil|fluorouracil|mesh-list
2653346|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
2653347|NCT02063529|Irinotecan|irinotecan|mesh-list
2179943|NCT00002489|Dactinomycin|dactinomycin|mesh-list
2653348|NCT02063529|Cetuximab|cetuximab|mesh-list
2653349|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
2653350|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
2653351|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653352|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2653353|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653354|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2653355|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
2653356|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653357|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2653358|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2653359|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653360|NCT02063529|Antidotes|antidotes|mesh-ancestor
2653361|NCT02063529|Protective Agents|protective agents|mesh-ancestor
2653362|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
2653363|NCT02063529|Vitamins|vitamins|mesh-ancestor
2653364|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
2653365|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2653366|NCT02063568|Oxytocin|oxytocin|mesh-list
2179944|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
2179945|NCT00002489|Carboplatin|carboplatin|mesh-list
2179946|NCT00002489|Doxorubicin|doxorubicin|mesh-list
2179947|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2179948|NCT00002489|Methotrexate|methotrexate|mesh-list
2179949|NCT00002489|Etoposide|etoposide|mesh-list
2179950|NCT00002489|Vincristine|vincristine|mesh-list
2179951|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
2179952|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2179953|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
2179954|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179955|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2179956|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2653367|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
2653368|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2653369|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653370|NCT02063620|Ketamine|ketamine|mesh-list
2653371|NCT02063620|Analgesics|analgesics|mesh-ancestor
2653372|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
2653373|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653374|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653375|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2653376|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2653377|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
2653378|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
2653379|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653380|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2653381|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2653382|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2653383|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179957|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
2179958|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179959|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179960|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2179961|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2179962|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2179963|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2179964|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179965|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2179966|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
2179967|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2179968|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2179969|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
2179970|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
2179971|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2179972|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179973|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2179974|NCT00002489|Antidotes|antidotes|mesh-ancestor
2179975|NCT00002489|Protective Agents|protective agents|mesh-ancestor
2179976|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
2179977|NCT00002489|Vitamins|vitamins|mesh-ancestor
2179978|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
2179979|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
2179980|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
2179981|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
2179982|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2179983|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2179984|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2179985|NCT00002490|Mitomycins|mitomycins|mesh-list
2653404|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
2653405|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2653406|NCT02063789|Antibodies|antibodies|mesh-list
2653407|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
2653408|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653409|NCT02063802|Metformin|metformin|mesh-list
2653410|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2653411|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653412|NCT02063841|Bismuth|bismuth|mesh-list
2653413|NCT02063841|Antacids|antacids|mesh-ancestor
2653414|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653415|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2179986|NCT00002490|Mitomycin|mitomycin|mesh-list
2179987|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
2179988|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2179989|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2179990|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
2179991|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2179992|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2179993|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2179994|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2179995|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
2179996|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2179997|NCT00002492|Doxorubicin|doxorubicin|mesh-list
2179998|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2179999|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180000|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180001|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180002|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180003|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180004|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180005|NCT00002493|Doxorubicin|doxorubicin|mesh-list
2180006|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2180007|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180008|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180009|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2653416|NCT02063945|Risperidone|risperidone|mesh-list
2653417|NCT02063945|Methylphenidate|methylphenidate|mesh-list
2653418|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2653419|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
2653420|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2653421|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653422|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653423|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2653424|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2653425|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653426|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2653427|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2653428|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
2653429|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2653430|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2653431|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2653432|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2180010|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180011|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653433|NCT02063997|Colchicine|colchicine|mesh-list
2653434|NCT02063997|Allopurinol|allopurinol|mesh-list
2653435|NCT02063997|Gout Suppressants|gout suppressants|mesh-ancestor
2653436|NCT02063997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2653437|NCT02063997|Tubulin Modulators|tubulin modulators|mesh-ancestor
2653438|NCT02063997|Antimitotic Agents|antimitotic agents|mesh-ancestor
2653439|NCT02063997|Mitosis Modulators|mitosis modulators|mesh-ancestor
2653440|NCT02063997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653441|NCT02063997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653442|NCT02063997|Antimetabolites|antimetabolites|mesh-ancestor
2653443|NCT02063997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653444|NCT02063997|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2653445|NCT02063997|Antioxidants|antioxidants|mesh-ancestor
2653446|NCT02063997|Protective Agents|protective agents|mesh-ancestor
2653447|NCT02063997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653448|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
2653449|NCT02064010|Acamprosate|acamprosate|mesh-list
2653450|NCT02064010|Calcium|calcium|mesh-list
2653451|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2653452|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653453|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2653454|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2653455|NCT02064023|Insulin|insulin|mesh-list
2653456|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2653457|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2653458|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653459|NCT02064036|Leuprolide|leuprolide|mesh-list
2653460|NCT02064036|Goserelin|goserelin|mesh-list
2653461|NCT02064036|Bicalutamide|bicalutamide|mesh-list
2653462|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2653463|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
2653464|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2653465|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653466|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2653467|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653468|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
2653469|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
2653470|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2653471|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
2653472|NCT02064049|Velpatasvir|velpatasvir|mesh-list
2653473|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
2653474|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653475|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
2653476|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
2653477|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
2653478|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653479|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653480|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
2653481|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653482|NCT02064140|Rocuronium|rocuronium|mesh-list
2653483|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2653484|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2653485|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2653486|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653487|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653488|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
2653489|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2653490|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
2653491|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
2653492|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2653493|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653494|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2653495|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2653496|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653497|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653498|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653499|NCT02064374|Metformin|metformin|mesh-list
2653500|NCT02064374|Dolutegravir|dolutegravir|mesh-list
2653501|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2653502|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653503|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2653504|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2653505|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653506|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653507|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2653508|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2653509|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
2653510|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653511|NCT02064426|Epoetin Alfa|epoetin alfa|mesh-list
2653512|NCT02064426|Hematinics|hematinics|mesh-ancestor
2653513|NCT02064465|Lamotrigine|lamotrigine|mesh-list
2653514|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
2653515|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2653516|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2653517|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653518|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2653519|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653520|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2653521|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2653522|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653523|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2653524|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2653525|NCT02064491|Paclitaxel|paclitaxel|mesh-list
2653526|NCT02064491|Docetaxel|docetaxel|mesh-list
2653527|NCT02064491|Cisplatin|cisplatin|mesh-list
2653528|NCT02064491|Carboplatin|carboplatin|mesh-list
2653529|NCT02064491|Pemetrexed|pemetrexed|mesh-list
2180012|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180013|NCT00002494|Leucovorin|leucovorin|mesh-list
2180014|NCT00002494|Cobalt|cobalt|mesh-list
2180015|NCT00002494|Cytarabine|cytarabine|mesh-list
2180016|NCT00002494|Dexamethasone|dexamethasone|mesh-list
2180017|NCT00002494|Prednisone|prednisone|mesh-list
2180018|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
2653530|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2653531|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2653532|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653533|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
2653534|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
2653535|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
2653536|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653537|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653538|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2653539|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2653540|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2653541|NCT02064504|Fluticasone|fluticasone|mesh-list
2653542|NCT02064504|Xhance|xhance|mesh-list
2653543|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2653544|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2653545|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
2653546|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653547|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653548|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2653549|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
2180019|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2180020|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2180021|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2180022|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
2180023|NCT00002494|Ifosfamide|ifosfamide|mesh-list
2180024|NCT00002494|Doxorubicin|doxorubicin|mesh-list
2653550|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
2653551|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2653552|NCT02064517|Calcium|calcium|mesh-list
2653553|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2653554|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653555|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
2653556|NCT02064530|Bupivacaine|bupivacaine|mesh-list
2653557|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
2653558|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
2653559|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653560|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653561|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
2653562|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653563|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2653564|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2653565|NCT02064530|Analgesics|analgesics|mesh-ancestor
2653566|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2653567|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2653568|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2653569|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
2653570|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2180025|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2180026|NCT00002494|Methotrexate|methotrexate|mesh-list
2180027|NCT00002494|Etoposide|etoposide|mesh-list
2180028|NCT00002494|Vincristine|vincristine|mesh-list
2180029|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
2653571|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653572|NCT02064556|Amlodipine|amlodipine|mesh-list
2653573|NCT02064556|Candesartan|candesartan|mesh-list
2653574|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2653575|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2653576|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2653577|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653578|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2653579|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653580|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
2653581|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2653582|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2653583|NCT02064621|Amlodipine|amlodipine|mesh-list
2653584|NCT02064621|Candesartan|candesartan|mesh-list
2180030|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180031|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
2180032|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180033|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180034|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180035|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
2180036|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180037|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180038|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180039|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2180040|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
2180041|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
2180042|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2180043|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2180044|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
2180045|NCT00002494|Hormones|hormones|mesh-ancestor
2180046|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180047|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2180048|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180049|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180050|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180051|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180052|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2180053|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
2180054|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2180055|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180056|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
2180057|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
2180058|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2180059|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2653585|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
2653586|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2653587|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2653588|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2653589|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653590|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2653591|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653592|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
2653593|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2653594|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2653595|NCT02064673|Curcumin|curcumin|mesh-list
2653596|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2653597|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2180060|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180061|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
2180062|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180063|NCT00002494|Antidotes|antidotes|mesh-ancestor
2180064|NCT00002494|Protective Agents|protective agents|mesh-ancestor
2180065|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
2653598|NCT02064673|Analgesics|analgesics|mesh-ancestor
2180066|NCT00002494|Vitamins|vitamins|mesh-ancestor
2180067|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
2180068|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
2180069|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
2180070|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
2180071|NCT00002494|Trace Elements|trace elements|mesh-ancestor
2180072|NCT00002495|Doxorubicin|doxorubicin|mesh-list
2180073|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2180074|NCT00002495|Vinblastine|vinblastine|mesh-list
2180075|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2653599|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
2653600|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653601|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653602|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2653603|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2653604|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653605|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653606|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653607|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
2653608|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
2653609|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
2653610|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653611|NCT02064777|Tacrolimus|tacrolimus|mesh-list
2653612|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2653613|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
2653614|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653615|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2653616|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653617|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653618|NCT02064829|Paclitaxel|paclitaxel|mesh-list
2653619|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2653620|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2653621|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653622|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
2653623|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
2653624|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
2653625|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653626|NCT02064842|Ritonavir|ritonavir|mesh-list
2653627|NCT02064842|Simeprevir|simeprevir|mesh-list
2653628|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2653629|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2653630|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
2653631|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653632|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180076|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180077|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180078|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180079|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180080|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180081|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180082|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
2180083|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
2653633|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2653634|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2653635|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
2653636|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653637|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2653638|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2653639|NCT02064881|Metformin|metformin|mesh-list
2653640|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2653641|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653642|NCT02064946|Vitamin D|vitamin d|mesh-list
2653643|NCT02064946|Vitamins|vitamins|mesh-ancestor
2653644|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
2653645|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653646|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2653647|NCT02065063|Palbociclib|palbociclib|mesh-list
2653648|NCT02065063|Trametinib|trametinib|mesh-list
2653649|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653650|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2653651|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653652|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653653|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
2653654|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
2653655|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
2653656|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653657|NCT02065128|Capsaicin|capsaicin|mesh-list
2653658|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
2653659|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
2653660|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
2653661|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653662|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653663|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
2653664|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2653665|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
2653666|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653667|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2653668|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2653669|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
2653670|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653671|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653672|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2653673|NCT02065219|Bupivacaine|bupivacaine|mesh-list
2653674|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
2653675|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
2653676|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653677|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653678|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
2653679|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653680|NCT02065349|ASP8477|asp8477|mesh-list
2653681|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653682|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653683|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
2653684|NCT02065362|Fludarabine|fludarabine|mesh-list
2653685|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2653686|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
2653687|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653688|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2653689|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2653690|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
2653691|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653692|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653693|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2653694|NCT02065388|Warfarin|warfarin|mesh-list
2653695|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
2653696|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
2653697|NCT02065401|Antacids|antacids|mesh-ancestor
2653698|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653699|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2653700|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
2653701|NCT02065414|Listerine|listerine|mesh-list
2653702|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2653703|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653704|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
2653705|NCT02065466|Paclitaxel|paclitaxel|mesh-list
2653706|NCT02065466|Bevacizumab|bevacizumab|mesh-list
2653707|NCT02065466|Temozolomide|temozolomide|mesh-list
2653708|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2653709|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653710|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
2653711|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
2653712|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
2653713|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653714|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2653715|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2653716|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2653717|NCT02065466|Growth Substances|growth substances|mesh-ancestor
2653718|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653719|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
2653720|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2653721|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
2653722|NCT02065492|Amlodipine|amlodipine|mesh-list
2653723|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
2653724|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2653725|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653726|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2653727|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2653728|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653729|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
2653730|NCT02065596|Vidarabine|vidarabine|mesh-list
2653731|NCT02065596|Fludarabine|fludarabine|mesh-list
2653732|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
2653733|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653734|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2653735|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
2653736|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653737|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2653738|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
2653739|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653740|NCT02065596|Antiviral Agents|antiviral agents|mesh-ancestor
2653741|NCT02065596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653742|NCT02065609|Trastuzumab|trastuzumab|mesh-list
2653743|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2653744|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653755|NCT02065739|Itraconazole|itraconazole|mesh-list
2653756|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
2653757|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
2653758|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653759|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2653760|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2653761|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653762|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653763|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2653764|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
2653765|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2653766|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653767|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2653768|NCT02065752|Metformin|metformin|mesh-list
2653769|NCT02065752|Canagliflozin|canagliflozin|mesh-list
2653770|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2653771|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653772|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2653773|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653774|NCT02065804|Bupivacaine|bupivacaine|mesh-list
2653775|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
2653776|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
2653777|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653778|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653779|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
2653780|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653781|NCT02065843|Midazolam|midazolam|mesh-list
2653782|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2653783|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2653784|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653785|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653786|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2653787|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2653788|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2653789|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2653790|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
2653791|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
2180084|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
2180085|NCT00002496|Cobalt|cobalt|mesh-list
2180086|NCT00002496|Fluorouracil|fluorouracil|mesh-list
2180087|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180088|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
2422640|NCT00817934|Cathartics|cathartics|mesh-ancestor
2422641|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2422642|NCT00817934|Laxatives|laxatives|mesh-ancestor
2422643|NCT00817960|Methylphenidate|methylphenidate|mesh-list
2422644|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2422645|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422646|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2422647|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2422648|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422649|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422650|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
2422651|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422652|NCT00817973|Caseins|caseins|mesh-list
2422653|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
2422654|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
2422655|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422656|NCT00817986|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
2653792|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
2653793|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
2653794|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2653795|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653796|NCT02065947|Lidocaine|lidocaine|mesh-list
2653797|NCT02065947|Epinephrine|epinephrine|mesh-list
2653798|NCT02065947|Racepinephrine|racepinephrine|mesh-list
2653799|NCT02065947|Fentanyl|fentanyl|mesh-list
2653800|NCT02065947|Midazolam|midazolam|mesh-list
2653801|NCT02065947|Ketamine|ketamine|mesh-list
2653802|NCT02065947|Bupivacaine|bupivacaine|mesh-list
2653803|NCT02065947|Propofol|propofol|mesh-list
2653804|NCT02065947|Sevoflurane|sevoflurane|mesh-list
2653805|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
2653806|NCT02065947|Atracurium|atracurium|mesh-list
2653807|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
2653808|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
2653809|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653810|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653811|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
2653812|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2653813|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2653814|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2653815|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2653816|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2653817|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653818|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2653819|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2653820|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
2653821|NCT02065947|Analgesics|analgesics|mesh-ancestor
2653822|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2653823|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2653824|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2653825|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2653826|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2180089|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180090|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180091|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180092|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
2180093|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180094|NCT00002496|Trace Elements|trace elements|mesh-ancestor
2180095|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
2653827|NCT02065947|Narcotics|narcotics|mesh-ancestor
2653828|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2653829|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2653830|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2653831|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2653832|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
2653833|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
2653834|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2180096|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
2180097|NCT00002498|Fluorouracil|fluorouracil|mesh-list
2180098|NCT00002498|Methotrexate|methotrexate|mesh-list
2180099|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
2180100|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180101|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
2180102|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180103|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180104|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180105|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
2180106|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180107|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180108|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180109|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
2180110|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180111|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2180112|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
2180113|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2180114|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
2180115|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180116|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2180117|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2653835|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2653836|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2653837|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2653838|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
2653839|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2653840|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2653841|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
2653842|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2653843|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
2653844|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
2653845|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
2653846|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2653847|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2653848|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2653849|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2653850|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2653851|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2653852|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
2653853|NCT02065986|Tenofovir|tenofovir|mesh-list
2653854|NCT02065986|Emtricitabine|emtricitabine|mesh-list
2653855|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2653856|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
2653857|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2653858|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2653859|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2653860|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653861|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653862|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2653863|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2653864|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2653865|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653866|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2653867|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653868|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653869|NCT02066077|Propofol|propofol|mesh-list
2653870|NCT02066077|Etomidate|etomidate|mesh-list
2653871|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2653872|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653873|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653874|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2653875|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
2653876|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
2653877|NCT02066103|Paclitaxel|paclitaxel|mesh-list
2653878|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2653879|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653880|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
2653881|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
2653882|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
2653883|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653884|NCT02066207|Atorvastatin|atorvastatin|mesh-list
2653885|NCT02066207|Fenofibrate|fenofibrate|mesh-list
2653886|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2653887|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2653888|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
2653889|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653890|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2653891|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2653892|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653893|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
2653894|NCT02066220|Lomustine|lomustine|mesh-list
2653895|NCT02066220|Cisplatin|cisplatin|mesh-list
2653896|NCT02066220|Carboplatin|carboplatin|mesh-list
2653897|NCT02066220|Vincristine|vincristine|mesh-list
2653898|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2653899|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
2653900|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653901|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2653902|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2653903|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
2653904|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653905|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653906|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2653907|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2653908|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
2653909|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
2653910|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
2653911|NCT02066350|Pancrelipase|pancrelipase|mesh-list
2653912|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2653913|NCT02066454|Apixaban|apixaban|mesh-list
2653914|NCT02066454|Anticoagulants|anticoagulants|mesh-list
2653915|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2653916|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
2653917|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2653918|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
2653919|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653920|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653921|NCT02066532|Trastuzumab|trastuzumab|mesh-list
2653922|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2653923|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653924|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
2653925|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
2653926|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653927|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
2653928|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2653929|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653930|NCT02066571|Droxidopa|droxidopa|mesh-list
2653931|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2653932|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2653933|NCT02066610|Selenium|selenium|mesh-list
2653934|NCT02066610|Selenious Acid|selenious acid|mesh-list
2653935|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
2653936|NCT02066610|Selenic Acid|selenic acid|mesh-list
2653937|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
2653938|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653939|NCT02066610|Protective Agents|protective agents|mesh-ancestor
2653940|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653941|NCT02066610|Trace Elements|trace elements|mesh-ancestor
2653942|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
2653943|NCT02066623|Everolimus|everolimus|mesh-list
2653944|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653945|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2653946|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
2653947|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180118|NCT00002498|Analgesics|analgesics|mesh-ancestor
2180119|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
2180120|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2180121|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180122|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2653953|NCT02066649|Carvedilol|carvedilol|mesh-list
2653954|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2653955|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2653956|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
2653957|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2653958|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653959|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653960|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2653961|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
2653962|NCT02066649|Protective Agents|protective agents|mesh-ancestor
2653963|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2653964|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2653965|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2653966|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
2653967|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2653968|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2653969|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
2653970|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
2653971|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2653972|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
2653973|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2653974|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
2653975|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2653976|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653977|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
2653978|NCT02066675|Trabectedin|trabectedin|mesh-list
2653979|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2653980|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
2653981|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2653982|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2653983|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
2180123|NCT00002499|Cytarabine|cytarabine|mesh-list
2653984|NCT02066688|Vitamin D|vitamin d|mesh-list
2653985|NCT02066688|Folic Acid|folic acid|mesh-list
2653986|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
2653987|NCT02066688|Calcium|calcium|mesh-list
2653988|NCT02066688|Vitamins|vitamins|mesh-ancestor
2653989|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
2653990|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2653991|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2653992|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2653993|NCT02066688|Hematinics|hematinics|mesh-ancestor
2653994|NCT02066818|Lidocaine|lidocaine|mesh-list
2653995|NCT02066818|Tetracaine|tetracaine|mesh-list
2653996|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
2653997|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
2653998|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2653999|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654000|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
2654001|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654002|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2654003|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2654004|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2654005|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2654006|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654007|NCT02066844|Betamethasone|betamethasone|mesh-list
2654008|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
2654009|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2654010|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
2654011|NCT02066844|Lidocaine|lidocaine|mesh-list
2654012|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2654013|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
2654014|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
2654015|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654016|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654017|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
2654018|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654019|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2654020|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2654021|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2654022|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2654023|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180124|NCT00002499|Dexamethasone|dexamethasone|mesh-list
2180125|NCT00002499|Prednisone|prednisone|mesh-list
2180126|NCT00002499|Methotrexate|methotrexate|mesh-list
2180127|NCT00002499|Vincristine|vincristine|mesh-list
2180128|NCT00002499|Daunorubicin|daunorubicin|mesh-list
2180129|NCT00002499|Asparaginase|asparaginase|mesh-list
2180130|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2180131|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
2180132|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
2654024|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2654025|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
2654026|NCT02066844|Hormones|hormones|mesh-ancestor
2654027|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2654028|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2654029|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
2654030|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
2654031|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654032|NCT02067013|Ranibizumab|ranibizumab|mesh-list
2654033|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2654034|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2654035|NCT02067013|Growth Substances|growth substances|mesh-ancestor
2654036|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654037|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
2654038|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654039|NCT02067065|Propofol|propofol|mesh-list
2654040|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2654041|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654042|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180133|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422657|NCT00817986|Baclofen|baclofen|mesh-list
2422658|NCT00817986|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2422659|NCT00817986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422660|NCT00817986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2422661|NCT00817986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422662|NCT00817986|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2422663|NCT00817986|GABA Agonists|gaba agonists|mesh-ancestor
2422664|NCT00817986|GABA Agents|gaba agents|mesh-ancestor
2422665|NCT00817986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654043|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2654044|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
2654045|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
2654046|NCT02067078|Dexamethasone|dexamethasone|mesh-list
2654047|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
2654048|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2654049|NCT02067078|Clonidine|clonidine|mesh-list
2654050|NCT02067078|Epinephrine|epinephrine|mesh-list
2654051|NCT02067078|Racepinephrine|racepinephrine|mesh-list
2654052|NCT02067078|Ropivacaine|ropivacaine|mesh-list
2654053|NCT02067078|Bupivacaine|bupivacaine|mesh-list
2654054|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
2654055|NCT02067078|BB 1101|bb 1101|mesh-list
2654056|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2654057|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
2654058|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
2654059|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654060|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654061|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2654062|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
2654063|NCT02067078|Hormones|hormones|mesh-ancestor
2654064|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2654065|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2654066|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180134|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180135|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2180136|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
2180137|NCT00002499|Hormones|hormones|mesh-ancestor
2180138|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180139|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2180140|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180141|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2180142|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
2180143|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2180144|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180145|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
2180146|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180147|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
2180148|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180149|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2180150|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180151|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
2180152|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180153|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2180154|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
2180155|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654067|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
2654068|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654069|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654070|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
2654071|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
2654072|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654073|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
2654074|NCT02067078|Analgesics|analgesics|mesh-ancestor
2654075|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2654076|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
2180156|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180157|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
2180158|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
2180159|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
2180160|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180161|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180162|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180163|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
2180164|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180165|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
2180166|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180167|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2654077|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2654078|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2654079|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2654080|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
2654081|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654082|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2654083|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2654084|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2654085|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2654086|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2654087|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2654088|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2654089|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
2654090|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
2654091|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
2654092|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2654093|NCT02067143|Cytarabine|cytarabine|mesh-list
2654094|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2654095|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
2654096|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654097|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654098|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
2654099|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654100|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2654101|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
2654102|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654103|NCT02067182|Dabigatran|dabigatran|mesh-list
2654104|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
2654105|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2654106|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
2654107|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654108|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654109|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
2654110|NCT02067338|Morphine|morphine|mesh-list
2654111|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
2654112|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2654113|NCT02067338|Narcotics|narcotics|mesh-ancestor
2654114|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654115|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654116|NCT02067338|Analgesics|analgesics|mesh-ancestor
2654117|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
2654118|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654119|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
2654120|NCT02067338|Coagulants|coagulants|mesh-ancestor
2654121|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
2654122|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2654123|NCT02067377|Antibodies|antibodies|mesh-list
2654124|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
2654125|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654126|NCT02067416|Paclitaxel|paclitaxel|mesh-list
2654127|NCT02067416|Docetaxel|docetaxel|mesh-list
2654128|NCT02067416|Epirubicin|epirubicin|mesh-list
2654129|NCT02067416|Taxane|taxane|mesh-list
2654130|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2654131|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654132|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
2654133|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
2654134|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
2654135|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654136|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2654137|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2654138|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2654139|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654140|NCT02067442|Acetaminophen|acetaminophen|mesh-list
2654141|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2654142|NCT02067442|Analgesics|analgesics|mesh-ancestor
2654143|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
2654144|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654145|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654146|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
2654147|NCT02067520|Hydromorphone|hydromorphone|mesh-list
2654148|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2654149|NCT02067520|Narcotics|narcotics|mesh-ancestor
2654150|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654151|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422666|NCT00817986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422667|NCT00818038|Natalizumab|natalizumab|mesh-list
2422668|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
2422669|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422670|NCT00818090|Paclitaxel|paclitaxel|mesh-list
2422671|NCT00818090|Cisplatin|cisplatin|mesh-list
2422672|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2422673|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422674|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
2422675|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
2422676|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
2180168|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180169|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
2180170|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180171|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180172|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2654152|NCT02067520|Analgesics|analgesics|mesh-ancestor
2654153|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
2654154|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654155|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2654156|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2654157|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654158|NCT02067767|Lamivudine|lamivudine|mesh-list
2654159|NCT02067767|Abacavir|abacavir|mesh-list
2654160|NCT02067767|Dolutegravir|dolutegravir|mesh-list
2654161|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2654162|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2654163|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654164|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654165|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
2654166|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654167|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2654168|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2654169|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2654170|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2654171|NCT02067780|Levofloxacin|levofloxacin|mesh-list
2654172|NCT02067780|Ofloxacin|ofloxacin|mesh-list
2654173|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2654174|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654175|NCT02067780|Renal Agents|renal agents|mesh-ancestor
2654176|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2654177|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2654178|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2654179|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654180|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654181|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654182|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2654183|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2654189|NCT02067910|Abatacept|abatacept|mesh-list
2654190|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2654191|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654192|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654193|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2654194|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
2654195|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654196|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2654197|NCT02067936|Remifentanil|remifentanil|mesh-list
2654198|NCT02067936|Propofol|propofol|mesh-list
2654199|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2654200|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654201|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654202|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2654203|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
2654204|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
2654205|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2654206|NCT02067936|Narcotics|narcotics|mesh-ancestor
2654207|NCT02067936|Analgesics|analgesics|mesh-ancestor
2654208|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
2654209|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654210|NCT02067949|Simvastatin|simvastatin|mesh-list
2654211|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2654212|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2654213|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
2654214|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654215|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2654216|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2654217|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654218|NCT02068079|Vemurafenib|vemurafenib|mesh-list
2654219|NCT02068079|Trientine|trientine|mesh-list
2654220|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654221|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2654222|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654223|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654224|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
2654225|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
2654226|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
2654227|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654228|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
2654229|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654230|NCT02068092|Protective Agents|protective agents|mesh-ancestor
2654231|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654232|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2654233|NCT02068131|Capecitabine|capecitabine|mesh-list
2654234|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2654235|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
2654236|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654237|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654238|NCT02068170|Azithromycin|azithromycin|mesh-list
2654239|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
2654240|NCT02068170|Clarithromycin|clarithromycin|mesh-list
2654241|NCT02068170|Levofloxacin|levofloxacin|mesh-list
2654242|NCT02068170|Erythromycin|erythromycin|mesh-list
2654243|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
2654244|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2654245|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
2654246|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2654247|NCT02068170|Itraconazole|itraconazole|mesh-list
2654248|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
2654249|NCT02068170|Fluconazole|fluconazole|mesh-list
2654250|NCT02068170|Ketoconazole|ketoconazole|mesh-list
2654251|NCT02068170|Voriconazole|voriconazole|mesh-list
2654252|NCT02068170|Sunitinib|sunitinib|mesh-list
2654253|NCT02068170|Methadone|methadone|mesh-list
2654254|NCT02068170|Haloperidol|haloperidol|mesh-list
2654255|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
2654256|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2654257|NCT02068170|Tacrolimus|tacrolimus|mesh-list
2654258|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2654259|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
2654260|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654261|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2654262|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654263|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654264|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2180173|NCT00002502|Cytarabine|cytarabine|mesh-list
2180174|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
2180175|NCT00002502|Busulfan|busulfan|mesh-list
2180176|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180177|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
2180178|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180179|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180180|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180181|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
2180182|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180183|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180184|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180185|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180186|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
2654265|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654266|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654267|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2654268|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2654269|NCT02068170|Growth Substances|growth substances|mesh-ancestor
2654270|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
2654271|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2654272|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2654273|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2654274|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2654275|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
2654276|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2654277|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2654278|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2654279|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2654280|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2654281|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2654282|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2654283|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
2654284|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2654285|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2654286|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
2654287|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2654288|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2654289|NCT02068170|Renal Agents|renal agents|mesh-ancestor
2654290|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2654291|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2654292|NCT02068170|Narcotics|narcotics|mesh-ancestor
2654293|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654294|NCT02068170|Analgesics|analgesics|mesh-ancestor
2654295|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
2654296|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654297|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
2654298|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
2180187|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
2180188|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180189|NCT00002504|Interferons|interferons|mesh-list
2180190|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
2180191|NCT00002504|Aldesleukin|aldesleukin|mesh-list
2180192|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180193|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
2180194|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180195|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
2180196|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180197|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2180198|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2180199|NCT00002505|Interferons|interferons|mesh-list
2180200|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
2180201|NCT00002505|Vaccines|vaccines|mesh-list
2180202|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180203|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
2180204|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180205|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
2180206|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180207|NCT00002506|Interferons|interferons|mesh-list
2654299|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2654300|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2654301|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
2654302|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
2654303|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2654304|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2654305|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2654306|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2654307|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2654308|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
2654309|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654310|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2654311|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
2654312|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2654313|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2654314|NCT02068196|Ipilimumab|ipilimumab|mesh-list
2654315|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2654316|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654317|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2654318|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654319|NCT02068209|Tramadol|tramadol|mesh-list
2654320|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2654321|NCT02068209|Narcotics|narcotics|mesh-ancestor
2654322|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654323|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654324|NCT02068209|Analgesics|analgesics|mesh-ancestor
2654325|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
2654326|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654327|NCT02068235|Ponesimod|ponesimod|mesh-list
2654328|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2654329|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180208|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
2180209|NCT00002506|Isotretinoin|isotretinoin|mesh-list
2180210|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180211|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
2180212|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180213|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
2180214|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180215|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
2180216|NCT00002507|Mitomycins|mitomycins|mesh-list
2180217|NCT00002507|Mitomycin|mitomycin|mesh-list
2180218|NCT00002507|Porfiromycin|porfiromycin|mesh-list
2654330|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2654331|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
2654332|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654333|NCT02068287|Esmolol|esmolol|mesh-list
2654334|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2654335|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2654336|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2654337|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
2654338|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654339|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654340|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654341|NCT02068339|Oltipraz|oltipraz|mesh-list
2654342|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
2654343|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654344|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
2654345|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2654346|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
2654347|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2654348|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2654349|NCT02068339|Protective Agents|protective agents|mesh-ancestor
2654350|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180219|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180220|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180221|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
2180222|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180223|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2180224|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654351|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654352|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2654353|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2654354|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654355|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654356|NCT02068404|Nifedipine|nifedipine|mesh-list
2654357|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2654358|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2654359|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654360|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2654361|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654362|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
2654363|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
2654364|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2654365|NCT02068430|Riboflavin|riboflavin|mesh-list
2654366|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
2654367|NCT02068430|Vitamins|vitamins|mesh-ancestor
2654368|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
2654369|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654370|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2654371|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
2654372|NCT02068482|Rifaximin|rifaximin|mesh-list
2654373|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2180225|NCT00002508|Carboplatin|carboplatin|mesh-list
2180226|NCT00002508|Etoposide|etoposide|mesh-list
2180227|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180228|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2654374|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654375|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2654376|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2654377|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
2654378|NCT02068560|Coagulants|coagulants|mesh-ancestor
2654379|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2654380|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
2654381|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654382|NCT02068586|Sunitinib|sunitinib|mesh-list
2654383|NCT02068586|Valproic Acid|valproic acid|mesh-list
2654384|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654385|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2654386|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2654387|NCT02068586|Growth Substances|growth substances|mesh-ancestor
2180229|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180230|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180231|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180232|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180233|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
2180234|NCT00002509|Carboplatin|carboplatin|mesh-list
2180235|NCT00002509|Etoposide|etoposide|mesh-list
2654388|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654389|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
2654390|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2654391|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654392|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654393|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
2654394|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
2654395|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654396|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
2654397|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2654398|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654399|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2654400|NCT02068625|Rasagiline|rasagiline|mesh-list
2654401|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2654402|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654403|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654404|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2654405|NCT02068625|Protective Agents|protective agents|mesh-ancestor
2654406|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654407|NCT02068690|BI 425809|bi 425809|mesh-list
2654408|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
2654409|NCT02068859|Diclofenac|diclofenac|mesh-list
2654410|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2654411|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2654412|NCT02068859|Analgesics|analgesics|mesh-ancestor
2654413|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
2654414|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654415|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654416|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2654417|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2654418|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2654419|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654420|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654421|NCT02068937|Furosemide|furosemide|mesh-list
2654422|NCT02068937|Diuretics|diuretics|mesh-ancestor
2654423|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
2654424|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654425|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2654426|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2654427|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654428|NCT02069080|Plerixafor|plerixafor|mesh-list
2654429|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2654430|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2654431|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
2654432|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654433|NCT02069132|Warfarin|warfarin|mesh-list
2654434|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
2654435|NCT02069145|Sorafenib|sorafenib|mesh-list
2654436|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2654437|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654438|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2654439|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654440|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654441|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
2654442|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654443|NCT02069158|Paclitaxel|paclitaxel|mesh-list
2654444|NCT02069158|Carboplatin|carboplatin|mesh-list
2654445|NCT02069158|Gedatolisib|gedatolisib|mesh-list
2654446|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2654447|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654448|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
2654449|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
2654450|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
2654451|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654452|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2654453|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654454|NCT02069197|Orlistat|orlistat|mesh-list
2654455|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654456|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654457|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2654458|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2654459|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
2654460|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2654461|NCT02069301|Fluoxetine|fluoxetine|mesh-list
2654462|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
2654463|NCT02069301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2654464|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2654465|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2654466|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654467|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654468|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
2654469|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654470|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2654471|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2654472|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2654473|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2654474|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654475|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
2654476|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2654477|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654478|NCT02069366|Dronabinol|dronabinol|mesh-list
2654479|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
2654480|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654481|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2654482|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2654483|NCT02069366|Analgesics|analgesics|mesh-ancestor
2654484|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
2654485|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654486|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2654487|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2654488|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654489|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654490|NCT02069366|Hormones|hormones|mesh-ancestor
2654491|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2654492|NCT02069418|Alovudine|alovudine|mesh-list
2654493|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2654494|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2654495|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654496|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
2654497|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654498|NCT02069431|Oxytocin|oxytocin|mesh-list
2654499|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
2654500|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2654501|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654502|NCT02069522|Carotenoids|carotenoids|mesh-list
2654503|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
2654504|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654505|NCT02069522|Protective Agents|protective agents|mesh-ancestor
2654506|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654507|NCT02069665|Ribavirin|ribavirin|mesh-list
2654508|NCT02069665|Ibuprofen|ibuprofen|mesh-list
2654509|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
2654510|NCT02069665|Albuterol|albuterol|mesh-list
2654511|NCT02069665|Guaifenesin|guaifenesin|mesh-list
2654512|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2654513|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
2654514|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654515|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
2654516|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654517|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2654518|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2654519|NCT02069665|Analgesics|analgesics|mesh-ancestor
2654520|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
2180236|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180237|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
2180238|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180239|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180240|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180241|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
2180242|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180243|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654521|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654522|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654523|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2654524|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2654525|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2654526|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180244|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180245|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2654527|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2654528|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
2654529|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2654530|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
2654531|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
2654532|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2654533|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2654534|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2654535|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2654536|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
2654537|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654538|NCT02069665|Expectorants|expectorants|mesh-ancestor
2654539|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2654540|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
2654541|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2654542|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
2654543|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
2180246|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180247|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180248|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180249|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
2180250|NCT00002510|Etoposide|etoposide|mesh-list
2654544|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2654545|NCT02069808|Leuprolide|leuprolide|mesh-list
2654546|NCT02069808|Menotropins|menotropins|mesh-list
2654547|NCT02069808|Ganirelix|ganirelix|mesh-list
2180251|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180252|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
2180253|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180254|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180255|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180256|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
2180257|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180258|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180259|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180260|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180261|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180262|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2654548|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2654549|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
2654550|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2654551|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654552|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2654553|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654554|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
2654555|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2654556|NCT02069886|Deferasirox|deferasirox|mesh-list
2654557|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2654558|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
2654559|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
2654560|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654561|NCT02069977|Aripiprazole|aripiprazole|mesh-list
2654562|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
2654563|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2654564|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2654565|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2654566|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654567|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654568|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
2654569|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
2654570|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654571|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654572|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2654573|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2654574|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
2654575|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2422677|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422678|NCT00818103|Interferons|interferons|mesh-list
2422679|NCT00818103|Atorvastatin|atorvastatin|mesh-list
2422680|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422681|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
2422682|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422683|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2422684|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2422685|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
2654576|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2654577|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2654578|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2654579|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
2654580|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2654581|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654582|NCT02069990|Vitamins|vitamins|mesh-ancestor
2654583|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
2654584|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2654585|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
2654586|NCT02070003|Narcotics|narcotics|mesh-ancestor
2654587|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654588|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654589|NCT02070003|Analgesics|analgesics|mesh-ancestor
2654590|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
2654591|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654592|NCT02070120|Mitomycins|mitomycins|mesh-list
2654593|NCT02070120|Mitomycin|mitomycin|mesh-list
2654594|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2654595|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654596|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
2654597|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654598|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2654599|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654600|NCT02070133|Simvastatin|simvastatin|mesh-list
2654601|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2654602|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2654603|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
2654604|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654605|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2654606|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2654607|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654608|NCT02070159|Clopidogrel|clopidogrel|mesh-list
2654609|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2654610|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2654611|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2654612|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2654613|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2654614|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
2654615|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654616|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654617|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654618|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2654619|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2654620|NCT02070198|Hormones|hormones|mesh-ancestor
2654621|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180263|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180264|NCT00002514|Leucovorin|leucovorin|mesh-list
2180265|NCT00002514|Cytarabine|cytarabine|mesh-list
2180266|NCT00002514|Dexamethasone|dexamethasone|mesh-list
2180267|NCT00002514|Prednisone|prednisone|mesh-list
2180268|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
2180269|NCT00002514|Methotrexate|methotrexate|mesh-list
2180270|NCT00002514|Etoposide|etoposide|mesh-list
2654622|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654623|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
2654624|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2654625|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
2654626|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2654627|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2654628|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2654629|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654630|NCT02070289|PF-06372865|pf-06372865|mesh-list
2654631|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
2654632|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
2654633|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654634|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654635|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654636|NCT02070406|Aldesleukin|aldesleukin|mesh-list
2654637|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
2654638|NCT02070406|Fludarabine|fludarabine|mesh-list
2654639|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
2654640|NCT02070406|Interleukin-2|interleukin-2|mesh-list
2654641|NCT02070406|Vaccines|vaccines|mesh-list
2180271|NCT00002514|Vincristine|vincristine|mesh-list
2180272|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
2180273|NCT00002514|Daunorubicin|daunorubicin|mesh-list
2180274|NCT00002514|Asparaginase|asparaginase|mesh-list
2180275|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
2180276|NCT00002514|Thioguanine|thioguanine|mesh-list
2180277|NCT00002514|Sargramostim|sargramostim|mesh-list
2180278|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
2654642|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2654643|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180279|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180280|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
2180281|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180282|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180283|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180284|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
2180285|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180286|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180287|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180288|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2180289|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
2654644|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
2654645|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654646|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2654647|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2654648|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
2654649|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654650|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654651|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2654652|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2654653|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
2654654|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2654655|NCT02070406|Analgesics|analgesics|mesh-ancestor
2654656|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
2654657|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654658|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2180290|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
2180291|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2180292|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2180293|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
2180294|NCT00002514|Hormones|hormones|mesh-ancestor
2180295|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180296|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2180297|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2654659|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2654660|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
2654661|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654662|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2654663|NCT02070458|Cytarabine|cytarabine|mesh-list
2654664|NCT02070458|Etoposide|etoposide|mesh-list
2654665|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
2654666|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
2654667|NCT02070458|Ixazomib|ixazomib|mesh-list
2654668|NCT02070458|Glycine|glycine|mesh-list
2654669|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
2654670|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2654671|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654672|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2654673|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2654674|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654675|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654676|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2654677|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
2654678|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
2654679|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654680|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2654681|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
2654682|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654683|NCT02070458|Analgesics|analgesics|mesh-ancestor
2654684|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
2654685|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654686|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
2654687|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
2654688|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654689|NCT02070510|Lisinopril|lisinopril|mesh-list
2180298|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
2180299|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2180300|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180301|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
2654690|NCT02070510|Warfarin|warfarin|mesh-list
2654691|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
2654692|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2654693|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
2654694|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654695|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654696|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2654697|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2654698|NCT02070510|Protective Agents|protective agents|mesh-ancestor
2654699|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654700|NCT02070549|Trametinib|trametinib|mesh-list
2654701|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654702|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2654703|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654704|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654705|NCT02070653|Ticagrelor|ticagrelor|mesh-list
2654706|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2654707|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2654708|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2654709|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2654710|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
2654711|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2180302|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
2180303|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180304|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2654712|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654713|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654714|NCT02070679|Vitamin E|vitamin e|mesh-list
2654715|NCT02070679|Tocopherols|tocopherols|mesh-list
2654716|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
2654717|NCT02070679|Vitamins|vitamins|mesh-ancestor
2654718|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
2654719|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654720|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
2654721|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654722|NCT02070679|Protective Agents|protective agents|mesh-ancestor
2654723|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2654724|NCT02070705|Hematinics|hematinics|mesh-ancestor
2654725|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2654726|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2654727|NCT02070718|Pentazocine|pentazocine|mesh-list
2654728|NCT02070718|Naloxone|naloxone|mesh-list
2654729|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2654730|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654731|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
2654732|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654733|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2654734|NCT02070718|Narcotics|narcotics|mesh-ancestor
2654735|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654736|NCT02070718|Analgesics|analgesics|mesh-ancestor
2654737|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2654738|NCT02070796|Rotigotine|rotigotine|mesh-list
2654739|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
2654740|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
2654741|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654742|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654743|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654744|NCT02071004|Aspirin|aspirin|mesh-list
2180305|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2180306|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180307|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180308|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180309|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
2654745|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2180310|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180311|NCT00002514|Antidotes|antidotes|mesh-ancestor
2180312|NCT00002514|Protective Agents|protective agents|mesh-ancestor
2180313|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
2180314|NCT00002514|Vitamins|vitamins|mesh-ancestor
2180315|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
2180316|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
2180317|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
2180318|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
2180319|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2180320|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180321|NCT00002515|Carboplatin|carboplatin|mesh-list
2654746|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2654747|NCT02071004|Analgesics|analgesics|mesh-ancestor
2654748|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
2654749|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654750|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654751|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2654752|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2654753|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2654754|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2654755|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654756|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2654757|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2654758|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654759|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
2654760|NCT02071043|Capecitabine|capecitabine|mesh-list
2654761|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
2654762|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2654763|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
2654764|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654765|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654766|NCT02071069|Fluorouracil|fluorouracil|mesh-list
2654767|NCT02071069|Irinotecan|irinotecan|mesh-list
2654768|NCT02071069|Cetuximab|cetuximab|mesh-list
2654769|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
2654770|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654771|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2654772|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654773|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2654774|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
2654775|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654776|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2654777|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180322|NCT00002515|Topotecan|topotecan|mesh-list
2180323|NCT00002515|Thiotepa|thiotepa|mesh-list
2180324|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180325|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
2180326|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180327|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2180328|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180329|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180330|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180331|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180332|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
2180333|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180334|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180335|NCT00002516|Cobalt|cobalt|mesh-list
2180336|NCT00002516|Dactinomycin|dactinomycin|mesh-list
2180337|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
2180338|NCT00002516|Ifosfamide|ifosfamide|mesh-list
2180339|NCT00002516|Doxorubicin|doxorubicin|mesh-list
2654778|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654779|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2654780|NCT02071160|Melatonin|melatonin|mesh-list
2654781|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
2654782|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654783|NCT02071160|Protective Agents|protective agents|mesh-ancestor
2654784|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654785|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654786|NCT02071212|Ticagrelor|ticagrelor|mesh-list
2654787|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2654788|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2654789|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2654790|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2654791|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
2654792|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654793|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654794|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654795|NCT02071303|Celecoxib|celecoxib|mesh-list
2654796|NCT02071303|Tramadol|tramadol|mesh-list
2654797|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2654798|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2654799|NCT02071303|Analgesics|analgesics|mesh-ancestor
2654800|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
2180340|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2180341|NCT00002516|Etoposide|etoposide|mesh-list
2180342|NCT00002516|Vincristine|vincristine|mesh-list
2180343|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180344|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
2180345|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180346|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180347|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180348|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
2180349|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180350|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180351|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180352|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180353|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180354|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180355|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654801|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654802|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654803|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2654804|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2654805|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2654806|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2654807|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654808|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654809|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2654810|NCT02071303|Narcotics|narcotics|mesh-ancestor
2654811|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654812|NCT02071316|Esomeprazole|esomeprazole|mesh-list
2654813|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
2654814|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2654815|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2654816|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654817|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
2654818|NCT02071316|Coagulants|coagulants|mesh-ancestor
2654819|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2654820|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2654821|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2654822|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654823|NCT02071342|Everolimus|everolimus|mesh-list
2654824|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654825|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2654826|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
2654827|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654828|NCT02071355|Simeprevir|simeprevir|mesh-list
2654829|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
2654830|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654831|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
2654832|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654833|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654834|NCT02071368|Metformin|metformin|mesh-list
2654835|NCT02071368|Canagliflozin|canagliflozin|mesh-list
2654836|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2654837|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654838|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2654839|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654840|NCT02071394|Xenon|xenon|mesh-list
2654841|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2654842|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
2654843|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
2654844|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654845|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654846|NCT02071407|Midazolam|midazolam|mesh-list
2654847|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2654848|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2654849|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2654850|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654851|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2654852|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2654853|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2654854|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2654855|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
2654856|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
2180356|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180357|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
2180358|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
2180359|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
2180360|NCT00002516|Trace Elements|trace elements|mesh-ancestor
2180361|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
2654857|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
2654858|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
2654859|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2180362|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2180363|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180364|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2180365|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2180366|NCT00002517|Cytarabine|cytarabine|mesh-list
2180367|NCT00002517|Dexamethasone|dexamethasone|mesh-list
2180368|NCT00002517|Etoposide|etoposide|mesh-list
2180369|NCT00002517|Daunorubicin|daunorubicin|mesh-list
2180370|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
2180371|NCT00002517|Idarubicin|idarubicin|mesh-list
2180372|NCT00002517|Thioguanine|thioguanine|mesh-list
2180373|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2180374|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
2180375|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
2180376|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2180377|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180378|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2180379|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
2654860|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654861|NCT02071433|Iodine|iodine|mesh-list
2654862|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2654863|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654864|NCT02071433|Trace Elements|trace elements|mesh-ancestor
2654865|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
2654866|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654867|NCT02071459|Droxidopa|droxidopa|mesh-list
2654868|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2654869|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2654870|NCT02071537|Gemcitabine|gemcitabine|mesh-list
2654871|NCT02071537|Chloroquine|chloroquine|mesh-list
2654872|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2654873|NCT02071537|Carboplatin|carboplatin|mesh-list
2654874|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654875|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2654876|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
2654877|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654878|NCT02071537|Antiviral Agents|antiviral agents|mesh-ancestor
2180380|NCT00002517|Hormones|hormones|mesh-ancestor
2180381|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180382|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2180383|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180384|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180385|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180386|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180387|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180388|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180389|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180390|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
2180391|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
2180392|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180393|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180394|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
2180395|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180396|NCT00002517|Analgesics|analgesics|mesh-ancestor
2180397|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
2180398|NCT00002519|Paclitaxel|paclitaxel|mesh-list
2180399|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180400|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180401|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
2180402|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
2180403|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
2180404|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180405|NCT00002520|Nicotine|nicotine|mesh-list
2180406|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2180407|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
2654879|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2654880|NCT02071537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654881|NCT02071537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2654882|NCT02071537|Immunologic Factors|immunologic factors|mesh-ancestor
2654883|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654884|NCT02071537|Amebicides|amebicides|mesh-ancestor
2654885|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2654886|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2654887|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
2654888|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2654889|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2654890|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2654891|NCT02071537|Analgesics|analgesics|mesh-ancestor
2654892|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
2654893|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654894|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2654895|NCT02071537|Filaricides|filaricides|mesh-ancestor
2654896|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
2654897|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
2654898|NCT02071589|Nifedipine|nifedipine|mesh-list
2654899|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2654900|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2654901|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654902|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2654903|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654904|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
2654905|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
2654906|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2654907|NCT02071615|Methylphenidate|methylphenidate|mesh-list
2654908|NCT02071615|Caffeine|caffeine|mesh-list
2654909|NCT02071615|Modafinil|modafinil|mesh-list
2654910|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2654911|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654912|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2654913|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2654914|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2654915|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654916|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
2654917|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654918|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2654919|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654920|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2654921|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2654922|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
2654923|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2654924|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2654925|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2654926|NCT02071641|Sunitinib|sunitinib|mesh-list
2654927|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654928|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2654929|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2654930|NCT02071641|Growth Substances|growth substances|mesh-ancestor
2654931|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654932|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
2654933|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2654934|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654935|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654936|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2654937|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654938|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654939|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654940|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2654941|NCT02071862|Paclitaxel|paclitaxel|mesh-list
2654942|NCT02071862|Docetaxel|docetaxel|mesh-list
2654943|NCT02071862|Everolimus|everolimus|mesh-list
2654944|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180408|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2180409|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180410|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2180411|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2180412|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
2180413|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2180414|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654945|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654946|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
2654947|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
2654948|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
2654949|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654950|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2654951|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
2654952|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654953|NCT02071888|Dexamethasone|dexamethasone|mesh-list
2654954|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
2654955|NCT02071888|Pomalidomide|pomalidomide|mesh-list
2654956|NCT02071888|BB 1101|bb 1101|mesh-list
2654957|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2654958|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
2654959|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
2654960|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2654961|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654962|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2654963|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
2654964|NCT02071888|Hormones|hormones|mesh-ancestor
2654965|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2654966|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2654967|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654968|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
2654969|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654970|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654971|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
2654972|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2654973|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2654974|NCT02071888|Growth Substances|growth substances|mesh-ancestor
2654975|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
2654976|NCT02071927|Azacitidine|azacitidine|mesh-list
2654977|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2654978|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
2654979|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654980|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654981|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2654982|NCT02071966|Clopidogrel|clopidogrel|mesh-list
2654983|NCT02071966|Ticagrelor|ticagrelor|mesh-list
2654984|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2654985|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2654986|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2654987|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2654988|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
2180415|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
2180416|NCT00002521|Etoposide|etoposide|mesh-list
2180417|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180418|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
2180419|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180420|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180421|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180422|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
2180423|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180424|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180425|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180426|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180427|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180428|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180429|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180430|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
2180431|NCT00002522|Etoposide|etoposide|mesh-list
2180432|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180433|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
2180434|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180435|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180436|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180437|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
2180438|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180439|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180440|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180441|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180442|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180443|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180444|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180445|NCT00002523|Leucovorin|leucovorin|mesh-list
2180446|NCT00002523|Fluorouracil|fluorouracil|mesh-list
2654989|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2654990|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2654991|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654992|NCT02072031|Sunitinib|sunitinib|mesh-list
2654993|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2654994|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2654995|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2654996|NCT02072031|Growth Substances|growth substances|mesh-ancestor
2180447|NCT00002523|Calcium|calcium|mesh-list
2180448|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
2654997|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2654998|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
2654999|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2655000|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655001|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655002|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
2655003|NCT02072083|Ketamine|ketamine|mesh-list
2655004|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2180449|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2180450|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180451|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
2180452|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180453|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2655005|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2655006|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655007|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2655008|NCT02072083|Analgesics|analgesics|mesh-ancestor
2655009|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
2655010|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655011|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2655012|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2655013|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2655014|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
2655015|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2180454|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180455|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180456|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
2180457|NCT00002523|Antidotes|antidotes|mesh-ancestor
2180458|NCT00002523|Protective Agents|protective agents|mesh-ancestor
2180459|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
2180460|NCT00002523|Vitamins|vitamins|mesh-ancestor
2180461|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
2180462|NCT00002524|Leucovorin|leucovorin|mesh-list
2180463|NCT00002524|Cytarabine|cytarabine|mesh-list
2180464|NCT00002524|Zidovudine|zidovudine|mesh-list
2180465|NCT00002524|Trimethoprim|trimethoprim|mesh-list
2180466|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
2180467|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2180468|NCT00002524|Pentamidine|pentamidine|mesh-list
2180469|NCT00002524|Prednisone|prednisone|mesh-list
2180470|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
2180471|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2655016|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655017|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2655018|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2655019|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
2655020|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
2655021|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2655022|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2655023|NCT02072135|Bupivacaine|bupivacaine|mesh-list
2655024|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
2655025|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
2655026|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2655027|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655028|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
2655029|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655030|NCT02072148|Cisplatin|cisplatin|mesh-list
2655031|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655032|NCT02072161|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2655033|NCT02072161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2655034|NCT02072161|Antimetabolites|antimetabolites|mesh-ancestor
2655035|NCT02072161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655036|NCT02072161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2180472|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2180473|NCT00002524|Prednisolone|prednisolone|mesh-list
2180474|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
2180475|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
2180476|NCT00002524|Ifosfamide|ifosfamide|mesh-list
2180477|NCT00002524|Doxorubicin|doxorubicin|mesh-list
2180478|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2180479|NCT00002524|Fluorouracil|fluorouracil|mesh-list
2180480|NCT00002524|Methotrexate|methotrexate|mesh-list
2180481|NCT00002524|Etoposide|etoposide|mesh-list
2180482|NCT00002524|Vincristine|vincristine|mesh-list
2180483|NCT00002524|Bleomycin|bleomycin|mesh-list
2180484|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2180485|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
2180486|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
2655037|NCT02072161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655038|NCT02072161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2655039|NCT02072161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655040|NCT02072213|Tamsulosin|tamsulosin|mesh-list
2655041|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2655042|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2655043|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2655044|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
2655045|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2655046|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655047|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655048|NCT02072213|Urological Agents|urological agents|mesh-ancestor
2655049|NCT02072278|Vortioxetine|vortioxetine|mesh-list
2655050|NCT02072278|Citalopram|citalopram|mesh-list
2655051|NCT02072278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2655052|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2655053|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2180487|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180488|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
2180489|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180490|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180491|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180492|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
2180493|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180494|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180495|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180496|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2655054|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655055|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2655056|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
2655057|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655058|NCT02072278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2655059|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
2655060|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2655061|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2655062|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2655063|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2655064|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2655065|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2655066|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2655067|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2655068|NCT02072291|Nifedipine|nifedipine|mesh-list
2655069|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2655070|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2180497|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180498|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180499|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180500|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2655071|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655072|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2655073|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655074|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
2655075|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
2655076|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2655077|NCT02072317|Raltitrexed|raltitrexed|mesh-list
2655078|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2655079|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
2655080|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655081|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655082|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2655083|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655084|NCT02072330|Amlodipine|amlodipine|mesh-list
2655085|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2655086|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2655087|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2655088|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2180501|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
2180502|NCT00002524|Hormones|hormones|mesh-ancestor
2180503|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180504|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2655089|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2668608|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2655090|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655091|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2655092|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180505|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
2180506|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180507|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2180508|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
2180509|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2180510|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
2180511|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2655093|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
2655094|NCT02072330|Diuretics|diuretics|mesh-ancestor
2655095|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
2655096|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2655097|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2655098|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2655099|NCT02072382|Metformin|metformin|mesh-list
2655100|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2655101|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655102|NCT02072408|Aflibercept|aflibercept|mesh-list
2655103|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2655104|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2655105|NCT02072408|Growth Substances|growth substances|mesh-ancestor
2655106|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655107|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
2655108|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655109|NCT02072486|Sorafenib|sorafenib|mesh-list
2655110|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655111|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2655112|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655113|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655114|NCT02072512|Fulvestrant|fulvestrant|mesh-list
2655115|NCT02072512|Anastrozole|anastrozole|mesh-list
2180512|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2180513|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180514|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
2180515|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180516|NCT00002524|Antidotes|antidotes|mesh-ancestor
2655116|NCT02072512|Goserelin|goserelin|mesh-list
2655117|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2655118|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655119|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2655120|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2655121|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
2655122|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2655123|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655124|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2655125|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2655126|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655127|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655128|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2655129|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
2655130|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655131|NCT02072720|Bevacizumab|bevacizumab|mesh-list
2655132|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2655133|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655134|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2655135|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2655136|NCT02072720|Growth Substances|growth substances|mesh-ancestor
2655137|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655138|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
2655139|NCT02072746|Zinc|zinc|mesh-list
2655140|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
2655141|NCT02072746|Trace Elements|trace elements|mesh-ancestor
2655142|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
2655143|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655144|NCT02072746|Astringents|astringents|mesh-ancestor
2655145|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
2655146|NCT02072785|Vincristine|vincristine|mesh-list
2655147|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2655148|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655149|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
2655150|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
2655151|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
2655152|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655153|NCT02072798|Cefuroxime|cefuroxime|mesh-list
2655154|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
2655155|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2655156|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655157|NCT02072811|Cytarabine|cytarabine|mesh-list
2655158|NCT02072811|Daunorubicin|daunorubicin|mesh-list
2655159|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
2655160|NCT02072811|Cladribine|cladribine|mesh-list
2655161|NCT02072811|Sargramostim|sargramostim|mesh-list
2655162|NCT02072811|Lenograstim|lenograstim|mesh-list
2655163|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2655164|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
2655165|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655166|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655167|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
2655168|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655169|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2655170|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
2655171|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655172|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2655173|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180517|NCT00002524|Protective Agents|protective agents|mesh-ancestor
2180518|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
2180519|NCT00002524|Vitamins|vitamins|mesh-ancestor
2180520|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
2180521|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
2180522|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
2180523|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
2180524|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
2180525|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
2180526|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2180527|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2180528|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2180529|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2180530|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2180531|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2180532|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2180533|NCT00002524|Renal Agents|renal agents|mesh-ancestor
2180534|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
2180535|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2180536|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2180537|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2180538|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2180539|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2180540|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2180541|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
2180542|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2180543|NCT00002526|Doxorubicin|doxorubicin|mesh-list
2180544|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2180545|NCT00002526|Ifosfamide|ifosfamide|mesh-list
2180546|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180547|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180548|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180549|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180550|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180551|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180552|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180553|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
2180554|NCT00002527|Aspirin|aspirin|mesh-list
2180555|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2180556|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2180557|NCT00002527|Analgesics|analgesics|mesh-ancestor
2655174|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2655175|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655176|NCT02072811|Analgesics|analgesics|mesh-ancestor
2655177|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
2655178|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655179|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2655180|NCT02072863|Prednisone|prednisone|mesh-list
2655181|NCT02072863|Melphalan|melphalan|mesh-list
2655182|NCT02072863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2655183|NCT02072863|Glucocorticoids|glucocorticoids|mesh-ancestor
2655184|NCT02072863|Hormones|hormones|mesh-ancestor
2655185|NCT02072863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2655186|NCT02072863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655187|NCT02072863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2655188|NCT02072863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655189|NCT02072863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2655190|NCT02072863|Alkylating Agents|alkylating agents|mesh-ancestor
2655191|NCT02072863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655192|NCT02072863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2655193|NCT02072863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2655194|NCT02072863|Immunologic Factors|immunologic factors|mesh-ancestor
2655195|NCT02072954|Asenapine|asenapine|mesh-list
2655196|NCT02072954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2655197|NCT02072954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2655198|NCT02072954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2655199|NCT02072954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655200|NCT02072954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2655201|NCT02072967|Rituximab|rituximab|mesh-list
2655202|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2655203|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2655204|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655205|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
2655206|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655207|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2655208|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2655209|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
2655210|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655211|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
2655212|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2655213|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655214|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2655215|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2655216|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655217|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655218|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180558|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
2180559|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2180560|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180561|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2180562|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180563|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2655254|NCT02073123|Pembrolizumab|pembrolizumab|mesh-list
2655255|NCT02073123|Nivolumab|nivolumab|mesh-list
2655256|NCT02073123|Ipilimumab|ipilimumab|mesh-list
2655257|NCT02073123|Tryptophan|tryptophan|mesh-list
2655258|NCT02073123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2655259|NCT02073123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655260|NCT02073123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2655261|NCT02073123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180564|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2180565|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180566|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2180567|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2180568|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180569|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
2180570|NCT00002528|Tamoxifen|tamoxifen|mesh-list
2180571|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2180572|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
2180573|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180574|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655262|NCT02073123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2655263|NCT02073123|Antidepressive Agents|antidepressive agents|mesh-ancestor
2655264|NCT02073123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2655265|NCT02073149|Iron|iron|mesh-list
2655266|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
2655267|NCT02073149|Trace Elements|trace elements|mesh-ancestor
2655268|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
2655269|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180575|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2180576|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180577|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2180578|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2180579|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2180580|NCT00002529|Tamoxifen|tamoxifen|mesh-list
2180581|NCT00002529|Toremifene|toremifene|mesh-list
2180582|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
2180583|NCT00002529|Doxorubicin|doxorubicin|mesh-list
2180584|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2180585|NCT00002529|Epirubicin|epirubicin|mesh-list
2180586|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180587|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
2180588|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180589|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180590|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180591|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
2655270|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2655271|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
2655272|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
2655273|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655274|NCT02073227|Metformin|metformin|mesh-list
2655275|NCT02073227|Canagliflozin|canagliflozin|mesh-list
2655276|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2655277|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655278|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2655279|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655280|NCT02073357|Anesthetics|anesthetics|mesh-list
2655281|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2655282|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655283|NCT02073474|Nabiximols|nabiximols|mesh-list
2655284|NCT02073474|Analgesics|analgesics|mesh-ancestor
2655285|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
2655286|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655287|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655288|NCT02073526|Adalimumab|adalimumab|mesh-list
2655289|NCT02073526|Infliximab|infliximab|mesh-list
2655290|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
2655291|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2655292|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2655293|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
2655294|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2655295|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2655296|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
2655297|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655298|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
2655299|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2655300|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
2655301|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655302|NCT02073552|Protective Agents|protective agents|mesh-ancestor
2655303|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655304|NCT02073552|Vitamins|vitamins|mesh-ancestor
2655305|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
2655306|NCT02073552|Laxatives|laxatives|mesh-ancestor
2655307|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2655308|NCT02073669|Interferons|interferons|mesh-list
2655309|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
2655310|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655311|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
2655312|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655313|NCT02073734|Dexamethasone|dexamethasone|mesh-list
2655314|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2655315|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
2655316|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
2655317|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655318|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655319|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2655320|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
2655321|NCT02073734|Hormones|hormones|mesh-ancestor
2655322|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2655323|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2655324|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655325|NCT02073773|Levodopa|levodopa|mesh-list
2655326|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2655327|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2655328|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
2655329|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2655330|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655331|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655332|NCT02073838|Ribavirin|ribavirin|mesh-list
2655333|NCT02073838|Decitabine|decitabine|mesh-list
2655334|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
2655335|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655336|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
2655337|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655338|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2655339|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655340|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655341|NCT02073916|Paclitaxel|paclitaxel|mesh-list
2655342|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2655343|NCT02073916|Trastuzumab|trastuzumab|mesh-list
2655344|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2655345|NCT02073916|Lapatinib|lapatinib|mesh-list
2180592|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180593|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180594|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180595|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180596|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180597|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180598|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180599|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2180600|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
2180601|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180602|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2655346|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2655347|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655348|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
2655349|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
2655350|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
2655351|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655352|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2655353|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2655354|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655355|NCT02073994|Ivosidenib|ivosidenib|mesh-list
2655356|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655357|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655358|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180603|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2180604|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2180605|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2180606|NCT00002531|Leucovorin|leucovorin|mesh-list
2180607|NCT00002531|Cytarabine|cytarabine|mesh-list
2180608|NCT00002531|Dexamethasone|dexamethasone|mesh-list
2180609|NCT00002531|Prednisolone|prednisolone|mesh-list
2180610|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
2180611|NCT00002531|Ifosfamide|ifosfamide|mesh-list
2180612|NCT00002531|Doxorubicin|doxorubicin|mesh-list
2180613|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2180614|NCT00002531|Methotrexate|methotrexate|mesh-list
2180615|NCT00002531|Etoposide|etoposide|mesh-list
2655359|NCT02074007|Benzocaine|benzocaine|mesh-list
2180616|NCT00002531|Vincristine|vincristine|mesh-list
2180617|NCT00002531|Daunorubicin|daunorubicin|mesh-list
2180618|NCT00002531|Asparaginase|asparaginase|mesh-list
2180619|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
2180620|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
2180621|NCT00002531|Thioguanine|thioguanine|mesh-list
2180622|NCT00002531|Vindesine|vindesine|mesh-list
2180623|NCT00002531|Teniposide|teniposide|mesh-list
2180624|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
2180625|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180626|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
2180627|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180628|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180629|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180630|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
2180631|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180632|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180633|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180634|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2655360|NCT02074007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655361|NCT02074007|Anesthetics, Local|anesthetics, local|mesh-ancestor
2655362|NCT02074007|Anesthetics|anesthetics|mesh-ancestor
2655363|NCT02074007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2655364|NCT02074007|Sensory System Agents|sensory system agents|mesh-ancestor
2655365|NCT02074007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655366|NCT02074137|Prednisone|prednisone|mesh-list
2655367|NCT02074137|Prednisolone|prednisolone|mesh-list
2180635|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
2180636|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
2180637|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2180638|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2180639|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
2180640|NCT00002531|Hormones|hormones|mesh-ancestor
2180641|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180642|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2180643|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180644|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180645|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2655368|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2655369|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
2655370|NCT02074137|Hormones|hormones|mesh-ancestor
2655371|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2655372|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655373|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2655374|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655375|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2655376|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2655377|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2655378|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655379|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180646|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180647|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2180648|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
2180649|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2180650|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180651|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
2180652|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
2180653|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2180654|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2180655|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180656|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
2180657|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655380|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2655381|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2655382|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655383|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
2655384|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2655385|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2655386|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2655387|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2655388|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655389|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655390|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2655391|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2668609|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2655392|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655393|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
2655394|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2655395|NCT02074189|Gemcitabine|gemcitabine|mesh-list
2655396|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655397|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2655398|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
2655399|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655400|NCT02074189|Antiviral Agents|antiviral agents|mesh-ancestor
2655401|NCT02074189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655402|NCT02074189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655403|NCT02074189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2655404|NCT02074189|Immunologic Factors|immunologic factors|mesh-ancestor
2655405|NCT02074189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655406|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2655407|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2655408|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655409|NCT02074228|Methylphenidate|methylphenidate|mesh-list
2655410|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2655411|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655412|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2655413|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2655414|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2655415|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655416|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
2655417|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2655418|NCT02074267|Gabapentin|gabapentin|mesh-list
2655419|NCT02074267|Analgesics|analgesics|mesh-ancestor
2655420|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
2655421|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655422|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655423|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
2655424|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2655425|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2655426|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2655427|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2655428|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2655429|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2655430|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2655431|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655432|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
2655433|NCT02074280|Rifaximin|rifaximin|mesh-list
2655434|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2655435|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655436|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2655437|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2655438|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2655439|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2655440|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2180658|NCT00002531|Antidotes|antidotes|mesh-ancestor
2180659|NCT00002531|Protective Agents|protective agents|mesh-ancestor
2180660|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
2180661|NCT00002531|Vitamins|vitamins|mesh-ancestor
2180662|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
2180663|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
2180664|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
2180665|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
2180666|NCT00002531|Analgesics|analgesics|mesh-ancestor
2180667|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
2180668|NCT00002532|Leucovorin|leucovorin|mesh-list
2180669|NCT00002532|Cytarabine|cytarabine|mesh-list
2180670|NCT00002532|Dexamethasone|dexamethasone|mesh-list
2180671|NCT00002532|Prednisolone|prednisolone|mesh-list
2180672|NCT00002532|Methotrexate|methotrexate|mesh-list
2180673|NCT00002532|Etoposide|etoposide|mesh-list
2180674|NCT00002532|Daunorubicin|daunorubicin|mesh-list
2180675|NCT00002532|Asparaginase|asparaginase|mesh-list
2180676|NCT00002532|Ifosfamide|ifosfamide|mesh-list
2180677|NCT00002532|Idarubicin|idarubicin|mesh-list
2180678|NCT00002532|Vindesine|vindesine|mesh-list
2180679|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
2180680|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2180681|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
2180682|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
2180683|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2180684|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180685|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2180686|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
2422686|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422687|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2655441|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655442|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2655443|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2655444|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655445|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
2655446|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2655447|NCT02074319|Methotrexate|methotrexate|mesh-list
2655448|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2655449|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
2655450|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2655451|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655452|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2655453|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
2655454|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655455|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655456|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
2655457|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655458|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2655459|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2655460|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
2655461|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2655462|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2655463|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
2655464|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2180687|NCT00002532|Hormones|hormones|mesh-ancestor
2180688|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180689|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2180690|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180691|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2180692|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
2180693|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2180694|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180695|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
2180696|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180697|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
2180698|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180699|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2180700|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180701|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
2180702|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180703|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2180704|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180705|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180706|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180707|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
2180708|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180709|NCT00002532|Antidotes|antidotes|mesh-ancestor
2180710|NCT00002532|Protective Agents|protective agents|mesh-ancestor
2422688|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2422689|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422690|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2422691|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2422692|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2422693|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422694|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422695|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422696|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422697|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
2422698|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2422699|NCT00818194|Cyclosporine|cyclosporine|mesh-list
2422700|NCT00818194|Tacrolimus|tacrolimus|mesh-list
2422701|NCT00818194|Cyclosporins|cyclosporins|mesh-list
2422702|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2422703|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
2422704|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422705|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2422706|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422707|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422708|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
2422709|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422710|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
2422711|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2422712|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
2422713|NCT00818298|Ziprasidone|ziprasidone|mesh-list
2422714|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2422715|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
2422716|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422717|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422718|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422719|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2422720|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2655465|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2655466|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655467|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
2655468|NCT02074436|Coagulants|coagulants|mesh-ancestor
2655469|NCT02074605|Interferons|interferons|mesh-list
2655470|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
2655471|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180711|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
2180712|NCT00002532|Vitamins|vitamins|mesh-ancestor
2180713|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
2180714|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180715|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180716|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
2180717|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
2180718|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
2180719|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
2180720|NCT00002533|Fluconazole|fluconazole|mesh-list
2180721|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
2180722|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180723|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2180724|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2180725|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655472|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
2655473|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655474|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
2655475|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655476|NCT02074631|Vitamin D|vitamin d|mesh-list
2655477|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
2655478|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
2655479|NCT02074631|Pamidronate|pamidronate|mesh-list
2655480|NCT02074631|Calcium|calcium|mesh-list
2655481|NCT02074631|Vitamins|vitamins|mesh-ancestor
2655482|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
2655483|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655484|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2655485|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2655486|NCT02074800|Siltuximab|siltuximab|mesh-list
2655487|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2655488|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655489|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
2655490|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655491|NCT02074839|Ivosidenib|ivosidenib|mesh-list
2655492|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655493|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655494|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655495|NCT02074878|Sunitinib|sunitinib|mesh-list
2655496|NCT02074878|Crizotinib|crizotinib|mesh-list
2655497|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655498|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2655499|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2655500|NCT02074878|Growth Substances|growth substances|mesh-ancestor
2655501|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655502|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
2655503|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2655504|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655505|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655506|NCT02074891|Tenofovir|tenofovir|mesh-list
2655507|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
2655508|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655509|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2655510|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2655511|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655512|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655513|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2655514|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2655515|NCT02075034|ON 01910|on 01910|mesh-list
2655516|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655517|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2655518|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655519|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655520|NCT02075086|Bevacizumab|bevacizumab|mesh-list
2655521|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2655522|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655523|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2655524|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2655525|NCT02075086|Growth Substances|growth substances|mesh-ancestor
2655526|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180726|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180727|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2180728|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
2180729|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180730|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180731|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2180732|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2180733|NCT00002534|Cytarabine|cytarabine|mesh-list
2180734|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
2655527|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
2655528|NCT02075112|Genistein|genistein|mesh-list
2655529|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655530|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2655531|NCT02075112|Protective Agents|protective agents|mesh-ancestor
2655532|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655533|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2655534|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655535|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655536|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
2655537|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2655538|NCT02075112|Estrogens|estrogens|mesh-ancestor
2655539|NCT02075112|Hormones|hormones|mesh-ancestor
2655540|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2655541|NCT02075177|Ketoconazole|ketoconazole|mesh-list
2655542|NCT02075177|Fenretinide|fenretinide|mesh-list
2655543|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
2655544|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655545|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2655546|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2655547|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655548|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180735|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
2180736|NCT00002534|Thiotepa|thiotepa|mesh-list
2180737|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2180738|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180739|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
2180740|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180741|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180742|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180743|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
2180744|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180745|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655549|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2655550|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
2655551|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2655552|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655553|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2655554|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655555|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2655556|NCT02075177|Protective Agents|protective agents|mesh-ancestor
2655557|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
2655558|NCT02075242|Tacrolimus|tacrolimus|mesh-list
2655559|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2655560|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
2655561|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655562|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2655563|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655564|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655565|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2655566|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655567|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2655568|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
2655569|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2655570|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655571|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2655572|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2655573|NCT02075294|Entecavir|entecavir|mesh-list
2655574|NCT02075294|Adefovir|adefovir|mesh-list
2655575|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2655576|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
2655577|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655578|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2655579|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2655580|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655581|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655582|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2655583|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2655584|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2655585|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2655586|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2655587|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655588|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2655589|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2655590|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2655591|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
2655592|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2655593|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655594|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2655595|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2655596|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
2655597|NCT02075619|Amlodipine|amlodipine|mesh-list
2655598|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2655599|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2655600|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2655601|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2655602|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655603|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2655604|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655605|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
2655606|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2655607|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2655608|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
2655609|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2655610|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2655611|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655612|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2655613|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2655614|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
2655615|NCT02075749|Triamcinolone|triamcinolone|mesh-list
2655616|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2655617|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2655618|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2655619|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2655620|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
2655621|NCT02075749|Hormones|hormones|mesh-ancestor
2655622|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2655623|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655624|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2655625|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
2655626|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655627|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655628|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
2655629|NCT02075970|Hematinics|hematinics|mesh-ancestor
2655630|NCT02076191|Decitabine|decitabine|mesh-list
2655631|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2655632|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
2655633|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655634|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655635|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655636|NCT02076217|Copper|copper|mesh-list
2655637|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2655638|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
2655639|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
2655640|NCT02076217|Etonogestrel|etonogestrel|mesh-list
2655641|NCT02076217|Desogestrel|desogestrel|mesh-list
2655642|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2655643|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655644|NCT02076217|Trace Elements|trace elements|mesh-ancestor
2655645|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
2655646|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2655647|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2655648|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2655649|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2655650|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2655651|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2655652|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2655653|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655654|NCT02076217|Progestins|progestins|mesh-ancestor
2655655|NCT02076217|Hormones|hormones|mesh-ancestor
2655656|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2655657|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
2655658|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2655659|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
2655660|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655661|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655662|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
2655663|NCT02076373|Hematinics|hematinics|mesh-ancestor
2655664|NCT02076386|Dolutegravir|dolutegravir|mesh-list
2655665|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2180746|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180747|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180748|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
2180749|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
2180750|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180751|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2180752|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
2180753|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
2180754|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655666|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2655667|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655668|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655669|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2655670|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2655671|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
2655672|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655673|NCT02076451|DS-8273a|ds-8273a|mesh-list
2655674|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2655675|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655676|NCT02076477|Docetaxel|docetaxel|mesh-list
2655677|NCT02076477|Pemetrexed|pemetrexed|mesh-list
2655678|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655679|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
2180755|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2180756|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
2180757|NCT00002534|Hormones|hormones|mesh-ancestor
2180758|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180759|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2180760|NCT00002534|Protective Agents|protective agents|mesh-ancestor
2180761|NCT00002535|Aldesleukin|aldesleukin|mesh-list
2180762|NCT00002535|Indomethacin|indomethacin|mesh-list
2180763|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
2180764|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180765|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
2180766|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180767|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180768|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180769|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
2180770|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180771|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180772|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180773|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2180774|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2180775|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
2180776|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180777|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2180778|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2180779|NCT00002535|Analgesics|analgesics|mesh-ancestor
2180780|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
2180781|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655680|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
2180782|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2180783|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
2180784|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
2180785|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2180786|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2180787|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180788|NCT00002536|Vincristine|vincristine|mesh-list
2180789|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180790|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180791|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
2655681|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
2655682|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655683|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655684|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2655685|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2655686|NCT02076529|Ramosetron|ramosetron|mesh-list
2655687|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
2655688|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
2180792|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
2180793|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
2180794|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655689|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655690|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655691|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2180795|NCT00002537|Topotecan|topotecan|mesh-list
2180796|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2180797|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180798|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180799|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180800|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180801|NCT00002539|Doxorubicin|doxorubicin|mesh-list
2180802|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2180803|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655692|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2655693|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
2655694|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2655695|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655696|NCT02076594|Docetaxel|docetaxel|mesh-list
2655697|NCT02076594|Capecitabine|capecitabine|mesh-list
2655698|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
2655699|NCT02076594|Epirubicin|epirubicin|mesh-list
2655700|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180804|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180805|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180806|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180807|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180808|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180809|NCT00002542|Tamoxifen|tamoxifen|mesh-list
2180810|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
2180811|NCT00002542|Doxorubicin|doxorubicin|mesh-list
2180812|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2180813|NCT00002542|Fluorouracil|fluorouracil|mesh-list
2180814|NCT00002542|Methotrexate|methotrexate|mesh-list
2655701|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
2655702|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
2655703|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
2655704|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655705|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2655706|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
2655707|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2655708|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180815|NCT00002542|Epirubicin|epirubicin|mesh-list
2180816|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180817|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
2180818|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180819|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180820|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180821|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
2180822|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180823|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180824|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180825|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180826|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180827|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180828|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180829|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
2655709|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180830|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180831|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2180832|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
2180833|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2180834|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
2180835|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2180836|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2180837|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2180838|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
2655710|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655711|NCT02076620|Doxorubicin|doxorubicin|mesh-list
2655712|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2655713|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655714|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2655715|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2655716|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655717|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655718|NCT02076646|Interleukin-2|interleukin-2|mesh-list
2655719|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655720|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2655721|NCT02076646|Analgesics|analgesics|mesh-ancestor
2655722|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
2655723|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655724|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655725|NCT02076659|Methotrexate|methotrexate|mesh-list
2655726|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2655727|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
2655728|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2655729|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655730|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2655731|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
2655732|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655733|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655734|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
2655735|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655736|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2655737|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2655738|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
2655739|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2655740|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2655741|NCT02076685|Isoniazid|isoniazid|mesh-list
2655742|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
2655743|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2655744|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655745|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2655746|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2655747|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
2655748|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655749|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2655750|NCT02076750|Vitamin D|vitamin d|mesh-list
2655751|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
2655752|NCT02076750|Vitamins|vitamins|mesh-ancestor
2655753|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
2655754|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655755|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2655756|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2655757|NCT02076815|Anagrelide|anagrelide|mesh-list
2655758|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2655759|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2655760|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180839|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180840|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2655761|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2655762|NCT02076828|Zinc|zinc|mesh-list
2655763|NCT02076828|Glycine|glycine|mesh-list
2655764|NCT02076828|Trace Elements|trace elements|mesh-ancestor
2655765|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
2655766|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655767|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
2655768|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2655769|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655770|NCT02076841|Interferons|interferons|mesh-list
2655771|NCT02076841|Interferon-beta|interferon-beta|mesh-list
2655772|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
2655773|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655774|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
2655775|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655776|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
2655777|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655778|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2655779|NCT02076893|Ibuprofen|ibuprofen|mesh-list
2655780|NCT02076893|Gabapentin|gabapentin|mesh-list
2655781|NCT02076893|Tramadol|tramadol|mesh-list
2655782|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2655783|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2655784|NCT02076893|Analgesics|analgesics|mesh-ancestor
2655785|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
2655786|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655787|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655788|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2655789|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2655790|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2655791|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655792|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655793|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
2180841|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2180842|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2180843|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2180844|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
2180845|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2180846|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180847|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180848|NCT00002544|Docetaxel|docetaxel|mesh-list
2180849|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
2180850|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180851|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
2180852|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
2180853|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
2180854|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180855|NCT00002544|Analgesics|analgesics|mesh-ancestor
2180856|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
2180857|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2180858|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180859|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180860|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180861|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180862|NCT00002545|Carmustine|carmustine|mesh-list
2180863|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2655794|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2655795|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2655796|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2655797|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2655798|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2655799|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2655800|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2655801|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
2655802|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2655803|NCT02076893|Narcotics|narcotics|mesh-ancestor
2655804|NCT02076945|Lidocaine|lidocaine|mesh-list
2655805|NCT02076945|Bupivacaine|bupivacaine|mesh-list
2655806|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
2655807|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
2655808|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2655809|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655810|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
2655811|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655812|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2655813|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2655814|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2655815|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2655816|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655817|NCT02077010|Milrinone|milrinone|mesh-list
2655818|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2655819|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2180864|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
2180865|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180866|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180867|NCT00002546|Ifosfamide|ifosfamide|mesh-list
2180868|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180869|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180870|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
2180871|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180872|NCT00002547|Cytarabine|cytarabine|mesh-list
2180873|NCT00002547|Cyclosporine|cyclosporine|mesh-list
2180874|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
2180875|NCT00002547|Busulfan|busulfan|mesh-list
2180876|NCT00002547|Methotrexate|methotrexate|mesh-list
2180877|NCT00002547|Cyclosporins|cyclosporins|mesh-list
2180878|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180879|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
2180880|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180881|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180882|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180883|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
2180884|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180885|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180886|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180887|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2180888|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
2180889|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2180890|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180891|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
2180892|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
2180893|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180894|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2180895|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2180896|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
2180897|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180898|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
2180899|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2180900|NCT00002548|Interferons|interferons|mesh-list
2180901|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
2180902|NCT00002548|Dexamethasone|dexamethasone|mesh-list
2180903|NCT00002548|Prednisone|prednisone|mesh-list
2180904|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
2180905|NCT00002548|Melphalan|melphalan|mesh-list
2180906|NCT00002548|Carmustine|carmustine|mesh-list
2180907|NCT00002548|Doxorubicin|doxorubicin|mesh-list
2180908|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2180909|NCT00002548|Vincristine|vincristine|mesh-list
2180910|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180911|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
2180912|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180913|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180914|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180915|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
2180916|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180917|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180918|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180919|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2180920|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
2180921|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
2180922|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655820|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
2655821|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2655822|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2655823|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655824|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655825|NCT02077010|Protective Agents|protective agents|mesh-ancestor
2655826|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655827|NCT02077166|Rituximab|rituximab|mesh-list
2655828|NCT02077166|Lenalidomide|lenalidomide|mesh-list
2655829|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2180923|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2180924|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
2180925|NCT00002548|Hormones|hormones|mesh-ancestor
2180926|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2180927|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2180928|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2655830|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655831|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
2655832|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655833|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180929|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180930|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180931|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180932|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
2180933|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180934|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180935|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
2655834|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2655835|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2655836|NCT02077166|Growth Substances|growth substances|mesh-ancestor
2655837|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
2655838|NCT02077231|Vitamins|vitamins|mesh-list
2655839|NCT02077231|Vitamin A|vitamin a|mesh-list
2655840|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
2655841|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
2655842|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655843|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
2180936|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
2180937|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
2180938|NCT00002549|Cytarabine|cytarabine|mesh-list
2180939|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
2180940|NCT00002549|Busulfan|busulfan|mesh-list
2180941|NCT00002549|Etoposide|etoposide|mesh-list
2180942|NCT00002549|Daunorubicin|daunorubicin|mesh-list
2180943|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
2180944|NCT00002549|Idarubicin|idarubicin|mesh-list
2180945|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180946|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
2180947|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180948|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180949|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2180950|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
2180951|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180952|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180953|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2180954|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180955|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180956|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180957|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180958|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180959|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
2180960|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
2180961|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180962|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2180963|NCT00002549|Analgesics|analgesics|mesh-ancestor
2180964|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
2180965|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2180966|NCT00002550|Etoposide|etoposide|mesh-list
2655844|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655845|NCT02077231|Protective Agents|protective agents|mesh-ancestor
2655846|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2655847|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655848|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2655849|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2655850|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2655851|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
2655852|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655853|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2655854|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2655855|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655856|NCT02077309|Linagliptin|linagliptin|mesh-list
2655857|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2655858|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655859|NCT02077309|Incretins|incretins|mesh-ancestor
2655860|NCT02077309|Hormones|hormones|mesh-ancestor
2655861|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2655862|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2655863|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
2655864|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655865|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655866|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
2655867|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
2655868|NCT02077322|Coagulants|coagulants|mesh-ancestor
2655869|NCT02077348|Hormones|hormones|mesh-list
2655870|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180967|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180968|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2180969|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2180970|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2180971|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2180972|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180973|NCT00002551|Leucovorin|leucovorin|mesh-list
2655871|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2655872|NCT02077400|Cefazolin|cefazolin|mesh-list
2655873|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2655874|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655875|NCT02077478|Remifentanil|remifentanil|mesh-list
2655876|NCT02077478|Propofol|propofol|mesh-list
2655877|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2655878|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2655879|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655880|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2655881|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
2655882|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
2655883|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2655884|NCT02077478|Narcotics|narcotics|mesh-ancestor
2655885|NCT02077478|Analgesics|analgesics|mesh-ancestor
2655886|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
2655887|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655888|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
2655889|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
2655890|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2655891|NCT02077556|Prednisolone|prednisolone|mesh-list
2180974|NCT00002551|Levamisole|levamisole|mesh-list
2180975|NCT00002551|Fluorouracil|fluorouracil|mesh-list
2655892|NCT02077556|Everolimus|everolimus|mesh-list
2655893|NCT02077556|Tacrolimus|tacrolimus|mesh-list
2655894|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2655895|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
2655896|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655897|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2655898|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655899|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655900|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655901|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2655902|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2655903|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
2655904|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2655905|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655906|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2655907|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
2655908|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
2655909|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655910|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2655911|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
2655912|NCT02077556|Hormones|hormones|mesh-ancestor
2180976|NCT00002551|Calcium|calcium|mesh-list
2180977|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
2180978|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2180979|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2180980|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
2180981|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180982|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2180983|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2180984|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2180985|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
2180986|NCT00002551|Antidotes|antidotes|mesh-ancestor
2180987|NCT00002551|Protective Agents|protective agents|mesh-ancestor
2180988|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
2180989|NCT00002551|Vitamins|vitamins|mesh-ancestor
2180990|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
2655913|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2655914|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2655915|NCT02077556|Protective Agents|protective agents|mesh-ancestor
2655916|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2655917|NCT02077634|Prednisone|prednisone|mesh-list
2655918|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
2655919|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2655920|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
2655921|NCT02077634|Hormones|hormones|mesh-ancestor
2655922|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2655923|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655924|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2655925|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655926|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2655927|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655928|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655929|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
2655930|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2655931|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
2655932|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2655933|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2655934|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655935|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2655936|NCT02077712|Analgesics|analgesics|mesh-ancestor
2655937|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
2655938|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655939|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2655940|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2655941|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2655942|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
2655943|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2655944|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655945|NCT02077751|Biotin|biotin|mesh-list
2655946|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
2655947|NCT02077751|Vitamins|vitamins|mesh-ancestor
2655948|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
2655949|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655950|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
2655951|NCT02077777|Mesalamine|mesalamine|mesh-list
2655952|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2655953|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2655954|NCT02077777|Analgesics|analgesics|mesh-ancestor
2655955|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
2655956|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2655957|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655958|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2655959|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2655960|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
2655961|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2655962|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655963|NCT02077803|Metformin|metformin|mesh-list
2655964|NCT02077803|Canagliflozin|canagliflozin|mesh-list
2655965|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2655966|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655967|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2655968|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655969|NCT02077881|Gemcitabine|gemcitabine|mesh-list
2655970|NCT02077881|Paclitaxel|paclitaxel|mesh-list
2655971|NCT02077881|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2655972|NCT02077881|Tryptophan|tryptophan|mesh-list
2655973|NCT02077881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2655974|NCT02077881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655975|NCT02077881|Tubulin Modulators|tubulin modulators|mesh-ancestor
2655976|NCT02077881|Antimitotic Agents|antimitotic agents|mesh-ancestor
2655977|NCT02077881|Mitosis Modulators|mitosis modulators|mesh-ancestor
2655978|NCT02077881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2655979|NCT02077881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2655980|NCT02077881|Antimetabolites|antimetabolites|mesh-ancestor
2655981|NCT02077881|Antiviral Agents|antiviral agents|mesh-ancestor
2655982|NCT02077881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655983|NCT02077881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2655984|NCT02077881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2655985|NCT02077881|Immunologic Factors|immunologic factors|mesh-ancestor
2655986|NCT02077881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2655987|NCT02077881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2655988|NCT02077881|Antidepressive Agents|antidepressive agents|mesh-ancestor
2655989|NCT02077881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2655990|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
2655991|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2655992|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2655993|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
2655994|NCT02077933|Everolimus|everolimus|mesh-list
2655995|NCT02077933|Exemestane|exemestane|mesh-list
2655996|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2655997|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2655998|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
2655999|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656000|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2656001|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2656002|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656003|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656004|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2656005|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
2656006|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2656007|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2656008|NCT02077946|Liraglutide|liraglutide|mesh-list
2656009|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2656010|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656011|NCT02077946|Incretins|incretins|mesh-ancestor
2656012|NCT02077946|Hormones|hormones|mesh-ancestor
2656013|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2656014|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2656015|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
2656016|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656017|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2180991|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2180992|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
2180993|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
2656018|NCT02077959|Lenalidomide|lenalidomide|mesh-list
2656019|NCT02077959|Pidilizumab|pidilizumab|mesh-list
2656020|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
2656021|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656022|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2656023|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2656024|NCT02077959|Growth Substances|growth substances|mesh-ancestor
2656025|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
2656026|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656027|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2180994|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2180995|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2180996|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2180997|NCT00002552|Leucovorin|leucovorin|mesh-list
2180998|NCT00002552|Cytarabine|cytarabine|mesh-list
2180999|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
2181000|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2181001|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2181002|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2181003|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
2181004|NCT00002552|Carmustine|carmustine|mesh-list
2181005|NCT00002552|Methotrexate|methotrexate|mesh-list
2181006|NCT00002552|Etoposide|etoposide|mesh-list
2181007|NCT00002552|Sargramostim|sargramostim|mesh-list
2181008|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
2181009|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181010|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
2181011|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181012|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181013|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181014|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
2181015|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656028|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
2656029|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656030|NCT02078063|Mepivacaine|mepivacaine|mesh-list
2656031|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
2656032|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
2656033|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656034|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656035|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
2656036|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656037|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
2656038|NCT02078089|Morphine|morphine|mesh-list
2656039|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2656040|NCT02078089|Narcotics|narcotics|mesh-ancestor
2656041|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656042|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656043|NCT02078089|Analgesics|analgesics|mesh-ancestor
2656044|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
2656045|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656046|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
2656047|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2656048|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2656049|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2656050|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181016|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656051|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2656052|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2656053|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
2656054|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
2656055|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656056|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
2656057|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2656058|NCT02078167|Policosanol|policosanol|mesh-list
2656059|NCT02078167|Red yeast rice|red yeast rice|mesh-list
2656060|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2656061|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2656062|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2656063|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
2656064|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656065|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656066|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2656067|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2656068|NCT02078232|Pancrelipase|pancrelipase|mesh-list
2656069|NCT02078232|Pancreatin|pancreatin|mesh-list
2656070|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2656071|NCT02078323|Linaclotide|linaclotide|mesh-list
2656072|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2656073|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
2656074|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656075|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2656076|NCT02078336|Atropine|atropine|mesh-list
2656077|NCT02078336|Midazolam|midazolam|mesh-list
2656078|NCT02078336|Droperidol|droperidol|mesh-list
2656079|NCT02078336|Lorazepam|lorazepam|mesh-list
2656080|NCT02078336|Biperiden|biperiden|mesh-list
2656081|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2656082|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2656083|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656084|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656085|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2656086|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2656087|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2656088|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2656089|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
2656090|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
2656091|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
2656092|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
2656093|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656094|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656095|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2656096|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2656097|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
2656098|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656099|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2656100|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
2656101|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
2656102|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
2656103|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2656104|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2656105|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
2656106|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
2656107|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
2656108|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2656109|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2656110|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2656111|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2656112|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2656113|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2656114|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
2656115|NCT02078388|Doxorubicin|doxorubicin|mesh-list
2656116|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2656117|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656118|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181017|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181018|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2181019|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
2181020|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2181021|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181022|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
2181023|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
2656119|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2656120|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656121|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656122|NCT02078440|Bromocriptine|bromocriptine|mesh-list
2656123|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2656124|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2656125|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
2656126|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2656127|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656128|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
2656129|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
2656130|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656131|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656132|NCT02078583|Fentanyl|fentanyl|mesh-list
2656133|NCT02078583|Remifentanil|remifentanil|mesh-list
2656134|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2656135|NCT02078583|Narcotics|narcotics|mesh-ancestor
2656136|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656137|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656138|NCT02078583|Analgesics|analgesics|mesh-ancestor
2656139|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
2656140|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656141|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2656142|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2656143|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
2656144|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
2656145|NCT02078596|Valproic Acid|valproic acid|mesh-list
2656146|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
2656147|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656148|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656149|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
2656150|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656151|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656152|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
2656153|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2181024|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181025|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2181026|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2181027|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181028|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181029|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2656154|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656155|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2656156|NCT02078609|Midostaurin|midostaurin|mesh-list
2656157|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656158|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2656159|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656160|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656161|NCT02078648|Poly I-C|poly i-c|mesh-list
2656162|NCT02078648|Bevacizumab|bevacizumab|mesh-list
2656163|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2656164|NCT02078648|Poly ICLC|poly iclc|mesh-list
2656165|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2656166|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656167|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2656168|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2656169|NCT02078648|Growth Substances|growth substances|mesh-ancestor
2656170|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656171|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
2656172|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
2656173|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
2656174|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
2656175|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2656176|NCT02078648|Laxatives|laxatives|mesh-ancestor
2656177|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2656178|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2656179|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2656180|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2656181|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656182|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656183|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2656184|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2656185|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656186|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
2656187|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656188|NCT02078869|Progesterone|progesterone|mesh-list
2656189|NCT02078869|Progestins|progestins|mesh-ancestor
2656190|NCT02078869|Hormones|hormones|mesh-ancestor
2656191|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2656192|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656193|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
2656194|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2656195|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2656196|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2656197|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2656198|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656199|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
2656200|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656201|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656202|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2656203|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656204|NCT02078973|Tolvaptan|tolvaptan|mesh-list
2656205|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2656206|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656207|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
2656208|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656209|NCT02079064|Propofol|propofol|mesh-list
2656210|NCT02079064|Desflurane|desflurane|mesh-list
2181030|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
2181031|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181032|NCT00002552|Antidotes|antidotes|mesh-ancestor
2181033|NCT00002552|Protective Agents|protective agents|mesh-ancestor
2181034|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
2181035|NCT00002552|Vitamins|vitamins|mesh-ancestor
2181036|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
2656211|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2656212|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656213|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656214|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2656215|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
2656216|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
2656217|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2656218|NCT02079181|Fluorides|fluorides|mesh-list
2656219|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
2656220|NCT02079181|Protective Agents|protective agents|mesh-ancestor
2656221|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656222|NCT02079194|Aspirin|aspirin|mesh-list
2656223|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2656224|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2656225|NCT02079194|Analgesics|analgesics|mesh-ancestor
2656226|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
2656227|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656228|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656229|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2656230|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2656231|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2656232|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2656233|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656234|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2656235|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2656236|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656237|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
2656238|NCT02079220|Capecitabine|capecitabine|mesh-list
2656239|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
2656240|NCT02079220|Aflibercept|aflibercept|mesh-list
2656241|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2656242|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
2656243|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656244|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656245|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2656246|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2656247|NCT02079220|Growth Substances|growth substances|mesh-ancestor
2656248|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656249|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
2656250|NCT02079298|Fluconazole|fluconazole|mesh-list
2656251|NCT02079298|Ibuprofen|ibuprofen|mesh-list
2656252|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2656253|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2656254|NCT02079298|Analgesics|analgesics|mesh-ancestor
2656255|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
2656256|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2181037|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2181038|NCT00002553|Cobalt|cobalt|mesh-list
2656257|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656258|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2656259|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2656260|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2656261|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656262|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656263|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
2656264|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181039|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
2181040|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181041|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
2181042|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181043|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181044|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181045|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
2181046|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181047|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181048|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181049|NCT00002553|Trace Elements|trace elements|mesh-ancestor
2181050|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
2181051|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
2181052|NCT00002554|Busulfan|busulfan|mesh-list
2181053|NCT00002554|Methotrexate|methotrexate|mesh-list
2181054|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181055|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
2181056|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181057|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181058|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181059|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
2181060|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181061|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181062|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181063|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2181064|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
2656265|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2656266|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2656267|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2656268|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
2656269|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2656270|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2656271|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2656272|NCT02079337|Rocuronium|rocuronium|mesh-list
2656273|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2656274|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2656275|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2656276|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656277|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181065|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2181066|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181067|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
2181068|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
2181069|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181070|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2181071|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2181072|NCT00002555|Cobalt|cobalt|mesh-list
2181073|NCT00002555|Trace Elements|trace elements|mesh-ancestor
2181074|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
2181075|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181076|NCT00002556|Interferons|interferons|mesh-list
2181077|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
2181078|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
2181079|NCT00002556|Prednisone|prednisone|mesh-list
2656278|NCT02079350|Polygeline|polygeline|mesh-list
2656279|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
2656280|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
2656281|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2656282|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2656283|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
2656284|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656285|NCT02079506|Candesartan|candesartan|mesh-list
2656286|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2656287|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2656288|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2181080|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
2181081|NCT00002556|Melphalan|melphalan|mesh-list
2181082|NCT00002556|Carmustine|carmustine|mesh-list
2181083|NCT00002556|Vincristine|vincristine|mesh-list
2181084|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181085|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
2656289|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
2656290|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656291|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2656292|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2656293|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656294|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2656295|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2656296|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2656297|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2656298|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
2656299|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656300|NCT02079558|Oxytocin|oxytocin|mesh-list
2656301|NCT02079558|Carbetocin|carbetocin|mesh-list
2656302|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
2656303|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2656304|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656305|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2656306|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
2656307|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656308|NCT02079727|Celecoxib|celecoxib|mesh-list
2181086|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181087|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181088|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181089|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
2181090|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181091|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181092|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181093|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2656309|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2656310|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2656311|NCT02079727|Analgesics|analgesics|mesh-ancestor
2656312|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
2656313|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656314|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656315|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2656316|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2656317|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2656318|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2656319|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656320|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656342|NCT02079961|Micronutrients|micronutrients|mesh-list
2656343|NCT02079961|Trace Elements|trace elements|mesh-list
2656344|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656345|NCT02079974|Pravastatin|pravastatin|mesh-list
2656346|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2656347|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2656348|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
2656349|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181094|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
2181095|NCT00002556|Hormones|hormones|mesh-ancestor
2181096|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2181097|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2181098|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
2656350|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2656351|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2656352|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656353|NCT02080026|Chloroquine|chloroquine|mesh-list
2656354|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2656355|NCT02080026|Atovaquone|atovaquone|mesh-list
2656356|NCT02080026|Proguanil|proguanil|mesh-list
2656357|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2656358|NCT02080026|Vaccines|vaccines|mesh-list
2656359|NCT02080026|Amebicides|amebicides|mesh-ancestor
2656360|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2656361|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2656362|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181099|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181100|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181101|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181102|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181103|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181104|NCT00002557|Leucovorin|leucovorin|mesh-list
2181105|NCT00002557|Doxorubicin|doxorubicin|mesh-list
2181106|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2181107|NCT00002557|Etoposide|etoposide|mesh-list
2181108|NCT00002557|Methotrexate|methotrexate|mesh-list
2181109|NCT00002557|Calcium|calcium|mesh-list
2656363|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
2656364|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2656365|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2656366|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2656367|NCT02080026|Analgesics|analgesics|mesh-ancestor
2656368|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
2656369|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656370|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656371|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2656372|NCT02080026|Filaricides|filaricides|mesh-ancestor
2656373|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
2656374|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
2656375|NCT02080026|Immunologic Factors|immunologic factors|mesh-ancestor
2656376|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656377|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656378|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
2656379|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2656380|NCT02080078|Theophylline|theophylline|mesh-list
2656381|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656382|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2656383|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656384|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656385|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2656386|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
2656387|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656388|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656389|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2656390|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
2656391|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2656392|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
2656393|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2656394|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2656395|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
2656396|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656397|NCT02080104|Oxytocin|oxytocin|mesh-list
2656398|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
2656399|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2656400|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656401|NCT02080169|Fentanyl|fentanyl|mesh-list
2656402|NCT02080169|Midazolam|midazolam|mesh-list
2656403|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
2656404|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2656405|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656406|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656407|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2656408|NCT02080169|Analgesics|analgesics|mesh-ancestor
2656409|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
2656410|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2181110|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
2656411|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2656412|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2656413|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2656414|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
2656415|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656416|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656417|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2656418|NCT02080169|Narcotics|narcotics|mesh-ancestor
2656419|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2656420|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2656421|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
2656422|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
2656423|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2656424|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2656425|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2656426|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
2656427|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
2656428|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
2656429|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2656430|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
2656431|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2656432|NCT02080182|Expectorants|expectorants|mesh-ancestor
2656433|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
2656434|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2656435|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
2656436|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656437|NCT02080182|Protective Agents|protective agents|mesh-ancestor
2181111|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181112|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181113|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181114|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181115|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181116|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181117|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2181118|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181119|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2181120|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
2181121|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2181122|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181123|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
2181124|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
2181125|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2181126|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181127|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
2181128|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181129|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2181130|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2656438|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656439|NCT02080182|Antidotes|antidotes|mesh-ancestor
2656440|NCT02080234|Gemcitabine|gemcitabine|mesh-list
2656441|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
2656442|NCT02080234|Asparaginase|asparaginase|mesh-list
2656443|NCT02080234|Pegaspargase|pegaspargase|mesh-list
2656444|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2656445|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
2656446|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656447|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656448|NCT02080234|Antiviral Agents|antiviral agents|mesh-ancestor
2656449|NCT02080234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181131|NCT00002557|Antidotes|antidotes|mesh-ancestor
2181132|NCT00002557|Protective Agents|protective agents|mesh-ancestor
2181133|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
2181134|NCT00002557|Vitamins|vitamins|mesh-ancestor
2181135|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
2181136|NCT00002559|Paclitaxel|paclitaxel|mesh-list
2181137|NCT00002559|Ifosfamide|ifosfamide|mesh-list
2181138|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181139|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656450|NCT02080234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656451|NCT02080234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2656452|NCT02080234|Immunologic Factors|immunologic factors|mesh-ancestor
2181140|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181141|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181142|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
2656453|NCT02080234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656454|NCT02080377|Glyburide|glyburide|mesh-list
2656455|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2181143|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181144|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181145|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
2181146|NCT00002560|Antibodies|antibodies|mesh-list
2181147|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2181148|NCT00002560|Sargramostim|sargramostim|mesh-list
2181149|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
2181150|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181151|NCT00002561|Doxorubicin|doxorubicin|mesh-list
2181152|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2181153|NCT00002561|Bleomycin|bleomycin|mesh-list
2181154|NCT00002561|Dacarbazine|dacarbazine|mesh-list
2181155|NCT00002561|Vinblastine|vinblastine|mesh-list
2181156|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181157|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181158|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181159|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181160|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181161|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181162|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181163|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
2181164|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181165|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181166|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181167|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181168|NCT00002562|Paclitaxel|paclitaxel|mesh-list
2181169|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181170|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181171|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181172|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181173|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181174|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181175|NCT00002565|Cytarabine|cytarabine|mesh-list
2181176|NCT00002565|Prednisone|prednisone|mesh-list
2181177|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
2181178|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
2181179|NCT00002565|Ifosfamide|ifosfamide|mesh-list
2181180|NCT00002565|Doxorubicin|doxorubicin|mesh-list
2181181|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2181182|NCT00002565|Etoposide|etoposide|mesh-list
2181183|NCT00002565|Vincristine|vincristine|mesh-list
2181184|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
2181185|NCT00002565|Idarubicin|idarubicin|mesh-list
2181186|NCT00002565|Bleomycin|bleomycin|mesh-list
2181187|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181188|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
2181189|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181190|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181191|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181192|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
2181193|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181194|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656456|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656457|NCT02080416|Nelfinavir|nelfinavir|mesh-list
2656458|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2656459|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2656460|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
2656461|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656462|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656463|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2656464|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2656465|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
2656466|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2656467|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
2656468|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2656469|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2656470|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656471|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
2656472|NCT02080494|Coagulants|coagulants|mesh-ancestor
2656473|NCT02080624|Sirolimus|sirolimus|mesh-list
2656474|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2656475|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2656476|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181195|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181196|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181197|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2656477|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656478|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
2181198|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181199|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181200|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2181201|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
2181202|NCT00002565|Hormones|hormones|mesh-ancestor
2181203|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2181204|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2181205|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181206|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181207|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
2181208|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
2181209|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181210|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181211|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181212|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181213|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
2181214|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
2181215|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2181216|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2181217|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2181218|NCT00002565|Protective Agents|protective agents|mesh-ancestor
2181219|NCT00002565|Analgesics|analgesics|mesh-ancestor
2181220|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
2181221|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
2181222|NCT00002566|Ifosfamide|ifosfamide|mesh-list
2181223|NCT00002566|Carboplatin|carboplatin|mesh-list
2181224|NCT00002566|Etoposide|etoposide|mesh-list
2656479|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2656480|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
2656481|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656482|NCT02080715|Tolcapone|tolcapone|mesh-list
2656483|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2656484|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2656485|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2656486|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656487|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656488|NCT02080728|Ropivacaine|ropivacaine|mesh-list
2656489|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
2656490|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
2656491|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656492|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656493|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
2656494|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656495|NCT02080845|Theobromine|theobromine|mesh-list
2656496|NCT02080845|Caffeine|caffeine|mesh-list
2656497|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2656498|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656499|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2181225|NCT00002566|Vinblastine|vinblastine|mesh-list
2181226|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181227|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
2656500|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656501|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656502|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2656503|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2656504|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
2656505|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656506|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2656507|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
2656508|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656509|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2656510|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
2656511|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
2656512|NCT02080858|Apixaban|apixaban|mesh-list
2656513|NCT02080858|Ticagrelor|ticagrelor|mesh-list
2656514|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2656515|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2656516|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2656517|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2656518|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
2656519|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656520|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656521|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181228|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181229|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2656522|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2656523|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
2656524|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2656525|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
2656526|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656527|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
2656528|NCT02081027|Riluzole|riluzole|mesh-list
2656529|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
2656530|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2656531|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2656532|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656533|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656534|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656535|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2656536|NCT02081027|Protective Agents|protective agents|mesh-ancestor
2656537|NCT02081118|Exenatide|exenatide|mesh-list
2656538|NCT02081118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2656539|NCT02081118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656540|NCT02081118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2656541|NCT02081118|Incretins|incretins|mesh-ancestor
2656542|NCT02081118|Hormones|hormones|mesh-ancestor
2656543|NCT02081118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2656544|NCT02081144|Nicotine|nicotine|mesh-list
2656545|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2656546|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
2656547|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656548|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656549|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2656550|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2656551|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
2656552|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656553|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656554|NCT02081287|Inositol|inositol|mesh-list
2656555|NCT02081287|Lamotrigine|lamotrigine|mesh-list
2656556|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
2656557|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2656558|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2656559|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656560|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2656561|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656562|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2656563|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2656564|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656565|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2656566|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2656567|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
2656568|NCT02081287|Vitamins|vitamins|mesh-ancestor
2656569|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
2656570|NCT02081300|Methyltestosterone|methyltestosterone|mesh-list
2656571|NCT02081300|Testosterone|testosterone|mesh-list
2181230|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181231|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
2181232|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181233|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181234|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181235|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181236|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181237|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181238|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181239|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181240|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181241|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181242|NCT00002567|Etoposide|etoposide|mesh-list
2656572|NCT02081300|Testosterone undecanoate|testosterone undecanoate|mesh-list
2656573|NCT02081300|Testosterone enanthate|testosterone enanthate|mesh-list
2656574|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2656575|NCT02081300|Androgens|androgens|mesh-ancestor
2656576|NCT02081300|Hormones|hormones|mesh-ancestor
2656577|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2656578|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181243|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181244|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181245|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2656579|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2656580|NCT02081300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656581|NCT02081300|Anabolic Agents|anabolic agents|mesh-ancestor
2656582|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
2656583|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2656584|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
2656585|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656586|NCT02081339|Ranibizumab|ranibizumab|mesh-list
2656587|NCT02081339|Aflibercept|aflibercept|mesh-list
2656588|NCT02081339|Verteporfin|verteporfin|mesh-list
2656589|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2656590|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2656591|NCT02081339|Growth Substances|growth substances|mesh-ancestor
2656592|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656593|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
2656594|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656595|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2656596|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
2656597|NCT02081391|Tapentadol|tapentadol|mesh-list
2656598|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2656599|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2656600|NCT02081391|Narcotics|narcotics|mesh-ancestor
2656601|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656602|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656603|NCT02081391|Analgesics|analgesics|mesh-ancestor
2656604|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
2656605|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656606|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2656607|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2656608|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2656609|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656610|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
2656611|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656612|NCT02081404|Esomeprazole|esomeprazole|mesh-list
2656613|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2656614|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2656615|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2656616|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656617|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656618|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2656619|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2656620|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656621|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2656622|NCT02081495|Doxorubicin|doxorubicin|mesh-list
2656623|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2656624|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656625|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2656626|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2656627|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656628|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656629|NCT02081560|Colistin|colistin|mesh-list
2656630|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2656631|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2656632|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
2656633|NCT02081755|Everolimus|everolimus|mesh-list
2181246|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181247|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181248|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181249|NCT00002568|Paclitaxel|paclitaxel|mesh-list
2181250|NCT00002568|Cisplatin|cisplatin|mesh-list
2181251|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181252|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181253|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181254|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181255|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181256|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181257|NCT00002569|Vincristine|vincristine|mesh-list
2181258|NCT00002569|Lomustine|lomustine|mesh-list
2181259|NCT00002569|Procarbazine|procarbazine|mesh-list
2181260|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181261|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181262|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181263|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181264|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181265|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181266|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181267|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
2181268|NCT00002570|Leucovorin|leucovorin|mesh-list
2656634|NCT02081755|Azathioprine|azathioprine|mesh-list
2656635|NCT02081755|Tacrolimus|tacrolimus|mesh-list
2656636|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2656637|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
2656638|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656639|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2656640|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656641|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181269|NCT00002570|Fluorouracil|fluorouracil|mesh-list
2181270|NCT00002570|Calcium|calcium|mesh-list
2181271|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
2181272|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2181273|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656642|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656643|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2656644|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2656645|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
2656646|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2656647|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2656648|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
2656649|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2656650|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2656651|NCT02081885|Chitosan|chitosan|mesh-list
2656652|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2656653|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2656654|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
2656655|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656656|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2656657|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
2656658|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
2656659|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
2656660|NCT02081885|Coagulants|coagulants|mesh-ancestor
2656661|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
2656662|NCT02082054|Atropine|atropine|mesh-list
2656663|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
2656664|NCT02082054|Ephedrine|ephedrine|mesh-list
2656665|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2656666|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2181274|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
2181275|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181276|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2656667|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2656668|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
2656669|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656670|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656671|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2656672|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
2656673|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
2181277|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181278|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181279|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
2181280|NCT00002570|Antidotes|antidotes|mesh-ancestor
2181281|NCT00002570|Protective Agents|protective agents|mesh-ancestor
2181282|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
2181283|NCT00002570|Vitamins|vitamins|mesh-ancestor
2181284|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
2181285|NCT00002571|Leucovorin|leucovorin|mesh-list
2181286|NCT00002571|Cytarabine|cytarabine|mesh-list
2181287|NCT00002571|Trimethoprim|trimethoprim|mesh-list
2181288|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
2181289|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2181290|NCT00002571|Prednisone|prednisone|mesh-list
2181291|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
2181292|NCT00002571|Doxorubicin|doxorubicin|mesh-list
2181293|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2181294|NCT00002571|Methotrexate|methotrexate|mesh-list
2181295|NCT00002571|Etoposide|etoposide|mesh-list
2181296|NCT00002571|Vincristine|vincristine|mesh-list
2181297|NCT00002571|Bleomycin|bleomycin|mesh-list
2181298|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
2181299|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181300|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
2656674|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
2656675|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2656676|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2181301|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181302|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181303|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2656677|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
2656678|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656679|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656680|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
2656681|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2656682|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2656683|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
2656684|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
2656685|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
2656686|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
2656687|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2656688|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
2656689|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
2656690|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2656691|NCT02082067|Ketorolac|ketorolac|mesh-list
2656692|NCT02082067|Morphine|morphine|mesh-list
2656693|NCT02082067|Anesthetics|anesthetics|mesh-list
2656694|NCT02082067|Ropivacaine|ropivacaine|mesh-list
2656695|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
2656696|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
2656697|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656698|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656699|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2656700|NCT02082067|Narcotics|narcotics|mesh-ancestor
2656701|NCT02082067|Analgesics|analgesics|mesh-ancestor
2656702|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
2656703|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656704|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2656705|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2656706|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2656707|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2656708|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2656709|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656710|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656711|NCT02082236|Sufentanil|sufentanil|mesh-list
2656712|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2656713|NCT02082236|Narcotics|narcotics|mesh-ancestor
2656714|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656715|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656716|NCT02082236|Analgesics|analgesics|mesh-ancestor
2656717|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
2656718|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656719|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2656720|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2656721|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
2656722|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
2656723|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
2656724|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
2656725|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2656726|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656727|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656728|NCT02082405|Dexamethasone|dexamethasone|mesh-list
2656729|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
2656730|NCT02082405|Bortezomib|bortezomib|mesh-list
2181304|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
2181305|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181306|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181307|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181308|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181309|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181310|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181311|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181312|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2181313|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
2181314|NCT00002571|Hormones|hormones|mesh-ancestor
2181315|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2181316|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2181317|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2181318|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
2181319|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2181320|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181321|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
2181322|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
2181323|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2181324|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2181325|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181326|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
2656731|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181327|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181328|NCT00002571|Antidotes|antidotes|mesh-ancestor
2181329|NCT00002571|Protective Agents|protective agents|mesh-ancestor
2181330|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
2181331|NCT00002571|Vitamins|vitamins|mesh-ancestor
2181332|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
2181333|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181334|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
2656732|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
2656733|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656734|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2656735|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2656736|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
2656737|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656738|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656739|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2656740|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2656741|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
2656742|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
2656743|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656744|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2656745|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
2656746|NCT02082405|Hormones|hormones|mesh-ancestor
2656747|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2656748|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2656749|NCT02082418|Caseins|caseins|mesh-list
2656750|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
2656751|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
2656752|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656753|NCT02082496|Liraglutide|liraglutide|mesh-list
2656754|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2656755|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656756|NCT02082496|Incretins|incretins|mesh-ancestor
2656757|NCT02082496|Hormones|hormones|mesh-ancestor
2656758|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2656759|NCT02082613|Polidocanol|polidocanol|mesh-list
2656760|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2656761|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2181335|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181336|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2181337|NCT00002571|Renal Agents|renal agents|mesh-ancestor
2181338|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
2181339|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2181340|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2181341|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2181342|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2181343|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2181344|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2181345|NCT00002572|Aldesleukin|aldesleukin|mesh-list
2181346|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
2181347|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181348|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2181349|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2181350|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
2181351|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181352|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
2656762|NCT02082652|Etonogestrel|etonogestrel|mesh-list
2656763|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2656764|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
2656765|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2181353|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181354|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181355|NCT00002574|Interferons|interferons|mesh-list
2181356|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
2181357|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
2181358|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181359|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
2656766|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656767|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2656768|NCT02082665|Dabrafenib|dabrafenib|mesh-list
2656769|NCT02082665|Midazolam|midazolam|mesh-list
2656770|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2656771|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2656772|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2181360|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181361|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
2181362|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181363|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181364|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2181365|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181366|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181367|NCT00002576|Prednisolone|prednisolone|mesh-list
2181368|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
2181369|NCT00002576|Doxorubicin|doxorubicin|mesh-list
2181370|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2181371|NCT00002576|Vincristine|vincristine|mesh-list
2181372|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
2181373|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181374|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
2181375|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181376|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181377|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181378|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
2656773|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656774|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656775|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2656776|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2656777|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2656778|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2656779|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
2656780|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
2656781|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
2656782|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
2656783|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656784|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656785|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2656786|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2656787|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
2656788|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2656789|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2656790|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656791|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656792|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2656793|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
2656794|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
2656795|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2656796|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656797|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656798|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2656799|NCT02083055|Analgesics|analgesics|mesh-ancestor
2656800|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
2656801|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656802|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2656803|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2656804|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2656805|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
2656806|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2181379|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181380|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181381|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181382|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181383|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181384|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181385|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181386|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2656807|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656808|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
2656809|NCT02083068|Vaccines|vaccines|mesh-list
2656810|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
2656811|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656812|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
2656813|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2656814|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181387|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181388|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181389|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181390|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2181391|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
2181392|NCT00002576|Hormones|hormones|mesh-ancestor
2181393|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2181394|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2656834|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
2656835|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2656836|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2656837|NCT02083276|Renal Agents|renal agents|mesh-ancestor
2656838|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2656839|NCT02083289|Latanoprost|latanoprost|mesh-list
2656840|NCT02083289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2656841|NCT02083289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2656842|NCT02083315|Morphine|morphine|mesh-list
2656843|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2656844|NCT02083315|Narcotics|narcotics|mesh-ancestor
2656845|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656846|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656847|NCT02083315|Analgesics|analgesics|mesh-ancestor
2656848|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
2656849|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656850|NCT02083328|Mannitol|mannitol|mesh-list
2656851|NCT02083328|Caffeine|caffeine|mesh-list
2656852|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2656853|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656854|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2656855|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656856|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656857|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2656858|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2656859|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
2656860|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2656861|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2656862|NCT02083328|Diuretics|diuretics|mesh-ancestor
2656863|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
2656864|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
2656865|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2656866|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656867|NCT02083510|Colchicine|colchicine|mesh-list
2656868|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
2656869|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2656870|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
2656871|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
2656872|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
2656873|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656874|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656875|NCT02083536|Docetaxel|docetaxel|mesh-list
2656876|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656877|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
2656878|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
2656879|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
2656880|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656881|NCT02083575|Vitamins|vitamins|mesh-list
2656882|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
2656883|NCT02083575|Deferiprone|deferiprone|mesh-list
2656884|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
2656885|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656886|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
2656887|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656888|NCT02083575|Protective Agents|protective agents|mesh-ancestor
2656889|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2656890|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
2656891|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
2656892|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
2656893|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2656894|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2656895|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2656896|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
2656897|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656898|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2656899|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2656900|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656901|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2656902|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2656903|NCT02083640|Palbociclib|palbociclib|mesh-list
2656904|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656905|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2656906|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656907|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656908|NCT02083692|Metformin|metformin|mesh-list
2656909|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2656910|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656911|NCT02083874|Cannabidiol|cannabidiol|mesh-list
2656912|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
2656913|NCT02083991|Prednisolone|prednisolone|mesh-list
2656914|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
2656915|NCT02083991|Basiliximab|basiliximab|mesh-list
2656916|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2656917|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
2656918|NCT02083991|Hormones|hormones|mesh-ancestor
2656919|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2656920|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181395|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2181396|NCT00002576|Analgesics|analgesics|mesh-ancestor
2181397|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
2181398|NCT00002578|Leucovorin|leucovorin|mesh-list
2181399|NCT00002578|Cytarabine|cytarabine|mesh-list
2181400|NCT00002578|Methotrexate|methotrexate|mesh-list
2181401|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
2181402|NCT00002578|Calcium|calcium|mesh-list
2181403|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
2656921|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2656922|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656923|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
2656924|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2656925|NCT02084043|Amikacin|amikacin|mesh-list
2656926|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2656927|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2656928|NCT02084225|Lidocaine|lidocaine|mesh-list
2656929|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
2656930|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
2656931|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2181404|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2181405|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181406|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2181407|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
2181408|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2181409|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181410|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
2181411|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181412|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181413|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
2181414|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181415|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2181416|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181417|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
2181418|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181419|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2181420|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
2181421|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181422|NCT00002578|Antidotes|antidotes|mesh-ancestor
2181423|NCT00002578|Protective Agents|protective agents|mesh-ancestor
2181424|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
2181425|NCT00002578|Vitamins|vitamins|mesh-ancestor
2181426|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
2181427|NCT00002579|Tamoxifen|tamoxifen|mesh-list
2656932|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656933|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
2656934|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2181428|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
2181429|NCT00002579|Fluorouracil|fluorouracil|mesh-list
2656935|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2656936|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2656937|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2656938|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2656939|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656940|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2656941|NCT02084303|Hematinics|hematinics|mesh-ancestor
2656942|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2656943|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2181430|NCT00002579|Methotrexate|methotrexate|mesh-list
2181431|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181432|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
2181433|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181434|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181435|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2656944|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2656945|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
2656946|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2656947|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2656948|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656949|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
2656950|NCT02084342|Coagulants|coagulants|mesh-ancestor
2656951|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2656952|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
2656953|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656954|NCT02084355|Fentanyl|fentanyl|mesh-list
2656955|NCT02084355|Oxycodone|oxycodone|mesh-list
2656956|NCT02084355|Hydromorphone|hydromorphone|mesh-list
2656957|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2656958|NCT02084355|Narcotics|narcotics|mesh-ancestor
2181436|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
2181437|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181438|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181439|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181440|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
2656959|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656960|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656961|NCT02084355|Analgesics|analgesics|mesh-ancestor
2656962|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
2656963|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656964|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2656965|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2656966|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
2656967|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
2656968|NCT02084368|Bupivacaine|bupivacaine|mesh-list
2656969|NCT02084368|Ropivacaine|ropivacaine|mesh-list
2656970|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
2656971|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
2656972|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656973|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656974|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
2656975|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2656976|NCT02084420|Pantoprazole|pantoprazole|mesh-list
2181441|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181442|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2181443|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
2181444|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2181445|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
2181446|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181447|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2181448|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2181449|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2181450|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
2181451|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2181452|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2181453|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2181454|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2181455|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2181456|NCT00002580|Tamoxifen|tamoxifen|mesh-list
2656977|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2656978|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2656979|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2656980|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2656981|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2656982|NCT02084433|Anesthetics|anesthetics|mesh-list
2656983|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2656984|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656985|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
2656986|NCT02084446|Prednisone|prednisone|mesh-list
2656987|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
2656988|NCT02084446|Everolimus|everolimus|mesh-list
2656989|NCT02084446|Tacrolimus|tacrolimus|mesh-list
2656990|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
2656991|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2656992|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2656993|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
2656994|NCT02084446|Hormones|hormones|mesh-ancestor
2656995|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2656996|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2656997|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2181457|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
2181458|NCT00002580|Fluorouracil|fluorouracil|mesh-list
2181459|NCT00002580|Methotrexate|methotrexate|mesh-list
2656998|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2656999|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2657000|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
2657001|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2657002|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657003|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657004|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2657005|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2657006|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
2657007|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2657008|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2657009|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
2181460|NCT00002580|Leuprolide|leuprolide|mesh-list
2181461|NCT00002580|Goserelin|goserelin|mesh-list
2181462|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181463|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
2181464|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181465|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181466|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181467|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
2181468|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181469|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181470|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181471|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
2181472|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181473|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2181474|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
2181475|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2657010|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
2657011|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657012|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657013|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2657014|NCT02084446|Protective Agents|protective agents|mesh-ancestor
2657015|NCT02084472|Petrolatum|petrolatum|mesh-list
2657016|NCT02084472|Mineral Oil|mineral oil|mesh-list
2657017|NCT02084472|Glycerol|glycerol|mesh-list
2657018|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2657019|NCT02084472|Protective Agents|protective agents|mesh-ancestor
2657020|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657021|NCT02084472|Emollients|emollients|mesh-ancestor
2657022|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
2181476|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
2181477|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181478|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2181479|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2181480|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2181481|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
2181482|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2181483|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2181484|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2657023|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
2657024|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2657025|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2657026|NCT02084563|Cytarabine|cytarabine|mesh-list
2657027|NCT02084563|Decitabine|decitabine|mesh-list
2657028|NCT02084563|Daunorubicin|daunorubicin|mesh-list
2657029|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2657030|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
2181485|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2657031|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657032|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657033|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
2657034|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2657035|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2657036|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
2657037|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657038|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2657039|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2657040|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2657041|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657042|NCT02084576|Ketorolac|ketorolac|mesh-list
2657043|NCT02084576|Nepafenac|nepafenac|mesh-list
2657044|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2657045|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2657046|NCT02084576|Analgesics|analgesics|mesh-ancestor
2657047|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
2657048|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657049|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657050|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2657051|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2657052|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2657053|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657054|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657055|NCT02084589|Fentanyl|fentanyl|mesh-list
2657056|NCT02084589|Ropivacaine|ropivacaine|mesh-list
2657057|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
2657058|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
2657059|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657060|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657061|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
2657062|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657063|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2657064|NCT02084589|Narcotics|narcotics|mesh-ancestor
2657065|NCT02084589|Analgesics|analgesics|mesh-ancestor
2657066|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2657067|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2657068|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
2657069|NCT02084602|Artesunate|artesunate|mesh-list
2657070|NCT02084602|Mefloquine|mefloquine|mesh-list
2657071|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
2657072|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2657073|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2657074|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181486|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2181487|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2181488|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
2181489|NCT00002581|Tamoxifen|tamoxifen|mesh-list
2657075|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657076|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
2657077|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
2657078|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2657079|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
2657080|NCT02084615|Aspirin|aspirin|mesh-list
2657081|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2657082|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2657083|NCT02084615|Analgesics|analgesics|mesh-ancestor
2657084|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
2657085|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657086|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657087|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2657088|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2657089|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2657090|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2657091|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657092|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2657093|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2657094|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657095|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
2657096|NCT02084654|Exenatide|exenatide|mesh-list
2657097|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2657098|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657099|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2657100|NCT02084654|Incretins|incretins|mesh-ancestor
2657101|NCT02084654|Hormones|hormones|mesh-ancestor
2657102|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2181490|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
2181491|NCT00002581|Fluorouracil|fluorouracil|mesh-list
2181492|NCT00002581|Methotrexate|methotrexate|mesh-list
2181493|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2657103|NCT02084719|Antibodies|antibodies|mesh-list
2657104|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
2657105|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657106|NCT02084732|Sorafenib|sorafenib|mesh-list
2657107|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657108|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2657109|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657110|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657111|NCT02084784|Methylene Blue|methylene blue|mesh-list
2657112|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657113|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657114|NCT02084875|Tofacitinib|tofacitinib|mesh-list
2657115|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2657116|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657117|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657118|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
2657119|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2657120|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2657121|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2657122|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2657123|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657124|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657125|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657126|NCT02085005|Capecitabine|capecitabine|mesh-list
2657127|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
2657128|NCT02085005|Aflibercept|aflibercept|mesh-list
2657129|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2657130|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
2657131|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657132|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657133|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2181494|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
2181495|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181496|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2657134|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2657135|NCT02085005|Growth Substances|growth substances|mesh-ancestor
2657136|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657137|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
2657138|NCT02085018|Omeprazole|omeprazole|mesh-list
2657139|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2657140|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657141|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2657142|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657143|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657144|NCT02085109|Theobromine|theobromine|mesh-list
2657145|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2657146|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
2657147|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657148|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657149|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2657150|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
2657151|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
2657152|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
2657153|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
2657154|NCT02085239|Lidocaine|lidocaine|mesh-list
2657155|NCT02085239|Ropivacaine|ropivacaine|mesh-list
2657156|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
2657157|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
2657158|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657159|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657160|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
2657161|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657162|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2657163|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2657164|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2657165|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2657166|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657167|NCT02085265|Telmisartan|telmisartan|mesh-list
2657168|NCT02085265|Perindopril|perindopril|mesh-list
2181497|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2657169|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2657170|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2657171|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2657172|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657173|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2657174|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
2657175|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657176|NCT02085291|Norepinephrine|norepinephrine|mesh-list
2657177|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2657178|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2657179|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
2657180|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657181|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657182|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657183|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
2657184|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
2657185|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657186|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2657187|NCT02085304|Temozolomide|temozolomide|mesh-list
2657188|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2657189|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
2657190|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657191|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657192|NCT02085317|Nitroprusside|nitroprusside|mesh-list
2657193|NCT02085317|Acetylcholine|acetylcholine|mesh-list
2657194|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2657195|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
2657196|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2657197|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657198|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2657199|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
2657200|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657201|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657202|NCT02085408|Cytarabine|cytarabine|mesh-list
2657203|NCT02085408|Decitabine|decitabine|mesh-list
2657204|NCT02085408|Clofarabine|clofarabine|mesh-list
2657205|NCT02085408|Azacitidine|azacitidine|mesh-list
2657206|NCT02085408|Daunorubicin|daunorubicin|mesh-list
2657207|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2657208|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
2657209|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657210|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657211|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
2657212|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2657213|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2657214|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
2657215|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657216|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2657217|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2657218|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2657219|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657220|NCT02085538|Palbociclib|palbociclib|mesh-list
2657221|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657222|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2657223|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657224|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657225|NCT02085577|Acetaminophen|acetaminophen|mesh-list
2657226|NCT02085577|Sufentanil|sufentanil|mesh-list
2657227|NCT02085577|Morphine|morphine|mesh-list
2657228|NCT02085577|Dsuvia|dsuvia|mesh-list
2657229|NCT02085577|Ketamine|ketamine|mesh-list
2657230|NCT02085577|Ondansetron|ondansetron|mesh-list
2657231|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2657232|NCT02085577|Narcotics|narcotics|mesh-ancestor
2657233|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657234|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657235|NCT02085577|Analgesics|analgesics|mesh-ancestor
2657236|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
2657237|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657238|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2657239|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2657240|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
2657241|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
2657242|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2657243|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2657244|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657245|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657246|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2657247|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
2657248|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
2657249|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
2657250|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657251|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
2657252|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
2657253|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2657254|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
2657255|NCT02085577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2657256|NCT02085577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2657257|NCT02085577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2657258|NCT02085577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2657259|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2657260|NCT02085590|Vaccines|vaccines|mesh-list
2657261|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
2657262|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
2657263|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657264|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2657265|NCT02085603|Saracatinib|saracatinib|mesh-list
2657266|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657267|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657268|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657269|NCT02085655|Gemcitabine|gemcitabine|mesh-list
2657270|NCT02085655|Thalidomide|thalidomide|mesh-list
2657271|NCT02085655|Dexamethasone|dexamethasone|mesh-list
2657272|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
2657273|NCT02085655|Methotrexate|methotrexate|mesh-list
2657274|NCT02085655|Pegaspargase|pegaspargase|mesh-list
2657275|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2657276|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
2657277|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
2657278|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657279|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657280|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657281|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
2657282|NCT02085655|Hormones|hormones|mesh-ancestor
2657283|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2657284|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2657285|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657286|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2657287|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
2657288|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657289|NCT02085655|Antiviral Agents|antiviral agents|mesh-ancestor
2657290|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2657291|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657292|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2657293|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
2657294|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2657295|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
2657296|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2657297|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
2657298|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2657299|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2657300|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2657301|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
2657302|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2657303|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2657304|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2657305|NCT02085655|Growth Substances|growth substances|mesh-ancestor
2657306|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
2657307|NCT02085824|Enoxaparin|enoxaparin|mesh-list
2657308|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
2657309|NCT02085824|Dabigatran|dabigatran|mesh-list
2657310|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2657311|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
2657312|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2657313|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
2657314|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657315|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657316|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
2657317|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2657318|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2657319|NCT02085902|Ropivacaine|ropivacaine|mesh-list
2657320|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
2657321|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
2657322|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657323|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657324|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
2657325|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657326|NCT02085967|Itraconazole|itraconazole|mesh-list
2657327|NCT02085967|Rifampin|rifampin|mesh-list
2657328|NCT02085967|Midazolam|midazolam|mesh-list
2657329|NCT02085967|Bupropion|bupropion|mesh-list
2657330|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2657331|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2657332|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657333|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657334|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2657335|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2657336|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2657337|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2657338|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
2657339|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
2657340|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
2657341|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
2657342|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657343|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657344|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2657345|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
2657346|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2657347|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2657348|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2657349|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
2657350|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2657351|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2657352|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657353|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
2657354|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2657355|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2657356|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2657357|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
2657358|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2657359|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2657360|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2657361|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
2657362|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2657363|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
2657364|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2657365|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2657366|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2657367|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2657368|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2657369|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2657370|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2657371|NCT02086019|Aspirin|aspirin|mesh-list
2181498|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
2181499|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181500|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181501|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181502|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
2181503|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181504|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2181505|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
2181506|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2181507|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
2181508|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181509|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2181510|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2181511|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2181512|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
2181513|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2181514|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2181515|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2181516|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2181517|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2657372|NCT02086019|Ramipril|ramipril|mesh-list
2657373|NCT02086019|Bisoprolol|bisoprolol|mesh-list
2657374|NCT02086019|Heparin|heparin|mesh-list
2181518|NCT00002582|Tamoxifen|tamoxifen|mesh-list
2181519|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
2181520|NCT00002582|Doxorubicin|doxorubicin|mesh-list
2181521|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2181522|NCT00002582|Fluorouracil|fluorouracil|mesh-list
2181523|NCT00002582|Methotrexate|methotrexate|mesh-list
2181524|NCT00002582|Leuprolide|leuprolide|mesh-list
2657375|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2657376|NCT02086019|Tinzaparin|tinzaparin|mesh-list
2657377|NCT02086019|Dalteparin|dalteparin|mesh-list
2657378|NCT02086019|Clopidogrel|clopidogrel|mesh-list
2657379|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2657380|NCT02086019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2657381|NCT02086019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2657382|NCT02086019|Analgesics|analgesics|mesh-ancestor
2657383|NCT02086019|Sensory System Agents|sensory system agents|mesh-ancestor
2657384|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657385|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657386|NCT02086019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2657387|NCT02086019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2657388|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2657389|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2657390|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657391|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2657392|NCT02086019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2657393|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657394|NCT02086019|Antipyretics|antipyretics|mesh-ancestor
2657395|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2657396|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2657397|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2657398|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
2657399|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657400|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
2181525|NCT00002582|Goserelin|goserelin|mesh-list
2181526|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181527|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
2181528|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181529|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181530|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181531|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
2181532|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181533|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181534|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181535|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181536|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181537|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181538|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181539|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
2181540|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2657401|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
2657402|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2657403|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2657404|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2657405|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
2657406|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
2657407|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
2657408|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2657409|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2657410|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2657411|NCT02086032|Estradiol|estradiol|mesh-list
2657412|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2657413|NCT02086032|Estrogens|estrogens|mesh-list
2657414|NCT02086032|Progesterone|progesterone|mesh-list
2657415|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
2657416|NCT02086032|Hormones|hormones|mesh-ancestor
2657417|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2657418|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657419|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2657420|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
2657421|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2657422|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2657423|NCT02086032|Progestins|progestins|mesh-ancestor
2657424|NCT02086097|Ibuprofen|ibuprofen|mesh-list
2657425|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2657426|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2657427|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2181541|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2657428|NCT02086097|Analgesics|analgesics|mesh-ancestor
2181542|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
2181543|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2181544|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
2181545|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2181546|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2181547|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2181548|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
2181549|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2181550|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2181551|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2181552|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2181553|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2181554|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2181555|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
2181556|NCT00002583|Vinorelbine|vinorelbine|mesh-list
2181557|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181558|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181559|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
2657429|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
2657430|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2181560|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181561|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181562|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657431|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657432|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2657433|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2657434|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2657435|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657436|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657437|NCT02086188|Mirabegron|mirabegron|mesh-list
2657438|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2657439|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2657440|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2657441|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
2657442|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657443|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657444|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657445|NCT02086188|Urological Agents|urological agents|mesh-ancestor
2657446|NCT02086227|Glucagon|glucagon|mesh-list
2657447|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2657448|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657449|NCT02086227|Hormones|hormones|mesh-ancestor
2657450|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2657451|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657452|NCT02086227|Incretins|incretins|mesh-ancestor
2657453|NCT02086253|BQ 788|bq 788|mesh-list
2657454|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2657455|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2657456|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657457|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2657458|NCT02086279|Hormones|hormones|mesh-list
2657459|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2657460|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657461|NCT02086292|Lidocaine|lidocaine|mesh-list
2657462|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
2657463|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
2181563|NCT00002585|NSC 366140|nsc 366140|mesh-list
2181564|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181565|NCT00002586|Vitamin E|vitamin e|mesh-list
2181566|NCT00002586|Tocopherols|tocopherols|mesh-list
2181567|NCT00002586|Tocotrienols|tocotrienols|mesh-list
2181568|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
2181569|NCT00002586|Tretinoin|tretinoin|mesh-list
2181570|NCT00002586|Isotretinoin|isotretinoin|mesh-list
2181571|NCT00002586|Vitamins|vitamins|mesh-ancestor
2181572|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
2181573|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181574|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
2181575|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181576|NCT00002586|Protective Agents|protective agents|mesh-ancestor
2181577|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657464|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657465|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657466|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
2657467|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657468|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2657469|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2657470|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2657471|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2657472|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181578|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
2181579|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
2181580|NCT00002587|Paclitaxel|paclitaxel|mesh-list
2181581|NCT00002587|Topotecan|topotecan|mesh-list
2181582|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181583|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181584|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181585|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181586|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181587|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181588|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2181589|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181590|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181591|NCT00002588|Etoposide|etoposide|mesh-list
2181592|NCT00002588|Topotecan|topotecan|mesh-list
2181593|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181594|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181595|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2657473|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
2657474|NCT02086409|Vitamin D|vitamin d|mesh-list
2657475|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
2657476|NCT02086409|Vitamins|vitamins|mesh-list
2657477|NCT02086409|Calcium|calcium|mesh-list
2657478|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
2657479|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657480|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2657481|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2657482|NCT02086474|Bupivacaine|bupivacaine|mesh-list
2657483|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
2657484|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
2657485|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
2657486|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657487|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657488|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
2657489|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657490|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2657491|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
2657492|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
2657493|NCT02086474|Protective Agents|protective agents|mesh-ancestor
2657494|NCT02086526|Metformin|metformin|mesh-list
2657495|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2657496|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657497|NCT02086604|Lenalidomide|lenalidomide|mesh-list
2657498|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2657499|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
2657500|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657501|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2657502|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2657503|NCT02086604|Growth Substances|growth substances|mesh-ancestor
2657504|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
2657505|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657506|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2657507|NCT02086656|Bevacizumab|bevacizumab|mesh-list
2657508|NCT02086656|Capecitabine|capecitabine|mesh-list
2657509|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
2657510|NCT02086656|Irinotecan|irinotecan|mesh-list
2657511|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2657512|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657513|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2657514|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2657515|NCT02086656|Growth Substances|growth substances|mesh-ancestor
2657516|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181596|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181597|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181598|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181599|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2181600|NCT00002589|Aldesleukin|aldesleukin|mesh-list
2181601|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
2181602|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657517|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
2181603|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2657518|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2657519|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
2657520|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657521|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2657522|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2657523|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657524|NCT02086747|Acetaminophen|acetaminophen|mesh-list
2657525|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2657526|NCT02086747|Analgesics|analgesics|mesh-ancestor
2657527|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
2657528|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657529|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657530|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
2657531|NCT02086825|Rifaximin|rifaximin|mesh-list
2657532|NCT02086825|Lactulose|lactulose|mesh-list
2657533|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2657534|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2657535|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657536|NCT02086838|Dextrans|dextrans|mesh-list
2657537|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
2181604|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2181605|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
2181606|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181607|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
2181608|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181609|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181610|NCT00002590|Leucovorin|leucovorin|mesh-list
2181611|NCT00002590|Cytarabine|cytarabine|mesh-list
2181612|NCT00002590|Prednisone|prednisone|mesh-list
2657538|NCT02086838|Hematinics|hematinics|mesh-list
2657539|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
2657540|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
2657541|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
2657542|NCT02086903|Clopidogrel|clopidogrel|mesh-list
2657543|NCT02086903|Ticagrelor|ticagrelor|mesh-list
2657544|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2657545|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2657546|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2657547|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2657548|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
2657549|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657550|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657551|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657552|NCT02086929|Trazodone|trazodone|mesh-list
2657553|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2657554|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2657555|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2657556|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2657557|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657558|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657559|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657560|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2657561|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
2657562|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2657563|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2657564|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2657565|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657566|NCT02086929|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2657567|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
2657568|NCT02086942|Dexamethasone|dexamethasone|mesh-list
2657569|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
2657570|NCT02086942|Bortezomib|bortezomib|mesh-list
2657571|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2657572|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
2657573|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657574|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2657575|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2657576|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
2657577|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657578|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657579|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2657580|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2657581|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
2657582|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
2181613|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
2181614|NCT00002590|Doxorubicin|doxorubicin|mesh-list
2657583|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657584|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657585|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
2657586|NCT02086942|Hormones|hormones|mesh-ancestor
2657587|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2657588|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2657589|NCT02086994|Misoprostol|misoprostol|mesh-list
2657590|NCT02086994|Carbetocin|carbetocin|mesh-list
2657591|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2657592|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
2657593|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2657594|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657595|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2657596|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657597|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
2657598|NCT02087007|Cilostazol|cilostazol|mesh-list
2657599|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2657600|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
2657601|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657602|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657603|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2657604|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
2657605|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2657606|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2657607|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657608|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2657609|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
2657610|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2657611|NCT02087007|Protective Agents|protective agents|mesh-ancestor
2657612|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2657613|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2657614|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657615|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2657616|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2657617|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
2181615|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2181616|NCT00002590|Methotrexate|methotrexate|mesh-list
2181617|NCT00002590|Etoposide|etoposide|mesh-list
2181618|NCT00002590|Vincristine|vincristine|mesh-list
2181619|NCT00002590|Daunorubicin|daunorubicin|mesh-list
2181620|NCT00002590|Asparaginase|asparaginase|mesh-list
2181621|NCT00002590|Thioguanine|thioguanine|mesh-list
2181622|NCT00002590|Pegaspargase|pegaspargase|mesh-list
2181623|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
2181624|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181625|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
2181626|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657618|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2657619|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2657620|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
2657621|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657622|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657623|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657624|NCT02087098|Urological Agents|urological agents|mesh-ancestor
2657625|NCT02087111|Interferons|interferons|mesh-list
2657626|NCT02087111|Ribavirin|ribavirin|mesh-list
2657627|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
2657628|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
2657629|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2657630|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657631|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
2657632|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2657633|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
2657634|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657635|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
2657636|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657637|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
2657638|NCT02087202|Ketamine|ketamine|mesh-list
2657639|NCT02087202|Analgesics|analgesics|mesh-ancestor
2657640|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
2657641|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657642|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657643|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2657644|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2181627|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181628|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2657645|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
2657646|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
2657647|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657648|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2657649|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2657650|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657651|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657652|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2657653|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
2657654|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2181629|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
2181630|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181631|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181632|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181633|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181634|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181635|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181636|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181637|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2181638|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
2181639|NCT00002590|Hormones|hormones|mesh-ancestor
2181640|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2181641|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2181642|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2181643|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
2181644|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2181645|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181646|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
2181647|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
2181648|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2181649|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2181650|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181651|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
2181652|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181653|NCT00002590|Antidotes|antidotes|mesh-ancestor
2181654|NCT00002590|Protective Agents|protective agents|mesh-ancestor
2181655|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
2181656|NCT00002590|Vitamins|vitamins|mesh-ancestor
2657655|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2657656|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2657657|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
2657658|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2657659|NCT02087215|Boron|boron|mesh-list
2657660|NCT02087215|Trace Elements|trace elements|mesh-ancestor
2657661|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
2657662|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657663|NCT02087332|Torsemide|torsemide|mesh-list
2657664|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2657665|NCT02087332|Diuretics|diuretics|mesh-ancestor
2657666|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
2657667|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657668|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2657669|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2657670|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657671|NCT02087384|Vaccines|vaccines|mesh-list
2657672|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
2657673|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657674|NCT02087462|Vitamins|vitamins|mesh-list
2657675|NCT02087462|Thiamine|thiamine|mesh-list
2657676|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
2657677|NCT02087462|Diclofenac|diclofenac|mesh-list
2657678|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
2657679|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657680|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2657681|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2657682|NCT02087462|Analgesics|analgesics|mesh-ancestor
2657683|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
2657684|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657685|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2657686|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2657687|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2657688|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657689|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657690|NCT02087475|Fluorouracil|fluorouracil|mesh-list
2657691|NCT02087475|Irinotecan|irinotecan|mesh-list
2181657|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
2181658|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181659|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181660|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181661|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
2181662|NCT00002592|Busulfan|busulfan|mesh-list
2181663|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181664|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
2657692|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
2657693|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657694|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2657695|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657696|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2657697|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
2657698|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657699|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2657700|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2657701|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657702|NCT02087488|Eszopiclone|eszopiclone|mesh-list
2657703|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2657704|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657705|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657706|NCT02087527|Dexamethasone|dexamethasone|mesh-list
2657707|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2657708|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
2657709|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
2181665|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181666|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181667|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181668|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
2181669|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181670|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181671|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181672|NCT00002593|Leucovorin|leucovorin|mesh-list
2181673|NCT00002593|Levamisole|levamisole|mesh-list
2181674|NCT00002593|Fluorouracil|fluorouracil|mesh-list
2181675|NCT00002593|Calcium|calcium|mesh-list
2181676|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
2181677|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2181678|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181679|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
2181680|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181681|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181682|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181683|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181684|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
2181685|NCT00002593|Antidotes|antidotes|mesh-ancestor
2181686|NCT00002593|Protective Agents|protective agents|mesh-ancestor
2181687|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
2181688|NCT00002593|Vitamins|vitamins|mesh-ancestor
2181689|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
2181690|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2181691|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
2181692|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
2181693|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2181694|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181695|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181696|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
2181697|NCT00002594|Melphalan|melphalan|mesh-list
2181698|NCT00002594|Molgramostim|molgramostim|mesh-list
2181699|NCT00002594|Sargramostim|sargramostim|mesh-list
2181700|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2657710|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657711|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657712|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657713|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
2657714|NCT02087527|Hormones|hormones|mesh-ancestor
2657715|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2657716|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2657717|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657718|NCT02087540|Telmisartan|telmisartan|mesh-list
2657719|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2657720|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2657721|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2657722|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
2181701|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
2181702|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181703|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2657723|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657724|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2657725|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2657726|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657727|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2657728|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2657729|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2657730|NCT02087566|Linezolid|linezolid|mesh-list
2181704|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181705|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
2181706|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181707|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181708|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181709|NCT00002595|Toremifene|toremifene|mesh-list
2181710|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2181711|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181712|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2181713|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2181714|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
2181715|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2181716|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181717|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2181718|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
2181719|NCT00002596|Carboplatin|carboplatin|mesh-list
2181720|NCT00002596|Etoposide|etoposide|mesh-list
2181721|NCT00002596|Bleomycin|bleomycin|mesh-list
2657731|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2657732|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2657733|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2657734|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657735|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657736|NCT02087579|Olanzapine|olanzapine|mesh-list
2657737|NCT02087579|Risperidone|risperidone|mesh-list
2657738|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2657739|NCT02087579|Aripiprazole|aripiprazole|mesh-list
2657740|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2657741|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2657742|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
2657743|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657744|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657745|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657746|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2657747|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2657748|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657749|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2657750|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2657751|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
2657752|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
2657753|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
2657754|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657755|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657756|NCT02087579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2181722|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181723|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
2181724|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181725|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181726|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181727|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
2181728|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657757|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2657758|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2657759|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
2657760|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
2657761|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2657762|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2657763|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2657764|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2657765|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2657766|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
2657767|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2657768|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2657769|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2657770|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657771|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657772|NCT02087683|Vitamin D|vitamin d|mesh-list
2657773|NCT02087683|Vitamins|vitamins|mesh-ancestor
2657774|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
2657775|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657776|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2657777|NCT02087722|Melatonin|melatonin|mesh-list
2657778|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
2657779|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657780|NCT02087722|Protective Agents|protective agents|mesh-ancestor
2657781|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657782|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657783|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
2657784|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2657785|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2657786|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
2657787|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
2657788|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2657789|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
2657790|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
2657791|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657792|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657793|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657794|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
2657795|NCT02087813|Hormones|hormones|mesh-ancestor
2657796|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2657797|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2657798|NCT02087813|Protective Agents|protective agents|mesh-ancestor
2657799|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2657800|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657801|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2657802|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2657803|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657804|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657805|NCT02087826|Metformin|metformin|mesh-list
2657806|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2657807|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657808|NCT02087865|Donepezil|donepezil|mesh-list
2657809|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2657810|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657811|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657812|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
2657813|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657814|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657815|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
2657816|NCT02088008|Valsartan|valsartan|mesh-list
2657817|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2657818|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2657819|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2657820|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657821|NCT02088060|Cannabidiol|cannabidiol|mesh-list
2657822|NCT02088060|Olanzapine|olanzapine|mesh-list
2657823|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
2657824|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
2657825|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657826|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657827|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657828|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2657829|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2657830|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657831|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2657832|NCT02088060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2657833|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2657834|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2657835|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657836|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657837|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
2657838|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
2657839|NCT02088112|Durvalumab|durvalumab|mesh-list
2657840|NCT02088112|Gefitinib|gefitinib|mesh-list
2657841|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2657842|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657843|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2657844|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657845|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657846|NCT02088398|Ricolinostat|ricolinostat|mesh-list
2657847|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657848|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2657849|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657850|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657851|NCT02088411|Diclofenac|diclofenac|mesh-list
2657852|NCT02088411|Wobenzym|wobenzym|mesh-list
2657853|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2657854|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2657855|NCT02088411|Analgesics|analgesics|mesh-ancestor
2657856|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
2657857|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657858|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657859|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2657860|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2657861|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2657862|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657863|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657864|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2657865|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
2657866|NCT02088424|Insulin|insulin|mesh-list
2657867|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2657868|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657869|NCT02088450|Nitrendipine|nitrendipine|mesh-list
2657870|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2657871|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2657872|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2657873|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657874|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2657875|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657876|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
2657877|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
2657878|NCT02088502|Theophylline|theophylline|mesh-list
2657879|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2657880|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
2657881|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2657882|NCT02088502|Expectorants|expectorants|mesh-ancestor
2657883|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
2657884|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2657885|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
2657886|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657887|NCT02088502|Protective Agents|protective agents|mesh-ancestor
2657888|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657889|NCT02088502|Antidotes|antidotes|mesh-ancestor
2657890|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2657891|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
2657892|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657893|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2657894|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2657895|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657896|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
2657897|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2657898|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2657899|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
2657900|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2657901|NCT02088515|Docetaxel|docetaxel|mesh-list
2657902|NCT02088515|Nedaplatin|nedaplatin|mesh-list
2657903|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657904|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
2657905|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
2657906|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181729|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181730|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181731|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181732|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181733|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181734|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181735|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181736|NCT00002598|Interferons|interferons|mesh-list
2181737|NCT00002598|Cytarabine|cytarabine|mesh-list
2181738|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
2181739|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
2657907|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657908|NCT02088528|Mitomycins|mitomycins|mesh-list
2657909|NCT02088528|Mitomycin|mitomycin|mesh-list
2657910|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2657911|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657912|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
2657913|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657914|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2657915|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2657925|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
2657926|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2657927|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657928|NCT02088671|Propofol|propofol|mesh-list
2657929|NCT02088671|Desflurane|desflurane|mesh-list
2657930|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2657931|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657932|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657933|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2657934|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
2657935|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
2657936|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2657937|NCT02088684|Fulvestrant|fulvestrant|mesh-list
2657938|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2657939|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2657940|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2657941|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2657942|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
2657943|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2657944|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657945|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
2657946|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
2657947|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
2657948|NCT02088866|Lidocaine|lidocaine|mesh-list
2657949|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
2657950|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
2657951|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2657952|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657953|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
2657954|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2657955|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2657956|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2181740|NCT00002598|Methotrexate|methotrexate|mesh-list
2181741|NCT00002598|Etoposide|etoposide|mesh-list
2181742|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
2181743|NCT00002598|Sargramostim|sargramostim|mesh-list
2181744|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2422721|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2422722|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2422723|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2422724|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
2422725|NCT00818350|Sunitinib|sunitinib|mesh-list
2422726|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422727|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2422728|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2422729|NCT00818350|Growth Substances|growth substances|mesh-ancestor
2422730|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422731|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
2657957|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2181745|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
2181746|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181747|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181748|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181749|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
2181750|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181751|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181752|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2422732|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2422733|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181753|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2181754|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
2657958|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2657959|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657960|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
2657961|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2657962|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
2657963|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657964|NCT02088918|Metformin|metformin|mesh-list
2657965|NCT02088918|Nateglinide|nateglinide|mesh-list
2657966|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2657967|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657968|NCT02088944|Infliximab|infliximab|mesh-list
2657969|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
2657970|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657971|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2657972|NCT02088970|Riboflavin|riboflavin|mesh-list
2657973|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2657974|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2657975|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
2181755|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2181756|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181757|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
2181758|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
2181759|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181760|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2181761|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2181762|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181763|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181764|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181765|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
2181766|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2657976|NCT02088970|Vitamins|vitamins|mesh-ancestor
2657977|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
2657978|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2657979|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2657980|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
2657981|NCT02088983|Choline|choline|mesh-list
2657982|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2657983|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
2657984|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2657985|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
2657986|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657987|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2657988|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2657989|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
2657990|NCT02089048|Auranofin|auranofin|mesh-list
2657991|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2657992|NCT02089061|Atorvastatin|atorvastatin|mesh-list
2181767|NCT00002598|Analgesics|analgesics|mesh-ancestor
2181768|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
2181769|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2181770|NCT00002599|Cobalt|cobalt|mesh-list
2181771|NCT00002599|Interferons|interferons|mesh-list
2181772|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
2181773|NCT00002599|Prednisone|prednisone|mesh-list
2181774|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
2181775|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
2657993|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2657994|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2657995|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2657996|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
2657997|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2657998|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2657999|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2658000|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658001|NCT02089126|Glimepiride|glimepiride|mesh-list
2181776|NCT00002599|Melphalan|melphalan|mesh-list
2181777|NCT00002599|Carmustine|carmustine|mesh-list
2181778|NCT00002599|Doxorubicin|doxorubicin|mesh-list
2181779|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2181780|NCT00002599|Vincristine|vincristine|mesh-list
2181781|NCT00002599|Sargramostim|sargramostim|mesh-list
2181782|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181783|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
2181784|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658002|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2658003|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2658004|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181785|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181786|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181787|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
2181788|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658005|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2658006|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
2658007|NCT02089178|Remifentanil|remifentanil|mesh-list
2658008|NCT02089178|Anesthetics|anesthetics|mesh-list
2658009|NCT02089178|Propofol|propofol|mesh-list
2658010|NCT02089178|Sevoflurane|sevoflurane|mesh-list
2658011|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2658012|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658013|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2658014|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2658015|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
2658016|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2658017|NCT02089178|Narcotics|narcotics|mesh-ancestor
2658018|NCT02089178|Analgesics|analgesics|mesh-ancestor
2658019|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
2658020|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658021|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2658022|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2658023|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
2658024|NCT02089204|Fluorides|fluorides|mesh-list
2658025|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
2658026|NCT02089204|Protective Agents|protective agents|mesh-ancestor
2658027|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658028|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
2658029|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658030|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
2658031|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658032|NCT02089256|Liraglutide|liraglutide|mesh-list
2658033|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2658034|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658035|NCT02089256|Incretins|incretins|mesh-ancestor
2658036|NCT02089256|Hormones|hormones|mesh-ancestor
2658037|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2658038|NCT02089295|Oxycodone|oxycodone|mesh-list
2658039|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2658040|NCT02089295|Narcotics|narcotics|mesh-ancestor
2658041|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2658042|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658043|NCT02089295|Analgesics|analgesics|mesh-ancestor
2658044|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
2658045|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658046|NCT02089308|Nicotine|nicotine|mesh-list
2658047|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2658048|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
2658049|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658050|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658051|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2658052|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2658053|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
2658054|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658055|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658056|NCT02089386|Tamoxifen|tamoxifen|mesh-list
2181789|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181790|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181791|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181792|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181793|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181794|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181795|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2181796|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
2181797|NCT00002599|Hormones|hormones|mesh-ancestor
2181798|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2181799|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2181800|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
2181801|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181802|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181803|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181804|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181805|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181806|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
2658057|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2658058|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
2658059|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2658060|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658061|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2658062|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181807|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
2181808|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2181809|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2181810|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2181811|NCT00002599|Protective Agents|protective agents|mesh-ancestor
2181812|NCT00002599|Trace Elements|trace elements|mesh-ancestor
2181813|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
2181814|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
2181815|NCT00002600|Carboplatin|carboplatin|mesh-list
2181816|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181817|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
2181818|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181819|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181820|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181821|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
2181822|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181823|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181824|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181825|NCT00002604|Carmustine|carmustine|mesh-list
2181826|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2658063|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2658064|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2658065|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2658066|NCT02089399|Olmesartan|olmesartan|mesh-list
2658067|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2658068|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2658069|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2658070|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
2658071|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658072|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2658073|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2658074|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658075|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2658076|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2658077|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2181827|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181828|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
2181829|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181830|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181831|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181832|NCT00002608|Tamoxifen|tamoxifen|mesh-list
2181833|NCT00002608|Doxorubicin|doxorubicin|mesh-list
2181834|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2181835|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658078|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2658079|NCT02089438|Vildagliptin|vildagliptin|mesh-list
2658080|NCT02089438|Saxagliptin|saxagliptin|mesh-list
2658081|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2658082|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658083|NCT02089438|Incretins|incretins|mesh-ancestor
2658084|NCT02089438|Hormones|hormones|mesh-ancestor
2658085|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2658086|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2181836|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181837|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181838|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181839|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181840|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181841|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2181842|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
2181843|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2658087|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
2658088|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658089|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658090|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
2658091|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2658092|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658093|NCT02089503|Ranibizumab|ranibizumab|mesh-list
2658094|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2658095|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2658096|NCT02089503|Growth Substances|growth substances|mesh-ancestor
2658097|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658098|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
2658099|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658100|NCT02089529|Ibuprofen|ibuprofen|mesh-list
2181844|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181845|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2181846|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2181847|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2181848|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2181849|NCT00002609|Cytarabine|cytarabine|mesh-list
2181850|NCT00002609|Idarubicin|idarubicin|mesh-list
2181851|NCT00002609|Lintuzumab|lintuzumab|mesh-list
2181852|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181853|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
2181854|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181855|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181856|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
2181857|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181858|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181859|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
2181860|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181861|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181862|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181863|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181864|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181865|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2181866|NCT00002610|Dactinomycin|dactinomycin|mesh-list
2658101|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2658102|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2658103|NCT02089529|Analgesics|analgesics|mesh-ancestor
2658104|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
2658105|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658106|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658107|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2658108|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2658109|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2658110|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658111|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658112|NCT02089542|Methylene Blue|methylene blue|mesh-list
2658113|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658114|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658115|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2658116|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2658117|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658118|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2658119|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658120|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658121|NCT02089633|BCT-100|bct-100|mesh-list
2658122|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658123|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
2658124|NCT02089685|Ipilimumab|ipilimumab|mesh-list
2658125|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2658126|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658127|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2658128|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658129|NCT02089763|BCT-100|bct-100|mesh-list
2658130|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658131|NCT02089841|Lumefantrine|lumefantrine|mesh-list
2658132|NCT02089841|Artemether|artemether|mesh-list
2658133|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2658134|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
2658135|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2658136|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2658137|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658138|NCT02089854|Toremifene|toremifene|mesh-list
2658139|NCT02089854|Anastrozole|anastrozole|mesh-list
2658140|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2658141|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658142|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2658143|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2658144|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181867|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
2658145|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658146|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2658147|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
2658148|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2658149|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658150|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2658151|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2658152|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2658153|NCT02089867|Ezetimibe|ezetimibe|mesh-list
2658154|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2658155|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2658156|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
2658157|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658158|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2658159|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
2658160|NCT02089932|Bupivacaine|bupivacaine|mesh-list
2658161|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
2181868|NCT00002610|Carboplatin|carboplatin|mesh-list
2181869|NCT00002610|Doxorubicin|doxorubicin|mesh-list
2658162|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
2658163|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2658164|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658165|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
2658166|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658167|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2658168|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2658169|NCT02089932|Analgesics|analgesics|mesh-ancestor
2658170|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2658171|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2658172|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2658173|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
2658174|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658175|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658176|NCT02090036|Lumefantrine|lumefantrine|mesh-list
2658177|NCT02090036|Artemether|artemether|mesh-list
2658178|NCT02090036|Primaquine|primaquine|mesh-list
2658179|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2658180|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
2658181|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2658182|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2658183|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658184|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2658185|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2658186|NCT02090153|Leucovorin|leucovorin|mesh-list
2658187|NCT02090153|Tegafur|tegafur|mesh-list
2181870|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2181871|NCT00002610|Etoposide|etoposide|mesh-list
2181872|NCT00002610|Vincristine|vincristine|mesh-list
2181873|NCT00002610|Lenograstim|lenograstim|mesh-list
2181874|NCT00002610|Sargramostim|sargramostim|mesh-list
2181875|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2658188|NCT02090153|Antidotes|antidotes|mesh-ancestor
2658189|NCT02090153|Protective Agents|protective agents|mesh-ancestor
2658190|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658191|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
2658192|NCT02090153|Vitamins|vitamins|mesh-ancestor
2658193|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
2658194|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2658195|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
2658196|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658197|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658198|NCT02090244|Teriparatide|teriparatide|mesh-list
2658199|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2658200|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658201|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2658202|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
2658203|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658204|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
2658205|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658206|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658207|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2658208|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
2658209|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2658210|NCT02090322|Bevacizumab|bevacizumab|mesh-list
2181876|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
2658211|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2658212|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658213|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2658214|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2658215|NCT02090322|Growth Substances|growth substances|mesh-ancestor
2658216|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658217|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
2658218|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2658219|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
2658220|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2658221|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
2658222|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658223|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
2658224|NCT02090400|Calcium|calcium|mesh-list
2658225|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2658226|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658227|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2658228|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2658229|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
2658230|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2658231|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2658232|NCT02090439|Silodosin|silodosin|mesh-list
2658233|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2658234|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2658235|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2658236|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
2658237|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658238|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658239|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658240|NCT02090439|Urological Agents|urological agents|mesh-ancestor
2658241|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
2658242|NCT02090504|Oxazepam|oxazepam|mesh-list
2658243|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2658244|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2658245|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
2658246|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
2658247|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2658248|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181877|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181878|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181879|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181880|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
2181881|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181882|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181883|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181884|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181885|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181886|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2658249|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2658250|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2658251|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2658252|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2658253|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
2658254|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
2658255|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658256|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658257|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
2658258|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
2658259|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2658260|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
2658261|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2658262|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
2658263|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658264|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658265|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
2658274|NCT02090673|Exenatide|exenatide|mesh-list
2658275|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2181887|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181888|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181889|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2181890|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181891|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181892|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181893|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2181894|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181895|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2181896|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2181897|NCT00002611|Dactinomycin|dactinomycin|mesh-list
2181898|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
2658276|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658277|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2658278|NCT02090673|Incretins|incretins|mesh-ancestor
2658279|NCT02090673|Hormones|hormones|mesh-ancestor
2658280|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2658281|NCT02090738|Amoxicillin|amoxicillin|mesh-list
2658282|NCT02090738|Clarithromycin|clarithromycin|mesh-list
2658283|NCT02090738|Acetazolamide|acetazolamide|mesh-list
2658284|NCT02090738|Esomeprazole|esomeprazole|mesh-list
2658285|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2658286|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658287|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2658288|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2658289|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2658290|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181899|NCT00002611|Doxorubicin|doxorubicin|mesh-list
2181900|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2181901|NCT00002611|Etoposide|etoposide|mesh-list
2181902|NCT00002611|Vincristine|vincristine|mesh-list
2181903|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181904|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
2181905|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181906|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181907|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2658291|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658292|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2658293|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2658294|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2658295|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
2658296|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2658297|NCT02090738|Diuretics|diuretics|mesh-ancestor
2658298|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
2658299|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658300|NCT02090790|Dexamethasone|dexamethasone|mesh-list
2658301|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
2658302|NCT02090790|BB 1101|bb 1101|mesh-list
2658303|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2658304|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
2658305|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
2658306|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658307|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658308|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2658309|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
2658310|NCT02090790|Hormones|hormones|mesh-ancestor
2658311|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2658312|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2422734|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422735|NCT00818415|Naproxen|naproxen|mesh-list
2422736|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2422737|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2422738|NCT00818415|Analgesics|analgesics|mesh-ancestor
2422739|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
2422740|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422741|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422742|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2422743|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2422744|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
2422745|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2422746|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658313|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658314|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
2658315|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181908|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
2181909|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658316|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658317|NCT02090829|Oxytocin|oxytocin|mesh-list
2658318|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
2658319|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2658320|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658321|NCT02090920|Nifedipine|nifedipine|mesh-list
2658322|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2658323|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2658324|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658325|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2658326|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658327|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
2658328|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
2658329|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2658330|NCT02090933|Celecoxib|celecoxib|mesh-list
2658331|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2658332|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2658333|NCT02090933|Analgesics|analgesics|mesh-ancestor
2658334|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
2658335|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2181910|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181911|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181912|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181913|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181914|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2658336|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658337|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2658338|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2658339|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2658340|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2658341|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658342|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658368|NCT02091063|Ricolinostat|ricolinostat|mesh-list
2658369|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658370|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2658371|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658372|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658383|NCT02091180|Mannitol|mannitol|mesh-list
2658384|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2658385|NCT02091180|Diuretics|diuretics|mesh-ancestor
2658386|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
2658387|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658388|NCT02091219|Vitamin D|vitamin d|mesh-list
2658389|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
2658390|NCT02091219|Calcifediol|calcifediol|mesh-list
2658391|NCT02091219|Vitamins|vitamins|mesh-ancestor
2658392|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
2658393|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658394|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2658395|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2658396|NCT02091297|Acetaminophen|acetaminophen|mesh-list
2658397|NCT02091297|Morphine|morphine|mesh-list
2658398|NCT02091297|Ropivacaine|ropivacaine|mesh-list
2658399|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2658400|NCT02091297|Narcotics|narcotics|mesh-ancestor
2658401|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2422747|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422748|NCT00818493|Acetaminophen|acetaminophen|mesh-list
2422749|NCT00818493|Morphine|morphine|mesh-list
2422750|NCT00818493|Oxycodone|oxycodone|mesh-list
2422751|NCT00818493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2422752|NCT00818493|Narcotics|narcotics|mesh-ancestor
2422753|NCT00818493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2422754|NCT00818493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422755|NCT00818493|Analgesics|analgesics|mesh-ancestor
2422756|NCT00818493|Sensory System Agents|sensory system agents|mesh-ancestor
2422757|NCT00818493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422758|NCT00818493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2658402|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658403|NCT02091297|Analgesics|analgesics|mesh-ancestor
2658404|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
2658405|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658406|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
2658407|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
2658408|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2658409|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
2658410|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
2658411|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2658412|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658413|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2658414|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2658415|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658416|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658417|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658418|NCT02091336|Metformin|metformin|mesh-list
2658419|NCT02091336|Glyburide|glyburide|mesh-list
2658420|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2658421|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658422|NCT02091388|Risperidone|risperidone|mesh-list
2658423|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2658424|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
2658425|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658426|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658427|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658428|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2658429|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2658430|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2658431|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2658432|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2658433|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
2658434|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
2658435|NCT02091401|Analgesics|analgesics|mesh-ancestor
2658436|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
2658437|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658438|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658439|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
2658440|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2658441|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2658442|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
2658443|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2658444|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2658445|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422759|NCT00818493|Antipyretics|antipyretics|mesh-ancestor
2658446|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2658447|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
2181915|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181916|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181917|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181918|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181919|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181920|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2181921|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181922|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2181923|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2658448|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2658449|NCT02091492|Teriparatide|teriparatide|mesh-list
2658450|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2658451|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658452|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2658453|NCT02091505|Ranibizumab|ranibizumab|mesh-list
2658454|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2658455|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2658456|NCT02091505|Growth Substances|growth substances|mesh-ancestor
2658457|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658458|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
2658459|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658460|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
2658461|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2658462|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
2658463|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658464|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
2658465|NCT02091674|Protective Agents|protective agents|mesh-ancestor
2658466|NCT02091817|Oxytocin|oxytocin|mesh-list
2658467|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
2658468|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2658469|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181924|NCT00002615|Fluorouracil|fluorouracil|mesh-list
2181925|NCT00002615|Epirubicin|epirubicin|mesh-list
2181926|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181927|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
2181928|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181929|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181930|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181931|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
2181932|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181933|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181934|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181935|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181936|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181937|NCT00002616|Aldesleukin|aldesleukin|mesh-list
2181938|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
2181939|NCT00002616|Thiotepa|thiotepa|mesh-list
2181940|NCT00002616|Carboplatin|carboplatin|mesh-list
2181941|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181942|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
2181943|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658470|NCT02091830|Acetaminophen|acetaminophen|mesh-list
2658471|NCT02091830|Cortisone|cortisone|mesh-list
2658472|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2658473|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2658474|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2658475|NCT02091830|Analgesics|analgesics|mesh-ancestor
2658476|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
2658477|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658478|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658479|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
2658480|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2658481|NCT02091908|Lactitol|lactitol|mesh-list
2658482|NCT02091908|Vaccines|vaccines|mesh-list
2658483|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
2658484|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658485|NCT02091908|Cathartics|cathartics|mesh-ancestor
2658486|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2658487|NCT02091973|Everolimus|everolimus|mesh-list
2658488|NCT02091973|Tacrolimus|tacrolimus|mesh-list
2658489|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2658490|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
2658491|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658492|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2658493|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658494|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658495|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658496|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2658497|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
2658498|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2658499|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2658500|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658501|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2658502|NCT02092012|Analgesics|analgesics|mesh-ancestor
2658503|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
2658504|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658505|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2658506|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2658507|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2658508|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
2658509|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658510|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658511|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2658512|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2658513|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2658514|NCT02092038|Temozolomide|temozolomide|mesh-list
2658515|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2658516|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
2658517|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658518|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658519|NCT02092142|Vaccines|vaccines|mesh-list
2658520|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
2658521|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658522|NCT02092363|Paclitaxel|paclitaxel|mesh-list
2658523|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2658524|NCT02092363|Carboplatin|carboplatin|mesh-list
2658525|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2658526|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2658527|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658528|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
2658529|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
2658530|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
2658531|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658532|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
2658533|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658534|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
2658535|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2658536|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658537|NCT02092376|Vitamins|vitamins|mesh-ancestor
2658538|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
2658539|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2658540|NCT02092428|Adenosine|adenosine|mesh-list
2658541|NCT02092428|Regadenoson|regadenoson|mesh-list
2658542|NCT02092428|Analgesics|analgesics|mesh-ancestor
2658543|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
2658544|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658545|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658546|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2658547|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
2658548|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2658549|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
2658550|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
2658551|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658552|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658553|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2658554|NCT02092454|Benzocaine|benzocaine|mesh-list
2658555|NCT02092454|Anesthetics, Local|anesthetics, local|mesh-ancestor
2658556|NCT02092454|Anesthetics|anesthetics|mesh-ancestor
2658557|NCT02092454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2658558|NCT02092454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658559|NCT02092454|Sensory System Agents|sensory system agents|mesh-ancestor
2658560|NCT02092454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658561|NCT02092506|Amoxicillin|amoxicillin|mesh-list
2658562|NCT02092506|Metronidazole|metronidazole|mesh-list
2658563|NCT02092506|Clarithromycin|clarithromycin|mesh-list
2658564|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2658565|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2658566|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658567|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2658568|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2658569|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2658570|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658571|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181944|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181945|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2181946|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
2181947|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181948|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181949|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2181950|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2181951|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2181952|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
2181953|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181954|NCT00002618|Leucovorin|leucovorin|mesh-list
2181955|NCT00002618|Cobalt|cobalt|mesh-list
2181956|NCT00002618|Cytarabine|cytarabine|mesh-list
2181957|NCT00002618|Prednisone|prednisone|mesh-list
2181958|NCT00002618|Doxorubicin|doxorubicin|mesh-list
2181959|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2181960|NCT00002618|Methotrexate|methotrexate|mesh-list
2181961|NCT00002618|Vincristine|vincristine|mesh-list
2181962|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
2181963|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
2181964|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2181965|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2181966|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2181967|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2181968|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2181969|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2181970|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181971|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2181972|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
2181973|NCT00002618|Hormones|hormones|mesh-ancestor
2181974|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2181975|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2181976|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2181977|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
2181978|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2181979|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2181980|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
2181981|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
2181982|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2181983|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2181984|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
2181985|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2181986|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2181987|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
2181988|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2181989|NCT00002618|Antidotes|antidotes|mesh-ancestor
2181990|NCT00002618|Protective Agents|protective agents|mesh-ancestor
2181991|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
2181992|NCT00002618|Vitamins|vitamins|mesh-ancestor
2181993|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
2181994|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2181995|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
2181996|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
2181997|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
2181998|NCT00002618|Trace Elements|trace elements|mesh-ancestor
2658572|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2658573|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2658574|NCT02092532|Aflibercept|aflibercept|mesh-list
2658575|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2658576|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2658577|NCT02092532|Growth Substances|growth substances|mesh-ancestor
2658578|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658579|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
2658580|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658581|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
2658582|NCT02092558|Cephalosporins|cephalosporins|mesh-list
2658583|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2658584|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658585|NCT02092558|Renal Agents|renal agents|mesh-ancestor
2658586|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2658587|NCT02092597|Exenatide|exenatide|mesh-list
2658588|NCT02092597|Linagliptin|linagliptin|mesh-list
2658589|NCT02092597|Gliclazide|gliclazide|mesh-list
2658590|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2658591|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2181999|NCT00002619|Carboplatin|carboplatin|mesh-list
2182000|NCT00002619|Thiotepa|thiotepa|mesh-list
2658592|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2658593|NCT02092597|Incretins|incretins|mesh-ancestor
2658594|NCT02092597|Hormones|hormones|mesh-ancestor
2658595|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2658596|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2658597|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
2658598|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182001|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182002|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
2182003|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182004|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182005|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
2182006|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182007|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182008|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182009|NCT00002620|Cobalt|cobalt|mesh-list
2182010|NCT00002620|Carmustine|carmustine|mesh-list
2182011|NCT00002620|Mitolactol|mitolactol|mesh-list
2182012|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182013|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
2182014|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182015|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182016|NCT00002620|Trace Elements|trace elements|mesh-ancestor
2182017|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
2182018|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182019|NCT00002621|Interferons|interferons|mesh-list
2182020|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
2182021|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
2182022|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182023|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
2182024|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182025|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
2182026|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658599|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658600|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
2658601|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2658602|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658603|NCT02092701|Vitamins|vitamins|mesh-ancestor
2658604|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
2658605|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2658606|NCT02092766|Artesunate|artesunate|mesh-list
2658607|NCT02092766|Quinine|quinine|mesh-list
2658608|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
2658609|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2658610|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2658611|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658612|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658613|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
2658614|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
2658615|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2658616|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
2658617|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2658618|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658619|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2658620|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658621|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2658622|NCT02092766|Analgesics|analgesics|mesh-ancestor
2658623|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
2658624|NCT02092818|Riociguat|riociguat|mesh-list
2658625|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
2658626|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658627|NCT02092896|Liraglutide|liraglutide|mesh-list
2658628|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2658629|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658630|NCT02092896|Incretins|incretins|mesh-ancestor
2658631|NCT02092896|Hormones|hormones|mesh-ancestor
2658632|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2658633|NCT02092922|Filanesib|filanesib|mesh-list
2658634|NCT02092922|Lenograstim|lenograstim|mesh-list
2658635|NCT02092922|Sargramostim|sargramostim|mesh-list
2658636|NCT02092922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2658637|NCT02092922|Immunologic Factors|immunologic factors|mesh-ancestor
2658638|NCT02092922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658639|NCT02092922|Antimitotic Agents|antimitotic agents|mesh-ancestor
2658640|NCT02092922|Mitosis Modulators|mitosis modulators|mesh-ancestor
2658641|NCT02092922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658642|NCT02092922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658643|NCT02092935|Vancomycin|vancomycin|mesh-list
2658644|NCT02092935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2658645|NCT02092935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658646|NCT02092974|Citalopram|citalopram|mesh-list
2658647|NCT02092974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2182027|NCT00002623|Carboplatin|carboplatin|mesh-list
2182028|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182029|NCT00002625|Topotecan|topotecan|mesh-list
2182030|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2182031|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182032|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182033|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182034|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182035|NCT00002627|Paclitaxel|paclitaxel|mesh-list
2182036|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
2182037|NCT00002627|Carboplatin|carboplatin|mesh-list
2182038|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182039|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182040|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
2182041|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
2182042|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182043|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182044|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182045|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
2182046|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182047|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182048|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182049|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
2182050|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182051|NCT00002628|Paclitaxel|paclitaxel|mesh-list
2182052|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
2182053|NCT00002628|Carboplatin|carboplatin|mesh-list
2182054|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182055|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182056|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
2182057|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
2658648|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2658649|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2658650|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658651|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658652|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
2658653|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658654|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2658655|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
2658656|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2658657|NCT02093000|Bevacizumab|bevacizumab|mesh-list
2658658|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2658659|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658660|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2658661|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2658662|NCT02093000|Growth Substances|growth substances|mesh-ancestor
2658663|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658664|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
2658665|NCT02093091|Vitremer|vitremer|mesh-list
2658666|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
2658667|NCT02093091|Protective Agents|protective agents|mesh-ancestor
2658668|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658669|NCT02093143|Remifentanil|remifentanil|mesh-list
2658670|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2658671|NCT02093143|Narcotics|narcotics|mesh-ancestor
2658672|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2658673|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182058|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182059|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182060|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182061|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
2182062|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182063|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2658674|NCT02093143|Analgesics|analgesics|mesh-ancestor
2658675|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
2658676|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658677|NCT02093195|Bosentan|bosentan|mesh-list
2658678|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2658679|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2182064|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182065|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
2182066|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182067|NCT00002630|Cobalt|cobalt|mesh-list
2182068|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
2658680|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
2658681|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2658682|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2658683|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658684|NCT02093299|Clopidogrel|clopidogrel|mesh-list
2658685|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2658686|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2658687|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2658688|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2658689|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
2658690|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658691|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658692|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658693|NCT02093403|Decitabine|decitabine|mesh-list
2658694|NCT02093403|Azacitidine|azacitidine|mesh-list
2658695|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2658696|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
2658697|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658698|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658699|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658700|NCT02093533|Eculizumab|eculizumab|mesh-list
2658701|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2658702|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182069|NCT00002630|Melphalan|melphalan|mesh-list
2182070|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182071|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
2182072|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182073|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182074|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182075|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
2182076|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182077|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182078|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182079|NCT00002630|Trace Elements|trace elements|mesh-ancestor
2182080|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
2182081|NCT00002631|Fluorouracil|fluorouracil|mesh-list
2182082|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182083|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
2658703|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
2658704|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658705|NCT02093585|Tenofovir|tenofovir|mesh-list
2658706|NCT02093585|Abacavir|abacavir|mesh-list
2658707|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
2658708|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658709|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2182084|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182085|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182086|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182087|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
2182088|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182089|NCT00002632|Paclitaxel|paclitaxel|mesh-list
2182090|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2658710|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2658711|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658712|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658713|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2658714|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2658715|NCT02093598|Sirolimus|sirolimus|mesh-list
2658716|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2658717|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658718|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2658719|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658720|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
2658721|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2658722|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
2658723|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658724|NCT02093728|Itraconazole|itraconazole|mesh-list
2658725|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
2182091|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182092|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
2182093|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
2658726|NCT02093728|Fluconazole|fluconazole|mesh-list
2658727|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
2658728|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658729|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2658730|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2658731|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658732|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658733|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2658734|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
2658735|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2658736|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658737|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2658738|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2182094|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182095|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182096|NCT00002633|Leuprolide|leuprolide|mesh-list
2182097|NCT00002633|Goserelin|goserelin|mesh-list
2182098|NCT00002633|Flutamide|flutamide|mesh-list
2182099|NCT00002633|Bicalutamide|bicalutamide|mesh-list
2182100|NCT00002633|Nilutamide|nilutamide|mesh-list
2182101|NCT00002633|Buserelin|buserelin|mesh-list
2182102|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2182103|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
2182104|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2658739|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2658740|NCT02093741|Factor VIII|factor viii|mesh-list
2658741|NCT02093741|Coagulants|coagulants|mesh-ancestor
2658742|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2658743|NCT02093845|Everolimus|everolimus|mesh-list
2658744|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658745|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2658746|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
2658747|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658748|NCT02093910|Dexamethasone|dexamethasone|mesh-list
2658749|NCT02093910|Bortezomib|bortezomib|mesh-list
2658750|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2658751|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
2658752|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
2658753|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658754|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182105|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182106|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2182107|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182108|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
2182109|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
2182110|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182111|NCT00002634|Cobalt|cobalt|mesh-list
2182112|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
2182113|NCT00002634|Doxorubicin|doxorubicin|mesh-list
2658755|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2658756|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
2658757|NCT02093910|Hormones|hormones|mesh-ancestor
2658758|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2658759|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2658760|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658761|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2658762|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2658763|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658764|NCT02094053|Donepezil|donepezil|mesh-list
2658765|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2658766|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658767|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658768|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
2658769|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658770|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658771|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
2658772|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
2658773|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2658774|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2658775|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658776|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
2658777|NCT02094066|Coagulants|coagulants|mesh-ancestor
2658778|NCT02094157|Heparin|heparin|mesh-list
2182114|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2182115|NCT00002634|Etoposide|etoposide|mesh-list
2658779|NCT02094157|Calcium heparin|calcium heparin|mesh-list
2658780|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2658781|NCT02094157|Tinzaparin|tinzaparin|mesh-list
2658782|NCT02094157|Dalteparin|dalteparin|mesh-list
2658783|NCT02094157|Warfarin|warfarin|mesh-list
2658784|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
2658785|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2658786|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2658787|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658788|NCT02094196|Ethanol|ethanol|mesh-list
2658789|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2658790|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658791|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2658792|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658793|NCT02094222|Glycerol|glycerol|mesh-list
2658794|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2658795|NCT02094222|Protective Agents|protective agents|mesh-ancestor
2658796|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658797|NCT02094274|Fluticasone|fluticasone|mesh-list
2658798|NCT02094274|Xhance|xhance|mesh-list
2658799|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2658800|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2658801|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2658802|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
2182116|NCT00002634|Vincristine|vincristine|mesh-list
2182117|NCT00002634|Antibodies|antibodies|mesh-list
2182118|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2182119|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182120|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
2182121|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182122|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182123|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182124|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
2182125|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182126|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182127|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182128|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2182129|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182130|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182131|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182132|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182133|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
2182134|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
2182135|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182136|NCT00002634|Trace Elements|trace elements|mesh-ancestor
2182137|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
2182138|NCT00002635|Lenograstim|lenograstim|mesh-list
2182139|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2182140|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
2658803|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658804|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658805|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2658806|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
2658807|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
2658808|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2658809|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2658810|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2658811|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2658812|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
2658813|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658814|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658815|NCT02094287|Dimethindene|dimethindene|mesh-list
2658816|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
2658817|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
2658818|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2658819|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
2658820|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
2658821|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658822|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658823|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658824|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2658825|NCT02094313|Atorvastatin|atorvastatin|mesh-list
2658826|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
2658827|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2658828|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
2658829|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658830|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2658831|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2658832|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658833|NCT02094339|Analgesics|analgesics|mesh-list
2182141|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182142|NCT00002637|Interferons|interferons|mesh-list
2182143|NCT00002637|Aldesleukin|aldesleukin|mesh-list
2182144|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
2182145|NCT00002637|Vaccines|vaccines|mesh-list
2182146|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182147|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
2182148|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182149|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2182150|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2182151|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
2182152|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182153|NCT00002638|Cytarabine|cytarabine|mesh-list
2182154|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
2182155|NCT00002638|Carmustine|carmustine|mesh-list
2182156|NCT00002638|Etoposide|etoposide|mesh-list
2182157|NCT00002638|Sargramostim|sargramostim|mesh-list
2182158|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182159|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
2182160|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182161|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182162|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182163|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
2182164|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182165|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182166|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182167|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182168|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182169|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182170|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182171|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182172|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
2182173|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
2182174|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658834|NCT02094339|Ropivacaine|ropivacaine|mesh-list
2658835|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
2658836|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
2658837|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2658838|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658839|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
2658840|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658841|NCT02094378|Esketamine|esketamine|mesh-list
2658842|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
2658843|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2658844|NCT02094391|Ipilimumab|ipilimumab|mesh-list
2658845|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2658846|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658847|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2658848|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658849|NCT02094469|Cilostazol|cilostazol|mesh-list
2658850|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2658851|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
2658852|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658853|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658854|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2658855|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
2658856|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2658857|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2658858|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658859|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2658860|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
2658861|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2182175|NCT00002639|Suramin|suramin|mesh-list
2182176|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
2182177|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
2182178|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2182179|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182180|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182181|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2182182|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2182183|NCT00002641|Doxorubicin|doxorubicin|mesh-list
2182184|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2182185|NCT00002641|Ifosfamide|ifosfamide|mesh-list
2182186|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2658862|NCT02094469|Protective Agents|protective agents|mesh-ancestor
2658863|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2658864|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2658865|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658866|NCT02094599|Dronabinol|dronabinol|mesh-list
2658867|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
2658868|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658869|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2658870|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2658871|NCT02094599|Analgesics|analgesics|mesh-ancestor
2658872|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
2658873|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658874|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2658875|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2658876|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658877|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658878|NCT02094599|Hormones|hormones|mesh-ancestor
2658879|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2658880|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
2658881|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2658882|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
2658883|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658884|NCT02094625|Expectorants|expectorants|mesh-ancestor
2658885|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
2658886|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2658887|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
2658888|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658889|NCT02094625|Protective Agents|protective agents|mesh-ancestor
2658890|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658891|NCT02094625|Antidotes|antidotes|mesh-ancestor
2658892|NCT02094651|Valproic Acid|valproic acid|mesh-list
2658893|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
2658894|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658895|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658896|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
2658897|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658898|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658899|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
2658900|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2658901|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2658902|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2658903|NCT02094703|Levofloxacin|levofloxacin|mesh-list
2182187|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182188|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182189|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182190|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182191|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182192|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182193|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
2182194|NCT00002642|Cobalt|cobalt|mesh-list
2658904|NCT02094703|Ofloxacin|ofloxacin|mesh-list
2658905|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
2658906|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2658907|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658908|NCT02094703|Renal Agents|renal agents|mesh-ancestor
2658909|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2658910|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182195|NCT00002642|Etoposide|etoposide|mesh-list
2182196|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182197|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182198|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182199|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182200|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182201|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182202|NCT00002642|Trace Elements|trace elements|mesh-ancestor
2182203|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
2182204|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182205|NCT00002643|Cobalt|cobalt|mesh-list
2182206|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
2182207|NCT00002643|Ifosfamide|ifosfamide|mesh-list
2182208|NCT00002643|Doxorubicin|doxorubicin|mesh-list
2182209|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2182210|NCT00002643|Etoposide|etoposide|mesh-list
2182211|NCT00002643|Vincristine|vincristine|mesh-list
2182212|NCT00002643|Topotecan|topotecan|mesh-list
2182213|NCT00002643|Amifostine|amifostine|mesh-list
2182214|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2658911|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2658912|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658913|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658914|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658915|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2658916|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2658917|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2658918|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2658919|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
2658920|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658921|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658922|NCT02094703|Urological Agents|urological agents|mesh-ancestor
2658923|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
2658924|NCT02094794|Etoposide|etoposide|mesh-list
2658925|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
2658926|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2658927|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
2658928|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658929|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2658930|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2658931|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
2658932|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658933|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658934|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2658935|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2658936|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2658937|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2658938|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658939|NCT02094807|Acetaminophen|acetaminophen|mesh-list
2658940|NCT02094807|Diclofenac|diclofenac|mesh-list
2658941|NCT02094807|Oxycodone|oxycodone|mesh-list
2658942|NCT02094807|Tramadol|tramadol|mesh-list
2182215|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
2182216|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182217|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182218|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182219|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
2182220|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658943|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2658944|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658945|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2658946|NCT02094807|Analgesics|analgesics|mesh-ancestor
2658947|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
2658948|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2658949|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
2658950|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2658951|NCT02094807|Narcotics|narcotics|mesh-ancestor
2658952|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2658953|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2658954|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2658955|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2658956|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658957|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658958|NCT02094833|Vaccines|vaccines|mesh-list
2658959|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
2658960|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658961|NCT02094924|Candesartan|candesartan|mesh-list
2658962|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
2658963|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2658964|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2182221|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182222|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182223|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2182224|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182225|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182226|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182227|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182228|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
2182229|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
2658965|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2658966|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658967|NCT02094963|Clopidogrel|clopidogrel|mesh-list
2658968|NCT02094963|Ticagrelor|ticagrelor|mesh-list
2658969|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2658970|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2658971|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2658972|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2658973|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
2658974|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2658975|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658976|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658977|NCT02095054|Cetuximab|cetuximab|mesh-list
2658978|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2658979|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658980|NCT02095119|Gemcitabine|gemcitabine|mesh-list
2658981|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
2658982|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2658983|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2658984|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
2658985|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2658986|NCT02095119|Antiviral Agents|antiviral agents|mesh-ancestor
2658987|NCT02095119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2658988|NCT02095119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658989|NCT02095119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2658990|NCT02095119|Immunologic Factors|immunologic factors|mesh-ancestor
2658991|NCT02095119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2658992|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2658993|NCT02095132|Irinotecan|irinotecan|mesh-list
2658994|NCT02095132|Camptothecin|camptothecin|mesh-list
2658995|NCT02095132|Adavosertib|adavosertib|mesh-list
2658996|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2658997|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2658998|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2658999|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659000|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659001|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2659002|NCT02095184|Letrozole|letrozole|mesh-list
2182230|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182231|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2182232|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2182233|NCT00002643|Protective Agents|protective agents|mesh-ancestor
2182234|NCT00002643|Trace Elements|trace elements|mesh-ancestor
2182235|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
2182236|NCT00002644|Tamoxifen|tamoxifen|mesh-list
2659003|NCT02095184|Anastrozole|anastrozole|mesh-list
2659004|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659005|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2659006|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2659007|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659008|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659009|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2659010|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
2659011|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2659012|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659013|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2659014|NCT02095314|Vaccines|vaccines|mesh-list
2659015|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
2659016|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659017|NCT02095366|Sufentanil|sufentanil|mesh-list
2659018|NCT02095366|Morphine|morphine|mesh-list
2659019|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2659020|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2659021|NCT02095366|Narcotics|narcotics|mesh-ancestor
2659022|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2659023|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659024|NCT02095366|Analgesics|analgesics|mesh-ancestor
2659025|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
2659026|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659027|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2659028|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2659029|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
2659030|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
2659031|NCT02095405|Caffeine|caffeine|mesh-list
2659032|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2659033|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659034|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2659035|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659036|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659037|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2659038|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2659039|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
2659040|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659041|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
2659042|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2659043|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659044|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2659045|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
2659046|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2659047|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659048|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659049|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182237|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2182238|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
2182239|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182240|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182241|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2182242|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659050|NCT02095509|Enoxaparin|enoxaparin|mesh-list
2659051|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
2659052|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2659053|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2659054|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659055|NCT02095522|Colchicine|colchicine|mesh-list
2659056|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
2659057|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2659058|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
2659059|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
2659060|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
2659061|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659062|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659063|NCT02095548|Lorecivivint|lorecivivint|mesh-list
2659064|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2659065|NCT02095574|Venetoclax|venetoclax|mesh-list
2659066|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659067|NCT02095665|Acetaminophen|acetaminophen|mesh-list
2659068|NCT02095665|Tamsulosin|tamsulosin|mesh-list
2659069|NCT02095665|Mirabegron|mirabegron|mesh-list
2659070|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2659071|NCT02095665|Analgesics|analgesics|mesh-ancestor
2659072|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
2659073|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659074|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659075|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
2659076|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2659077|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2659078|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2659079|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
2659080|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659081|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659082|NCT02095665|Urological Agents|urological agents|mesh-ancestor
2659083|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2659084|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2659085|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2659086|NCT02095704|Acetaminophen|acetaminophen|mesh-list
2659087|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2659088|NCT02095704|Analgesics|analgesics|mesh-ancestor
2659089|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
2659090|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659091|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659092|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
2659093|NCT02095717|Curcumin|curcumin|mesh-list
2659094|NCT02095717|Docetaxel|docetaxel|mesh-list
2659095|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659096|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
2659097|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
2659098|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
2659099|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659100|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2659101|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2659102|NCT02095717|Analgesics|analgesics|mesh-ancestor
2659103|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
2659104|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659105|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659106|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2659107|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2659108|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659109|NCT02095730|Vitamins|vitamins|mesh-list
2659110|NCT02095730|Riboflavin|riboflavin|mesh-list
2659111|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
2659112|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
2659113|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659114|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2659115|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
2659116|NCT02095782|Paclitaxel|paclitaxel|mesh-list
2659117|NCT02095782|Carboplatin|carboplatin|mesh-list
2659118|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2659119|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2659120|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659121|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
2659122|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
2659123|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
2659124|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659125|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2659126|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659127|NCT02095834|Dexamethasone|dexamethasone|mesh-list
2659128|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
2659129|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2659130|NCT02095834|Ichthammol|ichthammol|mesh-list
2659131|NCT02095834|BB 1101|bb 1101|mesh-list
2659132|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2659133|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
2659134|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
2659135|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659136|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659137|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2659138|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
2659139|NCT02095834|Hormones|hormones|mesh-ancestor
2659140|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2659141|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2659142|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659143|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2659144|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
2659145|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659146|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
2659147|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659148|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
2659149|NCT02095847|Proflavine|proflavine|mesh-list
2659150|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2659151|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659152|NCT02095886|BMS-955176|bms-955176|mesh-list
2659153|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2659154|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2659155|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
2659156|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659157|NCT02095899|Rufinamide|rufinamide|mesh-list
2659158|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
2659159|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2659160|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2659161|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2659162|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659163|NCT02095938|Amisulpride|amisulpride|mesh-list
2659164|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2659165|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2659166|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2659167|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659168|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2659169|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2659170|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
2422760|NCT00818571|Vildagliptin|vildagliptin|mesh-list
2422761|NCT00818571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2422762|NCT00818571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422763|NCT00818571|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2422764|NCT00818571|Protease Inhibitors|protease inhibitors|mesh-ancestor
2422765|NCT00818571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422766|NCT00818571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422767|NCT00818584|Micafungin|micafungin|mesh-list
2422768|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
2422769|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422770|NCT00818610|Amoxicillin|amoxicillin|mesh-list
2422771|NCT00818610|Clarithromycin|clarithromycin|mesh-list
2422772|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2422773|NCT00818610|Cefuroxime|cefuroxime|mesh-list
2422774|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
2659171|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659172|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659173|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2659174|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
2659175|NCT02095990|Hydroquinone|hydroquinone|mesh-list
2659176|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
2659177|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659178|NCT02095990|Protective Agents|protective agents|mesh-ancestor
2659179|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659180|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2659181|NCT02096055|Idarubicin|idarubicin|mesh-list
2659182|NCT02096055|Cladribine|cladribine|mesh-list
2659183|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
2659184|NCT02096055|Guadecitabine|guadecitabine|mesh-list
2659185|NCT02096055|Azacitidine|azacitidine|mesh-list
2659186|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2659187|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659188|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2659189|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2659190|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659191|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659192|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2659193|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
2659194|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659195|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2659196|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
2659197|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
2659198|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2659199|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2659200|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659201|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2659202|NCT02096068|Analgesics|analgesics|mesh-ancestor
2659203|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
2659204|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659205|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2659206|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2659207|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2659208|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
2659209|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659210|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659211|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
2659212|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2659213|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659214|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
2659215|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
2659216|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2659217|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659218|NCT02096133|Vitamins|vitamins|mesh-ancestor
2659219|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
2659220|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2659221|NCT02096159|Trimethoprim|trimethoprim|mesh-list
2659222|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2659223|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
2659224|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2659225|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659226|NCT02096159|Renal Agents|renal agents|mesh-ancestor
2659227|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
2659228|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2659229|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2659230|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2659231|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659232|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659233|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2659234|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2659235|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2659236|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2659237|NCT02096224|Sevoflurane|sevoflurane|mesh-list
2659238|NCT02096224|Desflurane|desflurane|mesh-list
2659239|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2659240|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2659241|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
2659242|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
2659243|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2659244|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659245|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
2659246|NCT02096250|Edetic Acid|edetic acid|mesh-list
2659247|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
2659248|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
2659249|NCT02096250|Trace Elements|trace elements|mesh-ancestor
2659250|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
2659251|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659252|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2659253|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
2659254|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
2659255|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659256|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
2659257|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2659258|NCT02096250|Hematinics|hematinics|mesh-ancestor
2659259|NCT02096289|Thioridazine|thioridazine|mesh-list
2659260|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2659261|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2659262|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2659263|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659264|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2659265|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2659266|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
2659267|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659268|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659269|NCT02096315|Murepavadin|murepavadin|mesh-list
2659270|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2659271|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659272|NCT02096328|Murepavadin|murepavadin|mesh-list
2659273|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2659274|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659275|NCT02096354|Irinotecan|irinotecan|mesh-list
2659276|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659277|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2659278|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2659279|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659280|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659281|NCT02096380|Cisplatin|cisplatin|mesh-list
2659282|NCT02096380|Docetaxel|docetaxel|mesh-list
2659283|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659284|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
2659285|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
2659286|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
2659287|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659288|NCT02096419|Clopidogrel|clopidogrel|mesh-list
2659289|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2659290|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2659291|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2659292|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2659293|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
2182243|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2182244|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2182245|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2182246|NCT00002646|Tamoxifen|tamoxifen|mesh-list
2182247|NCT00002646|Fenretinide|fenretinide|mesh-list
2182248|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2182249|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
2182250|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182251|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182252|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2182253|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182254|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2659294|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659295|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659296|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659297|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
2659298|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2659299|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2659300|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2659301|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2659302|NCT02096536|Vancomycin|vancomycin|mesh-list
2659303|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2659304|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659305|NCT02096601|Levodopa|levodopa|mesh-list
2659306|NCT02096601|Carbidopa|carbidopa|mesh-list
2659307|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2659308|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2659309|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
2659310|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659311|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659312|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659313|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2659314|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659315|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
2659316|NCT02096614|Fludarabine|fludarabine|mesh-list
2659317|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2659318|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
2659319|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659320|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2659321|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2659322|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
2659323|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659324|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659325|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2659326|NCT02096913|Ibuprofen|ibuprofen|mesh-list
2659327|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2659328|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2659329|NCT02096913|Analgesics|analgesics|mesh-ancestor
2659330|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
2659331|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659332|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659333|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2659334|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2659335|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2659336|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182255|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2182256|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2182257|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2182258|NCT00002646|Protective Agents|protective agents|mesh-ancestor
2182259|NCT00002647|Verteporfin|verteporfin|mesh-list
2182260|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2182261|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
2182262|NCT00002649|Aldesleukin|aldesleukin|mesh-list
2182263|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
2659337|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659338|NCT02096926|Ibuprofen|ibuprofen|mesh-list
2659339|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2659340|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2659341|NCT02096926|Analgesics|analgesics|mesh-ancestor
2659342|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
2659343|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659344|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659345|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2659346|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2659347|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2659348|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659349|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659350|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
2182264|NCT00002649|Etoposide|etoposide|mesh-list
2182265|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
2182266|NCT00002649|Interleukin-2|interleukin-2|mesh-list
2182267|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2659351|NCT02096965|Tolvaptan|tolvaptan|mesh-list
2659352|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2659353|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659354|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
2659355|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659356|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2659357|NCT02097004|Entecavir|entecavir|mesh-list
2659358|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
2659359|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659360|NCT02097017|Lidocaine|lidocaine|mesh-list
2659361|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
2659362|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
2659363|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2659364|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659365|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
2659366|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659367|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2659368|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2182268|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
2182269|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182270|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182271|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182272|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
2182273|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182274|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182275|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182276|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182277|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182278|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182279|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182280|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2659369|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2659370|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2659371|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659372|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
2659373|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2659374|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659375|NCT02097069|Folic Acid|folic acid|mesh-list
2659376|NCT02097069|Inositol|inositol|mesh-list
2659377|NCT02097069|Hematinics|hematinics|mesh-ancestor
2659378|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
2659379|NCT02097069|Vitamins|vitamins|mesh-ancestor
2659380|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
2659381|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659382|NCT02097082|Paclitaxel|paclitaxel|mesh-list
2659383|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182281|NCT00002649|Analgesics|analgesics|mesh-ancestor
2182282|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
2182283|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2182284|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2182285|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2182286|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
2182287|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182288|NCT00002650|Folic Acid|folic acid|mesh-list
2182289|NCT00002650|Hematinics|hematinics|mesh-ancestor
2182290|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
2182291|NCT00002650|Vitamins|vitamins|mesh-ancestor
2182292|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
2182293|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182294|NCT00002652|Suramin|suramin|mesh-list
2182295|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
2182296|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
2182297|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2182298|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422775|NCT00818610|Lactams|lactams|mesh-list
2422776|NCT00818610|beta-Lactams|beta-lactams|mesh-list
2422777|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2422778|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422779|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2422780|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422781|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422782|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2422783|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2422784|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2422785|NCT00818675|Sirolimus|sirolimus|mesh-list
2422786|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2422787|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422788|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2422789|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422790|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
2422791|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2422792|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
2422793|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422794|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2422795|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
2422796|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
2422797|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2422798|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2422799|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422800|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422801|NCT00818701|Urological Agents|urological agents|mesh-ancestor
2422802|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
2422803|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422804|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2659384|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659385|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
2659386|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
2659387|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
2659388|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659400|NCT02097147|Paroxetine|paroxetine|mesh-list
2659401|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
2659402|NCT02097147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2659403|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2659404|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2659405|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659406|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659407|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
2659408|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659409|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2659410|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
2659411|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2659412|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2659413|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2659414|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659415|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2659416|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2659417|NCT02097160|Vitamin D|vitamin d|mesh-list
2659418|NCT02097160|Vitamins|vitamins|mesh-ancestor
2659419|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
2659420|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659421|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2659422|NCT02097173|Methotrexate|methotrexate|mesh-list
2659423|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2659424|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
2659425|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2659426|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659427|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182299|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182300|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2182301|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2182302|NCT00002653|Prednisone|prednisone|mesh-list
2182303|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
2182304|NCT00002653|Melphalan|melphalan|mesh-list
2182305|NCT00002653|Carmustine|carmustine|mesh-list
2182306|NCT00002653|Doxorubicin|doxorubicin|mesh-list
2182307|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2182308|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182309|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
2182310|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182311|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182312|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182313|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
2182314|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182315|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182316|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182317|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2182318|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182319|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2659428|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
2659429|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659430|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659431|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
2659432|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659433|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2659434|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2659435|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
2659436|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2659437|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2659438|NCT02097225|Trametinib|trametinib|mesh-list
2659439|NCT02097225|Dabrafenib|dabrafenib|mesh-list
2659440|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659441|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2659442|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659443|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659444|NCT02097264|Adalimumab|adalimumab|mesh-list
2659445|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2659446|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2659447|NCT02097316|Insulin|insulin|mesh-list
2659448|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2659449|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659450|NCT02097329|Palbociclib|palbociclib|mesh-list
2659451|NCT02097329|Rabeprazole|rabeprazole|mesh-list
2659452|NCT02097329|Famotidine|famotidine|mesh-list
2659453|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
2659454|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
2659455|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2659456|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
2659457|NCT02097329|Antacids|antacids|mesh-list
2659458|NCT02097329|TEMPO|tempo|mesh-list
2659459|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659460|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2659461|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659462|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659463|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2659464|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2659465|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2659466|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
2659467|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
2659468|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659469|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659470|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
2659471|NCT02097329|Protective Agents|protective agents|mesh-ancestor
2659472|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2659473|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
2659474|NCT02097342|Linagliptin|linagliptin|mesh-list
2659475|NCT02097342|Voglibose|voglibose|mesh-list
2182320|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182321|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2182322|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
2182323|NCT00002653|Hormones|hormones|mesh-ancestor
2182324|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182325|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2182326|NCT00002654|Cobalt|cobalt|mesh-list
2659476|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2659477|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659478|NCT02097342|Incretins|incretins|mesh-ancestor
2659479|NCT02097342|Hormones|hormones|mesh-ancestor
2659480|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2659481|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2659482|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
2659483|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659484|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659485|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2659486|NCT02097381|Ritonavir|ritonavir|mesh-list
2659487|NCT02097381|Lopinavir|lopinavir|mesh-list
2659488|NCT02097381|Darunavir|darunavir|mesh-list
2659489|NCT02097381|Tenofovir|tenofovir|mesh-list
2659490|NCT02097381|Emtricitabine|emtricitabine|mesh-list
2659491|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2659492|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2659493|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
2659494|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659495|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659496|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2659497|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2659498|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
2659499|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659500|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2659501|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2659502|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2182327|NCT00002654|Trace Elements|trace elements|mesh-ancestor
2659503|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2659504|NCT02097394|Pancreatin|pancreatin|mesh-list
2659505|NCT02097394|Pancrelipase|pancrelipase|mesh-list
2659506|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2182328|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
2182329|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182330|NCT00002656|NSC 366140|nsc 366140|mesh-list
2182331|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182332|NCT00002657|Interferons|interferons|mesh-list
2182333|NCT00002657|Cytarabine|cytarabine|mesh-list
2182334|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
2182335|NCT00002657|Prednisone|prednisone|mesh-list
2182336|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
2659507|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
2659508|NCT02097407|Propofol|propofol|mesh-list
2659509|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2659510|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2659511|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659512|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2659513|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
2659514|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
2659515|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2659516|NCT02097407|Analgesics|analgesics|mesh-ancestor
2659517|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
2659518|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659519|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2659520|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2659521|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2659522|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
2659523|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659524|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659525|NCT02097459|Tamoxifen|tamoxifen|mesh-list
2659526|NCT02097459|Toremifene|toremifene|mesh-list
2659527|NCT02097459|Anastrozole|anastrozole|mesh-list
2659528|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2659529|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
2659530|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2659531|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659532|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2659533|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659534|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2659535|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2659536|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2659537|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2659538|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2659539|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659540|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659541|NCT02097511|Metoprolol|metoprolol|mesh-list
2659542|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
2659543|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2659544|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2659545|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
2659546|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
2659547|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659548|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659549|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2659550|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2659551|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2659552|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
2659553|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659554|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659555|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2659556|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2659557|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2659558|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2659559|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
2659560|NCT02097589|Atorvastatin|atorvastatin|mesh-list
2659561|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2659562|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
2659563|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659564|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2659565|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2659566|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
2659567|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659568|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2668610|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2182337|NCT00002657|Doxorubicin|doxorubicin|mesh-list
2182338|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2182339|NCT00002657|Methotrexate|methotrexate|mesh-list
2182340|NCT00002657|Etoposide|etoposide|mesh-list
2659569|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2659570|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659571|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
2659572|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2659573|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2659574|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659575|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
2659576|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
2182341|NCT00002657|Vincristine|vincristine|mesh-list
2182342|NCT00002657|Bleomycin|bleomycin|mesh-list
2182343|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182344|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
2182345|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659587|NCT02097810|Entrectinib|entrectinib|mesh-list
2659588|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2659589|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659590|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659591|NCT02097953|Rifampin|rifampin|mesh-list
2659592|NCT02097953|Daptomycin|daptomycin|mesh-list
2659593|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2659594|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
2659595|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2182346|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182347|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182348|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
2182349|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182350|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182351|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182352|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2659596|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659597|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
2659598|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2659599|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659600|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659601|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2659602|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2659603|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2659604|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2659605|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2659606|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2659607|NCT02097966|Ribavirin|ribavirin|mesh-list
2182353|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182354|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182355|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182356|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2182357|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
2182358|NCT00002657|Hormones|hormones|mesh-ancestor
2182359|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182360|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2659608|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
2659609|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
2659610|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659611|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
2659612|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659613|NCT02098148|Xenon|xenon|mesh-list
2659614|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2659615|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
2659616|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
2182361|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2182362|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
2182363|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2182364|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182365|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
2659617|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2659618|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659619|NCT02098317|Vitamin D|vitamin d|mesh-list
2659620|NCT02098317|Vitamins|vitamins|mesh-ancestor
2659621|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
2659622|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659623|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2659624|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
2659625|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2659626|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2659627|NCT02098330|Prednisolone|prednisolone|mesh-list
2659628|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
2659629|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2659630|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
2182366|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
2182367|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2182368|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2182369|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182370|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
2659631|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2659632|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
2659633|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
2659634|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659635|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659636|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2659637|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
2659638|NCT02098330|Hormones|hormones|mesh-ancestor
2659639|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2659640|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2659641|NCT02098330|Protective Agents|protective agents|mesh-ancestor
2659642|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2659643|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659644|NCT02098343|Carboplatin|carboplatin|mesh-list
2659645|NCT02098343|Doxorubicin|doxorubicin|mesh-list
2659646|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2659647|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659648|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2659649|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2659650|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182371|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182372|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
2182373|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
2182374|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182375|NCT00002658|Cytarabine|cytarabine|mesh-list
2182376|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
2182377|NCT00002658|Etoposide|etoposide|mesh-list
2182378|NCT00002658|Daunorubicin|daunorubicin|mesh-list
2182379|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
2182380|NCT00002658|Idarubicin|idarubicin|mesh-list
2182381|NCT00002658|Tretinoin|tretinoin|mesh-list
2182382|NCT00002658|Thioguanine|thioguanine|mesh-list
2182383|NCT00002658|Amsacrine|amsacrine|mesh-list
2182384|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182385|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
2182386|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182387|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182388|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182389|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
2182390|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182391|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182392|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182393|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182394|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182395|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182396|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182397|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182398|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
2182399|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
2182400|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182401|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2182402|NCT00002658|Analgesics|analgesics|mesh-ancestor
2182403|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
2182404|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2182405|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
2182406|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
2182407|NCT00002659|Cisplatin|cisplatin|mesh-list
2659651|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659652|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659653|NCT02098421|Oxytocin|oxytocin|mesh-list
2659654|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
2659655|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2659656|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659657|NCT02098460|Cilostazol|cilostazol|mesh-list
2659658|NCT02098460|Atorvastatin|atorvastatin|mesh-list
2659659|NCT02098460|Probucol|probucol|mesh-list
2659660|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2659661|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2659662|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
2659663|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659664|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2659665|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2659666|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659667|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2659668|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
2659669|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659670|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659671|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2659672|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
2659673|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2659674|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2659675|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2659676|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
2659677|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2659678|NCT02098460|Protective Agents|protective agents|mesh-ancestor
2659679|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2659680|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2659681|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
2182408|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182409|NCT00002662|Paclitaxel|paclitaxel|mesh-list
2182410|NCT00002662|Docetaxel|docetaxel|mesh-list
2182411|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182412|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182413|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
2182414|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
2182415|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182416|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182417|NCT00002664|Sargramostim|sargramostim|mesh-list
2182418|NCT00002664|Edrecolomab|edrecolomab|mesh-list
2182419|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
2182420|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659682|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
2659683|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
2659684|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2659685|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659686|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2659687|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2659688|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659689|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659690|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659691|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
2659692|NCT02098499|Promethazine|promethazine|mesh-list
2659693|NCT02098499|Haloperidol|haloperidol|mesh-list
2659694|NCT02098499|Metoclopramide|metoclopramide|mesh-list
2659695|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
2659696|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2659697|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2659698|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2659699|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659700|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
2659701|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
2659702|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
2659703|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659704|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
2659705|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
2659706|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2659707|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2659708|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
2659709|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
2659710|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659711|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659712|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2659713|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
2659714|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
2182421|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2659715|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2182422|NCT00002665|Leucovorin|leucovorin|mesh-list
2659716|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2659717|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2659718|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2659719|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
2659720|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2659721|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2659722|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2659723|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2659724|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659725|NCT02098590|Chloroquine|chloroquine|mesh-list
2659726|NCT02098590|Atovaquone|atovaquone|mesh-list
2659727|NCT02098590|Proguanil|proguanil|mesh-list
2659728|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2659729|NCT02098590|Vaccines|vaccines|mesh-list
2659730|NCT02098590|Amebicides|amebicides|mesh-ancestor
2659731|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2659732|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2659733|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659734|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
2659735|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2659736|NCT02098590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659737|NCT02098590|Immunologic Factors|immunologic factors|mesh-ancestor
2659738|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659739|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659740|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
2659741|NCT02098616|Asunaprevir|asunaprevir|mesh-list
2659742|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
2659743|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659744|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659745|NCT02098629|Milrinone|milrinone|mesh-list
2659746|NCT02098629|Esmolol|esmolol|mesh-list
2659747|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2659748|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2659749|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2659750|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
2659751|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659752|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659753|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659754|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2659755|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2659756|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
2659757|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2659758|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2659759|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659760|NCT02098629|Protective Agents|protective agents|mesh-ancestor
2659761|NCT02098785|Caffeine|caffeine|mesh-list
2659762|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
2659763|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659764|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2659765|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659766|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2659767|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659768|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2659769|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2182423|NCT00002665|Cytarabine|cytarabine|mesh-list
2182424|NCT00002665|Dexamethasone|dexamethasone|mesh-list
2659770|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
2659771|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659772|NCT02098824|Methylphenidate|methylphenidate|mesh-list
2659773|NCT02098824|Galantamine|galantamine|mesh-list
2659774|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2659775|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659776|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2659777|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2659778|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2659779|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659780|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
2182425|NCT00002665|Prednisone|prednisone|mesh-list
2182426|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
2182427|NCT00002665|Doxorubicin|doxorubicin|mesh-list
2182428|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2182429|NCT00002665|Methotrexate|methotrexate|mesh-list
2182430|NCT00002665|Etoposide|etoposide|mesh-list
2182431|NCT00002665|Vincristine|vincristine|mesh-list
2182432|NCT00002665|Daunorubicin|daunorubicin|mesh-list
2182433|NCT00002665|Asparaginase|asparaginase|mesh-list
2659781|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659782|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2659783|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659784|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
2659785|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2659786|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
2659787|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659788|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
2659789|NCT02098837|Dolutegravir|dolutegravir|mesh-list
2659790|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2659791|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2659792|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659793|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659794|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2659795|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2659796|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
2659797|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659803|NCT02098889|Scopolamine|scopolamine|mesh-list
2659804|NCT02098889|Bromides|bromides|mesh-list
2659805|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2182434|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
2182435|NCT00002665|Thioguanine|thioguanine|mesh-list
2182436|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
2182437|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182438|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
2182439|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182440|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182441|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182442|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
2182443|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182444|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182445|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182446|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2182447|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
2182448|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
2182449|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2182450|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2182451|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
2182452|NCT00002665|Hormones|hormones|mesh-ancestor
2182453|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182454|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2182455|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2182456|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182457|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182458|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182459|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2182460|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
2182461|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2182462|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182463|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
2182464|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
2182465|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2659806|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
2659807|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2659808|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
2659809|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
2659810|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659811|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182466|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2182467|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182468|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
2182469|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182470|NCT00002665|Antidotes|antidotes|mesh-ancestor
2182471|NCT00002665|Protective Agents|protective agents|mesh-ancestor
2182472|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
2182473|NCT00002665|Vitamins|vitamins|mesh-ancestor
2182474|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
2182475|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
2182476|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
2182477|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182478|NCT00002669|Interferons|interferons|mesh-list
2659812|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2659813|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
2659814|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2659815|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
2659816|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659817|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659818|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2659819|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
2659820|NCT02098915|Metoclopramide|metoclopramide|mesh-list
2659821|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
2659822|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
2659823|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659824|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659825|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2659826|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2659827|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2659828|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
2659829|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2659830|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659831|NCT02098954|Gemcitabine|gemcitabine|mesh-list
2659832|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2659833|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2659834|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
2659835|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659836|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659837|NCT02098954|Antiviral Agents|antiviral agents|mesh-ancestor
2659838|NCT02098954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2659839|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659840|NCT02098954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2659841|NCT02098954|Immunologic Factors|immunologic factors|mesh-ancestor
2659842|NCT02098954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659843|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2659844|NCT02098980|Vitamin D|vitamin d|mesh-list
2659845|NCT02098980|Vitamins|vitamins|mesh-ancestor
2659846|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
2659847|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659848|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2182479|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
2182480|NCT00002669|Aldesleukin|aldesleukin|mesh-list
2182481|NCT00002669|Dacarbazine|dacarbazine|mesh-list
2182482|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182483|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
2182484|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182485|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
2659861|NCT02099123|Atorvastatin|atorvastatin|mesh-list
2659862|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2659863|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2659864|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
2659865|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659866|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2659867|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2659868|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659869|NCT02099136|Celecoxib|celecoxib|mesh-list
2659870|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2659871|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2659872|NCT02099136|Analgesics|analgesics|mesh-ancestor
2659873|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
2659874|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2659875|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659876|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2659877|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2659878|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2659879|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2659880|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182486|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659881|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659882|NCT02099175|Leucovorin|leucovorin|mesh-list
2659883|NCT02099175|Docetaxel|docetaxel|mesh-list
2659884|NCT02099175|Fluorouracil|fluorouracil|mesh-list
2659885|NCT02099175|Etoposide|etoposide|mesh-list
2659886|NCT02099175|Doxorubicin|doxorubicin|mesh-list
2659887|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2659888|NCT02099175|Ifosfamide|ifosfamide|mesh-list
2659889|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659890|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
2659891|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
2659892|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
2659893|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659894|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
2659895|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2659896|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2659897|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
2659898|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659899|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2659900|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2659901|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2659902|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659903|NCT02099175|Antidotes|antidotes|mesh-ancestor
2659904|NCT02099175|Protective Agents|protective agents|mesh-ancestor
2659905|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
2659906|NCT02099175|Vitamins|vitamins|mesh-ancestor
2659907|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
2659908|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2659909|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2659910|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
2659911|NCT02099188|Leucovorin|leucovorin|mesh-list
2659912|NCT02099188|Docetaxel|docetaxel|mesh-list
2659913|NCT02099188|Fluorouracil|fluorouracil|mesh-list
2659914|NCT02099188|Etoposide|etoposide|mesh-list
2659915|NCT02099188|Doxorubicin|doxorubicin|mesh-list
2659916|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2659917|NCT02099188|Ifosfamide|ifosfamide|mesh-list
2659918|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2659919|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
2659920|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
2659921|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
2659922|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659923|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
2659924|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2659925|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2659926|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
2659927|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2659928|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2659929|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2659930|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2659931|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2659932|NCT02099188|Antidotes|antidotes|mesh-ancestor
2659933|NCT02099188|Protective Agents|protective agents|mesh-ancestor
2659934|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
2659935|NCT02099188|Vitamins|vitamins|mesh-ancestor
2659936|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
2659937|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2659938|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2659939|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
2659940|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2659941|NCT02099240|Amoxicillin|amoxicillin|mesh-list
2659942|NCT02099240|Azithromycin|azithromycin|mesh-list
2659943|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
2659944|NCT02099240|Vancomycin|vancomycin|mesh-list
2659945|NCT02099240|Clarithromycin|clarithromycin|mesh-list
2659946|NCT02099240|Doxycycline|doxycycline|mesh-list
2659947|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
2659948|NCT02099240|Levofloxacin|levofloxacin|mesh-list
2659949|NCT02099240|Ofloxacin|ofloxacin|mesh-list
2659950|NCT02099240|Minocycline|minocycline|mesh-list
2659951|NCT02099240|Rifampin|rifampin|mesh-list
2659952|NCT02099240|Clindamycin|clindamycin|mesh-list
2659953|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
2659954|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
2659955|NCT02099240|Gentamicins|gentamicins|mesh-list
2659956|NCT02099240|Isoniazid|isoniazid|mesh-list
2659957|NCT02099240|Meropenem|meropenem|mesh-list
2659958|NCT02099240|Tazobactam|tazobactam|mesh-list
2659959|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
2659960|NCT02099240|Cycloserine|cycloserine|mesh-list
2659961|NCT02099240|Linezolid|linezolid|mesh-list
2659962|NCT02099240|Piperacillin|piperacillin|mesh-list
2659963|NCT02099240|Metronidazole|metronidazole|mesh-list
2659964|NCT02099240|Imipenem|imipenem|mesh-list
2659965|NCT02099240|Penicillins|penicillins|mesh-list
2659966|NCT02099240|Erythromycin|erythromycin|mesh-list
2659967|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
2659968|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2659969|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
2182487|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2182488|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2182489|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182490|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
2182491|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182492|NCT00002670|Cobalt|cobalt|mesh-list
2182493|NCT00002670|Trace Elements|trace elements|mesh-ancestor
2182494|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
2182495|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182496|NCT00002674|Cytarabine|cytarabine|mesh-list
2182497|NCT00002674|Etoposide|etoposide|mesh-list
2182498|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
2182499|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
2182500|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182501|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182502|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182503|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182504|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182505|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2659970|NCT02099240|Amikacin|amikacin|mesh-list
2659971|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
2659972|NCT02099240|Ceftazidime|ceftazidime|mesh-list
2659973|NCT02099240|Colistin|colistin|mesh-list
2659974|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2659975|NCT02099240|Rifabutin|rifabutin|mesh-list
2659976|NCT02099240|Ampicillin|ampicillin|mesh-list
2659977|NCT02099240|Mupirocin|mupirocin|mesh-list
2659978|NCT02099240|Rifapentine|rifapentine|mesh-list
2659979|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
2659980|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
2659981|NCT02099240|Cefepime|cefepime|mesh-list
2659982|NCT02099240|Cefuroxime|cefuroxime|mesh-list
2659983|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
2659984|NCT02099240|Fosfomycin|fosfomycin|mesh-list
2659985|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2659986|NCT02099240|Paromomycin|paromomycin|mesh-list
2659987|NCT02099240|Polymyxins|polymyxins|mesh-list
2659988|NCT02099240|Aztreonam|aztreonam|mesh-list
2659989|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
2659990|NCT02099240|Bacitracin|bacitracin|mesh-list
2659991|NCT02099240|Neomycin|neomycin|mesh-list
2659992|NCT02099240|Sulbactam|sulbactam|mesh-list
2659993|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
2659994|NCT02099240|Cefotaxime|cefotaxime|mesh-list
2659995|NCT02099240|Cefoxitin|cefoxitin|mesh-list
2659996|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
2659997|NCT02099240|Polymyxin B|polymyxin b|mesh-list
2659998|NCT02099240|Cefixime|cefixime|mesh-list
2659999|NCT02099240|Cefdinir|cefdinir|mesh-list
2660000|NCT02099240|Penicillin G|penicillin g|mesh-list
2660001|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2660002|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
2660003|NCT02099240|Cloxacillin|cloxacillin|mesh-list
2660004|NCT02099240|Norfloxacin|norfloxacin|mesh-list
2660005|NCT02099240|Cefprozil|cefprozil|mesh-list
2660006|NCT02099240|Cephalosporins|cephalosporins|mesh-list
2660007|NCT02099240|Streptomycin|streptomycin|mesh-list
2660008|NCT02099240|Oxacillin|oxacillin|mesh-list
2660009|NCT02099240|Nafcillin|nafcillin|mesh-list
2660010|NCT02099240|Ticarcillin|ticarcillin|mesh-list
2660011|NCT02099240|Kanamycin|kanamycin|mesh-list
2660012|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
2660013|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
2660014|NCT02099240|Sultamicillin|sultamicillin|mesh-list
2660015|NCT02099240|Penicillin V|penicillin v|mesh-list
2660016|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
2660017|NCT02099240|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
2660018|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
2660019|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
2660020|NCT02099240|Cefoperazone|cefoperazone|mesh-list
2660021|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
2660022|NCT02099240|Lincomycin|lincomycin|mesh-list
2660023|NCT02099240|Demeclocycline|demeclocycline|mesh-list
2660024|NCT02099240|Ethionamide|ethionamide|mesh-list
2660025|NCT02099240|Cefotetan|cefotetan|mesh-list
2660026|NCT02099240|Dirithromycin|dirithromycin|mesh-list
2660027|NCT02099240|Ceftibuten|ceftibuten|mesh-list
2660028|NCT02099240|Capreomycin|capreomycin|mesh-list
2660029|NCT02099240|Cefaclor|cefaclor|mesh-list
2660030|NCT02099240|Mafenide|mafenide|mesh-list
2660031|NCT02099240|Tobramycin|tobramycin|mesh-list
2660032|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
2660033|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
2660034|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
2660035|NCT02099240|Netilmicin|netilmicin|mesh-list
2660036|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
2660037|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
2660038|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
2660039|NCT02099240|Virginiamycin|virginiamycin|mesh-list
2660040|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2660041|NCT02099240|Enoxacin|enoxacin|mesh-list
2660042|NCT02099240|Methicillin|methicillin|mesh-list
2660043|NCT02099240|Bacampicillin|bacampicillin|mesh-list
2660044|NCT02099240|Carbenicillin|carbenicillin|mesh-list
2660045|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
2660046|NCT02099240|Mezlocillin|mezlocillin|mesh-list
2660047|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
2660048|NCT02099240|Cefamandole|cefamandole|mesh-list
2660049|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
2660050|NCT02099240|Cefonicid|cefonicid|mesh-list
2660051|NCT02099240|Cefmetazole|cefmetazole|mesh-list
2660052|NCT02099240|Loracarbef|loracarbef|mesh-list
2660053|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
2660054|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
2660055|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
2660056|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
2660057|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
2660058|NCT02099240|Methacycline|methacycline|mesh-list
2660059|NCT02099240|Tetracycline|tetracycline|mesh-list
2660060|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
2660061|NCT02099240|Dalfopristin|dalfopristin|mesh-list
2660062|NCT02099240|Novobiocin|novobiocin|mesh-list
2660063|NCT02099240|Spectinomycin|spectinomycin|mesh-list
2182506|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
2182507|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182508|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182509|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
2182510|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
2182511|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182512|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182513|NCT00002674|Analgesics|analgesics|mesh-ancestor
2182514|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
2182515|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2182516|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
2182517|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2182518|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
2182519|NCT00002675|Carboplatin|carboplatin|mesh-list
2182520|NCT00002675|Etoposide|etoposide|mesh-list
2182521|NCT00002675|Vincristine|vincristine|mesh-list
2182522|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182523|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
2182524|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182525|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182526|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182527|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
2182528|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660064|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2660065|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
2660066|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
2660067|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2660068|NCT02099240|Methenamine|methenamine|mesh-list
2660069|NCT02099240|Sulperazone|sulperazone|mesh-list
2660070|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
2660071|NCT02099240|Cinoxacin|cinoxacin|mesh-list
2660072|NCT02099240|Trimethoprim|trimethoprim|mesh-list
2660073|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
2660074|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
2660075|NCT02099240|Procaine|procaine|mesh-list
2660076|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2182529|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182530|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182531|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182532|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182533|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182534|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182535|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
2660077|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2660078|NCT02099240|Cilastatin|cilastatin|mesh-list
2660079|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2660080|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
2660081|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182536|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
2660082|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2660083|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660084|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660085|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182537|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182538|NCT00002676|Cobalt|cobalt|mesh-list
2182539|NCT00002676|Cytarabine|cytarabine|mesh-list
2182540|NCT00002676|Dexamethasone|dexamethasone|mesh-list
2660086|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2660087|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
2660088|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2660089|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660090|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2660091|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2660092|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2660093|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2660094|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2660095|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2660096|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
2660097|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2660098|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2660099|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2660100|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2660101|NCT02099240|Renal Agents|renal agents|mesh-ancestor
2660102|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
2660103|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2660104|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2660105|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2660106|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2660107|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2660108|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2660109|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2660110|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2660111|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2660112|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
2660113|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2660114|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2660115|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2660116|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2660117|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2660118|NCT02099240|Analgesics|analgesics|mesh-ancestor
2660119|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
2660120|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660121|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2660122|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2660123|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
2660124|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2660125|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2660126|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2660127|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
2660128|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
2660129|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
2660130|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2660131|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2660132|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2660133|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2660134|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2660135|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
2660136|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
2660137|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2660138|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2660139|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660140|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2182541|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
2182542|NCT00002676|Carmustine|carmustine|mesh-list
2182543|NCT00002676|Doxorubicin|doxorubicin|mesh-list
2182544|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2182545|NCT00002676|Methotrexate|methotrexate|mesh-list
2182546|NCT00002676|Vincristine|vincristine|mesh-list
2182547|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182548|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
2182549|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182550|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182551|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2660141|NCT02099253|Analgesics|analgesics|mesh-ancestor
2660142|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
2660143|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660144|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2182552|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
2182553|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182554|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182555|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182556|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2182557|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
2182558|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
2182559|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2182560|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2182561|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
2182562|NCT00002676|Hormones|hormones|mesh-ancestor
2182563|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182564|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2182565|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2182566|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182567|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182568|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182569|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2182570|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
2182571|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2660145|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2660146|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2660147|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
2660148|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660149|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660150|NCT02099292|Rituximab|rituximab|mesh-list
2660151|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2660152|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660153|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
2660154|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660155|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2660156|NCT02099331|Melatonin|melatonin|mesh-list
2660157|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
2660158|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660159|NCT02099331|Protective Agents|protective agents|mesh-ancestor
2660160|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660161|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2660162|NCT02099357|Vitamin D|vitamin d|mesh-list
2660163|NCT02099357|Vitamins|vitamins|mesh-ancestor
2660164|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
2660165|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660166|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2660167|NCT02099396|Gemcitabine|gemcitabine|mesh-list
2660168|NCT02099396|Docetaxel|docetaxel|mesh-list
2660169|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2660170|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
2660171|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660172|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660173|NCT02099396|Antiviral Agents|antiviral agents|mesh-ancestor
2660174|NCT02099396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2660175|NCT02099396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660176|NCT02099396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2660177|NCT02099396|Immunologic Factors|immunologic factors|mesh-ancestor
2660178|NCT02099396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660179|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
2660180|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
2660181|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
2660182|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
2660183|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2660184|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2660185|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
2182572|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182573|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
2182574|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
2182575|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2182576|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2182577|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
2182578|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182579|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182580|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
2182581|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
2182582|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182583|NCT00002676|Trace Elements|trace elements|mesh-ancestor
2660186|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2660187|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2660188|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2660189|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660190|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660191|NCT02099604|Vitamin D|vitamin d|mesh-list
2182584|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
2182585|NCT00002678|Dexamethasone|dexamethasone|mesh-list
2182586|NCT00002678|Prednisone|prednisone|mesh-list
2182587|NCT00002678|Melphalan|melphalan|mesh-list
2182588|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2182589|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
2182590|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
2182591|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2182592|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182593|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2182594|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
2182595|NCT00002678|Hormones|hormones|mesh-ancestor
2182596|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182597|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2182598|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182599|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182600|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
2182601|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660192|NCT02099604|Interferons|interferons|mesh-list
2660193|NCT02099604|Ribavirin|ribavirin|mesh-list
2660194|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
2660195|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
2660196|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2660197|NCT02099604|Vitamins|vitamins|mesh-ancestor
2660198|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
2660199|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660200|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2660201|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660202|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
2660203|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2660204|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
2660205|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660206|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
2660207|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
2660208|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2660209|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2660210|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
2660211|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660212|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660213|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660214|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
2660215|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
2660216|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660217|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
2660218|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2660219|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
2660220|NCT02099695|Oxybutynin|oxybutynin|mesh-list
2660221|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
2660222|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
2660223|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660224|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660225|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2660226|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2660227|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
2660228|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660229|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660230|NCT02099695|Urological Agents|urological agents|mesh-ancestor
2660231|NCT02099825|Cycloserine|cycloserine|mesh-list
2660232|NCT02099825|Mifepristone|mifepristone|mesh-list
2660233|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2660234|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
2660235|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2660236|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660237|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2660238|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2660239|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2660240|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
2660241|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2660242|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2660243|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
2660244|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182602|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2660245|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
2660246|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2660247|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2660248|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2660249|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2660250|NCT02099825|Renal Agents|renal agents|mesh-ancestor
2660251|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2660252|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
2660253|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2660254|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
2660255|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660256|NCT02099877|Fentanyl|fentanyl|mesh-list
2660257|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2660258|NCT02099877|Narcotics|narcotics|mesh-ancestor
2660259|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2660260|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660261|NCT02099877|Analgesics|analgesics|mesh-ancestor
2660262|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
2660263|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660264|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2182603|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182604|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
2182605|NCT00002679|Tamoxifen|tamoxifen|mesh-list
2182606|NCT00002679|Paclitaxel|paclitaxel|mesh-list
2182607|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
2182608|NCT00002679|Doxorubicin|doxorubicin|mesh-list
2182609|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2182610|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182611|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182612|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
2182613|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
2182614|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182615|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182616|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182617|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
2182618|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182619|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182620|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2660265|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2660266|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
2660267|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
2660268|NCT02099890|Curcumin|curcumin|mesh-list
2660269|NCT02099890|Antioxidants|antioxidants|mesh-list
2660270|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2660271|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2660272|NCT02099890|Analgesics|analgesics|mesh-ancestor
2660273|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
2182621|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
2182622|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182623|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2182624|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2660274|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660275|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660276|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2660277|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2660278|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660279|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660280|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660281|NCT02099890|Protective Agents|protective agents|mesh-ancestor
2660282|NCT02099916|Menotropins|menotropins|mesh-list
2660283|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660284|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2660285|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
2660286|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2660287|NCT02099955|Vitamin D|vitamin d|mesh-list
2660288|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
2660289|NCT02099955|Vitamins|vitamins|mesh-ancestor
2660290|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
2660291|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660292|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2660293|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2660294|NCT02099981|Pimagedine|pimagedine|mesh-list
2660295|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660296|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182625|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2660297|NCT02100046|Ethosuximide|ethosuximide|mesh-list
2660298|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
2660299|NCT02100176|Dopamine|dopamine|mesh-list
2660300|NCT02100176|Rotigotine|rotigotine|mesh-list
2660301|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
2660302|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
2660303|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660304|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660305|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660306|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2660307|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
2660308|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
2660309|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660310|NCT02100176|Protective Agents|protective agents|mesh-ancestor
2660311|NCT02100202|Turmeric extract|turmeric extract|mesh-list
2660312|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
2660313|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660314|NCT02100202|Protective Agents|protective agents|mesh-ancestor
2660315|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660316|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
2660317|NCT02100267|Miotics|miotics|mesh-ancestor
2660318|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
2660319|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2182626|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182627|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2182628|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
2182629|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182630|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2182631|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2182632|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2182633|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2182634|NCT00002680|Tamoxifen|tamoxifen|mesh-list
2182635|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
2182636|NCT00002680|Melphalan|melphalan|mesh-list
2182637|NCT00002680|Thiotepa|thiotepa|mesh-list
2660320|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660321|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2660322|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2660323|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
2660324|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2660325|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2660326|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
2660327|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660328|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182638|NCT00002680|Megestrol|megestrol|mesh-list
2182639|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
2182640|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182641|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
2182642|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660329|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
2660330|NCT02100293|Analgesics|analgesics|mesh-ancestor
2660331|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
2660332|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660333|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660334|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
2660335|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2660336|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2660337|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
2660338|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2660339|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2660340|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660341|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2660342|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
2660343|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2660344|NCT02100423|Vitamin D|vitamin d|mesh-list
2660345|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
2660346|NCT02100423|Curcumin|curcumin|mesh-list
2660347|NCT02100423|Vitamins|vitamins|mesh-ancestor
2660348|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
2182643|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2422805|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2422806|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2422807|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422808|NCT00818844|Nepafenac|nepafenac|mesh-list
2422809|NCT00818844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2422810|NCT00818844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2422811|NCT00818844|Analgesics|analgesics|mesh-ancestor
2422812|NCT00818844|Sensory System Agents|sensory system agents|mesh-ancestor
2660349|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660350|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2660351|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2660352|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2660353|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2660354|NCT02100423|Analgesics|analgesics|mesh-ancestor
2660355|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
2660356|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660357|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2660358|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2660359|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660360|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660361|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660362|NCT02100462|Aspirin|aspirin|mesh-list
2660363|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2660364|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
2660365|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2660366|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2660367|NCT02100462|Analgesics|analgesics|mesh-ancestor
2660368|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
2660369|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660370|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660371|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2660372|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2660373|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2660374|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2660375|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660376|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2660377|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2660378|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660379|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
2660380|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2660381|NCT02100462|Diuretics|diuretics|mesh-ancestor
2660382|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
2660383|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2660384|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2660385|NCT02100488|Insulin|insulin|mesh-list
2660386|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2660387|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2660388|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660389|NCT02100553|Itraconazole|itraconazole|mesh-list
2660390|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
2660391|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
2182644|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182645|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
2182646|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182647|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182648|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2660392|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2660393|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2660394|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2660395|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660396|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660397|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2660398|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
2660399|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2660400|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660401|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2660402|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
2182649|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2182650|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
2182651|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182652|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2182653|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2182654|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2182655|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2182656|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2182657|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2660403|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
2660404|NCT02100605|Ephedrine|ephedrine|mesh-list
2660405|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2660406|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
2660407|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2660408|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660409|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
2660410|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
2660411|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660412|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
2660413|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660414|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660415|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2660416|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2660417|NCT02100761|Voriconazole|voriconazole|mesh-list
2660418|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
2660419|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2660420|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2660421|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2182658|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2182659|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
2182660|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2182661|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2182662|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2660422|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660423|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660424|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2660425|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
2660426|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2660427|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660428|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2660429|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2660430|NCT02100787|Laxatives|laxatives|mesh-ancestor
2660431|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2660432|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
2660433|NCT02100852|Chlorambucil|chlorambucil|mesh-list
2660434|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2660435|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660436|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2660437|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
2660438|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660439|NCT02100917|Trastuzumab|trastuzumab|mesh-list
2660440|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2660441|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660442|NCT02101047|Phenylephrine|phenylephrine|mesh-list
2660443|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
2660444|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2660445|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
2660446|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
2660447|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660448|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660449|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
2660450|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2660451|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
2660452|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
2660453|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2660454|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2660455|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2660456|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
2660457|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660458|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660459|NCT02101047|Protective Agents|protective agents|mesh-ancestor
2660460|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2660461|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2660462|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2660463|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
2660464|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660465|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2660466|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2660467|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660468|NCT02101138|Pramipexole|pramipexole|mesh-list
2660469|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
2660470|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660471|NCT02101138|Protective Agents|protective agents|mesh-ancestor
2660472|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182663|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
2182664|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2182665|NCT00002681|Aldesleukin|aldesleukin|mesh-list
2182666|NCT00002681|Daclizumab|daclizumab|mesh-list
2182667|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182668|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2182669|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2182670|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
2182671|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182672|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182673|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
2182674|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182675|NCT00002682|Amoxicillin|amoxicillin|mesh-list
2182676|NCT00002682|Metronidazole|metronidazole|mesh-list
2182677|NCT00002682|Clarithromycin|clarithromycin|mesh-list
2182678|NCT00002682|Tetracycline|tetracycline|mesh-list
2182679|NCT00002682|Omeprazole|omeprazole|mesh-list
2182680|NCT00002682|Bismuth|bismuth|mesh-list
2182681|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2182682|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2660473|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2660474|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2660475|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
2660476|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
2660477|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660478|NCT02101151|Vitamin D|vitamin d|mesh-list
2660479|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
2660480|NCT02101151|Vitamins|vitamins|mesh-ancestor
2660481|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
2660482|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660483|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2660484|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2660485|NCT02101164|Denosumab|denosumab|mesh-list
2660486|NCT02101164|Pamidronate|pamidronate|mesh-list
2660487|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2660488|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660489|NCT02101203|Buspirone|buspirone|mesh-list
2660490|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2660491|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2660492|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2660493|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660494|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2660495|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2660496|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
2660497|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660498|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660499|NCT02101216|Abacavir|abacavir|mesh-list
2660500|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
2660501|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2660502|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2660503|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660504|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660505|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
2660506|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2660507|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2660508|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2660509|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
2660510|NCT02101229|Insulin|insulin|mesh-list
2660511|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2660512|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2660513|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660514|NCT02101255|Fluorides|fluorides|mesh-list
2660515|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
2660516|NCT02101255|Protective Agents|protective agents|mesh-ancestor
2660517|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660518|NCT02101268|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2660519|NCT02101268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2660520|NCT02101268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660521|NCT02101268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660522|NCT02101476|Acetaminophen|acetaminophen|mesh-list
2660523|NCT02101476|Oxycodone|oxycodone|mesh-list
2660524|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2660525|NCT02101476|Analgesics|analgesics|mesh-ancestor
2660526|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
2182683|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182684|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2182685|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2182686|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2660527|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660528|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660529|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
2660530|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2660531|NCT02101476|Narcotics|narcotics|mesh-ancestor
2660532|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2660533|NCT02101567|Oxytocin|oxytocin|mesh-list
2660534|NCT02101567|Carbetocin|carbetocin|mesh-list
2660535|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
2660536|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2660537|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660538|NCT02101606|Tenecteplase|tenecteplase|mesh-list
2660539|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2660540|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2660541|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660542|NCT02101632|Petrolatum|petrolatum|mesh-list
2660543|NCT02101632|Emollients|emollients|mesh-ancestor
2660544|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
2660545|NCT02101710|Isosorbide|isosorbide|mesh-list
2660546|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2660547|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2660548|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2660549|NCT02101710|Diuretics|diuretics|mesh-ancestor
2660550|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
2660551|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660552|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
2660553|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2660554|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660555|NCT02101840|Oxycodone|oxycodone|mesh-list
2660556|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2660557|NCT02101840|Narcotics|narcotics|mesh-ancestor
2660558|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2660559|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660560|NCT02101840|Analgesics|analgesics|mesh-ancestor
2660561|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
2182687|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2182688|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2182689|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182690|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182691|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2660562|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422813|NCT00818844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422814|NCT00818844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422815|NCT00818844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2422816|NCT00818844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2422817|NCT00818870|Omeprazole|omeprazole|mesh-list
2422818|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2422819|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2422820|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2422821|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422822|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422823|NCT00819000|Interferon-beta|interferon-beta|mesh-list
2422824|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
2422825|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
2422826|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
2422827|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2422828|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
2422829|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422830|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182692|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2182693|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2182694|NCT00002682|Antacids|antacids|mesh-ancestor
2182695|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
2182696|NCT00002684|Paclitaxel|paclitaxel|mesh-list
2182697|NCT00002684|Ifosfamide|ifosfamide|mesh-list
2182698|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182699|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182700|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
2182701|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
2182702|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182703|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182704|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182705|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
2182706|NCT00002687|Aldesleukin|aldesleukin|mesh-list
2182707|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182708|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2182709|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2182710|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
2182711|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182712|NCT00002688|Cyclosporine|cyclosporine|mesh-list
2182713|NCT00002688|Etoposide|etoposide|mesh-list
2182714|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
2182715|NCT00002688|Cyclosporins|cyclosporins|mesh-list
2182716|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182717|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182718|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182719|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182720|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182721|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182722|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182723|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
2422831|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2660642|NCT02101892|Amitriptyline|amitriptyline|mesh-list
2660643|NCT02101892|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2660644|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2660645|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
2660646|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2660647|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2660648|NCT02101892|Analgesics|analgesics|mesh-ancestor
2660649|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
2660650|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660651|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660652|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2660653|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2660654|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2660655|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660656|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
2660657|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660658|NCT02101892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2660659|NCT02101892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2660660|NCT02101892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2660661|NCT02101905|Lapatinib|lapatinib|mesh-list
2660662|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660663|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2660664|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660665|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660666|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2660667|NCT02101931|Levulinic acid|levulinic acid|mesh-list
2660668|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2660669|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
2660670|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660671|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660672|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2660673|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2660674|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2660675|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
2660676|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660677|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660678|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2660679|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2660680|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
2660681|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182724|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182725|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
2660696|NCT02102139|Propofol|propofol|mesh-list
2660697|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2660698|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2660699|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660700|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2182726|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182727|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
2660701|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
2660702|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
2660703|NCT02102152|Tobramycin|tobramycin|mesh-list
2660704|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2660705|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2660706|NCT02102243|Insulin|insulin|mesh-list
2660707|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2660708|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2660709|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660710|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
2660711|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
2660712|NCT02102295|Fluorides|fluorides|mesh-list
2182728|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182729|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2182730|NCT00002688|Analgesics|analgesics|mesh-ancestor
2182731|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
2182732|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2182733|NCT00002689|Dexamethasone|dexamethasone|mesh-list
2182734|NCT00002689|Fluorouracil|fluorouracil|mesh-list
2182735|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2182736|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
2182737|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
2182738|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2182739|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182740|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2182741|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
2182742|NCT00002689|Hormones|hormones|mesh-ancestor
2660713|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
2660714|NCT02102295|Protective Agents|protective agents|mesh-ancestor
2660715|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660716|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
2660717|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660718|NCT02102295|Vitamins|vitamins|mesh-ancestor
2660719|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
2660720|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660721|NCT02102321|Albendazole|albendazole|mesh-list
2660722|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
2660723|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2660724|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2660725|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
2660726|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2660727|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2660728|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
2660729|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
2660730|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
2660731|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660732|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660733|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2660734|NCT02102373|Laxatives|laxatives|mesh-ancestor
2660735|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2660736|NCT02102438|Paclitaxel|paclitaxel|mesh-list
2660737|NCT02102438|Carboplatin|carboplatin|mesh-list
2660738|NCT02102438|Trastuzumab|trastuzumab|mesh-list
2660739|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182743|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182744|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2182745|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182746|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
2182747|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182748|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182749|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2660740|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660741|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
2660742|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
2660743|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
2660744|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660745|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2660746|NCT02102477|Androgens|androgens|mesh-list
2660747|NCT02102477|Hormones|hormones|mesh-ancestor
2660748|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2660749|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660750|NCT02102516|Ketorolac|ketorolac|mesh-list
2660751|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2660752|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2660753|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2660754|NCT02102516|Analgesics|analgesics|mesh-ancestor
2660755|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
2660756|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2182750|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
2182751|NCT00002691|Leucovorin|leucovorin|mesh-list
2182752|NCT00002691|Cytarabine|cytarabine|mesh-list
2182753|NCT00002691|Dexamethasone|dexamethasone|mesh-list
2182754|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
2182755|NCT00002691|Methotrexate|methotrexate|mesh-list
2182756|NCT00002691|Etoposide|etoposide|mesh-list
2182757|NCT00002691|Vincristine|vincristine|mesh-list
2182758|NCT00002691|Daunorubicin|daunorubicin|mesh-list
2182759|NCT00002691|Asparaginase|asparaginase|mesh-list
2182760|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
2182761|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182762|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
2182763|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182764|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182765|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182766|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
2182767|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182768|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182769|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182770|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2182771|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
2182772|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
2182773|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2182774|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2182775|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
2182776|NCT00002691|Hormones|hormones|mesh-ancestor
2182777|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182778|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2660757|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660758|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2660759|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2660760|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2660761|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660762|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660763|NCT02102555|Acetaminophen|acetaminophen|mesh-list
2660764|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2660765|NCT02102555|Analgesics|analgesics|mesh-ancestor
2660766|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
2660767|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660768|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660769|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
2660770|NCT02102594|Bortezomib|bortezomib|mesh-list
2660771|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660772|NCT02102620|Lidocaine|lidocaine|mesh-list
2660773|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
2660774|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
2660775|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2660776|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660777|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
2660778|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660779|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2660780|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2660781|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2660782|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2660783|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660784|NCT02102633|Dabigatran|dabigatran|mesh-list
2660785|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
2660786|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2660787|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
2660788|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660789|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660790|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
2660791|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2660792|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
2660793|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2660794|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
2660795|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2660796|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660797|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2660798|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2660799|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182779|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2182780|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
2660800|NCT02102672|Trimetazidine|trimetazidine|mesh-list
2660801|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
2660802|NCT02102698|Ecopipam|ecopipam|mesh-list
2660803|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2660804|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2660805|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2660806|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660807|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2660808|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2660809|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
2660810|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660811|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660812|NCT02102711|Vitamin A|vitamin a|mesh-list
2660813|NCT02102711|Vitamins|vitamins|mesh-ancestor
2660814|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
2660815|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660816|NCT02102776|Mitomycins|mitomycins|mesh-list
2660817|NCT02102776|Mitomycin|mitomycin|mesh-list
2660818|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2660819|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660820|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
2660821|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660822|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2660823|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660824|NCT02102789|Leucovorin|leucovorin|mesh-list
2660825|NCT02102789|Dexamethasone|dexamethasone|mesh-list
2660826|NCT02102789|Fluorouracil|fluorouracil|mesh-list
2660827|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
2660828|NCT02102789|Floxuridine|floxuridine|mesh-list
2660829|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2660830|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
2660831|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
2660832|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660833|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660834|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2660835|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
2660836|NCT02102789|Hormones|hormones|mesh-ancestor
2660837|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2660838|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2660839|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660840|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660841|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
2660842|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2660843|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2660844|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
2182781|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2182782|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182783|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
2182784|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
2182785|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182786|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2182787|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2660845|NCT02102789|Antidotes|antidotes|mesh-ancestor
2660846|NCT02102789|Protective Agents|protective agents|mesh-ancestor
2660847|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
2660848|NCT02102789|Vitamins|vitamins|mesh-ancestor
2660849|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
2660850|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2660851|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
2660852|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660853|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2660854|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
2660855|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660856|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660857|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2660858|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2660859|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2660860|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
2660861|NCT02102815|Dexamethasone|dexamethasone|mesh-list
2660862|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2660863|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
2660864|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
2660865|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660866|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660867|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2660868|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
2660869|NCT02102815|Hormones|hormones|mesh-ancestor
2182788|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182789|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182790|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182791|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
2182792|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182793|NCT00002691|Antidotes|antidotes|mesh-ancestor
2182794|NCT00002691|Protective Agents|protective agents|mesh-ancestor
2182795|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
2182796|NCT00002691|Vitamins|vitamins|mesh-ancestor
2182797|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
2182798|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
2182799|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
2182800|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182801|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2182802|NCT00002692|Leucovorin|leucovorin|mesh-list
2182803|NCT00002692|Fluorouracil|fluorouracil|mesh-list
2182804|NCT00002692|Calcium|calcium|mesh-list
2660870|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2660871|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2660872|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660873|NCT02102828|Aspirin|aspirin|mesh-list
2660874|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2660875|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2660876|NCT02102828|Analgesics|analgesics|mesh-ancestor
2660877|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
2660878|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660879|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660880|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2660881|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2660882|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2660883|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2660884|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182805|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
2182806|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2182807|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182808|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
2182809|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182810|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182811|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182812|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2660885|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2660886|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2660887|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660888|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
2660889|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
2660890|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2660891|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
2660892|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660893|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2660894|NCT02102971|Liver Extracts|liver extracts|mesh-list
2660895|NCT02102971|Hematinics|hematinics|mesh-ancestor
2660896|NCT02103023|Imiquimod|imiquimod|mesh-list
2660897|NCT02103023|Vaccines|vaccines|mesh-list
2660898|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
2660899|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660900|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2182813|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
2182814|NCT00002692|Antidotes|antidotes|mesh-ancestor
2182815|NCT00002692|Protective Agents|protective agents|mesh-ancestor
2182816|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
2182817|NCT00002692|Vitamins|vitamins|mesh-ancestor
2182818|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
2182819|NCT00002693|Carboplatin|carboplatin|mesh-list
2182820|NCT00002693|Topotecan|topotecan|mesh-list
2182821|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182822|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2182823|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182824|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182825|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182826|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
2660901|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660902|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
2660903|NCT02103049|Ezetimibe|ezetimibe|mesh-list
2660904|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2182827|NCT00002696|Doxorubicin|doxorubicin|mesh-list
2182828|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2182829|NCT00002696|Fluorouracil|fluorouracil|mesh-list
2182830|NCT00002696|Methotrexate|methotrexate|mesh-list
2182831|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182832|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
2182833|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182834|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182835|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2660905|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2660906|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
2660907|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660908|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2660909|NCT02103166|Scopolamine|scopolamine|mesh-list
2660910|NCT02103166|Bromides|bromides|mesh-list
2660911|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
2660912|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2660913|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
2660914|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
2660915|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660916|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660917|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2660918|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
2660919|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2660920|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
2660921|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660922|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660923|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2660924|NCT02103192|Antioxidants|antioxidants|mesh-list
2660925|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660926|NCT02103192|Protective Agents|protective agents|mesh-ancestor
2660927|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660928|NCT02103205|Iron|iron|mesh-list
2660929|NCT02103205|Lactoferrin|lactoferrin|mesh-list
2660930|NCT02103205|Trace Elements|trace elements|mesh-ancestor
2660931|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
2660932|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660933|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2660934|NCT02103244|Carboplatin|carboplatin|mesh-list
2660935|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660936|NCT02103322|Imatinib Mesylate|imatinib mesylate|mesh-list
2660937|NCT02103322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660938|NCT02103322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2660939|NCT02103322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2660940|NCT02103322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660941|NCT02103335|Dexamethasone|dexamethasone|mesh-list
2660942|NCT02103335|Pomalidomide|pomalidomide|mesh-list
2660943|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2660944|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
2660945|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
2660946|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660947|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660948|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2660949|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
2660950|NCT02103335|Hormones|hormones|mesh-ancestor
2660951|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2660952|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2660953|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2660954|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
2660955|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2660956|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2182836|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
2182837|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182838|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182839|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182840|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2182841|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182842|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182843|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182844|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
2182845|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182846|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2182847|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
2182848|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2182849|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
2660957|NCT02103335|Growth Substances|growth substances|mesh-ancestor
2660958|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
2660959|NCT02103361|Ustekinumab|ustekinumab|mesh-list
2660960|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
2660961|NCT02103374|Terbutaline|terbutaline|mesh-list
2660962|NCT02103374|Ipratropium|ipratropium|mesh-list
2660963|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2660964|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
2660965|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2660966|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660967|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2660968|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
2660969|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2182850|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2182851|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2182852|NCT00002697|Carboplatin|carboplatin|mesh-list
2182853|NCT00002697|Etoposide|etoposide|mesh-list
2182854|NCT00002697|Ifosfamide|ifosfamide|mesh-list
2182855|NCT00002697|Sargramostim|sargramostim|mesh-list
2182856|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182857|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182858|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182859|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182860|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182861|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182862|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
2182863|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182864|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182865|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
2182866|NCT00002700|Leucovorin|leucovorin|mesh-list
2182867|NCT00002700|Cytarabine|cytarabine|mesh-list
2182868|NCT00002700|Dexamethasone|dexamethasone|mesh-list
2182869|NCT00002700|Prednisone|prednisone|mesh-list
2182870|NCT00002700|Prednisolone|prednisolone|mesh-list
2182871|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
2182872|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2182873|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2182874|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2182875|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
2182876|NCT00002700|Doxorubicin|doxorubicin|mesh-list
2182877|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2182878|NCT00002700|Methotrexate|methotrexate|mesh-list
2182879|NCT00002700|Vincristine|vincristine|mesh-list
2660970|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
2660971|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660972|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660973|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
2660974|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
2660975|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2660976|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2660977|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2660978|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2660979|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
2660980|NCT02103465|Rotigotine|rotigotine|mesh-list
2660981|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
2660982|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
2660983|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2660984|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2660985|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660986|NCT02103556|Mineral Oil|mineral oil|mesh-list
2660987|NCT02103556|Emollients|emollients|mesh-ancestor
2660988|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
2660989|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2660990|NCT02103569|Norethindrone|norethindrone|mesh-list
2660991|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
2660992|NCT02103569|Estradiol|estradiol|mesh-list
2660993|NCT02103569|Asunaprevir|asunaprevir|mesh-list
2660994|NCT02103569|Estrogens|estrogens|mesh-ancestor
2660995|NCT02103569|Hormones|hormones|mesh-ancestor
2660996|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2660997|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2660998|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2660999|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
2661000|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2661001|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2661002|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2661003|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2661004|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2661005|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
2661006|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182880|NCT00002700|Daunorubicin|daunorubicin|mesh-list
2182881|NCT00002700|Asparaginase|asparaginase|mesh-list
2661007|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661008|NCT02103647|Pregabalin|pregabalin|mesh-list
2661009|NCT02103647|Analgesics|analgesics|mesh-ancestor
2661010|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
2661011|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661012|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661013|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
2661014|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2661015|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2661016|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182882|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
2182883|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
2182884|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
2182885|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182886|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
2182887|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182888|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182889|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182890|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
2182891|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182892|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182893|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182894|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2182895|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
2182896|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
2182897|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2182898|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2182899|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
2182900|NCT00002700|Hormones|hormones|mesh-ancestor
2182901|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2182902|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2182903|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2182904|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182905|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182906|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182907|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2182908|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
2182909|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2182910|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182911|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
2182912|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
2182913|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2661017|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2661018|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2661019|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2661020|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661021|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2661022|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2661023|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
2661024|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
2661025|NCT02103660|Progestins|progestins|mesh-list
2661026|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2661027|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661028|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2661029|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2661030|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2661031|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2661032|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2661033|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2661034|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2661035|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661036|NCT02103660|Hormones|hormones|mesh-ancestor
2661037|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2661038|NCT02103686|Pregabalin|pregabalin|mesh-list
2661039|NCT02103686|Analgesics|analgesics|mesh-ancestor
2661040|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
2661041|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661042|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661043|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
2661044|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2661045|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2661046|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661047|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2661048|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2661049|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2661050|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661051|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2661052|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
2661053|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2661054|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2661055|NCT02103725|Analgesics|analgesics|mesh-ancestor
2661056|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
2661057|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661058|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661059|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2661060|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2661061|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
2661062|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661063|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
2182914|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2182915|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
2182916|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182917|NCT00002700|Antidotes|antidotes|mesh-ancestor
2182918|NCT00002700|Protective Agents|protective agents|mesh-ancestor
2182919|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
2661064|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2661065|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661066|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661067|NCT02103738|Ranibizumab|ranibizumab|mesh-list
2661068|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2661069|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2661070|NCT02103738|Growth Substances|growth substances|mesh-ancestor
2661071|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661072|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
2661073|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661074|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2661075|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
2661076|NCT02103764|Desogestrel|desogestrel|mesh-list
2661077|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2661078|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2661079|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2661080|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
2661081|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2661082|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661083|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2182920|NCT00002700|Vitamins|vitamins|mesh-ancestor
2182921|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
2182922|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2182923|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
2182924|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
2661084|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2661085|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2661086|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2661087|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661088|NCT02103764|Progestins|progestins|mesh-ancestor
2661089|NCT02103764|Hormones|hormones|mesh-ancestor
2661090|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2661091|NCT02103777|Caffeine|caffeine|mesh-list
2661092|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
2182925|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
2182926|NCT00002700|Analgesics|analgesics|mesh-ancestor
2182927|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
2182928|NCT00002701|Cytarabine|cytarabine|mesh-list
2182929|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
2182930|NCT00002701|Busulfan|busulfan|mesh-list
2182931|NCT00002701|Methotrexate|methotrexate|mesh-list
2182932|NCT00002701|Etoposide|etoposide|mesh-list
2182933|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
2182934|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
2182935|NCT00002701|Idarubicin|idarubicin|mesh-list
2182936|NCT00002701|Tretinoin|tretinoin|mesh-list
2182937|NCT00002701|Thioguanine|thioguanine|mesh-list
2182938|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2182939|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
2182940|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182941|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182942|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182943|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
2182944|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182945|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182946|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2661093|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661094|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2661095|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661096|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2661097|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661098|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2661099|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2661100|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
2661101|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661102|NCT02103881|Ketamine|ketamine|mesh-list
2661103|NCT02103881|Haloperidol|haloperidol|mesh-list
2661104|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
2661105|NCT02103881|Analgesics|analgesics|mesh-ancestor
2182947|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2182948|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
2182949|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2182950|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2182951|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
2182952|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
2182953|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2182954|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2182955|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2182956|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2661106|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
2661107|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661108|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661109|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2661110|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2661111|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
2661112|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
2661113|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661114|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2661115|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2661116|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661117|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661118|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
2661119|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
2661120|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2661121|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2661122|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2661123|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2661124|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2661125|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
2661126|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2661127|NCT02103998|Iodine|iodine|mesh-list
2661128|NCT02103998|Hormones|hormones|mesh-list
2661129|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2661130|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661131|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2661132|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661133|NCT02103998|Trace Elements|trace elements|mesh-ancestor
2661134|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
2661135|NCT02104011|Propranolol|propranolol|mesh-list
2661136|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2661137|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2661138|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
2661139|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661140|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661141|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661142|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2661143|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2661144|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
2661145|NCT02104050|Dapansutrile|dapansutrile|mesh-list
2661146|NCT02104050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2661147|NCT02104128|Bupropion|bupropion|mesh-list
2661148|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2661149|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
2661150|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2661151|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2661152|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2661153|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2661154|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661155|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
2661156|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661157|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661158|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2661159|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2661160|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661161|NCT02104193|Simvastatin|simvastatin|mesh-list
2661162|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2661163|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2661164|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
2661165|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661166|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2661167|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2661168|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661169|NCT02104245|Ciprofloxacin|ciprofloxacin|mesh-list
2661170|NCT02104245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2661171|NCT02104245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661172|NCT02104245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2661173|NCT02104245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2661174|NCT02104245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661175|NCT02104245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661176|NCT02104245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661177|NCT02104245|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2661178|NCT02104245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2661179|NCT02104284|Mannitol|mannitol|mesh-list
2661180|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
2661181|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2661182|NCT02104284|Diuretics|diuretics|mesh-ancestor
2661183|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
2661184|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661185|NCT02104284|Miotics|miotics|mesh-ancestor
2661186|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
2661187|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661188|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2661189|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2661190|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
2661191|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2661192|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2661193|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
2661194|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661195|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661196|NCT02104297|Remifentanil|remifentanil|mesh-list
2661197|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2661198|NCT02104297|Narcotics|narcotics|mesh-ancestor
2661199|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661200|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661201|NCT02104297|Analgesics|analgesics|mesh-ancestor
2661202|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
2661203|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661204|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
2661205|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661206|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
2661207|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661208|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661209|NCT02104323|Endostatins|endostatins|mesh-list
2661210|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661211|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2182957|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2182958|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2182959|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
2182960|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182961|NCT00002701|Analgesics|analgesics|mesh-ancestor
2182962|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
2182963|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2182964|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2182965|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
2182966|NCT00002702|Aldesleukin|aldesleukin|mesh-list
2182967|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182968|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2182969|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2182970|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
2182971|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2182972|NCT00002704|Leucovorin|leucovorin|mesh-list
2182973|NCT00002704|Cytarabine|cytarabine|mesh-list
2182974|NCT00002704|Dexamethasone|dexamethasone|mesh-list
2182975|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
2182976|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2661212|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2661213|NCT02104323|Growth Substances|growth substances|mesh-ancestor
2661214|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661215|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
2661216|NCT02104388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2661217|NCT02104388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2661218|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
2661219|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2661220|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
2661221|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2661222|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661223|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2661224|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2661225|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2661226|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
2661227|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2661228|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2661229|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661230|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2661231|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2661232|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661233|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661234|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661235|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2182977|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2182978|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2182979|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
2182980|NCT00002704|Thiotepa|thiotepa|mesh-list
2182981|NCT00002704|Methotrexate|methotrexate|mesh-list
2182982|NCT00002704|Etoposide|etoposide|mesh-list
2182983|NCT00002704|Vincristine|vincristine|mesh-list
2182984|NCT00002704|Daunorubicin|daunorubicin|mesh-list
2182985|NCT00002704|Asparaginase|asparaginase|mesh-list
2182986|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
2182987|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
2182988|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661236|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
2661237|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2661238|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661239|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2661240|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2661241|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2661242|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
2661243|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
2661244|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2661245|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2661246|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2182989|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
2182990|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2182991|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2182992|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2182993|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
2182994|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2182995|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2182996|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2182997|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2182998|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
2661247|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661248|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2661249|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2661250|NCT02104674|Montelukast|montelukast|mesh-list
2661251|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2661252|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
2661253|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2661254|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
2661255|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2661256|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661257|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2661258|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2661259|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661260|NCT02104700|Tenofovir|tenofovir|mesh-list
2661261|NCT02104700|Emtricitabine|emtricitabine|mesh-list
2661262|NCT02104700|Rilpivirine|rilpivirine|mesh-list
2182999|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
2183000|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2183001|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2183002|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
2183003|NCT00002704|Hormones|hormones|mesh-ancestor
2183004|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2183005|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183006|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2183007|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
2661263|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
2661264|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661265|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2661266|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2661267|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661268|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661269|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2661270|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2661271|NCT02104778|Dexamethasone|dexamethasone|mesh-list
2661272|NCT02104778|Epinephrine|epinephrine|mesh-list
2661273|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2183008|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2183009|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183010|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
2183011|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
2183012|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183013|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2183014|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2183015|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183016|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183017|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183018|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
2183019|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661274|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
2661275|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
2661276|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661277|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661278|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2661279|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
2661280|NCT02104778|Hormones|hormones|mesh-ancestor
2661281|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2661282|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2661283|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661284|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2661285|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2661286|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
2661287|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661288|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661289|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2661290|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2661291|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2183020|NCT00002704|Antidotes|antidotes|mesh-ancestor
2183021|NCT00002704|Protective Agents|protective agents|mesh-ancestor
2183022|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
2183023|NCT00002704|Vitamins|vitamins|mesh-ancestor
2183024|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
2183025|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
2183026|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
2183027|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183028|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183029|NCT00002705|Topotecan|topotecan|mesh-list
2183030|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2183031|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183032|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183033|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183034|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183035|NCT00002707|Tamoxifen|tamoxifen|mesh-list
2183036|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
2183037|NCT00002707|Docetaxel|docetaxel|mesh-list
2183038|NCT00002707|Doxorubicin|doxorubicin|mesh-list
2183039|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183040|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
2183041|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183042|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183043|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183044|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
2183045|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183046|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661292|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
2661293|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
2661294|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
2661295|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2661296|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2661297|NCT02104843|Asunaprevir|asunaprevir|mesh-list
2661298|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2661299|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2661300|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
2661301|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661302|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2661303|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2661304|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661305|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
2661306|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
2661307|NCT02104986|Cisplatin|cisplatin|mesh-list
2661308|NCT02104986|Ifosfamide|ifosfamide|mesh-list
2661309|NCT02104986|Bleomycin|bleomycin|mesh-list
2661310|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661311|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2661312|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
2661313|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661314|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2661315|NCT02105077|Anesthetics|anesthetics|mesh-list
2661316|NCT02105077|Xenon|xenon|mesh-list
2661317|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661318|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661319|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2661320|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
2661321|NCT02105090|Anesthetics|anesthetics|mesh-list
2661322|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
2661323|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661324|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661325|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661326|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
2661327|NCT02105103|Insulin|insulin|mesh-list
2661328|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2661329|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661330|NCT02105155|Tacrolimus|tacrolimus|mesh-list
2661331|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661332|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
2661333|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661334|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2661335|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661336|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661337|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
2661338|NCT02105311|Travoprost|travoprost|mesh-list
2661339|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2661340|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2661341|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661342|NCT02105350|Gemcitabine|gemcitabine|mesh-list
2661343|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
2661344|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2661345|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
2661346|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661347|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661348|NCT02105350|Antiviral Agents|antiviral agents|mesh-ancestor
2661349|NCT02105350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661350|NCT02105350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661351|NCT02105350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661352|NCT02105350|Immunologic Factors|immunologic factors|mesh-ancestor
2661353|NCT02105350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661354|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
2661355|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
2661356|NCT02105610|Sevoflurane|sevoflurane|mesh-list
2661357|NCT02105610|Desflurane|desflurane|mesh-list
2661358|NCT02105610|Isoflurane|isoflurane|mesh-list
2661359|NCT02105610|Anesthetics|anesthetics|mesh-list
2661360|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
2661361|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2661362|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2661363|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
2661364|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661365|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661366|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2661367|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2661368|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2661369|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
2661370|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661371|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2661372|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2661373|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661374|NCT02105675|Docetaxel|docetaxel|mesh-list
2661375|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661376|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
2661377|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
2661378|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
2661379|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661380|NCT02105714|Formaldehyde|formaldehyde|mesh-list
2661381|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
2661382|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661383|NCT02105766|Sirolimus|sirolimus|mesh-list
2661384|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
2661385|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
2661386|NCT02105766|Pentostatin|pentostatin|mesh-list
2661387|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661388|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
2661389|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661390|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2661391|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183047|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183048|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
2183049|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
2183050|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183051|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183052|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183053|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183054|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183055|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2183056|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
2183057|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2183058|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2661392|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
2661393|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661394|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661395|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2661396|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2661397|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661398|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2661399|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
2661400|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2661401|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2661402|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661403|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2661404|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2661405|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661406|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2661407|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661408|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
2661409|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661410|NCT02105870|Abciximab|abciximab|mesh-list
2661411|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
2661412|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2661413|NCT02106104|Glimepiride|glimepiride|mesh-list
2661414|NCT02106104|Linagliptin|linagliptin|mesh-list
2661415|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2661416|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2661417|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661418|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661419|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
2661420|NCT02106104|Incretins|incretins|mesh-ancestor
2661421|NCT02106104|Hormones|hormones|mesh-ancestor
2661422|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2661423|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2661424|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
2661425|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661426|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661427|NCT02106130|Rebamipide|rebamipide|mesh-list
2661428|NCT02106130|Mosapride|mosapride|mesh-list
2661429|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661430|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2183059|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2183060|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2183061|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2183062|NCT00002711|Paclitaxel|paclitaxel|mesh-list
2183063|NCT00002711|Cisplatin|cisplatin|mesh-list
2183064|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183065|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183066|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
2183067|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
2183068|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183069|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183070|NCT00002714|Prednisone|prednisone|mesh-list
2183071|NCT00002714|Doxorubicin|doxorubicin|mesh-list
2183072|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2661431|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2661432|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
2661433|NCT02106130|Protective Agents|protective agents|mesh-ancestor
2661434|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661435|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661436|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2661437|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
2661438|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661439|NCT02106182|Silodosin|silodosin|mesh-list
2661440|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2661441|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2661442|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2661443|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
2661444|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661445|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661446|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661447|NCT02106182|Urological Agents|urological agents|mesh-ancestor
2661448|NCT02106286|Bisoprolol|bisoprolol|mesh-list
2661449|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2661450|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
2661451|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
2661452|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661453|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661454|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2661455|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2661456|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2661457|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
2661458|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661459|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661460|NCT02106364|Insulin|insulin|mesh-list
2661461|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2661462|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
2661463|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2661464|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661465|NCT02106468|Prednisone|prednisone|mesh-list
2661466|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2661467|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
2661468|NCT02106468|Hormones|hormones|mesh-ancestor
2661469|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2661470|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661471|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2661472|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661473|NCT02106481|Ropivacaine|ropivacaine|mesh-list
2661474|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
2661475|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
2661476|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661477|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661478|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
2661479|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661480|NCT02106507|Everolimus|everolimus|mesh-list
2661481|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661482|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661483|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
2661484|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661485|NCT02106520|Bevacizumab|bevacizumab|mesh-list
2661486|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2661487|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661488|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2661489|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2661490|NCT02106520|Growth Substances|growth substances|mesh-ancestor
2183073|NCT00002714|Bleomycin|bleomycin|mesh-list
2661491|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661492|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
2661493|NCT02106546|Paclitaxel|paclitaxel|mesh-list
2661494|NCT02106546|Carboplatin|carboplatin|mesh-list
2661495|NCT02106546|Veliparib|veliparib|mesh-list
2661496|NCT02106546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2661497|NCT02106546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661498|NCT02106546|Tubulin Modulators|tubulin modulators|mesh-ancestor
2661499|NCT02106546|Antimitotic Agents|antimitotic agents|mesh-ancestor
2661500|NCT02106546|Mitosis Modulators|mitosis modulators|mesh-ancestor
2661501|NCT02106546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661502|NCT02106546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2661503|NCT02106546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661504|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2661505|NCT02106559|Trioxsalen|trioxsalen|mesh-list
2661506|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661507|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
2661508|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2661509|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
2661510|NCT02106572|Mitomycins|mitomycins|mesh-list
2661511|NCT02106572|Mitomycin|mitomycin|mesh-list
2661512|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2661513|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661514|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
2661515|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661516|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2661517|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661518|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2661519|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2661520|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
2661521|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661522|NCT02106637|Varenicline|varenicline|mesh-list
2183074|NCT00002714|Etoposide|etoposide|mesh-list
2183075|NCT00002714|Vincristine|vincristine|mesh-list
2183076|NCT00002714|Vinblastine|vinblastine|mesh-list
2183077|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
2183078|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183079|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183080|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183081|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183082|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183083|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183084|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2183085|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
2183086|NCT00002714|Hormones|hormones|mesh-ancestor
2183087|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2183088|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183089|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183090|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183091|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
2183092|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
2183093|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183094|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
2183095|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183096|NCT00002715|Prednisone|prednisone|mesh-list
2183097|NCT00002715|Doxorubicin|doxorubicin|mesh-list
2183098|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2183099|NCT00002715|Bleomycin|bleomycin|mesh-list
2183100|NCT00002715|Etoposide|etoposide|mesh-list
2183101|NCT00002715|Vincristine|vincristine|mesh-list
2183102|NCT00002715|Vinblastine|vinblastine|mesh-list
2183103|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
2183104|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183105|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661523|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2661524|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2661525|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
2661526|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661527|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661528|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661529|NCT02106650|Leucovorin|leucovorin|mesh-list
2661530|NCT02106650|Folic Acid|folic acid|mesh-list
2661531|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
2661532|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
2661533|NCT02106650|Vitamins|vitamins|mesh-ancestor
2661534|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
2183106|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183107|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2661535|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661536|NCT02106650|Antidotes|antidotes|mesh-ancestor
2183108|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183109|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183110|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2183111|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
2183112|NCT00002715|Hormones|hormones|mesh-ancestor
2183113|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2183114|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183115|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183116|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183117|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
2183118|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
2183119|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183120|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
2183121|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183122|NCT00002716|Leucovorin|leucovorin|mesh-list
2661537|NCT02106650|Protective Agents|protective agents|mesh-ancestor
2661538|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
2661539|NCT02106650|Hematinics|hematinics|mesh-ancestor
2661540|NCT02106767|Rifampin|rifampin|mesh-list
2661541|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2661542|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2661543|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2661544|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
2661545|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661546|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2661547|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2661548|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661549|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2661550|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
2661551|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2661552|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661553|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
2661554|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2661555|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2661556|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2661557|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2661558|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2661559|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2661560|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2661561|NCT02106793|Mitomycins|mitomycins|mesh-list
2661562|NCT02106793|Mitomycin|mitomycin|mesh-list
2661563|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2661564|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661565|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
2661566|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661567|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2661568|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661569|NCT02106806|Zinc|zinc|mesh-list
2661570|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
2661571|NCT02106806|Trace Elements|trace elements|mesh-ancestor
2661572|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
2661573|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661574|NCT02106806|Astringents|astringents|mesh-ancestor
2661575|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
2661576|NCT02106845|Digoxin|digoxin|mesh-list
2661577|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2661578|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2661579|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2661580|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
2661581|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661582|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2661583|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2661584|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661585|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2661586|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2661587|NCT02106845|Protective Agents|protective agents|mesh-ancestor
2661588|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661589|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
2661590|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
2661591|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2661592|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2661593|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183123|NCT00002716|Dexamethasone|dexamethasone|mesh-list
2183124|NCT00002716|Fluorouracil|fluorouracil|mesh-list
2183125|NCT00002716|Floxuridine|floxuridine|mesh-list
2183126|NCT00002716|Calcium|calcium|mesh-list
2183127|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
2183128|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2183129|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
2183130|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
2183131|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2183132|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183133|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2183134|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
2183135|NCT00002716|Hormones|hormones|mesh-ancestor
2661594|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661595|NCT02106871|Urological Agents|urological agents|mesh-ancestor
2661596|NCT02106988|Dexamethasone|dexamethasone|mesh-list
2661597|NCT02106988|Carboplatin|carboplatin|mesh-list
2661598|NCT02106988|Etoposide|etoposide|mesh-list
2661599|NCT02106988|Ifosfamide|ifosfamide|mesh-list
2661600|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
2661601|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2661602|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
2661603|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
2661604|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661605|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661606|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2661607|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
2661608|NCT02106988|Hormones|hormones|mesh-ancestor
2661609|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2661610|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2661611|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661612|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2661613|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2661614|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2661615|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661616|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661617|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2661618|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
2661619|NCT02107079|Melatonin|melatonin|mesh-list
2661620|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
2661621|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661622|NCT02107079|Protective Agents|protective agents|mesh-ancestor
2661623|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661624|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661625|NCT02107118|Complement Factor H|complement factor h|mesh-list
2661626|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2661627|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661628|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
2661629|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661630|NCT02107144|Trimetazidine|trimetazidine|mesh-list
2661631|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
2661632|NCT02107170|Remifentanil|remifentanil|mesh-list
2661633|NCT02107170|Propofol|propofol|mesh-list
2183136|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2183137|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183138|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183139|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2183140|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
2661634|NCT02107170|Sevoflurane|sevoflurane|mesh-list
2661635|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2661636|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661637|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661638|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2661639|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
2661640|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
2661641|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2661642|NCT02107170|Narcotics|narcotics|mesh-ancestor
2661643|NCT02107170|Analgesics|analgesics|mesh-ancestor
2661644|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
2661645|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661646|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2661647|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2183141|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183142|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183143|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661648|NCT02107235|ON 01910|on 01910|mesh-list
2661649|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661650|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2661651|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661652|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661653|NCT02107365|Interferons|interferons|mesh-list
2661654|NCT02107365|Ribavirin|ribavirin|mesh-list
2661655|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
2661656|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
2183144|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
2183145|NCT00002716|Antidotes|antidotes|mesh-ancestor
2183146|NCT00002716|Protective Agents|protective agents|mesh-ancestor
2183147|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
2183148|NCT00002716|Vitamins|vitamins|mesh-ancestor
2183149|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
2183150|NCT00002717|Paclitaxel|paclitaxel|mesh-list
2183151|NCT00002717|Cisplatin|cisplatin|mesh-list
2183152|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183153|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183154|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
2183155|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
2183156|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183157|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183158|NCT00002718|Cytarabine|cytarabine|mesh-list
2183159|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
2661657|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2661658|NCT02107365|Asunaprevir|asunaprevir|mesh-list
2661659|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661660|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
2661661|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661662|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
2661663|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661664|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
2661665|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661666|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
2661667|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661668|NCT02107378|Paclitaxel|paclitaxel|mesh-list
2661669|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2661670|NCT02107378|Doxorubicin|doxorubicin|mesh-list
2661671|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2661672|NCT02107378|Topotecan|topotecan|mesh-list
2661673|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2661674|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661675|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
2661676|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
2661677|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
2661678|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661679|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2661680|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2661681|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2661682|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661683|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2661684|NCT02107391|Leuprolide|leuprolide|mesh-list
2661685|NCT02107391|Goserelin|goserelin|mesh-list
2661686|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2661687|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
2661688|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2661689|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661690|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2661691|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661692|NCT02107690|Lidocaine|lidocaine|mesh-list
2661693|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
2661694|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
2661695|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661696|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661697|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
2661698|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661699|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2661700|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2661701|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2661702|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2661703|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661704|NCT02107716|Lidocaine|lidocaine|mesh-list
2661705|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
2183160|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
2183161|NCT00002718|Thiotepa|thiotepa|mesh-list
2661706|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
2661707|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661708|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661709|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
2661710|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661711|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2661712|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2661713|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2661714|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2661715|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661716|NCT02107729|Lidocaine|lidocaine|mesh-list
2661717|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
2661718|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
2422832|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422833|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
2422834|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2422835|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
2422836|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2183162|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2183163|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183164|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
2183165|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183166|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2661719|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661720|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661721|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
2661722|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661723|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2661724|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2661725|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2661726|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2661727|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661728|NCT02107742|Lidocaine|lidocaine|mesh-list
2661729|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
2661730|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
2661731|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661732|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661733|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
2183167|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2422837|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2661734|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661735|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2661736|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2661737|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2661738|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2661739|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661740|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2661741|NCT02107755|Ipilimumab|ipilimumab|mesh-list
2422838|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2422839|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422840|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422841|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
2422842|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422843|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422844|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2422845|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422846|NCT00819078|Bupropion|bupropion|mesh-list
2661742|NCT02107755|Antibodies|antibodies|mesh-list
2661743|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
2661744|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2661745|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
2661746|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661747|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661748|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2661749|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661750|NCT02107807|Lactitol|lactitol|mesh-list
2661751|NCT02107807|Vaccines|vaccines|mesh-list
2661752|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
2661753|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661754|NCT02107807|Cathartics|cathartics|mesh-ancestor
2661755|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2661756|NCT02107924|Vancomycin|vancomycin|mesh-list
2661757|NCT02107924|Tobramycin|tobramycin|mesh-list
2661758|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2661759|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661760|NCT02107937|Paclitaxel|paclitaxel|mesh-list
2661761|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2661762|NCT02107937|Carboplatin|carboplatin|mesh-list
2661763|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2661764|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183168|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
2183169|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183170|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183171|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183172|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183173|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
2183174|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
2183175|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183176|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2183177|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
2183178|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
2183179|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2183180|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2183181|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
2183182|NCT00002718|Hormones|hormones|mesh-ancestor
2183183|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2183184|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2183185|NCT00002718|Protective Agents|protective agents|mesh-ancestor
2183186|NCT00002719|Cytarabine|cytarabine|mesh-list
2183187|NCT00002719|Etoposide|etoposide|mesh-list
2183188|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
2183189|NCT00002719|Idarubicin|idarubicin|mesh-list
2183190|NCT00002719|Carmustine|carmustine|mesh-list
2183191|NCT00002719|Amsacrine|amsacrine|mesh-list
2661765|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
2661766|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
2661767|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
2661768|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661769|NCT02107950|Gemcitabine|gemcitabine|mesh-list
2661770|NCT02107950|Carboplatin|carboplatin|mesh-list
2661771|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661772|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2661773|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
2661774|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661775|NCT02107950|Antiviral Agents|antiviral agents|mesh-ancestor
2661776|NCT02107950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661777|NCT02107950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661778|NCT02107950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661779|NCT02107950|Immunologic Factors|immunologic factors|mesh-ancestor
2661780|NCT02107950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661781|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
2661782|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661783|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
2661784|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661785|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2661786|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2661787|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
2661788|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661789|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661790|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2661791|NCT02108002|Vorinostat|vorinostat|mesh-list
2661792|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661793|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2661794|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661795|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661796|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
2661797|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2661798|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2661799|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2661800|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2661801|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661802|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
2661803|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661804|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661805|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2661806|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661807|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2661808|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2661809|NCT02108301|Cyclosporine|cyclosporine|mesh-list
2183192|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183193|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183194|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183195|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183196|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183197|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183198|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
2183199|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183200|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183201|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
2183202|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
2183203|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183204|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183205|NCT00002719|Analgesics|analgesics|mesh-ancestor
2183206|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
2183207|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2183208|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183209|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183210|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
2183211|NCT00002720|Tamoxifen|tamoxifen|mesh-list
2661810|NCT02108301|Tacrolimus|tacrolimus|mesh-list
2661811|NCT02108301|Cyclosporins|cyclosporins|mesh-list
2661812|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661813|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
2661814|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661815|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2661816|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661817|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661818|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
2661819|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661820|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
2661821|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2661822|NCT02108353|Melatonin|melatonin|mesh-list
2661823|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
2661824|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661825|NCT02108353|Protective Agents|protective agents|mesh-ancestor
2661826|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661827|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661828|NCT02108366|Oseltamivir|oseltamivir|mesh-list
2661829|NCT02108366|Celecoxib|celecoxib|mesh-list
2661830|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2661831|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2661832|NCT02108366|Analgesics|analgesics|mesh-ancestor
2661833|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
2661834|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661835|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661836|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2661837|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2661838|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2661839|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2661840|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661841|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661842|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
2661843|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661844|NCT02108483|Dapsone|dapsone|mesh-list
2661845|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661846|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
2661847|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2661848|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2661849|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2661850|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661851|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661852|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
2661853|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2661854|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
2661855|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2661856|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
2661857|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661858|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
2661859|NCT02108496|Protective Agents|protective agents|mesh-ancestor
2661860|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
2661861|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2661862|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2661863|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2661864|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2661865|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2661866|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
2183212|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2661867|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2183213|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
2661868|NCT02108548|Naproxen|naproxen|mesh-list
2661869|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2661870|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2661871|NCT02108548|Analgesics|analgesics|mesh-ancestor
2661872|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
2661873|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661874|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661875|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2661876|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2661877|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
2183214|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2183215|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183216|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183217|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183218|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2183219|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2183220|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2183221|NCT00002721|Doxorubicin|doxorubicin|mesh-list
2183222|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2183223|NCT00002721|Estramustine|estramustine|mesh-list
2183224|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183225|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183226|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183227|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183228|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183229|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183230|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183231|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
2183232|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183233|NCT00002722|Leucovorin|leucovorin|mesh-list
2183234|NCT00002722|Fluorouracil|fluorouracil|mesh-list
2183235|NCT00002722|Calcium|calcium|mesh-list
2183236|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
2183237|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183238|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2661878|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2661879|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661880|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661881|NCT02108626|Nicotine|nicotine|mesh-list
2661882|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2661883|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
2661884|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661885|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661886|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2661887|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2661888|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
2661889|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661890|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661891|NCT02108639|Asunaprevir|asunaprevir|mesh-list
2661892|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
2661893|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2661894|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661895|NCT02108743|Albuterol|albuterol|mesh-list
2661896|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2661897|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
2661898|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661899|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661900|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2661901|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
2661902|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
2661903|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2661904|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2661905|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2661906|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2661907|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
2661908|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661909|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661910|NCT02108756|Pantoprazole|pantoprazole|mesh-list
2661911|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2661912|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2661913|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2661914|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183239|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183240|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
2183241|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183242|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183243|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183244|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
2183245|NCT00002722|Antidotes|antidotes|mesh-ancestor
2183246|NCT00002722|Protective Agents|protective agents|mesh-ancestor
2183247|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
2183248|NCT00002722|Vitamins|vitamins|mesh-ancestor
2183249|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
2183250|NCT00002723|Suramin|suramin|mesh-list
2183251|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
2183252|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
2183253|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2183254|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183255|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183256|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2183257|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2183258|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
2183259|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2183260|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
2183261|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183262|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183263|NCT00002730|Melphalan|melphalan|mesh-list
2183264|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
2183265|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2661915|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661916|NCT02108795|Remifentanil|remifentanil|mesh-list
2661917|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2661918|NCT02108795|Narcotics|narcotics|mesh-ancestor
2661919|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661920|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661921|NCT02108795|Analgesics|analgesics|mesh-ancestor
2661922|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
2661923|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661924|NCT02108808|Clopidogrel|clopidogrel|mesh-list
2661925|NCT02108808|Ticagrelor|ticagrelor|mesh-list
2661926|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2661927|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2183266|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
2183267|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183268|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183269|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183270|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183271|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
2183272|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183273|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
2183274|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183275|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183276|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2183277|NCT00002730|Protective Agents|protective agents|mesh-ancestor
2183278|NCT00002733|Interferons|interferons|mesh-list
2183279|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
2183280|NCT00002733|Aldesleukin|aldesleukin|mesh-list
2183281|NCT00002733|Cimetidine|cimetidine|mesh-list
2183282|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183283|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
2183284|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183285|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
2183286|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661928|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2661929|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2661930|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2661931|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
2661932|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2661933|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661934|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661935|NCT02108847|Ropivacaine|ropivacaine|mesh-list
2661936|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
2661937|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
2661938|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2661939|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183287|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2183288|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2183289|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2183290|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2183291|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2183292|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
2183293|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
2661940|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
2661941|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661942|NCT02108860|Abatacept|abatacept|mesh-list
2661943|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2661944|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661945|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2661946|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661947|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
2661948|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661949|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2661950|NCT02108886|Montelukast|montelukast|mesh-list
2661951|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2661952|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
2661953|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2661954|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
2661955|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2661956|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661957|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2661958|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2661959|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2661960|NCT02108990|Acetaminophen|acetaminophen|mesh-list
2661961|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2661962|NCT02108990|Analgesics|analgesics|mesh-ancestor
2661963|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
2661964|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661965|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661966|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
2661979|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
2661980|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2661981|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
2661982|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2661983|NCT02109289|Etanercept|etanercept|mesh-list
2661984|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2661985|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2661986|NCT02109289|Analgesics|analgesics|mesh-ancestor
2661987|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
2661988|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2661989|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2661990|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2661991|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2661992|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2661993|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2661994|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
2661995|NCT02109315|Ascorbic Acid|ascorbic acid|mesh-list
2661996|NCT02109315|Liraglutide|liraglutide|mesh-list
2661997|NCT02109315|Vitamins|vitamins|mesh-ancestor
2661998|NCT02109315|Micronutrients|micronutrients|mesh-ancestor
2661999|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662000|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2662001|NCT02109315|Incretins|incretins|mesh-ancestor
2662002|NCT02109315|Hormones|hormones|mesh-ancestor
2662003|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662004|NCT02109315|Antioxidants|antioxidants|mesh-ancestor
2662005|NCT02109315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662006|NCT02109315|Protective Agents|protective agents|mesh-ancestor
2662007|NCT02109328|Paclitaxel|paclitaxel|mesh-list
2662008|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2662009|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662010|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
2662011|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
2662012|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
2662013|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662014|NCT02109341|Paclitaxel|paclitaxel|mesh-list
2662015|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2662016|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2662017|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662018|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
2662019|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
2662020|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
2662021|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662022|NCT02109354|Vaccines|vaccines|mesh-list
2183294|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2183295|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183296|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2183297|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2183298|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183299|NCT00002734|Interferons|interferons|mesh-list
2183300|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
2183301|NCT00002734|Paclitaxel|paclitaxel|mesh-list
2183302|NCT00002734|Topotecan|topotecan|mesh-list
2183303|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2183304|NCT00002734|Antibodies|antibodies|mesh-list
2183305|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
2183306|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2183307|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183308|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183309|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
2183310|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
2183311|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183312|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183313|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
2183314|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183315|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
2183316|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183317|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2183318|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183319|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662023|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
2662024|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662025|NCT02109510|Lidocaine|lidocaine|mesh-list
2662026|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
2662027|NCT02109510|Ketamine|ketamine|mesh-list
2662028|NCT02109510|Anesthetics|anesthetics|mesh-list
2662029|NCT02109510|Propofol|propofol|mesh-list
2662030|NCT02109510|Sevoflurane|sevoflurane|mesh-list
2662031|NCT02109510|Rocuronium|rocuronium|mesh-list
2662032|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
2662033|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662034|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662035|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
2662036|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662037|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2662038|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2662039|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2662040|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2662041|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662042|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2662043|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2662044|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
2662045|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2662046|NCT02109510|Analgesics|analgesics|mesh-ancestor
2662047|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2662048|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2662049|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2662050|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
2662051|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2662052|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2662053|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2662054|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2662055|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2662056|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2662057|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2662058|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2662059|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2183320|NCT00002735|Cobalt|cobalt|mesh-list
2662060|NCT02109614|Niacin|niacin|mesh-list
2662061|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2662062|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
2662063|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662064|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2662065|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
2662066|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
2662067|NCT02109614|Vitamins|vitamins|mesh-ancestor
2662068|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
2662069|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662070|NCT02109627|Cytarabine|cytarabine|mesh-list
2662071|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2662072|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
2662073|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662074|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662075|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
2662076|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662077|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662078|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
2662079|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662080|NCT02109666|Abatacept|abatacept|mesh-list
2662081|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2662082|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662083|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662084|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662085|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
2662086|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662087|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2662088|NCT02109679|Metformin|metformin|mesh-list
2662089|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2662090|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662091|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
2662092|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2662093|NCT02109718|Petrolatum|petrolatum|mesh-list
2662094|NCT02109718|Emollients|emollients|mesh-ancestor
2662095|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
2662096|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2662097|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662098|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2662099|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2662100|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
2662101|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2662108|NCT02109783|Caffeine|caffeine|mesh-list
2662109|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2662110|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662111|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2662112|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662113|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662114|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2662115|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2662116|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
2662117|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2662118|NCT02109861|Dexamethasone|dexamethasone|mesh-list
2662119|NCT02109861|Bortezomib|bortezomib|mesh-list
2662120|NCT02109861|Melphalan|melphalan|mesh-list
2662121|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662122|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
2662123|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
2662124|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662125|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662126|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2662127|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
2662128|NCT02109861|Hormones|hormones|mesh-ancestor
2662129|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662130|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2662131|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662132|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2662133|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
2662134|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662135|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2662136|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662137|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
2662138|NCT02109900|Progesterone|progesterone|mesh-list
2662139|NCT02109900|Progestins|progestins|mesh-ancestor
2662140|NCT02109900|Hormones|hormones|mesh-ancestor
2662141|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662142|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662143|NCT02109913|Everolimus|everolimus|mesh-list
2662144|NCT02109913|Exemestane|exemestane|mesh-list
2662145|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662146|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662147|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
2662148|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662149|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2662150|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2662151|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662152|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662153|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2662154|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
2662155|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662156|NCT02109965|Midazolam|midazolam|mesh-list
2662157|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
2662158|NCT02109965|Propofol|propofol|mesh-list
2662159|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2662160|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662161|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662162|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2662163|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
2662164|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
2662165|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2662166|NCT02109965|Analgesics|analgesics|mesh-ancestor
2183321|NCT00002735|Cisplatin|cisplatin|mesh-list
2183322|NCT00002735|Fluorouracil|fluorouracil|mesh-list
2183323|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183324|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
2183325|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183326|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183327|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183328|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
2183329|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183330|NCT00002735|Trace Elements|trace elements|mesh-ancestor
2183331|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
2183332|NCT00002737|Interferons|interferons|mesh-list
2662167|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
2662168|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662169|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2662170|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2662171|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2183333|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
2183334|NCT00002737|Isotretinoin|isotretinoin|mesh-list
2183335|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183336|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
2183337|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662172|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
2662173|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2662174|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662175|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2662176|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2662177|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2662178|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2662179|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
2662180|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
2662181|NCT02110082|Cetuximab|cetuximab|mesh-list
2662182|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2662183|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662184|NCT02110134|Hydroquinone|hydroquinone|mesh-list
2662185|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
2662186|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662187|NCT02110134|Protective Agents|protective agents|mesh-ancestor
2662188|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662189|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2662190|NCT02110303|Ticagrelor|ticagrelor|mesh-list
2662191|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2662192|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2662193|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2183338|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
2662194|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2662195|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
2662196|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2662197|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662198|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662199|NCT02110316|Voriconazole|voriconazole|mesh-list
2662200|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
2662201|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662202|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2662203|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2662204|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662205|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183339|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183340|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
2183341|NCT00002738|Leucovorin|leucovorin|mesh-list
2183342|NCT00002738|Trimetrexate|trimetrexate|mesh-list
2183343|NCT00002738|Calcium|calcium|mesh-list
2662206|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2662207|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
2662208|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662209|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662210|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2662211|NCT02110355|Trametinib|trametinib|mesh-list
2662212|NCT02110355|Dabrafenib|dabrafenib|mesh-list
2662213|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662214|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2662215|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662216|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662217|NCT02110368|Methyltestosterone|methyltestosterone|mesh-list
2662218|NCT02110368|Testosterone|testosterone|mesh-list
2662219|NCT02110368|Testosterone undecanoate|testosterone undecanoate|mesh-list
2662220|NCT02110368|Testosterone enanthate|testosterone enanthate|mesh-list
2662221|NCT02110368|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2662222|NCT02110368|Androgens|androgens|mesh-ancestor
2662223|NCT02110368|Hormones|hormones|mesh-ancestor
2662224|NCT02110368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662225|NCT02110368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662226|NCT02110368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2662227|NCT02110368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662228|NCT02110368|Anabolic Agents|anabolic agents|mesh-ancestor
2662229|NCT02110394|Rituximab|rituximab|mesh-list
2662230|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2662231|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2662232|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662233|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
2662234|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662235|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2662236|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2662237|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
2662238|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662239|NCT02110459|Murepavadin|murepavadin|mesh-list
2662240|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2662241|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662242|NCT02110524|Paclitaxel|paclitaxel|mesh-list
2662243|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2662244|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662245|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
2662246|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
2662247|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
2662248|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662249|NCT02110537|Flecainide|flecainide|mesh-list
2662250|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2662251|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2662252|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2662253|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2662254|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662255|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
2662256|NCT02110654|Montelukast|montelukast|mesh-list
2662257|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2662258|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
2662259|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2662260|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
2183344|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
2668611|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2662261|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662262|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662263|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2662264|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2662265|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662266|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662267|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
2662268|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2662269|NCT02110719|Acetaminophen|acetaminophen|mesh-list
2662270|NCT02110719|Dexamethasone|dexamethasone|mesh-list
2662271|NCT02110719|Ibuprofen|ibuprofen|mesh-list
2662272|NCT02110719|Celecoxib|celecoxib|mesh-list
2662273|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2662274|NCT02110719|Oxycodone|oxycodone|mesh-list
2662275|NCT02110719|Gabapentin|gabapentin|mesh-list
2662276|NCT02110719|Hydromorphone|hydromorphone|mesh-list
2662277|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662278|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
2662279|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
2662280|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662281|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662282|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2662283|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
2662284|NCT02110719|Hormones|hormones|mesh-ancestor
2662285|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662286|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2662287|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662288|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2662289|NCT02110719|Analgesics|analgesics|mesh-ancestor
2662290|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
2662291|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
2662292|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2662293|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2662294|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2662295|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662296|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662297|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2662298|NCT02110719|Narcotics|narcotics|mesh-ancestor
2662299|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662300|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
2662301|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2662302|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2662303|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2662304|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2662305|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2662306|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2662307|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
2662308|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2662309|NCT02110745|Propofol|propofol|mesh-list
2662310|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2662311|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662312|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662313|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2662314|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
2662315|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
2662316|NCT02110784|Piperaquine|piperaquine|mesh-list
2662317|NCT02110784|Artenimol|artenimol|mesh-list
2662318|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
2662319|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2662320|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2662321|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662322|NCT02110810|Indomethacin|indomethacin|mesh-list
2662323|NCT02110810|Glycerol|glycerol|mesh-list
2662324|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2662325|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2662326|NCT02110810|Analgesics|analgesics|mesh-ancestor
2662327|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
2662328|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662329|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662330|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662331|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2662332|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
2662333|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
2662334|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2662335|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2662336|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662337|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662338|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2662339|NCT02110810|Protective Agents|protective agents|mesh-ancestor
2662340|NCT02110953|Irinotecan|irinotecan|mesh-list
2662341|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2662342|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2662343|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662344|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662345|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662346|NCT02110966|Tramadol|tramadol|mesh-list
2662347|NCT02110966|Mepivacaine|mepivacaine|mesh-list
2662348|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2662349|NCT02110966|Narcotics|narcotics|mesh-ancestor
2662350|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662351|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662352|NCT02110966|Analgesics|analgesics|mesh-ancestor
2662353|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
2662354|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662355|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
2662356|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
2662357|NCT02110992|Docetaxel|docetaxel|mesh-list
2662358|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662359|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
2662360|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
2662361|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183345|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2183346|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183347|NCT00002738|Antidotes|antidotes|mesh-ancestor
2183348|NCT00002738|Protective Agents|protective agents|mesh-ancestor
2183349|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
2183350|NCT00002738|Vitamins|vitamins|mesh-ancestor
2183351|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
2183352|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
2183353|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183354|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183355|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
2183356|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183357|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183358|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2183359|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183360|NCT00002740|Cobalt|cobalt|mesh-list
2183361|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
2183362|NCT00002740|Carboplatin|carboplatin|mesh-list
2183363|NCT00002740|Doxorubicin|doxorubicin|mesh-list
2183364|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2183365|NCT00002740|Etoposide|etoposide|mesh-list
2183366|NCT00002740|Vincristine|vincristine|mesh-list
2662362|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662363|NCT02111044|Octreotide|octreotide|mesh-list
2662364|NCT02111044|Somatostatin|somatostatin|mesh-list
2662365|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2662366|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2662367|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662368|NCT02111044|Hormones|hormones|mesh-ancestor
2662369|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662370|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662371|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
2662372|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2662373|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2662374|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
2662375|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
2662376|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662377|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662378|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
2662379|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2662380|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
2662381|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
2662382|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2662383|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
2662384|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662385|NCT02111265|Sufentanil|sufentanil|mesh-list
2662386|NCT02111265|Remifentanil|remifentanil|mesh-list
2662387|NCT02111265|Cisatracurium|cisatracurium|mesh-list
2662388|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2183367|NCT00002740|Lenograstim|lenograstim|mesh-list
2183368|NCT00002740|Mesna|mesna|mesh-list
2183369|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662389|NCT02111265|Narcotics|narcotics|mesh-ancestor
2662390|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2183370|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
2183371|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662391|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662392|NCT02111265|Analgesics|analgesics|mesh-ancestor
2662393|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
2662394|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662395|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2662396|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2662397|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
2662398|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
2662399|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2662400|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2662401|NCT02111317|Verapamil|verapamil|mesh-list
2662402|NCT02111317|Peficitinib|peficitinib|mesh-list
2662403|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2662404|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2662405|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2662406|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662407|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2662408|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662409|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
2662410|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662411|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662412|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
2662413|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
2662414|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2662415|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662416|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662417|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2662418|NCT02111421|Analgesics|analgesics|mesh-ancestor
2662419|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
2662420|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662421|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2662422|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2662423|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2662424|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
2662425|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2662426|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662427|NCT02111434|Testosterone|testosterone|mesh-list
2662428|NCT02111434|Androgens|androgens|mesh-ancestor
2662429|NCT02111434|Hormones|hormones|mesh-ancestor
2662430|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662431|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662432|NCT02111473|Testosterone|testosterone|mesh-list
2662433|NCT02111473|Androgens|androgens|mesh-ancestor
2662434|NCT02111473|Hormones|hormones|mesh-ancestor
2662435|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662436|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662437|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
2662438|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2662439|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2662440|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
2662441|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2183372|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183373|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183374|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
2183375|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183376|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183377|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2662442|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662443|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662444|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
2662445|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2662446|NCT02111590|Antibodies|antibodies|mesh-list
2662447|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
2662448|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662449|NCT02111629|Fluconazole|fluconazole|mesh-list
2662450|NCT02111629|Secnidazole|secnidazole|mesh-list
2662451|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
2662452|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662453|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2662454|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2662455|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662456|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662457|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2662458|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
2662459|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662460|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662461|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2662462|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2662463|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2662464|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2662465|NCT02111707|Indomethacin|indomethacin|mesh-list
2662466|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2662467|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2662468|NCT02111707|Analgesics|analgesics|mesh-ancestor
2662469|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
2662470|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662471|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662472|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662473|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2662474|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
2662475|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
2662476|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2662477|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2662478|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662479|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662480|NCT02111850|Aldesleukin|aldesleukin|mesh-list
2662481|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
2662482|NCT02111850|Fludarabine|fludarabine|mesh-list
2662483|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662484|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
2662485|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662486|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2662487|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2662488|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
2662489|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662490|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662491|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2662492|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2662493|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2662494|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
2662495|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662496|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2662497|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2662498|NCT02111941|Vaccines|vaccines|mesh-list
2662499|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
2662500|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662501|NCT02112006|Bupivacaine|bupivacaine|mesh-list
2662502|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
2662503|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
2662504|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2183378|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183379|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183380|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183381|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183382|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183383|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2183384|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
2183385|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
2662505|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662506|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
2662507|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662508|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
2183386|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183387|NCT00002740|Protective Agents|protective agents|mesh-ancestor
2183388|NCT00002740|Trace Elements|trace elements|mesh-ancestor
2183389|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
2183390|NCT00002742|Amphotericin B|amphotericin b|mesh-list
2183391|NCT00002742|Nystatin|nystatin|mesh-list
2183392|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2183393|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
2183394|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
2183395|NCT00002742|Amebicides|amebicides|mesh-ancestor
2183396|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2662509|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662510|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2183397|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2662511|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
2662512|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2662513|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662514|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
2662515|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662516|NCT02112097|Etanercept|etanercept|mesh-list
2662517|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2662518|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2662519|NCT02112097|Analgesics|analgesics|mesh-ancestor
2662520|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
2662521|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662522|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662523|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662524|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2662525|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2662526|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662527|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
2662528|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
2662529|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2662530|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2662531|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662532|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
2662533|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
2662534|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662535|NCT02112175|Lenalidomide|lenalidomide|mesh-list
2662536|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
2662537|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662538|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2662539|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2662540|NCT02112175|Growth Substances|growth substances|mesh-ancestor
2662541|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
2662542|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662543|NCT02112214|Bismuth|bismuth|mesh-list
2662544|NCT02112214|Antacids|antacids|mesh-ancestor
2662545|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662546|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2662547|NCT02112292|Dronabinol|dronabinol|mesh-list
2662548|NCT02112292|Cannabidiol|cannabidiol|mesh-list
2662549|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
2662550|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
2662551|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662552|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2662553|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2662554|NCT02112292|Analgesics|analgesics|mesh-ancestor
2422847|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2422848|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
2422849|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2422850|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2662555|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
2662556|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662557|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2662558|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2662559|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2662560|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662561|NCT02112292|Hormones|hormones|mesh-ancestor
2662562|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662563|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
2662564|NCT02112305|Analgesics|analgesics|mesh-ancestor
2662565|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
2662566|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662567|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662568|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
2662569|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662570|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2662571|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
2662572|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2662573|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2662574|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662575|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2662576|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
2662577|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2422851|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2422852|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422853|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662578|NCT02112422|Dexamethasone|dexamethasone|mesh-list
2662579|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
2662580|NCT02112422|BB 1101|bb 1101|mesh-list
2662581|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662582|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
2662583|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
2662584|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662585|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662586|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2183398|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183399|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2183400|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
2183401|NCT00002742|Ionophores|ionophores|mesh-ancestor
2662587|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
2662588|NCT02112422|Hormones|hormones|mesh-ancestor
2183402|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2183403|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183404|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2183405|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2183406|NCT00002744|Cobalt|cobalt|mesh-list
2183407|NCT00002744|Cytarabine|cytarabine|mesh-list
2183408|NCT00002744|Dexamethasone|dexamethasone|mesh-list
2183409|NCT00002744|Prednisone|prednisone|mesh-list
2183410|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
2183411|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2183412|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2183413|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2183414|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
2183415|NCT00002744|Doxorubicin|doxorubicin|mesh-list
2183416|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2183417|NCT00002744|Methotrexate|methotrexate|mesh-list
2183418|NCT00002744|Vincristine|vincristine|mesh-list
2183419|NCT00002744|Daunorubicin|daunorubicin|mesh-list
2662589|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662590|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2662591|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662592|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
2662593|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662594|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662595|NCT02112487|Macitentan|macitentan|mesh-list
2662596|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2662597|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2662598|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662599|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2662600|NCT02112552|Paclitaxel|paclitaxel|mesh-list
2662601|NCT02112552|Carboplatin|carboplatin|mesh-list
2662602|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2662603|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662604|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
2662605|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
2662606|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
2662607|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662608|NCT02112578|Meclizine|meclizine|mesh-list
2662609|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
2662610|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
2662611|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
2662612|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662613|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662614|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2662615|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2662616|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
2662617|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
2662618|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2662619|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662620|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2662621|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2662622|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662623|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662624|NCT02112630|Interferons|interferons|mesh-list
2662625|NCT02112630|Ribavirin|ribavirin|mesh-list
2662626|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
2662627|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
2662628|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2183420|NCT00002744|Asparaginase|asparaginase|mesh-list
2183421|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
2183422|NCT00002744|Thioguanine|thioguanine|mesh-list
2662629|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2662630|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2662631|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662632|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
2662633|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662634|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
2662635|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662636|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
2662637|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662638|NCT02112643|Selenium|selenium|mesh-list
2662639|NCT02112643|Selenic Acid|selenic acid|mesh-list
2662640|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
2662641|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662642|NCT02112643|Protective Agents|protective agents|mesh-ancestor
2662643|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662644|NCT02112643|Trace Elements|trace elements|mesh-ancestor
2662645|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
2662646|NCT02112695|Diprenorphine|diprenorphine|mesh-list
2662647|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2662648|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662649|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
2662650|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662651|NCT02112721|Vitamin D|vitamin d|mesh-list
2662652|NCT02112721|Vitamins|vitamins|mesh-ancestor
2662653|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
2662654|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662655|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2662656|NCT02112734|Vitamin D|vitamin d|mesh-list
2662657|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
2662658|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
2662659|NCT02112734|Vitamins|vitamins|mesh-list
2662660|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
2662661|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662662|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2662663|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2662664|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2662665|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
2662666|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662667|NCT02112864|Dexamethasone|dexamethasone|mesh-list
2662668|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662669|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
2662670|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
2662671|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662672|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662673|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2662674|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
2662675|NCT02112864|Hormones|hormones|mesh-ancestor
2662676|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662677|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2662678|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662679|NCT02112903|Vortioxetine|vortioxetine|mesh-list
2662680|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
2662681|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2662682|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2662683|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2662684|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662685|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662686|NCT02112903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2662687|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2662688|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2662689|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662690|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2662691|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
2662692|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2662693|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2662694|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2662695|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2662696|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
2662697|NCT02112916|Leucovorin|leucovorin|mesh-list
2662698|NCT02112916|Folic Acid|folic acid|mesh-list
2662699|NCT02112916|Cytarabine|cytarabine|mesh-list
2662700|NCT02112916|Dexamethasone|dexamethasone|mesh-list
2662701|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
2662702|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
2662703|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2662704|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2662705|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2662706|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
2662707|NCT02112916|Ifosfamide|ifosfamide|mesh-list
2183423|NCT00002744|Pegaspargase|pegaspargase|mesh-list
2183424|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183425|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
2662708|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
2662709|NCT02112916|Doxorubicin|doxorubicin|mesh-list
2662710|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2662711|NCT02112916|Methotrexate|methotrexate|mesh-list
2662712|NCT02112916|Etoposide|etoposide|mesh-list
2183426|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183427|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183428|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183429|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
2183430|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183431|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183432|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183433|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2183434|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
2183435|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
2183436|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2183437|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2183438|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
2183439|NCT00002744|Hormones|hormones|mesh-ancestor
2183440|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2183441|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183442|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183443|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2662713|NCT02112916|Vincristine|vincristine|mesh-list
2662714|NCT02112916|Bortezomib|bortezomib|mesh-list
2662715|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
2662716|NCT02112916|Daunorubicin|daunorubicin|mesh-list
2662717|NCT02112916|Asparaginase|asparaginase|mesh-list
2662718|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
2662719|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
2662720|NCT02112916|Thioguanine|thioguanine|mesh-list
2662721|NCT02112916|Pegaspargase|pegaspargase|mesh-list
2662722|NCT02112916|BB 1101|bb 1101|mesh-list
2662723|NCT02112916|Calcium|calcium|mesh-list
2662724|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
2662725|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
2662726|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662727|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
2662728|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662729|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2662730|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2662731|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
2662732|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662733|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662734|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2662735|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662736|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
2662737|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
2662738|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662739|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2662740|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
2662741|NCT02112916|Hormones|hormones|mesh-ancestor
2662742|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662743|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2662744|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
2662745|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662746|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2662747|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2662748|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2662749|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2662750|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2662751|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2662752|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
2662753|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2662754|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2662755|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
2662756|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
2183444|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183445|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183446|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2662757|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2662758|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2662759|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2662760|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
2183447|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
2183448|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2183449|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183450|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
2183451|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
2183452|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2183453|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2183454|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
2183455|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183456|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183457|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
2183458|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
2183459|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183460|NCT00002744|Trace Elements|trace elements|mesh-ancestor
2183461|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
2183462|NCT00002746|Aldesleukin|aldesleukin|mesh-list
2183463|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183464|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2183465|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2183466|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
2183467|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662761|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662762|NCT02112916|Antidotes|antidotes|mesh-ancestor
2662763|NCT02112916|Protective Agents|protective agents|mesh-ancestor
2662764|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
2662765|NCT02112916|Vitamins|vitamins|mesh-ancestor
2662766|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
2662767|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
2662768|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
2662769|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
2662770|NCT02112916|Hematinics|hematinics|mesh-ancestor
2662771|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
2662772|NCT02112929|Xenon|xenon|mesh-list
2662773|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2662774|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
2662775|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
2662776|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662777|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662778|NCT02112981|Sirolimus|sirolimus|mesh-list
2662779|NCT02112981|Everolimus|everolimus|mesh-list
2662780|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662781|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662782|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
2662783|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662784|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2662785|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662786|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2662787|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
2662788|NCT02113072|Beclomethasone|beclomethasone|mesh-list
2662789|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662790|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
2662791|NCT02113072|Hormones|hormones|mesh-ancestor
2662792|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662793|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662794|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2662795|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
2662796|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
2662797|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
2662798|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
2183468|NCT00002747|Cobalt|cobalt|mesh-list
2183469|NCT00002747|Fluorouracil|fluorouracil|mesh-list
2183470|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183471|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
2183472|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183473|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2662799|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662800|NCT02113150|Ketamine|ketamine|mesh-list
2662801|NCT02113150|Remifentanil|remifentanil|mesh-list
2662802|NCT02113150|Analgesics|analgesics|mesh-ancestor
2662803|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
2662804|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662805|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662806|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2662807|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2183474|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662808|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
2662809|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
2662810|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662811|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2662812|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2662813|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2662814|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662815|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2662816|NCT02113150|Narcotics|narcotics|mesh-ancestor
2662817|NCT02113163|Metformin|metformin|mesh-list
2662818|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2662819|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2662820|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662821|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2662822|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2662823|NCT02113176|Minocycline|minocycline|mesh-list
2662824|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2662825|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662826|NCT02113202|Bevacizumab|bevacizumab|mesh-list
2662827|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2662828|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662829|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2662830|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2662831|NCT02113202|Growth Substances|growth substances|mesh-ancestor
2662832|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662833|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
2662834|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
2662835|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662836|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
2662837|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2662838|NCT02113319|Dasatinib|dasatinib|mesh-list
2662839|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662840|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2662841|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662842|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662843|NCT02113332|Liraglutide|liraglutide|mesh-list
2662844|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2662845|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662846|NCT02113332|Incretins|incretins|mesh-ancestor
2662847|NCT02113332|Hormones|hormones|mesh-ancestor
2662848|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662849|NCT02113397|Tobramycin|tobramycin|mesh-list
2662850|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2662851|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662852|NCT02113540|Atorvastatin|atorvastatin|mesh-list
2662853|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2662854|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2662855|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
2662856|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662857|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2662858|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2662859|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662860|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2662861|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
2662862|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2662863|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
2662864|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2662865|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662866|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2662867|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2662868|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662869|NCT02113566|Acetaminophen|acetaminophen|mesh-list
2662870|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2662871|NCT02113566|Analgesics|analgesics|mesh-ancestor
2662872|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
2662873|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662874|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662875|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
2662876|NCT02113631|Interferons|interferons|mesh-list
2662877|NCT02113631|Ribavirin|ribavirin|mesh-list
2662878|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
2662879|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
2662880|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2662881|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662882|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
2662883|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662884|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
2662885|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662886|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
2662887|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662888|NCT02113657|Ipilimumab|ipilimumab|mesh-list
2662889|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2662890|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662891|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2662892|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662893|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2662894|NCT02113735|Hormones|hormones|mesh-ancestor
2662895|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662896|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662897|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
2662898|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2662899|NCT02113800|Everolimus|everolimus|mesh-list
2662900|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662901|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662902|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
2662903|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662904|NCT02113813|Naquotinib|naquotinib|mesh-list
2662905|NCT02113813|Midazolam|midazolam|mesh-list
2662906|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2662907|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2662908|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662909|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662910|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2662911|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2662912|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2662913|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2662914|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
2662915|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
2662916|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
2662917|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
2662918|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2662919|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662920|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662921|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2662922|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662925|NCT02113891|Eculizumab|eculizumab|mesh-list
2662926|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2662927|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662928|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
2662929|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662930|NCT02113904|Adalimumab|adalimumab|mesh-list
2662931|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662932|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2662933|NCT02113943|Citalopram|citalopram|mesh-list
2662934|NCT02113943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2662935|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2662936|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2662937|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662938|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2662939|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
2662940|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662941|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2662942|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
2662943|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2662944|NCT02114021|Betamethasone|betamethasone|mesh-list
2662945|NCT02114021|Lidocaine|lidocaine|mesh-list
2662946|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
2662947|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
2183475|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
2183476|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183477|NCT00002747|Trace Elements|trace elements|mesh-ancestor
2183478|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
2183479|NCT00002748|Interleukin-2|interleukin-2|mesh-list
2183480|NCT00002748|Vaccines|vaccines|mesh-list
2183481|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183482|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2183483|NCT00002748|Analgesics|analgesics|mesh-ancestor
2183484|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
2183485|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2183486|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183487|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
2183488|NCT00002749|Carboplatin|carboplatin|mesh-list
2183489|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2662948|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2662949|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662950|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
2662951|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2662952|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2662953|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2662954|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2662955|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2662956|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662957|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662958|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
2662959|NCT02114021|Hormones|hormones|mesh-ancestor
2662960|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662961|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2662962|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
2662963|NCT02114060|Vaccines|vaccines|mesh-list
2662964|NCT02114060|Immunologic Factors|immunologic factors|mesh-ancestor
2662965|NCT02114060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662966|NCT02114073|Cyclosporine|cyclosporine|mesh-list
2662967|NCT02114073|Betamethasone|betamethasone|mesh-list
2662968|NCT02114073|Cyclosporins|cyclosporins|mesh-list
2662969|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662970|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662971|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2662972|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
2662973|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662974|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
2662975|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2662976|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
2662977|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2662978|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2662979|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2662980|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
2662981|NCT02114073|Hormones|hormones|mesh-ancestor
2662982|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2662983|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2662984|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
2662985|NCT02114099|Atorvastatin|atorvastatin|mesh-list
2183490|NCT00002750|Melphalan|melphalan|mesh-list
2183491|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183492|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
2183493|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183494|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183495|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183496|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183497|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
2662986|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2183498|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183499|NCT00002751|Antibodies|antibodies|mesh-list
2183500|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2183501|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
2183502|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2662987|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2662988|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
2662989|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2662990|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2662991|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2662992|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2662993|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
2662994|NCT02114229|Carboplatin|carboplatin|mesh-list
2662995|NCT02114229|Methotrexate|methotrexate|mesh-list
2662996|NCT02114229|Etoposide|etoposide|mesh-list
2662997|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
2662998|NCT02114229|Vincristine|vincristine|mesh-list
2662999|NCT02114229|Topotecan|topotecan|mesh-list
2663000|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2663001|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
2663002|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183503|NCT00002752|Antibodies|antibodies|mesh-list
2183504|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2183505|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
2183506|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183507|NCT00002753|Antibodies|antibodies|mesh-list
2183508|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2183509|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
2183510|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183511|NCT00002754|Antibodies|antibodies|mesh-list
2183512|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2663003|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2663004|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2663005|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
2663006|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663007|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663008|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2663009|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2663010|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
2663011|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2663012|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2663013|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
2663014|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
2183513|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
2183514|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183515|NCT00002755|Tamoxifen|tamoxifen|mesh-list
2183516|NCT00002755|Cobalt|cobalt|mesh-list
2183517|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
2663015|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663016|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2663017|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2663018|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2663019|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2663020|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2663021|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
2663022|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
2663023|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
2663024|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2663025|NCT02114333|Vaccines|vaccines|mesh-list
2663026|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
2663027|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663028|NCT02114346|Atorvastatin|atorvastatin|mesh-list
2663029|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2663030|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2663031|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
2663032|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663033|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2663034|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2663035|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663036|NCT02114359|Cisplatin|cisplatin|mesh-list
2183518|NCT00002755|Thiotepa|thiotepa|mesh-list
2183519|NCT00002755|Doxorubicin|doxorubicin|mesh-list
2183520|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2183521|NCT00002755|Fluorouracil|fluorouracil|mesh-list
2183522|NCT00002755|Methotrexate|methotrexate|mesh-list
2183523|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183524|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
2183525|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663037|NCT02114359|Fluorouracil|fluorouracil|mesh-list
2663038|NCT02114359|Capecitabine|capecitabine|mesh-list
2663039|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
2663040|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663041|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
2663042|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663043|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2663044|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2663045|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
2663046|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663047|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
2663048|NCT02114463|Analgesics|analgesics|mesh-list
2663049|NCT02114463|Ropivacaine|ropivacaine|mesh-list
2663050|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
2663051|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
2663052|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2663053|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663054|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
2663055|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663056|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2663057|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2663058|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2663059|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2663060|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2663061|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663062|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663063|NCT02114476|Progestins|progestins|mesh-list
2183526|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183527|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2663064|NCT02114476|Hormones|hormones|mesh-ancestor
2663065|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663066|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663067|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
2663068|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2663069|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663070|NCT02114502|Pyridoxine|pyridoxine|mesh-list
2663071|NCT02114502|Gemcitabine|gemcitabine|mesh-list
2663072|NCT02114502|Dexamethasone|dexamethasone|mesh-list
2663073|NCT02114502|Melphalan|melphalan|mesh-list
2663074|NCT02114502|Busulfan|busulfan|mesh-list
2663075|NCT02114502|Vorinostat|vorinostat|mesh-list
2663076|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2183528|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
2183529|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183530|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183531|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183532|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183533|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183534|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183535|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183536|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
2183537|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183538|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2183539|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
2183540|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2663077|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
2663078|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
2663079|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663080|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663081|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2663082|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
2663083|NCT02114502|Hormones|hormones|mesh-ancestor
2663084|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663085|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2663086|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663087|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2663088|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
2663089|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663090|NCT02114502|Antiviral Agents|antiviral agents|mesh-ancestor
2663091|NCT02114502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663092|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663093|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2663094|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
2663095|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2663096|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
2663097|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2663098|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2663099|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
2663100|NCT02114502|Vitamins|vitamins|mesh-ancestor
2663101|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
2663102|NCT02114528|Amiodarone|amiodarone|mesh-list
2663103|NCT02114528|Sotalol|sotalol|mesh-list
2663104|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2663105|NCT02114528|Mexiletine|mexiletine|mesh-list
2663106|NCT02114528|Procainamide|procainamide|mesh-list
2663107|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
2183541|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
2183542|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2183543|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2183544|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2663108|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2663109|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2663110|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663111|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2663112|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2663113|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2663114|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663115|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2663116|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2663117|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2663118|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2663119|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2663120|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
2663121|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2663122|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663123|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
2663124|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
2663125|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663126|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2663127|NCT02114645|Leuprolide|leuprolide|mesh-list
2663128|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2663129|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2663130|NCT02114645|Estradiol|estradiol|mesh-list
2663131|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2663132|NCT02114645|Progesterone|progesterone|mesh-list
2663133|NCT02114645|Estrogens|estrogens|mesh-ancestor
2663134|NCT02114645|Hormones|hormones|mesh-ancestor
2663135|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663136|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663137|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2663138|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
2663139|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2663140|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2663141|NCT02114645|Progestins|progestins|mesh-ancestor
2663142|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2663143|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
2663144|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2663145|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663146|NCT02114658|Sorafenib|sorafenib|mesh-list
2663147|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663148|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2663149|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663150|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663151|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
2663152|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2663153|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663154|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2663155|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2663156|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663157|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663158|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663159|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2663160|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2663161|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2663162|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2663163|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2663164|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
2663165|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663166|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2663167|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2663168|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663169|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
2663170|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2663171|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
2663172|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2663173|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2663174|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2663175|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663176|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
2663177|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2663178|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663179|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2663180|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663181|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
2663182|NCT02114775|Hormones|hormones|mesh-list
2663183|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663184|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663185|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
2663186|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2663187|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2663188|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663189|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663190|NCT02114775|Urological Agents|urological agents|mesh-ancestor
2663191|NCT02115035|Vemurafenib|vemurafenib|mesh-list
2663192|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663193|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2663194|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663195|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663196|NCT02115074|Celecoxib|celecoxib|mesh-list
2663197|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2663198|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2663199|NCT02115074|Analgesics|analgesics|mesh-ancestor
2663200|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
2663201|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663202|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663203|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2663204|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2663205|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2663206|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2663207|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663208|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663209|NCT02115087|Morphine|morphine|mesh-list
2663210|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2663211|NCT02115087|Narcotics|narcotics|mesh-ancestor
2663212|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2663213|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663214|NCT02115087|Analgesics|analgesics|mesh-ancestor
2663215|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
2663216|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663217|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
2663218|NCT02115152|Fluorouracil|fluorouracil|mesh-list
2663219|NCT02115152|Capecitabine|capecitabine|mesh-list
2663220|NCT02115152|Epirubicin|epirubicin|mesh-list
2663221|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2663222|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
2663223|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663224|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2663225|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2663226|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
2663227|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663228|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663229|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2663230|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
2663231|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2663232|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2663233|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2663234|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2663235|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663236|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
2663237|NCT02115204|Docetaxel|docetaxel|mesh-list
2663238|NCT02115204|Fluorouracil|fluorouracil|mesh-list
2663239|NCT02115204|Methotrexate|methotrexate|mesh-list
2663240|NCT02115204|Epirubicin|epirubicin|mesh-list
2663241|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2663242|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
2663243|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663244|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2663245|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2663246|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
2663247|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663248|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663249|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2663250|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
2663251|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
2663252|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
2663253|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
2663254|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183545|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
2184888|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663255|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2663256|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
2663257|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2663258|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
2663259|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663260|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2663261|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2663262|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2663263|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2663264|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2663265|NCT02115243|Ipilimumab|ipilimumab|mesh-list
2663266|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2663267|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663268|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2663269|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663270|NCT02115295|Cytarabine|cytarabine|mesh-list
2663271|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
2663272|NCT02115295|Venetoclax|venetoclax|mesh-list
2663273|NCT02115295|Idarubicin|idarubicin|mesh-list
2183546|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2183547|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183548|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2183549|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2183550|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2183551|NCT00002755|Trace Elements|trace elements|mesh-ancestor
2183552|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
2183553|NCT00002756|Leucovorin|leucovorin|mesh-list
2183554|NCT00002756|Cytarabine|cytarabine|mesh-list
2183555|NCT00002756|Prednisone|prednisone|mesh-list
2183556|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
2663274|NCT02115295|Cladribine|cladribine|mesh-list
2663275|NCT02115295|Midostaurin|midostaurin|mesh-list
2663276|NCT02115295|Staurosporine|staurosporine|mesh-list
2663277|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2663278|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
2663279|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663280|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663281|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
2663282|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663283|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2663284|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
2663285|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663286|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2663287|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2663288|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2663289|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663290|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2663291|NCT02115360|Calcitonin|calcitonin|mesh-list
2663292|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
2663293|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2663294|NCT02115360|Fentanyl|fentanyl|mesh-list
2663295|NCT02115360|Katacalcin|katacalcin|mesh-list
2663296|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2663297|NCT02115360|Narcotics|narcotics|mesh-ancestor
2663298|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2663299|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663300|NCT02115360|Analgesics|analgesics|mesh-ancestor
2663301|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
2663302|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663303|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2663304|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2663305|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
2663306|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
2663307|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2663308|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2663309|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
2663310|NCT02115464|Metformin|metformin|mesh-list
2663311|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2663312|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663313|NCT02115490|Diphosphonates|diphosphonates|mesh-list
2663314|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2663315|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663316|NCT02115529|Nabilone|nabilone|mesh-list
2663317|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
2663318|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
2663319|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663320|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663321|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2663322|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2663323|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2663324|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2663325|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2663326|NCT02115594|Fulvestrant|fulvestrant|mesh-list
2663327|NCT02115594|Entinostat|entinostat|mesh-list
2663328|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2663329|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663330|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2663331|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2663332|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
2663333|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663334|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663335|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2663336|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663337|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663338|NCT02115659|Triptolide|triptolide|mesh-list
2663339|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2663340|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663341|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2663342|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
2663343|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2663344|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2663345|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
2663346|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2663347|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
2663348|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663349|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663350|NCT02115724|Vitamins|vitamins|mesh-list
2663351|NCT02115724|Vitamin E|vitamin e|mesh-list
2663352|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
2663353|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
2663354|NCT02115724|Antioxidants|antioxidants|mesh-list
2663355|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
2663356|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663357|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663358|NCT02115724|Protective Agents|protective agents|mesh-ancestor
2663359|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
2663360|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
2663361|NCT02115763|Caffeine|caffeine|mesh-list
2663362|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2183557|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2183558|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2183559|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2183560|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
2183561|NCT00002756|Methotrexate|methotrexate|mesh-list
2183562|NCT00002756|Etoposide|etoposide|mesh-list
2183563|NCT00002756|Vincristine|vincristine|mesh-list
2183564|NCT00002756|Daunorubicin|daunorubicin|mesh-list
2183565|NCT00002756|Asparaginase|asparaginase|mesh-list
2183566|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
2183567|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
2663363|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663364|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2663365|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663366|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663367|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2663368|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2663369|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
2663370|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2663371|NCT02115776|Amoxicillin|amoxicillin|mesh-list
2663372|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
2663373|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
2663374|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
2663375|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2663376|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663377|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2663378|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
2663379|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2663380|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663381|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663382|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
2663383|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2663384|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2663385|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663386|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2663387|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2663388|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
2663389|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2663390|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
2663391|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2663392|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
2663393|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2663394|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
2663395|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663396|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663397|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
2183568|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2663398|NCT02116231|Cisplatin|cisplatin|mesh-list
2663399|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663400|NCT02116257|Propacetamol|propacetamol|mesh-list
2663401|NCT02116257|Analgesics|analgesics|mesh-ancestor
2663402|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
2663403|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663404|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663405|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2663406|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2663407|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2663408|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2663409|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
2663410|NCT02116348|Mitogens|mitogens|mesh-list
2663411|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
2663412|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663413|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2663414|NCT02116348|Protective Agents|protective agents|mesh-ancestor
2663415|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663416|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
2663417|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
2663418|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
2663419|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2663420|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663421|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663422|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
2663423|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2663424|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2663425|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663426|NCT02116465|Levodopa|levodopa|mesh-list
2663427|NCT02116465|Carbidopa|carbidopa|mesh-list
2663428|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2663429|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2663430|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2663431|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
2663432|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2663433|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663434|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663435|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2663436|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663437|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2663438|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
2663439|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
2663440|NCT02116556|Rifaximin|rifaximin|mesh-list
2663441|NCT02116556|Prednisone|prednisone|mesh-list
2663442|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2663443|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
2663444|NCT02116556|Hormones|hormones|mesh-ancestor
2663445|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663446|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663447|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2663448|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663449|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2663450|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663451|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2663452|NCT02116569|Daratumumab|daratumumab|mesh-list
2663453|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663454|NCT02116712|Saracatinib|saracatinib|mesh-list
2663455|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663456|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663457|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663458|NCT02116790|Naproxen|naproxen|mesh-list
2663459|NCT02116790|Levodopa|levodopa|mesh-list
2663460|NCT02116790|Carbidopa|carbidopa|mesh-list
2663461|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2663462|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2663463|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2663464|NCT02116790|Analgesics|analgesics|mesh-ancestor
2663465|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
2663466|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663467|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663468|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2663469|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2663470|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
2663471|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2663472|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663473|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663474|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2663475|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2663476|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
2663477|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2663478|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2663479|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2663480|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
2663481|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
2663482|NCT02116842|Fentanyl|fentanyl|mesh-list
2663483|NCT02116842|Bupivacaine|bupivacaine|mesh-list
2663484|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
2663485|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
2663486|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2663487|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663488|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
2663489|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663490|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2663491|NCT02116842|Narcotics|narcotics|mesh-ancestor
2663492|NCT02116842|Analgesics|analgesics|mesh-ancestor
2663493|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2663494|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2663495|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
2663496|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
2663497|NCT02116868|Nicardipine|nicardipine|mesh-list
2663498|NCT02116868|Urapidil|urapidil|mesh-list
2663499|NCT02116868|Remifentanil|remifentanil|mesh-list
2663500|NCT02116868|Esmolol|esmolol|mesh-list
2663501|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2663502|NCT02116868|Narcotics|narcotics|mesh-ancestor
2663503|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2663504|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663505|NCT02116868|Analgesics|analgesics|mesh-ancestor
2663506|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
2663507|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663508|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2663509|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2663510|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2663511|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
2663512|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2663513|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663514|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2663515|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2663516|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2663517|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
2663518|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2663519|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
2663520|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2663521|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2663522|NCT02116959|Carboplatin|carboplatin|mesh-list
2663523|NCT02116959|Etoposide|etoposide|mesh-list
2663524|NCT02116959|Vincristine|vincristine|mesh-list
2663525|NCT02116959|Melphalan|melphalan|mesh-list
2663526|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663527|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2663528|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2663529|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2663530|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663531|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663532|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
2663533|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
2663534|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
2663535|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2663536|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
2663537|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2663538|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2663539|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
2663540|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663541|NCT02116998|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2663542|NCT02116998|Vaccines|vaccines|mesh-list
2663543|NCT02116998|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2663544|NCT02116998|Immunologic Factors|immunologic factors|mesh-ancestor
2663545|NCT02116998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663546|NCT02116998|Antacids|antacids|mesh-ancestor
2663547|NCT02116998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663548|NCT02116998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2663549|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
2663550|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2663551|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2183569|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
2183570|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183571|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183572|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183573|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
2183574|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183575|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183576|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183577|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2183578|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
2183579|NCT00002756|Hormones|hormones|mesh-ancestor
2183580|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663552|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663553|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
2663554|NCT02117128|Coagulants|coagulants|mesh-ancestor
2663555|NCT02117141|Hydrocodone|hydrocodone|mesh-list
2663556|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2663557|NCT02117141|Narcotics|narcotics|mesh-ancestor
2663558|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2663559|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663560|NCT02117141|Analgesics|analgesics|mesh-ancestor
2663561|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
2663562|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663563|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
2663564|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
2663565|NCT02117167|Pemetrexed|pemetrexed|mesh-list
2663566|NCT02117167|Durvalumab|durvalumab|mesh-list
2663567|NCT02117167|Olaparib|olaparib|mesh-list
2663568|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663569|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663570|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663571|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2663572|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2663573|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2663574|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2663575|NCT02117219|Azacitidine|azacitidine|mesh-list
2663576|NCT02117219|Durvalumab|durvalumab|mesh-list
2663577|NCT02117219|Tremelimumab|tremelimumab|mesh-list
2663578|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2663579|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
2663580|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663581|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663582|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663583|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2663584|NCT02117362|Ipilimumab|ipilimumab|mesh-list
2663585|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2663586|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663587|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2663588|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663589|NCT02117401|Midazolam|midazolam|mesh-list
2663590|NCT02117401|Ketamine|ketamine|mesh-list
2663591|NCT02117401|Remifentanil|remifentanil|mesh-list
2663592|NCT02117401|Propofol|propofol|mesh-list
2663593|NCT02117401|Mivacurium|mivacurium|mesh-list
2663594|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2663595|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2663596|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663597|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2663598|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
2663599|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
2663600|NCT02117401|Analgesics|analgesics|mesh-ancestor
2663601|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
2663602|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663603|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2663604|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2663605|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2663606|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2663607|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183581|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183582|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2183583|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
2184889|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2663608|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2663609|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2663610|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2663611|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2663612|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
2663613|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
2663614|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2663615|NCT02117401|Narcotics|narcotics|mesh-ancestor
2663616|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2183584|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2183585|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2663617|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2663618|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2663619|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2663620|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2663621|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2663622|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
2663623|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663624|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2663625|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2663626|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663627|NCT02117466|Cetuximab|cetuximab|mesh-list
2663628|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2663629|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663630|NCT02117583|Oxycodone|oxycodone|mesh-list
2663631|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2663632|NCT02117583|Narcotics|narcotics|mesh-ancestor
2663633|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2663634|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663635|NCT02117583|Analgesics|analgesics|mesh-ancestor
2663636|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
2663637|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663638|NCT02117596|Sirolimus|sirolimus|mesh-list
2663639|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2663640|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663641|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2663642|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663643|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
2663644|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2663645|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
2663646|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663647|NCT02117622|Insulin|insulin|mesh-list
2663648|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2663649|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663650|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
2663651|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2663652|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
2663653|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663654|NCT02117700|Expectorants|expectorants|mesh-ancestor
2183586|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
2183587|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
2183588|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183589|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2422854|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
2663655|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
2663656|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2663657|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
2663658|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663659|NCT02117700|Protective Agents|protective agents|mesh-ancestor
2663660|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663661|NCT02117700|Antidotes|antidotes|mesh-ancestor
2663662|NCT02117726|Midazolam|midazolam|mesh-list
2663663|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
2663664|NCT02117726|Propofol|propofol|mesh-list
2663665|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2663666|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2663667|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663668|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2663669|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
2422855|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422856|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422857|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2422858|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2422859|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422860|NCT00819104|Metoprolol|metoprolol|mesh-list
2422861|NCT00819104|Amlodipine|amlodipine|mesh-list
2422862|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2663670|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
2663671|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2663672|NCT02117726|Analgesics|analgesics|mesh-ancestor
2663673|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
2663674|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663675|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2663676|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2663677|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2663678|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
2663679|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2663680|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663681|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2663682|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2663683|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2663684|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2663685|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
2663686|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
2663687|NCT02117739|Dapsone|dapsone|mesh-list
2663688|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663689|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
2663690|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2663691|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2663692|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2663693|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663694|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663695|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
2663696|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2663697|NCT02117752|Dapsone|dapsone|mesh-list
2183590|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2183591|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183592|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2663698|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663699|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
2663700|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2663701|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2663702|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2663703|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663704|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663705|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
2663706|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2663707|NCT02117765|Ustekinumab|ustekinumab|mesh-list
2663708|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
2663711|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
2663712|NCT02117830|Enclomiphene|enclomiphene|mesh-list
2663713|NCT02117830|Clomiphene|clomiphene|mesh-list
2663714|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
2663715|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2663716|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663717|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2663718|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2663719|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663720|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663721|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183593|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183594|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
2183595|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183596|NCT00002756|Antidotes|antidotes|mesh-ancestor
2183597|NCT00002756|Protective Agents|protective agents|mesh-ancestor
2183598|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
2183599|NCT00002756|Vitamins|vitamins|mesh-ancestor
2183600|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
2183601|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
2663722|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2663723|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663724|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2663725|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
2663726|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663727|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2663728|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
2663729|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2663730|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2663731|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
2663732|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663733|NCT02117869|Furocoumarins|furocoumarins|mesh-list
2663734|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
2663735|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2663736|NCT02117986|Colistin|colistin|mesh-list
2663737|NCT02117986|Polymyxins|polymyxins|mesh-list
2663738|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2663739|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663740|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2663741|NCT02118051|Progesterone|progesterone|mesh-list
2663742|NCT02118051|Ganirelix|ganirelix|mesh-list
2663743|NCT02118051|Progestins|progestins|mesh-ancestor
2663744|NCT02118051|Hormones|hormones|mesh-ancestor
2663745|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663746|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663747|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
2663748|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2663749|NCT02118064|Irinotecan|irinotecan|mesh-list
2663750|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2663751|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2663752|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663753|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663754|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663755|NCT02118090|Chloroquine|chloroquine|mesh-list
2663756|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2663757|NCT02118090|Amebicides|amebicides|mesh-ancestor
2663758|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2663759|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2663760|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663761|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
2663762|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2663763|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2663764|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2663765|NCT02118090|Analgesics|analgesics|mesh-ancestor
2663766|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
2663767|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663768|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663769|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2663770|NCT02118090|Filaricides|filaricides|mesh-ancestor
2663771|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
2663772|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
2663773|NCT02118142|Betaine|betaine|mesh-list
2663774|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2663775|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
2663776|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2663777|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
2663778|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663779|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2663780|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
2663781|NCT02118285|Fludarabine|fludarabine|mesh-list
2663782|NCT02118285|Interleukin-2|interleukin-2|mesh-list
2663783|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2663784|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
2663785|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663786|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2663787|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2663788|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
2663789|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663790|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663791|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2663792|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2663793|NCT02118285|Analgesics|analgesics|mesh-ancestor
2663794|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
2663795|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663796|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
2663797|NCT02118311|Fludarabine|fludarabine|mesh-list
2663798|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2663799|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
2663800|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663801|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2663802|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2663803|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
2663804|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663805|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663806|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2663807|NCT02118376|Exenatide|exenatide|mesh-list
2663808|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2663809|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663810|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2663811|NCT02118376|Incretins|incretins|mesh-ancestor
2663812|NCT02118376|Hormones|hormones|mesh-ancestor
2663813|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663814|NCT02118467|Phenylephrine|phenylephrine|mesh-list
2663815|NCT02118467|Vasopressins|vasopressins|mesh-list
2663816|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
2663817|NCT02118467|Epinephrine|epinephrine|mesh-list
2663818|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
2663819|NCT02118467|Norepinephrine|norepinephrine|mesh-list
2663820|NCT02118467|Synephrine|synephrine|mesh-list
2663821|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2663822|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2663823|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
2663824|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2663825|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663826|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663827|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2663828|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2663829|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
2663830|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663831|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2663832|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
2663833|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
2663834|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
2663835|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2663836|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2663837|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
2663838|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2663839|NCT02118467|Protective Agents|protective agents|mesh-ancestor
2663840|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
2663841|NCT02118467|Coagulants|coagulants|mesh-ancestor
2663842|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2663843|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
2663844|NCT02118532|Paclitaxel|paclitaxel|mesh-list
2663845|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2663846|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663847|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
2663848|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
2663849|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
2663850|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663855|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
2663856|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663857|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2663858|NCT02118675|Protective Agents|protective agents|mesh-ancestor
2663859|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663860|NCT02118688|Risperidone|risperidone|mesh-list
2663861|NCT02118688|Trazodone|trazodone|mesh-list
2663862|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2663863|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
2663864|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2663865|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663866|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663867|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2663868|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2663869|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2663870|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2663871|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2663872|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
2663873|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2663874|NCT02118688|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2663875|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2663876|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2663877|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2663878|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
2663879|NCT02118727|Memantine|memantine|mesh-list
2663880|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2663881|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2663882|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
2663883|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2663884|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663885|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663886|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2663887|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2663888|NCT02118753|Eplerenone|eplerenone|mesh-list
2663889|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2663890|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
2663891|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663892|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663893|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2663894|NCT02118753|Diuretics|diuretics|mesh-ancestor
2663895|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
2663896|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2663897|NCT02118844|Rocuronium|rocuronium|mesh-list
2663898|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2663899|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2663900|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2183602|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
2183603|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
2663901|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663902|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663903|NCT02118870|Aspirin|aspirin|mesh-list
2663904|NCT02118870|Clopidogrel|clopidogrel|mesh-list
2663905|NCT02118870|Ticagrelor|ticagrelor|mesh-list
2663906|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2663907|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2663908|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2663909|NCT02118870|Analgesics|analgesics|mesh-ancestor
2663910|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
2663911|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663912|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663913|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2663914|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2663915|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2663916|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2663917|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663918|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2663919|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2663920|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663921|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
2663922|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2663923|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2663924|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2663925|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
2663926|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2663927|NCT02118909|Itraconazole|itraconazole|mesh-list
2663928|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
2663929|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
2663930|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663931|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2663932|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2663933|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663934|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663935|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2663936|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
2663937|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663938|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663939|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2663940|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2663941|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2663942|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2663943|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663944|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2663945|NCT02118987|Omalizumab|omalizumab|mesh-list
2663946|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2663947|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2663948|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
2663949|NCT02119000|Bisacodyl|bisacodyl|mesh-list
2663950|NCT02119000|Cathartics|cathartics|mesh-ancestor
2663951|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2663952|NCT02119000|Laxatives|laxatives|mesh-ancestor
2663953|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2663954|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2663955|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
2663956|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2663957|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2663958|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2663959|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2663960|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2663961|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663962|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2663963|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
2663964|NCT02119117|Vitamins|vitamins|mesh-ancestor
2663965|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
2663966|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663967|NCT02119143|Vitamins|vitamins|mesh-list
2663968|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
2663969|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663970|NCT02119234|Beclomethasone|beclomethasone|mesh-list
2663971|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
2663972|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
2663973|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2663974|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
2663975|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2663976|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663977|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2663978|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
2663979|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2663980|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2663981|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2663982|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
2663983|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2663984|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2663985|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2663986|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2663987|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2663988|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
2663989|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2663990|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
2663991|NCT02119234|Hormones|hormones|mesh-ancestor
2663992|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663993|NCT02119273|Prednisone|prednisone|mesh-list
2663994|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2663995|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
2663996|NCT02119273|Hormones|hormones|mesh-ancestor
2663997|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2663998|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2663999|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2664000|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664001|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2664002|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2664003|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
2664004|NCT02119416|Caffeine|caffeine|mesh-list
2664005|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2664006|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664007|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2664008|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664009|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664010|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2664011|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2664012|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
2664013|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664014|NCT02119520|Atorvastatin|atorvastatin|mesh-list
2664015|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2664016|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2664017|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
2664018|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664019|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2664020|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2664021|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664022|NCT02119806|Fentanyl|fentanyl|mesh-list
2664023|NCT02119806|Midazolam|midazolam|mesh-list
2664024|NCT02119806|Propofol|propofol|mesh-list
2664025|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2664026|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664027|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664028|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2664029|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
2664030|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
2183604|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183605|NCT00002757|Cytarabine|cytarabine|mesh-list
2183606|NCT00002757|Prednisone|prednisone|mesh-list
2664031|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2664032|NCT02119806|Narcotics|narcotics|mesh-ancestor
2664033|NCT02119806|Analgesics|analgesics|mesh-ancestor
2183607|NCT00002757|Prednisolone|prednisolone|mesh-list
2183608|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
2183609|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2183610|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2183611|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2183612|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
2183613|NCT00002757|Doxorubicin|doxorubicin|mesh-list
2183614|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2183615|NCT00002757|Methotrexate|methotrexate|mesh-list
2183616|NCT00002757|Etoposide|etoposide|mesh-list
2183617|NCT00002757|Vincristine|vincristine|mesh-list
2183618|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2664034|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
2664035|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664036|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2664037|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2664038|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2664039|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2664040|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
2664041|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
2664042|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664043|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664044|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2664045|NCT02119884|Octreotide|octreotide|mesh-list
2664046|NCT02119884|Terlipressin|terlipressin|mesh-list
2664047|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2664048|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2664049|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664050|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2664051|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2664052|NCT02120066|Plasminogen|plasminogen|mesh-list
2664053|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2664054|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2664055|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2664056|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664057|NCT02120079|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2664058|NCT02120079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2664059|NCT02120079|Lubricant Eye Drops|lubricant eye drops|mesh-list
2664060|NCT02120079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2664061|NCT02120079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2664062|NCT02120092|Clopidogrel|clopidogrel|mesh-list
2664063|NCT02120092|Ticagrelor|ticagrelor|mesh-list
2664064|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2664065|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2664066|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2664067|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2664068|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
2664069|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664070|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664071|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664072|NCT02120118|Docetaxel|docetaxel|mesh-list
2664073|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664074|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
2664075|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
2664076|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183619|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
2183620|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183621|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183622|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183623|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
2664077|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664078|NCT02120196|Rifaximin|rifaximin|mesh-list
2664079|NCT02120196|Norfloxacin|norfloxacin|mesh-list
2664080|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2664081|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664082|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2664083|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2664084|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2664085|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664086|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664087|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664088|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2664089|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2664090|NCT02120274|Vitamin D|vitamin d|mesh-list
2664091|NCT02120274|Vitamins|vitamins|mesh-list
2664092|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
2664093|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
2664094|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
2664095|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664096|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2664097|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
2664098|NCT02120274|Hematinics|hematinics|mesh-ancestor
2664099|NCT02120339|Carvedilol|carvedilol|mesh-list
2664100|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2664101|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2664102|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
2664103|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664104|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664105|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664106|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2664107|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
2664108|NCT02120339|Protective Agents|protective agents|mesh-ancestor
2664109|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2664110|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2664111|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2664112|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
2664113|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2664114|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2664115|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
2664116|NCT02120404|Esmolol|esmolol|mesh-list
2664117|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2664118|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2664119|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2664120|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
2664121|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664122|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664123|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664124|NCT02120469|Everolimus|everolimus|mesh-list
2664125|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664126|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2664127|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
2664128|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664129|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
2664130|NCT02120547|Liver Extracts|liver extracts|mesh-list
2664131|NCT02120547|Hematinics|hematinics|mesh-ancestor
2664132|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2664133|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664134|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2664135|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2664136|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
2664137|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664138|NCT02120599|Folic Acid|folic acid|mesh-list
2664139|NCT02120599|Hematinics|hematinics|mesh-ancestor
2664140|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
2664141|NCT02120599|Vitamins|vitamins|mesh-ancestor
2664142|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
2664143|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664144|NCT02120612|Naloxone|naloxone|mesh-list
2664145|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2664146|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664147|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
2664148|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664149|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
2664150|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
2664151|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2664152|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664153|NCT02120651|Hemostatics|hemostatics|mesh-list
2664154|NCT02120651|Coagulants|coagulants|mesh-ancestor
2664155|NCT02120677|Itraconazole|itraconazole|mesh-list
2664156|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
2664157|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664158|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2664159|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2664160|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664161|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183624|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183625|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183626|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183627|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183628|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183629|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183630|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664162|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2664163|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
2664164|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2664165|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664166|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2664167|NCT02120703|Pregabalin|pregabalin|mesh-list
2664168|NCT02120703|Gabapentin|gabapentin|mesh-list
2664169|NCT02120703|Analgesics|analgesics|mesh-ancestor
2664170|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
2664171|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664172|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664173|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
2664174|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2664175|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2664176|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664177|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2664178|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2664179|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2664180|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664181|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2664182|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2664183|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2664184|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664185|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
2664186|NCT02120807|Pemetrexed|pemetrexed|mesh-list
2664187|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
2664188|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664189|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664190|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664191|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2664192|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2664193|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2664194|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
2664195|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664196|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2664197|NCT02120859|Paclitaxel|paclitaxel|mesh-list
2664198|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2664199|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664200|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
2664201|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
2664202|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
2664203|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664204|NCT02120872|Simvastatin|simvastatin|mesh-list
2664205|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2664206|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2664207|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
2664208|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664209|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2664210|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2664211|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664212|NCT02120911|Trastuzumab|trastuzumab|mesh-list
2664213|NCT02120911|Pertuzumab|pertuzumab|mesh-list
2664214|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2664215|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664216|NCT02121119|Lidocaine|lidocaine|mesh-list
2664217|NCT02121119|Bupivacaine|bupivacaine|mesh-list
2664218|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
2664219|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
2664220|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664221|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664222|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
2664223|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664224|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2664225|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2664226|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2664227|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2664228|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664229|NCT02121184|Oxytocin|oxytocin|mesh-list
2664230|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
2664231|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2664232|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664233|NCT02121197|Dexamethasone|dexamethasone|mesh-list
2664234|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2664235|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
2664236|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
2664237|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664238|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664239|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2664240|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
2664241|NCT02121197|Hormones|hormones|mesh-ancestor
2664242|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2664243|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2664244|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664245|NCT02121288|Clopidogrel|clopidogrel|mesh-list
2664246|NCT02121288|Ticagrelor|ticagrelor|mesh-list
2664247|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2664248|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2664249|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2664250|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2664251|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
2664252|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664253|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664254|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664255|NCT02121353|Ranibizumab|ranibizumab|mesh-list
2664256|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2664257|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2664258|NCT02121353|Growth Substances|growth substances|mesh-ancestor
2664259|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664260|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
2664261|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664262|NCT02121366|Ethanol|ethanol|mesh-list
2664263|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2664264|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664265|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664266|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664267|NCT02121405|Capecitabine|capecitabine|mesh-list
2664268|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
2664269|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2664270|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
2664271|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664272|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664273|NCT02121444|Interferons|interferons|mesh-list
2664274|NCT02121444|Interferon-beta|interferon-beta|mesh-list
2664275|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
2664276|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664277|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
2664278|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664279|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
2664280|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664281|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2664282|NCT02121457|Selenium|selenium|mesh-list
2664283|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
2664284|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664285|NCT02121457|Protective Agents|protective agents|mesh-ancestor
2664286|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664287|NCT02121457|Trace Elements|trace elements|mesh-ancestor
2664288|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
2664289|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
2664290|NCT02121613|Tamsulosin|tamsulosin|mesh-list
2664291|NCT02121613|Urological Agents|urological agents|mesh-ancestor
2664292|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2664293|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2664294|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2664295|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
2664296|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664297|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664298|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664299|NCT02121782|Vaccines|vaccines|mesh-list
2664300|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
2664301|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664302|NCT02121951|Lidocaine|lidocaine|mesh-list
2664303|NCT02121951|Fentanyl|fentanyl|mesh-list
2664304|NCT02121951|Midazolam|midazolam|mesh-list
2183631|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2183632|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
2183633|NCT00002757|Hormones|hormones|mesh-ancestor
2183634|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2183635|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183636|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2183637|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
2183638|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2183639|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183640|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
2183641|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
2183642|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2183643|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2183644|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183645|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
2183646|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183647|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
2183648|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
2183649|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183650|NCT00002759|Cyclosporine|cyclosporine|mesh-list
2183651|NCT00002759|Irinotecan|irinotecan|mesh-list
2183652|NCT00002759|Phenobarbital|phenobarbital|mesh-list
2183653|NCT00002759|Cyclosporins|cyclosporins|mesh-list
2183654|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2183655|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183656|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183657|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183658|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183659|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183660|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
2183661|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183662|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
2183663|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183664|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
2183665|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2664305|NCT02121951|Anesthetics|anesthetics|mesh-list
2664306|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
2664307|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
2664308|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2664309|NCT02121951|Narcotics|narcotics|mesh-ancestor
2664310|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664311|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664312|NCT02121951|Analgesics|analgesics|mesh-ancestor
2664313|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
2664314|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664315|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2664316|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2183666|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2183667|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
2183668|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2183669|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2183670|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2183671|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2183672|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2183673|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
2183674|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
2664317|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
2664318|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2664319|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2664320|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2664321|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2664322|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
2664323|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
2664324|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664325|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664326|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2664327|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2664328|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2664329|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2664330|NCT02121990|Paclitaxel|paclitaxel|mesh-list
2664331|NCT02121990|Bevacizumab|bevacizumab|mesh-list
2664332|NCT02121990|Olaparib|olaparib|mesh-list
2664333|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2664334|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664335|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
2664336|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
2664337|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
2664338|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664339|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2664340|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2664341|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2664342|NCT02121990|Growth Substances|growth substances|mesh-ancestor
2664343|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664344|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
2664345|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2664346|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664347|NCT02122003|Sorafenib|sorafenib|mesh-list
2664348|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664349|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2664350|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664351|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664352|NCT02122055|Fentanyl|fentanyl|mesh-list
2664353|NCT02122055|Midazolam|midazolam|mesh-list
2664354|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
2664355|NCT02122055|Propofol|propofol|mesh-list
2664356|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2664357|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664358|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664359|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2664360|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
2664361|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
2664362|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2664363|NCT02122055|Analgesics|analgesics|mesh-ancestor
2664364|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
2664365|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664366|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2664367|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2664368|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2664369|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
2664370|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664371|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664372|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2664373|NCT02122055|Narcotics|narcotics|mesh-ancestor
2664374|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2664375|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2664376|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2664377|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2664378|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
2664379|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
2664380|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
2664381|NCT02122081|Methotrexate|methotrexate|mesh-list
2664382|NCT02122081|Tacrolimus|tacrolimus|mesh-list
2664383|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
2664384|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2664385|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
2664386|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2664387|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
2664388|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664389|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183675|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2183676|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2183677|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2183678|NCT00002760|Ketoconazole|ketoconazole|mesh-list
2183679|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
2183680|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2664390|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2664391|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
2664392|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664393|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664394|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2664395|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2664396|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
2664397|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2664398|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2664399|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
2664400|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
2664401|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664402|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2664403|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2664404|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2664405|NCT02122172|Afatinib|afatinib|mesh-list
2664406|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664407|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2664408|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664409|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664410|NCT02122185|Metformin|metformin|mesh-list
2664411|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2664412|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183681|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2183682|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2183683|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
2183684|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2183685|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
2183686|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183687|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2183688|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2183689|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183690|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183691|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2183692|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
2183693|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2183694|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183695|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2183696|NCT00002761|Interferons|interferons|mesh-list
2183697|NCT00002761|Cytarabine|cytarabine|mesh-list
2183698|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
2183699|NCT00002761|Cyclosporine|cyclosporine|mesh-list
2183700|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
2664433|NCT02122211|Betaine|betaine|mesh-list
2664434|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2664435|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
2664436|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2664437|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
2664438|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664439|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2664440|NCT02122393|Sertraline|sertraline|mesh-list
2664441|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
2664442|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2664443|NCT02122393|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2664444|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2664445|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2664446|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664447|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664448|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
2664449|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664450|NCT02122484|Colchicine|colchicine|mesh-list
2664451|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
2664452|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2664453|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
2664454|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
2664455|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183701|NCT00002761|Busulfan|busulfan|mesh-list
2664456|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664457|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664458|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
2664459|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2664460|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664461|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664462|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2664463|NCT02122510|Analgesics|analgesics|mesh-ancestor
2664464|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
2664465|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664466|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2664467|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2664468|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2664469|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
2664470|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664471|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664472|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2664473|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2664474|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2664475|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2664476|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664477|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664478|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2664479|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2664480|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664481|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
2664482|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664483|NCT02122562|Ketamine|ketamine|mesh-list
2664484|NCT02122562|Analgesics|analgesics|mesh-ancestor
2664485|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
2183702|NCT00002761|Idarubicin|idarubicin|mesh-list
2183703|NCT00002761|Cyclosporins|cyclosporins|mesh-list
2183704|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183705|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
2183706|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183707|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183708|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183709|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
2183710|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183711|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183712|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183713|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
2183714|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183715|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183716|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
2183717|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664486|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664487|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664488|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2664489|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2664490|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
2664491|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
2664492|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664493|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2664494|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2664495|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664496|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664497|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
2664498|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2664499|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
2664500|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664501|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
2664502|NCT02122601|Protective Agents|protective agents|mesh-ancestor
2664503|NCT02122627|Vitamin D|vitamin d|mesh-list
2664504|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
2664505|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
2664506|NCT02122627|Vitamins|vitamins|mesh-list
2664507|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
2664508|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664509|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2664510|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2664511|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
2664512|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2664513|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2664514|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664515|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
2664516|NCT02122679|Coagulants|coagulants|mesh-ancestor
2664517|NCT02122692|Itraconazole|itraconazole|mesh-list
2664518|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
2664519|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
2664520|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664521|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2664522|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2664523|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664524|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664525|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2664526|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
2664527|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2664528|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664529|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2664530|NCT02122705|Remifentanil|remifentanil|mesh-list
2664531|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2664532|NCT02122705|Narcotics|narcotics|mesh-ancestor
2664533|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664534|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664535|NCT02122705|Analgesics|analgesics|mesh-ancestor
2664536|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
2664537|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664538|NCT02122731|Amiloride|amiloride|mesh-list
2664539|NCT02122731|Diuretics|diuretics|mesh-ancestor
2664540|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
2664541|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664542|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2664543|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2664544|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2664545|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664546|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2664547|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2664548|NCT02122809|Chiauranib|chiauranib|mesh-list
2664549|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664550|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2664551|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664552|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664553|NCT02122939|Citalopram|citalopram|mesh-list
2664554|NCT02122939|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2664555|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2183718|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
2183719|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
2183720|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2183721|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183722|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183723|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2664556|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2664557|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664558|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664559|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
2664560|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664561|NCT02122939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2664562|NCT02122939|Antidepressive Agents|antidepressive agents|mesh-ancestor
2664563|NCT02122939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2664564|NCT02123004|Clopidogrel|clopidogrel|mesh-list
2664565|NCT02123004|Ticagrelor|ticagrelor|mesh-list
2664566|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2664567|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2664568|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2664569|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2664570|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
2664571|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664572|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664573|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183724|NCT00002763|Interferons|interferons|mesh-list
2183725|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
2183726|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183727|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
2183728|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183729|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
2183730|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183731|NCT00002764|Doxorubicin|doxorubicin|mesh-list
2183732|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2664574|NCT02123056|Metoprolol|metoprolol|mesh-list
2664575|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2664576|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2664577|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
2664578|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
2664579|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664580|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183733|NCT00002764|Ifosfamide|ifosfamide|mesh-list
2664581|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2664582|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2664583|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2664584|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
2664585|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664586|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664587|NCT02123069|Nitroprusside|nitroprusside|mesh-list
2664588|NCT02123069|Phenylephrine|phenylephrine|mesh-list
2664589|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
2664590|NCT02123069|Norepinephrine|norepinephrine|mesh-list
2664591|NCT02123069|Acetylcholine|acetylcholine|mesh-list
2664592|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2664593|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
2664594|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
2664595|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664596|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664597|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
2664598|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2664599|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
2664600|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
2664601|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2664602|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2664603|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2664604|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
2664605|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664606|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664607|NCT02123069|Protective Agents|protective agents|mesh-ancestor
2664608|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2664609|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
2664610|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2664611|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2664612|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
2664613|NCT02123108|Basiliximab|basiliximab|mesh-list
2664614|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2664615|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
2664616|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664617|NCT02123121|Resveratrol|resveratrol|mesh-list
2664618|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
2664619|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664620|NCT02123121|Protective Agents|protective agents|mesh-ancestor
2664621|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664622|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664623|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2664624|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
2664625|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2664626|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664627|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
2664628|NCT02123355|Remifentanil|remifentanil|mesh-list
2664629|NCT02123355|Sevoflurane|sevoflurane|mesh-list
2664630|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
2664631|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
2664632|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664633|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664634|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2664635|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2664636|NCT02123355|Analgesics|analgesics|mesh-ancestor
2664637|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
2664638|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664639|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2664640|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2664641|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2664642|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
2664643|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2183734|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183735|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664644|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664645|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2664646|NCT02123355|Narcotics|narcotics|mesh-ancestor
2664647|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2664648|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2664649|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
2664650|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2664651|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2664652|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2664653|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2664654|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2664655|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
2664656|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
2664657|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2664658|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
2664659|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664660|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
2664661|NCT02123368|Protective Agents|protective agents|mesh-ancestor
2664662|NCT02123381|Cetuximab|cetuximab|mesh-list
2664663|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2664664|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664665|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2664666|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
2664667|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664668|NCT02123498|Omeprazole|omeprazole|mesh-list
2664669|NCT02123498|Pantoprazole|pantoprazole|mesh-list
2664670|NCT02123498|Ranitidine|ranitidine|mesh-list
2664671|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2664672|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2664673|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2664674|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2664675|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664676|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664677|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2664678|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
2664679|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
2664680|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664681|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664682|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
2664683|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2664684|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
2664685|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2664686|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
2664687|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664688|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664689|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
2664690|NCT02123563|Listerine|listerine|mesh-list
2664691|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2664692|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664693|NCT02123589|Fentanyl|fentanyl|mesh-list
2664694|NCT02123589|Midazolam|midazolam|mesh-list
2664695|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2664696|NCT02123589|Narcotics|narcotics|mesh-ancestor
2664697|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664698|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664699|NCT02123589|Analgesics|analgesics|mesh-ancestor
2664700|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
2664701|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664702|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2664703|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2664704|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
2664705|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
2183736|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183737|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183738|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183739|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183740|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183741|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
2183742|NCT00002765|Immunotoxins|immunotoxins|mesh-list
2183743|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
2183744|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183745|NCT00002767|Interferons|interferons|mesh-list
2664706|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2664707|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2664708|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2664709|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2664710|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
2664711|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
2664712|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664713|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664714|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
2664715|NCT02123615|Antibodies|antibodies|mesh-list
2664716|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
2664717|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2664718|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2664719|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
2664720|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
2664721|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664722|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2664723|NCT02123628|Doxycycline|doxycycline|mesh-list
2664724|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
2664725|NCT02123628|Levofloxacin|levofloxacin|mesh-list
2664726|NCT02123628|Rifampin|rifampin|mesh-list
2183746|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
2183747|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
2183748|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183749|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
2183750|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183751|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
2664727|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
2664728|NCT02123628|Linezolid|linezolid|mesh-list
2664729|NCT02123628|Cefepime|cefepime|mesh-list
2664730|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2664731|NCT02123628|Cefotaxime|cefotaxime|mesh-list
2664732|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
2664733|NCT02123628|Trimethoprim|trimethoprim|mesh-list
2664734|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
2664735|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664736|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2664737|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
2664738|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
2664739|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2664740|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2664741|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2664742|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2664743|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664744|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664745|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664746|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2664747|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2664748|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2664749|NCT02123628|Renal Agents|renal agents|mesh-ancestor
2664750|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
2664751|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2664752|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2664753|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2664754|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2664755|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2664756|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2664757|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2664758|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2664759|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2664760|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2664761|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2664762|NCT02123654|Asunaprevir|asunaprevir|mesh-list
2664763|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
2664764|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664765|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664780|NCT02123979|Rotigotine|rotigotine|mesh-list
2183752|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183753|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2183754|NCT00002768|Cytarabine|cytarabine|mesh-list
2183755|NCT00002768|Methotrexate|methotrexate|mesh-list
2183756|NCT00002768|Etoposide|etoposide|mesh-list
2664781|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
2664782|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
2664783|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664784|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664785|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664786|NCT02124005|Bupivacaine|bupivacaine|mesh-list
2664787|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
2664788|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
2664789|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664790|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664791|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
2664792|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664793|NCT02124070|Hormones|hormones|mesh-list
2664794|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2664795|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664796|NCT02124148|Leucovorin|leucovorin|mesh-list
2664797|NCT02124148|Fluorouracil|fluorouracil|mesh-list
2664798|NCT02124148|Pemetrexed|pemetrexed|mesh-list
2664799|NCT02124148|Cetuximab|cetuximab|mesh-list
2664800|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664801|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
2664802|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664803|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2664804|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2664805|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
2664806|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664807|NCT02124148|Antidotes|antidotes|mesh-ancestor
2664808|NCT02124148|Protective Agents|protective agents|mesh-ancestor
2664809|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
2664810|NCT02124148|Vitamins|vitamins|mesh-ancestor
2664811|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
2664812|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664813|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2664814|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2664815|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2664816|NCT02124174|Azacitidine|azacitidine|mesh-list
2664817|NCT02124174|Valproic Acid|valproic acid|mesh-list
2664818|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2664819|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
2664820|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664821|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664822|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664823|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
2664824|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
2664825|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664826|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664827|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
2664828|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2664829|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664830|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2664831|NCT02124187|Nicotine|nicotine|mesh-list
2664832|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2664833|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
2664834|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664835|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664836|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2664837|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2664838|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
2664839|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664840|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664841|NCT02124200|Nicotine|nicotine|mesh-list
2664842|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2664843|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
2664844|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2664845|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664846|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2664847|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2664848|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
2664849|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664850|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664851|NCT02124226|Methotrexate|methotrexate|mesh-list
2664852|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2664853|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
2664854|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2664855|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664856|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2664857|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
2664858|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664859|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664860|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
2664861|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664862|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2664863|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2664864|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
2664865|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2664866|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2664867|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
2664868|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
2664869|NCT02124317|Paclitaxel|paclitaxel|mesh-list
2664870|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2664871|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2664872|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664873|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
2664874|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
2664875|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
2664876|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664877|NCT02124330|Bentonite|bentonite|mesh-list
2664878|NCT02124330|Antidotes|antidotes|mesh-ancestor
2664879|NCT02124330|Protective Agents|protective agents|mesh-ancestor
2664880|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664881|NCT02124369|Gemcitabine|gemcitabine|mesh-list
2664882|NCT02124369|Paclitaxel|paclitaxel|mesh-list
2664883|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2664884|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2664885|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664886|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
2664887|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
2664888|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
2664889|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664890|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2664891|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
2664892|NCT02124369|Antiviral Agents|antiviral agents|mesh-ancestor
2664893|NCT02124369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664894|NCT02124369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664895|NCT02124369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2664896|NCT02124369|Immunologic Factors|immunologic factors|mesh-ancestor
2664897|NCT02124369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664898|NCT02124421|Paclitaxel|paclitaxel|mesh-list
2664899|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2664900|NCT02124421|Carboplatin|carboplatin|mesh-list
2664901|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2664902|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664903|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
2664904|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
2664905|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
2664906|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664907|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
2664908|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2664909|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
2664910|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664911|NCT02124525|Expectorants|expectorants|mesh-ancestor
2664912|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
2664913|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2664914|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
2664915|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664916|NCT02124525|Protective Agents|protective agents|mesh-ancestor
2664917|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664918|NCT02124525|Antidotes|antidotes|mesh-ancestor
2664919|NCT02124642|Folic Acid|folic acid|mesh-list
2664920|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
2664921|NCT02124642|Hematinics|hematinics|mesh-ancestor
2664922|NCT02124642|Vitamins|vitamins|mesh-ancestor
2664923|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
2664924|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664925|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
2664926|NCT02124655|Listerine|listerine|mesh-list
2664927|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2664928|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664929|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
2664930|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
2664931|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
2664932|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2664933|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2664934|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664935|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664936|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664937|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2664938|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2664939|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2664940|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
2664945|NCT02124850|Nivolumab|nivolumab|mesh-list
2664946|NCT02124850|Cetuximab|cetuximab|mesh-list
2664947|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2664948|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664949|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2664950|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664958|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
2664959|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2664960|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
2664961|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2664962|NCT02124941|Expectorants|expectorants|mesh-ancestor
2664963|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
2664964|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2664965|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
2664966|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664967|NCT02124941|Protective Agents|protective agents|mesh-ancestor
2664968|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664969|NCT02124941|Antidotes|antidotes|mesh-ancestor
2664970|NCT02124954|Digoxin|digoxin|mesh-list
2664971|NCT02124954|Midazolam|midazolam|mesh-list
2664972|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2664973|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2664974|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2664975|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664976|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2664977|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2664978|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2664979|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2664980|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
2664981|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
2664982|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
2664983|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
2664984|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2664985|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2664986|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2664987|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2664988|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2664989|NCT02124954|Protective Agents|protective agents|mesh-ancestor
2664990|NCT02125084|Everolimus|everolimus|mesh-list
2664991|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2664992|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2664993|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
2664994|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2664995|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2664996|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
2664997|NCT02125188|Coagulants|coagulants|mesh-ancestor
2183757|NCT00002768|Busulfan|busulfan|mesh-list
2183758|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2183759|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
2183760|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2183761|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183762|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183763|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
2183764|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183765|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183766|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
2183767|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183768|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2183769|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183770|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
2664998|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2664999|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
2665000|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665001|NCT02125201|Fentanyl|fentanyl|mesh-list
2665002|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2665003|NCT02125201|Narcotics|narcotics|mesh-ancestor
2665004|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2665005|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665006|NCT02125201|Analgesics|analgesics|mesh-ancestor
2665007|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
2665008|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665009|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2665010|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2665011|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
2665012|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
2665013|NCT02125227|Metformin|metformin|mesh-list
2665014|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2665015|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2665016|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665017|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2665018|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2665019|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
2665020|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665021|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2665022|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2665023|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665024|NCT02125253|Mometasone Furoate|mometasone furoate|mesh-list
2665025|NCT02125253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2665026|NCT02125253|Dermatologic Agents|dermatologic agents|mesh-ancestor
2665027|NCT02125253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2665028|NCT02125266|Methotrexate|methotrexate|mesh-list
2183771|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183772|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2183773|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183774|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183775|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183776|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
2183777|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183778|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
2183779|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183780|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183781|NCT00002771|Interferons|interferons|mesh-list
2183782|NCT00002771|Cytarabine|cytarabine|mesh-list
2183783|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
2183784|NCT00002771|Busulfan|busulfan|mesh-list
2183785|NCT00002771|Idarubicin|idarubicin|mesh-list
2183786|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
2183787|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665029|NCT02125266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2665030|NCT02125266|Abortifacient Agents|abortifacient agents|mesh-ancestor
2665031|NCT02125266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2665032|NCT02125266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665033|NCT02125266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2665034|NCT02125266|Antimetabolites|antimetabolites|mesh-ancestor
2665035|NCT02125266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665036|NCT02125266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665037|NCT02125266|Dermatologic Agents|dermatologic agents|mesh-ancestor
2665038|NCT02125266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665039|NCT02125266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2665040|NCT02125266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2665041|NCT02125266|Immunologic Factors|immunologic factors|mesh-ancestor
2665042|NCT02125266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2665043|NCT02125266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2665044|NCT02125305|Metformin|metformin|mesh-list
2665045|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2665046|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665047|NCT02125318|Anagrelide|anagrelide|mesh-list
2665048|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2665049|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2665050|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665051|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2665052|NCT02125344|Paclitaxel|paclitaxel|mesh-list
2665053|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
2665054|NCT02125344|Carboplatin|carboplatin|mesh-list
2665055|NCT02125344|Doxorubicin|doxorubicin|mesh-list
2665056|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2665057|NCT02125344|Trastuzumab|trastuzumab|mesh-list
2665058|NCT02125344|Epirubicin|epirubicin|mesh-list
2665059|NCT02125344|Pertuzumab|pertuzumab|mesh-list
2665060|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183788|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
2665061|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665062|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
2665063|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
2665064|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
2665065|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665066|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2665067|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
2665068|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665069|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2665070|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2665071|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
2665072|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2665073|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2665074|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2665075|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2665076|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665077|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2665078|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
2665079|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665080|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2665081|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665082|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665083|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
2665084|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2665085|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665086|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2665087|NCT02125409|Aspirin|aspirin|mesh-list
2665088|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2665089|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2665090|NCT02125409|Analgesics|analgesics|mesh-ancestor
2665091|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
2665092|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665093|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665094|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2665095|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2665096|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2665097|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2665098|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665099|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2665100|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2665101|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665102|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
2665103|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
2665104|NCT02125500|Ledipasvir|ledipasvir|mesh-list
2665105|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
2665106|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665107|NCT02125513|Paclitaxel|paclitaxel|mesh-list
2665108|NCT02125513|Carboplatin|carboplatin|mesh-list
2665109|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2665110|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665111|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
2665112|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
2665113|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
2665114|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665115|NCT02125565|Lidocaine|lidocaine|mesh-list
2665116|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
2665117|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
2665118|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2665119|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665120|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
2665121|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665122|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2665123|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2665124|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2665125|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2665126|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665127|NCT02125578|Interferons|interferons|mesh-list
2183789|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183790|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183791|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
2183792|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183793|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2665128|NCT02125578|Interferon-beta|interferon-beta|mesh-list
2665129|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
2665130|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665131|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
2665132|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665133|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
2665134|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665135|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2665136|NCT02125617|Prednisolone|prednisolone|mesh-list
2665137|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2665138|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
2665139|NCT02125617|Hormones|hormones|mesh-ancestor
2665140|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2665141|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665142|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2665143|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665144|NCT02125630|Hormones|hormones|mesh-list
2665145|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2665146|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665147|NCT02125643|Caffeine|caffeine|mesh-list
2665148|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2665149|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665150|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2665151|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665152|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665153|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2665154|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2665155|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
2665156|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2665157|NCT02125682|Atorvastatin|atorvastatin|mesh-list
2665158|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2665159|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2665160|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
2665161|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665162|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2665163|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2665164|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665165|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2665166|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2665167|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665168|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
2665169|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2665170|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665171|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2665172|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2665173|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665174|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665175|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665176|NCT02125864|Aflibercept|aflibercept|mesh-list
2665177|NCT02125864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2665178|NCT02125864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2665179|NCT02125864|Growth Substances|growth substances|mesh-ancestor
2665180|NCT02125864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665181|NCT02125864|Growth Inhibitors|growth inhibitors|mesh-ancestor
2665182|NCT02125864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665183|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
2665184|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2665185|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2665186|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665187|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
2665188|NCT02125890|Coagulants|coagulants|mesh-ancestor
2665189|NCT02125903|Ropivacaine|ropivacaine|mesh-list
2665190|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
2665191|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
2665192|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2665193|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665194|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
2665195|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665196|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
2665197|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2665198|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2665199|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
2665200|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2665201|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665202|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183794|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
2183795|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183796|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
2183797|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183798|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183799|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2665203|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
2665204|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
2665205|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665206|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
2665207|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2665208|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
2665209|NCT02126020|Infliximab|infliximab|mesh-list
2665210|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
2665211|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2665212|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2665213|NCT02126137|Ezetimibe|ezetimibe|mesh-list
2665214|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2665215|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2665216|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
2665217|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665218|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2665219|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
2665220|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2665221|NCT02126267|Azithromycin|azithromycin|mesh-list
2665222|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2665223|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665224|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
2665225|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
2665226|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2183800|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183801|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183802|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183803|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
2183804|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2183805|NCT00002772|Tamoxifen|tamoxifen|mesh-list
2183806|NCT00002772|Paclitaxel|paclitaxel|mesh-list
2665227|NCT02126293|Zinc|zinc|mesh-list
2665228|NCT02126293|Trace Elements|trace elements|mesh-ancestor
2665229|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
2665230|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665231|NCT02126332|Acetaminophen|acetaminophen|mesh-list
2665232|NCT02126332|Sufentanil|sufentanil|mesh-list
2665233|NCT02126332|Nefopam|nefopam|mesh-list
2665234|NCT02126332|Tramadol|tramadol|mesh-list
2665235|NCT02126332|Ropivacaine|ropivacaine|mesh-list
2665236|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
2665237|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
2665238|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2665239|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665240|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
2665241|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665242|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2665243|NCT02126332|Analgesics|analgesics|mesh-ancestor
2665244|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
2665245|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2665246|NCT02126332|Narcotics|narcotics|mesh-ancestor
2665247|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2665248|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2665249|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
2665250|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2665251|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2665252|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2665253|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
2665254|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665255|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2665256|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2665257|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665258|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2665259|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
2665260|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665261|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2665262|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2665263|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
2665264|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665265|NCT02126462|Antacids|antacids|mesh-ancestor
2183807|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
2183808|NCT00002772|Carboplatin|carboplatin|mesh-list
2665266|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665267|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2665268|NCT02126527|Sirolimus|sirolimus|mesh-list
2665269|NCT02126527|Auranofin|auranofin|mesh-list
2665270|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2665271|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665272|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2665273|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665274|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
2665275|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2665276|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
2665277|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665278|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183809|NCT00002772|Doxorubicin|doxorubicin|mesh-list
2183810|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2183811|NCT00002772|Thiotepa|thiotepa|mesh-list
2183812|NCT00002772|Carmustine|carmustine|mesh-list
2183813|NCT00002772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2183814|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183815|NCT00002772|Tubulin Modulators|tubulin modulators|mesh-ancestor
2183816|NCT00002772|Antimitotic Agents|antimitotic agents|mesh-ancestor
2183817|NCT00002772|Mitosis Modulators|mitosis modulators|mesh-ancestor
2665287|NCT02126579|Poly ICLC|poly iclc|mesh-list
2665288|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
2665289|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
2665290|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665291|NCT02126644|Glycolic acid|glycolic acid|mesh-list
2665292|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
2665293|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
2665294|NCT02126657|Glycolic acid|glycolic acid|mesh-list
2665295|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
2665296|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
2665297|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
2665298|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
2183818|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183819|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183820|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
2665299|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2665300|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2665301|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665302|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665303|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665304|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2665305|NCT02126761|Vaccines|vaccines|mesh-list
2665306|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
2665307|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665308|NCT02126917|Ethanol|ethanol|mesh-list
2665309|NCT02126917|Hydrocodone|hydrocodone|mesh-list
2665310|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2665311|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665312|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2665313|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665314|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2665315|NCT02126917|Narcotics|narcotics|mesh-ancestor
2665316|NCT02126917|Analgesics|analgesics|mesh-ancestor
2665317|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
2665318|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665319|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
2665320|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
2665321|NCT02126943|Macitentan|macitentan|mesh-list
2665322|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2665323|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2665324|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665325|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2665326|NCT02126956|Ponesimod|ponesimod|mesh-list
2665327|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2665328|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665329|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2665330|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
2665331|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665332|NCT02126995|Metadoxine|metadoxine|mesh-list
2665333|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2665334|NCT02127034|Digoxin|digoxin|mesh-list
2665335|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
2665336|NCT02127034|Mirabegron|mirabegron|mesh-list
2665337|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2665338|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2665339|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665340|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665341|NCT02127034|Protective Agents|protective agents|mesh-ancestor
2665342|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665343|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2665344|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2665345|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
2665346|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2665347|NCT02127034|Urological Agents|urological agents|mesh-ancestor
2665348|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2665349|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2183821|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183822|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183823|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183824|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
2665350|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2665351|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
2665352|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2665353|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2665354|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665355|NCT02127047|Incretins|incretins|mesh-ancestor
2665356|NCT02127047|Hormones|hormones|mesh-ancestor
2665357|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2665358|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2665359|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
2665360|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665361|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665362|NCT02127060|Ascorbic Acid|ascorbic acid|mesh-list
2665363|NCT02127060|Vitamins|vitamins|mesh-ancestor
2665364|NCT02127060|Micronutrients|micronutrients|mesh-ancestor
2665365|NCT02127060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665366|NCT02127060|Antioxidants|antioxidants|mesh-ancestor
2665367|NCT02127060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665368|NCT02127060|Protective Agents|protective agents|mesh-ancestor
2665369|NCT02127073|Oxytocin|oxytocin|mesh-list
2665370|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
2183825|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183826|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183827|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183828|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183829|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665371|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2665372|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665373|NCT02127086|Analgesics|analgesics|mesh-list
2665374|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
2665375|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665376|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665377|NCT02127138|Sirolimus|sirolimus|mesh-list
2665378|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2665379|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665380|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2665381|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665382|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
2665383|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2665384|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
2665385|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665386|NCT02127151|Talazoparib|talazoparib|mesh-list
2665387|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2665388|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665389|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665390|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665391|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2665392|NCT02127164|Eusol|eusol|mesh-list
2665393|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
2665394|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665395|NCT02127190|CXA-10|cxa-10|mesh-list
2665396|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2665397|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2665398|NCT02127320|Ezetimibe|ezetimibe|mesh-list
2665399|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2665400|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2665401|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
2665402|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665403|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2665404|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2665405|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665406|NCT02127437|Lanreotide|lanreotide|mesh-list
2665407|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665408|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2665409|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2665410|NCT02127489|Bupivacaine|bupivacaine|mesh-list
2665411|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
2665412|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
2665413|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2665414|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665415|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
2665416|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665417|NCT02127541|Exenatide|exenatide|mesh-list
2665418|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2665419|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665420|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2665421|NCT02127541|Incretins|incretins|mesh-ancestor
2665422|NCT02127541|Hormones|hormones|mesh-ancestor
2665423|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2665424|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
2665425|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2665426|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2665427|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2665428|NCT02127593|Norgestimate|norgestimate|mesh-list
2665429|NCT02127593|Norgestrel|norgestrel|mesh-list
2665430|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2665431|NCT02127593|Estradiol|estradiol|mesh-list
2665432|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2665433|NCT02127593|Estrogens|estrogens|mesh-ancestor
2665434|NCT02127593|Hormones|hormones|mesh-ancestor
2665435|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2665436|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665437|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2665438|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
2665439|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2665440|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2665441|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2665442|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2665443|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2665444|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2665445|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665446|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2665447|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2665448|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665449|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665450|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665451|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2665452|NCT02127684|Ranibizumab|ranibizumab|mesh-list
2665453|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2665454|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2665455|NCT02127684|Growth Substances|growth substances|mesh-ancestor
2665456|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665457|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
2183830|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2183831|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
2183832|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2183833|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183834|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2183835|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2183836|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2665458|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665459|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
2665460|NCT02127697|Albuterol|albuterol|mesh-list
2665461|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2665462|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
2665463|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665464|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665465|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2665466|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
2665467|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
2665468|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2665469|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2665470|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2665471|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2665472|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
2183837|NCT00002773|Interferons|interferons|mesh-list
2183838|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
2183839|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
2183840|NCT00002773|Sargramostim|sargramostim|mesh-list
2183841|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183842|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
2665473|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2665474|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665475|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2665476|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2665477|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2665478|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
2665479|NCT02127736|Amitriptyline|amitriptyline|mesh-list
2665480|NCT02127736|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2665481|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2665482|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
2665483|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2665484|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2665485|NCT02127736|Analgesics|analgesics|mesh-ancestor
2665486|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
2665487|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2183843|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183844|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183845|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183846|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
2183847|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665488|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665489|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2665490|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2665491|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2665492|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665493|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
2665494|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2665495|NCT02127736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2665496|NCT02127736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2665497|NCT02127736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2665498|NCT02127749|Metronidazole|metronidazole|mesh-list
2665499|NCT02127749|Vancomycin|vancomycin|mesh-list
2665500|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
2665501|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665502|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2665503|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2665504|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2665505|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2665506|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2665507|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665508|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665509|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665510|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2665511|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2665512|NCT02127775|Lesinurad|lesinurad|mesh-list
2183848|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183849|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183850|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
2183851|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2183852|NCT00002774|Cisplatin|cisplatin|mesh-list
2665513|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
2665514|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2665515|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
2665516|NCT02127775|Renal Agents|renal agents|mesh-ancestor
2665517|NCT02127788|Micafungin|micafungin|mesh-list
2665518|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
2665519|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665520|NCT02127840|Epinephrine|epinephrine|mesh-list
2665521|NCT02127840|Racepinephrine|racepinephrine|mesh-list
2665522|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
2665523|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2665524|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2183853|NCT00002774|Fluorouracil|fluorouracil|mesh-list
2183854|NCT00002774|Tirapazamine|tirapazamine|mesh-list
2665525|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
2665526|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2665527|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665528|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665529|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2665530|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2665531|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
2665532|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2183855|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183856|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
2183857|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665533|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2665534|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
2665535|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
2665536|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
2665537|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2665538|NCT02127853|Gabapentin|gabapentin|mesh-list
2665539|NCT02127853|Analgesics|analgesics|mesh-ancestor
2665540|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
2665541|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665542|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665543|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
2665544|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2665545|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2665546|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2665547|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2665548|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2665549|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2665550|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2665551|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665552|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
2665553|NCT02127866|Beclomethasone|beclomethasone|mesh-list
2665554|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
2665555|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
2665556|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2665557|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
2665558|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665559|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665560|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2665561|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
2665562|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2665563|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2665564|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2665565|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
2665566|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2665567|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665568|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2665569|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2665570|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2665571|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
2665572|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2665573|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
2665574|NCT02127866|Hormones|hormones|mesh-ancestor
2665575|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2665576|NCT02127918|Clobazam|clobazam|mesh-list
2665577|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
2665578|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2665579|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2665580|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2183858|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183859|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183860|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
2183861|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183862|NCT00002775|Docetaxel|docetaxel|mesh-list
2183863|NCT00002775|Estramustine|estramustine|mesh-list
2183864|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183865|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
2183866|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
2665581|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665582|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2665583|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2665584|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
2665585|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
2665586|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2665587|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183867|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
2183868|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183869|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2665588|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2665589|NCT02127996|Incretins|incretins|mesh-ancestor
2665590|NCT02127996|Hormones|hormones|mesh-ancestor
2665591|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2665592|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665593|NCT02128022|Glyburide|glyburide|mesh-list
2665594|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2665595|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183870|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
2183871|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183872|NCT00002777|Tamoxifen|tamoxifen|mesh-list
2183873|NCT00002777|Exemestane|exemestane|mesh-list
2183874|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183875|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2183876|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
2183877|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2422863|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2422864|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2665596|NCT02128061|Rituximab|rituximab|mesh-list
2665597|NCT02128061|Lenalidomide|lenalidomide|mesh-list
2665598|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2665599|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665600|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
2665601|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422865|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422866|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2422867|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422868|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
2422869|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2665602|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2665603|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2665604|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2665605|NCT02128061|Growth Substances|growth substances|mesh-ancestor
2665606|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
2665607|NCT02128100|Leucovorin|leucovorin|mesh-list
2665608|NCT02128100|Fluorouracil|fluorouracil|mesh-list
2665609|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
2665610|NCT02128100|Irinotecan|irinotecan|mesh-list
2665611|NCT02128100|Folfirinox|folfirinox|mesh-list
2665612|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
2665613|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665614|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2665615|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665616|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2665617|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
2665618|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665619|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2665620|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2665621|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665622|NCT02128100|Antidotes|antidotes|mesh-ancestor
2665623|NCT02128100|Protective Agents|protective agents|mesh-ancestor
2665624|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
2665625|NCT02128100|Vitamins|vitamins|mesh-ancestor
2665626|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
2665627|NCT02128126|Vaccines|vaccines|mesh-list
2665628|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
2665629|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665630|NCT02128178|Enoxaparin|enoxaparin|mesh-list
2665631|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
2665632|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
2665633|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2665634|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2665635|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665636|NCT02128191|Ibuprofen|ibuprofen|mesh-list
2665637|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2665638|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2665639|NCT02128191|Analgesics|analgesics|mesh-ancestor
2665640|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
2665641|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665642|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665643|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2665644|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183878|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183879|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183880|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183881|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2183882|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2183883|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2665645|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2665646|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665647|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665648|NCT02128204|Lidocaine|lidocaine|mesh-list
2665649|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
2665650|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
2665651|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2665652|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665653|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
2665654|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665655|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2665656|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2665657|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2665658|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2665659|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665660|NCT02128243|Leucovorin|leucovorin|mesh-list
2665661|NCT02128243|Cisplatin|cisplatin|mesh-list
2665662|NCT02128243|Docetaxel|docetaxel|mesh-list
2665663|NCT02128243|Fluorouracil|fluorouracil|mesh-list
2665664|NCT02128243|Capecitabine|capecitabine|mesh-list
2665665|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
2665666|NCT02128243|Epirubicin|epirubicin|mesh-list
2665667|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
2665668|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665669|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
2665670|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
2665671|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
2665672|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665673|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
2665674|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2665675|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2665676|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
2665677|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665678|NCT02128243|Antidotes|antidotes|mesh-ancestor
2665679|NCT02128243|Protective Agents|protective agents|mesh-ancestor
2665680|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
2665681|NCT02128243|Vitamins|vitamins|mesh-ancestor
2665682|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
2665683|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2665684|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2665685|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2665686|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665687|NCT02128282|Gemcitabine|gemcitabine|mesh-list
2665688|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665689|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2665690|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
2665691|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665692|NCT02128282|Antiviral Agents|antiviral agents|mesh-ancestor
2665693|NCT02128282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665694|NCT02128282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183884|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2183885|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2183886|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183887|NCT00002778|Sargramostim|sargramostim|mesh-list
2183888|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
2183889|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183890|NCT00002779|Fludarabine|fludarabine|mesh-list
2183891|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
2665695|NCT02128282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2665696|NCT02128282|Immunologic Factors|immunologic factors|mesh-ancestor
2665697|NCT02128282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665698|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
2665699|NCT02128308|Levofloxacin|levofloxacin|mesh-list
2665700|NCT02128308|Ofloxacin|ofloxacin|mesh-list
2665701|NCT02128308|Cycloserine|cycloserine|mesh-list
2665702|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
2665703|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
2665704|NCT02128308|Streptomycin|streptomycin|mesh-list
2665705|NCT02128308|Kanamycin|kanamycin|mesh-list
2665706|NCT02128308|Prothionamide|prothionamide|mesh-list
2665707|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2665708|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2665709|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665710|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2665711|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2665712|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665713|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183892|NCT00002779|Octreotide|octreotide|mesh-list
2183893|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183894|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183895|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
2183896|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183897|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183898|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
2183899|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183900|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2183901|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183902|NCT00002780|Aldesleukin|aldesleukin|mesh-list
2183903|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
2183904|NCT00002780|Thiotepa|thiotepa|mesh-list
2183905|NCT00002780|Carboplatin|carboplatin|mesh-list
2183906|NCT00002780|Sargramostim|sargramostim|mesh-list
2183907|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183908|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
2665714|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665715|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2665716|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
2665717|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2665718|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665719|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2665720|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2665721|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2665722|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2665723|NCT02128308|Renal Agents|renal agents|mesh-ancestor
2665724|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2665725|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2665726|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2665727|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
2665728|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
2665729|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2665730|NCT02128321|Repaglinide|repaglinide|mesh-list
2665731|NCT02128321|Isavuconazole|isavuconazole|mesh-list
2665732|NCT02128321|Caffeine|caffeine|mesh-list
2665733|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2665734|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665735|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2665736|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665737|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665738|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2665739|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2665740|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
2665741|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2665742|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2665743|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
2665744|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665745|NCT02128334|Leuprolide|leuprolide|mesh-list
2665746|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2665747|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
2665748|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2665749|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665750|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2665751|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665752|NCT02128360|Letrozole|letrozole|mesh-list
2665753|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665754|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2665755|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2665756|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665757|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665758|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2665759|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
2665760|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2665761|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665762|NCT02128425|Leucovorin|leucovorin|mesh-list
2665763|NCT02128425|Fluorouracil|fluorouracil|mesh-list
2665764|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
2665765|NCT02128425|Irinotecan|irinotecan|mesh-list
2183909|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665766|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
2665767|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
2665768|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665769|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2665770|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665771|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2665772|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
2665773|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665774|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2665775|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2665776|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665777|NCT02128425|Antidotes|antidotes|mesh-ancestor
2665778|NCT02128425|Protective Agents|protective agents|mesh-ancestor
2665779|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
2665780|NCT02128425|Vitamins|vitamins|mesh-ancestor
2665781|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
2665782|NCT02128451|Fentanyl|fentanyl|mesh-list
2665783|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2665784|NCT02128451|Narcotics|narcotics|mesh-ancestor
2665785|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2665786|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665787|NCT02128451|Analgesics|analgesics|mesh-ancestor
2665788|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
2665789|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665790|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2665791|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2665792|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
2665793|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
2665794|NCT02128633|Listerine|listerine|mesh-list
2665795|NCT02128633|Fluorides|fluorides|mesh-list
2665796|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
2665797|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
2665798|NCT02128633|Protective Agents|protective agents|mesh-ancestor
2665799|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665800|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2665801|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665802|NCT02128646|Ketorolac|ketorolac|mesh-list
2665803|NCT02128646|Bupivacaine|bupivacaine|mesh-list
2665804|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
2665805|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
2665806|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2665807|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665808|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
2665809|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665810|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2665811|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2665812|NCT02128646|Analgesics|analgesics|mesh-ancestor
2665813|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2665814|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2665815|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2665816|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665817|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665818|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
2665819|NCT02128685|Progestins|progestins|mesh-ancestor
2665820|NCT02128685|Hormones|hormones|mesh-ancestor
2665821|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2665822|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665823|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
2665824|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2665825|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
2665826|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2665827|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
2665828|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665829|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665830|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
2665831|NCT02128893|Isavuconazole|isavuconazole|mesh-list
2665832|NCT02128893|Esomeprazole|esomeprazole|mesh-list
2665833|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2665834|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2665835|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2665836|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665837|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665838|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
2665839|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665840|NCT02128906|Docetaxel|docetaxel|mesh-list
2665841|NCT02128906|Cetuximab|cetuximab|mesh-list
2665842|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665843|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
2665844|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
2665845|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
2665846|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665847|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2665848|NCT02128945|Fludarabine|fludarabine|mesh-list
2665849|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665850|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
2665851|NCT02128971|Trace Elements|trace elements|mesh-ancestor
2665852|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
2665853|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665854|NCT02128984|Antioxidants|antioxidants|mesh-list
2665855|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665856|NCT02128984|Protective Agents|protective agents|mesh-ancestor
2665857|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665858|NCT02129088|Esketamine|esketamine|mesh-list
2665859|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
2665860|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2665861|NCT02129101|Azacitidine|azacitidine|mesh-list
2665862|NCT02129101|Decitabine|decitabine|mesh-list
2665863|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2665864|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
2665865|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665866|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665867|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665868|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2665869|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2665870|NCT02129114|Estradiol|estradiol|mesh-list
2665871|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2665872|NCT02129114|Estrogens|estrogens|mesh-ancestor
2665873|NCT02129114|Hormones|hormones|mesh-ancestor
2665874|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2665875|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665876|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2183910|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183911|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183912|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
2183913|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183914|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183915|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183916|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2183917|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2183918|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
2183919|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665877|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
2665878|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2665879|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2665880|NCT02129127|Paclitaxel|paclitaxel|mesh-list
2665881|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2665882|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665883|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
2665884|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
2665885|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
2665886|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665887|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
2665888|NCT02129166|Dasatinib|dasatinib|mesh-list
2665889|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665890|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2665891|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665892|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665893|NCT02129179|Glucagon|glucagon|mesh-list
2665894|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2665895|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2665896|NCT02129179|Hormones|hormones|mesh-ancestor
2665897|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2665898|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665899|NCT02129179|Incretins|incretins|mesh-ancestor
2665900|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
2665901|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2665902|NCT02129231|Simvastatin|simvastatin|mesh-list
2665903|NCT02129231|Ezetimibe|ezetimibe|mesh-list
2665904|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2665905|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2183920|NCT00002783|Leucovorin|leucovorin|mesh-list
2183921|NCT00002783|Fluorouracil|fluorouracil|mesh-list
2665906|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2665907|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
2183922|NCT00002783|Floxuridine|floxuridine|mesh-list
2183923|NCT00002783|Calcium|calcium|mesh-list
2183924|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
2665908|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665909|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2665910|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2665911|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183925|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183926|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2183927|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183928|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
2665912|NCT02129231|Antacids|antacids|mesh-ancestor
2665913|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2665914|NCT02129257|Leucovorin|leucovorin|mesh-list
2665915|NCT02129257|Folic Acid|folic acid|mesh-list
2665916|NCT02129257|Fluorouracil|fluorouracil|mesh-list
2665917|NCT02129257|Irinotecan|irinotecan|mesh-list
2665918|NCT02129257|Aflibercept|aflibercept|mesh-list
2665919|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
2665920|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
2665921|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665922|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2665923|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665924|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2665925|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
2665926|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665927|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2665928|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2665929|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665930|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2665931|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2665932|NCT02129257|Growth Substances|growth substances|mesh-ancestor
2183929|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183930|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183931|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183932|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
2183933|NCT00002783|Antidotes|antidotes|mesh-ancestor
2183934|NCT00002783|Protective Agents|protective agents|mesh-ancestor
2183935|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
2183936|NCT00002783|Vitamins|vitamins|mesh-ancestor
2183937|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
2183938|NCT00002784|Tamoxifen|tamoxifen|mesh-list
2183939|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
2183940|NCT00002784|Doxorubicin|doxorubicin|mesh-list
2183941|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2183942|NCT00002784|Fluorouracil|fluorouracil|mesh-list
2183943|NCT00002784|Methotrexate|methotrexate|mesh-list
2183944|NCT00002784|Epirubicin|epirubicin|mesh-list
2183945|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183946|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
2183947|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183948|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183949|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183950|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
2183951|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2183952|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2183953|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2183954|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2183955|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2183956|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2183957|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2183958|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
2183959|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2183960|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2183961|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
2183962|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2183963|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
2183964|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2183965|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2183966|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2183967|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
2183968|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2183969|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2183970|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2183971|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2183972|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2183973|NCT00002785|Leucovorin|leucovorin|mesh-list
2183974|NCT00002785|Cobalt|cobalt|mesh-list
2183975|NCT00002785|Cytarabine|cytarabine|mesh-list
2183976|NCT00002785|Cyclosporine|cyclosporine|mesh-list
2183977|NCT00002785|Dexamethasone|dexamethasone|mesh-list
2183978|NCT00002785|Prednisone|prednisone|mesh-list
2183979|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
2183980|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
2183981|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2183982|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2183983|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2183984|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
2183985|NCT00002785|Methotrexate|methotrexate|mesh-list
2183986|NCT00002785|Etoposide|etoposide|mesh-list
2183987|NCT00002785|Vincristine|vincristine|mesh-list
2183988|NCT00002785|Daunorubicin|daunorubicin|mesh-list
2183989|NCT00002785|Asparaginase|asparaginase|mesh-list
2183990|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
2183991|NCT00002785|Pegaspargase|pegaspargase|mesh-list
2183992|NCT00002785|Cyclosporins|cyclosporins|mesh-list
2183993|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
2183994|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2183995|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
2183996|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2183997|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2183998|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2183999|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
2665933|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
2665934|NCT02129257|Antidotes|antidotes|mesh-ancestor
2665935|NCT02129257|Protective Agents|protective agents|mesh-ancestor
2665936|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
2665937|NCT02129257|Vitamins|vitamins|mesh-ancestor
2665938|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
2665939|NCT02129257|Hematinics|hematinics|mesh-ancestor
2665940|NCT02129270|Lidocaine|lidocaine|mesh-list
2665941|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
2665942|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
2665943|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2665944|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665945|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
2665946|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2665947|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2665948|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2665949|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2665950|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2665951|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665952|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
2665953|NCT02129322|Sorafenib|sorafenib|mesh-list
2665954|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665955|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2665956|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665957|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665958|NCT02129400|Anesthetics|anesthetics|mesh-list
2665959|NCT02129400|Xenon|xenon|mesh-list
2665960|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2665961|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665962|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2665963|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
2665964|NCT02129582|Methotrexate|methotrexate|mesh-list
2665965|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
2184000|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184001|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184002|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2184003|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2184004|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
2184005|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
2184006|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2184007|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2184008|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
2184009|NCT00002785|Hormones|hormones|mesh-ancestor
2184010|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2184011|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2422870|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
2422871|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
2422872|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2422873|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2422874|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2422875|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2422876|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
2184012|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2184013|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
2184014|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2184015|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184016|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
2184017|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2184018|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184019|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2665966|NCT02129582|Fludarabine|fludarabine|mesh-list
2665967|NCT02129582|Busulfan|busulfan|mesh-list
2665968|NCT02129582|Tacrolimus|tacrolimus|mesh-list
2665969|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
2665970|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2665971|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
2665972|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2665973|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
2184020|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2184021|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184022|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184023|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184024|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
2184025|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2665974|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2665975|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665976|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2665977|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
2665978|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665979|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2665980|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
2665981|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665982|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2665983|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2665984|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
2665985|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2665986|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2665987|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2665988|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
2665989|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2665990|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2665991|NCT02129595|Resveratrol|resveratrol|mesh-list
2665992|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
2665993|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2665994|NCT02129595|Protective Agents|protective agents|mesh-ancestor
2665995|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2665996|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2665997|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2665998|NCT02129621|Spironolactone|spironolactone|mesh-list
2665999|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2666000|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
2666001|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2184026|NCT00002785|Antidotes|antidotes|mesh-ancestor
2184027|NCT00002785|Protective Agents|protective agents|mesh-ancestor
2184028|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
2184029|NCT00002785|Vitamins|vitamins|mesh-ancestor
2184030|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
2184031|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184032|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184033|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184034|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
2184035|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2184036|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2184037|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2184038|NCT00002785|Trace Elements|trace elements|mesh-ancestor
2184039|NCT00002786|Aldesleukin|aldesleukin|mesh-list
2184040|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184041|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2184042|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2184043|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
2184044|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184045|NCT00002787|Aldesleukin|aldesleukin|mesh-list
2184046|NCT00002787|Interleukin-2|interleukin-2|mesh-list
2184047|NCT00002787|Vaccines|vaccines|mesh-list
2184048|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
2184049|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2184050|NCT00002787|Antibodies|antibodies|mesh-list
2184051|NCT00002787|Sargramostim|sargramostim|mesh-list
2184052|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2666002|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666003|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2666004|NCT02129621|Diuretics|diuretics|mesh-ancestor
2666005|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
2666006|NCT02129634|Paclitaxel|paclitaxel|mesh-list
2666007|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2666008|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666009|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
2666010|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
2666011|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
2666012|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666013|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2666014|NCT02129673|Latanoprost|latanoprost|mesh-list
2666015|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2666016|NCT02129699|Denosumab|denosumab|mesh-list
2666017|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2666018|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666019|NCT02129751|Bupropion|bupropion|mesh-list
2666020|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2666021|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
2666022|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2666023|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2666024|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2666025|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2666026|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666027|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
2666028|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2666029|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666030|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2666031|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2666032|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666033|NCT02129764|Prednisone|prednisone|mesh-list
2666034|NCT02129764|Allopurinol|allopurinol|mesh-list
2666035|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2666036|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
2666037|NCT02129764|Hormones|hormones|mesh-ancestor
2666038|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666039|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666040|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2666041|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666042|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
2666043|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666044|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666045|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
2666046|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2666047|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2666048|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
2666049|NCT02129764|Protective Agents|protective agents|mesh-ancestor
2666050|NCT02129829|Tenofovir|tenofovir|mesh-list
2666051|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
2666052|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666053|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2184053|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2184054|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
2184055|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666054|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2666055|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666056|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666057|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2666058|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2666059|NCT02129933|Bevacizumab|bevacizumab|mesh-list
2666060|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2666061|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666062|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2666063|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2666064|NCT02129933|Growth Substances|growth substances|mesh-ancestor
2666065|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666066|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
2666067|NCT02129985|Metformin|metformin|mesh-list
2666068|NCT02129985|Exenatide|exenatide|mesh-list
2666069|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2666070|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666071|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2666072|NCT02129985|Incretins|incretins|mesh-ancestor
2666073|NCT02129985|Hormones|hormones|mesh-ancestor
2666074|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666075|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2666076|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2666077|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666078|NCT02130167|Atropine|atropine|mesh-list
2666079|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2666080|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2666081|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2666082|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
2666083|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666084|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666085|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2666086|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
2666087|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
2666088|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
2666089|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2666090|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2666091|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
2666092|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2666093|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666094|NCT02130323|Imiquimod|imiquimod|mesh-list
2666095|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2666096|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
2666097|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666098|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666099|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
2666100|NCT02130414|Cyclosporine|cyclosporine|mesh-list
2666101|NCT02130414|Cyclosporins|cyclosporins|mesh-list
2666102|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666103|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666104|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2666105|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
2666106|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666107|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
2666108|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666109|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
2666110|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2666111|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2666112|NCT02130440|Resveratrol|resveratrol|mesh-list
2666113|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
2666114|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666115|NCT02130440|Protective Agents|protective agents|mesh-ancestor
2666116|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666117|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666118|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2666119|NCT02130453|Regadenoson|regadenoson|mesh-list
2666120|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2666121|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2666122|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
2184056|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184057|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2184058|NCT00002787|Analgesics|analgesics|mesh-ancestor
2184059|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
2184060|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2184061|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2184062|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2184063|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
2184064|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184065|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2184066|NCT00002788|Dexamethasone|dexamethasone|mesh-list
2184067|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
2184068|NCT00002788|Etoposide|etoposide|mesh-list
2184069|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184070|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
2184071|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666123|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
2666124|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2666125|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666126|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666127|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
2666128|NCT02130466|Trametinib|trametinib|mesh-list
2666129|NCT02130466|Dabrafenib|dabrafenib|mesh-list
2666130|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2666131|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666132|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2184072|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184073|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184074|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
2184075|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184076|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184077|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2666133|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666134|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666135|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2666136|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2666137|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666138|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2666139|NCT02130661|Itraconazole|itraconazole|mesh-list
2666140|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
2666141|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666142|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2666143|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2666144|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666145|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666146|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2666147|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
2666148|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666149|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666150|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2184078|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2184079|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
2184080|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
2184081|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2184082|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2184083|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
2184084|NCT00002788|Hormones|hormones|mesh-ancestor
2184085|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2184086|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2184087|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184088|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184089|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184090|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184091|NCT00002789|Cyclosporine|cyclosporine|mesh-list
2666151|NCT02130700|Seviteronel|seviteronel|mesh-list
2666152|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666153|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2666154|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666155|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666156|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
2666157|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2666158|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666159|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2666160|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666161|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666162|NCT02130739|Fentanyl|fentanyl|mesh-list
2666163|NCT02130739|Propofol|propofol|mesh-list
2666164|NCT02130739|Ropivacaine|ropivacaine|mesh-list
2666165|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
2666166|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2666167|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666168|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2666169|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2666170|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
2666171|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
2666172|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
2666173|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666174|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2666175|NCT02130739|Narcotics|narcotics|mesh-ancestor
2666176|NCT02130739|Analgesics|analgesics|mesh-ancestor
2666177|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2666178|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2666179|NCT02130804|Salicylates|salicylates|mesh-list
2666180|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2666181|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2666182|NCT02130804|Analgesics|analgesics|mesh-ancestor
2666183|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
2666184|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666185|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666186|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2666187|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2666188|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2666189|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666190|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666191|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
2666192|NCT02130817|Dexamethasone|dexamethasone|mesh-list
2666193|NCT02130817|Prednisone|prednisone|mesh-list
2666194|NCT02130817|Abatacept|abatacept|mesh-list
2666195|NCT02130817|Tacrolimus|tacrolimus|mesh-list
2666196|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
2666197|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2666198|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
2666199|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2666200|NCT02130817|Antibodies|antibodies|mesh-list
2666201|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
2666202|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
2666203|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2666204|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2666205|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
2666206|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
2666207|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666208|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666209|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2666210|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
2666211|NCT02130817|Hormones|hormones|mesh-ancestor
2666212|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666213|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2666214|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666215|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666216|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666217|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184092|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
2184093|NCT00002789|Busulfan|busulfan|mesh-list
2184094|NCT00002789|Methotrexate|methotrexate|mesh-list
2666218|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
2666219|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2666220|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2666221|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2666222|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
2666223|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2666224|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666225|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2666226|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2666227|NCT02130830|Lidocaine|lidocaine|mesh-list
2666228|NCT02130830|Prilocaine|prilocaine|mesh-list
2184095|NCT00002789|Cyclosporins|cyclosporins|mesh-list
2184096|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184097|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
2184098|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184099|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2666229|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
2666230|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
2666231|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2666232|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666233|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
2666234|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666235|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2666236|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2666237|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2666238|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2666239|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666240|NCT02130869|Cytarabine|cytarabine|mesh-list
2666241|NCT02130869|Aldesleukin|aldesleukin|mesh-list
2666242|NCT02130869|Carboplatin|carboplatin|mesh-list
2666243|NCT02130869|Etoposide|etoposide|mesh-list
2666244|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
2666245|NCT02130869|Melphalan|melphalan|mesh-list
2666246|NCT02130869|Busulfan|busulfan|mesh-list
2666247|NCT02130869|Interleukin-2|interleukin-2|mesh-list
2666248|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2666249|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
2666250|NCT02130869|Sargramostim|sargramostim|mesh-list
2184100|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2666251|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666252|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2666253|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2666254|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2666255|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666256|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666257|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
2666258|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666259|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2666260|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
2666261|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
2666262|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666263|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2666264|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2666265|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
2666266|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2666267|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2184101|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
2184102|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184103|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184104|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2666268|NCT02130869|Analgesics|analgesics|mesh-ancestor
2666269|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
2666270|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666271|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2666272|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2666273|NCT02130882|Benralizumab|benralizumab|mesh-list
2666274|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2666275|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
2666276|NCT02130973|Denosumab|denosumab|mesh-list
2666277|NCT02130973|Teriparatide|teriparatide|mesh-list
2666278|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2666279|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666280|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2666281|NCT02131012|Celecoxib|celecoxib|mesh-list
2666282|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2666283|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2666284|NCT02131012|Analgesics|analgesics|mesh-ancestor
2666285|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
2666286|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666287|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666288|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2666289|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2666290|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2666291|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2666292|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666293|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666294|NCT02131220|Tirofiban|tirofiban|mesh-list
2666295|NCT02131220|Saruplase|saruplase|mesh-list
2666296|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2666297|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2666298|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666299|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2666300|NCT02131246|Insulin|insulin|mesh-list
2666301|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2666302|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
2666303|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
2666304|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2666305|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2666306|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666307|NCT02131298|Itraconazole|itraconazole|mesh-list
2666308|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
2666309|NCT02131298|Palbociclib|palbociclib|mesh-list
2666310|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666311|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2666312|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666313|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666314|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
2666315|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666316|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2666317|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2666318|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2666319|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
2666320|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666321|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666322|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2666323|NCT02131350|Ranibizumab|ranibizumab|mesh-list
2666324|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2666325|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2666326|NCT02131350|Growth Substances|growth substances|mesh-ancestor
2666327|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666328|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
2666329|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666330|NCT02131480|Doxorubicin|doxorubicin|mesh-list
2666331|NCT02131480|Trabectedin|trabectedin|mesh-list
2666332|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2666333|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666334|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2666335|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2666336|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666337|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666338|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2666339|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
2666340|NCT02131493|Gemcitabine|gemcitabine|mesh-list
2666341|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2666342|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
2666343|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666344|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666345|NCT02131493|Antiviral Agents|antiviral agents|mesh-ancestor
2666346|NCT02131493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666347|NCT02131493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666348|NCT02131493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2666349|NCT02131493|Immunologic Factors|immunologic factors|mesh-ancestor
2666350|NCT02131493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666351|NCT02131506|Lapatinib|lapatinib|mesh-list
2666352|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2666353|NCT02131506|Doxorubicin|doxorubicin|mesh-list
2666354|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666355|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2666356|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184105|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2184106|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
2184107|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2184108|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184109|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
2666357|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666358|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2666359|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2666360|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2666361|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2666362|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
2666363|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2666364|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2666365|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2666366|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2666367|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666368|NCT02131597|Guadecitabine|guadecitabine|mesh-list
2666369|NCT02131597|Azacitidine|azacitidine|mesh-list
2666370|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666371|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2666372|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
2666373|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666374|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666375|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
2666376|NCT02131688|Analgesics|analgesics|mesh-ancestor
2666377|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
2666378|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666379|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666380|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666381|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2666382|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2666383|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184110|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
2184111|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184112|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2184113|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2184114|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
2666384|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666385|NCT02131753|Cladribine|cladribine|mesh-list
2666386|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666387|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2666388|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
2666389|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666390|NCT02131818|Amoxicillin|amoxicillin|mesh-list
2666391|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2666392|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666393|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
2666394|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2666395|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666396|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
2666397|NCT02131948|Insulin|insulin|mesh-list
2666398|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
2666399|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2666400|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666401|NCT02132000|Tamoxifen|tamoxifen|mesh-list
2666402|NCT02132000|Toremifene|toremifene|mesh-list
2666403|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2666404|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
2666405|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666406|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666407|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2666408|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666409|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2666410|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2666411|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2666412|NCT02132026|Denosumab|denosumab|mesh-list
2666413|NCT02132026|Alendronate|alendronate|mesh-list
2666414|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2666415|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666416|NCT02132091|Vitamins|vitamins|mesh-list
2666417|NCT02132091|Ascorbic Acid|ascorbic acid|mesh-list
2666418|NCT02132091|Vitamin E|vitamin e|mesh-list
2666419|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
2666420|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184115|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184116|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2184117|NCT00002790|Cyclosporine|cyclosporine|mesh-list
2184118|NCT00002790|Sirolimus|sirolimus|mesh-list
2184119|NCT00002790|Methotrexate|methotrexate|mesh-list
2184120|NCT00002790|Cyclosporins|cyclosporins|mesh-list
2184121|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2184122|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
2184123|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2184124|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184125|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184126|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
2184127|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666421|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
2666422|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666423|NCT02132091|Protective Agents|protective agents|mesh-ancestor
2666424|NCT02132104|Hormones|hormones|mesh-list
2666425|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666426|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666427|NCT02132234|Adalimumab|adalimumab|mesh-list
2666428|NCT02132234|Etanercept|etanercept|mesh-list
2666429|NCT02132234|Infliximab|infliximab|mesh-list
2666430|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
2666431|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2666432|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2666433|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2666434|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2666435|NCT02132234|Analgesics|analgesics|mesh-ancestor
2666436|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
2666437|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666438|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666439|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2666440|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2666441|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
2666442|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
2666443|NCT02132260|Naftifine|naftifine|mesh-list
2666444|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
2666445|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666446|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2666447|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
2666448|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2666449|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2184128|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666450|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2666451|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2666452|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666453|NCT02132390|Toremifene|toremifene|mesh-list
2666454|NCT02132390|Goserelin|goserelin|mesh-list
2666455|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2666456|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666457|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2666458|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2666459|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
2666460|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666461|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666462|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2666463|NCT02132403|Gemcitabine|gemcitabine|mesh-list
2666464|NCT02132403|Milk fat globule|milk fat globule|mesh-list
2666465|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2666466|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
2666467|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666468|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666469|NCT02132403|Antiviral Agents|antiviral agents|mesh-ancestor
2184129|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
2184130|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184131|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2184132|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184133|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
2184134|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184135|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2184136|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
2184137|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184138|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2666470|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666471|NCT02132403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666472|NCT02132403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2666473|NCT02132403|Immunologic Factors|immunologic factors|mesh-ancestor
2666474|NCT02132403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666475|NCT02132416|Acetaminophen|acetaminophen|mesh-list
2666476|NCT02132416|Ibuprofen|ibuprofen|mesh-list
2666477|NCT02132416|Diclofenac|diclofenac|mesh-list
2666478|NCT02132416|Morphine|morphine|mesh-list
2666479|NCT02132416|Oxycodone|oxycodone|mesh-list
2666480|NCT02132416|Tramadol|tramadol|mesh-list
2666481|NCT02132416|Anesthetics|anesthetics|mesh-list
2666482|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2666483|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666484|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2666485|NCT02132416|Narcotics|narcotics|mesh-ancestor
2666486|NCT02132416|Analgesics|analgesics|mesh-ancestor
2666487|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
2666488|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666489|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2666490|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2666491|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2666492|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2666493|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2666494|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666495|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666496|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
2666497|NCT02132442|Vitamin D|vitamin d|mesh-list
2666498|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
2666499|NCT02132442|Vitamins|vitamins|mesh-ancestor
2666500|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
2666501|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666502|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2666503|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2666504|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
2666505|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2666506|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666507|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
2666508|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2666509|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2184139|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2184140|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2666510|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
2666511|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666512|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2184141|NCT00002791|Doxorubicin|doxorubicin|mesh-list
2184142|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2184143|NCT00002791|Ifosfamide|ifosfamide|mesh-list
2184144|NCT00002791|Dacarbazine|dacarbazine|mesh-list
2666513|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
2666514|NCT02132689|Heparin|heparin|mesh-list
2666515|NCT02132689|Calcium heparin|calcium heparin|mesh-list
2666516|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2666517|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666518|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
2666519|NCT02132897|Carbamazepine|carbamazepine|mesh-list
2666520|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
2666521|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
2666522|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2666523|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2666524|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666525|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2666526|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2666527|NCT02132897|Analgesics|analgesics|mesh-ancestor
2666528|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
2666529|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666530|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2666531|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2666532|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666533|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2666534|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2666535|NCT02133014|Fluorouracil|fluorouracil|mesh-list
2666536|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
2666537|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666538|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2666539|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666540|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2666541|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
2666542|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666543|NCT02133053|Beclomethasone|beclomethasone|mesh-list
2666544|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2666545|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
2666546|NCT02133053|Hormones|hormones|mesh-ancestor
2666547|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666548|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666549|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2666550|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
2666551|NCT02133079|Vaccines|vaccines|mesh-list
2666552|NCT02133079|Immunologic Factors|immunologic factors|mesh-ancestor
2666553|NCT02133079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666554|NCT02133105|Simendan|simendan|mesh-list
2666555|NCT02133105|Dobutamine|dobutamine|mesh-list
2666556|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2666557|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
2666558|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2422877|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422878|NCT00819169|Conatumumab|conatumumab|mesh-list
2422879|NCT00819169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2422880|NCT00819169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422881|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
2422882|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
2422883|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2422884|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
2422885|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422886|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2422887|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2422888|NCT00819325|Pioglitazone|pioglitazone|mesh-list
2422889|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2184145|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2184146|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184147|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184148|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184149|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184150|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184151|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2666559|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2666560|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666561|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666562|NCT02133105|Protective Agents|protective agents|mesh-ancestor
2666563|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666564|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
2666565|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
2422890|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666566|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666567|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2666568|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2666569|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2666570|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
2666571|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2666572|NCT02133118|Pioglitazone|pioglitazone|mesh-list
2666573|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2666574|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666575|NCT02133196|Aldesleukin|aldesleukin|mesh-list
2666576|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
2666577|NCT02133196|Fludarabine|fludarabine|mesh-list
2666578|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2666579|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
2666580|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666581|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184152|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
2184153|NCT00002792|Cyclosporine|cyclosporine|mesh-list
2184154|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
2184155|NCT00002792|Busulfan|busulfan|mesh-list
2184156|NCT00002792|Methotrexate|methotrexate|mesh-list
2184157|NCT00002792|Tacrolimus|tacrolimus|mesh-list
2184158|NCT00002792|Cyclosporins|cyclosporins|mesh-list
2184159|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184160|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
2666582|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2666583|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
2666584|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666585|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666586|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2666587|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2666588|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2666589|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
2666590|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666591|NCT02133287|Sirolimus|sirolimus|mesh-list
2666592|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
2666593|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2666594|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666595|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2666596|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666597|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
2666598|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2666599|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
2666600|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666601|NCT02133326|Acetaminophen|acetaminophen|mesh-list
2666602|NCT02133326|Ibuprofen|ibuprofen|mesh-list
2666603|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2666604|NCT02133326|Analgesics|analgesics|mesh-ancestor
2666605|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
2666606|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666607|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666608|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
2666609|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2666610|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2666611|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2666612|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2666613|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666614|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666615|NCT02133378|Hemostatics|hemostatics|mesh-list
2666616|NCT02133378|Coagulants|coagulants|mesh-ancestor
2666617|NCT02133404|Cinacalcet|cinacalcet|mesh-list
2666618|NCT02133404|ASP7991|asp7991|mesh-list
2666619|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2666620|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666621|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2666622|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
2666623|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666624|NCT02133469|Vaccines|vaccines|mesh-list
2666625|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2666626|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
2666627|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184161|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184162|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2666633|NCT02133612|Paclitaxel|paclitaxel|mesh-list
2666634|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2666635|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2666636|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666637|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
2666638|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
2666639|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
2666640|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666641|NCT02133625|Pioglitazone|pioglitazone|mesh-list
2666642|NCT02133625|Carboplatin|carboplatin|mesh-list
2666643|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666644|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2666645|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666646|NCT02133638|Propofol|propofol|mesh-list
2666647|NCT02133638|Sevoflurane|sevoflurane|mesh-list
2666648|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2666649|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2666650|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666651|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2666652|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
2666653|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
2666654|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2666655|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2666656|NCT02133677|Temozolomide|temozolomide|mesh-list
2666657|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2666658|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
2666659|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666660|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666661|NCT02133755|Bromocriptine|bromocriptine|mesh-list
2666662|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2666663|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2666664|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
2666665|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666666|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666667|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
2666668|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
2666669|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2666670|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666671|NCT02133820|Analgesics|analgesics|mesh-list
2666672|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
2666673|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666674|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666675|NCT02133885|Minocycline|minocycline|mesh-list
2666676|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2666677|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666678|NCT02133911|Ranolazine|ranolazine|mesh-list
2666679|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2666680|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2666681|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666682|NCT02133924|Prednisone|prednisone|mesh-list
2666683|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
2666684|NCT02133924|Natalizumab|natalizumab|mesh-list
2666685|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2666686|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
2666687|NCT02133924|Hormones|hormones|mesh-ancestor
2666688|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666689|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666690|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2666691|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666692|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
2666693|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
2666694|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666695|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2666696|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2666697|NCT02133924|Protective Agents|protective agents|mesh-ancestor
2666698|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
2666699|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2666700|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
2666701|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666702|NCT02133989|Ticlopidine|ticlopidine|mesh-list
2666703|NCT02133989|Clopidogrel|clopidogrel|mesh-list
2666704|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2666705|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2666706|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2666707|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2666708|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
2666709|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2666710|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666711|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666712|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2666713|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2666714|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2666715|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2666716|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666717|NCT02134002|Disulfiram|disulfiram|mesh-list
2666718|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2666719|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2666720|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666721|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666722|NCT02134067|Paclitaxel|paclitaxel|mesh-list
2666723|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2666724|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666725|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
2666726|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
2666727|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
2666728|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184163|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184164|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
2184165|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184166|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184167|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2184168|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2184169|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
2184170|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2184171|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184172|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
2184173|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
2184174|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184175|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2184176|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2184177|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2184178|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
2184179|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184180|NCT00002793|Leucovorin|leucovorin|mesh-list
2184181|NCT00002793|Fluorouracil|fluorouracil|mesh-list
2666729|NCT02134093|Midazolam|midazolam|mesh-list
2666730|NCT02134093|Sufentanil|sufentanil|mesh-list
2666731|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
2666732|NCT02134093|Remifentanil|remifentanil|mesh-list
2666733|NCT02134093|Anesthetics|anesthetics|mesh-list
2666734|NCT02134093|Propofol|propofol|mesh-list
2666735|NCT02134093|Etomidate|etomidate|mesh-list
2666736|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
2666737|NCT02134093|Rocuronium|rocuronium|mesh-list
2666738|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2666739|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666740|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2666741|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2666742|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
2666743|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2666744|NCT02134093|Analgesics|analgesics|mesh-ancestor
2666745|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
2666746|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666747|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2666748|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2666749|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2666750|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
2666751|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2666752|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666753|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2666754|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2666755|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2666756|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2666757|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
2666758|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
2666759|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2666760|NCT02134093|Narcotics|narcotics|mesh-ancestor
2666761|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2666762|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2666763|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2666764|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2666765|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2666766|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
2666767|NCT02134106|Polymyxins|polymyxins|mesh-list
2666768|NCT02134106|Doripenem|doripenem|mesh-list
2666769|NCT02134106|Polymyxin B|polymyxin b|mesh-list
2666770|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2666771|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666772|NCT02134249|Cabergoline|cabergoline|mesh-list
2666773|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2666774|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2666775|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
2666776|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
2666777|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2666778|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666779|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666780|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
2666781|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2666782|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2666783|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
2666784|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666785|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2666786|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2666787|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
2666788|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666789|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666790|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2666791|NCT02134288|Everolimus|everolimus|mesh-list
2666792|NCT02134288|Abatacept|abatacept|mesh-list
2184182|NCT00002793|Calcium|calcium|mesh-list
2184183|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
2184184|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2184185|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184186|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
2184187|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184188|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184189|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184190|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184191|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
2184192|NCT00002793|Antidotes|antidotes|mesh-ancestor
2666793|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666794|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2666795|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
2666796|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666797|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2666798|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666799|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2666800|NCT02134301|Oritavancin|oritavancin|mesh-list
2666801|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2666802|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666803|NCT02134327|Midazolam|midazolam|mesh-list
2666804|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
2666805|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2666806|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2666807|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666808|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2666809|NCT02134327|Analgesics|analgesics|mesh-ancestor
2666810|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
2666811|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666812|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2666813|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2666814|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2666815|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
2666816|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2666817|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666818|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2666819|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2666820|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2666821|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2666822|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2666823|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
2666824|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
2666825|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
2666826|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
2666827|NCT02134366|Lorazepam|lorazepam|mesh-list
2666828|NCT02134366|Clonazepam|clonazepam|mesh-list
2666829|NCT02134366|Clobazam|clobazam|mesh-list
2666830|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
2666831|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
2666832|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
2666833|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666834|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666835|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2666836|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2666837|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2666838|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2666839|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2666840|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2666841|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
2666842|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
2666843|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2666844|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666845|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2666846|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
2666847|NCT02134379|Clotrimazole|clotrimazole|mesh-list
2666848|NCT02134379|Miconazole|miconazole|mesh-list
2666849|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2666850|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666851|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
2666852|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2666853|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2666854|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666855|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666856|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2666857|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
2666858|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666859|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666860|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2666861|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2666862|NCT02134405|Esomeprazole|esomeprazole|mesh-list
2666863|NCT02134405|Rebamipide|rebamipide|mesh-list
2666864|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2666865|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2666866|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2666867|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666868|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666869|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
2666870|NCT02134405|Protective Agents|protective agents|mesh-ancestor
2666871|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666872|NCT02134457|Ranibizumab|ranibizumab|mesh-list
2666873|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2666874|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2666875|NCT02134457|Growth Substances|growth substances|mesh-ancestor
2666876|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666877|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
2666878|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666879|NCT02134470|Testosterone|testosterone|mesh-list
2184193|NCT00002793|Protective Agents|protective agents|mesh-ancestor
2184194|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
2184195|NCT00002793|Vitamins|vitamins|mesh-ancestor
2184196|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
2184197|NCT00002794|Carboplatin|carboplatin|mesh-list
2184198|NCT00002794|Vincristine|vincristine|mesh-list
2184199|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184200|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184201|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
2666880|NCT02134470|Androgens|androgens|mesh-ancestor
2666881|NCT02134470|Hormones|hormones|mesh-ancestor
2666882|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2666883|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666884|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
2666885|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2666886|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666887|NCT02134626|Simvastatin|simvastatin|mesh-list
2666888|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2666889|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2184202|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184203|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184204|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184205|NCT00002796|Interferons|interferons|mesh-list
2184206|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
2184207|NCT00002796|Indomethacin|indomethacin|mesh-list
2184208|NCT00002796|Fluorouracil|fluorouracil|mesh-list
2184209|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2666890|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
2666891|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666892|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2666893|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2666894|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666895|NCT02134639|Edotreotide|edotreotide|mesh-list
2666896|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2666897|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666898|NCT02134717|Maraviroc|maraviroc|mesh-list
2666899|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2666900|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2666901|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666902|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2666903|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2666904|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
2666905|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2666906|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2666907|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2666908|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666909|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2666910|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184210|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
2184211|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184212|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184213|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184214|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2666911|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666912|NCT02134899|Everolimus|everolimus|mesh-list
2666913|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2666914|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666915|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2666916|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
2666917|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666918|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666919|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666920|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2666921|NCT02134938|Cathartics|cathartics|mesh-ancestor
2666922|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2666923|NCT02134964|Dapansutrile|dapansutrile|mesh-list
2666924|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2666925|NCT02134990|Docetaxel|docetaxel|mesh-list
2666926|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666927|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
2666928|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
2666929|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
2666930|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666931|NCT02135029|Atorvastatin|atorvastatin|mesh-list
2666932|NCT02135029|Bococizumab|bococizumab|mesh-list
2666933|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2666934|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2666935|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
2666936|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666937|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2666938|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2666939|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184215|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
2184216|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184217|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
2184218|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184219|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2184220|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2184221|NCT00002796|Analgesics|analgesics|mesh-ancestor
2184222|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
2184223|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2184224|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2184225|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184226|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
2184227|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
2184228|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2184229|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2184230|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184231|NCT00002798|Cytarabine|cytarabine|mesh-list
2184232|NCT00002798|Aldesleukin|aldesleukin|mesh-list
2184233|NCT00002798|Dexamethasone|dexamethasone|mesh-list
2184234|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
2666959|NCT02135055|Midazolam|midazolam|mesh-list
2666960|NCT02135055|Morphine|morphine|mesh-list
2666961|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2666962|NCT02135055|Narcotics|narcotics|mesh-ancestor
2666963|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2666964|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666965|NCT02135055|Analgesics|analgesics|mesh-ancestor
2184235|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2184236|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2184237|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2184238|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
2184239|NCT00002798|Busulfan|busulfan|mesh-list
2184240|NCT00002798|Methotrexate|methotrexate|mesh-list
2184241|NCT00002798|Fludarabine|fludarabine|mesh-list
2184242|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
2184243|NCT00002798|Etoposide|etoposide|mesh-list
2184244|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
2184245|NCT00002798|Daunorubicin|daunorubicin|mesh-list
2184246|NCT00002798|Interleukin-2|interleukin-2|mesh-list
2666966|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
2666967|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666968|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2666969|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2184247|NCT00002798|Asparaginase|asparaginase|mesh-list
2184248|NCT00002798|Idarubicin|idarubicin|mesh-list
2184249|NCT00002798|Thioguanine|thioguanine|mesh-list
2184250|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184251|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
2184252|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184253|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184254|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2666970|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2666971|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2666972|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2666973|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2666974|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
2666975|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
2666976|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
2666977|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
2666978|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2666979|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666980|NCT02135120|Morphine|morphine|mesh-list
2666981|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2666982|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666983|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2666984|NCT02135120|Narcotics|narcotics|mesh-ancestor
2666985|NCT02135120|Analgesics|analgesics|mesh-ancestor
2666986|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
2666987|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2666988|NCT02135133|Ofatumumab|ofatumumab|mesh-list
2666989|NCT02135133|Idelalisib|idelalisib|mesh-list
2666990|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2666991|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2666992|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666993|NCT02135224|Fentanyl|fentanyl|mesh-list
2666994|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2184255|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
2184256|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2666995|NCT02135224|Narcotics|narcotics|mesh-ancestor
2666996|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2666997|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2666998|NCT02135224|Analgesics|analgesics|mesh-ancestor
2666999|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
2667000|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667001|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2667002|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2667003|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
2667004|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
2667005|NCT02135263|Enalapril|enalapril|mesh-list
2667006|NCT02135263|Methylphenidate|methylphenidate|mesh-list
2667007|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2667008|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667009|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2667010|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2667011|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2667012|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667013|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
2667014|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667015|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2667016|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
2667017|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667018|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2667019|NCT02135315|Antihypertensive Agents|antihypertensive agents|mesh-list
2667020|NCT02135315|Labetalol|labetalol|mesh-list
2667021|NCT02135315|Nicardipine|nicardipine|mesh-list
2667022|NCT02135315|Isosorbide|isosorbide|mesh-list
2667023|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2667024|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2667025|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2667026|NCT02135315|Diuretics|diuretics|mesh-ancestor
2667027|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
2667028|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667029|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
2667030|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2667031|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667032|NCT02135315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2667033|NCT02135315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2667034|NCT02135315|Adrenergic Agents|adrenergic agents|mesh-ancestor
2667035|NCT02135315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667036|NCT02135315|Sympathomimetics|sympathomimetics|mesh-ancestor
2667037|NCT02135315|Autonomic Agents|autonomic agents|mesh-ancestor
2667038|NCT02135315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667039|NCT02135315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2667040|NCT02135315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2667041|NCT02135315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2667042|NCT02135315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2184257|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184258|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2184259|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2184260|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
2184261|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
2184262|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2184263|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2184264|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
2184265|NCT00002798|Hormones|hormones|mesh-ancestor
2184266|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2184267|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2184268|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2184269|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
2184270|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2184271|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184272|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
2184273|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
2184274|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184275|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2184276|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2184277|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184278|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184279|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184280|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
2184281|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184282|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2184283|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2184284|NCT00002798|Analgesics|analgesics|mesh-ancestor
2667043|NCT02135315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2667044|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
2667045|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2667046|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2667047|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2667048|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2667049|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2667050|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667051|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
2667052|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667053|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667054|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2667055|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667056|NCT02135354|Azithromycin|azithromycin|mesh-list
2667057|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2667058|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667059|NCT02135393|Folic Acid|folic acid|mesh-list
2667060|NCT02135393|Hematinics|hematinics|mesh-ancestor
2667061|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
2667062|NCT02135393|Vitamins|vitamins|mesh-ancestor
2667063|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
2667064|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667065|NCT02135419|Fluorouracil|fluorouracil|mesh-list
2667066|NCT02135419|Imiquimod|imiquimod|mesh-list
2667067|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
2667068|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667069|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2667070|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667071|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2667072|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
2667073|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667074|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2667075|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
2667076|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2667077|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667078|NCT02135510|Palonosetron|palonosetron|mesh-list
2667079|NCT02135510|Metoclopramide|metoclopramide|mesh-list
2667080|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
2667081|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
2667082|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667083|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667084|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2667085|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2667086|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2667087|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
2667088|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667089|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667090|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2667091|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2667092|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
2667093|NCT02135588|Plasminogen|plasminogen|mesh-list
2667094|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2667095|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2667096|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2667097|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184285|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
2184286|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2184287|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2184288|NCT00002800|Cytarabine|cytarabine|mesh-list
2184289|NCT00002800|Etoposide|etoposide|mesh-list
2184290|NCT00002800|Idarubicin|idarubicin|mesh-list
2184291|NCT00002800|Lintuzumab|lintuzumab|mesh-list
2184292|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184293|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184294|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184295|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184296|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184297|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184298|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
2184299|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184300|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184301|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
2184302|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
2184303|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184304|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184305|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2184306|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2184307|NCT00002801|Leucovorin|leucovorin|mesh-list
2184308|NCT00002801|Tegafur|tegafur|mesh-list
2184309|NCT00002801|Calcium|calcium|mesh-list
2184310|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
2184311|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2184312|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184313|NCT00002801|Antidotes|antidotes|mesh-ancestor
2184314|NCT00002801|Protective Agents|protective agents|mesh-ancestor
2184315|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
2667098|NCT02135627|Epinephrine|epinephrine|mesh-list
2667099|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2667100|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2667101|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
2667102|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667103|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667104|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184316|NCT00002801|Vitamins|vitamins|mesh-ancestor
2184317|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
2184318|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184319|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
2184320|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184321|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184322|NCT00002802|Cobalt|cobalt|mesh-list
2184323|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
2667105|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2667106|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2667107|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
2667108|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667109|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2667110|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
2667111|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
2667112|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
2667113|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2667114|NCT02135640|Denosumab|denosumab|mesh-list
2667115|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2667116|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667117|NCT02135770|Heparin|heparin|mesh-list
2667118|NCT02135770|Calcium heparin|calcium heparin|mesh-list
2667119|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
2667120|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2667121|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2667122|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667123|NCT02135822|Gemcitabine|gemcitabine|mesh-list
2667124|NCT02135822|Paclitaxel|paclitaxel|mesh-list
2667125|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2667126|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2667127|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667128|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
2667129|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
2667130|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
2667131|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667132|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2667133|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
2667134|NCT02135822|Antiviral Agents|antiviral agents|mesh-ancestor
2667135|NCT02135822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667136|NCT02135822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667137|NCT02135822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2667138|NCT02135822|Immunologic Factors|immunologic factors|mesh-ancestor
2667139|NCT02135822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667140|NCT02135874|Cytarabine|cytarabine|mesh-list
2667141|NCT02135874|Dexamethasone|dexamethasone|mesh-list
2667142|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
2667143|NCT02135874|Rituximab|rituximab|mesh-list
2667144|NCT02135874|Vincristine|vincristine|mesh-list
2667145|NCT02135874|Sorafenib|sorafenib|mesh-list
2667146|NCT02135874|Idarubicin|idarubicin|mesh-list
2667147|NCT02135874|Clofarabine|clofarabine|mesh-list
2667148|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2667149|NCT02135874|Antibodies|antibodies|mesh-list
2667150|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
2667151|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2667152|NCT02135874|BB 1101|bb 1101|mesh-list
2184324|NCT00002802|Melphalan|melphalan|mesh-list
2184325|NCT00002802|Ifosfamide|ifosfamide|mesh-list
2184326|NCT00002802|Dacarbazine|dacarbazine|mesh-list
2667153|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
2667154|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667155|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2667156|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
2667157|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
2667158|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667159|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2667160|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
2667161|NCT02135874|Hormones|hormones|mesh-ancestor
2667162|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2667163|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2667164|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667165|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
2667166|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667167|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667168|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2667169|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2667170|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
2667171|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
2667172|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667173|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2667174|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2667175|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
2667176|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
2667177|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
2667178|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2667179|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2667180|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2667181|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2667182|NCT02135887|Leucovorin|leucovorin|mesh-list
2667183|NCT02135887|Folic Acid|folic acid|mesh-list
2667184|NCT02135887|Fluorouracil|fluorouracil|mesh-list
2667185|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
2667186|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
2667187|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
2667188|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667189|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2667190|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667191|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2667192|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
2667193|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667194|NCT02135887|Antidotes|antidotes|mesh-ancestor
2667195|NCT02135887|Protective Agents|protective agents|mesh-ancestor
2184327|NCT00002802|Carboplatin|carboplatin|mesh-list
2184328|NCT00002802|Doxorubicin|doxorubicin|mesh-list
2184329|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2184330|NCT00002802|Etoposide|etoposide|mesh-list
2184331|NCT00002802|Vincristine|vincristine|mesh-list
2184332|NCT00002802|Vindesine|vindesine|mesh-list
2667196|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
2667197|NCT02135887|Vitamins|vitamins|mesh-ancestor
2667198|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
2184333|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184334|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
2184335|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184336|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184337|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184338|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
2184339|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184340|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184341|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2184342|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2184343|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184344|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184345|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184346|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184347|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184348|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184349|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184350|NCT00002802|Trace Elements|trace elements|mesh-ancestor
2184351|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
2184352|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
2184353|NCT00002803|Doxorubicin|doxorubicin|mesh-list
2184354|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2184355|NCT00002803|Vincristine|vincristine|mesh-list
2184356|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184357|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
2184358|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184359|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184360|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184361|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
2667199|NCT02135887|Hematinics|hematinics|mesh-ancestor
2667200|NCT02135913|Vitamin D|vitamin d|mesh-list
2667201|NCT02135913|Vitamins|vitamins|mesh-ancestor
2184362|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184363|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184364|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2184365|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2667202|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
2667203|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667204|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2667205|NCT02135965|Caffeine|caffeine|mesh-list
2667206|NCT02135965|Albuterol|albuterol|mesh-list
2667207|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2667208|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667209|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2667210|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667211|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667212|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2667213|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2667214|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
2667215|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667216|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2667217|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
2667218|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2184366|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184367|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184368|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184369|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184370|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184371|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184372|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184373|NCT00002804|Cobalt|cobalt|mesh-list
2184374|NCT00002804|Doxorubicin|doxorubicin|mesh-list
2184375|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2184376|NCT00002804|Vincristine|vincristine|mesh-list
2184377|NCT00002804|Ifosfamide|ifosfamide|mesh-list
2184378|NCT00002804|Lenograstim|lenograstim|mesh-list
2184379|NCT00002804|Sargramostim|sargramostim|mesh-list
2184380|NCT00002804|Mesna|mesna|mesh-list
2184381|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2184382|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667219|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2667220|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
2667221|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
2667222|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2667223|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2667224|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2667225|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2667226|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
2667227|NCT02136030|Amphotericin B|amphotericin b|mesh-list
2667228|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2667229|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
2667230|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
2667231|NCT02136030|Amebicides|amebicides|mesh-ancestor
2667232|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2667233|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2667234|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667235|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2667236|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
2667237|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2667238|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2184383|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184384|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184385|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184386|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184387|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2184388|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
2184389|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184390|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184391|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184392|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184393|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184394|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184395|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
2184396|NCT00002804|Protective Agents|protective agents|mesh-ancestor
2667239|NCT02136147|Guanfacine|guanfacine|mesh-list
2667240|NCT02136147|Methylphenidate|methylphenidate|mesh-list
2184397|NCT00002804|Trace Elements|trace elements|mesh-ancestor
2184398|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
2667241|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2667242|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2667243|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2667244|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667245|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2667246|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2667247|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2667248|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667249|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
2667250|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667251|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2667252|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
2667253|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2667254|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2667255|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2667256|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2667257|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2667258|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
2667259|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
2667260|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2667261|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2667262|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667263|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667264|NCT02136329|Urological Agents|urological agents|mesh-ancestor
2667265|NCT02136511|Rituximab|rituximab|mesh-list
2667266|NCT02136511|Idelalisib|idelalisib|mesh-list
2667267|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2667268|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667269|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
2667270|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667271|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2667272|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667273|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667274|NCT02136589|Diclofenac|diclofenac|mesh-list
2667275|NCT02136589|Travoprost|travoprost|mesh-list
2667276|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2667277|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2667278|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2667279|NCT02136589|Analgesics|analgesics|mesh-ancestor
2667280|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
2667281|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667282|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667283|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2667284|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2667285|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2667286|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667287|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667288|NCT02136641|Fentanyl|fentanyl|mesh-list
2667289|NCT02136641|Midazolam|midazolam|mesh-list
2667290|NCT02136641|Ketamine|ketamine|mesh-list
2667291|NCT02136641|Analgesics|analgesics|mesh-ancestor
2667292|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
2667293|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667294|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667295|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2667296|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2667297|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
2667298|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
2667299|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667300|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2667301|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2667302|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667303|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667304|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2667305|NCT02136641|Narcotics|narcotics|mesh-ancestor
2667306|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2667307|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2667308|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2667309|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2667310|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2667311|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
2667312|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
2667313|NCT02136693|Psyllium|psyllium|mesh-list
2667314|NCT02136693|Cathartics|cathartics|mesh-ancestor
2667315|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2667316|NCT02136771|Vitamin D|vitamin d|mesh-list
2667317|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
2667318|NCT02136771|Vitamins|vitamins|mesh-ancestor
2667319|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
2667320|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667321|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2667322|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2667323|NCT02136784|Morphine|morphine|mesh-list
2667324|NCT02136784|Oxycodone|oxycodone|mesh-list
2667325|NCT02136784|Buprenorphine|buprenorphine|mesh-list
2667326|NCT02136784|Hydromorphone|hydromorphone|mesh-list
2667327|NCT02136784|Hydrocodone|hydrocodone|mesh-list
2667328|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2667329|NCT02136784|Narcotics|narcotics|mesh-ancestor
2667330|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667331|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184399|NCT00002805|Cobalt|cobalt|mesh-list
2184400|NCT00002805|Cytarabine|cytarabine|mesh-list
2184401|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
2184402|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2184403|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2184404|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2184405|NCT00002805|Methotrexate|methotrexate|mesh-list
2667332|NCT02136784|Analgesics|analgesics|mesh-ancestor
2667333|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
2667334|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2184406|NCT00002805|Etoposide|etoposide|mesh-list
2184407|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
2184408|NCT00002805|Cladribine|cladribine|mesh-list
2184409|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2184410|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
2184411|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2184412|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184413|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184414|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
2184415|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184416|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184417|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
2184418|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184419|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2184420|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184421|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
2184422|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184423|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2184424|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184425|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184426|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184427|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
2184428|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184429|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2667335|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2667336|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
2667337|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
2667338|NCT02136823|Isradipine|isradipine|mesh-list
2667339|NCT02136823|Riluzole|riluzole|mesh-list
2667340|NCT02136823|Memantine|memantine|mesh-list
2667341|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2667342|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2667343|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
2667344|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667345|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667346|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667347|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2667348|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2667349|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
2184430|NCT00002805|Analgesics|analgesics|mesh-ancestor
2422891|NCT00819351|Asparaginase|asparaginase|mesh-list
2422892|NCT00819351|Pegaspargase|pegaspargase|mesh-list
2422893|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422894|NCT00819377|Milrinone|milrinone|mesh-list
2422895|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2422896|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2422897|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
2422898|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2422899|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2422900|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422901|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422902|NCT00819377|Protective Agents|protective agents|mesh-ancestor
2667350|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2667351|NCT02136823|Protective Agents|protective agents|mesh-ancestor
2667352|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2667353|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2667354|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2667355|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2184431|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
2184432|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2184433|NCT00002805|Trace Elements|trace elements|mesh-ancestor
2184434|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
2184435|NCT00002806|Vincristine|vincristine|mesh-list
2184436|NCT00002806|Lomustine|lomustine|mesh-list
2184437|NCT00002806|Procarbazine|procarbazine|mesh-list
2184438|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184439|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184440|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184441|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184442|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184443|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184444|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2667356|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
2667357|NCT02136875|Fluticasone|fluticasone|mesh-list
2667358|NCT02136875|Xhance|xhance|mesh-list
2667359|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2667360|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2667361|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2667362|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
2667363|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667364|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667365|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2667366|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
2667367|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
2667368|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2667369|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2667370|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2667371|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2667372|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
2184445|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
2184446|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
2184447|NCT00002809|Methotrexate|methotrexate|mesh-list
2184448|NCT00002809|Tacrolimus|tacrolimus|mesh-list
2184449|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2184450|NCT00002809|Sargramostim|sargramostim|mesh-list
2184451|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
2184452|NCT00002809|Antibodies|antibodies|mesh-list
2184453|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
2184454|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2184455|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2184456|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184457|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
2667373|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667374|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667375|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
2667376|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2667377|NCT02136888|Ponesimod|ponesimod|mesh-list
2667378|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2667379|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667380|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2667381|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2667382|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667383|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667384|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667385|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2667386|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
2667387|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2667388|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667389|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2667390|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2667391|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2667392|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2667393|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2667394|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
2184458|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184459|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2667395|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
2667396|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2667397|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
2667398|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667399|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
2667400|NCT02136901|Protective Agents|protective agents|mesh-ancestor
2667401|NCT02136979|Propofol|propofol|mesh-list
2667402|NCT02136979|Sevoflurane|sevoflurane|mesh-list
2667403|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2667404|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667405|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667406|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2667407|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
2667408|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
2667409|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2184460|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184461|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
2184462|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184463|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184464|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2184465|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2184466|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
2184467|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2184468|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184469|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
2184470|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
2184471|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184472|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2184473|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2667410|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2667411|NCT02136992|Pirfenidone|pirfenidone|mesh-list
2667412|NCT02136992|Analgesics|analgesics|mesh-ancestor
2667413|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
2667414|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667415|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667416|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2667417|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2667418|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2667419|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2667420|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667421|NCT02137083|Docetaxel|docetaxel|mesh-list
2667422|NCT02137083|Fulvestrant|fulvestrant|mesh-list
2667423|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667424|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
2667425|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
2667426|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
2667427|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667428|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2667429|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2667430|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2667431|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
2667432|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2667433|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667434|NCT02137109|Natalizumab|natalizumab|mesh-list
2667435|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
2667436|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667437|NCT02137161|Tobramycin|tobramycin|mesh-list
2667438|NCT02137161|Dexamethasone|dexamethasone|mesh-list
2667439|NCT02137161|Bromfenac|bromfenac|mesh-list
2667440|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2667441|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2667442|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
2667443|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
2667444|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667445|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667446|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2667447|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
2667448|NCT02137161|Hormones|hormones|mesh-ancestor
2667449|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2667450|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2667451|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667452|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2667453|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2667454|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667455|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2667456|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2667457|NCT02137161|Analgesics|analgesics|mesh-ancestor
2667458|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
2667459|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2667460|NCT02137213|Naloxone|naloxone|mesh-list
2667461|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2667462|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667463|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
2667464|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667465|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
2667466|NCT02137239|Prednisone|prednisone|mesh-list
2667467|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
2667468|NCT02137239|Everolimus|everolimus|mesh-list
2667469|NCT02137239|Abatacept|abatacept|mesh-list
2667470|NCT02137239|Tacrolimus|tacrolimus|mesh-list
2667471|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
2667472|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2667473|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
2667474|NCT02137239|Hormones|hormones|mesh-ancestor
2667475|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2667476|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667477|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2667478|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667479|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2667480|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
2667481|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2667482|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667483|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667484|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2667485|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2667486|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
2667487|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2667488|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667489|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
2667490|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
2667491|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667492|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2667493|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2667494|NCT02137239|Protective Agents|protective agents|mesh-ancestor
2667495|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2667496|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2667497|NCT02137265|Clomiphene|clomiphene|mesh-list
2667498|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2667499|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
2667500|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2667501|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667502|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2667503|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
2667504|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2667505|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2667506|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2667507|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
2667508|NCT02137278|Levodopa|levodopa|mesh-list
2667509|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
2667510|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
2667511|NCT02137278|Diuretics|diuretics|mesh-list
2667512|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2667513|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
2667514|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667515|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
2667516|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667517|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667518|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2667519|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2667520|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2667521|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667522|NCT02137343|Capecitabine|capecitabine|mesh-list
2667523|NCT02137343|Rilotumumab|rilotumumab|mesh-list
2667524|NCT02137343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667525|NCT02137343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2667526|NCT02137343|Antimetabolites|antimetabolites|mesh-ancestor
2667527|NCT02137343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667528|NCT02137343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2667529|NCT02137356|Capecitabine|capecitabine|mesh-list
2667530|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2667531|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
2667532|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667533|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667534|NCT02137395|Dexamethasone|dexamethasone|mesh-list
2667535|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2667536|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
2667537|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
2667538|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667539|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667540|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2667541|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
2667542|NCT02137395|Hormones|hormones|mesh-ancestor
2667543|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2667544|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2667545|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667546|NCT02137421|Resveratrol|resveratrol|mesh-list
2667547|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
2667548|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667549|NCT02137421|Protective Agents|protective agents|mesh-ancestor
2667550|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667551|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667552|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2667553|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
2667554|NCT02137434|Calcium|calcium|mesh-list
2667555|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2667556|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667557|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2667558|NCT02137525|Fentanyl|fentanyl|mesh-list
2667559|NCT02137525|Morphine|morphine|mesh-list
2667560|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2667561|NCT02137525|Narcotics|narcotics|mesh-ancestor
2667562|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667563|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667564|NCT02137525|Analgesics|analgesics|mesh-ancestor
2667565|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
2667566|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667567|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2667568|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2667569|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
2667570|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
2667571|NCT02137616|Olanzapine|olanzapine|mesh-list
2667572|NCT02137616|Risperidone|risperidone|mesh-list
2667573|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2667574|NCT02137616|Aripiprazole|aripiprazole|mesh-list
2667575|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2667576|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
2667577|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667578|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667579|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667580|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2667581|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2667582|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667583|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2667584|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2667585|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
2667586|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
2667587|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
2667588|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667589|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2667590|NCT02137616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2667591|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2667592|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2667593|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
2667594|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
2667595|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2667596|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2667597|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2667598|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2667599|NCT02137629|Azacitidine|azacitidine|mesh-list
2667600|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2667601|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
2667602|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667603|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667604|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667605|NCT02137668|Vancomycin|vancomycin|mesh-list
2667606|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2667607|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667608|NCT02137681|Rituximab|rituximab|mesh-list
2667609|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2667610|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667611|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
2667612|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667613|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2667614|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2667615|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2667616|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667617|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2667618|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
2667619|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667620|NCT02137733|Carvedilol|carvedilol|mesh-list
2667621|NCT02137733|Bisoprolol|bisoprolol|mesh-list
2667622|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2667623|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2667624|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
2667625|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667626|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667627|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667628|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2667629|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
2667630|NCT02137733|Protective Agents|protective agents|mesh-ancestor
2667631|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2667632|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2667633|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2667634|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
2667635|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2667636|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2667637|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
2667638|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
2667639|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667640|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2667641|NCT02137759|Temozolomide|temozolomide|mesh-list
2667642|NCT02137759|Belinostat|belinostat|mesh-list
2667643|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2667644|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
2667645|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667646|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667647|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2667648|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667649|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
2667650|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2667651|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667652|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667653|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2667654|NCT02137863|Analgesics|analgesics|mesh-ancestor
2667655|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
2667656|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667657|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2667658|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2667659|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2667660|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
2667661|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2184474|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2184475|NCT00002810|Melphalan|melphalan|mesh-list
2184476|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
2667662|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667663|NCT02137928|Carboplatin|carboplatin|mesh-list
2667664|NCT02137928|Etoposide|etoposide|mesh-list
2667665|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
2667666|NCT02137928|Vincristine|vincristine|mesh-list
2667667|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667668|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2667669|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2667670|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2667671|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667672|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667673|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
2667674|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
2667675|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
2667676|NCT02137954|Lidocaine|lidocaine|mesh-list
2667677|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
2667678|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
2667679|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667680|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667681|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
2667682|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667683|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2667684|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2667685|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2667686|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2667687|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184477|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184478|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184479|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
2184480|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184481|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184482|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2184483|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184484|NCT00002812|Cytarabine|cytarabine|mesh-list
2184485|NCT00002812|Dexamethasone|dexamethasone|mesh-list
2184486|NCT00002812|Prednisone|prednisone|mesh-list
2667688|NCT02137993|Olanzapine|olanzapine|mesh-list
2667689|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
2667690|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
2667691|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667692|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667693|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2667694|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2667695|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2667696|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667697|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2667698|NCT02137993|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2667699|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2667700|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2667701|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667702|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667703|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
2667704|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2667705|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
2667706|NCT02138019|Coagulants|coagulants|mesh-ancestor
2667707|NCT02138045|Liraglutide|liraglutide|mesh-list
2667708|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2667709|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667710|NCT02138045|Incretins|incretins|mesh-ancestor
2667711|NCT02138045|Hormones|hormones|mesh-ancestor
2667712|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2667713|NCT02138058|Topiramate|topiramate|mesh-list
2667714|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
2667715|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2667716|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667717|NCT02138084|Ritonavir|ritonavir|mesh-list
2667718|NCT02138084|Fostemsavir|fostemsavir|mesh-list
2667719|NCT02138084|Rifabutin|rifabutin|mesh-list
2667720|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2667721|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2667722|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
2667723|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667724|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667725|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2667726|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2667727|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
2667728|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667729|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2667730|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2667731|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2667732|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2667733|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
2667734|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2667735|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2667736|NCT02138292|Trametinib|trametinib|mesh-list
2667737|NCT02138292|Digoxin|digoxin|mesh-list
2667738|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667739|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2667740|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667741|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667742|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2667743|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2667744|NCT02138292|Protective Agents|protective agents|mesh-ancestor
2667745|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667746|NCT02138357|Buprenorphine|buprenorphine|mesh-list
2184487|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
2184488|NCT00002812|Doxorubicin|doxorubicin|mesh-list
2184489|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2184490|NCT00002812|Methotrexate|methotrexate|mesh-list
2184491|NCT00002812|Vincristine|vincristine|mesh-list
2184492|NCT00002812|Daunorubicin|daunorubicin|mesh-list
2184493|NCT00002812|Asparaginase|asparaginase|mesh-list
2184494|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
2184495|NCT00002812|Idarubicin|idarubicin|mesh-list
2184496|NCT00002812|Thioguanine|thioguanine|mesh-list
2184497|NCT00002812|Pegaspargase|pegaspargase|mesh-list
2667747|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2667748|NCT02138357|Narcotics|narcotics|mesh-ancestor
2667749|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667750|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667751|NCT02138357|Analgesics|analgesics|mesh-ancestor
2667752|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
2667753|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667754|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2667755|NCT02138383|Gemcitabine|gemcitabine|mesh-list
2667756|NCT02138383|Paclitaxel|paclitaxel|mesh-list
2667757|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2667758|NCT02138383|Androgens|androgens|mesh-list
2667759|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2667760|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667761|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
2667762|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
2667763|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
2667764|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667765|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2667766|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
2667767|NCT02138383|Antiviral Agents|antiviral agents|mesh-ancestor
2667768|NCT02138383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667769|NCT02138383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667770|NCT02138383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2667771|NCT02138383|Immunologic Factors|immunologic factors|mesh-ancestor
2667772|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667773|NCT02138383|Hormones|hormones|mesh-ancestor
2667774|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2667775|NCT02138396|Fentanyl|fentanyl|mesh-list
2667776|NCT02138396|Naltrexone|naltrexone|mesh-list
2667777|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2667778|NCT02138396|Narcotics|narcotics|mesh-ancestor
2667779|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667780|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667781|NCT02138396|Analgesics|analgesics|mesh-ancestor
2667782|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
2667783|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667784|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2667785|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2667786|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
2667787|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
2667788|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2667789|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2667790|NCT02138409|Fentanyl|fentanyl|mesh-list
2667791|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2667792|NCT02138409|Narcotics|narcotics|mesh-ancestor
2667793|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667794|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667795|NCT02138409|Analgesics|analgesics|mesh-ancestor
2667796|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
2667797|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667798|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2667799|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2667800|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
2667801|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
2667802|NCT02138500|PF-06372865|pf-06372865|mesh-list
2667803|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
2667804|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
2667805|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667806|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667807|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667808|NCT02138539|Hydroquinone|hydroquinone|mesh-list
2667809|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
2184498|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184499|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
2667810|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667811|NCT02138539|Protective Agents|protective agents|mesh-ancestor
2667812|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667813|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2667814|NCT02138552|Octenidine|octenidine|mesh-list
2667815|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667816|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2667817|NCT02138617|Leucovorin|leucovorin|mesh-list
2667818|NCT02138617|Bevacizumab|bevacizumab|mesh-list
2667819|NCT02138617|Fluorouracil|fluorouracil|mesh-list
2667820|NCT02138617|Irinotecan|irinotecan|mesh-list
2184500|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184501|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184502|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184503|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
2184504|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184505|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184506|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2184507|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2184508|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
2184509|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
2184510|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2184511|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2184512|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
2184513|NCT00002812|Hormones|hormones|mesh-ancestor
2667821|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
2667822|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2667823|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667824|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2667825|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2667826|NCT02138617|Growth Substances|growth substances|mesh-ancestor
2667827|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667828|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
2667829|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
2667830|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667831|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2667832|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2667833|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
2667834|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2667835|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2667836|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667837|NCT02138617|Antidotes|antidotes|mesh-ancestor
2667838|NCT02138617|Protective Agents|protective agents|mesh-ancestor
2667839|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
2667840|NCT02138617|Vitamins|vitamins|mesh-ancestor
2667841|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
2667842|NCT02138630|Capsaicin|capsaicin|mesh-list
2667843|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
2667844|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
2667845|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
2667846|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667847|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667848|NCT02138708|Adenosine|adenosine|mesh-list
2667849|NCT02138708|Acetylcholine|acetylcholine|mesh-list
2667850|NCT02138708|Analgesics|analgesics|mesh-ancestor
2667851|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
2667852|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667853|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667854|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2667855|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
2667856|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2184514|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2184515|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2667857|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
2667858|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
2667859|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667860|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667861|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2667862|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
2667863|NCT02138773|Tamsulosin|tamsulosin|mesh-list
2667864|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2667865|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2667866|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2667867|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
2667868|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667869|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667870|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667871|NCT02138773|Urological Agents|urological agents|mesh-ancestor
2667872|NCT02138799|Rifampin|rifampin|mesh-list
2667873|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2667874|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
2667875|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2667876|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667877|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
2667878|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2667879|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667880|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667881|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2667882|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2667883|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2667884|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2667885|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2667886|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2667887|NCT02138812|Paclitaxel|paclitaxel|mesh-list
2667888|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2667889|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667890|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
2667891|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
2667892|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
2667893|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667894|NCT02138929|Everolimus|everolimus|mesh-list
2184516|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2184517|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184518|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184519|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184520|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2184521|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
2184522|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2184523|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184524|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
2184525|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
2184526|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2184527|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2184528|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
2184529|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184530|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184531|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184532|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184533|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184534|NCT00002813|Vinorelbine|vinorelbine|mesh-list
2667895|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667896|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2667897|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
2667898|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667899|NCT02138955|Curcumin|curcumin|mesh-list
2667900|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2667901|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2184535|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184536|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184537|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184538|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184539|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184540|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184541|NCT00002814|Paclitaxel|paclitaxel|mesh-list
2184542|NCT00002814|Topotecan|topotecan|mesh-list
2184543|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184544|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184545|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184546|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
2667902|NCT02138955|Analgesics|analgesics|mesh-ancestor
2667903|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
2667904|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667905|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667906|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2184547|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184548|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667907|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2667908|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667909|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667910|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667911|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2184549|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2667912|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
2667913|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667914|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2667915|NCT02139098|Amitriptyline|amitriptyline|mesh-list
2667916|NCT02139098|Zolpidem|zolpidem|mesh-list
2667917|NCT02139098|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2667918|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2667919|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2667920|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667921|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667922|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2667923|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
2667924|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
2667925|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667926|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667927|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2667928|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
2184550|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184551|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184552|NCT00002816|Leucovorin|leucovorin|mesh-list
2184553|NCT00002816|Cobalt|cobalt|mesh-list
2184554|NCT00002816|Cytarabine|cytarabine|mesh-list
2184555|NCT00002816|Dexamethasone|dexamethasone|mesh-list
2184556|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
2184557|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2184558|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2184559|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2184560|NCT00002816|Methotrexate|methotrexate|mesh-list
2184561|NCT00002816|Etoposide|etoposide|mesh-list
2184562|NCT00002816|Vincristine|vincristine|mesh-list
2184563|NCT00002816|Asparaginase|asparaginase|mesh-list
2184564|NCT00002816|Ifosfamide|ifosfamide|mesh-list
2184565|NCT00002816|Idarubicin|idarubicin|mesh-list
2184566|NCT00002816|Thioguanine|thioguanine|mesh-list
2184567|NCT00002816|Pegaspargase|pegaspargase|mesh-list
2184568|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
2184569|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2184570|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
2184571|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
2184572|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2184573|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184574|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2184575|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
2667929|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2667930|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2667931|NCT02139098|Analgesics|analgesics|mesh-ancestor
2667932|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
2667933|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667934|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2667935|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2667936|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2667937|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
2667938|NCT02139098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2667939|NCT02139098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2667940|NCT02139241|Ramosetron|ramosetron|mesh-list
2667941|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
2667942|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
2667943|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2667944|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667945|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2667946|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2667947|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
2667948|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2667949|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667950|NCT02139267|Vaccines|vaccines|mesh-list
2667951|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
2667952|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667953|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
2667954|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2667955|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2667956|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667957|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
2667958|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2184576|NCT00002816|Hormones|hormones|mesh-ancestor
2184577|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2184578|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2184579|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667959|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667960|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2667961|NCT02139397|Eflornithine|eflornithine|mesh-list
2667962|NCT02139397|Bortezomib|bortezomib|mesh-list
2667963|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667964|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2667965|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2667966|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2667967|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2667968|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2667969|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2667970|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667971|NCT02139579|Bevacizumab|bevacizumab|mesh-list
2667972|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2667973|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2667974|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2667975|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2667976|NCT02139579|Growth Substances|growth substances|mesh-ancestor
2667977|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667978|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
2667979|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2667980|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2667981|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2667982|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
2667983|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
2667984|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
2667985|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667986|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
2667987|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2667988|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2667989|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2667990|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2667991|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2667992|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2667993|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2667994|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2667995|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2667996|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2667997|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2667998|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2184580|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2184581|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
2184582|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2184583|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184584|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
2184585|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184586|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
2184587|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184588|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2184589|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184590|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
2184591|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184592|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2184593|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184594|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184595|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184596|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
2184597|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184598|NCT00002816|Antidotes|antidotes|mesh-ancestor
2184599|NCT00002816|Protective Agents|protective agents|mesh-ancestor
2184600|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
2184601|NCT00002816|Vitamins|vitamins|mesh-ancestor
2184602|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
2184603|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184604|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184605|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184606|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184607|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
2184608|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2184609|NCT00002816|Trace Elements|trace elements|mesh-ancestor
2184610|NCT00002817|Sargramostim|sargramostim|mesh-list
2184611|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
2184612|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184613|NCT00002818|Cytarabine|cytarabine|mesh-list
2184614|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2667999|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
2668000|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668001|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
2668002|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2668003|NCT02139761|Analgesics|analgesics|mesh-ancestor
2668004|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
2668005|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668006|NCT02139852|Capsaicin|capsaicin|mesh-list
2668007|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
2668008|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
2668009|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
2184615|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
2184616|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184617|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184618|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
2184619|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2668010|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668011|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668012|NCT02139904|Vinorelbine|vinorelbine|mesh-list
2668013|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2668014|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668015|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
2668016|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
2668017|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
2668018|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668019|NCT02139930|Nicotine|nicotine|mesh-list
2184620|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184621|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
2184622|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184623|NCT00002819|Paclitaxel|paclitaxel|mesh-list
2184624|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
2184625|NCT00002819|Carboplatin|carboplatin|mesh-list
2184626|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
2184627|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184628|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184629|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184630|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184631|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184632|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184633|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184634|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
2184635|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184636|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184637|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184638|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
2184639|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2184640|NCT00002819|Analgesics|analgesics|mesh-ancestor
2184641|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
2184642|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2184643|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184644|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184645|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184646|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
2184647|NCT00002822|Ifosfamide|ifosfamide|mesh-list
2184648|NCT00002822|Carboplatin|carboplatin|mesh-list
2184649|NCT00002822|Doxorubicin|doxorubicin|mesh-list
2184650|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2184651|NCT00002822|Etoposide|etoposide|mesh-list
2184652|NCT00002822|Vincristine|vincristine|mesh-list
2184653|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184654|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
2184655|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184656|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184657|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184658|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
2184659|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184660|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184661|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2184662|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2184663|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184664|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184665|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184666|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184667|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184668|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184669|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
2668020|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2668021|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
2668022|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668023|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668024|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2668025|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2668026|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
2668027|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668028|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668029|NCT02140047|Vaccines|vaccines|mesh-list
2668030|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
2668031|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668032|NCT02140073|Domperidone|domperidone|mesh-list
2668033|NCT02140073|Omeprazole|omeprazole|mesh-list
2184670|NCT00002823|Etoposide|etoposide|mesh-list
2184671|NCT00002823|Vinorelbine|vinorelbine|mesh-list
2184672|NCT00002823|Vinblastine|vinblastine|mesh-list
2184673|NCT00002823|Vindesine|vindesine|mesh-list
2184674|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184675|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184676|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184677|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184678|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184679|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184680|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184681|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184682|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184890|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184891|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
2184892|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184893|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184894|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2668034|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2668035|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2668036|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2668037|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668038|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668039|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
2668040|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
2184895|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2184896|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
2184897|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2184898|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184899|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
2184900|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
2184901|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184902|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2184903|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2184904|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184905|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184906|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184907|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
2184908|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184909|NCT00002835|Antidotes|antidotes|mesh-ancestor
2184910|NCT00002835|Protective Agents|protective agents|mesh-ancestor
2184911|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
2184912|NCT00002835|Vitamins|vitamins|mesh-ancestor
2668041|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668042|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668043|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2668044|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
2668045|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668046|NCT02140151|Ranibizumab|ranibizumab|mesh-list
2668047|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2668048|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2668049|NCT02140151|Growth Substances|growth substances|mesh-ancestor
2668050|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668051|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
2668052|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668053|NCT02140242|Daunorubicin|daunorubicin|mesh-list
2668054|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2668055|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668056|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2668057|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184913|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
2668058|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668059|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668060|NCT02140255|Ritonavir|ritonavir|mesh-list
2668061|NCT02140255|Lopinavir|lopinavir|mesh-list
2668062|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
2668063|NCT02140255|Nevirapine|nevirapine|mesh-list
2668064|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2668065|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2668066|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2668067|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
2668068|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668069|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668070|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2668071|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2668072|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
2668073|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2668074|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2668075|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2668076|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2668077|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2668078|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2668079|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2668080|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2668081|NCT02140268|Midazolam|midazolam|mesh-list
2668082|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2668083|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2668084|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2668085|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668086|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2668087|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2668088|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2668089|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2668090|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
2668091|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
2668092|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
2668093|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
2668094|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668095|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668096|NCT02140281|Cefadroxil|cefadroxil|mesh-list
2668097|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2668098|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2668099|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2668100|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668101|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2668102|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668103|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668104|NCT02140437|Fulvestrant|fulvestrant|mesh-list
2668105|NCT02140437|Anastrozole|anastrozole|mesh-list
2668106|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2668107|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668108|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2668109|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2668110|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
2668111|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2668112|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668113|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2668114|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2668115|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668116|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668117|NCT02140450|Timolol|timolol|mesh-list
2668118|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2668119|NCT02140450|Mannitol|mannitol|mesh-list
2668120|NCT02140450|Acetazolamide|acetazolamide|mesh-list
2668121|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2668122|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2668123|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
2668124|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668125|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668126|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668127|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2668128|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2668129|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2668130|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2668131|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2668132|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2668133|NCT02140450|Diuretics|diuretics|mesh-ancestor
2668134|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
2184683|NCT00002824|Ganciclovir|ganciclovir|mesh-list
2184684|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2184685|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
2184686|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184687|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2184688|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184689|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184690|NCT00002825|Docetaxel|docetaxel|mesh-list
2184691|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184692|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184693|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184694|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184695|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184696|NCT00002826|Paclitaxel|paclitaxel|mesh-list
2184697|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184698|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184699|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184700|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184701|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184702|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184703|NCT00002827|Cobalt|cobalt|mesh-list
2184704|NCT00002827|Doxorubicin|doxorubicin|mesh-list
2184705|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2184706|NCT00002827|Bleomycin|bleomycin|mesh-list
2184707|NCT00002827|Etoposide|etoposide|mesh-list
2184708|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
2668135|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
2668136|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2668137|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668138|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2668139|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2668140|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2668141|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
2668142|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668143|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2668144|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2668145|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668146|NCT02140515|Hormones|hormones|mesh-list
2668147|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2668148|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2668149|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668150|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2668151|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
2668152|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
2184709|NCT00002827|Vincristine|vincristine|mesh-list
2184710|NCT00002827|Razoxane|razoxane|mesh-list
2184711|NCT00002827|Lenograstim|lenograstim|mesh-list
2184712|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2184713|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184714|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184715|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184716|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184717|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184718|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2668153|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2668154|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2668155|NCT02140632|Prednisolone|prednisolone|mesh-list
2668156|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
2668157|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2668158|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
2668159|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2668160|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
2668161|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
2668162|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668163|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668164|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2668165|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
2668166|NCT02140632|Hormones|hormones|mesh-ancestor
2668167|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2668168|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2668169|NCT02140632|Protective Agents|protective agents|mesh-ancestor
2668170|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2668171|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668172|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
2668173|NCT02140736|Hematinics|hematinics|mesh-ancestor
2668174|NCT02140801|Clopidogrel|clopidogrel|mesh-list
2668175|NCT02140801|Ticagrelor|ticagrelor|mesh-list
2668176|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2668177|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2668178|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2668179|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2668180|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
2668181|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668182|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668183|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668184|NCT02140814|Niacinamide|niacinamide|mesh-list
2668185|NCT02140814|Niacin|niacin|mesh-list
2668186|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
2668187|NCT02140814|Vitamins|vitamins|mesh-ancestor
2668188|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
2668189|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668190|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
2668191|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2668192|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
2184719|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2184720|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
2184721|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184722|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184723|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184724|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184725|NCT00002827|Trace Elements|trace elements|mesh-ancestor
2184726|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
2184727|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2184728|NCT00002827|Protective Agents|protective agents|mesh-ancestor
2184729|NCT00002828|Fluorouracil|fluorouracil|mesh-list
2184730|NCT00002828|Raltitrexed|raltitrexed|mesh-list
2184731|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
2184732|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184733|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184734|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184735|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184736|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
2184737|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184738|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2668193|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668194|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2668195|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
2668196|NCT02140840|Trametinib|trametinib|mesh-list
2668197|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668198|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2668199|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668200|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668201|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
2668202|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2668203|NCT02140983|Liraglutide|liraglutide|mesh-list
2668204|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2668205|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668206|NCT02140983|Incretins|incretins|mesh-ancestor
2668207|NCT02140983|Hormones|hormones|mesh-ancestor
2668208|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2668209|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2668210|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
2668211|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668212|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
2668213|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
2668214|NCT02141035|Vitamins|vitamins|mesh-ancestor
2668215|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
2668216|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668217|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
2668218|NCT02141087|Pirfenidone|pirfenidone|mesh-list
2668219|NCT02141087|Analgesics|analgesics|mesh-ancestor
2668220|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
2668221|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668222|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668223|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2668224|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2668225|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2668226|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2668227|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668228|NCT02141100|Thioguanine|thioguanine|mesh-list
2668229|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2668230|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
2668231|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668232|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668233|NCT02141113|Guanfacine|guanfacine|mesh-list
2668234|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2668235|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2668236|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2184739|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184740|NCT00002829|Interferons|interferons|mesh-list
2184741|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
2184742|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
2184743|NCT00002829|Etoposide|etoposide|mesh-list
2184744|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184745|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
2184746|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184747|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184748|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184749|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
2184750|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184751|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184752|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2184753|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184754|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184755|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184756|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184757|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
2184758|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184759|NCT00002831|Cyclosporine|cyclosporine|mesh-list
2184760|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
2184761|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2184762|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2184763|NCT00002831|Prednisolone|prednisolone|mesh-list
2184764|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
2668237|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2668238|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
2668239|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668240|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668241|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668242|NCT02141139|Ibuprofen|ibuprofen|mesh-list
2668243|NCT02141139|Ketorolac|ketorolac|mesh-list
2668244|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2668245|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2668246|NCT02141139|Analgesics|analgesics|mesh-ancestor
2668247|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
2668248|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668249|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668250|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2668251|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2668252|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2668253|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668254|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668255|NCT02141178|Bupivacaine|bupivacaine|mesh-list
2668256|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
2668257|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
2668258|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2668259|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668260|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
2668261|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668264|NCT02141321|Alprostadil|alprostadil|mesh-list
2668265|NCT02141321|Misoprostol|misoprostol|mesh-list
2668266|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2668267|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
2668268|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2668269|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668270|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2668271|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2668272|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
2668273|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2668274|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
2668275|NCT02141321|Urological Agents|urological agents|mesh-ancestor
2668276|NCT02141347|Durvalumab|durvalumab|mesh-list
2668277|NCT02141347|Tremelimumab|tremelimumab|mesh-list
2668278|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2668279|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668280|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
2668281|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2184765|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
2668282|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2668283|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668284|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2668285|NCT02141412|Analgesics|analgesics|mesh-ancestor
2668286|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
2668287|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668288|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2668289|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2668290|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2668291|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
2668292|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668293|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668294|NCT02141425|Peficitinib|peficitinib|mesh-list
2668295|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668296|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668297|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2668298|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
2668299|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668300|NCT02141477|Decitabine|decitabine|mesh-list
2668301|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
2668302|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2668303|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
2668304|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668305|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668306|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668307|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2668308|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2668309|NCT02141542|Tremelimumab|tremelimumab|mesh-list
2668310|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668311|NCT02141698|Esomeprazole|esomeprazole|mesh-list
2668312|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2668313|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2668314|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2668315|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668316|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668317|NCT02141737|Lidocaine|lidocaine|mesh-list
2668318|NCT02141737|Fentanyl|fentanyl|mesh-list
2668319|NCT02141737|Midazolam|midazolam|mesh-list
2668320|NCT02141737|Etomidate|etomidate|mesh-list
2668321|NCT02141737|Rocuronium|rocuronium|mesh-list
2668322|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
2668323|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
2668324|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2668325|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668326|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
2668327|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668328|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2668329|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2668330|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2668331|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2668332|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668333|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2668334|NCT02141737|Narcotics|narcotics|mesh-ancestor
2668335|NCT02141737|Analgesics|analgesics|mesh-ancestor
2668336|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2668337|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2668338|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
2668339|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2668340|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2668341|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2668342|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2668343|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
2668344|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
2668345|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668346|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2668347|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2668348|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2668349|NCT02141958|Fenretinide|fenretinide|mesh-list
2668350|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668351|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2668352|NCT02141958|Protective Agents|protective agents|mesh-ancestor
2668353|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668354|NCT02142010|Paclitaxel|paclitaxel|mesh-list
2668355|NCT02142010|Cisplatin|cisplatin|mesh-list
2668356|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2668357|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668358|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
2668359|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
2668360|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
2668361|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668362|NCT02142036|Trastuzumab|trastuzumab|mesh-list
2668363|NCT02142036|Cetuximab|cetuximab|mesh-list
2668364|NCT02142036|Panitumumab|panitumumab|mesh-list
2668365|NCT02142036|Everolimus|everolimus|mesh-list
2668366|NCT02142036|Sunitinib|sunitinib|mesh-list
2668367|NCT02142036|Dasatinib|dasatinib|mesh-list
2668368|NCT02142036|Lapatinib|lapatinib|mesh-list
2668369|NCT02142036|Gefitinib|gefitinib|mesh-list
2668370|NCT02142036|Afatinib|afatinib|mesh-list
2668371|NCT02142036|Vemurafenib|vemurafenib|mesh-list
2668372|NCT02142036|Dabrafenib|dabrafenib|mesh-list
2668373|NCT02142036|Crizotinib|crizotinib|mesh-list
2668374|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2668375|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668376|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2668377|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
2668378|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668379|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2668380|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668381|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668382|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2668383|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2668384|NCT02142036|Growth Substances|growth substances|mesh-ancestor
2668385|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
2668386|NCT02142075|Daptomycin|daptomycin|mesh-list
2668387|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2668388|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2668389|NCT02142140|Methylphenidate|methylphenidate|mesh-list
2668390|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2668391|NCT02142140|Adderall|adderall|mesh-list
2668392|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
2668393|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
2668394|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2668395|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668396|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2668397|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2668398|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2668399|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668400|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
2668401|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668402|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2668403|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
2668404|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
2668405|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2668406|NCT02142192|Natalizumab|natalizumab|mesh-list
2668407|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
2668408|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668409|NCT02142205|Natalizumab|natalizumab|mesh-list
2668410|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
2668411|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184766|NCT00002831|Busulfan|busulfan|mesh-list
2184767|NCT00002831|Methotrexate|methotrexate|mesh-list
2184768|NCT00002831|Decitabine|decitabine|mesh-list
2184769|NCT00002831|Tacrolimus|tacrolimus|mesh-list
2184770|NCT00002831|Cyclosporins|cyclosporins|mesh-list
2184771|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2184772|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
2184773|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184774|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
2184775|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184776|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2668412|NCT02142218|Nivolumab|nivolumab|mesh-list
2668413|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2668414|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668415|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2668416|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668417|NCT02142296|Aflibercept|aflibercept|mesh-list
2668418|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2668419|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2668420|NCT02142296|Growth Substances|growth substances|mesh-ancestor
2668421|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184777|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2668422|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
2668423|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668424|NCT02142309|Pioglitazone|pioglitazone|mesh-list
2184778|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
2668425|NCT02142309|Glimepiride|glimepiride|mesh-list
2668426|NCT02142309|Vildagliptin|vildagliptin|mesh-list
2668427|NCT02142309|Canagliflozin|canagliflozin|mesh-list
2668428|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2668429|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668430|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2668431|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2668432|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
2668433|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2668434|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
2668435|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668436|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668437|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2668438|NCT02142335|Rituximab|rituximab|mesh-list
2668439|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2668440|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668441|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
2668442|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668443|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2668444|NCT02142530|Belinostat|belinostat|mesh-list
2668445|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668446|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2668447|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668448|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668449|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
2668450|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
2668451|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
2668452|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2668453|NCT02142543|Protective Agents|protective agents|mesh-ancestor
2668454|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668455|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2668456|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
2668457|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2668458|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2668459|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2668460|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2668461|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668462|NCT02142569|Tocotrienols|tocotrienols|mesh-list
2668463|NCT02142569|Vitamin E|vitamin e|mesh-list
2668464|NCT02142569|Tocopherols|tocopherols|mesh-list
2668465|NCT02142569|Red yeast rice|red yeast rice|mesh-list
2668466|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
2668467|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184779|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184780|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184781|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2184782|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2184783|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
2184784|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2184785|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184786|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
2184787|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
2184788|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184789|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2184790|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2184791|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2184792|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
2184793|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184794|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2184795|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
2184796|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
2184797|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2184798|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2668468|NCT02142569|Protective Agents|protective agents|mesh-ancestor
2668469|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668470|NCT02142569|Vitamins|vitamins|mesh-ancestor
2668471|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
2668472|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2184799|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
2184800|NCT00002831|Hormones|hormones|mesh-ancestor
2184801|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2184802|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2184803|NCT00002831|Protective Agents|protective agents|mesh-ancestor
2184804|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2668615|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184941|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668622|NCT02143414|Prednisone|prednisone|mesh-list
2668623|NCT02143414|Cortisone|cortisone|mesh-list
2668624|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2668625|NCT02143414|Methotrexate|methotrexate|mesh-list
2668626|NCT02143414|Vincristine|vincristine|mesh-list
2668627|NCT02143414|Dasatinib|dasatinib|mesh-list
2668628|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
2668629|NCT02143414|Blinatumomab|blinatumomab|mesh-list
2668630|NCT02143414|Antibodies|antibodies|mesh-list
2668631|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
2668632|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2668633|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
2668634|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2668635|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
2668636|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668637|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668638|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2668639|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
2668640|NCT02143414|Hormones|hormones|mesh-ancestor
2668641|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2668642|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2668643|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2668644|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
2668645|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2668646|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2668647|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
2668648|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668649|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
2668650|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668651|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2668652|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2668653|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2668654|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2668655|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2668656|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
2668657|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
2668658|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
2668659|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2668660|NCT02143440|Insulin|insulin|mesh-list
2668661|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2668662|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668663|NCT02143466|Durvalumab|durvalumab|mesh-list
2668664|NCT02143466|Osimertinib|osimertinib|mesh-list
2668665|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2668666|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2668667|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668668|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
2668669|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668670|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2668671|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668672|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668673|NCT02143479|Tacrolimus|tacrolimus|mesh-list
2668674|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2668675|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
2668676|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668677|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2668678|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668679|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668680|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2668681|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
2668682|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2668683|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
2668684|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668685|NCT02143518|Antacids|antacids|mesh-ancestor
2668686|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668687|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2668688|NCT02143531|Haloperidol|haloperidol|mesh-list
2668689|NCT02143531|Ondansetron|ondansetron|mesh-list
2668690|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
2668691|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
2668692|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
2668693|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668694|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668695|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2668696|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
2668697|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
2668698|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2668699|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
2668700|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668701|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668702|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2668703|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2668704|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2668705|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2668706|NCT02143531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2668707|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2668708|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
2668709|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2668710|NCT02143570|Darifenacin|darifenacin|mesh-list
2668711|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2668712|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2668713|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
2668714|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668715|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668716|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668717|NCT02143570|Urological Agents|urological agents|mesh-ancestor
2668718|NCT02143622|Cetuximab|cetuximab|mesh-list
2668719|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2668720|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668721|NCT02143687|Sevoflurane|sevoflurane|mesh-list
2668722|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2668723|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2668724|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
2668725|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
2668726|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2668727|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668728|NCT02143726|Everolimus|everolimus|mesh-list
2668729|NCT02143726|Sorafenib|sorafenib|mesh-list
2668730|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668731|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2668732|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
2668733|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668734|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2668735|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668736|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668737|NCT02143765|Acarbose|acarbose|mesh-list
2668738|NCT02143765|Mitiglinide|mitiglinide|mesh-list
2668739|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2668740|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668741|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668742|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2668743|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668744|NCT02143804|Molgramostim|molgramostim|mesh-list
2668745|NCT02143804|Sargramostim|sargramostim|mesh-list
2668746|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
2668747|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668748|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668749|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
2668750|NCT02143830|Busulfan|busulfan|mesh-list
2668751|NCT02143830|Fludarabine|fludarabine|mesh-list
2668752|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
2668753|NCT02143830|Lenograstim|lenograstim|mesh-list
2668754|NCT02143830|Sargramostim|sargramostim|mesh-list
2668755|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2668756|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
2668757|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668758|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2668759|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2668760|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
2668761|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668762|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668763|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2668764|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2668765|NCT02143934|Chloroquine|chloroquine|mesh-list
2668766|NCT02143934|Lumefantrine|lumefantrine|mesh-list
2668767|NCT02143934|Artemether|artemether|mesh-list
2668768|NCT02143934|Primaquine|primaquine|mesh-list
2668769|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2668770|NCT02143934|Amebicides|amebicides|mesh-ancestor
2668771|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2668772|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2668773|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2668774|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
2668775|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2668776|NCT02144025|Cyclosporine|cyclosporine|mesh-list
2668777|NCT02144025|Cyclosporins|cyclosporins|mesh-list
2668778|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668779|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668780|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2668781|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
2668782|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668783|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
2668784|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2668785|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
2668786|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2668787|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2668788|NCT02144064|Heparin|heparin|mesh-list
2668789|NCT02144064|Calcium heparin|calcium heparin|mesh-list
2668790|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
2668791|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2668792|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2668793|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668794|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
2668795|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2668796|NCT02144194|Docetaxel|docetaxel|mesh-list
2668797|NCT02144194|Vinorelbine|vinorelbine|mesh-list
2668798|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668799|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
2668800|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
2668801|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
2668802|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668803|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2668804|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
2668805|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2668806|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2668807|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2668808|NCT02144246|Norgestimate|norgestimate|mesh-list
2668809|NCT02144246|Norgestrel|norgestrel|mesh-list
2668810|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2668811|NCT02144246|Estradiol|estradiol|mesh-list
2668812|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2668813|NCT02144246|Estrogens|estrogens|mesh-ancestor
2668814|NCT02144246|Hormones|hormones|mesh-ancestor
2668815|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2668816|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668817|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2668818|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
2668819|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2668820|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2668821|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2668822|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2668823|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2668824|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2668825|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2668826|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2668827|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2668828|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668829|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668830|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668831|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2668832|NCT02144376|Psyllium|psyllium|mesh-list
2668833|NCT02144376|Cathartics|cathartics|mesh-ancestor
2668834|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2668835|NCT02144389|Praziquantel|praziquantel|mesh-list
2668836|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
2668837|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2668838|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2668839|NCT02144415|Amphetamine|amphetamine|mesh-list
2668840|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2668841|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
2668842|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2668843|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668844|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
2668845|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
2668846|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668847|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
2668848|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668849|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668850|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
2668851|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2668852|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2668853|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2668854|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2668855|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
2668856|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2184942|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184943|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2184944|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184945|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184946|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184947|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184948|NCT00002837|Paclitaxel|paclitaxel|mesh-list
2184949|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
2184950|NCT00002837|Doxorubicin|doxorubicin|mesh-list
2184951|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2184952|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2184953|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184954|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
2668857|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668858|NCT02144584|Memantine|memantine|mesh-list
2668859|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2668860|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2668861|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
2668862|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668863|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668864|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668865|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2668866|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2668867|NCT02144623|Valproic Acid|valproic acid|mesh-list
2668868|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
2668869|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668870|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668871|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
2668872|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668873|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668874|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
2668875|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2668876|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2668877|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2668878|NCT02144662|Ranibizumab|ranibizumab|mesh-list
2668879|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2668880|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2668881|NCT02144662|Growth Substances|growth substances|mesh-ancestor
2668882|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668883|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
2668884|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668885|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2668886|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
2668887|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2668888|NCT02144753|Psyllium|psyllium|mesh-list
2668889|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
2668890|NCT02144753|Cathartics|cathartics|mesh-ancestor
2668891|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2668892|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
2668893|NCT02144766|Ropivacaine|ropivacaine|mesh-list
2668894|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
2668895|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
2668896|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2668897|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668898|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
2668899|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668900|NCT02144792|Verapamil|verapamil|mesh-list
2668901|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2668902|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2668903|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2668904|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668905|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2668906|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668907|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
2668908|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2668909|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
2668910|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2668911|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
2668912|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2668913|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668914|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2668915|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2668916|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668917|NCT02144831|Aspirin|aspirin|mesh-list
2668918|NCT02144831|Clopidogrel|clopidogrel|mesh-list
2668919|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2668920|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2668921|NCT02144831|Analgesics|analgesics|mesh-ancestor
2668922|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
2668923|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2668924|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668925|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2668926|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2668927|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2668928|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2668929|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668930|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2668931|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2668932|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668933|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
2668934|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2668935|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2668936|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2668937|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
2668938|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668939|NCT02144922|Pitavastatin|pitavastatin|mesh-list
2668940|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2668941|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2668942|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2668943|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
2668944|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668945|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668946|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2668947|NCT02145065|Paclitaxel|paclitaxel|mesh-list
2668948|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2668949|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668950|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
2668951|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
2668952|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
2668953|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668954|NCT02145091|Psilocybin|psilocybin|mesh-list
2668955|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
2668956|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
2668957|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668958|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2668959|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2668960|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
2668961|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2668962|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668963|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2668964|NCT02145104|Valsartan|valsartan|mesh-list
2668965|NCT02145104|Cilnidipine|cilnidipine|mesh-list
2668966|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2668967|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2668968|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2668969|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668970|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2668971|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2668972|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2668973|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668974|NCT02145143|Vemurafenib|vemurafenib|mesh-list
2668975|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2668976|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2668977|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668978|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2668979|NCT02145195|Vitamin D|vitamin d|mesh-list
2668980|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
2668981|NCT02145195|Vitamins|vitamins|mesh-ancestor
2668982|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
2668983|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2668984|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2668985|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2668986|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
2668987|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2668988|NCT02145338|Trimethoprim|trimethoprim|mesh-list
2668989|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
2668990|NCT02145338|Cephalexin|cephalexin|mesh-list
2668991|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2668992|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2668993|NCT02145338|Renal Agents|renal agents|mesh-ancestor
2668994|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
2668995|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2668996|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2668997|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2668998|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2668999|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669000|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2669001|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2669002|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2669003|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2669004|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
2669005|NCT02145520|Analgesics|analgesics|mesh-ancestor
2669006|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
2669007|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669008|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669009|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
2669010|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669011|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2669012|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
2669013|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2669014|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2669015|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669016|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2669017|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
2669018|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2669019|NCT02145546|Amiodarone|amiodarone|mesh-list
2669020|NCT02145546|Sotalol|sotalol|mesh-list
2669021|NCT02145546|Propafenone|propafenone|mesh-list
2669022|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2669023|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
2669024|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2669025|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2669026|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669027|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2669028|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2669029|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2669030|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669031|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2669032|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2669033|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2669034|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2669035|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2669036|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
2669037|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669038|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669039|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
2669040|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
2669041|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669042|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2669043|NCT02145559|Metformin|metformin|mesh-list
2669044|NCT02145559|Sirolimus|sirolimus|mesh-list
2669045|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2669046|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669047|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2669048|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669049|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2669050|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669051|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
2669052|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2669053|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
2669054|NCT02145585|Anesthetics|anesthetics|mesh-list
2669055|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669056|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669057|NCT02145598|Lenalidomide|lenalidomide|mesh-list
2669058|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
2669059|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669060|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2669061|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2669062|NCT02145598|Growth Substances|growth substances|mesh-ancestor
2669063|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
2669064|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669065|NCT02145611|Vildagliptin|vildagliptin|mesh-list
2669066|NCT02145611|Glyburide|glyburide|mesh-list
2669067|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2669068|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669069|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2669070|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
2669071|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669072|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669073|NCT02145624|Vaccines|vaccines|mesh-list
2669074|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
2669075|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669076|NCT02145637|Afatinib|afatinib|mesh-list
2669077|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669078|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2669079|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669080|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669081|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
2669082|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2669083|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2669084|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2669085|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2669086|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669087|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
2669088|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669089|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669090|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2669091|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669092|NCT02145715|Thalidomide|thalidomide|mesh-list
2669093|NCT02145715|Dexamethasone|dexamethasone|mesh-list
2669094|NCT02145715|Bortezomib|bortezomib|mesh-list
2669095|NCT02145715|Panobinostat|panobinostat|mesh-list
2669096|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2669097|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
2669098|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
2669099|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669100|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669101|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2669102|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
2669103|NCT02145715|Hormones|hormones|mesh-ancestor
2669104|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669105|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2669106|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669107|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2669108|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
2669109|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
2669110|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2669111|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669112|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2669113|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2669114|NCT02145715|Growth Substances|growth substances|mesh-ancestor
2669115|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
2669116|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2669117|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669118|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669119|NCT02145767|Progesterone|progesterone|mesh-list
2669120|NCT02145767|Progestins|progestins|mesh-ancestor
2669121|NCT02145767|Hormones|hormones|mesh-ancestor
2669122|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669123|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669124|NCT02145832|Fluconazole|fluconazole|mesh-list
2669125|NCT02145832|Micafungin|micafungin|mesh-list
2669126|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
2669127|NCT02145832|Clotrimazole|clotrimazole|mesh-list
2669128|NCT02145832|Miconazole|miconazole|mesh-list
2669129|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2184955|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184956|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184957|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184958|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184959|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
2184960|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184961|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184962|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184963|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
2184964|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2669130|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2669131|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2669132|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669133|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669134|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2669135|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
2669136|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669137|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669138|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2669139|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2669140|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2669141|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2669142|NCT02145884|Timolol|timolol|mesh-list
2669143|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2669144|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2669145|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
2669146|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669147|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669148|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669149|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2669150|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2669151|NCT02145910|Vemurafenib|vemurafenib|mesh-list
2669152|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669153|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2669154|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669155|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669156|NCT02145949|Tryptophan|tryptophan|mesh-list
2669157|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2669158|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
2669159|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2669160|NCT02145975|Fentanyl|fentanyl|mesh-list
2184965|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2184966|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2184967|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2184968|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2184969|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
2184970|NCT00002838|Fludarabine|fludarabine|mesh-list
2184971|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
2184972|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2669161|NCT02145975|Morphine|morphine|mesh-list
2669162|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
2669163|NCT02145975|Narcotics|narcotics|mesh-ancestor
2669164|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669165|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669166|NCT02145975|Analgesics|analgesics|mesh-ancestor
2669167|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
2669168|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669169|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2669170|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2669171|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
2669172|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
2669173|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2669174|NCT02146118|Silybin|silybin|mesh-list
2669175|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669176|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2669177|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669178|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669179|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2669180|NCT02146118|Protective Agents|protective agents|mesh-ancestor
2669181|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669182|NCT02146209|Metronidazole|metronidazole|mesh-list
2669183|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669184|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2669185|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2669186|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2669187|NCT02146222|Docetaxel|docetaxel|mesh-list
2669188|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669189|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
2669190|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
2669191|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
2669192|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669193|NCT02146261|Quetmolimab|quetmolimab|mesh-list
2669194|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2669195|NCT02146300|Xylometazoline|xylometazoline|mesh-list
2669196|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
2669197|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2669198|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
2669199|NCT02146391|Enclomiphene|enclomiphene|mesh-list
2669200|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2669201|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
2669202|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669203|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669204|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2669205|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
2669206|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2669207|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2669208|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2669209|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
2669210|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2669211|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2669212|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669213|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
2669214|NCT02146456|Coagulants|coagulants|mesh-ancestor
2669215|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
2669216|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2669217|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2669218|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669219|NCT02146547|Aripiprazole|aripiprazole|mesh-list
2669220|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2669221|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
2669222|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2669223|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2669224|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2669225|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669226|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669227|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
2669228|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
2669229|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669230|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669231|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2669232|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2669233|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
2669234|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2669235|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2669236|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2669237|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2669238|NCT02146638|Fentanyl|fentanyl|mesh-list
2669239|NCT02146638|Morphine|morphine|mesh-list
2669240|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2669241|NCT02146638|Narcotics|narcotics|mesh-ancestor
2669242|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669243|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669244|NCT02146638|Analgesics|analgesics|mesh-ancestor
2669245|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
2669246|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669247|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2669248|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2669249|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
2669250|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
2669251|NCT02146651|Insulin|insulin|mesh-list
2669252|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2669253|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
2669254|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2669255|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669256|NCT02146703|Gemcitabine|gemcitabine|mesh-list
2669257|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2669258|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
2669259|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669260|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669261|NCT02146703|Antiviral Agents|antiviral agents|mesh-ancestor
2669262|NCT02146703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669263|NCT02146703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669264|NCT02146703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2669265|NCT02146703|Immunologic Factors|immunologic factors|mesh-ancestor
2669266|NCT02146703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669267|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
2669268|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669269|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2669270|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669271|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669272|NCT02146911|Bupropion|bupropion|mesh-list
2669273|NCT02146911|Varenicline|varenicline|mesh-list
2184973|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
2184974|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184975|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2184976|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2184977|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
2184978|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184979|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184980|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2669274|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2669275|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
2669276|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2669277|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2669278|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2669279|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2669280|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669281|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
2669282|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669283|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669284|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2669285|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2669286|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669287|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2669288|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2669289|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
2669290|NCT02146937|Bicalutamide|bicalutamide|mesh-list
2669291|NCT02146937|Finasteride|finasteride|mesh-list
2184981|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184982|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
2184983|NCT00002839|Fluorouracil|fluorouracil|mesh-list
2184984|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184985|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
2184986|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2184987|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2184988|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2184989|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
2184990|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2184991|NCT00002840|Vincristine|vincristine|mesh-list
2184992|NCT00002840|Lomustine|lomustine|mesh-list
2184993|NCT00002840|Procarbazine|procarbazine|mesh-list
2184994|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2669292|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
2669293|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
2669294|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669295|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669296|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669297|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2669298|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2669299|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669300|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669301|NCT02146937|Urological Agents|urological agents|mesh-ancestor
2669302|NCT02146976|Propofol|propofol|mesh-list
2669303|NCT02146976|Sevoflurane|sevoflurane|mesh-list
2669304|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2669305|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669306|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669307|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2669308|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
2669309|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
2669310|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2669311|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2669312|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2669313|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
2669314|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
2669315|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
2669316|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
2669317|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669318|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2669319|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
2669320|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
2669321|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669322|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669323|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2669324|NCT02147015|Hormones|hormones|mesh-ancestor
2669325|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669326|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2669327|NCT02147015|Protective Agents|protective agents|mesh-ancestor
2184995|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2184996|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
2184997|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
2184998|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
2184999|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185000|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185001|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
2185002|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
2185003|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185004|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
2185005|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185006|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185007|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185008|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
2185009|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185010|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185011|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2185012|NCT00002845|Aldesleukin|aldesleukin|mesh-list
2185013|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669328|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669329|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669330|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2669331|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2669332|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
2669333|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669334|NCT02147041|Protective Agents|protective agents|mesh-ancestor
2669335|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669336|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2669337|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2669338|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669339|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2669340|NCT02147054|Rocuronium|rocuronium|mesh-list
2669341|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2669342|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2669343|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2669344|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669345|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669346|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2669347|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669348|NCT02147262|Doxycycline|doxycycline|mesh-list
2669349|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2669350|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669351|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
2669352|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2669353|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2669354|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2669355|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2669356|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2669357|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669358|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669359|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2669360|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2669361|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2669362|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2669363|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
2669364|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669365|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669366|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2669367|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2669368|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
2669369|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2669370|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2669371|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
2669372|NCT02147535|Methylphenidate|methylphenidate|mesh-list
2669373|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2669374|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669375|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2669376|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2669377|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2669378|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669379|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
2669380|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669381|NCT02147548|Lorazepam|lorazepam|mesh-list
2669382|NCT02147548|Etifoxine|etifoxine|mesh-list
2669383|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
2669384|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
2669385|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
2669386|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669387|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669388|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2669389|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2669390|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669391|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2669392|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2669393|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2669394|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
2669395|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
2669396|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669397|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185014|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2185015|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2185016|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
2185017|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185018|NCT00002846|Aldesleukin|aldesleukin|mesh-list
2185019|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669398|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
2669399|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2669400|NCT02147678|Remifentanil|remifentanil|mesh-list
2669401|NCT02147678|Propofol|propofol|mesh-list
2669402|NCT02147678|Etomidate|etomidate|mesh-list
2669403|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
2669404|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669405|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669406|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2669407|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2669408|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
2669409|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2669410|NCT02147678|Narcotics|narcotics|mesh-ancestor
2669411|NCT02147678|Analgesics|analgesics|mesh-ancestor
2669412|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
2669413|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669414|NCT02147730|Anesthetics|anesthetics|mesh-list
2669415|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669416|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669417|NCT02147808|Midazolam|midazolam|mesh-list
2669418|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2669419|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2669420|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669421|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669422|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2669423|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2185020|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2185021|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2185022|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
2185023|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185024|NCT00002847|Interferons|interferons|mesh-list
2185025|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
2185026|NCT00002847|Aldesleukin|aldesleukin|mesh-list
2185027|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185028|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
2669424|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2669425|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2669426|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
2669427|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
2669428|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
2185029|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185030|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
2669429|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
2669430|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669431|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669432|NCT02147873|Azacitidine|azacitidine|mesh-list
2669433|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2669434|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
2669435|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669436|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669437|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669438|NCT02147925|Metformin|metformin|mesh-list
2669439|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
2669440|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2669441|NCT02147925|Liraglutide|liraglutide|mesh-list
2669442|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2669443|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669444|NCT02147925|Incretins|incretins|mesh-ancestor
2669445|NCT02147925|Hormones|hormones|mesh-ancestor
2669446|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669447|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2669448|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
2669449|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669450|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669451|NCT02147938|Tacrolimus|tacrolimus|mesh-list
2669452|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2669453|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
2669454|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669455|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2669456|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669457|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669458|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2669459|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2669460|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669461|NCT02147964|Ketoconazole|ketoconazole|mesh-list
2669462|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
2669463|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2669464|NCT02147964|Testosterone|testosterone|mesh-list
2669465|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
2669466|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
2669467|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2669468|NCT02147964|Dutasteride|dutasteride|mesh-list
2669469|NCT02147964|Acyline|acyline|mesh-list
2669470|NCT02147964|Androgens|androgens|mesh-ancestor
2669471|NCT02147964|Hormones|hormones|mesh-ancestor
2669472|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669473|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669474|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2185031|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185032|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2185033|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2185034|NCT00002849|Interferons|interferons|mesh-list
2185035|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
2185036|NCT00002849|Dexamethasone|dexamethasone|mesh-list
2185037|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2185038|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
2185039|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
2185040|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2185041|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185042|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2669475|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669476|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
2669477|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
2669478|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669479|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2669480|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2669481|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669482|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669483|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2669484|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
2669485|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2185043|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
2185044|NCT00002849|Hormones|hormones|mesh-ancestor
2185045|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2185046|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2185047|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185048|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
2669486|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2669487|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2669488|NCT02148016|Levofloxacin|levofloxacin|mesh-list
2669489|NCT02148016|Ofloxacin|ofloxacin|mesh-list
2669490|NCT02148016|Betamethasone|betamethasone|mesh-list
2669491|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2669492|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669493|NCT02148016|Renal Agents|renal agents|mesh-ancestor
2669494|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2669495|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2669496|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2669497|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669498|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669499|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185049|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185050|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
2185051|NCT00002852|Paclitaxel|paclitaxel|mesh-list
2185052|NCT00002852|Carboplatin|carboplatin|mesh-list
2185053|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185054|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185055|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185056|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185057|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185058|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669500|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2669501|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2669502|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2669503|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
2669504|NCT02148016|Hormones|hormones|mesh-ancestor
2669505|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669506|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669507|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2669508|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
2669509|NCT02148094|Tenofovir|tenofovir|mesh-list
2669510|NCT02148094|Emtricitabine|emtricitabine|mesh-list
2669511|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2669512|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
2669513|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669514|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2669515|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2669516|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669517|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669518|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2669519|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2669520|NCT02148120|Beclomethasone|beclomethasone|mesh-list
2669521|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
2669522|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2669523|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
2669524|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669525|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669526|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2669527|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
2669528|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2669529|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2669530|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2669531|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
2669532|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669533|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669534|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2669535|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
2669536|NCT02148120|Hormones|hormones|mesh-ancestor
2669537|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669538|NCT02148328|Vaccines|vaccines|mesh-list
2669539|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
2669540|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669541|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
2669542|NCT02148367|Hematinics|hematinics|mesh-ancestor
2669543|NCT02148380|Carboplatin|carboplatin|mesh-list
2669544|NCT02148380|Pemetrexed|pemetrexed|mesh-list
2669545|NCT02148380|Gefitinib|gefitinib|mesh-list
2669546|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669547|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669548|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185059|NCT00002854|Paclitaxel|paclitaxel|mesh-list
2185060|NCT00002854|Etoposide|etoposide|mesh-list
2669549|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2669550|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2669551|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2669552|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2669553|NCT02148393|Estradiol|estradiol|mesh-list
2669554|NCT02148393|Progesterone|progesterone|mesh-list
2669555|NCT02148393|Estrogens|estrogens|mesh-ancestor
2669556|NCT02148393|Hormones|hormones|mesh-ancestor
2669557|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669558|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669559|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2669560|NCT02148393|Progestins|progestins|mesh-ancestor
2669561|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
2669562|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2185061|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
2185062|NCT00002854|Carboplatin|carboplatin|mesh-list
2185063|NCT00002854|Ifosfamide|ifosfamide|mesh-list
2669563|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669564|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669565|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2669566|NCT02148432|Analgesics|analgesics|mesh-ancestor
2669567|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
2669568|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669569|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2669570|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2669571|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2669572|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
2669573|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669574|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669575|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
2669576|NCT02148549|Irinotecan|irinotecan|mesh-list
2669577|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669578|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2669579|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2669580|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669581|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669582|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2669583|NCT02148601|Vancomycin|vancomycin|mesh-list
2669584|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669585|NCT02148640|Infliximab|infliximab|mesh-list
2669586|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
2669587|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2669588|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2669589|NCT02148783|Methylphenidate|methylphenidate|mesh-list
2669590|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2669591|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669592|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2669593|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2669594|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2669595|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669596|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
2669597|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669598|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
2185064|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185065|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185066|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
2669599|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2669600|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
2669601|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669602|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
2669603|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2669604|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2669605|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669606|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2669607|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669608|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2669609|NCT02148861|Insulin|insulin|mesh-list
2669610|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2669611|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2669612|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669613|NCT02148913|Melphalan|melphalan|mesh-list
2669614|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2669615|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2669616|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
2669617|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669618|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669619|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2669620|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2669621|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
2669622|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669623|NCT02148978|Saxagliptin|saxagliptin|mesh-list
2669624|NCT02148978|Incretins|incretins|mesh-ancestor
2669625|NCT02148978|Hormones|hormones|mesh-ancestor
2669626|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669627|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669628|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2669629|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
2669630|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669631|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669632|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2669633|NCT02149095|Treprostinil|treprostinil|mesh-list
2669634|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2669641|NCT02149212|Aminaftone|aminaftone|mesh-list
2669642|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
2669643|NCT02149212|Coagulants|coagulants|mesh-ancestor
2669644|NCT02149225|Poly I-C|poly i-c|mesh-list
2669645|NCT02149225|Molgramostim|molgramostim|mesh-list
2669646|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2669647|NCT02149225|Vaccines|vaccines|mesh-list
2669648|NCT02149225|Sargramostim|sargramostim|mesh-list
2669649|NCT02149225|Poly ICLC|poly iclc|mesh-list
2669650|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
2669651|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669652|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669653|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
2669654|NCT02149225|Laxatives|laxatives|mesh-ancestor
2669655|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2669656|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
2669657|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669658|NCT02149277|Lenograstim|lenograstim|mesh-list
2669659|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2669660|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
2669661|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669662|NCT02149329|Meropenem|meropenem|mesh-list
2669663|NCT02149329|Imipenem|imipenem|mesh-list
2669664|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
2669665|NCT02149329|Cilastatin|cilastatin|mesh-list
2669666|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2669667|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669668|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
2669669|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669670|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669671|NCT02149407|Glycerol|glycerol|mesh-list
2669672|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2669673|NCT02149407|Protective Agents|protective agents|mesh-ancestor
2669674|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669675|NCT02149433|Prednisone|prednisone|mesh-list
2669676|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2669677|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
2669678|NCT02149433|Hormones|hormones|mesh-ancestor
2669679|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2185067|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185068|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185069|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185070|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185071|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
2185072|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185073|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185074|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185075|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
2185076|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2669680|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669681|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2669682|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669683|NCT02149459|Metformin|metformin|mesh-list
2669684|NCT02149459|Biguanides|biguanides|mesh-list
2669685|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2669686|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669687|NCT02149628|Propofol|propofol|mesh-list
2669688|NCT02149628|Desflurane|desflurane|mesh-list
2669689|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2669690|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669691|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669692|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2669693|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
2669694|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
2669695|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2669696|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
2669697|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2669698|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
2669699|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669700|NCT02149758|Etoricoxib|etoricoxib|mesh-list
2669701|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2669702|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2669703|NCT02149758|Analgesics|analgesics|mesh-ancestor
2669704|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
2669705|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669706|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669707|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2669708|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2669709|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2669710|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2669711|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669712|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669713|NCT02149823|Oxytocin|oxytocin|mesh-list
2669714|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
2669715|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2669716|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669717|NCT02149888|Tenofovir|tenofovir|mesh-list
2669718|NCT02149888|Emtricitabine|emtricitabine|mesh-list
2669719|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
2669720|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669721|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2669722|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2669723|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669724|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669725|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2669726|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2669727|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
2669728|NCT02149901|Ephedrine|ephedrine|mesh-list
2669729|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2669730|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
2669731|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669732|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669733|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2669734|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
2669735|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
2669736|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2669737|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2669738|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
2669739|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
2669740|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669741|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669742|NCT02149914|Rabeprazole|rabeprazole|mesh-list
2669743|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2669744|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2669745|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2669746|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669747|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669748|NCT02149927|Sevoflurane|sevoflurane|mesh-list
2669749|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2669750|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2669751|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
2669752|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
2669753|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669754|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669755|NCT02149953|Glycine|glycine|mesh-list
2669756|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
2669757|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669758|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669759|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669760|NCT02149992|Inositol|inositol|mesh-list
2669761|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
2669762|NCT02149992|Vitamins|vitamins|mesh-ancestor
2669763|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
2669764|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669765|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
2669766|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2669767|NCT02150031|Lidocaine|lidocaine|mesh-list
2669768|NCT02150031|Epinephrine|epinephrine|mesh-list
2669769|NCT02150031|Racepinephrine|racepinephrine|mesh-list
2669770|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
2669771|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
2669772|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
2669773|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669774|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669775|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
2669776|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669777|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2669778|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2669779|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2669780|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2669781|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669782|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2669783|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669784|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
2669785|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
2669786|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2669787|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2669788|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
2669789|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669790|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2669791|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2669792|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
2669793|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2669794|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
2669795|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
2669796|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
2669797|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2669798|NCT02150122|Vitamin D|vitamin d|mesh-list
2669799|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
2669800|NCT02150122|Vitamins|vitamins|mesh-ancestor
2669801|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
2669802|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669803|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2669804|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2669805|NCT02150161|Lidocaine|lidocaine|mesh-list
2669806|NCT02150161|Fentanyl|fentanyl|mesh-list
2669807|NCT02150161|Ketamine|ketamine|mesh-list
2669808|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
2669809|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
2669810|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669811|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669812|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
2669813|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669814|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2185077|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185078|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185079|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185080|NCT00002855|Ketoconazole|ketoconazole|mesh-list
2185081|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
2185082|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2185083|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2185084|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2185085|NCT00002855|Doxorubicin|doxorubicin|mesh-list
2185086|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2185087|NCT00002855|Bicalutamide|bicalutamide|mesh-list
2185088|NCT00002855|Vinblastine|vinblastine|mesh-list
2185089|NCT00002855|Flutamide|flutamide|mesh-list
2185090|NCT00002855|Estramustine|estramustine|mesh-list
2185091|NCT00002855|Nilutamide|nilutamide|mesh-list
2185092|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2185093|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185094|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185095|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185096|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185097|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669815|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2185098|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2185099|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
2185100|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185101|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2185102|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2185103|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2185104|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
2185105|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2185106|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185107|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2185108|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
2185109|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185110|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185111|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185112|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185113|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2185114|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185115|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
2185116|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
2185117|NCT00002858|Doxorubicin|doxorubicin|mesh-list
2185118|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2185119|NCT00002858|Etoposide|etoposide|mesh-list
2185120|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185121|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
2185122|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185123|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185124|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185125|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
2185126|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185127|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185128|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2185129|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2669816|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2669817|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2669818|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669819|NCT02150161|Analgesics|analgesics|mesh-ancestor
2669820|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2669821|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2669822|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
2669823|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2669824|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2669825|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2669826|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2669827|NCT02150161|Narcotics|narcotics|mesh-ancestor
2669828|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2669829|NCT02150291|Folic Acid|folic acid|mesh-list
2669830|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
2669831|NCT02150291|Hematinics|hematinics|mesh-ancestor
2669832|NCT02150291|Vitamins|vitamins|mesh-ancestor
2669833|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
2669834|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669835|NCT02150317|Sorafenib|sorafenib|mesh-list
2669836|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
2669837|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669838|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2669839|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669840|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669841|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2669842|NCT02150317|Estrogens|estrogens|mesh-ancestor
2669843|NCT02150317|Hormones|hormones|mesh-ancestor
2669844|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669845|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669846|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2669847|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2669848|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2669849|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
2669850|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669851|NCT02150447|Lansoprazole|lansoprazole|mesh-list
2669852|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2669853|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2669854|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2669855|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669856|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669857|NCT02150473|Adalimumab|adalimumab|mesh-list
2669858|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2669859|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2669860|NCT02150616|Sevoflurane|sevoflurane|mesh-list
2669861|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2669862|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2669863|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
2669864|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
2669865|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669866|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669867|NCT02150707|Liraglutide|liraglutide|mesh-list
2669868|NCT02150707|Exenatide|exenatide|mesh-list
2669869|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2669870|NCT02150707|Glucagon|glucagon|mesh-list
2669871|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2669872|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2669873|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669874|NCT02150707|Incretins|incretins|mesh-ancestor
2669875|NCT02150707|Hormones|hormones|mesh-ancestor
2669876|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2669877|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2669878|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2669879|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
2669880|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669881|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669882|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
2669883|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2669884|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2669885|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2669886|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669887|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
2669888|NCT02150720|Coagulants|coagulants|mesh-ancestor
2669889|NCT02150785|Streptokinase|streptokinase|mesh-list
2669890|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2669891|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2669892|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669893|NCT02150928|Asparaginase|asparaginase|mesh-list
2669894|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669895|NCT02150993|Ritonavir|ritonavir|mesh-list
2669896|NCT02150993|Lopinavir|lopinavir|mesh-list
2669897|NCT02150993|Tenofovir|tenofovir|mesh-list
2669898|NCT02150993|Lamivudine|lamivudine|mesh-list
2669899|NCT02150993|Zidovudine|zidovudine|mesh-list
2669900|NCT02150993|Emtricitabine|emtricitabine|mesh-list
2669901|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
2669902|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2669903|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2669904|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2669905|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
2669906|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669907|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669908|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2669909|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2669910|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
2669911|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669912|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2669913|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2669914|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2669915|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2669916|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
2669917|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2669918|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2669919|NCT02151084|Gemcitabine|gemcitabine|mesh-list
2669920|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2669921|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2669922|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
2669923|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669924|NCT02151084|Antiviral Agents|antiviral agents|mesh-ancestor
2669925|NCT02151084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2669926|NCT02151084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669927|NCT02151084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2669928|NCT02151084|Immunologic Factors|immunologic factors|mesh-ancestor
2669929|NCT02151084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669930|NCT02151201|Vaccines|vaccines|mesh-list
2669931|NCT02151201|Immunologic Factors|immunologic factors|mesh-ancestor
2669932|NCT02151201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669933|NCT02151240|Acyclovir|acyclovir|mesh-list
2669934|NCT02151240|Foscarnet|foscarnet|mesh-list
2669935|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2669936|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
2669937|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185130|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185131|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185132|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185133|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2669938|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2669939|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2669940|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669941|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669942|NCT02151279|Chitosan|chitosan|mesh-list
2669943|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2669944|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2669945|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
2669946|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669947|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2669948|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
2669949|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
2669950|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
2185134|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
2185135|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185136|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185137|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185138|NCT00002864|Tamoxifen|tamoxifen|mesh-list
2185139|NCT00002864|Octreotide|octreotide|mesh-list
2185140|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2185141|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
2185142|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2185143|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185144|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2185145|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185146|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2669951|NCT02151279|Coagulants|coagulants|mesh-ancestor
2669952|NCT02151305|Remifentanil|remifentanil|mesh-list
2669953|NCT02151305|Propofol|propofol|mesh-list
2669954|NCT02151305|Sevoflurane|sevoflurane|mesh-list
2669955|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2669956|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669957|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669958|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2669959|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
2669960|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
2669961|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2669962|NCT02151305|Narcotics|narcotics|mesh-ancestor
2669963|NCT02151305|Analgesics|analgesics|mesh-ancestor
2669964|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
2669965|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669966|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2669967|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2669968|NCT02151344|Vaccines|vaccines|mesh-list
2669969|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
2669970|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669971|NCT02151604|Xenon|xenon|mesh-list
2669972|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2669973|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
2669974|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
2669975|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2669976|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669977|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
2669978|NCT02151630|Salicylates|salicylates|mesh-list
2669979|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185147|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2185148|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2185149|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2185150|NCT00002865|Leucovorin|leucovorin|mesh-list
2185151|NCT00002865|Cobalt|cobalt|mesh-list
2185152|NCT00002865|Cytarabine|cytarabine|mesh-list
2185153|NCT00002865|Dexamethasone|dexamethasone|mesh-list
2185154|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
2185155|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2185156|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2185157|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2185158|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
2185159|NCT00002865|Ifosfamide|ifosfamide|mesh-list
2185160|NCT00002865|Doxorubicin|doxorubicin|mesh-list
2185161|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2185162|NCT00002865|Methotrexate|methotrexate|mesh-list
2185163|NCT00002865|Etoposide|etoposide|mesh-list
2669980|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
2669981|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
2669982|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
2669983|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2669984|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2669985|NCT02151630|Analgesics|analgesics|mesh-ancestor
2669986|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
2669987|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2669988|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669989|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2669990|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2669991|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2669992|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2669993|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2669994|NCT02151695|Aflibercept|aflibercept|mesh-list
2669995|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2669996|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2669997|NCT02151695|Growth Substances|growth substances|mesh-ancestor
2669998|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2669999|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
2670000|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670001|NCT02151721|Gefitinib|gefitinib|mesh-list
2670002|NCT02151721|Vorinostat|vorinostat|mesh-list
2670003|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670004|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2670005|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670006|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670007|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2670008|NCT02151812|Paclitaxel|paclitaxel|mesh-list
2670009|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2670010|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2670011|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670012|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
2670013|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
2670014|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
2670015|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670016|NCT02151916|Fluorides|fluorides|mesh-list
2670017|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
2670018|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
2670019|NCT02151916|Protective Agents|protective agents|mesh-ancestor
2670020|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185164|NCT00002865|Vincristine|vincristine|mesh-list
2185165|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
2185166|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185167|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
2185168|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185169|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185170|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185171|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
2185172|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185173|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185174|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2185175|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2670021|NCT02151929|Everolimus|everolimus|mesh-list
2670022|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670023|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670024|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
2670025|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670026|NCT02151968|Anesthetics|anesthetics|mesh-list
2670027|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
2670028|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670029|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670030|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
2670031|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670032|NCT02152059|Nintedanib|nintedanib|mesh-list
2670033|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670034|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2670035|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670036|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670037|NCT02152176|Morphine|morphine|mesh-list
2670038|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2670039|NCT02152176|Narcotics|narcotics|mesh-ancestor
2670040|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670041|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670042|NCT02152176|Analgesics|analgesics|mesh-ancestor
2670043|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
2670044|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670045|NCT02152228|Teriparatide|teriparatide|mesh-list
2670046|NCT02152228|Hormones|hormones|mesh-list
2670047|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
2670048|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2670049|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185176|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
2185177|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
2185178|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2185179|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2185180|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
2185181|NCT00002865|Hormones|hormones|mesh-ancestor
2185182|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2185183|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2185184|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2185185|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185186|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185187|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185188|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2185189|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
2185190|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2185191|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185192|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
2185193|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
2185194|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2670050|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2670051|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2670052|NCT02152306|Amlodipine|amlodipine|mesh-list
2670053|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2670054|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2670055|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2670056|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670057|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2670058|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670059|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
2670060|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
2670061|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2670062|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2670063|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670064|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2670065|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2670066|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670067|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670068|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670069|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2670070|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
2670071|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2670072|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670073|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2670074|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2670075|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2670076|NCT02152358|Acyclovir|acyclovir|mesh-list
2670077|NCT02152358|Ganciclovir|ganciclovir|mesh-list
2670078|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2670079|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
2185195|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2185196|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185197|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
2185198|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185199|NCT00002865|Antidotes|antidotes|mesh-ancestor
2185200|NCT00002865|Protective Agents|protective agents|mesh-ancestor
2185201|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
2670080|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670081|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2670082|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670083|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670084|NCT02152410|Morphine|morphine|mesh-list
2670085|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2670086|NCT02152410|Narcotics|narcotics|mesh-ancestor
2670087|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670088|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670089|NCT02152410|Analgesics|analgesics|mesh-ancestor
2670090|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
2185202|NCT00002865|Vitamins|vitamins|mesh-ancestor
2185203|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
2185204|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185205|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
2670091|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670092|NCT02152423|Enoxaparin|enoxaparin|mesh-list
2670093|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
2670094|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2670095|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2670096|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670097|NCT02152475|Curcumin|curcumin|mesh-list
2670098|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2670099|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2670100|NCT02152475|Analgesics|analgesics|mesh-ancestor
2185206|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185207|NCT00002865|Trace Elements|trace elements|mesh-ancestor
2185208|NCT00002866|Docetaxel|docetaxel|mesh-list
2185209|NCT00002866|Epirubicin|epirubicin|mesh-list
2185210|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185211|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185212|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185213|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
2670101|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
2670102|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670103|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670104|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2670105|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2670106|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670107|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670108|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670109|NCT02152514|Sufentanil|sufentanil|mesh-list
2670110|NCT02152514|Morphine|morphine|mesh-list
2670111|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2670112|NCT02152514|Narcotics|narcotics|mesh-ancestor
2670113|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670114|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670115|NCT02152514|Analgesics|analgesics|mesh-ancestor
2670116|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
2670117|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670118|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2670119|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2670120|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
2670121|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
2670122|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
2670123|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2670124|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2670125|NCT02152579|Isosorbide|isosorbide|mesh-list
2670126|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2670127|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2670128|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2670129|NCT02152579|Diuretics|diuretics|mesh-ancestor
2670130|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
2670131|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670132|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
2670133|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2670134|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670135|NCT02152709|Vaccines|vaccines|mesh-list
2670136|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
2670137|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670138|NCT02152787|Propofol|propofol|mesh-list
2670139|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2670140|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670141|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670142|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2670143|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
2670144|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
2670145|NCT02152800|Valacyclovir|valacyclovir|mesh-list
2670146|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
2670147|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670148|NCT02152865|Lupeol|lupeol|mesh-list
2670149|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2670150|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
2670151|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2670152|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2670153|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185214|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185215|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2670154|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
2670155|NCT02152917|Coagulants|coagulants|mesh-ancestor
2185216|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2670156|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2670157|NCT02152943|Trastuzumab|trastuzumab|mesh-list
2670158|NCT02152943|Everolimus|everolimus|mesh-list
2670159|NCT02152943|Letrozole|letrozole|mesh-list
2670160|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2670161|NCT02152943|Antibodies|antibodies|mesh-list
2670162|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
2670163|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2670164|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
2670165|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185217|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185218|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185219|NCT00002868|Interferons|interferons|mesh-list
2185220|NCT00002868|Cytarabine|cytarabine|mesh-list
2185221|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
2670166|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670167|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670168|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2670169|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2670170|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670171|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670172|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2670173|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
2670174|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2670175|NCT02152969|Amlodipine|amlodipine|mesh-list
2670176|NCT02152969|Telmisartan|telmisartan|mesh-list
2185222|NCT00002868|Etoposide|etoposide|mesh-list
2185223|NCT00002868|Idarubicin|idarubicin|mesh-list
2185224|NCT00002868|Busulfan|busulfan|mesh-list
2185225|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
2185226|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185227|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185228|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185229|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185230|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185231|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185232|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
2185233|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185234|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
2670177|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
2670178|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2670179|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2670180|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2670181|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670182|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2670183|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670184|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
2670185|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2670186|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2670187|NCT02152969|Diuretics|diuretics|mesh-ancestor
2670188|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
2670189|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2670210|NCT02153060|Dexamethasone|dexamethasone|mesh-list
2670211|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
2185235|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670212|NCT02153060|BB 1101|bb 1101|mesh-list
2185236|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2670213|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2670214|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
2670215|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
2670216|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670217|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670218|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2670219|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
2670220|NCT02153060|Hormones|hormones|mesh-ancestor
2670221|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2670222|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2670223|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670224|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
2670225|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670226|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670227|NCT02153125|Eplerenone|eplerenone|mesh-list
2670228|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2670229|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
2670230|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2670231|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670232|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2670233|NCT02153125|Diuretics|diuretics|mesh-ancestor
2670234|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
2670235|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2670236|NCT02153177|Acetaminophen|acetaminophen|mesh-list
2670237|NCT02153177|Ibuprofen|ibuprofen|mesh-list
2670238|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2670239|NCT02153177|Hydrocodone|hydrocodone|mesh-list
2670240|NCT02153177|Oxycodone|oxycodone|mesh-list
2670241|NCT02153177|Omeprazole|omeprazole|mesh-list
2670242|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2670243|NCT02153177|Analgesics|analgesics|mesh-ancestor
2670244|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
2670245|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670246|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670247|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
2185237|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
2185238|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185239|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
2185240|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185241|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2670248|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2670249|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2670250|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2670251|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2670252|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670253|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670254|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2670255|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2670256|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2670257|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2670258|NCT02153177|Narcotics|narcotics|mesh-ancestor
2670259|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670260|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
2670261|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
2670262|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2670263|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670264|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
2670265|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2670266|NCT02153281|Phenelzine|phenelzine|mesh-list
2670267|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
2670268|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2670269|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2670270|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670271|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670272|NCT02153424|Apixaban|apixaban|mesh-list
2670273|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2670274|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
2670275|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2670276|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
2670277|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670278|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670279|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
2670280|NCT02153437|Sotalol|sotalol|mesh-list
2670281|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2670282|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2670283|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
2670284|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2670285|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670286|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670287|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2670288|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
2670289|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
2670290|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670291|NCT02153450|Metformin|metformin|mesh-list
2670292|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2670293|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670294|NCT02153502|Quinidine|quinidine|mesh-list
2670295|NCT02153502|Quinidine gluconate|quinidine gluconate|mesh-list
2670296|NCT02153502|Dextromethorphan|dextromethorphan|mesh-list
2670297|NCT02153502|Antitussive Agents|antitussive agents|mesh-ancestor
2670298|NCT02153502|Respiratory System Agents|respiratory system agents|mesh-ancestor
2670299|NCT02153502|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2670300|NCT02153502|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2670301|NCT02153502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2670302|NCT02153502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670303|NCT02153502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670304|NCT02153502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2670305|NCT02153502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2670306|NCT02153502|Adrenergic Agents|adrenergic agents|mesh-ancestor
2670307|NCT02153502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2670308|NCT02153502|Antimalarials|antimalarials|mesh-ancestor
2670309|NCT02153502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2670310|NCT02153502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2670311|NCT02153502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670312|NCT02153502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670313|NCT02153502|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2670314|NCT02153502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2670315|NCT02153502|Cholinergic Agents|cholinergic agents|mesh-ancestor
2670316|NCT02153502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2670317|NCT02153502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2670318|NCT02153502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2670319|NCT02153502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2670320|NCT02153502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2670321|NCT02153541|Antipyrine|antipyrine|mesh-list
2670322|NCT02153541|Benzocaine|benzocaine|mesh-list
2670323|NCT02153541|Mineral Oil|mineral oil|mesh-list
2670324|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
2670325|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
2670326|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670327|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670328|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
2670329|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2185242|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2185243|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
2185244|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2185245|NCT00002869|Interferons|interferons|mesh-list
2185246|NCT00002869|Cytarabine|cytarabine|mesh-list
2185247|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
2185248|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
2185249|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185250|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
2185251|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185252|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185253|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
2185254|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670330|NCT02153541|Emollients|emollients|mesh-ancestor
2670331|NCT02153541|Dermatologic Agents|dermatologic agents|mesh-ancestor
2670332|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2670333|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2670334|NCT02153541|Analgesics|analgesics|mesh-ancestor
2670335|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2670336|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2670337|NCT02153567|Citalopram|citalopram|mesh-list
2670338|NCT02153567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2670339|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2670340|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2670341|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670342|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2185255|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670343|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
2670344|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670345|NCT02153567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2670346|NCT02153567|Antidepressive Agents|antidepressive agents|mesh-ancestor
2670347|NCT02153567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2670348|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
2670349|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2185256|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
2185257|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185258|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
2185259|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185260|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2185261|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
2670350|NCT02153580|Fludarabine|fludarabine|mesh-list
2670351|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
2670352|NCT02153580|Etoposide|etoposide|mesh-list
2670353|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
2670354|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
2670355|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670356|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
2670357|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670358|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2670359|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2670360|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
2670361|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670362|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670363|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2670364|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2670365|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
2670366|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2670367|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2670368|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2670369|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670370|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
2670371|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
2670372|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
2670373|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
2670374|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
2670375|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
2670376|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2670377|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2670378|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2670379|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670380|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
2670381|NCT02153593|Coagulants|coagulants|mesh-ancestor
2670382|NCT02153606|Glycerol|glycerol|mesh-list
2670383|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2670384|NCT02153606|Protective Agents|protective agents|mesh-ancestor
2670385|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670386|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
2670387|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2185262|NCT00002870|Thiotepa|thiotepa|mesh-list
2185263|NCT00002870|Fluorouracil|fluorouracil|mesh-list
2185264|NCT00002870|Epirubicin|epirubicin|mesh-list
2185265|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185266|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
2185267|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185268|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185269|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185270|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
2185271|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185272|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185273|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2185274|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
2185275|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185276|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2185277|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185278|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2670388|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670389|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
2670390|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
2670391|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2670392|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2670393|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2670394|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2185279|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670395|NCT02153866|Vaccines|vaccines|mesh-list
2670396|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
2670397|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670398|NCT02153879|Niacin|niacin|mesh-list
2670399|NCT02153879|Fenofibrate|fenofibrate|mesh-list
2670400|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2670401|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
2670402|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670403|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2670404|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
2670405|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
2670406|NCT02153879|Vitamins|vitamins|mesh-ancestor
2670407|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
2670408|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670409|NCT02153944|Propranolol|propranolol|mesh-list
2670410|NCT02153944|Methylphenidate|methylphenidate|mesh-list
2670411|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2670412|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670413|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2670414|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2670415|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2670416|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670417|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
2670418|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2670419|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2670420|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2670421|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
2670422|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2670423|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2670424|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
2670425|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
2670426|NCT02154074|Isoflurane|isoflurane|mesh-list
2670427|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
2670428|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670429|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670430|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2670431|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2670432|NCT02154074|Analgesics|analgesics|mesh-ancestor
2670433|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
2670434|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670435|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2670436|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2670437|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2670438|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
2670439|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2670440|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670441|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2670442|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
2670443|NCT02154217|Timolol|timolol|mesh-list
2670444|NCT02154217|Bimatoprost|bimatoprost|mesh-list
2670445|NCT02154217|Latanoprost|latanoprost|mesh-list
2670446|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2670447|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2670448|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
2670449|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2670450|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670451|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670452|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2670453|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2670454|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2670455|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2670456|NCT02154230|Calcium|calcium|mesh-list
2670457|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2670458|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670459|NCT02154269|Lenograstim|lenograstim|mesh-list
2670460|NCT02154269|Sargramostim|sargramostim|mesh-list
2670461|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2670462|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
2670463|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670464|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
2670465|NCT02154334|Phenylephrine|phenylephrine|mesh-list
2670466|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
2670467|NCT02154334|Esketamine|esketamine|mesh-list
2670468|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2670469|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
2670470|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2670471|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
2670472|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2670473|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2670474|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2670475|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
2670476|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2670477|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670478|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670479|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
2670480|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
2185280|NCT00002872|Doxycycline|doxycycline|mesh-list
2185281|NCT00002872|Bleomycin|bleomycin|mesh-list
2185282|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2185283|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185284|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
2185285|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2185286|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2185287|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2185288|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185289|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
2185290|NCT00002875|Lomustine|lomustine|mesh-list
2185291|NCT00002875|Cisplatin|cisplatin|mesh-list
2185292|NCT00002875|Vincristine|vincristine|mesh-list
2185293|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670481|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670482|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
2670483|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2670484|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
2670485|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2670486|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
2670487|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2670488|NCT02154334|Protective Agents|protective agents|mesh-ancestor
2670489|NCT02154360|Aprepitant|aprepitant|mesh-list
2670490|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
2670491|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
2670492|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670493|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670494|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2670495|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2670496|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2670497|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670498|NCT02154438|Ketamine|ketamine|mesh-list
2670499|NCT02154438|Analgesics|analgesics|mesh-ancestor
2670500|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
2670501|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670502|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185294|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
2185295|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185296|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185297|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185298|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
2185299|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185300|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185301|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2185302|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185303|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185304|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185305|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185306|NCT00002876|Etoposide|etoposide|mesh-list
2185307|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185308|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185309|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185310|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185311|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185312|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185313|NCT00002878|Dexamethasone|dexamethasone|mesh-list
2670503|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2670504|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2670505|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
2670506|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
2670507|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670508|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2670509|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2670510|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2185314|NCT00002878|Doxorubicin|doxorubicin|mesh-list
2185315|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2670511|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670512|NCT02154464|Acetaminophen|acetaminophen|mesh-list
2670513|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2670514|NCT02154464|Analgesics|analgesics|mesh-ancestor
2670515|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
2670516|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670517|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670518|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
2670519|NCT02154503|Minoxidil|minoxidil|mesh-list
2670520|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2670521|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
2670522|NCT02154529|Trastuzumab|trastuzumab|mesh-list
2670523|NCT02154529|XL647|xl647|mesh-list
2670524|NCT02154529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2670525|NCT02154529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670526|NCT02154529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2670527|NCT02154529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670528|NCT02154529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670529|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
2670530|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2670531|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2670532|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670533|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
2670534|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
2670535|NCT02154646|Gemcitabine|gemcitabine|mesh-list
2670536|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2670537|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
2670538|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670539|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670540|NCT02154646|Antiviral Agents|antiviral agents|mesh-ancestor
2670541|NCT02154646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670542|NCT02154646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670543|NCT02154646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670544|NCT02154646|Immunologic Factors|immunologic factors|mesh-ancestor
2670545|NCT02154646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670546|NCT02154737|Gemcitabine|gemcitabine|mesh-list
2670547|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2670548|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2670549|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
2670550|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670551|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670552|NCT02154737|Antiviral Agents|antiviral agents|mesh-ancestor
2670553|NCT02154737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670554|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670555|NCT02154737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670556|NCT02154737|Immunologic Factors|immunologic factors|mesh-ancestor
2670557|NCT02154737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670558|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2670559|NCT02154776|Letrozole|letrozole|mesh-list
2670560|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670561|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2670562|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2670563|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670564|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670565|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2670566|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
2670567|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2670568|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670569|NCT02154789|Polidocanol|polidocanol|mesh-list
2670570|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2670571|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2670572|NCT02154854|Tacrolimus|tacrolimus|mesh-list
2670573|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670574|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
2670575|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670576|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2670577|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670578|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670579|NCT02154932|Misoprostol|misoprostol|mesh-list
2670580|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2670581|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
2670582|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2670583|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670584|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2670585|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2670586|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
2670587|NCT02155023|Insulin|insulin|mesh-list
2670588|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2670589|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2670590|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670591|NCT02155049|Bimatoprost|bimatoprost|mesh-list
2670592|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2670593|NCT02155088|Gemcitabine|gemcitabine|mesh-list
2670594|NCT02155088|Paclitaxel|paclitaxel|mesh-list
2422953|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422954|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2422955|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2422956|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422957|NCT00819754|Bevacizumab|bevacizumab|mesh-list
2422958|NCT00819754|Capecitabine|capecitabine|mesh-list
2422959|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
2422960|NCT00819754|Irinotecan|irinotecan|mesh-list
2422961|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2422962|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422963|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2422964|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2422965|NCT00819754|Growth Substances|growth substances|mesh-ancestor
2422966|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422967|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
2422968|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2422969|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
2422970|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422971|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2422972|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2422973|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422974|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
2422975|NCT00819806|Vaccines|vaccines|mesh-list
2422976|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
2422977|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670595|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2670596|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670597|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
2670598|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
2670599|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
2670600|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670601|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2670602|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
2670603|NCT02155088|Antiviral Agents|antiviral agents|mesh-ancestor
2670604|NCT02155088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670605|NCT02155088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670606|NCT02155088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670607|NCT02155088|Immunologic Factors|immunologic factors|mesh-ancestor
2670608|NCT02155088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670609|NCT02155166|Ibuprofen|ibuprofen|mesh-list
2670610|NCT02155166|Lidocaine|lidocaine|mesh-list
2670611|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
2670612|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
2670613|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670614|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670615|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
2670616|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670617|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2670618|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2670619|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2670620|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2670621|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670622|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2670623|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2670624|NCT02155166|Analgesics|analgesics|mesh-ancestor
2670625|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2670626|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2670627|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2670628|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670629|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
2670630|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2670631|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670632|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2670633|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2670634|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2422978|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670635|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670636|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670637|NCT02155374|Insulin|insulin|mesh-list
2670638|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2185316|NCT00002878|Vincristine|vincristine|mesh-list
2185317|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2185318|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
2185319|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
2185320|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2185321|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185322|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2185323|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
2185324|NCT00002878|Hormones|hormones|mesh-ancestor
2185325|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2185326|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2185327|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185328|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2185329|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185330|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185331|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185332|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185333|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185334|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185335|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
2670639|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
2670640|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
2670641|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2670642|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670643|NCT02155439|Triamcinolone|triamcinolone|mesh-list
2670644|NCT02155439|Fluorouracil|fluorouracil|mesh-list
2670645|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
2670646|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670647|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2670648|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670649|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670650|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
2670651|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670652|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2670653|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
2670654|NCT02155439|Hormones|hormones|mesh-ancestor
2670655|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2670656|NCT02155504|Itraconazole|itraconazole|mesh-list
2670657|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
2670658|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670659|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2670660|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2670661|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670662|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670663|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2670664|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
2670665|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2670666|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670667|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2670668|NCT02155517|Propofol|propofol|mesh-list
2670669|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2670670|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670671|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670672|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2670673|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
2185336|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185337|NCT00002879|Cladribine|cladribine|mesh-list
2185338|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185339|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185340|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
2185341|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185342|NCT00002880|Etoposide|etoposide|mesh-list
2185343|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
2185344|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2670674|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
2670675|NCT02155530|Atorvastatin|atorvastatin|mesh-list
2670676|NCT02155530|Pravastatin|pravastatin|mesh-list
2670677|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2670678|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2670679|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
2185345|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185346|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185347|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2670680|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670681|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2670682|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2670683|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670684|NCT02155634|Lenalidomide|lenalidomide|mesh-list
2670685|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
2670686|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670687|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2670688|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2670689|NCT02155634|Growth Substances|growth substances|mesh-ancestor
2670690|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
2670691|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670692|NCT02155777|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2670693|NCT02155777|Norinyl|norinyl|mesh-list
2670694|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2670695|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2670696|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2670697|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
2670698|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2670699|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670700|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2670701|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2670702|NCT02155777|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2670703|NCT02155777|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2670704|NCT02155803|Hormones|hormones|mesh-list
2670705|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2670706|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2670707|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
2670708|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2670709|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670710|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2670711|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670712|NCT02155920|Everolimus|everolimus|mesh-list
2670713|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670714|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670715|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
2670716|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670717|NCT02156336|Ranolazine|ranolazine|mesh-list
2670718|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2670719|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2670720|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670721|NCT02156375|Ustekinumab|ustekinumab|mesh-list
2670722|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
2670723|NCT02156570|Ribavirin|ribavirin|mesh-list
2670724|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
2670725|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
2670726|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670727|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
2670728|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670729|NCT02156596|Ketoprofen|ketoprofen|mesh-list
2670730|NCT02156596|Morphine|morphine|mesh-list
2670731|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2670732|NCT02156596|Narcotics|narcotics|mesh-ancestor
2670733|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670734|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670735|NCT02156596|Analgesics|analgesics|mesh-ancestor
2670736|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
2670737|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670738|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2670739|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2670740|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2670741|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2670742|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2670743|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670744|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670745|NCT02156661|Oxytocin|oxytocin|mesh-list
2670746|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
2670747|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2670748|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185348|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670749|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
2670750|NCT02156726|Fludarabine|fludarabine|mesh-list
2670751|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670752|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
2670753|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670754|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2670755|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2670756|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
2670757|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670758|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670759|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2670760|NCT02156739|Edetic Acid|edetic acid|mesh-list
2185349|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185350|NCT00002881|Suramin|suramin|mesh-list
2185351|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
2185352|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2185353|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2185354|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2185355|NCT00002881|Leuprolide|leuprolide|mesh-list
2185356|NCT00002881|Goserelin|goserelin|mesh-list
2185357|NCT00002881|Flutamide|flutamide|mesh-list
2185358|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2670761|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
2670762|NCT02156739|Antidotes|antidotes|mesh-ancestor
2670763|NCT02156739|Protective Agents|protective agents|mesh-ancestor
2670764|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670765|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
2670766|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
2670767|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670768|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2670769|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
2670770|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2670771|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
2670772|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
2670773|NCT02156843|Vitamins|vitamins|mesh-ancestor
2670774|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
2670775|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670776|NCT02156960|Denosumab|denosumab|mesh-list
2670777|NCT02156960|Teriparatide|teriparatide|mesh-list
2670778|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2670779|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670780|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2670781|NCT02156999|Vitamin D|vitamin d|mesh-list
2670782|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
2670783|NCT02156999|Vitamins|vitamins|mesh-ancestor
2670784|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
2670785|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670786|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2670787|NCT02157012|Tofacitinib|tofacitinib|mesh-list
2670788|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2670789|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670790|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670791|NCT02157077|Aflibercept|aflibercept|mesh-list
2670792|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2670793|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2670794|NCT02157077|Growth Substances|growth substances|mesh-ancestor
2670795|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670796|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
2670797|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670798|NCT02157181|Rituximab|rituximab|mesh-list
2670799|NCT02157181|Cladribine|cladribine|mesh-list
2670800|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2670801|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670802|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
2670803|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670804|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2670805|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670806|NCT02157207|Vitamins|vitamins|mesh-list
2670807|NCT02157207|Vitamin E|vitamin e|mesh-list
2670808|NCT02157207|Antioxidants|antioxidants|mesh-list
2670809|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
2670810|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670811|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670812|NCT02157207|Protective Agents|protective agents|mesh-ancestor
2670813|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
2670814|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2185359|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2670815|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
2670816|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2670817|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
2185360|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
2185361|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2185362|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185363|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2185364|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185365|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
2185366|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
2185367|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2185368|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
2185369|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
2185370|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2185371|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185372|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2185373|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2185374|NCT00002882|Interferons|interferons|mesh-list
2185375|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
2185376|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
2185377|NCT00002882|Aldesleukin|aldesleukin|mesh-list
2185378|NCT00002882|Cisplatin|cisplatin|mesh-list
2185379|NCT00002882|Interleukin-2|interleukin-2|mesh-list
2185380|NCT00002882|Dacarbazine|dacarbazine|mesh-list
2185381|NCT00002882|Vinblastine|vinblastine|mesh-list
2185382|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185383|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
2185384|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185385|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
2185386|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185387|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2185388|NCT00002882|Analgesics|analgesics|mesh-ancestor
2185389|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
2185390|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2185391|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2670818|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670819|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670820|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
2670821|NCT02157311|Tenofovir|tenofovir|mesh-list
2670822|NCT02157311|Lamivudine|lamivudine|mesh-list
2670823|NCT02157311|Emtricitabine|emtricitabine|mesh-list
2670824|NCT02157311|Efavirenz|efavirenz|mesh-list
2670825|NCT02157311|Lopinavir|lopinavir|mesh-list
2670826|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2670827|NCT02157311|Darunavir|darunavir|mesh-list
2670828|NCT02157311|Abacavir|abacavir|mesh-list
2670829|NCT02157311|Rilpivirine|rilpivirine|mesh-list
2670830|NCT02157311|Etravirine|etravirine|mesh-list
2670831|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
2670832|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670833|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2670834|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2670835|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670836|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670837|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2670838|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2670839|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2670840|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2670841|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2670842|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2670843|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2670844|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2670845|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2670846|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2670847|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
2670848|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2670851|NCT02157337|Atorvastatin|atorvastatin|mesh-list
2670852|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2670853|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2670854|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
2670855|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670856|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2670857|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2670858|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670859|NCT02157415|Polihexanide|polihexanide|mesh-list
2670860|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
2670861|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670862|NCT02157428|Flumazenil|flumazenil|mesh-list
2670863|NCT02157428|Antidotes|antidotes|mesh-ancestor
2670864|NCT02157428|Protective Agents|protective agents|mesh-ancestor
2670865|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670866|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
2670867|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
2670868|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2670869|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670870|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
2670871|NCT02157467|BMS-955176|bms-955176|mesh-list
2670872|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2670873|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2670874|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670875|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2670876|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2670877|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670878|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670879|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670880|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2670881|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
2670882|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2670883|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670884|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2670885|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2670886|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2670887|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2670888|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2670889|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
2670890|NCT02157558|Fexofenadine|fexofenadine|mesh-list
2670891|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2670892|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2670893|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2670894|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
2670895|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
2670896|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2670897|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670898|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670899|NCT02157571|Levofloxacin|levofloxacin|mesh-list
2670900|NCT02157571|Ofloxacin|ofloxacin|mesh-list
2670901|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
2670902|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
2670903|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2670904|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670905|NCT02157571|Renal Agents|renal agents|mesh-ancestor
2670906|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2670907|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2670908|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2670909|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670910|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670911|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670912|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2670913|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2670914|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2670915|NCT02157610|Nicotine|nicotine|mesh-list
2670916|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2670917|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
2670918|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670919|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670920|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2670921|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2670922|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
2670923|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2670924|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670925|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
2670926|NCT02157649|Codeine|codeine|mesh-list
2670927|NCT02157649|Guaifenesin|guaifenesin|mesh-list
2670928|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2670929|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2670930|NCT02157649|Narcotics|narcotics|mesh-ancestor
2670931|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670932|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670933|NCT02157649|Analgesics|analgesics|mesh-ancestor
2670934|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
2670935|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670936|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
2670937|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
2670938|NCT02157649|Expectorants|expectorants|mesh-ancestor
2670939|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2670940|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2670941|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
2670942|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2670943|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670944|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
2670945|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2670946|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
2670947|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
2670948|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
2670949|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2670950|NCT02157792|Gemcitabine|gemcitabine|mesh-list
2670951|NCT02157792|Carboplatin|carboplatin|mesh-list
2670952|NCT02157792|Etoposide|etoposide|mesh-list
2670953|NCT02157792|Irinotecan|irinotecan|mesh-list
2670954|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2670955|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2670956|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
2670957|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670958|NCT02157792|Antiviral Agents|antiviral agents|mesh-ancestor
2670959|NCT02157792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2670960|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2670961|NCT02157792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2670962|NCT02157792|Immunologic Factors|immunologic factors|mesh-ancestor
2670963|NCT02157792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670964|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2670965|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2670966|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2670967|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2670968|NCT02157818|Midazolam|midazolam|mesh-list
2670969|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
2670970|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2670971|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2670972|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670973|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2670974|NCT02157818|Analgesics|analgesics|mesh-ancestor
2670975|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
2670976|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2670977|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2670978|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2670979|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2670980|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
2670981|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2670982|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2670983|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2670984|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2670985|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2670986|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2670987|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2670988|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
2670989|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
2670990|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
2670991|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
2670992|NCT02157974|Exenatide|exenatide|mesh-list
2670993|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2670994|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2670995|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2670996|NCT02157974|Incretins|incretins|mesh-ancestor
2670997|NCT02157974|Hormones|hormones|mesh-ancestor
2670998|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2670999|NCT02158013|Diltiazem|diltiazem|mesh-list
2671000|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2671001|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2671002|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2671003|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671004|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2671005|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671006|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
2671007|NCT02158052|Tacrolimus|tacrolimus|mesh-list
2671008|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2671009|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2671010|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
2671011|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671012|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2671013|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671014|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671015|NCT02158078|Insulin|insulin|mesh-list
2671016|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2671017|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671018|NCT02158117|Naloxone|naloxone|mesh-list
2671019|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2671020|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671021|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
2671022|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671023|NCT02158143|Vitamin D|vitamin d|mesh-list
2671024|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
2671025|NCT02158143|Vitamins|vitamins|mesh-ancestor
2671026|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
2671027|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671028|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2671029|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2671030|NCT02158182|Rifaximin|rifaximin|mesh-list
2671031|NCT02158182|Lactulose|lactulose|mesh-list
2671032|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
2671033|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2671034|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2671035|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2671036|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2671037|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2671038|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671039|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671040|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671041|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
2671042|NCT02158221|Growth Substances|growth substances|mesh-ancestor
2671043|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671044|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
2671045|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671046|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671047|NCT02158234|Cisplatin|cisplatin|mesh-list
2671048|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
2671049|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671050|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185392|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2185393|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185394|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
2185395|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185396|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185397|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185398|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
2671051|NCT02158286|Acetaminophen|acetaminophen|mesh-list
2671052|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2671053|NCT02158286|Analgesics|analgesics|mesh-ancestor
2671054|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
2671055|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671056|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671057|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
2671058|NCT02158481|Carotenoids|carotenoids|mesh-list
2671059|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
2671060|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671061|NCT02158481|Protective Agents|protective agents|mesh-ancestor
2671062|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671063|NCT02158585|Lamotrigine|lamotrigine|mesh-list
2671064|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
2671065|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2671066|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2671067|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671068|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2671069|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671070|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2671071|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2671072|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2671073|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2671074|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2671075|NCT02158598|Vitamin D|vitamin d|mesh-list
2671076|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
2671077|NCT02158598|Vitamins|vitamins|mesh-list
2671078|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
2671079|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671080|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2671081|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2671082|NCT02158624|Ranibizumab|ranibizumab|mesh-list
2671083|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2671084|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2671085|NCT02158624|Growth Substances|growth substances|mesh-ancestor
2671086|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671087|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
2671088|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671089|NCT02158689|Letrozole|letrozole|mesh-list
2671090|NCT02158689|Menotropins|menotropins|mesh-list
2671091|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671092|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2671093|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2671094|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671095|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671096|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2671097|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
2671098|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2671099|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671100|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2671101|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
2671102|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2671103|NCT02158702|Dexamethasone|dexamethasone|mesh-list
2671104|NCT02158702|Pomalidomide|pomalidomide|mesh-list
2671105|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671106|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
2671107|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
2671108|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671109|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671110|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2671111|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
2671112|NCT02158702|Hormones|hormones|mesh-ancestor
2671113|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2671114|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2671115|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671116|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
2671117|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2671118|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2671119|NCT02158702|Growth Substances|growth substances|mesh-ancestor
2671120|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
2671121|NCT02158845|Leuprolide|leuprolide|mesh-list
2671122|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
2671123|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2671124|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
2671125|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2671126|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671127|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2671128|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671129|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2671130|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
2671131|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2671132|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2671133|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2671134|NCT02158910|Donepezil|donepezil|mesh-list
2671135|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2671136|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671137|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671138|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
2671139|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671140|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185399|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185400|NCT00002883|Fluorouracil|fluorouracil|mesh-list
2185401|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671141|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
2671142|NCT02159027|Maraviroc|maraviroc|mesh-list
2671143|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2671144|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2671145|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671146|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2671147|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2671148|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
2671149|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2671150|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2671151|NCT02159066|Infigratinib|infigratinib|mesh-list
2671152|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671153|NCT02159131|Cabotegravir|cabotegravir|mesh-list
2671154|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
2671155|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2671156|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
2671157|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2671158|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671159|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2671160|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2671161|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2671162|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2671163|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2671164|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671165|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671166|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2671167|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2671168|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
2671169|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2671170|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
2671171|NCT02159196|Albuterol|albuterol|mesh-list
2671172|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2671173|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
2671174|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2671175|NCT02159196|Expectorants|expectorants|mesh-ancestor
2671176|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
2671177|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2671178|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
2671179|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671180|NCT02159196|Protective Agents|protective agents|mesh-ancestor
2671181|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671182|NCT02159196|Antidotes|antidotes|mesh-ancestor
2185402|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
2185403|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185404|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185405|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185406|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
2185407|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185408|NCT00002884|Fluorouracil|fluorouracil|mesh-list
2185409|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185410|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
2422979|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2671183|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2671184|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
2671185|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671186|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2671187|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
2671188|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2671189|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2671190|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2671191|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2671192|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
2671193|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671194|NCT02159248|Gemcitabine|gemcitabine|mesh-list
2671195|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
2671196|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2671197|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
2671198|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671199|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671200|NCT02159248|Antiviral Agents|antiviral agents|mesh-ancestor
2422980|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2422981|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
2422982|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422983|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2422984|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2422985|NCT00819845|Carvedilol|carvedilol|mesh-list
2422986|NCT00819845|Ramipril|ramipril|mesh-list
2422987|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2422988|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2422989|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2422990|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
2422991|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2422992|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2422993|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2422994|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2185411|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185412|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185413|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185414|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
2185415|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185416|NCT00002887|Etoposide|etoposide|mesh-list
2185417|NCT00002887|Vinorelbine|vinorelbine|mesh-list
2185418|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
2185419|NCT00002887|Vinblastine|vinblastine|mesh-list
2185420|NCT00002887|Vindesine|vindesine|mesh-list
2185421|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185422|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185423|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185424|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185425|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185426|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185427|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185428|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185429|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185430|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
2185431|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2185432|NCT00002888|Paclitaxel|paclitaxel|mesh-list
2185433|NCT00002888|Fluorouracil|fluorouracil|mesh-list
2185434|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185435|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185436|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185437|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185438|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185439|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185440|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
2185441|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185442|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185443|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
2185444|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185445|NCT00002889|Leuprolide|leuprolide|mesh-list
2185446|NCT00002889|Goserelin|goserelin|mesh-list
2185447|NCT00002889|Flutamide|flutamide|mesh-list
2185448|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2185449|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
2185450|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2185451|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185452|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2185453|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185454|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
2185455|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
2185456|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2185457|NCT00002890|Lintuzumab|lintuzumab|mesh-list
2185458|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2185459|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671201|NCT02159248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2671202|NCT02159248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671203|NCT02159248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2671204|NCT02159248|Immunologic Factors|immunologic factors|mesh-ancestor
2671205|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671206|NCT02159248|Analgesics|analgesics|mesh-ancestor
2671207|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
2671208|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671209|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2671210|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2671211|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671212|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2671213|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2671214|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2671215|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2671216|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
2671217|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
2671218|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2671219|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2671220|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
2671221|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671222|NCT02159287|Heparin|heparin|mesh-list
2671223|NCT02159287|Calcium heparin|calcium heparin|mesh-list
2671224|NCT02159287|Enoxaparin|enoxaparin|mesh-list
2671225|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
2671226|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
2671227|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2671228|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2671229|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671230|NCT02159313|Riociguat|riociguat|mesh-list
2671231|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
2671232|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671233|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2671234|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2671235|NCT02159326|Riociguat|riociguat|mesh-list
2671236|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
2671237|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671238|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2671239|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
2671240|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2671241|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671242|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2671243|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2671244|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2671245|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2671246|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2671247|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2671248|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2671249|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2671250|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
2671251|NCT02159495|Fludarabine|fludarabine|mesh-list
2671252|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
2671253|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2671254|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
2671255|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671256|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2671257|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2671258|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
2671259|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671260|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671261|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2671262|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2671263|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
2671264|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2671265|NCT02159573|Natalizumab|natalizumab|mesh-list
2671266|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
2671267|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671268|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
2671269|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2671270|NCT02159599|Ritonavir|ritonavir|mesh-list
2185460|NCT00002892|Interferons|interferons|mesh-list
2185461|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
2185462|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671271|NCT02159599|Darunavir|darunavir|mesh-list
2671272|NCT02159599|Tenofovir|tenofovir|mesh-list
2671273|NCT02159599|Lamivudine|lamivudine|mesh-list
2671274|NCT02159599|Emtricitabine|emtricitabine|mesh-list
2671275|NCT02159599|Abacavir|abacavir|mesh-list
2671276|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2671277|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2671278|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
2671279|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671280|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671281|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2671282|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2671283|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
2671284|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2671285|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2671286|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2671287|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2671288|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2671289|NCT02159651|Tacrolimus|tacrolimus|mesh-list
2671290|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2671291|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
2671292|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671293|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2671294|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671295|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671296|NCT02159690|Prednisone|prednisone|mesh-list
2671297|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
2671298|NCT02159690|Dutasteride|dutasteride|mesh-list
2185463|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
2185464|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185465|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
2185466|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185467|NCT00002893|Leucovorin|leucovorin|mesh-list
2671299|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671300|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
2671301|NCT02159690|Hormones|hormones|mesh-ancestor
2671302|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2671303|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671304|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2671305|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671306|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2671307|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671308|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671309|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
2671310|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2671311|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2671312|NCT02159755|Palbociclib|palbociclib|mesh-list
2671313|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671314|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2671315|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185468|NCT00002893|Fluorouracil|fluorouracil|mesh-list
2185469|NCT00002893|Raltitrexed|raltitrexed|mesh-list
2185470|NCT00002893|Calcium|calcium|mesh-list
2185471|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
2185472|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2185473|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185474|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
2185475|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185476|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185477|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185478|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185479|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
2185480|NCT00002893|Antidotes|antidotes|mesh-ancestor
2185481|NCT00002893|Protective Agents|protective agents|mesh-ancestor
2671316|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671317|NCT02159820|Paclitaxel|paclitaxel|mesh-list
2671318|NCT02159820|Carboplatin|carboplatin|mesh-list
2671319|NCT02159820|Decitabine|decitabine|mesh-list
2671320|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2671321|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671322|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185482|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
2185483|NCT00002893|Vitamins|vitamins|mesh-ancestor
2185484|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
2185485|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2185486|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185487|NCT00002894|Paclitaxel|paclitaxel|mesh-list
2185488|NCT00002894|Carboplatin|carboplatin|mesh-list
2185489|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185490|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185491|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185492|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185493|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185494|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185495|NCT00002896|Leucovorin|leucovorin|mesh-list
2185496|NCT00002896|Cobalt|cobalt|mesh-list
2185497|NCT00002896|Fluorouracil|fluorouracil|mesh-list
2185498|NCT00002896|Calcium|calcium|mesh-list
2185499|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
2185500|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2185501|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185502|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
2185503|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185504|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185505|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185506|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185507|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
2185508|NCT00002896|Antidotes|antidotes|mesh-ancestor
2185509|NCT00002896|Protective Agents|protective agents|mesh-ancestor
2185510|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
2185511|NCT00002896|Vitamins|vitamins|mesh-ancestor
2185512|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
2185513|NCT00002896|Trace Elements|trace elements|mesh-ancestor
2185514|NCT00002897|Fluorouracil|fluorouracil|mesh-list
2185515|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185516|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
2671323|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
2671324|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
2671325|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671326|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2671327|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
2671328|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671329|NCT02159911|Misoprostol|misoprostol|mesh-list
2671330|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2671331|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
2671332|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2671333|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671334|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2671335|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2671336|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
2671345|NCT02160015|Rituximab|rituximab|mesh-list
2671346|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2671347|NCT02160015|Lenalidomide|lenalidomide|mesh-list
2671348|NCT02160015|Antibodies|antibodies|mesh-list
2671349|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
2671350|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2671351|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
2671352|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671353|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671354|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2671355|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2671356|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2671357|NCT02160015|Growth Substances|growth substances|mesh-ancestor
2671358|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
2671359|NCT02160028|Anesthetics|anesthetics|mesh-list
2671360|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2671361|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671362|NCT02160054|Tacrolimus|tacrolimus|mesh-list
2671363|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2671364|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
2671365|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671366|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2671367|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671368|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671369|NCT02160080|Interferons|interferons|mesh-list
2671370|NCT02160080|Ribavirin|ribavirin|mesh-list
2671371|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
2671372|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671373|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
2671374|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185517|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185518|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185519|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185520|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
2185521|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185522|NCT00002898|Dactinomycin|dactinomycin|mesh-list
2185523|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
2185524|NCT00002898|Ifosfamide|ifosfamide|mesh-list
2185525|NCT00002898|Carboplatin|carboplatin|mesh-list
2185526|NCT00002898|Etoposide|etoposide|mesh-list
2185527|NCT00002898|Vincristine|vincristine|mesh-list
2185528|NCT00002898|Epirubicin|epirubicin|mesh-list
2185529|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185530|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
2185531|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185532|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185533|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185534|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
2185535|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185536|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185537|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2185538|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185539|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2671375|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
2671376|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671377|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
2671378|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671379|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
2671380|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2185540|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185541|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185542|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185543|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185544|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185545|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2185546|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2185547|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185548|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2185549|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2185550|NCT00002901|Docetaxel|docetaxel|mesh-list
2671381|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2671382|NCT02160132|Prednisolone|prednisolone|mesh-list
2671383|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
2671384|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2671385|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
2671386|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671387|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
2671388|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
2671389|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671390|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671391|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2671392|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
2671393|NCT02160132|Hormones|hormones|mesh-ancestor
2671394|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2671395|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2671396|NCT02160132|Protective Agents|protective agents|mesh-ancestor
2671397|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2671398|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671399|NCT02160158|Fesoterodine|fesoterodine|mesh-list
2671400|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2671401|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2671402|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
2671403|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671404|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671405|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671406|NCT02160158|Urological Agents|urological agents|mesh-ancestor
2671407|NCT02160184|Pancrelipase|pancrelipase|mesh-list
2671408|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2671409|NCT02160223|Neostigmine|neostigmine|mesh-list
2671410|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2671411|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671412|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671413|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
2671414|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671415|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671416|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2671417|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
2671418|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671419|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2671420|NCT02160236|Tenoxicam|tenoxicam|mesh-list
2671421|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2671422|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2671423|NCT02160236|Analgesics|analgesics|mesh-ancestor
2671424|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
2671425|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671426|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671427|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671428|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2671429|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2671430|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671431|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671432|NCT02160275|Insulin|insulin|mesh-list
2671433|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2671434|NCT02160275|Pancrelipase|pancrelipase|mesh-list
2671435|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2671436|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671437|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2671438|NCT02160301|Acetaminophen|acetaminophen|mesh-list
2671439|NCT02160301|Dexamethasone|dexamethasone|mesh-list
2671440|NCT02160301|Celecoxib|celecoxib|mesh-list
2671441|NCT02160301|Oxycodone|oxycodone|mesh-list
2671442|NCT02160301|Gabapentin|gabapentin|mesh-list
2671443|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671444|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
2671445|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
2671446|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671447|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671448|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2671449|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
2671450|NCT02160301|Hormones|hormones|mesh-ancestor
2671451|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2671452|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2671453|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671454|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2671455|NCT02160301|Analgesics|analgesics|mesh-ancestor
2671456|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
2671457|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
2671458|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2671459|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2671460|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2671461|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2671462|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671463|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671464|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2671465|NCT02160301|Narcotics|narcotics|mesh-ancestor
2671466|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2671467|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
2671468|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2671469|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2671470|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2671471|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2671472|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2671473|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671474|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
2671475|NCT02160353|Prednisolone|prednisolone|mesh-list
2671476|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
2671477|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671478|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
2671479|NCT02160353|Hormones|hormones|mesh-ancestor
2671480|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2671481|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671482|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2671483|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671484|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2671485|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671486|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671487|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
2671488|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2671489|NCT02160548|Atropine|atropine|mesh-list
2671490|NCT02160548|Albuterol|albuterol|mesh-list
2671491|NCT02160548|Pralidoxime|pralidoxime|mesh-list
2671492|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2671493|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
2671494|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671495|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671496|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2671497|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
2671498|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
2671499|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2671500|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2671501|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2671502|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2671503|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
2671504|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671505|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671506|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2671507|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2671508|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
2671509|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
2671510|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2671511|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2671512|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
2671513|NCT02160548|Antidotes|antidotes|mesh-ancestor
2671514|NCT02160548|Protective Agents|protective agents|mesh-ancestor
2671515|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
2671516|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
2671517|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
2671518|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2671519|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2671520|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2671521|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
2671522|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
2671523|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
2671524|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2671525|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2671526|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2671527|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
2671528|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
2671529|NCT02160665|Tazarotene|tazarotene|mesh-list
2671530|NCT02160665|Dermatologic Agents|dermatologic agents|mesh-ancestor
2671531|NCT02160665|Keratolytic Agents|keratolytic agents|mesh-ancestor
2671532|NCT02160678|Tazarotene|tazarotene|mesh-list
2671533|NCT02160678|Dermatologic Agents|dermatologic agents|mesh-ancestor
2671534|NCT02160678|Keratolytic Agents|keratolytic agents|mesh-ancestor
2671535|NCT02160704|Enclomiphene|enclomiphene|mesh-list
2671536|NCT02160704|Clomiphene|clomiphene|mesh-list
2671537|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
2671538|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2671539|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
2671540|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2671541|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671542|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2671543|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
2671544|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2671545|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2671546|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2671547|NCT02160743|Metformin|metformin|mesh-list
2671548|NCT02160743|Atorvastatin|atorvastatin|mesh-list
2671549|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2671550|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671551|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2671552|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2671553|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
2671554|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671555|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2671556|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2671557|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671558|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2671559|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2671560|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671561|NCT02161055|Insulin|insulin|mesh-list
2671562|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2671563|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2671564|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671565|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
2671566|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2671567|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2671568|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2671569|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2671570|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671571|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
2671572|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671573|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671574|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2671575|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671576|NCT02161237|Tacrolimus|tacrolimus|mesh-list
2671577|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2671578|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
2671579|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671580|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2671581|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671582|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671583|NCT02161354|Buprenorphine|buprenorphine|mesh-list
2671584|NCT02161354|Naloxone|naloxone|mesh-list
2671585|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2671586|NCT02161354|Narcotics|narcotics|mesh-ancestor
2671587|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2671588|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671589|NCT02161354|Analgesics|analgesics|mesh-ancestor
2671590|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
2671591|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671592|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2185551|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185552|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185553|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185554|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185555|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185556|NCT00002902|Irinotecan|irinotecan|mesh-list
2185557|NCT00002902|Raltitrexed|raltitrexed|mesh-list
2185558|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2185559|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185560|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185561|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185562|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185563|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185564|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
2185565|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2185566|NCT00002903|Docetaxel|docetaxel|mesh-list
2185567|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185568|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185569|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185570|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185571|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185572|NCT00002904|Trabectedin|trabectedin|mesh-list
2185573|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185574|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
2671593|NCT02161367|Simethicone|simethicone|mesh-list
2671594|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
2671595|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671596|NCT02161367|Emollients|emollients|mesh-ancestor
2671597|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
2671598|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2671599|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2671600|NCT02161614|Estradiol|estradiol|mesh-list
2671601|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2671602|NCT02161614|Estrogens|estrogens|mesh-ancestor
2671603|NCT02161614|Hormones|hormones|mesh-ancestor
2671604|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2671605|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671606|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2671607|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
2671608|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2671609|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2671610|NCT02161653|Pyridoxine|pyridoxine|mesh-list
2671611|NCT02161653|Prednisone|prednisone|mesh-list
2671612|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
2671613|NCT02161653|Metadoxine|metadoxine|mesh-list
2671614|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671615|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
2671616|NCT02161653|Hormones|hormones|mesh-ancestor
2671617|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2671618|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671619|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2671620|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671621|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2671622|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671623|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671624|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2422995|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
2422996|NCT00819845|Protective Agents|protective agents|mesh-ancestor
2422997|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2422998|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2422999|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2423000|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
2423001|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2423002|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2423003|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
2423004|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423005|NCT00819962|Bupivacaine|bupivacaine|mesh-list
2423006|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
2423007|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
2423008|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423009|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423010|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
2423011|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423012|NCT00819975|Caseins|caseins|mesh-list
2423013|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
2671625|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2671626|NCT02161653|Protective Agents|protective agents|mesh-ancestor
2671627|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
2671628|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2671629|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
2671630|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2671631|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
2671632|NCT02161653|Vitamins|vitamins|mesh-ancestor
2671633|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
2671634|NCT02161679|Carboplatin|carboplatin|mesh-list
2671635|NCT02161679|Camptothecin|camptothecin|mesh-list
2671636|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
2185575|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185576|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185577|NCT00002905|Zidovudine|zidovudine|mesh-list
2185578|NCT00002905|Didanosine|didanosine|mesh-list
2185579|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
2185580|NCT00002905|Prednimustine|prednimustine|mesh-list
2185581|NCT00002905|Doxorubicin|doxorubicin|mesh-list
2185582|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2671637|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671638|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2671639|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2671640|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2671641|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671642|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671643|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
2671644|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671645|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
2671646|NCT02161692|Carboplatin|carboplatin|mesh-list
2671647|NCT02161692|Etoposide|etoposide|mesh-list
2671648|NCT02161692|Bleomycin|bleomycin|mesh-list
2671649|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2671650|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
2671651|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671652|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2671653|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2671654|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
2671655|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671656|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671657|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2671658|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2671659|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2671660|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2671661|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671662|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2671663|NCT02161770|Osimertinib|osimertinib|mesh-list
2671664|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671665|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2671666|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671667|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671668|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
2671669|NCT02161783|Fludarabine|fludarabine|mesh-list
2671670|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2671671|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
2671672|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671673|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2671674|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2671675|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
2671676|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671677|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671678|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2671679|NCT02161822|Simvastatin|simvastatin|mesh-list
2671680|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2671681|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2671682|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
2671683|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671684|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2671685|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2671686|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671687|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
2671688|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
2671689|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2671690|NCT02161952|Pirfenidone|pirfenidone|mesh-list
2671691|NCT02161952|Analgesics|analgesics|mesh-ancestor
2671692|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
2185583|NCT00002905|Etoposide|etoposide|mesh-list
2671693|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671694|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671695|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2671696|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2671697|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671698|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2671699|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671700|NCT02161965|Warfarin|warfarin|mesh-list
2671701|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
2671702|NCT02161965|Fluindione|fluindione|mesh-list
2671703|NCT02161965|Phenindione|phenindione|mesh-list
2671704|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
2671705|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2671706|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
2671707|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2671708|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
2671709|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671710|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671711|NCT02161991|Aprepitant|aprepitant|mesh-list
2671712|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
2671713|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
2671714|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671715|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671716|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2671717|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2671718|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671719|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671720|NCT02162121|Ketorolac|ketorolac|mesh-list
2671721|NCT02162121|Buprenorphine|buprenorphine|mesh-list
2671722|NCT02162121|Anesthetics|anesthetics|mesh-list
2671723|NCT02162121|Ropivacaine|ropivacaine|mesh-list
2671724|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
2671725|NCT02162121|Mepivacaine|mepivacaine|mesh-list
2671726|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
2671727|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2671728|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671729|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
2671730|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671731|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2671732|NCT02162121|Narcotics|narcotics|mesh-ancestor
2671733|NCT02162121|Analgesics|analgesics|mesh-ancestor
2671734|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2671735|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2671736|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2671737|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671738|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2671739|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2671740|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671741|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671742|NCT02162134|Cefuroxime|cefuroxime|mesh-list
2671743|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
2671744|NCT02162134|Ketorolac|ketorolac|mesh-list
2671745|NCT02162134|Midazolam|midazolam|mesh-list
2671746|NCT02162134|Propofol|propofol|mesh-list
2671747|NCT02162134|Sevoflurane|sevoflurane|mesh-list
2671748|NCT02162134|Atracurium|atracurium|mesh-list
2671749|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2671750|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2671751|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671752|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2671753|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
2671754|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
2671755|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2671756|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2671757|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2671758|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2671759|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
2671760|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
2671761|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671762|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671763|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2671764|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2671765|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2671766|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2671767|NCT02162134|Analgesics|analgesics|mesh-ancestor
2671768|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
2671769|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671770|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671771|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2671772|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2671773|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671774|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2671775|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2671776|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2671777|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2671778|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2671779|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2671780|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2671781|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
2671782|NCT02162251|Donepezil|donepezil|mesh-list
2671783|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2671784|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671785|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671786|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
2185584|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
2185585|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185586|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
2671787|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671788|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671789|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
2671790|NCT02162264|Donepezil|donepezil|mesh-list
2671791|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2671792|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671793|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671794|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
2671795|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671796|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671797|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
2185587|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185588|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185589|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185590|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
2185591|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185592|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185593|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2185594|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2185595|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185596|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185597|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671798|NCT02162303|Colchicine|colchicine|mesh-list
2671799|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
2671800|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2671801|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
2671802|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
2671803|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
2671804|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671805|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671806|NCT02162381|Methylphenidate|methylphenidate|mesh-list
2671807|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2671808|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671809|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2671810|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2671811|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2671812|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671813|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
2671814|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671815|NCT02162407|Insulin|insulin|mesh-list
2671816|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2671817|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
2671818|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2671819|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671834|NCT02162485|Fluticasone|fluticasone|mesh-list
2671835|NCT02162485|Xhance|xhance|mesh-list
2185598|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185599|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
2185600|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2185601|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2185602|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
2185603|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185604|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2185605|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2671836|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2671837|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2671838|NCT02162485|Charcoal|charcoal|mesh-list
2671839|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671840|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2671841|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
2671842|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671843|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671844|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2671845|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
2671846|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
2671847|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2671848|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2671849|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2671850|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2671851|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
2671852|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671853|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671854|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
2671855|NCT02162485|Hormones|hormones|mesh-ancestor
2671856|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2671857|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
2671858|NCT02162485|Antidotes|antidotes|mesh-ancestor
2671859|NCT02162485|Protective Agents|protective agents|mesh-ancestor
2671860|NCT02162537|Bevacizumab|bevacizumab|mesh-list
2671861|NCT02162537|Pemetrexed|pemetrexed|mesh-list
2671862|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2671863|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671864|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2671865|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2671866|NCT02162537|Growth Substances|growth substances|mesh-ancestor
2671867|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671868|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
2671869|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671870|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671871|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2671872|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2671873|NCT02162550|Exenatide|exenatide|mesh-list
2671874|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2671875|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671876|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2671877|NCT02162550|Incretins|incretins|mesh-ancestor
2671878|NCT02162550|Hormones|hormones|mesh-ancestor
2671879|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2671880|NCT02162563|Leucovorin|leucovorin|mesh-list
2671881|NCT02162563|Bevacizumab|bevacizumab|mesh-list
2671882|NCT02162563|Panitumumab|panitumumab|mesh-list
2671883|NCT02162563|Fluorouracil|fluorouracil|mesh-list
2671884|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
2671885|NCT02162563|Irinotecan|irinotecan|mesh-list
2671886|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
2671887|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2671888|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671889|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2671890|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2671891|NCT02162563|Growth Substances|growth substances|mesh-ancestor
2671892|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671893|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
2671894|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
2671895|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671896|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2671897|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2671898|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
2671899|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2671900|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2671901|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671902|NCT02162563|Antidotes|antidotes|mesh-ancestor
2671903|NCT02162563|Protective Agents|protective agents|mesh-ancestor
2671904|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
2671905|NCT02162563|Vitamins|vitamins|mesh-ancestor
2671906|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
2671907|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
2671908|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2671909|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
2671910|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671911|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
2671912|NCT02162693|Protective Agents|protective agents|mesh-ancestor
2671913|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2671914|NCT02162784|Budesonide|budesonide|mesh-list
2671915|NCT02162784|Albuterol|albuterol|mesh-list
2671916|NCT02162784|Procaterol|procaterol|mesh-list
2671917|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671918|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2671919|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
2671920|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671921|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671922|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2671923|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
2671924|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
2671925|NCT02162784|Hormones|hormones|mesh-ancestor
2671926|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2671927|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
2671928|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2671929|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2671930|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2671931|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2671932|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
2671933|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671934|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671935|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
2671936|NCT02162797|Zinc|zinc|mesh-list
2671937|NCT02162797|Trace Elements|trace elements|mesh-ancestor
2671938|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
2671939|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671940|NCT02162810|Prednisolone|prednisolone|mesh-list
2671941|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2671942|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
2671943|NCT02162810|Hormones|hormones|mesh-ancestor
2671944|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2185606|NCT00002905|Analgesics|analgesics|mesh-ancestor
2185607|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
2185608|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2185609|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
2185610|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2185611|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
2185612|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185613|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671945|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671946|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2671947|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671948|NCT02162849|Nicotine|nicotine|mesh-list
2671949|NCT02162849|Varenicline|varenicline|mesh-list
2185614|NCT00002908|Vincristine|vincristine|mesh-list
2185615|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
2185616|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185617|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185618|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185619|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185620|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185621|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185622|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2185623|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
2185624|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185625|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2185626|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671950|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2671951|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
2671952|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2671953|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671954|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2671955|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2671956|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
2671957|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2671958|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671959|NCT02162875|Praziquantel|praziquantel|mesh-list
2671960|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
2671961|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2671962|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2671963|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2671964|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2671965|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
2671966|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671967|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2671968|NCT02162966|Colistin|colistin|mesh-list
2671969|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2671970|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2671971|NCT02163070|Vitamins|vitamins|mesh-list
2671972|NCT02163070|Vitamin E|vitamin e|mesh-list
2671973|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
2671974|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671975|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
2671976|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671977|NCT02163070|Protective Agents|protective agents|mesh-ancestor
2671978|NCT02163161|Abrocitinib|abrocitinib|mesh-list
2671979|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2671980|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671981|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671982|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
2185627|NCT00002911|Marimastat|marimastat|mesh-list
2185628|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185629|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671983|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2671984|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2671985|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2671986|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2671987|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2671988|NCT02163174|Protective Agents|protective agents|mesh-ancestor
2671989|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671990|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
2671991|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2671992|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
2671993|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
2671994|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2671995|NCT02163213|Antibodies|antibodies|mesh-list
2671996|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
2671997|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2671998|NCT02163291|Paclitaxel|paclitaxel|mesh-list
2671999|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2672000|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672001|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
2672002|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
2672003|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
2672004|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672005|NCT02163330|Acetazolamide|acetazolamide|mesh-list
2672006|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
2672007|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2672008|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672009|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672010|NCT02163330|Diuretics|diuretics|mesh-ancestor
2672011|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
2672012|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672013|NCT02163356|Ketoconazole|ketoconazole|mesh-list
2672014|NCT02163356|Vincristine|vincristine|mesh-list
2672015|NCT02163356|Fenretinide|fenretinide|mesh-list
2672016|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2672017|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672018|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
2672019|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
2672020|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
2672021|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672022|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
2672023|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672024|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2185630|NCT00002912|Etoposide|etoposide|mesh-list
2672025|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2672026|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672027|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2672028|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
2672029|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2672030|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672031|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2672032|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2672033|NCT02163356|Protective Agents|protective agents|mesh-ancestor
2672034|NCT02163616|Misoprostol|misoprostol|mesh-list
2672035|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2672036|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
2672037|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2672038|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672039|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2672040|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2672041|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
2672042|NCT02163655|Furosemide|furosemide|mesh-list
2672043|NCT02163655|Diuretics|diuretics|mesh-ancestor
2672044|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
2672045|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672046|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2672047|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2672048|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672060|NCT02163707|Psilocybin|psilocybin|mesh-list
2672061|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
2672062|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672063|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2672064|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2672065|NCT02163720|Doxorubicin|doxorubicin|mesh-list
2672066|NCT02163720|Trabectedin|trabectedin|mesh-list
2672067|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2672068|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672069|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2672070|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2672071|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672072|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672073|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2672074|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
2672075|NCT02163954|Clopidogrel|clopidogrel|mesh-list
2672076|NCT02163954|Ticagrelor|ticagrelor|mesh-list
2672077|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2672078|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2672079|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2672080|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2672081|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
2672082|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672083|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672084|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672085|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
2672086|NCT02163980|Ropivacaine|ropivacaine|mesh-list
2672087|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2672088|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672089|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672090|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2672091|NCT02163980|Analgesics|analgesics|mesh-ancestor
2672092|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
2672093|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672094|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2672095|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2672096|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2672097|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
2672098|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672099|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672100|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
2672101|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
2672102|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2672103|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2672104|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2672105|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672106|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
2672107|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672108|NCT02164032|Insulin|insulin|mesh-list
2672109|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2672110|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2672111|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672112|NCT02164045|Fostemsavir|fostemsavir|mesh-list
2672113|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2672114|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2672115|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
2672116|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672117|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2672118|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2672119|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672120|NCT02164097|Heparin|heparin|mesh-list
2672121|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
2672122|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2672123|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2672124|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672125|NCT02164110|Vaccines|vaccines|mesh-list
2672126|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
2672127|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672128|NCT02164214|Etanercept|etanercept|mesh-list
2672129|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2672130|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2672131|NCT02164214|Analgesics|analgesics|mesh-ancestor
2672132|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
2672133|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672134|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672135|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2672136|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2672137|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2672138|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2672139|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
2185631|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
2185632|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185633|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185634|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185635|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185636|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185637|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185638|NCT00002912|Analgesics|analgesics|mesh-ancestor
2185639|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
2185640|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2185641|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185642|NCT00002913|Paclitaxel|paclitaxel|mesh-list
2185643|NCT00002913|Topotecan|topotecan|mesh-list
2185644|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185645|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185646|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185647|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185648|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185649|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185650|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2185651|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185652|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185653|NCT00002914|Piritrexim|piritrexim|mesh-list
2185654|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185655|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2185656|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185657|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185658|NCT00002915|Penclomedine|penclomedine|mesh-list
2185659|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672140|NCT02164253|Deferiprone|deferiprone|mesh-list
2672141|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2672142|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
2672143|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
2672144|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672145|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
2672146|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2672147|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672148|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
2672149|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2672150|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672151|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672152|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2672153|NCT02164448|Analgesics|analgesics|mesh-ancestor
2672154|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
2672155|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672156|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2185660|NCT00002917|Paclitaxel|paclitaxel|mesh-list
2185661|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185662|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185663|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185664|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185665|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185666|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185667|NCT00002919|Doxorubicin|doxorubicin|mesh-list
2185668|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2185669|NCT00002919|Methotrexate|methotrexate|mesh-list
2185670|NCT00002919|Vinblastine|vinblastine|mesh-list
2672157|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2672158|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2672159|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
2672160|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672161|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672162|NCT02164552|Vitamin D|vitamin d|mesh-list
2672163|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
2672164|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
2672165|NCT02164552|Vitamins|vitamins|mesh-list
2672166|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
2672167|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672168|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2672169|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2672170|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
2672171|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2672172|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2672173|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672174|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
2672175|NCT02164565|Coagulants|coagulants|mesh-ancestor
2672176|NCT02164578|Aspirin|aspirin|mesh-list
2672177|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
2672178|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2672179|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2672180|NCT02164578|Analgesics|analgesics|mesh-ancestor
2672181|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
2672182|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672183|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672184|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2672185|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2672186|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2672187|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2672188|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672189|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2672190|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2672191|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672192|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
2672193|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2672194|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
2672195|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2672196|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
2672197|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
2672198|NCT02164604|Ranibizumab|ranibizumab|mesh-list
2672199|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2672200|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2672201|NCT02164604|Growth Substances|growth substances|mesh-ancestor
2672202|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672203|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
2672204|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672205|NCT02164643|Flutemetamol|flutemetamol|mesh-list
2672206|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2672207|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672208|NCT02164734|Remifentanil|remifentanil|mesh-list
2672209|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2672210|NCT02164734|Narcotics|narcotics|mesh-ancestor
2672211|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672212|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672213|NCT02164734|Analgesics|analgesics|mesh-ancestor
2672214|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
2672215|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672216|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
2672217|NCT02164773|Analgesics|analgesics|mesh-ancestor
2672218|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
2672219|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672220|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672221|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
2672222|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672223|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2672224|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
2672225|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2672226|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2672227|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672228|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2672229|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
2672230|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2672231|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
2672232|NCT02164812|Efavirenz|efavirenz|mesh-list
2672233|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2672234|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672235|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2672236|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2672237|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672238|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672239|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672240|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2672241|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2672242|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
2672243|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2672244|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2672245|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2672246|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2672247|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2672248|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2672249|NCT02164825|Morphine|morphine|mesh-list
2672250|NCT02164825|Ropivacaine|ropivacaine|mesh-list
2672251|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2185671|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185672|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2185673|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185674|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185675|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185676|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185677|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2185678|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
2185679|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2423014|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
2672252|NCT02164825|Narcotics|narcotics|mesh-ancestor
2672253|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672254|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672255|NCT02164825|Analgesics|analgesics|mesh-ancestor
2672256|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
2423015|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423016|NCT00819988|Pregabalin|pregabalin|mesh-list
2423017|NCT00819988|Analgesics|analgesics|mesh-ancestor
2423018|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
2423019|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423020|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423021|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
2423022|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2423023|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2423024|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423025|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2423026|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2423027|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2423028|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672257|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672258|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
2672259|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
2672260|NCT02164838|Axitinib|axitinib|mesh-list
2672261|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672262|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2672263|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672264|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672265|NCT02164890|Micafungin|micafungin|mesh-list
2672266|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
2672267|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185680|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185681|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185682|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
2185683|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
2185684|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2185685|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2672268|NCT02164955|Pomalidomide|pomalidomide|mesh-list
2672269|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
2672270|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672271|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2672272|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2672273|NCT02164955|Growth Substances|growth substances|mesh-ancestor
2672274|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
2672275|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672276|NCT02165007|Sirolimus|sirolimus|mesh-list
2672277|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2672278|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672279|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2672280|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672281|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
2672282|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2672283|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
2672284|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672285|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
2672286|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2672287|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
2672288|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672289|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
2672290|NCT02165020|Protective Agents|protective agents|mesh-ancestor
2672291|NCT02165033|Budesonide|budesonide|mesh-list
2672292|NCT02165033|Procaterol|procaterol|mesh-list
2672293|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2672294|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2672295|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
2672296|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672297|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672298|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2672299|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
2672300|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
2672301|NCT02165033|Hormones|hormones|mesh-ancestor
2672302|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2672303|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
2672304|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2672305|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2672306|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2672307|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
2672308|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672309|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672310|NCT02165046|Budesonide|budesonide|mesh-list
2672311|NCT02165046|Procaterol|procaterol|mesh-list
2672312|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2672313|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2672314|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
2672315|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672316|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672317|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2672318|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
2672319|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
2672320|NCT02165046|Hormones|hormones|mesh-ancestor
2672321|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2672322|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
2672323|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2672324|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2672325|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2672326|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
2672327|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672328|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672329|NCT02165098|Cariprazine|cariprazine|mesh-list
2672330|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2672331|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2672332|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672333|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672334|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2672335|NCT02165189|Ribavirin|ribavirin|mesh-list
2672336|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
2672337|NCT02165189|Simeprevir|simeprevir|mesh-list
2672338|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
2672339|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672340|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
2672341|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672342|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
2672343|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672344|NCT02165215|Etrolizumab|etrolizumab|mesh-list
2672345|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2672346|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
2672347|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672348|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
2672349|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2672350|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2672351|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672352|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2672353|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185686|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
2185687|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185688|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2672354|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672355|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672356|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672357|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2672358|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
2672359|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2672360|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672361|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2672362|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2672363|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2672364|NCT02165449|Ketamine|ketamine|mesh-list
2672365|NCT02165449|Analgesics|analgesics|mesh-ancestor
2672366|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
2672367|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672368|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672369|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2672370|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2672371|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
2672372|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
2672373|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672374|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2672375|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2672376|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672377|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672378|NCT02165475|Loperamide|loperamide|mesh-list
2672379|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
2672380|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2672381|NCT02165566|Insulin|insulin|mesh-list
2672382|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2672383|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
2672384|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2672385|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672386|NCT02165644|Nimodipine|nimodipine|mesh-list
2672387|NCT02165644|Acetazolamide|acetazolamide|mesh-list
2672388|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
2672389|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2672390|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672391|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672392|NCT02165644|Diuretics|diuretics|mesh-ancestor
2672393|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
2672394|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672395|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2672396|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2672397|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2672398|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2672399|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
2672400|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
2672401|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672402|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672403|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
2672404|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2672405|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672406|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
2672407|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2672408|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
2672409|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185689|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185690|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185691|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185692|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185693|NCT00002920|Tamoxifen|tamoxifen|mesh-list
2185694|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2185695|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
2185696|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2185697|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
2185698|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2423029|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2672410|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
2672411|NCT02165917|Protective Agents|protective agents|mesh-ancestor
2672412|NCT02165930|Naltrexone|naltrexone|mesh-list
2672413|NCT02165930|Oxycodone|oxycodone|mesh-list
2672414|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2672415|NCT02165930|Narcotics|narcotics|mesh-ancestor
2672416|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672417|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672418|NCT02165930|Analgesics|analgesics|mesh-ancestor
2672419|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
2672420|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672421|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2672422|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2672423|NCT02166229|Valproic Acid|valproic acid|mesh-list
2672424|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
2672425|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672426|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672427|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
2672428|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672429|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672430|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
2672431|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2672432|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423030|NCT00820053|Epirubicin|epirubicin|mesh-list
2423031|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
2423032|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2423033|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423034|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2423035|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2423036|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423037|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423038|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
2423039|NCT00820092|Hormones|hormones|mesh-ancestor
2423040|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2423041|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423042|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2423043|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2423044|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2423045|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2423046|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423047|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423048|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
2423049|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423050|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2423051|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2423052|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2423053|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2423054|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
2423055|NCT00820300|Latanoprost|latanoprost|mesh-list
2423056|NCT00820300|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2423057|NCT00820300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2423058|NCT00820326|Dolasetron|dolasetron|mesh-list
2672433|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2672434|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2672435|NCT02166359|Icodextrin|icodextrin|mesh-list
2672436|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
2672437|NCT02166450|Nystatin|nystatin|mesh-list
2672438|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2672439|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672440|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
2672441|NCT02166450|Ionophores|ionophores|mesh-ancestor
2672442|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2672443|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672497|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
2672498|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2672499|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
2672500|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672501|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
2672502|NCT02166554|Protective Agents|protective agents|mesh-ancestor
2672503|NCT02166593|Atorvastatin|atorvastatin|mesh-list
2672504|NCT02166593|Pravastatin|pravastatin|mesh-list
2672505|NCT02166593|Fenofibrate|fenofibrate|mesh-list
2672506|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2672507|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2672508|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
2672509|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672510|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2185699|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185700|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2185701|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672511|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2672512|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672513|NCT02166632|Bupivacaine|bupivacaine|mesh-list
2672514|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
2672515|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
2672516|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2185702|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2185703|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2185704|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2185705|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2185706|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2185707|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2185708|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
2185709|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2185710|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2185711|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2672517|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672518|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
2672519|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672520|NCT02166671|Vaccines|vaccines|mesh-list
2672521|NCT02166671|Immunologic Factors|immunologic factors|mesh-ancestor
2672522|NCT02166671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672523|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2672524|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2672525|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2672526|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
2672527|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672528|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2672529|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2672530|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672531|NCT02166853|Midazolam|midazolam|mesh-list
2672532|NCT02166853|Sevoflurane|sevoflurane|mesh-list
2672533|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2672534|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2672535|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672536|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672537|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2672538|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2672539|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2672540|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2672541|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
2672542|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
2672543|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
2672544|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
2672545|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672546|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672547|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2672548|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2672549|NCT02166905|Poly I-C|poly i-c|mesh-list
2672550|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2672551|NCT02166905|Poly ICLC|poly iclc|mesh-list
2672552|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
2672553|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
2672554|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672555|NCT02166905|Laxatives|laxatives|mesh-ancestor
2672556|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2672557|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
2672558|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672559|NCT02166944|Tamoxifen|tamoxifen|mesh-list
2672560|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2672561|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
2672562|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2672563|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672564|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2672565|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672566|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2672567|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2185712|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2185713|NCT00002921|Suramin|suramin|mesh-list
2185714|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
2185715|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2672568|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2672569|NCT02167061|Metformin|metformin|mesh-list
2672570|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2672571|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672572|NCT02167165|Digoxin|digoxin|mesh-list
2672573|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2672574|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2672575|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672576|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672577|NCT02167165|Protective Agents|protective agents|mesh-ancestor
2672578|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672579|NCT02167178|Polygeline|polygeline|mesh-list
2672580|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
2672581|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
2672582|NCT02167321|Leucovorin|leucovorin|mesh-list
2672583|NCT02167321|Fluorouracil|fluorouracil|mesh-list
2672584|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
2672585|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
2672586|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672587|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2672588|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672589|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2672590|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
2672591|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672592|NCT02167321|Antidotes|antidotes|mesh-ancestor
2672593|NCT02167321|Protective Agents|protective agents|mesh-ancestor
2672594|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
2672595|NCT02167321|Vitamins|vitamins|mesh-ancestor
2672596|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
2672597|NCT02167425|Methadone|methadone|mesh-list
2672598|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2672599|NCT02167425|Narcotics|narcotics|mesh-ancestor
2672600|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672601|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672602|NCT02167425|Analgesics|analgesics|mesh-ancestor
2672603|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
2672604|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672605|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
2672606|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
2672607|NCT02167464|Coal Tar|coal tar|mesh-list
2672608|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
2672609|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
2672610|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
2672611|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
2672612|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2672613|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672614|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2672615|NCT02167464|Diuretics|diuretics|mesh-ancestor
2672616|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
2672617|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
2672618|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
2672619|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
2672620|NCT02167620|Metformin|metformin|mesh-list
2672621|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2672622|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672623|NCT02167633|Pantoprazole|pantoprazole|mesh-list
2672624|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2672625|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
2672626|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2672627|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2672628|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672629|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672630|NCT02167633|Hormones|hormones|mesh-ancestor
2672631|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2672632|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672633|NCT02167685|Brincidofovir|brincidofovir|mesh-list
2672634|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
2672635|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672636|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
2672637|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2672638|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2672639|NCT02167698|Prednisolone|prednisolone|mesh-list
2672640|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
2672641|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2672642|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
2672643|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2672644|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
2672645|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
2672646|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672647|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672648|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2672649|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
2672650|NCT02167698|Hormones|hormones|mesh-ancestor
2672651|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2672652|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2672653|NCT02167698|Protective Agents|protective agents|mesh-ancestor
2672654|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2672655|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672656|NCT02167763|Copper|copper|mesh-list
2672657|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
2672658|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2672659|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672660|NCT02167763|Trace Elements|trace elements|mesh-ancestor
2672661|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
2672662|NCT02167854|Trastuzumab|trastuzumab|mesh-list
2672663|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2672664|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672665|NCT02167945|Ribavirin|ribavirin|mesh-list
2672666|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
2672667|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672668|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
2672669|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672670|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
2672671|NCT02167958|Fludarabine|fludarabine|mesh-list
2672672|NCT02167958|Tacrolimus|tacrolimus|mesh-list
2672673|NCT02167958|Sargramostim|sargramostim|mesh-list
2672674|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2672675|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
2672676|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672677|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2672678|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2672679|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
2672680|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672681|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672682|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2672683|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2672684|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672685|NCT02168010|Neurotropin|neurotropin|mesh-list
2672686|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2672687|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
2672688|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672689|NCT02168010|Analgesics|analgesics|mesh-ancestor
2672690|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
2672691|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672692|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
2672693|NCT02168075|Mannitol|mannitol|mesh-list
2672694|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2672695|NCT02168075|Diuretics|diuretics|mesh-ancestor
2672696|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
2672697|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672698|NCT02168127|Methylphenidate|methylphenidate|mesh-list
2672699|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2672700|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672701|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2672702|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2672703|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2672704|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672705|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
2672706|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672707|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
2672708|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2672709|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2672710|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
2672711|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672712|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672713|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
2672714|NCT02168140|Protective Agents|protective agents|mesh-ancestor
2672715|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672716|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
2672717|NCT02168140|Vitamins|vitamins|mesh-ancestor
2672718|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
2672719|NCT02168205|Pomalidomide|pomalidomide|mesh-list
2672720|NCT02168205|Caffeine|caffeine|mesh-list
2672721|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2672722|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672723|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2672724|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672725|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672726|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2672727|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2672728|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
2185716|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2185717|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2185718|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2185719|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
2185720|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
2185721|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2185722|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185723|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185724|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2185725|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2185726|NCT00002922|Paclitaxel|paclitaxel|mesh-list
2185727|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185728|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672729|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672730|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
2672731|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2672732|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2672733|NCT02168205|Growth Substances|growth substances|mesh-ancestor
2672734|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
2672735|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185729|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185730|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185731|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185732|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185733|NCT00002923|KRN 5500|krn 5500|mesh-list
2185734|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185735|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2185736|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185737|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185738|NCT00002925|Aldesleukin|aldesleukin|mesh-list
2185739|NCT00002925|Etoposide|etoposide|mesh-list
2185740|NCT00002925|Daunorubicin|daunorubicin|mesh-list
2185741|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185742|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185743|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185744|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2672736|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
2672737|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2672738|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
2672739|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672740|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
2672741|NCT02168426|Protective Agents|protective agents|mesh-ancestor
2672742|NCT02168543|Alendronate|alendronate|mesh-list
2672743|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2672744|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672745|NCT02168569|Artesunate|artesunate|mesh-list
2672746|NCT02168569|Lumefantrine|lumefantrine|mesh-list
2672747|NCT02168569|Artemether|artemether|mesh-list
2672748|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2672749|NCT02168569|Amodiaquine|amodiaquine|mesh-list
2672750|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
2672751|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2672752|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2672753|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672754|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672755|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
2672756|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
2672757|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2672758|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
2672759|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
2672760|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2672761|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2672762|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672763|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
2672764|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672765|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672766|NCT02168751|Propofol|propofol|mesh-list
2672767|NCT02168751|Sevoflurane|sevoflurane|mesh-list
2672768|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2672769|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672770|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672771|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2672772|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
2672773|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
2672774|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2672775|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2672776|NCT02168829|Aspirin|aspirin|mesh-list
2672777|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
2672778|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2672779|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2672780|NCT02168829|Analgesics|analgesics|mesh-ancestor
2672781|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
2672782|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672783|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672784|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2672785|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2672786|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2672787|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2672788|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672789|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2672790|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2672791|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672792|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
2672793|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2672794|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
2672795|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2672796|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
2672797|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
2672798|NCT02168881|Misoprostol|misoprostol|mesh-list
2672799|NCT02168881|Dinoprostone|dinoprostone|mesh-list
2672800|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2672801|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
2672802|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2672803|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672804|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2672805|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2672806|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
2672807|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
2672808|NCT02168907|Rituximab|rituximab|mesh-list
2672809|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2672810|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2672811|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672812|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
2672813|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672814|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2672815|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2672816|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
2672817|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672818|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
2672819|NCT02168907|Protective Agents|protective agents|mesh-ancestor
2672820|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
2672821|NCT02168907|Vitamins|vitamins|mesh-ancestor
2672822|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
2672823|NCT02168959|Bupivacaine|bupivacaine|mesh-list
2423059|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
2423060|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
2423061|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423062|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423063|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2423064|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2423065|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
2423066|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423067|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672824|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
2672825|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
2672826|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672827|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672828|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
2672829|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672830|NCT02169063|Listerine|listerine|mesh-list
2672831|NCT02169063|Fluorides|fluorides|mesh-list
2672832|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
2672833|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
2672834|NCT02169063|Protective Agents|protective agents|mesh-ancestor
2672835|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672836|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2672837|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672838|NCT02169089|Spironolactone|spironolactone|mesh-list
2672839|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2672840|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
2672841|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2672842|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672843|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2672844|NCT02169089|Diuretics|diuretics|mesh-ancestor
2672845|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
2672846|NCT02169154|Diclofenac|diclofenac|mesh-list
2672847|NCT02169154|Menthol|menthol|mesh-list
2672848|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2672849|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2672850|NCT02169154|Analgesics|analgesics|mesh-ancestor
2672851|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
2672852|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672853|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672854|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2672855|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2672856|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2672857|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672858|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672859|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
2672860|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
2672861|NCT02169167|Octenidine|octenidine|mesh-list
2672862|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672863|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2185745|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185746|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185747|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2185748|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2185749|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2185750|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
2185751|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185752|NCT00002926|Cytarabine|cytarabine|mesh-list
2185753|NCT00002926|Etoposide|etoposide|mesh-list
2185754|NCT00002926|Idarubicin|idarubicin|mesh-list
2185755|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185756|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185757|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185758|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185759|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185760|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185761|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185762|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
2185763|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
2185764|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185765|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185766|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
2185767|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185768|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2185769|NCT00002928|Paclitaxel|paclitaxel|mesh-list
2185770|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185771|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185772|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185773|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185774|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185775|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185776|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2185777|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2185778|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185779|NCT00002932|Cisplatin|cisplatin|mesh-list
2185780|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672864|NCT02169544|Abatacept|abatacept|mesh-list
2672865|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2672866|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672867|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672868|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2672869|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
2672870|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672871|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2672872|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
2672873|NCT02169570|Vitamin D|vitamin d|mesh-list
2672874|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
2672875|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
2185781|NCT00002933|Irinotecan|irinotecan|mesh-list
2672876|NCT02169570|Vitamins|vitamins|mesh-list
2672877|NCT02169570|Calcium|calcium|mesh-list
2672878|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
2672879|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672880|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2672881|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2672882|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2672883|NCT02169596|Ticagrelor|ticagrelor|mesh-list
2672884|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2672885|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2672886|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2672887|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2672888|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
2672889|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672890|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672891|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672892|NCT02169609|Interleukin-2|interleukin-2|mesh-list
2672893|NCT02169609|Dinutuximab|dinutuximab|mesh-list
2672894|NCT02169609|Isotretinoin|isotretinoin|mesh-list
2672895|NCT02169609|Sargramostim|sargramostim|mesh-list
2672896|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672897|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2672898|NCT02169609|Analgesics|analgesics|mesh-ancestor
2672899|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
2672900|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672901|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672902|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
2672903|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
2672904|NCT02169648|Ranibizumab|ranibizumab|mesh-list
2672905|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2672906|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2672907|NCT02169648|Growth Substances|growth substances|mesh-ancestor
2672908|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672909|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
2672910|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2672911|NCT02169713|Tamsulosin|tamsulosin|mesh-list
2672912|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
2672913|NCT02169713|Mirabegron|mirabegron|mesh-list
2672914|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2672915|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2672916|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2672917|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
2672918|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672919|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672920|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672921|NCT02169713|Urological Agents|urological agents|mesh-ancestor
2672922|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2672923|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2672924|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
2672925|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2672926|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2672927|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2672928|NCT02169752|Ambrisentan|ambrisentan|mesh-list
2672929|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2672930|NCT02169804|Enclomiphene|enclomiphene|mesh-list
2672931|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2672932|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
2672933|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2672934|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672935|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2672936|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
2672937|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2672938|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2672939|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2672940|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
2672941|NCT02169843|Sevoflurane|sevoflurane|mesh-list
2672942|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2672943|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672944|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672945|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2672946|NCT02169843|Analgesics|analgesics|mesh-ancestor
2672947|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
2672948|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672949|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2672950|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2672951|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2672952|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
2672953|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2185782|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2185783|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185784|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185785|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185786|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185787|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2185788|NCT00002935|Trioxsalen|trioxsalen|mesh-list
2185789|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185790|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
2185791|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2185792|NCT00002936|Etoposide|etoposide|mesh-list
2185793|NCT00002936|Altretamine|altretamine|mesh-list
2185794|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185795|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185796|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185797|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185798|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185799|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185800|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185801|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
2185802|NCT00002937|Paclitaxel|paclitaxel|mesh-list
2185803|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185804|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185805|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185806|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185807|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185808|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185809|NCT00002939|Paclitaxel|paclitaxel|mesh-list
2185810|NCT00002939|Irinotecan|irinotecan|mesh-list
2185811|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185812|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185813|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185814|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185815|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185816|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672954|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672955|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2672956|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2672957|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
2672958|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
2672959|NCT02169856|Cefuroxime|cefuroxime|mesh-list
2672960|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
2672961|NCT02169856|Ketorolac|ketorolac|mesh-list
2672962|NCT02169856|Midazolam|midazolam|mesh-list
2672963|NCT02169856|Propofol|propofol|mesh-list
2672964|NCT02169856|Sevoflurane|sevoflurane|mesh-list
2672965|NCT02169856|Atracurium|atracurium|mesh-list
2672966|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2672967|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2672968|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2672969|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2672970|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
2672971|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
2672972|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2672973|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2672974|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2672975|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2185817|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2185818|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185819|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185820|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
2672976|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
2672977|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
2672978|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2672979|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2672980|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2672981|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2672982|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2672983|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2672984|NCT02169856|Analgesics|analgesics|mesh-ancestor
2672985|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
2672986|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2672987|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2672988|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185821|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185822|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
2185823|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185824|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185825|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2185826|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
2185827|NCT00002941|Carmustine|carmustine|mesh-list
2185828|NCT00002941|Etoposide|etoposide|mesh-list
2672989|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2672990|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2672991|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2672992|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2672993|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2672994|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2672995|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2672996|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2672997|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2672998|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
2672999|NCT02169882|Rifampin|rifampin|mesh-list
2673000|NCT02169882|Dexamethasone|dexamethasone|mesh-list
2673001|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2673002|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
2673003|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
2673004|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673005|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673006|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2673007|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
2673008|NCT02169882|Hormones|hormones|mesh-ancestor
2673009|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2673010|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2673011|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673012|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2673013|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
2673014|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2673015|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2673016|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
2673017|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2673018|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673019|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673020|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2673021|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2673022|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2673023|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2673024|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2673025|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2673026|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
2673027|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673028|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673029|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2673030|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2673031|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2673032|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
2673033|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2673034|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673035|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2673036|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2673037|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2673038|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2673039|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2673040|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2673041|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2673042|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2673043|NCT02170090|Gemcitabine|gemcitabine|mesh-list
2673044|NCT02170090|Capecitabine|capecitabine|mesh-list
2673045|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673046|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185829|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185830|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
2185831|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185832|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185833|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2673047|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
2673048|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673049|NCT02170090|Antiviral Agents|antiviral agents|mesh-ancestor
2673050|NCT02170090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2673051|NCT02170090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673052|NCT02170090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2673053|NCT02170090|Immunologic Factors|immunologic factors|mesh-ancestor
2673054|NCT02170090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673055|NCT02170116|Dabigatran|dabigatran|mesh-list
2673056|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
2673057|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673058|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673059|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673060|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673061|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
2673062|NCT02170246|Telmisartan|telmisartan|mesh-list
2673063|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2673064|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2673065|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2673066|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673067|NCT02170324|Exenatide|exenatide|mesh-list
2673068|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2673069|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673070|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2673071|NCT02170324|Incretins|incretins|mesh-ancestor
2673072|NCT02170324|Hormones|hormones|mesh-ancestor
2673073|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2673074|NCT02170402|Factor VIII|factor viii|mesh-list
2673075|NCT02170402|Coagulants|coagulants|mesh-ancestor
2673076|NCT02170415|Pregabalin|pregabalin|mesh-list
2673077|NCT02170415|Anesthetics|anesthetics|mesh-list
2673078|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
2673079|NCT02170415|Analgesics|analgesics|mesh-ancestor
2673080|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
2673081|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673082|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673083|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
2673084|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2673085|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2673086|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673087|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2673088|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2673089|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2673090|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2673091|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2673092|NCT02170571|Dabigatran|dabigatran|mesh-list
2673093|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
2673094|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673095|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673096|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673097|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673098|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
2673099|NCT02170584|Dabigatran|dabigatran|mesh-list
2673100|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
2673101|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673102|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673103|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673104|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673105|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
2673106|NCT02170597|Dabigatran|dabigatran|mesh-list
2673107|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
2673108|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673109|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673110|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673111|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673112|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
2673113|NCT02170610|Pantoprazole|pantoprazole|mesh-list
2673114|NCT02170610|Dabigatran|dabigatran|mesh-list
2673115|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2673116|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2673117|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2673118|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673119|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673120|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
2673121|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673122|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673123|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
2673124|NCT02170623|Pantoprazole|pantoprazole|mesh-list
2673125|NCT02170623|Dabigatran|dabigatran|mesh-list
2673126|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2673127|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2673128|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2673129|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673130|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673131|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
2673132|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673133|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673134|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
2673135|NCT02170636|Pantoprazole|pantoprazole|mesh-list
2673136|NCT02170636|Dabigatran|dabigatran|mesh-list
2673137|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2673138|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2673139|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2673140|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673141|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185834|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
2185835|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185836|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185837|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2185838|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2673142|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
2673143|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673144|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673145|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
2673146|NCT02170675|Ketoconazole|ketoconazole|mesh-list
2673147|NCT02170675|Dabigatran|dabigatran|mesh-list
2673148|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
2673149|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673150|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673151|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673152|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673153|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
2673154|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
2673155|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2673156|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2673157|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2673158|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2673159|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
2673160|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2673161|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673162|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2673163|NCT02170701|Dabigatran|dabigatran|mesh-list
2673164|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
2673165|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673166|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673167|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673168|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673169|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
2673170|NCT02170740|Pantoprazole|pantoprazole|mesh-list
2673171|NCT02170740|Dabigatran|dabigatran|mesh-list
2673172|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2673173|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2673174|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2673175|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673176|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673177|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
2673178|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673179|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673180|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
2673181|NCT02170766|Pantoprazole|pantoprazole|mesh-list
2673182|NCT02170766|Dabigatran|dabigatran|mesh-list
2673183|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2673184|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2673185|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2673186|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673187|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673188|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
2673189|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673190|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673191|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
2673192|NCT02170792|Ranitidine|ranitidine|mesh-list
2673193|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2673194|NCT02170792|Dabigatran|dabigatran|mesh-list
2673195|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2673196|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2673197|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2673198|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
2673199|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
2673200|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673201|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673202|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673203|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
2673204|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673205|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673206|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673207|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
2673208|NCT02170805|Pantoprazole|pantoprazole|mesh-list
2673209|NCT02170805|Dabigatran|dabigatran|mesh-list
2673210|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2673211|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2673212|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2673213|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673214|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673215|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
2673216|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673217|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673218|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
2673219|NCT02170831|Dabigatran|dabigatran|mesh-list
2673220|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
2673221|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673222|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673223|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673224|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673225|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
2673226|NCT02170844|Dabigatran|dabigatran|mesh-list
2673227|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
2673228|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673229|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673230|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673231|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673232|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
2673233|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
2673234|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2673235|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
2673236|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673237|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
2673238|NCT02170857|Protective Agents|protective agents|mesh-ancestor
2673239|NCT02170896|Pantoprazole|pantoprazole|mesh-list
2673240|NCT02170896|Dabigatran|dabigatran|mesh-list
2673241|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2673242|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2673243|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2673244|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673245|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673246|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
2673247|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673248|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673249|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
2673250|NCT02170909|Dabigatran|dabigatran|mesh-list
2673251|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
2673252|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673253|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673254|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673255|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673256|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
2673257|NCT02170922|Dabigatran|dabigatran|mesh-list
2673258|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
2673259|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673260|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673261|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673262|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673263|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
2673264|NCT02170935|Dabigatran|dabigatran|mesh-list
2673265|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
2673266|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673267|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673268|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673269|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673270|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
2673271|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
2673272|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2673273|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2673274|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673275|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2673276|NCT02170948|Analgesics|analgesics|mesh-ancestor
2673277|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
2673278|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673279|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2673280|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2673281|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2673282|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
2673283|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673284|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673285|NCT02170974|Dabigatran|dabigatran|mesh-list
2673286|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
2673287|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673288|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673289|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673290|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673291|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
2673292|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
2673293|NCT02170987|Dabigatran|dabigatran|mesh-list
2673294|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2673295|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2673296|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2673297|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2423068|NCT00820352|Bosentan|bosentan|mesh-list
2423069|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2423070|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2423071|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423072|NCT00820404|BLI-489|bli-489|mesh-list
2423073|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2423074|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423075|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423076|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2423077|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423078|NCT00820417|Cetuximab|cetuximab|mesh-list
2423079|NCT00820417|Gefitinib|gefitinib|mesh-list
2423080|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2423081|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423082|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2423083|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423084|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423085|NCT00820469|Rituximab|rituximab|mesh-list
2673298|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673299|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673300|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673301|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
2673302|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673303|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673304|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
2185839|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185840|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185841|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185842|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
2185843|NCT00002943|Carboplatin|carboplatin|mesh-list
2185844|NCT00002943|Etoposide|etoposide|mesh-list
2673305|NCT02171000|Dabigatran|dabigatran|mesh-list
2673306|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
2673307|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673308|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673309|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673310|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673311|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
2673312|NCT02171013|Dabigatran|dabigatran|mesh-list
2673313|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
2673314|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673315|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673316|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673317|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673318|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
2673319|NCT02171026|Amiodarone|amiodarone|mesh-list
2673320|NCT02171026|Dabigatran|dabigatran|mesh-list
2673321|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
2673322|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673323|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
2185845|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2673324|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673325|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673326|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
2673327|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2673328|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
2673329|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2673330|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2673331|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2673332|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2673333|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2673334|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2673335|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2673336|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2673337|NCT02171039|Dabigatran|dabigatran|mesh-list
2673338|NCT02171039|Atorvastatin|atorvastatin|mesh-list
2673339|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2673340|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2673341|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
2673342|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673343|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2673344|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2673345|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673346|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
2673347|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673348|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673349|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
2673350|NCT02171052|Digoxin|digoxin|mesh-list
2673351|NCT02171052|Dabigatran|dabigatran|mesh-list
2673352|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
2673353|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673354|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673355|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673356|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673357|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
2673358|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2673359|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2673360|NCT02171052|Protective Agents|protective agents|mesh-ancestor
2673361|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673362|NCT02171156|Nintedanib|nintedanib|mesh-list
2673363|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673364|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2673365|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673366|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673367|NCT02171182|Capsaicin|capsaicin|mesh-list
2673368|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
2673369|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
2673370|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
2673371|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673372|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185846|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
2185847|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185848|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185849|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185850|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
2185851|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185852|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185853|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2185854|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185855|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185856|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185857|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185858|NCT00002944|Carboplatin|carboplatin|mesh-list
2185859|NCT00002944|Vincristine|vincristine|mesh-list
2185860|NCT00002944|Thioguanine|thioguanine|mesh-list
2673373|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2673374|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
2673375|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2673376|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
2673377|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673378|NCT02171221|DFP-11207|dfp-11207|mesh-list
2673379|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2673380|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
2673381|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673382|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185861|NCT00002944|Lomustine|lomustine|mesh-list
2185862|NCT00002944|Procarbazine|procarbazine|mesh-list
2673383|NCT02171299|Ropivacaine|ropivacaine|mesh-list
2673384|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
2673385|NCT02171299|Anesthetics|anesthetics|mesh-list
2673386|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2673387|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673388|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
2673389|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673390|NCT02171325|Irinotecan|irinotecan|mesh-list
2673391|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2673392|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2673393|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673394|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673395|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673396|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2673397|NCT02171338|Azithromycin|azithromycin|mesh-list
2673398|NCT02171338|Clarithromycin|clarithromycin|mesh-list
2673399|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
2673400|NCT02171338|Tazobactam|tazobactam|mesh-list
2673401|NCT02171338|Piperacillin|piperacillin|mesh-list
2673402|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2673403|NCT02171338|Penicillin G|penicillin g|mesh-list
2673404|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2673405|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2673406|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673407|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673408|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2673409|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2673410|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2673411|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2673412|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673413|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2673414|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2673415|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
2673416|NCT02171390|Testosterone|testosterone|mesh-list
2673417|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
2673418|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
2673419|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2673420|NCT02171390|Androgens|androgens|mesh-ancestor
2673421|NCT02171390|Hormones|hormones|mesh-ancestor
2673422|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2673423|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673424|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2673425|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673426|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
2673427|NCT02171416|Rilonacept|rilonacept|mesh-list
2673428|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2673429|NCT02171442|Dabigatran|dabigatran|mesh-list
2673430|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
2673431|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673432|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673433|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673434|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673435|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
2673436|NCT02171455|Dabigatran|dabigatran|mesh-list
2673437|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
2673438|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673439|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673440|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673441|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673442|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
2673443|NCT02171468|Dabigatran|dabigatran|mesh-list
2673444|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
2673445|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673446|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673447|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673448|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673449|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
2673450|NCT02171481|Dabigatran|dabigatran|mesh-list
2673451|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
2673452|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673453|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673454|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673455|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673456|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
2673457|NCT02171494|Warfarin|warfarin|mesh-list
2673458|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
2673459|NCT02171507|Diclofenac|diclofenac|mesh-list
2673460|NCT02171507|Dabigatran|dabigatran|mesh-list
2673461|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2673462|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2673463|NCT02171507|Analgesics|analgesics|mesh-ancestor
2673464|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
2673465|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673466|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673467|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2673468|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2673469|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2673470|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673471|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673472|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
2673473|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673474|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
2185863|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185864|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185865|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185866|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
2673475|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
2673476|NCT02171520|Dabigatran|dabigatran|mesh-list
2673477|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
2673478|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673479|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673480|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673481|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673482|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
2673483|NCT02171533|Verapamil|verapamil|mesh-list
2673484|NCT02171533|Dabigatran|dabigatran|mesh-list
2673485|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
2673486|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673487|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673488|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673489|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673490|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
2673491|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2673492|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2673493|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2673494|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2673495|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673496|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
2673497|NCT02171546|Fexofenadine|fexofenadine|mesh-list
2673498|NCT02171546|Quinidine|quinidine|mesh-list
2673499|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
2185867|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185868|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185869|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185870|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
2185871|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185872|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
2185873|NCT00002945|Cytarabine|cytarabine|mesh-list
2185874|NCT00002945|Aldesleukin|aldesleukin|mesh-list
2185875|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
2185876|NCT00002945|Melphalan|melphalan|mesh-list
2185877|NCT00002945|Etoposide|etoposide|mesh-list
2673500|NCT02171546|Dabigatran|dabigatran|mesh-list
2673501|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
2673502|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673503|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673504|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673505|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673506|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
2673507|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2673508|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2673509|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2673510|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
2673511|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
2673512|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673513|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673514|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2673515|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2673516|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
2673517|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2673518|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
2673519|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2185878|NCT00002945|Idarubicin|idarubicin|mesh-list
2673520|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2673521|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2673522|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2673523|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2673524|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
2673525|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2673526|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2673527|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2673528|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2673529|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2673530|NCT02171559|Enoxaparin|enoxaparin|mesh-list
2673531|NCT02171559|Dabigatran|dabigatran|mesh-list
2673532|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
2673533|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2673534|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2673535|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673536|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
2673537|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673538|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673539|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673540|NCT02171572|Dabigatran|dabigatran|mesh-list
2673541|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
2673542|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673543|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673544|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673545|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673546|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
2673547|NCT02171585|Clarithromycin|clarithromycin|mesh-list
2673548|NCT02171585|Dabigatran|dabigatran|mesh-list
2673549|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2673550|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2673551|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2673552|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673553|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673554|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2673555|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2673556|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
2673557|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673558|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673559|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
2673560|NCT02171598|Dabigatran|dabigatran|mesh-list
2673561|NCT02171598|Clopidogrel|clopidogrel|mesh-list
2673562|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2673563|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2673564|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2673565|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2673566|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
2673567|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673568|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673569|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673570|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
2673571|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2185879|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185880|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
2185881|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185882|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2673572|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673573|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673574|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
2673575|NCT02171624|Quinidine|quinidine|mesh-list
2673576|NCT02171624|Dabigatran|dabigatran|mesh-list
2673577|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
2673578|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2673579|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673580|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673581|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673582|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
2673583|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2673584|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2673585|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
2673586|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673587|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673588|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2673589|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
2673590|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2673591|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2673592|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2673593|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2673594|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2673595|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
2673596|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2673597|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2673598|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2673599|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2673600|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2673601|NCT02171637|Afatinib|afatinib|mesh-list
2673602|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673603|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2673604|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673605|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673606|NCT02171650|Afatinib|afatinib|mesh-list
2673607|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673608|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2673609|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673610|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673611|NCT02171663|Afatinib|afatinib|mesh-list
2673612|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673613|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2673614|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673615|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673616|NCT02171676|Docetaxel|docetaxel|mesh-list
2673617|NCT02171676|Afatinib|afatinib|mesh-list
2673618|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673619|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
2673620|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
2673621|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
2673622|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673623|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2673624|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673625|NCT02171689|Afatinib|afatinib|mesh-list
2673626|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673627|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2673628|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673629|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673630|NCT02171702|Afatinib|afatinib|mesh-list
2673631|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673632|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2673633|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185883|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185884|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
2185885|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185886|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185887|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2185888|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2185889|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185890|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185891|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185892|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185893|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
2185894|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
2185895|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185896|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2185897|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2185898|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2185899|NCT00002946|Penclomedine|penclomedine|mesh-list
2185900|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185901|NCT00002948|Topotecan|topotecan|mesh-list
2185902|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2185903|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185904|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185905|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185906|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185907|NCT00002949|Paclitaxel|paclitaxel|mesh-list
2185908|NCT00002949|Vinorelbine|vinorelbine|mesh-list
2185909|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2673634|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673635|NCT02171715|Afatinib|afatinib|mesh-list
2673636|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673637|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2673638|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673639|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673640|NCT02171728|Afatinib|afatinib|mesh-list
2673641|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673642|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2673643|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673644|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673645|NCT02171741|Docetaxel|docetaxel|mesh-list
2673646|NCT02171741|Afatinib|afatinib|mesh-list
2673647|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673648|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
2673649|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
2673650|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
2673651|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673652|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2673653|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673654|NCT02171754|Ritonavir|ritonavir|mesh-list
2673655|NCT02171754|Afatinib|afatinib|mesh-list
2673656|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2673657|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2673658|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673659|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673660|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673661|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2673662|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2673663|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
2673664|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2673665|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2673666|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2673667|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673668|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2673669|NCT02171767|Afatinib|afatinib|mesh-list
2673670|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673671|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2673672|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673673|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673674|NCT02171780|Olodaterol|olodaterol|mesh-list
2673675|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673676|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
2673677|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673678|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673679|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673680|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673681|NCT02171793|Olodaterol|olodaterol|mesh-list
2673682|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673683|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
2673684|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673685|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673686|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673687|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673688|NCT02171806|Olodaterol|olodaterol|mesh-list
2673689|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673690|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
2673691|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673692|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673693|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673694|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673695|NCT02171832|Olodaterol|olodaterol|mesh-list
2673696|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673697|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
2673698|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673699|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673700|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673701|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673702|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
2673703|NCT02171910|Doxapram|doxapram|mesh-list
2673704|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2673705|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673706|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673707|NCT02171975|Anesthetics|anesthetics|mesh-list
2673708|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2673709|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673710|NCT02171988|Propranolol|propranolol|mesh-list
2673711|NCT02171988|Bisoprolol|bisoprolol|mesh-list
2673712|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2673713|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2673714|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2673715|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
2673716|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673717|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673718|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673719|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2673720|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2673721|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
2673722|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
2673723|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
2673724|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673725|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2673726|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2673727|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673728|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
2673729|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2673730|NCT02172001|Hematinics|hematinics|mesh-ancestor
2673731|NCT02172014|Fentanyl|fentanyl|mesh-list
2673732|NCT02172014|Midazolam|midazolam|mesh-list
2673733|NCT02172014|Citric Acid|citric acid|mesh-list
2673734|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
2673735|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2673736|NCT02172014|Narcotics|narcotics|mesh-ancestor
2673737|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2673738|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673739|NCT02172014|Analgesics|analgesics|mesh-ancestor
2673740|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
2673741|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673742|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2673743|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2185910|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185911|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185912|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185913|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185914|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185915|NCT00002950|Topotecan|topotecan|mesh-list
2185916|NCT00002950|Sargramostim|sargramostim|mesh-list
2185917|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2185918|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2185919|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185920|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185921|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185922|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
2185923|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673744|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
2673745|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
2673746|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2673747|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2673748|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2673749|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2673750|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
2673751|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
2673752|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673753|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673754|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
2673755|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2673756|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
2673757|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
2673758|NCT02172105|Olodaterol|olodaterol|mesh-list
2673759|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673760|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
2673761|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673762|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673763|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673764|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673765|NCT02172131|Olodaterol|olodaterol|mesh-list
2673766|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673767|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
2673768|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673769|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673770|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673771|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673772|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
2673773|NCT02172144|Olodaterol|olodaterol|mesh-list
2673774|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2673775|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2673776|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2673777|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2673778|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185924|NCT00002951|Fluorouracil|fluorouracil|mesh-list
2185925|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
2185926|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
2185927|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673779|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673780|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673781|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673782|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673783|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
2673784|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673785|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673786|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673787|NCT02172157|Olodaterol|olodaterol|mesh-list
2673788|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2185928|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185929|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185930|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185931|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
2185932|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185933|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
2185934|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185935|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2185936|NCT00002952|Interleukin-12|interleukin-12|mesh-list
2185937|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2185938|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
2185939|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185940|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2185941|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2185942|NCT00002952|Growth Substances|growth substances|mesh-ancestor
2185943|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
2185944|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673789|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
2673790|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673791|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673792|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673793|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
2185945|NCT00002953|Paclitaxel|paclitaxel|mesh-list
2185946|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
2185947|NCT00002953|Epirubicin|epirubicin|mesh-list
2185948|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2673794|NCT02172170|Empagliflozin|empagliflozin|mesh-list
2673795|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2673796|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673797|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2673798|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673799|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2673800|NCT02172196|Empagliflozin|empagliflozin|mesh-list
2673801|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2673802|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673803|NCT02172196|Incretins|incretins|mesh-ancestor
2673804|NCT02172196|Hormones|hormones|mesh-ancestor
2673805|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2673806|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2673807|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673808|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673809|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673810|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2673811|NCT02172209|Empagliflozin|empagliflozin|mesh-list
2673812|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2673813|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673814|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2673815|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673816|NCT02172222|Linagliptin|linagliptin|mesh-list
2673817|NCT02172222|Empagliflozin|empagliflozin|mesh-list
2673818|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2673819|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673820|NCT02172222|Incretins|incretins|mesh-ancestor
2673821|NCT02172222|Hormones|hormones|mesh-ancestor
2673822|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2673823|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2673824|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
2673825|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185949|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2673826|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673827|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2673828|NCT02172235|Pioglitazone|pioglitazone|mesh-list
2673829|NCT02172235|Empagliflozin|empagliflozin|mesh-list
2673830|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2673831|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673832|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2673833|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673834|NCT02172248|Metformin|metformin|mesh-list
2673835|NCT02172248|Empagliflozin|empagliflozin|mesh-list
2673836|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2673837|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673838|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2673839|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673840|NCT02172261|Glimepiride|glimepiride|mesh-list
2673841|NCT02172261|Empagliflozin|empagliflozin|mesh-list
2673842|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2673843|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2673844|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673845|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2673846|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
2673847|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2673848|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673849|NCT02172274|Empagliflozin|empagliflozin|mesh-list
2673850|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2673851|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673852|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2673853|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673854|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
2673855|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2673856|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673857|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
2673858|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673859|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673860|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673861|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
2185950|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
2185951|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
2185952|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
2185953|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185954|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2673862|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
2673863|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2673864|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
2673865|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673866|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673867|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2673868|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2673869|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2673870|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
2673871|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
2673872|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673873|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
2673874|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673875|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673876|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673877|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673878|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
2673879|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2673880|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
2673881|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673882|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673883|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
2673884|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673885|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
2673886|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2185955|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
2185956|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185957|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185958|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185959|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
2673887|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673888|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673889|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673890|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
2673891|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2673892|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
2673893|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673894|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673895|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
2673896|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673897|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
2673898|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673899|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673900|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673901|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673902|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
2673903|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2673904|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
2673905|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673906|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673907|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
2673908|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673909|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
2673910|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673911|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673912|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673913|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673914|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
2673915|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2673916|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
2673917|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673918|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673919|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
2673920|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673921|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
2673922|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673923|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673924|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673925|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673926|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
2673927|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2673928|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
2673929|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673930|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673931|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
2673932|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673933|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
2673934|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673935|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673936|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673937|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673938|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
2673939|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2673940|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
2673941|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673942|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673943|NCT02172404|Ipratropium|ipratropium|mesh-list
2673944|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673945|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
2673946|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673947|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673948|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673949|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673950|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2673951|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
2673952|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673953|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673954|NCT02172417|Ranitidine|ranitidine|mesh-list
2673955|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2673956|NCT02172417|Cimetidine|cimetidine|mesh-list
2673957|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
2673958|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673959|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
2673960|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673961|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673962|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673963|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673964|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
2673965|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2673966|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
2673967|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673968|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673969|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2673970|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2673971|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2673972|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
2673973|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
2673974|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2673975|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2673976|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2673977|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
2673978|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673979|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
2673980|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673981|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673982|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673983|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673984|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
2673985|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2673986|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
2185960|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2185961|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2185962|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2185963|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2673987|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2673988|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2673989|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
2673990|NCT02172443|Ipratropium|ipratropium|mesh-list
2673991|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2673992|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
2673993|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2673994|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2673995|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2673996|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
2673997|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
2673998|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2673999|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674000|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674001|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674002|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
2674003|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674004|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
2674005|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674006|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674007|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674008|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674009|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
2674010|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674011|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674012|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674013|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674014|NCT02172469|Bromides|bromides|mesh-list
2674015|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
2674016|NCT02172469|Ipratropium|ipratropium|mesh-list
2674017|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674018|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
2674019|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674020|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674021|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674022|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674023|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
2674024|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674025|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674026|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674027|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674028|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
2674029|NCT02172482|Bromides|bromides|mesh-list
2674030|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
2674031|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674032|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
2674033|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674034|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674035|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674036|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674037|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
2674038|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674039|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674040|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674041|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674042|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
2674043|NCT02172495|Bromides|bromides|mesh-list
2674044|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
2674045|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674046|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
2674047|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674048|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674049|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674050|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674051|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
2674052|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674053|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674054|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674055|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674056|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
2674057|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
2674058|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674059|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
2674060|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674061|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674062|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674063|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674064|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
2674065|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674066|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674067|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674068|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674069|NCT02172521|Bromides|bromides|mesh-list
2674070|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
2674071|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674072|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
2674073|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674074|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674075|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674076|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674077|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
2674078|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674079|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674080|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674081|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674082|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
2674083|NCT02172534|Bromides|bromides|mesh-list
2674084|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
2674085|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674086|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
2674087|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674088|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674089|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674090|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674091|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
2674092|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674093|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674094|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674095|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674096|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
2674097|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
2674098|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674099|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
2674100|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674101|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674102|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674103|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674104|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
2674105|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674106|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674107|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674108|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674109|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
2674110|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674111|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
2674112|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674113|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185964|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185965|NCT00002955|Leucovorin|leucovorin|mesh-list
2185966|NCT00002955|Trimetrexate|trimetrexate|mesh-list
2185967|NCT00002955|Fluorouracil|fluorouracil|mesh-list
2185968|NCT00002955|Calcium|calcium|mesh-list
2185969|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
2185970|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2185971|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185972|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
2185973|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2185974|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2185975|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2185976|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185977|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
2185978|NCT00002955|Antidotes|antidotes|mesh-ancestor
2674114|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674115|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674116|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
2674117|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674118|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674119|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674120|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674121|NCT02172573|Pramipexole|pramipexole|mesh-list
2674122|NCT02172573|Bromocriptine|bromocriptine|mesh-list
2674123|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
2674124|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674125|NCT02172573|Protective Agents|protective agents|mesh-ancestor
2674126|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674127|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2674128|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2674129|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
2674130|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
2674131|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674132|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
2674133|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2674134|NCT02172586|Losartan|losartan|mesh-list
2674135|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2674136|NCT02172586|Telmisartan|telmisartan|mesh-list
2674137|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2674138|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2674139|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2674140|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2674141|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674142|NCT02172586|Diuretics|diuretics|mesh-ancestor
2674143|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
2674144|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674145|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2674146|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2674147|NCT02172651|Vitamin D|vitamin d|mesh-list
2185979|NCT00002955|Protective Agents|protective agents|mesh-ancestor
2185980|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
2185981|NCT00002955|Vitamins|vitamins|mesh-ancestor
2185982|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
2185983|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
2185984|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2185985|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2185986|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2185987|NCT00002961|Cyclosporine|cyclosporine|mesh-list
2185988|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
2185989|NCT00002961|Busulfan|busulfan|mesh-list
2185990|NCT00002961|Methotrexate|methotrexate|mesh-list
2185991|NCT00002961|Etoposide|etoposide|mesh-list
2185992|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
2674148|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
2674149|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
2674150|NCT02172651|Vitamins|vitamins|mesh-list
2185993|NCT00002961|Cyclosporins|cyclosporins|mesh-list
2185994|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2185995|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
2674151|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
2674152|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674153|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2674154|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2674155|NCT02172729|Lidocaine|lidocaine|mesh-list
2674156|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
2674157|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
2674158|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2674159|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674160|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
2674161|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674162|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2674163|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2674164|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2674165|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2674166|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674167|NCT02172768|Micafungin|micafungin|mesh-list
2674168|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
2674169|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674170|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
2674171|NCT02172781|Ipratropium|ipratropium|mesh-list
2674172|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674173|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
2674174|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674175|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674176|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674177|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674178|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
2674179|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674180|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674181|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674182|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674183|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
2674184|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2674185|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674186|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
2674187|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674188|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674189|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674190|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674191|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
2674192|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674193|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674194|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674195|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674196|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2674197|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2674198|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2674199|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
2674200|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
2674201|NCT02172807|Oxitropium|oxitropium|mesh-list
2674202|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674203|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
2674204|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674205|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674206|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674207|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674208|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
2674209|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674210|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674211|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674212|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674213|NCT02172846|Paclitaxel|paclitaxel|mesh-list
2674214|NCT02172846|Carboplatin|carboplatin|mesh-list
2674215|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2674216|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674217|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
2674218|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
2674219|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
2674220|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674221|NCT02172872|Decitabine|decitabine|mesh-list
2674222|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2674223|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
2674224|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674225|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674226|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674227|NCT02172976|Gemcitabine|gemcitabine|mesh-list
2674228|NCT02172976|Fluorouracil|fluorouracil|mesh-list
2674229|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
2674230|NCT02172976|Irinotecan|irinotecan|mesh-list
2674231|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2674232|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
2674233|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674234|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674235|NCT02172976|Antiviral Agents|antiviral agents|mesh-ancestor
2674236|NCT02172976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674237|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674238|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2674239|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
2674240|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674241|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2674242|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2674243|NCT02173093|Aldesleukin|aldesleukin|mesh-list
2674244|NCT02173093|Interleukin-2|interleukin-2|mesh-list
2674245|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674246|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2674247|NCT02173093|Analgesics|analgesics|mesh-ancestor
2674248|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
2674249|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674250|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674251|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2674252|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2674253|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
2674254|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674255|NCT02173106|Cyclosporine|cyclosporine|mesh-list
2674256|NCT02173106|Cyclosporins|cyclosporins|mesh-list
2674257|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674258|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674259|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2674260|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
2674261|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674262|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
2674263|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674264|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
2674265|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2674266|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2674267|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
2674268|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
2674269|NCT02173132|Vitamins|vitamins|mesh-ancestor
2674270|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
2674271|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674272|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
2674273|NCT02173145|Azithromycin|azithromycin|mesh-list
2674274|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2674275|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674276|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
2674277|NCT02173262|Sargramostim|sargramostim|mesh-list
2674278|NCT02173262|Lenograstim|lenograstim|mesh-list
2674279|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
2674280|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674281|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2674282|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2674283|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674284|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2674285|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2674286|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674287|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674288|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674289|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2674290|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2674291|NCT02173288|Furosemide|furosemide|mesh-list
2674292|NCT02173288|Spironolactone|spironolactone|mesh-list
2674293|NCT02173288|Tolvaptan|tolvaptan|mesh-list
2674294|NCT02173288|Midodrine|midodrine|mesh-list
2674295|NCT02173288|Diuretics|diuretics|mesh-ancestor
2185996|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2185997|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2185998|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2185999|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
2674296|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
2674297|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674298|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2674299|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2674300|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674301|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2674302|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
2674303|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2186000|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186001|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186002|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186003|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2186004|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
2186005|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2186006|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186007|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
2186008|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
2186009|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186010|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2186011|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2186012|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186013|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186014|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186015|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
2186016|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186017|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2186018|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2186019|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2186020|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
2186021|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2186022|NCT00002964|Trioxsalen|trioxsalen|mesh-list
2186023|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186024|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
2186025|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2186026|NCT00002965|Interferons|interferons|mesh-list
2674304|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2674305|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2674306|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
2674307|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
2674308|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674309|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2674310|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2674311|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2674312|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2674313|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
2674314|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674315|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2674316|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2674317|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2674318|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674319|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674320|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2674321|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2674322|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674323|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674324|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674325|NCT02173418|Ropivacaine|ropivacaine|mesh-list
2674326|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
2674327|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
2674328|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2674329|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674330|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
2674331|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674332|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2674333|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2674334|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674335|NCT02173457|Incretins|incretins|mesh-ancestor
2674336|NCT02173457|Hormones|hormones|mesh-ancestor
2674337|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2674338|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2674339|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
2674340|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674341|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674342|NCT02173639|Metformin|metformin|mesh-list
2186027|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
2674343|NCT02173639|Linagliptin|linagliptin|mesh-list
2674344|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2674345|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674346|NCT02173639|Incretins|incretins|mesh-ancestor
2674347|NCT02173639|Hormones|hormones|mesh-ancestor
2674348|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2674349|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2674350|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
2674351|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674352|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674353|NCT02173652|Linagliptin|linagliptin|mesh-list
2674354|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2674355|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674356|NCT02173652|Incretins|incretins|mesh-ancestor
2674357|NCT02173652|Hormones|hormones|mesh-ancestor
2674358|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2674359|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2674360|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
2674361|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674362|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674363|NCT02173665|Linagliptin|linagliptin|mesh-list
2674364|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2674365|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674366|NCT02173665|Incretins|incretins|mesh-ancestor
2674367|NCT02173665|Hormones|hormones|mesh-ancestor
2674368|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2674369|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2674370|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
2674371|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674372|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674373|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
2674374|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2674375|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674376|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
2186028|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
2186029|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2186030|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186031|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
2186032|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186033|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
2186034|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186035|NCT00002967|Tamoxifen|tamoxifen|mesh-list
2186036|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
2186037|NCT00002967|Doxorubicin|doxorubicin|mesh-list
2186038|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2674377|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674378|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674379|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674380|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674381|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
2674382|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674383|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674384|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674385|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674386|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2674387|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2674388|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2674389|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
2674390|NCT02173717|Rifampin|rifampin|mesh-list
2674391|NCT02173717|Dabigatran|dabigatran|mesh-list
2674392|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
2674393|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2674394|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
2674395|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674396|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674397|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
2674398|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2674399|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
2674400|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2674401|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674402|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
2674403|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2674404|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2674405|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2186039|NCT00002967|Octreotide|octreotide|mesh-list
2674406|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2674407|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2674408|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2674409|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2674410|NCT02173730|Pantoprazole|pantoprazole|mesh-list
2674411|NCT02173730|Dabigatran|dabigatran|mesh-list
2674412|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2674413|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2674414|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2674415|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674416|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674417|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
2674418|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2674419|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
2674420|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
2674421|NCT02173756|Morphine|morphine|mesh-list
2674422|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2674423|NCT02173756|Narcotics|narcotics|mesh-ancestor
2674424|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2674425|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674426|NCT02173756|Analgesics|analgesics|mesh-ancestor
2674427|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
2674428|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674429|NCT02173782|Fenoterol|fenoterol|mesh-list
2674430|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2674431|NCT02173782|Ipratropium|ipratropium|mesh-list
2674432|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674433|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
2674434|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674435|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674436|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674437|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674438|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
2674439|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
2674440|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2674441|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2674442|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2674443|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2674444|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
2674445|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674446|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674447|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674448|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674449|NCT02173795|Fenoterol|fenoterol|mesh-list
2674450|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2674451|NCT02173795|Ipratropium|ipratropium|mesh-list
2674452|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674453|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
2674454|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674455|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674456|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674457|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674458|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
2674459|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
2674460|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2674461|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2674462|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2674463|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2674464|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
2674465|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674466|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674467|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2674468|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674469|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
2674470|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
2674471|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2674472|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
2674473|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2674474|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674475|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2674476|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2674477|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2674478|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2674479|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2674480|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2674481|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2674482|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674483|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674484|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674485|NCT02173873|Aflibercept|aflibercept|mesh-list
2674486|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2674487|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2674488|NCT02173873|Growth Substances|growth substances|mesh-ancestor
2674489|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674490|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
2674491|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674492|NCT02173886|Bupropion|bupropion|mesh-list
2674493|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2674494|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
2674495|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2674496|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2674497|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2674498|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2674499|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674500|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
2674501|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674502|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674503|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2674504|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2674505|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674506|NCT02173912|Amlodipine|amlodipine|mesh-list
2674507|NCT02173912|Candesartan|candesartan|mesh-list
2674508|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
2674509|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2674510|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2674511|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2674512|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674513|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2674514|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674515|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
2674516|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2674517|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2674518|NCT02173951|Deferiprone|deferiprone|mesh-list
2674519|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2674520|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
2674521|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
2674522|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674523|NCT02173964|Pinaverium|pinaverium|mesh-list
2674524|NCT02173964|Bromides|bromides|mesh-list
2674525|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
2674526|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2674527|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2674528|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674529|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2674530|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674531|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
2674532|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
2674533|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674534|NCT02173990|Aflibercept|aflibercept|mesh-list
2674535|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2674536|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2674537|NCT02173990|Growth Substances|growth substances|mesh-ancestor
2674538|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674539|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
2674540|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674541|NCT02174068|Acetaminophen|acetaminophen|mesh-list
2674542|NCT02174068|Nefopam|nefopam|mesh-list
2674543|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2674544|NCT02174068|Analgesics|analgesics|mesh-ancestor
2674545|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
2674546|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674547|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674548|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
2674549|NCT02174094|Clobazam|clobazam|mesh-list
2674550|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
2674551|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2674552|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2674553|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2674554|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674555|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2674556|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2674557|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
2674558|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
2674559|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674560|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674561|NCT02174120|Propofol|propofol|mesh-list
2674562|NCT02174120|Etomidate|etomidate|mesh-list
2674563|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2674564|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2674565|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674566|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2674567|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
2674568|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
2674569|NCT02174172|Interferons|interferons|mesh-list
2674570|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
2674571|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
2186040|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186041|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
2186042|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186043|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186044|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186045|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
2186046|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186047|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186048|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186049|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186050|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186051|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186052|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186053|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2186054|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
2186055|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2186056|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2186057|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2186058|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2186059|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2186060|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2674572|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2674573|NCT02174172|Bevacizumab|bevacizumab|mesh-list
2674574|NCT02174172|Ipilimumab|ipilimumab|mesh-list
2674575|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
2674576|NCT02174172|Atezolizumab|atezolizumab|mesh-list
2674577|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2674578|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674579|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2674580|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2674581|NCT02174172|Growth Substances|growth substances|mesh-ancestor
2674582|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674583|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
2674584|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
2674585|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674586|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2674587|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674588|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
2186061|NCT00002968|Edrecolomab|edrecolomab|mesh-list
2186062|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2186063|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
2186064|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186065|NCT00002969|Paclitaxel|paclitaxel|mesh-list
2186066|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186067|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186068|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
2186069|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186070|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186071|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186072|NCT00002970|Cytarabine|cytarabine|mesh-list
2186073|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
2186074|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2186075|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2186076|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2186077|NCT00002970|Methotrexate|methotrexate|mesh-list
2674589|NCT02174211|Ranibizumab|ranibizumab|mesh-list
2674590|NCT02174211|Aflibercept|aflibercept|mesh-list
2674591|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2674592|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2674593|NCT02174211|Growth Substances|growth substances|mesh-ancestor
2674594|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674595|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
2674596|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674597|NCT02174250|Rifampin|rifampin|mesh-list
2674598|NCT02174250|Istradefylline|istradefylline|mesh-list
2186078|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2186079|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
2186080|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2186081|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186082|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186083|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
2186084|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186085|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186086|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
2186087|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186088|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2186089|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186090|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
2186091|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186092|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2186093|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
2186094|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186095|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2186096|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2674599|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2674600|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
2674601|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2674602|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674603|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
2674604|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2674605|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674606|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674607|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2674608|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2674609|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2674610|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2674611|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2674612|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2674613|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2674614|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2674615|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2674616|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
2674617|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674618|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674619|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
2674620|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
2674621|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
2674622|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674623|NCT02174328|Aspirin|aspirin|mesh-list
2674624|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2674625|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2674626|NCT02174328|Analgesics|analgesics|mesh-ancestor
2674627|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
2674628|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674629|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674630|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2674631|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2674632|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2674633|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2674634|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674635|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2674636|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2674637|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674638|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
2674639|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
2674640|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674641|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2674642|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674643|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674644|NCT02174549|Tirapazamine|tirapazamine|mesh-list
2674645|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674646|NCT02174575|Sevoflurane|sevoflurane|mesh-list
2186097|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186098|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186099|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186100|NCT00002972|Paclitaxel|paclitaxel|mesh-list
2186101|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186102|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674647|NCT02174575|Desflurane|desflurane|mesh-list
2674648|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2674649|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2674650|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
2674651|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
2674652|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2674653|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674654|NCT02174588|Midazolam|midazolam|mesh-list
2674655|NCT02174588|Propofol|propofol|mesh-list
2674656|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2674657|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2674658|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674659|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2674660|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
2674661|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
2674662|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2674663|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2674664|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2674665|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2674666|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
2674667|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
2674668|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674669|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674670|NCT02174666|Vitamin D|vitamin d|mesh-list
2674671|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
2674672|NCT02174666|Vitamins|vitamins|mesh-list
2674673|NCT02174666|Genistein|genistein|mesh-list
2674674|NCT02174666|Biochanin A|biochanin a|mesh-list
2674675|NCT02174666|Daidzein|daidzein|mesh-list
2186103|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
2186104|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186105|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186106|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186107|NCT00002973|Melphalan|melphalan|mesh-list
2186108|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186109|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
2186110|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186111|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186112|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186113|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186114|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
2186115|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186116|NCT00002974|Carboplatin|carboplatin|mesh-list
2186117|NCT00002974|Etoposide|etoposide|mesh-list
2186118|NCT00002974|Ifosfamide|ifosfamide|mesh-list
2186119|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186120|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186121|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186122|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2674676|NCT02174666|Formononetin|formononetin|mesh-list
2674677|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
2674678|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674679|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2674680|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2674681|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2674682|NCT02174666|Protective Agents|protective agents|mesh-ancestor
2674683|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674684|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2674685|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674686|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674687|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
2674688|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2674689|NCT02174666|Estrogens|estrogens|mesh-ancestor
2674690|NCT02174666|Hormones|hormones|mesh-ancestor
2674691|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2674692|NCT02174718|Vitamin D|vitamin d|mesh-list
2674693|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
2674694|NCT02174718|Vitamins|vitamins|mesh-ancestor
2674695|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
2674696|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674697|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2674698|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2674699|NCT02174757|Doxycycline|doxycycline|mesh-list
2674700|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2674701|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674702|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
2674703|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2674704|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2674705|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2674706|NCT02174822|Paroxetine|paroxetine|mesh-list
2674707|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2674708|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2674709|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2674710|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674711|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674712|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674713|NCT02174822|Analgesics|analgesics|mesh-ancestor
2674714|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
2674715|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674716|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
2674717|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2674718|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
2674719|NCT02174822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2674720|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
2674721|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2674722|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2674723|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2674724|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674725|NCT02174887|Gemcitabine|gemcitabine|mesh-list
2674726|NCT02174887|Paclitaxel|paclitaxel|mesh-list
2674727|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2674728|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674729|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
2674730|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
2674731|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
2674732|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674733|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2674734|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
2674735|NCT02174887|Antiviral Agents|antiviral agents|mesh-ancestor
2674736|NCT02174887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674737|NCT02174887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674738|NCT02174887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2674739|NCT02174887|Immunologic Factors|immunologic factors|mesh-ancestor
2674740|NCT02174887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674741|NCT02174900|Lumefantrine|lumefantrine|mesh-list
2674742|NCT02174900|Artemether|artemether|mesh-list
2674743|NCT02174900|Primaquine|primaquine|mesh-list
2674744|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2674745|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
2674746|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2674747|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2674748|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674749|NCT02174939|Cilostazol|cilostazol|mesh-list
2674750|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674751|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
2674752|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674753|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674754|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674755|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674756|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2674757|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2674758|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186123|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186124|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186125|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186126|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
2186127|NCT00002976|Estrogens|estrogens|mesh-list
2186128|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2186129|NCT00002976|Hormones|hormones|mesh-ancestor
2186130|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2186131|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186132|NCT00002977|Melphalan|melphalan|mesh-list
2186133|NCT00002977|Thiotepa|thiotepa|mesh-list
2186134|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
2186135|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186136|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186137|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
2186138|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186139|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186140|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186141|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186142|NCT00002980|Decitabine|decitabine|mesh-list
2186143|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186144|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
2186145|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186146|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186147|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186148|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2186149|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2186150|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186151|NCT00002982|Cytarabine|cytarabine|mesh-list
2674759|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2674760|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
2674761|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2674762|NCT02174939|Protective Agents|protective agents|mesh-ancestor
2674763|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2674764|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2674765|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674766|NCT02175017|Nivolumab|nivolumab|mesh-list
2674767|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2674768|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674769|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2674770|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674771|NCT02175030|Copper|copper|mesh-list
2674772|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
2674773|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2674774|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
2674775|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2674776|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674777|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2674778|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2674779|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2674780|NCT02175030|Trace Elements|trace elements|mesh-ancestor
2674781|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
2674782|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2674783|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2674784|NCT02175069|Ropivacaine|ropivacaine|mesh-list
2674785|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
2674786|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
2674787|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2674788|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674789|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
2674790|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674791|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
2674792|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2674793|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
2674794|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2674795|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674796|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2674797|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674798|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
2674799|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2186152|NCT00002982|Carboplatin|carboplatin|mesh-list
2186153|NCT00002982|Etoposide|etoposide|mesh-list
2186154|NCT00002982|Melphalan|melphalan|mesh-list
2186155|NCT00002982|Ifosfamide|ifosfamide|mesh-list
2186156|NCT00002982|Carmustine|carmustine|mesh-list
2186157|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186158|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186159|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186160|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186161|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186162|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186163|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
2674800|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
2674801|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674802|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674803|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2674804|NCT02175355|Telmisartan|telmisartan|mesh-list
2186164|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674805|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2674806|NCT02175355|Diuretics|diuretics|mesh-ancestor
2674807|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
2674808|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674809|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2674810|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2674811|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674812|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2674813|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2674814|NCT02175381|Gemcitabine|gemcitabine|mesh-list
2423086|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2423087|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423088|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
2423089|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423090|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2423091|NCT00820482|Menotropins|menotropins|mesh-list
2423092|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2423093|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
2423094|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2423095|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423096|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
2674815|NCT02175381|Carboplatin|carboplatin|mesh-list
2674816|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674817|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2674818|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
2674819|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674820|NCT02175381|Antiviral Agents|antiviral agents|mesh-ancestor
2674821|NCT02175381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674822|NCT02175381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674823|NCT02175381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2674824|NCT02175381|Immunologic Factors|immunologic factors|mesh-ancestor
2674825|NCT02175381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674826|NCT02175394|Linagliptin|linagliptin|mesh-list
2674827|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2674828|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2674829|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2674830|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674831|NCT02175394|Incretins|incretins|mesh-ancestor
2674832|NCT02175394|Hormones|hormones|mesh-ancestor
2674833|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2674834|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2674835|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
2674836|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674837|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674838|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2674839|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
2674840|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2674841|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2674842|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2674843|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2674844|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2674845|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2674846|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2674847|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2674848|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2674849|NCT02175407|Itraconazole|itraconazole|mesh-list
2674850|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
2674851|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674852|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2674853|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2674854|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674855|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674856|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2674857|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
2674858|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2674859|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674860|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2674861|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
2674862|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
2674863|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674864|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2674865|NCT02175446|Bevacizumab|bevacizumab|mesh-list
2674866|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2674867|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674868|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2674869|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2674870|NCT02175446|Growth Substances|growth substances|mesh-ancestor
2674871|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674872|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
2674873|NCT02175485|Fexofenadine|fexofenadine|mesh-list
2674874|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2674875|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2674876|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2674877|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
2674878|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
2674879|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674880|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674881|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674882|NCT02175589|Colchicine|colchicine|mesh-list
2674883|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
2674884|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2674885|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
2674886|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
2674887|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
2674888|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674889|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674890|NCT02175602|Citalopram|citalopram|mesh-list
2674891|NCT02175602|Sertraline|sertraline|mesh-list
2674892|NCT02175602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2674893|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2674894|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2674895|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674896|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2674897|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
2674898|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674899|NCT02175602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2674900|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
2674901|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2674902|NCT02175680|Leronlimab|leronlimab|mesh-list
2674903|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2674904|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2674905|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674906|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2674907|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2674908|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
2674909|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674910|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
2674911|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2674912|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186165|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186166|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
2186167|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
2186168|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186169|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186170|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186171|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
2186172|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186173|NCT00002984|Paclitaxel|paclitaxel|mesh-list
2186174|NCT00002984|Fluorouracil|fluorouracil|mesh-list
2186175|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186176|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186177|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
2674913|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2674914|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674915|NCT02175888|Iron|iron|mesh-list
2674916|NCT02175888|Trace Elements|trace elements|mesh-ancestor
2674917|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
2674918|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674919|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2674920|NCT02175901|Amoxicillin|amoxicillin|mesh-list
2674921|NCT02175901|Metronidazole|metronidazole|mesh-list
2674922|NCT02175901|Clarithromycin|clarithromycin|mesh-list
2674923|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2674924|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
2674925|NCT02175901|Lansoprazole|lansoprazole|mesh-list
2674926|NCT02175901|Bismuth|bismuth|mesh-list
2674927|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2674928|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674929|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674930|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
2674931|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2674932|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2674933|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2674934|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674935|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2674936|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2674937|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2674938|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2186178|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186179|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186180|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186181|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
2186182|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186183|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186184|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
2186185|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186186|NCT00002985|Doxorubicin|doxorubicin|mesh-list
2186187|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2186188|NCT00002985|Daunorubicin|daunorubicin|mesh-list
2186189|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186190|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2674939|NCT02175901|Antacids|antacids|mesh-ancestor
2674940|NCT02175901|Diuretics|diuretics|mesh-ancestor
2674941|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
2674942|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674943|NCT02175901|Expectorants|expectorants|mesh-ancestor
2674944|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674945|NCT02175914|Erythromycin|erythromycin|mesh-list
2186191|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186192|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186193|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186194|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186195|NCT00002986|Topotecan|topotecan|mesh-list
2186196|NCT00002986|Carmustine|carmustine|mesh-list
2186197|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2186198|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186199|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186200|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186201|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186202|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186203|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
2186204|NCT00002987|Prednisolone|prednisolone|mesh-list
2186205|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
2186206|NCT00002987|Doxorubicin|doxorubicin|mesh-list
2186207|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2186208|NCT00002987|Etoposide|etoposide|mesh-list
2186209|NCT00002987|Vincristine|vincristine|mesh-list
2186210|NCT00002987|Bleomycin|bleomycin|mesh-list
2186211|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186212|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
2186213|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186214|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186215|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186216|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
2186217|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186218|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186219|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186220|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2674946|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
2674947|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2674948|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
2674949|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2674950|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674951|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2674952|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2674953|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674954|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674955|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2674956|NCT02175927|Amoxicillin|amoxicillin|mesh-list
2674957|NCT02175927|Metronidazole|metronidazole|mesh-list
2674958|NCT02175927|Tetracycline|tetracycline|mesh-list
2674959|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2674960|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
2674961|NCT02175927|Lansoprazole|lansoprazole|mesh-list
2674962|NCT02175927|Bismuth|bismuth|mesh-list
2674963|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2186221|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186222|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186223|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186224|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186225|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
2186226|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186227|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186228|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2186229|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
2186230|NCT00002987|Hormones|hormones|mesh-ancestor
2186231|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2674964|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674965|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674966|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
2674967|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2674968|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2674969|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2674970|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2674971|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674972|NCT02175927|Antacids|antacids|mesh-ancestor
2674973|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2674974|NCT02175927|Diuretics|diuretics|mesh-ancestor
2674975|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
2674976|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2674977|NCT02175927|Expectorants|expectorants|mesh-ancestor
2674978|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
2674979|NCT02176044|Nitroprusside|nitroprusside|mesh-list
2674980|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2674981|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
2674982|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2674983|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674984|NCT02176057|Azithromycin|azithromycin|mesh-list
2674985|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2674986|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674987|NCT02176122|Meropenem|meropenem|mesh-list
2674988|NCT02176122|Tazobactam|tazobactam|mesh-list
2674989|NCT02176122|Piperacillin|piperacillin|mesh-list
2674990|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2674991|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2674992|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2674993|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2674994|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2674995|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2674996|NCT02176135|Auranofin|auranofin|mesh-list
2674997|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2674998|NCT02176161|Metformin|metformin|mesh-list
2674999|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2675000|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675001|NCT02176187|Fenoterol|fenoterol|mesh-list
2675002|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2675003|NCT02176187|Ipratropium|ipratropium|mesh-list
2675004|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2675005|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
2675006|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675007|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675008|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2675009|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
2675010|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
2675011|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
2675012|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2675013|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2675014|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2675015|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2675016|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
2675017|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675018|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675019|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2675020|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
2675021|NCT02176200|Fenoterol|fenoterol|mesh-list
2675022|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2675023|NCT02176200|Ipratropium|ipratropium|mesh-list
2675024|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2675025|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
2675026|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675027|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675028|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2675029|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
2675030|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
2675031|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
2675032|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2675033|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2675034|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2675035|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2675036|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
2675037|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675038|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675039|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2675040|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
2675041|NCT02176213|Dexamethasone|dexamethasone|mesh-list
2675042|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
2675043|NCT02176213|Pomalidomide|pomalidomide|mesh-list
2675044|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2675045|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
2675046|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675047|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2675048|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2675049|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
2675050|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675051|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675052|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2675053|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2675054|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
2675055|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
2675056|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675057|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2675058|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
2675059|NCT02176213|Hormones|hormones|mesh-ancestor
2675060|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2675061|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2675062|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2675063|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2675064|NCT02176213|Growth Substances|growth substances|mesh-ancestor
2675065|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
2675066|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2675067|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
2675068|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2675069|NCT02176304|Prednisolone|prednisolone|mesh-list
2675070|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
2675071|NCT02176304|Lidocaine|lidocaine|mesh-list
2675072|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2675073|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
2675074|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
2675075|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
2675076|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2675077|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675078|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
2675079|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2186232|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2186233|NCT00002988|Irinotecan|irinotecan|mesh-list
2186234|NCT00002988|Carmustine|carmustine|mesh-list
2186235|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2186236|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186237|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186238|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186239|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186240|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186241|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
2186242|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
2186243|NCT00002989|Melphalan|melphalan|mesh-list
2186244|NCT00002989|Busulfan|busulfan|mesh-list
2186245|NCT00002989|Idarubicin|idarubicin|mesh-list
2186246|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186247|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
2186248|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186249|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186250|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186251|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
2675080|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2675081|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2675082|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2675083|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2675084|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675085|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2675086|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
2675087|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
2675088|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2675089|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
2675090|NCT02176304|Hormones|hormones|mesh-ancestor
2675091|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2675092|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2675093|NCT02176304|Protective Agents|protective agents|mesh-ancestor
2675094|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2675095|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675096|NCT02176369|Vinorelbine|vinorelbine|mesh-list
2675097|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2675098|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675099|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
2675100|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
2675101|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
2675102|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675103|NCT02176460|Colchicine|colchicine|mesh-list
2675104|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
2675105|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2675106|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
2675107|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
2675108|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
2675109|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186252|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186253|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186254|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186255|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186256|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186257|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186258|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186259|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
2675110|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675111|NCT02176499|Telmisartan|telmisartan|mesh-list
2675112|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675113|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2675114|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2675115|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675116|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2675117|NCT02176512|Telmisartan|telmisartan|mesh-list
2675118|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675119|NCT02176512|Diuretics|diuretics|mesh-ancestor
2675120|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
2675121|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675122|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2675123|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2675124|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675125|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2675126|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2675127|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
2675128|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
2675129|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675130|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675131|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2675132|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
2675139|NCT02176681|Vildagliptin|vildagliptin|mesh-list
2675140|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2675141|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675142|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2675143|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
2675144|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675145|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675146|NCT02176720|Fluorides|fluorides|mesh-list
2675147|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
2675148|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
2675149|NCT02176720|Protective Agents|protective agents|mesh-ancestor
2675150|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675151|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
2675152|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675153|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186260|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2186261|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
2186262|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186263|NCT00002993|Doxorubicin|doxorubicin|mesh-list
2186264|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2186265|NCT00002993|Mitomycins|mitomycins|mesh-list
2186266|NCT00002993|Mitomycin|mitomycin|mesh-list
2186267|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186268|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186269|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186270|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186271|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186272|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186273|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
2186274|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2186275|NCT00002994|Interleukin-2|interleukin-2|mesh-list
2186276|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186277|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2186278|NCT00002994|Analgesics|analgesics|mesh-ancestor
2186279|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
2186280|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675154|NCT02176733|Cyclosporine|cyclosporine|mesh-list
2675155|NCT02176733|Cyclosporins|cyclosporins|mesh-list
2675156|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675157|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675158|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2675159|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
2675160|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675161|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
2675162|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2675163|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
2675164|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2675165|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2675166|NCT02176759|Citric Acid|citric acid|mesh-list
2675167|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
2675168|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
2675169|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2675170|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
2675171|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
2675172|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675173|NCT02176850|Telmisartan|telmisartan|mesh-list
2675174|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675175|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2675176|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2675177|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675178|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2675179|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
2675180|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675181|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
2675182|NCT02176967|Carboplatin|carboplatin|mesh-list
2675183|NCT02176967|Doxorubicin|doxorubicin|mesh-list
2675184|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2675185|NCT02176967|Etoposide|etoposide|mesh-list
2675186|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
2675187|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
2675188|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2675189|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
2675190|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675191|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2675192|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2675193|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
2675194|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675195|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675196|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2675197|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186281|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186282|NCT00002995|Dactinomycin|dactinomycin|mesh-list
2186283|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
2186284|NCT00002995|Vincristine|vincristine|mesh-list
2675198|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2675199|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2675200|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675201|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2675202|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
2675203|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
2675204|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
2675205|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
2675206|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
2675207|NCT02177071|Methotrexate|methotrexate|mesh-list
2675208|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
2186285|NCT00002995|Sargramostim|sargramostim|mesh-list
2186286|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186287|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
2186288|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186289|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186290|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186291|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
2675209|NCT02177071|Azathioprine|azathioprine|mesh-list
2675210|NCT02177071|Infliximab|infliximab|mesh-list
2675211|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2675212|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
2675213|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2675214|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675215|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2675216|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
2675217|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675218|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675219|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
2675220|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675221|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2675222|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2675223|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
2675224|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2675225|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2675226|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2675227|NCT02177175|Carvedilol|carvedilol|mesh-list
2675228|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2675229|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2675230|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
2675231|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675232|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675233|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675234|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675235|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
2675236|NCT02177175|Protective Agents|protective agents|mesh-ancestor
2675237|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2675238|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2675239|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2675240|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
2186292|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186293|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186294|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186295|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186296|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
2186297|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186298|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186299|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2186300|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186301|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186302|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2186303|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186304|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2186305|NCT00002996|Flecainide|flecainide|mesh-list
2186306|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2186307|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2186308|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2186309|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2675241|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2675242|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2675243|NCT02177253|Bromides|bromides|mesh-list
2675244|NCT02177253|Albuterol|albuterol|mesh-list
2675245|NCT02177253|Ipratropium|ipratropium|mesh-list
2675246|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
2675247|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2675248|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
2675249|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675250|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675251|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2675252|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
2675253|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
2675254|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2675255|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2675256|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2675257|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2675258|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
2675259|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675260|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675261|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2675262|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
2675263|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2675264|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
2675265|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2675266|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
2675267|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675268|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675269|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2675270|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
2675271|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
2675272|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2675273|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
2675274|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2186310|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186311|NCT00002998|Gemcitabine|gemcitabine|mesh-list
2186312|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186313|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186314|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
2186315|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675275|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675276|NCT02177318|Bromides|bromides|mesh-list
2675277|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
2675278|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2675279|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
2675280|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675281|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675282|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2675283|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
2675284|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
2675285|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2675286|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
2675287|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675288|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675289|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
2675290|NCT02177331|Lacidipine|lacidipine|mesh-list
2675291|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675292|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2675293|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2675294|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675295|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2675296|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675297|NCT02177344|Bromides|bromides|mesh-list
2675298|NCT02177344|Ipratropium|ipratropium|mesh-list
2675299|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
2675300|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2675301|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
2675302|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675303|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675304|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2675305|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
2675306|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2675307|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
2675308|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675309|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675310|NCT02177357|Pramipexole|pramipexole|mesh-list
2675311|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
2675312|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675313|NCT02177357|Protective Agents|protective agents|mesh-ancestor
2675314|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675315|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2675316|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2675317|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
2675318|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
2675319|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675320|NCT02177370|Fenoterol|fenoterol|mesh-list
2675321|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2675322|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
2675323|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675324|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675325|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2675326|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
2675327|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
2675328|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
2675329|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2675330|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2675331|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2675332|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2675333|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
2675334|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675335|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675336|NCT02177396|Valsartan|valsartan|mesh-list
2675337|NCT02177396|Telmisartan|telmisartan|mesh-list
2675338|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675339|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2675340|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2675341|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675342|NCT02177409|Amlodipine|amlodipine|mesh-list
2675343|NCT02177409|Telmisartan|telmisartan|mesh-list
2675344|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675345|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2675346|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2675347|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675348|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2675349|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675350|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
2675351|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2675352|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2675353|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2675354|NCT02177422|Telmisartan|telmisartan|mesh-list
2675355|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675356|NCT02177422|Diuretics|diuretics|mesh-ancestor
2675357|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
2675358|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675359|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2675360|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2675361|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675362|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2675363|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2675364|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2675365|NCT02177435|Telmisartan|telmisartan|mesh-list
2675366|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
2675367|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675368|NCT02177435|Diuretics|diuretics|mesh-ancestor
2675369|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
2675370|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186316|NCT00002998|Antiviral Agents|antiviral agents|mesh-ancestor
2186317|NCT00002998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186318|NCT00002998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186319|NCT00002998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186320|NCT00002998|Immunologic Factors|immunologic factors|mesh-ancestor
2186321|NCT00002998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186322|NCT00002999|Fluorouracil|fluorouracil|mesh-list
2186323|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186324|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
2186325|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186326|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186327|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186328|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
2675371|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2675372|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2675373|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675374|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2675375|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2675376|NCT02177448|Enalapril|enalapril|mesh-list
2675377|NCT02177448|Enalaprilat|enalaprilat|mesh-list
2675378|NCT02177448|Telmisartan|telmisartan|mesh-list
2675379|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2675380|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
2675381|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675382|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675383|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675384|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2675385|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2675386|NCT02177461|Telmisartan|telmisartan|mesh-list
2675387|NCT02177461|Clonidine|clonidine|mesh-list
2675388|NCT02177461|Enalapril|enalapril|mesh-list
2675389|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675390|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2675391|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2675392|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675393|NCT02177461|Analgesics|analgesics|mesh-ancestor
2675394|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
2675395|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675396|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675397|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
2675398|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
2675399|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2675400|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2675401|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2675402|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
2675403|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675404|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2675405|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
2675406|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675407|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2675408|NCT02177487|Telmisartan|telmisartan|mesh-list
2675409|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
2675410|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675411|NCT02177487|Diuretics|diuretics|mesh-ancestor
2675412|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
2186329|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186330|NCT00003000|Fentanyl|fentanyl|mesh-list
2186331|NCT00003000|Morphine|morphine|mesh-list
2186332|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2186333|NCT00003000|Narcotics|narcotics|mesh-ancestor
2186334|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2186335|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186336|NCT00003000|Analgesics|analgesics|mesh-ancestor
2186337|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
2186338|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2186339|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2186340|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2186341|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
2186342|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
2186343|NCT00003001|Leucovorin|leucovorin|mesh-list
2186344|NCT00003001|Gemcitabine|gemcitabine|mesh-list
2186345|NCT00003001|Fluorouracil|fluorouracil|mesh-list
2186346|NCT00003001|Calcium|calcium|mesh-list
2186347|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
2186348|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186349|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
2186350|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186351|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186352|NCT00003001|Antiviral Agents|antiviral agents|mesh-ancestor
2186353|NCT00003001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186354|NCT00003001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186355|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186356|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
2186357|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186358|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2186359|NCT00003001|Antidotes|antidotes|mesh-ancestor
2186360|NCT00003001|Protective Agents|protective agents|mesh-ancestor
2186361|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
2675413|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675414|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2675415|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2675416|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675417|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2675418|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2675419|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2675420|NCT02177500|Telmisartan|telmisartan|mesh-list
2675421|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
2675422|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675423|NCT02177500|Diuretics|diuretics|mesh-ancestor
2675424|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
2675425|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675426|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2675427|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2675428|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675429|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2675430|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2675431|NCT02177539|Phenylephrine|phenylephrine|mesh-list
2675432|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
2675433|NCT02177539|Tropicamide|tropicamide|mesh-list
2675434|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
2675435|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2675436|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
2675437|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
2675438|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675439|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675440|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
2675441|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2675442|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
2675443|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
2675444|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2675445|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2675446|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2675447|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
2675448|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675449|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186362|NCT00003001|Vitamins|vitamins|mesh-ancestor
2186363|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
2186364|NCT00003002|Sargramostim|sargramostim|mesh-list
2186365|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
2186366|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186367|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
2186368|NCT00003003|Mitomycins|mitomycins|mesh-list
2186369|NCT00003003|Mitomycin|mitomycin|mesh-list
2186370|NCT00003003|Sargramostim|sargramostim|mesh-list
2186371|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
2186372|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186373|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186374|NCT00003003|Analgesics|analgesics|mesh-ancestor
2186375|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
2186376|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675450|NCT02177539|Protective Agents|protective agents|mesh-ancestor
2675451|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2675452|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2675453|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
2675454|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
2675455|NCT02177552|Carboplatin|carboplatin|mesh-list
2675456|NCT02177552|Docetaxel|docetaxel|mesh-list
2675457|NCT02177552|Capecitabine|capecitabine|mesh-list
2675458|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
2675459|NCT02177552|Epirubicin|epirubicin|mesh-list
2675460|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675461|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
2675462|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
2675463|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
2675464|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675465|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2675466|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
2675467|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2675468|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2675469|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2675470|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675471|NCT02177578|Temozolomide|temozolomide|mesh-list
2186377|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2675472|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2675473|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
2675474|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675475|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675476|NCT02177643|Diacetylrhein|diacetylrhein|mesh-list
2675477|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2186378|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186379|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186380|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186381|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186382|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
2186383|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2186384|NCT00003004|Paclitaxel|paclitaxel|mesh-list
2186385|NCT00003004|Alvocidib|alvocidib|mesh-list
2186386|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186387|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186388|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
2186389|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186390|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
2675506|NCT02177734|Vaccines|vaccines|mesh-list
2675507|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
2675508|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675509|NCT02177760|Sirolimus|sirolimus|mesh-list
2675510|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2675511|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2675512|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2675513|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675514|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
2675515|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2675516|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
2675517|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675518|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
2675519|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675520|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2675521|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675522|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675523|NCT02177851|Iron|iron|mesh-list
2675524|NCT02177851|Trace Elements|trace elements|mesh-ancestor
2675525|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
2675526|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675527|NCT02177955|Midazolam|midazolam|mesh-list
2675528|NCT02177955|Diazepam|diazepam|mesh-list
2675529|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2675530|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2675531|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2675532|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675533|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2186391|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675534|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2675535|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2675536|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2675537|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
2675538|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
2675539|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
2675540|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
2675541|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675542|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675543|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
2675544|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
2675545|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
2675546|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675547|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2675548|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2675549|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2675550|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
2675551|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2675552|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2675553|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2675554|NCT02178098|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
2675555|NCT02178098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2675556|NCT02178098|Antimetabolites|antimetabolites|mesh-ancestor
2675557|NCT02178098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675558|NCT02178098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2675559|NCT02178098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675560|NCT02178098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2186392|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
2186393|NCT00003004|Growth Substances|growth substances|mesh-ancestor
2186394|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186395|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2186396|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186397|NCT00003005|Cordycepin|cordycepin|mesh-list
2186398|NCT00003005|Pentostatin|pentostatin|mesh-list
2186399|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186400|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2186401|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675561|NCT02178098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675562|NCT02178124|Donepezil|donepezil|mesh-list
2675563|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2675564|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675565|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675566|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
2675567|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675568|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675569|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
2675570|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
2675571|NCT02178137|Astringents|astringents|mesh-ancestor
2675572|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675573|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
2675574|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
2675575|NCT02178150|Antacids|antacids|mesh-ancestor
2675576|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675577|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2675578|NCT02178254|Fosfomycin|fosfomycin|mesh-list
2675579|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2675580|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2675581|NCT02178293|Ketoprofen|ketoprofen|mesh-list
2675582|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
2675583|NCT02178293|Benzydamine|benzydamine|mesh-list
2675584|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2675585|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2186402|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186403|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
2186404|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186405|NCT00003007|Interferons|interferons|mesh-list
2186406|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
2186407|NCT00003007|Dexamethasone|dexamethasone|mesh-list
2186408|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
2186409|NCT00003007|Melphalan|melphalan|mesh-list
2186410|NCT00003007|Sargramostim|sargramostim|mesh-list
2675586|NCT02178293|Analgesics|analgesics|mesh-ancestor
2675587|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
2675588|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675589|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675590|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2675591|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2675592|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2675593|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675594|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186411|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186412|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
2186413|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186414|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186415|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186416|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
2186417|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675595|NCT02178306|Telmisartan|telmisartan|mesh-list
2675596|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675597|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2675598|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2675599|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675600|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2675601|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675602|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2675603|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675604|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675605|NCT02178410|Vitamin D|vitamin d|mesh-list
2675606|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
2675607|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
2675608|NCT02178410|Vitamins|vitamins|mesh-list
2675609|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
2675610|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675611|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2675612|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2675613|NCT02178436|Gemcitabine|gemcitabine|mesh-list
2675614|NCT02178436|Paclitaxel|paclitaxel|mesh-list
2675615|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2675616|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2675617|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675618|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
2675619|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
2675620|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
2675621|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675622|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2675623|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
2675624|NCT02178436|Antiviral Agents|antiviral agents|mesh-ancestor
2675625|NCT02178436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2675626|NCT02178436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675627|NCT02178436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2675628|NCT02178436|Immunologic Factors|immunologic factors|mesh-ancestor
2675629|NCT02178436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675630|NCT02178449|Dexamethasone|dexamethasone|mesh-list
2675631|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
2675632|NCT02178449|Ropivacaine|ropivacaine|mesh-list
2675633|NCT02178449|BB 1101|bb 1101|mesh-list
2675634|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2675635|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
2675636|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
2675637|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675638|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675639|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2675640|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
2675641|NCT02178449|Hormones|hormones|mesh-ancestor
2675642|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2675643|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2675644|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675645|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
2675646|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
2675647|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2675648|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
2675649|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
2675650|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675651|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675652|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
2675653|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2675654|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675655|NCT02178488|Vitamins|vitamins|mesh-ancestor
2675656|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
2675657|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2675658|NCT02178566|Treprostinil|treprostinil|mesh-list
2675659|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675660|NCT02178644|Capecitabine|capecitabine|mesh-list
2186418|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186419|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2675661|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2675662|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
2186420|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2186421|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
2186422|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
2186423|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2186424|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2186425|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
2186426|NCT00003007|Hormones|hormones|mesh-ancestor
2186427|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2186428|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2186429|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
2675663|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675664|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675665|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
2675666|NCT02178683|Tacrolimus|tacrolimus|mesh-list
2675667|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2675668|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
2675669|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675670|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2675671|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675672|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675673|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2675674|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675675|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2675676|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
2675677|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2675678|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2675679|NCT02178761|Chromium|chromium|mesh-list
2675680|NCT02178761|Everolimus|everolimus|mesh-list
2675681|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675682|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2675683|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
2675684|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675685|NCT02178761|Trace Elements|trace elements|mesh-ancestor
2675686|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
2675687|NCT02178813|Minocycline|minocycline|mesh-list
2675688|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2675689|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2675690|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2675691|NCT02179008|Latanoprost|latanoprost|mesh-list
2675692|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2675693|NCT02179034|Menthol|menthol|mesh-list
2675694|NCT02179034|Nicotine|nicotine|mesh-list
2675695|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2675696|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
2675697|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675698|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675699|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2675700|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2675701|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
2675702|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675703|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675704|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
2675705|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
2675711|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
2675712|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2675713|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2675714|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2675715|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675716|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
2675717|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675718|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675719|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2675720|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675721|NCT02179151|CKD732|ckd732|mesh-list
2675722|NCT02179151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2186430|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186431|NCT00003008|Ritonavir|ritonavir|mesh-list
2186432|NCT00003008|Nelfinavir|nelfinavir|mesh-list
2186433|NCT00003008|Indinavir|indinavir|mesh-list
2186434|NCT00003008|Saquinavir|saquinavir|mesh-list
2186435|NCT00003008|Paclitaxel|paclitaxel|mesh-list
2186436|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186437|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186438|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
2186439|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186440|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186441|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186442|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2186443|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2186444|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
2186445|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186446|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2186447|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2186448|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
2186449|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186450|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2186451|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2186452|NCT00003009|Aldesleukin|aldesleukin|mesh-list
2186453|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186454|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2186455|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2186456|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
2186457|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186458|NCT00003010|Marimastat|marimastat|mesh-list
2186459|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186460|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186461|NCT00003011|Marimastat|marimastat|mesh-list
2186462|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675723|NCT02179151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2675724|NCT02179151|Growth Substances|growth substances|mesh-ancestor
2675725|NCT02179151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675726|NCT02179151|Growth Inhibitors|growth inhibitors|mesh-ancestor
2675727|NCT02179151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675728|NCT02179255|Hormones|hormones|mesh-list
2675729|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2675730|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2675731|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675732|NCT02179268|Sertraline|sertraline|mesh-list
2675733|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2675734|NCT02179268|Citalopram|citalopram|mesh-list
2675735|NCT02179268|Reboxetine|reboxetine|mesh-list
2675736|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
2675737|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2675738|NCT02179268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2675739|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2675740|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2675741|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675742|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675743|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
2675744|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675745|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2675746|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2675747|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2675748|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
2675749|NCT02179294|Meperidine|meperidine|mesh-list
2675750|NCT02179294|Remifentanil|remifentanil|mesh-list
2675751|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2675752|NCT02179294|Narcotics|narcotics|mesh-ancestor
2675753|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2675754|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675755|NCT02179294|Analgesics|analgesics|mesh-ancestor
2675756|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
2675757|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675758|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2675759|NCT02179528|Etoposide|etoposide|mesh-list
2675760|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2675761|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186463|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186464|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
2186465|NCT00003012|Fluorouracil|fluorouracil|mesh-list
2186466|NCT00003012|Methotrexate|methotrexate|mesh-list
2186467|NCT00003012|Epirubicin|epirubicin|mesh-list
2675762|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2675763|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2675764|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675765|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675766|NCT02179567|Bevacizumab|bevacizumab|mesh-list
2675767|NCT02179567|Docetaxel|docetaxel|mesh-list
2675768|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2675769|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675770|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2675771|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2675772|NCT02179567|Growth Substances|growth substances|mesh-ancestor
2675773|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675774|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
2675775|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
2675776|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
2675777|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
2675778|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675779|NCT02179645|Celecoxib|celecoxib|mesh-list
2675780|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2675781|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2675782|NCT02179645|Analgesics|analgesics|mesh-ancestor
2675783|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
2675784|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675785|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675786|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2675787|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2675788|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2675789|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2675790|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675791|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675792|NCT02179658|Vancomycin|vancomycin|mesh-list
2675793|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
2675794|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2675795|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2675796|NCT02179749|Mifepristone|mifepristone|mesh-list
2675797|NCT02179749|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2675798|NCT02179749|Abortifacient Agents|abortifacient agents|mesh-ancestor
2675799|NCT02179749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2675800|NCT02179749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675801|NCT02179749|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2675802|NCT02179749|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2675803|NCT02179749|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2675804|NCT02179749|Contraceptive Agents|contraceptive agents|mesh-ancestor
2186468|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186469|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
2186470|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186471|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186472|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186473|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
2186474|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186475|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186476|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186477|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
2186478|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186479|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2186480|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
2186481|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2675805|NCT02179749|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2675806|NCT02179749|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2675807|NCT02179749|Hormone Antagonists|hormone antagonists|mesh-ancestor
2675808|NCT02179749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2675809|NCT02179749|Luteolytic Agents|luteolytic agents|mesh-ancestor
2675810|NCT02179749|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2675811|NCT02179749|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2675812|NCT02179775|Propranolol|propranolol|mesh-list
2675813|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2675814|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2675815|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
2675816|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675817|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675818|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675819|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2675820|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2675821|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
2675822|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
2675823|NCT02179814|Promethazine|promethazine|mesh-list
2675824|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2675825|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2186482|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
2186483|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186484|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2186485|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2186486|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186487|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186488|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186489|NCT00003013|Tamoxifen|tamoxifen|mesh-list
2186490|NCT00003013|Paclitaxel|paclitaxel|mesh-list
2186491|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
2186492|NCT00003013|Doxorubicin|doxorubicin|mesh-list
2186493|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2186494|NCT00003013|Fluorouracil|fluorouracil|mesh-list
2186495|NCT00003013|Methotrexate|methotrexate|mesh-list
2186496|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186497|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186498|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
2186499|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186500|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186501|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186502|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186503|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
2186504|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186505|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186506|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2675826|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2675827|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675828|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
2675829|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
2675830|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
2675831|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2186507|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
2186508|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186509|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186510|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2675832|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
2675833|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
2675834|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2675835|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2675836|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
2675837|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
2675838|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675839|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675840|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2675841|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
2675842|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
2675843|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2675844|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2675845|NCT02179931|Flupenthixol|flupenthixol|mesh-list
2675846|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
2675847|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2675848|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2675849|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2675850|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675851|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2675852|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2675853|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
2675854|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675855|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675856|NCT02179970|Plerixafor|plerixafor|mesh-list
2675857|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2675858|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2675859|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
2675860|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2675861|NCT02179996|Vaccines|vaccines|mesh-list
2675862|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
2675863|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675864|NCT02180048|Caffeine|caffeine|mesh-list
2675865|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2675866|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186511|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186512|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186513|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
2186514|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186515|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2186516|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
2186517|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2186518|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
2675867|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2675868|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675869|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675870|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2675871|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2675872|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
2675873|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675874|NCT02180087|Ketoprofen|ketoprofen|mesh-list
2675875|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2675876|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2675877|NCT02180087|Analgesics|analgesics|mesh-ancestor
2675878|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
2675879|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675880|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675881|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2675882|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2675883|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2675884|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675885|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675886|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2675887|NCT02180204|Tenecteplase|tenecteplase|mesh-list
2675888|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2675889|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2675890|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675891|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
2675892|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2675893|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2675894|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675895|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
2675896|NCT02180321|Coagulants|coagulants|mesh-ancestor
2675897|NCT02180334|Acetaminophen|acetaminophen|mesh-list
2675898|NCT02180334|Linagliptin|linagliptin|mesh-list
2675899|NCT02180334|Mosapride|mosapride|mesh-list
2675900|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2675901|NCT02180334|Analgesics|analgesics|mesh-ancestor
2675902|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
2675903|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675904|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675905|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
2675906|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675907|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2675908|NCT02180334|Incretins|incretins|mesh-ancestor
2675909|NCT02180334|Hormones|hormones|mesh-ancestor
2675910|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2675911|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2675912|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
2675913|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675914|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2675915|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2675916|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
2675917|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675918|NCT02180425|Adapalene|adapalene|mesh-list
2675919|NCT02180425|Tretinoin|tretinoin|mesh-list
2675920|NCT02180425|Isotretinoin|isotretinoin|mesh-list
2675921|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
2675922|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2675923|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2675924|NCT02180425|Analgesics|analgesics|mesh-ancestor
2675925|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
2675926|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675927|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675928|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2675929|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2675930|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675931|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
2675932|NCT02180503|Linagliptin|linagliptin|mesh-list
2186519|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2675933|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2675934|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675935|NCT02180503|Incretins|incretins|mesh-ancestor
2675936|NCT02180503|Hormones|hormones|mesh-ancestor
2675937|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2675938|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2675939|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
2675940|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675941|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675942|NCT02180516|Meloxicam|meloxicam|mesh-list
2675943|NCT02180516|Etodolac|etodolac|mesh-list
2675944|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2675945|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2675946|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2675947|NCT02180516|Analgesics|analgesics|mesh-ancestor
2675948|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
2675949|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675950|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675951|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2675952|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2675953|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2675954|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2675955|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675956|NCT02180529|Methylphenidate|methylphenidate|mesh-list
2675957|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2675958|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675959|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2675960|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2675961|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2675962|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675963|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
2675964|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2186520|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2186521|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2186522|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
2186523|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2186524|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2186525|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2186526|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2186527|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2186528|NCT00003014|Carboplatin|carboplatin|mesh-list
2186529|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186530|NCT00003015|Carboplatin|carboplatin|mesh-list
2186531|NCT00003015|Vincristine|vincristine|mesh-list
2186532|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675965|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
2675966|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675967|NCT02180711|Rituximab|rituximab|mesh-list
2675968|NCT02180711|Lenalidomide|lenalidomide|mesh-list
2675969|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
2675970|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2675971|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2675972|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
2675973|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675974|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2675975|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2675976|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2675977|NCT02180711|Growth Substances|growth substances|mesh-ancestor
2675978|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
2675979|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
2675980|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2675981|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2675982|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2675983|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2675984|NCT02180737|Analgesics|analgesics|mesh-ancestor
2675985|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
2675986|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2675987|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2675988|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2675989|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2675990|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
2675991|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675992|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675993|NCT02180789|Tamsulosin|tamsulosin|mesh-list
2675994|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2675995|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2675996|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2186533|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186534|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
2186535|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186536|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186537|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2675997|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
2675998|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2675999|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676000|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676001|NCT02180789|Urological Agents|urological agents|mesh-ancestor
2676002|NCT02180880|Pregabalin|pregabalin|mesh-list
2676003|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
2676004|NCT02180880|Analgesics|analgesics|mesh-ancestor
2676005|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
2676006|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676007|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676008|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
2676009|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2676010|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2676011|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676012|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2676013|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2676014|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2676015|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2676016|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2676017|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2676018|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2676019|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2676020|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2676021|NCT02180997|Tamsulosin|tamsulosin|mesh-list
2676022|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
2676023|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2676024|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2676025|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2676026|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
2676027|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676028|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676029|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676030|NCT02180997|Urological Agents|urological agents|mesh-ancestor
2676031|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2676032|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2676033|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
2676034|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
2676035|NCT02181023|Bromides|bromides|mesh-list
2676036|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
2676037|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2676038|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2676039|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2676040|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
2676041|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676042|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676043|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676044|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
2676045|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2676046|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676047|NCT02181205|Bupivacaine|bupivacaine|mesh-list
2676048|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
2676049|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
2186538|NCT00003016|Tamoxifen|tamoxifen|mesh-list
2186539|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2186540|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
2186541|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2186542|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186543|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2186544|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186545|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2186546|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2186547|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2676050|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2676051|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676052|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
2676053|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676054|NCT02181218|Gemcitabine|gemcitabine|mesh-list
2676055|NCT02181218|Dexamethasone|dexamethasone|mesh-list
2676056|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
2676057|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
2676058|NCT02181218|Romidepsin|romidepsin|mesh-list
2676059|NCT02181218|BB 1101|bb 1101|mesh-list
2676060|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676061|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
2676062|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
2676063|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676064|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676065|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2676066|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
2676067|NCT02181218|Hormones|hormones|mesh-ancestor
2676068|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2676069|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2676070|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676071|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
2676072|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676073|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676074|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2676075|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
2676076|NCT02181218|Antiviral Agents|antiviral agents|mesh-ancestor
2676077|NCT02181218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2676078|NCT02181218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2676079|NCT02181218|Immunologic Factors|immunologic factors|mesh-ancestor
2676080|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2676081|NCT02181309|Meloxicam|meloxicam|mesh-list
2676082|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676083|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676084|NCT02181309|Analgesics|analgesics|mesh-ancestor
2676085|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
2676086|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676087|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676088|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676089|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676090|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676091|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676092|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676093|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676094|NCT02181322|Meloxicam|meloxicam|mesh-list
2676095|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676096|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676097|NCT02181322|Analgesics|analgesics|mesh-ancestor
2676098|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
2676099|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676100|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676101|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676102|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676103|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676104|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676105|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676106|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676107|NCT02181335|Budesonide|budesonide|mesh-list
2676108|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676109|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2676110|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
2676111|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676112|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676113|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2676114|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
2676115|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
2676116|NCT02181335|Hormones|hormones|mesh-ancestor
2676117|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2676118|NCT02181348|Vitamin E|vitamin e|mesh-list
2676119|NCT02181348|Vitamins|vitamins|mesh-ancestor
2676120|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
2676121|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676122|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
2676123|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676124|NCT02181348|Protective Agents|protective agents|mesh-ancestor
2186548|NCT00003017|Interleukin-12|interleukin-12|mesh-list
2186549|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2186550|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
2186551|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186552|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2186553|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2186554|NCT00003017|Growth Substances|growth substances|mesh-ancestor
2186555|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
2186556|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186557|NCT00003018|Leucovorin|leucovorin|mesh-list
2186558|NCT00003018|Fluorouracil|fluorouracil|mesh-list
2186559|NCT00003018|Mitomycins|mitomycins|mesh-list
2186560|NCT00003018|Mitomycin|mitomycin|mesh-list
2186561|NCT00003018|Dipyridamole|dipyridamole|mesh-list
2186562|NCT00003018|Calcium|calcium|mesh-list
2186563|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
2186564|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2186565|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186566|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
2186567|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186568|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186569|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186570|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186571|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
2186572|NCT00003018|Antidotes|antidotes|mesh-ancestor
2676125|NCT02181361|Aspirin|aspirin|mesh-list
2676126|NCT02181361|Hirudins|hirudins|mesh-list
2676127|NCT02181361|Warfarin|warfarin|mesh-list
2676128|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676129|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676130|NCT02181361|Analgesics|analgesics|mesh-ancestor
2676131|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
2676132|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676133|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676134|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2186573|NCT00003018|Protective Agents|protective agents|mesh-ancestor
2186574|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
2186575|NCT00003018|Vitamins|vitamins|mesh-ancestor
2186576|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
2186577|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186578|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
2186579|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2186580|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186581|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2186582|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2186583|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
2186584|NCT00003019|Methotrexate|methotrexate|mesh-list
2186585|NCT00003019|Vinblastine|vinblastine|mesh-list
2676135|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676136|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2676137|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2676138|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676139|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2676140|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676141|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676142|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
2676143|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
2676144|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
2676145|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2676146|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
2676147|NCT02181478|Cyclosporine|cyclosporine|mesh-list
2676148|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
2676149|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
2676150|NCT02181478|Fludarabine|fludarabine|mesh-list
2676151|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
2186586|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2186587|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
2186588|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2186589|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423097|NCT00820547|Bevacizumab|bevacizumab|mesh-list
2423098|NCT00820547|Docetaxel|docetaxel|mesh-list
2423099|NCT00820547|Fluorouracil|fluorouracil|mesh-list
2423100|NCT00820547|Epirubicin|epirubicin|mesh-list
2423101|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2423102|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
2423103|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423104|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2423105|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2423106|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
2676152|NCT02181478|Cyclosporins|cyclosporins|mesh-list
2676153|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2676154|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
2676155|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676156|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676157|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2676158|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
2676159|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676160|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676161|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186590|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186591|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
2186592|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676162|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2676163|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
2676164|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676165|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
2676166|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2676167|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
2676168|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2676169|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2676170|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2676171|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
2676172|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2676173|NCT02181543|Clonidine|clonidine|mesh-list
2676174|NCT02181543|Analgesics|analgesics|mesh-ancestor
2676175|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
2676176|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676177|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676178|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2676179|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
2676180|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
2676181|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2676182|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2676183|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2676184|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
2676185|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676186|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676187|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
2676188|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2676189|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2676190|NCT02181920|Dipyrone|dipyrone|mesh-list
2676191|NCT02181920|Diclofenac|diclofenac|mesh-list
2676192|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676193|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676194|NCT02181920|Analgesics|analgesics|mesh-ancestor
2676195|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
2676196|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676197|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676198|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676199|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676200|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676201|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676202|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676203|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
2676204|NCT02181933|Lamivudine|lamivudine|mesh-list
2676205|NCT02181933|Zidovudine|zidovudine|mesh-list
2676206|NCT02181933|Nevirapine|nevirapine|mesh-list
2676207|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2676208|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2676209|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676210|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676211|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
2676212|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2676213|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2676214|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2676215|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
2676216|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2676217|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2676218|NCT02181946|Nevirapine|nevirapine|mesh-list
2676219|NCT02181946|Fluconazole|fluconazole|mesh-list
2676220|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2676221|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2676222|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676223|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676224|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
2676225|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2676226|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2676227|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2676228|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2676229|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2676230|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
2676231|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2676232|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2676233|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2676234|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
2676235|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2676236|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676237|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2676238|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2676239|NCT02181985|Heparin|heparin|mesh-list
2676240|NCT02181985|Enoxaparin|enoxaparin|mesh-list
2676241|NCT02181985|Tenecteplase|tenecteplase|mesh-list
2676242|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2676243|NCT02181985|Abciximab|abciximab|mesh-list
2676244|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
2676245|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2676246|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2676247|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676248|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2676249|NCT02181998|Heparin|heparin|mesh-list
2676250|NCT02181998|Enoxaparin|enoxaparin|mesh-list
2676251|NCT02181998|Tenecteplase|tenecteplase|mesh-list
2676252|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
2676253|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2676254|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2676255|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676256|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2676257|NCT02182011|Tenecteplase|tenecteplase|mesh-list
2676258|NCT02182011|Streptokinase|streptokinase|mesh-list
2676259|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2676260|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2676261|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676262|NCT02182024|Dabigatran|dabigatran|mesh-list
2676263|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
2676264|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2676265|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
2676266|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676267|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676268|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
2676269|NCT02182050|Nintedanib|nintedanib|mesh-list
2676270|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676271|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2676272|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676273|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676274|NCT02182063|Nintedanib|nintedanib|mesh-list
2676275|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676276|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2676277|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676278|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676279|NCT02182076|Nintedanib|nintedanib|mesh-list
2676280|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676281|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2676282|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676283|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676284|NCT02182102|Pemetrexed|pemetrexed|mesh-list
2676285|NCT02182102|Nintedanib|nintedanib|mesh-list
2676286|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676287|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676288|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676289|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2676290|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2676291|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2676292|NCT02182128|Nintedanib|nintedanib|mesh-list
2676293|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676294|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2676295|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676296|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676297|NCT02182141|Nintedanib|nintedanib|mesh-list
2676298|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676299|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2676300|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676301|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676302|NCT02182154|Nintedanib|nintedanib|mesh-list
2676303|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676304|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2676305|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676306|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676307|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
2676308|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2676309|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
2676310|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2676311|NCT02182167|Expectorants|expectorants|mesh-ancestor
2676312|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
2676313|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2676314|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
2676315|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676316|NCT02182167|Protective Agents|protective agents|mesh-ancestor
2676317|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676318|NCT02182167|Antidotes|antidotes|mesh-ancestor
2676319|NCT02182193|Nintedanib|nintedanib|mesh-list
2676320|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676321|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2676322|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676323|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676324|NCT02182206|Nintedanib|nintedanib|mesh-list
2676325|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676326|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2676327|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676328|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676329|NCT02182219|Nintedanib|nintedanib|mesh-list
2676330|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676331|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2676332|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676333|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676334|NCT02182232|Paclitaxel|paclitaxel|mesh-list
2676335|NCT02182232|Carboplatin|carboplatin|mesh-list
2676336|NCT02182232|Nintedanib|nintedanib|mesh-list
2676337|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2676338|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676339|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
2676340|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
2676341|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
2676342|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676343|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2676344|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676345|NCT02182245|Paclitaxel|paclitaxel|mesh-list
2676346|NCT02182245|Carboplatin|carboplatin|mesh-list
2676347|NCT02182245|Nintedanib|nintedanib|mesh-list
2676348|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2676349|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676350|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
2676351|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
2676352|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
2676353|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676354|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2676355|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676356|NCT02182258|Nintedanib|nintedanib|mesh-list
2676357|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676358|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2676359|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676360|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676361|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
2676362|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2676363|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2676364|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2676365|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2676366|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676367|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676368|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676369|NCT02182336|Vitamin K|vitamin k|mesh-list
2676370|NCT02182336|Digoxin|digoxin|mesh-list
2676371|NCT02182336|Midazolam|midazolam|mesh-list
2676372|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
2676373|NCT02182336|Caffeine|caffeine|mesh-list
2676374|NCT02182336|Omeprazole|omeprazole|mesh-list
2676375|NCT02182336|Warfarin|warfarin|mesh-list
2676376|NCT02182336|Vitamins|vitamins|mesh-ancestor
2676377|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
2676378|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676379|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2676380|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2676381|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2676382|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2676383|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2676384|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2676385|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2676386|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
2676387|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
2676388|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
2676389|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
2676390|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676391|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676392|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
2676393|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2676394|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2676395|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2676396|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676397|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2676398|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2676399|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2676400|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2676401|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
2676402|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2676403|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2676404|NCT02182336|Protective Agents|protective agents|mesh-ancestor
2676405|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2676406|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2676407|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
2676408|NCT02182336|Coagulants|coagulants|mesh-ancestor
2676409|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
2676410|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
2676411|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2676412|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2676413|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
2676414|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2186593|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186594|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
2186595|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186596|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2186597|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186598|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
2186599|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186600|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2676415|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2676416|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
2676417|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2676418|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2676419|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2676420|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676421|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186601|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186602|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
2676422|NCT02182401|Tolbutamide|tolbutamide|mesh-list
2676423|NCT02182401|Midazolam|midazolam|mesh-list
2676424|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2676425|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2676426|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2676427|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676428|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2676429|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2676430|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2676431|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2676432|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
2676433|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
2676434|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
2676435|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
2676436|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676437|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676438|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2676439|NCT02182453|Empagliflozin|empagliflozin|mesh-list
2676440|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2676441|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186603|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186604|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186605|NCT00003020|Immunotoxins|immunotoxins|mesh-list
2186606|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
2186607|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186608|NCT00003021|Bizelesin|bizelesin|mesh-list
2186609|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186610|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186611|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186612|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
2186613|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186614|NCT00003022|Antibodies|antibodies|mesh-list
2186615|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2186616|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
2186617|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186618|NCT00003023|Vaccines|vaccines|mesh-list
2186619|NCT00003023|Antibodies|antibodies|mesh-list
2186620|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2186621|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
2186622|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
2186623|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186624|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2186625|NCT00003026|Bicalutamide|bicalutamide|mesh-list
2186626|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2186627|NCT00003026|Flutamide|flutamide|mesh-list
2186628|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
2676442|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2676443|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676444|NCT02182479|Fenoterol|fenoterol|mesh-list
2676445|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2676446|NCT02182479|Ipratropium|ipratropium|mesh-list
2676447|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2676448|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
2676449|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676450|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676451|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2676452|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
2676453|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
2676454|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
2676455|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2676456|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2676457|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2676458|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2676459|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
2676460|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676461|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676462|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2676463|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
2676464|NCT02182505|Fenoterol|fenoterol|mesh-list
2676465|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2676466|NCT02182505|Ipratropium|ipratropium|mesh-list
2676467|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2676468|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
2676469|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676470|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676471|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2676472|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
2676473|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
2676474|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
2676475|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2676476|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2676477|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2676478|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2676479|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
2676480|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676481|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676482|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2676483|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
2676484|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
2676485|NCT02182518|Ephedrine|ephedrine|mesh-list
2676486|NCT02182518|Epinastine|epinastine|mesh-list
2676487|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2676488|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
2676489|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676490|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186629|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
2676491|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2676492|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
2676493|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
2676494|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2676495|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2676496|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
2676497|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
2676498|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676499|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676500|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2676501|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
2676502|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
2676503|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
2676504|NCT02182531|Ephedrine|ephedrine|mesh-list
2676505|NCT02182531|Epinastine|epinastine|mesh-list
2676506|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2676507|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
2676508|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676509|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676510|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2676511|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
2676512|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
2676513|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2676514|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2676515|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
2676516|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
2676517|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676518|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676519|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2676520|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
2676521|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
2676522|NCT02182544|Ketotifen|ketotifen|mesh-list
2676523|NCT02182544|Epinastine|epinastine|mesh-list
2676524|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
2676525|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
2676526|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2676527|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
2676528|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
2676529|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676530|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676531|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676532|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2676533|NCT02182557|Ketotifen|ketotifen|mesh-list
2676534|NCT02182557|Epinastine|epinastine|mesh-list
2676535|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
2676536|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
2676537|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2676538|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
2676539|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
2676540|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676541|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676542|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676543|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2676544|NCT02182570|Epinastine|epinastine|mesh-list
2676545|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2676546|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
2676547|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
2676548|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676549|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676550|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676551|NCT02182583|Oxitropium|oxitropium|mesh-list
2676552|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
2676553|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
2676554|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676555|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676556|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
2676557|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2676558|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676559|NCT02182622|Prednisone|prednisone|mesh-list
2676560|NCT02182622|Docetaxel|docetaxel|mesh-list
2676561|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676562|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
2676563|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
2676564|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
2676565|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676566|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676567|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
2676568|NCT02182622|Hormones|hormones|mesh-ancestor
2676569|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2676570|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676571|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2676572|NCT02182635|Oxitropium|oxitropium|mesh-list
2676573|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
2676574|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
2676575|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676576|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676577|NCT02182648|Propofol|propofol|mesh-list
2676578|NCT02182648|Etomidate|etomidate|mesh-list
2676579|NCT02182648|Sevoflurane|sevoflurane|mesh-list
2676580|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2676581|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2676582|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676583|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2676584|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
2676585|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
2676586|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2676587|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2676588|NCT02182661|Oxitropium|oxitropium|mesh-list
2676589|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
2676590|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
2676591|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676592|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676601|NCT02182700|Bromides|bromides|mesh-list
2676602|NCT02182700|Albuterol|albuterol|mesh-list
2676603|NCT02182700|Ipratropium|ipratropium|mesh-list
2676604|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
2676605|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2676606|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
2676607|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676608|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676609|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2676610|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
2676611|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
2676612|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2676613|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2676614|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2676615|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2676616|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
2676617|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676618|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676619|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2676620|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
2676621|NCT02182713|Bromides|bromides|mesh-list
2676622|NCT02182713|Albuterol|albuterol|mesh-list
2676623|NCT02182713|Ipratropium|ipratropium|mesh-list
2676624|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
2676625|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2676626|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
2676627|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676628|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676629|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2676630|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
2676631|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
2676632|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2676633|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2676634|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2676635|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2676636|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
2676637|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676638|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676639|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2676640|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
2676641|NCT02182739|Meloxicam|meloxicam|mesh-list
2676642|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676643|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676644|NCT02182739|Analgesics|analgesics|mesh-ancestor
2676645|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
2676646|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676647|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676648|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676649|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676650|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676651|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676652|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676653|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676654|NCT02182752|Tramadol|tramadol|mesh-list
2676655|NCT02182752|Ropivacaine|ropivacaine|mesh-list
2676656|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
2676657|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
2676658|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2676659|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676660|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
2676661|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676662|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2676663|NCT02182752|Narcotics|narcotics|mesh-ancestor
2676664|NCT02182752|Analgesics|analgesics|mesh-ancestor
2676665|NCT02182765|Nevirapine|nevirapine|mesh-list
2676666|NCT02182765|Abacavir|abacavir|mesh-list
2676667|NCT02182765|Amprenavir|amprenavir|mesh-list
2676668|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2676669|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2676670|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676671|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676672|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
2676673|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2676674|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2676675|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2676676|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2676677|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2676678|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2676679|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
2676680|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2676681|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2676682|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2676683|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
2676684|NCT02182778|Gemcitabine|gemcitabine|mesh-list
2676685|NCT02182778|Cisplatin|cisplatin|mesh-list
2676686|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676687|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2676688|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
2676689|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676690|NCT02182778|Antiviral Agents|antiviral agents|mesh-ancestor
2676691|NCT02182778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2676692|NCT02182778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186630|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2186631|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676693|NCT02182778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2676694|NCT02182778|Immunologic Factors|immunologic factors|mesh-ancestor
2676695|NCT02182778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676696|NCT02182791|Nevirapine|nevirapine|mesh-list
2676697|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2676698|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2676699|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676700|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676701|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
2676702|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2676703|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2676704|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2676705|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2676706|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2676707|NCT02182856|Bromides|bromides|mesh-list
2676708|NCT02182856|Albuterol|albuterol|mesh-list
2676709|NCT02182856|Ipratropium|ipratropium|mesh-list
2676710|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
2676711|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2676712|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
2676713|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676714|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676715|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2676716|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
2676717|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
2676718|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2676719|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2676720|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2676721|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2676722|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
2676723|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676724|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676725|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2676726|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
2676727|NCT02182960|Ibuprofen|ibuprofen|mesh-list
2676728|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676729|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676730|NCT02182960|Analgesics|analgesics|mesh-ancestor
2676731|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
2676732|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676733|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676734|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676735|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186632|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186633|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
2186634|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2676736|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676737|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676738|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676739|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2676740|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
2676741|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676742|NCT02183012|Ibuprofen|ibuprofen|mesh-list
2676743|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676744|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676745|NCT02183012|Analgesics|analgesics|mesh-ancestor
2676746|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
2676747|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2186635|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
2186636|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2186637|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2186638|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2186639|NCT00003027|Interferons|interferons|mesh-list
2186640|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
2186641|NCT00003027|Aldesleukin|aldesleukin|mesh-list
2186642|NCT00003027|Dacarbazine|dacarbazine|mesh-list
2186643|NCT00003027|Vinblastine|vinblastine|mesh-list
2186644|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186645|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
2186646|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186647|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
2186648|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186649|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2186650|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2186651|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2676748|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676749|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676750|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676751|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676752|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676753|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676754|NCT02183025|Meloxicam|meloxicam|mesh-list
2676755|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
2676756|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676757|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676758|NCT02183025|Analgesics|analgesics|mesh-ancestor
2676759|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
2676760|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676761|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676762|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676763|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186652|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
2186653|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186654|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186655|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
2186656|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186657|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186658|NCT00003029|Fluorouracil|fluorouracil|mesh-list
2676764|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676765|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676766|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676767|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676768|NCT02183038|Naproxen|naproxen|mesh-list
2676769|NCT02183038|Meloxicam|meloxicam|mesh-list
2676770|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676771|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676772|NCT02183038|Analgesics|analgesics|mesh-ancestor
2676773|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
2676774|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676775|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676776|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676777|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676778|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
2676779|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676780|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676781|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676782|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676783|NCT02183051|Ibuprofen|ibuprofen|mesh-list
2676784|NCT02183051|Meloxicam|meloxicam|mesh-list
2676785|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676786|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676787|NCT02183051|Analgesics|analgesics|mesh-ancestor
2676788|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
2676789|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676790|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676791|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676792|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676793|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676794|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676795|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676796|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676797|NCT02183064|Meloxicam|meloxicam|mesh-list
2676798|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676799|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676800|NCT02183064|Analgesics|analgesics|mesh-ancestor
2676801|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
2676802|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676803|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676804|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676805|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676806|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676807|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676808|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676809|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676810|NCT02183077|Meloxicam|meloxicam|mesh-list
2676811|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676812|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676813|NCT02183077|Analgesics|analgesics|mesh-ancestor
2676814|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
2676815|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676816|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676817|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676818|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676819|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676820|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676821|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676822|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676823|NCT02183090|Meloxicam|meloxicam|mesh-list
2676824|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676825|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676826|NCT02183090|Analgesics|analgesics|mesh-ancestor
2676827|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
2676828|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2186659|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186660|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
2186661|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186662|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186663|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186664|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
2186665|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186666|NCT00003031|Voriconazole|voriconazole|mesh-list
2676829|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676830|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676831|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676832|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676833|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676834|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676835|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676836|NCT02183103|Meloxicam|meloxicam|mesh-list
2676837|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676838|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676839|NCT02183103|Analgesics|analgesics|mesh-ancestor
2676840|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
2676841|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676842|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676843|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676844|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676845|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676846|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676847|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676848|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676849|NCT02183116|Meloxicam|meloxicam|mesh-list
2676850|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676851|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676852|NCT02183116|Analgesics|analgesics|mesh-ancestor
2676853|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
2676854|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676855|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676856|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676857|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676858|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676859|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676860|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676861|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676862|NCT02183129|Diclofenac|diclofenac|mesh-list
2676863|NCT02183129|Meloxicam|meloxicam|mesh-list
2676864|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676865|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676866|NCT02183129|Analgesics|analgesics|mesh-ancestor
2676867|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
2676868|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676869|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676870|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676871|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676872|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676873|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676874|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676875|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676876|NCT02183142|Meloxicam|meloxicam|mesh-list
2676877|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676878|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676879|NCT02183142|Analgesics|analgesics|mesh-ancestor
2676880|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
2676881|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676882|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676883|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676884|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676885|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676886|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676887|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676888|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676889|NCT02183155|Indomethacin|indomethacin|mesh-list
2676890|NCT02183155|Meloxicam|meloxicam|mesh-list
2676891|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676892|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676893|NCT02183155|Analgesics|analgesics|mesh-ancestor
2676894|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
2186667|NCT00003031|Amphotericin B|amphotericin b|mesh-list
2186668|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2186669|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
2676895|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676896|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676897|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676898|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676899|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
2676900|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
2676901|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2676902|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676903|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676904|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676905|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676906|NCT02183168|Indomethacin|indomethacin|mesh-list
2676907|NCT02183168|Meloxicam|meloxicam|mesh-list
2676908|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676909|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676910|NCT02183168|Analgesics|analgesics|mesh-ancestor
2676911|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
2676912|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676913|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676914|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676915|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676916|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
2676917|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
2676918|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2676919|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676920|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676921|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676922|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676923|NCT02183181|Meloxicam|meloxicam|mesh-list
2676924|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676925|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676926|NCT02183181|Analgesics|analgesics|mesh-ancestor
2676927|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
2676928|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676929|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676930|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676931|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676932|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2676933|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676934|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676935|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676936|NCT02183194|Paclitaxel|paclitaxel|mesh-list
2676937|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2676938|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676939|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
2676940|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
2676941|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
2676942|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676943|NCT02183220|Aspirin|aspirin|mesh-list
2676944|NCT02183220|Dipyrone|dipyrone|mesh-list
2676945|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2676946|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2676947|NCT02183220|Analgesics|analgesics|mesh-ancestor
2676948|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
2676949|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676950|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676951|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2676952|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2676953|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2676954|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2676955|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676956|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2676957|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2676958|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676959|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
2676960|NCT02183246|Porfiromycin|porfiromycin|mesh-list
2676961|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186670|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
2186671|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
2186672|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186673|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2186674|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2186675|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186676|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186677|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2186678|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
2186679|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2676962|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2676963|NCT02183272|Ketamine|ketamine|mesh-list
2676964|NCT02183272|Analgesics|analgesics|mesh-ancestor
2676965|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
2676966|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2676967|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676968|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2676969|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2676970|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
2676971|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
2676972|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2676973|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2676974|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2676975|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2676976|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676977|NCT02183298|Linagliptin|linagliptin|mesh-list
2676978|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2676979|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676980|NCT02183298|Incretins|incretins|mesh-ancestor
2676981|NCT02183298|Hormones|hormones|mesh-ancestor
2676982|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2676983|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2676984|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
2676985|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676986|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676987|NCT02183311|Linagliptin|linagliptin|mesh-list
2676988|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2676989|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2676990|NCT02183311|Incretins|incretins|mesh-ancestor
2676991|NCT02183311|Hormones|hormones|mesh-ancestor
2676992|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2676993|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2676994|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
2676995|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2676996|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2676997|NCT02183324|Linagliptin|linagliptin|mesh-list
2676998|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2676999|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677000|NCT02183324|Incretins|incretins|mesh-ancestor
2677001|NCT02183324|Hormones|hormones|mesh-ancestor
2677002|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2186680|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186681|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2186682|NCT00003031|Amebicides|amebicides|mesh-ancestor
2186683|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2186684|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2186685|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2186686|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2186687|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2186688|NCT00003032|Tamoxifen|tamoxifen|mesh-list
2186689|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
2186690|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
2186691|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186692|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
2186693|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186694|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186695|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186696|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
2186697|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186698|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186699|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186700|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2186701|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
2186702|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2186703|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2186704|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2186705|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2186706|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2186707|NCT00003032|Analgesics|analgesics|mesh-ancestor
2186708|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
2186709|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2186710|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2677003|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677004|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677005|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677006|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677007|NCT02183337|Pioglitazone|pioglitazone|mesh-list
2677008|NCT02183337|Linagliptin|linagliptin|mesh-list
2677009|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677010|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677011|NCT02183337|Incretins|incretins|mesh-ancestor
2677012|NCT02183337|Hormones|hormones|mesh-ancestor
2186711|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186712|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186713|NCT00003034|Doxorubicin|doxorubicin|mesh-list
2677013|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677014|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677015|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677016|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677017|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677018|NCT02183350|Linagliptin|linagliptin|mesh-list
2677019|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677020|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677021|NCT02183350|Incretins|incretins|mesh-ancestor
2677022|NCT02183350|Hormones|hormones|mesh-ancestor
2677023|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677024|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677025|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677026|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677027|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677028|NCT02183363|Linagliptin|linagliptin|mesh-list
2677029|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677030|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677031|NCT02183363|Incretins|incretins|mesh-ancestor
2677032|NCT02183363|Hormones|hormones|mesh-ancestor
2677033|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677034|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677035|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677036|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677037|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677038|NCT02183376|Linagliptin|linagliptin|mesh-list
2677039|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677040|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677041|NCT02183376|Incretins|incretins|mesh-ancestor
2677042|NCT02183376|Hormones|hormones|mesh-ancestor
2677043|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677044|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677045|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677046|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677047|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677048|NCT02183389|Linagliptin|linagliptin|mesh-list
2677049|NCT02183389|Warfarin|warfarin|mesh-list
2677050|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
2677051|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677052|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677053|NCT02183389|Incretins|incretins|mesh-ancestor
2677054|NCT02183389|Hormones|hormones|mesh-ancestor
2677055|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677056|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677057|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677058|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677059|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677060|NCT02183402|Linagliptin|linagliptin|mesh-list
2677061|NCT02183402|Digoxin|digoxin|mesh-list
2677062|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2186714|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2186715|NCT00003034|Ranpirnase|ranpirnase|mesh-list
2186716|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186717|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186718|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186719|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2677063|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2677064|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677065|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677066|NCT02183402|Protective Agents|protective agents|mesh-ancestor
2186720|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677067|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186721|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186722|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2186723|NCT00003035|Tamoxifen|tamoxifen|mesh-list
2186724|NCT00003035|Paclitaxel|paclitaxel|mesh-list
2186725|NCT00003035|Doxorubicin|doxorubicin|mesh-list
2186726|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2677068|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677069|NCT02183402|Incretins|incretins|mesh-ancestor
2677070|NCT02183402|Hormones|hormones|mesh-ancestor
2677071|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677072|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677073|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677074|NCT02183415|Linagliptin|linagliptin|mesh-list
2677075|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677076|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677077|NCT02183415|Incretins|incretins|mesh-ancestor
2677078|NCT02183415|Hormones|hormones|mesh-ancestor
2677079|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677080|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677081|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677082|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677083|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677084|NCT02183428|Glyburide|glyburide|mesh-list
2677085|NCT02183428|Linagliptin|linagliptin|mesh-list
2677086|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677087|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677088|NCT02183428|Incretins|incretins|mesh-ancestor
2677089|NCT02183428|Hormones|hormones|mesh-ancestor
2677090|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677091|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677092|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677093|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677094|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677095|NCT02183441|Linagliptin|linagliptin|mesh-list
2677096|NCT02183441|Ritonavir|ritonavir|mesh-list
2677097|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2677098|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2677099|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677100|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677101|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677102|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2677103|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2677104|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
2677105|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677106|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2677107|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2677108|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677109|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677110|NCT02183441|Incretins|incretins|mesh-ancestor
2677111|NCT02183441|Hormones|hormones|mesh-ancestor
2677112|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677113|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677114|NCT02183467|Linagliptin|linagliptin|mesh-list
2677115|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
2677116|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2677117|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677118|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2677119|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2677120|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677121|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677122|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677123|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677124|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677125|NCT02183467|Incretins|incretins|mesh-ancestor
2677126|NCT02183467|Hormones|hormones|mesh-ancestor
2677127|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677128|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677129|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677130|NCT02183480|Linagliptin|linagliptin|mesh-list
2677131|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677132|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677133|NCT02183480|Incretins|incretins|mesh-ancestor
2186727|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2677134|NCT02183480|Hormones|hormones|mesh-ancestor
2677135|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677136|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677137|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677138|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677139|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677140|NCT02183493|Linagliptin|linagliptin|mesh-list
2677141|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677142|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677143|NCT02183493|Incretins|incretins|mesh-ancestor
2677144|NCT02183493|Hormones|hormones|mesh-ancestor
2677145|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677146|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677147|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677148|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677149|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677150|NCT02183506|Metformin|metformin|mesh-list
2677151|NCT02183506|Linagliptin|linagliptin|mesh-list
2677152|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677153|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677154|NCT02183506|Incretins|incretins|mesh-ancestor
2677155|NCT02183506|Hormones|hormones|mesh-ancestor
2677156|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677157|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677158|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677159|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677160|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677161|NCT02183532|Linagliptin|linagliptin|mesh-list
2677162|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677163|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677164|NCT02183532|Incretins|incretins|mesh-ancestor
2677165|NCT02183532|Hormones|hormones|mesh-ancestor
2677166|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677167|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677168|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677169|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677170|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677171|NCT02183571|Metformin|metformin|mesh-list
2677172|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677173|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677174|NCT02183584|Linagliptin|linagliptin|mesh-list
2677175|NCT02183584|Rifampin|rifampin|mesh-list
2186728|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186729|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
2186730|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186731|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186732|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186733|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186734|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186735|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186736|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186737|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186738|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2186739|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
2186740|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2186741|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2186742|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2186743|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2186744|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2677176|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677177|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677178|NCT02183584|Incretins|incretins|mesh-ancestor
2677179|NCT02183584|Hormones|hormones|mesh-ancestor
2677180|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677181|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677182|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677183|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677184|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677185|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2677186|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
2677187|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2677188|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677189|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
2677190|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2677191|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2677192|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2677193|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2677194|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2677195|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2677196|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2677197|NCT02183610|Linagliptin|linagliptin|mesh-list
2677198|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2677199|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677200|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677201|NCT02183610|Incretins|incretins|mesh-ancestor
2677202|NCT02183610|Hormones|hormones|mesh-ancestor
2677203|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677204|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677205|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677206|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677207|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677208|NCT02183623|Linagliptin|linagliptin|mesh-list
2677209|NCT02183623|Simvastatin|simvastatin|mesh-list
2677210|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2677211|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2677212|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
2677213|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677214|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2677215|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2677216|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677217|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677218|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677219|NCT02183623|Incretins|incretins|mesh-ancestor
2677220|NCT02183623|Hormones|hormones|mesh-ancestor
2677221|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677222|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677223|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677224|NCT02183636|Pioglitazone|pioglitazone|mesh-list
2186745|NCT00003037|Gemcitabine|gemcitabine|mesh-list
2186746|NCT00003037|Docetaxel|docetaxel|mesh-list
2186747|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186748|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186749|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
2186750|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186751|NCT00003037|Antiviral Agents|antiviral agents|mesh-ancestor
2186752|NCT00003037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186753|NCT00003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186754|NCT00003037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186755|NCT00003037|Immunologic Factors|immunologic factors|mesh-ancestor
2186756|NCT00003037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677225|NCT02183636|Linagliptin|linagliptin|mesh-list
2677226|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677227|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677228|NCT02183636|Incretins|incretins|mesh-ancestor
2677229|NCT02183636|Hormones|hormones|mesh-ancestor
2677230|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677231|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2677232|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677233|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677234|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677235|NCT02183649|Carbetapentane|carbetapentane|mesh-list
2677236|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
2677237|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
2677238|NCT02183688|Acetaminophen|acetaminophen|mesh-list
2677239|NCT02183688|Caffeine|caffeine|mesh-list
2677240|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2186757|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
2186758|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186759|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186760|NCT00003038|Suramin|suramin|mesh-list
2186761|NCT00003038|Doxorubicin|doxorubicin|mesh-list
2186762|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2186763|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186764|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186765|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186766|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186767|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677241|NCT02183688|Analgesics|analgesics|mesh-ancestor
2677242|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
2677243|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677244|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186768|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186769|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
2186770|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
2186771|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2186772|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186773|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2186774|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2186775|NCT00003039|Alvocidib|alvocidib|mesh-list
2186776|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186777|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
2186778|NCT00003039|Growth Substances|growth substances|mesh-ancestor
2186779|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186780|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2186781|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186782|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186783|NCT00003041|NSC 366140|nsc 366140|mesh-list
2186784|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186785|NCT00003044|Cisplatin|cisplatin|mesh-list
2677245|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
2677246|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2677247|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2677248|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677249|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677250|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2677251|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2677252|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
2677253|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2677254|NCT02183701|Losartan|losartan|mesh-list
2677255|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2677256|NCT02183701|Telmisartan|telmisartan|mesh-list
2677257|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2677258|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2677259|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2677260|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2677261|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677262|NCT02183701|Diuretics|diuretics|mesh-ancestor
2677263|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
2677264|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677265|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2677266|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2677267|NCT02183779|Fluconazole|fluconazole|mesh-list
2677268|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
2677269|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677270|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2677271|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2677272|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677273|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677274|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2677275|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
2677276|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677277|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677278|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2186786|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186787|NCT00003046|Interleukin-12|interleukin-12|mesh-list
2186788|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2186789|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
2186790|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186791|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2186792|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2186793|NCT00003046|Growth Substances|growth substances|mesh-ancestor
2186794|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
2186795|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186796|NCT00003048|Amifostine|amifostine|mesh-list
2186797|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2186798|NCT00003048|Protective Agents|protective agents|mesh-ancestor
2186799|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186800|NCT00003049|Leucovorin|leucovorin|mesh-list
2186801|NCT00003049|Fluorouracil|fluorouracil|mesh-list
2186802|NCT00003049|Calcium|calcium|mesh-list
2186803|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
2186804|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2186805|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186806|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
2186807|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186808|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186809|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186810|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186811|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
2677279|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2677280|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
2677281|NCT02183805|Carboplatin|carboplatin|mesh-list
2677282|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2677283|NCT02183805|Paclitaxel|paclitaxel|mesh-list
2677284|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2677285|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
2677286|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677287|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2677288|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2677289|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
2677290|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677291|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677292|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2677293|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2677294|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
2677295|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
2677296|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
2677297|NCT02183870|Crizotinib|crizotinib|mesh-list
2677298|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677299|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2677300|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677301|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677302|NCT02183883|Afatinib|afatinib|mesh-list
2677303|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677304|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2677305|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677306|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677307|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2677308|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2677309|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2677310|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
2677311|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677312|NCT02183948|Oxytocin|oxytocin|mesh-list
2677313|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
2677314|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2677315|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677316|NCT02184052|Meloxicam|meloxicam|mesh-list
2677317|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2677318|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2677319|NCT02184052|Analgesics|analgesics|mesh-ancestor
2677320|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
2677321|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677322|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677323|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2677324|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2677325|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2677326|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2677327|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677328|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677329|NCT02184065|Meloxicam|meloxicam|mesh-list
2677330|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2677331|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2677332|NCT02184065|Analgesics|analgesics|mesh-ancestor
2677333|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
2677334|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677335|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677336|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2677337|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2677338|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2677339|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2677340|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677341|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677342|NCT02184078|Nevirapine|nevirapine|mesh-list
2677343|NCT02184078|Rifabutin|rifabutin|mesh-list
2677344|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2677345|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2677346|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677347|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677348|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
2677349|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677350|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2677351|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2677352|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2677353|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2677354|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2677355|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2677356|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
2677357|NCT02184091|Nevirapine|nevirapine|mesh-list
2677358|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2677359|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2677360|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677361|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677362|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
2677363|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677364|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2677365|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2677366|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2677367|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2677368|NCT02184104|Caffeine|caffeine|mesh-list
2677369|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2186812|NCT00003049|Antidotes|antidotes|mesh-ancestor
2186813|NCT00003049|Protective Agents|protective agents|mesh-ancestor
2186814|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
2186815|NCT00003049|Vitamins|vitamins|mesh-ancestor
2186816|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
2186817|NCT00003050|Tamoxifen|tamoxifen|mesh-list
2186818|NCT00003050|Paclitaxel|paclitaxel|mesh-list
2186819|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
2677370|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677371|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2677372|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677373|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677374|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2677375|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2677376|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
2677377|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2677378|NCT02184117|Adenosine|adenosine|mesh-list
2677379|NCT02184117|Analgesics|analgesics|mesh-ancestor
2677380|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
2677381|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677382|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677383|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2677384|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
2677385|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2677386|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
2677387|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
2677388|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2677389|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677390|NCT02184247|Theophylline|theophylline|mesh-list
2677391|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2677392|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
2677393|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677394|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677395|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2677396|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
2677397|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2677398|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677399|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677400|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
2677401|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2677402|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2677403|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
2677404|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2677405|NCT02184260|Dipyrone|dipyrone|mesh-list
2677406|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2677407|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2677408|NCT02184260|Analgesics|analgesics|mesh-ancestor
2186820|NCT00003050|Doxorubicin|doxorubicin|mesh-list
2186821|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2677409|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
2677410|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677411|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186822|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186823|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186824|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
2677412|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2677413|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2677414|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
2677415|NCT02184273|Dipyrone|dipyrone|mesh-list
2677416|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2677417|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2677418|NCT02184273|Analgesics|analgesics|mesh-ancestor
2677419|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
2677420|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677421|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677422|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2677423|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2677424|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
2677425|NCT02184286|Nevirapine|nevirapine|mesh-list
2677426|NCT02184286|Saquinavir|saquinavir|mesh-list
2677427|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2677428|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2677429|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677430|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677431|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
2677432|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677433|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2677434|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2677435|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2677436|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2677437|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2677438|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2677439|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677440|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2677441|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2677442|NCT02184299|Nevirapine|nevirapine|mesh-list
2677443|NCT02184299|Prednisone|prednisone|mesh-list
2677444|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2677445|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
2677446|NCT02184299|Hormones|hormones|mesh-ancestor
2677447|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677448|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677449|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2677450|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677451|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2186825|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186826|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186827|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186828|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186829|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
2186830|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186831|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2677452|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2677453|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677454|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677455|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
2677456|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677457|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2677458|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2677459|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2677460|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2677461|NCT02184312|Nevirapine|nevirapine|mesh-list
2677462|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2677463|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2677464|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677465|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677466|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
2677467|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677468|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2677469|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2677470|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2677471|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2677472|NCT02184351|Clotrimazole|clotrimazole|mesh-list
2677473|NCT02184351|Miconazole|miconazole|mesh-list
2186832|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186833|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
2186834|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186835|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186836|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186837|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186838|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186839|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2186840|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
2186841|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2186842|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2186843|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2186844|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2186845|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2677474|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2677475|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677476|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
2186846|NCT00003052|Doxorubicin|doxorubicin|mesh-list
2186847|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2186848|NCT00003052|Etoposide|etoposide|mesh-list
2186849|NCT00003052|Ifosfamide|ifosfamide|mesh-list
2186850|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2186851|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186852|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186853|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186854|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186855|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186856|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186857|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186858|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
2186859|NCT00003053|Etoposide|etoposide|mesh-list
2186860|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186861|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186862|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186863|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2677477|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2677478|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2677479|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677480|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677481|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2677482|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
2677483|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677484|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677485|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2677486|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2677487|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2677488|NCT02184364|Estrogens|estrogens|mesh-ancestor
2677489|NCT02184364|Hormones|hormones|mesh-ancestor
2677490|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677491|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677492|NCT02184429|PF-06669571|pf-06669571|mesh-list
2677493|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
2677494|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
2677495|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2677496|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677497|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677498|NCT02184533|Selenious Acid|selenious acid|mesh-list
2677499|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
2677500|NCT02184533|Trace Elements|trace elements|mesh-ancestor
2677501|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
2677502|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677503|NCT02184559|Ropivacaine|ropivacaine|mesh-list
2677504|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
2677505|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
2677506|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2677507|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677508|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
2677509|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677510|NCT02184637|Lumefantrine|lumefantrine|mesh-list
2677511|NCT02184637|Artemether|artemether|mesh-list
2677512|NCT02184637|Piperaquine|piperaquine|mesh-list
2677513|NCT02184637|Artenimol|artenimol|mesh-list
2677514|NCT02184637|Tafenoquine|tafenoquine|mesh-list
2677515|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2677516|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
2677517|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2677518|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2677519|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677520|NCT02184819|Riboflavin|riboflavin|mesh-list
2677521|NCT02184819|Simendan|simendan|mesh-list
2677522|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
2677523|NCT02184819|Vitamins|vitamins|mesh-ancestor
2677524|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
2677525|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186864|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186865|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186866|NCT00003054|Paclitaxel|paclitaxel|mesh-list
2186867|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186868|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186869|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
2186870|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186871|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186872|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186873|NCT00003055|Irinotecan|irinotecan|mesh-list
2186874|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186875|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2186876|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2186877|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186878|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186879|NCT00003056|Cyclosporine|cyclosporine|mesh-list
2186880|NCT00003056|Methotrexate|methotrexate|mesh-list
2186881|NCT00003056|Cyclosporins|cyclosporins|mesh-list
2186882|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2677526|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2677527|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
2677528|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2677529|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
2677530|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2677531|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2677532|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677533|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677534|NCT02184819|Protective Agents|protective agents|mesh-ancestor
2677535|NCT02184832|Metformin|metformin|mesh-list
2677536|NCT02184832|Tryptophan|tryptophan|mesh-list
2677537|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677538|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677539|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2677540|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
2677541|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2677542|NCT02184858|Lisinopril|lisinopril|mesh-list
2677543|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2677544|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
2677545|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677546|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677547|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2677548|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2677549|NCT02184858|Protective Agents|protective agents|mesh-ancestor
2677550|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677551|NCT02184897|Lenograstim|lenograstim|mesh-list
2677552|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2677553|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
2186883|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
2186884|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2186885|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186886|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186887|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
2186888|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186889|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186890|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
2186891|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186892|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2186893|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186894|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
2186895|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186896|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2677554|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677555|NCT02184910|Gastrins|gastrins|mesh-list
2677556|NCT02184910|Hormones|hormones|mesh-ancestor
2677557|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677558|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677559|NCT02184975|Hemostatics|hemostatics|mesh-list
2677560|NCT02184975|Coagulants|coagulants|mesh-ancestor
2677561|NCT02185066|Metformin|metformin|mesh-list
2677562|NCT02185066|Atorvastatin|atorvastatin|mesh-list
2677563|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677564|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677565|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2677566|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2677567|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
2677568|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677569|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2677570|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2677571|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677572|NCT02185118|Sevoflurane|sevoflurane|mesh-list
2677573|NCT02185118|Isoflurane|isoflurane|mesh-list
2677574|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2677575|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2677576|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
2677577|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
2677578|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2677579|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677580|NCT02185196|Vitamin D|vitamin d|mesh-list
2677581|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
2677582|NCT02185196|Vitamins|vitamins|mesh-ancestor
2677583|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
2677584|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677585|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2677586|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2677587|NCT02185209|Amoxicillin|amoxicillin|mesh-list
2677588|NCT02185209|Metronidazole|metronidazole|mesh-list
2677589|NCT02185209|Penicillin V|penicillin v|mesh-list
2677590|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2677591|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677592|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2677593|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2677594|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
2677595|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2677596|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677597|NCT02185222|Vitamins|vitamins|mesh-ancestor
2677598|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
2677599|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2677600|NCT02185261|Interferons|interferons|mesh-list
2677601|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
2677602|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
2677603|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677604|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
2677605|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677606|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
2677607|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677608|NCT02185300|Dolutegravir|dolutegravir|mesh-list
2677609|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2677610|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2677611|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677612|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677613|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2677614|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2677615|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
2677616|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677617|NCT02185326|Hormones|hormones|mesh-list
2677618|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677619|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677620|NCT02185352|Cisplatin|cisplatin|mesh-list
2677621|NCT02185352|Etoposide|etoposide|mesh-list
2677622|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677623|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2677624|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2677625|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2677626|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677627|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677628|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2186897|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
2186898|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677629|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
2677630|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2677631|NCT02185417|Diuretics|diuretics|mesh-ancestor
2677632|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
2677633|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677634|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2677635|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2677636|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677637|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
2677638|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2677639|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2677640|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677641|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2677642|NCT02185430|Analgesics|analgesics|mesh-ancestor
2677643|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
2677644|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677645|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2677646|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2677647|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2677648|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
2677649|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2677650|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677651|NCT02185456|Metronidazole|metronidazole|mesh-list
2677652|NCT02185456|Miconazole|miconazole|mesh-list
2677653|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677654|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2677655|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2677656|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2677657|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
2186899|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2186900|NCT00003057|Octreotide|octreotide|mesh-list
2186901|NCT00003057|Loperamide|loperamide|mesh-list
2186902|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
2186903|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2186904|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2186905|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186906|NCT00003058|Troglitazone|troglitazone|mesh-list
2186907|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2186908|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186909|NCT00003060|Cyclosporine|cyclosporine|mesh-list
2186910|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
2186911|NCT00003060|Busulfan|busulfan|mesh-list
2186912|NCT00003060|Methotrexate|methotrexate|mesh-list
2677658|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2677659|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2677660|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677661|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677662|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2677663|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
2677664|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677665|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677666|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2677667|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2677668|NCT02185547|Sertraline|sertraline|mesh-list
2677669|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
2677670|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2677671|NCT02185547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2677672|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2677673|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2677674|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186913|NCT00003060|Cyclosporins|cyclosporins|mesh-list
2186914|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186915|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
2186916|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186917|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186918|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186919|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
2186920|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186921|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186922|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2186923|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2186924|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
2186925|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2186926|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186927|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
2677675|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2677676|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
2677677|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677678|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
2677679|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2677680|NCT02185651|Miglustat|miglustat|mesh-list
2677681|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677682|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677683|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2677684|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2677685|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
2677686|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677687|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2677688|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2186928|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
2186929|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677689|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677690|NCT02185690|Carboplatin|carboplatin|mesh-list
2677691|NCT02185690|Pemetrexed|pemetrexed|mesh-list
2677692|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677693|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677694|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677695|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2677696|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2677697|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
2677698|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
2677699|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
2677700|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2677701|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677702|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
2677703|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677704|NCT02185768|Idarubicin|idarubicin|mesh-list
2677705|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2677706|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677707|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2677708|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2677709|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677710|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677711|NCT02185820|Dexamethasone|dexamethasone|mesh-list
2677712|NCT02185820|Pomalidomide|pomalidomide|mesh-list
2677713|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2677714|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
2677715|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
2677716|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677717|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677718|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2677719|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
2677720|NCT02185820|Hormones|hormones|mesh-ancestor
2677721|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677722|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2677723|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677724|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
2677725|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2677726|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2677727|NCT02185820|Growth Substances|growth substances|mesh-ancestor
2677728|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
2677729|NCT02185833|Dirithromycin|dirithromycin|mesh-list
2677730|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2677731|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677732|NCT02185846|Dirithromycin|dirithromycin|mesh-list
2677733|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2677734|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677735|NCT02185859|Lidocaine|lidocaine|mesh-list
2677736|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
2677737|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
2677738|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
2677739|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2677740|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677741|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
2677742|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677743|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2677744|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2677745|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2677746|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2677747|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677748|NCT02185859|Analgesics|analgesics|mesh-ancestor
2677749|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
2677750|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2677751|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2677752|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
2677753|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2677754|NCT02185898|Menthol|menthol|mesh-list
2677755|NCT02185898|Nicotine|nicotine|mesh-list
2186930|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2186931|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2186932|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
2186933|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186934|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2186935|NCT00003061|Cytarabine|cytarabine|mesh-list
2186936|NCT00003061|Methotrexate|methotrexate|mesh-list
2186937|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2186938|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
2186939|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2186940|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186941|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186942|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
2677756|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2677757|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
2677758|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677759|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677760|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2677761|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2677762|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
2677763|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2677764|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677765|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
2677766|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
2677767|NCT02185924|Parecoxib|parecoxib|mesh-list
2677768|NCT02185924|Ropivacaine|ropivacaine|mesh-list
2677769|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
2677770|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
2677771|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2677772|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677773|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
2677774|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677775|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2677776|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2677777|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677778|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677779|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2677780|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2677781|NCT02185924|Analgesics|analgesics|mesh-ancestor
2677782|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2677783|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2677784|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2677785|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2677786|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2677787|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
2677788|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677789|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2677790|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2677791|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677792|NCT02186028|Vitamin D|vitamin d|mesh-list
2677793|NCT02186028|Vitamins|vitamins|mesh-ancestor
2677794|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
2677795|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677796|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2677797|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
2677798|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2677799|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677800|NCT02186106|Vitamins|vitamins|mesh-ancestor
2677801|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
2677802|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2677803|NCT02186119|Ranibizumab|ranibizumab|mesh-list
2677804|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2677805|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2677806|NCT02186119|Growth Substances|growth substances|mesh-ancestor
2677807|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677808|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
2677809|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677810|NCT02186132|Atropine|atropine|mesh-list
2677811|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2677812|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2677813|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2677814|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
2677815|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677816|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677817|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2677818|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
2677819|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
2677820|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
2677821|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2677822|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2677823|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
2677824|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2677825|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677826|NCT02186145|Metronidazole|metronidazole|mesh-list
2677827|NCT02186145|Nystatin|nystatin|mesh-list
2677828|NCT02186145|Dexamethasone|dexamethasone|mesh-list
2677829|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2677830|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
2677831|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
2677832|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2677833|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677834|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2677835|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
2677836|NCT02186145|Hormones|hormones|mesh-ancestor
2677837|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677838|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2677839|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677840|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677841|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2677842|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2677843|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2186943|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186944|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186945|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
2186946|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2186947|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2186948|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186949|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
2186950|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186951|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2186952|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
2186953|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186954|NCT00003062|Temozolomide|temozolomide|mesh-list
2186955|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2186956|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
2186957|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186958|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677844|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
2677845|NCT02186145|Ionophores|ionophores|mesh-ancestor
2677846|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2677847|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677848|NCT02186158|Ascorbic Acid|ascorbic acid|mesh-list
2677849|NCT02186158|Vitamins|vitamins|mesh-ancestor
2677850|NCT02186158|Micronutrients|micronutrients|mesh-ancestor
2677851|NCT02186158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186959|NCT00003063|Leucovorin|leucovorin|mesh-list
2186960|NCT00003063|Interferons|interferons|mesh-list
2186961|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
2186962|NCT00003063|Levamisole|levamisole|mesh-list
2186963|NCT00003063|Fluorouracil|fluorouracil|mesh-list
2186964|NCT00003063|Calcium|calcium|mesh-list
2677852|NCT02186158|Antioxidants|antioxidants|mesh-ancestor
2677853|NCT02186158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677854|NCT02186158|Protective Agents|protective agents|mesh-ancestor
2677855|NCT02186249|Nivolumab|nivolumab|mesh-list
2677856|NCT02186249|Ipilimumab|ipilimumab|mesh-list
2677857|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2677858|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2677859|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2677860|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677861|NCT02186275|Vitamin D|vitamin d|mesh-list
2186965|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
2677862|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
2677863|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
2677864|NCT02186275|Vitamins|vitamins|mesh-list
2677865|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
2186966|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2677866|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677867|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2677868|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2677869|NCT02186366|Buspirone|buspirone|mesh-list
2677870|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2677871|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2677872|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2677873|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677874|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2677875|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2677876|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
2677877|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2677878|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677879|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2677880|NCT02186457|Polymyxins|polymyxins|mesh-list
2677881|NCT02186457|Polymyxin B|polymyxin b|mesh-list
2677882|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677883|NCT02186483|Metformin|metformin|mesh-list
2677884|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2186967|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2186968|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
2186969|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186970|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2186971|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186972|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2186973|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
2186974|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
2186975|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2186976|NCT00003063|Antidotes|antidotes|mesh-ancestor
2186977|NCT00003063|Protective Agents|protective agents|mesh-ancestor
2677885|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2677886|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677887|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2677888|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2677889|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
2677890|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677891|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2677892|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2677893|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677894|NCT02186496|Amlodipine|amlodipine|mesh-list
2677895|NCT02186496|Candesartan|candesartan|mesh-list
2677896|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2677897|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2677898|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2677899|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677900|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2677901|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677902|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
2677903|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2677904|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2677905|NCT02186535|Vitamin D|vitamin d|mesh-list
2677906|NCT02186535|Calcium|calcium|mesh-list
2677907|NCT02186535|Vitamins|vitamins|mesh-ancestor
2677908|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
2677909|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677910|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2677911|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2677912|NCT02186574|Tenofovir|tenofovir|mesh-list
2677913|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
2677914|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677915|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2677916|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2677917|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677918|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677919|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2677920|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2186978|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
2186979|NCT00003063|Vitamins|vitamins|mesh-ancestor
2186980|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
2186981|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2186982|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
2186983|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
2186984|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2677921|NCT02186600|Vitamin D|vitamin d|mesh-list
2677922|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
2677923|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
2677924|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
2677925|NCT02186600|Calcium|calcium|mesh-list
2186985|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2186986|NCT00003064|Paclitaxel|paclitaxel|mesh-list
2186987|NCT00003064|Etoposide|etoposide|mesh-list
2186988|NCT00003064|Carboplatin|carboplatin|mesh-list
2677926|NCT02186600|Vitamins|vitamins|mesh-ancestor
2677927|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
2677928|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677929|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2677930|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2677931|NCT02186600|Antacids|antacids|mesh-ancestor
2677932|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677933|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2677934|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2677935|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2677936|NCT02186769|Risperidone|risperidone|mesh-list
2677937|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2677938|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
2677939|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2677940|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677941|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677942|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2677943|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2186989|NCT00003064|Topotecan|topotecan|mesh-list
2186990|NCT00003064|Thiotepa|thiotepa|mesh-list
2186991|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
2186992|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2186993|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2186994|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
2186995|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
2186996|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
2186997|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2186998|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2186999|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187000|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187001|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
2677944|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2677945|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2677946|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2677947|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
2677948|NCT02186782|Citric Acid|citric acid|mesh-list
2677949|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
2677950|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2677951|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2677952|NCT02186782|Clomiphene|clomiphene|mesh-list
2677953|NCT02186782|Enclomiphene|enclomiphene|mesh-list
2677954|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
2677955|NCT02186782|Estradiol|estradiol|mesh-list
2677956|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2677957|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
2677958|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2677959|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
2677960|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
2677961|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677962|NCT02186782|Estrogens|estrogens|mesh-ancestor
2677963|NCT02186782|Hormones|hormones|mesh-ancestor
2677964|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2677965|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677966|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2677967|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
2677968|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2677969|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2677970|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2677971|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
2677972|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2677973|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
2677974|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2677975|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2677976|NCT02186886|Golimumab|golimumab|mesh-list
2677977|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2677978|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2677979|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2677980|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
2187002|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677981|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677982|NCT02186899|Anesthetics|anesthetics|mesh-list
2677983|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2677984|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677985|NCT02186951|Amoxicillin|amoxicillin|mesh-list
2677986|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
2677987|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
2677988|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2677989|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2677990|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2677991|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2677992|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2677993|NCT02186990|Propofol|propofol|mesh-list
2677994|NCT02186990|Etomidate|etomidate|mesh-list
2677995|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2677996|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2677997|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2677998|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2187003|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2187004|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187005|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
2187006|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187007|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187008|NCT00003065|Paclitaxel|paclitaxel|mesh-list
2187009|NCT00003065|Topotecan|topotecan|mesh-list
2187010|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187011|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187012|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187013|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187014|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
2677999|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
2678000|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
2678001|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
2678002|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2678003|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678004|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678005|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2678006|NCT02187068|Analgesics|analgesics|mesh-ancestor
2678007|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
2678008|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678009|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2678010|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2678011|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2678012|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
2678013|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2678014|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187015|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187016|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2187017|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187018|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187019|NCT00003066|Docetaxel|docetaxel|mesh-list
2187020|NCT00003066|Estramustine|estramustine|mesh-list
2187021|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187022|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187023|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187024|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187025|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187026|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187027|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
2187028|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2187029|NCT00003067|Aldesleukin|aldesleukin|mesh-list
2187030|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187031|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2187032|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2187033|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
2187034|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187035|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
2187036|NCT00003068|Thiotepa|thiotepa|mesh-list
2187037|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
2187038|NCT00003068|Amifostine|amifostine|mesh-list
2187039|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187040|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
2187041|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187042|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2187043|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187044|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
2187045|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187046|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187047|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187048|NCT00003068|Analgesics|analgesics|mesh-ancestor
2187049|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
2187050|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2187051|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187052|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187053|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187054|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2187055|NCT00003068|Protective Agents|protective agents|mesh-ancestor
2187056|NCT00003070|Enalapril|enalapril|mesh-list
2187057|NCT00003070|Enalaprilat|enalaprilat|mesh-list
2187058|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187059|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187060|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2187061|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
2187062|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2187063|NCT00003072|Paclitaxel|paclitaxel|mesh-list
2187064|NCT00003072|Carboplatin|carboplatin|mesh-list
2187065|NCT00003072|Amifostine|amifostine|mesh-list
2187066|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187067|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187068|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187069|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187070|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187071|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187072|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2187073|NCT00003072|Protective Agents|protective agents|mesh-ancestor
2187074|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187075|NCT00003073|Cytarabine|cytarabine|mesh-list
2678015|NCT02187081|Sorafenib|sorafenib|mesh-list
2678016|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678017|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2678018|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678019|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678020|NCT02187107|Darunavir|darunavir|mesh-list
2678021|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2678022|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2678023|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
2678024|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678025|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678026|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2678027|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2678028|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
2678029|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678030|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
2678031|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2678032|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2678033|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678034|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
2678035|NCT02187120|Coagulants|coagulants|mesh-ancestor
2678036|NCT02187133|Rituximab|rituximab|mesh-list
2678037|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2678038|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2678039|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678040|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
2678041|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678042|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2678043|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2678044|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
2678045|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678046|NCT02187198|Buprenorphine|buprenorphine|mesh-list
2678047|NCT02187198|Naloxone|naloxone|mesh-list
2678048|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2678049|NCT02187198|Narcotics|narcotics|mesh-ancestor
2678050|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678051|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678052|NCT02187198|Analgesics|analgesics|mesh-ancestor
2678053|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
2678054|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678055|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2678056|NCT02187211|Minocycline|minocycline|mesh-list
2678057|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2678058|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678059|NCT02187224|Progesterone|progesterone|mesh-list
2678060|NCT02187224|Progestins|progestins|mesh-ancestor
2678061|NCT02187224|Hormones|hormones|mesh-ancestor
2678062|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678063|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678064|NCT02187250|Metformin|metformin|mesh-list
2678065|NCT02187250|Liraglutide|liraglutide|mesh-list
2678066|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2678067|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678068|NCT02187250|Incretins|incretins|mesh-ancestor
2678069|NCT02187250|Hormones|hormones|mesh-ancestor
2678070|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678071|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
2678072|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678073|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187076|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187077|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
2187078|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187079|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187080|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
2187081|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187082|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187083|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
2187084|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187085|NCT00003075|Fenretinide|fenretinide|mesh-list
2678074|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
2678075|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2678076|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678077|NCT02187302|Bevacizumab|bevacizumab|mesh-list
2678078|NCT02187302|Sunitinib|sunitinib|mesh-list
2678079|NCT02187302|Everolimus|everolimus|mesh-list
2678080|NCT02187302|Sorafenib|sorafenib|mesh-list
2678081|NCT02187302|Axitinib|axitinib|mesh-list
2678082|NCT02187302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2678083|NCT02187302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678084|NCT02187302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2678085|NCT02187302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2678086|NCT02187302|Growth Substances|growth substances|mesh-ancestor
2678087|NCT02187302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678088|NCT02187302|Growth Inhibitors|growth inhibitors|mesh-ancestor
2678089|NCT02187302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2678090|NCT02187302|Immunologic Factors|immunologic factors|mesh-ancestor
2678091|NCT02187302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2678092|NCT02187302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678093|NCT02187302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678094|NCT02187315|Cisplatin|cisplatin|mesh-list
2678095|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678096|NCT02187354|Blinatumomab|blinatumomab|mesh-list
2678097|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678098|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
2678099|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2678100|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
2678101|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678102|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2678103|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2678104|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
2678105|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678106|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678107|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2678108|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2678109|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678110|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678111|NCT02187445|Budesonide|budesonide|mesh-list
2678112|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678113|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2678114|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
2678115|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678116|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678117|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2678118|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
2678119|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
2678120|NCT02187445|Hormones|hormones|mesh-ancestor
2678121|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678122|NCT02187484|Telmisartan|telmisartan|mesh-list
2678123|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2678124|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2187086|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187087|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2187088|NCT00003075|Protective Agents|protective agents|mesh-ancestor
2187089|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187090|NCT00003076|Eflornithine|eflornithine|mesh-list
2187091|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187092|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2187093|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2187094|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2187095|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187096|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2187097|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187098|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678125|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2678126|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678127|NCT02187497|Telmisartan|telmisartan|mesh-list
2678128|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2678129|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2187099|NCT00003078|Fluorouracil|fluorouracil|mesh-list
2187100|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187101|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
2187102|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187103|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187104|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187105|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
2187106|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187107|NCT00003079|Cytarabine|cytarabine|mesh-list
2187108|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
2187109|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187110|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
2187111|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187112|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187113|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
2187114|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187115|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187116|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
2187117|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187118|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2187119|NCT00003080|Tamoxifen|tamoxifen|mesh-list
2678130|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2678131|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678132|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2678133|NCT02187523|Telmisartan|telmisartan|mesh-list
2678134|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2678135|NCT02187523|Diuretics|diuretics|mesh-ancestor
2678136|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
2678137|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678138|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2678139|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2678140|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678141|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2678142|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2678143|NCT02187536|Telmisartan|telmisartan|mesh-list
2678144|NCT02187536|Simvastatin|simvastatin|mesh-list
2678145|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2678146|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2678147|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
2678148|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678149|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2678150|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2678151|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678152|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2678153|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2678154|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2678155|NCT02187562|Aspirin|aspirin|mesh-list
2678156|NCT02187562|Meloxicam|meloxicam|mesh-list
2678157|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2678158|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2678159|NCT02187562|Analgesics|analgesics|mesh-ancestor
2678160|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
2678161|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678162|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678163|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678164|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2678165|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2678166|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2678167|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678168|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2678169|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2678170|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678171|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
2678172|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2678173|NCT02187588|Ibuprofen|ibuprofen|mesh-list
2678174|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2678175|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2678176|NCT02187588|Analgesics|analgesics|mesh-ancestor
2678177|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
2678178|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2187120|NCT00003080|Melphalan|melphalan|mesh-list
2187121|NCT00003080|Thiotepa|thiotepa|mesh-list
2187122|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
2187123|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187124|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187125|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
2187126|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187127|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187128|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187129|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
2187130|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187131|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2187132|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
2187133|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2187134|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2187135|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2187136|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2187137|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2187138|NCT00003080|Analgesics|analgesics|mesh-ancestor
2187139|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
2187140|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2187141|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187142|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187143|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187144|NCT00003081|Melphalan|melphalan|mesh-list
2187145|NCT00003081|Busulfan|busulfan|mesh-list
2187146|NCT00003081|Thiotepa|thiotepa|mesh-list
2187147|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
2187148|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187149|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187150|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
2187151|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187152|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187153|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187154|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187155|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2187156|NCT00003082|Antibodies|antibodies|mesh-list
2187157|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
2187158|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2187159|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
2187160|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187161|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187162|NCT00003084|Ketoconazole|ketoconazole|mesh-list
2187163|NCT00003084|Paclitaxel|paclitaxel|mesh-list
2187164|NCT00003084|Etoposide|etoposide|mesh-list
2187165|NCT00003084|Vinblastine|vinblastine|mesh-list
2187166|NCT00003084|Doxorubicin|doxorubicin|mesh-list
2187167|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2678179|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678180|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678181|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2678182|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2678183|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678184|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678185|NCT02187614|Acetaminophen|acetaminophen|mesh-list
2678186|NCT02187614|Diclofenac|diclofenac|mesh-list
2678187|NCT02187614|Morphine|morphine|mesh-list
2678188|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2187168|NCT00003084|Estramustine|estramustine|mesh-list
2187169|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187170|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678189|NCT02187614|Narcotics|narcotics|mesh-ancestor
2678190|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678191|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678192|NCT02187614|Analgesics|analgesics|mesh-ancestor
2678193|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
2678194|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678195|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2678196|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
2678197|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2678198|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678199|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2678200|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2678201|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678202|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678203|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2678204|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2678205|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2678206|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2678207|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678208|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
2678209|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2678210|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678211|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2678212|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678213|NCT02187705|Telmisartan|telmisartan|mesh-list
2678214|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2678215|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2678216|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2678217|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678218|NCT02187718|Anesthetics|anesthetics|mesh-list
2678219|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678220|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678221|NCT02187822|Taxane|taxane|mesh-list
2678222|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678223|NCT02187874|Oxytocin|oxytocin|mesh-list
2678224|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
2678225|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2678226|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678227|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
2678228|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
2678229|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2678230|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678231|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2678232|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
2678233|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2678234|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678235|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678236|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678237|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2678238|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2678239|NCT02187900|Protective Agents|protective agents|mesh-ancestor
2678240|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678248|NCT02188121|Losartan|losartan|mesh-list
2678249|NCT02188121|Simvastatin|simvastatin|mesh-list
2678250|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2678251|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2678252|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
2678253|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678254|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2678255|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2678256|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678257|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2678258|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2678259|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2678260|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2678261|NCT02188173|Dexamethasone|dexamethasone|mesh-list
2187171|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187172|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187173|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187174|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187175|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2187176|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187177|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187178|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187179|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
2187180|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187181|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2187182|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2187183|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2187184|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
2678262|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678263|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
2678264|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
2678265|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678266|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678267|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2678268|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
2678269|NCT02188173|Hormones|hormones|mesh-ancestor
2678270|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678271|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2678272|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678273|NCT02188186|Metformin|metformin|mesh-list
2678274|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2678275|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2678276|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678277|NCT02188186|Incretins|incretins|mesh-ancestor
2678278|NCT02188186|Hormones|hormones|mesh-ancestor
2678279|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678280|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2678281|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
2678282|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678283|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678284|NCT02188225|Fluoxetine|fluoxetine|mesh-list
2678285|NCT02188225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2678286|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2678287|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2678288|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678289|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2678290|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
2678291|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678292|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2678293|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
2678294|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2678295|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2678296|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2678297|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678298|NCT02188264|Cyclosporine|cyclosporine|mesh-list
2678299|NCT02188264|Cyclosporins|cyclosporins|mesh-list
2678300|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678301|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678302|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2678303|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
2678304|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678305|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
2678306|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678307|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
2678308|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2678309|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2678310|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
2678311|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2678312|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2678313|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2678314|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2678315|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2678316|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678317|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
2678318|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2678319|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678320|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2187185|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2187186|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187187|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2187188|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187189|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
2187190|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2187191|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
2187192|NCT00003086|Carboplatin|carboplatin|mesh-list
2187193|NCT00003086|Doxorubicin|doxorubicin|mesh-list
2187194|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2187195|NCT00003086|Fluorouracil|fluorouracil|mesh-list
2187196|NCT00003086|Melphalan|melphalan|mesh-list
2187197|NCT00003086|Ifosfamide|ifosfamide|mesh-list
2187198|NCT00003086|Thiotepa|thiotepa|mesh-list
2187199|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
2187200|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187201|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187202|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187203|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
2187204|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187205|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2187206|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187207|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
2187208|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187209|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2187210|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187211|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187212|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678321|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678322|NCT02188368|Clarithromycin|clarithromycin|mesh-list
2678323|NCT02188368|Dexamethasone|dexamethasone|mesh-list
2678324|NCT02188368|Prednisone|prednisone|mesh-list
2678325|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
2678326|NCT02188368|Bortezomib|bortezomib|mesh-list
2678327|NCT02188368|Pomalidomide|pomalidomide|mesh-list
2678328|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2678329|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
2678330|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678331|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2678332|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2678333|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
2678334|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678335|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678336|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2678337|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678338|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
2678339|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
2678340|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678341|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2678342|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
2187213|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
2187214|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187215|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2187216|NCT00003086|Analgesics|analgesics|mesh-ancestor
2187217|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
2187218|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2187219|NCT00003087|Paclitaxel|paclitaxel|mesh-list
2187220|NCT00003087|Cisplatin|cisplatin|mesh-list
2187221|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2678343|NCT02188368|Hormones|hormones|mesh-ancestor
2678344|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678345|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2678346|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678347|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2678348|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678349|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2678350|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2678351|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2678352|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2678353|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2678354|NCT02188368|Growth Substances|growth substances|mesh-ancestor
2678355|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
2678356|NCT02188394|Bupivacaine|bupivacaine|mesh-list
2678357|NCT02188394|Anesthetics|anesthetics|mesh-list
2678358|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
2187222|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187223|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187224|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
2678359|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678360|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678361|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
2678362|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678363|NCT02188407|Propofol|propofol|mesh-list
2678364|NCT02188407|Sevoflurane|sevoflurane|mesh-list
2678365|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2678366|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678367|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678368|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2678369|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
2678370|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
2678371|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2678372|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2678373|NCT02188472|Trimethoprim|trimethoprim|mesh-list
2678374|NCT02188472|Penicillins|penicillins|mesh-list
2678375|NCT02188472|Penicillin V|penicillin v|mesh-list
2678376|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2678377|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187225|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187226|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187227|NCT00003088|Paclitaxel|paclitaxel|mesh-list
2187228|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
2187229|NCT00003088|Doxorubicin|doxorubicin|mesh-list
2187230|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2187231|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187232|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187233|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187234|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187235|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187236|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187237|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187238|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
2187239|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678378|NCT02188472|Renal Agents|renal agents|mesh-ancestor
2678379|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
2678380|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2678381|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2678382|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2678383|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678384|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678385|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2187240|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2187241|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187242|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
2187243|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187244|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2187245|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187246|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187247|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187248|NCT00003089|Paclitaxel|paclitaxel|mesh-list
2187249|NCT00003089|Carboplatin|carboplatin|mesh-list
2187250|NCT00003089|Amifostine|amifostine|mesh-list
2187251|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187252|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187253|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
2678386|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2678387|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2678388|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2678389|NCT02188511|Nicotine|nicotine|mesh-list
2678390|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2678391|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
2678392|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678393|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187254|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187255|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187256|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187257|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2187258|NCT00003089|Protective Agents|protective agents|mesh-ancestor
2187259|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187260|NCT00003090|Aldesleukin|aldesleukin|mesh-list
2187261|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187262|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2678394|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2187263|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2187264|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
2187265|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678395|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2678396|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
2678397|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2678398|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678399|NCT02188537|Nelfinavir|nelfinavir|mesh-list
2678400|NCT02188537|Dexamethasone|dexamethasone|mesh-list
2678401|NCT02188537|Bortezomib|bortezomib|mesh-list
2678402|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678403|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
2678404|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
2678405|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678406|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678407|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2678408|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
2678409|NCT02188537|Hormones|hormones|mesh-ancestor
2678410|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678411|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2678412|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678413|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2678414|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2678415|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
2678416|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678417|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678418|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2678419|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2678420|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
2678421|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678422|NCT02188550|Everolimus|everolimus|mesh-list
2678423|NCT02188550|Letrozole|letrozole|mesh-list
2678424|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678425|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2678426|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
2678427|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678428|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2678429|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2678430|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678431|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678432|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2678433|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
2678434|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678435|NCT02188615|Vinorelbine|vinorelbine|mesh-list
2678436|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678437|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2678438|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
2678439|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
2678440|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
2678441|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187266|NCT00003091|Interferons|interferons|mesh-list
2187267|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
2187268|NCT00003091|Aldesleukin|aldesleukin|mesh-list
2187269|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187270|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
2187271|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187272|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
2187273|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678442|NCT02188654|Metformin|metformin|mesh-list
2678443|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2678444|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678445|NCT02188745|Letrozole|letrozole|mesh-list
2678446|NCT02188745|Anastrozole|anastrozole|mesh-list
2678447|NCT02188745|Exemestane|exemestane|mesh-list
2678448|NCT02188745|Estradiol|estradiol|mesh-list
2678449|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2678450|NCT02188745|Estrogens|estrogens|mesh-ancestor
2678451|NCT02188745|Hormones|hormones|mesh-ancestor
2678452|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678453|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678454|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678455|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2678456|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678457|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187274|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2187275|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2678458|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2187276|NCT00003092|Paclitaxel|paclitaxel|mesh-list
2187277|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187278|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187279|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187280|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187281|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187282|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678459|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
2678460|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2678461|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
2678462|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2678463|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
2678464|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678465|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
2678466|NCT02188771|Protective Agents|protective agents|mesh-ancestor
2678467|NCT02188810|Vaccines|vaccines|mesh-list
2678468|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
2678469|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678470|NCT02188888|Esmolol|esmolol|mesh-list
2678471|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2678472|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2678473|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2678474|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
2678475|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2678476|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678477|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678478|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
2678479|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
2678480|NCT02188953|Calcium|calcium|mesh-list
2678481|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2678482|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678483|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2678484|NCT02188953|Antacids|antacids|mesh-ancestor
2187283|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
2187284|NCT00003093|Carboplatin|carboplatin|mesh-list
2187285|NCT00003093|Doxorubicin|doxorubicin|mesh-list
2187286|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2187287|NCT00003093|Etoposide|etoposide|mesh-list
2187288|NCT00003093|Molgramostim|molgramostim|mesh-list
2678485|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678486|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2678487|NCT02189304|Budesonide|budesonide|mesh-list
2678488|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
2678489|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
2678490|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2678491|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678492|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2678493|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
2678494|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678495|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678496|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2678497|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
2678498|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
2678499|NCT02189304|Hormones|hormones|mesh-ancestor
2678500|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678501|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2678502|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2678503|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2678504|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
2678505|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2678506|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678507|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2678508|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2678509|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2678510|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
2678511|NCT02189343|Thalidomide|thalidomide|mesh-list
2678512|NCT02189343|Dexamethasone|dexamethasone|mesh-list
2678513|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
2678514|NCT02189343|Pomalidomide|pomalidomide|mesh-list
2678515|NCT02189343|Ricolinostat|ricolinostat|mesh-list
2678516|NCT02189343|BB 1101|bb 1101|mesh-list
2678517|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678518|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
2678519|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
2678520|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2187289|NCT00003093|Lenograstim|lenograstim|mesh-list
2187290|NCT00003093|Sargramostim|sargramostim|mesh-list
2678521|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678522|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2678523|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
2678524|NCT02189343|Hormones|hormones|mesh-ancestor
2678525|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678526|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2678527|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678528|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
2678529|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678530|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678531|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
2678532|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2678533|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2678534|NCT02189343|Growth Substances|growth substances|mesh-ancestor
2678535|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
2187291|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187292|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
2187293|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187294|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2187295|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187296|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
2187297|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187298|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678536|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2678537|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
2678538|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2678539|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678540|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2678541|NCT02189395|Insulin|insulin|mesh-list
2678542|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
2678543|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2678544|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2678545|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678546|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
2678547|NCT02189577|Bromides|bromides|mesh-list
2678548|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
2678549|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2678550|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2678551|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2187299|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187300|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2187301|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187302|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187303|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187304|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187305|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2187306|NCT00003099|Tamoxifen|tamoxifen|mesh-list
2187307|NCT00003099|Fenretinide|fenretinide|mesh-list
2187308|NCT00003099|Retinamide|retinamide|mesh-list
2187309|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2187310|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
2187311|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2187312|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187313|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2187314|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187315|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2187316|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2187317|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2678552|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
2678553|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2678554|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678555|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678556|NCT02189655|Bupivacaine|bupivacaine|mesh-list
2678557|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
2678558|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
2678559|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678560|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678561|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
2678562|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678563|NCT02189681|Anesthetics|anesthetics|mesh-list
2678564|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678565|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678566|NCT02189694|Hormones|hormones|mesh-list
2678567|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678568|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678569|NCT02189720|Amifampridine|amifampridine|mesh-list
2678570|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2678571|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678572|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678573|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2187318|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2187319|NCT00003099|Protective Agents|protective agents|mesh-ancestor
2187320|NCT00003101|Vincristine|vincristine|mesh-list
2187321|NCT00003101|Busulfan|busulfan|mesh-list
2187322|NCT00003101|Thiotepa|thiotepa|mesh-list
2187323|NCT00003101|Lomustine|lomustine|mesh-list
2187324|NCT00003101|Procarbazine|procarbazine|mesh-list
2187325|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
2187326|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187327|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187328|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187329|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187330|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
2678574|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2678575|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678576|NCT02189772|Metadoxine|metadoxine|mesh-list
2678577|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2678583|NCT02190149|Factor VIII|factor viii|mesh-list
2678584|NCT02190149|Coagulants|coagulants|mesh-ancestor
2678585|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
2678586|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
2678587|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678588|NCT02190318|Losartan|losartan|mesh-list
2678589|NCT02190318|Spironolactone|spironolactone|mesh-list
2678590|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2678591|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2678592|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2678593|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2678594|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678595|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2678596|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
2678597|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678598|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678599|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2678600|NCT02190318|Diuretics|diuretics|mesh-ancestor
2678601|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
2678602|NCT02190357|Rifaximin|rifaximin|mesh-list
2678603|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2678604|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678605|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2678606|NCT02190526|Mesalamine|mesalamine|mesh-list
2678607|NCT02190526|Amitriptyline|amitriptyline|mesh-list
2678608|NCT02190526|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2678609|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2678610|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2678611|NCT02190526|Analgesics|analgesics|mesh-ancestor
2678612|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
2678613|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678614|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678615|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678616|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2678617|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2678618|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
2678619|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2678620|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2678621|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2678622|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2678623|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678624|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
2678625|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2187331|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187332|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678626|NCT02190526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2678627|NCT02190526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2678628|NCT02190526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678629|NCT02190695|Carboplatin|carboplatin|mesh-list
2678630|NCT02190695|Decitabine|decitabine|mesh-list
2678631|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
2678632|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678633|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2678634|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
2678635|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678636|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678637|NCT02190708|Midazolam|midazolam|mesh-list
2678638|NCT02190708|Omeprazole|omeprazole|mesh-list
2678639|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2678640|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2187333|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
2187334|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187335|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187336|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187341|NCT00003103|Docetaxel|docetaxel|mesh-list
2187342|NCT00003103|Oblimersen|oblimersen|mesh-list
2187343|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187344|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187345|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187346|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187347|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187348|NCT00003105|Gemcitabine|gemcitabine|mesh-list
2187349|NCT00003105|Paclitaxel|paclitaxel|mesh-list
2187350|NCT00003105|Doxorubicin|doxorubicin|mesh-list
2187351|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2678641|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2678642|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678643|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678644|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2678645|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2678646|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2678647|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2678648|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
2678649|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
2678650|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
2678651|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
2678652|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2187352|NCT00003105|Ifosfamide|ifosfamide|mesh-list
2187353|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187354|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187355|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187356|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187357|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187358|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187359|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187360|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
2187361|NCT00003105|Antiviral Agents|antiviral agents|mesh-ancestor
2187362|NCT00003105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187363|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187364|NCT00003105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187365|NCT00003105|Immunologic Factors|immunologic factors|mesh-ancestor
2187366|NCT00003105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187367|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2187368|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187369|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2678653|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678654|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2678655|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2678656|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678657|NCT02190760|Dexamethasone|dexamethasone|mesh-list
2678658|NCT02190760|Bupivacaine|bupivacaine|mesh-list
2678659|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678660|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
2678661|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
2187370|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2678662|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678663|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678664|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2678665|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
2678666|NCT02190760|Hormones|hormones|mesh-ancestor
2678667|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678668|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2678669|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678670|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
2678671|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
2678672|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678673|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
2678674|NCT02190838|Metformin|metformin|mesh-list
2678675|NCT02190838|Dacarbazine|dacarbazine|mesh-list
2678676|NCT02190838|Melatonin|melatonin|mesh-list
2678677|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2678678|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678679|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
2678680|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678681|NCT02190838|Protective Agents|protective agents|mesh-ancestor
2678682|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678683|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2678684|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
2678685|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678686|NCT02190994|Prednisone|prednisone|mesh-list
2678687|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
2678688|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678689|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
2678690|NCT02190994|Hormones|hormones|mesh-ancestor
2187371|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
2187372|NCT00003107|Interleukin-12|interleukin-12|mesh-list
2187373|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2187374|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
2187375|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187376|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2187377|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2187378|NCT00003107|Growth Substances|growth substances|mesh-ancestor
2187379|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
2187380|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187381|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
2678691|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678692|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678693|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2678694|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678695|NCT02191007|Calcitriol|calcitriol|mesh-list
2678696|NCT02191007|Betamethasone|betamethasone|mesh-list
2678697|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
2678698|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2678699|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
2678700|NCT02191007|Calcipotriene|calcipotriene|mesh-list
2678701|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2678702|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678703|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
2678704|NCT02191007|Hormones|hormones|mesh-ancestor
2678705|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678706|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678707|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2678708|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
2678709|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
2678710|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2678711|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2678712|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2678713|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678714|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2678715|NCT02191007|Vitamins|vitamins|mesh-ancestor
2678716|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
2678717|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2678718|NCT02191020|Acitretin|acitretin|mesh-list
2678719|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
2678720|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
2678721|NCT02191059|Docetaxel|docetaxel|mesh-list
2678722|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678723|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
2678724|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
2678725|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
2678726|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678727|NCT02191072|Omalizumab|omalizumab|mesh-list
2678728|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2678729|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2678730|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
2187382|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187383|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2187384|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
2187385|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187386|NCT00003109|Irinotecan|irinotecan|mesh-list
2187387|NCT00003109|Raltitrexed|raltitrexed|mesh-list
2187388|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2678731|NCT02191124|Mirtazapine|mirtazapine|mesh-list
2678732|NCT02191124|Paroxetine|paroxetine|mesh-list
2678733|NCT02191124|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2678734|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2678735|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2678736|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678737|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2678738|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
2678739|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678740|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2678741|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
2678742|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2678743|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2678744|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2678745|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678746|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2678747|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
2678748|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
2678749|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2678750|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2678751|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678752|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2678753|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2678754|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2678755|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
2678756|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2678757|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2678758|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2678759|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
2678760|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
2678761|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
2678762|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2678763|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2678764|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2678765|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678766|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678767|NCT02191189|Nevirapine|nevirapine|mesh-list
2678768|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2678769|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2678770|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678771|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678772|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
2678773|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678774|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2678775|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2678776|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2678777|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2678778|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2678779|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2678780|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678781|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678782|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
2678783|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678784|NCT02191215|Nevirapine|nevirapine|mesh-list
2678785|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2678786|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2678787|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678788|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678789|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
2678790|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678791|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2678792|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2678793|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2678794|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2187389|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187390|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187391|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187392|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187393|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187394|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
2187395|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2187396|NCT00003110|Bleomycin|bleomycin|mesh-list
2187397|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2187398|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187399|NCT00003111|Paclitaxel|paclitaxel|mesh-list
2187400|NCT00003111|Carboplatin|carboplatin|mesh-list
2187401|NCT00003111|Irinotecan|irinotecan|mesh-list
2187402|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2678795|NCT02191228|Linagliptin|linagliptin|mesh-list
2678796|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2678797|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678798|NCT02191228|Incretins|incretins|mesh-ancestor
2678799|NCT02191228|Hormones|hormones|mesh-ancestor
2678800|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678801|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2678802|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
2678803|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678804|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678805|NCT02191280|Quercetin|quercetin|mesh-list
2678806|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
2678807|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678808|NCT02191280|Protective Agents|protective agents|mesh-ancestor
2678809|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678810|NCT02191293|Nevirapine|nevirapine|mesh-list
2678811|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2678812|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2678813|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678814|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678815|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
2678816|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678817|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2678818|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2678819|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2678820|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2678821|NCT02191319|Nevirapine|nevirapine|mesh-list
2678822|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2187403|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187404|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187405|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187406|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187407|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187408|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2678823|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2678824|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678825|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678826|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
2678827|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678828|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2678829|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2678830|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2678831|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2678832|NCT02191332|Nevirapine|nevirapine|mesh-list
2678833|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2678834|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2678835|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678836|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678837|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
2678838|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678839|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2678840|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2678841|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2678842|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2678843|NCT02191371|Propofol|propofol|mesh-list
2678844|NCT02191371|Desflurane|desflurane|mesh-list
2678845|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2678846|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2678847|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678848|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2187409|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187410|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678849|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
2678850|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
2678851|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2678852|NCT02191423|Oxytocin|oxytocin|mesh-list
2678853|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
2678854|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2678855|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678856|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2678857|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2678858|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678859|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2678860|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678861|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678862|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2678863|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2678864|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
2678865|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
2678866|NCT02191566|Tegafur|tegafur|mesh-list
2678867|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678868|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2678869|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
2678870|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678871|NCT02191657|Deferiprone|deferiprone|mesh-list
2678872|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2678873|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
2678874|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
2678875|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678876|NCT02191670|Tenecteplase|tenecteplase|mesh-list
2678877|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2678878|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2678879|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678880|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
2678881|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
2678882|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
2678883|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2678884|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2678885|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2678886|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678887|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678888|NCT02191748|Triamcinolone|triamcinolone|mesh-list
2678889|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678890|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
2678891|NCT02191748|Hormones|hormones|mesh-ancestor
2678892|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678893|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678894|NCT02191826|Tolcapone|tolcapone|mesh-list
2187411|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
2187412|NCT00003113|Lomustine|lomustine|mesh-list
2187413|NCT00003113|Etoposide|etoposide|mesh-list
2187414|NCT00003113|Procarbazine|procarbazine|mesh-list
2187415|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187416|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
2187417|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187418|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2187419|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2678895|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2678896|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2678897|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2678898|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678899|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678900|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2678901|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
2678902|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2678903|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2678904|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
2678905|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678906|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678907|NCT02191891|Afatinib|afatinib|mesh-list
2678908|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678909|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2678910|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187420|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
2678911|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678912|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
2678913|NCT02191930|Doxorubicin|doxorubicin|mesh-list
2678914|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2678915|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2678916|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2678917|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
2678918|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678919|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2678920|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2678921|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
2678922|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678923|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678924|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2678925|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2678926|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2678927|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2678928|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678929|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2678930|NCT02191943|Fluorides|fluorides|mesh-list
2678931|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
2678932|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
2678933|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
2678934|NCT02191943|Protective Agents|protective agents|mesh-ancestor
2187421|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187422|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187423|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187424|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187425|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187426|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187427|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187428|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
2187429|NCT00003114|Lomustine|lomustine|mesh-list
2187430|NCT00003114|Etoposide|etoposide|mesh-list
2187431|NCT00003114|Procarbazine|procarbazine|mesh-list
2678935|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678936|NCT02192060|Triclosan|triclosan|mesh-list
2678937|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2678938|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2678939|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2678940|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2678941|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
2678942|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678943|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2678944|NCT02192203|Diclofenac|diclofenac|mesh-list
2678945|NCT02192203|Menthol|menthol|mesh-list
2678946|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2678947|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2678948|NCT02192203|Analgesics|analgesics|mesh-ancestor
2678949|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
2678950|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678951|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678952|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678953|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2678954|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2678955|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678956|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678957|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
2678958|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
2678959|NCT02192229|Vitamin D|vitamin d|mesh-list
2678960|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
2678961|NCT02192229|Vitamins|vitamins|mesh-ancestor
2678962|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
2678963|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678964|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2678965|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2678966|NCT02192320|Dexamethasone|dexamethasone|mesh-list
2678967|NCT02192320|Atorvastatin|atorvastatin|mesh-list
2678968|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2678969|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
2678970|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
2678971|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2678972|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2678973|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2678974|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
2678975|NCT02192320|Hormones|hormones|mesh-ancestor
2678976|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2678977|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2187432|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187433|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
2187434|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187435|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2187436|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187437|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
2187438|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187439|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187440|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187441|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187442|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187443|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187444|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187445|NCT00003115|Hydromorphone|hydromorphone|mesh-list
2187446|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2678978|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2678979|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2678980|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2678981|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
2678982|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2678983|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2678984|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2678985|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2678994|NCT02192398|Guanfacine|guanfacine|mesh-list
2678995|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2678996|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2678997|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2678998|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2678999|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
2679000|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2679001|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679002|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679003|NCT02192411|Lidocaine|lidocaine|mesh-list
2679004|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
2679005|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
2679006|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679007|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679008|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
2679009|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679010|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2679011|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2679012|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2679013|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2679014|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679015|NCT02192424|Insulin|insulin|mesh-list
2679016|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2679017|NCT02192424|Metformin|metformin|mesh-list
2679018|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
2679019|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
2679020|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2679021|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679022|NCT02192450|Insulin|insulin|mesh-list
2679023|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2679024|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
2679025|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
2679026|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2679027|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2679028|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187447|NCT00003115|Narcotics|narcotics|mesh-ancestor
2187448|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2187449|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679029|NCT02192463|Nevirapine|nevirapine|mesh-list
2679030|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2679031|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2679032|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679033|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679034|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
2679035|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679036|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2679037|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2679038|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2679039|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2679040|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
2187450|NCT00003115|Analgesics|analgesics|mesh-ancestor
2187451|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
2187452|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2187453|NCT00003116|Cyclosporine|cyclosporine|mesh-list
2187454|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
2187455|NCT00003116|Busulfan|busulfan|mesh-list
2187456|NCT00003116|Cyclosporins|cyclosporins|mesh-list
2187457|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187458|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
2187459|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187460|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2187461|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187462|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
2187463|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187464|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187465|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187466|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679041|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2679042|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2679043|NCT02192632|Analgesics|analgesics|mesh-ancestor
2679044|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
2679045|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679046|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679047|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2679048|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2679049|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
2679050|NCT02192697|Naquotinib|naquotinib|mesh-list
2679051|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679052|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2679053|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679054|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679055|NCT02192710|Midazolam|midazolam|mesh-list
2679056|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2679057|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2679058|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679059|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679060|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2679061|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2679062|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2679063|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2679064|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
2679065|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
2679066|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
2679067|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
2679068|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2679069|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679070|NCT02192723|Olanzapine|olanzapine|mesh-list
2679071|NCT02192723|Risperidone|risperidone|mesh-list
2679072|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2679073|NCT02192723|Aripiprazole|aripiprazole|mesh-list
2679074|NCT02192723|Ziprasidone|ziprasidone|mesh-list
2679075|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
2679076|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2679077|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
2679078|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2679079|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679080|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679081|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2679082|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679083|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2679084|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2679085|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
2679086|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
2679087|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
2679088|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679089|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2679090|NCT02192723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2679091|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2679092|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2187467|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
2187468|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187469|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
2187470|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2187471|NCT00003117|Paclitaxel|paclitaxel|mesh-list
2187472|NCT00003117|Carboplatin|carboplatin|mesh-list
2187473|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187474|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187475|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187476|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187477|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
2679093|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
2679094|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
2679095|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2679096|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2679097|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2679098|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2679099|NCT02192827|Dexamethasone|dexamethasone|mesh-list
2679100|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
2679101|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2679102|NCT02192827|BB 1101|bb 1101|mesh-list
2679103|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2679104|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
2679105|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
2679106|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679107|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679108|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2679109|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
2679110|NCT02192827|Hormones|hormones|mesh-ancestor
2679111|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2679112|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2679113|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679114|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
2679115|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679116|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679117|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2679118|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2679119|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679120|NCT02192853|Incretins|incretins|mesh-ancestor
2679121|NCT02192853|Hormones|hormones|mesh-ancestor
2679122|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2679123|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2679124|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
2679125|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679126|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679127|NCT02192944|Chloroquine|chloroquine|mesh-list
2679128|NCT02192944|Piperaquine|piperaquine|mesh-list
2187478|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187479|NCT00003118|Fluorouracil|fluorouracil|mesh-list
2187480|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187481|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
2187482|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187483|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187484|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187485|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
2187486|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187487|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
2187488|NCT00003119|Carboplatin|carboplatin|mesh-list
2187489|NCT00003119|Doxorubicin|doxorubicin|mesh-list
2187490|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2187491|NCT00003119|Etoposide|etoposide|mesh-list
2187492|NCT00003119|Sargramostim|sargramostim|mesh-list
2187493|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187494|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
2187495|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187496|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2187497|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2679129|NCT02192944|Artenimol|artenimol|mesh-list
2679130|NCT02192944|Amebicides|amebicides|mesh-ancestor
2679131|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2679132|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2679133|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679134|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
2187498|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
2679135|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2679136|NCT02193022|Miltefosine|miltefosine|mesh-list
2679137|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
2679138|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679139|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679140|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2679141|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2679142|NCT02193191|Plerixafor|plerixafor|mesh-list
2679143|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2679144|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2679145|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
2679146|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679147|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2679148|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2679149|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679150|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2679151|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
2679152|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679153|NCT02193256|Prazosin|prazosin|mesh-list
2679154|NCT02193256|Varenicline|varenicline|mesh-list
2679155|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2679156|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2679157|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
2679158|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2679159|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679160|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679161|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2679162|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2679163|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2679164|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2679165|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
2679166|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2679167|NCT02193269|Minocycline|minocycline|mesh-list
2679168|NCT02193269|Tetracycline|tetracycline|mesh-list
2679169|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679170|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2679171|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679172|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679173|NCT02193308|Amlodipine|amlodipine|mesh-list
2679174|NCT02193308|Telmisartan|telmisartan|mesh-list
2679175|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2679176|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2679177|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2679178|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2679179|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679180|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2679181|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679182|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
2679183|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2679184|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2679185|NCT02193334|Mitogens|mitogens|mesh-list
2679186|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
2679187|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679188|NCT02193568|Anesthetics|anesthetics|mesh-list
2679189|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679190|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679191|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
2679192|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679193|NCT02193620|Nalbuphine|nalbuphine|mesh-list
2679194|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2679195|NCT02193620|Narcotics|narcotics|mesh-ancestor
2679196|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679197|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679198|NCT02193620|Analgesics|analgesics|mesh-ancestor
2679199|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
2679200|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679201|NCT02193633|Paclitaxel|paclitaxel|mesh-list
2679202|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2679203|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2679204|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679205|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
2679206|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
2679207|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
2679208|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679209|NCT02193698|Dexamethasone|dexamethasone|mesh-list
2187499|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187500|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187501|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187502|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2679210|NCT02193698|Lenalidomide|lenalidomide|mesh-list
2679211|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2679212|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
2679213|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
2679214|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679215|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679216|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2679217|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
2679218|NCT02193698|Hormones|hormones|mesh-ancestor
2679219|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2679220|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2679221|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679222|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
2679223|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2679224|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2679225|NCT02193698|Growth Substances|growth substances|mesh-ancestor
2679226|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
2679227|NCT02193841|Calcium|calcium|mesh-list
2679228|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2679229|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679230|NCT02193893|Coal Tar|coal tar|mesh-list
2679231|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
2679232|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
2679233|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2679234|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2679235|NCT02194049|Etoposide|etoposide|mesh-list
2679236|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
2679237|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679238|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2679239|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2679240|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2679241|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679242|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679243|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
2679244|NCT02194075|Methylphenidate|methylphenidate|mesh-list
2679245|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2679246|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679247|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2679248|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2679249|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2679250|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679251|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
2679252|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2679253|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2679254|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2679255|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679256|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2679257|NCT02194075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2679258|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
2679259|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2679260|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
2679261|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2679262|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2679263|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679264|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2679265|NCT02194153|Tenecteplase|tenecteplase|mesh-list
2679266|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2679267|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2679268|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679269|NCT02194166|Paclitaxel|paclitaxel|mesh-list
2679270|NCT02194166|Docetaxel|docetaxel|mesh-list
2679271|NCT02194166|Trastuzumab|trastuzumab|mesh-list
2679272|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2679273|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187503|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187504|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187505|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187506|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2679274|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187507|NCT00003120|Paclitaxel|paclitaxel|mesh-list
2187508|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187509|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187510|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
2679275|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
2679276|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
2679277|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679278|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2679279|NCT02194179|Nevirapine|nevirapine|mesh-list
2679280|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2679281|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2679282|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679283|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679284|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
2679285|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679286|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2679287|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2679288|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2679289|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2679290|NCT02194192|Ephedrine|ephedrine|mesh-list
2679291|NCT02194192|Ondansetron|ondansetron|mesh-list
2679292|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
2679293|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
2679294|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679295|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679296|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2679297|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
2679298|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
2679299|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2679300|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
2679301|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2679302|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679303|NCT02194192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2679304|NCT02194192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2679305|NCT02194192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679306|NCT02194192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2679307|NCT02194192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2679308|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2679309|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
2679310|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2679311|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
2679312|NCT02194218|Nevirapine|nevirapine|mesh-list
2679313|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2679314|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2679315|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679316|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187511|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187512|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187513|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187514|NCT00003123|Amifostine|amifostine|mesh-list
2187515|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2187516|NCT00003123|Protective Agents|protective agents|mesh-ancestor
2187517|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187518|NCT00003124|Leuprolide|leuprolide|mesh-list
2187519|NCT00003124|Flutamide|flutamide|mesh-list
2187520|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2679317|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
2679318|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679319|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2679320|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2679321|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2679322|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2679323|NCT02194231|Trabectedin|trabectedin|mesh-list
2679324|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2679325|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
2679326|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679327|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679328|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2679329|NCT02194257|Ambroxol|ambroxol|mesh-list
2679330|NCT02194257|Expectorants|expectorants|mesh-ancestor
2679331|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
2679332|NCT02194270|Ambroxol|ambroxol|mesh-list
2679333|NCT02194270|Expectorants|expectorants|mesh-ancestor
2187521|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
2187522|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2679334|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
2679335|NCT02194283|Ambroxol|ambroxol|mesh-list
2187523|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187524|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2187525|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187526|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
2187527|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
2187528|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2187529|NCT00003125|Aldesleukin|aldesleukin|mesh-list
2187530|NCT00003125|Vaccines|vaccines|mesh-list
2187531|NCT00003125|Sargramostim|sargramostim|mesh-list
2187532|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
2187533|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187534|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187535|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2187536|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2187537|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
2187538|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187539|NCT00003126|Aldesleukin|aldesleukin|mesh-list
2187540|NCT00003126|Interleukin-2|interleukin-2|mesh-list
2187541|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187542|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2187543|NCT00003126|Analgesics|analgesics|mesh-ancestor
2679336|NCT02194283|Expectorants|expectorants|mesh-ancestor
2679337|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
2679338|NCT02194296|Ambroxol|ambroxol|mesh-list
2679339|NCT02194296|Expectorants|expectorants|mesh-ancestor
2679340|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
2679341|NCT02194309|Amlodipine|amlodipine|mesh-list
2679342|NCT02194309|Telmisartan|telmisartan|mesh-list
2187544|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
2187545|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2187546|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187547|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2187548|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2187549|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
2187550|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187551|NCT00003127|Paclitaxel|paclitaxel|mesh-list
2187552|NCT00003127|Carboplatin|carboplatin|mesh-list
2187553|NCT00003127|Amifostine|amifostine|mesh-list
2187554|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187555|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187556|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187557|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187558|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187559|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187560|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2187561|NCT00003127|Protective Agents|protective agents|mesh-ancestor
2187562|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187563|NCT00003128|Paclitaxel|paclitaxel|mesh-list
2679343|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2679344|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2679345|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2679346|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679347|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2679348|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679349|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
2679350|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2679351|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2679352|NCT02194374|Vidarabine|vidarabine|mesh-list
2679353|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
2679354|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2679355|NCT02194374|Rituximab|rituximab|mesh-list
2679356|NCT02194374|Fludarabine|fludarabine|mesh-list
2679357|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
2679358|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2679359|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
2679360|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679361|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2679362|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2679363|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
2679364|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679365|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679366|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2679367|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2679368|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187564|NCT00003128|Ifosfamide|ifosfamide|mesh-list
2679369|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
2679370|NCT02194374|Antiviral Agents|antiviral agents|mesh-ancestor
2679371|NCT02194374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679372|NCT02194452|Octreotide|octreotide|mesh-list
2679373|NCT02194452|Edotreotide|edotreotide|mesh-list
2679374|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2679375|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2679376|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679377|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2679378|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187565|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187566|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187567|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187568|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187569|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187570|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187571|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187572|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
2187573|NCT00003129|Valrubicin|valrubicin|mesh-list
2187574|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187575|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2679379|NCT02194491|AS2471907|as2471907|mesh-list
2679380|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2679381|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679382|NCT02194556|Gemcitabine|gemcitabine|mesh-list
2679383|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2679384|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
2679385|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679386|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679387|NCT02194556|Antiviral Agents|antiviral agents|mesh-ancestor
2679388|NCT02194556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679389|NCT02194556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679390|NCT02194556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2679391|NCT02194556|Immunologic Factors|immunologic factors|mesh-ancestor
2679392|NCT02194556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679393|NCT02194595|Insulin|insulin|mesh-list
2679394|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2679395|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
2679396|NCT02194595|Exenatide|exenatide|mesh-list
2679397|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
2679398|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2679399|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679400|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2679401|NCT02194595|Incretins|incretins|mesh-ancestor
2679402|NCT02194595|Hormones|hormones|mesh-ancestor
2679403|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2679404|NCT02194686|Cilostazol|cilostazol|mesh-list
2679405|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2679406|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
2679407|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679408|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679409|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2679410|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
2679411|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2679412|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2679413|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679414|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2679415|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
2679416|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2679417|NCT02194686|Protective Agents|protective agents|mesh-ancestor
2679418|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2679419|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2679420|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679421|NCT02194764|Naltrexone|naltrexone|mesh-list
2679422|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2679423|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2679424|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679425|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
2679426|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679427|NCT02194829|Gemcitabine|gemcitabine|mesh-list
2679428|NCT02194829|Paclitaxel|paclitaxel|mesh-list
2679429|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2679430|NCT02194829|Adavosertib|adavosertib|mesh-list
2679431|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2679432|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679433|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
2679434|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
2679435|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
2679436|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679437|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2679438|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
2679439|NCT02194829|Antiviral Agents|antiviral agents|mesh-ancestor
2679440|NCT02194829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679441|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679442|NCT02194829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2679443|NCT02194829|Immunologic Factors|immunologic factors|mesh-ancestor
2679444|NCT02194829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187576|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187577|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187578|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187579|NCT00003130|Paclitaxel|paclitaxel|mesh-list
2187580|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187581|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187582|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187583|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
2679445|NCT02194855|Rocuronium|rocuronium|mesh-list
2679446|NCT02194855|Cisatracurium|cisatracurium|mesh-list
2679447|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2679448|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2679449|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2679450|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679451|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679452|NCT02194881|Ivacaftor|ivacaftor|mesh-list
2679453|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2679454|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2679455|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679456|NCT02194894|Acetaminophen|acetaminophen|mesh-list
2679457|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2187584|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187585|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187586|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
2187587|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2187588|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187589|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
2187590|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187591|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2187592|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
2187593|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187594|NCT00003133|Gemcitabine|gemcitabine|mesh-list
2187595|NCT00003133|Paclitaxel|paclitaxel|mesh-list
2187596|NCT00003133|Doxorubicin|doxorubicin|mesh-list
2187597|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2187598|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187599|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187600|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187601|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187602|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187603|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187604|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187605|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
2679458|NCT02194894|Analgesics|analgesics|mesh-ancestor
2679459|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
2679460|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679461|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679462|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
2679463|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
2679464|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2679465|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187606|NCT00003133|Antiviral Agents|antiviral agents|mesh-ancestor
2187607|NCT00003133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187608|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187609|NCT00003133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187610|NCT00003133|Immunologic Factors|immunologic factors|mesh-ancestor
2187611|NCT00003133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187612|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2187613|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187614|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2679466|NCT02195089|Vaccines|vaccines|mesh-list
2679467|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
2187615|NCT00003134|Irinotecan|irinotecan|mesh-list
2679468|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679469|NCT02195115|Amitriptyline|amitriptyline|mesh-list
2679470|NCT02195115|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2679471|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2679472|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
2679473|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2679474|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2679475|NCT02195115|Analgesics|analgesics|mesh-ancestor
2679476|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
2679477|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679478|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679479|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2679480|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2679481|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2679482|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679483|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
2679484|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2679485|NCT02195115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2679486|NCT02195115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2679487|NCT02195115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679488|NCT02195180|Leucovorin|leucovorin|mesh-list
2679489|NCT02195180|Gemcitabine|gemcitabine|mesh-list
2679490|NCT02195180|Fluorouracil|fluorouracil|mesh-list
2679491|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
2679492|NCT02195180|Asparaginase|asparaginase|mesh-list
2679493|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2679494|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
2679495|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679496|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679497|NCT02195180|Antiviral Agents|antiviral agents|mesh-ancestor
2679498|NCT02195180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679499|NCT02195180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679500|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2679501|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
2679502|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679503|NCT02195180|Antidotes|antidotes|mesh-ancestor
2679504|NCT02195180|Protective Agents|protective agents|mesh-ancestor
2679505|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
2679506|NCT02195180|Vitamins|vitamins|mesh-ancestor
2679507|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
2679508|NCT02195271|Melatonin|melatonin|mesh-list
2679509|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
2679510|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679511|NCT02195271|Protective Agents|protective agents|mesh-ancestor
2679512|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679513|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679514|NCT02195336|Paclitaxel|paclitaxel|mesh-list
2679515|NCT02195336|Bevacizumab|bevacizumab|mesh-list
2679516|NCT02195336|Carboplatin|carboplatin|mesh-list
2679517|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2679518|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679519|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
2679520|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
2679521|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
2679522|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679523|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2679524|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2679525|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2679526|NCT02195336|Growth Substances|growth substances|mesh-ancestor
2679527|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679528|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
2679529|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2679530|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2679531|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
2679532|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679533|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679534|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2679535|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
2679536|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
2679537|NCT02195375|Hormones|hormones|mesh-ancestor
2679538|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2679539|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
2679540|NCT02195466|Ritonavir|ritonavir|mesh-list
2679541|NCT02195466|Tipranavir|tipranavir|mesh-list
2679542|NCT02195466|Fluconazole|fluconazole|mesh-list
2679543|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2679544|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2679545|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
2679546|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679547|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679548|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2679549|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2679550|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
2679551|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679552|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2679553|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2679554|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
2679555|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2679556|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2679557|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
2679558|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2679559|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679560|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2679561|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2679562|NCT02195492|Hylan|hylan|mesh-list
2679563|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
2679564|NCT02195492|Protective Agents|protective agents|mesh-ancestor
2679565|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679566|NCT02195544|Hylan|hylan|mesh-list
2679567|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
2679568|NCT02195544|Protective Agents|protective agents|mesh-ancestor
2679569|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679570|NCT02195557|Hylan|hylan|mesh-list
2679571|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
2679572|NCT02195557|Protective Agents|protective agents|mesh-ancestor
2679573|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187616|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2187617|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187618|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187619|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187620|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187621|NCT00003135|Doxorubicin|doxorubicin|mesh-list
2187622|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2187623|NCT00003135|Fluorouracil|fluorouracil|mesh-list
2187624|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2187625|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187626|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187627|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187628|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187629|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187630|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
2187631|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187632|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187633|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
2187634|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679574|NCT02195635|Octreotide|octreotide|mesh-list
2679575|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2679576|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2679577|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679578|NCT02195661|Melatonin|melatonin|mesh-list
2679579|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
2679580|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
2679581|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679582|NCT02195661|Protective Agents|protective agents|mesh-ancestor
2679583|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679584|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679585|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2679586|NCT02195791|Pioglitazone|pioglitazone|mesh-list
2679587|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2679588|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679589|NCT02195804|Ranitidine|ranitidine|mesh-list
2679590|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2679591|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2679592|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2679593|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2679594|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
2679595|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
2679596|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2679597|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679598|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679599|NCT02195817|Nalmefene|nalmefene|mesh-list
2679600|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2187635|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
2187636|NCT00003136|Carboplatin|carboplatin|mesh-list
2187637|NCT00003136|Amifostine|amifostine|mesh-list
2187638|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187639|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
2187640|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187641|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2679601|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679602|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
2679603|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679604|NCT02195908|Antiemetics|antiemetics|mesh-list
2679605|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
2679606|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679607|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679608|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2679609|NCT02195973|Paclitaxel|paclitaxel|mesh-list
2679610|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2679611|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679612|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
2679613|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
2679614|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
2679615|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679616|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
2679617|NCT02196142|Mannitol|mannitol|mesh-list
2679618|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2679619|NCT02196142|Diuretics|diuretics|mesh-ancestor
2679620|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
2679621|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679622|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2679623|NCT02196155|Cortisone|cortisone|mesh-list
2679624|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
2679625|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2679626|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2679627|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2679628|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2679629|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679630|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
2679631|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2679632|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679633|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2679634|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2679635|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679648|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
2679649|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2679650|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
2679651|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679652|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679653|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2679654|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
2679655|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
2679656|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2679657|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
2679658|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2679659|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679660|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2679661|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
2679662|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679663|NCT02196285|Vaccines|vaccines|mesh-list
2187642|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187643|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
2187644|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187645|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679664|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
2679665|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187646|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187647|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2187648|NCT00003136|Protective Agents|protective agents|mesh-ancestor
2187649|NCT00003137|Irinotecan|irinotecan|mesh-list
2187650|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2187651|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187652|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187653|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187654|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187655|NCT00003139|Pilocarpine|pilocarpine|mesh-list
2187656|NCT00003139|Miotics|miotics|mesh-ancestor
2187657|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
2187658|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2187659|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187660|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2679666|NCT02196441|Bupivacaine|bupivacaine|mesh-list
2679667|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
2679668|NCT02196441|Tetracaine|tetracaine|mesh-list
2679669|NCT02196441|Anesthetics|anesthetics|mesh-list
2679670|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679671|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679672|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
2679673|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679674|NCT02196493|Azithromycin|azithromycin|mesh-list
2679675|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2679676|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679677|NCT02196662|Mesalamine|mesalamine|mesh-list
2679678|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2679679|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2679680|NCT02196662|Analgesics|analgesics|mesh-ancestor
2679681|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
2679682|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679683|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679684|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2679685|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2679686|NCT02196740|Metronidazole|metronidazole|mesh-list
2679687|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
2679688|NCT02196740|Clindamycin|clindamycin|mesh-list
2679689|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
2679690|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
2679691|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
2679692|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679693|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2679694|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2679695|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2679696|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2679697|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2679698|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679699|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679700|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679701|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2679702|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2679703|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2679704|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2679705|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2679706|NCT02196805|Probucol|probucol|mesh-list
2679707|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2679708|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2679709|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
2679710|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679711|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2679712|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
2679713|NCT02196805|Protective Agents|protective agents|mesh-ancestor
2679714|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679720|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
2679721|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2679722|NCT02197000|Protective Agents|protective agents|mesh-ancestor
2679723|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679724|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679725|NCT02197026|Hylan|hylan|mesh-list
2679726|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
2679727|NCT02197026|Protective Agents|protective agents|mesh-ancestor
2187661|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2187662|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
2187663|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2187664|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187665|NCT00003140|Letrozole|letrozole|mesh-list
2679728|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679729|NCT02197039|Esomeprazole|esomeprazole|mesh-list
2679730|NCT02197039|Pantoprazole|pantoprazole|mesh-list
2679731|NCT02197039|Hemostatics|hemostatics|mesh-list
2679732|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2679733|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2679734|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2679735|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679736|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679737|NCT02197039|Coagulants|coagulants|mesh-ancestor
2679738|NCT02197143|Esomeprazole|esomeprazole|mesh-list
2187666|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187667|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2187668|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2187669|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187670|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187671|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2187672|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
2187673|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2187674|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187675|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
2187676|NCT00003141|Thiotepa|thiotepa|mesh-list
2187677|NCT00003141|Cisplatin|cisplatin|mesh-list
2187678|NCT00003141|Carboplatin|carboplatin|mesh-list
2187679|NCT00003141|Etoposide|etoposide|mesh-list
2187680|NCT00003141|Vincristine|vincristine|mesh-list
2187681|NCT00003141|Lenograstim|lenograstim|mesh-list
2679739|NCT02197143|Ranitidine|ranitidine|mesh-list
2679740|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2679741|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2187682|NCT00003141|Sargramostim|sargramostim|mesh-list
2187683|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187684|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
2187685|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187686|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2187687|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187688|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
2187689|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187690|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187691|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187692|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187693|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187694|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187695|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187696|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2679742|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2679743|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2679744|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679745|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679746|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2679747|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
2679748|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
2679749|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2679750|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679751|NCT02197156|Acetaminophen|acetaminophen|mesh-list
2679752|NCT02197156|Hydrocodone|hydrocodone|mesh-list
2679753|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2679754|NCT02197156|Analgesics|analgesics|mesh-ancestor
2679755|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
2679756|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679757|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679758|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
2679759|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2679760|NCT02197156|Narcotics|narcotics|mesh-ancestor
2679761|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679762|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
2679763|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
2679764|NCT02197169|Interferons|interferons|mesh-list
2679765|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
2679766|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679767|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
2679768|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679769|NCT02197182|Copper|copper|mesh-list
2187697|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187698|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187699|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
2679770|NCT02197182|Metronidazole|metronidazole|mesh-list
2679771|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679772|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2679773|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2679774|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2679775|NCT02197182|Trace Elements|trace elements|mesh-ancestor
2679776|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
2679777|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679778|NCT02197221|Bortezomib|bortezomib|mesh-list
2679779|NCT02197221|Melphalan|melphalan|mesh-list
2679780|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679781|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2679782|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
2679783|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679784|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2679785|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2679786|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
2679787|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679788|NCT02197260|Amoxicillin|amoxicillin|mesh-list
2679789|NCT02197260|Metronidazole|metronidazole|mesh-list
2679790|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2679791|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679792|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2679793|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2679794|NCT02197286|Vitamin D|vitamin d|mesh-list
2679795|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
2679796|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
2679797|NCT02197286|Vitamins|vitamins|mesh-list
2679798|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
2679799|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679800|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2187700|NCT00003143|Amifostine|amifostine|mesh-list
2187701|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2187702|NCT00003143|Protective Agents|protective agents|mesh-ancestor
2187703|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187704|NCT00003144|Gemcitabine|gemcitabine|mesh-list
2187705|NCT00003144|Amifostine|amifostine|mesh-list
2187706|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187707|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187708|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
2187709|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187710|NCT00003144|Antiviral Agents|antiviral agents|mesh-ancestor
2187711|NCT00003144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187712|NCT00003144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187713|NCT00003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187714|NCT00003144|Immunologic Factors|immunologic factors|mesh-ancestor
2187715|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679801|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2679802|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
2679803|NCT02197403|Propofol|propofol|mesh-list
2679804|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2679805|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679806|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679807|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2679808|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
2679809|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
2679810|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2679811|NCT02197403|Analgesics|analgesics|mesh-ancestor
2679812|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
2679813|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679814|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2679815|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2679816|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2679817|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
2679818|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2679819|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679820|NCT02197442|Valsartan|valsartan|mesh-list
2679821|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2679822|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2679823|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2679824|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187716|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2187717|NCT00003144|Protective Agents|protective agents|mesh-ancestor
2679825|NCT02197494|Valsartan|valsartan|mesh-list
2679826|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2679827|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2679828|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2679829|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679830|NCT02197598|Nalmefene|nalmefene|mesh-list
2679831|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2679832|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679833|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
2679834|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679835|NCT02197637|Vinorelbine|vinorelbine|mesh-list
2679836|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2679837|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679838|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
2679839|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
2679840|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
2679841|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679842|NCT02197650|Asparaginase|asparaginase|mesh-list
2679843|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679844|NCT02197676|Guadecitabine|guadecitabine|mesh-list
2679845|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679846|NCT02197702|Vitamin D|vitamin d|mesh-list
2679847|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
2679848|NCT02197702|Vitamins|vitamins|mesh-ancestor
2679849|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
2679850|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679851|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2679852|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2679853|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
2679854|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2679855|NCT02197741|Narcotics|narcotics|mesh-ancestor
2679856|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679857|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679858|NCT02197741|Analgesics|analgesics|mesh-ancestor
2679859|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
2679860|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679861|NCT02197884|Clarithromycin|clarithromycin|mesh-list
2679862|NCT02197884|Itraconazole|itraconazole|mesh-list
2679863|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2679864|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679865|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2679866|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679867|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679868|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2679869|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2679870|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
2679871|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2679872|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2679873|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
2679874|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2679875|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679876|NCT02197988|Fentanyl|fentanyl|mesh-list
2679877|NCT02197988|Bupivacaine|bupivacaine|mesh-list
2679878|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
2679879|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
2679880|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679881|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679882|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
2679883|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679884|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2679885|NCT02197988|Narcotics|narcotics|mesh-ancestor
2679886|NCT02197988|Analgesics|analgesics|mesh-ancestor
2679887|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2679888|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2679889|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
2679890|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2679891|NCT02198001|Amoxicillin|amoxicillin|mesh-list
2679892|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
2679893|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
2679894|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2679895|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679896|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2679897|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679898|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679899|NCT02198027|Bupivacaine|bupivacaine|mesh-list
2679900|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
2679901|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
2679902|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679903|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679904|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
2679905|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679906|NCT02198170|Ketoconazole|ketoconazole|mesh-list
2679907|NCT02198170|Lenvatinib|lenvatinib|mesh-list
2679908|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
2679909|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679910|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2679911|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2679912|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679913|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679914|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2679915|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
2679916|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2679917|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679918|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2679919|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679920|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2679921|NCT02198209|Liraglutide|liraglutide|mesh-list
2679922|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2679923|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679924|NCT02198209|Incretins|incretins|mesh-ancestor
2679925|NCT02198209|Hormones|hormones|mesh-ancestor
2679926|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2679927|NCT02198248|Prednisolone|prednisolone|mesh-list
2679928|NCT02198248|Rituximab|rituximab|mesh-list
2187718|NCT00003145|Cyclosporine|cyclosporine|mesh-list
2187719|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
2187720|NCT00003145|Fludarabine|fludarabine|mesh-list
2187721|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
2187722|NCT00003145|Cyclosporins|cyclosporins|mesh-list
2187723|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187724|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187725|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
2187726|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187727|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187728|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
2187729|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187730|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187731|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
2187732|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187733|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
2187734|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2187735|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2187736|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2187737|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2187738|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
2187739|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2187740|NCT00003146|Melphalan|melphalan|mesh-list
2187741|NCT00003146|Busulfan|busulfan|mesh-list
2187742|NCT00003146|Thiotepa|thiotepa|mesh-list
2187743|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187744|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
2187745|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187746|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187747|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187748|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187749|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
2187750|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187751|NCT00003148|Aldesleukin|aldesleukin|mesh-list
2187752|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187753|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2187754|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2187755|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
2187756|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187757|NCT00003149|Interleukin-12|interleukin-12|mesh-list
2187758|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2187759|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
2187760|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187761|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2187762|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2187763|NCT00003149|Growth Substances|growth substances|mesh-ancestor
2187764|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
2187765|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679929|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
2679930|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2679931|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2679932|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
2679933|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679934|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2679935|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2679936|NCT02198248|Hormones|hormones|mesh-ancestor
2679937|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2679938|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2679939|NCT02198261|Minoxidil|minoxidil|mesh-list
2679940|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2679941|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
2679942|NCT02198300|Clopidogrel|clopidogrel|mesh-list
2679943|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2679944|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2679945|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2679946|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2679947|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
2679948|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2679949|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679950|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679951|NCT02198378|Acetaminophen|acetaminophen|mesh-list
2679952|NCT02198378|Morphine|morphine|mesh-list
2679953|NCT02198378|Entonox|entonox|mesh-list
2679954|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2679955|NCT02198378|Narcotics|narcotics|mesh-ancestor
2679956|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2187766|NCT00003150|Prednisone|prednisone|mesh-list
2187767|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
2187768|NCT00003150|Rituximab|rituximab|mesh-list
2187769|NCT00003150|Doxorubicin|doxorubicin|mesh-list
2187770|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2187771|NCT00003150|Vincristine|vincristine|mesh-list
2187772|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187773|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
2187774|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187775|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2187776|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187777|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
2187778|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187779|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187780|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187781|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2187782|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2187783|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187784|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187785|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187786|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2187787|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
2187788|NCT00003150|Hormones|hormones|mesh-ancestor
2187789|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2187790|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2679957|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679958|NCT02198378|Analgesics|analgesics|mesh-ancestor
2679959|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
2679960|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2679961|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2679962|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
2679963|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2679964|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
2679965|NCT02198404|Propofol|propofol|mesh-list
2679966|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2679967|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2679968|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679969|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2679970|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
2679971|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
2679972|NCT02198417|Metformin|metformin|mesh-list
2679973|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2679974|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2679975|NCT02198443|Ritonavir|ritonavir|mesh-list
2679976|NCT02198443|Lopinavir|lopinavir|mesh-list
2679977|NCT02198443|Tenofovir|tenofovir|mesh-list
2679978|NCT02198443|Emtricitabine|emtricitabine|mesh-list
2679979|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2679980|NCT02198443|Cobicistat|cobicistat|mesh-list
2679981|NCT02198443|Elvitegravir|elvitegravir|mesh-list
2679982|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2679983|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2679984|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
2679985|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2679986|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2679987|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2679988|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2679989|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
2679990|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2679991|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2679992|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2679993|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2187791|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187792|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187793|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
2679994|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2187794|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187795|NCT00003151|Amoxicillin|amoxicillin|mesh-list
2187796|NCT00003151|Metronidazole|metronidazole|mesh-list
2187797|NCT00003151|Clarithromycin|clarithromycin|mesh-list
2187798|NCT00003151|Tetracycline|tetracycline|mesh-list
2187799|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
2187800|NCT00003151|Omeprazole|omeprazole|mesh-list
2187801|NCT00003151|Bismuth|bismuth|mesh-list
2187802|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2187803|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187804|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2679995|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2679996|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2679997|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2679998|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
2679999|NCT02198482|Cytarabine|cytarabine|mesh-list
2680000|NCT02198482|Daunorubicin|daunorubicin|mesh-list
2680001|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
2680002|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2680003|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
2680004|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680005|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680006|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
2680007|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680008|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2680009|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
2680010|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680011|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2680012|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2680013|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2680014|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680015|NCT02198482|Analgesics|analgesics|mesh-ancestor
2680016|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
2680017|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680018|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2680019|NCT02198495|Hematinics|hematinics|mesh-ancestor
2680020|NCT02198508|Deferasirox|deferasirox|mesh-list
2680021|NCT02198508|Deferiprone|deferiprone|mesh-list
2680022|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2680023|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
2680024|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
2680025|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680026|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
2680027|NCT02198547|Ropivacaine|ropivacaine|mesh-list
2680028|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
2680029|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
2680030|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680031|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680032|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
2680033|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680034|NCT02198547|Analgesics|analgesics|mesh-ancestor
2680035|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2680036|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
2680037|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2680038|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2680039|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187805|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2680040|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2680041|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
2680042|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2680043|NCT02198807|Piperaquine|piperaquine|mesh-list
2680044|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
2680045|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
2680046|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2680047|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2680048|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680049|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2680050|NCT02198820|Anesthetics|anesthetics|mesh-list
2680051|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680052|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680053|NCT02198846|Insulin|insulin|mesh-list
2680054|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2680055|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680056|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
2680057|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
2680058|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2680059|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680060|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680061|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
2680062|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2680063|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680064|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680065|NCT02198924|Celecoxib|celecoxib|mesh-list
2680066|NCT02198924|Parecoxib|parecoxib|mesh-list
2680067|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2680068|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2680069|NCT02198924|Analgesics|analgesics|mesh-ancestor
2680070|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
2680071|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680072|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680073|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2680074|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2680075|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2680076|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2680077|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680078|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680079|NCT02199171|Carboplatin|carboplatin|mesh-list
2680080|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680081|NCT02199184|Prednisone|prednisone|mesh-list
2680082|NCT02199184|Cortisone|cortisone|mesh-list
2680083|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
2187806|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2187807|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2187808|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2187809|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680084|NCT02199184|Rituximab|rituximab|mesh-list
2680085|NCT02199184|Doxorubicin|doxorubicin|mesh-list
2680086|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2680087|NCT02199184|Etoposide|etoposide|mesh-list
2680088|NCT02199184|Vincristine|vincristine|mesh-list
2680089|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
2680090|NCT02199184|Ofatumumab|ofatumumab|mesh-list
2187810|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187811|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2187812|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2187813|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2187814|NCT00003151|Antacids|antacids|mesh-ancestor
2187815|NCT00003152|Interferons|interferons|mesh-list
2187816|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
2187817|NCT00003152|Prednisone|prednisone|mesh-list
2187818|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
2187819|NCT00003152|Vincristine|vincristine|mesh-list
2187820|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187821|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
2187822|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187823|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2187824|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187825|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
2187826|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187827|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187828|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187829|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2187830|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
2187831|NCT00003152|Hormones|hormones|mesh-ancestor
2680091|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
2680092|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2680093|NCT02199184|Antibodies|antibodies|mesh-list
2680094|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
2680095|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2680096|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2680097|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
2680098|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680099|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2680100|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2680101|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
2680102|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680103|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680104|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187832|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2187833|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2187834|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
2187835|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187836|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187837|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187838|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187839|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187840|NCT00003156|Topotecan|topotecan|mesh-list
2187841|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2187842|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187843|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187844|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187845|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187846|NCT00003157|Gemcitabine|gemcitabine|mesh-list
2187847|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187848|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187849|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
2187850|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187851|NCT00003157|Antiviral Agents|antiviral agents|mesh-ancestor
2187852|NCT00003157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187853|NCT00003157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187854|NCT00003157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187855|NCT00003157|Immunologic Factors|immunologic factors|mesh-ancestor
2187856|NCT00003157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187857|NCT00003158|Paclitaxel|paclitaxel|mesh-list
2187858|NCT00003158|Etoposide|etoposide|mesh-list
2187859|NCT00003158|Carboplatin|carboplatin|mesh-list
2187860|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2680105|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2680106|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2680107|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2680108|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680109|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2680110|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
2680111|NCT02199184|Hormones|hormones|mesh-ancestor
2680112|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2680113|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2680114|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2680115|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
2680116|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
2680117|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
2680118|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
2680119|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
2680120|NCT02199223|Panitumumab|panitumumab|mesh-list
2680121|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2680122|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680123|NCT02199236|Capecitabine|capecitabine|mesh-list
2680124|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2680125|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
2680126|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680127|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680128|NCT02199327|Interferons|interferons|mesh-list
2680129|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
2680130|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
2680131|NCT02199327|Mitomycins|mitomycins|mesh-list
2680132|NCT02199327|Mitomycin|mitomycin|mesh-list
2680133|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680134|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
2680135|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680136|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
2680137|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680138|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2680139|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
2680140|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187861|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680141|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2680142|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680143|NCT02199379|Lenvatinib|lenvatinib|mesh-list
2680144|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680145|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2680146|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680147|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680148|NCT02199392|Lenvatinib|lenvatinib|mesh-list
2680149|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680150|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2680151|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680152|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680153|NCT02199418|Paclitaxel|paclitaxel|mesh-list
2680154|NCT02199418|Cisplatin|cisplatin|mesh-list
2680155|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2680156|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680157|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
2680158|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
2680159|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
2680160|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680161|NCT02199431|Itraconazole|itraconazole|mesh-list
2680162|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
2680163|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680164|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2680165|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2680166|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680167|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680168|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2680169|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
2680170|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2187862|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187863|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187864|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187865|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680171|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680172|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2680173|NCT02199444|Sevelamer|sevelamer|mesh-list
2680174|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
2680175|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
2680176|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680177|NCT02199522|Propofol|propofol|mesh-list
2680178|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2680179|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680180|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680181|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2680182|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
2680183|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
2680184|NCT02199613|Darunavir|darunavir|mesh-list
2680185|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2680186|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2187866|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187867|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187868|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187869|NCT00003159|Gemcitabine|gemcitabine|mesh-list
2680187|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
2680188|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680189|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680190|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2680191|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2680192|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
2680193|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187870|NCT00003159|Paclitaxel|paclitaxel|mesh-list
2187871|NCT00003159|Vinorelbine|vinorelbine|mesh-list
2187872|NCT00003159|Vinblastine|vinblastine|mesh-list
2187873|NCT00003159|Docetaxel|docetaxel|mesh-list
2187874|NCT00003159|Carboplatin|carboplatin|mesh-list
2187875|NCT00003159|Ifosfamide|ifosfamide|mesh-list
2187876|NCT00003159|Mitomycins|mitomycins|mesh-list
2187877|NCT00003159|Mitomycin|mitomycin|mesh-list
2187878|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187879|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187880|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187881|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
2680206|NCT02199678|Ketamine|ketamine|mesh-list
2680207|NCT02199678|Analgesics|analgesics|mesh-ancestor
2680208|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
2680209|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680210|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680211|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2680212|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2680213|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
2680214|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
2680215|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680216|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2680217|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2680218|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2680219|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680220|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
2680221|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2680222|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2680223|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
2680224|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680225|NCT02199951|Piperaquine|piperaquine|mesh-list
2680226|NCT02199951|Artenimol|artenimol|mesh-list
2680227|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
2680228|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2680229|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2680230|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680231|NCT02200094|Telmisartan|telmisartan|mesh-list
2680232|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2680233|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2680234|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2680235|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680236|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
2680237|NCT02200146|Prednisone|prednisone|mesh-list
2680238|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2680239|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
2680240|NCT02200146|Hormones|hormones|mesh-ancestor
2680241|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2680242|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680243|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2680244|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680245|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
2680246|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2680247|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2680248|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680249|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680250|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680251|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2680252|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
2680253|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2680254|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680255|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680256|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2680257|NCT02200159|Analgesics|analgesics|mesh-ancestor
2680258|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
2680259|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680260|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2680261|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2680262|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2680263|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
2680264|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2680265|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680266|NCT02200172|Melatonin|melatonin|mesh-list
2680267|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
2680268|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680269|NCT02200172|Protective Agents|protective agents|mesh-ancestor
2680270|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680271|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680272|NCT02200185|Morphine|morphine|mesh-list
2680273|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2680274|NCT02200185|Narcotics|narcotics|mesh-ancestor
2680275|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680276|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680277|NCT02200185|Analgesics|analgesics|mesh-ancestor
2680278|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
2680279|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680280|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
2680281|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2680282|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
2680283|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680284|NCT02200237|Antacids|antacids|mesh-ancestor
2680285|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680286|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2680287|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
2680288|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2680289|NCT02200354|Bevacizumab|bevacizumab|mesh-list
2680290|NCT02200354|Pemetrexed|pemetrexed|mesh-list
2680291|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2187882|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187883|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187884|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187885|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
2187886|NCT00003159|Antiviral Agents|antiviral agents|mesh-ancestor
2187887|NCT00003159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187888|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187889|NCT00003159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187890|NCT00003159|Immunologic Factors|immunologic factors|mesh-ancestor
2187891|NCT00003159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187892|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187893|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
2187894|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2187895|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2187896|NCT00003160|Paclitaxel|paclitaxel|mesh-list
2187897|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187898|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187899|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187900|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187901|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187902|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187903|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
2187904|NCT00003163|Melphalan|melphalan|mesh-list
2187905|NCT00003163|Sargramostim|sargramostim|mesh-list
2187906|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187907|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
2187908|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187909|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2187910|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187911|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
2187912|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187913|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187914|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187915|NCT00003165|Doxorubicin|doxorubicin|mesh-list
2187916|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2187917|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187918|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187919|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187920|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2187921|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187922|NCT00003166|Vincristine|vincristine|mesh-list
2187923|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
2187924|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2187925|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187926|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187927|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187928|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187929|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187930|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2187931|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
2187932|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187933|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
2680292|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680293|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2680294|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2680295|NCT02200354|Growth Substances|growth substances|mesh-ancestor
2680296|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680297|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
2680298|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680299|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680300|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2680301|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2680302|NCT02200380|Plerixafor|plerixafor|mesh-list
2680303|NCT02200380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2680304|NCT02200380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2680305|NCT02200380|Antiviral Agents|antiviral agents|mesh-ancestor
2680306|NCT02200380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680307|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2680308|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2680309|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2680310|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2680311|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680312|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2680313|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680314|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
2680315|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2680316|NCT02200562|Ipilimumab|ipilimumab|mesh-list
2680317|NCT02200562|Dabrafenib|dabrafenib|mesh-list
2680318|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2680319|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680320|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2680321|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680322|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2680323|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680324|NCT02200575|Telmisartan|telmisartan|mesh-list
2680325|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2680326|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2680327|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2680328|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680329|NCT02200640|Losartan|losartan|mesh-list
2680330|NCT02200640|Telmisartan|telmisartan|mesh-list
2680331|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2680332|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2680333|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2680334|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2680335|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187934|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2187935|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
2187936|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187937|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187938|NCT00003172|Interferons|interferons|mesh-list
2187939|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
2187940|NCT00003172|Docetaxel|docetaxel|mesh-list
2187941|NCT00003172|Doxorubicin|doxorubicin|mesh-list
2187942|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2187943|NCT00003172|Fluorouracil|fluorouracil|mesh-list
2187944|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
2187945|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187946|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
2187947|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
2187948|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
2187949|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187950|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2187951|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2187952|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2187953|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680336|NCT02200653|Losartan|losartan|mesh-list
2680337|NCT02200653|Telmisartan|telmisartan|mesh-list
2680338|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2680339|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2680340|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2680341|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2680342|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680343|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
2680344|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2680345|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
2187954|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
2187955|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187956|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2680346|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680347|NCT02200757|Topotecan|topotecan|mesh-list
2680348|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2680349|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2680350|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680351|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680352|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680353|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2680354|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2680355|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
2680356|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2680357|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680358|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680359|NCT02200848|Rituximab|rituximab|mesh-list
2680360|NCT02200848|Lenalidomide|lenalidomide|mesh-list
2680361|NCT02200848|Glutarimide|glutarimide|mesh-list
2680362|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2680363|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680364|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
2680365|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680366|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2680367|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2680368|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2680369|NCT02200848|Growth Substances|growth substances|mesh-ancestor
2680370|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
2680371|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2680372|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680373|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680374|NCT02200978|Cytarabine|cytarabine|mesh-list
2680375|NCT02200978|Methotrexate|methotrexate|mesh-list
2680376|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
2680377|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
2680378|NCT02200978|Tretinoin|tretinoin|mesh-list
2680379|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
2680380|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2680381|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
2680382|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2680383|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680384|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2680385|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
2680386|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680387|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680388|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
2187957|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
2187958|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187959|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
2187960|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187961|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
2187962|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2187963|NCT00003173|Thiotepa|thiotepa|mesh-list
2187964|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
2187965|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187966|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187967|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
2187968|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187969|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187970|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2187971|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187972|NCT00003174|Cladribine|cladribine|mesh-list
2187973|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
2680389|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680390|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2680391|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2680392|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
2680393|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2680394|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2680395|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
2680396|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680397|NCT02200978|Analgesics|analgesics|mesh-ancestor
2680398|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
2187974|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680399|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680400|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2680401|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2680402|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
2680403|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
2680404|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2680405|NCT02200991|Lixisenatide|lixisenatide|mesh-list
2680406|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2680407|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680408|NCT02200991|Incretins|incretins|mesh-ancestor
2680409|NCT02200991|Hormones|hormones|mesh-ancestor
2187975|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187976|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
2187977|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2187978|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2187979|NCT00003175|Fluorouracil|fluorouracil|mesh-list
2187980|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
2187981|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187982|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2187983|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187984|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2187985|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
2187986|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680410|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2680411|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2680412|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
2680413|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680414|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680415|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
2680416|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2680417|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680418|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2680419|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680420|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2680421|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
2680422|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680423|NCT02201043|Thalidomide|thalidomide|mesh-list
2680424|NCT02201043|Tolnaftate|tolnaftate|mesh-list
2680425|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2680426|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
2680427|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680428|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
2680429|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2680430|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680431|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2680432|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2680433|NCT02201043|Growth Substances|growth substances|mesh-ancestor
2680434|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
2680435|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680436|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
2680437|NCT02201082|Amikacin|amikacin|mesh-list
2680438|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2680439|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680440|NCT02201121|Phenylephrine|phenylephrine|mesh-list
2680441|NCT02201121|Dopamine|dopamine|mesh-list
2680442|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
2680443|NCT02201121|Ephedrine|ephedrine|mesh-list
2680444|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2680445|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
2680446|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
2680447|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680448|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680449|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
2680450|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2680451|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
2680452|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
2680453|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2680454|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2680455|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2680456|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
2680457|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2680458|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680459|NCT02201121|Protective Agents|protective agents|mesh-ancestor
2680460|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
2680461|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2680462|NCT02201134|Sevoflurane|sevoflurane|mesh-list
2680463|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2680464|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2680465|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
2680466|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
2680467|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680468|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680469|NCT02201199|Insulin|insulin|mesh-list
2680470|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2680471|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
2680472|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2680473|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680474|NCT02201225|Micronutrients|micronutrients|mesh-list
2680475|NCT02201225|Trace Elements|trace elements|mesh-list
2680476|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680477|NCT02201238|Diclofenac|diclofenac|mesh-list
2680478|NCT02201238|Menthol|menthol|mesh-list
2680479|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2680480|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2680481|NCT02201238|Analgesics|analgesics|mesh-ancestor
2680482|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
2680483|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680484|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680485|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2680486|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2680487|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2680488|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680489|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680490|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
2680491|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
2680492|NCT02201316|Mosapride|mosapride|mesh-list
2680493|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680494|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2680495|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2680496|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
2680497|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2680498|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680499|NCT02201342|Udenafil|udenafil|mesh-list
2680500|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2680501|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2680502|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680503|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680504|NCT02201381|Metformin|metformin|mesh-list
2680505|NCT02201381|Doxycycline|doxycycline|mesh-list
2680506|NCT02201381|Mebendazole|mebendazole|mesh-list
2680507|NCT02201381|Atorvastatin|atorvastatin|mesh-list
2680508|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2680509|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680510|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2680511|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2680512|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
2680513|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680514|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2680515|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2680516|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680517|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2680518|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2187987|NCT00003176|Temozolomide|temozolomide|mesh-list
2187988|NCT00003176|Carmustine|carmustine|mesh-list
2187989|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2187990|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
2187991|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2187992|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2187993|NCT00003178|Idarubicin|idarubicin|mesh-list
2680519|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
2680520|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2680521|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2680522|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
2680523|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
2680524|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
2680525|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
2680526|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
2680527|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680528|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2680529|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
2187994|NCT00003178|Cladribine|cladribine|mesh-list
2680530|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680531|NCT02201459|Interferons|interferons|mesh-list
2680532|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
2680533|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
2680534|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2680535|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680536|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
2680537|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680538|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
2680539|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680540|NCT02201563|Minocycline|minocycline|mesh-list
2680541|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2680542|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680543|NCT02201576|Bortezomib|bortezomib|mesh-list
2680544|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
2680545|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2680546|NCT02201576|Antibodies|antibodies|mesh-list
2680547|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
2680548|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2680549|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680550|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
2680551|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680552|NCT02201602|Gliclazide|gliclazide|mesh-list
2680553|NCT02201602|Glyburide|glyburide|mesh-list
2680554|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2680555|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680556|NCT02201641|Calcium|calcium|mesh-list
2680557|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2680558|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680559|NCT02201667|Aspirin|aspirin|mesh-list
2680560|NCT02201667|Clopidogrel|clopidogrel|mesh-list
2680561|NCT02201667|Ticagrelor|ticagrelor|mesh-list
2680562|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2680563|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2680564|NCT02201667|Analgesics|analgesics|mesh-ancestor
2680565|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
2680566|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2187995|NCT00003178|Lenograstim|lenograstim|mesh-list
2187996|NCT00003178|Sargramostim|sargramostim|mesh-list
2187997|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2187998|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
2187999|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188000|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2188001|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188002|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188003|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188004|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188005|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188006|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188007|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2188008|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
2188009|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2188010|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2188011|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2188012|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
2188013|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2188014|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188015|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2188016|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2188017|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2188018|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2188019|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188020|NCT00003181|Aldesleukin|aldesleukin|mesh-list
2188021|NCT00003181|Vinblastine|vinblastine|mesh-list
2188022|NCT00003181|Sargramostim|sargramostim|mesh-list
2188023|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
2188024|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188025|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188026|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2188027|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2188028|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
2680567|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680568|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2680569|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2680570|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2680571|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2680572|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680573|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2680574|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2680575|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680576|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
2680577|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2680578|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2680579|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2680580|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
2680581|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2680582|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2680583|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
2680584|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2680585|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
2680586|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680587|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2680588|NCT02201914|Clomiphene|clomiphene|mesh-list
2680589|NCT02201914|Enclomiphene|enclomiphene|mesh-list
2680590|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
2680591|NCT02201914|Cetrorelix|cetrorelix|mesh-list
2680592|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2188029|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188030|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188031|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188032|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188033|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188034|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188035|NCT00003182|Gemcitabine|gemcitabine|mesh-list
2188036|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188037|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188038|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
2188039|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188040|NCT00003182|Antiviral Agents|antiviral agents|mesh-ancestor
2188041|NCT00003182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188042|NCT00003182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188043|NCT00003182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188044|NCT00003182|Immunologic Factors|immunologic factors|mesh-ancestor
2188045|NCT00003182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188046|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
2188047|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188048|NCT00003183|Analgesics|analgesics|mesh-ancestor
2188049|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
2188050|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2188051|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680593|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
2680594|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2680595|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680596|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2680597|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
2680598|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2680599|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2680600|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2680601|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
2680602|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2680603|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
2680604|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2680605|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2680606|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680607|NCT02201992|Crizotinib|crizotinib|mesh-list
2680608|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680609|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2680610|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680611|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680612|NCT02202005|Nevirapine|nevirapine|mesh-list
2680613|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2680614|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2680615|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680616|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680617|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
2680618|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680619|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2680620|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2680621|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2680622|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2680623|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2680624|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2680625|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2680626|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680627|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680628|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2680629|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2680630|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680631|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
2680632|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2680633|NCT02202200|Palbociclib|palbociclib|mesh-list
2680634|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680635|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2680636|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680637|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680638|NCT02202239|Fentanyl|fentanyl|mesh-list
2680639|NCT02202239|Midazolam|midazolam|mesh-list
2680640|NCT02202239|Remifentanil|remifentanil|mesh-list
2680641|NCT02202239|Propofol|propofol|mesh-list
2680642|NCT02202239|Etomidate|etomidate|mesh-list
2680643|NCT02202239|Sevoflurane|sevoflurane|mesh-list
2680644|NCT02202239|Cisatracurium|cisatracurium|mesh-list
2680645|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2680646|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680647|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680648|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2680649|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
2680650|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
2680651|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2680652|NCT02202239|Narcotics|narcotics|mesh-ancestor
2680653|NCT02202239|Analgesics|analgesics|mesh-ancestor
2680654|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
2680655|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680656|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2680657|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2680658|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2680659|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2680660|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
2680661|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
2680662|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2680663|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680664|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2680665|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2680666|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2680667|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2680668|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
2680669|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2680670|NCT02202304|Thymol|thymol|mesh-list
2680671|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2680672|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680673|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
2680674|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
2680675|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
2680676|NCT02202473|Lamivudine|lamivudine|mesh-list
2680677|NCT02202473|Oxymatrine|oxymatrine|mesh-list
2680678|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2680679|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2188052|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188053|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188054|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188055|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188056|NCT00003184|Vaccines|vaccines|mesh-list
2188057|NCT00003184|Sargramostim|sargramostim|mesh-list
2188058|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
2188059|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
2680680|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680681|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680682|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
2680683|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680684|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2680685|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2680686|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2680687|NCT02202512|Naproxen|naproxen|mesh-list
2680688|NCT02202512|Cimetidine|cimetidine|mesh-list
2680689|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2680690|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2680691|NCT02202512|Analgesics|analgesics|mesh-ancestor
2680692|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
2680693|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680694|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680695|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2680696|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2680697|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
2680698|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2680699|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680700|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680701|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2680702|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2680703|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2680704|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
2680705|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
2680706|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2680707|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2680708|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2680709|NCT02202525|Telmisartan|telmisartan|mesh-list
2680710|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2680711|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2680712|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2680713|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680714|NCT02202564|Ganciclovir|ganciclovir|mesh-list
2680715|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2680716|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
2680717|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680718|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2680719|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680720|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680721|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
2680722|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
2680723|NCT02202577|Povidone|povidone|mesh-list
2680724|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2680725|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680726|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
2680727|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
2680728|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
2680729|NCT02202603|Teriparatide|teriparatide|mesh-list
2680730|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2680731|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680732|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2680733|NCT02202707|Gabapentin|gabapentin|mesh-list
2680734|NCT02202707|Analgesics|analgesics|mesh-ancestor
2680735|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
2680736|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680737|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680738|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
2680739|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2680740|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2680741|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680742|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2680743|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2680744|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2680745|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2680746|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680747|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
2188060|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188061|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2188062|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
2188063|NCT00003185|Sargramostim|sargramostim|mesh-list
2188064|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188065|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
2188066|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188067|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188068|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188069|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
2188070|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188071|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188072|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2188073|NCT00003187|Cytarabine|cytarabine|mesh-list
2188074|NCT00003187|Cyclosporine|cyclosporine|mesh-list
2188075|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
2680748|NCT02202720|Sevoflurane|sevoflurane|mesh-list
2680749|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2680750|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2680751|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
2680752|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
2188076|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
2680753|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680754|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680755|NCT02202772|Gemcitabine|gemcitabine|mesh-list
2680756|NCT02202772|Cisplatin|cisplatin|mesh-list
2680757|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680758|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2680759|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
2680760|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680761|NCT02202772|Antiviral Agents|antiviral agents|mesh-ancestor
2680762|NCT02202772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680763|NCT02202772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680764|NCT02202772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2680765|NCT02202772|Immunologic Factors|immunologic factors|mesh-ancestor
2680766|NCT02202772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680767|NCT02202889|Calcium|calcium|mesh-list
2680768|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2680769|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680770|NCT02202967|Misoprostol|misoprostol|mesh-list
2680771|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2680772|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
2680773|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2680774|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680775|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2680776|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2680777|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
2680778|NCT02202993|Mibefradil|mibefradil|mesh-list
2680779|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2680780|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2680781|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2680782|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680783|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2680784|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680785|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
2680786|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2188077|NCT00003187|Methotrexate|methotrexate|mesh-list
2188078|NCT00003187|Cyclosporins|cyclosporins|mesh-list
2188079|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188080|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
2188081|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188082|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188083|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188084|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
2188085|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188086|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188087|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2188088|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2188089|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
2188090|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2188091|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188092|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
2188093|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
2188094|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188095|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2188096|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2188097|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
2188098|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188099|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
2188100|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2680787|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2680788|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680789|NCT02203097|Propofol|propofol|mesh-list
2680790|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2680791|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680792|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680793|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2680794|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
2680795|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
2680796|NCT02203175|Fentanyl|fentanyl|mesh-list
2680797|NCT02203175|Propofol|propofol|mesh-list
2680798|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2680799|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2680800|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680801|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2680802|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
2680803|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
2680804|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2680805|NCT02203175|Narcotics|narcotics|mesh-ancestor
2680806|NCT02203175|Analgesics|analgesics|mesh-ancestor
2680807|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
2680808|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680809|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2680810|NCT02203227|Turmeric extract|turmeric extract|mesh-list
2680811|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
2680812|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680813|NCT02203227|Protective Agents|protective agents|mesh-ancestor
2680814|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680815|NCT02203253|Thalidomide|thalidomide|mesh-list
2680816|NCT02203253|Dexamethasone|dexamethasone|mesh-list
2680817|NCT02203253|Palonosetron|palonosetron|mesh-list
2680818|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2680819|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
2680820|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
2680821|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680822|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680823|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2680824|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
2680825|NCT02203253|Hormones|hormones|mesh-ancestor
2680826|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2680827|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2680828|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680829|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2680830|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
2680831|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
2680832|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2680833|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680834|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2680835|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2680836|NCT02203253|Growth Substances|growth substances|mesh-ancestor
2680837|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
2680838|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2680839|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2680840|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
2188101|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2188102|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
2188103|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
2188104|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2188105|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2188106|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
2188107|NCT00003187|Hormones|hormones|mesh-ancestor
2188108|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2188109|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2188110|NCT00003187|Protective Agents|protective agents|mesh-ancestor
2188111|NCT00003190|Cytarabine|cytarabine|mesh-list
2188112|NCT00003190|Etoposide|etoposide|mesh-list
2188113|NCT00003190|Daunorubicin|daunorubicin|mesh-list
2188114|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
2188115|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188116|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188117|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188118|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188119|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188120|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188121|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188122|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
2188123|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
2188124|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188125|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188126|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
2188127|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188128|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2188129|NCT00003191|Fenretinide|fenretinide|mesh-list
2188130|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188131|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2188132|NCT00003191|Protective Agents|protective agents|mesh-ancestor
2188133|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188134|NCT00003193|Paclitaxel|paclitaxel|mesh-list
2188135|NCT00003193|Amifostine|amifostine|mesh-list
2188136|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188137|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188138|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188139|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
2680841|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2680842|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680843|NCT02203396|Cyclosporine|cyclosporine|mesh-list
2680844|NCT02203396|Levamisole|levamisole|mesh-list
2680845|NCT02203396|Cyclosporins|cyclosporins|mesh-list
2680846|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
2680847|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680848|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680849|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2680850|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
2680851|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680852|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
2680853|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680854|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
2680855|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2680856|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2680857|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2680858|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
2680859|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
2680860|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2680861|NCT02203422|Cyclosporine|cyclosporine|mesh-list
2680862|NCT02203422|Cyclosporins|cyclosporins|mesh-list
2680863|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680864|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680865|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2680866|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
2680867|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680868|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
2680869|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680870|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
2680871|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2680872|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2680873|NCT02203461|Ritonavir|ritonavir|mesh-list
2680874|NCT02203461|Lopinavir|lopinavir|mesh-list
2680875|NCT02203461|Darunavir|darunavir|mesh-list
2680876|NCT02203461|Tenofovir|tenofovir|mesh-list
2680877|NCT02203461|Emtricitabine|emtricitabine|mesh-list
2680878|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2680879|NCT02203461|Cobicistat|cobicistat|mesh-list
2680880|NCT02203461|Elvitegravir|elvitegravir|mesh-list
2188140|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188141|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188142|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2188143|NCT00003193|Protective Agents|protective agents|mesh-ancestor
2188144|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188145|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
2188146|NCT00003194|Thiotepa|thiotepa|mesh-list
2188147|NCT00003194|Carboplatin|carboplatin|mesh-list
2680881|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2680882|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2680883|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
2680884|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680885|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680886|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2680887|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2680888|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
2680889|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680890|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2680891|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2680892|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2680893|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2680894|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2680895|NCT02203500|Telmisartan|telmisartan|mesh-list
2680896|NCT02203500|Lacidipine|lacidipine|mesh-list
2680897|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2680898|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2680899|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2680900|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680901|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2680902|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2680903|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2680904|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680905|NCT02203552|Minocycline|minocycline|mesh-list
2680906|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2680907|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680908|NCT02203604|Aldesleukin|aldesleukin|mesh-list
2680909|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2680910|NCT02203604|Ipilimumab|ipilimumab|mesh-list
2680911|NCT02203604|Interleukin-2|interleukin-2|mesh-list
2680912|NCT02203604|Antibodies|antibodies|mesh-list
2680913|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
2680914|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2680915|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
2680916|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680917|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680918|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2680919|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680920|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2680921|NCT02203604|Analgesics|analgesics|mesh-ancestor
2680922|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
2680923|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680924|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2680925|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2680926|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
2680927|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680928|NCT02203643|Dexamethasone|dexamethasone|mesh-list
2680929|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
2680930|NCT02203643|Lenalidomide|lenalidomide|mesh-list
2680931|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2680932|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
2680933|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680934|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2680935|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2680936|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
2680937|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680938|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680939|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2680940|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2680941|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
2680942|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
2680943|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2680944|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2680945|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
2680946|NCT02203643|Hormones|hormones|mesh-ancestor
2680947|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2680948|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2680949|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2680950|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2680951|NCT02203643|Growth Substances|growth substances|mesh-ancestor
2680952|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
2680953|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
2680954|NCT02203656|Testosterone|testosterone|mesh-list
2680955|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
2680956|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
2680957|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2680958|NCT02203656|Androgens|androgens|mesh-ancestor
2680959|NCT02203656|Hormones|hormones|mesh-ancestor
2680960|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2680961|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680962|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2680963|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680964|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
2680965|NCT02203760|Gemcitabine|gemcitabine|mesh-list
2680966|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2680967|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
2680968|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680969|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680970|NCT02203760|Antiviral Agents|antiviral agents|mesh-ancestor
2680971|NCT02203760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680972|NCT02203760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2680973|NCT02203760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2680974|NCT02203760|Immunologic Factors|immunologic factors|mesh-ancestor
2680975|NCT02203760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680976|NCT02203773|Posaconazole|posaconazole|mesh-list
2680977|NCT02203773|Azacitidine|azacitidine|mesh-list
2680978|NCT02203773|Decitabine|decitabine|mesh-list
2680979|NCT02203773|Venetoclax|venetoclax|mesh-list
2680980|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2680981|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
2680982|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2680983|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680984|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188148|NCT00003194|Etoposide|etoposide|mesh-list
2188149|NCT00003194|Topotecan|topotecan|mesh-list
2188150|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188151|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
2188152|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188153|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188154|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188155|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
2188156|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188157|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2680985|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
2680986|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2680987|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2680988|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2680989|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2188158|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2188159|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188160|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188161|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188162|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188163|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2188164|NCT00003195|Interferons|interferons|mesh-list
2188165|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
2188166|NCT00003195|Busulfan|busulfan|mesh-list
2188167|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188168|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
2188169|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188170|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
2680990|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2680991|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2680992|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2680993|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
2680994|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2680995|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680996|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
2680997|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2680998|NCT02204020|Azacitidine|azacitidine|mesh-list
2680999|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2681000|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
2681001|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681002|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681003|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681010|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2681011|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2681012|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681013|NCT02204241|Dexamethasone|dexamethasone|mesh-list
2681014|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
2681015|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2681016|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
2681017|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681018|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2681019|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2681020|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
2681021|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681022|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681023|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2681024|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2681025|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
2681026|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
2681027|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681028|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2681029|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
2681030|NCT02204241|Hormones|hormones|mesh-ancestor
2681031|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2681032|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2681033|NCT02204254|Doxycycline|doxycycline|mesh-list
2681034|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2681035|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681036|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
2681037|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2681038|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2681039|NCT02204345|Paclitaxel|paclitaxel|mesh-list
2681040|NCT02204345|Carboplatin|carboplatin|mesh-list
2681041|NCT02204345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2681042|NCT02204345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681043|NCT02204345|Tubulin Modulators|tubulin modulators|mesh-ancestor
2681044|NCT02204345|Antimitotic Agents|antimitotic agents|mesh-ancestor
2681045|NCT02204345|Mitosis Modulators|mitosis modulators|mesh-ancestor
2681046|NCT02204345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681047|NCT02204397|Ustekinumab|ustekinumab|mesh-list
2681048|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
2681049|NCT02204475|Interferons|interferons|mesh-list
2681050|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2681051|NCT02204475|Grazoprevir|grazoprevir|mesh-list
2681052|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681053|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
2681054|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681055|NCT02204501|Midazolam|midazolam|mesh-list
2681056|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2681057|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2681058|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2681059|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681060|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2681061|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2681062|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2681063|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2681064|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
2681065|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
2681066|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
2681067|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
2681068|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2681069|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681070|NCT02204527|Vitamin D|vitamin d|mesh-list
2681071|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
2681072|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
2681073|NCT02204527|Vitamins|vitamins|mesh-list
2681074|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
2681075|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681076|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2681077|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2681078|NCT02204553|Panobinostat|panobinostat|mesh-list
2681079|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681080|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2681081|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681082|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681083|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
2681084|NCT02204644|HH-GV-678|hh-gv-678|mesh-list
2681085|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681086|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2681087|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681088|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681089|NCT02204683|Aflibercept|aflibercept|mesh-list
2681090|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2681091|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2681092|NCT02204683|Growth Substances|growth substances|mesh-ancestor
2188171|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188172|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
2188173|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188174|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188175|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188176|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2188177|NCT00003196|Cyclosporine|cyclosporine|mesh-list
2681093|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681094|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
2681095|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681096|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
2681097|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681098|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2681099|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681100|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681101|NCT02204839|Insulin|insulin|mesh-list
2681102|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
2681103|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
2681104|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2681105|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681106|NCT02204852|Iloprost|iloprost|mesh-list
2681107|NCT02204852|Eptifibatide|eptifibatide|mesh-list
2681108|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2681109|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
2681110|NCT02204878|Parecoxib|parecoxib|mesh-list
2681111|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2681112|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2681113|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681114|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681115|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2681116|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2681117|NCT02204878|Analgesics|analgesics|mesh-ancestor
2681118|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
2681119|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681120|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681121|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2681122|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2681123|NCT02205034|Oxytocin|oxytocin|mesh-list
2681124|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
2681125|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2681126|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681127|NCT02205047|Fluorouracil|fluorouracil|mesh-list
2681128|NCT02205047|Capecitabine|capecitabine|mesh-list
2681129|NCT02205047|Trastuzumab|trastuzumab|mesh-list
2681130|NCT02205047|Pertuzumab|pertuzumab|mesh-list
2681131|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681132|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
2681133|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681134|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2681135|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2681136|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
2681137|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681138|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2681139|NCT02205112|Levofloxacin|levofloxacin|mesh-list
2681140|NCT02205112|Ofloxacin|ofloxacin|mesh-list
2681141|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2681142|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681143|NCT02205112|Renal Agents|renal agents|mesh-ancestor
2681144|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2681145|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2681146|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2681147|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681148|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681149|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681150|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2681151|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2681152|NCT02205151|Amlodipine|amlodipine|mesh-list
2681153|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2681154|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2681155|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2681156|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681157|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2681158|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681159|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
2681160|NCT02205164|Aprepitant|aprepitant|mesh-list
2681161|NCT02205164|Palonosetron|palonosetron|mesh-list
2681162|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
2681163|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
2681164|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681165|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681166|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2681167|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2681168|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2681169|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681170|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2681171|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2681172|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
2681173|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2681174|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2681175|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2681176|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
2681177|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681178|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2681179|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2681180|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681181|NCT02205242|Azithromycin|azithromycin|mesh-list
2681182|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2681183|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681184|NCT02205255|Azithromycin|azithromycin|mesh-list
2681185|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2681186|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681187|NCT02205398|Cetuximab|cetuximab|mesh-list
2681188|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2681189|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681190|NCT02205489|Cetirizine|cetirizine|mesh-list
2681191|NCT02205489|Acyclovir|acyclovir|mesh-list
2681192|NCT02205489|Ibuprofen|ibuprofen|mesh-list
2681193|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
2681194|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2681195|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2681196|NCT02205489|Prednisolone|prednisolone|mesh-list
2681197|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
2681198|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
2681199|NCT02205489|Esomeprazole|esomeprazole|mesh-list
2681200|NCT02205489|Ranitidine|ranitidine|mesh-list
2681201|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2681202|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
2681203|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2681204|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2681205|NCT02205489|Analgesics|analgesics|mesh-ancestor
2681206|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
2681207|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681208|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681209|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2681210|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2681211|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2681212|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681213|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681214|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
2681215|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
2681216|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2681217|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
2681218|NCT02205489|Hormones|hormones|mesh-ancestor
2681219|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2681220|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2681221|NCT02205489|Protective Agents|protective agents|mesh-ancestor
2681222|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2681223|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681224|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2681225|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2681226|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2681227|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
2681228|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681229|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2681230|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2681231|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2681232|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
2681233|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
2681234|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2681235|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2681236|NCT02205502|Lidocaine|lidocaine|mesh-list
2681237|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
2681238|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
2681239|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2681240|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681241|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
2681242|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681243|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2681244|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2681245|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2681246|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2681247|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681248|NCT02205515|Everolimus|everolimus|mesh-list
2681249|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681250|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2681251|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
2681252|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681253|NCT02205528|Metformin|metformin|mesh-list
2681254|NCT02205528|Liraglutide|liraglutide|mesh-list
2681255|NCT02205528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2681256|NCT02205528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681257|NCT02205528|Incretins|incretins|mesh-ancestor
2681258|NCT02205528|Hormones|hormones|mesh-ancestor
2681259|NCT02205528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2681260|NCT02205541|Eculizumab|eculizumab|mesh-list
2681261|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2681262|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2681263|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
2681264|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681265|NCT02205554|Tramadol|tramadol|mesh-list
2681266|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2681267|NCT02205554|Narcotics|narcotics|mesh-ancestor
2681268|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2681269|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681270|NCT02205554|Analgesics|analgesics|mesh-ancestor
2681271|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
2681272|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681273|NCT02205580|Sufentanil|sufentanil|mesh-list
2681274|NCT02205580|Dsuvia|dsuvia|mesh-list
2681275|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2681276|NCT02205580|Narcotics|narcotics|mesh-ancestor
2681277|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2681278|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681279|NCT02205580|Analgesics|analgesics|mesh-ancestor
2681280|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
2681281|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681282|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2681283|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2681284|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
2681285|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
2681286|NCT02205619|Glycine|glycine|mesh-list
2681287|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
2681288|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2681289|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681290|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681291|NCT02205762|Cytarabine|cytarabine|mesh-list
2681292|NCT02205762|Prednisone|prednisone|mesh-list
2681293|NCT02205762|Indomethacin|indomethacin|mesh-list
2681294|NCT02205762|Methotrexate|methotrexate|mesh-list
2681295|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
2681296|NCT02205762|Vinblastine|vinblastine|mesh-list
2681297|NCT02205762|Cladribine|cladribine|mesh-list
2681298|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
2681299|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2681300|NCT02205762|Antibodies|antibodies|mesh-list
2681301|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
2423107|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423108|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423109|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2681302|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2681303|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2681304|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
2681305|NCT02205762|Hormones|hormones|mesh-ancestor
2681306|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2681307|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681308|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2188178|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
2188179|NCT00003196|Cyclosporins|cyclosporins|mesh-list
2188180|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188181|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188182|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188183|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
2188184|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188185|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
2423110|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2423111|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2423112|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2423113|NCT00820547|Growth Substances|growth substances|mesh-ancestor
2423114|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
2423115|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
2423116|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
2423117|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423118|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
2423119|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2423120|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2423121|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2423122|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2423123|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681309|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681310|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2681311|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
2188186|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188187|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
2188188|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188189|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2188190|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2188191|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188192|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2188193|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
2188194|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2188195|NCT00003198|Topotecan|topotecan|mesh-list
2188196|NCT00003198|Ifosfamide|ifosfamide|mesh-list
2188197|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2188198|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188199|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188200|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681312|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2681313|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2681314|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
2681315|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681316|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
2681317|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681318|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2681319|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2681320|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
2681321|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2681322|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2681323|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
2681324|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681325|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2681326|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
2681327|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
2681328|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
2681329|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2681330|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2681331|NCT02205762|Analgesics|analgesics|mesh-ancestor
2681332|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
2681333|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681334|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
2681335|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
2681336|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2681337|NCT02205775|Atorvastatin|atorvastatin|mesh-list
2681338|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2681339|NCT02205775|Ezetimibe|ezetimibe|mesh-list
2681340|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2681341|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2681342|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
2681343|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681344|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2681345|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2681346|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681347|NCT02205879|Pregabalin|pregabalin|mesh-list
2681348|NCT02205879|Analgesics|analgesics|mesh-ancestor
2681349|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
2681350|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681351|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681352|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
2681353|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2188201|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188202|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188203|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
2188204|NCT00003200|Docetaxel|docetaxel|mesh-list
2188205|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188206|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188207|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188208|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188209|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188210|NCT00003202|Gemcitabine|gemcitabine|mesh-list
2188211|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188212|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188213|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
2188214|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681354|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2681355|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681356|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2681357|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2681358|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2681359|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2681360|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2681361|NCT02205892|Lupeol|lupeol|mesh-list
2681362|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2681363|NCT02205931|Topiramate|topiramate|mesh-list
2681364|NCT02205931|Lamotrigine|lamotrigine|mesh-list
2681365|NCT02205931|Zonisamide|zonisamide|mesh-list
2681366|NCT02205931|Carbamazepine|carbamazepine|mesh-list
2681367|NCT02205931|Phenytoin|phenytoin|mesh-list
2681368|NCT02205931|Rufinamide|rufinamide|mesh-list
2681369|NCT02205931|Levetiracetam|levetiracetam|mesh-list
2681370|NCT02205931|Valproic Acid|valproic acid|mesh-list
2681371|NCT02205931|Clonazepam|clonazepam|mesh-list
2681372|NCT02205931|Vigabatrin|vigabatrin|mesh-list
2681373|NCT02205931|Clobazam|clobazam|mesh-list
2681374|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
2681375|NCT02205931|Ethosuximide|ethosuximide|mesh-list
2681376|NCT02205931|Stiripentol|stiripentol|mesh-list
2681377|NCT02205931|Nitrazepam|nitrazepam|mesh-list
2681378|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2681379|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681380|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
2681381|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2681382|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2681383|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681384|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2188215|NCT00003202|Antiviral Agents|antiviral agents|mesh-ancestor
2188216|NCT00003202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188217|NCT00003202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188218|NCT00003202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188219|NCT00003202|Immunologic Factors|immunologic factors|mesh-ancestor
2188220|NCT00003202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188221|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
2188222|NCT00003203|Cisplatin|cisplatin|mesh-list
2188223|NCT00003203|Carboplatin|carboplatin|mesh-list
2188224|NCT00003203|Vincristine|vincristine|mesh-list
2188225|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188226|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
2188227|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188228|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2681385|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2681386|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2681387|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2681388|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2681389|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2423124|NCT00820690|Paclitaxel|paclitaxel|mesh-list
2423125|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
2681390|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681391|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
2681392|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2681393|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
2681394|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2188229|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188230|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
2423126|NCT00820690|Doxorubicin|doxorubicin|mesh-list
2423127|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2423128|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423129|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
2423130|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
2423131|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423132|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423133|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2423134|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
2423135|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423136|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2423137|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2423138|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
2423139|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2423140|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2423141|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2423142|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2423143|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423144|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2423145|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423146|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
2188231|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188232|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188233|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2188234|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188235|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188236|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188237|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188238|NCT00003204|Prednisone|prednisone|mesh-list
2188239|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
2188240|NCT00003204|Rituximab|rituximab|mesh-list
2188241|NCT00003204|Fludarabine|fludarabine|mesh-list
2681395|NCT02205931|Analgesics|analgesics|mesh-ancestor
2681396|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
2681397|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681398|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2681399|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2681400|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2681401|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2681402|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
2681403|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2681404|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2681405|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
2681406|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2681407|NCT02205996|Insulin|insulin|mesh-list
2681408|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2681409|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2681410|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681411|NCT02206022|Remifentanil|remifentanil|mesh-list
2681412|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2681413|NCT02206022|Narcotics|narcotics|mesh-ancestor
2681414|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2681415|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681416|NCT02206022|Analgesics|analgesics|mesh-ancestor
2681417|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
2681418|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681419|NCT02206035|Methotrexate|methotrexate|mesh-list
2681420|NCT02206035|Tacrolimus|tacrolimus|mesh-list
2681421|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2681422|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
2681423|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2681424|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681425|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2681426|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
2681427|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681428|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681429|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
2681430|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681431|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2681432|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2681433|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
2681434|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2681435|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2681436|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2681437|NCT02206048|Proflavine|proflavine|mesh-list
2681438|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2681439|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681440|NCT02206087|Heparin|heparin|mesh-list
2681441|NCT02206087|Calcium heparin|calcium heparin|mesh-list
2681442|NCT02206087|Anticoagulants|anticoagulants|mesh-ancestor
2681443|NCT02206087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2681444|NCT02206087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2681445|NCT02206087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681446|NCT02206100|Enoxaparin|enoxaparin|mesh-list
2681447|NCT02206100|Anticoagulants|anticoagulants|mesh-ancestor
2681448|NCT02206100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2681449|NCT02206100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2681450|NCT02206100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681451|NCT02206165|Amlodipine|amlodipine|mesh-list
2681452|NCT02206165|Candesartan|candesartan|mesh-list
2681453|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
2681454|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2681455|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2681456|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2681457|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681458|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2681459|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681460|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
2681461|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2681462|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2681463|NCT02206178|Acetaminophen|acetaminophen|mesh-list
2681464|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
2681465|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2681466|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2681467|NCT02206178|Analgesics|analgesics|mesh-ancestor
2681468|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
2681469|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681470|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681471|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
2681472|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
2681473|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681474|NCT02206178|Expectorants|expectorants|mesh-ancestor
2681475|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
2681476|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2188242|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
2188243|NCT00003204|Vincristine|vincristine|mesh-list
2188244|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188245|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
2188246|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188247|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188248|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188249|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
2188250|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188251|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188252|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2188253|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2188254|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2188255|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
2188256|NCT00003204|Hormones|hormones|mesh-ancestor
2681477|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
2681478|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681479|NCT02206178|Protective Agents|protective agents|mesh-ancestor
2681480|NCT02206178|Antidotes|antidotes|mesh-ancestor
2681481|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
2681482|NCT02206204|Selexipag|selexipag|mesh-list
2681483|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2681484|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2681485|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681486|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2681487|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2681488|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681489|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681490|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681491|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2681492|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
2681493|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2681494|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681495|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2681496|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2681497|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2681498|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2681499|NCT02206295|Selexipag|selexipag|mesh-list
2681500|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2681501|NCT02206308|Antibodies|antibodies|mesh-list
2681502|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2681503|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
2681504|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681505|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
2681506|NCT02206425|Dexamethasone|dexamethasone|mesh-list
2681507|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
2681508|NCT02206425|Prednisone|prednisone|mesh-list
2681509|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
2681510|NCT02206425|Melphalan|melphalan|mesh-list
2188257|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2188258|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2188259|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188260|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
2188261|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188262|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188263|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
2681511|NCT02206425|Doxorubicin|doxorubicin|mesh-list
2681512|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2681513|NCT02206425|Lenalidomide|lenalidomide|mesh-list
2681514|NCT02206425|Pomalidomide|pomalidomide|mesh-list
2188264|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188265|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
2188266|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2188267|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
2188268|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188269|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188270|NCT00003206|Paclitaxel|paclitaxel|mesh-list
2188271|NCT00003206|Carboplatin|carboplatin|mesh-list
2188272|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188273|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188274|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188275|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188276|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188277|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188278|NCT00003207|Doxorubicin|doxorubicin|mesh-list
2188279|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2188280|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2188281|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188282|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188283|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188284|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188285|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188286|NCT00003209|Fluorouracil|fluorouracil|mesh-list
2188287|NCT00003209|Methotrexate|methotrexate|mesh-list
2188288|NCT00003209|Ifosfamide|ifosfamide|mesh-list
2188289|NCT00003209|Mitomycins|mitomycins|mesh-list
2188290|NCT00003209|Mitomycin|mitomycin|mesh-list
2188291|NCT00003209|Bleomycin|bleomycin|mesh-list
2681515|NCT02206425|BB 1101|bb 1101|mesh-list
2681516|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2681517|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
2681518|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681519|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2681520|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2681521|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
2681522|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681523|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681524|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2681525|NCT02206425|Vitamins|vitamins|mesh-ancestor
2681526|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
2681527|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2681528|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
2681529|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
2681530|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681531|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2681532|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
2681533|NCT02206425|Hormones|hormones|mesh-ancestor
2681534|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2681535|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2681536|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
2681537|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681538|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2681539|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2681540|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2681541|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2681542|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2681543|NCT02206425|Growth Substances|growth substances|mesh-ancestor
2681544|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
2681545|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
2681546|NCT02206425|Protective Agents|protective agents|mesh-ancestor
2681547|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2681548|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2681549|NCT02206477|Protective Agents|protective agents|mesh-ancestor
2681550|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681551|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2681552|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
2681553|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188292|NCT00003209|Vinblastine|vinblastine|mesh-list
2188293|NCT00003209|Vindesine|vindesine|mesh-list
2188294|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188295|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
2188296|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188297|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188298|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188299|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
2188300|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188301|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2188302|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
2188303|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2188304|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
2188305|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188306|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2188307|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188308|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2681554|NCT02206490|Naltrexone|naltrexone|mesh-list
2681555|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
2681556|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2681557|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2681558|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681559|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
2681560|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681561|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
2681562|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
2681563|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2681564|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2681565|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2681566|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681567|NCT02206503|Dexamethasone|dexamethasone|mesh-list
2681568|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
2681569|NCT02206503|Lenalidomide|lenalidomide|mesh-list
2681570|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2681571|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
2681572|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681573|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2681574|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2681575|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
2681576|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681577|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681578|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2681579|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2681580|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
2681581|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
2681582|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681583|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2681584|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
2188309|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188310|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
2188311|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2188312|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188313|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188314|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188315|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188316|NCT00003210|Interleukin-12|interleukin-12|mesh-list
2188317|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2188318|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
2188319|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188320|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2681585|NCT02206503|Hormones|hormones|mesh-ancestor
2681586|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2681587|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2681588|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2681589|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2681590|NCT02206503|Growth Substances|growth substances|mesh-ancestor
2681591|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
2188321|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2681592|NCT02206555|Tenofovir|tenofovir|mesh-list
2681593|NCT02206555|Emtricitabine|emtricitabine|mesh-list
2681594|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2681595|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
2681596|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681597|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2681598|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2681599|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681600|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681601|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2681602|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2681603|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
2681604|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
2681605|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2681606|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681607|NCT02206646|Tenecteplase|tenecteplase|mesh-list
2188322|NCT00003210|Growth Substances|growth substances|mesh-ancestor
2188323|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
2188324|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188325|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
2188326|NCT00003211|Vincristine|vincristine|mesh-list
2188327|NCT00003211|Amifostine|amifostine|mesh-list
2188328|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188329|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
2188330|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188331|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188332|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188333|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
2188334|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188335|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188336|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2188337|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188338|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188339|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188340|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188341|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2188342|NCT00003211|Protective Agents|protective agents|mesh-ancestor
2188343|NCT00003212|Doxorubicin|doxorubicin|mesh-list
2188344|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2188345|NCT00003212|Ifosfamide|ifosfamide|mesh-list
2188346|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2188347|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188348|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188349|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188350|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188351|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188352|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188353|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
2188354|NCT00003213|Dexamethasone|dexamethasone|mesh-list
2188355|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
2188356|NCT00003213|Metoclopramide|metoclopramide|mesh-list
2188357|NCT00003213|Granisetron|granisetron|mesh-list
2188358|NCT00003213|BB 1101|bb 1101|mesh-list
2188359|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2188360|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
2681608|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2681609|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2681610|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681611|NCT02206659|Telmisartan|telmisartan|mesh-list
2681612|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2681613|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2681614|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2681615|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681616|NCT02206711|BMS-955176|bms-955176|mesh-list
2681617|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2681618|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2681619|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
2681620|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681621|NCT02206737|Nicotine|nicotine|mesh-list
2681622|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2681623|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
2681624|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681625|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188361|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
2188362|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2188363|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188364|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2188365|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
2188366|NCT00003213|Hormones|hormones|mesh-ancestor
2188367|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2188368|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2188369|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423147|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
2423148|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2423149|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423150|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423151|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
2423152|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2423153|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423154|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423155|NCT00820846|Vaccines|vaccines|mesh-list
2681626|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2681627|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2681628|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
2681629|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2681630|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681631|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2681632|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2681633|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681634|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2681635|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681636|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681637|NCT02206789|Cyclosporine|cyclosporine|mesh-list
2681638|NCT02206789|Prednisolone|prednisolone|mesh-list
2681639|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2681640|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
2681641|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2681642|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
2681643|NCT02206789|Cyclosporins|cyclosporins|mesh-list
2681644|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2681645|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
2681646|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681647|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681648|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2681649|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
2681650|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681651|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
2681652|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681653|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
2681654|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2681655|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2681656|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2681657|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
2681658|NCT02206789|Hormones|hormones|mesh-ancestor
2681659|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2681660|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2681661|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681662|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
2681663|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
2681664|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681665|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2681666|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2681667|NCT02206789|Protective Agents|protective agents|mesh-ancestor
2188370|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
2188371|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188372|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188373|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2188374|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2188375|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
2188376|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2188377|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2188378|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
2188379|NCT00003214|Paclitaxel|paclitaxel|mesh-list
2188380|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
2188381|NCT00003214|Carboplatin|carboplatin|mesh-list
2188382|NCT00003214|Doxorubicin|doxorubicin|mesh-list
2188383|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2188384|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188385|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188386|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188387|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188388|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423156|NCT00820846|Immunologic Factors|immunologic factors|mesh-ancestor
2423157|NCT00820846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423158|NCT00820885|Teduglutide|teduglutide|mesh-list
2423159|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2423160|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2423161|NCT00820885|Protective Agents|protective agents|mesh-ancestor
2423162|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423163|NCT00820911|Cyclosporine|cyclosporine|mesh-list
2423164|NCT00820911|Everolimus|everolimus|mesh-list
2423165|NCT00820911|Cyclosporins|cyclosporins|mesh-list
2423166|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423167|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423168|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2423169|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
2423170|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681668|NCT02206802|Minoxidil|minoxidil|mesh-list
2681669|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2681670|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
2681671|NCT02206815|Aspirin|aspirin|mesh-list
2681672|NCT02206815|Warfarin|warfarin|mesh-list
2681673|NCT02206815|Clopidogrel|clopidogrel|mesh-list
2681674|NCT02206815|Ticagrelor|ticagrelor|mesh-list
2681675|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2681676|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2681677|NCT02206815|Analgesics|analgesics|mesh-ancestor
2681678|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
2681679|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681680|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681681|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2681682|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2681683|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2681684|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2681685|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681686|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2681687|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2681688|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681689|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
2681690|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2681691|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2681692|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2681693|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
2681694|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2681695|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
2681696|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
2681697|NCT02206854|Analgesics|analgesics|mesh-ancestor
2681698|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
2681699|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681700|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681701|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2681702|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2188389|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188390|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188391|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
2188392|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188393|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188394|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188395|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
2188396|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2423171|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
2423172|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681703|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2681704|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2681705|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2681706|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681707|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681708|NCT02206867|Adalimumab|adalimumab|mesh-list
2681709|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2681710|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2681711|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
2681712|NCT02206932|Simeprevir|simeprevir|mesh-list
2681713|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
2681714|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681715|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
2681716|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681717|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681718|NCT02206984|Tamoxifen|tamoxifen|mesh-list
2681719|NCT02206984|Fulvestrant|fulvestrant|mesh-list
2681720|NCT02206984|Anastrozole|anastrozole|mesh-list
2681721|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2681722|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
2681723|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2423173|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
2423174|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2423175|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2423176|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423177|NCT00820924|Lapatinib|lapatinib|mesh-list
2423178|NCT00820924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423179|NCT00820924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2423180|NCT00820924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423181|NCT00820924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423182|NCT00820950|Betamethasone|betamethasone|mesh-list
2681724|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681725|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2681726|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681727|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2681728|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2681729|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2681730|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2681731|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2681732|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2681733|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681734|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681735|NCT02207010|Adavosertib|adavosertib|mesh-list
2681736|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681737|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681738|NCT02207257|Edoxaban|edoxaban|mesh-list
2681739|NCT02207257|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2681740|NCT02207257|Antithrombins|antithrombins|mesh-ancestor
2681741|NCT02207257|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2681742|NCT02207257|Protease Inhibitors|protease inhibitors|mesh-ancestor
2681743|NCT02207257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681744|NCT02207257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681745|NCT02207257|Anticoagulants|anticoagulants|mesh-ancestor
2681746|NCT02207335|Gemcitabine|gemcitabine|mesh-list
2681747|NCT02207335|Carboplatin|carboplatin|mesh-list
2681748|NCT02207335|Capecitabine|capecitabine|mesh-list
2681749|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681750|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2681751|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
2681752|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681753|NCT02207335|Antiviral Agents|antiviral agents|mesh-ancestor
2681754|NCT02207335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188397|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2188398|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188399|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188400|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188401|NCT00003215|Leucovorin|leucovorin|mesh-list
2188402|NCT00003215|Cytarabine|cytarabine|mesh-list
2188403|NCT00003215|Prednisone|prednisone|mesh-list
2188404|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
2188405|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
2188406|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2188407|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2188408|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2188409|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
2188410|NCT00003215|Melphalan|melphalan|mesh-list
2188411|NCT00003215|Doxorubicin|doxorubicin|mesh-list
2188412|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2188413|NCT00003215|Methotrexate|methotrexate|mesh-list
2188414|NCT00003215|Etoposide|etoposide|mesh-list
2681755|NCT02207335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681756|NCT02207335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2681757|NCT02207335|Immunologic Factors|immunologic factors|mesh-ancestor
2681758|NCT02207335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681759|NCT02207348|Liraglutide|liraglutide|mesh-list
2681760|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2681761|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681762|NCT02207348|Incretins|incretins|mesh-ancestor
2681763|NCT02207348|Hormones|hormones|mesh-ancestor
2681764|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2188415|NCT00003215|Vincristine|vincristine|mesh-list
2188416|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
2188417|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
2188418|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188419|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
2188420|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188421|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188422|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188423|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
2188424|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188425|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188426|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2188427|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2188428|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188429|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188430|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188431|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2188432|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
2681765|NCT02207361|Paclitaxel|paclitaxel|mesh-list
2681766|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2681767|NCT02207361|Carboplatin|carboplatin|mesh-list
2681768|NCT02207361|Epirubicin|epirubicin|mesh-list
2681769|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2681770|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681771|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
2681772|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
2681773|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
2681774|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681775|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2681776|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2681777|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2681778|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681779|NCT02207387|Rasagiline|rasagiline|mesh-list
2681780|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2681781|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188433|NCT00003215|Hormones|hormones|mesh-ancestor
2188434|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2188435|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2188436|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2188437|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
2188438|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2188439|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188440|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
2188441|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
2188442|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2188443|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2188444|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188445|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
2188446|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188447|NCT00003215|Antidotes|antidotes|mesh-ancestor
2188448|NCT00003215|Protective Agents|protective agents|mesh-ancestor
2188449|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
2681782|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681783|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2681784|NCT02207387|Protective Agents|protective agents|mesh-ancestor
2681785|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681786|NCT02207426|Tobramycin|tobramycin|mesh-list
2681787|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2681788|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681789|NCT02207439|Nelfinavir|nelfinavir|mesh-list
2681790|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2681791|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2681792|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
2681793|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681794|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681795|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2681796|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2681797|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
2681798|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681799|NCT02207452|Albuterol|albuterol|mesh-list
2681800|NCT02207452|Ipratropium|ipratropium|mesh-list
2681801|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2681802|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
2188450|NCT00003215|Vitamins|vitamins|mesh-ancestor
2188451|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
2188452|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188453|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188454|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188455|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
2188456|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
2188457|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681803|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681804|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681805|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2681806|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
2681807|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
2681808|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2681809|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2188458|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2188459|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2188460|NCT00003215|Analgesics|analgesics|mesh-ancestor
2188461|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
2188462|NCT00003216|Gemcitabine|gemcitabine|mesh-list
2188463|NCT00003216|Fluorouracil|fluorouracil|mesh-list
2188464|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2681810|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2681811|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2681812|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
2681813|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2681814|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681815|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2681816|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
2681822|NCT02207660|Fluorouracil|fluorouracil|mesh-list
2681823|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681824|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
2681825|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681826|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2681827|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2681828|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
2681829|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681830|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
2681831|NCT02207699|Benzonatate|benzonatate|mesh-list
2681832|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2681833|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681834|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2681835|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2681836|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681837|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681838|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681839|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
2681840|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
2681841|NCT02207712|Ranibizumab|ranibizumab|mesh-list
2681842|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2681843|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2681844|NCT02207712|Growth Substances|growth substances|mesh-ancestor
2681845|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681846|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
2681847|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681848|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
2681849|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
2681850|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
2681851|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2681852|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681853|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
2681854|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681855|NCT02207920|Vaccines|vaccines|mesh-list
2681856|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
2681857|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681858|NCT02207959|Proflavine|proflavine|mesh-list
2681859|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2681860|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681861|NCT02208128|Bevacizumab|bevacizumab|mesh-list
2681862|NCT02208128|Sunitinib|sunitinib|mesh-list
2681863|NCT02208128|Everolimus|everolimus|mesh-list
2681864|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2681865|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681866|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2681867|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2681868|NCT02208128|Growth Substances|growth substances|mesh-ancestor
2681869|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681870|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
2681871|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2681872|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
2681873|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2681874|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681875|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681876|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
2681877|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2681878|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2681879|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681880|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
2681881|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
2681882|NCT02208245|Ropivacaine|ropivacaine|mesh-list
2681883|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
2681884|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
2681885|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2681886|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681887|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
2681888|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681889|NCT02208375|Olaparib|olaparib|mesh-list
2681890|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2681891|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681892|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681893|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681894|NCT02208427|Isoniazid|isoniazid|mesh-list
2681895|NCT02208427|Rifapentine|rifapentine|mesh-list
2681896|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
2188465|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
2188466|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188467|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188468|NCT00003216|Antiviral Agents|antiviral agents|mesh-ancestor
2188469|NCT00003216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188470|NCT00003216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188471|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188472|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
2188473|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188474|NCT00003217|Cytarabine|cytarabine|mesh-list
2188475|NCT00003217|Dexamethasone|dexamethasone|mesh-list
2188476|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
2188477|NCT00003217|Doxorubicin|doxorubicin|mesh-list
2681897|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2681898|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681899|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2681900|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2681901|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
2681902|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681903|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2681904|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2681905|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
2681906|NCT02208492|Levetiracetam|levetiracetam|mesh-list
2681907|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
2681908|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
2681909|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
2681910|NCT02208505|Remifentanil|remifentanil|mesh-list
2681911|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2681912|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2681913|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681914|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2681915|NCT02208505|Analgesics|analgesics|mesh-ancestor
2681916|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
2681917|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681918|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2681919|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2681920|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2188478|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2188479|NCT00003217|Methotrexate|methotrexate|mesh-list
2188480|NCT00003217|Vincristine|vincristine|mesh-list
2188481|NCT00003217|Lenograstim|lenograstim|mesh-list
2188482|NCT00003217|Sargramostim|sargramostim|mesh-list
2188483|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188484|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
2188485|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188486|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188487|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188488|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
2188489|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188490|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188491|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2188492|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2188493|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
2188494|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
2188495|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2188496|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2188497|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
2681921|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
2681922|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2681923|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681924|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2681925|NCT02208505|Narcotics|narcotics|mesh-ancestor
2188498|NCT00003217|Hormones|hormones|mesh-ancestor
2188499|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2188500|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2423183|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
2423184|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2423185|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
2423186|NCT00820950|Calcipotriene|calcipotriene|mesh-list
2423187|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2423188|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2423189|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
2423190|NCT00820950|Hormones|hormones|mesh-ancestor
2423191|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2423192|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423193|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2188501|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2188502|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188503|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188504|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188505|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2188506|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
2188507|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2188508|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188509|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
2188510|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
2188511|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2188512|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2681926|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2681927|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2681928|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681929|NCT02208583|Prednisone|prednisone|mesh-list
2681930|NCT02208583|Cisplatin|cisplatin|mesh-list
2681931|NCT02208583|Docetaxel|docetaxel|mesh-list
2681932|NCT02208583|Etoposide|etoposide|mesh-list
2681933|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
2681934|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681935|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
2681936|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188513|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2188514|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
2188515|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188516|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188517|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188518|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188519|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188520|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
2188521|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188522|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188523|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188524|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
2188525|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2188526|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
2188527|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188528|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188529|NCT00003223|Fenretinide|fenretinide|mesh-list
2188530|NCT00003223|Retinamide|retinamide|mesh-list
2681937|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
2681938|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681939|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2681940|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
2681941|NCT02208583|Hormones|hormones|mesh-ancestor
2681942|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2681943|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423194|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
2423195|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
2423196|NCT00820963|Temozolomide|temozolomide|mesh-list
2423197|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2423198|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
2423199|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423200|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423201|NCT00821002|Latanoprost|latanoprost|mesh-list
2681944|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2681945|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2681946|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2681947|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2681948|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681949|NCT02208596|Pentazocine|pentazocine|mesh-list
2423202|NCT00821002|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2681950|NCT02208596|Propofol|propofol|mesh-list
2681951|NCT02208596|Etomidate|etomidate|mesh-list
2188531|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188532|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2188533|NCT00003223|Protective Agents|protective agents|mesh-ancestor
2188534|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188535|NCT00003225|Irinotecan|irinotecan|mesh-list
2188536|NCT00003225|Amifostine|amifostine|mesh-list
2188537|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2188538|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188539|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188540|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2681952|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2681953|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2681954|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681955|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2681956|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
2681957|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
2681958|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2681959|NCT02208596|Narcotics|narcotics|mesh-ancestor
2681960|NCT02208596|Analgesics|analgesics|mesh-ancestor
2681961|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
2681962|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681963|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2681964|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2681965|NCT02208778|Remifentanil|remifentanil|mesh-list
2681966|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2681967|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2681968|NCT02208778|Narcotics|narcotics|mesh-ancestor
2188541|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188542|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2188543|NCT00003225|Protective Agents|protective agents|mesh-ancestor
2188544|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188545|NCT00003229|Aldesleukin|aldesleukin|mesh-list
2188546|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188547|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2188548|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2188549|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
2188550|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188551|NCT00003230|Paclitaxel|paclitaxel|mesh-list
2188552|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188553|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188554|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188555|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188556|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188557|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188558|NCT00003231|Docetaxel|docetaxel|mesh-list
2681969|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2681970|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681971|NCT02208778|Analgesics|analgesics|mesh-ancestor
2681972|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
2681973|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2188559|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188560|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188561|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188562|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188563|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188564|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
2188565|NCT00003232|Prednisone|prednisone|mesh-list
2188566|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
2188567|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2188568|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
2188569|NCT00003232|Hormones|hormones|mesh-ancestor
2188570|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2188571|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188572|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2188573|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188574|NCT00003232|Analgesics|analgesics|mesh-ancestor
2188575|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
2188576|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2681974|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2681975|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2681976|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2681977|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188577|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188578|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188579|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2681978|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2681979|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
2681980|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2681981|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
2681982|NCT02208791|Sirolimus|sirolimus|mesh-list
2681983|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2681984|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2681985|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2681986|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2681987|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
2681988|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2681989|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
2681990|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681991|NCT02208882|Midazolam|midazolam|mesh-list
2681992|NCT02208882|BMS-986120|bms-986120|mesh-list
2681993|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2681994|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2681995|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2681996|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2681997|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2681998|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2681999|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2682000|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2682001|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
2682002|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
2682003|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
2682004|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
2682005|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682006|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682007|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2682008|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2682009|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
2682010|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2682011|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
2682012|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2188580|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188581|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2188582|NCT00003234|Vinorelbine|vinorelbine|mesh-list
2188583|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188584|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188585|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188586|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188587|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
2682013|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682014|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2682015|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2682016|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682017|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2682018|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2682019|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
2682020|NCT02209025|Theobromine|theobromine|mesh-list
2682021|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2682022|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
2682023|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682024|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682025|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2682026|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
2682027|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
2682028|NCT02209155|Verapamil|verapamil|mesh-list
2682029|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2682030|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2682031|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2682032|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188588|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188589|NCT00003235|Paclitaxel|paclitaxel|mesh-list
2188590|NCT00003235|Carboplatin|carboplatin|mesh-list
2188591|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188592|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188593|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188594|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188595|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188596|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682033|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2682034|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682035|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
2682036|NCT02209350|Aspirin|aspirin|mesh-list
2682037|NCT02209350|Clopidogrel|clopidogrel|mesh-list
2682038|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2682039|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2682040|NCT02209350|Analgesics|analgesics|mesh-ancestor
2682041|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
2188597|NCT00003236|ISIS 5132|isis 5132|mesh-list
2188598|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188599|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188600|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188601|NCT00003237|Paclitaxel|paclitaxel|mesh-list
2188602|NCT00003237|Cisplatin|cisplatin|mesh-list
2188603|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188604|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188605|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188606|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188607|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188608|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188609|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
2188610|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682042|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682043|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682044|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2682045|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2682046|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2682047|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2682048|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682049|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2682050|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2682051|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682052|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
2682053|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2682054|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2682055|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2682056|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
2682057|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682058|NCT02209428|Temozolomide|temozolomide|mesh-list
2682059|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2682060|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
2682061|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682062|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682063|NCT02209441|Sorafenib|sorafenib|mesh-list
2682064|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682065|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2682066|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682067|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682081|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
2682082|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
2682083|NCT02209636|Vitamins|vitamins|mesh-ancestor
2682084|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
2682085|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682086|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
2682087|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682088|NCT02209636|Protective Agents|protective agents|mesh-ancestor
2682089|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
2682090|NCT02209649|Telmisartan|telmisartan|mesh-list
2682091|NCT02209649|Lacidipine|lacidipine|mesh-list
2682092|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2682093|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2188611|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682094|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2682095|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682096|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2682097|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2682098|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2682099|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682100|NCT02209701|Porfiromycin|porfiromycin|mesh-list
2682101|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2682102|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682103|NCT02209740|Tenofovir|tenofovir|mesh-list
2682104|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
2682105|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682106|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2682107|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2682108|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682109|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682110|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2682111|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2682112|NCT02209831|Pantoprazole|pantoprazole|mesh-list
2682113|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2188612|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188613|NCT00003239|Interferons|interferons|mesh-list
2188614|NCT00003239|Cytarabine|cytarabine|mesh-list
2188615|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
2188616|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
2188617|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
2188618|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188619|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
2188620|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188621|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188622|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
2188623|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188624|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188625|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
2188626|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188627|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188628|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2188629|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188630|NCT00003240|Vinorelbine|vinorelbine|mesh-list
2188631|NCT00003240|Ifosfamide|ifosfamide|mesh-list
2188632|NCT00003240|Mitomycins|mitomycins|mesh-list
2682114|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2682115|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2682116|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682117|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682118|NCT02209909|Aspirin|aspirin|mesh-list
2682119|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2682120|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2682121|NCT02209909|Analgesics|analgesics|mesh-ancestor
2682122|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
2682123|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682124|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682125|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2682126|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2682127|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2682128|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2682129|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682130|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2682131|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2682132|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682133|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
2682134|NCT02209974|Fluticasone|fluticasone|mesh-list
2682135|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2682136|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2682137|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
2682138|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682139|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682140|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2682141|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
2682142|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
2682143|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2682144|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2682145|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
2682146|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682147|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
2682148|NCT02210104|Ipilimumab|ipilimumab|mesh-list
2188633|NCT00003240|Mitomycin|mitomycin|mesh-list
2188634|NCT00003240|Vinblastine|vinblastine|mesh-list
2188635|NCT00003240|Vindesine|vindesine|mesh-list
2188636|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188637|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188638|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188639|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188640|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188641|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188642|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188643|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
2188644|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2188645|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2188646|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682149|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2682150|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
2682151|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682152|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2682153|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188647|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
2188648|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188649|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
2188650|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188651|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188652|NCT00003242|Paclitaxel|paclitaxel|mesh-list
2188653|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
2188654|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188655|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682154|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
2682155|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682156|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682157|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2682158|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2682159|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2682160|NCT02210117|Bevacizumab|bevacizumab|mesh-list
2682161|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2682162|NCT02210117|Nivolumab|nivolumab|mesh-list
2682163|NCT02210117|Ipilimumab|ipilimumab|mesh-list
2682164|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
2682165|NCT02210117|Antibodies|antibodies|mesh-list
2188656|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188657|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188658|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188659|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188660|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2188661|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
2188662|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188663|NCT00003243|Aldesleukin|aldesleukin|mesh-list
2188664|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
2188665|NCT00003243|Doxorubicin|doxorubicin|mesh-list
2188666|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2188667|NCT00003243|Etoposide|etoposide|mesh-list
2188668|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188669|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
2188670|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188671|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188672|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188673|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
2188674|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188675|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188676|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2188677|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2188678|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188679|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2682166|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
2682167|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2682168|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
2682169|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682170|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2682171|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2682172|NCT02210117|Growth Substances|growth substances|mesh-ancestor
2682173|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682174|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
2682175|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
2682176|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2682177|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682178|NCT02210156|Micronutrients|micronutrients|mesh-list
2682179|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682180|NCT02210169|Vancomycin|vancomycin|mesh-list
2682181|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2682182|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682183|NCT02210182|Pentamidine|pentamidine|mesh-list
2682184|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
2682185|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682186|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2682187|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2682188|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2682189|NCT02210260|Heroin|heroin|mesh-list
2682190|NCT02210260|Bupivacaine|bupivacaine|mesh-list
2682191|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
2682192|NCT02210260|Anesthetics|anesthetics|mesh-list
2682193|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2682194|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682195|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
2682196|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682197|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2682198|NCT02210260|Narcotics|narcotics|mesh-ancestor
2682199|NCT02210260|Analgesics|analgesics|mesh-ancestor
2682200|NCT02210325|Azithromycin|azithromycin|mesh-list
2682201|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
2682202|NCT02210325|Solithromycin|solithromycin|mesh-list
2682203|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2682204|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188680|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188681|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188682|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2682205|NCT02210364|Capecitabine|capecitabine|mesh-list
2682206|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2682207|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
2682208|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682209|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682210|NCT02210559|Gemcitabine|gemcitabine|mesh-list
2682211|NCT02210559|Paclitaxel|paclitaxel|mesh-list
2682212|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2682213|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682214|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
2682215|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
2682216|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
2682217|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682218|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188683|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2188684|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
2188685|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188686|NCT00003245|Irinotecan|irinotecan|mesh-list
2188687|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2188688|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188689|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188690|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188691|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188692|NCT00003248|Rituximab|rituximab|mesh-list
2188693|NCT00003248|Fludarabine|fludarabine|mesh-list
2188694|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
2188695|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2188696|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188697|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
2188698|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188699|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188700|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188701|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
2188702|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188703|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188704|NCT00003249|Ketoconazole|ketoconazole|mesh-list
2188705|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
2188706|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
2188707|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188708|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2188709|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2188710|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188711|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188712|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2188713|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
2682219|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
2682220|NCT02210559|Antiviral Agents|antiviral agents|mesh-ancestor
2682221|NCT02210559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188714|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2188715|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188716|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2188717|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188718|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2188719|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2188720|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2188721|NCT00003250|Fenretinide|fenretinide|mesh-list
2188722|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188723|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2188724|NCT00003250|Protective Agents|protective agents|mesh-ancestor
2188725|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682222|NCT02210559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682223|NCT02210559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2682224|NCT02210559|Immunologic Factors|immunologic factors|mesh-ancestor
2682225|NCT02210559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682226|NCT02210598|Oxytocin|oxytocin|mesh-list
2682227|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
2682228|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2682229|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682230|NCT02210663|Veliparib|veliparib|mesh-list
2682231|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2682232|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682233|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682234|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682235|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2682236|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2682237|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2682238|NCT02210702|Norethindrone|norethindrone|mesh-list
2682239|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
2682240|NCT02210702|Estradiol|estradiol|mesh-list
2682241|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2682242|NCT02210702|Estrogens|estrogens|mesh-ancestor
2682243|NCT02210702|Hormones|hormones|mesh-ancestor
2682244|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2682245|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682246|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2682247|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
2682248|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2682249|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2682250|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2682251|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2682252|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2682253|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
2682254|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2682255|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2682256|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
2682257|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682258|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2682259|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2188726|NCT00003251|Paclitaxel|paclitaxel|mesh-list
2188727|NCT00003251|Amifostine|amifostine|mesh-list
2188728|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188729|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188730|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188731|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188732|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188733|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188734|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2188735|NCT00003251|Protective Agents|protective agents|mesh-ancestor
2188736|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682260|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682261|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682262|NCT02210728|Methylphenidate|methylphenidate|mesh-list
2682263|NCT02210728|Amphetamine|amphetamine|mesh-list
2682264|NCT02210728|Adderall|adderall|mesh-list
2682265|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
2682266|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2682267|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682268|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2682269|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2682270|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2682271|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682272|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
2188737|NCT00003252|Amifostine|amifostine|mesh-list
2188738|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2188739|NCT00003252|Protective Agents|protective agents|mesh-ancestor
2188740|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188741|NCT00003253|Paclitaxel|paclitaxel|mesh-list
2188742|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
2188743|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188744|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188745|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188746|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188747|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188748|NCT00003254|Fluorouracil|fluorouracil|mesh-list
2188749|NCT00003254|Eniluracil|eniluracil|mesh-list
2188750|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
2188751|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188752|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188753|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188754|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188755|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
2188756|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682273|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682274|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
2682275|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
2682276|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682277|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
2682278|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2682279|NCT02210754|Menthol|menthol|mesh-list
2682280|NCT02210754|Nicotine|nicotine|mesh-list
2682281|NCT02210754|Glycerol|glycerol|mesh-list
2682282|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2682283|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
2682284|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682285|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682286|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2682287|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2682288|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
2682289|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682290|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682291|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
2682292|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
2682293|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2682294|NCT02210754|Protective Agents|protective agents|mesh-ancestor
2682295|NCT02210806|Albuterol|albuterol|mesh-list
2682296|NCT02210806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2682297|NCT02210806|Autonomic Agents|autonomic agents|mesh-ancestor
2682298|NCT02210806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682299|NCT02210806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682300|NCT02210806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2682301|NCT02210806|Respiratory System Agents|respiratory system agents|mesh-ancestor
2682302|NCT02210806|Tocolytic Agents|tocolytic agents|mesh-ancestor
2682303|NCT02210806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2682304|NCT02210806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2682305|NCT02210806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2682306|NCT02210806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2682307|NCT02210806|Adrenergic Agents|adrenergic agents|mesh-ancestor
2682308|NCT02210806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682309|NCT02210806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682310|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
2682311|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2682312|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
2682313|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2682314|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
2682315|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682316|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682317|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
2682318|NCT02210858|Tipifarnib|tipifarnib|mesh-list
2682319|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682320|NCT02210884|Vitamin D|vitamin d|mesh-list
2682321|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
2682322|NCT02210884|Vitamins|vitamins|mesh-list
2682323|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
2682324|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682325|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2682326|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2682327|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
2682328|NCT02210949|Hematinics|hematinics|mesh-ancestor
2682329|NCT02211066|Clopidogrel|clopidogrel|mesh-list
2682330|NCT02211066|Ticagrelor|ticagrelor|mesh-list
2188757|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188758|NCT00003255|Carboplatin|carboplatin|mesh-list
2188759|NCT00003255|Topotecan|topotecan|mesh-list
2188760|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188761|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2188762|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188763|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188764|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188765|NCT00003256|Alvocidib|alvocidib|mesh-list
2188766|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188767|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
2188768|NCT00003256|Growth Substances|growth substances|mesh-ancestor
2188769|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188770|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2188771|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188772|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188773|NCT00003259|Vinorelbine|vinorelbine|mesh-list
2188774|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2682331|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2682332|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2682333|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2682334|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2682335|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
2682336|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682337|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682338|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682339|NCT02211079|Tolbutamide|tolbutamide|mesh-list
2682340|NCT02211079|Midazolam|midazolam|mesh-list
2682341|NCT02211079|Caffeine|caffeine|mesh-list
2682342|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2682343|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2682344|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2682345|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682346|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2682347|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2682348|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2682349|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2682350|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
2682351|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
2682352|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
2682353|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
2188775|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188776|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188777|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188778|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188779|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188780|NCT00003260|Leucovorin|leucovorin|mesh-list
2188781|NCT00003260|Fluorouracil|fluorouracil|mesh-list
2188782|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
2188783|NCT00003260|Irinotecan|irinotecan|mesh-list
2682354|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682355|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682356|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2682357|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2682358|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682359|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2682360|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2682361|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
2682362|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2682363|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
2682364|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2682365|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2682366|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682367|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2682368|NCT02211118|Analgesics|analgesics|mesh-ancestor
2682369|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
2682370|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682371|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2682372|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2682373|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2682374|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
2682375|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682376|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682377|NCT02211222|Lenvatinib|lenvatinib|mesh-list
2682378|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682379|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2682380|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682381|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682382|NCT02211326|Warfarin|warfarin|mesh-list
2682383|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
2682384|NCT02211391|Caseins|caseins|mesh-list
2682385|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
2682386|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
2682387|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682388|NCT02211417|Mineral Oil|mineral oil|mesh-list
2682389|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
2682390|NCT02211417|Emollients|emollients|mesh-ancestor
2682391|NCT02211443|Cetuximab|cetuximab|mesh-list
2682392|NCT02211443|Antibodies|antibodies|mesh-list
2682393|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2682394|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
2682395|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682396|NCT02211443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2682397|NCT02211443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682398|NCT02211482|Lamivudine|lamivudine|mesh-list
2682399|NCT02211482|Dolutegravir|dolutegravir|mesh-list
2682400|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2682401|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2682402|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682403|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682404|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
2682405|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682406|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2188784|NCT00003260|Calcium|calcium|mesh-list
2188785|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
2188786|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2188787|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188788|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
2188789|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188790|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188791|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188792|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188793|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
2188794|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2188795|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188796|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188797|NCT00003260|Antidotes|antidotes|mesh-ancestor
2682407|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2682408|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2682409|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2682410|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
2682411|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2682412|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
2682413|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682414|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
2682415|NCT02211521|Protective Agents|protective agents|mesh-ancestor
2682416|NCT02211625|Oxycodone|oxycodone|mesh-list
2682417|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2682418|NCT02211625|Narcotics|narcotics|mesh-ancestor
2682419|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2682420|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682421|NCT02211625|Analgesics|analgesics|mesh-ancestor
2682422|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
2682423|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682424|NCT02211690|Tenofovir|tenofovir|mesh-list
2682425|NCT02211690|Emtricitabine|emtricitabine|mesh-list
2682426|NCT02211690|Dolutegravir|dolutegravir|mesh-list
2682427|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
2682428|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682429|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2682430|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2682431|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682432|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682433|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2682434|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2682435|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2682436|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2682437|NCT02211729|Azithromycin|azithromycin|mesh-list
2682438|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
2682439|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
2682440|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2682441|NCT02211729|Amodiaquine|amodiaquine|mesh-list
2682442|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2682443|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682444|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
2682445|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2682446|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2682447|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2682448|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682449|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682450|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2682451|NCT02211729|Renal Agents|renal agents|mesh-ancestor
2682452|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
2682453|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2682454|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682455|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2682456|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682457|NCT02211833|Pemetrexed|pemetrexed|mesh-list
2682458|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682459|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682460|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682461|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2682462|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2682463|NCT02211846|Mirabegron|mirabegron|mesh-list
2682464|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2682465|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2682466|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2682467|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
2682468|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682469|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682470|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188798|NCT00003260|Protective Agents|protective agents|mesh-ancestor
2188799|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
2188800|NCT00003260|Vitamins|vitamins|mesh-ancestor
2188801|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
2188802|NCT00003261|Zidovudine|zidovudine|mesh-list
2188803|NCT00003261|Methotrexate|methotrexate|mesh-list
2188804|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2188805|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
2188806|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2682471|NCT02211846|Urological Agents|urological agents|mesh-ancestor
2682472|NCT02211911|Bisacodyl|bisacodyl|mesh-list
2682473|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
2682474|NCT02211911|Cathartics|cathartics|mesh-ancestor
2682475|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2682476|NCT02211911|Laxatives|laxatives|mesh-ancestor
2682477|NCT02211950|Acarbose|acarbose|mesh-list
2682478|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2682479|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682480|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682481|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2682482|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682483|NCT02211976|Bisacodyl|bisacodyl|mesh-list
2682484|NCT02211976|Cathartics|cathartics|mesh-ancestor
2682485|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2682486|NCT02211976|Laxatives|laxatives|mesh-ancestor
2682487|NCT02212015|Paclitaxel|paclitaxel|mesh-list
2682488|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2682489|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682490|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
2682491|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
2682492|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
2682493|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682494|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
2682495|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2682496|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2682497|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682498|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
2682499|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682500|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682501|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
2682502|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2682503|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2682504|NCT02212210|Prednisolone|prednisolone|mesh-list
2682505|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
2682506|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2188807|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682507|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
2682508|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2188808|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188809|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
2188810|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188811|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188812|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
2188813|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188814|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2188815|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188816|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
2188817|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188818|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2188819|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2188820|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
2682509|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
2682510|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
2682511|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682512|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682513|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2682514|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
2682515|NCT02212210|Hormones|hormones|mesh-ancestor
2682516|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2682517|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2682518|NCT02212210|Protective Agents|protective agents|mesh-ancestor
2682519|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2682520|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682521|NCT02212223|Vitamin D|vitamin d|mesh-list
2682522|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
2682523|NCT02212223|Vitamins|vitamins|mesh-ancestor
2682524|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
2682525|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682526|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2682527|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2682528|NCT02212340|Remifentanil|remifentanil|mesh-list
2682529|NCT02212340|Desflurane|desflurane|mesh-list
2682530|NCT02212340|Propofol|propofol|mesh-list
2682531|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2682532|NCT02212340|Narcotics|narcotics|mesh-ancestor
2682533|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2682534|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682535|NCT02212340|Analgesics|analgesics|mesh-ancestor
2682536|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
2682537|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682538|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2682539|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
2682540|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
2682541|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2682542|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2682543|NCT02212392|Meropenem|meropenem|mesh-list
2682544|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2682545|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682546|NCT02212431|Cysteamine|cysteamine|mesh-list
2682547|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2682548|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682549|NCT02212535|Plerixafor|plerixafor|mesh-list
2682550|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2682551|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2682552|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
2682553|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682554|NCT02212561|Vidarabine|vidarabine|mesh-list
2682555|NCT02212561|Cytarabine|cytarabine|mesh-list
2682556|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
2682557|NCT02212561|Methotrexate|methotrexate|mesh-list
2682558|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
2682559|NCT02212561|Fludarabine|fludarabine|mesh-list
2682560|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2682561|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
2682562|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2682563|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188821|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188822|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2188823|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2188824|NCT00003262|Prednisone|prednisone|mesh-list
2188825|NCT00003262|Doxorubicin|doxorubicin|mesh-list
2188826|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2188827|NCT00003262|Epirubicin|epirubicin|mesh-list
2682564|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2682565|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
2682566|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682567|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682568|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
2682569|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682570|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2682571|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2682572|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
2682573|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2682574|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2682575|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
2682576|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188828|NCT00003262|Bleomycin|bleomycin|mesh-list
2188829|NCT00003262|Etoposide|etoposide|mesh-list
2188830|NCT00003262|Vincristine|vincristine|mesh-list
2188831|NCT00003262|Vinblastine|vinblastine|mesh-list
2188832|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
2188833|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2188834|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188835|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2682577|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2682578|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
2682579|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
2682580|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682581|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682582|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682583|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
2682584|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
2682585|NCT02212639|Digoxin|digoxin|mesh-list
2682586|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2682587|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2682588|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682589|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682590|NCT02212639|Protective Agents|protective agents|mesh-ancestor
2682591|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682592|NCT02212652|Vitamin D|vitamin d|mesh-list
2682593|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
2682594|NCT02212652|Vitamins|vitamins|mesh-list
2682595|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
2682596|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188836|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188837|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188838|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188839|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2188840|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
2682597|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2682598|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2682599|NCT02212756|Metformin|metformin|mesh-list
2682600|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2682601|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682602|NCT02212769|Losartan|losartan|mesh-list
2682603|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2682604|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2682605|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2682606|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2682607|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682608|NCT02212782|Linagliptin|linagliptin|mesh-list
2682609|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2682610|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682611|NCT02212782|Incretins|incretins|mesh-ancestor
2682612|NCT02212782|Hormones|hormones|mesh-ancestor
2682613|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2682614|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2188841|NCT00003262|Hormones|hormones|mesh-ancestor
2188842|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2188843|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188844|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2188845|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188846|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188847|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188848|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188849|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
2682615|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
2682616|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682617|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682618|NCT02212795|Levofloxacin|levofloxacin|mesh-list
2682619|NCT02212795|Ofloxacin|ofloxacin|mesh-list
2682620|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
2682621|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2682622|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682623|NCT02212795|Renal Agents|renal agents|mesh-ancestor
2682624|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2682625|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2682626|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2682627|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682628|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682629|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682630|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2682631|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2682632|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2682633|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
2682634|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2682635|NCT02212821|Erythromycin|erythromycin|mesh-list
2682636|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
2682637|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2682638|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
2682639|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2682640|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682641|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2682642|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2682643|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682644|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682645|NCT02212951|Insulin Lispro|insulin lispro|mesh-list
2682646|NCT02212951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2682647|NCT02212951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682648|NCT02212990|Acetaminophen|acetaminophen|mesh-list
2682649|NCT02212990|Ibuprofen|ibuprofen|mesh-list
2682650|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2188850|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188851|NCT00003263|Interferons|interferons|mesh-list
2188852|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
2188853|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188854|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
2188855|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188856|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
2188857|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188858|NCT00003264|Gemcitabine|gemcitabine|mesh-list
2188859|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188860|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188861|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
2188862|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188863|NCT00003264|Antiviral Agents|antiviral agents|mesh-ancestor
2423203|NCT00821002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2423204|NCT00821028|Paclitaxel|paclitaxel|mesh-list
2423205|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2423206|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423207|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
2423208|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188864|NCT00003264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188865|NCT00003264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188866|NCT00003264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188867|NCT00003264|Immunologic Factors|immunologic factors|mesh-ancestor
2188868|NCT00003264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188869|NCT00003266|Methylphenidate|methylphenidate|mesh-list
2188870|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2188871|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188872|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2188873|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2188874|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2188875|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188876|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
2188877|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2188878|NCT00003268|Cytarabine|cytarabine|mesh-list
2423209|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423210|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682651|NCT02212990|Analgesics|analgesics|mesh-ancestor
2682652|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
2682653|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682654|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682655|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
2682656|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2423211|NCT00821054|Lapatinib|lapatinib|mesh-list
2682657|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2682658|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2682659|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2682660|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682661|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682662|NCT02213029|Oxytocin|oxytocin|mesh-list
2682663|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
2682664|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2682665|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682666|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
2682667|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2682668|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
2682669|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2682670|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682671|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2682672|NCT02213107|Dutasteride|dutasteride|mesh-list
2682673|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2682674|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2682675|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682676|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682677|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
2682678|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2682679|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682680|NCT02213146|Insulin|insulin|mesh-list
2682681|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
2682682|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2682683|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2682684|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682685|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
2682686|NCT02213159|Morphine|morphine|mesh-list
2682687|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2682688|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2682689|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682690|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2682691|NCT02213159|Analgesics|analgesics|mesh-ancestor
2682692|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
2682693|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682694|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2682695|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2682696|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2682697|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
2188879|NCT00003268|Idarubicin|idarubicin|mesh-list
2188880|NCT00003268|Amifostine|amifostine|mesh-list
2188881|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188882|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
2682698|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682699|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682700|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2682701|NCT02213159|Narcotics|narcotics|mesh-ancestor
2682702|NCT02213211|Lumefantrine|lumefantrine|mesh-list
2682703|NCT02213211|Artemether|artemether|mesh-list
2682704|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2682705|NCT02213211|Artemisinins|artemisinins|mesh-list
2682706|NCT02213211|Artemisinin|artemisinin|mesh-list
2682707|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
2682708|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2682709|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2682710|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682711|NCT02213224|Amlodipine|amlodipine|mesh-list
2682712|NCT02213224|Telmisartan|telmisartan|mesh-list
2682713|NCT02213224|Perindopril|perindopril|mesh-list
2682714|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2682715|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2682716|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2682717|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682718|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2682719|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682720|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
2682721|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2682722|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2682723|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2682724|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
2682725|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682726|NCT02213302|Midazolam|midazolam|mesh-list
2682727|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2682728|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2682729|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2682730|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682731|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2682732|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2682733|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2682734|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2682735|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
2682736|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
2682737|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
2682738|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
2682739|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682740|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682741|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
2682742|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2682743|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2682744|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
2682745|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682746|NCT02213328|Tenofovir|tenofovir|mesh-list
2682747|NCT02213328|Emtricitabine|emtricitabine|mesh-list
2682748|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2682749|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
2682750|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682751|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2682752|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2682753|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682754|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682755|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2682756|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2682757|NCT02213419|Ethanol|ethanol|mesh-list
2682758|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2682759|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682760|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2682761|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682762|NCT02213432|Vaccines|vaccines|mesh-list
2682763|NCT02213432|Immunologic Factors|immunologic factors|mesh-ancestor
2682764|NCT02213432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682765|NCT02213497|Paclitaxel|paclitaxel|mesh-list
2682766|NCT02213497|Carboplatin|carboplatin|mesh-list
2682767|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2682768|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2682769|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682770|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
2682771|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
2682772|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
2682773|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682774|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2682775|NCT02213588|Antioxidants|antioxidants|mesh-list
2682776|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682777|NCT02213588|Protective Agents|protective agents|mesh-ancestor
2682778|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682779|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
2682780|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
2682781|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2682782|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682783|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682784|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
2682785|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2682786|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2682787|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682788|NCT02213627|Menotropins|menotropins|mesh-list
2682789|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2682790|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
2188883|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188884|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188885|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
2188886|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2188887|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188888|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
2188889|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188890|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2188891|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188892|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188893|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682791|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2682792|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682793|NCT02213653|Iron|iron|mesh-list
2682794|NCT02213653|Trace Elements|trace elements|mesh-ancestor
2682795|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
2682796|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682797|NCT02213718|Sufentanil|sufentanil|mesh-list
2682798|NCT02213718|Propofol|propofol|mesh-list
2682799|NCT02213718|Desflurane|desflurane|mesh-list
2682800|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2682801|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2682802|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682803|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2682804|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
2682805|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
2682806|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2682807|NCT02213718|Narcotics|narcotics|mesh-ancestor
2682808|NCT02213718|Analgesics|analgesics|mesh-ancestor
2682809|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
2682810|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2682811|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2682812|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2682813|NCT02213744|Gemcitabine|gemcitabine|mesh-list
2682814|NCT02213744|Capecitabine|capecitabine|mesh-list
2682815|NCT02213744|Trastuzumab|trastuzumab|mesh-list
2682816|NCT02213744|Vinorelbine|vinorelbine|mesh-list
2682817|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2682818|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
2682819|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682820|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682821|NCT02213744|Antiviral Agents|antiviral agents|mesh-ancestor
2682822|NCT02213744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682823|NCT02213744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682824|NCT02213744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2682825|NCT02213744|Immunologic Factors|immunologic factors|mesh-ancestor
2682826|NCT02213744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682827|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2682828|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2682829|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
2682830|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
2682831|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
2682832|NCT02213757|Estrogens|estrogens|mesh-list
2682833|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2682834|NCT02213757|Hormones|hormones|mesh-ancestor
2682835|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2682836|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682837|NCT02213783|Imipenem|imipenem|mesh-list
2682838|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2682839|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682840|NCT02213796|Meropenem|meropenem|mesh-list
2682841|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2682842|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682843|NCT02213848|Calcium|calcium|mesh-list
2682844|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2682845|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682846|NCT02213887|Pantoprazole|pantoprazole|mesh-list
2682847|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2682848|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2682849|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2682850|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682851|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682852|NCT02213913|Prednisone|prednisone|mesh-list
2682853|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
2682854|NCT02213913|Rituximab|rituximab|mesh-list
2682855|NCT02213913|Doxorubicin|doxorubicin|mesh-list
2682856|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2682857|NCT02213913|Etoposide|etoposide|mesh-list
2682858|NCT02213913|Vincristine|vincristine|mesh-list
2682859|NCT02213913|Lenalidomide|lenalidomide|mesh-list
2682860|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
2682861|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2682862|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
2682863|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682864|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2682865|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2682866|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
2682867|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682868|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682869|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2682870|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2682871|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2682872|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2682873|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2682874|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682875|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2682876|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
2682877|NCT02213913|Hormones|hormones|mesh-ancestor
2682878|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2682879|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2682880|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2682881|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
2682882|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
2682883|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
2682884|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2682885|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2682886|NCT02213913|Growth Substances|growth substances|mesh-ancestor
2682887|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
2682888|NCT02214004|Trastuzumab|trastuzumab|mesh-list
2682889|NCT02214004|Letrozole|letrozole|mesh-list
2682890|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2682891|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682892|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2682893|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2682894|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682895|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682896|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2682897|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
2682898|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2682899|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682900|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2682901|NCT02214368|Propofol|propofol|mesh-list
2682902|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2682903|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2682904|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682905|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2682906|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
2682907|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
2682908|NCT02214381|Paclitaxel|paclitaxel|mesh-list
2682909|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
2682910|NCT02214381|Doxorubicin|doxorubicin|mesh-list
2682911|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2682912|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682913|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
2682914|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
2682915|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
2682916|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682917|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2682918|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
2682919|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682920|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2682921|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2682922|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
2682923|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2682924|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2682925|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2682926|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2682927|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682928|NCT02214433|Pantoprazole|pantoprazole|mesh-list
2682929|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2682930|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2682931|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2682932|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2682933|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682934|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682935|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2682936|NCT02214498|Enalapril|enalapril|mesh-list
2682937|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2682938|NCT02214498|Diuretics|diuretics|mesh-ancestor
2682939|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
2682940|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682941|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2682942|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2682943|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682944|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2682945|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
2682946|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682958|NCT02214563|Vitamin D|vitamin d|mesh-list
2682959|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
2682960|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
2682961|NCT02214563|Vitamins|vitamins|mesh-list
2682962|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
2682963|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682964|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2682965|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2682966|NCT02214602|Doxorubicin|doxorubicin|mesh-list
2682967|NCT02214602|Epirubicin|epirubicin|mesh-list
2682968|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2682969|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682970|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2682971|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2682972|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2682973|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682974|NCT02214680|Timolol|timolol|mesh-list
2682975|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2682976|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
2682977|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2682978|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2682979|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
2682980|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2682981|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2682982|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2682983|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2682984|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2682985|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2682986|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2682987|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2682988|NCT02214706|Sirolimus|sirolimus|mesh-list
2682989|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2682990|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2682991|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2682992|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2682993|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
2682994|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2682995|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
2682996|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188894|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2188895|NCT00003268|Protective Agents|protective agents|mesh-ancestor
2188896|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
2682997|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
2682998|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2682999|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683000|NCT02214810|Bupivacaine|bupivacaine|mesh-list
2683001|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
2683002|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
2683003|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2683004|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683005|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
2683006|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683007|NCT02214966|Telmisartan|telmisartan|mesh-list
2683008|NCT02214966|Ramipril|ramipril|mesh-list
2683009|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2683010|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2683011|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2683012|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683013|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2683014|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
2683015|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683016|NCT02214979|Telmisartan|telmisartan|mesh-list
2683017|NCT02214979|Ramipril|ramipril|mesh-list
2683018|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2188897|NCT00003269|Etoposide|etoposide|mesh-list
2188898|NCT00003269|Sargramostim|sargramostim|mesh-list
2188899|NCT00003269|Amifostine|amifostine|mesh-list
2188900|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188901|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
2188902|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188903|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188904|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188905|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
2188906|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188907|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188908|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2188909|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188910|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188911|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188912|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188913|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2188914|NCT00003269|Protective Agents|protective agents|mesh-ancestor
2188915|NCT00003273|Leucovorin|leucovorin|mesh-list
2188916|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
2188917|NCT00003273|Temozolomide|temozolomide|mesh-list
2188918|NCT00003273|Thiotepa|thiotepa|mesh-list
2188919|NCT00003273|Carboplatin|carboplatin|mesh-list
2188920|NCT00003273|Methotrexate|methotrexate|mesh-list
2188921|NCT00003273|Etoposide|etoposide|mesh-list
2188922|NCT00003273|Vincristine|vincristine|mesh-list
2188923|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
2683019|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2683020|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2683021|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683022|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2683023|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
2683024|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683025|NCT02214992|Telmisartan|telmisartan|mesh-list
2683026|NCT02214992|Ramipril|ramipril|mesh-list
2683027|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2683028|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2683029|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2683030|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683031|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2683032|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
2683033|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683034|NCT02215005|Telmisartan|telmisartan|mesh-list
2683035|NCT02215005|Ramipril|ramipril|mesh-list
2683036|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2683037|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2683038|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2683039|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683040|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2683041|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
2683042|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683043|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2683044|NCT02215044|Gemcitabine|gemcitabine|mesh-list
2683045|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2683046|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
2683047|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683048|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683049|NCT02215044|Antiviral Agents|antiviral agents|mesh-ancestor
2683050|NCT02215044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683051|NCT02215044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683052|NCT02215044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2683053|NCT02215044|Immunologic Factors|immunologic factors|mesh-ancestor
2683054|NCT02215044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683055|NCT02215057|Lidocaine|lidocaine|mesh-list
2683056|NCT02215057|Anesthetics|anesthetics|mesh-list
2683057|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
2188924|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2188925|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
2683058|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2188926|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188927|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188928|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188929|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
2188930|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188931|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188932|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2188933|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2188934|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
2188935|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2188936|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2188937|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
2683059|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683060|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
2683061|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683062|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2683063|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2683064|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2683065|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2683066|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683067|NCT02215096|GSK2636771|gsk2636771|mesh-list
2683068|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683069|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2683070|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683071|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683072|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2683073|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2683074|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
2683075|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683076|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683077|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2188938|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
2188939|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188940|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2188941|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2188942|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188943|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2188944|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188945|NCT00003273|Antidotes|antidotes|mesh-ancestor
2188946|NCT00003273|Protective Agents|protective agents|mesh-ancestor
2188947|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
2188948|NCT00003273|Vitamins|vitamins|mesh-ancestor
2188949|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
2188950|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188951|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188952|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188953|NCT00003274|Sargramostim|sargramostim|mesh-list
2188954|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
2188955|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
2188956|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188957|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2188958|NCT00003276|Irinotecan|irinotecan|mesh-list
2188959|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2188960|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2683078|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
2683079|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
2683080|NCT02215122|Hormones|hormones|mesh-ancestor
2683081|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683082|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
2683083|NCT02215148|Tolvaptan|tolvaptan|mesh-list
2683084|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2683085|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683086|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
2683087|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683088|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2683089|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2683090|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2683091|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
2683092|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683093|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2683094|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2683095|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683096|NCT02215213|Vitamin D|vitamin d|mesh-list
2683097|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
2683098|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
2683099|NCT02215213|Vitamins|vitamins|mesh-list
2683100|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
2683101|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683102|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2683103|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2683104|NCT02215265|Cisplatin|cisplatin|mesh-list
2683105|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683106|NCT02215330|Eplerenone|eplerenone|mesh-list
2683107|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2683108|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
2683109|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683110|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683111|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2683112|NCT02215330|Diuretics|diuretics|mesh-ancestor
2683113|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
2683114|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2683115|NCT02215382|Atropine|atropine|mesh-list
2683116|NCT02215382|Neostigmine|neostigmine|mesh-list
2683117|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2683118|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2683119|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2683120|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
2683121|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683122|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683123|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2683124|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
2683125|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
2683126|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
2188961|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188962|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188963|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188964|NCT00003278|Dexamethasone|dexamethasone|mesh-list
2188965|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2188966|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
2188967|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
2683127|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2683128|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2683129|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
2683130|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2683131|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683132|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2683133|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683134|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2188968|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2188969|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188970|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2188971|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
2188972|NCT00003278|Hormones|hormones|mesh-ancestor
2188973|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2188974|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2188975|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188976|NCT00003279|Antibodies|antibodies|mesh-list
2188977|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2188978|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
2188979|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
2188980|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683135|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2683136|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
2683137|NCT02215395|Estradiol|estradiol|mesh-list
2683138|NCT02215395|Estrogens|estrogens|mesh-ancestor
2683139|NCT02215395|Hormones|hormones|mesh-ancestor
2683140|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683141|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683142|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2683143|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2683144|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2683145|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2683146|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2683147|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
2683148|NCT02215434|Testosterone|testosterone|mesh-list
2683149|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
2683150|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
2683151|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2683152|NCT02215434|Androgens|androgens|mesh-ancestor
2683153|NCT02215434|Hormones|hormones|mesh-ancestor
2683154|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683155|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683156|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2683157|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683158|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
2683159|NCT02215447|Paclitaxel|paclitaxel|mesh-list
2683160|NCT02215447|Carboplatin|carboplatin|mesh-list
2683161|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2683162|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683163|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
2683164|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
2683165|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
2683166|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683167|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
2683168|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2683169|NCT02215460|Azithromycin|azithromycin|mesh-list
2683170|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2683171|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683172|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
2683173|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
2683174|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2683175|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
2683176|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2683177|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2683178|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683179|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
2683180|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
2683181|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
2683182|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2683183|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2683184|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
2683185|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
2683186|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2683187|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683188|NCT02215538|Methylphenidate|methylphenidate|mesh-list
2683189|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2683190|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683191|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2683192|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2683193|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2683194|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683195|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
2683196|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2683197|NCT02215720|Sirolimus|sirolimus|mesh-list
2683198|NCT02215720|Cetuximab|cetuximab|mesh-list
2683199|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2683200|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683201|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2683202|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683203|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2683204|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
2683205|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2683206|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
2683207|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683208|NCT02215733|Telmisartan|telmisartan|mesh-list
2683209|NCT02215733|Diuretics|diuretics|mesh-list
2683210|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2683211|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2683212|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2683213|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2683214|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683215|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
2683216|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683217|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2683218|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
2683219|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2683220|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2683221|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2683222|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2683223|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2683224|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683225|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2683226|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683227|NCT02215798|Analgesics|analgesics|mesh-ancestor
2683228|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
2683229|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683230|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
2683231|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2683232|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
2683233|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2683234|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
2683235|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683236|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
2683237|NCT02215876|Doxorubicin|doxorubicin|mesh-list
2683238|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2683239|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
2683240|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683241|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2683242|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2188981|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2188982|NCT00003280|Rituximab|rituximab|mesh-list
2188983|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2188984|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188985|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
2188986|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2188987|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2188988|NCT00003281|Paclitaxel|paclitaxel|mesh-list
2188989|NCT00003281|Topotecan|topotecan|mesh-list
2188990|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2188991|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2188992|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
2188993|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
2188994|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
2188995|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2188996|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2188997|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2188998|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2188999|NCT00003283|Prednisone|prednisone|mesh-list
2189000|NCT00003283|Octreotide|octreotide|mesh-list
2189001|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2189002|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
2189003|NCT00003283|Hormones|hormones|mesh-ancestor
2189004|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2189005|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189006|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2189007|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189008|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2189009|NCT00003284|Paclitaxel|paclitaxel|mesh-list
2189010|NCT00003284|Etoposide|etoposide|mesh-list
2189011|NCT00003284|Carboplatin|carboplatin|mesh-list
2189012|NCT00003284|Ifosfamide|ifosfamide|mesh-list
2189013|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189014|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189015|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189016|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189017|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189018|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189019|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189020|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189021|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189022|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189023|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
2189024|NCT00003287|Leucovorin|leucovorin|mesh-list
2189025|NCT00003287|Fluorouracil|fluorouracil|mesh-list
2189026|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
2189027|NCT00003287|Calcium|calcium|mesh-list
2189028|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
2189029|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2189030|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189031|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
2189032|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683243|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
2683244|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683245|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683246|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2683247|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2683248|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2683249|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2683250|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683251|NCT02215980|Dexamethasone|dexamethasone|mesh-list
2683252|NCT02215980|Lenalidomide|lenalidomide|mesh-list
2683253|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2683254|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
2683255|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
2683256|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683257|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683258|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2683259|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
2683260|NCT02215980|Hormones|hormones|mesh-ancestor
2683261|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683262|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2683263|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683264|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
2683265|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2683266|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2683267|NCT02215980|Growth Substances|growth substances|mesh-ancestor
2683268|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
2683269|NCT02215993|Ticagrelor|ticagrelor|mesh-list
2683270|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2683271|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2683272|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2683273|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2683274|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2683275|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
2683276|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2683277|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683278|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683279|NCT02216045|Ribavirin|ribavirin|mesh-list
2683280|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2683281|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
2683282|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
2683283|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683284|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
2683285|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683286|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
2683287|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683288|NCT02216058|Sirolimus|sirolimus|mesh-list
2683289|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2683290|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683291|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2683292|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683293|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
2683294|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2683295|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
2683296|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683297|NCT02216149|Capecitabine|capecitabine|mesh-list
2683298|NCT02216149|Tegafur|tegafur|mesh-list
2683299|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
2683300|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2683301|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
2683302|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683303|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683304|NCT02216227|Iodine|iodine|mesh-list
2683305|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
2683306|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2683307|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
2683308|NCT02216227|Vancomycin|vancomycin|mesh-list
2683309|NCT02216227|Cefazolin|cefazolin|mesh-list
2683310|NCT02216227|Mupirocin|mupirocin|mesh-list
2683311|NCT02216227|Povidone|povidone|mesh-list
2683312|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2683313|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683314|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
2683315|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
2683316|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2683317|NCT02216227|Trace Elements|trace elements|mesh-ancestor
2683318|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
2683319|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683320|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
2683321|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
2683322|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2683323|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683324|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683325|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2683326|NCT02216266|Physostigmine|physostigmine|mesh-list
2423212|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423213|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2423214|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423215|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683327|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2683328|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683329|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683330|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
2683331|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2683332|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683333|NCT02216266|Miotics|miotics|mesh-ancestor
2683334|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
2683335|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683336|NCT02216331|Rifampin|rifampin|mesh-list
2683337|NCT02216331|Rifapentine|rifapentine|mesh-list
2683338|NCT02216331|Bedaquiline|bedaquiline|mesh-list
2683339|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2683340|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
2683341|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2683342|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683343|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
2683344|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2683345|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683346|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683347|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2683348|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2683349|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2683350|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2683351|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2683352|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2683353|NCT02216383|Oxytocin|oxytocin|mesh-list
2683354|NCT02216383|Carbetocin|carbetocin|mesh-list
2683355|NCT02216383|Syntometrine|syntometrine|mesh-list
2683356|NCT02216383|Ergonovine|ergonovine|mesh-list
2683357|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
2683358|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2683359|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189033|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2189034|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189035|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189036|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
2189037|NCT00003287|Antidotes|antidotes|mesh-ancestor
2189038|NCT00003287|Protective Agents|protective agents|mesh-ancestor
2189039|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
2189040|NCT00003287|Vitamins|vitamins|mesh-ancestor
2189041|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
2189042|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
2189043|NCT00003288|Tirapazamine|tirapazamine|mesh-list
2683360|NCT02216409|Magrolimab|magrolimab|mesh-list
2683361|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2683362|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683363|NCT02216487|Irinotecan|irinotecan|mesh-list
2683364|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2683365|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2683366|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683367|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683368|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683369|NCT02216513|Deferoxamine|deferoxamine|mesh-list
2683370|NCT02216513|Siderophores|siderophores|mesh-ancestor
2683371|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2683372|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
2683373|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
2683374|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683375|NCT02216552|Resveratrol|resveratrol|mesh-list
2683376|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
2683377|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683378|NCT02216552|Protective Agents|protective agents|mesh-ancestor
2683379|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683380|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189044|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2423216|NCT00821080|Sirolimus|sirolimus|mesh-list
2423217|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2423218|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423219|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2423220|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423221|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
2189045|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
2189046|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189047|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189048|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189049|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
2189050|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189051|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189052|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189053|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2189054|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189055|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2189056|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189057|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683381|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2683382|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2683383|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2683384|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2683385|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683386|NCT02216617|Docetaxel|docetaxel|mesh-list
2683387|NCT02216617|Afatinib|afatinib|mesh-list
2683388|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683389|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189058|NCT00003290|Hormones|hormones|mesh-list
2189059|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2189060|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189061|NCT00003292|Ifosfamide|ifosfamide|mesh-list
2189062|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189063|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
2189064|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189065|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189066|NCT00003293|Procarbazine|procarbazine|mesh-list
2189067|NCT00003293|Leflunomide|leflunomide|mesh-list
2189068|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189069|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189070|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189071|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
2189072|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189073|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189074|NCT00003294|Paclitaxel|paclitaxel|mesh-list
2683390|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
2683391|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
2683392|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683393|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2683394|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683395|NCT02216656|Cinacalcet|cinacalcet|mesh-list
2683396|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2683397|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683398|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2683399|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
2683400|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683401|NCT02216669|Imidazole|imidazole|mesh-list
2683402|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683403|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683404|NCT02216747|Prednisone|prednisone|mesh-list
2683405|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2683406|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
2683407|NCT02216747|Hormones|hormones|mesh-ancestor
2683408|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683409|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683410|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2683411|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683412|NCT02216786|Everolimus|everolimus|mesh-list
2683413|NCT02216786|Fulvestrant|fulvestrant|mesh-list
2683414|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683415|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2683416|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
2683417|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683418|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2683419|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2683420|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2683421|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
2683422|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683423|NCT02216799|Insulin|insulin|mesh-list
2683424|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2683425|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
2683426|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2683427|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189075|NCT00003294|Carboplatin|carboplatin|mesh-list
2189076|NCT00003294|Amifostine|amifostine|mesh-list
2683439|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
2683440|NCT02216877|Antacids|antacids|mesh-ancestor
2683441|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683442|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2683443|NCT02216994|Mineral Oil|mineral oil|mesh-list
2683444|NCT02216994|Lactulose|lactulose|mesh-list
2683445|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2683446|NCT02216994|Emollients|emollients|mesh-ancestor
2683447|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
2683448|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
2683449|NCT02217007|Acamprosate|acamprosate|mesh-list
2683450|NCT02217007|Calcium|calcium|mesh-list
2683451|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2683452|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683453|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2683454|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2683455|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
2683456|NCT02217020|Irinotecan|irinotecan|mesh-list
2683457|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683458|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2683459|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2683460|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683461|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683462|NCT02217163|Dexamethasone|dexamethasone|mesh-list
2683463|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
2683464|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2683465|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
2683466|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683467|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2683468|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2683469|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
2683470|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683471|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683472|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2683473|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2683474|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
2683475|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
2683476|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683477|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2683478|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
2683479|NCT02217163|Hormones|hormones|mesh-ancestor
2683480|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683481|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2683482|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
2683483|NCT02217189|Astringents|astringents|mesh-ancestor
2683484|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683485|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
2683486|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2683487|NCT02217202|Laxatives|laxatives|mesh-ancestor
2683488|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2683489|NCT02217267|Lidocaine|lidocaine|mesh-list
2683490|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
2683491|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
2683492|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2683493|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683494|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
2683495|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683496|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2683497|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2189077|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189078|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189079|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189080|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189081|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189082|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189083|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189084|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2189085|NCT00003294|Protective Agents|protective agents|mesh-ancestor
2189086|NCT00003296|Doxorubicin|doxorubicin|mesh-list
2189087|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2189088|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2189089|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683498|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2683499|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2683500|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683501|NCT02217319|Sevoflurane|sevoflurane|mesh-list
2683502|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2683503|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2683504|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
2683505|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
2683506|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2683507|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683508|NCT02217514|Midazolam|midazolam|mesh-list
2683509|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2683510|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2683511|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2683512|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683513|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2683514|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2683515|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2683516|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2683517|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
2683518|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
2683519|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
2683520|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
2683521|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2189090|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189091|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189092|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189093|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189094|NCT00003297|Topotecan|topotecan|mesh-list
2189095|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
2189096|NCT00003297|Thiotepa|thiotepa|mesh-list
2189097|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2189098|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189099|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189100|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189101|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189102|NCT00003297|Analgesics|analgesics|mesh-ancestor
2189103|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
2189104|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2189105|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683522|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683523|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
2683524|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2683525|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683526|NCT02217553|Vitamins|vitamins|mesh-ancestor
2683527|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
2683528|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2683529|NCT02217631|Prednisolone|prednisolone|mesh-list
2683530|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2683531|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
2683532|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2683533|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
2683534|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2683535|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
2683536|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2683537|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
2683538|NCT02217631|Hormones|hormones|mesh-ancestor
2683539|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683540|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683541|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2683542|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189106|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189107|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2683543|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
2683544|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
2683545|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683546|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2683547|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2683548|NCT02217631|Protective Agents|protective agents|mesh-ancestor
2683549|NCT02217670|Metformin|metformin|mesh-list
2683550|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2683551|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683552|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
2683553|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2683554|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
2683555|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683556|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423222|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2423223|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
2423224|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423225|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2423226|NCT00821158|Antioxidants|antioxidants|mesh-list
2423227|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423228|NCT00821158|Protective Agents|protective agents|mesh-ancestor
2423229|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423230|NCT00821249|Dexamethasone|dexamethasone|mesh-list
2423231|NCT00821249|Filanesib|filanesib|mesh-list
2423232|NCT00821249|Lenograstim|lenograstim|mesh-list
2423233|NCT00821249|Sargramostim|sargramostim|mesh-list
2683557|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2683558|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
2683559|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2683560|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
2683561|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683562|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2683563|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2683564|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
2683565|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
2683566|NCT02217683|Protective Agents|protective agents|mesh-ancestor
2683567|NCT02217709|Phenelzine|phenelzine|mesh-list
2683568|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
2683569|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2683570|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2683571|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683572|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683573|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2683574|NCT02217722|Amoxicillin|amoxicillin|mesh-list
2683575|NCT02217722|Metronidazole|metronidazole|mesh-list
2683576|NCT02217722|Doxycycline|doxycycline|mesh-list
2683577|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683578|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2683579|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2683580|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
2683581|NCT02217787|PF-06372865|pf-06372865|mesh-list
2683582|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
2683583|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
2683584|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2683585|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683586|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683587|NCT02217826|Octreotide|octreotide|mesh-list
2683588|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2683589|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2683590|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683591|NCT02217839|Octreotide|octreotide|mesh-list
2683592|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2683593|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2683594|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683595|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2683596|NCT02217852|Captopril|captopril|mesh-list
2683597|NCT02217852|Nitrendipine|nitrendipine|mesh-list
2683598|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
2683599|NCT02217852|Diuretics|diuretics|mesh-ancestor
2683600|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
2683601|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683602|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2683603|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2189108|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
2683604|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683605|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2683606|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
2683607|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683608|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2683609|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2683610|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
2683611|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
2683612|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2683613|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683614|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2683615|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2683616|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683617|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683618|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683619|NCT02217956|Bevacizumab|bevacizumab|mesh-list
2683620|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2683621|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683622|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2683623|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2683624|NCT02217956|Growth Substances|growth substances|mesh-ancestor
2683625|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683626|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
2683627|NCT02218021|Oxycodone|oxycodone|mesh-list
2683628|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2683629|NCT02218021|Narcotics|narcotics|mesh-ancestor
2683630|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2683631|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683632|NCT02218021|Analgesics|analgesics|mesh-ancestor
2683633|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
2683634|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683635|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
2683636|NCT02218034|Tazarotene|tazarotene|mesh-list
2683637|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
2683638|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
2683639|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
2683640|NCT02218034|Vitamins|vitamins|mesh-ancestor
2683641|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
2683642|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683643|NCT02218047|Interferons|interferons|mesh-list
2683644|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
2683645|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
2683646|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683647|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
2683648|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683649|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
2683650|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189109|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189110|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189111|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
2189112|NCT00003299|Paclitaxel|paclitaxel|mesh-list
2189113|NCT00003299|Etoposide|etoposide|mesh-list
2189114|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189115|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189116|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189117|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189118|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189119|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189120|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189121|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189122|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189123|NCT00003301|Irinotecan|irinotecan|mesh-list
2189124|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2189125|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189126|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423234|NCT00821249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2423235|NCT00821249|Antiemetics|antiemetics|mesh-ancestor
2423236|NCT00821249|Autonomic Agents|autonomic agents|mesh-ancestor
2423237|NCT00821249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423238|NCT00821249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423239|NCT00821249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2423240|NCT00821249|Glucocorticoids|glucocorticoids|mesh-ancestor
2423241|NCT00821249|Hormones|hormones|mesh-ancestor
2423242|NCT00821249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2423243|NCT00821249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2423244|NCT00821249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423245|NCT00821249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2683651|NCT02218177|Ranibizumab|ranibizumab|mesh-list
2683652|NCT02218177|Aflibercept|aflibercept|mesh-list
2683653|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2683654|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2683655|NCT02218177|Growth Substances|growth substances|mesh-ancestor
2683656|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683657|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
2683658|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683659|NCT02218359|Amikacin|amikacin|mesh-list
2683660|NCT02218359|Fosfomycin|fosfomycin|mesh-list
2189127|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683661|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2683662|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2683663|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683664|NCT02218398|Albuterol|albuterol|mesh-list
2683665|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2683666|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
2683667|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683668|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683669|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2683670|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
2683671|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
2683672|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2683673|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2683674|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2683675|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2683676|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
2683677|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2683678|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683679|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
2683680|NCT02218476|Vitamins|vitamins|mesh-ancestor
2683681|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
2683682|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683683|NCT02218606|Prednisone|prednisone|mesh-list
2683684|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
2683685|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2683686|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
2683687|NCT02218606|Hormones|hormones|mesh-ancestor
2683688|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683689|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683690|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2683691|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683692|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2683693|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683694|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683695|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
2683696|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2683697|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
2683698|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
2683699|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683700|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2683701|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2683702|NCT02218645|Brotizolam|brotizolam|mesh-list
2683703|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2683704|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2683705|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683706|NCT02218658|Brotizolam|brotizolam|mesh-list
2683707|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2683708|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2683709|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683710|NCT02218671|Brotizolam|brotizolam|mesh-list
2683711|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2683712|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2683713|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683714|NCT02218684|Telmisartan|telmisartan|mesh-list
2683715|NCT02218684|Lacidipine|lacidipine|mesh-list
2683716|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2683717|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2683718|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2683719|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683720|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2683721|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2683722|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2683723|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189128|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189129|NCT00003304|Temozolomide|temozolomide|mesh-list
2189130|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189131|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
2189132|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189133|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189134|NCT00003305|Leucovorin|leucovorin|mesh-list
2189135|NCT00003305|Calcium|calcium|mesh-list
2189136|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
2189137|NCT00003305|Aminopterin|aminopterin|mesh-list
2189138|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2683724|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2683725|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
2683726|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683727|NCT02218762|Fluticasone|fluticasone|mesh-list
2683728|NCT02218762|Xhance|xhance|mesh-list
2683729|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2683730|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2683731|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2683732|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2683733|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
2683734|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683735|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683736|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2683737|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
2683738|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
2683739|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2683740|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2683741|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2683742|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2683743|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
2683744|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2683745|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683746|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
2683747|NCT02218762|Hormones|hormones|mesh-ancestor
2683748|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683749|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
2683750|NCT02218775|Aticaprant|aticaprant|mesh-list
2683751|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2683752|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683753|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
2683754|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683755|NCT02218814|Bupivacaine|bupivacaine|mesh-list
2683756|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
2683757|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
2683758|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2683759|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683760|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
2683761|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683762|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2683763|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2683764|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2683765|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
2683766|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2683767|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
2683768|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683769|NCT02219100|Mifepristone|mifepristone|mesh-list
2683770|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2683771|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
2683772|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2683773|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683774|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2683775|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2683776|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2683777|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
2683778|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2683779|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2683780|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
2683781|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683782|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
2683783|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2683784|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2189139|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189140|NCT00003305|Antidotes|antidotes|mesh-ancestor
2189141|NCT00003305|Protective Agents|protective agents|mesh-ancestor
2189142|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
2189143|NCT00003305|Vitamins|vitamins|mesh-ancestor
2189144|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
2189145|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2189146|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189147|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189148|NCT00003307|Amifostine|amifostine|mesh-list
2189149|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2189150|NCT00003307|Protective Agents|protective agents|mesh-ancestor
2189151|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189152|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
2189153|NCT00003309|Etoposide|etoposide|mesh-list
2683785|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
2683786|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2683787|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2683788|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683789|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
2683790|NCT02219152|Coagulants|coagulants|mesh-ancestor
2683791|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
2683792|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2683793|NCT02219165|Antibodies|antibodies|mesh-list
2683794|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
2189154|NCT00003309|Vincristine|vincristine|mesh-list
2189155|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189156|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
2189157|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189158|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189159|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189160|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
2189161|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189162|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189163|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189164|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189165|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189166|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189167|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189168|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189169|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189170|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189171|NCT00003311|Cytarabine|cytarabine|mesh-list
2189172|NCT00003311|Dexamethasone|dexamethasone|mesh-list
2189173|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
2189174|NCT00003311|Doxorubicin|doxorubicin|mesh-list
2189175|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2189176|NCT00003311|Methotrexate|methotrexate|mesh-list
2189177|NCT00003311|Vincristine|vincristine|mesh-list
2189178|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189179|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
2189180|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189181|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189182|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189183|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
2683795|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683796|NCT02219178|Dexamethasone|dexamethasone|mesh-list
2683797|NCT02219178|Lenalidomide|lenalidomide|mesh-list
2683798|NCT02219178|Bortezomib|bortezomib|mesh-list
2189184|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189185|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189186|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189187|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2189188|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
2189189|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
2189190|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683799|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2683800|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
2683801|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
2683802|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683803|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683804|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2683805|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
2683806|NCT02219178|Hormones|hormones|mesh-ancestor
2683807|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683808|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2189191|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2189192|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
2683809|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683810|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
2189193|NCT00003311|Hormones|hormones|mesh-ancestor
2189194|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2189195|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2189196|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2189197|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189198|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2683811|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2683812|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2683813|NCT02219178|Growth Substances|growth substances|mesh-ancestor
2683814|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
2683815|NCT02219191|Puerarin|puerarin|mesh-list
2683816|NCT02219191|Atorvastatin|atorvastatin|mesh-list
2683817|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2683818|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2683819|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
2683820|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683821|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2683822|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2683823|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683824|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
2683825|NCT02219217|Dolutegravir|dolutegravir|mesh-list
2683826|NCT02219217|Cobicistat|cobicistat|mesh-list
2683827|NCT02219217|Elvitegravir|elvitegravir|mesh-list
2683828|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2683829|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2683830|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683831|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683832|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2683833|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2683834|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
2683835|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683836|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2683837|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2683838|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
2683839|NCT02219373|Gabapentin|gabapentin|mesh-list
2683840|NCT02219373|Analgesics|analgesics|mesh-ancestor
2683841|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
2683842|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683843|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683844|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
2683845|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2683846|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2683847|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2683848|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2683849|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2683850|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2683851|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2683852|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683853|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
2683854|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2683855|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2683856|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2683857|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2683858|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2683859|NCT02219412|Aspirin|aspirin|mesh-list
2683860|NCT02219412|Ticagrelor|ticagrelor|mesh-list
2683861|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2683862|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2683863|NCT02219412|Analgesics|analgesics|mesh-ancestor
2683864|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
2683865|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683866|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683867|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2683868|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2683869|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2683870|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2683871|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683872|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2683873|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2683874|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683875|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
2683876|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2683877|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2683878|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2683879|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
2683880|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2683881|NCT02219490|Ribavirin|ribavirin|mesh-list
2683882|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
2683883|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683884|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
2683885|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683886|NCT02219581|Dexamethasone|dexamethasone|mesh-list
2683887|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
2683888|NCT02219581|BB 1101|bb 1101|mesh-list
2683889|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2683890|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
2683891|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
2683892|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683893|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683894|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2683895|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
2683896|NCT02219581|Hormones|hormones|mesh-ancestor
2683897|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2683898|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2683899|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683900|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
2683901|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683902|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683903|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2683904|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
2683905|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2683906|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2683907|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683908|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683909|NCT02219646|Urological Agents|urological agents|mesh-ancestor
2683910|NCT02219659|Fentanyl|fentanyl|mesh-list
2683911|NCT02219659|Midazolam|midazolam|mesh-list
2683912|NCT02219659|Propofol|propofol|mesh-list
2683913|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2683914|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2683915|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683916|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2683917|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
2683918|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
2683919|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2683920|NCT02219659|Narcotics|narcotics|mesh-ancestor
2683921|NCT02219659|Analgesics|analgesics|mesh-ancestor
2683922|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
2683923|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683924|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2683925|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2683926|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2683927|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2683928|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
2683929|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
2683930|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2683931|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683932|NCT02219672|Ritonavir|ritonavir|mesh-list
2683933|NCT02219672|Lopinavir|lopinavir|mesh-list
2683934|NCT02219672|Tenofovir|tenofovir|mesh-list
2683935|NCT02219672|Lamivudine|lamivudine|mesh-list
2683936|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
2683937|NCT02219672|Triptolide|triptolide|mesh-list
2683938|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2683939|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2683940|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
2683941|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683942|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683943|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2683944|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2683945|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
2683946|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2683947|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2683948|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2683949|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2683950|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2683951|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2683952|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2683953|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2683954|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683955|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2189199|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189200|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2189201|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
2189202|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2189203|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2189204|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
2189205|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
2189206|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2189207|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2189208|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
2189209|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2189210|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189211|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189212|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189213|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189214|NCT00003313|Paclitaxel|paclitaxel|mesh-list
2189215|NCT00003313|Carboplatin|carboplatin|mesh-list
2189216|NCT00003313|Amifostine|amifostine|mesh-list
2189217|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189218|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189219|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189220|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189221|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189222|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189223|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189224|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2189225|NCT00003313|Protective Agents|protective agents|mesh-ancestor
2189226|NCT00003315|Amphotericin B|amphotericin b|mesh-list
2189227|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2683956|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
2683957|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2683958|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2683959|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
2683960|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2683961|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
2683962|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683963|NCT02219698|Acetaminophen|acetaminophen|mesh-list
2683964|NCT02219698|Ibuprofen|ibuprofen|mesh-list
2683965|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2683966|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2683967|NCT02219698|Analgesics|analgesics|mesh-ancestor
2683968|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
2683969|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2683970|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683971|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2683972|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2683973|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2683974|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683975|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683976|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
2683977|NCT02219737|Rituximab|rituximab|mesh-list
2683978|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2683979|NCT02219737|Carboplatin|carboplatin|mesh-list
2683980|NCT02219737|Etoposide|etoposide|mesh-list
2683981|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
2683982|NCT02219737|Ifosfamide|ifosfamide|mesh-list
2683983|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
2683984|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
2683985|NCT02219737|Antibodies|antibodies|mesh-list
2683986|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
2683987|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2683988|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
2683989|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2683990|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2683991|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2683992|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2683993|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2683994|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2683995|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2683996|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2683997|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2683998|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
2683999|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
2684000|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
2684001|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
2684002|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
2684003|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
2684004|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2684005|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2684006|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684007|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
2684008|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2684009|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2684010|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2684011|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2684012|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
2684013|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
2684014|NCT02219789|Fulvestrant|fulvestrant|mesh-list
2684015|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2684016|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684017|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2684018|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2684019|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
2684020|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2684021|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189228|NCT00003315|Sargramostim|sargramostim|mesh-list
2189229|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
2189230|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189231|NCT00003315|Amebicides|amebicides|mesh-ancestor
2189232|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2189233|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2189234|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2189235|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2684022|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2684023|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2684024|NCT02219867|Ketamine|ketamine|mesh-list
2684025|NCT02219867|Analgesics|analgesics|mesh-ancestor
2684026|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
2684027|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684028|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684029|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2684030|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2189236|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
2189237|NCT00003316|Gemcitabine|gemcitabine|mesh-list
2189238|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2189239|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
2189240|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684031|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
2684032|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
2684033|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684034|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2684035|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2684036|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684037|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684038|NCT02219893|Immunotoxins|immunotoxins|mesh-list
2684039|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
2684040|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684041|NCT02219906|Resveratrol|resveratrol|mesh-list
2684042|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
2684043|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684044|NCT02219906|Protective Agents|protective agents|mesh-ancestor
2684045|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684046|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684047|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2684048|NCT02219984|Anticoagulants|anticoagulants|mesh-list
2684049|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
2684050|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2684051|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
2684052|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684053|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684054|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2684055|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
2684056|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2684057|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
2684058|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684059|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684060|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2684061|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
2684062|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
2684063|NCT02220023|Protective Agents|protective agents|mesh-ancestor
2684064|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
2189241|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189242|NCT00003316|Antiviral Agents|antiviral agents|mesh-ancestor
2189243|NCT00003316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2189244|NCT00003316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189245|NCT00003316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189246|NCT00003316|Immunologic Factors|immunologic factors|mesh-ancestor
2684065|NCT02220036|Antacids|antacids|mesh-ancestor
2684066|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684067|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2684068|NCT02220049|Bortezomib|bortezomib|mesh-list
2684069|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684070|NCT02220088|Leucovorin|leucovorin|mesh-list
2684071|NCT02220088|Fluorouracil|fluorouracil|mesh-list
2684072|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
2684073|NCT02220088|Sorafenib|sorafenib|mesh-list
2684074|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
2684075|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684076|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2684077|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684078|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2684079|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
2684080|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684081|NCT02220088|Antidotes|antidotes|mesh-ancestor
2684082|NCT02220088|Protective Agents|protective agents|mesh-ancestor
2684083|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
2684084|NCT02220088|Vitamins|vitamins|mesh-ancestor
2684085|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
2684086|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2684087|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684088|NCT02220114|Vigabatrin|vigabatrin|mesh-list
2684089|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
2684090|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684091|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684092|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
2684093|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684094|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684095|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
2684096|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2684097|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
2684098|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684099|NCT02220218|Metformin|metformin|mesh-list
2684100|NCT02220218|Canagliflozin|canagliflozin|mesh-list
2684101|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2684102|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684103|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2684104|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684105|NCT02220296|Insulin|insulin|mesh-list
2684106|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2684107|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
2684108|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2684109|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684120|NCT02220335|Digoxin|digoxin|mesh-list
2684121|NCT02220335|Diuretics|diuretics|mesh-list
2684122|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2684123|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
2684124|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2684125|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2684126|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684127|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684128|NCT02220335|Protective Agents|protective agents|mesh-ancestor
2684129|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684130|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
2684131|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
2684132|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
2684133|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2189247|NCT00003316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684134|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2684135|NCT02220348|Linaclotide|linaclotide|mesh-list
2684136|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2684137|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
2684138|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684139|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2684140|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
2684141|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2684142|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684143|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684144|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2684145|NCT02220361|Analgesics|analgesics|mesh-ancestor
2684146|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
2684147|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684148|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2684149|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2684150|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2684151|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
2684152|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684153|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684154|NCT02220400|Ketamine|ketamine|mesh-list
2684155|NCT02220400|Analgesics|analgesics|mesh-ancestor
2684156|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
2684157|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684158|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684159|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2684160|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2684161|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
2684162|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
2684163|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684164|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2684165|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2684166|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684167|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684168|NCT02220426|Xenon|xenon|mesh-list
2684169|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2684170|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
2684171|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
2684172|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684173|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684177|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
2684178|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2684179|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684180|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684181|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2684182|NCT02220530|Fentanyl|fentanyl|mesh-list
2684183|NCT02220530|Midazolam|midazolam|mesh-list
2684184|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2684185|NCT02220530|Narcotics|narcotics|mesh-ancestor
2684186|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684187|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684188|NCT02220530|Analgesics|analgesics|mesh-ancestor
2684189|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
2684190|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684191|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2684192|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2684193|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
2684194|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
2684195|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2684196|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2684197|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2684198|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2684199|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
2684200|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
2684201|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684202|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684203|NCT02220608|Bortezomib|bortezomib|mesh-list
2684204|NCT02220608|Lenograstim|lenograstim|mesh-list
2684205|NCT02220608|Sargramostim|sargramostim|mesh-list
2684206|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2684207|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
2684208|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189248|NCT00003317|Paclitaxel|paclitaxel|mesh-list
2189249|NCT00003317|Carboplatin|carboplatin|mesh-list
2684209|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684210|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
2684211|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2684212|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
2684213|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684214|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
2684215|NCT02220621|Protective Agents|protective agents|mesh-ancestor
2684216|NCT02220634|Regadenoson|regadenoson|mesh-list
2684217|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2684218|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2684219|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
2684220|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
2684221|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684222|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684223|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684224|NCT02220647|Metformin|metformin|mesh-list
2189250|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189251|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189252|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189253|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
2684225|NCT02220647|Linagliptin|linagliptin|mesh-list
2684226|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2684227|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684228|NCT02220647|Incretins|incretins|mesh-ancestor
2684229|NCT02220647|Hormones|hormones|mesh-ancestor
2684230|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2684231|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2684232|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
2684233|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684234|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684235|NCT02220660|Olodaterol|olodaterol|mesh-list
2684236|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2684237|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
2684238|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684239|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684240|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2684241|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
2684242|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
2684243|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
2684244|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684245|NCT02220673|Protective Agents|protective agents|mesh-ancestor
2684246|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684247|NCT02220751|Doxycycline|doxycycline|mesh-list
2684248|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2684249|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2684250|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
2684251|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2684252|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2684253|NCT02220777|Omeprazole|omeprazole|mesh-list
2684254|NCT02220777|ASP8477|asp8477|mesh-list
2684255|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2684256|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2684257|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2684258|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684259|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684260|NCT02220803|Acetazolamide|acetazolamide|mesh-list
2684261|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
2684262|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2684263|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684264|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684265|NCT02220803|Diuretics|diuretics|mesh-ancestor
2684266|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
2684267|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684268|NCT02220829|Silodosin|silodosin|mesh-list
2684269|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2684270|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2684271|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2684272|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
2684273|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684274|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684275|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684276|NCT02220829|Urological Agents|urological agents|mesh-ancestor
2684277|NCT02220842|Atezolizumab|atezolizumab|mesh-list
2189254|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
2684278|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
2684279|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189255|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189256|NCT00003322|Paclitaxel|paclitaxel|mesh-list
2189257|NCT00003322|Cisplatin|cisplatin|mesh-list
2189258|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189259|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189260|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189261|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189262|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189263|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189264|NCT00003323|Flutamide|flutamide|mesh-list
2189265|NCT00003323|Finasteride|finasteride|mesh-list
2684280|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2684281|NCT02220868|Ribavirin|ribavirin|mesh-list
2684282|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
2684283|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2684284|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
2684285|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684286|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
2684287|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2684288|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2684289|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2684321|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2684322|NCT02221063|Thiamine|thiamine|mesh-list
2684323|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
2684324|NCT02221063|Vitamins|vitamins|mesh-ancestor
2684325|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
2684326|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684327|NCT02221102|Aspirin|aspirin|mesh-list
2684328|NCT02221102|Edoxaban|edoxaban|mesh-list
2684329|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2684330|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2684331|NCT02221102|Analgesics|analgesics|mesh-ancestor
2684332|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
2684333|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684334|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684335|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2684336|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2684337|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2684338|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2189266|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2189267|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2189268|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684339|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684340|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2684341|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2684342|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684343|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
2684344|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2684345|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
2684346|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2684347|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
2684348|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
2684349|NCT02221154|Folic Acid|folic acid|mesh-list
2684350|NCT02221154|Hematinics|hematinics|mesh-ancestor
2684351|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
2684352|NCT02221154|Vitamins|vitamins|mesh-ancestor
2684353|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
2684354|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684355|NCT02221180|Metformin|metformin|mesh-list
2684356|NCT02221180|Canagliflozin|canagliflozin|mesh-list
2684357|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2684358|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684359|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2684360|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684361|NCT02221232|Ethanol|ethanol|mesh-list
2684362|NCT02221232|Chlorhexidine|chlorhexidine|mesh-list
2684363|NCT02221232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2684364|NCT02221232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2684365|NCT02221232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2684366|NCT02221232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684367|NCT02221232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684368|NCT02221232|Disinfectants|disinfectants|mesh-ancestor
2684369|NCT02221232|Dermatologic Agents|dermatologic agents|mesh-ancestor
2684370|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
2684371|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2684372|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684373|NCT02221375|Ciclesonide|ciclesonide|mesh-list
2684374|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
2684375|NCT02221375|Hormones|hormones|mesh-ancestor
2684376|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2684377|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684378|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2684379|NCT02221401|Metformin|metformin|mesh-list
2684380|NCT02221401|Linagliptin|linagliptin|mesh-list
2684381|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2684382|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684383|NCT02221401|Incretins|incretins|mesh-ancestor
2684384|NCT02221401|Hormones|hormones|mesh-ancestor
2684385|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2684386|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2684387|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
2684388|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684389|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684390|NCT02221414|Metformin|metformin|mesh-list
2684391|NCT02221414|Linagliptin|linagliptin|mesh-list
2684392|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2684393|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684394|NCT02221414|Incretins|incretins|mesh-ancestor
2684395|NCT02221414|Hormones|hormones|mesh-ancestor
2684396|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2684397|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2684398|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
2684399|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684400|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684401|NCT02221453|Triamcinolone|triamcinolone|mesh-list
2684402|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2684403|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2684404|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2684405|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2684406|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
2684407|NCT02221453|Hormones|hormones|mesh-ancestor
2684408|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2684409|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684410|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2684411|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
2684412|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684413|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684414|NCT02221479|Plerixafor|plerixafor|mesh-list
2684415|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2684416|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2684417|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
2684418|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2684419|NCT02221492|Plerixafor|plerixafor|mesh-list
2684420|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2684421|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2684422|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
2684423|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2684424|NCT02221531|Carbetocin|carbetocin|mesh-list
2684425|NCT02221531|Oxytocin|oxytocin|mesh-list
2684426|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
2684427|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2684428|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684429|NCT02221570|Baclofen|baclofen|mesh-list
2684430|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2684431|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684432|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2684433|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684434|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2684435|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
2684436|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
2684437|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684438|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684439|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
2684440|NCT02221583|Tacrolimus|tacrolimus|mesh-list
2684441|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2684442|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
2684443|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684444|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2684445|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684446|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684447|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2684448|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684449|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2684450|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
2684451|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2684452|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2684453|NCT02221596|Vitamin D|vitamin d|mesh-list
2684454|NCT02221596|Vitamins|vitamins|mesh-ancestor
2684455|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
2684456|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684457|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2684458|NCT02221622|Pregnanolone|pregnanolone|mesh-list
2684459|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2684460|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
2684461|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684462|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684463|NCT02221635|Risperidone|risperidone|mesh-list
2684464|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2684465|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
2684466|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2189269|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189270|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
2189271|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2189272|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189273|NCT00003323|Urological Agents|urological agents|mesh-ancestor
2189274|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
2189275|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2189276|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189277|NCT00003326|Paclitaxel|paclitaxel|mesh-list
2189278|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189279|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189280|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189281|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189282|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423246|NCT00821249|Immunologic Factors|immunologic factors|mesh-ancestor
2684467|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684468|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684469|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2423247|NCT00821249|Antimitotic Agents|antimitotic agents|mesh-ancestor
2423248|NCT00821249|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423249|NCT00821249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423250|NCT00821262|Propofol|propofol|mesh-list
2423251|NCT00821262|Sevoflurane|sevoflurane|mesh-list
2423252|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2423253|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684470|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2684471|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684472|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2684473|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2684474|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
2684475|NCT02221752|Folic Acid|folic acid|mesh-list
2684476|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
2684477|NCT02221752|Hematinics|hematinics|mesh-ancestor
2684478|NCT02221752|Vitamins|vitamins|mesh-ancestor
2684479|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
2684480|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684481|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
2684482|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2684483|NCT02221765|Hormones|hormones|mesh-ancestor
2684484|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2684485|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684486|NCT02221830|Oxytocin|oxytocin|mesh-list
2684487|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
2684488|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2684489|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684490|NCT02221960|Durvalumab|durvalumab|mesh-list
2684491|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2684492|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684493|NCT02221999|Paclitaxel|paclitaxel|mesh-list
2684494|NCT02221999|Letrozole|letrozole|mesh-list
2684495|NCT02221999|Hormones|hormones|mesh-list
2684496|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2684497|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684498|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
2684499|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
2684500|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
2684501|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684502|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2684503|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684504|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2684505|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2684506|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684507|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2684508|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
2684509|NCT02222142|Anesthetics|anesthetics|mesh-list
2684510|NCT02222142|Isoflurane|isoflurane|mesh-list
2684511|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684512|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684513|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2684514|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
2684515|NCT02222168|BI 409306|bi 409306|mesh-list
2684516|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2684517|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684518|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684519|NCT02222220|Metoclopramide|metoclopramide|mesh-list
2684520|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
2684521|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
2684522|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684523|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684524|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2684525|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2684526|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2684527|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
2684528|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684529|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684530|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
2684531|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2684532|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2684533|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2684534|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2684535|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684536|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684537|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684538|NCT02222350|Firuglipel|firuglipel|mesh-list
2684539|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2684540|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684541|NCT02222376|Pirfenidone|pirfenidone|mesh-list
2684542|NCT02222376|Analgesics|analgesics|mesh-ancestor
2684543|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
2684544|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684545|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684546|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2684547|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2684548|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2684549|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2684550|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684551|NCT02222428|Olodaterol|olodaterol|mesh-list
2684552|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2684553|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
2684554|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684555|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684556|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2684557|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
2684558|NCT02222441|Pioglitazone|pioglitazone|mesh-list
2684559|NCT02222441|Palbociclib|palbociclib|mesh-list
2684560|NCT02222441|Modafinil|modafinil|mesh-list
2684561|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2684562|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684563|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684564|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2684565|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684566|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684567|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2684568|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2684569|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2684570|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2684571|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2684572|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2189283|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189284|NCT00003327|Paclitaxel|paclitaxel|mesh-list
2189285|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189286|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189287|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189288|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189289|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
2684573|NCT02222480|Diuretics|diuretics|mesh-ancestor
2684574|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
2684575|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684576|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2684577|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2684578|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684579|NCT02222519|Bromides|bromides|mesh-list
2684580|NCT02222519|Rocuronium|rocuronium|mesh-list
2684581|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
2684582|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2684583|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2684584|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2684585|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684586|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684587|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
2684588|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2684589|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684590|NCT02222636|Fentanyl|fentanyl|mesh-list
2684591|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
2684592|NCT02222636|Anesthetics|anesthetics|mesh-list
2684593|NCT02222636|Sevoflurane|sevoflurane|mesh-list
2684594|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2189290|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189291|NCT00003328|Porfiromycin|porfiromycin|mesh-list
2189292|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2189293|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189294|NCT00003330|Interleukin-12|interleukin-12|mesh-list
2189295|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2189296|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
2189297|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189298|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2189299|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2189300|NCT00003330|Growth Substances|growth substances|mesh-ancestor
2189301|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
2189302|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189303|NCT00003331|Leucovorin|leucovorin|mesh-list
2189304|NCT00003331|Fluorouracil|fluorouracil|mesh-list
2189305|NCT00003331|Topotecan|topotecan|mesh-list
2189306|NCT00003331|Calcium|calcium|mesh-list
2189307|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
2189308|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2684595|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684596|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2684597|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2684598|NCT02222636|Analgesics|analgesics|mesh-ancestor
2684599|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
2684600|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684601|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2684602|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2684603|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2684604|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
2684605|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2189309|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189310|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
2189311|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684606|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684607|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2684608|NCT02222636|Narcotics|narcotics|mesh-ancestor
2684609|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2684610|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2684611|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
2684612|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2684613|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2684614|NCT02222649|Vitamin D|vitamin d|mesh-list
2684615|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
2684616|NCT02222649|Vitamins|vitamins|mesh-ancestor
2684617|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
2684618|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684619|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2684620|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2684621|NCT02222727|Donepezil|donepezil|mesh-list
2684622|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2684623|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684624|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684625|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
2684626|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684627|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684628|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
2684629|NCT02222740|Hydrocodone|hydrocodone|mesh-list
2189312|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2189313|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189314|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189315|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
2189316|NCT00003331|Antidotes|antidotes|mesh-ancestor
2189317|NCT00003331|Protective Agents|protective agents|mesh-ancestor
2189318|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
2189319|NCT00003331|Vitamins|vitamins|mesh-ancestor
2189320|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
2189321|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2189322|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2684630|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2684631|NCT02222740|Narcotics|narcotics|mesh-ancestor
2684632|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684633|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684634|NCT02222740|Analgesics|analgesics|mesh-ancestor
2684635|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
2684636|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684637|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
2684638|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
2684639|NCT02222987|Clopidogrel|clopidogrel|mesh-list
2684640|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2684641|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2684642|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2684643|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2684644|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
2684645|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684646|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684647|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684648|NCT02223026|Metformin|metformin|mesh-list
2684649|NCT02223026|Linagliptin|linagliptin|mesh-list
2684650|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2684651|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684652|NCT02223026|Incretins|incretins|mesh-ancestor
2189323|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189324|NCT00003332|Gemcitabine|gemcitabine|mesh-list
2684653|NCT02223026|Hormones|hormones|mesh-ancestor
2684654|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2684655|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2684656|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
2684657|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684658|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684659|NCT02223052|Azacitidine|azacitidine|mesh-list
2684660|NCT02223052|Cc-486|cc-486|mesh-list
2684661|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2684662|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
2684663|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684664|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684665|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189325|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189326|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2189327|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
2189328|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189329|NCT00003332|Antiviral Agents|antiviral agents|mesh-ancestor
2189330|NCT00003332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2189331|NCT00003332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189332|NCT00003332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189333|NCT00003332|Immunologic Factors|immunologic factors|mesh-ancestor
2189334|NCT00003332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189335|NCT00003334|Paclitaxel|paclitaxel|mesh-list
2189336|NCT00003334|Doxorubicin|doxorubicin|mesh-list
2189337|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2189338|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189339|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189340|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189341|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189342|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189343|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189344|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2189345|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189346|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189347|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189348|NCT00003335|Cyclosporine|cyclosporine|mesh-list
2189349|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
2189350|NCT00003335|Melphalan|melphalan|mesh-list
2189351|NCT00003335|Busulfan|busulfan|mesh-list
2189352|NCT00003335|Cyclosporins|cyclosporins|mesh-list
2189353|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2189354|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189355|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189356|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189357|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
2189358|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189359|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
2189360|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2189361|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
2189362|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189363|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2189364|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189365|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
2189366|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189367|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189368|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2189369|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
2189370|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
2189371|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2189372|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2189373|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
2189374|NCT00003335|Hormones|hormones|mesh-ancestor
2189375|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2189376|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2684696|NCT02223299|Tryptophan|tryptophan|mesh-list
2684697|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2684698|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
2684699|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2684700|NCT02223377|Morphine|morphine|mesh-list
2684701|NCT02223377|Hydromorphone|hydromorphone|mesh-list
2684702|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2684703|NCT02223377|Narcotics|narcotics|mesh-ancestor
2684704|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684705|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684706|NCT02223377|Analgesics|analgesics|mesh-ancestor
2684707|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
2684708|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684709|NCT02223416|Teriparatide|teriparatide|mesh-list
2684710|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2684711|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684712|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2684713|NCT02223533|Morphine|morphine|mesh-list
2684714|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2684715|NCT02223533|Narcotics|narcotics|mesh-ancestor
2684716|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684717|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189377|NCT00003335|Protective Agents|protective agents|mesh-ancestor
2189378|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
2189379|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
2189380|NCT00003336|Melphalan|melphalan|mesh-list
2189381|NCT00003336|Busulfan|busulfan|mesh-list
2684718|NCT02223533|Analgesics|analgesics|mesh-ancestor
2684719|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
2684720|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684721|NCT02223598|Dexamethasone|dexamethasone|mesh-list
2684722|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2684723|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
2684724|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
2684725|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684726|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684727|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2684728|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
2684729|NCT02223598|Hormones|hormones|mesh-ancestor
2684730|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2684731|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2684732|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684733|NCT02223611|Cisplatin|cisplatin|mesh-list
2684734|NCT02223611|Vinorelbine|vinorelbine|mesh-list
2684735|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684736|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2684737|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
2684738|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
2684739|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
2684740|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684741|NCT02223819|Crizotinib|crizotinib|mesh-list
2684742|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684743|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2684744|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684745|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684746|NCT02223832|Ponesimod|ponesimod|mesh-list
2189382|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2684747|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2684748|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684749|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2684750|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
2684751|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684752|NCT02223884|Carboplatin|carboplatin|mesh-list
2684753|NCT02223884|Docetaxel|docetaxel|mesh-list
2684754|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684755|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
2684756|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
2684757|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
2684758|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684759|NCT02223949|Alprostadil|alprostadil|mesh-list
2684760|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2684761|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
2684762|NCT02223949|Urological Agents|urological agents|mesh-ancestor
2684763|NCT02224014|Brotizolam|brotizolam|mesh-list
2684764|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2684765|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684766|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684767|NCT02224040|Azithromycin|azithromycin|mesh-list
2684768|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
2684769|NCT02224040|Cefixime|cefixime|mesh-list
2684770|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2684771|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2684772|NCT02224066|Aspirin|aspirin|mesh-list
2684773|NCT02224066|Clopidogrel|clopidogrel|mesh-list
2684774|NCT02224066|Ticagrelor|ticagrelor|mesh-list
2684775|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2684776|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2684777|NCT02224066|Analgesics|analgesics|mesh-ancestor
2684778|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
2684779|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684780|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684781|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2684782|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2684783|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2189383|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189384|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
2189385|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189386|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189387|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2684784|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2684785|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684786|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2684787|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2684788|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684789|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
2684790|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2684791|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2684792|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2684793|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
2684794|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684795|NCT02224105|Prednisolone|prednisolone|mesh-list
2684796|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2684797|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
2684798|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2684799|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
2684800|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2684801|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
2684802|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2684803|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
2684804|NCT02224105|Hormones|hormones|mesh-ancestor
2684805|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2684806|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684807|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2684808|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684809|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
2684810|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
2684811|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684812|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2684813|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2684814|NCT02224105|Protective Agents|protective agents|mesh-ancestor
2684815|NCT02224131|Aspirin|aspirin|mesh-list
2684816|NCT02224131|Clopidogrel|clopidogrel|mesh-list
2684817|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2684818|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2684819|NCT02224131|Analgesics|analgesics|mesh-ancestor
2684820|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
2684821|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684822|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684823|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2684824|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2684825|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2684826|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2684827|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684828|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2684829|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2684830|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684831|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
2684832|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2684833|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2684834|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2684835|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
2684836|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684837|NCT02224144|Vitamin D|vitamin d|mesh-list
2684838|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
2684839|NCT02224144|Calcitriol|calcitriol|mesh-list
2684840|NCT02224144|Vitamins|vitamins|mesh-ancestor
2684841|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
2684842|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684843|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2684844|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2684845|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2684846|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2684847|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684848|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2684849|NCT02224170|Dexamethasone|dexamethasone|mesh-list
2684850|NCT02224170|Lidocaine|lidocaine|mesh-list
2684851|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2684852|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
2684853|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
2684854|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684855|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684856|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2684857|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
2684858|NCT02224170|Hormones|hormones|mesh-ancestor
2684859|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2684860|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2684861|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684862|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
2684863|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
2684864|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684865|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
2684866|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2684867|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2684868|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2684869|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2684870|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684871|NCT02224235|Aspirin|aspirin|mesh-list
2684872|NCT02224235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2684873|NCT02224235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2684874|NCT02224235|Analgesics|analgesics|mesh-ancestor
2684875|NCT02224235|Sensory System Agents|sensory system agents|mesh-ancestor
2684876|NCT02224235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684877|NCT02224235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684878|NCT02224235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2684879|NCT02224235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189388|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
2189389|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189390|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189391|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189392|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2189393|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
2189394|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
2189395|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2189396|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2189397|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
2189398|NCT00003336|Hormones|hormones|mesh-ancestor
2684880|NCT02224235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2684881|NCT02224235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2684882|NCT02224235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684883|NCT02224235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2684884|NCT02224235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2684885|NCT02224235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684886|NCT02224235|Antipyretics|antipyretics|mesh-ancestor
2684887|NCT02224391|Nicotine|nicotine|mesh-list
2684888|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2684889|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
2684890|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684891|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684892|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2684893|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2684894|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
2684895|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684896|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684897|NCT02224443|Fentanyl|fentanyl|mesh-list
2684898|NCT02224443|Midazolam|midazolam|mesh-list
2684899|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
2684900|NCT02224443|Remifentanil|remifentanil|mesh-list
2684901|NCT02224443|Propofol|propofol|mesh-list
2684902|NCT02224443|Etomidate|etomidate|mesh-list
2684903|NCT02224443|Sevoflurane|sevoflurane|mesh-list
2684904|NCT02224443|Atracurium|atracurium|mesh-list
2684905|NCT02224443|Cisatracurium|cisatracurium|mesh-list
2684906|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2684907|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2684908|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684909|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2684910|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
2684911|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
2684912|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2684913|NCT02224443|Analgesics|analgesics|mesh-ancestor
2684914|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
2684915|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2684916|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2684917|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2684918|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2684919|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
2684920|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684921|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684922|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2684923|NCT02224443|Narcotics|narcotics|mesh-ancestor
2684924|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2684925|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2684926|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2684927|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2684928|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
2189399|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2189400|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2189401|NCT00003336|Protective Agents|protective agents|mesh-ancestor
2189402|NCT00003337|Epratuzumab|epratuzumab|mesh-list
2684929|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
2684930|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2684931|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2684932|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2684933|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2684934|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2684935|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2684936|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2684937|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
2684938|NCT02224456|Tenofovir|tenofovir|mesh-list
2684939|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
2684940|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2684941|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2684942|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2684943|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684944|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684945|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2684946|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2684947|NCT02224534|Clopidogrel|clopidogrel|mesh-list
2684948|NCT02224534|Ticagrelor|ticagrelor|mesh-list
2684949|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2684950|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2684951|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2684952|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2684953|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
2684954|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2684955|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684956|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684957|NCT02224573|Cannabidiol|cannabidiol|mesh-list
2684958|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
2684959|NCT02224768|Ipilimumab|ipilimumab|mesh-list
2684960|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2684961|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684962|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2684963|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189403|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2189404|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189405|NCT00003338|Epratuzumab|epratuzumab|mesh-list
2189406|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2189407|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189408|NCT00003339|Interleukin-12|interleukin-12|mesh-list
2189409|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
2189410|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2189411|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
2189412|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189413|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2189414|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2684980|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
2189415|NCT00003339|Growth Substances|growth substances|mesh-ancestor
2189416|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
2189417|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189418|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
2189419|NCT00003340|Topotecan|topotecan|mesh-list
2189420|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189421|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
2189422|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189423|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189424|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189425|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
2189426|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684981|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
2684982|NCT02224872|Fludarabine|fludarabine|mesh-list
2684983|NCT02224872|Tacrolimus|tacrolimus|mesh-list
2684984|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
2684985|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2423254|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423255|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2423256|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
2423257|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
2423258|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2423259|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2423260|NCT00821301|Fluphenazine|fluphenazine|mesh-list
2423261|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
2423262|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
2423263|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2423264|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2423265|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423266|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423267|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2423268|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2423269|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
2189427|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189428|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2684986|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
2684987|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2684988|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2684989|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2684990|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
2189429|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2189430|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189431|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189432|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
2684991|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2684992|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2684993|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2684994|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2684995|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2684996|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2684997|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2684998|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
2684999|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2685000|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2685001|NCT02224937|Melatonin|melatonin|mesh-list
2189433|NCT00003341|Hematinics|hematinics|mesh-ancestor
2189434|NCT00003342|Gemcitabine|gemcitabine|mesh-list
2189435|NCT00003342|Paclitaxel|paclitaxel|mesh-list
2189436|NCT00003342|Carboplatin|carboplatin|mesh-list
2189437|NCT00003342|Doxorubicin|doxorubicin|mesh-list
2189438|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2685002|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
2685003|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685004|NCT02224937|Protective Agents|protective agents|mesh-ancestor
2685005|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685006|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2685007|NCT02224950|Emollients|emollients|mesh-list
2685008|NCT02224950|Chitosan|chitosan|mesh-list
2685009|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2685010|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2685011|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
2685012|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685013|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2685014|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
2685015|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
2685016|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
2685017|NCT02224950|Coagulants|coagulants|mesh-ancestor
2685018|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
2685019|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
2685020|NCT02225054|Ropivacaine|ropivacaine|mesh-list
2685021|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2685022|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2685023|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685024|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2685025|NCT02225054|Analgesics|analgesics|mesh-ancestor
2685026|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
2685027|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685028|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2685029|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2685030|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2685031|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
2685032|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685033|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685034|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
2685035|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
2685036|NCT02225067|Calcium|calcium|mesh-list
2685037|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2685038|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685039|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
2685040|NCT02225093|Caffeine|caffeine|mesh-list
2685041|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2685042|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685043|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2685044|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685045|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685046|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2685047|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2685048|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
2685049|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685050|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
2685051|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
2189439|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189440|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685052|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2685053|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2685054|NCT02225210|Fentanyl|fentanyl|mesh-list
2685055|NCT02225210|Midazolam|midazolam|mesh-list
2685056|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
2189441|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189442|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189443|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189444|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189445|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2685057|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2685058|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2685059|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685060|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2685061|NCT02225210|Analgesics|analgesics|mesh-ancestor
2685062|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
2685063|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685064|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2685065|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2685066|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2685067|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
2685068|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685069|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685070|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2685071|NCT02225210|Narcotics|narcotics|mesh-ancestor
2685072|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2685073|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2685074|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
2685075|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
2685076|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2685077|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2685078|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2685079|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
2189446|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
2189447|NCT00003342|Antiviral Agents|antiviral agents|mesh-ancestor
2189448|NCT00003342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2189449|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189450|NCT00003342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189451|NCT00003342|Immunologic Factors|immunologic factors|mesh-ancestor
2189452|NCT00003342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189453|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2189454|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189455|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189456|NCT00003343|Prednisone|prednisone|mesh-list
2189457|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
2189458|NCT00003343|Prinomastat|prinomastat|mesh-list
2189459|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2189460|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
2189461|NCT00003343|Hormones|hormones|mesh-ancestor
2189462|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2685080|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
2685081|NCT02225275|Lenalidomide|lenalidomide|mesh-list
2685082|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
2685083|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
2685084|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685085|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2685086|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2685087|NCT02225275|Growth Substances|growth substances|mesh-ancestor
2685088|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
2685089|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685090|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2685091|NCT02225405|Cisplatin|cisplatin|mesh-list
2685092|NCT02225405|Docetaxel|docetaxel|mesh-list
2685093|NCT02225405|Nintedanib|nintedanib|mesh-list
2685094|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685095|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
2685096|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
2685097|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
2685098|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685099|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2685100|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685101|NCT02225418|Ropivacaine|ropivacaine|mesh-list
2685102|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
2685103|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
2685104|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2685105|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685106|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
2685107|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685108|NCT02225470|Vinorelbine|vinorelbine|mesh-list
2685109|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2685110|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685111|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
2685112|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
2685113|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
2685114|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685115|NCT02225548|Tadalafil|tadalafil|mesh-list
2685116|NCT02225548|Selegiline|selegiline|mesh-list
2685117|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
2685118|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2685119|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2685120|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685121|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685122|NCT02225548|Urological Agents|urological agents|mesh-ancestor
2685123|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
2685124|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2685125|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2685126|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2685127|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2685128|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2685129|NCT02225548|Protective Agents|protective agents|mesh-ancestor
2685130|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685135|NCT02225652|Paclitaxel|paclitaxel|mesh-list
2685136|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
2685137|NCT02225652|Fluorouracil|fluorouracil|mesh-list
2685138|NCT02225652|Epirubicin|epirubicin|mesh-list
2685139|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2685140|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685141|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
2685142|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
2685143|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
2685144|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685145|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2685146|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
2685147|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685148|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2685149|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2685150|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
2685151|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2685152|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
2685153|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2685154|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2685155|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2685156|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2685157|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685158|NCT02225756|Cyclosporine|cyclosporine|mesh-list
2685159|NCT02225756|Cyclosporins|cyclosporins|mesh-list
2685160|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685161|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685162|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2685163|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
2685164|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685165|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
2685166|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2685167|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
2685168|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2685169|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2685170|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2685171|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2685172|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2685173|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685174|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
2685175|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2685176|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
2685177|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2685178|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
2685179|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685180|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2685181|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2685182|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
2685183|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685184|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685185|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2685186|NCT02225834|Atorvastatin|atorvastatin|mesh-list
2685187|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2685188|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2685189|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
2685190|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685191|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2685192|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2685193|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685194|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
2685195|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
2685196|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685197|NCT02225886|Protective Agents|protective agents|mesh-ancestor
2685198|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685199|NCT02225886|Vitamins|vitamins|mesh-ancestor
2685200|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
2685201|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2685202|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2685203|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685204|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2685205|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
2189463|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189464|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2189465|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189466|NCT00003343|Analgesics|analgesics|mesh-ancestor
2189467|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
2189468|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2189469|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189470|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189471|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189472|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189473|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
2189474|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
2685206|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685207|NCT02226068|Cyclosporine|cyclosporine|mesh-list
2685208|NCT02226068|Cyclosporins|cyclosporins|mesh-list
2685209|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685210|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685211|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2685212|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
2685213|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685214|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
2685215|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2685216|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
2685217|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2685218|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2685219|NCT02226276|Copper|copper|mesh-list
2685220|NCT02226276|Trastuzumab|trastuzumab|mesh-list
2685221|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2685222|NCT02226276|Maytansine|maytansine|mesh-list
2685223|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2685224|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
2685225|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2685226|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685227|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685228|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2685229|NCT02226276|Trace Elements|trace elements|mesh-ancestor
2685230|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
2685231|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685232|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2685233|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
2685234|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
2685235|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
2685236|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
2685237|NCT02226289|Bevacizumab|bevacizumab|mesh-list
2685238|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2685239|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685240|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2685241|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2685242|NCT02226289|Growth Substances|growth substances|mesh-ancestor
2685243|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685244|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
2685245|NCT02226328|Fentanyl|fentanyl|mesh-list
2685246|NCT02226328|Midazolam|midazolam|mesh-list
2685247|NCT02226328|Propofol|propofol|mesh-list
2685248|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2685249|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2685250|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685251|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2685252|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
2685253|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
2685254|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2685255|NCT02226328|Narcotics|narcotics|mesh-ancestor
2685256|NCT02226328|Analgesics|analgesics|mesh-ancestor
2685257|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
2685258|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685259|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2685260|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2685261|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2685262|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2685263|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
2685264|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
2685265|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685266|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685267|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
2685268|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2685269|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2685270|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685271|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2685272|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
2685273|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2685274|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2685275|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685276|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685277|NCT02226341|Hormones|hormones|mesh-ancestor
2685278|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2685279|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685280|NCT02226367|Prazosin|prazosin|mesh-list
2685281|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2685282|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2685283|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2685284|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2685285|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
2685286|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685287|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685288|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685289|NCT02226484|Quercetin|quercetin|mesh-list
2685290|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
2685291|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685292|NCT02226484|Protective Agents|protective agents|mesh-ancestor
2685293|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685294|NCT02226510|Metformin|metformin|mesh-list
2685295|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2189475|NCT00003344|Irinotecan|irinotecan|mesh-list
2189476|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2189477|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189478|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189479|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189480|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189481|NCT00003345|Irinotecan|irinotecan|mesh-list
2189482|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189483|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2189484|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189485|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189486|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189487|NCT00003346|Acetaminophen|acetaminophen|mesh-list
2189488|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
2189489|NCT00003346|Carmustine|carmustine|mesh-list
2189490|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2189491|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2189492|NCT00003346|Analgesics|analgesics|mesh-ancestor
2189493|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
2189494|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2189495|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685296|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685297|NCT02226588|Misoprostol|misoprostol|mesh-list
2685298|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2685299|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
2189496|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
2189497|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
2189498|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2189499|NCT00003346|Expectorants|expectorants|mesh-ancestor
2189500|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
2189501|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2189502|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
2685300|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2685301|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685302|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2685303|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2685304|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
2685305|NCT02226601|Aprepitant|aprepitant|mesh-list
2685306|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
2685307|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
2685308|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685309|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685310|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2685311|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2685312|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685313|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685314|NCT02226757|Paclitaxel|paclitaxel|mesh-list
2685315|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2685316|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685317|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
2685318|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
2685319|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
2685320|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685321|NCT02226783|Omeprazole|omeprazole|mesh-list
2685322|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2685323|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2685324|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2685325|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685326|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685327|NCT02226913|Lidocaine|lidocaine|mesh-list
2685328|NCT02226913|Epinephrine|epinephrine|mesh-list
2685329|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
2685330|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
2685331|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2685332|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685333|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
2685334|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685335|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2685336|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2685337|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2685338|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2685339|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685340|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2685341|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2685342|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
2685343|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685344|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2685345|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2685346|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
2685347|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2685348|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
2685349|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
2685350|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
2685351|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2685352|NCT02226926|Aspirin|aspirin|mesh-list
2685353|NCT02226926|Dipyridamole|dipyridamole|mesh-list
2685354|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2685355|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2685356|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2685357|NCT02226926|Analgesics|analgesics|mesh-ancestor
2685358|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
2189503|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189504|NCT00003346|Protective Agents|protective agents|mesh-ancestor
2189505|NCT00003346|Antidotes|antidotes|mesh-ancestor
2189506|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189507|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
2189508|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189509|NCT00003348|Carmustine|carmustine|mesh-list
2189510|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2189511|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2685359|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685360|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685361|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2685362|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2685363|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2685364|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2685365|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685366|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2685367|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2685368|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685369|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
2685370|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2685371|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
2685372|NCT02226978|Ritonavir|ritonavir|mesh-list
2685373|NCT02226978|Tipranavir|tipranavir|mesh-list
2685374|NCT02226978|Valacyclovir|valacyclovir|mesh-list
2685375|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2685376|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2685377|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
2685378|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685379|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685380|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2685381|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2685382|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
2685383|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2685384|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2685385|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2685386|NCT02226991|Ritonavir|ritonavir|mesh-list
2685387|NCT02226991|Tipranavir|tipranavir|mesh-list
2685388|NCT02226991|Efavirenz|efavirenz|mesh-list
2685389|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2685390|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2685391|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
2685392|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685393|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685394|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2685395|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2685396|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
2685397|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2685398|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2685399|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2685400|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2685401|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2685402|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2685403|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2685404|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2685405|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2685406|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2685407|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2685408|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2685409|NCT02227056|Methylphenidate|methylphenidate|mesh-list
2685410|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2685411|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685412|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2685413|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2685414|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2685415|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685416|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
2685417|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685418|NCT02227082|Olaparib|olaparib|mesh-list
2685419|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2685420|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685421|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685422|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685423|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
2685424|NCT02227173|Digoxin|digoxin|mesh-list
2685425|NCT02227173|Montelukast|montelukast|mesh-list
2685426|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2685427|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
2685428|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2685429|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
2685430|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2685431|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685432|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2685433|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2685434|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685435|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2685436|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2685437|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685438|NCT02227173|Protective Agents|protective agents|mesh-ancestor
2685439|NCT02227173|Analgesics|analgesics|mesh-ancestor
2685440|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
2685441|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685442|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2685443|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2685444|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2685445|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2685446|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2685447|NCT02227186|Vaccines|vaccines|mesh-list
2685448|NCT02227186|Immunologic Factors|immunologic factors|mesh-ancestor
2685449|NCT02227186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685450|NCT02227212|Insulin|insulin|mesh-list
2685451|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
2685452|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2685453|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685454|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
2685455|NCT02227264|Cinacalcet|cinacalcet|mesh-list
2685456|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2685457|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685458|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2685459|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
2685460|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2685461|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2685462|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
2685463|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
2685464|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2685465|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685469|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2685470|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2685471|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2685472|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2189512|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
2189513|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189514|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189515|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189516|NCT00003350|Paclitaxel|paclitaxel|mesh-list
2189517|NCT00003350|Doxorubicin|doxorubicin|mesh-list
2189518|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2189519|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189520|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189521|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189522|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189523|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
2685473|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685474|NCT02227550|Vitamin K|vitamin k|mesh-list
2685475|NCT02227550|Warfarin|warfarin|mesh-list
2685476|NCT02227550|Apixaban|apixaban|mesh-list
2189524|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189525|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2189526|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189527|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189528|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189529|NCT00003351|Irinotecan|irinotecan|mesh-list
2189530|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2189531|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189532|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189533|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685477|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
2685478|NCT02227550|Fluindione|fluindione|mesh-list
2685479|NCT02227550|Vitamins|vitamins|mesh-ancestor
2685480|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
2685481|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685482|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
2685483|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2685484|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
2685485|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2189534|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189535|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
2189536|NCT00003352|Docetaxel|docetaxel|mesh-list
2189537|NCT00003352|Doxorubicin|doxorubicin|mesh-list
2189538|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2685486|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
2685487|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685488|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685489|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2685490|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2685491|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
2685492|NCT02227550|Coagulants|coagulants|mesh-ancestor
2685493|NCT02227745|Dorzolamide|dorzolamide|mesh-list
2685494|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
2685495|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2685496|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
2685497|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685498|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
2685499|NCT02227745|Protective Agents|protective agents|mesh-ancestor
2685500|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2685501|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2685502|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685503|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685504|NCT02227797|Voriconazole|voriconazole|mesh-list
2685505|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
2685506|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2685507|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2685508|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2685509|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685510|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685511|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2685512|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
2685513|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2685514|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685515|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2685516|NCT02227823|Bromides|bromides|mesh-list
2685517|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2685518|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
2685519|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2685520|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685521|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685522|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
2685523|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685524|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685525|NCT02227901|Temozolomide|temozolomide|mesh-list
2685526|NCT02227901|Tipifarnib|tipifarnib|mesh-list
2685527|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2685528|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
2685529|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685530|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685531|NCT02227914|Sorafenib|sorafenib|mesh-list
2685532|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685533|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2685534|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685535|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189539|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189540|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
2189541|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189542|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189543|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189544|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
2685536|NCT02227927|Domperidone|domperidone|mesh-list
2685537|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
2685538|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
2685539|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685540|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423270|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423271|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423272|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2423273|NCT00821392|Febuxostat|febuxostat|mesh-list
2423274|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
2423275|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2423276|NCT00821444|Ziprasidone|ziprasidone|mesh-list
2423277|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2423278|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
2685541|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2685542|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2685543|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
2685544|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685545|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685546|NCT02227940|Gemcitabine|gemcitabine|mesh-list
2685547|NCT02227940|Paclitaxel|paclitaxel|mesh-list
2685548|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2685549|NCT02227940|Cisplatin|cisplatin|mesh-list
2685550|NCT02227940|Ceritinib|ceritinib|mesh-list
2685551|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2685552|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685553|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
2685554|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
2685555|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189545|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189546|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189547|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189548|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189549|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189550|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
2685556|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685557|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2685558|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
2685559|NCT02227940|Antiviral Agents|antiviral agents|mesh-ancestor
2685560|NCT02227940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2685561|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685562|NCT02227940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2685563|NCT02227940|Immunologic Factors|immunologic factors|mesh-ancestor
2685564|NCT02227940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685565|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2685566|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2685567|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
2685568|NCT02227992|Coagulants|coagulants|mesh-ancestor
2685569|NCT02228005|Sertraline|sertraline|mesh-list
2685570|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
2685571|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2685572|NCT02228005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2685573|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2685574|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2685575|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685576|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685577|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
2685578|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685579|NCT02228031|Oxytocin|oxytocin|mesh-list
2685580|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
2685581|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2685582|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685583|NCT02228083|Lidocaine|lidocaine|mesh-list
2685584|NCT02228083|Epinephrine|epinephrine|mesh-list
2685585|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
2685586|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
2685587|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2685588|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685589|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
2685590|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685591|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2685592|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2685593|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2685594|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2685595|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685596|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2685597|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2685598|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
2685599|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685600|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2685601|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2685602|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
2685603|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2685604|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
2685605|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
2685606|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
2685607|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2189551|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2685608|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2685609|NCT02228122|Laxatives|laxatives|mesh-ancestor
2685610|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2685611|NCT02228135|Dexamethasone|dexamethasone|mesh-list
2685612|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2685613|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
2685614|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
2685615|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685616|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685617|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2685618|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
2685619|NCT02228135|Hormones|hormones|mesh-ancestor
2685620|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2685621|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2685622|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685623|NCT02228239|Mirtazapine|mirtazapine|mesh-list
2685624|NCT02228239|Esketamine|esketamine|mesh-list
2685625|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
2685626|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2685627|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2685628|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
2685629|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
2685630|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685631|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685632|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685633|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2189552|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189553|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189554|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189555|NCT00003353|Melphalan|melphalan|mesh-list
2189556|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
2189557|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189558|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189559|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
2189560|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189561|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189562|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189563|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2685634|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2685635|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2685636|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2685637|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2685638|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2685639|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
2685640|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2685641|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2685642|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
2685643|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2685644|NCT02228252|Caseins|caseins|mesh-list
2685645|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
2685646|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
2685647|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685648|NCT02228369|Osimertinib|osimertinib|mesh-list
2685649|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685650|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2685651|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685652|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685653|NCT02228473|Atropine|atropine|mesh-list
2685654|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
2685655|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2685656|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2685657|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2685658|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
2685659|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685660|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685661|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2685662|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
2685663|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
2685664|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
2685665|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2685666|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2685667|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
2685668|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685669|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685670|NCT02228512|Prednisone|prednisone|mesh-list
2685671|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
2685672|NCT02228512|Rituximab|rituximab|mesh-list
2685673|NCT02228512|Doxorubicin|doxorubicin|mesh-list
2685674|NCT02228512|Etoposide|etoposide|mesh-list
2685675|NCT02228512|Vincristine|vincristine|mesh-list
2685676|NCT02228512|Pomalidomide|pomalidomide|mesh-list
2685677|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2685678|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
2685679|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685680|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2685681|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2685682|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
2685683|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685684|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685685|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2685686|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2685687|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2685688|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2685689|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2685690|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685691|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2685692|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
2685693|NCT02228512|Hormones|hormones|mesh-ancestor
2685694|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2685695|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2685696|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2685697|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
2685698|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
2685699|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
2685700|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2685701|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2685702|NCT02228512|Growth Substances|growth substances|mesh-ancestor
2685703|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
2685704|NCT02228616|Lactulose|lactulose|mesh-list
2685705|NCT02228616|Prucalopride|prucalopride|mesh-list
2685706|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2685707|NCT02228616|Laxatives|laxatives|mesh-ancestor
2685708|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2685709|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2685710|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
2685711|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685712|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685713|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685714|NCT02228772|Cytarabine|cytarabine|mesh-list
2685715|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
2685716|NCT02228772|Doxorubicin|doxorubicin|mesh-list
2685717|NCT02228772|Methotrexate|methotrexate|mesh-list
2685718|NCT02228772|Vincristine|vincristine|mesh-list
2685719|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
2685720|NCT02228772|Ixazomib|ixazomib|mesh-list
2685721|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2685722|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
2685723|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685724|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2685725|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2685726|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
2685727|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685728|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685729|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2685730|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2685731|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2685732|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2685733|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685734|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2685735|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
2685736|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2685737|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2685738|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
2685739|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
2685740|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2685741|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2685742|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
2685743|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2685744|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2685745|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
2685746|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
2685747|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
2685748|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
2685749|NCT02228850|Alprostadil|alprostadil|mesh-list
2685750|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2685751|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
2685752|NCT02228850|Urological Agents|urological agents|mesh-ancestor
2685753|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2685754|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2685755|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2685756|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685757|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685758|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2685759|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2685760|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685761|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
2685762|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685763|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
2685764|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
2685765|NCT02228902|Trace Elements|trace elements|mesh-ancestor
2685766|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
2685767|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685768|NCT02228902|Hematinics|hematinics|mesh-ancestor
2685769|NCT02228928|Capsaicin|capsaicin|mesh-list
2685770|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
2685771|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
2685772|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
2685773|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685774|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685775|NCT02229045|Paclitaxel|paclitaxel|mesh-list
2685776|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2685777|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2685778|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685779|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
2685780|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
2685781|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
2685782|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685783|NCT02229058|Paclitaxel|paclitaxel|mesh-list
2685784|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2685785|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2685786|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685787|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
2685788|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
2685789|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
2685790|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685791|NCT02229084|Paclitaxel|paclitaxel|mesh-list
2685792|NCT02229084|Docetaxel|docetaxel|mesh-list
2685793|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
2685794|NCT02229084|Doxorubicin|doxorubicin|mesh-list
2685795|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
2685796|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2685797|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685798|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
2685799|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
2685800|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
2685801|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685802|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2685803|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
2685804|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685805|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2685806|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2685807|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
2685808|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2685809|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2685810|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2685811|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2685812|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685813|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2685814|NCT02229123|Levetiracetam|levetiracetam|mesh-list
2685815|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
2685816|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
2685841|NCT02229175|Bevacizumab|bevacizumab|mesh-list
2685842|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2685843|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685844|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2685845|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2685846|NCT02229175|Growth Substances|growth substances|mesh-ancestor
2685847|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685848|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
2685849|NCT02229201|Propofol|propofol|mesh-list
2685850|NCT02229201|Sevoflurane|sevoflurane|mesh-list
2685851|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2685852|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2685853|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685854|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2685855|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
2685856|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
2685857|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2685858|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2685859|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
2685860|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2685861|NCT02229240|Incretins|incretins|mesh-ancestor
2685862|NCT02229240|Hormones|hormones|mesh-ancestor
2685863|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2685864|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685865|NCT02229266|Cytarabine|cytarabine|mesh-list
2685866|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2685867|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
2685868|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685869|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685870|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
2685871|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2685872|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2685873|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
2685874|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685875|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
2685876|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2685877|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2685878|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685879|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
2685880|NCT02229292|Coagulants|coagulants|mesh-ancestor
2685881|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
2685882|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2685883|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685884|NCT02229578|Lidocaine|lidocaine|mesh-list
2685885|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
2685886|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
2685887|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2685888|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685889|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
2685890|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685891|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2685892|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2685893|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2685894|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2685895|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685896|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
2685897|NCT02229617|Testosterone|testosterone|mesh-list
2685898|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
2685899|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
2685900|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2685901|NCT02229617|Androgens|androgens|mesh-ancestor
2685902|NCT02229617|Hormones|hormones|mesh-ancestor
2685903|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2685904|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685905|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2685906|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685907|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
2685908|NCT02229656|Olaparib|olaparib|mesh-list
2685909|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2685910|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685911|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685912|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685913|NCT02229721|Oxytocin|oxytocin|mesh-list
2685914|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
2685915|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2685916|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685917|NCT02229734|Androgens|androgens|mesh-list
2685918|NCT02229734|Hormones|hormones|mesh-ancestor
2685919|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2685920|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685921|NCT02229747|Diclofenac|diclofenac|mesh-list
2685922|NCT02229747|Meloxicam|meloxicam|mesh-list
2685923|NCT02229747|Nimesulide|nimesulide|mesh-list
2685924|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2685925|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2685926|NCT02229747|Analgesics|analgesics|mesh-ancestor
2685927|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
2685928|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685929|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685930|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2685931|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2685932|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2685933|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685934|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685935|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2685936|NCT02229760|Ritonavir|ritonavir|mesh-list
2685937|NCT02229760|Tipranavir|tipranavir|mesh-list
2685938|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2685939|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2685940|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
2685941|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685942|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685943|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2685944|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2685945|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
2685946|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2685947|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2685948|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2685949|NCT02229773|Pravastatin|pravastatin|mesh-list
2685950|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2685951|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2685952|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
2685953|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685954|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2685955|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2685956|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2685957|NCT02229786|Acetaminophen|acetaminophen|mesh-list
2685958|NCT02229786|Scopolamine|scopolamine|mesh-list
2685959|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2685960|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2685961|NCT02229786|Analgesics|analgesics|mesh-ancestor
2685962|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
2685963|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685964|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685965|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
2685966|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
2685967|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
2685968|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2685969|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2685970|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
2685971|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685972|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685973|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2685974|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
2685975|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2685976|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
2685977|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2685978|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2685979|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2685980|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685981|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2685982|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2685983|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2685984|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685985|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2685986|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2685987|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2685988|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2685989|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2685990|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2685991|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2685992|NCT02229825|Analgesics|analgesics|mesh-ancestor
2189564|NCT00003356|Aldesleukin|aldesleukin|mesh-list
2189565|NCT00003356|Rituximab|rituximab|mesh-list
2189566|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2189567|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189568|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
2189569|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189570|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189571|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2189572|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2189573|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
2189574|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2189575|NCT00003358|Gemcitabine|gemcitabine|mesh-list
2189576|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189577|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2189578|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
2189579|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189580|NCT00003358|Antiviral Agents|antiviral agents|mesh-ancestor
2189581|NCT00003358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2189582|NCT00003358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189583|NCT00003358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189584|NCT00003358|Immunologic Factors|immunologic factors|mesh-ancestor
2189585|NCT00003358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189586|NCT00003360|Antibodies|antibodies|mesh-list
2189587|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2189588|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
2189589|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189590|NCT00003361|Decitabine|decitabine|mesh-list
2189591|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2189592|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
2189593|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189594|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2685993|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
2685994|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2685995|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
2685996|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2685997|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
2685998|NCT02229877|Omeprazole|omeprazole|mesh-list
2685999|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2686000|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2686001|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2686002|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686003|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686004|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2686005|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2686006|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2686007|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686008|NCT02229942|Rituximab|rituximab|mesh-list
2686009|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2189595|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189596|NCT00003362|Sargramostim|sargramostim|mesh-list
2189597|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
2189598|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
2189599|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189600|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2189601|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
2189602|NCT00003364|Doxorubicin|doxorubicin|mesh-list
2189603|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2189604|NCT00003364|Etoposide|etoposide|mesh-list
2686010|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686011|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
2686012|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686013|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2686014|NCT02229955|Cyclosporine|cyclosporine|mesh-list
2686015|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2686016|NCT02229955|Cyclosporins|cyclosporins|mesh-list
2686017|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686018|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189605|NCT00003364|Vincristine|vincristine|mesh-list
2189606|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189607|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
2686019|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2686020|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
2686021|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686022|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
2686023|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2686024|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
2686025|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2686026|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2686027|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2686028|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
2686029|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2686030|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2686031|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686032|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
2686033|NCT02229968|Coagulants|coagulants|mesh-ancestor
2686034|NCT02230033|Itraconazole|itraconazole|mesh-list
2686035|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
2686036|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
2686037|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2686038|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2686039|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2686040|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686041|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686042|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2686043|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
2686044|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2686045|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686046|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2686047|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2686048|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
2686049|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2686050|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2686051|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
2686052|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686053|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2686054|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686055|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686056|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
2686057|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2686058|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686059|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2686060|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
2686061|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2686062|NCT02230163|Antibodies|antibodies|mesh-list
2686063|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
2686064|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686065|NCT02230176|Sunitinib|sunitinib|mesh-list
2686066|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2686067|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686068|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2686069|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2686070|NCT02230176|Growth Substances|growth substances|mesh-ancestor
2686071|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686072|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
2686073|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2686074|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686075|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686076|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2686077|NCT02230228|Vitamin A|vitamin a|mesh-list
2686078|NCT02230228|Retinol acetate|retinol acetate|mesh-list
2686079|NCT02230228|Vitamins|vitamins|mesh-ancestor
2686080|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
2686081|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686082|NCT02230228|Protective Agents|protective agents|mesh-ancestor
2686083|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2686084|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686085|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2686086|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
2686087|NCT02230319|Paclitaxel|paclitaxel|mesh-list
2686088|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2686089|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686090|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
2686091|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
2686092|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
2686093|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686094|NCT02230358|Anesthetics|anesthetics|mesh-list
2686095|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2686096|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686097|NCT02230371|Granisetron|granisetron|mesh-list
2686098|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
2686099|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
2686100|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686101|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686102|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2686103|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2686104|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
2686105|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686106|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686107|NCT02230553|Lapatinib|lapatinib|mesh-list
2686108|NCT02230553|Trametinib|trametinib|mesh-list
2189608|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189609|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189610|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189611|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
2189612|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189613|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686109|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686110|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2686111|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686112|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686113|NCT02230618|Insulin|insulin|mesh-list
2686114|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
2686115|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2686116|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686117|NCT02230735|Epinephrine|epinephrine|mesh-list
2686118|NCT02230735|Racepinephrine|racepinephrine|mesh-list
2686119|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
2686120|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2686121|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2686122|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
2686123|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686124|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686125|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686126|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2686127|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2686128|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
2686129|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2189614|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189615|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2189616|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189617|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189618|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189619|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189620|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189621|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189622|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189623|NCT00003365|Curcumin|curcumin|mesh-list
2189624|NCT00003365|Sulindac|sulindac|mesh-list
2189625|NCT00003365|Quercetin|quercetin|mesh-list
2189626|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2189627|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2686130|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2686131|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
2686132|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
2686133|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
2686134|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2686135|NCT02230800|Tocovid|tocovid|mesh-list
2189628|NCT00003365|Analgesics|analgesics|mesh-ancestor
2686136|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
2686137|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2686138|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686139|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686140|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2686141|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2686142|NCT02230800|Protective Agents|protective agents|mesh-ancestor
2686143|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686144|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
2686145|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2189629|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
2189630|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2189631|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189632|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2189633|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189634|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189635|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189636|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189637|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
2189638|NCT00003365|Protective Agents|protective agents|mesh-ancestor
2189639|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2686146|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
2686147|NCT02230800|Vitamins|vitamins|mesh-ancestor
2686148|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
2686172|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
2686173|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2686174|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2686175|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2686176|NCT02230930|Apomorphine|apomorphine|mesh-list
2686177|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2686178|NCT02230930|Emetics|emetics|mesh-ancestor
2686179|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686180|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
2686181|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686182|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2686183|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
2686184|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
2686185|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686186|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686187|NCT02230969|Interferons|interferons|mesh-list
2686188|NCT02230969|Interferon-beta|interferon-beta|mesh-list
2686189|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
2686190|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686191|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
2686192|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2686193|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
2686194|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686195|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2686196|NCT02230982|Nintedanib|nintedanib|mesh-list
2686197|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189640|NCT00003367|Vitamin E|vitamin e|mesh-list
2686198|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2189641|NCT00003367|Vitamins|vitamins|mesh-ancestor
2189642|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
2189643|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189644|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
2189645|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189646|NCT00003367|Protective Agents|protective agents|mesh-ancestor
2189647|NCT00003368|Irinotecan|irinotecan|mesh-list
2189648|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2686199|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686200|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686201|NCT02231021|Pioglitazone|pioglitazone|mesh-list
2686202|NCT02231021|Alogliptin|alogliptin|mesh-list
2686203|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2686204|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686205|NCT02231021|Incretins|incretins|mesh-ancestor
2686206|NCT02231021|Hormones|hormones|mesh-ancestor
2686207|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2686208|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2686209|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
2686210|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686211|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686212|NCT02231125|Losartan|losartan|mesh-list
2686213|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2686214|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2686215|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2686216|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2686217|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686218|NCT02231203|Tocopherols|tocopherols|mesh-list
2686219|NCT02231203|Antioxidants|antioxidants|mesh-list
2686220|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686221|NCT02231203|Protective Agents|protective agents|mesh-ancestor
2686222|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686223|NCT02231203|Vitamins|vitamins|mesh-ancestor
2686224|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
2686225|NCT02231255|Pramipexole|pramipexole|mesh-list
2686226|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
2686227|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686228|NCT02231255|Protective Agents|protective agents|mesh-ancestor
2686229|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686230|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2686231|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2686232|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
2686233|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
2686234|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686235|NCT02231281|Ritonavir|ritonavir|mesh-list
2686236|NCT02231281|Lopinavir|lopinavir|mesh-list
2686237|NCT02231281|Tenofovir|tenofovir|mesh-list
2686238|NCT02231281|Lamivudine|lamivudine|mesh-list
2686239|NCT02231281|Zidovudine|zidovudine|mesh-list
2686240|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2686241|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2686242|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
2686243|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686244|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686245|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2686246|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2686247|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
2686248|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2686249|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2686250|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2686251|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2686252|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2686253|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
2686254|NCT02231294|Pramipexole|pramipexole|mesh-list
2686255|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
2686256|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686257|NCT02231294|Protective Agents|protective agents|mesh-ancestor
2686258|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686259|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2686260|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2686261|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
2686262|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
2686263|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686264|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2686265|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2686266|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
2189649|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189650|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189651|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189652|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189653|NCT00003369|Tirapazamine|tirapazamine|mesh-list
2189654|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189655|NCT00003370|Irofulven|irofulven|mesh-list
2189656|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2686267|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686268|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686269|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2686270|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
2686271|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
2686272|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2686273|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686274|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686275|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2686276|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2686277|NCT02231333|Protective Agents|protective agents|mesh-ancestor
2686278|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686279|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
2686280|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2686281|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
2686282|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2686283|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2686284|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
2686285|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686286|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686287|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2686288|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
2686289|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2686290|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2686291|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
2686292|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686293|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686294|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2686295|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
2686296|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2686297|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2686298|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
2686299|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686300|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686301|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2686302|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
2686303|NCT02231385|Acetic Acid|acetic acid|mesh-list
2686304|NCT02231385|Retinol acetate|retinol acetate|mesh-list
2686305|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2686306|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2686307|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2686308|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
2686309|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686310|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2686311|NCT02231385|Protective Agents|protective agents|mesh-ancestor
2686312|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686313|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2686314|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2686315|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
2686316|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686317|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686318|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2686319|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
2686320|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2686321|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2686322|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
2686323|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686324|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686325|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2686326|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
2686327|NCT02231606|Methamphetamine|methamphetamine|mesh-list
2686328|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2686329|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189657|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
2686330|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
2686331|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
2686332|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686333|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
2686334|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686335|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686336|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
2686337|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2686338|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2686339|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2686340|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2686341|NCT02231632|Vaccines|vaccines|mesh-list
2686342|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
2686343|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686344|NCT02231658|Liraglutide|liraglutide|mesh-list
2189658|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189659|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189660|NCT00003372|Topotecan|topotecan|mesh-list
2189661|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2686345|NCT02231658|Lixisenatide|lixisenatide|mesh-list
2686346|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2686347|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686348|NCT02231658|Incretins|incretins|mesh-ancestor
2686349|NCT02231658|Hormones|hormones|mesh-ancestor
2686350|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2686351|NCT02231723|Leucovorin|leucovorin|mesh-list
2686352|NCT02231723|Gemcitabine|gemcitabine|mesh-list
2686353|NCT02231723|Paclitaxel|paclitaxel|mesh-list
2686354|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2686355|NCT02231723|Fluorouracil|fluorouracil|mesh-list
2686356|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
2686357|NCT02231723|Irinotecan|irinotecan|mesh-list
2686358|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2686359|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189662|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189663|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189664|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189665|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189666|NCT00003375|Vincristine|vincristine|mesh-list
2189667|NCT00003375|Lomustine|lomustine|mesh-list
2189668|NCT00003375|Procarbazine|procarbazine|mesh-list
2189669|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189670|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189671|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189672|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189673|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189674|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189675|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189676|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
2189677|NCT00003376|Paclitaxel|paclitaxel|mesh-list
2686360|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
2686361|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
2686362|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
2686363|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686364|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2686365|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
2686366|NCT02231723|Antiviral Agents|antiviral agents|mesh-ancestor
2686367|NCT02231723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2686368|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686369|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2686370|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
2686371|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686372|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2686373|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2686374|NCT02231723|Antidotes|antidotes|mesh-ancestor
2686375|NCT02231723|Protective Agents|protective agents|mesh-ancestor
2686376|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
2686377|NCT02231723|Vitamins|vitamins|mesh-ancestor
2686378|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
2686379|NCT02231762|Temozolomide|temozolomide|mesh-list
2686380|NCT02231762|Lanreotide|lanreotide|mesh-list
2686381|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2686382|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
2686383|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686384|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189678|NCT00003376|Vinblastine|vinblastine|mesh-list
2686385|NCT02231775|Trametinib|trametinib|mesh-list
2686386|NCT02231775|Dabrafenib|dabrafenib|mesh-list
2686387|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686388|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2686389|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686390|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686391|NCT02231788|Amlodipine|amlodipine|mesh-list
2686392|NCT02231788|Telmisartan|telmisartan|mesh-list
2686393|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2686394|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2686395|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2686396|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686397|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2686398|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686399|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
2686400|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2686401|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2686402|NCT02231879|Plerixafor|plerixafor|mesh-list
2686403|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2686404|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2686405|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
2686406|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2686407|NCT02231905|Pramipexole|pramipexole|mesh-list
2686408|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
2686409|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686410|NCT02231905|Protective Agents|protective agents|mesh-ancestor
2686411|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686412|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2686413|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2686414|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
2686415|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
2686416|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686417|NCT02231931|Metformin|metformin|mesh-list
2686418|NCT02231931|Digoxin|digoxin|mesh-list
2686419|NCT02231931|Furosemide|furosemide|mesh-list
2686420|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2686421|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2686422|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686423|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2686424|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2686425|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
2686426|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686427|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2686428|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2686429|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686430|NCT02231931|Diuretics|diuretics|mesh-ancestor
2686431|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
2686432|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2686433|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2686434|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2686435|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2686436|NCT02231931|Protective Agents|protective agents|mesh-ancestor
2189679|NCT00003376|Carboplatin|carboplatin|mesh-list
2189680|NCT00003376|Doxorubicin|doxorubicin|mesh-list
2189681|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2189682|NCT00003376|Methotrexate|methotrexate|mesh-list
2189683|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189684|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189685|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189686|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189687|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189688|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189689|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2189690|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189691|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189692|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189693|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2189694|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
2189695|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2189696|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686437|NCT02231957|Vaccines|vaccines|mesh-list
2686438|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
2686439|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686440|NCT02232035|Diazepam|diazepam|mesh-list
2686441|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2686442|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
2686443|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
2686444|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
2686445|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686446|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686447|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2686448|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2686449|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2686450|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2686451|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2686452|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2686453|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2686454|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2686455|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2686456|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
2686457|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
2686458|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
2686459|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
2686460|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686461|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686462|NCT02232139|Midazolam|midazolam|mesh-list
2686463|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2686464|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2686465|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2686466|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686467|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2686468|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2686469|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2686470|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2686471|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
2686472|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
2686473|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
2686474|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
2686475|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686476|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686477|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
2686478|NCT02232152|Fluorouracil|fluorouracil|mesh-list
2686479|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
2686480|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686481|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2686482|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686483|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2686484|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
2686485|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686486|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
2686487|NCT02232152|Protective Agents|protective agents|mesh-ancestor
2686488|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
2686489|NCT02232152|Vitamins|vitamins|mesh-ancestor
2686490|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
2686494|NCT02232269|Felodipine|felodipine|mesh-list
2686495|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2686496|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2686497|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2189697|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2189698|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
2189699|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
2189700|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2189701|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2686498|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2686499|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686500|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2686501|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686502|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
2686503|NCT02232308|Lisinopril|lisinopril|mesh-list
2686504|NCT02232308|Nizatidine|nizatidine|mesh-list
2686505|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2686506|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
2686507|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686508|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686509|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2686510|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2686511|NCT02232308|Protective Agents|protective agents|mesh-ancestor
2686512|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686513|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2686514|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2686515|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2686516|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
2686517|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
2686518|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686519|NCT02232347|Sufentanil|sufentanil|mesh-list
2686520|NCT02232347|Ketamine|ketamine|mesh-list
2189702|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
2189703|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189704|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2189705|NCT00003378|Gemcitabine|gemcitabine|mesh-list
2189706|NCT00003378|Paclitaxel|paclitaxel|mesh-list
2189707|NCT00003378|Carboplatin|carboplatin|mesh-list
2189708|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189709|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189710|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189711|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189712|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189713|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189714|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2189715|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
2189716|NCT00003378|Antiviral Agents|antiviral agents|mesh-ancestor
2189717|NCT00003378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2189718|NCT00003378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189719|NCT00003378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189720|NCT00003378|Immunologic Factors|immunologic factors|mesh-ancestor
2189721|NCT00003378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189722|NCT00003379|Paclitaxel|paclitaxel|mesh-list
2189723|NCT00003379|Cisplatin|cisplatin|mesh-list
2189724|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2686521|NCT02232347|Analgesics|analgesics|mesh-ancestor
2686522|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
2686523|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686524|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686525|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2686526|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2686527|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
2686528|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
2686529|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2686530|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2686531|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2686532|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686533|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686534|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2686535|NCT02232347|Narcotics|narcotics|mesh-ancestor
2686536|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2686537|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2686538|NCT02232360|Fenofibrate|fenofibrate|mesh-list
2686539|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2686540|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2686541|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
2686542|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686543|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2686544|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2686545|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686546|NCT02232386|Rituximab|rituximab|mesh-list
2686547|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2686548|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686549|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
2686550|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686551|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2686552|NCT02232399|Simendan|simendan|mesh-list
2686553|NCT02232399|Milrinone|milrinone|mesh-list
2686554|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2686555|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
2686556|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2686557|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2686558|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686559|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686560|NCT02232399|Protective Agents|protective agents|mesh-ancestor
2686561|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686562|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2686563|NCT02232516|Lenalidomide|lenalidomide|mesh-list
2686564|NCT02232516|Romidepsin|romidepsin|mesh-list
2686565|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
2189725|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686566|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189726|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189727|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189728|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189729|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189730|NCT00003380|Doxorubicin|doxorubicin|mesh-list
2189731|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2189732|NCT00003380|Etoposide|etoposide|mesh-list
2189733|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2189734|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189735|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189736|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189737|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189738|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189739|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189740|NCT00003382|Gemcitabine|gemcitabine|mesh-list
2189741|NCT00003382|Topotecan|topotecan|mesh-list
2189742|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2189743|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
2189744|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189745|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189746|NCT00003382|Antiviral Agents|antiviral agents|mesh-ancestor
2189747|NCT00003382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2189748|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189749|NCT00003382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189750|NCT00003382|Immunologic Factors|immunologic factors|mesh-ancestor
2189751|NCT00003382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189752|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2189753|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189754|NCT00003385|Paclitaxel|paclitaxel|mesh-list
2189755|NCT00003385|Carboplatin|carboplatin|mesh-list
2189756|NCT00003385|Doxorubicin|doxorubicin|mesh-list
2189757|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2189758|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189759|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686567|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2686568|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2686569|NCT02232516|Growth Substances|growth substances|mesh-ancestor
2686570|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
2686571|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686572|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2686573|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2686574|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2686575|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2686576|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2686577|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686578|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686579|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686580|NCT02232542|Analgesics|analgesics|mesh-ancestor
2686581|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
2686582|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686583|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
2686584|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2686585|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
2686586|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2686587|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2686588|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2686589|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2686590|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686591|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686592|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686593|NCT02232555|Analgesics|analgesics|mesh-ancestor
2686594|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
2686595|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686596|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
2686597|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2686598|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
2686599|NCT02232581|Alovudine|alovudine|mesh-list
2686600|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
2686601|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
2686602|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2686603|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
2686604|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686605|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2686606|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2686607|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686608|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
2686609|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2686610|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
2686611|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686612|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686613|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2686614|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
2686615|NCT02232607|Lacidipine|lacidipine|mesh-list
2686616|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2686617|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2686618|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2686619|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686620|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2686621|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686622|NCT02232672|Choline|choline|mesh-list
2686623|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
2686624|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2686625|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
2189760|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189761|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189762|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189763|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189764|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2686626|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686627|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2686628|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2686629|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
2686630|NCT02232685|Choline|choline|mesh-list
2686631|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
2686632|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2686633|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
2686634|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686635|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2686636|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2686637|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
2686638|NCT02232724|Choline|choline|mesh-list
2686639|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
2686640|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2686641|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
2686642|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686643|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2686644|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2686645|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
2686646|NCT02232737|Nicotine|nicotine|mesh-list
2686647|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2686648|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
2686649|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686650|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686651|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2686652|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2686653|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
2686654|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686655|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686656|NCT02232763|Losartan|losartan|mesh-list
2686657|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2686658|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2686659|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2686660|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2686661|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686662|NCT02232776|Losartan|losartan|mesh-list
2686663|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2686664|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2686665|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2686666|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2686667|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686668|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2686669|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
2686670|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686671|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2686672|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
2686673|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2189765|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189766|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189767|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189768|NCT00003386|Paclitaxel|paclitaxel|mesh-list
2189769|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
2189770|NCT00003386|Carboplatin|carboplatin|mesh-list
2686674|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686675|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2686676|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2686677|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2686678|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
2686679|NCT02232932|Capecitabine|capecitabine|mesh-list
2686680|NCT02232932|Liver Extracts|liver extracts|mesh-list
2686681|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2686682|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
2686683|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686684|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686685|NCT02232932|Hematinics|hematinics|mesh-ancestor
2686686|NCT02232945|Oseltamivir|oseltamivir|mesh-list
2686687|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
2686688|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2686689|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686690|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686691|NCT02232971|Glucagon|glucagon|mesh-list
2686692|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2686693|NCT02232971|Hormones|hormones|mesh-ancestor
2686694|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2686695|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686696|NCT02233023|Dopamine|dopamine|mesh-list
2686697|NCT02233023|Pramipexole|pramipexole|mesh-list
2686698|NCT02233023|Bromocriptine|bromocriptine|mesh-list
2686699|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
2686700|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
2686701|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686702|NCT02233023|Protective Agents|protective agents|mesh-ancestor
2686703|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686704|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2686705|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2686706|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
2686707|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686708|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2686709|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
2189771|NCT00003386|Vaccines|vaccines|mesh-list
2189772|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
2189773|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
2189774|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189775|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189776|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189777|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189778|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
2686710|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
2189779|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423279|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423280|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423281|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423282|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2423283|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2423284|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423285|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2423286|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2423287|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
2423288|NCT00821457|Mitogens|mitogens|mesh-list
2423289|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423290|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423291|NCT00821483|Frovatriptan|frovatriptan|mesh-list
2423292|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2423293|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
2423294|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423295|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423296|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423297|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2423298|NCT00821496|Norethindrone|norethindrone|mesh-list
2423299|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
2423300|NCT00821496|Norinyl|norinyl|mesh-list
2423301|NCT00821496|Estradiol|estradiol|mesh-list
2423302|NCT00821496|Estrogens|estrogens|mesh-ancestor
2423303|NCT00821496|Hormones|hormones|mesh-ancestor
2686711|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686712|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
2686713|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2686714|NCT02233049|Everolimus|everolimus|mesh-list
2686715|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2686716|NCT02233049|Dasatinib|dasatinib|mesh-list
2686717|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686718|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2686719|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
2686720|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686721|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2189780|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189781|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189782|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189783|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189784|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
2189785|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2686722|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686723|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686724|NCT02233075|Interferons|interferons|mesh-list
2686725|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
2686726|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
2686727|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2686728|NCT02233075|REP 2139|rep 2139|mesh-list
2686729|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686730|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
2686731|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2686732|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
2686733|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686734|NCT02233179|Calpastatin|calpastatin|mesh-list
2686735|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2686736|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
2686737|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686738|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686739|NCT02233205|Gemcitabine|gemcitabine|mesh-list
2686740|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2686741|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
2686742|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686743|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686744|NCT02233205|Antiviral Agents|antiviral agents|mesh-ancestor
2686745|NCT02233205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2686746|NCT02233205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686747|NCT02233205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189786|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2189787|NCT00003387|Paclitaxel|paclitaxel|mesh-list
2189788|NCT00003387|Carboplatin|carboplatin|mesh-list
2189789|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189790|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189791|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189792|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189793|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
2686748|NCT02233205|Immunologic Factors|immunologic factors|mesh-ancestor
2686749|NCT02233205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686750|NCT02233218|Amlodipine|amlodipine|mesh-list
2686751|NCT02233218|Telmisartan|telmisartan|mesh-list
2686752|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2686753|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2686754|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2686755|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2686756|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686757|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2686758|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686759|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
2686760|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2686761|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2686762|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
2686763|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2686764|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2686765|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686766|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2686767|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2686768|NCT02233231|Varenicline|varenicline|mesh-list
2686769|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2686770|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2686771|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
2686772|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686773|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686774|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686775|NCT02233244|Midazolam|midazolam|mesh-list
2686776|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2686777|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2686778|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2686779|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686780|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2686781|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2686782|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2686783|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2686784|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
2686785|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
2686786|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
2686787|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
2686788|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686789|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686790|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
2686791|NCT02233322|Hematinics|hematinics|mesh-ancestor
2686792|NCT02233387|Imidazole|imidazole|mesh-list
2686793|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686794|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686795|NCT02233400|Acetaminophen|acetaminophen|mesh-list
2686796|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2686797|NCT02233400|Analgesics|analgesics|mesh-ancestor
2686798|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
2686799|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686800|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686801|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
2686802|NCT02233439|Galactogogues|galactogogues|mesh-list
2686803|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686804|NCT02233452|Ketamine|ketamine|mesh-list
2686805|NCT02233452|Methadone|methadone|mesh-list
2686806|NCT02233452|Analgesics|analgesics|mesh-ancestor
2686807|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
2686808|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686809|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686810|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2686811|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2686812|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
2686813|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
2686814|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2686815|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2686816|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2686817|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686818|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686819|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2686820|NCT02233452|Narcotics|narcotics|mesh-ancestor
2686821|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
2686822|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
2686823|NCT02233504|Deferasirox|deferasirox|mesh-list
2686824|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2686825|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
2686826|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
2686827|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686828|NCT02233556|Memantine|memantine|mesh-list
2686829|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2686830|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2686831|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
2686832|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686833|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686834|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686835|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2686836|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2686837|NCT02233582|Ibuprofen|ibuprofen|mesh-list
2686838|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2686839|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2686840|NCT02233582|Analgesics|analgesics|mesh-ancestor
2686841|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
2686842|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686843|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686844|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2686845|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2686846|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2189794|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189795|NCT00003388|Cytarabine|cytarabine|mesh-list
2189796|NCT00003388|Prednisone|prednisone|mesh-list
2189797|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
2189798|NCT00003388|Doxorubicin|doxorubicin|mesh-list
2686847|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686848|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686849|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2686850|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2686851|NCT02233621|Estradiol|estradiol|mesh-list
2686852|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2686853|NCT02233621|Estrogens|estrogens|mesh-ancestor
2686854|NCT02233621|Hormones|hormones|mesh-ancestor
2686855|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2686856|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686857|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2686858|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
2686859|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2686860|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2686861|NCT02233777|Pregabalin|pregabalin|mesh-list
2686862|NCT02233777|Analgesics|analgesics|mesh-ancestor
2686863|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
2686864|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686865|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686866|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
2686867|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2686868|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2686869|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686870|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2686871|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2686872|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2686873|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2686874|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2686875|NCT02233790|Clopidogrel|clopidogrel|mesh-list
2686876|NCT02233790|Ticagrelor|ticagrelor|mesh-list
2686877|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2686878|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2686879|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2686880|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2686881|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
2686882|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686883|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686884|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686885|NCT02233816|Vaccines|vaccines|mesh-list
2686886|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
2686887|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686898|NCT02233881|Ipratropium|ipratropium|mesh-list
2686899|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2686900|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
2686901|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686902|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686903|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2686904|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
2686905|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2686906|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
2686907|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686908|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686909|NCT02233894|Ipratropium|ipratropium|mesh-list
2686910|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2686911|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
2189799|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2189800|NCT00003388|Methotrexate|methotrexate|mesh-list
2189801|NCT00003388|Vincristine|vincristine|mesh-list
2189802|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189803|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
2686912|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686913|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686914|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2686915|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
2686916|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2686917|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
2686918|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686919|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686920|NCT02233907|Oxitropium|oxitropium|mesh-list
2686921|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
2686922|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
2686923|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686924|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686925|NCT02233920|Oxitropium|oxitropium|mesh-list
2686926|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
2686927|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
2686928|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686929|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686930|NCT02233972|Midazolam|midazolam|mesh-list
2686931|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2686932|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2686933|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2686934|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686935|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2686936|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2686937|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2686938|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2686939|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
2686940|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
2686941|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
2686942|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
2686943|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686944|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686945|NCT02234037|Decitabine|decitabine|mesh-list
2686946|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2686947|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
2686948|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686949|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686950|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2686951|NCT02234050|Trabectedin|trabectedin|mesh-list
2686952|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2686953|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
2686954|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686955|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686956|NCT02234193|Lidocaine|lidocaine|mesh-list
2686957|NCT02234193|Epinephrine|epinephrine|mesh-list
2686958|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
2686959|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
2686960|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2686961|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686962|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
2686963|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686964|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2686965|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2686966|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2686967|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2686968|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2686969|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2686970|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2686971|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
2686972|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2686973|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2686974|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2686975|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
2686976|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2686977|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
2686978|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
2686979|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
2686980|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2686981|NCT02234349|Pancrelipase|pancrelipase|mesh-list
2686982|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2686983|NCT02234440|Metformin|metformin|mesh-list
2686984|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2686985|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686986|NCT02234466|Dexamethasone|dexamethasone|mesh-list
2686987|NCT02234466|Ondansetron|ondansetron|mesh-list
2189804|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189805|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2686988|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2686989|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
2686990|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
2686991|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2686992|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2686993|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2686994|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
2686995|NCT02234466|Hormones|hormones|mesh-ancestor
2686996|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2686997|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2686998|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2686999|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
2687000|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
2687001|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2687002|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
2687003|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687004|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687005|NCT02234466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2687006|NCT02234466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2687007|NCT02234466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2687008|NCT02234466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2687009|NCT02234466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2687010|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2687011|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2687012|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2687013|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
2687014|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687015|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2687016|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2687017|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687018|NCT02234544|Vitamin D|vitamin d|mesh-list
2687019|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
2687020|NCT02234544|Ezetimibe|ezetimibe|mesh-list
2687021|NCT02234544|Vitamins|vitamins|mesh-ancestor
2687022|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
2687023|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687024|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2687025|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2687026|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2687027|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2687028|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
2687029|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687030|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2687031|NCT02234739|Voriconazole|voriconazole|mesh-list
2687032|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
2687033|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687034|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2687035|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2687036|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687037|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687038|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2687039|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
2687040|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2687041|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687042|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2189806|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189807|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
2189808|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189809|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189810|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189811|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2189812|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189813|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189814|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189815|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2189816|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
2189817|NCT00003388|Hormones|hormones|mesh-ancestor
2687043|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
2687044|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2687045|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
2687046|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2687047|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
2687048|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687049|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687050|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
2687051|NCT02234869|Interferons|interferons|mesh-list
2687052|NCT02234869|Interferon-beta|interferon-beta|mesh-list
2687053|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
2687054|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
2687055|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687056|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
2687057|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687058|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
2687059|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687060|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2687061|NCT02234882|Fostemsavir|fostemsavir|mesh-list
2687062|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2687063|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2687064|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2687065|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
2687066|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687067|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2687068|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2687069|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687070|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2687071|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2687072|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
2687073|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687074|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2687075|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2687076|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
2687077|NCT02234921|Imiquimod|imiquimod|mesh-list
2687078|NCT02234921|Vaccines|vaccines|mesh-list
2687079|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
2687080|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687081|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2687082|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2687083|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2687084|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
2687085|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687086|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687087|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2687088|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2687089|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
2687090|NCT02235012|Ketamine|ketamine|mesh-list
2687091|NCT02235012|Analgesics|analgesics|mesh-ancestor
2687092|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
2687093|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687094|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687095|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2687096|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2687097|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
2687098|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
2687099|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2687100|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2687101|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2687102|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687103|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687104|NCT02235194|Chromium|chromium|mesh-list
2687105|NCT02235194|Picolinic acid|picolinic acid|mesh-list
2687106|NCT02235194|Trace Elements|trace elements|mesh-ancestor
2687107|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
2687108|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687109|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2687110|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
2687111|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
2687112|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687113|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
2687114|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2687115|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687116|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
2687117|NCT02235246|Analgesics|analgesics|mesh-ancestor
2687118|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
2687119|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687120|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687121|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
2687122|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2687123|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2687124|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
2687125|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2687126|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2687127|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687128|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2687129|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
2687130|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2687131|NCT02235324|Leucovorin|leucovorin|mesh-list
2687132|NCT02235324|Fluorouracil|fluorouracil|mesh-list
2687133|NCT02235324|Aflibercept|aflibercept|mesh-list
2687134|NCT02235324|Calcium|calcium|mesh-list
2423304|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2423305|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423306|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2423307|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
2687135|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
2687136|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
2687137|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2687138|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687139|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
2687140|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687141|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2687142|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687143|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2687144|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
2687145|NCT02235324|Antidotes|antidotes|mesh-ancestor
2687146|NCT02235324|Protective Agents|protective agents|mesh-ancestor
2687147|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
2687148|NCT02235324|Vitamins|vitamins|mesh-ancestor
2687149|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
2687150|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2687151|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2687152|NCT02235324|Growth Substances|growth substances|mesh-ancestor
2687153|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
2687154|NCT02235337|Riboflavin|riboflavin|mesh-list
2687155|NCT02235337|Vitamins|vitamins|mesh-ancestor
2687156|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
2687157|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687158|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
2687159|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2687160|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
2687161|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2687162|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2687163|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2687164|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687165|NCT02235402|Lacidipine|lacidipine|mesh-list
2687166|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
2687167|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2687168|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2687169|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2687170|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687171|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2687172|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687173|NCT02235402|Diuretics|diuretics|mesh-ancestor
2687174|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
2687175|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2687176|NCT02235415|Lacidipine|lacidipine|mesh-list
2687177|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2687178|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2687179|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2687180|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687181|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2423308|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2423309|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2423310|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2423311|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2423312|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2423313|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2423314|NCT00821535|Maraviroc|maraviroc|mesh-list
2423315|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2423316|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2687182|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687183|NCT02235428|Bromides|bromides|mesh-list
2687184|NCT02235428|Albuterol|albuterol|mesh-list
2687185|NCT02235428|Ipratropium|ipratropium|mesh-list
2687186|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
2687187|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687188|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
2687189|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687190|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687191|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687192|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687193|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
2687194|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2687195|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2687196|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2687197|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2687198|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
2687199|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687200|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687201|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2687202|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687203|NCT02235480|Tazarotene|tazarotene|mesh-list
2687204|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
2687205|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
2687206|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2687207|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2687208|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2687209|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687210|NCT02235532|Fluorides|fluorides|mesh-list
2687211|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
2687212|NCT02235532|Protective Agents|protective agents|mesh-ancestor
2687213|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687214|NCT02235558|Verapamil|verapamil|mesh-list
2687215|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2687216|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2687217|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2687218|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687219|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2687220|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687221|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
2687222|NCT02235584|Dexamethasone|dexamethasone|mesh-list
2687223|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2687224|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
2687225|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
2687226|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687227|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687228|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2687229|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
2687230|NCT02235584|Hormones|hormones|mesh-ancestor
2687231|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2687232|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2687233|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687234|NCT02235662|Tenofovir|tenofovir|mesh-list
2687235|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
2687236|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
2687237|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687238|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2687239|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2687240|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687241|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687242|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2687243|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2687244|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2687245|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
2687246|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2687247|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687248|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2687249|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2687250|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2687251|NCT02235688|Gemcitabine|gemcitabine|mesh-list
2687252|NCT02235688|Doxorubicin|doxorubicin|mesh-list
2687253|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2687254|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
2687255|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687256|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687257|NCT02235688|Antiviral Agents|antiviral agents|mesh-ancestor
2687258|NCT02235688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687259|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687260|NCT02235688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2687261|NCT02235688|Immunologic Factors|immunologic factors|mesh-ancestor
2687262|NCT02235688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687263|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2189818|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2189819|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2189820|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2189821|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
2189822|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2189823|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2687264|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2687265|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2687266|NCT02235701|Ifosfamide|ifosfamide|mesh-list
2687267|NCT02235701|Doxorubicin|doxorubicin|mesh-list
2687268|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2687269|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
2687270|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687271|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687272|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2687273|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2687274|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2687275|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687276|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
2687277|NCT02235805|Cathartics|cathartics|mesh-ancestor
2687278|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2687279|NCT02235857|Dextrans|dextrans|mesh-list
2687280|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
2687281|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
2687282|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
2687283|NCT02235909|Losartan|losartan|mesh-list
2189824|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
2189825|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
2189826|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2189827|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2189828|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
2189829|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2189830|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189831|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189832|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189833|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189834|NCT00003390|Irofulven|irofulven|mesh-list
2189835|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189836|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
2189837|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189838|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189839|NCT00003391|Antibodies|antibodies|mesh-list
2189840|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2189841|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
2189842|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189843|NCT00003392|Paclitaxel|paclitaxel|mesh-list
2189844|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
2687284|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
2687285|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2687286|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2687287|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2687288|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2687289|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687290|NCT02235948|Folic Acid|folic acid|mesh-list
2687291|NCT02235948|Hematinics|hematinics|mesh-ancestor
2687292|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
2687293|NCT02235948|Vitamins|vitamins|mesh-ancestor
2687294|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
2687295|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687296|NCT02235961|Liraglutide|liraglutide|mesh-list
2687297|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2687298|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687299|NCT02235961|Incretins|incretins|mesh-ancestor
2687300|NCT02235961|Hormones|hormones|mesh-ancestor
2687301|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2687302|NCT02236013|Cytarabine|cytarabine|mesh-list
2687303|NCT02236013|Daunorubicin|daunorubicin|mesh-list
2687304|NCT02236013|Idarubicin|idarubicin|mesh-list
2687305|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2687306|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
2687307|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687308|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687309|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
2687310|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687311|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2687312|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
2687313|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687314|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2687315|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2687316|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2687317|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687318|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
2687319|NCT02236026|ST 1435|st 1435|mesh-list
2687320|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2687321|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687322|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2687323|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2687324|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687325|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687326|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687327|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2687328|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
2687329|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2687330|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687331|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2687332|NCT02236052|Vaccines|vaccines|mesh-list
2687333|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
2687334|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189845|NCT00003392|Carboplatin|carboplatin|mesh-list
2189846|NCT00003392|Melphalan|melphalan|mesh-list
2189847|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189848|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189849|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189850|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
2687335|NCT02236065|Lenograstim|lenograstim|mesh-list
2687336|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2687337|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
2687338|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687339|NCT02236078|Isoniazid|isoniazid|mesh-list
2687340|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
2687341|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2687342|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687343|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2687344|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2687345|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
2687346|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687347|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2687348|NCT02236156|Metronidazole|metronidazole|mesh-list
2687349|NCT02236156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687350|NCT02236156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2687351|NCT02236156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2687352|NCT02236156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2687353|NCT02236169|Bromides|bromides|mesh-list
2687354|NCT02236169|Norflurane|norflurane|mesh-list
2687355|NCT02236169|Ipratropium|ipratropium|mesh-list
2687356|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
2687357|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687358|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
2687359|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687360|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687361|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687362|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687363|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2687364|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687365|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687366|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687367|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
2687368|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2687369|NCT02236182|Bromides|bromides|mesh-list
2687370|NCT02236182|Ipratropium|ipratropium|mesh-list
2687371|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
2687372|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687373|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
2189851|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
2687374|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687375|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687376|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687377|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687378|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2687379|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687380|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687381|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687382|NCT02236195|Mocetinostat|mocetinostat|mesh-list
2687383|NCT02236195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2687384|NCT02236195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687385|NCT02236195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687386|NCT02236260|Lidocaine|lidocaine|mesh-list
2687387|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
2687388|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
2687389|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2687390|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687391|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
2687392|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687393|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2687394|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2687395|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2687396|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2687397|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687398|NCT02236312|Botulinum Toxins|botulinum toxins|mesh-list
2687399|NCT02236312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2687400|NCT02236312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2687401|NCT02236312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2687402|NCT02236312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2687403|NCT02236312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687404|NCT02236312|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687405|NCT02236312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687406|NCT02236312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687407|NCT02236312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2687408|NCT02236312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687409|NCT02236403|Metronidazole|metronidazole|mesh-list
2687410|NCT02236403|Ivermectin|ivermectin|mesh-list
2687411|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687412|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2687413|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2687414|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2687415|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2687416|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2687422|NCT02236715|Ipratropium|ipratropium|mesh-list
2687423|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687424|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
2687425|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687426|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687427|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687428|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687429|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2687430|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687431|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687432|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687433|NCT02236728|Pramipexole|pramipexole|mesh-list
2687434|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
2687435|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687436|NCT02236728|Protective Agents|protective agents|mesh-ancestor
2687437|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687438|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2687439|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2687440|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
2687441|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
2189852|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189853|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189854|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
2189855|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189856|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189857|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189858|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
2687442|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687443|NCT02236741|Pramipexole|pramipexole|mesh-list
2687444|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
2687445|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687446|NCT02236741|Protective Agents|protective agents|mesh-ancestor
2687447|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687448|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2687449|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2687450|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
2687451|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
2687452|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687453|NCT02236793|Becaplermin|becaplermin|mesh-list
2687454|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
2687455|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2687456|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2189859|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189860|NCT00003394|Paclitaxel|paclitaxel|mesh-list
2189861|NCT00003394|Carboplatin|carboplatin|mesh-list
2189862|NCT00003394|Leuprolide|leuprolide|mesh-list
2189863|NCT00003394|Goserelin|goserelin|mesh-list
2687457|NCT02236793|Growth Substances|growth substances|mesh-ancestor
2687458|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687475|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
2687476|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2687477|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687478|NCT02236936|Cetuximab|cetuximab|mesh-list
2687479|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687480|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2687481|NCT02236962|Pioglitazone|pioglitazone|mesh-list
2687482|NCT02236962|Ephedrine|ephedrine|mesh-list
2687483|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2687484|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687485|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2687486|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
2687487|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
2687488|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687489|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2687490|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
2687491|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687492|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687493|NCT02237027|Tenofovir|tenofovir|mesh-list
2687494|NCT02237027|Emtricitabine|emtricitabine|mesh-list
2687495|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2687496|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
2687497|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687498|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2687499|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2687500|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687501|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687502|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2687503|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2687504|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2687505|NCT02237053|Octreotide|octreotide|mesh-list
2687506|NCT02237053|Glucagon|glucagon|mesh-list
2687507|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687508|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2687509|NCT02237053|Hormones|hormones|mesh-ancestor
2687510|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2687511|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2189864|NCT00003394|Estramustine|estramustine|mesh-list
2687512|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687513|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
2687514|NCT02237079|Estrogens|estrogens|mesh-list
2687515|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2687516|NCT02237079|Hormones|hormones|mesh-ancestor
2687517|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2687518|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687519|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2687520|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2687521|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
2687522|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2687523|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
2687524|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
2687525|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2687526|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2687527|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687528|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2687532|NCT02237209|Vaccines|vaccines|mesh-list
2687533|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
2687534|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687535|NCT02237261|Prednisone|prednisone|mesh-list
2687536|NCT02237261|Bortezomib|bortezomib|mesh-list
2687537|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2687538|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2687539|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
2687540|NCT02237261|Hormones|hormones|mesh-ancestor
2687541|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2687542|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687543|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2687544|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687545|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2687546|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
2687547|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687548|NCT02237326|Acetic Acid|acetic acid|mesh-list
2687549|NCT02237326|Retinol acetate|retinol acetate|mesh-list
2687550|NCT02237326|Lugol's solution|lugol's solution|mesh-list
2687551|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2687552|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687553|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2687554|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
2687555|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687556|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2687557|NCT02237326|Protective Agents|protective agents|mesh-ancestor
2687558|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189865|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189866|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189867|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189868|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189869|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189870|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189871|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2189872|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
2189873|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2189874|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189875|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2189876|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189877|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
2189878|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
2189879|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189880|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
2189881|NCT00003396|Melphalan|melphalan|mesh-list
2189882|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2189883|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189884|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
2687559|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
2687560|NCT02237326|Coagulants|coagulants|mesh-ancestor
2687561|NCT02237339|Allopurinol|allopurinol|mesh-list
2687562|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
2189885|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687563|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687564|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687565|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
2687566|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2687567|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2687568|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
2687569|NCT02237339|Protective Agents|protective agents|mesh-ancestor
2687570|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687571|NCT02237365|Aspirin|aspirin|mesh-list
2687572|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2687573|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2687574|NCT02237365|Analgesics|analgesics|mesh-ancestor
2687575|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
2687576|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687577|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687578|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2687579|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2687580|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2687581|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2687582|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687583|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2687584|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2687585|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687586|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
2687587|NCT02237443|Bromides|bromides|mesh-list
2687588|NCT02237443|Rocuronium|rocuronium|mesh-list
2687589|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
2687590|NCT02237443|Succinylcholine|succinylcholine|mesh-list
2687591|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
2687592|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2687593|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2687594|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2687595|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687596|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687597|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2687598|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2687599|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2687600|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687601|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687602|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687603|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
2687604|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2687605|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2687606|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687607|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2687608|NCT02237495|Analgesics|analgesics|mesh-ancestor
2687609|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
2687610|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687611|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2687612|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2687613|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2687614|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
2687615|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687616|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687639|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
2687640|NCT02237534|Calcium|calcium|mesh-list
2687641|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2687642|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687643|NCT02237534|Antacids|antacids|mesh-ancestor
2687644|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687645|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2687646|NCT02237560|Camphor|camphor|mesh-list
2687647|NCT02237560|Salicylates|salicylates|mesh-list
2687648|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
2687649|NCT02237560|Menthol|menthol|mesh-list
2687650|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2687651|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687652|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
2687653|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
2687654|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2687655|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2687656|NCT02237560|Analgesics|analgesics|mesh-ancestor
2687657|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
2687658|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687659|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687660|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2687661|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2687662|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2687663|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189886|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189887|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189888|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
2687664|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687665|NCT02237651|Anesthetics|anesthetics|mesh-list
2687666|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2687667|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687668|NCT02237690|Doxorubicin|doxorubicin|mesh-list
2687669|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2687670|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2687671|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687672|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2687673|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2687674|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687675|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687676|NCT02237729|Adalimumab|adalimumab|mesh-list
2189889|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189890|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189891|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189892|NCT00003397|Gemcitabine|gemcitabine|mesh-list
2189893|NCT00003397|Dexamethasone|dexamethasone|mesh-list
2189894|NCT00003397|Paclitaxel|paclitaxel|mesh-list
2189895|NCT00003397|Etoposide|etoposide|mesh-list
2189896|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
2189897|NCT00003397|Rituximab|rituximab|mesh-list
2189898|NCT00003397|Melphalan|melphalan|mesh-list
2189899|NCT00003397|Carmustine|carmustine|mesh-list
2189900|NCT00003397|Sargramostim|sargramostim|mesh-list
2189901|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189902|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189903|NCT00003397|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189904|NCT00003397|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189905|NCT00003397|Mitosis Modulators|mitosis modulators|mesh-ancestor
2687677|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2687678|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2687679|NCT02237755|Citric Acid|citric acid|mesh-list
2687680|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
2687681|NCT02237755|Clomiphene|clomiphene|mesh-list
2687682|NCT02237755|Enclomiphene|enclomiphene|mesh-list
2687683|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
2687684|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
2687685|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2687686|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
2687687|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
2687688|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687689|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2687690|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
2189906|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189907|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189908|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
2687691|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2687692|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687693|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2687694|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
2687695|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2687696|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2687697|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2687698|NCT02237768|Dirithromycin|dirithromycin|mesh-list
2687699|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2687700|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687701|NCT02237807|Dirithromycin|dirithromycin|mesh-list
2687702|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2687703|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687704|NCT02237820|Dexamethasone|dexamethasone|mesh-list
2687705|NCT02237820|Prednisone|prednisone|mesh-list
2687706|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2687707|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
2687708|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
2687709|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687710|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687711|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2687712|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
2687713|NCT02237820|Hormones|hormones|mesh-ancestor
2687714|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2687715|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2687716|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687717|NCT02237859|Vancomycin|vancomycin|mesh-list
2687718|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2687719|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687720|NCT02237924|Endostar protein|endostar protein|mesh-list
2189909|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189910|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2687721|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2687722|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2687723|NCT02237924|Growth Substances|growth substances|mesh-ancestor
2687724|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687725|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
2687726|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687727|NCT02237937|Amitriptyline|amitriptyline|mesh-list
2687728|NCT02237937|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2687729|NCT02237937|Citalopram|citalopram|mesh-list
2687730|NCT02237937|Paroxetine|paroxetine|mesh-list
2687731|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2687732|NCT02237937|Sertraline|sertraline|mesh-list
2687733|NCT02237937|Nortriptyline|nortriptyline|mesh-list
2687734|NCT02237937|Trimipramine|trimipramine|mesh-list
2687735|NCT02237937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2687736|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2687737|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2687738|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687739|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687740|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
2687741|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687742|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2687743|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
2687744|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2687745|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687746|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2687747|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2687748|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687749|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2687750|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2687751|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2687752|NCT02237937|Analgesics|analgesics|mesh-ancestor
2687753|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
2687754|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2687755|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
2687756|NCT02237937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2687757|NCT02237937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2687758|NCT02237937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2687759|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2687760|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687761|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
2687762|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687763|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687764|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687765|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687766|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2189911|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189912|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
2189913|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189914|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2189915|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
2189916|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
2189917|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2189918|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2189919|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
2189920|NCT00003397|Hormones|hormones|mesh-ancestor
2189921|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2687767|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2687768|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2687769|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
2687770|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687771|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687772|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
2687773|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
2687774|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687775|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
2687776|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687777|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687778|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687779|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687780|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2687781|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2687782|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2687783|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
2687784|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687785|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687786|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
2687787|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2687788|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687789|NCT02238132|Ipratropium|ipratropium|mesh-list
2687790|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687791|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
2687792|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687793|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687794|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687795|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687796|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2687797|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687798|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687799|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687800|NCT02238145|Ipratropium|ipratropium|mesh-list
2687801|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687802|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
2687803|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687804|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687805|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687806|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687807|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2687808|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687809|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687810|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189922|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2189923|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2687811|NCT02238158|Ipratropium|ipratropium|mesh-list
2687812|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687813|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
2687814|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687815|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687816|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687817|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687818|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2687819|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687820|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687821|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687822|NCT02238171|Ipratropium|ipratropium|mesh-list
2687823|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687824|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
2687825|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687826|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687827|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687828|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687829|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2687830|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687831|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687832|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687833|NCT02238184|Ipratropium|ipratropium|mesh-list
2687834|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687835|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
2687836|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687837|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687838|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687839|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687840|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2687841|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687842|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687843|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687844|NCT02238197|Ipratropium|ipratropium|mesh-list
2687845|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687846|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
2687847|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687848|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687849|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687850|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687851|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2687852|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687853|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687854|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687855|NCT02238210|Ipratropium|ipratropium|mesh-list
2687856|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687857|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
2189924|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2189925|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
2189926|NCT00003397|Antiviral Agents|antiviral agents|mesh-ancestor
2189927|NCT00003397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2189928|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687858|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687859|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687860|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687861|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687862|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2687863|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
2687864|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687865|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687866|NCT02238223|Epinastine|epinastine|mesh-list
2687867|NCT02238223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2687868|NCT02238223|Histamine Antagonists|histamine antagonists|mesh-ancestor
2687869|NCT02238223|Histamine Agents|histamine agents|mesh-ancestor
2687870|NCT02238223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687871|NCT02238223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189929|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189930|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189931|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
2189932|NCT00003398|Thiotepa|thiotepa|mesh-list
2189933|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2189934|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189935|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
2189936|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189937|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189938|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189939|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
2189940|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189941|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189942|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189943|NCT00003399|Dexamethasone|dexamethasone|mesh-list
2189944|NCT00003399|Paclitaxel|paclitaxel|mesh-list
2189945|NCT00003399|Etoposide|etoposide|mesh-list
2189946|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
2687872|NCT02238223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687873|NCT02238236|Epinastine|epinastine|mesh-list
2687874|NCT02238236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2687875|NCT02238236|Histamine Antagonists|histamine antagonists|mesh-ancestor
2687876|NCT02238236|Histamine Agents|histamine agents|mesh-ancestor
2189947|NCT00003399|Melphalan|melphalan|mesh-list
2189948|NCT00003399|Carmustine|carmustine|mesh-list
2687877|NCT02238236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687878|NCT02238236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687879|NCT02238236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687880|NCT02238249|Epinastine|epinastine|mesh-list
2687881|NCT02238249|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2687882|NCT02238249|Histamine Antagonists|histamine antagonists|mesh-ancestor
2687883|NCT02238249|Histamine Agents|histamine agents|mesh-ancestor
2687884|NCT02238249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687885|NCT02238249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687886|NCT02238249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687887|NCT02238262|Telmisartan|telmisartan|mesh-list
2687888|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2687889|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2687890|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2687891|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687892|NCT02238275|Telmisartan|telmisartan|mesh-list
2687893|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2687894|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2687895|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2687896|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687897|NCT02238288|Acetaminophen|acetaminophen|mesh-list
2687898|NCT02238288|Lidocaine|lidocaine|mesh-list
2687899|NCT02238288|Epinephrine|epinephrine|mesh-list
2687900|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
2687901|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
2189949|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189950|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2189951|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189952|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189953|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
2687902|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
2687903|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2687904|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687905|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
2687906|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687907|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2687908|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2189954|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189955|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189956|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
2189957|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189958|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2189959|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189960|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
2189961|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189962|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2189963|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
2189964|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
2189965|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2189966|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2189967|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
2189968|NCT00003399|Hormones|hormones|mesh-ancestor
2189969|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2189970|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2189971|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2189972|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2189973|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2189974|NCT00003400|Melphalan|melphalan|mesh-list
2189975|NCT00003400|Vinorelbine|vinorelbine|mesh-list
2189976|NCT00003400|Carmustine|carmustine|mesh-list
2189977|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687909|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2687910|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2687911|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687912|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2687913|NCT02238288|Analgesics|analgesics|mesh-ancestor
2687914|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
2687915|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2687916|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2687917|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
2687918|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687919|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2687920|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687921|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
2687922|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687923|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687924|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
2687925|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
2687926|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2687927|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2687928|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2687929|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
2687930|NCT02238288|Coagulants|coagulants|mesh-ancestor
2687931|NCT02238314|Ritonavir|ritonavir|mesh-list
2687932|NCT02238314|Tipranavir|tipranavir|mesh-list
2687933|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2687934|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2687935|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2687936|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
2687937|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687938|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687939|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2687940|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2687941|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
2687942|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2687943|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2687944|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2687945|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2687946|NCT02238340|Ketoprofen|ketoprofen|mesh-list
2189978|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
2189979|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2189980|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2189981|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
2189982|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189983|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2189984|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2189985|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189986|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
2687947|NCT02238340|Morphine|morphine|mesh-list
2687948|NCT02238340|Oxycodone|oxycodone|mesh-list
2687949|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2687950|NCT02238340|Narcotics|narcotics|mesh-ancestor
2687951|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2687952|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687953|NCT02238340|Analgesics|analgesics|mesh-ancestor
2687954|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
2687955|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687956|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2687957|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2687958|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2687959|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2687960|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2687961|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687962|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687963|NCT02238353|Fluticasone|fluticasone|mesh-list
2687964|NCT02238353|Azelastine|azelastine|mesh-list
2687965|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2687966|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2687967|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
2687968|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687969|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687970|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2687971|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
2687972|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
2687973|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2687974|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2687975|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2687976|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2687977|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2687978|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2687979|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
2687980|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
2687981|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2687982|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2687983|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
2687984|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2687985|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
2687986|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2687987|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687988|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2687989|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2687990|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2687991|NCT02238392|Adenosine|adenosine|mesh-list
2687992|NCT02238392|Analgesics|analgesics|mesh-ancestor
2687993|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
2687994|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2687995|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2687996|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2687997|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
2687998|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2687999|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
2688000|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
2688001|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688002|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688003|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
2688004|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2688005|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688006|NCT02238418|Vitamins|vitamins|mesh-ancestor
2688007|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
2688008|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2688009|NCT02238431|Leuprolide|leuprolide|mesh-list
2688010|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2688011|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
2688012|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2688013|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688014|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2688015|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688016|NCT02238444|Aspirin|aspirin|mesh-list
2688017|NCT02238444|Heparin|heparin|mesh-list
2688018|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2688019|NCT02238444|Tinzaparin|tinzaparin|mesh-list
2688020|NCT02238444|Dalteparin|dalteparin|mesh-list
2688021|NCT02238444|Dipyridamole|dipyridamole|mesh-list
2688022|NCT02238444|Warfarin|warfarin|mesh-list
2688023|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2688024|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2688025|NCT02238444|Analgesics|analgesics|mesh-ancestor
2688026|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
2688027|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688028|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688029|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2688030|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2688031|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2688032|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2688033|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2189987|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
2189988|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
2189989|NCT00003401|Gemcitabine|gemcitabine|mesh-list
2189990|NCT00003401|Dexamethasone|dexamethasone|mesh-list
2189991|NCT00003401|Paclitaxel|paclitaxel|mesh-list
2189992|NCT00003401|Etoposide|etoposide|mesh-list
2189993|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
2189994|NCT00003401|Melphalan|melphalan|mesh-list
2189995|NCT00003401|Carmustine|carmustine|mesh-list
2688034|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2688035|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2688036|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688037|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
2688038|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
2688039|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2688040|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
2688041|NCT02238457|Losartan|losartan|mesh-list
2688042|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2688043|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688044|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688045|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688046|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688047|NCT02238470|Warfarin|warfarin|mesh-list
2688048|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
2688049|NCT02238470|Dabigatran|dabigatran|mesh-list
2688050|NCT02238470|Apixaban|apixaban|mesh-list
2688051|NCT02238470|Anticoagulants|anticoagulants|mesh-list
2688052|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2688053|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
2189996|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2189997|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688054|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2688055|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
2688056|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688057|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688058|NCT02238496|Sirolimus|sirolimus|mesh-list
2189998|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
2189999|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190000|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423317|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423318|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2423319|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2423320|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
2423321|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423322|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2423323|NCT00821574|Valsartan|valsartan|mesh-list
2423324|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2688059|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2688060|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688061|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2688062|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688063|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
2688064|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2688065|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
2688066|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688067|NCT02238509|Trastuzumab|trastuzumab|mesh-list
2688068|NCT02238509|Lapatinib|lapatinib|mesh-list
2688069|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2688070|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688071|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2688072|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688073|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688074|NCT02238535|Iloprost|iloprost|mesh-list
2688075|NCT02238535|Warfarin|warfarin|mesh-list
2688076|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
2688077|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2688078|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
2688079|NCT02238548|Vaccines|vaccines|mesh-list
2688080|NCT02238548|Immunologic Factors|immunologic factors|mesh-ancestor
2688081|NCT02238548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688082|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
2688083|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2688084|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2688085|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688086|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
2688087|NCT02238639|Coagulants|coagulants|mesh-ancestor
2688088|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
2688089|NCT02238704|Iron|iron|mesh-list
2688090|NCT02238704|Folic Acid|folic acid|mesh-list
2688091|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
2190001|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190002|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190003|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
2190004|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190005|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2190006|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190007|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
2190008|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190009|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2190010|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
2688092|NCT02238704|Calcium|calcium|mesh-list
2688093|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2688094|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688095|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2688096|NCT02238704|Trace Elements|trace elements|mesh-ancestor
2688097|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
2688098|NCT02238704|Hematinics|hematinics|mesh-ancestor
2688099|NCT02238704|Vitamins|vitamins|mesh-ancestor
2688100|NCT02238717|Pregabalin|pregabalin|mesh-list
2688101|NCT02238717|PF-06372865|pf-06372865|mesh-list
2688102|NCT02238717|Analgesics|analgesics|mesh-ancestor
2688103|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
2688104|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688105|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688106|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
2688107|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2688108|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2688109|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190011|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
2423325|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688110|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2688111|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2688112|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2688113|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688114|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2688115|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
2688116|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
2688117|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688118|NCT02238808|Estradiol|estradiol|mesh-list
2688119|NCT02238808|Estrogens|estrogens|mesh-list
2688120|NCT02238808|Hormones|hormones|mesh-ancestor
2688121|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2688122|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688123|NCT02238860|Tenofovir|tenofovir|mesh-list
2688124|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
2688125|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688126|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2688127|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2688128|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688129|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688130|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2190012|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2190013|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2190014|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
2190015|NCT00003401|Hormones|hormones|mesh-ancestor
2190016|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2190017|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2190018|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2688131|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2688132|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
2688133|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2688134|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
2688135|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688136|NCT02239107|Expectorants|expectorants|mesh-ancestor
2688137|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
2688138|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2688139|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
2688140|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688141|NCT02239107|Protective Agents|protective agents|mesh-ancestor
2688142|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688143|NCT02239107|Antidotes|antidotes|mesh-ancestor
2688144|NCT02239276|Stiripentol|stiripentol|mesh-list
2688145|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
2688146|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
2688147|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
2688148|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2688149|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688150|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688151|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2688152|NCT02239445|Analgesics|analgesics|mesh-ancestor
2688153|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
2688154|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688155|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2688156|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2688157|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2688158|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
2688159|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688160|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688161|NCT02239458|Saxagliptin|saxagliptin|mesh-list
2688162|NCT02239458|Incretins|incretins|mesh-ancestor
2688163|NCT02239458|Hormones|hormones|mesh-ancestor
2688164|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2688165|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688166|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2688167|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
2688168|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688169|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688170|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2688171|NCT02239484|Tadalafil|tadalafil|mesh-list
2688172|NCT02239484|Tamsulosin|tamsulosin|mesh-list
2688173|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
2688174|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2688175|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2688176|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688177|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688178|NCT02239484|Urological Agents|urological agents|mesh-ancestor
2688179|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2688180|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2688181|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2688182|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
2688183|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688184|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688185|NCT02239523|Denosumab|denosumab|mesh-list
2688186|NCT02239523|Teriparatide|teriparatide|mesh-list
2688187|NCT02239523|Diphosphonates|diphosphonates|mesh-list
2688188|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2688189|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688190|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2688191|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2688192|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
2688193|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
2688194|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688195|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2688196|NCT02239614|Antacids|antacids|mesh-ancestor
2688197|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688198|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2688199|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2688200|NCT02239731|Doxycycline|doxycycline|mesh-list
2688201|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688202|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
2688203|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2688204|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2688205|NCT02239835|Ritonavir|ritonavir|mesh-list
2688206|NCT02239835|Saquinavir|saquinavir|mesh-list
2688207|NCT02239835|Tipranavir|tipranavir|mesh-list
2688208|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2688209|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2688210|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
2688211|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688212|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688213|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2688214|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2688215|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
2688216|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688217|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2688218|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2688219|NCT02239874|Vitamin D|vitamin d|mesh-list
2688220|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
2688221|NCT02239874|Vitamins|vitamins|mesh-list
2688222|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
2688223|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688224|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2688225|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2688226|NCT02239900|Ipilimumab|ipilimumab|mesh-list
2688227|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2688228|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688229|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2688230|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688231|NCT02239913|Topiramate|topiramate|mesh-list
2688232|NCT02239913|Phentermine|phentermine|mesh-list
2688233|NCT02239913|Cocaine|cocaine|mesh-list
2688234|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
2688235|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2688236|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688237|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
2688238|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
2688239|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688240|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
2688241|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688242|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2688243|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2688244|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2688245|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2688246|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688247|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
2688248|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688249|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2688250|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
2688251|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2688252|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
2688253|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
2688254|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
2688255|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2688256|NCT02239952|Sunitinib|sunitinib|mesh-list
2688257|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688258|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2688259|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688260|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688261|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2688262|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2688263|NCT02239952|Growth Substances|growth substances|mesh-ancestor
2688264|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688265|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
2688266|NCT02240017|Gemcitabine|gemcitabine|mesh-list
2688267|NCT02240017|Carboplatin|carboplatin|mesh-list
2688268|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688269|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2688270|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
2688271|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688272|NCT02240017|Antiviral Agents|antiviral agents|mesh-ancestor
2688273|NCT02240017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688274|NCT02240017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688275|NCT02240017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2688276|NCT02240017|Immunologic Factors|immunologic factors|mesh-ancestor
2688277|NCT02240017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688278|NCT02240043|Hormones|hormones|mesh-list
2688279|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2688280|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688281|NCT02240160|Nabiximols|nabiximols|mesh-list
2688282|NCT02240160|Analgesics|analgesics|mesh-ancestor
2688283|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
2688284|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688285|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688286|NCT02240173|Haloperidol|haloperidol|mesh-list
2688287|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
2688288|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
2688289|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
2688290|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688291|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688292|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2688293|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2688294|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2688295|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688296|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2688297|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2688298|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
2688299|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688300|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688301|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2688302|NCT02240199|Lidocaine|lidocaine|mesh-list
2688303|NCT02240199|Pregabalin|pregabalin|mesh-list
2688304|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
2688305|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
2688306|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688307|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688308|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
2688309|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688310|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2688311|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2688312|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2688313|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2688314|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688315|NCT02240199|Analgesics|analgesics|mesh-ancestor
2688316|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
2688317|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2190019|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
2190020|NCT00003401|Antiviral Agents|antiviral agents|mesh-ancestor
2190021|NCT00003401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190022|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190023|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2190024|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190025|NCT00003402|Dexamethasone|dexamethasone|mesh-list
2190026|NCT00003402|Paclitaxel|paclitaxel|mesh-list
2190027|NCT00003402|Etoposide|etoposide|mesh-list
2190028|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
2190029|NCT00003402|Melphalan|melphalan|mesh-list
2190030|NCT00003402|Carmustine|carmustine|mesh-list
2688318|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2688319|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2688320|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2688321|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2688322|NCT02240212|Paclitaxel|paclitaxel|mesh-list
2688323|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2688324|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688325|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
2688326|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
2688327|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
2688328|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688329|NCT02240238|Gemcitabine|gemcitabine|mesh-list
2688330|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2688331|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
2688332|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688333|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688334|NCT02240238|Antiviral Agents|antiviral agents|mesh-ancestor
2688335|NCT02240238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688336|NCT02240238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688337|NCT02240238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2688338|NCT02240238|Immunologic Factors|immunologic factors|mesh-ancestor
2688339|NCT02240238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688340|NCT02240407|Acetaminophen|acetaminophen|mesh-list
2688341|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
2688342|NCT02240407|Promethazine|promethazine|mesh-list
2688343|NCT02240407|Sirolimus|sirolimus|mesh-list
2688344|NCT02240407|Rituximab|rituximab|mesh-list
2688345|NCT02240407|Lidocaine|lidocaine|mesh-list
2688346|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2688347|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688348|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
2688349|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688350|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2190031|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190032|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190033|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
2688351|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
2688352|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
2688353|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688354|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
2688355|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688356|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2688357|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2688358|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2688359|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2688360|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688361|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2688362|NCT02240407|Analgesics|analgesics|mesh-ancestor
2688363|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
2688364|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2688365|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688366|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2688367|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
2688368|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2688369|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2688370|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2688371|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
2688372|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
2688373|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2688374|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2688375|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
2688376|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
2190034|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190035|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
2688377|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688378|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2688379|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
2688380|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
2688381|NCT02240433|Sorafenib|sorafenib|mesh-list
2688382|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688383|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2688384|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688385|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190036|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688386|NCT02240459|Fesoterodine|fesoterodine|mesh-list
2688387|NCT02240459|Oxybutynin|oxybutynin|mesh-list
2190037|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190038|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
2190039|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190040|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2190041|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190042|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
2190043|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190044|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2190045|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
2190046|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
2190047|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2190048|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2190049|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
2190050|NCT00003402|Hormones|hormones|mesh-ancestor
2190051|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2190052|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2190053|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2190054|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190055|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190056|NCT00003405|Interferons|interferons|mesh-list
2190057|NCT00003405|Cytarabine|cytarabine|mesh-list
2190058|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
2190059|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
2190060|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
2190061|NCT00003405|Idoxuridine|idoxuridine|mesh-list
2190062|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
2190063|NCT00003405|Idarubicin|idarubicin|mesh-list
2190064|NCT00003405|Isotretinoin|isotretinoin|mesh-list
2190065|NCT00003405|Amifostine|amifostine|mesh-list
2688388|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2688389|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2688390|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
2688391|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688392|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688393|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688394|NCT02240459|Urological Agents|urological agents|mesh-ancestor
2688395|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
2688396|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
2190066|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190067|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
2190068|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190069|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190070|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
2190071|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190072|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2688397|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688398|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2688399|NCT02240498|Methylene Blue|methylene blue|mesh-list
2688400|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2688401|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2688402|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2688403|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688404|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688405|NCT02240537|Sargramostim|sargramostim|mesh-list
2688406|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
2688407|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688408|NCT02240602|Oxycodone|oxycodone|mesh-list
2688409|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2688410|NCT02240602|Narcotics|narcotics|mesh-ancestor
2688411|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688412|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688413|NCT02240602|Analgesics|analgesics|mesh-ancestor
2190073|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
2190074|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688414|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
2688415|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688416|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
2688417|NCT02240641|Lacidipine|lacidipine|mesh-list
2688418|NCT02240641|Diuretics|diuretics|mesh-list
2688419|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2688420|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2688421|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2688422|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
2688423|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
2190075|NCT00003405|Analgesics|analgesics|mesh-ancestor
2190076|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
2688424|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688425|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2688426|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
2688427|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688428|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688429|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
2688430|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2688431|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2688432|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2688433|NCT02240719|Everolimus|everolimus|mesh-list
2688434|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2688435|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688436|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2688437|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
2688438|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688439|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2688440|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
2688441|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688442|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2688443|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
2688444|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688445|NCT02240927|Enoxaparin|enoxaparin|mesh-list
2688446|NCT02240927|Warfarin|warfarin|mesh-list
2688447|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
2688448|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
2688449|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2688450|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2688451|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688452|NCT02240953|Warfarin|warfarin|mesh-list
2688453|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
2688454|NCT02241005|Allantoin|allantoin|mesh-list
2688455|NCT02241005|Dermatologic Agents|dermatologic agents|mesh-ancestor
2688456|NCT02241018|Antibodies|antibodies|mesh-list
2688457|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2688458|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2688459|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
2688460|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688461|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688462|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688463|NCT02241031|Oprelvekin|oprelvekin|mesh-list
2688464|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688465|NCT02241083|Dopamine|dopamine|mesh-list
2688466|NCT02241083|Norepinephrine|norepinephrine|mesh-list
2688467|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2688468|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2688469|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
2688470|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688471|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688472|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688473|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
2688474|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
2688475|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688476|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2688477|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2190077|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2190078|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2190079|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190080|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190081|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2190082|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
2190083|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2190084|NCT00003405|Protective Agents|protective agents|mesh-ancestor
2688478|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
2688479|NCT02241083|Protective Agents|protective agents|mesh-ancestor
2688480|NCT02241096|Lidocaine|lidocaine|mesh-list
2688481|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
2688482|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
2688483|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688484|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688485|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
2688486|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688487|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2688488|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2688489|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2688490|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2688491|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688492|NCT02241148|Acetaminophen|acetaminophen|mesh-list
2688493|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2688494|NCT02241148|Analgesics|analgesics|mesh-ancestor
2688495|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
2688496|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688497|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688498|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
2688499|NCT02241161|Bacteriocins|bacteriocins|mesh-list
2688500|NCT02241161|Antioxidants|antioxidants|mesh-list
2688501|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688502|NCT02241161|Protective Agents|protective agents|mesh-ancestor
2688503|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688504|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2688505|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688506|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2688507|NCT02241174|Eusol|eusol|mesh-list
2688508|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
2688509|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688510|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
2688511|NCT02241200|Hematinics|hematinics|mesh-ancestor
2688512|NCT02241278|Ketamine|ketamine|mesh-list
2688513|NCT02241278|Analgesics|analgesics|mesh-ancestor
2688514|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
2688515|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688516|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688517|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2688518|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2688519|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
2688520|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
2190085|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2190086|NCT00003406|Carboplatin|carboplatin|mesh-list
2190087|NCT00003406|Docetaxel|docetaxel|mesh-list
2190088|NCT00003406|Ifosfamide|ifosfamide|mesh-list
2190089|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190090|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190091|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190092|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190093|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190094|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2688521|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688522|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2688523|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2688524|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688525|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688526|NCT02241356|Methamphetamine|methamphetamine|mesh-list
2688527|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2688528|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688529|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
2688530|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
2688531|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688532|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
2688533|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688534|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688535|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
2688536|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2688537|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2688538|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2688539|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2688540|NCT02241421|Amoxicillin|amoxicillin|mesh-list
2688541|NCT02241421|Vancomycin|vancomycin|mesh-list
2688542|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2688543|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688544|NCT02241460|Lidocaine|lidocaine|mesh-list
2688545|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
2688546|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
2688547|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688548|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688549|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
2688550|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688551|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2688552|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2688553|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2688554|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2688555|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190095|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
2688556|NCT02241499|Fluorouracil|fluorouracil|mesh-list
2688557|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
2688558|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
2688559|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688560|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2688561|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688562|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2688563|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
2688564|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688565|NCT02241564|Sirolimus|sirolimus|mesh-list
2190096|NCT00003407|Cytarabine|cytarabine|mesh-list
2190097|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
2190098|NCT00003407|Amifostine|amifostine|mesh-list
2190099|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190100|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
2688566|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2688567|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688568|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688569|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2688570|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688571|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2688572|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688573|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
2688574|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2688575|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
2688576|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688577|NCT02241590|Entecavir|entecavir|mesh-list
2688578|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
2688579|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688580|NCT02241616|Entecavir|entecavir|mesh-list
2688581|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
2688582|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688583|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
2688584|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2688585|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688586|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2688587|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2688588|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688589|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688590|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688591|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
2688592|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2688593|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
2688594|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688595|NCT02241876|Expectorants|expectorants|mesh-ancestor
2688596|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
2688597|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2688598|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
2688599|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688600|NCT02241876|Protective Agents|protective agents|mesh-ancestor
2688601|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688602|NCT02241876|Antidotes|antidotes|mesh-ancestor
2688603|NCT02241941|Daptomycin|daptomycin|mesh-list
2688604|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2688605|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688606|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2688607|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2688608|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2688609|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2688610|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2688611|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688612|NCT02242149|Diacetylrhein|diacetylrhein|mesh-list
2688613|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2688614|NCT02242214|Misoprostol|misoprostol|mesh-list
2688615|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2688616|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
2688617|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2688618|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688619|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2688620|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2190101|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190102|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190103|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
2190104|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190105|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2688621|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
2688622|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2190106|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
2190107|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688623|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2688624|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
2688625|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688626|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688627|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2688628|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
2688629|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2688630|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2688631|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2688632|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
2688633|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688634|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688635|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
2688636|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
2688637|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2688638|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
2688639|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688640|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688641|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2688642|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
2688643|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2688644|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2688645|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2688646|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
2688647|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688648|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688649|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
2688650|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2688651|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
2688652|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
2688653|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2688654|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2688655|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
2688656|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2190108|NCT00003407|Analgesics|analgesics|mesh-ancestor
2190109|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
2190110|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2190111|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2190112|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190113|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190114|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2190115|NCT00003407|Protective Agents|protective agents|mesh-ancestor
2190116|NCT00003408|Interferons|interferons|mesh-list
2190117|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
2688657|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688658|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2688659|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
2688660|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
2688661|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2688662|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
2688663|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688664|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688665|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2688666|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2688667|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2688668|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
2688669|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
2688670|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2688671|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
2688672|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688673|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688674|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2688675|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
2688676|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
2688677|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2688678|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
2688679|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688680|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688681|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
2688682|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2688683|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
2688684|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688685|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688686|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2688687|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
2688688|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
2688689|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2688690|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
2688691|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688692|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688693|NCT02242292|Scopolamine|scopolamine|mesh-list
2688694|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2688695|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2688696|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
2688697|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
2688698|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688699|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688700|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2688701|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
2688702|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2688703|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
2688704|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688705|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688706|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2688707|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
2688708|NCT02242318|Valsartan|valsartan|mesh-list
2688709|NCT02242318|Telmisartan|telmisartan|mesh-list
2688710|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688711|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688712|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688713|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688714|NCT02242331|Telmisartan|telmisartan|mesh-list
2688715|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688716|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688717|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688718|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688719|NCT02242344|Telmisartan|telmisartan|mesh-list
2688720|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688721|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688722|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688723|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688724|NCT02242357|Telmisartan|telmisartan|mesh-list
2688725|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688726|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688727|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688728|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688729|NCT02242370|Telmisartan|telmisartan|mesh-list
2688730|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688731|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688732|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688733|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688734|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2688735|NCT02242383|Telmisartan|telmisartan|mesh-list
2688736|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688737|NCT02242383|Diuretics|diuretics|mesh-ancestor
2688738|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
2688739|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688740|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2688741|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2190118|NCT00003408|Aldesleukin|aldesleukin|mesh-list
2190119|NCT00003408|Sargramostim|sargramostim|mesh-list
2190120|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190121|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
2190122|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190123|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
2190124|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190125|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2190126|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2190127|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
2190128|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190129|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2190130|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
2190131|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
2190132|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190133|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2190134|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
2190135|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
2190136|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190137|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2190138|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
2190139|NCT00003412|Interleukin-12|interleukin-12|mesh-list
2190140|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2190141|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
2190142|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190143|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2190144|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2190145|NCT00003412|Growth Substances|growth substances|mesh-ancestor
2190146|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
2190147|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190148|NCT00003413|Paclitaxel|paclitaxel|mesh-list
2190149|NCT00003413|Melphalan|melphalan|mesh-list
2190150|NCT00003413|Carmustine|carmustine|mesh-list
2190151|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190152|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688742|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688743|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688744|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688745|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2688746|NCT02242396|Telmisartan|telmisartan|mesh-list
2688747|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
2688748|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688749|NCT02242396|Diuretics|diuretics|mesh-ancestor
2688750|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
2688751|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688752|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2688753|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2688754|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688755|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688756|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688757|NCT02242409|Gemcitabine|gemcitabine|mesh-list
2688758|NCT02242409|Paclitaxel|paclitaxel|mesh-list
2688759|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2688760|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2688761|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688762|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
2688763|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
2688764|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
2688765|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688766|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2688767|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
2688768|NCT02242409|Antiviral Agents|antiviral agents|mesh-ancestor
2688769|NCT02242409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688770|NCT02242409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688771|NCT02242409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2688772|NCT02242409|Immunologic Factors|immunologic factors|mesh-ancestor
2688773|NCT02242409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688774|NCT02242474|Adalimumab|adalimumab|mesh-list
2688775|NCT02242474|Etanercept|etanercept|mesh-list
2688776|NCT02242474|Golimumab|golimumab|mesh-list
2688777|NCT02242474|Infliximab|infliximab|mesh-list
2688778|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
2688779|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2688780|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2688781|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2688782|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2688783|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2688784|NCT02242474|Analgesics|analgesics|mesh-ancestor
2688785|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
2688786|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688787|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688788|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2688789|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2688790|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
2688791|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
2688792|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2688793|NCT02242513|Lidocaine|lidocaine|mesh-list
2688794|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
2190153|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
2688795|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
2688796|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688797|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688798|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
2688799|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688800|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2190154|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190155|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190156|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190157|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
2190158|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190159|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190160|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
2190161|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190162|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190163|NCT00003414|Interferons|interferons|mesh-list
2190164|NCT00003414|Aldesleukin|aldesleukin|mesh-list
2190165|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
2190166|NCT00003414|Cyclosporine|cyclosporine|mesh-list
2688801|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2688802|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2688803|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2688804|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688805|NCT02242591|Ropivacaine|ropivacaine|mesh-list
2688806|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
2688807|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
2688808|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688809|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688810|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
2688811|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688812|NCT02242656|Opium|opium|mesh-list
2688813|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2688814|NCT02242656|Narcotics|narcotics|mesh-ancestor
2688815|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688816|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688817|NCT02242656|Analgesics|analgesics|mesh-ancestor
2688818|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
2688819|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688820|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
2688821|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2688822|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
2688823|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
2688824|NCT02242695|Clotrimazole|clotrimazole|mesh-list
2688825|NCT02242695|Dequalinium|dequalinium|mesh-list
2688826|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2688827|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688828|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
2688829|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2688830|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2688831|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688832|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688833|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2688834|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
2688835|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2688836|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688837|NCT02242734|Hydrocodone|hydrocodone|mesh-list
2688838|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2688839|NCT02242734|Narcotics|narcotics|mesh-ancestor
2688840|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688841|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190167|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
2190168|NCT00003414|Busulfan|busulfan|mesh-list
2190169|NCT00003414|Cyclosporins|cyclosporins|mesh-list
2190170|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190171|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
2190172|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190173|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2688842|NCT02242734|Analgesics|analgesics|mesh-ancestor
2688843|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
2688844|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688845|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
2688846|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
2688847|NCT02242799|Artesunate|artesunate|mesh-list
2688848|NCT02242799|Lumefantrine|lumefantrine|mesh-list
2688849|NCT02242799|Artemether|artemether|mesh-list
2688850|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2190174|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2688851|NCT02242799|Amodiaquine|amodiaquine|mesh-list
2688852|NCT02242799|Dolutegravir|dolutegravir|mesh-list
2688853|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
2688854|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2688855|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2688856|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2688857|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688858|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
2688859|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
2688860|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2688861|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
2688862|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2688863|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2688864|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688865|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688866|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2688867|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2688868|NCT02242812|Metoprolol|metoprolol|mesh-list
2688869|NCT02242812|Telmisartan|telmisartan|mesh-list
2688870|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688871|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688872|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688873|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688874|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2688875|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
2688876|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
2688877|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688878|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688879|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2688880|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2688881|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2688882|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
2688883|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2688884|NCT02242825|Telmisartan|telmisartan|mesh-list
2688885|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
2688886|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688887|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688888|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688889|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688890|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2688891|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2688892|NCT02242825|Diuretics|diuretics|mesh-ancestor
2688893|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
2688894|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688895|NCT02242838|Telmisartan|telmisartan|mesh-list
2688896|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688897|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688898|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688899|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688900|NCT02242851|Telmisartan|telmisartan|mesh-list
2688901|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688902|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688903|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688904|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688905|NCT02242864|Telmisartan|telmisartan|mesh-list
2688906|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
2688907|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688908|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688909|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688910|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688911|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2688912|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2688913|NCT02242864|Diuretics|diuretics|mesh-ancestor
2688914|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
2688915|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688916|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2688917|NCT02242877|Telmisartan|telmisartan|mesh-list
2688918|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2688919|NCT02242877|Diuretics|diuretics|mesh-ancestor
2688920|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
2688921|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688922|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2688923|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2688924|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688925|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2688926|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2688927|NCT02242929|Imiquimod|imiquimod|mesh-list
2688928|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2688929|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
2688930|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688931|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688932|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
2688933|NCT02242955|Diazepam|diazepam|mesh-list
2688934|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2688935|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
2688936|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
2688937|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
2688938|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688939|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688940|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2688941|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2688942|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2688943|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2688944|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2688945|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2688946|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2688947|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2688948|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2688949|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
2688950|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
2688951|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
2688952|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
2688953|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2190175|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
2190176|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190177|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190178|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190179|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
2190180|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190181|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190182|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
2190183|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
2190184|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2190185|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2190186|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2688954|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688955|NCT02243098|Digoxin|digoxin|mesh-list
2688956|NCT02243098|Atorvastatin|atorvastatin|mesh-list
2688957|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2688958|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2688959|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
2688960|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688961|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2688962|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2688963|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688964|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2688965|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2688966|NCT02243098|Protective Agents|protective agents|mesh-ancestor
2688967|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688968|NCT02243124|Dexamethasone|dexamethasone|mesh-list
2688969|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2688970|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
2688971|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
2190187|NCT00003415|Topotecan|topotecan|mesh-list
2190188|NCT00003415|Amifostine|amifostine|mesh-list
2190189|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2190190|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190191|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190192|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190193|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190194|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2190195|NCT00003415|Protective Agents|protective agents|mesh-ancestor
2190196|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190197|NCT00003416|Interferons|interferons|mesh-list
2190198|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
2190199|NCT00003416|Dexamethasone|dexamethasone|mesh-list
2190200|NCT00003416|Melphalan|melphalan|mesh-list
2688972|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688973|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688974|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2688975|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
2688976|NCT02243124|Hormones|hormones|mesh-ancestor
2688977|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2688978|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2688979|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2688980|NCT02243137|Aspirin|aspirin|mesh-list
2688981|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
2688982|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2688983|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2688984|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2688985|NCT02243137|Analgesics|analgesics|mesh-ancestor
2688986|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
2688987|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2688988|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2688989|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2688990|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2688991|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2688992|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2688993|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2688994|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2688995|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2688996|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2688997|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
2688998|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
2688999|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2689000|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2689001|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2689002|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2689003|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2689004|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689005|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689006|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689007|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2689008|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
2689009|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2689010|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689011|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2689012|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2689013|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2689014|NCT02243254|Ibuprofen|ibuprofen|mesh-list
2689015|NCT02243254|Remifentanil|remifentanil|mesh-list
2689016|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2689017|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2689018|NCT02243254|Analgesics|analgesics|mesh-ancestor
2689019|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
2689020|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689021|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689022|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2689023|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2689024|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2190201|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2190202|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
2190203|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
2190204|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2190205|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190206|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2190207|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
2190208|NCT00003416|Hormones|hormones|mesh-ancestor
2190209|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2190210|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2190211|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190212|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
2190213|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190214|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
2190215|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190216|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
2190217|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190218|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190219|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190220|NCT00003417|Carmustine|carmustine|mesh-list
2689025|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689026|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689027|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2689028|NCT02243254|Narcotics|narcotics|mesh-ancestor
2689029|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689030|NCT02243358|Gemcitabine|gemcitabine|mesh-list
2689031|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2689032|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
2689033|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689034|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689035|NCT02243358|Antiviral Agents|antiviral agents|mesh-ancestor
2689036|NCT02243358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2689037|NCT02243358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689038|NCT02243358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2689039|NCT02243358|Immunologic Factors|immunologic factors|mesh-ancestor
2689040|NCT02243358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689041|NCT02243436|Cytarabine|cytarabine|mesh-list
2689042|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
2689043|NCT02243436|Etoposide|etoposide|mesh-list
2689044|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2689045|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689046|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2689047|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2689048|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2689049|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689050|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689051|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190221|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190222|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
2190223|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190224|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190225|NCT00003418|Tamoxifen|tamoxifen|mesh-list
2190226|NCT00003418|Exemestane|exemestane|mesh-list
2190227|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190228|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2190229|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
2190230|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2689052|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
2689053|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
2689054|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2689055|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2689056|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
2689057|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689058|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2689059|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
2689060|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
2689061|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689062|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2689063|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
2689064|NCT02243436|Hormones|hormones|mesh-ancestor
2689065|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2689066|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2689067|NCT02243436|Protective Agents|protective agents|mesh-ancestor
2689068|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2689069|NCT02243553|Vitamin K|vitamin k|mesh-list
2689070|NCT02243553|Ritonavir|ritonavir|mesh-list
2689071|NCT02243553|Tipranavir|tipranavir|mesh-list
2689072|NCT02243553|Digoxin|digoxin|mesh-list
2689073|NCT02243553|Midazolam|midazolam|mesh-list
2689074|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
2689075|NCT02243553|Caffeine|caffeine|mesh-list
2689076|NCT02243553|Omeprazole|omeprazole|mesh-list
2689077|NCT02243553|Warfarin|warfarin|mesh-list
2689078|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2689079|NCT02243553|Vitamins|vitamins|mesh-ancestor
2689080|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
2689081|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689082|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2689083|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2689084|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689085|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2689086|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2689087|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2689088|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2689089|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
2689090|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
2689091|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
2689092|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
2689093|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689094|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689095|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2689096|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2689097|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
2689098|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689099|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2689100|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2689101|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
2689102|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2689103|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2689104|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2689105|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
2689106|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2689107|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2689108|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2689109|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2689110|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2689111|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2689112|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2689113|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
2689114|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2689115|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2689116|NCT02243553|Protective Agents|protective agents|mesh-ancestor
2689117|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2689118|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2689119|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
2689120|NCT02243553|Coagulants|coagulants|mesh-ancestor
2689121|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
2689122|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
2689123|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2689124|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2689125|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2689126|NCT02243566|Telmisartan|telmisartan|mesh-list
2689127|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
2689128|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2689129|NCT02243566|Diuretics|diuretics|mesh-ancestor
2689130|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
2689131|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689132|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2689133|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2689134|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689135|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2689136|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2689137|NCT02243618|Rebamipide|rebamipide|mesh-list
2689138|NCT02243618|Polaprezinc|polaprezinc|mesh-list
2689139|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2689140|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2689141|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
2689142|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689143|NCT02243618|Protective Agents|protective agents|mesh-ancestor
2689144|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689145|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689146|NCT02243631|Probenecid|probenecid|mesh-list
2689147|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
2689148|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
2689149|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2689150|NCT02243631|Renal Agents|renal agents|mesh-ancestor
2689151|NCT02243644|Albendazole|albendazole|mesh-list
2689152|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
2689153|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2689154|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2689155|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
2689156|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2689157|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2689158|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190231|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190232|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2190233|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190234|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2190235|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2190236|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2689159|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
2689160|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
2689161|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689162|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689179|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
2689180|NCT02243735|Trace Elements|trace elements|mesh-ancestor
2689181|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
2689182|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689183|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
2689184|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2689185|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689186|NCT02243800|Vitamins|vitamins|mesh-ancestor
2689187|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
2689188|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2689189|NCT02243813|Psilocybin|psilocybin|mesh-list
2689190|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
2689191|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689192|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2689193|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
2689194|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2689195|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
2689196|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
2689197|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689198|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689199|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2689200|NCT02243826|Analgesics|analgesics|mesh-ancestor
2190237|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2190238|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2190239|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190240|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
2190241|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190242|NCT00003421|Prednisolone|prednisolone|mesh-list
2689201|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
2689202|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689203|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
2689204|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2689205|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689206|NCT02243852|Hormones|hormones|mesh-list
2689207|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2689208|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689209|NCT02243878|Ranibizumab|ranibizumab|mesh-list
2689210|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2689211|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2689212|NCT02243878|Growth Substances|growth substances|mesh-ancestor
2689213|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689214|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
2689215|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689216|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2689217|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2689218|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689219|NCT02244073|Insulin|insulin|mesh-list
2689220|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2689221|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2689222|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689223|NCT02244086|Bupivacaine|bupivacaine|mesh-list
2689224|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
2689225|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
2689226|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689227|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689228|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
2689229|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689230|NCT02244112|Midazolam|midazolam|mesh-list
2689231|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2689232|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2689233|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689234|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689235|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2689236|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2689237|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2689238|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2689239|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
2689240|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
2689241|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
2689242|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
2689243|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689244|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689245|NCT02244125|Dexamethasone|dexamethasone|mesh-list
2689246|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
2689247|NCT02244125|Pomalidomide|pomalidomide|mesh-list
2689248|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2689249|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
2689250|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689251|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2689252|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2689253|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
2689254|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689255|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689256|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2689257|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2689258|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
2689259|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
2689260|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689261|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2689262|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
2689263|NCT02244125|Hormones|hormones|mesh-ancestor
2689264|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2689265|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2689266|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2689267|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2689268|NCT02244125|Growth Substances|growth substances|mesh-ancestor
2689269|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
2689270|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2689271|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
2689272|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2689273|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
2689274|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2689275|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689276|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2689277|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2689278|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689279|NCT02244164|Liraglutide|liraglutide|mesh-list
2689280|NCT02244164|Exenatide|exenatide|mesh-list
2689281|NCT02244164|Lixisenatide|lixisenatide|mesh-list
2689282|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2689283|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2689284|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689285|NCT02244164|Incretins|incretins|mesh-ancestor
2689286|NCT02244164|Hormones|hormones|mesh-ancestor
2689287|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2689288|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2689289|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
2689290|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689291|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689292|NCT02244190|Ritonavir|ritonavir|mesh-list
2689293|NCT02244190|Tipranavir|tipranavir|mesh-list
2689294|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2689295|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2689296|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
2689297|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689298|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689299|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2689300|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2689301|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
2689302|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2689303|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2689304|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2689305|NCT02244216|Fenoterol|fenoterol|mesh-list
2689306|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2689307|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
2689308|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689309|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689310|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2689311|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
2689312|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
2689313|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
2689314|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2689315|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2689316|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2689317|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2689318|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689319|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689320|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689321|NCT02244229|Tamsulosin|tamsulosin|mesh-list
2689322|NCT02244229|Finasteride|finasteride|mesh-list
2689323|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2689324|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2689325|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2689326|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689327|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689328|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689329|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689330|NCT02244229|Urological Agents|urological agents|mesh-ancestor
2689331|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2689332|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2689333|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689334|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
2689335|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2689336|NCT02244242|Tamsulosin|tamsulosin|mesh-list
2689337|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2689338|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2689339|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2689340|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689341|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689342|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689343|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689344|NCT02244242|Urological Agents|urological agents|mesh-ancestor
2689345|NCT02244255|Tamsulosin|tamsulosin|mesh-list
2689346|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2689347|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2689348|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2689349|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689350|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689351|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689352|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689353|NCT02244255|Urological Agents|urological agents|mesh-ancestor
2689354|NCT02244268|Tamsulosin|tamsulosin|mesh-list
2689355|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2689356|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2689357|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2689358|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689359|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689360|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689361|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689362|NCT02244268|Urological Agents|urological agents|mesh-ancestor
2190243|NCT00003421|Doxorubicin|doxorubicin|mesh-list
2190244|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2190245|NCT00003421|Bleomycin|bleomycin|mesh-list
2190246|NCT00003421|Etoposide|etoposide|mesh-list
2190247|NCT00003421|Vincristine|vincristine|mesh-list
2190248|NCT00003421|Dacarbazine|dacarbazine|mesh-list
2190249|NCT00003421|Vinblastine|vinblastine|mesh-list
2190250|NCT00003421|Procarbazine|procarbazine|mesh-list
2190251|NCT00003421|Chlorambucil|chlorambucil|mesh-list
2689363|NCT02244281|Tamsulosin|tamsulosin|mesh-list
2689364|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2689365|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2689366|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2190252|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2190253|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689367|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689368|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689369|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689370|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689371|NCT02244281|Urological Agents|urological agents|mesh-ancestor
2689372|NCT02244294|Tamsulosin|tamsulosin|mesh-list
2689373|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2689374|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2689375|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2689376|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689377|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689378|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689379|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190254|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2190255|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190256|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190257|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190258|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190259|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190260|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190261|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190262|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2190263|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
2190264|NCT00003421|Hormones|hormones|mesh-ancestor
2190265|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2190266|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190267|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2190268|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190269|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
2190270|NCT00003422|Leucovorin|leucovorin|mesh-list
2190271|NCT00003422|Fluorouracil|fluorouracil|mesh-list
2190272|NCT00003422|Calcium|calcium|mesh-list
2190273|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
2190274|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2190275|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190276|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
2689380|NCT02244294|Urological Agents|urological agents|mesh-ancestor
2689381|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
2689382|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
2689383|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
2689384|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689385|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689386|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689387|NCT02244320|Tamsulosin|tamsulosin|mesh-list
2689388|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2689389|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2689390|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2689391|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689392|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689393|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689394|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689395|NCT02244320|Urological Agents|urological agents|mesh-ancestor
2689396|NCT02244437|Acetaminophen|acetaminophen|mesh-list
2689397|NCT02244437|Ibuprofen|ibuprofen|mesh-list
2689398|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2689399|NCT02244437|Analgesics|analgesics|mesh-ancestor
2689400|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
2689401|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689402|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689403|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
2689404|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2190277|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190278|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190279|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190280|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190281|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
2190282|NCT00003422|Antidotes|antidotes|mesh-ancestor
2190283|NCT00003422|Protective Agents|protective agents|mesh-ancestor
2190284|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
2190285|NCT00003422|Vitamins|vitamins|mesh-ancestor
2190286|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
2190287|NCT00003423|Cytarabine|cytarabine|mesh-list
2190288|NCT00003423|Dexamethasone|dexamethasone|mesh-list
2190289|NCT00003423|Prednisolone|prednisolone|mesh-list
2689405|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2689406|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2689407|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2689408|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689409|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689410|NCT02244489|Capecitabine|capecitabine|mesh-list
2689411|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
2689412|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2689413|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2689414|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
2689415|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689416|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689417|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2190290|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
2190291|NCT00003423|Methotrexate|methotrexate|mesh-list
2190292|NCT00003423|Etoposide|etoposide|mesh-list
2190293|NCT00003423|Vincristine|vincristine|mesh-list
2190294|NCT00003423|Daunorubicin|daunorubicin|mesh-list
2689418|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689419|NCT02244502|Paclitaxel|paclitaxel|mesh-list
2689420|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2689421|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689422|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
2689423|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
2689424|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
2689425|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689426|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
2689427|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2689428|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689429|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689430|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2689431|NCT02244515|Analgesics|analgesics|mesh-ancestor
2689432|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
2689433|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689434|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2689435|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2689436|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2689437|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689438|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689439|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689440|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
2689441|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
2689442|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2689443|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2689444|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689445|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689446|NCT02244528|Urological Agents|urological agents|mesh-ancestor
2689447|NCT02244567|Metformin|metformin|mesh-list
2689448|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689449|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2689450|NCT02244606|Fluconazole|fluconazole|mesh-list
2689451|NCT02244606|Micafungin|micafungin|mesh-list
2689452|NCT02244606|Ibrexafungerp|ibrexafungerp|mesh-list
2689453|NCT02244606|Antifungal Agents|antifungal agents|mesh-ancestor
2689454|NCT02244606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2689455|NCT02244606|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2689456|NCT02244606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2689457|NCT02244606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689458|NCT02244606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689459|NCT02244606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2689460|NCT02244606|Hormone Antagonists|hormone antagonists|mesh-ancestor
2689461|NCT02244606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2689462|NCT02244606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689463|NCT02244606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2689464|NCT02244606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2689465|NCT02244632|Bevacizumab|bevacizumab|mesh-list
2689466|NCT02244632|Fluorouracil|fluorouracil|mesh-list
2689467|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
2689468|NCT02244632|Irinotecan|irinotecan|mesh-list
2689469|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2689470|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689471|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2190295|NCT00003423|Asparaginase|asparaginase|mesh-list
2190296|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
2689472|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2689473|NCT02244632|Growth Substances|growth substances|mesh-ancestor
2689474|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689475|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
2689476|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
2689477|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689478|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190297|NCT00003423|Thioguanine|thioguanine|mesh-list
2190298|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190299|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
2689479|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2689480|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
2689481|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2689482|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2689483|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689484|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
2689485|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2689486|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2689487|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689488|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
2689489|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689490|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689491|NCT02244710|Clopidogrel|clopidogrel|mesh-list
2689492|NCT02244710|Ticagrelor|ticagrelor|mesh-list
2689493|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2689494|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2689495|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2689496|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2689497|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
2689498|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689499|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689500|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689501|NCT02244762|Hydrocodone|hydrocodone|mesh-list
2689502|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2689503|NCT02244762|Narcotics|narcotics|mesh-ancestor
2689504|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689505|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689506|NCT02244762|Analgesics|analgesics|mesh-ancestor
2689507|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
2689508|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689509|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
2689510|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
2689511|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
2689512|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2689513|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2689514|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2689515|NCT02244866|Hormones|hormones|mesh-ancestor
2689516|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2689517|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689518|NCT02244879|Resveratrol|resveratrol|mesh-list
2689519|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
2689520|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689521|NCT02244879|Protective Agents|protective agents|mesh-ancestor
2689522|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689523|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689524|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2689525|NCT02245022|Tenofovir|tenofovir|mesh-list
2689526|NCT02245022|Lamivudine|lamivudine|mesh-list
2689527|NCT02245022|Efavirenz|efavirenz|mesh-list
2689528|NCT02245022|Dolutegravir|dolutegravir|mesh-list
2689529|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
2689530|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2689531|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2689532|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2689533|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689534|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689535|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2689536|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2689537|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2689538|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2689539|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2689540|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2190300|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689541|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2689542|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2689543|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2689544|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2689545|NCT02245087|Atorvastatin|atorvastatin|mesh-list
2689546|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2689547|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2689548|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
2689549|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689550|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2689551|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2689552|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689553|NCT02245126|Lidocaine|lidocaine|mesh-list
2689554|NCT02245126|Bupivacaine|bupivacaine|mesh-list
2689555|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
2689556|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
2689557|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689558|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689559|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
2689560|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689561|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2689562|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2689563|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2689564|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2689565|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689566|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2689567|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689568|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689569|NCT02245191|Phenylephrine|phenylephrine|mesh-list
2689570|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
2689571|NCT02245191|Ephedrine|ephedrine|mesh-list
2689572|NCT02245191|Metaraminol|metaraminol|mesh-list
2689573|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2689574|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
2689575|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
2689576|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689577|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689578|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
2689579|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2689580|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
2689581|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
2689582|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2689583|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2689584|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2689585|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689586|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689587|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689588|NCT02245191|Protective Agents|protective agents|mesh-ancestor
2689589|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2190301|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2190302|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190303|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
2190304|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190305|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190306|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190307|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2190308|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
2190309|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
2190310|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2190311|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2190312|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
2190313|NCT00003423|Hormones|hormones|mesh-ancestor
2689618|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
2689619|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2689620|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689621|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689622|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2689623|NCT02245256|Analgesics|analgesics|mesh-ancestor
2689624|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
2689625|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689626|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2689627|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2689628|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2689629|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689630|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689631|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689632|NCT02245269|Ritonavir|ritonavir|mesh-list
2689633|NCT02245269|Tipranavir|tipranavir|mesh-list
2689634|NCT02245269|Atorvastatin|atorvastatin|mesh-list
2689635|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2689636|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2689637|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
2689638|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689639|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2689640|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2689641|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689642|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2689643|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2689644|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
2689645|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2689646|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2689647|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
2689648|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2689649|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2689650|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2689651|NCT02245295|Anesthetics|anesthetics|mesh-list
2689652|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689653|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689654|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
2689655|NCT02245321|Hematinics|hematinics|mesh-ancestor
2689656|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
2689657|NCT02245334|Povidone|povidone|mesh-list
2689658|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
2689659|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
2689660|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2190314|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2689661|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2689662|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
2689663|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2689664|NCT02245438|Ritonavir|ritonavir|mesh-list
2689665|NCT02245438|Tipranavir|tipranavir|mesh-list
2689666|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2689667|NCT02245438|Norethindrone|norethindrone|mesh-list
2689668|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
2689669|NCT02245438|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2689670|NCT02245438|Norinyl|norinyl|mesh-list
2689671|NCT02245438|Estradiol|estradiol|mesh-list
2689672|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2689673|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2689674|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
2689675|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689676|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190315|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2190316|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2190317|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
2190318|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2190319|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190320|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
2190321|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
2190322|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190323|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2190324|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2190325|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2689677|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2689678|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2689679|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
2689680|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2689681|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2689682|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2689683|NCT02245438|Estrogens|estrogens|mesh-ancestor
2689684|NCT02245438|Hormones|hormones|mesh-ancestor
2689685|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2689686|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689687|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2190326|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2190327|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190328|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
2190329|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190330|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190331|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190332|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190333|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2190334|NCT00003424|Tamoxifen|tamoxifen|mesh-list
2190335|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2190336|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
2190337|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2190338|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190339|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2190340|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190341|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2689688|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
2689689|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2689690|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2689691|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2689692|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2689693|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2689694|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2689695|NCT02245438|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2689696|NCT02245451|Ritonavir|ritonavir|mesh-list
2689697|NCT02245451|Tipranavir|tipranavir|mesh-list
2689698|NCT02245451|Methadone|methadone|mesh-list
2689699|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2689700|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2689701|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
2689702|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689703|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689704|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2689705|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2689706|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
2689707|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2689708|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2689709|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2689710|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2689711|NCT02245451|Narcotics|narcotics|mesh-ancestor
2689712|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689713|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689714|NCT02245451|Analgesics|analgesics|mesh-ancestor
2689715|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
2689716|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689717|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
2689718|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
2689719|NCT02245464|Telmisartan|telmisartan|mesh-list
2689720|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2689721|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2689722|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2190342|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2190343|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2190344|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
2190345|NCT00003425|Melphalan|melphalan|mesh-list
2190346|NCT00003425|Amifostine|amifostine|mesh-list
2190347|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2689723|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689724|NCT02245477|Mitogens|mitogens|mesh-list
2689725|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
2689726|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
2689727|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689728|NCT02245477|Growth Substances|growth substances|mesh-ancestor
2689729|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689730|NCT02245490|Tamsulosin|tamsulosin|mesh-list
2689731|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2689732|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2689733|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2689734|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689735|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689736|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689737|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689738|NCT02245490|Urological Agents|urological agents|mesh-ancestor
2689739|NCT02245503|Tamsulosin|tamsulosin|mesh-list
2689740|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2689741|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2689742|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2689743|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689744|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689745|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689746|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689747|NCT02245503|Urological Agents|urological agents|mesh-ancestor
2689748|NCT02245529|Tamsulosin|tamsulosin|mesh-list
2689749|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2689750|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2689751|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2689752|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689753|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689754|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689755|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689756|NCT02245529|Urological Agents|urological agents|mesh-ancestor
2689757|NCT02245555|Tamsulosin|tamsulosin|mesh-list
2689758|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2689759|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2689760|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2689761|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689762|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689763|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689764|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689765|NCT02245555|Urological Agents|urological agents|mesh-ancestor
2689766|NCT02245789|Remifentanil|remifentanil|mesh-list
2689767|NCT02245789|Propofol|propofol|mesh-list
2689768|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
2689769|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689770|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689771|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2689772|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2689773|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
2689774|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2689775|NCT02245789|Narcotics|narcotics|mesh-ancestor
2689776|NCT02245789|Analgesics|analgesics|mesh-ancestor
2689777|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
2689778|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689779|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2190348|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
2190349|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190350|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2190351|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190352|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
2190353|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190354|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190355|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190356|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2190357|NCT00003425|Protective Agents|protective agents|mesh-ancestor
2689780|NCT02245841|Hormones|hormones|mesh-ancestor
2689781|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2689782|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689783|NCT02245867|Antibodies|antibodies|mesh-list
2689784|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2689785|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
2689786|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689787|NCT02245932|Resveratrol|resveratrol|mesh-list
2689788|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
2689789|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689790|NCT02245932|Protective Agents|protective agents|mesh-ancestor
2689791|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689792|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689793|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2689794|NCT02246023|Propofol|propofol|mesh-list
2689795|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2689796|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689797|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689798|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2689799|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
2689800|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
2689801|NCT02246049|Leucovorin|leucovorin|mesh-list
2689802|NCT02246049|Bevacizumab|bevacizumab|mesh-list
2689803|NCT02246049|Fluorouracil|fluorouracil|mesh-list
2689804|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
2689805|NCT02246049|Irinotecan|irinotecan|mesh-list
2689806|NCT02246049|Calcium|calcium|mesh-list
2689807|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
2689808|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2689809|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190358|NCT00003426|Gemcitabine|gemcitabine|mesh-list
2190359|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190360|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
2190361|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190362|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190363|NCT00003426|Antiviral Agents|antiviral agents|mesh-ancestor
2190364|NCT00003426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190365|NCT00003426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190366|NCT00003426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190367|NCT00003426|Immunologic Factors|immunologic factors|mesh-ancestor
2190368|NCT00003426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689810|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2689811|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2689812|NCT02246049|Growth Substances|growth substances|mesh-ancestor
2689813|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689814|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
2689815|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2689816|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
2689817|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689818|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2689819|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2689820|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
2689821|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2689822|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2689823|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689824|NCT02246049|Antidotes|antidotes|mesh-ancestor
2689825|NCT02246049|Protective Agents|protective agents|mesh-ancestor
2689826|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
2689827|NCT02246049|Vitamins|vitamins|mesh-ancestor
2689828|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
2689829|NCT02246127|Everolimus|everolimus|mesh-list
2689830|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689831|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190369|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
2190370|NCT00003427|Irinotecan|irinotecan|mesh-list
2190371|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190372|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2190373|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190374|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190375|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190376|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2190377|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2689832|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
2689833|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689834|NCT02246179|Lidocaine|lidocaine|mesh-list
2689835|NCT02246179|Epinephrine|epinephrine|mesh-list
2689836|NCT02246179|Prilocaine|prilocaine|mesh-list
2689837|NCT02246179|Carticaine|carticaine|mesh-list
2689838|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2689839|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
2689840|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
2689841|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689842|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689843|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
2689844|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689845|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2689846|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2689847|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2689848|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2689849|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689850|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2689851|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2689852|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
2689853|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689854|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2689855|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2689856|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
2689857|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2689858|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
2689859|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
2689860|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
2689861|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2689862|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2689863|NCT02246244|Citalopram|citalopram|mesh-list
2689864|NCT02246244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2689865|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2689866|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2689867|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689868|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689869|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
2689870|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689871|NCT02246244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2689872|NCT02246244|Antidepressive Agents|antidepressive agents|mesh-ancestor
2689873|NCT02246244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2689874|NCT02246257|Metformin|metformin|mesh-list
2689875|NCT02246257|Losartan|losartan|mesh-list
2689876|NCT02246257|Simvastatin|simvastatin|mesh-list
2689877|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2689878|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689879|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2689880|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2689881|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
2689882|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689883|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2689884|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2689885|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689886|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2689887|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2689888|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2689889|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2689890|NCT02246270|Heparin|heparin|mesh-list
2689891|NCT02246270|Calcium heparin|calcium heparin|mesh-list
2689892|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
2689893|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2689894|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2689895|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689896|NCT02246595|Vilobelimab|vilobelimab|mesh-list
2689897|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2689898|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2689899|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
2689900|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689901|NCT02246621|Letrozole|letrozole|mesh-list
2689902|NCT02246621|Anastrozole|anastrozole|mesh-list
2689903|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689904|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2689905|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2689906|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689907|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689908|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2689909|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
2689910|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2689911|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689912|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2689913|NCT02246712|Tramadol|tramadol|mesh-list
2689914|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2689915|NCT02246712|Narcotics|narcotics|mesh-ancestor
2689916|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689917|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689918|NCT02246712|Analgesics|analgesics|mesh-ancestor
2689919|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
2689920|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689921|NCT02246816|Opium|opium|mesh-list
2689922|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2689923|NCT02246816|Narcotics|narcotics|mesh-ancestor
2689924|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2689925|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689926|NCT02246816|Analgesics|analgesics|mesh-ancestor
2689927|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
2689928|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689929|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
2689930|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2689931|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
2689932|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
2689933|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
2689934|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2689935|NCT02246842|Antibodies|antibodies|mesh-list
2689936|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2689937|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
2689938|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
2689939|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689940|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
2689941|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2689942|NCT02246855|Antibodies|antibodies|mesh-list
2689943|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
2689944|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689945|NCT02246868|Factor VIII|factor viii|mesh-list
2689946|NCT02246868|Coagulants|coagulants|mesh-ancestor
2689947|NCT02246881|Factor VIII|factor viii|mesh-list
2689948|NCT02246881|Coagulants|coagulants|mesh-ancestor
2689949|NCT02246894|Factor VIII|factor viii|mesh-list
2689950|NCT02246894|Coagulants|coagulants|mesh-ancestor
2689951|NCT02246920|Fluticasone|fluticasone|mesh-list
2689952|NCT02246920|Xhance|xhance|mesh-list
2689953|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2689954|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2689955|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
2689956|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689957|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689958|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2689959|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
2689960|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
2689961|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2689962|NCT02247128|Aspirin|aspirin|mesh-list
2689963|NCT02247128|Clopidogrel|clopidogrel|mesh-list
2689964|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2689965|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2689966|NCT02247128|Analgesics|analgesics|mesh-ancestor
2689967|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
2689968|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2689969|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689970|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2689971|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2689972|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2689973|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2689974|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689975|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2689976|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2689977|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2689978|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
2689979|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2689980|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2689981|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2689982|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
2689983|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2689984|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
2689985|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2689986|NCT02247141|Antibodies|antibodies|mesh-list
2689987|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
2689988|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689989|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
2689990|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2689991|NCT02247154|Antibodies|antibodies|mesh-list
2689992|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
2689993|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2689994|NCT02247258|Azathioprine|azathioprine|mesh-list
2689995|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
2689996|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2689997|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2689998|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2689999|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2690000|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
2690001|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690002|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2690003|NCT02247310|Interferons|interferons|mesh-list
2690004|NCT02247310|Interferon-beta|interferon-beta|mesh-list
2690005|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
2690006|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690007|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
2690008|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690009|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
2690010|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690011|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2690012|NCT02247362|Vaccines|vaccines|mesh-list
2690013|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
2690014|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
2690015|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690016|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
2690017|NCT02247414|Aspirin|aspirin|mesh-list
2690018|NCT02247414|Heparin|heparin|mesh-list
2690019|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2690020|NCT02247414|Tinzaparin|tinzaparin|mesh-list
2690021|NCT02247414|Dalteparin|dalteparin|mesh-list
2690022|NCT02247414|Dipyridamole|dipyridamole|mesh-list
2690023|NCT02247414|Warfarin|warfarin|mesh-list
2690024|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2690025|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2690026|NCT02247414|Analgesics|analgesics|mesh-ancestor
2690027|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
2690028|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690029|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690030|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2690031|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2690032|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2690033|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2690034|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690035|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2690036|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2690037|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690038|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
2690039|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
2690040|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2190378|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190379|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
2190380|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2690041|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
2690042|NCT02247505|Tadalafil|tadalafil|mesh-list
2690043|NCT02247505|Tamsulosin|tamsulosin|mesh-list
2690044|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
2690045|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2690046|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2690047|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690048|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690049|NCT02247505|Urological Agents|urological agents|mesh-ancestor
2690050|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2690051|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2690052|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2690053|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
2690054|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690055|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690056|NCT02247518|Tadalafil|tadalafil|mesh-list
2690057|NCT02247518|Tamsulosin|tamsulosin|mesh-list
2690058|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
2690059|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2690060|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2690061|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690062|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690063|NCT02247518|Urological Agents|urological agents|mesh-ancestor
2690064|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2690065|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2690066|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2690067|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
2690068|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690069|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690070|NCT02247544|Trabectedin|trabectedin|mesh-list
2690071|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2690072|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
2690073|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690074|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690075|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2690076|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2690077|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2690078|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2190381|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
2190382|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190383|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2190384|NCT00003431|Protective Agents|protective agents|mesh-ancestor
2190385|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
2190386|NCT00003435|Melphalan|melphalan|mesh-list
2190387|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2190388|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190389|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
2190390|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690079|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690080|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2690081|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2690082|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690083|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
2690084|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690085|NCT02247596|Resveratrol|resveratrol|mesh-list
2690086|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
2690087|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690088|NCT02247596|Protective Agents|protective agents|mesh-ancestor
2690089|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690090|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690091|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2690092|NCT02247648|Tramadol|tramadol|mesh-list
2690093|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2690094|NCT02247648|Narcotics|narcotics|mesh-ancestor
2690095|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2690096|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690097|NCT02247648|Analgesics|analgesics|mesh-ancestor
2690098|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
2690099|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690100|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
2190391|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190392|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190393|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190394|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
2190395|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190396|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190397|NCT00003436|Cytarabine|cytarabine|mesh-list
2190398|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
2190399|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2190400|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2190401|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2690101|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2690102|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
2690103|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2690104|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2690105|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
2690106|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690107|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2690108|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2690109|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690110|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690111|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2690112|NCT02247986|Methylphenidate|methylphenidate|mesh-list
2690113|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2690114|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690115|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2690116|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2690117|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2690118|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690119|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
2690120|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690121|NCT02248012|Everolimus|everolimus|mesh-list
2690122|NCT02248012|Temozolomide|temozolomide|mesh-list
2690123|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690124|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2690125|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
2690126|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690127|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2690128|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
2690129|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690130|NCT02248051|CXA-10|cxa-10|mesh-list
2690131|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2690132|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2690133|NCT02248129|Telmisartan|telmisartan|mesh-list
2690134|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2690135|NCT02248129|Diuretics|diuretics|mesh-ancestor
2690136|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
2690137|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690138|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2690139|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2690140|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690141|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2690142|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2190402|NCT00003436|Methotrexate|methotrexate|mesh-list
2190403|NCT00003436|Etoposide|etoposide|mesh-list
2190404|NCT00003436|Daunorubicin|daunorubicin|mesh-list
2190405|NCT00003436|Asparaginase|asparaginase|mesh-list
2190406|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
2690143|NCT02248142|Pramipexole|pramipexole|mesh-list
2690144|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
2690145|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690146|NCT02248142|Protective Agents|protective agents|mesh-ancestor
2690147|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690148|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2690149|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2690150|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
2690151|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
2690152|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690153|NCT02248155|Pramipexole|pramipexole|mesh-list
2690154|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
2690155|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690156|NCT02248155|Protective Agents|protective agents|mesh-ancestor
2690157|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690158|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2690159|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2690160|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
2690161|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
2690162|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690163|NCT02248168|Pramipexole|pramipexole|mesh-list
2690164|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
2690165|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690166|NCT02248168|Protective Agents|protective agents|mesh-ancestor
2690167|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690168|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2690169|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2690170|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
2690171|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
2690172|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690173|NCT02248181|Pramipexole|pramipexole|mesh-list
2690174|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
2690175|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690176|NCT02248181|Protective Agents|protective agents|mesh-ancestor
2690177|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690178|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2690179|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2690180|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
2690181|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
2690182|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690183|NCT02248207|Pramipexole|pramipexole|mesh-list
2690184|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
2690185|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190407|NCT00003436|Amsacrine|amsacrine|mesh-list
2690186|NCT02248207|Protective Agents|protective agents|mesh-ancestor
2690187|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690188|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2690189|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2690190|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
2690191|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
2690192|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690193|NCT02248220|Pramipexole|pramipexole|mesh-list
2690194|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
2690195|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690196|NCT02248220|Protective Agents|protective agents|mesh-ancestor
2690197|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690198|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2690199|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2690200|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
2690201|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
2690202|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690203|NCT02248233|Nimodipine|nimodipine|mesh-list
2690204|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2690205|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
2690206|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2690207|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2690208|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2690209|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690210|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2690211|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690212|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
2690213|NCT02248259|Itraconazole|itraconazole|mesh-list
2690214|NCT02248259|BI 409306|bi 409306|mesh-list
2690215|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
2690216|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690217|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2690218|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2690219|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690220|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690221|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2690222|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
2690223|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2690224|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690225|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690226|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2690227|NCT02248415|Anesthetics|anesthetics|mesh-list
2690228|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2690229|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690230|NCT02248428|Thalidomide|thalidomide|mesh-list
2690231|NCT02248428|Clarithromycin|clarithromycin|mesh-list
2690232|NCT02248428|Dexamethasone|dexamethasone|mesh-list
2690233|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
2690234|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2690235|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
2690236|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690237|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2690238|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2690239|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
2690240|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690241|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690242|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2690243|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2690244|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
2690245|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
2690246|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690247|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2690248|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
2690249|NCT02248428|Hormones|hormones|mesh-ancestor
2690250|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2690251|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2690252|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
2690253|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2690254|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690255|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2690256|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2690257|NCT02248428|Growth Substances|growth substances|mesh-ancestor
2690258|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
2690259|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2690260|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690261|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690262|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2690263|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
2690264|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2690265|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690266|NCT02248493|Acetaminophen|acetaminophen|mesh-list
2690267|NCT02248493|Ketoprofen|ketoprofen|mesh-list
2690268|NCT02248493|Morphine|morphine|mesh-list
2690269|NCT02248493|Tramadol|tramadol|mesh-list
2690270|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2690271|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2690272|NCT02248493|Narcotics|narcotics|mesh-ancestor
2690273|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2690274|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690275|NCT02248493|Analgesics|analgesics|mesh-ancestor
2690276|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
2690277|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690278|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2690279|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
2690280|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2690281|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2690282|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2690283|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2690284|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690285|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690286|NCT02248506|Clotrimazole|clotrimazole|mesh-list
2690287|NCT02248506|Miconazole|miconazole|mesh-list
2690288|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2690289|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690290|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
2690291|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2690292|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2690293|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690294|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690295|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2690296|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
2690297|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2690298|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690299|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2690300|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690301|NCT02248571|Bevacizumab|bevacizumab|mesh-list
2690302|NCT02248571|Capecitabine|capecitabine|mesh-list
2690303|NCT02248571|Everolimus|everolimus|mesh-list
2690304|NCT02248571|Exemestane|exemestane|mesh-list
2690305|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2690306|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690307|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2690308|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2690309|NCT02248571|Growth Substances|growth substances|mesh-ancestor
2690310|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690311|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
2690312|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2690313|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
2690314|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690315|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2690316|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
2690317|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2690318|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2690319|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690320|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2690321|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
2690322|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2690323|NCT02248584|Ascorbic Acid|ascorbic acid|mesh-list
2690324|NCT02248584|Vitamins|vitamins|mesh-ancestor
2690325|NCT02248584|Micronutrients|micronutrients|mesh-ancestor
2690326|NCT02248584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690327|NCT02248584|Antioxidants|antioxidants|mesh-ancestor
2690328|NCT02248584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690329|NCT02248584|Protective Agents|protective agents|mesh-ancestor
2690330|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
2690331|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
2690332|NCT02248597|Busulfan|busulfan|mesh-list
2690333|NCT02248597|Fludarabine|fludarabine|mesh-list
2690334|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
2690335|NCT02248597|Tacrolimus|tacrolimus|mesh-list
2190408|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2190409|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
2190410|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2190411|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190412|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190413|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
2190414|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190415|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190416|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
2190417|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190418|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2190419|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190420|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
2190421|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2190422|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2190423|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190424|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2190425|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190426|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
2190427|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190428|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2690336|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2690337|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
2690338|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690339|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2690340|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2690341|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
2690342|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690343|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690344|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2690345|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2690346|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
2690347|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2690348|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690349|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2690350|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2690351|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
2690352|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2690353|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690354|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
2690355|NCT02248701|Finasteride|finasteride|mesh-list
2690356|NCT02248701|Testosterone|testosterone|mesh-list
2690357|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
2690358|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
2690359|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2690360|NCT02248701|Androgens|androgens|mesh-ancestor
2690361|NCT02248701|Hormones|hormones|mesh-ancestor
2690362|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2690363|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690364|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2690365|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690366|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
2690367|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2690368|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2690369|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690370|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690371|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
2690372|NCT02248701|Urological Agents|urological agents|mesh-ancestor
2690373|NCT02248753|Metoprolol|metoprolol|mesh-list
2690374|NCT02248753|Digoxin|digoxin|mesh-list
2690375|NCT02248753|Amiodarone|amiodarone|mesh-list
2690376|NCT02248753|Verapamil|verapamil|mesh-list
2690377|NCT02248753|Flecainide|flecainide|mesh-list
2690378|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2690379|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2690380|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
2690381|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
2690382|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690383|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690384|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2690385|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2690386|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2690387|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
2690388|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690389|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690390|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2690391|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690392|NCT02248753|Protective Agents|protective agents|mesh-ancestor
2690393|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
2690394|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2690395|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2690396|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2690397|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2690398|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2690399|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2690400|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2690401|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690402|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2690403|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2690404|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2690405|NCT02248792|Methotrexate|methotrexate|mesh-list
2690406|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2690407|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
2690408|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2690409|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690410|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2690411|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
2690412|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690413|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690414|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
2690415|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690416|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2690417|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2690418|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
2690419|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2690420|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2690421|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
2690422|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2690423|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2690424|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2690425|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2690426|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690427|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
2690428|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690429|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690430|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2690431|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690432|NCT02248870|Dexamethasone|dexamethasone|mesh-list
2690433|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2690434|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
2690435|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
2690436|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690437|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690438|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2690439|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
2690440|NCT02248870|Hormones|hormones|mesh-ancestor
2690441|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2690442|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2690443|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690444|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
2690445|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2690446|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690447|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2690448|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2690449|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690450|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690451|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690452|NCT02248896|Telmisartan|telmisartan|mesh-list
2690453|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
2690454|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2690455|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
2690456|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2690457|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2690458|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690459|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
2190429|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2190430|NCT00003436|Analgesics|analgesics|mesh-ancestor
2190431|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
2190432|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2190433|NCT00003437|Cytarabine|cytarabine|mesh-list
2190434|NCT00003437|Dexamethasone|dexamethasone|mesh-list
2190435|NCT00003437|Prednisolone|prednisolone|mesh-list
2190436|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
2190437|NCT00003437|Doxorubicin|doxorubicin|mesh-list
2190438|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2190439|NCT00003437|Methotrexate|methotrexate|mesh-list
2190440|NCT00003437|Vincristine|vincristine|mesh-list
2190441|NCT00003437|Daunorubicin|daunorubicin|mesh-list
2190442|NCT00003437|Asparaginase|asparaginase|mesh-list
2190443|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
2190444|NCT00003437|Thioguanine|thioguanine|mesh-list
2190445|NCT00003437|Pegaspargase|pegaspargase|mesh-list
2190446|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2690460|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
2690461|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2690462|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2690463|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690464|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2690465|NCT02249013|Paclitaxel|paclitaxel|mesh-list
2690466|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2690467|NCT02249013|Carboplatin|carboplatin|mesh-list
2690468|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2690469|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690470|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
2690471|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
2690472|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
2690473|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690474|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2690475|NCT02249026|Buprenorphine|buprenorphine|mesh-list
2690476|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
2690477|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2690478|NCT02249026|Narcotics|narcotics|mesh-ancestor
2690479|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2690480|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690481|NCT02249026|Analgesics|analgesics|mesh-ancestor
2690482|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
2690483|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690484|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2690485|NCT02249039|Clonidine|clonidine|mesh-list
2690486|NCT02249039|Analgesics|analgesics|mesh-ancestor
2690487|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
2690488|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690489|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690490|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2690491|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
2690492|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
2690493|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2690494|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2690495|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2690496|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
2690497|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690498|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690499|NCT02249078|Quetmolimab|quetmolimab|mesh-list
2690500|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2690501|NCT02249130|Ritonavir|ritonavir|mesh-list
2690502|NCT02249130|Lamivudine|lamivudine|mesh-list
2690503|NCT02249130|Zidovudine|zidovudine|mesh-list
2690504|NCT02249130|Stavudine|stavudine|mesh-list
2690505|NCT02249130|Tipranavir|tipranavir|mesh-list
2690506|NCT02249130|Delavirdine|delavirdine|mesh-list
2690507|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2690508|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2690509|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
2690510|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690511|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690512|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2690513|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2190447|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
2190448|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190449|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2190450|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2690514|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
2690515|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690516|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690517|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2190451|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
2190452|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190453|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190454|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190455|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2190456|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
2190457|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
2190458|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2190459|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2190460|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
2190461|NCT00003437|Hormones|hormones|mesh-ancestor
2190462|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2190463|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2190464|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2690518|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2690519|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2690520|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
2690521|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2690522|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2690523|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690524|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690525|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2690526|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2690527|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690528|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
2690529|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690530|NCT02249299|Nabiximols|nabiximols|mesh-list
2690531|NCT02249299|Analgesics|analgesics|mesh-ancestor
2690532|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
2690533|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690534|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690535|NCT02249364|Propofol|propofol|mesh-list
2690536|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2690537|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2690538|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690539|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2690540|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
2690541|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
2690542|NCT02249416|Ritonavir|ritonavir|mesh-list
2690543|NCT02249416|Zidovudine|zidovudine|mesh-list
2690544|NCT02249416|Tipranavir|tipranavir|mesh-list
2690545|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2690546|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2690547|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
2690548|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690549|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690550|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2690551|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2690552|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
2690553|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690554|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690555|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2690556|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
2690557|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2690558|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2690559|NCT02249442|Ritonavir|ritonavir|mesh-list
2690560|NCT02249442|Tipranavir|tipranavir|mesh-list
2690561|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2690562|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2690563|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
2690564|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690565|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690566|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2690567|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2690568|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
2690569|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690570|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690571|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2690572|NCT02249481|Bupivacaine|bupivacaine|mesh-list
2690573|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
2690574|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
2690575|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2690576|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690577|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
2690578|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690579|NCT02249546|Amoxicillin|amoxicillin|mesh-list
2690580|NCT02249546|Clarithromycin|clarithromycin|mesh-list
2690581|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
2690582|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2690583|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2690584|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690585|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2690586|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690587|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690588|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690589|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2690590|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
2690591|NCT02249546|Expectorants|expectorants|mesh-ancestor
2690592|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
2690593|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2690594|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
2690595|NCT02249546|Protective Agents|protective agents|mesh-ancestor
2690596|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690597|NCT02249546|Antidotes|antidotes|mesh-ancestor
2690598|NCT02249663|Fluticasone|fluticasone|mesh-list
2690599|NCT02249663|Xhance|xhance|mesh-list
2690600|NCT02249663|Azelastine|azelastine|mesh-list
2690601|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2690602|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2690603|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
2690604|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690605|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690606|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2690607|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
2690608|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
2690609|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2690610|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2690611|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690612|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690613|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2690614|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2690615|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
2690616|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
2690617|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690618|NCT02249702|Gemcitabine|gemcitabine|mesh-list
2690619|NCT02249702|Docetaxel|docetaxel|mesh-list
2690620|NCT02249702|Trabectedin|trabectedin|mesh-list
2690621|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2690622|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
2690623|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690624|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690625|NCT02249702|Antiviral Agents|antiviral agents|mesh-ancestor
2690626|NCT02249702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690627|NCT02249702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690628|NCT02249702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2690629|NCT02249702|Immunologic Factors|immunologic factors|mesh-ancestor
2690630|NCT02249702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690631|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
2690632|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
2690633|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
2690634|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2690635|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
2690636|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
2690637|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2690638|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690639|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
2690640|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2690641|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690642|NCT02249871|Omeprazole|omeprazole|mesh-list
2690643|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2690644|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2690645|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2690646|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690647|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690648|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
2690649|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2690650|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690651|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
2690652|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2690653|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2690654|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
2690655|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690656|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2690657|NCT02249910|Metformin|metformin|mesh-list
2690658|NCT02249910|Digoxin|digoxin|mesh-list
2690659|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2690660|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690661|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2690662|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2690663|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690664|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690665|NCT02249910|Protective Agents|protective agents|mesh-ancestor
2690666|NCT02249936|Omeprazole|omeprazole|mesh-list
2690667|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2690668|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2690669|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2690670|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690671|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690672|NCT02250014|Sargramostim|sargramostim|mesh-list
2690673|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
2690674|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690675|NCT02250118|Bevacizumab|bevacizumab|mesh-list
2690676|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2690677|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690678|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2690679|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2690680|NCT02250118|Growth Substances|growth substances|mesh-ancestor
2690681|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690682|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
2690683|NCT02250157|Irinotecan|irinotecan|mesh-list
2690684|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2690685|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2690686|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690687|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690688|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690689|NCT02250209|Capecitabine|capecitabine|mesh-list
2690690|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
2690691|NCT02250209|Trastuzumab|trastuzumab|mesh-list
2690692|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2690693|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
2690694|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690695|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690696|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2690697|NCT02250300|Ixazomib|ixazomib|mesh-list
2690698|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690699|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
2690700|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690701|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690702|NCT02250482|Factor VIII|factor viii|mesh-list
2690703|NCT02250482|Coagulants|coagulants|mesh-ancestor
2690704|NCT02250508|Factor VIII|factor viii|mesh-list
2690705|NCT02250508|Coagulants|coagulants|mesh-ancestor
2690706|NCT02250534|Nicotine|nicotine|mesh-list
2690707|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2690708|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
2690709|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690710|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690711|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2690712|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2690713|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
2690714|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690715|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690716|NCT02250599|Paclitaxel|paclitaxel|mesh-list
2690717|NCT02250599|Bevacizumab|bevacizumab|mesh-list
2690718|NCT02250599|Carboplatin|carboplatin|mesh-list
2690719|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2690720|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690721|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
2690722|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
2690723|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
2690724|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690725|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2690726|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2690727|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2690728|NCT02250599|Growth Substances|growth substances|mesh-ancestor
2690729|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690730|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
2690731|NCT02250664|Nicotine|nicotine|mesh-list
2690732|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2690733|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
2690734|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690735|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690736|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2690737|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2690738|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
2690739|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690740|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690741|NCT02250729|Pholcodine|pholcodine|mesh-list
2690742|NCT02250729|Analgesics|analgesics|mesh-ancestor
2690743|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
2690744|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690745|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690746|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
2690747|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
2690748|NCT02250781|TIC10 compound|tic10 compound|mesh-list
2690749|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190465|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2190466|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190467|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190468|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2190469|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
2190470|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2190471|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190472|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
2190473|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
2190474|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2190475|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2190476|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
2190477|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190478|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190479|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190480|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190481|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190482|NCT00003439|Interleukin-12|interleukin-12|mesh-list
2190483|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2190484|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
2190485|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190486|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2190487|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2190488|NCT00003439|Growth Substances|growth substances|mesh-ancestor
2190489|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
2190490|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190491|NCT00003440|Paclitaxel|paclitaxel|mesh-list
2190492|NCT00003440|Trastuzumab|trastuzumab|mesh-list
2190493|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190494|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190495|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190496|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190497|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190498|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190499|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2190500|NCT00003441|Irofulven|irofulven|mesh-list
2190501|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190502|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
2190503|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190504|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190505|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
2690750|NCT02250794|Insulin|insulin|mesh-list
2690751|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2690752|NCT02250794|Metformin|metformin|mesh-list
2690753|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
2690754|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2690755|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
2690756|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2690757|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690758|NCT02250794|Incretins|incretins|mesh-ancestor
2690759|NCT02250794|Hormones|hormones|mesh-ancestor
2690760|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2690761|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2690762|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
2690763|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690764|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690765|NCT02250820|Pentobarbital|pentobarbital|mesh-list
2690766|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
2690767|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2690768|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2690769|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690770|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2690771|NCT02250820|Analgesics|analgesics|mesh-ancestor
2690772|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
2690773|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690774|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2690775|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2690776|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2690777|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
2690778|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690779|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690780|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2690781|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
2690782|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
2690783|NCT02250833|Amlodipine|amlodipine|mesh-list
2690784|NCT02250833|Telmisartan|telmisartan|mesh-list
2690785|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2690786|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2690787|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2690788|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690789|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2690790|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690791|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
2690792|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2690793|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2690794|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2690795|NCT02250859|Minocycline|minocycline|mesh-list
2690796|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690797|NCT02250872|Cisplatin|cisplatin|mesh-list
2690798|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2690799|NCT02250924|Caffeine|caffeine|mesh-list
2690800|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2690801|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690802|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2690803|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690804|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690805|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2690806|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2690807|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
2690808|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2690809|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
2690810|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690811|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
2690812|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
2690813|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
2690814|NCT02251041|Tocopherols|tocopherols|mesh-list
2690815|NCT02251041|Vitamin E|vitamin e|mesh-list
2690816|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
2690817|NCT02251041|Infliximab|infliximab|mesh-list
2690818|NCT02251041|Epoprostenol|epoprostenol|mesh-list
2690819|NCT02251041|Tezosentan|tezosentan|mesh-list
2690820|NCT02251041|Melatonin|melatonin|mesh-list
2690821|NCT02251041|Antithrombins|antithrombins|mesh-list
2690822|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
2690823|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
2690824|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
2690825|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2690826|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2690827|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
2690828|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690829|NCT02251041|Protective Agents|protective agents|mesh-ancestor
2690830|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690831|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2690832|NCT02251041|Hematinics|hematinics|mesh-ancestor
2690833|NCT02251041|Vitamins|vitamins|mesh-ancestor
2690834|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
2690835|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2690836|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
2690837|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690838|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
2690839|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2690840|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2690841|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
2690842|NCT02251119|Ritonavir|ritonavir|mesh-list
2690843|NCT02251119|Tipranavir|tipranavir|mesh-list
2690844|NCT02251119|Loperamide|loperamide|mesh-list
2690845|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
2690846|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2690847|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2690848|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
2690849|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690850|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690851|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2690852|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2690853|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
2690854|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690855|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690856|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2690857|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2190506|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2190507|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
2190508|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190509|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190510|NCT00003444|Interferons|interferons|mesh-list
2190511|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
2690858|NCT02251132|Ritonavir|ritonavir|mesh-list
2690859|NCT02251132|Erythromycin|erythromycin|mesh-list
2690860|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
2690861|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2690862|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
2690863|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2690864|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2690865|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
2690866|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690867|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690868|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2690869|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2690870|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
2690871|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690872|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690873|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2690874|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2690875|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2690876|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2690877|NCT02251145|Ritonavir|ritonavir|mesh-list
2690878|NCT02251145|Tenofovir|tenofovir|mesh-list
2690879|NCT02251145|Tipranavir|tipranavir|mesh-list
2690880|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2690881|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2690882|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
2690883|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690884|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690885|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2690886|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2690887|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
2690888|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690889|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690890|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2690891|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2690892|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2690893|NCT02251158|Ritonavir|ritonavir|mesh-list
2690894|NCT02251158|Tipranavir|tipranavir|mesh-list
2690895|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2690896|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2690897|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2690898|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
2690899|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690900|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690901|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2690902|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2690903|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
2690904|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690905|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690906|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2690907|NCT02251171|Ritonavir|ritonavir|mesh-list
2690908|NCT02251171|Tipranavir|tipranavir|mesh-list
2690909|NCT02251171|Rifabutin|rifabutin|mesh-list
2690910|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2690911|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2690912|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
2690913|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690914|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690915|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2690916|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2690917|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
2690918|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690919|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690920|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2690921|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2690922|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2690923|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
2690924|NCT02251184|Aspirin|aspirin|mesh-list
2690925|NCT02251184|Dipyridamole|dipyridamole|mesh-list
2690926|NCT02251184|Lansoprazole|lansoprazole|mesh-list
2690927|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
2690928|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2690929|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2690930|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2690931|NCT02251184|Analgesics|analgesics|mesh-ancestor
2690932|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
2690933|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690934|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690935|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2690936|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2690937|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2690938|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2690939|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690940|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2690941|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2690942|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690943|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
2690944|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2690945|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2690946|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2690947|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2690948|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
2690949|NCT02251223|Ritonavir|ritonavir|mesh-list
2690950|NCT02251223|Tipranavir|tipranavir|mesh-list
2690951|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2690952|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2690953|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
2690954|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2690955|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690956|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2690957|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2690958|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
2690959|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2690960|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2690961|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2690962|NCT02251249|Acetaminophen|acetaminophen|mesh-list
2690963|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2690964|NCT02251249|Analgesics|analgesics|mesh-ancestor
2690965|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
2690966|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690967|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690968|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
2690969|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2690970|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2690971|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690972|NCT02251288|Vaccines|vaccines|mesh-list
2690973|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
2690974|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690975|NCT02251431|Exenatide|exenatide|mesh-list
2690976|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2690977|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690978|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2690979|NCT02251431|Incretins|incretins|mesh-ancestor
2690980|NCT02251431|Hormones|hormones|mesh-ancestor
2690981|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2690982|NCT02251457|Ranolazine|ranolazine|mesh-list
2690983|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2690984|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2690985|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2690986|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
2690987|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2690988|NCT02251483|Antibodies|antibodies|mesh-list
2690989|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
2690990|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690991|NCT02251509|Metoprolol|metoprolol|mesh-list
2690992|NCT02251509|Carvedilol|carvedilol|mesh-list
2690993|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2690994|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2690995|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
2690996|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
2690997|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2690998|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2690999|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2691000|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2691001|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2691002|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
2691003|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691004|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691005|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
2691006|NCT02251509|Protective Agents|protective agents|mesh-ancestor
2691007|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2691008|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2691009|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2691010|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
2691011|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2691012|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2691013|NCT02251600|Deflazacort|deflazacort|mesh-list
2691014|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2691015|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2691016|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
2691017|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691018|NCT02251626|Ubiquinone|ubiquinone|mesh-list
2691019|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
2691020|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
2691021|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691022|NCT02251626|Vitamins|vitamins|mesh-ancestor
2691023|NCT02251691|Tacrolimus|tacrolimus|mesh-list
2691024|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2691025|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
2691026|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691027|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2691028|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691029|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691030|NCT02251769|Ritonavir|ritonavir|mesh-list
2691031|NCT02251769|Tipranavir|tipranavir|mesh-list
2691032|NCT02251769|Clarithromycin|clarithromycin|mesh-list
2691033|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2691034|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2691035|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691036|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691037|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691038|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2691039|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2691040|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
2691041|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691042|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2691043|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691044|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2691045|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2691046|NCT02251795|Aspirin|aspirin|mesh-list
2691047|NCT02251795|Ritonavir|ritonavir|mesh-list
2691048|NCT02251795|Darunavir|darunavir|mesh-list
2691049|NCT02251795|Tipranavir|tipranavir|mesh-list
2691050|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2691051|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2691052|NCT02251795|Analgesics|analgesics|mesh-ancestor
2691053|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
2691054|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691055|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691056|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2691057|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2691058|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2691059|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2691060|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691061|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2691062|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2691063|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691064|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
2691065|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2691066|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2691067|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691068|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2691069|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2691070|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
2691071|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691072|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2691073|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2190512|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190513|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
2190514|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190515|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
2691108|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2691109|NCT02251847|Ezetimibe|ezetimibe|mesh-list
2691110|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2691111|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2691112|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
2691113|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691114|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2691115|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2691116|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691117|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2691118|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2691119|NCT02251925|Estradiol|estradiol|mesh-list
2691120|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2691121|NCT02251925|Estrogens|estrogens|mesh-ancestor
2691122|NCT02251925|Hormones|hormones|mesh-ancestor
2691123|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2691124|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691125|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2691126|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
2691127|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2691128|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2691129|NCT02251951|Paclitaxel|paclitaxel|mesh-list
2691130|NCT02251951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2691131|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2691132|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691133|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
2691134|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
2691135|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
2691136|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691137|NCT02251964|Rituximab|rituximab|mesh-list
2691138|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2691139|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691140|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
2691141|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691142|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2691143|NCT02251977|Leucovorin|leucovorin|mesh-list
2691144|NCT02251977|Fluorouracil|fluorouracil|mesh-list
2691145|NCT02251977|Capecitabine|capecitabine|mesh-list
2691146|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691147|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
2691148|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691149|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2691150|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691151|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2691152|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
2691153|NCT02251977|Antidotes|antidotes|mesh-ancestor
2691154|NCT02251977|Protective Agents|protective agents|mesh-ancestor
2691155|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
2691156|NCT02251977|Vitamins|vitamins|mesh-ancestor
2691157|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
2691158|NCT02252107|Decitabine|decitabine|mesh-list
2691159|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2691160|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
2691161|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691162|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691163|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691164|NCT02252263|Elotuzumab|elotuzumab|mesh-list
2691165|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691166|NCT02252302|Albuterol|albuterol|mesh-list
2691167|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2691168|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
2691169|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691170|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691171|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2691172|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
2691173|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
2691174|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2691175|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2691176|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2190516|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190517|NCT00003445|Docetaxel|docetaxel|mesh-list
2190518|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190519|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190520|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190521|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190522|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190523|NCT00003446|Leucovorin|leucovorin|mesh-list
2190524|NCT00003446|Trimetrexate|trimetrexate|mesh-list
2190525|NCT00003446|Fluorouracil|fluorouracil|mesh-list
2190526|NCT00003446|Calcium|calcium|mesh-list
2190527|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
2190528|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2190529|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190530|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
2190531|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190532|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190533|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190534|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190535|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
2190536|NCT00003446|Antidotes|antidotes|mesh-ancestor
2190537|NCT00003446|Protective Agents|protective agents|mesh-ancestor
2190538|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
2190539|NCT00003446|Vitamins|vitamins|mesh-ancestor
2190540|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
2190541|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
2691177|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2691178|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
2691179|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691180|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190542|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190543|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2691181|NCT02252328|Simvastatin|simvastatin|mesh-list
2691182|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2691183|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2190544|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190545|NCT00003447|Gemcitabine|gemcitabine|mesh-list
2190546|NCT00003447|Vinorelbine|vinorelbine|mesh-list
2190547|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190548|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
2190549|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190550|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190551|NCT00003447|Antiviral Agents|antiviral agents|mesh-ancestor
2190552|NCT00003447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190553|NCT00003447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190554|NCT00003447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2691184|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
2691185|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691186|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2691187|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2691188|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691189|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
2691190|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2691191|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
2691192|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691193|NCT02252341|Expectorants|expectorants|mesh-ancestor
2691194|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
2691195|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2691196|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
2691197|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691198|NCT02252341|Protective Agents|protective agents|mesh-ancestor
2691199|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691200|NCT02252341|Antidotes|antidotes|mesh-ancestor
2691201|NCT02252367|Tadalafil|tadalafil|mesh-list
2691202|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
2691203|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2691204|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2691205|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691206|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691207|NCT02252367|Urological Agents|urological agents|mesh-ancestor
2691208|NCT02252419|Acetaminophen|acetaminophen|mesh-list
2691209|NCT02252419|Dexamethasone|dexamethasone|mesh-list
2691210|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2691211|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
2691212|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
2691213|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691214|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691215|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2691216|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
2691217|NCT02252419|Hormones|hormones|mesh-ancestor
2691218|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2691219|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2691220|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691221|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2691222|NCT02252419|Analgesics|analgesics|mesh-ancestor
2691223|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
2691224|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
2691225|NCT02252432|Ketamine|ketamine|mesh-list
2691226|NCT02252432|Methadone|methadone|mesh-list
2691227|NCT02252432|Analgesics|analgesics|mesh-ancestor
2691228|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
2691229|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691230|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691231|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2691232|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2691233|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
2691234|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
2691235|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2691236|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2691237|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2691238|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691239|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691240|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2691241|NCT02252432|Narcotics|narcotics|mesh-ancestor
2691242|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
2691243|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
2691244|NCT02252458|Fentanyl|fentanyl|mesh-list
2691245|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2691246|NCT02252458|Narcotics|narcotics|mesh-ancestor
2691247|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2691248|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190555|NCT00003447|Immunologic Factors|immunologic factors|mesh-ancestor
2190556|NCT00003447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190557|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190558|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190559|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190560|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190561|NCT00003449|Gemcitabine|gemcitabine|mesh-list
2691249|NCT02252458|Analgesics|analgesics|mesh-ancestor
2691250|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
2691251|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691252|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2691253|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2691254|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
2691255|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
2691256|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
2691257|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2691258|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2691259|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691260|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
2691261|NCT02252497|Coagulants|coagulants|mesh-ancestor
2691262|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
2691263|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2691264|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2691265|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691266|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2691267|NCT02252523|Analgesics|analgesics|mesh-ancestor
2691268|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
2691269|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691270|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2691271|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2691272|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2691273|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
2691274|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691275|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691276|NCT02252614|Acetaminophen|acetaminophen|mesh-list
2190562|NCT00003449|Dexamethasone|dexamethasone|mesh-list
2190563|NCT00003449|Paclitaxel|paclitaxel|mesh-list
2190564|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190565|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190566|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190567|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190568|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
2691277|NCT02252614|Naproxen|naproxen|mesh-list
2691278|NCT02252614|Codeine|codeine|mesh-list
2691279|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2691280|NCT02252614|Analgesics|analgesics|mesh-ancestor
2691281|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
2691282|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691283|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691284|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
2691285|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2691286|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2691287|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2691288|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
2691289|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2691290|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691291|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691292|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2691293|NCT02252614|Narcotics|narcotics|mesh-ancestor
2691294|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2691295|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
2691296|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
2691297|NCT02252627|Phenylephrine|phenylephrine|mesh-list
2190569|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190570|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2190571|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
2190572|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
2190573|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2190574|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190575|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2190576|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
2190577|NCT00003449|Hormones|hormones|mesh-ancestor
2190578|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2190579|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2190580|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2691298|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
2691299|NCT02252627|Ephedrine|ephedrine|mesh-list
2691300|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2691301|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
2691302|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
2691303|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691304|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691305|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
2691306|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2691307|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
2691308|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
2691309|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2691310|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2691311|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2691312|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
2691313|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691314|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691315|NCT02252627|Protective Agents|protective agents|mesh-ancestor
2691316|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2691317|NCT02252692|Enalapril|enalapril|mesh-list
2190581|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
2190582|NCT00003449|Antiviral Agents|antiviral agents|mesh-ancestor
2190583|NCT00003449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190584|NCT00003449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190585|NCT00003449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190586|NCT00003449|Immunologic Factors|immunologic factors|mesh-ancestor
2190587|NCT00003451|Interferons|interferons|mesh-list
2190588|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
2190589|NCT00003451|Interleukin-12|interleukin-12|mesh-list
2190590|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190591|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
2691318|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2691319|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691320|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691321|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691322|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2691323|NCT02252731|Warfarin|warfarin|mesh-list
2691324|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
2691325|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
2691326|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2691327|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
2691328|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691329|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691330|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2691331|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
2691332|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2691333|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
2691334|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691335|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691336|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2691337|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
2691338|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
2691339|NCT02252770|Protective Agents|protective agents|mesh-ancestor
2691340|NCT02252796|Paclitaxel|paclitaxel|mesh-list
2691341|NCT02252796|Carboplatin|carboplatin|mesh-list
2691342|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2691343|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691344|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
2691345|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
2691346|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
2691347|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691348|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
2691349|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2691350|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2691351|NCT02252809|Prednisolone|prednisolone|mesh-list
2691352|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
2691353|NCT02252809|Adalimumab|adalimumab|mesh-list
2691354|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2691355|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
2691356|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2691357|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
2691358|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
2691359|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691360|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190592|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190593|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
2691361|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2691362|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
2691363|NCT02252809|Hormones|hormones|mesh-ancestor
2691364|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2691365|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2691366|NCT02252809|Protective Agents|protective agents|mesh-ancestor
2691367|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2691368|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691369|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2691370|NCT02252835|Colchicine|colchicine|mesh-list
2691371|NCT02252835|Febuxostat|febuxostat|mesh-list
2691372|NCT02252835|Gout Suppressants|gout suppressants|mesh-ancestor
2691373|NCT02252835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2691374|NCT02252835|Tubulin Modulators|tubulin modulators|mesh-ancestor
2691375|NCT02252835|Antimitotic Agents|antimitotic agents|mesh-ancestor
2691376|NCT02252835|Mitosis Modulators|mitosis modulators|mesh-ancestor
2691377|NCT02252835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691378|NCT02252835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691379|NCT02252887|Gemcitabine|gemcitabine|mesh-list
2691380|NCT02252887|Trastuzumab|trastuzumab|mesh-list
2691381|NCT02252887|Pertuzumab|pertuzumab|mesh-list
2691382|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2691383|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
2691384|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691385|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691386|NCT02252887|Antiviral Agents|antiviral agents|mesh-ancestor
2691387|NCT02252887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691388|NCT02252887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691389|NCT02252887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2691390|NCT02252887|Immunologic Factors|immunologic factors|mesh-ancestor
2691391|NCT02252887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691392|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2691393|NCT02252913|Docetaxel|docetaxel|mesh-list
2691394|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691395|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
2691396|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
2691397|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
2691398|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691399|NCT02252926|Acetaminophen|acetaminophen|mesh-list
2691400|NCT02252926|Lidocaine|lidocaine|mesh-list
2691401|NCT02252926|Morphine|morphine|mesh-list
2691402|NCT02252926|Gabapentin|gabapentin|mesh-list
2691403|NCT02252926|Bupivacaine|bupivacaine|mesh-list
2691404|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
2691405|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
2691406|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2691407|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691408|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
2691409|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691410|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2691411|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2691412|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2691413|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2691414|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691415|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2691416|NCT02252926|Narcotics|narcotics|mesh-ancestor
2691417|NCT02252926|Analgesics|analgesics|mesh-ancestor
2691418|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2691419|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
2691420|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
2691421|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2691422|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2691423|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2691424|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2691425|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2691426|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691427|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
2691428|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
2691429|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2691430|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190594|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190595|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2190596|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2190597|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2190598|NCT00003451|Growth Substances|growth substances|mesh-ancestor
2190599|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
2190600|NCT00003461|Antibodies|antibodies|mesh-list
2190601|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2190602|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
2691431|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2691432|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2691433|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691434|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691435|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691436|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2691437|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691438|NCT02253004|Cilostazol|cilostazol|mesh-list
2691439|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2691440|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
2691441|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691442|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691443|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2691444|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
2691445|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2691446|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2691447|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691448|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2691449|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
2691450|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2691451|NCT02253004|Protective Agents|protective agents|mesh-ancestor
2691452|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2691453|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2691454|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691455|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2691456|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691457|NCT02253095|Micronutrients|micronutrients|mesh-list
2691458|NCT02253095|Trace Elements|trace elements|mesh-list
2691459|NCT02253095|Albendazole|albendazole|mesh-list
2691460|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
2691461|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2691462|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691463|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
2691464|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2691465|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2691466|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
2691467|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
2691468|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
2691469|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691470|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691471|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691472|NCT02253108|Everolimus|everolimus|mesh-list
2691473|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691474|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2691475|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
2691476|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691477|NCT02253121|Insulin|insulin|mesh-list
2691478|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2691479|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
2691480|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2691481|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691482|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2691483|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691484|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
2691485|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2691486|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2691487|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691488|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2691489|NCT02253199|Analgesics|analgesics|mesh-ancestor
2691490|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
2691491|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691492|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2691493|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2691494|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2691495|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
2691496|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691497|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691498|NCT02253212|Carboplatin|carboplatin|mesh-list
2691499|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190603|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190604|NCT00003462|Busulfan|busulfan|mesh-list
2190605|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
2190606|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190607|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190608|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
2691500|NCT02253264|Rituximab|rituximab|mesh-list
2691501|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2691502|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691503|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
2691504|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691505|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2691506|NCT02253420|Itraconazole|itraconazole|mesh-list
2691507|NCT02253420|Rifampin|rifampin|mesh-list
2691508|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
2691509|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691510|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2691511|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691512|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691513|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691514|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2691515|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
2691516|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2691517|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691518|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2691519|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2691520|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
2691521|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2691522|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
2691523|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2691524|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2691525|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2691526|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2691527|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2691528|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2691529|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2691530|NCT02253446|Diclofenac|diclofenac|mesh-list
2691531|NCT02253446|Piroxicam|piroxicam|mesh-list
2691532|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2691533|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2190609|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190610|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190611|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691534|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2691535|NCT02253446|Analgesics|analgesics|mesh-ancestor
2691536|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
2691537|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691538|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691539|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2691540|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2691541|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2691542|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691543|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691544|NCT02253459|Capecitabine|capecitabine|mesh-list
2691545|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2691546|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
2691547|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691548|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691549|NCT02253485|Telbivudine|telbivudine|mesh-list
2691550|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
2691551|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691552|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2691553|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691554|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691555|NCT02253524|Metoclopramide|metoclopramide|mesh-list
2691556|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
2691557|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
2691558|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
2691559|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691560|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691561|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2691562|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2691563|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2691564|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
2691565|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691566|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691567|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2691568|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
2691569|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
2691570|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
2691571|NCT02253550|Simeprevir|simeprevir|mesh-list
2691572|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
2691573|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691574|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691575|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691576|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691577|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2691578|NCT02253602|Hematinics|hematinics|mesh-ancestor
2691579|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2691580|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2691581|NCT02253758|Propofol|propofol|mesh-list
2691582|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2691583|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2691584|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691585|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2691586|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
2691587|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
2691588|NCT02253784|Dexamethasone|dexamethasone|mesh-list
2691589|NCT02253784|Bupivacaine|bupivacaine|mesh-list
2691590|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2691591|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
2691592|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
2691593|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691594|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691595|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2691596|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
2691597|NCT02253784|Hormones|hormones|mesh-ancestor
2691598|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2691599|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2691600|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691601|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
2691602|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
2691603|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2691604|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
2691605|NCT02253797|Ritonavir|ritonavir|mesh-list
2691606|NCT02253797|Tipranavir|tipranavir|mesh-list
2691607|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2691608|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2691609|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691610|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691611|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691612|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2691613|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2691614|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
2691615|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691616|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2691617|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691618|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
2691619|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2691620|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2691621|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691622|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
2691623|NCT02253810|Coagulants|coagulants|mesh-ancestor
2691624|NCT02253836|Ritonavir|ritonavir|mesh-list
2691625|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2691626|NCT02253836|Tipranavir|tipranavir|mesh-list
2691627|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2691628|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2691629|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691630|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691631|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691632|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2691633|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2691634|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
2691635|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691636|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2190612|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190613|NCT00003463|Irinotecan|irinotecan|mesh-list
2190614|NCT00003463|Carmustine|carmustine|mesh-list
2190615|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2190616|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190617|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190618|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691637|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691638|NCT02253849|Ritonavir|ritonavir|mesh-list
2691639|NCT02253849|Tipranavir|tipranavir|mesh-list
2691640|NCT02253849|Carbamazepine|carbamazepine|mesh-list
2691641|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2691642|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2691643|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691644|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691645|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691646|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2691647|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2691648|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
2691649|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691650|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2691651|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691652|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
2691653|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
2691654|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2691655|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2691656|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691657|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2691658|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2691659|NCT02253849|Analgesics|analgesics|mesh-ancestor
2691660|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
2691661|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691662|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2691663|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2691664|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2691665|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2691666|NCT02253862|Ritonavir|ritonavir|mesh-list
2691667|NCT02253862|Tipranavir|tipranavir|mesh-list
2691668|NCT02253862|Tadalafil|tadalafil|mesh-list
2691669|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2691670|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2691671|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691672|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691673|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691674|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2691675|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2691676|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
2691677|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691678|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2691679|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691680|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
2691681|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2691682|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2691683|NCT02253862|Urological Agents|urological agents|mesh-ancestor
2691684|NCT02253875|Ritonavir|ritonavir|mesh-list
2691685|NCT02253875|Tipranavir|tipranavir|mesh-list
2691686|NCT02253875|Omeprazole|omeprazole|mesh-list
2691687|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2691688|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2691689|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691690|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190619|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190620|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190621|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
2190622|NCT00003464|Temozolomide|temozolomide|mesh-list
2691691|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691692|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2691693|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2691694|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
2691695|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691696|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2691697|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691698|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2691699|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2691700|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2691701|NCT02253888|Ritonavir|ritonavir|mesh-list
2691702|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2190623|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190624|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
2190625|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190626|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190627|NCT00003465|Temozolomide|temozolomide|mesh-list
2691703|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2691704|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691705|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691706|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691707|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2691708|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2691709|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
2691710|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691711|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2691712|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691713|NCT02253901|Ritonavir|ritonavir|mesh-list
2691714|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2691715|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2691716|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2691717|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691718|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691719|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691720|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2691721|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2691722|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
2691723|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691724|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2691725|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691726|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2691727|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2691728|NCT02253914|Ritonavir|ritonavir|mesh-list
2691729|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2190628|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190629|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
2190630|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190631|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190632|NCT00003466|Temozolomide|temozolomide|mesh-list
2190633|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190634|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
2190635|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190636|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190637|NCT00003467|Carmustine|carmustine|mesh-list
2190638|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190639|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
2190640|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190641|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190642|NCT00003478|Antibodies|antibodies|mesh-list
2190643|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2190644|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
2190645|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190646|NCT00003484|Irinotecan|irinotecan|mesh-list
2190647|NCT00003484|Carmustine|carmustine|mesh-list
2691730|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2691731|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691732|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691733|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691734|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2691735|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2691736|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
2691737|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691738|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2691739|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691740|NCT02253927|Ritonavir|ritonavir|mesh-list
2691741|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2691742|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2691743|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691744|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691745|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691746|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2691747|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2691748|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
2691749|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691750|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2691751|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691752|NCT02253940|Ritonavir|ritonavir|mesh-list
2691753|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2691754|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2691755|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691756|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691757|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691758|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2190648|NCT00003484|Antibodies|antibodies|mesh-list
2190649|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2190650|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
2190651|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190652|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2190653|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190654|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190655|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190656|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190657|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190658|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
2190659|NCT00003490|Prednisone|prednisone|mesh-list
2190660|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
2190661|NCT00003490|Vincristine|vincristine|mesh-list
2190662|NCT00003490|Sargramostim|sargramostim|mesh-list
2190663|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190664|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
2190665|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190666|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2190667|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190668|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
2190669|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190670|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190671|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190672|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2190673|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
2190674|NCT00003490|Hormones|hormones|mesh-ancestor
2190675|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2691759|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2691760|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
2691761|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691762|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2691763|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691764|NCT02253953|Ritonavir|ritonavir|mesh-list
2691765|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2691766|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2691767|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
2691768|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691769|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190676|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2691770|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2691771|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2691772|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
2691773|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691774|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2691775|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2691776|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2691777|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
2691778|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2691779|NCT02253966|Prednisolone|prednisolone|mesh-list
2691780|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
2691781|NCT02253966|Lidocaine|lidocaine|mesh-list
2691782|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2691783|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
2691784|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
2691785|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
2691786|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2691787|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691788|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
2691789|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691790|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2691791|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2691792|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2691793|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2691794|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691795|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2691796|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
2691797|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
2691798|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2691799|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
2691800|NCT02253966|Hormones|hormones|mesh-ancestor
2691801|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2691802|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2691803|NCT02253966|Protective Agents|protective agents|mesh-ancestor
2691804|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2691805|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691806|NCT02254005|Maytansine|maytansine|mesh-list
2691807|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
2691808|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2691809|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691810|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
2691811|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
2691812|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
2691813|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691814|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2691815|NCT02254018|Maytansine|maytansine|mesh-list
2691816|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
2691817|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2691818|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691819|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
2691820|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
2691821|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
2691822|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691823|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2691824|NCT02254031|Maytansine|maytansine|mesh-list
2691825|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
2691826|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2691827|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691828|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
2691829|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
2691830|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
2691831|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691832|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2691833|NCT02254044|Maytansine|maytansine|mesh-list
2691834|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
2691835|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2691836|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691837|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
2691838|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
2691839|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
2691840|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691841|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2691842|NCT02254148|Metoprolol|metoprolol|mesh-list
2691843|NCT02254148|Digoxin|digoxin|mesh-list
2691844|NCT02254148|Midazolam|midazolam|mesh-list
2691845|NCT02254148|Caffeine|caffeine|mesh-list
2691846|NCT02254148|Omeprazole|omeprazole|mesh-list
2691847|NCT02254148|Warfarin|warfarin|mesh-list
2691848|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2691849|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2691850|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2691851|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691852|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2691853|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2691854|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2691855|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2691856|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
2691857|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
2691858|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
2691859|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
2691860|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691861|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691862|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
2691863|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2691864|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2691865|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2691866|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691867|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2691868|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2691869|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2691870|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2691871|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
2691872|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2691873|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2691874|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
2691875|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
2691876|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691877|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2691878|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2691879|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2691880|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
2691881|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2691882|NCT02254148|Protective Agents|protective agents|mesh-ancestor
2691883|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
2691884|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2691885|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2691886|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
2691887|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691888|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691889|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2691890|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
2691891|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
2691892|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2691893|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
2691894|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691895|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190677|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190678|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190679|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190680|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190681|NCT00003493|Dexamethasone|dexamethasone|mesh-list
2190682|NCT00003493|Doxorubicin|doxorubicin|mesh-list
2190683|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2190684|NCT00003493|Vincristine|vincristine|mesh-list
2190685|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2190686|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
2190687|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
2190688|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2190689|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190690|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2691896|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2691897|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2691898|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2691899|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
2691900|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2691901|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2691902|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
2691903|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691904|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691905|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2691906|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
2691907|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2691908|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2691909|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2691910|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
2691911|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691912|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691913|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2691914|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2691915|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
2691916|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691917|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691918|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2691919|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
2691920|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2691921|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2691922|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2691923|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
2691924|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691925|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691926|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2691927|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2691928|NCT02254239|Everolimus|everolimus|mesh-list
2691929|NCT02254239|Antibodies|antibodies|mesh-list
2691930|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
2691931|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2691932|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
2691933|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
2691934|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691935|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190691|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
2190692|NCT00003493|Hormones|hormones|mesh-ancestor
2190693|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2190694|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2190695|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190696|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2190697|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2190698|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190699|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691936|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2691937|NCT02254447|Candesartan|candesartan|mesh-list
2691938|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
2691939|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2691940|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2691941|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2691942|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691943|NCT02254525|Ibuprofen|ibuprofen|mesh-list
2691944|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2190700|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190701|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190702|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190703|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190704|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190705|NCT00003517|Leuprolide|leuprolide|mesh-list
2190706|NCT00003517|Flutamide|flutamide|mesh-list
2190707|NCT00003517|Bicalutamide|bicalutamide|mesh-list
2190708|NCT00003517|Hormones|hormones|mesh-list
2190709|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
2190710|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2190711|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190712|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2190713|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
2190714|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2190715|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2190716|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190717|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
2190718|NCT00003518|Gemcitabine|gemcitabine|mesh-list
2190719|NCT00003518|Paclitaxel|paclitaxel|mesh-list
2190720|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190721|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190722|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190723|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190724|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190725|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691945|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2691946|NCT02254525|Analgesics|analgesics|mesh-ancestor
2691947|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
2691948|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2691949|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691950|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2691951|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2691952|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2691953|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691954|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691955|NCT02254577|Progesterone|progesterone|mesh-list
2691956|NCT02254577|Progestins|progestins|mesh-ancestor
2691957|NCT02254577|Hormones|hormones|mesh-ancestor
2190726|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190727|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
2190728|NCT00003518|Antiviral Agents|antiviral agents|mesh-ancestor
2190729|NCT00003518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190730|NCT00003518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691958|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2691959|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691960|NCT02254629|Laxatives|laxatives|mesh-list
2691961|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2691962|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
2691963|NCT02254655|Puerarin|puerarin|mesh-list
2691964|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
2691965|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
2691966|NCT02254668|Everolimus|everolimus|mesh-list
2691967|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2691968|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2691969|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
2691970|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691971|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2691972|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2691973|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
2691974|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2691975|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2691976|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2691977|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691978|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2691979|NCT02254759|Midazolam|midazolam|mesh-list
2691980|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2190731|NCT00003518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190732|NCT00003518|Immunologic Factors|immunologic factors|mesh-ancestor
2190733|NCT00003518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190734|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
2190735|NCT00003519|Docetaxel|docetaxel|mesh-list
2190736|NCT00003519|Doxorubicin|doxorubicin|mesh-list
2190737|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2190738|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190739|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
2190740|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190741|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2190742|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190743|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
2691981|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2691982|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2691983|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2691984|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2691985|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2691986|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2691987|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2691988|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
2691989|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
2691990|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
2691991|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
2691992|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2691993|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190744|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190745|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190746|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190747|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190748|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190749|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
2691994|NCT02254824|Atorvastatin|atorvastatin|mesh-list
2691995|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2691996|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2691997|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
2691998|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2691999|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2692000|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2692001|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692002|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2692003|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692004|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692005|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
2692006|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2692007|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
2692008|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692009|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2692010|NCT02254941|Antibodies|antibodies|mesh-list
2692011|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
2692012|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2692013|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
2692014|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692015|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692016|NCT02254954|Temozolomide|temozolomide|mesh-list
2692017|NCT02254954|Macitentan|macitentan|mesh-list
2692018|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2692019|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
2692020|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692021|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692022|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2692023|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2692024|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2692025|NCT02254967|Vancomycin|vancomycin|mesh-list
2692026|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
2692027|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2692028|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692029|NCT02254980|Vitamin E|vitamin e|mesh-list
2692030|NCT02254980|Vitamins|vitamins|mesh-ancestor
2692031|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
2692032|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692033|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
2692034|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692035|NCT02254980|Protective Agents|protective agents|mesh-ancestor
2692036|NCT02255006|Glyburide|glyburide|mesh-list
2692037|NCT02255006|Celecoxib|celecoxib|mesh-list
2692038|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2692039|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2692040|NCT02255006|Analgesics|analgesics|mesh-ancestor
2692041|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
2692042|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692043|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692044|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2692045|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2692046|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2692047|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2692048|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692049|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692050|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2692051|NCT02255045|Diclofenac|diclofenac|mesh-list
2692052|NCT02255045|Meloxicam|meloxicam|mesh-list
2692053|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2692054|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2692055|NCT02255045|Analgesics|analgesics|mesh-ancestor
2692056|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
2190750|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2190751|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2190752|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190753|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190754|NCT00003528|Raltitrexed|raltitrexed|mesh-list
2190755|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190756|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
2190757|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692057|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692058|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692059|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2692060|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2692061|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2692062|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692063|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692064|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2692065|NCT02255084|Menthol|menthol|mesh-list
2692066|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
2692067|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
2692068|NCT02255162|Cytarabine|cytarabine|mesh-list
2692069|NCT02255162|Lenalidomide|lenalidomide|mesh-list
2692070|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2692071|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
2692072|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692073|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692074|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
2692075|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692076|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2692077|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
2692078|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692079|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2692080|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2692081|NCT02255162|Growth Substances|growth substances|mesh-ancestor
2692082|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
2692083|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2692084|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
2692085|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692086|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2692087|NCT02255253|Telmisartan|telmisartan|mesh-list
2692088|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2692089|NCT02255253|Diuretics|diuretics|mesh-ancestor
2692090|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
2692091|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692092|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2692093|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2692094|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692095|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2692096|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2692097|NCT02255266|Liraglutide|liraglutide|mesh-list
2692098|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2692099|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692100|NCT02255266|Incretins|incretins|mesh-ancestor
2692101|NCT02255266|Hormones|hormones|mesh-ancestor
2692102|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2692103|NCT02255292|Cannabidiol|cannabidiol|mesh-list
2692104|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
2692105|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
2692106|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2692107|NCT02255370|Curcumin|curcumin|mesh-list
2692108|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2692109|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2190758|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190759|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2190760|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190761|NCT00003536|Methotrexate|methotrexate|mesh-list
2190762|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2190763|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
2190764|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2190765|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190766|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190767|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
2692110|NCT02255370|Analgesics|analgesics|mesh-ancestor
2692111|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
2692112|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692113|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692114|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2692115|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2692116|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692117|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692118|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692119|NCT02255396|Estradiol|estradiol|mesh-list
2692120|NCT02255396|Estrogens|estrogens|mesh-ancestor
2692121|NCT02255396|Hormones|hormones|mesh-ancestor
2692122|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2692123|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692124|NCT02255409|Vaccines|vaccines|mesh-list
2692125|NCT02255409|Immunologic Factors|immunologic factors|mesh-ancestor
2692126|NCT02255409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692127|NCT02255578|Clomiphene|clomiphene|mesh-list
2692128|NCT02255578|Enclomiphene|enclomiphene|mesh-list
2692129|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
2692130|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2692131|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
2692132|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2692133|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692134|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2692135|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
2692136|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2692137|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2692138|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2692139|NCT02255591|Lidocaine|lidocaine|mesh-list
2692140|NCT02255591|Epinephrine|epinephrine|mesh-list
2692141|NCT02255591|Racepinephrine|racepinephrine|mesh-list
2692142|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
2692143|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
2692144|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
2692145|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2692146|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692147|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
2692148|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692149|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2692150|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2692151|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2692152|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2692153|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692154|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2692155|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2692156|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
2692157|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692158|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2692159|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2692160|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
2692161|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2692162|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
2692163|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
2692164|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
2692165|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2692166|NCT02255682|Simvastatin|simvastatin|mesh-list
2692167|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2692168|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2692169|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
2692170|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692171|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2692172|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2692173|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692174|NCT02255734|Acyclovir|acyclovir|mesh-list
2692175|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
2692176|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692177|NCT02255747|Lactulose|lactulose|mesh-list
2692178|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2692179|NCT02255799|Donepezil|donepezil|mesh-list
2692180|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2692181|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692182|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692183|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
2692184|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692185|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692186|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
2692187|NCT02255812|Quinine|quinine|mesh-list
2692188|NCT02255812|Citric Acid|citric acid|mesh-list
2190768|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190769|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190770|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
2190771|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190772|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2190773|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190774|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
2190775|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2190776|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2190777|NCT00003539|Paclitaxel|paclitaxel|mesh-list
2190778|NCT00003539|Trastuzumab|trastuzumab|mesh-list
2190779|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190780|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190781|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190782|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190783|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190784|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190785|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2190786|NCT00003540|Gemcitabine|gemcitabine|mesh-list
2190787|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190788|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
2190789|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190790|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692189|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
2692190|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
2692191|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2692192|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2692193|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692194|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2692195|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692196|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2692197|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692198|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2692199|NCT02255812|Analgesics|analgesics|mesh-ancestor
2692200|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
2692201|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
2692202|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2692203|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
2692204|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
2692205|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692206|NCT02255942|Zinc|zinc|mesh-list
2692207|NCT02255942|Iron|iron|mesh-list
2692208|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
2692209|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
2692210|NCT02255942|Trace Elements|trace elements|mesh-ancestor
2692211|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
2692212|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692213|NCT02255942|Astringents|astringents|mesh-ancestor
2692214|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
2692215|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
2692216|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2190791|NCT00003540|Antiviral Agents|antiviral agents|mesh-ancestor
2190792|NCT00003540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190793|NCT00003540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190794|NCT00003540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190795|NCT00003540|Immunologic Factors|immunologic factors|mesh-ancestor
2190796|NCT00003540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190797|NCT00003541|Prednisone|prednisone|mesh-list
2190798|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
2190799|NCT00003541|Ifosfamide|ifosfamide|mesh-list
2190800|NCT00003541|Carboplatin|carboplatin|mesh-list
2190801|NCT00003541|Doxorubicin|doxorubicin|mesh-list
2190802|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2190803|NCT00003541|Etoposide|etoposide|mesh-list
2190804|NCT00003541|Vincristine|vincristine|mesh-list
2190805|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190806|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
2190807|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190808|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2190809|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190810|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
2190811|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190812|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692217|NCT02255942|Protective Agents|protective agents|mesh-ancestor
2692218|NCT02255955|Acetaminophen|acetaminophen|mesh-list
2692219|NCT02255955|Naproxen|naproxen|mesh-list
2692220|NCT02255955|Codeine|codeine|mesh-list
2692221|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2692222|NCT02255955|Analgesics|analgesics|mesh-ancestor
2692223|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
2692224|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692225|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692226|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
2692227|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2692228|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2692229|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2692230|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
2692231|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2692232|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692233|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692234|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2692235|NCT02255955|Narcotics|narcotics|mesh-ancestor
2692236|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2692237|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
2692238|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
2692239|NCT02256033|Istradefylline|istradefylline|mesh-list
2692240|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2692241|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2692242|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2692243|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
2692244|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692245|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692246|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692247|NCT02256124|Lamotrigine|lamotrigine|mesh-list
2692248|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
2692249|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2692250|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2692251|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692252|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2692253|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692254|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2692255|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2692256|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2692257|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2692258|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2692259|NCT02256150|Mizoribine|mizoribine|mesh-list
2692260|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
2692261|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2692262|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
2692263|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692264|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2692265|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2692266|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
2190813|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2692267|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692268|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692269|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2692270|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2692271|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2692272|NCT02256150|Analgesics|analgesics|mesh-ancestor
2692273|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
2692274|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692275|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2692276|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2692277|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692278|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2692279|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
2692280|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2692281|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2692282|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692283|NCT02256215|Vitamin D|vitamin d|mesh-list
2692284|NCT02256215|Vitamins|vitamins|mesh-ancestor
2692285|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
2692286|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692287|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2692288|NCT02256228|Ropivacaine|ropivacaine|mesh-list
2692289|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
2692290|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
2692291|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2692292|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692293|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
2692294|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692295|NCT02256254|Simvastatin|simvastatin|mesh-list
2692296|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2692297|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2692298|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
2692299|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692300|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2692301|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2692302|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692303|NCT02256280|Neostigmine|neostigmine|mesh-list
2692304|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2692305|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692306|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692307|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
2692308|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692309|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692310|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2692311|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
2692312|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692313|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
2692314|NCT02256319|Propofol|propofol|mesh-list
2692315|NCT02256319|Imidazole|imidazole|mesh-list
2692316|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2692317|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2692318|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692319|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2692320|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
2190814|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2190815|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2190816|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190817|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190818|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2692321|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
2692322|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2692323|NCT02256319|Analgesics|analgesics|mesh-ancestor
2692324|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
2692325|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692326|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2692327|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2692328|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2692329|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
2692330|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692331|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692332|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692333|NCT02256423|Ibuprofen|ibuprofen|mesh-list
2692334|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2692335|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2692336|NCT02256423|Analgesics|analgesics|mesh-ancestor
2692337|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
2692338|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692339|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692340|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2692341|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2692342|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2692343|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692344|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692345|NCT02256462|Adalimumab|adalimumab|mesh-list
2692346|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2692347|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2692348|NCT02256605|Vitamin D|vitamin d|mesh-list
2692349|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
2692350|NCT02256605|Vitamins|vitamins|mesh-ancestor
2692351|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
2692352|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692353|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2692354|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2692355|NCT02256683|Dabigatran|dabigatran|mesh-list
2692356|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
2692357|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
2692358|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2692359|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
2692360|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190819|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
2190820|NCT00003541|Hormones|hormones|mesh-ancestor
2692361|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692362|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
2190821|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2190822|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2190823|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190824|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190825|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190826|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190827|NCT00003542|Interferons|interferons|mesh-list
2190828|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
2190829|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190830|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
2190831|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190832|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
2692386|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2692387|NCT02256722|Propranolol|propranolol|mesh-list
2692388|NCT02256722|Bisoprolol|bisoprolol|mesh-list
2692389|NCT02256722|Acipimox|acipimox|mesh-list
2692390|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2692391|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2692392|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
2692393|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692394|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692395|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2692396|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
2692397|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2692398|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2692399|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2692400|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
2692401|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692402|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692403|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2692404|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2692405|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2692406|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2692407|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
2692408|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
2692409|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2692410|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2692411|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
2692412|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2692413|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
2692414|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
2692415|NCT02256735|Ritobegron|ritobegron|mesh-list
2692416|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2692417|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692418|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2692419|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2692420|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190833|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190834|NCT00003543|Fluorouracil|fluorouracil|mesh-list
2190835|NCT00003543|Vincristine|vincristine|mesh-list
2190836|NCT00003543|Carmustine|carmustine|mesh-list
2692421|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692422|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692423|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692424|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
2692425|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
2692426|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692427|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
2692428|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2692429|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2692430|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2692431|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
2692432|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692433|NCT02256748|Midazolam|midazolam|mesh-list
2692434|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2692435|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2692436|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2692437|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692438|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2692439|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2692440|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2692441|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2692442|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
2692443|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
2692444|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
2692445|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
2692446|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692447|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692448|NCT02256774|Ritonavir|ritonavir|mesh-list
2692449|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2423326|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2423327|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2423328|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423329|NCT00821574|Diuretics|diuretics|mesh-ancestor
2423330|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
2423331|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423332|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2423333|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2423334|NCT00821600|Risperidone|risperidone|mesh-list
2423335|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2423336|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
2692450|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2692451|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2692452|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
2692453|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692454|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692455|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2692456|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2692457|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
2190837|NCT00003543|Streptozocin|streptozocin|mesh-list
2190838|NCT00003543|Antibodies|antibodies|mesh-list
2692458|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692459|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2692460|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2692461|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2692462|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2692463|NCT02256813|Vitamin K|vitamin k|mesh-list
2692464|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
2692465|NCT02256813|Midazolam|midazolam|mesh-list
2692466|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
2692467|NCT02256813|Caffeine|caffeine|mesh-list
2692468|NCT02256813|Omeprazole|omeprazole|mesh-list
2692469|NCT02256813|Warfarin|warfarin|mesh-list
2692470|NCT02256813|Vitamins|vitamins|mesh-ancestor
2692471|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
2692472|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692473|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2692474|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2692475|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2692476|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2692477|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2692478|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2692479|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2692480|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
2692481|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
2692482|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
2692483|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
2692484|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692485|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692486|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
2692487|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2692488|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2692489|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2692490|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692491|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2692492|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2692493|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2692494|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2692495|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
2692496|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2692497|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2692498|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
2692499|NCT02256813|Coagulants|coagulants|mesh-ancestor
2692500|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
2692501|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
2692502|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2692503|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2692504|NCT02256826|Ritonavir|ritonavir|mesh-list
2692505|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2692506|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2692507|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
2692508|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692509|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692510|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2692511|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2692512|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
2692513|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692514|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2692515|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2692516|NCT02256865|Ketoconazole|ketoconazole|mesh-list
2692517|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
2692518|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2692519|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2692520|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2692521|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
2692522|NCT02256865|Testosterone|testosterone|mesh-list
2692523|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
2692524|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
2692525|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2692526|NCT02256865|Androgens|androgens|mesh-ancestor
2692527|NCT02256865|Hormones|hormones|mesh-ancestor
2692528|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2692529|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692530|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2692531|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692532|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
2692533|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2692534|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
2692535|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692536|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2692537|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2692538|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692539|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692540|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2692541|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
2692542|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2692543|NCT02256878|Amitriptyline|amitriptyline|mesh-list
2692544|NCT02256878|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2692545|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2692546|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
2692547|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2692548|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2692549|NCT02256878|Analgesics|analgesics|mesh-ancestor
2692550|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
2692551|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692552|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692553|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2692554|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2692555|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2692556|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692557|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
2692558|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692559|NCT02256878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2692560|NCT02256878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2692561|NCT02256878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2692562|NCT02256943|Amitriptyline|amitriptyline|mesh-list
2692563|NCT02256943|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2692564|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2692565|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2692566|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2692567|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
2692568|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692569|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692570|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692571|NCT02256943|Urological Agents|urological agents|mesh-ancestor
2692572|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2692573|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
2692574|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2692575|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2692576|NCT02256943|Analgesics|analgesics|mesh-ancestor
2692577|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
2692578|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692579|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2692580|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2692581|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2692582|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
2692583|NCT02256943|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2692584|NCT02256943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2692585|NCT02256943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2692586|NCT02256956|Amitriptyline|amitriptyline|mesh-list
2692587|NCT02256956|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2692588|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2692589|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2692590|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2692591|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
2692592|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692593|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692594|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692595|NCT02256956|Urological Agents|urological agents|mesh-ancestor
2692596|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2692597|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
2692598|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2692599|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2692600|NCT02256956|Analgesics|analgesics|mesh-ancestor
2692601|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
2692602|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692603|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2692604|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2692605|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2692606|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
2692607|NCT02256956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2692608|NCT02256956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2692609|NCT02256956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2692610|NCT02257008|Ritonavir|ritonavir|mesh-list
2692611|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2692612|NCT02257008|Nelfinavir|nelfinavir|mesh-list
2692613|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2692614|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2692615|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
2692616|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692617|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692618|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2692619|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2692620|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
2692621|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692622|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2692623|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2692624|NCT02257021|Ritonavir|ritonavir|mesh-list
2692625|NCT02257021|Tipranavir|tipranavir|mesh-list
2692626|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2692627|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2692628|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
2692629|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692630|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692631|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2190839|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2190840|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
2190841|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190842|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
2190843|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190844|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190845|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190846|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190847|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190848|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190849|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190850|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190851|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190852|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
2692632|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2692633|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
2692634|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692635|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2692636|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2692637|NCT02257138|Decitabine|decitabine|mesh-list
2692638|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2692639|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
2692640|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692641|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692642|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692643|NCT02257242|Rituximab|rituximab|mesh-list
2692644|NCT02257242|Vincristine|vincristine|mesh-list
2692645|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2692646|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2692647|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692648|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
2692649|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692650|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2692651|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2692652|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
2692653|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
2692654|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
2692655|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692656|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2692657|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
2692658|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2692659|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2692660|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2692661|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692662|NCT02257346|Lidocaine|lidocaine|mesh-list
2692663|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
2692664|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
2692665|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2190853|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2190854|NCT00003544|Irinotecan|irinotecan|mesh-list
2190855|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2190856|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190857|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190858|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190859|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190860|NCT00003546|Gemcitabine|gemcitabine|mesh-list
2190861|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190862|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
2692666|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692667|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
2692668|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692669|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2692670|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2692671|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2692672|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2692673|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692674|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
2692675|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2692676|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2692677|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692678|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2692679|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2692680|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692681|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692682|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692683|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2692684|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
2692685|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2692686|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692687|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2692688|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2692689|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2190863|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190864|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190865|NCT00003546|Antiviral Agents|antiviral agents|mesh-ancestor
2692702|NCT02257463|Theophylline|theophylline|mesh-list
2692703|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
2190866|NCT00003546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190867|NCT00003546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190868|NCT00003546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2692704|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
2692705|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692706|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692707|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2692708|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
2692709|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692710|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692711|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2692712|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692713|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
2692714|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2692715|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2692716|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
2692717|NCT02257476|Dexamethasone|dexamethasone|mesh-list
2692718|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2692719|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
2692720|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
2692721|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692722|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692723|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2692724|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
2692725|NCT02257476|Hormones|hormones|mesh-ancestor
2692726|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2692727|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2692728|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692729|NCT02257502|Aflibercept|aflibercept|mesh-list
2692730|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2692731|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2692732|NCT02257502|Growth Substances|growth substances|mesh-ancestor
2692733|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692734|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
2692735|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692736|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
2692737|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2692738|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2692739|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692740|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
2692741|NCT02257580|Coagulants|coagulants|mesh-ancestor
2692742|NCT02257619|Docetaxel|docetaxel|mesh-list
2692743|NCT02257619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692744|NCT02257619|Tubulin Modulators|tubulin modulators|mesh-ancestor
2692745|NCT02257619|Antimitotic Agents|antimitotic agents|mesh-ancestor
2692746|NCT02257619|Mitosis Modulators|mitosis modulators|mesh-ancestor
2692747|NCT02257619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692748|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
2692749|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
2692750|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2692751|NCT02257671|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2692752|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
2692753|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2692754|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692755|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2692756|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2692757|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2692758|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2692759|NCT02257671|Estrogens|estrogens|mesh-ancestor
2692760|NCT02257671|Hormones|hormones|mesh-ancestor
2692761|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2692762|NCT02257671|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2692763|NCT02257697|Mizoribine|mizoribine|mesh-list
2692764|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
2692765|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2692766|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
2692767|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692768|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2692769|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2692770|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
2692771|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692772|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692773|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2692774|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2692775|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2692776|NCT02257697|Analgesics|analgesics|mesh-ancestor
2692777|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
2692778|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692779|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2692780|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2692781|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692782|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2692783|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
2692784|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2692785|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2692786|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692787|NCT02257788|Leronlimab|leronlimab|mesh-list
2692788|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2692789|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2692790|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692791|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2692792|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2692793|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
2692794|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692795|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
2692796|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2692797|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692798|NCT02257983|Ubiquinone|ubiquinone|mesh-list
2692799|NCT02257983|Micronutrients|micronutrients|mesh-ancestor
2692800|NCT02257983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692801|NCT02258009|Ranibizumab|ranibizumab|mesh-list
2692802|NCT02258009|Aflibercept|aflibercept|mesh-list
2692803|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2692804|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2692805|NCT02258009|Growth Substances|growth substances|mesh-ancestor
2190869|NCT00003546|Immunologic Factors|immunologic factors|mesh-ancestor
2190870|NCT00003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190871|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
2190872|NCT00003549|Fluorouracil|fluorouracil|mesh-list
2190873|NCT00003549|Methotrexate|methotrexate|mesh-list
2190874|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190875|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
2190876|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692806|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692807|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
2692808|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692809|NCT02258204|Ketamine|ketamine|mesh-list
2692810|NCT02258204|Analgesics|analgesics|mesh-ancestor
2692811|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
2692812|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692813|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692814|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2692815|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2692816|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
2692817|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
2692818|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2692819|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2692820|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2692821|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692822|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692823|NCT02258282|Etanercept|etanercept|mesh-list
2692824|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2692825|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2692826|NCT02258282|Analgesics|analgesics|mesh-ancestor
2692827|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
2692828|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692829|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692830|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2692831|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2692832|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2692833|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2692834|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
2692849|NCT02258542|Benralizumab|benralizumab|mesh-list
2692850|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2692851|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
2692852|NCT02258581|Tenofovir|tenofovir|mesh-list
2692853|NCT02258581|Vesatolimod|vesatolimod|mesh-list
2692854|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
2692855|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692856|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2692857|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2692858|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692859|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692860|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2692861|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2190877|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2692862|NCT02258607|Trametinib|trametinib|mesh-list
2692863|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2692864|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692865|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2692866|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692867|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692868|NCT02258620|Isosorbide|isosorbide|mesh-list
2692869|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2190878|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190879|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
2190880|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190881|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190882|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190883|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
2190884|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190885|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2190886|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
2190887|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2190888|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
2190889|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190890|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2190891|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2190892|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
2190893|NCT00003552|Fludarabine|fludarabine|mesh-list
2190894|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2190895|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190896|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
2190897|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190898|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2190899|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190900|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
2190901|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190902|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692870|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2692871|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
2692872|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
2692873|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2692874|NCT02258620|Diuretics|diuretics|mesh-ancestor
2692875|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
2190903|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190904|NCT00003554|Prednisone|prednisone|mesh-list
2190905|NCT00003554|Rituximab|rituximab|mesh-list
2190906|NCT00003554|Melphalan|melphalan|mesh-list
2190907|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2692876|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692877|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2692878|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692879|NCT02258763|Amoxicillin|amoxicillin|mesh-list
2692880|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
2692881|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
2692882|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2692883|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2692884|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692885|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2692886|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692887|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692888|NCT02258815|Dinutuximab|dinutuximab|mesh-list
2692889|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2692890|NCT02258828|Memantine|memantine|mesh-list
2692891|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2692892|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2692893|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
2692894|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692895|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692896|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692897|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2692898|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2692899|NCT02258906|Urinastatin|urinastatin|mesh-list
2692900|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2692901|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2692902|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
2692903|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692904|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692905|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
2692906|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2692907|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2692908|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2692909|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2692910|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692911|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
2692912|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692913|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692914|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2692915|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692916|NCT02259179|Naltrexone|naltrexone|mesh-list
2692917|NCT02259179|Bupropion|bupropion|mesh-list
2692918|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2692919|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2692920|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692921|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
2692922|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692923|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2692924|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
2692925|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2692926|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2692927|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2692928|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2692929|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692930|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
2692931|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2692932|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2692933|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2692934|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692935|NCT02259309|Misoprostol|misoprostol|mesh-list
2692936|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2692937|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
2692938|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2692939|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692940|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2692941|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2692942|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
2692943|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
2692944|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2692945|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2692946|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190908|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190909|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
2190910|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190911|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2190912|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2190913|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
2190914|NCT00003554|Hormones|hormones|mesh-ancestor
2190915|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2190916|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2190917|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2190918|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
2190919|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692947|NCT02259374|Ropivacaine|ropivacaine|mesh-list
2692948|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
2692949|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
2692950|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2692951|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2692952|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
2692953|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2692954|NCT02259426|Piperaquine|piperaquine|mesh-list
2692955|NCT02259426|Primaquine|primaquine|mesh-list
2692956|NCT02259426|Artenimol|artenimol|mesh-list
2692957|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
2692958|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2692959|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2692960|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692961|NCT02259491|Calcium|calcium|mesh-list
2692962|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2692963|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190920|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2190921|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2190922|NCT00003555|Paclitaxel|paclitaxel|mesh-list
2190923|NCT00003555|Amifostine|amifostine|mesh-list
2190924|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190925|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190926|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190927|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190928|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190929|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692979|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
2692980|NCT02259543|Tetracycline|tetracycline|mesh-list
2692981|NCT02259543|Citric Acid|citric acid|mesh-list
2692982|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
2692983|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2190930|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2190931|NCT00003555|Protective Agents|protective agents|mesh-ancestor
2190932|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190933|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
2190934|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190935|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190936|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190937|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190938|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190939|NCT00003558|Leucovorin|leucovorin|mesh-list
2190940|NCT00003558|Paclitaxel|paclitaxel|mesh-list
2190941|NCT00003558|Etoposide|etoposide|mesh-list
2190942|NCT00003558|Carboplatin|carboplatin|mesh-list
2190943|NCT00003558|Fluorouracil|fluorouracil|mesh-list
2190944|NCT00003558|Calcium|calcium|mesh-list
2190945|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
2190946|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2190947|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190948|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190949|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190950|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190951|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190952|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2190953|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190954|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
2190955|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2190956|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2692984|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692985|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2692986|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2692987|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2692988|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
2692989|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2692990|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
2692991|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
2692992|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
2692993|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2692994|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
2692995|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
2692996|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2692997|NCT02259595|Expectorants|expectorants|mesh-ancestor
2692998|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
2692999|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2693000|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
2693001|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693002|NCT02259595|Protective Agents|protective agents|mesh-ancestor
2693003|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190957|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
2190958|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2693004|NCT02259595|Antidotes|antidotes|mesh-ancestor
2693005|NCT02259621|Paclitaxel|paclitaxel|mesh-list
2693006|NCT02259621|Carboplatin|carboplatin|mesh-list
2693007|NCT02259621|Nivolumab|nivolumab|mesh-list
2693008|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2693009|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693010|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
2693011|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
2693012|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
2693013|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693014|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2693015|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2693016|NCT02259647|Sorafenib|sorafenib|mesh-list
2693017|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693018|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2693019|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693020|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693021|NCT02259738|Kallikreins|kallikreins|mesh-list
2693022|NCT02259738|Coagulants|coagulants|mesh-ancestor
2693023|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
2693024|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
2693025|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2693026|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693027|NCT02259777|Amlodipine|amlodipine|mesh-list
2693028|NCT02259777|Telmisartan|telmisartan|mesh-list
2693029|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2693030|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693031|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2693032|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693033|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693034|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2693035|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693036|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
2693037|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693038|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693039|NCT02259790|Amlodipine|amlodipine|mesh-list
2693040|NCT02259790|Telmisartan|telmisartan|mesh-list
2693041|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2693042|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693043|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2693044|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693045|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693046|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2693047|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693048|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
2693049|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693050|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693051|NCT02259803|Amlodipine|amlodipine|mesh-list
2693052|NCT02259803|Telmisartan|telmisartan|mesh-list
2693053|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2190959|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2190960|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2190961|NCT00003558|Antidotes|antidotes|mesh-ancestor
2190962|NCT00003558|Protective Agents|protective agents|mesh-ancestor
2190963|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
2190964|NCT00003558|Vitamins|vitamins|mesh-ancestor
2190965|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
2190966|NCT00003560|Carboplatin|carboplatin|mesh-list
2190967|NCT00003560|Docetaxel|docetaxel|mesh-list
2190968|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190969|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190970|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
2693054|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693055|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2190971|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423337|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423338|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423339|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423340|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2423341|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2423342|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423343|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2423344|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2423345|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
2423346|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
2693056|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693057|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693058|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2693059|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693060|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
2693061|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693062|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693063|NCT02259816|Amlodipine|amlodipine|mesh-list
2693064|NCT02259816|Telmisartan|telmisartan|mesh-list
2693065|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693066|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2693067|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693068|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693069|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2693070|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693071|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
2693072|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693073|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693074|NCT02259829|Amlodipine|amlodipine|mesh-list
2693075|NCT02259829|Telmisartan|telmisartan|mesh-list
2693076|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2693077|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693078|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2693079|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693080|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693081|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2693082|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693083|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
2693084|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693085|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693086|NCT02259855|Interferons|interferons|mesh-list
2693087|NCT02259855|Ritonavir|ritonavir|mesh-list
2693088|NCT02259855|Ribavirin|ribavirin|mesh-list
2693089|NCT02259855|Tipranavir|tipranavir|mesh-list
2693090|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693091|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
2693092|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693093|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2693094|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2693095|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
2693096|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693097|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693098|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2693099|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2693100|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2693101|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2693102|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
2190972|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190973|NCT00003561|Interferons|interferons|mesh-list
2190974|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
2190975|NCT00003561|Sargramostim|sargramostim|mesh-list
2190976|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190977|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
2190978|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2190979|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
2190980|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2190981|NCT00003562|Carboplatin|carboplatin|mesh-list
2190982|NCT00003562|Docetaxel|docetaxel|mesh-list
2190983|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190984|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190985|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190986|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
2693103|NCT02259868|Ritonavir|ritonavir|mesh-list
2693104|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2693105|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2693106|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
2693107|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693108|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693109|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2693110|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2693111|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
2693112|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693113|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2693114|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2693115|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
2693116|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
2693117|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
2693118|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693119|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693120|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
2190987|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190988|NCT00003564|Procarbazine|procarbazine|mesh-list
2190989|NCT00003564|Isotretinoin|isotretinoin|mesh-list
2190990|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190991|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
2190992|NCT00003565|Docetaxel|docetaxel|mesh-list
2190993|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2190994|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
2190995|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
2190996|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
2190997|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693121|NCT02259946|Bromides|bromides|mesh-list
2693122|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
2693123|NCT02259946|Olodaterol|olodaterol|mesh-list
2693124|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2693125|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
2693126|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693127|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693128|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2693129|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
2693130|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
2693131|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2693132|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
2693133|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693134|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693135|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
2693136|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2693137|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
2693138|NCT02259959|Olodaterol|olodaterol|mesh-list
2693139|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2693140|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
2693141|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693142|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693143|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2693144|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
2693145|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
2693146|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2693147|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
2693148|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693149|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693150|NCT02259985|Itasetron|itasetron|mesh-list
2693151|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
2693152|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
2693153|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693154|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693155|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2693156|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2693157|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2693158|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
2693159|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693160|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693161|NCT02259998|Dipyridamole|dipyridamole|mesh-list
2693162|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2693163|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693164|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2190998|NCT00003567|Temozolomide|temozolomide|mesh-list
2190999|NCT00003567|Carmustine|carmustine|mesh-list
2191000|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2191001|NCT00003567|Sargramostim|sargramostim|mesh-list
2191002|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
2191003|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191004|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191005|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
2191006|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191007|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191008|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191009|NCT00003568|Aldesleukin|aldesleukin|mesh-list
2191010|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
2191011|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693165|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2693166|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
2693167|NCT02260011|Bromides|bromides|mesh-list
2693168|NCT02260011|Norflurane|norflurane|mesh-list
2693169|NCT02260011|Ipratropium|ipratropium|mesh-list
2693170|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
2693171|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2693172|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
2693173|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693174|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693175|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2693176|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
2693177|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2693178|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
2693179|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693180|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693181|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
2693182|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2693183|NCT02260024|Pramipexole|pramipexole|mesh-list
2693184|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
2693185|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693186|NCT02260024|Protective Agents|protective agents|mesh-ancestor
2693187|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693188|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2693189|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2693190|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
2693191|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
2693192|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693193|NCT02260037|Epinastine|epinastine|mesh-list
2693194|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2693195|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
2693196|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
2693197|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693198|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693199|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693200|NCT02260050|Epinastine|epinastine|mesh-list
2693201|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2693202|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
2693203|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
2693204|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2191012|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2191013|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2191014|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
2191015|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693205|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693206|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693207|NCT02260063|Epinastine|epinastine|mesh-list
2693208|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2693209|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
2693210|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
2693211|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693212|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693213|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693214|NCT02260089|Telmisartan|telmisartan|mesh-list
2693215|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693216|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693217|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693218|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693219|NCT02260102|Temocillin|temocillin|mesh-list
2693220|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2693221|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693222|NCT02260193|Glycine|glycine|mesh-list
2693223|NCT02260193|Glycine Agents|glycine agents|mesh-ancestor
2693224|NCT02260193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693225|NCT02260193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693226|NCT02260193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693227|NCT02260206|Colchicine|colchicine|mesh-list
2693228|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
2693229|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2693230|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
2693231|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
2693232|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191016|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2693233|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693234|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693235|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
2693236|NCT02260336|Celecoxib|celecoxib|mesh-list
2693237|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2693238|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2693239|NCT02260336|Analgesics|analgesics|mesh-ancestor
2693240|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
2693241|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693242|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693243|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2693244|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2693245|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2693246|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2693247|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693248|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693249|NCT02260414|Tinzaparin|tinzaparin|mesh-list
2693250|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2693251|NCT02260414|Dalteparin|dalteparin|mesh-list
2191017|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
2191018|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191019|NCT00003569|Paclitaxel|paclitaxel|mesh-list
2191020|NCT00003569|Cisplatin|cisplatin|mesh-list
2191021|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191022|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191023|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
2693252|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
2693253|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2693254|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2693255|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693256|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
2693257|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693258|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2693259|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693260|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693261|NCT02260544|Doxorubicin|doxorubicin|mesh-list
2693262|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2693263|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2693264|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693265|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2693266|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2693267|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693268|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693269|NCT02260557|Selexipag|selexipag|mesh-list
2693270|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693271|NCT02260570|Tolcapone|tolcapone|mesh-list
2693272|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2693273|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2693274|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2693275|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693276|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693277|NCT02260661|Fulvestrant|fulvestrant|mesh-list
2693278|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2693279|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693280|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2693281|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2693282|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
2191024|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191025|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191026|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191027|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
2191028|NCT00003572|Tacrolimus|tacrolimus|mesh-list
2191029|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191030|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
2191031|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191032|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2191033|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423347|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2423348|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
2423349|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423350|NCT00821782|Azithromycin|azithromycin|mesh-list
2423351|NCT00821782|Levofloxacin|levofloxacin|mesh-list
2423352|NCT00821782|Ofloxacin|ofloxacin|mesh-list
2423353|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2423354|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423355|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2423356|NCT00821782|Renal Agents|renal agents|mesh-ancestor
2693283|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2693284|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693285|NCT02260687|Aflibercept|aflibercept|mesh-list
2693286|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2693287|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2693288|NCT02260687|Growth Substances|growth substances|mesh-ancestor
2693289|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693290|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
2693291|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693292|NCT02260908|Enoxaparin|enoxaparin|mesh-list
2693293|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
2693294|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2693295|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2693296|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693297|NCT02260947|Ibuprofen|ibuprofen|mesh-list
2693298|NCT02260947|Pregabalin|pregabalin|mesh-list
2693299|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2693300|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2693301|NCT02260947|Analgesics|analgesics|mesh-ancestor
2693302|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
2693303|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693304|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693305|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2693306|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2693307|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2693308|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693309|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693310|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
2693311|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2693312|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693313|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2693314|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2693315|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2693316|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2693317|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2693318|NCT02261025|Aspirin|aspirin|mesh-list
2693319|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2693320|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2693321|NCT02261025|Analgesics|analgesics|mesh-ancestor
2693322|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
2693323|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693324|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693325|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2693326|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2693327|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2693328|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2693329|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693330|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2693331|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2693332|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693333|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
2693334|NCT02261064|Amlodipine|amlodipine|mesh-list
2693335|NCT02261064|Telmisartan|telmisartan|mesh-list
2693336|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
2693337|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693338|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2693339|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693340|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693341|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2693342|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693343|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
2693344|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693345|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693346|NCT02261077|Scopolamine|scopolamine|mesh-list
2693347|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2693348|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2693349|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
2693350|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
2693351|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693352|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693353|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2693354|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
2693355|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2191034|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191035|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2191036|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191037|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2191038|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
2693356|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
2693357|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693358|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191039|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2191040|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191041|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
2191042|NCT00003573|Cisplatin|cisplatin|mesh-list
2191043|NCT00003573|Etoposide|etoposide|mesh-list
2191044|NCT00003573|Vincristine|vincristine|mesh-list
2191045|NCT00003573|Lenograstim|lenograstim|mesh-list
2191046|NCT00003573|Sargramostim|sargramostim|mesh-list
2191047|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191048|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
2191049|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191050|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191051|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2693359|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2693360|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
2693361|NCT02261090|Pramipexole|pramipexole|mesh-list
2693362|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
2693363|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693364|NCT02261090|Protective Agents|protective agents|mesh-ancestor
2693365|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693366|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2693367|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2693368|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
2693369|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
2693370|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693371|NCT02261103|Pramipexole|pramipexole|mesh-list
2693372|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
2693373|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693374|NCT02261103|Protective Agents|protective agents|mesh-ancestor
2693375|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693376|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2693377|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2693378|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
2693379|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
2693380|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693381|NCT02261116|Telmisartan|telmisartan|mesh-list
2693382|NCT02261116|Candesartan|candesartan|mesh-list
2693383|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693384|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693385|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693386|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693387|NCT02261129|Telmisartan|telmisartan|mesh-list
2693388|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693389|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693390|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693391|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693392|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2693393|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2693394|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693395|NCT02261207|Axitinib|axitinib|mesh-list
2693396|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693397|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2693398|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693399|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693400|NCT02261220|Durvalumab|durvalumab|mesh-list
2693401|NCT02261220|Tremelimumab|tremelimumab|mesh-list
2693402|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2693403|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693404|NCT02261298|Nivolumab|nivolumab|mesh-list
2693405|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2693406|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693407|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2693408|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191052|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
2191053|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191054|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191055|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191056|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191057|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191058|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191059|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191060|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2191061|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191062|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
2693415|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2693416|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2693417|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693418|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
2693419|NCT02261636|Mesalamine|mesalamine|mesh-list
2693420|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2693421|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2693422|NCT02261636|Analgesics|analgesics|mesh-ancestor
2693423|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
2693424|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693425|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693426|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2693427|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2693428|NCT02261662|Ribavirin|ribavirin|mesh-list
2693429|NCT02261662|Betamethasone|betamethasone|mesh-list
2693430|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
2693431|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693432|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
2693433|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693434|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2693435|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
2693436|NCT02261662|Hormones|hormones|mesh-ancestor
2693437|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2693438|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693439|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2693440|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
2693441|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
2693442|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2693443|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2693444|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693445|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2693446|NCT02261675|Analgesics|analgesics|mesh-ancestor
2693447|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
2693448|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2191063|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191064|NCT00003575|Etoposide|etoposide|mesh-list
2191065|NCT00003575|Ifosfamide|ifosfamide|mesh-list
2191066|NCT00003575|Interleukin-12|interleukin-12|mesh-list
2191067|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191068|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191069|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191070|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191071|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191072|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191073|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2191074|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
2191075|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191076|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2693449|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2693450|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2693451|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2693452|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
2693453|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693454|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693455|NCT02261779|Tretinoin|tretinoin|mesh-list
2693456|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
2191077|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
2191078|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2191079|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2191080|NCT00003575|Growth Substances|growth substances|mesh-ancestor
2191081|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
2693457|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693458|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
2693459|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
2693460|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
2693461|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2693462|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2693463|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693464|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693465|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2693466|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2693467|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2693468|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191082|NCT00003576|Fluorouracil|fluorouracil|mesh-list
2191083|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191084|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
2191085|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191086|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191087|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191088|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
2191089|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191090|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
2693469|NCT02261844|Resveratrol|resveratrol|mesh-list
2693470|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
2693471|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693472|NCT02261844|Protective Agents|protective agents|mesh-ancestor
2693473|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693474|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693475|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2693476|NCT02261883|Treprostinil|treprostinil|mesh-list
2693477|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693478|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
2693479|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2693480|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693481|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2693482|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2693483|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693484|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693485|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693486|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2693487|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2693488|NCT02261922|Ticagrelor|ticagrelor|mesh-list
2693489|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2693490|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2693491|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2693492|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2693493|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2693494|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
2693495|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693496|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693497|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693502|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2693503|NCT02262143|Fenofibrate|fenofibrate|mesh-list
2693504|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2693505|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2693506|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
2693507|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693508|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2693509|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2693510|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693511|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
2693512|NCT02262156|Serotonin|serotonin|mesh-list
2693513|NCT02262156|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2693514|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2693515|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2693516|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
2693517|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693518|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693519|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191091|NCT00003577|Fluorouracil|fluorouracil|mesh-list
2191092|NCT00003577|Methotrexate|methotrexate|mesh-list
2191093|NCT00003577|Epirubicin|epirubicin|mesh-list
2191094|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191095|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
2191096|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191097|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191098|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2693520|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2693521|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693522|NCT02262169|Omeprazole|omeprazole|mesh-list
2693523|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2693524|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2693525|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2693526|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693527|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693528|NCT02262299|Pirfenidone|pirfenidone|mesh-list
2693529|NCT02262299|Analgesics|analgesics|mesh-ancestor
2693530|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
2693531|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693532|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693533|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2693534|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2693535|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2693536|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2693537|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693538|NCT02262325|Etoposide|etoposide|mesh-list
2693539|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
2693540|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693541|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2693542|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2693543|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2693544|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693545|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693546|NCT02262416|Leuprolide|leuprolide|mesh-list
2693547|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2693548|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
2693549|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2191099|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
2191100|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191101|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191102|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191103|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
2191104|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2693550|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693551|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2693552|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693553|NCT02262455|Doxorubicin|doxorubicin|mesh-list
2693554|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2693555|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2693556|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693557|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2693558|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2693559|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693560|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693561|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
2693562|NCT02262481|Progestins|progestins|mesh-ancestor
2693563|NCT02262481|Hormones|hormones|mesh-ancestor
2693564|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2693565|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693566|NCT02262520|Digoxin|digoxin|mesh-list
2693567|NCT02262520|Apixaban|apixaban|mesh-list
2693568|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2693569|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
2693570|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2693571|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
2693572|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693573|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693574|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
2693575|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2693576|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2693577|NCT02262520|Protective Agents|protective agents|mesh-ancestor
2693578|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693579|NCT02262533|Atenolol|atenolol|mesh-list
2693580|NCT02262533|Apixaban|apixaban|mesh-list
2693581|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2693582|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
2693583|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2693584|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
2693585|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693586|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693587|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
2693588|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2693589|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693590|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
2693591|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
2693592|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693593|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693594|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2693595|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2693596|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2693597|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
2693598|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693599|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
2693600|NCT02262546|Pramipexole|pramipexole|mesh-list
2693601|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2693602|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2693603|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693604|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2693605|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2693606|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693607|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693608|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693609|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2693610|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
2693611|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2693612|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693613|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2693614|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2693615|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2693616|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
2693617|NCT02262546|Protective Agents|protective agents|mesh-ancestor
2693618|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2693619|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2693620|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
2693621|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
2693622|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693623|NCT02262559|Telmisartan|telmisartan|mesh-list
2693624|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693625|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693626|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693627|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693628|NCT02262572|Telmisartan|telmisartan|mesh-list
2693629|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2693630|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693631|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693632|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693633|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693634|NCT02262572|Diuretics|diuretics|mesh-ancestor
2693635|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
2693636|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693637|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2693638|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2191105|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2191106|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
2191107|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2191108|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191109|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693639|NCT02262585|Telmisartan|telmisartan|mesh-list
2693640|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693641|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2191110|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2191111|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2191112|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2191113|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2693642|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693643|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693644|NCT02262598|Telmisartan|telmisartan|mesh-list
2693645|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2693646|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693647|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693648|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693649|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693650|NCT02262598|Diuretics|diuretics|mesh-ancestor
2693651|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
2693652|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693653|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2693654|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693655|NCT02262611|Telmisartan|telmisartan|mesh-list
2693656|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
2693657|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693658|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693659|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693660|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693661|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2693662|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693663|NCT02262611|Diuretics|diuretics|mesh-ancestor
2693664|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
2693665|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693666|NCT02262624|Telmisartan|telmisartan|mesh-list
2693667|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2693668|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693669|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693670|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693671|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693672|NCT02262624|Diuretics|diuretics|mesh-ancestor
2693673|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
2693674|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693675|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2191114|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191115|NCT00003578|Cytarabine|cytarabine|mesh-list
2191116|NCT00003578|Prednisone|prednisone|mesh-list
2191117|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
2191118|NCT00003578|Melphalan|melphalan|mesh-list
2191119|NCT00003578|Carmustine|carmustine|mesh-list
2191120|NCT00003578|Doxorubicin|doxorubicin|mesh-list
2191121|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2191122|NCT00003578|Etoposide|etoposide|mesh-list
2191123|NCT00003578|Vincristine|vincristine|mesh-list
2191124|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191125|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
2191126|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191127|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191128|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191129|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
2423357|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2423358|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2423359|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423360|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423361|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423362|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2423363|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2423364|NCT00821834|Ticlopidine|ticlopidine|mesh-list
2423365|NCT00821834|Clopidogrel|clopidogrel|mesh-list
2423366|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2423367|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2423368|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2423369|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2423370|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
2423371|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423372|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423373|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423374|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2423375|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2423376|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2423377|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2423378|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423379|NCT00821912|Docetaxel|docetaxel|mesh-list
2423380|NCT00821912|Capecitabine|capecitabine|mesh-list
2191130|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191131|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191132|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191133|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2191134|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191135|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191136|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191137|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2191138|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
2191139|NCT00003578|Hormones|hormones|mesh-ancestor
2191140|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2191141|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2191142|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191143|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191144|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
2191145|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
2693676|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693677|NCT02262637|Telmisartan|telmisartan|mesh-list
2693678|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
2693679|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693680|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693681|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693682|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693683|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2693684|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693685|NCT02262637|Diuretics|diuretics|mesh-ancestor
2693686|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
2693687|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693688|NCT02262650|Telmisartan|telmisartan|mesh-list
2693689|NCT02262650|Clopidogrel|clopidogrel|mesh-list
2693690|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2693691|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2693692|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2693693|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2693694|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
2693695|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693696|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693697|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693698|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693699|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693700|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693701|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
2693702|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2693703|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
2693704|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2693705|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
2693706|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693707|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693708|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
2693709|NCT02262702|Acetaminophen|acetaminophen|mesh-list
2693710|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2693711|NCT02262702|Analgesics|analgesics|mesh-ancestor
2693712|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
2693713|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693714|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693715|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
2693716|NCT02262715|Oseltamivir|oseltamivir|mesh-list
2693717|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
2693718|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693719|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693720|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693721|NCT02262741|Durvalumab|durvalumab|mesh-list
2693722|NCT02262741|Tremelimumab|tremelimumab|mesh-list
2693723|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2693724|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693725|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
2693726|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
2693727|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
2693728|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693729|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693730|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2693731|NCT02262780|Telmisartan|telmisartan|mesh-list
2693732|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693733|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693734|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693735|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693736|NCT02262793|Telmisartan|telmisartan|mesh-list
2693737|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693738|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693739|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693740|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693741|NCT02262858|Telmisartan|telmisartan|mesh-list
2693742|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2191146|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191147|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191148|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191149|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191150|NCT00003580|Amifostine|amifostine|mesh-list
2191151|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2191152|NCT00003580|Protective Agents|protective agents|mesh-ancestor
2191153|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191154|NCT00003582|Paclitaxel|paclitaxel|mesh-list
2191155|NCT00003582|Fluorouracil|fluorouracil|mesh-list
2191156|NCT00003582|Amifostine|amifostine|mesh-list
2191157|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2693743|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693744|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693745|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693746|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693747|NCT02262858|Diuretics|diuretics|mesh-ancestor
2693748|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
2693749|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693750|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2693751|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693752|NCT02262897|Paclitaxel|paclitaxel|mesh-list
2693753|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2693754|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2693755|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693756|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
2693757|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
2693758|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
2693759|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693760|NCT02262923|Metoclopramide|metoclopramide|mesh-list
2693761|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
2693762|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
2693763|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693764|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693765|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2693766|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2693767|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2693768|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
2693769|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693770|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693771|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2693772|NCT02262936|Fesoterodine|fesoterodine|mesh-list
2693773|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2693774|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2693775|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
2693776|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693777|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693778|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693779|NCT02262936|Urological Agents|urological agents|mesh-ancestor
2693780|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
2693781|NCT02262936|Coagulants|coagulants|mesh-ancestor
2693782|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2693783|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
2693784|NCT02263027|Vaccines|vaccines|mesh-list
2693785|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
2693786|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693787|NCT02263066|Factor VIII|factor viii|mesh-list
2693788|NCT02263066|Coagulants|coagulants|mesh-ancestor
2693789|NCT02263105|Temozolomide|temozolomide|mesh-list
2693790|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2693791|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
2693792|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693793|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191158|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693794|NCT02263170|Phenobarbital|phenobarbital|mesh-list
2693795|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
2693796|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2693797|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2693798|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693799|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2693800|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2693801|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693802|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693803|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
2693804|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
2693805|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2693806|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2693807|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2693808|NCT02263196|Ethanol|ethanol|mesh-list
2693809|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
2693810|NCT02263196|Povidone|povidone|mesh-list
2693811|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2693812|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693813|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2693814|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693815|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
2693816|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
2693817|NCT02263248|Buprenorphine|buprenorphine|mesh-list
2693818|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2693819|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2693820|NCT02263248|Narcotics|narcotics|mesh-ancestor
2693821|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2693822|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693823|NCT02263248|Analgesics|analgesics|mesh-ancestor
2693824|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
2693825|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693826|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2693827|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2693828|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2693829|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693830|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693831|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693832|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2693833|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
2693834|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2693835|NCT02263352|Carotenoids|carotenoids|mesh-list
2693836|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
2693837|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693838|NCT02263352|Protective Agents|protective agents|mesh-ancestor
2693839|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693840|NCT02263495|Gemcitabine|gemcitabine|mesh-list
2693841|NCT02263495|Paclitaxel|paclitaxel|mesh-list
2693842|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2693843|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693844|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
2693845|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
2693846|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
2693847|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693848|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2693849|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
2693850|NCT02263495|Antiviral Agents|antiviral agents|mesh-ancestor
2693851|NCT02263495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693852|NCT02263495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693853|NCT02263495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2693854|NCT02263495|Immunologic Factors|immunologic factors|mesh-ancestor
2693855|NCT02263495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693856|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2693857|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2693858|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2693859|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2693860|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693861|NCT02263677|Incretins|incretins|mesh-ancestor
2693862|NCT02263677|Hormones|hormones|mesh-ancestor
2693863|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2693864|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2693865|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
2693866|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693867|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693868|NCT02263690|Lidocaine|lidocaine|mesh-list
2693869|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
2693870|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
2693871|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2693872|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693873|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
2191159|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191160|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191161|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191162|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191163|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
2191164|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191165|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191166|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
2191167|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191168|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2693874|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693875|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2693876|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2693877|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2693878|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2693879|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693886|NCT02263872|Minocycline|minocycline|mesh-list
2693887|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2693888|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693889|NCT02263924|Tocotrienols|tocotrienols|mesh-list
2693890|NCT02263924|Vitamin E|vitamin e|mesh-list
2693891|NCT02263924|Tocopherols|tocopherols|mesh-list
2693892|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
2693893|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693894|NCT02263924|Protective Agents|protective agents|mesh-ancestor
2693895|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693896|NCT02263924|Vitamins|vitamins|mesh-ancestor
2693897|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
2693898|NCT02263950|Artemether|artemether|mesh-list
2693899|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
2693900|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2693901|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2693902|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693903|NCT02263976|Bromides|bromides|mesh-list
2693904|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
2693905|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
2693906|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2693907|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
2693908|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693909|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693910|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2693911|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
2693912|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
2693913|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2693914|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
2693915|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693916|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693917|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
2693918|NCT02263976|Miotics|miotics|mesh-ancestor
2693919|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2693920|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2693921|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2693922|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2693923|NCT02263989|Telmisartan|telmisartan|mesh-list
2693924|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693925|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2693926|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2693927|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693928|NCT02264002|Metoprolol|metoprolol|mesh-list
2693929|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2693930|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693931|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
2693932|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
2693933|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2693934|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693935|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2693936|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2693937|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2693938|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
2693939|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693940|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693941|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
2693942|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2693943|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693944|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2693945|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2693946|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693947|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693948|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2693949|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2693950|NCT02264041|Itraconazole|itraconazole|mesh-list
2693951|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
2693952|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2693953|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2693954|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2693955|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693956|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693957|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2693958|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
2693959|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2693960|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191169|NCT00003582|Protective Agents|protective agents|mesh-ancestor
2191170|NCT00003583|Etoposide|etoposide|mesh-list
2191171|NCT00003583|Amifostine|amifostine|mesh-list
2693961|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2693962|NCT02264093|Propranolol|propranolol|mesh-list
2693963|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2693964|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2693965|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
2693966|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693967|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693968|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693969|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2693970|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2693971|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
2693972|NCT02264106|Pantoprazole|pantoprazole|mesh-list
2693973|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2693974|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2693975|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2693976|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693977|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693978|NCT02264119|Pantoprazole|pantoprazole|mesh-list
2693979|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2693980|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2693981|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2693982|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2693983|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693984|NCT02264132|Pramipexole|pramipexole|mesh-list
2693985|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
2693986|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2693987|NCT02264132|Protective Agents|protective agents|mesh-ancestor
2693988|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693989|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2191172|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191173|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191174|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191175|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191176|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191177|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191178|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2191179|NCT00003583|Protective Agents|protective agents|mesh-ancestor
2191180|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191181|NCT00003584|Prednisone|prednisone|mesh-list
2191182|NCT00003584|Estramustine|estramustine|mesh-list
2693990|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2693991|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
2693992|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
2693993|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2693994|NCT02264145|Norflurane|norflurane|mesh-list
2693995|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2693996|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
2693997|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2693998|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2693999|NCT02264158|Telmisartan|telmisartan|mesh-list
2694000|NCT02264158|Lacidipine|lacidipine|mesh-list
2694001|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2694002|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2694003|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2694004|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694005|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2694006|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2694007|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2694008|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694009|NCT02264171|Ketoconazole|ketoconazole|mesh-list
2694010|NCT02264171|Tamsulosin|tamsulosin|mesh-list
2694011|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2694012|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2694013|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2694014|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
2694015|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694016|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694017|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694018|NCT02264171|Urological Agents|urological agents|mesh-ancestor
2694019|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
2694020|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694021|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2694022|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2694023|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694024|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2694025|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
2694026|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2694027|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2694028|NCT02264184|Paroxetine|paroxetine|mesh-list
2694029|NCT02264184|Tamsulosin|tamsulosin|mesh-list
2694030|NCT02264184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2694031|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2694032|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2694033|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191183|NCT00003584|Vinorelbine|vinorelbine|mesh-list
2191184|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2191185|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
2191186|NCT00003584|Hormones|hormones|mesh-ancestor
2191187|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2191188|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191189|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2191190|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191191|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191192|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191193|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191194|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191195|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191196|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191197|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
2191198|NCT00003585|Interferons|interferons|mesh-list
2191199|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
2191200|NCT00003585|Aldesleukin|aldesleukin|mesh-list
2694034|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694035|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
2694036|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694037|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2694038|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
2694039|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2694040|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2694041|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2694042|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694043|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2694044|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2694045|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2694046|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
2694047|NCT02264184|Urological Agents|urological agents|mesh-ancestor
2694048|NCT02264236|Vaccines|vaccines|mesh-list
2694049|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
2694050|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694051|NCT02264301|Puerarin|puerarin|mesh-list
2694052|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
2694053|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
2694054|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2694055|NCT02264561|Caffeine|caffeine|mesh-list
2694056|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2694057|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694058|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2694059|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191201|NCT00003585|Fluorouracil|fluorouracil|mesh-list
2191202|NCT00003585|Isotretinoin|isotretinoin|mesh-list
2191203|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
2191204|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191205|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191206|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191207|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191208|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
2191209|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191210|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
2191211|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191212|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2694060|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694061|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2694062|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2694063|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
2694064|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694065|NCT02264587|Domperidone|domperidone|mesh-list
2694066|NCT02264587|Mosapride|mosapride|mesh-list
2694067|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
2694068|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
2694069|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694070|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694071|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2694072|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2694073|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
2694074|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694075|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694076|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2191213|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2191214|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191215|NCT00003587|Gemcitabine|gemcitabine|mesh-list
2191216|NCT00003587|Paclitaxel|paclitaxel|mesh-list
2191217|NCT00003587|Vinorelbine|vinorelbine|mesh-list
2191218|NCT00003587|Docetaxel|docetaxel|mesh-list
2191219|NCT00003587|Carboplatin|carboplatin|mesh-list
2191220|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191221|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191222|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191223|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191224|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191225|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191226|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191227|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
2694077|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
2694078|NCT02264626|Remifentanil|remifentanil|mesh-list
2694079|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2694080|NCT02264626|Narcotics|narcotics|mesh-ancestor
2694081|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694082|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694083|NCT02264626|Analgesics|analgesics|mesh-ancestor
2694084|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
2694085|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694086|NCT02264665|Everolimus|everolimus|mesh-list
2694087|NCT02264665|Sunitinib|sunitinib|mesh-list
2694088|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694089|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2694090|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
2694091|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191228|NCT00003587|Antiviral Agents|antiviral agents|mesh-ancestor
2694092|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2694093|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2694094|NCT02264665|Growth Substances|growth substances|mesh-ancestor
2694095|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
2694096|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2694097|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694098|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694099|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2694100|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2694101|NCT02264743|Estradiol|estradiol|mesh-list
2694102|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2694103|NCT02264743|Estrogens|estrogens|mesh-ancestor
2694104|NCT02264743|Hormones|hormones|mesh-ancestor
2191229|NCT00003587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191230|NCT00003587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191231|NCT00003587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191232|NCT00003587|Immunologic Factors|immunologic factors|mesh-ancestor
2191233|NCT00003587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191234|NCT00003589|Gemcitabine|gemcitabine|mesh-list
2191235|NCT00003589|Paclitaxel|paclitaxel|mesh-list
2191236|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191237|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191238|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191239|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191240|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
2694105|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2694106|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694107|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2694108|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
2694109|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2694110|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2694111|NCT02264769|Carbetocin|carbetocin|mesh-list
2694112|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
2694113|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2694114|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694115|NCT02264795|Lidocaine|lidocaine|mesh-list
2694116|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
2694117|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
2694118|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2191241|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191242|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191243|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
2191244|NCT00003589|Antiviral Agents|antiviral agents|mesh-ancestor
2191245|NCT00003589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191246|NCT00003589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191247|NCT00003589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191248|NCT00003589|Immunologic Factors|immunologic factors|mesh-ancestor
2191249|NCT00003589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191250|NCT00003591|Paclitaxel|paclitaxel|mesh-list
2191251|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191252|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191253|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191254|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
2694119|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694120|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
2694121|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694122|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2694123|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2694124|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2694125|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2694126|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694127|NCT02264834|Sufentanil|sufentanil|mesh-list
2694128|NCT02264834|Dsuvia|dsuvia|mesh-list
2694129|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
2694130|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
2694131|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
2694132|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694133|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694134|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
2694135|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694136|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2694137|NCT02264834|Narcotics|narcotics|mesh-ancestor
2694138|NCT02264834|Analgesics|analgesics|mesh-ancestor
2694139|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2694140|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2191255|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
2694141|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
2694142|NCT02264847|Clomiphene|clomiphene|mesh-list
2694143|NCT02264847|Enclomiphene|enclomiphene|mesh-list
2694144|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
2694145|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2694146|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2694147|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
2694148|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2694149|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694150|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2694151|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
2694152|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2694153|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2694154|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2694155|NCT02264873|Decitabine|decitabine|mesh-list
2694156|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2694157|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
2694158|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694159|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694160|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694161|NCT02264912|Clopidogrel|clopidogrel|mesh-list
2694162|NCT02264912|Ticagrelor|ticagrelor|mesh-list
2694163|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2694164|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2694165|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2694166|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2694167|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2694168|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
2694169|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694170|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694171|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694172|NCT02264938|Antioxidants|antioxidants|mesh-list
2694173|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694174|NCT02264938|Protective Agents|protective agents|mesh-ancestor
2694175|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694176|NCT02265068|Ticagrelor|ticagrelor|mesh-list
2694177|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2694178|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2694179|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2694180|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2694181|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
2694182|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694183|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694184|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694185|NCT02265276|Pioglitazone|pioglitazone|mesh-list
2694186|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2694187|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694188|NCT02265289|Clopidogrel|clopidogrel|mesh-list
2694189|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2694190|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2694191|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2694192|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2694193|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
2694194|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694195|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694196|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694197|NCT02265328|Prednisolone|prednisolone|mesh-list
2694198|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2694199|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
2694200|NCT02265328|Hormones|hormones|mesh-ancestor
2694201|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2694202|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694203|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2694204|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694205|NCT02265367|Milnacipran|milnacipran|mesh-list
2694206|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
2694207|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2694208|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2694209|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2694210|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694211|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694212|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694213|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
2694214|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2694215|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2694216|NCT02265367|Analgesics|analgesics|mesh-ancestor
2694217|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
2694218|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694219|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
2694220|NCT02265445|beta-Lactams|beta-lactams|mesh-list
2694221|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2694222|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694223|NCT02265484|Rifaximin|rifaximin|mesh-list
2694224|NCT02265484|Bromocriptine|bromocriptine|mesh-list
2694225|NCT02265484|Lactulose|lactulose|mesh-list
2694226|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2694227|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694228|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2694229|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2694230|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2694231|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
2694232|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2694233|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191256|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191257|NCT00003592|Paclitaxel|paclitaxel|mesh-list
2191258|NCT00003592|Methotrexate|methotrexate|mesh-list
2191259|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191260|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191261|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
2694234|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
2694235|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
2694236|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694237|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694238|NCT02265562|Alprostadil|alprostadil|mesh-list
2694239|NCT02265562|Misoprostol|misoprostol|mesh-list
2694240|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2694241|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
2694242|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2694243|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694244|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2694245|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2694246|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
2694247|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2694248|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
2694249|NCT02265562|Urological Agents|urological agents|mesh-ancestor
2694250|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
2694251|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2694252|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
2694253|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694254|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
2694255|NCT02265575|Protective Agents|protective agents|mesh-ancestor
2694256|NCT02265718|Methylphenidate|methylphenidate|mesh-list
2694257|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2694258|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694259|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2694260|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2694261|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2694262|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694263|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
2694264|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694265|NCT02265731|Rituximab|rituximab|mesh-list
2694266|NCT02265731|Venetoclax|venetoclax|mesh-list
2694267|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2694268|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694269|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
2694270|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694271|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2694272|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
2694273|NCT02265770|Cisplatin|cisplatin|mesh-list
2694274|NCT02265770|Carboplatin|carboplatin|mesh-list
2694275|NCT02265770|Methotrexate|methotrexate|mesh-list
2694276|NCT02265770|Etoposide|etoposide|mesh-list
2694277|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
2694278|NCT02265770|Vincristine|vincristine|mesh-list
2694279|NCT02265770|Valproic Acid|valproic acid|mesh-list
2191262|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
2694280|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2694281|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
2694282|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694283|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2694284|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2423381|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423382|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
2423383|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
2423384|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423385|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423386|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2423387|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
2423388|NCT00821977|Vildagliptin|vildagliptin|mesh-list
2423389|NCT00821977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2423390|NCT00821977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694285|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
2694286|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694287|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694288|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2694289|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2694290|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
2694291|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2694292|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2694293|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
2694294|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
2694295|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694296|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2694297|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2694298|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2694299|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2694300|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2694301|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
2694302|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
2694303|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
2694304|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
2694305|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
2694306|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694307|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
2694308|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2694309|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694310|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2694311|NCT02265809|Aldesleukin|aldesleukin|mesh-list
2694312|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694313|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2694314|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2694315|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
2694316|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694317|NCT02265822|Midazolam|midazolam|mesh-list
2694318|NCT02265822|Melatonin|melatonin|mesh-list
2694319|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2694320|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2694321|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694322|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694323|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2694324|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2694325|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2694326|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2694327|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
2694328|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
2694329|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
2694330|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
2694331|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694332|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694333|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
2694334|NCT02265822|Protective Agents|protective agents|mesh-ancestor
2694335|NCT02265874|Nicotine|nicotine|mesh-list
2694336|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2694337|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
2694338|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694339|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694340|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2694341|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2694342|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
2694343|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694344|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694345|NCT02266030|Aspirin|aspirin|mesh-list
2694346|NCT02266030|Cilostazol|cilostazol|mesh-list
2694347|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2694348|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2694349|NCT02266030|Analgesics|analgesics|mesh-ancestor
2191263|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191264|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694350|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
2694351|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694352|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694353|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2694354|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2694355|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2694356|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2694357|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191265|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2191266|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
2191267|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2191268|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191269|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191270|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
2191271|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191272|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191273|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2191274|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191275|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
2191276|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2694358|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2694359|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2694360|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694361|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
2694362|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2694363|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
2694364|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2694365|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
2694366|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
2694367|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2694368|NCT02266030|Protective Agents|protective agents|mesh-ancestor
2694369|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2694370|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2694371|NCT02266056|Rocuronium|rocuronium|mesh-list
2191277|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2191278|NCT00003593|Cytarabine|cytarabine|mesh-list
2191279|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
2191280|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2191281|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2191282|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2191283|NCT00003593|Methotrexate|methotrexate|mesh-list
2191284|NCT00003593|Thioguanine|thioguanine|mesh-list
2191285|NCT00003593|Daunorubicin|daunorubicin|mesh-list
2191286|NCT00003593|Asparaginase|asparaginase|mesh-list
2191287|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2191288|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
2191289|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2191290|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191291|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191292|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
2191293|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191294|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191295|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191296|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694372|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2694373|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2694374|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2694375|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694376|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694377|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2694378|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
2694379|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
2694380|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694381|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694382|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
2694383|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694384|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2694385|NCT02266173|Pertuzumab|pertuzumab|mesh-list
2694386|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2694387|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694388|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
2191297|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2694389|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2694390|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2694391|NCT02266303|Insulin|insulin|mesh-list
2694392|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2694393|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694394|NCT02266329|Prazosin|prazosin|mesh-list
2694395|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2694396|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2694397|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2694398|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2694399|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
2694400|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694401|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694402|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694403|NCT02266355|Omalizumab|omalizumab|mesh-list
2694404|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2694405|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2694406|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
2694407|NCT02266485|Pravastatin|pravastatin|mesh-list
2694408|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2694409|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2694410|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
2694411|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694412|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2694413|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2694414|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694415|NCT02266511|Tamsulosin|tamsulosin|mesh-list
2694416|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2694417|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2694418|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2694419|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
2694420|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694421|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694422|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694423|NCT02266511|Urological Agents|urological agents|mesh-ancestor
2694424|NCT02266524|Tamsulosin|tamsulosin|mesh-list
2694425|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2694426|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2694427|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2694428|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
2694429|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694430|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694431|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694432|NCT02266524|Urological Agents|urological agents|mesh-ancestor
2694433|NCT02266537|Doxazosin|doxazosin|mesh-list
2694434|NCT02266537|Tamsulosin|tamsulosin|mesh-list
2694435|NCT02266537|Alfuzosin|alfuzosin|mesh-list
2694436|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2694437|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2694438|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2694439|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
2694440|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694441|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694442|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694443|NCT02266537|Urological Agents|urological agents|mesh-ancestor
2694444|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2694445|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
2694446|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2694447|NCT02266784|Nicotine|nicotine|mesh-list
2694448|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2694449|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
2694450|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694451|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694452|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2694453|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2694454|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
2694455|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694456|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694457|NCT02266849|Loperamide|loperamide|mesh-list
2694458|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
2694459|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2694460|NCT02266927|Fluticasone|fluticasone|mesh-list
2694461|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2694462|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2694463|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
2694464|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694465|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694466|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2694467|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
2694468|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
2694469|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2694470|NCT02267044|Ropivacaine|ropivacaine|mesh-list
2694471|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
2694472|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
2694473|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694474|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694475|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
2694476|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694477|NCT02267057|Acetaminophen|acetaminophen|mesh-list
2694478|NCT02267057|Buprenorphine|buprenorphine|mesh-list
2694479|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2191298|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191299|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
2191300|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191301|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2191302|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
2191303|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694480|NCT02267057|Analgesics|analgesics|mesh-ancestor
2694481|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
2694482|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694483|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694484|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
2694485|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2694486|NCT02267057|Narcotics|narcotics|mesh-ancestor
2694487|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694488|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2694489|NCT02267122|Mupirocin|mupirocin|mesh-list
2694490|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2694491|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694492|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2694493|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694494|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694495|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
2694496|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2694497|NCT02267239|Listerine|listerine|mesh-list
2694498|NCT02267239|Hexetidine|hexetidine|mesh-list
2694499|NCT02267239|Menthol|menthol|mesh-list
2694500|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
2694501|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2694502|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694503|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
2694504|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
2694505|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
2694506|NCT02267239|Protective Agents|protective agents|mesh-ancestor
2694507|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694508|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
2694509|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
2694510|NCT02267252|Antibodies|antibodies|mesh-list
2694511|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
2694512|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694513|NCT02267304|Morphine|morphine|mesh-list
2694514|NCT02267304|Naloxone|naloxone|mesh-list
2694515|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2694516|NCT02267304|Narcotics|narcotics|mesh-ancestor
2694517|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694518|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694519|NCT02267304|Analgesics|analgesics|mesh-ancestor
2694520|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
2694521|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694522|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2694523|NCT02267408|Warfarin|warfarin|mesh-list
2694524|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
2694525|NCT02267616|Etonogestrel|etonogestrel|mesh-list
2694526|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2694527|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
2694528|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2694529|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694530|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2694531|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
2694532|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2694533|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
2694534|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694535|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694536|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2694537|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
2694538|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2694539|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
2694540|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694541|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694542|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2694543|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
2694544|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
2694545|NCT02267655|Protective Agents|protective agents|mesh-ancestor
2694546|NCT02267681|Fentanyl|fentanyl|mesh-list
2694547|NCT02267681|Alfentanil|alfentanil|mesh-list
2694548|NCT02267681|Propofol|propofol|mesh-list
2694549|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2694550|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694551|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694552|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2694553|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
2694554|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
2694555|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2694556|NCT02267681|Narcotics|narcotics|mesh-ancestor
2694557|NCT02267681|Analgesics|analgesics|mesh-ancestor
2694558|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
2694559|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2191304|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2191305|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2191306|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191307|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191308|NCT00003594|Leucovorin|leucovorin|mesh-list
2191309|NCT00003594|Fluorouracil|fluorouracil|mesh-list
2191310|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
2191311|NCT00003594|Irinotecan|irinotecan|mesh-list
2191312|NCT00003594|Calcium|calcium|mesh-list
2191313|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
2191314|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2191315|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191316|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
2191317|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191318|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191319|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191320|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191321|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
2191322|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2191323|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191324|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191325|NCT00003594|Antidotes|antidotes|mesh-ancestor
2191326|NCT00003594|Protective Agents|protective agents|mesh-ancestor
2191327|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
2191328|NCT00003594|Vitamins|vitamins|mesh-ancestor
2191329|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
2191330|NCT00003595|Prednisone|prednisone|mesh-list
2191331|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
2191332|NCT00003595|Rituximab|rituximab|mesh-list
2191333|NCT00003595|Doxorubicin|doxorubicin|mesh-list
2191334|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2191335|NCT00003595|Vincristine|vincristine|mesh-list
2191336|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191337|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
2191338|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191339|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191340|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191341|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
2423391|NCT00821977|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2423392|NCT00821977|Protease Inhibitors|protease inhibitors|mesh-ancestor
2423393|NCT00821977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423394|NCT00821977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423395|NCT00822029|Alendronate|alendronate|mesh-list
2423396|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2423397|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423398|NCT00822055|Timolol|timolol|mesh-list
2423399|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2423400|NCT00822055|Dorzolamide|dorzolamide|mesh-list
2423401|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
2423402|NCT00822055|Maleic acid|maleic acid|mesh-list
2423403|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2423404|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2423405|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
2423406|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2191342|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694560|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2694561|NCT02267707|Gemcitabine|gemcitabine|mesh-list
2694562|NCT02267707|Paclitaxel|paclitaxel|mesh-list
2694563|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2694564|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694565|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
2694566|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
2694567|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191343|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191344|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191345|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2191346|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2191347|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191348|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191349|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191350|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2191351|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
2191352|NCT00003595|Hormones|hormones|mesh-ancestor
2191353|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2694568|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694569|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2694570|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
2694571|NCT02267707|Antiviral Agents|antiviral agents|mesh-ancestor
2694572|NCT02267707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694573|NCT02267707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694574|NCT02267707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2694575|NCT02267707|Immunologic Factors|immunologic factors|mesh-ancestor
2694576|NCT02267707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694577|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
2694578|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694579|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
2694580|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
2694581|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
2694582|NCT02267915|Rituximab|rituximab|mesh-list
2694583|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2694584|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694585|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
2694586|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694587|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2694588|NCT02267980|Ketamine|ketamine|mesh-list
2694589|NCT02267980|Sevoflurane|sevoflurane|mesh-list
2694590|NCT02267980|Analgesics|analgesics|mesh-ancestor
2694591|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
2694592|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694593|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694594|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2694595|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2694596|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
2694597|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
2694598|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694599|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2694600|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2694601|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694602|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694603|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2694604|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2694605|NCT02268006|Capecitabine|capecitabine|mesh-list
2694606|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2694607|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
2694608|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694609|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694610|NCT02268019|Epinephrine|epinephrine|mesh-list
2694611|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2694612|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2694613|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
2694614|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694615|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694616|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694617|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2694618|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2694619|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
2694620|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694621|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2694622|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
2694623|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
2694624|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
2694625|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2694626|NCT02268032|Androgens|androgens|mesh-list
2694627|NCT02268032|Hormones|hormones|mesh-ancestor
2694628|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2694629|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694630|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
2694631|NCT02268149|Prednisone|prednisone|mesh-list
2694632|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2694633|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
2694634|NCT02268149|Hormones|hormones|mesh-ancestor
2694635|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2694636|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694637|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2694638|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694639|NCT02268201|Tacrolimus|tacrolimus|mesh-list
2694640|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2694641|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
2694642|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694643|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2694644|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694645|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694646|NCT02268279|Solithromycin|solithromycin|mesh-list
2694647|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2694648|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694649|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
2694650|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2694651|NCT02268357|Propranolol|propranolol|mesh-list
2694652|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2694653|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2694654|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
2694655|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694656|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694657|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694658|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2694659|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2694660|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
2694661|NCT02268370|Dasatinib|dasatinib|mesh-list
2694662|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694663|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2694664|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694665|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694666|NCT02268383|Luspatercept|luspatercept|mesh-list
2694667|NCT02268383|Hematinics|hematinics|mesh-ancestor
2694668|NCT02268409|Luspatercept|luspatercept|mesh-list
2694669|NCT02268409|Hematinics|hematinics|mesh-ancestor
2694670|NCT02268422|Buprenorphine|buprenorphine|mesh-list
2694671|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2694672|NCT02268422|Narcotics|narcotics|mesh-ancestor
2694673|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694674|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694675|NCT02268422|Analgesics|analgesics|mesh-ancestor
2694676|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
2694677|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694678|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2694679|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
2694680|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694681|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2694682|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694683|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694684|NCT02268448|Clonidine|clonidine|mesh-list
2694685|NCT02268448|Naltrexone|naltrexone|mesh-list
2694686|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2694687|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2694688|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694689|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
2191354|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2191355|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191356|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191357|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191358|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191359|NCT00003596|Fluorouracil|fluorouracil|mesh-list
2191360|NCT00003596|Mitomycins|mitomycins|mesh-list
2694690|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694691|NCT02268448|Analgesics|analgesics|mesh-ancestor
2191361|NCT00003596|Mitomycin|mitomycin|mesh-list
2191362|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694692|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2694693|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
2694694|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
2694695|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2694696|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2694697|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2694698|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
2694699|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694700|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694701|NCT02268487|Sertraline|sertraline|mesh-list
2694702|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
2694703|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2694704|NCT02268487|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2694705|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2694706|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2694707|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694708|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694709|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
2694710|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694711|NCT02268565|Aspirin|aspirin|mesh-list
2694712|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2694713|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2694714|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2694715|NCT02268565|Analgesics|analgesics|mesh-ancestor
2694716|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
2694717|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694718|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694719|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2694720|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2694721|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2694722|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694723|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2694724|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2694725|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694726|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
2694727|NCT02268656|Propofol|propofol|mesh-list
2694728|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2694729|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694730|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694731|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2694732|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
2694733|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
2694734|NCT02268695|Docetaxel|docetaxel|mesh-list
2694735|NCT02268695|Cetuximab|cetuximab|mesh-list
2694736|NCT02268695|Sargramostim|sargramostim|mesh-list
2694737|NCT02268695|Lenograstim|lenograstim|mesh-list
2694738|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191363|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
2191364|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191365|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191366|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191367|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
2191368|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191369|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2191370|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
2191371|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2191372|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191373|NCT00003597|Carboplatin|carboplatin|mesh-list
2191374|NCT00003597|Etoposide|etoposide|mesh-list
2191375|NCT00003597|Ifosfamide|ifosfamide|mesh-list
2191376|NCT00003597|Lenograstim|lenograstim|mesh-list
2191377|NCT00003597|Sargramostim|sargramostim|mesh-list
2191378|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191379|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191380|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191381|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191382|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191383|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191384|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2191385|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
2191386|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694739|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
2694740|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
2694741|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
2694742|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694743|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2694744|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
2694745|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694746|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2694747|NCT02268773|Aspirin|aspirin|mesh-list
2694748|NCT02268773|Dipyridamole|dipyridamole|mesh-list
2694749|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2694750|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2694751|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2694752|NCT02268773|Analgesics|analgesics|mesh-ancestor
2694753|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
2694754|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694755|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694756|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2694757|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2694758|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2694759|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2694760|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694761|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2694762|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2694763|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694764|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
2694765|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2694766|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
2694767|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
2694768|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2694769|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694770|NCT02268890|Bortezomib|bortezomib|mesh-list
2694771|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694772|NCT02268903|Furosemide|furosemide|mesh-list
2694773|NCT02268903|Diuretics|diuretics|mesh-list
2694774|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
2694775|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694776|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2694777|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2694778|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694779|NCT02268968|Lidocaine|lidocaine|mesh-list
2694780|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
2694781|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
2694782|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694783|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694784|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
2694785|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694786|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2694787|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2694788|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2694789|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2694790|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694791|NCT02269046|Simvastatin|simvastatin|mesh-list
2694792|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2694793|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2694794|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
2694795|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694796|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2694797|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2694798|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694799|NCT02269072|Anastrozole|anastrozole|mesh-list
2694800|NCT02269072|Leuprolide|leuprolide|mesh-list
2694801|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2694802|NCT02269072|Testosterone|testosterone|mesh-list
2694803|NCT02269072|Androgens|androgens|mesh-ancestor
2694804|NCT02269072|Hormones|hormones|mesh-ancestor
2694805|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2694806|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694807|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2694808|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694809|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2694810|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2694811|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694812|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694813|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2694814|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
2694815|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2694816|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
2694817|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2694818|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
2694819|NCT02269176|Losartan|losartan|mesh-list
2694820|NCT02269176|Telmisartan|telmisartan|mesh-list
2694821|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2694822|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2694823|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2694824|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2694825|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694826|NCT02269202|Midazolam|midazolam|mesh-list
2694827|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2694828|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2694829|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2694830|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694831|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2694832|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2694833|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2191387|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191388|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
2191389|NCT00003598|Tretinoin|tretinoin|mesh-list
2191390|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191391|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
2191392|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191393|NCT00003599|Vitamin E|vitamin e|mesh-list
2191394|NCT00003599|Tocopherols|tocopherols|mesh-list
2191395|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
2191396|NCT00003599|Isotretinoin|isotretinoin|mesh-list
2191397|NCT00003599|Vitamins|vitamins|mesh-ancestor
2191398|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
2191399|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191400|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
2191401|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191402|NCT00003599|Protective Agents|protective agents|mesh-ancestor
2191403|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191404|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
2191405|NCT00003600|Hematinics|hematinics|mesh-ancestor
2191406|NCT00003601|Tretinoin|tretinoin|mesh-list
2191407|NCT00003601|Fenretinide|fenretinide|mesh-list
2191408|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191409|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
2191410|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
2694834|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2694835|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
2694836|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
2694837|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
2694838|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
2694839|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694840|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694841|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2694842|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2694847|NCT02269280|Azacitidine|azacitidine|mesh-list
2694848|NCT02269280|Decitabine|decitabine|mesh-list
2694849|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2694850|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
2694851|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694852|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694853|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694854|NCT02269293|Paclitaxel|paclitaxel|mesh-list
2694855|NCT02269293|Carboplatin|carboplatin|mesh-list
2694856|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2694857|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694858|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
2694859|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
2694860|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
2694861|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694862|NCT02269319|Linezolid|linezolid|mesh-list
2694863|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2694864|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191411|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2191412|NCT00003601|Protective Agents|protective agents|mesh-ancestor
2191413|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191414|NCT00003602|Cytarabine|cytarabine|mesh-list
2191415|NCT00003602|Etoposide|etoposide|mesh-list
2694865|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2694866|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694867|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694868|NCT02269358|Methotrexate|methotrexate|mesh-list
2694869|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2694870|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
2694871|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2694872|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694873|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2694874|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
2694875|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694876|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694877|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
2694878|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694879|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2694880|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2694881|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
2694882|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2694883|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2694884|NCT02269449|Hemostatics|hemostatics|mesh-list
2694885|NCT02269449|Coagulants|coagulants|mesh-ancestor
2694886|NCT02269462|Efavirenz|efavirenz|mesh-list
2191416|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
2191417|NCT00003602|Idarubicin|idarubicin|mesh-list
2191418|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191419|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191420|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191421|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191422|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191423|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191424|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191425|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
2191426|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
2191427|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694887|NCT02269462|Nevirapine|nevirapine|mesh-list
2694888|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2694889|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2694890|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694891|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694892|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
2694893|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694894|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2694895|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2694896|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2694897|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2694898|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2694899|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2694900|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2694901|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2694902|NCT02269514|Nicotine|nicotine|mesh-list
2694903|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2694904|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
2694905|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694906|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694907|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2694908|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2694909|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
2694910|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694911|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694912|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
2694913|NCT02269540|Sertraline|sertraline|mesh-list
2694914|NCT02269540|Citalopram|citalopram|mesh-list
2694915|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2694916|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
2694917|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694918|NCT02269540|Expectorants|expectorants|mesh-ancestor
2694919|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
2694920|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2694921|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
2694922|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694923|NCT02269540|Protective Agents|protective agents|mesh-ancestor
2694924|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694925|NCT02269540|Antidotes|antidotes|mesh-ancestor
2191428|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2694926|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
2694927|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2694928|NCT02269540|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2694929|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2694930|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2694931|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694932|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
2694933|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2694934|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
2694935|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2694936|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
2694937|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694938|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2694939|NCT02269644|Azithromycin|azithromycin|mesh-list
2694940|NCT02269644|Linezolid|linezolid|mesh-list
2694941|NCT02269644|Dalbavancin|dalbavancin|mesh-list
2694942|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2694943|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2694944|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2694945|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2694946|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694979|NCT02269696|Metoprolol|metoprolol|mesh-list
2694980|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2694981|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2191429|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
2191430|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191431|NCT00003602|Analgesics|analgesics|mesh-ancestor
2191432|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
2191433|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2191434|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2191435|NCT00003603|Dexamethasone|dexamethasone|mesh-list
2191436|NCT00003603|Prednisolone|prednisolone|mesh-list
2191437|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
2191438|NCT00003603|Melphalan|melphalan|mesh-list
2191439|NCT00003603|Lomustine|lomustine|mesh-list
2191440|NCT00003603|Idarubicin|idarubicin|mesh-list
2191441|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191442|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
2191443|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191444|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191445|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191446|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
2191447|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694982|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
2694983|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
2694984|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2694985|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694986|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2694987|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2694988|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2694989|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
2694990|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2694991|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2694992|NCT02269735|Insulin|insulin|mesh-list
2694993|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2694994|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
2694995|NCT02269735|MK-2640|mk-2640|mesh-list
2694996|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2694997|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2694998|NCT02269748|Analgesics|analgesics|mesh-list
2694999|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
2695000|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695001|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695002|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
2695003|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2695004|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695005|NCT02269904|Fluorouracil|fluorouracil|mesh-list
2695006|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
2695007|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695008|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2695009|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695010|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2695011|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
2695012|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695013|NCT02269969|Tobramycin|tobramycin|mesh-list
2695014|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2695015|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695016|NCT02270034|Crizotinib|crizotinib|mesh-list
2695017|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695018|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2695019|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695020|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695021|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
2695022|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2695023|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2695024|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695025|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2695026|NCT02270281|Analgesics|analgesics|mesh-ancestor
2695027|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
2695028|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695029|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2695030|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2695031|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2695032|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
2695033|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695034|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695035|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
2695036|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2695037|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
2695038|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695039|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2695040|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2695041|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
2695042|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695043|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695044|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2695045|NCT02270424|Fluticasone|fluticasone|mesh-list
2695046|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2695047|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2695048|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2695049|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2695050|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
2695051|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695052|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695053|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2695054|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
2695055|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
2695056|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2695057|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2695058|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2695059|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2695060|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
2695061|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695062|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695063|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
2695064|NCT02270424|Hormones|hormones|mesh-ancestor
2695065|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2695066|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
2695067|NCT02270437|Epinephrine|epinephrine|mesh-list
2695068|NCT02270437|Racepinephrine|racepinephrine|mesh-list
2695069|NCT02270437|Fentanyl|fentanyl|mesh-list
2695070|NCT02270437|Ropivacaine|ropivacaine|mesh-list
2695071|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
2695072|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
2695073|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
2695074|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2695075|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695076|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
2695077|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695078|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2695079|NCT02270437|Narcotics|narcotics|mesh-ancestor
2695080|NCT02270437|Analgesics|analgesics|mesh-ancestor
2695081|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2695082|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2695083|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
2695084|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2695085|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2695086|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
2695087|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695088|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695089|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2695090|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2695091|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
2695092|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2695093|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
2695094|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
2695095|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
2695096|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2695097|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
2695098|NCT02270606|Leucovorin|leucovorin|mesh-list
2695099|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
2695100|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
2695101|NCT02270606|Fluorouracil|fluorouracil|mesh-list
2695102|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
2695103|NCT02270606|Calcium|calcium|mesh-list
2695104|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
2695105|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2695106|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695107|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2695108|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
2695109|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695110|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2695111|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695112|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2695113|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
2695114|NCT02270606|Antidotes|antidotes|mesh-ancestor
2695115|NCT02270606|Protective Agents|protective agents|mesh-ancestor
2695116|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
2695117|NCT02270606|Vitamins|vitamins|mesh-ancestor
2695118|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
2695119|NCT02270632|Methotrexate|methotrexate|mesh-list
2695120|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2695121|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
2695122|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2695123|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695124|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2695125|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
2695126|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695127|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695128|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
2695129|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695130|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2695131|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2695132|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
2695133|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191448|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695134|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2695135|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
2695136|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
2695137|NCT02270749|Vitamins|vitamins|mesh-ancestor
2695138|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
2695139|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695140|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
2695141|NCT02270749|Hematinics|hematinics|mesh-ancestor
2695142|NCT02270788|Leucovorin|leucovorin|mesh-list
2695143|NCT02270788|Cytarabine|cytarabine|mesh-list
2695144|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
2695145|NCT02270788|Methotrexate|methotrexate|mesh-list
2695146|NCT02270788|Sorafenib|sorafenib|mesh-list
2695147|NCT02270788|Crenolanib|crenolanib|mesh-list
2695148|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2695149|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
2695150|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2695151|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695152|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2695153|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
2695154|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695155|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695156|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
2695157|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695158|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2695159|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2695160|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
2695161|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2695162|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2695163|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
2695164|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695165|NCT02270788|Antidotes|antidotes|mesh-ancestor
2695166|NCT02270788|Protective Agents|protective agents|mesh-ancestor
2695167|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
2695168|NCT02270788|Vitamins|vitamins|mesh-ancestor
2695169|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
2695170|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2695171|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2695172|NCT02270814|Paclitaxel|paclitaxel|mesh-list
2695173|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2695174|NCT02270814|Cisplatin|cisplatin|mesh-list
2695175|NCT02270814|Carboplatin|carboplatin|mesh-list
2695176|NCT02270814|Cetuximab|cetuximab|mesh-list
2695177|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2695178|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695179|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
2695180|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
2695181|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
2695182|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695183|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2695184|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
2695185|NCT02270827|Aminophylline|aminophylline|mesh-list
2695186|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2191449|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191450|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2191451|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
2191452|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
2191453|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2191454|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2191455|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
2191456|NCT00003603|Hormones|hormones|mesh-ancestor
2191457|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2191458|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2191459|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2191460|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191461|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191462|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191463|NCT00003604|Aldesleukin|aldesleukin|mesh-list
2191464|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695187|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2695188|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
2695189|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695190|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695191|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2695192|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
2695193|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2695194|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2695195|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695196|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695197|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2695198|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2695199|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
2695200|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695201|NCT02270827|Protective Agents|protective agents|mesh-ancestor
2695202|NCT02270918|Apixaban|apixaban|mesh-list
2695203|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2695204|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
2695205|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2695206|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
2695207|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695208|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695209|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
2695210|NCT02270970|Belimumab|belimumab|mesh-list
2695211|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2695212|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
2695213|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695214|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
2695215|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2191465|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2191466|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2191467|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
2191468|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191469|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
2191470|NCT00003605|Rituximab|rituximab|mesh-list
2191471|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191472|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
2191473|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191474|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191475|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191476|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
2695216|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
2695217|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2695218|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
2695219|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695220|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
2695221|NCT02271035|Protective Agents|protective agents|mesh-ancestor
2695222|NCT02271113|Enoxaparin|enoxaparin|mesh-list
2695223|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
2695224|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
2695225|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2695226|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2695227|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191477|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191478|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191479|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191480|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2695228|NCT02271126|Heparin|heparin|mesh-list
2695229|NCT02271126|Thromboplastin|thromboplastin|mesh-list
2695230|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
2695231|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2695232|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2695233|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695234|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
2695235|NCT02271126|Coagulants|coagulants|mesh-ancestor
2695236|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
2695237|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2695238|NCT02271165|Antibodies|antibodies|mesh-list
2191481|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
2191482|NCT00003606|Etoposide|etoposide|mesh-list
2191483|NCT00003606|Epirubicin|epirubicin|mesh-list
2191484|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191485|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
2191486|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191487|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191488|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191489|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
2191490|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191491|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191492|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191493|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191494|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191495|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2695239|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
2695240|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695241|NCT02271191|Nicardipine|nicardipine|mesh-list
2695242|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2695243|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2695244|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2695245|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695246|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2695247|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695248|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
2695249|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
2695250|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2695251|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695252|NCT02271230|Vitamin D|vitamin d|mesh-list
2695253|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
2695254|NCT02271230|Vitamins|vitamins|mesh-list
2695255|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
2695256|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695257|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2695258|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2695259|NCT02271282|Toremifene|toremifene|mesh-list
2695260|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2695261|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695262|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2695263|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2695264|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
2695265|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2695266|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695267|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2695268|NCT02271295|Enoxaparin|enoxaparin|mesh-list
2695269|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
2695270|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2695271|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2695272|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695273|NCT02271334|Albuterol|albuterol|mesh-list
2695274|NCT02271334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2695275|NCT02271334|Autonomic Agents|autonomic agents|mesh-ancestor
2695276|NCT02271334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695277|NCT02271334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695278|NCT02271334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2695279|NCT02271334|Respiratory System Agents|respiratory system agents|mesh-ancestor
2695280|NCT02271334|Tocolytic Agents|tocolytic agents|mesh-ancestor
2695281|NCT02271334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2695282|NCT02271334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2191496|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191497|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2191498|NCT00003610|Capsaicin|capsaicin|mesh-list
2191499|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
2191500|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191501|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
2191502|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2191503|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191504|NCT00003611|Acitretin|acitretin|mesh-list
2695283|NCT02271334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2695284|NCT02271334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2695285|NCT02271334|Adrenergic Agents|adrenergic agents|mesh-ancestor
2695286|NCT02271334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2191505|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
2191506|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191507|NCT00003612|Paclitaxel|paclitaxel|mesh-list
2191508|NCT00003612|Carboplatin|carboplatin|mesh-list
2191509|NCT00003612|Trastuzumab|trastuzumab|mesh-list
2695287|NCT02271334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695288|NCT02271347|Brincidofovir|brincidofovir|mesh-list
2695289|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
2695290|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695291|NCT02271360|Cabergoline|cabergoline|mesh-list
2695292|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
2695293|NCT02271360|Calcium|calcium|mesh-list
2695294|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2695295|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695296|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2695297|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2695298|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
2695299|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
2191510|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191511|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695300|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695301|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695302|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
2695303|NCT02271360|Coagulants|coagulants|mesh-ancestor
2695304|NCT02271399|Aspirin|aspirin|mesh-list
2695305|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
2695306|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2695307|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2695308|NCT02271399|Analgesics|analgesics|mesh-ancestor
2695309|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
2695310|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695311|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695312|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2695313|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2695314|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2695315|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2695316|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695317|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2695318|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2695319|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695320|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
2695321|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2695322|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
2695323|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2695324|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
2695325|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
2695326|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2695327|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2423407|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423408|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423409|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2423410|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2423411|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423412|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2423413|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2423414|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2423415|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2423416|NCT00822081|Timolol|timolol|mesh-list
2423417|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2423418|NCT00822081|Dorzolamide|dorzolamide|mesh-list
2423419|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
2423420|NCT00822081|Maleic acid|maleic acid|mesh-list
2423421|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2695328|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2695329|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2695330|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695331|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695332|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695333|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
2695334|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2695335|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
2695336|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2695337|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2695338|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695339|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2695340|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2695341|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695342|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695343|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695344|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2695345|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
2695346|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2695347|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695348|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2695349|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2695350|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2695351|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
2695352|NCT02271464|Bevacizumab|bevacizumab|mesh-list
2695353|NCT02271464|Capecitabine|capecitabine|mesh-list
2695354|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2695355|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
2695356|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695357|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2695358|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2695359|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
2695360|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695361|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695362|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2695363|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2695364|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2695365|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2695366|NCT02271464|Growth Substances|growth substances|mesh-ancestor
2695367|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
2695368|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2695369|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
2695370|NCT02271503|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2695371|NCT02271503|Carbidopa|carbidopa|mesh-list
2695372|NCT02271503|Levodopa|levodopa|mesh-list
2695373|NCT02271503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2695374|NCT02271503|Immunologic Factors|immunologic factors|mesh-ancestor
2695375|NCT02271503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695376|NCT02271503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2695377|NCT02271503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2695378|NCT02271503|Dopamine Agonists|dopamine agonists|mesh-ancestor
2695379|NCT02271503|Dopamine Agents|dopamine agents|mesh-ancestor
2695380|NCT02271503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695381|NCT02271503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695382|NCT02271503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2191512|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191513|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191514|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191515|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191516|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2191517|NCT00003613|Carmustine|carmustine|mesh-list
2695383|NCT02271503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695384|NCT02271542|Propofol|propofol|mesh-list
2695385|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2695386|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2695387|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695388|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2695389|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
2695390|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
2695391|NCT02271555|Remifentanil|remifentanil|mesh-list
2695392|NCT02271555|Sevoflurane|sevoflurane|mesh-list
2695393|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2695394|NCT02271555|Narcotics|narcotics|mesh-ancestor
2695395|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2695396|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695397|NCT02271555|Analgesics|analgesics|mesh-ancestor
2695398|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
2695399|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695400|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2695401|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2695402|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
2191518|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2191519|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191520|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
2191521|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191522|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191523|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191524|NCT00003614|Paclitaxel|paclitaxel|mesh-list
2191525|NCT00003614|Estramustine|estramustine|mesh-list
2191526|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191527|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191528|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191529|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191530|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191531|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695403|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
2695404|NCT02271646|Bupivacaine|bupivacaine|mesh-list
2695405|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
2695406|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
2695407|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2191532|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191533|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
2191534|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2191535|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
2695408|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695409|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
2695410|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695411|NCT02271802|Butyric Acid|butyric acid|mesh-list
2695412|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
2695413|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
2695414|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695415|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695416|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695417|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
2695418|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
2695419|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
2695420|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2695421|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2695422|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695423|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695424|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695438|NCT02271958|Mifepristone|mifepristone|mesh-list
2695439|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2695440|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
2695441|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2695442|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695443|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2695444|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2695445|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2695446|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
2695447|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2695448|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2695449|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
2695450|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2695451|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
2695452|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2695453|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2695454|NCT02271971|Vitamin D|vitamin d|mesh-list
2695455|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
2695456|NCT02271971|Vitamins|vitamins|mesh-ancestor
2695457|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
2695458|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695459|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2695460|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2695461|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
2695462|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
2695463|NCT02271997|Trace Elements|trace elements|mesh-ancestor
2695464|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
2695465|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695466|NCT02271997|Hematinics|hematinics|mesh-ancestor
2695467|NCT02272049|Xenon|xenon|mesh-list
2695468|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2695469|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
2695470|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
2695471|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2695472|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695473|NCT02272101|Vitamin D|vitamin d|mesh-list
2695474|NCT02272101|Vitamins|vitamins|mesh-ancestor
2695475|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
2695476|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695477|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2695478|NCT02272166|Propofol|propofol|mesh-list
2695479|NCT02272166|Sevoflurane|sevoflurane|mesh-list
2695480|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2695481|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2695482|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695483|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2695484|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
2695485|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
2695486|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2695487|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2695488|NCT02272270|Minocycline|minocycline|mesh-list
2695489|NCT02272270|Temozolomide|temozolomide|mesh-list
2695490|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2695491|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
2695492|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695493|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695494|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2695495|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695499|NCT02272387|Vitamin D|vitamin d|mesh-list
2695500|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
2695501|NCT02272387|Vitamins|vitamins|mesh-ancestor
2695502|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
2695503|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695504|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2695505|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2191536|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191537|NCT00003616|Irinotecan|irinotecan|mesh-list
2191538|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2191539|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191540|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695506|NCT02272478|Decitabine|decitabine|mesh-list
2695507|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
2695508|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2695509|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
2695510|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695511|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695512|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695513|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2695514|NCT02272517|Vortioxetine|vortioxetine|mesh-list
2695515|NCT02272517|Citalopram|citalopram|mesh-list
2695516|NCT02272517|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2695517|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2695518|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2695519|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695520|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695521|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
2695522|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695523|NCT02272517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2695524|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
2695525|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2695526|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2695527|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2695528|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2695529|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2695530|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2695531|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2695532|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2695533|NCT02272582|Heparin|heparin|mesh-list
2695534|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
2695535|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2695536|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2695537|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695538|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2695539|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2695540|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2695541|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
2695542|NCT02272647|Estradiol|estradiol|mesh-list
2695543|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2695544|NCT02272647|Progesterone|progesterone|mesh-list
2695545|NCT02272647|Estrogens|estrogens|mesh-ancestor
2695546|NCT02272647|Hormones|hormones|mesh-ancestor
2695547|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2695548|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695549|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2695550|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
2695551|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2695552|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2191541|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191542|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191543|NCT00003617|Clarithromycin|clarithromycin|mesh-list
2191544|NCT00003617|Tinidazole|tinidazole|mesh-list
2191545|NCT00003617|Chlorambucil|chlorambucil|mesh-list
2191546|NCT00003617|Omeprazole|omeprazole|mesh-list
2191547|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2191548|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2191549|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2191550|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191551|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191552|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2695553|NCT02272647|Progestins|progestins|mesh-ancestor
2695554|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2695555|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2695556|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2695557|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2695558|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2695559|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695560|NCT02272660|Parecoxib|parecoxib|mesh-list
2695561|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2695562|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2695563|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695564|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695565|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2695566|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2695567|NCT02272660|Analgesics|analgesics|mesh-ancestor
2695568|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
2695569|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695570|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695571|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2695572|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2695573|NCT02272699|Paclitaxel|paclitaxel|mesh-list
2695574|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
2695575|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2695576|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695577|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
2695578|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
2695579|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
2695580|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695581|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2695582|NCT02272738|Gemcitabine|gemcitabine|mesh-list
2695583|NCT02272738|Paclitaxel|paclitaxel|mesh-list
2695584|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2695585|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2695586|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695587|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
2695588|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
2695589|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
2695590|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695591|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2695592|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
2695593|NCT02272738|Antiviral Agents|antiviral agents|mesh-ancestor
2695594|NCT02272738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695595|NCT02272738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695596|NCT02272738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2695597|NCT02272738|Immunologic Factors|immunologic factors|mesh-ancestor
2695598|NCT02272738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695599|NCT02272764|Itraconazole|itraconazole|mesh-list
2695600|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
2191553|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191554|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2191555|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2191556|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2191557|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191558|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
2191559|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695601|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
2695602|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695603|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2695604|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2695605|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191560|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2191561|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2191562|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2191563|NCT00003619|Vitamin E|vitamin e|mesh-list
2695606|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695607|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2695608|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
2695609|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2695610|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695611|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2695612|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
2695613|NCT02272829|Narcotics|narcotics|mesh-ancestor
2695614|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2695615|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695616|NCT02272829|Analgesics|analgesics|mesh-ancestor
2695617|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
2695618|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695619|NCT02272855|Ipilimumab|ipilimumab|mesh-list
2695620|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2695621|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695622|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2695623|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695624|NCT02272868|Rifaximin|rifaximin|mesh-list
2695625|NCT02272868|Omeprazole|omeprazole|mesh-list
2695626|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2695627|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2695628|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2695629|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2695630|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695631|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695632|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2695633|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695634|NCT02272868|Laxatives|laxatives|mesh-ancestor
2695635|NCT02272998|Ponatinib|ponatinib|mesh-list
2695636|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695637|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2695638|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695639|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695640|NCT02273102|Tretinoin|tretinoin|mesh-list
2695641|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
2695642|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695643|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
2695644|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
2695645|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
2695646|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2695647|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2695648|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695649|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695650|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2695651|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2695652|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2695653|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695654|NCT02273128|Calcitonin|calcitonin|mesh-list
2695655|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2695656|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695657|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2695658|NCT02273154|Buspirone|buspirone|mesh-list
2695659|NCT02273154|Paroxetine|paroxetine|mesh-list
2695660|NCT02273154|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2695661|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2695662|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2695663|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695664|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695665|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
2695666|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695667|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2695668|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
2695669|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2695670|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2695671|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2695672|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695673|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2695674|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2695675|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2191564|NCT00003619|Cytarabine|cytarabine|mesh-list
2191565|NCT00003619|Fludarabine|fludarabine|mesh-list
2191566|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
2191567|NCT00003619|Etoposide|etoposide|mesh-list
2695676|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2695677|NCT02273258|Insulin|insulin|mesh-list
2695678|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2695679|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
2695680|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2695681|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695682|NCT02273271|Alovudine|alovudine|mesh-list
2695683|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
2695684|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695685|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2695686|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695687|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2695688|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695689|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695690|NCT02273375|Durvalumab|durvalumab|mesh-list
2695691|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2695692|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695693|NCT02273440|Theophylline|theophylline|mesh-list
2695694|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2695695|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
2695696|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695697|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695698|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2695699|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
2695700|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2695701|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695702|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695703|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
2695704|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2695705|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2695706|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
2695707|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695708|NCT02273453|Oxazepam|oxazepam|mesh-list
2695709|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2695710|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2695711|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695712|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2695713|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2695714|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2695715|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
2695716|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
2695717|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695718|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695719|NCT02273466|Desipramine|desipramine|mesh-list
2695720|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2695721|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
2695722|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2695723|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695724|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695725|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2695726|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2695727|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2695728|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
2695729|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695730|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191568|NCT00003619|Busulfan|busulfan|mesh-list
2191569|NCT00003619|Topotecan|topotecan|mesh-list
2191570|NCT00003619|Isotretinoin|isotretinoin|mesh-list
2191571|NCT00003619|Vitamins|vitamins|mesh-ancestor
2191572|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
2191573|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191574|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191575|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191576|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
2191577|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191578|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2695731|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2695732|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2695733|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2695734|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2695735|NCT02273505|Aspirin|aspirin|mesh-list
2695736|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
2191579|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
2191580|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191581|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191582|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2695737|NCT02273505|Salicylates|salicylates|mesh-list
2695738|NCT02273505|Dipyridamole|dipyridamole|mesh-list
2695739|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2695740|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695741|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
2695742|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
2695743|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
2695744|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2695745|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2695746|NCT02273505|Analgesics|analgesics|mesh-ancestor
2695747|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
2695748|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695749|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695750|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2695751|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2695752|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2695753|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695754|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695755|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2695756|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2695757|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2695758|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
2695759|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2695760|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
2695761|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2695762|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2695763|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2695764|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2695765|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2695766|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2695767|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2695768|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2695769|NCT02273570|Vitamin D|vitamin d|mesh-list
2695770|NCT02273570|Calcium|calcium|mesh-list
2695771|NCT02273570|Vitamins|vitamins|mesh-ancestor
2695772|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
2695773|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695774|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2695775|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2695776|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
2695777|NCT02273583|Methotrexate|methotrexate|mesh-list
2695778|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2695779|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
2695780|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695781|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2695782|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2695783|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
2695784|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695785|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695786|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2695787|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2695788|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
2695789|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2695790|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2695791|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
2695792|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
2695793|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695794|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2695795|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2695796|NCT02273609|Vitamin K|vitamin k|mesh-list
2695797|NCT02273609|Warfarin|warfarin|mesh-list
2695798|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
2695799|NCT02273609|Vitamins|vitamins|mesh-ancestor
2695800|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
2695801|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695802|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
2695803|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2695804|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2695805|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695806|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
2695807|NCT02273609|Coagulants|coagulants|mesh-ancestor
2695808|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
2695809|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695810|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
2695811|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695812|NCT02273622|Protective Agents|protective agents|mesh-ancestor
2695813|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695814|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2695815|NCT02273635|Andrographolide|andrographolide|mesh-list
2695816|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2695817|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2695818|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2695819|NCT02273635|Analgesics|analgesics|mesh-ancestor
2695820|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
2695821|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695822|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695823|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2695824|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2695825|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2695826|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695827|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
2695828|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2695829|NCT02273661|Amphotericin B|amphotericin b|mesh-list
2695830|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2695831|NCT02273661|Amebicides|amebicides|mesh-ancestor
2695832|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2695833|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2695834|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695835|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2695836|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
2695837|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
2695838|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2695839|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
2695840|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2695841|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
2695842|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695843|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695844|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
2695845|NCT02273713|Paclitaxel|paclitaxel|mesh-list
2695846|NCT02273713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2695847|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2695848|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695849|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
2695850|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
2695851|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
2695852|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695853|NCT02273765|Tenofovir|tenofovir|mesh-list
2695854|NCT02273765|Lamivudine|lamivudine|mesh-list
2695855|NCT02273765|Efavirenz|efavirenz|mesh-list
2695856|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
2695857|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
2695858|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695859|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2695860|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2695861|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695862|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695863|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2695864|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2695865|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2695866|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2695867|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2695868|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2695869|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2695870|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2695871|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2695872|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2695873|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2695874|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2191583|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191584|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
2191585|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191586|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
2191587|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191588|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191589|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2695875|NCT02273791|Clomiphene|clomiphene|mesh-list
2695876|NCT02273791|Enclomiphene|enclomiphene|mesh-list
2695877|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
2695878|NCT02273791|Estradiol|estradiol|mesh-list
2695879|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2695880|NCT02273791|Estrogens|estrogens|mesh-ancestor
2695881|NCT02273791|Hormones|hormones|mesh-ancestor
2695882|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2695883|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695884|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2695885|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
2695886|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2695887|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2695888|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2695889|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
2695890|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2695891|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
2695892|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2695893|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2695894|NCT02273804|Topiramate|topiramate|mesh-list
2695895|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
2695896|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2695897|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695898|NCT02273817|Ciclesonide|ciclesonide|mesh-list
2191590|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
2191591|NCT00003619|Protective Agents|protective agents|mesh-ancestor
2191592|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191593|NCT00003620|Alvocidib|alvocidib|mesh-list
2191594|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191595|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
2191596|NCT00003620|Growth Substances|growth substances|mesh-ancestor
2191597|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191598|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2191599|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191600|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191601|NCT00003621|Etoposide|etoposide|mesh-list
2191602|NCT00003621|Carmustine|carmustine|mesh-list
2191603|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191604|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191605|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191606|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191607|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191608|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191609|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2695899|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
2695900|NCT02273817|Hormones|hormones|mesh-ancestor
2695901|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2695902|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695903|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2695904|NCT02273843|Vitamin D|vitamin d|mesh-list
2695905|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
2695906|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
2695907|NCT02273843|Vitamins|vitamins|mesh-list
2695908|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
2695909|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695910|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2695911|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2695912|NCT02273895|Scopolamine|scopolamine|mesh-list
2695913|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2695914|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2695915|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
2695916|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
2695917|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695918|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695919|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2695920|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
2695921|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2695922|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
2695923|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695924|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695925|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2695926|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
2695927|NCT02273947|BMS-955176|bms-955176|mesh-list
2695928|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2695929|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2695930|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
2695931|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2695932|NCT02273986|Digoxin|digoxin|mesh-list
2695933|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2695934|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2695935|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695936|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695937|NCT02273986|Protective Agents|protective agents|mesh-ancestor
2695938|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695939|NCT02274012|Paclitaxel|paclitaxel|mesh-list
2695940|NCT02274012|Afatinib|afatinib|mesh-list
2695941|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2695942|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695943|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
2695944|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
2695945|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
2695946|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695947|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2695948|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2695949|NCT02274051|Kinetin|kinetin|mesh-list
2695950|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2695951|NCT02274051|Growth Substances|growth substances|mesh-ancestor
2695952|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695953|NCT02274077|Bupivacaine|bupivacaine|mesh-list
2695954|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
2695955|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
2695956|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2695957|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695958|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
2695959|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695960|NCT02274090|Metformin|metformin|mesh-list
2695961|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2695962|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695963|NCT02274142|Methamphetamine|methamphetamine|mesh-list
2695964|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2695965|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695966|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
2695967|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
2695968|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2695969|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
2695970|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2695971|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2695972|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
2695973|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2695974|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2695975|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2695976|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2695977|NCT02274155|Antibodies|antibodies|mesh-list
2695978|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
2695979|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695980|NCT02274181|Enclomiphene|enclomiphene|mesh-list
2695981|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2695982|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
2695983|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2695984|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695985|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2695986|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
2695987|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2695988|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2695989|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2695990|NCT02274259|Ranibizumab|ranibizumab|mesh-list
2695991|NCT02274259|Aflibercept|aflibercept|mesh-list
2695992|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2695993|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2695994|NCT02274259|Growth Substances|growth substances|mesh-ancestor
2695995|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2695996|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
2695997|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2695998|NCT02274285|Vaccines|vaccines|mesh-list
2695999|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
2696000|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696001|NCT02274337|Abivertinib|abivertinib|mesh-list
2696002|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2696003|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696004|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696005|NCT02274415|Vaccines|vaccines|mesh-list
2696006|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2696007|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
2696008|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696009|NCT02274454|Oxytocin|oxytocin|mesh-list
2696010|NCT02274454|Calcium|calcium|mesh-list
2696011|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2696012|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696013|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
2696014|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2696015|NCT02274506|Vidarabine|vidarabine|mesh-list
2696016|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
2696017|NCT02274506|Fludarabine|fludarabine|mesh-list
2696018|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
2696019|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2696020|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
2696021|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696022|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2696023|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2696024|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
2696025|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696026|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696027|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2696028|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2696029|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
2696030|NCT02274506|Antiviral Agents|antiviral agents|mesh-ancestor
2696031|NCT02274506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696032|NCT02274545|Vaccines|vaccines|mesh-list
2696033|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
2696034|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696039|NCT02274610|Docetaxel|docetaxel|mesh-list
2696040|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696041|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
2696042|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
2696043|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
2696044|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696045|NCT02274623|Calcifediol|calcifediol|mesh-list
2696046|NCT02274623|Vitamins|vitamins|mesh-ancestor
2696047|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
2696048|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696049|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2696050|NCT02274662|Cyclosporine|cyclosporine|mesh-list
2696051|NCT02274662|Tacrolimus|tacrolimus|mesh-list
2696052|NCT02274662|Cyclosporins|cyclosporins|mesh-list
2696053|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2696054|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
2696055|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2696056|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
2696057|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696058|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2696059|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696060|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696061|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
2696062|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696063|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
2696064|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2696065|NCT02274740|Metformin|metformin|mesh-list
2696066|NCT02274740|Lixisenatide|lixisenatide|mesh-list
2696067|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2696068|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696069|NCT02274779|Leuprolide|leuprolide|mesh-list
2696070|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2696071|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
2696072|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2696073|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696074|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2696075|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696076|NCT02274961|Pantoprazole|pantoprazole|mesh-list
2696077|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2696078|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2696079|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2696080|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696081|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696082|NCT02274974|Lidocaine|lidocaine|mesh-list
2696083|NCT02274974|Epinephrine|epinephrine|mesh-list
2696084|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
2696085|NCT02274974|Anesthetics|anesthetics|mesh-list
2696086|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2696087|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696088|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
2696089|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696090|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2696091|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2696092|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2696093|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2696094|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696095|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2696096|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2696097|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
2696098|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2696099|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2696100|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2696101|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
2696102|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2696103|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
2696104|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
2696105|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
2696106|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2696107|NCT02275013|Simendan|simendan|mesh-list
2696108|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2191610|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
2191611|NCT00003622|Paclitaxel|paclitaxel|mesh-list
2191612|NCT00003622|Vinorelbine|vinorelbine|mesh-list
2191613|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191614|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191615|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191616|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191617|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191618|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191619|NCT00003624|Paclitaxel|paclitaxel|mesh-list
2191620|NCT00003624|Amifostine|amifostine|mesh-list
2191621|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191622|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191623|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
2696109|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
2696110|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2696111|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2696112|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696113|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696114|NCT02275013|Protective Agents|protective agents|mesh-ancestor
2696115|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696116|NCT02275039|Gemcitabine|gemcitabine|mesh-list
2696117|NCT02275039|Vaccines|vaccines|mesh-list
2696118|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
2696119|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696120|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2696121|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
2696122|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696123|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696124|NCT02275039|Antiviral Agents|antiviral agents|mesh-ancestor
2696125|NCT02275039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696126|NCT02275039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696127|NCT02275039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2696128|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
2191624|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191625|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191626|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191627|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2191628|NCT00003624|Protective Agents|protective agents|mesh-ancestor
2191629|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191630|NCT00003625|Cyclosporine|cyclosporine|mesh-list
2191631|NCT00003625|Etoposide|etoposide|mesh-list
2191632|NCT00003625|Vincristine|vincristine|mesh-list
2696129|NCT02275130|Calcium|calcium|mesh-list
2696130|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2696131|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696132|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2696133|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
2696134|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2191633|NCT00003625|Cyclosporins|cyclosporins|mesh-list
2191634|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2696135|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2696136|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696137|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2696138|NCT02275182|Analgesics|analgesics|mesh-ancestor
2696139|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
2696140|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696141|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2696142|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2696143|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2696144|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
2696145|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2696146|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696147|NCT02275247|Ropivacaine|ropivacaine|mesh-list
2696148|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
2696149|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2696150|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696151|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
2696152|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
2696153|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696154|NCT02275286|Trabectedin|trabectedin|mesh-list
2696155|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2696156|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
2696157|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696158|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696159|NCT02275299|Methotrexate|methotrexate|mesh-list
2696160|NCT02275299|Leflunomide|leflunomide|mesh-list
2696161|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2696162|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
2696163|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2696164|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696165|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2696166|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
2696167|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696168|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696169|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
2696170|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696171|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2696172|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2696173|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
2696174|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2696175|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2696176|NCT02275416|Ipilimumab|ipilimumab|mesh-list
2696177|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2696178|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696179|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2696180|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696181|NCT02275533|Nivolumab|nivolumab|mesh-list
2696182|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2696183|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696184|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2696185|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696186|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2696187|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2696188|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696189|NCT02275663|Cytarabine|cytarabine|mesh-list
2696190|NCT02275663|Fludarabine|fludarabine|mesh-list
2696191|NCT02275663|Azacitidine|azacitidine|mesh-list
2696192|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696193|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2696194|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
2696195|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696196|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2696197|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
2696198|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696199|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
2696200|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696201|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696202|NCT02275702|Dexamethasone|dexamethasone|mesh-list
2696203|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2696204|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
2696205|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
2696206|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696207|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696208|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2696209|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
2696210|NCT02275702|Hormones|hormones|mesh-ancestor
2696211|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2696212|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2696213|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696214|NCT02275806|Irinotecan|irinotecan|mesh-list
2696215|NCT02275806|Camptothecin|camptothecin|mesh-list
2696216|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696217|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2696218|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2696219|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696220|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696221|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2696222|NCT02275832|Minoxidil|minoxidil|mesh-list
2696223|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2696224|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
2696225|NCT02275845|Metformin|metformin|mesh-list
2696226|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2696227|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696228|NCT02275897|Methamphetamine|methamphetamine|mesh-list
2696229|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2696230|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696231|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
2696232|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
2696233|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696234|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
2696235|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2696236|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191635|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191636|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191637|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191638|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191639|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191640|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191641|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191642|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191643|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191644|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
2191645|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191646|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
2191647|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191648|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191649|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191650|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2191651|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
2191652|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191653|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191654|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191655|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191656|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191657|NCT00003627|Fluorouracil|fluorouracil|mesh-list
2191658|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191659|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
2191660|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191661|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191662|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191663|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
2191664|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191665|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
2191666|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191667|NCT00003632|Cytarabine|cytarabine|mesh-list
2191668|NCT00003632|Methotrexate|methotrexate|mesh-list
2191669|NCT00003632|Etoposide|etoposide|mesh-list
2191670|NCT00003632|Melphalan|melphalan|mesh-list
2191671|NCT00003632|Carmustine|carmustine|mesh-list
2191672|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2191673|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
2191674|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2191675|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191676|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191677|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
2191678|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191679|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191680|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191681|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191682|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2191683|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191684|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
2191685|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191686|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2191687|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191688|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191689|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191690|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
2191691|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191692|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191693|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
2191694|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191695|NCT00003633|Prednisone|prednisone|mesh-list
2191696|NCT00003633|Docetaxel|docetaxel|mesh-list
2191697|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
2191698|NCT00003633|Estramustine|estramustine|mesh-list
2191699|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191700|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191701|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191702|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191703|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191704|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2191705|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
2191706|NCT00003633|Hormones|hormones|mesh-ancestor
2191707|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2191708|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696237|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
2696238|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2696239|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2696240|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2696241|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2696242|NCT02275962|Rifampin|rifampin|mesh-list
2696243|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2696244|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
2696245|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2696246|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696247|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
2696248|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2696249|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696250|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696251|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2696252|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2696253|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2696254|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2696255|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2696256|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2696257|NCT02275975|Fluconazole|fluconazole|mesh-list
2696258|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
2696259|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696260|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2696261|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2696262|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696263|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696264|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2696265|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
2696266|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2696267|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696268|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2696269|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2696270|NCT02275988|Clarithromycin|clarithromycin|mesh-list
2696271|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2696272|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696273|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2696274|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696275|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696276|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2696277|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2696278|NCT02276001|Cyclosporine|cyclosporine|mesh-list
2696279|NCT02276001|Cyclosporins|cyclosporins|mesh-list
2696280|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696281|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696282|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2696283|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
2696284|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696285|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
2696286|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696287|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
2696288|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2696289|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2696290|NCT02276014|Beta Carotene|beta carotene|mesh-list
2696291|NCT02276014|Carotenoids|carotenoids|mesh-list
2696292|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
2696293|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696294|NCT02276014|Protective Agents|protective agents|mesh-ancestor
2696295|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696296|NCT02276014|Provitamins|provitamins|mesh-ancestor
2696297|NCT02276014|Vitamins|vitamins|mesh-ancestor
2696298|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
2696299|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
2696300|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2696301|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
2696302|NCT02276196|Lixisenatide|lixisenatide|mesh-list
2696303|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2696304|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696305|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
2696306|NCT02276300|Imiquimod|imiquimod|mesh-list
2696307|NCT02276300|Sargramostim|sargramostim|mesh-list
2696308|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2696309|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
2696310|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696311|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2696312|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2696313|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
2696314|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696315|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696316|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2696317|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2696318|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
2696319|NCT02276365|Pioglitazone|pioglitazone|mesh-list
2696320|NCT02276365|Empagliflozin|empagliflozin|mesh-list
2696321|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2696322|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696323|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2696324|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696325|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2696326|NCT02276378|Telmisartan|telmisartan|mesh-list
2696327|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2696328|NCT02276378|Diuretics|diuretics|mesh-ancestor
2696329|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
2696330|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696331|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2696332|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2696333|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696334|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2696335|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2696336|NCT02276391|Telmisartan|telmisartan|mesh-list
2696337|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2696338|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2696339|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2696340|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696341|NCT02276495|Ketorolac|ketorolac|mesh-list
2696342|NCT02276495|Clonidine|clonidine|mesh-list
2696343|NCT02276495|Epinephrine|epinephrine|mesh-list
2696344|NCT02276495|Ropivacaine|ropivacaine|mesh-list
2696345|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
2696346|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
2696347|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2696348|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696349|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
2696350|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696351|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2696352|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2696353|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
2696354|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2696355|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191709|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2696356|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2696357|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2696358|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
2696359|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2696360|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
2696361|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
2696362|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
2696363|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2696364|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2696365|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2696366|NCT02276495|Analgesics|analgesics|mesh-ancestor
2696367|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2696368|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2696369|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2696370|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696371|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2696372|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
2696373|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2696374|NCT02276677|Oxytocin|oxytocin|mesh-list
2696375|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
2696376|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2696377|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696378|NCT02276690|Hepcidins|hepcidins|mesh-list
2696379|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696380|NCT02276755|Vitamin D|vitamin d|mesh-list
2696381|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
2696382|NCT02276755|Vitamins|vitamins|mesh-ancestor
2696383|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
2696384|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696385|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2696386|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2696387|NCT02276768|Trimebutine|trimebutine|mesh-list
2696388|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2696389|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
2696390|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
2696391|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696392|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696393|NCT02276846|Paclitaxel|paclitaxel|mesh-list
2696394|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2696395|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696396|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
2696397|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
2696398|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
2696399|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696400|NCT02276859|Insulin|insulin|mesh-list
2696401|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2696402|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
2696403|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
2191710|NCT00003633|Analgesics|analgesics|mesh-ancestor
2191711|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
2191712|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2191713|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191714|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191715|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191716|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191717|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
2191718|NCT00003634|Oregovomab|oregovomab|mesh-list
2191719|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2191720|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191721|NCT00003636|Carboplatin|carboplatin|mesh-list
2191722|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191723|NCT00003637|Fluorouracil|fluorouracil|mesh-list
2191724|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191725|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
2696404|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
2696405|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2191726|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191727|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191728|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2696406|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696407|NCT02276911|Ibuprofen|ibuprofen|mesh-list
2696408|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2696409|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2191729|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
2696410|NCT02276911|Analgesics|analgesics|mesh-ancestor
2696411|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
2696412|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696413|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696414|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2696415|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2696416|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2696417|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696418|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696419|NCT02276989|Riboflavin|riboflavin|mesh-list
2696420|NCT02276989|Quinine|quinine|mesh-list
2696421|NCT02276989|Acetazolamide|acetazolamide|mesh-list
2696422|NCT02276989|Vitamins|vitamins|mesh-ancestor
2696423|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
2696424|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696425|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
2696426|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2696427|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
2696428|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
2696429|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2696430|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696431|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696432|NCT02276989|Diuretics|diuretics|mesh-ancestor
2696433|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
2696434|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
2696435|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2696436|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2696437|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696438|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2696439|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2696440|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696441|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2696442|NCT02276989|Analgesics|analgesics|mesh-ancestor
2696443|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
2696444|NCT02277041|Misoprostol|misoprostol|mesh-list
2696445|NCT02277041|Carbetocin|carbetocin|mesh-list
2696446|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2696447|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
2696448|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2696449|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696450|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2696451|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2696452|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
2696453|NCT02277067|Misoprostol|misoprostol|mesh-list
2696454|NCT02277067|Carbetocin|carbetocin|mesh-list
2696455|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2696456|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
2696457|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2696458|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696459|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2696460|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2696461|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
2696462|NCT02277106|Brexanolone|brexanolone|mesh-list
2696463|NCT02277106|Neurosteroids|neurosteroids|mesh-ancestor
2696464|NCT02277106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2696465|NCT02277106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696466|NCT02277106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696467|NCT02277106|GABA Modulators|gaba modulators|mesh-ancestor
2696468|NCT02277106|GABA Agents|gaba agents|mesh-ancestor
2696469|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
2696470|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
2696471|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2191730|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191731|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
2191732|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2191733|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
2191734|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191735|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
2191736|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191737|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191738|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191739|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
2191740|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191741|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191742|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191743|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2191744|NCT00003639|Interferons|interferons|mesh-list
2696472|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2696473|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696474|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696475|NCT02277132|Urological Agents|urological agents|mesh-ancestor
2696476|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
2696477|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2696478|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
2696479|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696480|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191745|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
2191746|NCT00003639|Dexamethasone|dexamethasone|mesh-list
2191747|NCT00003639|Idarubicin|idarubicin|mesh-list
2191748|NCT00003639|Chlorambucil|chlorambucil|mesh-list
2191749|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2191750|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
2191751|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
2191752|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2191753|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191754|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2191755|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
2191756|NCT00003639|Hormones|hormones|mesh-ancestor
2191757|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2191758|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2191759|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191760|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
2191761|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191762|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
2191763|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2191764|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191765|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191766|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191767|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191768|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191769|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
2191770|NCT00003640|Doxorubicin|doxorubicin|mesh-list
2191771|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2191772|NCT00003640|Methotrexate|methotrexate|mesh-list
2191773|NCT00003640|Vinblastine|vinblastine|mesh-list
2191774|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191775|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2191776|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191777|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191778|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191779|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191780|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2191781|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
2191782|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2191783|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191784|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191785|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
2191786|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191787|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2191788|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191789|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
2191790|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191791|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2191792|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191793|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191794|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
2696481|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2696482|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
2696483|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2696484|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
2696485|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696486|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2696487|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2696488|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
2696489|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
2696490|NCT02277171|Protective Agents|protective agents|mesh-ancestor
2696491|NCT02277184|Cisplatin|cisplatin|mesh-list
2696492|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696493|NCT02277197|Cetuximab|cetuximab|mesh-list
2696494|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2696495|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696496|NCT02277223|Curcumin|curcumin|mesh-list
2696497|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2696498|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2696499|NCT02277223|Analgesics|analgesics|mesh-ancestor
2696500|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
2696501|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696502|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696503|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2696504|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2696505|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696506|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696507|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696508|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2696509|NCT02277457|Crizotinib|crizotinib|mesh-list
2696510|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696511|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2696512|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696513|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696514|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
2696515|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2696516|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2696517|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2696518|NCT02277587|Cortisone|cortisone|mesh-list
2696519|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
2696520|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2696521|NCT02277587|Hormones|hormones|mesh-ancestor
2696522|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2191795|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191796|NCT00003642|Fluorouracil|fluorouracil|mesh-list
2191797|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191798|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
2191799|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191800|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191801|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191802|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
2696523|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696524|NCT02277600|Darunavir|darunavir|mesh-list
2696525|NCT02277600|Cobicistat|cobicistat|mesh-list
2696526|NCT02277600|Fostemsavir|fostemsavir|mesh-list
2696527|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2696528|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2696529|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
2696530|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191803|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191804|NCT00003643|Paclitaxel|paclitaxel|mesh-list
2191805|NCT00003643|Etoposide|etoposide|mesh-list
2191806|NCT00003643|Bleomycin|bleomycin|mesh-list
2191807|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191808|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191809|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191810|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191811|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191812|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191813|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191814|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191815|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191816|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2191817|NCT00003647|Dacarbazine|dacarbazine|mesh-list
2191818|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191819|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
2191820|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191821|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191822|NCT00003650|Cytarabine|cytarabine|mesh-list
2191823|NCT00003650|Dexamethasone|dexamethasone|mesh-list
2191824|NCT00003650|Prednisone|prednisone|mesh-list
2191825|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
2191826|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
2191827|NCT00003650|Methotrexate|methotrexate|mesh-list
2191828|NCT00003650|Etoposide|etoposide|mesh-list
2191829|NCT00003650|Vincristine|vincristine|mesh-list
2191830|NCT00003650|Daunorubicin|daunorubicin|mesh-list
2191831|NCT00003650|Asparaginase|asparaginase|mesh-list
2191832|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
2191833|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
2191834|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191835|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
2191836|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191837|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191838|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2696531|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696532|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2696533|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2696534|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
2696535|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696536|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2696537|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2696538|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2696539|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2696540|NCT02277678|Morphine|morphine|mesh-list
2696541|NCT02277678|Oxycodone|oxycodone|mesh-list
2696542|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
2696543|NCT02277678|Narcotics|narcotics|mesh-ancestor
2696544|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2696545|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696546|NCT02277678|Analgesics|analgesics|mesh-ancestor
2696547|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
2696548|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696549|NCT02277717|Trastuzumab|trastuzumab|mesh-list
2696550|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2696551|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696552|NCT02277730|Phenylephrine|phenylephrine|mesh-list
2696553|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
2696554|NCT02277730|Ephedrine|ephedrine|mesh-list
2696555|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2696556|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2696557|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
2696558|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
2696559|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2191839|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
2191840|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696560|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696561|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
2696562|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
2696563|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
2696564|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2696565|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2696566|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2696567|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
2696568|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2696569|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696570|NCT02277730|Protective Agents|protective agents|mesh-ancestor
2696571|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2696572|NCT02277782|Fentanyl|fentanyl|mesh-list
2696573|NCT02277782|Hydromorphone|hydromorphone|mesh-list
2696574|NCT02277782|Bupivacaine|bupivacaine|mesh-list
2696575|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
2696576|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
2696577|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2696578|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696579|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
2696580|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696581|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2696582|NCT02277782|Narcotics|narcotics|mesh-ancestor
2696583|NCT02277782|Analgesics|analgesics|mesh-ancestor
2696584|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2696585|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2696586|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
2696587|NCT02277808|Amikacin|amikacin|mesh-list
2696588|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2696589|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696590|NCT02277847|Cytarabine|cytarabine|mesh-list
2696591|NCT02277847|Idarubicin|idarubicin|mesh-list
2696592|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2696593|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
2696594|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696595|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696596|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
2696597|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696598|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2696599|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
2696600|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696601|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2696602|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2696603|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2696604|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696605|NCT02277886|Esomeprazole|esomeprazole|mesh-list
2696606|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2191841|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191842|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191843|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2191844|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
2191845|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
2191846|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2191847|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2191848|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
2191849|NCT00003650|Hormones|hormones|mesh-ancestor
2191850|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2191851|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2191852|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2191853|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
2191854|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2191855|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191856|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
2191857|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191858|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191859|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2191860|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2191861|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191862|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2191863|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191864|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
2191865|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191866|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191867|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
2191868|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
2191869|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2191870|NCT00003650|Protective Agents|protective agents|mesh-ancestor
2191871|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2191872|NCT00003650|Analgesics|analgesics|mesh-ancestor
2191873|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
2191874|NCT00003652|Fluorouracil|fluorouracil|mesh-list
2191875|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191876|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
2191877|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191878|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191879|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191880|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
2191881|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191882|NCT00003653|Leuprolide|leuprolide|mesh-list
2191883|NCT00003653|Goserelin|goserelin|mesh-list
2191884|NCT00003653|Flutamide|flutamide|mesh-list
2191885|NCT00003653|Bicalutamide|bicalutamide|mesh-list
2191886|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
2191887|NCT00003653|Nilutamide|nilutamide|mesh-list
2191888|NCT00003653|Buserelin|buserelin|mesh-list
2191889|NCT00003653|Cyproterone|cyproterone|mesh-list
2191890|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2191891|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
2191892|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2191893|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191894|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2191895|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191896|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
2191897|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
2191898|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2191899|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2191900|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
2696607|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2696608|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2696609|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696610|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696611|NCT02277938|Amantadine|amantadine|mesh-list
2696612|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2696613|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2696614|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
2696615|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696616|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
2696617|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2696618|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696619|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696620|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2696621|NCT02277938|Analgesics|analgesics|mesh-ancestor
2696622|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
2696623|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696624|NCT02278081|Lansoprazole|lansoprazole|mesh-list
2696625|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
2696626|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2696627|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2696628|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2696629|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696630|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696631|NCT02278133|Cetuximab|cetuximab|mesh-list
2696632|NCT02278133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2696633|NCT02278133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696634|NCT02278172|Vitamin D|vitamin d|mesh-list
2696635|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
2696636|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
2696637|NCT02278172|Vitamins|vitamins|mesh-list
2696638|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
2696639|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696640|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2696641|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2696642|NCT02278185|Leuprolide|leuprolide|mesh-list
2696643|NCT02278185|Goserelin|goserelin|mesh-list
2696644|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2696645|NCT02278185|Tryptophan|tryptophan|mesh-list
2696646|NCT02278185|Androgens|androgens|mesh-list
2696647|NCT02278185|Hormones|hormones|mesh-ancestor
2696648|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2696649|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696650|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2696651|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
2696652|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2696653|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2696654|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696655|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
2696656|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2696657|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
2696658|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2696659|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2696660|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
2696661|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2696662|NCT02278250|Carboplatin|carboplatin|mesh-list
2696663|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696664|NCT02278302|Ethanol|ethanol|mesh-list
2191901|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2191902|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2191903|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191904|NCT00003656|Interferons|interferons|mesh-list
2191905|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
2191906|NCT00003656|Tretinoin|tretinoin|mesh-list
2191907|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696665|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
2696666|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2696667|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696668|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2696669|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696670|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2696671|NCT02278315|Dexamethasone|dexamethasone|mesh-list
2696672|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2696673|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
2696674|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
2191908|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
2191909|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191910|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
2191911|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191912|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
2696675|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696676|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696677|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2696678|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
2191913|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191914|NCT00003657|Carboplatin|carboplatin|mesh-list
2191915|NCT00003657|Etoposide|etoposide|mesh-list
2191916|NCT00003657|Ifosfamide|ifosfamide|mesh-list
2191917|NCT00003657|Amifostine|amifostine|mesh-list
2696679|NCT02278315|Hormones|hormones|mesh-ancestor
2696680|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2696681|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2191918|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696682|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696683|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
2696684|NCT02278419|Simeprevir|simeprevir|mesh-list
2696685|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
2696686|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696687|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
2696688|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696689|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696690|NCT02278458|Gemcitabine|gemcitabine|mesh-list
2696691|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2696692|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
2696693|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696694|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696695|NCT02278458|Antiviral Agents|antiviral agents|mesh-ancestor
2696696|NCT02278458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696697|NCT02278458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696698|NCT02278458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2696699|NCT02278458|Immunologic Factors|immunologic factors|mesh-ancestor
2696700|NCT02278458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696701|NCT02278510|Topotecan|topotecan|mesh-list
2696702|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2696703|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2696704|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696705|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696706|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696707|NCT02278575|Antithrombins|antithrombins|mesh-list
2696708|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
2696709|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2696710|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
2696711|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696712|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696713|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
2696714|NCT02278588|Rasagiline|rasagiline|mesh-list
2696715|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2696716|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696717|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696718|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2696719|NCT02278588|Protective Agents|protective agents|mesh-ancestor
2696720|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696721|NCT02278601|Fentanyl|fentanyl|mesh-list
2696722|NCT02278601|Ropivacaine|ropivacaine|mesh-list
2696723|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
2696724|NCT02278601|Anesthetics|anesthetics|mesh-list
2696725|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2696726|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696727|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
2696728|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696729|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2696730|NCT02278601|Narcotics|narcotics|mesh-ancestor
2696731|NCT02278601|Analgesics|analgesics|mesh-ancestor
2696732|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2191919|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2191920|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2696733|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2696734|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
2696735|NCT02278692|Vitamin K|vitamin k|mesh-list
2696736|NCT02278692|Vitamins|vitamins|mesh-ancestor
2696737|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
2696738|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696739|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2696740|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2696741|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696742|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
2696743|NCT02278692|Coagulants|coagulants|mesh-ancestor
2696744|NCT02278861|Tretinoin|tretinoin|mesh-list
2696745|NCT02278861|Isotretinoin|isotretinoin|mesh-list
2696746|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
2191921|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2191922|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191923|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191924|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696747|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
2696748|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696749|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
2696750|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2696751|NCT02278861|Protective Agents|protective agents|mesh-ancestor
2696752|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696753|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
2696754|NCT02278887|Fludarabine|fludarabine|mesh-list
2696755|NCT02278887|Ipilimumab|ipilimumab|mesh-list
2696756|NCT02278887|Interleukin-2|interleukin-2|mesh-list
2696757|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2696758|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
2696759|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696760|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2696761|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2696762|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
2696763|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696764|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696765|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2696766|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2696767|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2696768|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2696769|NCT02278887|Analgesics|analgesics|mesh-ancestor
2696770|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
2696771|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696772|NCT02278913|Insulin|insulin|mesh-list
2696773|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
2696774|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2696775|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2696776|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696777|NCT02278926|Insulin|insulin|mesh-list
2696778|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2696779|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696780|NCT02278965|Metformin|metformin|mesh-list
2696781|NCT02278965|Biguanides|biguanides|mesh-list
2696782|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2696783|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696784|NCT02278978|Nintedanib|nintedanib|mesh-list
2696785|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696786|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2696787|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696788|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696789|NCT02279121|Taurolidine|taurolidine|mesh-list
2696790|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2696791|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696792|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2696793|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696794|NCT02279134|Paclitaxel|paclitaxel|mesh-list
2696795|NCT02279134|Nedaplatin|nedaplatin|mesh-list
2696796|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2696797|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696798|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
2696799|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
2696800|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
2696801|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696802|NCT02279147|Neostigmine|neostigmine|mesh-list
2696803|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2696804|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696805|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696806|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
2696807|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2696808|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696809|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2696810|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
2696811|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696812|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
2696813|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2696814|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2696815|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696816|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
2696817|NCT02279186|Coagulants|coagulants|mesh-ancestor
2696818|NCT02279316|Vitamin D|vitamin d|mesh-list
2696819|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
2696820|NCT02279316|Vitamins|vitamins|mesh-ancestor
2696821|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
2696822|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696823|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2696824|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2696825|NCT02279342|Febuxostat|febuxostat|mesh-list
2696826|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
2696827|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2696828|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
2696829|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2696830|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696831|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
2696832|NCT02279394|Dexamethasone|dexamethasone|mesh-list
2696833|NCT02279394|Lenalidomide|lenalidomide|mesh-list
2696834|NCT02279394|Elotuzumab|elotuzumab|mesh-list
2696835|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2696836|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
2696837|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
2696838|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696839|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696840|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2696841|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
2696842|NCT02279394|Hormones|hormones|mesh-ancestor
2696843|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2696844|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2696845|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696846|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
2696847|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2696848|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2696849|NCT02279394|Growth Substances|growth substances|mesh-ancestor
2696850|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
2696851|NCT02279511|Adenosine|adenosine|mesh-list
2696852|NCT02279511|Analgesics|analgesics|mesh-ancestor
2696853|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
2696854|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696855|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696856|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2696857|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
2696858|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2696859|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
2696860|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
2696861|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2696862|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696863|NCT02279537|Aflibercept|aflibercept|mesh-list
2696864|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2696865|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2696866|NCT02279537|Growth Substances|growth substances|mesh-ancestor
2696867|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696868|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
2696869|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696870|NCT02279563|Fluticasone|fluticasone|mesh-list
2696871|NCT02279563|Xhance|xhance|mesh-list
2696872|NCT02279563|Azelastine|azelastine|mesh-list
2696873|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2696874|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2696875|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
2696876|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696877|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696878|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2696879|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
2696880|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
2696881|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2696882|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2696883|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2696884|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696885|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2696886|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2696887|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
2696888|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
2696889|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2696890|NCT02279576|Paclitaxel|paclitaxel|mesh-list
2696891|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2696892|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2696893|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696894|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
2696895|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
2696896|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
2696897|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696898|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2696899|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
2696900|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696901|NCT02279602|Fosbretabulin|fosbretabulin|mesh-list
2696902|NCT02279602|Combretastatin|combretastatin|mesh-list
2696903|NCT02279602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2696904|NCT02279602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696905|NCT02279602|Tubulin Modulators|tubulin modulators|mesh-ancestor
2191925|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191926|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
2191927|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2191928|NCT00003657|Protective Agents|protective agents|mesh-ancestor
2696906|NCT02279602|Antimitotic Agents|antimitotic agents|mesh-ancestor
2696907|NCT02279602|Mitosis Modulators|mitosis modulators|mesh-ancestor
2696908|NCT02279602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696909|NCT02279615|Tamsulosin|tamsulosin|mesh-list
2696910|NCT02279615|Mirabegron|mirabegron|mesh-list
2696911|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2696912|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2696913|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2696914|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
2696915|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2696916|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696917|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191929|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
2191930|NCT00003658|Rituximab|rituximab|mesh-list
2191931|NCT00003658|Pentostatin|pentostatin|mesh-list
2696918|NCT02279615|Urological Agents|urological agents|mesh-ancestor
2696919|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2696920|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2696921|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2696922|NCT02279628|Morphine|morphine|mesh-list
2696923|NCT02279628|Ropivacaine|ropivacaine|mesh-list
2696924|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2696925|NCT02279628|Narcotics|narcotics|mesh-ancestor
2696926|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2696927|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696928|NCT02279628|Analgesics|analgesics|mesh-ancestor
2696929|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
2696930|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2696931|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
2696932|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
2696933|NCT02279654|Lenalidomide|lenalidomide|mesh-list
2696934|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
2696935|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696936|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2696937|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2696938|NCT02279654|Growth Substances|growth substances|mesh-ancestor
2696939|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
2696940|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2696941|NCT02279758|Metformin|metformin|mesh-list
2696942|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2696943|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696944|NCT02279823|Minoxidil|minoxidil|mesh-list
2696945|NCT02279823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2696946|NCT02279823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2696947|NCT02279823|Vasodilator Agents|vasodilator agents|mesh-ancestor
2696948|NCT02279875|Rifampin|rifampin|mesh-list
2696949|NCT02279875|Isoniazid|isoniazid|mesh-list
2696950|NCT02279875|Linezolid|linezolid|mesh-list
2696951|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
2696952|NCT02279875|Ethambutol|ethambutol|mesh-list
2696953|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2696954|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
2696955|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2696956|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2696957|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
2696958|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2696959|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191932|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191933|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
2191934|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191935|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2696960|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696961|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2696962|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2696963|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2696964|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2696965|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2696966|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2696967|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2696968|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2696969|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
2696970|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2696971|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2696972|NCT02279914|Misoprostol|misoprostol|mesh-list
2696973|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2696974|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
2696975|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2696976|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696977|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2696978|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2696979|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
2696980|NCT02279953|Vortioxetine|vortioxetine|mesh-list
2696981|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
2696982|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2696983|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2696984|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2696985|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2696986|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2696987|NCT02279953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2696988|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2696989|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2696990|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2696991|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2696992|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
2696993|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2696994|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2696995|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2696996|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2696997|NCT02279966|Vortioxetine|vortioxetine|mesh-list
2696998|NCT02279966|Paroxetine|paroxetine|mesh-list
2696999|NCT02279966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2697000|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2697001|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2697002|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697003|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2697004|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
2697005|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697006|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2697007|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
2697008|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2697009|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2697010|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2697011|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697012|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2697013|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2697014|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2697015|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2697016|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2697017|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2697018|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2697019|NCT02279992|Carboplatin|carboplatin|mesh-list
2697020|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2697021|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697022|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
2697023|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2697024|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2697025|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697026|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697027|NCT02279992|Urological Agents|urological agents|mesh-ancestor
2697028|NCT02280031|Aspirin|aspirin|mesh-list
2697029|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2697030|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2697031|NCT02280031|Analgesics|analgesics|mesh-ancestor
2697032|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
2697033|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697034|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697035|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2697036|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697037|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2697038|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2697039|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697040|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2697041|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2697042|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697043|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
2697044|NCT02280057|Metformin|metformin|mesh-list
2697045|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2697046|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697047|NCT02280070|Leucovorin|leucovorin|mesh-list
2697048|NCT02280070|Fluorouracil|fluorouracil|mesh-list
2697049|NCT02280070|Tegafur|tegafur|mesh-list
2697050|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
2697051|NCT02280070|Antibodies|antibodies|mesh-list
2697052|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
2697053|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
2697054|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
2697055|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697056|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
2697057|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697058|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2191936|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191937|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
2191938|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191939|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191940|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191941|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2191942|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2191943|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191944|NCT00003661|Cyclosporine|cyclosporine|mesh-list
2191945|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
2191946|NCT00003661|Melphalan|melphalan|mesh-list
2423422|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2423423|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
2423424|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423425|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423426|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423427|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2423428|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2697059|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697060|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2697061|NCT02280070|Antidotes|antidotes|mesh-ancestor
2697062|NCT02280070|Protective Agents|protective agents|mesh-ancestor
2697063|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
2697064|NCT02280070|Vitamins|vitamins|mesh-ancestor
2697065|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
2697066|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
2697067|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2697068|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2697069|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2697070|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2697071|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697072|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
2697073|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2697074|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697075|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2697076|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697077|NCT02280109|Tenofovir|tenofovir|mesh-list
2697078|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
2697079|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697080|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2697081|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2697082|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697083|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697084|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2697085|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2697086|NCT02280148|Propofol|propofol|mesh-list
2697087|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
2697088|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2697089|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697090|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2697091|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2697092|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
2697093|NCT02280174|Linagliptin|linagliptin|mesh-list
2697094|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2697095|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697096|NCT02280174|Incretins|incretins|mesh-ancestor
2697097|NCT02280174|Hormones|hormones|mesh-ancestor
2423429|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423430|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2697098|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2697099|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2697100|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
2697101|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697102|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697103|NCT02280239|Acetaminophen|acetaminophen|mesh-list
2697104|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2697105|NCT02280239|Analgesics|analgesics|mesh-ancestor
2697106|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
2697107|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697108|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697109|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
2697110|NCT02280265|Factor VIII|factor viii|mesh-list
2697111|NCT02280265|Coagulants|coagulants|mesh-ancestor
2697112|NCT02280447|Vaccines|vaccines|mesh-list
2697113|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
2697114|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697115|NCT02280486|Glimepiride|glimepiride|mesh-list
2697116|NCT02280486|Saxagliptin|saxagliptin|mesh-list
2697117|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2697118|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2697119|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697120|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2697121|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
2697122|NCT02280486|Incretins|incretins|mesh-ancestor
2697123|NCT02280486|Hormones|hormones|mesh-ancestor
2697124|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2697125|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2697126|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
2697127|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697128|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697129|NCT02280525|Vidarabine|vidarabine|mesh-list
2697130|NCT02280525|Cytarabine|cytarabine|mesh-list
2697131|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
2697132|NCT02280525|Rituximab|rituximab|mesh-list
2697133|NCT02280525|Fludarabine|fludarabine|mesh-list
2697134|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
2697135|NCT02280525|Lenalidomide|lenalidomide|mesh-list
2697136|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191947|NCT00003661|Busulfan|busulfan|mesh-list
2191948|NCT00003661|Cyclosporins|cyclosporins|mesh-list
2191949|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2191950|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2191951|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191952|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191953|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
2191954|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191955|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
2191956|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697137|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
2697138|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697139|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697140|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2697141|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
2697142|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697143|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697144|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2697145|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2697146|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2697147|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
2697148|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
2697149|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697150|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2697151|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2697152|NCT02280525|Growth Substances|growth substances|mesh-ancestor
2697153|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
2697154|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
2697155|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2697156|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
2697157|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697158|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
2697159|NCT02280538|Protective Agents|protective agents|mesh-ancestor
2697160|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2697161|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2191957|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191958|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697162|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2697163|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
2697164|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697165|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2697166|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2697167|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697168|NCT02280603|Minoxidil|minoxidil|mesh-list
2697169|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2697170|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
2697171|NCT02280616|Budesonide|budesonide|mesh-list
2697172|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2697173|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2697174|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
2697175|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697176|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697177|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2697178|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
2697179|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
2697180|NCT02280616|Hormones|hormones|mesh-ancestor
2697181|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2697182|NCT02280629|Mesalamine|mesalamine|mesh-list
2697183|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2697184|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2697185|NCT02280629|Analgesics|analgesics|mesh-ancestor
2697186|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
2697187|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697188|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697189|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2697190|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697191|NCT02280694|Celecoxib|celecoxib|mesh-list
2697192|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
2697193|NCT02280694|Capecitabine|capecitabine|mesh-list
2697194|NCT02280694|Methotrexate|methotrexate|mesh-list
2697195|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2697196|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
2697197|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697198|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697199|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2697200|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
2697201|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697202|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697203|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2697204|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2697205|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
2697206|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2697207|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
2697208|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2697209|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
2697210|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697211|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2697212|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2697213|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2697214|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2697215|NCT02280694|Analgesics|analgesics|mesh-ancestor
2697216|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
2697217|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697218|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2697219|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2697220|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2697221|NCT02280720|Tryptophan|tryptophan|mesh-list
2697222|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2697223|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
2697224|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2191959|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2191960|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191961|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
2191962|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191963|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191964|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2191965|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
2191966|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
2191967|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2191968|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2191969|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
2191970|NCT00003661|Hormones|hormones|mesh-ancestor
2191971|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2697225|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
2697226|NCT02280772|Cathartics|cathartics|mesh-ancestor
2697227|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2697228|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2697229|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2697230|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697231|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
2697232|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
2697233|NCT02280876|Andrographolide|andrographolide|mesh-list
2697234|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2697235|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2697236|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2697237|NCT02280876|Analgesics|analgesics|mesh-ancestor
2697238|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
2697239|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697240|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697241|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697242|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2697243|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2697244|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697245|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
2191972|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2191973|NCT00003661|Protective Agents|protective agents|mesh-ancestor
2191974|NCT00003662|Cyclosporine|cyclosporine|mesh-list
2697246|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2697247|NCT02280993|Dexamethasone|dexamethasone|mesh-list
2697248|NCT02280993|Cisplatin|cisplatin|mesh-list
2697249|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2697250|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697251|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2697252|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
2697253|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
2697254|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697255|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697256|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2697257|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
2697258|NCT02280993|Hormones|hormones|mesh-ancestor
2697259|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2697260|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2697261|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2697262|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
2697263|NCT02281006|Antidotes|antidotes|mesh-ancestor
2697264|NCT02281006|Protective Agents|protective agents|mesh-ancestor
2697265|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697266|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
2697267|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697268|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
2697269|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2697270|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697271|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
2697272|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
2697273|NCT02281045|Citric Acid|citric acid|mesh-list
2697274|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
2697275|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
2697276|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2697277|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
2697278|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
2697279|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697280|NCT02281058|Abatacept|abatacept|mesh-list
2697281|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2697282|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697283|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697284|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2697285|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
2697286|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697287|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697288|NCT02281201|Thrombin|thrombin|mesh-list
2697289|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
2697290|NCT02281201|Coagulants|coagulants|mesh-ancestor
2697291|NCT02281240|Oprelvekin|oprelvekin|mesh-list
2697292|NCT02281240|Heparin|heparin|mesh-list
2697293|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
2697294|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2697295|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2697296|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697297|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697298|NCT02281266|Entecavir|entecavir|mesh-list
2697299|NCT02281266|Thymalfasin|thymalfasin|mesh-list
2697300|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
2697301|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697302|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2697303|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
2697304|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697305|NCT02281279|Rituximab|rituximab|mesh-list
2697306|NCT02281279|Lenalidomide|lenalidomide|mesh-list
2697307|NCT02281279|Romidepsin|romidepsin|mesh-list
2697308|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2697309|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697310|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
2697311|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697312|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697313|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2697314|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2697315|NCT02281279|Growth Substances|growth substances|mesh-ancestor
2697316|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
2697317|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2697318|NCT02281292|Ranibizumab|ranibizumab|mesh-list
2697319|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2697320|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2697321|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2697322|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2697323|NCT02281292|Growth Substances|growth substances|mesh-ancestor
2697324|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697325|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
2697326|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697327|NCT02281305|Colchicine|colchicine|mesh-list
2697328|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
2697329|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697330|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
2697331|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
2697332|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
2697333|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697334|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191975|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
2191976|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
2191977|NCT00003662|Melphalan|melphalan|mesh-list
2191978|NCT00003662|Busulfan|busulfan|mesh-list
2191979|NCT00003662|Cyclosporins|cyclosporins|mesh-list
2191980|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2191981|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2191982|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
2191983|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2191984|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2191985|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2191986|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
2191987|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2191988|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2191989|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2191990|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697335|NCT02281370|Cyclosporine|cyclosporine|mesh-list
2697336|NCT02281370|Cyclosporins|cyclosporins|mesh-list
2697337|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697338|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697339|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2697340|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
2697341|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697342|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
2697343|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697344|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
2697345|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697346|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2697347|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
2697348|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2697349|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
2697350|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697351|NCT02281396|Vaccines|vaccines|mesh-list
2697352|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
2697353|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697354|NCT02281643|Doxycycline|doxycycline|mesh-list
2697355|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2697356|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697357|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
2697358|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2697359|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2697360|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
2697361|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2697362|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2697363|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697364|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
2697365|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2697366|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
2697367|NCT02281682|Fluorouracil|fluorouracil|mesh-list
2697368|NCT02281682|Imiquimod|imiquimod|mesh-list
2697369|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2697370|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
2697371|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697372|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2697373|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697374|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2697375|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
2697376|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697377|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2697378|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
2697379|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2697380|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
2697381|NCT02281708|Cisplatin|cisplatin|mesh-list
2697382|NCT02281708|Vinorelbine|vinorelbine|mesh-list
2697383|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697384|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2697385|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
2697386|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
2697387|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
2697388|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697389|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
2697390|NCT02281721|Antacids|antacids|mesh-ancestor
2697391|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697392|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2697393|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
2697394|NCT02281799|Azathioprine|azathioprine|mesh-list
2697395|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
2697396|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697397|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2697398|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697399|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2697400|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
2697401|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697402|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2697403|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697404|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697405|NCT02281838|Enalapril|enalapril|mesh-list
2697406|NCT02281838|Hydralazine|hydralazine|mesh-list
2697407|NCT02281838|Labetalol|labetalol|mesh-list
2697408|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2697409|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
2697410|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697411|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697412|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2697413|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
2697414|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2697415|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2697416|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
2697417|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2697418|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697419|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
2697420|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
2697421|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697422|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2697423|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2697424|NCT02281929|Amoxicillin|amoxicillin|mesh-list
2697425|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
2697426|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
2697427|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2697428|NCT02281929|Prednisolone|prednisolone|mesh-list
2697429|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2697430|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
2191991|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
2191992|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2191993|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
2191994|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2191995|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2191996|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
2697431|NCT02281929|Hormones|hormones|mesh-ancestor
2191997|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
2191998|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2191999|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2192000|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
2192001|NCT00003662|Hormones|hormones|mesh-ancestor
2697432|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2697433|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697434|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2697435|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697436|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2697437|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697438|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697439|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697440|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2697441|NCT02281968|Naproxen|naproxen|mesh-list
2697442|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2697443|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2697444|NCT02281968|Analgesics|analgesics|mesh-ancestor
2697445|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
2697446|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697447|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697448|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2697449|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697450|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
2697451|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2697452|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697453|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697454|NCT02281981|Curcumin|curcumin|mesh-list
2697455|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2697456|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2697457|NCT02281981|Analgesics|analgesics|mesh-ancestor
2697458|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
2697459|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2192002|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2192003|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2192004|NCT00003662|Protective Agents|protective agents|mesh-ancestor
2192005|NCT00003663|Dexamethasone|dexamethasone|mesh-list
2192006|NCT00003663|Rituximab|rituximab|mesh-list
2697460|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697461|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2697462|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697463|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697464|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697465|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697466|NCT02282059|Sunitinib|sunitinib|mesh-list
2697467|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697468|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2697469|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2697470|NCT02282059|Growth Substances|growth substances|mesh-ancestor
2697471|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697472|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
2697473|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2697474|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697475|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697476|NCT02282085|Olanzapine|olanzapine|mesh-list
2697477|NCT02282085|Risperidone|risperidone|mesh-list
2697478|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2697479|NCT02282085|Aripiprazole|aripiprazole|mesh-list
2697480|NCT02282085|Ziprasidone|ziprasidone|mesh-list
2697481|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
2697482|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2697483|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2697484|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
2697485|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2697486|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697487|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697488|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2697489|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2697490|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2697491|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2697492|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
2697493|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
2697494|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
2192007|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2192008|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
2192009|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
2192010|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2192011|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192012|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2192013|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
2192014|NCT00003663|Hormones|hormones|mesh-ancestor
2192015|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2192016|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2192017|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192018|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2192019|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
2192020|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192021|NCT00003664|Gemcitabine|gemcitabine|mesh-list
2192022|NCT00003664|Interferons|interferons|mesh-list
2697495|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697496|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2697497|NCT02282085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2697498|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2697499|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2697500|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
2697501|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
2697502|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2697503|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2697504|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2697505|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2192023|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
2192024|NCT00003664|Aldesleukin|aldesleukin|mesh-list
2192025|NCT00003664|Fluorouracil|fluorouracil|mesh-list
2192026|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192027|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
2192028|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192029|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192030|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
2192031|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192032|NCT00003664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192033|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2697506|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2697507|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2697508|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2697509|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
2697510|NCT02282098|Colchicine|colchicine|mesh-list
2697511|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
2697512|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697513|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
2697514|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
2697515|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
2697516|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697517|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697518|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2697519|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2697520|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697521|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
2697522|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2697523|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2192034|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
2192035|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192036|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2192037|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2192038|NCT00003666|Irofulven|irofulven|mesh-list
2192039|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192040|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
2192041|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192042|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192043|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
2192044|NCT00003667|Doxorubicin|doxorubicin|mesh-list
2192045|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2192046|NCT00003667|Vincristine|vincristine|mesh-list
2192047|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
2697524|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2697525|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2697526|NCT02282176|Azithromycin|azithromycin|mesh-list
2697527|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2192048|NCT00003667|Razoxane|razoxane|mesh-list
2192049|NCT00003667|Glycerol|glycerol|mesh-list
2192050|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2697528|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697529|NCT02282215|Lenograstim|lenograstim|mesh-list
2697530|NCT02282215|Sargramostim|sargramostim|mesh-list
2697531|NCT02282215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2697532|NCT02282215|Immunologic Factors|immunologic factors|mesh-ancestor
2697533|NCT02282215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697534|NCT02282241|Melatonin|melatonin|mesh-list
2697535|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
2697536|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697537|NCT02282241|Protective Agents|protective agents|mesh-ancestor
2697538|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697539|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2697540|NCT02282267|Gefitinib|gefitinib|mesh-list
2697541|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697542|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2697543|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697544|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697545|NCT02282280|Prilocaine|prilocaine|mesh-list
2697546|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
2697547|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
2697548|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2697549|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697550|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
2697551|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697552|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
2697553|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
2697554|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2697555|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2697556|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697557|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2697558|NCT02282319|Analgesics|analgesics|mesh-ancestor
2192051|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
2192052|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192053|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2697559|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
2697560|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697561|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2697562|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2697563|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2697564|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
2697565|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2697566|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697567|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
2192054|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192055|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
2192056|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192057|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192058|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2192059|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2192060|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192061|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192062|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192063|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192064|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192065|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192066|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
2192067|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2192068|NCT00003667|Protective Agents|protective agents|mesh-ancestor
2192069|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2192070|NCT00003671|Leucovorin|leucovorin|mesh-list
2192071|NCT00003671|Cytarabine|cytarabine|mesh-list
2192072|NCT00003671|Dexamethasone|dexamethasone|mesh-list
2192073|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
2192074|NCT00003671|Methotrexate|methotrexate|mesh-list
2192075|NCT00003671|Vincristine|vincristine|mesh-list
2192076|NCT00003671|Daunorubicin|daunorubicin|mesh-list
2192077|NCT00003671|Asparaginase|asparaginase|mesh-list
2697568|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
2697569|NCT02282345|Talazoparib|talazoparib|mesh-list
2697570|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2697571|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697572|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697573|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697574|NCT02282358|Mocetinostat|mocetinostat|mesh-list
2192078|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
2192079|NCT00003671|Thioguanine|thioguanine|mesh-list
2192080|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
2697575|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2697576|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697577|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697578|NCT02282371|Cetuximab|cetuximab|mesh-list
2697579|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2697580|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192081|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192082|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
2192083|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192084|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192085|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192086|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
2697581|NCT02282384|Oseltamivir|oseltamivir|mesh-list
2697582|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
2697583|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
2697584|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697585|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697586|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697587|NCT02282384|Antacids|antacids|mesh-ancestor
2697588|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2697589|NCT02282410|Factor VIII|factor viii|mesh-list
2697590|NCT02282410|Coagulants|coagulants|mesh-ancestor
2697591|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
2697592|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2697593|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697594|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697595|NCT02282683|Prednisone|prednisone|mesh-list
2697596|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2192087|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192088|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192089|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2192090|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2192091|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
2192092|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
2192093|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2192094|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2192095|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
2192096|NCT00003671|Hormones|hormones|mesh-ancestor
2192097|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2192098|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2697597|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
2697598|NCT02282683|Hormones|hormones|mesh-ancestor
2697599|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2697600|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697601|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2697602|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192099|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2192100|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
2192101|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2192102|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192103|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
2192104|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
2192105|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192106|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2192107|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2192108|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
2192109|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192110|NCT00003671|Antidotes|antidotes|mesh-ancestor
2192111|NCT00003671|Protective Agents|protective agents|mesh-ancestor
2192112|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
2192113|NCT00003671|Vitamins|vitamins|mesh-ancestor
2192114|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
2192115|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192116|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192117|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192118|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
2192119|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2697603|NCT02282709|Asunaprevir|asunaprevir|mesh-list
2697604|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
2697605|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697606|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697607|NCT02282774|Lidocaine|lidocaine|mesh-list
2697608|NCT02282774|Bupivacaine|bupivacaine|mesh-list
2697609|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
2697610|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
2697611|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2192120|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192121|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2697612|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697613|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
2697614|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697615|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2697616|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2697617|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2697618|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2697619|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697620|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
2697621|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2697622|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2697623|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697624|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2697625|NCT02282787|Analgesics|analgesics|mesh-ancestor
2697626|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
2697627|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697628|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2697629|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2697630|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2697631|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
2697632|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2697633|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697634|NCT02282800|Vitamin D|vitamin d|mesh-list
2697635|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
2697636|NCT02282800|Vitamins|vitamins|mesh-ancestor
2697637|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
2697638|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697639|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2192122|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
2192123|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2192124|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192125|NCT00003674|Dalteparin|dalteparin|mesh-list
2192126|NCT00003674|Tinzaparin|tinzaparin|mesh-list
2697640|NCT02282826|Acyclovir|acyclovir|mesh-list
2697641|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
2697642|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697643|NCT02282891|Ketamine|ketamine|mesh-list
2697644|NCT02282891|Propofol|propofol|mesh-list
2697645|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2697646|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2697647|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697648|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2697649|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
2697650|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
2697651|NCT02282891|Analgesics|analgesics|mesh-ancestor
2697652|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
2697653|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697654|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2697655|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2697656|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2697657|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2697658|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697659|NCT02282956|Droperidol|droperidol|mesh-list
2697660|NCT02282956|Morphine|morphine|mesh-list
2697661|NCT02282956|Ropivacaine|ropivacaine|mesh-list
2697662|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2697663|NCT02282956|Narcotics|narcotics|mesh-ancestor
2192127|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2192128|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
2192129|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2192130|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2192131|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192132|NCT00003675|Topotecan|topotecan|mesh-list
2192133|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2192134|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192135|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697664|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2697665|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697666|NCT02282956|Analgesics|analgesics|mesh-ancestor
2697667|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
2697668|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697669|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
2697670|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
2697671|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2697672|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
2697673|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
2697674|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2697675|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2697676|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2697677|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2697678|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2697679|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2697680|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
2697681|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2697682|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697683|NCT02283060|Tenofovir|tenofovir|mesh-list
2697684|NCT02283060|Emtricitabine|emtricitabine|mesh-list
2697685|NCT02283060|Efavirenz|efavirenz|mesh-list
2697686|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2697687|NCT02283060|Cobicistat|cobicistat|mesh-list
2697688|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2192136|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192137|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192138|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
2192139|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192140|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192141|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192142|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
2192143|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192144|NCT00003678|Tamoxifen|tamoxifen|mesh-list
2192145|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2192146|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
2192147|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2192148|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697689|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2697690|NCT02283060|Elvitegravir|elvitegravir|mesh-list
2697691|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
2697692|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697693|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2697694|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2697695|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697696|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697697|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2697698|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2697699|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2697700|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2697701|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2697702|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2697703|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2697704|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2697705|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2697706|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2697707|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
2697708|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2697709|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
2697710|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
2697711|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
2697712|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2697713|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697714|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2697715|NCT02283177|Cytarabine|cytarabine|mesh-list
2697716|NCT02283177|Daunorubicin|daunorubicin|mesh-list
2697717|NCT02283177|Idarubicin|idarubicin|mesh-list
2697718|NCT02283177|Crenolanib|crenolanib|mesh-list
2697719|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2697720|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
2697721|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697722|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697723|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
2697724|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697725|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2697726|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
2697727|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697728|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2697729|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2697730|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2697731|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697732|NCT02283190|Asparaginase|asparaginase|mesh-list
2697733|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697734|NCT02283203|Acetaminophen|acetaminophen|mesh-list
2697735|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2697736|NCT02283203|Analgesics|analgesics|mesh-ancestor
2697737|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
2697738|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697739|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697740|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
2697741|NCT02283242|Galantamine|galantamine|mesh-list
2697742|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2697743|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697744|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697745|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
2697746|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2697747|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697748|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2697749|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
2697750|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697751|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
2697752|NCT02283281|Dronabinol|dronabinol|mesh-list
2697753|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
2697754|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697755|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2697756|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2697757|NCT02283281|Analgesics|analgesics|mesh-ancestor
2697758|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
2697759|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697760|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2697761|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2697762|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2697763|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697764|NCT02283281|Hormones|hormones|mesh-ancestor
2697765|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2697766|NCT02283320|Docetaxel|docetaxel|mesh-list
2697767|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697768|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
2697769|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
2697770|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
2697771|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697772|NCT02283359|Irinotecan|irinotecan|mesh-list
2697773|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2697774|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2697775|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697776|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697777|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697778|NCT02283372|Gemcitabine|gemcitabine|mesh-list
2697779|NCT02283372|Paclitaxel|paclitaxel|mesh-list
2697780|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2697781|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2697782|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697783|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
2697784|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
2697785|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
2697786|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697787|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2697788|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
2697789|NCT02283372|Antiviral Agents|antiviral agents|mesh-ancestor
2697790|NCT02283372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697791|NCT02283372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697792|NCT02283372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2697793|NCT02283372|Immunologic Factors|immunologic factors|mesh-ancestor
2192149|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2192150|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192151|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2192152|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2192153|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2192154|NCT00003679|Tamoxifen|tamoxifen|mesh-list
2192155|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
2192156|NCT00003679|Docetaxel|docetaxel|mesh-list
2192157|NCT00003679|Doxorubicin|doxorubicin|mesh-list
2192158|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2697794|NCT02283372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697795|NCT02283424|Carboplatin|carboplatin|mesh-list
2697796|NCT02283424|Docetaxel|docetaxel|mesh-list
2697797|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697798|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
2697799|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
2697800|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
2697801|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697802|NCT02283476|Gemcitabine|gemcitabine|mesh-list
2697803|NCT02283476|Endostar protein|endostar protein|mesh-list
2697804|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697805|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2697806|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
2697807|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697808|NCT02283476|Antiviral Agents|antiviral agents|mesh-ancestor
2697809|NCT02283476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697810|NCT02283476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697811|NCT02283476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2697812|NCT02283476|Immunologic Factors|immunologic factors|mesh-ancestor
2697813|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697814|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2697815|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2697816|NCT02283476|Growth Substances|growth substances|mesh-ancestor
2697817|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
2697818|NCT02283489|Paclitaxel|paclitaxel|mesh-list
2697819|NCT02283489|Endostatins|endostatins|mesh-list
2697820|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2697821|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697822|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
2697823|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
2697824|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
2697825|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697826|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2697827|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2697828|NCT02283489|Growth Substances|growth substances|mesh-ancestor
2697829|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697830|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
2697831|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2697832|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2697833|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2697834|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
2697835|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697836|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2697837|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2697838|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697839|NCT02283554|Metformin|metformin|mesh-list
2697840|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2697841|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697842|NCT02283645|Minoxidil|minoxidil|mesh-list
2697843|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2697844|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
2697845|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
2697846|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2697847|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697848|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697849|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2697850|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2697851|NCT02283710|Protective Agents|protective agents|mesh-ancestor
2697852|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697853|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
2697854|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2697855|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
2697856|NCT02283775|Dexamethasone|dexamethasone|mesh-list
2697857|NCT02283775|Pomalidomide|pomalidomide|mesh-list
2697858|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2697859|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
2697860|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
2697861|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697862|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697863|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2697864|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
2697865|NCT02283775|Hormones|hormones|mesh-ancestor
2697866|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2697867|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2697868|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697869|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
2697870|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2697871|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2697872|NCT02283775|Growth Substances|growth substances|mesh-ancestor
2697873|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
2697874|NCT02283801|Lamotrigine|lamotrigine|mesh-list
2697875|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
2697876|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
2697877|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2697878|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2697879|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697880|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2697881|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697882|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2697883|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2697884|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2697885|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2697886|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2697887|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2192159|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192160|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
2192161|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192162|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192163|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192164|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
2192165|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192166|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192167|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2192168|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192169|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192170|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
2192171|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2192172|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192173|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192174|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192175|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2192176|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
2192177|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2192178|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2192179|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2192180|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2192181|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2192182|NCT00003680|Tamoxifen|tamoxifen|mesh-list
2192183|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
2192184|NCT00003680|Thiotepa|thiotepa|mesh-list
2192185|NCT00003680|Fluorouracil|fluorouracil|mesh-list
2192186|NCT00003680|Methotrexate|methotrexate|mesh-list
2192187|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192188|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
2192189|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192190|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192191|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192192|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
2192193|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192194|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192195|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2192196|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
2697900|NCT02283866|Desflurane|desflurane|mesh-list
2697901|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2697902|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
2697903|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
2697904|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2697905|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697906|NCT02283905|Voriconazole|voriconazole|mesh-list
2697907|NCT02283905|Amphotericin B|amphotericin b|mesh-list
2697908|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2697909|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
2697910|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697911|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2697912|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2697913|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192197|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192198|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2192199|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
2192200|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2192201|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
2697914|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697915|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2697916|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
2697917|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2697918|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697919|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2697920|NCT02283905|Amebicides|amebicides|mesh-ancestor
2697921|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2697922|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2697923|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2697924|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
2697925|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2697926|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2697927|NCT02283996|Prednisolone|prednisolone|mesh-list
2697928|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
2697929|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2697930|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
2697931|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2697932|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
2697933|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
2697934|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697935|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697936|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2697937|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
2697938|NCT02283996|Hormones|hormones|mesh-ancestor
2192202|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192203|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2192204|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2192205|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2697939|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2697940|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2697941|NCT02283996|Protective Agents|protective agents|mesh-ancestor
2697942|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2697943|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2697944|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
2697945|NCT02284035|Lamivudine|lamivudine|mesh-list
2697946|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2697947|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2697948|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
2697949|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2697950|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2697951|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2697952|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2697953|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697954|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2697955|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2697956|NCT02284048|Ticagrelor|ticagrelor|mesh-list
2697957|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2697958|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2697959|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2697960|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2697961|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
2697962|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2697963|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697964|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697965|NCT02284204|Midazolam|midazolam|mesh-list
2697966|NCT02284204|Ketamine|ketamine|mesh-list
2697967|NCT02284204|Sevoflurane|sevoflurane|mesh-list
2192206|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
2192207|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2192208|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2192209|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2697968|NCT02284204|Analgesics|analgesics|mesh-ancestor
2697969|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
2697970|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2697971|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697972|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2697973|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2697974|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
2697975|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
2697976|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2697977|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2697978|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2697979|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2697980|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697981|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2697982|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2697983|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2192210|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2192211|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2192212|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
2192213|NCT00003681|Amifostine|amifostine|mesh-list
2192214|NCT00003681|Hematinics|hematinics|mesh-ancestor
2192215|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2192216|NCT00003681|Protective Agents|protective agents|mesh-ancestor
2192217|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192218|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
2192219|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2192220|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2192221|NCT00003682|Prednisolone|prednisolone|mesh-list
2192222|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
2192223|NCT00003682|Doxorubicin|doxorubicin|mesh-list
2192224|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2192225|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2192226|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
2697984|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2697985|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2697986|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
2697987|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
2697988|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2697989|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2697990|NCT02284230|Liraglutide|liraglutide|mesh-list
2697991|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2697992|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2697993|NCT02284230|Incretins|incretins|mesh-ancestor
2697994|NCT02284230|Hormones|hormones|mesh-ancestor
2697995|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2697996|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2697997|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2697998|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2697999|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698000|NCT02284282|Lidocaine|lidocaine|mesh-list
2698001|NCT02284282|Morphine|morphine|mesh-list
2698002|NCT02284282|Bupivacaine|bupivacaine|mesh-list
2698003|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
2698004|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
2698005|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698006|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698007|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
2698008|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698009|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2698010|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2698011|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2698012|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2698013|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698014|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2698015|NCT02284282|Narcotics|narcotics|mesh-ancestor
2698016|NCT02284282|Analgesics|analgesics|mesh-ancestor
2698017|NCT02284412|Neostigmine|neostigmine|mesh-list
2698018|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2698019|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698020|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698021|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
2698022|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698023|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698024|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2698025|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
2192227|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2698026|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698027|NCT02284490|Pemetrexed|pemetrexed|mesh-list
2698028|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698029|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698030|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698031|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2698032|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2698033|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2698034|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2698035|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2698036|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
2698037|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698038|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2698039|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2698040|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698041|NCT02284529|Leucovorin|leucovorin|mesh-list
2698042|NCT02284529|Fluorouracil|fluorouracil|mesh-list
2698043|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
2698044|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698045|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2698046|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698047|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2698048|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
2698049|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698050|NCT02284529|Antidotes|antidotes|mesh-ancestor
2192228|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192229|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192230|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192231|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192232|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192233|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2192234|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
2192235|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
2192236|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2192237|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192238|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2192239|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
2192240|NCT00003682|Hormones|hormones|mesh-ancestor
2192241|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2698051|NCT02284529|Protective Agents|protective agents|mesh-ancestor
2698052|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
2698053|NCT02284529|Vitamins|vitamins|mesh-ancestor
2698054|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
2698055|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
2698056|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2698057|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698058|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698059|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2698060|NCT02284672|Analgesics|analgesics|mesh-ancestor
2698061|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
2698062|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698063|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2698064|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2698065|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2698066|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
2698067|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698068|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192242|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2192243|NCT00003682|Protective Agents|protective agents|mesh-ancestor
2192244|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2192245|NCT00003683|Doxorubicin|doxorubicin|mesh-list
2192246|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2192247|NCT00003683|Ifosfamide|ifosfamide|mesh-list
2192248|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2192249|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192250|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192251|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192252|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192253|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192254|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192255|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
2192256|NCT00003684|Theophylline|theophylline|mesh-list
2698069|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
2192257|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2698070|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
2698071|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2698072|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2698073|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698074|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698075|NCT02284737|Urological Agents|urological agents|mesh-ancestor
2698076|NCT02284984|Rituximab|rituximab|mesh-list
2698077|NCT02284984|Belimumab|belimumab|mesh-list
2698078|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2698079|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698080|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
2698081|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698082|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2698083|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2698084|NCT02285036|Vaccines|vaccines|mesh-list
2698085|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2698086|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
2192258|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
2192259|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2192260|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192261|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2192262|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
2698087|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698088|NCT02285075|Temocillin|temocillin|mesh-list
2698089|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2698090|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2698091|NCT02285101|BCT-100|bct-100|mesh-list
2192263|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2192264|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192265|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192266|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
2192267|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2192268|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2192269|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
2192270|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2192271|NCT00003686|Pilocarpine|pilocarpine|mesh-list
2192272|NCT00003686|Miotics|miotics|mesh-ancestor
2192273|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
2192274|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423431|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2423432|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2423433|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2423434|NCT00822133|Lidocaine|lidocaine|mesh-list
2423435|NCT00822133|Ketamine|ketamine|mesh-list
2423436|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
2423437|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
2423438|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423439|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423440|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
2423441|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423442|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2423443|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2423444|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2698092|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698093|NCT02285140|Vancomycin|vancomycin|mesh-list
2698094|NCT02285140|Cefazolin|cefazolin|mesh-list
2698095|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2698096|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2698097|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
2698098|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
2698099|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698100|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2698101|NCT02285179|Tamoxifen|tamoxifen|mesh-list
2698102|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2698103|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
2698104|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2698105|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698106|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2698107|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698108|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2698109|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2192275|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192276|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2192277|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2698110|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2698114|NCT02285309|Enoximone|enoximone|mesh-list
2698115|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2698116|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
2698117|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2698118|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2698119|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698120|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698121|NCT02285309|Protective Agents|protective agents|mesh-ancestor
2698122|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698123|NCT02285374|Tenofovir|tenofovir|mesh-list
2698124|NCT02285374|Emtricitabine|emtricitabine|mesh-list
2698125|NCT02285374|Efavirenz|efavirenz|mesh-list
2698126|NCT02285374|Dolutegravir|dolutegravir|mesh-list
2698127|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2698128|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
2698129|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2698130|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2698131|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2698132|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698133|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698134|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2698135|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2698136|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2698137|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2698138|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2698139|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2698140|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2698141|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2698142|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2698143|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2698144|NCT02285413|Cisplatin|cisplatin|mesh-list
2698145|NCT02285413|Vaccines|vaccines|mesh-list
2698146|NCT02285413|Immunologic Factors|immunologic factors|mesh-ancestor
2698147|NCT02285413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698148|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192278|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
2192279|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2192280|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192281|NCT00003687|Morphine|morphine|mesh-list
2192282|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
2192283|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2192284|NCT00003687|Narcotics|narcotics|mesh-ancestor
2192285|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2192286|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192287|NCT00003687|Analgesics|analgesics|mesh-ancestor
2192288|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
2192289|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2192290|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
2192291|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
2192292|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2192293|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2192294|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2192295|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192296|NCT00003688|Dactinomycin|dactinomycin|mesh-list
2192297|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2192298|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192299|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2192300|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698149|NCT02285491|Bupivacaine|bupivacaine|mesh-list
2698150|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
2698151|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
2698152|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698153|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698154|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
2698155|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698156|NCT02285647|Rolapitant|rolapitant|mesh-list
2698157|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2192301|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2192302|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698158|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2192303|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192304|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2192305|NCT00003690|Carboplatin|carboplatin|mesh-list
2698159|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698160|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698161|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
2698162|NCT02285699|Citalopram|citalopram|mesh-list
2698163|NCT02285699|Fluoxetine|fluoxetine|mesh-list
2698164|NCT02285699|Paroxetine|paroxetine|mesh-list
2698165|NCT02285699|Sertraline|sertraline|mesh-list
2698166|NCT02285699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2698167|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2698168|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2698169|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698170|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698171|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
2698172|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698173|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2698174|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
2192306|NCT00003690|Alvocidib|alvocidib|mesh-list
2192307|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192308|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
2192309|NCT00003690|Growth Substances|growth substances|mesh-ancestor
2698175|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2698176|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2698177|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2698178|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698179|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2698180|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2698181|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698182|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2698183|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2698184|NCT02285738|Aspirin|aspirin|mesh-list
2698185|NCT02285738|Simvastatin|simvastatin|mesh-list
2698186|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2698187|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2192310|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192311|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2192312|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192313|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192314|NCT00003691|Paclitaxel|paclitaxel|mesh-list
2192315|NCT00003691|Doxorubicin|doxorubicin|mesh-list
2192316|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2192317|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192318|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192319|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192320|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192321|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
2698188|NCT02285738|Analgesics|analgesics|mesh-ancestor
2698189|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
2698190|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698191|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698192|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698193|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2698194|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2698195|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2698196|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698197|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2698198|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2698199|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698200|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
2698201|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2698202|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2698203|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
2698204|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2698205|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2698206|NCT02285751|Aspirin|aspirin|mesh-list
2698207|NCT02285751|Clopidogrel|clopidogrel|mesh-list
2698208|NCT02285751|Ticagrelor|ticagrelor|mesh-list
2698209|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2698210|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2698211|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2698212|NCT02285751|Analgesics|analgesics|mesh-ancestor
2698213|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
2192322|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192323|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2192324|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192325|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192326|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192327|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
2698214|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698215|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698216|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698217|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2698218|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2698219|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2698220|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698221|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2698222|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2698223|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698224|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
2698225|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2698226|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2698227|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2698228|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
2698229|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698230|NCT02285829|Bromides|bromides|mesh-list
2698231|NCT02285829|Rocuronium|rocuronium|mesh-list
2698232|NCT02285829|Cisatracurium|cisatracurium|mesh-list
2192328|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192329|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192330|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192331|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
2192332|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192333|NCT00003694|Cytarabine|cytarabine|mesh-list
2192334|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
2192335|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192336|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
2192337|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192338|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192339|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
2192340|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192341|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192342|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
2192343|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192344|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192345|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2192346|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192347|NCT00003696|Paclitaxel|paclitaxel|mesh-list
2192348|NCT00003696|Etoposide|etoposide|mesh-list
2192349|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
2192350|NCT00003696|Carboplatin|carboplatin|mesh-list
2192351|NCT00003696|Doxorubicin|doxorubicin|mesh-list
2698233|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
2698234|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2698235|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2698236|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2698237|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698238|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698239|NCT02285959|Bevacizumab|bevacizumab|mesh-list
2698240|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2698241|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698242|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2698243|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2698244|NCT02285959|Growth Substances|growth substances|mesh-ancestor
2698245|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698246|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
2698247|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
2192352|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2192353|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192354|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192355|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192356|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192357|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
2192358|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192359|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192360|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
2192361|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192362|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192363|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192364|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
2192365|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2192366|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2192367|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192368|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192369|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192370|NCT00003697|Vadimezan|vadimezan|mesh-list
2192371|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192372|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
2192373|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192374|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192375|NCT00003700|Leucovorin|leucovorin|mesh-list
2192376|NCT00003700|Cytarabine|cytarabine|mesh-list
2192377|NCT00003700|Prednisone|prednisone|mesh-list
2192378|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
2192379|NCT00003700|Methotrexate|methotrexate|mesh-list
2192380|NCT00003700|Vincristine|vincristine|mesh-list
2192381|NCT00003700|Daunorubicin|daunorubicin|mesh-list
2192382|NCT00003700|Asparaginase|asparaginase|mesh-list
2192383|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
2192384|NCT00003700|Allopurinol|allopurinol|mesh-list
2192385|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
2192386|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192387|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
2698248|NCT02285972|Tenoxicam|tenoxicam|mesh-list
2698249|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2698250|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2192388|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192389|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192390|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192391|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
2192392|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192393|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192394|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2192395|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2192396|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
2192397|NCT00003700|Hormones|hormones|mesh-ancestor
2192398|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2192399|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2192400|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2192401|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
2192402|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2192403|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192404|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
2192405|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
2192406|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192407|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2192408|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2192409|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
2192410|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192411|NCT00003700|Antidotes|antidotes|mesh-ancestor
2192412|NCT00003700|Protective Agents|protective agents|mesh-ancestor
2192413|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
2192414|NCT00003700|Vitamins|vitamins|mesh-ancestor
2192415|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
2192416|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192417|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192418|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192419|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
2192420|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2192421|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2698251|NCT02285972|Analgesics|analgesics|mesh-ancestor
2698252|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
2698253|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698254|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698255|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698256|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2698257|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2698258|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698259|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698260|NCT02285985|Saxagliptin|saxagliptin|mesh-list
2698261|NCT02285985|Incretins|incretins|mesh-ancestor
2698262|NCT02285985|Hormones|hormones|mesh-ancestor
2192422|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192423|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
2192424|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2192425|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
2698263|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2698264|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698265|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2698266|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
2698267|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698268|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698269|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2698276|NCT02286206|Clozapine|clozapine|mesh-list
2698277|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2698278|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
2698279|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698280|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698281|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698282|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2698283|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2698284|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698285|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2698286|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
2698287|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
2698288|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
2698289|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
2192426|NCT00003701|Paclitaxel|paclitaxel|mesh-list
2192427|NCT00003701|Vinblastine|vinblastine|mesh-list
2192428|NCT00003701|Carboplatin|carboplatin|mesh-list
2698290|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
2698291|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698292|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
2698293|NCT02286258|Edetic Acid|edetic acid|mesh-list
2698294|NCT02286258|Calcium|calcium|mesh-list
2698295|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2698296|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698297|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2698298|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
2698299|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
2698300|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698301|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
2698302|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2698303|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2698304|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2698305|NCT02286414|Vitamins|vitamins|mesh-list
2698306|NCT02286414|Vitamin K|vitamin k|mesh-list
2698307|NCT02286414|Warfarin|warfarin|mesh-list
2698308|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
2698309|NCT02286414|Dabigatran|dabigatran|mesh-list
2698310|NCT02286414|Apixaban|apixaban|mesh-list
2698311|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
2698312|NCT02286414|Fluindione|fluindione|mesh-list
2192429|NCT00003701|Doxorubicin|doxorubicin|mesh-list
2192430|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2192431|NCT00003701|Methotrexate|methotrexate|mesh-list
2192432|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192433|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192434|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192435|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192436|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
2698313|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
2698314|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698315|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
2698316|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2698317|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
2698318|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2698319|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
2698320|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698321|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698322|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2698323|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2698324|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
2698325|NCT02286414|Coagulants|coagulants|mesh-ancestor
2698326|NCT02286453|Diclofenac|diclofenac|mesh-list
2192437|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698327|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2698328|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2192438|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2192439|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192440|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192441|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192442|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2192443|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
2698329|NCT02286453|Analgesics|analgesics|mesh-ancestor
2698330|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
2698331|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698332|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698333|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698334|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2698335|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2698336|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698337|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698338|NCT02286544|Atorvastatin|atorvastatin|mesh-list
2698339|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2698340|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2698341|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
2698342|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698343|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2698344|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2698345|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698346|NCT02286596|Heparin|heparin|mesh-list
2698347|NCT02286596|Dextrans|dextrans|mesh-list
2698348|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
2698349|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2698350|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2698351|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698352|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
2698353|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
2698354|NCT02286609|Deflazacort|deflazacort|mesh-list
2698355|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698356|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2698357|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
2698358|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698359|NCT02286622|Deflazacort|deflazacort|mesh-list
2698360|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698361|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2698362|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
2698363|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698364|NCT02286635|Clarithromycin|clarithromycin|mesh-list
2698365|NCT02286635|Rifampin|rifampin|mesh-list
2698366|NCT02286635|Deflazacort|deflazacort|mesh-list
2698367|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2698368|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2698369|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2698370|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698371|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698372|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2698373|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2698374|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2698375|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
2698376|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
2698377|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2698378|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2698379|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2698380|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2698381|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2698382|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2698383|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2698384|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698385|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2698386|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
2698387|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698388|NCT02286687|Talazoparib|talazoparib|mesh-list
2698389|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2698390|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698391|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698392|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698393|NCT02286700|Desonide|desonide|mesh-list
2698394|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698395|NCT02286752|Neostigmine|neostigmine|mesh-list
2698396|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2698397|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698398|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698399|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
2698400|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698401|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698402|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2698403|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
2698404|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698405|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
2698406|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2698407|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698408|NCT02286934|Carvedilol|carvedilol|mesh-list
2698409|NCT02286934|Isoproterenol|isoproterenol|mesh-list
2698410|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2698411|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2698412|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
2698413|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698414|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698415|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698416|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2698417|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
2698418|NCT02286934|Protective Agents|protective agents|mesh-ancestor
2698419|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2698420|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2698421|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2698422|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
2698423|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2698424|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2698425|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2698426|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2698427|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2698428|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
2698429|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698430|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2698431|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
2698432|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2698433|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
2698434|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
2698435|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2698436|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2698437|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698438|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
2698439|NCT02286973|Coagulants|coagulants|mesh-ancestor
2698440|NCT02286986|Cannabidiol|cannabidiol|mesh-list
2698441|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
2698442|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
2698443|NCT02287064|Antibodies|antibodies|mesh-list
2698444|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
2698445|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2698446|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2698447|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
2698448|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698449|NCT02287129|Paclitaxel|paclitaxel|mesh-list
2698450|NCT02287129|Carboplatin|carboplatin|mesh-list
2698451|NCT02287129|Capecitabine|capecitabine|mesh-list
2698452|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
2698453|NCT02287129|Epirubicin|epirubicin|mesh-list
2698454|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2698455|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698456|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
2698457|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
2698458|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
2698459|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698460|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2698461|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
2698462|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2698463|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2698464|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2698465|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698466|NCT02287181|Remifentanil|remifentanil|mesh-list
2698467|NCT02287181|Propofol|propofol|mesh-list
2698468|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2698469|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698470|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192444|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2192445|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698471|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2698472|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
2698473|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
2698474|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2698475|NCT02287181|Narcotics|narcotics|mesh-ancestor
2698476|NCT02287181|Analgesics|analgesics|mesh-ancestor
2698477|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
2698478|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698479|NCT02287233|Cytarabine|cytarabine|mesh-list
2698480|NCT02287233|Venetoclax|venetoclax|mesh-list
2698481|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2698482|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
2698483|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698484|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698485|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
2698486|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2698487|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2698488|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
2698489|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698490|NCT02287246|Bupivacaine|bupivacaine|mesh-list
2698491|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
2698492|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
2698493|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698494|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698495|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
2698496|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698497|NCT02287259|Olanzapine|olanzapine|mesh-list
2698498|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
2698499|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
2698500|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698501|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698502|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2698503|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2698504|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2698505|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698506|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2698507|NCT02287259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2698508|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2698509|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2698510|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698511|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698512|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
2698513|NCT02287272|Cimetidine|cimetidine|mesh-list
2698514|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2698515|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2698516|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2698517|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
2698518|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
2698519|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698520|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698521|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698522|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2698523|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2698524|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698536|NCT02287389|Mitomycins|mitomycins|mesh-list
2698537|NCT02287389|Mitomycin|mitomycin|mesh-list
2698538|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2698539|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698540|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
2698541|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698542|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2698543|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698544|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
2698545|NCT02287428|Temozolomide|temozolomide|mesh-list
2698546|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2698547|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698548|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2698549|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
2698550|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698551|NCT02287558|Pomalidomide|pomalidomide|mesh-list
2698552|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
2698553|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698554|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2698555|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2698556|NCT02287558|Growth Substances|growth substances|mesh-ancestor
2698557|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
2698558|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698559|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2698560|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2698561|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698562|NCT02287857|Tenofovir|tenofovir|mesh-list
2698563|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
2698564|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2698565|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2698566|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2698567|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698568|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698569|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2698570|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2698571|NCT02287870|Lidocaine|lidocaine|mesh-list
2698572|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
2698573|NCT02287870|Procaine|procaine|mesh-list
2698574|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
2698575|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
2698576|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698577|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698578|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
2698579|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698580|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2698581|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2698582|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2698583|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2698584|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698585|NCT02288000|Memantine|memantine|mesh-list
2698586|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2698587|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2698588|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
2698589|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698590|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698591|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698592|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2698593|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2698594|NCT02288078|Dexamethasone|dexamethasone|mesh-list
2698595|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2698596|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698597|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
2698598|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
2698599|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698600|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698601|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2698602|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
2698603|NCT02288078|Hormones|hormones|mesh-ancestor
2698604|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2698605|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2698606|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698607|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698608|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698609|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
2698610|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2698611|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
2698612|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2698613|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698614|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2698615|NCT02288195|Capecitabine|capecitabine|mesh-list
2698616|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
2698617|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2698618|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
2698619|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698620|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698621|NCT02288208|Tenofovir|tenofovir|mesh-list
2698622|NCT02288208|Entecavir|entecavir|mesh-list
2698623|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
2698624|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2698625|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2192446|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192447|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
2192448|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
2192449|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2192450|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192451|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
2192452|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192453|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2192454|NCT00003704|Capecitabine|capecitabine|mesh-list
2192455|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192456|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
2192457|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192458|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192459|NCT00003706|Pemetrexed|pemetrexed|mesh-list
2192460|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192461|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698626|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2698627|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698628|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698629|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2698630|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2698631|NCT02288234|Telavancin|telavancin|mesh-list
2698632|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2698633|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2698647|NCT02288286|Vaccines|vaccines|mesh-list
2698648|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
2698649|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698650|NCT02288338|Atorvastatin|atorvastatin|mesh-list
2698651|NCT02288338|Ezetimibe|ezetimibe|mesh-list
2698652|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2698653|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2698654|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
2698655|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698656|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2698657|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2698658|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698659|NCT02288429|Colistin|colistin|mesh-list
2698660|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2698661|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192462|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192463|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2192464|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2192465|NCT00003707|Gemcitabine|gemcitabine|mesh-list
2192466|NCT00003707|Tipifarnib|tipifarnib|mesh-list
2192467|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192468|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
2192469|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192470|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192471|NCT00003707|Antiviral Agents|antiviral agents|mesh-ancestor
2192472|NCT00003707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192473|NCT00003707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192474|NCT00003707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192475|NCT00003707|Immunologic Factors|immunologic factors|mesh-ancestor
2698662|NCT02288507|Sorafenib|sorafenib|mesh-list
2698663|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698664|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2698665|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698666|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698667|NCT02288741|Dexamethasone|dexamethasone|mesh-list
2698668|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
2698669|NCT02288741|Melphalan|melphalan|mesh-list
2698670|NCT02288741|BB 1101|bb 1101|mesh-list
2192476|NCT00003707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192477|NCT00003708|Temozolomide|temozolomide|mesh-list
2192478|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192479|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
2192480|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192481|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192482|NCT00003709|Carbendazim|carbendazim|mesh-list
2192483|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
2192484|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
2192485|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2192486|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192487|NCT00003710|Irinotecan|irinotecan|mesh-list
2192488|NCT00003710|Mitomycins|mitomycins|mesh-list
2192489|NCT00003710|Mitomycin|mitomycin|mesh-list
2192490|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2192491|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192492|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192493|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192494|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192495|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2192496|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
2192497|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2192498|NCT00003711|Irinotecan|irinotecan|mesh-list
2192499|NCT00003711|Pemetrexed|pemetrexed|mesh-list
2192500|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2192501|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192502|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192503|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192504|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192505|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2192506|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2192507|NCT00003712|Sirolimus|sirolimus|mesh-list
2192508|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2192509|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192510|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2192511|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192512|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
2192513|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192514|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
2192515|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192516|NCT00003714|NSC 366140|nsc 366140|mesh-list
2192517|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192518|NCT00003715|Interferons|interferons|mesh-list
2192519|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
2192520|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
2192521|NCT00003715|Vaccines|vaccines|mesh-list
2192522|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
2192523|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
2192524|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192525|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192526|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192527|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192528|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
2192529|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192530|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192531|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2192532|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
2192533|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192534|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2192535|NCT00003716|Rituximab|rituximab|mesh-list
2192536|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2192537|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698671|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698672|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
2698673|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
2698674|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698675|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698676|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2698677|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
2192538|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
2698678|NCT02288741|Hormones|hormones|mesh-ancestor
2698679|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2698680|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2698681|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698682|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
2698683|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698684|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698685|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2698686|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
2698687|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2698688|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2698689|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
2192539|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192540|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192541|NCT00003717|Paclitaxel|paclitaxel|mesh-list
2192542|NCT00003717|Estramustine|estramustine|mesh-list
2192543|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2698690|NCT02288832|Azithromycin|azithromycin|mesh-list
2698691|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2698692|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2698701|NCT02288923|Acetaminophen|acetaminophen|mesh-list
2698702|NCT02288923|Ibuprofen|ibuprofen|mesh-list
2698703|NCT02288923|Morphine|morphine|mesh-list
2698704|NCT02288923|Antiemetics|antiemetics|mesh-list
2698705|NCT02288923|Anesthetics|anesthetics|mesh-list
2698706|NCT02288923|Emetics|emetics|mesh-list
2698707|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698708|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698709|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2698710|NCT02288923|Narcotics|narcotics|mesh-ancestor
2698711|NCT02288923|Analgesics|analgesics|mesh-ancestor
2192544|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192545|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192546|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192547|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423445|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2698712|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
2698713|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698714|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2698715|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2698716|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698717|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2698718|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2698719|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698720|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698721|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
2698722|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
2698723|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2698724|NCT02288962|Cabergoline|cabergoline|mesh-list
2698725|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2698726|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2698727|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
2698728|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
2698729|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698730|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698731|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698732|NCT02289027|Vaccines|vaccines|mesh-list
2698733|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
2698734|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698735|NCT02289144|Ceritinib|ceritinib|mesh-list
2698736|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423446|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423447|NCT00822133|Analgesics|analgesics|mesh-ancestor
2423448|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2423449|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2423450|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
2423451|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2423452|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2698737|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2698738|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698739|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698740|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
2698741|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2698742|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698743|NCT02289248|Ketamine|ketamine|mesh-list
2698744|NCT02289248|Analgesics|analgesics|mesh-ancestor
2698745|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
2698746|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698747|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698748|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2698749|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2698750|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
2698751|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
2698752|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698753|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2698754|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2698755|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698756|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698757|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
2698758|NCT02289261|Morphine|morphine|mesh-list
2698759|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2698760|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698761|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698762|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2698763|NCT02289261|Analgesics|analgesics|mesh-ancestor
2698764|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
2698765|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698766|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2698767|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2698768|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2698769|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
2698770|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698771|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698772|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2698773|NCT02289261|Narcotics|narcotics|mesh-ancestor
2698774|NCT02289274|Aceclofenac|aceclofenac|mesh-list
2698775|NCT02289274|Eperisone|eperisone|mesh-list
2698776|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
2698777|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2698778|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2698779|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698780|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2698781|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698782|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2698783|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2698784|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698785|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
2698786|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
2698787|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
2698788|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2698789|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2698790|NCT02289274|Analgesics|analgesics|mesh-ancestor
2698791|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
2698792|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698793|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2698794|NCT02289378|Docetaxel|docetaxel|mesh-list
2698795|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
2698796|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698797|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
2698798|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
2698799|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
2698800|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698801|NCT02289391|Anesthetics|anesthetics|mesh-list
2698802|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698803|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698804|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2698805|NCT02289430|Ezetimibe|ezetimibe|mesh-list
2698806|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2192548|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192549|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192550|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
2192551|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2698807|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2698808|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
2698809|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698810|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2698811|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2698812|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698813|NCT02289482|Ritonavir|ritonavir|mesh-list
2698814|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
2698815|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2698816|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2698817|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
2698818|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698819|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698820|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2698821|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2698822|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
2698823|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2698824|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2698825|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2698826|NCT02289495|Ritonavir|ritonavir|mesh-list
2698827|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
2698828|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2698829|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2698830|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
2698831|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698832|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698833|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2698834|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2698835|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
2698836|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2698837|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2698838|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2698839|NCT02289547|Capecitabine|capecitabine|mesh-list
2698840|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2698841|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
2698842|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698843|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698844|NCT02289586|Fentanyl|fentanyl|mesh-list
2698845|NCT02289586|Midazolam|midazolam|mesh-list
2698846|NCT02289586|Remifentanil|remifentanil|mesh-list
2698847|NCT02289586|Dezocine|dezocine|mesh-list
2698848|NCT02289586|Propofol|propofol|mesh-list
2698849|NCT02289586|Rocuronium|rocuronium|mesh-list
2698850|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
2698851|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698852|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698853|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2698854|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2698855|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
2698856|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2698857|NCT02289586|Narcotics|narcotics|mesh-ancestor
2698858|NCT02289586|Analgesics|analgesics|mesh-ancestor
2698859|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
2698860|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698861|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2698862|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2698863|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2698864|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2698865|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
2698866|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
2698867|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698868|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698869|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2698870|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2698871|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2698872|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
2698873|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2698874|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
2698875|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2698876|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
2698877|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698878|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698879|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
2698880|NCT02289716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2698881|NCT02289716|Immunologic Factors|immunologic factors|mesh-ancestor
2698882|NCT02289716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698883|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
2698884|NCT02289768|Salicylates|salicylates|mesh-list
2698885|NCT02289768|Fluorouracil|fluorouracil|mesh-list
2698886|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
2698887|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698888|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2698889|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698890|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2698891|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
2698892|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698893|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2698894|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
2698895|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
2698896|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
2192552|NCT00003718|Temozolomide|temozolomide|mesh-list
2192553|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192554|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
2192555|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192556|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192557|NCT00003719|Irinotecan|irinotecan|mesh-list
2192558|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2192559|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192560|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192561|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192562|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698897|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2698898|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2698899|NCT02289768|Analgesics|analgesics|mesh-ancestor
2698900|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
2698901|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698902|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698903|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2698904|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2698905|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698906|NCT02289807|Cisplatin|cisplatin|mesh-list
2698907|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698908|NCT02289924|Aflibercept|aflibercept|mesh-list
2192563|NCT00003720|Semaxinib|semaxinib|mesh-list
2192564|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2192565|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2192566|NCT00003720|Growth Substances|growth substances|mesh-ancestor
2192567|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192568|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
2192569|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192570|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2698909|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2698910|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2698911|NCT02289924|Growth Substances|growth substances|mesh-ancestor
2698912|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698913|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
2698914|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698915|NCT02289937|Ropivacaine|ropivacaine|mesh-list
2698916|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
2698917|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
2698918|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698919|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698920|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
2698921|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698922|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
2698923|NCT02290002|Calcium|calcium|mesh-list
2698924|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2698925|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698926|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
2698927|NCT02290002|Coagulants|coagulants|mesh-ancestor
2698928|NCT02290054|Anesthetics|anesthetics|mesh-list
2698929|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698930|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698931|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
2192571|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192572|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192573|NCT00003723|Gemcitabine|gemcitabine|mesh-list
2192574|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192575|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
2192576|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192577|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698932|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
2192578|NCT00003723|Antiviral Agents|antiviral agents|mesh-ancestor
2192579|NCT00003723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192580|NCT00003723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192581|NCT00003723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192582|NCT00003723|Immunologic Factors|immunologic factors|mesh-ancestor
2192583|NCT00003723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192584|NCT00003725|Valrubicin|valrubicin|mesh-list
2192585|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192586|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192587|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192588|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698933|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698934|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2698935|NCT02290327|Pantoprazole|pantoprazole|mesh-list
2698936|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2698937|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2698938|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2698939|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698940|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698941|NCT02290431|Dexamethasone|dexamethasone|mesh-list
2698942|NCT02290431|Bortezomib|bortezomib|mesh-list
2698943|NCT02290431|Panobinostat|panobinostat|mesh-list
2698944|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698945|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
2698946|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
2698947|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698948|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698949|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2698950|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
2698951|NCT02290431|Hormones|hormones|mesh-ancestor
2698952|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2698953|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2698954|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698955|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2698956|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698957|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698958|NCT02290470|Dexamethasone|dexamethasone|mesh-list
2698959|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
2698960|NCT02290470|Paclitaxel|paclitaxel|mesh-list
2698961|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2698962|NCT02290470|Carboplatin|carboplatin|mesh-list
2698963|NCT02290470|Olanzapine|olanzapine|mesh-list
2698964|NCT02290470|Palonosetron|palonosetron|mesh-list
2698965|NCT02290470|BB 1101|bb 1101|mesh-list
2698966|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2698967|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698968|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
2698969|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
2698970|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
2698971|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2698972|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698973|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
2698974|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
2698975|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2698976|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2698977|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2192589|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192590|NCT00003727|Gemcitabine|gemcitabine|mesh-list
2192591|NCT00003727|Interferons|interferons|mesh-list
2192592|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
2192593|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
2192594|NCT00003727|Melphalan|melphalan|mesh-list
2192595|NCT00003727|Carmustine|carmustine|mesh-list
2192596|NCT00003727|Etoposide|etoposide|mesh-list
2192597|NCT00003727|Sargramostim|sargramostim|mesh-list
2192598|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2698978|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
2698979|NCT02290470|Hormones|hormones|mesh-ancestor
2698980|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2698981|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2698982|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
2698983|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2698984|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2698985|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2192599|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
2192600|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192601|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192602|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192603|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
2192604|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192605|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2698986|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2698987|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2698988|NCT02290470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2698989|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2698990|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2698991|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2698992|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
2698993|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2698994|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2698995|NCT02290717|Fluticasone|fluticasone|mesh-list
2698996|NCT02290717|Xhance|xhance|mesh-list
2698997|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2698998|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2698999|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
2699000|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699001|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699002|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2699003|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
2699004|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
2699005|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2699006|NCT02291055|Durvalumab|durvalumab|mesh-list
2699007|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2699008|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699009|NCT02291094|Lidocaine|lidocaine|mesh-list
2699010|NCT02291094|Remifentanil|remifentanil|mesh-list
2699011|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
2699012|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
2699013|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699014|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699015|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
2699016|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699017|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2699018|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2699019|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2699020|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2699021|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699022|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2699023|NCT02291094|Narcotics|narcotics|mesh-ancestor
2699024|NCT02291094|Analgesics|analgesics|mesh-ancestor
2699025|NCT02291211|Cisplatin|cisplatin|mesh-list
2699026|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699027|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2699028|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2699029|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2699030|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2699031|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699032|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699033|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699034|NCT02291341|Analgesics|analgesics|mesh-ancestor
2699035|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
2192606|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2192607|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192608|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
2192609|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
2192610|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192611|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192612|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192613|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192614|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192615|NCT00003728|Leucovorin|leucovorin|mesh-list
2192616|NCT00003728|Cytarabine|cytarabine|mesh-list
2192617|NCT00003728|Dexamethasone|dexamethasone|mesh-list
2192618|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
2192619|NCT00003728|Prednisolone|prednisolone|mesh-list
2699036|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699037|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
2699038|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2192620|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
2192621|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2192622|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2192623|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2192624|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
2699039|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
2699040|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2699041|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2699042|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2699043|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2699044|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699045|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699046|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699047|NCT02291367|Analgesics|analgesics|mesh-ancestor
2699048|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
2699049|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699050|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
2699051|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2699052|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
2699053|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
2699054|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2699055|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2699056|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2699057|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2192625|NCT00003728|Doxorubicin|doxorubicin|mesh-list
2192626|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2192627|NCT00003728|Methotrexate|methotrexate|mesh-list
2192628|NCT00003728|Etoposide|etoposide|mesh-list
2192629|NCT00003728|Vincristine|vincristine|mesh-list
2192630|NCT00003728|Daunorubicin|daunorubicin|mesh-list
2192631|NCT00003728|Asparaginase|asparaginase|mesh-list
2192632|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
2192633|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
2192634|NCT00003728|Thioguanine|thioguanine|mesh-list
2192635|NCT00003728|Vindesine|vindesine|mesh-list
2192636|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
2192637|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192638|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
2192639|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192640|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192641|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192642|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
2192643|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192644|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192645|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2192646|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2192647|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
2192648|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
2192649|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2192650|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2192651|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
2192652|NCT00003728|Hormones|hormones|mesh-ancestor
2192653|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2192654|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2192655|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2699058|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699059|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
2699060|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699061|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699062|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2699063|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699071|NCT02291471|T0001|t0001|mesh-list
2699072|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2699073|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2699074|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
2699075|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699076|NCT02291536|Dronabinol|dronabinol|mesh-list
2699077|NCT02291536|Cannabidiol|cannabidiol|mesh-list
2699078|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
2699079|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
2699080|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699081|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2699082|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2699083|NCT02291536|Analgesics|analgesics|mesh-ancestor
2699084|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
2192656|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192657|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192658|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192659|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2192660|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
2192661|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2192662|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192663|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
2192664|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
2192665|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2192666|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2192667|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192668|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
2699085|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699086|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2699087|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2699088|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699089|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699090|NCT02291536|Hormones|hormones|mesh-ancestor
2699091|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2699092|NCT02291562|Dronabinol|dronabinol|mesh-list
2192669|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192670|NCT00003728|Antidotes|antidotes|mesh-ancestor
2192671|NCT00003728|Protective Agents|protective agents|mesh-ancestor
2192672|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
2423453|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423454|NCT00822211|Vildagliptin|vildagliptin|mesh-list
2423455|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2423456|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423457|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2699093|NCT02291562|Cannabidiol|cannabidiol|mesh-list
2699094|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
2699095|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
2699096|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699097|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2699098|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2699099|NCT02291562|Analgesics|analgesics|mesh-ancestor
2699100|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
2699101|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699102|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2699103|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2699104|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699105|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699106|NCT02291562|Hormones|hormones|mesh-ancestor
2699107|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2699108|NCT02291666|Tolbutamide|tolbutamide|mesh-list
2699109|NCT02291666|Midazolam|midazolam|mesh-list
2699110|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
2699111|NCT02291666|Caffeine|caffeine|mesh-list
2699112|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
2699113|NCT02291666|Bupropion|bupropion|mesh-list
2699114|NCT02291666|Omeprazole|omeprazole|mesh-list
2699115|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2699116|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2699117|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699118|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699119|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2699120|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2699121|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2699122|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2699123|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
2699124|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
2699125|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
2699126|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
2699127|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699128|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699129|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2699130|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2699131|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2192673|NCT00003728|Vitamins|vitamins|mesh-ancestor
2423458|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
2423459|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423460|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423461|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
2423462|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2423463|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
2192674|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
2699132|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699133|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2699134|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2699135|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2699136|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2699137|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
2699138|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2699139|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
2699140|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2699141|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2699142|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2699143|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
2699144|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2699145|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2699146|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
2699147|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
2699148|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2699149|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2699150|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2699151|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2699152|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2699153|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699154|NCT02291705|Tramadol|tramadol|mesh-list
2699155|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2192675|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192676|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192677|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
2192678|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2192679|NCT00003728|Analgesics|analgesics|mesh-ancestor
2192680|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
2192681|NCT00003729|Cytarabine|cytarabine|mesh-list
2192682|NCT00003729|Fludarabine|fludarabine|mesh-list
2192683|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
2192684|NCT00003729|Idarubicin|idarubicin|mesh-list
2192685|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192686|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192687|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
2192688|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192689|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192690|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
2192691|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192692|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
2192693|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192694|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2192695|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192696|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192697|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192698|NCT00003730|Fluorouracil|fluorouracil|mesh-list
2192699|NCT00003730|Vinorelbine|vinorelbine|mesh-list
2192700|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
2192701|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192702|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192703|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699156|NCT02291705|Narcotics|narcotics|mesh-ancestor
2699157|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699158|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699159|NCT02291705|Analgesics|analgesics|mesh-ancestor
2699160|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
2699161|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699162|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2699163|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2699164|NCT02291796|Bezafibrate|bezafibrate|mesh-list
2699165|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2699166|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
2699167|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699168|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2699169|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
2699170|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2699171|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699172|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2699173|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192704|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192705|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
2699174|NCT02291887|Ranibizumab|ranibizumab|mesh-list
2699175|NCT02291887|Aflibercept|aflibercept|mesh-list
2699176|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2699177|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2699178|NCT02291887|Growth Substances|growth substances|mesh-ancestor
2699179|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699180|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
2699181|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699182|NCT02292069|Amlodipine|amlodipine|mesh-list
2699183|NCT02292069|Atorvastatin|atorvastatin|mesh-list
2699184|NCT02292069|Calcium|calcium|mesh-list
2699185|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2699186|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699187|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2699188|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2699189|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
2699190|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699191|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2699192|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2699193|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699194|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2699195|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2699196|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2699197|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
2699198|NCT02292121|Mannitol|mannitol|mesh-list
2699199|NCT02292121|Lactitol|lactitol|mesh-list
2699200|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2699201|NCT02292121|Diuretics|diuretics|mesh-ancestor
2699202|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
2699203|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699204|NCT02292121|Cathartics|cathartics|mesh-ancestor
2699205|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2699206|NCT02292173|Sorafenib|sorafenib|mesh-list
2699207|NCT02292173|Trametinib|trametinib|mesh-list
2699208|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699209|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2699210|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699211|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699212|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
2699213|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2699214|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699215|NCT02292238|Benphothiamine|benphothiamine|mesh-list
2699216|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2699217|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
2699218|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699219|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
2699220|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
2699221|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699222|NCT02292277|Ticagrelor|ticagrelor|mesh-list
2699223|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2699224|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2699225|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2699226|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2699227|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
2699228|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699229|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699230|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699231|NCT02292290|Pioglitazone|pioglitazone|mesh-list
2699232|NCT02292290|Liraglutide|liraglutide|mesh-list
2699233|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2699234|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699235|NCT02292290|Incretins|incretins|mesh-ancestor
2699236|NCT02292290|Hormones|hormones|mesh-ancestor
2699237|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2699238|NCT02292303|Zinc|zinc|mesh-list
2699239|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
2699240|NCT02292303|Trace Elements|trace elements|mesh-ancestor
2699241|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
2699242|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699243|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
2699244|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
2699245|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2699246|NCT02292303|Protective Agents|protective agents|mesh-ancestor
2699247|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2699248|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2699249|NCT02292459|Laxatives|laxatives|mesh-ancestor
2699250|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2699251|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
2699252|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2699253|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2699254|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2699255|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2699256|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699257|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
2699258|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699259|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699260|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2699261|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699262|NCT02292550|Ceritinib|ceritinib|mesh-list
2699263|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699264|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2699265|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699266|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699267|NCT02292667|Acetaminophen|acetaminophen|mesh-list
2699268|NCT02292667|Morphine|morphine|mesh-list
2699269|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2699270|NCT02292667|Narcotics|narcotics|mesh-ancestor
2699271|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699272|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699273|NCT02292667|Analgesics|analgesics|mesh-ancestor
2699274|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
2699275|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699276|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2699277|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
2699278|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
2699279|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
2699280|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2699281|NCT02292732|Trametinib|trametinib|mesh-list
2699282|NCT02292732|Norinyl|norinyl|mesh-list
2699283|NCT02292732|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2699284|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699285|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2699286|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699287|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699288|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2699289|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2699290|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2192706|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192707|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192708|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192709|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192710|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
2192711|NCT00003731|Temozolomide|temozolomide|mesh-list
2699291|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
2699292|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2699293|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699294|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2699295|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2699296|NCT02292732|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2699297|NCT02292732|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2699298|NCT02292966|Asunaprevir|asunaprevir|mesh-list
2699299|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
2699300|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699301|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699302|NCT02292979|Doxorubicin|doxorubicin|mesh-list
2699303|NCT02292979|Bleomycin|bleomycin|mesh-list
2699304|NCT02292979|Dacarbazine|dacarbazine|mesh-list
2699305|NCT02292979|Vinblastine|vinblastine|mesh-list
2699306|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2699307|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2699308|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699309|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2699310|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2699311|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699312|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699313|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2699314|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
2699315|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2699316|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
2699317|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
2699318|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
2699319|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2699320|NCT02293109|Leucovorin|leucovorin|mesh-list
2699321|NCT02293109|Cytarabine|cytarabine|mesh-list
2699322|NCT02293109|Dexamethasone|dexamethasone|mesh-list
2192712|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192713|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
2192714|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192715|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192716|NCT00003732|Paclitaxel|paclitaxel|mesh-list
2192717|NCT00003732|Carboplatin|carboplatin|mesh-list
2192718|NCT00003732|Topotecan|topotecan|mesh-list
2192719|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192720|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192721|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192722|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192723|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
2192724|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699323|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
2699324|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2699325|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2699326|NCT02293109|Prednisolone|prednisolone|mesh-list
2699327|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
2699328|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
2699329|NCT02293109|Rituximab|rituximab|mesh-list
2699330|NCT02293109|Doxorubicin|doxorubicin|mesh-list
2699331|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2699332|NCT02293109|Methotrexate|methotrexate|mesh-list
2699333|NCT02293109|Vincristine|vincristine|mesh-list
2699334|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2699335|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
2699336|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
2699337|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192725|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2192726|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192727|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192728|NCT00003733|Paclitaxel|paclitaxel|mesh-list
2192729|NCT00003733|Carboplatin|carboplatin|mesh-list
2192730|NCT00003733|Topotecan|topotecan|mesh-list
2192731|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192732|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699338|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
2699339|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699340|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2699341|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2699342|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
2699343|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699344|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699345|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2699346|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2699347|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
2699348|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
2699349|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699350|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2699351|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
2699352|NCT02293109|Hormones|hormones|mesh-ancestor
2699353|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2699354|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2699355|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2699356|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2699357|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2699358|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2699359|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699360|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2699361|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
2699362|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2699363|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2699364|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
2699365|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
2699366|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2699367|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2699368|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
2699369|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2699370|NCT02293109|Antidotes|antidotes|mesh-ancestor
2699371|NCT02293109|Protective Agents|protective agents|mesh-ancestor
2699372|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
2192733|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192734|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
2699373|NCT02293109|Vitamins|vitamins|mesh-ancestor
2699374|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
2699375|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2699376|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
2699377|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
2699378|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
2699379|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2699380|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
2699381|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2699382|NCT02293148|Glycine|glycine|mesh-list
2699383|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2699384|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2699385|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2699386|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2699387|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699388|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699389|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699390|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2699391|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
2699392|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2699393|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699394|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2699395|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2699396|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2699397|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
2699398|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699399|NCT02293187|Vitamin D|vitamin d|mesh-list
2699400|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
2699401|NCT02293187|Vitamins|vitamins|mesh-ancestor
2699402|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
2699403|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699404|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2699405|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2699406|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
2699407|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
2699408|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2699409|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699410|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699411|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
2699412|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2699413|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699414|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699415|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
2699416|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
2699417|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
2699418|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699419|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699420|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
2699421|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699422|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
2699423|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2699424|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699425|NCT02293447|Lidocaine|lidocaine|mesh-list
2699426|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
2699427|NCT02293447|Anesthetics|anesthetics|mesh-list
2699428|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699429|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699430|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
2699431|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699432|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2699433|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2699434|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2699435|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2699436|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699437|NCT02293525|Morphine|morphine|mesh-list
2699438|NCT02293525|Oxycodone|oxycodone|mesh-list
2699439|NCT02293525|Ropivacaine|ropivacaine|mesh-list
2699440|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2699441|NCT02293525|Narcotics|narcotics|mesh-ancestor
2699442|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699443|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699444|NCT02293525|Analgesics|analgesics|mesh-ancestor
2699445|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
2699446|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699447|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
2699448|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
2192735|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
2192736|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192737|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2192738|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192739|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192740|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2192741|NCT00003734|Flutamide|flutamide|mesh-list
2192742|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
2192743|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2699449|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
2699450|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2699451|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699452|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
2699453|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
2699454|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2699455|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
2699456|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699457|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2699458|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2699459|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2699460|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2699461|NCT02293590|Analgesics|analgesics|mesh-ancestor
2699462|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
2699463|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699464|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2699465|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2699466|NCT02293655|Methylphenidate|methylphenidate|mesh-list
2699467|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2699468|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699469|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2699470|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2699471|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2192744|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
2192745|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2192746|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192747|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2192748|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2699472|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699473|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
2699474|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699475|NCT02293668|Letrozole|letrozole|mesh-list
2699476|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699477|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2699478|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2699479|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699480|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699481|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2699482|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
2699483|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2699484|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699485|NCT02293681|Infliximab|infliximab|mesh-list
2699486|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
2699487|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2699488|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2699489|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2699490|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
2699491|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2699492|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2699493|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2699494|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
2699495|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2699496|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699497|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2699498|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2699499|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2699500|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2699501|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699502|NCT02293785|Oxycodone|oxycodone|mesh-list
2699503|NCT02293785|Naloxone|naloxone|mesh-list
2699504|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2699505|NCT02293785|Narcotics|narcotics|mesh-ancestor
2699506|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699507|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699508|NCT02293785|Analgesics|analgesics|mesh-ancestor
2699509|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
2699510|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699511|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2699512|NCT02293824|Caffeine|caffeine|mesh-list
2699513|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
2699514|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699515|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2699516|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192749|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192750|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
2192751|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
2192752|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2192753|NCT00003735|Topotecan|topotecan|mesh-list
2192754|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
2192755|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2192756|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192757|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192758|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192759|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192760|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192761|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
2192762|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192763|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2192764|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
2192765|NCT00003739|Lenograstim|lenograstim|mesh-list
2192766|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2192767|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
2192768|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192769|NCT00003740|Trastuzumab|trastuzumab|mesh-list
2192770|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2192771|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192772|NCT00003741|Antibodies|antibodies|mesh-list
2192773|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2192774|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
2192775|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192776|NCT00003742|Paclitaxel|paclitaxel|mesh-list
2192777|NCT00003742|Irinotecan|irinotecan|mesh-list
2192778|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192779|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192780|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192781|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192782|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
2192783|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192784|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2699517|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2699518|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699519|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2699520|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2699521|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
2699522|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699523|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2699524|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2699525|NCT02293889|Vitamin D|vitamin d|mesh-list
2699526|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
2699527|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
2699528|NCT02293889|Vitamins|vitamins|mesh-list
2699529|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
2699530|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699531|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2192785|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192786|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192787|NCT00003743|Aldesleukin|aldesleukin|mesh-list
2192788|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192789|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2699532|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2699533|NCT02293954|Antibodies|antibodies|mesh-list
2699534|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2699535|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
2699536|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699537|NCT02293980|Nivolumab|nivolumab|mesh-list
2699538|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2699539|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699540|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2192790|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2192791|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
2699541|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699542|NCT02294006|Metformin|metformin|mesh-list
2699543|NCT02294006|Everolimus|everolimus|mesh-list
2699544|NCT02294006|Octreotide|octreotide|mesh-list
2699545|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2699546|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699547|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699548|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2699549|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
2699550|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2699551|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2699552|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2699553|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
2699554|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699555|NCT02294071|Acetaminophen|acetaminophen|mesh-list
2699556|NCT02294071|Ibuprofen|ibuprofen|mesh-list
2699557|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2699558|NCT02294071|Analgesics|analgesics|mesh-ancestor
2699559|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
2699560|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699561|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699562|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
2699563|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2699564|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2699565|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2699566|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2699567|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699568|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699569|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2699570|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2699571|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699572|NCT02294084|Incretins|incretins|mesh-ancestor
2699573|NCT02294084|Hormones|hormones|mesh-ancestor
2699574|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2699575|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2699576|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
2699577|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699578|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699579|NCT02294110|Anesthetics|anesthetics|mesh-list
2699580|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699581|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699582|NCT02294162|Ketamine|ketamine|mesh-list
2699583|NCT02294162|Analgesics|analgesics|mesh-ancestor
2699584|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
2699585|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699586|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699587|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2699588|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2699589|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
2699590|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
2699591|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699592|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2699593|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2699594|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699595|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699596|NCT02294240|Folic Acid|folic acid|mesh-list
2699597|NCT02294240|Hematinics|hematinics|mesh-ancestor
2699598|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
2699599|NCT02294240|Vitamins|vitamins|mesh-ancestor
2699600|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
2699601|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699602|NCT02294266|Ethanol|ethanol|mesh-list
2699603|NCT02294266|Methamphetamine|methamphetamine|mesh-list
2192792|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192793|NCT00003744|Gemcitabine|gemcitabine|mesh-list
2192794|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192795|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
2192796|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192797|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192798|NCT00003744|Antiviral Agents|antiviral agents|mesh-ancestor
2192799|NCT00003744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192800|NCT00003744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192801|NCT00003744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192802|NCT00003744|Immunologic Factors|immunologic factors|mesh-ancestor
2699604|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2699605|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2699606|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699607|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699608|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2699609|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
2699610|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
2699611|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699612|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
2192803|NCT00003744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192804|NCT00003745|Topotecan|topotecan|mesh-list
2192805|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2192806|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192807|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192808|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192809|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192810|NCT00003746|Cladribine|cladribine|mesh-list
2192811|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192812|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192813|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
2192814|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699613|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699614|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699615|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
2192815|NCT00003747|Carboplatin|carboplatin|mesh-list
2192816|NCT00003747|Temozolomide|temozolomide|mesh-list
2192817|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192818|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192819|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
2192820|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192821|NCT00003748|Irinotecan|irinotecan|mesh-list
2192822|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2192823|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192824|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192825|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192826|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192827|NCT00003751|Penicillamine|penicillamine|mesh-list
2192828|NCT00003751|Antidotes|antidotes|mesh-ancestor
2192829|NCT00003751|Protective Agents|protective agents|mesh-ancestor
2699616|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2699617|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2699618|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2699619|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2699620|NCT02294279|Beclomethasone|beclomethasone|mesh-list
2699621|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2699622|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
2699623|NCT02294279|Hormones|hormones|mesh-ancestor
2699624|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2699625|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699626|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2699627|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
2699628|NCT02294292|Carvedilol|carvedilol|mesh-list
2699629|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2699630|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2699631|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
2699632|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699633|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699634|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699635|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2699636|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
2699637|NCT02294292|Protective Agents|protective agents|mesh-ancestor
2699638|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2699639|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2699640|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2699641|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
2699642|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2699643|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2699644|NCT02294305|Vortioxetine|vortioxetine|mesh-list
2699645|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
2699646|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2699647|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2699648|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2699649|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699650|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192830|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192831|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
2192832|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
2192833|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192834|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192835|NCT00003752|Bexarotene|bexarotene|mesh-list
2699651|NCT02294305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2699652|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2699653|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2699654|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699655|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699656|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
2699657|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2699658|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2699659|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2699660|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2699661|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
2699662|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2699663|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
2699664|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699665|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2699666|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2699667|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
2699668|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699669|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699670|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2699671|NCT02294357|Dexamethasone|dexamethasone|mesh-list
2699672|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
2699673|NCT02294357|Prednisone|prednisone|mesh-list
2699674|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
2699675|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2699676|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2699677|NCT02294357|Prednisolone|prednisolone|mesh-list
2699678|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
2699679|NCT02294357|Lenalidomide|lenalidomide|mesh-list
2699680|NCT02294357|Pomalidomide|pomalidomide|mesh-list
2699681|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2699682|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
2699683|NCT02294357|BB 1101|bb 1101|mesh-list
2699684|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2699685|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
2699686|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
2699687|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699688|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699689|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2699690|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
2699691|NCT02294357|Hormones|hormones|mesh-ancestor
2699692|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2699693|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2699694|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699695|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
2699696|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699697|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699698|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
2699699|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2699700|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2699701|NCT02294357|Growth Substances|growth substances|mesh-ancestor
2699702|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
2192836|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192837|NCT00003753|Dexamethasone|dexamethasone|mesh-list
2192838|NCT00003753|Irinotecan|irinotecan|mesh-list
2192839|NCT00003753|Floxuridine|floxuridine|mesh-list
2192840|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2699703|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2699704|NCT02294357|Protective Agents|protective agents|mesh-ancestor
2699705|NCT02294539|Losartan|losartan|mesh-list
2699706|NCT02294539|Amlodipine|amlodipine|mesh-list
2699707|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2699708|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2699709|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2699710|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2699711|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699712|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2699713|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192841|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
2699714|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
2699715|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2699716|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2699717|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2699718|NCT02294539|Diuretics|diuretics|mesh-ancestor
2699719|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
2699720|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2699721|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
2699722|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
2699723|NCT02294552|Busulfan|busulfan|mesh-list
2699724|NCT02294552|Fludarabine|fludarabine|mesh-list
2699725|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
2699726|NCT02294552|Tacrolimus|tacrolimus|mesh-list
2699727|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2699728|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
2699729|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699730|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2699731|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2699732|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
2699733|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699734|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699735|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2699736|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2699737|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
2699738|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2699739|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699740|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2699741|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2699742|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
2699743|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2192842|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
2192843|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2192844|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192845|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2192846|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
2192847|NCT00003753|Hormones|hormones|mesh-ancestor
2192848|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2192849|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2192850|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699744|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2699745|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
2699746|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2699747|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
2699748|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2699749|NCT02294591|Expectorants|expectorants|mesh-ancestor
2699750|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
2699751|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2699752|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
2699753|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699754|NCT02294591|Protective Agents|protective agents|mesh-ancestor
2699755|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699756|NCT02294591|Antidotes|antidotes|mesh-ancestor
2699757|NCT02294617|Nicotine|nicotine|mesh-list
2699758|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2699759|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
2699760|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699761|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699762|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2699763|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2699764|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
2699765|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699766|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699767|NCT02294643|Aspirin|aspirin|mesh-list
2699768|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
2699769|NCT02294643|Clopidogrel|clopidogrel|mesh-list
2699770|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2699771|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2699772|NCT02294643|Analgesics|analgesics|mesh-ancestor
2699773|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
2699774|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699775|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699776|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2699777|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2699778|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2699779|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2699780|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699781|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2699782|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2699783|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699784|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
2699785|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2699786|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2699787|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2699788|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
2699789|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699790|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2699791|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
2699792|NCT02294656|Triamcinolone|triamcinolone|mesh-list
2699793|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2699794|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2699795|NCT02294656|Ranibizumab|ranibizumab|mesh-list
2699796|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2192851|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2192852|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192853|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192854|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192855|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192856|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
2192857|NCT00003754|Thalidomide|thalidomide|mesh-list
2192858|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
2192859|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192860|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
2192861|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192862|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192863|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192864|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
2192865|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192866|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192867|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2192868|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
2192869|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2192870|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192871|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2192872|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2699797|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2699798|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2699799|NCT02294656|Growth Substances|growth substances|mesh-ancestor
2699800|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699801|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
2699802|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699803|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2699804|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
2699805|NCT02294656|Hormones|hormones|mesh-ancestor
2699806|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2699807|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192873|NCT00003754|Growth Substances|growth substances|mesh-ancestor
2699808|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
2699809|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699810|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699811|NCT02294838|Citric Acid|citric acid|mesh-list
2699812|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
2699813|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
2699814|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2699815|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
2699816|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
2699817|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699818|NCT02294955|Amiodarone|amiodarone|mesh-list
2699819|NCT02294955|Sotalol|sotalol|mesh-list
2699820|NCT02294955|Flecainide|flecainide|mesh-list
2699821|NCT02294955|Dronedarone|dronedarone|mesh-list
2699822|NCT02294955|Propafenone|propafenone|mesh-list
2699823|NCT02294955|Disopyramide|disopyramide|mesh-list
2699824|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2699825|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
2699826|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2699827|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2699828|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699829|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2699830|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2699831|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2699832|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699833|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2699834|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2699835|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2699836|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2699837|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2699838|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
2699839|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699840|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699841|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
2699842|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
2699843|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699844|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2699845|NCT02294994|Tirofiban|tirofiban|mesh-list
2699846|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2699847|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2699848|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699849|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2699850|NCT02295046|Amlodipine|amlodipine|mesh-list
2699851|NCT02295046|Atorvastatin|atorvastatin|mesh-list
2699852|NCT02295046|Calcium|calcium|mesh-list
2699853|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2699854|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699855|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2699856|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2699857|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
2699858|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699859|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2699860|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2699861|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699862|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2699863|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2699864|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2699865|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
2699866|NCT02295124|Oxycodone|oxycodone|mesh-list
2699867|NCT02295124|Hydromorphone|hydromorphone|mesh-list
2699868|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2699869|NCT02295124|Narcotics|narcotics|mesh-ancestor
2699870|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699871|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699872|NCT02295124|Analgesics|analgesics|mesh-ancestor
2699873|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
2699874|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699875|NCT02295150|Nadroparin|nadroparin|mesh-list
2699876|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
2699877|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2699878|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2192874|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
2192875|NCT00003757|Rituximab|rituximab|mesh-list
2192876|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2192877|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192878|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
2699879|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699880|NCT02295189|Triamcinolone|triamcinolone|mesh-list
2699881|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2699882|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2699883|NCT02295189|Ketorolac|ketorolac|mesh-list
2699884|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2699885|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2699886|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2699887|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
2699888|NCT02295189|Hormones|hormones|mesh-ancestor
2699889|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2699890|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699891|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2699892|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
2699893|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699894|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699895|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2699896|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2699897|NCT02295189|Analgesics|analgesics|mesh-ancestor
2699898|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
2699899|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699900|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2699901|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2699902|NCT02295475|Warfarin|warfarin|mesh-list
2699903|NCT02295475|Apixaban|apixaban|mesh-list
2699904|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
2699905|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2699906|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
2699907|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2699908|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
2699909|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699910|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699911|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
2699912|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2699913|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
2699914|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699915|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699916|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2699917|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
2699918|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2699919|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
2699920|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699921|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699922|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2699923|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
2699924|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
2699925|NCT02295566|Protective Agents|protective agents|mesh-ancestor
2192879|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192880|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192881|NCT00003758|Cytarabine|cytarabine|mesh-list
2192882|NCT00003758|Idarubicin|idarubicin|mesh-list
2192883|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192884|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
2192885|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192886|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192887|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
2192888|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192889|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192890|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
2192891|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192892|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2192893|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192894|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192895|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192896|NCT00003759|Valrubicin|valrubicin|mesh-list
2192897|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
2192898|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2699926|NCT02295709|Dexamethasone|dexamethasone|mesh-list
2699927|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
2699928|NCT02295709|BB 1101|bb 1101|mesh-list
2699929|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2699930|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
2699931|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
2699932|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699933|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699934|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2699935|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
2699936|NCT02295709|Hormones|hormones|mesh-ancestor
2699937|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2192899|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
2192900|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192901|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192902|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192903|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192904|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192905|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192906|NCT00003760|Irofulven|irofulven|mesh-list
2192907|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192908|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
2192909|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192910|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699938|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2699939|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699940|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
2699941|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699942|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192911|NCT00003762|Gemcitabine|gemcitabine|mesh-list
2192912|NCT00003762|Docetaxel|docetaxel|mesh-list
2192913|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192914|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
2192915|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699943|NCT02295722|Gemcitabine|gemcitabine|mesh-list
2699944|NCT02295722|Melphalan|melphalan|mesh-list
2699945|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2699946|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
2699947|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699948|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2699949|NCT02295722|Antiviral Agents|antiviral agents|mesh-ancestor
2699950|NCT02295722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2699951|NCT02295722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699952|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2699953|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
2699954|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699955|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2699956|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
2699957|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2699958|NCT02295748|Deflazacort|deflazacort|mesh-list
2699959|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2699960|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2699961|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
2699962|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699963|NCT02295787|Ketamine|ketamine|mesh-list
2699964|NCT02295787|Analgesics|analgesics|mesh-ancestor
2699965|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
2699966|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699967|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699968|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2699969|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2699970|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
2699971|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
2699972|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2699973|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2699974|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2699975|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2699976|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699977|NCT02295826|Aspirin|aspirin|mesh-list
2699978|NCT02295826|Dabigatran|dabigatran|mesh-list
2699979|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2699980|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2699981|NCT02295826|Analgesics|analgesics|mesh-ancestor
2699982|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
2699983|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2699984|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2699985|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2699986|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2699987|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2699988|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2699989|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2699990|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2699991|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2699992|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2699993|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
2699994|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
2699995|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2699996|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
2699997|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
2699998|NCT02295852|Calcium|calcium|mesh-list
2699999|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2700000|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700001|NCT02295865|Toreforant|toreforant|mesh-list
2700002|NCT02295865|Histamine Antagonists|histamine antagonists|mesh-ancestor
2700003|NCT02295865|Histamine Agents|histamine agents|mesh-ancestor
2700004|NCT02295865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700005|NCT02295865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700006|NCT02295865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700007|NCT02295930|Bevacizumab|bevacizumab|mesh-list
2192916|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192917|NCT00003762|Antiviral Agents|antiviral agents|mesh-ancestor
2192918|NCT00003762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192919|NCT00003762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192920|NCT00003762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192921|NCT00003762|Immunologic Factors|immunologic factors|mesh-ancestor
2700008|NCT02295930|Cetuximab|cetuximab|mesh-list
2700009|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2700010|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700011|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2700012|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2700013|NCT02295930|Growth Substances|growth substances|mesh-ancestor
2700014|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700015|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
2700016|NCT02296021|Amoxicillin|amoxicillin|mesh-list
2700017|NCT02296021|Clarithromycin|clarithromycin|mesh-list
2700018|NCT02296021|Esomeprazole|esomeprazole|mesh-list
2700019|NCT02296021|Bismuth|bismuth|mesh-list
2700020|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2700021|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700022|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2700023|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2700024|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2700025|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700026|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700027|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2700028|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2700029|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2700030|NCT02296021|Antacids|antacids|mesh-ancestor
2700031|NCT02296047|Bromides|bromides|mesh-list
2700032|NCT02296047|Albuterol|albuterol|mesh-list
2700033|NCT02296047|Ipratropium|ipratropium|mesh-list
2700034|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
2700035|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2700036|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
2700037|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700038|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700039|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2700040|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
2700041|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
2700042|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2700043|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2700044|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2700045|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2700046|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
2700047|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700048|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700049|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2700050|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
2700051|NCT02296073|Fentanyl|fentanyl|mesh-list
2700052|NCT02296073|Midazolam|midazolam|mesh-list
2700053|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
2700054|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2700055|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700056|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700057|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2700058|NCT02296073|Analgesics|analgesics|mesh-ancestor
2700059|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
2700060|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700061|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2700062|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2700063|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2700064|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
2700065|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700066|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700067|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2700068|NCT02296073|Narcotics|narcotics|mesh-ancestor
2700069|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2700070|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2700071|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
2700072|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
2700073|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2700074|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2700075|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2700076|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
2700077|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
2700078|NCT02296203|Irinotecan|irinotecan|mesh-list
2700079|NCT02296203|Cetuximab|cetuximab|mesh-list
2700080|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2700081|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2700082|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700083|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700084|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700085|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2700086|NCT02296229|Androgens|androgens|mesh-list
2700087|NCT02296229|Hormones|hormones|mesh-ancestor
2700088|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2700089|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700090|NCT02296281|Pirfenidone|pirfenidone|mesh-list
2700091|NCT02296281|Analgesics|analgesics|mesh-ancestor
2192922|NCT00003762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192923|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
2192924|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
2192925|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
2192926|NCT00003763|Folic Acid|folic acid|mesh-list
2192927|NCT00003763|Hematinics|hematinics|mesh-ancestor
2192928|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
2192929|NCT00003763|Vitamins|vitamins|mesh-ancestor
2192930|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
2700092|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
2700093|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700094|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700095|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2700096|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2700097|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2700098|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2700099|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700100|NCT02296333|Ondansetron|ondansetron|mesh-list
2700101|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
2700102|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
2700103|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700104|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700105|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2700106|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
2700107|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
2700108|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2700109|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
2700110|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700111|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700112|NCT02296333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2700113|NCT02296333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2700114|NCT02296333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700115|NCT02296333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2700116|NCT02296333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2700117|NCT02296359|Vaccines|vaccines|mesh-list
2700118|NCT02296359|Immunologic Factors|immunologic factors|mesh-ancestor
2700119|NCT02296359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700120|NCT02296398|Romidepsin|romidepsin|mesh-list
2700121|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2700122|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700123|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
2700124|NCT02296411|Bromides|bromides|mesh-list
2700125|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
2700126|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2700127|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2700128|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2700129|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
2700130|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700131|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700132|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700133|NCT02296463|Vaccines|vaccines|mesh-list
2700134|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
2700135|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192931|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192932|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
2192933|NCT00003764|Fludarabine|fludarabine|mesh-list
2192934|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
2192935|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2192936|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
2700136|NCT02296567|Bevacizumab|bevacizumab|mesh-list
2700137|NCT02296567|Ranibizumab|ranibizumab|mesh-list
2700138|NCT02296567|Aflibercept|aflibercept|mesh-list
2700139|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2700140|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192937|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192938|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2192939|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192940|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
2192941|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192942|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700141|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2700142|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2700143|NCT02296567|Growth Substances|growth substances|mesh-ancestor
2700144|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700145|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
2700146|NCT02296645|Ethanol|ethanol|mesh-list
2700147|NCT02296645|Chlorhexidine|chlorhexidine|mesh-list
2700148|NCT02296645|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2700149|NCT02296645|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2700150|NCT02296645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2192943|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2192944|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2192945|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
2192946|NCT00003765|Carmustine|carmustine|mesh-list
2192947|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2192948|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2192949|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
2192950|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192951|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192952|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192953|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2192954|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192955|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192956|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192957|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
2192958|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2192959|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192960|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
2192961|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192962|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192963|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192964|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2192965|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2192966|NCT00003771|Norethindrone|norethindrone|mesh-list
2192967|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
2192968|NCT00003771|Estradiol|estradiol|mesh-list
2192969|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2192970|NCT00003771|Estrogens|estrogens|mesh-ancestor
2192971|NCT00003771|Hormones|hormones|mesh-ancestor
2192972|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2192973|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192974|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2192975|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
2192976|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2192977|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2192978|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2192979|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2192980|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2192981|NCT00003775|Leflunomide|leflunomide|mesh-list
2192982|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2192983|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192984|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2700151|NCT02296645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700152|NCT02296645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700153|NCT02296645|Disinfectants|disinfectants|mesh-ancestor
2700154|NCT02296645|Dermatologic Agents|dermatologic agents|mesh-ancestor
2700155|NCT02296671|Leucovorin|leucovorin|mesh-list
2700156|NCT02296671|Fluorouracil|fluorouracil|mesh-list
2700157|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
2700158|NCT02296671|Pemetrexed|pemetrexed|mesh-list
2700159|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
2700160|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700161|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2700162|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700163|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2700164|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
2700165|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700166|NCT02296671|Antidotes|antidotes|mesh-ancestor
2192985|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
2192986|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2192987|NCT00003776|Leucovorin|leucovorin|mesh-list
2192988|NCT00003776|Trimetrexate|trimetrexate|mesh-list
2192989|NCT00003776|Doxorubicin|doxorubicin|mesh-list
2192990|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2192991|NCT00003776|Methotrexate|methotrexate|mesh-list
2700167|NCT02296671|Protective Agents|protective agents|mesh-ancestor
2700168|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
2700169|NCT02296671|Vitamins|vitamins|mesh-ancestor
2700170|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
2700171|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700172|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2700173|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2700174|NCT02296684|Cisplatin|cisplatin|mesh-list
2700175|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
2700176|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700177|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2700178|NCT02296723|Valganciclovir|valganciclovir|mesh-list
2700179|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
2700180|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700181|NCT02296749|Sirolimus|sirolimus|mesh-list
2700182|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2700183|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700184|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2700185|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700186|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
2700187|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2700188|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
2192992|NCT00003776|Ifosfamide|ifosfamide|mesh-list
2192993|NCT00003776|Calcium|calcium|mesh-list
2192994|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
2700189|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700190|NCT02296762|Sirolimus|sirolimus|mesh-list
2700191|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2700192|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700193|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2700194|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700195|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
2700196|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2700197|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
2700198|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700220|NCT02296996|Trametinib|trametinib|mesh-list
2700221|NCT02296996|Dabrafenib|dabrafenib|mesh-list
2700222|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700223|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2700224|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700225|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2192995|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2192996|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2192997|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2192998|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2192999|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193000|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193001|NCT00003776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2193002|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193003|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2193004|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
2193005|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2193006|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193007|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
2193008|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
2193009|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2193010|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2700231|NCT02297204|Aflibercept|aflibercept|mesh-list
2700232|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2700233|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2193011|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
2193012|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193013|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2193014|NCT00003776|Antidotes|antidotes|mesh-ancestor
2193015|NCT00003776|Protective Agents|protective agents|mesh-ancestor
2193016|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
2193017|NCT00003776|Vitamins|vitamins|mesh-ancestor
2193018|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
2193019|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193020|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
2193021|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
2193022|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700234|NCT02297204|Growth Substances|growth substances|mesh-ancestor
2700235|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700236|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
2700237|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700238|NCT02297217|Paclitaxel|paclitaxel|mesh-list
2700239|NCT02297217|Carboplatin|carboplatin|mesh-list
2700240|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2700241|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700242|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
2700243|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
2700244|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
2700245|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700246|NCT02297386|Testosterone|testosterone|mesh-list
2700247|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
2700248|NCT02297386|Androgens|androgens|mesh-ancestor
2700249|NCT02297386|Hormones|hormones|mesh-ancestor
2700250|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2700251|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700252|NCT02297477|Artesunate|artesunate|mesh-list
2700253|NCT02297477|Atovaquone|atovaquone|mesh-list
2700254|NCT02297477|Proguanil|proguanil|mesh-list
2700255|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
2700256|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
2700257|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2700258|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2700259|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700260|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193034|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
2193035|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193036|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193037|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193038|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193039|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193040|NCT00003780|Gemcitabine|gemcitabine|mesh-list
2193041|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193042|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
2193043|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193044|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193045|NCT00003780|Antiviral Agents|antiviral agents|mesh-ancestor
2193046|NCT00003780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193047|NCT00003780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193048|NCT00003780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193049|NCT00003780|Immunologic Factors|immunologic factors|mesh-ancestor
2193050|NCT00003780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700261|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
2700262|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
2700263|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2193051|NCT00003781|Docetaxel|docetaxel|mesh-list
2700264|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
2700265|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700266|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700267|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
2700268|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2700269|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2700270|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700271|NCT02297568|Vitamin D|vitamin d|mesh-list
2700272|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
2700273|NCT02297568|Vitamins|vitamins|mesh-ancestor
2700274|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
2700275|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700276|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2700277|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2700278|NCT02297594|Ziresovir|ziresovir|mesh-list
2700279|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
2700280|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700281|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
2700282|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2700283|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700284|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2700285|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700286|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2700287|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
2700288|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2700289|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2700290|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2700291|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700292|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700293|NCT02297854|Valganciclovir|valganciclovir|mesh-list
2193052|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193053|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193054|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193055|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193056|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193057|NCT00003783|Leucovorin|leucovorin|mesh-list
2193058|NCT00003783|Cytarabine|cytarabine|mesh-list
2193059|NCT00003783|Dexamethasone|dexamethasone|mesh-list
2193060|NCT00003783|Prednisone|prednisone|mesh-list
2700294|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
2700295|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700296|NCT02297906|Ketorolac|ketorolac|mesh-list
2700297|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2700298|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2700299|NCT02297906|Analgesics|analgesics|mesh-ancestor
2700300|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
2700301|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700302|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700303|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2700304|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2700305|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2700306|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193061|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
2193062|NCT00003783|Methotrexate|methotrexate|mesh-list
2193063|NCT00003783|Etoposide|etoposide|mesh-list
2193064|NCT00003783|Vincristine|vincristine|mesh-list
2700307|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700308|NCT02297945|Metyrapone|metyrapone|mesh-list
2700309|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
2700310|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700311|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700312|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
2700313|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2700314|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700315|NCT02298010|Capecitabine|capecitabine|mesh-list
2700316|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
2700317|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2700318|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
2700319|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700320|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700321|NCT02298062|Infliximab|infliximab|mesh-list
2700322|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
2700323|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2193065|NCT00003783|Daunorubicin|daunorubicin|mesh-list
2193066|NCT00003783|Asparaginase|asparaginase|mesh-list
2700324|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2700325|NCT02298088|Clopidogrel|clopidogrel|mesh-list
2700326|NCT02298088|Ticagrelor|ticagrelor|mesh-list
2700327|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2700328|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2700329|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2700330|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2700331|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
2700332|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700333|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700334|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700335|NCT02298101|Edetic Acid|edetic acid|mesh-list
2700336|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
2700337|NCT02298101|Antidotes|antidotes|mesh-ancestor
2700338|NCT02298101|Protective Agents|protective agents|mesh-ancestor
2700339|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700340|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
2700341|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
2700342|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700343|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2700344|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
2700345|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2700346|NCT02298153|Atezolizumab|atezolizumab|mesh-list
2700347|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700348|NCT02298166|Cytarabine|cytarabine|mesh-list
2700349|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
2700350|NCT02298166|Crenolanib|crenolanib|mesh-list
2700351|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2700352|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
2700353|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700354|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700355|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
2700356|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700357|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2700358|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
2700359|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700360|NCT02298166|Analgesics|analgesics|mesh-ancestor
2700361|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
2700362|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700363|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2700364|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193067|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
2193068|NCT00003783|Idarubicin|idarubicin|mesh-list
2193069|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
2193070|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2700365|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700366|NCT02298205|Beclomethasone|beclomethasone|mesh-list
2700367|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2700368|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
2700369|NCT02298205|Hormones|hormones|mesh-ancestor
2700370|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2700371|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700372|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2700373|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
2700374|NCT02298218|Meloxicam|meloxicam|mesh-list
2700375|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2700376|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2700377|NCT02298218|Analgesics|analgesics|mesh-ancestor
2700378|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
2193071|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
2193072|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193073|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193074|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193075|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
2193076|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193077|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193078|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2193079|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2193080|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
2193081|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
2193082|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2193083|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2193084|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
2193085|NCT00003783|Hormones|hormones|mesh-ancestor
2193086|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2193087|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2193088|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2700379|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700380|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700381|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2700382|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2700383|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2700384|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2700385|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700386|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193089|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
2193090|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2193091|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193092|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
2193093|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
2193094|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193095|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2193096|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2193097|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193098|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2193099|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193100|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
2193101|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193102|NCT00003783|Antidotes|antidotes|mesh-ancestor
2193103|NCT00003783|Protective Agents|protective agents|mesh-ancestor
2193104|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
2193105|NCT00003783|Vitamins|vitamins|mesh-ancestor
2193106|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
2193107|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193108|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193109|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193110|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2193111|NCT00003784|Prednisone|prednisone|mesh-list
2193112|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
2193113|NCT00003784|Doxorubicin|doxorubicin|mesh-list
2193114|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2193115|NCT00003784|Vincristine|vincristine|mesh-list
2193116|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
2700411|NCT02298283|Prednisone|prednisone|mesh-list
2700412|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
2700413|NCT02298283|Doxorubicin|doxorubicin|mesh-list
2700414|NCT02298283|Etoposide|etoposide|mesh-list
2193117|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193118|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
2193119|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193120|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193121|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193122|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
2193123|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700415|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2700416|NCT02298283|Vincristine|vincristine|mesh-list
2700417|NCT02298283|Bleomycin|bleomycin|mesh-list
2700418|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2193124|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193125|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2700419|NCT02298283|Procarbazine|procarbazine|mesh-list
2700420|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193126|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2193127|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2193128|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193129|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193130|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2193131|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
2193132|NCT00003784|Hormones|hormones|mesh-ancestor
2193133|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2193134|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2193135|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2700421|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
2700422|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700423|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2700424|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2700425|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
2700426|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700427|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700428|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2700429|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2700430|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2700431|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2700432|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700433|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2700434|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
2700435|NCT02298283|Hormones|hormones|mesh-ancestor
2700436|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2700437|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2700438|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2700439|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
2700440|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
2700441|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
2700442|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2700443|NCT02298335|Prednisone|prednisone|mesh-list
2700444|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2700445|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
2700446|NCT02298335|Hormones|hormones|mesh-ancestor
2700447|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2700448|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700449|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2700450|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700451|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
2700452|NCT02298348|Sorafenib|sorafenib|mesh-list
2700453|NCT02298348|Topotecan|topotecan|mesh-list
2700454|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2700455|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
2700456|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700457|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2700458|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2700459|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
2700460|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700461|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700462|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2700463|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2700464|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700465|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2700466|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2700467|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2700468|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
2700469|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700470|NCT02298530|Caffeine|caffeine|mesh-list
2700471|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2700472|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700473|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2700474|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700475|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700476|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2700477|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2700478|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
2700479|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700480|NCT02298582|Fentanyl|fentanyl|mesh-list
2700481|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2700482|NCT02298582|Narcotics|narcotics|mesh-ancestor
2700483|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700484|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700485|NCT02298582|Analgesics|analgesics|mesh-ancestor
2700486|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
2700487|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700488|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2700489|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2700490|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
2700491|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
2700492|NCT02298595|Cetuximab|cetuximab|mesh-list
2700493|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700494|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2700495|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
2700496|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2700497|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2700498|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2700499|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2700500|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700501|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
2700502|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700503|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700504|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2193136|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193137|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193138|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193139|NCT00003786|Irofulven|irofulven|mesh-list
2193140|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193141|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
2193142|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193143|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193144|NCT00003788|Carmustine|carmustine|mesh-list
2193145|NCT00003788|Lomustine|lomustine|mesh-list
2193146|NCT00003788|Procarbazine|procarbazine|mesh-list
2193147|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2193148|NCT00003788|Trioxsalen|trioxsalen|mesh-list
2193149|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193150|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
2193151|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193152|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193153|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
2193154|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2193155|NCT00003789|Melphalan|melphalan|mesh-list
2193156|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193157|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
2193158|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700505|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700506|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
2700507|NCT02298985|Curcumin|curcumin|mesh-list
2700508|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
2700509|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2700510|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2700511|NCT02298985|Analgesics|analgesics|mesh-ancestor
2700512|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
2700513|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700514|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700515|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2700516|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2700517|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700518|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700519|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700520|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2700521|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700522|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2700523|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
2700524|NCT02299024|Narcotics|narcotics|mesh-ancestor
2700525|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700526|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700527|NCT02299024|Analgesics|analgesics|mesh-ancestor
2700528|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
2700529|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700530|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
2700531|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2700532|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700533|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700534|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2700535|NCT02299063|Analgesics|analgesics|mesh-ancestor
2700536|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
2700537|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700538|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2700539|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2700540|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2700541|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
2700542|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700543|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700544|NCT02299115|Prednisolone|prednisolone|mesh-list
2700545|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2700546|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
2700547|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2700548|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
2700549|NCT02299115|Vigabatrin|vigabatrin|mesh-list
2700550|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2700551|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
2700552|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2700553|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
2700554|NCT02299115|Hormones|hormones|mesh-ancestor
2700555|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2700556|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700557|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2193159|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193160|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2193161|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193162|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
2193163|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193164|NCT00003792|Lenograstim|lenograstim|mesh-list
2193165|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2193166|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
2193167|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193168|NCT00003796|Irofulven|irofulven|mesh-list
2193169|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193170|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
2193171|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193172|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193173|NCT00003797|Gemcitabine|gemcitabine|mesh-list
2193174|NCT00003797|Trastuzumab|trastuzumab|mesh-list
2193175|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193176|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
2193177|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193178|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193179|NCT00003797|Antiviral Agents|antiviral agents|mesh-ancestor
2193180|NCT00003797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700558|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700559|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
2700560|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
2700561|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700562|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2700563|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2700564|NCT02299115|Protective Agents|protective agents|mesh-ancestor
2700565|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
2700566|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700567|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700568|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
2700569|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700570|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
2700571|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2700572|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700573|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700574|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2700575|NCT02299232|Analgesics|analgesics|mesh-ancestor
2700576|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
2700577|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700578|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2700579|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2700580|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2700581|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
2700582|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700583|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700584|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2700585|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2700586|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2700587|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
2700588|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700589|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2700590|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2700591|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700592|NCT02299271|Ropivacaine|ropivacaine|mesh-list
2700593|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
2700594|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
2700595|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700596|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700597|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
2700598|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700599|NCT02299310|Valsartan|valsartan|mesh-list
2700600|NCT02299310|Perindopril|perindopril|mesh-list
2700601|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2193181|NCT00003797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193182|NCT00003797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193183|NCT00003797|Immunologic Factors|immunologic factors|mesh-ancestor
2193184|NCT00003797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700602|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2700603|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2700604|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700605|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2700606|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
2700607|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700608|NCT02299401|Misoprostol|misoprostol|mesh-list
2700609|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2700610|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
2700611|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2700612|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700613|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2700614|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2700615|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
2700626|NCT02299440|Ketamine|ketamine|mesh-list
2193185|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2193186|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
2193187|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193188|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2193189|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
2193190|NCT00003799|Leucovorin|leucovorin|mesh-list
2193191|NCT00003799|Fluorouracil|fluorouracil|mesh-list
2193192|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
2193193|NCT00003799|Calcium|calcium|mesh-list
2193194|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
2193195|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2193196|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193197|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
2193198|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193199|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193200|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193201|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193202|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
2193203|NCT00003799|Antidotes|antidotes|mesh-ancestor
2193204|NCT00003799|Protective Agents|protective agents|mesh-ancestor
2193205|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
2193206|NCT00003799|Vitamins|vitamins|mesh-ancestor
2193207|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
2193208|NCT00003802|NSC 366140|nsc 366140|mesh-list
2193209|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193210|NCT00003803|Gemcitabine|gemcitabine|mesh-list
2193211|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193212|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193213|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
2193214|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193215|NCT00003803|Antiviral Agents|antiviral agents|mesh-ancestor
2193216|NCT00003803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700627|NCT02299440|Analgesics|analgesics|mesh-ancestor
2700628|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
2700629|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700630|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700631|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2700632|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2700633|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
2700634|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
2700635|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700636|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2700637|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2700638|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700639|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700640|NCT02299505|Ceritinib|ceritinib|mesh-list
2700641|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700642|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2700643|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700644|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700645|NCT02299518|Cytarabine|cytarabine|mesh-list
2700646|NCT02299518|Etoposide|etoposide|mesh-list
2700647|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
2700648|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
2700649|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2700650|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700651|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2700652|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2700653|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700654|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700655|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2700656|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
2700657|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
2700658|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700659|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2700660|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
2700661|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700662|NCT02299518|Analgesics|analgesics|mesh-ancestor
2700663|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
2700664|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700665|NCT02299557|Phenylephrine|phenylephrine|mesh-list
2700666|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
2700667|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2700668|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2700669|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
2700670|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700671|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700672|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700673|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
2700674|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
2700675|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700676|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
2700677|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2700678|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
2700679|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2700680|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
2700681|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2700682|NCT02299557|Protective Agents|protective agents|mesh-ancestor
2700683|NCT02299687|Omeprazole|omeprazole|mesh-list
2700684|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2700685|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2700686|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2700687|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700688|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700689|NCT02299726|Spironolactone|spironolactone|mesh-list
2700690|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2700691|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
2700692|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2700693|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700694|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2700695|NCT02299726|Diuretics|diuretics|mesh-ancestor
2700696|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
2700697|NCT02299765|Gemcitabine|gemcitabine|mesh-list
2700698|NCT02299765|Carboplatin|carboplatin|mesh-list
2700699|NCT02299765|Gefitinib|gefitinib|mesh-list
2193217|NCT00003803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193218|NCT00003803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2700700|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193219|NCT00003803|Immunologic Factors|immunologic factors|mesh-ancestor
2193220|NCT00003803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193221|NCT00003804|Dactinomycin|dactinomycin|mesh-list
2193222|NCT00003804|Vincristine|vincristine|mesh-list
2193223|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193224|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193225|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193226|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193227|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193228|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193229|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2700701|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2700702|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
2700703|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700704|NCT02299765|Antiviral Agents|antiviral agents|mesh-ancestor
2700705|NCT02299765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700706|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700707|NCT02299765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2700708|NCT02299765|Immunologic Factors|immunologic factors|mesh-ancestor
2193230|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193231|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2193232|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2193233|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193234|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2193235|NCT00003805|Vancomycin|vancomycin|mesh-list
2193236|NCT00003805|Tazobactam|tazobactam|mesh-list
2193237|NCT00003805|Piperacillin|piperacillin|mesh-list
2193238|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2193239|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2193240|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193241|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2193242|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193243|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193244|NCT00003808|Theophylline|theophylline|mesh-list
2193245|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2193246|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
2193247|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2193248|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193249|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2193250|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
2193251|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2193252|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193253|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700709|NCT02299765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700710|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2700711|NCT02299817|Denosumab|denosumab|mesh-list
2700712|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2700713|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700714|NCT02299882|Vancomycin|vancomycin|mesh-list
2700715|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2700716|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700717|NCT02299908|Bupivacaine|bupivacaine|mesh-list
2700718|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
2700719|NCT02299908|Anesthetics|anesthetics|mesh-list
2700720|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2700721|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2193254|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
2193255|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2193256|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2193257|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
2193258|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2193259|NCT00003809|Cetuximab|cetuximab|mesh-list
2193260|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193261|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2193262|NCT00003810|Gemcitabine|gemcitabine|mesh-list
2193263|NCT00003810|Docetaxel|docetaxel|mesh-list
2193264|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193265|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
2193266|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193267|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193268|NCT00003810|Antiviral Agents|antiviral agents|mesh-ancestor
2193269|NCT00003810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193270|NCT00003810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700722|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193271|NCT00003810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193272|NCT00003810|Immunologic Factors|immunologic factors|mesh-ancestor
2193273|NCT00003810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193274|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193275|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193276|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
2700723|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
2700724|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700725|NCT02299999|Gemcitabine|gemcitabine|mesh-list
2700726|NCT02299999|Paclitaxel|paclitaxel|mesh-list
2700727|NCT02299999|Vincristine|vincristine|mesh-list
2700728|NCT02299999|Vinorelbine|vinorelbine|mesh-list
2700729|NCT02299999|Vinblastine|vinblastine|mesh-list
2700730|NCT02299999|Docetaxel|docetaxel|mesh-list
2700731|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
2700732|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
2700733|NCT02299999|Bevacizumab|bevacizumab|mesh-list
2700734|NCT02299999|Cisplatin|cisplatin|mesh-list
2700735|NCT02299999|Carboplatin|carboplatin|mesh-list
2700736|NCT02299999|Doxorubicin|doxorubicin|mesh-list
2700737|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2700738|NCT02299999|Capecitabine|capecitabine|mesh-list
2700739|NCT02299999|Methotrexate|methotrexate|mesh-list
2700740|NCT02299999|Durvalumab|durvalumab|mesh-list
2700741|NCT02299999|Epirubicin|epirubicin|mesh-list
2700742|NCT02299999|Olaparib|olaparib|mesh-list
2700743|NCT02299999|Mitomycins|mitomycins|mesh-list
2700744|NCT02299999|Mitomycin|mitomycin|mesh-list
2700745|NCT02299999|Bicalutamide|bicalutamide|mesh-list
2193277|NCT00003811|Etoposide|etoposide|mesh-list
2193278|NCT00003811|Bleomycin|bleomycin|mesh-list
2193279|NCT00003811|Amifostine|amifostine|mesh-list
2193280|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193281|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193282|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2193283|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193284|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193285|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193286|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2193287|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2193288|NCT00003811|Protective Agents|protective agents|mesh-ancestor
2193289|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193290|NCT00003812|Paclitaxel|paclitaxel|mesh-list
2193291|NCT00003812|Etoposide|etoposide|mesh-list
2193292|NCT00003812|Carboplatin|carboplatin|mesh-list
2193293|NCT00003812|Topotecan|topotecan|mesh-list
2193294|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193295|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193296|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193297|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193298|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193299|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193300|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2193301|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193302|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193303|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2700746|NCT02299999|Taxane|taxane|mesh-list
2700747|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2700748|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700749|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
2700750|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
2700751|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
2700752|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700753|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2700754|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
2700755|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700756|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2700757|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2700758|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
2700759|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2700760|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2700761|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2700762|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2193304|NCT00003814|Eflornithine|eflornithine|mesh-list
2700763|NCT02299999|Growth Substances|growth substances|mesh-ancestor
2700764|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
2700765|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2700766|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
2700767|NCT02299999|Antiviral Agents|antiviral agents|mesh-ancestor
2700768|NCT02299999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700769|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700770|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2700771|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2700772|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2700773|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2193305|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193306|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2193307|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2193308|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2193309|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193310|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2193311|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193312|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193313|NCT00003815|Cytarabine|cytarabine|mesh-list
2193314|NCT00003815|Prednisolone|prednisolone|mesh-list
2700774|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
2700775|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2700776|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
2700777|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2700778|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2700779|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2700780|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
2700781|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
2700782|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2700783|NCT02300038|Lidocaine|lidocaine|mesh-list
2700784|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
2700785|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
2700786|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700787|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700788|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
2700789|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700790|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2700791|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2700792|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2700793|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2700794|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700795|NCT02300064|Antioxidants|antioxidants|mesh-list
2700796|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700797|NCT02300064|Protective Agents|protective agents|mesh-ancestor
2700798|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700799|NCT02300142|Vaccines|vaccines|mesh-list
2700800|NCT02300142|Immunologic Factors|immunologic factors|mesh-ancestor
2700801|NCT02300142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700802|NCT02300194|Morphine|morphine|mesh-list
2700803|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2700804|NCT02300194|Narcotics|narcotics|mesh-ancestor
2700805|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700806|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700807|NCT02300194|Analgesics|analgesics|mesh-ancestor
2700808|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
2700809|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700810|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2700811|NCT02300350|Digoxin|digoxin|mesh-list
2700812|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2700813|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2700814|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700815|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700816|NCT02300350|Protective Agents|protective agents|mesh-ancestor
2700817|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700818|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2700819|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2700820|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
2700821|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2700822|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2700823|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2700824|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
2700825|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700826|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2700827|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2700828|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193315|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
2700829|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2700830|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2700831|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700832|NCT02300376|Edetic Acid|edetic acid|mesh-list
2700833|NCT02300376|Calcium|calcium|mesh-list
2700834|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
2700835|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2700836|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700837|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
2700838|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2700839|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
2700840|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
2700841|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700842|NCT02300376|Antidotes|antidotes|mesh-ancestor
2700843|NCT02300376|Protective Agents|protective agents|mesh-ancestor
2700844|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2700845|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
2700846|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
2700847|NCT02300428|Trace Elements|trace elements|mesh-ancestor
2700848|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
2700849|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700850|NCT02300428|Hematinics|hematinics|mesh-ancestor
2700851|NCT02300623|Lamivudine|lamivudine|mesh-list
2700852|NCT02300623|Stavudine|stavudine|mesh-list
2700853|NCT02300623|Indinavir|indinavir|mesh-list
2700854|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2700855|NCT02300623|Interleukin-2|interleukin-2|mesh-list
2700856|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2700857|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2700858|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700859|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700860|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
2700861|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700862|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2700863|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700864|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2700865|NCT02300623|Analgesics|analgesics|mesh-ancestor
2700866|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
2700867|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700868|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700869|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
2700870|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2700871|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2700872|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
2700873|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
2700874|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2700875|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2700876|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700877|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2700878|NCT02300649|Analgesics|analgesics|mesh-ancestor
2700879|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
2700880|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700881|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2700882|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2700883|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2700884|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
2700885|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700886|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700887|NCT02300688|Maleic acid|maleic acid|mesh-list
2700888|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700889|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700890|NCT02300701|Omalizumab|omalizumab|mesh-list
2700891|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2700892|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2700893|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
2700894|NCT02300740|Niacinamide|niacinamide|mesh-list
2700895|NCT02300740|Niacin|niacin|mesh-list
2700896|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
2700897|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
2700898|NCT02300740|Vitamins|vitamins|mesh-ancestor
2700899|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
2700900|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700901|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2700902|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
2700903|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700904|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2700905|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
2700906|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2700907|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2700908|NCT02300922|Antibodies|antibodies|mesh-list
2700909|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
2700910|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700911|NCT02300935|Paclitaxel|paclitaxel|mesh-list
2700912|NCT02300935|Trametinib|trametinib|mesh-list
2700913|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2700914|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700915|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
2700916|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
2700917|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
2700918|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700919|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2700920|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700921|NCT02300948|Folic Acid|folic acid|mesh-list
2700922|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
2700923|NCT02300948|Hematinics|hematinics|mesh-ancestor
2700924|NCT02300948|Vitamins|vitamins|mesh-ancestor
2700925|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
2700926|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700927|NCT02301000|Metronidazole|metronidazole|mesh-list
2700928|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700929|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2700930|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2700931|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2700932|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
2700933|NCT02301026|Hematinics|hematinics|mesh-ancestor
2193316|NCT00003815|Melphalan|melphalan|mesh-list
2193317|NCT00003815|Carmustine|carmustine|mesh-list
2193318|NCT00003815|Doxorubicin|doxorubicin|mesh-list
2193319|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2193320|NCT00003815|Etoposide|etoposide|mesh-list
2193321|NCT00003815|Vincristine|vincristine|mesh-list
2193322|NCT00003815|Bleomycin|bleomycin|mesh-list
2193323|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193324|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
2193325|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193326|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193327|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193328|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
2193329|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193330|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193331|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2193332|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2193333|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2193334|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193335|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193336|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193337|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193338|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
2193339|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
2193340|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193341|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193342|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193343|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193344|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2193345|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
2193346|NCT00003815|Hormones|hormones|mesh-ancestor
2193347|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2193348|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2700934|NCT02301091|Mitomycins|mitomycins|mesh-list
2700935|NCT02301091|Mitomycin|mitomycin|mesh-list
2700936|NCT02301091|Pirarubicin|pirarubicin|mesh-list
2700937|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2700938|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700939|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
2700940|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700941|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2700942|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700943|NCT02301130|Durvalumab|durvalumab|mesh-list
2700944|NCT02301130|Tremelimumab|tremelimumab|mesh-list
2700945|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
2700946|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2700947|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2193349|NCT00003817|Ondansetron|ondansetron|mesh-list
2193350|NCT00003817|Granisetron|granisetron|mesh-list
2700948|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700949|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
2700950|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700951|NCT02301208|Nedaplatin|nedaplatin|mesh-list
2700952|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700953|NCT02301221|Vancomycin|vancomycin|mesh-list
2700954|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2700955|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2700956|NCT02301234|Celecoxib|celecoxib|mesh-list
2700957|NCT02301234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2700958|NCT02301234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2700959|NCT02301234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2700960|NCT02301234|Analgesics|analgesics|mesh-ancestor
2700961|NCT02301234|Sensory System Agents|sensory system agents|mesh-ancestor
2700962|NCT02301234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700963|NCT02301234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700964|NCT02301234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2700965|NCT02301234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2700966|NCT02301234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2193351|NCT00003817|Tropisetron|tropisetron|mesh-list
2193352|NCT00003817|Dolasetron|dolasetron|mesh-list
2193353|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
2193354|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
2193355|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2193356|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193357|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2193358|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
2193359|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
2193360|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2193361|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
2193362|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2700967|NCT02301234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2700968|NCT02301234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700969|NCT02301234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700970|NCT02301234|Immunologic Factors|immunologic factors|mesh-ancestor
2700971|NCT02301286|Aspirin|aspirin|mesh-list
2700972|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2700973|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2700974|NCT02301286|Analgesics|analgesics|mesh-ancestor
2700975|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
2700976|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2700977|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700978|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2700979|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2700980|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2700981|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2700982|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2700983|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2700984|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2700985|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2700986|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
2700987|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
2700988|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700989|NCT02301494|Fluocinonide|fluocinonide|mesh-list
2700990|NCT02301494|Imiquimod|imiquimod|mesh-list
2700991|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2700992|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
2700993|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2700994|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2700995|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
2700996|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2700997|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
2700998|NCT02301494|Hormones|hormones|mesh-ancestor
2193363|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193364|NCT00003817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2193365|NCT00003817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2193366|NCT00003817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2193367|NCT00003817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2193368|NCT00003817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2193369|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2193370|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2193371|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2193372|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
2700999|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701000|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2701001|NCT02301650|Tenofovir|tenofovir|mesh-list
2701002|NCT02301650|Lamivudine|lamivudine|mesh-list
2701003|NCT02301650|Telbivudine|telbivudine|mesh-list
2701004|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
2701005|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2701006|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2701007|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2701008|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701009|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701010|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2701011|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2701012|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
2193373|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193374|NCT00003821|Aminopterin|aminopterin|mesh-list
2193375|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2193376|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193377|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193378|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2193379|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
2193380|NCT00003824|Cephalexin|cephalexin|mesh-list
2193381|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193382|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2193383|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193384|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193385|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193386|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193387|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2193388|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2193389|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
2193390|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
2193391|NCT00003827|Cytarabine|cytarabine|mesh-list
2193392|NCT00003827|Topotecan|topotecan|mesh-list
2193393|NCT00003827|Amifostine|amifostine|mesh-list
2193394|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193395|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
2193396|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193397|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193398|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
2701013|NCT02301676|Propofol|propofol|mesh-list
2701014|NCT02301676|Sevoflurane|sevoflurane|mesh-list
2701015|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2701016|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2701017|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701018|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2701019|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
2701020|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
2701021|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2701022|NCT02301676|Analgesics|analgesics|mesh-ancestor
2701023|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
2701024|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701025|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2701026|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2701027|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2701028|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
2701029|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701030|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701031|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2701032|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2701033|NCT02301715|Oxytocin|oxytocin|mesh-list
2701034|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
2701035|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2701036|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701037|NCT02301780|Aspirin|aspirin|mesh-list
2701038|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2701039|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2701040|NCT02301780|Analgesics|analgesics|mesh-ancestor
2701041|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
2701042|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701043|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701044|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2701045|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2701046|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2701047|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2701048|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701049|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2701050|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2701051|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701052|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
2701053|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2701054|NCT02301806|Glimepiride|glimepiride|mesh-list
2701055|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2701056|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701057|NCT02301806|Incretins|incretins|mesh-ancestor
2701058|NCT02301806|Hormones|hormones|mesh-ancestor
2701059|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701060|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2193399|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193400|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193401|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
2193402|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193403|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2193404|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193405|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193406|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2193407|NCT00003827|Protective Agents|protective agents|mesh-ancestor
2193408|NCT00003828|Vinorelbine|vinorelbine|mesh-list
2193409|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193410|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701061|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
2701062|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701063|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701064|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2701065|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2701066|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
2701067|NCT02301910|Tenecteplase|tenecteplase|mesh-list
2701068|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2701069|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2701070|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701071|NCT02301949|Thalidomide|thalidomide|mesh-list
2701072|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2701073|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
2193411|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193412|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
2701074|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701075|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
2701076|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2701077|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2701078|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2701079|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2701080|NCT02301949|Growth Substances|growth substances|mesh-ancestor
2701081|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
2701082|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701083|NCT02301962|Panitumumab|panitumumab|mesh-list
2701084|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2701085|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701086|NCT02302079|Ranibizumab|ranibizumab|mesh-list
2701087|NCT02302079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2701088|NCT02302079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2701089|NCT02302079|Growth Substances|growth substances|mesh-ancestor
2701090|NCT02302079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701091|NCT02302079|Growth Inhibitors|growth inhibitors|mesh-ancestor
2701092|NCT02302079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701093|NCT02302170|Vaccines|vaccines|mesh-list
2701094|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
2701095|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701096|NCT02302209|Oxytocin|oxytocin|mesh-list
2701097|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
2701098|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2701099|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701100|NCT02302274|Flecainide|flecainide|mesh-list
2701101|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2701102|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2701103|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2701104|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2701105|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701106|NCT02302326|Folic Acid|folic acid|mesh-list
2701107|NCT02302326|Inositol|inositol|mesh-list
2701108|NCT02302326|Metformin|metformin|mesh-list
2701109|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2701110|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701111|NCT02302326|Hematinics|hematinics|mesh-ancestor
2701112|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
2701113|NCT02302326|Vitamins|vitamins|mesh-ancestor
2701114|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
2701115|NCT02302378|Bupivacaine|bupivacaine|mesh-list
2701116|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
2701117|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
2701118|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2701119|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701120|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
2701121|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701122|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2701123|NCT02302430|Oxytocin|oxytocin|mesh-list
2701124|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
2701125|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2701126|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701127|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
2701128|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2701129|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2701130|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701131|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
2701132|NCT02302456|Coagulants|coagulants|mesh-ancestor
2701133|NCT02302469|Lenalidomide|lenalidomide|mesh-list
2701134|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
2701135|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701136|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2701137|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2701138|NCT02302469|Growth Substances|growth substances|mesh-ancestor
2701139|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
2701140|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701141|NCT02302495|Prednisone|prednisone|mesh-list
2701142|NCT02302495|Melphalan|melphalan|mesh-list
2701143|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2701144|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
2701145|NCT02302495|Hormones|hormones|mesh-ancestor
2701146|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701147|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701148|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2701149|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701150|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2701151|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
2701152|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701153|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2701154|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2701155|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
2193413|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
2701156|NCT02302508|Clopidogrel|clopidogrel|mesh-list
2701157|NCT02302508|Ticagrelor|ticagrelor|mesh-list
2701158|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2701159|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2701160|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2701161|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2701162|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2701163|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
2701164|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701165|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701166|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701167|NCT02302547|Ritonavir|ritonavir|mesh-list
2701168|NCT02302547|Lopinavir|lopinavir|mesh-list
2701169|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2701170|NCT02302547|Darunavir|darunavir|mesh-list
2701171|NCT02302547|Indinavir|indinavir|mesh-list
2701172|NCT02302547|Saquinavir|saquinavir|mesh-list
2701173|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
2701174|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2701175|NCT02302547|Tenofovir|tenofovir|mesh-list
2701176|NCT02302547|Emtricitabine|emtricitabine|mesh-list
2701177|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
2701178|NCT02302547|Nevirapine|nevirapine|mesh-list
2701179|NCT02302547|Maraviroc|maraviroc|mesh-list
2701180|NCT02302547|Dolutegravir|dolutegravir|mesh-list
2701181|NCT02302547|Cobicistat|cobicistat|mesh-list
2701182|NCT02302547|Rilpivirine|rilpivirine|mesh-list
2701183|NCT02302547|Tipranavir|tipranavir|mesh-list
2701184|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
2701185|NCT02302547|Elvitegravir|elvitegravir|mesh-list
2701186|NCT02302547|Efavirenz|efavirenz|mesh-list
2701187|NCT02302547|Etravirine|etravirine|mesh-list
2701188|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2701189|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
2701190|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
2701191|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2701192|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701193|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701194|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2701195|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2701196|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
2701197|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2701198|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2701199|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2701200|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2701201|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2701202|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2193414|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193415|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
2193416|NCT00003829|Fludarabine|fludarabine|mesh-list
2193417|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
2193418|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193419|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
2193420|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193421|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193422|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193423|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
2193424|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193425|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193426|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2193427|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2701203|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2701204|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2193428|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
2193429|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
2193430|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
2193431|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
2193432|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193433|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193434|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193435|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
2193436|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2701205|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2701206|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2701207|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2701208|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2701209|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2701210|NCT02302586|Morphine|morphine|mesh-list
2701211|NCT02302586|Bupivacaine|bupivacaine|mesh-list
2701212|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
2701213|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
2701214|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2701215|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701216|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
2701217|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701218|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2701219|NCT02302586|Narcotics|narcotics|mesh-ancestor
2701220|NCT02302586|Analgesics|analgesics|mesh-ancestor
2701221|NCT02302729|Micronutrients|micronutrients|mesh-list
2701222|NCT02302729|Trace Elements|trace elements|mesh-list
2701223|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701224|NCT02302768|Selenium|selenium|mesh-list
2701225|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
2701226|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701227|NCT02302768|Protective Agents|protective agents|mesh-ancestor
2193437|NCT00003834|Leucovorin|leucovorin|mesh-list
2193438|NCT00003834|Fluorouracil|fluorouracil|mesh-list
2193439|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
2193440|NCT00003834|Calcium|calcium|mesh-list
2193441|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
2193442|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2193443|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193444|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
2193445|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193446|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193447|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193448|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193449|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
2193450|NCT00003834|Antidotes|antidotes|mesh-ancestor
2193451|NCT00003834|Protective Agents|protective agents|mesh-ancestor
2193452|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
2193453|NCT00003834|Vitamins|vitamins|mesh-ancestor
2193454|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
2193455|NCT00003835|Leucovorin|leucovorin|mesh-list
2193456|NCT00003835|Fluorouracil|fluorouracil|mesh-list
2193457|NCT00003835|Irinotecan|irinotecan|mesh-list
2193458|NCT00003835|Calcium|calcium|mesh-list
2193459|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
2193460|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2193461|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193462|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
2193463|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701228|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701229|NCT02302768|Trace Elements|trace elements|mesh-ancestor
2701230|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
2701231|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
2701232|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2701233|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2701234|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
2701235|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2701236|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2701237|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2701238|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701239|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701240|NCT02302976|Exenatide|exenatide|mesh-list
2701241|NCT02302976|Cocaine|cocaine|mesh-list
2701242|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2701243|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701244|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2701245|NCT02302976|Incretins|incretins|mesh-ancestor
2701246|NCT02302976|Hormones|hormones|mesh-ancestor
2701247|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701248|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
2701249|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
2701250|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2701251|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
2701252|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701253|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2701254|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2701255|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2701256|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2701257|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701258|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
2701259|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701260|NCT02302989|Ranibizumab|ranibizumab|mesh-list
2701261|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2701262|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2701263|NCT02302989|Growth Substances|growth substances|mesh-ancestor
2701264|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701265|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
2193464|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193465|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193466|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193467|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
2193468|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2193469|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193470|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193471|NCT00003835|Antidotes|antidotes|mesh-ancestor
2193472|NCT00003835|Protective Agents|protective agents|mesh-ancestor
2193473|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
2193474|NCT00003835|Vitamins|vitamins|mesh-ancestor
2193475|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
2193476|NCT00003842|Interleukin-4|interleukin-4|mesh-list
2193477|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2701266|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701267|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
2701268|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2701269|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2701270|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2701271|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2701272|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701273|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
2701274|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701275|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701276|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2701277|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701278|NCT02303028|Topotecan|topotecan|mesh-list
2701279|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2701280|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2701281|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701282|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701283|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193478|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
2193479|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193480|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193481|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193482|NCT00003843|Irinotecan|irinotecan|mesh-list
2701284|NCT02303106|Lamotrigine|lamotrigine|mesh-list
2701285|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
2701286|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2701287|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2701288|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701289|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2701290|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701291|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2701292|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2701293|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2701294|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2701295|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2701296|NCT02303119|Rituximab|rituximab|mesh-list
2701297|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2701298|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701299|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
2701300|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701301|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2701302|NCT02303171|Enoxaparin|enoxaparin|mesh-list
2701303|NCT02303171|Warfarin|warfarin|mesh-list
2701304|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
2701305|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2701306|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2701307|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701308|NCT02303223|Propofol|propofol|mesh-list
2701309|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2701310|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2701311|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701312|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2701313|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
2701314|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
2701315|NCT02303327|Androgens|androgens|mesh-list
2701316|NCT02303327|Hormones|hormones|mesh-ancestor
2701317|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701318|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701319|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
2701320|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2701321|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701322|NCT02303405|Pioglitazone|pioglitazone|mesh-list
2701323|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
2193483|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2193484|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193485|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193486|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193487|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193488|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
2193489|NCT00003846|Thiotepa|thiotepa|mesh-list
2193490|NCT00003846|Carboplatin|carboplatin|mesh-list
2701324|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2701325|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701326|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
2701327|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2701328|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2701329|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2701330|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701331|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701332|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2701333|NCT02303418|Oxytocin|oxytocin|mesh-list
2701334|NCT02303418|Carbetocin|carbetocin|mesh-list
2701335|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
2701336|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2701337|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193491|NCT00003846|Vincristine|vincristine|mesh-list
2193492|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2701346|NCT02303444|Sorafenib|sorafenib|mesh-list
2701347|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701348|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2701349|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701350|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701351|NCT02303483|Niacinamide|niacinamide|mesh-list
2701352|NCT02303483|Niacin|niacin|mesh-list
2701353|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
2701354|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
2701355|NCT02303483|Vitamins|vitamins|mesh-ancestor
2701356|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
2701357|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701358|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2701359|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
2701360|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701361|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2701362|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
2701363|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
2701364|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2701365|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2701366|NCT02303587|Prednisolone|prednisolone|mesh-list
2701367|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
2701368|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2701369|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
2701370|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2701371|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
2701372|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
2701373|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701374|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701375|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2701376|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
2701377|NCT02303587|Hormones|hormones|mesh-ancestor
2701378|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701379|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2701380|NCT02303587|Protective Agents|protective agents|mesh-ancestor
2701381|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2701382|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701383|NCT02303600|Montelukast|montelukast|mesh-list
2701384|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2701385|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
2701386|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2701387|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
2701388|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701389|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701390|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2701391|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2701392|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701393|NCT02303639|Amiodarone|amiodarone|mesh-list
2701394|NCT02303639|Sotalol|sotalol|mesh-list
2701395|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2701396|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
2701397|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2701398|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2193493|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
2193494|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193495|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193496|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193497|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
2193498|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193499|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193500|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2193501|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193502|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193503|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193504|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193505|NCT00003847|Doxorubicin|doxorubicin|mesh-list
2193506|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2193507|NCT00003847|Vincristine|vincristine|mesh-list
2701399|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701400|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2701401|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2701402|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2701403|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701404|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2701405|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2701406|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2701407|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2701408|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2701409|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
2701410|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701411|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701412|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
2701413|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
2701414|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701415|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
2701416|NCT02303730|Exenatide|exenatide|mesh-list
2701417|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2701418|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701419|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2701420|NCT02303730|Incretins|incretins|mesh-ancestor
2701421|NCT02303730|Hormones|hormones|mesh-ancestor
2701422|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701423|NCT02303769|Tamsulosin|tamsulosin|mesh-list
2701424|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2701425|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2701426|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2701427|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
2701428|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701429|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701430|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701431|NCT02303769|Urological Agents|urological agents|mesh-ancestor
2701432|NCT02303782|Azacitidine|azacitidine|mesh-list
2701433|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2701434|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
2701435|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701436|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701437|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193508|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2193509|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193510|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2193511|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193512|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193513|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193514|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193515|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193516|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193517|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193518|NCT00003849|Rituximab|rituximab|mesh-list
2193519|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2193520|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193521|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
2193522|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193523|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193524|NCT00003850|Thalidomide|thalidomide|mesh-list
2193525|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193526|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
2193527|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193528|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
2193529|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2193530|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193531|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2701438|NCT02303795|Warfarin|warfarin|mesh-list
2701439|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
2701440|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
2193532|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2193533|NCT00003850|Growth Substances|growth substances|mesh-ancestor
2193534|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
2193535|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193536|NCT00003851|Gemcitabine|gemcitabine|mesh-list
2193537|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193538|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
2193539|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193540|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193541|NCT00003851|Antiviral Agents|antiviral agents|mesh-ancestor
2193542|NCT00003851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193543|NCT00003851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193544|NCT00003851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2701441|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2701442|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
2701443|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2701444|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
2701445|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701446|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701496|NCT02303847|Ketamine|ketamine|mesh-list
2701497|NCT02303847|Analgesics|analgesics|mesh-ancestor
2701498|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
2701499|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701500|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701501|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2701502|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2701503|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
2701504|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
2701505|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2701506|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2701507|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2701508|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701509|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701510|NCT02303873|Alendronate|alendronate|mesh-list
2701511|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2701512|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701513|NCT02303886|Methylene Blue|methylene blue|mesh-list
2701514|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701515|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193545|NCT00003851|Immunologic Factors|immunologic factors|mesh-ancestor
2701516|NCT02303899|Gemcitabine|gemcitabine|mesh-list
2701517|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
2193546|NCT00003851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193547|NCT00003852|Paclitaxel|paclitaxel|mesh-list
2193548|NCT00003852|Etoposide|etoposide|mesh-list
2193549|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
2193550|NCT00003852|Carboplatin|carboplatin|mesh-list
2193551|NCT00003852|Epirubicin|epirubicin|mesh-list
2193552|NCT00003852|Ifosfamide|ifosfamide|mesh-list
2193553|NCT00003852|Thiotepa|thiotepa|mesh-list
2193554|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193555|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193556|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193557|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193558|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193559|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193560|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193561|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
2193562|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193563|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193564|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193565|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
2193566|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2193567|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2193568|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193569|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193570|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2193571|NCT00003853|Esorubicin|esorubicin|mesh-list
2193572|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2193573|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193574|NCT00003856|Temoporfin|temoporfin|mesh-list
2193575|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193576|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2193577|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
2193578|NCT00003857|Tamoxifen|tamoxifen|mesh-list
2193579|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2193580|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
2193581|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2193582|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701518|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2701519|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
2701520|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701521|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701522|NCT02303899|Antiviral Agents|antiviral agents|mesh-ancestor
2701523|NCT02303899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2701524|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701525|NCT02303899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2701526|NCT02303899|Immunologic Factors|immunologic factors|mesh-ancestor
2701527|NCT02303899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701528|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2701529|NCT02303912|Carboplatin|carboplatin|mesh-list
2701530|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701531|NCT02303951|Atezolizumab|atezolizumab|mesh-list
2701532|NCT02303951|Vemurafenib|vemurafenib|mesh-list
2701533|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701534|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2701535|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701536|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701537|NCT02304042|Oxytocin|oxytocin|mesh-list
2701538|NCT02304042|Carbetocin|carbetocin|mesh-list
2701539|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
2701540|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2701541|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701542|NCT02304055|Oxytocin|oxytocin|mesh-list
2701543|NCT02304055|Carbetocin|carbetocin|mesh-list
2701544|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
2701545|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2701546|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701547|NCT02304081|Saxagliptin|saxagliptin|mesh-list
2701548|NCT02304081|Incretins|incretins|mesh-ancestor
2701549|NCT02304081|Hormones|hormones|mesh-ancestor
2701550|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701551|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701552|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2701553|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
2701554|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193583|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2193584|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193585|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2193586|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2193587|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2701555|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701556|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2701557|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
2701558|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2701559|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2701560|NCT02304094|Prednisolone|prednisolone|mesh-list
2701561|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
2701562|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2701563|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
2701564|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2701565|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
2701566|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
2701567|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701568|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701569|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2701570|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
2701571|NCT02304094|Hormones|hormones|mesh-ancestor
2701572|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701573|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2701574|NCT02304094|Protective Agents|protective agents|mesh-ancestor
2701575|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2701576|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701577|NCT02304107|Letrozole|letrozole|mesh-list
2701578|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701579|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2193588|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
2193589|NCT00003858|Analgesics|analgesics|mesh-ancestor
2193590|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
2193591|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2193592|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193593|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193594|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2193595|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2701580|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2701581|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701582|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701583|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2701584|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
2701585|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701586|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701587|NCT02304198|Udenafil|udenafil|mesh-list
2701588|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2701589|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2701590|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701591|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701592|NCT02304211|Insulin|insulin|mesh-list
2701593|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2701594|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701595|NCT02304237|Progesterone|progesterone|mesh-list
2701596|NCT02304237|Progestins|progestins|mesh-ancestor
2701597|NCT02304237|Hormones|hormones|mesh-ancestor
2701598|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701599|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701600|NCT02304250|Dexamethasone|dexamethasone|mesh-list
2701601|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2701602|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
2701603|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
2701604|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701605|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701606|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2701607|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
2701608|NCT02304250|Hormones|hormones|mesh-ancestor
2701609|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701610|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2701611|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701612|NCT02304276|Calcium|calcium|mesh-list
2701613|NCT02304276|Fluorides|fluorides|mesh-list
2701614|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2701615|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701616|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
2701617|NCT02304276|Protective Agents|protective agents|mesh-ancestor
2701618|NCT02304289|Artesunate|artesunate|mesh-list
2701619|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
2701620|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2701621|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2701622|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2701623|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701624|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
2701625|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
2701626|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2701627|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
2701628|NCT02304302|Memantine|memantine|mesh-list
2701629|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2701630|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2701631|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
2701632|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701633|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701634|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701635|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2701636|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2701637|NCT02304354|Rituximab|rituximab|mesh-list
2701638|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2701639|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701640|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
2701641|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701642|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2701643|NCT02304393|Atezolizumab|atezolizumab|mesh-list
2701644|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701645|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
2701646|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2701647|NCT02304445|Estrogens|estrogens|mesh-ancestor
2701648|NCT02304445|Hormones|hormones|mesh-ancestor
2701649|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701650|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701651|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2701652|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701653|NCT02304458|Nivolumab|nivolumab|mesh-list
2701654|NCT02304458|Ipilimumab|ipilimumab|mesh-list
2701655|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2701656|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701657|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2701658|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701659|NCT02304627|Insulin|insulin|mesh-list
2701660|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2701661|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701662|NCT02304783|Acetaminophen|acetaminophen|mesh-list
2701663|NCT02304783|Piroxicam|piroxicam|mesh-list
2701664|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2701665|NCT02304783|Analgesics|analgesics|mesh-ancestor
2701666|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
2701667|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701668|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701669|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
2701670|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2701671|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2701672|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2701673|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2701674|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701675|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701676|NCT02304809|Vemurafenib|vemurafenib|mesh-list
2701677|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701678|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2701679|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701680|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701681|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
2701682|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2701683|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2701684|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2701685|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2701686|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701687|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701688|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701689|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2701690|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2193596|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193597|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193598|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
2193599|NCT00003859|Carboplatin|carboplatin|mesh-list
2193600|NCT00003859|Etoposide|etoposide|mesh-list
2193601|NCT00003859|Vincristine|vincristine|mesh-list
2193602|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193603|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
2193604|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193605|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2701691|NCT02304887|Denosumab|denosumab|mesh-list
2701692|NCT02304887|Teriparatide|teriparatide|mesh-list
2701693|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2701694|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701695|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2701700|NCT02305030|Opicapone|opicapone|mesh-list
2701701|NCT02305030|Warfarin|warfarin|mesh-list
2701702|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
2701703|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2193606|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193607|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
2193608|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193609|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193610|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2193611|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193612|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2193613|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193614|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193615|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193616|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193617|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193618|NCT00003860|Carboplatin|carboplatin|mesh-list
2193619|NCT00003860|Etoposide|etoposide|mesh-list
2193620|NCT00003860|Ifosfamide|ifosfamide|mesh-list
2193621|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193622|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193623|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2193624|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193625|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193626|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193627|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193628|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
2701704|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701705|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701706|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2701707|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2701708|NCT02305069|Pioglitazone|pioglitazone|mesh-list
2701709|NCT02305069|Octreotide|octreotide|mesh-list
2701710|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2701711|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701712|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2701713|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2701714|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701715|NCT02305160|Poractant alfa|poractant alfa|mesh-list
2701716|NCT02305160|Beractant|beractant|mesh-list
2701717|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2701718|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
2701719|NCT02305173|Dexamethasone|dexamethasone|mesh-list
2701720|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2701721|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
2701722|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
2701723|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701724|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701725|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2701726|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
2701727|NCT02305173|Hormones|hormones|mesh-ancestor
2701728|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701729|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2701730|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701731|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
2701732|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2701733|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701734|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2193629|NCT00003862|Leucovorin|leucovorin|mesh-list
2193630|NCT00003862|Paclitaxel|paclitaxel|mesh-list
2193631|NCT00003862|Fluorouracil|fluorouracil|mesh-list
2193632|NCT00003862|Calcium|calcium|mesh-list
2193633|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
2701735|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2701736|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2701737|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701738|NCT02305355|Atorvastatin|atorvastatin|mesh-list
2701739|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2701740|NCT02305355|Simvastatin|simvastatin|mesh-list
2701741|NCT02305355|Pravastatin|pravastatin|mesh-list
2701742|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2701743|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2701744|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
2701745|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701746|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2701747|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2701748|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701749|NCT02305394|Ketamine|ketamine|mesh-list
2701750|NCT02305394|Propofol|propofol|mesh-list
2701751|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2701752|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2701753|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701754|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2701755|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
2701756|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
2701757|NCT02305394|Analgesics|analgesics|mesh-ancestor
2701758|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
2701759|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701760|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2701761|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2701762|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2701763|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701764|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701765|NCT02305485|Everolimus|everolimus|mesh-list
2423464|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423465|NCT00822263|Expectorants|expectorants|mesh-ancestor
2423466|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
2423467|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2423468|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
2423469|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423470|NCT00822263|Protective Agents|protective agents|mesh-ancestor
2423471|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701766|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193634|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193635|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193636|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193637|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193638|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193639|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193640|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2193641|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193642|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
2193643|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193644|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193645|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
2193646|NCT00003862|Antidotes|antidotes|mesh-ancestor
2193647|NCT00003862|Protective Agents|protective agents|mesh-ancestor
2193648|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
2193649|NCT00003862|Vitamins|vitamins|mesh-ancestor
2193650|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
2193651|NCT00003864|Carboplatin|carboplatin|mesh-list
2193652|NCT00003864|Docetaxel|docetaxel|mesh-list
2193653|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193654|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193655|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193656|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193657|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193658|NCT00003865|Toremifene|toremifene|mesh-list
2193659|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2193660|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193661|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2193662|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2193663|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
2193664|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701767|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2701768|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
2701769|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701770|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
2701771|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2701772|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
2701773|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701774|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701775|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2701776|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
2701777|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2701778|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
2701779|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701780|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701781|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2701782|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
2701783|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
2701784|NCT02305550|Protective Agents|protective agents|mesh-ancestor
2701785|NCT02305615|Bevacizumab|bevacizumab|mesh-list
2701786|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2701787|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701788|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2701789|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2701790|NCT02305615|Growth Substances|growth substances|mesh-ancestor
2701791|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701792|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
2701793|NCT02305654|Paclitaxel|paclitaxel|mesh-list
2701794|NCT02305654|Ifosfamide|ifosfamide|mesh-list
2701795|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2701796|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701797|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
2701798|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
2701799|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
2701800|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701801|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2701802|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
2701803|NCT02305693|Letrozole|letrozole|mesh-list
2701804|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701805|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2701806|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2701807|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701808|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701809|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2701810|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
2193665|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193666|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2193667|NCT00003867|Capecitabine|capecitabine|mesh-list
2193668|NCT00003867|Irinotecan|irinotecan|mesh-list
2193669|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193670|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
2193671|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193672|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193673|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2193674|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193675|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193676|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
2193677|NCT00003868|Methotrexate|methotrexate|mesh-list
2193678|NCT00003868|Antibodies|antibodies|mesh-list
2193679|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2193680|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193681|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
2193682|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701811|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2701812|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701813|NCT02305810|Everolimus|everolimus|mesh-list
2701814|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701815|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2701816|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
2701817|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701818|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2701819|NCT02305823|Aripiprazole|aripiprazole|mesh-list
2701820|NCT02305823|Ziprasidone|ziprasidone|mesh-list
2701821|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
2701822|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2701823|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2701824|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2701825|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2701826|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701827|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
2701828|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
2701829|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701830|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701831|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2701832|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2701833|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
2701834|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2701835|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2701836|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2701837|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2701838|NCT02305836|Donepezil|donepezil|mesh-list
2701839|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2701840|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701841|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701842|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
2701843|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701844|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701845|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
2701846|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2701847|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2701848|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2701849|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
2701850|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701851|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2701852|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2701853|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701854|NCT02305901|Repaglinide|repaglinide|mesh-list
2701855|NCT02305901|Bupropion|bupropion|mesh-list
2701856|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2701857|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
2701858|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2701859|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2701860|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2701861|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2701862|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701863|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
2701864|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2193683|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193684|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193685|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
2193686|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193687|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193688|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2193689|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2193690|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
2193691|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2193692|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193693|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
2193694|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
2193695|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193696|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2193697|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2193698|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
2193699|NCT00003870|Methotrexate|methotrexate|mesh-list
2193700|NCT00003870|Antibodies|antibodies|mesh-list
2193701|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2193702|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193703|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
2193704|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193705|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193706|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193707|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
2193708|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193709|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193710|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2193711|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2701865|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701866|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2701867|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2701868|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701869|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2701870|NCT02305927|Vitamin D|vitamin d|mesh-list
2701871|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
2701872|NCT02305927|Vitamins|vitamins|mesh-ancestor
2701873|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
2701874|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701875|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2701876|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2701877|NCT02305940|Doxycycline|doxycycline|mesh-list
2701878|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2701879|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2701880|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
2701881|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2701882|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2701883|NCT02305979|Loratadine|loratadine|mesh-list
2701884|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
2701885|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
2701886|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2701887|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2701888|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2701889|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
2701890|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
2701891|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701892|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701893|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701894|NCT02305992|Bupivacaine|bupivacaine|mesh-list
2701895|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
2701896|NCT02305992|Anesthetics|anesthetics|mesh-list
2701897|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2701898|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701899|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
2701900|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701901|NCT02306031|Diclofenac|diclofenac|mesh-list
2701902|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
2193712|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
2193713|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2193714|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193715|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
2193716|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
2193717|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193718|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2193719|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2193720|NCT00003871|Vaccines|vaccines|mesh-list
2193721|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
2193722|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193723|NCT00003873|Fluorouracil|fluorouracil|mesh-list
2193724|NCT00003873|Eniluracil|eniluracil|mesh-list
2193725|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
2193726|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193727|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193728|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193729|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2701903|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2701904|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2701905|NCT02306031|Analgesics|analgesics|mesh-ancestor
2701906|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
2701907|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701908|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701909|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2701910|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2701911|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2701912|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701913|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701914|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2701915|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2701916|NCT02306070|Metformin|metformin|mesh-list
2701917|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2701918|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701919|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
2701920|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2701921|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701922|NCT02306239|Terlipressin|terlipressin|mesh-list
2701923|NCT02306239|Norepinephrine|norepinephrine|mesh-list
2701924|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2701925|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2701926|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
2701927|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701928|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701929|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701930|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
2701931|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
2701932|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701933|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2701934|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2701935|NCT02306278|Gabapentin|gabapentin|mesh-list
2701936|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701937|NCT02306278|Analgesics|analgesics|mesh-ancestor
2701938|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
2701939|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701940|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
2701941|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2193730|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
2193731|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193732|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193733|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2193734|NCT00003874|Antibodies|antibodies|mesh-list
2193735|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
2193736|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2193737|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
2193738|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193739|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193740|NCT00003876|Carmustine|carmustine|mesh-list
2193741|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193742|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
2193743|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701942|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2701943|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2701944|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2701945|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2701946|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2701947|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701948|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701949|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
2701950|NCT02306291|Cytarabine|cytarabine|mesh-list
2701951|NCT02306291|Etoposide|etoposide|mesh-list
2701952|NCT02306291|Mitoxantrone|mitoxantrone|mesh-list
2701953|NCT02306291|Idarubicin|idarubicin|mesh-list
2701954|NCT02306291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2701955|NCT02306291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701956|NCT02306291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2701957|NCT02306291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2701958|NCT02306291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2701959|NCT02306291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701960|NCT02306291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2701961|NCT02306291|Antimetabolites|antimetabolites|mesh-ancestor
2701962|NCT02306291|Antiviral Agents|antiviral agents|mesh-ancestor
2701963|NCT02306291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2701964|NCT02306291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2701965|NCT02306291|Immunologic Factors|immunologic factors|mesh-ancestor
2701966|NCT02306291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701967|NCT02306291|Analgesics|analgesics|mesh-ancestor
2701968|NCT02306291|Sensory System Agents|sensory system agents|mesh-ancestor
2701969|NCT02306291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2701970|NCT02306291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2701971|NCT02306473|Mannitol|mannitol|mesh-list
2701972|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2701973|NCT02306473|Diuretics|diuretics|mesh-ancestor
2701974|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
2701975|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701976|NCT02306564|Cabergoline|cabergoline|mesh-list
2701977|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2701978|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2701979|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
2701980|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
2701981|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2701982|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2701983|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701984|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2701985|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2701986|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2701987|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
2701988|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2701989|NCT02306629|Epratuzumab|epratuzumab|mesh-list
2701990|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2193744|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193745|NCT00003877|Paclitaxel|paclitaxel|mesh-list
2193746|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
2193747|NCT00003877|Carboplatin|carboplatin|mesh-list
2193748|NCT00003877|Thiotepa|thiotepa|mesh-list
2193749|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193750|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193751|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193752|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193753|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193754|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193755|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193756|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
2701991|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2701992|NCT02306733|Oxytocin|oxytocin|mesh-list
2701993|NCT02306733|Ergonovine|ergonovine|mesh-list
2701994|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
2701995|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2701996|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2701997|NCT02306772|Mesalamine|mesalamine|mesh-list
2701998|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2701999|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2702000|NCT02306772|Analgesics|analgesics|mesh-ancestor
2702001|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
2193757|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193758|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193759|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193760|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
2193761|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2702002|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702003|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702004|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2702005|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2702006|NCT02306785|Mesalamine|mesalamine|mesh-list
2193762|NCT00003878|Carmustine|carmustine|mesh-list
2193763|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193764|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
2193765|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193766|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193767|NCT00003880|Paclitaxel|paclitaxel|mesh-list
2193768|NCT00003880|Carboplatin|carboplatin|mesh-list
2193769|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193770|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193771|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193772|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193773|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193774|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193775|NCT00003881|Paclitaxel|paclitaxel|mesh-list
2193776|NCT00003881|Carboplatin|carboplatin|mesh-list
2702007|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2702008|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2702009|NCT02306785|Analgesics|analgesics|mesh-ancestor
2702010|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
2702011|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702012|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702013|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2702014|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2702015|NCT02306798|Mesalamine|mesalamine|mesh-list
2702016|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2702017|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2702018|NCT02306798|Analgesics|analgesics|mesh-ancestor
2702019|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
2702020|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702021|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702022|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2702023|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2702024|NCT02306889|Fenofibrate|fenofibrate|mesh-list
2702025|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2702026|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
2702027|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193777|NCT00003881|Trastuzumab|trastuzumab|mesh-list
2702028|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2702029|NCT02306902|Fenofibrate|fenofibrate|mesh-list
2702030|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2702031|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
2702032|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702033|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2702034|NCT02306954|Aldesleukin|aldesleukin|mesh-list
2702035|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702036|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2702037|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2702038|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
2702039|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702040|NCT02307006|Vancomycin|vancomycin|mesh-list
2702041|NCT02307006|Cefazolin|cefazolin|mesh-list
2702042|NCT02307006|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2702043|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2193778|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193779|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193780|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193781|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193782|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193783|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193784|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2193785|NCT00003883|Itraconazole|itraconazole|mesh-list
2193786|NCT00003883|Fluconazole|fluconazole|mesh-list
2193787|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
2193788|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193789|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2193790|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2193791|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193792|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193793|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2193794|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
2193795|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2193796|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193797|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2193798|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2193799|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2193800|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
2193801|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2193802|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193803|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
2193804|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702044|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702045|NCT02307045|Nicotine|nicotine|mesh-list
2193805|NCT00003888|Docetaxel|docetaxel|mesh-list
2193806|NCT00003888|Fluorouracil|fluorouracil|mesh-list
2193807|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193808|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193809|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193810|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193811|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193812|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
2193813|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193814|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193815|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
2193816|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702046|NCT02307045|Varenicline|varenicline|mesh-list
2702047|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2702048|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
2702049|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702050|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702051|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2702052|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2702053|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
2702054|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702055|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702056|NCT02307149|Ipilimumab|ipilimumab|mesh-list
2702057|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2702058|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702059|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2702060|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702061|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
2702062|NCT02307201|Analgesics|analgesics|mesh-ancestor
2702063|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
2702064|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702065|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702066|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
2702067|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2702068|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2702069|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
2702070|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2702071|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2702072|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702073|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2702074|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
2702075|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2702076|NCT02307227|Paclitaxel|paclitaxel|mesh-list
2702077|NCT02307227|Docetaxel|docetaxel|mesh-list
2702078|NCT02307227|Trastuzumab|trastuzumab|mesh-list
2702079|NCT02307227|Epirubicin|epirubicin|mesh-list
2702080|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2702081|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702082|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
2702083|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
2702084|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
2702085|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702086|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2702087|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2702088|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2702089|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2702090|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702091|NCT02307305|Acetaminophen|acetaminophen|mesh-list
2702092|NCT02307305|Celecoxib|celecoxib|mesh-list
2702093|NCT02307305|Naproxen|naproxen|mesh-list
2702094|NCT02307305|Oxycodone|oxycodone|mesh-list
2702095|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2702096|NCT02307305|Tramadol|tramadol|mesh-list
2702097|NCT02307305|Naloxone|naloxone|mesh-list
2702098|NCT02307305|Esomeprazole|esomeprazole|mesh-list
2702099|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2702100|NCT02307305|Analgesics|analgesics|mesh-ancestor
2702101|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
2702102|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702103|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702104|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
2702105|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2702106|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2702107|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2702108|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2702109|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2702110|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702111|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702112|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2702113|NCT02307305|Narcotics|narcotics|mesh-ancestor
2702114|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2702115|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2702116|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2702117|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2702118|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2702119|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2702120|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2702121|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702122|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
2702123|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2702124|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
2702125|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
2702126|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2702127|NCT02307383|Lactitol|lactitol|mesh-list
2702128|NCT02307383|Cathartics|cathartics|mesh-ancestor
2702129|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2702130|NCT02307396|Haloperidol|haloperidol|mesh-list
2702131|NCT02307396|Pimozide|pimozide|mesh-list
2702132|NCT02307396|Olanzapine|olanzapine|mesh-list
2702133|NCT02307396|Risperidone|risperidone|mesh-list
2702134|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2702135|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2702136|NCT02307396|Ziprasidone|ziprasidone|mesh-list
2702137|NCT02307396|Amisulpride|amisulpride|mesh-list
2702138|NCT02307396|Perphenazine|perphenazine|mesh-list
2702139|NCT02307396|Sertindole|sertindole|mesh-list
2702140|NCT02307396|Fluphenazine|fluphenazine|mesh-list
2702141|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
2193817|NCT00003891|Lurtotecan|lurtotecan|mesh-list
2193818|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193819|NCT00003892|ISIS 5132|isis 5132|mesh-list
2193820|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193821|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193822|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193823|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
2193824|NCT00003893|Doxorubicin|doxorubicin|mesh-list
2193825|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2193826|NCT00003893|Fluorouracil|fluorouracil|mesh-list
2193827|NCT00003893|Methotrexate|methotrexate|mesh-list
2193828|NCT00003893|Epirubicin|epirubicin|mesh-list
2193829|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
2193830|NCT00003893|Mitomycins|mitomycins|mesh-list
2193831|NCT00003893|Mitomycin|mitomycin|mesh-list
2193832|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193833|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
2193834|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193835|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193836|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193837|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
2193838|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193839|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193840|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2193841|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2193842|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2193843|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193844|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193845|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
2193846|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193847|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2193848|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
2193849|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2193850|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
2702142|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
2702143|NCT02307396|Sulpiride|sulpiride|mesh-list
2702144|NCT02307396|Thioridazine|thioridazine|mesh-list
2702145|NCT02307396|Clopenthixol|clopenthixol|mesh-list
2702146|NCT02307396|Fluspirilene|fluspirilene|mesh-list
2702147|NCT02307396|Benperidol|benperidol|mesh-list
2702148|NCT02307396|Bromperidol|bromperidol|mesh-list
2702149|NCT02307396|Perazine|perazine|mesh-list
2702150|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2702151|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
2702152|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702153|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702154|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702155|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2702156|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2702157|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2193851|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2193852|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2193853|NCT00003893|Analgesics|analgesics|mesh-ancestor
2193854|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
2193855|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2193856|NCT00003894|Thalidomide|thalidomide|mesh-list
2193857|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193858|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
2193859|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193860|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
2193861|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2193862|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193863|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2193864|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2193865|NCT00003894|Growth Substances|growth substances|mesh-ancestor
2193866|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
2193867|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193868|NCT00003897|Sargramostim|sargramostim|mesh-list
2193869|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
2193870|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193871|NCT00003899|Paclitaxel|paclitaxel|mesh-list
2193872|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
2193873|NCT00003899|Melphalan|melphalan|mesh-list
2193874|NCT00003899|Thiotepa|thiotepa|mesh-list
2193875|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193876|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193877|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
2702158|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2702159|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2702160|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
2702161|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
2702162|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
2702163|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702164|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2702165|NCT02307396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2702166|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2702167|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2702168|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
2702169|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2702170|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2702171|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2702172|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2702173|NCT02307487|Mitomycins|mitomycins|mesh-list
2702174|NCT02307487|Mitomycin|mitomycin|mesh-list
2702175|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2702176|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702177|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
2702178|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702179|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2702180|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702181|NCT02307565|Midodrine|midodrine|mesh-list
2702182|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
2702183|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
2702184|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702185|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702186|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2702187|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2702188|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2702189|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2702190|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
2702191|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702192|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702193|NCT02307591|Amiodarone|amiodarone|mesh-list
2702194|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2702195|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
2702196|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2702197|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2702198|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702199|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2702200|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2702201|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2702202|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702203|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2702204|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2702205|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2702219|NCT02307695|Saxagliptin|saxagliptin|mesh-list
2702220|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2702221|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2702222|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702223|NCT02307695|Incretins|incretins|mesh-ancestor
2702224|NCT02307695|Hormones|hormones|mesh-ancestor
2702225|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2702226|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
2702227|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702228|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702229|NCT02307721|Remifentanil|remifentanil|mesh-list
2702230|NCT02307721|Naloxone|naloxone|mesh-list
2702231|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2702232|NCT02307721|Narcotics|narcotics|mesh-ancestor
2702233|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2702234|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702235|NCT02307721|Analgesics|analgesics|mesh-ancestor
2702236|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
2702237|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702238|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2702239|NCT02307825|Azithromycin|azithromycin|mesh-list
2702240|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2702241|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702242|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
2702243|NCT02307864|Tramadol|tramadol|mesh-list
2702244|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2702245|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2702246|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702247|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2702248|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2702249|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702250|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702251|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702252|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2702253|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
2702254|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2702255|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702256|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2702257|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2702258|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2702259|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2702260|NCT02307864|Narcotics|narcotics|mesh-ancestor
2702261|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2702262|NCT02307864|Analgesics|analgesics|mesh-ancestor
2702263|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
2702264|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702265|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
2702266|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
2702267|NCT02307955|Protective Agents|protective agents|mesh-ancestor
2702268|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702269|NCT02307968|Insulin|insulin|mesh-list
2702270|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2702271|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702272|NCT02308072|Olaparib|olaparib|mesh-list
2193878|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193879|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193880|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193881|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193882|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
2193883|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193884|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193885|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193886|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
2193887|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2702273|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702274|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2702275|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702276|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702277|NCT02308098|Budesonide|budesonide|mesh-list
2702278|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
2702279|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2702280|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2702281|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2702282|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
2702283|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702284|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702285|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2702286|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
2702287|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
2702288|NCT02308098|Hormones|hormones|mesh-ancestor
2702289|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2702290|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2702291|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2702292|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2702293|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
2702294|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702295|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193888|NCT00003900|Docetaxel|docetaxel|mesh-list
2193889|NCT00003900|Irinotecan|irinotecan|mesh-list
2193890|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193891|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193892|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193893|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193894|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193895|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2193896|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193897|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193898|NCT00003902|Capecitabine|capecitabine|mesh-list
2193899|NCT00003902|Vinorelbine|vinorelbine|mesh-list
2193900|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2193901|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
2193902|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193903|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193904|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2193905|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193906|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193907|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193908|NCT00003906|Tamoxifen|tamoxifen|mesh-list
2193909|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2193910|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2193911|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
2702296|NCT02308137|Domperidone|domperidone|mesh-list
2702297|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702298|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
2702299|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
2702300|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702301|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702302|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2702303|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2702304|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
2702305|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702306|NCT02308202|Perindopril|perindopril|mesh-list
2702307|NCT02308202|Doxazosin|doxazosin|mesh-list
2702308|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2702309|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
2702310|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702311|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702312|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2702313|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2702314|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2702315|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2702316|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
2702317|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702318|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702319|NCT02308241|Ribavirin|ribavirin|mesh-list
2702320|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
2702321|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702322|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
2702323|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702324|NCT02308254|Lixisenatide|lixisenatide|mesh-list
2702325|NCT02308254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2702326|NCT02308254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702327|NCT02308280|Bortezomib|bortezomib|mesh-list
2702328|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702329|NCT02308319|Tenofovir|tenofovir|mesh-list
2702330|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
2702331|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702332|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2702333|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2702334|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702335|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702336|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2702337|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2702338|NCT02308332|Tenofovir|tenofovir|mesh-list
2702339|NCT02308332|Emtricitabine|emtricitabine|mesh-list
2702340|NCT02308332|Rilpivirine|rilpivirine|mesh-list
2702341|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
2702342|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702343|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2702344|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2702345|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193912|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2702346|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193913|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193914|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2193915|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193916|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2193917|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2193918|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2193919|NCT00003908|Carboplatin|carboplatin|mesh-list
2193920|NCT00003908|Docetaxel|docetaxel|mesh-list
2193921|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193922|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193923|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193924|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193925|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193926|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
2193927|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193928|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2193929|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
2193930|NCT00003912|Carboplatin|carboplatin|mesh-list
2193931|NCT00003912|Doxorubicin|doxorubicin|mesh-list
2193932|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2193933|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702347|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2702348|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2702349|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
2702350|NCT02308527|Temozolomide|temozolomide|mesh-list
2702351|NCT02308527|Bevacizumab|bevacizumab|mesh-list
2702352|NCT02308527|Irinotecan|irinotecan|mesh-list
2702353|NCT02308527|Topotecan|topotecan|mesh-list
2702354|NCT02308527|Dinutuximab|dinutuximab|mesh-list
2702355|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2702356|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
2702357|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702358|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2702359|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2702360|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
2702361|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702362|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702363|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2702364|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2702365|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2702366|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2702367|NCT02308527|Growth Substances|growth substances|mesh-ancestor
2702368|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
2702369|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2702370|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2702371|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702372|NCT02308553|Paclitaxel|paclitaxel|mesh-list
2702373|NCT02308553|Nintedanib|nintedanib|mesh-list
2702374|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2702375|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193934|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2193935|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2193936|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193937|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193938|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193939|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
2193940|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
2193941|NCT00003913|Busulfan|busulfan|mesh-list
2193942|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2193943|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193944|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
2193945|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2193946|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193947|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2193948|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
2193949|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193950|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193951|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2702376|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
2702377|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
2702378|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
2702379|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702380|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2702381|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193952|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2193953|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
2702382|NCT02308644|Bevacizumab|bevacizumab|mesh-list
2702383|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2702384|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702385|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2702386|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2702387|NCT02308644|Growth Substances|growth substances|mesh-ancestor
2702388|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702389|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
2702390|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2193954|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
2193955|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2193956|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2193957|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
2193958|NCT00003913|Hormones|hormones|mesh-ancestor
2193959|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2193960|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2193961|NCT00003913|Protective Agents|protective agents|mesh-ancestor
2193962|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
2702391|NCT02308930|Vitamin D|vitamin d|mesh-list
2702392|NCT02308930|Vitamins|vitamins|mesh-list
2702393|NCT02308930|Vitamin A|vitamin a|mesh-list
2702394|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
2702395|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
2702396|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702397|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
2193963|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193964|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
2193965|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
2193966|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
2193967|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193968|NCT00003917|Topotecan|topotecan|mesh-list
2193969|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2193970|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2193971|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193972|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193973|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193974|NCT00003920|Cyclosporine|cyclosporine|mesh-list
2193975|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2193976|NCT00003920|Antibodies|antibodies|mesh-list
2193977|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
2193978|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2193979|NCT00003920|Cyclosporins|cyclosporins|mesh-list
2193980|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
2193981|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423472|NCT00822263|Antidotes|antidotes|mesh-ancestor
2702398|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702399|NCT02308930|Protective Agents|protective agents|mesh-ancestor
2702400|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2702401|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702402|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2702403|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
2702404|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
2702405|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702406|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2702407|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2702408|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
2702409|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702410|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702411|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2702412|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
2702413|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2702414|NCT02308982|Antibodies|antibodies|mesh-list
2702415|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
2702416|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2702417|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
2702418|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423473|NCT00822315|Efavirenz|efavirenz|mesh-list
2423474|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
2423475|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2423476|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2423477|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423478|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423479|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
2423480|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423481|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2423482|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2193982|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193983|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2193984|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2193985|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2193986|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
2193987|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2193988|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
2193989|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2193990|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2193991|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
2193992|NCT00003923|Trioxsalen|trioxsalen|mesh-list
2193993|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193994|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
2193995|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2193996|NCT00003924|Interferons|interferons|mesh-list
2193997|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
2193998|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2193999|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
2194000|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194001|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
2194002|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194003|NCT00003925|Leucovorin|leucovorin|mesh-list
2194004|NCT00003925|Gemcitabine|gemcitabine|mesh-list
2194005|NCT00003925|Tegafur|tegafur|mesh-list
2194006|NCT00003925|Calcium|calcium|mesh-list
2194007|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
2194008|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2194009|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
2194010|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702419|NCT02309177|Gemcitabine|gemcitabine|mesh-list
2702420|NCT02309177|Paclitaxel|paclitaxel|mesh-list
2702421|NCT02309177|Carboplatin|carboplatin|mesh-list
2702422|NCT02309177|Nivolumab|nivolumab|mesh-list
2702423|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2702424|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702425|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
2702426|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
2702427|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
2702428|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702429|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2702430|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
2702431|NCT02309177|Antiviral Agents|antiviral agents|mesh-ancestor
2702432|NCT02309177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702433|NCT02309177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702434|NCT02309177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2702435|NCT02309177|Immunologic Factors|immunologic factors|mesh-ancestor
2702436|NCT02309177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702437|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2702438|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2702439|NCT02309281|Aflibercept|aflibercept|mesh-list
2702440|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2702441|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2194011|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194012|NCT00003925|Antiviral Agents|antiviral agents|mesh-ancestor
2194013|NCT00003925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194014|NCT00003925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194015|NCT00003925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194016|NCT00003925|Immunologic Factors|immunologic factors|mesh-ancestor
2194017|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194018|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2702442|NCT02309281|Growth Substances|growth substances|mesh-ancestor
2702443|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702444|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
2702445|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702446|NCT02309320|Gontivimab|gontivimab|mesh-list
2702447|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
2702448|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702449|NCT02309346|Clindamycin|clindamycin|mesh-list
2702450|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
2702451|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
2702452|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2702453|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702454|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2702455|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702456|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702457|NCT02309385|Dexamethasone|dexamethasone|mesh-list
2194019|NCT00003925|Antidotes|antidotes|mesh-ancestor
2702458|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
2702459|NCT02309385|Prednisolone|prednisolone|mesh-list
2702460|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2702461|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
2702462|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2702463|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
2194020|NCT00003925|Protective Agents|protective agents|mesh-ancestor
2194021|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
2702464|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2702465|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
2702466|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2702467|NCT02309385|BB 1101|bb 1101|mesh-list
2702468|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2702469|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
2702470|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
2702471|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702472|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702473|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2702474|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
2702475|NCT02309385|Hormones|hormones|mesh-ancestor
2702476|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2702477|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2702478|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702479|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
2702480|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702481|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702482|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2702483|NCT02309385|Protective Agents|protective agents|mesh-ancestor
2702484|NCT02309424|Acetic Acid|acetic acid|mesh-list
2702485|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2702486|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702487|NCT02309437|Oxycodone|oxycodone|mesh-list
2702488|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2702489|NCT02309437|Narcotics|narcotics|mesh-ancestor
2702490|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2702491|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702492|NCT02309437|Analgesics|analgesics|mesh-ancestor
2702493|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
2702494|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702495|NCT02309450|Asunaprevir|asunaprevir|mesh-list
2702496|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
2702497|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702498|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702499|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
2702500|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702501|NCT02309554|Nonoxynol|nonoxynol|mesh-list
2702502|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2702503|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2702504|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702505|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2702506|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
2702507|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2702508|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2702509|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2702510|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
2702511|NCT02309645|Coagulants|coagulants|mesh-ancestor
2702512|NCT02309658|Gemcitabine|gemcitabine|mesh-list
2702513|NCT02309658|Cisplatin|cisplatin|mesh-list
2702514|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423483|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2423484|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2423485|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2423486|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2423487|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2423488|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2702515|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2702516|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
2423489|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2423490|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2423491|NCT00822380|Iron|iron|mesh-list
2423492|NCT00822380|Trace Elements|trace elements|mesh-list
2423493|NCT00822380|Folic Acid|folic acid|mesh-list
2423494|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
2423495|NCT00822380|Micronutrients|micronutrients|mesh-list
2423496|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423497|NCT00822380|Hematinics|hematinics|mesh-ancestor
2423498|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
2423499|NCT00822380|Vitamins|vitamins|mesh-ancestor
2702517|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702518|NCT02309658|Antiviral Agents|antiviral agents|mesh-ancestor
2702519|NCT02309658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702520|NCT02309658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702521|NCT02309658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2702522|NCT02309658|Immunologic Factors|immunologic factors|mesh-ancestor
2702523|NCT02309658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702524|NCT02309671|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2702525|NCT02309671|Hormones|hormones|mesh-ancestor
2702526|NCT02309671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2702527|NCT02309671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702528|NCT02309801|Daidzin|daidzin|mesh-list
2702529|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2702530|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702531|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194022|NCT00003925|Vitamins|vitamins|mesh-ancestor
2194023|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
2194024|NCT00003926|Melphalan|melphalan|mesh-list
2194025|NCT00003926|Busulfan|busulfan|mesh-list
2194026|NCT00003926|Thiotepa|thiotepa|mesh-list
2194027|NCT00003926|Lenograstim|lenograstim|mesh-list
2194028|NCT00003926|Sargramostim|sargramostim|mesh-list
2194029|NCT00003926|Amifostine|amifostine|mesh-list
2194030|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2194031|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
2194032|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194033|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194034|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
2194035|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194036|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702532|NCT02309879|Lidocaine|lidocaine|mesh-list
2702533|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
2702534|NCT02309879|Remifentanil|remifentanil|mesh-list
2702535|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
2702536|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
2702537|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2702538|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702539|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
2702540|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2194037|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194038|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194039|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2194040|NCT00003926|Protective Agents|protective agents|mesh-ancestor
2702541|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2702542|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2702543|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2702544|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2702545|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702546|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2702547|NCT02309879|Narcotics|narcotics|mesh-ancestor
2702548|NCT02309879|Analgesics|analgesics|mesh-ancestor
2702549|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
2702550|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2702551|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2702552|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
2702553|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2702554|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
2702555|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2702556|NCT02309970|Aspirin|aspirin|mesh-list
2702557|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2702558|NCT02309970|Warfarin|warfarin|mesh-list
2702559|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
2702560|NCT02309970|Dabigatran|dabigatran|mesh-list
2194041|NCT00003927|Paclitaxel|paclitaxel|mesh-list
2194042|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
2194043|NCT00003927|Doxorubicin|doxorubicin|mesh-list
2194044|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2194045|NCT00003927|Amifostine|amifostine|mesh-list
2702561|NCT02309970|Apixaban|apixaban|mesh-list
2702562|NCT02309970|Clopidogrel|clopidogrel|mesh-list
2702563|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2702564|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2702565|NCT02309970|Analgesics|analgesics|mesh-ancestor
2702566|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
2702567|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702568|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194046|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2702569|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2194047|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194048|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194049|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194050|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194051|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194052|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194053|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
2194054|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194055|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194056|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194057|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
2702570|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2702571|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2702572|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2702573|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194058|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194059|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194060|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194061|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194062|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194063|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2702574|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2702575|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2702576|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702577|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
2702578|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2702579|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2702580|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2702581|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
2702582|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702583|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
2702584|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2702585|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
2702586|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2702587|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
2702588|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2702589|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2702590|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2702591|NCT02310074|Hormones|hormones|mesh-list
2702592|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2702593|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2702594|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702595|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2702596|NCT02310087|Vitamin E|vitamin e|mesh-list
2702597|NCT02310087|Vitamins|vitamins|mesh-ancestor
2702598|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
2702599|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702600|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
2702601|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702602|NCT02310087|Protective Agents|protective agents|mesh-ancestor
2702603|NCT02310243|Palbociclib|palbociclib|mesh-list
2194064|NCT00003927|Protective Agents|protective agents|mesh-ancestor
2194065|NCT00003928|Gemcitabine|gemcitabine|mesh-list
2194066|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194067|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2194068|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
2194069|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194070|NCT00003928|Antiviral Agents|antiviral agents|mesh-ancestor
2194071|NCT00003928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194072|NCT00003928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194073|NCT00003928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194074|NCT00003928|Immunologic Factors|immunologic factors|mesh-ancestor
2194075|NCT00003928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194076|NCT00003929|Lomustine|lomustine|mesh-list
2194077|NCT00003929|Procarbazine|procarbazine|mesh-list
2194078|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194079|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
2194080|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194081|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194082|NCT00003930|Gemcitabine|gemcitabine|mesh-list
2194083|NCT00003930|Paclitaxel|paclitaxel|mesh-list
2194084|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194085|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194086|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194087|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
2702604|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702605|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2702606|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702607|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702608|NCT02310269|Pasireotide|pasireotide|mesh-list
2702609|NCT02310269|Hormones|hormones|mesh-ancestor
2702610|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2702611|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702612|NCT02310295|Triamcinolone|triamcinolone|mesh-list
2702613|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2702614|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2702615|NCT02310295|Bevacizumab|bevacizumab|mesh-list
2702616|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2702617|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2702618|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702619|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2702620|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2702621|NCT02310295|Growth Substances|growth substances|mesh-ancestor
2702622|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702623|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
2702624|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2702625|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
2702626|NCT02310295|Hormones|hormones|mesh-ancestor
2702627|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2702628|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2702629|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
2702630|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702631|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194088|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194089|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194090|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2194091|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
2194092|NCT00003930|Antiviral Agents|antiviral agents|mesh-ancestor
2194093|NCT00003930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194094|NCT00003930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194095|NCT00003930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194096|NCT00003930|Immunologic Factors|immunologic factors|mesh-ancestor
2194097|NCT00003930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702632|NCT02310347|Dronabinol|dronabinol|mesh-list
2702633|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
2702634|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702635|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2702636|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2702637|NCT02310347|Analgesics|analgesics|mesh-ancestor
2702638|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
2702639|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702640|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2194098|NCT00003934|Cytarabine|cytarabine|mesh-list
2194099|NCT00003934|Methotrexate|methotrexate|mesh-list
2194100|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
2194101|NCT00003934|Daunorubicin|daunorubicin|mesh-list
2194102|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
2194103|NCT00003934|Tretinoin|tretinoin|mesh-list
2194104|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2194105|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
2194106|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2194107|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194108|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2194109|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
2194110|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194111|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702641|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2702642|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702643|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702644|NCT02310347|Hormones|hormones|mesh-ancestor
2702645|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2702646|NCT02310360|Fallypride|fallypride|mesh-list
2702647|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2702648|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2702649|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
2702650|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702651|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702652|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702653|NCT02310373|Nicotine|nicotine|mesh-list
2194112|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
2194113|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194114|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2194115|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194116|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
2194117|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194118|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2194119|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
2194120|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194121|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194122|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194123|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194124|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
2702654|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2702655|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
2702656|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702657|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702658|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2702659|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2702660|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
2702661|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702662|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702663|NCT02310490|Mannitol|mannitol|mesh-list
2702664|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2702665|NCT02310490|Diuretics|diuretics|mesh-ancestor
2702666|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
2702667|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702676|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
2702677|NCT02310997|Melphalan|melphalan|mesh-list
2194125|NCT00003935|Etoposide|etoposide|mesh-list
2194126|NCT00003935|Vincristine|vincristine|mesh-list
2194127|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194128|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702678|NCT02310997|Busulfan|busulfan|mesh-list
2702679|NCT02310997|Fludarabine|fludarabine|mesh-list
2702680|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2702681|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
2702682|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702683|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2702684|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2702685|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
2702686|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702687|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702688|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2702689|NCT02311010|Tacrolimus|tacrolimus|mesh-list
2702690|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2702691|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
2702692|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702693|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2702694|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702695|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702696|NCT02311088|Caffeine|caffeine|mesh-list
2702697|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2702698|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702699|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2702700|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702701|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702702|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2702703|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2702704|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
2702705|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702706|NCT02311101|Mitomycins|mitomycins|mesh-list
2702707|NCT02311101|Mitomycin|mitomycin|mesh-list
2702708|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2702709|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194129|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2702710|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
2702711|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702712|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2702713|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702714|NCT02311179|Cimetidine|cimetidine|mesh-list
2702715|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2702716|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2702717|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2702718|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
2702719|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
2702720|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702721|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702722|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702723|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2702724|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2702725|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702726|NCT02311205|Sorafenib|sorafenib|mesh-list
2702727|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702728|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2702729|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702730|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702731|NCT02311231|Heparin|heparin|mesh-list
2702732|NCT02311231|Calcium heparin|calcium heparin|mesh-list
2702733|NCT02311231|Bivalirudin|bivalirudin|mesh-list
2702734|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
2702735|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2702736|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2702737|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702738|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
2702739|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2702740|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
2702741|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702742|NCT02311439|Folfirinox|folfirinox|mesh-list
2702743|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702744|NCT02311517|Ropivacaine|ropivacaine|mesh-list
2702745|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
2702746|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
2702747|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2702748|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702749|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
2702750|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2194130|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194131|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194132|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194133|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194134|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194135|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194136|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
2194137|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2194138|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
2194139|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194140|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194141|NCT00003937|Cisplatin|cisplatin|mesh-list
2194142|NCT00003937|Doxorubicin|doxorubicin|mesh-list
2194143|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2194144|NCT00003937|Methotrexate|methotrexate|mesh-list
2194145|NCT00003937|Etoposide|etoposide|mesh-list
2194146|NCT00003937|Ifosfamide|ifosfamide|mesh-list
2194147|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
2194148|NCT00003937|Razoxane|razoxane|mesh-list
2194149|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194150|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194151|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194152|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194153|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423500|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
2423501|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423502|NCT00822380|Protective Agents|protective agents|mesh-ancestor
2423503|NCT00822393|Busulfan|busulfan|mesh-list
2423504|NCT00822393|Treosulfan|treosulfan|mesh-list
2423505|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
2423506|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423507|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2423508|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
2423509|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423510|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2423511|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194154|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194155|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2194156|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
2194157|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2702751|NCT02311530|Felodipine|felodipine|mesh-list
2702752|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2702753|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2702754|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2702755|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2702756|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702757|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2702758|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702759|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
2702760|NCT02311569|Mirabegron|mirabegron|mesh-list
2702761|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2702762|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2702763|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2702764|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
2702765|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702766|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702767|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702768|NCT02311569|Urological Agents|urological agents|mesh-ancestor
2702769|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
2702770|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2702771|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702772|NCT02311608|Octreotide|octreotide|mesh-list
2702773|NCT02311608|Terlipressin|terlipressin|mesh-list
2702774|NCT02311608|Somatostatin|somatostatin|mesh-list
2702775|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2194158|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194159|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2702776|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2702777|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702778|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2702779|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2702780|NCT02311608|Hormones|hormones|mesh-ancestor
2702781|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2702782|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702783|NCT02311686|Ethanol|ethanol|mesh-list
2702784|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2702785|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702786|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2702787|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702788|NCT02311764|Carboplatin|carboplatin|mesh-list
2702789|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702790|NCT02311777|Pregabalin|pregabalin|mesh-list
2702791|NCT02311777|Ketamine|ketamine|mesh-list
2702792|NCT02311777|Analgesics|analgesics|mesh-ancestor
2702793|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
2702794|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2702795|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702796|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2702797|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2702798|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
2702799|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
2702800|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2702801|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2702802|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2702803|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702804|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702805|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
2702806|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2702807|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2702808|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2702809|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2702810|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2702811|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2702821|NCT02311946|Palbociclib|palbociclib|mesh-list
2702822|NCT02311946|Rabeprazole|rabeprazole|mesh-list
2702823|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2702824|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702825|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2702826|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702827|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702828|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2702829|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2702830|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
2702831|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2702832|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702833|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2702834|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
2702835|NCT02312037|Antibodies|antibodies|mesh-list
2702836|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
2194160|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
2194161|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
2194162|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2194163|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194164|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
2194165|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2423512|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2702837|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
2702838|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702839|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2702840|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702841|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2702842|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
2702843|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2702844|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
2702845|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2702846|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702847|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2702848|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2702849|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702850|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2702851|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
2702852|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2702853|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
2702854|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2702855|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702856|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2423513|NCT00822419|Lidocaine|lidocaine|mesh-list
2423514|NCT00822419|Ketamine|ketamine|mesh-list
2423515|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
2423516|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
2423517|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423518|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423519|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
2423520|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423521|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2423522|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2423523|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2423524|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2423525|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702857|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2702858|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702859|NCT02312102|Lenalidomide|lenalidomide|mesh-list
2702860|NCT02312102|Bortezomib|bortezomib|mesh-list
2702861|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
2702862|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702863|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2702864|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2702865|NCT02312102|Growth Substances|growth substances|mesh-ancestor
2702866|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
2702867|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702868|NCT02312115|Furosemide|furosemide|mesh-list
2702869|NCT02312115|Diuretics|diuretics|mesh-ancestor
2702870|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
2702871|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702872|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2702873|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2702874|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702875|NCT02312180|Plasminogen|plasminogen|mesh-list
2702876|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2702877|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2702878|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702879|NCT02312232|Levodopa|levodopa|mesh-list
2702880|NCT02312232|Carbidopa|carbidopa|mesh-list
2702881|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2702882|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2702883|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
2702884|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702885|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702886|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702887|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2702888|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702889|NCT02312245|Gemcitabine|gemcitabine|mesh-list
2702890|NCT02312245|Paclitaxel|paclitaxel|mesh-list
2702891|NCT02312245|Bevacizumab|bevacizumab|mesh-list
2702892|NCT02312245|Doxorubicin|doxorubicin|mesh-list
2702893|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2702894|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2702895|NCT02312245|Topotecan|topotecan|mesh-list
2702896|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2702897|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
2194166|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2194167|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194168|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194169|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
2194170|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2194171|NCT00003937|Protective Agents|protective agents|mesh-ancestor
2194172|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194173|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194174|NCT00003938|Amphotericin B|amphotericin b|mesh-list
2194175|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2194176|NCT00003938|Amebicides|amebicides|mesh-ancestor
2194177|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2702898|NCT02312245|Antibodies|antibodies|mesh-list
2702899|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
2702900|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2702901|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
2702902|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2423526|NCT00822419|Analgesics|analgesics|mesh-ancestor
2423527|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2423528|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2423529|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
2423530|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2423531|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2423532|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423533|NCT00822536|Aspirin|aspirin|mesh-list
2423534|NCT00822536|Clopidogrel|clopidogrel|mesh-list
2194178|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2194179|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194180|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2194181|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
2194182|NCT00003939|Trabectedin|trabectedin|mesh-list
2194183|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194184|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
2194185|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194186|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194187|NCT00003941|Etoposide|etoposide|mesh-list
2194188|NCT00003941|Ifosfamide|ifosfamide|mesh-list
2194189|NCT00003941|Bleomycin|bleomycin|mesh-list
2194190|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194191|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194192|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194193|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194194|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702903|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702904|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
2702905|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
2702906|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
2702907|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702908|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2423535|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2702909|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2702910|NCT02312245|Growth Substances|growth substances|mesh-ancestor
2702911|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702912|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
2702913|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
2702914|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2702915|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
2702916|NCT02312245|Antiviral Agents|antiviral agents|mesh-ancestor
2702917|NCT02312245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702918|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702919|NCT02312245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2702920|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2702921|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2702922|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2702923|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2702924|NCT02312297|Minocycline|minocycline|mesh-list
2702925|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2702926|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702927|NCT02312375|Amlodipine|amlodipine|mesh-list
2702928|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2702929|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2702930|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2702931|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702932|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2702933|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702934|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
2702935|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2702936|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
2702937|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702938|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702939|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2702940|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702941|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
2702942|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2702943|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2702944|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702945|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
2702946|NCT02312440|Coagulants|coagulants|mesh-ancestor
2702947|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
2702948|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2702949|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702950|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
2702951|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2702952|NCT02312531|Antibodies|antibodies|mesh-list
2702953|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
2702954|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702955|NCT02312544|Timolol|timolol|mesh-list
2702956|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2702957|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2702958|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
2702959|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2702960|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702961|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702962|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2702963|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2702964|NCT02312609|Minocycline|minocycline|mesh-list
2702965|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2702966|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702967|NCT02312635|Cycloserine|cycloserine|mesh-list
2702968|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2702969|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2702970|NCT02312635|Renal Agents|renal agents|mesh-ancestor
2702971|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2702972|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
2702973|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2702974|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
2194195|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194196|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194197|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
2194198|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194199|NCT00003943|Paclitaxel|paclitaxel|mesh-list
2194200|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
2194201|NCT00003943|Carboplatin|carboplatin|mesh-list
2194202|NCT00003943|Topotecan|topotecan|mesh-list
2702975|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702976|NCT02312661|Metformin|metformin|mesh-list
2702977|NCT02312661|Paclitaxel|paclitaxel|mesh-list
2702978|NCT02312661|Carboplatin|carboplatin|mesh-list
2702979|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2702980|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702981|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
2702982|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
2702983|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
2702984|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702985|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2702986|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2702987|NCT02312804|Paclitaxel|paclitaxel|mesh-list
2702988|NCT02312804|Carboplatin|carboplatin|mesh-list
2702989|NCT02312804|Infigratinib|infigratinib|mesh-list
2702990|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2702991|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2702992|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
2702993|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
2702994|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194203|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194204|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194205|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194206|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194207|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194208|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702995|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2702996|NCT02312908|Clonazepam|clonazepam|mesh-list
2702997|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
2702998|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
2702999|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
2703000|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703001|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194209|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194210|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
2194211|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194212|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194213|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194214|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
2194215|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194216|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194217|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194218|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194219|NCT00003944|Paclitaxel|paclitaxel|mesh-list
2194220|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
2194221|NCT00003944|Carboplatin|carboplatin|mesh-list
2194222|NCT00003944|Topotecan|topotecan|mesh-list
2194223|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194224|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194225|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194226|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194227|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194228|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703002|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703003|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
2703004|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2703005|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2703006|NCT02313051|Everolimus|everolimus|mesh-list
2703007|NCT02313051|Letrozole|letrozole|mesh-list
2194229|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194230|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
2194231|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194232|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194233|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2703008|NCT02313051|Goserelin|goserelin|mesh-list
2703009|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703010|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2703011|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
2703012|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703013|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2703014|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2703015|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703016|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703017|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2703018|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
2703019|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2703020|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2703021|NCT02313064|CXA-10|cxa-10|mesh-list
2703022|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2703023|NCT02313103|Lofexidine|lofexidine|mesh-list
2703024|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2703025|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2703026|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703027|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
2703028|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703029|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2703030|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2703031|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2703032|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
2703033|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703034|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703035|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
2703036|NCT02313220|Exenatide|exenatide|mesh-list
2703037|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2703038|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703039|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2703040|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194234|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
2194235|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194236|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194237|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194238|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194239|NCT00003945|Topotecan|topotecan|mesh-list
2194240|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194241|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194242|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194243|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703041|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2703042|NCT02313220|Incretins|incretins|mesh-ancestor
2703043|NCT02313220|Hormones|hormones|mesh-ancestor
2703044|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2703045|NCT02313272|Bevacizumab|bevacizumab|mesh-list
2703046|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
2703047|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2703048|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703049|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2703050|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2703051|NCT02313272|Growth Substances|growth substances|mesh-ancestor
2703052|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703053|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
2703054|NCT02313337|Fentanyl|fentanyl|mesh-list
2703055|NCT02313337|Midazolam|midazolam|mesh-list
2703056|NCT02313337|Anesthetics|anesthetics|mesh-list
2703057|NCT02313337|Propofol|propofol|mesh-list
2703058|NCT02313337|Atracurium|atracurium|mesh-list
2703059|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2703060|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703061|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2703062|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2703063|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
2703064|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2703065|NCT02313337|Narcotics|narcotics|mesh-ancestor
2703066|NCT02313337|Analgesics|analgesics|mesh-ancestor
2703067|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
2703068|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703069|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2703070|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2703071|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2703072|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2703073|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
2703074|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
2703075|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703076|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703077|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2703078|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2703079|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2703080|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2703081|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2194244|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194245|NCT00003946|Danazol|danazol|mesh-list
2194246|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2703082|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
2703083|NCT02313389|Rituximab|rituximab|mesh-list
2703084|NCT02313389|Methotrexate|methotrexate|mesh-list
2703085|NCT02313389|Temozolomide|temozolomide|mesh-list
2703086|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2703087|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703088|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
2703089|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703090|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2703091|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2703092|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
2703093|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2703094|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2703095|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
2703096|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703097|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
2703098|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703099|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2703100|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2703101|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2703102|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2703103|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
2703104|NCT02313584|Dabigatran|dabigatran|mesh-list
2703105|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
2703106|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2703107|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
2703108|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194247|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
2194248|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2194249|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194250|NCT00003950|Cyclosporine|cyclosporine|mesh-list
2194251|NCT00003950|Irinotecan|irinotecan|mesh-list
2194252|NCT00003950|Cyclosporins|cyclosporins|mesh-list
2703109|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703110|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
2703111|NCT02313727|Pamidronate|pamidronate|mesh-list
2703112|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2703113|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703114|NCT02313805|Insulin|insulin|mesh-list
2703115|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2703116|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194253|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194254|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194255|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194256|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194257|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194258|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194259|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
2194260|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194261|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
2194262|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194263|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
2194264|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194265|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2194266|NCT00003951|Exatecan|exatecan|mesh-list
2194267|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194268|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194269|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194270|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194271|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194272|NCT00003953|Tamoxifen|tamoxifen|mesh-list
2194273|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
2194274|NCT00003953|Docetaxel|docetaxel|mesh-list
2194275|NCT00003953|Doxorubicin|doxorubicin|mesh-list
2194276|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2194277|NCT00003953|Fluorouracil|fluorouracil|mesh-list
2194278|NCT00003953|Methotrexate|methotrexate|mesh-list
2194279|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2703138|NCT02313883|Taurolidine|taurolidine|mesh-list
2703139|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703140|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2703141|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703142|NCT02313922|Etanercept|etanercept|mesh-list
2703143|NCT02313922|Methotrexate|methotrexate|mesh-list
2703144|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2703145|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
2703146|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2703147|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703148|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2703149|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
2703150|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703151|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703152|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
2703153|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194280|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
2194281|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194282|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194283|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194284|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
2194285|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194286|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194287|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194288|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194289|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194290|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194291|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194292|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194293|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194294|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194295|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
2194296|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2194297|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2194298|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
2194299|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2194300|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
2194301|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2194302|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2194303|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2194304|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
2194305|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2194306|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2194307|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2194308|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2194309|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2194310|NCT00003954|Cyclosporine|cyclosporine|mesh-list
2194311|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
2194312|NCT00003954|Melphalan|melphalan|mesh-list
2194313|NCT00003954|Cyclosporins|cyclosporins|mesh-list
2194314|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194315|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703154|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2703155|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2703156|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
2703157|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2703158|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2703159|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2703160|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2703161|NCT02313922|Analgesics|analgesics|mesh-ancestor
2703162|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
2703163|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703164|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2703165|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2703166|NCT02314013|Metronidazole|metronidazole|mesh-list
2703167|NCT02314013|Cephalosporins|cephalosporins|mesh-list
2703168|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703169|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2703170|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2703171|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2703172|NCT02314169|Nivolumab|nivolumab|mesh-list
2703173|NCT02314169|Ipilimumab|ipilimumab|mesh-list
2703174|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2703175|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703176|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2703177|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703178|NCT02314182|Bevacizumab|bevacizumab|mesh-list
2703179|NCT02314182|Capecitabine|capecitabine|mesh-list
2703180|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
2703181|NCT02314182|Irinotecan|irinotecan|mesh-list
2703182|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2703183|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703184|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2703185|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2703186|NCT02314182|Growth Substances|growth substances|mesh-ancestor
2703187|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703188|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
2703189|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2703190|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
2703191|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703192|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2703193|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2703194|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703195|NCT02314195|Serotonin|serotonin|mesh-list
2703196|NCT02314195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2703197|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2703198|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
2703199|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703200|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703201|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703202|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2194316|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194317|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
2194318|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194319|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
2194320|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194321|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
2194322|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194323|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2703203|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2703204|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2703205|NCT02314208|Resveratrol|resveratrol|mesh-list
2703206|NCT02314208|Atorvastatin|atorvastatin|mesh-list
2703207|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2703208|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2703209|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
2703210|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703211|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2194324|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194325|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194326|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2194327|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
2194328|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2194329|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194330|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
2194331|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2703212|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2703213|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703214|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
2703215|NCT02314208|Protective Agents|protective agents|mesh-ancestor
2703216|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703217|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2703218|NCT02314208|Cathartics|cathartics|mesh-ancestor
2703219|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2194332|NCT00003955|Dactinomycin|dactinomycin|mesh-list
2194333|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
2194334|NCT00003955|Irinotecan|irinotecan|mesh-list
2194335|NCT00003955|Vincristine|vincristine|mesh-list
2194336|NCT00003955|Sargramostim|sargramostim|mesh-list
2194337|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194338|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
2194339|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194340|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194341|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194342|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
2194343|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194344|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703220|NCT02314273|Oprelvekin|oprelvekin|mesh-list
2703221|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703222|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2703223|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2703224|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2703225|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
2703226|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703227|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2703228|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2703229|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703230|NCT02314312|Cyclosporine|cyclosporine|mesh-list
2703231|NCT02314312|Prednisolone|prednisolone|mesh-list
2703232|NCT02314312|Everolimus|everolimus|mesh-list
2703233|NCT02314312|Cyclosporins|cyclosporins|mesh-list
2703234|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703235|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703236|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2703237|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
2703238|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703239|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
2703240|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703241|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
2703242|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2703243|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2703244|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703245|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2703246|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
2194345|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194346|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194347|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194348|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194349|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194350|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194351|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194352|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194353|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2194354|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194355|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194356|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2194357|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2194358|NCT00003956|Leucovorin|leucovorin|mesh-list
2194359|NCT00003956|Fluorouracil|fluorouracil|mesh-list
2194360|NCT00003956|Calcium|calcium|mesh-list
2194361|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
2194362|NCT00003956|Lonafarnib|lonafarnib|mesh-list
2194363|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2194364|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194365|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
2194366|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194367|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2194368|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194369|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194370|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
2194371|NCT00003956|Antidotes|antidotes|mesh-ancestor
2194372|NCT00003956|Protective Agents|protective agents|mesh-ancestor
2194373|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
2194374|NCT00003956|Vitamins|vitamins|mesh-ancestor
2194375|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
2194376|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194377|NCT00003957|Cytarabine|cytarabine|mesh-list
2194378|NCT00003957|Paclitaxel|paclitaxel|mesh-list
2194379|NCT00003957|Etoposide|etoposide|mesh-list
2194380|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
2194381|NCT00003957|Melphalan|melphalan|mesh-list
2194382|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
2194383|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2703247|NCT02314312|Hormones|hormones|mesh-ancestor
2703248|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2703249|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2703250|NCT02314325|Factor VIII|factor viii|mesh-list
2703251|NCT02314325|Coagulants|coagulants|mesh-ancestor
2703252|NCT02314351|Fentanyl|fentanyl|mesh-list
2703253|NCT02314351|Metoclopramide|metoclopramide|mesh-list
2703254|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2703255|NCT02314351|Narcotics|narcotics|mesh-ancestor
2703256|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2703257|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703258|NCT02314351|Analgesics|analgesics|mesh-ancestor
2703259|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
2703260|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703261|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2703262|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2703263|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
2703264|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
2703265|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
2703266|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
2703267|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2703268|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2703269|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2703270|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
2703271|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703272|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703273|NCT02314377|Bevacizumab|bevacizumab|mesh-list
2703274|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2703275|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703276|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2703277|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2703278|NCT02314377|Growth Substances|growth substances|mesh-ancestor
2703279|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703280|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
2703281|NCT02314468|Glycerol|glycerol|mesh-list
2703282|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2703283|NCT02314468|Protective Agents|protective agents|mesh-ancestor
2194384|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194385|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194386|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194387|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194388|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194389|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194390|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
2194391|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194392|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194393|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194394|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
2194395|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194396|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194397|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194398|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703284|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703285|NCT02314481|Trastuzumab|trastuzumab|mesh-list
2703286|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2703287|NCT02314481|Atezolizumab|atezolizumab|mesh-list
2703288|NCT02314481|Vemurafenib|vemurafenib|mesh-list
2703289|NCT02314481|Maytansine|maytansine|mesh-list
2703290|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2703291|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703292|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2703293|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703294|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703295|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2703296|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
2703297|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
2703298|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
2703299|NCT02314533|Fenofibrate|fenofibrate|mesh-list
2703300|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2703301|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
2703302|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703303|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2703304|NCT02314559|Propofol|propofol|mesh-list
2703305|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2703306|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2703307|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703308|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2194399|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2194400|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
2194401|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
2194402|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194403|NCT00003957|Analgesics|analgesics|mesh-ancestor
2194404|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
2194405|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2194406|NCT00003958|Dactinomycin|dactinomycin|mesh-list
2194407|NCT00003958|Cactinomycin|cactinomycin|mesh-list
2194408|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
2194409|NCT00003958|Vincristine|vincristine|mesh-list
2703309|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
2703310|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
2703311|NCT02314754|Misoprostol|misoprostol|mesh-list
2703312|NCT02314754|Mifepristone|mifepristone|mesh-list
2703313|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2703314|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
2194410|NCT00003958|Topotecan|topotecan|mesh-list
2194411|NCT00003958|Sargramostim|sargramostim|mesh-list
2194412|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194413|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
2194414|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194415|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194416|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194417|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
2194418|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194419|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194420|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194421|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194422|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194423|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194424|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194425|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194426|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194427|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194428|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2194429|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194430|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194431|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2703315|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2703316|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194432|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2194433|NCT00003959|Sargramostim|sargramostim|mesh-list
2194434|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
2194435|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194436|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
2194437|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2194438|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2194439|NCT00003960|Prednisolone|prednisolone|mesh-list
2194440|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
2194441|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
2194442|NCT00003960|Busulfan|busulfan|mesh-list
2703317|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2703318|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2703319|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
2703320|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2703321|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2703322|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2703323|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2703324|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
2703325|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2703326|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2703327|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
2703328|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2194443|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2194444|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
2194445|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2703329|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
2703330|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2703331|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2703332|NCT02314806|Clindamycin|clindamycin|mesh-list
2703333|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
2703334|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
2703335|NCT02314806|Gentamicins|gentamicins|mesh-list
2703336|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2703337|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2194446|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
2703338|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703339|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2703340|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703341|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703342|NCT02314871|Morphine|morphine|mesh-list
2703343|NCT02314871|Pirinitramide|pirinitramide|mesh-list
2703344|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2194447|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194448|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194449|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194450|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
2194451|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194452|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194453|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194454|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2194455|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
2194456|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
2194457|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2194458|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2194459|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
2703345|NCT02314871|Narcotics|narcotics|mesh-ancestor
2703346|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2703347|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703348|NCT02314871|Analgesics|analgesics|mesh-ancestor
2703349|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
2703350|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703351|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
2703352|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2703353|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2703354|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703355|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
2703356|NCT02314988|Coagulants|coagulants|mesh-ancestor
2703357|NCT02315001|Liraglutide|liraglutide|mesh-list
2703358|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2703359|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703360|NCT02315001|Incretins|incretins|mesh-ancestor
2703361|NCT02315001|Hormones|hormones|mesh-ancestor
2703362|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2703363|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2703364|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
2703365|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
2703366|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703367|NCT02315118|Rituximab|rituximab|mesh-list
2703368|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2703369|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703370|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
2703371|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703372|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2703373|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2703374|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2703375|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
2703376|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703377|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703378|NCT02315196|Paclitaxel|paclitaxel|mesh-list
2703379|NCT02315196|Carboplatin|carboplatin|mesh-list
2703380|NCT02315196|Doxorubicin|doxorubicin|mesh-list
2703381|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2703382|NCT02315196|Epirubicin|epirubicin|mesh-list
2703383|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2703384|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703385|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
2703386|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
2703387|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
2703388|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703389|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2703390|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2703391|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2703392|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703393|NCT02315287|Pioglitazone|pioglitazone|mesh-list
2703394|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2703395|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703396|NCT02315326|Rituximab|rituximab|mesh-list
2703397|NCT02315326|Methotrexate|methotrexate|mesh-list
2703398|NCT02315326|Procarbazine|procarbazine|mesh-list
2703399|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2703400|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703401|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
2703402|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703403|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2703404|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2703405|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
2703406|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2703407|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2703408|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
2703409|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194460|NCT00003960|Hormones|hormones|mesh-ancestor
2194461|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2194462|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2194463|NCT00003960|Protective Agents|protective agents|mesh-ancestor
2194464|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2194465|NCT00003961|Sargramostim|sargramostim|mesh-list
2194466|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
2194467|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194468|NCT00003962|Aldesleukin|aldesleukin|mesh-list
2194469|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194470|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2194471|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2194472|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
2194473|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194474|NCT00003963|Rituximab|rituximab|mesh-list
2194475|NCT00003963|Vinorelbine|vinorelbine|mesh-list
2194476|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2194477|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194478|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
2194479|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703410|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
2703411|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703412|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2703413|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2703414|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2703415|NCT02315391|Glycine|glycine|mesh-list
2703416|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
2703417|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703418|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703419|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703420|NCT02315495|Saxagliptin|saxagliptin|mesh-list
2703421|NCT02315495|Acarbose|acarbose|mesh-list
2703422|NCT02315495|Incretins|incretins|mesh-ancestor
2703423|NCT02315495|Hormones|hormones|mesh-ancestor
2703424|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2703425|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703426|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2703427|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
2703428|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703429|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703430|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2703431|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2703432|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2703433|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703434|NCT02315573|Lidocaine|lidocaine|mesh-list
2703435|NCT02315573|Epinephrine|epinephrine|mesh-list
2703436|NCT02315573|Racepinephrine|racepinephrine|mesh-list
2703437|NCT02315573|Bupivacaine|bupivacaine|mesh-list
2703438|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
2703439|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
2703440|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
2703441|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2703442|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703443|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
2703444|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703445|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2703446|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2703447|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2703448|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2703449|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703450|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2703451|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2703452|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
2703453|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703454|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2703455|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2703456|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
2703457|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2703458|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
2703459|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
2703460|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
2703461|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2703462|NCT02315651|Ubiquinone|ubiquinone|mesh-list
2703463|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
2703464|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
2703465|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703466|NCT02315651|Vitamins|vitamins|mesh-ancestor
2703467|NCT02315690|Piperaquine|piperaquine|mesh-list
2703468|NCT02315690|Artenimol|artenimol|mesh-list
2703469|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
2703470|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2703471|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2703472|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703473|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
2703474|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2703475|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703476|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2703477|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2703478|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2703479|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703480|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
2703481|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2703482|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2703483|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703484|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
2703485|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703486|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703487|NCT02316028|Decitabine|decitabine|mesh-list
2703488|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2703489|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
2703490|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703491|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703492|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194480|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194481|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194482|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194483|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194484|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194485|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194486|NCT00003966|Defibrotide|defibrotide|mesh-list
2194487|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2703498|NCT02316197|Peposertib|peposertib|mesh-list
2703499|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2703500|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703501|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703502|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
2703503|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2194488|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2194489|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194490|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2194491|NCT00003967|Etoposide|etoposide|mesh-list
2194492|NCT00003967|Topotecan|topotecan|mesh-list
2194493|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194494|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194495|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194496|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194497|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194498|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703504|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2703505|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703506|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2703507|NCT02316236|Analgesics|analgesics|mesh-ancestor
2703508|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
2703509|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703510|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2703511|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2194499|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194500|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
2703512|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2703513|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
2703514|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703515|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703516|NCT02316249|Estradiol|estradiol|mesh-list
2703517|NCT02316249|Hormones|hormones|mesh-ancestor
2703518|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2703519|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703520|NCT02316249|Estrogens|estrogens|mesh-ancestor
2703521|NCT02316301|Misoprostol|misoprostol|mesh-list
2703522|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2703523|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
2194501|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2194502|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
2194503|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194504|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194505|NCT00003970|Irinotecan|irinotecan|mesh-list
2194506|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194507|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194508|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194509|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194510|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194511|NCT00003972|Tamoxifen|tamoxifen|mesh-list
2194512|NCT00003972|Paclitaxel|paclitaxel|mesh-list
2194513|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
2194514|NCT00003972|Carboplatin|carboplatin|mesh-list
2194515|NCT00003972|Melphalan|melphalan|mesh-list
2194516|NCT00003972|Busulfan|busulfan|mesh-list
2703524|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2703525|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703526|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2703527|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2703528|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
2703529|NCT02316327|Gemcitabine|gemcitabine|mesh-list
2703530|NCT02316327|Bevacizumab|bevacizumab|mesh-list
2703531|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2703532|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703533|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2703534|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2703535|NCT02316327|Growth Substances|growth substances|mesh-ancestor
2703536|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703537|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
2703538|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2703539|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
2703540|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703541|NCT02316327|Antiviral Agents|antiviral agents|mesh-ancestor
2703542|NCT02316327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703543|NCT02316327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703544|NCT02316327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2703545|NCT02316327|Immunologic Factors|immunologic factors|mesh-ancestor
2703546|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
2703547|NCT02316340|Vorinostat|vorinostat|mesh-list
2703548|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
2703549|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2703550|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2703551|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703552|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703553|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703554|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2703555|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703556|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2703557|NCT02316379|Xenon|xenon|mesh-list
2703558|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2703559|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
2703560|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
2703561|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2194517|NCT00003972|Thiotepa|thiotepa|mesh-list
2194518|NCT00003972|Sargramostim|sargramostim|mesh-list
2194519|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194520|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194521|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194522|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194523|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194524|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703562|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703563|NCT02316496|Irinotecan|irinotecan|mesh-list
2703564|NCT02316496|Cetuximab|cetuximab|mesh-list
2703565|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2703566|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2703567|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703568|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703569|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703570|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2194525|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194526|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
2194527|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194528|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194529|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194530|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
2194531|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194532|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2194533|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
2194534|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2194535|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2194536|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2194537|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2194538|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2194539|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
2194540|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194541|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
2194542|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703571|NCT02316535|Capecitabine|capecitabine|mesh-list
2703572|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2703573|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
2703574|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703575|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703576|NCT02316626|Progesterone|progesterone|mesh-list
2194543|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194544|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194545|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
2194546|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194547|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703577|NCT02316626|Progestins|progestins|mesh-ancestor
2703578|NCT02316626|Hormones|hormones|mesh-ancestor
2703579|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2703580|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703581|NCT02316704|Tacrine|tacrine|mesh-list
2703582|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2703583|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703584|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703585|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
2703586|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703587|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703588|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2703589|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
2703590|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703591|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
2703592|NCT02316834|Talazoparib|talazoparib|mesh-list
2703593|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2703594|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703595|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703596|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703597|NCT02316899|Linaclotide|linaclotide|mesh-list
2703598|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2703599|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
2703600|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703601|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2703602|NCT02316964|Aldesleukin|aldesleukin|mesh-list
2703603|NCT02316964|Decitabine|decitabine|mesh-list
2703604|NCT02316964|Azacitidine|azacitidine|mesh-list
2703605|NCT02316964|Interleukin-2|interleukin-2|mesh-list
2703606|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2194548|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194549|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
2194550|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194551|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2703607|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
2703608|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703609|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703610|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703611|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2703612|NCT02316964|Analgesics|analgesics|mesh-ancestor
2703613|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
2703614|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703615|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703616|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2703617|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2703618|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
2703619|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703620|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
2703621|NCT02317146|Analgesics|analgesics|mesh-ancestor
2703622|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
2703623|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703624|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703625|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
2703626|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2703627|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2703628|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
2703629|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2703630|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2703631|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703632|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2194552|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194553|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194554|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
2194555|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194556|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2194557|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194558|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194559|NCT00003984|Lintuzumab|lintuzumab|mesh-list
2194560|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2194561|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194562|NCT00003985|KRN 7000|krn 7000|mesh-list
2194563|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2194564|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
2194565|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194566|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194567|NCT00003991|Aldesleukin|aldesleukin|mesh-list
2194568|NCT00003991|Histamine|histamine|mesh-list
2194569|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
2194570|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194571|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2194572|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2194573|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
2194574|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194575|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
2194576|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
2194577|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2194578|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194579|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194580|NCT00003992|Tamoxifen|tamoxifen|mesh-list
2194581|NCT00003992|Paclitaxel|paclitaxel|mesh-list
2194582|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
2194583|NCT00003992|Doxorubicin|doxorubicin|mesh-list
2194584|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2194585|NCT00003992|Trastuzumab|trastuzumab|mesh-list
2194586|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194587|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194588|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194589|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194590|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194591|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194592|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194593|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
2194594|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194595|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194596|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194597|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
2194598|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194599|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194600|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2703633|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
2194601|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194602|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194603|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2194604|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2194605|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
2194606|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2703634|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2703635|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
2703636|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703637|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2703638|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703639|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703640|NCT02317198|Clopidogrel|clopidogrel|mesh-list
2703641|NCT02317198|Ticagrelor|ticagrelor|mesh-list
2703642|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2703643|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2703644|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2703645|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2703646|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2703647|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
2703648|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703649|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703650|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703651|NCT02317237|Anesthetics|anesthetics|mesh-list
2703652|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2703653|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703654|NCT02317263|Testosterone|testosterone|mesh-list
2703655|NCT02317263|Androgens|androgens|mesh-ancestor
2703656|NCT02317263|Hormones|hormones|mesh-ancestor
2703657|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2703658|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703659|NCT02317341|Midazolam|midazolam|mesh-list
2703660|NCT02317341|Ketamine|ketamine|mesh-list
2703661|NCT02317341|Analgesics|analgesics|mesh-ancestor
2703662|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
2703663|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703664|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703665|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2703666|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2703667|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
2703668|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
2703669|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2703670|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2703671|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2703672|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703673|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703674|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2703675|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2194607|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2194608|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2194609|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2194610|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2194611|NCT00003993|Aldesleukin|aldesleukin|mesh-list
2194612|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
2194613|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194614|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2703676|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2703677|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2703678|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2703679|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
2703680|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
2703681|NCT02317419|Gemcitabine|gemcitabine|mesh-list
2703682|NCT02317419|Paclitaxel|paclitaxel|mesh-list
2703683|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2703684|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703685|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
2703686|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
2703687|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
2703688|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703689|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2703690|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
2194615|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2703691|NCT02317419|Antiviral Agents|antiviral agents|mesh-ancestor
2194616|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
2194617|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194618|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2194619|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
2194620|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194621|NCT00003994|Carboplatin|carboplatin|mesh-list
2703692|NCT02317419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703693|NCT02317419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703694|NCT02317419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2703695|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
2703696|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703697|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
2703698|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703699|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
2703700|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
2703701|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703702|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2703703|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703704|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2703705|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
2703706|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2703707|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2703708|NCT02317601|Prednisolone|prednisolone|mesh-list
2703709|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
2703710|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2703711|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
2703712|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2703713|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
2703714|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
2703715|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703716|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703717|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2703718|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
2703719|NCT02317601|Hormones|hormones|mesh-ancestor
2703720|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2703721|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2703722|NCT02317601|Protective Agents|protective agents|mesh-ancestor
2703723|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2703724|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703725|NCT02317640|Testosterone|testosterone|mesh-list
2703726|NCT02317640|Androgens|androgens|mesh-ancestor
2703727|NCT02317640|Hormones|hormones|mesh-ancestor
2703728|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2703729|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703730|NCT02317679|Bosentan|bosentan|mesh-list
2703731|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2423536|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2423537|NCT00822536|Analgesics|analgesics|mesh-ancestor
2423538|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
2423539|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423540|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423541|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2423542|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2423543|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2423544|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2423545|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423546|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2423547|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2423548|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423549|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
2423550|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2423551|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2423552|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2703732|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2703733|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703734|NCT02317770|Lidocaine|lidocaine|mesh-list
2703735|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
2703736|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
2703737|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2703738|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703739|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
2194622|NCT00003994|Fluorouracil|fluorouracil|mesh-list
2194623|NCT00003994|Vincristine|vincristine|mesh-list
2194624|NCT00003994|Amifostine|amifostine|mesh-list
2194625|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703740|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703741|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2703742|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2703743|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2703744|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2703745|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703753|NCT02317861|Febuxostat|febuxostat|mesh-list
2703754|NCT02317861|Verinurad|verinurad|mesh-list
2703755|NCT02317861|Benzbromarone|benzbromarone|mesh-list
2703756|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
2703757|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2703758|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
2703759|NCT02317861|Renal Agents|renal agents|mesh-ancestor
2703772|NCT02317991|Paclitaxel|paclitaxel|mesh-list
2703773|NCT02317991|Ramucirumab|ramucirumab|mesh-list
2703774|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2703775|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703776|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
2703777|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
2703778|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
2703779|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703780|NCT02318017|Methylphenidate|methylphenidate|mesh-list
2703781|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2703782|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703783|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2703784|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2703785|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2703786|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703787|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
2703788|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703789|NCT02318043|Fluticasone|fluticasone|mesh-list
2703790|NCT02318043|Budesonide|budesonide|mesh-list
2703791|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2703792|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2703793|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2703794|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2703795|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
2703796|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703797|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703798|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2703799|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
2194626|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
2194627|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194628|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2194629|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194630|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
2194631|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423553|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
2423554|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423555|NCT00822549|Morphine|morphine|mesh-list
2423556|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2423557|NCT00822549|Narcotics|narcotics|mesh-ancestor
2423558|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423559|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423560|NCT00822549|Analgesics|analgesics|mesh-ancestor
2423561|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
2703800|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
2703801|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2703802|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
2703803|NCT02318043|Hormones|hormones|mesh-ancestor
2703804|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2703805|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2703806|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2703807|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2703808|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
2703809|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703810|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703811|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
2703812|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2703813|NCT02318056|Bacitracin|bacitracin|mesh-list
2703814|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2703815|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703816|NCT02318056|Laxatives|laxatives|mesh-ancestor
2703817|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2703818|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2703819|NCT02318082|Aldesleukin|aldesleukin|mesh-list
2703820|NCT02318082|Interleukin-2|interleukin-2|mesh-list
2703821|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703822|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2703823|NCT02318082|Analgesics|analgesics|mesh-ancestor
2703824|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
2703825|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703826|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703827|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2703828|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2703829|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
2703830|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703831|NCT02318121|Oxytocin|oxytocin|mesh-list
2703832|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
2703833|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2703834|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703835|NCT02318199|Anesthetics|anesthetics|mesh-list
2703836|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2703837|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703838|NCT02318225|Misoprostol|misoprostol|mesh-list
2703839|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2703840|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
2703841|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2703842|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703843|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2703844|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2703845|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
2703846|NCT02318290|Analgesics|analgesics|mesh-list
2703847|NCT02318290|Narcotics|narcotics|mesh-list
2703848|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
2703849|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2194632|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194633|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194634|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194635|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194636|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2194637|NCT00003994|Protective Agents|protective agents|mesh-ancestor
2194638|NCT00003995|Trastuzumab|trastuzumab|mesh-list
2194639|NCT00003995|Irinotecan|irinotecan|mesh-list
2194640|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2194641|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194642|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194643|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2703850|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703851|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2703854|NCT02318433|Dexamethasone|dexamethasone|mesh-list
2703855|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2703856|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
2703857|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
2703858|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703859|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703860|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2703861|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
2194644|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703862|NCT02318433|Hormones|hormones|mesh-ancestor
2703863|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2194645|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194646|NCT00003996|Etoposide|etoposide|mesh-list
2194647|NCT00003996|Carmustine|carmustine|mesh-list
2194648|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703864|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2703865|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703866|NCT02318446|Folic Acid|folic acid|mesh-list
2703867|NCT02318446|Hematinics|hematinics|mesh-ancestor
2703868|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
2703869|NCT02318446|Vitamins|vitamins|mesh-ancestor
2703870|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
2703871|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703872|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
2703873|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2703874|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
2703875|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703876|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
2703877|NCT02318511|Protective Agents|protective agents|mesh-ancestor
2703878|NCT02318537|Cannabidiol|cannabidiol|mesh-list
2703879|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2703880|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
2703881|NCT02318563|Cannabidiol|cannabidiol|mesh-list
2703882|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2703883|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
2703892|NCT02318758|Ethanol|ethanol|mesh-list
2703893|NCT02318758|Treprostinil|treprostinil|mesh-list
2703894|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2703895|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703896|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2703897|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703898|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2703899|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
2703900|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2703901|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703902|NCT02318810|Rocuronium|rocuronium|mesh-list
2703903|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2703904|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2703905|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2703906|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703907|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703908|NCT02318836|Lofexidine|lofexidine|mesh-list
2703909|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2703910|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2703911|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703912|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
2703913|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2703914|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2703915|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2703916|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2703917|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
2703918|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703919|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703920|NCT02318888|Icodextrin|icodextrin|mesh-list
2703921|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
2703922|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2703923|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
2703924|NCT02319018|Leucovorin|leucovorin|mesh-list
2703925|NCT02319018|Folic Acid|folic acid|mesh-list
2703926|NCT02319018|Fluorouracil|fluorouracil|mesh-list
2703927|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
2703928|NCT02319018|Calcium|calcium|mesh-list
2703929|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
2703930|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2703931|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703932|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2703933|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
2194649|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2703934|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703935|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2703936|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703937|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2703938|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
2703939|NCT02319018|Antidotes|antidotes|mesh-ancestor
2703940|NCT02319018|Protective Agents|protective agents|mesh-ancestor
2703941|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
2703942|NCT02319018|Vitamins|vitamins|mesh-ancestor
2703943|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
2703944|NCT02319018|Hematinics|hematinics|mesh-ancestor
2703945|NCT02319135|Cytarabine|cytarabine|mesh-list
2703946|NCT02319135|Fludarabine|fludarabine|mesh-list
2703947|NCT02319135|Lenograstim|lenograstim|mesh-list
2703948|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703949|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2703950|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
2703951|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703952|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2703953|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
2703954|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703955|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
2703956|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2703957|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2703958|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
2703959|NCT02319161|Calcium|calcium|mesh-list
2703960|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2703961|NCT02319161|Esmolol|esmolol|mesh-list
2703962|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2703963|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703964|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2703965|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
2703966|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2703967|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703968|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2703969|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2703970|NCT02319187|Irinotecan|irinotecan|mesh-list
2703971|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2703972|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2703973|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2703974|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703975|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2703976|NCT02319200|Metformin|metformin|mesh-list
2703977|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2703978|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703979|NCT02319265|Melatonin|melatonin|mesh-list
2703980|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
2703981|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2703982|NCT02319265|Protective Agents|protective agents|mesh-ancestor
2703983|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2703984|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2194650|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194651|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194652|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194653|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194654|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194655|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
2194656|NCT00003997|Irofulven|irofulven|mesh-list
2194657|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194658|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
2194659|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194660|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194661|NCT00003998|Paclitaxel|paclitaxel|mesh-list
2194662|NCT00003998|Docetaxel|docetaxel|mesh-list
2194663|NCT00003998|Carboplatin|carboplatin|mesh-list
2194664|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194665|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194666|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194667|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194668|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194669|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194670|NCT00004001|Prednisone|prednisone|mesh-list
2194671|NCT00004001|Docetaxel|docetaxel|mesh-list
2194672|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
2194673|NCT00004001|Estramustine|estramustine|mesh-list
2194674|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194675|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194676|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
2703985|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2703986|NCT02319278|Hematinics|hematinics|mesh-ancestor
2703987|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2703988|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2703989|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
2703990|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2703991|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2703992|NCT02319343|Prednisolone|prednisolone|mesh-list
2703993|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
2703994|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2703995|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
2703996|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2703997|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
2703998|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
2703999|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704000|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704001|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2704002|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
2704003|NCT02319343|Hormones|hormones|mesh-ancestor
2704004|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2704005|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2194677|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194678|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194679|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2194680|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
2194681|NCT00004001|Hormones|hormones|mesh-ancestor
2194682|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2194683|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194684|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2194685|NCT00004001|Analgesics|analgesics|mesh-ancestor
2194686|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
2194687|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2194688|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194689|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194690|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194691|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194692|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
2194693|NCT00004002|Bortezomib|bortezomib|mesh-list
2194694|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194695|NCT00004003|Gemcitabine|gemcitabine|mesh-list
2194696|NCT00004003|Fluorouracil|fluorouracil|mesh-list
2194697|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194698|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2194699|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
2194700|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194701|NCT00004003|Antiviral Agents|antiviral agents|mesh-ancestor
2194702|NCT00004003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194703|NCT00004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194704|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194705|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
2704006|NCT02319343|Protective Agents|protective agents|mesh-ancestor
2704007|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2704008|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704009|NCT02319460|Thrombin|thrombin|mesh-list
2704010|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
2194706|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194707|NCT00004004|Procarbazine|procarbazine|mesh-list
2194708|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194709|NCT00004005|Leucovorin|leucovorin|mesh-list
2194710|NCT00004005|Fluorouracil|fluorouracil|mesh-list
2194711|NCT00004005|Irinotecan|irinotecan|mesh-list
2194712|NCT00004005|Calcium|calcium|mesh-list
2194713|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
2194714|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2704011|NCT02319460|Coagulants|coagulants|mesh-ancestor
2704012|NCT02319499|Vitamin A|vitamin a|mesh-list
2704013|NCT02319499|Iron|iron|mesh-list
2704014|NCT02319499|Zinc|zinc|mesh-list
2704015|NCT02319499|Vitamins|vitamins|mesh-ancestor
2704016|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
2704017|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704018|NCT02319499|Trace Elements|trace elements|mesh-ancestor
2194715|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194716|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
2194717|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704019|NCT02319564|Beclomethasone|beclomethasone|mesh-list
2704020|NCT02319564|Albuterol|albuterol|mesh-list
2704021|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2704022|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
2704023|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704024|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704025|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2194718|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2194719|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194720|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194721|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
2194722|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194723|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194724|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194725|NCT00004005|Antidotes|antidotes|mesh-ancestor
2194726|NCT00004005|Protective Agents|protective agents|mesh-ancestor
2194727|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
2194728|NCT00004005|Vitamins|vitamins|mesh-ancestor
2194729|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
2704026|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
2704027|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
2704028|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2704029|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2704030|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2704031|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2704032|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
2704033|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704034|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704035|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2704036|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
2704037|NCT02319564|Hormones|hormones|mesh-ancestor
2704038|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2704039|NCT02319577|Vinorelbine|vinorelbine|mesh-list
2704040|NCT02319577|Gefitinib|gefitinib|mesh-list
2194730|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
2194731|NCT00004006|Carboplatin|carboplatin|mesh-list
2194732|NCT00004006|Doxorubicin|doxorubicin|mesh-list
2194733|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2194734|NCT00004006|Etoposide|etoposide|mesh-list
2194735|NCT00004006|Topotecan|topotecan|mesh-list
2194736|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194737|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
2194738|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194739|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194740|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194741|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
2194742|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194743|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194744|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194745|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194746|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194747|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194748|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194749|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194750|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194751|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
2194752|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2194753|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
2194754|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194755|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194756|NCT00004009|Tipifarnib|tipifarnib|mesh-list
2194757|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194758|NCT00004010|Prednisone|prednisone|mesh-list
2194759|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
2194760|NCT00004010|Dacarbazine|dacarbazine|mesh-list
2194761|NCT00004010|Doxorubicin|doxorubicin|mesh-list
2194762|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2194763|NCT00004010|Etoposide|etoposide|mesh-list
2194764|NCT00004010|Vincristine|vincristine|mesh-list
2194765|NCT00004010|Bleomycin|bleomycin|mesh-list
2194766|NCT00004010|Vinblastine|vinblastine|mesh-list
2194767|NCT00004010|Procarbazine|procarbazine|mesh-list
2194768|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194769|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
2194770|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194771|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194772|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194773|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
2194774|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194775|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194776|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194777|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2704041|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2704042|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704043|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
2704044|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
2704045|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
2704046|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704047|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2704048|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704049|NCT02319616|Clobetasol|clobetasol|mesh-list
2704050|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2704051|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
2704052|NCT02319616|Hormones|hormones|mesh-ancestor
2704053|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2704054|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704055|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2704056|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2704057|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2704058|NCT02319707|Oxytocin|oxytocin|mesh-list
2704059|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
2704060|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2704061|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704062|NCT02319772|Galidesivir|galidesivir|mesh-list
2704063|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
2704064|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704065|NCT02319889|Paclitaxel|paclitaxel|mesh-list
2704066|NCT02319889|Carboplatin|carboplatin|mesh-list
2704067|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2704068|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2704069|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704070|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
2704071|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
2704072|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
2704073|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704074|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
2704075|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2704076|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2704077|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194778|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194779|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194780|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194781|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2194782|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
2194783|NCT00004010|Hormones|hormones|mesh-ancestor
2194784|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2194785|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2194786|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194787|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194788|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194789|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
2704078|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
2704079|NCT02319915|Coagulants|coagulants|mesh-ancestor
2704080|NCT02319941|Clopidogrel|clopidogrel|mesh-list
2704081|NCT02319941|Ticagrelor|ticagrelor|mesh-list
2704082|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2704083|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2704084|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2704085|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2704086|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
2704087|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704088|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704089|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704090|NCT02320032|Aripiprazole|aripiprazole|mesh-list
2704091|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
2704092|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
2704093|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2704094|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2704095|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2704096|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704097|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704098|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
2704099|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
2704100|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704101|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704102|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2704103|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2704104|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
2704105|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2704106|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2704107|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2704108|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2704109|NCT02320045|Exenatide|exenatide|mesh-list
2704110|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2704111|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704112|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2704113|NCT02320045|Incretins|incretins|mesh-ancestor
2704114|NCT02320045|Hormones|hormones|mesh-ancestor
2704115|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2704116|NCT02320084|Nitisinone|nitisinone|mesh-list
2704117|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704118|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704119|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2704120|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
2194790|NCT00004011|Paclitaxel|paclitaxel|mesh-list
2194791|NCT00004011|Carboplatin|carboplatin|mesh-list
2194792|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194793|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194794|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194795|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194796|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194797|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194798|NCT00004012|Capecitabine|capecitabine|mesh-list
2194799|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2194800|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
2194801|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194802|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194803|NCT00004013|Paclitaxel|paclitaxel|mesh-list
2194804|NCT00004013|Trastuzumab|trastuzumab|mesh-list
2194805|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194806|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194807|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194808|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194809|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194810|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194811|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2194812|NCT00004014|Doxorubicin|doxorubicin|mesh-list
2704121|NCT02320240|Citalopram|citalopram|mesh-list
2704122|NCT02320240|Fluoxetine|fluoxetine|mesh-list
2704123|NCT02320240|Paroxetine|paroxetine|mesh-list
2704124|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2704125|NCT02320240|Sertraline|sertraline|mesh-list
2704126|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2704127|NCT02320240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2704128|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2704129|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2704130|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704131|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704132|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
2704133|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704134|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2704135|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
2704136|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2704137|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704138|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2704139|NCT02320240|Analgesics|analgesics|mesh-ancestor
2704140|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
2704141|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
2704142|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2704143|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2704144|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704145|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2704146|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2194813|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2194814|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194815|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194816|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194817|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194818|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194819|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194820|NCT00004016|Interferons|interferons|mesh-list
2194821|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
2194822|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194823|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
2194824|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194825|NCT00004017|Antibodies|antibodies|mesh-list
2704147|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704148|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2704149|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2704150|NCT02320292|Rituximab|rituximab|mesh-list
2704151|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2704152|NCT02320292|Antibodies|antibodies|mesh-list
2704153|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
2704154|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2704155|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
2704156|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704157|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704158|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2704159|NCT02320357|Clopidogrel|clopidogrel|mesh-list
2704160|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2704161|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2704162|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2704163|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2704164|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
2704165|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704166|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704167|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704168|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2704169|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
2704170|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2704171|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
2704172|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704173|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704174|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2704175|NCT02320448|Cisplatin|cisplatin|mesh-list
2704176|NCT02320448|Doxorubicin|doxorubicin|mesh-list
2704177|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
2704178|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704179|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2704180|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2704181|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2704182|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704183|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704184|NCT02320474|Aflibercept|aflibercept|mesh-list
2704185|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2704186|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2704187|NCT02320474|Growth Substances|growth substances|mesh-ancestor
2704188|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704189|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
2704190|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704191|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2704192|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
2704193|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704194|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2704195|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2704196|NCT02320708|Acetaminophen|acetaminophen|mesh-list
2704197|NCT02320708|Ibuprofen|ibuprofen|mesh-list
2704198|NCT02320708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2704199|NCT02320708|Analgesics|analgesics|mesh-ancestor
2704200|NCT02320708|Sensory System Agents|sensory system agents|mesh-ancestor
2704201|NCT02320708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704202|NCT02320708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704203|NCT02320708|Antipyretics|antipyretics|mesh-ancestor
2704204|NCT02320708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2704205|NCT02320708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2704206|NCT02320708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2704207|NCT02320708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2704208|NCT02320708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704209|NCT02320708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704210|NCT02320734|Rocuronium|rocuronium|mesh-list
2704211|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2704212|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2704213|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2704214|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2194826|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2704215|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704216|NCT02320773|Mirabegron|mirabegron|mesh-list
2704217|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2194827|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
2194828|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194829|NCT00004022|Aldesleukin|aldesleukin|mesh-list
2194830|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
2194831|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194832|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2194833|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2194834|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
2194835|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194836|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
2194837|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194838|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194839|NCT00004024|Aldesleukin|aldesleukin|mesh-list
2194840|NCT00004024|Sargramostim|sargramostim|mesh-list
2194841|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
2194842|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
2704218|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2704219|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2704220|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
2704221|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704222|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704223|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704224|NCT02320773|Urological Agents|urological agents|mesh-ancestor
2704225|NCT02320877|Methaqualone|methaqualone|mesh-list
2704226|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2704227|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704228|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704229|NCT02321176|Resveratrol|resveratrol|mesh-list
2704230|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
2704231|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704232|NCT02321176|Protective Agents|protective agents|mesh-ancestor
2704233|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704234|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704235|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2194843|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194844|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194845|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2194846|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2194847|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
2194848|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194849|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2704236|NCT02321241|Aflibercept|aflibercept|mesh-list
2704237|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2704238|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2704239|NCT02321241|Growth Substances|growth substances|mesh-ancestor
2704240|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704241|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
2704242|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704243|NCT02321267|Ranibizumab|ranibizumab|mesh-list
2704244|NCT02321267|Aflibercept|aflibercept|mesh-list
2704245|NCT02321267|Verteporfin|verteporfin|mesh-list
2704246|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2704247|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2704248|NCT02321267|Growth Substances|growth substances|mesh-ancestor
2704249|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194850|NCT00004025|Aldesleukin|aldesleukin|mesh-list
2194851|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704250|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
2704251|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704252|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2704253|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
2704254|NCT02321280|Denosumab|denosumab|mesh-list
2704255|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2704256|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704257|NCT02321293|Curcumin|curcumin|mesh-list
2704258|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2704259|NCT02321293|Gefitinib|gefitinib|mesh-list
2704260|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704261|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2704262|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704263|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704264|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2194852|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2194853|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2194854|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
2194855|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194856|NCT00004028|Carmustine|carmustine|mesh-list
2194857|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194858|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
2194859|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194860|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194861|NCT00004029|Sargramostim|sargramostim|mesh-list
2194862|NCT00004029|Vaccines|vaccines|mesh-list
2194863|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
2194864|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194865|NCT00004030|Doxorubicin|doxorubicin|mesh-list
2194866|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2194867|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194868|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194869|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194870|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194871|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194872|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194873|NCT00004032|Interferons|interferons|mesh-list
2194874|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
2194875|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194876|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
2704265|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2704266|NCT02321293|Analgesics|analgesics|mesh-ancestor
2704267|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
2704268|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704269|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704270|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2704271|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2704272|NCT02321371|Rifaximin|rifaximin|mesh-list
2704273|NCT02321371|Lactulose|lactulose|mesh-list
2704274|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2704275|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704276|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2704277|NCT02321384|Ritonavir|ritonavir|mesh-list
2704278|NCT02321384|Midazolam|midazolam|mesh-list
2704279|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2704280|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2704281|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704282|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704283|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2704284|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2704285|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2704286|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2704287|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
2194877|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194878|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
2194879|NCT00004036|Carboplatin|carboplatin|mesh-list
2194880|NCT00004036|Sargramostim|sargramostim|mesh-list
2194881|NCT00004036|Amifostine|amifostine|mesh-list
2194882|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194883|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
2194884|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194885|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2423562|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423563|NCT00822614|Fentanyl|fentanyl|mesh-list
2423564|NCT00822614|Morphine|morphine|mesh-list
2423565|NCT00822614|Oxycodone|oxycodone|mesh-list
2423566|NCT00822614|Hydromorphone|hydromorphone|mesh-list
2194886|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194887|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
2194888|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194889|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194890|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194891|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2194892|NCT00004036|Protective Agents|protective agents|mesh-ancestor
2194893|NCT00004037|Docetaxel|docetaxel|mesh-list
2704288|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
2704289|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
2704290|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
2194894|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194895|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194896|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
2423567|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2423568|NCT00822614|Narcotics|narcotics|mesh-ancestor
2423569|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704291|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704292|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704293|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2704294|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2704295|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
2704296|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704297|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2704298|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2704299|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
2704300|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704301|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2704302|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2704303|NCT02321397|Oxycodone|oxycodone|mesh-list
2704304|NCT02321397|Naloxone|naloxone|mesh-list
2704305|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2704306|NCT02321397|Narcotics|narcotics|mesh-ancestor
2194897|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194898|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194899|NCT00004039|Interferons|interferons|mesh-list
2194900|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
2194901|NCT00004039|Prednisone|prednisone|mesh-list
2194902|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
2194903|NCT00004039|Rituximab|rituximab|mesh-list
2194904|NCT00004039|Doxorubicin|doxorubicin|mesh-list
2194905|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2194906|NCT00004039|Vincristine|vincristine|mesh-list
2194907|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2194908|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
2194909|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194910|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2194911|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2194912|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
2194913|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194914|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194915|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2194916|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2194917|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194918|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194919|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194920|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194921|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2194922|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
2194923|NCT00004039|Hormones|hormones|mesh-ancestor
2194924|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2194925|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2194926|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
2194927|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194928|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2194929|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
2194930|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
2194931|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
2194932|NCT00004040|Interferons|interferons|mesh-list
2194933|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
2194934|NCT00004040|Rituximab|rituximab|mesh-list
2194935|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2194936|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194937|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
2194938|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194939|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2704307|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704308|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704309|NCT02321397|Analgesics|analgesics|mesh-ancestor
2704310|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
2704311|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704312|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2704313|NCT02321501|Everolimus|everolimus|mesh-list
2704314|NCT02321501|Ceritinib|ceritinib|mesh-list
2704315|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704316|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2704317|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
2704318|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704319|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2704320|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704321|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704322|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
2704323|NCT02321579|Pyridoxal|pyridoxal|mesh-list
2704324|NCT02321579|Pyridoxine|pyridoxine|mesh-list
2194940|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
2704325|NCT02321579|Vitamins|vitamins|mesh-ancestor
2704326|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
2704327|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704328|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
2704329|NCT02321761|Amantadine|amantadine|mesh-list
2704330|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2704331|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2704332|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
2704333|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704334|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
2704335|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704336|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704337|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704338|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2704339|NCT02321761|Analgesics|analgesics|mesh-ancestor
2194941|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2194942|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2194943|NCT00004042|Antibodies|antibodies|mesh-list
2194944|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
2194945|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2194946|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
2194947|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194948|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194949|NCT00004043|Calcitriol|calcitriol|mesh-list
2704340|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
2704341|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704342|NCT02321839|Ranibizumab|ranibizumab|mesh-list
2704343|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2704344|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2704345|NCT02321839|Growth Substances|growth substances|mesh-ancestor
2704346|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704347|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
2704348|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704349|NCT02321852|Mannitol|mannitol|mesh-list
2704350|NCT02321852|Triflusal|triflusal|mesh-list
2704351|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2704352|NCT02321852|Diuretics|diuretics|mesh-ancestor
2704353|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
2704354|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704355|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2704356|NCT02321878|Liraglutide|liraglutide|mesh-list
2704357|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2704358|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704359|NCT02321878|Incretins|incretins|mesh-ancestor
2704360|NCT02321878|Hormones|hormones|mesh-ancestor
2704361|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2704362|NCT02322008|Adalimumab|adalimumab|mesh-list
2704363|NCT02322008|Infliximab|infliximab|mesh-list
2704364|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2194950|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2194951|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194952|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2194953|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2194954|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194955|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2194956|NCT00004043|Vitamins|vitamins|mesh-ancestor
2194957|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
2194958|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2194959|NCT00004045|Exatecan|exatecan|mesh-list
2194960|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2704365|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2704366|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
2704367|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2704368|NCT02322099|Alendronate|alendronate|mesh-list
2704369|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
2704370|NCT02322099|Tenofovir|tenofovir|mesh-list
2704371|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
2704372|NCT02322099|Calcium|calcium|mesh-list
2704373|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2704374|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704375|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
2704376|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704377|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2704378|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2704379|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704380|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704381|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2704382|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2704383|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2194961|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194962|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194963|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194964|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194965|NCT00004046|Exatecan|exatecan|mesh-list
2194966|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194967|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194968|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194969|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194970|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194971|NCT00004047|Exatecan|exatecan|mesh-list
2194972|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2194973|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194974|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194975|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194976|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194977|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2194978|NCT00004048|Doxorubicin|doxorubicin|mesh-list
2194979|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2194980|NCT00004048|Antibodies|antibodies|mesh-list
2194981|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
2194982|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2194983|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
2194984|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194985|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194986|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2194987|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2194988|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2194989|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2194990|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2194991|NCT00004050|Interleukin-2|interleukin-2|mesh-list
2194992|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2194993|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2194994|NCT00004050|Analgesics|analgesics|mesh-ancestor
2194995|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
2194996|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2194997|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2194998|NCT00004051|Irinotecan|irinotecan|mesh-list
2194999|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2704384|NCT02322099|Antacids|antacids|mesh-ancestor
2704385|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2704386|NCT02322099|Vitamins|vitamins|mesh-ancestor
2704387|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
2704388|NCT02322203|Niacin|niacin|mesh-list
2704389|NCT02322203|Niacinamide|niacinamide|mesh-list
2704390|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
2704391|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2704392|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
2704393|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704394|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2704395|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
2704396|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
2704397|NCT02322203|Vitamins|vitamins|mesh-ancestor
2704398|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
2704399|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704400|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
2704401|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
2704402|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
2704403|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704404|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704405|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
2704406|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704407|NCT02322372|Bupivacaine|bupivacaine|mesh-list
2704408|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
2704409|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704410|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704411|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
2704412|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
2704413|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704414|NCT02322502|Propofol|propofol|mesh-list
2704415|NCT02322502|Sevoflurane|sevoflurane|mesh-list
2704416|NCT02322502|Desflurane|desflurane|mesh-list
2704417|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2195000|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2704418|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704419|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704420|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2195001|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704421|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
2704422|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
2704423|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2704424|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2704425|NCT02322580|Etanercept|etanercept|mesh-list
2704426|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2704427|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2704428|NCT02322580|Analgesics|analgesics|mesh-ancestor
2704429|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
2704430|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704431|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704432|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2704433|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2704434|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2704435|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2704436|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
2704439|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
2704440|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2704441|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704442|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2704443|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2704444|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704445|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195002|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195003|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195004|NCT00004055|Paclitaxel|paclitaxel|mesh-list
2195005|NCT00004055|Topotecan|topotecan|mesh-list
2195006|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195007|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195008|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
2704446|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704447|NCT02322645|Eszopiclone|eszopiclone|mesh-list
2704448|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2704449|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704450|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704451|NCT02322658|Eszopiclone|eszopiclone|mesh-list
2704452|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2704453|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704454|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704455|NCT02322671|Montelukast|montelukast|mesh-list
2704456|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2704457|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
2704458|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2704459|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
2704460|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2704461|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704462|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2704463|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2704464|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704465|NCT02322853|Tamoxifen|tamoxifen|mesh-list
2704466|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2704467|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
2704468|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2704469|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704470|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2704471|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704472|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2704473|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2704474|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2704475|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2704476|NCT02323100|Glycerol|glycerol|mesh-list
2195009|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195010|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195011|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195012|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2195013|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195014|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195015|NCT00004056|Cytarabine|cytarabine|mesh-list
2195016|NCT00004056|Thioguanine|thioguanine|mesh-list
2704477|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2195017|NCT00004056|Melphalan|melphalan|mesh-list
2704478|NCT02323100|Protective Agents|protective agents|mesh-ancestor
2704479|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704480|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704481|NCT02323139|Azacitidine|azacitidine|mesh-list
2704482|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2704483|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
2704484|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704485|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704486|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704487|NCT02323191|Atezolizumab|atezolizumab|mesh-list
2704488|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704489|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
2704490|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195018|NCT00004056|Daunorubicin|daunorubicin|mesh-list
2195019|NCT00004056|Asparaginase|asparaginase|mesh-list
2195020|NCT00004056|Lenograstim|lenograstim|mesh-list
2195021|NCT00004056|Sargramostim|sargramostim|mesh-list
2195022|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2195023|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
2195024|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195025|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195026|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
2195027|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195028|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195029|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
2704491|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
2704492|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704493|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2704494|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2704495|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
2704496|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704497|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704498|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2704499|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2704500|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
2704501|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2704502|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
2704503|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704504|NCT02323282|Ropivacaine|ropivacaine|mesh-list
2704505|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
2704506|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
2704507|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704508|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704509|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
2704510|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704511|NCT02323347|Progesterone|progesterone|mesh-list
2704512|NCT02323347|Progestins|progestins|mesh-ancestor
2704513|NCT02323347|Hormones|hormones|mesh-ancestor
2704514|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2704515|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704516|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
2704517|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2704518|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2704519|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704520|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
2704521|NCT02323373|Coagulants|coagulants|mesh-ancestor
2704522|NCT02323399|Phenylephrine|phenylephrine|mesh-list
2704523|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
2704524|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2704525|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
2704526|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
2704527|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704528|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704529|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
2704530|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2704531|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
2704532|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
2704533|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2704534|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2704535|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2704536|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
2704537|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704538|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704539|NCT02323399|Protective Agents|protective agents|mesh-ancestor
2704540|NCT02323412|Amoxicillin|amoxicillin|mesh-list
2704541|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2704542|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704543|NCT02323438|Menthol|menthol|mesh-list
2704544|NCT02323438|Nicotine|nicotine|mesh-list
2704545|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2704546|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
2704547|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704548|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704549|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2704550|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2704551|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
2704552|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704553|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704554|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
2704555|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
2704556|NCT02323451|Chitosan|chitosan|mesh-list
2704557|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
2704558|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2195030|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195031|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195032|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195033|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
2195034|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195035|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2195036|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195037|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195038|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195039|NCT00004057|Paclitaxel|paclitaxel|mesh-list
2195040|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195041|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704559|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
2704560|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704561|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
2704562|NCT02323451|Protective Agents|protective agents|mesh-ancestor
2704563|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2704564|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2704565|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
2704566|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704567|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2704568|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
2704569|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
2704570|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
2704571|NCT02323451|Coagulants|coagulants|mesh-ancestor
2704572|NCT02323516|Aspirin|aspirin|mesh-list
2704573|NCT02323516|Loperamide|loperamide|mesh-list
2704574|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
2704575|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2704576|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2704577|NCT02323516|Analgesics|analgesics|mesh-ancestor
2704578|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
2195042|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195043|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195044|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195045|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195046|NCT00004059|Fluorouracil|fluorouracil|mesh-list
2195047|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2195048|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
2195049|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195050|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2704579|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704580|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704581|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2704582|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2704583|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2704584|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2704585|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704586|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2195051|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195052|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195053|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
2195054|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195055|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2195056|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195057|NCT00004060|Exatecan|exatecan|mesh-list
2195058|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2195059|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2704587|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2704588|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704589|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
2704590|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2704591|NCT02323529|Nitisinone|nitisinone|mesh-list
2704592|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704593|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704594|NCT02323594|Asunaprevir|asunaprevir|mesh-list
2704595|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
2704596|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704597|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704598|NCT02323607|Cytarabine|cytarabine|mesh-list
2704599|NCT02323607|Decitabine|decitabine|mesh-list
2704600|NCT02323607|Daunorubicin|daunorubicin|mesh-list
2704601|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2704602|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
2704603|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704604|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704605|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
2704606|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704607|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2704608|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
2704609|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704610|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2704611|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2704612|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2704613|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704645|NCT02323737|Cisplatin|cisplatin|mesh-list
2704646|NCT02323737|Etoposide|etoposide|mesh-list
2704647|NCT02323737|Irinotecan|irinotecan|mesh-list
2704648|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704649|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2704650|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2704651|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2704652|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704653|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704654|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2704655|NCT02323906|Sorafenib|sorafenib|mesh-list
2704656|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704657|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2195060|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195061|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195062|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195063|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
2195064|NCT00004061|Ifosfamide|ifosfamide|mesh-list
2704658|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704659|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704660|NCT02323971|Ticagrelor|ticagrelor|mesh-list
2704661|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2704662|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2704663|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2704664|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2704665|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
2704666|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704667|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704668|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704669|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2704670|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2704671|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704672|NCT02324010|Incretins|incretins|mesh-ancestor
2704673|NCT02324010|Hormones|hormones|mesh-ancestor
2704674|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2704675|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2704676|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
2704677|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704678|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704679|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
2704680|NCT02324088|Docetaxel|docetaxel|mesh-list
2704681|NCT02324088|Epirubicin|epirubicin|mesh-list
2704682|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2704683|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
2704684|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704685|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2704686|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2704687|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
2704688|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704689|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704690|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2704691|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
2704692|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
2704693|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
2704694|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2704695|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2704696|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2704697|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704698|NCT02324166|Cefazolin|cefazolin|mesh-list
2704699|NCT02324166|Lidocaine|lidocaine|mesh-list
2704700|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
2704701|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
2704702|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704703|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704704|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
2704705|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704706|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2704707|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2704708|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2704709|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2704710|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704711|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2704712|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704713|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
2704714|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2704715|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704716|NCT02324283|Propofol|propofol|mesh-list
2704717|NCT02324283|Desflurane|desflurane|mesh-list
2704718|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2704719|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704720|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704721|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2704722|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
2704723|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
2704724|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2704725|NCT02324296|Cisplatin|cisplatin|mesh-list
2704726|NCT02324296|Etoposide|etoposide|mesh-list
2704727|NCT02324296|Ifosfamide|ifosfamide|mesh-list
2704728|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704729|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2704730|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2704731|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2704732|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704733|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704734|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2704735|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
2704736|NCT02324309|Insulin Lispro|insulin lispro|mesh-list
2704737|NCT02324309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2704738|NCT02324309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704739|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2704740|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2704741|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704742|NCT02324413|Clonidine|clonidine|mesh-list
2704743|NCT02324413|Analgesics|analgesics|mesh-ancestor
2704744|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
2704745|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704746|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704747|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2704748|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
2704749|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
2704750|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2704751|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2704752|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2704753|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
2704754|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704755|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704756|NCT02324452|Fluorouracil|fluorouracil|mesh-list
2704757|NCT02324452|Capecitabine|capecitabine|mesh-list
2704758|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
2704759|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704760|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2704761|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704762|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2704763|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
2704764|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704765|NCT02324491|CKD732|ckd732|mesh-list
2704766|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2704767|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2704768|NCT02324491|Growth Substances|growth substances|mesh-ancestor
2704769|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195065|NCT00004061|Etoposide|etoposide|mesh-list
2195066|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195067|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
2195068|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195069|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195070|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195071|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
2195072|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195073|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195074|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195075|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2704770|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
2704771|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704772|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
2704773|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2704774|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704775|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2704776|NCT02324608|Cetuximab|cetuximab|mesh-list
2704777|NCT02324608|Antibodies|antibodies|mesh-list
2704778|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
2195076|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195077|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195078|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704779|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2704780|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
2704781|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704782|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704783|NCT02324621|TIC10 compound|tic10 compound|mesh-list
2704784|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704785|NCT02324686|Vitamin K|vitamin k|mesh-list
2704786|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
2704787|NCT02324686|Vitamins|vitamins|mesh-ancestor
2704788|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
2704789|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704790|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2704791|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2704792|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704793|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
2704794|NCT02324686|Coagulants|coagulants|mesh-ancestor
2704795|NCT02324725|Naltrexone|naltrexone|mesh-list
2704796|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2704797|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2704798|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704799|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
2704800|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704801|NCT02324738|Piperaquine|piperaquine|mesh-list
2704802|NCT02324738|Artenimol|artenimol|mesh-list
2704803|NCT02324738|Mefloquine|mefloquine|mesh-list
2704804|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
2704805|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2704806|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2704807|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704808|NCT02324933|Fentanyl|fentanyl|mesh-list
2704809|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2704810|NCT02324933|Narcotics|narcotics|mesh-ancestor
2704811|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704812|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704813|NCT02324933|Analgesics|analgesics|mesh-ancestor
2704814|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
2704815|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704816|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2704817|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2704818|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
2704819|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
2704820|NCT02324985|Ibuprofen|ibuprofen|mesh-list
2704821|NCT02324985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2704822|NCT02324985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2704823|NCT02324985|Analgesics|analgesics|mesh-ancestor
2704824|NCT02324985|Sensory System Agents|sensory system agents|mesh-ancestor
2704825|NCT02324985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704826|NCT02324985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704827|NCT02324985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2704828|NCT02324985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195079|NCT00004062|Azacitidine|azacitidine|mesh-list
2195080|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195081|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
2195082|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195083|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195084|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704829|NCT02324985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2704830|NCT02324985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704831|NCT02324985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704832|NCT02324998|Olaparib|olaparib|mesh-list
2704833|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2704834|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704835|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704836|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704837|NCT02325011|Fluconazole|fluconazole|mesh-list
2704838|NCT02325011|Nabiximols|nabiximols|mesh-list
2704839|NCT02325011|Dronabinol|dronabinol|mesh-list
2704840|NCT02325011|Cannabidiol|cannabidiol|mesh-list
2704841|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
2704842|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704843|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2704844|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2704845|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704846|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704847|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2704848|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
2704849|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2704850|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704851|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2704852|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2704853|NCT02325011|Analgesics|analgesics|mesh-ancestor
2704854|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
2704855|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704856|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
2704857|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
2704858|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2704859|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2704860|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2704861|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2704862|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704863|NCT02325011|Hormones|hormones|mesh-ancestor
2195085|NCT00004063|Gemcitabine|gemcitabine|mesh-list
2195086|NCT00004063|Interferons|interferons|mesh-list
2195087|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
2195088|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195089|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195090|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
2195091|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195092|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
2195093|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195094|NCT00004063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195095|NCT00004063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195096|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
2195097|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195098|NCT00004064|Oregovomab|oregovomab|mesh-list
2195099|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2195100|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195101|NCT00004066|Gemcitabine|gemcitabine|mesh-list
2704864|NCT02325024|Nabiximols|nabiximols|mesh-list
2704865|NCT02325024|Analgesics|analgesics|mesh-ancestor
2704866|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
2704867|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2195102|NCT00004066|Docetaxel|docetaxel|mesh-list
2195103|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195104|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
2195105|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195106|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195107|NCT00004066|Antiviral Agents|antiviral agents|mesh-ancestor
2195108|NCT00004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195109|NCT00004066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195110|NCT00004066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195111|NCT00004066|Immunologic Factors|immunologic factors|mesh-ancestor
2195112|NCT00004066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195113|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195114|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195115|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195116|NCT00004067|Paclitaxel|paclitaxel|mesh-list
2195117|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
2195118|NCT00004067|Doxorubicin|doxorubicin|mesh-list
2195119|NCT00004067|Trastuzumab|trastuzumab|mesh-list
2704868|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704869|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
2704870|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2704871|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2704872|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704873|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
2704874|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704875|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704876|NCT02325180|Lumefantrine|lumefantrine|mesh-list
2704877|NCT02325180|Artemether|artemether|mesh-list
2704878|NCT02325180|Piperaquine|piperaquine|mesh-list
2704879|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2704880|NCT02325180|Artenimol|artenimol|mesh-list
2704881|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
2704882|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2704883|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2704884|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704885|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
2704886|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2704887|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195120|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2195121|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195122|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195123|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195124|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195125|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423570|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423571|NCT00822614|Analgesics|analgesics|mesh-ancestor
2423572|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
2423573|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423574|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2423575|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2423576|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
2423577|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
2423578|NCT00822627|Vaccines|vaccines|mesh-list
2423579|NCT00822627|Immunologic Factors|immunologic factors|mesh-ancestor
2423580|NCT00822627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423581|NCT00822666|Clopidogrel|clopidogrel|mesh-list
2704888|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2704889|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195126|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195127|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195128|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
2195129|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195130|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195131|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195132|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
2195133|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195134|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2195135|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195136|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195137|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195138|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2195139|NCT00004068|Irinotecan|irinotecan|mesh-list
2195140|NCT00004068|Temozolomide|temozolomide|mesh-list
2195141|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2195142|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195143|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195144|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195145|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195146|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195147|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
2195148|NCT00004070|Interleukin-12|interleukin-12|mesh-list
2195149|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2195150|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
2195151|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195152|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2195153|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2195154|NCT00004070|Growth Substances|growth substances|mesh-ancestor
2195155|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
2195156|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195157|NCT00004071|Prednisone|prednisone|mesh-list
2195158|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
2704890|NCT02325245|Metformin|metformin|mesh-list
2704891|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2704892|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704893|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
2704894|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704895|NCT02325362|Miglustat|miglustat|mesh-list
2704896|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
2704897|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704898|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704899|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2704900|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2704901|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
2704902|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2704903|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2704904|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2704905|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704906|NCT02325440|Natalizumab|natalizumab|mesh-list
2704907|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2704908|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
2195159|NCT00004071|Leflunomide|leflunomide|mesh-list
2195160|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2195161|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
2195162|NCT00004071|Hormones|hormones|mesh-ancestor
2195163|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2195164|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195165|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2704909|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704910|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2704911|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704912|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2704913|NCT02325466|Aspirin|aspirin|mesh-list
2704914|NCT02325466|Ticagrelor|ticagrelor|mesh-list
2704915|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2704916|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2704917|NCT02325466|Analgesics|analgesics|mesh-ancestor
2704918|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
2704919|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704920|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704921|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2195166|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195167|NCT00004071|Analgesics|analgesics|mesh-ancestor
2195168|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
2195169|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2195170|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195171|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195172|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704922|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2704923|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2704924|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2704925|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704926|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2195173|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195174|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195175|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
2195176|NCT00004072|Carmustine|carmustine|mesh-list
2195177|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2195178|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195179|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
2195180|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195181|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195182|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195183|NCT00004073|Suramin|suramin|mesh-list
2195184|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
2195185|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
2195186|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2195187|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195188|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704927|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2704928|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2704929|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
2704930|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2704931|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2704932|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2704933|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
2704934|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704935|NCT02325479|Enoxaparin|enoxaparin|mesh-list
2704936|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
2704937|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2704938|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2704939|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704940|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
2704941|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2704942|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704943|NCT02325583|Midazolam|midazolam|mesh-list
2704944|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2195189|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2195190|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2195191|NCT00004074|Carboplatin|carboplatin|mesh-list
2195192|NCT00004074|Trastuzumab|trastuzumab|mesh-list
2195193|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2195194|NCT00004074|Interleukin-12|interleukin-12|mesh-list
2195195|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195196|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2195197|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2704945|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2704946|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704947|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704948|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2704949|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2704950|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2704951|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2704952|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
2704953|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
2704954|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
2704955|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
2704956|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704957|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704958|NCT02325882|Fentanyl|fentanyl|mesh-list
2704959|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
2704960|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2704961|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2704962|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2704963|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2704964|NCT02325882|Analgesics|analgesics|mesh-ancestor
2704965|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
2704966|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2704967|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2704968|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2704969|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2704970|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
2704971|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2704972|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704973|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2704974|NCT02325882|Narcotics|narcotics|mesh-ancestor
2704975|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2704976|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2704977|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
2704978|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
2423582|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2423583|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2423584|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2423585|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2423586|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
2423587|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423588|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704979|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2195198|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
2195199|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195200|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2195201|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2195202|NCT00004074|Growth Substances|growth substances|mesh-ancestor
2195203|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
2195204|NCT00004077|Paclitaxel|paclitaxel|mesh-list
2195205|NCT00004077|Ifosfamide|ifosfamide|mesh-list
2195206|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195207|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195208|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195209|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195210|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195211|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195212|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195213|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
2195214|NCT00004078|Irinotecan|irinotecan|mesh-list
2195215|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2195216|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195217|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195218|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195219|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195220|NCT00004081|Docetaxel|docetaxel|mesh-list
2195221|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195222|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195223|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
2704980|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2704981|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2704982|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
2704983|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195224|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195225|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195226|NCT00004082|Gemcitabine|gemcitabine|mesh-list
2195227|NCT00004082|Carboplatin|carboplatin|mesh-list
2195228|NCT00004082|Docetaxel|docetaxel|mesh-list
2195229|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195230|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195231|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
2195232|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195233|NCT00004082|Antiviral Agents|antiviral agents|mesh-ancestor
2195234|NCT00004082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195235|NCT00004082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195236|NCT00004082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195237|NCT00004082|Immunologic Factors|immunologic factors|mesh-ancestor
2195238|NCT00004082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195239|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195240|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195241|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195242|NCT00004083|Cisplatin|cisplatin|mesh-list
2704984|NCT05144854|Capecitabine|capecitabine|mesh-list
2704985|NCT05144854|Tegafur|tegafur|mesh-list
2704986|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
2704987|NCT05144854|Nivolumab|nivolumab|mesh-list
2704988|NCT05144854|Ipilimumab|ipilimumab|mesh-list
2704989|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2704990|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
2704991|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2704992|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2704993|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2704994|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2195243|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195244|NCT00004084|Epratuzumab|epratuzumab|mesh-list
2195245|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2195246|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195247|NCT00004085|Antibodies|antibodies|mesh-list
2195248|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2195249|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
2195250|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195251|NCT00004086|Cytarabine|cytarabine|mesh-list
2195252|NCT00004086|Etoposide|etoposide|mesh-list
2705014|NCT05144529|Nivolumab|nivolumab|mesh-list
2705015|NCT05144529|Ipilimumab|ipilimumab|mesh-list
2705016|NCT05144529|Evolocumab|evolocumab|mesh-list
2705017|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2705018|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705019|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2705020|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705021|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2705022|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2705023|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
2705024|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2705025|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2705026|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195253|NCT00004086|Ifosfamide|ifosfamide|mesh-list
2195254|NCT00004086|Epratuzumab|epratuzumab|mesh-list
2195255|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195256|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195257|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195258|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195259|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195260|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195261|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
2195262|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195263|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195264|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
2195265|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
2195266|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195267|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195268|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195269|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
2195270|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2195271|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2195272|NCT00004087|Antibodies|antibodies|mesh-list
2195273|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
2195274|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2195275|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
2195276|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195277|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195278|NCT00004089|Paclitaxel|paclitaxel|mesh-list
2195279|NCT00004089|Fluorouracil|fluorouracil|mesh-list
2195280|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
2195281|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195282|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195283|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195284|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195285|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195286|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195287|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
2195288|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195289|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2705052|NCT05144282|Bevacizumab|bevacizumab|mesh-list
2705053|NCT05144282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2705054|NCT05144282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705055|NCT05144282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2705056|NCT05144282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2705057|NCT05144282|Growth Substances|growth substances|mesh-ancestor
2705058|NCT05144282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705059|NCT05144282|Growth Inhibitors|growth inhibitors|mesh-ancestor
2195290|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
2195291|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195292|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
2195293|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195294|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2195295|NCT00004090|Gemcitabine|gemcitabine|mesh-list
2195296|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195297|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195298|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
2195299|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195300|NCT00004090|Antiviral Agents|antiviral agents|mesh-ancestor
2195301|NCT00004090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195302|NCT00004090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195303|NCT00004090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195304|NCT00004090|Immunologic Factors|immunologic factors|mesh-ancestor
2195305|NCT00004090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705067|NCT05144100|Cisplatin|cisplatin|mesh-list
2705068|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705069|NCT05144009|Prednisone|prednisone|mesh-list
2195306|NCT00004091|Antibodies|antibodies|mesh-list
2195307|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
2195308|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195309|NCT00004093|Gemcitabine|gemcitabine|mesh-list
2705070|NCT05144009|Cyclophosphamide|cyclophosphamide|mesh-list
2705071|NCT05144009|Rituximab|rituximab|mesh-list
2705072|NCT05144009|Doxorubicin|doxorubicin|mesh-list
2705073|NCT05144009|Vincristine|vincristine|mesh-list
2705074|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
2705075|NCT05144009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195310|NCT00004093|Paclitaxel|paclitaxel|mesh-list
2195311|NCT00004093|Vinorelbine|vinorelbine|mesh-list
2195312|NCT00004093|Carboplatin|carboplatin|mesh-list
2195313|NCT00004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2705076|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
2705077|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705078|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2705079|NCT05144009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2705080|NCT05144009|Alkylating Agents|alkylating agents|mesh-ancestor
2195314|NCT00004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195315|NCT00004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195316|NCT00004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195317|NCT00004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195318|NCT00004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195319|NCT00004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195320|NCT00004093|Antimetabolites|antimetabolites|mesh-ancestor
2195321|NCT00004093|Antiviral Agents|antiviral agents|mesh-ancestor
2195322|NCT00004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195323|NCT00004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195324|NCT00004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195325|NCT00004093|Immunologic Factors|immunologic factors|mesh-ancestor
2195326|NCT00004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195327|NCT00004094|Paclitaxel|paclitaxel|mesh-list
2195328|NCT00004094|Carboplatin|carboplatin|mesh-list
2705081|NCT05144009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705082|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705083|NCT05144009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2705084|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2705085|NCT05144009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2705086|NCT05144009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2705087|NCT05144009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2705088|NCT05144009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2705089|NCT05144009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2705090|NCT05144009|Glucocorticoids|glucocorticoids|mesh-ancestor
2705091|NCT05144009|Hormones|hormones|mesh-ancestor
2705092|NCT05144009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2705093|NCT05144009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2705094|NCT05144009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2705095|NCT05144009|Tubulin Modulators|tubulin modulators|mesh-ancestor
2705096|NCT05144009|Antimitotic Agents|antimitotic agents|mesh-ancestor
2705097|NCT05144009|Mitosis Modulators|mitosis modulators|mesh-ancestor
2705098|NCT05143970|Trastuzumab|trastuzumab|mesh-list
2705099|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2705100|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705101|NCT05143762|Acetaminophen|acetaminophen|mesh-list
2705102|NCT05143762|Dexamethasone|dexamethasone|mesh-list
2705103|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2705104|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
2705105|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
2705106|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2705107|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705108|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2705109|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
2705110|NCT05143762|Hormones|hormones|mesh-ancestor
2705111|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2705112|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2705113|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705114|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2705115|NCT05143762|Analgesics|analgesics|mesh-ancestor
2705116|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
2705117|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
2705118|NCT05143723|Hormones|hormones|mesh-list
2705119|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2705120|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705121|NCT05143502|Fluticasone|fluticasone|mesh-list
2705122|NCT05143502|Xhance|xhance|mesh-list
2705123|NCT05143502|Prednisolone|prednisolone|mesh-list
2705124|NCT05143502|Montelukast|montelukast|mesh-list
2705125|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2705126|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2705127|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
2705128|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2705129|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705130|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2705131|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
2705132|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
2705133|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2705134|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
2705135|NCT05143502|Hormones|hormones|mesh-ancestor
2705136|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2705137|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2705138|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705139|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2705140|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
2705141|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2705142|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2705143|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195329|NCT00004094|Fluorouracil|fluorouracil|mesh-list
2195330|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
2195331|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195332|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195333|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195334|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195335|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195336|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705156|NCT05143424|Morphine|morphine|mesh-list
2705157|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2705158|NCT05143424|Narcotics|narcotics|mesh-ancestor
2195337|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
2195338|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195339|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195340|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
2195341|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195342|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
2705159|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2705160|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705161|NCT05143424|Analgesics|analgesics|mesh-ancestor
2705162|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
2705163|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2705164|NCT05143281|Dexamethasone|dexamethasone|mesh-list
2705165|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
2705166|NCT05143281|BB 1101|bb 1101|mesh-list
2705167|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2705168|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
2705169|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
2705170|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2705171|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705172|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2705173|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
2705174|NCT05143281|Hormones|hormones|mesh-ancestor
2705175|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2705176|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2705177|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705178|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
2705179|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2705180|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705181|NCT05143164|Gentamicins|gentamicins|mesh-list
2705182|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2705183|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2705184|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2705185|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2705186|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195343|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2705187|NCT05143125|Decitabine|decitabine|mesh-list
2705188|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2705189|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
2705190|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705191|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705192|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195344|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2195345|NCT00004095|Gemcitabine|gemcitabine|mesh-list
2195346|NCT00004095|Irinotecan|irinotecan|mesh-list
2705202|NCT05142904|Iodine|iodine|mesh-list
2705203|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
2705204|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2195347|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195348|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
2195349|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195350|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195351|NCT00004095|Antiviral Agents|antiviral agents|mesh-ancestor
2195352|NCT00004095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195353|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195354|NCT00004095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195355|NCT00004095|Immunologic Factors|immunologic factors|mesh-ancestor
2195356|NCT00004095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195357|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2705205|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2705206|NCT05142904|Trace Elements|trace elements|mesh-ancestor
2705207|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
2705208|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705209|NCT05142865|Carboplatin|carboplatin|mesh-list
2705210|NCT05142865|Etoposide|etoposide|mesh-list
2705211|NCT05142865|Apatinib|apatinib|mesh-list
2705212|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705213|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2705214|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2705215|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2705216|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2705217|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705218|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2195358|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195359|NCT00004096|Carboplatin|carboplatin|mesh-list
2195360|NCT00004096|Vinorelbine|vinorelbine|mesh-list
2195361|NCT00004096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195362|NCT00004096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195363|NCT00004096|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195364|NCT00004096|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195365|NCT00004096|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195366|NCT00004096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195367|NCT00004097|Gemcitabine|gemcitabine|mesh-list
2195368|NCT00004097|Paclitaxel|paclitaxel|mesh-list
2195369|NCT00004097|Fluorouracil|fluorouracil|mesh-list
2195370|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195371|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195372|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195373|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195374|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195375|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195376|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195377|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
2705231|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2705232|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705233|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705234|NCT05139225|Daratumumab|daratumumab|mesh-list
2705235|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705236|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
2705237|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2705238|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2705239|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705240|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2705241|NCT05139212|Analgesics|analgesics|mesh-ancestor
2705242|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
2705243|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2705244|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2705245|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2705246|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2705247|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
2705248|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2705249|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705250|NCT05118737|Colchicine|colchicine|mesh-list
2705251|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
2705252|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2705253|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
2705254|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
2705255|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
2705256|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705257|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705258|NCT05118685|Estrogens|estrogens|mesh-list
2705259|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2705260|NCT05118685|Hormones|hormones|mesh-ancestor
2705261|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2705262|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705304|NCT05109364|Terazosin|terazosin|mesh-list
2705305|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2705306|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2705307|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2705308|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
2705309|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2705310|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705311|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705312|NCT05109364|Urological Agents|urological agents|mesh-ancestor
2423589|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423590|NCT00822744|Citalopram|citalopram|mesh-list
2423591|NCT00822744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2423592|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2423593|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2423594|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423595|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423596|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
2423597|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195378|NCT00004097|Antiviral Agents|antiviral agents|mesh-ancestor
2195379|NCT00004097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195380|NCT00004097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195381|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195382|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
2195383|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195384|NCT00004099|Leucovorin|leucovorin|mesh-list
2195385|NCT00004099|Fluorouracil|fluorouracil|mesh-list
2195386|NCT00004099|Calcium|calcium|mesh-list
2195387|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
2195388|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195389|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2195390|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705378|NCT05063734|Aflibercept|aflibercept|mesh-list
2705379|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2705380|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2705381|NCT05063734|Growth Substances|growth substances|mesh-ancestor
2705382|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705383|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
2195391|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
2195392|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195393|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195394|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195395|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
2195396|NCT00004099|Antidotes|antidotes|mesh-ancestor
2195397|NCT00004099|Protective Agents|protective agents|mesh-ancestor
2195398|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
2195399|NCT00004099|Vitamins|vitamins|mesh-ancestor
2195400|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
2195401|NCT00004100|Gemcitabine|gemcitabine|mesh-list
2195402|NCT00004100|Vinorelbine|vinorelbine|mesh-list
2195403|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195404|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195405|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
2195406|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705384|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195407|NCT00004100|Antiviral Agents|antiviral agents|mesh-ancestor
2195408|NCT00004100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195409|NCT00004100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195410|NCT00004100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195411|NCT00004100|Immunologic Factors|immunologic factors|mesh-ancestor
2195412|NCT00004100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195413|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195414|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195415|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195416|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195417|NCT00004102|Leucovorin|leucovorin|mesh-list
2705397|NCT05055024|Mazindol|mazindol|mesh-list
2705398|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2705399|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705400|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2705401|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2705402|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2705403|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195418|NCT00004102|Fluorouracil|fluorouracil|mesh-list
2195419|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
2195420|NCT00004102|Calcium|calcium|mesh-list
2705404|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
2705405|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2705406|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2195421|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
2195422|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2195423|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195424|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
2195425|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195426|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195427|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195428|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195429|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
2195430|NCT00004102|Antidotes|antidotes|mesh-ancestor
2195431|NCT00004102|Protective Agents|protective agents|mesh-ancestor
2195432|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
2195433|NCT00004102|Vitamins|vitamins|mesh-ancestor
2195434|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
2195435|NCT00004103|Irinotecan|irinotecan|mesh-list
2705407|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
2705426|NCT05048264|Dexamethasone|dexamethasone|mesh-list
2705427|NCT05048264|Methylprednisolone|methylprednisolone|mesh-list
2705428|NCT05048264|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2705429|NCT05048264|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2705430|NCT05048264|Prednisolone|prednisolone|mesh-list
2705431|NCT05048264|Prednisolone acetate|prednisolone acetate|mesh-list
2705432|NCT05048264|Triamcinolone|triamcinolone|mesh-list
2705433|NCT05048264|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2705434|NCT05048264|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2705435|NCT05048264|Betamethasone|betamethasone|mesh-list
2705436|NCT05048264|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2705437|NCT05048264|Prednisolone phosphate|prednisolone phosphate|mesh-list
2705438|NCT05048264|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2705439|NCT05048264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2705440|NCT05048264|Antiemetics|antiemetics|mesh-ancestor
2705441|NCT05048264|Autonomic Agents|autonomic agents|mesh-ancestor
2705442|NCT05048264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2705443|NCT05048264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705444|NCT05048264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2705445|NCT05048264|Glucocorticoids|glucocorticoids|mesh-ancestor
2705446|NCT05048264|Hormones|hormones|mesh-ancestor
2705447|NCT05048264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2705448|NCT05048264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2705449|NCT05048264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705450|NCT05048264|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2705451|NCT05048264|Protective Agents|protective agents|mesh-ancestor
2705452|NCT05048264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195436|NCT00004103|Floxuridine|floxuridine|mesh-list
2195437|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195438|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2195439|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195440|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195441|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195442|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195443|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
2195444|NCT00004104|Interferons|interferons|mesh-list
2195445|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
2195446|NCT00004104|Interleukin-2|interleukin-2|mesh-list
2705453|NCT05048264|Immunologic Factors|immunologic factors|mesh-ancestor
2705454|NCT05048264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2705455|NCT05048264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705456|NCT05048264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2705457|NCT05048264|Respiratory System Agents|respiratory system agents|mesh-ancestor
2705458|NCT05045313|Probenecid|probenecid|mesh-list
2705459|NCT05045313|Digoxin|digoxin|mesh-list
2705460|NCT05045313|Warfarin|warfarin|mesh-list
2705461|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
2705462|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2705463|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2705464|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2705465|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705466|NCT05045313|Protective Agents|protective agents|mesh-ancestor
2705467|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705468|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
2705469|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
2705470|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2705471|NCT05045313|Renal Agents|renal agents|mesh-ancestor
2705472|NCT05042466|Psilocybin|psilocybin|mesh-list
2705473|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
2705474|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705475|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2705476|NCT05037552|Hemostatics|hemostatics|mesh-list
2705477|NCT05037552|Coagulants|coagulants|mesh-ancestor
2705478|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
2705479|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
2705480|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705481|NCT05036980|Protective Agents|protective agents|mesh-ancestor
2705482|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705483|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2705484|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195447|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195448|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
2195449|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195450|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
2195451|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195452|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2195453|NCT00004104|Analgesics|analgesics|mesh-ancestor
2195454|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
2195455|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2195456|NCT00004105|Paclitaxel|paclitaxel|mesh-list
2195457|NCT00004105|Vinorelbine|vinorelbine|mesh-list
2195458|NCT00004105|Estramustine|estramustine|mesh-list
2195459|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195460|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195461|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195462|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195463|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195464|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195465|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195466|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
2195467|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2195468|NCT00004106|Temozolomide|temozolomide|mesh-list
2195469|NCT00004106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195470|NCT00004106|Alkylating Agents|alkylating agents|mesh-ancestor
2195471|NCT00004106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195472|NCT00004106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195473|NCT00004107|Epratuzumab|epratuzumab|mesh-list
2195474|NCT00004107|Antibodies|antibodies|mesh-list
2195475|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2195476|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
2195477|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195478|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2705562|NCT05021926|Lidocaine|lidocaine|mesh-list
2705563|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
2705564|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
2705565|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
2705566|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2705567|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705568|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
2705569|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2705570|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2705571|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2705572|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2705573|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2195479|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195480|NCT00004108|Exatecan|exatecan|mesh-list
2705574|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195481|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2195482|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195483|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195484|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195485|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195486|NCT00004109|Doxorubicin|doxorubicin|mesh-list
2195487|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2195488|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2195489|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195490|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195491|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195492|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195493|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705575|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2705576|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
2705577|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
2705578|NCT05021926|Protective Agents|protective agents|mesh-ancestor
2705579|NCT05021913|Lidocaine|lidocaine|mesh-list
2705580|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
2705581|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
2705582|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
2705583|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2705584|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705585|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
2705586|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2705587|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2705588|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2705589|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2705590|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2705591|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195494|NCT00004110|Etoposide|etoposide|mesh-list
2195495|NCT00004110|Isotretinoin|isotretinoin|mesh-list
2195496|NCT00004110|Antibodies|antibodies|mesh-list
2195497|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2195498|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
2195499|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195500|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195501|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195502|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195503|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195504|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2705592|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2705593|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
2705594|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
2705595|NCT05021913|Protective Agents|protective agents|mesh-ancestor
2195505|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195506|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
2195507|NCT00004112|Prednisone|prednisone|mesh-list
2195508|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
2195509|NCT00004112|Rituximab|rituximab|mesh-list
2195510|NCT00004112|Doxorubicin|doxorubicin|mesh-list
2195511|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2195512|NCT00004112|Vincristine|vincristine|mesh-list
2195513|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195514|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
2195515|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195516|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195517|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195518|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
2195519|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195520|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195521|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195522|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2195523|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2195524|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195525|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195526|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195527|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2195528|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
2195529|NCT00004112|Hormones|hormones|mesh-ancestor
2195530|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2195531|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2195532|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195533|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195534|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195535|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195536|NCT00004113|Temozolomide|temozolomide|mesh-list
2195537|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195538|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
2195539|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195540|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195541|NCT00004114|Cytarabine|cytarabine|mesh-list
2195542|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
2195543|NCT00004114|Fludarabine|fludarabine|mesh-list
2195544|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
2195545|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195546|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
2195547|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195548|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195549|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195550|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
2195551|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195552|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195553|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195554|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195555|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
2195556|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
2195557|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195558|NCT00004115|Antibodies|antibodies|mesh-list
2195559|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2195560|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
2195561|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195562|NCT00004122|Interferons|interferons|mesh-list
2195563|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
2195564|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
2195565|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195566|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
2195567|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195568|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
2195569|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195570|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2195571|NCT00004123|Doxorubicin|doxorubicin|mesh-list
2195572|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2195573|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2195574|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195575|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195576|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195577|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195578|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195579|NCT00004125|Tamoxifen|tamoxifen|mesh-list
2195580|NCT00004125|Paclitaxel|paclitaxel|mesh-list
2195581|NCT00004125|Docetaxel|docetaxel|mesh-list
2195582|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
2195583|NCT00004125|Doxorubicin|doxorubicin|mesh-list
2195584|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2195585|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195586|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195587|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195588|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195589|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195590|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195591|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2705648|NCT05001373|Vaccines|vaccines|mesh-list
2705649|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
2195592|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
2195593|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195594|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2705650|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705662|NCT04987931|Talazoparib|talazoparib|mesh-list
2705663|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2705664|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2705665|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705666|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705675|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
2705676|NCT04961190|Paroxetine|paroxetine|mesh-list
2705677|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2705678|NCT04961190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2705679|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2705680|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2705681|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705682|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2705683|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
2705684|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705685|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2705686|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
2705687|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2705688|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2705689|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2705690|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2705691|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2705692|NCT04958811|Bevacizumab|bevacizumab|mesh-list
2705693|NCT04958811|Atezolizumab|atezolizumab|mesh-list
2705694|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2705695|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2705696|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2705697|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2705698|NCT04958811|Growth Substances|growth substances|mesh-ancestor
2705699|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705700|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
2705701|NCT04956627|Itraconazole|itraconazole|mesh-list
2705702|NCT04956627|Phenytoin|phenytoin|mesh-list
2705703|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
2705704|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
2705705|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2705706|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2705707|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2705708|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2705709|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705710|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2705711|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
2705712|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2705713|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705714|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2705715|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
2705716|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2705717|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2705718|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2705719|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2705720|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2705721|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2705722|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
2705723|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2705724|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2195595|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195596|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
2195597|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195598|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2195599|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195600|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195601|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195602|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2195603|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
2195604|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2195605|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2195606|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2195607|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2195608|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2195609|NCT00004126|Paclitaxel|paclitaxel|mesh-list
2195610|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
2195611|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195612|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195613|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195614|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195615|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195616|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195617|NCT00004127|Leucovorin|leucovorin|mesh-list
2195618|NCT00004127|Fluorouracil|fluorouracil|mesh-list
2195619|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
2195620|NCT00004127|Calcium|calcium|mesh-list
2195621|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
2195622|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2195623|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195624|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
2195625|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195626|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195627|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195628|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195629|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
2195630|NCT00004127|Antidotes|antidotes|mesh-ancestor
2195631|NCT00004127|Protective Agents|protective agents|mesh-ancestor
2195632|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
2195633|NCT00004127|Vitamins|vitamins|mesh-ancestor
2195634|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
2195635|NCT00004128|Cytarabine|cytarabine|mesh-list
2195636|NCT00004128|Aldesleukin|aldesleukin|mesh-list
2195637|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
2195638|NCT00004128|Busulfan|busulfan|mesh-list
2195639|NCT00004128|Etoposide|etoposide|mesh-list
2195640|NCT00004128|Daunorubicin|daunorubicin|mesh-list
2195641|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195642|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
2195643|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705745|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2705746|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195644|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195645|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195646|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
2705792|NCT04929847|Emollients|emollients|mesh-list
2705793|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
2705794|NCT04929834|Emollients|emollients|mesh-list
2705795|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
2195647|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195648|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195649|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195650|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195651|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195652|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195653|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195654|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195655|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
2195656|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
2195657|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195658|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2195659|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2195660|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2195661|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
2195662|NCT00004132|Ifosfamide|ifosfamide|mesh-list
2195663|NCT00004132|Etoposide|etoposide|mesh-list
2195664|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195665|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
2195666|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195667|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195668|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195669|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
2195670|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195671|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195672|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195673|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195674|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195675|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195676|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195677|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
2195678|NCT00004135|Fludarabine|fludarabine|mesh-list
2195679|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
2195680|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195681|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
2195682|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195683|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195684|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195685|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
2195686|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195687|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195688|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195689|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195690|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
2195691|NCT00004137|Paclitaxel|paclitaxel|mesh-list
2195692|NCT00004137|Carboplatin|carboplatin|mesh-list
2195693|NCT00004137|Topotecan|topotecan|mesh-list
2195694|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195695|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195696|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195697|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195698|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195699|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195700|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2195701|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195702|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195703|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2195704|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2195705|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195706|NCT00004139|Gemcitabine|gemcitabine|mesh-list
2195707|NCT00004139|Docetaxel|docetaxel|mesh-list
2195708|NCT00004139|Irinotecan|irinotecan|mesh-list
2705944|NCT04881955|Ecopipam|ecopipam|mesh-list
2705945|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2705946|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2705947|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2195709|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195710|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
2195711|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195712|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195713|NCT00004139|Antiviral Agents|antiviral agents|mesh-ancestor
2705948|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705949|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2705950|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2705951|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
2705952|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2705953|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705954|NCT04860713|Aspirin|aspirin|mesh-list
2705955|NCT04860713|Ketamine|ketamine|mesh-list
2705956|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2705957|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2705958|NCT04860713|Analgesics|analgesics|mesh-ancestor
2705959|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
2705960|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2705961|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705962|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2705963|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2705964|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2705965|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2705966|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705967|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2705968|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2705969|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2705970|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
2705971|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2705972|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2705973|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
2705974|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
2705975|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2705976|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2705977|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2195714|NCT00004139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195715|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195716|NCT00004139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195717|NCT00004139|Immunologic Factors|immunologic factors|mesh-ancestor
2195718|NCT00004139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195719|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195720|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195721|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195722|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2195723|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2423598|NCT00822744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2705978|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2705984|NCT04850222|Fluoxetine|fluoxetine|mesh-list
2705985|NCT04850222|Calcium|calcium|mesh-list
2705986|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2705987|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2705988|NCT04850222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2705989|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2705990|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2705991|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2705992|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2705993|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
2705994|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2705995|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
2423599|NCT00822744|Antidepressive Agents|antidepressive agents|mesh-ancestor
2423600|NCT00822744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2423601|NCT00822783|Omalizumab|omalizumab|mesh-list
2423602|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2423603|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2423604|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
2705996|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2423605|NCT00822809|Prednisolone|prednisolone|mesh-list
2423606|NCT00822809|Catumaxomab|catumaxomab|mesh-list
2423607|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2423608|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
2423609|NCT00822809|Hormones|hormones|mesh-ancestor
2195724|NCT00004141|Dacarbazine|dacarbazine|mesh-list
2195725|NCT00004141|Molgramostim|molgramostim|mesh-list
2195726|NCT00004141|Sargramostim|sargramostim|mesh-list
2195727|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195728|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
2195729|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195730|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195731|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
2195732|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195733|NCT00004142|Fluorouracil|fluorouracil|mesh-list
2705997|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2705998|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2705999|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195734|NCT00004142|Floxuridine|floxuridine|mesh-list
2195735|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
2195736|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195737|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195738|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195739|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195740|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
2195741|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195742|NCT00004144|Gemcitabine|gemcitabine|mesh-list
2195743|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
2195744|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195745|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
2195746|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195747|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195748|NCT00004144|Antiviral Agents|antiviral agents|mesh-ancestor
2195749|NCT00004144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195750|NCT00004144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195751|NCT00004144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195752|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
2195753|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195754|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2195755|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
2195756|NCT00004145|Fludarabine|fludarabine|mesh-list
2195757|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
2195758|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2195759|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195760|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
2195761|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706097|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
2706098|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2706099|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195762|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195763|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195764|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
2706105|NCT04743804|Ravulizumab|ravulizumab|mesh-list
2706106|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2706107|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2706108|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
2706109|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706117|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
2706118|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
2706119|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
2706120|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2706121|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706122|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2706123|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2706124|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
2706125|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
2706126|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2706127|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706128|NCT04722952|Cytarabine|cytarabine|mesh-list
2706129|NCT04722952|Azacitidine|azacitidine|mesh-list
2706130|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
2706131|NCT04722952|Visilizumab|visilizumab|mesh-list
2706132|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2706133|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
2195765|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195766|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195767|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195768|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195769|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
2195770|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
2195771|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195772|NCT00004150|Leucovorin|leucovorin|mesh-list
2195773|NCT00004150|Fluorouracil|fluorouracil|mesh-list
2195774|NCT00004150|Calcium|calcium|mesh-list
2195775|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
2195776|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2195777|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195778|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
2195779|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195780|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195781|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195782|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195783|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
2195784|NCT00004150|Antidotes|antidotes|mesh-ancestor
2706134|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706135|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2706136|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
2706137|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2706138|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2706139|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
2706140|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195785|NCT00004150|Protective Agents|protective agents|mesh-ancestor
2195786|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
2195787|NCT00004150|Vitamins|vitamins|mesh-ancestor
2195788|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
2195789|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2195790|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2195791|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195792|NCT00004154|Fenretinide|fenretinide|mesh-list
2195793|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2706141|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2706142|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2706143|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2706155|NCT04716933|Carboplatin|carboplatin|mesh-list
2195794|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2706156|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
2706157|NCT04716933|Pemetrexed|pemetrexed|mesh-list
2706158|NCT04716933|Lenvatinib|lenvatinib|mesh-list
2706159|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2706160|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2706161|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2706162|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706163|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2706164|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2706165|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2706166|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
2706167|NCT04715191|Fludarabine|fludarabine|mesh-list
2706168|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
2706169|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2706170|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
2195795|NCT00004154|Protective Agents|protective agents|mesh-ancestor
2195796|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195797|NCT00004157|Oprelvekin|oprelvekin|mesh-list
2195798|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195799|NCT00004158|Melphalan|melphalan|mesh-list
2195800|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195801|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
2195802|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195803|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195804|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195805|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195806|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
2195807|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706171|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706172|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2706173|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2706174|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
2706175|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706176|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2706177|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2706178|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2706179|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
2706180|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2706181|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
2706182|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195808|NCT00004159|Gemcitabine|gemcitabine|mesh-list
2195809|NCT00004159|Paclitaxel|paclitaxel|mesh-list
2195810|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195811|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195812|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
2706201|NCT04707664|Sargramostim|sargramostim|mesh-list
2706202|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
2706203|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706204|NCT04703361|Niacin|niacin|mesh-list
2706205|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2706206|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
2706207|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706208|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2706209|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
2706210|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
2706211|NCT04703361|Vitamins|vitamins|mesh-ancestor
2706212|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
2706213|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706217|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
2706218|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2706219|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2706220|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706221|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2706222|NCT04674241|Analgesics|analgesics|mesh-ancestor
2706223|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
2706224|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2706225|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2706226|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2195813|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195814|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195815|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195816|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195817|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
2195818|NCT00004159|Antiviral Agents|antiviral agents|mesh-ancestor
2195819|NCT00004159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2706227|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2706228|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
2706229|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2706230|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706236|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
2706237|NCT04670068|Fludarabine|fludarabine|mesh-list
2706238|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2706239|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
2195820|NCT00004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195821|NCT00004159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195822|NCT00004159|Immunologic Factors|immunologic factors|mesh-ancestor
2195823|NCT00004159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195824|NCT00004160|Gemcitabine|gemcitabine|mesh-list
2195825|NCT00004160|Paclitaxel|paclitaxel|mesh-list
2195826|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195827|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195828|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195829|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195830|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195831|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195832|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195833|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
2195834|NCT00004160|Antiviral Agents|antiviral agents|mesh-ancestor
2195835|NCT00004160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195836|NCT00004160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195837|NCT00004160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195838|NCT00004160|Immunologic Factors|immunologic factors|mesh-ancestor
2195839|NCT00004160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195840|NCT00004161|Fenretinide|fenretinide|mesh-list
2195841|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195842|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2195843|NCT00004161|Protective Agents|protective agents|mesh-ancestor
2195844|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195845|NCT00004162|Doxorubicin|doxorubicin|mesh-list
2195846|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2195847|NCT00004162|Methotrexate|methotrexate|mesh-list
2195848|NCT00004162|Vincristine|vincristine|mesh-list
2195849|NCT00004162|Sargramostim|sargramostim|mesh-list
2195850|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2195851|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195852|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195853|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195854|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195855|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195856|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2195857|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
2195858|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2706240|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706241|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2706242|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2706243|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
2706244|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195859|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195860|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195861|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
2195862|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
2195863|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2195864|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195865|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
2195866|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195867|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2195868|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195869|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195870|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195871|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
2706245|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2706246|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195872|NCT00004163|Trastuzumab|trastuzumab|mesh-list
2195873|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2195874|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195875|NCT00004164|Leucovorin|leucovorin|mesh-list
2195876|NCT00004164|Docetaxel|docetaxel|mesh-list
2195877|NCT00004164|Fluorouracil|fluorouracil|mesh-list
2195878|NCT00004164|Calcium|calcium|mesh-list
2195879|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
2195880|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195881|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195882|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195883|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195884|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195885|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2195886|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195887|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
2195888|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2195889|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195890|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
2195891|NCT00004164|Antidotes|antidotes|mesh-ancestor
2195892|NCT00004164|Protective Agents|protective agents|mesh-ancestor
2195893|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
2195894|NCT00004164|Vitamins|vitamins|mesh-ancestor
2195895|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
2195896|NCT00004165|Melphalan|melphalan|mesh-list
2195897|NCT00004165|Immunologic Factors|immunologic factors|mesh-ancestor
2195898|NCT00004165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706272|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
2706285|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
2706286|NCT04641728|Olaparib|olaparib|mesh-list
2706287|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2706288|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2706289|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2706290|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2706291|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195899|NCT00004165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195900|NCT00004165|Alkylating Agents|alkylating agents|mesh-ancestor
2195901|NCT00004165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195902|NCT00004165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195903|NCT00004165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195904|NCT00004165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195905|NCT00004166|Amifostine|amifostine|mesh-list
2195906|NCT00004166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2195907|NCT00004166|Protective Agents|protective agents|mesh-ancestor
2195908|NCT00004166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195909|NCT00004169|Cyclophosphamide|cyclophosphamide|mesh-list
2195910|NCT00004169|Carboplatin|carboplatin|mesh-list
2195911|NCT00004169|Etoposide|etoposide|mesh-list
2195912|NCT00004169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195913|NCT00004169|Immunologic Factors|immunologic factors|mesh-ancestor
2195914|NCT00004169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195915|NCT00004169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195916|NCT00004169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195917|NCT00004169|Alkylating Agents|alkylating agents|mesh-ancestor
2195918|NCT00004169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195919|NCT00004169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195920|NCT00004169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195921|NCT00004169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195922|NCT00004169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195923|NCT00004169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195924|NCT00004169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195925|NCT00004171|Cyclophosphamide|cyclophosphamide|mesh-list
2195926|NCT00004171|Busulfan|busulfan|mesh-list
2195927|NCT00004171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2706320|NCT04600895|Favipiravir|favipiravir|mesh-list
2706321|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
2706322|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2195928|NCT00004171|Immunologic Factors|immunologic factors|mesh-ancestor
2195929|NCT00004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195930|NCT00004171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195931|NCT00004171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195932|NCT00004171|Alkylating Agents|alkylating agents|mesh-ancestor
2195933|NCT00004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195934|NCT00004171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2706348|NCT04586660|Denosumab|denosumab|mesh-list
2706349|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2706350|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195935|NCT00004171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195936|NCT00004172|Cyclophosphamide|cyclophosphamide|mesh-list
2195937|NCT00004172|Ifosfamide|ifosfamide|mesh-list
2195938|NCT00004172|Thiotepa|thiotepa|mesh-list
2195939|NCT00004172|Carboplatin|carboplatin|mesh-list
2195940|NCT00004172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195941|NCT00004172|Immunologic Factors|immunologic factors|mesh-ancestor
2195942|NCT00004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195943|NCT00004172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195944|NCT00004172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195945|NCT00004172|Alkylating Agents|alkylating agents|mesh-ancestor
2195946|NCT00004172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195947|NCT00004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195948|NCT00004172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195949|NCT00004173|Paclitaxel|paclitaxel|mesh-list
2195950|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
2195951|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195952|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195953|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195954|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195955|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195956|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195957|NCT00004174|Paclitaxel|paclitaxel|mesh-list
2195958|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
2195959|NCT00004174|Thiotepa|thiotepa|mesh-list
2195960|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195961|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195962|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195963|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195964|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195965|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195966|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195967|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
2195968|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195969|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195970|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195971|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
2195972|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195973|NCT00004175|Cyclophosphamide|cyclophosphamide|mesh-list
2195974|NCT00004175|Docetaxel|docetaxel|mesh-list
2195975|NCT00004175|Doxorubicin|doxorubicin|mesh-list
2195976|NCT00004175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2195977|NCT00004175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2195978|NCT00004175|Immunologic Factors|immunologic factors|mesh-ancestor
2195979|NCT00004175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2195980|NCT00004175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2195981|NCT00004175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2195982|NCT00004175|Alkylating Agents|alkylating agents|mesh-ancestor
2195983|NCT00004175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2195984|NCT00004175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195985|NCT00004175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2195986|NCT00004175|Tubulin Modulators|tubulin modulators|mesh-ancestor
2195987|NCT00004175|Antimitotic Agents|antimitotic agents|mesh-ancestor
2195988|NCT00004175|Mitosis Modulators|mitosis modulators|mesh-ancestor
2195989|NCT00004175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2195990|NCT00004175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195991|NCT00004175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195992|NCT00004175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2195993|NCT00004176|Etoposide|etoposide|mesh-list
2195994|NCT00004176|Amifostine|amifostine|mesh-list
2195995|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2195996|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2195997|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2195998|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2195999|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196000|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196001|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2196002|NCT00004176|Protective Agents|protective agents|mesh-ancestor
2196003|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196004|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2196005|NCT00004177|Antibodies|antibodies|mesh-list
2196006|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
2196007|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2196008|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
2196009|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196010|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196011|NCT00004179|Prednisone|prednisone|mesh-list
2196012|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
2196013|NCT00004179|Rituximab|rituximab|mesh-list
2196014|NCT00004179|Doxorubicin|doxorubicin|mesh-list
2196015|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2196016|NCT00004179|Vincristine|vincristine|mesh-list
2196017|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196018|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
2196019|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196020|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196021|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196022|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
2196023|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196024|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196025|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2196026|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2196027|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2196028|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2196029|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196030|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196031|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2196032|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
2196033|NCT00004179|Hormones|hormones|mesh-ancestor
2196034|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2196035|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2196036|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196037|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196038|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196039|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196040|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
2196041|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2196042|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196043|NCT00004181|Cyclophosphamide|cyclophosphamide|mesh-list
2196044|NCT00004181|Busulfan|busulfan|mesh-list
2196045|NCT00004181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196046|NCT00004181|Immunologic Factors|immunologic factors|mesh-ancestor
2196047|NCT00004181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196048|NCT00004181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196049|NCT00004181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196050|NCT00004181|Alkylating Agents|alkylating agents|mesh-ancestor
2196051|NCT00004181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196052|NCT00004181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196053|NCT00004181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2196054|NCT00004182|Irinotecan|irinotecan|mesh-list
2196055|NCT00004182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2196056|NCT00004182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196057|NCT00004182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196058|NCT00004182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196059|NCT00004182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196060|NCT00004183|Capecitabine|capecitabine|mesh-list
2196061|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196062|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
2196063|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196064|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196065|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2196066|NCT00004184|Antibodies|antibodies|mesh-list
2196067|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2196068|NCT00004184|Sargramostim|sargramostim|mesh-list
2196069|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
2196070|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
2196071|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196072|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2196073|NCT00004184|Antacids|antacids|mesh-ancestor
2196074|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196075|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2196076|NCT00004186|Carboplatin|carboplatin|mesh-list
2706421|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
2706422|NCT04558359|Giapreza|giapreza|mesh-list
2706423|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
2706424|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2706425|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2706426|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
2706427|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2706428|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706429|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
2706430|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2706431|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2706432|NCT04551144|Estradiol|estradiol|mesh-list
2706433|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2706434|NCT04551144|Testosterone|testosterone|mesh-list
2706435|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
2706436|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
2706437|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2706438|NCT04551144|Estrogens|estrogens|mesh-ancestor
2706439|NCT04551144|Hormones|hormones|mesh-ancestor
2706440|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2706441|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706442|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2706443|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
2706444|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2706445|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2706446|NCT04551144|Androgens|androgens|mesh-ancestor
2706447|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2706448|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2706449|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
2706450|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2706451|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
2706452|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706462|NCT04534881|Progesterone|progesterone|mesh-list
2706463|NCT04534881|Progestins|progestins|mesh-ancestor
2706464|NCT04534881|Hormones|hormones|mesh-ancestor
2706465|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2706466|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706467|NCT04532502|Anesthetics|anesthetics|mesh-list
2706468|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
2706469|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2706470|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706471|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
2706472|NCT04532463|Fluconazole|fluconazole|mesh-list
2706473|NCT04532463|Amphotericin B|amphotericin b|mesh-list
2706474|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2706475|NCT04532463|Flucytosine|flucytosine|mesh-list
2706476|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
2706477|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2706478|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2706479|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2706480|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196077|NCT00004186|Etoposide|etoposide|mesh-list
2706481|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706482|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2706483|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
2706484|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2706485|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706486|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2706487|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2706488|NCT04532463|Amebicides|amebicides|mesh-ancestor
2706489|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2706490|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2706491|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2706492|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
2196078|NCT00004186|Topotecan|topotecan|mesh-list
2196079|NCT00004186|Ifosfamide|ifosfamide|mesh-list
2196080|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196081|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196082|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2196083|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196084|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196085|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196086|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2196087|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196088|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
2196089|NCT00004187|Capecitabine|capecitabine|mesh-list
2196090|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
2196091|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196092|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
2196093|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196094|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196095|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
2196096|NCT00004188|Melphalan|melphalan|mesh-list
2196097|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
2196098|NCT00004188|Cisplatin|cisplatin|mesh-list
2196099|NCT00004188|Carboplatin|carboplatin|mesh-list
2196100|NCT00004188|Doxorubicin|doxorubicin|mesh-list
2196101|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2196102|NCT00004188|Etoposide|etoposide|mesh-list
2196103|NCT00004188|Vincristine|vincristine|mesh-list
2196104|NCT00004188|Topotecan|topotecan|mesh-list
2196105|NCT00004188|Isotretinoin|isotretinoin|mesh-list
2196106|NCT00004188|Lenograstim|lenograstim|mesh-list
2196107|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196108|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
2196109|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196110|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196111|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196112|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
2196113|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196114|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196115|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2706531|NCT04496908|Misoprostol|misoprostol|mesh-list
2706532|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2706533|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
2196116|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2196117|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2196118|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196119|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196120|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196121|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2706534|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2706535|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706536|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2706537|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2706538|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
2196122|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196123|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196124|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196125|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2196126|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
2196127|NCT00004189|Cisplatin|cisplatin|mesh-list
2196128|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196129|NCT00004190|Gemcitabine|gemcitabine|mesh-list
2196130|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
2196131|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196132|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
2196133|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196134|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196135|NCT00004190|Antiviral Agents|antiviral agents|mesh-ancestor
2196136|NCT00004190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2706556|NCT04452747|Dinoprostone|dinoprostone|mesh-list
2706557|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
2706558|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2706559|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706577|NCT04428307|Artemisinins|artemisinins|mesh-list
2706578|NCT04428307|Artemisinin|artemisinin|mesh-list
2706579|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
2706580|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2706581|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2706582|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2706583|NCT04425538|Infliximab|infliximab|mesh-list
2706584|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
2706585|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2706586|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2706587|NCT04384107|Vaccines|vaccines|mesh-list
2706588|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
2706589|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706590|NCT04382924|Ifenprodil|ifenprodil|mesh-list
2706591|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2706592|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2706593|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
2706594|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2706595|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706596|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196137|NCT00004190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196138|NCT00004190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196139|NCT00004190|Immunologic Factors|immunologic factors|mesh-ancestor
2196140|NCT00004190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196141|NCT00004192|Cytarabine|cytarabine|mesh-list
2196142|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
2196143|NCT00004192|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2196144|NCT00004192|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2196145|NCT00004192|Prednisolone|prednisolone|mesh-list
2196146|NCT00004192|Prednisolone acetate|prednisolone acetate|mesh-list
2706597|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
2706598|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2706599|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2706600|NCT04377932|Cyclophosphamide|cyclophosphamide|mesh-list
2706601|NCT04377932|Fludarabine|fludarabine|mesh-list
2706602|NCT04377932|Fludarabine phosphate|fludarabine phosphate|mesh-list
2706603|NCT04377932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2706604|NCT04377932|Immunologic Factors|immunologic factors|mesh-ancestor
2706605|NCT04377932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706606|NCT04377932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2706607|NCT04377932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2706608|NCT04377932|Alkylating Agents|alkylating agents|mesh-ancestor
2706609|NCT04377932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706610|NCT04377932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2706611|NCT04377932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2706612|NCT04377932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2706613|NCT04377932|Antimetabolites|antimetabolites|mesh-ancestor
2706617|NCT04371640|Sirolimus|sirolimus|mesh-list
2706618|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2706619|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2706620|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2706621|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2706622|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
2706623|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2706624|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
2706625|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196147|NCT00004192|Etoposide|etoposide|mesh-list
2196148|NCT00004192|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2196149|NCT00004192|Prednisolone phosphate|prednisolone phosphate|mesh-list
2196150|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196151|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196152|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2196153|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196154|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196155|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196156|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
2196157|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196158|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2706640|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2706641|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2706642|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2706643|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2706644|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2706645|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706646|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2706647|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706648|NCT04364997|Analgesics|analgesics|mesh-ancestor
2706649|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
2706650|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2196159|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
2196160|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
2196161|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196162|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196163|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2196164|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
2196165|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
2196166|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2196167|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2196168|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
2196169|NCT00004192|Hormones|hormones|mesh-ancestor
2196170|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2196171|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2196172|NCT00004192|Protective Agents|protective agents|mesh-ancestor
2196173|NCT00004192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2196174|NCT00004194|Fludarabine|fludarabine|mesh-list
2196175|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
2196176|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196177|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196178|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
2196179|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196180|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196181|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
2196182|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196183|NCT00004195|Eniluracil|eniluracil|mesh-list
2196184|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196185|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196186|NCT00004196|Interferons|interferons|mesh-list
2196187|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
2196188|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196189|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
2706651|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
2706652|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2706653|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
2706654|NCT04356196|Verapamil|verapamil|mesh-list
2196190|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196191|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
2196192|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196193|NCT00004197|Prednisone|prednisone|mesh-list
2196194|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
2196195|NCT00004197|Doxorubicin|doxorubicin|mesh-list
2196196|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2196197|NCT00004197|Vincristine|vincristine|mesh-list
2196198|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
2196199|NCT00004197|Sargramostim|sargramostim|mesh-list
2196200|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2196201|NCT00004197|Vaccines|vaccines|mesh-list
2196202|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196203|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
2196204|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196205|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196206|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196207|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
2706655|NCT04356196|Bisoprolol|bisoprolol|mesh-list
2706656|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2706657|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2706658|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2706659|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706660|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2706661|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706662|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
2706663|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2706664|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
2706665|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
2706666|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2706667|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2706668|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2706669|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2706670|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
2706671|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2706685|NCT04306315|Brodalumab|brodalumab|mesh-list
2706686|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
2706693|NCT04258488|Vitamin K|vitamin k|mesh-list
2706694|NCT04258488|Warfarin|warfarin|mesh-list
2706695|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
2706696|NCT04258488|Vitamins|vitamins|mesh-ancestor
2706697|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
2706698|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706699|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
2706700|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2706701|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
2196208|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196209|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196210|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2196211|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2196212|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2706702|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2706703|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
2706704|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2706705|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706706|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2706707|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2706708|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
2706709|NCT04258488|Coagulants|coagulants|mesh-ancestor
2706710|NCT04258410|Quercetin|quercetin|mesh-list
2706711|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
2706712|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196213|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196214|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196215|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2196216|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
2196217|NCT00004197|Hormones|hormones|mesh-ancestor
2196218|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2196219|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2196220|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196221|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196222|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196223|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
2706713|NCT04258410|Protective Agents|protective agents|mesh-ancestor
2196224|NCT00004197|Analgesics|analgesics|mesh-ancestor
2706714|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196225|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
2196226|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2196227|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2196228|NCT00004198|Sargramostim|sargramostim|mesh-list
2196229|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2196230|NCT00004198|Vaccines|vaccines|mesh-list
2196231|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
2196232|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196233|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2196234|NCT00004199|Gemcitabine|gemcitabine|mesh-list
2196235|NCT00004199|Prinomastat|prinomastat|mesh-list
2196236|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196237|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196238|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
2196239|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196240|NCT00004199|Antiviral Agents|antiviral agents|mesh-ancestor
2196241|NCT00004199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196242|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2706765|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
2706766|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2706767|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
2196243|NCT00004199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2706768|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706769|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2706770|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2196244|NCT00004199|Immunologic Factors|immunologic factors|mesh-ancestor
2196245|NCT00004199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196246|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
2196247|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
2196248|NCT00004200|Temozolomide|temozolomide|mesh-list
2196249|NCT00004200|Prinomastat|prinomastat|mesh-list
2196250|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196251|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
2196252|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196253|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196254|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
2196255|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
2196256|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196257|NCT00004201|Gemcitabine|gemcitabine|mesh-list
2196258|NCT00004201|Carboplatin|carboplatin|mesh-list
2196259|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196260|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196261|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
2706771|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2706772|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2706773|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706774|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2706775|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706776|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2706777|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
2706778|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2706782|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2706783|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2706784|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706789|NCT04199728|Liraglutide|liraglutide|mesh-list
2706790|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2706791|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706792|NCT04199728|Incretins|incretins|mesh-ancestor
2706793|NCT04199728|Hormones|hormones|mesh-ancestor
2706794|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2196262|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196263|NCT00004201|Antiviral Agents|antiviral agents|mesh-ancestor
2196264|NCT00004201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196265|NCT00004201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196266|NCT00004201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196267|NCT00004201|Immunologic Factors|immunologic factors|mesh-ancestor
2196268|NCT00004201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196269|NCT00004202|Paclitaxel|paclitaxel|mesh-list
2196270|NCT00004202|Carboplatin|carboplatin|mesh-list
2196271|NCT00004202|Efaproxiral|efaproxiral|mesh-list
2196272|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196273|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196274|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196275|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196276|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196277|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706803|NCT04191616|Dexamethasone|dexamethasone|mesh-list
2706804|NCT04191616|Pomalidomide|pomalidomide|mesh-list
2706805|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2706806|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
2706807|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
2706808|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2706809|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706810|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2706811|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
2706812|NCT04191616|Hormones|hormones|mesh-ancestor
2706813|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2706814|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2706815|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2706816|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
2706817|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2706818|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2706819|NCT04191616|Growth Substances|growth substances|mesh-ancestor
2706820|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
2706821|NCT04184622|Tirzepatide|tirzepatide|mesh-list
2706822|NCT04184622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2706823|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706824|NCT04184622|Incretins|incretins|mesh-ancestor
2706825|NCT04184622|Hormones|hormones|mesh-ancestor
2706826|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2196278|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
2196279|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
2196280|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196281|NCT00004204|Temozolomide|temozolomide|mesh-list
2196282|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196283|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
2196284|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196285|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196286|NCT00004205|Tamoxifen|tamoxifen|mesh-list
2196287|NCT00004205|Letrozole|letrozole|mesh-list
2196288|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196289|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196290|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2196291|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2196292|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196293|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2196294|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
2196295|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2196296|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196297|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2196298|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2196299|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2196300|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2196301|NCT00004206|Leucovorin|leucovorin|mesh-list
2196302|NCT00004206|Fluorouracil|fluorouracil|mesh-list
2196303|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
2196304|NCT00004206|Calcium|calcium|mesh-list
2196305|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
2196306|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2196307|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196308|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
2196309|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196310|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196311|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196312|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196313|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
2706863|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
2706864|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2706865|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706866|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2706867|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196314|NCT00004206|Antidotes|antidotes|mesh-ancestor
2196315|NCT00004206|Protective Agents|protective agents|mesh-ancestor
2196316|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
2196317|NCT00004206|Vitamins|vitamins|mesh-ancestor
2196318|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
2196319|NCT00004207|Daunorubicin|daunorubicin|mesh-list
2196320|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196321|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2196322|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196323|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2196324|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196325|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196326|NCT00004209|Mitomycins|mitomycins|mesh-list
2196327|NCT00004209|Mitomycin|mitomycin|mesh-list
2196328|NCT00004209|Vinblastine|vinblastine|mesh-list
2196329|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196330|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2196331|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
2196332|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196333|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2196334|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196335|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196336|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196337|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196338|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196339|NCT00004212|Exatecan|exatecan|mesh-list
2196340|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2196341|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196342|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196343|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196344|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196345|NCT00004215|Cytarabine|cytarabine|mesh-list
2196346|NCT00004215|Daunorubicin|daunorubicin|mesh-list
2196347|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
2196348|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196349|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196350|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
2196351|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196352|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196353|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
2196354|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196355|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196356|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2196357|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2196358|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196359|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196360|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
2196361|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
2196362|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2196363|NCT00004216|Cefixime|cefixime|mesh-list
2196364|NCT00004216|Trimethoprim|trimethoprim|mesh-list
2196365|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
2196366|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2196367|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196368|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2196369|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196370|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196371|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196372|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196373|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2196374|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2196375|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2196376|NCT00004216|Renal Agents|renal agents|mesh-ancestor
2196377|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
2196378|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2196379|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2196380|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2196381|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2196382|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2196383|NCT00004217|Cytarabine|cytarabine|mesh-list
2196384|NCT00004217|Daunorubicin|daunorubicin|mesh-list
2196385|NCT00004217|Sargramostim|sargramostim|mesh-list
2196386|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
2196387|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196388|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196389|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
2196390|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196391|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196392|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
2196393|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196394|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196395|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2196396|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2196397|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196398|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196399|NCT00004218|Prednisolone|prednisolone|mesh-list
2196400|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
2196401|NCT00004218|Chlorambucil|chlorambucil|mesh-list
2196402|NCT00004218|Doxorubicin|doxorubicin|mesh-list
2196403|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2196404|NCT00004218|Fludarabine|fludarabine|mesh-list
2196405|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
2196406|NCT00004218|Vincristine|vincristine|mesh-list
2196407|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196408|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
2196409|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196410|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196411|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196412|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
2196413|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196414|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196415|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2196416|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2196417|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2196418|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196419|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196420|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196421|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
2706954|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2706955|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
2706956|NCT04120454|Ramucirumab|ramucirumab|mesh-list
2706957|NCT04120454|Antibodies|antibodies|mesh-list
2706958|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
2706959|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2706960|NCT04120454|Lexatumumab|lexatumumab|mesh-list
2706961|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
2706962|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706963|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2706977|NCT04107168|Bevacizumab|bevacizumab|mesh-list
2706978|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
2706979|NCT04107168|Nivolumab|nivolumab|mesh-list
2706980|NCT04107168|Ipilimumab|ipilimumab|mesh-list
2706981|NCT04107168|Durvalumab|durvalumab|mesh-list
2706982|NCT04107168|Atezolizumab|atezolizumab|mesh-list
2706983|NCT04107168|Tremelimumab|tremelimumab|mesh-list
2706984|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2706985|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2706986|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2706987|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2706988|NCT04107168|Growth Substances|growth substances|mesh-ancestor
2706989|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2706990|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
2706991|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2706992|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2706993|NCT04098237|Pancrelipase|pancrelipase|mesh-list
2706994|NCT04098237|Pancreatin|pancreatin|mesh-list
2706995|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2706996|NCT04097730|Riboflavin|riboflavin|mesh-list
2706997|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
2706998|NCT04097730|Difluprednate|difluprednate|mesh-list
2706999|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2707000|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2707001|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2707002|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2707003|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2707004|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707005|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707006|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707007|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
2707008|NCT04097730|Vitamins|vitamins|mesh-ancestor
2707009|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
2707010|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2707011|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
2707012|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
2707013|NCT04097730|Hormones|hormones|mesh-ancestor
2707014|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2707064|NCT04050540|Doxycycline|doxycycline|mesh-list
2707065|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2707066|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2707067|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
2707068|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2707069|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2196422|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196423|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196424|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196425|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196426|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2196427|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
2196428|NCT00004218|Hormones|hormones|mesh-ancestor
2196429|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2196430|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2196431|NCT00004219|Granisetron|granisetron|mesh-list
2196432|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
2196433|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
2196434|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2196435|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196436|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2196437|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2196438|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
2196439|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2196440|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196441|NCT00004220|Gemcitabine|gemcitabine|mesh-list
2196442|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
2196443|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196444|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
2196445|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196446|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196447|NCT00004220|Antiviral Agents|antiviral agents|mesh-ancestor
2196448|NCT00004220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196449|NCT00004220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196450|NCT00004220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196451|NCT00004220|Immunologic Factors|immunologic factors|mesh-ancestor
2196452|NCT00004220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196453|NCT00004221|Paclitaxel|paclitaxel|mesh-list
2196454|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
2196455|NCT00004221|Carboplatin|carboplatin|mesh-list
2196456|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2196457|NCT00004221|Topotecan|topotecan|mesh-list
2196458|NCT00004221|Lenograstim|lenograstim|mesh-list
2196459|NCT00004221|Sargramostim|sargramostim|mesh-list
2196460|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196461|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196462|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196463|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196464|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196465|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196466|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196467|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
2196468|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196469|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196470|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196471|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
2196472|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2196473|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2196474|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2196475|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196476|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2707087|NCT04034459|Leucovorin|leucovorin|mesh-list
2707088|NCT04034459|Folic Acid|folic acid|mesh-list
2707089|NCT04034459|Bevacizumab|bevacizumab|mesh-list
2707090|NCT04034459|Cetuximab|cetuximab|mesh-list
2707091|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
2707092|NCT04034459|Irinotecan|irinotecan|mesh-list
2707093|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
2707094|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2707095|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707096|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2707097|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2707098|NCT04034459|Growth Substances|growth substances|mesh-ancestor
2707099|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707100|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
2707101|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2707102|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2707103|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2707104|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707105|NCT04034459|Antidotes|antidotes|mesh-ancestor
2707106|NCT04034459|Protective Agents|protective agents|mesh-ancestor
2707107|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
2707108|NCT04034459|Vitamins|vitamins|mesh-ancestor
2707109|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
2707110|NCT04034459|Hematinics|hematinics|mesh-ancestor
2196477|NCT00004223|Gemcitabine|gemcitabine|mesh-list
2196478|NCT00004223|Docetaxel|docetaxel|mesh-list
2196479|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196480|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
2196481|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196482|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196483|NCT00004223|Antiviral Agents|antiviral agents|mesh-ancestor
2196484|NCT00004223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196485|NCT00004223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196486|NCT00004223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196487|NCT00004223|Immunologic Factors|immunologic factors|mesh-ancestor
2196488|NCT00004223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196489|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196490|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196491|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196492|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
2196493|NCT00004224|Etoposide|etoposide|mesh-list
2196494|NCT00004224|Vincristine|vincristine|mesh-list
2707128|NCT04030052|Factor VIII|factor viii|mesh-list
2707129|NCT04030052|Coagulants|coagulants|mesh-ancestor
2196495|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196496|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
2196497|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196498|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196499|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196500|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
2196501|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707143|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
2707144|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707145|NCT04005729|Cangrelor|cangrelor|mesh-list
2707146|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2707147|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2707148|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2707149|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2707150|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
2707151|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2707152|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707153|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707154|NCT04000737|Sorafenib|sorafenib|mesh-list
2707155|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707156|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2707157|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2707158|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707159|NCT03980314|Nivolumab|nivolumab|mesh-list
2707160|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2707161|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707162|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2707163|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196502|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196503|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2196504|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196505|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2196506|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196507|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196508|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196509|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196510|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196511|NCT00004227|Cetuximab|cetuximab|mesh-list
2196512|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2196513|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196514|NCT00004229|Endostatins|endostatins|mesh-list
2196515|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196516|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2196517|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2196518|NCT00004229|Growth Substances|growth substances|mesh-ancestor
2196519|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196520|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
2196521|NCT00004230|Cyclophosphamide|cyclophosphamide|mesh-list
2196522|NCT00004230|Captopril|captopril|mesh-list
2196523|NCT00004230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196524|NCT00004230|Immunologic Factors|immunologic factors|mesh-ancestor
2196525|NCT00004230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196526|NCT00004230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196527|NCT00004230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196528|NCT00004230|Alkylating Agents|alkylating agents|mesh-ancestor
2196529|NCT00004230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196530|NCT00004230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196531|NCT00004230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2196532|NCT00004230|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2196533|NCT00004230|Protease Inhibitors|protease inhibitors|mesh-ancestor
2707178|NCT03950076|Edoxaban|edoxaban|mesh-list
2707179|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2707180|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
2707181|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2707182|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
2707183|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2707184|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707185|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
2707211|NCT03927690|Ranibizumab|ranibizumab|mesh-list
2707212|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2707213|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2707214|NCT03927690|Growth Substances|growth substances|mesh-ancestor
2707215|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707216|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
2707217|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707218|NCT03914885|Fludarabine|fludarabine|mesh-list
2707219|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2707220|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196534|NCT00004230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196535|NCT00004230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2196536|NCT00004231|Leucovorin|leucovorin|mesh-list
2196537|NCT00004231|Interferons|interferons|mesh-list
2196538|NCT00004231|Cytarabine|cytarabine|mesh-list
2196539|NCT00004231|Interferon-alpha|interferon-alpha|mesh-list
2196540|NCT00004231|Aldesleukin|aldesleukin|mesh-list
2196541|NCT00004231|Prednisone|prednisone|mesh-list
2196542|NCT00004231|Cyclophosphamide|cyclophosphamide|mesh-list
2196543|NCT00004231|Busulfan|busulfan|mesh-list
2196544|NCT00004231|Doxorubicin|doxorubicin|mesh-list
2196545|NCT00004231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2196546|NCT00004231|Methotrexate|methotrexate|mesh-list
2196547|NCT00004231|Vincristine|vincristine|mesh-list
2196548|NCT00004231|Teniposide|teniposide|mesh-list
2196549|NCT00004231|Levoleucovorin|levoleucovorin|mesh-list
2196550|NCT00004231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196551|NCT00004231|Immunologic Factors|immunologic factors|mesh-ancestor
2196552|NCT00004231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707221|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707222|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2707223|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
2707235|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
2707236|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2707237|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196553|NCT00004231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196554|NCT00004231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196555|NCT00004231|Alkylating Agents|alkylating agents|mesh-ancestor
2196556|NCT00004231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196557|NCT00004231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196558|NCT00004231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2196559|NCT00004231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2196560|NCT00004231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2196561|NCT00004231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196562|NCT00004231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196563|NCT00004231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2196564|NCT00004231|Glucocorticoids|glucocorticoids|mesh-ancestor
2196565|NCT00004231|Hormones|hormones|mesh-ancestor
2196566|NCT00004231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2196567|NCT00004231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2196568|NCT00004231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2196569|NCT00004231|Abortifacient Agents|abortifacient agents|mesh-ancestor
2196570|NCT00004231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2196571|NCT00004231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196572|NCT00004231|Antimetabolites|antimetabolites|mesh-ancestor
2196573|NCT00004231|Dermatologic Agents|dermatologic agents|mesh-ancestor
2196574|NCT00004231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2196575|NCT00004231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2196576|NCT00004231|Antiviral Agents|antiviral agents|mesh-ancestor
2196577|NCT00004231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196578|NCT00004231|Antidotes|antidotes|mesh-ancestor
2196579|NCT00004231|Protective Agents|protective agents|mesh-ancestor
2196580|NCT00004231|Vitamin B Complex|vitamin b complex|mesh-ancestor
2196581|NCT00004231|Vitamins|vitamins|mesh-ancestor
2196582|NCT00004231|Micronutrients|micronutrients|mesh-ancestor
2196583|NCT00004231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196584|NCT00004231|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196585|NCT00004231|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196586|NCT00004231|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196587|NCT00004231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2196588|NCT00004231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2196589|NCT00004232|Cyclosporine|cyclosporine|mesh-list
2196590|NCT00004232|Prednisone|prednisone|mesh-list
2196591|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
2196592|NCT00004232|Cyclosporins|cyclosporins|mesh-list
2196593|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2196594|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
2196595|NCT00004232|Hormones|hormones|mesh-ancestor
2196596|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2196597|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196598|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2196599|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196600|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
2196601|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196602|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196603|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196604|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
2196605|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2707279|NCT03885089|Infliximab|infliximab|mesh-list
2707280|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
2707281|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2707282|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2707286|NCT03873402|Nivolumab|nivolumab|mesh-list
2707287|NCT03873402|Ipilimumab|ipilimumab|mesh-list
2707288|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2707289|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707290|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2707291|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707317|NCT03866239|Atezolizumab|atezolizumab|mesh-list
2707318|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
2707319|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707320|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2707324|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2707325|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2707326|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2707327|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2707328|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707329|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
2707330|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2707331|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2707332|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2707333|NCT03832998|Erenumab|erenumab|mesh-list
2707334|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2707335|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2707336|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707337|NCT03832998|Analgesics|analgesics|mesh-ancestor
2707338|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
2707339|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2707340|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707341|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
2707342|NCT03823534|Acetaminophen|acetaminophen|mesh-list
2707343|NCT03823534|Ketorolac|ketorolac|mesh-list
2707344|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2707345|NCT03823534|Morphine|morphine|mesh-list
2707346|NCT03823534|Oxycodone|oxycodone|mesh-list
2707347|NCT03823534|Hydrocodone|hydrocodone|mesh-list
2707348|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2707349|NCT03823534|Narcotics|narcotics|mesh-ancestor
2707350|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2707351|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707352|NCT03823534|Analgesics|analgesics|mesh-ancestor
2196606|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
2196607|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196608|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2196609|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
2196610|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
2196611|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2707353|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
2707354|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2707355|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2707356|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
2707357|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2707358|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2707359|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2707360|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2707361|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2707362|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707363|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
2196612|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2196613|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2196614|NCT00004232|Protective Agents|protective agents|mesh-ancestor
2196615|NCT00004233|Leucovorin|leucovorin|mesh-list
2196616|NCT00004233|Fluorouracil|fluorouracil|mesh-list
2196617|NCT00004233|Calcium|calcium|mesh-list
2196618|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
2196619|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2196620|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196621|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
2196622|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196623|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196624|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196625|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196626|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
2707364|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
2196627|NCT00004233|Antidotes|antidotes|mesh-ancestor
2196628|NCT00004233|Protective Agents|protective agents|mesh-ancestor
2196629|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
2196630|NCT00004233|Vitamins|vitamins|mesh-ancestor
2707373|NCT03812991|Calcitonin|calcitonin|mesh-list
2707374|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
2707375|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2707376|NCT03812991|Katacalcin|katacalcin|mesh-list
2707377|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2707378|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707379|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2196631|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
2196632|NCT00004235|Docetaxel|docetaxel|mesh-list
2196633|NCT00004235|Irinotecan|irinotecan|mesh-list
2196634|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196635|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196636|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196637|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196638|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196639|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2196640|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196641|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196642|NCT00004236|Doxorubicin|doxorubicin|mesh-list
2196643|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2196644|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2196645|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196646|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2707380|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
2196647|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196648|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196649|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196650|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
2196651|NCT00004237|Doxorubicin|doxorubicin|mesh-list
2196652|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2196653|NCT00004237|Vinorelbine|vinorelbine|mesh-list
2196654|NCT00004237|Epirubicin|epirubicin|mesh-list
2707407|NCT03793478|Cytarabine|cytarabine|mesh-list
2707408|NCT03793478|Fludarabine|fludarabine|mesh-list
2707409|NCT03793478|Etoposide|etoposide|mesh-list
2707410|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707411|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2707412|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
2707413|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707414|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2707415|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
2707416|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707417|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196655|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
2196656|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196657|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
2707418|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2707419|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2707420|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2707421|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
2707422|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2707442|NCT03779243|Melatonin|melatonin|mesh-list
2707443|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
2707444|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707445|NCT03779243|Protective Agents|protective agents|mesh-ancestor
2707446|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707447|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2707450|NCT03757013|Apremilast|apremilast|mesh-list
2707451|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2707452|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2707453|NCT03757013|Analgesics|analgesics|mesh-ancestor
2707454|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
2707455|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2707456|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707457|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2707458|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2707459|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2707460|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2707461|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2707462|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196658|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196659|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196660|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196661|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
2196662|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196663|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196664|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2196665|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2196666|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2707479|NCT03738228|Cisplatin|cisplatin|mesh-list
2707480|NCT03738228|Atezolizumab|atezolizumab|mesh-list
2707481|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2707482|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707483|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
2707484|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707499|NCT03729271|Rifaximin|rifaximin|mesh-list
2707500|NCT03729271|Lactulose|lactulose|mesh-list
2707501|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2707502|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2707503|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2707504|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
2707505|NCT03721068|Fludarabine|fludarabine|mesh-list
2707506|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2707507|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
2707508|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707509|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2707510|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2707511|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
2707512|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707513|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707514|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2707525|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
2707526|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2707527|NCT03696784|Fludarabine|fludarabine|mesh-list
2707528|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2707529|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
2707530|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707531|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2707532|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2707533|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
2707534|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707535|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707536|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2707537|NCT03693846|Nivolumab|nivolumab|mesh-list
2707538|NCT03693846|Ipilimumab|ipilimumab|mesh-list
2707539|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2707540|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707541|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2196667|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196668|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196669|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196670|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196671|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
2707542|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196672|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196673|NCT00004237|Analgesics|analgesics|mesh-ancestor
2196674|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
2196675|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2196676|NCT00004242|Gemcitabine|gemcitabine|mesh-list
2196677|NCT00004242|Fluorouracil|fluorouracil|mesh-list
2196678|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
2196679|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196680|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
2196681|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196682|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196683|NCT00004242|Antiviral Agents|antiviral agents|mesh-ancestor
2196684|NCT00004242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196685|NCT00004242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196686|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196687|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
2196688|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196689|NCT00004243|Docetaxel|docetaxel|mesh-list
2196690|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
2196691|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196692|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196693|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196694|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196695|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196696|NCT00004244|Interferons|interferons|mesh-list
2196697|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
2196698|NCT00004244|Interleukin-12|interleukin-12|mesh-list
2196699|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196700|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
2196701|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196702|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
2196703|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196704|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2707596|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
2707597|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2707598|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
2196705|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2707599|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2707600|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707601|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2707602|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
2707603|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2707604|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2707605|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2707612|NCT03635788|Rilpivirine|rilpivirine|mesh-list
2707613|NCT03635788|Cabotegravir|cabotegravir|mesh-list
2707614|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2707615|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2707616|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2707617|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707618|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
2707619|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2707620|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2707621|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2707622|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2707623|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2707624|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
2707625|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2707626|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707627|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2707628|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707635|NCT03611751|Apremilast|apremilast|mesh-list
2707636|NCT03611751|BMS-986165|bms-986165|mesh-list
2707637|NCT03611751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2707638|NCT03611751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2707639|NCT03611751|Analgesics|analgesics|mesh-ancestor
2707640|NCT03611751|Sensory System Agents|sensory system agents|mesh-ancestor
2707641|NCT03611751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2707642|NCT03611751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707643|NCT03611751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2707644|NCT03611751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2707645|NCT03611751|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2707646|NCT03611751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2707647|NCT03611751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2707648|NCT03611751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707649|NCT03611751|Dermatologic Agents|dermatologic agents|mesh-ancestor
2196706|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2196707|NCT00004244|Growth Substances|growth substances|mesh-ancestor
2196708|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
2707650|NCT03611751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2707651|NCT03603288|Idebenone|idebenone|mesh-list
2707652|NCT03603288|Antioxidants|antioxidants|mesh-ancestor
2707653|NCT03603288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707654|NCT03603288|Protective Agents|protective agents|mesh-ancestor
2707655|NCT03603288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707656|NCT03602157|Fludarabine|fludarabine|mesh-list
2707657|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2707658|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196709|NCT00004245|Salicylates|salicylates|mesh-list
2196710|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
2196711|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2196712|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2196713|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2196714|NCT00004245|Analgesics|analgesics|mesh-ancestor
2196715|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
2196716|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2196717|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196718|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2196719|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2707659|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707660|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2707661|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
2707662|NCT03601455|Durvalumab|durvalumab|mesh-list
2707663|NCT03601455|Ipilimumab|ipilimumab|mesh-list
2707664|NCT03601455|Tremelimumab|tremelimumab|mesh-list
2707665|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
2707666|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2707667|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
2707668|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2707669|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707670|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
2707671|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707672|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2707673|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707679|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
2707680|NCT03594162|Fludarabine|fludarabine|mesh-list
2707681|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2707682|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
2707683|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707684|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2707685|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2707686|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
2707687|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707688|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707689|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2196720|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2196721|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196722|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707715|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
2707716|NCT03519997|Bavituximab|bavituximab|mesh-list
2707717|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2707718|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196723|NCT00004246|Vidarabine|vidarabine|mesh-list
2196724|NCT00004246|Fludarabine|fludarabine|mesh-list
2196725|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
2196726|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196727|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196728|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
2196729|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196730|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196731|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
2196732|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196733|NCT00004246|Antiviral Agents|antiviral agents|mesh-ancestor
2196734|NCT00004246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196735|NCT00004248|Aldesleukin|aldesleukin|mesh-list
2196736|NCT00004248|Doxorubicin|doxorubicin|mesh-list
2196737|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2196738|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2196739|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196740|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2196741|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2196742|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196743|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196744|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2196745|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2196746|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
2196747|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196748|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2196749|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2196750|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
2196751|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196752|NCT00004250|Dactinomycin|dactinomycin|mesh-list
2196753|NCT00004250|Melphalan|melphalan|mesh-list
2196754|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196755|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
2196756|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196757|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196758|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2196759|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196760|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
2196761|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196762|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2196763|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196764|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2196765|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2707773|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
2707774|NCT03437330|Empagliflozin|empagliflozin|mesh-list
2707775|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2707776|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707777|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2196766|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196767|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2196768|NCT00004251|Letrozole|letrozole|mesh-list
2196769|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196770|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2196771|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2196772|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196773|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196774|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2196775|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
2196776|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2707778|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196777|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196778|NCT00004252|Leucovorin|leucovorin|mesh-list
2196779|NCT00004252|Fluorouracil|fluorouracil|mesh-list
2707795|NCT03424122|Rituximab|rituximab|mesh-list
2707796|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2707797|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2707798|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707799|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
2707800|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2707801|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2707802|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2707803|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
2707804|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196780|NCT00004252|Calcium|calcium|mesh-list
2196781|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
2196782|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2196783|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196784|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
2196785|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196786|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196787|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196788|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196789|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
2196790|NCT00004252|Antidotes|antidotes|mesh-ancestor
2196791|NCT00004252|Protective Agents|protective agents|mesh-ancestor
2196792|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
2707840|NCT03405714|Brivaracetam|brivaracetam|mesh-list
2707841|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
2196793|NCT00004252|Vitamins|vitamins|mesh-ancestor
2196794|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
2196795|NCT00004253|Paclitaxel|paclitaxel|mesh-list
2196796|NCT00004253|Carboplatin|carboplatin|mesh-list
2196797|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196798|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196799|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196800|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196801|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196802|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196803|NCT00004254|Raltitrexed|raltitrexed|mesh-list
2196804|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196805|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
2196806|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196807|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196808|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2196809|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196810|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
2196811|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
2196812|NCT00004255|Fludarabine|fludarabine|mesh-list
2196813|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
2196814|NCT00004255|Tacrolimus|tacrolimus|mesh-list
2196815|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2196816|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196817|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
2196818|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196819|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196820|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2196821|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
2196822|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196823|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196824|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2196825|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196826|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
2196827|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2196828|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196829|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2196830|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
2196831|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
2196832|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2196833|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2196834|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
2196835|NCT00004255|Hormones|hormones|mesh-ancestor
2196836|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2196837|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2196838|NCT00004255|Protective Agents|protective agents|mesh-ancestor
2196839|NCT00004256|Sargramostim|sargramostim|mesh-list
2196840|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
2196841|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196842|NCT00004257|Fluorouracil|fluorouracil|mesh-list
2196843|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
2196844|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
2196845|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196846|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196847|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196848|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196849|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
2196850|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196851|NCT00004260|Rituximab|rituximab|mesh-list
2196852|NCT00004260|Interleukin-12|interleukin-12|mesh-list
2196853|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2196854|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196855|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
2196856|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196857|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196858|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2196859|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2196860|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2196861|NCT00004260|Growth Substances|growth substances|mesh-ancestor
2196862|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
2196863|NCT00004261|Antibodies|antibodies|mesh-list
2196864|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
2196865|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196866|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
2196867|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196868|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2196869|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
2196870|NCT00004263|Cytarabine|cytarabine|mesh-list
2196871|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2196872|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196873|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
2196874|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196875|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196876|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
2196877|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196878|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196879|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
2196880|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196881|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2196882|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196883|NCT00004264|Docetaxel|docetaxel|mesh-list
2196884|NCT00004264|Amifostine|amifostine|mesh-list
2196885|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196886|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196887|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196888|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196889|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196890|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2196891|NCT00004264|Protective Agents|protective agents|mesh-ancestor
2196892|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196893|NCT00004265|Paclitaxel|paclitaxel|mesh-list
2196894|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2196895|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196896|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
2196897|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
2196898|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
2196899|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196900|NCT00004266|Lisinopril|lisinopril|mesh-list
2196901|NCT00004266|Nifedipine|nifedipine|mesh-list
2196902|NCT00004266|Simvastatin|simvastatin|mesh-list
2196903|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2196904|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2196905|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
2196906|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196907|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2196908|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2196909|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196910|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2196911|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2196912|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2196913|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196914|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
2196915|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
2196916|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2196917|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2196918|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
2196919|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2196920|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2196921|NCT00004266|Protective Agents|protective agents|mesh-ancestor
2196922|NCT00004268|Midodrine|midodrine|mesh-list
2196923|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
2196924|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
2196925|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2196926|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196927|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2707950|NCT03317392|Olaparib|olaparib|mesh-list
2707951|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2707952|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2707953|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2707954|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2707955|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2707974|NCT03261830|Clindamycin|clindamycin|mesh-list
2707975|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
2707976|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
2707977|NCT03261830|Cefazolin|cefazolin|mesh-list
2707978|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2707979|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2707980|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2707981|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196928|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2196929|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2196930|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2196931|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
2196932|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2196933|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196934|NCT00004274|Estrogens|estrogens|mesh-list
2196935|NCT00004274|Hormones|hormones|mesh-ancestor
2196936|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2196937|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196938|NCT00004275|Hormones|hormones|mesh-list
2196939|NCT00004275|Oxandrolone|oxandrolone|mesh-list
2196940|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2196941|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196942|NCT00004275|Androgens|androgens|mesh-ancestor
2196943|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
2196944|NCT00004276|Thalidomide|thalidomide|mesh-list
2196945|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2196946|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
2196947|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196948|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
2196949|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2196950|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196951|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2196952|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2196953|NCT00004276|Growth Substances|growth substances|mesh-ancestor
2196954|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
2196955|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2196956|NCT00004278|Ganciclovir|ganciclovir|mesh-list
2196957|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2196958|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
2196959|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2196960|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2196961|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2196962|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2196963|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
2196964|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
2196965|NCT00004284|Diuretics|diuretics|mesh-ancestor
2196966|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
2196967|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196968|NCT00004284|Expectorants|expectorants|mesh-ancestor
2707982|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708000|NCT03219528|Rifaximin|rifaximin|mesh-list
2708001|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2708002|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2708003|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2196969|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
2196970|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
2196971|NCT00004284|Protective Agents|protective agents|mesh-ancestor
2196972|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
2196973|NCT00004286|Antibodies|antibodies|mesh-list
2196974|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
2708043|NCT03141684|Bevacizumab|bevacizumab|mesh-list
2708044|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2708045|NCT03141684|Atezolizumab|atezolizumab|mesh-list
2708046|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
2708047|NCT03141684|Antibodies|antibodies|mesh-list
2708048|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
2196975|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2196976|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2196977|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
2708049|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2708050|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
2708051|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708052|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2708053|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2708054|NCT03141684|Growth Substances|growth substances|mesh-ancestor
2708055|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708056|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
2196978|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196979|NCT00004288|Olsalazine|olsalazine|mesh-list
2196980|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2708057|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
2708058|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
2708059|NCT03126630|Maytansine|maytansine|mesh-list
2708060|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708061|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708062|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2708063|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
2708064|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
2708065|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
2708066|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708072|NCT03121534|Dexamethasone|dexamethasone|mesh-list
2708073|NCT03121534|Blinatumomab|blinatumomab|mesh-list
2708074|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2708075|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
2708076|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
2708077|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2196981|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2196982|NCT00004288|Analgesics|analgesics|mesh-ancestor
2708078|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708079|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2708080|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
2708081|NCT03121534|Hormones|hormones|mesh-ancestor
2708082|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2708083|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2708084|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708085|NCT03111732|Capecitabine|capecitabine|mesh-list
2708086|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
2708087|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
2708088|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2196983|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
2196984|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2196985|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196986|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2196987|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2196988|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2196989|NCT00004297|Diazepam|diazepam|mesh-list
2196990|NCT00004297|Lorazepam|lorazepam|mesh-list
2196991|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
2196992|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
2196993|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
2196994|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2196995|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2196996|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2196997|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2708089|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
2708090|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708091|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708092|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708096|NCT03088059|Durvalumab|durvalumab|mesh-list
2708097|NCT03088059|Palbociclib|palbociclib|mesh-list
2708098|NCT03088059|Afatinib|afatinib|mesh-list
2708099|NCT03088059|Niraparib|niraparib|mesh-list
2708100|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708101|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708102|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2708103|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2708104|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708105|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2708106|NCT03065244|Infliximab|infliximab|mesh-list
2708107|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
2708108|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2708109|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
2708110|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2708111|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
2708112|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708113|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
2708114|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2708115|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2708127|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
2708128|NCT03007732|Prednisone|prednisone|mesh-list
2708129|NCT03007732|Leuprolide|leuprolide|mesh-list
2708130|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
2708131|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
2708132|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
2708133|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2708134|NCT03007732|Androgens|androgens|mesh-list
2708135|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2708136|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
2708137|NCT03007732|Hormones|hormones|mesh-ancestor
2196998|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2708138|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2708139|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708140|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2196999|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2197000|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2197001|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2197002|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
2708141|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708142|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708143|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2708144|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
2708145|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2708146|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2708147|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2708148|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708149|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
2708150|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2708151|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
2708152|NCT03007732|Protective Agents|protective agents|mesh-ancestor
2708153|NCT03007732|Vitamins|vitamins|mesh-ancestor
2708154|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
2708155|NCT03007732|Estrogens|estrogens|mesh-ancestor
2708156|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
2708179|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
2708180|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2708181|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708182|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708183|NCT02952924|Midazolam|midazolam|mesh-list
2708184|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2708185|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2708186|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2708187|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708188|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2708189|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2708190|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2708191|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2708192|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
2708193|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
2708194|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
2708195|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
2708196|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2708197|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708198|NCT02946996|Metformin|metformin|mesh-list
2708199|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2708200|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708201|NCT02934529|Leucovorin|leucovorin|mesh-list
2708202|NCT02934529|Folic Acid|folic acid|mesh-list
2708203|NCT02934529|Bevacizumab|bevacizumab|mesh-list
2708204|NCT02934529|Cetuximab|cetuximab|mesh-list
2708205|NCT02934529|Fluorouracil|fluorouracil|mesh-list
2708206|NCT02934529|Capecitabine|capecitabine|mesh-list
2708207|NCT02934529|Irinotecan|irinotecan|mesh-list
2708208|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
2708209|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708210|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708211|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2708212|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2197003|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
2708213|NCT02934529|Growth Substances|growth substances|mesh-ancestor
2708214|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708215|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
2197004|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197005|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197006|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2197007|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2197008|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2197009|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2197010|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
2197011|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
2197012|NCT00004300|Bromocriptine|bromocriptine|mesh-list
2197013|NCT00004300|Sertraline|sertraline|mesh-list
2197014|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
2197015|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2197016|NCT00004300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2197017|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2197018|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2197019|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197020|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197021|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
2197022|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197023|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2197024|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2197025|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
2197026|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197027|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
2197028|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
2197029|NCT00004310|Clomipramine|clomipramine|mesh-list
2197030|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2197031|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
2197032|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2197033|NCT00004310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2197034|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2197035|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2197036|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197037|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197038|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
2197039|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197040|NCT00004311|Leuprolide|leuprolide|mesh-list
2197041|NCT00004311|Spironolactone|spironolactone|mesh-list
2197042|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2197043|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
2197044|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2197045|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197046|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2197047|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197048|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2197049|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
2197050|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197051|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2197052|NCT00004311|Diuretics|diuretics|mesh-ancestor
2197053|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
2197054|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2197055|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2197056|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
2197057|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197058|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2197059|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2708216|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
2708217|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708218|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2708219|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2708220|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
2708221|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2708222|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2197060|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2197061|NCT00004316|Capsaicin|capsaicin|mesh-list
2197062|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
2197063|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
2197064|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
2197065|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197066|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197067|NCT00004317|Leucovorin|leucovorin|mesh-list
2197068|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
2708223|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2708224|NCT02934529|Antidotes|antidotes|mesh-ancestor
2708225|NCT02934529|Protective Agents|protective agents|mesh-ancestor
2708226|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
2708227|NCT02934529|Vitamins|vitamins|mesh-ancestor
2708228|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
2708229|NCT02934529|Hematinics|hematinics|mesh-ancestor
2197069|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
2197070|NCT00004317|Spiramycin|spiramycin|mesh-list
2197071|NCT00004317|Calcium|calcium|mesh-list
2197072|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
2197073|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2197074|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197075|NCT00004317|Antidotes|antidotes|mesh-ancestor
2197076|NCT00004317|Protective Agents|protective agents|mesh-ancestor
2197077|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
2197078|NCT00004317|Vitamins|vitamins|mesh-ancestor
2197079|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
2197080|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
2197081|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2197082|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2197083|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197084|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2197085|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197086|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197087|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2197088|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
2197089|NCT00004323|Cyclosporine|cyclosporine|mesh-list
2197090|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
2197091|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
2197092|NCT00004323|Methotrexate|methotrexate|mesh-list
2197093|NCT00004323|Cyclosporins|cyclosporins|mesh-list
2197094|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2197095|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2197096|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
2197097|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197098|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2197099|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2197100|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
2197101|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197102|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197103|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2197104|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2197105|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
2197106|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2197107|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2197108|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
2197109|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
2197110|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197111|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2197112|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2197113|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
2197114|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197115|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2197116|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2197117|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
2197118|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
2197119|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197120|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2197121|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
2197122|NCT00004323|Hormones|hormones|mesh-ancestor
2197123|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2708289|NCT02816736|Valsartan|valsartan|mesh-list
2708290|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2708291|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2708292|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2708293|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2708294|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708295|NCT02814019|Idebenone|idebenone|mesh-list
2708296|NCT02814019|Antioxidants|antioxidants|mesh-ancestor
2708297|NCT02814019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708298|NCT02814019|Protective Agents|protective agents|mesh-ancestor
2708299|NCT02814019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708300|NCT02774421|Trastuzumab|trastuzumab|mesh-list
2708301|NCT02774421|Molgramostim|molgramostim|mesh-list
2708302|NCT02774421|Sargramostim|sargramostim|mesh-list
2708303|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708304|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708305|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
2708306|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708307|NCT02736968|Auranofin|auranofin|mesh-list
2708308|NCT02736968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2708309|NCT02725567|Ivacaftor|ivacaftor|mesh-list
2708310|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2708311|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2708312|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197124|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2708342|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2708343|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
2708344|NCT02713373|Cetuximab|cetuximab|mesh-list
2197125|NCT00004323|Protective Agents|protective agents|mesh-ancestor
2197126|NCT00004327|Octreotide|octreotide|mesh-list
2197127|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2197128|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2197129|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197130|NCT00004328|Enalapril|enalapril|mesh-list
2197131|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
2197132|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2197133|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
2197134|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197135|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197136|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2197137|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
2197138|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
2197139|NCT00004330|Hormones|hormones|mesh-list
2197140|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197141|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708345|NCT02713373|Antibodies|antibodies|mesh-list
2708346|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
2708347|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2708348|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
2708349|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708350|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708351|NCT02681302|Nivolumab|nivolumab|mesh-list
2708352|NCT02681302|Ipilimumab|ipilimumab|mesh-list
2708353|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708354|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197142|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2197143|NCT00004339|Trientine|trientine|mesh-list
2197144|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
2197145|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
2197146|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197147|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197148|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2197149|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2197150|NCT00004339|Growth Substances|growth substances|mesh-ancestor
2197151|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197152|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
2197153|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197154|NCT00004340|Calcitriol|calcitriol|mesh-list
2197155|NCT00004340|Hormones|hormones|mesh-list
2197156|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2708355|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2708356|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197157|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197158|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2197159|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2197160|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2197161|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197162|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2197163|NCT00004340|Vitamins|vitamins|mesh-ancestor
2197164|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
2197165|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2197166|NCT00004344|Leuprolide|leuprolide|mesh-list
2708363|NCT02632409|Nivolumab|nivolumab|mesh-list
2708364|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708365|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708366|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2708367|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708368|NCT02627443|Gemcitabine|gemcitabine|mesh-list
2708369|NCT02627443|Carboplatin|carboplatin|mesh-list
2708370|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708371|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2708372|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
2708373|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708374|NCT02627443|Antiviral Agents|antiviral agents|mesh-ancestor
2708375|NCT02627443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2708376|NCT02627443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2708377|NCT02627443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2708378|NCT02627443|Immunologic Factors|immunologic factors|mesh-ancestor
2708379|NCT02627443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197167|NCT00004344|Testosterone|testosterone|mesh-list
2197168|NCT00004344|Androgens|androgens|mesh-ancestor
2197169|NCT00004344|Hormones|hormones|mesh-ancestor
2197170|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197171|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197172|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2197173|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197174|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2197175|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
2197176|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2197177|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2197178|NCT00004346|Lovastatin|lovastatin|mesh-list
2197179|NCT00004346|L 647318|l 647318|mesh-list
2197180|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
2197181|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2197182|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2197183|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
2197184|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197185|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2197186|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2197187|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197188|NCT00004346|Cathartics|cathartics|mesh-ancestor
2197189|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2197190|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
2197191|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2197192|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2197193|NCT00004357|Prednisolone|prednisolone|mesh-list
2197194|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
2197195|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2197196|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
2197197|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2197198|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
2197199|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
2197200|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197201|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197202|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2197203|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
2197204|NCT00004357|Hormones|hormones|mesh-ancestor
2197205|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197206|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2197207|NCT00004357|Protective Agents|protective agents|mesh-ancestor
2197208|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2197209|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197210|NCT00004358|Calcitonin|calcitonin|mesh-list
2197211|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
2197212|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
2197213|NCT00004358|Katacalcin|katacalcin|mesh-list
2197214|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2197215|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708425|NCT02590094|Bevacizumab|bevacizumab|mesh-list
2708426|NCT02590094|Aflibercept|aflibercept|mesh-list
2708427|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708428|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708429|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2708430|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2708431|NCT02590094|Growth Substances|growth substances|mesh-ancestor
2708432|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708433|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
2708442|NCT02516241|Gemcitabine|gemcitabine|mesh-list
2708443|NCT02516241|Carboplatin|carboplatin|mesh-list
2708444|NCT02516241|Durvalumab|durvalumab|mesh-list
2708445|NCT02516241|Tremelimumab|tremelimumab|mesh-list
2708446|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708447|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2708448|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
2708449|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708450|NCT02516241|Antiviral Agents|antiviral agents|mesh-ancestor
2708451|NCT02516241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2708452|NCT02516241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2708453|NCT02516241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2708454|NCT02516241|Immunologic Factors|immunologic factors|mesh-ancestor
2708455|NCT02516241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708456|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708457|NCT02431702|Haloperidol|haloperidol|mesh-list
2708458|NCT02431702|Olanzapine|olanzapine|mesh-list
2708459|NCT02431702|Risperidone|risperidone|mesh-list
2708460|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2708461|NCT02431702|Aripiprazole|aripiprazole|mesh-list
2708462|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2708463|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
2708464|NCT02431702|Perphenazine|perphenazine|mesh-list
2708465|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2708466|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
2708467|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2708468|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708469|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708470|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2708471|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2708472|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2708473|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2708474|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2708475|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
2708476|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
2708477|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
2708478|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2708479|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2708480|NCT02431702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2708481|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2708482|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2708483|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
2708484|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
2708485|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2708486|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2708487|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2708488|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2708489|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2708490|NCT02420912|Nivolumab|nivolumab|mesh-list
2708491|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708492|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708493|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2708494|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197216|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2197217|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
2197218|NCT00004359|Methoxsalen|methoxsalen|mesh-list
2197219|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2197220|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
2197221|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
2197222|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2197223|NCT00004360|Diuretics|diuretics|mesh-ancestor
2197224|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
2197225|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197226|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2197227|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2197228|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197229|NCT00004361|Citric Acid|citric acid|mesh-list
2197230|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
2197231|NCT00004361|Calcium|calcium|mesh-list
2197232|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2197233|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197234|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
2197235|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2197236|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
2197237|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
2197238|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197239|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
2197240|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2197241|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
2197242|NCT00004363|Coagulants|coagulants|mesh-ancestor
2197243|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2197244|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
2197245|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197246|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2197247|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2197248|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
2197249|NCT00004364|Coagulants|coagulants|mesh-ancestor
2197250|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2197251|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
2197252|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197253|NCT00004368|Colchicine|colchicine|mesh-list
2197254|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
2197255|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2197256|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
2197257|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
2197258|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
2197259|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197260|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197261|NCT00004373|Alprazolam|alprazolam|mesh-list
2197262|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2197263|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2197264|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197265|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2197266|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2197267|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2197268|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
2197269|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
2197270|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197271|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197272|NCT00004376|Guanfacine|guanfacine|mesh-list
2197273|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2197274|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2197275|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2197276|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2197277|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
2197278|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197279|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197280|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197281|NCT00004380|Methocarbamol|methocarbamol|mesh-list
2197282|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2197283|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197284|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2197285|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197286|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
2197287|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197288|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197289|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
2197290|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197291|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197292|NCT00004390|Morphine|morphine|mesh-list
2197293|NCT00004390|Methadone|methadone|mesh-list
2197294|NCT00004390|Nortriptyline|nortriptyline|mesh-list
2197295|NCT00004390|Desipramine|desipramine|mesh-list
2197296|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2197297|NCT00004390|Narcotics|narcotics|mesh-ancestor
2197298|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2197299|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197300|NCT00004390|Analgesics|analgesics|mesh-ancestor
2197301|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
2197302|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197303|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
2197304|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
2708642|NCT02136069|Infliximab|infliximab|mesh-list
2708643|NCT02136069|Etrolizumab|etrolizumab|mesh-list
2708644|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
2708645|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2708646|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2708647|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
2708648|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197305|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2197306|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
2197307|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2197308|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2197309|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2197310|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2197311|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197312|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
2197313|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2708662|NCT02096874|Bevacizumab|bevacizumab|mesh-list
2708663|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708664|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708665|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2708666|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2708667|NCT02096874|Growth Substances|growth substances|mesh-ancestor
2708668|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708669|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
2708670|NCT02086552|Lenalidomide|lenalidomide|mesh-list
2708671|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
2708672|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708673|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2708674|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2708675|NCT02086552|Growth Substances|growth substances|mesh-ancestor
2708676|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
2708677|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197314|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197315|NCT00004393|Risperidone|risperidone|mesh-list
2197316|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2197317|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
2197318|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197319|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197320|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197321|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2197322|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2197323|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2197324|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2197325|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2197326|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
2197327|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
2197328|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197329|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197330|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
2197331|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197332|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197333|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
2708754|NCT01024608|Beclomethasone|beclomethasone|mesh-list
2708755|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2708756|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
2708757|NCT01024608|Hormones|hormones|mesh-ancestor
2708758|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2708759|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708760|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2708761|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
2708762|NCT00988247|Beclomethasone|beclomethasone|mesh-list
2708763|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2708764|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
2708765|NCT00988247|Hormones|hormones|mesh-ancestor
2708766|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2708767|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708768|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2708769|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
2708770|NCT00838981|Methadone|methadone|mesh-list
2708771|NCT00838981|Modafinil|modafinil|mesh-list
2708772|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2708773|NCT00838981|Narcotics|narcotics|mesh-ancestor
2708774|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2708775|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708776|NCT00838981|Analgesics|analgesics|mesh-ancestor
2708777|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
2708778|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2708779|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
2708780|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
2708781|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2708782|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2708783|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2708784|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2708785|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708786|NCT00730639|Nivolumab|nivolumab|mesh-list
2708787|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708788|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197334|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2708789|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2708790|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708791|NCT00363038|Vitamins|vitamins|mesh-list
2708792|NCT00363038|Vitamin K|vitamin k|mesh-list
2708793|NCT00363038|Vitamin A|vitamin a|mesh-list
2708794|NCT00363038|Petrolatum|petrolatum|mesh-list
2708795|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
2708796|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708797|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2708798|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2708799|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708800|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
2197335|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197336|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
2197337|NCT00004399|Nimodipine|nimodipine|mesh-list
2197338|NCT00004399|Analgesics|analgesics|mesh-ancestor
2197339|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
2197340|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197341|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197342|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
2197343|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2197344|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2197345|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
2197346|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2197347|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2197348|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197349|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2197350|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
2197351|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2197352|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2197353|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
2197354|NCT00004400|Testosterone|testosterone|mesh-list
2197355|NCT00004400|Androgens|androgens|mesh-ancestor
2197356|NCT00004400|Hormones|hormones|mesh-ancestor
2197357|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197358|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197359|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
2708801|NCT00363038|Coagulants|coagulants|mesh-ancestor
2708802|NCT00363038|Emollients|emollients|mesh-ancestor
2708803|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
2197360|NCT00004401|Antibodies|antibodies|mesh-list
2197361|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
2197362|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2197363|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2197364|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
2197365|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197366|NCT00004402|Calcitriol|calcitriol|mesh-list
2197367|NCT00004402|Interferons|interferons|mesh-list
2197368|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
2197369|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197370|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
2197371|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197372|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2197373|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197374|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2197375|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2197376|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197377|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2197378|NCT00004402|Vitamins|vitamins|mesh-ancestor
2197379|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
2197380|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2197381|NCT00004403|Albendazole|albendazole|mesh-list
2197382|NCT00004403|Dexamethasone|dexamethasone|mesh-list
2197383|NCT00004403|Phenytoin|phenytoin|mesh-list
2197384|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2197385|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
2197386|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
2197387|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197388|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197389|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2197390|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
2197391|NCT00004403|Hormones|hormones|mesh-ancestor
2197392|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197393|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2197394|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197395|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
2197396|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2197397|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197398|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
2197399|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2197400|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2197401|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
2197402|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
2197403|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
2708844|NCT05146453|Anesthetics|anesthetics|mesh-list
2708845|NCT05146453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2708846|NCT05146453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197404|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197405|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
2197406|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2197407|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2197408|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2197409|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2197410|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2197411|NCT00004404|Clotrimazole|clotrimazole|mesh-list
2197412|NCT00004404|Miconazole|miconazole|mesh-list
2197413|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
2197414|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708847|NCT05146271|Anesthetics|anesthetics|mesh-list
2708848|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2708849|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708850|NCT05146245|Risperidone|risperidone|mesh-list
2708851|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2708852|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
2708853|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2708854|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708855|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708856|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2197415|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
2197416|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197417|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197418|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2197419|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2197420|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197421|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
2197422|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2197423|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2197424|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2197425|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
2197426|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197427|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708857|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2708858|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2708859|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2708860|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2708861|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
2708865|NCT05146154|Imipenem|imipenem|mesh-list
2708866|NCT05146154|Relebactam|relebactam|mesh-list
2708867|NCT05146154|Cilastatin|cilastatin|mesh-list
2708868|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2708869|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2708870|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
2708871|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2708872|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708873|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2708874|NCT05146089|Bosentan|bosentan|mesh-list
2197428|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2197429|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2197430|NCT00004406|Hormones|hormones|mesh-list
2197431|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
2197432|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197433|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197434|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2197435|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
2197436|NCT00004407|Antibodies|antibodies|mesh-list
2708875|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2708876|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2708877|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708878|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
2708879|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2708880|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708889|NCT05145660|Cisplatin|cisplatin|mesh-list
2708890|NCT05145660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708891|NCT05145634|Anticoagulants|anticoagulants|mesh-list
2197437|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
2197438|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2197439|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2197440|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
2197441|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197442|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
2197443|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
2197444|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197445|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2197446|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2197447|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
2197448|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2197449|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2197450|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2197451|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2197452|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197453|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
2197454|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197455|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197456|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2197457|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197458|NCT00004419|Mitogens|mitogens|mesh-list
2197459|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
2197460|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197461|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
2197462|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2197463|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2197464|NCT00004420|Analgesics|analgesics|mesh-ancestor
2197465|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
2197466|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197467|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197468|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2197469|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2197470|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2197471|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
2197472|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197473|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2197474|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
2197475|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
2197476|NCT00004422|Antibodies|antibodies|mesh-list
2197477|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
2197478|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2197479|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2197480|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
2197481|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197482|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
2197483|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
2197484|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2197485|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197486|NCT00004424|Fentanyl|fentanyl|mesh-list
2197487|NCT00004424|Midazolam|midazolam|mesh-list
2197488|NCT00004424|Propofol|propofol|mesh-list
2197489|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2197490|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2197491|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197492|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2197493|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
2197494|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
2197495|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2197496|NCT00004424|Narcotics|narcotics|mesh-ancestor
2197497|NCT00004424|Analgesics|analgesics|mesh-ancestor
2197498|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
2197499|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197500|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2197501|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2197502|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2197503|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2197504|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
2197505|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
2197506|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197507|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197508|NCT00004426|Leuprolide|leuprolide|mesh-list
2197509|NCT00004426|Hormones|hormones|mesh-list
2197510|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197511|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197512|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2197513|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
2197514|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2197515|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2197516|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197517|NCT00004429|Hormones|hormones|mesh-list
2197518|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197519|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197520|NCT00004430|Prednisolone|prednisolone|mesh-list
2197521|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2197522|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
2197523|NCT00004430|Hormones|hormones|mesh-ancestor
2708918|NCT05145543|Dexamethasone|dexamethasone|mesh-list
2708919|NCT05145543|Fentanyl|fentanyl|mesh-list
2708920|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
2708921|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2708922|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
2708923|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
2708924|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2708925|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708926|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2708927|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
2708928|NCT05145543|Hormones|hormones|mesh-ancestor
2708929|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2708930|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2708931|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708932|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2708933|NCT05145543|Narcotics|narcotics|mesh-ancestor
2708934|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2708935|NCT05145543|Analgesics|analgesics|mesh-ancestor
2708936|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
2708937|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2708938|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2708939|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
2708940|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
2708941|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
2197524|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197525|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197526|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2197527|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197528|NCT00004431|Baclofen|baclofen|mesh-list
2197529|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2197530|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197531|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2197532|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197533|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2197534|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
2197535|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
2197536|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197537|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197538|NCT00004433|Pergolide|pergolide|mesh-list
2708982|NCT05145296|Daratumumab|daratumumab|mesh-list
2708983|NCT05145296|Abatacept|abatacept|mesh-list
2708984|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2708985|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2708986|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2708987|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2708988|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
2708989|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708990|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2708991|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
2708992|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2708993|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2708994|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
2708995|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2708996|NCT05145270|Sulforaphane|sulforaphane|mesh-list
2708997|NCT05145270|Dexetimide|dexetimide|mesh-list
2708998|NCT05145270|Citalopram|citalopram|mesh-list
2708999|NCT05145270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2709000|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2709001|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2709002|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709003|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2709004|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
2709005|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2709006|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2709007|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
2709008|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2709009|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2709010|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2709011|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
2709012|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
2709013|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2709014|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2709015|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2709016|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
2709017|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2709018|NCT05145270|Protective Agents|protective agents|mesh-ancestor
2709019|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197539|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
2197540|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
2197541|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197542|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197543|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197544|NCT00004436|Prednisone|prednisone|mesh-list
2197545|NCT00004436|Leuprolide|leuprolide|mesh-list
2197546|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2197547|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
2197548|NCT00004436|Hormones|hormones|mesh-ancestor
2197549|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197550|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197551|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2197552|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197553|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2197554|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
2709030|NCT05145010|Infigratinib|infigratinib|mesh-list
2709031|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2709035|NCT05136196|Nivolumab|nivolumab|mesh-list
2709036|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2709037|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2709038|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2709039|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709052|NCT05131386|Trabectedin|trabectedin|mesh-list
2709053|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2709054|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
2709055|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709056|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2709057|NCT05128617|Paclitaxel|paclitaxel|mesh-list
2709058|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
2709059|NCT05128617|Epirubicin|epirubicin|mesh-list
2709060|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2709061|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2709062|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
2709063|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
2709064|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
2709065|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709066|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2709067|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
2709068|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2709069|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2709070|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2709071|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
2709072|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2709073|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2709074|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2709075|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2709076|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2709119|NCT05100134|Ceritinib|ceritinib|mesh-list
2709120|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2709121|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2709122|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2709123|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709130|NCT05079620|Amoxicillin|amoxicillin|mesh-list
2709131|NCT05079620|Vancomycin|vancomycin|mesh-list
2709132|NCT05079620|Levofloxacin|levofloxacin|mesh-list
2709133|NCT05079620|Ofloxacin|ofloxacin|mesh-list
2709134|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
2709135|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2709136|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
2197555|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2709137|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
2709138|NCT05079620|Cefepime|cefepime|mesh-list
2709139|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2709140|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2709141|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2709142|NCT05079620|Renal Agents|renal agents|mesh-ancestor
2709143|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2709144|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2709145|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2709146|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709147|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2709148|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2709149|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2709150|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2197556|NCT00004438|Leuprolide|leuprolide|mesh-list
2197557|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2197558|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
2197559|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2197560|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197561|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2197562|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197563|NCT00004440|Ibuprofen|ibuprofen|mesh-list
2197564|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2197565|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2197566|NCT00004440|Analgesics|analgesics|mesh-ancestor
2197567|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
2197568|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197569|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197570|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2197571|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2197572|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2197573|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197574|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197575|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
2197576|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2197577|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2197578|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2197579|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
2197580|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197581|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2197582|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
2197583|NCT00004442|Cholic Acids|cholic acids|mesh-list
2197584|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2709213|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
2709214|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
2709215|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
2709216|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2709217|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2709218|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2709219|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709220|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197585|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2197586|NCT00004442|Cathartics|cathartics|mesh-ancestor
2197587|NCT00004444|Paromomycin|paromomycin|mesh-list
2197588|NCT00004444|Streptomycin|streptomycin|mesh-list
2197589|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2197590|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197591|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2197592|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2197593|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2709297|NCT05021991|Pramoxine|pramoxine|mesh-list
2709298|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
2709299|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
2709300|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2709301|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2709302|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
2709303|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2709304|NCT05021978|Pramoxine|pramoxine|mesh-list
2709305|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
2709306|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
2709307|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2709308|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2709309|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
2709310|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2709330|NCT05019430|Cocaine|cocaine|mesh-list
2709331|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
2709332|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
2709333|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
2709334|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2709335|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2709336|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
2709337|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2709338|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2709339|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2709340|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2709341|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2709342|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709343|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
2709344|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2709345|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2709346|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2709347|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
2709348|NCT05017012|Paclitaxel|paclitaxel|mesh-list
2709349|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2709350|NCT05017012|Carboplatin|carboplatin|mesh-list
2709351|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
2709352|NCT05017012|Pemetrexed|pemetrexed|mesh-list
2709353|NCT05017012|Axitinib|axitinib|mesh-list
2709354|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2709355|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2709356|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
2709357|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
2709358|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
2709359|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709360|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2709361|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2709362|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2709363|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2709364|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2197594|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197595|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197596|NCT00004446|Fluoxetine|fluoxetine|mesh-list
2197597|NCT00004446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2197598|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2197599|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2197600|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197601|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197602|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
2197603|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197604|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2197605|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
2197606|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2197607|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2197608|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2197609|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197610|NCT00004448|Prednisone|prednisone|mesh-list
2197611|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2197612|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
2197613|NCT00004448|Hormones|hormones|mesh-ancestor
2197614|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197615|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197616|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2197617|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197618|NCT00004450|Interferons|interferons|mesh-list
2197619|NCT00004450|Interferon-beta|interferon-beta|mesh-list
2197620|NCT00004450|Thalidomide|thalidomide|mesh-list
2197621|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197622|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
2197623|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197624|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2197625|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
2197626|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197627|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
2709416|NCT04991480|Talazoparib|talazoparib|mesh-list
2709417|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2709418|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2709419|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709420|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197628|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2197629|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2197630|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2197631|NCT00004450|Growth Substances|growth substances|mesh-ancestor
2197632|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
2197633|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
2423610|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2423611|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423612|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2423613|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423614|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2423615|NCT00822848|Sorafenib|sorafenib|mesh-list
2423616|NCT00822848|Epirubicin|epirubicin|mesh-list
2423617|NCT00822848|Ifosfamide|ifosfamide|mesh-list
2423618|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423619|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2423620|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423621|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197634|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2709437|NCT04987294|Rasburicase|rasburicase|mesh-list
2709438|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
2709439|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2709449|NCT04961541|Vaccines|vaccines|mesh-list
2709450|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
2709451|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197635|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
2197636|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197637|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2197638|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2197639|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
2197640|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197641|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197642|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2197643|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
2197644|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2709467|NCT04956302|Dexamethasone|dexamethasone|mesh-list
2709468|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
2709469|NCT04956302|Bortezomib|bortezomib|mesh-list
2709470|NCT04956302|Daratumumab|daratumumab|mesh-list
2709471|NCT04956302|Panobinostat|panobinostat|mesh-list
2709472|NCT04956302|Ichthammol|ichthammol|mesh-list
2709473|NCT04956302|BB 1101|bb 1101|mesh-list
2709474|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2709475|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2197645|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197646|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197647|NCT00004466|Atorvastatin|atorvastatin|mesh-list
2197648|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2197649|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2197650|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
2197651|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197652|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2709476|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
2709477|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
2709478|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2709479|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197653|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2197654|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197655|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
2197656|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2197657|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
2709480|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2709481|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
2709482|NCT04956302|Hormones|hormones|mesh-ancestor
2709483|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2709484|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2709485|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2709486|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
2709487|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2709488|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709489|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
2709490|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2709491|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
2709497|NCT04944654|Emtricitabine|emtricitabine|mesh-list
2709498|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
2709499|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2709500|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2709501|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2709502|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197658|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197659|NCT00004467|Expectorants|expectorants|mesh-ancestor
2197660|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
2197661|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2197662|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
2423622|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2423623|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2423624|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2423625|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2423626|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
2423627|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2423628|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2423629|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2423630|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423631|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423632|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2423633|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2423634|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423635|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
2423636|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423637|NCT00823004|Letrozole|letrozole|mesh-list
2423638|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
2423639|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
2423640|NCT00823004|Buserelin|buserelin|mesh-list
2423641|NCT00823004|Ganirelix|ganirelix|mesh-list
2423642|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197663|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197664|NCT00004467|Protective Agents|protective agents|mesh-ancestor
2197665|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197666|NCT00004467|Antidotes|antidotes|mesh-ancestor
2197667|NCT00004468|Calcitriol|calcitriol|mesh-list
2197668|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2197669|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197670|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2197671|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2197672|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197673|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2197674|NCT00004468|Vitamins|vitamins|mesh-ancestor
2197675|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
2197676|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2709503|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709504|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2709505|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2197677|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
2197678|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2197679|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2197680|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
2197681|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197682|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2423643|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2423644|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2423645|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423646|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423647|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2423648|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
2423649|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2423650|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423651|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2423652|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2423653|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2423654|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
2423655|NCT00823030|Lidocaine|lidocaine|mesh-list
2423656|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
2423657|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
2197683|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2197684|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
2197685|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709591|NCT04907032|Mirabegron|mirabegron|mesh-list
2709592|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2709593|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2709594|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2709595|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
2709596|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2709597|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709598|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2709599|NCT04907032|Urological Agents|urological agents|mesh-ancestor
2197686|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197687|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2197688|NCT00004478|Droxidopa|droxidopa|mesh-list
2197689|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2197690|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2197691|NCT00004479|Midodrine|midodrine|mesh-list
2197692|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
2197693|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
2197694|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197695|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197696|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2197697|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2197698|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2197699|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2197700|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
2197701|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197702|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197703|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
2197704|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2197705|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2197706|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2197707|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2709714|NCT04834362|Insulin|insulin|mesh-list
2709715|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2709716|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
2709717|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
2709718|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2709719|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197708|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197709|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
2197710|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197711|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197712|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2197713|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197714|NCT00004482|Cyclosporine|cyclosporine|mesh-list
2197715|NCT00004482|Prednisone|prednisone|mesh-list
2197716|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
2197717|NCT00004482|Cyclosporins|cyclosporins|mesh-list
2197718|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
2197719|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2197720|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
2197721|NCT00004482|Hormones|hormones|mesh-ancestor
2197722|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197723|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197724|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2197725|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2709727|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2709728|NCT04826354|Ezetimibe|ezetimibe|mesh-list
2709729|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2709730|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2709731|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
2709732|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709733|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2709734|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2709735|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2709742|NCT04816214|Carboplatin|carboplatin|mesh-list
2709743|NCT04816214|Pemetrexed|pemetrexed|mesh-list
2709744|NCT04816214|Osimertinib|osimertinib|mesh-list
2197726|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2709745|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2709746|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2709747|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709748|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2709749|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2709750|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2709754|NCT04802356|Dexamethasone|dexamethasone|mesh-list
2709755|NCT04802356|Lenalidomide|lenalidomide|mesh-list
2709756|NCT04802356|Bortezomib|bortezomib|mesh-list
2709757|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2709758|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
2709759|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
2709760|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2709761|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2709762|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2709763|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
2709764|NCT04802356|Hormones|hormones|mesh-ancestor
2709765|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2709766|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2709767|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2709768|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
2709769|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2709770|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2709771|NCT04802356|Growth Substances|growth substances|mesh-ancestor
2709772|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
2709778|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2709779|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2709780|NCT04777006|Amitriptyline|amitriptyline|mesh-list
2709781|NCT04777006|Fluoxetine|fluoxetine|mesh-list
2709782|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
2709783|NCT04777006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2709784|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2709785|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2709786|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2709787|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2709788|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
2709789|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2709790|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2709791|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2709792|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2709793|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2709794|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2709795|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2709796|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2709797|NCT04777006|Analgesics|analgesics|mesh-ancestor
2709798|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
2709799|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2709800|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2709801|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
2197727|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197728|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2197729|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
2197730|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
2197731|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2709883|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
2709884|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2709885|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2709886|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
2709887|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197732|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
2197733|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2197734|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2197735|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
2197736|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
2197737|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197738|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2197739|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2709964|NCT04708613|Corticosterone|corticosterone|mesh-list
2709965|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2709995|NCT04681482|Apixaban|apixaban|mesh-list
2709996|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2709997|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
2709998|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2709999|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
2710000|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2710001|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710002|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
2197740|NCT00004482|Protective Agents|protective agents|mesh-ancestor
2197741|NCT00004485|Cyclosporine|cyclosporine|mesh-list
2197742|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
2197743|NCT00004485|Fludarabine|fludarabine|mesh-list
2197744|NCT00004485|Cyclosporins|cyclosporins|mesh-list
2197745|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197746|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197747|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2197748|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
2710039|NCT04651400|Antithrombins|antithrombins|mesh-list
2710040|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
2710041|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2710042|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
2710043|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2710044|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710045|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
2710058|NCT04635943|Ivermectin|ivermectin|mesh-list
2710059|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2710060|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197749|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197750|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197751|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
2197752|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197753|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
2197754|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2197755|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2197756|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2197757|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2197758|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
2197759|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2197760|NCT00004486|Fluoxetine|fluoxetine|mesh-list
2197761|NCT00004486|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2197762|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2197763|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2197764|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197765|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197766|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
2197767|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197768|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2197769|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
2197770|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2197771|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2197772|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2197773|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197774|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
2197775|NCT00004488|Alendronate|alendronate|mesh-list
2197776|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
2197777|NCT00004488|Calcium|calcium|mesh-list
2197778|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2197779|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197780|NCT00004488|Vitamins|vitamins|mesh-ancestor
2197781|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
2197782|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2197783|NCT00004488|Antacids|antacids|mesh-ancestor
2197784|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197785|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2197786|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
2197787|NCT00004489|Alendronate|alendronate|mesh-list
2197788|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
2197789|NCT00004489|Calcium|calcium|mesh-list
2197790|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2197791|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2710073|NCT04633239|Olaparib|olaparib|mesh-list
2710074|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2710075|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2710076|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710077|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710078|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
2710079|NCT04629729|Fludarabine|fludarabine|mesh-list
2710080|NCT04629729|Interleukin-2|interleukin-2|mesh-list
2710081|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2710082|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
2710083|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2710084|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2710085|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2710086|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
2710087|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710088|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710089|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2710090|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2710091|NCT04629729|Analgesics|analgesics|mesh-ancestor
2710092|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
2710093|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197792|NCT00004489|Vitamins|vitamins|mesh-ancestor
2197793|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
2197794|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2197795|NCT00004489|Antacids|antacids|mesh-ancestor
2197796|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197797|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2197798|NCT00004492|Clotrimazole|clotrimazole|mesh-list
2197799|NCT00004492|Miconazole|miconazole|mesh-list
2197800|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
2197801|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197802|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
2197803|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197804|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197805|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2197806|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2197807|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197808|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
2197809|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2197810|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2197811|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2197812|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
2197813|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197814|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197815|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2197816|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2197817|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
2197818|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2197819|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
2197820|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2197821|NCT00004494|Protective Agents|protective agents|mesh-ancestor
2197822|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197823|NCT00004495|Folic Acid|folic acid|mesh-list
2197824|NCT00004495|Pyridoxine|pyridoxine|mesh-list
2197825|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
2197826|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
2197827|NCT00004495|Hematinics|hematinics|mesh-ancestor
2197828|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
2197829|NCT00004495|Vitamins|vitamins|mesh-ancestor
2710123|NCT04576156|Imetelstat|imetelstat|mesh-list
2710124|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
2710125|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197830|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
2197831|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197832|NCT00004496|Hormones|hormones|mesh-list
2197833|NCT00004496|alpha-MSH|alpha-msh|mesh-list
2197834|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2197835|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2197836|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
2197837|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197838|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197839|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197840|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197841|NCT00004551|Nicotine|nicotine|mesh-list
2197842|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2197843|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
2197844|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2197845|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197846|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2197847|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2197848|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
2197849|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197850|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197851|NCT00004552|Acamprosate|acamprosate|mesh-list
2197852|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2197853|NCT00004554|Naltrexone|naltrexone|mesh-list
2197854|NCT00004554|Sertraline|sertraline|mesh-list
2197855|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2197856|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2197857|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197858|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
2197859|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2710126|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710127|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2197860|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
2197861|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2197862|NCT00004554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2710168|NCT04546633|Lumefantrine|lumefantrine|mesh-list
2710169|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
2710170|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2710171|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2710172|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197863|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2197864|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2197865|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197866|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197867|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
2197868|NCT00004564|Clopidogrel|clopidogrel|mesh-list
2197869|NCT00004564|Atorvastatin|atorvastatin|mesh-list
2197870|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2197871|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2197872|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
2197873|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197874|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2197875|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2197876|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197877|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2197878|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2197879|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2197880|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2197881|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
2197882|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2197883|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197884|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
2197885|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2197886|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2197887|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2197888|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
2197889|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2197890|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197891|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197892|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197893|NCT00004573|Ganciclovir|ganciclovir|mesh-list
2197894|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2197895|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
2197896|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197897|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2197898|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197899|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197900|NCT00004575|Miconazole|miconazole|mesh-list
2197901|NCT00004575|Bradykinin|bradykinin|mesh-list
2197902|NCT00004575|Kininogens|kininogens|mesh-list
2197903|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197904|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197905|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
2197906|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197907|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2197908|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2197909|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2197910|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
2197911|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2197912|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197913|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2197914|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2197915|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
2197916|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2197917|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
2197918|NCT00004578|Ritonavir|ritonavir|mesh-list
2197919|NCT00004578|Lopinavir|lopinavir|mesh-list
2197920|NCT00004578|Lamivudine|lamivudine|mesh-list
2197921|NCT00004578|Stavudine|stavudine|mesh-list
2197922|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2197923|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2197924|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
2197925|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197926|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197927|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2197928|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2197929|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
2197930|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2710254|NCT04512534|Antibodies|antibodies|mesh-list
2710255|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2710256|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
2710257|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2710258|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2710259|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710260|NCT04510506|Pancrelipase|pancrelipase|mesh-list
2710261|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2710277|NCT04495179|Durvalumab|durvalumab|mesh-list
2710278|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2710279|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710289|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
2710290|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2710291|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710292|NCT04477486|Venetoclax|venetoclax|mesh-list
2710293|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710294|NCT04425447|Anesthetics|anesthetics|mesh-list
2710295|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2710296|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197931|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2197932|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2197933|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2423658|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423659|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423660|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
2197934|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2197935|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
2197936|NCT00004580|Ritonavir|ritonavir|mesh-list
2197937|NCT00004580|Lopinavir|lopinavir|mesh-list
2197938|NCT00004580|Nevirapine|nevirapine|mesh-list
2197939|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2197940|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2197941|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
2197942|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197943|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423661|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423662|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2423663|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2423664|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2423665|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2423666|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423667|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2423668|NCT00823121|Buserelin|buserelin|mesh-list
2423669|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2423670|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423671|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2423672|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
2710318|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2710319|NCT04355728|Heparin|heparin|mesh-list
2710320|NCT04355728|Calcium heparin|calcium heparin|mesh-list
2710321|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
2710322|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2197944|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2197945|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2197946|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
2197947|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197948|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2197949|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2710323|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2710324|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197950|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2197951|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2197952|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2197953|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2197954|NCT00004581|Ritonavir|ritonavir|mesh-list
2197955|NCT00004581|Lopinavir|lopinavir|mesh-list
2197956|NCT00004581|Nevirapine|nevirapine|mesh-list
2197957|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2197958|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2197959|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
2197960|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197961|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197962|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2197963|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2197964|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
2197965|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197966|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2197967|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2197968|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2197969|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2197970|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2197971|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2197972|NCT00004582|Ritonavir|ritonavir|mesh-list
2197973|NCT00004582|Lopinavir|lopinavir|mesh-list
2197974|NCT00004582|Efavirenz|efavirenz|mesh-list
2197975|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2197976|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2197977|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
2197978|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2197979|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2197980|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2197981|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2197982|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
2197983|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197984|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2710370|NCT04328714|Interferons|interferons|mesh-list
2710371|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
2197985|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2197986|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2710372|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710373|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
2710374|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2197987|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2197988|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2197989|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2710393|NCT04303780|Docetaxel|docetaxel|mesh-list
2710394|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710395|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
2710396|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
2710397|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
2710398|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710399|NCT04300309|Lumefantrine|lumefantrine|mesh-list
2710400|NCT04300309|Artemether|artemether|mesh-list
2710401|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
2710402|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2710403|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2710404|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2710434|NCT04283656|Tenofovir|tenofovir|mesh-list
2710435|NCT04283656|Lamivudine|lamivudine|mesh-list
2710436|NCT04283656|Spironolactone|spironolactone|mesh-list
2710437|NCT04283656|Estradiol|estradiol|mesh-list
2710438|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
2710439|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2710440|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2710441|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2710442|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2710443|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710444|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2710445|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2710446|NCT04283656|Estrogens|estrogens|mesh-ancestor
2710447|NCT04283656|Hormones|hormones|mesh-ancestor
2710448|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2710449|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2197990|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2197991|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2710450|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2710451|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
2710452|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2710453|NCT04283656|Diuretics|diuretics|mesh-ancestor
2710454|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
2197992|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2197993|NCT00004583|Ritonavir|ritonavir|mesh-list
2197994|NCT00004583|Lopinavir|lopinavir|mesh-list
2197995|NCT00004583|Nelfinavir|nelfinavir|mesh-list
2197996|NCT00004583|Lamivudine|lamivudine|mesh-list
2197997|NCT00004583|Stavudine|stavudine|mesh-list
2197998|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2197999|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2198000|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
2198001|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198002|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198003|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2198004|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2198005|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
2198006|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198007|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2198008|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2198009|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2198010|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2198011|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
2198012|NCT00004584|Ritonavir|ritonavir|mesh-list
2198013|NCT00004584|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2198014|NCT00004584|Saquinavir|saquinavir|mesh-list
2198015|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2198016|NCT00004584|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2198017|NCT00004584|Protease Inhibitors|protease inhibitors|mesh-ancestor
2198018|NCT00004584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198019|NCT00004584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198020|NCT00004584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2198021|NCT00004584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2198022|NCT00004584|Antiviral Agents|antiviral agents|mesh-ancestor
2198023|NCT00004584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198024|NCT00004584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2198025|NCT00004584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2198026|NCT00004585|Lamivudine|lamivudine|mesh-list
2198027|NCT00004585|Zidovudine|zidovudine|mesh-list
2198028|NCT00004585|Efavirenz|efavirenz|mesh-list
2198029|NCT00004585|Abacavir|abacavir|mesh-list
2198030|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
2198031|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2423673|NCT00823186|Paclitaxel|paclitaxel|mesh-list
2423674|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2198032|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2198033|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2423675|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423676|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
2423677|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
2423678|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423679|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423680|NCT00823238|Tobramycin|tobramycin|mesh-list
2423681|NCT00823238|Ceftazidime|ceftazidime|mesh-list
2710483|NCT04261439|Spartalizumab|spartalizumab|mesh-list
2710484|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2710485|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710486|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710495|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
2710496|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2710497|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2710498|NCT04233164|Prednisolone|prednisolone|mesh-list
2710499|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
2710500|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2710501|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
2710502|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2710503|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
2710504|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
2710505|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2710506|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198034|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198035|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198036|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
2198037|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198038|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2198039|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2198040|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
2198041|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2198042|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2198043|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2198044|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2198045|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2198046|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2198047|NCT00004637|Vitamin E|vitamin e|mesh-list
2198048|NCT00004637|Vitamins|vitamins|mesh-ancestor
2198049|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
2198050|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198051|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
2198052|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198053|NCT00004637|Protective Agents|protective agents|mesh-ancestor
2198054|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
2710507|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2710508|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
2710509|NCT04233164|Hormones|hormones|mesh-ancestor
2710510|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2710511|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2710512|NCT04233164|Protective Agents|protective agents|mesh-ancestor
2710513|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2710514|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710515|NCT04227288|Betamethasone|betamethasone|mesh-list
2710516|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
2710517|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2710518|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
2710519|NCT04227288|Calcipotriene|calcipotriene|mesh-list
2710520|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2710521|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2710522|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
2710523|NCT04227288|Hormones|hormones|mesh-ancestor
2710524|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2710525|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2710526|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2198055|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2198056|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198057|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
2198058|NCT00004643|Cytarabine|cytarabine|mesh-list
2710527|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
2710528|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
2710529|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
2710530|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2710531|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198059|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2198060|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
2198061|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198062|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198063|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
2198064|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198065|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2198066|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
2198067|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2710558|NCT04194554|Leuprolide|leuprolide|mesh-list
2710559|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
2710560|NCT04194554|Niraparib|niraparib|mesh-list
2710561|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2710562|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
2710563|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2710564|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2710565|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2710566|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710567|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2710568|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2710569|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710570|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
2710571|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2710572|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2710573|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2710585|NCT04182997|Dexamethasone|dexamethasone|mesh-list
2710586|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2710587|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
2198068|NCT00004644|Acyclovir|acyclovir|mesh-list
2198069|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
2198070|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198071|NCT00004646|Prednisone|prednisone|mesh-list
2198072|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2198073|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
2198074|NCT00004646|Hormones|hormones|mesh-ancestor
2198075|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2198076|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198077|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2423682|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2423683|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423684|NCT00823290|Sorafenib|sorafenib|mesh-list
2423685|NCT00823290|Panobinostat|panobinostat|mesh-list
2423686|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423687|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2423688|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423689|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423690|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2423691|NCT00823342|Tenofovir|tenofovir|mesh-list
2423692|NCT00823342|Clevudine|clevudine|mesh-list
2423693|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
2423694|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423695|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2198078|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198079|NCT00004647|Mexiletine|mexiletine|mesh-list
2198080|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2198081|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2198082|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2198083|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2198084|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198085|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2198086|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
2198087|NCT00004650|Estrogens|estrogens|mesh-list
2198088|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2198089|NCT00004650|Hormones|hormones|mesh-ancestor
2198090|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2198091|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198092|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2198093|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2198094|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2198095|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
2198096|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2198097|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2198098|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2198099|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2198100|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2198101|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198102|NCT00004652|Pimozide|pimozide|mesh-list
2198103|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2198104|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2198105|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2198106|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198107|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2198108|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2198109|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
2198110|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2198111|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198112|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2198113|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2198114|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2198115|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
2198116|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198117|NCT00004664|Megestrol|megestrol|mesh-list
2198118|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2710588|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
2710589|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2710590|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2710591|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2710592|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
2710593|NCT04182997|Hormones|hormones|mesh-ancestor
2710594|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2710595|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2710596|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198119|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2198120|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2198121|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
2198122|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2198123|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198124|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2198125|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2198126|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2198127|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198128|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2198129|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2198130|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
2198131|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198132|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
2198133|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2198134|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
2710624|NCT04137354|Vitamins|vitamins|mesh-list
2710625|NCT04137354|Vitamin A|vitamin a|mesh-list
2710626|NCT04137354|Iron|iron|mesh-list
2710627|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
2710628|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
2198135|NCT00004682|Antibodies|antibodies|mesh-list
2198136|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
2198137|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2198138|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2198139|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
2198140|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198141|NCT00004685|Albuterol|albuterol|mesh-list
2198142|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2198143|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
2198144|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198145|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198146|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2198147|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
2198148|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
2198149|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2710629|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2710630|NCT04137354|Trace Elements|trace elements|mesh-ancestor
2710631|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
2710632|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710633|NCT04137354|Protective Agents|protective agents|mesh-ancestor
2710634|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2710635|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710644|NCT04125836|Octreotide|octreotide|mesh-list
2710645|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2710646|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2710647|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198150|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2198151|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2198152|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2198153|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
2198154|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2198155|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198156|NCT00004686|Prednisone|prednisone|mesh-list
2198157|NCT00004686|Methotrexate|methotrexate|mesh-list
2198158|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2198159|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
2198160|NCT00004686|Hormones|hormones|mesh-ancestor
2198161|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2198162|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198163|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2198164|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423696|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2423697|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423698|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423699|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2423700|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2423701|NCT00823381|Resveratrol|resveratrol|mesh-list
2423702|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
2423703|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198165|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2198166|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
2198167|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2198168|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2198169|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
2710699|NCT04076462|Octreotide|octreotide|mesh-list
2710700|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2710701|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2710702|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198170|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198171|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
2198172|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198173|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2198174|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2198175|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
2198176|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2198177|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2198178|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
2198179|NCT00004688|Carmustine|carmustine|mesh-list
2198180|NCT00004688|Streptozocin|streptozocin|mesh-list
2198181|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
2198182|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198183|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2198184|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198185|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2198186|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
2198187|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198188|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2198189|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198190|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2198191|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
2198192|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2198193|NCT00004689|Clarithromycin|clarithromycin|mesh-list
2198194|NCT00004689|Rifampin|rifampin|mesh-list
2198195|NCT00004689|Ethambutol|ethambutol|mesh-list
2198196|NCT00004689|Streptomycin|streptomycin|mesh-list
2198197|NCT00004689|Thioacetazone|thioacetazone|mesh-list
2198198|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2198199|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198200|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2198201|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198202|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198203|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2198204|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2198205|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2710713|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
2710714|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2710715|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2710716|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710720|NCT04033068|Vaccines|vaccines|mesh-list
2710721|NCT04033068|Immunologic Factors|immunologic factors|mesh-ancestor
2710722|NCT04033068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198206|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
2198207|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
2198208|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2198209|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2198210|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2198211|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2198212|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2198213|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2198214|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2198215|NCT00004690|Monolaurin|monolaurin|mesh-list
2198216|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
2198217|NCT00004690|Protective Agents|protective agents|mesh-ancestor
2198218|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198219|NCT00004694|Heparin|heparin|mesh-list
2198220|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
2198221|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2198222|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2198223|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198224|NCT00004695|Interleukin-2|interleukin-2|mesh-list
2198225|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198226|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2198227|NCT00004695|Analgesics|analgesics|mesh-ancestor
2198228|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
2198229|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198230|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198231|NCT00004696|Morphine|morphine|mesh-list
2198232|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2198233|NCT00004696|Narcotics|narcotics|mesh-ancestor
2198234|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2198235|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198236|NCT00004696|Analgesics|analgesics|mesh-ancestor
2198237|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
2198238|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198239|NCT00004697|Choline|choline|mesh-list
2198240|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
2710750|NCT04023227|Valsartan|valsartan|mesh-list
2710751|NCT04023227|Enalapril|enalapril|mesh-list
2710752|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2710753|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2710754|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2710755|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710756|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2710757|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
2710758|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2710759|NCT04002037|Dexamethasone|dexamethasone|mesh-list
2710760|NCT04002037|Triamcinolone|triamcinolone|mesh-list
2710761|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2710762|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2710763|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2710764|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2710765|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
2710766|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
2710767|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2710768|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2710769|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2710770|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
2710771|NCT04002037|Hormones|hormones|mesh-ancestor
2710772|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2710773|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2710774|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710775|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2198241|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2198242|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
2198243|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198244|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2198245|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2198246|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
2198247|NCT00004699|Mitogens|mitogens|mesh-list
2198248|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
2198249|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198250|NCT00004700|Mitogens|mitogens|mesh-list
2198251|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
2198252|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198253|NCT00004705|Amiloride|amiloride|mesh-list
2198254|NCT00004705|Diuretics|diuretics|mesh-ancestor
2198255|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
2198256|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198257|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2198258|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2198259|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2198260|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198261|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2198262|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2198263|NCT00004727|Aspirin|aspirin|mesh-list
2198264|NCT00004727|Ticlopidine|ticlopidine|mesh-list
2198265|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2198266|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2198267|NCT00004727|Analgesics|analgesics|mesh-ancestor
2198268|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
2198269|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198270|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198271|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2198272|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2710776|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
2710777|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2710778|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710779|NCT04000529|Spartalizumab|spartalizumab|mesh-list
2710780|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2710781|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710782|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198273|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2198274|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2198275|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198276|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2198277|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2710795|NCT03988634|Valsartan|valsartan|mesh-list
2710796|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2710797|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2710798|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2710799|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710805|NCT03961516|Pancrelipase|pancrelipase|mesh-list
2710806|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2710807|NCT03954938|Cocaine|cocaine|mesh-list
2710808|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
2710809|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
2710810|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2710811|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198278|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198279|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
2198280|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2198281|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2198282|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2198283|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
2198284|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2198285|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2198286|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2198287|NCT00004728|Aspirin|aspirin|mesh-list
2198288|NCT00004728|Warfarin|warfarin|mesh-list
2198289|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2198290|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2198291|NCT00004728|Analgesics|analgesics|mesh-ancestor
2198292|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
2198293|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198294|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198295|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2198296|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2198297|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2198298|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2198299|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198300|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2198301|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2198302|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198303|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
2198304|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
2710812|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
2710813|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2710814|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2710815|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2710816|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2710817|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2710818|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710819|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
2710820|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2710821|NCT03940352|Venetoclax|venetoclax|mesh-list
2710822|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710823|NCT03937986|Cocaine|cocaine|mesh-list
2710824|NCT03937986|Suvorexant|suvorexant|mesh-list
2710825|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
2710826|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
2710827|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2710828|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2710829|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
2710830|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2710831|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2710832|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2710833|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2710834|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2710835|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2710836|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
2710837|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2198305|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
2198306|NCT00004730|Analgesics|analgesics|mesh-ancestor
2198307|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
2198308|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198309|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198310|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
2198311|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2198312|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2198313|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
2198314|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2198315|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2198316|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198317|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2198318|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
2198319|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2198320|NCT00004731|Ubiquinone|ubiquinone|mesh-list
2198321|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
2198322|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
2198323|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198324|NCT00004731|Vitamins|vitamins|mesh-ancestor
2198325|NCT00004733|Levodopa|levodopa|mesh-list
2710838|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2710839|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2710840|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2198326|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2198327|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2198328|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
2198329|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2198330|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198331|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198332|NCT00004734|Folic Acid|folic acid|mesh-list
2198333|NCT00004734|Pyridoxine|pyridoxine|mesh-list
2198334|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
2198335|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
2198336|NCT00004734|Hematinics|hematinics|mesh-ancestor
2198337|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
2198338|NCT00004734|Vitamins|vitamins|mesh-ancestor
2198339|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
2198340|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198341|NCT00004736|Lamivudine|lamivudine|mesh-list
2198342|NCT00004736|Zidovudine|zidovudine|mesh-list
2198343|NCT00004736|Stavudine|stavudine|mesh-list
2198344|NCT00004736|Nelfinavir|nelfinavir|mesh-list
2198345|NCT00004736|Isoniazid|isoniazid|mesh-list
2198346|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
2198347|NCT00004736|Ethambutol|ethambutol|mesh-list
2198348|NCT00004736|Rifabutin|rifabutin|mesh-list
2198349|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2198350|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2198351|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198352|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198353|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
2198354|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198355|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2198356|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2198357|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
2198358|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
2198359|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2198360|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2198361|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2198362|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2198363|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2198364|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2198365|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
2198366|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2198367|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2198368|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
2198369|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198370|NCT00004740|Isoniazid|isoniazid|mesh-list
2198371|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
2198372|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2198373|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198374|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2198375|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2198376|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
2198377|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198378|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2198379|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
2198380|NCT00004744|Antibodies|antibodies|mesh-list
2198381|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
2198382|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2198383|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2198384|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
2198385|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198386|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
2198387|NCT00004747|Antibodies|antibodies|mesh-list
2198388|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
2198389|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2198390|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2198391|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
2198392|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198393|NCT00004748|Methotrexate|methotrexate|mesh-list
2198394|NCT00004748|Colchicine|colchicine|mesh-list
2198395|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2198396|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2198397|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
2198398|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2198399|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198400|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2198401|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
2198402|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198403|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198404|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
2198405|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2710951|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
2710952|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2710953|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198406|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2198407|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2710985|NCT03829501|Atezolizumab|atezolizumab|mesh-list
2710986|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2710987|NCT03822897|Cisplatin|cisplatin|mesh-list
2710988|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198408|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
2198409|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2198410|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2198411|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
2198412|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
2198413|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
2198414|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
2198415|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2198416|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2198417|NCT00004754|Epoprostenol|epoprostenol|mesh-list
2198418|NCT00004754|Tezosentan|tezosentan|mesh-list
2198419|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2198420|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2198421|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
2198422|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2198423|NCT00004755|Allopurinol|allopurinol|mesh-list
2198424|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
2198425|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198426|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198427|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
2198428|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2198429|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2198430|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
2198431|NCT00004755|Protective Agents|protective agents|mesh-ancestor
2198432|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198433|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2198434|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2198435|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198436|NCT00004757|Acyclovir|acyclovir|mesh-list
2198437|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
2198438|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198439|NCT00004758|Pyridoxine|pyridoxine|mesh-list
2198440|NCT00004758|Carbamazepine|carbamazepine|mesh-list
2198441|NCT00004758|Valproic Acid|valproic acid|mesh-list
2711022|NCT03785405|Valsartan|valsartan|mesh-list
2711023|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2711024|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2711025|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2711026|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198442|NCT00004758|Nitrazepam|nitrazepam|mesh-list
2198443|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2198444|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
2198445|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198446|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198447|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
2198448|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2198449|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198450|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
2198451|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2198452|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2198453|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2198454|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2198455|NCT00004758|Analgesics|analgesics|mesh-ancestor
2198456|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
2198457|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198458|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2198459|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2198460|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2198461|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2711038|NCT03749616|Acetaminophen|acetaminophen|mesh-list
2711039|NCT03749616|Ibuprofen|ibuprofen|mesh-list
2711040|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2711041|NCT03749616|Analgesics|analgesics|mesh-ancestor
2711042|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
2711043|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2711044|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711045|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
2711046|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2711047|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2711048|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2711049|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2711050|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711051|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711056|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
2711057|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711058|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2711059|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711060|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198462|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
2198463|NCT00004758|Vitamins|vitamins|mesh-ancestor
2198464|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
2198465|NCT00004758|Hormones|hormones|mesh-ancestor
2198466|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2198467|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2198468|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2198469|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
2198470|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
2198471|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2198472|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2198473|NCT00004759|Prednisolone|prednisolone|mesh-list
2198474|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
2198475|NCT00004759|Tirilazad|tirilazad|mesh-list
2198476|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2198477|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
2198478|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2198479|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
2198480|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
2198481|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198482|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198483|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2198484|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
2198485|NCT00004759|Hormones|hormones|mesh-ancestor
2198486|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2198487|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2198488|NCT00004759|Protective Agents|protective agents|mesh-ancestor
2198489|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2198490|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198491|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
2198492|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198493|NCT00004762|Cladribine|cladribine|mesh-list
2198494|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198495|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2198496|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
2198497|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198498|NCT00004763|Leuprolide|leuprolide|mesh-list
2198499|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2198500|NCT00004763|Norethindrone|norethindrone|mesh-list
2198501|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
2198502|NCT00004763|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2198503|NCT00004763|Norinyl|norinyl|mesh-list
2198504|NCT00004763|Estradiol|estradiol|mesh-list
2198505|NCT00004763|Estrogens|estrogens|mesh-ancestor
2198506|NCT00004763|Hormones|hormones|mesh-ancestor
2198507|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2198508|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198509|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2198510|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
2198511|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2198512|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2198513|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2198514|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
2198515|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2198516|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198517|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2198518|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2198519|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2198520|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2198521|NCT00004763|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2711138|NCT03612466|Plerixafor|plerixafor|mesh-list
2711139|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
2711140|NCT03612466|Calcium|calcium|mesh-list
2711141|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2711142|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711143|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2711144|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2711145|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
2711146|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2711147|NCT03612466|Antacids|antacids|mesh-ancestor
2711148|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711149|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2711163|NCT03599635|Bupivacaine|bupivacaine|mesh-list
2711164|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
2711165|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
2711166|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2711167|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711168|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
2711169|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2711184|NCT03570632|Metformin|metformin|mesh-list
2711185|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2711186|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711187|NCT03565835|Prednisone|prednisone|mesh-list
2711188|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
2711189|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2711190|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
2711191|NCT03565835|Hormones|hormones|mesh-ancestor
2198522|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
2198523|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2198524|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
2198525|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198526|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2198527|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
2198528|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198529|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
2198530|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198531|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
2198532|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
2198533|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198534|NCT00004770|Protective Agents|protective agents|mesh-ancestor
2198535|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198536|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
2198537|NCT00004770|Vitamins|vitamins|mesh-ancestor
2198538|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
2198539|NCT00004771|Leuprolide|leuprolide|mesh-list
2198540|NCT00004771|Testosterone|testosterone|mesh-list
2198541|NCT00004771|Androgens|androgens|mesh-ancestor
2198542|NCT00004771|Hormones|hormones|mesh-ancestor
2198543|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2711192|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2711193|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711194|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2711195|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711196|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2711197|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711198|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711199|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
2711200|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2711201|NCT03546829|Vancomycin|vancomycin|mesh-list
2711202|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2711203|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2711204|NCT03543839|Belimumab|belimumab|mesh-list
2711205|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2711206|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
2711207|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198544|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198545|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2198546|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198547|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2198548|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
2198549|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2198550|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
2198551|NCT00004772|Antibodies|antibodies|mesh-list
2198552|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
2198553|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2198554|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2711231|NCT03499119|Erenumab|erenumab|mesh-list
2711232|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2711233|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711234|NCT03499119|Analgesics|analgesics|mesh-ancestor
2711235|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
2711236|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2711237|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711238|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2711239|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2711240|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2711241|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711242|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711243|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
2711244|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2711245|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2711246|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2711247|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
2711248|NCT03456843|Docetaxel|docetaxel|mesh-list
2711249|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
2711250|NCT03456843|Hormones|hormones|mesh-list
2711251|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2711252|NCT03456843|Androgens|androgens|mesh-list
2711253|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
2711254|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711255|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
2711256|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
2711257|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
2711258|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711259|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2711260|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711261|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
2711262|NCT03456843|Protective Agents|protective agents|mesh-ancestor
2711263|NCT03456843|Vitamins|vitamins|mesh-ancestor
2711264|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
2711265|NCT03456843|Estrogens|estrogens|mesh-ancestor
2711266|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2711267|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
2711268|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
2711269|NCT03451825|Avelumab|avelumab|mesh-list
2711270|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2711271|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2711272|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711273|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
2711274|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711275|NCT03439046|Letrozole|letrozole|mesh-list
2198555|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
2198556|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198557|NCT00004776|Topiramate|topiramate|mesh-list
2198558|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
2198559|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2198560|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198561|NCT00004778|Dexamethasone|dexamethasone|mesh-list
2198562|NCT00004778|Betamethasone|betamethasone|mesh-list
2198563|NCT00004778|Hormones|hormones|mesh-list
2198564|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
2198565|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2198566|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
2711276|NCT03439046|Fulvestrant|fulvestrant|mesh-list
2711277|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711278|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2711279|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2711280|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198567|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
2198568|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198569|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198570|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2198571|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
2711281|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711282|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2711283|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
2711284|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2711285|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711286|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2711287|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2198572|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2198573|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2198574|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198575|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2198576|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
2198577|NCT00004784|Methotrexate|methotrexate|mesh-list
2198578|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2198579|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2198580|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
2198581|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2198582|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198583|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2198584|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
2711322|NCT03406897|Vitamin D|vitamin d|mesh-list
2711323|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
2198585|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198586|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198587|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
2198588|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198589|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2198590|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2198591|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
2198592|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2198593|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2198594|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2198595|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2198596|NCT00004785|Dexamethasone|dexamethasone|mesh-list
2198597|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
2198598|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2198599|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2198600|NCT00004785|Prednisolone|prednisolone|mesh-list
2711324|NCT03406897|Vitamins|vitamins|mesh-ancestor
2711325|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
2711326|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711327|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2711328|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2711365|NCT03369041|Irinotecan|irinotecan|mesh-list
2711366|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2711367|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2711368|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711369|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711370|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711371|NCT03350984|Insulin|insulin|mesh-list
2711372|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2711373|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
2711374|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
2711375|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
2711376|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
2711377|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
2711378|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2711379|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711396|NCT03331341|Doxorubicin|doxorubicin|mesh-list
2711397|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2711398|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
2711399|NCT03331341|Dacarbazine|dacarbazine|mesh-list
2711400|NCT03331341|Vinblastine|vinblastine|mesh-list
2711401|NCT03331341|Imidazole|imidazole|mesh-list
2711402|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2711403|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198601|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
2198602|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2711404|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2711405|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2711406|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711407|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711408|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2711409|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2711410|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
2711411|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2711412|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
2711413|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
2711414|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
2711415|NCT03328845|Insulin|insulin|mesh-list
2711416|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2711417|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
2711418|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
2711419|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2711420|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711436|NCT03305341|Molgramostim|molgramostim|mesh-list
2711437|NCT03305341|Sargramostim|sargramostim|mesh-list
2711438|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
2711439|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711440|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711441|NCT03300427|Valsartan|valsartan|mesh-list
2711442|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2711443|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2711444|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2711445|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2711446|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711447|NCT03288324|Tofacitinib|tofacitinib|mesh-list
2711448|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2711449|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711450|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711454|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
2711455|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2711456|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2711457|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2711458|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2711459|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711460|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
2711461|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2711462|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711463|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2711464|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2711465|NCT03277261|Teriflunomide|teriflunomide|mesh-list
2711466|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2711467|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2711468|NCT03277261|Analgesics|analgesics|mesh-ancestor
2711469|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
2711470|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2711471|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711472|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2711473|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2198603|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
2198604|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2711474|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2711475|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
2711476|NCT03277248|Teriflunomide|teriflunomide|mesh-list
2711477|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2711478|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2711479|NCT03277248|Analgesics|analgesics|mesh-ancestor
2711480|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
2711481|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2711482|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711483|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2711484|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2711485|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2711486|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
2711491|NCT03229499|Anastrozole|anastrozole|mesh-list
2711492|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2711493|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711494|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2198605|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
2198606|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
2198607|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198608|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198609|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2198610|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
2198611|NCT00004785|Hormones|hormones|mesh-ancestor
2198612|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2198613|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2198614|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198615|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2198616|NCT00004785|Protective Agents|protective agents|mesh-ancestor
2198617|NCT00004786|Iloprost|iloprost|mesh-list
2198618|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2198619|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
2198620|NCT00004787|Lenograstim|lenograstim|mesh-list
2198621|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2198622|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
2198623|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198624|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
2198625|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198626|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198627|NCT00004794|Cidofovir|cidofovir|mesh-list
2198628|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
2198629|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198630|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711495|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2711496|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711497|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711498|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2711499|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
2711500|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2711501|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711502|NCT03203850|Deferasirox|deferasirox|mesh-list
2711503|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2711504|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
2711505|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
2711506|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711526|NCT03190174|Sirolimus|sirolimus|mesh-list
2711527|NCT03190174|Nivolumab|nivolumab|mesh-list
2711528|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2711529|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711530|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2198631|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198632|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2198633|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2198634|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
2198635|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198636|NCT00004796|Lactulose|lactulose|mesh-list
2198637|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2198638|NCT00004799|Vaccines|vaccines|mesh-list
2198639|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
2198640|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198641|NCT00004800|Vaccines|vaccines|mesh-list
2198642|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
2198643|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198644|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
2198645|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2198646|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198647|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198648|NCT00004804|Interferons|interferons|mesh-list
2198649|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
2198650|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198651|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
2198652|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2711531|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711532|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2711533|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2711534|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2711535|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
2711536|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2711537|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
2711538|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711539|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2711540|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2711541|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711542|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2711543|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2711544|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2711545|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711546|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
2711547|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2711551|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
2711552|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2711553|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711554|NCT03148899|Oxytocin|oxytocin|mesh-list
2711555|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
2711556|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2711557|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711564|NCT03136627|Nivolumab|nivolumab|mesh-list
2711565|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2711566|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711567|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2711568|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711569|NCT03114319|Nazartinib|nazartinib|mesh-list
2711570|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711571|NCT03096834|Erenumab|erenumab|mesh-list
2711572|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2711573|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711574|NCT03096834|Analgesics|analgesics|mesh-ancestor
2711575|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
2711576|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2711577|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711578|NCT03084549|Ropivacaine|ropivacaine|mesh-list
2711579|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
2711580|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
2711581|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2711582|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711583|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
2711584|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2711588|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2711589|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2711590|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711591|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
2711592|NCT03030378|Interleukin-12|interleukin-12|mesh-list
2711593|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2711594|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711595|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2711596|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
2711597|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198653|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
2198654|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198655|NCT00004807|Topiramate|topiramate|mesh-list
2198656|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
2198657|NCT00004807|Donepezil|donepezil|mesh-list
2198658|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2198659|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198660|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198661|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
2198662|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2198663|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198664|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
2198665|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
2198666|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2198667|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
2711598|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2711599|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2711600|NCT03030378|Growth Substances|growth substances|mesh-ancestor
2711601|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
2711602|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
2711603|NCT03026348|Vaccines|vaccines|mesh-list
2711604|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
2711605|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711606|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2711607|NCT03026348|Antacids|antacids|mesh-ancestor
2711608|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711609|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2198668|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
2711657|NCT02989402|Rivastigmine|rivastigmine|mesh-list
2711658|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2711659|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711660|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711661|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
2711662|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2711663|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711664|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2711665|NCT02989402|Protective Agents|protective agents|mesh-ancestor
2711671|NCT02966548|Nivolumab|nivolumab|mesh-list
2711672|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2711673|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711674|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2711675|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711681|NCT02959164|Gemcitabine|gemcitabine|mesh-list
2711682|NCT02959164|Decitabine|decitabine|mesh-list
2711683|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2711684|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
2711685|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711686|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711687|NCT02959164|Antiviral Agents|antiviral agents|mesh-ancestor
2711688|NCT02959164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2711689|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711690|NCT02959164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2711691|NCT02959164|Immunologic Factors|immunologic factors|mesh-ancestor
2711692|NCT02959164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711709|NCT02928224|Leucovorin|leucovorin|mesh-list
2711710|NCT02928224|Folic Acid|folic acid|mesh-list
2711711|NCT02928224|Fluorouracil|fluorouracil|mesh-list
2711712|NCT02928224|Irinotecan|irinotecan|mesh-list
2711713|NCT02928224|Cetuximab|cetuximab|mesh-list
2711714|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
2711715|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
2711716|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711717|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2711718|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711719|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2711720|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
2711721|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711722|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2711723|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2711724|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711725|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2711726|NCT02928224|Antidotes|antidotes|mesh-ancestor
2711727|NCT02928224|Protective Agents|protective agents|mesh-ancestor
2711728|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
2711729|NCT02928224|Vitamins|vitamins|mesh-ancestor
2711730|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
2711731|NCT02928224|Hematinics|hematinics|mesh-ancestor
2711735|NCT02922985|Acetaminophen|acetaminophen|mesh-list
2711736|NCT02922985|Ketorolac|ketorolac|mesh-list
2711737|NCT02922985|Bupivacaine|bupivacaine|mesh-list
2711738|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
2711739|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
2711740|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2711741|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711742|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
2711743|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2711744|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2711745|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2711746|NCT02922985|Analgesics|analgesics|mesh-ancestor
2711747|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2711748|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2711749|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2711750|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711751|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711752|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
2711763|NCT02869789|Nivolumab|nivolumab|mesh-list
2711764|NCT02869789|Ipilimumab|ipilimumab|mesh-list
2198669|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2198670|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2198671|NCT00004808|Fluconazole|fluconazole|mesh-list
2198672|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
2198673|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198674|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2198675|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2198676|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198677|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198678|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2198679|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
2198680|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2423704|NCT00823381|Protective Agents|protective agents|mesh-ancestor
2423705|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423706|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423707|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2423708|NCT00823433|Penicillins|penicillins|mesh-list
2423709|NCT00823433|Penicillin V|penicillin v|mesh-list
2423710|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2423711|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423712|NCT00823550|Lamivudine|lamivudine|mesh-list
2423713|NCT00823550|Entecavir|entecavir|mesh-list
2423714|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2423715|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2423716|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198681|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198682|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2198683|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2198684|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
2198685|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
2198686|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2198687|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198688|NCT00004811|Itraconazole|itraconazole|mesh-list
2711765|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2711766|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711767|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2711768|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711778|NCT02837783|Linaclotide|linaclotide|mesh-list
2711779|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2711780|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
2711781|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711782|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2711783|NCT02831673|Tenofovir|tenofovir|mesh-list
2711784|NCT02831673|Lamivudine|lamivudine|mesh-list
2711785|NCT02831673|Emtricitabine|emtricitabine|mesh-list
2711786|NCT02831673|Dolutegravir|dolutegravir|mesh-list
2711787|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
2711788|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2711789|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2711790|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2711791|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711792|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198689|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
2198690|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198691|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2198692|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2198693|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198694|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198695|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2198696|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
2198697|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2198698|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198699|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2198700|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
2198701|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
2198702|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2198703|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
2198704|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198705|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2198706|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2198707|NCT00004815|Hormones|hormones|mesh-list
2711793|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2711794|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2711795|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2711796|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2711797|NCT02827201|Gemcitabine|gemcitabine|mesh-list
2711798|NCT02827201|Paclitaxel|paclitaxel|mesh-list
2711799|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2711800|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711801|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
2711802|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
2711803|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
2711804|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711805|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2711806|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
2711807|NCT02827201|Antiviral Agents|antiviral agents|mesh-ancestor
2711808|NCT02827201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2711809|NCT02827201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711810|NCT02827201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2711811|NCT02827201|Immunologic Factors|immunologic factors|mesh-ancestor
2198708|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2198709|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198710|NCT00004816|Antibodies|antibodies|mesh-list
2198711|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2198712|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
2198713|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198714|NCT00004817|Phenytoin|phenytoin|mesh-list
2198715|NCT00004817|Valproic Acid|valproic acid|mesh-list
2711812|NCT02827201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711813|NCT02786537|Ritonavir|ritonavir|mesh-list
2711814|NCT02786537|Ribavirin|ribavirin|mesh-list
2711815|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
2711816|NCT02786537|Grazoprevir|grazoprevir|mesh-list
2711817|NCT02786537|Ledipasvir|ledipasvir|mesh-list
2711818|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2711819|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2711820|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
2711821|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198716|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
2198717|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198718|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711822|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711823|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2711824|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2711825|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
2711826|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2711827|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2711828|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2711829|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
2711839|NCT02710084|Oxytocin|oxytocin|mesh-list
2711840|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
2711841|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2711842|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198719|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
2198720|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2198721|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198722|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
2198723|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2198724|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2198725|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2198726|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2198727|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2198728|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2711855|NCT02683239|Fasinumab|fasinumab|mesh-list
2711856|NCT02683239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2711857|NCT02683239|Analgesics|analgesics|mesh-ancestor
2711858|NCT02683239|Sensory System Agents|sensory system agents|mesh-ancestor
2711859|NCT02683239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2711860|NCT02683239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711861|NCT02678312|Enalapril|enalapril|mesh-list
2711862|NCT02678312|Enalaprilat|enalaprilat|mesh-list
2711863|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2711864|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2711865|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
2711866|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711867|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711868|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2711869|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2711870|NCT02645474|Ropivacaine|ropivacaine|mesh-list
2711871|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
2711872|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
2711873|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2711874|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711875|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
2711876|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2711877|NCT02617277|Durvalumab|durvalumab|mesh-list
2711878|NCT02617277|Adavosertib|adavosertib|mesh-list
2711879|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2711880|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711881|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711882|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711916|NCT02530034|Antibodies|antibodies|mesh-list
2711917|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2711918|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
2711919|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711920|NCT02519348|Bevacizumab|bevacizumab|mesh-list
2711921|NCT02519348|Durvalumab|durvalumab|mesh-list
2711922|NCT02519348|Tremelimumab|tremelimumab|mesh-list
2711923|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2711924|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711925|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2711926|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2711927|NCT02519348|Growth Substances|growth substances|mesh-ancestor
2711928|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2711929|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
2711930|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
2711931|NCT02512172|Azacitidine|azacitidine|mesh-list
2711932|NCT02512172|Romidepsin|romidepsin|mesh-list
2711933|NCT02512172|Cc-486|cc-486|mesh-list
2711934|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2711935|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711936|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2711937|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
2711938|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711939|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711940|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2711941|NCT02501096|Pembrolizumab|pembrolizumab|mesh-list
2711942|NCT02501096|Lenvatinib|lenvatinib|mesh-list
2711943|NCT02501096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2198729|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2198730|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2198731|NCT00004825|Insulin|insulin|mesh-list
2198732|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2198733|NCT00004825|Mitogens|mitogens|mesh-list
2198734|NCT00004825|Mecasermin|mecasermin|mesh-list
2198735|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2198736|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198737|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
2198738|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711944|NCT02501096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711945|NCT02501096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2711946|NCT02501096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711947|NCT02501096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711950|NCT02494258|Azacitidine|azacitidine|mesh-list
2711951|NCT02494258|Cc-486|cc-486|mesh-list
2711952|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2711953|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
2711954|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711955|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711956|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198739|NCT00004825|Growth Substances|growth substances|mesh-ancestor
2198740|NCT00004826|Clozapine|clozapine|mesh-list
2198741|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2711988|NCT02352337|Gemcitabine|gemcitabine|mesh-list
2711989|NCT02352337|Folfirinox|folfirinox|mesh-list
2711990|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2711991|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
2711992|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2711993|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2711994|NCT02352337|Antiviral Agents|antiviral agents|mesh-ancestor
2711995|NCT02352337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2711996|NCT02352337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2711997|NCT02352337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2711998|NCT02352337|Immunologic Factors|immunologic factors|mesh-ancestor
2711999|NCT02352337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712000|NCT02338609|Everolimus|everolimus|mesh-list
2712001|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712002|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2712003|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
2712004|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712005|NCT02229149|Paclitaxel|paclitaxel|mesh-list
2712006|NCT02229149|Vinorelbine|vinorelbine|mesh-list
2712007|NCT02229149|Docetaxel|docetaxel|mesh-list
2712008|NCT02229149|Capecitabine|capecitabine|mesh-list
2712009|NCT02229149|Trastuzumab|trastuzumab|mesh-list
2198742|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
2198743|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2198744|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198745|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198746|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2198747|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2198748|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2198749|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2198750|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
2198751|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
2198752|NCT00004829|Tobramycin|tobramycin|mesh-list
2198753|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2198754|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198755|NCT00004832|Amifampridine|amifampridine|mesh-list
2198756|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2198757|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198758|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198759|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2198760|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2198761|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198762|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
2198763|NCT00004833|Antibodies|antibodies|mesh-list
2198764|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
2198765|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2198766|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2198767|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
2198768|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198769|NCT00004834|Imipramine|imipramine|mesh-list
2198770|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2198771|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
2198772|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2198773|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2198774|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2198775|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2198776|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198777|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
2198778|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2198779|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198780|NCT00004838|Succimer|succimer|mesh-list
2198781|NCT00004838|Antidotes|antidotes|mesh-ancestor
2198782|NCT00004838|Protective Agents|protective agents|mesh-ancestor
2198783|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198784|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
2198785|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
2198786|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198787|NCT00004840|Hormones|hormones|mesh-list
2198788|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
2198789|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2198790|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198791|NCT00004842|Budesonide|budesonide|mesh-list
2198792|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2198793|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2198794|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
2198795|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198796|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198797|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2198798|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
2198799|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
2198800|NCT00004842|Hormones|hormones|mesh-ancestor
2198801|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2198802|NCT00004845|Naproxen|naproxen|mesh-list
2198803|NCT00004845|Rofecoxib|rofecoxib|mesh-list
2198804|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2198805|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2198806|NCT00004845|Analgesics|analgesics|mesh-ancestor
2198807|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
2198808|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198809|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198810|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2198811|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2198812|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
2198813|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2198814|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198815|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712010|NCT02229149|Pertuzumab|pertuzumab|mesh-list
2198816|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2198817|NCT00004852|Lamivudine|lamivudine|mesh-list
2198818|NCT00004852|Zidovudine|zidovudine|mesh-list
2198819|NCT00004852|Efavirenz|efavirenz|mesh-list
2198820|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2198821|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2198822|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198823|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198824|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
2198825|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198826|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2198827|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2198828|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
2198829|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2198830|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2198831|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2198832|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2198833|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2198834|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2198835|NCT00004853|Lenograstim|lenograstim|mesh-list
2198836|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2198837|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
2198838|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198839|NCT00004854|Carvedilol|carvedilol|mesh-list
2198840|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2198841|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2198842|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
2198843|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2198844|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198845|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198846|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2198847|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
2198848|NCT00004854|Protective Agents|protective agents|mesh-ancestor
2198849|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2198850|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2198851|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2198852|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
2198853|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2198854|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2198855|NCT00004855|Ritonavir|ritonavir|mesh-list
2198856|NCT00004855|Lopinavir|lopinavir|mesh-list
2198857|NCT00004855|Lamivudine|lamivudine|mesh-list
2198858|NCT00004855|Nevirapine|nevirapine|mesh-list
2198859|NCT00004855|Abacavir|abacavir|mesh-list
2198860|NCT00004855|Stavudine|stavudine|mesh-list
2198861|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2198862|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2198863|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
2198864|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198865|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198866|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2198867|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2198868|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
2198869|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198870|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2198871|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2712011|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2712012|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712013|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
2712014|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
2712015|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
2712016|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712017|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2712018|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
2712019|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2712048|NCT02187991|Paclitaxel|paclitaxel|mesh-list
2712049|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2712050|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712051|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
2712052|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
2198872|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2198873|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2198874|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2198875|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2198876|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
2198877|NCT00004856|Trastuzumab|trastuzumab|mesh-list
2198878|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2198879|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198880|NCT00004857|Fludarabine|fludarabine|mesh-list
2198881|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
2198882|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
2198883|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198884|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2198885|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
2198886|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198887|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2198888|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
2198889|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198890|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2198891|NCT00004858|Genistein|genistein|mesh-list
2198892|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
2198893|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2198894|NCT00004858|Protective Agents|protective agents|mesh-ancestor
2198895|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198896|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198897|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2198898|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712053|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
2712054|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712055|NCT02184416|Everolimus|everolimus|mesh-list
2712056|NCT02184416|Sorafenib|sorafenib|mesh-list
2712057|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712058|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2712059|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
2712060|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712061|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2712062|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712063|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712064|NCT02182687|Doxorubicin|doxorubicin|mesh-list
2712065|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2712066|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2712067|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712068|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2712069|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2712070|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712071|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712072|NCT01976273|Glycolic acid|glycolic acid|mesh-list
2712073|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
2712074|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
2712075|NCT01950390|Bevacizumab|bevacizumab|mesh-list
2712076|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2712077|NCT01950390|Ipilimumab|ipilimumab|mesh-list
2712078|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
2712079|NCT01950390|Antibodies|antibodies|mesh-list
2712080|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
2712081|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2712082|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
2712083|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712084|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2712085|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2712086|NCT01950390|Growth Substances|growth substances|mesh-ancestor
2712087|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712088|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
2712089|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
2712090|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2198899|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198900|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
2198901|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2198902|NCT00004858|Estrogens|estrogens|mesh-ancestor
2198903|NCT00004858|Hormones|hormones|mesh-ancestor
2198904|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2198905|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
2198906|NCT00004860|Leucovorin|leucovorin|mesh-list
2198907|NCT00004860|Tegafur|tegafur|mesh-list
2198908|NCT00004860|Calcium|calcium|mesh-list
2198909|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
2198910|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2198911|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712091|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712107|NCT01802086|Lidocaine|lidocaine|mesh-list
2712108|NCT01802086|Prilocaine|prilocaine|mesh-list
2712109|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2712110|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
2712111|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
2712112|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2712113|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712114|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
2712115|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2712116|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2712117|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2712118|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2712119|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2712120|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198912|NCT00004860|Antidotes|antidotes|mesh-ancestor
2198913|NCT00004860|Protective Agents|protective agents|mesh-ancestor
2198914|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
2198915|NCT00004860|Vitamins|vitamins|mesh-ancestor
2712121|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2712122|NCT01525316|Lactoferrin|lactoferrin|mesh-list
2712123|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2712124|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2712125|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2712126|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2712127|NCT01388491|Desogestrel|desogestrel|mesh-list
2712128|NCT01388491|Estradiol|estradiol|mesh-list
2712129|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2712130|NCT01388491|Estrogens|estrogens|mesh-ancestor
2712131|NCT01388491|Hormones|hormones|mesh-ancestor
2712132|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2712133|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712134|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2712135|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
2712136|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2198916|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
2712137|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2712138|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2198917|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2198918|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
2198919|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198920|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198921|NCT00004861|Gemcitabine|gemcitabine|mesh-list
2198922|NCT00004861|Tacedinaline|tacedinaline|mesh-list
2198923|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2198924|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
2198925|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198926|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712139|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2712140|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2712141|NCT01388491|Progestins|progestins|mesh-ancestor
2712142|NCT01373151|Adalimumab|adalimumab|mesh-list
2712143|NCT01373151|Methotrexate|methotrexate|mesh-list
2712144|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2712145|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
2712146|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2712147|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712148|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2712149|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
2712150|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712151|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712152|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
2712153|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712154|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2712155|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2712156|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
2712157|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2712158|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2712159|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2712160|NCT01351103|Spartalizumab|spartalizumab|mesh-list
2712161|NCT01351103|LGK974|lgk974|mesh-list
2712162|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2712163|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712164|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712165|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712173|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
2712174|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2712175|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2712176|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2712177|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2712178|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712179|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
2712180|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2712181|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712182|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2712183|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2198927|NCT00004861|Antiviral Agents|antiviral agents|mesh-ancestor
2198928|NCT00004861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198929|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198930|NCT00004861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2198931|NCT00004861|Immunologic Factors|immunologic factors|mesh-ancestor
2198932|NCT00004861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198933|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2198934|NCT00004862|Cytarabine|cytarabine|mesh-list
2198935|NCT00004862|Fludarabine|fludarabine|mesh-list
2198936|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
2198937|NCT00004862|Oblimersen|oblimersen|mesh-list
2198938|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198939|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2198940|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
2198941|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198942|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2198943|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
2198944|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198945|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
2198946|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2198947|NCT00004863|Paclitaxel|paclitaxel|mesh-list
2198948|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2198949|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198950|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
2198951|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
2198952|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
2198953|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198954|NCT00004864|Docetaxel|docetaxel|mesh-list
2712201|NCT00960297|Paclitaxel|paclitaxel|mesh-list
2712202|NCT00960297|Bevacizumab|bevacizumab|mesh-list
2712203|NCT00960297|Carboplatin|carboplatin|mesh-list
2712204|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2712205|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712206|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
2712207|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
2712208|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
2712209|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712210|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2712211|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2712212|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2712213|NCT00960297|Growth Substances|growth substances|mesh-ancestor
2712214|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712215|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
2712216|NCT00910650|Aldesleukin|aldesleukin|mesh-list
2712217|NCT00910650|Interleukin-2|interleukin-2|mesh-list
2712218|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712219|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2712220|NCT00910650|Analgesics|analgesics|mesh-ancestor
2712221|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
2712222|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2712223|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712224|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2712225|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2712226|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
2712227|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2712228|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
2712229|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
2712230|NCT00703326|Docetaxel|docetaxel|mesh-list
2712231|NCT00703326|Ramucirumab|ramucirumab|mesh-list
2712232|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712233|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
2712234|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
2712235|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
2712236|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198955|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712255|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
2712256|NCT00602667|Cisplatin|cisplatin|mesh-list
2712257|NCT00602667|Carboplatin|carboplatin|mesh-list
2712258|NCT00602667|Methotrexate|methotrexate|mesh-list
2712259|NCT00602667|Etoposide|etoposide|mesh-list
2712260|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
2712261|NCT00602667|Vincristine|vincristine|mesh-list
2712262|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2712263|NCT00602667|Topotecan|topotecan|mesh-list
2712264|NCT00602667|Vinblastine|vinblastine|mesh-list
2712265|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2712266|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
2712267|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712268|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2712269|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2712270|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
2712271|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712272|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712273|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2712274|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2712275|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
2712276|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2712277|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2712278|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
2712279|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
2712280|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712281|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2712282|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2712283|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2712284|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2712285|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2712286|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
2712287|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
2712288|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
2712289|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2712290|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2712291|NCT00472186|Lansoprazole|lansoprazole|mesh-list
2712292|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
2712293|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2198956|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
2198957|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
2198958|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
2198959|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198960|NCT00004865|Paclitaxel|paclitaxel|mesh-list
2198961|NCT00004865|Fluorouracil|fluorouracil|mesh-list
2198962|NCT00004865|Cetuximab|cetuximab|mesh-list
2198963|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2198964|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198965|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
2198966|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
2198967|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
2198968|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712294|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2712295|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2712296|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712297|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712298|NCT05148000|Botulinum Toxins|botulinum toxins|mesh-list
2712299|NCT05148000|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2712300|NCT05148000|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2712301|NCT05148000|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2712302|NCT05148000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2712303|NCT05148000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712304|NCT05148000|Cholinergic Agents|cholinergic agents|mesh-ancestor
2712305|NCT05148000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2712306|NCT05148000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712307|NCT05148000|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2712308|NCT05148000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2712309|NCT05147857|Misoprostol|misoprostol|mesh-list
2712310|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2712311|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
2712312|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2712313|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712314|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2712315|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2712316|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
2712317|NCT05147805|Treprostinil|treprostinil|mesh-list
2712318|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2712319|NCT05147753|Moxonidine|moxonidine|mesh-list
2712320|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2712321|NCT05147727|Fluconazole|fluconazole|mesh-list
2712322|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
2712323|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2712324|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2712325|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2712326|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712327|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712328|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2712329|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
2712330|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2712331|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712332|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2712333|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2712343|NCT05147493|Dexamethasone|dexamethasone|mesh-list
2712344|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
2712345|NCT05147493|Lenalidomide|lenalidomide|mesh-list
2712346|NCT05147493|Bortezomib|bortezomib|mesh-list
2712347|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2712348|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
2712349|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712350|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2712351|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2712352|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
2712353|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198969|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
2198970|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2198971|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2198972|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
2198973|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198974|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2198975|NCT00004866|Exatecan|exatecan|mesh-list
2198976|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2198977|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2198978|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198979|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2198980|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198981|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2712354|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712355|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2198982|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2198983|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712356|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2712357|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
2712358|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
2712359|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2712360|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2712361|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
2712362|NCT05147493|Hormones|hormones|mesh-ancestor
2712363|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2712364|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2712365|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2712366|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2712367|NCT05147493|Growth Substances|growth substances|mesh-ancestor
2712368|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
2198984|NCT00004868|Semaxinib|semaxinib|mesh-list
2198985|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2198986|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2198987|NCT00004868|Growth Substances|growth substances|mesh-ancestor
2198988|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2198989|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
2198990|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2198991|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2198992|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198993|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712416|NCT05147233|Dexamethasone|dexamethasone|mesh-list
2712417|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2712418|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
2198994|NCT00004870|Irinotecan|irinotecan|mesh-list
2712419|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
2712420|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2712421|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712422|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2712423|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
2712424|NCT05147233|Hormones|hormones|mesh-ancestor
2712425|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2712426|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2712427|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712439|NCT05147194|Trimetazidine|trimetazidine|mesh-list
2712440|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
2712441|NCT05147090|Empagliflozin|empagliflozin|mesh-list
2712442|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2712443|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712444|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2712445|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712446|NCT05146895|Imiquimod|imiquimod|mesh-list
2712447|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2198995|NCT00004870|Oblimersen|oblimersen|mesh-list
2198996|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2198997|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2198998|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2198999|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199000|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199001|NCT00004871|Azacitidine|azacitidine|mesh-list
2199002|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2712448|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
2712449|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712450|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712451|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
2712452|NCT05146804|Sulforaphane|sulforaphane|mesh-list
2712453|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2712454|NCT05146804|Protective Agents|protective agents|mesh-ancestor
2712455|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712456|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712457|NCT05146778|Lidocaine|lidocaine|mesh-list
2712458|NCT05146778|Fentanyl|fentanyl|mesh-list
2712459|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
2712460|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
2712461|NCT05146778|Anesthetics|anesthetics|mesh-list
2712462|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
2712463|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2712464|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712465|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
2712466|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2712467|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2712468|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2712469|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2712470|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2712471|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712472|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2712473|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2712474|NCT05146778|Analgesics|analgesics|mesh-ancestor
2199003|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2199004|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
2199005|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199006|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199007|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712475|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2712476|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2712477|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2712478|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
2712479|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2199008|NCT00004872|Endostatins|endostatins|mesh-list
2712480|NCT05146778|Narcotics|narcotics|mesh-ancestor
2712481|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2712482|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2712483|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
2712484|NCT05146739|Vidarabine|vidarabine|mesh-list
2712485|NCT05146739|Cytarabine|cytarabine|mesh-list
2712486|NCT05146739|Fludarabine|fludarabine|mesh-list
2199009|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199010|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2199011|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2199012|NCT00004872|Growth Substances|growth substances|mesh-ancestor
2199013|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199014|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
2199015|NCT00004873|Docetaxel|docetaxel|mesh-list
2199016|NCT00004873|Fluorouracil|fluorouracil|mesh-list
2199017|NCT00004873|Epirubicin|epirubicin|mesh-list
2199018|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199019|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199020|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
2199021|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199022|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199023|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
2199024|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2199025|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199026|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
2199027|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199028|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2199029|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199030|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199031|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199032|NCT00004874|Iodine|iodine|mesh-list
2199033|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
2199034|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2199035|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2712487|NCT05146739|Fludarabine phosphate|fludarabine phosphate|mesh-list
2712488|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712489|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2712490|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
2712491|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712492|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199036|NCT00004874|Trace Elements|trace elements|mesh-ancestor
2199037|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
2199038|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712493|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
2712494|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712495|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
2712496|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2712497|NCT05146713|Propolis|propolis|mesh-list
2712498|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2712499|NCT05146713|Eusol|eusol|mesh-list
2199039|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199040|NCT00004875|Heparin|heparin|mesh-list
2199041|NCT00004875|Enoxaparin|enoxaparin|mesh-list
2199042|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
2199043|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2199044|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2199045|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199046|NCT00004876|Thalidomide|thalidomide|mesh-list
2199047|NCT00004876|Carboplatin|carboplatin|mesh-list
2199048|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199049|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199050|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
2199051|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199052|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
2199053|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2199054|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199055|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2199056|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2199057|NCT00004876|Growth Substances|growth substances|mesh-ancestor
2199058|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
2199059|NCT00004878|Cytarabine|cytarabine|mesh-list
2199060|NCT00004878|Methotrexate|methotrexate|mesh-list
2712500|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199061|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
2199062|NCT00004878|Fludarabine|fludarabine|mesh-list
2199063|NCT00004878|Idarubicin|idarubicin|mesh-list
2199064|NCT00004878|Tacrolimus|tacrolimus|mesh-list
2199065|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2199066|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
2712501|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
2712526|NCT05145608|Lamotrigine|lamotrigine|mesh-list
2712527|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
2712528|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2712529|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2712530|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712531|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2712532|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712533|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2712534|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2712535|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2712536|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2712537|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2199067|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2199068|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199069|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2199070|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
2199071|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199072|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199073|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
2199074|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199075|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2199076|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199077|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
2199078|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199079|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199080|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
2199081|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199082|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2199083|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2199084|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199085|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199086|NCT00004879|Panitumumab|panitumumab|mesh-list
2199087|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2199088|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199089|NCT00004880|Vaccines|vaccines|mesh-list
2199090|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
2199091|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199092|NCT00004883|Trastuzumab|trastuzumab|mesh-list
2199093|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2199094|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199095|NCT00004884|Gemcitabine|gemcitabine|mesh-list
2199096|NCT00004884|Docetaxel|docetaxel|mesh-list
2199097|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199098|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2199099|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
2199100|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199101|NCT00004884|Antiviral Agents|antiviral agents|mesh-ancestor
2199102|NCT00004884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199103|NCT00004884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199104|NCT00004884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199105|NCT00004884|Immunologic Factors|immunologic factors|mesh-ancestor
2199106|NCT00004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199107|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199108|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
2199109|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199110|NCT00004885|Leucovorin|leucovorin|mesh-list
2199111|NCT00004885|Fluorouracil|fluorouracil|mesh-list
2712549|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
2712550|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2712551|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712572|NCT05122182|Proxigermanium|proxigermanium|mesh-list
2712573|NCT05122182|Candesartan|candesartan|mesh-list
2712574|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
2712575|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2712576|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2712577|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2712578|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712579|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712580|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
2712581|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
2712582|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712583|NCT05118308|Liver Extracts|liver extracts|mesh-list
2712584|NCT05118308|Hematinics|hematinics|mesh-ancestor
2199112|NCT00004885|Irinotecan|irinotecan|mesh-list
2199113|NCT00004885|Calcium|calcium|mesh-list
2199114|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
2199115|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2199116|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199117|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
2199118|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199119|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2199120|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199121|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199122|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
2199123|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2199124|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199125|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199126|NCT00004885|Antidotes|antidotes|mesh-ancestor
2199127|NCT00004885|Protective Agents|protective agents|mesh-ancestor
2199128|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
2199129|NCT00004885|Vitamins|vitamins|mesh-ancestor
2199130|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
2199131|NCT00004886|Docetaxel|docetaxel|mesh-list
2199132|NCT00004886|Dofequidar|dofequidar|mesh-list
2199133|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712585|NCT05116800|Gemcitabine|gemcitabine|mesh-list
2712586|NCT05116800|Docetaxel|docetaxel|mesh-list
2712587|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2712588|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
2712589|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712590|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712591|NCT05116800|Antiviral Agents|antiviral agents|mesh-ancestor
2712592|NCT05116800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2712593|NCT05116800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712594|NCT05116800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2712595|NCT05116800|Immunologic Factors|immunologic factors|mesh-ancestor
2712596|NCT05116800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712597|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
2712598|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
2712599|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199134|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199135|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
2199136|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199137|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199138|NCT00004887|Paclitaxel|paclitaxel|mesh-list
2199139|NCT00004887|Vinblastine|vinblastine|mesh-list
2199140|NCT00004887|Carboplatin|carboplatin|mesh-list
2199141|NCT00004887|Ifosfamide|ifosfamide|mesh-list
2199142|NCT00004887|Mitomycins|mitomycins|mesh-list
2199143|NCT00004887|Mitomycin|mitomycin|mesh-list
2199144|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199145|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199146|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199147|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
2199148|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199149|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199150|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199151|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
2199152|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2199153|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199154|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199155|NCT00004889|Rituximab|rituximab|mesh-list
2199156|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2199157|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199158|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
2199159|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712629|NCT05112861|Bevacizumab|bevacizumab|mesh-list
2712630|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2712631|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712632|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2712633|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2712634|NCT05112861|Growth Substances|growth substances|mesh-ancestor
2712635|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199160|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199161|NCT00004890|Aldesleukin|aldesleukin|mesh-list
2199162|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712636|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
2199163|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2199164|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2199165|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
2199166|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199167|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2199168|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2199169|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712658|NCT05089565|Interferons|interferons|mesh-list
2712659|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
2712660|NCT05089565|Antibodies|antibodies|mesh-list
2712661|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
2712662|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
2712663|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712664|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712665|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
2199170|NCT00004892|Carmustine|carmustine|mesh-list
2199171|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2199172|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199173|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
2199174|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199175|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199176|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199177|NCT00004893|Interleukin-12|interleukin-12|mesh-list
2199178|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2199179|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
2199180|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199181|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2199182|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2199183|NCT00004893|Growth Substances|growth substances|mesh-ancestor
2199184|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
2199185|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199186|NCT00004895|Octreotide|octreotide|mesh-list
2199187|NCT00004895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2199188|NCT00004895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2199189|NCT00004895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199190|NCT00004896|Cyclophosphamide|cyclophosphamide|mesh-list
2199191|NCT00004896|Busulfan|busulfan|mesh-list
2199192|NCT00004896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199193|NCT00004896|Immunologic Factors|immunologic factors|mesh-ancestor
2199194|NCT00004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199195|NCT00004896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199196|NCT00004896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199197|NCT00004896|Alkylating Agents|alkylating agents|mesh-ancestor
2199198|NCT00004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199199|NCT00004896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199200|NCT00004896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2199201|NCT00004897|Leucovorin|leucovorin|mesh-list
2199202|NCT00004897|Interferons|interferons|mesh-list
2712666|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2712667|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
2199203|NCT00004897|Interferon-alpha|interferon-alpha|mesh-list
2199204|NCT00004897|Fluorouracil|fluorouracil|mesh-list
2712668|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2712669|NCT05085327|Protective Agents|protective agents|mesh-ancestor
2712670|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712671|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
2712672|NCT05083975|Anesthetics|anesthetics|mesh-list
2712673|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
2712674|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2712675|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712676|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
2712677|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2712678|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2712679|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
2712680|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
2712681|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
2712682|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2712683|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712684|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
2712685|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2712686|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2712687|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2712688|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
2712689|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712690|NCT05078463|Protective Agents|protective agents|mesh-ancestor
2712715|NCT05042440|Factor VIII|factor viii|mesh-list
2712716|NCT05042440|BAX 855|bax 855|mesh-list
2712717|NCT05042440|Coagulants|coagulants|mesh-ancestor
2423717|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423718|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
2423719|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423720|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2423721|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2423722|NCT00823563|Adenosine|adenosine|mesh-list
2423723|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
2423724|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
2423725|NCT00823563|Analgesics|analgesics|mesh-ancestor
2423726|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
2423727|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423728|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423729|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2423730|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2423731|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
2423732|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
2423733|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423734|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423735|NCT00823576|Ropivacaine|ropivacaine|mesh-list
2423736|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
2423737|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
2423738|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423739|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423740|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
2423741|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423742|NCT00823602|Buserelin|buserelin|mesh-list
2423743|NCT00823602|Ganirelix|ganirelix|mesh-list
2423744|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
2423745|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2423746|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423747|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2423748|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
2423749|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2423750|NCT00823641|Infliximab|infliximab|mesh-list
2423751|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
2423752|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2423753|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199205|NCT00004897|Hydroxyurea|hydroxyurea|mesh-list
2199206|NCT00004897|Calcium|calcium|mesh-list
2199207|NCT00004897|Levoleucovorin|levoleucovorin|mesh-list
2199208|NCT00004897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199209|NCT00004897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2199210|NCT00004897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199211|NCT00004897|Antimetabolites|antimetabolites|mesh-ancestor
2199212|NCT00004897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199213|NCT00004897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2199214|NCT00004897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199215|NCT00004897|Immunologic Factors|immunologic factors|mesh-ancestor
2199216|NCT00004897|Antiviral Agents|antiviral agents|mesh-ancestor
2199217|NCT00004897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199218|NCT00004897|Antidotes|antidotes|mesh-ancestor
2199219|NCT00004897|Protective Agents|protective agents|mesh-ancestor
2199220|NCT00004897|Vitamin B Complex|vitamin b complex|mesh-ancestor
2199221|NCT00004897|Vitamins|vitamins|mesh-ancestor
2199222|NCT00004897|Micronutrients|micronutrients|mesh-ancestor
2199223|NCT00004897|Antisickling Agents|antisickling agents|mesh-ancestor
2199224|NCT00004897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199225|NCT00004897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199226|NCT00004898|Cyclophosphamide|cyclophosphamide|mesh-list
2199227|NCT00004898|Etoposide|etoposide|mesh-list
2199228|NCT00004898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199229|NCT00004898|Immunologic Factors|immunologic factors|mesh-ancestor
2199230|NCT00004898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199231|NCT00004898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199232|NCT00004898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199233|NCT00004898|Alkylating Agents|alkylating agents|mesh-ancestor
2199234|NCT00004898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712801|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2712802|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2712803|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2712804|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
2199235|NCT00004898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712835|NCT04984889|Protein C|protein c|mesh-list
2712836|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
2712837|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2712838|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2712839|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712840|NCT04984837|Gemcitabine|gemcitabine|mesh-list
2712841|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
2712842|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2712843|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
2712844|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712845|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712846|NCT04984837|Antiviral Agents|antiviral agents|mesh-ancestor
2712847|NCT04984837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2712848|NCT04984837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712849|NCT04984837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2712850|NCT04984837|Immunologic Factors|immunologic factors|mesh-ancestor
2712851|NCT04984837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712852|NCT04974216|Rituximab|rituximab|mesh-list
2199236|NCT00004898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2199237|NCT00004898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2712853|NCT04974216|Lenalidomide|lenalidomide|mesh-list
2712854|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2712855|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712856|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
2712857|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712858|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2712859|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2712860|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2712861|NCT04974216|Growth Substances|growth substances|mesh-ancestor
2712862|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
2712870|NCT04969510|Pramoxine|pramoxine|mesh-list
2712871|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
2199238|NCT00004898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199239|NCT00004898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199240|NCT00004898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199241|NCT00004899|Etoposide|etoposide|mesh-list
2199242|NCT00004899|Busulfan|busulfan|mesh-list
2199243|NCT00004899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199244|NCT00004899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199245|NCT00004899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199246|NCT00004899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199247|NCT00004899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199248|NCT00004899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199249|NCT00004899|Immunologic Factors|immunologic factors|mesh-ancestor
2199250|NCT00004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199251|NCT00004899|Alkylating Agents|alkylating agents|mesh-ancestor
2199252|NCT00004899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199253|NCT00004899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199254|NCT00004899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2199255|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
2199256|NCT00004900|Thiotepa|thiotepa|mesh-list
2199257|NCT00004900|Carboplatin|carboplatin|mesh-list
2199258|NCT00004900|Etoposide|etoposide|mesh-list
2199259|NCT00004900|Anastrozole|anastrozole|mesh-list
2199260|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2712872|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
2712873|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2712874|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712875|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
2712876|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2712877|NCT04968106|Doxorubicin|doxorubicin|mesh-list
2712878|NCT04968106|Ifosfamide|ifosfamide|mesh-list
2712879|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2712880|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712881|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2712882|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2712883|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712884|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712885|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2712886|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
2712887|NCT04952753|Leucovorin|leucovorin|mesh-list
2712888|NCT04952753|Bevacizumab|bevacizumab|mesh-list
2712889|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
2712890|NCT04952753|Irinotecan|irinotecan|mesh-list
2712891|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
2712892|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2712893|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712894|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2712895|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2712896|NCT04952753|Growth Substances|growth substances|mesh-ancestor
2712897|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712898|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
2712899|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2712900|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2712901|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712902|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712903|NCT04952753|Antidotes|antidotes|mesh-ancestor
2712904|NCT04952753|Protective Agents|protective agents|mesh-ancestor
2712905|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
2712906|NCT04952753|Vitamins|vitamins|mesh-ancestor
2712907|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
2712918|NCT04948463|Vancomycin|vancomycin|mesh-list
2712919|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
2712920|NCT04948463|Tazobactam|tazobactam|mesh-list
2712921|NCT04948463|Piperacillin|piperacillin|mesh-list
2712922|NCT04948463|Amikacin|amikacin|mesh-list
2712923|NCT04948463|Ceftazidime|ceftazidime|mesh-list
2712924|NCT04948463|Cefepime|cefepime|mesh-list
2712925|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2712926|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2712927|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2712928|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2712929|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2712930|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2712931|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712932|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2712933|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2712934|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2712935|NCT04941261|Vaccines|vaccines|mesh-list
2712936|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
2712937|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2712938|NCT04939363|Venetoclax|venetoclax|mesh-list
2712939|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
2712940|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2712941|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2199261|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
2199262|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199263|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2713066|NCT04899349|Metformin|metformin|mesh-list
2713067|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
2713068|NCT04899349|Fulvestrant|fulvestrant|mesh-list
2713069|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2713070|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713071|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2713072|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713073|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2713074|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713075|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2713076|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2713077|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
2713078|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2199264|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199265|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
2199266|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199267|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199268|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2199269|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199270|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199271|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199272|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199273|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2199274|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2199275|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2199276|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2199277|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
2713084|NCT04894721|Ivermectin|ivermectin|mesh-list
2713085|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2713086|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2713108|NCT04874311|Doxorubicin|doxorubicin|mesh-list
2713109|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2713110|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713111|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2713112|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2713113|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713114|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199278|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2199279|NCT00004901|Fluorouracil|fluorouracil|mesh-list
2199280|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
2199281|NCT00004901|Eniluracil|eniluracil|mesh-list
2199282|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
2713185|NCT04833140|Estradiol|estradiol|mesh-list
2713186|NCT04833140|Estrogens|estrogens|mesh-ancestor
2713187|NCT04833140|Hormones|hormones|mesh-ancestor
2713188|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2713189|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713197|NCT04825197|Poractant alfa|poractant alfa|mesh-list
2713198|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2713199|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
2713205|NCT04817956|Trastuzumab|trastuzumab|mesh-list
2713206|NCT04817956|Pertuzumab|pertuzumab|mesh-list
2713207|NCT04817956|Atezolizumab|atezolizumab|mesh-list
2713208|NCT04817956|Vemurafenib|vemurafenib|mesh-list
2713209|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2713210|NCT04817956|Entrectinib|entrectinib|mesh-list
2713211|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2713212|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713213|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713214|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
2713215|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2713216|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713217|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199283|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199284|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2199285|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199286|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199287|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
2713229|NCT04802590|Venetoclax|venetoclax|mesh-list
2713230|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713234|NCT04796922|Rituximab|rituximab|mesh-list
2713235|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
2713236|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2713237|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713238|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
2713239|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713240|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2713246|NCT04793659|Fasudil|fasudil|mesh-list
2713247|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
2713248|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2713249|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2713250|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713251|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2713252|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713253|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
2713254|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2713255|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713256|NCT04789148|Oxytocin|oxytocin|mesh-list
2713257|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
2713258|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2713259|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713260|NCT04783675|Rituximab|rituximab|mesh-list
2713261|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2713262|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713263|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
2713264|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713265|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2713266|NCT04776148|Trifluridine|trifluridine|mesh-list
2713267|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
2713268|NCT04776148|Lenvatinib|lenvatinib|mesh-list
2713269|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2713270|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713271|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2713272|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713273|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713274|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
2713275|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
2713276|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199288|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199289|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
2199290|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199291|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199292|NCT00004902|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
2199293|NCT00004902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199294|NCT00004902|Immunologic Factors|immunologic factors|mesh-ancestor
2199295|NCT00004902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199296|NCT00004903|Interferons|interferons|mesh-list
2199297|NCT00004903|Cytarabine|cytarabine|mesh-list
2199298|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
2199299|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
2199300|NCT00004903|Melphalan|melphalan|mesh-list
2199301|NCT00004903|Etoposide|etoposide|mesh-list
2199302|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199303|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
2199304|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199305|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199306|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199307|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
2199308|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199309|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199310|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2199311|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199312|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199313|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199314|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199315|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
2199316|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199317|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2199318|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
2199319|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
2199320|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
2199321|NCT00004904|Etoposide|etoposide|mesh-list
2199322|NCT00004904|Cladribine|cladribine|mesh-list
2199323|NCT00004904|Tacrolimus|tacrolimus|mesh-list
2199324|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2713357|NCT04752696|Leucovorin|leucovorin|mesh-list
2713358|NCT04752696|Fluorouracil|fluorouracil|mesh-list
2713359|NCT04752696|Irinotecan|irinotecan|mesh-list
2713360|NCT04752696|Onvansertib|onvansertib|mesh-list
2713361|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
2713362|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713363|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2713364|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713365|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2713366|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
2713367|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713368|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2713369|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2713370|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713371|NCT04752696|Antidotes|antidotes|mesh-ancestor
2713372|NCT04752696|Protective Agents|protective agents|mesh-ancestor
2713373|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
2713374|NCT04752696|Vitamins|vitamins|mesh-ancestor
2713375|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
2713376|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2199325|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199326|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
2199327|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199328|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199329|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199330|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
2199331|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199332|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199333|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2199334|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199335|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199336|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199337|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199338|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2199339|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2199340|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
2199341|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
2199342|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2199343|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2199344|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
2713401|NCT04745689|Carboplatin|carboplatin|mesh-list
2713402|NCT04745689|Etoposide|etoposide|mesh-list
2713403|NCT04745689|Durvalumab|durvalumab|mesh-list
2713404|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713405|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2713406|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2713407|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2713408|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713409|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713410|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2713411|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
2713412|NCT04742140|Analgesics|analgesics|mesh-ancestor
2713413|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
2713414|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2713415|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713416|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
2713417|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2713418|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2713419|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
2713420|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2713421|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2713422|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713423|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2713424|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
2713425|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2713426|NCT04736173|Paclitaxel|paclitaxel|mesh-list
2713427|NCT04736173|Carboplatin|carboplatin|mesh-list
2713428|NCT04736173|Pemetrexed|pemetrexed|mesh-list
2713429|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2713430|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713431|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
2713432|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
2713433|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
2713434|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713435|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713436|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2713437|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2713438|NCT04715230|Lorazepam|lorazepam|mesh-list
2713439|NCT04715230|Haloperidol|haloperidol|mesh-list
2713440|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
2713441|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
2713442|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
2713443|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2713444|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713445|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2713446|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2713447|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2713448|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2713449|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2713450|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2713451|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
2713452|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2713453|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713454|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2713455|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
2199345|NCT00004904|Hormones|hormones|mesh-ancestor
2199346|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2199347|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2199348|NCT00004904|Protective Agents|protective agents|mesh-ancestor
2199349|NCT00004905|Interferons|interferons|mesh-list
2199350|NCT00004905|Cytarabine|cytarabine|mesh-list
2199351|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
2199352|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
2199353|NCT00004905|Etoposide|etoposide|mesh-list
2199354|NCT00004905|Idarubicin|idarubicin|mesh-list
2199355|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199356|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
2199357|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199358|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199359|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199360|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
2199361|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713456|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2713457|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2713458|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
2713459|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
2713460|NCT04677387|Naloxone|naloxone|mesh-list
2713461|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2713462|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713463|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
2713464|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2713465|NCT04674683|Nivolumab|nivolumab|mesh-list
2713466|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2713467|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713468|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2713469|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713470|NCT04665037|Posaconazole|posaconazole|mesh-list
2713471|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
2713472|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2713473|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2713474|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2713475|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2713476|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2713477|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2713478|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713479|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713480|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2713481|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
2713482|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2713483|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713484|NCT04643379|Carboplatin|carboplatin|mesh-list
2713485|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
2199362|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199363|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2199364|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199365|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199366|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199367|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199368|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
2199369|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199370|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2199371|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
2199372|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2199373|NCT00004906|Pamidronate|pamidronate|mesh-list
2713486|NCT04643379|Olaparib|olaparib|mesh-list
2713487|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713488|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2199374|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
2199375|NCT00004906|Thiotepa|thiotepa|mesh-list
2199376|NCT00004906|Carboplatin|carboplatin|mesh-list
2199377|NCT00004906|Docetaxel|docetaxel|mesh-list
2713489|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2713490|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713491|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199378|NCT00004906|Doxorubicin|doxorubicin|mesh-list
2199379|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2199380|NCT00004906|Etoposide|etoposide|mesh-list
2199381|NCT00004906|Anastrozole|anastrozole|mesh-list
2199382|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199383|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
2199384|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199385|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199386|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199387|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
2199388|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199389|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199390|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2199391|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199392|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
2199393|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
2713520|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
2713521|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713527|NCT04590274|Azithromycin|azithromycin|mesh-list
2713528|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
2713529|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2199394|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2199395|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199396|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199397|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199398|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199399|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2199400|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2199401|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2199402|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2713530|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2713531|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
2713532|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2713533|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2199403|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
2199404|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2199405|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2199406|NCT00004907|Cyclophosphamide|cyclophosphamide|mesh-list
2199407|NCT00004907|Busulfan|busulfan|mesh-list
2199408|NCT00004907|Etoposide|etoposide|mesh-list
2199409|NCT00004907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199410|NCT00004907|Immunologic Factors|immunologic factors|mesh-ancestor
2199411|NCT00004907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199412|NCT00004907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2713534|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713535|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713536|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2713574|NCT04567784|Cannabidiol|cannabidiol|mesh-list
2713575|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
2199413|NCT00004907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199414|NCT00004907|Alkylating Agents|alkylating agents|mesh-ancestor
2199415|NCT00004907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199416|NCT00004907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199417|NCT00004907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2199418|NCT00004907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199419|NCT00004907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199420|NCT00004907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199421|NCT00004907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199422|NCT00004908|Cyclophosphamide|cyclophosphamide|mesh-list
2199423|NCT00004908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199424|NCT00004908|Immunologic Factors|immunologic factors|mesh-ancestor
2199425|NCT00004908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199426|NCT00004908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199427|NCT00004908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199428|NCT00004908|Alkylating Agents|alkylating agents|mesh-ancestor
2199429|NCT00004908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199430|NCT00004908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199431|NCT00004908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2199432|NCT00004912|Megestrol|megestrol|mesh-list
2199433|NCT00004912|Megestrol Acetate|megestrol acetate|mesh-list
2199434|NCT00004912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2199435|NCT00004912|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2199436|NCT00004912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2199437|NCT00004912|Contraceptive Agents|contraceptive agents|mesh-ancestor
2199438|NCT00004912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2199439|NCT00004912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199440|NCT00004912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2199441|NCT00004912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2199442|NCT00004912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2199443|NCT00004912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199444|NCT00004912|Appetite Stimulants|appetite stimulants|mesh-ancestor
2199445|NCT00004912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2199446|NCT00004913|Leucovorin|leucovorin|mesh-list
2199447|NCT00004913|Docetaxel|docetaxel|mesh-list
2199448|NCT00004913|Fluorouracil|fluorouracil|mesh-list
2713606|NCT04526899|Cemiplimab|cemiplimab|mesh-list
2713607|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2713608|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713609|NCT04526691|Carboplatin|carboplatin|mesh-list
2713610|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
2713611|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713612|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2713639|NCT04515147|Vaccines|vaccines|mesh-list
2713640|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2713641|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
2713642|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713648|NCT04512235|Dexamethasone|dexamethasone|mesh-list
2713649|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
2713650|NCT04512235|Bortezomib|bortezomib|mesh-list
2713651|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2713652|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
2713653|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713654|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2713655|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2713656|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
2713657|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199449|NCT00004913|Calcium|calcium|mesh-list
2199450|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
2199451|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199452|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199453|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
2199454|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199455|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199456|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2199457|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199458|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
2199459|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2713658|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713659|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2713660|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2713661|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
2713662|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
2713663|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2713664|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2713665|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
2713666|NCT04512235|Hormones|hormones|mesh-ancestor
2713667|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2713668|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2713669|NCT04504825|Dexamethasone|dexamethasone|mesh-list
2713670|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
2713671|NCT04504825|Bortezomib|bortezomib|mesh-list
2713672|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2713673|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
2713674|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713675|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2713676|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2713677|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
2713678|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713679|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713680|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2713681|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2713682|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
2713683|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
2713684|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2713685|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2713686|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
2713687|NCT04504825|Hormones|hormones|mesh-ancestor
2713688|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2713689|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2713703|NCT04497116|Gemcitabine|gemcitabine|mesh-list
2713704|NCT04497116|Talazoparib|talazoparib|mesh-list
2713705|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2713706|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
2713707|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713708|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713709|NCT04497116|Antiviral Agents|antiviral agents|mesh-ancestor
2713710|NCT04497116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2713711|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713712|NCT04497116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2713713|NCT04497116|Immunologic Factors|immunologic factors|mesh-ancestor
2713714|NCT04497116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713715|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2713721|NCT04474470|Cetuximab|cetuximab|mesh-list
2713722|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2713723|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713733|NCT04440358|Carboplatin|carboplatin|mesh-list
2713734|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713754|NCT04381832|Docetaxel|docetaxel|mesh-list
2713755|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713756|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
2713757|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
2713758|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
2713759|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713788|NCT04339140|Zafirlukast|zafirlukast|mesh-list
2713789|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2713790|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
2199460|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199461|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
2199462|NCT00004913|Antidotes|antidotes|mesh-ancestor
2199463|NCT00004913|Protective Agents|protective agents|mesh-ancestor
2199464|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
2199465|NCT00004913|Vitamins|vitamins|mesh-ancestor
2199466|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
2713791|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2713792|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
2713793|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2713794|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713795|NCT04336098|Gemcitabine|gemcitabine|mesh-list
2713796|NCT04336098|Paclitaxel|paclitaxel|mesh-list
2713797|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
2713798|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2713799|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2713800|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713801|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199467|NCT00004914|Epoetin Alfa|epoetin alfa|mesh-list
2199468|NCT00004914|Hematinics|hematinics|mesh-ancestor
2713802|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
2713803|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
2713804|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713805|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2713806|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
2713807|NCT04336098|Antiviral Agents|antiviral agents|mesh-ancestor
2713808|NCT04336098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2713809|NCT04336098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713810|NCT04336098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2713811|NCT04336098|Immunologic Factors|immunologic factors|mesh-ancestor
2713812|NCT04336098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713813|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2713814|NCT04329728|Dexamethasone|dexamethasone|mesh-list
2713815|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2713816|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2713817|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
2713818|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
2713819|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2713820|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713821|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2713822|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
2713823|NCT04329728|Hormones|hormones|mesh-ancestor
2713824|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2713825|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2713826|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713827|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
2713828|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2713829|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199469|NCT00004915|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2199470|NCT00004915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2199471|NCT00004915|Hormone Antagonists|hormone antagonists|mesh-ancestor
2199472|NCT00004915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2199473|NCT00004915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199474|NCT00004915|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2199475|NCT00004915|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2199476|NCT00004915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2199477|NCT00004916|Paclitaxel|paclitaxel|mesh-list
2199478|NCT00004916|Ifosfamide|ifosfamide|mesh-list
2199479|NCT00004916|Teniposide|teniposide|mesh-list
2199480|NCT00004916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199481|NCT00004916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199482|NCT00004916|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199483|NCT00004916|Antimitotic Agents|antimitotic agents|mesh-ancestor
2199484|NCT00004916|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199485|NCT00004916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199486|NCT00004916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199487|NCT00004916|Alkylating Agents|alkylating agents|mesh-ancestor
2199488|NCT00004916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199489|NCT00004916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2713859|NCT04294810|Atezolizumab|atezolizumab|mesh-list
2713860|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713861|NCT04283617|Insulin|insulin|mesh-list
2713862|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2199490|NCT00004916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199491|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
2199492|NCT00004917|Hematinics|hematinics|mesh-ancestor
2199493|NCT00004918|Sargramostim|sargramostim|mesh-list
2199494|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
2199495|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199496|NCT00004919|Irinotecan|irinotecan|mesh-list
2199497|NCT00004919|Amifostine|amifostine|mesh-list
2199498|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713863|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713864|NCT04268277|Rituximab|rituximab|mesh-list
2713865|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
2713866|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2713867|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713868|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
2713869|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713870|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199499|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2199500|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199501|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199502|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199503|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2199504|NCT00004919|Protective Agents|protective agents|mesh-ancestor
2199505|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199506|NCT00004920|Raltitrexed|raltitrexed|mesh-list
2199507|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199508|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2199509|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
2199510|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199511|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2199512|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199513|NCT00004921|Paclitaxel|paclitaxel|mesh-list
2199514|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
2199515|NCT00004921|Carboplatin|carboplatin|mesh-list
2199516|NCT00004921|Melphalan|melphalan|mesh-list
2199517|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199518|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199519|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199520|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
2199521|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199522|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199523|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199524|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
2199525|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713873|NCT04246372|Tofacitinib|tofacitinib|mesh-list
2713874|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2713875|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713876|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713892|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2713893|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2713894|NCT04182321|Metformin|metformin|mesh-list
2199526|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199527|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199528|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
2199529|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2199530|NCT00004922|Irinotecan|irinotecan|mesh-list
2199531|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2199532|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199533|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199534|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199535|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713895|NCT04182321|Entecavir|entecavir|mesh-list
2713896|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2713897|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713898|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
2713899|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199536|NCT00004923|Docetaxel|docetaxel|mesh-list
2199537|NCT00004923|Irinotecan|irinotecan|mesh-list
2199538|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199539|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199540|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
2199541|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199542|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199543|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2199544|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199545|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199546|NCT00004924|Paclitaxel|paclitaxel|mesh-list
2199547|NCT00004924|Irinotecan|irinotecan|mesh-list
2199548|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199549|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713922|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2713923|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2713924|NCT04143282|Metformin|metformin|mesh-list
2713925|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2713926|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2713933|NCT04135495|Ivacaftor|ivacaftor|mesh-list
2713934|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2713935|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2713936|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2713937|NCT04124588|Hemostatics|hemostatics|mesh-list
2713938|NCT04124588|Coagulants|coagulants|mesh-ancestor
2713957|NCT04104672|Gemcitabine|gemcitabine|mesh-list
2713958|NCT04104672|Paclitaxel|paclitaxel|mesh-list
2713959|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2713960|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2713961|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
2713962|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
2713963|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
2713964|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199550|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199551|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
2199552|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199553|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199554|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2199555|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199556|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199557|NCT00004925|Doxorubicin|doxorubicin|mesh-list
2199558|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2199559|NCT00004925|Trastuzumab|trastuzumab|mesh-list
2199560|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2199561|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199562|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199563|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199564|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199565|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199566|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2199567|NCT00004926|Vitamin D|vitamin d|mesh-list
2199568|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
2199569|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
2199570|NCT00004926|Vitamins|vitamins|mesh-ancestor
2199571|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
2199572|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199573|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2199574|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2199575|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199576|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
2199577|NCT00004928|Calcitriol|calcitriol|mesh-list
2199578|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2199579|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199580|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2199581|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2199582|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2199583|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199584|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2199585|NCT00004928|Vitamins|vitamins|mesh-ancestor
2199586|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
2199587|NCT00004930|Doxorubicin|doxorubicin|mesh-list
2199588|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2199589|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2199590|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199591|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199592|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199593|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199594|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199595|NCT00004931|Leucovorin|leucovorin|mesh-list
2199596|NCT00004931|Fluorouracil|fluorouracil|mesh-list
2199597|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
2199598|NCT00004931|Calcium|calcium|mesh-list
2199599|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
2199600|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2199601|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199602|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
2199603|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199604|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2199605|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199606|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199607|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
2199608|NCT00004931|Antidotes|antidotes|mesh-ancestor
2199609|NCT00004931|Protective Agents|protective agents|mesh-ancestor
2713965|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2713966|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
2713967|NCT04104672|Antiviral Agents|antiviral agents|mesh-ancestor
2713968|NCT04104672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2713969|NCT04104672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2713970|NCT04104672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2713971|NCT04104672|Immunologic Factors|immunologic factors|mesh-ancestor
2713972|NCT04104672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199610|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
2199611|NCT00004931|Vitamins|vitamins|mesh-ancestor
2199612|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
2199613|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
2199614|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199615|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2199616|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199617|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199618|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
2199619|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
2199620|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199621|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
2199622|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199623|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199624|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199625|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199626|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2199627|NCT00004934|Paclitaxel|paclitaxel|mesh-list
2199628|NCT00004934|Carboplatin|carboplatin|mesh-list
2199629|NCT00004934|Epirubicin|epirubicin|mesh-list
2199630|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199631|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199632|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199633|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
2199634|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199635|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199636|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2199637|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199638|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199639|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714015|NCT04062279|Autoantibodies|autoantibodies|mesh-list
2714016|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
2714017|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714024|NCT04035278|Vaccines|vaccines|mesh-list
2714025|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
2199640|NCT00004935|Trastuzumab|trastuzumab|mesh-list
2199641|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2199642|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199643|NCT00004938|Fluconazole|fluconazole|mesh-list
2199644|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
2199645|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199646|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2199647|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2199648|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199649|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199650|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2199651|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
2714026|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714048|NCT04015739|Bevacizumab|bevacizumab|mesh-list
2714049|NCT04015739|Durvalumab|durvalumab|mesh-list
2714050|NCT04015739|Olaparib|olaparib|mesh-list
2714051|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714052|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714053|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2714054|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2714055|NCT04015739|Growth Substances|growth substances|mesh-ancestor
2714056|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714057|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
2714058|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2714059|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714060|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714074|NCT03989414|Dexamethasone|dexamethasone|mesh-list
2714075|NCT03989414|Bortezomib|bortezomib|mesh-list
2714076|NCT03989414|Daratumumab|daratumumab|mesh-list
2714077|NCT03989414|Elotuzumab|elotuzumab|mesh-list
2714078|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2714079|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
2714080|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
2714081|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2714082|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714083|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2714084|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
2714085|NCT03989414|Hormones|hormones|mesh-ancestor
2199652|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2199653|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199654|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2199655|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2199656|NCT00004941|Infliximab|infliximab|mesh-list
2199657|NCT00004941|Antibodies|antibodies|mesh-list
2199658|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2199659|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
2199660|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199661|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
2714086|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2714087|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2714088|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714123|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
2714124|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2714125|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
2714126|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2714127|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714128|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2714129|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
2714130|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
2714131|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2714132|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
2714133|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2714134|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714158|NCT03937830|Bevacizumab|bevacizumab|mesh-list
2714159|NCT03937830|Durvalumab|durvalumab|mesh-list
2714160|NCT03937830|Doxorubicin|doxorubicin|mesh-list
2714161|NCT03937830|Tremelimumab|tremelimumab|mesh-list
2714162|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714163|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714164|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2714165|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2714166|NCT03937830|Growth Substances|growth substances|mesh-ancestor
2714167|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714168|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
2714169|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2714170|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2714171|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2714172|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714173|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714174|NCT03916341|Nicotine|nicotine|mesh-list
2714175|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2714176|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
2714177|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2714178|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714179|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2714180|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2714181|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
2714182|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2714183|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199662|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2199663|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199664|NCT00004979|Paclitaxel|paclitaxel|mesh-list
2199665|NCT00004979|Topotecan|topotecan|mesh-list
2199666|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2714184|NCT03891446|Bimatoprost|bimatoprost|mesh-list
2714185|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2714186|NCT03881020|Fluorides|fluorides|mesh-list
2714187|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
2714188|NCT03881020|Protective Agents|protective agents|mesh-ancestor
2199667|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199668|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199669|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
2199670|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199671|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199672|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2199673|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199674|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199675|NCT00004981|Lamivudine|lamivudine|mesh-list
2199676|NCT00004981|Zidovudine|zidovudine|mesh-list
2199677|NCT00004981|Abacavir|abacavir|mesh-list
2199678|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
2199679|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2199680|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2199681|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199682|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199683|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199684|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
2199685|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2714189|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714190|NCT03872401|Evolocumab|evolocumab|mesh-list
2714191|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2714192|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2714193|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
2714194|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714195|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2199686|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2199687|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2199688|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
2199689|NCT00004984|Insulin|insulin|mesh-list
2199690|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2199691|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2199692|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199693|NCT00004985|Nelfinavir|nelfinavir|mesh-list
2199694|NCT00004985|Capravirine|capravirine|mesh-list
2199695|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2199696|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2199697|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
2199698|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714224|NCT03797261|Venetoclax|venetoclax|mesh-list
2714225|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199699|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199700|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2199701|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2199702|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
2199703|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199704|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2199705|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199706|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
2199707|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2199708|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199709|NCT00004990|Dexamethasone|dexamethasone|mesh-list
2199710|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2199711|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
2199712|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
2199713|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2714232|NCT03773666|Durvalumab|durvalumab|mesh-list
2714233|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714234|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199714|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199715|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2199716|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
2199717|NCT00004990|Hormones|hormones|mesh-ancestor
2199718|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2199719|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2199720|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199721|NCT00004992|Metformin|metformin|mesh-list
2199722|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2199723|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199724|NCT00004993|Hormones|hormones|mesh-list
2199725|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
2199726|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2199727|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199728|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2199729|NCT00004997|Leucovorin|leucovorin|mesh-list
2199730|NCT00004997|Antidotes|antidotes|mesh-ancestor
2199731|NCT00004997|Protective Agents|protective agents|mesh-ancestor
2199732|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199733|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
2199734|NCT00004997|Vitamins|vitamins|mesh-ancestor
2199735|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
2199736|NCT00004998|Lamivudine|lamivudine|mesh-list
2199737|NCT00004998|Zidovudine|zidovudine|mesh-list
2199738|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2199739|NCT00004998|Capravirine|capravirine|mesh-list
2199740|NCT00004998|Nelfinavir|nelfinavir|mesh-list
2199741|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2199742|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199743|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199744|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199745|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
2199746|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199747|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2199748|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2199749|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
2423754|NCT00823849|Cilostazol|cilostazol|mesh-list
2423755|NCT00823849|Probucol|probucol|mesh-list
2423756|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2423757|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
2423758|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423759|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423760|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2423761|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
2423762|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2423763|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2714286|NCT03719924|Paclitaxel|paclitaxel|mesh-list
2714287|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2714288|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714289|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
2714290|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
2714291|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
2714292|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714307|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
2714308|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
2714309|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2714310|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2714311|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714312|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714313|NCT03686306|Urological Agents|urological agents|mesh-ancestor
2714314|NCT03661138|Upadacitinib|upadacitinib|mesh-list
2714315|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2714316|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2714317|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714318|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714319|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2714351|NCT03641560|Androgens|androgens|mesh-list
2714352|NCT03641560|Hormones|hormones|mesh-ancestor
2714353|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2714354|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714355|NCT03631199|Paclitaxel|paclitaxel|mesh-list
2714356|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2714357|NCT03631199|Carboplatin|carboplatin|mesh-list
2714358|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
2714359|NCT03631199|Pemetrexed|pemetrexed|mesh-list
2714360|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2714361|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2714362|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714363|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
2714364|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
2714365|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
2714366|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714367|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714368|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714369|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2714370|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2714371|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
2714372|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714379|NCT03620903|Rituximab|rituximab|mesh-list
2714380|NCT03620903|Bortezomib|bortezomib|mesh-list
2714381|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714382|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714383|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
2714384|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714385|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199750|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2199751|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2199752|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
2199753|NCT00004999|Lamivudine|lamivudine|mesh-list
2199754|NCT00004999|Zidovudine|zidovudine|mesh-list
2199755|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2199756|NCT00004999|Capravirine|capravirine|mesh-list
2199757|NCT00004999|Nelfinavir|nelfinavir|mesh-list
2199758|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2199759|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199760|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199761|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199762|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
2199763|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199764|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2199765|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2199766|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
2199767|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2199768|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2199769|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
2199770|NCT00005000|Lamivudine|lamivudine|mesh-list
2199771|NCT00005000|Zidovudine|zidovudine|mesh-list
2199772|NCT00005000|Efavirenz|efavirenz|mesh-list
2199773|NCT00005000|Stavudine|stavudine|mesh-list
2199774|NCT00005000|Didanosine|didanosine|mesh-list
2199775|NCT00005000|Nelfinavir|nelfinavir|mesh-list
2199776|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2199777|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2199778|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199779|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714386|NCT03589976|Sirolimus|sirolimus|mesh-list
2714387|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2714388|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2714389|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2714390|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714391|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
2714392|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2714393|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
2714394|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714395|NCT03579615|Insulin|insulin|mesh-list
2714396|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
2714397|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2714398|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199780|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199781|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
2199782|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199783|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2199784|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2199785|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
2199786|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2199787|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2199788|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2199789|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2199790|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2199791|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2199792|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2714418|NCT03532139|Enoxaparin|enoxaparin|mesh-list
2714419|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
2714420|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2714421|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2714422|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2714423|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
2714424|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199793|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2199794|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
2199795|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2199796|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
2199797|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199798|NCT00005002|Lamivudine|lamivudine|mesh-list
2199799|NCT00005002|Zidovudine|zidovudine|mesh-list
2199800|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2199801|NCT00005002|Nelfinavir|nelfinavir|mesh-list
2199802|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2199803|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199804|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199805|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199806|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
2199807|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199808|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2199809|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2199810|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
2199811|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2199812|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2199813|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
2714425|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2714426|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2714427|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714428|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
2714429|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2714430|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2714431|NCT03517449|Paclitaxel|paclitaxel|mesh-list
2714432|NCT03517449|Doxorubicin|doxorubicin|mesh-list
2714433|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
2714434|NCT03517449|Lenvatinib|lenvatinib|mesh-list
2199814|NCT00005005|Alendronate|alendronate|mesh-list
2199815|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2199816|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199817|NCT00005006|Alendronate|alendronate|mesh-list
2199818|NCT00005006|Teriparatide|teriparatide|mesh-list
2199819|NCT00005006|Hormones|hormones|mesh-list
2199820|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
2199821|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2199822|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199823|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2199824|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2199825|NCT00005007|Etanercept|etanercept|mesh-list
2714435|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2714436|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714437|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
2714438|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
2714439|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
2714440|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714441|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2714442|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2714443|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2714444|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714445|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714446|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2714450|NCT03475953|Avelumab|avelumab|mesh-list
2714451|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2714452|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714453|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714454|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
2714455|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199826|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2199827|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2199828|NCT00005007|Analgesics|analgesics|mesh-ancestor
2199829|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
2199830|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2199831|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199832|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2199833|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199834|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2714478|NCT03447574|Ethanol|ethanol|mesh-list
2714479|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2714480|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2714481|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2714482|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714483|NCT03421353|Gemcitabine|gemcitabine|mesh-list
2714484|NCT03421353|Paclitaxel|paclitaxel|mesh-list
2714485|NCT03421353|Carboplatin|carboplatin|mesh-list
2714486|NCT03421353|Durvalumab|durvalumab|mesh-list
2199835|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2714487|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2714488|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714489|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
2714490|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
2714491|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
2714492|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714493|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2714494|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
2714495|NCT03421353|Antiviral Agents|antiviral agents|mesh-ancestor
2714496|NCT03421353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2714497|NCT03421353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714498|NCT03421353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2714499|NCT03421353|Immunologic Factors|immunologic factors|mesh-ancestor
2714500|NCT03421353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714501|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714509|NCT03368729|Trastuzumab|trastuzumab|mesh-list
2714510|NCT03368729|Niraparib|niraparib|mesh-list
2714511|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714512|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714513|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2714514|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714515|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714516|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
2714517|NCT03344341|Acarbose|acarbose|mesh-list
2714518|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2714519|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714520|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2714521|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714522|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2714523|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714524|NCT03336216|Leucovorin|leucovorin|mesh-list
2714525|NCT03336216|Gemcitabine|gemcitabine|mesh-list
2714526|NCT03336216|Paclitaxel|paclitaxel|mesh-list
2714527|NCT03336216|Fluorouracil|fluorouracil|mesh-list
2714528|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
2714529|NCT03336216|Nivolumab|nivolumab|mesh-list
2714530|NCT03336216|Irinotecan|irinotecan|mesh-list
2714531|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2714532|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714533|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
2714534|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
2714535|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
2714536|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714537|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2714538|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
2714539|NCT03336216|Antiviral Agents|antiviral agents|mesh-ancestor
2714540|NCT03336216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2714541|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714542|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2714543|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
2714544|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714545|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714546|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2714547|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2714548|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2714549|NCT03336216|Antidotes|antidotes|mesh-ancestor
2714550|NCT03336216|Protective Agents|protective agents|mesh-ancestor
2714551|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
2714552|NCT03336216|Vitamins|vitamins|mesh-ancestor
2714553|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
2714554|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
2714555|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714556|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714560|NCT03276468|Atezolizumab|atezolizumab|mesh-list
2714561|NCT03276468|Venetoclax|venetoclax|mesh-list
2714562|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
2714563|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714564|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714565|NCT03260881|Liraglutide|liraglutide|mesh-list
2714566|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2714567|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714568|NCT03260881|Incretins|incretins|mesh-ancestor
2714569|NCT03260881|Hormones|hormones|mesh-ancestor
2714570|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2714574|NCT03238495|Metformin|metformin|mesh-list
2714575|NCT03238495|Carboplatin|carboplatin|mesh-list
2714576|NCT03238495|Docetaxel|docetaxel|mesh-list
2714577|NCT03238495|Trastuzumab|trastuzumab|mesh-list
2714578|NCT03238495|Pertuzumab|pertuzumab|mesh-list
2714579|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714580|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2714581|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714582|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
2714583|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
2714584|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
2714585|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714586|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714587|NCT03232138|Sulforaphane|sulforaphane|mesh-list
2714588|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2714589|NCT03232138|Protective Agents|protective agents|mesh-ancestor
2714590|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714591|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714592|NCT03212963|Clobetasol|clobetasol|mesh-list
2714593|NCT03212963|Halobetasol|halobetasol|mesh-list
2714594|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2714595|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2714596|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
2714597|NCT03212963|Hormones|hormones|mesh-ancestor
2714598|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2714599|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714600|NCT03135262|Rituximab|rituximab|mesh-list
2714601|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
2714602|NCT03135262|Venetoclax|venetoclax|mesh-list
2714603|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714604|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714605|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
2714606|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714607|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2714608|NCT03104075|Vaccines|vaccines|mesh-list
2714609|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2714610|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
2714611|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714612|NCT03103750|Calcitriol|calcitriol|mesh-list
2714613|NCT03103750|Amphetamine|amphetamine|mesh-list
2199836|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
2199837|NCT00005009|Vaccines|vaccines|mesh-list
2199838|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
2199839|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199840|NCT00005010|Irbesartan|irbesartan|mesh-list
2199841|NCT00005010|Pravastatin|pravastatin|mesh-list
2199842|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2199843|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2199844|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
2199845|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199846|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2199847|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2199848|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199849|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2199850|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2199851|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2199852|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2199853|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
2199854|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199855|NCT00005013|Sertraline|sertraline|mesh-list
2199856|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
2199857|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2199858|NCT00005013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2199859|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2199860|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2714614|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
2714615|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2199861|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199862|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2199863|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
2199864|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199865|NCT00005014|Risperidone|risperidone|mesh-list
2199866|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2199867|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
2199868|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2199869|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199870|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199871|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2714616|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714617|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2714618|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2714619|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714620|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2714621|NCT03103750|Vitamins|vitamins|mesh-ancestor
2714622|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
2714623|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2714624|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2714625|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
2714626|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
2714627|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2199872|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2199873|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2199874|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2199875|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2199876|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
2199877|NCT00005015|Fluoxetine|fluoxetine|mesh-list
2199878|NCT00005015|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2199879|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2199880|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2199881|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714628|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
2714629|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2714630|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
2714631|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2714632|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2714633|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2714646|NCT03080935|Evolocumab|evolocumab|mesh-list
2714647|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2714648|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2714649|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
2714650|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714651|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2714652|NCT03077620|Suvorexant|suvorexant|mesh-list
2714653|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2714654|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2714655|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2714656|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714657|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2714658|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2714659|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714663|NCT03072628|Nicotine|nicotine|mesh-list
2714664|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2714665|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
2714666|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2714667|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714668|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2714669|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2714670|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
2714671|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2714672|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714692|NCT02998645|Cyclosporine|cyclosporine|mesh-list
2714693|NCT02998645|Cyclosporins|cyclosporins|mesh-list
2714694|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714695|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714696|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2714697|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
2714698|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714699|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
2714700|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2714701|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
2714702|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2714703|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2714704|NCT02981472|Vitamin K|vitamin k|mesh-list
2714705|NCT02981472|Heparin|heparin|mesh-list
2714706|NCT02981472|Enoxaparin|enoxaparin|mesh-list
2714707|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2714708|NCT02981472|Tinzaparin|tinzaparin|mesh-list
2714709|NCT02981472|Dalteparin|dalteparin|mesh-list
2714710|NCT02981472|Warfarin|warfarin|mesh-list
2714711|NCT02981472|Apixaban|apixaban|mesh-list
2714712|NCT02981472|Vitamins|vitamins|mesh-ancestor
2714713|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
2714714|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714715|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
2714716|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2714717|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2714718|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714719|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2714720|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
2714721|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2714722|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
2714723|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714724|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2714725|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
2714726|NCT02981472|Coagulants|coagulants|mesh-ancestor
2714736|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2714737|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2714738|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199882|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2199883|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
2199884|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199885|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2199886|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
2199887|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2199888|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2199889|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2199890|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199891|NCT00005017|Ritonavir|ritonavir|mesh-list
2714765|NCT02907983|Bupivacaine|bupivacaine|mesh-list
2714766|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
2714767|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
2714768|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2714769|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714770|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
2714771|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2714772|NCT02880540|Fentanyl|fentanyl|mesh-list
2714773|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
2714774|NCT02880540|Morphine|morphine|mesh-list
2714775|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2714776|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2714777|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714778|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2714779|NCT02880540|Analgesics|analgesics|mesh-ancestor
2714780|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
2714781|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2714782|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2714783|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2714784|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2714785|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
2714786|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2714787|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714788|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2714789|NCT02880540|Narcotics|narcotics|mesh-ancestor
2714790|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2714791|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2199892|NCT00005017|Amprenavir|amprenavir|mesh-list
2199893|NCT00005017|Lamivudine|lamivudine|mesh-list
2199894|NCT00005017|Abacavir|abacavir|mesh-list
2199895|NCT00005017|Stavudine|stavudine|mesh-list
2199896|NCT00005017|Efavirenz|efavirenz|mesh-list
2199897|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2199898|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2199899|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
2199900|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199901|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199902|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2199903|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2199904|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
2714792|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
2714793|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
2714794|NCT02859415|Plicamycin|plicamycin|mesh-list
2714795|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2714796|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714797|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2714798|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199905|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199906|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2714799|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2199907|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2199908|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2199909|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199910|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2199911|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2199912|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2199913|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2714800|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714801|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714802|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2714803|NCT02841215|Ivermectin|ivermectin|mesh-list
2714804|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2714805|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2714828|NCT02802566|Vitamins|vitamins|mesh-list
2714829|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
2714830|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714831|NCT02799641|Lidocaine|lidocaine|mesh-list
2714832|NCT02799641|Diazepam|diazepam|mesh-list
2714833|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
2714834|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
2714835|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2714836|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714837|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
2714838|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2714839|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2714840|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2714841|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2714842|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2714843|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199914|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2199915|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
2199916|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2714844|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2714845|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
2714846|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
2714847|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
2714848|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2714849|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2714850|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2714851|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2714852|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2714853|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2714854|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2714855|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2714856|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
2714857|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
2714858|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
2714859|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2714860|NCT02782663|Upadacitinib|upadacitinib|mesh-list
2714861|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2714862|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2714863|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714864|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714865|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199917|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
2199918|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2199919|NCT00005018|Efavirenz|efavirenz|mesh-list
2199920|NCT00005018|Abacavir|abacavir|mesh-list
2199921|NCT00005018|Didanosine|didanosine|mesh-list
2199922|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
2199923|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2199924|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199925|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199926|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199927|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
2199928|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199929|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2199930|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2199931|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2199932|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2199933|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2714895|NCT02755844|Metformin|metformin|mesh-list
2714896|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
2714897|NCT02755844|Olaparib|olaparib|mesh-list
2714898|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2714899|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
2714900|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714901|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2714902|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2714903|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
2714904|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714905|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714906|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2199934|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2199935|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2199936|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2199937|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199938|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
2199939|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
2199940|NCT00005021|Paclitaxel|paclitaxel|mesh-list
2199941|NCT00005021|Carboplatin|carboplatin|mesh-list
2714907|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2714908|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2714909|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199942|NCT00005021|Topotecan|topotecan|mesh-list
2714915|NCT02741388|Gemcitabine|gemcitabine|mesh-list
2714916|NCT02741388|Cytarabine|cytarabine|mesh-list
2714917|NCT02741388|Dexamethasone|dexamethasone|mesh-list
2199943|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199944|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199945|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
2199946|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
2199947|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199948|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199949|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2199950|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199951|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199952|NCT00005022|Etoposide|etoposide|mesh-list
2199953|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199954|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2714918|NCT02741388|Rituximab|rituximab|mesh-list
2714919|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
2714920|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714921|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2714922|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
2714923|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
2714924|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2714925|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714926|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2714927|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
2714928|NCT02741388|Hormones|hormones|mesh-ancestor
2714929|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2714930|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2714931|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714932|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
2714933|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2714934|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2714935|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
2714936|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714937|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
2714938|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2714939|NCT02741388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714940|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2714941|NCT02686346|Etoposide|etoposide|mesh-list
2714942|NCT02686346|Ifosfamide|ifosfamide|mesh-list
2714943|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2714944|NCT02686346|Carboplatin|carboplatin|mesh-list
2714945|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2714946|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714947|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2714948|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2714949|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2714950|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714951|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2714952|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
2714953|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714954|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2714955|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
2714956|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2714963|NCT02536339|Trastuzumab|trastuzumab|mesh-list
2714964|NCT02536339|Pertuzumab|pertuzumab|mesh-list
2714965|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714966|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714967|NCT02523469|Nivolumab|nivolumab|mesh-list
2714968|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2714969|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714970|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2714971|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2714972|NCT02514083|Fludarabine|fludarabine|mesh-list
2714973|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714992|NCT02333370|Tamoxifen|tamoxifen|mesh-list
2714993|NCT02333370|Letrozole|letrozole|mesh-list
2714994|NCT02333370|Fulvestrant|fulvestrant|mesh-list
2714995|NCT02333370|Goserelin|goserelin|mesh-list
2714996|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2714997|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2714998|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2714999|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715000|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715001|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2715002|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
2715003|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2715004|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715005|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2715006|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2715007|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2715008|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2715009|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2715010|NCT02298257|Doxorubicin|doxorubicin|mesh-list
2715011|NCT02298257|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2715012|NCT02298257|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2715013|NCT02298257|Dacarbazine|dacarbazine|mesh-list
2715014|NCT02298257|Vinblastine|vinblastine|mesh-list
2715015|NCT02298257|Antibodies|antibodies|mesh-list
2715016|NCT02298257|Immunoglobulins|immunoglobulins|mesh-list
2199955|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199956|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199957|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199958|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199959|NCT00005023|Sargramostim|sargramostim|mesh-list
2199960|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
2199961|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199962|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
2199963|NCT00005024|Carboplatin|carboplatin|mesh-list
2199964|NCT00005024|Doxorubicin|doxorubicin|mesh-list
2199965|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2199966|NCT00005024|Granisetron|granisetron|mesh-list
2199967|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2199968|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
2199969|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2199970|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2199971|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2199972|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
2199973|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199974|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199975|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2199976|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2199977|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2199978|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2199979|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199980|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
2199981|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
2199982|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2199983|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2199984|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2715017|NCT02298257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2715018|NCT02298257|Immunoconjugates|immunoconjugates|mesh-list
2715019|NCT02298257|Immunologic Factors|immunologic factors|mesh-ancestor
2715020|NCT02298257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715021|NCT02298257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2715022|NCT02298257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199985|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
2199986|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2715023|NCT02298257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2715024|NCT02298257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2715025|NCT02298257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715026|NCT02298257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715027|NCT02298257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2715028|NCT02298257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2715029|NCT02298257|Alkylating Agents|alkylating agents|mesh-ancestor
2715030|NCT02298257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2715031|NCT02298257|Tubulin Modulators|tubulin modulators|mesh-ancestor
2715032|NCT02298257|Antimitotic Agents|antimitotic agents|mesh-ancestor
2715033|NCT02298257|Mitosis Modulators|mitosis modulators|mesh-ancestor
2199987|NCT00005025|Ganciclovir|ganciclovir|mesh-list
2199988|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2199989|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
2199990|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2199991|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2199992|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2199993|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2199994|NCT00005026|Paclitaxel|paclitaxel|mesh-list
2199995|NCT00005026|Carboplatin|carboplatin|mesh-list
2199996|NCT00005026|Topotecan|topotecan|mesh-list
2199997|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2199998|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2199999|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200000|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200001|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200002|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200003|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2200004|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200005|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200006|NCT00005028|Paclitaxel|paclitaxel|mesh-list
2200007|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
2200008|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200009|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200010|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200011|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200012|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200013|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200014|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2200015|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
2200016|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200017|NCT00005029|Topotecan|topotecan|mesh-list
2200018|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2200019|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200020|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200021|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200022|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200023|NCT00005030|Lonafarnib|lonafarnib|mesh-list
2200024|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200025|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200026|NCT00005031|Irofulven|irofulven|mesh-list
2715070|NCT02229136|Prednisolone|prednisolone|mesh-list
2715071|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
2200027|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200028|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
2200029|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200030|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200031|NCT00005032|Paclitaxel|paclitaxel|mesh-list
2200032|NCT00005032|Oblimersen|oblimersen|mesh-list
2200033|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200034|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200035|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200036|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200037|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200038|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200039|NCT00005033|Trastuzumab|trastuzumab|mesh-list
2200040|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2200041|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200042|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
2200043|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200044|NCT00005036|Leucovorin|leucovorin|mesh-list
2200045|NCT00005036|Fluorouracil|fluorouracil|mesh-list
2200046|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
2200047|NCT00005036|Irinotecan|irinotecan|mesh-list
2200048|NCT00005036|Calcium|calcium|mesh-list
2200049|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
2200050|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2200051|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200052|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
2200053|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200054|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200055|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200056|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200057|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
2200058|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2715072|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2715073|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
2715074|NCT02229136|Hormones|hormones|mesh-ancestor
2715075|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2715076|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715077|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2715078|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715082|NCT02189798|Imidacloprid|imidacloprid|mesh-list
2715083|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
2715084|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2715085|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715086|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715087|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
2715088|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715089|NCT02108964|Nazartinib|nazartinib|mesh-list
2715090|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715091|NCT02098876|Everolimus|everolimus|mesh-list
2715092|NCT02098876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715093|NCT02098876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2715094|NCT02098876|Immunologic Factors|immunologic factors|mesh-ancestor
2715095|NCT02098876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715099|NCT02050308|Nicotine|nicotine|mesh-list
2715100|NCT02050308|Varenicline|varenicline|mesh-list
2715101|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2715102|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
2715103|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2715104|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715105|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2715106|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2715107|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
2715108|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2715109|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715119|NCT01958021|Letrozole|letrozole|mesh-list
2715120|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715121|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2715122|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2715123|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715124|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715125|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2715126|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
2715127|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2715128|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715129|NCT01872260|Letrozole|letrozole|mesh-list
2715130|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715131|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2715132|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2715133|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715134|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715135|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2715136|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
2715137|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2715138|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715139|NCT01869361|Indomethacin|indomethacin|mesh-list
2715140|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2715141|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2715142|NCT01869361|Analgesics|analgesics|mesh-ancestor
2715143|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
2715144|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2715145|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715146|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2200059|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200060|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200061|NCT00005036|Antidotes|antidotes|mesh-ancestor
2200062|NCT00005036|Protective Agents|protective agents|mesh-ancestor
2200063|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
2200064|NCT00005036|Vitamins|vitamins|mesh-ancestor
2200065|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
2200066|NCT00005037|Temozolomide|temozolomide|mesh-list
2200067|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200068|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
2200069|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200070|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200071|NCT00005038|Aldesleukin|aldesleukin|mesh-list
2715147|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2715148|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
2715149|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
2715150|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2715151|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2715152|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715153|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715154|NCT01828099|Carboplatin|carboplatin|mesh-list
2715155|NCT01828099|Pemetrexed|pemetrexed|mesh-list
2715156|NCT01828099|Ceritinib|ceritinib|mesh-list
2715157|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715158|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715159|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715160|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2715161|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2200072|NCT00005038|Histamine|histamine|mesh-list
2200073|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
2200074|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200075|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2200076|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2200077|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
2200078|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200079|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
2200080|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
2200081|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2200082|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200083|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200084|NCT00005039|Vaccines|vaccines|mesh-list
2200085|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
2200086|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200087|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
2200088|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200089|NCT00005041|Tipifarnib|tipifarnib|mesh-list
2200090|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200091|NCT00005042|Semaxinib|semaxinib|mesh-list
2200092|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2200093|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2200094|NCT00005042|Growth Substances|growth substances|mesh-ancestor
2200095|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715162|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2715189|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
2715190|NCT01593254|Dasatinib|dasatinib|mesh-list
2200096|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
2200097|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200098|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2200099|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200100|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715191|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715192|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2715193|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715194|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715195|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2715196|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2715197|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200101|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
2200102|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200103|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2200104|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2200105|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200106|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2715208|NCT01364597|Brivaracetam|brivaracetam|mesh-list
2715209|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
2715231|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
2715232|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2715233|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715258|NCT00943618|Bupropion|bupropion|mesh-list
2715259|NCT00943618|Varenicline|varenicline|mesh-list
2715260|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2715261|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
2715262|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2715263|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2715264|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2715265|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2715266|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715267|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
2715268|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2715269|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200107|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200108|NCT00005046|Paclitaxel|paclitaxel|mesh-list
2200109|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200110|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200111|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200112|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200113|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
2715270|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2200114|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200115|NCT00005048|Paclitaxel|paclitaxel|mesh-list
2200116|NCT00005048|Estramustine|estramustine|mesh-list
2200117|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200118|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200119|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200120|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200121|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200122|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200123|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200124|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
2200125|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2200126|NCT00005049|Carboplatin|carboplatin|mesh-list
2200127|NCT00005049|Floxuridine|floxuridine|mesh-list
2200128|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200129|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200130|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
2200131|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200132|NCT00005050|Fluorouracil|fluorouracil|mesh-list
2200133|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
2200134|NCT00005050|Eniluracil|eniluracil|mesh-list
2200135|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
2715271|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2715272|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715273|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2715274|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2715275|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
2715276|NCT00914823|Hormones|hormones|mesh-list
2715277|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2715278|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715279|NCT00529763|Dasatinib|dasatinib|mesh-list
2715280|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715281|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2200136|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200137|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200138|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200139|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200140|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
2715282|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715283|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200141|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200142|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200143|NCT00005051|Paclitaxel|paclitaxel|mesh-list
2200144|NCT00005051|Carboplatin|carboplatin|mesh-list
2200145|NCT00005051|Topotecan|topotecan|mesh-list
2200146|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200147|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200148|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200149|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200150|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200151|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200152|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2200153|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200154|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200155|NCT00005054|Temozolomide|temozolomide|mesh-list
2200156|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200157|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
2200158|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200159|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200160|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
2200161|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2200162|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
2200163|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200164|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200165|NCT00005057|Ganciclovir|ganciclovir|mesh-list
2200166|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2200167|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
2200168|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200169|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2200170|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200171|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200172|NCT00005059|Paclitaxel|paclitaxel|mesh-list
2200173|NCT00005059|Carboplatin|carboplatin|mesh-list
2200174|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200175|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200176|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200177|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200178|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200179|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200180|NCT00005060|Docetaxel|docetaxel|mesh-list
2200181|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200182|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200183|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200184|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200185|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200186|NCT00005061|Bevacizumab|bevacizumab|mesh-list
2200187|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2200188|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200189|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2200190|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2200191|NCT00005061|Growth Substances|growth substances|mesh-ancestor
2200192|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200193|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
2200194|NCT00005064|Bortezomib|bortezomib|mesh-list
2200195|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200196|NCT00005065|Paclitaxel|paclitaxel|mesh-list
2200197|NCT00005065|Carboplatin|carboplatin|mesh-list
2200198|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
2200199|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200200|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200201|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200202|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200203|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200204|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200205|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2200206|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
2200207|NCT00005066|Carmustine|carmustine|mesh-list
2200208|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2200209|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200210|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
2200211|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200212|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200213|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200214|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
2200215|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2200216|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
2200217|NCT00005068|Leucovorin|leucovorin|mesh-list
2200218|NCT00005068|Fluorouracil|fluorouracil|mesh-list
2200219|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
2200220|NCT00005068|Irinotecan|irinotecan|mesh-list
2200221|NCT00005068|Calcium|calcium|mesh-list
2200222|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
2200223|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2423764|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423765|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2423766|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
2423767|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2423768|NCT00823849|Protective Agents|protective agents|mesh-ancestor
2423769|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2423770|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2423771|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423772|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2423773|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2423774|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
2423775|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2715346|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2715347|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2715348|NCT05149898|Cannabidiol|cannabidiol|mesh-list
2715349|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
2715351|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2715352|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2715353|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715354|NCT05149638|Cosyntropin|cosyntropin|mesh-list
2715355|NCT05149638|Hormones|hormones|mesh-ancestor
2715356|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2715357|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715367|NCT05149378|Azacitidine|azacitidine|mesh-list
2715368|NCT05149378|Venetoclax|venetoclax|mesh-list
2715369|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2715370|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
2715371|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715372|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715373|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715384|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
2715385|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2715386|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200224|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200225|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
2200226|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715387|NCT05149339|Vitamins|vitamins|mesh-ancestor
2715388|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
2200227|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200228|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200229|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200230|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
2200231|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2200232|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200233|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200234|NCT00005068|Antidotes|antidotes|mesh-ancestor
2200235|NCT00005068|Protective Agents|protective agents|mesh-ancestor
2200236|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
2200237|NCT00005068|Vitamins|vitamins|mesh-ancestor
2715389|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2715390|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2715391|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
2715392|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200238|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
2200239|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
2200240|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200241|NCT00005070|Irofulven|irofulven|mesh-list
2200242|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200243|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
2200244|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200245|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200246|NCT00005072|Interleukin-2|interleukin-2|mesh-list
2200247|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200248|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2200249|NCT00005072|Analgesics|analgesics|mesh-ancestor
2200250|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
2200251|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2200252|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200253|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
2200254|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2200255|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200256|NCT00005074|Alvocidib|alvocidib|mesh-list
2200257|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200258|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
2200259|NCT00005074|Growth Substances|growth substances|mesh-ancestor
2715408|NCT05149248|Vaccines|vaccines|mesh-list
2715409|NCT05149248|Immunologic Factors|immunologic factors|mesh-ancestor
2715410|NCT05149248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715411|NCT05149170|Antibodies|antibodies|mesh-list
2715412|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2715413|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
2715414|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200260|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200261|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2200262|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200263|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200264|NCT00005076|Irinotecan|irinotecan|mesh-list
2200265|NCT00005076|Cetuximab|cetuximab|mesh-list
2200266|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2200267|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200268|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200269|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200270|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200271|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2715422|NCT05149092|Caseins|caseins|mesh-list
2715423|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
2715424|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
2715425|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715429|NCT05148910|Copper|copper|mesh-list
2715430|NCT05148910|Trace Elements|trace elements|mesh-ancestor
2715431|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
2715432|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715433|NCT05148884|Befiradol|befiradol|mesh-list
2715434|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2715435|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2715436|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
2715437|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2715438|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715439|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715440|NCT05148767|Irinotecan|irinotecan|mesh-list
2715441|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2715442|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2715443|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715444|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200272|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
2715445|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200273|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200274|NCT00005078|Paclitaxel|paclitaxel|mesh-list
2200275|NCT00005078|Carboplatin|carboplatin|mesh-list
2200276|NCT00005078|Tirapazamine|tirapazamine|mesh-list
2200277|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200278|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200279|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200280|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200281|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200282|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200283|NCT00005081|Carmustine|carmustine|mesh-list
2200284|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2200285|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200286|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
2200287|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200288|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200289|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200290|NCT00005086|Gemcitabine|gemcitabine|mesh-list
2200291|NCT00005086|Docetaxel|docetaxel|mesh-list
2200292|NCT00005086|Methotrexate|methotrexate|mesh-list
2200293|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200294|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200295|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
2200296|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200297|NCT00005086|Antiviral Agents|antiviral agents|mesh-ancestor
2200298|NCT00005086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200299|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200300|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200301|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
2200302|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200303|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200304|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200305|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200306|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2200307|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
2200308|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2200309|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
2715451|NCT05148715|Tacrolimus|tacrolimus|mesh-list
2715452|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2715453|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
2715454|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715455|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2715456|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715457|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715458|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2715459|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2715460|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2715461|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
2200310|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2200311|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200312|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2200313|NCT00005087|Paclitaxel|paclitaxel|mesh-list
2200314|NCT00005087|Cisplatin|cisplatin|mesh-list
2200315|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200316|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200317|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200318|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200319|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200320|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200321|NCT00005088|Cisplatin|cisplatin|mesh-list
2200322|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200323|NCT00005089|Prednisone|prednisone|mesh-list
2200324|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
2200325|NCT00005089|Rituximab|rituximab|mesh-list
2200326|NCT00005089|Doxorubicin|doxorubicin|mesh-list
2200327|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2200328|NCT00005089|Vincristine|vincristine|mesh-list
2200329|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200330|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
2200331|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200332|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200333|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2715462|NCT05148689|Phenylephrine|phenylephrine|mesh-list
2715463|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
2715464|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2715465|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2715466|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
2715467|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2715468|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715469|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715470|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
2715471|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
2715472|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2715473|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
2715474|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2715475|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
2715476|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2715477|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
2715478|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2715479|NCT05148689|Protective Agents|protective agents|mesh-ancestor
2715503|NCT05148546|Nivolumab|nivolumab|mesh-list
2715504|NCT05148546|Ipilimumab|ipilimumab|mesh-list
2715505|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2715506|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715507|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2715508|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715509|NCT05148442|Azacitidine|azacitidine|mesh-list
2715510|NCT05148442|Decitabine|decitabine|mesh-list
2715511|NCT05148442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2715512|NCT05148442|Antimetabolites|antimetabolites|mesh-ancestor
2715513|NCT05148442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715514|NCT05148442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715515|NCT05148442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715516|NCT05148403|Glyburide|glyburide|mesh-list
2715517|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2715518|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715524|NCT05148312|Budesonide|budesonide|mesh-list
2715525|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2715526|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2715527|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
2715528|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2715529|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200334|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
2200335|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200336|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200337|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2200338|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2200339|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2200340|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2715530|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2200341|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200342|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200343|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2200344|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
2200345|NCT00005089|Hormones|hormones|mesh-ancestor
2200346|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2200347|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2200348|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200349|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200350|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200351|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200352|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
2200353|NCT00005090|Dacarbazine|dacarbazine|mesh-list
2200354|NCT00005090|Carmustine|carmustine|mesh-list
2200355|NCT00005090|Doxorubicin|doxorubicin|mesh-list
2200356|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2200357|NCT00005090|Etoposide|etoposide|mesh-list
2200358|NCT00005090|Bleomycin|bleomycin|mesh-list
2200359|NCT00005090|Vinblastine|vinblastine|mesh-list
2200360|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200361|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
2200362|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200363|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200364|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200365|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
2200366|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200367|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200368|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2200369|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2200370|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2200371|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200372|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200373|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2715531|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
2715532|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
2715533|NCT05148312|Hormones|hormones|mesh-ancestor
2715534|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2715541|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
2715542|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2715543|NCT05148195|Leucovorin|leucovorin|mesh-list
2715544|NCT05148195|Docetaxel|docetaxel|mesh-list
2715545|NCT05148195|Irinotecan|irinotecan|mesh-list
2715546|NCT05148195|Calcium|calcium|mesh-list
2715547|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
2715548|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715549|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
2715550|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
2715551|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
2715552|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715553|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2715554|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715555|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2715556|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2715557|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715558|NCT05148195|Antidotes|antidotes|mesh-ancestor
2715559|NCT05148195|Protective Agents|protective agents|mesh-ancestor
2715560|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
2715561|NCT05148195|Vitamins|vitamins|mesh-ancestor
2715562|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
2715563|NCT05148169|Sulforaphane|sulforaphane|mesh-list
2715564|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2715565|NCT05148169|Protective Agents|protective agents|mesh-ancestor
2715566|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715567|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715568|NCT05148143|Raltitrexed|raltitrexed|mesh-list
2715569|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2715570|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
2715571|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715572|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200374|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
2715573|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2715574|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715578|NCT05148026|Heparin|heparin|mesh-list
2715579|NCT05148026|Calcium heparin|calcium heparin|mesh-list
2715580|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
2715581|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
2715582|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2715583|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2715584|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715585|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2715586|NCT05145400|Dexamethasone|dexamethasone|mesh-list
2715587|NCT05145400|Lenalidomide|lenalidomide|mesh-list
2715588|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2715589|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
2715590|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
2715591|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2715592|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715593|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2715594|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
2715595|NCT05145400|Hormones|hormones|mesh-ancestor
2715596|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2715597|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2200375|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200376|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200377|NCT00005091|Exatecan|exatecan|mesh-list
2200378|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2200379|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200380|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200381|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200382|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200383|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
2200384|NCT00005092|Thiotepa|thiotepa|mesh-list
2200385|NCT00005092|Methoxsalen|methoxsalen|mesh-list
2200386|NCT00005092|Furocoumarins|furocoumarins|mesh-list
2200387|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2715598|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715599|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
2715600|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2715601|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2715602|NCT05145400|Growth Substances|growth substances|mesh-ancestor
2715603|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
2715604|NCT05145218|Paclitaxel|paclitaxel|mesh-list
2715605|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2715606|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715607|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
2715608|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
2715609|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
2715610|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715611|NCT05138029|Dexamethasone|dexamethasone|mesh-list
2715612|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
2715613|NCT05138029|Ranibizumab|ranibizumab|mesh-list
2715614|NCT05138029|BB 1101|bb 1101|mesh-list
2715615|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2715616|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
2715617|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
2715618|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2715619|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715620|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2715621|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
2715622|NCT05138029|Hormones|hormones|mesh-ancestor
2715623|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2715624|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2715625|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715626|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
2715627|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715628|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715629|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2715630|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2715631|NCT05138029|Growth Substances|growth substances|mesh-ancestor
2715632|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
2715633|NCT05136040|Bupivacaine|bupivacaine|mesh-list
2200388|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
2715634|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
2715635|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
2715636|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2715637|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715638|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
2715639|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2715640|NCT05135650|Myeloma Proteins|myeloma proteins|mesh-list
2715641|NCT05135650|Paraproteins|paraproteins|mesh-list
2715642|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
2200389|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200390|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200391|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200392|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
2200393|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200394|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200395|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2200396|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2200397|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
2200398|NCT00005093|Gemcitabine|gemcitabine|mesh-list
2200399|NCT00005093|Tacedinaline|tacedinaline|mesh-list
2200400|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200401|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
2200402|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200403|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200404|NCT00005093|Antiviral Agents|antiviral agents|mesh-ancestor
2200405|NCT00005093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200406|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200407|NCT00005093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200408|NCT00005093|Immunologic Factors|immunologic factors|mesh-ancestor
2200409|NCT00005093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200410|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2200411|NCT00005094|Celecoxib|celecoxib|mesh-list
2200412|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2200413|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2200414|NCT00005094|Analgesics|analgesics|mesh-ancestor
2200415|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
2715643|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715644|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2715645|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2715646|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
2715647|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2715648|NCT05131061|Fludrocortisone|fludrocortisone|mesh-list
2715649|NCT05131061|Captopril|captopril|mesh-list
2715650|NCT05131061|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2715651|NCT05131061|Protease Inhibitors|protease inhibitors|mesh-ancestor
2715652|NCT05131061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715653|NCT05131061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715654|NCT05131061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2715655|NCT05131061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2715656|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
2715657|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2715658|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2715659|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715660|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
2715661|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2715662|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715663|NCT05124275|Pilocarpine|pilocarpine|mesh-list
2715664|NCT05124275|Miotics|miotics|mesh-ancestor
2715665|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
2715666|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2715667|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715668|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2715669|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2715670|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
2715671|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2715672|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715676|NCT05121974|Azithromycin|azithromycin|mesh-list
2200416|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2200417|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200418|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2200419|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200420|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2715677|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
2715678|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2715679|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2715680|NCT05121298|Upadacitinib|upadacitinib|mesh-list
2715681|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2715682|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2715683|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715684|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715685|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2715686|NCT05119920|Pilocarpine|pilocarpine|mesh-list
2715687|NCT05119920|Miotics|miotics|mesh-ancestor
2715688|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
2715689|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2715690|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715691|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2715692|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2715693|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
2715694|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2715695|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715718|NCT05103644|Atorvastatin|atorvastatin|mesh-list
2715719|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2715720|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2715721|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
2715722|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715723|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2715724|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2715725|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715726|NCT05100264|Acetic Acid|acetic acid|mesh-list
2200421|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2200422|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200423|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200424|NCT00005096|Docetaxel|docetaxel|mesh-list
2200425|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200426|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200427|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
2715727|NCT05100264|Retinol acetate|retinol acetate|mesh-list
2715728|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2715729|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200428|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200429|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200430|NCT00005104|Metformin|metformin|mesh-list
2200431|NCT00005104|Clomiphene|clomiphene|mesh-list
2200432|NCT00005104|Enclomiphene|enclomiphene|mesh-list
2715730|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2715731|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
2715732|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715733|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2715734|NCT05100264|Protective Agents|protective agents|mesh-ancestor
2715735|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200433|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
2200434|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2200435|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200436|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2200437|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
2200438|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2200439|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2715736|NCT05098210|Poly I-C|poly i-c|mesh-list
2715737|NCT05098210|Nivolumab|nivolumab|mesh-list
2715738|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2715739|NCT05098210|Poly ICLC|poly iclc|mesh-list
2715740|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2715741|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715742|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2715743|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715744|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
2715745|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
2715746|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715747|NCT05098210|Laxatives|laxatives|mesh-ancestor
2715748|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2715749|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
2715750|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2715751|NCT05084521|Famotidine|famotidine|mesh-list
2715752|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2715753|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2715754|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2715755|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
2715756|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
2715757|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2715758|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715759|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715766|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
2715767|NCT05078931|Lenvatinib|lenvatinib|mesh-list
2715768|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2715769|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715770|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2715771|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715772|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715773|NCT05078060|Vaccines|vaccines|mesh-list
2715774|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
2715775|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200440|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
2200441|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2200442|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2200443|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2200444|NCT00005106|Lamivudine|lamivudine|mesh-list
2200445|NCT00005106|Zidovudine|zidovudine|mesh-list
2200446|NCT00005106|Abacavir|abacavir|mesh-list
2200447|NCT00005106|Stavudine|stavudine|mesh-list
2200448|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2200449|NCT00005106|Nelfinavir|nelfinavir|mesh-list
2200450|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2200451|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2200452|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200453|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200454|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
2200455|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200456|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2200457|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2200458|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
2200459|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2200460|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2200461|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
2715830|NCT05029856|Vaccines|vaccines|mesh-list
2715831|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
2715832|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715876|NCT05012631|Losartan|losartan|mesh-list
2715877|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2715878|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2715879|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2715880|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2715881|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715888|NCT05008809|Leucovorin|leucovorin|mesh-list
2715889|NCT05008809|Fluorouracil|fluorouracil|mesh-list
2715890|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
2715891|NCT05008809|Irinotecan|irinotecan|mesh-list
2715892|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
2715893|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
2715894|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715895|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2715896|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715897|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2715898|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
2715899|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715900|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2715901|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2715902|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715903|NCT05008809|Antidotes|antidotes|mesh-ancestor
2715904|NCT05008809|Protective Agents|protective agents|mesh-ancestor
2200462|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2200463|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200464|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200465|NCT00005108|Estradiol|estradiol|mesh-list
2200466|NCT00005108|Progesterone|progesterone|mesh-list
2200467|NCT00005108|Estrogens|estrogens|mesh-ancestor
2200468|NCT00005108|Hormones|hormones|mesh-ancestor
2200469|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2200470|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200471|NCT00005108|Progestins|progestins|mesh-ancestor
2715905|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
2715906|NCT05008809|Vitamins|vitamins|mesh-ancestor
2715907|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
2715919|NCT04992260|Vaccines|vaccines|mesh-list
2715920|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
2715921|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715922|NCT04989491|Rituximab|rituximab|mesh-list
2715923|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2715924|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715925|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
2715926|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2715927|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2715928|NCT04989322|Carboplatin|carboplatin|mesh-list
2715929|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
2715930|NCT04989322|Pemetrexed|pemetrexed|mesh-list
2715931|NCT04989322|Lenvatinib|lenvatinib|mesh-list
2715932|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2715933|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2715934|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200472|NCT00005110|Albuterol|albuterol|mesh-list
2200473|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2200474|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2200475|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
2200476|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2200477|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200478|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2200479|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
2200480|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2200481|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2200482|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2200483|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
2200484|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2200485|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715935|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715936|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2715937|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2715938|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2715945|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2715946|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2715947|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2715948|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715959|NCT04935112|Pantoprazole|pantoprazole|mesh-list
2715960|NCT04935112|Famotidine|famotidine|mesh-list
2715961|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2715962|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2715963|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2715964|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2715965|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2715966|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2715967|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
2715968|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
2715969|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2200486|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
2200487|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2200488|NCT00005112|Hormones|hormones|mesh-list
2200489|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2200490|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200491|NCT00005113|Cyclosporine|cyclosporine|mesh-list
2200492|NCT00005113|Sirolimus|sirolimus|mesh-list
2200493|NCT00005113|Tacrolimus|tacrolimus|mesh-list
2200494|NCT00005113|Cyclosporins|cyclosporins|mesh-list
2200495|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200496|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
2200497|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200498|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2200499|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200500|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200501|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
2200502|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200503|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
2200504|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200505|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2200506|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2200507|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200508|NCT00005117|Pravastatin|pravastatin|mesh-list
2200509|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2200510|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2200511|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
2715970|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200512|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200513|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2200514|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2200515|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200516|NCT00005118|Ritonavir|ritonavir|mesh-list
2200517|NCT00005118|Indinavir|indinavir|mesh-list
2200518|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2200519|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2200520|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
2200521|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200522|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200523|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2200524|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2200525|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
2200526|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200527|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2200528|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2200529|NCT00005119|Calcium|calcium|mesh-list
2200530|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2200531|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200532|NCT00005120|Calanolide A|calanolide a|mesh-list
2200533|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2200534|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2200535|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
2200536|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200537|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2200538|NCT00005520|Candesartan|candesartan|mesh-list
2200539|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2200540|NCT00005520|Diuretics|diuretics|mesh-ancestor
2200541|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
2200542|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200543|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2200544|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2200545|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200546|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2200547|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2716013|NCT04931511|Betamethasone|betamethasone|mesh-list
2716014|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
2716015|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2716016|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
2716017|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2716018|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2716019|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
2716020|NCT04931511|Hormones|hormones|mesh-ancestor
2716021|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2716022|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716023|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2716024|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
2716025|NCT04929028|Fluorouracil|fluorouracil|mesh-list
2716026|NCT04929028|Capecitabine|capecitabine|mesh-list
2716027|NCT04929028|Nivolumab|nivolumab|mesh-list
2716028|NCT04929028|Mitomycins|mitomycins|mesh-list
2716029|NCT04929028|Mitomycin|mitomycin|mesh-list
2716030|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
2716031|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716032|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2716033|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716034|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2716035|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
2716036|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716037|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2716038|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2716039|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2716040|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
2716041|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2716042|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2716043|NCT04920942|Ivermectin|ivermectin|mesh-list
2716044|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2716045|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200548|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2200549|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
2200550|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
2200551|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2716079|NCT04905121|Psilocybin|psilocybin|mesh-list
2716080|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
2716081|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716082|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2716095|NCT04901754|Apatinib|apatinib|mesh-list
2716096|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716097|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2716098|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2716099|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200552|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200553|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2200554|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2200555|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2200556|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
2200557|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200558|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2200559|NCT00005571|Eculizumab|eculizumab|mesh-list
2200560|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2200561|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200562|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
2200563|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200564|NCT00005574|Gentamicins|gentamicins|mesh-list
2200565|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2200566|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200567|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2200568|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200569|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200570|NCT00005575|Imipramine|imipramine|mesh-list
2200571|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2200572|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
2200573|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2200574|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2200575|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2200576|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2200577|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200578|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
2200579|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2200580|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200581|NCT00005576|Aldesleukin|aldesleukin|mesh-list
2200582|NCT00005576|Interleukin-2|interleukin-2|mesh-list
2200583|NCT00005576|Dinutuximab|dinutuximab|mesh-list
2200584|NCT00005576|Isotretinoin|isotretinoin|mesh-list
2200585|NCT00005576|Antibodies|antibodies|mesh-list
2200586|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2200587|NCT00005576|Sargramostim|sargramostim|mesh-list
2200588|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
2200589|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200590|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716152|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
2716153|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
2716154|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2716155|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716159|NCT04848753|Paclitaxel|paclitaxel|mesh-list
2716160|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2716161|NCT04848753|Cisplatin|cisplatin|mesh-list
2716162|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2716163|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716164|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
2716165|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
2716166|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
2716167|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716168|NCT04848480|Insulin|insulin|mesh-list
2716169|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2716170|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
2716171|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2716172|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716187|NCT04804709|Panobinostat|panobinostat|mesh-list
2716188|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716189|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2200591|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2716190|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2716191|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200592|NCT00005576|Analgesics|analgesics|mesh-ancestor
2200593|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
2200594|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2200595|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2200596|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2200597|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
2200598|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200599|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
2200600|NCT00005577|Gemcitabine|gemcitabine|mesh-list
2200601|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200602|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
2200603|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200604|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200605|NCT00005577|Antiviral Agents|antiviral agents|mesh-ancestor
2200606|NCT00005577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200607|NCT00005577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200608|NCT00005577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200609|NCT00005577|Immunologic Factors|immunologic factors|mesh-ancestor
2200610|NCT00005577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200611|NCT00005578|Prednisone|prednisone|mesh-list
2200612|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
2200613|NCT00005578|Doxorubicin|doxorubicin|mesh-list
2200614|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2200615|NCT00005578|Etoposide|etoposide|mesh-list
2200616|NCT00005578|Vincristine|vincristine|mesh-list
2200617|NCT00005578|Bleomycin|bleomycin|mesh-list
2200618|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
2200619|NCT00005578|Razoxane|razoxane|mesh-list
2200620|NCT00005578|Lenograstim|lenograstim|mesh-list
2200621|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200622|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
2200623|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200624|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200625|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200626|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
2200627|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200628|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423776|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
2423777|NCT00823862|Ribavirin|ribavirin|mesh-list
2423778|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
2423779|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423780|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
2423781|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423782|NCT00823875|Cilostazol|cilostazol|mesh-list
2423783|NCT00823875|Probucol|probucol|mesh-list
2423784|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2423785|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
2423786|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423787|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423788|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2423789|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
2423790|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2423791|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2200629|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2200630|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2200631|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2200632|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200633|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200634|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2200635|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
2200636|NCT00005578|Hormones|hormones|mesh-ancestor
2200637|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2200638|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2200639|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200640|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2200641|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200642|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200643|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200644|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2200645|NCT00005578|Protective Agents|protective agents|mesh-ancestor
2200646|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
2200647|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200648|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200649|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200650|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200651|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200652|NCT00005580|Fludarabine|fludarabine|mesh-list
2200653|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
2200654|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
2200655|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200656|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200657|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
2716360|NCT04731103|Lamivudine|lamivudine|mesh-list
2716361|NCT04731103|Zidovudine|zidovudine|mesh-list
2716362|NCT04731103|Abacavir|abacavir|mesh-list
2716363|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
2716364|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2716365|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2716366|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2716367|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716368|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
2716369|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2716370|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2716371|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2716372|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
2200658|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200659|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200660|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
2200661|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200662|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2716396|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
2716397|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2716398|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716399|NCT04690673|Acetaminophen|acetaminophen|mesh-list
2716400|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2716401|NCT04690673|Analgesics|analgesics|mesh-ancestor
2716402|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
2716403|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2716404|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200663|NCT00005581|Paclitaxel|paclitaxel|mesh-list
2200664|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
2200665|NCT00005581|Fluorouracil|fluorouracil|mesh-list
2200666|NCT00005581|Epirubicin|epirubicin|mesh-list
2200667|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2716405|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
2716415|NCT04682288|Levofloxacin|levofloxacin|mesh-list
2716416|NCT04682288|Ofloxacin|ofloxacin|mesh-list
2716417|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2716418|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2716419|NCT04682288|Renal Agents|renal agents|mesh-ancestor
2716420|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2716421|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2716422|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2716423|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2716424|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716425|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716426|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2716427|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2716430|NCT04675866|Paclitaxel|paclitaxel|mesh-list
2716431|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2716432|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2716433|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716434|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
2716435|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
2716436|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
2716437|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716444|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2200668|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200669|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200670|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200671|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200672|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200673|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200674|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
2200675|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200676|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200677|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200678|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
2716476|NCT04618744|Insulin|insulin|mesh-list
2716477|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2716478|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2716479|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716488|NCT04608409|Paclitaxel|paclitaxel|mesh-list
2716489|NCT04608409|Lapatinib|lapatinib|mesh-list
2716490|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2716491|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716492|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
2716493|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
2716494|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
2716495|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716496|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2716497|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2716498|NCT04606797|Nicotine|nicotine|mesh-list
2716499|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2716500|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
2716501|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2716502|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716503|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2716504|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2716505|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
2716506|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2716507|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716508|NCT04606576|Insulin|insulin|mesh-list
2716509|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2716510|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2716511|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200679|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2200680|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
2200681|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200682|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2200683|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2200684|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200685|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200686|NCT00005583|Doxorubicin|doxorubicin|mesh-list
2200687|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2200688|NCT00005583|Epirubicin|epirubicin|mesh-list
2200689|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200690|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2200691|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2200692|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200693|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200694|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200695|NCT00005584|Prednisone|prednisone|mesh-list
2200696|NCT00005584|Epirubicin|epirubicin|mesh-list
2200697|NCT00005584|Bleomycin|bleomycin|mesh-list
2200698|NCT00005584|Vinblastine|vinblastine|mesh-list
2200699|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2200700|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
2716517|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
2716518|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2716519|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716520|NCT04580992|Ajmaline|ajmaline|mesh-list
2716521|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2716522|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2200701|NCT00005584|Hormones|hormones|mesh-ancestor
2716523|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2716524|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2716525|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716533|NCT04572451|Nivolumab|nivolumab|mesh-list
2716534|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2716535|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716536|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2716537|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716563|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
2716564|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716565|NCT04554732|Mitogens|mitogens|mesh-list
2716566|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
2716567|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716568|NCT04544111|Trametinib|trametinib|mesh-list
2716569|NCT04544111|Dabrafenib|dabrafenib|mesh-list
2716570|NCT04544111|Spartalizumab|spartalizumab|mesh-list
2716571|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716572|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2716573|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2716574|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716575|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2716576|NCT04536467|Goserelin|goserelin|mesh-list
2716577|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2716578|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716579|NCT04530981|Repaglinide|repaglinide|mesh-list
2716580|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2716581|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716589|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
2716590|NCT04523480|Testosterone|testosterone|mesh-list
2716591|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
2716592|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
2716593|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2716594|NCT04523480|Androgens|androgens|mesh-ancestor
2716595|NCT04523480|Hormones|hormones|mesh-ancestor
2716596|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2716597|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716598|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2716599|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716600|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
2716609|NCT04500548|Nivolumab|nivolumab|mesh-list
2716610|NCT04500548|Ipilimumab|ipilimumab|mesh-list
2716611|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2716612|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716613|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2716614|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716615|NCT04469634|Antibodies|antibodies|mesh-list
2716616|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
2716617|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716618|NCT04455178|Indapamide|indapamide|mesh-list
2716619|NCT04455178|Spironolactone|spironolactone|mesh-list
2716620|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2716621|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
2716622|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2716623|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716624|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2716625|NCT04455178|Diuretics|diuretics|mesh-ancestor
2716626|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
2716627|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2716628|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2716629|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2716630|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716631|NCT04454658|Navitoclax|navitoclax|mesh-list
2716632|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200702|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2200703|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200704|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2200705|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200706|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2200707|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2200708|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200709|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200710|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200711|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200712|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200713|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200714|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200715|NCT00005585|Leucovorin|leucovorin|mesh-list
2200716|NCT00005585|Cytarabine|cytarabine|mesh-list
2200717|NCT00005585|Dexamethasone|dexamethasone|mesh-list
2200718|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
2200719|NCT00005585|Methotrexate|methotrexate|mesh-list
2200720|NCT00005585|Vincristine|vincristine|mesh-list
2200721|NCT00005585|Daunorubicin|daunorubicin|mesh-list
2716700|NCT04400110|Amoxicillin|amoxicillin|mesh-list
2716701|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
2716702|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
2716703|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2716704|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2716705|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2716706|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716707|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2716717|NCT04388501|Atorvastatin|atorvastatin|mesh-list
2716718|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2716719|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2716720|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
2716721|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716722|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2716723|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2716724|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200722|NCT00005585|Asparaginase|asparaginase|mesh-list
2716739|NCT04358393|Azacitidine|azacitidine|mesh-list
2716740|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2716741|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
2716742|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716743|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716744|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2716745|NCT04356339|Interferons|interferons|mesh-list
2716746|NCT04356339|Interferon-beta|interferon-beta|mesh-list
2716747|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
2716748|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716749|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
2716750|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2716751|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
2716752|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716753|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2716759|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
2716760|NCT04308837|Promethazine|promethazine|mesh-list
2716761|NCT04308837|Dexamethasone|dexamethasone|mesh-list
2716762|NCT04308837|Paclitaxel|paclitaxel|mesh-list
2716763|NCT04308837|Carboplatin|carboplatin|mesh-list
2716764|NCT04308837|Palonosetron|palonosetron|mesh-list
2716765|NCT04308837|Famotidine|famotidine|mesh-list
2716766|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2716767|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716768|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
2716769|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
2716770|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
2716771|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716772|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2716773|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
2716774|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
2200723|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
2200724|NCT00005585|Thioguanine|thioguanine|mesh-list
2200725|NCT00005585|Pegaspargase|pegaspargase|mesh-list
2200726|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
2200727|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200728|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
2200729|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200730|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200731|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2716775|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2716776|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716777|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2423792|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423793|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2423794|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
2423795|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2423796|NCT00823875|Protective Agents|protective agents|mesh-ancestor
2423797|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2423798|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2423799|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423800|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2423801|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2423802|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
2423803|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2423804|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
2423805|NCT00823940|Glucagon|glucagon|mesh-list
2423806|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2423807|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2423808|NCT00823940|Hormones|hormones|mesh-ancestor
2423809|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2423810|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423811|NCT00823940|Incretins|incretins|mesh-ancestor
2200732|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
2423812|NCT00824057|Midazolam|midazolam|mesh-list
2716778|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
2716779|NCT04308837|Hormones|hormones|mesh-ancestor
2716780|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2716781|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2716782|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2716783|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2716784|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2716785|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
2716786|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
2716787|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
2716788|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2716789|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
2716790|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
2716791|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2716792|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2716793|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
2716794|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
2716795|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2716796|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2716797|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
2716798|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2716799|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2716808|NCT04303702|Oxytocin|oxytocin|mesh-list
2716809|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
2716810|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2716811|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716812|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
2716813|NCT04303000|Naloxone|naloxone|mesh-list
2716814|NCT04303000|Narcotics|narcotics|mesh-ancestor
2716815|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2716816|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716817|NCT04303000|Analgesics|analgesics|mesh-ancestor
2716818|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
2716819|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2716820|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2716821|NCT04298034|Labetalol|labetalol|mesh-list
2716822|NCT04298034|Nifedipine|nifedipine|mesh-list
2716823|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2716824|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2716825|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716826|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2200733|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200734|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200735|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2200736|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2200737|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
2200738|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
2200739|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2200740|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2200741|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
2200742|NCT00005585|Hormones|hormones|mesh-ancestor
2200743|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2200744|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2200745|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2200746|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
2200747|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2200748|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2716827|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716828|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
2716829|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
2716830|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2716831|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2716832|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2716833|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
2716834|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2716835|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2716836|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
2716837|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
2716838|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2716839|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2716840|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2200749|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
2200750|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
2200751|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200752|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2200753|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2200754|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
2200755|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200756|NCT00005585|Antidotes|antidotes|mesh-ancestor
2200757|NCT00005585|Protective Agents|protective agents|mesh-ancestor
2200758|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
2200759|NCT00005585|Vitamins|vitamins|mesh-ancestor
2200760|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
2200761|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200762|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200763|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200764|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200765|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2200766|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2200767|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200768|NCT00005586|Leucovorin|leucovorin|mesh-list
2200769|NCT00005586|Fluorouracil|fluorouracil|mesh-list
2200770|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
2200771|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
2200772|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200773|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200774|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200775|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200776|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
2200777|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200778|NCT00005586|Antidotes|antidotes|mesh-ancestor
2200779|NCT00005586|Protective Agents|protective agents|mesh-ancestor
2200780|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
2200781|NCT00005586|Vitamins|vitamins|mesh-ancestor
2200782|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
2200783|NCT00005589|Cytarabine|cytarabine|mesh-list
2200784|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
2200785|NCT00005589|Melphalan|melphalan|mesh-list
2200786|NCT00005589|Carmustine|carmustine|mesh-list
2200787|NCT00005589|Rituximab|rituximab|mesh-list
2200788|NCT00005589|Etoposide|etoposide|mesh-list
2200789|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200790|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
2716896|NCT04254549|Rifaximin|rifaximin|mesh-list
2200791|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200792|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200793|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200794|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
2200795|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200796|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200797|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2200798|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2200799|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200800|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2200801|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200802|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2716897|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2716898|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2716899|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2716900|NCT04252287|Canagliflozin|canagliflozin|mesh-list
2716901|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2716902|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716903|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2716904|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200803|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200804|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
2200805|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
2200806|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200807|NCT00005590|Levofloxacin|levofloxacin|mesh-list
2200808|NCT00005590|Ofloxacin|ofloxacin|mesh-list
2200809|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2200810|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200811|NCT00005590|Renal Agents|renal agents|mesh-ancestor
2200812|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2200813|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2200814|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200815|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200816|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200817|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200818|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2200819|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2200820|NCT00005591|Gemcitabine|gemcitabine|mesh-list
2200821|NCT00005591|Cetuximab|cetuximab|mesh-list
2200822|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200823|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
2200824|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200825|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200826|NCT00005591|Antiviral Agents|antiviral agents|mesh-ancestor
2200827|NCT00005591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200828|NCT00005591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200829|NCT00005591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200830|NCT00005591|Immunologic Factors|immunologic factors|mesh-ancestor
2200831|NCT00005591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200832|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2200833|NCT00005592|Rituximab|rituximab|mesh-list
2200834|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2200835|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2200836|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200837|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
2200838|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200839|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200840|NCT00005593|Carboplatin|carboplatin|mesh-list
2200841|NCT00005593|Fludarabine|fludarabine|mesh-list
2200842|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
2200843|NCT00005593|Topotecan|topotecan|mesh-list
2200844|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200845|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200846|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
2200847|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200848|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200849|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
2200850|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200851|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2200852|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200853|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200854|NCT00005595|Arsenic Trioxide|arsenic trioxide|mesh-list
2200855|NCT00005595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200856|NCT00005596|Leucovorin|leucovorin|mesh-list
2200857|NCT00005596|Cytarabine|cytarabine|mesh-list
2200858|NCT00005596|Dexamethasone|dexamethasone|mesh-list
2200859|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
2200860|NCT00005596|Methotrexate|methotrexate|mesh-list
2716924|NCT04231318|Triamcinolone|triamcinolone|mesh-list
2716925|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2716926|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2716927|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2716928|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2716929|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
2716930|NCT04231318|Hormones|hormones|mesh-ancestor
2716931|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2716932|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716933|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2716934|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
2716935|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2716936|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716937|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
2716938|NCT04225078|Loperamide|loperamide|mesh-list
2716939|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
2716940|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2716941|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2716942|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2716943|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2716944|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2716945|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2716946|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2716947|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2200861|NCT00005596|Vincristine|vincristine|mesh-list
2200862|NCT00005596|Daunorubicin|daunorubicin|mesh-list
2200863|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
2200864|NCT00005596|Thioguanine|thioguanine|mesh-list
2200865|NCT00005596|Pegaspargase|pegaspargase|mesh-list
2200866|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
2200867|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200868|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
2200869|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200870|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200871|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200872|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
2200873|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200874|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200875|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2200876|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2200877|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
2200878|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
2200879|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2200880|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2200881|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
2200882|NCT00005596|Hormones|hormones|mesh-ancestor
2200883|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2200884|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2200885|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2200886|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
2200887|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2200888|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200889|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
2200890|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
2200891|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200892|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2200893|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2200894|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
2200895|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200896|NCT00005596|Antidotes|antidotes|mesh-ancestor
2200897|NCT00005596|Protective Agents|protective agents|mesh-ancestor
2200898|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
2200899|NCT00005596|Vitamins|vitamins|mesh-ancestor
2200900|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
2200901|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200902|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200903|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200904|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200905|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2200906|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2200907|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200908|NCT00005597|Temozolomide|temozolomide|mesh-list
2200909|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200910|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
2200911|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200912|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200913|NCT00005598|Azacitidine|azacitidine|mesh-list
2200914|NCT00005598|Amifostine|amifostine|mesh-list
2200915|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200916|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
2200917|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200918|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200919|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200920|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2200921|NCT00005598|Protective Agents|protective agents|mesh-ancestor
2200922|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2716956|NCT04198649|Azithromycin|azithromycin|mesh-list
2716957|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2716958|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200923|NCT00005599|Paclitaxel|paclitaxel|mesh-list
2200924|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
2200925|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2200926|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200927|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
2200928|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
2200929|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
2200930|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200931|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2200932|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
2200933|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200934|NCT00005601|Cytarabine|cytarabine|mesh-list
2200935|NCT00005601|Dexamethasone|dexamethasone|mesh-list
2200936|NCT00005601|Rituximab|rituximab|mesh-list
2200937|NCT00005601|Sargramostim|sargramostim|mesh-list
2200938|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200939|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2200940|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
2200941|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
2716998|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2716999|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717000|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717001|NCT04180813|Linagliptin|linagliptin|mesh-list
2717002|NCT04180813|Acarbose|acarbose|mesh-list
2717003|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2717004|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717005|NCT04180813|Incretins|incretins|mesh-ancestor
2717006|NCT04180813|Hormones|hormones|mesh-ancestor
2717007|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2200942|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2200943|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200944|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2200945|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
2200946|NCT00005601|Hormones|hormones|mesh-ancestor
2200947|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2200948|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2200949|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2717008|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2717009|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
2717010|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717011|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717012|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2717013|NCT04177654|Albendazole|albendazole|mesh-list
2717014|NCT04177654|Mebendazole|mebendazole|mesh-list
2717015|NCT04177654|Benzimidazole|benzimidazole|mesh-list
2717016|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
2717017|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2717018|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2717019|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
2717020|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2717021|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2717022|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
2717023|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
2717024|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
2717025|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717026|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717027|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
2717030|NCT04172402|Gemcitabine|gemcitabine|mesh-list
2717031|NCT04172402|Nivolumab|nivolumab|mesh-list
2717032|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2717033|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
2717034|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717035|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717036|NCT04172402|Antiviral Agents|antiviral agents|mesh-ancestor
2717037|NCT04172402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2717038|NCT04172402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717039|NCT04172402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2717040|NCT04172402|Immunologic Factors|immunologic factors|mesh-ancestor
2717041|NCT04172402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200950|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
2200951|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200952|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200953|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
2200954|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717042|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2717043|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2717052|NCT04111419|Amlodipine|amlodipine|mesh-list
2717053|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
2717054|NCT04111419|Atorvastatin|atorvastatin|mesh-list
2717055|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2717056|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2717057|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
2717058|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717059|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2717060|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2717061|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717062|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2717063|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2717064|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2717065|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2717066|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717067|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
2200955|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
2200956|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2200957|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200958|NCT00005602|Carboplatin|carboplatin|mesh-list
2200959|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200960|NCT00005603|Cytarabine|cytarabine|mesh-list
2200961|NCT00005603|Dexamethasone|dexamethasone|mesh-list
2717089|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2717090|NCT04071613|Plasminogen|plasminogen|mesh-list
2717091|NCT04071613|Tenecteplase|tenecteplase|mesh-list
2717092|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2717093|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2717094|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717095|NCT04062708|Durvalumab|durvalumab|mesh-list
2717096|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2717097|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717101|NCT04040231|Nivolumab|nivolumab|mesh-list
2717102|NCT04040231|Sargramostim|sargramostim|mesh-list
2717103|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2717104|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717105|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2717106|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717107|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
2717108|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200962|NCT00005603|Prednisone|prednisone|mesh-list
2200963|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
2200964|NCT00005603|Doxorubicin|doxorubicin|mesh-list
2200965|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2200966|NCT00005603|Methotrexate|methotrexate|mesh-list
2200967|NCT00005603|Vincristine|vincristine|mesh-list
2200968|NCT00005603|Daunorubicin|daunorubicin|mesh-list
2200969|NCT00005603|Asparaginase|asparaginase|mesh-list
2200970|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
2200971|NCT00005603|Thioguanine|thioguanine|mesh-list
2200972|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2200973|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
2200974|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2200975|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2200976|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2200977|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
2200978|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2200979|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2200980|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2200981|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2200982|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
2200983|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
2200984|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2200985|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2200986|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
2200987|NCT00005603|Hormones|hormones|mesh-ancestor
2423813|NCT00824057|Caffeine|caffeine|mesh-list
2423814|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2423815|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2423816|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423817|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423818|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2423819|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2423820|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2423821|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2423822|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
2423823|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
2423824|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
2717119|NCT04030026|Nalbuphine|nalbuphine|mesh-list
2717120|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2717121|NCT04030026|Narcotics|narcotics|mesh-ancestor
2717122|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2717123|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717124|NCT04030026|Analgesics|analgesics|mesh-ancestor
2717125|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
2717126|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2717127|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
2717128|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2717129|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
2717130|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717131|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
2717132|NCT04026191|Protective Agents|protective agents|mesh-ancestor
2200988|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2200989|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2200990|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2200991|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2200992|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2200993|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2200994|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2200995|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
2200996|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2200997|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2200998|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
2200999|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
2201000|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2201001|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2201002|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
2201003|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201004|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201005|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201006|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201007|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201008|NCT00005604|Aldesleukin|aldesleukin|mesh-list
2717138|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
2717139|NCT04006769|Entacapone|entacapone|mesh-list
2717140|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717141|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2717142|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717143|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717144|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2717145|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2717146|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2717147|NCT03971253|Peficitinib|peficitinib|mesh-list
2717148|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717149|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201009|NCT00005604|Interleukin-2|interleukin-2|mesh-list
2201010|NCT00005604|Interleukin-12|interleukin-12|mesh-list
2201011|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201012|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2201013|NCT00005604|Analgesics|analgesics|mesh-ancestor
2201014|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
2201015|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2201016|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201017|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2201018|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2201019|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
2201020|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201021|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2201022|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
2201023|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2201024|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2201025|NCT00005604|Growth Substances|growth substances|mesh-ancestor
2201026|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
2201027|NCT00005607|Leucovorin|leucovorin|mesh-list
2201028|NCT00005607|Fluorouracil|fluorouracil|mesh-list
2201029|NCT00005607|Irinotecan|irinotecan|mesh-list
2201030|NCT00005607|Calcium|calcium|mesh-list
2201031|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
2201032|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2201033|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201034|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
2201035|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201036|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201037|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201038|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201039|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
2201040|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2201041|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201042|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201043|NCT00005607|Antidotes|antidotes|mesh-ancestor
2201044|NCT00005607|Protective Agents|protective agents|mesh-ancestor
2201045|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
2201046|NCT00005607|Vitamins|vitamins|mesh-ancestor
2201047|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
2201048|NCT00005608|Leucovorin|leucovorin|mesh-list
2201049|NCT00005608|Tegafur|tegafur|mesh-list
2201050|NCT00005608|Calcium|calcium|mesh-list
2201051|NCT00005608|Levoleucovorin|levoleucovorin|mesh-list
2201052|NCT00005608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2201053|NCT00005608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201054|NCT00005608|Antidotes|antidotes|mesh-ancestor
2201055|NCT00005608|Protective Agents|protective agents|mesh-ancestor
2201056|NCT00005608|Vitamin B Complex|vitamin b complex|mesh-ancestor
2201057|NCT00005608|Vitamins|vitamins|mesh-ancestor
2201058|NCT00005608|Micronutrients|micronutrients|mesh-ancestor
2201059|NCT00005608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201060|NCT00005608|Antimetabolites|antimetabolites|mesh-ancestor
2201061|NCT00005608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201062|NCT00005608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201063|NCT00005609|Rituximab|rituximab|mesh-list
2201064|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2201065|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201066|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
2201067|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201068|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201069|NCT00005610|Sargramostim|sargramostim|mesh-list
2201070|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
2201071|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201072|NCT00005612|Paclitaxel|paclitaxel|mesh-list
2201073|NCT00005612|Etoposide|etoposide|mesh-list
2717150|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2717151|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
2717152|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717153|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
2717154|NCT03970746|Pemetrexed|pemetrexed|mesh-list
2717155|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2717156|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717157|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717158|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717159|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2717160|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2717161|NCT03969420|Cytarabine|cytarabine|mesh-list
2717162|NCT03969420|Alvocidib|alvocidib|mesh-list
2717163|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2717164|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
2201074|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
2201075|NCT00005612|Carboplatin|carboplatin|mesh-list
2201076|NCT00005612|Topotecan|topotecan|mesh-list
2201077|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201078|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201079|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201080|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201081|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201082|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201083|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201084|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
2201085|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201086|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201087|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201088|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
2201089|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2717165|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717166|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201090|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2201091|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201092|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201093|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2201094|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
2201095|NCT00005613|Carmustine|carmustine|mesh-list
2201096|NCT00005613|Etoposide|etoposide|mesh-list
2201097|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201098|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
2201099|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201100|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201101|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201102|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
2201103|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201104|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201105|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2201106|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201107|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2201108|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201109|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201110|NCT00005614|Gemcitabine|gemcitabine|mesh-list
2201111|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2717167|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
2717168|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2717169|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2717170|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
2717171|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717172|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
2717173|NCT03969420|Growth Substances|growth substances|mesh-ancestor
2717174|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2717175|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717176|NCT03962894|Prednisolone|prednisolone|mesh-list
2717177|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2717178|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
2717179|NCT03962894|Hormones|hormones|mesh-ancestor
2717180|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2717181|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717182|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2717183|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201112|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
2201113|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201114|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201115|NCT00005614|Antiviral Agents|antiviral agents|mesh-ancestor
2201116|NCT00005614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201117|NCT00005614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201118|NCT00005614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201119|NCT00005614|Immunologic Factors|immunologic factors|mesh-ancestor
2201120|NCT00005614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201121|NCT00005615|Interferons|interferons|mesh-list
2201122|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
2201123|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201124|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
2201125|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201126|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
2201127|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201128|NCT00005616|Antibodies|antibodies|mesh-list
2201129|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2201130|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
2201131|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201132|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
2201133|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201134|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
2201135|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201136|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
2201137|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201138|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201139|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201140|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
2201141|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201142|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201143|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2201144|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
2201145|NCT00005623|Cyproterone|cyproterone|mesh-list
2201146|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
2201147|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
2201148|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2201149|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201150|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201151|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2201152|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
2201153|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2201154|NCT00005624|Tacedinaline|tacedinaline|mesh-list
2201155|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2201156|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201157|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201158|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201159|NCT00005625|Trabectedin|trabectedin|mesh-list
2201160|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2717227|NCT03917472|Aflibercept|aflibercept|mesh-list
2717228|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2717229|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2717230|NCT03917472|Growth Substances|growth substances|mesh-ancestor
2717231|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717232|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
2717233|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717234|NCT03916627|Cemiplimab|cemiplimab|mesh-list
2717235|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2717236|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201161|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
2201162|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201163|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201164|NCT00005626|Irinotecan|irinotecan|mesh-list
2201165|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2201166|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201167|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201168|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201169|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201170|NCT00005627|Carboplatin|carboplatin|mesh-list
2201171|NCT00005627|Docetaxel|docetaxel|mesh-list
2201172|NCT00005627|Estramustine|estramustine|mesh-list
2201173|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201174|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201175|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201176|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201177|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201178|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201179|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
2201180|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2201181|NCT00005630|Sargramostim|sargramostim|mesh-list
2201182|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
2201183|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201184|NCT00005631|Rituximab|rituximab|mesh-list
2201185|NCT00005631|Carboplatin|carboplatin|mesh-list
2201186|NCT00005631|Etoposide|etoposide|mesh-list
2201187|NCT00005631|Ifosfamide|ifosfamide|mesh-list
2201188|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2201189|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201190|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
2201191|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201192|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201193|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201194|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2201195|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201196|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201197|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201198|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201199|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
2717383|NCT03893318|Lidocaine|lidocaine|mesh-list
2717384|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
2717385|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
2717386|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2717387|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717388|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
2717389|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2717390|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2717391|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2717392|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2717393|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2717394|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717413|NCT03832010|Triamcinolone|triamcinolone|mesh-list
2717414|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
2717415|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2717416|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
2717417|NCT03832010|Hormones|hormones|mesh-ancestor
2717418|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2717419|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717420|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2717421|NCT03817125|Vancomycin|vancomycin|mesh-list
2717422|NCT03817125|Nivolumab|nivolumab|mesh-list
2717423|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2717424|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717425|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2717426|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717427|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201200|NCT00005634|Vorinostat|vorinostat|mesh-list
2201201|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201202|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2201203|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201204|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201205|NCT00005635|Paclitaxel|paclitaxel|mesh-list
2201206|NCT00005635|Trastuzumab|trastuzumab|mesh-list
2201207|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201208|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201209|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201210|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201211|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201212|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201213|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2201214|NCT00005636|Pemetrexed|pemetrexed|mesh-list
2201215|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201216|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201217|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201218|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2201219|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2201220|NCT00005637|Temozolomide|temozolomide|mesh-list
2201221|NCT00005637|Carmustine|carmustine|mesh-list
2201222|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201223|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
2201224|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201225|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201226|NCT00005638|Irinotecan|irinotecan|mesh-list
2201227|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201228|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2201229|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201230|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201231|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201232|NCT00005639|Azacitidine|azacitidine|mesh-list
2201233|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2201234|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201235|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
2201236|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201237|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201238|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201239|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2201240|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2201241|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201242|NCT00005641|Leucovorin|leucovorin|mesh-list
2201243|NCT00005641|Cyclosporine|cyclosporine|mesh-list
2201244|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
2201245|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
2201246|NCT00005641|Busulfan|busulfan|mesh-list
2201247|NCT00005641|Methotrexate|methotrexate|mesh-list
2201248|NCT00005641|Cyclosporins|cyclosporins|mesh-list
2201249|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2201250|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
2201251|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201252|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
2201253|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201254|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201255|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2717474|NCT03783026|Apremilast|apremilast|mesh-list
2717475|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2717476|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2717477|NCT03783026|Analgesics|analgesics|mesh-ancestor
2717478|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
2717479|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2717480|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717481|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2717482|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2717483|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2717484|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2717485|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717486|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717508|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
2717509|NCT03740009|Estrogens|estrogens|mesh-list
2717510|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2717511|NCT03740009|Hormones|hormones|mesh-ancestor
2717512|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2717513|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717514|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2717515|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2717516|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
2717517|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2717518|NCT03733132|Metformin|metformin|mesh-list
2717519|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2717520|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201256|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
2201257|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201258|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201259|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2201260|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2201261|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
2201262|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2717538|NCT03691974|Fasinumab|fasinumab|mesh-list
2717539|NCT03691974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2717540|NCT03691974|Analgesics|analgesics|mesh-ancestor
2717541|NCT03691974|Sensory System Agents|sensory system agents|mesh-ancestor
2717542|NCT03691974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2717543|NCT03691974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717551|NCT03625466|Ivacaftor|ivacaftor|mesh-list
2717552|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2717553|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2717554|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717555|NCT03605719|Dexamethasone|dexamethasone|mesh-list
2717556|NCT03605719|Nivolumab|nivolumab|mesh-list
2717557|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2717558|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
2717559|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
2717560|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2717561|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717562|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2717563|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
2717564|NCT03605719|Hormones|hormones|mesh-ancestor
2717565|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2717566|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2717567|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717568|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2717569|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2717570|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201263|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201264|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
2201265|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
2201266|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201267|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2201268|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2201269|NCT00005641|Antidotes|antidotes|mesh-ancestor
2201270|NCT00005641|Protective Agents|protective agents|mesh-ancestor
2201271|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
2201272|NCT00005641|Vitamins|vitamins|mesh-ancestor
2201273|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
2201274|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
2201275|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201276|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2201277|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2201278|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
2201279|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
2201280|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2201281|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2201282|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
2201283|NCT00005641|Hormones|hormones|mesh-ancestor
2201284|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2201285|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2201286|NCT00005642|Semaxinib|semaxinib|mesh-list
2717616|NCT03529890|Nivolumab|nivolumab|mesh-list
2717617|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2717618|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717619|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2717620|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201287|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2201288|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2201289|NCT00005642|Growth Substances|growth substances|mesh-ancestor
2201290|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201291|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
2201292|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201293|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2201294|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201295|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201296|NCT00005643|Doxorubicin|doxorubicin|mesh-list
2201297|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2201298|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2201299|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717636|NCT03476239|Blinatumomab|blinatumomab|mesh-list
2717637|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717638|NCT03451799|Temozolomide|temozolomide|mesh-list
2717639|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2717640|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
2717641|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717642|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717643|NCT03436862|Nivolumab|nivolumab|mesh-list
2717644|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2717645|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717646|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2717647|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717648|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
2717649|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
2717650|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2717651|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2717652|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2717653|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717654|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717655|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2717656|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
2717657|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
2717658|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2717659|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2717660|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2201300|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2201301|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201302|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201303|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201304|NCT00005644|Gemcitabine|gemcitabine|mesh-list
2201305|NCT00005644|Paclitaxel|paclitaxel|mesh-list
2201306|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201307|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201308|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201309|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201310|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201311|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201312|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201313|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
2201314|NCT00005644|Antiviral Agents|antiviral agents|mesh-ancestor
2201315|NCT00005644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201316|NCT00005644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201317|NCT00005644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201318|NCT00005644|Immunologic Factors|immunologic factors|mesh-ancestor
2201319|NCT00005644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201320|NCT00005646|Paclitaxel|paclitaxel|mesh-list
2201321|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201322|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201323|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201324|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201325|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201326|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201327|NCT00005647|Paclitaxel|paclitaxel|mesh-list
2201328|NCT00005647|Semaxinib|semaxinib|mesh-list
2201329|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201330|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201331|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201332|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201333|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201334|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201335|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2201336|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2201337|NCT00005647|Growth Substances|growth substances|mesh-ancestor
2201338|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201339|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
2201340|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2201341|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201342|NCT00005648|Gemcitabine|gemcitabine|mesh-list
2201343|NCT00005648|Tipifarnib|tipifarnib|mesh-list
2201344|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201345|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
2201346|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201347|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201348|NCT00005648|Antiviral Agents|antiviral agents|mesh-ancestor
2201349|NCT00005648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201350|NCT00005648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717666|NCT03417479|Gabapentin|gabapentin|mesh-list
2717667|NCT03417479|Analgesics|analgesics|mesh-ancestor
2717668|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
2717669|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2717670|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717671|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
2717672|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2717673|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2717674|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2717675|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2717676|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2717677|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2717678|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2717679|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717680|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
2717681|NCT03400306|Paclitaxel|paclitaxel|mesh-list
2717682|NCT03400306|Carboplatin|carboplatin|mesh-list
2717683|NCT03400306|Veliparib|veliparib|mesh-list
2717684|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2717685|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717686|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
2717687|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
2717688|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
2717689|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717690|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2717691|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717695|NCT03374800|Pantoprazole|pantoprazole|mesh-list
2717696|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2717697|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2717698|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2717699|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717700|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717701|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
2717702|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
2717703|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2717704|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2717705|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717706|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
2717707|NCT03317795|Coagulants|coagulants|mesh-ancestor
2717708|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2717709|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
2717710|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2717711|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717712|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2717713|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2201351|NCT00005648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201352|NCT00005648|Immunologic Factors|immunologic factors|mesh-ancestor
2201353|NCT00005648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201354|NCT00005649|Paclitaxel|paclitaxel|mesh-list
2201355|NCT00005649|Capecitabine|capecitabine|mesh-list
2201356|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201357|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201358|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201359|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201360|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423825|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
2423826|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423827|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423828|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2423829|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2423830|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423831|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2423832|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2423833|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
2423834|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
2423835|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2717714|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2717730|NCT03284723|Letrozole|letrozole|mesh-list
2717731|NCT03284723|Palbociclib|palbociclib|mesh-list
2717732|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717733|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2717734|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2717735|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717736|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201361|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201362|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201363|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
2201364|NCT00005652|Rituximab|rituximab|mesh-list
2201365|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2201366|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201367|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
2201368|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201369|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201370|NCT00005654|Metformin|metformin|mesh-list
2201371|NCT00005654|Clomiphene|clomiphene|mesh-list
2201372|NCT00005654|Enclomiphene|enclomiphene|mesh-list
2201373|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
2201374|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2201375|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201376|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2201377|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
2201378|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2201379|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2201380|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
2201381|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2201382|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2201383|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2201384|NCT00005658|Glycine|glycine|mesh-list
2201385|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
2201386|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2201387|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201388|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201389|NCT00005663|Valacyclovir|valacyclovir|mesh-list
2201390|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
2423836|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
2717737|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2717738|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
2717739|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2717740|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717741|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2423837|NCT00824135|Rituximab|rituximab|mesh-list
2423838|NCT00824135|Melphalan|melphalan|mesh-list
2423839|NCT00824135|Thiotepa|thiotepa|mesh-list
2423840|NCT00824135|Clofarabine|clofarabine|mesh-list
2423841|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
2423842|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2423843|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423844|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
2423845|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423846|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2423847|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2423848|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2423849|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
2423850|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2423851|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423852|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717764|NCT03223610|Prednisone|prednisone|mesh-list
2717765|NCT03223610|Lenalidomide|lenalidomide|mesh-list
2717766|NCT03223610|Venetoclax|venetoclax|mesh-list
2717767|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
2717768|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2717769|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
2717770|NCT03223610|Hormones|hormones|mesh-ancestor
2717771|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2717772|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717773|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2717774|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717775|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
2717776|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2717777|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2717778|NCT03223610|Growth Substances|growth substances|mesh-ancestor
2717779|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
2717780|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2201391|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201392|NCT00005665|Interferons|interferons|mesh-list
2201393|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
2201394|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201395|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
2201396|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201397|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
2717786|NCT03214250|Gemcitabine|gemcitabine|mesh-list
2717787|NCT03214250|Paclitaxel|paclitaxel|mesh-list
2717788|NCT03214250|Nivolumab|nivolumab|mesh-list
2717789|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2717790|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717791|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
2717792|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
2717793|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
2717794|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717795|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2717796|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
2717797|NCT03214250|Antiviral Agents|antiviral agents|mesh-ancestor
2717798|NCT03214250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2717799|NCT03214250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717800|NCT03214250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2717801|NCT03214250|Immunologic Factors|immunologic factors|mesh-ancestor
2717802|NCT03214250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717803|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2717804|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2201398|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717839|NCT03180684|Imiquimod|imiquimod|mesh-list
2717840|NCT03180684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2717841|NCT03180684|Immunologic Factors|immunologic factors|mesh-ancestor
2717842|NCT03180684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717843|NCT03180684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717844|NCT03180684|Interferon Inducers|interferon inducers|mesh-ancestor
2717845|NCT03174275|Paclitaxel|paclitaxel|mesh-list
2201399|NCT00005668|Itraconazole|itraconazole|mesh-list
2201400|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
2201401|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201402|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2201403|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2201404|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201405|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201406|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2201407|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
2201408|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2717846|NCT03174275|Carboplatin|carboplatin|mesh-list
2717847|NCT03174275|Durvalumab|durvalumab|mesh-list
2717848|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2717849|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717850|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
2717851|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
2717852|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
2717853|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717854|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2201409|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717873|NCT03123783|Nivolumab|nivolumab|mesh-list
2717874|NCT03123783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2717875|NCT03123783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717876|NCT03123783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2717877|NCT03123783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717878|NCT03115294|Theophylline|theophylline|mesh-list
2717879|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2717880|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
2717881|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2717882|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717883|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2717884|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
2717885|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2717886|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717887|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717888|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
2717889|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2717890|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2717891|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
2717892|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2717893|NCT03087656|Levofloxacin|levofloxacin|mesh-list
2717894|NCT03087656|Ofloxacin|ofloxacin|mesh-list
2717895|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
2717896|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2717897|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2717898|NCT03087656|Renal Agents|renal agents|mesh-ancestor
2717899|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2717900|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2717901|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2717902|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717903|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717904|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717905|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2201410|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2201411|NCT00005673|Capravirine|capravirine|mesh-list
2201412|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2201413|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2201414|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201415|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201416|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
2201417|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201418|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2717906|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2717907|NCT03085004|Gemcitabine|gemcitabine|mesh-list
2717908|NCT03085004|Ethanol|ethanol|mesh-list
2717909|NCT03085004|Paclitaxel|paclitaxel|mesh-list
2717910|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2717911|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717912|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
2717913|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
2717914|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
2717915|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717916|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2717917|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
2717918|NCT03085004|Antiviral Agents|antiviral agents|mesh-ancestor
2717919|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2717920|NCT03085004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2717921|NCT03085004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2717922|NCT03085004|Immunologic Factors|immunologic factors|mesh-ancestor
2717923|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717924|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2717925|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2717926|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
2717927|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2717928|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2717955|NCT03033069|Sertraline|sertraline|mesh-list
2717956|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
2717957|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
2717958|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2717959|NCT03033069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2717960|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2717961|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2717962|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2717963|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2717964|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
2717965|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2717966|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
2717967|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
2201419|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2201420|NCT00005684|Heparin|heparin|mesh-list
2201421|NCT00005684|Warfarin|warfarin|mesh-list
2201422|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
2201423|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2201424|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2201425|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201426|NCT00005762|Ritonavir|ritonavir|mesh-list
2201427|NCT00005762|Nelfinavir|nelfinavir|mesh-list
2201428|NCT00005762|Indinavir|indinavir|mesh-list
2201429|NCT00005762|Saquinavir|saquinavir|mesh-list
2201430|NCT00005762|Amprenavir|amprenavir|mesh-list
2201431|NCT00005762|Efavirenz|efavirenz|mesh-list
2201432|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2201433|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2201434|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
2717994|NCT02976753|Factor VIII|factor viii|mesh-list
2717995|NCT02976753|Coagulants|coagulants|mesh-ancestor
2717996|NCT02946424|Simvastatin|simvastatin|mesh-list
2201435|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201436|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423853|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423854|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2423855|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
2423856|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2423857|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201437|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2201438|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2201439|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
2201440|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201441|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2201442|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2201443|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2201444|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2201445|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2201446|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2201447|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2201448|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2201449|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2201450|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2201451|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
2201452|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2201453|NCT00005764|Lamivudine|lamivudine|mesh-list
2717997|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2717998|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2717999|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
2718000|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718001|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2718002|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2718003|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718004|NCT02941926|Letrozole|letrozole|mesh-list
2718005|NCT02941926|Leuprolide|leuprolide|mesh-list
2718006|NCT02941926|Goserelin|goserelin|mesh-list
2718007|NCT02941926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718008|NCT02941926|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2718009|NCT02941926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2718010|NCT02941926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718011|NCT02941926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718012|NCT02941926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2718013|NCT02941926|Hormone Antagonists|hormone antagonists|mesh-ancestor
2718014|NCT02941926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2718015|NCT02941926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201454|NCT00005764|Zidovudine|zidovudine|mesh-list
2201455|NCT00005764|Abacavir|abacavir|mesh-list
2201456|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2201457|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2201458|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2201459|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201460|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201461|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
2201462|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201463|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2201464|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2201465|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
2201466|NCT00005765|Nicotine|nicotine|mesh-list
2201467|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2201468|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
2201469|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2201470|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201471|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2423858|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2423859|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
2423860|NCT00824200|Tamsulosin|tamsulosin|mesh-list
2718016|NCT02941926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2718017|NCT02941926|Fertility Agents|fertility agents|mesh-ancestor
2718018|NCT02941926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2718019|NCT02941926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2423861|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
2423862|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
2423863|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
2423864|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2718044|NCT02891954|Canagliflozin|canagliflozin|mesh-list
2718045|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2718046|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718047|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2718048|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718066|NCT02863770|Pancrelipase|pancrelipase|mesh-list
2718067|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2201472|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2201473|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
2201474|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2201475|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201476|NCT00005768|Estrogens|estrogens|mesh-list
2201477|NCT00005768|Hormones|hormones|mesh-ancestor
2201478|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2201479|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718098|NCT02663622|Methotrexate|methotrexate|mesh-list
2718099|NCT02663622|Tacrolimus|tacrolimus|mesh-list
2718100|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2718101|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
2718102|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2718103|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718104|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2718105|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
2718106|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718107|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718108|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
2718109|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718110|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2718111|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2718112|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
2201480|NCT00005769|Hormones|hormones|mesh-list
2201481|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2201482|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201483|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
2201484|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2201485|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
2201486|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2201487|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201488|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2201489|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
2718113|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2718114|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2718115|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2718116|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
2718117|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2718118|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718122|NCT02587598|Cytarabine|cytarabine|mesh-list
2718123|NCT02587598|Azacitidine|azacitidine|mesh-list
2718124|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2718125|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
2718126|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718127|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718128|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
2718129|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2718130|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2718131|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
2718132|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718133|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201490|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2201491|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
2201492|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718164|NCT02485574|Calcium|calcium|mesh-list
2718165|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2718166|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718167|NCT02481310|Cytarabine|cytarabine|mesh-list
2718168|NCT02481310|Prednisone|prednisone|mesh-list
2718169|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
2718170|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2718171|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2718172|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2718173|NCT02481310|Cortisone|cortisone|mesh-list
2718174|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
2718175|NCT02481310|Rituximab|rituximab|mesh-list
2718176|NCT02481310|Doxorubicin|doxorubicin|mesh-list
2718177|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2718178|NCT02481310|Methotrexate|methotrexate|mesh-list
2718179|NCT02481310|Etoposide|etoposide|mesh-list
2718180|NCT02481310|Vincristine|vincristine|mesh-list
2718181|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
2718182|NCT02481310|Ixazomib|ixazomib|mesh-list
2718183|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
2718184|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2718185|NCT02481310|Antibodies|antibodies|mesh-list
2718186|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
2718187|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2718188|NCT02481310|Glycine|glycine|mesh-list
2718189|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2718190|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
2718191|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718192|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2718193|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2718194|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
2718195|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718196|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718197|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2718198|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2718199|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2718200|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2718201|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718202|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2718203|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
2718204|NCT02481310|Hormones|hormones|mesh-ancestor
2718205|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2718206|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2718207|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2718208|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
2718209|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2718210|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2718211|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
2718212|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
2718213|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2718214|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2718215|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2718216|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
2718217|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2718218|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
2718219|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
2718220|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
2718221|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
2718222|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
2718223|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
2718224|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2201493|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2201494|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2201495|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
2201496|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
2201497|NCT00005773|Protective Agents|protective agents|mesh-ancestor
2201498|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2201499|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
2201500|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
2201501|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2201502|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2201503|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
2201504|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2201505|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
2201506|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2201507|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201508|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2201509|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
2201510|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2201511|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
2201512|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201513|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2201514|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2201515|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
2718262|NCT02462421|Canagliflozin|canagliflozin|mesh-list
2718263|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2718264|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718265|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2718266|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718267|NCT02350764|Nivolumab|nivolumab|mesh-list
2718268|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2718269|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718270|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2718271|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718272|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
2718273|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2718274|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201516|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
2201517|NCT00005776|Protective Agents|protective agents|mesh-ancestor
2201518|NCT00005777|Dexamethasone|dexamethasone|mesh-list
2201519|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2201520|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
2201521|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
2201522|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2201523|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201524|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2201525|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
2201526|NCT00005777|Hormones|hormones|mesh-ancestor
2201527|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2201528|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2201529|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201530|NCT00005779|Interleukin-12|interleukin-12|mesh-list
2718303|NCT02091934|Dipivefrin|dipivefrin|mesh-list
2718304|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2718305|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
2718306|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2718307|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718308|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201531|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2201532|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
2201533|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201534|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2201535|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2201536|NCT00005779|Growth Substances|growth substances|mesh-ancestor
2201537|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
2201538|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201542|NCT00005782|Sargramostim|sargramostim|mesh-list
2201543|NCT00005782|Lenograstim|lenograstim|mesh-list
2201544|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
2201545|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201546|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2201547|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
2201548|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201549|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
2201550|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
2201551|NCT00005787|Sargramostim|sargramostim|mesh-list
2201552|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2201553|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
2201554|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201555|NCT00005787|Hematinics|hematinics|mesh-ancestor
2201556|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2201557|NCT00005787|Protective Agents|protective agents|mesh-ancestor
2201558|NCT00005788|Aldesleukin|aldesleukin|mesh-list
2201559|NCT00005788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718325|NCT02032823|Olaparib|olaparib|mesh-list
2718326|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2718327|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718328|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718329|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718330|NCT02023996|Trastuzumab|trastuzumab|mesh-list
2718331|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2718332|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718333|NCT01639690|Busulfan|busulfan|mesh-list
2201560|NCT00005788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2201561|NCT00005788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2201562|NCT00005788|Antiviral Agents|antiviral agents|mesh-ancestor
2201563|NCT00005788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201564|NCT00005791|Fluorouracil|fluorouracil|mesh-list
2201565|NCT00005791|Irinotecan|irinotecan|mesh-list
2201566|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201567|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
2201568|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201569|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201570|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201571|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
2201572|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718334|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
2718335|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718336|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
2718337|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718338|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2718339|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2718340|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718341|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2718342|NCT01612351|Paclitaxel|paclitaxel|mesh-list
2718343|NCT01612351|Cisplatin|cisplatin|mesh-list
2718344|NCT01612351|Carboplatin|carboplatin|mesh-list
2718345|NCT01612351|Lapatinib|lapatinib|mesh-list
2201573|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2201574|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201575|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201576|NCT00005792|Etoposide|etoposide|mesh-list
2201577|NCT00005792|Melphalan|melphalan|mesh-list
2201578|NCT00005792|Topotecan|topotecan|mesh-list
2201579|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
2201580|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201581|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201582|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2201583|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201584|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201585|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201586|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201587|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
2201588|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2201589|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201590|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
2201591|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201592|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2201593|NCT00005793|Cytarabine|cytarabine|mesh-list
2201594|NCT00005793|Etoposide|etoposide|mesh-list
2201595|NCT00005793|Daunorubicin|daunorubicin|mesh-list
2201596|NCT00005793|Topotecan|topotecan|mesh-list
2201597|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201598|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201599|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2201600|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201601|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201602|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201603|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201604|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
2201605|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
2201606|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201607|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2718346|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2718347|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718348|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
2718349|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
2718350|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201608|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
2201609|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201610|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2201611|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2201612|NCT00005795|Arsenic Trioxide|arsenic trioxide|mesh-list
2201613|NCT00005795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201614|NCT00005796|Vincristine|vincristine|mesh-list
2201615|NCT00005796|Lomustine|lomustine|mesh-list
2201616|NCT00005796|Procarbazine|procarbazine|mesh-list
2201617|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201618|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201619|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201620|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201621|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201622|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201623|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201624|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
2201625|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
2201626|NCT00005797|Busulfan|busulfan|mesh-list
2201627|NCT00005797|Etoposide|etoposide|mesh-list
2201628|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201629|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
2718351|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718352|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2718353|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718354|NCT01460160|Dasatinib|dasatinib|mesh-list
2718355|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718356|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2718357|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718358|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718359|NCT01291004|Drospirenone|drospirenone|mesh-list
2718360|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2718361|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2718362|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
2718363|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2718364|NCT01291004|Desogestrel|desogestrel|mesh-list
2718365|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
2718366|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
2718367|NCT01291004|Estradiol|estradiol|mesh-list
2718368|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2718369|NCT01291004|Estrogens|estrogens|mesh-ancestor
2718370|NCT01291004|Hormones|hormones|mesh-ancestor
2718371|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2718372|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718373|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2718374|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2718375|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2718376|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2718377|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2718378|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2718379|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
2718380|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2718381|NCT01291004|Diuretics|diuretics|mesh-ancestor
2718382|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
2718383|NCT01291004|Progestins|progestins|mesh-ancestor
2718384|NCT01233960|Remestemcel-l|remestemcel-l|mesh-list
2718385|NCT01233960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2718386|NCT01233960|Antiviral Agents|antiviral agents|mesh-ancestor
2718387|NCT01233960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201630|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201631|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201632|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201633|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
2201634|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201635|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201636|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2201637|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201638|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2201639|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2718388|NCT01170702|Ropivacaine|ropivacaine|mesh-list
2718389|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
2718390|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
2718391|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2718392|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718393|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
2718394|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2718416|NCT01018563|Farletuzumab|farletuzumab|mesh-list
2718417|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718427|NCT00805961|Bevacizumab|bevacizumab|mesh-list
2718428|NCT00805961|Everolimus|everolimus|mesh-list
2718429|NCT00805961|Temozolomide|temozolomide|mesh-list
2718430|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2718431|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718432|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2718433|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2718434|NCT00805961|Growth Substances|growth substances|mesh-ancestor
2718435|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718436|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
2718437|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2718438|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
2718439|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2718440|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
2718441|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718442|NCT00750841|Cediranib|cediranib|mesh-list
2718443|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718444|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2718445|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718446|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718447|NCT00600496|Sirolimus|sirolimus|mesh-list
2718448|NCT00600496|Docetaxel|docetaxel|mesh-list
2718449|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2718450|NCT00600496|Dacarbazine|dacarbazine|mesh-list
2718451|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718452|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
2718453|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
2718454|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
2718455|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718456|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2718457|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718458|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2718459|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2718460|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2718461|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
2718462|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2718463|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
2201640|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718464|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718465|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2718466|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
2718471|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
2718472|NCT00374660|Irofulven|irofulven|mesh-list
2718473|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718474|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2718475|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
2718476|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718477|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
2718478|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
2718479|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2718480|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718481|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2718482|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
2718483|NCT00109668|Beclomethasone|beclomethasone|mesh-list
2718484|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2718485|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
2718486|NCT00109668|Hormones|hormones|mesh-ancestor
2718487|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2718488|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718489|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2718490|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
2201641|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
2201642|NCT00005798|Thiotepa|thiotepa|mesh-list
2201643|NCT00005798|Carboplatin|carboplatin|mesh-list
2201644|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201645|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
2201646|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201647|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201648|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201649|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
2201650|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201651|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201652|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2201653|NCT00005799|Cyclosporine|cyclosporine|mesh-list
2201654|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
2201655|NCT00005799|Fludarabine|fludarabine|mesh-list
2201656|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
2201657|NCT00005799|Cyclosporins|cyclosporins|mesh-list
2201658|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201659|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201660|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
2201661|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201662|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201663|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
2201664|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201665|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718491|NCT05152472|Atezolizumab|atezolizumab|mesh-list
2718492|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
2718493|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718494|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2718495|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718496|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718497|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
2718498|NCT05152420|Apixaban|apixaban|mesh-list
2718499|NCT05152420|Edoxaban|edoxaban|mesh-list
2718500|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2718501|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
2718502|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2718503|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
2718504|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718505|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718506|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
2718507|NCT05152355|Budesonide|budesonide|mesh-list
2718508|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2718509|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2718510|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
2718511|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2718512|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718513|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2718514|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
2718515|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
2718516|NCT05152355|Hormones|hormones|mesh-ancestor
2718517|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2718518|NCT05152303|Propofol|propofol|mesh-list
2718519|NCT05152303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2718520|NCT05152303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2718521|NCT05152303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718522|NCT05152303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2718523|NCT05152303|Anesthetics, General|anesthetics, general|mesh-ancestor
2718524|NCT05152303|Anesthetics|anesthetics|mesh-ancestor
2718525|NCT05152264|Analgesics|analgesics|mesh-list
2718526|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
2718527|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2718528|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718529|NCT05152186|Disinfectants|disinfectants|mesh-list
2718530|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2718562|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2718563|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2718564|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2718565|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2718566|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718567|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
2718568|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2718569|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718570|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2718571|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2718575|NCT05151796|Aspirin|aspirin|mesh-list
2718576|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2718577|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2718578|NCT05151796|Analgesics|analgesics|mesh-ancestor
2718579|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
2718580|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2718581|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718582|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2718583|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2718584|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2718585|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2718586|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718587|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2718588|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2718589|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718590|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
2718605|NCT05151679|Iron|iron|mesh-list
2718606|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2718607|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
2718608|NCT05151679|Trace Elements|trace elements|mesh-ancestor
2718609|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
2718610|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718611|NCT05151679|Hematinics|hematinics|mesh-ancestor
2201666|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
2201667|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201668|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
2718612|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
2718613|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
2718614|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718620|NCT05151614|Colchicine|colchicine|mesh-list
2718621|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
2718622|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2718623|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
2718624|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
2718625|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
2718626|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718627|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718641|NCT05151549|Carboplatin|carboplatin|mesh-list
2718642|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718643|NCT05151510|Lidocaine|lidocaine|mesh-list
2718644|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
2718645|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
2718646|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2718647|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718648|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
2718649|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2718650|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2718651|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2718652|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2718653|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2718654|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718660|NCT05151471|Edaravone|edaravone|mesh-list
2718661|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2718662|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
2718663|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718664|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2718665|NCT05151471|Protective Agents|protective agents|mesh-ancestor
2718666|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718667|NCT05151393|Vitamin D|vitamin d|mesh-list
2718668|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
2718669|NCT05151393|Vitamins|vitamins|mesh-ancestor
2718670|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
2718671|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718672|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2718673|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2718674|NCT05151328|Plecanatide|plecanatide|mesh-list
2718675|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2718676|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
2718677|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718678|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2201669|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201670|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2201671|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2201672|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2201673|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
2201674|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2201675|NCT00005800|Docetaxel|docetaxel|mesh-list
2201676|NCT00005800|Doxorubicin|doxorubicin|mesh-list
2201677|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2201678|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201679|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201680|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201681|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201682|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201683|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2201684|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2718702|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
2718703|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2718704|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
2718705|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
2718706|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
2718707|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2718708|NCT05151016|Mifepristone|mifepristone|mesh-list
2718709|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2718710|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
2718711|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2201685|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201686|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201687|NCT00005802|Cytarabine|cytarabine|mesh-list
2201688|NCT00005802|Aldesleukin|aldesleukin|mesh-list
2201689|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
2201690|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2201691|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2201692|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2201693|NCT00005802|Methotrexate|methotrexate|mesh-list
2201694|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
2201695|NCT00005802|Fludarabine|fludarabine|mesh-list
2201696|NCT00005802|Etoposide|etoposide|mesh-list
2201697|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
2201698|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2201699|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
2201700|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2201701|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201702|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201703|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
2201704|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201705|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201706|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
2201707|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201708|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2201709|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201710|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
2718712|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718713|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2718714|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2718715|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2718716|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
2718717|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2718718|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2718719|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
2718720|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2718721|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
2718722|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2718723|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2718724|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2718725|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201711|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201712|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2201713|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201714|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2201715|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201716|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
2201717|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201718|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2201719|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2201720|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2201721|NCT00005802|Analgesics|analgesics|mesh-ancestor
2201722|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
2201723|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2201724|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
2201725|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201726|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
2718747|NCT05150899|Fexofenadine|fexofenadine|mesh-list
2718748|NCT05150899|Tamsulosin|tamsulosin|mesh-list
2718749|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2718750|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2718751|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2718752|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
2718753|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2718754|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718755|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718756|NCT05150899|Urological Agents|urological agents|mesh-ancestor
2718757|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2718758|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2718759|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2718760|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
2718761|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
2718762|NCT05150795|Pregabalin|pregabalin|mesh-list
2718763|NCT05150795|Fentanyl|fentanyl|mesh-list
2718764|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2718765|NCT05150795|Narcotics|narcotics|mesh-ancestor
2718766|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2718767|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718768|NCT05150795|Analgesics|analgesics|mesh-ancestor
2718769|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
2718770|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2718771|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2718772|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2718773|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
2718774|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
2718775|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
2718776|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2718777|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2718778|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718779|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2718780|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2718781|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2718782|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2201727|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201728|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201729|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201730|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
2201731|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201732|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201733|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2201734|NCT00005806|Paclitaxel|paclitaxel|mesh-list
2201735|NCT00005806|Carboplatin|carboplatin|mesh-list
2201736|NCT00005806|Gefitinib|gefitinib|mesh-list
2201737|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201738|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201739|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201740|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201741|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201742|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201743|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2201744|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201745|NCT00005807|Epothilones|epothilones|mesh-list
2201746|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201747|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201748|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201749|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201750|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201751|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
2201752|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2201753|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
2201754|NCT00005810|Carboplatin|carboplatin|mesh-list
2201755|NCT00005810|Docetaxel|docetaxel|mesh-list
2201756|NCT00005810|Estramustine|estramustine|mesh-list
2201757|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201758|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201759|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201760|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
2423865|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2718800|NCT05150756|Lidocaine|lidocaine|mesh-list
2718801|NCT05150756|Morphine|morphine|mesh-list
2718802|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
2718803|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
2718804|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2718805|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718806|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
2718807|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2718808|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2718809|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2718810|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2718811|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2718812|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718813|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2718814|NCT05150756|Narcotics|narcotics|mesh-ancestor
2718815|NCT05150756|Analgesics|analgesics|mesh-ancestor
2423866|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423867|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423868|NCT00824200|Urological Agents|urological agents|mesh-ancestor
2423869|NCT00824239|Fentanyl|fentanyl|mesh-list
2423870|NCT00824239|Midazolam|midazolam|mesh-list
2423871|NCT00824239|Propofol|propofol|mesh-list
2423872|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2423873|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423874|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423875|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2423876|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
2423877|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
2423878|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2423879|NCT00824239|Narcotics|narcotics|mesh-ancestor
2423880|NCT00824239|Analgesics|analgesics|mesh-ancestor
2423881|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
2201761|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201762|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201763|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
2201764|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2201765|NCT00005811|Topotecan|topotecan|mesh-list
2201766|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2201767|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201768|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201769|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201770|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201771|NCT00005812|Temozolomide|temozolomide|mesh-list
2201772|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201773|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
2201774|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201775|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718853|NCT05150587|Rifaximin|rifaximin|mesh-list
2718854|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2718855|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2718856|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2201776|NCT00005813|Antibodies|antibodies|mesh-list
2201777|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2201778|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
2201779|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201780|NCT00005814|Cetuximab|cetuximab|mesh-list
2201781|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201782|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2201783|NCT00005815|Thalidomide|thalidomide|mesh-list
2201784|NCT00005815|Temozolomide|temozolomide|mesh-list
2201785|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2718873|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
2718874|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
2718875|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718876|NCT05150236|Nivolumab|nivolumab|mesh-list
2718877|NCT05150236|Ipilimumab|ipilimumab|mesh-list
2718878|NCT05150236|177Lu-PSMA-617|177lu-psma-617|mesh-list
2718879|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2718880|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718881|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2718882|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718883|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2718884|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
2718885|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2718886|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2718887|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
2718888|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423882|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2423883|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2423884|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2423885|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2423886|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2423887|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
2423888|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
2423889|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423890|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423891|NCT00824317|Methylphenidate|methylphenidate|mesh-list
2423892|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2423893|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423894|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2423895|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2423896|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2423897|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718913|NCT05133817|Norepinephrine|norepinephrine|mesh-list
2718914|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2718915|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2718916|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2718917|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
2718918|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2718919|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718920|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718921|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
2718922|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
2718923|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2718924|NCT05130268|Dronedarone|dronedarone|mesh-list
2718925|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2718934|NCT05111353|Poly ICLC|poly iclc|mesh-list
2718935|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
2718936|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
2201786|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
2201787|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201788|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201789|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201790|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
2201791|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201792|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
2718937|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2718938|NCT05108740|Everolimus|everolimus|mesh-list
2718939|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718940|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2718941|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
2718942|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201793|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2201794|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201795|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2201796|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2201797|NCT00005815|Growth Substances|growth substances|mesh-ancestor
2201798|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
2201799|NCT00005818|Irinotecan|irinotecan|mesh-list
2201800|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2201801|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201802|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201803|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201804|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201805|NCT00005819|Paclitaxel|paclitaxel|mesh-list
2201806|NCT00005819|Fenretinide|fenretinide|mesh-list
2201807|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201808|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201809|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201810|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201811|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201812|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201813|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2201814|NCT00005819|Protective Agents|protective agents|mesh-ancestor
2201815|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201816|NCT00005822|Tamoxifen|tamoxifen|mesh-list
2201817|NCT00005822|Doxorubicin|doxorubicin|mesh-list
2201818|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2201819|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2201820|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201821|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2201822|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201823|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201824|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201825|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2201826|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
2201827|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2201828|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201829|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2201830|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2201831|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2201832|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2201833|NCT00005823|Cytarabine|cytarabine|mesh-list
2201834|NCT00005823|Etoposide|etoposide|mesh-list
2201835|NCT00005823|Daunorubicin|daunorubicin|mesh-list
2201836|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
2201837|NCT00005823|Idarubicin|idarubicin|mesh-list
2201838|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
2201839|NCT00005823|Tretinoin|tretinoin|mesh-list
2201840|NCT00005823|Thioguanine|thioguanine|mesh-list
2201841|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201842|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201843|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2201844|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201845|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201846|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201847|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201848|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
2201849|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
2201850|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201851|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201852|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
2201853|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201854|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2201855|NCT00005823|Analgesics|analgesics|mesh-ancestor
2201856|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
2201857|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2201858|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
2201859|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2201860|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
2201861|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
2201862|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
2201863|NCT00005824|Busulfan|busulfan|mesh-list
2201864|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201865|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
2201866|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201867|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201868|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201869|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
2201870|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2718976|NCT05084586|Epirubicin|epirubicin|mesh-list
2718977|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2718978|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2718979|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2718980|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2718981|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2718982|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2718983|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201871|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201872|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2201873|NCT00005825|Vinorelbine|vinorelbine|mesh-list
2423898|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
2423899|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423900|NCT00824668|Insulin|insulin|mesh-list
2423901|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2423902|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
2423903|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
2423904|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
2423905|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2201874|NCT00005825|Mitomycins|mitomycins|mesh-list
2719024|NCT05076513|Niraparib|niraparib|mesh-list
2719025|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2719026|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2719027|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719028|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719029|NCT05051891|Prednisone|prednisone|mesh-list
2719030|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
2719031|NCT05051891|Vincristine|vincristine|mesh-list
2719032|NCT05051891|Rituximab|rituximab|mesh-list
2719033|NCT05051891|Doxorubicin|doxorubicin|mesh-list
2719034|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2719035|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
2719036|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719037|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2719038|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2719039|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
2719040|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719041|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719042|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2719043|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2719044|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
2719045|NCT05051891|Hormones|hormones|mesh-ancestor
2719046|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2719047|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2719048|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2719049|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
2719050|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
2719051|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
2719052|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2719053|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2719054|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2719055|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2719056|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201875|NCT00005825|Mitomycin|mitomycin|mesh-list
2201876|NCT00005825|Tretinoin|tretinoin|mesh-list
2201877|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201878|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201879|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201880|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201881|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201882|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201883|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2201884|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
2201885|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2201886|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201887|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
2201888|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
2201889|NCT00005826|Rubitecan|rubitecan|mesh-list
2201890|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201891|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2201892|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201893|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201894|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201895|NCT00005827|Genistein|genistein|mesh-list
2719110|NCT05011123|Vaccines|vaccines|mesh-list
2719111|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
2719112|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201896|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2201897|NCT00005827|Protective Agents|protective agents|mesh-ancestor
2201898|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201899|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201900|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2201901|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201902|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201903|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
2201904|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2201905|NCT00005827|Estrogens|estrogens|mesh-ancestor
2201906|NCT00005827|Hormones|hormones|mesh-ancestor
2719141|NCT04998981|Fenofibrate|fenofibrate|mesh-list
2719142|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2719143|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
2719144|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719145|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2201907|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2719164|NCT04991350|Bevacizumab|bevacizumab|mesh-list
2719165|NCT04991350|Ranibizumab|ranibizumab|mesh-list
2719166|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2719167|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719168|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2719169|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2719170|NCT04991350|Growth Substances|growth substances|mesh-ancestor
2719171|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719172|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
2719173|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
2719174|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2719175|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719176|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2719177|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2719220|NCT04940572|Valproic Acid|valproic acid|mesh-list
2719221|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
2719222|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2719223|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719224|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
2719225|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2719226|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719227|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
2719228|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2719229|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2719230|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2719249|NCT04936685|Vaccines|vaccines|mesh-list
2719250|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
2719251|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201908|NCT00005829|Gemcitabine|gemcitabine|mesh-list
2201909|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201910|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
2201911|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201912|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201913|NCT00005829|Antiviral Agents|antiviral agents|mesh-ancestor
2201914|NCT00005829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201915|NCT00005829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2719294|NCT04933240|Tamoxifen|tamoxifen|mesh-list
2719295|NCT04933240|Estradiol|estradiol|mesh-list
2719296|NCT04933240|Estrogens|estrogens|mesh-ancestor
2719297|NCT04933240|Hormones|hormones|mesh-ancestor
2719298|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2719299|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719300|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2719301|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
2719302|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2719303|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719304|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2719305|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2719306|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2719307|NCT04933058|Acetaminophen|acetaminophen|mesh-list
2719308|NCT04933058|Fentanyl|fentanyl|mesh-list
2201916|NCT00005829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201917|NCT00005829|Immunologic Factors|immunologic factors|mesh-ancestor
2201918|NCT00005829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719309|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2719310|NCT04933058|Narcotics|narcotics|mesh-ancestor
2719311|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2719312|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719313|NCT04933058|Analgesics|analgesics|mesh-ancestor
2719314|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
2719315|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2719316|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2719317|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2719318|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
2719319|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
2719320|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2719321|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
2719340|NCT04924062|Gemcitabine|gemcitabine|mesh-list
2719341|NCT04924062|Cisplatin|cisplatin|mesh-list
2719342|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
2719343|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719344|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2719345|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
2719346|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719347|NCT04924062|Antiviral Agents|antiviral agents|mesh-ancestor
2719348|NCT04924062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2719349|NCT04924062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2719350|NCT04924062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2719351|NCT04924062|Immunologic Factors|immunologic factors|mesh-ancestor
2719352|NCT04924062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719353|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2719374|NCT04899583|Sirolimus|sirolimus|mesh-list
2201919|NCT00005830|Doxorubicin|doxorubicin|mesh-list
2201920|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2201921|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201922|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2201923|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2201924|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201925|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201926|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201927|NCT00005831|Gemcitabine|gemcitabine|mesh-list
2201928|NCT00005831|Paclitaxel|paclitaxel|mesh-list
2201929|NCT00005831|Carboplatin|carboplatin|mesh-list
2201930|NCT00005831|Trastuzumab|trastuzumab|mesh-list
2201931|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201932|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201933|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
2201934|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
2201935|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
2201936|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201937|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201938|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
2201939|NCT00005831|Antiviral Agents|antiviral agents|mesh-ancestor
2201940|NCT00005831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2719375|NCT04899583|Paclitaxel|paclitaxel|mesh-list
2719376|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2719377|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719378|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
2719379|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
2719380|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
2719381|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719382|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2719383|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2719384|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2719385|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
2719386|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201941|NCT00005831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2719387|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
2719388|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719394|NCT04891991|Infliximab|infliximab|mesh-list
2719395|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
2719396|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2201942|NCT00005831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201943|NCT00005831|Immunologic Factors|immunologic factors|mesh-ancestor
2201944|NCT00005831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201945|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2201946|NCT00005832|Tipifarnib|tipifarnib|mesh-list
2201947|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201948|NCT00005833|Tipifarnib|tipifarnib|mesh-list
2201949|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201950|NCT00005834|Thalidomide|thalidomide|mesh-list
2201951|NCT00005834|Dexamethasone|dexamethasone|mesh-list
2201952|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
2201953|NCT00005834|Etoposide|etoposide|mesh-list
2201954|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201955|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
2201956|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201957|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2201958|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201959|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
2201960|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201961|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201962|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2201963|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2201964|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
2201965|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
2201966|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2719397|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2719433|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
2719434|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2719435|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719446|NCT04825223|Vaccines|vaccines|mesh-list
2719447|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
2719448|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201967|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2201968|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
2201969|NCT00005834|Hormones|hormones|mesh-ancestor
2201970|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2201971|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2201972|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2201973|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2201974|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2201975|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201976|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
2201977|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2201978|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2201979|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2201980|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2201981|NCT00005834|Growth Substances|growth substances|mesh-ancestor
2201982|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
2201983|NCT00005835|Melphalan|melphalan|mesh-list
2201984|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
2719480|NCT04777851|Nivolumab|nivolumab|mesh-list
2719481|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2719482|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719483|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2719484|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201985|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
2201986|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2201987|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2201988|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
2201989|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2201990|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2201991|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2201992|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2201993|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
2201994|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2201995|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2201996|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2201997|NCT00005835|Protective Agents|protective agents|mesh-ancestor
2201998|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
2201999|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202000|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
2202001|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202002|NCT00005838|Paclitaxel|paclitaxel|mesh-list
2202003|NCT00005838|Vinorelbine|vinorelbine|mesh-list
2202004|NCT00005838|Carboplatin|carboplatin|mesh-list
2202005|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2202006|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202007|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
2202008|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
2202009|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
2202010|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202011|NCT00005839|Capecitabine|capecitabine|mesh-list
2202012|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
2202013|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202014|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
2202015|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202016|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202017|NCT00005840|Paclitaxel|paclitaxel|mesh-list
2202018|NCT00005840|Cisplatin|cisplatin|mesh-list
2202019|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2202020|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202021|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
2719501|NCT04761887|Ropivacaine|ropivacaine|mesh-list
2719502|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
2719503|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
2719504|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2719505|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719506|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
2719507|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2202022|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
2202023|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
2202024|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202025|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
2202026|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2202027|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
2202028|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202029|NCT00005842|Trastuzumab|trastuzumab|mesh-list
2202030|NCT00005842|Tipifarnib|tipifarnib|mesh-list
2202031|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2202032|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202033|NCT00005843|Tipifarnib|tipifarnib|mesh-list
2202034|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202035|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
2202036|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202037|NCT00005845|Tipifarnib|tipifarnib|mesh-list
2719564|NCT04753879|Gemcitabine|gemcitabine|mesh-list
2719565|NCT04753879|Paclitaxel|paclitaxel|mesh-list
2719566|NCT04753879|Capecitabine|capecitabine|mesh-list
2719567|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
2719568|NCT04753879|Irinotecan|irinotecan|mesh-list
2719569|NCT04753879|Olaparib|olaparib|mesh-list
2719570|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2719571|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719572|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
2719573|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
2719574|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
2719575|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719576|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2719577|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
2719578|NCT04753879|Antiviral Agents|antiviral agents|mesh-ancestor
2719579|NCT04753879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2719580|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2719581|NCT04753879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2719582|NCT04753879|Immunologic Factors|immunologic factors|mesh-ancestor
2719583|NCT04753879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719584|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2719585|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2719586|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2719587|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2719588|NCT04750759|Niclosamide|niclosamide|mesh-list
2719589|NCT04750759|Camostat|camostat|mesh-list
2719590|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
2719591|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2719592|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719593|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2719594|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2719595|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
2719596|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2719597|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
2719598|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2719599|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2719600|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
2719610|NCT04721977|Capecitabine|capecitabine|mesh-list
2719611|NCT04721977|Trastuzumab|trastuzumab|mesh-list
2719612|NCT04721977|Tucatinib|tucatinib|mesh-list
2719613|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2719614|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
2719615|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719616|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719617|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2719618|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2719619|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2719620|NCT04720716|Sorafenib|sorafenib|mesh-list
2719621|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719622|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2719623|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2719624|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719640|NCT04698187|Nivolumab|nivolumab|mesh-list
2719641|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2719642|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719643|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2719644|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202038|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202039|NCT00005847|Interferons|interferons|mesh-list
2202040|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
2202041|NCT00005847|Paclitaxel|paclitaxel|mesh-list
2202042|NCT00005847|Vinorelbine|vinorelbine|mesh-list
2202043|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
2202044|NCT00005847|Estramustine|estramustine|mesh-list
2202045|NCT00005847|Isotretinoin|isotretinoin|mesh-list
2202046|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2202047|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202048|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
2202049|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
2202050|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
2202051|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202052|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
2202053|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202054|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
2202055|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202056|NCT00005847|Analgesics|analgesics|mesh-ancestor
2202057|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
2202058|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2202059|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2202060|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202061|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202062|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
2202063|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202064|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
2202065|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2202066|NCT00005848|Tipifarnib|tipifarnib|mesh-list
2202067|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202068|NCT00005849|Paclitaxel|paclitaxel|mesh-list
2202069|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
2423906|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
2423907|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2423908|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423909|NCT00824707|Entecavir|entecavir|mesh-list
2423910|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
2423911|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423912|NCT00824785|Capecitabine|capecitabine|mesh-list
2423913|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
2423914|NCT00824785|Epirubicin|epirubicin|mesh-list
2423915|NCT00824785|Panitumumab|panitumumab|mesh-list
2423916|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2423917|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
2423918|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423919|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719783|NCT04622839|Acetaminophen|acetaminophen|mesh-list
2719784|NCT04622839|Ibuprofen|ibuprofen|mesh-list
2719785|NCT04622839|Diclofenac|diclofenac|mesh-list
2719786|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2719787|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2719788|NCT04622839|Analgesics|analgesics|mesh-ancestor
2719789|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
2719790|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2719791|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719792|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2719793|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2719794|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2719795|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2719796|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719797|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
2719807|NCT04614909|Temozolomide|temozolomide|mesh-list
2719808|NCT04614909|Olaparib|olaparib|mesh-list
2719809|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2719810|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
2719811|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202070|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2202071|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202072|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
2719812|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719813|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2719814|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2719815|NCT04612725|Benralizumab|benralizumab|mesh-list
2719816|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2719817|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
2719818|NCT04609423|Vitamin D|vitamin d|mesh-list
2719819|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
2719820|NCT04609423|Vitamins|vitamins|mesh-ancestor
2719821|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
2719822|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719823|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2719855|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2719856|NCT04602975|Vaccines|vaccines|mesh-list
2719857|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
2719858|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719859|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2719860|NCT04602975|Antacids|antacids|mesh-ancestor
2719861|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719862|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2202073|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
2202074|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
2202075|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202076|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2202077|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
2202078|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202079|NCT00005850|Gemcitabine|gemcitabine|mesh-list
2202080|NCT00005850|Fluoxetine|fluoxetine|mesh-list
2202081|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202082|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202083|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
2202084|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202085|NCT00005850|Antiviral Agents|antiviral agents|mesh-ancestor
2202086|NCT00005850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202087|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202088|NCT00005850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202089|NCT00005850|Immunologic Factors|immunologic factors|mesh-ancestor
2202090|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202091|NCT00005850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2202092|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2202093|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2202094|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2202095|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
2202096|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2202097|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
2202098|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2202099|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2202100|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2202101|NCT00005851|Cyclosporine|cyclosporine|mesh-list
2202102|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
2202103|NCT00005851|Fludarabine|fludarabine|mesh-list
2202104|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
2202105|NCT00005851|Cyclosporins|cyclosporins|mesh-list
2202106|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719871|NCT04597372|Tamsulosin|tamsulosin|mesh-list
2719872|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2719873|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2719874|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2719875|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
2719876|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2719877|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719878|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719879|NCT04597372|Urological Agents|urological agents|mesh-ancestor
2719880|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
2719881|NCT04591626|Dulaglutide|dulaglutide|mesh-list
2719882|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2719883|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719884|NCT04584684|Ethanol|ethanol|mesh-list
2719885|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2719886|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
2719887|NCT04584684|Povidone|povidone|mesh-list
2719888|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2719889|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2719890|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2719891|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719892|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
2202107|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202108|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
2202109|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719893|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
2719894|NCT04574154|Anesthetics|anesthetics|mesh-list
2719895|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2719896|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719915|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
2719916|NCT04558866|Testosterone|testosterone|mesh-list
2719917|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
2719918|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
2719919|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2719920|NCT04558866|Androgens|androgens|mesh-ancestor
2719921|NCT04558866|Hormones|hormones|mesh-ancestor
2719922|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2719923|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719924|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2719925|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719926|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
2202110|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202111|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
2202112|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202113|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202114|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
2202115|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202116|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
2202117|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202118|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2202119|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2202120|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2202121|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
2202122|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2719939|NCT04556370|Norepinephrine|norepinephrine|mesh-list
2719940|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2719941|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2719942|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
2719943|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2719944|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719945|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719946|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
2719947|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
2719948|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2719949|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2719959|NCT04527107|Aflibercept|aflibercept|mesh-list
2719960|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2719961|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2719962|NCT04527107|Growth Substances|growth substances|mesh-ancestor
2719963|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719964|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
2719965|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2719966|NCT04526821|Lactoferrin|lactoferrin|mesh-list
2719967|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2719977|NCT04516447|Gemcitabine|gemcitabine|mesh-list
2719978|NCT04516447|Paclitaxel|paclitaxel|mesh-list
2719979|NCT04516447|Carboplatin|carboplatin|mesh-list
2719980|NCT04516447|Doxorubicin|doxorubicin|mesh-list
2202123|NCT00005852|Cyclosporine|cyclosporine|mesh-list
2202124|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
2202125|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
2719981|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2719982|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2719983|NCT04516447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202126|NCT00005852|Cyclosporins|cyclosporins|mesh-list
2202127|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2202128|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
2202129|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202130|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
2202131|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719984|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
2719985|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
2719986|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
2719987|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2719988|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2719989|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
2719990|NCT04516447|Antiviral Agents|antiviral agents|mesh-ancestor
2719991|NCT04516447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2719992|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2719993|NCT04516447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2719994|NCT04516447|Immunologic Factors|immunologic factors|mesh-ancestor
2719995|NCT04516447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2719996|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2719997|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2719998|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2720015|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2202132|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2720039|NCT04445389|Vaccines|vaccines|mesh-list
2720040|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
2720041|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720054|NCT04416386|Ascorbic Acid|ascorbic acid|mesh-list
2720055|NCT04416386|Vitamins|vitamins|mesh-ancestor
2720056|NCT04416386|Micronutrients|micronutrients|mesh-ancestor
2720057|NCT04416386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720058|NCT04416386|Antioxidants|antioxidants|mesh-ancestor
2720059|NCT04416386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720060|NCT04416386|Protective Agents|protective agents|mesh-ancestor
2720082|NCT04394624|Ramucirumab|ramucirumab|mesh-list
2720083|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2720121|NCT04365257|Prazosin|prazosin|mesh-list
2720122|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
2720123|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
2720124|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2720125|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2720126|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
2720127|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2720128|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720129|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720130|NCT04365088|Deflazacort|deflazacort|mesh-list
2720131|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2720132|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2720133|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
2720134|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720135|NCT04349579|Rifamycins|rifamycins|mesh-list
2720136|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
2720137|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2720138|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2720139|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202133|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202134|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
2202135|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202136|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202137|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202138|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202139|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
2202140|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202141|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
2202142|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2202143|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2202144|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
2202145|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
2202146|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2202147|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2202148|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
2202149|NCT00005852|Hormones|hormones|mesh-ancestor
2202150|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2202151|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2202152|NCT00005852|Protective Agents|protective agents|mesh-ancestor
2202153|NCT00005853|Etanercept|etanercept|mesh-list
2202154|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2202155|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2202156|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2202157|NCT00005853|Analgesics|analgesics|mesh-ancestor
2202158|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
2202159|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2202160|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202161|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2202162|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202163|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2202164|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202165|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
2202166|NCT00005854|Cyclosporine|cyclosporine|mesh-list
2202167|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
2202168|NCT00005854|Methotrexate|methotrexate|mesh-list
2202169|NCT00005854|Cyclosporins|cyclosporins|mesh-list
2202170|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202171|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
2202172|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202173|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202174|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202175|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
2202176|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202177|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202178|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202179|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2202180|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
2202181|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2202182|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202183|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
2202184|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
2202185|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202186|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2202187|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2202188|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
2202189|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202190|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2202191|NCT00005855|Carmustine|carmustine|mesh-list
2202192|NCT00005855|Efaproxiral|efaproxiral|mesh-list
2202193|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202194|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
2202195|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202196|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202197|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
2202198|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
2202199|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202200|NCT00005857|Docetaxel|docetaxel|mesh-list
2202201|NCT00005857|Trastuzumab|trastuzumab|mesh-list
2202202|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202203|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
2202204|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
2202205|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
2202206|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202207|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2202208|NCT00005858|Immunotoxins|immunotoxins|mesh-list
2202209|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
2202210|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202211|NCT00005859|Tipifarnib|tipifarnib|mesh-list
2202212|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202213|NCT00005860|Leucovorin|leucovorin|mesh-list
2202214|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
2202215|NCT00005860|Floxuridine|floxuridine|mesh-list
2202216|NCT00005860|Calcium|calcium|mesh-list
2202217|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
2202218|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2202219|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202220|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202221|NCT00005860|Antidotes|antidotes|mesh-ancestor
2202222|NCT00005860|Protective Agents|protective agents|mesh-ancestor
2202223|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
2202224|NCT00005860|Vitamins|vitamins|mesh-ancestor
2202225|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
2202226|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202227|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
2202228|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202229|NCT00005861|Doxorubicin|doxorubicin|mesh-list
2202230|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2202231|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2202232|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202233|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2202234|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202235|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202236|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202237|NCT00005862|Semaxinib|semaxinib|mesh-list
2202238|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2202239|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2202240|NCT00005862|Growth Substances|growth substances|mesh-ancestor
2202241|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202242|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
2202243|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202244|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2202245|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202246|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202247|NCT00005863|Cytarabine|cytarabine|mesh-list
2202248|NCT00005863|Fludarabine|fludarabine|mesh-list
2202249|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
2202250|NCT00005863|Etoposide|etoposide|mesh-list
2202251|NCT00005863|Daunorubicin|daunorubicin|mesh-list
2202252|NCT00005863|Tretinoin|tretinoin|mesh-list
2202253|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202254|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202255|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
2202256|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202257|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202258|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
2202259|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202260|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2202261|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2202262|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2720276|NCT04234529|Caffeine|caffeine|mesh-list
2720277|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2720278|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720279|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2720280|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2720281|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720282|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2720283|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2720284|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
2720285|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2202263|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202264|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
2202265|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2720317|NCT04224740|Cisplatin|cisplatin|mesh-list
2720318|NCT04224740|Carboplatin|carboplatin|mesh-list
2720319|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
2720320|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2720321|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2720322|NCT04217954|Bevacizumab|bevacizumab|mesh-list
2720323|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2720324|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2720325|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2720326|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2720327|NCT04217954|Growth Substances|growth substances|mesh-ancestor
2720328|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720329|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
2720330|NCT04197713|Olaparib|olaparib|mesh-list
2720331|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2720332|NCT04197713|Adavosertib|adavosertib|mesh-list
2720333|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2720334|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720335|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2720336|NCT04195776|Tenofovir|tenofovir|mesh-list
2720337|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
2720338|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2720339|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2720340|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2720341|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2720342|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720343|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2720344|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2720358|NCT04192110|Diuretics|diuretics|mesh-list
2720359|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
2720360|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720361|NCT04182100|Aspirin|aspirin|mesh-list
2720362|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2720363|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2720364|NCT04182100|Analgesics|analgesics|mesh-ancestor
2720365|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
2720366|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2720367|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720368|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2720369|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2720370|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2720371|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2720372|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720373|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2720374|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2720375|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2720376|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
2720377|NCT04179019|Amlodipine|amlodipine|mesh-list
2720378|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2720379|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2720380|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2720381|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720382|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2720383|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720384|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
2720434|NCT04127578|Sirolimus|sirolimus|mesh-list
2720435|NCT04127578|Prednisone|prednisone|mesh-list
2720436|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
2720437|NCT04127578|Rituximab|rituximab|mesh-list
2720438|NCT04127578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2720439|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2720440|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
2720441|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720442|NCT04127578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2720443|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2720444|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
2720445|NCT04127578|Hormones|hormones|mesh-ancestor
2720446|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2720447|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2720448|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2720449|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2720450|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2720451|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
2720452|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202266|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2202267|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
2202268|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
2202269|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
2202270|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202271|NCT00005865|Vinorelbine|vinorelbine|mesh-list
2202272|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2202273|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202274|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
2202275|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
2202276|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
2202277|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720453|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
2720454|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
2720455|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2720456|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2720457|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2720458|NCT04127578|Protective Agents|protective agents|mesh-ancestor
2720459|NCT04126317|Aflibercept|aflibercept|mesh-list
2720460|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2720461|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2720462|NCT04126317|Growth Substances|growth substances|mesh-ancestor
2720463|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720464|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
2720465|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202278|NCT00005866|Cyclosporine|cyclosporine|mesh-list
2202279|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
2202280|NCT00005866|Busulfan|busulfan|mesh-list
2202281|NCT00005866|Methotrexate|methotrexate|mesh-list
2202282|NCT00005866|Cyclosporins|cyclosporins|mesh-list
2202283|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202284|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
2202285|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202286|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202287|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202288|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
2202289|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202290|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202291|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202292|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2202293|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
2202294|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2202295|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202296|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
2202297|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
2202298|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202299|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2202300|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2202301|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
2202302|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202303|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2202304|NCT00005867|Prednisolone|prednisolone|mesh-list
2202305|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
2202306|NCT00005867|Doxorubicin|doxorubicin|mesh-list
2202307|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2720523|NCT04084717|Crizotinib|crizotinib|mesh-list
2720524|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2720525|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2720526|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2720527|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720535|NCT04056182|Lofexidine|lofexidine|mesh-list
2720536|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2202308|NCT00005867|Etoposide|etoposide|mesh-list
2720537|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2720538|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720539|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
2720540|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2720541|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2720542|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2720543|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2720544|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
2720545|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2720546|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720550|NCT04049851|Ivermectin|ivermectin|mesh-list
2720551|NCT04049851|Moxidectin|moxidectin|mesh-list
2720552|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2720553|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2720554|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
2720555|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
2720556|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2720557|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202309|NCT00005867|Vincristine|vincristine|mesh-list
2202310|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
2202311|NCT00005867|Bleomycin|bleomycin|mesh-list
2202312|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202313|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
2202314|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202315|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202316|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202317|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
2720618|NCT03966625|Autoantibodies|autoantibodies|mesh-list
2720619|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
2720620|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720621|NCT03961568|Cenobamate|cenobamate|mesh-list
2720622|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
2720623|NCT03959358|Lenalidomide|lenalidomide|mesh-list
2720624|NCT03959358|Pomalidomide|pomalidomide|mesh-list
2720625|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
2720626|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720627|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2720628|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2720629|NCT03959358|Growth Substances|growth substances|mesh-ancestor
2720630|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
2720631|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2720632|NCT03954106|Defibrotide|defibrotide|mesh-list
2720633|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2720634|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2720635|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720636|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2720637|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
2720638|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2720639|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
2720640|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2720641|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202318|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202319|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202320|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202321|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2202322|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2202323|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202324|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202325|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2202326|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
2202327|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
2202328|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
2202329|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2202330|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
2202331|NCT00005867|Hormones|hormones|mesh-ancestor
2202332|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2202333|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2202334|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2202335|NCT00005867|Analgesics|analgesics|mesh-ancestor
2202336|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
2202337|NCT00005868|Docetaxel|docetaxel|mesh-list
2202338|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202339|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
2202340|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
2202341|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
2202342|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202343|NCT00005869|Gemcitabine|gemcitabine|mesh-list
2202344|NCT00005869|Rubitecan|rubitecan|mesh-list
2202345|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202346|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
2202347|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202348|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202349|NCT00005869|Antiviral Agents|antiviral agents|mesh-ancestor
2202350|NCT00005869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202351|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202352|NCT00005869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202353|NCT00005869|Immunologic Factors|immunologic factors|mesh-ancestor
2202354|NCT00005869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202355|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2720642|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2720643|NCT03944356|Trametinib|trametinib|mesh-list
2720644|NCT03944356|Dabrafenib|dabrafenib|mesh-list
2720645|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2720646|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2720647|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2720648|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720651|NCT03930498|Antibodies|antibodies|mesh-list
2720652|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
2720653|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
2720654|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720690|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2720691|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
2720692|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202356|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202357|NCT00005870|Gemcitabine|gemcitabine|mesh-list
2202358|NCT00005870|Fluorouracil|fluorouracil|mesh-list
2202359|NCT00005870|Mitomycins|mitomycins|mesh-list
2202360|NCT00005870|Mitomycin|mitomycin|mesh-list
2202361|NCT00005870|Rubitecan|rubitecan|mesh-list
2202362|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202363|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
2202364|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202365|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202366|NCT00005870|Antiviral Agents|antiviral agents|mesh-ancestor
2202367|NCT00005870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202368|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202369|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202370|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
2202371|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202372|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2202373|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
2202374|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2202375|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2202376|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202377|NCT00005871|Fluorouracil|fluorouracil|mesh-list
2202378|NCT00005871|Rubitecan|rubitecan|mesh-list
2202379|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
2423920|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2423921|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2423922|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2423923|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423924|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2423925|NCT00824811|Fluorometholone|fluorometholone|mesh-list
2423926|NCT00824811|Cyclosporine|cyclosporine|mesh-list
2423927|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2202380|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202381|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202382|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202383|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202384|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
2202385|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202386|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2202387|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202388|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202389|NCT00005872|Rubitecan|rubitecan|mesh-list
2202390|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202391|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2202392|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202393|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202394|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202395|NCT00005873|Rubitecan|rubitecan|mesh-list
2202396|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202397|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2202398|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202399|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202400|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202401|NCT00005874|Rubitecan|rubitecan|mesh-list
2202402|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202403|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2202404|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202405|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2720818|NCT03898934|Vitamin D|vitamin d|mesh-list
2720819|NCT03898934|Vitamins|vitamins|mesh-ancestor
2720820|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
2720821|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720822|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2720823|NCT03893617|Propranolol|propranolol|mesh-list
2720824|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2720825|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2720826|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
2720827|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2720828|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720829|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720830|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2720831|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2720832|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
2202406|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202407|NCT00005875|Rubitecan|rubitecan|mesh-list
2202408|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202409|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2202410|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202411|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202412|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202413|NCT00005876|Rubitecan|rubitecan|mesh-list
2202414|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202415|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2202416|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202417|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202418|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202419|NCT00005877|Rubitecan|rubitecan|mesh-list
2202420|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202421|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2202422|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202423|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2720841|NCT03860844|Cytarabine|cytarabine|mesh-list
2720842|NCT03860844|Dexamethasone|dexamethasone|mesh-list
2720843|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
2720844|NCT03860844|Doxorubicin|doxorubicin|mesh-list
2720845|NCT03860844|Methotrexate|methotrexate|mesh-list
2720846|NCT03860844|Fludarabine|fludarabine|mesh-list
2720847|NCT03860844|Etoposide|etoposide|mesh-list
2720848|NCT03860844|Vincristine|vincristine|mesh-list
2720849|NCT03860844|Daunorubicin|daunorubicin|mesh-list
2720850|NCT03860844|Asparaginase|asparaginase|mesh-list
2720851|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
2720852|NCT03860844|Idarubicin|idarubicin|mesh-list
2720853|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
2720854|NCT03860844|Pegaspargase|pegaspargase|mesh-list
2720855|NCT03860844|Montelukast|montelukast|mesh-list
2720856|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2720857|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
2720858|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720859|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2720860|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2720861|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
2720862|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720863|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2720864|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2720865|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2720866|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
2720867|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
2720868|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2720869|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2720870|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
2202424|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202425|NCT00005878|Celecoxib|celecoxib|mesh-list
2720871|NCT03860844|Hormones|hormones|mesh-ancestor
2720872|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2720873|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2720874|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2720875|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2720876|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2720877|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2720878|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2720879|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
2720880|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2720881|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2720882|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
2720883|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
2720884|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2720885|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2720886|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2720887|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
2720888|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2720889|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
2720890|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
2720891|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
2720892|NCT03860844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2720893|NCT03860844|Respiratory System Agents|respiratory system agents|mesh-ancestor
2720894|NCT03860844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2720895|NCT03860844|Hormone Antagonists|hormone antagonists|mesh-ancestor
2720896|NCT03860844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2720897|NCT03860844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2720898|NCT03860844|Analgesics|analgesics|mesh-ancestor
2720899|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
2720900|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
2720901|NCT03831932|Osimertinib|osimertinib|mesh-list
2720902|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2720903|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2720904|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2720905|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720922|NCT03817554|Dopamine|dopamine|mesh-list
2720923|NCT03817554|Pramipexole|pramipexole|mesh-list
2720924|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
2720925|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
2720926|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202426|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2202427|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2202428|NCT00005878|Analgesics|analgesics|mesh-ancestor
2202429|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
2202430|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2202431|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202432|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2202433|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202434|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2202435|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2202436|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202437|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202438|NCT00005880|Budesonide|budesonide|mesh-list
2202439|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2202440|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2202441|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
2202442|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2202443|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202444|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2202445|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
2202446|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
2202447|NCT00005880|Hormones|hormones|mesh-ancestor
2720927|NCT03817554|Protective Agents|protective agents|mesh-ancestor
2720928|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2720929|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2720930|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2720931|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
2720932|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2720933|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2720934|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
2720935|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
2720936|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2202448|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2202449|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
2202450|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202451|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202452|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2202453|NCT00005883|Protective Agents|protective agents|mesh-ancestor
2202454|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202455|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2720972|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
2720973|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2720974|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
2720975|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2720976|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2720977|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2202456|NCT00005884|Eflornithine|eflornithine|mesh-list
2202457|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202458|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2202459|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2202460|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2202461|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202462|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2202463|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202464|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721030|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
2721031|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2721032|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721033|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2721034|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721037|NCT03778294|Temozolomide|temozolomide|mesh-list
2721038|NCT03778294|Levodopa|levodopa|mesh-list
2721039|NCT03778294|Fluorides|fluorides|mesh-list
2721040|NCT03778294|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
2721041|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2721042|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
2721043|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721044|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721045|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
2721046|NCT03778294|Protective Agents|protective agents|mesh-ancestor
2202465|NCT00005886|Tamoxifen|tamoxifen|mesh-list
2202466|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2202467|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
2202468|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2202469|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202470|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2202471|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2423928|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
2423929|NCT00824811|Cyclosporins|cyclosporins|mesh-list
2423930|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423931|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423932|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2423933|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
2423934|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423935|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
2423936|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423937|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
2423938|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2721047|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721048|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
2721049|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2721050|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2721051|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2721072|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
2721073|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2721074|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
2721075|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
2721076|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2721077|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721078|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2721079|NCT03736538|Analgesics|analgesics|mesh-ancestor
2721080|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
2721081|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2721096|NCT03717896|Thiamine|thiamine|mesh-list
2721097|NCT03717896|Vitamins|vitamins|mesh-ancestor
2721098|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
2721099|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721100|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
2721104|NCT03678753|Cenobamate|cenobamate|mesh-list
2721105|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
2721109|NCT03651206|Niraparib|niraparib|mesh-list
2721110|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2721111|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721112|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721113|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202472|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2202473|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2721121|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
2721122|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2721123|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2721124|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2721125|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2721126|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202474|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2202475|NCT00005887|Efaproxiral|efaproxiral|mesh-list
2202476|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
2202477|NCT00005889|Glucagon|glucagon|mesh-list
2202478|NCT00005889|Glycerol|glycerol|mesh-list
2202479|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202480|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2202481|NCT00005889|Hormones|hormones|mesh-ancestor
2202482|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2202483|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2202484|NCT00005889|Protective Agents|protective agents|mesh-ancestor
2202485|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2202486|NCT00005890|Hormones|hormones|mesh-ancestor
2202487|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2202488|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202489|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
2202490|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202491|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
2202492|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202493|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202494|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202495|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
2202496|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202497|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202498|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202499|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
2721127|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
2721128|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2721129|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721130|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2721131|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2721132|NCT03596645|Golimumab|golimumab|mesh-list
2721133|NCT03596645|Infliximab|infliximab|mesh-list
2721134|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
2721135|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2721136|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2721137|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2721138|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2721139|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2721140|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
2721141|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721142|NCT03593252|Metronidazole|metronidazole|mesh-list
2721143|NCT03593252|Cefazolin|cefazolin|mesh-list
2721144|NCT03593252|Neomycin|neomycin|mesh-list
2721145|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
2721146|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
2721147|NCT03593252|Citric Acid|citric acid|mesh-list
2721148|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
2721149|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2721150|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2721151|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2721152|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2721153|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
2202500|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202501|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
2202502|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202503|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202504|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202505|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
2202506|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202507|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202508|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202509|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
2202510|NCT00005893|Busulfan|busulfan|mesh-list
2202511|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2202512|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202513|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
2202514|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202515|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2721154|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2721155|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
2721156|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
2721157|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721158|NCT03593252|Cathartics|cathartics|mesh-ancestor
2721159|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2721160|NCT03593252|Antacids|antacids|mesh-ancestor
2721161|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2721162|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721163|NCT03582488|Corticosterone|corticosterone|mesh-list
2721164|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2721165|NCT03574792|Oxycodone|oxycodone|mesh-list
2721166|NCT03574792|Methadone|methadone|mesh-list
2721167|NCT03574792|Gabapentin|gabapentin|mesh-list
2721168|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2202516|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202517|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
2202518|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202519|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721169|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2721170|NCT03574792|Narcotics|narcotics|mesh-ancestor
2721171|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2721172|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721173|NCT03574792|Analgesics|analgesics|mesh-ancestor
2721174|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
2721175|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2721176|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
2721177|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2721178|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2721179|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2721180|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2721181|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2721182|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2721183|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721184|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
2721185|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
2721186|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
2721187|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2721188|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2721189|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2721190|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2721191|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
2721231|NCT03450707|Thiamine|thiamine|mesh-list
2721232|NCT03450707|Vitamins|vitamins|mesh-ancestor
2721233|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
2721234|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721235|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
2721236|NCT03440450|Gemcitabine|gemcitabine|mesh-list
2721237|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2721238|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
2721239|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721240|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721241|NCT03440450|Antiviral Agents|antiviral agents|mesh-ancestor
2721242|NCT03440450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2721243|NCT03440450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721244|NCT03440450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2721245|NCT03440450|Immunologic Factors|immunologic factors|mesh-ancestor
2721246|NCT03440450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721272|NCT03391479|Avelumab|avelumab|mesh-list
2721273|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2721274|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721297|NCT03368066|Cosyntropin|cosyntropin|mesh-list
2721298|NCT03368066|Hormones|hormones|mesh-ancestor
2721299|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2721300|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721301|NCT03365622|Acetaminophen|acetaminophen|mesh-list
2721302|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2721303|NCT03365622|Analgesics|analgesics|mesh-ancestor
2721304|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
2721305|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2721306|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721307|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
2721308|NCT03361436|Halichondrin B|halichondrin b|mesh-list
2721309|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
2721310|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
2721311|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
2721312|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721313|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721314|NCT03356483|Niacin|niacin|mesh-list
2721315|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
2721316|NCT03356483|Psilocybin|psilocybin|mesh-list
2721317|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2721318|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
2721319|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721320|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2202520|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202521|NCT00005896|Lenograstim|lenograstim|mesh-list
2202522|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2202523|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
2202524|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202525|NCT00005898|Cyclosporine|cyclosporine|mesh-list
2202526|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
2202527|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
2202528|NCT00005898|Fludarabine|fludarabine|mesh-list
2202529|NCT00005898|Cyclosporins|cyclosporins|mesh-list
2202530|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2202531|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202532|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
2721321|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
2721322|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
2721323|NCT03356483|Vitamins|vitamins|mesh-ancestor
2202533|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202534|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202535|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2721324|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
2721325|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721326|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
2721327|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2721340|NCT03289650|Tacrolimus|tacrolimus|mesh-list
2721341|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2721342|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
2721343|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721344|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2721345|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721346|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202536|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
2202537|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202538|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202539|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202540|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202541|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
2202542|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202543|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
2721411|NCT03276052|Bromides|bromides|mesh-list
2721412|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
2721413|NCT03275857|Cisplatin|cisplatin|mesh-list
2721414|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721415|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
2721416|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
2721417|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2721418|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721419|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721420|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2721433|NCT03219437|Methotrexate|methotrexate|mesh-list
2202544|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2202545|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2202546|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
2202547|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
2202548|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2202549|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2202550|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
2202551|NCT00005898|Hormones|hormones|mesh-ancestor
2202552|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2202553|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2202554|NCT00005898|Protective Agents|protective agents|mesh-ancestor
2721434|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2721435|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
2721436|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2721437|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721438|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2721439|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
2721440|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721441|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721442|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
2721443|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721444|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2721445|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2721446|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
2202555|NCT00005912|Voriconazole|voriconazole|mesh-list
2202556|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
2202557|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202558|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2721447|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2721448|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2721456|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
2721457|NCT03202537|Lansoprazole|lansoprazole|mesh-list
2721458|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2721459|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2721460|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2721461|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721462|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202559|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2202560|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202561|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202562|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2202563|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
2202564|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2202565|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202566|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2202567|NCT00005918|Lamivudine|lamivudine|mesh-list
2202568|NCT00005918|Efavirenz|efavirenz|mesh-list
2202569|NCT00005918|Stavudine|stavudine|mesh-list
2202570|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2202571|NCT00005918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2202572|NCT00005918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202573|NCT00005918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202574|NCT00005918|Antiviral Agents|antiviral agents|mesh-ancestor
2202575|NCT00005918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202576|NCT00005918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2202577|NCT00005918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2202578|NCT00005918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2202579|NCT00005918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2202580|NCT00005918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2202581|NCT00005918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2202582|NCT00005918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2202583|NCT00005918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2202584|NCT00005918|Antimetabolites|antimetabolites|mesh-ancestor
2202585|NCT00005920|Caspofungin|caspofungin|mesh-list
2202586|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
2202587|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202588|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202589|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202590|NCT00005921|Caspofungin|caspofungin|mesh-list
2202591|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
2202592|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202593|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202594|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202595|NCT00005922|Triamcinolone|triamcinolone|mesh-list
2721485|NCT03197935|Paclitaxel|paclitaxel|mesh-list
2721486|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
2721487|NCT03197935|Doxorubicin|doxorubicin|mesh-list
2721488|NCT03197935|Atezolizumab|atezolizumab|mesh-list
2721489|NCT03197935|Antibodies|antibodies|mesh-list
2721490|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2721491|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721492|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
2721493|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
2721494|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
2721495|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721496|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2721497|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
2721498|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721499|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2721500|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2721501|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
2721502|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2721503|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2721504|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2721505|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2721506|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721529|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
2721530|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721531|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
2721532|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721533|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721534|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2721535|NCT03150511|Tesamorelin|tesamorelin|mesh-list
2721536|NCT03150511|Growth Substances|growth substances|mesh-ancestor
2721537|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202596|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2202597|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2202598|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2202599|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2202600|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
2202601|NCT00005922|Hormones|hormones|mesh-ancestor
2202602|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2202603|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202604|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202605|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
2202606|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202607|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202608|NCT00005925|Muscimol|muscimol|mesh-list
2202609|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2202610|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
2721561|NCT03042819|Doxorubicin|doxorubicin|mesh-list
2721562|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2721563|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721564|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2721565|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2721566|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721567|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721568|NCT03037385|Pralsetinib|pralsetinib|mesh-list
2721569|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721570|NCT03030222|Empagliflozin|empagliflozin|mesh-list
2202611|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
2202612|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2202613|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202614|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202615|NCT00005926|Gemcitabine|gemcitabine|mesh-list
2202616|NCT00005926|Trastuzumab|trastuzumab|mesh-list
2202617|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202618|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
2202619|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202620|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202621|NCT00005926|Antiviral Agents|antiviral agents|mesh-ancestor
2202622|NCT00005926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202623|NCT00005926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721571|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2721572|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721573|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2721574|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202624|NCT00005926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2721611|NCT02892604|Insulin|insulin|mesh-list
2721612|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2721613|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721614|NCT02877134|Ustekinumab|ustekinumab|mesh-list
2721615|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
2721616|NCT02832687|Acetaminophen|acetaminophen|mesh-list
2721617|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2721618|NCT02832687|Analgesics|analgesics|mesh-ancestor
2721619|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
2721620|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2721621|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721622|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
2721623|NCT02830477|Factor VIII|factor viii|mesh-list
2721624|NCT02830477|Coagulants|coagulants|mesh-ancestor
2721625|NCT02819440|Tadalafil|tadalafil|mesh-list
2721626|NCT02819440|Vasodilator Agents|vasodilator agents|mesh-ancestor
2721627|NCT02819440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2721628|NCT02819440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2721629|NCT02819440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721630|NCT02819440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721631|NCT02819440|Urological Agents|urological agents|mesh-ancestor
2721632|NCT02789345|Osimertinib|osimertinib|mesh-list
2721633|NCT02789345|Ramucirumab|ramucirumab|mesh-list
2721634|NCT02789345|Necitumumab|necitumumab|mesh-list
2721635|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721636|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2721637|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721638|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721639|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2721643|NCT02703220|Acetazolamide|acetazolamide|mesh-list
2721644|NCT02703220|Finasteride|finasteride|mesh-list
2721645|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
2721646|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2721647|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721648|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721649|NCT02703220|Diuretics|diuretics|mesh-ancestor
2721650|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
2721651|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721652|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2721653|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2721654|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
2721655|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2721656|NCT02703220|Urological Agents|urological agents|mesh-ancestor
2721657|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
2721658|NCT02650986|Decitabine|decitabine|mesh-list
2721659|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2721660|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
2721661|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721662|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2721663|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2721664|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
2721665|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721666|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721667|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202625|NCT00005926|Immunologic Factors|immunologic factors|mesh-ancestor
2202626|NCT00005926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202627|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2202628|NCT00005928|Ramipril|ramipril|mesh-list
2202629|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2721668|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2721669|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
2721670|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721675|NCT02568449|Nintedanib|nintedanib|mesh-list
2721676|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721677|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2721678|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721679|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202630|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
2202631|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202632|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202633|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2202634|NCT00005931|Semaxinib|semaxinib|mesh-list
2202635|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2202636|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2202637|NCT00005931|Growth Substances|growth substances|mesh-ancestor
2202638|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721710|NCT02546622|Factor VIII|factor viii|mesh-list
2721711|NCT02546622|Coagulants|coagulants|mesh-ancestor
2721712|NCT02542696|Apomorphine|apomorphine|mesh-list
2721713|NCT02542696|Emetics|emetics|mesh-ancestor
2721714|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721715|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
2721716|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2721717|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2721718|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
2721719|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
2721720|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2721721|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721722|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
2202639|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
2202640|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202641|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2202642|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202643|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202644|NCT00005934|Azacitidine|azacitidine|mesh-list
2202645|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202646|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
2202647|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202648|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202649|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202650|NCT00005935|Cyclosporine|cyclosporine|mesh-list
2202651|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
2202652|NCT00005935|Cyclosporins|cyclosporins|mesh-list
2202653|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202654|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202655|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202656|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
2202657|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202658|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
2202659|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202660|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
2202661|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202662|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2202663|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2202664|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202665|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2202666|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
2202667|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2202668|NCT00005938|Exatecan|exatecan|mesh-list
2202669|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2202670|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202671|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202672|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202673|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721723|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
2721724|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2721725|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
2721726|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721727|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2721728|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202674|NCT00005940|Iodine|iodine|mesh-list
2202675|NCT00005940|Cyclosporine|cyclosporine|mesh-list
2202676|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
2202677|NCT00005940|Busulfan|busulfan|mesh-list
2202678|NCT00005940|Methotrexate|methotrexate|mesh-list
2202679|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2202680|NCT00005940|Cyclosporins|cyclosporins|mesh-list
2202681|NCT00005940|Antibodies|antibodies|mesh-list
2202682|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
2202683|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2202684|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202685|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
2202686|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202687|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202688|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202689|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
2202690|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202691|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202692|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202693|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2202694|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
2202695|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2202696|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202697|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
2202698|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
2202699|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202700|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2202701|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2721823|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
2721824|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721825|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
2721826|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721827|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721828|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2721829|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
2721830|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
2721831|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2721832|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721833|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2721834|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2721835|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2721836|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
2721837|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202702|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
2202703|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202704|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2721924|NCT02143388|Cisplatin|cisplatin|mesh-list
2721925|NCT02143388|Capecitabine|capecitabine|mesh-list
2721926|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721927|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2721928|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
2721929|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721933|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2721934|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
2721935|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202705|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2202706|NCT00005940|Trace Elements|trace elements|mesh-ancestor
2202707|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
2202708|NCT00005941|Cyclosporine|cyclosporine|mesh-list
2202709|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
2202710|NCT00005941|Fludarabine|fludarabine|mesh-list
2202711|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
2721970|NCT01530997|Cisplatin|cisplatin|mesh-list
2721971|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721972|NCT01331616|Bevacizumab|bevacizumab|mesh-list
2721973|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2721974|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2721975|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2721976|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2721977|NCT01331616|Growth Substances|growth substances|mesh-ancestor
2721978|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2721979|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
2721991|NCT01109004|Dexamethasone|dexamethasone|mesh-list
2721992|NCT01109004|Lenalidomide|lenalidomide|mesh-list
2721993|NCT01109004|Bortezomib|bortezomib|mesh-list
2721994|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2202712|NCT00005941|Cyclosporins|cyclosporins|mesh-list
2202713|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202714|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202715|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
2202716|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202717|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2721995|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
2721996|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
2721997|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2721998|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202718|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
2202719|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202720|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202721|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
2202722|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202723|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
2202724|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202725|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2202726|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2202727|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2202728|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
2202729|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2202730|NCT00005942|Daunorubicin|daunorubicin|mesh-list
2202731|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2721999|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2722000|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
2722001|NCT01109004|Hormones|hormones|mesh-ancestor
2722002|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2722003|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2722004|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2722005|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
2722006|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2722007|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2722008|NCT01109004|Growth Substances|growth substances|mesh-ancestor
2722009|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
2722010|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
2722011|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
2722012|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2722013|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
2722014|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722015|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2722016|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2722017|NCT00861705|Paclitaxel|paclitaxel|mesh-list
2722018|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
2722019|NCT00861705|Bevacizumab|bevacizumab|mesh-list
2722020|NCT00861705|Carboplatin|carboplatin|mesh-list
2722021|NCT00861705|Doxorubicin|doxorubicin|mesh-list
2722022|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2722023|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2722024|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2722025|NCT00861705|Antibodies|antibodies|mesh-list
2722026|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
2722027|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2722028|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
2722029|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
2722030|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2722031|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2722032|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
2722033|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
2722034|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
2722035|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722036|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2722037|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
2722038|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722039|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2722040|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2722041|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
2722042|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2722043|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2722044|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2722045|NCT00861705|Growth Substances|growth substances|mesh-ancestor
2722046|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
2722047|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2722048|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2722049|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2722050|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722055|NCT00603616|Rifaximin|rifaximin|mesh-list
2722056|NCT00603616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2722057|NCT00603616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2722058|NCT00603616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2722059|NCT00593905|Bosentan|bosentan|mesh-list
2722060|NCT00593905|Ambrisentan|ambrisentan|mesh-list
2722061|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
2722062|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2722063|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2722064|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722065|NCT00548912|Spironolactone|spironolactone|mesh-list
2722066|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2722067|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
2722068|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2722069|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722070|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2722071|NCT00548912|Diuretics|diuretics|mesh-ancestor
2722072|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
2722073|NCT00501826|Cytarabine|cytarabine|mesh-list
2722074|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
2722075|NCT00501826|Dexamethasone|dexamethasone|mesh-list
2722076|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
2722077|NCT00501826|Prednisone|prednisone|mesh-list
2722078|NCT00501826|Cortisone|cortisone|mesh-list
2722079|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
2722080|NCT00501826|Doxorubicin|doxorubicin|mesh-list
2722081|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2722082|NCT00501826|Methotrexate|methotrexate|mesh-list
2722083|NCT00501826|Vincristine|vincristine|mesh-list
2722084|NCT00501826|Asparaginase|asparaginase|mesh-list
2722085|NCT00501826|Venetoclax|venetoclax|mesh-list
2722086|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
2722087|NCT00501826|Pegaspargase|pegaspargase|mesh-list
2722088|NCT00501826|BB 1101|bb 1101|mesh-list
2722089|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2722090|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
2722091|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722092|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2722093|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2722094|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
2722095|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722096|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2722097|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2722098|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2722099|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
2722100|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
2722101|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2722102|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2722103|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
2722104|NCT00501826|Hormones|hormones|mesh-ancestor
2722105|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2722106|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2722107|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
2722108|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722109|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2722110|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2722111|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2722112|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2722113|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
2722114|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2722115|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202732|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2202733|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202734|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2202735|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202736|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202737|NCT00005943|Aldesleukin|aldesleukin|mesh-list
2202738|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202739|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2202740|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2202741|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
2202742|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202743|NCT00005944|Leucovorin|leucovorin|mesh-list
2202744|NCT00005944|Fluorouracil|fluorouracil|mesh-list
2202745|NCT00005944|Mitomycins|mitomycins|mesh-list
2202746|NCT00005944|Mitomycin|mitomycin|mesh-list
2202747|NCT00005944|Calcium|calcium|mesh-list
2202748|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
2202749|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2202750|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202751|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
2202752|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722116|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
2722117|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
2722118|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2722119|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2722120|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
2722121|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2722122|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2722123|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
2722124|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
2722125|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
2722126|NCT05154136|Itraconazole|itraconazole|mesh-list
2722127|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
2722128|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2722129|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2722130|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2722131|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722132|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722133|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2722134|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
2722135|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2722136|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722137|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2722138|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2722139|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2722140|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2722141|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
2722142|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722143|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2722144|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2722145|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722146|NCT05153928|Norethindrone|norethindrone|mesh-list
2722147|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
2722148|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2722149|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2722150|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2722151|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
2722152|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2722153|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722154|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2722155|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2722156|NCT05153915|Tacrolimus|tacrolimus|mesh-list
2722157|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2722158|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
2722159|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722160|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2722161|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722162|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722163|NCT05153785|Lidocaine|lidocaine|mesh-list
2722164|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
2722165|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
2722166|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2722167|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722168|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
2722169|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2722170|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2722171|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2722172|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2722173|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2722174|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722179|NCT05153668|Everolimus|everolimus|mesh-list
2722180|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2722181|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2722182|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
2722183|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722184|NCT05153603|Olaparib|olaparib|mesh-list
2722185|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2722186|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722187|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722188|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202753|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202754|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202755|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202756|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
2202757|NCT00005944|Antidotes|antidotes|mesh-ancestor
2202758|NCT00005944|Protective Agents|protective agents|mesh-ancestor
2202759|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
2202760|NCT00005944|Vitamins|vitamins|mesh-ancestor
2722221|NCT05153486|Ethanol|ethanol|mesh-list
2722222|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2722223|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2722224|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2722225|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722235|NCT05153395|Insulin|insulin|mesh-list
2722236|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2722237|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2722238|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722239|NCT05153317|Ivacaftor|ivacaftor|mesh-list
2722240|NCT05153317|Elexacaftor|elexacaftor|mesh-list
2722241|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2722242|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2722243|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722244|NCT05153304|Nivolumab|nivolumab|mesh-list
2722245|NCT05153304|Ipilimumab|ipilimumab|mesh-list
2722246|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2722247|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2722248|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2722249|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722257|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
2722258|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2722259|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
2722260|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722261|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2722262|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2722263|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
2722264|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722265|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2722266|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2722267|NCT05153200|Adalimumab|adalimumab|mesh-list
2722268|NCT05153200|Upadacitinib|upadacitinib|mesh-list
2722269|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2722270|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2722271|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2722272|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2722273|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722274|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722285|NCT05153070|Cyclosporine|cyclosporine|mesh-list
2722286|NCT05153070|Cyclosporins|cyclosporins|mesh-list
2722287|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722288|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722289|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2722290|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
2722291|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722292|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
2722293|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2722294|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
2722295|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2722296|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2722297|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
2722298|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2722299|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722300|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2722301|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722302|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
2722303|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2722304|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722305|NCT05152901|Epinephrine|epinephrine|mesh-list
2722306|NCT05152901|Racepinephrine|racepinephrine|mesh-list
2202761|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
2202762|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2202763|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
2202764|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2202765|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202766|NCT00005945|Cytarabine|cytarabine|mesh-list
2202767|NCT00005945|Dexamethasone|dexamethasone|mesh-list
2202768|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
2202769|NCT00005945|Doxorubicin|doxorubicin|mesh-list
2202770|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2202771|NCT00005945|Methotrexate|methotrexate|mesh-list
2202772|NCT00005945|Vincristine|vincristine|mesh-list
2202773|NCT00005945|Daunorubicin|daunorubicin|mesh-list
2202774|NCT00005945|Asparaginase|asparaginase|mesh-list
2202775|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
2202776|NCT00005945|Thioguanine|thioguanine|mesh-list
2202777|NCT00005945|Pegaspargase|pegaspargase|mesh-list
2202778|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202779|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
2202780|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722307|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
2722308|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2722309|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2722310|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
2722311|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2722312|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722313|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722314|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2722315|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2722316|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
2202781|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202782|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2722317|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2722318|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2722319|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
2722320|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
2722321|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
2722322|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2722337|NCT05152667|Dienogest|dienogest|mesh-list
2722338|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
2722339|NCT05152667|Progestins|progestins|mesh-list
2722340|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2722341|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
2722342|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2722343|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722344|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2722345|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2722346|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2722347|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2722348|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2722349|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
2722350|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2722351|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2722352|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2722353|NCT05152667|Hormones|hormones|mesh-ancestor
2722354|NCT05152628|Tacrolimus|tacrolimus|mesh-list
2722355|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2722356|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
2722357|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722358|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2722359|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202783|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
2722360|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722371|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
2722372|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2722373|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722374|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722375|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2722376|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2722377|NCT05152511|Protective Agents|protective agents|mesh-ancestor
2722378|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722379|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
2722380|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2722381|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
2202784|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202785|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202786|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202787|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2202788|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
2202789|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
2202790|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2202791|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2202792|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
2202793|NCT00005945|Hormones|hormones|mesh-ancestor
2202794|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2202795|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2202796|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2202797|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2202798|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2722396|NCT05132985|Carboplatin|carboplatin|mesh-list
2722397|NCT05132985|Pemetrexed|pemetrexed|mesh-list
2722398|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2722399|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722400|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722401|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2722402|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2722406|NCT05124171|Vaccines|vaccines|mesh-list
2722407|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
2722408|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722412|NCT05118399|Bupivacaine|bupivacaine|mesh-list
2722413|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
2722414|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
2722415|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2722416|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722417|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
2722418|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2202799|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202800|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2202801|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
2202802|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2722422|NCT05111821|Deferiprone|deferiprone|mesh-list
2722423|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2722424|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
2722425|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
2722426|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722437|NCT05096468|Pregabalin|pregabalin|mesh-list
2722438|NCT05096468|Ketamine|ketamine|mesh-list
2722439|NCT05096468|Esketamine|esketamine|mesh-list
2722440|NCT05096468|Analgesics|analgesics|mesh-ancestor
2202803|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202804|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
2202805|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
2722441|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
2722442|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2722443|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722444|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2722445|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2722446|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
2722447|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
2722448|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2722449|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2722450|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2722451|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2722452|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722453|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
2722454|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2722455|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2722456|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2722457|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2722458|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2722459|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2722460|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
2722461|NCT05095922|Valsartan|valsartan|mesh-list
2722462|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
2722463|NCT05095922|Calcium|calcium|mesh-list
2722464|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2722465|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722466|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2722467|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2722468|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2722469|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722470|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
2722471|NCT05095922|Coagulants|coagulants|mesh-ancestor
2722472|NCT05092698|Vitamin D|vitamin d|mesh-list
2722473|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
2722474|NCT05092698|Vitamins|vitamins|mesh-ancestor
2722475|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
2722476|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722477|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2722478|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2722479|NCT05090033|Ofatumumab|ofatumumab|mesh-list
2722480|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2722515|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
2722516|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2722517|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202806|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2202807|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2202808|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
2202809|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202810|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2202811|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
2202812|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
2202813|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
2202814|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
2202815|NCT00005946|Etoposide|etoposide|mesh-list
2202816|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202817|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
2202818|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202819|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202820|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202821|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
2202822|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202823|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202824|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202825|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2202826|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2202827|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202828|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202829|NCT00005948|Interferons|interferons|mesh-list
2202830|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
2202831|NCT00005948|Aldesleukin|aldesleukin|mesh-list
2202832|NCT00005948|Busulfan|busulfan|mesh-list
2202833|NCT00005948|Sargramostim|sargramostim|mesh-list
2202834|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202835|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
2202836|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202837|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
2202838|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202839|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
2423939|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2423940|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2423941|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2423942|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
2423943|NCT00824811|Hormones|hormones|mesh-ancestor
2423944|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2423945|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2423946|NCT00824863|Ketoconazole|ketoconazole|mesh-list
2423947|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
2423948|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2423949|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2202840|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202841|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202842|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202843|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202844|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2202845|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2202846|NCT00005949|Aldesleukin|aldesleukin|mesh-list
2202847|NCT00005949|Interleukin-2|interleukin-2|mesh-list
2202848|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202849|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2202850|NCT00005949|Analgesics|analgesics|mesh-ancestor
2202851|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
2202852|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2722562|NCT05010304|Amoxicillin|amoxicillin|mesh-list
2722563|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2722564|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2722568|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
2722569|NCT05003895|Fludarabine|fludarabine|mesh-list
2722570|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2722571|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
2722572|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722573|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2722574|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2722575|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
2722576|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722577|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2722578|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202853|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202854|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2202855|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2202856|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
2202857|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202858|NCT00005951|Irinotecan|irinotecan|mesh-list
2202859|NCT00005951|Temozolomide|temozolomide|mesh-list
2202860|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2202861|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202862|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202863|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202864|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202865|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202866|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
2202867|NCT00005952|Temozolomide|temozolomide|mesh-list
2202868|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202869|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
2202870|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202871|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202872|NCT00005954|Temozolomide|temozolomide|mesh-list
2202873|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202874|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
2202875|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202876|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202877|NCT00005955|Temozolomide|temozolomide|mesh-list
2202878|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202879|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
2202880|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202881|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202882|NCT00005958|Gemcitabine|gemcitabine|mesh-list
2202883|NCT00005958|Docetaxel|docetaxel|mesh-list
2202884|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202885|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
2202886|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202887|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202888|NCT00005958|Antiviral Agents|antiviral agents|mesh-ancestor
2202889|NCT00005958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202890|NCT00005958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202891|NCT00005958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202892|NCT00005958|Immunologic Factors|immunologic factors|mesh-ancestor
2202893|NCT00005958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202894|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
2202895|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
2202896|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
2202897|NCT00005959|Prednisone|prednisone|mesh-list
2202898|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
2202899|NCT00005959|Rituximab|rituximab|mesh-list
2202900|NCT00005959|Doxorubicin|doxorubicin|mesh-list
2202901|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2202902|NCT00005959|Vincristine|vincristine|mesh-list
2722635|NCT04947631|Tadalafil|tadalafil|mesh-list
2722636|NCT04947631|Dutasteride|dutasteride|mesh-list
2722637|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
2722638|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2722639|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2722640|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722641|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722642|NCT04947631|Urological Agents|urological agents|mesh-ancestor
2722643|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2722644|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2722645|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
2722646|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2722647|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202903|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202904|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
2202905|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202906|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202907|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202908|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
2202909|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202910|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202911|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2722702|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
2722711|NCT04905316|Durvalumab|durvalumab|mesh-list
2722712|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2722713|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202912|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2202913|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2202914|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2202915|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202916|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202917|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2202918|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
2202919|NCT00005959|Hormones|hormones|mesh-ancestor
2202920|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2202921|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2202922|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2202923|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
2202924|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
2202925|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
2202926|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
2202927|NCT00005960|Docetaxel|docetaxel|mesh-list
2202928|NCT00005960|Doxorubicin|doxorubicin|mesh-list
2202929|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2202930|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202931|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
2722726|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
2722727|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2722728|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202932|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202933|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202934|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202935|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
2202936|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202937|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202938|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202939|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
2202940|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
2202941|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
2202942|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2202943|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2202944|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202945|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202946|NCT00005961|Carmustine|carmustine|mesh-list
2202947|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2202948|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202949|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
2202950|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202951|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202952|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202953|NCT00005962|Cytarabine|cytarabine|mesh-list
2202954|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
2202955|NCT00005962|Topotecan|topotecan|mesh-list
2202956|NCT00005962|Daunorubicin|daunorubicin|mesh-list
2202957|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
2202958|NCT00005962|Sargramostim|sargramostim|mesh-list
2202959|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202960|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
2202961|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2202962|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202963|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202964|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
2722780|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
2722781|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2722782|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
2722783|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
2722784|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2722785|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722786|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2722787|NCT04884893|Analgesics|analgesics|mesh-ancestor
2722788|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
2722789|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2722790|NCT04883242|Dexamethasone|dexamethasone|mesh-list
2722791|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
2722792|NCT04883242|Pomalidomide|pomalidomide|mesh-list
2722793|NCT04883242|Ichthammol|ichthammol|mesh-list
2722794|NCT04883242|BB 1101|bb 1101|mesh-list
2722795|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2722796|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2722797|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
2722798|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
2202965|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722799|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2202966|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202967|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2202968|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2202969|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
2202970|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
2202971|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202972|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2202973|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2202974|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2202975|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2202976|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2722800|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722801|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2722802|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
2722803|NCT04883242|Hormones|hormones|mesh-ancestor
2722804|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2722805|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2722806|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2722807|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
2722808|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722809|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722810|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
2722811|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2722812|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2722813|NCT04883242|Growth Substances|growth substances|mesh-ancestor
2722814|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
2722815|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
2722823|NCT04877379|Ceftibuten|ceftibuten|mesh-list
2722824|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2722825|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2202977|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2202978|NCT00005963|Carboplatin|carboplatin|mesh-list
2202979|NCT00005963|Docetaxel|docetaxel|mesh-list
2202980|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202981|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
2202982|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
2202983|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
2202984|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202985|NCT00005964|Prednisone|prednisone|mesh-list
2202986|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
2202987|NCT00005964|Doxorubicin|doxorubicin|mesh-list
2202988|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2202989|NCT00005964|Etoposide|etoposide|mesh-list
2202990|NCT00005964|Vincristine|vincristine|mesh-list
2202991|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2202992|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
2202993|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722836|NCT04852679|Lanreotide|lanreotide|mesh-list
2722837|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2202994|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2202995|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2202996|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
2202997|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2202998|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2722884|NCT04814446|Vaccines|vaccines|mesh-list
2722885|NCT04814446|Immunologic Factors|immunologic factors|mesh-ancestor
2722886|NCT04814446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722892|NCT04778267|Dexamethasone|dexamethasone|mesh-list
2722893|NCT04778267|Bupivacaine|bupivacaine|mesh-list
2722894|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2722895|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2722896|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
2722897|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
2722898|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2722899|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722900|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2722901|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
2722902|NCT04778267|Hormones|hormones|mesh-ancestor
2722903|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2722904|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2722905|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2722906|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
2722907|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
2722908|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2722909|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
2722910|NCT04760717|Spironolactone|spironolactone|mesh-list
2722911|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2722912|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
2722913|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2722914|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722915|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2722916|NCT04760717|Diuretics|diuretics|mesh-ancestor
2722917|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
2202999|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2203000|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2203001|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203002|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203003|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203004|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2203005|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
2203006|NCT00005964|Hormones|hormones|mesh-ancestor
2203007|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2203008|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2203009|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203010|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
2722968|NCT04732182|Donepezil|donepezil|mesh-list
2722969|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2722970|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722971|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203011|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
2203012|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
2203013|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
2203014|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203015|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2203016|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
2203017|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203018|NCT00005966|Interferons|interferons|mesh-list
2203019|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
2203020|NCT00005966|Thalidomide|thalidomide|mesh-list
2722972|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
2722973|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2203021|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203022|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
2203023|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203024|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
2203025|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203026|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203027|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
2203028|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2203029|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2203030|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2203031|NCT00005966|Growth Substances|growth substances|mesh-ancestor
2203032|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
2203033|NCT00005967|Tipifarnib|tipifarnib|mesh-list
2722974|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722975|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
2722976|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
2722977|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2722978|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722979|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2722980|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2722983|NCT04703075|Rifapentine|rifapentine|mesh-list
2722984|NCT04703075|Rifampin|rifampin|mesh-list
2722985|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2722986|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
2722987|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2722988|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2722989|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
2722990|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2722991|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2722992|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2722993|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2722994|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2722995|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2722996|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2722997|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2722998|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2722999|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
2723000|NCT04702256|Prednisone|prednisone|mesh-list
2723001|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
2723002|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2723003|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2723004|NCT04702256|Prednisolone|prednisolone|mesh-list
2723005|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
2723006|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
2723007|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2723008|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
2723009|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
2723010|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2723011|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
2203034|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203035|NCT00005968|Irofulven|irofulven|mesh-list
2203036|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203037|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
2203038|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203039|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203040|NCT00005969|Tretinoin|tretinoin|mesh-list
2203041|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203042|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
2203043|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
2203044|NCT00005970|Tamoxifen|tamoxifen|mesh-list
2203045|NCT00005970|Paclitaxel|paclitaxel|mesh-list
2203046|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
2203047|NCT00005970|Doxorubicin|doxorubicin|mesh-list
2203048|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2203049|NCT00005970|Trastuzumab|trastuzumab|mesh-list
2203050|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2203051|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2203052|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2723012|NCT04702256|Hormones|hormones|mesh-ancestor
2723013|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2723014|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723015|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2203053|NCT00005970|Antibodies|antibodies|mesh-list
2203054|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
2723016|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2723017|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2723018|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2723019|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
2723020|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2723021|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2723022|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2723023|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723024|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
2723025|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
2723026|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2723027|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2723028|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2723029|NCT04702256|Protective Agents|protective agents|mesh-ancestor
2723030|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2723031|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2723032|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
2723033|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
2723034|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2723035|NCT04688814|Morphine|morphine|mesh-list
2723036|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2723037|NCT04688814|Narcotics|narcotics|mesh-ancestor
2723038|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2723039|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723040|NCT04688814|Analgesics|analgesics|mesh-ancestor
2723041|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
2723042|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2723069|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
2723070|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
2723071|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723092|NCT04624854|Aspirin|aspirin|mesh-list
2723093|NCT04624854|Clopidogrel|clopidogrel|mesh-list
2723094|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2723095|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2723096|NCT04624854|Analgesics|analgesics|mesh-ancestor
2723097|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
2723098|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2723099|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723100|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2723101|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2723102|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2723103|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2723104|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723105|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2723106|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2723107|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2723108|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
2723109|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2723110|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2723111|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2723112|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
2723113|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2723114|NCT04624230|Tofacitinib|tofacitinib|mesh-list
2723115|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2723116|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2723117|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203055|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2203056|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2203057|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203058|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203059|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
2203060|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
2203061|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
2203062|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203063|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203064|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
2203065|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203066|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2723215|NCT04571645|Heparin|heparin|mesh-list
2723216|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
2723217|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2723218|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2723219|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723220|NCT04570839|Nivolumab|nivolumab|mesh-list
2723221|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2723222|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2723223|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2723224|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203067|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203068|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
2203069|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2203070|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2203071|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203072|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203073|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203074|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2723236|NCT04564547|Islatravir|islatravir|mesh-list
2723237|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
2723238|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2723239|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2723240|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723241|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2723242|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2723243|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2723244|NCT04561180|Dexamethasone|dexamethasone|mesh-list
2723245|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2723246|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
2723247|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
2723248|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2723249|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723250|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2723251|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
2723252|NCT04561180|Hormones|hormones|mesh-ancestor
2723253|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2723254|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2723255|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2723256|NCT04546425|Vaccines|vaccines|mesh-list
2723257|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2723258|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
2723259|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203075|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
2203076|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2203077|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2203078|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2203079|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2203080|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2203081|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2203082|NCT00005971|Alvocidib|alvocidib|mesh-list
2203083|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203084|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
2203085|NCT00005971|Growth Substances|growth substances|mesh-ancestor
2203086|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203087|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2203088|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203089|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203090|NCT00005972|Gemcitabine|gemcitabine|mesh-list
2203091|NCT00005972|Irinotecan|irinotecan|mesh-list
2203092|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203093|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
2203094|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203095|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203096|NCT00005972|Antiviral Agents|antiviral agents|mesh-ancestor
2203097|NCT00005972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203098|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203099|NCT00005972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203100|NCT00005972|Immunologic Factors|immunologic factors|mesh-ancestor
2203101|NCT00005972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203102|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2203103|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2723277|NCT04527003|Cannabidiol|cannabidiol|mesh-list
2723278|NCT04527003|Norethindrone|norethindrone|mesh-list
2723279|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
2723280|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
2723281|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2723282|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2723283|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2723284|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
2723285|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2723286|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723287|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2723288|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2203104|NCT00005974|Alvocidib|alvocidib|mesh-list
2203105|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203106|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
2723302|NCT04486833|Osimertinib|osimertinib|mesh-list
2723303|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2723304|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2723305|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203107|NCT00005974|Growth Substances|growth substances|mesh-ancestor
2203108|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203109|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2203110|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203111|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203112|NCT00005975|Megestrol|megestrol|mesh-list
2203113|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
2203114|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2723306|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203115|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2203116|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2203117|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
2203118|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2203119|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203120|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2203121|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2203122|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2203123|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203124|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
2203125|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2203126|NCT00005976|Carboplatin|carboplatin|mesh-list
2203127|NCT00005976|NSC 366140|nsc 366140|mesh-list
2203128|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203129|NCT00005977|Leucovorin|leucovorin|mesh-list
2203130|NCT00005977|Cytarabine|cytarabine|mesh-list
2203131|NCT00005977|Dexamethasone|dexamethasone|mesh-list
2203132|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
2203133|NCT00005977|Ifosfamide|ifosfamide|mesh-list
2723337|NCT04477733|Butorphanol|butorphanol|mesh-list
2723338|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2723339|NCT04477733|Narcotics|narcotics|mesh-ancestor
2723340|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2723341|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723342|NCT04477733|Analgesics|analgesics|mesh-ancestor
2723343|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
2723344|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2723345|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
2723346|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
2723347|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2723348|NCT04457323|Metoprolol|metoprolol|mesh-list
2723349|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2203134|NCT00005977|Doxorubicin|doxorubicin|mesh-list
2203135|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2203136|NCT00005977|Methotrexate|methotrexate|mesh-list
2203137|NCT00005977|Etoposide|etoposide|mesh-list
2203138|NCT00005977|Vincristine|vincristine|mesh-list
2203139|NCT00005977|Lenograstim|lenograstim|mesh-list
2203140|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
2203141|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2723350|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2723351|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
2723352|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
2723353|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2723354|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723355|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2723356|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2723357|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2723358|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
2723359|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2723360|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723361|NCT04448431|Vortioxetine|vortioxetine|mesh-list
2723362|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2723363|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
2723364|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2723365|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2723366|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2723367|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2723368|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723369|NCT04448431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2723370|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2723371|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2723372|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723373|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2723374|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
2723375|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2203142|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
2203143|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203144|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2203145|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203146|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
2203147|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203148|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2723376|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2723377|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2723378|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2723379|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2203149|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2203150|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2203151|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
2203152|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
2203153|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2203154|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2203155|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
2203156|NCT00005977|Hormones|hormones|mesh-ancestor
2203157|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2203158|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2203159|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2203160|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203161|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203162|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203163|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2203164|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
2203165|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2203166|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203167|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
2203168|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
2203169|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2203170|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2723392|NCT04428385|Artemisinins|artemisinins|mesh-list
2723393|NCT04428385|Artemisinin|artemisinin|mesh-list
2723394|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
2723395|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2723396|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2723397|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2723438|NCT04372017|Vitamin D|vitamin d|mesh-list
2723439|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
2723440|NCT04372017|Vitamins|vitamins|mesh-ancestor
2723441|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
2723442|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723443|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2723444|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
2723445|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2723446|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2723447|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2723448|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203171|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203172|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2203173|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
2203174|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203175|NCT00005977|Antidotes|antidotes|mesh-ancestor
2203176|NCT00005977|Protective Agents|protective agents|mesh-ancestor
2203177|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
2203178|NCT00005977|Vitamins|vitamins|mesh-ancestor
2203179|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
2203180|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
2203181|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
2203182|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
2203183|NCT00005978|Carboplatin|carboplatin|mesh-list
2203184|NCT00005978|Etoposide|etoposide|mesh-list
2203185|NCT00005978|Melphalan|melphalan|mesh-list
2203186|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2203187|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203188|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203189|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2723449|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723450|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2203190|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203191|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203192|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203193|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
2723483|NCT04339049|Lidocaine|lidocaine|mesh-list
2723484|NCT04339049|Misoprostol|misoprostol|mesh-list
2203194|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203195|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203196|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
2203197|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2203198|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203199|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2203200|NCT00005979|Leucovorin|leucovorin|mesh-list
2203201|NCT00005979|Fluorouracil|fluorouracil|mesh-list
2203202|NCT00005979|Irinotecan|irinotecan|mesh-list
2203203|NCT00005979|Calcium|calcium|mesh-list
2203204|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
2203205|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2203206|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203207|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
2203208|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203209|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203210|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203211|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203212|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
2203213|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2203214|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2723485|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
2723486|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
2723487|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2723488|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723489|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
2723490|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2723491|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2723492|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2723493|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2723494|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2723495|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723496|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2723497|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
2723498|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2723499|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2723500|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2723501|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
2203215|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203216|NCT00005979|Antidotes|antidotes|mesh-ancestor
2203217|NCT00005979|Protective Agents|protective agents|mesh-ancestor
2203218|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
2203219|NCT00005979|Vitamins|vitamins|mesh-ancestor
2203220|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
2203221|NCT00005980|Doxorubicin|doxorubicin|mesh-list
2203222|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2203223|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2203224|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203225|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203226|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203227|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203228|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203229|NCT00005981|Carmustine|carmustine|mesh-list
2203230|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2203231|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203232|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
2203233|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203234|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203235|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2723522|NCT04312971|Norepinephrine|norepinephrine|mesh-list
2723523|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2723524|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2723525|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
2723526|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2723527|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723528|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723529|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
2723530|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
2723531|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2723532|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2723535|NCT04282278|Apatinib|apatinib|mesh-list
2723536|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2723537|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2723538|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2723539|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723546|NCT04243629|Pramlintide|pramlintide|mesh-list
2723547|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
2723548|NCT04243629|Pancrelipase|pancrelipase|mesh-list
2723549|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2723550|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723551|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2723576|NCT04194528|Acetaminophen|acetaminophen|mesh-list
2723577|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2723578|NCT04194528|Oxycodone|oxycodone|mesh-list
2723579|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2723580|NCT04194528|Analgesics|analgesics|mesh-ancestor
2723581|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
2723582|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2723583|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723584|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
2723585|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2723586|NCT04194528|Narcotics|narcotics|mesh-ancestor
2723587|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2723588|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2723589|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2723590|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2723591|NCT04179162|Gemcitabine|gemcitabine|mesh-list
2723592|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
2723593|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2723594|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
2723595|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723596|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2723597|NCT04179162|Antiviral Agents|antiviral agents|mesh-ancestor
2723598|NCT04179162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2723599|NCT04179162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2723600|NCT04179162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2723601|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
2723602|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723603|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2723604|NCT04176172|Nicotine|nicotine|mesh-list
2723605|NCT04176172|Varenicline|varenicline|mesh-list
2723606|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2723607|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
2723608|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2723609|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723610|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2723611|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2723612|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
2723613|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2723614|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723615|NCT04170998|Metformin|metformin|mesh-list
2723616|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
2723617|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2723618|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723619|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2723620|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723621|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2723622|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2723636|NCT04091750|Nivolumab|nivolumab|mesh-list
2723637|NCT04091750|Ipilimumab|ipilimumab|mesh-list
2723638|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2723639|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2723640|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2723641|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203236|NCT00005984|Interferons|interferons|mesh-list
2203237|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
2723647|NCT04082442|Evolocumab|evolocumab|mesh-list
2723648|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2723649|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2723650|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
2723651|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723652|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2723664|NCT04070573|Aspirin|aspirin|mesh-list
2723665|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2723666|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2723667|NCT04070573|Analgesics|analgesics|mesh-ancestor
2723668|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
2723669|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2723670|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723671|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2723672|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2723673|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2723674|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2723675|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723676|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2723677|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2723678|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2723679|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
2723680|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
2723681|NCT04070443|Ponatinib|ponatinib|mesh-list
2723682|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2723683|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2723684|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2723685|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723696|NCT04058067|Aflibercept|aflibercept|mesh-list
2723697|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2723698|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2723699|NCT04058067|Growth Substances|growth substances|mesh-ancestor
2723700|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723701|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
2723702|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203238|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
2203239|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203240|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
2203241|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203242|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2203243|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203244|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
2203245|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203246|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203247|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2203248|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
2203249|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203250|NCT00005985|Cytarabine|cytarabine|mesh-list
2203251|NCT00005985|Dexamethasone|dexamethasone|mesh-list
2203252|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
2203253|NCT00005985|Carmustine|carmustine|mesh-list
2203254|NCT00005985|Etoposide|etoposide|mesh-list
2203255|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
2203256|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203257|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
2203258|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203259|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2203260|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203261|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
2203262|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203263|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203264|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2203265|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2203266|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
2203267|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
2203268|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2723728|NCT03990077|Docetaxel|docetaxel|mesh-list
2723729|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2723730|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
2723731|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
2723732|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
2723733|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723734|NCT03972280|Antibodies|antibodies|mesh-list
2723735|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2723736|NCT03972280|Sargramostim|sargramostim|mesh-list
2723737|NCT03972280|Lenograstim|lenograstim|mesh-list
2723738|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
2723739|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723740|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2723741|NCT03954613|Memantine|memantine|mesh-list
2723742|NCT03954613|Donepezil|donepezil|mesh-list
2723743|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2723744|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2723745|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723746|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
2723747|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2723748|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723749|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
2723750|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2723751|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2723752|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
2723753|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2723754|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2723755|NCT03934372|Ponatinib|ponatinib|mesh-list
2723756|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2723757|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2723758|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2723759|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203269|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2203270|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
2203271|NCT00005985|Hormones|hormones|mesh-ancestor
2203272|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2203273|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2203274|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203275|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203276|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203277|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203278|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203279|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
2203280|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
2203281|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203282|NCT00005985|Analgesics|analgesics|mesh-ancestor
2203283|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
2203284|NCT00005986|Interferons|interferons|mesh-list
2203285|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
2203286|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
2203287|NCT00005986|Busulfan|busulfan|mesh-list
2203288|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203289|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
2203290|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203291|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2203292|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203293|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
2203294|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203295|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203296|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2203297|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
2203298|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203299|NCT00005987|Interferons|interferons|mesh-list
2203300|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
2203301|NCT00005987|Dexamethasone|dexamethasone|mesh-list
2203302|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
2203303|NCT00005987|Carmustine|carmustine|mesh-list
2203304|NCT00005987|Etoposide|etoposide|mesh-list
2203305|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
2203306|NCT00005987|Sargramostim|sargramostim|mesh-list
2203307|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203308|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
2203309|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203310|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2203311|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203312|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
2203313|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203314|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203315|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2203316|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2203317|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
2203318|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
2203319|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2203320|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2203321|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
2203322|NCT00005987|Hormones|hormones|mesh-ancestor
2203323|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2203324|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2203325|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203326|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203327|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203328|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203329|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
2203330|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2723904|NCT03842696|Cyclosporine|cyclosporine|mesh-list
2723905|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
2723906|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
2723907|NCT03842696|Methotrexate|methotrexate|mesh-list
2723908|NCT03842696|Vorinostat|vorinostat|mesh-list
2723909|NCT03842696|Tacrolimus|tacrolimus|mesh-list
2723910|NCT03842696|Cyclosporins|cyclosporins|mesh-list
2723911|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2723912|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
2723913|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2723914|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2723915|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2723916|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
2723917|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2723918|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2723919|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2723920|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2723921|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
2723922|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2723923|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2723924|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
2723925|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
2723926|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2723927|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2723928|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2203331|NCT00005987|Analgesics|analgesics|mesh-ancestor
2203332|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
2203333|NCT00005988|Leucovorin|leucovorin|mesh-list
2203334|NCT00005988|Cyclosporine|cyclosporine|mesh-list
2203335|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
2203336|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
2203337|NCT00005988|Methotrexate|methotrexate|mesh-list
2203338|NCT00005988|Cyclosporins|cyclosporins|mesh-list
2203339|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
2203340|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203341|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
2203342|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203343|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2203344|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203345|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
2203346|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203347|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2723929|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2723930|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
2723931|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2723932|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2723933|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2723934|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
2723935|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2723936|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2203348|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2203349|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2203350|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
2203351|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2203352|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203353|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
2203354|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
2203355|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203356|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2203357|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2203358|NCT00005988|Antidotes|antidotes|mesh-ancestor
2203359|NCT00005988|Protective Agents|protective agents|mesh-ancestor
2203360|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
2724010|NCT03792841|Etanercept|etanercept|mesh-list
2724011|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
2724012|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2724013|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2724014|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724015|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2724016|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2724017|NCT03792841|Analgesics|analgesics|mesh-ancestor
2724018|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
2724019|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2724020|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724021|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2724022|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2724023|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2724024|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2724025|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
2724026|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724038|NCT03775486|Gemcitabine|gemcitabine|mesh-list
2724039|NCT03775486|Paclitaxel|paclitaxel|mesh-list
2724040|NCT03775486|Cisplatin|cisplatin|mesh-list
2724041|NCT03775486|Carboplatin|carboplatin|mesh-list
2724042|NCT03775486|Pemetrexed|pemetrexed|mesh-list
2724043|NCT03775486|Durvalumab|durvalumab|mesh-list
2724044|NCT03775486|Olaparib|olaparib|mesh-list
2724045|NCT03775486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2724046|NCT03775486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2724047|NCT03775486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724048|NCT03775486|Tubulin Modulators|tubulin modulators|mesh-ancestor
2724049|NCT03775486|Antimitotic Agents|antimitotic agents|mesh-ancestor
2724050|NCT03775486|Mitosis Modulators|mitosis modulators|mesh-ancestor
2203361|NCT00005988|Vitamins|vitamins|mesh-ancestor
2203362|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
2203363|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
2203364|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203365|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2203366|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2203367|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
2203368|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
2203369|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2203370|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2203371|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
2203372|NCT00005988|Hormones|hormones|mesh-ancestor
2203373|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2203374|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2203375|NCT00005989|Tipifarnib|tipifarnib|mesh-list
2203376|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203377|NCT00005990|Topotecan|topotecan|mesh-list
2203378|NCT00005990|Tipifarnib|tipifarnib|mesh-list
2203379|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2203380|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203381|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203382|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203383|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203384|NCT00005991|Gemcitabine|gemcitabine|mesh-list
2203385|NCT00005991|Doxorubicin|doxorubicin|mesh-list
2203386|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2203387|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203388|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
2203389|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724051|NCT03775486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724052|NCT03775486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2724053|NCT03775486|Antimetabolites|antimetabolites|mesh-ancestor
2203390|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724054|NCT03775486|Antiviral Agents|antiviral agents|mesh-ancestor
2724055|NCT03775486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2724056|NCT03775486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203391|NCT00005991|Antiviral Agents|antiviral agents|mesh-ancestor
2203392|NCT00005991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203393|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203394|NCT00005991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203395|NCT00005991|Immunologic Factors|immunologic factors|mesh-ancestor
2203396|NCT00005991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203397|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2203398|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203399|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203400|NCT00005993|Aldesleukin|aldesleukin|mesh-list
2203401|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203402|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2203403|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2203404|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
2724057|NCT03775486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2724058|NCT03775486|Immunologic Factors|immunologic factors|mesh-ancestor
2724059|NCT03775486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724060|NCT03775486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2724061|NCT03775486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2724062|NCT03775486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2724063|NCT03775486|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2203405|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203406|NCT00005994|Ondansetron|ondansetron|mesh-list
2203407|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
2203408|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
2203409|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2203410|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203411|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2203412|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
2203413|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
2203414|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2203415|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
2203416|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2203417|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724088|NCT03761277|Morphine|morphine|mesh-list
2724089|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2724090|NCT03761277|Narcotics|narcotics|mesh-ancestor
2724091|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2724092|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203418|NCT00005994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2203419|NCT00005994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2203420|NCT00005994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2203421|NCT00005994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2203422|NCT00005994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2203423|NCT00005996|Gemcitabine|gemcitabine|mesh-list
2203424|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203425|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203426|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
2203427|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203428|NCT00005996|Antiviral Agents|antiviral agents|mesh-ancestor
2203429|NCT00005996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203430|NCT00005996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203431|NCT00005996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2724093|NCT03761277|Analgesics|analgesics|mesh-ancestor
2724094|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
2724095|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2724104|NCT03729258|Amantadine|amantadine|mesh-list
2724105|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2724106|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2724107|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
2724108|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2724109|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
2724110|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2724111|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724112|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724113|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2724114|NCT03729258|Analgesics|analgesics|mesh-ancestor
2724115|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
2724116|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2724140|NCT03716349|Anesthetics|anesthetics|mesh-list
2724141|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
2724142|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2724143|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724144|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
2724145|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2724171|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
2724172|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724173|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
2724174|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724175|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724176|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2724190|NCT03573960|Lenvatinib|lenvatinib|mesh-list
2724191|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724192|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2724193|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724194|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724195|NCT03527238|Tacrolimus|tacrolimus|mesh-list
2724196|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2724197|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
2724198|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724199|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2724200|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724201|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724202|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2724203|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724204|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724205|NCT03511664|177Lu-PSMA-617|177lu-psma-617|mesh-list
2724206|NCT03511664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2724207|NCT03511664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724208|NCT03490864|Melatonin|melatonin|mesh-list
2724209|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
2724210|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724211|NCT03490864|Protective Agents|protective agents|mesh-ancestor
2724212|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724213|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2724229|NCT03455764|Trametinib|trametinib|mesh-list
2724230|NCT03455764|Dabrafenib|dabrafenib|mesh-list
2724231|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724232|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2724233|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724234|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724235|NCT03380507|Thiamine|thiamine|mesh-list
2724236|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
2724237|NCT03380507|Vitamins|vitamins|mesh-ancestor
2724238|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
2724239|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724240|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2724241|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
2724242|NCT03376659|Bevacizumab|bevacizumab|mesh-list
2724243|NCT03376659|Durvalumab|durvalumab|mesh-list
2724244|NCT03376659|Capecitabine|capecitabine|mesh-list
2724245|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2724246|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724247|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2724248|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2724249|NCT03376659|Growth Substances|growth substances|mesh-ancestor
2724250|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724251|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
2724252|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2724253|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
2724254|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724255|NCT03363503|Fluticasone|fluticasone|mesh-list
2724256|NCT03363503|Xhance|xhance|mesh-list
2724257|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2724258|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2724259|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2724260|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
2724261|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2724262|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724263|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2724264|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
2724265|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
2724266|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2724267|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2724268|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2724269|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2724270|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
2724271|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2724272|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724276|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
2724277|NCT03321630|Lenvatinib|lenvatinib|mesh-list
2724278|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2724279|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724280|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2724281|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724282|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724303|NCT03257033|Gemcitabine|gemcitabine|mesh-list
2724304|NCT03257033|Paclitaxel|paclitaxel|mesh-list
2724305|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2724306|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724307|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
2724308|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
2724309|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
2724310|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724311|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2724312|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
2724313|NCT03257033|Antiviral Agents|antiviral agents|mesh-ancestor
2724314|NCT03257033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2724315|NCT03257033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724316|NCT03257033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2724317|NCT03257033|Immunologic Factors|immunologic factors|mesh-ancestor
2203432|NCT00005996|Immunologic Factors|immunologic factors|mesh-ancestor
2724318|NCT03257033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203433|NCT00005996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203434|NCT00005998|Cytarabine|cytarabine|mesh-list
2203435|NCT00005998|Dexamethasone|dexamethasone|mesh-list
2203436|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
2203437|NCT00005998|Carmustine|carmustine|mesh-list
2203438|NCT00005998|Etoposide|etoposide|mesh-list
2203439|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
2203440|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203441|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
2203442|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203443|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2203444|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203445|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
2203446|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203447|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724321|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
2724322|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2724323|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
2724324|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724325|NCT03235739|Naloxegol|naloxegol|mesh-list
2724326|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2724327|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724328|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
2724329|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2724334|NCT03194165|Ritonavir|ritonavir|mesh-list
2724335|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2724336|NCT03194165|Darunavir|darunavir|mesh-list
2724337|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
2724338|NCT03194165|Nevirapine|nevirapine|mesh-list
2724339|NCT03194165|Dolutegravir|dolutegravir|mesh-list
2724340|NCT03194165|Rilpivirine|rilpivirine|mesh-list
2724341|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2724342|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2724343|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
2724344|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724345|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724346|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2724347|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2724348|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
2724349|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2724350|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2724351|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2724352|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2724353|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2724354|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2724355|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2724356|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2724357|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2203448|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2203449|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2203450|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
2203451|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
2203452|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2203453|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2203454|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
2203455|NCT00005998|Hormones|hormones|mesh-ancestor
2203456|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2203457|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2203458|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203459|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203460|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203461|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203462|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203463|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
2724368|NCT03179475|Oxycodone|oxycodone|mesh-list
2724369|NCT03179475|Naloxone|naloxone|mesh-list
2724370|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2724371|NCT03179475|Narcotics|narcotics|mesh-ancestor
2724372|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2724373|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724374|NCT03179475|Analgesics|analgesics|mesh-ancestor
2724375|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
2724376|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2724377|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2724381|NCT03177746|Tadalafil|tadalafil|mesh-list
2724382|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
2724383|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2724384|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2724385|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724386|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724387|NCT03177746|Urological Agents|urological agents|mesh-ancestor
2724388|NCT03136497|Rituximab|rituximab|mesh-list
2724389|NCT03136497|Venetoclax|venetoclax|mesh-list
2724390|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2724391|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724392|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
2724393|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724394|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2724395|NCT03132129|Manganese|manganese|mesh-list
2724396|NCT03132129|Calcium|calcium|mesh-list
2724397|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2724398|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724399|NCT03132129|Trace Elements|trace elements|mesh-ancestor
2724400|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
2724401|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
2724402|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2724403|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724424|NCT03022097|Bromides|bromides|mesh-list
2724425|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
2724426|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2724427|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
2724428|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2724429|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724430|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2724431|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
2724432|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2724433|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2724434|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2203464|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
2724435|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
2724436|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2724437|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724438|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
2203465|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203466|NCT00005998|Analgesics|analgesics|mesh-ancestor
2203467|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
2203468|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
2203469|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203470|NCT00006000|Irinotecan|irinotecan|mesh-list
2203471|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203472|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2203473|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203474|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203475|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203476|NCT00006001|Semaxinib|semaxinib|mesh-list
2203477|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2203478|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2203479|NCT00006001|Growth Substances|growth substances|mesh-ancestor
2203480|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203481|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
2203482|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203483|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2203484|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203485|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203486|NCT00006002|Dexamethasone|dexamethasone|mesh-list
2724503|NCT02910700|Nivolumab|nivolumab|mesh-list
2724504|NCT02910700|Trametinib|trametinib|mesh-list
2724505|NCT02910700|Dabrafenib|dabrafenib|mesh-list
2724506|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2724507|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724508|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2724509|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724510|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2724511|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724512|NCT02898207|Olaparib|olaparib|mesh-list
2724513|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2724514|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724515|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724516|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203487|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2203488|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
2203489|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
2203490|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2203491|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203492|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2203493|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
2203494|NCT00006002|Hormones|hormones|mesh-ancestor
2203495|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2203496|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2203497|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203498|NCT00006003|Semaxinib|semaxinib|mesh-list
2203499|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2203500|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2203501|NCT00006003|Growth Substances|growth substances|mesh-ancestor
2203502|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203503|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
2203504|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203505|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2203506|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203507|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203508|NCT00006004|Gemcitabine|gemcitabine|mesh-list
2203509|NCT00006004|Paclitaxel|paclitaxel|mesh-list
2203510|NCT00006004|Carboplatin|carboplatin|mesh-list
2203511|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203512|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203513|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
2203514|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
2203515|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
2203516|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203517|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203518|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
2203519|NCT00006004|Antiviral Agents|antiviral agents|mesh-ancestor
2203520|NCT00006004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203521|NCT00006004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203522|NCT00006004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203523|NCT00006004|Immunologic Factors|immunologic factors|mesh-ancestor
2724557|NCT02777372|Sertraline|sertraline|mesh-list
2724558|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
2724559|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2724560|NCT02777372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2724561|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2724562|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2724563|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724564|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2724565|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
2724566|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724567|NCT02744092|Enoxaparin|enoxaparin|mesh-list
2724568|NCT02744092|Dalteparin|dalteparin|mesh-list
2724569|NCT02744092|PENTA|penta|mesh-list
2724570|NCT02744092|Warfarin|warfarin|mesh-list
2724571|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
2724572|NCT02744092|Dabigatran|dabigatran|mesh-list
2724573|NCT02744092|Apixaban|apixaban|mesh-list
2724574|NCT02744092|Edoxaban|edoxaban|mesh-list
2724575|NCT02744092|Fondaparinux|fondaparinux|mesh-list
2724576|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
2724577|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2724578|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
2724579|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2724580|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
2724581|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724582|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724583|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2724584|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2724607|NCT02682901|Bromocriptine|bromocriptine|mesh-list
2724608|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2724609|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2724610|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
2724611|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2724612|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724613|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
2724614|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
2724615|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2724616|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203524|NCT00006004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203525|NCT00006005|Thalidomide|thalidomide|mesh-list
2203526|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203527|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
2203528|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203529|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
2203530|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2203531|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203532|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2203533|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2203534|NCT00006005|Growth Substances|growth substances|mesh-ancestor
2203535|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
2203536|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203537|NCT00006006|Interferons|interferons|mesh-list
2203538|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
2203539|NCT00006006|Thalidomide|thalidomide|mesh-list
2203540|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203541|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
2203542|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203543|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
2203544|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203545|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2724637|NCT02567825|Amoxicillin|amoxicillin|mesh-list
2724638|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
2724639|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
2724640|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
2724641|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2724642|NCT02567825|Ofloxacin|ofloxacin|mesh-list
2724643|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2724644|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2724645|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2724646|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724647|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724648|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2724649|NCT02567825|Renal Agents|renal agents|mesh-ancestor
2724650|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2724651|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2724652|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724653|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2724654|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2203546|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
2203547|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2203548|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2203549|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2203550|NCT00006006|Growth Substances|growth substances|mesh-ancestor
2203551|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
2203552|NCT00006007|Gemcitabine|gemcitabine|mesh-list
2203553|NCT00006007|Pemetrexed|pemetrexed|mesh-list
2203554|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203555|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
2203556|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203557|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203558|NCT00006007|Antiviral Agents|antiviral agents|mesh-ancestor
2203559|NCT00006007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203560|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203561|NCT00006007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203562|NCT00006007|Immunologic Factors|immunologic factors|mesh-ancestor
2203563|NCT00006007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203564|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2203565|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2203566|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
2203567|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203568|NCT00006009|Visilizumab|visilizumab|mesh-list
2203569|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
2203570|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203571|NCT00006010|Gemcitabine|gemcitabine|mesh-list
2203572|NCT00006010|Docetaxel|docetaxel|mesh-list
2203573|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203574|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
2203575|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203576|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203577|NCT00006010|Antiviral Agents|antiviral agents|mesh-ancestor
2203578|NCT00006010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203579|NCT00006010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203580|NCT00006010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203581|NCT00006010|Immunologic Factors|immunologic factors|mesh-ancestor
2203582|NCT00006010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203583|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
2203584|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
2203585|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
2203586|NCT00006012|Paclitaxel|paclitaxel|mesh-list
2203587|NCT00006012|Etoposide|etoposide|mesh-list
2203588|NCT00006012|Topotecan|topotecan|mesh-list
2203589|NCT00006012|Amifostine|amifostine|mesh-list
2203590|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203591|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203592|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
2203593|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
2203594|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
2203595|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203596|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203597|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203598|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203599|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203600|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2203601|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2203602|NCT00006012|Protective Agents|protective agents|mesh-ancestor
2203603|NCT00006013|Semaxinib|semaxinib|mesh-list
2203604|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2203605|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2203606|NCT00006013|Growth Substances|growth substances|mesh-ancestor
2203607|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203608|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
2203609|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203610|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2203611|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203612|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203613|NCT00006014|Semaxinib|semaxinib|mesh-list
2203614|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2203615|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2203616|NCT00006014|Growth Substances|growth substances|mesh-ancestor
2203617|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724688|NCT02555657|Gemcitabine|gemcitabine|mesh-list
2724689|NCT02555657|Capecitabine|capecitabine|mesh-list
2724690|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
2724691|NCT02555657|Vinorelbine|vinorelbine|mesh-list
2724692|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2724693|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
2724694|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724695|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724696|NCT02555657|Antiviral Agents|antiviral agents|mesh-ancestor
2724697|NCT02555657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2724698|NCT02555657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724699|NCT02555657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2724700|NCT02555657|Immunologic Factors|immunologic factors|mesh-ancestor
2724701|NCT02555657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724702|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2724703|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2724704|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
2724705|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
2724706|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
2724711|NCT02457156|Octreotide|octreotide|mesh-list
2724712|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2724713|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2724714|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724715|NCT02451553|Capecitabine|capecitabine|mesh-list
2724716|NCT02451553|Afatinib|afatinib|mesh-list
2724717|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2724718|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
2724719|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724720|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724721|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2724722|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724723|NCT02402439|Pancrelipase|pancrelipase|mesh-list
2724724|NCT02402439|Pancreatin|pancreatin|mesh-list
2724725|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2724729|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
2724730|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724731|NCT02272348|Insulin|insulin|mesh-list
2724732|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2724733|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203618|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
2203619|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203620|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2203621|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203622|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203623|NCT00006015|Leucovorin|leucovorin|mesh-list
2203624|NCT00006015|Fluorouracil|fluorouracil|mesh-list
2203625|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
2203626|NCT00006015|Trastuzumab|trastuzumab|mesh-list
2203627|NCT00006015|Calcium|calcium|mesh-list
2203628|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
2203629|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2203630|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203631|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
2203632|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203633|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203634|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203635|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203636|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
2203637|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2203638|NCT00006015|Antidotes|antidotes|mesh-ancestor
2203639|NCT00006015|Protective Agents|protective agents|mesh-ancestor
2203640|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
2203641|NCT00006015|Vitamins|vitamins|mesh-ancestor
2203642|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
2203643|NCT00006016|Thalidomide|thalidomide|mesh-list
2203644|NCT00006016|Doxorubicin|doxorubicin|mesh-list
2203645|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2203646|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2203647|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724771|NCT02190721|Lenograstim|lenograstim|mesh-list
2724772|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2724773|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
2724774|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724775|NCT02109744|Decitabine|decitabine|mesh-list
2724776|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2724777|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
2724778|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724779|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724780|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724792|NCT01811576|Hormones|hormones|mesh-list
2724793|NCT01811576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2724794|NCT01811576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203648|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203649|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203650|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203651|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203652|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203653|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
2203654|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203655|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
2203656|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2203657|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2724810|NCT01740557|Aldesleukin|aldesleukin|mesh-list
2724811|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
2724812|NCT01740557|Fludarabine|fludarabine|mesh-list
2724813|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
2724814|NCT01740557|Interleukin-2|interleukin-2|mesh-list
2724815|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2724816|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
2724817|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724818|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2724819|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2724820|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
2724821|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724822|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724823|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2724824|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203658|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2203659|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2203660|NCT00006016|Growth Substances|growth substances|mesh-ancestor
2203661|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
2203662|NCT00006018|Paclitaxel|paclitaxel|mesh-list
2203663|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203664|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203665|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
2203666|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
2203667|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
2203668|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203669|NCT00006019|Azacitidine|azacitidine|mesh-list
2203670|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2203671|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203672|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
2203673|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203674|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203675|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203676|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
2203677|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
2203678|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
2203679|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203680|NCT00006021|Protective Agents|protective agents|mesh-ancestor
2203681|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203682|NCT00006021|Vitamins|vitamins|mesh-ancestor
2724825|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
2724826|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2724827|NCT01740557|Analgesics|analgesics|mesh-ancestor
2724828|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
2724829|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2724830|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2203683|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
2724831|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2724832|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
2724833|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2724834|NCT01625611|Naltrexone|naltrexone|mesh-list
2724835|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2724836|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2724837|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724838|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
2724839|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2203684|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203685|NCT00006022|Aldesleukin|aldesleukin|mesh-list
2203686|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
2203687|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203688|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2203689|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2203690|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
2203691|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203692|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2203693|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
2203694|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724930|NCT00903110|Mecasermin|mecasermin|mesh-list
2724931|NCT00903110|Growth Substances|growth substances|mesh-ancestor
2724932|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724933|NCT00715611|Carboplatin|carboplatin|mesh-list
2724934|NCT00715611|Pemetrexed|pemetrexed|mesh-list
2724935|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724936|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2724937|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724938|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2724939|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2724940|NCT00308516|Leucovorin|leucovorin|mesh-list
2724941|NCT00308516|Bevacizumab|bevacizumab|mesh-list
2724942|NCT00308516|Fluorouracil|fluorouracil|mesh-list
2724943|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
2724944|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2724945|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724946|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2724947|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2724948|NCT00308516|Growth Substances|growth substances|mesh-ancestor
2724949|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2724950|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
2724951|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
2724952|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2724953|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2724954|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2724955|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
2203695|NCT00006023|Capecitabine|capecitabine|mesh-list
2203696|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203697|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
2203698|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203699|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203700|NCT00006024|Temozolomide|temozolomide|mesh-list
2203701|NCT00006024|Lomustine|lomustine|mesh-list
2203702|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203703|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
2203704|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203705|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203706|NCT00006025|Irinotecan|irinotecan|mesh-list
2203707|NCT00006025|Temozolomide|temozolomide|mesh-list
2203708|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2203709|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203710|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203711|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203712|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2724956|NCT00308516|Antidotes|antidotes|mesh-ancestor
2724957|NCT00308516|Protective Agents|protective agents|mesh-ancestor
2203713|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203714|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
2203715|NCT00006026|Rubitecan|rubitecan|mesh-list
2203716|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203717|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2203718|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2724958|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
2724959|NCT00308516|Vitamins|vitamins|mesh-ancestor
2724960|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
2203719|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203720|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203721|NCT00006027|Paclitaxel|paclitaxel|mesh-list
2203722|NCT00006027|Cisplatin|cisplatin|mesh-list
2203723|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203724|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203725|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
2203726|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
2203727|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
2203728|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203729|NCT00006028|Gemcitabine|gemcitabine|mesh-list
2203730|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203731|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203732|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
2203733|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203734|NCT00006028|Antiviral Agents|antiviral agents|mesh-ancestor
2203735|NCT00006028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203736|NCT00006028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203737|NCT00006028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203738|NCT00006028|Immunologic Factors|immunologic factors|mesh-ancestor
2203739|NCT00006028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203740|NCT00006029|Gemcitabine|gemcitabine|mesh-list
2203741|NCT00006029|Doxorubicin|doxorubicin|mesh-list
2203742|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2203743|NCT00006029|Vinorelbine|vinorelbine|mesh-list
2725028|NCT00005780|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2725029|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
2725030|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203744|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203745|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
2203746|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203747|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203748|NCT00006029|Antiviral Agents|antiviral agents|mesh-ancestor
2203749|NCT00006029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203750|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203751|NCT00006029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203752|NCT00006029|Immunologic Factors|immunologic factors|mesh-ancestor
2203753|NCT00006029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203754|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2203755|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203756|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203757|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203758|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
2203759|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
2203760|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
2203761|NCT00006030|Tamoxifen|tamoxifen|mesh-list
2203762|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2203763|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
2203764|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2203765|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203766|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2725085|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
2725086|NCT02325960|Exenatide|exenatide|mesh-list
2725087|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2725088|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725089|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2725090|NCT02325960|Incretins|incretins|mesh-ancestor
2725091|NCT02325960|Hormones|hormones|mesh-ancestor
2725092|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2725093|NCT05155592|Adalimumab|adalimumab|mesh-list
2725094|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2725095|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2725096|NCT05155579|Vaccines|vaccines|mesh-list
2725097|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
2725098|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203767|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203768|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2203769|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2203770|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2203771|NCT00006032|Etoposide|etoposide|mesh-list
2203772|NCT00006032|Topotecan|topotecan|mesh-list
2203773|NCT00006032|Ifosfamide|ifosfamide|mesh-list
2203774|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203775|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203776|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203777|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203778|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203779|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2725104|NCT05155527|Ivermectin|ivermectin|mesh-list
2725105|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2725106|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2725107|NCT05155436|Amlodipine|amlodipine|mesh-list
2725108|NCT05155436|Telmisartan|telmisartan|mesh-list
2725109|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2725110|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2725111|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2725112|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203780|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2725113|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2725114|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725115|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
2725116|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2725117|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2725128|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
2725129|NCT05155215|Fludarabine|fludarabine|mesh-list
2725130|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2725131|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
2725132|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725133|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2725134|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2725135|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
2725136|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2725137|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2725138|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2725139|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
2725158|NCT05155124|Cetuximab|cetuximab|mesh-list
2725159|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2203781|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203782|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
2203783|NCT00006033|Methotrexate|methotrexate|mesh-list
2203784|NCT00006033|Interleukin-2|interleukin-2|mesh-list
2203785|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2203786|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
2203787|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2203788|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203789|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203790|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
2203791|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203792|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203793|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
2203794|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203795|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2203796|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203797|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
2203798|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2203799|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2203800|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2203801|NCT00006033|Analgesics|analgesics|mesh-ancestor
2203802|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
2203803|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2203804|NCT00006034|Doxorubicin|doxorubicin|mesh-list
2203805|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2203806|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2203807|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2203808|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203809|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203810|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203811|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203812|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203813|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2203814|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
2203815|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203816|NCT00006035|Bleomycin|bleomycin|mesh-list
2203817|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2203818|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203819|NCT00006036|Lurtotecan|lurtotecan|mesh-list
2203820|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203821|NCT00006037|Fluorouracil|fluorouracil|mesh-list
2203822|NCT00006037|Irinotecan|irinotecan|mesh-list
2203823|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
2203824|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203825|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203826|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203827|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203828|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
2203829|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203830|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2203831|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203832|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203833|NCT00006038|Leucovorin|leucovorin|mesh-list
2203834|NCT00006038|Docetaxel|docetaxel|mesh-list
2203835|NCT00006038|Fluorouracil|fluorouracil|mesh-list
2203836|NCT00006038|Floxuridine|floxuridine|mesh-list
2203837|NCT00006038|Calcium|calcium|mesh-list
2203838|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
2203839|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203840|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
2203841|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
2203842|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
2203843|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203844|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2203845|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203846|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
2203847|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203848|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203849|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
2203850|NCT00006038|Antidotes|antidotes|mesh-ancestor
2203851|NCT00006038|Protective Agents|protective agents|mesh-ancestor
2203852|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
2203853|NCT00006038|Vitamins|vitamins|mesh-ancestor
2203854|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
2203855|NCT00006039|Interferons|interferons|mesh-list
2203856|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
2203857|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203858|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
2203859|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203860|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
2203861|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203862|NCT00006040|Etoposide|etoposide|mesh-list
2203863|NCT00006040|Antibodies|antibodies|mesh-list
2203864|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2203865|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
2203866|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203867|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203868|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203869|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203870|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203871|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203872|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203873|NCT00006041|Vaccines|vaccines|mesh-list
2203874|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
2203875|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
2203876|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203877|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2203878|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
2203879|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
2203880|NCT00006042|Fludarabine|fludarabine|mesh-list
2203881|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
2203882|NCT00006042|Tacrolimus|tacrolimus|mesh-list
2203883|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203884|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
2203885|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203886|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2203887|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2725160|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203888|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
2203889|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203890|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203891|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2203892|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203893|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
2203894|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2203895|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203896|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2203897|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2203898|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
2203899|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2203900|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203901|NCT00006043|Temozolomide|temozolomide|mesh-list
2203902|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2203903|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
2203904|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203905|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203906|NCT00006044|Testosterone|testosterone|mesh-list
2203907|NCT00006044|Androgens|androgens|mesh-ancestor
2203908|NCT00006044|Hormones|hormones|mesh-ancestor
2203909|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2203910|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203911|NCT00006045|Cytarabine|cytarabine|mesh-list
2203912|NCT00006045|Etoposide|etoposide|mesh-list
2203913|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
2203914|NCT00006045|Lintuzumab|lintuzumab|mesh-list
2203915|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203916|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203917|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2203918|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203919|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2725201|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2725202|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2725203|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
2725204|NCT05154747|Rilpivirine|rilpivirine|mesh-list
2725205|NCT05154747|Cabotegravir|cabotegravir|mesh-list
2725206|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2725207|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2725208|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2725209|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203920|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203921|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203922|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
2203923|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
2203924|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203925|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203926|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
2203927|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203928|NCT00006045|Analgesics|analgesics|mesh-ancestor
2203929|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
2203930|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2203931|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2203932|NCT00006047|Etoposide|etoposide|mesh-list
2203933|NCT00006047|Rubitecan|rubitecan|mesh-list
2203934|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
2203935|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203936|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203937|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2725210|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
2725211|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2725212|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2725213|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2725214|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2725215|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2203938|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2203939|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203940|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203941|NCT00006048|Gemcitabine|gemcitabine|mesh-list
2203942|NCT00006048|Gefitinib|gefitinib|mesh-list
2203943|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203944|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203945|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
2203946|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203947|NCT00006048|Antiviral Agents|antiviral agents|mesh-ancestor
2203948|NCT00006048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2203949|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203950|NCT00006048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203951|NCT00006048|Immunologic Factors|immunologic factors|mesh-ancestor
2203952|NCT00006048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203953|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2203954|NCT00006049|Paclitaxel|paclitaxel|mesh-list
2203955|NCT00006049|Carboplatin|carboplatin|mesh-list
2203956|NCT00006049|Gefitinib|gefitinib|mesh-list
2203957|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2203958|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203959|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
2203960|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
2203961|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
2203962|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203963|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2203964|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203965|NCT00006050|Leucovorin|leucovorin|mesh-list
2203966|NCT00006050|Fluorouracil|fluorouracil|mesh-list
2203967|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
2203968|NCT00006050|Calcium|calcium|mesh-list
2203969|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
2203970|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2203971|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203972|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
2203973|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203974|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203975|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203976|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203977|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
2203978|NCT00006050|Antidotes|antidotes|mesh-ancestor
2203979|NCT00006050|Protective Agents|protective agents|mesh-ancestor
2203980|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
2725220|NCT05154682|Acetaminophen|acetaminophen|mesh-list
2725221|NCT05154682|Naproxen|naproxen|mesh-list
2725222|NCT05154682|Oxycodone|oxycodone|mesh-list
2725223|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2725224|NCT05154682|Analgesics|analgesics|mesh-ancestor
2725225|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
2725226|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2203981|NCT00006050|Vitamins|vitamins|mesh-ancestor
2203982|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
2203983|NCT00006051|Fluorouracil|fluorouracil|mesh-list
2203984|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203985|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
2203986|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2725227|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725228|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
2725229|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2725230|NCT05154682|Narcotics|narcotics|mesh-ancestor
2725231|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2203987|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2203988|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2203989|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
2203990|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2203991|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
2203992|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203993|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2203994|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2203995|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2203996|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
2203997|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2203998|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2203999|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204000|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204001|NCT00006054|Cyclosporine|cyclosporine|mesh-list
2204002|NCT00006054|Prednisone|prednisone|mesh-list
2204003|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
2204004|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
2204005|NCT00006054|Busulfan|busulfan|mesh-list
2204006|NCT00006054|Methotrexate|methotrexate|mesh-list
2204007|NCT00006054|Etoposide|etoposide|mesh-list
2204008|NCT00006054|Cyclosporins|cyclosporins|mesh-list
2204009|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2204010|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204011|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
2204012|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204013|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2204014|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2204015|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
2204016|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204017|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204018|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2204019|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2204020|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
2204021|NCT00006054|Hormones|hormones|mesh-ancestor
2204022|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2204023|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2204024|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2204025|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
2204026|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2204027|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204028|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
2204029|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
2204030|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204031|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2204032|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2204033|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2204034|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2204035|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2204036|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
2204037|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204038|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2204039|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
2204040|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
2204041|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2204042|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2204043|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2204044|NCT00006054|Protective Agents|protective agents|mesh-ancestor
2204045|NCT00006055|Cyclosporine|cyclosporine|mesh-list
2725232|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2725233|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2725234|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2725235|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
2725236|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2725237|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2725238|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2725239|NCT05154487|Fulvestrant|fulvestrant|mesh-list
2725240|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2725241|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2725242|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2725243|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2725244|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
2725245|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2725246|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725247|NCT05154396|Loperamide|loperamide|mesh-list
2725248|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
2725249|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2725250|NCT05154383|Vaccines|vaccines|mesh-list
2725251|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
2725252|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204046|NCT00006055|Prednisone|prednisone|mesh-list
2204047|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
2204048|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
2204049|NCT00006055|Cyclosporins|cyclosporins|mesh-list
2204050|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2204051|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204052|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
2204053|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204054|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2204055|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2204056|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
2204057|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204058|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204059|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2204060|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2204061|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
2204062|NCT00006055|Hormones|hormones|mesh-ancestor
2204063|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2204064|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2204065|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204066|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
2204067|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204068|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
2204069|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2204070|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
2204071|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
2204072|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2204073|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2204074|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2204075|NCT00006055|Protective Agents|protective agents|mesh-ancestor
2204076|NCT00006056|Cyclosporine|cyclosporine|mesh-list
2204077|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
2204078|NCT00006056|Busulfan|busulfan|mesh-list
2204079|NCT00006056|Methotrexate|methotrexate|mesh-list
2204080|NCT00006056|Etoposide|etoposide|mesh-list
2204081|NCT00006056|Cyclosporins|cyclosporins|mesh-list
2204082|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2204083|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204084|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
2204085|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204086|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2204087|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2204088|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
2204089|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204090|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204091|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2204092|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2204093|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
2204094|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2204095|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204096|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
2204097|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
2204098|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204099|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2725253|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
2725254|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
2725255|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725256|NCT05154279|Terlipressin|terlipressin|mesh-list
2725257|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2725258|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2204100|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2204101|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2204102|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2204103|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2204104|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
2204105|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204106|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2204107|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
2204108|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204109|NCT00006063|Pancrelipase|pancrelipase|mesh-list
2204110|NCT00006063|Pancreatin|pancreatin|mesh-list
2204111|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2204112|NCT00006066|Aldesleukin|aldesleukin|mesh-list
2204113|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204114|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2204115|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2204116|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
2204117|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204118|NCT00006070|Etanercept|etanercept|mesh-list
2204119|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2204120|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2204121|NCT00006070|Analgesics|analgesics|mesh-ancestor
2204122|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
2204123|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2204124|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204125|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2204126|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2204127|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2204128|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204129|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
2204130|NCT00006072|Rituximab|rituximab|mesh-list
2204131|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2204132|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204133|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
2204134|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204135|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2204136|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
2204137|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2204138|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2204139|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204140|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
2204141|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
2204142|NCT00006077|Levodopa|levodopa|mesh-list
2204143|NCT00006077|Domperidone|domperidone|mesh-list
2204144|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2204145|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2204146|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
2204147|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2204148|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204149|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204150|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
2204151|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
2725295|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
2725296|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2204152|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2204153|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2204154|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2204155|NCT00006078|Lycopene|lycopene|mesh-list
2204156|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2204157|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
2204158|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204159|NCT00006078|Protective Agents|protective agents|mesh-ancestor
2204160|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204161|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2204162|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2204163|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204164|NCT00006079|Eflornithine|eflornithine|mesh-list
2204165|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204166|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2204167|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2204168|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2204169|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204170|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2204171|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204172|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204173|NCT00006080|Fenretinide|fenretinide|mesh-list
2204174|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204175|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2204176|NCT00006080|Protective Agents|protective agents|mesh-ancestor
2204177|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204178|NCT00006081|Paclitaxel|paclitaxel|mesh-list
2204179|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
2204180|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2204181|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204182|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
2204183|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
2204184|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
2204185|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204186|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2204187|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
2204188|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204189|NCT00006082|Rubitecan|rubitecan|mesh-list
2204190|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204191|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2204192|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2204193|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204194|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204195|NCT00006083|Dalteparin|dalteparin|mesh-list
2204196|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
2204197|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2204198|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2204199|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204200|NCT00006084|Lintuzumab|lintuzumab|mesh-list
2204201|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2204202|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204203|NCT00006086|Carboplatin|carboplatin|mesh-list
2204204|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204205|NCT00006088|Vinorelbine|vinorelbine|mesh-list
2204206|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2204207|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204208|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
2725297|NCT05134584|Lactulose|lactulose|mesh-list
2725298|NCT05134584|Linaclotide|linaclotide|mesh-list
2204209|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
2204210|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
2204211|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204212|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2204213|NCT00006089|Trastuzumab|trastuzumab|mesh-list
2204214|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2204215|NCT00006089|Antibodies|antibodies|mesh-list
2204216|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
2204217|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2204218|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
2204219|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204220|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204221|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
2204222|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204223|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
2204224|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204225|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
2204226|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204227|NCT00006094|Fluorouracil|fluorouracil|mesh-list
2204228|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
2204229|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
2204230|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204231|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204232|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204233|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204234|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
2204235|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204236|NCT00006095|Irinotecan|irinotecan|mesh-list
2204237|NCT00006095|Vincristine|vincristine|mesh-list
2204238|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2204239|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2204240|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204241|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204242|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204243|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2204244|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
2204245|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
2204246|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
2204247|NCT00006096|Cisplatin|cisplatin|mesh-list
2725299|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2725300|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2725301|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
2725302|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2725303|NCT05134415|Menthol|menthol|mesh-list
2725304|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
2725305|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
2725306|NCT05129475|Ritonavir|ritonavir|mesh-list
2725307|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2725308|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2725309|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
2725310|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2725311|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2725312|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2725313|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2204248|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204249|NCT00006098|Bortezomib|bortezomib|mesh-list
2204250|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204251|NCT00006100|Aldesleukin|aldesleukin|mesh-list
2204252|NCT00006100|Fludarabine|fludarabine|mesh-list
2204253|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
2204254|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204255|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204256|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
2204257|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204258|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204259|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
2204260|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204261|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2204262|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2204263|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
2204264|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204265|NCT00006103|Leucovorin|leucovorin|mesh-list
2204266|NCT00006103|Fluorouracil|fluorouracil|mesh-list
2204267|NCT00006103|Irinotecan|irinotecan|mesh-list
2204268|NCT00006103|Calcium|calcium|mesh-list
2204269|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
2204270|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2204271|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725314|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
2725315|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2725316|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2725317|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2204272|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
2204273|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204274|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204275|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204276|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204277|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
2204278|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2204279|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2204280|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204281|NCT00006103|Antidotes|antidotes|mesh-ancestor
2204282|NCT00006103|Protective Agents|protective agents|mesh-ancestor
2204283|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
2204284|NCT00006103|Vitamins|vitamins|mesh-ancestor
2204285|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
2204286|NCT00006104|Docetaxel|docetaxel|mesh-list
2204287|NCT00006104|Trastuzumab|trastuzumab|mesh-list
2204288|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204289|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
2204290|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
2204291|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
2204292|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204293|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2204294|NCT00006105|Gemcitabine|gemcitabine|mesh-list
2204295|NCT00006105|Amifostine|amifostine|mesh-list
2204296|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204297|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204298|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
2204299|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204300|NCT00006105|Antiviral Agents|antiviral agents|mesh-ancestor
2204301|NCT00006105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204302|NCT00006105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204303|NCT00006105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204304|NCT00006105|Immunologic Factors|immunologic factors|mesh-ancestor
2204305|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204306|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2204307|NCT00006105|Protective Agents|protective agents|mesh-ancestor
2204308|NCT00006106|Fluorouracil|fluorouracil|mesh-list
2204309|NCT00006106|Dl1520|dl1520|mesh-list
2204310|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204311|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
2204312|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204313|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204314|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204315|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
2204316|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204317|NCT00006107|Docetaxel|docetaxel|mesh-list
2204318|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204319|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
2204320|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
2204321|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
2204322|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204323|NCT00006108|Paclitaxel|paclitaxel|mesh-list
2204324|NCT00006108|Capecitabine|capecitabine|mesh-list
2204325|NCT00006108|Trastuzumab|trastuzumab|mesh-list
2204326|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2204327|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204328|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
2204329|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
2204330|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
2725342|NCT05115838|Islatravir|islatravir|mesh-list
2725343|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
2725344|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2725345|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2725346|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2725347|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2725348|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2725349|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2725350|NCT05109234|Brivaracetam|brivaracetam|mesh-list
2725351|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
2204331|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204332|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204333|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
2204334|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2204335|NCT00006111|Fluorouracil|fluorouracil|mesh-list
2204336|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204337|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
2204338|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204339|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204340|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204341|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
2204342|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204343|NCT00006112|Leucovorin|leucovorin|mesh-list
2204344|NCT00006112|Fluorouracil|fluorouracil|mesh-list
2204345|NCT00006112|Mitomycins|mitomycins|mesh-list
2204346|NCT00006112|Mitomycin|mitomycin|mesh-list
2204347|NCT00006112|Calcium|calcium|mesh-list
2204348|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
2204349|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2204350|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204351|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
2204352|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204353|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204354|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204355|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204356|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
2204357|NCT00006112|Antidotes|antidotes|mesh-ancestor
2204358|NCT00006112|Protective Agents|protective agents|mesh-ancestor
2204359|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
2204360|NCT00006112|Vitamins|vitamins|mesh-ancestor
2204361|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
2204362|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2204363|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
2204364|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2204365|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204366|NCT00006113|Interferons|interferons|mesh-list
2204367|NCT00006113|Aldesleukin|aldesleukin|mesh-list
2204368|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
2204369|NCT00006113|Interleukin-4|interleukin-4|mesh-list
2204370|NCT00006113|Sargramostim|sargramostim|mesh-list
2204371|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204372|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
2204373|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204374|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
2204375|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204376|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2204377|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2204378|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2204379|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2204380|NCT00006114|Vinorelbine|vinorelbine|mesh-list
2204381|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
2204382|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2204383|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204384|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
2204385|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
2204386|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
2204387|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204388|NCT00006114|Analgesics|analgesics|mesh-ancestor
2204389|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
2204390|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2204391|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204392|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2204393|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2204394|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204395|NCT00006115|Leucovorin|leucovorin|mesh-list
2204396|NCT00006115|Fluorouracil|fluorouracil|mesh-list
2204397|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
2204398|NCT00006115|Irinotecan|irinotecan|mesh-list
2204399|NCT00006115|Calcium|calcium|mesh-list
2204400|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
2204401|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2204402|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204403|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
2204404|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204405|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204406|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204407|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204408|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
2204409|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2204410|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2204411|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204412|NCT00006115|Antidotes|antidotes|mesh-ancestor
2204413|NCT00006115|Protective Agents|protective agents|mesh-ancestor
2204414|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
2204415|NCT00006115|Vitamins|vitamins|mesh-ancestor
2204416|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
2204417|NCT00006116|Gemcitabine|gemcitabine|mesh-list
2204418|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204419|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204420|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
2204421|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204422|NCT00006116|Antiviral Agents|antiviral agents|mesh-ancestor
2204423|NCT00006116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204424|NCT00006116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204425|NCT00006116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204426|NCT00006116|Immunologic Factors|immunologic factors|mesh-ancestor
2204427|NCT00006116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204428|NCT00006117|Gemcitabine|gemcitabine|mesh-list
2204429|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
2204430|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204431|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
2204432|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204433|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204434|NCT00006117|Antiviral Agents|antiviral agents|mesh-ancestor
2204435|NCT00006117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204436|NCT00006117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204437|NCT00006117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204438|NCT00006117|Immunologic Factors|immunologic factors|mesh-ancestor
2204439|NCT00006117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204440|NCT00006118|Gemcitabine|gemcitabine|mesh-list
2204441|NCT00006118|Paclitaxel|paclitaxel|mesh-list
2204442|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2204443|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204444|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
2204445|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
2204446|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
2204447|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204448|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204449|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
2204450|NCT00006118|Antiviral Agents|antiviral agents|mesh-ancestor
2204451|NCT00006118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204452|NCT00006118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204453|NCT00006118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204454|NCT00006118|Immunologic Factors|immunologic factors|mesh-ancestor
2204455|NCT00006118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204456|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
2204457|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2725371|NCT05075876|Granisetron|granisetron|mesh-list
2725372|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
2204458|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
2204459|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204460|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204461|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2204462|NCT00006120|Paclitaxel|paclitaxel|mesh-list
2204463|NCT00006120|Docetaxel|docetaxel|mesh-list
2204464|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2204465|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204466|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
2204467|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
2204468|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
2204469|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204470|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
2204471|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204472|NCT00006122|Cytarabine|cytarabine|mesh-list
2204473|NCT00006122|Etoposide|etoposide|mesh-list
2204474|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
2204475|NCT00006122|Idarubicin|idarubicin|mesh-list
2204476|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
2204477|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2204478|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204479|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2204480|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2204481|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204482|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204483|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204484|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
2204485|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
2204486|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204487|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204488|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
2204489|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204490|NCT00006122|Analgesics|analgesics|mesh-ancestor
2204491|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
2204492|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2204493|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2204494|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2204495|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
2204496|NCT00006123|Thiotepa|thiotepa|mesh-list
2204497|NCT00006123|Carmustine|carmustine|mesh-list
2204498|NCT00006123|Carboplatin|carboplatin|mesh-list
2204499|NCT00006123|Trastuzumab|trastuzumab|mesh-list
2204500|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204501|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
2204502|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204503|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2204504|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2204505|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
2204506|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204507|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204508|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2204509|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2204510|NCT00006124|Celecoxib|celecoxib|mesh-list
2204511|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2204512|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2204513|NCT00006124|Analgesics|analgesics|mesh-ancestor
2204514|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
2204515|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2204516|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204517|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2204518|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2725373|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
2725374|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2725375|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725376|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2725377|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2725378|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
2725379|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2204519|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2204520|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2204521|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204522|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204523|NCT00006125|Doxorubicin|doxorubicin|mesh-list
2204524|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2204525|NCT00006125|Topotecan|topotecan|mesh-list
2204526|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2204527|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204528|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2204529|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2204530|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204531|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204532|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2204533|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
2204534|NCT00006126|Busulfan|busulfan|mesh-list
2204535|NCT00006126|Fludarabine|fludarabine|mesh-list
2204536|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
2204537|NCT00006126|Etoposide|etoposide|mesh-list
2204538|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204539|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
2204540|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204541|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2204542|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2204543|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
2204544|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204545|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204546|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2204547|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204548|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
2204549|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2204550|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2204551|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2204552|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204553|NCT00006127|Amifostine|amifostine|mesh-list
2204554|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2204555|NCT00006127|Protective Agents|protective agents|mesh-ancestor
2204556|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204557|NCT00006129|Testosterone|testosterone|mesh-list
2204558|NCT00006129|Androgens|androgens|mesh-ancestor
2204559|NCT00006129|Hormones|hormones|mesh-ancestor
2204560|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2204561|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204562|NCT00006131|Valacyclovir|valacyclovir|mesh-list
2204563|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
2204564|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204565|NCT00006132|Acyclovir|acyclovir|mesh-list
2204566|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
2204567|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204568|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2204569|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2204570|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2204571|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2204572|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
2204573|NCT00006133|Norethindrone|norethindrone|mesh-list
2204574|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
2204575|NCT00006133|Estradiol|estradiol|mesh-list
2204576|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2204577|NCT00006133|Estrogens|estrogens|mesh-ancestor
2204578|NCT00006133|Hormones|hormones|mesh-ancestor
2204579|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2204580|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204581|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2204582|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
2204583|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2204584|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2204585|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2204586|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2204587|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2725380|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204588|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2204589|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2204590|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204591|NCT00006135|Acyclovir|acyclovir|mesh-list
2204592|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
2204593|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204594|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
2204595|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
2204596|NCT00006136|Hematinics|hematinics|mesh-ancestor
2204597|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204598|NCT00006137|Enalapril|enalapril|mesh-list
2204599|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2204600|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
2204601|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204602|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204603|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2204604|NCT00006144|Ritonavir|ritonavir|mesh-list
2204605|NCT00006144|Lopinavir|lopinavir|mesh-list
2204606|NCT00006144|Emtricitabine|emtricitabine|mesh-list
2204607|NCT00006144|Stavudine|stavudine|mesh-list
2204608|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2204609|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2204610|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
2204611|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204612|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204613|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2204614|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2204615|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
2204616|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204617|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2204618|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2204619|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2204620|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2204621|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
2204622|NCT00006145|Valganciclovir|valganciclovir|mesh-list
2204623|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
2204624|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204625|NCT00006152|Ritonavir|ritonavir|mesh-list
2204626|NCT00006152|Amprenavir|amprenavir|mesh-list
2204627|NCT00006152|Abacavir|abacavir|mesh-list
2204628|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2204629|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2204630|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
2204631|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204632|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204633|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2204634|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2204635|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
2204636|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204637|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2204638|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2204639|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2204640|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2204641|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2204642|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
2204643|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2204644|NCT00006154|Ritonavir|ritonavir|mesh-list
2204645|NCT00006154|Indinavir|indinavir|mesh-list
2204646|NCT00006154|Aldesleukin|aldesleukin|mesh-list
2204647|NCT00006154|Abacavir|abacavir|mesh-list
2204648|NCT00006154|Stavudine|stavudine|mesh-list
2204649|NCT00006154|Didanosine|didanosine|mesh-list
2204650|NCT00006154|Efavirenz|efavirenz|mesh-list
2204651|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2204652|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2204653|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
2204654|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204655|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204656|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2204657|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2204658|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
2204659|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204660|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2204661|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2204662|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204663|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2204664|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2204665|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2204666|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2204667|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2204668|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2204669|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2204670|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
2204671|NCT00006155|Carboplatin|carboplatin|mesh-list
2204672|NCT00006155|Semaxinib|semaxinib|mesh-list
2204673|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204674|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2204675|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2204676|NCT00006155|Growth Substances|growth substances|mesh-ancestor
2204677|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204678|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
2204679|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2204680|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204681|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204682|NCT00006157|Desipramine|desipramine|mesh-list
2204683|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2204684|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
2204685|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2204686|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204687|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204688|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2204689|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2204690|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2204691|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
2204692|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2204693|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204694|NCT00006158|Testosterone|testosterone|mesh-list
2204695|NCT00006158|Androgens|androgens|mesh-ancestor
2204696|NCT00006158|Hormones|hormones|mesh-ancestor
2204697|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2204698|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204699|NCT00006167|Oxandrolone|oxandrolone|mesh-list
2204700|NCT00006167|Androgens|androgens|mesh-ancestor
2204701|NCT00006167|Hormones|hormones|mesh-ancestor
2204702|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2204703|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204704|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
2204705|NCT00006168|Methotrexate|methotrexate|mesh-list
2204706|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2204707|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
2204708|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2204709|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204710|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204711|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
2204712|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204713|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204714|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
2204715|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204716|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2204717|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204718|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
2204719|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2204720|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2204721|NCT00006174|Letrozole|letrozole|mesh-list
2204722|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204723|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2204724|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2725396|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2725397|NCT05052710|Midazolam|midazolam|mesh-list
2725398|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2725399|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2725400|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2725401|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725402|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2725403|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2725404|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2725405|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2725406|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
2725407|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
2725408|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
2725409|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
2725410|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2725411|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2725412|NCT05051293|Testosterone|testosterone|mesh-list
2725413|NCT05051293|Estrogens|estrogens|mesh-list
2725414|NCT05051293|Androgens|androgens|mesh-ancestor
2725415|NCT05051293|Hormones|hormones|mesh-ancestor
2725416|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2725417|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725437|NCT05047770|Vaccines|vaccines|mesh-list
2725438|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
2725439|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204725|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204726|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204727|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2204728|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
2204729|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2204730|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204731|NCT00006180|Alendronate|alendronate|mesh-list
2204732|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2204733|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204734|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
2204735|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2204736|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204737|NCT00006190|Lamivudine|lamivudine|mesh-list
2204738|NCT00006190|Efavirenz|efavirenz|mesh-list
2204739|NCT00006190|Stavudine|stavudine|mesh-list
2204740|NCT00006190|Nelfinavir|nelfinavir|mesh-list
2204741|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2204742|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2725514|NCT05017584|Bupivacaine|bupivacaine|mesh-list
2725515|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
2725516|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
2725517|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2725518|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725519|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
2725520|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2725521|NCT05015439|Cannabidiol|cannabidiol|mesh-list
2725522|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
2725578|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
2725579|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
2725580|NCT05005897|Vitamins|vitamins|mesh-ancestor
2725581|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
2725582|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725583|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
2725584|NCT05005897|Hematinics|hematinics|mesh-ancestor
2725611|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
2725612|NCT04976634|Lenvatinib|lenvatinib|mesh-list
2725613|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2725614|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2725615|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2725616|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2725617|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2725620|NCT04960215|Ubiquinone|ubiquinone|mesh-list
2204743|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204744|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204745|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
2204746|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204747|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2204748|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2204749|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2204750|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2204751|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2204752|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2204753|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2204754|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2204755|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
2204756|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2204757|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2204758|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
2204759|NCT00006195|Olanzapine|olanzapine|mesh-list
2204760|NCT00006195|Risperidone|risperidone|mesh-list
2204761|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2204762|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
2204763|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2204764|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204765|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204766|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2204767|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2204768|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2204769|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2204770|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2204771|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
2204772|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
2204773|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
2204774|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2204775|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2204776|NCT00006195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2204777|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2204778|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2204779|NCT00006196|Vitamin D|vitamin d|mesh-list
2204780|NCT00006196|Vitamins|vitamins|mesh-ancestor
2204781|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
2204782|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204783|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2204784|NCT00006198|Thalidomide|thalidomide|mesh-list
2204785|NCT00006198|Doxorubicin|doxorubicin|mesh-list
2204786|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2204787|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204788|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2204789|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2204790|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204791|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204792|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204793|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
2204794|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204795|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
2204796|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2204797|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204798|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2204799|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2204800|NCT00006198|Growth Substances|growth substances|mesh-ancestor
2725621|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
2725622|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
2725623|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204801|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
2204802|NCT00006199|Topotecan|topotecan|mesh-list
2204803|NCT00006199|Tipifarnib|tipifarnib|mesh-list
2204804|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2204805|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2204806|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204807|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204808|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204809|NCT00006200|Thalidomide|thalidomide|mesh-list
2204810|NCT00006200|Dacarbazine|dacarbazine|mesh-list
2204811|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204812|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
2204813|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204814|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
2204815|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2204816|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204817|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2204818|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2204819|NCT00006200|Growth Substances|growth substances|mesh-ancestor
2204820|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
2204821|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204822|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2204823|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
2204824|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204825|NCT00006203|Naltrexone|naltrexone|mesh-list
2204826|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2204827|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2204828|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204829|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
2204830|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2204831|NCT00006204|Naltrexone|naltrexone|mesh-list
2204832|NCT00006204|Fluoxetine|fluoxetine|mesh-list
2204833|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2204834|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2204835|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204836|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
2204837|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2204838|NCT00006204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2204839|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2204840|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2204841|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204842|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2204843|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
2204844|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2204845|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
2204846|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2204847|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2204848|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2204849|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2725624|NCT04960215|Vitamins|vitamins|mesh-ancestor
2204850|NCT00006205|Topiramate|topiramate|mesh-list
2204851|NCT00006205|Ondansetron|ondansetron|mesh-list
2204852|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
2204853|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
2204854|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2204855|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204856|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2204857|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
2204858|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
2204859|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2204860|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
2204861|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2204862|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204863|NCT00006205|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2204864|NCT00006205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2204865|NCT00006205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2204866|NCT00006205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2204867|NCT00006205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2204868|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
2204869|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2204870|NCT00006206|Naltrexone|naltrexone|mesh-list
2204871|NCT00006206|Acamprosate|acamprosate|mesh-list
2204872|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2204873|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2204874|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204875|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
2204876|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2204877|NCT00006208|Emtricitabine|emtricitabine|mesh-list
2204878|NCT00006208|Efavirenz|efavirenz|mesh-list
2204879|NCT00006208|Stavudine|stavudine|mesh-list
2204880|NCT00006208|Didanosine|didanosine|mesh-list
2204881|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
2204882|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204883|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2204884|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2204885|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204886|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204887|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2204888|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2204889|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2204890|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2204891|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2204892|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2204893|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2204894|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2204895|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
2204896|NCT00006211|Nelfinavir|nelfinavir|mesh-list
2204897|NCT00006211|Capravirine|capravirine|mesh-list
2204898|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2204899|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2204900|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
2204901|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423950|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2423951|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423952|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423953|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2423954|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
2423955|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2423956|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423957|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2423958|NCT00825019|Paroxetine|paroxetine|mesh-list
2423959|NCT00825019|Amibegron|amibegron|mesh-list
2423960|NCT00825019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2204902|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204903|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2204904|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2204905|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
2204906|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204907|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2204908|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2204909|NCT00006212|Vinblastine|vinblastine|mesh-list
2204910|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204911|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2204912|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
2204913|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
2204914|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
2204915|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204916|NCT00006214|Flutamide|flutamide|mesh-list
2204917|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
2204918|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
2204919|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2204920|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204921|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2204922|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204923|NCT00006215|Docetaxel|docetaxel|mesh-list
2204924|NCT00006215|Vinorelbine|vinorelbine|mesh-list
2725822|NCT04881032|Temozolomide|temozolomide|mesh-list
2725823|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2725824|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
2725825|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2725826|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2725835|NCT04849650|Amisulpride|amisulpride|mesh-list
2725836|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2725837|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2725838|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2725839|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725840|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2725841|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2725842|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
2725843|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2725844|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2725845|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2725846|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
2204925|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204926|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
2204927|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
2204928|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
2725897|NCT04783376|Insulin|insulin|mesh-list
2725898|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2725899|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2725900|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2725907|NCT04775953|Vancomycin|vancomycin|mesh-list
2725908|NCT04775953|Cefazolin|cefazolin|mesh-list
2725909|NCT04775953|Daptomycin|daptomycin|mesh-list
2725910|NCT04775953|Dalbavancin|dalbavancin|mesh-list
2725911|NCT04775953|Oxacillin|oxacillin|mesh-list
2725912|NCT04775953|Nafcillin|nafcillin|mesh-list
2725913|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2725914|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2725920|NCT04765137|Atorvastatin|atorvastatin|mesh-list
2725921|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2725922|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2725923|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
2725924|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2725925|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2725926|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2725927|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204929|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204930|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2204931|NCT00006216|Ganciclovir|ganciclovir|mesh-list
2204932|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2204933|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
2204934|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204935|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2204936|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204937|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204938|NCT00006219|Clarithromycin|clarithromycin|mesh-list
2204939|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2204940|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2204941|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204942|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2726002|NCT04721821|Tofacitinib|tofacitinib|mesh-list
2726003|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2726004|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2726005|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726006|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
2726007|NCT04721457|Listerine|listerine|mesh-list
2726008|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2726009|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
2726010|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
2726011|NCT04721457|Eusol|eusol|mesh-list
2726012|NCT04721457|Povidone|povidone|mesh-list
2726013|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
2726014|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
2726015|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
2726016|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2726017|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2726018|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
2726019|NCT04721457|Protective Agents|protective agents|mesh-ancestor
2726020|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726021|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
2726022|NCT04704505|Androgens|androgens|mesh-list
2726023|NCT04704505|Hormones|hormones|mesh-ancestor
2726024|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2726025|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204943|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204944|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204945|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2204946|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2204947|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2204948|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
2204949|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204950|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
2204951|NCT00006220|Tretinoin|tretinoin|mesh-list
2204952|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204953|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
2204954|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
2204955|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
2204956|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2204957|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
2204958|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204959|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2204960|NCT00006223|Protective Agents|protective agents|mesh-ancestor
2204961|NCT00006224|Gemcitabine|gemcitabine|mesh-list
2204962|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2204963|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
2204964|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204965|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204966|NCT00006224|Antiviral Agents|antiviral agents|mesh-ancestor
2204967|NCT00006224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204968|NCT00006224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2204969|NCT00006224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2726080|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
2726081|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2726082|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
2726083|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2726084|NCT04627922|Expectorants|expectorants|mesh-ancestor
2726085|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
2726086|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2726087|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
2726088|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726089|NCT04627922|Protective Agents|protective agents|mesh-ancestor
2726090|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726091|NCT04627922|Antidotes|antidotes|mesh-ancestor
2204970|NCT00006224|Immunologic Factors|immunologic factors|mesh-ancestor
2204971|NCT00006224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204972|NCT00006225|Flt3 ligand protein|flt3 ligand protein|mesh-list
2204973|NCT00006225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2204974|NCT00006225|Immunologic Factors|immunologic factors|mesh-ancestor
2204975|NCT00006225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204976|NCT00006225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2726124|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
2726125|NCT04601857|Futibatinib|futibatinib|mesh-list
2726126|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2726127|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726135|NCT04586920|Itraconazole|itraconazole|mesh-list
2726136|NCT04586920|Midazolam|midazolam|mesh-list
2726137|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2726138|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2726139|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2726140|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726141|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2726142|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2726143|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2726144|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2726145|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
2726146|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
2726147|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
2726148|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
2726149|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2726150|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726151|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
2726152|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2726153|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2726154|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2726155|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2726156|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2726157|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
2726158|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2726159|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2204977|NCT00006225|Protective Agents|protective agents|mesh-ancestor
2726208|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
2726209|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2726210|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
2726211|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2726212|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2726213|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726214|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2726215|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2726216|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2726217|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2726228|NCT04454905|Apatinib|apatinib|mesh-list
2726229|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726230|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2726231|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2726232|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204978|NCT00006226|Thalidomide|thalidomide|mesh-list
2204979|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2204980|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
2204981|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2204982|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
2204983|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2204984|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204985|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2204986|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2204987|NCT00006226|Growth Substances|growth substances|mesh-ancestor
2204988|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
2204989|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204990|NCT00006228|Aldesleukin|aldesleukin|mesh-list
2204991|NCT00006228|Trastuzumab|trastuzumab|mesh-list
2204992|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2204993|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2204994|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2204995|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2204996|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
2726271|NCT04418167|Dabrafenib|dabrafenib|mesh-list
2726272|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726273|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2726274|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2726275|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2204997|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2204998|NCT00006229|Paclitaxel|paclitaxel|mesh-list
2204999|NCT00006229|Carboplatin|carboplatin|mesh-list
2205000|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205001|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205002|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205003|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205004|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205005|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205006|NCT00006230|Rubitecan|rubitecan|mesh-list
2205007|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205008|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2205009|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205010|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205011|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205012|NCT00006232|Dexamethasone|dexamethasone|mesh-list
2205013|NCT00006232|Doxorubicin|doxorubicin|mesh-list
2205014|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2205015|NCT00006232|Vincristine|vincristine|mesh-list
2205016|NCT00006232|Idarubicin|idarubicin|mesh-list
2205017|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2205018|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
2205019|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
2205020|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2205021|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205022|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2205023|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
2205024|NCT00006232|Hormones|hormones|mesh-ancestor
2205025|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2205026|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2205027|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205028|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2726299|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
2726300|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2726301|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726323|NCT04331717|Leuprolide|leuprolide|mesh-list
2726324|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2726325|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
2726326|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2726327|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726328|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2726329|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726330|NCT04309409|Nivolumab|nivolumab|mesh-list
2726331|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2726332|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726333|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2726334|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726342|NCT04285684|Ketamine|ketamine|mesh-list
2726343|NCT04285684|Analgesics|analgesics|mesh-ancestor
2726344|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
2726345|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2726346|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726347|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2726348|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2726349|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
2726350|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
2726351|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2726352|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2726353|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2726354|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2726355|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726356|NCT04248829|Gefitinib|gefitinib|mesh-list
2726357|NCT04248829|Lazertinib|lazertinib|mesh-list
2726358|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726359|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2726360|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2726361|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205029|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2205030|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205031|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205032|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205033|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205034|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205035|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205036|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205037|NCT00006233|Cyclosporine|cyclosporine|mesh-list
2205038|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
2205039|NCT00006233|Fludarabine|fludarabine|mesh-list
2205040|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
2205041|NCT00006233|Cyclosporins|cyclosporins|mesh-list
2726372|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
2726373|NCT04198766|Antibodies|antibodies|mesh-list
2726374|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
2726375|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205042|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726376|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2726377|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205043|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2205044|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
2205045|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205046|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205047|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
2205048|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205049|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205050|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
2205051|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205052|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
2726395|NCT04144023|Molgramostim|molgramostim|mesh-list
2726396|NCT04144023|Vaccines|vaccines|mesh-list
2726397|NCT04144023|Sargramostim|sargramostim|mesh-list
2726398|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
2726399|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726400|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726447|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2726448|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2726449|NCT04079218|Estradiol|estradiol|mesh-list
2726450|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2726451|NCT04079218|Estrogens|estrogens|mesh-ancestor
2726452|NCT04079218|Hormones|hormones|mesh-ancestor
2726453|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2726454|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726455|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2726456|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
2726457|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2726458|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2726459|NCT04078152|Durvalumab|durvalumab|mesh-list
2726460|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2726461|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726479|NCT04026009|Vaccines|vaccines|mesh-list
2205053|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2205054|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2205055|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2205056|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2205057|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
2205058|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2205059|NCT00006235|Carboplatin|carboplatin|mesh-list
2205060|NCT00006235|Doxorubicin|doxorubicin|mesh-list
2205061|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2205062|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205063|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2726480|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
2726481|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726482|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
2726483|NCT04013555|Tryptophan|tryptophan|mesh-list
2726484|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2726485|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
2726486|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2726487|NCT04013555|Expectorants|expectorants|mesh-ancestor
2726488|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
2726489|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2726490|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
2726491|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726492|NCT04013555|Protective Agents|protective agents|mesh-ancestor
2726493|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726494|NCT04013555|Antidotes|antidotes|mesh-ancestor
2726495|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2726496|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
2726497|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2726498|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
2726499|NCT03994172|Vitamin D|vitamin d|mesh-list
2726500|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
2726501|NCT03994172|Teriparatide|teriparatide|mesh-list
2726502|NCT03994172|Citric Acid|citric acid|mesh-list
2726503|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
2726504|NCT03994172|Calcium|calcium|mesh-list
2726505|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
2726506|NCT03994172|Cinacalcet|cinacalcet|mesh-list
2726507|NCT03994172|Hormones|hormones|mesh-list
2726508|NCT03994172|Vitamins|vitamins|mesh-ancestor
2726509|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
2726510|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726511|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2726512|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2726513|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
2726514|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2726515|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
2726516|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
2726517|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726518|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2726519|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2726520|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
2726543|NCT03924947|Pancrelipase|pancrelipase|mesh-list
2726544|NCT03924947|Pancreatin|pancreatin|mesh-list
2726545|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2726546|NCT03919435|Trimethoprim|trimethoprim|mesh-list
2726547|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2726548|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
2726549|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2726550|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2726551|NCT03919435|Renal Agents|renal agents|mesh-ancestor
2726552|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
2726553|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2726554|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2726555|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2726556|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2726557|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726558|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2726559|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2726560|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2726561|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2205064|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2205065|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205066|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205067|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726624|NCT03887936|Testosterone|testosterone|mesh-list
2726625|NCT03887936|Androgens|androgens|mesh-ancestor
2726626|NCT03887936|Hormones|hormones|mesh-ancestor
2726627|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2726628|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726629|NCT03884439|Infliximab|infliximab|mesh-list
2726630|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
2726631|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2726632|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2726633|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
2726634|NCT03831711|Bombesin|bombesin|mesh-list
2726635|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726636|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2726637|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726638|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2726646|NCT03829462|Irinotecan|irinotecan|mesh-list
2726647|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2726648|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2726649|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2726650|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726651|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726652|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
2726653|NCT03809624|Antibodies|antibodies|mesh-list
2726654|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
2726655|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726656|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2205068|NCT00006239|Tretinoin|tretinoin|mesh-list
2205069|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2205070|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205071|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
2205072|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
2205073|NCT00006240|Dexamethasone|dexamethasone|mesh-list
2205074|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2205075|NCT00006240|Sargramostim|sargramostim|mesh-list
2205076|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2205077|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
2205078|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
2205079|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2205080|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205081|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2205082|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
2205083|NCT00006240|Hormones|hormones|mesh-ancestor
2205084|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2205085|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2205086|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205087|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
2205088|NCT00006241|Lenograstim|lenograstim|mesh-list
2205089|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2205090|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
2205091|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205092|NCT00006243|Sargramostim|sargramostim|mesh-list
2205093|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
2205094|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
2205095|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205096|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2205097|NCT00006245|Paclitaxel|paclitaxel|mesh-list
2205098|NCT00006245|Alvocidib|alvocidib|mesh-list
2205099|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205100|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205101|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205102|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205103|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205104|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205105|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
2205106|NCT00006245|Growth Substances|growth substances|mesh-ancestor
2205107|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205108|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2205109|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205110|NCT00006246|Busulfan|busulfan|mesh-list
2205111|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
2205112|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205113|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205114|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
2205115|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205116|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2726657|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205117|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205118|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2205119|NCT00006247|Semaxinib|semaxinib|mesh-list
2205120|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2205121|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2205122|NCT00006247|Growth Substances|growth substances|mesh-ancestor
2205123|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205124|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
2205125|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205126|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2726665|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
2726666|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2726667|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726668|NCT03774641|Lamotrigine|lamotrigine|mesh-list
2726669|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
2726670|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2726671|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2726672|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726673|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2726674|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726675|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2726676|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2205127|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205128|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205129|NCT00006248|Paclitaxel|paclitaxel|mesh-list
2205130|NCT00006248|Fluorouracil|fluorouracil|mesh-list
2205131|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205132|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205133|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205134|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205135|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205136|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205137|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
2726677|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2726678|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2726679|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2205138|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2726699|NCT03695380|Atezolizumab|atezolizumab|mesh-list
2726700|NCT03695380|Niraparib|niraparib|mesh-list
2726701|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726702|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2726703|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2726704|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726705|NCT03669718|Cemiplimab|cemiplimab|mesh-list
2726706|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2726707|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726708|NCT03643965|Budesonide|budesonide|mesh-list
2726709|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2726710|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2726711|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
2726712|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2726713|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726714|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2726715|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
2726716|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
2726717|NCT03643965|Hormones|hormones|mesh-ancestor
2726718|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2726719|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2726720|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
2726721|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726722|NCT03616574|Trifluridine|trifluridine|mesh-list
2726723|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
2726724|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726725|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
2726726|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2726765|NCT03595566|Vancomycin|vancomycin|mesh-list
2726766|NCT03595566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2726767|NCT03595566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2726768|NCT03595553|Vancomycin|vancomycin|mesh-list
2726769|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2726770|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2726771|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2726772|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2726773|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726778|NCT03530397|Carboplatin|carboplatin|mesh-list
2726779|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
2726780|NCT03530397|Pemetrexed|pemetrexed|mesh-list
2726781|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726782|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2726783|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2726784|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726785|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2726786|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2726787|NCT03516292|Mitogens|mitogens|mesh-list
2726788|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
2726789|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726821|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2726822|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2726823|NCT03336541|Ketamine|ketamine|mesh-list
2726824|NCT03336541|Analgesics|analgesics|mesh-ancestor
2726825|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
2726826|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2726827|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726828|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2726829|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2726830|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
2726831|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
2726832|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2726833|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2726834|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2726835|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2726836|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726837|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
2726838|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2726839|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2726840|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
2726841|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2726842|NCT03241732|Expectorants|expectorants|mesh-ancestor
2726843|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
2726844|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2726845|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
2726846|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726847|NCT03241732|Protective Agents|protective agents|mesh-ancestor
2726848|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726849|NCT03241732|Antidotes|antidotes|mesh-ancestor
2726850|NCT03230916|Relebactam|relebactam|mesh-list
2726851|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2726852|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2726853|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726854|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2726855|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2726856|NCT03202667|Empagliflozin|empagliflozin|mesh-list
2726857|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2726858|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726859|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2726860|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726861|NCT03190954|Raclopride|raclopride|mesh-list
2726862|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2726863|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2726864|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2726865|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726866|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2726867|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2726868|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
2726869|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2726870|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726871|NCT03176277|Venetoclax|venetoclax|mesh-list
2726872|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726876|NCT03169972|Factor VIII|factor viii|mesh-list
2726877|NCT03169972|BAX 855|bax 855|mesh-list
2726878|NCT03169972|Coagulants|coagulants|mesh-ancestor
2726911|NCT03021993|Nivolumab|nivolumab|mesh-list
2726912|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2726913|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726914|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2726915|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726916|NCT02954081|Apremilast|apremilast|mesh-list
2726917|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2726918|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2726919|NCT02954081|Analgesics|analgesics|mesh-ancestor
2726920|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
2726921|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2726922|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726923|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2726924|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2726925|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2726926|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2726927|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2726928|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423961|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2423962|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2423963|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423964|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423965|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
2423966|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423967|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2423968|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
2423969|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2423970|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2423971|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2423972|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2423973|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2423974|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2423975|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
2423976|NCT00825045|Risperidone|risperidone|mesh-list
2423977|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2423978|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
2423979|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423980|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423981|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423982|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2726976|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
2726977|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2726978|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2726979|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726980|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
2726981|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2726982|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726983|NCT02763319|Rituximab|rituximab|mesh-list
2726984|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2726985|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2726986|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726987|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
2726988|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2726989|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2726990|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2726991|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
2205139|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205140|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
2205141|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205142|NCT00006249|Interferons|interferons|mesh-list
2205143|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
2205144|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205145|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
2205146|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205147|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
2205148|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205149|NCT00006250|Dexamethasone|dexamethasone|mesh-list
2205150|NCT00006250|Fludarabine|fludarabine|mesh-list
2205151|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
2205152|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
2205153|NCT00006250|Chlorambucil|chlorambucil|mesh-list
2205154|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2205155|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
2205156|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
2205157|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2205158|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205159|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2205160|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
2205161|NCT00006250|Hormones|hormones|mesh-ancestor
2205162|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2205163|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2205164|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205165|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2205166|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
2205167|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205168|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2726992|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726993|NCT02759835|Osimertinib|osimertinib|mesh-list
2726994|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2726995|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2726996|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2726997|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2726998|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2726999|NCT02673567|Antibodies|antibodies|mesh-list
2727000|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
2727001|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2727002|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
2727003|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727004|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727005|NCT02628626|Clonidine|clonidine|mesh-list
2727006|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2727007|NCT02628626|Analgesics|analgesics|mesh-ancestor
2727008|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
2727009|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2727010|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727011|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2727012|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
2727013|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
2727014|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2727015|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2727016|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2727017|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
2727018|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2727019|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727020|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2727021|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2727022|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
2727023|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2727024|NCT02553460|Leucovorin|leucovorin|mesh-list
2727025|NCT02553460|Cytarabine|cytarabine|mesh-list
2727026|NCT02553460|Dexamethasone|dexamethasone|mesh-list
2727027|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
2727028|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
2727029|NCT02553460|Methotrexate|methotrexate|mesh-list
2727030|NCT02553460|Etoposide|etoposide|mesh-list
2727031|NCT02553460|Vincristine|vincristine|mesh-list
2727032|NCT02553460|Bortezomib|bortezomib|mesh-list
2727033|NCT02553460|Asparaginase|asparaginase|mesh-list
2727034|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
2727035|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
2205169|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
2205170|NCT00006250|Analgesics|analgesics|mesh-ancestor
2727036|NCT02553460|Vorinostat|vorinostat|mesh-list
2727037|NCT02553460|Pegaspargase|pegaspargase|mesh-list
2727038|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
2727039|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2727040|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
2727041|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727042|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2727043|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2727044|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
2727045|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727046|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727047|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2727048|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2727049|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
2727050|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
2727051|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2727052|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2727053|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
2727054|NCT02553460|Hormones|hormones|mesh-ancestor
2727055|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2727056|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2727057|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2727058|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
2727059|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2727060|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2727061|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
2727062|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
2205171|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
2205172|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2205173|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205174|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205175|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2205176|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
2205177|NCT00006251|Cyclosporine|cyclosporine|mesh-list
2205178|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
2205179|NCT00006251|Fludarabine|fludarabine|mesh-list
2205180|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
2205181|NCT00006251|Cyclosporins|cyclosporins|mesh-list
2205182|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205183|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2205184|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
2205185|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205186|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205187|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
2205188|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205189|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205190|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
2727063|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727064|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2727065|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2727066|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2727067|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2727068|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2727069|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
2727070|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2727071|NCT02553460|Antidotes|antidotes|mesh-ancestor
2727072|NCT02553460|Protective Agents|protective agents|mesh-ancestor
2727073|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
2727074|NCT02553460|Vitamins|vitamins|mesh-ancestor
2727075|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
2727076|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
2727077|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
2727078|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
2727079|NCT02553460|Analgesics|analgesics|mesh-ancestor
2727080|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
2727081|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2727082|NCT02536183|Doxorubicin|doxorubicin|mesh-list
2727083|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2727084|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2727085|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727086|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2727087|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2727088|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727089|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727090|NCT02523313|Nivolumab|nivolumab|mesh-list
2727091|NCT02523313|Ipilimumab|ipilimumab|mesh-list
2727092|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2727093|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205191|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2727094|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2727095|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727096|NCT02464969|Apixaban|apixaban|mesh-list
2727097|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2727098|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
2727099|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2727100|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
2727101|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727102|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727103|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
2727104|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
2727105|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2727106|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
2727107|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2727108|NCT02445651|Expectorants|expectorants|mesh-ancestor
2727109|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
2727110|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2727111|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
2727112|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727113|NCT02445651|Protective Agents|protective agents|mesh-ancestor
2727114|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727115|NCT02445651|Antidotes|antidotes|mesh-ancestor
2727125|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
2727126|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2727127|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727156|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
2727157|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2727158|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2727159|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727160|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2727161|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2727162|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727163|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
2727164|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2727165|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
2727166|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
2727167|NCT01861106|Busulfan|busulfan|mesh-list
2727168|NCT01861106|Fludarabine|fludarabine|mesh-list
2727169|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
2727170|NCT01861106|Tacrolimus|tacrolimus|mesh-list
2205192|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
2205193|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2205194|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2205195|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2205196|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2205197|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
2205198|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2205199|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
2205200|NCT00006252|Fludarabine|fludarabine|mesh-list
2727171|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2727172|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2727173|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
2727174|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727175|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2727176|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2727177|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
2727178|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727179|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727180|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2727181|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2727182|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
2727183|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2727184|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727185|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2727186|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2727187|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
2727188|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2727189|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2727218|NCT01602666|Carboplatin|carboplatin|mesh-list
2727219|NCT01602666|Etoposide|etoposide|mesh-list
2727220|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
2727221|NCT01602666|Ifosfamide|ifosfamide|mesh-list
2727222|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
2727223|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
2727224|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727225|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2727226|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2727227|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2727228|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727229|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727230|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2727231|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
2727232|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
2727233|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
2727234|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205201|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
2205202|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205203|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
2205204|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205205|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2205206|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2205207|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
2205208|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205209|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205210|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2205211|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2205212|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
2205213|NCT00006256|Paclitaxel|paclitaxel|mesh-list
2205214|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205215|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205216|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205217|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205218|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205219|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205220|NCT00006257|Paclitaxel|paclitaxel|mesh-list
2205221|NCT00006257|Semaxinib|semaxinib|mesh-list
2205222|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205223|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205224|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205225|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205226|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205227|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205228|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2205229|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2205230|NCT00006257|Growth Substances|growth substances|mesh-ancestor
2205231|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205232|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
2205233|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2205234|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205235|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
2205236|NCT00006258|Methotrexate|methotrexate|mesh-list
2205237|NCT00006258|Etoposide|etoposide|mesh-list
2205238|NCT00006258|Vincristine|vincristine|mesh-list
2205239|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205240|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
2205241|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205242|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2205243|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2205244|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
2205245|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727235|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
2727236|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
2727239|NCT01494662|Capecitabine|capecitabine|mesh-list
2727240|NCT01494662|Trastuzumab|trastuzumab|mesh-list
2727241|NCT01494662|Maytansine|maytansine|mesh-list
2727242|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2727243|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2727244|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
2727245|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727246|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727247|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2727248|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2727249|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
2727250|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
2727251|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
2727252|NCT01489813|Genistein|genistein|mesh-list
2727253|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2727254|NCT01489813|Protective Agents|protective agents|mesh-ancestor
2727255|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727256|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727257|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2727258|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727259|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727260|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
2727261|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2727262|NCT01489813|Estrogens|estrogens|mesh-ancestor
2727263|NCT01489813|Hormones|hormones|mesh-ancestor
2727264|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2205246|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205247|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2205248|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2205249|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
2205250|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2727286|NCT01375959|Resveratrol|resveratrol|mesh-list
2727287|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
2727288|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727289|NCT01375959|Protective Agents|protective agents|mesh-ancestor
2727290|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727291|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727292|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2727323|NCT00567567|Vitamin A|vitamin a|mesh-list
2727324|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
2727325|NCT00567567|Melphalan|melphalan|mesh-list
2727326|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
2727327|NCT00567567|Thiotepa|thiotepa|mesh-list
2727328|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2727329|NCT00567567|Cisplatin|cisplatin|mesh-list
2727330|NCT00567567|Carboplatin|carboplatin|mesh-list
2727331|NCT00567567|Doxorubicin|doxorubicin|mesh-list
2727332|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2727333|NCT00567567|Etoposide|etoposide|mesh-list
2727334|NCT00567567|Vincristine|vincristine|mesh-list
2727335|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
2727336|NCT00567567|Topotecan|topotecan|mesh-list
2727337|NCT00567567|Tretinoin|tretinoin|mesh-list
2727338|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
2727339|NCT00567567|Isotretinoin|isotretinoin|mesh-list
2727340|NCT00567567|Lenograstim|lenograstim|mesh-list
2727341|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2727342|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
2727343|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727344|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2727345|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2727346|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
2727347|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727348|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727349|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2727350|NCT00567567|Vitamins|vitamins|mesh-ancestor
2727351|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
2727352|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2727353|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2727354|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2727355|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727356|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2727357|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2727358|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
2727359|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
2727360|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
2727361|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2727362|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
2727363|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
2727364|NCT00380653|Sapacitabine|sapacitabine|mesh-list
2727365|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727366|NCT00354835|Dactinomycin|dactinomycin|mesh-list
2727367|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
2727368|NCT00354835|Irinotecan|irinotecan|mesh-list
2727369|NCT00354835|Vincristine|vincristine|mesh-list
2727370|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2727371|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
2727372|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727373|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2727374|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2727375|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
2727376|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727377|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727378|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2727379|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2727380|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2727381|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727382|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2727383|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
2727384|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
2727385|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
2727386|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2727387|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2727388|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2727389|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2727390|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2727391|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
2727392|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2727393|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2727394|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
2727395|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2727396|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2727407|NCT05156970|Carboplatin|carboplatin|mesh-list
2727408|NCT05156970|Docetaxel|docetaxel|mesh-list
2727409|NCT05156970|Apatinib|apatinib|mesh-list
2727410|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727411|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
2727412|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
2727413|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
2727414|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727415|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2727416|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727423|NCT05156892|Tamoxifen|tamoxifen|mesh-list
2727424|NCT05156892|Itraconazole|itraconazole|mesh-list
2727425|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2727426|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
2727427|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2727428|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727429|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2727430|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727431|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2727432|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2727433|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2727434|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
2727435|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2727436|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2727437|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2727438|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727439|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727440|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2727441|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2205251|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2205252|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
2205253|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
2205254|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205255|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2205256|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2205257|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205258|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2205259|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205260|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205261|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205262|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205263|NCT00006260|Etoposide|etoposide|mesh-list
2205264|NCT00006260|Ifosfamide|ifosfamide|mesh-list
2205265|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205266|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205267|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2205268|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205269|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205270|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205271|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2727490|NCT05156788|Lenvatinib|lenvatinib|mesh-list
2727491|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727492|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2727493|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727494|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727495|NCT05156749|Calpastatin|calpastatin|mesh-list
2727496|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2727497|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
2727498|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727499|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727534|NCT05156658|Etonogestrel|etonogestrel|mesh-list
2727535|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2727536|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
2727537|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2727538|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727539|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2727540|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2727541|NCT05156632|Vaccines|vaccines|mesh-list
2727542|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
2727543|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727544|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2727545|NCT05156632|Antacids|antacids|mesh-ancestor
2727546|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727547|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2727548|NCT05156606|Testosterone|testosterone|mesh-list
2727549|NCT05156606|Androgens|androgens|mesh-ancestor
2727550|NCT05156606|Hormones|hormones|mesh-ancestor
2727551|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2727552|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727553|NCT05156541|Interferons|interferons|mesh-list
2727554|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
2727555|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727556|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
2727557|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2727558|NCT05156450|Prednisone|prednisone|mesh-list
2727559|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
2727560|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2727561|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
2727562|NCT05156450|Hormones|hormones|mesh-ancestor
2727563|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2727564|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727565|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2727566|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727567|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2727568|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727569|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727570|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
2727571|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2727572|NCT05156437|Amoxicillin|amoxicillin|mesh-list
2727573|NCT05156437|Vancomycin|vancomycin|mesh-list
2727574|NCT05156437|Levofloxacin|levofloxacin|mesh-list
2727575|NCT05156437|Rifampin|rifampin|mesh-list
2727576|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
2727577|NCT05156437|Linezolid|linezolid|mesh-list
2727578|NCT05156437|Daptomycin|daptomycin|mesh-list
2727579|NCT05156437|Cephalexin|cephalexin|mesh-list
2727580|NCT05156437|Ampicillin|ampicillin|mesh-list
2727581|NCT05156437|Cefepime|cefepime|mesh-list
2727582|NCT05156437|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
2727583|NCT05156437|Oxacillin|oxacillin|mesh-list
2727584|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
2727585|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2727586|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2727587|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2727588|NCT05156437|Renal Agents|renal agents|mesh-ancestor
2727589|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2727590|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2727591|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2727592|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727593|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727594|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2727595|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2727596|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2727597|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
2727598|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
2727599|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2727600|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2727601|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2727602|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2727603|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2727604|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2727605|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2727606|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2727607|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
2727646|NCT05156021|Bevacizumab|bevacizumab|mesh-list
2727647|NCT05156021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2727648|NCT05156021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727649|NCT05156021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2727650|NCT05156021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2727651|NCT05156021|Growth Substances|growth substances|mesh-ancestor
2727652|NCT05156021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727653|NCT05156021|Growth Inhibitors|growth inhibitors|mesh-ancestor
2727654|NCT05155969|Ketamine|ketamine|mesh-list
2727655|NCT05155969|Esketamine|esketamine|mesh-list
2727656|NCT05155969|Analgesics|analgesics|mesh-ancestor
2727657|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
2727658|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2727659|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727660|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2727661|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2727662|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
2727663|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
2727664|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2727665|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2727666|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2727667|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2727668|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727669|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
2727670|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2727671|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
2727672|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2727673|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727689|NCT05150496|Vaccines|vaccines|mesh-list
2727690|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
2727691|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727703|NCT05117034|Morphine|morphine|mesh-list
2727704|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2727705|NCT05117034|Narcotics|narcotics|mesh-ancestor
2727706|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2727707|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727708|NCT05117034|Analgesics|analgesics|mesh-ancestor
2727709|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
2727710|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2727711|NCT05112913|Vaccines|vaccines|mesh-list
2727712|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
2727713|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727714|NCT05112549|Nivolumab|nivolumab|mesh-list
2727715|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2727716|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727717|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2727718|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727757|NCT05057689|Fentanyl|fentanyl|mesh-list
2727758|NCT05057689|Midazolam|midazolam|mesh-list
2727759|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
2727760|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2727761|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2727762|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727763|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2727764|NCT05057689|Analgesics|analgesics|mesh-ancestor
2727765|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
2727766|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2727767|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2727768|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2727769|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2727770|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
2727771|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2727772|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727773|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2727774|NCT05057689|Narcotics|narcotics|mesh-ancestor
2727775|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2727776|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2727777|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
2727778|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
2727779|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2727780|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2727781|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2727782|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
2727783|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
2205272|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
2205273|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
2205274|NCT00006261|Docetaxel|docetaxel|mesh-list
2205275|NCT00006261|Doxorubicin|doxorubicin|mesh-list
2205276|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2205277|NCT00006261|Fludarabine|fludarabine|mesh-list
2205278|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
2205279|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205280|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
2205281|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205282|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2205283|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2205284|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
2205285|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205286|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205287|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2205288|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205289|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205290|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205291|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2205292|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2205293|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205294|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205295|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2205296|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
2205297|NCT00006263|Carboplatin|carboplatin|mesh-list
2205298|NCT00006263|Temozolomide|temozolomide|mesh-list
2205299|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205300|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2205301|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
2205302|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205303|NCT00006264|Zidovudine|zidovudine|mesh-list
2205304|NCT00006264|Aldesleukin|aldesleukin|mesh-list
2727879|NCT05004259|Daratumumab|daratumumab|mesh-list
2727880|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727891|NCT04996719|Sirolimus|sirolimus|mesh-list
2727892|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2727893|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2727894|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2727895|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727896|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
2727897|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2727898|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
2727899|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727900|NCT04992624|Dronabinol|dronabinol|mesh-list
2727901|NCT04992624|Cannabidiol|cannabidiol|mesh-list
2727902|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
2727903|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
2727904|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727905|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2727906|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2727907|NCT04992624|Analgesics|analgesics|mesh-ancestor
2727908|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
2727909|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2727910|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2727911|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2727912|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2727913|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727914|NCT04992624|Hormones|hormones|mesh-ancestor
2727915|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2727922|NCT04969887|Nivolumab|nivolumab|mesh-list
2727923|NCT04969887|Ipilimumab|ipilimumab|mesh-list
2727924|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2727925|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2727926|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2727927|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2727944|NCT04952324|Folic Acid|folic acid|mesh-list
2727945|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
2727946|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
2727947|NCT04952324|Vitamins|vitamins|mesh-ancestor
2727948|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
2727949|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2727950|NCT04952324|Hematinics|hematinics|mesh-ancestor
2727951|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
2727961|NCT04934020|Metronidazole|metronidazole|mesh-list
2727962|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2727963|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2727964|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2727965|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2728008|NCT04931017|Metformin|metformin|mesh-list
2728009|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2728010|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728011|NCT04915950|APD791|apd791|mesh-list
2728012|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2728013|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2728014|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
2728015|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2728016|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728017|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728031|NCT04914741|Prednisolone|prednisolone|mesh-list
2728032|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
2728033|NCT04914741|Rituximab|rituximab|mesh-list
2728034|NCT04914741|Doxorubicin|doxorubicin|mesh-list
2728035|NCT04914741|Vincristine|vincristine|mesh-list
2728036|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2728037|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
2728038|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728039|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2728040|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2728041|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
2728042|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728043|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2728044|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2728045|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2728046|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2728047|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2728048|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2728049|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2728050|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2728051|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
2728052|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
2728053|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
2728054|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2728055|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
2728056|NCT04914741|Hormones|hormones|mesh-ancestor
2728057|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2728058|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2728059|NCT04910061|Niacinamide|niacinamide|mesh-list
2728060|NCT04910061|Niacin|niacin|mesh-list
2728061|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
2728062|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
2728063|NCT04910061|Vitamins|vitamins|mesh-ancestor
2728064|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
2728065|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728066|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2728067|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
2728068|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728069|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2728070|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
2728083|NCT04903353|Risperidone|risperidone|mesh-list
2728084|NCT04903353|Aripiprazole|aripiprazole|mesh-list
2728085|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2728086|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
2728087|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2728088|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728089|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728090|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2728091|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2728092|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2728093|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2728094|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2728095|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
2728096|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
2728097|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
2728098|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2728099|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2728100|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2728101|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2728102|NCT04902443|Nivolumab|nivolumab|mesh-list
2728103|NCT04902443|Pomalidomide|pomalidomide|mesh-list
2728104|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2728105|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2728106|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2205305|NCT00006264|Ganciclovir|ganciclovir|mesh-list
2205306|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2205307|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
2205308|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205309|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2205310|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2205311|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205312|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
2205313|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205314|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2205315|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2205316|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205317|NCT00006265|Cytarabine|cytarabine|mesh-list
2205318|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
2205319|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2728107|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728108|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
2728109|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728110|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2728111|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2728112|NCT04902443|Growth Substances|growth substances|mesh-ancestor
2728113|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
2728114|NCT04901702|Irinotecan|irinotecan|mesh-list
2728115|NCT04901702|Temozolomide|temozolomide|mesh-list
2728116|NCT04901702|Talazoparib|talazoparib|mesh-list
2728117|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2728118|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2728119|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2728120|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728121|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2728122|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2728123|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
2728124|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2205320|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
2423983|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2423984|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2423985|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2423986|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2423987|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
2423988|NCT00825058|Paroxetine|paroxetine|mesh-list
2423989|NCT00825058|Amibegron|amibegron|mesh-list
2423990|NCT00825058|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2423991|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2423992|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2423993|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2423994|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2423995|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
2423996|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2423997|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2423998|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
2423999|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2424000|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2728140|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
2728141|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2728148|NCT04862338|Niacinamide|niacinamide|mesh-list
2728149|NCT04862338|Niacin|niacin|mesh-list
2728150|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
2728151|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
2728152|NCT04862338|Vitamins|vitamins|mesh-ancestor
2728153|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
2728154|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728155|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2728156|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
2728157|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728158|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2728159|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
2728189|NCT04843423|Cariprazine|cariprazine|mesh-list
2728190|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2728191|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2728192|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2728193|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728194|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2205321|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205322|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205323|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
2205324|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205325|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205326|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
2205327|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205328|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2205329|NCT00006267|Rubitecan|rubitecan|mesh-list
2205330|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205331|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2205332|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205333|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205334|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205335|NCT00006269|Irinotecan|irinotecan|mesh-list
2205336|NCT00006269|Octreotide|octreotide|mesh-list
2205337|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2205338|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205339|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205340|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205341|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205342|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2205343|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2728226|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
2728227|NCT04798469|Testosterone|testosterone|mesh-list
2728228|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
2728229|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
2728230|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2728231|NCT04798469|Androgens|androgens|mesh-ancestor
2728232|NCT04798469|Hormones|hormones|mesh-ancestor
2728233|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2728234|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728235|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2728236|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2728237|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
2728241|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2728242|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
2728243|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728244|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2728245|NCT04774250|Zonisamide|zonisamide|mesh-list
2728246|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
2728247|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2728248|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2728249|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728250|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2728251|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728260|NCT04768569|Zonisamide|zonisamide|mesh-list
2728261|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
2728262|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2728263|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2728264|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728265|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2728266|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728355|NCT04750070|Dopamine|dopamine|mesh-list
2728356|NCT04750070|Epinephrine|epinephrine|mesh-list
2728357|NCT04750070|Racepinephrine|racepinephrine|mesh-list
2728358|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
2728359|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2728360|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2728361|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
2728362|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2728363|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728364|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728365|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2728366|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2728367|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
2728368|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2728369|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2728370|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
2728371|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
2728372|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
2728373|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2728374|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2728375|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
2728376|NCT04750070|Protective Agents|protective agents|mesh-ancestor
2728405|NCT04699461|Idelalisib|idelalisib|mesh-list
2728406|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
2728407|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2728408|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2728409|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728410|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2728436|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
2728437|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
2728438|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
2728439|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
2728440|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2728441|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728442|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728443|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
2728444|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
2728445|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728446|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
2728447|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2728448|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728467|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
2728468|NCT04666740|Olaparib|olaparib|mesh-list
2728469|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2728470|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2728471|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2728472|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2728473|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728482|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
2728483|NCT04645602|Lenvatinib|lenvatinib|mesh-list
2728484|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2728485|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2728486|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2728487|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2728488|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205344|NCT00006270|Cosyntropin|cosyntropin|mesh-list
2205345|NCT00006270|Metyrapone|metyrapone|mesh-list
2205346|NCT00006270|Hormones|hormones|mesh-ancestor
2205347|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2205348|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205349|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
2205350|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205351|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205352|NCT00006275|Calcitriol|calcitriol|mesh-list
2205353|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2205354|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205355|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2205356|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2205357|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205358|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2205359|NCT00006275|Vitamins|vitamins|mesh-ancestor
2205360|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
2205361|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2205362|NCT00006276|Paclitaxel|paclitaxel|mesh-list
2205363|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205364|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205365|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205366|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205367|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205368|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205369|NCT00006279|Nevirapine|nevirapine|mesh-list
2205370|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2205371|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2205372|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205373|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728593|NCT04560725|Choline|choline|mesh-list
2728594|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
2728595|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2728596|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
2728597|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728598|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2728599|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2728600|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
2205374|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
2205375|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205376|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2205377|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2205378|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2728606|NCT04553692|Leucovorin|leucovorin|mesh-list
2728607|NCT04553692|Bevacizumab|bevacizumab|mesh-list
2728608|NCT04553692|Fluorouracil|fluorouracil|mesh-list
2728609|NCT04553692|Irinotecan|irinotecan|mesh-list
2205379|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2205380|NCT00006280|Tobramycin|tobramycin|mesh-list
2205381|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2205382|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205383|NCT00006286|Fluoxetine|fluoxetine|mesh-list
2205384|NCT00006286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2728610|NCT04553692|Venetoclax|venetoclax|mesh-list
2728611|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2728612|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2728613|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2728614|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2728615|NCT04553692|Growth Substances|growth substances|mesh-ancestor
2728616|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728617|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
2728618|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
2728619|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728620|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2728621|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2728622|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
2728623|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2728624|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2728625|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2728626|NCT04553692|Antidotes|antidotes|mesh-ancestor
2728627|NCT04553692|Protective Agents|protective agents|mesh-ancestor
2728628|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
2728629|NCT04553692|Vitamins|vitamins|mesh-ancestor
2728630|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
2728631|NCT04552288|Benralizumab|benralizumab|mesh-list
2728632|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2728633|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
2728634|NCT04549051|Anesthetics|anesthetics|mesh-list
2728635|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
2728636|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2728637|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728638|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
2728639|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2728647|NCT04542148|Insulin|insulin|mesh-list
2728648|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2728649|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
2728650|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
2728651|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2728652|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728660|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
2728661|NCT04530539|Melatonin|melatonin|mesh-list
2728662|NCT04530539|Vitamins|vitamins|mesh-ancestor
2728663|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
2728664|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728665|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
2728666|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728667|NCT04530539|Protective Agents|protective agents|mesh-ancestor
2728668|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2728689|NCT04518306|Amlodipine|amlodipine|mesh-list
2728690|NCT04518306|Telmisartan|telmisartan|mesh-list
2728691|NCT04518306|Indapamide|indapamide|mesh-list
2728692|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2728693|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2728694|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2728695|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728696|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2728697|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728698|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
2728699|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2728700|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2728701|NCT04518306|Diuretics|diuretics|mesh-ancestor
2728702|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
2728703|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2728704|NCT04518293|Amlodipine|amlodipine|mesh-list
2728705|NCT04518293|Telmisartan|telmisartan|mesh-list
2728706|NCT04518293|Indapamide|indapamide|mesh-list
2728707|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2728708|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2728709|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2728710|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728711|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2728712|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728713|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
2728714|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2728715|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2728716|NCT04518293|Diuretics|diuretics|mesh-ancestor
2728717|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
2728718|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2728719|NCT04506138|Paclitaxel|paclitaxel|mesh-list
2728720|NCT04506138|Carboplatin|carboplatin|mesh-list
2728721|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2728722|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2728723|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
2728724|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
2728725|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
2728726|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728727|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2728728|NCT04503707|Hormones|hormones|mesh-ancestor
2728729|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2728730|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728731|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
2205385|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2205386|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2205387|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205388|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2205389|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
2205390|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728732|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2728733|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2728743|NCT04462952|Adavosertib|adavosertib|mesh-list
2728744|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2728745|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728777|NCT04456153|Atovaquone|atovaquone|mesh-list
2728778|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2728779|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
2728780|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2728781|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2728782|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2728783|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728784|NCT04455464|Midodrine|midodrine|mesh-list
2728785|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
2728786|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
2728787|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2728788|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728789|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2728790|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2728791|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2728792|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2728793|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
2728794|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2728795|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728796|NCT04447027|Dexamethasone|dexamethasone|mesh-list
2728797|NCT04447027|Lenalidomide|lenalidomide|mesh-list
2728798|NCT04447027|Azacitidine|azacitidine|mesh-list
2728799|NCT04447027|Romidepsin|romidepsin|mesh-list
2728800|NCT04447027|Cc-486|cc-486|mesh-list
2728801|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2728802|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
2728803|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
2728804|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2728805|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728806|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2728807|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
2728808|NCT04447027|Hormones|hormones|mesh-ancestor
2728809|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2728810|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2728811|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2728812|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
2728813|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2728814|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2728815|NCT04447027|Growth Substances|growth substances|mesh-ancestor
2728816|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
2728817|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2728818|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
2728819|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728820|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2728821|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2728856|NCT04430517|Niacinamide|niacinamide|mesh-list
2728857|NCT04430517|Niacin|niacin|mesh-list
2728858|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
2728859|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
2728860|NCT04430517|Vitamins|vitamins|mesh-ancestor
2728861|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
2728862|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728863|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2728864|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
2728865|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728866|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2728867|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
2205391|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2205392|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
2205393|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2205394|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2205395|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2205396|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205397|NCT00006291|Aldesleukin|aldesleukin|mesh-list
2205398|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205399|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2205400|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2205401|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
2205402|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205403|NCT00006292|Infliximab|infliximab|mesh-list
2205404|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
2205405|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2205406|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2205407|NCT00006294|Amlodipine|amlodipine|mesh-list
2205408|NCT00006294|Lisinopril|lisinopril|mesh-list
2205409|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
2205410|NCT00006294|Doxazosin|doxazosin|mesh-list
2205411|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2205412|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2728880|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
2728881|NCT04403971|Listerine|listerine|mesh-list
2728882|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2728883|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2728884|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
2205413|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2205414|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205415|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2205416|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205417|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
2205418|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2205419|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
2205420|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205421|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2205422|NCT00006294|Protective Agents|protective agents|mesh-ancestor
2205423|NCT00006294|Diuretics|diuretics|mesh-ancestor
2728930|NCT04379518|Interferons|interferons|mesh-list
2728931|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
2728932|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
2728933|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2728934|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2728935|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
2728936|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2728937|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
2728938|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728981|NCT04351243|Gimsilumab|gimsilumab|mesh-list
2728982|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2728983|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
2728984|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2728985|NCT04351061|Acetazolamide|acetazolamide|mesh-list
2728986|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
2728987|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2728988|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2728989|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2728990|NCT04351061|Diuretics|diuretics|mesh-ancestor
2728991|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
2728992|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2728998|NCT04338204|Tofacitinib|tofacitinib|mesh-list
2728999|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2729000|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2729001|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729002|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2729003|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2729004|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729011|NCT04325659|Lofexidine|lofexidine|mesh-list
2729012|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2729013|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2729014|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729015|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
2729016|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2729017|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2729018|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2729019|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2729020|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
2729021|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2729022|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729028|NCT04321174|Ritonavir|ritonavir|mesh-list
2729029|NCT04321174|Lopinavir|lopinavir|mesh-list
2729030|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2729031|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2729032|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
2729033|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2729034|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729035|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2729036|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2729037|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
2729038|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2729039|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2729040|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2729041|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2729072|NCT04300140|Nivolumab|nivolumab|mesh-list
2729073|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2729074|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729075|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2729076|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729077|NCT04278781|Ivosidenib|ivosidenib|mesh-list
2729078|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729079|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2729080|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205424|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
2205425|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2205426|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2205427|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2205428|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2205429|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
2205430|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2205431|NCT00006299|Celecoxib|celecoxib|mesh-list
2205432|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2205433|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2205434|NCT00006299|Analgesics|analgesics|mesh-ancestor
2205435|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
2205436|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2205437|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205438|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2205439|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2729085|NCT04216329|Temozolomide|temozolomide|mesh-list
2729086|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2729087|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
2729088|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729089|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729159|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
2729160|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
2729161|NCT04206761|Bromides|bromides|mesh-list
2729162|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
2729163|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2729164|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
2729165|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2729166|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2729167|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2729168|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2729169|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
2729170|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2729171|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729172|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729173|NCT04194814|Betamethasone|betamethasone|mesh-list
2729174|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
2729175|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2729176|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
2729177|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2729178|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2729179|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
2729180|NCT04194814|Hormones|hormones|mesh-ancestor
2729181|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2729182|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729183|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2729184|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
2205440|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2205441|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2205442|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205443|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205444|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
2205445|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2205446|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
2205447|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205448|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2205449|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
2205450|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2205451|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
2205452|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2205453|NCT00006324|Estradiol|estradiol|mesh-list
2205454|NCT00006324|Estrogens|estrogens|mesh-ancestor
2205455|NCT00006324|Hormones|hormones|mesh-ancestor
2205456|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2205457|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205458|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2205459|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
2205460|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2205461|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2205462|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2729196|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
2729197|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205463|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2205464|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2205465|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2205466|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2205467|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205468|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2205469|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2205470|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
2205471|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205472|NCT00006326|Ritonavir|ritonavir|mesh-list
2205473|NCT00006326|Indinavir|indinavir|mesh-list
2205474|NCT00006326|Delavirdine|delavirdine|mesh-list
2205475|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2205476|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2205477|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
2205478|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205479|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205480|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2205481|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2205482|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
2205483|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2729243|NCT04143204|Insulin|insulin|mesh-list
2729244|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2729245|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729266|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
2729267|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
2729268|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729269|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2729270|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2729271|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729272|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2729273|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
2729274|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729280|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
2729281|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2729282|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729297|NCT04099251|Nivolumab|nivolumab|mesh-list
2729298|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2729299|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729300|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2729301|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729332|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
2729333|NCT04093752|Tirzepatide|tirzepatide|mesh-list
2729334|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2729335|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729336|NCT04093752|Incretins|incretins|mesh-ancestor
2729337|NCT04093752|Hormones|hormones|mesh-ancestor
2729338|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2205484|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2205485|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2205486|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2205487|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2205488|NCT00006330|Digoxin|digoxin|mesh-list
2205489|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2205490|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2729377|NCT04055428|Valsartan|valsartan|mesh-list
2729378|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2729379|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2729380|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2729381|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729402|NCT03998293|Somatostatin|somatostatin|mesh-list
2729403|NCT03998293|Hormones|hormones|mesh-ancestor
2729404|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2729405|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729411|NCT03962998|Lactulose|lactulose|mesh-list
2729412|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2729419|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2729420|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2729421|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205491|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205492|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729437|NCT03925246|Nivolumab|nivolumab|mesh-list
2729438|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2729439|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729440|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2729441|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205493|NCT00006330|Protective Agents|protective agents|mesh-ancestor
2205494|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205495|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
2729490|NCT03836261|Venetoclax|venetoclax|mesh-list
2729491|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
2729492|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
2729493|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729494|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2729508|NCT03815175|Aspirin|aspirin|mesh-list
2729509|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2729510|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2729511|NCT03815175|Analgesics|analgesics|mesh-ancestor
2729512|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
2729513|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2729514|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729515|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2729516|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2729517|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2729518|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2729519|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729520|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2729521|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2729522|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2729523|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
2205496|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
2205497|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
2205498|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205499|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205500|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2205501|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2205502|NCT00006332|Growth Substances|growth substances|mesh-ancestor
2205503|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205504|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
2729565|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2729566|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2205505|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205506|NCT00006337|Levodopa|levodopa|mesh-list
2205507|NCT00006337|Istradefylline|istradefylline|mesh-list
2205508|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2205509|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2205510|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
2205511|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2205512|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205513|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205514|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2205515|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2205516|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2205517|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
2205518|NCT00006339|Ritonavir|ritonavir|mesh-list
2205519|NCT00006339|Indinavir|indinavir|mesh-list
2205520|NCT00006339|Stavudine|stavudine|mesh-list
2205521|NCT00006339|Didanosine|didanosine|mesh-list
2205522|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
2205523|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2205524|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2729567|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
2729591|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
2729592|NCT03743402|Narcotics|narcotics|mesh-ancestor
2729593|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2729594|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729595|NCT03743402|Analgesics|analgesics|mesh-ancestor
2729596|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
2729597|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2729598|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
2729599|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2729600|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729601|NCT03742505|Vitamins|vitamins|mesh-ancestor
2729602|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
2205525|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
2729603|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2729666|NCT03668639|Dexamethasone|dexamethasone|mesh-list
2729667|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2729668|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
2729669|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
2729670|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2729671|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729672|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2729673|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
2729674|NCT03668639|Hormones|hormones|mesh-ancestor
2729675|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2729676|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2729677|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729700|NCT03638128|Denosumab|denosumab|mesh-list
2729701|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2729702|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729703|NCT03618693|Anesthetics|anesthetics|mesh-list
2729704|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2729705|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729706|NCT03612713|Oxycodone|oxycodone|mesh-list
2729707|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2729708|NCT03612713|Narcotics|narcotics|mesh-ancestor
2729709|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2729710|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729711|NCT03612713|Analgesics|analgesics|mesh-ancestor
2729712|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
2729713|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2205526|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205527|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205528|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2205529|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2205530|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
2205531|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205532|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2205533|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2205534|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205535|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
2205536|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2205537|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
2205538|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2205539|NCT00006340|Ganciclovir|ganciclovir|mesh-list
2205540|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2205541|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
2205542|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
2205543|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205544|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2205545|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205546|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205547|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205548|NCT00006343|Interferons|interferons|mesh-list
2205549|NCT00006343|Cytarabine|cytarabine|mesh-list
2729738|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2729739|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2729740|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
2729741|NCT03600714|Interferons|interferons|mesh-list
2729742|NCT03600714|Ritonavir|ritonavir|mesh-list
2729743|NCT03600714|Lonafarnib|lonafarnib|mesh-list
2729744|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729745|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
2729746|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2729747|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2729748|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2729749|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
2729750|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2729751|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729752|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2729753|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2729754|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2729755|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2729787|NCT03530124|Vaccines|vaccines|mesh-list
2729788|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2729789|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
2729790|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729796|NCT03518203|Eculizumab|eculizumab|mesh-list
2729797|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2729798|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2729799|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
2729800|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729801|NCT03499899|Carboplatin|carboplatin|mesh-list
2729802|NCT03499899|Spartalizumab|spartalizumab|mesh-list
2729803|NCT03499899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729804|NCT03499899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2729805|NCT03499899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729809|NCT03479307|Ketotifen|ketotifen|mesh-list
2729810|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2729811|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2729812|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
2729813|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
2205550|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
2205551|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
2205552|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729814|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2729815|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
2729816|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
2729817|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2729818|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729819|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729820|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2729821|NCT03474640|Antibodies|antibodies|mesh-list
2729822|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2729823|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
2729824|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729827|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2729828|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
2205553|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
2205554|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205555|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2205556|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
2205557|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205558|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205559|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
2205560|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205561|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2729879|NCT03393741|Paclitaxel|paclitaxel|mesh-list
2729880|NCT03393741|Vinorelbine|vinorelbine|mesh-list
2729881|NCT03393741|Docetaxel|docetaxel|mesh-list
2729882|NCT03393741|Epothilones|epothilones|mesh-list
2729883|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
2729884|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2729885|NCT03393741|Taxane|taxane|mesh-list
2729886|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2729887|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729888|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
2729889|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
2729890|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
2729891|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729892|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2729893|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
2729894|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
2729895|NCT03379389|Methenamine|methenamine|mesh-list
2729896|NCT03379389|Acriflavine|acriflavine|mesh-list
2729897|NCT03379389|Methylene Blue|methylene blue|mesh-list
2729898|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2729899|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2729900|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205562|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205563|NCT00006345|Dexamethasone|dexamethasone|mesh-list
2205564|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
2205565|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2205566|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
2729901|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2729902|NCT03379389|Renal Agents|renal agents|mesh-ancestor
2729903|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2729904|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2729905|NCT03377803|Cantharidin|cantharidin|mesh-list
2729906|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2729907|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729922|NCT03301896|Spartalizumab|spartalizumab|mesh-list
2729923|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2729924|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729925|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729926|NCT03283371|Natalizumab|natalizumab|mesh-list
2729927|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
2729928|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729929|NCT03269994|Tazobactam|tazobactam|mesh-list
2729930|NCT03269994|Piperacillin|piperacillin|mesh-list
2729931|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2729932|NCT03269994|Cefoxitin|cefoxitin|mesh-list
2729933|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2729934|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2729935|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2729936|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2729937|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729941|NCT03257254|Polidocanol|polidocanol|mesh-list
2729942|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2729943|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2729944|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2729945|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
2729946|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
2729947|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2729948|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
2729949|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2729950|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2729951|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
2729952|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2729953|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205567|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
2205568|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2729983|NCT03153319|Adalimumab|adalimumab|mesh-list
2729984|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2729985|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2729986|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
2729987|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2729988|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
2729989|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2729990|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2729991|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2729992|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
2729993|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2729994|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2729995|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2729996|NCT03084718|Beclomethasone|beclomethasone|mesh-list
2729997|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2729998|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
2729999|NCT03084718|Hormones|hormones|mesh-ancestor
2730000|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2730001|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730002|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2730003|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
2730027|NCT03059511|Nalbuphine|nalbuphine|mesh-list
2730028|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2730029|NCT03059511|Narcotics|narcotics|mesh-ancestor
2730030|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2730031|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730032|NCT03059511|Analgesics|analgesics|mesh-ancestor
2730033|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
2730034|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730035|NCT03033303|Isotretinoin|isotretinoin|mesh-list
2730036|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
2730037|NCT03003546|Paclitaxel|paclitaxel|mesh-list
2730038|NCT03003546|Rituximab|rituximab|mesh-list
2730039|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2730040|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730041|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
2730042|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
2730043|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
2730044|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730045|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2730046|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
2730047|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730048|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2730089|NCT02972840|Rituximab|rituximab|mesh-list
2730090|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2730091|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
2730092|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2730093|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730094|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
2730095|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730096|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2730097|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2730098|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
2730099|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730100|NCT02965703|Aspirin|aspirin|mesh-list
2730101|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2730102|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2730103|NCT02965703|Analgesics|analgesics|mesh-ancestor
2730104|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
2730105|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730106|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730107|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2730108|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2730109|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2730110|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2730111|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730112|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2730113|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2730114|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730115|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
2730116|NCT02944578|Curcumin|curcumin|mesh-list
2730117|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2730118|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2730119|NCT02944578|Analgesics|analgesics|mesh-ancestor
2730120|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
2205569|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205570|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2205571|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
2205572|NCT00006345|Hormones|hormones|mesh-ancestor
2205573|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2730121|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730122|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730123|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2730124|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2730125|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730126|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730127|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730128|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
2730129|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2730130|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730131|NCT02913664|Losartan|losartan|mesh-list
2730132|NCT02913664|Amlodipine|amlodipine|mesh-list
2730133|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
2730134|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
2730135|NCT02913664|Giapreza|giapreza|mesh-list
2730136|NCT02913664|Calcium|calcium|mesh-list
2730137|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2730138|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
2730139|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2730140|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205574|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2205575|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205576|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2730141|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2730142|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2730143|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730144|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
2730145|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2730146|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2730147|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2730148|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2730149|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
2730150|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205577|NCT00006347|Antibodies|antibodies|mesh-list
2205578|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
2730175|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
2205579|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2205580|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
2205581|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205582|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205583|NCT00006348|Ondansetron|ondansetron|mesh-list
2205584|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
2205585|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
2205586|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2205587|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205588|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2205589|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
2730176|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2730177|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2730178|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730179|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
2730180|NCT02866838|Coagulants|coagulants|mesh-ancestor
2205590|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
2205591|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2205592|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
2205593|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2205594|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205595|NCT00006348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2205596|NCT00006348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2205597|NCT00006348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2205598|NCT00006348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2730195|NCT02824679|Scopolamine|scopolamine|mesh-list
2730196|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2730197|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2730198|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
2730199|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
2730200|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730201|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730202|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2730203|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
2730204|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2730205|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
2730206|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2730207|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730208|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2730209|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
2730210|NCT02754141|Nivolumab|nivolumab|mesh-list
2730211|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2730212|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730213|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2730214|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730215|NCT02684461|Paclitaxel|paclitaxel|mesh-list
2730216|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
2730217|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2730218|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730219|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
2730220|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
2730221|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
2730222|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730223|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2730224|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
2730225|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2730226|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205599|NCT00006348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2205600|NCT00006349|Vitamin E|vitamin e|mesh-list
2205601|NCT00006349|Donepezil|donepezil|mesh-list
2205602|NCT00006349|Vitamins|vitamins|mesh-ancestor
2205603|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
2205604|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205605|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2205606|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205607|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205608|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
2205609|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2205610|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
2730271|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2730272|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
2730273|NCT02445131|Idelalisib|idelalisib|mesh-list
2730274|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2730275|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
2730276|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730277|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730278|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2205611|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
2730279|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730280|NCT02437318|Fulvestrant|fulvestrant|mesh-list
2730281|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2730282|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730283|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2730284|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2730285|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
2730286|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2730287|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730320|NCT02422615|Fulvestrant|fulvestrant|mesh-list
2730321|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2730322|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730323|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2730324|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2730325|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
2730326|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2730327|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730382|NCT02296918|Rituximab|rituximab|mesh-list
2730383|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
2730384|NCT02296918|Venetoclax|venetoclax|mesh-list
2730385|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
2730386|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2730387|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730388|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
2730389|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730390|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2730391|NCT02259517|Guanfacine|guanfacine|mesh-list
2730392|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
2730393|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2730394|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730395|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2730396|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2730397|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2730398|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730399|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
2730400|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2730401|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2730402|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2730403|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2730404|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2730405|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
2730406|NCT02209545|Pyridoxine|pyridoxine|mesh-list
2730407|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
2730408|NCT02209545|Misoprostol|misoprostol|mesh-list
2730409|NCT02209545|Vitamins|vitamins|mesh-ancestor
2730410|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
2730411|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730412|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2730413|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
2730414|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2730415|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2730416|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2730417|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
2730418|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
2730422|NCT01969643|Trastuzumab|trastuzumab|mesh-list
2730423|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2730424|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730425|NCT01910402|Ritonavir|ritonavir|mesh-list
2730426|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2730427|NCT01910402|Tenofovir|tenofovir|mesh-list
2730428|NCT01910402|Lamivudine|lamivudine|mesh-list
2730429|NCT01910402|Emtricitabine|emtricitabine|mesh-list
2730430|NCT01910402|Abacavir|abacavir|mesh-list
2730431|NCT01910402|Dolutegravir|dolutegravir|mesh-list
2730432|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2730433|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2730434|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
2730435|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730436|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730437|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2730438|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2730439|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
2730440|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2730441|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2730442|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2730443|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2730444|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2730445|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2730446|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2730480|NCT01796197|Paclitaxel|paclitaxel|mesh-list
2730481|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
2730482|NCT01796197|Doxorubicin|doxorubicin|mesh-list
2730483|NCT01796197|Trastuzumab|trastuzumab|mesh-list
2730484|NCT01796197|Pertuzumab|pertuzumab|mesh-list
2730485|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2730486|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730487|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
2730488|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
2730489|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
2730490|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730491|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2730492|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
2730493|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730494|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2730495|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2730496|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
2730497|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2730498|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2730499|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2730500|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2730501|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730502|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2730503|NCT01585805|Gemcitabine|gemcitabine|mesh-list
2730504|NCT01585805|Cisplatin|cisplatin|mesh-list
2730505|NCT01585805|Veliparib|veliparib|mesh-list
2730506|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730507|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2730508|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
2730509|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730510|NCT01585805|Antiviral Agents|antiviral agents|mesh-ancestor
2730511|NCT01585805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2730512|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730513|NCT01585805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2730514|NCT01585805|Immunologic Factors|immunologic factors|mesh-ancestor
2730515|NCT01585805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730516|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2730528|NCT01147822|Sunitinib|sunitinib|mesh-list
2730529|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730530|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2730531|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2730532|NCT01147822|Growth Substances|growth substances|mesh-ancestor
2730533|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730534|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
2730535|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2730536|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730537|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730538|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
2730539|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2730540|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
2730541|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730542|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2730543|NCT00695279|Vaccines|vaccines|mesh-list
2730544|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
2730545|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730546|NCT00521846|Cimetidine|cimetidine|mesh-list
2730547|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2730548|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2730549|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2730550|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
2730551|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
2730552|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2730553|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730554|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730555|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2730556|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2730557|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730558|NCT00328653|Cyclosporine|cyclosporine|mesh-list
2730559|NCT00328653|Cyclosporins|cyclosporins|mesh-list
2730560|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730561|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730562|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2730563|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
2730564|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730565|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
2730566|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2730567|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
2730568|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2730569|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2730570|NCT05159050|Paclitaxel|paclitaxel|mesh-list
2730571|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2730572|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730573|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
2730574|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
2730575|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
2730576|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730587|NCT05158777|Vaccines|vaccines|mesh-list
2730588|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
2730589|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730590|NCT05158699|Dexamethasone|dexamethasone|mesh-list
2730591|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
2730592|NCT05158699|Triamcinolone|triamcinolone|mesh-list
2730593|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2730594|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2730595|NCT05158699|Ketorolac|ketorolac|mesh-list
2730596|NCT05158699|Bromfenac|bromfenac|mesh-list
2730597|NCT05158699|Phenylephrine|phenylephrine|mesh-list
2730598|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2730599|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2730600|NCT05158699|BB 1101|bb 1101|mesh-list
2730601|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2730602|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2730603|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
2730604|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
2730605|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730606|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730607|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2730608|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
2730609|NCT05158699|Hormones|hormones|mesh-ancestor
2730610|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2730611|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2730612|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730613|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
2730614|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730615|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730616|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2730617|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
2730618|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2730619|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2730620|NCT05158699|Analgesics|analgesics|mesh-ancestor
2730621|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
2730622|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2730623|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2730624|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2730625|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
2730626|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
2730627|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2730628|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
2730629|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
2730630|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2730631|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2730632|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2730633|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
2730634|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2730635|NCT05158699|Protective Agents|protective agents|mesh-ancestor
2730636|NCT05158686|Paclitaxel|paclitaxel|mesh-list
2730637|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2730638|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730639|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
2730640|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
2730641|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
2730642|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730643|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
2730644|NCT05158647|Analgesics|analgesics|mesh-ancestor
2730645|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
2730646|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730647|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730648|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
2730649|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2730650|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2730651|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
2730652|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2730653|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2730654|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730655|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2730656|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
2730657|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2730668|NCT05158517|Vedolizumab|vedolizumab|mesh-list
2730669|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2730676|NCT05158426|Propofol|propofol|mesh-list
2730677|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2730678|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2730679|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730680|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2730681|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
2730682|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
2730701|NCT05158348|Lidocaine|lidocaine|mesh-list
2730702|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
2730703|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
2730704|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
2730705|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2730706|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730707|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
2730708|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730709|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2730710|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2730711|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2730712|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2730713|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730714|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2730715|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2730716|NCT05158348|Analgesics|analgesics|mesh-ancestor
2730717|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2730718|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2730719|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2730720|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
2730721|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2730722|NCT05158309|Capsaicin|capsaicin|mesh-list
2730723|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
2730724|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
2730725|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
2730726|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730727|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730728|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2730729|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2730730|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2730731|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730732|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730733|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2730734|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2730735|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730736|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
2730737|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2730738|NCT05158153|Furosemide|furosemide|mesh-list
2730739|NCT05158153|Diuretics|diuretics|mesh-ancestor
2730740|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
2730741|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730742|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2730743|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2730744|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730748|NCT05158062|Paclitaxel|paclitaxel|mesh-list
2730749|NCT05158062|Docetaxel|docetaxel|mesh-list
2730750|NCT05158062|Bevacizumab|bevacizumab|mesh-list
2730751|NCT05158062|Carboplatin|carboplatin|mesh-list
2730752|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
2730753|NCT05158062|Olaparib|olaparib|mesh-list
2730754|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2730755|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730756|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
2730757|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
2730758|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
2730759|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730760|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2730761|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2730762|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2730763|NCT05158062|Growth Substances|growth substances|mesh-ancestor
2730764|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730765|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
2730766|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2730767|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730768|NCT05157997|Antibodies|antibodies|mesh-list
2730769|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
2730770|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205612|NCT00006349|Protective Agents|protective agents|mesh-ancestor
2205613|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
2205614|NCT00006350|Tacrolimus|tacrolimus|mesh-list
2205615|NCT00006350|Daclizumab|daclizumab|mesh-list
2205616|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205617|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
2205618|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205619|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2205620|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205621|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205622|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2205623|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205624|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2205625|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
2205626|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2205627|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205628|NCT00006351|Gemcitabine|gemcitabine|mesh-list
2205629|NCT00006351|Lonafarnib|lonafarnib|mesh-list
2205630|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2205631|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
2205632|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205633|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205634|NCT00006351|Antiviral Agents|antiviral agents|mesh-ancestor
2205635|NCT00006351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2730814|NCT05157893|Analgesics|analgesics|mesh-list
2730815|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
2730816|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730817|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730818|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
2730819|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2730820|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
2730821|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730822|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730823|NCT05157841|Bupivacaine|bupivacaine|mesh-list
2730824|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
2730825|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
2730826|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2730827|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730828|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
2730829|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730830|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
2730831|NCT05157711|Phenylephrine|phenylephrine|mesh-list
2730832|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
2730833|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
2730834|NCT05157711|Bismuth|bismuth|mesh-list
2730835|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2730836|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
2730837|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
2730838|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730839|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730840|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
2730841|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2730842|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
2730843|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
2730844|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2730845|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2730846|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2730847|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
2730848|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2730849|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730850|NCT05157711|Protective Agents|protective agents|mesh-ancestor
2730851|NCT05157711|Antacids|antacids|mesh-ancestor
2730852|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2730853|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
2730854|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
2730855|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2730856|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2730857|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
2730858|NCT05157711|Coagulants|coagulants|mesh-ancestor
2730859|NCT05157698|Naltrexone|naltrexone|mesh-list
2730860|NCT05157698|Bupropion|bupropion|mesh-list
2730861|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2730862|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2730863|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730864|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
2730865|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730866|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2730867|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
2730868|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2730869|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2730870|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2730871|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2730872|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730873|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
2730874|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2730875|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2730876|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2730877|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730878|NCT05157685|Azithromycin|azithromycin|mesh-list
2730879|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2730880|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2730881|NCT05157672|Letrozole|letrozole|mesh-list
2730882|NCT05157672|Nicotine|nicotine|mesh-list
2730883|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2730884|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
2730885|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730886|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730887|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2730888|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2730889|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
2730890|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2730891|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730892|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730893|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2730894|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2730895|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2730896|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2730897|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
2730898|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2730899|NCT05157581|Methoxsalen|methoxsalen|mesh-list
2730900|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2730901|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
2730902|NCT05157542|Paclitaxel|paclitaxel|mesh-list
2730903|NCT05157542|Durvalumab|durvalumab|mesh-list
2730904|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2730905|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2730906|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730907|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
2730908|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
2730909|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
2730910|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730911|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2730918|NCT05157412|Doxycycline|doxycycline|mesh-list
2730919|NCT05157412|Prednisolone|prednisolone|mesh-list
2730920|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2730921|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
2730922|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2730923|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
2730924|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2730925|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
2730926|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2730927|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
2730928|NCT05157412|Hormones|hormones|mesh-ancestor
2730929|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2730930|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730931|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2205636|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205637|NCT00006351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205638|NCT00006351|Immunologic Factors|immunologic factors|mesh-ancestor
2205639|NCT00006351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205640|NCT00006352|Antibodies|antibodies|mesh-list
2205641|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2205642|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
2205643|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
2730932|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2730933|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
2730934|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
2730935|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730936|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2730937|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2730938|NCT05157412|Protective Agents|protective agents|mesh-ancestor
2730939|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2730940|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2730941|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
2730942|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2730943|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2730944|NCT05157360|Vitamins|vitamins|mesh-list
2730945|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
2730946|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
2730947|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730948|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2730949|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2730950|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2730951|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2730952|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2205644|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205645|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2205646|NCT00006353|Temozolomide|temozolomide|mesh-list
2205647|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2205648|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
2205649|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205650|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205651|NCT00006355|NSC 366140|nsc 366140|mesh-list
2205652|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205653|NCT00006356|Carboplatin|carboplatin|mesh-list
2205654|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205655|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
2205656|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205657|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2205658|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205659|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205660|NCT00006358|Thalidomide|thalidomide|mesh-list
2205661|NCT00006358|Temozolomide|temozolomide|mesh-list
2205662|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2205663|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
2205664|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205665|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205666|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205667|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
2205668|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205669|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
2205670|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2730953|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2730954|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2730955|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2730956|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2730957|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
2205671|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205672|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2205673|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2205674|NCT00006358|Growth Substances|growth substances|mesh-ancestor
2730958|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2205675|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
2205676|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
2205677|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
2205678|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2205679|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205680|NCT00006361|Semaxinib|semaxinib|mesh-list
2205681|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2205682|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2205683|NCT00006361|Growth Substances|growth substances|mesh-ancestor
2205684|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205685|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
2205686|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205687|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2205688|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205689|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205690|NCT00006362|Bortezomib|bortezomib|mesh-list
2205691|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205692|NCT00006363|Cytarabine|cytarabine|mesh-list
2730993|NCT05080946|Aspirin|aspirin|mesh-list
2730994|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2730995|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2730996|NCT05080946|Analgesics|analgesics|mesh-ancestor
2730997|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
2205693|NCT00006363|Aldesleukin|aldesleukin|mesh-list
2205694|NCT00006363|Etoposide|etoposide|mesh-list
2205695|NCT00006363|Daunorubicin|daunorubicin|mesh-list
2205696|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
2205697|NCT00006363|Busulfan|busulfan|mesh-list
2205698|NCT00006363|Interleukin-2|interleukin-2|mesh-list
2730998|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2730999|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731000|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2731001|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2731002|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2731003|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2731004|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731005|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2731006|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2731007|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731008|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
2731009|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
2731010|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
2731011|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731012|NCT05079126|Protective Agents|protective agents|mesh-ancestor
2731013|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731014|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2731015|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731038|NCT05076253|Ivermectin|ivermectin|mesh-list
2731039|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2731040|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2731044|NCT05071183|Trametinib|trametinib|mesh-list
2731045|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731046|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2731047|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731048|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205699|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205700|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205701|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2205702|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205703|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205704|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205705|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
2205706|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205707|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2205708|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
2205709|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
2205710|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205711|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205712|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
2205713|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2205714|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2205715|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2205716|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2205717|NCT00006363|Analgesics|analgesics|mesh-ancestor
2205718|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
2731074|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2731075|NCT05039073|Nivolumab|nivolumab|mesh-list
2731076|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2731077|NCT05039073|Antibodies|antibodies|mesh-list
2731078|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
2731079|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2731080|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
2731081|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
2731082|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731083|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731084|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2731085|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731102|NCT05028829|Atorvastatin|atorvastatin|mesh-list
2731103|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2731104|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2731105|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
2731106|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731107|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2731108|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2731109|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205719|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2205720|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2205721|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2205722|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
2205723|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205724|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205725|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2205726|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205727|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205728|NCT00006366|Fluorouracil|fluorouracil|mesh-list
2205729|NCT00006366|Irinotecan|irinotecan|mesh-list
2205730|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
2205731|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205732|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2205733|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731131|NCT05022563|Warfarin|warfarin|mesh-list
2731132|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
2731133|NCT05022563|Dabigatran|dabigatran|mesh-list
2731134|NCT05022563|Apixaban|apixaban|mesh-list
2731135|NCT05022563|Edoxaban|edoxaban|mesh-list
2731136|NCT05022563|Anticoagulants|anticoagulants|mesh-list
2731137|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2731138|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
2731139|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2731140|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
2731141|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731142|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731143|NCT05020327|Amoxicillin|amoxicillin|mesh-list
2731144|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2731145|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2731172|NCT04998617|Curcumin|curcumin|mesh-list
2731173|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2731174|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2731175|NCT04998617|Analgesics|analgesics|mesh-ancestor
2731176|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
2731177|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2731178|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731179|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2731180|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2731181|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731182|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731183|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731200|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
2731201|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2731202|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731203|NCT04983498|Ondansetron|ondansetron|mesh-list
2731204|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
2731205|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
2731206|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2731207|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731208|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2731209|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
2731210|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
2731211|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2731212|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
2731213|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2731214|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731215|NCT04983498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2731216|NCT04983498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2731217|NCT04983498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2731218|NCT04983498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2731219|NCT04983498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2731226|NCT04963439|Macitentan|macitentan|mesh-list
2731227|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2731228|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2731229|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731230|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
2731241|NCT04949828|Pancrelipase|pancrelipase|mesh-list
2731242|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2731243|NCT04947592|Fluconazole|fluconazole|mesh-list
2731244|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
2731245|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2731246|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2731247|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2731248|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731249|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731250|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2731251|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
2731252|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2731253|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731254|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2731255|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2205734|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205735|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
2205736|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205737|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2731355|NCT04905810|Azacitidine|azacitidine|mesh-list
2731356|NCT04905810|Decitabine|decitabine|mesh-list
2731357|NCT04905810|Venetoclax|venetoclax|mesh-list
2731358|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2731359|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
2731360|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731361|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731362|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731418|NCT04865939|Gemcitabine|gemcitabine|mesh-list
2731419|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2731420|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
2731421|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731422|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731423|NCT04865939|Antiviral Agents|antiviral agents|mesh-ancestor
2731424|NCT04865939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2731425|NCT04865939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731426|NCT04865939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2731427|NCT04865939|Immunologic Factors|immunologic factors|mesh-ancestor
2731428|NCT04865939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731450|NCT04831892|Isosorbide|isosorbide|mesh-list
2731451|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
2731452|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
2731453|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2731454|NCT04831892|Diuretics|diuretics|mesh-ancestor
2731455|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
2731456|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731457|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
2731458|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2731459|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205738|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205739|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205740|NCT00006367|Cytarabine|cytarabine|mesh-list
2205741|NCT00006367|Busulfan|busulfan|mesh-list
2205742|NCT00006367|Idarubicin|idarubicin|mesh-list
2205743|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
2205744|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205745|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2205746|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
2205747|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205748|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205749|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
2205750|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205751|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205752|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
2205753|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2205754|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2205755|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2205756|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2205757|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205758|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205759|NCT00006368|Edotreotide|edotreotide|mesh-list
2205760|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2731552|NCT04761627|Ustekinumab|ustekinumab|mesh-list
2731553|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
2731554|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
2731555|NCT04761614|Leucovorin|leucovorin|mesh-list
2731556|NCT04761614|Folic Acid|folic acid|mesh-list
2731557|NCT04761614|Bevacizumab|bevacizumab|mesh-list
2731558|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2205761|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205762|NCT00006370|Edotreotide|edotreotide|mesh-list
2205763|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2205764|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205765|NCT00006371|Ketoconazole|ketoconazole|mesh-list
2205766|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
2205767|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2205768|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2205769|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2731559|NCT04761614|Fluorouracil|fluorouracil|mesh-list
2731560|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
2731561|NCT04761614|Riluzole|riluzole|mesh-list
2731562|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
2731563|NCT04761614|Antibodies|antibodies|mesh-list
2731564|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
2731565|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2731566|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
2731567|NCT04761614|Calcium|calcium|mesh-list
2731568|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
2731569|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731570|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2731571|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2731572|NCT04761614|Growth Substances|growth substances|mesh-ancestor
2731573|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731574|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
2731575|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
2731576|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2731577|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2731578|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
2731579|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731580|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2731581|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2731582|NCT04761614|Antidotes|antidotes|mesh-ancestor
2731583|NCT04761614|Protective Agents|protective agents|mesh-ancestor
2731584|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
2205770|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
2205771|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2205772|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
2205773|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205774|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2205775|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2205776|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205777|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205778|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2205779|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
2205780|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2205781|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205782|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2205783|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2205784|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205785|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2205786|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2205787|NCT00006372|Gemcitabine|gemcitabine|mesh-list
2205788|NCT00006372|Doxorubicin|doxorubicin|mesh-list
2205789|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2205790|NCT00006372|Vinorelbine|vinorelbine|mesh-list
2205791|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2205792|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
2205793|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205794|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205795|NCT00006372|Antiviral Agents|antiviral agents|mesh-ancestor
2205796|NCT00006372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205797|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205798|NCT00006372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2731585|NCT04761614|Vitamins|vitamins|mesh-ancestor
2731586|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
2731587|NCT04761614|Hematinics|hematinics|mesh-ancestor
2731588|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
2731589|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2731590|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2731591|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2731592|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2731652|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2731653|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
2731654|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731655|NCT04694248|Aspirin|aspirin|mesh-list
2731656|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
2731657|NCT04694248|Anticoagulants|anticoagulants|mesh-list
2731658|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2731659|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2731660|NCT04694248|Analgesics|analgesics|mesh-ancestor
2731661|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
2731662|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2731663|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731664|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2731665|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2731666|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2731667|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2731668|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731669|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2731670|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2731671|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731672|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
2731673|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2731674|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
2731675|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2731676|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
2731677|NCT04684238|Midazolam|midazolam|mesh-list
2731678|NCT04684238|Isoflurane|isoflurane|mesh-list
2731679|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2731680|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2731681|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2731682|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731683|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2731684|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2731685|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2731686|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2731687|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
2731688|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
2731689|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
2731690|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
2731691|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2731692|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731693|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2731694|NCT04650152|Fenofibrate|fenofibrate|mesh-list
2731695|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2731696|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
2731697|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731698|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2731724|NCT04634162|Cangrelor|cangrelor|mesh-list
2731725|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2731726|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2731727|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2731728|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2731729|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
2731730|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2731731|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731732|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731733|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2731734|NCT04631601|Androgens|androgens|mesh-list
2731735|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
2731736|NCT04631601|Hormones|hormones|mesh-ancestor
2731737|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2731738|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731739|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731740|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731741|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
2731742|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
2731743|NCT04623216|Azacitidine|azacitidine|mesh-list
2731744|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2731745|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
2731746|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731747|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731748|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731761|NCT04615624|Furosemide|furosemide|mesh-list
2731762|NCT04615624|Diuretics|diuretics|mesh-ancestor
2731763|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
2731764|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731765|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2731766|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2731767|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731768|NCT04608955|Bedaquiline|bedaquiline|mesh-list
2205799|NCT00006372|Immunologic Factors|immunologic factors|mesh-ancestor
2205800|NCT00006372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205801|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2205802|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2205803|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205804|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205805|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205806|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205807|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205808|NCT00006373|Etoposide|etoposide|mesh-list
2205809|NCT00006373|Topotecan|topotecan|mesh-list
2205810|NCT00006373|Ifosfamide|ifosfamide|mesh-list
2731769|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
2731770|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2731771|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205811|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205812|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205813|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2205814|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205815|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205816|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205817|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2205818|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2205819|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
2205820|NCT00006374|Paclitaxel|paclitaxel|mesh-list
2205821|NCT00006374|Etoposide|etoposide|mesh-list
2205822|NCT00006374|Topotecan|topotecan|mesh-list
2205823|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2731811|NCT04579783|Triamcinolone|triamcinolone|mesh-list
2731812|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2731813|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2731814|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2731815|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2731816|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
2731817|NCT04579783|Hormones|hormones|mesh-ancestor
2731818|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2731819|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731820|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2731821|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
2731822|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731823|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731858|NCT04559347|Bupivacaine|bupivacaine|mesh-list
2731859|NCT04559347|Ropivacaine|ropivacaine|mesh-list
2731860|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
2731861|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
2731862|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2731863|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731864|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
2731865|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2731866|NCT04558918|Eculizumab|eculizumab|mesh-list
2731867|NCT04558918|Ravulizumab|ravulizumab|mesh-list
2731868|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2731869|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2731870|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
2731871|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731872|NCT04557956|Trametinib|trametinib|mesh-list
2731873|NCT04557956|Dabrafenib|dabrafenib|mesh-list
2731874|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2731875|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731876|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2731877|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731878|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731879|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2731880|NCT04557956|Protective Agents|protective agents|mesh-ancestor
2731881|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731882|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2731883|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
2731892|NCT04533737|Brodalumab|brodalumab|mesh-list
2731893|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
2731894|NCT04531462|Empagliflozin|empagliflozin|mesh-list
2731895|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2731896|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731897|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2731898|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731904|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
2731905|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
2731906|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2731907|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2731908|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2731909|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731910|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731911|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2731925|NCT04455750|Leuprolide|leuprolide|mesh-list
2731926|NCT04455750|Goserelin|goserelin|mesh-list
2731927|NCT04455750|Rucaparib|rucaparib|mesh-list
2731928|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2731929|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
2731930|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2731931|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731932|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2731933|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731934|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2731935|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731936|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731943|NCT04439110|Trastuzumab|trastuzumab|mesh-list
2731944|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2731945|NCT04439110|Maytansine|maytansine|mesh-list
2731946|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
2731947|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2731948|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731949|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2731950|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
2731951|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
2731952|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
2731953|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731954|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
2731955|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731956|NCT04435600|Ustekinumab|ustekinumab|mesh-list
2731957|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
2731963|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
2731964|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2731965|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2731966|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2731967|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
2731968|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
2731969|NCT04375631|Cytarabine|cytarabine|mesh-list
2731970|NCT04375631|Cyclosporine|cyclosporine|mesh-list
2731971|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
2731972|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
2731973|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
2731974|NCT04375631|Cladribine|cladribine|mesh-list
2731975|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
2205824|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205825|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205826|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205827|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205828|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205829|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2205830|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205831|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205832|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2205833|NCT00006376|Tipifarnib|tipifarnib|mesh-list
2205834|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205835|NCT00006377|Paclitaxel|paclitaxel|mesh-list
2205836|NCT00006377|Carboplatin|carboplatin|mesh-list
2205837|NCT00006377|Doxorubicin|doxorubicin|mesh-list
2205838|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2205839|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205840|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205841|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205842|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205843|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205844|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205845|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2205846|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2205847|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205848|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205849|NCT00006378|Paclitaxel|paclitaxel|mesh-list
2205850|NCT00006378|Carboplatin|carboplatin|mesh-list
2205851|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205852|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205853|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205854|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205855|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205856|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205857|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
2205858|NCT00006379|Fludarabine|fludarabine|mesh-list
2205859|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
2205860|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2205861|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205862|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
2205863|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205864|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2205865|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2205866|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
2205867|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205868|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731976|NCT04375631|Cyclosporins|cyclosporins|mesh-list
2731977|NCT04375631|Lenograstim|lenograstim|mesh-list
2731978|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2731979|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
2731980|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2731981|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2731982|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2731983|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
2731984|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2731985|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2731986|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2731987|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2731988|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2731989|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
2731990|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
2731991|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2731992|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2731993|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
2731994|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
2731995|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2731996|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2731997|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2731998|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
2731999|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2732000|NCT04375631|Analgesics|analgesics|mesh-ancestor
2732001|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
2732002|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2732003|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2732004|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2732029|NCT04345861|Azithromycin|azithromycin|mesh-list
2732030|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
2732031|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2732032|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2732033|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
2732034|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2732035|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2732036|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732037|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732038|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2732048|NCT04278404|Metformin|metformin|mesh-list
2732049|NCT04278404|Interferons|interferons|mesh-list
2732050|NCT04278404|Ritonavir|ritonavir|mesh-list
2732051|NCT04278404|Ribavirin|ribavirin|mesh-list
2732052|NCT04278404|Lopinavir|lopinavir|mesh-list
2732053|NCT04278404|Oseltamivir|oseltamivir|mesh-list
2732054|NCT04278404|Remdesivir|remdesivir|mesh-list
2732055|NCT04278404|Azithromycin|azithromycin|mesh-list
2732056|NCT04278404|Clindamycin|clindamycin|mesh-list
2732057|NCT04278404|Meropenem|meropenem|mesh-list
2732058|NCT04278404|Voriconazole|voriconazole|mesh-list
2732059|NCT04278404|Ceftazidime|ceftazidime|mesh-list
2732060|NCT04278404|Cefepime|cefepime|mesh-list
2732061|NCT04278404|Fosfomycin|fosfomycin|mesh-list
2732062|NCT04278404|Cefdinir|cefdinir|mesh-list
2732063|NCT04278404|Dexamethasone|dexamethasone|mesh-list
2732064|NCT04278404|Budesonide|budesonide|mesh-list
2732065|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
2732066|NCT04278404|Colchicine|colchicine|mesh-list
2732067|NCT04278404|Amiodarone|amiodarone|mesh-list
2732068|NCT04278404|Bosentan|bosentan|mesh-list
2732069|NCT04278404|Guanfacine|guanfacine|mesh-list
2732070|NCT04278404|Labetalol|labetalol|mesh-list
2732071|NCT04278404|Nicardipine|nicardipine|mesh-list
2732072|NCT04278404|Nifedipine|nifedipine|mesh-list
2732073|NCT04278404|Milrinone|milrinone|mesh-list
2732074|NCT04278404|Furosemide|furosemide|mesh-list
2732075|NCT04278404|Spironolactone|spironolactone|mesh-list
2205869|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2205870|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2205871|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
2205872|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2205873|NCT00006380|Antibodies|antibodies|mesh-list
2205874|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
2205875|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2205876|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
2205877|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205878|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205879|NCT00006381|Celecoxib|celecoxib|mesh-list
2205880|NCT00006381|Trastuzumab|trastuzumab|mesh-list
2205881|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2205882|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732076|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
2732077|NCT04278404|Oxycodone|oxycodone|mesh-list
2732078|NCT04278404|Gabapentin|gabapentin|mesh-list
2732079|NCT04278404|Nalbuphine|nalbuphine|mesh-list
2732080|NCT04278404|Clobazam|clobazam|mesh-list
2732081|NCT04278404|Zolpidem|zolpidem|mesh-list
2732082|NCT04278404|Risperidone|risperidone|mesh-list
2732083|NCT04278404|Amphetamine|amphetamine|mesh-list
2732084|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
2732085|NCT04278404|Sertraline|sertraline|mesh-list
2732086|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
2732087|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
2732088|NCT04278404|Terbutaline|terbutaline|mesh-list
2732089|NCT04278404|Sevelamer|sevelamer|mesh-list
2732090|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2732091|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
2732092|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
2732093|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2732094|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732095|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2732096|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
2732097|NCT04278404|Hormones|hormones|mesh-ancestor
2732098|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2732099|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2732100|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732101|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
2732102|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732103|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732104|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2732105|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
2732106|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2732107|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2732108|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2732109|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2732110|NCT04278404|Analgesics|analgesics|mesh-ancestor
2732111|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
2732112|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2732113|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2732114|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2732115|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
2732116|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2205883|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2732117|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2732118|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2732119|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2732120|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2732121|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2732122|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2732123|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2732124|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2732125|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2732126|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
2732127|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2732128|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2732129|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
2732130|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2732131|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2732132|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
2732133|NCT04278404|Coagulants|coagulants|mesh-ancestor
2732134|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2732135|NCT04278404|Narcotics|narcotics|mesh-ancestor
2732136|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2732137|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
2732138|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2732139|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2732140|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2732141|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2732142|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
2732143|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
2732144|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2732145|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2732146|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2732147|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
2732148|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
2732149|NCT04278404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2732150|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2732151|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2732152|NCT04278404|Diuretics|diuretics|mesh-ancestor
2732153|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
2732154|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2732155|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2732156|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
2732157|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2732158|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
2732159|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
2732160|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
2732161|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
2732162|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2732163|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2732164|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2732165|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
2732166|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
2732167|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2732168|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
2732169|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2732170|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2732171|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2732172|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2732173|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
2732174|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
2732175|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2732176|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2732177|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2732178|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2732179|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2732180|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2732181|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2732182|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
2732183|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2732184|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2732185|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2732186|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2732187|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
2732188|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
2732189|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2732190|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2732191|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2732192|NCT04278404|Protective Agents|protective agents|mesh-ancestor
2732193|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2732194|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2732195|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2732196|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2732197|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2732198|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2732199|NCT04266379|Insulin|insulin|mesh-list
2732200|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2732201|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2732202|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732209|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
2732210|NCT04240093|Narcotics|narcotics|mesh-ancestor
2732211|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2732212|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732213|NCT04240093|Analgesics|analgesics|mesh-ancestor
2732214|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
2732215|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2732216|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
2732217|NCT04237792|Propofol|propofol|mesh-list
2732218|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2732219|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2732220|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732221|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2732222|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
2732223|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
2205884|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2205885|NCT00006381|Analgesics|analgesics|mesh-ancestor
2205886|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
2205887|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2205888|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205889|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2205890|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2205891|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2732224|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2732225|NCT04237792|Analgesics|analgesics|mesh-ancestor
2732226|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
2732227|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2732228|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2732229|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2732230|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2732231|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
2732232|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2732233|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732234|NCT04234477|Metoprolol|metoprolol|mesh-list
2732235|NCT04234477|Verapamil|verapamil|mesh-list
2732236|NCT04234477|Diltiazem|diltiazem|mesh-list
2732237|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
2732238|NCT04234477|Calcium|calcium|mesh-list
2732239|NCT04234477|Esmolol|esmolol|mesh-list
2732240|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2732241|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2732242|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732243|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2732244|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2732245|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
2732246|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
2732247|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2732248|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2732249|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2732250|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
2732251|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2732252|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732253|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2732254|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
2732255|NCT04224987|Azithromycin|azithromycin|mesh-list
2732256|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2732257|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2732258|NCT04217967|Lenalidomide|lenalidomide|mesh-list
2732259|NCT04217967|Ixazomib|ixazomib|mesh-list
2732260|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
2732261|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732262|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2732263|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2732264|NCT04217967|Growth Substances|growth substances|mesh-ancestor
2732265|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
2732266|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732267|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
2732268|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732269|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732278|NCT04196283|Paclitaxel|paclitaxel|mesh-list
2732279|NCT04196283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2732280|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2732281|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732282|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
2732283|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
2732284|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
2732285|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205892|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2205893|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732309|NCT04156698|Docetaxel|docetaxel|mesh-list
2732310|NCT04156698|Capecitabine|capecitabine|mesh-list
2732311|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732312|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
2732313|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
2732314|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
2732315|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732316|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2732317|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
2732340|NCT04093323|Interferons|interferons|mesh-list
2732341|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
2732342|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
2205894|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205895|NCT00006383|Vincristine|vincristine|mesh-list
2205896|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2205897|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205898|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
2205899|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
2205900|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
2205901|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205902|NCT00006384|Interferons|interferons|mesh-list
2205903|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
2205904|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732343|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
2732344|NCT04093323|Celecoxib|celecoxib|mesh-list
2732345|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2732346|NCT04093323|Benzenesulfonamide|benzenesulfonamide|mesh-list
2732347|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732348|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
2732349|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2732350|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
2732351|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732352|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2732353|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2732354|NCT04093323|Analgesics|analgesics|mesh-ancestor
2732355|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
2732356|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2732357|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2732358|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2732359|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2732360|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2732361|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732362|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732363|NCT04093323|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2732364|NCT04091022|Eflornithine|eflornithine|mesh-list
2732365|NCT04091022|Diclofenac|diclofenac|mesh-list
2732366|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2732367|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2732368|NCT04091022|Analgesics|analgesics|mesh-ancestor
2732369|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
2732370|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2732371|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732372|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2732373|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2732374|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2732375|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732376|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732377|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732378|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2732379|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2732380|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2732381|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2732382|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2732400|NCT04059484|Tamoxifen|tamoxifen|mesh-list
2732401|NCT04059484|Letrozole|letrozole|mesh-list
2205905|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
2205906|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205907|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
2205908|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205909|NCT00006385|Interferons|interferons|mesh-list
2205910|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
2205911|NCT00006385|Sargramostim|sargramostim|mesh-list
2205912|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
2205913|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205914|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
2205915|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205916|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
2205917|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732402|NCT04059484|Fulvestrant|fulvestrant|mesh-list
2732403|NCT04059484|Anastrozole|anastrozole|mesh-list
2732404|NCT04059484|Exemestane|exemestane|mesh-list
2732405|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732406|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2732407|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2732408|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732409|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732410|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2732411|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
2732412|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2732413|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732414|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2732415|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2732416|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2732417|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2732418|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2732434|NCT04046614|Nivolumab|nivolumab|mesh-list
2732435|NCT04046614|Nintedanib|nintedanib|mesh-list
2732436|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2732437|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732438|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2732439|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732440|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2732441|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732452|NCT04001881|Anesthetics|anesthetics|mesh-list
2732453|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2732454|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205918|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2732463|NCT03940196|Paclitaxel|paclitaxel|mesh-list
2732464|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2732465|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2732466|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732467|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
2732468|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
2732469|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
2732470|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732476|NCT03916185|Vaccines|vaccines|mesh-list
2732477|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
2732478|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732479|NCT03915860|Trifarotene|trifarotene|mesh-list
2732480|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
2732557|NCT03852901|Empagliflozin|empagliflozin|mesh-list
2732558|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2732559|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732560|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2732561|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732594|NCT03795233|Vancomycin|vancomycin|mesh-list
2732595|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2732596|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2732603|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
2732604|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
2732605|NCT03783091|Hematinics|hematinics|mesh-ancestor
2732606|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
2732607|NCT03783091|Vitamins|vitamins|mesh-ancestor
2732608|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
2732609|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732639|NCT03770286|Fluorides|fluorides|mesh-list
2732640|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
2732641|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
2732642|NCT03770286|Protective Agents|protective agents|mesh-ancestor
2732643|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732644|NCT03769376|Salvin|salvin|mesh-list
2732645|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2732646|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2732647|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
2732648|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732649|NCT03769376|Protective Agents|protective agents|mesh-ancestor
2732650|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732669|NCT03712371|Chitosan|chitosan|mesh-list
2732670|NCT03712371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2732671|NCT03712371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2732672|NCT03712371|Antimetabolites|antimetabolites|mesh-ancestor
2732673|NCT03712371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732674|NCT03712371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2732675|NCT03712371|Chelating Agents|chelating agents|mesh-ancestor
2732676|NCT03712371|Sequestering Agents|sequestering agents|mesh-ancestor
2732677|NCT03712371|Hemostatics|hemostatics|mesh-ancestor
2732678|NCT03712371|Coagulants|coagulants|mesh-ancestor
2732679|NCT03683251|Ranibizumab|ranibizumab|mesh-list
2732680|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2732681|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2732682|NCT03683251|Growth Substances|growth substances|mesh-ancestor
2732683|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732684|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
2732685|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732686|NCT03645863|Iron|iron|mesh-list
2732687|NCT03645863|Trace Elements|trace elements|mesh-ancestor
2732688|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
2732689|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732732|NCT03565991|Avelumab|avelumab|mesh-list
2732733|NCT03565991|Talazoparib|talazoparib|mesh-list
2732734|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2732735|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732736|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2732737|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732738|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732739|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2732740|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
2732741|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2732742|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
2732757|NCT03476369|Fentanyl|fentanyl|mesh-list
2732758|NCT03476369|Ticagrelor|ticagrelor|mesh-list
2732759|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2732760|NCT03476369|Narcotics|narcotics|mesh-ancestor
2732761|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2732762|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732763|NCT03476369|Analgesics|analgesics|mesh-ancestor
2732764|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
2732765|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2732766|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2732767|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2732768|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
2732769|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
2732770|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2732771|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2732772|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2732773|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2732774|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
2732775|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2732776|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732777|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
2732778|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2732779|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2732780|NCT03423355|Diuretics|diuretics|mesh-ancestor
2732781|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
2732782|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732783|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2732784|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2732785|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732786|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2732787|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2732792|NCT03417544|Trastuzumab|trastuzumab|mesh-list
2732793|NCT03417544|Pertuzumab|pertuzumab|mesh-list
2732794|NCT03417544|Atezolizumab|atezolizumab|mesh-list
2732795|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2732796|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205919|NCT00006386|Carmustine|carmustine|mesh-list
2732810|NCT03365635|Ribavirin|ribavirin|mesh-list
2732811|NCT03365635|Grazoprevir|grazoprevir|mesh-list
2732812|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
2732813|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
2732814|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732815|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
2732816|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2732825|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
2732826|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2732827|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732828|NCT03330405|Avelumab|avelumab|mesh-list
2732829|NCT03330405|Talazoparib|talazoparib|mesh-list
2732830|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2732831|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2732832|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732833|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
2732834|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732835|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2732836|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732837|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732838|NCT03324373|Everolimus|everolimus|mesh-list
2732839|NCT03324373|Lenvatinib|lenvatinib|mesh-list
2732840|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732841|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2732842|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
2732843|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732844|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2732845|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732846|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732847|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
2732848|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2732849|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732865|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
2732866|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2732867|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732888|NCT03254667|Brodalumab|brodalumab|mesh-list
2732889|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
2732890|NCT03238534|Omeprazole|omeprazole|mesh-list
2732891|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2732892|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2732893|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2732894|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732895|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732903|NCT03223350|Capsaicin|capsaicin|mesh-list
2732904|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
2732905|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
2732906|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
2732907|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2732908|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205920|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2205921|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
2205922|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205923|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732928|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
2732929|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2732930|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732931|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
2732932|NCT03193931|Methotrexate|methotrexate|mesh-list
2732933|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2732934|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732935|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2732936|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
2732937|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2732938|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2732939|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2732940|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
2732941|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732942|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
2732943|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732944|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2732945|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2732946|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
2732947|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2732948|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2732949|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
2732950|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2732951|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2732952|NCT03181529|Psilocybin|psilocybin|mesh-list
2732953|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
2732954|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205924|NCT00006388|Tamoxifen|tamoxifen|mesh-list
2205925|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2205926|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
2205927|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2205928|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205929|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2205930|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2732955|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2732956|NCT03164928|Denosumab|denosumab|mesh-list
2732957|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2732958|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733014|NCT03106987|Olaparib|olaparib|mesh-list
2733015|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2733016|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733017|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733018|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733019|NCT03089606|Pembrolizumab|pembrolizumab|mesh-list
2733020|NCT03089606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2733021|NCT03089606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733022|NCT03056001|Doxorubicin|doxorubicin|mesh-list
2733023|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
2733024|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2733025|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733026|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2733027|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2733028|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733029|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733030|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2733031|NCT03049189|Everolimus|everolimus|mesh-list
2733032|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2733033|NCT03049189|Edotreotide|edotreotide|mesh-list
2733034|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733035|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2733036|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
2733037|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733038|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2733039|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733040|NCT03043729|Leucovorin|leucovorin|mesh-list
2733041|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
2733042|NCT03043729|Aflibercept|aflibercept|mesh-list
2733043|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733044|NCT03043729|Antidotes|antidotes|mesh-ancestor
2733045|NCT03043729|Protective Agents|protective agents|mesh-ancestor
2733046|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733047|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
2733048|NCT03043729|Vitamins|vitamins|mesh-ancestor
2733049|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
2733050|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2733051|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2733052|NCT03043729|Growth Substances|growth substances|mesh-ancestor
2733053|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
2733054|NCT03018080|Paclitaxel|paclitaxel|mesh-list
2733055|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
2733056|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2733057|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733058|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
2733059|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
2733060|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
2733061|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733062|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2733090|NCT02973789|Docetaxel|docetaxel|mesh-list
2733091|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2733092|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733093|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
2733094|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
2733095|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
2733096|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733097|NCT02932475|Metformin|metformin|mesh-list
2733098|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2733099|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733100|NCT02914938|Rituximab|rituximab|mesh-list
2733101|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
2733102|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2733103|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733104|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
2733105|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733106|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2733107|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2733108|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733109|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733139|NCT02899052|Dexamethasone|dexamethasone|mesh-list
2733140|NCT02899052|Venetoclax|venetoclax|mesh-list
2733141|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2733142|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
2733143|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
2733144|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2733145|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733146|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2733147|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
2733148|NCT02899052|Hormones|hormones|mesh-ancestor
2733149|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2733150|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2733151|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733152|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2733153|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
2733154|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733155|NCT02891538|Protective Agents|protective agents|mesh-ancestor
2733156|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733157|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2733158|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2733159|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733160|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2733161|NCT02884206|Valsartan|valsartan|mesh-list
2733162|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2733163|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2733164|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2733165|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2733166|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733167|NCT02840136|Meropenem|meropenem|mesh-list
2733168|NCT02840136|Tazobactam|tazobactam|mesh-list
2733169|NCT02840136|Piperacillin|piperacillin|mesh-list
2733170|NCT02840136|Ceftazidime|ceftazidime|mesh-list
2733171|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2733172|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2733173|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2733174|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2733175|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733176|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205931|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2205932|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2205933|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2205934|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
2205935|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
2205936|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2205937|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
2205938|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205939|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2205940|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2205941|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
2205942|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205943|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205944|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2205945|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2205946|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
2205947|NCT00006391|Topotecan|topotecan|mesh-list
2205948|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2205949|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2205950|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2205951|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424001|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2424002|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424003|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2424004|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2424005|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
2424006|NCT00825071|Dexamethasone|dexamethasone|mesh-list
2424007|NCT00825071|Ondansetron|ondansetron|mesh-list
2424008|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2424009|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
2424010|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
2424011|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2733183|NCT02820961|Exemestane|exemestane|mesh-list
2733184|NCT02820961|Entinostat|entinostat|mesh-list
2733185|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733186|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2733187|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2733188|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733189|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733190|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2733191|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
2733192|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2733193|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733194|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2733195|NCT02804932|Methamphetamine|methamphetamine|mesh-list
2733196|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2733197|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733198|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
2733199|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
2733200|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2733201|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
2733202|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2733203|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733204|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
2733205|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2733206|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2733207|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2733208|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2733209|NCT02722941|Panobinostat|panobinostat|mesh-list
2733210|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733211|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2733212|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733213|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733214|NCT02704390|Methylphenidate|methylphenidate|mesh-list
2733215|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2733216|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733217|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2733218|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2733219|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2733220|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733221|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
2733222|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2733223|NCT02659930|Doxorubicin|doxorubicin|mesh-list
2205952|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205953|NCT00006394|Hormones|hormones|mesh-list
2205954|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2733224|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2733225|NCT02659930|Pomalidomide|pomalidomide|mesh-list
2733226|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2733227|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733228|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2733229|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2733230|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733231|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733232|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
2733233|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733234|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2733235|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2733236|NCT02659930|Growth Substances|growth substances|mesh-ancestor
2733237|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
2733238|NCT02643381|Ketamine|ketamine|mesh-list
2733239|NCT02643381|Etomidate|etomidate|mesh-list
2733240|NCT02643381|Analgesics|analgesics|mesh-ancestor
2733241|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
2205955|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205956|NCT00006396|Zidovudine|zidovudine|mesh-list
2205957|NCT00006396|Nevirapine|nevirapine|mesh-list
2205958|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
2733242|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2733243|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733244|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2733245|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2733246|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
2733247|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
2733248|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2733249|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2733250|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2733251|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2733252|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733253|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2733254|NCT02611960|Gemcitabine|gemcitabine|mesh-list
2733255|NCT02611960|Capecitabine|capecitabine|mesh-list
2733256|NCT02611960|Docetaxel|docetaxel|mesh-list
2733257|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
2733258|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2733259|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
2733260|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733261|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733262|NCT02611960|Antiviral Agents|antiviral agents|mesh-ancestor
2733263|NCT02611960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2733264|NCT02611960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733265|NCT02611960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2733266|NCT02611960|Immunologic Factors|immunologic factors|mesh-ancestor
2733267|NCT02611960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733268|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
2733269|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
2733270|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
2733271|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2733276|NCT02603900|Bupivacaine|bupivacaine|mesh-list
2205959|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205960|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2205961|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2205962|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205963|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
2205964|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205965|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2205966|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2205967|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2205968|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2205969|NCT00006397|Ritonavir|ritonavir|mesh-list
2733277|NCT02603900|Ropivacaine|ropivacaine|mesh-list
2733278|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
2733279|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
2733280|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2733281|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733282|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
2733283|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2733290|NCT02595372|Omeprazole|omeprazole|mesh-list
2733291|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2733292|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2733293|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2733294|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733295|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733296|NCT02584634|Avelumab|avelumab|mesh-list
2733297|NCT02584634|Crizotinib|crizotinib|mesh-list
2733298|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2733299|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733300|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2733301|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733302|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733303|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
2733304|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2733305|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733306|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
2733307|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2733308|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733314|NCT02334722|Levetiracetam|levetiracetam|mesh-list
2733315|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
2733316|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
2733337|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
2733338|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
2733339|NCT02251821|Melphalan|melphalan|mesh-list
2733340|NCT02251821|Busulfan|busulfan|mesh-list
2733341|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
2733342|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2733343|NCT02251821|Methotrexate|methotrexate|mesh-list
2733344|NCT02251821|Fludarabine|fludarabine|mesh-list
2733345|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
2733346|NCT02251821|Tacrolimus|tacrolimus|mesh-list
2733347|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2733348|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
2733349|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733350|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2733351|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2733352|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
2733353|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733354|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733355|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2733356|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2733357|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
2733358|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2733359|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2733360|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
2733361|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
2733362|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733363|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2733364|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2733365|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2733366|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2733367|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2733368|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
2733369|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2733370|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2733406|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
2733407|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733408|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
2733409|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733410|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733411|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2733412|NCT01952288|Simvastatin|simvastatin|mesh-list
2733413|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2733414|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2733415|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
2733416|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733417|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2733418|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2733419|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733420|NCT01905046|Metformin|metformin|mesh-list
2733421|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2733422|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733423|NCT01858740|Methotrexate|methotrexate|mesh-list
2733424|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
2733425|NCT01858740|Fludarabine|fludarabine|mesh-list
2733426|NCT01858740|Thiotepa|thiotepa|mesh-list
2733427|NCT01858740|Tacrolimus|tacrolimus|mesh-list
2733428|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2733429|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
2733430|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2733431|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733432|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2733433|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
2733434|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733435|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733436|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
2733437|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733438|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2733439|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2733440|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
2733441|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2733442|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2733443|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2733444|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2733445|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
2733446|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2205970|NCT00006397|Indinavir|indinavir|mesh-list
2205971|NCT00006397|Stavudine|stavudine|mesh-list
2733465|NCT01846663|Rifaximin|rifaximin|mesh-list
2733466|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2733467|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2733468|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2733469|NCT01844518|Abatacept|abatacept|mesh-list
2733470|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2733471|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733472|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733473|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2733474|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
2733475|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205972|NCT00006397|Didanosine|didanosine|mesh-list
2205973|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2205974|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2733476|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2733477|NCT01795586|Carboplatin|carboplatin|mesh-list
2733478|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733479|NCT01717586|Pravastatin|pravastatin|mesh-list
2733480|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2733481|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2733482|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
2733483|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733484|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2733485|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2733486|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733487|NCT01398839|Riboflavin|riboflavin|mesh-list
2733488|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
2733489|NCT01398839|Vitamins|vitamins|mesh-ancestor
2733490|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
2733491|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733492|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2733493|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
2733494|NCT01349959|Azacitidine|azacitidine|mesh-list
2733495|NCT01349959|Entinostat|entinostat|mesh-list
2733496|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2733497|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2733498|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
2733499|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733500|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733501|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733502|NCT01331018|Plerixafor|plerixafor|mesh-list
2733503|NCT01331018|Prednisone|prednisone|mesh-list
2733504|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
2733505|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2733506|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2733507|NCT01331018|Prednisolone|prednisolone|mesh-list
2733508|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
2733509|NCT01331018|Cortisone|cortisone|mesh-list
2733510|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2733511|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
2733512|NCT01331018|Lenograstim|lenograstim|mesh-list
2733513|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2733514|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
2733515|NCT01331018|Hormones|hormones|mesh-ancestor
2733516|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2733517|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733518|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2733519|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733520|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2733521|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
2733522|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
2733523|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
2733524|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2733525|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2733526|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2733527|NCT01331018|Protective Agents|protective agents|mesh-ancestor
2733528|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2205975|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
2205976|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205977|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2205978|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2733529|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2733530|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
2733531|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2733532|NCT01327781|Tamoxifen|tamoxifen|mesh-list
2733533|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2733534|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
2733535|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2733536|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733537|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2733538|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733539|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2733540|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2733541|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2733542|NCT01281176|Paclitaxel|paclitaxel|mesh-list
2733543|NCT01281176|Carboplatin|carboplatin|mesh-list
2733544|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2733545|NCT01281176|Vorinostat|vorinostat|mesh-list
2733546|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2733547|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733548|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
2733549|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
2733550|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
2733551|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733552|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2733553|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2205979|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2205980|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
2205981|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2205982|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2205983|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2205984|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
2205985|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2205986|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2205987|NCT00006398|Timolol|timolol|mesh-list
2205988|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2205989|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2205990|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
2205991|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2205992|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733584|NCT01193842|Prednisone|prednisone|mesh-list
2733585|NCT01193842|Cortisone|cortisone|mesh-list
2733586|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
2733587|NCT01193842|Rituximab|rituximab|mesh-list
2733588|NCT01193842|Doxorubicin|doxorubicin|mesh-list
2733589|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2733590|NCT01193842|Etoposide|etoposide|mesh-list
2733591|NCT01193842|Vincristine|vincristine|mesh-list
2733592|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
2733593|NCT01193842|Vorinostat|vorinostat|mesh-list
2733594|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
2733595|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2733596|NCT01193842|Antibodies|antibodies|mesh-list
2733597|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
2733598|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2733599|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2733600|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
2733601|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733602|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2733603|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2733604|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
2733605|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733606|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733607|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2733608|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2733609|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2733610|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2733611|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733612|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2733613|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
2733614|NCT01193842|Hormones|hormones|mesh-ancestor
2733615|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2733616|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2733617|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2733618|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
2733619|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
2733620|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
2733621|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2733622|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
2733623|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
2733624|NCT01168219|Methotrexate|methotrexate|mesh-list
2733625|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
2733626|NCT01168219|Azacitidine|azacitidine|mesh-list
2733627|NCT01168219|Fludarabine|fludarabine|mesh-list
2733628|NCT01168219|Busulfan|busulfan|mesh-list
2733629|NCT01168219|Tacrolimus|tacrolimus|mesh-list
2733630|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2733631|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2733632|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
2733633|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2733634|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733635|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2733636|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
2733637|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733638|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733639|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
2733640|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733641|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2733642|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2733643|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
2733644|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2733645|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2733646|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2733647|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
2733648|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2733649|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2733650|NCT01081262|Paclitaxel|paclitaxel|mesh-list
2733651|NCT01081262|Bevacizumab|bevacizumab|mesh-list
2733652|NCT01081262|Carboplatin|carboplatin|mesh-list
2733653|NCT01081262|Capecitabine|capecitabine|mesh-list
2733654|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
2733655|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2733656|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2733657|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
2733658|NCT01081262|Antibodies|antibodies|mesh-list
2733659|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
2733660|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2733661|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
2733662|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2733663|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733664|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
2733665|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
2733666|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
2733667|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733668|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2733669|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2733670|NCT01081262|Growth Substances|growth substances|mesh-ancestor
2733671|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733672|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
2733673|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
2733674|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2733675|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
2733676|NCT01062425|Temozolomide|temozolomide|mesh-list
2733677|NCT01062425|Cediranib|cediranib|mesh-list
2733678|NCT01062425|Maleic acid|maleic acid|mesh-list
2733679|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2733680|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
2733681|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733682|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733683|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733684|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2733685|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
2733686|NCT01023737|Vorinostat|vorinostat|mesh-list
2733687|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
2733688|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2733689|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2733690|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2733691|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733692|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733693|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2733694|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733695|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2733717|NCT00741988|Bevacizumab|bevacizumab|mesh-list
2733718|NCT00741988|Carboplatin|carboplatin|mesh-list
2733719|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2733720|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733721|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2733722|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2733723|NCT00741988|Growth Substances|growth substances|mesh-ancestor
2733724|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733725|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
2733726|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
2733727|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2733728|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2733729|NCT00568997|Analgesics|analgesics|mesh-ancestor
2733730|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
2733731|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2733732|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733733|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2733734|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2733735|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
2733736|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2733737|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
2733738|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2733739|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733740|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733741|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2733742|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
2733743|NCT00563576|Estradiol|estradiol|mesh-list
2733744|NCT00563576|Estrogens|estrogens|mesh-ancestor
2733745|NCT00563576|Hormones|hormones|mesh-ancestor
2733746|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2733747|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733748|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2733749|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
2733750|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2733751|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2733752|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2733753|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2205993|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2205994|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2205995|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2205996|NCT00006399|Donepezil|donepezil|mesh-list
2205997|NCT00006399|Progesterone|progesterone|mesh-list
2205998|NCT00006399|Estrogens|estrogens|mesh-list
2205999|NCT00006399|Progestins|progestins|mesh-ancestor
2206000|NCT00006399|Hormones|hormones|mesh-ancestor
2206001|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2206002|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206003|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2206004|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206005|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206006|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
2206007|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2206008|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
2206009|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
2206010|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2206011|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
2206012|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2206013|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206014|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2206015|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
2206016|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2206017|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
2206018|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206019|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2206020|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2206021|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
2206022|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
2206023|NCT00006401|Protective Agents|protective agents|mesh-ancestor
2206024|NCT00006412|Fenofibrate|fenofibrate|mesh-list
2206025|NCT00006412|Pravastatin|pravastatin|mesh-list
2206026|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2206027|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
2206028|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206029|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2733754|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2733755|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2733756|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2733757|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733758|NCT00455403|Chloroquine|chloroquine|mesh-list
2733759|NCT00455403|Amebicides|amebicides|mesh-ancestor
2733760|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2733761|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2733762|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2733763|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
2733764|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2733765|NCT00238420|Paclitaxel|paclitaxel|mesh-list
2733766|NCT00238420|Trastuzumab|trastuzumab|mesh-list
2733767|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2733768|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2733769|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2733770|NCT00238420|Antibodies|antibodies|mesh-list
2733771|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
2733772|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2733773|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2733774|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733775|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
2733776|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
2733777|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
2733778|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733779|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
2733780|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733781|NCT05160987|Midazolam|midazolam|mesh-list
2733782|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2733783|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2733784|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2733785|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733786|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2733787|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2733788|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2733789|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2733790|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
2733791|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
2733792|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
2733793|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
2733794|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2733795|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733819|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2733820|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2206030|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2206031|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2206032|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206033|NCT00006427|Amitriptyline|amitriptyline|mesh-list
2206034|NCT00006427|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2206035|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2206036|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
2206037|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2206038|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2206039|NCT00006427|Analgesics|analgesics|mesh-ancestor
2206040|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
2206041|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2206042|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206043|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2206044|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2206045|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2206046|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206047|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
2206048|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2206049|NCT00006427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2206050|NCT00006427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2206051|NCT00006427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2206052|NCT00006428|Amitriptyline|amitriptyline|mesh-list
2424012|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424013|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2424014|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
2424015|NCT00825071|Hormones|hormones|mesh-ancestor
2424016|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424017|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2424018|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424019|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
2424020|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
2733827|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
2733828|NCT05160623|Povidone|povidone|mesh-list
2733829|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
2733830|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
2733831|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2733832|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2733833|NCT05160597|Edetic Acid|edetic acid|mesh-list
2733834|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2733835|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
2733836|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
2733837|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733838|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
2733839|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2733840|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2733841|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
2206053|NCT00006428|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2206054|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2206055|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
2206056|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2206057|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2206058|NCT00006428|Analgesics|analgesics|mesh-ancestor
2206059|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
2206060|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2733842|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2733843|NCT05160493|Pregabalin|pregabalin|mesh-list
2733844|NCT05160493|Ketamine|ketamine|mesh-list
2733845|NCT05160493|Esketamine|esketamine|mesh-list
2733846|NCT05160493|Analgesics|analgesics|mesh-ancestor
2733847|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
2733848|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2733849|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733850|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2733851|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2733852|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
2733853|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
2733854|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2733855|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2733856|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2733857|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2733858|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733859|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
2733860|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2733861|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2733862|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2733863|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2733864|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2733865|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2733866|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
2733870|NCT05160363|Piperaquine|piperaquine|mesh-list
2733871|NCT05160363|Pyronaridine|pyronaridine|mesh-list
2733872|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
2733873|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2733874|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2733875|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2733876|NCT05160298|Ropivacaine|ropivacaine|mesh-list
2733877|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
2733878|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
2733879|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2733880|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733881|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
2733882|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424021|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2424022|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
2424023|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424024|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424025|NCT00825071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2424026|NCT00825071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2424027|NCT00825071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2424028|NCT00825071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2733883|NCT05160285|Nivolumab|nivolumab|mesh-list
2733884|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2733885|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733886|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2733887|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733888|NCT05160220|Psilocybin|psilocybin|mesh-list
2733889|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
2733890|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733891|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2733892|NCT05160090|Bupropion|bupropion|mesh-list
2733893|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2206061|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206062|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2206063|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2206064|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2206065|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206066|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
2206067|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424029|NCT00825071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2424030|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
2733894|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
2733895|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2733896|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2733897|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2733898|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2733899|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733900|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
2733901|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2733902|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733903|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2733904|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2733905|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733906|NCT05160051|FAPI-46|fapi-46|mesh-list
2733907|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2733908|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733910|NCT05159934|Nicotine|nicotine|mesh-list
2733911|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2733912|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
2733913|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2733914|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733915|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2733916|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2733917|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
2733918|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2733919|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733920|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
2733921|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2733922|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733923|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2733924|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733925|NCT05159830|Cannabidiol|cannabidiol|mesh-list
2733926|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
2733927|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
2733928|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2733929|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2733932|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2733933|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2733934|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2733935|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2424031|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2424032|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2424033|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424034|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
2424035|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424036|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424037|NCT00825123|Metoprolol|metoprolol|mesh-list
2424038|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2424039|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2424040|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
2733936|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733937|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
2733938|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2733939|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733940|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
2733941|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2733942|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733943|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2733944|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2733945|NCT05159674|Analgesics|analgesics|mesh-ancestor
2733946|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
2733947|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2733948|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2733949|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2733950|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2733951|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
2733952|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2733953|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733954|NCT05159531|Tenofovir|tenofovir|mesh-list
2733955|NCT05159531|Emtricitabine|emtricitabine|mesh-list
2733956|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
2733957|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2733958|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2733959|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2733960|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2733961|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2733962|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2733963|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2733975|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
2733976|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
2733977|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
2733978|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2733979|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2733980|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
2733981|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2733982|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
2733983|NCT05159284|Protective Agents|protective agents|mesh-ancestor
2733984|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2733985|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2733996|NCT05159219|Colchicine|colchicine|mesh-list
2733997|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
2733998|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2733999|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
2734000|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
2734001|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
2734002|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734003|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734004|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
2734005|NCT05159193|Carboplatin|carboplatin|mesh-list
2734006|NCT05159193|Docetaxel|docetaxel|mesh-list
2734007|NCT05159193|Doxorubicin|doxorubicin|mesh-list
2734008|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2734009|NCT05159193|Trastuzumab|trastuzumab|mesh-list
2734010|NCT05159193|Pertuzumab|pertuzumab|mesh-list
2734011|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2734012|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
2734013|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734014|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2734015|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2734016|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
2734017|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734018|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734019|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2734020|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
2734021|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
2734022|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
2734023|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2734024|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2734025|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2734026|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2734027|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2734028|NCT05157087|Omalizumab|omalizumab|mesh-list
2734029|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2734030|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2734031|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
2734040|NCT05150431|Parecoxib|parecoxib|mesh-list
2734041|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2734042|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2734043|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2734044|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734045|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2734046|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2734047|NCT05150431|Analgesics|analgesics|mesh-ancestor
2734048|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
2734049|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2734050|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734051|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2734052|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2734059|NCT05146687|Bevacizumab|bevacizumab|mesh-list
2734060|NCT05146687|Ranibizumab|ranibizumab|mesh-list
2734061|NCT05146687|Aflibercept|aflibercept|mesh-list
2734062|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2734063|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734064|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2734065|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2734066|NCT05146687|Growth Substances|growth substances|mesh-ancestor
2734067|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734068|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
2734069|NCT05142098|Dexamethasone|dexamethasone|mesh-list
2734070|NCT05142098|Etoricoxib|etoricoxib|mesh-list
2734071|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
2734072|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
2734073|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2734074|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
2734075|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
2734076|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2734077|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734078|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2734079|NCT05142098|Hormones|hormones|mesh-ancestor
2734080|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2734081|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2734082|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734083|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2734084|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2734085|NCT05142098|Analgesics|analgesics|mesh-ancestor
2734086|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
2734087|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2734088|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2734089|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2734090|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734091|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2734092|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2734093|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734094|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2734095|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
2734096|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734097|NCT05141240|Palbociclib|palbociclib|mesh-list
2734098|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734099|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2734100|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2734101|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734122|NCT05137080|Dexamethasone|dexamethasone|mesh-list
2734123|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2734124|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
2734125|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
2734126|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2734127|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734128|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2734129|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
2734130|NCT05137080|Hormones|hormones|mesh-ancestor
2734131|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2734132|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2734133|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734137|NCT05132660|Levodopa|levodopa|mesh-list
2734138|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2734139|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2734140|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2734141|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
2734142|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2734143|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734144|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734145|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2734146|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
2734147|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
2734148|NCT05130086|Islatravir|islatravir|mesh-list
2734149|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
2734150|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2734151|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2734152|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734153|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2734154|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2734155|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2734156|NCT05124340|Vaccines|vaccines|mesh-list
2734157|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
2734158|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734159|NCT05117450|Heparin|heparin|mesh-list
2734160|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
2734161|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2734162|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2734163|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734164|NCT05116930|Atropine|atropine|mesh-list
2734165|NCT05116930|Neostigmine|neostigmine|mesh-list
2734166|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2734167|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2734168|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2206068|NCT00006428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2206069|NCT00006428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2206070|NCT00006428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2206077|NCT00006441|Lamivudine|lamivudine|mesh-list
2206078|NCT00006441|Zidovudine|zidovudine|mesh-list
2424041|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
2734169|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
2734170|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2734171|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734172|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2734173|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
2734174|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
2734175|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
2734176|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2734177|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2734178|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
2734179|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2734180|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734181|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2734182|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2734183|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2734186|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
2734187|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2734188|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2734189|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734190|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2734191|NCT05111431|Analgesics|analgesics|mesh-ancestor
2734192|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
2734193|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2734194|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2734195|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2734196|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2734197|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
2734198|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2734199|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734200|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2734201|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
2734202|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2734203|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
2734204|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2734205|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734206|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2734207|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2734208|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734209|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
2734210|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2734211|NCT05110001|Natamycin|natamycin|mesh-list
2734212|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
2734213|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2734214|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2734215|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
2734216|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
2734217|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2734218|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2424042|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424043|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424044|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2424045|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2424046|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2424047|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
2424048|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2734219|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2734220|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2734221|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734222|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734223|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
2734233|NCT05096039|Valsartan|valsartan|mesh-list
2734234|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2734235|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2734236|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2734237|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2734238|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734239|NCT05084651|Itraconazole|itraconazole|mesh-list
2734240|NCT05084651|Lumefantrine|lumefantrine|mesh-list
2734241|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
2734242|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2734243|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2734244|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2734245|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206079|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2206080|NCT00006441|Aldesleukin|aldesleukin|mesh-list
2206081|NCT00006441|Nelfinavir|nelfinavir|mesh-list
2206082|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2206083|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2206084|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206085|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206086|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
2206087|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206088|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2206089|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2206090|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
2206091|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206092|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2206093|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2206094|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
2734246|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734247|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2734248|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
2734249|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2734250|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734251|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2734252|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
2734253|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2734254|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2734258|NCT05070650|Acetaminophen|acetaminophen|mesh-list
2734259|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
2734260|NCT05070650|Phenylephrine|phenylephrine|mesh-list
2734261|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
2734262|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2734263|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2734264|NCT05070650|Analgesics|analgesics|mesh-ancestor
2734265|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
2734266|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2734267|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734268|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
2734269|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
2734270|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2734271|NCT05070650|Expectorants|expectorants|mesh-ancestor
2734272|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
2734273|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2734274|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
2734275|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734276|NCT05070650|Protective Agents|protective agents|mesh-ancestor
2734277|NCT05070650|Antidotes|antidotes|mesh-ancestor
2734278|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2734279|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
2734280|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
2734281|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
2734282|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2734283|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
2734284|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2734285|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2734286|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2734287|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
2734288|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2734304|NCT05061563|Esomeprazole|esomeprazole|mesh-list
2734305|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2734306|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2734307|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2734308|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2734309|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206095|NCT00006443|Lamivudine|lamivudine|mesh-list
2206096|NCT00006443|Stavudine|stavudine|mesh-list
2734366|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
2734367|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2734368|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734369|NCT05022472|Vaccines|vaccines|mesh-list
2734370|NCT05022472|Immunologic Factors|immunologic factors|mesh-ancestor
2734371|NCT05022472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734372|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2734373|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2734374|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
2734375|NCT05013632|Remdesivir|remdesivir|mesh-list
2734376|NCT05013632|Antibodies|antibodies|mesh-list
2734377|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2734378|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
2734379|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734380|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
2734381|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734382|NCT05013632|Antiviral Agents|antiviral agents|mesh-ancestor
2734383|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2734387|NCT05003453|Palmidrol|palmidrol|mesh-list
2734388|NCT05003453|Analgesics|analgesics|mesh-ancestor
2734389|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
2734390|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2734391|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734392|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2734393|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2734394|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2734395|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2734396|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
2734397|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2734398|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2734399|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2734400|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2734401|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734402|NCT05003453|Hormones|hormones|mesh-ancestor
2734403|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2734404|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
2734405|NCT05000216|Methotrexate|methotrexate|mesh-list
2734406|NCT05000216|Vaccines|vaccines|mesh-list
2734407|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
2734408|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734409|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2734410|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
2734411|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2734412|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2734413|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
2734414|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734415|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734416|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
2734417|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2734418|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2734419|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2734420|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2734421|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2734422|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2734423|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2734424|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
2734425|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2206097|NCT00006443|Nelfinavir|nelfinavir|mesh-list
2206098|NCT00006443|Indinavir|indinavir|mesh-list
2206099|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2206100|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2206101|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206102|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206103|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
2206104|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2734426|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2734455|NCT04979052|Interferons|interferons|mesh-list
2734456|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
2734457|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734458|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
2734459|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2734481|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
2734482|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2734483|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734507|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
2734508|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
2734509|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734510|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2734511|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424049|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424050|NCT00825149|Prednisone|prednisone|mesh-list
2424051|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
2424052|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2424053|NCT00825149|Doxorubicin|doxorubicin|mesh-list
2424054|NCT00825149|Fludarabine|fludarabine|mesh-list
2424055|NCT00825149|Vincristine|vincristine|mesh-list
2424056|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
2424057|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2424058|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
2424059|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424060|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2424061|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2424062|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
2424063|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424064|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424065|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2424066|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2424067|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2734618|NCT04903314|Cenobamate|cenobamate|mesh-list
2734619|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
2734625|NCT04893096|Felzartamab|felzartamab|mesh-list
2734626|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734627|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
2734628|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206105|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2206106|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2206107|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
2206108|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2206109|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2206110|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
2206111|NCT00006448|Methadone|methadone|mesh-list
2206112|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2206113|NCT00006448|Narcotics|narcotics|mesh-ancestor
2206114|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2206115|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206116|NCT00006448|Analgesics|analgesics|mesh-ancestor
2206117|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
2206118|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2206119|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
2206120|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
2206121|NCT00006449|Naltrexone|naltrexone|mesh-list
2206122|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2206123|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2206124|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206125|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
2206126|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2206127|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2206128|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206129|NCT00006451|Cyclosporine|cyclosporine|mesh-list
2734639|NCT04888377|Aspirin|aspirin|mesh-list
2734640|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2734641|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2734642|NCT04888377|Analgesics|analgesics|mesh-ancestor
2734643|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
2734644|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2734645|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734646|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2734647|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2734648|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2734649|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2734650|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734651|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2734652|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2734653|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2734654|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
2734660|NCT04876248|Lenalidomide|lenalidomide|mesh-list
2734661|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
2734662|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734663|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2206130|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
2206131|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
2206132|NCT00006451|Methotrexate|methotrexate|mesh-list
2206133|NCT00006451|Cyclosporins|cyclosporins|mesh-list
2206134|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2206135|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206136|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
2206137|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206138|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2206139|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2206140|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
2734664|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2734665|NCT04876248|Growth Substances|growth substances|mesh-ancestor
2734666|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
2206141|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734667|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734695|NCT04859582|Fluorouracil|fluorouracil|mesh-list
2734696|NCT04859582|Capecitabine|capecitabine|mesh-list
2734697|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
2734698|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
2734699|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734700|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
2206142|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206143|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2206144|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2206145|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
2206146|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2206147|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2206148|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
2206149|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
2206150|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206151|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2206152|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2206153|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
2206154|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206155|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2206156|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2206157|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
2206158|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
2206159|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2206160|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2206161|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
2206162|NCT00006451|Hormones|hormones|mesh-ancestor
2206163|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2734701|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734702|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2734703|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2734704|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
2734705|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734706|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2734719|NCT04856215|Antibodies|antibodies|mesh-list
2734720|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2734721|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
2734722|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734850|NCT04756726|Dexamethasone|dexamethasone|mesh-list
2734851|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2734852|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
2734853|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
2734854|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2734855|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734856|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2734857|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
2734858|NCT04756726|Hormones|hormones|mesh-ancestor
2734859|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2734860|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2734861|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2734862|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
2734863|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2734864|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
2734865|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2734866|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
2734867|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2734868|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734869|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
2734870|NCT04744363|Ustekinumab|ustekinumab|mesh-list
2734871|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
2734939|NCT04732065|Dopamine|dopamine|mesh-list
2734940|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2734941|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
2734942|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
2734943|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2734944|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2734945|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
2734946|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2734947|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2734948|NCT04732065|Protective Agents|protective agents|mesh-ancestor
2734959|NCT04713137|Erythritol|erythritol|mesh-list
2734960|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
2734988|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2734989|NCT04682847|Hematinics|hematinics|mesh-ancestor
2734990|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2734991|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2735052|NCT04622553|Mexiletine|mexiletine|mesh-list
2735053|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2735054|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2735055|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2735056|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2735057|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735067|NCT04588727|Aspirin|aspirin|mesh-list
2735068|NCT04588727|Ticagrelor|ticagrelor|mesh-list
2735069|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2735070|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2735071|NCT04588727|Analgesics|analgesics|mesh-ancestor
2735072|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
2735073|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2735074|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735075|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2735076|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2735077|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2735078|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2735079|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735080|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2735081|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2735082|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735083|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
2735084|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2735085|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2735086|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2735087|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
2735088|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2735138|NCT04564443|Calcium|calcium|mesh-list
2735139|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2735140|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735141|NCT04564339|Ravulizumab|ravulizumab|mesh-list
2735142|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2735143|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2735144|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
2735145|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735146|NCT04557085|Cenobamate|cenobamate|mesh-list
2735147|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
2735148|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
2735149|NCT04545008|Famotidine|famotidine|mesh-list
2735150|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2735151|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
2735152|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2735153|NCT04545008|Expectorants|expectorants|mesh-ancestor
2735154|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
2735155|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2735156|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
2735157|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735158|NCT04545008|Protective Agents|protective agents|mesh-ancestor
2735159|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735160|NCT04545008|Antidotes|antidotes|mesh-ancestor
2735161|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2735162|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2735163|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2735164|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
2735165|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
2735166|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2735167|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
2735168|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
2735169|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2735170|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2735171|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2735172|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735173|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735174|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2735175|NCT04524351|Phenserine|phenserine|mesh-list
2735176|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2735177|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735178|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735179|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
2735180|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2735181|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735198|NCT04499677|Ritonavir|ritonavir|mesh-list
2735199|NCT04499677|Lopinavir|lopinavir|mesh-list
2735200|NCT04499677|Favipiravir|favipiravir|mesh-list
2735201|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2735202|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2735203|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
2735204|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735205|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735206|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2735207|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2735208|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
2735209|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2735210|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2735211|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2735212|NCT04492956|Ecopipam|ecopipam|mesh-list
2735213|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2735214|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2735215|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2735216|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735217|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2735218|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2735219|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
2735220|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2735221|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735222|NCT04491526|Tamsulosin|tamsulosin|mesh-list
2735223|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2735224|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2735225|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2735226|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
2735227|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2735228|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735229|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735230|NCT04491526|Urological Agents|urological agents|mesh-ancestor
2735231|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
2735232|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735233|NCT04481113|Niraparib|niraparib|mesh-list
2735234|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2735235|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735236|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735237|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735238|NCT04478266|Letrozole|letrozole|mesh-list
2735239|NCT04478266|Palbociclib|palbociclib|mesh-list
2735240|NCT04478266|Goserelin|goserelin|mesh-list
2735241|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735242|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2735243|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2735244|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735245|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735246|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2735247|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
2735248|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2735249|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735250|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2735251|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2735252|NCT04477343|Nivolumab|nivolumab|mesh-list
2735253|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2735254|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735255|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2735256|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735301|NCT04452877|Trametinib|trametinib|mesh-list
2735302|NCT04452877|Dabrafenib|dabrafenib|mesh-list
2735303|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735304|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2735305|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735306|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735307|NCT04425018|Paclitaxel|paclitaxel|mesh-list
2735308|NCT04425018|Trastuzumab|trastuzumab|mesh-list
2735309|NCT04425018|Pertuzumab|pertuzumab|mesh-list
2735310|NCT04425018|Margetuximab|margetuximab|mesh-list
2735311|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2735312|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735313|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
2735314|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
2735315|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
2735316|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735317|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2735318|NCT04419519|Venetoclax|venetoclax|mesh-list
2735319|NCT04419519|Antibodies|antibodies|mesh-list
2735320|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2735321|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
2735322|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735323|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735329|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
2735330|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
2735331|NCT04384692|Melphalan|melphalan|mesh-list
2735332|NCT04384692|Busulfan|busulfan|mesh-list
2735333|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
2735334|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2735335|NCT04384692|Methotrexate|methotrexate|mesh-list
2735336|NCT04384692|Fludarabine|fludarabine|mesh-list
2735337|NCT04384692|Tacrolimus|tacrolimus|mesh-list
2735338|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2735339|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
2735340|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735341|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2735342|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2735343|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
2735344|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735345|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735346|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2735347|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2735348|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
2735349|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2735350|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2735351|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
2735352|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
2735353|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735354|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2735355|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2735356|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2735357|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2735358|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2735359|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
2735360|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2735361|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2735474|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
2735475|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
2735476|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
2735477|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2735478|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2735479|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2735480|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735481|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735482|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2735483|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
2735484|NCT04328961|Protective Agents|protective agents|mesh-ancestor
2735485|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735486|NCT04328961|Vitamins|vitamins|mesh-ancestor
2735487|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
2735493|NCT04303195|Metopimazine|metopimazine|mesh-list
2735494|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
2735495|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
2735496|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2735497|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735498|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2735509|NCT04274361|Ketamine|ketamine|mesh-list
2735510|NCT04274361|Analgesics|analgesics|mesh-ancestor
2735511|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
2735512|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2735513|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735514|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2735515|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2735516|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
2735517|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
2735518|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2735519|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2735520|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2735521|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2735522|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735523|NCT04263792|Trimethoprim|trimethoprim|mesh-list
2735524|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2735525|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2735526|NCT04263792|Renal Agents|renal agents|mesh-ancestor
2735527|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
2735528|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2735529|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2735530|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2735531|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735532|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735533|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2735534|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2735535|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2735536|NCT04259996|Estradiol|estradiol|mesh-list
2735537|NCT04259996|Progesterone|progesterone|mesh-list
2735538|NCT04259996|Estrogens|estrogens|mesh-ancestor
2735539|NCT04259996|Hormones|hormones|mesh-ancestor
2735540|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2735541|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735542|NCT04259996|Progestins|progestins|mesh-ancestor
2735543|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2735544|NCT04253626|Hematinics|hematinics|mesh-ancestor
2735545|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2735546|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2735569|NCT04210349|Vaccines|vaccines|mesh-list
2735570|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
2735571|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735579|NCT04192136|Niacinamide|niacinamide|mesh-list
2735580|NCT04192136|Niacin|niacin|mesh-list
2735581|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
2735582|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
2735583|NCT04192136|Vitamins|vitamins|mesh-ancestor
2735584|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
2735585|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735586|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2735587|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
2735588|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735589|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2735590|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
2735591|NCT04190550|Cytarabine|cytarabine|mesh-list
2735592|NCT04190550|Idarubicin|idarubicin|mesh-list
2735593|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2735594|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
2735595|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735596|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735597|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
2735598|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2735599|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2735600|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
2735601|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735602|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2735603|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2735604|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2735605|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735637|NCT04142983|Vaccines|vaccines|mesh-list
2735638|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
2735639|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735644|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
2735645|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2735646|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735677|NCT04076579|Olaparib|olaparib|mesh-list
2735678|NCT04076579|Trabectedin|trabectedin|mesh-list
2735679|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2735680|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735681|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735682|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735683|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2735684|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
2735688|NCT04047472|Aflibercept|aflibercept|mesh-list
2735689|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2735690|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2735691|NCT04047472|Growth Substances|growth substances|mesh-ancestor
2735692|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735693|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
2735694|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735695|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2735696|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
2735697|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735698|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
2735699|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2735700|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2735701|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735729|NCT03971071|Erenumab|erenumab|mesh-list
2735730|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2735731|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2735732|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735733|NCT03971071|Analgesics|analgesics|mesh-ancestor
2735734|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
2735735|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2735736|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735737|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
2735741|NCT03945448|Fluconazole|fluconazole|mesh-list
2735742|NCT03945448|Amphotericin B|amphotericin b|mesh-list
2735743|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2735744|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
2735745|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2735746|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2735747|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2735748|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735749|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735750|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2735751|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
2735752|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2735753|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735754|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2735755|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2735756|NCT03945448|Amebicides|amebicides|mesh-ancestor
2735757|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2735758|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2735759|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2735848|NCT03909334|Osimertinib|osimertinib|mesh-list
2735849|NCT03909334|Ramucirumab|ramucirumab|mesh-list
2735850|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735851|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2735852|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2735853|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735901|NCT03866174|Niacin|niacin|mesh-list
2735902|NCT03866174|Psilocybin|psilocybin|mesh-list
2735903|NCT03866174|Vitamins|vitamins|mesh-ancestor
2735904|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
2735905|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735906|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
2735907|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2735908|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
2735909|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735910|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2735911|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
2735912|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
2735913|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2735938|NCT03829722|Paclitaxel|paclitaxel|mesh-list
2735939|NCT03829722|Carboplatin|carboplatin|mesh-list
2735940|NCT03829722|Nivolumab|nivolumab|mesh-list
2735941|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2735942|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735943|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
2735944|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
2735945|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
2735946|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2735947|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2735948|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2735949|NCT03818399|Buprenorphine|buprenorphine|mesh-list
2735950|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2735951|NCT03818399|Narcotics|narcotics|mesh-ancestor
2735952|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2735953|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2735954|NCT03818399|Analgesics|analgesics|mesh-ancestor
2735955|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
2735956|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2735957|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2735979|NCT03782636|Aldesleukin|aldesleukin|mesh-list
2735980|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2735981|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2735982|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2735983|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
2735984|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2736010|NCT03761810|Tretinoin|tretinoin|mesh-list
2736011|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2736012|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
2736013|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736014|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
2736015|NCT03761784|Tretinoin|tretinoin|mesh-list
2736016|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2736017|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
2736018|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736019|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
2206164|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2206165|NCT00006451|Protective Agents|protective agents|mesh-ancestor
2206166|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
2206167|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206168|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2206169|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
2736043|NCT03739099|Pancrelipase|pancrelipase|mesh-list
2736044|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2736053|NCT03729245|Nivolumab|nivolumab|mesh-list
2736054|NCT03729245|Sunitinib|sunitinib|mesh-list
2736055|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736056|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736057|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2736058|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736059|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2736060|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2736061|NCT03729245|Growth Substances|growth substances|mesh-ancestor
2736062|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736063|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
2736064|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2736065|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736066|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
2736067|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
2736068|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2736069|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
2736070|NCT03703778|Androgens|androgens|mesh-list
2736071|NCT03703778|Hormones|hormones|mesh-ancestor
2736072|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2736073|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736074|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
2736075|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736076|NCT03703778|Protective Agents|protective agents|mesh-ancestor
2736077|NCT03703778|Vitamins|vitamins|mesh-ancestor
2736078|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
2736079|NCT03703778|Estrogens|estrogens|mesh-ancestor
2736080|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2736081|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736082|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
2736083|NCT03702283|Penicillins|penicillins|mesh-list
2736084|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2736085|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2736086|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
2736087|NCT03684785|Cemiplimab|cemiplimab|mesh-list
2736088|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736089|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736090|NCT03675737|Fluorouracil|fluorouracil|mesh-list
2736091|NCT03675737|Capecitabine|capecitabine|mesh-list
2736092|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
2736093|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
2736094|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736095|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
2736096|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736097|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2736098|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2736099|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
2736100|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736101|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736102|NCT03625141|Atezolizumab|atezolizumab|mesh-list
2736103|NCT03625141|Vemurafenib|vemurafenib|mesh-list
2736104|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736105|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2736106|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736107|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736130|NCT03576261|Polygeline|polygeline|mesh-list
2736131|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
2736132|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
2736138|NCT03527186|Risperidone|risperidone|mesh-list
2736139|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2736140|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
2736141|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2736142|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736143|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736144|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2736145|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2736146|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2736147|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2736148|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2736149|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
2424068|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2424069|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424070|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2424071|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
2424072|NCT00825149|Hormones|hormones|mesh-ancestor
2424073|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424074|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2736207|NCT03369223|Nivolumab|nivolumab|mesh-list
2736208|NCT03369223|Ipilimumab|ipilimumab|mesh-list
2736209|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736210|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736211|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2736212|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736213|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
2736214|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736215|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736216|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2736217|NCT03320070|Hormones|hormones|mesh-ancestor
2736218|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2736219|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736225|NCT03294304|Gemcitabine|gemcitabine|mesh-list
2736226|NCT03294304|Nivolumab|nivolumab|mesh-list
2736227|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736228|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2736229|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
2736230|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736231|NCT03294304|Antiviral Agents|antiviral agents|mesh-ancestor
2736232|NCT03294304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2736233|NCT03294304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736234|NCT03294304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2736235|NCT03294304|Immunologic Factors|immunologic factors|mesh-ancestor
2736236|NCT03294304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736237|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736238|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2736239|NCT03252756|Cannabidiol|cannabidiol|mesh-list
2736240|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
2736249|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
2736250|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2736251|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736252|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736268|NCT03188796|Vitamin D|vitamin d|mesh-list
2736269|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
2736270|NCT03188796|Vitamins|vitamins|mesh-ancestor
2736271|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
2736272|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736273|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2736274|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2736275|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2736276|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2736277|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736306|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
2736307|NCT03122431|Thalidomide|thalidomide|mesh-list
2736308|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
2736309|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2736310|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2736311|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2736312|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736313|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736314|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2736315|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2736316|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
2736317|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736318|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
2736319|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2736320|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2736321|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2736322|NCT03122431|Growth Substances|growth substances|mesh-ancestor
2736323|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
2736324|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736325|NCT03119363|Methamphetamine|methamphetamine|mesh-list
2736326|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2736327|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736328|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
2736329|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
2736330|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2736331|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
2736332|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2206170|NCT00006453|Gemcitabine|gemcitabine|mesh-list
2206171|NCT00006453|Carboplatin|carboplatin|mesh-list
2206172|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206173|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2206174|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
2206175|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206176|NCT00006453|Antiviral Agents|antiviral agents|mesh-ancestor
2206177|NCT00006453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206178|NCT00006453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206179|NCT00006453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206180|NCT00006453|Immunologic Factors|immunologic factors|mesh-ancestor
2206181|NCT00006453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206182|NCT00006454|Paclitaxel|paclitaxel|mesh-list
2206183|NCT00006454|Carboplatin|carboplatin|mesh-list
2206184|NCT00006454|Topotecan|topotecan|mesh-list
2206185|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206186|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206187|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
2736333|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736334|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
2736335|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2736336|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2736337|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2736338|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2736339|NCT03099356|Sirolimus|sirolimus|mesh-list
2736340|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
2736341|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2736342|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
2736343|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736344|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2736345|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2736346|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
2736347|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736348|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736349|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2736350|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2736351|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2736352|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2206188|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
2206189|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
2206190|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206191|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2424075|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2424076|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
2424077|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
2424078|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
2424079|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2424080|NCT00825188|Amlodipine|amlodipine|mesh-list
2424081|NCT00825188|Eplerenone|eplerenone|mesh-list
2424082|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2206192|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2424083|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2424084|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2736353|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
2736354|NCT03084939|Capecitabine|capecitabine|mesh-list
2736355|NCT03084939|Trastuzumab|trastuzumab|mesh-list
2736356|NCT03084939|Lapatinib|lapatinib|mesh-list
2736357|NCT03084939|Maytansine|maytansine|mesh-list
2736358|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2736359|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2736360|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
2736361|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736362|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736363|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736364|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2736365|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736366|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2736367|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
2736368|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
2736369|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
2206193|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206194|NCT00006455|Leucovorin|leucovorin|mesh-list
2206195|NCT00006455|Cytarabine|cytarabine|mesh-list
2206196|NCT00006455|Dexamethasone|dexamethasone|mesh-list
2206197|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
2206198|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2206199|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2206200|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2206201|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
2206202|NCT00006455|Ifosfamide|ifosfamide|mesh-list
2206203|NCT00006455|Doxorubicin|doxorubicin|mesh-list
2206204|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2206205|NCT00006455|Methotrexate|methotrexate|mesh-list
2206206|NCT00006455|Etoposide|etoposide|mesh-list
2206207|NCT00006455|Vinblastine|vinblastine|mesh-list
2206208|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
2206209|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206210|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
2206211|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736386|NCT03009201|Doxorubicin|doxorubicin|mesh-list
2736387|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2736388|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2736389|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736390|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2736391|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2736392|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736393|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206212|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2206213|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2736421|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2736422|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2736423|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
2736424|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2736425|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736426|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2736427|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2736428|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2736429|NCT02956382|Venetoclax|venetoclax|mesh-list
2736430|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736431|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
2736432|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2736433|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2736434|NCT02936843|Analgesics|analgesics|mesh-ancestor
2736435|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
2736436|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2736437|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736438|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2736439|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2736464|NCT02896855|Docetaxel|docetaxel|mesh-list
2736465|NCT02896855|Trastuzumab|trastuzumab|mesh-list
2736466|NCT02896855|Pertuzumab|pertuzumab|mesh-list
2736467|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736468|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
2736469|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
2736470|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
2736471|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736472|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736473|NCT02871778|Ivacaftor|ivacaftor|mesh-list
2736474|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2736475|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2736476|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736489|NCT02756208|Vaccines|vaccines|mesh-list
2736490|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
2736491|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736492|NCT02714218|Nivolumab|nivolumab|mesh-list
2736493|NCT02714218|Ipilimumab|ipilimumab|mesh-list
2736494|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736495|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736496|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2736497|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736498|NCT02621151|Gemcitabine|gemcitabine|mesh-list
2736499|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
2736500|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2736501|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
2736502|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736503|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736504|NCT02621151|Antiviral Agents|antiviral agents|mesh-ancestor
2736505|NCT02621151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2736506|NCT02621151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736507|NCT02621151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2736508|NCT02621151|Immunologic Factors|immunologic factors|mesh-ancestor
2736509|NCT02621151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736510|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736541|NCT02564263|Paclitaxel|paclitaxel|mesh-list
2736542|NCT02564263|Docetaxel|docetaxel|mesh-list
2736543|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
2736544|NCT02564263|Irinotecan|irinotecan|mesh-list
2736545|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2736546|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736547|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
2736548|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
2736549|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
2736550|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736551|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736552|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2736553|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2736554|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736615|NCT02450331|Atezolizumab|atezolizumab|mesh-list
2736616|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736648|NCT02421341|Fentanyl|fentanyl|mesh-list
2736649|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
2736650|NCT02421341|Analgesics|analgesics|mesh-list
2736651|NCT02421341|Narcotics|narcotics|mesh-ancestor
2736652|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2736653|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736654|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
2736655|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2736656|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2736657|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2736658|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
2736659|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
2206214|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
2206215|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206216|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206217|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2206218|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2206219|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
2206220|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
2206221|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2206222|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2206223|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
2206224|NCT00006455|Hormones|hormones|mesh-ancestor
2206225|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2206226|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2206227|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2206228|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2206229|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2736751|NCT02192359|Irinotecan|irinotecan|mesh-list
2736752|NCT02192359|Camptothecin|camptothecin|mesh-list
2736753|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2736754|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2736755|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736756|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736757|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736758|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2736812|NCT02149121|Rituximab|rituximab|mesh-list
2736813|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736814|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736815|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
2736816|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736817|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2736818|NCT02066181|Sorafenib|sorafenib|mesh-list
2736819|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736820|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2736821|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736822|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736823|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2736824|NCT01935921|Cetuximab|cetuximab|mesh-list
2736825|NCT01935921|Ipilimumab|ipilimumab|mesh-list
2736826|NCT01935921|Antibodies|antibodies|mesh-list
2736827|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
2736828|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2736829|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
2736830|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736831|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736832|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2736833|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736834|NCT01933932|Docetaxel|docetaxel|mesh-list
2206230|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206231|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2206232|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
2206233|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2424085|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424086|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2424087|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424088|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
2424089|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2424090|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
2424091|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424092|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2424093|NCT00825188|Diuretics|diuretics|mesh-ancestor
2424094|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
2424095|NCT00825201|Paclitaxel|paclitaxel|mesh-list
2424096|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2424097|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2424098|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424099|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
2424100|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
2424101|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
2424102|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424103|NCT00825253|Insulin|insulin|mesh-list
2424104|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2424105|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
2424106|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
2736835|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736836|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
2736837|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
2736838|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
2736839|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736840|NCT01927419|Nivolumab|nivolumab|mesh-list
2736841|NCT01927419|Ipilimumab|ipilimumab|mesh-list
2736842|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736843|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736844|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2736845|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736859|NCT01889186|Venetoclax|venetoclax|mesh-list
2736860|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736861|NCT01861314|Bortezomib|bortezomib|mesh-list
2736862|NCT01861314|Sorafenib|sorafenib|mesh-list
2736863|NCT01861314|Decitabine|decitabine|mesh-list
2736864|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736865|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2736866|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736867|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736868|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2736869|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
2736870|NCT01850004|Dasatinib|dasatinib|mesh-list
2736871|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736872|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2736873|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736874|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736875|NCT01844505|Nivolumab|nivolumab|mesh-list
2736876|NCT01844505|Ipilimumab|ipilimumab|mesh-list
2736877|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736878|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736879|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2736880|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736881|NCT01829568|Rituximab|rituximab|mesh-list
2736882|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2736883|NCT01829568|Lenalidomide|lenalidomide|mesh-list
2736884|NCT01829568|Antibodies|antibodies|mesh-list
2736885|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
2736886|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2736887|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
2736888|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736889|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736890|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2736891|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2736892|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2736893|NCT01829568|Growth Substances|growth substances|mesh-ancestor
2736894|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
2736895|NCT01757535|Azacitidine|azacitidine|mesh-list
2736896|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2736897|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
2736898|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736899|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424107|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2424108|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2424109|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424110|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2424111|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2424112|NCT00825422|Ropivacaine|ropivacaine|mesh-list
2424113|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
2424114|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
2424115|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2424116|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424117|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
2736900|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736901|NCT01750281|Docetaxel|docetaxel|mesh-list
2736902|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736903|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
2736904|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
2736905|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
2736906|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736907|NCT01660971|Gemcitabine|gemcitabine|mesh-list
2736908|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2736909|NCT01660971|Dasatinib|dasatinib|mesh-list
2736910|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2736911|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
2736912|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736913|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736914|NCT01660971|Antiviral Agents|antiviral agents|mesh-ancestor
2736915|NCT01660971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2736916|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736917|NCT01660971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2736918|NCT01660971|Immunologic Factors|immunologic factors|mesh-ancestor
2736919|NCT01660971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736920|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2736921|NCT01523977|Prednisone|prednisone|mesh-list
2736922|NCT01523977|Doxorubicin|doxorubicin|mesh-list
2736923|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
2736924|NCT01523977|Vincristine|vincristine|mesh-list
2736925|NCT01523977|Everolimus|everolimus|mesh-list
2736926|NCT01523977|Asparaginase|asparaginase|mesh-list
2736927|NCT01523977|Pegaspargase|pegaspargase|mesh-list
2736928|NCT01523977|Razoxane|razoxane|mesh-list
2736929|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2736930|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736931|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2736932|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2736933|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736934|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736935|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2736936|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
2736937|NCT01523977|Hormones|hormones|mesh-ancestor
2736938|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2736939|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736940|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2736941|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2736942|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
2736943|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
2736944|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
2736945|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2736946|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
2736947|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2736948|NCT01523977|Protective Agents|protective agents|mesh-ancestor
2736949|NCT01510184|Rituximab|rituximab|mesh-list
2736950|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2736951|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2736952|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736953|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
2736954|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736955|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2736956|NCT01471444|Vidarabine|vidarabine|mesh-list
2736957|NCT01471444|Methotrexate|methotrexate|mesh-list
2736958|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
2736959|NCT01471444|Clofarabine|clofarabine|mesh-list
2736960|NCT01471444|Fludarabine|fludarabine|mesh-list
2736961|NCT01471444|Busulfan|busulfan|mesh-list
2736962|NCT01471444|Tacrolimus|tacrolimus|mesh-list
2736963|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
2736964|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2736965|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2736966|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
2736967|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2736968|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2736969|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2736970|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
2736971|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2736972|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2736973|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
2736974|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2736975|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2736976|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2736977|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
2736978|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2736979|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2736980|NCT01471444|Antiviral Agents|antiviral agents|mesh-ancestor
2736981|NCT01471444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2736982|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2736983|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
2736984|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2736985|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2737016|NCT01238211|Cytarabine|cytarabine|mesh-list
2737017|NCT01238211|Daunorubicin|daunorubicin|mesh-list
2737018|NCT01238211|Dasatinib|dasatinib|mesh-list
2737019|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2737020|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
2737021|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737022|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737023|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
2737024|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2737025|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2737026|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
2737027|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737028|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2737029|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2737030|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2737031|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737032|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2424118|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424119|NCT00825552|Risperidone|risperidone|mesh-list
2424120|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2424121|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
2424122|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424123|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424124|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424125|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2424126|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2737042|NCT05162872|Niraparib|niraparib|mesh-list
2737043|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2737044|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737045|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737046|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737047|NCT05162742|Colchicine|colchicine|mesh-list
2737048|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
2737049|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2737050|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
2737051|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
2737052|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
2737053|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737054|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737055|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
2737056|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2737057|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737058|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2737059|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737060|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
2737061|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
2737062|NCT05162625|Cefazolin|cefazolin|mesh-list
2737063|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2737064|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2737065|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2737066|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2737067|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2737068|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2737069|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737070|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737071|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737072|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2737073|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2737077|NCT05162456|Antibodies|antibodies|mesh-list
2737078|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
2737079|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
2737080|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
2737081|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737084|NCT05162430|Propofol|propofol|mesh-list
2737085|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2737086|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2737087|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737088|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2737089|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
2737090|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
2737091|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
2737092|NCT05162417|Methylene Blue|methylene blue|mesh-list
2737093|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737094|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737095|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
2737096|NCT05162417|Coagulants|coagulants|mesh-ancestor
2737097|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
2737098|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
2737099|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2737100|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2737101|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737102|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
2737103|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2737104|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737105|NCT05162274|Lazertinib|lazertinib|mesh-list
2737106|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2737107|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737108|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206234|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2206235|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
2206236|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
2206237|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2206238|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2206239|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206240|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
2206241|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206242|NCT00006455|Antidotes|antidotes|mesh-ancestor
2206243|NCT00006455|Protective Agents|protective agents|mesh-ancestor
2206244|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
2737127|NCT05162196|Niraparib|niraparib|mesh-list
2737128|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2737129|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737130|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737131|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737132|NCT05162183|Liraglutide|liraglutide|mesh-list
2737133|NCT05162183|Glimepiride|glimepiride|mesh-list
2206245|NCT00006455|Vitamins|vitamins|mesh-ancestor
2206246|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
2206247|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
2206248|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
2206249|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
2206250|NCT00006457|Oltipraz|oltipraz|mesh-list
2206251|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
2206252|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206253|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
2206254|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2206255|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
2206256|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2206257|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2206258|NCT00006457|Protective Agents|protective agents|mesh-ancestor
2206259|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206260|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206261|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2206262|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2206263|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206264|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206265|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2206266|NCT00006458|Antibodies|antibodies|mesh-list
2206267|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
2206268|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2206269|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
2206270|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206271|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206272|NCT00006459|Gemcitabine|gemcitabine|mesh-list
2206273|NCT00006459|Paclitaxel|paclitaxel|mesh-list
2206274|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206275|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206276|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
2206277|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
2206278|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
2206279|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206280|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2206281|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
2206282|NCT00006459|Antiviral Agents|antiviral agents|mesh-ancestor
2206283|NCT00006459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206284|NCT00006459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206285|NCT00006459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2737134|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2737135|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737136|NCT05162183|Incretins|incretins|mesh-ancestor
2737137|NCT05162183|Hormones|hormones|mesh-ancestor
2737138|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2737139|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2737140|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2737141|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
2737156|NCT05162053|Clopidogrel|clopidogrel|mesh-list
2737157|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2737158|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2737159|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2737160|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2206286|NCT00006459|Immunologic Factors|immunologic factors|mesh-ancestor
2206287|NCT00006459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206288|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
2206289|NCT00006461|Etoposide|etoposide|mesh-list
2206290|NCT00006461|Vincristine|vincristine|mesh-list
2206291|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
2737161|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
2737162|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2737163|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737164|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737165|NCT05162027|Erenumab|erenumab|mesh-list
2737166|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
2737167|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737168|NCT05162027|Analgesics|analgesics|mesh-ancestor
2737169|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
2737170|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2737171|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737177|NCT05162001|Disulfiram|disulfiram|mesh-list
2737178|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2737179|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2737180|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737181|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737182|NCT05161975|Vitamin K|vitamin k|mesh-list
2737183|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
2737184|NCT05161975|Vitamins|vitamins|mesh-ancestor
2737185|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
2737186|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737187|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2737188|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2737189|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737190|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
2737191|NCT05161975|Coagulants|coagulants|mesh-ancestor
2737192|NCT05161806|Aflibercept|aflibercept|mesh-list
2737193|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2737194|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2737195|NCT05161806|Growth Substances|growth substances|mesh-ancestor
2737196|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737197|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
2737198|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737208|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
2737209|NCT05161572|Tegafur|tegafur|mesh-list
2737210|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737211|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2737212|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
2737213|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737214|NCT05161533|Cisplatin|cisplatin|mesh-list
2737215|NCT05161533|Carboplatin|carboplatin|mesh-list
2737216|NCT05161533|Etoposide|etoposide|mesh-list
2737217|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
2737218|NCT05161533|Durvalumab|durvalumab|mesh-list
2737219|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
2737220|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
2206292|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206293|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
2206294|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206295|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2206296|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2206297|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
2206298|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206299|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206300|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2206301|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206302|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2206303|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2737221|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2737222|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
2737223|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737224|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2737225|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2737226|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2737227|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737228|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737229|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2737230|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
2737231|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737232|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
2737233|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
2737234|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
2737235|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
2737236|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
2206304|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206305|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
2206306|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
2206307|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
2206308|NCT00006462|Gemcitabine|gemcitabine|mesh-list
2206309|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2206310|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
2206311|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206312|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206313|NCT00006462|Antiviral Agents|antiviral agents|mesh-ancestor
2206314|NCT00006462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206315|NCT00006462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206316|NCT00006462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206317|NCT00006462|Immunologic Factors|immunologic factors|mesh-ancestor
2206318|NCT00006462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206319|NCT00006463|Trabectedin|trabectedin|mesh-list
2206320|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2206321|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
2206322|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206323|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206324|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2206325|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206326|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2737265|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
2737266|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2737267|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
2737268|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737269|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
2737270|NCT05161403|Protective Agents|protective agents|mesh-ancestor
2737271|NCT05161351|Vitamin D|vitamin d|mesh-list
2737272|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
2737273|NCT05161351|Baclofen|baclofen|mesh-list
2737274|NCT05161351|Vitamins|vitamins|mesh-ancestor
2737275|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
2737276|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737277|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2737278|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2737279|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2737280|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2737281|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2737282|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2737283|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
2737284|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
2737285|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2737286|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737287|NCT05161338|Estradiol|estradiol|mesh-list
2737288|NCT05161338|Progesterone|progesterone|mesh-list
2737289|NCT05161338|Estrogens|estrogens|mesh-ancestor
2737290|NCT05161338|Hormones|hormones|mesh-ancestor
2737291|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2737292|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737293|NCT05161338|Progestins|progestins|mesh-ancestor
2737294|NCT05161221|Acetaminophen|acetaminophen|mesh-list
2737295|NCT05161221|Naproxen|naproxen|mesh-list
2737296|NCT05161221|Oxycodone|oxycodone|mesh-list
2737297|NCT05161221|Bupivacaine|bupivacaine|mesh-list
2737298|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
2737299|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
2737300|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2737301|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737302|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
2737303|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2737304|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2737305|NCT05161221|Narcotics|narcotics|mesh-ancestor
2737306|NCT05161221|Analgesics|analgesics|mesh-ancestor
2737307|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2737308|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2737309|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2737310|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2737311|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
2737312|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2737313|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737314|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737315|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
2737316|NCT05161208|Varenicline|varenicline|mesh-list
2737317|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2737318|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2737319|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
2737320|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2737321|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737322|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737323|NCT05161195|Tamoxifen|tamoxifen|mesh-list
2737324|NCT05161195|Letrozole|letrozole|mesh-list
2737325|NCT05161195|Fulvestrant|fulvestrant|mesh-list
2737326|NCT05161195|Anastrozole|anastrozole|mesh-list
2737327|NCT05161195|Goserelin|goserelin|mesh-list
2737328|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737329|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2737330|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2737331|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206327|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206328|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206329|NCT00006465|Capecitabine|capecitabine|mesh-list
2206330|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
2206331|NCT00006465|Irinotecan|irinotecan|mesh-list
2206332|NCT00006465|Camptothecin|camptothecin|mesh-list
2206333|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2206334|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
2206335|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206336|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737332|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737333|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2737334|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
2737335|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2737336|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737337|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2737338|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2737339|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2737340|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2737341|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2737342|NCT05161156|Bromides|bromides|mesh-list
2737343|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
2737344|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2737345|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
2737346|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2737347|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737348|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2737349|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
2737350|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
2737351|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2737352|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
2737353|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2737354|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737355|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
2737356|NCT05156281|Teriflunomide|teriflunomide|mesh-list
2737357|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2737358|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2737359|NCT05156281|Analgesics|analgesics|mesh-ancestor
2737360|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
2206337|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2206338|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2206339|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206340|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206341|NCT00006467|Gemcitabine|gemcitabine|mesh-list
2424127|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2424128|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2424129|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2424130|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
2424131|NCT00825591|Melatonin|melatonin|mesh-list
2424132|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
2424133|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424134|NCT00825591|Protective Agents|protective agents|mesh-ancestor
2424135|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424136|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2424137|NCT00825617|Hormones|hormones|mesh-list
2424138|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424139|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424140|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
2424141|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2424142|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424143|NCT00825656|Capsaicin|capsaicin|mesh-list
2737361|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2737362|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737363|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2737364|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2737365|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2737366|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
2737390|NCT05152147|Fluorouracil|fluorouracil|mesh-list
2737391|NCT05152147|Capecitabine|capecitabine|mesh-list
2737392|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
2737393|NCT05152147|Trastuzumab|trastuzumab|mesh-list
2737394|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737395|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
2737396|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737397|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2737398|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2737399|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
2737400|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737401|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2737419|NCT05144542|Nicotine|nicotine|mesh-list
2737420|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2737421|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
2737422|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2737423|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737424|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2737425|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2737426|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
2737427|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2737428|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737434|NCT05142696|Carboplatin|carboplatin|mesh-list
2737435|NCT05142696|Etoposide|etoposide|mesh-list
2737436|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
2737437|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2737438|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737439|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2737440|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2737441|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2737442|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737443|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737444|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
2737445|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
2737446|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2737458|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2737459|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2737460|NCT05141838|Vitamin D|vitamin d|mesh-list
2424144|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
2424145|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
2424146|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
2424147|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424148|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737461|NCT05141838|Vitamins|vitamins|mesh-ancestor
2737462|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
2737463|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737464|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2737465|NCT05141149|Gemcitabine|gemcitabine|mesh-list
2206342|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2206343|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
2206344|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206345|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206346|NCT00006467|Antiviral Agents|antiviral agents|mesh-ancestor
2206347|NCT00006467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206348|NCT00006467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206349|NCT00006467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206350|NCT00006467|Immunologic Factors|immunologic factors|mesh-ancestor
2206351|NCT00006467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206352|NCT00006468|Leucovorin|leucovorin|mesh-list
2206353|NCT00006468|Fluorouracil|fluorouracil|mesh-list
2206354|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
2737466|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2737467|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
2737468|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737469|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737470|NCT05141149|Antiviral Agents|antiviral agents|mesh-ancestor
2737471|NCT05141149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2737472|NCT05141149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737473|NCT05141149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2737474|NCT05141149|Immunologic Factors|immunologic factors|mesh-ancestor
2737475|NCT05141149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737476|NCT05137886|Decitabine|decitabine|mesh-list
2737477|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2737478|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2737479|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
2737480|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737481|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737482|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737483|NCT05137600|Clarithromycin|clarithromycin|mesh-list
2737484|NCT05137600|Midazolam|midazolam|mesh-list
2737485|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2206355|NCT00006468|Calcium|calcium|mesh-list
2424149|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2424150|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2424151|NCT00825851|Nicotine|nicotine|mesh-list
2424152|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2424153|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
2424154|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424155|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424156|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2737486|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2737487|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2737488|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737489|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2737490|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2737491|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2737492|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2737493|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
2737494|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
2737495|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
2737496|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
2737497|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2737498|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737499|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2737500|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2737501|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2737502|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737503|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2737504|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2737505|NCT05137548|Tenofovir|tenofovir|mesh-list
2737506|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
2737507|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2737508|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2737509|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2737510|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737511|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737512|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2737513|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2737514|NCT05132231|Brodalumab|brodalumab|mesh-list
2737515|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
2737527|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2737528|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2737542|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2737543|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2737544|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
2737545|NCT05096728|Nifedipine|nifedipine|mesh-list
2737546|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2737547|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2737548|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737549|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2737550|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737551|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
2737552|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
2737553|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2737554|NCT05079698|177Lu-PSMA-617|177lu-psma-617|mesh-list
2737555|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2737556|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737562|NCT05074056|Ketorolac|ketorolac|mesh-list
2737563|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2737564|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2737565|NCT05074056|Analgesics|analgesics|mesh-ancestor
2737566|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
2737567|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2737568|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737569|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2737570|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2737571|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2737572|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737573|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737574|NCT05067933|Vaccines|vaccines|mesh-list
2737575|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
2737576|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737577|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
2737578|NCT05067270|Treprostinil|treprostinil|mesh-list
2737579|NCT05067270|Citric Acid|citric acid|mesh-list
2737580|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
2737581|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
2737582|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2737583|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
2737584|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
2737585|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737586|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2737587|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737588|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2206356|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
2206357|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2206358|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206359|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
2206360|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206361|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2206362|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206363|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206364|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
2206365|NCT00006468|Antidotes|antidotes|mesh-ancestor
2206366|NCT00006468|Protective Agents|protective agents|mesh-ancestor
2737601|NCT05063851|Memantine|memantine|mesh-list
2737602|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2737603|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2737604|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
2737605|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2737606|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737607|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737608|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2737609|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2737610|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2737611|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2737612|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
2737633|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2737634|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2737635|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2737636|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737637|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737638|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
2737639|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2737640|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2737641|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2737650|NCT05046522|Palmidrol|palmidrol|mesh-list
2737651|NCT05046522|Analgesics|analgesics|mesh-ancestor
2737652|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
2737653|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2737654|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737655|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2737656|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2737657|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2737658|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2737659|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
2737660|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2737661|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2737662|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2737663|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2737664|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737665|NCT05046522|Hormones|hormones|mesh-ancestor
2737666|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2737667|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2737668|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424157|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2424158|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
2424159|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424160|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424161|NCT00825864|Dexamethasone|dexamethasone|mesh-list
2424162|NCT00825864|Diclofenac|diclofenac|mesh-list
2424163|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
2424164|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2424165|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2424166|NCT00825864|BB 1101|bb 1101|mesh-list
2424167|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2424168|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
2424169|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
2424170|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424171|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424172|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2424173|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
2424174|NCT00825864|Hormones|hormones|mesh-ancestor
2424175|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2737681|NCT05041946|Methylphenidate|methylphenidate|mesh-list
2737682|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2737683|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737684|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2737685|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2737686|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2737687|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737688|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
2737689|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2206367|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
2206368|NCT00006468|Vitamins|vitamins|mesh-ancestor
2206369|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
2206370|NCT00006469|Paclitaxel|paclitaxel|mesh-list
2206371|NCT00006469|Carboplatin|carboplatin|mesh-list
2206372|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206373|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206374|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
2206375|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
2206376|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
2206377|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737706|NCT05034952|Acetaminophen|acetaminophen|mesh-list
2737707|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2737708|NCT05034952|Analgesics|analgesics|mesh-ancestor
2737709|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
2737710|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2737711|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737712|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
2737751|NCT04998786|Dexamethasone|dexamethasone|mesh-list
2737752|NCT04998786|Ixazomib|ixazomib|mesh-list
2737753|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2737754|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
2737755|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
2737756|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2737757|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737758|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2737759|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
2737760|NCT04998786|Hormones|hormones|mesh-ancestor
2737761|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2737762|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2737763|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737764|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
2737765|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737766|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737772|NCT04991974|Buprenorphine|buprenorphine|mesh-list
2737773|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2737774|NCT04991974|Naloxone|naloxone|mesh-list
2737775|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2737776|NCT04991974|Narcotics|narcotics|mesh-ancestor
2737777|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2737778|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737779|NCT04991974|Analgesics|analgesics|mesh-ancestor
2737780|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
2737781|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2737782|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2737788|NCT04983589|Pilocarpine|pilocarpine|mesh-list
2737789|NCT04983589|Miotics|miotics|mesh-ancestor
2737790|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
2737791|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2737792|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2737793|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2737794|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2737795|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
2737796|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2737797|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737803|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
2737804|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2737805|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2737806|NCT04976192|Omalizumab|omalizumab|mesh-list
2737807|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2737808|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2737809|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
2737851|NCT04961619|Trametinib|trametinib|mesh-list
2737852|NCT04961619|Dabrafenib|dabrafenib|mesh-list
2737853|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2737854|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2737855|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2737856|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206378|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2206379|NCT00006470|Vaccines|vaccines|mesh-list
2206380|NCT00006470|Antibodies|antibodies|mesh-list
2424176|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2424177|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424178|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2424179|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2424180|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2424181|NCT00825864|Analgesics|analgesics|mesh-ancestor
2424182|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
2424183|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2424184|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2424185|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424186|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424187|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
2424188|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2424189|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2424190|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
2737980|NCT04886284|Ertapenem|ertapenem|mesh-list
2737981|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2737982|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2738001|NCT04869488|Prednisone|prednisone|mesh-list
2738002|NCT04869488|Apatinib|apatinib|mesh-list
2738003|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
2738004|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2738005|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
2738006|NCT04869488|Hormones|hormones|mesh-ancestor
2738007|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2738008|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738009|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2738010|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738011|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2738012|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2738013|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738014|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2738015|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
2738016|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2424191|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2424192|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
2424193|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424194|NCT00826163|Budesonide|budesonide|mesh-list
2424195|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2424196|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2424197|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
2424198|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424199|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738017|NCT04867798|Tenofovir|tenofovir|mesh-list
2738018|NCT04867798|Lamivudine|lamivudine|mesh-list
2738019|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
2738020|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2738021|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2738022|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2738023|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2738024|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738025|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2738026|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2738035|NCT04858009|Cisplatin|cisplatin|mesh-list
2738036|NCT04858009|Mitomycins|mitomycins|mesh-list
2738037|NCT04858009|Mitomycin|mitomycin|mesh-list
2738038|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738039|NCT04858009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2738040|NCT04858009|Alkylating Agents|alkylating agents|mesh-ancestor
2738041|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738042|NCT04858009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2738043|NCT04858009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2738044|NCT04853355|Spironolactone|spironolactone|mesh-list
2738045|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2738046|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
2738047|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2738048|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738049|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2738050|NCT04853355|Diuretics|diuretics|mesh-ancestor
2738051|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
2738058|NCT04844606|Mirikizumab|mirikizumab|mesh-list
2738059|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2738060|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2738061|NCT04844606|Analgesics|analgesics|mesh-ancestor
2738062|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
2738063|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2738064|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738065|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2738066|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2738067|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2738068|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2738069|NCT04840888|Itraconazole|itraconazole|mesh-list
2738070|NCT04840888|Carbamazepine|carbamazepine|mesh-list
2424200|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2424201|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
2424202|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
2424203|NCT00826163|Hormones|hormones|mesh-ancestor
2424204|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424205|NCT00826254|Vitamins|vitamins|mesh-list
2424206|NCT00826254|Vitamin K|vitamin k|mesh-list
2424207|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
2424208|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424209|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2424210|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2424211|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424212|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
2424213|NCT00826254|Coagulants|coagulants|mesh-ancestor
2424214|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
2424215|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2424216|NCT00826306|Protective Agents|protective agents|mesh-ancestor
2424217|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738071|NCT04840888|Omeprazole|omeprazole|mesh-list
2424218|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
2738072|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2738073|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2738074|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2738075|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2738076|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738077|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
2738078|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2738079|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2738080|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2738081|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2738082|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
2738083|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2738084|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738085|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2738086|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
2738087|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
2738088|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2738089|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2738090|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2738091|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2738092|NCT04840888|Analgesics|analgesics|mesh-ancestor
2738093|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
2738094|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2738095|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2738096|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2738097|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2738098|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2738116|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
2738117|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424219|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2424220|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2424221|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2424222|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
2424223|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424224|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2424225|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2424226|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424227|NCT00826371|Ranibizumab|ranibizumab|mesh-list
2424228|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2424229|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2424230|NCT00826371|Growth Substances|growth substances|mesh-ancestor
2424231|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424232|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
2424233|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738121|NCT04821869|Albuterol|albuterol|mesh-list
2738122|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2738123|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
2738124|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2206381|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
2206382|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2206383|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2206384|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
2206385|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206386|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206387|NCT00006471|Fenretinide|fenretinide|mesh-list
2206388|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738125|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738126|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2738127|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
2738128|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2738129|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2738130|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2738131|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
2738132|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2738133|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738134|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
2738135|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2738141|NCT04821284|Leucovorin|leucovorin|mesh-list
2738142|NCT04821284|Gemcitabine|gemcitabine|mesh-list
2738143|NCT04821284|Paclitaxel|paclitaxel|mesh-list
2738144|NCT04821284|Fluorouracil|fluorouracil|mesh-list
2738145|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
2738146|NCT04821284|Irinotecan|irinotecan|mesh-list
2738147|NCT04821284|Calcium|calcium|mesh-list
2738148|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
2738149|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2738150|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738151|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
2738152|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
2738153|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
2738154|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738155|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2738156|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
2738157|NCT04821284|Antiviral Agents|antiviral agents|mesh-ancestor
2738158|NCT04821284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2738159|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2738160|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2738161|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
2424264|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
2424265|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2424266|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2424267|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
2206389|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2206390|NCT00006471|Protective Agents|protective agents|mesh-ancestor
2738162|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738163|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2738164|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2738165|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2738166|NCT04821284|Antidotes|antidotes|mesh-ancestor
2738167|NCT04821284|Protective Agents|protective agents|mesh-ancestor
2738168|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
2738169|NCT04821284|Vitamins|vitamins|mesh-ancestor
2738170|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
2206391|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206392|NCT00006472|Paclitaxel|paclitaxel|mesh-list
2206393|NCT00006472|Carboplatin|carboplatin|mesh-list
2206394|NCT00006472|Fluorouracil|fluorouracil|mesh-list
2206395|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206396|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206397|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
2206398|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
2424268|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2206399|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
2424269|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424270|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424271|NCT00826527|Urological Agents|urological agents|mesh-ancestor
2424272|NCT00826553|Midazolam|midazolam|mesh-list
2424273|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
2424274|NCT00826553|Lorazepam|lorazepam|mesh-list
2424275|NCT00826553|Propofol|propofol|mesh-list
2424276|NCT00826553|GABA Agonists|gaba agonists|mesh-list
2424277|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2424278|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2424279|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424280|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2424281|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
2424282|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
2424283|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2424284|NCT00826553|Analgesics|analgesics|mesh-ancestor
2424285|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
2424286|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424287|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2424288|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2424289|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2424290|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
2424291|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2738293|NCT04738123|Xanomeline|xanomeline|mesh-list
2738294|NCT04738123|Trospium chloride|trospium chloride|mesh-list
2738295|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
2738296|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
2738297|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2738298|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738299|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2738300|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2738301|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
2738302|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2738303|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738304|NCT04738123|Urological Agents|urological agents|mesh-ancestor
2738305|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2738306|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2738307|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2738308|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2738309|NCT04729621|Denosumab|denosumab|mesh-list
2738310|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2738311|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738312|NCT04712903|Carboplatin|carboplatin|mesh-list
2738313|NCT04712903|Etoposide|etoposide|mesh-list
2738314|NCT04712903|Durvalumab|durvalumab|mesh-list
2738315|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738316|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2738317|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2738318|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2738319|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2738320|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738321|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2206400|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206401|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
2206402|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2424292|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424293|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2424294|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2424295|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2424296|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2424297|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
2424298|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
2424299|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
2424300|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
2424301|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
2424302|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2424303|NCT00826566|Caffeine|caffeine|mesh-list
2424304|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2424305|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424306|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2424307|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424308|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424309|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2424310|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2424311|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
2424312|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424313|NCT00826644|Etoposide|etoposide|mesh-list
2424314|NCT00826644|Belotecan|belotecan|mesh-list
2424315|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424316|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2424317|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2424318|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2424319|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206403|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206404|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
2206405|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206406|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
2206407|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206408|NCT00006474|Temozolomide|temozolomide|mesh-list
2206409|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
2206410|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2206411|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
2206412|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206413|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206414|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206415|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
2206416|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206417|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2206418|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424320|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424321|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2424322|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
2424323|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
2424324|NCT00826657|Vitamins|vitamins|mesh-ancestor
2424325|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
2424326|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424327|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
2424328|NCT00826657|Hematinics|hematinics|mesh-ancestor
2424329|NCT00826722|Levetiracetam|levetiracetam|mesh-list
2424330|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
2424331|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
2424332|NCT00826787|Levetiracetam|levetiracetam|mesh-list
2424333|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
2424334|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
2424335|NCT00826826|Amiodarone|amiodarone|mesh-list
2424336|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2424337|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
2424338|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2424339|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2424340|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424341|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2424342|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2424343|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2424344|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424345|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2424346|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2424347|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2424348|NCT00826839|Leuprolide|leuprolide|mesh-list
2424349|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
2424350|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
2424351|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2424352|NCT00826839|Ganirelix|ganirelix|mesh-list
2424353|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2424354|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424355|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2424356|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
2424357|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2424358|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424359|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2424360|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
2424361|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424362|NCT00826852|Carboplatin|carboplatin|mesh-list
2424363|NCT00826852|Docetaxel|docetaxel|mesh-list
2424364|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424365|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
2424366|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
2424367|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
2424368|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424369|NCT00826865|Levetiracetam|levetiracetam|mesh-list
2424370|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
2424371|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
2424372|NCT00826891|Topotecan|topotecan|mesh-list
2424373|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424374|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2738425|NCT04659161|Xanomeline|xanomeline|mesh-list
2738426|NCT04659161|Trospium chloride|trospium chloride|mesh-list
2738427|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
2738428|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
2738429|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2738430|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738431|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2738432|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2738433|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
2738434|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2738435|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738436|NCT04659161|Urological Agents|urological agents|mesh-ancestor
2738437|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2738438|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2738439|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2738440|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2738451|NCT04648826|Azacitidine|azacitidine|mesh-list
2424375|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2424376|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424377|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424378|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
2424379|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
2424380|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424381|NCT00826930|Protective Agents|protective agents|mesh-ancestor
2424382|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424383|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2424384|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424385|NCT00826969|Ciclesonide|ciclesonide|mesh-list
2424386|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
2206419|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206420|NCT00006476|Suramin|suramin|mesh-list
2424387|NCT00826969|Hormones|hormones|mesh-ancestor
2424388|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424389|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424390|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2424391|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
2424392|NCT00827021|Hematinics|hematinics|mesh-list
2424393|NCT00827034|Warfarin|warfarin|mesh-list
2424394|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
2424395|NCT00827138|Rebastinib|rebastinib|mesh-list
2424396|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424397|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2424398|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424399|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424400|NCT00827151|Estrogens|estrogens|mesh-list
2738452|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2424401|NCT00827151|Hormones|hormones|mesh-ancestor
2738453|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
2738454|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738455|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738456|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206421|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
2206422|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
2206423|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2206424|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206425|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206426|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2206427|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2206428|NCT00006479|Leucovorin|leucovorin|mesh-list
2206429|NCT00006479|Fluorouracil|fluorouracil|mesh-list
2738481|NCT04606394|Albuterol|albuterol|mesh-list
2738482|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2738483|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
2738484|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2738485|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738486|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2738487|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
2738488|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
2738489|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2738490|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2738491|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2738492|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2738493|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
2738494|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2738495|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738496|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
2738497|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2738498|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738507|NCT04586985|Midazolam|midazolam|mesh-list
2738508|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2424402|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424403|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424404|NCT00827177|Sorafenib|sorafenib|mesh-list
2424405|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424406|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2424407|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424408|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424409|NCT00827216|Erythromycin|erythromycin|mesh-list
2424410|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
2738509|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2206430|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
2738510|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2738511|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738512|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2738513|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2738514|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2738515|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2738516|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
2738517|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
2738518|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
2738519|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
2738520|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2738521|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738546|NCT04577690|Epinephrine|epinephrine|mesh-list
2738547|NCT04577690|Racepinephrine|racepinephrine|mesh-list
2738548|NCT04577690|Bupivacaine|bupivacaine|mesh-list
2738549|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
2738550|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
2738551|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
2738552|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2738553|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738554|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
2738555|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2738556|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2738557|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2738558|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
2738559|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2738560|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738561|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2738562|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2738563|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
2738564|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2738565|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
2738566|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
2738567|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
2738568|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2738569|NCT04574856|Temozolomide|temozolomide|mesh-list
2206431|NCT00006479|Calcium|calcium|mesh-list
2206432|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
2206433|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2206434|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206435|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
2206436|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206437|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2206438|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206439|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206440|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
2206441|NCT00006479|Antidotes|antidotes|mesh-ancestor
2206442|NCT00006479|Protective Agents|protective agents|mesh-ancestor
2206443|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
2206444|NCT00006479|Vitamins|vitamins|mesh-ancestor
2738570|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2738571|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
2738572|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738573|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738574|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2738575|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2738576|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
2424411|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2424412|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
2424413|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2424414|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424415|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2424416|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2206445|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
2206446|NCT00006480|Aldesleukin|aldesleukin|mesh-list
2206447|NCT00006480|Ganciclovir|ganciclovir|mesh-list
2206448|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2206449|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206450|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2206451|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2206452|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
2424417|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424418|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424419|NCT00827281|Cycloserine|cycloserine|mesh-list
2424420|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2424421|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424422|NCT00827281|Renal Agents|renal agents|mesh-ancestor
2424423|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2424424|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
2424425|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2424426|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
2424427|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424428|NCT00827307|Tamoxifen|tamoxifen|mesh-list
2424429|NCT00827307|Goserelin|goserelin|mesh-list
2424430|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2424431|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
2424432|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424433|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424434|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2424435|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424436|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2424437|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2424438|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2424439|NCT00827320|Levetiracetam|levetiracetam|mesh-list
2424440|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
2424441|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
2206453|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206454|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2206455|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206456|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206457|NCT00006482|Gemcitabine|gemcitabine|mesh-list
2206458|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424442|NCT00827346|Clopidogrel|clopidogrel|mesh-list
2424443|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2424444|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2424445|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2424446|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2424447|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
2424448|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424449|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424450|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424451|NCT00827411|Aspirin|aspirin|mesh-list
2206459|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2424452|NCT00827411|Clopidogrel|clopidogrel|mesh-list
2424453|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2424454|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2424455|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2424456|NCT00827411|Analgesics|analgesics|mesh-ancestor
2424457|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
2424458|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424459|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424460|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2424461|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2424462|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2424463|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2424464|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424465|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2424466|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2424467|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424468|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
2424469|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2424470|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2424471|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2424472|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
2424473|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424474|NCT00827450|Caffeine|caffeine|mesh-list
2424475|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2424476|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424477|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2424478|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424479|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424480|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2424481|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2424482|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
2424483|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424484|NCT00827554|Nadroparin|nadroparin|mesh-list
2424485|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
2424486|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2424487|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2424488|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424489|NCT00827580|Eniluracil|eniluracil|mesh-list
2424490|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424491|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424492|NCT00827671|Cetuximab|cetuximab|mesh-list
2424493|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2424494|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424495|NCT00827684|Sirolimus|sirolimus|mesh-list
2424496|NCT00827684|Irinotecan|irinotecan|mesh-list
2424497|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2424498|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2424499|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424500|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424501|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424502|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2424503|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424504|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2424505|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
2424506|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2424507|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
2424508|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424509|NCT00827814|Dutasteride|dutasteride|mesh-list
2424510|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2424511|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2424512|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424513|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424514|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
2424515|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424516|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206460|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
2206461|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206462|NCT00006482|Antiviral Agents|antiviral agents|mesh-ancestor
2206463|NCT00006482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206464|NCT00006482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206465|NCT00006482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206466|NCT00006482|Immunologic Factors|immunologic factors|mesh-ancestor
2206467|NCT00006482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424517|NCT00827840|Risperidone|risperidone|mesh-list
2424518|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2424519|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2424520|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
2424521|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424522|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424523|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424524|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2424525|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2424526|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2424527|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2424528|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2424529|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
2424530|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2424531|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2424532|NCT00827892|Pioglitazone|pioglitazone|mesh-list
2424533|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2424534|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424535|NCT00827996|Adalimumab|adalimumab|mesh-list
2424536|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2424537|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2424538|NCT00828087|Cobalt|cobalt|mesh-list
2424539|NCT00828087|Chromium|chromium|mesh-list
2424540|NCT00828087|Everolimus|everolimus|mesh-list
2424541|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424542|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2424543|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
2424544|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424545|NCT00828087|Trace Elements|trace elements|mesh-ancestor
2424546|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
2424547|NCT00828230|Budesonide|budesonide|mesh-list
2424548|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2424549|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2424550|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
2424551|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424552|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424553|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2424554|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
2424555|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
2424556|NCT00828230|Hormones|hormones|mesh-ancestor
2424557|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424558|NCT00828282|Simvastatin|simvastatin|mesh-list
2424559|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2424560|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2424561|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
2424562|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424563|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2424564|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2424565|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424566|NCT00828373|Lidocaine|lidocaine|mesh-list
2424567|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
2424568|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
2424569|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2424570|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424571|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
2424572|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424573|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2424574|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2424575|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2424576|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2424577|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424578|NCT00828477|Nepafenac|nepafenac|mesh-list
2424579|NCT00828477|Bromfenac|bromfenac|mesh-list
2424580|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2424581|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2424582|NCT00828477|Analgesics|analgesics|mesh-ancestor
2424583|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
2424584|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424585|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424586|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2424587|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2424588|NCT00828503|Valganciclovir|valganciclovir|mesh-list
2424589|NCT00828503|Everolimus|everolimus|mesh-list
2424590|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424591|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2424592|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
2424593|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424594|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
2424595|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424596|NCT00828529|Bedaquiline|bedaquiline|mesh-list
2424597|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
2424598|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2424599|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424600|NCT00828555|Vaccines|vaccines|mesh-list
2424601|NCT00828555|Immunologic Factors|immunologic factors|mesh-ancestor
2424602|NCT00828555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424603|NCT00828594|Sorafenib|sorafenib|mesh-list
2424604|NCT00828594|Everolimus|everolimus|mesh-list
2424605|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424606|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2424607|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424608|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424609|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2424610|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
2424611|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424612|NCT00828763|Dolutegravir|dolutegravir|mesh-list
2424613|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2424614|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2424615|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424616|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424617|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2424618|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2424619|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
2424620|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424621|NCT00828776|Heparin|heparin|mesh-list
2424622|NCT00828776|Calcium heparin|calcium heparin|mesh-list
2424623|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
2424624|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2424625|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2424626|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424627|NCT00828789|Tenofovir|tenofovir|mesh-list
2424628|NCT00828789|Efavirenz|efavirenz|mesh-list
2424629|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
2424630|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424631|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2424632|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2424633|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424634|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424635|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2424636|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2424637|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2424638|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2424639|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2424640|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2424641|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2424642|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2424643|NCT00828802|Lenalidomide|lenalidomide|mesh-list
2424644|NCT00828802|Decitabine|decitabine|mesh-list
2424645|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
2424646|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424647|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2424648|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2424649|NCT00828802|Growth Substances|growth substances|mesh-ancestor
2424650|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
2424651|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424652|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2424653|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
2424654|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424655|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424656|NCT00828815|Etravirine|etravirine|mesh-list
2424657|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2206468|NCT00006483|Sargramostim|sargramostim|mesh-list
2206469|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
2206470|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206471|NCT00006484|Paclitaxel|paclitaxel|mesh-list
2206472|NCT00006484|Carboplatin|carboplatin|mesh-list
2206473|NCT00006484|Tirapazamine|tirapazamine|mesh-list
2206474|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206475|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424658|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2206476|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
2206477|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
2206478|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
2206479|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206480|NCT00006485|Irinotecan|irinotecan|mesh-list
2206481|NCT00006485|Alvocidib|alvocidib|mesh-list
2206482|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2206483|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2206484|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206485|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206486|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206487|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
2206488|NCT00006485|Growth Substances|growth substances|mesh-ancestor
2206489|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424659|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424660|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424661|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
2206490|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2206491|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
2206492|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206493|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2206494|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2206495|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206496|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2206497|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206498|NCT00006487|Etoposide|etoposide|mesh-list
2206499|NCT00006487|Tirapazamine|tirapazamine|mesh-list
2206500|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206501|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206502|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2206503|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2206504|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206505|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206506|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
2206507|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2206508|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206509|NCT00006508|Insulin|insulin|mesh-list
2206510|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2206511|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206512|NCT00006519|Capravirine|capravirine|mesh-list
2206513|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2206514|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2206515|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206516|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206517|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
2206518|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206519|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2206520|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2206521|NCT00006578|Ritonavir|ritonavir|mesh-list
2206522|NCT00006578|Amprenavir|amprenavir|mesh-list
2206523|NCT00006578|Lamivudine|lamivudine|mesh-list
2206524|NCT00006578|Abacavir|abacavir|mesh-list
2206525|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2206526|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2206527|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
2206528|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206529|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206530|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2206531|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2206532|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
2206533|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206534|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2206535|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2206536|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2206537|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2206538|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2206539|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
2206540|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2206541|NCT00006591|Ritonavir|ritonavir|mesh-list
2206542|NCT00006591|Amprenavir|amprenavir|mesh-list
2206543|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2206544|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2206545|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
2206546|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206547|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424662|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424663|NCT00828828|Vaccines|vaccines|mesh-list
2424664|NCT00828828|Immunologic Factors|immunologic factors|mesh-ancestor
2424665|NCT00828828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424666|NCT00828854|Entinostat|entinostat|mesh-list
2424667|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424668|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2424669|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424670|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424671|NCT00828919|Axitinib|axitinib|mesh-list
2424672|NCT00828919|Crizotinib|crizotinib|mesh-list
2424673|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424674|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2424675|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424676|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424677|NCT00828958|Risperidone|risperidone|mesh-list
2424678|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2424679|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
2424680|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424681|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424682|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424683|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2424684|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2424685|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2424686|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2424687|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2424688|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
2424689|NCT00828971|Amoxicillin|amoxicillin|mesh-list
2424690|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
2424691|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2424692|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2424693|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424694|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2424695|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2424696|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424697|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424698|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424699|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2424700|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
2424701|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2424702|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424703|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2424704|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2424705|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2424706|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2424707|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
2424708|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424709|NCT00829023|Ethanol|ethanol|mesh-list
2424710|NCT00829023|Chlorhexidine|chlorhexidine|mesh-list
2424711|NCT00829023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2424712|NCT00829023|Povidone-Iodine|povidone-iodine|mesh-list
2424713|NCT00829023|Povidone|povidone|mesh-list
2424714|NCT00829023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2424715|NCT00829023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424716|NCT00829023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2424717|NCT00829023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424718|NCT00829023|Disinfectants|disinfectants|mesh-ancestor
2424719|NCT00829023|Dermatologic Agents|dermatologic agents|mesh-ancestor
2424720|NCT00829023|Plasma Substitutes|plasma substitutes|mesh-ancestor
2424721|NCT00829023|Blood Substitutes|blood substitutes|mesh-ancestor
2424722|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2424723|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2424724|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2424725|NCT00829114|Estradiol|estradiol|mesh-list
2424726|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2424727|NCT00829114|Estrogens|estrogens|mesh-ancestor
2424728|NCT00829114|Hormones|hormones|mesh-ancestor
2424729|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424730|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424731|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2424732|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
2424733|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2424734|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2424735|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2424736|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2424737|NCT00829192|Afamelanotide|afamelanotide|mesh-list
2424738|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
2424739|NCT00829205|Rituximab|rituximab|mesh-list
2424740|NCT00829205|Carboplatin|carboplatin|mesh-list
2424741|NCT00829205|Etoposide|etoposide|mesh-list
2424742|NCT00829205|Ifosfamide|ifosfamide|mesh-list
2424743|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
2424744|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2424745|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424746|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
2424747|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424748|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2424749|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2424750|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2424751|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2424752|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424753|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424754|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2424755|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
2424756|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2424757|NCT00829205|Protective Agents|protective agents|mesh-ancestor
2424758|NCT00829231|Sorafenib|sorafenib|mesh-list
2424759|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424760|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2424761|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424762|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424763|NCT00829257|Fluticasone|fluticasone|mesh-list
2424764|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2424765|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2424766|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2424767|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
2424768|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424769|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424770|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2424771|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
2424772|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
2424773|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2424774|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
2424775|NCT00829257|Hormones|hormones|mesh-ancestor
2424776|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424777|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
2424778|NCT00829322|Modafinil|modafinil|mesh-list
2424779|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2424780|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424781|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2424782|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2424783|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2424784|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424785|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2424786|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
2424787|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424788|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2424789|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2424790|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2424791|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2206548|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2206549|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2206550|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
2206551|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206552|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2206553|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2206554|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2206555|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
2206556|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2206557|NCT00006617|Lamivudine|lamivudine|mesh-list
2206558|NCT00006617|Zidovudine|zidovudine|mesh-list
2206559|NCT00006617|Abacavir|abacavir|mesh-list
2206560|NCT00006617|Amprenavir|amprenavir|mesh-list
2206561|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2206562|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2206563|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206564|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206565|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
2424792|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2424793|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
2424794|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424795|NCT00829608|Vaccines|vaccines|mesh-list
2424796|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
2424797|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424798|NCT00829634|Methamphetamine|methamphetamine|mesh-list
2424799|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2424800|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424801|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
2424802|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
2424803|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424804|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
2424805|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424806|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424807|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
2206566|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206567|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2206568|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2206569|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
2206570|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2206571|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
2206572|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2424808|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2424809|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2424810|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2424811|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2424812|NCT00829647|Lenalidomide|lenalidomide|mesh-list
2424813|NCT00829647|Dasatinib|dasatinib|mesh-list
2424814|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
2424815|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424816|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2424817|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2424818|NCT00829647|Growth Substances|growth substances|mesh-ancestor
2424819|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
2424820|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424821|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2424822|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424823|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424824|NCT00829660|Acarbose|acarbose|mesh-list
2424825|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2424826|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424827|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424828|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2424829|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424830|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2424831|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2424832|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2424833|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2424834|NCT00829777|Naloxone|naloxone|mesh-list
2424835|NCT00829777|Lactulose|lactulose|mesh-list
2424836|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2424837|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424838|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
2424839|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424840|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2424841|NCT00829881|Betahistine|betahistine|mesh-list
2424842|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
2424843|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
2424844|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
2424845|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2206573|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2206574|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2206575|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
2206576|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
2206577|NCT00006630|Antibodies|antibodies|mesh-list
2206578|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
2206579|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2206580|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2424846|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424847|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424848|NCT00829894|Risperidone|risperidone|mesh-list
2424849|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2424850|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
2206581|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
2424851|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424852|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424853|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424854|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2424855|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2424856|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2424857|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2424858|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2424859|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
2424860|NCT00830050|Naproxen|naproxen|mesh-list
2424861|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2424862|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2424863|NCT00830050|Analgesics|analgesics|mesh-ancestor
2424864|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
2424865|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424866|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424867|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2424868|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2424869|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
2424870|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2424871|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424872|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424873|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
2424874|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
2424875|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
2424876|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2424877|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424878|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
2424879|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424880|NCT00830102|Fluticasone|fluticasone|mesh-list
2424881|NCT00830102|Xhance|xhance|mesh-list
2424882|NCT00830102|Formoterol Fumarate|formoterol fumarate|mesh-list
2424883|NCT00830102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2424884|NCT00830102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2424885|NCT00830102|Autonomic Agents|autonomic agents|mesh-ancestor
2424886|NCT00830102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424887|NCT00830102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206582|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206583|NCT00006656|Ethanol|ethanol|mesh-list
2206584|NCT00006656|Carmustine|carmustine|mesh-list
2206585|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2206586|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206587|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2206588|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206589|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2206590|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
2206591|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206592|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206593|NCT00006669|Prednisone|prednisone|mesh-list
2206594|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
2424888|NCT00830102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2424889|NCT00830102|Respiratory System Agents|respiratory system agents|mesh-ancestor
2424890|NCT00830102|Dermatologic Agents|dermatologic agents|mesh-ancestor
2424891|NCT00830102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2424892|NCT00830102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2424893|NCT00830102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2424894|NCT00830102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2424895|NCT00830102|Adrenergic Agents|adrenergic agents|mesh-ancestor
2424896|NCT00830102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424897|NCT00830102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424898|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
2424899|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2424900|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
2424901|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424902|NCT00830193|Expectorants|expectorants|mesh-ancestor
2424903|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
2424904|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2424905|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
2424906|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424907|NCT00830193|Protective Agents|protective agents|mesh-ancestor
2424908|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424909|NCT00830193|Antidotes|antidotes|mesh-ancestor
2424910|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2424911|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424912|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2424913|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424914|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424915|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
2424916|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
2424917|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
2424918|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
2424919|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2424920|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424921|NCT00830323|Oseltamivir|oseltamivir|mesh-list
2424922|NCT00830323|Amantadine|amantadine|mesh-list
2424923|NCT00830323|Zanamivir|zanamivir|mesh-list
2424924|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
2424925|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424926|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2424927|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424928|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2424929|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2424930|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
2424931|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424932|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424933|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2424934|NCT00830323|Analgesics|analgesics|mesh-ancestor
2424935|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
2424936|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424937|NCT00830349|Risperidone|risperidone|mesh-list
2424938|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2424939|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
2424940|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2424941|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2424942|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424943|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2424944|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2424945|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2424946|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2424947|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2424948|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
2424949|NCT00830401|Doxycycline|doxycycline|mesh-list
2424950|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2424951|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424952|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
2424953|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2424954|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2424955|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2424956|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
2424957|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2424958|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2424959|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2424960|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
2424961|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2424962|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424963|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2424964|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2424965|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2424966|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2424967|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424968|NCT00830466|Sirolimus|sirolimus|mesh-list
2424969|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2424970|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2424971|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2424972|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2424973|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
2424974|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2424975|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
2424976|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424977|NCT00830492|Clomiphene|clomiphene|mesh-list
2424978|NCT00830492|Enclomiphene|enclomiphene|mesh-list
2424979|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
2424980|NCT00830492|Buserelin|buserelin|mesh-list
2424981|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2424982|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
2424983|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2424984|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424985|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2424986|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
2424987|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2424988|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2424989|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2424990|NCT00830505|Fluticasone|fluticasone|mesh-list
2424991|NCT00830505|Xhance|xhance|mesh-list
2424992|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2424993|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2424994|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2424995|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2424996|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
2424997|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2424998|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2424999|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2425000|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
2425001|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
2425002|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2425003|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2425004|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2425005|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2425006|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
2425007|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425008|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425009|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
2425010|NCT00830505|Hormones|hormones|mesh-ancestor
2425011|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2425012|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
2425013|NCT00830531|Bumetanide|bumetanide|mesh-list
2425014|NCT00830531|Diuretics|diuretics|mesh-ancestor
2425015|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
2425016|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425017|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2425018|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2425019|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425020|NCT00830570|Warfarin|warfarin|mesh-list
2425021|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
2425022|NCT00830609|Ribavirin|ribavirin|mesh-list
2425023|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2425024|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
2425025|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
2425026|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425027|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
2425028|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425029|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
2425030|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425031|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
2425032|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2425033|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
2425034|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425035|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
2425036|NCT00830830|Protective Agents|protective agents|mesh-ancestor
2425037|NCT00830843|Propofol|propofol|mesh-list
2425038|NCT00830843|Isoflurane|isoflurane|mesh-list
2425039|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2425040|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2425041|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425042|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2425043|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
2425044|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
2425045|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2425046|NCT00830856|Lamivudine|lamivudine|mesh-list
2425047|NCT00830856|Nevirapine|nevirapine|mesh-list
2425048|NCT00830856|Stavudine|stavudine|mesh-list
2425049|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
2425050|NCT00830856|Fluconazole|fluconazole|mesh-list
2425051|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2425052|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2425053|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425054|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425055|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
2425056|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425057|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2425058|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2425059|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2425060|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2425061|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
2425062|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2425063|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2206595|NCT00006669|Rituximab|rituximab|mesh-list
2206596|NCT00006669|Doxorubicin|doxorubicin|mesh-list
2206597|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2206598|NCT00006669|Etoposide|etoposide|mesh-list
2206599|NCT00006669|Vincristine|vincristine|mesh-list
2206600|NCT00006669|Sargramostim|sargramostim|mesh-list
2206601|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206602|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
2206603|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206604|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2206605|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2206606|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
2206607|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425064|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2425065|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
2425066|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2425067|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425068|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2425069|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2425070|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
2425071|NCT00830882|Albuterol|albuterol|mesh-list
2425072|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2425073|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
2425074|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425075|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425076|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2425077|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
2425078|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
2425079|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2425080|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2425081|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2425082|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2425083|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
2425084|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425085|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425086|NCT00830895|Everolimus|everolimus|mesh-list
2425087|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425088|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2425089|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
2425090|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425091|NCT00831051|Morphine|morphine|mesh-list
2425092|NCT00831051|Oxycodone|oxycodone|mesh-list
2425093|NCT00831051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2425094|NCT00831051|Narcotics|narcotics|mesh-ancestor
2425095|NCT00831051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2425096|NCT00831051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425097|NCT00831051|Analgesics|analgesics|mesh-ancestor
2425098|NCT00831051|Sensory System Agents|sensory system agents|mesh-ancestor
2425099|NCT00831051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425100|NCT00831103|Valacyclovir|valacyclovir|mesh-list
2425101|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
2425102|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425103|NCT00831155|Nicotine|nicotine|mesh-list
2425104|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2425105|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
2425106|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425107|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425108|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2425109|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2425110|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
2425111|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425112|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206608|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206609|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2206610|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2206611|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2206612|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2206613|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2206614|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206615|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2206616|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
2206617|NCT00006669|Hormones|hormones|mesh-ancestor
2206618|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2206619|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2206620|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2425113|NCT00831350|Ranibizumab|ranibizumab|mesh-list
2425114|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2425115|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2425116|NCT00831350|Growth Substances|growth substances|mesh-ancestor
2425117|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425118|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
2425119|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425120|NCT00831376|Albuterol|albuterol|mesh-list
2425121|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2425122|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
2425123|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425124|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425125|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2425126|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
2425127|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
2425128|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2425129|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2425130|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2425131|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2425132|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
2425133|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425134|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425135|NCT00831506|Digoxin|digoxin|mesh-list
2425136|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2425137|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2425138|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425139|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425140|NCT00831506|Protective Agents|protective agents|mesh-ancestor
2425141|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425142|NCT00831545|Temozolomide|temozolomide|mesh-list
2425143|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2425144|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
2425145|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206621|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
2206622|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
2206623|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
2206624|NCT00006682|Docetaxel|docetaxel|mesh-list
2206625|NCT00006682|Vinorelbine|vinorelbine|mesh-list
2206626|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206627|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
2206628|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
2206629|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
2206630|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206631|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2425146|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425147|NCT00831597|Rituximab|rituximab|mesh-list
2425148|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2425149|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2425150|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425151|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
2425152|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425153|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2425154|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2425155|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
2425156|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425157|NCT00831636|Cytarabine|cytarabine|mesh-list
2425158|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2425159|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
2425160|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425161|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425162|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
2425163|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425164|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2425165|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
2425166|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425167|NCT00831649|Natalizumab|natalizumab|mesh-list
2425168|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
2425169|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425170|NCT00831662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2425171|NCT00831662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2425172|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
2425173|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2425174|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
2425175|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2425176|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
2425177|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425178|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425179|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
2425180|NCT00831857|Bevacizumab|bevacizumab|mesh-list
2425181|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
2425182|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2425183|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425184|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2425185|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2425186|NCT00831857|Growth Substances|growth substances|mesh-ancestor
2425187|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425188|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
2425189|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2425190|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425191|NCT00832013|Propofol|propofol|mesh-list
2425192|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2425193|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2425194|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425195|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2425196|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
2425197|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
2425198|NCT00832039|Selenious Acid|selenious acid|mesh-list
2425199|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
2425200|NCT00832039|Trace Elements|trace elements|mesh-ancestor
2425201|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
2425202|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425203|NCT00832182|Insulin|insulin|mesh-list
2425204|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2425205|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
2425206|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
2425207|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
2425208|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
2425209|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2425210|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425211|NCT00832208|Amphotericin B|amphotericin b|mesh-list
2425212|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2425213|NCT00832208|Amebicides|amebicides|mesh-ancestor
2425214|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2425215|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2425216|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425217|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2425218|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
2425219|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2425220|NCT00832221|Raclopride|raclopride|mesh-list
2425221|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
2425222|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2425223|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2425224|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2425225|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2425226|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425227|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2425228|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
2425229|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425230|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425231|NCT00832234|Dexamethasone|dexamethasone|mesh-list
2425232|NCT00832234|Rituximab|rituximab|mesh-list
2425233|NCT00832234|Bortezomib|bortezomib|mesh-list
2425234|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2425235|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
2425236|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
2425237|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425238|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425239|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2425240|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
2425241|NCT00832234|Hormones|hormones|mesh-ancestor
2425242|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2425243|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2425244|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425245|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2425246|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
2425247|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2425248|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
2425249|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2425250|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425251|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2425252|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2425253|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206632|NCT00006695|Iodine|iodine|mesh-list
2206633|NCT00006695|Cytarabine|cytarabine|mesh-list
2206634|NCT00006695|Etoposide|etoposide|mesh-list
2206635|NCT00006695|Melphalan|melphalan|mesh-list
2206636|NCT00006695|Carmustine|carmustine|mesh-list
2206637|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
2206638|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206639|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206640|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2206641|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2206642|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206643|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425254|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425255|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425256|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2425257|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2425258|NCT00832364|Etanercept|etanercept|mesh-list
2425259|NCT00832364|Acitretin|acitretin|mesh-list
2425260|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2425261|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2425262|NCT00832364|Analgesics|analgesics|mesh-ancestor
2425263|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
2425264|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425265|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425266|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2425267|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2425268|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2425269|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2425270|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
2425271|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
2425272|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
2425273|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2425274|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2425275|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425276|NCT00832442|Metoprolol|metoprolol|mesh-list
2425277|NCT00832442|Carvedilol|carvedilol|mesh-list
2425278|NCT00832442|Nebivolol|nebivolol|mesh-list
2425279|NCT00832442|Bisoprolol|bisoprolol|mesh-list
2425280|NCT00832442|Bucindolol|bucindolol|mesh-list
2425281|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2425282|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2425283|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2425284|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
2425285|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
2425286|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425287|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425288|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2425289|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2425290|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
2425291|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425292|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425293|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
2425294|NCT00832442|Protective Agents|protective agents|mesh-ancestor
2425295|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2425296|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2425297|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2425298|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
2425299|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2425300|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2425301|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2425302|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2425303|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2425304|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
2425305|NCT00832481|Metformin|metformin|mesh-list
2425306|NCT00832481|Repaglinide|repaglinide|mesh-list
2425307|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2425308|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425309|NCT00832494|Paclitaxel|paclitaxel|mesh-list
2425310|NCT00832494|Carboplatin|carboplatin|mesh-list
2425311|NCT00832494|Vadimezan|vadimezan|mesh-list
2425312|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2425313|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425314|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
2425315|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
2425316|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
2425317|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425318|NCT00832507|Cicletanine|cicletanine|mesh-list
2425319|NCT00832507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2425320|NCT00832507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2425321|NCT00832507|Diuretics|diuretics|mesh-ancestor
2425322|NCT00832507|Natriuretic Agents|natriuretic agents|mesh-ancestor
2425323|NCT00832507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425324|NCT00832689|Gemcitabine|gemcitabine|mesh-list
2425325|NCT00832689|Irinotecan|irinotecan|mesh-list
2425326|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2425327|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
2425328|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425329|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425330|NCT00832689|Antiviral Agents|antiviral agents|mesh-ancestor
2425331|NCT00832689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425332|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425333|NCT00832689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2425334|NCT00832689|Immunologic Factors|immunologic factors|mesh-ancestor
2425335|NCT00832689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425336|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2425337|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2425338|NCT00832806|Varenicline|varenicline|mesh-list
2425339|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2425340|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2425341|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
2425342|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425343|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425344|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425345|NCT00832884|Lacosamide|lacosamide|mesh-list
2425346|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
2425347|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2425348|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2425349|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2425350|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425351|NCT00833079|Tacrolimus|tacrolimus|mesh-list
2425352|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2425353|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
2425354|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425355|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2425356|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425357|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425358|NCT00833157|Ibuprofen|ibuprofen|mesh-list
2425359|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2425360|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2425361|NCT00833157|Analgesics|analgesics|mesh-ancestor
2425362|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
2425363|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425364|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425365|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2425366|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2425367|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2425368|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425369|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425370|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
2425371|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2425372|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2425373|NCT00833300|Haloperidol|haloperidol|mesh-list
2425374|NCT00833300|Olanzapine|olanzapine|mesh-list
2425375|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
2425376|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
2425377|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
2425378|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425379|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425380|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2425381|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2425382|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2425383|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2425384|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2425385|NCT00833300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2425386|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2425387|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2425388|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425389|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425390|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
2425391|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2425392|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
2425393|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2425394|NCT00833326|Docetaxel|docetaxel|mesh-list
2425395|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
2206644|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2206645|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
2206646|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
2206647|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206648|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206649|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
2206650|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206651|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2206652|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
2206653|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2206654|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2206655|NCT00006695|Trace Elements|trace elements|mesh-ancestor
2206656|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
2206657|NCT00006708|Rituximab|rituximab|mesh-list
2206658|NCT00006708|Carboplatin|carboplatin|mesh-list
2206659|NCT00006708|Etoposide|etoposide|mesh-list
2206660|NCT00006708|Ifosfamide|ifosfamide|mesh-list
2425396|NCT00833326|Mitogens|mitogens|mesh-list
2425397|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425398|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
2425399|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
2425400|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425401|NCT00833339|Mifepristone|mifepristone|mesh-list
2425402|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2425403|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
2425404|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2425405|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425406|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2425407|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2425408|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2425409|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
2425410|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2425411|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2425412|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
2425413|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2425414|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
2425415|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2425416|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2425417|NCT00833378|Ritonavir|ritonavir|mesh-list
2425418|NCT00833378|Lopinavir|lopinavir|mesh-list
2425419|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2425420|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2425421|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
2425422|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425423|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425424|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2425425|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2425426|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
2425427|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425428|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2425429|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2425430|NCT00833404|Nicotine|nicotine|mesh-list
2425431|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2425432|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
2425433|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425434|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425435|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2425436|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2425437|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
2425438|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425439|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425440|NCT00833495|Prednisolone|prednisolone|mesh-list
2425441|NCT00833495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2425442|NCT00833495|Methylprednisolone|methylprednisolone|mesh-list
2425443|NCT00833495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2425444|NCT00833495|Prednisolone acetate|prednisolone acetate|mesh-list
2425445|NCT00833495|Prednisone|prednisone|mesh-list
2425446|NCT00833495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2425447|NCT00833495|Prednisolone phosphate|prednisolone phosphate|mesh-list
2425448|NCT00833495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2425449|NCT00833495|Glucocorticoids|glucocorticoids|mesh-ancestor
2206661|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2206662|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425450|NCT00833495|Hormones|hormones|mesh-ancestor
2425451|NCT00833495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2425452|NCT00833495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425453|NCT00833495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2425454|NCT00833495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425455|NCT00833495|Antiemetics|antiemetics|mesh-ancestor
2425456|NCT00833495|Autonomic Agents|autonomic agents|mesh-ancestor
2425457|NCT00833495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425458|NCT00833495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2425459|NCT00833495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2425460|NCT00833495|Protective Agents|protective agents|mesh-ancestor
2425461|NCT00833534|Rituximab|rituximab|mesh-list
2425462|NCT00833534|Lenalidomide|lenalidomide|mesh-list
2425463|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2425464|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425465|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
2425466|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425467|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2425468|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2425469|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2425470|NCT00833534|Growth Substances|growth substances|mesh-ancestor
2425471|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
2425472|NCT00833729|Etanercept|etanercept|mesh-list
2425473|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2425474|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2425475|NCT00833729|Analgesics|analgesics|mesh-ancestor
2425476|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
2425477|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425478|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425479|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2425480|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2425481|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2425482|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2425483|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
2425484|NCT00833768|Sevelamer|sevelamer|mesh-list
2425485|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
2425486|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
2425487|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425488|NCT00833807|Paclitaxel|paclitaxel|mesh-list
2425489|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2425490|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2425491|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425492|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
2425493|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
2425494|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
2425495|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425496|NCT00833963|Trastuzumab|trastuzumab|mesh-list
2425497|NCT00833963|Pertuzumab|pertuzumab|mesh-list
2425498|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2425499|NCT00833963|Maytansine|maytansine|mesh-list
2425500|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2425501|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206663|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
2206664|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206665|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2206666|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206667|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2206668|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2206669|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206670|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425502|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2425503|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
2425504|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
2425505|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
2425506|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425507|NCT00834093|Vaccines|vaccines|mesh-list
2425508|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
2425509|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425510|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
2425511|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2425512|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
2425513|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2425514|NCT00834184|Nikkomycin|nikkomycin|mesh-list
2425515|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
2425516|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425517|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425518|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425519|NCT00834262|Insulin|insulin|mesh-list
2425520|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2425521|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
2425522|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
2425523|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2425524|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
2425525|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2425526|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2425527|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425528|NCT00834379|Pravastatin|pravastatin|mesh-list
2425529|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2425530|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2425531|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
2425532|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425533|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2425534|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2425535|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425536|NCT00834457|Ritonavir|ritonavir|mesh-list
2425537|NCT00834457|Lopinavir|lopinavir|mesh-list
2425538|NCT00834457|Zidovudine|zidovudine|mesh-list
2425539|NCT00834457|Lamivudine|lamivudine|mesh-list
2425540|NCT00834457|Abacavir|abacavir|mesh-list
2425541|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
2425542|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2425543|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2425544|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
2425545|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425546|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425547|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2425548|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2206671|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2206672|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
2206673|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
2206674|NCT00006734|Ifosfamide|ifosfamide|mesh-list
2206675|NCT00006734|Doxorubicin|doxorubicin|mesh-list
2206676|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2206677|NCT00006734|Etoposide|etoposide|mesh-list
2206678|NCT00006734|Vincristine|vincristine|mesh-list
2206679|NCT00006734|Lenograstim|lenograstim|mesh-list
2206680|NCT00006734|Sargramostim|sargramostim|mesh-list
2425549|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
2425550|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425551|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2425552|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2425553|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
2425554|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2425555|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2425556|NCT00834470|Atropine|atropine|mesh-list
2425557|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2425558|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2425559|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2425560|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
2425561|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425562|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425563|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2425564|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
2425565|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
2425566|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
2425567|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2425568|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2425569|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
2425570|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425571|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425572|NCT00834600|Amlodipine|amlodipine|mesh-list
2425573|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2425574|NCT00834600|Olmesartan|olmesartan|mesh-list
2425575|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2425576|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2425577|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2425578|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2425579|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425580|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2425581|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206681|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206682|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
2425582|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
2425583|NCT00834600|Diuretics|diuretics|mesh-ancestor
2425584|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
2425585|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2425586|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2425587|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2425588|NCT00834665|Molgramostim|molgramostim|mesh-list
2425589|NCT00834665|Sargramostim|sargramostim|mesh-list
2425590|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
2425591|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425592|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425593|NCT00834730|Ketamine|ketamine|mesh-list
2425594|NCT00834730|Analgesics|analgesics|mesh-ancestor
2425595|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
2425596|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425597|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425598|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2425599|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2425600|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
2425601|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
2425602|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2425603|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2425604|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2425605|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425606|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425607|NCT00834847|Pravastatin|pravastatin|mesh-list
2425608|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2425609|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2425610|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
2425611|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425612|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2425613|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2425614|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425615|NCT00834860|Ribavirin|ribavirin|mesh-list
2425616|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2425617|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
2425618|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425619|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
2425620|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425621|NCT00834925|Diltiazem|diltiazem|mesh-list
2425622|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2425623|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2425624|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2425625|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425626|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2425627|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425628|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
2425629|NCT00835029|Clotrimazole|clotrimazole|mesh-list
2425630|NCT00835029|Miconazole|miconazole|mesh-list
2425631|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2425632|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425633|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
2425634|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2425635|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2425636|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425637|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425638|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2425639|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
2425640|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2425641|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425642|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2425643|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2425644|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
2425645|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2206683|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206684|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2206685|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2206686|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
2206687|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206688|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206689|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2206690|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2425646|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
2425647|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2425648|NCT00835107|Ziprasidone|ziprasidone|mesh-list
2425649|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2425650|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
2425651|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425652|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425653|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425654|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2425655|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2425656|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2425657|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2425658|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2425659|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
2425660|NCT00835393|Pantoprazole|pantoprazole|mesh-list
2425661|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2425662|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2425663|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2425664|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425665|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425666|NCT00835471|Docetaxel|docetaxel|mesh-list
2425667|NCT00835471|Pemetrexed|pemetrexed|mesh-list
2425668|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2425669|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425670|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
2425671|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
2425672|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
2425673|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425674|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425675|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2425676|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2425677|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2425678|NCT00835627|Sertraline|sertraline|mesh-list
2425679|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
2425680|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2425681|NCT00835627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2425682|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2425683|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2425684|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425685|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425686|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
2425687|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425688|NCT00835744|Clomiphene|clomiphene|mesh-list
2425689|NCT00835744|Enclomiphene|enclomiphene|mesh-list
2425690|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
2425691|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2425692|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
2425693|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2425694|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425695|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2425696|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
2425697|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2425698|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2425699|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2425700|NCT00835848|Exenatide|exenatide|mesh-list
2425701|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2425702|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425703|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2425704|NCT00835848|Incretins|incretins|mesh-ancestor
2425705|NCT00835848|Hormones|hormones|mesh-ancestor
2425706|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2425707|NCT00835939|Lidocaine|lidocaine|mesh-list
2425708|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
2425709|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
2425710|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2425711|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425712|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
2425713|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425714|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2425715|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2425716|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2425717|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2425718|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425719|NCT00835965|Dexamethasone|dexamethasone|mesh-list
2425720|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
2425721|NCT00835965|Aprepitant|aprepitant|mesh-list
2425722|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
2425723|NCT00835965|BB 1101|bb 1101|mesh-list
2425724|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2425725|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
2425726|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
2425727|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425728|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425729|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2425730|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
2425731|NCT00835965|Hormones|hormones|mesh-ancestor
2425732|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2425733|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2425734|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425735|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
2425736|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425737|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425738|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2425739|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425740|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
2425741|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2425742|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425743|NCT00836069|Paroxetine|paroxetine|mesh-list
2425744|NCT00836069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2425745|NCT00836069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2425746|NCT00836069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2425747|NCT00836069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425748|NCT00836069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425749|NCT00836069|Serotonin Agents|serotonin agents|mesh-ancestor
2425750|NCT00836069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425751|NCT00836069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2425752|NCT00836069|Antidepressive Agents|antidepressive agents|mesh-ancestor
2425753|NCT00836069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2425754|NCT00836069|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2425755|NCT00836069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2425756|NCT00836069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425757|NCT00836134|Bupivacaine|bupivacaine|mesh-list
2425758|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
2425759|NCT00836134|Anesthetics|anesthetics|mesh-list
2425760|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2425761|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425762|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
2425763|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425764|NCT00836199|Vaccines|vaccines|mesh-list
2425765|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
2425766|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425767|NCT00836212|Efavirenz|efavirenz|mesh-list
2425768|NCT00836212|Lopinavir|lopinavir|mesh-list
2425769|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2425770|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2425771|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425772|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425773|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
2425774|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425775|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2425776|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2425777|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2425778|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2425779|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2425780|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2425781|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2425782|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2425783|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
2425784|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2425785|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2425786|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2425787|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
2425788|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
2425789|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
2425790|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2425791|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425792|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
2425793|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425794|NCT00836368|Vitamin E|vitamin e|mesh-list
2425795|NCT00836368|Tocopherols|tocopherols|mesh-list
2425796|NCT00836368|Tocotrienols|tocotrienols|mesh-list
2425797|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
2425798|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
2425799|NCT00836368|Vitamins|vitamins|mesh-ancestor
2425800|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
2425801|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425802|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
2425803|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425804|NCT00836368|Protective Agents|protective agents|mesh-ancestor
2425805|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2425806|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2425807|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2425808|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
2425809|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425810|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425811|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425812|NCT00836381|Urological Agents|urological agents|mesh-ancestor
2425813|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2425814|NCT00836485|Ketotifen|ketotifen|mesh-list
2425815|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
2425816|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2425817|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2425818|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2425819|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2425820|NCT00836485|Analgesics|analgesics|mesh-ancestor
2425821|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
2425822|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425823|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425824|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2425825|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2425826|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2425827|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2425828|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2425829|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
2425830|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
2425831|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425832|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425833|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
2425834|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
2425835|NCT00836537|Benazepril|benazepril|mesh-list
2425836|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2425837|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
2425838|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425839|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425840|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2425841|NCT00836576|Benazepril|benazepril|mesh-list
2425842|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2425843|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
2425844|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425845|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425846|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2425847|NCT00836628|Busulfan|busulfan|mesh-list
2425848|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
2425849|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425850|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2425851|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
2425852|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425853|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2425854|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425855|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2425856|NCT00836654|Catumaxomab|catumaxomab|mesh-list
2425857|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2425858|NCT00836667|Sertraline|sertraline|mesh-list
2425859|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
2425860|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2425861|NCT00836667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2425862|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2425863|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2425864|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425865|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425866|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
2425867|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425868|NCT00836823|Alfuzosin|alfuzosin|mesh-list
2425869|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2425870|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2425871|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2425872|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
2425873|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425874|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425875|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425876|NCT00836823|Urological Agents|urological agents|mesh-ancestor
2425877|NCT00836849|Sertraline|sertraline|mesh-list
2425878|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
2425879|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2425880|NCT00836849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2425881|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2425882|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2425883|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425884|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425885|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
2425886|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425887|NCT00836914|Idelalisib|idelalisib|mesh-list
2425888|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425889|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425890|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425891|NCT00837044|Naproxen|naproxen|mesh-list
2425892|NCT00837044|Sumatriptan|sumatriptan|mesh-list
2425893|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2425894|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2425895|NCT00837044|Analgesics|analgesics|mesh-ancestor
2425896|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
2425897|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425898|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425899|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2425900|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2425901|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
2425902|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2425903|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425904|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425905|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2425906|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2425907|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2425908|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
2425909|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425910|NCT00837135|Vaccines|vaccines|mesh-list
2425911|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
2425912|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206691|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2206692|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2206693|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206694|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206695|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2206696|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
2206697|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
2425913|NCT00837174|Bortezomib|bortezomib|mesh-list
2425914|NCT00837174|Vorinostat|vorinostat|mesh-list
2425915|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425916|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2206698|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
2206699|NCT00006747|Cytarabine|cytarabine|mesh-list
2206700|NCT00006747|Methotrexate|methotrexate|mesh-list
2206701|NCT00006747|Etoposide|etoposide|mesh-list
2206702|NCT00006747|Melphalan|melphalan|mesh-list
2206703|NCT00006747|Carmustine|carmustine|mesh-list
2206704|NCT00006747|Tacrolimus|tacrolimus|mesh-list
2206705|NCT00006747|Sargramostim|sargramostim|mesh-list
2206706|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2206707|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
2206708|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2206709|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206710|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2206711|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
2206712|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206713|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206714|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
2206715|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425917|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425918|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425919|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
2425920|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2425921|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2425922|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425923|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2425924|NCT00837187|Analgesics|analgesics|mesh-ancestor
2425925|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
2425926|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2425927|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2425928|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2425929|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2425930|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
2425931|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425932|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425933|NCT00837239|Gemcitabine|gemcitabine|mesh-list
2425934|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2425935|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
2425936|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425937|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425938|NCT00837239|Antiviral Agents|antiviral agents|mesh-ancestor
2425939|NCT00837239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425940|NCT00837239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425941|NCT00837239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2425942|NCT00837239|Immunologic Factors|immunologic factors|mesh-ancestor
2425943|NCT00837239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425944|NCT00837265|Docetaxel|docetaxel|mesh-list
2425945|NCT00837265|Doxorubicin|doxorubicin|mesh-list
2425946|NCT00837265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2425947|NCT00837265|Tubulin Modulators|tubulin modulators|mesh-ancestor
2425948|NCT00837265|Antimitotic Agents|antimitotic agents|mesh-ancestor
2425949|NCT00837265|Mitosis Modulators|mitosis modulators|mesh-ancestor
2425950|NCT00837265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425951|NCT00837265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2425952|NCT00837265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2425953|NCT00837265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2425954|NCT00837265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2425955|NCT00837317|Phenol|phenol|mesh-list
2425956|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2425957|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2425958|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
2425959|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
2425960|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2425961|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2425962|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
2425963|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2425964|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2425965|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2425966|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2425967|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425968|NCT00837369|Regadenoson|regadenoson|mesh-list
2425969|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2425970|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2425971|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
2425972|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
2425973|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425974|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425975|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425976|NCT00837564|Citalopram|citalopram|mesh-list
2425977|NCT00837564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2425978|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2425979|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2425980|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425981|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2425982|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
2425983|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425984|NCT00837564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2425985|NCT00837564|Antidepressive Agents|antidepressive agents|mesh-ancestor
2425986|NCT00837564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2425987|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
2425988|NCT00837655|Calcium|calcium|mesh-list
2425989|NCT00837655|Sevelamer|sevelamer|mesh-list
2425990|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2425991|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2425992|NCT00837655|Antacids|antacids|mesh-ancestor
2425993|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2425994|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2425995|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
2425996|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
2425997|NCT00837707|Aripiprazole|aripiprazole|mesh-list
2425998|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
2425999|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2426000|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2426001|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2426002|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2426003|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426004|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
2426005|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
2426006|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426007|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426008|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2426009|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2426010|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
2426011|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2426012|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2426013|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2426014|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2426015|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
2426016|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2426017|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2426018|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426019|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2426020|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426021|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2426022|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2426023|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
2426024|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2426025|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
2426026|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426027|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
2426028|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
2426029|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
2426030|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2426031|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
2426032|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
2426033|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426034|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426035|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426036|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2426037|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2426038|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
2426039|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2426040|NCT00837850|Protective Agents|protective agents|mesh-ancestor
2426041|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426042|NCT00837889|Diuretics|diuretics|mesh-list
2426043|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
2426044|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426045|NCT00837915|Loratadine|loratadine|mesh-list
2426046|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
2426047|NCT00837915|Ephedrine|ephedrine|mesh-list
2426048|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2426049|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
2426050|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426051|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426052|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2426053|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
2426054|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
2426055|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2426056|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2426057|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
2426058|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
2426059|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426060|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426061|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
2426062|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
2426063|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2426064|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2426065|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2426066|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
2426067|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
2426068|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2426069|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2426070|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
2426071|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426072|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426073|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
2426074|NCT00837941|Promethazine|promethazine|mesh-list
2426075|NCT00837941|Pregabalin|pregabalin|mesh-list
2426076|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2426077|NCT00837941|Analgesics|analgesics|mesh-ancestor
2426078|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
2426079|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426080|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426081|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
2426082|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2426083|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2426084|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426085|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2426086|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2426087|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2426088|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2426089|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2426090|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2426091|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2426092|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426093|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
2426094|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
2426095|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2426096|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2426097|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
2426098|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
2426099|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
2426100|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
2426101|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2426102|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2426103|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
2426104|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
2426105|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2426106|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
2426107|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
2426108|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
2426109|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
2426110|NCT00837954|Coagulants|coagulants|mesh-ancestor
2426111|NCT00838032|Haloperidol|haloperidol|mesh-list
2426112|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2426113|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
2426114|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
2426115|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2426116|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2426117|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2426118|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2426119|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426120|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
2426121|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
2426122|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426123|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2426124|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2426125|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
2426126|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426127|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426128|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2426129|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
2426130|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2426131|NCT00838071|Antibodies|antibodies|mesh-list
2426132|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
2426133|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426134|NCT00838214|Prednisone|prednisone|mesh-list
2426135|NCT00838214|Budesonide|budesonide|mesh-list
2426136|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2426137|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
2426138|NCT00838214|Hormones|hormones|mesh-ancestor
2426139|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2426140|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426141|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2426142|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426143|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2426144|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
2426145|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426146|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2426147|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
2426148|NCT00838227|Modafinil|modafinil|mesh-list
2426149|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2426150|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426151|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2426152|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2426153|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2426154|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426155|NCT00838240|Cytarabine|cytarabine|mesh-list
2426156|NCT00838240|Clofarabine|clofarabine|mesh-list
2426157|NCT00838240|Idarubicin|idarubicin|mesh-list
2426158|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2426159|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
2426160|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426161|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426162|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
2426163|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426164|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2426165|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
2426166|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426167|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2426168|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2426169|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2426170|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426171|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
2426172|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2426173|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426174|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
2426175|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426176|NCT00838266|Protective Agents|protective agents|mesh-ancestor
2426177|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426178|NCT00838305|Citalopram|citalopram|mesh-list
2426179|NCT00838305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2426180|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2426181|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2426182|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426183|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426184|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
2426185|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206716|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2206717|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206718|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
2206719|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2206720|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2206721|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2426186|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2426187|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
2426188|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2426189|NCT00838357|Plerixafor|plerixafor|mesh-list
2426190|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2426191|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2426192|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
2426193|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426194|NCT00838370|Fluorouracil|fluorouracil|mesh-list
2426195|NCT00838370|Capecitabine|capecitabine|mesh-list
2426196|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
2426197|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426198|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2426199|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426200|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2426201|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
2426202|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426203|NCT00838383|Sitaxsentan|sitaxsentan|mesh-list
2426204|NCT00838383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2426205|NCT00838383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426206|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
2206722|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2426207|NCT00838396|Baclofen|baclofen|mesh-list
2426208|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2426209|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426210|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2426211|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426212|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2426213|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
2426214|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
2426215|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426216|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426217|NCT00838656|Gemcitabine|gemcitabine|mesh-list
2426218|NCT00838656|Paclitaxel|paclitaxel|mesh-list
2426219|NCT00838656|Carboplatin|carboplatin|mesh-list
2426220|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2426221|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426222|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
2426223|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
2426224|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
2426225|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426226|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2426227|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
2426228|NCT00838656|Antiviral Agents|antiviral agents|mesh-ancestor
2426229|NCT00838656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426230|NCT00838656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426231|NCT00838656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2426232|NCT00838656|Immunologic Factors|immunologic factors|mesh-ancestor
2426233|NCT00838656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426234|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2426235|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2426236|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2426237|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2426238|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426239|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2426240|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2426241|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2426242|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
2426243|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426244|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426245|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2426246|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2426247|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
2426248|NCT00838760|Darunavir|darunavir|mesh-list
2426249|NCT00838760|TMC-310911|tmc-310911|mesh-list
2426250|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2426251|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2426252|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
2426253|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426254|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426255|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2426256|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2426257|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
2426258|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426259|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
2426260|NCT00838838|Testosterone|testosterone|mesh-list
2426261|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
2426262|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
2426263|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2426264|NCT00838838|Androgens|androgens|mesh-ancestor
2426265|NCT00838838|Hormones|hormones|mesh-ancestor
2426266|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2426267|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426268|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2426269|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426270|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
2426271|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
2426272|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2426273|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426274|NCT00838955|Sirolimus|sirolimus|mesh-list
2426275|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2426276|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426277|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2426278|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426279|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
2426280|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2426281|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
2426282|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426283|NCT00838968|Interferons|interferons|mesh-list
2426284|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
2426285|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426286|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
2426287|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426288|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
2426289|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426290|NCT00839059|Lenalidomide|lenalidomide|mesh-list
2426291|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
2426292|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426293|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2426294|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2206723|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2206724|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
2206725|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206726|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2206727|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2206728|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
2206729|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2206730|NCT00006760|Vinorelbine|vinorelbine|mesh-list
2206731|NCT00006760|Ifosfamide|ifosfamide|mesh-list
2206732|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206733|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206734|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
2206735|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
2206736|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
2206737|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206738|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2206739|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
2206740|NCT00006773|Bortezomib|bortezomib|mesh-list
2206741|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206742|NCT00006786|Leucovorin|leucovorin|mesh-list
2206743|NCT00006786|Bevacizumab|bevacizumab|mesh-list
2206744|NCT00006786|Fluorouracil|fluorouracil|mesh-list
2206745|NCT00006786|Irinotecan|irinotecan|mesh-list
2206746|NCT00006786|Calcium|calcium|mesh-list
2206747|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
2206748|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2206749|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206750|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2206751|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2206752|NCT00006786|Growth Substances|growth substances|mesh-ancestor
2206753|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426295|NCT00839059|Growth Substances|growth substances|mesh-ancestor
2426296|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
2426297|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426298|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
2426299|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
2426300|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
2426301|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426302|NCT00839085|Protective Agents|protective agents|mesh-ancestor
2426303|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426304|NCT00839085|Vitamins|vitamins|mesh-ancestor
2426305|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
2426306|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2426307|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426308|NCT00839111|Irinotecan|irinotecan|mesh-list
2426309|NCT00839111|Sorafenib|sorafenib|mesh-list
2426310|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2426311|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2426312|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426313|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426314|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426315|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2426316|NCT00839163|Vitamin K|vitamin k|mesh-list
2426317|NCT00839163|Enoxaparin|enoxaparin|mesh-list
2426318|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
2426319|NCT00839163|Vitamins|vitamins|mesh-ancestor
2426320|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
2426321|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426322|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2426323|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
2426324|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2426325|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
2426326|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426327|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426328|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
2426329|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2426330|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2426331|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2426332|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
2426333|NCT00839163|Coagulants|coagulants|mesh-ancestor
2426334|NCT00839228|Perhexiline|perhexiline|mesh-list
2426335|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2426336|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2426337|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426338|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2426339|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426340|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
2426341|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
2426342|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
2426343|NCT00839280|Vitamins|vitamins|mesh-ancestor
2426344|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
2426345|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426346|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
2426347|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2426348|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2426349|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
2206754|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
2206755|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2206756|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
2206757|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206758|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2206759|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206760|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
2206761|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2206762|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2206763|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206764|NCT00006786|Antidotes|antidotes|mesh-ancestor
2426350|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426351|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2426352|NCT00839345|Clopidogrel|clopidogrel|mesh-list
2426353|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2426354|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2426355|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2426356|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2426357|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
2426358|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426359|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426360|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426361|NCT00839358|Midodrine|midodrine|mesh-list
2426362|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
2426363|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
2426364|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426365|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426366|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2426367|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2426368|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2426369|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2426370|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
2426371|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426372|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426373|NCT00839371|Midazolam|midazolam|mesh-list
2426374|NCT00839371|Propofol|propofol|mesh-list
2426375|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2426376|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2426377|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426378|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2426379|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
2426380|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
2426381|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2426382|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2426383|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2426384|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2426385|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
2426386|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
2426387|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426388|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426389|NCT00839397|Paroxetine|paroxetine|mesh-list
2426390|NCT00839397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2426391|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2426392|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2426393|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426394|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426395|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
2426396|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426397|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2426398|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
2426399|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2426400|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2426401|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2426402|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426403|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2426404|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2426405|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2426406|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
2426407|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
2426408|NCT00839462|Vitamins|vitamins|mesh-ancestor
2426409|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
2426410|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426411|NCT00839488|Pantoprazole|pantoprazole|mesh-list
2426412|NCT00839488|Famotidine|famotidine|mesh-list
2426413|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2426414|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2426415|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2426416|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426417|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426418|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2426419|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
2426420|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
2426421|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426422|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426423|NCT00839501|Acetazolamide|acetazolamide|mesh-list
2426424|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
2426425|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2426426|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426427|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426428|NCT00839501|Diuretics|diuretics|mesh-ancestor
2426429|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
2426430|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426431|NCT00839553|Minocycline|minocycline|mesh-list
2426432|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2426433|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426434|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
2426435|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2426436|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2426437|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426438|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2426439|NCT00839605|Analgesics|analgesics|mesh-ancestor
2426440|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
2426441|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426442|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2426443|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2426444|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2426445|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
2426446|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426447|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426448|NCT00839657|Warfarin|warfarin|mesh-list
2426449|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
2426450|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
2426451|NCT00839683|Valsartan|valsartan|mesh-list
2426452|NCT00839683|Simvastatin|simvastatin|mesh-list
2426453|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2426454|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2426455|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
2426456|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426457|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2426458|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2426459|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426460|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2426461|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2426462|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2426463|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2426464|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2426465|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426466|NCT00839761|Iron|iron|mesh-list
2426467|NCT00839761|Trace Elements|trace elements|mesh-ancestor
2426468|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
2206765|NCT00006786|Protective Agents|protective agents|mesh-ancestor
2206766|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
2206767|NCT00006786|Vitamins|vitamins|mesh-ancestor
2206768|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
2206769|NCT00006799|Megestrol|megestrol|mesh-list
2206770|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
2206771|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2206772|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2206773|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2206774|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
2206775|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2206776|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206777|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2206778|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2206779|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2206780|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206781|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
2206782|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2206783|NCT00006812|Capecitabine|capecitabine|mesh-list
2206784|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2206785|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
2206786|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206787|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206788|NCT00006825|Doxorubicin|doxorubicin|mesh-list
2206789|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2206790|NCT00006825|Trastuzumab|trastuzumab|mesh-list
2206791|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2206792|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206793|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2206794|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2206795|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206796|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206797|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2206798|NCT00006864|Aldesleukin|aldesleukin|mesh-list
2206799|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426469|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426470|NCT00839787|Morphine|morphine|mesh-list
2426471|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2426472|NCT00839787|Narcotics|narcotics|mesh-ancestor
2426473|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2426474|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426475|NCT00839787|Analgesics|analgesics|mesh-ancestor
2426476|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
2426477|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426478|NCT00839826|Enoxaparin|enoxaparin|mesh-list
2426479|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
2426480|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2426481|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
2426482|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2426483|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
2426484|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426485|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426486|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
2426487|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2426488|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2426489|NCT00840112|Vitamin E|vitamin e|mesh-list
2426490|NCT00840112|Tocopherols|tocopherols|mesh-list
2426491|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
2426492|NCT00840112|Vitamins|vitamins|mesh-ancestor
2426493|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
2426494|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426495|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
2426496|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426497|NCT00840112|Protective Agents|protective agents|mesh-ancestor
2426498|NCT00840125|Docetaxel|docetaxel|mesh-list
2426499|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2426500|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426501|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
2426502|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
2426503|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
2426504|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426505|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2426506|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426507|NCT00840229|Triamcinolone|triamcinolone|mesh-list
2426508|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2426509|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2426510|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2426511|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2426512|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
2426513|NCT00840229|Hormones|hormones|mesh-ancestor
2426514|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2426515|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426516|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2426517|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
2426518|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426519|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426520|NCT00840242|Nicotine|nicotine|mesh-list
2426521|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2426522|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
2426523|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426524|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426525|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2426526|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2426527|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
2426528|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426529|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426530|NCT00840333|Levofloxacin|levofloxacin|mesh-list
2426531|NCT00840333|Ofloxacin|ofloxacin|mesh-list
2426532|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2426533|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426534|NCT00840333|Renal Agents|renal agents|mesh-ancestor
2426535|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2426536|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2426537|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2426538|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426539|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426540|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426541|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2426542|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2426543|NCT00840346|Panobinostat|panobinostat|mesh-list
2426544|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426545|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2426546|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426547|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426548|NCT00840385|Vidarabine|vidarabine|mesh-list
2426549|NCT00840385|Fludarabine|fludarabine|mesh-list
2426550|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
2426551|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426552|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2426553|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
2426554|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426555|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2426556|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
2426557|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426558|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
2426559|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426560|NCT00840398|Buspirone|buspirone|mesh-list
2426561|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2426562|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2426563|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2426564|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426565|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2426566|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2426567|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
2426568|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426569|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426570|NCT00840489|Ribavirin|ribavirin|mesh-list
2426571|NCT00840489|Colchicine|colchicine|mesh-list
2426572|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
2426573|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426574|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
2426575|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426576|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
2426577|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2426578|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
2426579|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
2426580|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
2426581|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426582|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
2426583|NCT00840580|Levofloxacin|levofloxacin|mesh-list
2426584|NCT00840580|Ofloxacin|ofloxacin|mesh-list
2426585|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2426586|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2426587|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2426588|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2426589|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426590|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2426591|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2426592|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426593|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426594|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426595|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2426596|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
2426597|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2426598|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426599|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2426600|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2426601|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2426602|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2426603|NCT00840580|Renal Agents|renal agents|mesh-ancestor
2426604|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2426605|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2426606|NCT00840606|Buspirone|buspirone|mesh-list
2426607|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2426608|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2426609|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2426610|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426611|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2426612|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2426613|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
2426614|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426615|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426616|NCT00840645|Mirabegron|mirabegron|mesh-list
2426617|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2426618|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2426619|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2426620|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
2426621|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426622|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426623|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426624|NCT00840645|Urological Agents|urological agents|mesh-ancestor
2426625|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
2426626|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2426627|NCT00840671|Protective Agents|protective agents|mesh-ancestor
2426628|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426629|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
2426630|NCT00840684|Cytarabine|cytarabine|mesh-list
2426631|NCT00840684|Melphalan|melphalan|mesh-list
2426632|NCT00840684|Busulfan|busulfan|mesh-list
2426633|NCT00840684|Daunorubicin|daunorubicin|mesh-list
2426634|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
2426635|NCT00840684|Amsacrine|amsacrine|mesh-list
2426636|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2426637|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
2426638|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426639|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426640|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
2426641|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426642|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2426643|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
2426644|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426645|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2426646|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
2426647|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2426648|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2426649|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2426650|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2426651|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426652|NCT00840684|Analgesics|analgesics|mesh-ancestor
2426653|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
2426654|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426655|NCT00840801|Vaccines|vaccines|mesh-list
2426656|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
2426657|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426658|NCT00840853|Acetaminophen|acetaminophen|mesh-list
2426659|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
2426660|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2426661|NCT00840853|Analgesics|analgesics|mesh-ancestor
2426662|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
2426663|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426664|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426665|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
2426666|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2426667|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2426668|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2426669|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
2426670|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
2426671|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
2426672|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
2426673|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2426674|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2426675|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
2426676|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
2426677|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426678|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426679|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2426680|NCT00840918|Lidocaine|lidocaine|mesh-list
2426681|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
2426682|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
2426683|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2426684|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426685|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
2426686|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426687|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2426688|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2426689|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2426690|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2426691|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426692|NCT00840931|Lenalidomide|lenalidomide|mesh-list
2426693|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
2426694|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426695|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2426696|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2426697|NCT00840931|Growth Substances|growth substances|mesh-ancestor
2426698|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
2426699|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426700|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2426701|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426702|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
2426703|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2426704|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
2426705|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2426706|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2426707|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2426708|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426709|NCT00840957|Infliximab|infliximab|mesh-list
2426710|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
2426711|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2426712|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2426713|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
2426714|NCT00841061|Trace Elements|trace elements|mesh-ancestor
2426715|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
2426716|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426717|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
2426718|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2426719|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2426720|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426721|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
2426722|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
2426723|NCT00841113|Goserelin|goserelin|mesh-list
2426724|NCT00841113|Bicalutamide|bicalutamide|mesh-list
2426725|NCT00841113|Abarelix|abarelix|mesh-list
2426726|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2426727|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426728|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
2426729|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
2426730|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2426731|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426732|NCT00841126|Iron|iron|mesh-list
2426733|NCT00841126|Trace Elements|trace elements|mesh-ancestor
2426734|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
2426735|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426736|NCT00841139|Perhexiline|perhexiline|mesh-list
2426737|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2426738|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2426739|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426740|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2426741|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426742|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
2426743|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2426744|NCT00841191|Siltuximab|siltuximab|mesh-list
2426745|NCT00841191|Antibodies|antibodies|mesh-list
2426746|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
2426747|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2426748|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
2426749|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426750|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426751|NCT00841256|Glycerol|glycerol|mesh-list
2426752|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2426753|NCT00841256|Protective Agents|protective agents|mesh-ancestor
2426754|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426755|NCT00841373|Ranibizumab|ranibizumab|mesh-list
2426756|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2426757|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2426758|NCT00841373|Growth Substances|growth substances|mesh-ancestor
2426759|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426760|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
2426761|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426762|NCT00841386|Riboflavin|riboflavin|mesh-list
2426763|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
2426764|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
2426765|NCT00841386|Vitamins|vitamins|mesh-ancestor
2426766|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
2426767|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426768|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2426769|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
2426770|NCT00841438|Abciximab|abciximab|mesh-list
2426771|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
2426772|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2426773|NCT00841477|Vaccines|vaccines|mesh-list
2426774|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
2426775|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426776|NCT00841581|Ranibizumab|ranibizumab|mesh-list
2426777|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2426778|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2426779|NCT00841581|Growth Substances|growth substances|mesh-ancestor
2426780|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426781|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
2426782|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426783|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
2426784|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
2426785|NCT00841633|Norepinephrine|norepinephrine|mesh-list
2426786|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2426787|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2426788|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
2426789|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426790|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426791|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426792|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
2426793|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
2426794|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426795|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2426796|NCT00841724|Fludarabine|fludarabine|mesh-list
2426797|NCT00841724|Busulfan|busulfan|mesh-list
2426798|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
2426799|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426800|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426801|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2426802|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
2426803|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426804|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
2426805|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2426806|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2426807|NCT00841789|Etanercept|etanercept|mesh-list
2426808|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2426809|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2426810|NCT00841789|Analgesics|analgesics|mesh-ancestor
2426811|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
2426812|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426813|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426814|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2426815|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2426816|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2426817|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2426818|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
2426819|NCT00841802|Prednisone|prednisone|mesh-list
2426820|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
2426821|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2426822|NCT00841802|Hormones|hormones|mesh-ancestor
2426823|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2426824|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426825|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2426826|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426827|NCT00841841|Acetaminophen|acetaminophen|mesh-list
2426828|NCT00841841|Dipyrone|dipyrone|mesh-list
2426829|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2426830|NCT00841841|Analgesics|analgesics|mesh-ancestor
2426831|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
2426832|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2426833|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426834|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
2426835|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2426836|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2426837|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2426838|NCT00841854|Metronidazole|metronidazole|mesh-list
2426839|NCT00841854|Tetracycline|tetracycline|mesh-list
2426840|NCT00841854|Pantoprazole|pantoprazole|mesh-list
2426841|NCT00841854|Bismuth|bismuth|mesh-list
2426842|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426843|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2426844|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2426845|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2426846|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2426847|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2426848|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2426849|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426850|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426851|NCT00841854|Antacids|antacids|mesh-ancestor
2426852|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2426853|NCT00841880|Felodipine|felodipine|mesh-list
2426854|NCT00841880|Ramipril|ramipril|mesh-list
2426855|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2426856|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
2426857|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426858|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426859|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2426860|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2426861|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2426862|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2426863|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2426864|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426865|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
2426866|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
2426867|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
2426868|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426869|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2426870|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426871|NCT00841919|Insulin|insulin|mesh-list
2426872|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2426873|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
2426874|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
2206800|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2206801|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2206802|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
2206803|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206804|NCT00006877|Temozolomide|temozolomide|mesh-list
2206805|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2206806|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
2206807|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206808|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206809|NCT00006890|Thalidomide|thalidomide|mesh-list
2206810|NCT00006890|Prednisone|prednisone|mesh-list
2206811|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2206812|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
2206813|NCT00006890|Hormones|hormones|mesh-ancestor
2206814|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2426875|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
2426876|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
2426877|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
2426878|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2426879|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426880|NCT00841945|Prednisone|prednisone|mesh-list
2426881|NCT00841945|Rituximab|rituximab|mesh-list
2426882|NCT00841945|Doxorubicin|doxorubicin|mesh-list
2426883|NCT00841945|Vincristine|vincristine|mesh-list
2426884|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2426885|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426886|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
2426887|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426888|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2426889|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2426890|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2426891|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2426892|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426893|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426894|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2426895|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
2426896|NCT00841945|Hormones|hormones|mesh-ancestor
2426897|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2426898|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2426899|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2426900|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
2426901|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
2426902|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
2426903|NCT00842114|Interferons|interferons|mesh-list
2426904|NCT00842114|Prednisone|prednisone|mesh-list
2426905|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
2426906|NCT00842114|Vincristine|vincristine|mesh-list
2426907|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2426908|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
2426909|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426910|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2426911|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2426912|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
2426913|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426914|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426915|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2426916|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2426917|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
2426918|NCT00842114|Hormones|hormones|mesh-ancestor
2426919|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2426920|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2426921|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
2426922|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426923|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2426924|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
2426925|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
2426926|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
2426927|NCT00842127|Methylphenidate|methylphenidate|mesh-list
2426928|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2426929|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426930|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2426931|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2426932|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2426933|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426934|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
2426935|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2426936|NCT00842140|Metformin|metformin|mesh-list
2426937|NCT00842140|Spironolactone|spironolactone|mesh-list
2426938|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
2426939|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
2426940|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2426941|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426942|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2426943|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2426944|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
2426945|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2426946|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2426947|NCT00842140|Diuretics|diuretics|mesh-ancestor
2426948|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
2426949|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2426950|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
2426951|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2426952|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426953|NCT00842205|Interferons|interferons|mesh-list
2426954|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426955|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
2426956|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426957|NCT00842400|Metformin|metformin|mesh-list
2426958|NCT00842400|Probenecid|probenecid|mesh-list
2426959|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2426960|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426961|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
2426962|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
2426963|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2426964|NCT00842400|Renal Agents|renal agents|mesh-ancestor
2426965|NCT00842452|Topotecan|topotecan|mesh-list
2426966|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2426967|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2426968|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426969|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206815|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206816|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2206817|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206818|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206819|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
2206820|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
2206821|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2206822|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206823|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2206824|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2206825|NCT00006890|Growth Substances|growth substances|mesh-ancestor
2206826|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
2206827|NCT00006929|Suramin|suramin|mesh-list
2206828|NCT00006929|Paclitaxel|paclitaxel|mesh-list
2206829|NCT00006929|Carboplatin|carboplatin|mesh-list
2206830|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2206831|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206832|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
2206833|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
2206834|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
2206835|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206836|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
2206837|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
2206838|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2206839|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206840|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2206841|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2206842|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
2206843|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206844|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2426970|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426971|NCT00842491|Cisplatin|cisplatin|mesh-list
2426972|NCT00842491|Capecitabine|capecitabine|mesh-list
2426973|NCT00842491|Endostar protein|endostar protein|mesh-list
2426974|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2426975|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2426976|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
2426977|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426978|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2426979|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2426980|NCT00842491|Growth Substances|growth substances|mesh-ancestor
2426981|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426982|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
2426983|NCT00842504|Micafungin|micafungin|mesh-list
2426984|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
2426985|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2426986|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2426987|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
2426988|NCT00842556|Glimepiride|glimepiride|mesh-list
2426989|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2426990|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2426991|NCT00842556|Incretins|incretins|mesh-ancestor
2426992|NCT00842556|Hormones|hormones|mesh-ancestor
2426993|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2426994|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2426995|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
2426996|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2426997|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2426998|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2426999|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2427000|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2427001|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
2427002|NCT00842582|Azacitidine|azacitidine|mesh-list
2427003|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2427004|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
2427005|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427006|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427007|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427008|NCT00842595|Prednisone|prednisone|mesh-list
2427009|NCT00842595|Rituximab|rituximab|mesh-list
2427010|NCT00842595|Vinorelbine|vinorelbine|mesh-list
2427011|NCT00842595|Ifosfamide|ifosfamide|mesh-list
2427012|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
2427013|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2427014|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427015|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
2427016|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427017|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2427018|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2427019|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
2427020|NCT00842595|Hormones|hormones|mesh-ancestor
2427021|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427022|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2427023|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2427024|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
2427025|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
2427026|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
2427027|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427028|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2427029|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
2427030|NCT00842595|Analgesics|analgesics|mesh-ancestor
2427031|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
2427032|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427033|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2427034|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2427035|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427036|NCT00842660|Gemcitabine|gemcitabine|mesh-list
2427037|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2427038|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
2427039|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427040|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427041|NCT00842660|Antiviral Agents|antiviral agents|mesh-ancestor
2427042|NCT00842660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2427043|NCT00842660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427044|NCT00842660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206845|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
2206846|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206847|NCT00006968|Cyclosporine|cyclosporine|mesh-list
2206848|NCT00006968|Pentostatin|pentostatin|mesh-list
2206849|NCT00006968|Cyclosporins|cyclosporins|mesh-list
2206850|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
2206851|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206852|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206853|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206854|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2206855|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
2206856|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206857|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
2206858|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2206859|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2206860|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206861|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2206862|NCT00006981|Immunotoxins|immunotoxins|mesh-list
2206863|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
2206864|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206865|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
2206866|NCT00007033|Analgesics|analgesics|mesh-ancestor
2427045|NCT00842660|Immunologic Factors|immunologic factors|mesh-ancestor
2427046|NCT00842660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427047|NCT00842686|Bevacizumab|bevacizumab|mesh-list
2427048|NCT00842686|Capecitabine|capecitabine|mesh-list
2427049|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2427050|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427051|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2427052|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2427053|NCT00842686|Growth Substances|growth substances|mesh-ancestor
2427054|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427055|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
2427056|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2427057|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
2427058|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427059|NCT00842894|Insulin|insulin|mesh-list
2427060|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2427061|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
2427062|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
2427063|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
2427064|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2427065|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2427066|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427067|NCT00842907|Tretinoin|tretinoin|mesh-list
2427068|NCT00842907|Isotretinoin|isotretinoin|mesh-list
2427069|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427070|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
2427071|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
2427072|NCT00842920|Simvastatin|simvastatin|mesh-list
2427073|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2427074|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2427075|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
2427076|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427077|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2427078|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2427079|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427080|NCT00842933|Prednisone|prednisone|mesh-list
2427081|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
2427082|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
2427083|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2427084|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2427085|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2427086|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2427087|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
2427088|NCT00842933|Hormones|hormones|mesh-ancestor
2427089|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427090|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427091|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2427092|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427093|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
2427094|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
2427095|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427096|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2427097|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2427098|NCT00842933|Protective Agents|protective agents|mesh-ancestor
2427099|NCT00842998|Trastuzumab|trastuzumab|mesh-list
2427100|NCT00842998|Lapatinib|lapatinib|mesh-list
2427101|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2427102|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427103|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2427104|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427105|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427106|NCT00843063|Pantoprazole|pantoprazole|mesh-list
2427107|NCT00843063|Famotidine|famotidine|mesh-list
2427108|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2427109|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2427110|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2427111|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427112|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427113|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2427114|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
2427115|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
2427116|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427117|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427118|NCT00843154|Candesartan|candesartan|mesh-list
2206867|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
2206868|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2206869|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206870|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
2206871|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2206872|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2206873|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
2206874|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2427119|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2427120|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2427121|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2427122|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427123|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
2427124|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2427125|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
2427126|NCT00843362|Dinoprostone|dinoprostone|mesh-list
2427127|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
2427128|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2427129|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206875|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2206876|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206877|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2427130|NCT00843440|Bevacizumab|bevacizumab|mesh-list
2427131|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2427132|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427133|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2427134|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2427135|NCT00843440|Growth Substances|growth substances|mesh-ancestor
2427136|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427137|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
2427138|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
2427139|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
2427140|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
2427141|NCT00843453|Vitamins|vitamins|mesh-ancestor
2427142|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
2427143|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427144|NCT00843453|Hematinics|hematinics|mesh-ancestor
2427145|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2427146|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2427147|NCT00843570|Nafarelin|nafarelin|mesh-list
2427148|NCT00843570|Estradiol|estradiol|mesh-list
2427149|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2427150|NCT00843570|Progesterone|progesterone|mesh-list
2427151|NCT00843570|Estrogens|estrogens|mesh-ancestor
2427152|NCT00843570|Hormones|hormones|mesh-ancestor
2427153|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427154|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427155|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2427156|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
2427157|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2427158|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2427159|NCT00843570|Progestins|progestins|mesh-ancestor
2427160|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2427161|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
2427162|NCT00843661|Ezetimibe|ezetimibe|mesh-list
2427163|NCT00843661|Pravastatin|pravastatin|mesh-list
2427164|NCT00843661|Fenofibrate|fenofibrate|mesh-list
2427165|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2427166|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2427167|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
2427168|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427169|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2206878|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
2206879|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2206880|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
2206881|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2427170|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2427171|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427172|NCT00843687|Risperidone|risperidone|mesh-list
2206882|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206883|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2206884|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
2206885|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2206886|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206887|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206888|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206889|NCT00007189|Celecoxib|celecoxib|mesh-list
2206890|NCT00007189|Naproxen|naproxen|mesh-list
2206891|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2206892|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2206893|NCT00007189|Analgesics|analgesics|mesh-ancestor
2206894|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
2206895|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427173|NCT00843687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2427174|NCT00843687|Serotonin Agents|serotonin agents|mesh-ancestor
2427175|NCT00843687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427176|NCT00843687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427177|NCT00843687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427178|NCT00843687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2427179|NCT00843687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2427180|NCT00843687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2427181|NCT00843687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2427182|NCT00843687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2427183|NCT00843687|Dopamine Agents|dopamine agents|mesh-ancestor
2427184|NCT00843791|Pioglitazone|pioglitazone|mesh-list
2427185|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
2427186|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2427187|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427188|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2427189|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
2427190|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427191|NCT00843908|Imidacloprid|imidacloprid|mesh-list
2427192|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
2427193|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2206896|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206897|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2206898|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2206899|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2206900|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2206901|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206902|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206903|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
2206904|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2206905|NCT00007202|Stavudine|stavudine|mesh-list
2206906|NCT00007202|Didanosine|didanosine|mesh-list
2206907|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2206908|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2206909|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
2206910|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427194|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427195|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427196|NCT00843934|Epirubicin|epirubicin|mesh-list
2427197|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427198|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2427199|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2427200|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2427201|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427202|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427203|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2427204|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2427205|NCT00844012|Estradiol|estradiol|mesh-list
2427206|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2427207|NCT00844012|Estrogens|estrogens|mesh-ancestor
2427208|NCT00844012|Hormones|hormones|mesh-ancestor
2427209|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427210|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427211|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2427212|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
2427213|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2427214|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2427215|NCT00844064|Trabedersen|trabedersen|mesh-list
2427216|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427217|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
2427218|NCT00844142|Etanercept|etanercept|mesh-list
2427219|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2427220|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2427221|NCT00844142|Analgesics|analgesics|mesh-ancestor
2427222|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
2427223|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427224|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427225|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2427226|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2427227|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2427228|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2427229|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
2427230|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2427231|NCT00844155|Oseltamivir|oseltamivir|mesh-list
2427232|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
2427233|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2427234|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427235|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427236|NCT00844168|Sorafenib|sorafenib|mesh-list
2427237|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427238|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2427239|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427240|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427241|NCT00844207|Azithromycin|azithromycin|mesh-list
2427242|NCT00844207|Chloroquine|chloroquine|mesh-list
2427243|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2427244|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2427245|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2427246|NCT00844207|Amebicides|amebicides|mesh-ancestor
2427247|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2427248|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2427249|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
2427250|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2427251|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2427252|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2427253|NCT00844207|Analgesics|analgesics|mesh-ancestor
2427254|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
2427255|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427256|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427257|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2427258|NCT00844207|Filaricides|filaricides|mesh-ancestor
2427259|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
2427260|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
2427261|NCT00844233|Irinotecan|irinotecan|mesh-list
2427262|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2427263|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2427264|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427265|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427266|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427267|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
2427268|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2427269|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
2427270|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427271|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2427272|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2427273|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2427274|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427275|NCT00844324|Candesartan|candesartan|mesh-list
2427276|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
2427277|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2427278|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2427279|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2427280|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427281|NCT00844337|Amoxicillin|amoxicillin|mesh-list
2427282|NCT00844337|Gentamicins|gentamicins|mesh-list
2427283|NCT00844337|Penicillins|penicillins|mesh-list
2427284|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2427285|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2427286|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2427287|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427288|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427289|NCT00844350|Letrozole|letrozole|mesh-list
2427290|NCT00844350|Oxytocin|oxytocin|mesh-list
2427291|NCT00844350|Clomiphene|clomiphene|mesh-list
2427292|NCT00844350|Enclomiphene|enclomiphene|mesh-list
2427293|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
2427294|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427295|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
2427296|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2427297|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427298|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427299|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2427300|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2427301|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427302|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2427303|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
2427304|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427305|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2427306|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
2427307|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2206911|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206912|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2206913|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2206914|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
2206915|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206916|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
2206917|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2206918|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2206919|NCT00007306|Hormones|hormones|mesh-list
2206920|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
2206921|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2206922|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206923|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2206924|NCT00007358|Dexamethasone|dexamethasone|mesh-list
2206925|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2206926|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
2206927|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
2427308|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2427309|NCT00844402|Atorvastatin|atorvastatin|mesh-list
2427310|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2427311|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2427312|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
2427313|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427314|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2427315|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2427316|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427317|NCT00844454|Ethanol|ethanol|mesh-list
2427318|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2427319|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2427320|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2427321|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427322|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
2427323|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2427324|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427325|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
2427326|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2427327|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
2427328|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427329|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2427330|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2427331|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
2206928|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2206929|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206930|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2206931|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
2206932|NCT00007358|Hormones|hormones|mesh-ancestor
2206933|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427332|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427333|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427334|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2427335|NCT00844662|Sevelamer|sevelamer|mesh-list
2427336|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
2427337|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
2427338|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427339|NCT00844675|Rabeprazole|rabeprazole|mesh-list
2427340|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2427341|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2427342|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2427343|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427344|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427345|NCT00844688|Gemcitabine|gemcitabine|mesh-list
2427346|NCT00844688|Sorafenib|sorafenib|mesh-list
2427347|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2427348|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
2427349|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427350|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427351|NCT00844688|Antiviral Agents|antiviral agents|mesh-ancestor
2427352|NCT00844688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2427353|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427354|NCT00844688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2427355|NCT00844688|Immunologic Factors|immunologic factors|mesh-ancestor
2427356|NCT00844688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427357|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2427358|NCT00844727|Rofecoxib|rofecoxib|mesh-list
2427359|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2427360|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2427361|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427362|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427363|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2427364|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2427365|NCT00844727|Analgesics|analgesics|mesh-ancestor
2427366|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
2427367|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427368|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427369|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2427370|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2427371|NCT00844740|Cinacalcet|cinacalcet|mesh-list
2427372|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2427373|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427374|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2427375|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
2427376|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427377|NCT00844792|Vitamin D|vitamin d|mesh-list
2427378|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
2427379|NCT00844792|Vitamins|vitamins|mesh-list
2427380|NCT00844792|Vitamin E|vitamin e|mesh-list
2427381|NCT00844792|Selenium|selenium|mesh-list
2427382|NCT00844792|Lycopene|lycopene|mesh-list
2427383|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
2427384|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427385|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2427386|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2427387|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
2427388|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427389|NCT00844792|Protective Agents|protective agents|mesh-ancestor
2427390|NCT00844792|Trace Elements|trace elements|mesh-ancestor
2427391|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2427392|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2427393|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2427394|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427395|NCT00845026|Olanzapine|olanzapine|mesh-list
2427396|NCT00845026|Risperidone|risperidone|mesh-list
2427397|NCT00845026|Aripiprazole|aripiprazole|mesh-list
2427398|NCT00845026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2427399|NCT00845026|Serotonin Agents|serotonin agents|mesh-ancestor
2427400|NCT00845026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427401|NCT00845026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427402|NCT00845026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427403|NCT00845026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2427404|NCT00845026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2427405|NCT00845026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2427406|NCT00845026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2427407|NCT00845026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2427408|NCT00845026|Dopamine Agents|dopamine agents|mesh-ancestor
2427409|NCT00845026|Antiemetics|antiemetics|mesh-ancestor
2427410|NCT00845026|Autonomic Agents|autonomic agents|mesh-ancestor
2427411|NCT00845026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427412|NCT00845026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2427413|NCT00845026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2427414|NCT00845026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2427415|NCT00845026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2427416|NCT00845026|Antidepressive Agents|antidepressive agents|mesh-ancestor
2427417|NCT00845026|Dopamine Agonists|dopamine agonists|mesh-ancestor
2427418|NCT00845026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2427419|NCT00845026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2427420|NCT00845026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2427421|NCT00845026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2427422|NCT00845104|Bevacizumab|bevacizumab|mesh-list
2427423|NCT00845104|Rituximab|rituximab|mesh-list
2427424|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2427425|NCT00845104|Fludarabine|fludarabine|mesh-list
2427426|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
2427427|NCT00845104|Antibodies|antibodies|mesh-list
2427428|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
2427429|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2427430|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427431|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2427432|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2427433|NCT00845104|Growth Substances|growth substances|mesh-ancestor
2427434|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427435|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
2427436|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
2427437|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2427438|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2427439|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
2427440|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427441|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2427442|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
2427443|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
2427444|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427445|NCT00845156|Protective Agents|protective agents|mesh-ancestor
2427446|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427447|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
2427448|NCT00845156|Vitamins|vitamins|mesh-ancestor
2427449|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
2427450|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
2427451|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427452|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2427453|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427454|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427455|NCT00845299|Benzalkonium Compounds|benzalkonium compounds|mesh-list
2427456|NCT00845299|Latanoprost|latanoprost|mesh-list
2427457|NCT00845299|Lubricant Eye Drops|lubricant eye drops|mesh-list
2427458|NCT00845299|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2427459|NCT00845299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2427460|NCT00845299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2427461|NCT00845299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2427462|NCT00845338|Darifenacin|darifenacin|mesh-list
2427463|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2427464|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2427465|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
2427466|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427467|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427468|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427469|NCT00845338|Urological Agents|urological agents|mesh-ancestor
2427470|NCT00845351|Bexarotene|bexarotene|mesh-list
2427471|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427472|NCT00845364|Perhexiline|perhexiline|mesh-list
2427473|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2427474|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2427475|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427476|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2427477|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427478|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
2427479|NCT00845533|Piperaquine|piperaquine|mesh-list
2427480|NCT00845533|Artenimol|artenimol|mesh-list
2427481|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
2427482|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2427483|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2427484|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2427485|NCT00845546|Loratadine|loratadine|mesh-list
2427486|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
2427487|NCT00845546|Ephedrine|ephedrine|mesh-list
2427488|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2427489|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
2427490|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427491|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427492|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2427493|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
2427494|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
2427495|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2427496|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2427497|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
2427498|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
2427499|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427500|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427501|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
2427502|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
2427503|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2427504|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2427505|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2427506|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
2427507|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
2427508|NCT00845559|Exenatide|exenatide|mesh-list
2427509|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2206934|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2206935|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206936|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
2427510|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427511|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2427512|NCT00845559|Incretins|incretins|mesh-ancestor
2427513|NCT00845559|Hormones|hormones|mesh-ancestor
2427514|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427515|NCT00845572|Risperidone|risperidone|mesh-list
2427516|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2206937|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2206938|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
2206939|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206940|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2206941|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2206942|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
2206943|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206944|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
2206945|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2206946|NCT00007423|Protective Agents|protective agents|mesh-ancestor
2206947|NCT00007436|Tenofovir|tenofovir|mesh-list
2206948|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
2206949|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2206950|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2206951|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2206952|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206953|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206954|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2206955|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2427517|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
2427518|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427519|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427520|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427521|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2427522|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2427523|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2427524|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2427525|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2427526|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
2427527|NCT00845598|Fluticasone|fluticasone|mesh-list
2427528|NCT00845598|Xhance|xhance|mesh-list
2427529|NCT00845598|Azelastine|azelastine|mesh-list
2427530|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2427531|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2427532|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
2427533|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427534|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427535|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2427536|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
2427537|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
2427538|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2427539|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2427540|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427541|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427542|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2427543|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2427544|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
2427545|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
2427546|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427547|NCT00845689|Adenosine|adenosine|mesh-list
2427548|NCT00845689|Analgesics|analgesics|mesh-ancestor
2427549|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
2427550|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427551|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427552|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2427553|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
2427554|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2427555|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
2427556|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
2427557|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427558|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427559|NCT00845754|Ketorolac|ketorolac|mesh-list
2427560|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2427561|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2206956|NCT00007527|Buprenorphine|buprenorphine|mesh-list
2427562|NCT00845754|Analgesics|analgesics|mesh-ancestor
2427563|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
2427564|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427565|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427566|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2427567|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2427568|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2427569|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427570|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427571|NCT00845780|Amiodarone|amiodarone|mesh-list
2427572|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2427573|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
2427574|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2427575|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2427576|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427577|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2427578|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2427579|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2427580|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427581|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2427582|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2427583|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2427584|NCT00845819|Iodine|iodine|mesh-list
2427585|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
2427586|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2427587|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
2427588|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
2427589|NCT00845819|Nystatin|nystatin|mesh-list
2427590|NCT00845819|Povidone|povidone|mesh-list
2427591|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2427592|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2427593|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
2427594|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
2427595|NCT00845819|Trace Elements|trace elements|mesh-ancestor
2427596|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
2427597|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427598|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
2427599|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
2427600|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2427601|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
2427602|NCT00845819|Ionophores|ionophores|mesh-ancestor
2427603|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2427604|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427605|NCT00845884|Bevacizumab|bevacizumab|mesh-list
2427606|NCT00845884|Cisplatin|cisplatin|mesh-list
2427607|NCT00845884|Docetaxel|docetaxel|mesh-list
2427608|NCT00845884|Capecitabine|capecitabine|mesh-list
2427609|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2427610|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427611|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2427612|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2427613|NCT00845884|Growth Substances|growth substances|mesh-ancestor
2427614|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427615|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
2427616|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
2427617|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
2427618|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
2427619|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427620|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2427621|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
2427622|NCT00845910|Bevacizumab|bevacizumab|mesh-list
2427623|NCT00845910|Docetaxel|docetaxel|mesh-list
2427624|NCT00845910|Capecitabine|capecitabine|mesh-list
2427625|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2427626|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427627|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2427628|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2427629|NCT00845910|Growth Substances|growth substances|mesh-ancestor
2427630|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427631|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
2427632|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
2427633|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
2427634|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
2427635|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427636|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2427637|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
2427638|NCT00845936|Metformin|metformin|mesh-list
2427639|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2427640|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427641|NCT00845962|Bupivacaine|bupivacaine|mesh-list
2427642|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
2427643|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
2427644|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
2427645|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2427646|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427647|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
2427648|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427649|NCT00845988|Aripiprazole|aripiprazole|mesh-list
2427650|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
2427651|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2427652|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2427653|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2427654|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2427655|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427656|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
2427657|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
2427658|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427659|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427660|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2427661|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2427662|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
2427663|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2427664|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2427665|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2427666|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2427667|NCT00846079|Regadenoson|regadenoson|mesh-list
2427668|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2427669|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2427670|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
2427671|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
2427672|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427673|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427674|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427675|NCT00846118|Pitavastatin|pitavastatin|mesh-list
2427676|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2427677|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2427678|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2427679|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
2427680|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427681|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427682|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2427683|NCT00846131|Sorafenib|sorafenib|mesh-list
2427684|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427685|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2427686|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427687|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427688|NCT00846144|Copper|copper|mesh-list
2427689|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
2427690|NCT00846144|Trace Elements|trace elements|mesh-ancestor
2427691|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
2427692|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427693|NCT00846144|Antidotes|antidotes|mesh-ancestor
2427694|NCT00846144|Protective Agents|protective agents|mesh-ancestor
2427695|NCT00846144|Emetics|emetics|mesh-ancestor
2427696|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
2427697|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427698|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2427699|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
2427700|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
2427701|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2427702|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2427703|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427704|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2427705|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427706|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2427707|NCT00846235|Glycerol|glycerol|mesh-list
2427708|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2427709|NCT00846235|Protective Agents|protective agents|mesh-ancestor
2427710|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427711|NCT00846248|Chromium|chromium|mesh-list
2427712|NCT00846248|Trace Elements|trace elements|mesh-ancestor
2427713|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
2427714|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427715|NCT00846274|Antithrombins|antithrombins|mesh-list
2427716|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
2427717|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2427718|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
2427719|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427720|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427721|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
2427722|NCT00846326|Fluticasone|fluticasone|mesh-list
2427723|NCT00846326|Xhance|xhance|mesh-list
2427724|NCT00846326|Phenylephrine|phenylephrine|mesh-list
2427725|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
2427726|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2427727|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2427728|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
2427729|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427730|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427731|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2427732|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
2427733|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
2427734|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2427735|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2427736|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2427737|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
2427738|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427739|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427740|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
2427741|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
2427742|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2427743|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2427744|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
2427745|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2427746|NCT00846326|Protective Agents|protective agents|mesh-ancestor
2427747|NCT00846339|Bupropion|bupropion|mesh-list
2427748|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2427749|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
2427750|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2427751|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2427752|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2427753|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2427754|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427755|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
2427756|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427757|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427758|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2427759|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2427760|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427761|NCT00846430|Interferons|interferons|mesh-list
2427762|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
2427763|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
2427764|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2427765|NCT00846430|Celecoxib|celecoxib|mesh-list
2427766|NCT00846430|Vincristine|vincristine|mesh-list
2427767|NCT00846430|Temozolomide|temozolomide|mesh-list
2427768|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427769|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
2427770|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2427771|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2427772|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
2427773|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
2427774|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
2427775|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427776|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2427777|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
2427778|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
2427779|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427780|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2427781|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2427782|NCT00846430|Analgesics|analgesics|mesh-ancestor
2427783|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
2427784|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427785|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2427786|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2427787|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2427788|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2427789|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427790|NCT00846443|Cisplatin|cisplatin|mesh-list
2427791|NCT00846443|Pemetrexed|pemetrexed|mesh-list
2427792|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427793|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427794|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427795|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2427796|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2427797|NCT00846508|Cisplatin|cisplatin|mesh-list
2427798|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427799|NCT00846612|Bevacizumab|bevacizumab|mesh-list
2427800|NCT00846612|Doxorubicin|doxorubicin|mesh-list
2427801|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2427802|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427803|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2427804|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2427805|NCT00846612|Growth Substances|growth substances|mesh-ancestor
2427806|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427807|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
2427808|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2206957|NCT00007527|Naloxone|naloxone|mesh-list
2206958|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2206959|NCT00007527|Narcotics|narcotics|mesh-ancestor
2206960|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2206961|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206962|NCT00007527|Analgesics|analgesics|mesh-ancestor
2206963|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
2206964|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2206965|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2206966|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
2206967|NCT00007592|Furosemide|furosemide|mesh-list
2206968|NCT00007592|Diuretics|diuretics|mesh-ancestor
2206969|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
2206970|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206971|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2206972|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2206973|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206974|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2427809|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2427810|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2427811|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427812|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427813|NCT00846625|Triamcinolone|triamcinolone|mesh-list
2427814|NCT00846625|Ranibizumab|ranibizumab|mesh-list
2427815|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2427816|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2427817|NCT00846625|Growth Substances|growth substances|mesh-ancestor
2427818|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427819|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
2427820|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427821|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2427822|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
2427823|NCT00846625|Hormones|hormones|mesh-ancestor
2427824|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427825|NCT00846677|Vitamin D|vitamin d|mesh-list
2427826|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
2427827|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
2427828|NCT00846677|Vitamins|vitamins|mesh-list
2427829|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
2427830|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427831|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2427832|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2427833|NCT00846690|Lidocaine|lidocaine|mesh-list
2427834|NCT00846690|Phenylephrine|phenylephrine|mesh-list
2427835|NCT00846690|Benzocaine|benzocaine|mesh-list
2427836|NCT00846690|Tetracaine|tetracaine|mesh-list
2427837|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
2427838|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
2427839|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2427840|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427841|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
2427842|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427843|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2206975|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2427844|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2427845|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2427846|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2427847|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427848|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2427849|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
2427850|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
2427851|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
2427852|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2427853|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
2427854|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
2427855|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2427856|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2427857|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2427858|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
2427859|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427860|NCT00846690|Protective Agents|protective agents|mesh-ancestor
2427861|NCT00846703|Dexamethasone|dexamethasone|mesh-list
2427862|NCT00846703|Methotrexate|methotrexate|mesh-list
2427863|NCT00846703|Vincristine|vincristine|mesh-list
2427864|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
2427865|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2427866|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
2427867|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
2427868|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427869|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427870|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2427871|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
2427872|NCT00846703|Hormones|hormones|mesh-ancestor
2427873|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427874|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2427875|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427876|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2427877|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
2427878|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2427879|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2427880|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
2427881|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427882|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
2427883|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427884|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2427885|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2427886|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
2427887|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2427888|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2427889|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2427890|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
2427891|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
2427892|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
2427893|NCT00846716|Pioglitazone|pioglitazone|mesh-list
2427894|NCT00846716|Biguanides|biguanides|mesh-list
2427895|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2427896|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427897|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
2427898|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
2427899|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427900|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
2427901|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
2427902|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427903|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427904|NCT00846859|Varenicline|varenicline|mesh-list
2427905|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2427906|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2427907|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
2427908|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427909|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427910|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427911|NCT00846872|Mannitol|mannitol|mesh-list
2427912|NCT00846872|Hormones|hormones|mesh-list
2427913|NCT00846872|Secretagogues|secretagogues|mesh-list
2427914|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427915|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427916|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2427917|NCT00846872|Diuretics|diuretics|mesh-ancestor
2427918|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
2427919|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
2427920|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2427921|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2427922|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2427923|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2427924|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2427925|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427926|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427927|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427928|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2427929|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
2427930|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2427931|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427932|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2427933|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2427934|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2427935|NCT00846950|Lorazepam|lorazepam|mesh-list
2427936|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
2427937|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
2427938|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
2427939|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
2427940|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2206976|NCT00007605|Amiodarone|amiodarone|mesh-list
2206977|NCT00007605|Sotalol|sotalol|mesh-list
2206978|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2206979|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
2206980|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2206981|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2206982|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2206983|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2206984|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2206985|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2206986|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2206987|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2206988|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2206989|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2206990|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2206991|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2206992|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
2206993|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2206994|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206995|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
2206996|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
2206997|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427941|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427942|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2427943|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2427944|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2427945|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2427946|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2427947|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2427948|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
2427949|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
2427950|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2427951|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427952|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2427953|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
2427954|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
2427955|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2427956|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2427957|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2427958|NCT00846976|Bicalutamide|bicalutamide|mesh-list
2427959|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
2427960|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
2427961|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427962|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427963|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2427964|NCT00846989|Latanoprost|latanoprost|mesh-list
2427965|NCT00846989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2427966|NCT00846989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2427967|NCT00847054|Antibodies|antibodies|mesh-list
2427968|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2427969|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
2427970|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427971|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2427972|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2427973|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427974|NCT00847080|Incretins|incretins|mesh-ancestor
2427975|NCT00847080|Hormones|hormones|mesh-ancestor
2427976|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2427977|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2427978|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
2427979|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2427980|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427981|NCT00847093|Lidocaine|lidocaine|mesh-list
2427982|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
2427983|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
2427984|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2427985|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2206998|NCT00007631|Tretinoin|tretinoin|mesh-list
2206999|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207000|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
2207001|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
2207002|NCT00007670|Lamotrigine|lamotrigine|mesh-list
2207003|NCT00007670|Carbamazepine|carbamazepine|mesh-list
2207004|NCT00007670|Gabapentin|gabapentin|mesh-list
2207005|NCT00007670|Analgesics|analgesics|mesh-ancestor
2207006|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
2427986|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
2427987|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2427988|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2427989|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2427990|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2427991|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2427992|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2427993|NCT00847106|Daclizumab|daclizumab|mesh-list
2427994|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2427995|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
2427996|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2427997|NCT00847119|Bevacizumab|bevacizumab|mesh-list
2427998|NCT00847119|Capecitabine|capecitabine|mesh-list
2427999|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2428000|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428001|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2428002|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2428003|NCT00847119|Growth Substances|growth substances|mesh-ancestor
2428004|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428005|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
2428006|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2428007|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
2428008|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428009|NCT00847223|Tipifarnib|tipifarnib|mesh-list
2428010|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428011|NCT00847262|Amlodipine|amlodipine|mesh-list
2428012|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2428013|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2428014|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2428015|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428016|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2428017|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428018|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
2428019|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
2428020|NCT00847314|Testosterone|testosterone|mesh-list
2428021|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
2428022|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
2428023|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2428024|NCT00847314|Androgens|androgens|mesh-ancestor
2428025|NCT00847314|Hormones|hormones|mesh-ancestor
2428026|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2428027|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428028|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2428029|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428030|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
2428031|NCT00847366|Tamoxifen|tamoxifen|mesh-list
2428032|NCT00847366|Trastuzumab|trastuzumab|mesh-list
2428033|NCT00847366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2428034|NCT00847366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428035|NCT00847366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2428036|NCT00847366|Hormone Antagonists|hormone antagonists|mesh-ancestor
2207007|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428037|NCT00847366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2428038|NCT00847366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428039|NCT00847366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2428040|NCT00847366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2428041|NCT00847366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2428042|NCT00847366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2428043|NCT00847418|Esketamine|esketamine|mesh-list
2428044|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
2207008|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207009|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
2207010|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2207011|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2207012|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2207013|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2207014|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2207015|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2207016|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428045|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2428046|NCT00847483|Bimatoprost|bimatoprost|mesh-list
2428047|NCT00847483|Travoprost|travoprost|mesh-list
2428048|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2428049|NCT00847483|Latanoprost|latanoprost|mesh-list
2428050|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2428051|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2428052|NCT00847639|Lenalidomide|lenalidomide|mesh-list
2428053|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
2428054|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428055|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2428056|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2428057|NCT00847639|Growth Substances|growth substances|mesh-ancestor
2428058|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
2428059|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428060|NCT00847678|Amphotericin B|amphotericin b|mesh-list
2428061|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2428062|NCT00847678|Flucytosine|flucytosine|mesh-list
2428063|NCT00847678|Efungumab|efungumab|mesh-list
2428064|NCT00847678|Amebicides|amebicides|mesh-ancestor
2428065|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2428066|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2428067|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428068|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2428069|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
2428070|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
2428071|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428072|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2428073|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
2428074|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2428075|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
2428076|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2428077|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428078|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2428079|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2428080|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2428081|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2428082|NCT00847834|Irbesartan|irbesartan|mesh-list
2428083|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2428084|NCT00847834|Diuretics|diuretics|mesh-ancestor
2428085|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
2428086|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428087|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2428088|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2428089|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428090|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2428091|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2428092|NCT00847860|Aspirin|aspirin|mesh-list
2428093|NCT00847860|Cilostazol|cilostazol|mesh-list
2428094|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2428095|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2428096|NCT00847860|Analgesics|analgesics|mesh-ancestor
2428097|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
2428098|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428099|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428100|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2428101|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2428102|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2428103|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2428104|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428105|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2428106|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2428107|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428108|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
2428109|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2428110|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
2428111|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2428112|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
2428113|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
2428114|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2428115|NCT00847860|Protective Agents|protective agents|mesh-ancestor
2428116|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2428117|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2428118|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
2428119|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2428120|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428121|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428122|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2428123|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
2428124|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2428125|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
2428126|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2428127|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
2428128|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428129|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428130|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2428131|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
2428132|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2428133|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
2428134|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428135|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428136|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2428137|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
2428138|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
2428139|NCT00848302|Protective Agents|protective agents|mesh-ancestor
2428140|NCT00848432|Risperidone|risperidone|mesh-list
2428141|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2428142|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
2428143|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428144|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428145|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428146|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2428147|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2428148|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2428149|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2428150|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2428151|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
2428152|NCT00848458|Azelaic acid|azelaic acid|mesh-list
2428153|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428154|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
2207017|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207018|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
2207019|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2207020|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2207021|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2207022|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2207023|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2207024|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2207025|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2207026|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2207027|NCT00007683|Aspirin|aspirin|mesh-list
2207028|NCT00007683|Warfarin|warfarin|mesh-list
2207029|NCT00007683|Clopidogrel|clopidogrel|mesh-list
2428155|NCT00848523|Panobinostat|panobinostat|mesh-list
2428156|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428157|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2428158|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428159|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428160|NCT00848562|Nicorandil|nicorandil|mesh-list
2428161|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2428162|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2428163|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
2428164|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
2428165|NCT00848562|Vitamins|vitamins|mesh-ancestor
2428166|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
2428167|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428168|NCT00848640|Sorafenib|sorafenib|mesh-list
2428169|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428170|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2428171|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428172|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428173|NCT00848679|Lidocaine|lidocaine|mesh-list
2428174|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
2428175|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
2428176|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2428177|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428178|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
2428179|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428180|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2428181|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2428182|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2428183|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2428184|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428185|NCT00848692|Rituximab|rituximab|mesh-list
2428186|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2428187|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428188|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
2428189|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428190|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2428191|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
2428192|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2428193|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
2428194|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428195|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428196|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2428197|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
2428198|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2428199|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
2428200|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428201|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428202|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2428203|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
2428204|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
2428205|NCT00848731|Protective Agents|protective agents|mesh-ancestor
2428206|NCT00848770|Norepinephrine|norepinephrine|mesh-list
2428207|NCT00848770|Esmolol|esmolol|mesh-list
2428208|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2428209|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2428210|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
2428211|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428212|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428213|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428214|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
2428215|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
2428216|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428217|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2428218|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2428219|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2428220|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2428221|NCT00848796|Heparin|heparin|mesh-list
2428222|NCT00848796|Calcium heparin|calcium heparin|mesh-list
2428223|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
2428224|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2428225|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2428226|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428227|NCT00848809|Vancomycin|vancomycin|mesh-list
2428228|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2428229|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428230|NCT00848848|Vaccines|vaccines|mesh-list
2428231|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
2428232|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428233|NCT00848861|Midazolam|midazolam|mesh-list
2428234|NCT00848861|Meperidine|meperidine|mesh-list
2428235|NCT00848861|Propofol|propofol|mesh-list
2428236|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2428237|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2428238|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428239|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2428240|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
2428241|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
2428242|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2428243|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2428244|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2428245|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2428246|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
2428247|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
2428248|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428249|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428250|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2428251|NCT00848861|Narcotics|narcotics|mesh-ancestor
2428252|NCT00848861|Analgesics|analgesics|mesh-ancestor
2428253|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
2428254|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428255|NCT00848939|Treprostinil|treprostinil|mesh-list
2428256|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2428257|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
2428258|NCT00848991|Propofol|propofol|mesh-list
2428259|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2428260|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2428261|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428262|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2428263|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
2428264|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
2428265|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2428266|NCT00848991|Analgesics|analgesics|mesh-ancestor
2428267|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
2428268|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428269|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2428270|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2428271|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2428272|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
2428273|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428274|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428275|NCT00849030|Tamoxifen|tamoxifen|mesh-list
2428276|NCT00849030|Anastrozole|anastrozole|mesh-list
2428277|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2428278|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
2428279|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2428280|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428281|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2428282|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428283|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2428284|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2428285|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2428286|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2428287|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2428288|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428289|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428290|NCT00849082|Goserelin|goserelin|mesh-list
2428291|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
2428292|NCT00849082|Cyproterone|cyproterone|mesh-list
2428293|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2428294|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428295|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
2428296|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
2428297|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2428298|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428299|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2428300|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
2428301|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2428302|NCT00849095|Budesonide|budesonide|mesh-list
2428303|NCT00849095|Terbutaline|terbutaline|mesh-list
2428304|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
2428305|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2428306|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2428307|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2428308|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
2428309|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428310|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428311|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2428312|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
2428313|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
2428314|NCT00849095|Hormones|hormones|mesh-ancestor
2428315|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2428316|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2428317|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2428318|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2428319|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
2428320|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428321|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428322|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
2428323|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
2428324|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2428325|NCT00849160|Darunavir|darunavir|mesh-list
2428326|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2428327|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2428328|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
2428329|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428330|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428331|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2428332|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2428333|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
2428334|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428335|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
2428336|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2428337|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428338|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2428339|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
2428340|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2428341|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428342|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428343|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428344|NCT00849264|Fluorouracil|fluorouracil|mesh-list
2428345|NCT00849264|Endostar protein|endostar protein|mesh-list
2428346|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
2428347|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428348|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2428349|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428350|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2428351|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
2428352|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428353|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2428354|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2428355|NCT00849264|Growth Substances|growth substances|mesh-ancestor
2428356|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
2428357|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
2428358|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2428359|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428360|NCT00849329|Lapatinib|lapatinib|mesh-list
2428361|NCT00849329|Esomeprazole|esomeprazole|mesh-list
2428362|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2428363|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2428364|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2428365|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428366|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428367|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428368|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2428369|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
2428370|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2428371|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428372|NCT00849355|Rituximab|rituximab|mesh-list
2428373|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2428374|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428375|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
2428376|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428377|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2428378|NCT00849368|Azathioprine|azathioprine|mesh-list
2428379|NCT00849368|Allopurinol|allopurinol|mesh-list
2428380|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
2428381|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428382|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428383|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
2428384|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2428385|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2428386|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
2428387|NCT00849368|Protective Agents|protective agents|mesh-ancestor
2428388|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428389|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2428390|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428391|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2428392|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
2428393|NCT00849459|Interleukin-12|interleukin-12|mesh-list
2428394|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2428395|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
2428396|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428397|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2428398|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2428399|NCT00849459|Growth Substances|growth substances|mesh-ancestor
2428400|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
2428401|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428402|NCT00849511|Melatonin|melatonin|mesh-list
2428403|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
2428404|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428405|NCT00849511|Protective Agents|protective agents|mesh-ancestor
2428406|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428407|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2428408|NCT00849537|Triamcinolone|triamcinolone|mesh-list
2428409|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2428410|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
2428411|NCT00849537|Hormones|hormones|mesh-ancestor
2428412|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2428413|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428414|NCT00849550|Bevacizumab|bevacizumab|mesh-list
2428415|NCT00849550|Capecitabine|capecitabine|mesh-list
2428416|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
2428417|NCT00849550|Everolimus|everolimus|mesh-list
2428418|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2428419|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428420|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2428421|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2428422|NCT00849550|Growth Substances|growth substances|mesh-ancestor
2428423|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428424|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
2428425|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2428426|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
2428427|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428428|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2428429|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
2428430|NCT00849576|Insulin|insulin|mesh-list
2428431|NCT00849576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2428432|NCT00849576|Insulin Lispro|insulin lispro|mesh-list
2428433|NCT00849576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2428434|NCT00849576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428435|NCT00849602|Chloroquine|chloroquine|mesh-list
2428436|NCT00849602|Amebicides|amebicides|mesh-ancestor
2428437|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2428438|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2428439|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428440|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
2428441|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2428442|NCT00849615|Leucovorin|leucovorin|mesh-list
2428443|NCT00849615|Folic Acid|folic acid|mesh-list
2428444|NCT00849615|Docetaxel|docetaxel|mesh-list
2428445|NCT00849615|Fluorouracil|fluorouracil|mesh-list
2428446|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
2428447|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
2428448|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428449|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
2428450|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
2428451|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
2428452|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428453|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
2428454|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2428455|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2428456|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
2428457|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428458|NCT00849615|Antidotes|antidotes|mesh-ancestor
2428459|NCT00849615|Protective Agents|protective agents|mesh-ancestor
2428460|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
2428461|NCT00849615|Vitamins|vitamins|mesh-ancestor
2428462|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
2428463|NCT00849615|Hematinics|hematinics|mesh-ancestor
2428464|NCT00849667|Farletuzumab|farletuzumab|mesh-list
2428465|NCT00849667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428466|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
2428467|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2428468|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428469|NCT00849966|Celecoxib|celecoxib|mesh-list
2428470|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2428471|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2428472|NCT00849966|Analgesics|analgesics|mesh-ancestor
2428473|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
2428474|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428475|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428476|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2428477|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2428478|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2428479|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2428480|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428481|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428482|NCT00849992|Imiquimod|imiquimod|mesh-list
2428483|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2428484|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
2428485|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428486|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428487|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
2428488|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
2428489|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2428490|NCT00850005|Antibodies|antibodies|mesh-list
2428491|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
2428492|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2428493|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
2428494|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428495|NCT00850044|Ritonavir|ritonavir|mesh-list
2428496|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2428497|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2428498|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
2428499|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428500|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428501|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2428502|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2428503|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
2428504|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428505|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2428506|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2428507|NCT00850122|Cefazolin|cefazolin|mesh-list
2428508|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2428509|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428510|NCT00850161|Insulin|insulin|mesh-list
2428511|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2428512|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
2428513|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2428514|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428515|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
2428516|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428517|NCT00850382|Cytarabine|cytarabine|mesh-list
2428518|NCT00850382|Daunorubicin|daunorubicin|mesh-list
2428519|NCT00850382|Dasatinib|dasatinib|mesh-list
2428520|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2428521|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
2428522|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428523|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428524|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
2428525|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428526|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2428527|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
2428528|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428529|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2428530|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2428531|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2428532|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428533|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2428534|NCT00850577|Paclitaxel|paclitaxel|mesh-list
2428535|NCT00850577|Bevacizumab|bevacizumab|mesh-list
2428536|NCT00850577|Carboplatin|carboplatin|mesh-list
2428537|NCT00850577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2428538|NCT00850577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2428539|NCT00850577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428540|NCT00850577|Tubulin Modulators|tubulin modulators|mesh-ancestor
2428541|NCT00850577|Antimitotic Agents|antimitotic agents|mesh-ancestor
2428542|NCT00850577|Mitosis Modulators|mitosis modulators|mesh-ancestor
2428543|NCT00850577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428544|NCT00850577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2428545|NCT00850577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2428546|NCT00850577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2428547|NCT00850577|Growth Substances|growth substances|mesh-ancestor
2428548|NCT00850577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428549|NCT00850577|Growth Inhibitors|growth inhibitors|mesh-ancestor
2428550|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
2428551|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
2428552|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428553|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
2428554|NCT00850746|Z 338|z 338|mesh-list
2428555|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2428556|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428557|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2428558|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2428559|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428560|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428561|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428562|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428563|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2428564|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
2428565|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428566|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2428567|NCT00850850|Physostigmine|physostigmine|mesh-list
2428568|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2428569|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428570|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428571|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
2428572|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428573|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428574|NCT00850850|Miotics|miotics|mesh-ancestor
2428575|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
2428576|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428577|NCT00851045|Leucovorin|leucovorin|mesh-list
2428578|NCT00851045|Bevacizumab|bevacizumab|mesh-list
2428579|NCT00851045|Fluorouracil|fluorouracil|mesh-list
2428580|NCT00851045|Irinotecan|irinotecan|mesh-list
2428581|NCT00851045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2428582|NCT00851045|Calcium|calcium|mesh-list
2428583|NCT00851045|Levoleucovorin|levoleucovorin|mesh-list
2428584|NCT00851045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2428585|NCT00851045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428586|NCT00851045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2428587|NCT00851045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2428588|NCT00851045|Growth Substances|growth substances|mesh-ancestor
2428589|NCT00851045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428590|NCT00851045|Growth Inhibitors|growth inhibitors|mesh-ancestor
2428591|NCT00851045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2428592|NCT00851045|Antimetabolites|antimetabolites|mesh-ancestor
2428593|NCT00851045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428594|NCT00851045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2428595|NCT00851045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2428596|NCT00851045|Immunologic Factors|immunologic factors|mesh-ancestor
2428597|NCT00851045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2428598|NCT00851045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2428599|NCT00851045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428600|NCT00851045|Antidotes|antidotes|mesh-ancestor
2428601|NCT00851045|Protective Agents|protective agents|mesh-ancestor
2428602|NCT00851045|Vitamin B Complex|vitamin b complex|mesh-ancestor
2428603|NCT00851045|Vitamins|vitamins|mesh-ancestor
2428604|NCT00851045|Micronutrients|micronutrients|mesh-ancestor
2428605|NCT00851136|Bevacizumab|bevacizumab|mesh-list
2428606|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2428607|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428608|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2428609|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2428610|NCT00851136|Growth Substances|growth substances|mesh-ancestor
2428611|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428612|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
2428613|NCT00851175|Caffeine|caffeine|mesh-list
2428614|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2428615|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2428616|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2428617|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
2428618|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207030|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2207031|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2428619|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2428620|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2428621|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428622|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2428623|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428624|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2428625|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2428626|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2428627|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
2428628|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428629|NCT00851227|Conivaptan|conivaptan|mesh-list
2428630|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2428631|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428632|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
2428633|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428634|NCT00851344|Cetirizine|cetirizine|mesh-list
2428635|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2428636|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2428637|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2428638|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
2428639|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
2428640|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428641|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428642|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428643|NCT00851370|Omalizumab|omalizumab|mesh-list
2428644|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2428645|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2428646|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
2428647|NCT00851461|Goserelin|goserelin|mesh-list
2428648|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2428649|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428650|NCT00851487|Amoxicillin|amoxicillin|mesh-list
2428651|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2428652|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428653|NCT00851513|Lidocaine|lidocaine|mesh-list
2428654|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
2428655|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
2428656|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2428657|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428658|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
2428659|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428660|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2428661|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2428662|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2428663|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2428664|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428665|NCT00851565|Infliximab|infliximab|mesh-list
2428666|NCT00851565|Antibodies|antibodies|mesh-list
2428667|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
2428668|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428669|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
2428670|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2428671|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2428672|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
2428673|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2428674|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
2428675|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428676|NCT00851708|Expectorants|expectorants|mesh-ancestor
2428677|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
2428678|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2207032|NCT00007683|Analgesics|analgesics|mesh-ancestor
2207033|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
2207034|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2207035|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207036|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2207037|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207038|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2207039|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2207040|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207041|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2207042|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2207043|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207044|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
2207045|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2207046|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2207047|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2207048|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
2207049|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2207050|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
2207051|NCT00007735|Doxycycline|doxycycline|mesh-list
2207052|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2207053|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207054|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
2207055|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2207056|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2207057|NCT00007774|Haloperidol|haloperidol|mesh-list
2207058|NCT00007774|Olanzapine|olanzapine|mesh-list
2207059|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
2207060|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
2207061|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
2207062|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2207063|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207064|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2207065|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2207066|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2207067|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2207068|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2207069|NCT00007774|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2207070|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2428679|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
2428680|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428681|NCT00851708|Protective Agents|protective agents|mesh-ancestor
2428682|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428683|NCT00851708|Antidotes|antidotes|mesh-ancestor
2428684|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2428685|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2428686|NCT00851864|Tinzaparin|tinzaparin|mesh-list
2428687|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2428688|NCT00851864|Dalteparin|dalteparin|mesh-list
2428689|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
2428690|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2428691|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2428692|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428693|NCT00851929|Ambrisentan|ambrisentan|mesh-list
2428694|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2428695|NCT00851942|Cosyntropin|cosyntropin|mesh-list
2428696|NCT00851942|Hormones|hormones|mesh-ancestor
2428697|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2428698|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428699|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
2428700|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2428701|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2428702|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428703|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2428704|NCT00852046|Analgesics|analgesics|mesh-ancestor
2428705|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
2428706|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428707|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2428708|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2428709|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2428710|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
2428711|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428712|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428713|NCT00852059|Methylphenidate|methylphenidate|mesh-list
2428714|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2428715|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428716|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2428717|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2428718|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2428719|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428720|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
2428721|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428722|NCT00852163|Busulfan|busulfan|mesh-list
2428723|NCT00852163|Clofarabine|clofarabine|mesh-list
2207071|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2207072|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428724|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
2428725|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428726|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2428727|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
2428728|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428729|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2428730|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428731|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2428732|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2428733|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
2428734|NCT00852189|Folic Acid|folic acid|mesh-list
2428735|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
2428736|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
2428737|NCT00852189|Hematinics|hematinics|mesh-ancestor
2428738|NCT00852189|Vitamins|vitamins|mesh-ancestor
2428739|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
2428740|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428741|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428742|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
2428743|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
2428744|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
2428745|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428746|NCT00852228|Cetuximab|cetuximab|mesh-list
2428747|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
2428748|NCT00852228|Irinotecan|irinotecan|mesh-list
2428749|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2428750|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428751|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2428752|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2428753|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428754|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428755|NCT00852332|Curcumin|curcumin|mesh-list
2428756|NCT00852332|Docetaxel|docetaxel|mesh-list
2428757|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428758|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
2428759|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
2428760|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
2428761|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428762|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2428763|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2428764|NCT00852332|Analgesics|analgesics|mesh-ancestor
2428765|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
2428766|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428767|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428768|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2428769|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2428770|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428771|NCT00852345|Clofazimine|clofazimine|mesh-list
2428772|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2428773|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
2428774|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2428775|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428776|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
2428777|NCT00852371|Piperaquine|piperaquine|mesh-list
2428778|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
2428779|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2428780|NCT00852371|Amodiaquine|amodiaquine|mesh-list
2428781|NCT00852371|Artenimol|artenimol|mesh-list
2428782|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
2428783|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2428784|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2428785|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428786|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2428787|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428788|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428789|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2428790|NCT00852371|Renal Agents|renal agents|mesh-ancestor
2428791|NCT00852410|Lidocaine|lidocaine|mesh-list
2428792|NCT00852410|Epinephrine|epinephrine|mesh-list
2428793|NCT00852410|Racepinephrine|racepinephrine|mesh-list
2428794|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
2428795|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
2428796|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
2428797|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2428798|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428799|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
2428800|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428801|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2428802|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2428803|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2428804|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2428805|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428806|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2428807|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2428808|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
2428809|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428810|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2428811|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2428812|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
2428813|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2428814|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
2428815|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
2428816|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
2428817|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2428818|NCT00852423|Artesunate|artesunate|mesh-list
2428819|NCT00852423|Lumefantrine|lumefantrine|mesh-list
2428820|NCT00852423|Artemether|artemether|mesh-list
2428821|NCT00852423|Piperaquine|piperaquine|mesh-list
2428822|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2428823|NCT00852423|Amodiaquine|amodiaquine|mesh-list
2428824|NCT00852423|Artenimol|artenimol|mesh-list
2428825|NCT00852423|Mefloquine|mefloquine|mesh-list
2428826|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
2428827|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2428828|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2428829|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428830|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428831|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
2428832|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
2428833|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2428834|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
2428835|NCT00852436|Pregabalin|pregabalin|mesh-list
2428836|NCT00852436|Analgesics|analgesics|mesh-ancestor
2428837|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
2428838|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428839|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428840|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
2428841|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2428842|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2428843|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428844|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2428845|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2428846|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2428847|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2428848|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2428849|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
2428850|NCT00852566|Dasatinib|dasatinib|mesh-list
2428851|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428852|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2428853|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428854|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428855|NCT00852579|Azithromycin|azithromycin|mesh-list
2428856|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2428857|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428858|NCT00852670|Ponesimod|ponesimod|mesh-list
2428859|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2428860|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428861|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2428862|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
2428863|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428864|NCT00852683|Pregabalin|pregabalin|mesh-list
2428865|NCT00852683|Analgesics|analgesics|mesh-ancestor
2428866|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
2428867|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428868|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428869|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
2428870|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2428871|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2428872|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428873|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2428874|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2428875|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2428876|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2428877|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2428878|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
2428879|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2428880|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2428881|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2428882|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
2428883|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428884|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428885|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428886|NCT00852696|Urological Agents|urological agents|mesh-ancestor
2428887|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
2428888|NCT00852709|Clofarabine|clofarabine|mesh-list
2428889|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2428890|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
2428891|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428892|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2428893|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2428894|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
2428895|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428896|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428897|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2428898|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2428899|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
2428900|NCT00852787|Digoxin|digoxin|mesh-list
2428901|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2428902|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2428903|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428904|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428905|NCT00852787|Protective Agents|protective agents|mesh-ancestor
2428906|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428907|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2207073|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2207074|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
2207075|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2207076|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
2207077|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2207078|NCT00007787|Cyclosporine|cyclosporine|mesh-list
2207079|NCT00007787|Tacrolimus|tacrolimus|mesh-list
2207080|NCT00007787|Cyclosporins|cyclosporins|mesh-list
2207081|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
2207082|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207083|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
2207084|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207085|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2207086|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207087|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207088|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
2207089|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428908|NCT00852956|Betahistine|betahistine|mesh-list
2428909|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
2428910|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
2428911|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
2428912|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428913|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428914|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428915|NCT00853008|Cytarabine|cytarabine|mesh-list
2428916|NCT00853008|Dexamethasone|dexamethasone|mesh-list
2428917|NCT00853008|Prednisone|prednisone|mesh-list
2428918|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
2428919|NCT00853008|Methotrexate|methotrexate|mesh-list
2428920|NCT00853008|Vincristine|vincristine|mesh-list
2428921|NCT00853008|Daunorubicin|daunorubicin|mesh-list
2428922|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
2428923|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
2428924|NCT00853008|Teniposide|teniposide|mesh-list
2428925|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2428926|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
2428927|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
2428928|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428929|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428930|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2428931|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
2428932|NCT00853008|Hormones|hormones|mesh-ancestor
2428933|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2428934|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2207090|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
2428935|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428936|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2428937|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
2428938|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2428939|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2428940|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
2428941|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428942|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
2428943|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2428944|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2428945|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2428946|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
2428947|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2428948|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2428949|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
2428950|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2428951|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2428952|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
2428953|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
2428954|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
2428955|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2428956|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2428957|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2428958|NCT00853008|Analgesics|analgesics|mesh-ancestor
2428959|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
2428960|NCT00853177|Lidocaine|lidocaine|mesh-list
2428961|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
2428962|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2428963|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428964|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
2428965|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
2428966|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428967|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2428968|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2428969|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2428970|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2428971|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2428972|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
2428973|NCT00853190|Hydrocodone|hydrocodone|mesh-list
2428974|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207091|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207092|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
2207093|NCT00007813|Carboplatin|carboplatin|mesh-list
2207094|NCT00007813|Etoposide|etoposide|mesh-list
2207095|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207096|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
2207097|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207098|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207099|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2207100|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
2207101|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207102|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207103|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2207104|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2207105|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2207106|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2207107|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207108|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2207109|NCT00007826|Vaccines|vaccines|mesh-list
2207110|NCT00007826|Antibodies|antibodies|mesh-list
2207111|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2207112|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
2207113|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
2207114|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
2207115|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207116|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2207117|NCT00007826|Antacids|antacids|mesh-ancestor
2207118|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207119|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2207120|NCT00007852|Cytarabine|cytarabine|mesh-list
2207121|NCT00007852|Rituximab|rituximab|mesh-list
2207122|NCT00007852|Etoposide|etoposide|mesh-list
2207123|NCT00007852|Melphalan|melphalan|mesh-list
2207124|NCT00007852|Carmustine|carmustine|mesh-list
2207125|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2207126|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2428975|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2428976|NCT00853190|Narcotics|narcotics|mesh-ancestor
2428977|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2428978|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428979|NCT00853190|Analgesics|analgesics|mesh-ancestor
2428980|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
2428981|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428982|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
2428983|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
2428984|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
2428985|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
2428986|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2428987|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
2428988|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
2428989|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2428990|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2428991|NCT00853216|Oxycodone|oxycodone|mesh-list
2428992|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2428993|NCT00853216|Narcotics|narcotics|mesh-ancestor
2428994|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2428995|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2428996|NCT00853216|Analgesics|analgesics|mesh-ancestor
2428997|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
2428998|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2428999|NCT00853268|Oxycodone|oxycodone|mesh-list
2429000|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2429001|NCT00853268|Narcotics|narcotics|mesh-ancestor
2429002|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429003|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429004|NCT00853268|Analgesics|analgesics|mesh-ancestor
2429005|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
2429006|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429007|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
2429008|NCT00853294|Hydrocodone|hydrocodone|mesh-list
2429009|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429010|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2429011|NCT00853294|Narcotics|narcotics|mesh-ancestor
2429012|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429013|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429014|NCT00853294|Analgesics|analgesics|mesh-ancestor
2429015|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
2429016|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429017|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
2429018|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
2429019|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
2429020|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
2429021|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2429022|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
2429023|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
2429024|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429025|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2429026|NCT00853320|Oxycodone|oxycodone|mesh-list
2429027|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2429028|NCT00853320|Narcotics|narcotics|mesh-ancestor
2429029|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429030|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429031|NCT00853320|Analgesics|analgesics|mesh-ancestor
2429032|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
2429033|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429034|NCT00853411|Prednisone|prednisone|mesh-list
2429035|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2429036|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
2429037|NCT00853411|Hormones|hormones|mesh-ancestor
2429038|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429039|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429040|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2429041|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429042|NCT00853450|Clopidogrel|clopidogrel|mesh-list
2429043|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2429044|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2429045|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2429046|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2429047|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
2429048|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429049|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429050|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429051|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
2429052|NCT00853502|Testosterone|testosterone|mesh-list
2429053|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
2429054|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
2429055|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2429056|NCT00853502|Androgens|androgens|mesh-ancestor
2429057|NCT00853502|Hormones|hormones|mesh-ancestor
2429058|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429059|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429060|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2429061|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429062|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
2429063|NCT00853554|Hydromorphone|hydromorphone|mesh-list
2429064|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2429065|NCT00853554|Narcotics|narcotics|mesh-ancestor
2429066|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429067|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429068|NCT00853554|Analgesics|analgesics|mesh-ancestor
2429069|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
2429070|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429071|NCT00853684|Capecitabine|capecitabine|mesh-list
2429072|NCT00853684|Endostar protein|endostar protein|mesh-list
2429073|NCT00853684|Endostatins|endostatins|mesh-list
2429074|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2429075|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
2429076|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429077|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429078|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2429079|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2429080|NCT00853684|Growth Substances|growth substances|mesh-ancestor
2429081|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429082|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
2429083|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
2429084|NCT00853697|Testosterone|testosterone|mesh-list
2429085|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
2429086|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
2429087|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2429088|NCT00853697|Dutasteride|dutasteride|mesh-list
2429089|NCT00853697|Androgens|androgens|mesh-ancestor
2429090|NCT00853697|Hormones|hormones|mesh-ancestor
2429091|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429092|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429093|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2429094|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429095|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
2429096|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2429097|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2429098|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429099|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429100|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
2429101|NCT00853736|Oxycodone|oxycodone|mesh-list
2429102|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2429103|NCT00853736|Narcotics|narcotics|mesh-ancestor
2429104|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429105|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429106|NCT00853736|Analgesics|analgesics|mesh-ancestor
2429107|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
2429108|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429109|NCT00853866|Reboxetine|reboxetine|mesh-list
2429110|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
2429111|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2429112|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2429113|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2429114|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2429115|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429116|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
2429117|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429118|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429119|NCT00853879|Vitamins|vitamins|mesh-list
2429120|NCT00853879|Folic Acid|folic acid|mesh-list
2429121|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
2429122|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
2429123|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
2429124|NCT00853879|Pyridoxal|pyridoxal|mesh-list
2429125|NCT00853879|Pyridoxine|pyridoxine|mesh-list
2429126|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
2429127|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
2429128|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429129|NCT00853879|Hematinics|hematinics|mesh-ancestor
2429130|NCT00853892|Oxycodone|oxycodone|mesh-list
2429131|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2429132|NCT00853892|Narcotics|narcotics|mesh-ancestor
2429133|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429134|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429135|NCT00853892|Analgesics|analgesics|mesh-ancestor
2429136|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
2429137|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429138|NCT00853931|Panitumumab|panitumumab|mesh-list
2429139|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2429140|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429141|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2429142|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2429143|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2429144|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429145|NCT00853944|Incretins|incretins|mesh-ancestor
2429146|NCT00853944|Hormones|hormones|mesh-ancestor
2429147|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429148|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
2429149|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429150|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429151|NCT00853983|Saracatinib|saracatinib|mesh-list
2429152|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429153|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429154|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429155|NCT00854009|BLI-489|bli-489|mesh-list
2429156|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2429157|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429158|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429159|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2429160|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429161|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2429162|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2429163|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429164|NCT00854035|Incretins|incretins|mesh-ancestor
2429165|NCT00854035|Hormones|hormones|mesh-ancestor
2429166|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429167|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2429168|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
2429169|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429170|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429171|NCT00854139|Cyclosporine|cyclosporine|mesh-list
2429172|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
2429173|NCT00854139|Cyclosporins|cyclosporins|mesh-list
2429174|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2429175|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2429176|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
2429177|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429178|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2429179|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2429180|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
2429181|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429182|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429183|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2429184|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429185|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
2429186|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429187|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
2429188|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2429189|NCT00854178|Anesthetics|anesthetics|mesh-list
2429190|NCT00854178|Isoflurane|isoflurane|mesh-list
2429191|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429192|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429193|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
2429194|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2429195|NCT00854204|Darunavir|darunavir|mesh-list
2429196|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2429197|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2429198|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
2429199|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429200|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429201|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2429202|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2429203|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
2429204|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429205|NCT00854230|Naltrexone|naltrexone|mesh-list
2429206|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2429207|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2429208|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429209|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
2429210|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429211|NCT00854256|Mitomycins|mitomycins|mesh-list
2429212|NCT00854256|Mitomycin|mitomycin|mesh-list
2429213|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2429214|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429215|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
2429216|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429217|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2429218|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429219|NCT00854321|Rituximab|rituximab|mesh-list
2429220|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2429221|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429222|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
2429223|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429224|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2429225|NCT00854425|Asparaginase|asparaginase|mesh-list
2429226|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429227|NCT00854451|Amoxicillin|amoxicillin|mesh-list
2429228|NCT00854451|Omeprazole|omeprazole|mesh-list
2429229|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2429230|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429231|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2429232|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2429233|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2429234|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429235|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429236|NCT00854477|Capecitabine|capecitabine|mesh-list
2429237|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2429238|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
2429239|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429240|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429241|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2429242|NCT00854503|Simvastatin|simvastatin|mesh-list
2429243|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2429244|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2429245|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
2429246|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429247|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2429248|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2429249|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429250|NCT00854529|Bevacizumab|bevacizumab|mesh-list
2429251|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2429252|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429253|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2429254|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2429255|NCT00854529|Growth Substances|growth substances|mesh-ancestor
2429256|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429257|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
2429258|NCT00854633|Lactoferrin|lactoferrin|mesh-list
2429259|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
2429260|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429261|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429262|NCT00854646|ON 01910|on 01910|mesh-list
2429263|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429264|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2429265|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429266|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429267|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
2429268|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2429269|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
2429270|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429271|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429272|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2429273|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
2429274|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2429275|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
2429276|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429277|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429278|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2429279|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
2429280|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
2429281|NCT00854711|Protective Agents|protective agents|mesh-ancestor
2429282|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2429283|NCT00854750|Hormones|hormones|mesh-ancestor
2429284|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429285|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429286|NCT00854763|Olmesartan|olmesartan|mesh-list
2429287|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2429288|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2429289|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2429290|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429291|NCT00854776|Lansoprazole|lansoprazole|mesh-list
2429292|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
2429293|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2429294|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2429295|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2429296|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2429297|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429298|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429299|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2429300|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
2429301|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429302|NCT00854776|Antacids|antacids|mesh-ancestor
2429303|NCT00854802|Ribavirin|ribavirin|mesh-list
2429304|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2429305|NCT00854802|Cyclosporine|cyclosporine|mesh-list
2429306|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
2429307|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429308|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
2429309|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429310|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
2429311|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
2429312|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429313|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2429314|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
2429315|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429316|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2429317|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2429318|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
2429319|NCT00854841|Dasatinib|dasatinib|mesh-list
2429320|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429321|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2429322|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429323|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429324|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
2429325|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2429326|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429327|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429328|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2429329|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2429330|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429331|NCT00854945|ON 01910|on 01910|mesh-list
2429332|NCT00854945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429333|NCT00854945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2429334|NCT00854945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429335|NCT00854945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429336|NCT00855049|Acetaminophen|acetaminophen|mesh-list
2429337|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2429338|NCT00855049|Analgesics|analgesics|mesh-ancestor
2429339|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
2429340|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429341|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429342|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
2429343|NCT00855088|Ritonavir|ritonavir|mesh-list
2429344|NCT00855088|Darunavir|darunavir|mesh-list
2429345|NCT00855088|Etravirine|etravirine|mesh-list
2429346|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2429347|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2429348|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
2429349|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429350|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429351|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2429352|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2429353|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
2429354|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429355|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2429356|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2429357|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2429358|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2429359|NCT00855101|Voriconazole|voriconazole|mesh-list
2429360|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
2429361|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429362|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2429363|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2429364|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429365|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429366|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2429367|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
2429368|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429369|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429370|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2429371|NCT00855114|Everolimus|everolimus|mesh-list
2429372|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429373|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2429374|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
2429375|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429376|NCT00855153|Cycloserine|cycloserine|mesh-list
2429377|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2429378|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429379|NCT00855153|Renal Agents|renal agents|mesh-ancestor
2429380|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2429381|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
2429382|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2429383|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
2429384|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429385|NCT00855205|Rituximab|rituximab|mesh-list
2429386|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2429387|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429388|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
2429389|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429390|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2429391|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
2429392|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2429393|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
2429394|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2429395|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2429396|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2429397|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
2429398|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429399|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429400|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429401|NCT00855361|Rabeprazole|rabeprazole|mesh-list
2429402|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2429403|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2429404|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2429405|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429406|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429407|NCT00855387|Pancrelipase|pancrelipase|mesh-list
2429408|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2429409|NCT00855517|Latanoprost|latanoprost|mesh-list
2429410|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2429411|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2429412|NCT00855530|Amibegron|amibegron|mesh-list
2429413|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2429414|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2429415|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
2429416|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429417|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429418|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429419|NCT00855608|Adalimumab|adalimumab|mesh-list
2429420|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2429421|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2429422|NCT00855660|Riociguat|riociguat|mesh-list
2429423|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
2429424|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429425|NCT00855686|Memantine|memantine|mesh-list
2429426|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2429427|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2429428|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
2429429|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429430|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429431|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429432|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2429433|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2429434|NCT00855699|Acamprosate|acamprosate|mesh-list
2429435|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2429436|NCT00855712|Cardioplegic Solutions|cardioplegic solutions|mesh-list
2429437|NCT00855712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2429438|NCT00855764|Paclitaxel|paclitaxel|mesh-list
2429439|NCT00855764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2429440|NCT00855764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429441|NCT00855764|Tubulin Modulators|tubulin modulators|mesh-ancestor
2429442|NCT00855764|Antimitotic Agents|antimitotic agents|mesh-ancestor
2429443|NCT00855764|Mitosis Modulators|mitosis modulators|mesh-ancestor
2429444|NCT00855764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429445|NCT00855777|Ibuprofen|ibuprofen|mesh-list
2429446|NCT00855777|Etoricoxib|etoricoxib|mesh-list
2429447|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2429448|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2429449|NCT00855777|Analgesics|analgesics|mesh-ancestor
2429450|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
2429451|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429452|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429453|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2429454|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2429455|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2429456|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429457|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429458|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2429459|NCT00855881|Tegafur|tegafur|mesh-list
2429460|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2429461|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
2429462|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429463|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429464|NCT00855972|Naltrexone|naltrexone|mesh-list
2429465|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2429466|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2429467|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429468|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
2429469|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429470|NCT00856037|Doxorubicin|doxorubicin|mesh-list
2429471|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2429472|NCT00856037|Topotecan|topotecan|mesh-list
2429473|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2429474|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429475|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2429476|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2429477|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429478|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429479|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2429480|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2429481|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2429482|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2429483|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2429484|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429485|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
2429486|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429487|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429488|NCT00856089|Retapamulin|retapamulin|mesh-list
2429489|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2429490|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429491|NCT00856271|Losartan|losartan|mesh-list
2429492|NCT00856271|Olmesartan|olmesartan|mesh-list
2429493|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2429494|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2429495|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2429496|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2429497|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2429498|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429499|NCT00856310|Fasinumab|fasinumab|mesh-list
2429500|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2429501|NCT00856310|Analgesics|analgesics|mesh-ancestor
2429502|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
2429503|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429504|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429505|NCT00856362|Moxidectin|moxidectin|mesh-list
2429506|NCT00856362|Midazolam|midazolam|mesh-list
2429507|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2429508|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2429509|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429510|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429511|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2429512|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2429513|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2429514|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2429515|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
2429516|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
2429517|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
2429518|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
2429519|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429520|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429521|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
2429522|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2429523|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429524|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
2429525|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
2429526|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429527|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2429528|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
2429529|NCT00856505|Everolimus|everolimus|mesh-list
2429530|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429531|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2429532|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
2429533|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429534|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2429535|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2429536|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
2429537|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2429538|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429539|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429540|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429541|NCT00856570|Warfarin|warfarin|mesh-list
2429542|NCT00856570|Mirabegron|mirabegron|mesh-list
2429543|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
2429544|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2429545|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2429546|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2429547|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
2429548|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429549|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429550|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429551|NCT00856570|Urological Agents|urological agents|mesh-ancestor
2429552|NCT00856596|Sertaconazole|sertaconazole|mesh-list
2429553|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
2429554|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429555|NCT00856622|Timolol|timolol|mesh-list
2429556|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2429557|NCT00856622|Latanoprost|latanoprost|mesh-list
2429558|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2429559|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2429560|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2429561|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
2429562|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429563|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429564|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429565|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2429566|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2429567|NCT00856687|Montelukast|montelukast|mesh-list
2429568|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2429569|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
2429570|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2429571|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
2429572|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429573|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429574|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2429575|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2429576|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429577|NCT00856700|Incretins|incretins|mesh-list
2429578|NCT00856700|Hormones|hormones|mesh-ancestor
2429579|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429580|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429581|NCT00856804|Ribavirin|ribavirin|mesh-list
2429582|NCT00856804|Thalidomide|thalidomide|mesh-list
2429583|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
2429584|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429585|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
2429586|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429587|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2429588|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
2429589|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429590|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
2429591|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2429592|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2429593|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2429594|NCT00856804|Growth Substances|growth substances|mesh-ancestor
2429595|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
2429596|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429597|NCT00856882|Caseins|caseins|mesh-list
2429598|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
2429599|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
2429600|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429601|NCT00856947|Vitamin D|vitamin d|mesh-list
2429602|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
2429603|NCT00856947|Vitamins|vitamins|mesh-ancestor
2429604|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
2429605|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429606|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2429607|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2429608|NCT00856960|Losartan|losartan|mesh-list
2429609|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2429610|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2429611|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2429612|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2429613|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429614|NCT00857038|Doxycycline|doxycycline|mesh-list
2429615|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2429616|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429617|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
2429618|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2429619|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2429620|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
2429621|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
2429622|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2429623|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
2429624|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2429625|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2429626|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429627|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2429628|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429629|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429630|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2429631|NCT00857077|Renal Agents|renal agents|mesh-ancestor
2429632|NCT00857116|Albendazole|albendazole|mesh-list
2429633|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
2429634|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2429635|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429636|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
2429637|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2429638|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2429639|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
2429640|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
2429641|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
2429642|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429643|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429644|NCT00857142|Oxymorphone|oxymorphone|mesh-list
2429645|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2429646|NCT00857142|Narcotics|narcotics|mesh-ancestor
2429647|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429648|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429649|NCT00857142|Analgesics|analgesics|mesh-ancestor
2429650|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
2429651|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429652|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2429653|NCT00857155|Clopidogrel|clopidogrel|mesh-list
2429654|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2429655|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2429656|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2429657|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2429658|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
2429659|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429660|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429661|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429662|NCT00857168|Testosterone|testosterone|mesh-list
2429663|NCT00857168|Androgens|androgens|mesh-ancestor
2429664|NCT00857168|Hormones|hormones|mesh-ancestor
2429665|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429666|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429667|NCT00857324|Vorinostat|vorinostat|mesh-list
2429668|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429669|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2429670|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429671|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429672|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
2429673|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
2429674|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429675|NCT00857376|Protective Agents|protective agents|mesh-ancestor
2429676|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429677|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
2429678|NCT00857376|Vitamins|vitamins|mesh-ancestor
2429679|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
2429680|NCT00857428|Oxymorphone|oxymorphone|mesh-list
2429681|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2429682|NCT00857428|Narcotics|narcotics|mesh-ancestor
2429683|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429684|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429685|NCT00857428|Analgesics|analgesics|mesh-ancestor
2429686|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
2429687|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429688|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2429689|NCT00857519|Carboplatin|carboplatin|mesh-list
2429690|NCT00857519|Melphalan|melphalan|mesh-list
2429691|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429692|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2429693|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
2429694|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429695|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2429696|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2429697|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
2429698|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429699|NCT00857558|Saxagliptin|saxagliptin|mesh-list
2429700|NCT00857558|Incretins|incretins|mesh-ancestor
2429701|NCT00857558|Hormones|hormones|mesh-ancestor
2429702|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429703|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429704|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2429705|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
2429706|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429707|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429708|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2429709|NCT00857597|Esomeprazole|esomeprazole|mesh-list
2429710|NCT00857597|Omeprazole|omeprazole|mesh-list
2429711|NCT00857597|Rabeprazole|rabeprazole|mesh-list
2429712|NCT00857597|Pantoprazole|pantoprazole|mesh-list
2429713|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2429714|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2429715|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2429716|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429717|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429718|NCT00857753|Fentanyl|fentanyl|mesh-list
2429719|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2429720|NCT00857753|Narcotics|narcotics|mesh-ancestor
2429721|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429722|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429723|NCT00857753|Analgesics|analgesics|mesh-ancestor
2429724|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
2429725|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429726|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2429727|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2429728|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
2429729|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
2429730|NCT00857831|Vitamin D|vitamin d|mesh-list
2429731|NCT00857831|Calcium|calcium|mesh-list
2429732|NCT00857831|Vitamins|vitamins|mesh-ancestor
2429733|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
2429734|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429735|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2429736|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2429737|NCT00857870|Metformin|metformin|mesh-list
2429738|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
2429739|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2429740|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429741|NCT00857909|Amiloride|amiloride|mesh-list
2429742|NCT00857909|Spironolactone|spironolactone|mesh-list
2429743|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2207127|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
2207128|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207129|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207130|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2207131|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2207132|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2207133|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207134|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207135|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2207136|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
2207137|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
2207138|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207139|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207140|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2207141|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
2207142|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2207143|NCT00007865|Rituximab|rituximab|mesh-list
2207144|NCT00007865|Carboplatin|carboplatin|mesh-list
2207145|NCT00007865|Etoposide|etoposide|mesh-list
2207146|NCT00007865|Ifosfamide|ifosfamide|mesh-list
2207147|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2207148|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207149|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
2207150|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207151|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207152|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2207153|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2207154|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2207155|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207156|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207157|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2207158|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
2207159|NCT00007878|Leucovorin|leucovorin|mesh-list
2207160|NCT00007878|Fluorouracil|fluorouracil|mesh-list
2429744|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
2429745|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429746|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429747|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2429748|NCT00857909|Diuretics|diuretics|mesh-ancestor
2429749|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
2429750|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2429751|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2429752|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2429753|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429754|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2429755|NCT00857935|Permethrin|permethrin|mesh-list
2429756|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429757|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429758|NCT00857987|Expectorants|expectorants|mesh-list
2429759|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
2429760|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2429761|NCT00858195|Indomethacin|indomethacin|mesh-list
2429762|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2429763|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2429764|NCT00858195|Analgesics|analgesics|mesh-ancestor
2429765|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
2429766|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429767|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429768|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2429769|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2429770|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
2429771|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
2429772|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2429773|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2429774|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429775|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429776|NCT00858273|Insulin|insulin|mesh-list
2429777|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2429778|NCT00858273|Antioxidants|antioxidants|mesh-list
2429779|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2429780|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429781|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429782|NCT00858273|Protective Agents|protective agents|mesh-ancestor
2429783|NCT00858299|Valsartan|valsartan|mesh-list
2429784|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2429785|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2429786|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2429787|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429788|NCT00858325|Daptomycin|daptomycin|mesh-list
2429789|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2429790|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429791|NCT00858338|Floxuridine|floxuridine|mesh-list
2429792|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2429793|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
2429794|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429795|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429796|NCT00858377|Complement Factor H|complement factor h|mesh-list
2429797|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2429798|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2429799|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
2429800|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429801|NCT00858429|Capecitabine|capecitabine|mesh-list
2429802|NCT00858429|Doxifluridine|doxifluridine|mesh-list
2429803|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2429804|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
2429805|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429806|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429807|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2429808|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
2429809|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429810|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
2429811|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2429812|NCT00858455|Dolutegravir|dolutegravir|mesh-list
2429813|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2429814|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2429815|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429816|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429817|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2429818|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2429819|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
2429820|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429821|NCT00858624|Ketamine|ketamine|mesh-list
2429822|NCT00858624|Analgesics|analgesics|mesh-ancestor
2429823|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
2429824|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429825|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429826|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2429827|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2429828|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
2429829|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
2429830|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429831|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2429832|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2429833|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429834|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429835|NCT00858663|Everolimus|everolimus|mesh-list
2429836|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429837|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2429838|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
2429839|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429840|NCT00858676|Acarbose|acarbose|mesh-list
2429841|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2429842|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429843|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429844|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2429845|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429846|NCT00858715|Aspirin|aspirin|mesh-list
2429847|NCT00858715|Clopidogrel|clopidogrel|mesh-list
2429848|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2429849|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2429850|NCT00858715|Analgesics|analgesics|mesh-ancestor
2429851|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
2429852|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429853|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429854|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2429855|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2429856|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2429857|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2429858|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429859|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2429860|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2429861|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429862|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
2429863|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2429864|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2429865|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2429866|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
2429867|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429868|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
2429869|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2429870|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429871|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
2429872|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429873|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
2429874|NCT00858767|Vitamin K|vitamin k|mesh-list
2429875|NCT00858767|Vitamin MK 7|vitamin mk 7|mesh-list
2429876|NCT00858767|Caseins|caseins|mesh-list
2429877|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
2429878|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
2429879|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429880|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2429881|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2429882|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
2429883|NCT00858767|Coagulants|coagulants|mesh-ancestor
2429884|NCT00858767|Vitamins|vitamins|mesh-ancestor
2429885|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
2429886|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429887|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
2429888|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429889|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2429890|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429891|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429892|NCT00858871|Sorafenib|sorafenib|mesh-list
2429893|NCT00858871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429894|NCT00858871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2429895|NCT00858871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429896|NCT00858871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429897|NCT00858897|Insulin|insulin|mesh-list
2429898|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2429899|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2429900|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429901|NCT00859079|Insulin|insulin|mesh-list
2429902|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2429903|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2429904|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2429905|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429906|NCT00859079|Incretins|incretins|mesh-ancestor
2429907|NCT00859079|Hormones|hormones|mesh-ancestor
2429908|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429909|NCT00859105|Imiquimod|imiquimod|mesh-list
2429910|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2429911|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
2429912|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429913|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429914|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
2429915|NCT00859118|Axitinib|axitinib|mesh-list
2429916|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429917|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2429918|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429919|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429920|NCT00859183|Sirolimus|sirolimus|mesh-list
2429921|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2429922|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429923|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2429924|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2429925|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
2429926|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2429927|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
2429928|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429929|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
2429930|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2429931|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2429932|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429933|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
2429934|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
2429935|NCT00859274|Budesonide|budesonide|mesh-list
2429936|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2429937|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2429938|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
2429939|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2429940|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429941|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2429942|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
2429943|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
2429944|NCT00859274|Hormones|hormones|mesh-ancestor
2429945|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429946|NCT00859352|Midazolam|midazolam|mesh-list
2429947|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2429948|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2429949|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2429950|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429951|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2429952|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2429953|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2429954|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2429955|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
2429956|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
2429957|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
2429958|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
2429959|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429960|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429961|NCT00859534|Afamelanotide|afamelanotide|mesh-list
2429962|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
2429963|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
2429964|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2429965|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2429966|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429967|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2429968|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429969|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2429970|NCT00859781|Ketoconazole|ketoconazole|mesh-list
2429971|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
2429972|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2429973|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
2429974|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429975|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2429976|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2429977|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2429978|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429979|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2429980|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
2429981|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2429982|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429983|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2429984|NCT00859807|Amodiaquine|amodiaquine|mesh-list
2429985|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
2429986|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2429987|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2429988|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2429989|NCT00859872|Haloperidol|haloperidol|mesh-list
2429990|NCT00859872|Risperidone|risperidone|mesh-list
2429991|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
2429992|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2429993|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
2429994|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2429995|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2429996|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2429997|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2429998|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2429999|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2430000|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2430001|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2430002|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
2430003|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
2430004|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
2430005|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430006|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2430007|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2430008|NCT00859885|Aspirin|aspirin|mesh-list
2430009|NCT00859885|Clopidogrel|clopidogrel|mesh-list
2430010|NCT00859885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2430011|NCT00859885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2430012|NCT00859885|Analgesics|analgesics|mesh-ancestor
2430013|NCT00859885|Sensory System Agents|sensory system agents|mesh-ancestor
2430014|NCT00859885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430015|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430016|NCT00859885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2430017|NCT00859885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2430018|NCT00859885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2430019|NCT00859885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2430020|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430021|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2430022|NCT00859885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2430023|NCT00859885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430024|NCT00859885|Antipyretics|antipyretics|mesh-ancestor
2430025|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2430026|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2430027|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2430028|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
2430029|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430030|NCT00859911|Micronutrients|micronutrients|mesh-list
2430031|NCT00859911|Trace Elements|trace elements|mesh-list
2207161|NCT00007878|Bortezomib|bortezomib|mesh-list
2207162|NCT00007878|Calcium|calcium|mesh-list
2207163|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
2207164|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2207165|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207166|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
2207167|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207168|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2207169|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207170|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207171|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
2207172|NCT00007878|Antidotes|antidotes|mesh-ancestor
2207173|NCT00007878|Protective Agents|protective agents|mesh-ancestor
2207174|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
2207175|NCT00007878|Vitamins|vitamins|mesh-ancestor
2207176|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
2207177|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2207178|NCT00007891|Antibodies|antibodies|mesh-list
2207179|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
2207180|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2207181|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
2207182|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207183|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207184|NCT00007904|Tamoxifen|tamoxifen|mesh-list
2207185|NCT00007904|Paclitaxel|paclitaxel|mesh-list
2207186|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
2207187|NCT00007904|Doxorubicin|doxorubicin|mesh-list
2207188|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2207189|NCT00007904|Lenograstim|lenograstim|mesh-list
2207190|NCT00007904|Sargramostim|sargramostim|mesh-list
2207191|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2207192|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207193|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
2207194|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
2207195|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
2207196|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207197|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2430032|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430033|NCT00860119|Alprazolam|alprazolam|mesh-list
2430034|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2430035|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2430036|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430037|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2430038|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2430039|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2430040|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
2430041|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
2430042|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430043|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430044|NCT00860223|Digoxin|digoxin|mesh-list
2430045|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2430046|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2430047|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430048|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430049|NCT00860223|Protective Agents|protective agents|mesh-ancestor
2430050|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430051|NCT00860275|Fluconazole|fluconazole|mesh-list
2430052|NCT00860275|Ketoconazole|ketoconazole|mesh-list
2430053|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
2430054|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430055|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2430056|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2430057|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430058|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430059|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2430060|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
2430061|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2430062|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430063|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2430064|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2430065|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2430066|NCT00860288|Metformin|metformin|mesh-list
2430067|NCT00860288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2430068|NCT00860288|Vildagliptin|vildagliptin|mesh-list
2430069|NCT00860288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2430070|NCT00860288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430071|NCT00860288|Incretins|incretins|mesh-ancestor
2430072|NCT00860288|Hormones|hormones|mesh-ancestor
2430073|NCT00860288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2430074|NCT00860288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2430075|NCT00860288|Protease Inhibitors|protease inhibitors|mesh-ancestor
2430076|NCT00860288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430077|NCT00860288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430078|NCT00860340|Spironolactone|spironolactone|mesh-list
2430079|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2430080|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
2430081|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2430082|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430083|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2430084|NCT00860340|Diuretics|diuretics|mesh-ancestor
2430085|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
2430086|NCT00860366|Uric Acid|uric acid|mesh-list
2207198|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
2207199|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207200|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207201|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2207202|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
2207203|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2207204|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2207205|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2207206|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2207207|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207208|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2207209|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2207210|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
2207211|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2207212|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2207213|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2430087|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
2430088|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430089|NCT00860366|Protective Agents|protective agents|mesh-ancestor
2430090|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430091|NCT00860496|Cyclosporine|cyclosporine|mesh-list
2430092|NCT00860496|Tacrolimus|tacrolimus|mesh-list
2430093|NCT00860496|Cyclosporins|cyclosporins|mesh-list
2430094|NCT00860496|Tofacitinib|tofacitinib|mesh-list
2430095|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2430096|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
2430097|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430098|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2430099|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430100|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430101|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
2430102|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430103|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
2430104|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2430105|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2430106|NCT00860626|Interferons|interferons|mesh-list
2430107|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430108|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
2430109|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430110|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
2430111|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2430112|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430113|NCT00860899|Clonidine|clonidine|mesh-list
2430114|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
2430115|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
2430116|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
2430117|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2430118|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430119|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
2430120|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430121|NCT00860899|Analgesics|analgesics|mesh-ancestor
2430122|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2430123|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
2430124|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
2430125|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2430126|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2430127|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2430128|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
2430129|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430130|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430131|NCT00860925|Clonidine|clonidine|mesh-list
2430132|NCT00860925|Analgesics|analgesics|mesh-ancestor
2430133|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
2430134|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430135|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430136|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2430137|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
2430138|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
2430139|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2430140|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2430141|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2430142|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
2430143|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430144|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430145|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2430146|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2430147|NCT00860964|Estradiol|estradiol|mesh-list
2430148|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2430149|NCT00860964|Estrogens|estrogens|mesh-ancestor
2430150|NCT00860964|Hormones|hormones|mesh-ancestor
2430151|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2430152|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430153|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2430154|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
2430155|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2430156|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2430157|NCT00860977|Valacyclovir|valacyclovir|mesh-list
2430158|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
2430159|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430160|NCT00861016|Metoprolol|metoprolol|mesh-list
2430161|NCT00861016|Felodipine|felodipine|mesh-list
2430162|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2430163|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2430164|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
2430165|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
2430166|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430167|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430168|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2430169|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2430170|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2430171|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
2430172|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430173|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430174|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2430175|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430176|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2430177|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
2430178|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
2430179|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2430180|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2430181|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430182|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2430183|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2430184|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430185|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430186|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430187|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2430188|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
2430189|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2430190|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430191|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2430192|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2430193|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2430194|NCT00861042|Lacosamide|lacosamide|mesh-list
2430195|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
2430196|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2430197|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2430198|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430199|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430200|NCT00861068|Lacosamide|lacosamide|mesh-list
2430201|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
2430202|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2430203|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2430204|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430205|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430206|NCT00861094|Leucovorin|leucovorin|mesh-list
2430207|NCT00861094|Folic Acid|folic acid|mesh-list
2430208|NCT00861094|Fluorouracil|fluorouracil|mesh-list
2430209|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
2430210|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
2430211|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430212|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
2430213|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430214|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2430215|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2430216|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
2430217|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430218|NCT00861094|Antidotes|antidotes|mesh-ancestor
2430219|NCT00861094|Protective Agents|protective agents|mesh-ancestor
2430220|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
2430221|NCT00861094|Vitamins|vitamins|mesh-ancestor
2430222|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
2430223|NCT00861094|Hematinics|hematinics|mesh-ancestor
2430224|NCT00861107|Vaccines|vaccines|mesh-list
2430225|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
2430226|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430227|NCT00861120|Doxorubicin|doxorubicin|mesh-list
2430228|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2430229|NCT00861120|Panitumumab|panitumumab|mesh-list
2430230|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2430231|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430232|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2430233|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2430234|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430235|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430236|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2430237|NCT00861250|Dexamethasone|dexamethasone|mesh-list
2430238|NCT00861250|Bortezomib|bortezomib|mesh-list
2430239|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2430240|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
2430241|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
2430242|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430243|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430244|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2430245|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
2430246|NCT00861250|Hormones|hormones|mesh-ancestor
2430247|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2430248|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2430249|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430250|NCT00861276|Nicotine|nicotine|mesh-list
2430251|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2430252|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
2430253|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430254|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430255|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2430256|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2430257|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
2430258|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430259|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430260|NCT00861315|Amikacin|amikacin|mesh-list
2430261|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2430262|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430263|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
2430264|NCT00861328|Irinotecan|irinotecan|mesh-list
2430265|NCT00861328|Camptothecin|camptothecin|mesh-list
2430266|NCT00861328|ON 01910|on 01910|mesh-list
2430267|NCT00861328|Glycine|glycine|mesh-list
2430268|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430269|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2430270|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2430271|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430272|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430273|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2430274|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2430275|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
2430276|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430277|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430278|NCT00861367|Aspirin|aspirin|mesh-list
2430279|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2430280|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2430281|NCT00861367|Analgesics|analgesics|mesh-ancestor
2430282|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
2430283|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430284|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430285|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2430286|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2430287|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2430288|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2430289|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430290|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2430291|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2430292|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430293|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
2430294|NCT00861406|Interferons|interferons|mesh-list
2430295|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
2430296|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
2430297|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2430298|NCT00861406|Vaccines|vaccines|mesh-list
2430299|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
2430300|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430301|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430302|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
2430303|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430304|NCT00861419|Niacinamide|niacinamide|mesh-list
2430305|NCT00861419|Bevacizumab|bevacizumab|mesh-list
2430306|NCT00861419|Sunitinib|sunitinib|mesh-list
2430307|NCT00861419|Trebananib|trebananib|mesh-list
2430308|NCT00861419|Sorafenib|sorafenib|mesh-list
2430309|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
2430310|NCT00861419|Imetelstat|imetelstat|mesh-list
2430311|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2430312|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430313|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2430314|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2430315|NCT00861419|Growth Substances|growth substances|mesh-ancestor
2430316|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430317|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
2430318|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2430319|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430320|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430321|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
2430322|NCT00861419|Vitamins|vitamins|mesh-ancestor
2430323|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
2207214|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2207215|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2207216|NCT00007917|Gemcitabine|gemcitabine|mesh-list
2207217|NCT00007917|Alvocidib|alvocidib|mesh-list
2207218|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2207219|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
2207220|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207221|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207222|NCT00007917|Antiviral Agents|antiviral agents|mesh-ancestor
2430324|NCT00861445|Lacosamide|lacosamide|mesh-list
2430325|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
2430326|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2430327|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2430328|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430329|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430330|NCT00861510|ON 01910|on 01910|mesh-list
2430331|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430332|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2430333|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430334|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430335|NCT00861523|Thiamine|thiamine|mesh-list
2430336|NCT00861523|Promethazine|promethazine|mesh-list
2430337|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
2430338|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
2430339|NCT00861523|Vitamins|vitamins|mesh-ancestor
2430340|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
2430341|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430342|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
2430343|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
2430344|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2430345|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
2430346|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
2430347|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430348|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430349|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2430350|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2430351|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2430352|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2430353|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
2430354|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
2430355|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
2430356|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430357|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
2430358|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
2430359|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2430360|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
2430361|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
2430362|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430363|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2430364|NCT00861627|Paclitaxel|paclitaxel|mesh-list
2430365|NCT00861627|Carboplatin|carboplatin|mesh-list
2430366|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2430367|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430368|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
2430369|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
2430370|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
2430371|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430372|NCT00861640|Omeprazole|omeprazole|mesh-list
2430373|NCT00861640|Rabeprazole|rabeprazole|mesh-list
2430374|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2430375|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2430376|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2430377|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430378|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430379|NCT00861731|Simvastatin|simvastatin|mesh-list
2430380|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2430381|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2430382|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
2430383|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430384|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2430385|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2430386|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430387|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
2430388|NCT00861783|Irinotecan|irinotecan|mesh-list
2430389|NCT00861783|Camptothecin|camptothecin|mesh-list
2430390|NCT00861783|ON 01910|on 01910|mesh-list
2430391|NCT00861783|Glycine|glycine|mesh-list
2430392|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430393|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2430394|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2430395|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430396|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430397|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2430398|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2430399|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
2430400|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430401|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430402|NCT00861861|Atorvastatin|atorvastatin|mesh-list
2430403|NCT00861861|Pitavastatin|pitavastatin|mesh-list
2430404|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2430405|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2430406|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
2430407|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430408|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2430409|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2430410|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430411|NCT00861874|Sirolimus|sirolimus|mesh-list
2430412|NCT00861874|Decitabine|decitabine|mesh-list
2430413|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2430414|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430415|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2430416|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430417|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
2430418|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2430419|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
2430420|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430421|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2430422|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
2430423|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430424|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430425|NCT00861887|Vancomycin|vancomycin|mesh-list
2430426|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2430427|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430428|NCT00861926|Beclomethasone|beclomethasone|mesh-list
2430429|NCT00861926|Albuterol|albuterol|mesh-list
2430430|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
2430431|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2430432|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
2430433|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430434|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430435|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2430436|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
2430437|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2430438|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2430439|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2430440|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
2430441|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430442|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430443|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
2430444|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2430445|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2430446|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
2430447|NCT00861926|Hormones|hormones|mesh-ancestor
2430448|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2430449|NCT00861939|Bupropion|bupropion|mesh-list
2430450|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2430451|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
2430452|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2430453|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2430454|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2430455|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430456|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430457|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
2430458|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430459|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430460|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2430461|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2430462|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430463|NCT00861952|Mineral Oil|mineral oil|mesh-list
2430464|NCT00861952|Emollients|emollients|mesh-ancestor
2430465|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
2430466|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
2430467|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430468|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
2430469|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2430470|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2430471|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430472|NCT00862043|Urological Agents|urological agents|mesh-ancestor
2430473|NCT00862095|Topiramate|topiramate|mesh-list
2430474|NCT00862095|Propranolol|propranolol|mesh-list
2430475|NCT00862095|Amitriptyline|amitriptyline|mesh-list
2430476|NCT00862095|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2430477|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2430478|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2430479|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
2430480|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430481|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430482|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430483|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2430484|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2430485|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
2430486|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
2430487|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2430488|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2430489|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
2430490|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2430491|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2430492|NCT00862095|Analgesics|analgesics|mesh-ancestor
2430493|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
2430494|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430495|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2430496|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2430497|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430498|NCT00862095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2430499|NCT00862095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2430500|NCT00862095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2430501|NCT00862108|Methylphenidate|methylphenidate|mesh-list
2430502|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2430503|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430504|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2430505|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2430506|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430507|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430508|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
2430509|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430510|NCT00862264|Beclomethasone|beclomethasone|mesh-list
2430511|NCT00862264|Norflurane|norflurane|mesh-list
2430512|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
2430513|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2430514|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
2430515|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430516|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430517|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2430518|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
2430519|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2430520|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2430521|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2430522|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
2430523|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430524|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430525|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2430526|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
2430527|NCT00862264|Hormones|hormones|mesh-ancestor
2430528|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2430529|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
2430530|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2430531|NCT00862329|Caseins|caseins|mesh-list
2430532|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
2430533|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
2430534|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430535|NCT00862342|Bevacizumab|bevacizumab|mesh-list
2430536|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2430537|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430538|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2430539|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2430540|NCT00862342|Growth Substances|growth substances|mesh-ancestor
2430541|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430542|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
2430543|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
2430544|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2430545|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
2430546|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2430547|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
2430548|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430549|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430550|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2430551|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
2430552|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2430553|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2430554|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2430555|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
2430556|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430557|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430558|NCT00862420|Ticlopidine|ticlopidine|mesh-list
2430559|NCT00862420|Clopidogrel|clopidogrel|mesh-list
2430560|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2430561|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2430562|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2430563|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2430564|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
2430565|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430566|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430567|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430568|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2430569|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2430570|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2430571|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2430572|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430573|NCT00862433|Vitamins|vitamins|mesh-list
2430574|NCT00862433|Vitamin E|vitamin e|mesh-list
2430575|NCT00862433|Tocopherols|tocopherols|mesh-list
2430576|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
2430577|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
2430578|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430579|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
2430580|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430581|NCT00862433|Protective Agents|protective agents|mesh-ancestor
2430582|NCT00862472|Timolol|timolol|mesh-list
2430583|NCT00862472|Cloprostenol|cloprostenol|mesh-list
2430584|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
2430585|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2430586|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
2430587|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2430588|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430589|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2430590|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2430591|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2430592|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
2430593|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430594|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430595|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2430596|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2430597|NCT00862524|Gemcitabine|gemcitabine|mesh-list
2430598|NCT00862524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2430599|NCT00862524|Antimetabolites|antimetabolites|mesh-ancestor
2430600|NCT00862524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430601|NCT00862524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430602|NCT00862524|Antiviral Agents|antiviral agents|mesh-ancestor
2430603|NCT00862524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430604|NCT00862524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430605|NCT00862524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2430606|NCT00862524|Immunologic Factors|immunologic factors|mesh-ancestor
2430607|NCT00862524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430608|NCT00862628|Rebamipide|rebamipide|mesh-list
2430609|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2430610|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2430611|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
2430612|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430613|NCT00862628|Protective Agents|protective agents|mesh-ancestor
2430614|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430615|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430616|NCT00862693|Calcitriol|calcitriol|mesh-list
2430617|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2430618|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430619|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2430620|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430621|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430622|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2430623|NCT00862693|Vitamins|vitamins|mesh-ancestor
2430624|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
2430625|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2430626|NCT00862706|Telbivudine|telbivudine|mesh-list
2430627|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
2430628|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430629|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2430630|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430631|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430632|NCT00862875|Insulin|insulin|mesh-list
2430633|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2430634|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
2430635|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
2430636|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2430637|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430638|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
2430639|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
2430640|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2430641|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2430642|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430643|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430644|NCT00862888|Urological Agents|urological agents|mesh-ancestor
2430645|NCT00862966|Heparin|heparin|mesh-list
2430646|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
2430647|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430648|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2430649|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2430650|NCT00863096|Vaccines|vaccines|mesh-list
2430651|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
2430652|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430653|NCT00863148|Busulfan|busulfan|mesh-list
2430654|NCT00863148|Clofarabine|clofarabine|mesh-list
2430655|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
2430656|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430657|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2430658|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
2430659|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430660|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2430661|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430662|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2430663|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2430664|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
2430665|NCT00863161|Lesogaberan|lesogaberan|mesh-list
2430666|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2430667|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2430668|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
2430669|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
2430670|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430671|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430672|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430673|NCT00863187|Rituximab|rituximab|mesh-list
2430674|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2430675|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430676|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
2430677|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430678|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2430679|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2430680|NCT00863239|Interferons|interferons|mesh-list
2430681|NCT00863239|Ribavirin|ribavirin|mesh-list
2430682|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
2430683|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
2430684|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2430685|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430686|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
2430687|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430688|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
2430689|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430690|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
2430691|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430692|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
2430693|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2207223|NCT00007917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207224|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207225|NCT00007917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207226|NCT00007917|Immunologic Factors|immunologic factors|mesh-ancestor
2207227|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207228|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
2207229|NCT00007917|Growth Substances|growth substances|mesh-ancestor
2207230|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2207231|NCT00007943|Gemcitabine|gemcitabine|mesh-list
2207232|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2207233|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
2207234|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207235|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207236|NCT00007943|Antiviral Agents|antiviral agents|mesh-ancestor
2207237|NCT00007943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207238|NCT00007943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207239|NCT00007943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207240|NCT00007943|Immunologic Factors|immunologic factors|mesh-ancestor
2207241|NCT00007943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207242|NCT00007956|Antibodies|antibodies|mesh-list
2207243|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2207244|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
2207245|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207246|NCT00007969|Verteporfin|verteporfin|mesh-list
2207247|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
2207248|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2207249|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
2207250|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2207251|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
2207252|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207253|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
2207254|NCT00007982|Thiotepa|thiotepa|mesh-list
2207255|NCT00007982|Carmustine|carmustine|mesh-list
2207256|NCT00007982|Etoposide|etoposide|mesh-list
2207257|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207258|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
2207259|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207260|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207261|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2207262|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
2207263|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430694|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430695|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2430696|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
2430697|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2430698|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430699|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430700|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430701|NCT00863291|Buprenorphine|buprenorphine|mesh-list
2430702|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2430703|NCT00863291|Narcotics|narcotics|mesh-ancestor
2430704|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2430705|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430706|NCT00863291|Analgesics|analgesics|mesh-ancestor
2430707|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
2430708|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430709|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2430710|NCT00863369|Gemcitabine|gemcitabine|mesh-list
2430711|NCT00863369|Rituximab|rituximab|mesh-list
2430712|NCT00863369|Bortezomib|bortezomib|mesh-list
2430713|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2430714|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430715|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
2430716|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430717|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2430718|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2430719|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
2430720|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430721|NCT00863369|Antiviral Agents|antiviral agents|mesh-ancestor
2430722|NCT00863369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430723|NCT00863369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430724|NCT00863369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2430725|NCT00863395|Lidocaine|lidocaine|mesh-list
2430726|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
2430727|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
2430728|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2430729|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430730|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
2430731|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430732|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2430733|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2430734|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2430735|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430736|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430737|NCT00863460|Cytarabine|cytarabine|mesh-list
2430738|NCT00863460|Prednisone|prednisone|mesh-list
2430739|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
2430740|NCT00863460|Busulfan|busulfan|mesh-list
2430741|NCT00863460|Thiotepa|thiotepa|mesh-list
2430742|NCT00863460|Carmustine|carmustine|mesh-list
2430743|NCT00863460|Methotrexate|methotrexate|mesh-list
2430744|NCT00863460|Etoposide|etoposide|mesh-list
2430745|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2430746|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
2430747|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430748|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2430749|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2430750|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
2430751|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430752|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430753|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2430754|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2430755|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
2430756|NCT00863460|Hormones|hormones|mesh-ancestor
2430757|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2430758|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2430759|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2430760|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
2430761|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2430762|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2430763|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
2430764|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
2430765|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430766|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2430767|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2430768|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2430769|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2430770|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2430771|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
2430772|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430773|NCT00863499|Methylphenidate|methylphenidate|mesh-list
2430774|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2430775|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430776|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2430777|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2430778|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430779|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430780|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
2430781|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430782|NCT00863577|Bemiparin|bemiparin|mesh-list
2430783|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
2430784|NCT00863629|Insulin|insulin|mesh-list
2430785|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2430786|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430787|NCT00863668|Tenofovir|tenofovir|mesh-list
2430788|NCT00863668|Emtricitabine|emtricitabine|mesh-list
2430789|NCT00863668|Efavirenz|efavirenz|mesh-list
2430790|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
2430791|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2430792|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
2430793|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
2430794|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
2430795|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430796|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2430797|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430798|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430799|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2430800|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2430801|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2430802|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2430803|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2430804|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2430805|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2430806|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2430807|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2430808|NCT00863733|Acetic Acid|acetic acid|mesh-list
2430809|NCT00863733|Vadimezan|vadimezan|mesh-list
2430810|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2430811|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430812|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430813|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
2430814|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2430815|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
2430816|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430817|NCT00863785|Expectorants|expectorants|mesh-ancestor
2430818|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
2430819|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2430820|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
2430821|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430822|NCT00863785|Protective Agents|protective agents|mesh-ancestor
2430823|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430824|NCT00863785|Antidotes|antidotes|mesh-ancestor
2430825|NCT00863837|Terlipressin|terlipressin|mesh-list
2430826|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
2430827|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2430828|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430829|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430830|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2430831|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2430832|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2430833|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
2430834|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430835|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430836|NCT00863863|Griseofulvin|griseofulvin|mesh-list
2430837|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
2430838|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430839|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2430840|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
2430841|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2430842|NCT00863889|Prednisolone|prednisolone|mesh-list
2430843|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
2430844|NCT00863889|Lidocaine|lidocaine|mesh-list
2430845|NCT00863889|Bupivacaine|bupivacaine|mesh-list
2430846|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2430847|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
2430848|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
2430849|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
2430850|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2430851|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430852|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
2430853|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430854|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2430855|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2430856|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2430857|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430858|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430859|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2430860|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
2430861|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
2430862|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2430863|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
2430864|NCT00863889|Hormones|hormones|mesh-ancestor
2430865|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2430866|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2430867|NCT00863889|Protective Agents|protective agents|mesh-ancestor
2430868|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2430869|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2430870|NCT00863902|Cetirizine|cetirizine|mesh-list
2430871|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2430872|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2430873|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2430874|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
2430875|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
2430876|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430877|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430878|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430879|NCT00863915|Ramipril|ramipril|mesh-list
2430880|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2430881|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
2430882|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430883|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430884|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2430885|NCT00863941|Bupropion|bupropion|mesh-list
2430886|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2430887|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
2430888|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2430889|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2430890|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2430891|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430892|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430893|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
2430894|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430895|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430896|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2430897|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2430898|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430899|NCT00863980|Telmisartan|telmisartan|mesh-list
2430900|NCT00863980|Candesartan|candesartan|mesh-list
2430901|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
2430902|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2430903|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2430904|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2430905|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430906|NCT00864006|Valproic Acid|valproic acid|mesh-list
2430907|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
2430908|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430909|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430910|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
2430911|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430912|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430913|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
2430914|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2430915|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2430916|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2430917|NCT00864019|Sertraline|sertraline|mesh-list
2430918|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
2430919|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2430920|NCT00864019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2430921|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2430922|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430923|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430924|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430925|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
2430926|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430927|NCT00864045|Olanzapine|olanzapine|mesh-list
2430928|NCT00864045|Sertindole|sertindole|mesh-list
2430929|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
2430930|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
2430931|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430932|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430933|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2430934|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2430935|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2430936|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2430937|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2430938|NCT00864045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2430939|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2430940|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430941|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430942|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430943|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
2430944|NCT00864058|Gabapentin|gabapentin|mesh-list
2430945|NCT00864058|Analgesics|analgesics|mesh-ancestor
2430946|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
2430947|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2430948|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430949|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
2430950|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2430951|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2430952|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2430953|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2430954|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2430955|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2430956|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430957|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430958|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
2430959|NCT00864071|Griseofulvin|griseofulvin|mesh-list
2430960|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
2430961|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430962|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
2430963|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2430964|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2430965|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430966|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
2430967|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
2430968|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2430969|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
2430970|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2430971|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
2430972|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2430973|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430974|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2430975|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2430976|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2430977|NCT00864149|Carvedilol|carvedilol|mesh-list
2430978|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2430979|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2430980|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
2430981|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2430982|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430983|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2430984|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2430985|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
2430986|NCT00864149|Protective Agents|protective agents|mesh-ancestor
2430987|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2430988|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2430989|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2430990|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
2430991|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2430992|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2430993|NCT00864162|Ramipril|ramipril|mesh-list
2430994|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2430995|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
2430996|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2430997|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2430998|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2430999|NCT00864175|Docetaxel|docetaxel|mesh-list
2431000|NCT00864175|Trastuzumab|trastuzumab|mesh-list
2431001|NCT00864175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431002|NCT00864175|Tubulin Modulators|tubulin modulators|mesh-ancestor
2431003|NCT00864175|Antimitotic Agents|antimitotic agents|mesh-ancestor
2431004|NCT00864175|Mitosis Modulators|mitosis modulators|mesh-ancestor
2431005|NCT00864175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431006|NCT00864175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2431007|NCT00864188|Beta Carotene|beta carotene|mesh-list
2431008|NCT00864188|Carotenoids|carotenoids|mesh-list
2431009|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
2431010|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431011|NCT00864188|Protective Agents|protective agents|mesh-ancestor
2431012|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431013|NCT00864188|Provitamins|provitamins|mesh-ancestor
2431014|NCT00864188|Vitamins|vitamins|mesh-ancestor
2431015|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
2431016|NCT00864201|Bosentan|bosentan|mesh-list
2431017|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2431018|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2431019|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431020|NCT00864214|Hormones|hormones|mesh-list
2431021|NCT00864214|Estradiol|estradiol|mesh-list
2431022|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431023|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431024|NCT00864214|Estrogens|estrogens|mesh-ancestor
2431025|NCT00864240|Clobetasol|clobetasol|mesh-list
2431026|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2431027|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
2431028|NCT00864240|Hormones|hormones|mesh-ancestor
2431029|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431030|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431031|NCT00864279|Cetirizine|cetirizine|mesh-list
2431032|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2431033|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2431034|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2431035|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
2431036|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
2431037|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431038|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431039|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431040|NCT00864305|Gabapentin|gabapentin|mesh-list
2431041|NCT00864305|Analgesics|analgesics|mesh-ancestor
2431042|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
2431043|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431044|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431045|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
2431046|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2431047|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2431048|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431049|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431050|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2431051|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2431052|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431053|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431054|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
2431055|NCT00864318|Paclitaxel|paclitaxel|mesh-list
2431056|NCT00864318|Etoposide|etoposide|mesh-list
2431057|NCT00864318|Ifosfamide|ifosfamide|mesh-list
2431058|NCT00864318|Carboplatin|carboplatin|mesh-list
2431059|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2431060|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431061|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
2431062|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
2431063|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
2431064|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431065|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2431066|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2431067|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431068|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2431069|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
2431070|NCT00864344|Sertraline|sertraline|mesh-list
2431071|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
2431072|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431073|NCT00864344|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2431074|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2431075|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2431076|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431077|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431078|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
2431079|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431080|NCT00864357|Ibuprofen|ibuprofen|mesh-list
2431081|NCT00864357|Oxycodone|oxycodone|mesh-list
2431082|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2431083|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2431084|NCT00864357|Analgesics|analgesics|mesh-ancestor
2431085|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
2431086|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431087|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431088|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2431089|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2431090|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2431091|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431092|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431093|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2431094|NCT00864357|Narcotics|narcotics|mesh-ancestor
2431095|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431096|NCT00864396|Lansoprazole|lansoprazole|mesh-list
2431097|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2431098|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2431099|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2431100|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431101|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431102|NCT00864409|Ropivacaine|ropivacaine|mesh-list
2431103|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
2431104|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
2431105|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431106|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431107|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
2431108|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431109|NCT00864435|Carvedilol|carvedilol|mesh-list
2431110|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2431111|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2431112|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
2431113|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431114|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431115|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431116|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2431117|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
2431118|NCT00864435|Protective Agents|protective agents|mesh-ancestor
2431119|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2431120|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2431121|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2431122|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
2431123|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2431124|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2431125|NCT00864448|Ramipril|ramipril|mesh-list
2431126|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2431127|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
2431128|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431129|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431130|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2431131|NCT00864474|Maraviroc|maraviroc|mesh-list
2431132|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2431133|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2431134|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431135|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2431136|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2431137|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
2431138|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2431139|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2431140|NCT00864500|Clobetasol|clobetasol|mesh-list
2431141|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2431142|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
2431143|NCT00864500|Hormones|hormones|mesh-ancestor
2431144|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431145|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431146|NCT00864526|Ibuprofen|ibuprofen|mesh-list
2431147|NCT00864526|Oxycodone|oxycodone|mesh-list
2431148|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2431149|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2431150|NCT00864526|Analgesics|analgesics|mesh-ancestor
2431151|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
2431152|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431153|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431154|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2431155|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2431156|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2431157|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431158|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431159|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2431160|NCT00864526|Narcotics|narcotics|mesh-ancestor
2431161|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431162|NCT00864552|Factor VIII|factor viii|mesh-list
2431163|NCT00864552|Coagulants|coagulants|mesh-ancestor
2431164|NCT00864565|Fentanyl|fentanyl|mesh-list
2431165|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2431166|NCT00864565|Narcotics|narcotics|mesh-ancestor
2431167|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431168|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431169|NCT00864565|Analgesics|analgesics|mesh-ancestor
2431170|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
2431171|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431172|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2431173|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2431174|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
2431175|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
2431176|NCT00864591|Adenosine|adenosine|mesh-list
2431177|NCT00864591|Analgesics|analgesics|mesh-ancestor
2431178|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
2431179|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431180|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207264|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207265|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2207266|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2207267|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2207268|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2207269|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207270|NCT00007995|Interferons|interferons|mesh-list
2207271|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
2207272|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
2207273|NCT00007995|Melphalan|melphalan|mesh-list
2207274|NCT00007995|Busulfan|busulfan|mesh-list
2207275|NCT00007995|Sargramostim|sargramostim|mesh-list
2207276|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207277|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
2207278|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207279|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207280|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2207281|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
2207282|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207283|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207284|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2207285|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
2207286|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207287|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
2207288|NCT00008008|Thiotepa|thiotepa|mesh-list
2207289|NCT00008008|Sargramostim|sargramostim|mesh-list
2207290|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2431181|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2431182|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
2431183|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2431184|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
2431185|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
2431186|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431187|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431188|NCT00864604|Nabumetone|nabumetone|mesh-list
2431189|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2431190|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2431191|NCT00864604|Analgesics|analgesics|mesh-ancestor
2431192|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
2431193|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431194|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431195|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2431196|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2431197|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2431198|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2431199|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431200|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431201|NCT00864617|Nifedipine|nifedipine|mesh-list
2431202|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2431203|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2431204|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431205|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2431206|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207291|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
2431207|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
2431208|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
2431209|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2431210|NCT00864643|Atorvastatin|atorvastatin|mesh-list
2431211|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2431212|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2431213|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
2431214|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431215|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2431216|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2431217|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431218|NCT00864669|Metformin|metformin|mesh-list
2431219|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2431220|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431221|NCT00864734|Metformin|metformin|mesh-list
2431222|NCT00864734|Glyburide|glyburide|mesh-list
2431223|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2431224|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431225|NCT00864747|Propranolol|propranolol|mesh-list
2431226|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2431227|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2431228|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
2431229|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431230|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431231|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431232|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2431233|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2431234|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
2431235|NCT00864760|Gabapentin|gabapentin|mesh-list
2431236|NCT00864760|Analgesics|analgesics|mesh-ancestor
2431237|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
2431238|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431239|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431240|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
2431241|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2431242|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2431243|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431244|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431245|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2431246|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2431247|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431248|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431249|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
2431250|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
2431251|NCT00864773|Growth Substances|growth substances|mesh-ancestor
2431252|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431253|NCT00864799|Misoprostol|misoprostol|mesh-list
2431254|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2431255|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
2431256|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2431257|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431258|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2431259|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2431260|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
2431261|NCT00864812|Fluticasone|fluticasone|mesh-list
2431262|NCT00864812|Xhance|xhance|mesh-list
2431263|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
2431264|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2431265|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2431266|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2431267|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2431268|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
2431269|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431270|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431271|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2431272|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
2431273|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
2431274|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2431275|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
2431276|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2431277|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
2431278|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431279|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431280|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2431281|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2431282|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2431283|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
2431284|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
2431285|NCT00864812|Hormones|hormones|mesh-ancestor
2431286|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431287|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
2431288|NCT00864825|Allopurinol|allopurinol|mesh-list
2431289|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
2431290|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431291|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431292|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
2431293|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2431294|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2431295|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
2431296|NCT00864825|Protective Agents|protective agents|mesh-ancestor
2431297|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431298|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2431299|NCT00864838|Acetazolamide|acetazolamide|mesh-list
2431300|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2431301|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2431302|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2431303|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2431304|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
2431305|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431306|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431307|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431308|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
2431309|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2431310|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431311|NCT00864838|Diuretics|diuretics|mesh-ancestor
2431312|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
2431313|NCT00864864|Sunitinib|sunitinib|mesh-list
2431314|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431315|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2431316|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2431317|NCT00864864|Growth Substances|growth substances|mesh-ancestor
2431318|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431319|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
2431320|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2431321|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431322|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431323|NCT00864890|Dexetimide|dexetimide|mesh-list
2431324|NCT00864890|Citalopram|citalopram|mesh-list
2431325|NCT00864890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2431326|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2431327|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2431328|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431329|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431330|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
2431331|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431332|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2431333|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
2431334|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431335|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2431336|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2431337|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
2431338|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
2431339|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431340|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2431341|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2431342|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
2431343|NCT00864942|Lenalidomide|lenalidomide|mesh-list
2431344|NCT00864942|Rituximab|rituximab|mesh-list
2431345|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2431346|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
2431347|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431348|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2431349|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2431350|NCT00864942|Growth Substances|growth substances|mesh-ancestor
2431351|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
2431352|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431353|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2431354|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2431355|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2431356|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
2431357|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431358|NCT00864968|Nabumetone|nabumetone|mesh-list
2431359|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2431360|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2431361|NCT00864968|Analgesics|analgesics|mesh-ancestor
2431362|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
2431363|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431364|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431365|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2431366|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2431367|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2431368|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2431369|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431370|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431371|NCT00864981|Bupropion|bupropion|mesh-list
2431372|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2431373|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
2431374|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431375|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2431376|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2431377|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2431378|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431379|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
2431380|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431381|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431382|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2431383|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2431384|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431385|NCT00865007|Ritonavir|ritonavir|mesh-list
2431386|NCT00865007|Lopinavir|lopinavir|mesh-list
2431387|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2431388|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2431389|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
2431390|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431391|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431392|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2431393|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2431394|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
2431395|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2431396|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2431397|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2431398|NCT00865033|Metformin|metformin|mesh-list
2431399|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2431400|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431401|NCT00865059|Gabapentin|gabapentin|mesh-list
2431402|NCT00865059|Analgesics|analgesics|mesh-ancestor
2431403|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
2431404|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431405|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431406|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
2431407|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2431408|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2431409|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431410|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431411|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2431412|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2431413|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431414|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431415|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
2431416|NCT00865072|Metformin|metformin|mesh-list
2431417|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2431418|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431419|NCT00865085|Dexetimide|dexetimide|mesh-list
2431420|NCT00865085|Citalopram|citalopram|mesh-list
2431421|NCT00865085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2431422|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2431423|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2431424|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431425|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431426|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
2431427|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431428|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2431429|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
2431430|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431431|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2431432|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2431433|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
2431434|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
2431435|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431436|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2431437|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2431438|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
2431439|NCT00865111|Bupropion|bupropion|mesh-list
2431440|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2431441|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
2431442|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431443|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2431444|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2431445|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2431446|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431447|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
2431448|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431449|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431450|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2431451|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2431452|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431453|NCT00865137|Tacrolimus|tacrolimus|mesh-list
2431454|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2431455|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
2431456|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431457|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2431458|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431459|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431460|NCT00865176|Eplerenone|eplerenone|mesh-list
2431461|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2431462|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
2431463|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431464|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431465|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2431466|NCT00865176|Diuretics|diuretics|mesh-ancestor
2431467|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
2431468|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2431469|NCT00865215|Propranolol|propranolol|mesh-list
2431470|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2431471|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2431472|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
2431473|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431474|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431475|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431476|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2431477|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2431478|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
2431479|NCT00865241|Metformin|metformin|mesh-list
2431480|NCT00865241|Glyburide|glyburide|mesh-list
2431481|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2431482|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431483|NCT00865267|Halobetasol|halobetasol|mesh-list
2431484|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2431485|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
2431486|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2431487|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2431488|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431489|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
2431490|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
2431491|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2431492|NCT00865371|Bupropion|bupropion|mesh-list
2431493|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2431494|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
2431495|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431496|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2431497|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2431498|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2431499|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431500|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
2431501|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431502|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431503|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2431504|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2431505|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431506|NCT00865384|Mirtazapine|mirtazapine|mesh-list
2431507|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
2431508|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431509|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2431510|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
2431511|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
2431512|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431513|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431514|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431515|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2431516|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2431517|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431518|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2431519|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2431520|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2431521|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
2431522|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2431523|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2431524|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
2431525|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2431526|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
2431527|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2431528|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431529|NCT00865410|Bupropion|bupropion|mesh-list
2431530|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2431531|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
2431532|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431533|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2431534|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2431535|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2431536|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431537|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
2431538|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431539|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431540|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2431541|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2431542|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431543|NCT00865423|Gabapentin|gabapentin|mesh-list
2431544|NCT00865423|Analgesics|analgesics|mesh-ancestor
2431545|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
2431546|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431547|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431548|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
2431549|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2431550|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2431551|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431552|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431553|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2431554|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2431555|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431556|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431557|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
2431558|NCT00865436|Metformin|metformin|mesh-list
2431559|NCT00865436|Glyburide|glyburide|mesh-list
2431560|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2431561|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431562|NCT00865449|Spironolactone|spironolactone|mesh-list
2431563|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2431564|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
2431565|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431566|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431567|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2431568|NCT00865449|Diuretics|diuretics|mesh-ancestor
2431569|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
2431570|NCT00865462|Bupropion|bupropion|mesh-list
2431571|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2431572|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
2431573|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431574|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2431575|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2431576|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2431577|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431578|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
2431579|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431580|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431581|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2431582|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2431583|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431584|NCT00865475|Lopinavir|lopinavir|mesh-list
2431585|NCT00865475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2431586|NCT00865475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2431587|NCT00865475|Protease Inhibitors|protease inhibitors|mesh-ancestor
2431588|NCT00865475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431589|NCT00865475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431590|NCT00865475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2431591|NCT00865475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2431592|NCT00865475|Antiviral Agents|antiviral agents|mesh-ancestor
2431593|NCT00865475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2431594|NCT00865475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2431595|NCT00865475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2431596|NCT00865501|Spironolactone|spironolactone|mesh-list
2431597|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2431598|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
2431599|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431600|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431601|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2431602|NCT00865501|Diuretics|diuretics|mesh-ancestor
2431603|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
2431604|NCT00865540|Prednisolone|prednisolone|mesh-list
2431605|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2431606|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
2431607|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2431608|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
2431609|NCT00865540|Ketorolac|ketorolac|mesh-list
2431610|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2431611|NCT00865540|Nepafenac|nepafenac|mesh-list
2431612|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2431613|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
2431614|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2431615|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
2431616|NCT00865540|Hormones|hormones|mesh-ancestor
2431617|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431618|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431619|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2431620|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431621|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
2431622|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
2431623|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431624|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2431625|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2431626|NCT00865540|Protective Agents|protective agents|mesh-ancestor
2431627|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2431628|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2431629|NCT00865540|Analgesics|analgesics|mesh-ancestor
2431630|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
2431631|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2431632|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2431633|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431634|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431635|NCT00865605|Clobetasol|clobetasol|mesh-list
2431636|NCT00865605|Halobetasol|halobetasol|mesh-list
2431637|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2431638|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2431639|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
2431640|NCT00865605|Hormones|hormones|mesh-ancestor
2431641|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431642|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431643|NCT00865618|Eplerenone|eplerenone|mesh-list
2431644|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2431645|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
2431646|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431647|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431648|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2431649|NCT00865618|Diuretics|diuretics|mesh-ancestor
2431650|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
2431651|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2431652|NCT00865631|Gabapentin|gabapentin|mesh-list
2431653|NCT00865631|Analgesics|analgesics|mesh-ancestor
2431654|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
2431655|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431656|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431657|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
2431658|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2431659|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2431660|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431661|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431662|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2431663|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2431664|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431665|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431666|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
2431667|NCT00865644|Imiquimod|imiquimod|mesh-list
2431668|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2431669|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
2431670|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431671|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431672|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
2431673|NCT00865657|Alprazolam|alprazolam|mesh-list
2431674|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2431675|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431676|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431677|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2431678|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2431679|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431680|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
2431681|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
2431682|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431683|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431684|NCT00865670|Azithromycin|azithromycin|mesh-list
2431685|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2431686|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2431687|NCT00865696|Mirtazapine|mirtazapine|mesh-list
2431688|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
2431689|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431690|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2431691|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
2431692|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
2431693|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431694|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431695|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431696|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2431697|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2431698|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431699|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2431700|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2431701|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2431702|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
2431703|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2431704|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2431705|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
2431706|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2431707|NCT00865748|Metformin|metformin|mesh-list
2431708|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2431709|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431710|NCT00865761|Alprazolam|alprazolam|mesh-list
2431711|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2431712|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431713|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431714|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2431715|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2431716|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431717|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
2431718|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
2431719|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431720|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431721|NCT00865839|Metformin|metformin|mesh-list
2431722|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2431723|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431724|NCT00865852|Metformin|metformin|mesh-list
2431725|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2431726|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431727|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2431728|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2431729|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
2431730|NCT00865891|Nifedipine|nifedipine|mesh-list
2431731|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2431732|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2431733|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431734|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2431735|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431736|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
2431737|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
2431738|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2431739|NCT00865917|Metoprolol|metoprolol|mesh-list
2431740|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2431741|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2431742|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2431743|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
2431744|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
2431745|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431746|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431747|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2431748|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2431749|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
2431750|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431751|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431752|NCT00865943|Dexetimide|dexetimide|mesh-list
2431753|NCT00865943|Citalopram|citalopram|mesh-list
2431754|NCT00865943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2431755|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2431756|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2431757|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431758|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431759|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
2431760|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431761|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2431762|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
2431763|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431764|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2431765|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2431766|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
2431767|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
2431768|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431769|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2431770|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2431771|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
2431772|NCT00865982|Docetaxel|docetaxel|mesh-list
2431773|NCT00865982|Capecitabine|capecitabine|mesh-list
2431774|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431775|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
2431776|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
2431777|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
2431778|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431779|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2431780|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
2431781|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2431782|NCT00866008|Ganirelix|ganirelix|mesh-list
2431783|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
2431784|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2431785|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
2431786|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2431787|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431788|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2431789|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2431790|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431791|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
2431792|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431793|NCT00866021|Ritonavir|ritonavir|mesh-list
2431794|NCT00866021|Lopinavir|lopinavir|mesh-list
2431795|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2431796|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2431797|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
2431798|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431799|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431800|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2431801|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2431802|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
2431803|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2431804|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2431805|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2431806|NCT00866060|Memantine|memantine|mesh-list
2431807|NCT00866060|Donepezil|donepezil|mesh-list
2431808|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2431809|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431810|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431811|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
2431812|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431813|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431814|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
2431815|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2431816|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2431817|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
2431818|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2431819|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2431820|NCT00866073|Decitabine|decitabine|mesh-list
2431821|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2431822|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
2431823|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431824|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431825|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431826|NCT00866216|Azithromycin|azithromycin|mesh-list
2431827|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2431828|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2431829|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2431830|NCT00866229|Simvastatin|simvastatin|mesh-list
2431831|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2431832|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2431833|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
2431834|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431835|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2431836|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2431837|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431838|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2431839|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2431840|NCT00866437|Estropipate|estropipate|mesh-list
2431841|NCT00866437|Estradiol|estradiol|mesh-list
2431842|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2431843|NCT00866437|Estrone|estrone|mesh-list
2431844|NCT00866437|Progesterone|progesterone|mesh-list
2431845|NCT00866437|Estrogens|estrogens|mesh-ancestor
2431846|NCT00866437|Hormones|hormones|mesh-ancestor
2431847|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431848|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431849|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2431850|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
2431851|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2431852|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2431853|NCT00866437|Progestins|progestins|mesh-ancestor
2431854|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
2431855|NCT00866450|Calcium|calcium|mesh-list
2431856|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2431857|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431858|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2431859|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
2431860|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
2431861|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2431862|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2431863|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431864|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431865|NCT00866463|Urological Agents|urological agents|mesh-ancestor
2431866|NCT00866515|Ketoconazole|ketoconazole|mesh-list
2431867|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
2431868|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2431869|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2431870|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2431871|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431872|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431873|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2431874|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
2431875|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431876|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431877|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2431878|NCT00866528|Paclitaxel|paclitaxel|mesh-list
2431879|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2431880|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431881|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
2431882|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
2431883|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
2431884|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431885|NCT00866554|Tamoxifen|tamoxifen|mesh-list
2431886|NCT00866554|Bicalutamide|bicalutamide|mesh-list
2431887|NCT00866554|Dutasteride|dutasteride|mesh-list
2431888|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2431889|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
2431890|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2431891|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431892|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2431893|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431894|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2431895|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2431896|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2431897|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
2431898|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2431899|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2431900|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431901|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431902|NCT00866593|Dexetimide|dexetimide|mesh-list
2431903|NCT00866593|Citalopram|citalopram|mesh-list
2431904|NCT00866593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2431905|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2431906|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2431907|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431908|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431909|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
2431910|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431911|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2431912|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
2431913|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431914|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2431915|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2431916|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
2431917|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
2431918|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431919|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2431920|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2431921|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
2431922|NCT00866645|Haloperidol|haloperidol|mesh-list
2431923|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
2431924|NCT00866645|Sulpiride|sulpiride|mesh-list
2431925|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2431926|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
2431927|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
2431928|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2431929|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431930|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2431931|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2431932|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2431933|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2431934|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2431935|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2431936|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
2431937|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431938|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431939|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2431940|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2431941|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
2431942|NCT00866684|Cyclosporine|cyclosporine|mesh-list
2431943|NCT00866684|Sirolimus|sirolimus|mesh-list
2431944|NCT00866684|Azathioprine|azathioprine|mesh-list
2431945|NCT00866684|Tacrolimus|tacrolimus|mesh-list
2431946|NCT00866684|Cyclosporins|cyclosporins|mesh-list
2431947|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2431948|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
2431949|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431950|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2431951|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431952|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431953|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
2431954|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2431955|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
2431956|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2431957|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2431958|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431959|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2431960|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
2431961|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2431962|NCT00866736|Dasatinib|dasatinib|mesh-list
2431963|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431964|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2431965|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431966|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431967|NCT00866762|Vorinostat|vorinostat|mesh-list
2431968|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2431969|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431970|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431971|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2431972|NCT00866840|Riluzole|riluzole|mesh-list
2431973|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
2431974|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2431975|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2431976|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2431977|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431978|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431979|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2431980|NCT00866840|Protective Agents|protective agents|mesh-ancestor
2431981|NCT00866853|Simeprevir|simeprevir|mesh-list
2431982|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
2431983|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2431984|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
2431985|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2431986|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431987|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
2431988|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2431989|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
2431990|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2431991|NCT00866866|Expectorants|expectorants|mesh-ancestor
2431992|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
2431993|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2431994|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
2431995|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2431996|NCT00866866|Protective Agents|protective agents|mesh-ancestor
2431997|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2431998|NCT00866866|Antidotes|antidotes|mesh-ancestor
2431999|NCT00866944|Leucovorin|leucovorin|mesh-list
2432000|NCT00866944|Fluorouracil|fluorouracil|mesh-list
2432001|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
2432002|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2432003|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
2432004|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432005|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2432006|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432007|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2432008|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
2432009|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432010|NCT00866944|Antidotes|antidotes|mesh-ancestor
2432011|NCT00866944|Protective Agents|protective agents|mesh-ancestor
2432012|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
2432013|NCT00866944|Vitamins|vitamins|mesh-ancestor
2432014|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
2432015|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
2432016|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
2432017|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2432018|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2432019|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432020|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432021|NCT00866983|Urological Agents|urological agents|mesh-ancestor
2432022|NCT00866996|Methylphenidate|methylphenidate|mesh-list
2432023|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2432024|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2432025|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432026|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2432027|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2432028|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2432029|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432030|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
2432031|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432032|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2432033|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
2432034|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2432035|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
2432036|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432037|NCT00867061|ON 01910|on 01910|mesh-list
2432038|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432039|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2432040|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432041|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432042|NCT00867126|Pioglitazone|pioglitazone|mesh-list
2432043|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2432044|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432045|NCT00867152|Ritonavir|ritonavir|mesh-list
2432046|NCT00867152|Lopinavir|lopinavir|mesh-list
2432047|NCT00867152|Darunavir|darunavir|mesh-list
2432048|NCT00867152|Dolutegravir|dolutegravir|mesh-list
2432049|NCT00867152|Etravirine|etravirine|mesh-list
2432050|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2432051|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2432052|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
2432053|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432054|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432055|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2432056|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2432057|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
2432058|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432059|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2432060|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2432061|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2432062|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2432063|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2432064|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2432097|NCT00867191|Desloratadine|desloratadine|mesh-list
2432098|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2432099|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
2432100|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432101|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432102|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432103|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2432104|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2432105|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
2432106|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
2432107|NCT00867295|Cefazolin|cefazolin|mesh-list
2432108|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2432109|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432110|NCT00867672|Decitabine|decitabine|mesh-list
2432111|NCT00867672|Tretinoin|tretinoin|mesh-list
2432112|NCT00867672|Valproic Acid|valproic acid|mesh-list
2432113|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2432114|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
2432115|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432116|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432117|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432118|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
2432119|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
2432120|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
2432121|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
2432122|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432123|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432124|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
2432125|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2432126|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2432127|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2432128|NCT00867737|Fluticasone|fluticasone|mesh-list
2432129|NCT00867737|Budesonide|budesonide|mesh-list
2432130|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
2432131|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2432132|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2432133|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2432134|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2432135|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2432136|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
2432137|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432138|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432139|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2432140|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
2432141|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
2432142|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2432143|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
2432144|NCT00867737|Hormones|hormones|mesh-ancestor
2432145|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2432146|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2432147|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2432148|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2432149|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
2432150|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432151|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432152|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
2432153|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
2432154|NCT00867867|Trace Elements|trace elements|mesh-ancestor
2432155|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
2432156|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432157|NCT00868010|Donepezil|donepezil|mesh-list
2432158|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2432159|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432160|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432161|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
2432162|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432163|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432164|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
2432165|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
2432166|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2432167|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
2432168|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432169|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432170|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2432171|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
2432172|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2432173|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2432174|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2432175|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
2432176|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432177|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432178|NCT00868062|Polygeline|polygeline|mesh-list
2432179|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
2432180|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
2432181|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
2432182|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2432183|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
2432184|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2432185|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432186|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2432187|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2432188|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2432189|NCT00868179|Dabigatran|dabigatran|mesh-list
2432190|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
2432191|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2432192|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
2432193|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432194|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432195|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
2432196|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
2432197|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2432198|NCT00868283|Protective Agents|protective agents|mesh-ancestor
2432199|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432200|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
2432201|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
2432202|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2432203|NCT00868413|Rituximab|rituximab|mesh-list
2432204|NCT00868413|Fludarabine|fludarabine|mesh-list
2432205|NCT00868413|Navitoclax|navitoclax|mesh-list
2432206|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2432207|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
2432208|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432209|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2432210|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2432211|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
2432212|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432213|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432214|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2432215|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2432216|NCT00868426|Budesonide|budesonide|mesh-list
2432217|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
2432218|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2432219|NCT00868426|Charcoal|charcoal|mesh-list
2432220|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2432221|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2432222|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
2432223|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432224|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432225|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2432226|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
2432227|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
2432228|NCT00868426|Hormones|hormones|mesh-ancestor
2432229|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2432230|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2432231|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2432232|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2432233|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
2432234|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432235|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432236|NCT00868426|Antidotes|antidotes|mesh-ancestor
2432237|NCT00868426|Protective Agents|protective agents|mesh-ancestor
2432238|NCT00868465|Lumefantrine|lumefantrine|mesh-list
2432239|NCT00868465|Artemether|artemether|mesh-list
2432240|NCT00868465|Piperaquine|piperaquine|mesh-list
2432241|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2432242|NCT00868465|Artenimol|artenimol|mesh-list
2432243|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
2432244|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2432245|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2432246|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432247|NCT00868491|Cisplatin|cisplatin|mesh-list
2432248|NCT00868491|Docetaxel|docetaxel|mesh-list
2432249|NCT00868491|Fluorouracil|fluorouracil|mesh-list
2432250|NCT00868491|Cetuximab|cetuximab|mesh-list
2432251|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432252|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
2432253|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
2432254|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
2432255|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432256|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
2432257|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2432258|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2432259|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
2432260|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432261|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2432262|NCT00868569|Leucovorin|leucovorin|mesh-list
2432263|NCT00868569|Fluorouracil|fluorouracil|mesh-list
2432264|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
2432265|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
2432266|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432267|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2432268|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432269|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2432270|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
2432271|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432272|NCT00868569|Antidotes|antidotes|mesh-ancestor
2432273|NCT00868569|Protective Agents|protective agents|mesh-ancestor
2432274|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
2432275|NCT00868569|Vitamins|vitamins|mesh-ancestor
2432276|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
2432277|NCT00868634|Bevacizumab|bevacizumab|mesh-list
2432278|NCT00868634|Capecitabine|capecitabine|mesh-list
2432279|NCT00868634|Vinorelbine|vinorelbine|mesh-list
2432280|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2432281|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432282|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2432283|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2432284|NCT00868634|Growth Substances|growth substances|mesh-ancestor
2432285|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432286|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
2432287|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2432288|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
2432289|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432290|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2207292|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207293|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207294|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2207295|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
2207296|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207297|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207298|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2207299|NCT00008021|Cyclosporine|cyclosporine|mesh-list
2207300|NCT00008021|Paclitaxel|paclitaxel|mesh-list
2207301|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2207302|NCT00008021|Antibodies|antibodies|mesh-list
2207303|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
2207304|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2207305|NCT00008021|Cyclosporins|cyclosporins|mesh-list
2207306|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2207307|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207308|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
2207309|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
2207310|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
2207311|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207312|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
2432291|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
2432292|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
2432293|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
2432294|NCT00868738|Vitamin D|vitamin d|mesh-list
2432295|NCT00868738|Vitamins|vitamins|mesh-ancestor
2432296|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
2432297|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432298|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2432299|NCT00868764|Granisetron|granisetron|mesh-list
2432300|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
2432301|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
2432302|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432303|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432304|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2432305|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2432306|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
2432307|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432308|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432309|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
2432310|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432311|NCT00868829|Chromium|chromium|mesh-list
2432312|NCT00868829|Sirolimus|sirolimus|mesh-list
2432313|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2432314|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432315|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2432316|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432317|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
2432318|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2432319|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
2432320|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432321|NCT00868829|Trace Elements|trace elements|mesh-ancestor
2432322|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
2432323|NCT00868855|Bradykinin|bradykinin|mesh-list
2207313|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207314|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207315|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207316|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
2207317|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207318|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
2207319|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207320|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2207321|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
2207322|NCT00008034|Capecitabine|capecitabine|mesh-list
2207323|NCT00008034|Epirubicin|epirubicin|mesh-list
2207324|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2432324|NCT00868855|Kininogens|kininogens|mesh-list
2432325|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
2432326|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2432327|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
2432328|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432329|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432330|NCT00868894|Latanoprost|latanoprost|mesh-list
2432331|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2432332|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2432333|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
2432334|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
2432335|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2432336|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2432337|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432338|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2432339|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432340|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2432341|NCT00868946|Ribavirin|ribavirin|mesh-list
2432342|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
2432343|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432344|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
2432345|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432346|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2432347|NCT00868985|Laxatives|laxatives|mesh-ancestor
2432348|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2432349|NCT00869063|Diclofenac|diclofenac|mesh-list
2432350|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2432351|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2432352|NCT00869063|Analgesics|analgesics|mesh-ancestor
2432353|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
2432354|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432355|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432356|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2432357|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2432358|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2432359|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432360|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432361|NCT00869180|Diclofenac|diclofenac|mesh-list
2432362|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2432363|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2432364|NCT00869180|Analgesics|analgesics|mesh-ancestor
2432365|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
2432366|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432367|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432368|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2432369|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2432370|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2432371|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432372|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432373|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
2432374|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2432375|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432376|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
2432377|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432378|NCT00869193|Protective Agents|protective agents|mesh-ancestor
2432379|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432380|NCT00869219|Nepafenac|nepafenac|mesh-list
2432381|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2432382|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2432383|NCT00869219|Analgesics|analgesics|mesh-ancestor
2432384|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
2432385|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432386|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432387|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2432388|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2432389|NCT00869232|Thalidomide|thalidomide|mesh-list
2432390|NCT00869232|Dexamethasone|dexamethasone|mesh-list
2432391|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
2432392|NCT00869232|Melphalan|melphalan|mesh-list
2432393|NCT00869232|Doxorubicin|doxorubicin|mesh-list
2432394|NCT00869232|Etoposide|etoposide|mesh-list
2432395|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2432396|NCT00869232|Bortezomib|bortezomib|mesh-list
2432397|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2432398|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
2432399|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432400|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2432401|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2432402|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
2432403|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432404|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432405|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2432406|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2432407|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
2432408|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
2432409|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432410|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2432411|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
2432412|NCT00869232|Hormones|hormones|mesh-ancestor
2432413|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2432414|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2432415|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2432416|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2432417|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2432418|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432419|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2432420|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
2432421|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2432422|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432423|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2432424|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2432425|NCT00869232|Growth Substances|growth substances|mesh-ancestor
2432426|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
2432427|NCT00869271|Leucovorin|leucovorin|mesh-list
2432428|NCT00869271|Fluorouracil|fluorouracil|mesh-list
2432429|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
2432430|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
2432431|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432432|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2432433|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432434|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2432435|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
2432436|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432437|NCT00869271|Antidotes|antidotes|mesh-ancestor
2432438|NCT00869271|Protective Agents|protective agents|mesh-ancestor
2432439|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
2432440|NCT00869271|Vitamins|vitamins|mesh-ancestor
2432441|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
2432442|NCT00869310|Dexamethasone|dexamethasone|mesh-list
2432443|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
2432444|NCT00869310|Aprepitant|aprepitant|mesh-list
2432445|NCT00869310|Metoclopramide|metoclopramide|mesh-list
2432446|NCT00869310|BB 1101|bb 1101|mesh-list
2432447|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2432448|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
2207325|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
2207326|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207327|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207328|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2207329|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
2207330|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207331|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207332|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2432449|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
2432450|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432451|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432452|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2432453|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
2432454|NCT00869310|Hormones|hormones|mesh-ancestor
2432455|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2432456|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2432457|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432458|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
2432459|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432460|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432461|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2432462|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432463|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2432464|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2432465|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
2432466|NCT00869336|Luliconazole|luliconazole|mesh-list
2432467|NCT00869336|Antifungal Agents|antifungal agents|mesh-ancestor
2432468|NCT00869336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432469|NCT00869427|Ascorbic Acid|ascorbic acid|mesh-list
2432470|NCT00869427|Vitamins|vitamins|mesh-ancestor
2432471|NCT00869427|Micronutrients|micronutrients|mesh-ancestor
2432472|NCT00869427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432473|NCT00869427|Antioxidants|antioxidants|mesh-ancestor
2432474|NCT00869427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432475|NCT00869427|Protective Agents|protective agents|mesh-ancestor
2432476|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2432477|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
2432478|NCT00869570|Capecitabine|capecitabine|mesh-list
2432479|NCT00869570|Sorafenib|sorafenib|mesh-list
2432480|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2432481|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
2432482|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432483|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432484|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2432485|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432486|NCT00869596|Fluticasone|fluticasone|mesh-list
2432487|NCT00869596|Xhance|xhance|mesh-list
2432488|NCT00869596|Albuterol|albuterol|mesh-list
2432489|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2432490|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2432491|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
2432492|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432493|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432494|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2432495|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
2432496|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
2432497|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2432498|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
2432499|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2432500|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2432501|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2432502|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2432503|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
2432504|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432505|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432506|NCT00869661|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2432507|NCT00869661|Interferon-alpha|interferon-alpha|mesh-list
2432508|NCT00869661|Ribavirin|ribavirin|mesh-list
2432509|NCT00869661|Antiviral Agents|antiviral agents|mesh-ancestor
2432510|NCT00869661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432511|NCT00869661|Immunologic Factors|immunologic factors|mesh-ancestor
2432512|NCT00869661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432513|NCT00869661|Antimetabolites|antimetabolites|mesh-ancestor
2432514|NCT00869661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432515|NCT00869700|Lumefantrine|lumefantrine|mesh-list
2432516|NCT00869700|Artemether|artemether|mesh-list
2207333|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2207334|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
2207335|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2207336|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2207337|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2207338|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207339|NCT00008047|Paclitaxel|paclitaxel|mesh-list
2207340|NCT00008047|Fluorouracil|fluorouracil|mesh-list
2207341|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
2207342|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2207343|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207344|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
2207345|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
2207346|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
2207347|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207348|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
2207349|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2207350|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207351|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
2207352|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207353|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
2207354|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207355|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2207356|NCT00008060|Leucovorin|leucovorin|mesh-list
2207357|NCT00008060|Fluorouracil|fluorouracil|mesh-list
2207358|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
2432517|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2432518|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
2432519|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2432520|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2432521|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432522|NCT00869752|Etoposide|etoposide|mesh-list
2432523|NCT00869752|Antibodies|antibodies|mesh-list
2432524|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2432525|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432526|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
2432527|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432528|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2432529|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2432530|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2432531|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432532|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432533|NCT00869765|Cycloserine|cycloserine|mesh-list
2432534|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2432535|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432536|NCT00869765|Renal Agents|renal agents|mesh-ancestor
2432537|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2432538|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
2432539|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2432540|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
2432541|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432542|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
2432543|NCT00869856|Hematinics|hematinics|mesh-ancestor
2432544|NCT00869869|Melatonin|melatonin|mesh-list
2432545|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
2432546|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432547|NCT00869869|Protective Agents|protective agents|mesh-ancestor
2432548|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432549|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2432550|NCT00869908|Insulin|insulin|mesh-list
2432551|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2432552|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
2432553|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
2432554|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2432555|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
2432556|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
2432557|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2432558|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432559|NCT00869973|Dexamethasone|dexamethasone|mesh-list
2432560|NCT00869973|Aprepitant|aprepitant|mesh-list
2432561|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2432562|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
2432563|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
2432564|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432565|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432566|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2207359|NCT00008060|Irinotecan|irinotecan|mesh-list
2207360|NCT00008060|Calcium|calcium|mesh-list
2432567|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
2432568|NCT00869973|Hormones|hormones|mesh-ancestor
2432569|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2432570|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2432571|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432572|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2432573|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432574|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432575|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2432576|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2432577|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432578|NCT00870038|Paclitaxel|paclitaxel|mesh-list
2432579|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2432580|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432581|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
2432582|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
2432583|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
2432584|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432585|NCT00870142|Amlodipine|amlodipine|mesh-list
2432586|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2432587|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2432588|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2432589|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432590|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2432591|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432592|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
2432593|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2432594|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2432595|NCT00870220|Estradiol|estradiol|mesh-list
2432596|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2432597|NCT00870220|Estrogens|estrogens|mesh-ancestor
2432598|NCT00870220|Hormones|hormones|mesh-ancestor
2432599|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2432600|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432601|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2432602|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
2432603|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2432604|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2432605|NCT00870272|Misoprostol|misoprostol|mesh-list
2432606|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2432607|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
2432608|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2432609|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432610|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2432611|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2432612|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
2432613|NCT00870298|Trimethoprim|trimethoprim|mesh-list
2432614|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
2432615|NCT00870298|Warfarin|warfarin|mesh-list
2432616|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
2432617|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2432618|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432619|NCT00870298|Renal Agents|renal agents|mesh-ancestor
2432620|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
2432621|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2432622|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2432623|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2432624|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432625|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432626|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2432627|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2432628|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2432629|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
2432630|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
2432631|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2432632|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432633|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432634|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
2432635|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2432636|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2432637|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432638|NCT00870337|Everolimus|everolimus|mesh-list
2432639|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432640|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2432641|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
2432642|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432643|NCT00870402|Spironolactone|spironolactone|mesh-list
2432644|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2432645|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
2432646|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2432647|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432648|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2432649|NCT00870402|Diuretics|diuretics|mesh-ancestor
2432650|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
2432651|NCT00870441|Valacyclovir|valacyclovir|mesh-list
2432652|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
2432653|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432654|NCT00870454|Pregabalin|pregabalin|mesh-list
2432655|NCT00870454|Analgesics|analgesics|mesh-ancestor
2432656|NCT00870454|Sensory System Agents|sensory system agents|mesh-ancestor
2432657|NCT00870454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432658|NCT00870454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432659|NCT00870454|Anticonvulsants|anticonvulsants|mesh-ancestor
2432660|NCT00870454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2432661|NCT00870454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2432662|NCT00870454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432663|NCT00870454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2432664|NCT00870454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2432665|NCT00870454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2432666|NCT00870454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2432667|NCT00870454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2432668|NCT00870480|Finasteride|finasteride|mesh-list
2432669|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2432670|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2432671|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432672|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432673|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
2432674|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2432675|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432676|NCT00870480|Urological Agents|urological agents|mesh-ancestor
2432677|NCT00870532|Sorafenib|sorafenib|mesh-list
2432678|NCT00870532|Vinorelbine|vinorelbine|mesh-list
2432679|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432680|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2432681|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432682|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432683|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2432684|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
2432685|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
2432686|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
2432687|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
2432688|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432689|NCT00870571|Amlodipine|amlodipine|mesh-list
2432690|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2432691|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2432692|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2432693|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432694|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2432695|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432696|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
2432697|NCT00870636|Bevacizumab|bevacizumab|mesh-list
2432698|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2432699|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432700|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2432701|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2432702|NCT00870636|Growth Substances|growth substances|mesh-ancestor
2432703|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432704|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
2432705|NCT00870714|Ketoconazole|ketoconazole|mesh-list
2432706|NCT00870714|Docetaxel|docetaxel|mesh-list
2432707|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432708|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
2432709|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
2432710|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
2432711|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432712|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
2432713|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432714|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2432715|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2432716|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432717|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2432718|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
2432719|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2432720|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432721|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2432722|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2432723|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2432724|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
2432725|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
2207361|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
2207362|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2207363|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207364|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
2207365|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207366|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2207367|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207368|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207369|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
2207370|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2207371|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2207372|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207373|NCT00008060|Antidotes|antidotes|mesh-ancestor
2207374|NCT00008060|Protective Agents|protective agents|mesh-ancestor
2207375|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
2207376|NCT00008060|Vitamins|vitamins|mesh-ancestor
2207377|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
2207378|NCT00008073|Doxorubicin|doxorubicin|mesh-list
2207379|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2432726|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2432727|NCT00870883|Deferoxamine|deferoxamine|mesh-list
2432728|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
2432729|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432730|NCT00870883|Expectorants|expectorants|mesh-ancestor
2432731|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
2432732|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2432733|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
2207380|NCT00008073|Octreotide|octreotide|mesh-list
2207381|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2432734|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432735|NCT00870883|Protective Agents|protective agents|mesh-ancestor
2432736|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432737|NCT00870883|Antidotes|antidotes|mesh-ancestor
2432738|NCT00870883|Siderophores|siderophores|mesh-ancestor
2432739|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2432740|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
2432741|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
2432742|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
2432743|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2432744|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432745|NCT00870961|Vitamins|vitamins|mesh-ancestor
2432746|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
2432747|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2432748|NCT00870987|Vaccines|vaccines|mesh-list
2432749|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
2432750|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432751|NCT00871039|Midazolam|midazolam|mesh-list
2432752|NCT00871039|Propofol|propofol|mesh-list
2432753|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2432754|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2432755|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432756|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2432757|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
2432758|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
2432759|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2432760|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2432761|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2432762|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2432763|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
2432764|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
2432765|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432766|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432767|NCT00871052|Vitamin D|vitamin d|mesh-list
2432768|NCT00871052|Calcipotriene|calcipotriene|mesh-list
2432769|NCT00871052|Vitamins|vitamins|mesh-ancestor
2432770|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
2432771|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432772|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2432773|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
2432774|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
2432775|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432776|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
2432777|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2432778|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2432779|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432780|NCT00871065|Urological Agents|urological agents|mesh-ancestor
2432781|NCT00871104|Vancomycin|vancomycin|mesh-list
2432782|NCT00871104|Imipenem|imipenem|mesh-list
2432783|NCT00871104|Fosfomycin|fosfomycin|mesh-list
2432784|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2432785|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432786|NCT00871156|Chloroquine|chloroquine|mesh-list
2432787|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2432788|NCT00871156|Tafenoquine|tafenoquine|mesh-list
2432789|NCT00871156|Amebicides|amebicides|mesh-ancestor
2432790|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2432791|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2432792|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432793|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
2432794|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2432795|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2432796|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2432797|NCT00871156|Analgesics|analgesics|mesh-ancestor
2432798|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
2432799|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432800|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432801|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2432802|NCT00871156|Filaricides|filaricides|mesh-ancestor
2432803|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
2432804|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
2432805|NCT00871182|Tiotropium Bromide|tiotropium bromide|mesh-list
2432806|NCT00871182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2432807|NCT00871182|Autonomic Agents|autonomic agents|mesh-ancestor
2432808|NCT00871182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432809|NCT00871182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432810|NCT00871182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2432811|NCT00871182|Respiratory System Agents|respiratory system agents|mesh-ancestor
2432812|NCT00871182|Parasympatholytics|parasympatholytics|mesh-ancestor
2432813|NCT00871182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2432814|NCT00871182|Cholinergic Agents|cholinergic agents|mesh-ancestor
2432815|NCT00871182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432816|NCT00871182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432817|NCT00871208|Retapamulin|retapamulin|mesh-list
2432818|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
2432819|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2432820|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2432821|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2432822|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
2432823|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
2432824|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2432825|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2432826|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432827|NCT00871247|Finasteride|finasteride|mesh-list
2432828|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2432829|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2432830|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432831|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432832|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
2432833|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2432834|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432835|NCT00871247|Urological Agents|urological agents|mesh-ancestor
2432836|NCT00871273|Capecitabine|capecitabine|mesh-list
2432837|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2432838|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
2432839|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432840|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432841|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2432842|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2432843|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2432844|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2432845|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432846|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432847|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432848|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2432849|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
2432850|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2432851|NCT00871442|Fentanyl|fentanyl|mesh-list
2432852|NCT00871442|Bupivacaine|bupivacaine|mesh-list
2432853|NCT00871442|Anesthetics|anesthetics|mesh-list
2432854|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
2432855|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2432856|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432857|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
2432858|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432859|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2432860|NCT00871442|Narcotics|narcotics|mesh-ancestor
2432861|NCT00871442|Analgesics|analgesics|mesh-ancestor
2432862|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2432863|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2432864|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
2432865|NCT00871455|Baclofen|baclofen|mesh-list
2432866|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2432867|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432868|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2432869|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432870|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2432871|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
2432872|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
2432873|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432874|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432875|NCT00871481|Aldesleukin|aldesleukin|mesh-list
2432876|NCT00871481|Cyclophosphamide|cyclophosphamide|mesh-list
2432877|NCT00871481|Ipilimumab|ipilimumab|mesh-list
2432878|NCT00871481|Interleukin-2|interleukin-2|mesh-list
2432879|NCT00871481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2432880|NCT00871481|Antibodies|antibodies|mesh-list
2432881|NCT00871481|Immunoglobulins|immunoglobulins|mesh-list
2432882|NCT00871481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2432883|NCT00871481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2432884|NCT00871481|Immunologic Factors|immunologic factors|mesh-ancestor
2432885|NCT00871481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432886|NCT00871481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2432887|NCT00871481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2432888|NCT00871481|Alkylating Agents|alkylating agents|mesh-ancestor
2432889|NCT00871481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432890|NCT00871481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432891|NCT00871481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2432892|NCT00871481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2432893|NCT00871481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2432894|NCT00871481|Analgesics|analgesics|mesh-ancestor
2432895|NCT00871481|Sensory System Agents|sensory system agents|mesh-ancestor
2432896|NCT00871481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432897|NCT00871481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2432898|NCT00871481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2432899|NCT00871481|Antiviral Agents|antiviral agents|mesh-ancestor
2432900|NCT00871481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432901|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2432902|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2432903|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432904|NCT00871507|Incretins|incretins|mesh-ancestor
2432905|NCT00871507|Hormones|hormones|mesh-ancestor
2432906|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2432907|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2432908|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
2432909|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432910|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432911|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
2432912|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
2432913|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2432914|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2432915|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
2432916|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432917|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
2432918|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432919|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432920|NCT00871546|Bortezomib|bortezomib|mesh-list
2432921|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
2432922|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432923|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2432924|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2432925|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
2432926|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432927|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
2432928|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2432929|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432930|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2432931|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2432932|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
2432933|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432934|NCT00871910|Dexamethasone|dexamethasone|mesh-list
2432935|NCT00871910|Ondansetron|ondansetron|mesh-list
2432936|NCT00871910|Aprepitant|aprepitant|mesh-list
2432937|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2432938|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
2432939|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
2432940|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432941|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432942|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2432943|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
2432944|NCT00871910|Hormones|hormones|mesh-ancestor
2432945|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2432946|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2432947|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432948|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
2432949|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
2432950|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2432951|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
2432952|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432953|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432954|NCT00871910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2432955|NCT00871910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2432956|NCT00871910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2432957|NCT00871910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2432958|NCT00871910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2432959|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2432960|NCT00871936|Metformin|metformin|mesh-list
2432961|NCT00871936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2432962|NCT00871936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432963|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
2432964|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432965|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2432966|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432967|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432968|NCT00872014|Sorafenib|sorafenib|mesh-list
2432969|NCT00872014|Trebananib|trebananib|mesh-list
2432970|NCT00872014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2432971|NCT00872014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2432972|NCT00872014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2432973|NCT00872014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432974|NCT00872014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2432975|NCT00872014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2432976|NCT00872014|Growth Substances|growth substances|mesh-ancestor
2432977|NCT00872014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432978|NCT00872014|Growth Inhibitors|growth inhibitors|mesh-ancestor
2432979|NCT00872131|Sertraline|sertraline|mesh-list
2432980|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
2432981|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2432982|NCT00872131|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2432983|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2432984|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2432985|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2432986|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2432987|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
2432988|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432989|NCT00872144|Nabiximols|nabiximols|mesh-list
2432990|NCT00872144|Analgesics|analgesics|mesh-ancestor
2432991|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
2432992|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2432993|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2432994|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
2432995|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2432996|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2432997|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2432998|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2432999|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433000|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433001|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433002|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2433003|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2433004|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2433005|NCT00872235|Quinapril|quinapril|mesh-list
2433006|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2433007|NCT00872235|Diuretics|diuretics|mesh-ancestor
2433008|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
2433009|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433010|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2433011|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2433012|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433013|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2433014|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
2433015|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433016|NCT00872248|Anesthetics|anesthetics|mesh-list
2433017|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2433018|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433019|NCT00872274|Sumatriptan|sumatriptan|mesh-list
2433020|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2433021|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2433022|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2433023|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
2433024|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433025|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433026|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433027|NCT00872365|Micronutrients|micronutrients|mesh-list
2433028|NCT00872365|Trace Elements|trace elements|mesh-list
2433029|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433030|NCT00872378|Exenatide|exenatide|mesh-list
2433031|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2433032|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433033|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2433034|NCT00872378|Incretins|incretins|mesh-ancestor
2433035|NCT00872378|Hormones|hormones|mesh-ancestor
2433036|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2433037|NCT00872417|Lamivudine|lamivudine|mesh-list
2433038|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2433039|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2433040|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433041|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433042|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
2433043|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433044|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2433045|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2433046|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
2433047|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2433048|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2433049|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433050|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
2433051|NCT00872469|Coagulants|coagulants|mesh-ancestor
2433052|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
2433053|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2433054|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207382|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207383|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2207384|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2207385|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207386|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207387|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2207388|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2207389|NCT00008086|Calcitriol|calcitriol|mesh-list
2207390|NCT00008086|Carboplatin|carboplatin|mesh-list
2207391|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207392|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2207393|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433055|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2433056|NCT00872586|Olmesartan|olmesartan|mesh-list
2433057|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2433058|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2433059|NCT00872586|Diuretics|diuretics|mesh-ancestor
2433060|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
2433061|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433062|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2433063|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2433064|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433065|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2433066|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2433067|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
2433068|NCT00872625|Docetaxel|docetaxel|mesh-list
2433069|NCT00872625|Fluorouracil|fluorouracil|mesh-list
2433070|NCT00872625|Epirubicin|epirubicin|mesh-list
2433071|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2433072|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
2433073|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433074|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2433075|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2433076|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
2433077|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433078|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433079|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2433080|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
2433081|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
2433082|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
2433083|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
2433084|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2433085|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2433086|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2433087|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2433088|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433089|NCT00872651|Timolol|timolol|mesh-list
2433090|NCT00872651|Travoprost|travoprost|mesh-list
2433091|NCT00872651|Latanoprost|latanoprost|mesh-list
2433092|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2433093|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2433094|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
2433095|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433096|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433097|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433098|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2433099|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2433100|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2433101|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2433102|NCT00872664|Carotenoids|carotenoids|mesh-list
2433103|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
2433104|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433105|NCT00872664|Protective Agents|protective agents|mesh-ancestor
2433106|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433107|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2433108|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
2433109|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2433110|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2433111|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2433112|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2433113|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433114|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2433115|NCT00872781|Quinapril|quinapril|mesh-list
2433116|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2433117|NCT00872781|Diuretics|diuretics|mesh-ancestor
2433118|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
2433119|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433120|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2433121|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2433122|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433123|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2433124|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
2433125|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433126|NCT00872885|Morphine|morphine|mesh-list
2433127|NCT00872885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2433128|NCT00872885|Narcotics|narcotics|mesh-ancestor
2433129|NCT00872885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2433130|NCT00872885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433131|NCT00872885|Analgesics|analgesics|mesh-ancestor
2433132|NCT00872885|Sensory System Agents|sensory system agents|mesh-ancestor
2433133|NCT00872885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2433134|NCT00872924|Sumatriptan|sumatriptan|mesh-list
2433135|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2433136|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2433137|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2433138|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
2433139|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433140|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433141|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433142|NCT00872950|Amifampridine|amifampridine|mesh-list
2433143|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2433144|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2433145|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433146|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2433147|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2433148|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433149|NCT00872963|Vaccines|vaccines|mesh-list
2433150|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
2433151|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433152|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2433153|NCT00872976|Dasatinib|dasatinib|mesh-list
2433154|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2433155|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
2433156|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433157|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433158|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2433159|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433160|NCT00873002|Sorafenib|sorafenib|mesh-list
2433161|NCT00873002|Panobinostat|panobinostat|mesh-list
2433162|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433163|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2433164|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433165|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433166|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2433167|NCT00873197|Granisetron|granisetron|mesh-list
2433168|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
2433169|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
2433170|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2433171|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433172|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2433173|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2433174|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
2433175|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433176|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433177|NCT00873210|Sunitinib|sunitinib|mesh-list
2433178|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433179|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2433180|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2433181|NCT00873210|Growth Substances|growth substances|mesh-ancestor
2433182|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433183|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
2433184|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2433185|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433186|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433187|NCT00873223|Liraglutide|liraglutide|mesh-list
2433188|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
2433189|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2433190|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433191|NCT00873223|Incretins|incretins|mesh-ancestor
2433192|NCT00873223|Hormones|hormones|mesh-ancestor
2433193|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2433194|NCT00873236|Interferons|interferons|mesh-list
2433195|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
2433196|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
2433197|NCT00873236|Bevacizumab|bevacizumab|mesh-list
2433198|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2433199|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433200|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2433201|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2433202|NCT00873236|Growth Substances|growth substances|mesh-ancestor
2433203|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433204|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
2433205|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
2433206|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433207|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
2433208|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2433209|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2433210|NCT00873262|Estropipate|estropipate|mesh-list
2433211|NCT00873262|Estradiol|estradiol|mesh-list
2433212|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2433213|NCT00873262|Estrone|estrone|mesh-list
2433214|NCT00873262|Progesterone|progesterone|mesh-list
2433215|NCT00873262|Estrogens|estrogens|mesh-ancestor
2433216|NCT00873262|Hormones|hormones|mesh-ancestor
2433217|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2433218|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433219|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2433220|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
2433221|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2433222|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2433223|NCT00873262|Progestins|progestins|mesh-ancestor
2433224|NCT00873275|Leucovorin|leucovorin|mesh-list
2433225|NCT00873275|Bevacizumab|bevacizumab|mesh-list
2433226|NCT00873275|Fluorouracil|fluorouracil|mesh-list
2433227|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
2433228|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2433229|NCT00873275|Calcium|calcium|mesh-list
2433230|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
2433231|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2433232|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433233|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2433234|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2433235|NCT00873275|Growth Substances|growth substances|mesh-ancestor
2433236|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433237|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
2433238|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2433239|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
2433240|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433241|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2433242|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2433243|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
2433244|NCT00873275|Antidotes|antidotes|mesh-ancestor
2433245|NCT00873275|Protective Agents|protective agents|mesh-ancestor
2433246|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
2433247|NCT00873275|Vitamins|vitamins|mesh-ancestor
2433248|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
2433249|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2433250|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2433251|NCT00873340|Interferons|interferons|mesh-list
2433252|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
2433253|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433254|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
2433255|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433256|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2433257|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
2433258|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433259|NCT00873353|Capecitabine|capecitabine|mesh-list
2433260|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2433261|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2433262|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
2433263|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433264|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433265|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2433266|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433267|NCT00873366|Tamoxifen|tamoxifen|mesh-list
2433268|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
2433269|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433270|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2433271|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
2433272|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2433273|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433274|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2433275|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433276|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2433277|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2433278|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2433279|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
2433280|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
2433281|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2433282|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2433283|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433284|NCT00873379|Melatonin|melatonin|mesh-list
2433285|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
2433286|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433287|NCT00873379|Protective Agents|protective agents|mesh-ancestor
2433288|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433289|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2433290|NCT00873392|Nicotine|nicotine|mesh-list
2433291|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2433292|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
2433293|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2433294|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433295|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2433296|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2433297|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
2433298|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433299|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433300|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2433301|NCT00873483|Gestodene|gestodene|mesh-list
2433302|NCT00873483|Femovan|femovan|mesh-list
2433303|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2433304|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2433305|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2433306|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
2433307|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2433308|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433309|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2433310|NCT00873483|Estrogens|estrogens|mesh-ancestor
2433311|NCT00873483|Hormones|hormones|mesh-ancestor
2433312|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2433313|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2433314|NCT00873483|Progestins|progestins|mesh-ancestor
2433315|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2433316|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
2433317|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
2433318|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2433319|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2433320|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433321|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433322|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433323|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2433324|NCT00873509|Buspirone|buspirone|mesh-list
2433325|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2433326|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2433327|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2433328|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433329|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2433330|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2433331|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
2433332|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433333|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433334|NCT00873535|Varenicline|varenicline|mesh-list
2433335|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2433336|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2433337|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
2433338|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433339|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433340|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433341|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
2433342|NCT00873626|Levofloxacin|levofloxacin|mesh-list
2433343|NCT00873626|Ofloxacin|ofloxacin|mesh-list
2433344|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
2433345|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2433346|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433347|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2433348|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2433349|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433350|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433351|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433352|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2433353|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2433354|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2433355|NCT00873626|Renal Agents|renal agents|mesh-ancestor
2433356|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2433357|NCT00873639|Insulin|insulin|mesh-list
2433358|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2433359|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
2433360|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
2433361|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2433362|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433363|NCT00873652|Vaccines|vaccines|mesh-list
2433364|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
2433365|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433366|NCT00873756|Bevacizumab|bevacizumab|mesh-list
2433367|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2433368|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433369|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2433370|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2433371|NCT00873756|Growth Substances|growth substances|mesh-ancestor
2433372|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433373|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
2433374|NCT00873769|Loxapine|loxapine|mesh-list
2433375|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2433376|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2433377|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2433378|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433379|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2433380|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2433381|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
2433382|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433383|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433384|NCT00873795|Aripiprazole|aripiprazole|mesh-list
2433385|NCT00873795|Sertraline|sertraline|mesh-list
2433386|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
2433387|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2433388|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2433389|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2433390|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2433391|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433392|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
2433393|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
2433394|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433395|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433396|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2433397|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2433398|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
2433399|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2433400|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2433401|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2433402|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2433403|NCT00873795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2433404|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2433405|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2433406|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
2433407|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
2433408|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
2433409|NCT00873808|Tetracycline|tetracycline|mesh-list
2433410|NCT00873808|Demeclocycline|demeclocycline|mesh-list
2433411|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2433412|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433413|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2433414|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433415|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2433416|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433417|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433418|NCT00873834|Fluoxetine|fluoxetine|mesh-list
2433419|NCT00873834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2433420|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2433421|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2433422|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433423|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433424|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
2433425|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433426|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2433427|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
2433428|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2433429|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2433430|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2433431|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433432|NCT00873886|Oseltamivir|oseltamivir|mesh-list
2433433|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
2433434|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433435|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433436|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433437|NCT00873925|Vitamin D|vitamin d|mesh-list
2433438|NCT00873925|Vitamins|vitamins|mesh-ancestor
2433439|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
2433440|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433441|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2433442|NCT00873951|Caseins|caseins|mesh-list
2433443|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
2433444|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
2433445|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433446|NCT00874003|Mirtazapine|mirtazapine|mesh-list
2433447|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
2433448|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2433449|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2433450|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
2433451|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
2433452|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433453|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433454|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433455|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2433456|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2433457|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2433458|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2433459|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2433460|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2433461|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
2433462|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2433463|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2207394|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2207395|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2207396|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207397|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2207398|NCT00008086|Vitamins|vitamins|mesh-ancestor
2207399|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
2207400|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2207401|NCT00008112|Cisplatin|cisplatin|mesh-list
2433464|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
2433465|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2433466|NCT00874042|Gemcitabine|gemcitabine|mesh-list
2433467|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2433468|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
2433469|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433470|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433471|NCT00874042|Antiviral Agents|antiviral agents|mesh-ancestor
2433472|NCT00874042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433473|NCT00874042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433474|NCT00874042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2433475|NCT00874042|Immunologic Factors|immunologic factors|mesh-ancestor
2433476|NCT00874042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433477|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
2433478|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433479|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433480|NCT00874107|Paclitaxel|paclitaxel|mesh-list
2433481|NCT00874107|Bevacizumab|bevacizumab|mesh-list
2433482|NCT00874107|Carboplatin|carboplatin|mesh-list
2433483|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2433484|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433485|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
2433486|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
2433487|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
2433488|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433489|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2433490|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2433491|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2433492|NCT00874107|Growth Substances|growth substances|mesh-ancestor
2433493|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433494|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
2433495|NCT00874133|Domperidone|domperidone|mesh-list
2433496|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
2207402|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207403|NCT00008125|Gemcitabine|gemcitabine|mesh-list
2207404|NCT00008125|Carboplatin|carboplatin|mesh-list
2207405|NCT00008125|Docetaxel|docetaxel|mesh-list
2207406|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207407|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2207408|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
2207409|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207410|NCT00008125|Antiviral Agents|antiviral agents|mesh-ancestor
2207411|NCT00008125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207412|NCT00008125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207413|NCT00008125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207414|NCT00008125|Immunologic Factors|immunologic factors|mesh-ancestor
2207415|NCT00008125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433497|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
2433498|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2433499|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433500|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2433501|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2433502|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
2433503|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433504|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433505|NCT00874172|Analgesics|analgesics|mesh-list
2433506|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
2433507|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2433508|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433509|NCT00874315|Cyclosporine|cyclosporine|mesh-list
2433510|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
2433511|NCT00874315|Fludarabine|fludarabine|mesh-list
2433512|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
2433513|NCT00874315|Busulfan|busulfan|mesh-list
2433514|NCT00874315|Tacrolimus|tacrolimus|mesh-list
2433515|NCT00874315|Cyclosporins|cyclosporins|mesh-list
2433516|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
2433517|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2433518|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433519|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2433520|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
2433521|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433522|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2433523|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
2433524|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433525|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2433526|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433527|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
2433528|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433529|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
2433530|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2433531|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2433532|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2433533|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
2433534|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2433535|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
2433536|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2433537|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2433538|NCT00874328|Irinotecan|irinotecan|mesh-list
2433539|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433540|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2433541|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2433542|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433543|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433544|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
2433545|NCT00874393|Dopamine|dopamine|mesh-list
2433546|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2433547|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2433548|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
2433549|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
2433550|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2433551|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433552|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
2433553|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433554|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433555|NCT00874393|Protective Agents|protective agents|mesh-ancestor
2433556|NCT00874406|Leucovorin|leucovorin|mesh-list
2433557|NCT00874406|Fluorouracil|fluorouracil|mesh-list
2433558|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
2433559|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
2433560|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433561|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2433562|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433563|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2433564|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
2433565|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433566|NCT00874406|Antidotes|antidotes|mesh-ancestor
2433567|NCT00874406|Protective Agents|protective agents|mesh-ancestor
2433568|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
2433569|NCT00874406|Vitamins|vitamins|mesh-ancestor
2433570|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
2433571|NCT00874419|Gemcitabine|gemcitabine|mesh-list
2433572|NCT00874419|Carboplatin|carboplatin|mesh-list
2433573|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2433574|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433575|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2433576|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
2433577|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433578|NCT00874419|Antiviral Agents|antiviral agents|mesh-ancestor
2433579|NCT00874419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433580|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433581|NCT00874419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2433582|NCT00874419|Immunologic Factors|immunologic factors|mesh-ancestor
2433583|NCT00874419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433584|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2433585|NCT00874484|Enoxaparin|enoxaparin|mesh-list
2433586|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
2433587|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2433588|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2433589|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433590|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
2433591|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2433592|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2433593|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2433594|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
2433595|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433596|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2433597|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2433598|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433599|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433600|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2433601|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2433602|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
2433603|NCT00874562|Sirolimus|sirolimus|mesh-list
2433604|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2433605|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433606|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2433607|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433608|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
2433609|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2433610|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
2433611|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433612|NCT00874575|Vitamin D|vitamin d|mesh-list
2433613|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
2433614|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
2433615|NCT00874575|Vitamins|vitamins|mesh-list
2433616|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
2433617|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433618|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2433619|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2433620|NCT00874601|Valsartan|valsartan|mesh-list
2433621|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2433622|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2433623|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2433624|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433625|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
2433626|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2433627|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
2433628|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2433629|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433630|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2433631|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2433632|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2433633|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2433634|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
2433635|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2433636|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2433637|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433638|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433639|NCT00874679|Urological Agents|urological agents|mesh-ancestor
2433640|NCT00874744|Triamcinolone|triamcinolone|mesh-list
2433641|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2433642|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2433643|NCT00874744|Bevacizumab|bevacizumab|mesh-list
2433644|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2433645|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2433646|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433647|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2433648|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2433649|NCT00874744|Growth Substances|growth substances|mesh-ancestor
2433650|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433651|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
2433652|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2433653|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
2433654|NCT00874744|Hormones|hormones|mesh-ancestor
2433655|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2433656|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2433657|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
2433658|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433659|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433660|NCT00874809|Insulin|insulin|mesh-list
2433661|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
2433662|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2433663|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433664|NCT00874861|Poly ICLC|poly iclc|mesh-list
2433665|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
2433666|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
2433667|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433668|NCT00874874|Sorafenib|sorafenib|mesh-list
2433669|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433670|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2433671|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433672|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433673|NCT00874926|Factor VIII|factor viii|mesh-list
2433674|NCT00874926|Coagulants|coagulants|mesh-ancestor
2433675|NCT00874978|Lenalidomide|lenalidomide|mesh-list
2433676|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
2433677|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433678|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2433679|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2433680|NCT00874978|Growth Substances|growth substances|mesh-ancestor
2433681|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
2433682|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433683|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
2433684|NCT00875004|Hematinics|hematinics|mesh-ancestor
2433685|NCT00875030|Artesunate|artesunate|mesh-list
2433686|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
2433687|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2433688|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2433689|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433690|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433691|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
2433692|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
2433693|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2433694|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
2433695|NCT00875069|Ethanol|ethanol|mesh-list
2433696|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2433697|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433698|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2433699|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433700|NCT00875082|Montelukast|montelukast|mesh-list
2433701|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2433702|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
2433703|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2433704|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
2433705|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2433706|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433707|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2433708|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2433709|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433710|NCT00875108|Insulin|insulin|mesh-list
2433711|NCT00875108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2433712|NCT00875108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2433713|NCT00875108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433714|NCT00875147|Bevacizumab|bevacizumab|mesh-list
2433715|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2433716|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433717|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2433718|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2433719|NCT00875147|Growth Substances|growth substances|mesh-ancestor
2433720|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433721|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
2433722|NCT00875173|Selenium|selenium|mesh-list
2433723|NCT00875173|Antioxidants|antioxidants|mesh-list
2433724|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433725|NCT00875173|Protective Agents|protective agents|mesh-ancestor
2433726|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433727|NCT00875173|Trace Elements|trace elements|mesh-ancestor
2433728|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
2433729|NCT00875238|Doxorubicin|doxorubicin|mesh-list
2433730|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2433731|NCT00875238|Trastuzumab|trastuzumab|mesh-list
2433732|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2433733|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433734|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2433735|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2433736|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433737|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433738|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2433739|NCT00875355|Temozolomide|temozolomide|mesh-list
2433740|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2433741|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
2433742|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433743|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433744|NCT00875368|Maraviroc|maraviroc|mesh-list
2433745|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2433746|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2433747|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433748|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2433749|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2433750|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
2433751|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433752|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2433753|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
2433754|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2433755|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
2433756|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433757|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433758|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433759|NCT00875459|Insulin|insulin|mesh-list
2433760|NCT00875459|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2433761|NCT00875459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2433762|NCT00875459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433763|NCT00875537|Capsaicin|capsaicin|mesh-list
2433764|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
2433765|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
2433766|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
2433767|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2433768|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433769|NCT00875745|Sorafenib|sorafenib|mesh-list
2433770|NCT00875745|Vorinostat|vorinostat|mesh-list
2433771|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433772|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2433773|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433774|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433775|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2433776|NCT00875771|Bevacizumab|bevacizumab|mesh-list
2433777|NCT00875771|Capecitabine|capecitabine|mesh-list
2433778|NCT00875771|Irinotecan|irinotecan|mesh-list
2433779|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2433780|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433781|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2433782|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2433783|NCT00875771|Growth Substances|growth substances|mesh-ancestor
2433784|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433785|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
2433786|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2433787|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
2433788|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433789|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2433790|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2433791|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433792|NCT00875784|Sumatriptan|sumatriptan|mesh-list
2433793|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2433794|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2433795|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2433796|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
2433797|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433798|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433799|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433800|NCT00875849|Cetuximab|cetuximab|mesh-list
2433801|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433802|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2433803|NCT00875875|Rifaximin|rifaximin|mesh-list
2433804|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2433805|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433806|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2433807|NCT00875927|Zinc|zinc|mesh-list
2433808|NCT00875927|Propolis|propolis|mesh-list
2433809|NCT00875927|Trace Elements|trace elements|mesh-ancestor
2433810|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
2433811|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433812|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433813|NCT00875966|Azithromycin|azithromycin|mesh-list
2433814|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2433815|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433816|NCT00876044|Aflibercept|aflibercept|mesh-list
2433817|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2433818|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2433819|NCT00876044|Growth Substances|growth substances|mesh-ancestor
2433820|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433821|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
2433822|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433823|NCT00876135|Albuterol|albuterol|mesh-list
2433824|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2433825|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
2433826|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2433827|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433828|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2433829|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
2433830|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
2433831|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2433832|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2433833|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2433834|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2433835|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
2433836|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433837|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433838|NCT00876226|Citalopram|citalopram|mesh-list
2433839|NCT00876226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2433840|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2433841|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2433842|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433843|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433844|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
2433845|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433846|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2433847|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
2433848|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2433849|NCT00876317|Etoricoxib|etoricoxib|mesh-list
2433850|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2433851|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2433852|NCT00876317|Analgesics|analgesics|mesh-ancestor
2433853|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
2433854|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2433855|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433856|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2433857|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2433858|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2433859|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2433860|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433861|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433862|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
2433863|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2433864|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2433865|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2433866|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
2433867|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433868|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433869|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433870|NCT00876421|Urological Agents|urological agents|mesh-ancestor
2433871|NCT00876434|Sirolimus|sirolimus|mesh-list
2433872|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2433873|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433874|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2433875|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433876|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
2433877|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2433878|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
2433879|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433880|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
2433881|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2433882|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2433883|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433884|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2433885|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2433886|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433887|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433888|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433889|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2433890|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
2433891|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2433892|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433893|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2433894|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2433895|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2433896|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
2433897|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
2433898|NCT00876616|Tacrolimus|tacrolimus|mesh-list
2433899|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2433900|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
2433901|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433902|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2433903|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2433904|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
2433905|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433906|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433907|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2433908|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2433909|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433910|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2433911|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2433912|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
2433913|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2433914|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433915|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
2433916|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2433917|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433918|NCT00876772|Olanzapine|olanzapine|mesh-list
2433919|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
2433920|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
2433921|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2433922|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433923|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2433924|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2433925|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2433926|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2433927|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2433928|NCT00876772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2433929|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2433930|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2433931|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433932|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433933|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
2433934|NCT00876824|Amphotericin B|amphotericin b|mesh-list
2433935|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2433936|NCT00876824|Amebicides|amebicides|mesh-ancestor
2433937|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2433938|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2433939|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433940|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2433941|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
2433942|NCT00876850|Linezolid|linezolid|mesh-list
2433943|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2433944|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433945|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2433946|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2433947|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433948|NCT00876889|Riluzole|riluzole|mesh-list
2433949|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
2433950|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2433951|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2433952|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2433953|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433954|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433955|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2433956|NCT00876889|Protective Agents|protective agents|mesh-ancestor
2433957|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
2433958|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2433959|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
2433960|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433961|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2433962|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433963|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
2433964|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2433965|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
2433966|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2433967|NCT00876902|Protective Agents|protective agents|mesh-ancestor
2433968|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
2433969|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
2433970|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
2433971|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
2433972|NCT00877097|Trisequens|trisequens|mesh-list
2433973|NCT00877097|Norethindrone|norethindrone|mesh-list
2433974|NCT00877097|Estradiol|estradiol|mesh-list
2433975|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2433976|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433977|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2433978|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2433979|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2433980|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
2433981|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2433982|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2433983|NCT00877097|Estrogens|estrogens|mesh-ancestor
2433984|NCT00877097|Hormones|hormones|mesh-ancestor
2433985|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2433986|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2433987|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
2433988|NCT00877110|Vincristine|vincristine|mesh-list
2433989|NCT00877110|Topotecan|topotecan|mesh-list
2433990|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2433991|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
2433992|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2433993|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2433994|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2433995|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
2433996|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2433997|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2433998|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2433999|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2434000|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
2434001|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
2434002|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
2434003|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2434004|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2434005|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434006|NCT00877123|Vitamin D|vitamin d|mesh-list
2434007|NCT00877123|Vitamins|vitamins|mesh-ancestor
2434008|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
2434009|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434010|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2434011|NCT00877149|Telbivudine|telbivudine|mesh-list
2434012|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
2434013|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434014|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2434015|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434016|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434017|NCT00877175|Phenylephrine|phenylephrine|mesh-list
2434018|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
2434019|NCT00877175|Tropicamide|tropicamide|mesh-list
2434020|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2434021|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
2434022|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
2434023|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434024|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434025|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
2434026|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2434027|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
2434028|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
2434029|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2434030|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2434031|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2434032|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
2434033|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434034|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434035|NCT00877175|Protective Agents|protective agents|mesh-ancestor
2434036|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2434037|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2434038|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
2434039|NCT00877214|Rituximab|rituximab|mesh-list
2434040|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2434041|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434042|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
2434043|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434044|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2434045|NCT00877227|Leucovorin|leucovorin|mesh-list
2434046|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
2434047|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
2434048|NCT00877227|Antidotes|antidotes|mesh-ancestor
2434049|NCT00877227|Protective Agents|protective agents|mesh-ancestor
2434050|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434051|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
2434052|NCT00877227|Vitamins|vitamins|mesh-ancestor
2434053|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
2434054|NCT00877253|Carboplatin|carboplatin|mesh-list
2434055|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434056|NCT00877266|Mepivacaine|mepivacaine|mesh-list
2434057|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
2434058|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
2434059|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434060|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434061|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
2434062|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434063|NCT00877396|Vaccines|vaccines|mesh-list
2434064|NCT00877396|Immunologic Factors|immunologic factors|mesh-ancestor
2434065|NCT00877396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434066|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2434067|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
2434068|NCT00877422|Vitamin D|vitamin d|mesh-list
2434069|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
2434070|NCT00877422|Vitamins|vitamins|mesh-ancestor
2434071|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
2434072|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434073|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2434074|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2434075|NCT00877500|Epothilones|epothilones|mesh-list
2434076|NCT00877500|Epothilone B|epothilone b|mesh-list
2434077|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
2434078|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
2434079|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
2434080|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434081|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434082|NCT00877539|Fluticasone|fluticasone|mesh-list
2434083|NCT00877539|Xhance|xhance|mesh-list
2434084|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2434085|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2434086|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
2434087|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434088|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434089|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2434090|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
2434091|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
2434092|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2434093|NCT00877591|Ritonavir|ritonavir|mesh-list
2434094|NCT00877591|Darunavir|darunavir|mesh-list
2434095|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
2434096|NCT00877591|Rifampin|rifampin|mesh-list
2434097|NCT00877591|Rifabutin|rifabutin|mesh-list
2434098|NCT00877591|Buprenorphine|buprenorphine|mesh-list
2434099|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2434100|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2434101|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
2434102|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434103|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434104|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2434105|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2434106|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
2434107|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434108|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2434109|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2434110|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2434111|NCT00877591|Narcotics|narcotics|mesh-ancestor
2434112|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434113|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434114|NCT00877591|Analgesics|analgesics|mesh-ancestor
2434115|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
2434116|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434117|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2434118|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2434119|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
2434120|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2434121|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
2434122|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2434123|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2434124|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2434125|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2434126|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2434127|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2434128|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2434129|NCT00877656|Zanolimumab|zanolimumab|mesh-list
2434130|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2434131|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434132|NCT00877734|Baclofen|baclofen|mesh-list
2434133|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2434134|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434135|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2434136|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434137|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2434138|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
2434139|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
2434140|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434141|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434142|NCT00877760|Interferons|interferons|mesh-list
2434143|NCT00877760|Entecavir|entecavir|mesh-list
2434144|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434145|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
2434146|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434147|NCT00877812|Glycine|glycine|mesh-list
2434148|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
2434149|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434150|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434151|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434156|NCT00877955|Alprazolam|alprazolam|mesh-list
2434157|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2434158|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434159|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434160|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2434161|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2434162|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2434163|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
2434164|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
2434165|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434166|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434167|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
2434168|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2434169|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434170|NCT00878124|Ubiquinone|ubiquinone|mesh-list
2434171|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
2434172|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
2434173|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434174|NCT00878124|Vitamins|vitamins|mesh-ancestor
2434175|NCT00878163|Gemcitabine|gemcitabine|mesh-list
2434176|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2434177|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2434178|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
2434179|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434180|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434181|NCT00878163|Antiviral Agents|antiviral agents|mesh-ancestor
2434182|NCT00878163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434183|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434184|NCT00878163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2434185|NCT00878163|Immunologic Factors|immunologic factors|mesh-ancestor
2434186|NCT00878163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434187|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2434188|NCT00878254|Leucovorin|leucovorin|mesh-list
2434189|NCT00878254|Cytarabine|cytarabine|mesh-list
2434190|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
2434191|NCT00878254|Ifosfamide|ifosfamide|mesh-list
2434192|NCT00878254|Rituximab|rituximab|mesh-list
2434193|NCT00878254|Doxorubicin|doxorubicin|mesh-list
2434194|NCT00878254|Methotrexate|methotrexate|mesh-list
2434195|NCT00878254|Etoposide|etoposide|mesh-list
2434196|NCT00878254|Vincristine|vincristine|mesh-list
2434197|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2434198|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
2434199|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434200|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2434201|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2434202|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
2434203|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434204|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434205|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2434206|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2434207|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2434208|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2434209|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2434210|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434211|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2434212|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
2434213|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2434214|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2434215|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
2434216|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
2434217|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2434218|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2434219|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2434220|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
2434221|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434222|NCT00878254|Antidotes|antidotes|mesh-ancestor
2434223|NCT00878254|Protective Agents|protective agents|mesh-ancestor
2434224|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
2434225|NCT00878254|Vitamins|vitamins|mesh-ancestor
2434226|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
2434227|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
2434228|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
2434229|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
2434230|NCT00878306|Ritonavir|ritonavir|mesh-list
2434231|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2434232|NCT00878306|Efavirenz|efavirenz|mesh-list
2434233|NCT00878306|Disulfiram|disulfiram|mesh-list
2434234|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2434235|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2434236|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
2434237|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434238|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434239|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2434240|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2434241|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
2434242|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434243|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2434244|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2434245|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2434246|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2434247|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2434248|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2434249|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2434250|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2434251|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2434252|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2434253|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2434254|NCT00878345|Pentobarbital|pentobarbital|mesh-list
2434255|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
2434256|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2434257|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434258|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434259|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2434260|NCT00878345|Analgesics|analgesics|mesh-ancestor
2434261|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
2434262|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434263|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2434264|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2434265|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2434266|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
2207416|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
2207417|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
2207418|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
2207419|NCT00008151|Cyclosporine|cyclosporine|mesh-list
2207420|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
2207421|NCT00008151|Methotrexate|methotrexate|mesh-list
2207422|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
2207423|NCT00008151|Fludarabine|fludarabine|mesh-list
2207424|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
2207425|NCT00008151|Cyclosporins|cyclosporins|mesh-list
2207426|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2207427|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
2207428|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2207429|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207430|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2207431|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
2207432|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207433|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434267|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434268|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434269|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2434270|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
2434271|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
2434272|NCT00878371|Morphine|morphine|mesh-list
2434273|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2434274|NCT00878371|Narcotics|narcotics|mesh-ancestor
2434275|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434276|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434277|NCT00878371|Analgesics|analgesics|mesh-ancestor
2434278|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
2434279|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434280|NCT00878449|Etoposide|etoposide|mesh-list
2434281|NCT00878449|Navitoclax|navitoclax|mesh-list
2434282|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434283|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2434284|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2434285|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2434286|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434287|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434288|NCT00878462|Asenapine|asenapine|mesh-list
2434289|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2434290|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2434291|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434292|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434293|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2434294|NCT00878514|Alprazolam|alprazolam|mesh-list
2434295|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2434296|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434297|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434298|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2434299|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2434300|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2434301|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
2434302|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
2434303|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434304|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434305|NCT00878540|Mirtazapine|mirtazapine|mesh-list
2434306|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
2434307|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2434308|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2434309|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
2434310|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
2434311|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434312|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434313|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434314|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2434315|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2434316|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434317|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2434318|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2207434|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
2207435|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207436|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2207437|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207438|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
2207439|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207440|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2207441|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
2207442|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207443|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2434319|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2434320|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
2434321|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2434322|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2434323|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
2434324|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2434325|NCT00878631|Dextrans|dextrans|mesh-list
2434326|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
2434327|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
2434328|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
2434329|NCT00878657|Gemcitabine|gemcitabine|mesh-list
2434330|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2434331|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
2434332|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434333|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434334|NCT00878657|Antiviral Agents|antiviral agents|mesh-ancestor
2434335|NCT00878657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434336|NCT00878657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434337|NCT00878657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2434338|NCT00878657|Immunologic Factors|immunologic factors|mesh-ancestor
2434339|NCT00878657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434340|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
2434341|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2434342|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2434343|NCT00878670|Analgesics|analgesics|mesh-ancestor
2434344|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
2434345|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434346|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434347|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2434348|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2434349|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2434350|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
2434351|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434352|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2434353|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
2434354|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2434355|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2434356|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2207444|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2207445|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2434357|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2434358|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434359|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434360|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434361|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2434362|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
2434363|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2434364|NCT00878865|Alprazolam|alprazolam|mesh-list
2434365|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2434366|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434367|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434368|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2434369|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2434370|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2434371|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
2434372|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
2434373|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434374|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434375|NCT00878904|Epirubicin|epirubicin|mesh-list
2434376|NCT00878904|Panobinostat|panobinostat|mesh-list
2434377|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2434378|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434379|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2434380|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2434381|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434382|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434383|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2434384|NCT00878917|Dorzolamide|dorzolamide|mesh-list
2434385|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2434386|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2434387|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2434388|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2434389|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434390|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434391|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
2434392|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434393|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
2434394|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2434395|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2434396|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434397|NCT00878943|Urological Agents|urological agents|mesh-ancestor
2434398|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
2434399|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2434400|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2434401|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434402|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2434403|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2434404|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434405|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434406|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434407|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2434408|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
2434409|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2434410|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434411|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2434412|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2434413|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2434414|NCT00879021|Pregabalin|pregabalin|mesh-list
2434415|NCT00879021|Analgesics|analgesics|mesh-ancestor
2434416|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
2434417|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434418|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434419|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
2434420|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2434421|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2434422|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434423|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2434424|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2434425|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2434426|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434427|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2434428|NCT00879047|Ethanol|ethanol|mesh-list
2434429|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2434430|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434431|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434432|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434433|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2434434|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2434435|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
2434436|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434437|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434438|NCT00879099|Timolol|timolol|mesh-list
2434439|NCT00879099|Paroxetine|paroxetine|mesh-list
2434440|NCT00879099|Maleic acid|maleic acid|mesh-list
2434441|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2434442|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2434443|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
2434444|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434445|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434446|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434447|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2434448|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2434449|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434450|NCT00879099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2434451|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2434452|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2434453|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
2434454|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2434455|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
2434456|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2434457|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2434458|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2434459|NCT00879164|Bupivacaine|bupivacaine|mesh-list
2434460|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
2434461|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
2434462|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434463|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434464|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
2434465|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434466|NCT00879177|Varenicline|varenicline|mesh-list
2434467|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2434468|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2434469|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
2434470|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434471|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434472|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434473|NCT00879242|Deferasirox|deferasirox|mesh-list
2434474|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2434475|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
2434476|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
2434477|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434478|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2434479|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2434480|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
2434481|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2434482|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2434483|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2434484|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434485|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434486|NCT00879372|Tianeptine|tianeptine|mesh-list
2434487|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2434488|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
2434489|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2434490|NCT00879385|Decitabine|decitabine|mesh-list
2434491|NCT00879385|Panitumumab|panitumumab|mesh-list
2434492|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2434493|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
2434494|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434495|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434496|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434497|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2434498|NCT00879424|Vitamin D|vitamin d|mesh-list
2434499|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
2434500|NCT00879424|Vitamins|vitamins|mesh-ancestor
2434501|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
2434502|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434503|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2434504|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2434505|NCT00879476|Ramipril|ramipril|mesh-list
2434506|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2434507|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
2434508|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434509|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434510|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2434511|NCT00879489|Vaccines|vaccines|mesh-list
2434512|NCT00879489|Immunologic Factors|immunologic factors|mesh-ancestor
2434513|NCT00879489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434514|NCT00879541|Factor VIII|factor viii|mesh-list
2434515|NCT00879541|Coagulants|coagulants|mesh-ancestor
2434516|NCT00879723|Vitamins|vitamins|mesh-list
2434517|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
2434518|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434519|NCT00879788|Ramipril|ramipril|mesh-list
2434520|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2434521|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
2434522|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434523|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434524|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2434525|NCT00879827|PENTA|penta|mesh-list
2434526|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
2434527|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2434528|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2434529|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434530|NCT00879892|Xenon|xenon|mesh-list
2434531|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2434532|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
2434533|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
2434534|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434535|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434536|NCT00879918|Nicotine|nicotine|mesh-list
2434537|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2434538|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
2434539|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434540|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434541|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2434542|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2434543|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
2434544|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434545|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434546|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
2434547|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2434548|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2434549|NCT00879931|Prednisolone|prednisolone|mesh-list
2434550|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
2434551|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2434552|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
2434553|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2434554|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
2434555|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
2434556|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434557|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434558|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2434559|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
2434560|NCT00879931|Hormones|hormones|mesh-ancestor
2434561|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2434562|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2434563|NCT00879931|Protective Agents|protective agents|mesh-ancestor
2434564|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2434565|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434566|NCT00879957|Heparin|heparin|mesh-list
2434567|NCT00879957|Calcium heparin|calcium heparin|mesh-list
2434568|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
2434569|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2434570|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2434571|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434572|NCT00879983|Azithromycin|azithromycin|mesh-list
2434573|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2434574|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434575|NCT00880178|Niacin|niacin|mesh-list
2434576|NCT00880178|Niacinamide|niacinamide|mesh-list
2434577|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
2434578|NCT00880178|Simvastatin|simvastatin|mesh-list
2434579|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2434580|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2434581|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
2434582|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434583|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2434584|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2434585|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434586|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
2434587|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
2434588|NCT00880178|Vitamins|vitamins|mesh-ancestor
2434589|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
2434590|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434591|NCT00880217|Methylphenidate|methylphenidate|mesh-list
2434592|NCT00880217|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2434593|NCT00880217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2434594|NCT00880217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434595|NCT00880217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2434596|NCT00880217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2434597|NCT00880217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2434598|NCT00880217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434599|NCT00880217|Dopamine Agents|dopamine agents|mesh-ancestor
2434600|NCT00880217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434601|NCT00880217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2434602|NCT00880217|Adrenergic Agents|adrenergic agents|mesh-ancestor
2434603|NCT00880243|Cytarabine|cytarabine|mesh-list
2434604|NCT00880243|Etoposide|etoposide|mesh-list
2434605|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
2434606|NCT00880243|Daunorubicin|daunorubicin|mesh-list
2434607|NCT00880243|Molgramostim|molgramostim|mesh-list
2434608|NCT00880243|Sargramostim|sargramostim|mesh-list
2434609|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2434610|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434611|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2434612|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2434613|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434614|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434615|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2434616|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
2434617|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
2434618|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434619|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2434620|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
2434621|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434622|NCT00880243|Analgesics|analgesics|mesh-ancestor
2434623|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
2434624|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434625|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2434626|NCT00880282|Sirolimus|sirolimus|mesh-list
2434627|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2434628|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2434629|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434630|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2434631|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434632|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
2434633|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2434634|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
2434635|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434636|NCT00880321|Dabrafenib|dabrafenib|mesh-list
2434637|NCT00880321|Midazolam|midazolam|mesh-list
2434638|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2434639|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2434640|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434641|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434642|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2434643|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2434644|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2434645|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2434646|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
2434647|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
2434648|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
2434649|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
2434650|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434651|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434652|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434653|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2434654|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434655|NCT00880373|Ibuprofen|ibuprofen|mesh-list
2434656|NCT00880373|Morphine|morphine|mesh-list
2434657|NCT00880373|Heroin|heroin|mesh-list
2434658|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2434659|NCT00880373|Narcotics|narcotics|mesh-ancestor
2434660|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434661|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434662|NCT00880373|Analgesics|analgesics|mesh-ancestor
2434663|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
2434664|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434665|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2434666|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2434667|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2434668|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2434669|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2434670|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434671|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434672|NCT00880386|Losartan|losartan|mesh-list
2434673|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2434674|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2434675|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2434676|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2434677|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434678|NCT00880412|Etazolate|etazolate|mesh-list
2434679|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2434680|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434681|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434682|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2434683|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2434684|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434685|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434686|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2434687|NCT00880477|Edetic Acid|edetic acid|mesh-list
2434688|NCT00880477|Vaccines|vaccines|mesh-list
2434689|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
2434690|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
2434691|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434692|NCT00880477|Antidotes|antidotes|mesh-ancestor
2434693|NCT00880477|Protective Agents|protective agents|mesh-ancestor
2434694|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
2434695|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
2434696|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434697|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2434698|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
2434699|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2434700|NCT00880490|Formoterol Fumarate|formoterol fumarate|mesh-list
2434701|NCT00880490|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2434702|NCT00880490|Autonomic Agents|autonomic agents|mesh-ancestor
2434703|NCT00880490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434704|NCT00880490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434705|NCT00880490|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2434706|NCT00880490|Respiratory System Agents|respiratory system agents|mesh-ancestor
2434707|NCT00880490|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2434708|NCT00880490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2434709|NCT00880490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2434710|NCT00880490|Adrenergic Agents|adrenergic agents|mesh-ancestor
2434711|NCT00880490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434712|NCT00880490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434713|NCT00880529|Morphine|morphine|mesh-list
2434714|NCT00880529|Bupivacaine|bupivacaine|mesh-list
2434715|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
2434716|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
2434717|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434718|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434719|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
2434720|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434721|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2434722|NCT00880529|Narcotics|narcotics|mesh-ancestor
2434723|NCT00880529|Analgesics|analgesics|mesh-ancestor
2434724|NCT00880594|Desipramine|desipramine|mesh-list
2434725|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2434726|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
2434727|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2434728|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434729|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434730|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2434731|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2434732|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2434733|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
2434734|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434735|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434736|NCT00880672|Dutasteride|dutasteride|mesh-list
2434737|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2434738|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2434739|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434740|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434741|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
2434742|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2434743|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434744|NCT00880815|Rituximab|rituximab|mesh-list
2434745|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2434746|NCT00880815|Methotrexate|methotrexate|mesh-list
2434747|NCT00880815|Fludarabine|fludarabine|mesh-list
2434748|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2434749|NCT00880815|Antibodies|antibodies|mesh-list
2434750|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
2434751|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2434752|NCT00880815|Lenograstim|lenograstim|mesh-list
2434753|NCT00880815|Tacrolimus|tacrolimus|mesh-list
2434754|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
2434755|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2434756|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
2434757|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434758|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434759|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2434760|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2434761|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
2434762|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2434763|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2434764|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
2434765|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434766|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
2434767|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434768|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2434769|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2434770|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2434771|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2434772|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2434773|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2434774|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
2434775|NCT00880828|Acetaminophen|acetaminophen|mesh-list
2434776|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2434777|NCT00880828|Analgesics|analgesics|mesh-ancestor
2434778|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
2434779|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434780|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434781|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
2434782|NCT00880841|Buprenorphine|buprenorphine|mesh-list
2434783|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2434784|NCT00880841|Naloxone|naloxone|mesh-list
2434785|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2434786|NCT00880841|Narcotics|narcotics|mesh-ancestor
2434787|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2434788|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434789|NCT00880841|Analgesics|analgesics|mesh-ancestor
2434790|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
2434791|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434792|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2434793|NCT00880854|Tremelimumab|tremelimumab|mesh-list
2434794|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434795|NCT00880867|Poly ICLC|poly iclc|mesh-list
2434796|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
2434797|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
2434798|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434799|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
2434800|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434801|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2434802|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434803|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434804|NCT00881088|PENTA|penta|mesh-list
2434805|NCT00881088|Nadroparin|nadroparin|mesh-list
2434806|NCT00881088|Fondaparinux|fondaparinux|mesh-list
2434807|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2434808|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
2434809|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2434810|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
2434811|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434812|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434813|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
2434814|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2434815|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2434816|NCT00881101|Paclitaxel|paclitaxel|mesh-list
2434817|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2434818|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434819|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
2434820|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
2434821|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
2434822|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434823|NCT00881114|Cetuximab|cetuximab|mesh-list
2434824|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434825|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2434826|NCT00881127|Cetirizine|cetirizine|mesh-list
2434827|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
2434828|NCT00881127|Ephedrine|ephedrine|mesh-list
2434829|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2434830|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2434831|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2434832|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
2434833|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
2434834|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434835|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434836|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434837|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2434838|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
2434839|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434840|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2434841|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
2434842|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
2434843|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2434844|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2434845|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
2434846|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
2434847|NCT00881140|Mifepristone|mifepristone|mesh-list
2434848|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2434849|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
2434850|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2434851|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434852|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2434853|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2434854|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2434855|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
2434856|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2434857|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2434858|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
2434859|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2434860|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
2434861|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2434862|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2434863|NCT00881153|Cefprozil|cefprozil|mesh-list
2434864|NCT00881153|Cephalosporins|cephalosporins|mesh-list
2434865|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2434866|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434867|NCT00881166|Paclitaxel|paclitaxel|mesh-list
2434868|NCT00881166|Etoposide|etoposide|mesh-list
2434869|NCT00881166|Docetaxel|docetaxel|mesh-list
2434870|NCT00881166|Carboplatin|carboplatin|mesh-list
2434871|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2434872|NCT00881166|Topotecan|topotecan|mesh-list
2434873|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2434874|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434875|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
2434876|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
2434877|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
2434878|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434879|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2434880|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2434881|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434882|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2434883|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2434884|NCT00881179|Clarithromycin|clarithromycin|mesh-list
2434885|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2434886|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434887|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2434888|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434889|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434890|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2434891|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2434892|NCT00881218|Regadenoson|regadenoson|mesh-list
2434893|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2434894|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2434895|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
2434896|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
2434897|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2434898|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434899|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434900|NCT00881231|Cilostazol|cilostazol|mesh-list
2434901|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2434902|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
2434903|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2434904|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434905|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2434906|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
2434907|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2434908|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2434909|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434910|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2434911|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
2434912|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2434913|NCT00881231|Protective Agents|protective agents|mesh-ancestor
2434914|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2434915|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2434916|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434917|NCT00881296|Gemcitabine|gemcitabine|mesh-list
2434918|NCT00881296|Carboplatin|carboplatin|mesh-list
2434919|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434920|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2434921|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
2434922|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434923|NCT00881296|Antiviral Agents|antiviral agents|mesh-ancestor
2434924|NCT00881296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434925|NCT00881296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434926|NCT00881296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2434927|NCT00881296|Immunologic Factors|immunologic factors|mesh-ancestor
2434928|NCT00881296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434929|NCT00881387|Gemcitabine|gemcitabine|mesh-list
2434930|NCT00881387|Rituximab|rituximab|mesh-list
2434931|NCT00881387|Vinorelbine|vinorelbine|mesh-list
2434932|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2434933|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434934|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
2434935|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434936|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2434937|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2434938|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
2434939|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434940|NCT00881387|Antiviral Agents|antiviral agents|mesh-ancestor
2434941|NCT00881387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434942|NCT00881387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434943|NCT00881387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2434944|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2434945|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
2434946|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
2434947|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
2434948|NCT00881400|Cefprozil|cefprozil|mesh-list
2434949|NCT00881400|Cephalosporins|cephalosporins|mesh-list
2434950|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2434951|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434952|NCT00881413|Esomeprazole|esomeprazole|mesh-list
2434953|NCT00881413|Pantoprazole|pantoprazole|mesh-list
2434954|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2434955|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2434956|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2434957|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434958|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434959|NCT00881426|Cefprozil|cefprozil|mesh-list
2434960|NCT00881426|Cephalosporins|cephalosporins|mesh-list
2434961|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2434962|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434963|NCT00881452|Citric Acid|citric acid|mesh-list
2207446|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
2207447|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2434964|NCT00881452|Anticoagulants|anticoagulants|mesh-ancestor
2434965|NCT00881452|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2434966|NCT00881452|Chelating Agents|chelating agents|mesh-ancestor
2434967|NCT00881452|Sequestering Agents|sequestering agents|mesh-ancestor
2434968|NCT00881452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434969|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2434970|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2434971|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2434972|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
2434973|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
2434974|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
2434975|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434976|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2434977|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
2434978|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2434979|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434980|NCT00881543|Incretins|incretins|mesh-ancestor
2434981|NCT00881543|Hormones|hormones|mesh-ancestor
2434982|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2434983|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
2207448|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2207449|NCT00008177|Iodine|iodine|mesh-list
2207450|NCT00008177|Cyclosporine|cyclosporine|mesh-list
2207451|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
2207452|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2434984|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434985|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434986|NCT00881556|Fludarabine|fludarabine|mesh-list
2434987|NCT00881556|Busulfan|busulfan|mesh-list
2434988|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
2434989|NCT00881556|Lorazepam|lorazepam|mesh-list
2434990|NCT00881556|Tacrolimus|tacrolimus|mesh-list
2434991|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2434992|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2434993|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2434994|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
2434995|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2434996|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2434997|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2434998|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
2434999|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2435000|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2435001|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2435002|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
2435003|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
2435004|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
2435005|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435006|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2435007|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2435008|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2435009|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2435010|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2435011|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2435012|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
2435013|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
2435014|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435015|NCT00881582|Interferons|interferons|mesh-list
2435016|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
2435017|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
2435018|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2435019|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435020|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
2435021|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435022|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
2435023|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435024|NCT00881595|Temozolomide|temozolomide|mesh-list
2435025|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2207453|NCT00008177|Fludarabine|fludarabine|mesh-list
2207454|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
2207455|NCT00008177|Antibodies|antibodies|mesh-list
2207456|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
2207457|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2207458|NCT00008177|Cyclosporins|cyclosporins|mesh-list
2207459|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
2435026|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
2435027|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435028|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435029|NCT00881634|Cetirizine|cetirizine|mesh-list
2435030|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
2435031|NCT00881634|Ephedrine|ephedrine|mesh-list
2435032|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2435033|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2435034|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2435035|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
2435036|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
2435037|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435038|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435039|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435040|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2435041|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
2435042|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435043|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2435044|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
2435045|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
2435046|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2435047|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2435048|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
2435049|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
2435050|NCT00881673|Dexamethasone|dexamethasone|mesh-list
2435051|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2435052|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2435053|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2435054|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
2435055|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
2435056|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435057|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435058|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2435059|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
2435060|NCT00881673|Hormones|hormones|mesh-ancestor
2435061|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2435062|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2435063|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435064|NCT00881686|Adenosine|adenosine|mesh-list
2435065|NCT00881686|Analgesics|analgesics|mesh-ancestor
2435066|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
2435067|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435068|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435069|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2435070|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
2435071|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2435072|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
2435073|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
2435074|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435075|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435076|NCT00881725|Metformin|metformin|mesh-list
2435077|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2435078|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435079|NCT00881738|Clarithromycin|clarithromycin|mesh-list
2435080|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2435081|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435082|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2435083|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435084|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435085|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2435086|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2435087|NCT00881764|Anesthetics|anesthetics|mesh-list
2435088|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2435089|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207460|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207461|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207462|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2207463|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
2207464|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207465|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2435090|NCT00881790|Fluorides|fluorides|mesh-list
2435091|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
2435092|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
2435093|NCT00881790|Protective Agents|protective agents|mesh-ancestor
2435094|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435095|NCT00881816|Paclitaxel|paclitaxel|mesh-list
2435096|NCT00881816|Capecitabine|capecitabine|mesh-list
2435097|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2435098|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435099|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
2435100|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
2435101|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
2435102|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435103|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2435104|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
2435105|NCT00881855|Cefprozil|cefprozil|mesh-list
2435106|NCT00881855|Cephalosporins|cephalosporins|mesh-list
2435107|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2435108|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435109|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2435110|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2435111|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435112|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
2435113|NCT00882024|Tranilast|tranilast|mesh-list
2435114|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2435115|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2435116|NCT00882024|Analgesics|analgesics|mesh-ancestor
2435117|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
2435118|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435119|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435120|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2435121|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2435122|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2435123|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2435124|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435125|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2435126|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2435127|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
2435128|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
2435129|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435130|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2435131|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2435139|NCT00882076|Etoposide|etoposide|mesh-list
2435140|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
2435141|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
2435142|NCT00882076|Clofarabine|clofarabine|mesh-list
2435143|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2435144|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435145|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2435146|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2435147|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435148|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435149|NCT00882076|Analgesics|analgesics|mesh-ancestor
2435150|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
2435151|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435152|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435153|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2435154|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
2435155|NCT00882154|Cefdinir|cefdinir|mesh-list
2435156|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2435157|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435158|NCT00882193|Ribavirin|ribavirin|mesh-list
2435159|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2435160|NCT00882193|Betaine|betaine|mesh-list
2435161|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
2435162|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435163|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
2435164|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435165|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2435166|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
2435167|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2435168|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2435169|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
2435170|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2435171|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
2435172|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435173|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
2435174|NCT00882232|Protective Agents|protective agents|mesh-ancestor
2435175|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
2435176|NCT00882323|Fludarabine|fludarabine|mesh-list
2435177|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
2435178|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2435179|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
2435180|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435181|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2435182|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2435183|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
2435184|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435185|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435186|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2435187|NCT00882375|Nicotine|nicotine|mesh-list
2435188|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2435189|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
2435190|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435191|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435192|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2435193|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2435194|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
2435195|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435196|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435197|NCT00882388|Aspirin|aspirin|mesh-list
2435198|NCT00882388|Celecoxib|celecoxib|mesh-list
2435199|NCT00882388|Clopidogrel|clopidogrel|mesh-list
2435200|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2435201|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2435202|NCT00882388|Analgesics|analgesics|mesh-ancestor
2435203|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
2435204|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435205|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435206|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2435207|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2435208|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2435209|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2435210|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435211|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2435212|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2435213|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435214|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
2435215|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2435216|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2435217|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2435218|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
2435219|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435220|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2435221|NCT00882401|Vitamin D|vitamin d|mesh-list
2435222|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
2435223|NCT00882401|Vitamins|vitamins|mesh-ancestor
2435224|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
2435225|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435226|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2435227|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2435228|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
2435229|NCT00882414|Hematinics|hematinics|mesh-ancestor
2435230|NCT00882453|Interferons|interferons|mesh-list
2435231|NCT00882453|Interferon-beta|interferon-beta|mesh-list
2435232|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
2435233|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435234|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
2435235|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435236|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
2435237|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435238|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2435239|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
2435240|NCT00882466|Hematinics|hematinics|mesh-ancestor
2435241|NCT00882531|Isotretinoin|isotretinoin|mesh-list
2435242|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
2435243|NCT00882570|Cefdinir|cefdinir|mesh-list
2435244|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2435245|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435246|NCT00882609|Fluorides|fluorides|mesh-list
2435247|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
2435248|NCT00882609|Protective Agents|protective agents|mesh-ancestor
2435249|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435250|NCT00882635|Heparin|heparin|mesh-list
2435251|NCT00882635|Enoxaparin|enoxaparin|mesh-list
2435252|NCT00882635|Calcium heparin|calcium heparin|mesh-list
2435253|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
2435254|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2435255|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2435256|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435257|NCT00882700|Cefdinir|cefdinir|mesh-list
2435258|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2435259|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435260|NCT00882739|Clopidogrel|clopidogrel|mesh-list
2435261|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2435262|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2435263|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2435264|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2435265|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
2435266|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435267|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435268|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435269|NCT00882765|Genistein|genistein|mesh-list
2435270|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2435271|NCT00882765|Protective Agents|protective agents|mesh-ancestor
2435272|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435273|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435274|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2435275|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435276|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435277|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
2435278|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2435279|NCT00882765|Estrogens|estrogens|mesh-ancestor
2435280|NCT00882765|Hormones|hormones|mesh-ancestor
2435281|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2435282|NCT00882856|Bisoprolol|bisoprolol|mesh-list
2435283|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2435284|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
2435285|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
2435286|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435287|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435288|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2435289|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2435290|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2435291|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
2435292|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435293|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435294|NCT00882869|Sorafenib|sorafenib|mesh-list
2435295|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435296|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2435297|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435298|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435299|NCT00882882|Metformin|metformin|mesh-list
2435300|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2435301|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435336|NCT00882947|Iloprost|iloprost|mesh-list
2435337|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2435338|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
2435339|NCT00882960|Fentanyl|fentanyl|mesh-list
2435340|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2435341|NCT00882960|Narcotics|narcotics|mesh-ancestor
2435342|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2435343|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435344|NCT00882960|Analgesics|analgesics|mesh-ancestor
2435345|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
2435346|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435347|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2435348|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2435349|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
2435350|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
2435351|NCT00883064|Lisinopril|lisinopril|mesh-list
2435352|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2435353|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
2435354|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435355|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435356|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2435357|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2435358|NCT00883064|Protective Agents|protective agents|mesh-ancestor
2435359|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435360|NCT00883155|Bupropion|bupropion|mesh-list
2435361|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2435362|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
2435363|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2435364|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2435365|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2435366|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2435367|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435368|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
2435369|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435370|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435371|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2435372|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2435373|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435374|NCT00883194|Ropivacaine|ropivacaine|mesh-list
2435375|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
2435376|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
2435377|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2435378|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435379|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
2435380|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435381|NCT00883259|Metformin|metformin|mesh-list
2435382|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2435383|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435384|NCT00883298|Bevacizumab|bevacizumab|mesh-list
2435385|NCT00883298|Temozolomide|temozolomide|mesh-list
2435386|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2435387|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435388|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2435389|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2435390|NCT00883298|Growth Substances|growth substances|mesh-ancestor
2435391|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435392|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
2435393|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2435394|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
2435395|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435396|NCT00883480|Gemcitabine|gemcitabine|mesh-list
2435397|NCT00883480|Cisplatin|cisplatin|mesh-list
2435398|NCT00883480|Docetaxel|docetaxel|mesh-list
2435399|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2435400|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435401|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2435402|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
2435403|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435404|NCT00883480|Antiviral Agents|antiviral agents|mesh-ancestor
2435405|NCT00883480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435406|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435407|NCT00883480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2435408|NCT00883480|Immunologic Factors|immunologic factors|mesh-ancestor
2435409|NCT00883480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435410|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
2435411|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
2435412|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
2435413|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2435414|NCT00883506|Lisinopril|lisinopril|mesh-list
2435415|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2435416|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
2435417|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435418|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435419|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2435420|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2435421|NCT00883506|Protective Agents|protective agents|mesh-ancestor
2435422|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435423|NCT00883532|Budesonide|budesonide|mesh-list
2435424|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
2435425|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2435426|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2435427|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
2435428|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435429|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435430|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2435431|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
2435432|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
2435433|NCT00883532|Hormones|hormones|mesh-ancestor
2435434|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2435435|NCT00883623|Lenalidomide|lenalidomide|mesh-list
2435436|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
2435437|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435438|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2435439|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2435440|NCT00883623|Growth Substances|growth substances|mesh-ancestor
2435441|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
2435442|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435443|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
2435444|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2435445|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
2435446|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2207466|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207467|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
2207468|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435447|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435448|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2435449|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2435450|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2435451|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
2435452|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2435453|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2207469|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
2207470|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207471|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2207472|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2207473|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2207474|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
2207475|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2207476|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2207477|NCT00008177|Trace Elements|trace elements|mesh-ancestor
2207478|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
2207479|NCT00008190|Aldesleukin|aldesleukin|mesh-list
2435454|NCT00883818|Azithromycin|azithromycin|mesh-list
2435455|NCT00883818|Doxycycline|doxycycline|mesh-list
2435456|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2435457|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435458|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
2435459|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2435460|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2435461|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
2435462|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2435463|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2435464|NCT00883883|Cefdinir|cefdinir|mesh-list
2435465|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2435466|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435467|NCT00883896|Fezakinumab|fezakinumab|mesh-list
2435468|NCT00883896|Dermatologic Agents|dermatologic agents|mesh-ancestor
2435469|NCT00883909|Dutasteride|dutasteride|mesh-list
2435470|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2435471|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2435472|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435473|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435474|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
2435475|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2435476|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435477|NCT00883935|Ritonavir|ritonavir|mesh-list
2435478|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2435479|NCT00883935|Dolutegravir|dolutegravir|mesh-list
2435480|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2435481|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2435482|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
2435483|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435484|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435485|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2435486|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2435487|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
2435488|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435489|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2435490|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2435491|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2435492|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2435493|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
2435494|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2435495|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2435496|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
2435497|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435498|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435499|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435500|NCT00884104|Urological Agents|urological agents|mesh-ancestor
2435501|NCT00884234|Botulinum Toxins|botulinum toxins|mesh-list
2435502|NCT00884234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2435503|NCT00884234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2435504|NCT00884234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2435505|NCT00884234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2435506|NCT00884234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435507|NCT00884234|Cholinergic Agents|cholinergic agents|mesh-ancestor
2435508|NCT00884234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435509|NCT00884234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435510|NCT00884234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2435511|NCT00884234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435512|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
2435513|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2435514|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
2435515|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2435516|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435517|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2435518|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2435519|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2435520|NCT00884299|Antioxidants|antioxidants|mesh-list
2435521|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435522|NCT00884299|Protective Agents|protective agents|mesh-ancestor
2435523|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435524|NCT00884416|Sorafenib|sorafenib|mesh-list
2435525|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435526|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2435527|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435528|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435529|NCT00884442|Nifedipine|nifedipine|mesh-list
2435530|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2435531|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2435532|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435533|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2435534|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435535|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
2435536|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
2435537|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2435538|NCT00884481|Natalizumab|natalizumab|mesh-list
2435539|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
2435540|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435541|NCT00884494|Insulin|insulin|mesh-list
2435542|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2435543|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435544|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
2435545|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2435546|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435547|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2435548|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2435549|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435550|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435551|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435552|NCT00884546|Dexamethasone|dexamethasone|mesh-list
2435553|NCT00884546|Lenalidomide|lenalidomide|mesh-list
2435554|NCT00884546|Bortezomib|bortezomib|mesh-list
2435555|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2435556|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
2435557|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
2435558|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435559|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435560|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2435561|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
2435562|NCT00884546|Hormones|hormones|mesh-ancestor
2435563|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2435564|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2435565|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435566|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
2435567|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2435568|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2435569|NCT00884546|Growth Substances|growth substances|mesh-ancestor
2435570|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
2435571|NCT00884663|Propranolol|propranolol|mesh-list
2435572|NCT00884663|Candesartan|candesartan|mesh-list
2435573|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2435574|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2435575|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
2435576|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435577|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435578|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435579|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2435580|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2435581|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
2435582|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2435583|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2435584|NCT00884676|Sunitinib|sunitinib|mesh-list
2435585|NCT00884676|Epothilone B|epothilone b|mesh-list
2435586|NCT00884676|Epothilones|epothilones|mesh-list
2435587|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435588|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2435589|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2435590|NCT00884676|Growth Substances|growth substances|mesh-ancestor
2435591|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435592|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
2435593|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2435594|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435595|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435596|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
2435597|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
2435598|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
2435599|NCT00884715|Octreotide|octreotide|mesh-list
2435600|NCT00884715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2435601|NCT00884715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2435602|NCT00884715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435603|NCT00884767|Leucovorin|leucovorin|mesh-list
2435604|NCT00884767|Fluorouracil|fluorouracil|mesh-list
2435605|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
2435606|NCT00884767|Calcium|calcium|mesh-list
2435607|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
2435608|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2435609|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435610|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
2435611|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435612|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2435613|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435614|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2435615|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
2435616|NCT00884767|Antidotes|antidotes|mesh-ancestor
2435617|NCT00884767|Protective Agents|protective agents|mesh-ancestor
2435618|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
2435619|NCT00884767|Vitamins|vitamins|mesh-ancestor
2435620|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
2435621|NCT00884819|Fenofibrate|fenofibrate|mesh-list
2435622|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2435623|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
2435624|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435625|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2435626|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2435627|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435628|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2435629|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435630|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435631|NCT00884858|Maraviroc|maraviroc|mesh-list
2435632|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2435633|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2435634|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435635|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2435636|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2435637|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
2435638|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435639|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2435640|NCT00884884|Topiramate|topiramate|mesh-list
2435641|NCT00884884|Aripiprazole|aripiprazole|mesh-list
2435642|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
2435643|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2435644|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2435645|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2435646|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2435647|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435648|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
2435649|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
2435650|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435651|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435652|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2435653|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2435654|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
2435655|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2435656|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2435657|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2435658|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2435659|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
2435660|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2435661|NCT00885066|Gemcitabine|gemcitabine|mesh-list
2435662|NCT00885066|Capecitabine|capecitabine|mesh-list
2435663|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2435664|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2435665|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
2435666|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435667|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435668|NCT00885066|Antiviral Agents|antiviral agents|mesh-ancestor
2435669|NCT00885066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435670|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435671|NCT00885066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2435672|NCT00885066|Immunologic Factors|immunologic factors|mesh-ancestor
2435673|NCT00885066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435674|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2435675|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
2435676|NCT00885274|Citric Acid|citric acid|mesh-list
2435677|NCT00885274|Antacids|antacids|mesh-ancestor
2435678|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435679|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2435680|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
2435681|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2435682|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
2435683|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
2435684|NCT00885287|Lumefantrine|lumefantrine|mesh-list
2435685|NCT00885287|Artemether|artemether|mesh-list
2435686|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2435687|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
2435688|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2435689|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2435690|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435691|NCT00885300|Cloxacillin|cloxacillin|mesh-list
2435692|NCT00885300|Heparin|heparin|mesh-list
2435693|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
2435694|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2435695|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2435696|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435697|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2435698|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435699|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
2435700|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
2435701|NCT00885326|Bevacizumab|bevacizumab|mesh-list
2435702|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2435703|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
2435704|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435705|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2435706|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2435707|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
2435708|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435709|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435710|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2435711|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2435712|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2435713|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2435714|NCT00885326|Growth Substances|growth substances|mesh-ancestor
2435715|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
2435716|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2435717|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2435718|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
2435719|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2435720|NCT00885443|Propofol|propofol|mesh-list
2435721|NCT00885443|Sevoflurane|sevoflurane|mesh-list
2435722|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2435723|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2435724|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435725|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2435726|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
2435727|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
2435728|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2435729|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2435749|NCT00885508|Lenalidomide|lenalidomide|mesh-list
2435750|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
2435751|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435752|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2435753|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2435754|NCT00885508|Growth Substances|growth substances|mesh-ancestor
2435755|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
2435756|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435757|NCT00885586|Gabapentin|gabapentin|mesh-list
2435758|NCT00885586|Analgesics|analgesics|mesh-ancestor
2435759|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
2435760|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435761|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435762|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
2435763|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2435764|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2435765|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2435766|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2435767|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2435768|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2435769|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435770|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435771|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
2435772|NCT00885599|Listerine|listerine|mesh-list
2435773|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
2435774|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435775|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2435776|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
2435777|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435778|NCT00885664|Ritonavir|ritonavir|mesh-list
2435779|NCT00885664|Lopinavir|lopinavir|mesh-list
2435780|NCT00885664|Tenofovir|tenofovir|mesh-list
2435781|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2435782|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2435783|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2435784|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
2435785|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435786|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435787|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2435788|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2435789|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
2435790|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435791|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2435792|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2435793|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2435794|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2435795|NCT00885690|Olanzapine|olanzapine|mesh-list
2435796|NCT00885690|Sertindole|sertindole|mesh-list
2435797|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
2435798|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
2435799|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435800|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435801|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2435802|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2435803|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2435804|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2435805|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2435806|NCT00885690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2435807|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2435808|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2435809|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435810|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435811|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
2435812|NCT00885781|SMOFlipid|smoflipid|mesh-list
2435813|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2207480|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
2207481|NCT00008190|Melphalan|melphalan|mesh-list
2207482|NCT00008190|Busulfan|busulfan|mesh-list
2207483|NCT00008190|Etoposide|etoposide|mesh-list
2207484|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207485|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
2207486|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207487|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207488|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2207489|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
2207490|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207491|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207492|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2207493|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2207494|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2435814|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2435815|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2435816|NCT00885794|Ranibizumab|ranibizumab|mesh-list
2435817|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2435818|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2435819|NCT00885794|Growth Substances|growth substances|mesh-ancestor
2435820|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435821|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
2435822|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435823|NCT00885820|Prednisone|prednisone|mesh-list
2435824|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
2435825|NCT00885820|Tacrolimus|tacrolimus|mesh-list
2435826|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2435827|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
2435828|NCT00885820|Hormones|hormones|mesh-ancestor
2435829|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2435830|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435831|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2435832|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435833|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2435834|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
2435835|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2435836|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435837|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435838|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
2435839|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
2435840|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435841|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2435842|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2435843|NCT00885820|Protective Agents|protective agents|mesh-ancestor
2435844|NCT00885833|Fludarabine|fludarabine|mesh-list
2435845|NCT00885833|Busulfan|busulfan|mesh-list
2435846|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
2435847|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435848|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435849|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2435850|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
2435851|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435852|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
2435853|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2435854|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2435855|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2435856|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2435857|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2435858|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
2435859|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435860|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2435861|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2435862|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435863|NCT00885885|Panitumumab|panitumumab|mesh-list
2435864|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2435865|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435866|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2435867|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
2435868|NCT00885924|Coagulants|coagulants|mesh-ancestor
2435869|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2435870|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
2435871|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435874|NCT00886002|Fentanyl|fentanyl|mesh-list
2435875|NCT00886002|Buprenorphine|buprenorphine|mesh-list
2435876|NCT00886002|Naloxone|naloxone|mesh-list
2435877|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2435878|NCT00886002|Narcotics|narcotics|mesh-ancestor
2435879|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2435880|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435881|NCT00886002|Analgesics|analgesics|mesh-ancestor
2435882|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
2435883|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435884|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2435885|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2435886|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
2435887|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
2435888|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2435889|NCT00886028|Doxorubicin|doxorubicin|mesh-list
2435890|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2435891|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435892|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2435893|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2435894|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2435895|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435896|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435897|NCT00886106|Midazolam|midazolam|mesh-list
2435898|NCT00886106|Remifentanil|remifentanil|mesh-list
2435899|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2435900|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2435901|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2435902|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435903|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2435904|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2435905|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2435906|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2435907|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
2435908|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
2435909|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
2435910|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
2435911|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435912|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435913|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2435914|NCT00886106|Narcotics|narcotics|mesh-ancestor
2435915|NCT00886106|Analgesics|analgesics|mesh-ancestor
2435916|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
2435917|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435918|NCT00886132|Sunitinib|sunitinib|mesh-list
2435919|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435920|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2435921|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2435922|NCT00886132|Growth Substances|growth substances|mesh-ancestor
2435923|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435924|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
2435925|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2435926|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435927|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435928|NCT00886275|Midazolam|midazolam|mesh-list
2435929|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
2435930|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2435931|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2435932|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435933|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2435934|NCT00886275|Analgesics|analgesics|mesh-ancestor
2435935|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
2435936|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435937|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2435938|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2435939|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2435940|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
2435941|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435942|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435943|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2435944|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2435945|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2435946|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2435947|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2435948|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
2435949|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
2435950|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
2435951|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
2435952|NCT00886314|Midazolam|midazolam|mesh-list
2435953|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2435954|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2435955|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2435956|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435957|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2435958|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2435959|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2435960|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2435961|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
2435962|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
2435963|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
2435964|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
2435965|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2435966|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435967|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
2435968|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
2435969|NCT00886457|Interferons|interferons|mesh-list
2435970|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
2435971|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
2435972|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2435973|NCT00886457|Decitabine|decitabine|mesh-list
2435974|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2435975|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
2435976|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2435977|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
2435978|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435979|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2435980|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
2435981|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2435982|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2435983|NCT00886496|Lectins|lectins|mesh-list
2435984|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
2435985|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
2435986|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435987|NCT00886496|Coagulants|coagulants|mesh-ancestor
2435988|NCT00886509|Lenograstim|lenograstim|mesh-list
2435989|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2435990|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
2435991|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2435992|NCT00886574|Aspirin|aspirin|mesh-list
2435993|NCT00886574|Cilostazol|cilostazol|mesh-list
2435994|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2435995|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2435996|NCT00886574|Analgesics|analgesics|mesh-ancestor
2435997|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
2435998|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2435999|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436000|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2436001|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2436002|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2436003|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2436004|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436005|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2436006|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2436007|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436008|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
2436009|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2436010|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
2436011|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2436012|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
2436013|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
2436014|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2436015|NCT00886574|Protective Agents|protective agents|mesh-ancestor
2436016|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2436017|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2436018|NCT00886678|Carboplatin|carboplatin|mesh-list
2436019|NCT00886678|Pemetrexed|pemetrexed|mesh-list
2436020|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436021|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436022|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436023|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2436024|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2436025|NCT00886717|Paclitaxel|paclitaxel|mesh-list
2436026|NCT00886717|Carboplatin|carboplatin|mesh-list
2436027|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2436028|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436029|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
2436030|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
2436031|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
2436032|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436033|NCT00886860|Misoprostol|misoprostol|mesh-list
2436034|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2436035|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
2436036|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2436037|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436038|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2436039|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2436040|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
2436041|NCT00886873|Mifepristone|mifepristone|mesh-list
2436042|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2436043|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
2436044|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2436045|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436046|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2436047|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2436048|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2436049|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
2436050|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2436051|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2436052|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
2436053|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2436054|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
2436055|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2436056|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2436057|NCT00886886|Reboxetine|reboxetine|mesh-list
2436058|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
2436059|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2436060|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2436061|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2436062|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2436063|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436064|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
2436065|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436066|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436067|NCT00886990|Ritonavir|ritonavir|mesh-list
2436068|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2436069|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2436070|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
2436071|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436072|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436073|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2436074|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2436075|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
2436076|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436077|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2436078|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2436079|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
2436080|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2436081|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2436082|NCT00887003|Prednisolone|prednisolone|mesh-list
2436083|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
2436084|NCT00887003|Bupivacaine|bupivacaine|mesh-list
2436085|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2436086|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
2436087|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
2436088|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
2436089|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2436090|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436091|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
2436092|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436093|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2436094|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
2436095|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
2436096|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2436097|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
2436098|NCT00887003|Hormones|hormones|mesh-ancestor
2436099|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2436100|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2436101|NCT00887003|Protective Agents|protective agents|mesh-ancestor
2436102|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2436103|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436104|NCT00887029|Timolol|timolol|mesh-list
2436105|NCT00887029|Travoprost|travoprost|mesh-list
2436106|NCT00887029|Latanoprost|latanoprost|mesh-list
2436107|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2436108|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2436109|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2436110|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
2436111|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436112|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436113|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436114|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2436115|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2436116|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2436117|NCT00887042|Fludarabine|fludarabine|mesh-list
2436118|NCT00887042|Busulfan|busulfan|mesh-list
2436119|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
2436120|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436121|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436122|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2436123|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
2436124|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436125|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
2436126|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2436127|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2436128|NCT00887081|Ribavirin|ribavirin|mesh-list
2436129|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
2436130|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
2436131|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2436132|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2436133|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2436134|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
2436135|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436136|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
2436137|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436138|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
2436139|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436140|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436141|NCT00887107|Sorafenib|sorafenib|mesh-list
2436142|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436143|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2436144|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436145|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436146|NCT00887120|Ritonavir|ritonavir|mesh-list
2436147|NCT00887120|Lopinavir|lopinavir|mesh-list
2436148|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2436149|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2436150|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
2436151|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436152|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436153|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2436154|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2436155|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
2436156|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436157|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2436158|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2436159|NCT00887211|Sirolimus|sirolimus|mesh-list
2436160|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2436161|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436162|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2436163|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436164|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
2436165|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2436166|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
2436167|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436168|NCT00887263|Budesonide|budesonide|mesh-list
2436169|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2436170|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2436171|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
2436172|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436173|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436174|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2436175|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
2436176|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
2436177|NCT00887263|Hormones|hormones|mesh-ancestor
2436178|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2436179|NCT00887276|Amoxicillin|amoxicillin|mesh-list
2436180|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
2436181|NCT00887276|Ampicillin|ampicillin|mesh-list
2436182|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2436183|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436184|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2436185|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2436186|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436187|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436188|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436189|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2436190|NCT00887328|Plasminogen|plasminogen|mesh-list
2436191|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2436192|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2436193|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436194|NCT00887367|Ethanol|ethanol|mesh-list
2436195|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2436196|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436197|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2436198|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436199|NCT00887380|Anastrozole|anastrozole|mesh-list
2436200|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2436201|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436202|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2436203|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2436204|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436205|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436206|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2436207|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
2436208|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2436209|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436210|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
2436211|NCT00887536|Bevacizumab|bevacizumab|mesh-list
2436212|NCT00887536|Docetaxel|docetaxel|mesh-list
2436213|NCT00887536|Doxorubicin|doxorubicin|mesh-list
2436214|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2436215|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
2436216|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436217|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2436218|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2436219|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
2436220|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436221|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436222|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2436223|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2436224|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2436225|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2436226|NCT00887536|Growth Substances|growth substances|mesh-ancestor
2436227|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
2436228|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
2436229|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
2436230|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
2436231|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2436232|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2436233|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2436234|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436235|NCT00887601|Donepezil|donepezil|mesh-list
2436236|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2436237|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436238|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436239|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
2436240|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436241|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436242|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
2436243|NCT00887627|Conivaptan|conivaptan|mesh-list
2436244|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2436245|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436246|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
2436247|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436248|NCT00887757|Gemcitabine|gemcitabine|mesh-list
2436249|NCT00887757|Navitoclax|navitoclax|mesh-list
2436250|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2436251|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
2436252|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436253|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436254|NCT00887757|Antiviral Agents|antiviral agents|mesh-ancestor
2436255|NCT00887757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436256|NCT00887757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436257|NCT00887757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2436258|NCT00887757|Immunologic Factors|immunologic factors|mesh-ancestor
2436259|NCT00887757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436260|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
2436261|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
2436262|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2436263|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436264|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2436265|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2436266|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436267|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436268|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436269|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2436270|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2436271|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2436272|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
2436273|NCT00888043|Bevacizumab|bevacizumab|mesh-list
2436274|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2436275|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436276|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2436277|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2436278|NCT00888043|Growth Substances|growth substances|mesh-ancestor
2436279|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436280|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
2436281|NCT00888082|Goserelin|goserelin|mesh-list
2436282|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2436283|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436284|NCT00888108|Docetaxel|docetaxel|mesh-list
2436285|NCT00888108|Navitoclax|navitoclax|mesh-list
2436286|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436287|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
2436288|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
2436289|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
2436290|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436291|NCT00888186|Levodopa|levodopa|mesh-list
2436292|NCT00888186|Carbidopa|carbidopa|mesh-list
2436293|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2436294|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2436295|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
2436296|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436297|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436298|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436299|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2436300|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436301|NCT00888303|Dexamethasone|dexamethasone|mesh-list
2436302|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2436303|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
2436304|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
2436305|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436306|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436307|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2436308|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
2436309|NCT00888303|Hormones|hormones|mesh-ancestor
2436310|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2436311|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2436312|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436313|NCT00888342|Ethanol|ethanol|mesh-list
2436314|NCT00888342|Zopiclone|zopiclone|mesh-list
2436315|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2436316|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436317|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2436318|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436319|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2436320|NCT00888394|Imidacloprid|imidacloprid|mesh-list
2436321|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
2436322|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436323|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436324|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436325|NCT00888602|Psyllium|psyllium|mesh-list
2436326|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
2436327|NCT00888602|Cathartics|cathartics|mesh-ancestor
2436328|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2436329|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
2436330|NCT00888732|Insulin|insulin|mesh-list
2436331|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2436332|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
2436333|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
2436334|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2436335|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2436336|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436337|NCT00888758|Sirolimus|sirolimus|mesh-list
2436338|NCT00888758|Umirolimus|umirolimus|mesh-list
2436339|NCT00888758|Everolimus|everolimus|mesh-list
2436340|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436341|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2436342|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
2436343|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436344|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2436345|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2436346|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436347|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2436348|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
2436349|NCT00888784|Propranolol|propranolol|mesh-list
2436350|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2436351|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2436352|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
2436353|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436354|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436355|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436356|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2436357|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2436358|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
2436359|NCT00888797|Etodolac|etodolac|mesh-list
2436360|NCT00888797|Propranolol|propranolol|mesh-list
2436361|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2436362|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2436363|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
2436364|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436365|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436366|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436367|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2436368|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2436369|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
2436370|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2436371|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2436372|NCT00888797|Analgesics|analgesics|mesh-ancestor
2436373|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
2436374|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436375|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2436376|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2436377|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2436378|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2436379|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436380|NCT00888810|Topotecan|topotecan|mesh-list
2436381|NCT00888810|Lapatinib|lapatinib|mesh-list
2436382|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2436383|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2207495|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2207496|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207497|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2207498|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2207499|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
2207500|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207501|NCT00008203|Interferons|interferons|mesh-list
2436384|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436385|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436386|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436387|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2436388|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2436389|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436390|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
2436391|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2436392|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2436393|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2436394|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436395|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436396|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436397|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
2436398|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2436399|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2436400|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
2436401|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2436402|NCT00888901|Prednisolone|prednisolone|mesh-list
2436403|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
2436404|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2436405|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
2436406|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2436407|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
2436408|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
2207502|NCT00008203|Aldesleukin|aldesleukin|mesh-list
2207503|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
2436409|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436410|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436411|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2436412|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
2436413|NCT00888901|Hormones|hormones|mesh-ancestor
2436414|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2436415|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2436416|NCT00888901|Protective Agents|protective agents|mesh-ancestor
2436417|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2436418|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436419|NCT00889018|Carboplatin|carboplatin|mesh-list
2436420|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436421|NCT00889044|Clopidogrel|clopidogrel|mesh-list
2436422|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2436423|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2436424|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2436425|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2436426|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
2436427|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436428|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436429|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436430|NCT00889057|Sorafenib|sorafenib|mesh-list
2436431|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436432|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2436433|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436434|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436435|NCT00889096|Propranolol|propranolol|mesh-list
2436436|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2436437|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2436438|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
2436439|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436440|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436441|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436442|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2436443|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2436444|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
2436445|NCT00889135|Droxidopa|droxidopa|mesh-list
2436446|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2436447|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2436448|NCT00889148|Gabapentin|gabapentin|mesh-list
2436449|NCT00889148|Analgesics|analgesics|mesh-ancestor
2436450|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
2436451|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436452|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436453|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
2436454|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2436455|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2436456|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2436457|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2436458|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2436459|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2436460|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436461|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436462|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
2436463|NCT00889161|Curcumin|curcumin|mesh-list
2436464|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2436465|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2436466|NCT00889161|Analgesics|analgesics|mesh-ancestor
2436467|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
2436468|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436469|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436470|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2436471|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2436472|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436473|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436474|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436475|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2436476|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
2436477|NCT00889213|Coagulants|coagulants|mesh-ancestor
2436478|NCT00889343|Leucovorin|leucovorin|mesh-list
2436479|NCT00889343|Fluorouracil|fluorouracil|mesh-list
2436480|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
2436481|NCT00889343|Irinotecan|irinotecan|mesh-list
2436482|NCT00889343|Sorafenib|sorafenib|mesh-list
2436483|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
2436484|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436485|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2436486|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436487|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2436488|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
2436489|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436490|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2436491|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2436492|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436493|NCT00889343|Antidotes|antidotes|mesh-ancestor
2436494|NCT00889343|Protective Agents|protective agents|mesh-ancestor
2436495|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
2436496|NCT00889343|Vitamins|vitamins|mesh-ancestor
2436497|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
2436498|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2436499|NCT00889356|Clindamycin|clindamycin|mesh-list
2436500|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
2436501|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
2436502|NCT00889356|Amphotericin B|amphotericin b|mesh-list
2436503|NCT00889356|Tetracycline|tetracycline|mesh-list
2436504|NCT00889356|Ketoconazole|ketoconazole|mesh-list
2436505|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2436506|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2436507|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436508|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2436509|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436510|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436511|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
2436512|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2436513|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2436514|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2436515|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
2436516|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2436517|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436518|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2436519|NCT00889356|Amebicides|amebicides|mesh-ancestor
2436520|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2436521|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2436522|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2436523|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2436524|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2436525|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2436526|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436527|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436528|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436529|NCT00889369|Analgesics|analgesics|mesh-ancestor
2436530|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
2436531|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436532|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
2436533|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2436534|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
2436535|NCT00889382|Paclitaxel|paclitaxel|mesh-list
2436536|NCT00889382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2436537|NCT00889382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436538|NCT00889382|Tubulin Modulators|tubulin modulators|mesh-ancestor
2436539|NCT00889382|Antimitotic Agents|antimitotic agents|mesh-ancestor
2436540|NCT00889382|Mitosis Modulators|mitosis modulators|mesh-ancestor
2436541|NCT00889382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436542|NCT00889434|Tocotrienols|tocotrienols|mesh-list
2436543|NCT00889434|Vitamin E|vitamin e|mesh-list
2436544|NCT00889434|Tocopherols|tocopherols|mesh-list
2436545|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
2436546|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436547|NCT00889434|Protective Agents|protective agents|mesh-ancestor
2436548|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436549|NCT00889434|Vitamins|vitamins|mesh-ancestor
2436550|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
2436551|NCT00889499|Tropisetron|tropisetron|mesh-list
2436552|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
2436553|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
2436554|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436555|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436556|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2436557|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2436558|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2436559|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
2436560|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436561|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436562|NCT00889525|Cabergoline|cabergoline|mesh-list
2436563|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2436564|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2436565|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
2436566|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
2436567|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436568|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436569|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436570|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
2436571|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2436572|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436573|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2436574|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2436575|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
2436576|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436577|NCT00889616|Antacids|antacids|mesh-ancestor
2436578|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436579|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2436580|NCT00889629|Vitamin D|vitamin d|mesh-list
2436581|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
2436582|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
2436583|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
2436584|NCT00889629|Vitamins|vitamins|mesh-ancestor
2436585|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
2436586|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436587|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2436588|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2436589|NCT00889642|Lidocaine|lidocaine|mesh-list
2436590|NCT00889642|Epinephrine|epinephrine|mesh-list
2436591|NCT00889642|Racepinephrine|racepinephrine|mesh-list
2436592|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
2436593|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
2436594|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
2436595|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2436596|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436597|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
2436598|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436599|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2436600|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2436601|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2436602|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2436603|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436604|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2436605|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2436606|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
2436607|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436608|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2436609|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2436610|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
2436611|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2436612|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
2436613|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
2436614|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
2436615|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2436616|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2436617|NCT00889655|Laxatives|laxatives|mesh-ancestor
2436618|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2207504|NCT00008203|Cyclosporine|cyclosporine|mesh-list
2207505|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
2207506|NCT00008203|Thiotepa|thiotepa|mesh-list
2207507|NCT00008203|Carboplatin|carboplatin|mesh-list
2207508|NCT00008203|Cyclosporins|cyclosporins|mesh-list
2207509|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207510|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
2207511|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207512|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207513|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2207514|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
2207515|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207516|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436619|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
2436620|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436621|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2436622|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2436623|NCT00889694|Analgesics|analgesics|mesh-ancestor
2436624|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
2436625|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436626|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436627|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2436628|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2436629|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2436630|NCT00889733|Cisplatin|cisplatin|mesh-list
2436631|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436632|NCT00889837|Loxapine|loxapine|mesh-list
2436633|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2436634|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2436635|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2436636|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436637|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2436638|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2436639|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
2436640|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436641|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436642|NCT00889850|Esomeprazole|esomeprazole|mesh-list
2436643|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2436644|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2436645|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2436646|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436647|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436648|NCT00889876|Metformin|metformin|mesh-list
2436649|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2436650|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436651|NCT00889967|Ciprofloxacin|ciprofloxacin|mesh-list
2436652|NCT00889967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2436653|NCT00889967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436654|NCT00889967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2436655|NCT00889967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2436656|NCT00889967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436657|NCT00889967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436658|NCT00889967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436659|NCT00889967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2436660|NCT00889967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2436661|NCT00890110|Sunitinib|sunitinib|mesh-list
2436662|NCT00890110|Vaccines|vaccines|mesh-list
2436663|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
2436664|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436665|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436666|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2436667|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2436668|NCT00890110|Growth Substances|growth substances|mesh-ancestor
2436669|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
2436670|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2436671|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436672|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436673|NCT00890149|Ondansetron|ondansetron|mesh-list
2436674|NCT00890149|Antiemetics|antiemetics|mesh-ancestor
2436675|NCT00890149|Autonomic Agents|autonomic agents|mesh-ancestor
2436676|NCT00890149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436677|NCT00890149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436678|NCT00890149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2436679|NCT00890149|Antipruritics|antipruritics|mesh-ancestor
2436680|NCT00890149|Dermatologic Agents|dermatologic agents|mesh-ancestor
2436681|NCT00890149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2436682|NCT00890149|Serotonin Agents|serotonin agents|mesh-ancestor
2436683|NCT00890149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436684|NCT00890149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436685|NCT00890149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2436686|NCT00890149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2436687|NCT00890149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2436688|NCT00890149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2436689|NCT00890149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2436690|NCT00890175|Loxapine|loxapine|mesh-list
2436691|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2436692|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2436693|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2436694|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436695|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2436696|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2436697|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
2436698|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436699|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436700|NCT00890188|Thalidomide|thalidomide|mesh-list
2436701|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2436702|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
2436703|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436704|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
2436705|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2436706|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436707|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2436708|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2436709|NCT00890188|Growth Substances|growth substances|mesh-ancestor
2436710|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
2436711|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436712|NCT00890214|Epoprostenol|epoprostenol|mesh-list
2436713|NCT00890214|Heparin|heparin|mesh-list
2436714|NCT00890214|Calcium heparin|calcium heparin|mesh-list
2436715|NCT00890214|Tezosentan|tezosentan|mesh-list
2436716|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
2436717|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2436718|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2436719|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436720|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2436721|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2436722|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
2436723|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
2436724|NCT00890253|Prednisone|prednisone|mesh-list
2436725|NCT00890253|Prednisolone|prednisolone|mesh-list
2436726|NCT00890253|Everolimus|everolimus|mesh-list
2436727|NCT00890253|Basiliximab|basiliximab|mesh-list
2436728|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2436729|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
2436730|NCT00890253|Hormones|hormones|mesh-ancestor
2436731|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2436732|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436733|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2436734|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436735|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2436736|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
2436737|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2436738|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2436739|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
2436740|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2436741|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436742|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436743|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436744|NCT00890266|Riboflavin|riboflavin|mesh-list
2436745|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
2436746|NCT00890266|Vitamins|vitamins|mesh-ancestor
2436747|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
2436748|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436749|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2436750|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
2436751|NCT00890279|Imidapril|imidapril|mesh-list
2436752|NCT00890279|Cilnidipine|cilnidipine|mesh-list
2436753|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2436754|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2436755|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436756|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2436757|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436758|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2436759|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
2436760|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436761|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2436762|NCT00890305|Pidilizumab|pidilizumab|mesh-list
2207517|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2207518|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
2207519|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207520|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207521|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
2207522|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
2207523|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2207524|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2207525|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2207526|NCT00008229|Melphalan|melphalan|mesh-list
2207527|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
2207528|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436763|NCT00890305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2436764|NCT00890305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436765|NCT00890318|Ketoconazole|ketoconazole|mesh-list
2436766|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
2436767|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436768|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2436769|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2436770|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436771|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436772|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2436773|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
2436774|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2436775|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436776|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2436777|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2436778|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
2436779|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
2436780|NCT00890422|Vaccines|vaccines|mesh-list
2436781|NCT00890422|Immunologic Factors|immunologic factors|mesh-ancestor
2436782|NCT00890422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436783|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
2436784|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2436785|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
2436786|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436787|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
2436788|NCT00890487|Protective Agents|protective agents|mesh-ancestor
2436789|NCT00890500|Sirolimus|sirolimus|mesh-list
2436790|NCT00890500|Fludarabine|fludarabine|mesh-list
2436791|NCT00890500|Melphalan|melphalan|mesh-list
2436792|NCT00890500|Tacrolimus|tacrolimus|mesh-list
2436793|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2436794|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436795|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436796|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2436797|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
2436798|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436799|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2436800|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436801|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2436802|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436803|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2436804|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
2436805|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2436806|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
2436807|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2436808|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
2436809|NCT00890539|Miotics|miotics|mesh-ancestor
2436810|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
2436811|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436812|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436813|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2436814|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2436815|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
2436816|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2436817|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2436818|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
2436819|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436820|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436821|NCT00890565|Granisetron|granisetron|mesh-list
2436822|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
2436823|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
2436824|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436825|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436826|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2436827|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2436828|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
2436829|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436830|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436831|NCT00890604|Acetaminophen|acetaminophen|mesh-list
2436832|NCT00890604|Ibuprofen|ibuprofen|mesh-list
2436833|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2436834|NCT00890604|Analgesics|analgesics|mesh-ancestor
2436835|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
2436836|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436837|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436838|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
2436839|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2436840|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2436841|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2436842|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2436843|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436844|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436845|NCT00890630|Oxytocin|oxytocin|mesh-list
2436846|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
2436847|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2436848|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436849|NCT00890643|Prazosin|prazosin|mesh-list
2436850|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2436851|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2436852|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2436853|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2436854|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
2436855|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2436856|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436857|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436858|NCT00890708|Voriconazole|voriconazole|mesh-list
2436859|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
2436860|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436861|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2436862|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2436863|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436864|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436865|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2436866|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
2436867|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2436868|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436869|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2436870|NCT00890747|Sunitinib|sunitinib|mesh-list
2436871|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436872|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2436873|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2436874|NCT00890747|Growth Substances|growth substances|mesh-ancestor
2436875|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436876|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
2436877|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2436878|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436879|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436880|NCT00890786|Bevacizumab|bevacizumab|mesh-list
2436881|NCT00890786|Irinotecan|irinotecan|mesh-list
2436882|NCT00890786|Temozolomide|temozolomide|mesh-list
2436883|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2436884|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436885|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2436886|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2436887|NCT00890786|Growth Substances|growth substances|mesh-ancestor
2436888|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436889|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
2436890|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2436891|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2436892|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436893|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436894|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2436895|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
2436896|NCT00890942|Naloxone|naloxone|mesh-list
2436897|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2436898|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436899|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
2436900|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436901|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
2436902|NCT00890955|Amrubicin|amrubicin|mesh-list
2436903|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2436904|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
2436905|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436906|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2436907|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2436908|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
2436909|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436910|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436911|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2436912|NCT00890968|Triamcinolone|triamcinolone|mesh-list
2436913|NCT00890968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2436914|NCT00890968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2436915|NCT00890968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2207529|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2207530|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
2207531|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207532|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207533|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2207534|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207535|NCT00008242|Thalidomide|thalidomide|mesh-list
2207536|NCT00008242|Dexamethasone|dexamethasone|mesh-list
2207537|NCT00008242|Doxorubicin|doxorubicin|mesh-list
2207538|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2207539|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2207540|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
2207541|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
2207542|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2207543|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207544|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2207545|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
2207546|NCT00008242|Hormones|hormones|mesh-ancestor
2207547|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2207548|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2207549|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207550|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2207551|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2207552|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2207553|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207554|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436916|NCT00890968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2436917|NCT00890968|Glucocorticoids|glucocorticoids|mesh-ancestor
2436918|NCT00890968|Hormones|hormones|mesh-ancestor
2436919|NCT00890968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2436920|NCT00890968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436921|NCT00890968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2436922|NCT00890968|Immunologic Factors|immunologic factors|mesh-ancestor
2436923|NCT00890968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436924|NCT00890968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436925|NCT00891033|Bortezomib|bortezomib|mesh-list
2436926|NCT00891033|Panobinostat|panobinostat|mesh-list
2436927|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436928|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2436929|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436930|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436931|NCT00891072|Acetic Acid|acetic acid|mesh-list
2436932|NCT00891072|Paclitaxel|paclitaxel|mesh-list
2436933|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
2436934|NCT00891072|Carboplatin|carboplatin|mesh-list
2436935|NCT00891072|Retinol acetate|retinol acetate|mesh-list
2436936|NCT00891072|Gossypol|gossypol|mesh-list
2436937|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2436938|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2436939|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
2436940|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
2436941|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
2436942|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436943|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2436944|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436945|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2436946|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
2436947|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436948|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2436949|NCT00891072|Protective Agents|protective agents|mesh-ancestor
2436950|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2436951|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
2436952|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2436953|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2436954|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
2436955|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
2436956|NCT00891150|Oxytocin|oxytocin|mesh-list
2436957|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
2436958|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2436959|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436960|NCT00891163|Lidocaine|lidocaine|mesh-list
2436961|NCT00891163|Tetracaine|tetracaine|mesh-list
2436962|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
2436963|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
2436964|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2436965|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436966|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
2436967|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2436968|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2436969|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2436970|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2436971|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2436972|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436973|NCT00891267|Amlodipine|amlodipine|mesh-list
2436974|NCT00891267|Olmesartan|olmesartan|mesh-list
2436975|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2436976|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2436977|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2436978|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2436979|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436980|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2436981|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436982|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
2436983|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2436984|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2436985|NCT00891306|Cyclosporine|cyclosporine|mesh-list
2436986|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
2436987|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
2436988|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2436989|NCT00891306|Cyclosporins|cyclosporins|mesh-list
2436990|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2436991|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2436992|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2436993|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
2436994|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2436995|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
2436996|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2436997|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
2436998|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2436999|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2437000|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2437001|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437002|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2437003|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
2437004|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2437005|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2437006|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
2437007|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
2437008|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437009|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2437010|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
2437011|NCT00891306|Hormones|hormones|mesh-ancestor
2437012|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2437013|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2437014|NCT00891306|Protective Agents|protective agents|mesh-ancestor
2437015|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2437016|NCT00891332|Leucovorin|leucovorin|mesh-list
2437017|NCT00891332|Antidotes|antidotes|mesh-ancestor
2437018|NCT00891332|Protective Agents|protective agents|mesh-ancestor
2437019|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437020|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
2437021|NCT00891332|Vitamins|vitamins|mesh-ancestor
2437022|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
2437023|NCT00891384|Lenalidomide|lenalidomide|mesh-list
2437024|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
2437025|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437026|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2437027|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2437028|NCT00891384|Growth Substances|growth substances|mesh-ancestor
2437029|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
2437030|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437031|NCT00891397|Pregabalin|pregabalin|mesh-list
2437032|NCT00891397|Analgesics|analgesics|mesh-ancestor
2437033|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
2207555|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207556|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
2207557|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
2207558|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2207559|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207560|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2207561|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2207562|NCT00008242|Growth Substances|growth substances|mesh-ancestor
2207563|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
2207564|NCT00008268|Melphalan|melphalan|mesh-list
2207565|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
2207566|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207567|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2207568|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
2207569|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207570|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207571|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2207572|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207573|NCT00008281|Leucovorin|leucovorin|mesh-list
2207574|NCT00008281|Fluorouracil|fluorouracil|mesh-list
2207575|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
2207576|NCT00008281|Calcium|calcium|mesh-list
2207577|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
2207578|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2207579|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207580|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
2207581|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207582|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2207583|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207584|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207585|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
2207586|NCT00008281|Antidotes|antidotes|mesh-ancestor
2207587|NCT00008281|Protective Agents|protective agents|mesh-ancestor
2207588|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
2207589|NCT00008281|Vitamins|vitamins|mesh-ancestor
2207590|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
2207591|NCT00008294|Leucovorin|leucovorin|mesh-list
2207592|NCT00008294|Dexamethasone|dexamethasone|mesh-list
2207593|NCT00008294|Fluorouracil|fluorouracil|mesh-list
2207594|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
2207595|NCT00008294|Floxuridine|floxuridine|mesh-list
2207596|NCT00008294|Calcium|calcium|mesh-list
2207597|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
2207598|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2207599|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
2207600|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
2207601|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2207602|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207603|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2207604|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
2207605|NCT00008294|Hormones|hormones|mesh-ancestor
2207606|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2207607|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2437034|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437035|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437036|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
2437037|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2437038|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2437039|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437040|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2437041|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2437042|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2437043|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437044|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2437045|NCT00891423|Meropenem|meropenem|mesh-list
2437046|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2437047|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437048|NCT00891475|Interferons|interferons|mesh-list
2437049|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
2437050|NCT00891475|Sunitinib|sunitinib|mesh-list
2437051|NCT00891475|Maleic acid|maleic acid|mesh-list
2437052|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437053|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
2437054|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437055|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
2437056|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437057|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2437058|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2437059|NCT00891475|Growth Substances|growth substances|mesh-ancestor
2437060|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
2437061|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2437062|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437063|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437064|NCT00891540|Ropivacaine|ropivacaine|mesh-list
2437065|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
2437066|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
2437067|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437068|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437069|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
2437070|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437071|NCT00891579|Pemetrexed|pemetrexed|mesh-list
2437072|NCT00891579|Gefitinib|gefitinib|mesh-list
2437073|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437074|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437075|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437076|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2437077|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2437078|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2437079|NCT00891605|Paclitaxel|paclitaxel|mesh-list
2437080|NCT00891605|Navitoclax|navitoclax|mesh-list
2437081|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2437082|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437083|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
2437084|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
2437085|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
2437086|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437087|NCT00891670|Aspirin|aspirin|mesh-list
2437088|NCT00891670|Cilostazol|cilostazol|mesh-list
2437089|NCT00891670|Clopidogrel|clopidogrel|mesh-list
2437090|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2437091|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2437092|NCT00891670|Analgesics|analgesics|mesh-ancestor
2437093|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
2437094|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437095|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437096|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2437097|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2437098|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2437099|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2437100|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207608|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207609|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2207610|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
2207611|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207612|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2207613|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207614|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
2207615|NCT00008294|Antidotes|antidotes|mesh-ancestor
2207616|NCT00008294|Protective Agents|protective agents|mesh-ancestor
2207617|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
2207618|NCT00008294|Vitamins|vitamins|mesh-ancestor
2207619|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
2207620|NCT00008307|Cyclosporine|cyclosporine|mesh-list
2437101|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2437102|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2437103|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437104|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
2437105|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2437106|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2437107|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2437108|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
2437109|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437110|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2437111|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
2437112|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2437113|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
2437114|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
2437115|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2437116|NCT00891670|Protective Agents|protective agents|mesh-ancestor
2437117|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2437118|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2437119|NCT00891696|Sirolimus|sirolimus|mesh-list
2437120|NCT00891696|Nitroprusside|nitroprusside|mesh-list
2437121|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2437122|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437123|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2437124|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437125|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
2437126|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2437127|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
2437128|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437129|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2437130|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
2437131|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2437132|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437133|NCT00891761|Dexamethasone|dexamethasone|mesh-list
2437134|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
2437135|NCT00891761|Ondansetron|ondansetron|mesh-list
2437136|NCT00891761|Casopitant|casopitant|mesh-list
2437137|NCT00891761|BB 1101|bb 1101|mesh-list
2437138|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2437139|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
2437140|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
2437141|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437142|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437143|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2437144|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
2437145|NCT00891761|Hormones|hormones|mesh-ancestor
2437146|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2437147|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2437148|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437149|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
2437150|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437151|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437152|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
2437153|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
2437154|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2437155|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
2437156|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437157|NCT00891761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2437158|NCT00891761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2437159|NCT00891761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437160|NCT00891761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2437161|NCT00891761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2437162|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2437163|NCT00892073|Metformin|metformin|mesh-list
2437164|NCT00892073|Diazoxide|diazoxide|mesh-list
2437165|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2437166|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437167|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2437168|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
2437169|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
2437170|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
2437171|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2437172|NCT00892112|Antibodies|antibodies|mesh-list
2437173|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
2437174|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2437175|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
2437176|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437177|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
2437178|NCT00892125|Carbamazepine|carbamazepine|mesh-list
2437179|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2437180|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2437181|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2437182|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437183|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437184|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2437185|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2437186|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2437187|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
2437188|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437189|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437190|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2437191|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2437192|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
2437193|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
2437194|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
2437195|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2437196|NCT00892125|Analgesics|analgesics|mesh-ancestor
2437197|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
2437198|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437199|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2437200|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2437201|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2437202|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2437203|NCT00892190|Dasatinib|dasatinib|mesh-list
2437204|NCT00892190|Tretinoin|tretinoin|mesh-list
2437205|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437206|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2437207|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437208|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437209|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
2437210|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
2437211|NCT00892203|Sumatriptan|sumatriptan|mesh-list
2437212|NCT00892203|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2437213|NCT00892203|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2437214|NCT00892203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2437215|NCT00892203|Serotonin Agents|serotonin agents|mesh-ancestor
2437216|NCT00892203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437217|NCT00892203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437218|NCT00892203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437219|NCT00892229|Misoprostol|misoprostol|mesh-list
2437220|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2437221|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
2437222|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2437223|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437224|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2437225|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2437226|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
2437227|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
2437228|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2437229|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437230|NCT00892307|Adenosine|adenosine|mesh-list
2437231|NCT00892307|Analgesics|analgesics|mesh-ancestor
2437232|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
2437233|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437234|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437235|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2437236|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
2437237|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2437238|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
2437239|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
2437240|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437241|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207621|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
2207622|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
2207623|NCT00008307|Fludarabine|fludarabine|mesh-list
2207624|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
2207625|NCT00008307|Melphalan|melphalan|mesh-list
2207626|NCT00008307|Cyclosporins|cyclosporins|mesh-list
2207627|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2207628|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207629|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2207630|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
2207631|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207632|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207633|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
2207634|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207635|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207636|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
2207637|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207638|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
2207639|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207640|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2207641|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2207642|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2207643|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
2207644|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2207645|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2437242|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2437243|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2437244|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2437245|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437246|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437247|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2207646|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
2437248|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2437249|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2437250|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
2437251|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437252|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437253|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2437254|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2437255|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
2437256|NCT00892346|Thalidomide|thalidomide|mesh-list
2437257|NCT00892346|Melphalan|melphalan|mesh-list
2437258|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2437259|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
2437260|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437261|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437262|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2437263|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2437264|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
2437265|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437266|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
2437267|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2437268|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437269|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2437270|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2437271|NCT00892346|Growth Substances|growth substances|mesh-ancestor
2437272|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
2437273|NCT00892359|Anidulafungin|anidulafungin|mesh-list
2437274|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
2437275|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437276|NCT00892385|Temozolomide|temozolomide|mesh-list
2437277|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2437278|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
2437279|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437280|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437281|NCT00892398|Ranibizumab|ranibizumab|mesh-list
2437282|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2437283|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2437284|NCT00892398|Growth Substances|growth substances|mesh-ancestor
2437285|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437286|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
2437287|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437288|NCT00892424|Sorafenib|sorafenib|mesh-list
2437289|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437290|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2437291|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437292|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437293|NCT00892450|Oxybutynin|oxybutynin|mesh-list
2437294|NCT00892450|Darifenacin|darifenacin|mesh-list
2437295|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
2437296|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
2437297|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437298|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437299|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2437300|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2437301|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
2437302|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437303|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437304|NCT00892450|Urological Agents|urological agents|mesh-ancestor
2437305|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2437306|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
2437307|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2437308|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2437309|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2437310|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437311|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437312|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
2437313|NCT00892476|Calcium|calcium|mesh-list
2437314|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2437315|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437316|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2437317|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2437318|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2437319|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2437320|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437321|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437322|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2437323|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2437324|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2437325|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
2437326|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437327|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437328|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2437329|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2437330|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
2437331|NCT00892502|Bismuth|bismuth|mesh-list
2437332|NCT00892502|Antacids|antacids|mesh-ancestor
2437333|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437334|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2437335|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2437336|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2437337|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2437338|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437339|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437340|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2437341|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2437342|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2437343|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
2437344|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437345|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437346|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2437347|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2437348|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
2437349|NCT00892658|Sorafenib|sorafenib|mesh-list
2437350|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437351|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2437352|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437353|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437354|NCT00892736|Veliparib|veliparib|mesh-list
2437355|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2437356|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437357|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437358|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437359|NCT00892762|Travoprost|travoprost|mesh-list
2437360|NCT00892762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2437361|NCT00892762|Latanoprost|latanoprost|mesh-list
2437362|NCT00892762|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2437363|NCT00892762|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2437364|NCT00892801|Everolimus|everolimus|mesh-list
2437365|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437366|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2437367|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
2437368|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437369|NCT00892827|Rituximab|rituximab|mesh-list
2437370|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2437371|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437372|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
2437373|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437374|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2437375|NCT00892892|Nitrendipine|nitrendipine|mesh-list
2437376|NCT00892892|Rilmenidine|rilmenidine|mesh-list
2437377|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2437378|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2437379|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2437380|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437381|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2437382|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437383|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
2437384|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
2437385|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
2437386|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437387|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2437388|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2437389|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2437390|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
2437391|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437392|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
2437393|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
2437394|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2437395|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2437396|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2207647|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2207648|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2207649|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
2207650|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
2207651|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2207652|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2207653|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
2207654|NCT00008307|Hormones|hormones|mesh-ancestor
2207655|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2207656|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2207657|NCT00008307|Protective Agents|protective agents|mesh-ancestor
2207658|NCT00008333|Vinorelbine|vinorelbine|mesh-list
2207659|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2437397|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437398|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2437399|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2437400|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437401|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437402|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437403|NCT00892970|Azithromycin|azithromycin|mesh-list
2437404|NCT00892970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2437405|NCT00892970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2437406|NCT00892970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2437407|NCT00892970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437408|NCT00892996|Dexamethasone|dexamethasone|mesh-list
2437409|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
2437410|NCT00892996|BB 1101|bb 1101|mesh-list
2437411|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2437412|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
2437413|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
2437414|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437415|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437416|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2437417|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
2437418|NCT00892996|Hormones|hormones|mesh-ancestor
2437419|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2437420|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2437421|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437422|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
2437423|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437424|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437425|NCT00893009|Theophylline|theophylline|mesh-list
2437426|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2437427|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
2437428|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437429|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437430|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2437431|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
2437432|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2437433|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437434|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437435|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
2437436|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2437437|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2437438|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
2437439|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437440|NCT00893048|Prednisone|prednisone|mesh-list
2437441|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2437442|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
2437443|NCT00893048|Hormones|hormones|mesh-ancestor
2437444|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2437445|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437446|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2437447|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437448|NCT00893061|Tamoxifen|tamoxifen|mesh-list
2437449|NCT00893061|Letrozole|letrozole|mesh-list
2437450|NCT00893061|Anastrozole|anastrozole|mesh-list
2437451|NCT00893061|Exemestane|exemestane|mesh-list
2437452|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437453|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437454|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2437455|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2437456|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207660|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207661|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
2207662|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
2207663|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
2207664|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207665|NCT00008359|Amphotericin B|amphotericin b|mesh-list
2207666|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2207667|NCT00008359|Caspofungin|caspofungin|mesh-list
2207668|NCT00008359|Amebicides|amebicides|mesh-ancestor
2207669|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2437457|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2437458|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
2437459|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2437460|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437461|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2437462|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2437463|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2437464|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2437465|NCT00893100|Diltiazem|diltiazem|mesh-list
2437466|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2437467|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2437468|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2437469|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437470|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2437471|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437472|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
2437473|NCT00893139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2437474|NCT00893139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2437475|NCT00893217|Interferons|interferons|mesh-list
2437476|NCT00893217|Interferon-beta|interferon-beta|mesh-list
2437477|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
2437478|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437479|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
2437480|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437481|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
2437482|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437483|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2437484|NCT00893256|Risperidone|risperidone|mesh-list
2437485|NCT00893256|Citalopram|citalopram|mesh-list
2437486|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2437487|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
2437488|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437489|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437490|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437491|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2437492|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2437493|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437494|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2437495|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2437496|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
2437497|NCT00893256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2437498|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2437499|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2437500|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2437501|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
2437502|NCT00893269|Zolpidem|zolpidem|mesh-list
2437503|NCT00893269|Eszopiclone|eszopiclone|mesh-list
2437504|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2437505|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2437506|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437507|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437508|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2437509|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
2437510|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
2437511|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437512|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437513|NCT00893373|Sorafenib|sorafenib|mesh-list
2437514|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437515|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2437516|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437517|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437518|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
2437519|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2437520|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437521|NCT00893412|Tramadol|tramadol|mesh-list
2437522|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2437523|NCT00893412|Narcotics|narcotics|mesh-ancestor
2437524|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437525|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437526|NCT00893412|Analgesics|analgesics|mesh-ancestor
2437527|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
2437528|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437529|NCT00893425|Ramipril|ramipril|mesh-list
2437530|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2437531|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
2437532|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437533|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437534|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2437535|NCT00893451|Vitamin D|vitamin d|mesh-list
2437536|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
2437537|NCT00893451|Vitamins|vitamins|mesh-ancestor
2437538|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
2437539|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437540|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2437541|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2437542|NCT00893477|Rituximab|rituximab|mesh-list
2437543|NCT00893477|Sargramostim|sargramostim|mesh-list
2437544|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2437545|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437546|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
2437547|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437548|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2437549|NCT00893490|Mitomycins|mitomycins|mesh-list
2437550|NCT00893490|Mitomycin|mitomycin|mesh-list
2437551|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2437552|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437553|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
2437554|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437555|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2437556|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437557|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
2437558|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2437559|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437560|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2437561|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
2437562|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2437563|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437564|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437565|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437566|NCT00893555|Voriconazole|voriconazole|mesh-list
2437567|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
2437568|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437569|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2437570|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2437571|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437572|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437573|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2437574|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
2437575|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2437576|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437577|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2437578|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2437579|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
2437580|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2437581|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2437582|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2437583|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437584|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437585|NCT00893594|Naproxen|naproxen|mesh-list
2437586|NCT00893594|Sumatriptan|sumatriptan|mesh-list
2437587|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2437588|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2437589|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2437590|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
2437591|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437592|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437593|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437594|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2437595|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2437596|NCT00893594|Analgesics|analgesics|mesh-ancestor
2437597|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
2437598|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437599|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2437600|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2437601|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
2437602|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2437603|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437604|NCT00893607|Methoxamine|methoxamine|mesh-list
2437605|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
2437606|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
2437607|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437608|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437609|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2437610|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2437611|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2437612|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2437613|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
2437614|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437615|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437616|NCT00893711|Vitamin D|vitamin d|mesh-list
2437617|NCT00893711|Vitamins|vitamins|mesh-ancestor
2437618|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
2437619|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437620|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2437621|NCT00893724|Tocopherols|tocopherols|mesh-list
2437622|NCT00893724|Vitamin E|vitamin e|mesh-list
2437623|NCT00893724|Tocotrienols|tocotrienols|mesh-list
2437624|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
2437625|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
2437626|NCT00893724|Niacinamide|niacinamide|mesh-list
2437627|NCT00893724|Niacin|niacin|mesh-list
2437628|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
2437629|NCT00893724|Ubiquinone|ubiquinone|mesh-list
2437630|NCT00893724|Minocycline|minocycline|mesh-list
2437631|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
2437632|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2437633|NCT00893724|Vitamins|vitamins|mesh-ancestor
2437634|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
2437635|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437636|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
2437637|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437638|NCT00893724|Protective Agents|protective agents|mesh-ancestor
2437639|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2437640|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437641|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
2437642|NCT00893724|Expectorants|expectorants|mesh-ancestor
2437643|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
2437644|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2437645|NCT00893724|Antidotes|antidotes|mesh-ancestor
2437646|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
2437647|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2437648|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
2437649|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2437650|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
2437651|NCT00893841|Pramipexole|pramipexole|mesh-list
2207670|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2207671|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207672|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2207673|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
2207674|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207675|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207676|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
2207677|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207678|NCT00008398|Sargramostim|sargramostim|mesh-list
2207679|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
2207680|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207681|NCT00008411|Docetaxel|docetaxel|mesh-list
2207682|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207683|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
2207684|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
2207685|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
2207686|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207687|NCT00008424|Irinotecan|irinotecan|mesh-list
2207688|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2207689|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2437652|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2437653|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
2437654|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2437655|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2437656|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2437657|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437658|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437659|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
2437660|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437661|NCT00893841|Protective Agents|protective agents|mesh-ancestor
2437662|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2437663|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2207690|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207691|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207692|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207693|NCT00008450|Cyclosporine|cyclosporine|mesh-list
2207694|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
2207695|NCT00008450|Cyclosporins|cyclosporins|mesh-list
2207696|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207697|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207698|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207699|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
2207700|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207701|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
2207702|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207703|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
2207704|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207705|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2207706|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2207707|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207708|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2207709|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
2207710|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2207711|NCT00008463|Interferons|interferons|mesh-list
2207712|NCT00008463|Ribavirin|ribavirin|mesh-list
2207713|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
2207714|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
2207715|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2207716|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207717|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
2207718|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207719|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
2207720|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437664|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
2437665|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
2437666|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437667|NCT00893854|Triamcinolone|triamcinolone|mesh-list
2437668|NCT00893854|Diclofenac|diclofenac|mesh-list
2437669|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2437670|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
2437671|NCT00893854|Hormones|hormones|mesh-ancestor
2437672|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2437673|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437674|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437675|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437676|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2437677|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2437678|NCT00893854|Analgesics|analgesics|mesh-ancestor
2437679|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
2437680|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437681|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2437682|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2437683|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
2437684|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2437685|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
2437686|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437687|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437688|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2437689|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
2437690|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2437691|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
2437692|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437693|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437694|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2437695|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
2437696|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
2437697|NCT00893880|Protective Agents|protective agents|mesh-ancestor
2437698|NCT00893906|Vaccines|vaccines|mesh-list
2437699|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
2437700|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437701|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
2437702|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2437703|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437704|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2437705|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
2437706|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2437707|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437708|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437709|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437710|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
2437711|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2437712|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437713|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2437714|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
2437715|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2437716|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437717|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437718|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437719|NCT00894010|Carbamazepine|carbamazepine|mesh-list
2437720|NCT00894010|Levetiracetam|levetiracetam|mesh-list
2437721|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
2437722|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
2437723|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
2437724|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2437725|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437726|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437727|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2437728|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2437729|NCT00894010|Analgesics|analgesics|mesh-ancestor
2207721|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
2207722|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207723|NCT00008476|Capsaicin|capsaicin|mesh-list
2207724|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
2207725|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
2207726|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
2207727|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437730|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
2437731|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437732|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2437733|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2437734|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437735|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2437736|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2437737|NCT00894023|Abciximab|abciximab|mesh-list
2437738|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
2437739|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2437740|NCT00894062|Everolimus|everolimus|mesh-list
2437741|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437742|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2437743|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
2437744|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437745|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
2437746|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2437747|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437748|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2437749|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
2437750|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2437751|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437752|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437753|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437754|NCT00894231|Levocetirizine|levocetirizine|mesh-list
2437755|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2437756|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2437757|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
2437758|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
2437759|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437760|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437761|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437762|NCT00894283|Enoxaparin|enoxaparin|mesh-list
2437763|NCT00894283|PENTA|penta|mesh-list
2437764|NCT00894283|Fondaparinux|fondaparinux|mesh-list
2437765|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
2207728|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207729|NCT00008489|Didanosine|didanosine|mesh-list
2437766|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2437767|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2437768|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437769|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2437770|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
2437771|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2437772|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
2437773|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437774|NCT00894374|Artesunate|artesunate|mesh-list
2437775|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
2437776|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2437777|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2437778|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437779|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437780|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
2437781|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
2437782|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2437783|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
2437784|NCT00894439|Piperacillin|piperacillin|mesh-list
2437785|NCT00894439|BLI-489|bli-489|mesh-list
2437786|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2437787|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437788|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2437789|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437790|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437791|NCT00894530|Azithromycin|azithromycin|mesh-list
2437792|NCT00894530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2437793|NCT00894530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2437794|NCT00894530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2437795|NCT00894530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437796|NCT00894569|Paclitaxel|paclitaxel|mesh-list
2437797|NCT00894569|Carboplatin|carboplatin|mesh-list
2437798|NCT00894569|Cetuximab|cetuximab|mesh-list
2437799|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2437800|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437801|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
2437802|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
2437803|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
2437804|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437805|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2437806|NCT00894608|Letrozole|letrozole|mesh-list
2437807|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437808|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2437809|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2437810|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437811|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437812|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2437813|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
2437814|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2437815|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437816|NCT00894621|Norepinephrine|norepinephrine|mesh-list
2437817|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2437818|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2437819|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
2437820|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437821|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437822|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437823|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
2437824|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
2437825|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437826|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2437827|NCT00894634|Brompheniramine|brompheniramine|mesh-list
2437828|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437829|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2437830|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
2437831|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
2437832|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437833|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437834|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2437835|NCT00894660|Amodiaquine|amodiaquine|mesh-list
2437836|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
2437837|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2437838|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2437839|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437840|NCT00894673|Heparin|heparin|mesh-list
2437841|NCT00894673|Calcium heparin|calcium heparin|mesh-list
2437842|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
2437843|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2437844|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2437845|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437846|NCT00894712|Sulforaphane|sulforaphane|mesh-list
2437847|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2437848|NCT00894712|Protective Agents|protective agents|mesh-ancestor
2437849|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437850|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437851|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
2437852|NCT00894751|Propofol|propofol|mesh-list
2437853|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2437854|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2437855|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437856|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2437857|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
2437858|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
2437859|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2437860|NCT00894751|Analgesics|analgesics|mesh-ancestor
2437861|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
2437862|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437863|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2437864|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2437865|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2437866|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
2437867|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437868|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437869|NCT00894829|Heparin|heparin|mesh-list
2437870|NCT00894829|Calcium heparin|calcium heparin|mesh-list
2437871|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
2437872|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2437873|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2437874|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437875|NCT00894868|Vildagliptin|vildagliptin|mesh-list
2437876|NCT00894868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2437877|NCT00894868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437878|NCT00894868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2437879|NCT00894868|Protease Inhibitors|protease inhibitors|mesh-ancestor
2437880|NCT00894868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437881|NCT00894868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437882|NCT00894920|Biotin|biotin|mesh-list
2437883|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
2437884|NCT00894920|Vitamins|vitamins|mesh-ancestor
2437885|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
2437886|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437887|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
2437888|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437889|NCT00894959|Heparin|heparin|mesh-list
2437890|NCT00894959|Calcium heparin|calcium heparin|mesh-list
2437891|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
2437892|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2437893|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2437894|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437895|NCT00894985|Heparin|heparin|mesh-list
2437896|NCT00894985|Calcium heparin|calcium heparin|mesh-list
2437897|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
2437898|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2437899|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2437900|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437901|NCT00894998|Heparin|heparin|mesh-list
2437902|NCT00894998|Calcium heparin|calcium heparin|mesh-list
2437903|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
2437904|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2437905|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2437906|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437907|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
2437908|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2437909|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2437910|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437911|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
2437912|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437913|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437914|NCT00895076|Dexamethasone|dexamethasone|mesh-list
2437915|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2437916|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
2437917|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
2437918|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437919|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437920|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2437921|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
2437922|NCT00895076|Hormones|hormones|mesh-ancestor
2437923|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2437924|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2437925|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437926|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
2437927|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
2437928|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2437929|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2437930|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2437931|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2437932|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2437933|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437934|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437935|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437936|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2437937|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
2437938|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2437939|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437940|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2437941|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2437942|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2437943|NCT00895115|Vitamin E|vitamin e|mesh-list
2437944|NCT00895115|Vitamins|vitamins|mesh-ancestor
2437945|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
2437946|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437947|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
2437948|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437949|NCT00895115|Protective Agents|protective agents|mesh-ancestor
2437950|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2437951|NCT00895128|Dasatinib|dasatinib|mesh-list
2437952|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437953|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2437954|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437955|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437956|NCT00895167|Curcumin|curcumin|mesh-list
2437957|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2437958|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2437959|NCT00895167|Analgesics|analgesics|mesh-ancestor
2437960|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
2437961|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2437962|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437963|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2437964|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2437965|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437966|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437967|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437968|NCT00895297|Dasatinib|dasatinib|mesh-list
2437969|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437970|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2437971|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437972|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437973|NCT00895323|Antibodies|antibodies|mesh-list
2437974|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2437975|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2437976|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
2437977|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437978|NCT00895362|Cetuximab|cetuximab|mesh-list
2437979|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2437980|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2437981|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2437982|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2437983|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2437984|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437985|NCT00895505|Warfarin|warfarin|mesh-list
2437986|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
2437987|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
2437988|NCT00895544|Vaccines|vaccines|mesh-list
2437989|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
2437990|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437991|NCT00895557|Varenicline|varenicline|mesh-list
2437992|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2437993|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2437994|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
2437995|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2437996|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2437997|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2437998|NCT00895570|Modafinil|modafinil|mesh-list
2437999|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2438000|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438001|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2438002|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2438003|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2438004|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438005|NCT00895609|Neostigmine|neostigmine|mesh-list
2438006|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2438007|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438008|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438009|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
2438010|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438011|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438012|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2438013|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
2438014|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438015|NCT00895648|Pemetrexed|pemetrexed|mesh-list
2438016|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438017|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438018|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438019|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2438020|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2438021|NCT00895674|Sorafenib|sorafenib|mesh-list
2438022|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438023|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2438024|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438025|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438026|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2438027|NCT00895687|Bortezomib|bortezomib|mesh-list
2438028|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438029|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2438030|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438031|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438032|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
2438033|NCT00895713|Antibodies|antibodies|mesh-list
2438034|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
2438035|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2438036|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2438037|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
2438038|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438039|NCT00895739|Cyclosporine|cyclosporine|mesh-list
2438040|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
2438041|NCT00895739|Cyclosporins|cyclosporins|mesh-list
2438042|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438043|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438044|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2438045|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
2438046|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438047|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
2438048|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438049|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
2438050|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2438051|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2438052|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2438053|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438054|NCT00895778|Rocuronium|rocuronium|mesh-list
2438055|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2438056|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2438057|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2438058|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438059|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438060|NCT00895791|Umirolimus|umirolimus|mesh-list
2438061|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2438062|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2438063|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
2438064|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438065|NCT00895804|Pindolol|pindolol|mesh-list
2438066|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2438067|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2438068|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
2438069|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438070|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438071|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438072|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2438073|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2438074|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
2438075|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
2438076|NCT00895882|Interferons|interferons|mesh-list
2438077|NCT00895882|Ribavirin|ribavirin|mesh-list
2438078|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438079|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
2438080|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438081|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
2438082|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438083|NCT00895960|Temozolomide|temozolomide|mesh-list
2438084|NCT00895960|Dasatinib|dasatinib|mesh-list
2438085|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2438086|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
2438087|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438088|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438089|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2438090|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438091|NCT00896077|Lisofylline|lisofylline|mesh-list
2438092|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2438093|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
2438094|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438095|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2438096|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2438097|NCT00896077|Analgesics|analgesics|mesh-ancestor
2438098|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
2438099|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438100|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2438101|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2438102|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2438103|NCT00896155|Tamoxifen|tamoxifen|mesh-list
2438104|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2438105|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
2438106|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2438107|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438108|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2438109|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438110|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2438111|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2438112|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2438113|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2438114|NCT00896285|Analgesics|analgesics|mesh-list
2438115|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
2438116|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
2438117|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438118|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438119|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2438120|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2438121|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2438122|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2438123|NCT00896285|Narcotics|narcotics|mesh-ancestor
2438124|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2438125|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
2438126|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
2438127|NCT00896376|Trastuzumab|trastuzumab|mesh-list
2438128|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2438129|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438130|NCT00896402|Iodine|iodine|mesh-list
2438131|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
2438132|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2438133|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
2438134|NCT00896402|Povidone|povidone|mesh-list
2438135|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2438136|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438137|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
2438138|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
2438139|NCT00896402|Trace Elements|trace elements|mesh-ancestor
2438140|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
2438141|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438142|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
2438143|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
2438144|NCT00896428|Gallopamil|gallopamil|mesh-list
2438145|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2438146|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2438147|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438148|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2438149|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438150|NCT00896493|Cyclosporine|cyclosporine|mesh-list
2438151|NCT00896493|Cyclosporins|cyclosporins|mesh-list
2438152|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2438153|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438154|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438155|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2438156|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
2438157|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438158|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
2438159|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438160|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
2438161|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2438162|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2438163|NCT00896519|Prednisone|prednisone|mesh-list
2438164|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
2438165|NCT00896519|Rituximab|rituximab|mesh-list
2438166|NCT00896519|Doxorubicin|doxorubicin|mesh-list
2438167|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2438168|NCT00896519|Vincristine|vincristine|mesh-list
2438169|NCT00896519|Sargramostim|sargramostim|mesh-list
2438170|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2438171|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
2438172|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438173|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2438174|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2438175|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
2438176|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438177|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438178|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2438179|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2438180|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2438181|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2438182|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2438183|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438184|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2438185|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
2438186|NCT00896519|Hormones|hormones|mesh-ancestor
2438187|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2438188|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2438189|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2438190|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
2438191|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
2438192|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
2438193|NCT00896558|Midazolam|midazolam|mesh-list
2438194|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2438195|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2438196|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2438197|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438198|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2438199|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2438200|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2438201|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2438202|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
2438203|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
2438204|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
2438205|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
2438206|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438207|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438208|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2438209|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2438210|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2438211|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2438212|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
2438213|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2438214|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438215|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2438216|NCT00896571|Estrogens|estrogens|mesh-ancestor
2438217|NCT00896571|Hormones|hormones|mesh-ancestor
2438218|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2438219|NCT00896714|Anesthetics|anesthetics|mesh-list
2438220|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2438221|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438222|NCT00896727|Antibodies|antibodies|mesh-list
2438223|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
2438224|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438225|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
2438226|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2438227|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2438228|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438229|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438230|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438231|NCT00896948|Antibodies|antibodies|mesh-list
2438232|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
2438233|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438234|NCT00896987|Lamotrigine|lamotrigine|mesh-list
2438235|NCT00896987|Carbamazepine|carbamazepine|mesh-list
2438236|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
2438237|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2438238|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2438239|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438240|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2438241|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438242|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2438243|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2438244|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2438245|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2438246|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2438247|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
2438248|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2438249|NCT00896987|Analgesics|analgesics|mesh-ancestor
2438250|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
2438251|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438252|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2438253|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2438254|NCT00897026|Paclitaxel|paclitaxel|mesh-list
2438255|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
2438256|NCT00897026|Doxorubicin|doxorubicin|mesh-list
2438257|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2438258|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2438259|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438260|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
2438261|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
2438262|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
2438263|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438264|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2438265|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
2438266|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438267|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2438268|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2438269|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
2438270|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2438271|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2207730|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
2207731|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207732|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2207733|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2207734|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207735|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
2207736|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207737|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2207738|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2207739|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2207740|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2207741|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
2207742|NCT00008515|Hormones|hormones|mesh-ancestor
2207743|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2207744|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207745|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
2207746|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2207747|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2207748|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438272|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2438273|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2438274|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438275|NCT00897065|Antibodies|antibodies|mesh-list
2438276|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
2438277|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438278|NCT00897130|Azacitidine|azacitidine|mesh-list
2438279|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2438280|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
2438281|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438282|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438283|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438284|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2438285|NCT00897221|Deferiprone|deferiprone|mesh-list
2438286|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2438287|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
2438288|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
2438289|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438290|NCT00897312|Interferons|interferons|mesh-list
2438291|NCT00897312|Ribavirin|ribavirin|mesh-list
2438292|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
2438293|NCT00897312|Tremelimumab|tremelimumab|mesh-list
2438294|NCT00897312|Infliximab|infliximab|mesh-list
2438295|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438296|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
2438297|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438298|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
2438299|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438300|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
2438301|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438302|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
2438303|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2438304|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2438305|NCT00897377|Temozolomide|temozolomide|mesh-list
2438306|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2438307|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
2438308|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438309|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438310|NCT00897520|Interferons|interferons|mesh-list
2438311|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
2438312|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438313|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
2438314|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438315|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
2438316|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438317|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
2438318|NCT00897871|Carboplatin|carboplatin|mesh-list
2438319|NCT00897871|Etoposide|etoposide|mesh-list
2438320|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
2438321|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2438322|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
2438323|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438324|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2438325|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2438326|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
2438327|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438328|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438329|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2438330|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2438331|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2438332|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2438333|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438334|NCT00897884|Metformin|metformin|mesh-list
2438335|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2438336|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438337|NCT00897975|Red yeast rice|red yeast rice|mesh-list
2438338|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2438339|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2438340|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2438341|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
2438342|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438343|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438344|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2438345|NCT00898287|Gemcitabine|gemcitabine|mesh-list
2438346|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2438347|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
2438348|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438349|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438350|NCT00898287|Antiviral Agents|antiviral agents|mesh-ancestor
2438351|NCT00898287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438352|NCT00898287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438353|NCT00898287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2438354|NCT00898287|Immunologic Factors|immunologic factors|mesh-ancestor
2438355|NCT00898287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438356|NCT00898417|Paclitaxel|paclitaxel|mesh-list
2438357|NCT00898417|Bevacizumab|bevacizumab|mesh-list
2438358|NCT00898417|Carboplatin|carboplatin|mesh-list
2438359|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2438360|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438361|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
2438362|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
2438363|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
2438364|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438365|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2438366|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2438367|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2438368|NCT00898417|Growth Substances|growth substances|mesh-ancestor
2438369|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438370|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
2438371|NCT00898508|Antibodies|antibodies|mesh-list
2438372|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
2438373|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438374|NCT00898573|Lapatinib|lapatinib|mesh-list
2438375|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438376|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2438377|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438378|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438379|NCT00898794|Bevacizumab|bevacizumab|mesh-list
2438380|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2438381|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438382|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2438383|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2438384|NCT00898794|Growth Substances|growth substances|mesh-ancestor
2438385|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438386|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
2438387|NCT00898846|Tegafur|tegafur|mesh-list
2438388|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2438389|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
2438390|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438391|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438392|NCT00898950|Aspirin|aspirin|mesh-list
2438393|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
2438394|NCT00898950|Salicylates|salicylates|mesh-list
2438395|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2438396|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2438397|NCT00898950|Analgesics|analgesics|mesh-ancestor
2438398|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
2438399|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438400|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438401|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2438402|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2438403|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2438404|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2438405|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438406|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2438407|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2438408|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438409|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
2438410|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438411|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
2438412|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
2438413|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
2438414|NCT00899197|Tamoxifen|tamoxifen|mesh-list
2438415|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2438416|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
2438417|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2438418|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438419|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2438420|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438421|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2438422|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2438423|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2438424|NCT00899483|Insulin|insulin|mesh-list
2438425|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2438426|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438427|NCT00899587|Enalapril|enalapril|mesh-list
2438428|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2438429|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
2438430|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438431|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438432|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2438433|NCT00899821|Aldesleukin|aldesleukin|mesh-list
2438434|NCT00899821|Interleukin-12|interleukin-12|mesh-list
2438435|NCT00899821|Sargramostim|sargramostim|mesh-list
2438436|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
2438437|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438438|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438439|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2438440|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2438441|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
2438442|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438443|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2438444|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2438445|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2438446|NCT00899821|Growth Substances|growth substances|mesh-ancestor
2438447|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
2438448|NCT00899951|Fentanyl|fentanyl|mesh-list
2438449|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2438450|NCT00899951|Narcotics|narcotics|mesh-ancestor
2438451|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2438452|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438453|NCT00899951|Analgesics|analgesics|mesh-ancestor
2438454|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
2438455|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438456|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2438457|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2438458|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
2438459|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
2438460|NCT00900172|Paclitaxel|paclitaxel|mesh-list
2438461|NCT00900172|Bevacizumab|bevacizumab|mesh-list
2438462|NCT00900172|Carboplatin|carboplatin|mesh-list
2438463|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2438464|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438465|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
2438466|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
2438467|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
2438468|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438469|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2438470|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2438471|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2207749|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2207750|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2207751|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
2207752|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207753|NCT00008554|Lamivudine|lamivudine|mesh-list
2207754|NCT00008554|Abacavir|abacavir|mesh-list
2438472|NCT00900172|Growth Substances|growth substances|mesh-ancestor
2438473|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438474|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
2438475|NCT00900445|Prednisone|prednisone|mesh-list
2438476|NCT00900445|Prednisolone|prednisolone|mesh-list
2438477|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2438478|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
2438479|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2438480|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
2438481|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
2438482|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2207755|NCT00008554|Nelfinavir|nelfinavir|mesh-list
2207756|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
2207757|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2207758|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2207759|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207760|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207761|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
2207762|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207763|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2207764|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2207765|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2438483|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2438484|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2438485|NCT00900445|Cortisone|cortisone|mesh-list
2438486|NCT00900445|Vincristine|vincristine|mesh-list
2438487|NCT00900445|Daunorubicin|daunorubicin|mesh-list
2438488|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2438489|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
2438490|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2438491|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
2438492|NCT00900445|Hormones|hormones|mesh-ancestor
2438493|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2438494|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438495|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2438496|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438497|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2438498|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
2438499|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
2438500|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
2438501|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438502|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
2438503|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
2438504|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438505|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2438506|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2438507|NCT00900445|Protective Agents|protective agents|mesh-ancestor
2438508|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2438509|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2438510|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2438511|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438512|NCT00900510|Trimethoprim|trimethoprim|mesh-list
2438513|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2438514|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
2438515|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2438516|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438517|NCT00900510|Renal Agents|renal agents|mesh-ancestor
2438518|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
2438519|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2438520|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2438521|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2438522|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438523|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438524|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2438525|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2438526|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2438527|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2438528|NCT00900744|Tamoxifen|tamoxifen|mesh-list
2438529|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2438530|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
2438531|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2438532|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438533|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2438534|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438535|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2438536|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2438537|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2438538|NCT00900783|Valacyclovir|valacyclovir|mesh-list
2438539|NCT00900783|Antiviral Agents|antiviral agents|mesh-ancestor
2438540|NCT00900783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438541|NCT00900874|Albuterol|albuterol|mesh-list
2438542|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
2438543|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2438544|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
2438545|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438546|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438547|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2438548|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
2438549|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2438550|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2438551|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2438552|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
2438553|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438554|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438555|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
2438556|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2438557|NCT00900887|Ketorolac|ketorolac|mesh-list
2438558|NCT00900887|Nepafenac|nepafenac|mesh-list
2438559|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2438560|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2438561|NCT00900887|Analgesics|analgesics|mesh-ancestor
2438562|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
2438563|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438564|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438565|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2438566|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2438567|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2438568|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438569|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438570|NCT00900900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2438571|NCT00900900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2438572|NCT00900900|Immunologic Factors|immunologic factors|mesh-ancestor
2438573|NCT00900900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438574|NCT00900913|Ropivacaine|ropivacaine|mesh-list
2438575|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
2438576|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
2438577|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2438578|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438579|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
2438580|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438581|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2438582|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
2438583|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438584|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
2438585|NCT00901069|Rituximab|rituximab|mesh-list
2438586|NCT00901069|Vincristine|vincristine|mesh-list
2438587|NCT00901069|Azacitidine|azacitidine|mesh-list
2438588|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2438589|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
2438590|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438591|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2438592|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2438593|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
2438594|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438595|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438596|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2438597|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2438598|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2438599|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
2438600|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
2438601|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
2438602|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2438603|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
2438604|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438605|NCT00901147|Bortezomib|bortezomib|mesh-list
2438606|NCT00901147|Panobinostat|panobinostat|mesh-list
2438607|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438608|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2438609|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438610|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438611|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
2438612|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
2438613|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2438614|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438615|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2438616|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2438617|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2438618|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
2438619|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438620|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438621|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2438622|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
2438623|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
2438624|NCT00901368|Hormones|hormones|mesh-ancestor
2438625|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2438626|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
2438627|NCT00901381|Lenograstim|lenograstim|mesh-list
2438628|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2438629|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
2438630|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438631|NCT00901407|Lamotrigine|lamotrigine|mesh-list
2438632|NCT00901407|Paroxetine|paroxetine|mesh-list
2438633|NCT00901407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2438634|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2438635|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2438636|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438637|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438638|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
2438639|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438640|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2438641|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
2438642|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2438643|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2438644|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2438645|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438646|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
2438647|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2438648|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2438649|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2438650|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2438651|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2438652|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2438653|NCT00901511|Molgramostim|molgramostim|mesh-list
2438654|NCT00901511|Sargramostim|sargramostim|mesh-list
2438655|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
2438656|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438657|NCT00901511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438658|NCT00901524|Interferons|interferons|mesh-list
2438659|NCT00901524|Ribavirin|ribavirin|mesh-list
2438660|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
2438661|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
2438662|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2438663|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438664|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
2438665|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438666|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
2438667|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438668|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
2438669|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438670|NCT00901537|Azacitidine|azacitidine|mesh-list
2438671|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438672|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2438673|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
2438674|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438675|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438676|NCT00901550|Methotrexate|methotrexate|mesh-list
2438677|NCT00901550|Infliximab|infliximab|mesh-list
2438678|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2438679|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
2438680|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2438681|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438682|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2438683|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
2438684|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438685|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438686|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
2438687|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438688|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2438689|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2438690|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
2438691|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2438692|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2438693|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2438694|NCT00901615|Lenalidomide|lenalidomide|mesh-list
2438695|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
2438696|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438697|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2438698|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2438699|NCT00901615|Growth Substances|growth substances|mesh-ancestor
2438700|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
2438701|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438702|NCT00901654|Vaccines|vaccines|mesh-list
2438703|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
2438704|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438705|NCT00901693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2438706|NCT00901693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2438707|NCT00901719|Nitroprusside|nitroprusside|mesh-list
2438708|NCT00901719|Acetylcholine|acetylcholine|mesh-list
2438709|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2438710|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
2438711|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2438712|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438713|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2438714|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
2438715|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438716|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438717|NCT00901732|Calcium|calcium|mesh-list
2438718|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2438719|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438720|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
2438721|NCT00901745|Giapreza|giapreza|mesh-list
2438722|NCT00901745|Norepinephrine|norepinephrine|mesh-list
2438723|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
2438724|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2438725|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2438726|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
2438727|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438728|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438729|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2438730|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2438731|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
2438732|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438733|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438734|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
2438735|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
2438736|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438737|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
2438738|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
2438739|NCT00901784|Topiramate|topiramate|mesh-list
2438740|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
2438741|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2438742|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438743|NCT00901823|Diazoxide|diazoxide|mesh-list
2438744|NCT00901823|Choline|choline|mesh-list
2438745|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
2438746|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2438747|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
2438748|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438749|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2438750|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2438751|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
2438752|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2438753|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
2438754|NCT00901849|Sirolimus|sirolimus|mesh-list
2438755|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2438756|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2438757|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438758|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2438759|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438760|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
2438761|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2438762|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
2438763|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438764|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2438765|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438766|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438767|NCT00901875|Buprenorphine|buprenorphine|mesh-list
2438768|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2438769|NCT00901875|Naloxone|naloxone|mesh-list
2438770|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2438771|NCT00901875|Narcotics|narcotics|mesh-ancestor
2438772|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2438773|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438774|NCT00901875|Analgesics|analgesics|mesh-ancestor
2438775|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
2438776|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438777|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2438778|NCT00901888|Nitroprusside|nitroprusside|mesh-list
2438779|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2438780|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
2438781|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2438782|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207766|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2207767|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
2207768|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
2207769|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207770|NCT00008736|Metoclopramide|metoclopramide|mesh-list
2207771|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
2207772|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
2207773|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2207774|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207775|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2207776|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2207777|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2207778|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
2207779|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2207780|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207781|NCT00008866|Didanosine|didanosine|mesh-list
2207782|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
2207783|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207784|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
2438783|NCT00901979|Metformin|metformin|mesh-list
2438784|NCT00901979|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2438785|NCT00901979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2438786|NCT00901979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438787|NCT00901979|Incretins|incretins|mesh-ancestor
2438788|NCT00901979|Hormones|hormones|mesh-ancestor
2438789|NCT00901979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2438790|NCT00901979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2438791|NCT00901979|Protease Inhibitors|protease inhibitors|mesh-ancestor
2438792|NCT00901979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438793|NCT00901979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438794|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
2438795|NCT00902031|Sennosides|sennosides|mesh-list
2438796|NCT00902031|Senna Extract|senna extract|mesh-list
2438797|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
2438798|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2438799|NCT00902031|Laxatives|laxatives|mesh-ancestor
2438800|NCT00902031|Cathartics|cathartics|mesh-ancestor
2438812|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2438813|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
2438814|NCT00902057|Coagulants|coagulants|mesh-ancestor
2438815|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2438816|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
2438817|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438818|NCT00902070|Rocuronium|rocuronium|mesh-list
2438819|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2438820|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2438821|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2438822|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438823|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438824|NCT00902135|Interferons|interferons|mesh-list
2438825|NCT00902135|Interferon-beta|interferon-beta|mesh-list
2438826|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
2438827|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438828|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
2438829|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438830|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
2438831|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438832|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2438833|NCT00902187|Fesoterodine|fesoterodine|mesh-list
2438834|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2438835|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2438836|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
2438837|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2207785|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207786|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438838|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438839|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438840|NCT00902187|Urological Agents|urological agents|mesh-ancestor
2438841|NCT00902291|Gemcitabine|gemcitabine|mesh-list
2438842|NCT00902291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2438843|NCT00902291|Antimetabolites|antimetabolites|mesh-ancestor
2438844|NCT00902291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438845|NCT00902291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438846|NCT00902291|Antiviral Agents|antiviral agents|mesh-ancestor
2438847|NCT00902291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438848|NCT00902291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438849|NCT00902291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2438850|NCT00902291|Immunologic Factors|immunologic factors|mesh-ancestor
2438851|NCT00902291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438852|NCT00902395|Midazolam|midazolam|mesh-list
2438853|NCT00902395|Ketamine|ketamine|mesh-list
2438854|NCT00902395|Analgesics|analgesics|mesh-ancestor
2438855|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
2438856|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438857|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438858|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2438859|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2438860|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
2438861|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
2438862|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2438863|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2438864|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2438865|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438866|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438867|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2438868|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2438869|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2438870|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2438871|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2438872|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
2438873|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
2438874|NCT00902421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
2438875|NCT00902421|Serotonin|serotonin|mesh-list
2438876|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
2438877|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2438878|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2438879|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438880|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438881|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
2438882|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438883|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2438884|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2438885|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
2438886|NCT00902460|Midazolam|midazolam|mesh-list
2438887|NCT00902460|Tofacitinib|tofacitinib|mesh-list
2438888|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2438889|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2438890|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2438891|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438892|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2438893|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2438894|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2438895|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2438896|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
2438897|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
2438898|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
2438899|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
2438900|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438901|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438902|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2438903|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438904|NCT00902473|Topiramate|topiramate|mesh-list
2438905|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
2438906|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2438907|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438908|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
2438909|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
2438910|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2438911|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2438912|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2438913|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438914|NCT00902512|Urological Agents|urological agents|mesh-ancestor
2438915|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2438916|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
2438917|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438918|NCT00902603|Iloprost|iloprost|mesh-list
2438919|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2438920|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
2438921|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2438922|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
2438923|NCT00902655|Coagulants|coagulants|mesh-ancestor
2438924|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2438925|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
2438926|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438927|NCT00902681|Fesoterodine|fesoterodine|mesh-list
2438928|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2438929|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2438930|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
2438931|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438932|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438933|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438934|NCT00902681|Urological Agents|urological agents|mesh-ancestor
2438935|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
2438936|NCT00902707|Guaifenesin|guaifenesin|mesh-list
2438937|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
2438938|NCT00902707|Expectorants|expectorants|mesh-ancestor
2438939|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
2438940|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2438941|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2438942|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
2438943|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438944|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438945|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438946|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
2438947|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2438948|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
2438949|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
2438950|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438951|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
2438952|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2438953|NCT00902772|Lorazepam|lorazepam|mesh-list
2438954|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
2438955|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
2438956|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
2438957|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438958|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438959|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2438960|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2438961|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2438962|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2438963|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2438964|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2438965|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
2438966|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
2438967|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2438968|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2438969|NCT00902811|Artesunate|artesunate|mesh-list
2438970|NCT00902811|Amodiaquine|amodiaquine|mesh-list
2438971|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
2438972|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2438973|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2438974|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438975|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2438976|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
2438977|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
2438978|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2438979|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
2438980|NCT00902837|Oxycodone|oxycodone|mesh-list
2438981|NCT00902837|Naloxone|naloxone|mesh-list
2438982|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2438983|NCT00902837|Narcotics|narcotics|mesh-ancestor
2438984|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2438985|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438986|NCT00902837|Analgesics|analgesics|mesh-ancestor
2438987|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
2438988|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438989|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2438990|NCT00902915|Dexamethasone|dexamethasone|mesh-list
2438991|NCT00902915|Lenalidomide|lenalidomide|mesh-list
2207787|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2207788|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
2207789|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2207790|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
2207791|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2438992|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2438993|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
2438994|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
2438995|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2438996|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2438997|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2438998|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
2438999|NCT00902915|Hormones|hormones|mesh-ancestor
2439000|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2439001|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2439002|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439003|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
2439004|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2439005|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2439006|NCT00902915|Growth Substances|growth substances|mesh-ancestor
2439007|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
2439008|NCT00902928|Enoxaparin|enoxaparin|mesh-list
2439009|NCT00902928|Anticoagulants|anticoagulants|mesh-ancestor
2439010|NCT00902928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2439011|NCT00902928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2439012|NCT00902928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439013|NCT00902941|Rasagiline|rasagiline|mesh-list
2439014|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2439015|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439016|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439017|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2439018|NCT00902941|Protective Agents|protective agents|mesh-ancestor
2439019|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439020|NCT00902954|Letrozole|letrozole|mesh-list
2439021|NCT00902954|Anastrozole|anastrozole|mesh-list
2439022|NCT00902954|Exemestane|exemestane|mesh-list
2439023|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439024|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2439025|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2439026|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439027|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439028|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2439029|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
2439030|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2439031|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439032|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2439033|NCT00902967|Atorvastatin|atorvastatin|mesh-list
2439034|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2439035|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2439036|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
2439037|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439038|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2439039|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2439040|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439041|NCT00903045|Propiverine|propiverine|mesh-list
2439042|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
2439043|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
2439044|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439045|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439046|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2439047|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2439048|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
2439049|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439050|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439051|NCT00903045|Urological Agents|urological agents|mesh-ancestor
2439052|NCT00903084|Tenofovir|tenofovir|mesh-list
2439053|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
2439054|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439055|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2207792|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2207793|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2207794|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
2207795|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
2207796|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
2439056|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2439057|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439058|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439059|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2439060|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2439064|NCT00903188|Cyclosporine|cyclosporine|mesh-list
2439065|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
2439066|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
2439067|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2439068|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2439069|NCT00903188|Prednisolone|prednisolone|mesh-list
2439070|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
2439071|NCT00903188|Everolimus|everolimus|mesh-list
2439072|NCT00903188|Cyclosporins|cyclosporins|mesh-list
2439073|NCT00903188|Basiliximab|basiliximab|mesh-list
2439074|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2439075|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
2439076|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439077|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439078|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2439079|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
2439080|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439081|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
2439082|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439083|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
2439084|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2439085|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2439086|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439087|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2439088|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
2439089|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
2439090|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439091|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2439092|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
2207797|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207798|NCT00009048|Levodopa|levodopa|mesh-list
2207799|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2207800|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2207801|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
2207802|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2207803|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207804|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207805|NCT00009061|Ritonavir|ritonavir|mesh-list
2207806|NCT00009061|Nelfinavir|nelfinavir|mesh-list
2207807|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
2207808|NCT00009061|Lamivudine|lamivudine|mesh-list
2207809|NCT00009061|Abacavir|abacavir|mesh-list
2207810|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2207811|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2207812|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
2439093|NCT00903188|Hormones|hormones|mesh-ancestor
2439094|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2439095|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2439096|NCT00903188|Protective Agents|protective agents|mesh-ancestor
2439097|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2439098|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2439099|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2439100|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
2439101|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2439102|NCT00903214|Riluzole|riluzole|mesh-list
2439103|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
2439104|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2439105|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2439106|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439107|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439108|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439109|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2439110|NCT00903214|Protective Agents|protective agents|mesh-ancestor
2439111|NCT00903227|Fluticasone|fluticasone|mesh-list
2439112|NCT00903227|Xhance|xhance|mesh-list
2439113|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2439114|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2439115|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
2207813|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439116|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439117|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439118|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2439119|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
2439120|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
2439121|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2439122|NCT00903279|Retapamulin|retapamulin|mesh-list
2439123|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2439124|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439125|NCT00903292|Pemetrexed|pemetrexed|mesh-list
2439126|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2439127|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439128|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439129|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439130|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2439131|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2439132|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2439133|NCT00903656|Lapatinib|lapatinib|mesh-list
2439134|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439135|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2439136|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439137|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439138|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
2439139|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2439140|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
2439141|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2439142|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2439143|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439144|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2439145|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439146|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439147|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
2439148|NCT00903747|Prucalopride|prucalopride|mesh-list
2439149|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2439150|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439151|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2439152|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2439153|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439154|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439155|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439156|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439157|NCT00903747|Laxatives|laxatives|mesh-ancestor
2439158|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2439159|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2439160|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2439161|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
2439162|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439163|NCT00903825|Lidocaine|lidocaine|mesh-list
2439164|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
2439165|NCT00903825|Anesthetics|anesthetics|mesh-list
2439166|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439167|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439168|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
2439169|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439170|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2439171|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2439172|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2439173|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2439174|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439175|NCT00903838|Pramipexole|pramipexole|mesh-list
2439176|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
2439177|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439178|NCT00903838|Protective Agents|protective agents|mesh-ancestor
2439179|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439180|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2439181|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2439182|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
2439183|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
2439184|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439185|NCT00903851|Lidocaine|lidocaine|mesh-list
2439186|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
2439187|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
2439188|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439189|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439190|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
2439191|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439192|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2439193|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2439194|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2439195|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2439196|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439197|NCT00903942|Paclitaxel|paclitaxel|mesh-list
2439198|NCT00903942|Carboplatin|carboplatin|mesh-list
2439199|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2439200|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2439201|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439202|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
2439203|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
2439204|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
2439205|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439206|NCT00903994|Ketoprofen|ketoprofen|mesh-list
2439207|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2439208|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2439209|NCT00903994|Analgesics|analgesics|mesh-ancestor
2439210|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
2439211|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439212|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439213|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2439214|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2439215|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2439216|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439217|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439218|NCT00904020|Lidocaine|lidocaine|mesh-list
2439219|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
2439220|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
2439221|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439222|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439223|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
2439224|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439225|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2439226|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2439227|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2439228|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2439229|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439234|NCT00904059|Asunaprevir|asunaprevir|mesh-list
2439235|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
2439236|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439237|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439238|NCT00904085|Oxymorphone|oxymorphone|mesh-list
2439239|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2439240|NCT00904085|Narcotics|narcotics|mesh-ancestor
2439241|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439242|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439243|NCT00904085|Analgesics|analgesics|mesh-ancestor
2439244|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
2439245|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439246|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2439247|NCT00904098|Frovatriptan|frovatriptan|mesh-list
2439248|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2439249|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
2439250|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439251|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439252|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439253|NCT00904111|Lidocaine|lidocaine|mesh-list
2439254|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
2439255|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
2439256|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439257|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439258|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
2439259|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439260|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2439261|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2439262|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2439263|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2439264|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439265|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
2439266|NCT00904176|Digoxin|digoxin|mesh-list
2439267|NCT00904176|Warfarin|warfarin|mesh-list
2439268|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
2439269|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2439270|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439271|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2439272|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439273|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2439274|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2439275|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439276|NCT00904176|Protective Agents|protective agents|mesh-ancestor
2439277|NCT00904202|Lidocaine|lidocaine|mesh-list
2439278|NCT00904202|Gabapentin|gabapentin|mesh-list
2439279|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
2439280|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
2439281|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439282|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439283|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
2439284|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439285|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2439286|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2439287|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2439288|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2439289|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439290|NCT00904202|Analgesics|analgesics|mesh-ancestor
2439291|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
2439292|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2439293|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2439294|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2439295|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2439296|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2439297|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439298|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
2439299|NCT00904280|Oxymorphone|oxymorphone|mesh-list
2439300|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2439301|NCT00904280|Narcotics|narcotics|mesh-ancestor
2439302|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439303|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439304|NCT00904280|Analgesics|analgesics|mesh-ancestor
2439305|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
2439306|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439307|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2439308|NCT00904293|Warfarin|warfarin|mesh-list
2439309|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
2439310|NCT00904306|Chromium|chromium|mesh-list
2439311|NCT00904306|Picolinic acid|picolinic acid|mesh-list
2439312|NCT00904306|Trace Elements|trace elements|mesh-ancestor
2439313|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
2439314|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439315|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2439316|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
2439317|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
2439318|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439319|NCT00904397|Celecoxib|celecoxib|mesh-list
2439320|NCT00904397|Lidocaine|lidocaine|mesh-list
2439321|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
2439322|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
2439323|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439324|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439325|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
2439326|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439327|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2439328|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2439329|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2439330|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2439331|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439332|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2439333|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2439334|NCT00904397|Analgesics|analgesics|mesh-ancestor
2439335|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2439336|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2439337|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2439338|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2439339|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439340|NCT00904436|Ipratropium|ipratropium|mesh-list
2439341|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2439342|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
2439343|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439344|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439345|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2439346|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
2439347|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2439348|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
2439349|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439350|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439351|NCT00904449|Oxymorphone|oxymorphone|mesh-list
2439352|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2439353|NCT00904449|Narcotics|narcotics|mesh-ancestor
2439354|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439355|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439356|NCT00904449|Analgesics|analgesics|mesh-ancestor
2439357|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
2439358|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439359|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2439360|NCT00904462|Lidocaine|lidocaine|mesh-list
2439361|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
2439362|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
2439363|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439364|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439365|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
2439366|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439367|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2439368|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2439369|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2439370|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2439371|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439372|NCT00904475|Lidocaine|lidocaine|mesh-list
2439373|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
2439374|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
2439375|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439376|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439377|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
2439378|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439379|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2439380|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2439381|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2439382|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2439383|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439384|NCT00904540|Lidocaine|lidocaine|mesh-list
2439385|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
2439386|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
2439387|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439388|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439389|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
2439390|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439391|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2439392|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2439393|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2439394|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2439395|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439396|NCT00904605|Celecoxib|celecoxib|mesh-list
2439397|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2439398|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2439399|NCT00904605|Analgesics|analgesics|mesh-ancestor
2439400|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
2439401|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439402|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439403|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2439404|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2439405|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2439406|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2439407|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439408|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439409|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
2439410|NCT00904631|Salicylates|salicylates|mesh-list
2439411|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439412|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
2439413|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
2439414|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
2439415|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2439416|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2439417|NCT00904631|Analgesics|analgesics|mesh-ancestor
2439418|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
2439419|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439420|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439421|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2439422|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2439423|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2439424|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439425|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439426|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
2439427|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2439428|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2439429|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
2439430|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439431|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2439432|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2439433|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439434|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439435|NCT00904657|Sunitinib|sunitinib|mesh-list
2439436|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439437|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2439438|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2439439|NCT00904657|Growth Substances|growth substances|mesh-ancestor
2439440|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439441|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
2439442|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2439443|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439444|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439445|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
2439446|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2439447|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2439448|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439449|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
2439450|NCT00904709|Coagulants|coagulants|mesh-ancestor
2439451|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
2439452|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
2439453|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439454|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2439455|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439456|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439457|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
2439458|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2439459|NCT00904852|Bevacizumab|bevacizumab|mesh-list
2439460|NCT00904852|Temozolomide|temozolomide|mesh-list
2439461|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2439462|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439463|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2439464|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2439465|NCT00904852|Growth Substances|growth substances|mesh-ancestor
2439466|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439467|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
2439468|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2439469|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
2439470|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439471|NCT00904904|Ketorolac|ketorolac|mesh-list
2439472|NCT00904904|Indomethacin|indomethacin|mesh-list
2439473|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2439474|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2439475|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2439476|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2439477|NCT00904904|Analgesics|analgesics|mesh-ancestor
2439478|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
2439479|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439480|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439481|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2439482|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2439483|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2439484|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439485|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439486|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
2439487|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
2439488|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2439489|NCT00905047|Leucovorin|leucovorin|mesh-list
2439490|NCT00905047|Folic Acid|folic acid|mesh-list
2439491|NCT00905047|Tegafur|tegafur|mesh-list
2439492|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
2439493|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2439494|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
2439495|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439496|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439497|NCT00905047|Antidotes|antidotes|mesh-ancestor
2439498|NCT00905047|Protective Agents|protective agents|mesh-ancestor
2439499|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439500|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
2439501|NCT00905047|Vitamins|vitamins|mesh-ancestor
2439502|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
2439503|NCT00905047|Hematinics|hematinics|mesh-ancestor
2439504|NCT00905073|Cyclosporine|cyclosporine|mesh-list
2439505|NCT00905073|Methotrexate|methotrexate|mesh-list
2439506|NCT00905073|Cyclosporins|cyclosporins|mesh-list
2439507|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2439508|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
2439509|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2439510|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439511|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2439512|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
2439513|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439514|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439515|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
2439516|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439517|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2439518|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2439519|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
2439520|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2439521|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2439522|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
2439523|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439524|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2439525|NCT00905190|Ondansetron|ondansetron|mesh-list
2439526|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
2439527|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
2439528|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439529|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439530|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2439531|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
2439532|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
2439533|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2439534|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
2439535|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439536|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439537|NCT00905190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2439538|NCT00905190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2439539|NCT00905190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439540|NCT00905190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2439541|NCT00905190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2439542|NCT00905216|Heparin|heparin|mesh-list
2439543|NCT00905216|Calcium heparin|calcium heparin|mesh-list
2439544|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
2439545|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2439546|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2439547|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439548|NCT00905229|Vitamins|vitamins|mesh-list
2439549|NCT00905229|Vitamin K|vitamin k|mesh-list
2439550|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
2439551|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
2439552|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439553|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2439554|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2439555|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439556|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
2439557|NCT00905229|Coagulants|coagulants|mesh-ancestor
2439558|NCT00905333|Felodipine|felodipine|mesh-list
2439559|NCT00905333|Candesartan|candesartan|mesh-list
2439560|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
2439561|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2439562|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2439563|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2439564|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439565|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2439566|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2439567|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2439568|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2439569|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439570|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
2439571|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2439572|NCT00905528|Telmisartan|telmisartan|mesh-list
2439573|NCT00905528|Ramipril|ramipril|mesh-list
2439574|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2439575|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2439576|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2439577|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439578|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2439579|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
2439580|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439581|NCT00905541|Simvastatin|simvastatin|mesh-list
2439582|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2439583|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2439584|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
2439585|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439586|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2439587|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2439588|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439589|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2439590|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2439591|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439592|NCT00905723|Estradiol|estradiol|mesh-list
2439593|NCT00905723|Estrogens|estrogens|mesh-ancestor
2439594|NCT00905723|Hormones|hormones|mesh-ancestor
2439595|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2439596|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439597|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
2439598|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
2439599|NCT00905762|Besifloxacin|besifloxacin|mesh-list
2439600|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2439601|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439602|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2439603|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2439604|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439605|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439606|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439607|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2439608|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2439609|NCT00905814|Axitinib|axitinib|mesh-list
2439610|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439611|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2439612|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439613|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439614|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
2439615|NCT00905853|Amiodarone|amiodarone|mesh-list
2439616|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
2439617|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2439618|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2439619|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439620|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2439621|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2439622|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2439623|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439624|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2439625|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2439626|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2439627|NCT00905905|Simvastatin|simvastatin|mesh-list
2439628|NCT00905905|Ezetimibe|ezetimibe|mesh-list
2439629|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2439630|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2439631|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2439632|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
2439633|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439634|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2439635|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2439636|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439637|NCT00905918|Vitamin E|vitamin e|mesh-list
2439638|NCT00905918|Vitamins|vitamins|mesh-ancestor
2439639|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
2439640|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439641|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
2439642|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439643|NCT00905918|Protective Agents|protective agents|mesh-ancestor
2439644|NCT00905931|Lycopene|lycopene|mesh-list
2439645|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2439646|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
2439647|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439648|NCT00905931|Protective Agents|protective agents|mesh-ancestor
2439649|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439650|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2439651|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2439652|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439653|NCT00905983|Gemcitabine|gemcitabine|mesh-list
2439654|NCT00905983|Docetaxel|docetaxel|mesh-list
2439655|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2439656|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
2439657|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439658|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439659|NCT00905983|Antiviral Agents|antiviral agents|mesh-ancestor
2439660|NCT00905983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439661|NCT00905983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439662|NCT00905983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2439663|NCT00905983|Immunologic Factors|immunologic factors|mesh-ancestor
2439664|NCT00905983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439665|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
2439666|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
2439667|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
2439668|NCT00905996|Propranolol|propranolol|mesh-list
2439669|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2439670|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2439671|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
2439672|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439673|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439674|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439675|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2439676|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2439677|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
2439678|NCT00906048|Levofloxacin|levofloxacin|mesh-list
2439679|NCT00906048|Ofloxacin|ofloxacin|mesh-list
2439680|NCT00906048|Rifampin|rifampin|mesh-list
2439681|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2439682|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439683|NCT00906048|Renal Agents|renal agents|mesh-ancestor
2439684|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2439685|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2439686|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2207814|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207815|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2207816|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2207817|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
2207818|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207819|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2207820|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2207821|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2207822|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2207823|NCT00009178|Fluoxetine|fluoxetine|mesh-list
2207824|NCT00009178|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2207825|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2439687|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439688|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439689|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439690|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2439691|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2439692|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2439693|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
2439694|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
2439695|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2439696|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2439697|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2439698|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2439699|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2439700|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2439701|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2439702|NCT00906061|Gemcitabine|gemcitabine|mesh-list
2439703|NCT00906061|Docetaxel|docetaxel|mesh-list
2439704|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2439705|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
2439706|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439707|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439708|NCT00906061|Antiviral Agents|antiviral agents|mesh-ancestor
2439709|NCT00906061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439710|NCT00906061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439711|NCT00906061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2439712|NCT00906061|Immunologic Factors|immunologic factors|mesh-ancestor
2439713|NCT00906061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439714|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
2439715|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
2439716|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
2439717|NCT00906113|Melphalan|melphalan|mesh-list
2439718|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2439719|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
2439720|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439721|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439722|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2439723|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2439724|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
2439725|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439726|NCT00906126|Misoprostol|misoprostol|mesh-list
2439727|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2439728|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
2439729|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2439730|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439731|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2439732|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2439733|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
2439734|NCT00906139|Fentanyl|fentanyl|mesh-list
2439735|NCT00906139|Midazolam|midazolam|mesh-list
2439736|NCT00906139|Propofol|propofol|mesh-list
2439737|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2439738|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2439739|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439740|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2439741|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
2439742|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
2439743|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2439744|NCT00906139|Narcotics|narcotics|mesh-ancestor
2439745|NCT00906139|Analgesics|analgesics|mesh-ancestor
2439746|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
2439747|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439748|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2439749|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2439750|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2439751|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2439752|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
2439753|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
2439754|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439755|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439756|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
2439757|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
2439758|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2439759|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2439760|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439761|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439762|NCT00906269|Urological Agents|urological agents|mesh-ancestor
2439763|NCT00906334|ON 01910|on 01910|mesh-list
2439764|NCT00906334|Glycine|glycine|mesh-list
2439765|NCT00906334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439766|NCT00906334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2439767|NCT00906334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439768|NCT00906334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439769|NCT00906334|Glycine Agents|glycine agents|mesh-ancestor
2439770|NCT00906334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439771|NCT00906334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439772|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2439773|NCT00906360|Cetuximab|cetuximab|mesh-list
2439774|NCT00906360|Sunitinib|sunitinib|mesh-list
2207826|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2207827|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207828|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2207829|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
2207830|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207831|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2207832|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
2207833|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2207834|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2207835|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2207836|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207837|NCT00009191|Sertraline|sertraline|mesh-list
2207838|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
2207839|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2207840|NCT00009191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2207841|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2207842|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2439775|NCT00906360|Antibodies|antibodies|mesh-list
2439776|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
2439777|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2439778|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
2439779|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439780|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439781|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2439782|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2439783|NCT00906360|Growth Substances|growth substances|mesh-ancestor
2439784|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
2439785|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2439786|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439787|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439788|NCT00906386|Varenicline|varenicline|mesh-list
2439789|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2439790|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2439791|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
2439792|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439793|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439794|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439795|NCT00906451|Simvastatin|simvastatin|mesh-list
2439796|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2439797|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2439798|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
2439799|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439800|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2439801|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2439802|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439803|NCT00906516|Bevacizumab|bevacizumab|mesh-list
2439804|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2439805|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439806|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2439807|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2439808|NCT00906516|Growth Substances|growth substances|mesh-ancestor
2439809|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439810|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
2439811|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
2439812|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
2439813|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2439814|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439815|NCT00906594|Latanoprost|latanoprost|mesh-list
2439816|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2439817|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2439818|NCT00906685|Bevacizumab|bevacizumab|mesh-list
2439819|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2439820|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439821|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2439822|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2439823|NCT00906685|Growth Substances|growth substances|mesh-ancestor
2439824|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439825|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
2439826|NCT00906724|Insulin|insulin|mesh-list
2207843|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207844|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2207845|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
2439827|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2439828|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439829|NCT00906828|Levodopa|levodopa|mesh-list
2439830|NCT00906828|Carbidopa|carbidopa|mesh-list
2439831|NCT00906828|Entacapone|entacapone|mesh-list
2439832|NCT00906828|Tolcapone|tolcapone|mesh-list
2439833|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2439834|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2439835|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
2439836|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439837|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439838|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439839|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2439840|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439841|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2439842|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
2439843|NCT00906867|Miotics|miotics|mesh-ancestor
2439844|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
2439845|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439846|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439847|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2439848|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2439849|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
2439850|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2439851|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2439852|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
2439853|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2439854|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439855|NCT00906880|Eflornithine|eflornithine|mesh-list
2439856|NCT00906880|Nifurtimox|nifurtimox|mesh-list
2439857|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439858|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2439859|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2439860|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2439861|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439862|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
2439863|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439864|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439865|NCT00907036|Cyclosporine|cyclosporine|mesh-list
2439866|NCT00907036|Fludarabine|fludarabine|mesh-list
2439867|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
2439868|NCT00907036|Melphalan|melphalan|mesh-list
2439869|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
2439870|NCT00907036|Cyclosporins|cyclosporins|mesh-list
2439871|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439872|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2439873|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
2439874|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439875|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2439876|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
2439877|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439878|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439879|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
2439880|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439881|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
2439882|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2439883|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2439884|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2439885|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
2439886|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2439887|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2439888|NCT00907114|Ketorolac|ketorolac|mesh-list
2439889|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2439890|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2439891|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2439892|NCT00907114|Analgesics|analgesics|mesh-ancestor
2439893|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
2439894|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2207846|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207847|NCT00009204|Perphenazine|perphenazine|mesh-list
2207848|NCT00009204|Citalopram|citalopram|mesh-list
2207849|NCT00009204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2207850|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2439895|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439896|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2439897|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2439898|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2439899|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439900|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439901|NCT00907166|Gemcitabine|gemcitabine|mesh-list
2439902|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2439903|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
2439904|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439905|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439906|NCT00907166|Antiviral Agents|antiviral agents|mesh-ancestor
2439907|NCT00907166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439908|NCT00907166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439909|NCT00907166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2439910|NCT00907166|Immunologic Factors|immunologic factors|mesh-ancestor
2439911|NCT00907166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439912|NCT00907179|Pemetrexed|pemetrexed|mesh-list
2439913|NCT00907179|Panobinostat|panobinostat|mesh-list
2439914|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439915|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439916|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439917|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2439918|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2439919|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2439920|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
2439921|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2439922|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439923|NCT00907270|Vitamins|vitamins|mesh-ancestor
2439924|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
2439925|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2439926|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2439927|NCT00907283|Deferiprone|deferiprone|mesh-list
2439928|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2439929|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
2439930|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
2439931|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439932|NCT00907400|Naproxen|naproxen|mesh-list
2439933|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2439934|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2439935|NCT00907400|Analgesics|analgesics|mesh-ancestor
2439936|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
2439937|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439938|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439939|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2439940|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2439941|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
2439942|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2439943|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439944|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439945|NCT00907452|Thalidomide|thalidomide|mesh-list
2439946|NCT00907452|Dexamethasone|dexamethasone|mesh-list
2439947|NCT00907452|Prednisone|prednisone|mesh-list
2439948|NCT00907452|Lenalidomide|lenalidomide|mesh-list
2439949|NCT00907452|Melphalan|melphalan|mesh-list
2439950|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2439951|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
2439952|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
2439953|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2439954|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439955|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2439956|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
2439957|NCT00907452|Hormones|hormones|mesh-ancestor
2439958|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2439959|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2439960|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439961|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
2439962|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2439963|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2439964|NCT00907452|Growth Substances|growth substances|mesh-ancestor
2439965|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
2439966|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2439967|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
2439968|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439969|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2439970|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2439971|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
2439972|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2439973|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439974|NCT00907504|Gemcitabine|gemcitabine|mesh-list
2439975|NCT00907504|Cisplatin|cisplatin|mesh-list
2439976|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439977|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2439978|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
2439979|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2439980|NCT00907504|Antiviral Agents|antiviral agents|mesh-ancestor
2439981|NCT00907504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2439982|NCT00907504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2439983|NCT00907504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2439984|NCT00907504|Immunologic Factors|immunologic factors|mesh-ancestor
2439985|NCT00907504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2439986|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
2439987|NCT00907608|Hematinics|hematinics|mesh-ancestor
2439988|NCT00907751|Rituximab|rituximab|mesh-list
2439989|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2439990|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2439991|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
2439992|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207851|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2207852|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207853|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2207854|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
2207855|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207856|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2207857|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
2207858|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2207859|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2207860|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2207861|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2207862|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2207863|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
2207864|NCT00009217|Haloperidol|haloperidol|mesh-list
2207865|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
2207866|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
2207867|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
2207868|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2207869|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207870|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2207871|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2207872|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2439993|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2439994|NCT00907764|Regadenoson|regadenoson|mesh-list
2439995|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2439996|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2439997|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
2439998|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
2439999|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2440000|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440001|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440002|NCT00907829|Lidocaine|lidocaine|mesh-list
2440003|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
2440004|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
2440005|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2440006|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440007|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
2440008|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440009|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2440010|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2440011|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2440012|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2440013|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440014|NCT00907894|Telbivudine|telbivudine|mesh-list
2440015|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
2440016|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440017|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2440018|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440019|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440020|NCT00907972|Vitamin D|vitamin d|mesh-list
2440021|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
2440022|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
2440023|NCT00907972|Vitamins|vitamins|mesh-list
2440024|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
2440025|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440026|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2440027|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2440028|NCT00907985|Lamotrigine|lamotrigine|mesh-list
2440029|NCT00907985|Vofopitant|vofopitant|mesh-list
2440030|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
2440031|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2440032|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2440033|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440034|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2440035|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440036|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2440037|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2440038|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2440039|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2440040|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2440041|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
2440042|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
2440043|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440044|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2440045|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2440046|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2440047|NCT00908024|Cetuximab|cetuximab|mesh-list
2440048|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2440049|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440050|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
2440051|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2440052|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2440053|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2440054|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2440055|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440056|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
2440057|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2440058|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440059|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2440060|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440061|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
2440062|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
2440063|NCT00908089|Prednisolone|prednisolone|mesh-list
2440064|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2440065|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
2440066|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2440067|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
2440068|NCT00908089|Infliximab|infliximab|mesh-list
2440069|NCT00908089|Naltrexone|naltrexone|mesh-list
2440070|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2440071|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
2440072|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2440073|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
2440074|NCT00908089|Hormones|hormones|mesh-ancestor
2440075|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440076|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440077|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2440078|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440079|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
2440080|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
2440081|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440082|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2440083|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2440084|NCT00908089|Protective Agents|protective agents|mesh-ancestor
2440085|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
2440086|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2440087|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440088|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2440089|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2440090|NCT00908089|Analgesics|analgesics|mesh-ancestor
2440091|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
2440092|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2440093|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2440094|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
2440095|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2440096|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2440097|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440098|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440099|NCT00908167|Cytarabine|cytarabine|mesh-list
2440100|NCT00908167|Clofarabine|clofarabine|mesh-list
2440101|NCT00908167|Sorafenib|sorafenib|mesh-list
2440102|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2440103|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
2440104|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440105|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440106|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
2440107|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440108|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440109|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
2440110|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440111|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2440112|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440113|NCT00908180|Cytarabine|cytarabine|mesh-list
2440114|NCT00908180|Cyclosporine|cyclosporine|mesh-list
2440115|NCT00908180|Etoposide|etoposide|mesh-list
2440116|NCT00908180|Melphalan|melphalan|mesh-list
2440117|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
2440118|NCT00908180|Carmustine|carmustine|mesh-list
2440119|NCT00908180|Cyclosporins|cyclosporins|mesh-list
2440120|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2440121|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440122|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2440123|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2440124|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440125|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440126|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2440127|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
2440128|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
2440129|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440130|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440131|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
2440132|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440133|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
2440134|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
2440135|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2440136|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2440137|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2440138|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
2440139|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2440140|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2440141|NCT00908219|Bevacizumab|bevacizumab|mesh-list
2440142|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2440143|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440144|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2440145|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2440146|NCT00908219|Growth Substances|growth substances|mesh-ancestor
2440147|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440148|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
2440149|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
2440150|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2440151|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440152|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2440153|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440154|NCT00908297|Ubiquinone|ubiquinone|mesh-list
2440155|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
2440156|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
2440157|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440158|NCT00908297|Vitamins|vitamins|mesh-ancestor
2440159|NCT00908323|Vaccines|vaccines|mesh-list
2440160|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
2440161|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440162|NCT00908336|Docetaxel|docetaxel|mesh-list
2440163|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2440164|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440165|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
2440166|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
2440167|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
2440168|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440169|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2440170|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440171|NCT00908362|Fluticasone|fluticasone|mesh-list
2440172|NCT00908362|Xhance|xhance|mesh-list
2440173|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2440174|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2440175|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2440176|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2440177|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
2440178|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440179|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440180|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2440181|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
2440182|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
2440183|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2440184|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2440185|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2440186|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2440187|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
2440188|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2440189|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440190|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
2440191|NCT00908362|Hormones|hormones|mesh-ancestor
2440192|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440193|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
2440194|NCT00908414|TMC-310911|tmc-310911|mesh-list
2440195|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
2440196|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440197|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440198|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
2440199|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
2440200|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2440201|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2440202|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440203|NCT00908531|Letrozole|letrozole|mesh-list
2440204|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440205|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2440206|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2440207|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440208|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440209|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2440210|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
2440211|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440212|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440213|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
2440214|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
2440215|NCT00908661|Coagulants|coagulants|mesh-ancestor
2440216|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
2440217|NCT00908674|Cyproterone|cyproterone|mesh-list
2440218|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
2440219|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
2440220|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440221|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440222|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440223|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2440224|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
2440225|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2440226|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
2440227|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2440228|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2440229|NCT00908713|Prednisolone|prednisolone|mesh-list
2440230|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
2440231|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2440232|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
2440233|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2440234|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
2440235|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
2440236|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440237|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440238|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2440239|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
2440240|NCT00908713|Hormones|hormones|mesh-ancestor
2440241|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440242|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2440243|NCT00908713|Protective Agents|protective agents|mesh-ancestor
2440244|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2440245|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440246|NCT00908726|Propofol|propofol|mesh-list
2440247|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2440248|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2440249|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440250|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2440251|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
2440252|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
2440253|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
2440254|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2440255|NCT00908817|Triamcinolone|triamcinolone|mesh-list
2440256|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2440257|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2440258|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2440259|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2440260|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440261|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
2440262|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
2440263|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2440264|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
2440265|NCT00908817|Hormones|hormones|mesh-ancestor
2440266|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440267|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440268|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440269|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
2440270|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440271|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440272|NCT00908869|Interferons|interferons|mesh-list
2440273|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
2440274|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
2440275|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
2440276|NCT00908869|Vinorelbine|vinorelbine|mesh-list
2440277|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440278|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
2440279|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440280|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2440281|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2440282|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
2440283|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440284|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440285|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2440286|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
2440287|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440288|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2440289|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
2440290|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
2440291|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
2440292|NCT00908921|Glimepiride|glimepiride|mesh-list
2440293|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2440294|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2440295|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440296|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440297|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
2440298|NCT00908986|Rituximab|rituximab|mesh-list
2440299|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2440300|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440301|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
2440302|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440303|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2440304|NCT00909051|Acarbose|acarbose|mesh-list
2440305|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2440306|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440307|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440308|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2440309|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440310|NCT00909077|Dexamethasone|dexamethasone|mesh-list
2440311|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
2440312|NCT00909077|Rituximab|rituximab|mesh-list
2440313|NCT00909077|BB 1101|bb 1101|mesh-list
2440314|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2440315|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
2440316|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
2440317|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440318|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440319|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2440320|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
2440321|NCT00909077|Hormones|hormones|mesh-ancestor
2440322|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440323|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2440324|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440325|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
2440326|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440327|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440328|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2440329|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
2440330|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2440331|NCT00909129|Interferons|interferons|mesh-list
2440332|NCT00909129|Ribavirin|ribavirin|mesh-list
2440333|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
2440334|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2440335|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440336|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
2440337|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440338|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
2440339|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440340|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
2440341|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440342|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
2440343|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2440344|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440345|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
2440346|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2440347|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440348|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2440349|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
2440350|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2440351|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2440352|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440353|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440354|NCT00909233|Urological Agents|urological agents|mesh-ancestor
2440355|NCT00909311|Ritonavir|ritonavir|mesh-list
2440356|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2440357|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2440358|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
2440359|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440360|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440361|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2440362|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2440363|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
2440364|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440365|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2440366|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2440367|NCT00909337|Bosentan|bosentan|mesh-list
2440368|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2440369|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2440370|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440371|NCT00909402|Capecitabine|capecitabine|mesh-list
2440372|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440373|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2440374|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
2440375|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440376|NCT00909454|Vitamin D|vitamin d|mesh-list
2440377|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
2440378|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
2440379|NCT00909454|Vitamins|vitamins|mesh-list
2440380|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
2440381|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440382|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2440383|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2440384|NCT00909506|Metformin|metformin|mesh-list
2440385|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2440386|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440387|NCT00909519|Naproxen|naproxen|mesh-list
2440388|NCT00909519|Furosemide|furosemide|mesh-list
2440389|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
2440390|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2440391|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2440392|NCT00909519|Analgesics|analgesics|mesh-ancestor
2440393|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
2440394|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440395|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440396|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2440397|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2440398|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
2440399|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2440400|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440401|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440402|NCT00909519|Diuretics|diuretics|mesh-ancestor
2440403|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
2440404|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2440405|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2440406|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
2440407|NCT00909571|Tacrolimus|tacrolimus|mesh-list
2440408|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440409|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
2440410|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440411|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2440412|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440413|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440414|NCT00909597|Pioglitazone|pioglitazone|mesh-list
2440415|NCT00909597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2440416|NCT00909597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2440417|NCT00909597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440418|NCT00909597|Incretins|incretins|mesh-ancestor
2440419|NCT00909597|Hormones|hormones|mesh-ancestor
2440420|NCT00909597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440421|NCT00909688|BLI-489|bli-489|mesh-list
2440422|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2440423|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440424|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440425|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2440426|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440427|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
2440428|NCT00909831|Sirolimus|sirolimus|mesh-list
2440429|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
2440430|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2440431|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2207873|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2207874|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2207875|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2207876|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
2207877|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2207878|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207879|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2207880|NCT00009230|Celecoxib|celecoxib|mesh-list
2440432|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440433|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440434|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440435|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2440436|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2440437|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2440438|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440439|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
2440440|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440441|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
2440442|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440443|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
2440444|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2440445|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2440446|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440447|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
2440448|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2440449|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440450|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
2440451|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2440452|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2440453|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440454|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2440455|NCT00909935|Analgesics|analgesics|mesh-ancestor
2207881|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2207882|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2207883|NCT00009230|Analgesics|analgesics|mesh-ancestor
2207884|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
2207885|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2207886|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207887|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2207888|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207889|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2440456|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
2440457|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440458|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2440459|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2440460|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2440461|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
2440462|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2440463|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440464|NCT00909948|Fludarabine|fludarabine|mesh-list
2440465|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440466|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
2440467|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2440468|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440469|NCT00909974|Micronutrients|micronutrients|mesh-list
2440470|NCT00909974|Trace Elements|trace elements|mesh-list
2440471|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440472|NCT00909987|Bevacizumab|bevacizumab|mesh-list
2440473|NCT00909987|Capecitabine|capecitabine|mesh-list
2440474|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
2440475|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2440476|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440477|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2440478|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2440479|NCT00909987|Growth Substances|growth substances|mesh-ancestor
2440480|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440481|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
2440482|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2440483|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
2440484|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440485|NCT00910013|Ropivacaine|ropivacaine|mesh-list
2440486|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
2440487|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
2440488|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2440489|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440490|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
2440491|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440492|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2440493|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
2440494|NCT00910052|Coagulants|coagulants|mesh-ancestor
2440495|NCT00910065|Aspirin|aspirin|mesh-list
2440496|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
2440497|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2440498|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2440499|NCT00910065|Analgesics|analgesics|mesh-ancestor
2440500|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
2440501|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440502|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440503|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2440504|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2440505|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2440506|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2440507|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440508|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2440509|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2440510|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440511|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
2440512|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
2440513|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440514|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2440515|NCT00910195|Acetaminophen|acetaminophen|mesh-list
2440516|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2440517|NCT00910195|Analgesics|analgesics|mesh-ancestor
2440518|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
2440519|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440520|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440521|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
2440522|NCT00910221|Atorvastatin|atorvastatin|mesh-list
2440523|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2440524|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2440525|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
2440526|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440527|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2440528|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2440529|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440530|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
2440531|NCT00910234|Hematinics|hematinics|mesh-ancestor
2440532|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
2440533|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2440534|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440535|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2440536|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2440537|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207890|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2207891|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207892|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207893|NCT00009555|Testosterone|testosterone|mesh-list
2207894|NCT00009555|Androgens|androgens|mesh-ancestor
2207895|NCT00009555|Hormones|hormones|mesh-ancestor
2207896|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440538|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440539|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440540|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2440541|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2440542|NCT00910390|Ethylene|ethylene|mesh-list
2440543|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
2440544|NCT00910390|Growth Substances|growth substances|mesh-ancestor
2440545|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440546|NCT00910416|Remifentanil|remifentanil|mesh-list
2440547|NCT00910416|Propofol|propofol|mesh-list
2440548|NCT00910416|Sevoflurane|sevoflurane|mesh-list
2440549|NCT00910416|Atracurium|atracurium|mesh-list
2440550|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2440551|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2440552|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440553|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2440554|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
2440555|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
2440556|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2440557|NCT00910416|Narcotics|narcotics|mesh-ancestor
2440558|NCT00910416|Analgesics|analgesics|mesh-ancestor
2440559|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
2440560|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440561|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2440562|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2440563|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2440564|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2440565|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2440566|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2440567|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2440568|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
2440569|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2440570|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440571|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
2440572|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2440573|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
2440574|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440575|NCT00910442|Expectorants|expectorants|mesh-ancestor
2440576|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
2440577|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2440578|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
2440579|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440580|NCT00910442|Protective Agents|protective agents|mesh-ancestor
2440581|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440582|NCT00910442|Antidotes|antidotes|mesh-ancestor
2440583|NCT00910455|SRX246|srx246|mesh-list
2440584|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2440585|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440586|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
2440587|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440588|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
2440589|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2440590|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440591|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
2440592|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
2440593|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2440594|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
2440595|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440596|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440597|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2440598|NCT00910637|Gestodene|gestodene|mesh-list
2440599|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2440600|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2440601|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2440602|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
2440603|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2440604|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440605|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2440606|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2440607|NCT00910637|Progestins|progestins|mesh-ancestor
2440608|NCT00910637|Hormones|hormones|mesh-ancestor
2440609|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440610|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2440611|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2440612|NCT00910741|Gemcitabine|gemcitabine|mesh-list
2440613|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2440614|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
2440615|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440616|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440617|NCT00910741|Antiviral Agents|antiviral agents|mesh-ancestor
2440618|NCT00910741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440619|NCT00910741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440620|NCT00910741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440621|NCT00910741|Immunologic Factors|immunologic factors|mesh-ancestor
2440622|NCT00910741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440623|NCT00910754|Prednisone|prednisone|mesh-list
2440624|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
2440625|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2440626|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
2440627|NCT00910754|Hormones|hormones|mesh-ancestor
2440628|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440629|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440630|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2440631|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440632|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2440633|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440634|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440635|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
2440636|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2440637|NCT00910767|Insulin|insulin|mesh-list
2440638|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2440639|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440640|NCT00910780|Olanzapine|olanzapine|mesh-list
2440641|NCT00910780|Aripiprazole|aripiprazole|mesh-list
2440642|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
2440643|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2440644|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2440645|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2440646|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2440647|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440648|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
2440649|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
2440650|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2440651|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440652|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2440653|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2440654|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
2440655|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2440656|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2440657|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2440658|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2440659|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
2440660|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
2440661|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440662|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2440663|NCT00910780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2440664|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2440665|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2440666|NCT00910806|Nevirapine|nevirapine|mesh-list
2440667|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2440668|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2440669|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440670|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440671|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
2440672|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440673|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2440674|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2440675|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2440676|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2440677|NCT00910897|Thalidomide|thalidomide|mesh-list
2440678|NCT00910897|Dexamethasone|dexamethasone|mesh-list
2440679|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
2440680|NCT00910897|Bortezomib|bortezomib|mesh-list
2440681|NCT00910897|BB 1101|bb 1101|mesh-list
2440682|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2440683|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
2440684|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
2440685|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440686|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440687|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2440688|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
2440689|NCT00910897|Hormones|hormones|mesh-ancestor
2440690|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440691|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2440692|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440693|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
2440694|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440695|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440696|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440697|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
2440698|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
2440699|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2440700|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440701|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2440702|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2440703|NCT00910897|Growth Substances|growth substances|mesh-ancestor
2440704|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
2440705|NCT00910975|Interferons|interferons|mesh-list
2440706|NCT00910975|Ribavirin|ribavirin|mesh-list
2440707|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
2440708|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
2440709|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2440710|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440711|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
2440712|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440713|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
2440714|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440715|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
2440716|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440717|NCT00911066|Azacitidine|azacitidine|mesh-list
2440718|NCT00911066|Pevonedistat|pevonedistat|mesh-list
2440719|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2440720|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
2440721|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440722|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440723|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440724|NCT00911092|Fluorouracil|fluorouracil|mesh-list
2440725|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440726|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
2440727|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440728|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2440729|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440730|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
2440731|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440732|NCT00911183|Prednisone|prednisone|mesh-list
2440733|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
2440734|NCT00911183|Rituximab|rituximab|mesh-list
2440735|NCT00911183|Doxorubicin|doxorubicin|mesh-list
2440736|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2440737|NCT00911183|Vincristine|vincristine|mesh-list
2440738|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440739|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
2440740|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440741|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2440742|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2440743|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
2440744|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440745|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440746|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2440747|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2440748|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2440749|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2440750|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2440751|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440752|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2440753|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
2440754|NCT00911183|Hormones|hormones|mesh-ancestor
2440755|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440756|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2440757|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2440758|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
2440759|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
2440760|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
2440761|NCT00911235|Fluconazole|fluconazole|mesh-list
2440762|NCT00911235|Fesoterodine|fesoterodine|mesh-list
2440763|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
2440764|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440765|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2440766|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2207897|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207898|NCT00009581|Acetylcholine|acetylcholine|mesh-list
2207899|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
2207900|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2207901|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
2207902|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2207903|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207904|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207905|NCT00009620|Phenobarbital|phenobarbital|mesh-list
2207906|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
2207907|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2207908|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2207909|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207910|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2207911|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2207912|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2207913|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207914|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
2207915|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
2207916|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2207917|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2207918|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2440767|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440768|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440769|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2440770|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
2440771|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440772|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440773|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2440774|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2440775|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2440776|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2440777|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
2440778|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2440779|NCT00911235|Urological Agents|urological agents|mesh-ancestor
2440780|NCT00911261|Oxymorphone|oxymorphone|mesh-list
2440781|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2440782|NCT00911261|Narcotics|narcotics|mesh-ancestor
2440783|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2440784|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440785|NCT00911261|Analgesics|analgesics|mesh-ancestor
2440786|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
2440787|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440788|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2440789|NCT00911287|Oxymorphone|oxymorphone|mesh-list
2440790|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2440791|NCT00911287|Narcotics|narcotics|mesh-ancestor
2440792|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2440793|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440794|NCT00911287|Analgesics|analgesics|mesh-ancestor
2440795|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
2440796|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440797|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2440798|NCT00911313|Metformin|metformin|mesh-list
2440799|NCT00911313|Letrozole|letrozole|mesh-list
2440800|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2440801|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440802|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440803|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2440804|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2440805|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440806|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440807|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2440808|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
2440809|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440810|NCT00911339|Atorvastatin|atorvastatin|mesh-list
2440811|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2440812|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2440813|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
2440814|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440815|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2440816|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2440817|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440818|NCT00911521|Vaccines|vaccines|mesh-list
2440819|NCT00911521|Immunologic Factors|immunologic factors|mesh-ancestor
2440820|NCT00911521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440821|NCT00911573|Vancomycin|vancomycin|mesh-list
2440822|NCT00911573|Clindamycin|clindamycin|mesh-list
2440823|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
2440824|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
2440825|NCT00911573|Tigecycline|tigecycline|mesh-list
2440826|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2440827|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440828|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2440829|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440830|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440831|NCT00911651|Bromides|bromides|mesh-list
2440832|NCT00911651|Albuterol|albuterol|mesh-list
2440833|NCT00911651|Ipratropium|ipratropium|mesh-list
2440834|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
2440835|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2440836|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
2440837|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440838|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440839|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2440840|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
2440841|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
2440842|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2440843|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2440844|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2440845|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2440846|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
2440847|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2440848|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440849|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2440850|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
2440851|NCT00911664|Vitamin D|vitamin d|mesh-list
2440852|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
2440853|NCT00911664|Vitamins|vitamins|mesh-list
2440854|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
2440855|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440856|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2440857|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2440858|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
2440859|NCT00911716|Bevacizumab|bevacizumab|mesh-list
2440860|NCT00911716|Docetaxel|docetaxel|mesh-list
2440861|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440862|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
2440863|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440864|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2440865|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2440866|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
2440867|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440868|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440869|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2440870|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2440871|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2440872|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2440873|NCT00911716|Growth Substances|growth substances|mesh-ancestor
2440874|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
2440875|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
2440876|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
2440877|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
2440878|NCT00911963|Ribavirin|ribavirin|mesh-list
2440879|NCT00911963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2440880|NCT00911963|Antimetabolites|antimetabolites|mesh-ancestor
2440881|NCT00911963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440882|NCT00911963|Antiviral Agents|antiviral agents|mesh-ancestor
2440883|NCT00911963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2440884|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
2440885|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2440886|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2440887|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440888|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
2440889|NCT00912119|Coagulants|coagulants|mesh-ancestor
2440890|NCT00912145|Alprazolam|alprazolam|mesh-list
2440891|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2440892|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2440893|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440894|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2440895|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2440896|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2440897|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
2440898|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
2440899|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2440900|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440901|NCT00912171|Budesonide|budesonide|mesh-list
2440902|NCT00912171|Montelukast|montelukast|mesh-list
2440903|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2440904|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2440905|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
2440906|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440907|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440908|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2440909|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
2440910|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
2440911|NCT00912171|Hormones|hormones|mesh-ancestor
2440912|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440913|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2440914|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
2440915|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2440916|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2440917|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440918|NCT00912262|Capsaicin|capsaicin|mesh-list
2440919|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
2440920|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
2440921|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
2440922|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2440923|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440924|NCT00912275|Vinorelbine|vinorelbine|mesh-list
2440925|NCT00912275|Lapatinib|lapatinib|mesh-list
2440926|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2440927|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440928|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
2440929|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
2440930|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
2440931|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440932|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2440933|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440934|NCT00912327|Cetuximab|cetuximab|mesh-list
2440935|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2440936|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440937|NCT00912392|Carboplatin|carboplatin|mesh-list
2440938|NCT00912392|Etoposide|etoposide|mesh-list
2440939|NCT00912392|Endostar protein|endostar protein|mesh-list
2440940|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440941|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2440942|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2440943|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2440944|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440945|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440946|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2440947|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2440948|NCT00912392|Growth Substances|growth substances|mesh-ancestor
2440949|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440950|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
2440951|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
2440952|NCT00912444|Docetaxel|docetaxel|mesh-list
2440953|NCT00912444|Doxorubicin|doxorubicin|mesh-list
2440954|NCT00912444|Epirubicin|epirubicin|mesh-list
2440955|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2440956|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
2440957|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440958|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2440959|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2440960|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
2440961|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440962|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2440963|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2440964|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
2440965|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
2440966|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
2440967|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2440968|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2440969|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2440970|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440971|NCT00912457|Donepezil|donepezil|mesh-list
2440972|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2440973|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2440974|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440975|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
2440976|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2440977|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440978|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
2440979|NCT00912483|Heparin|heparin|mesh-list
2440980|NCT00912483|Calcium heparin|calcium heparin|mesh-list
2440981|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
2440982|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2440983|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2440984|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2440985|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2440986|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
2440987|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2440988|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2440989|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2440990|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2440991|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440992|NCT00912548|Tamoxifen|tamoxifen|mesh-list
2440993|NCT00912548|Goserelin|goserelin|mesh-list
2440994|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2440995|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
2440996|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2440997|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2440998|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2440999|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441000|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2441001|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2441002|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2441003|NCT00912574|Molgramostim|molgramostim|mesh-list
2441004|NCT00912574|Sargramostim|sargramostim|mesh-list
2441005|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
2441006|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
2441007|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441008|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441009|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2441010|NCT00912639|Paclitaxel|paclitaxel|mesh-list
2441011|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2441012|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441013|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
2441014|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
2441015|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
2441016|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441017|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
2441018|NCT00912678|Tacrolimus|tacrolimus|mesh-list
2441019|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2441020|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
2441021|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441022|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2441023|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441024|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441025|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2441026|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441027|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2441028|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
2441029|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2441030|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441031|NCT00912756|Cilostazol|cilostazol|mesh-list
2441032|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2441033|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
2441034|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441035|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441036|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2441037|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
2441038|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2441039|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2441040|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441041|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2441042|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
2441043|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2441044|NCT00912756|Protective Agents|protective agents|mesh-ancestor
2441045|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2441046|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2441047|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441048|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
2441049|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2441050|NCT00912860|Interferons|interferons|mesh-list
2441051|NCT00912860|Interferon-beta|interferon-beta|mesh-list
2441052|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
2441053|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441054|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
2441055|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441056|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
2441057|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441058|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2441059|NCT00912899|Noscapine|noscapine|mesh-list
2441060|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
2441061|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
2441062|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
2441063|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2441064|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441065|NCT00913029|Timolol|timolol|mesh-list
2441066|NCT00913029|Latanoprost|latanoprost|mesh-list
2441067|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2441068|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2441069|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
2441070|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441071|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441072|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441073|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2441074|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2441075|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2441076|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2441077|NCT00913055|Octreotide|octreotide|mesh-list
2441078|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2441079|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2441080|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441081|NCT00913107|Lamotrigine|lamotrigine|mesh-list
2441082|NCT00913107|Carbamazepine|carbamazepine|mesh-list
2441083|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
2441084|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2441085|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2441086|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441087|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2441088|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441089|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2441090|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2441091|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2441092|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441093|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2441094|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
2441095|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2441096|NCT00913107|Analgesics|analgesics|mesh-ancestor
2441097|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
2441098|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441099|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2441100|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2441101|NCT00913120|Enoxaparin|enoxaparin|mesh-list
2441102|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
2441103|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2441104|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2441105|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441106|NCT00913224|Diclofenac|diclofenac|mesh-list
2441107|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2441108|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2441109|NCT00913224|Analgesics|analgesics|mesh-ancestor
2441110|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
2441111|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441112|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441113|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2441114|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2441115|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2441116|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441117|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441118|NCT00913237|Desipramine|desipramine|mesh-list
2441119|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2441120|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
2441121|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441122|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441123|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441124|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2441125|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2441126|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2441127|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
2441128|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441129|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441130|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
2441131|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2441132|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
2441133|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441134|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441135|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
2441136|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441137|NCT00913276|Propofol|propofol|mesh-list
2441138|NCT00913276|Sevoflurane|sevoflurane|mesh-list
2441139|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2441140|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2441141|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441142|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2441143|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
2441144|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
2441145|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2441146|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2441147|NCT00913315|Tamsulosin|tamsulosin|mesh-list
2441148|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2441149|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2441150|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2441151|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2441152|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
2441153|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441154|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441155|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441156|NCT00913315|Urological Agents|urological agents|mesh-ancestor
2441157|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2441158|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2441159|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
2441160|NCT00913328|Montelukast|montelukast|mesh-list
2441161|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2441162|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
2441163|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2441164|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
2441165|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2441166|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441167|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2441168|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2441169|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441170|NCT00913341|Alprazolam|alprazolam|mesh-list
2441171|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2441172|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2441173|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441174|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2441175|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2441176|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441177|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
2441178|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
2441179|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441180|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441181|NCT00913367|Insulin|insulin|mesh-list
2441182|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2441183|NCT00913367|Metformin|metformin|mesh-list
2441184|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
2441185|NCT00913367|Glimepiride|glimepiride|mesh-list
2441186|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2441187|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441188|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2441189|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2441190|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
2441191|NCT00913393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2441192|NCT00913393|Immunologic Factors|immunologic factors|mesh-ancestor
2441193|NCT00913393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441194|NCT00913419|Amitriptyline|amitriptyline|mesh-list
2441195|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
2441196|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2441197|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
2441198|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441199|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2441200|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441201|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2441202|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441203|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2441204|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2441205|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2441206|NCT00913419|Analgesics|analgesics|mesh-ancestor
2441207|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
2441208|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2441209|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2441210|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2441211|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441212|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
2441213|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441214|NCT00913484|Disulfiram|disulfiram|mesh-list
2441215|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2441216|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
2441217|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441218|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441219|NCT00913497|Insulin|insulin|mesh-list
2441220|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2441221|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
2441222|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
2441223|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2441224|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441225|NCT00913549|Clemastine|clemastine|mesh-list
2441226|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
2441227|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
2441228|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2441229|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
2441230|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
2441231|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2207919|NCT00009646|Indomethacin|indomethacin|mesh-list
2207920|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2207921|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2207922|NCT00009646|Analgesics|analgesics|mesh-ancestor
2207923|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
2207924|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2207925|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207926|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2207927|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207928|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
2207929|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
2207930|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2207931|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2207932|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207933|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207934|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
2207935|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2207936|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
2207937|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2207938|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207939|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2207940|NCT00009672|Morphine|morphine|mesh-list
2441232|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441233|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441234|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2441235|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2441236|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2441237|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2441238|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
2441239|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441240|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2441241|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2441242|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441243|NCT00913588|Fluoxetine|fluoxetine|mesh-list
2441244|NCT00913588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2441245|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2441246|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2441247|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441248|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441249|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
2441250|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441251|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2441252|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
2441253|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441254|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2441255|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2441256|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441257|NCT00913614|SR 46349B|sr 46349b|mesh-list
2441258|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2441259|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2441260|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441261|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2441262|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2441263|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
2441264|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441265|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441266|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
2441267|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2441268|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441269|NCT00913666|Interferons|interferons|mesh-list
2441270|NCT00913666|Interferon-beta|interferon-beta|mesh-list
2441271|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
2441272|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207941|NCT00009672|Nortriptyline|nortriptyline|mesh-list
2207942|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2207943|NCT00009672|Narcotics|narcotics|mesh-ancestor
2207944|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2207945|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207946|NCT00009672|Analgesics|analgesics|mesh-ancestor
2207947|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
2207948|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2207949|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2207950|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
2207951|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2207952|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2207953|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2207954|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2207955|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207956|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
2207957|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2207958|NCT00009698|Aldesleukin|aldesleukin|mesh-list
2207959|NCT00009698|Interleukin-2|interleukin-2|mesh-list
2207960|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207961|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2207962|NCT00009698|Analgesics|analgesics|mesh-ancestor
2207963|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
2207964|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441273|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
2441274|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441275|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
2441276|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441277|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2441278|NCT00913705|Carboplatin|carboplatin|mesh-list
2441279|NCT00913705|Paclitaxel|paclitaxel|mesh-list
2441280|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2441281|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441282|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2441283|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
2441284|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
2441285|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
2441286|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441287|NCT00913718|Fluoxetine|fluoxetine|mesh-list
2441288|NCT00913718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2441289|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2441290|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2441291|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441292|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441293|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
2441294|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441295|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2441296|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
2441297|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441298|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2441299|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2441300|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441301|NCT00913783|Clomipramine|clomipramine|mesh-list
2441302|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2441303|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
2441304|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441305|NCT00913783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2441306|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2441307|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2441308|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441309|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441310|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
2441311|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441312|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
2441313|NCT00913796|Diuretics|diuretics|mesh-ancestor
2441314|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
2441315|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441316|NCT00913796|Expectorants|expectorants|mesh-ancestor
2441317|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
2441318|NCT00913809|Desipramine|desipramine|mesh-list
2441319|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2441320|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
2441321|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441322|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441323|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441324|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2441325|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2441326|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2441327|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
2441328|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441329|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441330|NCT00913822|Desipramine|desipramine|mesh-list
2441331|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2441332|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
2441333|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441334|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441335|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441336|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2441337|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2441338|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2441339|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
2441340|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441341|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441342|NCT00913848|Valproic Acid|valproic acid|mesh-list
2441343|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
2441344|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441345|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441346|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
2441347|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441348|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441349|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
2441350|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2441351|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2441352|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441353|NCT00913861|Fentanyl|fentanyl|mesh-list
2441354|NCT00913861|Propofol|propofol|mesh-list
2441355|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2441356|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2441357|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441358|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2441359|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
2441360|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
2441361|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2441362|NCT00913861|Narcotics|narcotics|mesh-ancestor
2441363|NCT00913861|Analgesics|analgesics|mesh-ancestor
2441364|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
2441365|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441366|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2441367|NCT00913874|Valproic Acid|valproic acid|mesh-list
2441368|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
2441369|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441370|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441371|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
2441372|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441373|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441374|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
2441375|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2441376|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2441377|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441378|NCT00913887|Diclofenac|diclofenac|mesh-list
2441379|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2441380|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2441381|NCT00913887|Analgesics|analgesics|mesh-ancestor
2441382|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
2441383|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441384|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441385|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2441386|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2441387|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2441388|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441389|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441390|NCT00913952|Clomipramine|clomipramine|mesh-list
2441391|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2441392|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
2441393|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441394|NCT00913952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2441395|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2441396|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2441397|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441398|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441399|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
2441400|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441401|NCT00913965|Atenolol|atenolol|mesh-list
2441402|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2441403|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2441404|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
2441405|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
2441406|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441407|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441408|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2441409|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2441410|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2441411|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
2441412|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441413|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441414|NCT00914004|Desipramine|desipramine|mesh-list
2441415|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2441416|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
2441417|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441418|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441419|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441420|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2441421|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2441422|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2441423|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
2441424|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441425|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441426|NCT00914017|Atorvastatin|atorvastatin|mesh-list
2441427|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2441428|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2441429|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
2441430|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441431|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2441432|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2441433|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441434|NCT00914056|Lactulose|lactulose|mesh-list
2441435|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2441436|NCT00914095|Methylphenidate|methylphenidate|mesh-list
2441437|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2441438|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441439|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2441440|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2441441|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2441442|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441443|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
2441444|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441445|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
2441446|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2441447|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441448|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2441449|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2441450|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441451|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441452|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441453|NCT00914134|Levodopa|levodopa|mesh-list
2441454|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2441455|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2441456|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
2441457|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441458|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441459|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441460|NCT00914160|Diclofenac|diclofenac|mesh-list
2441461|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2441462|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2441463|NCT00914160|Analgesics|analgesics|mesh-ancestor
2441464|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
2441465|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441466|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441467|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2441468|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2441469|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2441470|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441471|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441472|NCT00914212|Sibutramine|sibutramine|mesh-list
2441473|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
2441474|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441475|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
2441476|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2441477|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
2441478|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
2441479|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2441480|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2441481|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441482|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441483|NCT00914277|Urological Agents|urological agents|mesh-ancestor
2441484|NCT00914290|Baclofen|baclofen|mesh-list
2441485|NCT00914290|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2441486|NCT00914290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441487|NCT00914290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2441488|NCT00914290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441489|NCT00914290|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2441490|NCT00914290|GABA Agonists|gaba agonists|mesh-ancestor
2441491|NCT00914290|GABA Agents|gaba agents|mesh-ancestor
2441492|NCT00914290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441493|NCT00914290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441494|NCT00914368|Clopidogrel|clopidogrel|mesh-list
2441495|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2441496|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2441497|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2441498|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2441499|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
2441500|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441501|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441502|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441503|NCT00914394|Phenylephrine|phenylephrine|mesh-list
2441504|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
2441505|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2441506|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2441507|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
2441508|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
2441509|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441510|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441511|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
2441512|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2441513|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
2441514|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
2441515|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2441516|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2441517|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2441518|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
2441519|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441520|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441521|NCT00914394|Protective Agents|protective agents|mesh-ancestor
2441522|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441523|NCT00914420|Trapidil|trapidil|mesh-list
2441524|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2441525|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441526|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441527|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2441528|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
2441529|NCT00914472|Heparin|heparin|mesh-list
2441530|NCT00914472|Calcium heparin|calcium heparin|mesh-list
2441531|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
2441532|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2441533|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2441534|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441535|NCT00914498|Lidocaine|lidocaine|mesh-list
2441536|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
2441537|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
2441538|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2441539|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441540|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
2441541|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441542|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2441543|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2441544|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2441545|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2441546|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441547|NCT00914524|Olmesartan|olmesartan|mesh-list
2441548|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2441549|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2441550|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2441551|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2441552|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441553|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
2441554|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
2441555|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441556|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441557|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441558|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
2441559|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2441560|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2441561|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441562|NCT00914576|Vitamins|vitamins|mesh-list
2441563|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
2441564|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441565|NCT00914602|Levodopa|levodopa|mesh-list
2441566|NCT00914602|Carbidopa|carbidopa|mesh-list
2441567|NCT00914602|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2441568|NCT00914602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2441569|NCT00914602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2441570|NCT00914602|Dopamine Agents|dopamine agents|mesh-ancestor
2441571|NCT00914602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441572|NCT00914602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441573|NCT00914602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441574|NCT00914602|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2441575|NCT00914602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441576|NCT00914602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2441577|NCT00914602|Immunologic Factors|immunologic factors|mesh-ancestor
2441578|NCT00914602|Dopamine Agonists|dopamine agonists|mesh-ancestor
2441579|NCT00914641|Apixaban|apixaban|mesh-list
2441580|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2441581|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
2441582|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2441583|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
2441584|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441585|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441586|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
2441587|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
2441588|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2441589|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
2441590|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441591|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441592|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2441593|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
2441594|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2441595|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2441596|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2441597|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
2441598|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441599|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441600|NCT00914667|Warfarin|warfarin|mesh-list
2441601|NCT00914667|Fesoterodine|fesoterodine|mesh-list
2441602|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
2441603|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2441604|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2441605|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
2441606|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441607|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441608|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441609|NCT00914667|Urological Agents|urological agents|mesh-ancestor
2441610|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2441611|NCT00914693|Gestodene|gestodene|mesh-list
2441612|NCT00914693|Femovan|femovan|mesh-list
2441613|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2441614|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2441615|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2441616|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
2441617|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2441618|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441619|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2441620|NCT00914693|Estrogens|estrogens|mesh-ancestor
2441621|NCT00914693|Hormones|hormones|mesh-ancestor
2441622|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2441623|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2441624|NCT00914693|Progestins|progestins|mesh-ancestor
2441625|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2441626|NCT00914771|Vaccines|vaccines|mesh-list
2441627|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
2441628|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441629|NCT00914797|Terbutaline|terbutaline|mesh-list
2441630|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2441631|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
2441632|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441633|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441634|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2441635|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
2441636|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
2441637|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
2441638|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2441639|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2441640|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2441641|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2441642|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
2441643|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441644|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441648|NCT00914836|Betamethasone|betamethasone|mesh-list
2441649|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
2441650|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2441651|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
2441652|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
2441653|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2441654|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2441655|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
2441656|NCT00914836|Hormones|hormones|mesh-ancestor
2441657|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2441658|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441659|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2441660|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
2441661|NCT00914888|Metronidazole|metronidazole|mesh-list
2441662|NCT00914888|Clarithromycin|clarithromycin|mesh-list
2441663|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
2441664|NCT00914888|Tigecycline|tigecycline|mesh-list
2441665|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441666|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2441667|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2441668|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2441669|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2441670|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441671|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441672|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2441673|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2441674|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2441675|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2441676|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
2441677|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441678|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441679|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2441680|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
2441681|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2441682|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2441683|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2441684|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
2441685|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441686|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441687|NCT00914953|Oxytocin|oxytocin|mesh-list
2441688|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
2441689|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2441690|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441691|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
2441692|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2441693|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2441694|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441695|NCT00915083|Amrubicin|amrubicin|mesh-list
2441696|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441697|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
2441698|NCT00915200|Silybin|silybin|mesh-list
2441699|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2441700|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
2441701|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441702|NCT00915200|Expectorants|expectorants|mesh-ancestor
2441703|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
2207965|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207966|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2207967|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2207968|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
2207969|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207970|NCT00009750|Cyclosporine|cyclosporine|mesh-list
2207971|NCT00009750|Paclitaxel|paclitaxel|mesh-list
2207972|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2207973|NCT00009750|Antibodies|antibodies|mesh-list
2207974|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
2441704|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2441705|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
2441706|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441707|NCT00915200|Protective Agents|protective agents|mesh-ancestor
2441708|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441709|NCT00915200|Antidotes|antidotes|mesh-ancestor
2441710|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2441711|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441712|NCT00915239|Pantoprazole|pantoprazole|mesh-list
2441713|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2441714|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2441715|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2441716|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441717|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441718|NCT00915252|Cytarabine|cytarabine|mesh-list
2441719|NCT00915252|Azacitidine|azacitidine|mesh-list
2441720|NCT00915252|Daunorubicin|daunorubicin|mesh-list
2441721|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2441722|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
2441723|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441724|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441725|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
2441726|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441727|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2441728|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
2441729|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441730|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441731|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2441732|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2441733|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2441734|NCT00915369|Paclitaxel|paclitaxel|mesh-list
2441735|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2441736|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441737|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
2441738|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
2441739|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
2441740|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441741|NCT00915382|Cisplatin|cisplatin|mesh-list
2441742|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441743|NCT00915408|Dexamethasone|dexamethasone|mesh-list
2441744|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
2441745|NCT00915408|Lenalidomide|lenalidomide|mesh-list
2441746|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2441747|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
2441748|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207975|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2207976|NCT00009750|Cyclosporins|cyclosporins|mesh-list
2207977|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2207978|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2207979|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
2207980|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
2207981|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
2207982|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2207983|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
2207984|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2207985|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2207986|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2207987|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
2207988|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2207989|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
2207990|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2207991|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2207992|NCT00009763|Cyclosporine|cyclosporine|mesh-list
2207993|NCT00009763|Paclitaxel|paclitaxel|mesh-list
2207994|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2207995|NCT00009763|Antibodies|antibodies|mesh-list
2207996|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
2207997|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2207998|NCT00009763|Cyclosporins|cyclosporins|mesh-list
2207999|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208000|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208001|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
2208002|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
2208003|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208004|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441749|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2441750|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2441751|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
2441752|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441753|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441754|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2441755|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2441756|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
2441757|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
2441758|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441759|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2441760|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
2441761|NCT00915408|Hormones|hormones|mesh-ancestor
2441762|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2441763|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2441764|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2441765|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2441766|NCT00915408|Growth Substances|growth substances|mesh-ancestor
2441767|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
2441768|NCT00915460|Interferons|interferons|mesh-list
2441769|NCT00915460|Interferon-beta|interferon-beta|mesh-list
2441770|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
2441771|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441772|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
2441773|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441774|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
2441775|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441776|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2441777|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2441778|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2441779|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2441780|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2441781|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441782|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2441783|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2441784|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2441785|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
2441786|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441787|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441788|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2441789|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2441790|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
2441791|NCT00915564|Simeprevir|simeprevir|mesh-list
2441792|NCT00915564|Methadone|methadone|mesh-list
2441793|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2441794|NCT00915564|Narcotics|narcotics|mesh-ancestor
2441795|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2441796|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441797|NCT00915564|Analgesics|analgesics|mesh-ancestor
2441798|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
2441799|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441800|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
2441801|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
2441802|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
2441803|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441804|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
2441805|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441806|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441807|NCT00915577|Interferons|interferons|mesh-list
2441808|NCT00915577|Interferon-beta|interferon-beta|mesh-list
2441809|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
2441810|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441811|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
2441812|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441813|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
2441814|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441815|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2441816|NCT00915616|Melatonin|melatonin|mesh-list
2441817|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
2441818|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441819|NCT00915616|Protective Agents|protective agents|mesh-ancestor
2441820|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441821|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2441822|NCT00915681|Silybin|silybin|mesh-list
2441823|NCT00915681|Protective Agents|protective agents|mesh-ancestor
2441824|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441825|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2441826|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441827|NCT00915694|Nelfinavir|nelfinavir|mesh-list
2441828|NCT00915694|Temozolomide|temozolomide|mesh-list
2441829|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2441830|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
2441831|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208005|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
2208006|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208007|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208008|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208009|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
2208010|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208011|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
2208012|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2208013|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2208014|NCT00009776|Cyclosporine|cyclosporine|mesh-list
2208015|NCT00009776|Paclitaxel|paclitaxel|mesh-list
2208016|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2208017|NCT00009776|Antibodies|antibodies|mesh-list
2208018|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
2208019|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2208020|NCT00009776|Cyclosporins|cyclosporins|mesh-list
2208021|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208022|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208023|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
2208024|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
2208025|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208026|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208027|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
2208028|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208029|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208030|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208031|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
2208032|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208033|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
2208034|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2441832|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441833|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2441834|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2441835|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
2441836|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441837|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2208035|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2208036|NCT00009802|Calcitriol|calcitriol|mesh-list
2208037|NCT00009802|Paclitaxel|paclitaxel|mesh-list
2208038|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208039|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208040|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
2208041|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
2208042|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208043|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208044|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2208045|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208046|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2208047|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2208048|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2208049|NCT00009802|Vitamins|vitamins|mesh-ancestor
2208050|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
2208051|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2208052|NCT00009815|Leucovorin|leucovorin|mesh-list
2208053|NCT00009815|Etoposide|etoposide|mesh-list
2208054|NCT00009815|Tegafur|tegafur|mesh-list
2208055|NCT00009815|Calcium|calcium|mesh-list
2208056|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
2208057|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2441838|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2441839|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
2441840|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441841|NCT00915733|Aspirin|aspirin|mesh-list
2441842|NCT00915733|Cilostazol|cilostazol|mesh-list
2441843|NCT00915733|Clopidogrel|clopidogrel|mesh-list
2441844|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2441845|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2441846|NCT00915733|Analgesics|analgesics|mesh-ancestor
2441847|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
2441848|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2441849|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441850|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2441851|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2441852|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2441853|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2441854|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441855|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2441856|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2441857|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441858|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
2441859|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2441860|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2441861|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2441862|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
2441863|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2441864|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2441865|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
2441866|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2441867|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
2441868|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
2441869|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2441870|NCT00915733|Protective Agents|protective agents|mesh-ancestor
2441871|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2441872|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2441873|NCT00915746|Ketoconazole|ketoconazole|mesh-list
2441874|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
2441875|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441876|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2441877|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2441878|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441879|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441880|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2441881|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
2441882|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2441883|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441884|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2441885|NCT00915785|Azacitidine|azacitidine|mesh-list
2441886|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2441887|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
2441888|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441889|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441890|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441891|NCT00915811|Fludarabine|fludarabine|mesh-list
2441892|NCT00915811|Busulfan|busulfan|mesh-list
2441893|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
2441894|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2441895|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441896|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441897|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2441898|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
2441899|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441900|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
2441901|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2441902|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2441903|NCT00915837|Triamcinolone|triamcinolone|mesh-list
2441904|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2441905|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2441906|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2441907|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2441908|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
2441909|NCT00915837|Hormones|hormones|mesh-ancestor
2441910|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2441911|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441912|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2441913|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
2441914|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441915|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441916|NCT00915850|Cisplatin|cisplatin|mesh-list
2441917|NCT00915850|Docetaxel|docetaxel|mesh-list
2441918|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441919|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
2441920|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
2441921|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
2441922|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441923|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2441924|NCT00915915|Gestodene|gestodene|mesh-list
2441925|NCT00915915|Femovan|femovan|mesh-list
2441926|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2441927|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2441928|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2441929|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
2441930|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2441931|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441932|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2441933|NCT00915915|Estrogens|estrogens|mesh-ancestor
2441934|NCT00915915|Hormones|hormones|mesh-ancestor
2441935|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2441936|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2441937|NCT00915915|Progestins|progestins|mesh-ancestor
2441938|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2441939|NCT00916045|Vidarabine|vidarabine|mesh-list
2441940|NCT00916045|Cyclosporine|cyclosporine|mesh-list
2441941|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
2441942|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
2441943|NCT00916045|Melphalan|melphalan|mesh-list
2441944|NCT00916045|Busulfan|busulfan|mesh-list
2441945|NCT00916045|Thiotepa|thiotepa|mesh-list
2441946|NCT00916045|Fludarabine|fludarabine|mesh-list
2441947|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
2441948|NCT00916045|Cyclosporins|cyclosporins|mesh-list
2441949|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
2441950|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2441951|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2441952|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
2441953|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441954|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2441955|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2441956|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
2441957|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441958|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441959|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2441960|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2441961|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
2441962|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
2441963|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2441964|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2441965|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
2441966|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
2441967|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2441968|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2441969|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2441970|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
2441971|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2441972|NCT00916097|Docetaxel|docetaxel|mesh-list
2441973|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441974|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
2441975|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
2441976|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
2441977|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441978|NCT00916123|Prednisone|prednisone|mesh-list
2441979|NCT00916123|Docetaxel|docetaxel|mesh-list
2441980|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2441981|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
2441982|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
2441983|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
2441984|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2441985|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2441986|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
2441987|NCT00916123|Hormones|hormones|mesh-ancestor
2441988|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2441989|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441990|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2441991|NCT00916201|Cannabidiol|cannabidiol|mesh-list
2441992|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
2441993|NCT00916253|Modafinil|modafinil|mesh-list
2441994|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2441995|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2441996|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2441997|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2441998|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2441999|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442000|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
2442001|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2442002|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
2442003|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442004|NCT00916409|Temozolomide|temozolomide|mesh-list
2442005|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2442006|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
2442007|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442008|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442009|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2442010|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2442011|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2442012|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
2442013|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442014|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442015|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2442016|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2442017|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
2442018|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442019|NCT00916461|Minocycline|minocycline|mesh-list
2442020|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2442021|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442022|NCT00916500|Cisplatin|cisplatin|mesh-list
2442023|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442024|NCT00916526|Mannitol|mannitol|mesh-list
2442025|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2442026|NCT00916526|Diuretics|diuretics|mesh-ancestor
2442027|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
2442028|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442029|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
2442030|NCT00916552|Hematinics|hematinics|mesh-ancestor
2442031|NCT00916630|Pemetrexed|pemetrexed|mesh-list
2442032|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442033|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442034|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442035|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2442036|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2442037|NCT00916669|Etoposide|etoposide|mesh-list
2442038|NCT00916669|Enoxaparin|enoxaparin|mesh-list
2442039|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
2442040|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442041|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2442042|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2442043|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2442044|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442045|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442046|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
2442047|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2442048|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2442049|NCT00916695|Everolimus|everolimus|mesh-list
2442050|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442051|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2442052|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
2442053|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442054|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
2442055|NCT00916747|Pravastatin|pravastatin|mesh-list
2442056|NCT00916747|Lonafarnib|lonafarnib|mesh-list
2442057|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2442058|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442059|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2442060|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2442061|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
2442062|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208058|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208059|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208060|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208061|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2208062|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2208063|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208064|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208065|NCT00009815|Antidotes|antidotes|mesh-ancestor
2208066|NCT00009815|Protective Agents|protective agents|mesh-ancestor
2208067|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
2208068|NCT00009815|Vitamins|vitamins|mesh-ancestor
2208069|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
2442063|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2442064|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2442065|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442066|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2442067|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2442068|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
2442069|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442070|NCT00916760|Antacids|antacids|mesh-ancestor
2442071|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442072|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2442073|NCT00916890|Fentanyl|fentanyl|mesh-list
2442074|NCT00916890|Morphine|morphine|mesh-list
2442075|NCT00916890|Oxycodone|oxycodone|mesh-list
2442076|NCT00916890|Buprenorphine|buprenorphine|mesh-list
2442077|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2442078|NCT00916890|Narcotics|narcotics|mesh-ancestor
2442079|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2442080|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442081|NCT00916890|Analgesics|analgesics|mesh-ancestor
2442082|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
2442083|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2442084|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2442085|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2442086|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
2442087|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
2442088|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2442089|NCT00916942|Lidocaine|lidocaine|mesh-list
2442090|NCT00916942|Prilocaine|prilocaine|mesh-list
2208070|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208071|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
2208072|NCT00009828|Leucovorin|leucovorin|mesh-list
2208073|NCT00009828|Paclitaxel|paclitaxel|mesh-list
2208074|NCT00009828|Tegafur|tegafur|mesh-list
2208075|NCT00009828|Calcium|calcium|mesh-list
2208076|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
2208077|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208078|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208079|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
2208080|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
2208081|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208082|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208083|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2208084|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208085|NCT00009828|Antidotes|antidotes|mesh-ancestor
2208086|NCT00009828|Protective Agents|protective agents|mesh-ancestor
2208087|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
2208088|NCT00009828|Vitamins|vitamins|mesh-ancestor
2208089|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
2208090|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208091|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
2208092|NCT00009841|Mitogens|mitogens|mesh-list
2208093|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208094|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208095|NCT00009854|Ethanol|ethanol|mesh-list
2208096|NCT00009854|Carmustine|carmustine|mesh-list
2208097|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2208098|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208099|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2208100|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208101|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2208102|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
2208103|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208104|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208105|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
2442091|NCT00916942|Capsaicin|capsaicin|mesh-list
2442092|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
2442093|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
2442094|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2442095|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442096|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
2442097|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2442098|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2442099|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2442100|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2442101|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2442102|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442103|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
2442104|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
2442105|NCT00917059|Citalopram|citalopram|mesh-list
2442106|NCT00917059|Bupropion|bupropion|mesh-list
2442107|NCT00917059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2442108|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2442109|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2442110|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442111|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442112|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
2442113|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442114|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2442115|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
2442116|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2442117|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2442118|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
2442119|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2442120|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2442121|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442122|NCT00917163|Sirolimus|sirolimus|mesh-list
2442123|NCT00917163|Everolimus|everolimus|mesh-list
2442124|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442125|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2442126|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
2442127|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442128|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2442129|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442130|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2442131|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
2442132|NCT00917241|Dexamethasone|dexamethasone|mesh-list
2442133|NCT00917241|Methimazole|methimazole|mesh-list
2442134|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2442135|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
2442136|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
2442137|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2442138|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442139|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2442140|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
2442141|NCT00917241|Hormones|hormones|mesh-ancestor
2442142|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442143|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2442144|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442145|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
2442146|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
2442147|NCT00917254|Enoxaparin|enoxaparin|mesh-list
2442148|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
2442149|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2442150|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2442151|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442152|NCT00917293|Pyridoxal|pyridoxal|mesh-list
2442153|NCT00917293|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
2442154|NCT00917293|Vitamin B Complex|vitamin b complex|mesh-ancestor
2442155|NCT00917293|Vitamins|vitamins|mesh-ancestor
2442156|NCT00917293|Micronutrients|micronutrients|mesh-ancestor
2442157|NCT00917293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442158|NCT00917345|Captopril|captopril|mesh-list
2442159|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2442160|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
2442161|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442162|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442163|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2442164|NCT00917358|Interferons|interferons|mesh-list
2442165|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
2442166|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
2442167|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2442168|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442169|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
2442170|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442171|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
2442172|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442173|NCT00917397|Sertraline|sertraline|mesh-list
2442174|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
2442175|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2442176|NCT00917397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2442177|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2442178|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2442179|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442180|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442181|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
2442182|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442183|NCT00917527|Atorvastatin|atorvastatin|mesh-list
2442184|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2442185|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2442186|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
2442187|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442188|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2442189|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2442190|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442191|NCT00917592|Amoxicillin|amoxicillin|mesh-list
2442192|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
2442193|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
2442194|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2442195|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442196|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442197|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442198|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2442199|NCT00917748|Docetaxel|docetaxel|mesh-list
2442200|NCT00917748|Modafinil|modafinil|mesh-list
2442201|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442202|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
2442203|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
2442204|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
2442205|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442206|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2442207|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442208|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2442209|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2442210|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2442211|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2442212|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
2442213|NCT00917761|Entecavir|entecavir|mesh-list
2442214|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
2442215|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442216|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
2442217|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442218|NCT00917826|Valganciclovir|valganciclovir|mesh-list
2442219|NCT00917826|Ganciclovir|ganciclovir|mesh-list
2442220|NCT00917826|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2442221|NCT00917826|Arginine butyrate|arginine butyrate|mesh-list
2442222|NCT00917826|Antiviral Agents|antiviral agents|mesh-ancestor
2442223|NCT00917826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442224|NCT00917826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2442225|NCT00917826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442226|NCT00917826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442227|NCT00917826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442228|NCT00917839|Lamotrigine|lamotrigine|mesh-list
2442229|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
2442230|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2442231|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2442232|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442233|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2442234|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442235|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2442236|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2442237|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2442238|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2442239|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2442240|NCT00917878|Calcium|calcium|mesh-list
2442241|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2442242|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442243|NCT00917891|Dapivirine|dapivirine|mesh-list
2442244|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2442245|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2442246|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
2442247|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442248|NCT00917904|Dapivirine|dapivirine|mesh-list
2442249|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2442250|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2442251|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
2442252|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442253|NCT00918021|Olanzapine|olanzapine|mesh-list
2442254|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
2442255|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
2442256|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2442257|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442258|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2442259|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2442260|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2442261|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2442262|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2442263|NCT00918021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2442264|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2442265|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2442266|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442267|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442268|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
2442269|NCT00918034|Talaporfin|talaporfin|mesh-list
2442270|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442271|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2442272|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
2442273|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
2442274|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
2442275|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2442276|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2442277|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2442278|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442279|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2442280|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2442281|NCT00918086|Vitamin D|vitamin d|mesh-list
2442282|NCT00918086|Vitamins|vitamins|mesh-ancestor
2442283|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
2442284|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442285|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2442286|NCT00918177|Levodopa|levodopa|mesh-list
2442287|NCT00918177|Carbidopa|carbidopa|mesh-list
2442288|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2442289|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2442290|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2442291|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
2442292|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442293|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442294|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442295|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2442296|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442297|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2442298|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
2442299|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
2442300|NCT00918190|Dexamethasone|dexamethasone|mesh-list
2442301|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
2442302|NCT00918190|Midazolam|midazolam|mesh-list
2442303|NCT00918190|Ondansetron|ondansetron|mesh-list
2442304|NCT00918190|BB 1101|bb 1101|mesh-list
2442305|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2442306|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
2442307|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
2442308|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2442309|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442310|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2442311|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
2442312|NCT00918190|Hormones|hormones|mesh-ancestor
2442313|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442314|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2442315|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442316|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
2442317|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442318|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442319|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2442320|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2442321|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2442322|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2442323|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2442324|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2442325|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2442326|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
2442327|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
2442328|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
2442329|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
2442330|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442331|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
2442332|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
2442333|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2442334|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
2442335|NCT00918190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2442336|NCT00918307|Varenicline|varenicline|mesh-list
2442337|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2442338|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2442339|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
2442340|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442341|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442342|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442343|NCT00918320|Temozolomide|temozolomide|mesh-list
2442344|NCT00918320|Topotecan|topotecan|mesh-list
2442345|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2442346|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
2442347|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442348|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442349|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2442350|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2442351|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442352|NCT00918411|Ramosetron|ramosetron|mesh-list
2442353|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
2442354|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
2442355|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2442356|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442357|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2442358|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2442359|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
2442360|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442361|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442362|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
2442363|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
2442364|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2442365|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2442366|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2442367|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442368|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2442369|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2442370|NCT00918450|Navitoclax|navitoclax|mesh-list
2442371|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442372|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
2442373|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
2442374|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2442375|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442376|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2442377|NCT00918489|Vorinostat|vorinostat|mesh-list
2442378|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442379|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2442380|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442381|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442382|NCT00918528|Mitomycins|mitomycins|mesh-list
2442383|NCT00918528|Mitomycin|mitomycin|mesh-list
2442384|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2442385|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442386|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
2442387|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442388|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2442389|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442390|NCT00918554|Methotrexate|methotrexate|mesh-list
2442391|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2442392|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
2442393|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2442394|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442395|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2442396|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
2442397|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442398|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442399|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
2442400|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442401|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2442402|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2442403|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
2442404|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2442405|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2442406|NCT00918593|Bleomycin|bleomycin|mesh-list
2442407|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2442408|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442409|NCT00918632|Axitinib|axitinib|mesh-list
2442410|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442411|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2442412|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442413|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442414|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2442415|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
2442416|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442417|NCT00918853|Pancrelipase|pancrelipase|mesh-list
2442418|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2442419|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
2442420|NCT00919022|Cyproterone|cyproterone|mesh-list
2442421|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
2442422|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
2442423|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442424|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442425|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442426|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2442427|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
2442428|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2442429|NCT00919178|Vaccines|vaccines|mesh-list
2442430|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
2442431|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442432|NCT00919204|Axitinib|axitinib|mesh-list
2442433|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442434|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2442435|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442436|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442437|NCT00919243|Prednisone|prednisone|mesh-list
2442438|NCT00919243|Allopurinol|allopurinol|mesh-list
2442439|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2442440|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
2442441|NCT00919243|Hormones|hormones|mesh-ancestor
2442442|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442443|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442444|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2442445|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442446|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
2442447|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442448|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442449|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
2442450|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2442451|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2442452|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
2442453|NCT00919243|Protective Agents|protective agents|mesh-ancestor
2442454|NCT00919282|Leucovorin|leucovorin|mesh-list
2442455|NCT00919282|Folic Acid|folic acid|mesh-list
2442456|NCT00919282|Gemcitabine|gemcitabine|mesh-list
2442457|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
2442458|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2442459|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
2442460|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442461|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442462|NCT00919282|Antiviral Agents|antiviral agents|mesh-ancestor
2442463|NCT00919282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442464|NCT00919282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442465|NCT00919282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2442466|NCT00919282|Immunologic Factors|immunologic factors|mesh-ancestor
2442467|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442468|NCT00919282|Antidotes|antidotes|mesh-ancestor
2442469|NCT00919282|Protective Agents|protective agents|mesh-ancestor
2442470|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
2442471|NCT00919282|Vitamins|vitamins|mesh-ancestor
2442472|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
2442473|NCT00919282|Hematinics|hematinics|mesh-ancestor
2442474|NCT00919295|Mirtazapine|mirtazapine|mesh-list
2442475|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
2442476|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2442477|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2442478|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
2442479|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
2442480|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442481|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442482|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442483|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2442484|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2442485|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2442486|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2442487|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2442488|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2442489|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
2442490|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2442491|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2442492|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
2442493|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2442494|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2442495|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
2442496|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442497|NCT00919399|Tamoxifen|tamoxifen|mesh-list
2442498|NCT00919399|Exemestane|exemestane|mesh-list
2442499|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2442500|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
2442501|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442502|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442503|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2442504|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442505|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2442506|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2442507|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2442508|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2442509|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2442510|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442511|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442512|NCT00919438|Diuretics|diuretics|mesh-list
2442513|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
2442514|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442515|NCT00919451|Cyclosporine|cyclosporine|mesh-list
2442516|NCT00919451|Cyclosporins|cyclosporins|mesh-list
2442517|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442518|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442519|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2442520|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
2442521|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442522|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
2442523|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442524|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
2442525|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2442526|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2442527|NCT00919542|Cyclosporine|cyclosporine|mesh-list
2442528|NCT00919542|Prednisolone|prednisolone|mesh-list
2442529|NCT00919542|Cyclosporins|cyclosporins|mesh-list
2442530|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442531|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442532|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2442533|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
2442534|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442535|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
2442536|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442537|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
2442538|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2442539|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2442540|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2442541|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
2442542|NCT00919542|Hormones|hormones|mesh-ancestor
2442543|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442544|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2442545|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442546|NCT00919555|Pioglitazone|pioglitazone|mesh-list
2442547|NCT00919555|Tretinoin|tretinoin|mesh-list
2442548|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2442549|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442550|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442551|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
2442552|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
2442553|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2442554|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
2442555|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2442556|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2442557|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2442558|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2442559|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442560|NCT00919776|Cyclosporine|cyclosporine|mesh-list
2442561|NCT00919776|Prednisolone|prednisolone|mesh-list
2442562|NCT00919776|Cyclosporins|cyclosporins|mesh-list
2442563|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442564|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442565|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2442566|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
2442567|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442568|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
2442569|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442570|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
2442571|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2442572|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2442573|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2442574|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
2442575|NCT00919776|Hormones|hormones|mesh-ancestor
2442576|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442577|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2442578|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442579|NCT00919815|Cyclosporine|cyclosporine|mesh-list
2442580|NCT00919815|Prednisolone|prednisolone|mesh-list
2442581|NCT00919815|Cyclosporins|cyclosporins|mesh-list
2442582|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442583|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442584|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2442585|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
2442586|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442587|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
2442588|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442589|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
2442590|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2442591|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2442592|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2442593|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
2442594|NCT00919815|Hormones|hormones|mesh-ancestor
2442595|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442596|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2442597|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442598|NCT00919880|Paclitaxel|paclitaxel|mesh-list
2442599|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2442600|NCT00919880|Carboplatin|carboplatin|mesh-list
2442601|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2442602|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442603|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
2442604|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
2442605|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
2442606|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442607|NCT00919919|Progesterone|progesterone|mesh-list
2442608|NCT00919919|Progestins|progestins|mesh-ancestor
2442609|NCT00919919|Hormones|hormones|mesh-ancestor
2442610|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442611|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442612|NCT00919984|Paclitaxel|paclitaxel|mesh-list
2442613|NCT00919984|Carboplatin|carboplatin|mesh-list
2442614|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2442615|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442616|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
2442617|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
2442618|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
2442619|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442620|NCT00920088|Ritonavir|ritonavir|mesh-list
2442621|NCT00920088|Lopinavir|lopinavir|mesh-list
2442622|NCT00920088|Darunavir|darunavir|mesh-list
2442623|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
2442624|NCT00920088|Midazolam|midazolam|mesh-list
2442625|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
2442626|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2442627|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2442628|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2442629|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442630|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2442631|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2442632|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2442633|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2442634|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
2442635|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
2442636|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
2442637|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
2442638|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442639|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442640|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2442641|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2442642|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
2442643|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442644|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2442645|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2442646|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
2442647|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442648|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2442649|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2442650|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
2442651|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
2442652|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2442653|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2442654|NCT00920088|Analgesics|analgesics|mesh-ancestor
2442655|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
2442656|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2442657|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2442658|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2442659|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2442660|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2442661|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2442662|NCT00920101|Atorvastatin|atorvastatin|mesh-list
2442663|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2442664|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2442665|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
2442666|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442667|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2442668|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2442669|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442670|NCT00920153|Gemcitabine|gemcitabine|mesh-list
2442671|NCT00920153|Cytarabine|cytarabine|mesh-list
2442672|NCT00920153|Dexamethasone|dexamethasone|mesh-list
2442673|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
2442674|NCT00920153|Doxorubicin|doxorubicin|mesh-list
2442675|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2442676|NCT00920153|Etoposide|etoposide|mesh-list
2442677|NCT00920153|Vincristine|vincristine|mesh-list
2442678|NCT00920153|Melphalan|melphalan|mesh-list
2442679|NCT00920153|Vinorelbine|vinorelbine|mesh-list
2442680|NCT00920153|Ifosfamide|ifosfamide|mesh-list
2442681|NCT00920153|Dacarbazine|dacarbazine|mesh-list
2442682|NCT00920153|Carmustine|carmustine|mesh-list
2442683|NCT00920153|Bleomycin|bleomycin|mesh-list
2442684|NCT00920153|Vindesine|vindesine|mesh-list
2442685|NCT00920153|Mitoguazone|mitoguazone|mesh-list
2442686|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442687|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2442688|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
2442689|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
2442690|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2442691|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442692|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2442693|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
2442694|NCT00920153|Hormones|hormones|mesh-ancestor
2442695|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442696|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2442697|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2442698|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
2442699|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442700|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
2442701|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442702|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442703|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2442704|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
2442705|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2442706|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2442707|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2442708|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2442709|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
2442710|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
2442711|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
2442712|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2442713|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
2442714|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2442715|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2442716|NCT00920153|Protective Agents|protective agents|mesh-ancestor
2442717|NCT00920244|Atropine|atropine|mesh-list
2442718|NCT00920244|Amiodarone|amiodarone|mesh-list
2442719|NCT00920244|Epinephrine|epinephrine|mesh-list
2442720|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2442721|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2442722|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
2442723|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442724|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442725|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442726|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2442727|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2442728|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
2442729|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2442730|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2442731|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
2442732|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
2442733|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
2442734|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2442735|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2442736|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2442737|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
2442738|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2442739|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2442740|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
2442741|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
2442742|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2442743|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2442744|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2442745|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2442746|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2442747|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442748|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2442749|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2442750|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2442751|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2442752|NCT00920270|Colistin|colistin|mesh-list
2442753|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442754|NCT00920283|Cobalt|cobalt|mesh-list
2442755|NCT00920283|Trace Elements|trace elements|mesh-ancestor
2442756|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
2442757|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442758|NCT00920296|Cabotegravir|cabotegravir|mesh-list
2442759|NCT00920296|Etravirine|etravirine|mesh-list
2442760|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2442761|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2442762|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442763|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442764|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2442765|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2442766|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
2442767|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442768|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2442769|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2442770|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2442771|NCT00920361|Hormones|hormones|mesh-ancestor
2442772|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442773|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442783|NCT00920413|Ascorbic Acid|ascorbic acid|mesh-list
2442784|NCT00920413|Vitamins|vitamins|mesh-ancestor
2442785|NCT00920413|Micronutrients|micronutrients|mesh-ancestor
2442786|NCT00920413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442787|NCT00920413|Antioxidants|antioxidants|mesh-ancestor
2208106|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208107|NCT00009880|Paclitaxel|paclitaxel|mesh-list
2208108|NCT00009880|Fluorouracil|fluorouracil|mesh-list
2208109|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208110|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208111|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
2442788|NCT00920413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442789|NCT00920413|Protective Agents|protective agents|mesh-ancestor
2442790|NCT00920465|Misoprostol|misoprostol|mesh-list
2442791|NCT00920465|Mifepristone|mifepristone|mesh-list
2442792|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2442793|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
2442794|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2442795|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442796|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2442797|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2442798|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
2442799|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2442800|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2442801|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2442802|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2442803|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
2442804|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2442805|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2442806|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
2442807|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442808|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
2442809|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2442810|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2442811|NCT00920608|Methotrexate|methotrexate|mesh-list
2442812|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2442813|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
2442814|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2442815|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442816|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2442817|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
2442818|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442819|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442820|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
2442821|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442822|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2442823|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2442824|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
2442825|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2442826|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2442827|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2442828|NCT00920634|Hormones|hormones|mesh-ancestor
2442829|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442830|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442831|NCT00920660|Prednisolone|prednisolone|mesh-list
2442832|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2442833|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
2442834|NCT00920660|Hormones|hormones|mesh-ancestor
2442835|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442836|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442837|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2442838|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442839|NCT00920725|Insulin|insulin|mesh-list
2442840|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2442841|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
2442842|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2442843|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442844|NCT00920764|Atrasentan|atrasentan|mesh-list
2442845|NCT00920764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442846|NCT00920764|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
2442847|NCT00920764|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2442848|NCT00920764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442849|NCT00920803|Resveratrol|resveratrol|mesh-list
2442850|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
2208112|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
2208113|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208114|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208115|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
2442851|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442852|NCT00920803|Protective Agents|protective agents|mesh-ancestor
2442853|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442854|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442855|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2442856|NCT00920868|Bevacizumab|bevacizumab|mesh-list
2442857|NCT00920868|Capecitabine|capecitabine|mesh-list
2442858|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
2442859|NCT00920868|Dasatinib|dasatinib|mesh-list
2442860|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2442861|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442862|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2442863|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2442864|NCT00920868|Growth Substances|growth substances|mesh-ancestor
2442865|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442866|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
2442867|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2442868|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
2442869|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442870|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2442871|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442872|NCT00920933|Prednisolone|prednisolone|mesh-list
2442873|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2442874|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
2442875|NCT00920933|Hormones|hormones|mesh-ancestor
2442876|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442877|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442878|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2442879|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442880|NCT00920985|Contraceptive Agents|contraceptive agents|mesh-list
2442881|NCT00920985|Gestodene|gestodene|mesh-list
2442882|NCT00920985|Contraceptives, Oral|contraceptives, oral|mesh-list
2442883|NCT00920985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2442884|NCT00920985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442885|NCT00920985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2442886|NCT00920985|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2442887|NCT00920985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2442888|NCT00920985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2442889|NCT00920985|Progestins|progestins|mesh-ancestor
2442890|NCT00920985|Hormones|hormones|mesh-ancestor
2442891|NCT00920985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2442892|NCT00920998|Z 338|z 338|mesh-list
2442893|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2442894|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442895|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442896|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
2442897|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442898|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442899|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2442900|NCT00921063|Alprazolam|alprazolam|mesh-list
2442901|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2442902|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2442903|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442904|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2442905|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2442906|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2442907|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
2442908|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
2442909|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442910|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442911|NCT00921102|Atropine|atropine|mesh-list
2442912|NCT00921102|Morphine|morphine|mesh-list
2442913|NCT00921102|Bupivacaine|bupivacaine|mesh-list
2442914|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
2442915|NCT00921102|Anesthetics|anesthetics|mesh-list
2442916|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2442917|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442918|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
2442919|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2442920|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2442921|NCT00921102|Narcotics|narcotics|mesh-ancestor
2442922|NCT00921102|Analgesics|analgesics|mesh-ancestor
2442923|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2442924|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2442925|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2442926|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
2442927|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2442928|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
2442929|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
2442930|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
2442931|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2442932|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2442933|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
2442934|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442935|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442936|NCT00921128|Muscimol|muscimol|mesh-list
2442937|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2442938|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
2442939|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
2442940|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442941|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442942|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442943|NCT00921154|Ivermectin|ivermectin|mesh-list
2442944|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2442945|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442946|NCT00921167|Bevacizumab|bevacizumab|mesh-list
2442947|NCT00921167|Irinotecan|irinotecan|mesh-list
2442948|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2442949|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2442950|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2442951|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2442952|NCT00921167|Growth Substances|growth substances|mesh-ancestor
2442953|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442954|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
2442955|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2442956|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2442957|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2442958|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442959|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2442960|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
2442961|NCT00921180|Entecavir|entecavir|mesh-list
2442962|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
2208116|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208117|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208118|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
2208119|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208120|NCT00009893|Leucovorin|leucovorin|mesh-list
2208121|NCT00009893|Gemcitabine|gemcitabine|mesh-list
2208122|NCT00009893|Fluorouracil|fluorouracil|mesh-list
2208123|NCT00009893|Calcium|calcium|mesh-list
2208124|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
2208125|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208126|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
2208127|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208128|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208129|NCT00009893|Antiviral Agents|antiviral agents|mesh-ancestor
2208130|NCT00009893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442963|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442964|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
2442965|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442966|NCT00921219|Ivermectin|ivermectin|mesh-list
2442967|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2442968|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2442969|NCT00921245|Darifenacin|darifenacin|mesh-list
2442970|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2442971|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2442972|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
2442973|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442974|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442975|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442976|NCT00921245|Urological Agents|urological agents|mesh-ancestor
2442977|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
2442978|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2442979|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2442980|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442981|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2442982|NCT00921284|Analgesics|analgesics|mesh-ancestor
2442983|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
2442984|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2442985|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2442986|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2442987|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2442988|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
2442989|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442990|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442991|NCT00921349|Nadolol|nadolol|mesh-list
2442992|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2442993|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2442994|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
2442995|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2442996|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2442997|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2442998|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2442999|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2443000|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
2443001|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
2443002|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443003|NCT00921388|Varenicline|varenicline|mesh-list
2443004|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2443005|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2443006|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
2443007|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443008|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443009|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443010|NCT00921414|Rituximab|rituximab|mesh-list
2443011|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2443012|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443013|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
2443014|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443015|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2443016|NCT00921505|Acetaminophen|acetaminophen|mesh-list
2443017|NCT00921505|Ibuprofen|ibuprofen|mesh-list
2443018|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2443019|NCT00921505|Analgesics|analgesics|mesh-ancestor
2443020|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
2443021|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443022|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443023|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
2443024|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2443025|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2443026|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2443027|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2443028|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443029|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443030|NCT00921531|Thalidomide|thalidomide|mesh-list
2443031|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2443032|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
2443033|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443034|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
2443035|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2443036|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443037|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2443038|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2443039|NCT00921531|Growth Substances|growth substances|mesh-ancestor
2443040|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
2443041|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443042|NCT00921570|Amlodipine|amlodipine|mesh-list
2443043|NCT00921570|Valsartan|valsartan|mesh-list
2443044|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2443045|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2443046|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2443047|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443048|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2443049|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443050|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
2443051|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2443052|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2443053|NCT00921622|Vitamin D|vitamin d|mesh-list
2443054|NCT00921622|Vitamins|vitamins|mesh-list
2443055|NCT00921622|Ascorbic Acid|ascorbic acid|mesh-list
2443056|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
2443057|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443058|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2443059|NCT00921622|Antioxidants|antioxidants|mesh-ancestor
2443060|NCT00921622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443061|NCT00921622|Protective Agents|protective agents|mesh-ancestor
2443062|NCT00921661|Aflibercept|aflibercept|mesh-list
2443063|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2443064|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2443065|NCT00921661|Growth Substances|growth substances|mesh-ancestor
2443066|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443067|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
2443068|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443069|NCT00921674|Ivermectin|ivermectin|mesh-list
2443070|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2443071|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443072|NCT00921700|Acetaminophen|acetaminophen|mesh-list
2443073|NCT00921700|Ibuprofen|ibuprofen|mesh-list
2443074|NCT00921700|Codeine|codeine|mesh-list
2443075|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2443076|NCT00921700|Analgesics|analgesics|mesh-ancestor
2443077|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
2443078|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443079|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443080|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
2443081|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2443082|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2443083|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2443084|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2443085|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443086|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443087|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2443088|NCT00921700|Narcotics|narcotics|mesh-ancestor
2443089|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443090|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
2443091|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
2443092|NCT00921726|Oseltamivir|oseltamivir|mesh-list
2443093|NCT00921726|Zanamivir|zanamivir|mesh-list
2443094|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
2443095|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443096|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443097|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443098|NCT00921765|Ketamine|ketamine|mesh-list
2443099|NCT00921765|Naloxone|naloxone|mesh-list
2443100|NCT00921765|Analgesics|analgesics|mesh-ancestor
2443101|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
2443102|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443103|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443104|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2443105|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2443106|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
2443107|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
2443108|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443109|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2443110|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2443111|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443112|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443113|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2443114|NCT00921804|Risperidone|risperidone|mesh-list
2443115|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2443116|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
2443117|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443118|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443119|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443120|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2443121|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2443122|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443123|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2443124|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2443125|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
2443126|NCT00921830|Ibuprofen|ibuprofen|mesh-list
2443127|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2443128|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2443129|NCT00921830|Analgesics|analgesics|mesh-ancestor
2443130|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
2443131|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443132|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443133|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2443134|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2443135|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2443136|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443137|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443145|NCT00921973|Vaccines|vaccines|mesh-list
2443146|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
2443147|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443148|NCT00922129|Cyclosporine|cyclosporine|mesh-list
2443149|NCT00922129|Sirolimus|sirolimus|mesh-list
2443150|NCT00922129|Tacrolimus|tacrolimus|mesh-list
2443151|NCT00922129|Cyclosporins|cyclosporins|mesh-list
2443152|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2443153|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
2443154|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443155|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2443156|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443157|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443158|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
2443159|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443160|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
2443161|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2443162|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2443163|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2443164|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443165|NCT00922389|Lenograstim|lenograstim|mesh-list
2443166|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2443167|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
2443168|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443169|NCT00922402|Insulin|insulin|mesh-list
2443170|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2443171|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443172|NCT00922467|Esmolol|esmolol|mesh-list
2443173|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2443174|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2443175|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2443176|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
2443177|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443178|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443179|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443180|NCT00922506|Doxazosin|doxazosin|mesh-list
2443181|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2443182|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2443183|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2443184|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
2443185|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443186|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443187|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443188|NCT00922506|Urological Agents|urological agents|mesh-ancestor
2443189|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2443190|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2443191|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2443192|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2443193|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
2443194|NCT00922519|Listerine|listerine|mesh-list
2443195|NCT00922519|Fluorides|fluorides|mesh-list
2443196|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
2443197|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
2443198|NCT00922519|Protective Agents|protective agents|mesh-ancestor
2443199|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443200|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2443201|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443202|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
2443203|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2443204|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
2443205|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443206|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443207|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2443208|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
2443209|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2443210|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
2443211|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443212|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443213|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2443214|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
2443215|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
2443216|NCT00922532|Protective Agents|protective agents|mesh-ancestor
2443217|NCT00922584|Sorafenib|sorafenib|mesh-list
2443218|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443219|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2443220|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443221|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443222|NCT00922597|Factor VIII|factor viii|mesh-list
2443223|NCT00922597|Coagulants|coagulants|mesh-ancestor
2443224|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
2443225|NCT00922610|Hematinics|hematinics|mesh-ancestor
2443226|NCT00922649|Insulin|insulin|mesh-list
2443227|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2443228|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443229|NCT00922844|Sevoflurane|sevoflurane|mesh-list
2443230|NCT00922844|Isoflurane|isoflurane|mesh-list
2443231|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2443232|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2443233|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
2443234|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
2443235|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443236|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443237|NCT00922896|Gemcitabine|gemcitabine|mesh-list
2443238|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2443239|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443240|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2443241|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
2443242|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443243|NCT00922896|Antiviral Agents|antiviral agents|mesh-ancestor
2443244|NCT00922896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443245|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443246|NCT00922896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2443247|NCT00922896|Immunologic Factors|immunologic factors|mesh-ancestor
2443248|NCT00922896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443249|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2443250|NCT00923000|Morphine|morphine|mesh-list
2443251|NCT00923000|Nalbuphine|nalbuphine|mesh-list
2443252|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2443253|NCT00923000|Narcotics|narcotics|mesh-ancestor
2443254|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443255|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443256|NCT00923000|Analgesics|analgesics|mesh-ancestor
2443257|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
2443258|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443259|NCT00923169|Mitogens|mitogens|mesh-list
2443260|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
2443261|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443262|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
2443263|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2443264|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443265|NCT00923234|Lenalidomide|lenalidomide|mesh-list
2443266|NCT00923234|Azacitidine|azacitidine|mesh-list
2443267|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
2443268|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443269|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2443270|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2443271|NCT00923234|Growth Substances|growth substances|mesh-ancestor
2443272|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
2443273|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443274|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208131|NCT00009893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208132|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208133|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
2208134|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208135|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2208136|NCT00009893|Antidotes|antidotes|mesh-ancestor
2208137|NCT00009893|Protective Agents|protective agents|mesh-ancestor
2208138|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
2208139|NCT00009893|Vitamins|vitamins|mesh-ancestor
2208140|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
2208141|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
2208142|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208143|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2208144|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443275|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
2443276|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443277|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443278|NCT00923247|Bortezomib|bortezomib|mesh-list
2443279|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443280|NCT00923299|Trastuzumab|trastuzumab|mesh-list
2443281|NCT00923299|Cetuximab|cetuximab|mesh-list
2443282|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2443283|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443284|NCT00923390|Aldesleukin|aldesleukin|mesh-list
2443285|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
2443286|NCT00923390|Fludarabine|fludarabine|mesh-list
2443287|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2443288|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
2443289|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443290|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2443291|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2443292|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
2443293|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443294|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443295|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2443296|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2443297|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2443298|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
2443299|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443300|NCT00923494|Ropivacaine|ropivacaine|mesh-list
2443301|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
2443302|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
2443303|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443304|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443305|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
2443306|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443307|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2443308|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2443309|NCT00923533|Diuretics|diuretics|mesh-ancestor
2443310|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
2443311|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443312|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2443313|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2443314|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443315|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2443316|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2443317|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443318|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
2443319|NCT00923637|Pemetrexed|pemetrexed|mesh-list
2443320|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443321|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443322|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443323|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2443324|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2443325|NCT00923663|Lenalidomide|lenalidomide|mesh-list
2443326|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
2443327|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443328|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2443329|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2443330|NCT00923663|Growth Substances|growth substances|mesh-ancestor
2443331|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
2443332|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443333|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2443334|NCT00923676|Fenofibrate|fenofibrate|mesh-list
2443335|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2443336|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2443337|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
2443338|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443339|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2443340|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2443341|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443342|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
2443343|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443344|NCT00923806|Aldesleukin|aldesleukin|mesh-list
2443345|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443346|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2443347|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2443348|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
2443349|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443350|NCT00923962|Adenosine|adenosine|mesh-list
2443351|NCT00923962|Glucagon|glucagon|mesh-list
2443352|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2443353|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2443354|NCT00923962|Hormones|hormones|mesh-ancestor
2443355|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2443356|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443357|NCT00923962|Incretins|incretins|mesh-ancestor
2443358|NCT00923962|Analgesics|analgesics|mesh-ancestor
2443359|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
2443360|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443361|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2443362|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
2443363|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2443364|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
2443365|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
2443366|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443367|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443368|NCT00924014|Furosemide|furosemide|mesh-list
2443369|NCT00924014|Conivaptan|conivaptan|mesh-list
2443370|NCT00924014|Diuretics|diuretics|mesh-ancestor
2443371|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
2443372|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443373|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2443374|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2443375|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443376|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2443377|NCT00924079|Nalbuphine|nalbuphine|mesh-list
2443378|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2443379|NCT00924079|Narcotics|narcotics|mesh-ancestor
2443380|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443381|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443382|NCT00924079|Analgesics|analgesics|mesh-ancestor
2443383|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
2443384|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443385|NCT00924222|Propofol|propofol|mesh-list
2443386|NCT00924222|Sevoflurane|sevoflurane|mesh-list
2443387|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2443388|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443389|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443390|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2443391|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
2443392|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
2443393|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2443394|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2443395|NCT00924430|Simvastatin|simvastatin|mesh-list
2443396|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2443397|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2443398|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
2443399|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443400|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2443401|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2443402|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443403|NCT00924573|Metformin|metformin|mesh-list
2443404|NCT00924573|Glimepiride|glimepiride|mesh-list
2443405|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2443406|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443407|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2443408|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2443409|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
2443410|NCT00924586|Landiolol|landiolol|mesh-list
2443411|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2443412|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2443413|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
2443414|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443415|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443416|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443417|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2443418|NCT00924742|Tazobactam|tazobactam|mesh-list
2443419|NCT00924742|Piperacillin|piperacillin|mesh-list
2443420|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2443421|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443422|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2443423|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443424|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443425|NCT00924755|Caffeine|caffeine|mesh-list
2443426|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2443427|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443428|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2443429|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443430|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443431|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2443432|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2443433|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
2443434|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443435|NCT00924963|Lidocaine|lidocaine|mesh-list
2443436|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
2443437|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
2443438|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443439|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443440|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
2443441|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443442|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2443443|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2443444|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2443445|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2443446|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443447|NCT00925028|Warfarin|warfarin|mesh-list
2443448|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
2443449|NCT00925093|Vancomycin|vancomycin|mesh-list
2443450|NCT00925093|Linezolid|linezolid|mesh-list
2443451|NCT00925093|Teicoplanin|teicoplanin|mesh-list
2443452|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2443453|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443454|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2443455|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443456|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443457|NCT00925106|Celecoxib|celecoxib|mesh-list
2443458|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2443459|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2443460|NCT00925106|Analgesics|analgesics|mesh-ancestor
2443461|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
2443462|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443463|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443464|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2443465|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2443466|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2443467|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2443468|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443469|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443470|NCT00925314|Vaccines|vaccines|mesh-list
2443471|NCT00925314|Immunologic Factors|immunologic factors|mesh-ancestor
2443472|NCT00925314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443473|NCT00925327|Riboflavin|riboflavin|mesh-list
2443474|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
2443475|NCT00925327|Vitamins|vitamins|mesh-ancestor
2443476|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
2443477|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443478|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2443479|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
2443480|NCT00925392|Doripenem|doripenem|mesh-list
2443481|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2443482|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443483|NCT00925457|Domperidone|domperidone|mesh-list
2443484|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2443485|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443486|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443487|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
2443488|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
2443489|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443490|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443491|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2443492|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2443493|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
2443494|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443495|NCT00925535|Rifabutin|rifabutin|mesh-list
2443496|NCT00925535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2443497|NCT00925535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443498|NCT00925535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2443499|NCT00925535|Antitubercular Agents|antitubercular agents|mesh-ancestor
2443526|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
2443527|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2443528|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2443529|NCT00925730|Analgesics|analgesics|mesh-ancestor
2443530|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
2443531|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443532|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443533|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2443534|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2443535|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
2443536|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2443537|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
2443538|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2443539|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443540|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443541|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
2443542|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
2443543|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2443544|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443545|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443546|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
2443547|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2443548|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443549|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443550|NCT00925873|Vidarabine|vidarabine|mesh-list
2443551|NCT00925873|Fludarabine|fludarabine|mesh-list
2443552|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
2443553|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443554|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2443555|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
2443556|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443557|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2443558|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
2443559|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443560|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
2443561|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443562|NCT00925912|Bupivacaine|bupivacaine|mesh-list
2443563|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
2443564|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
2443565|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443566|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443567|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
2443568|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443569|NCT00925951|Acetaminophen|acetaminophen|mesh-list
2443570|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2443571|NCT00925951|Analgesics|analgesics|mesh-ancestor
2443572|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
2443573|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443574|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443575|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
2443576|NCT00925977|Insulin|insulin|mesh-list
2443577|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2443578|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
2443579|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
2443580|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
2443581|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
2443582|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
2443583|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2443584|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443585|NCT00926016|Pioglitazone|pioglitazone|mesh-list
2443586|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2443587|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443588|NCT00926055|Simvastatin|simvastatin|mesh-list
2443589|NCT00926055|Ezetimibe|ezetimibe|mesh-list
2443590|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2443591|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2443592|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2443593|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
2443594|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443595|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2443596|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2443597|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443598|NCT00926107|Sirolimus|sirolimus|mesh-list
2443599|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2443600|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443601|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2443602|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443603|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
2443604|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2443605|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
2443606|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443607|NCT00926302|Levetiracetam|levetiracetam|mesh-list
2443608|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
2443609|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
2443610|NCT00926315|Calcitriol|calcitriol|mesh-list
2443611|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2443612|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443613|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2443614|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2443615|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443616|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2443617|NCT00926315|Vitamins|vitamins|mesh-ancestor
2443618|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
2443619|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2443620|NCT00926341|Pioglitazone|pioglitazone|mesh-list
2443621|NCT00926341|Telmisartan|telmisartan|mesh-list
2443622|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2443623|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443624|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2443625|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2443626|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2443627|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443628|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
2443629|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2443630|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
2443631|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443632|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443633|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2443634|NCT00926354|Protective Agents|protective agents|mesh-ancestor
2443635|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2443636|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2443637|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443638|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443639|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
2443640|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443641|NCT00926419|Vaccines|vaccines|mesh-list
2443642|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
2443643|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443644|NCT00926614|Pioglitazone|pioglitazone|mesh-list
2443645|NCT00926614|Atorvastatin|atorvastatin|mesh-list
2443646|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2443647|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2443648|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
2443649|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443650|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2443651|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2443652|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443653|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2443654|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443655|NCT00926627|Bosentan|bosentan|mesh-list
2443656|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2443657|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2443658|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443659|NCT00926640|Etoposide|etoposide|mesh-list
2443660|NCT00926640|Belinostat|belinostat|mesh-list
2443661|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443662|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2443663|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2443664|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2443665|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443666|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443667|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2443668|NCT00926653|Citalopram|citalopram|mesh-list
2443669|NCT00926653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2443670|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2443671|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2443672|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443673|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443674|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
2443675|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443676|NCT00926653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2443677|NCT00926653|Antidepressive Agents|antidepressive agents|mesh-ancestor
2443678|NCT00926653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2443679|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
2443680|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
2443681|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
2443682|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443683|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443684|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
2443685|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443686|NCT00926705|Fentanyl|fentanyl|mesh-list
2443687|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
2443688|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2443689|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443690|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443691|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2443692|NCT00926705|Analgesics|analgesics|mesh-ancestor
2443693|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
2443694|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443695|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2443696|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2443697|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2443698|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
2443699|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443700|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443701|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2443702|NCT00926705|Narcotics|narcotics|mesh-ancestor
2443703|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2443704|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2443705|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
2443706|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
2443707|NCT00926718|Remifentanil|remifentanil|mesh-list
2443708|NCT00926718|Rocuronium|rocuronium|mesh-list
2443709|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2443710|NCT00926718|Narcotics|narcotics|mesh-ancestor
2443711|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443712|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443713|NCT00926718|Analgesics|analgesics|mesh-ancestor
2443714|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
2443715|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443716|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2443717|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2443718|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2443719|NCT00926731|Cytarabine|cytarabine|mesh-list
2443720|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2443721|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
2443722|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443723|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443724|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
2443725|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443726|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2443727|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
2443728|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443729|NCT00926757|Entecavir|entecavir|mesh-list
2443730|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
2443731|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443732|NCT00926809|Amoxicillin|amoxicillin|mesh-list
2443733|NCT00926809|Clarithromycin|clarithromycin|mesh-list
2443734|NCT00926809|Lansoprazole|lansoprazole|mesh-list
2443735|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
2443736|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2443737|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2443738|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443739|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2443740|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443741|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443742|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2443743|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2443744|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2443745|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2443746|NCT00926835|Lamotrigine|lamotrigine|mesh-list
2443747|NCT00926835|Dexetimide|dexetimide|mesh-list
2443748|NCT00926835|Aripiprazole|aripiprazole|mesh-list
2443749|NCT00926835|Mirtazapine|mirtazapine|mesh-list
2443750|NCT00926835|Citalopram|citalopram|mesh-list
2443751|NCT00926835|Bupropion|bupropion|mesh-list
2443752|NCT00926835|Paroxetine|paroxetine|mesh-list
2443753|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2443754|NCT00926835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2443755|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2443756|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2443757|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443758|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443759|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
2443760|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443761|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2443762|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
2443763|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2443764|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2443765|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2443766|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
2443767|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
2443768|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443769|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2443770|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2443771|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
2443772|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2443773|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
2443774|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2443775|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2443776|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443777|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2443778|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2443779|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443780|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
2443781|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2443782|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2443783|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2443784|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2443785|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2443786|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2443787|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2443788|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
2443789|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2443790|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2443791|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2443792|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2443793|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
2443794|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
2443795|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2443796|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2443797|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2443798|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2443799|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
2443800|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2443801|NCT00926900|Cycloserine|cycloserine|mesh-list
2443802|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2443803|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443804|NCT00926900|Renal Agents|renal agents|mesh-ancestor
2443805|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2443806|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
2443807|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2443808|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
2443809|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443810|NCT00926926|Oxybutynin|oxybutynin|mesh-list
2443811|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
2443812|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
2443813|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443814|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443815|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2443816|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2443817|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
2443818|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443819|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443820|NCT00926926|Urological Agents|urological agents|mesh-ancestor
2443821|NCT00926965|Olanzapine|olanzapine|mesh-list
2443822|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
2443823|NCT00926965|Amisulpride|amisulpride|mesh-list
2443824|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
2443825|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
2443826|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443827|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443828|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2443829|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2443830|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443831|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2443832|NCT00926965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2443833|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2443834|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2443835|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443836|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443837|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
2443838|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2443839|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
2443840|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2443841|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
2443842|NCT00927004|Etoricoxib|etoricoxib|mesh-list
2443843|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2443844|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2443845|NCT00927004|Analgesics|analgesics|mesh-ancestor
2443846|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
2443847|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443848|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443849|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2443850|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2443851|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2443852|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2443853|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443854|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443855|NCT00927030|Melatonin|melatonin|mesh-list
2443856|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
2443857|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443858|NCT00927030|Protective Agents|protective agents|mesh-ancestor
2443859|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443860|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443861|NCT00927147|Cetuximab|cetuximab|mesh-list
2443862|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2443863|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443864|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
2443865|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2443866|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
2443867|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443868|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443869|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2443870|NCT00927212|Protective Agents|protective agents|mesh-ancestor
2443871|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2443872|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2443873|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443874|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443875|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
2443876|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443877|NCT00927225|Ropivacaine|ropivacaine|mesh-list
2443878|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
2443879|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
2443880|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443881|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443882|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
2443883|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443884|NCT00927290|Pioglitazone|pioglitazone|mesh-list
2443885|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2443886|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443887|NCT00927407|Malathion|malathion|mesh-list
2443888|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2443889|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443890|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443891|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
2443892|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443893|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443894|NCT00927498|Cytarabine|cytarabine|mesh-list
2443895|NCT00927498|Daunorubicin|daunorubicin|mesh-list
2443896|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
2443897|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2443898|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443899|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2443900|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2443901|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443902|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443903|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2443904|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2443905|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
2443906|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
2443907|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443908|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2443909|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
2443910|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443911|NCT00927511|Fulvestrant|fulvestrant|mesh-list
2443912|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2443913|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2443914|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2443915|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2443916|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
2443917|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2443918|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443919|NCT00927524|Insulin|insulin|mesh-list
2443920|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2443921|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
2443922|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2443923|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443924|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2443925|NCT00927537|Telmisartan|telmisartan|mesh-list
2443926|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2443927|NCT00927537|Diuretics|diuretics|mesh-ancestor
2443928|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
2443929|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443930|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2443931|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2443932|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443933|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2443934|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2443935|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
2443936|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
2443937|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2443938|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443939|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443940|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
2443941|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2443942|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2443943|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443944|NCT00927602|PENTA|penta|mesh-list
2443945|NCT00927602|Fondaparinux|fondaparinux|mesh-list
2443946|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2443947|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
2443948|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2443949|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
2443950|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443951|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443952|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
2443953|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2443954|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2443955|NCT00927615|Abciximab|abciximab|mesh-list
2443956|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
2443957|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2443958|NCT00927641|Ketoprofen|ketoprofen|mesh-list
2443959|NCT00927641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2443960|NCT00927641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2443961|NCT00927641|Analgesics|analgesics|mesh-ancestor
2443962|NCT00927641|Sensory System Agents|sensory system agents|mesh-ancestor
2443963|NCT00927641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443964|NCT00927641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443965|NCT00927641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2443966|NCT00927641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2443967|NCT00927641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2443968|NCT00927641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443969|NCT00927641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443970|NCT00927654|Iloprost|iloprost|mesh-list
2443971|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2443972|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
2443973|NCT00927693|Calcium|calcium|mesh-list
2443974|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2443975|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443976|NCT00927732|Quinidine|quinidine|mesh-list
2443977|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
2443978|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2443979|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
2443980|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
2443981|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2443982|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2443983|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2443984|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2443985|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
2443986|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2443987|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2443988|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
2443989|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2443990|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2443991|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2443992|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2443993|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2443994|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2443995|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
2443996|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2443997|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2443998|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2443999|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2444000|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2444001|NCT00927771|Azelaic acid|azelaic acid|mesh-list
2444002|NCT00927771|Hydroquinone|hydroquinone|mesh-list
2444003|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444004|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
2444005|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
2444006|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444007|NCT00927771|Protective Agents|protective agents|mesh-ancestor
2444008|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444009|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2444010|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
2444011|NCT00927797|Rituximab|rituximab|mesh-list
2444012|NCT00927797|Pentostatin|pentostatin|mesh-list
2444013|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2444014|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
2444015|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444016|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2444017|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2444018|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
2444019|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444020|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444021|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2444022|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2444023|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2444024|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444025|NCT00927836|Lenograstim|lenograstim|mesh-list
2444026|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2444027|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
2444028|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444029|NCT00927875|Carboplatin|carboplatin|mesh-list
2444030|NCT00927875|Etoposide|etoposide|mesh-list
2444031|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444032|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2444033|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2444034|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2444035|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444036|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444037|NCT00927914|Ranirestat|ranirestat|mesh-list
2444038|NCT00927914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444039|NCT00927914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444040|NCT00927966|Everolimus|everolimus|mesh-list
2444041|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444042|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2444043|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
2444044|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444045|NCT00927979|Ropivacaine|ropivacaine|mesh-list
2444046|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
2444047|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
2444048|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2444049|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444050|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
2444051|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444052|NCT00928148|Amphetamine|amphetamine|mesh-list
2444053|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2444054|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444055|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
2444056|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
2444057|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444058|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
2444059|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444060|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444061|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
2444062|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2444063|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2444064|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2444065|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2444066|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
2444067|NCT00928161|Lansoprazole|lansoprazole|mesh-list
2444068|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2444069|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2444070|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2444071|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444072|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444073|NCT00928213|Heparin|heparin|mesh-list
2444074|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2444075|NCT00928213|Tinzaparin|tinzaparin|mesh-list
2444076|NCT00928213|Dalteparin|dalteparin|mesh-list
2444077|NCT00928213|Progesterone|progesterone|mesh-list
2444078|NCT00928213|Hormones|hormones|mesh-ancestor
2444079|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444080|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444081|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
2444082|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2444083|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2444084|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444085|NCT00928213|Progestins|progestins|mesh-ancestor
2444086|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2444087|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444088|NCT00928330|Trastuzumab|trastuzumab|mesh-list
2444089|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2444090|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2444091|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444092|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
2444093|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
2444094|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
2444095|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444096|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
2444097|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444098|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2444099|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444100|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444101|NCT00928590|Timolol|timolol|mesh-list
2444102|NCT00928590|Travoprost|travoprost|mesh-list
2444103|NCT00928590|Cloprostenol|cloprostenol|mesh-list
2444104|NCT00928590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2444105|NCT00928590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2444106|NCT00928590|Adrenergic Agents|adrenergic agents|mesh-ancestor
2444107|NCT00928590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444108|NCT00928590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444109|NCT00928590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444110|NCT00928590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2444111|NCT00928590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2444112|NCT00928590|Luteolytic Agents|luteolytic agents|mesh-ancestor
2444113|NCT00928590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2444114|NCT00928590|Contraceptive Agents|contraceptive agents|mesh-ancestor
2444115|NCT00928590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2444116|NCT00928590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2444117|NCT00928655|Acetazolamide|acetazolamide|mesh-list
2444118|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
2444119|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2444120|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444121|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444122|NCT00928655|Diuretics|diuretics|mesh-ancestor
2444123|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
2444124|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444125|NCT00928798|Sirolimus|sirolimus|mesh-list
2444126|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2444127|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444128|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2444129|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444130|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
2444131|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2444132|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
2444133|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444134|NCT00928811|Basiliximab|basiliximab|mesh-list
2444135|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2444136|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
2444137|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444138|NCT00928837|Naproxen|naproxen|mesh-list
2444139|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2444140|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2444141|NCT00928837|Analgesics|analgesics|mesh-ancestor
2444142|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
2444143|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444144|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444145|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2444146|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2444147|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
2444148|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2444149|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444150|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444151|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2444152|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2444153|NCT00928915|Thrombin|thrombin|mesh-list
2444154|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
2444155|NCT00928915|Coagulants|coagulants|mesh-ancestor
2444156|NCT00928967|Interferons|interferons|mesh-list
2444157|NCT00928967|Interferon-beta|interferon-beta|mesh-list
2444158|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
2444159|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444160|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
2444161|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444162|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
2444163|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444164|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2444165|NCT00929006|Progesterone|progesterone|mesh-list
2444166|NCT00929006|Progestins|progestins|mesh-ancestor
2444167|NCT00929006|Hormones|hormones|mesh-ancestor
2444168|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444169|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444170|NCT00929045|Hormones|hormones|mesh-list
2444171|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444172|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444173|NCT00929058|Bevacizumab|bevacizumab|mesh-list
2444174|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2444175|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444176|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2444177|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2444178|NCT00929058|Growth Substances|growth substances|mesh-ancestor
2444179|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444180|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
2444181|NCT00929253|Buprenorphine|buprenorphine|mesh-list
2444182|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2444183|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2444184|NCT00929253|Narcotics|narcotics|mesh-ancestor
2444185|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2444186|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444187|NCT00929253|Analgesics|analgesics|mesh-ancestor
2444188|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
2444189|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444190|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2444191|NCT00929279|Abciximab|abciximab|mesh-list
2444192|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
2444193|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2444194|NCT00929370|Glycine|glycine|mesh-list
2444195|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
2444196|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444197|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444198|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444199|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2444200|NCT00929591|Tamoxifen|tamoxifen|mesh-list
2444201|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
2444202|NCT00929591|Doxorubicin|doxorubicin|mesh-list
2444203|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2444204|NCT00929591|Fluorouracil|fluorouracil|mesh-list
2444205|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2444206|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
2444207|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444208|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2444209|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2444210|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
2444211|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444212|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444213|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2444214|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2444215|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2444216|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2444217|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444218|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
2444219|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2444220|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2444221|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
2444222|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444223|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2444224|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2444225|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2444226|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2444227|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2444228|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
2444229|NCT00929630|Coagulants|coagulants|mesh-ancestor
2444230|NCT00929799|Hormones|hormones|mesh-list
2444231|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444232|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444233|NCT00929812|Glucagon|glucagon|mesh-list
2444234|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2444235|NCT00929812|Hormones|hormones|mesh-ancestor
2444236|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444237|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444238|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
2444239|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2444240|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
2444241|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444242|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444243|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2444244|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
2444245|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2444246|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2444247|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2444248|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
2444249|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444250|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444251|NCT00929877|Ketoprofen|ketoprofen|mesh-list
2444252|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2444253|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2444254|NCT00929877|Analgesics|analgesics|mesh-ancestor
2444255|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
2444256|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444257|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444258|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2444259|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2444260|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2444261|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444262|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444263|NCT00929955|Ondansetron|ondansetron|mesh-list
2444264|NCT00929955|Simvastatin|simvastatin|mesh-list
2444265|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2444266|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2444267|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
2444268|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444269|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2444270|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2444271|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444272|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
2444273|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
2444274|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444275|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444276|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2444277|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
2444278|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
2444279|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2444280|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
2444281|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444282|NCT00929955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2444283|NCT00929955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2444284|NCT00929955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2444285|NCT00929955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2444286|NCT00929955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2444287|NCT00929968|Fluticasone|fluticasone|mesh-list
2444288|NCT00929968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2444289|NCT00929968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2444290|NCT00929968|Autonomic Agents|autonomic agents|mesh-ancestor
2444291|NCT00929968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444292|NCT00929968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444293|NCT00929968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2444294|NCT00929968|Respiratory System Agents|respiratory system agents|mesh-ancestor
2444295|NCT00929968|Dermatologic Agents|dermatologic agents|mesh-ancestor
2444296|NCT00929968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2444297|NCT00930020|Minocycline|minocycline|mesh-list
2444298|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2444299|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444300|NCT00930033|Sunitinib|sunitinib|mesh-list
2444301|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444302|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2444303|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2444304|NCT00930033|Growth Substances|growth substances|mesh-ancestor
2444305|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444306|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
2444307|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2444308|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444309|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444310|NCT00930072|Clonidine|clonidine|mesh-list
2444311|NCT00930072|Bupivacaine|bupivacaine|mesh-list
2444312|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
2444313|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
2444314|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2444315|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444316|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
2444317|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444318|NCT00930072|Analgesics|analgesics|mesh-ancestor
2444319|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2444320|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
2444321|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
2444322|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2444323|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2444324|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2444325|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
2444326|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444327|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444328|NCT00930098|Clofarabine|clofarabine|mesh-list
2444329|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2444330|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
2444331|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444332|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444333|NCT00930189|Triamcinolone|triamcinolone|mesh-list
2444334|NCT00930189|Ranibizumab|ranibizumab|mesh-list
2444335|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2444336|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2444337|NCT00930189|Growth Substances|growth substances|mesh-ancestor
2444338|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444339|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
2444340|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444341|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2444342|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
2444343|NCT00930189|Hormones|hormones|mesh-ancestor
2444344|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444345|NCT00930202|Conivaptan|conivaptan|mesh-list
2444346|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2444347|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444348|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
2444349|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444350|NCT00930228|Flutamide|flutamide|mesh-list
2444351|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
2444352|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
2444353|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444354|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444355|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2444356|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444357|NCT00930241|Tacrolimus|tacrolimus|mesh-list
2444358|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2444359|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
2444360|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444361|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2444362|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444363|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444364|NCT00930306|Tolbutamide|tolbutamide|mesh-list
2444365|NCT00930306|Midazolam|midazolam|mesh-list
2444366|NCT00930306|Caffeine|caffeine|mesh-list
2444367|NCT00930306|Omeprazole|omeprazole|mesh-list
2444368|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2444369|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2444370|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2444371|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444372|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2444373|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2444374|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2444375|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2444376|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
2444377|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
2444378|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
2444379|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
2444380|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444381|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444382|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2444383|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2444384|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2444385|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444386|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2444387|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2444388|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2444389|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2444390|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
2444391|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2444392|NCT00930332|Methadone|methadone|mesh-list
2444393|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2444394|NCT00930332|Narcotics|narcotics|mesh-ancestor
2444395|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2444396|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444397|NCT00930332|Analgesics|analgesics|mesh-ancestor
2444398|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
2444399|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444400|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
2444401|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
2444402|NCT00930345|Sunitinib|sunitinib|mesh-list
2444403|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444404|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2444405|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2444406|NCT00930345|Growth Substances|growth substances|mesh-ancestor
2444407|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444408|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
2444409|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2444410|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444411|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444412|NCT00930358|Anesthetics|anesthetics|mesh-list
2444413|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2444414|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444415|NCT00930475|Carboplatin|carboplatin|mesh-list
2444416|NCT00930475|Everolimus|everolimus|mesh-list
2444417|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444418|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2444419|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
2444420|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444421|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
2444422|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2444423|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2444424|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444425|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2444426|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2444427|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444428|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444429|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444430|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2444431|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
2444432|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2444433|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444434|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2444435|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2444436|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2444437|NCT00930514|Rituximab|rituximab|mesh-list
2444438|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2444439|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444440|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
2444441|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444442|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2444443|NCT00930566|Methoxsalen|methoxsalen|mesh-list
2444444|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2444445|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
2444446|NCT00930579|Metformin|metformin|mesh-list
2444447|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2444448|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444449|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
2444450|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2444451|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444452|NCT00930670|Esomeprazole|esomeprazole|mesh-list
2444453|NCT00930670|Omeprazole|omeprazole|mesh-list
2444454|NCT00930670|Pantoprazole|pantoprazole|mesh-list
2444455|NCT00930670|Ranitidine|ranitidine|mesh-list
2444456|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
2444457|NCT00930670|Atorvastatin|atorvastatin|mesh-list
2444458|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2444459|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2444460|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2444461|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
2444462|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444463|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2444464|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2444465|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444466|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2444467|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2444468|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2444469|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2444470|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
2444471|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
2444472|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444473|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444474|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2444475|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
2444476|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444477|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
2444478|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2444479|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2444480|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2444481|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2444482|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444483|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
2444484|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444485|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444486|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2444487|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444488|NCT00930722|Quinapril|quinapril|mesh-list
2444489|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2444490|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
2444491|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444492|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444493|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2444494|NCT00930839|Aspirin|aspirin|mesh-list
2444495|NCT00930839|Niacin|niacin|mesh-list
2444496|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
2444497|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2444498|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2444499|NCT00930839|Analgesics|analgesics|mesh-ancestor
2444500|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
2444501|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444502|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444503|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2444504|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2444505|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2444506|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2444507|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444508|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2444509|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2444510|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444511|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
2444512|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2444513|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
2444514|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2444515|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
2444516|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
2444517|NCT00930839|Vitamins|vitamins|mesh-ancestor
2444518|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
2444519|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
2444520|NCT00930865|Bumetanide|bumetanide|mesh-list
2444521|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2444522|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444523|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2444524|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444525|NCT00930865|Diuretics|diuretics|mesh-ancestor
2444526|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
2444527|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2444528|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2444529|NCT00930891|Bevacizumab|bevacizumab|mesh-list
2444530|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2444531|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444532|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2444533|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2444534|NCT00930891|Growth Substances|growth substances|mesh-ancestor
2444535|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444536|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
2444537|NCT00930943|Oxymorphone|oxymorphone|mesh-list
2444538|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2444539|NCT00930943|Narcotics|narcotics|mesh-ancestor
2444540|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2444541|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444542|NCT00930943|Analgesics|analgesics|mesh-ancestor
2444543|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
2444544|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444545|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2444546|NCT00930995|Candesartan|candesartan|mesh-list
2444547|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2444548|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2444549|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2444550|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444551|NCT00931008|Docetaxel|docetaxel|mesh-list
2444552|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444553|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
2444554|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
2444555|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
2444556|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444557|NCT00931021|Nicotine|nicotine|mesh-list
2444558|NCT00931021|Varenicline|varenicline|mesh-list
2444559|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2444560|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
2444561|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444562|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444563|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2444564|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2444565|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
2444566|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444567|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444568|NCT00931073|Ketoconazole|ketoconazole|mesh-list
2444569|NCT00931073|Omeprazole|omeprazole|mesh-list
2444570|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2444571|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2444572|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2444573|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444574|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444575|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
2444576|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444577|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2444578|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2444579|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2444580|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
2444581|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444582|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444583|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2444584|NCT00931086|Belimumab|belimumab|mesh-list
2444585|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2444586|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
2444587|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444588|NCT00931125|Ranibizumab|ranibizumab|mesh-list
2444589|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2444590|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2444591|NCT00931125|Growth Substances|growth substances|mesh-ancestor
2444592|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444593|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
2444594|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444595|NCT00931138|Cytarabine|cytarabine|mesh-list
2444596|NCT00931138|Daunorubicin|daunorubicin|mesh-list
2444597|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2444598|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444599|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2444600|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2444601|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444602|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444603|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2444604|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
2444605|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
2444606|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444607|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2444608|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
2444609|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444610|NCT00931203|Celecoxib|celecoxib|mesh-list
2444611|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2444612|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2444613|NCT00931203|Analgesics|analgesics|mesh-ancestor
2444614|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
2444615|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444616|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444617|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2208145|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208146|NCT00009919|Semaxinib|semaxinib|mesh-list
2208147|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2208148|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2208149|NCT00009919|Growth Substances|growth substances|mesh-ancestor
2208150|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208151|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
2208152|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208153|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2208154|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208155|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208156|NCT00009932|Paclitaxel|paclitaxel|mesh-list
2208157|NCT00009932|Fenretinide|fenretinide|mesh-list
2208158|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208159|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208160|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
2444618|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2444619|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2444620|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2444621|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444622|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444623|NCT00931229|Entecavir|entecavir|mesh-list
2444624|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
2444625|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444626|NCT00931281|Ritonavir|ritonavir|mesh-list
2444627|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2444628|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2444629|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
2444630|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444631|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444632|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2444633|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2444634|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
2444635|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444636|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2444637|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2444638|NCT00931372|Lixisenatide|lixisenatide|mesh-list
2444639|NCT00931372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2444640|NCT00931372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444641|NCT00931398|Methylphenidate|methylphenidate|mesh-list
2444642|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2444643|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444644|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2444645|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2444646|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2444647|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444648|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
2444649|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444650|NCT00931437|Vitamin K|vitamin k|mesh-list
2444651|NCT00931437|Vitamins|vitamins|mesh-ancestor
2444652|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
2444653|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444654|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2444655|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2444656|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444657|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
2444658|NCT00931437|Coagulants|coagulants|mesh-ancestor
2444659|NCT00931450|Sunitinib|sunitinib|mesh-list
2444660|NCT00931450|Exemestane|exemestane|mesh-list
2444661|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444662|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2444663|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2444664|NCT00931450|Growth Substances|growth substances|mesh-ancestor
2444665|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444666|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
2444667|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2444668|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444669|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444670|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2444671|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2444672|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2444673|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
2444674|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444675|NCT00931580|Vitamin D|vitamin d|mesh-list
2444676|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
2444677|NCT00931580|Vitamins|vitamins|mesh-ancestor
2444678|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
2444679|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444680|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2444681|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2444682|NCT00931645|Cytarabine|cytarabine|mesh-list
2444683|NCT00931645|Dexamethasone|dexamethasone|mesh-list
2444684|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
2444685|NCT00931645|Cisplatin|cisplatin|mesh-list
2444686|NCT00931645|Fludarabine|fludarabine|mesh-list
2444687|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2444688|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
2444689|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444690|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2444691|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2444692|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
2444693|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444694|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444695|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2444696|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2444697|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
2444698|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
2444699|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444700|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2444701|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
2444702|NCT00931645|Hormones|hormones|mesh-ancestor
2444703|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444704|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2444705|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2444706|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
2444707|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
2444708|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444709|NCT00931697|Mefloquine|mefloquine|mesh-list
2444710|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
2444711|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2444712|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2444713|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444714|NCT00931736|Rifampin|rifampin|mesh-list
2444715|NCT00931736|Isoniazid|isoniazid|mesh-list
2444716|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2444717|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
2444718|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2444719|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444720|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
2444721|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2444722|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444723|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444724|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2444725|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2444726|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2444727|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2444728|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2444729|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2444730|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2444731|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2444732|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
2444733|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2444734|NCT00931775|Pindolol|pindolol|mesh-list
2444735|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2444736|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2444737|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
2444738|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444739|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444740|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444741|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2444742|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2444743|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
2444744|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
2444745|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
2444746|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
2444747|NCT00931827|Etonogestrel|etonogestrel|mesh-list
2444748|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2444749|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
2444750|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2444751|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444752|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2444753|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2444754|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2444755|NCT00931840|Irinotecan|irinotecan|mesh-list
2444756|NCT00931840|Cetuximab|cetuximab|mesh-list
2444757|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2444758|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2444759|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444760|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444761|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444762|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2444763|NCT00931866|Diclofenac|diclofenac|mesh-list
2444764|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2444765|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2444766|NCT00931866|Analgesics|analgesics|mesh-ancestor
2444767|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
2444768|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444769|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444770|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2444771|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2444772|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2444773|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444774|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444775|NCT00931957|Prednisolone|prednisolone|mesh-list
2444776|NCT00931957|Etanercept|etanercept|mesh-list
2444777|NCT00931957|Methotrexate|methotrexate|mesh-list
2444778|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2444779|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
2444780|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2444781|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444782|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2444783|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
2444784|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444785|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444786|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
2444787|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444788|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2444789|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2444790|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
2444791|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2444792|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2444793|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2444794|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
2444795|NCT00931957|Hormones|hormones|mesh-ancestor
2444796|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444797|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2444798|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444799|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2444800|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2444801|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2444802|NCT00931957|Analgesics|analgesics|mesh-ancestor
2444803|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
2444804|NCT00932048|Atorvastatin|atorvastatin|mesh-list
2444805|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2444806|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2444807|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
2444808|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444809|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2444810|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2444811|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444812|NCT00932100|Heparin|heparin|mesh-list
2444813|NCT00932100|Calcium heparin|calcium heparin|mesh-list
2444814|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2444815|NCT00932100|Tinzaparin|tinzaparin|mesh-list
2444816|NCT00932100|Dalteparin|dalteparin|mesh-list
2444817|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
2444818|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2444819|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2444820|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444821|NCT00932217|Lenograstim|lenograstim|mesh-list
2444822|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2444823|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
2444824|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444825|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
2444826|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2444827|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2444828|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444829|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2444830|NCT00932386|Analgesics|analgesics|mesh-ancestor
2444831|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
2444832|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444833|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2444834|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2444835|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2444836|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
2444837|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444838|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444839|NCT00932529|Olanzapine|olanzapine|mesh-list
2444840|NCT00932529|Risperidone|risperidone|mesh-list
2444841|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2444842|NCT00932529|Ziprasidone|ziprasidone|mesh-list
2444843|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2444844|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
2444845|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444846|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444847|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444848|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2444849|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2444850|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2444851|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2444852|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2444853|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
2444854|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
2444855|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
2444856|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444857|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2444858|NCT00932529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2444859|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2444860|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2444861|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
2444862|NCT00932542|Lidocaine|lidocaine|mesh-list
2444863|NCT00932542|Prilocaine|prilocaine|mesh-list
2444864|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
2444865|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
2444866|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2444867|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444868|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
2444869|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2444870|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2444871|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2444872|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2444873|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2444874|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444875|NCT00932555|Factor VIII|factor viii|mesh-list
2444876|NCT00932555|Coagulants|coagulants|mesh-ancestor
2444877|NCT00932685|Midazolam|midazolam|mesh-list
2444878|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2444879|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2444880|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2444881|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444882|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2444883|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2444884|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2444885|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2444886|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
2444887|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
2444888|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
2444889|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
2444890|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2444891|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444892|NCT00932763|Amlodipine|amlodipine|mesh-list
2444893|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2444894|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2444895|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2444896|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444897|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2444898|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444899|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
2444900|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
2444901|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2444902|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2444903|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444904|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2444905|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2444906|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444907|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444908|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444909|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2444910|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
2444911|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2444912|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444913|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2444914|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2444915|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2444916|NCT00932867|Telmisartan|telmisartan|mesh-list
2444917|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2444918|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2444919|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2444920|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444921|NCT00932880|Amlodipine|amlodipine|mesh-list
2444922|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2444923|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2444924|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2444925|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444926|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2444927|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444928|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
2444929|NCT00932971|Tenofovir|tenofovir|mesh-list
2444930|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2444931|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
2444932|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
2444933|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2444934|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
2444935|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444936|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2444937|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2444938|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2444939|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2444940|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2444941|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2444942|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
2444943|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444944|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2444945|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
2444946|NCT00933023|Betamethasone|betamethasone|mesh-list
2444947|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2444948|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
2444949|NCT00933023|Hormones|hormones|mesh-ancestor
2444950|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444951|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444952|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2444953|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
2444954|NCT00933049|Amoxicillin|amoxicillin|mesh-list
2444955|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2444956|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2444957|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444958|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2444959|NCT00933049|Renal Agents|renal agents|mesh-ancestor
2444960|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
2444961|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2444962|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2444963|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
2444964|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
2444965|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
2444966|NCT00933179|Gestodene|gestodene|mesh-list
2444967|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2444968|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
2444969|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2444970|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444971|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2444972|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2444973|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2444974|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2444975|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2444976|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
2444977|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2444978|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2444979|NCT00933179|Progestins|progestins|mesh-ancestor
2444980|NCT00933179|Hormones|hormones|mesh-ancestor
2444981|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444982|NCT00933205|Tipranavir|tipranavir|mesh-list
2444983|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2444984|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2444985|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
2444986|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2444987|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
2444988|NCT00933231|Prednisone|prednisone|mesh-list
2444989|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
2444990|NCT00933231|Ramipril|ramipril|mesh-list
2444991|NCT00933231|Irbesartan|irbesartan|mesh-list
2444992|NCT00933231|Tacrolimus|tacrolimus|mesh-list
2444993|NCT00933231|Basiliximab|basiliximab|mesh-list
2444994|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2444995|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
2444996|NCT00933231|Hormones|hormones|mesh-ancestor
2444997|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2444998|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2444999|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2445000|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445001|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445002|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
2445003|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2445004|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445005|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445006|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
2445007|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
2445008|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445009|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2445010|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2445011|NCT00933231|Protective Agents|protective agents|mesh-ancestor
2445012|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2445013|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2445014|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
2445015|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2445016|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445017|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2445018|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
2445019|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2445020|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2445021|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2445022|NCT00933283|Methadone|methadone|mesh-list
2445023|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2445024|NCT00933283|Narcotics|narcotics|mesh-ancestor
2445025|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2445026|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445027|NCT00933283|Analgesics|analgesics|mesh-ancestor
2445028|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
2445029|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445030|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
2445031|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
2445032|NCT00933309|Metformin|metformin|mesh-list
2445033|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
2445034|NCT00933309|Exemestane|exemestane|mesh-list
2445035|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2445036|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445037|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445038|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2445039|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2445040|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445041|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445042|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2445043|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
2445044|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445045|NCT00933374|Paclitaxel|paclitaxel|mesh-list
2445046|NCT00933374|Everolimus|everolimus|mesh-list
2445047|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2445048|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445049|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
2445050|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
2445051|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
2445052|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445053|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445054|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
2445055|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445056|NCT00933387|Paclitaxel|paclitaxel|mesh-list
2445057|NCT00933387|Cetuximab|cetuximab|mesh-list
2445058|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2445059|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445060|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
2445061|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
2445062|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
2445063|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445064|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2445065|NCT00933426|Paclitaxel|paclitaxel|mesh-list
2445066|NCT00933426|Lenalidomide|lenalidomide|mesh-list
2445067|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2445068|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445069|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
2445070|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
2445071|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
2445072|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445073|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
2445074|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445075|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2445076|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2445077|NCT00933426|Growth Substances|growth substances|mesh-ancestor
2445078|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
2445079|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2445080|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2445081|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2445082|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2445083|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445084|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445085|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445086|NCT00933439|Analgesics|analgesics|mesh-ancestor
2445087|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
2445088|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445089|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
2445090|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2445091|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
2445092|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2445093|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2445094|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2445095|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2445096|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445097|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445098|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445099|NCT00933452|Analgesics|analgesics|mesh-ancestor
2445100|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
2445101|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445102|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
2445103|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2445104|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
2445105|NCT00933465|Loperamide|loperamide|mesh-list
2445106|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
2445107|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2445108|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
2445109|NCT00933517|Docetaxel|docetaxel|mesh-list
2445110|NCT00933517|Panitumumab|panitumumab|mesh-list
2445111|NCT00933517|Epirubicin|epirubicin|mesh-list
2445112|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445113|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
2445114|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445115|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2445116|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2445117|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
2445118|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445119|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445120|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2445121|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
2445122|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
2445123|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
2445124|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2445125|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2445126|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2445127|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2445128|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445129|NCT00933582|Naproxen|naproxen|mesh-list
2445130|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2445131|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2445132|NCT00933582|Analgesics|analgesics|mesh-ancestor
2445133|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
2445134|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445135|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445136|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2445137|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2445138|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
2445139|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2445140|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445141|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445142|NCT00933634|Propafenone|propafenone|mesh-list
2445143|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2445144|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2445145|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2445146|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2445147|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445148|NCT00933777|Everolimus|everolimus|mesh-list
2445149|NCT00933777|Sorafenib|sorafenib|mesh-list
2445150|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445151|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445152|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
2445153|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445154|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2445155|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445156|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445157|NCT00933790|Rifampin|rifampin|mesh-list
2445158|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
2445159|NCT00933790|Ethambutol|ethambutol|mesh-list
2445160|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2445161|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
2445162|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2445163|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445164|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
2445165|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2445166|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445167|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445168|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2445169|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2445170|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2445171|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2445172|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2445173|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2445174|NCT00933816|Fluorouracil|fluorouracil|mesh-list
2445175|NCT00933816|Sorafenib|sorafenib|mesh-list
2445176|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445177|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
2445178|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445179|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2445180|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445181|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
2445182|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445183|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2445184|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445185|NCT00933894|Citalopram|citalopram|mesh-list
2445186|NCT00933894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2445187|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2445188|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2445189|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445190|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445191|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
2445192|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445193|NCT00933894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2445194|NCT00933894|Antidepressive Agents|antidepressive agents|mesh-ancestor
2208161|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
2208162|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208163|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208164|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2208165|NCT00009932|Protective Agents|protective agents|mesh-ancestor
2208166|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208167|NCT00009958|Metronidazole|metronidazole|mesh-list
2208168|NCT00009958|Vaccines|vaccines|mesh-list
2208169|NCT00009958|Sargramostim|sargramostim|mesh-list
2208170|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
2208171|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208172|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208173|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2208174|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2208175|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2208176|NCT00009971|Fenretinide|fenretinide|mesh-list
2208177|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208178|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2208179|NCT00009971|Protective Agents|protective agents|mesh-ancestor
2208180|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208181|NCT00009984|Thalidomide|thalidomide|mesh-list
2208182|NCT00009984|Fludarabine|fludarabine|mesh-list
2208183|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
2208184|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208185|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208186|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
2208187|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208188|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208189|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
2208190|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445195|NCT00933894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2445196|NCT00933985|Doxorubicin|doxorubicin|mesh-list
2445197|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2445198|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
2445199|NCT00933985|Vincristine|vincristine|mesh-list
2445200|NCT00933985|Razoxane|razoxane|mesh-list
2445201|NCT00933985|Obatoclax|obatoclax|mesh-list
2445202|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2445203|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445204|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2445205|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2445206|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445207|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445208|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2445209|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
2445210|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
2445211|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
2445212|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2445213|NCT00933985|Protective Agents|protective agents|mesh-ancestor
2445214|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445215|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
2445216|NCT00933998|Pyridoxal|pyridoxal|mesh-list
2445217|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
2445218|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
2445219|NCT00933998|Vitamins|vitamins|mesh-ancestor
2445220|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
2445221|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445222|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2445223|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2445224|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445225|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
2445226|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2445227|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445228|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2445229|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445230|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445231|NCT00934154|Thalidomide|thalidomide|mesh-list
2445232|NCT00934154|Prednisolone|prednisolone|mesh-list
2445233|NCT00934154|Melphalan|melphalan|mesh-list
2445234|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2445235|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
2445236|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208191|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
2445237|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445238|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2445239|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445240|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
2445241|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445242|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2445243|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
2445244|NCT00934154|Hormones|hormones|mesh-ancestor
2445245|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445246|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2445247|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
2445248|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2445249|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445250|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2445251|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2445252|NCT00934154|Growth Substances|growth substances|mesh-ancestor
2445253|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
2445254|NCT00934167|Heparin|heparin|mesh-list
2445255|NCT00934167|Calcium heparin|calcium heparin|mesh-list
2445256|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
2445257|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2445258|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2445259|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445260|NCT00934193|Gabapentin|gabapentin|mesh-list
2445261|NCT00934193|Analgesics|analgesics|mesh-ancestor
2445262|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
2445263|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445264|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445265|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
2445266|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2445267|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2445268|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2445269|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2445270|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2445271|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2445272|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445273|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445274|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
2445275|NCT00934232|Busulfan|busulfan|mesh-list
2445276|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
2445277|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445278|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208192|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2208193|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208194|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2208195|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2208196|NCT00009984|Growth Substances|growth substances|mesh-ancestor
2208197|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
2208198|NCT00009997|Tamoxifen|tamoxifen|mesh-list
2208199|NCT00009997|Paclitaxel|paclitaxel|mesh-list
2208200|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
2208201|NCT00009997|Doxorubicin|doxorubicin|mesh-list
2208202|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2208203|NCT00009997|Trastuzumab|trastuzumab|mesh-list
2208204|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208205|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208206|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
2208207|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
2208208|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208209|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208210|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208211|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
2208212|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445279|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
2445280|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445281|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2445282|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445283|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2445284|NCT00934245|Vaccines|vaccines|mesh-list
2445285|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
2445286|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445287|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2445288|NCT00934258|Fenofibrate|fenofibrate|mesh-list
2445289|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2445290|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2445291|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
2445292|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445293|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2445294|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2445295|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445296|NCT00934323|Metformin|metformin|mesh-list
2445297|NCT00934323|Glimepiride|glimepiride|mesh-list
2445298|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2445299|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445300|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2445301|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445302|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
2445303|NCT00934414|Insulin|insulin|mesh-list
2445304|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2445305|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445306|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
2445307|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
2445308|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
2445309|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
2445310|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
2445311|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2445312|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2445313|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445314|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445315|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445316|NCT00934479|Lubiprostone|lubiprostone|mesh-list
2445317|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2445318|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2445319|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445320|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2445321|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2445322|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445323|NCT00934492|Renal Agents|renal agents|mesh-ancestor
2445324|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2445325|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
2445326|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2445327|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2445328|NCT00934518|Cetuximab|cetuximab|mesh-list
2445329|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2445330|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445331|NCT00934531|Donepezil|donepezil|mesh-list
2445332|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2445333|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445334|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445335|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
2445336|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445337|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445338|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
2445339|NCT00934570|Metformin|metformin|mesh-list
2445340|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2445341|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445342|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
2445343|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2445344|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2445345|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2445346|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2445347|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445348|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
2445349|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445350|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445351|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2445352|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445353|NCT00934700|Xenon|xenon|mesh-list
2445354|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2445355|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
2445356|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
2445357|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2445358|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445359|NCT00934713|Montelukast|montelukast|mesh-list
2445360|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2445361|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
2445362|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2445363|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
2445364|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445365|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445366|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2445367|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2445368|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445369|NCT00934739|Thalidomide|thalidomide|mesh-list
2445370|NCT00934739|Dexamethasone|dexamethasone|mesh-list
2445371|NCT00934739|Celecoxib|celecoxib|mesh-list
2445372|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
2445373|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445374|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
2445375|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445376|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2445377|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2445378|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
2445379|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445380|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445381|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2445382|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2445383|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
2445384|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
2445385|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445386|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2445387|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
2445388|NCT00934739|Hormones|hormones|mesh-ancestor
2445389|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445390|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2445391|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
2445392|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2445393|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445394|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2445395|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2445396|NCT00934739|Growth Substances|growth substances|mesh-ancestor
2445397|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
2445398|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2445399|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2445400|NCT00934739|Analgesics|analgesics|mesh-ancestor
2445401|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
2445402|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2445403|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2445404|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445405|NCT00934752|Paclitaxel|paclitaxel|mesh-list
2445406|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2445407|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445408|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
2445409|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
2445410|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
2445411|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445412|NCT00934817|Metformin|metformin|mesh-list
2445413|NCT00934817|Glimepiride|glimepiride|mesh-list
2445414|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2445415|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445416|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2445417|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445418|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
2445419|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2445420|NCT00934830|Amoxicillin|amoxicillin|mesh-list
2445421|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445422|NCT00934895|Paclitaxel|paclitaxel|mesh-list
2445423|NCT00934895|Everolimus|everolimus|mesh-list
2445424|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2445425|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2445426|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445427|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
2445428|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
2445429|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
2445430|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445431|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445432|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
2445433|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445434|NCT00934973|Mebeverine|mebeverine|mesh-list
2445435|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
2445436|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
2445437|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
2445438|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445439|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445440|NCT00935116|Etoricoxib|etoricoxib|mesh-list
2445441|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2445442|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2445443|NCT00935116|Analgesics|analgesics|mesh-ancestor
2445444|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
2445445|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445446|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445447|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2445448|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2445449|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2445450|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2445451|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445452|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445453|NCT00935194|Oseltamivir|oseltamivir|mesh-list
2445454|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
2445455|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445456|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445457|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445458|NCT00935246|Dexetimide|dexetimide|mesh-list
2445459|NCT00935246|Citalopram|citalopram|mesh-list
2445460|NCT00935246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2445461|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2445462|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2445463|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445464|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445465|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
2445466|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445467|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2445468|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
2445469|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2445470|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2445471|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2445472|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
2445473|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
2445474|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445475|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2445476|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2445477|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
2445478|NCT00935298|Tacrolimus|tacrolimus|mesh-list
2445479|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445480|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
2445481|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445482|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2445483|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445484|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445485|NCT00935363|Glyburide|glyburide|mesh-list
2445486|NCT00935363|Rifampin|rifampin|mesh-list
2445487|NCT00935363|Fluconazole|fluconazole|mesh-list
2445488|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2445489|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
2445490|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2445491|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445492|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
2445493|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2445494|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445495|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445496|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2445497|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2445498|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2445499|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2445500|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2445501|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2445502|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
2445503|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2445504|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2208213|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2208214|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2208215|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
2208216|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2208217|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2208218|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2208219|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2208220|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208221|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2208222|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2208223|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
2445505|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2445506|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
2445507|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445508|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445509|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2445510|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2445511|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2445512|NCT00935415|Montelukast|montelukast|mesh-list
2445513|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2445514|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
2445515|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2445516|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
2445517|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445518|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445519|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2445520|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2445521|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445522|NCT00935467|Saxagliptin|saxagliptin|mesh-list
2445523|NCT00935467|Incretins|incretins|mesh-ancestor
2445524|NCT00935467|Hormones|hormones|mesh-ancestor
2445525|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445526|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445527|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2445528|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
2445529|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445530|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445531|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2445532|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
2445533|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2445534|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2445535|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
2445536|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445537|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2445538|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2445539|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445540|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445541|NCT00935506|Aspirin|aspirin|mesh-list
2445542|NCT00935506|Clopidogrel|clopidogrel|mesh-list
2445543|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2445544|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2445545|NCT00935506|Analgesics|analgesics|mesh-ancestor
2445546|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
2445547|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445548|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445549|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2445550|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2445551|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2445552|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2445553|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445554|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2445555|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2445556|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445557|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
2445558|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2445559|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2445560|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2445561|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
2445562|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445563|NCT00935558|Interleukin-2|interleukin-2|mesh-list
2445564|NCT00935558|Exemestane|exemestane|mesh-list
2445565|NCT00935558|Anastrozole|anastrozole|mesh-list
2445566|NCT00935558|Letrozole|letrozole|mesh-list
2445567|NCT00935558|Lactitol|lactitol|mesh-list
2445568|NCT00935558|Vaccines|vaccines|mesh-list
2445569|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2445570|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
2445571|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445572|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445573|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2445574|NCT00935558|Analgesics|analgesics|mesh-ancestor
2445575|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
2445576|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445577|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2445578|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445579|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445580|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2445581|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
2445582|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445583|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2445584|NCT00935558|Cathartics|cathartics|mesh-ancestor
2445585|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2445586|NCT00935571|Remifentanil|remifentanil|mesh-list
2445587|NCT00935571|Propofol|propofol|mesh-list
2445588|NCT00935571|Sevoflurane|sevoflurane|mesh-list
2445589|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2445590|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2445591|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445592|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2445593|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
2445594|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
2445595|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2445596|NCT00935571|Narcotics|narcotics|mesh-ancestor
2445597|NCT00935571|Analgesics|analgesics|mesh-ancestor
2445598|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
2445599|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445600|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2445601|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2445602|NCT00935610|Caseins|caseins|mesh-list
2445603|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
2445604|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
2445605|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445606|NCT00935675|Citalopram|citalopram|mesh-list
2445607|NCT00935675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2445608|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2445609|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2445610|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445611|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445612|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
2445613|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445614|NCT00935675|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2445615|NCT00935675|Antidepressive Agents|antidepressive agents|mesh-ancestor
2445616|NCT00935675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2445617|NCT00935805|Insulin|insulin|mesh-list
2445618|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2445619|NCT00935805|Metformin|metformin|mesh-list
2445620|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
2445621|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
2445622|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
2445623|NCT00935805|Glyburide|glyburide|mesh-list
2445624|NCT00935805|Propranolol|propranolol|mesh-list
2445625|NCT00935805|Amlodipine|amlodipine|mesh-list
2445626|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2445627|NCT00935805|Captopril|captopril|mesh-list
2445628|NCT00935805|Diuretics|diuretics|mesh-list
2445629|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2445630|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445631|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2445632|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2445633|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2445634|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445635|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2445636|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
2445637|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
2445638|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2445639|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2445640|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2445641|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
2445642|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445643|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2445644|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2445645|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
2445646|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445647|NCT00935961|Docetaxel|docetaxel|mesh-list
2445648|NCT00935961|Everolimus|everolimus|mesh-list
2445649|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445650|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
2445651|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
2445652|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
2445653|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445654|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445655|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
2445656|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445657|NCT00935987|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
2445658|NCT00935987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2445659|NCT00935987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445660|NCT00935987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445661|NCT00936013|Oseltamivir|oseltamivir|mesh-list
2445662|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
2445663|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445664|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445665|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445666|NCT00936091|Vitamin A|vitamin a|mesh-list
2445667|NCT00936091|Vitamins|vitamins|mesh-ancestor
2445668|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
2445669|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445670|NCT00936143|Infliximab|infliximab|mesh-list
2445671|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
2445672|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2445673|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2445674|NCT00936156|Carboplatin|carboplatin|mesh-list
2445675|NCT00936156|Etoposide|etoposide|mesh-list
2445676|NCT00936156|Thiotepa|thiotepa|mesh-list
2445677|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445678|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2445679|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2445680|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2445681|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445682|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445683|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2445684|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
2445685|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2445686|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445687|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
2445688|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445689|NCT00936182|Fluconazole|fluconazole|mesh-list
2445690|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
2445691|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445692|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2445693|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2445694|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445695|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445696|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2445697|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
2445698|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445699|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445700|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2445701|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2445702|NCT00936195|Ritonavir|ritonavir|mesh-list
2445703|NCT00936195|Lopinavir|lopinavir|mesh-list
2445704|NCT00936195|Tenofovir|tenofovir|mesh-list
2445705|NCT00936195|Lamivudine|lamivudine|mesh-list
2445706|NCT00936195|Zidovudine|zidovudine|mesh-list
2445707|NCT00936195|Emtricitabine|emtricitabine|mesh-list
2445708|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2445709|NCT00936195|Efavirenz|efavirenz|mesh-list
2445710|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2445711|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2445712|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
2445713|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445714|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445715|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2445716|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2445717|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
2445718|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445719|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2445720|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2445721|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2445722|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2445723|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
2445724|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2445725|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2445726|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2445727|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2445728|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2445729|NCT00936234|Vildagliptin|vildagliptin|mesh-list
2445730|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2445731|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445732|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2445733|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
2445734|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445735|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445736|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2445737|NCT00936260|Alendronate|alendronate|mesh-list
2445738|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2445739|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445740|NCT00936390|Leuprolide|leuprolide|mesh-list
2445741|NCT00936390|Goserelin|goserelin|mesh-list
2445742|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2445743|NCT00936390|Flutamide|flutamide|mesh-list
2445744|NCT00936390|Bicalutamide|bicalutamide|mesh-list
2445745|NCT00936390|Buserelin|buserelin|mesh-list
2445746|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2445747|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
2445748|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2445749|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445750|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2445751|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445752|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-ancestor
2445753|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
2445754|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445755|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
2445756|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2445757|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
2445758|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2445759|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2445760|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2445761|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
2445762|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445763|NCT00936429|Antacids|antacids|mesh-ancestor
2445764|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445765|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2445766|NCT00936442|Anastrozole|anastrozole|mesh-list
2445767|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2445768|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445769|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2445770|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2445771|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445772|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445773|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2445774|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
2445775|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445776|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445777|NCT00936520|Lifitegrast|lifitegrast|mesh-list
2445778|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2445779|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2445780|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2445781|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2445782|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
2445783|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2445784|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2445785|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445786|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
2445787|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445788|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445789|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2445790|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445791|NCT00936546|Rituximab|rituximab|mesh-list
2445792|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2445793|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445794|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
2445795|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445796|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2445797|NCT00936624|Montelukast|montelukast|mesh-list
2445798|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2445799|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
2445800|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2445801|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
2445802|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445803|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445804|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2445805|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2445806|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445807|NCT00936650|Cinacalcet|cinacalcet|mesh-list
2445808|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2445809|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445810|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2445811|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
2445812|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445813|NCT00936676|Rasagiline|rasagiline|mesh-list
2445814|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2445815|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445816|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445817|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2445818|NCT00936676|Protective Agents|protective agents|mesh-ancestor
2445819|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445820|NCT00936689|Doxorubicin|doxorubicin|mesh-list
2445821|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
2445822|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2445823|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445824|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2445825|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2445826|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445827|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445828|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2445829|NCT00936689|Estrogens|estrogens|mesh-ancestor
2445830|NCT00936689|Hormones|hormones|mesh-ancestor
2445831|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445832|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445833|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2445834|NCT00936767|Artesunate|artesunate|mesh-list
2445835|NCT00936767|Mefloquine|mefloquine|mesh-list
2445836|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
2445837|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2445838|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2445839|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445840|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445841|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
2445842|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
2445843|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2445844|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
2445845|NCT00936780|Paclitaxel|paclitaxel|mesh-list
2445846|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2445847|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445848|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
2445849|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
2445850|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
2445851|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445852|NCT00936793|Ritonavir|ritonavir|mesh-list
2445853|NCT00936793|Darunavir|darunavir|mesh-list
2445854|NCT00936793|Beclomethasone|beclomethasone|mesh-list
2445855|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2445856|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2445857|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
2445858|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445859|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445860|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2445861|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2445862|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
2445863|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445864|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2445865|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2445866|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2445867|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
2445868|NCT00936793|Hormones|hormones|mesh-ancestor
2445869|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445870|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445871|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2445872|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
2445873|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
2445874|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2445875|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2445876|NCT00936832|Leucovorin|leucovorin|mesh-list
2445877|NCT00936832|Fluorouracil|fluorouracil|mesh-list
2445878|NCT00936832|Irinotecan|irinotecan|mesh-list
2445879|NCT00936832|Sunitinib|sunitinib|mesh-list
2445880|NCT00936832|Calcium|calcium|mesh-list
2445881|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
2445882|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2445883|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445884|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
2445885|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445886|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2445887|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445888|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445889|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
2445890|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2445891|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2445892|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445893|NCT00936832|Antidotes|antidotes|mesh-ancestor
2445894|NCT00936832|Protective Agents|protective agents|mesh-ancestor
2445895|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
2445896|NCT00936832|Vitamins|vitamins|mesh-ancestor
2445897|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
2445898|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2445899|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2445900|NCT00936832|Growth Substances|growth substances|mesh-ancestor
2445901|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
2445902|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2445903|NCT00936871|Moxifloxacin|moxifloxacin|mesh-list
2445904|NCT00936871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2445905|NCT00936871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445906|NCT00936871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2445907|NCT00936871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2445908|NCT00936871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445909|NCT00936871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445910|NCT00936871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445911|NCT00936923|Furosemide|furosemide|mesh-list
2445912|NCT00936923|Diuretics|diuretics|mesh-list
2445913|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
2445914|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445915|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2445916|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2445917|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445918|NCT00936936|Gemcitabine|gemcitabine|mesh-list
2445919|NCT00936936|Carboplatin|carboplatin|mesh-list
2445920|NCT00936936|Docetaxel|docetaxel|mesh-list
2445921|NCT00936936|Etoposide|etoposide|mesh-list
2445922|NCT00936936|Melphalan|melphalan|mesh-list
2445923|NCT00936936|Ifosfamide|ifosfamide|mesh-list
2445924|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445925|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2445926|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
2445927|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445928|NCT00936936|Antiviral Agents|antiviral agents|mesh-ancestor
2445929|NCT00936936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2445930|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445931|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2445932|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
2445933|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445934|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
2445935|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
2445936|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
2445937|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2445938|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2445939|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2445940|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2445941|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
2445942|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2445943|NCT00936962|Vaccines|vaccines|mesh-list
2445944|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
2445945|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445946|NCT00936988|Cinacalcet|cinacalcet|mesh-list
2445947|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2445948|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445949|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2445950|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
2445951|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445952|NCT00937027|Aminopterin|aminopterin|mesh-list
2445953|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2445954|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445955|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445956|NCT00937079|Exenatide|exenatide|mesh-list
2445957|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2445958|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445959|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2445960|NCT00937079|Incretins|incretins|mesh-ancestor
2445961|NCT00937079|Hormones|hormones|mesh-ancestor
2445962|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2445963|NCT00937092|Dopamine|dopamine|mesh-list
2445964|NCT00937092|Furosemide|furosemide|mesh-list
2445965|NCT00937092|Diuretics|diuretics|mesh-ancestor
2445966|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
2445967|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445968|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2445969|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2445970|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445971|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2445972|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
2445973|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
2445974|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2445975|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
2445976|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445977|NCT00937092|Protective Agents|protective agents|mesh-ancestor
2445978|NCT00937131|Rituximab|rituximab|mesh-list
2445979|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2445980|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2445981|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
2445982|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445983|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2445984|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
2445985|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
2445986|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2445987|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2445988|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2445989|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2445990|NCT00937144|Urological Agents|urological agents|mesh-ancestor
2445991|NCT00937183|Vaccines|vaccines|mesh-list
2445992|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
2445993|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2445994|NCT00937261|Risperidone|risperidone|mesh-list
2445995|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2445996|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2445997|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
2445998|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2445999|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446000|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446001|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2446002|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2446003|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2446004|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2446005|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2446006|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
2446007|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2446008|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2446009|NCT00937300|Vidarabine|vidarabine|mesh-list
2446010|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
2446011|NCT00937300|Fludarabine|fludarabine|mesh-list
2446012|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
2446013|NCT00937300|Interleukin-2|interleukin-2|mesh-list
2446014|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2446015|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
2446016|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446017|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2446018|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2446019|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
2446020|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446021|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446022|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2446023|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2446024|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
2446025|NCT00937300|Antiviral Agents|antiviral agents|mesh-ancestor
2446026|NCT00937300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446027|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2446028|NCT00937300|Analgesics|analgesics|mesh-ancestor
2446029|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
2446030|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446031|NCT00937417|Docetaxel|docetaxel|mesh-list
2446032|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446033|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
2446034|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
2446035|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
2446036|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446037|NCT00937482|Cediranib|cediranib|mesh-list
2446038|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446039|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446040|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446041|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2446042|NCT00937508|Varenicline|varenicline|mesh-list
2446043|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2446044|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2446045|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
2446046|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446047|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446048|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446049|NCT00937625|Vidarabine|vidarabine|mesh-list
2446050|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
2446051|NCT00937625|Fludarabine|fludarabine|mesh-list
2446052|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
2446053|NCT00937625|Interleukin-2|interleukin-2|mesh-list
2446054|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2446055|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
2446056|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446057|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2446058|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2446059|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
2446060|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446061|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446062|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2446063|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2446064|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
2446065|NCT00937625|Antiviral Agents|antiviral agents|mesh-ancestor
2446066|NCT00937625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446067|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2446068|NCT00937625|Analgesics|analgesics|mesh-ancestor
2446069|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
2446070|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446071|NCT00937664|Gemcitabine|gemcitabine|mesh-list
2446072|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2446073|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
2446074|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446075|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446076|NCT00937664|Antiviral Agents|antiviral agents|mesh-ancestor
2446077|NCT00937664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446078|NCT00937664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446079|NCT00937664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2446080|NCT00937664|Immunologic Factors|immunologic factors|mesh-ancestor
2446081|NCT00937664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446082|NCT00937677|Natalizumab|natalizumab|mesh-list
2446083|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
2446084|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446085|NCT00937807|Sevoflurane|sevoflurane|mesh-list
2446086|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2446087|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2446088|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
2446089|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
2446090|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2446091|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446092|NCT00937820|Darexaban|darexaban|mesh-list
2446093|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2446094|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
2446095|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2446096|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
2446097|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446098|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446099|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
2446100|NCT00937911|Darexaban|darexaban|mesh-list
2446101|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2446102|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
2446103|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2446104|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
2446105|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446106|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446107|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
2446108|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
2446109|NCT00937924|Promethazine|promethazine|mesh-list
2446110|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2446111|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2446112|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2446113|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446114|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
2446115|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
2446116|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
2446117|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446118|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
2446119|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
2446120|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2446121|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2446122|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
2446123|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
2446124|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446125|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446126|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2446127|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
2446128|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
2446129|NCT00938132|Warfarin|warfarin|mesh-list
2446130|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
2446131|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
2446132|NCT00938158|Incretins|incretins|mesh-ancestor
2446133|NCT00938158|Hormones|hormones|mesh-ancestor
2446134|NCT00938158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2446135|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446136|NCT00938171|Anesthetics|anesthetics|mesh-list
2446137|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2446138|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446139|NCT00938184|Paroxetine|paroxetine|mesh-list
2446140|NCT00938184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2446141|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2446142|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2446143|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446144|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446145|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
2446146|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446147|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2446148|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
2446149|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2446150|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2446151|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2446152|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446153|NCT00938197|Amlodipine|amlodipine|mesh-list
2446154|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2446155|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2446156|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2446157|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446158|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2446159|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446160|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
2446161|NCT00938236|Cyclosporine|cyclosporine|mesh-list
2446162|NCT00938236|Cyclosporins|cyclosporins|mesh-list
2446163|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446164|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446165|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2446166|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
2446167|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446168|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
2446169|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446170|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
2446171|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2446172|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2446173|NCT00938262|Ketoconazole|ketoconazole|mesh-list
2446174|NCT00938262|Rifampin|rifampin|mesh-list
2446175|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
2446176|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446177|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2446178|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2446179|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446180|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446181|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2446182|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
2446183|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2446184|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446185|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2446186|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2446187|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
2446188|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2446189|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
2446190|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2446191|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2446192|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2446193|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2446194|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2446195|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2446196|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2446197|NCT00938353|Beclomethasone|beclomethasone|mesh-list
2446198|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2446199|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
2446200|NCT00938353|Hormones|hormones|mesh-ancestor
2446201|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2446202|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446203|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2446204|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
2446205|NCT00938379|Insect Repellents|insect repellents|mesh-list
2446206|NCT00938379|Protective Agents|protective agents|mesh-ancestor
2446207|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446208|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
2446209|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2446210|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2446211|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
2446212|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446213|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2446214|NCT00938509|Ibuprofen|ibuprofen|mesh-list
2446215|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2446216|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2446217|NCT00938509|Analgesics|analgesics|mesh-ancestor
2446218|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
2446219|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446220|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446221|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2446222|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2446223|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2446224|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446225|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446226|NCT00938522|Cilostazol|cilostazol|mesh-list
2446227|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2446228|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
2446229|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446230|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446231|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2446232|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
2446233|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2446234|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2446235|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446236|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2446237|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
2446238|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2446239|NCT00938522|Protective Agents|protective agents|mesh-ancestor
2446240|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2446241|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2446242|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446243|NCT00938587|Prednisone|prednisone|mesh-list
2446244|NCT00938587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2446245|NCT00938587|Glucocorticoids|glucocorticoids|mesh-ancestor
2446246|NCT00938587|Hormones|hormones|mesh-ancestor
2446247|NCT00938587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2446248|NCT00938587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446249|NCT00938587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2446250|NCT00938587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446251|NCT00938600|Vitamin D|vitamin d|mesh-list
2446252|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
2446253|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
2446254|NCT00938600|Vitamins|vitamins|mesh-list
2446255|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
2446256|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446257|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2446258|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2446259|NCT00938613|Budesonide|budesonide|mesh-list
2446260|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2446261|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2446262|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
2446263|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446264|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446265|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2446266|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
2446267|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
2446268|NCT00938613|Hormones|hormones|mesh-ancestor
2446269|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2446270|NCT00938626|Antibodies|antibodies|mesh-list
2446271|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
2446272|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
2446273|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446274|NCT00938652|Gemcitabine|gemcitabine|mesh-list
2446275|NCT00938652|Carboplatin|carboplatin|mesh-list
2446276|NCT00938652|Iniparib|iniparib|mesh-list
2446277|NCT00938652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446278|NCT00938652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2446279|NCT00938652|Antimetabolites|antimetabolites|mesh-ancestor
2446280|NCT00938652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446281|NCT00938652|Antiviral Agents|antiviral agents|mesh-ancestor
2446282|NCT00938652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446283|NCT00938652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446284|NCT00938652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2446285|NCT00938652|Immunologic Factors|immunologic factors|mesh-ancestor
2446286|NCT00938652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446287|NCT00938652|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2446288|NCT00938730|Warfarin|warfarin|mesh-list
2446289|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
2446290|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2446291|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2446292|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2446293|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2446294|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446295|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
2446296|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446297|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446298|NCT00938821|Morphine|morphine|mesh-list
2446299|NCT00938821|Bupivacaine|bupivacaine|mesh-list
2446300|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
2446301|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
2446302|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2446303|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446304|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
2446305|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446306|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2446307|NCT00938821|Narcotics|narcotics|mesh-ancestor
2446308|NCT00938821|Analgesics|analgesics|mesh-ancestor
2446309|NCT00938899|Simeprevir|simeprevir|mesh-list
2446310|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
2446311|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446312|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
2446313|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446314|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446321|NCT00938990|Midazolam|midazolam|mesh-list
2446322|NCT00938990|Etomidate|etomidate|mesh-list
2446323|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2446324|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2446325|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2446326|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446327|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2446328|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2446329|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2446330|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2446331|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
2446332|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
2446333|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
2446334|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
2446335|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446336|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446337|NCT00939068|Telbivudine|telbivudine|mesh-list
2446338|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
2446339|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446340|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2446341|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446342|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446343|NCT00939133|Tretinoin|tretinoin|mesh-list
2446344|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446345|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
2446346|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
2446347|NCT00939276|Nepafenac|nepafenac|mesh-list
2446348|NCT00939276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2446349|NCT00939276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2446350|NCT00939276|Analgesics|analgesics|mesh-ancestor
2446351|NCT00939276|Sensory System Agents|sensory system agents|mesh-ancestor
2446352|NCT00939276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446353|NCT00939276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446354|NCT00939276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2446355|NCT00939276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2446356|NCT00939328|Rituximab|rituximab|mesh-list
2446357|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2446358|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2446359|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446360|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
2446361|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446362|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2446363|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2446364|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
2446365|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446366|NCT00939458|Lamotrigine|lamotrigine|mesh-list
2446367|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
2446368|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2446369|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2446370|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446371|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2446372|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446373|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2446374|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2446375|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2446376|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2446377|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2446378|NCT00939497|Risperidone|risperidone|mesh-list
2446379|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2446380|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
2446381|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446382|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446383|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446384|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2446385|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2446386|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2446387|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2446388|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2446389|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
2446390|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
2446391|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
2446392|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
2446393|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2446394|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
2446395|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446396|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2446397|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2446398|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
2446399|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446400|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446401|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2446402|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2446403|NCT00939588|Valsartan|valsartan|mesh-list
2446404|NCT00939588|Telmisartan|telmisartan|mesh-list
2446405|NCT00939588|Ramipril|ramipril|mesh-list
2446406|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2446407|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2446408|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2446409|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446410|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2446411|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
2446412|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446413|NCT00939614|Lamotrigine|lamotrigine|mesh-list
2446414|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
2446415|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2446416|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2446417|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446418|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2446419|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446420|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2446421|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2446422|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2446423|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2446424|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2446425|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
2446426|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
2446427|NCT00939718|Vitamins|vitamins|mesh-ancestor
2446428|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
2446429|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446430|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
2446431|NCT00939718|Hematinics|hematinics|mesh-ancestor
2446432|NCT00939757|Mirabegron|mirabegron|mesh-list
2446433|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2446434|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2446435|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2446436|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
2446437|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446438|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446439|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446440|NCT00939757|Urological Agents|urological agents|mesh-ancestor
2446441|NCT00939835|Dexetimide|dexetimide|mesh-list
2446442|NCT00939835|Citalopram|citalopram|mesh-list
2446443|NCT00939835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2446444|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2446445|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2446446|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446447|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446448|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
2446449|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446450|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2446451|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
2446452|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2446453|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2446454|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2446455|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
2446456|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
2446457|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446458|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2446459|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2446460|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
2446461|NCT00939848|Gemcitabine|gemcitabine|mesh-list
2446462|NCT00939848|Cisplatin|cisplatin|mesh-list
2446463|NCT00939848|Cediranib|cediranib|mesh-list
2446464|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446465|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2446466|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
2446467|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446468|NCT00939848|Antiviral Agents|antiviral agents|mesh-ancestor
2446469|NCT00939848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446470|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446471|NCT00939848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2446472|NCT00939848|Immunologic Factors|immunologic factors|mesh-ancestor
2446473|NCT00939848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446474|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2446475|NCT00939926|Risperidone|risperidone|mesh-list
2446476|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2446477|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
2446478|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446479|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446480|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446481|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2208224|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208225|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2208226|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2208227|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2208228|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2208229|NCT00010010|Exemestane|exemestane|mesh-list
2208230|NCT00010010|Goserelin|goserelin|mesh-list
2208231|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208232|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2208233|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2208234|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208235|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208236|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2446482|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2446483|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2446484|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2446485|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2446486|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
2446487|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2446488|NCT00939939|Glimepiride|glimepiride|mesh-list
2446489|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2446490|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446491|NCT00939939|Incretins|incretins|mesh-ancestor
2446492|NCT00939939|Hormones|hormones|mesh-ancestor
2446493|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2446494|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2446495|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
2446496|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446497|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446498|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2446499|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2446500|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
2446501|NCT00939965|Isotretinoin|isotretinoin|mesh-list
2446502|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
2446503|NCT00940004|Vaccines|vaccines|mesh-list
2446504|NCT00940004|Immunologic Factors|immunologic factors|mesh-ancestor
2446505|NCT00940004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446506|NCT00940069|Pemetrexed|pemetrexed|mesh-list
2446507|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446508|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446509|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446510|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2446511|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2446512|NCT00940121|Mirabegron|mirabegron|mesh-list
2446513|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2446514|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2446515|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2446516|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
2446517|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446518|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446519|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446520|NCT00940121|Urological Agents|urological agents|mesh-ancestor
2446521|NCT00940238|Dexetimide|dexetimide|mesh-list
2446522|NCT00940238|Citalopram|citalopram|mesh-list
2446523|NCT00940238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2446524|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2446525|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2446526|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446527|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446528|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
2446529|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446530|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2446531|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
2446532|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2446533|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2446534|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2446535|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
2446536|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
2446537|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446538|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2446539|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2446540|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
2446541|NCT00940303|Leucovorin|leucovorin|mesh-list
2446542|NCT00940303|Bevacizumab|bevacizumab|mesh-list
2446543|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
2446544|NCT00940303|Irinotecan|irinotecan|mesh-list
2446545|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2446546|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446547|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2446548|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2446549|NCT00940303|Growth Substances|growth substances|mesh-ancestor
2446550|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446551|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
2446552|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2446553|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2446554|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446555|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446556|NCT00940303|Antidotes|antidotes|mesh-ancestor
2446557|NCT00940303|Protective Agents|protective agents|mesh-ancestor
2446558|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
2446559|NCT00940303|Vitamins|vitamins|mesh-ancestor
2446560|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
2446561|NCT00940381|Sirolimus|sirolimus|mesh-list
2446562|NCT00940381|Cetuximab|cetuximab|mesh-list
2446563|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2446564|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446565|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2446566|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446567|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2446568|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
2446569|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2446570|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
2446571|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446572|NCT00940420|Ribavirin|ribavirin|mesh-list
2446573|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2446574|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
2446575|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
2446576|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446577|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
2446578|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446579|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
2446580|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446581|NCT00940472|Metformin|metformin|mesh-list
2446582|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2446583|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446584|NCT00940498|Gedatolisib|gedatolisib|mesh-list
2208237|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
2208238|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208239|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208240|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2208241|NCT00010023|Capecitabine|capecitabine|mesh-list
2208242|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446585|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2446586|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446587|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446588|NCT00940524|Cytarabine|cytarabine|mesh-list
2446589|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
2446590|NCT00940524|Methotrexate|methotrexate|mesh-list
2446591|NCT00940524|Etoposide|etoposide|mesh-list
2446592|NCT00940524|Asparaginase|asparaginase|mesh-list
2446593|NCT00940524|Dasatinib|dasatinib|mesh-list
2446594|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
2446595|NCT00940524|Pegaspargase|pegaspargase|mesh-list
2446596|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208243|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208244|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
2208245|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208246|NCT00010036|Carboplatin|carboplatin|mesh-list
2208247|NCT00010036|Irinotecan|irinotecan|mesh-list
2208248|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208249|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2208250|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2446597|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
2446598|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446599|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2446600|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2446601|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
2446602|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446603|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446604|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2446605|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2446606|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
2446607|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2446608|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2446609|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
2446610|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
2446611|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446612|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2446613|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2446614|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2446615|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2446616|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2446617|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
2446618|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446619|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2446620|NCT00940524|Analgesics|analgesics|mesh-ancestor
2446621|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
2446622|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446623|NCT00940550|Melatonin|melatonin|mesh-list
2446624|NCT00940550|Zolpidem|zolpidem|mesh-list
2446625|NCT00940550|Temazepam|temazepam|mesh-list
2446626|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
2446627|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446628|NCT00940550|Protective Agents|protective agents|mesh-ancestor
2446629|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446630|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2446631|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2446632|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2446633|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2446634|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
2446635|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
2446636|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446637|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2446638|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2446639|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2446640|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
2446641|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
2446642|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446643|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2446644|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446645|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446646|NCT00940628|Orlistat|orlistat|mesh-list
2446647|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446648|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446649|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2446650|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2446651|NCT00940654|Acetaminophen|acetaminophen|mesh-list
2446652|NCT00940654|Antipyretics|antipyretics|mesh-list
2446653|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2446654|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2446655|NCT00940654|Analgesics|analgesics|mesh-ancestor
2446656|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
2446657|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446658|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446659|NCT00940667|Losartan|losartan|mesh-list
2446660|NCT00940667|Amlodipine|amlodipine|mesh-list
2446661|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2446662|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2446663|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2446664|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446665|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2446666|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446667|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
2446668|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2446669|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2446670|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2446671|NCT00940680|Losartan|losartan|mesh-list
2446672|NCT00940680|Amlodipine|amlodipine|mesh-list
2446673|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2446674|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2446675|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2446676|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446677|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2446678|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446679|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
2446680|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2446681|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2446682|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2446683|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2446684|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2446685|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2446686|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2446687|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446688|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446689|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446690|NCT00940693|Analgesics|analgesics|mesh-ancestor
2446691|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
2446692|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446693|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
2446694|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2446695|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
2446696|NCT00940719|Vitamin D|vitamin d|mesh-list
2446697|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
2446698|NCT00940719|Vitamins|vitamins|mesh-ancestor
2446699|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
2446700|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446701|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2446702|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2446703|NCT00940784|Aspirin|aspirin|mesh-list
2446704|NCT00940784|Clopidogrel|clopidogrel|mesh-list
2446705|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2446706|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2446707|NCT00940784|Analgesics|analgesics|mesh-ancestor
2446708|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
2446709|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446710|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446711|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2446712|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2446713|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2446714|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2446715|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446716|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2446717|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2446718|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446719|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
2446720|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2446721|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2446722|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2446723|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
2446724|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446725|NCT00940836|Acetaminophen|acetaminophen|mesh-list
2446726|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
2446727|NCT00940836|Phenylephrine|phenylephrine|mesh-list
2446728|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2446729|NCT00940836|Analgesics|analgesics|mesh-ancestor
2446730|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
2446731|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446732|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446733|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
2446734|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2446735|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
2446736|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
2446737|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
2446738|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2446739|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
2446740|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
2446741|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2446742|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2446743|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2446744|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
2446745|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446746|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446747|NCT00940836|Protective Agents|protective agents|mesh-ancestor
2446748|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
2446749|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
2446750|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2446751|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
2446752|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
2446753|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2446754|NCT00940862|Adalimumab|adalimumab|mesh-list
2446755|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2446756|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2446757|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
2446758|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2446759|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446760|NCT00940940|Vaccines|vaccines|mesh-list
2446761|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
2446762|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446763|NCT00940953|Azelastine|azelastine|mesh-list
2446764|NCT00940953|Budesonide|budesonide|mesh-list
2446765|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2446766|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2446767|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
2446768|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2446769|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446770|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2446771|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
2446772|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
2446773|NCT00940953|Hormones|hormones|mesh-ancestor
2446774|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2446775|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
2446776|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446777|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446778|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2446779|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2446780|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2446781|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
2446782|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
2446783|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446784|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
2446785|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
2446786|NCT00941057|Dienogest|dienogest|mesh-list
2446787|NCT00941057|Calcium|calcium|mesh-list
2446788|NCT00941057|Nandrolone|nandrolone|mesh-list
2446789|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2446790|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446791|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2446792|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2446793|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
2446794|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2446795|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2446796|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2446797|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2446798|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2446799|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
2446800|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2446801|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2446802|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446803|NCT00941057|Androgens|androgens|mesh-ancestor
2446804|NCT00941057|Hormones|hormones|mesh-ancestor
2446805|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
2446806|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
2446807|NCT00941057|Vitamins|vitamins|mesh-ancestor
2446808|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
2446809|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
2446810|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2446811|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2446812|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
2446813|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446814|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2446815|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2446816|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446817|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446818|NCT00941096|Timolol|timolol|mesh-list
2446819|NCT00941096|Bimatoprost|bimatoprost|mesh-list
2446820|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2446821|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2446822|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
2446823|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446824|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446825|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446826|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2446827|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2446828|NCT00941109|Decitabine|decitabine|mesh-list
2446829|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2446830|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
2446831|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446832|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446833|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446834|NCT00941135|Docetaxel|docetaxel|mesh-list
2446835|NCT00941135|Cetuximab|cetuximab|mesh-list
2446836|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446837|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
2446838|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
2446839|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
2446840|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446841|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2446842|NCT00941148|Insulin|insulin|mesh-list
2446843|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2446844|NCT00941148|Metformin|metformin|mesh-list
2446845|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
2446846|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
2446847|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
2446848|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
2446849|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2446850|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446851|NCT00941161|Metformin|metformin|mesh-list
2446852|NCT00941161|Glimepiride|glimepiride|mesh-list
2446853|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2446854|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446855|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2446856|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2446857|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
2446858|NCT00941174|Leucovorin|leucovorin|mesh-list
2446859|NCT00941174|Calcium|calcium|mesh-list
2446860|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
2446861|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2446862|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446863|NCT00941174|Antidotes|antidotes|mesh-ancestor
2446864|NCT00941174|Protective Agents|protective agents|mesh-ancestor
2446865|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
2446866|NCT00941174|Vitamins|vitamins|mesh-ancestor
2446867|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
2446868|NCT00941239|Metformin|metformin|mesh-list
2446869|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2446870|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446871|NCT00941252|Imiquimod|imiquimod|mesh-list
2446872|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2446873|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
2446874|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446875|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446876|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
2446877|NCT00941265|Levodopa|levodopa|mesh-list
2446878|NCT00941265|Benserazide|benserazide|mesh-list
2446879|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2446880|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2446881|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
2446882|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446883|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446884|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446885|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446886|NCT00941343|Alfuzosin|alfuzosin|mesh-list
2446887|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2446888|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2446889|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2446890|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
2446891|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2446892|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446893|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446894|NCT00941343|Urological Agents|urological agents|mesh-ancestor
2446895|NCT00941369|Insulin|insulin|mesh-list
2446896|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
2446897|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
2446898|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
2446899|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
2446900|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2446901|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446902|NCT00941382|Metformin|metformin|mesh-list
2446903|NCT00941382|Sibutramine|sibutramine|mesh-list
2446904|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2446905|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446906|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
2446907|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2446908|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
2446909|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2446910|NCT00941460|Temozolomide|temozolomide|mesh-list
2446911|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2446912|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
2446913|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446914|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446915|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2446916|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2446917|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
2446918|NCT00941473|Hormones|hormones|mesh-ancestor
2446919|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2446920|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446921|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2446922|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
2446923|NCT00941499|Leucovorin|leucovorin|mesh-list
2446924|NCT00941499|Bevacizumab|bevacizumab|mesh-list
2446925|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2446926|NCT00941499|Cetuximab|cetuximab|mesh-list
2446927|NCT00941499|Fluorouracil|fluorouracil|mesh-list
2446928|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
2446929|NCT00941499|Antibodies|antibodies|mesh-list
2446930|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
2446931|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2446932|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446933|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2446934|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2446935|NCT00941499|Growth Substances|growth substances|mesh-ancestor
2446936|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446937|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
2446938|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
2446939|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
2446940|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446941|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2446942|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2446943|NCT00941499|Antidotes|antidotes|mesh-ancestor
2446944|NCT00941499|Protective Agents|protective agents|mesh-ancestor
2446945|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
2446946|NCT00941499|Vitamins|vitamins|mesh-ancestor
2446947|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
2446948|NCT00941525|Latanoprost|latanoprost|mesh-list
2446949|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2446950|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2446951|NCT00941616|Factor VIII|factor viii|mesh-list
2446952|NCT00941616|Coagulants|coagulants|mesh-ancestor
2446953|NCT00941785|Amodiaquine|amodiaquine|mesh-list
2446954|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
2446955|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2446956|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2446957|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446958|NCT00941811|Imiquimod|imiquimod|mesh-list
2446959|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2446960|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
2446961|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446962|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446963|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
2446964|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
2446965|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2446966|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446967|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2446968|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
2446969|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2446970|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446971|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446972|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446973|NCT00941967|Gemcitabine|gemcitabine|mesh-list
2446974|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
2446975|NCT00941967|Sorafenib|sorafenib|mesh-list
2446976|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2446977|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
2446978|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2446979|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2446980|NCT00941967|Antiviral Agents|antiviral agents|mesh-ancestor
2446981|NCT00941967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446982|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2446983|NCT00941967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2446984|NCT00941967|Immunologic Factors|immunologic factors|mesh-ancestor
2446985|NCT00941967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2446986|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2446987|NCT00942006|Doxycycline|doxycycline|mesh-list
2446988|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
2446989|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2446990|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2446991|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
2446992|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2446993|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2446994|NCT00942136|Dolutegravir|dolutegravir|mesh-list
2446995|NCT00942136|Omeprazole|omeprazole|mesh-list
2446996|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2446997|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2446998|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2446999|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447000|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447001|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2447002|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2447003|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2447004|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2447005|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
2447006|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447007|NCT00942201|Dexamethasone|dexamethasone|mesh-list
2447008|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
2447009|NCT00942201|BB 1101|bb 1101|mesh-list
2447010|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2447011|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
2447012|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
2447013|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447014|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447015|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2447016|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
2447017|NCT00942201|Hormones|hormones|mesh-ancestor
2447018|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2447019|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2447020|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447021|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
2447022|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447023|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447024|NCT00942214|Natalizumab|natalizumab|mesh-list
2447025|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
2447026|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447027|NCT00942253|Dopamine|dopamine|mesh-list
2447028|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
2447029|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2447030|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
2447031|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
2447032|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447033|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447034|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
2447035|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447036|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447037|NCT00942253|Protective Agents|protective agents|mesh-ancestor
2447038|NCT00942318|Insulin|insulin|mesh-list
2447039|NCT00942318|Metformin|metformin|mesh-list
2447040|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
2447041|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2447042|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447043|NCT00942344|Losartan|losartan|mesh-list
2447044|NCT00942344|Amlodipine|amlodipine|mesh-list
2447045|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2447046|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2447047|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2447048|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447049|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2447050|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447051|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
2447052|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2447053|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2447054|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2447055|NCT00942435|Darexaban|darexaban|mesh-list
2447056|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2447057|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
2447058|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2447059|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
2447060|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447061|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447062|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
2447063|NCT00942487|Nebivolol|nebivolol|mesh-list
2447064|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2447065|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
2447066|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2447067|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2447068|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2447069|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
2447070|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447071|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447072|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447073|NCT00942526|Nystatin|nystatin|mesh-list
2447074|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2447075|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447076|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
2447077|NCT00942526|Ionophores|ionophores|mesh-ancestor
2447078|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2447079|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447080|NCT00942539|Midazolam|midazolam|mesh-list
2447081|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2447082|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2447083|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2447084|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447085|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2447086|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2447087|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2447088|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2447089|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
2447090|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
2447091|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
2447092|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
2447093|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447094|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447095|NCT00942565|Acetaminophen|acetaminophen|mesh-list
2447096|NCT00942565|Tramadol|tramadol|mesh-list
2447097|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2447098|NCT00942565|Analgesics|analgesics|mesh-ancestor
2447099|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
2447100|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447101|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447102|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
2447103|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2447104|NCT00942565|Narcotics|narcotics|mesh-ancestor
2447105|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2447106|NCT00942591|Interferons|interferons|mesh-list
2447107|NCT00942591|Interferon-beta|interferon-beta|mesh-list
2447108|NCT00942591|Atorvastatin|atorvastatin|mesh-list
2447109|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
2447110|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447111|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
2447112|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447113|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2447114|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2447115|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
2447116|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447117|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2447118|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2447119|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447120|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
2447121|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447122|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2447123|NCT00942617|Aspirin|aspirin|mesh-list
2447124|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2447125|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2447126|NCT00942617|Analgesics|analgesics|mesh-ancestor
2447127|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
2447128|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447129|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447130|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2447131|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2447132|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2447133|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2447134|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447135|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2447136|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2447137|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447138|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
2447139|NCT00942682|Sorafenib|sorafenib|mesh-list
2447140|NCT00942682|Everolimus|everolimus|mesh-list
2447141|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447142|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2447143|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447144|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447145|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2447146|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
2447147|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447148|NCT00942747|Sirolimus|sirolimus|mesh-list
2447149|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2447150|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447151|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2447152|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447153|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
2447154|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2447155|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
2447156|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447157|NCT00942773|Voriconazole|voriconazole|mesh-list
2447158|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
2447159|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447160|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2447161|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2447162|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447163|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447164|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2447165|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
2447166|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2447167|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447168|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2447169|NCT00942838|Cisplatin|cisplatin|mesh-list
2447170|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447171|NCT00942864|Ranibizumab|ranibizumab|mesh-list
2447172|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2447173|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2447174|NCT00942864|Growth Substances|growth substances|mesh-ancestor
2447175|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447176|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
2447177|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447178|NCT00943059|Acipimox|acipimox|mesh-list
2447179|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2447180|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
2447181|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447182|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2447183|NCT00943137|Fluorouracil|fluorouracil|mesh-list
2447184|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
2447185|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447186|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2447187|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447188|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2447189|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
2447190|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447191|NCT00943176|Modafinil|modafinil|mesh-list
2447192|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2447193|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447194|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2447195|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2447196|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2447197|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447198|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
2447199|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2447200|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447201|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2447202|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
2447203|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2447204|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447205|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447206|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447207|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
2447208|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447209|NCT00943293|Fludarabine|fludarabine|mesh-list
2447210|NCT00943293|Melphalan|melphalan|mesh-list
2447211|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
2447212|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447213|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447214|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2447215|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
2447216|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447217|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2447218|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
2447219|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2447220|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2447221|NCT00943345|Indomethacin|indomethacin|mesh-list
2447222|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2447223|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2447224|NCT00943345|Analgesics|analgesics|mesh-ancestor
2447225|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
2447226|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447227|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447228|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2447229|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2447230|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
2447231|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
2447232|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2447233|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2447234|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447235|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447236|NCT00943358|Vaccines|vaccines|mesh-list
2447237|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
2447238|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447239|NCT00943410|Trastuzumab|trastuzumab|mesh-list
2447240|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2447241|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447242|NCT00943449|Sorafenib|sorafenib|mesh-list
2447243|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447244|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2447245|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447246|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447247|NCT00943462|Temozolomide|temozolomide|mesh-list
2447248|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2447249|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
2447250|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447251|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447252|NCT00943501|Liraglutide|liraglutide|mesh-list
2447253|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2447254|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447255|NCT00943501|Incretins|incretins|mesh-ancestor
2447256|NCT00943501|Hormones|hormones|mesh-ancestor
2447257|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2447258|NCT00943540|Lamivudine|lamivudine|mesh-list
2447259|NCT00943540|Emtricitabine|emtricitabine|mesh-list
2447260|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
2447261|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2447262|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2447263|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2447264|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447265|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447266|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
2447267|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447268|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2447269|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2447270|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2447271|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2447272|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2447273|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2447274|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
2447275|NCT00943553|Decitabine|decitabine|mesh-list
2447276|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2447277|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
2447278|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447279|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447280|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447281|NCT00943566|Sufentanil|sufentanil|mesh-list
2447282|NCT00943566|Morphine|morphine|mesh-list
2447283|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2447284|NCT00943566|Narcotics|narcotics|mesh-ancestor
2447285|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2447286|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447287|NCT00943566|Analgesics|analgesics|mesh-ancestor
2447288|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
2447289|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447290|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2447291|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2447292|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
2447293|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
2447294|NCT00943709|Insulin|insulin|mesh-list
2447295|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2447296|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
2447297|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2447298|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447299|NCT00943748|Deferiprone|deferiprone|mesh-list
2447300|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2447301|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
2447302|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
2447303|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447304|NCT00943839|Sunitinib|sunitinib|mesh-list
2447305|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447306|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2447307|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2447308|NCT00943839|Growth Substances|growth substances|mesh-ancestor
2447309|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447310|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
2447311|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2447312|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447313|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447314|NCT00943930|Dronabinol|dronabinol|mesh-list
2447315|NCT00943930|Amphetamine|amphetamine|mesh-list
2447316|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
2447317|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2447318|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447319|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
2447320|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
2447321|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447322|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
2447323|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447324|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447325|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
2447326|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2447327|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2447328|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2447329|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2447330|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
2447331|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2447332|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2447333|NCT00943930|Analgesics|analgesics|mesh-ancestor
2447334|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
2447335|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2447336|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2447337|NCT00943930|Hormones|hormones|mesh-ancestor
2447338|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2447339|NCT00943943|Plerixafor|plerixafor|mesh-list
2447340|NCT00943943|Sorafenib|sorafenib|mesh-list
2447341|NCT00943943|Lenograstim|lenograstim|mesh-list
2447342|NCT00943943|Sargramostim|sargramostim|mesh-list
2447343|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2447344|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
2447345|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447346|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447347|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2447348|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447349|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447350|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2447351|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2447352|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
2447353|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447354|NCT00943956|Everolimus|everolimus|mesh-list
2447355|NCT00943956|Leuprolide|leuprolide|mesh-list
2447356|NCT00943956|Bicalutamide|bicalutamide|mesh-list
2447357|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447358|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2447359|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
2447360|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447361|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2447362|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
2447363|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2447364|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2447365|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
2447366|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
2447367|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2447368|NCT00943982|Interferons|interferons|mesh-list
2447369|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
2447370|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447371|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
2447372|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447373|NCT00944177|Metformin|metformin|mesh-list
2447374|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2447375|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447376|NCT00944216|Emollients|emollients|mesh-list
2447377|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
2447378|NCT00944242|Sertraline|sertraline|mesh-list
2447379|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
2447380|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2447381|NCT00944242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2447382|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2447383|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2447384|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447385|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447386|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
2447387|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447388|NCT00944294|Adenosine|adenosine|mesh-list
2447389|NCT00944294|Binodenoson|binodenoson|mesh-list
2447390|NCT00944294|Analgesics|analgesics|mesh-ancestor
2447391|NCT00944294|Sensory System Agents|sensory system agents|mesh-ancestor
2447392|NCT00944294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447393|NCT00944294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447394|NCT00944294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2447395|NCT00944294|Vasodilator Agents|vasodilator agents|mesh-ancestor
2447396|NCT00944294|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2447397|NCT00944294|Purinergic Agonists|purinergic agonists|mesh-ancestor
2447398|NCT00944294|Purinergic Agents|purinergic agents|mesh-ancestor
2447399|NCT00944294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447400|NCT00944294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447401|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
2447402|NCT00944307|Antacids|antacids|mesh-list
2447403|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
2447404|NCT00944307|TEMPO|tempo|mesh-list
2447405|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2447406|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2447407|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
2447408|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447409|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2447410|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2447411|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447412|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447413|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2447414|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
2447415|NCT00944307|Protective Agents|protective agents|mesh-ancestor
2447416|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447417|NCT00944333|Clopidogrel|clopidogrel|mesh-list
2447418|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2447419|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2447420|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2447421|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2447422|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
2447423|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447424|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447425|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447426|NCT00944346|Metformin|metformin|mesh-list
2447427|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2447428|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447429|NCT00944359|Zinc|zinc|mesh-list
2447430|NCT00944359|Trace Elements|trace elements|mesh-ancestor
2447431|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
2447432|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447433|NCT00944385|Urinastatin|urinastatin|mesh-list
2447434|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2447435|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2447436|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
2447437|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447438|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447439|NCT00944398|Vitamins|vitamins|mesh-list
2447440|NCT00944398|Zinc|zinc|mesh-list
2447441|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
2447442|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
2447443|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
2447444|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447445|NCT00944398|Trace Elements|trace elements|mesh-ancestor
2447446|NCT00944398|Astringents|astringents|mesh-ancestor
2447447|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
2447448|NCT00944424|Vitamin D|vitamin d|mesh-list
2447449|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
2447450|NCT00944424|Vitamins|vitamins|mesh-list
2447451|NCT00944424|Docetaxel|docetaxel|mesh-list
2447452|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
2447453|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447454|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447455|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
2447456|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
2447457|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
2447458|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447459|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2447460|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2447461|NCT00944463|Gemcitabine|gemcitabine|mesh-list
2447462|NCT00944463|Simvastatin|simvastatin|mesh-list
2447463|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2447464|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
2447465|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447466|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447467|NCT00944463|Antiviral Agents|antiviral agents|mesh-ancestor
2447468|NCT00944463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447469|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447470|NCT00944463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2447471|NCT00944463|Immunologic Factors|immunologic factors|mesh-ancestor
2447472|NCT00944463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447473|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2447474|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2447475|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2447476|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2447477|NCT00944502|Dexamethasone|dexamethasone|mesh-list
2447478|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2447479|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
2447480|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
2447481|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447482|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447483|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2447484|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
2447485|NCT00944502|Hormones|hormones|mesh-ancestor
2447486|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2447487|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2447488|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447489|NCT00944515|Azithromycin|azithromycin|mesh-list
2447490|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2447491|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447492|NCT00944541|Maraviroc|maraviroc|mesh-list
2447493|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2447494|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2447495|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447496|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2447497|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2447498|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
2447499|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447500|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2447501|NCT00944606|Vitamin D|vitamin d|mesh-list
2447502|NCT00944606|Vitamins|vitamins|mesh-ancestor
2447503|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
2447504|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447505|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2447506|NCT00944619|Insulin|insulin|mesh-list
2447507|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2447508|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447509|NCT00944684|Ribavirin|ribavirin|mesh-list
2447510|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
2447511|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447512|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
2447513|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447514|NCT00944723|Vitamins|vitamins|mesh-list
2447515|NCT00944723|Zinc|zinc|mesh-list
2447516|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
2447517|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
2447518|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
2447519|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447520|NCT00944723|Trace Elements|trace elements|mesh-ancestor
2447521|NCT00944723|Astringents|astringents|mesh-ancestor
2447522|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
2447523|NCT00944801|Doxorubicin|doxorubicin|mesh-list
2447524|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2447525|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2447526|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447527|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2447528|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2447529|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447530|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447531|NCT00944814|Zinc|zinc|mesh-list
2447532|NCT00944814|Trace Elements|trace elements|mesh-ancestor
2447533|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
2447534|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447535|NCT00944840|Amodiaquine|amodiaquine|mesh-list
2447536|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
2447537|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2447538|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2447539|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447540|NCT00944853|Zinc|zinc|mesh-list
2447541|NCT00944853|Trace Elements|trace elements|mesh-ancestor
2447542|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
2447543|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447544|NCT00944892|Fasinumab|fasinumab|mesh-list
2447545|NCT00944892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2447546|NCT00944892|Analgesics|analgesics|mesh-ancestor
2447547|NCT00944892|Sensory System Agents|sensory system agents|mesh-ancestor
2447548|NCT00944892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447549|NCT00944892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447550|NCT00944918|Fulvestrant|fulvestrant|mesh-list
2447551|NCT00944918|Anastrozole|anastrozole|mesh-list
2447552|NCT00944918|Exemestane|exemestane|mesh-list
2447553|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2447554|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447555|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2447556|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2447557|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
2447558|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2447559|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447560|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2447561|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2447562|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447563|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447564|NCT00944957|Efavirenz|efavirenz|mesh-list
2447565|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
2447566|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2447567|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2447568|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447569|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447570|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
2447571|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447572|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2447573|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2447574|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2447575|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2447576|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2447577|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2447578|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2447579|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2447580|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2447581|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2447582|NCT00944970|Adenosine|adenosine|mesh-list
2447583|NCT00944970|Binodenoson|binodenoson|mesh-list
2447584|NCT00944970|Analgesics|analgesics|mesh-ancestor
2447585|NCT00944970|Sensory System Agents|sensory system agents|mesh-ancestor
2447586|NCT00944970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447587|NCT00944970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447588|NCT00944970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2447589|NCT00944970|Vasodilator Agents|vasodilator agents|mesh-ancestor
2447590|NCT00944970|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2447591|NCT00944970|Purinergic Agonists|purinergic agonists|mesh-ancestor
2447592|NCT00944970|Purinergic Agents|purinergic agents|mesh-ancestor
2447593|NCT00944970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447594|NCT00944970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447595|NCT00944996|Citalopram|citalopram|mesh-list
2447596|NCT00944996|Fluoxetine|fluoxetine|mesh-list
2447597|NCT00944996|Paroxetine|paroxetine|mesh-list
2447598|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2447599|NCT00944996|Sertraline|sertraline|mesh-list
2447600|NCT00944996|Clomipramine|clomipramine|mesh-list
2447601|NCT00944996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2447602|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2447603|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2447604|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447605|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447606|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
2447607|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447608|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2447609|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
2447610|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2447611|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2447612|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2447613|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447614|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2447615|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2447616|NCT00945022|Anesthetics|anesthetics|mesh-list
2447617|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2447618|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447619|NCT00945152|Vancomycin|vancomycin|mesh-list
2447620|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2447621|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447622|NCT00945178|Naproxen|naproxen|mesh-list
2447623|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2447624|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2447625|NCT00945178|Analgesics|analgesics|mesh-ancestor
2447626|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
2447627|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447628|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447629|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2447630|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2447631|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
2447632|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2447633|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447634|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447635|NCT00945269|Aldesleukin|aldesleukin|mesh-list
2447636|NCT00945269|Interleukin-2|interleukin-2|mesh-list
2447637|NCT00945269|Denileukin diftitox|denileukin diftitox|mesh-list
2447638|NCT00945269|Immunotoxins|immunotoxins|mesh-list
2447639|NCT00945269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447640|NCT00945269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2447641|NCT00945269|Analgesics|analgesics|mesh-ancestor
2447642|NCT00945269|Sensory System Agents|sensory system agents|mesh-ancestor
2447643|NCT00945269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447644|NCT00945269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447645|NCT00945269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2447646|NCT00945269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2447647|NCT00945269|Antiviral Agents|antiviral agents|mesh-ancestor
2447648|NCT00945269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447649|NCT00945269|Immunologic Factors|immunologic factors|mesh-ancestor
2447650|NCT00945308|Eptifibatide|eptifibatide|mesh-list
2447651|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2447652|NCT00945347|Miglustat|miglustat|mesh-list
2447653|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447654|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447655|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2447656|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2447657|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
2447658|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447659|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2447660|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2447661|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447662|NCT00945360|Letrozole|letrozole|mesh-list
2447663|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2447664|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447665|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2447666|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447667|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447668|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2447669|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
2447670|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2447671|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447672|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
2447673|NCT00945373|Calcium|calcium|mesh-list
2447674|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2447675|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447676|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
2447677|NCT00945373|Coagulants|coagulants|mesh-ancestor
2447678|NCT00945438|Vaccines|vaccines|mesh-list
2447679|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
2447680|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447681|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
2447682|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2447683|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
2447684|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447685|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447686|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2447687|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
2447688|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2447689|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
2447690|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447691|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447692|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2447693|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
2447694|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
2447695|NCT00945529|Protective Agents|protective agents|mesh-ancestor
2447696|NCT00945542|Hemostatics|hemostatics|mesh-list
2447697|NCT00945542|Coagulants|coagulants|mesh-ancestor
2447698|NCT00945620|Ropivacaine|ropivacaine|mesh-list
2447699|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
2447700|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
2447701|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2447702|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447703|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
2447704|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447705|NCT00945646|Dexamethasone|dexamethasone|mesh-list
2447706|NCT00945646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2447707|NCT00945646|Antiemetics|antiemetics|mesh-ancestor
2447708|NCT00945646|Autonomic Agents|autonomic agents|mesh-ancestor
2447709|NCT00945646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447710|NCT00945646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447711|NCT00945646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2447712|NCT00945646|Glucocorticoids|glucocorticoids|mesh-ancestor
2447713|NCT00945646|Hormones|hormones|mesh-ancestor
2447714|NCT00945646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2447715|NCT00945646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2447716|NCT00945646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447717|NCT00945724|Cytarabine|cytarabine|mesh-list
2447718|NCT00945724|Prednisolone|prednisolone|mesh-list
2447719|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
2447720|NCT00945724|Rituximab|rituximab|mesh-list
2447721|NCT00945724|Doxorubicin|doxorubicin|mesh-list
2447722|NCT00945724|Methotrexate|methotrexate|mesh-list
2447723|NCT00945724|Vincristine|vincristine|mesh-list
2447724|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2447725|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
2447726|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447727|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2447728|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2447729|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
2447730|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447731|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447732|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2447733|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2447734|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2447735|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2208251|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208252|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208253|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
2208254|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208255|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2208256|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208257|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208258|NCT00010062|Fluorouracil|fluorouracil|mesh-list
2208259|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
2208260|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208261|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208262|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447736|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2447737|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447738|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2447739|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
2447740|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2447741|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2447742|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
2447743|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
2447744|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2447745|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2447746|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
2447747|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447748|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2447749|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
2447750|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
2447751|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
2447752|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2447753|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
2447754|NCT00945724|Hormones|hormones|mesh-ancestor
2447755|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2447756|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2447757|NCT00945763|Ibuprofen|ibuprofen|mesh-list
2447758|NCT00945763|Meloxicam|meloxicam|mesh-list
2447759|NCT00945763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2447760|NCT00945763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2447761|NCT00945763|Analgesics|analgesics|mesh-ancestor
2447762|NCT00945763|Sensory System Agents|sensory system agents|mesh-ancestor
2447763|NCT00945763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447764|NCT00945763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447765|NCT00945763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2447766|NCT00945763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2447767|NCT00945763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2447768|NCT00945763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447769|NCT00945763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447770|NCT00945763|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2447771|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
2447772|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
2447773|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2447774|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
2447775|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447776|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447777|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2447778|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
2447779|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2447780|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
2447781|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447782|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447783|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
2447784|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
2447785|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
2447786|NCT00945789|Protective Agents|protective agents|mesh-ancestor
2447787|NCT00945789|Hematinics|hematinics|mesh-ancestor
2447788|NCT00945802|Ciprofloxacin|ciprofloxacin|mesh-list
2447789|NCT00945802|Dexamethasone|dexamethasone|mesh-list
2447790|NCT00945802|Dexamethasone acetate|dexamethasone acetate|mesh-list
2447791|NCT00945802|BB 1101|bb 1101|mesh-list
2447792|NCT00945802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2447793|NCT00945802|Antiemetics|antiemetics|mesh-ancestor
2447794|NCT00945802|Autonomic Agents|autonomic agents|mesh-ancestor
2447795|NCT00945802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447796|NCT00945802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447797|NCT00945802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2447798|NCT00945802|Glucocorticoids|glucocorticoids|mesh-ancestor
2447799|NCT00945802|Hormones|hormones|mesh-ancestor
2447800|NCT00945802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2447801|NCT00945802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2447802|NCT00945802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447803|NCT00945802|Protease Inhibitors|protease inhibitors|mesh-ancestor
2447804|NCT00945802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447805|NCT00945802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447806|NCT00945802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2447807|NCT00945802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447808|NCT00945802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2447809|NCT00945802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2447810|NCT00945802|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2447811|NCT00945802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2447812|NCT00945919|Oxymorphone|oxymorphone|mesh-list
2447813|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2447814|NCT00945919|Narcotics|narcotics|mesh-ancestor
2447815|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2447816|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447817|NCT00945919|Analgesics|analgesics|mesh-ancestor
2447818|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
2447819|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447820|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2447821|NCT00945997|Misoprostol|misoprostol|mesh-list
2447822|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2447823|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
2447824|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2447825|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447826|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2447827|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2447828|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
2447829|NCT00946036|Sertraline|sertraline|mesh-list
2447830|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
2447831|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2447832|NCT00946036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2447833|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2447834|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2447835|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447836|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447837|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
2447838|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447839|NCT00946166|Simvastatin|simvastatin|mesh-list
2447840|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2447841|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2447842|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
2447843|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447844|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2447845|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2447846|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447847|NCT00946179|Vaccines|vaccines|mesh-list
2447848|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
2447849|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447850|NCT00946335|Temozolomide|temozolomide|mesh-list
2447851|NCT00946335|Veliparib|veliparib|mesh-list
2447852|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2447853|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
2447854|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447855|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447856|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2447857|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447858|NCT00946374|Cyclosporine|cyclosporine|mesh-list
2447859|NCT00946374|Doxorubicin|doxorubicin|mesh-list
2447860|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2447861|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447862|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2447863|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2447864|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447865|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447866|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
2447867|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447868|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2447869|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2447870|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
2447871|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447872|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
2447873|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2447874|NCT00946387|Ondansetron|ondansetron|mesh-list
2447875|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
2447876|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
2447877|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447878|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447879|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2447880|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
2447881|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
2447882|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2447883|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
2447884|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447885|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447886|NCT00946387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2447887|NCT00946387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2447888|NCT00946387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2447889|NCT00946387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2447890|NCT00946387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2447891|NCT00946465|Ramipril|ramipril|mesh-list
2447892|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2447893|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
2447894|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447895|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447896|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2447897|NCT00946491|Haloperidol|haloperidol|mesh-list
2447898|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
2447899|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
2447900|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
2447901|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447902|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447903|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2447904|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2447905|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2447906|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2447907|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2447908|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2447909|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
2447910|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447911|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447912|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2447913|NCT00946504|Glipizide|glipizide|mesh-list
2447914|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2447915|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447916|NCT00946556|Valacyclovir|valacyclovir|mesh-list
2447917|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
2447918|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447919|NCT00946595|Ritonavir|ritonavir|mesh-list
2447920|NCT00946595|Lopinavir|lopinavir|mesh-list
2447921|NCT00946595|Tenofovir|tenofovir|mesh-list
2447922|NCT00946595|Efavirenz|efavirenz|mesh-list
2447923|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2447924|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2447925|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
2447926|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447927|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447928|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2447929|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2447930|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
2447931|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2447932|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2447933|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2447934|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2447935|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2447936|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2447937|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2447938|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2447939|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2447940|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2447941|NCT00946608|Loratadine|loratadine|mesh-list
2447942|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
2447943|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
2447944|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2447945|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2447946|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2447947|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
2447948|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
2447949|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447950|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447951|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447952|NCT00946621|Ramipril|ramipril|mesh-list
2447953|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2447954|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
2447955|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447956|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447957|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2447958|NCT00946673|Vorinostat|vorinostat|mesh-list
2447959|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2447960|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2447961|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447962|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447963|NCT00946686|Leflunomide|leflunomide|mesh-list
2447964|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2447965|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447966|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2447967|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
2447968|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447969|NCT00946725|Atenolol|atenolol|mesh-list
2447970|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2447971|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2447972|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
2447973|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
2447974|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2447975|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447976|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2447977|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2447978|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2447979|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
2447980|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447981|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447982|NCT00946751|Levetiracetam|levetiracetam|mesh-list
2447983|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
2447984|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
2447985|NCT00946764|Imipramine|imipramine|mesh-list
2447986|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2447987|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
2447988|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2447989|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2447990|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2447991|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2447992|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2447993|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
2447994|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2447995|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2447996|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
2447997|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
2447998|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2447999|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2448000|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448001|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448002|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448003|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2448004|NCT00946829|Telmisartan|telmisartan|mesh-list
2448005|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2448006|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2448007|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2448008|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448009|NCT00946907|Aspirin|aspirin|mesh-list
2448010|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2448011|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2448012|NCT00946907|Analgesics|analgesics|mesh-ancestor
2448013|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
2448014|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448015|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448016|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2448017|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2448018|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2448019|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2448020|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448021|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2448022|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2448023|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448024|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
2448025|NCT00946946|Mesalamine|mesalamine|mesh-list
2448026|NCT00946946|Azathioprine|azathioprine|mesh-list
2448027|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
2448028|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448029|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2448030|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448031|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2448032|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
2448033|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448034|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2448035|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2448036|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2448037|NCT00946946|Analgesics|analgesics|mesh-ancestor
2448038|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
2448039|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448040|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2448041|NCT00947024|Glipizide|glipizide|mesh-list
2448042|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2448043|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448044|NCT00947063|Promethazine|promethazine|mesh-list
2448045|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
2448046|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
2448047|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
2448048|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2448049|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
2448050|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
2448051|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2448052|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448053|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448054|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2448055|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2448056|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2448057|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2448058|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
2448059|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
2448060|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
2448061|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448062|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
2448063|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
2448064|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2448065|NCT00947076|Fluoxetine|fluoxetine|mesh-list
2448066|NCT00947076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2448067|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2448068|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2448069|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448070|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2448071|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
2448072|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448073|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2448074|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
2448075|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2448076|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2448077|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2448078|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448079|NCT00947128|Ondansetron|ondansetron|mesh-list
2448080|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
2448081|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
2448082|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448083|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448084|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2448085|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
2448086|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
2448087|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2448088|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
2448089|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2448090|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448091|NCT00947128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2448092|NCT00947128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2448093|NCT00947128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2448094|NCT00947128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2448095|NCT00947128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2448096|NCT00947141|Valganciclovir|valganciclovir|mesh-list
2448097|NCT00947141|Ganciclovir|ganciclovir|mesh-list
2448098|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2448099|NCT00947141|Foscarnet|foscarnet|mesh-list
2448100|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2448101|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
2448102|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448103|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2448104|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448105|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448106|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2448107|NCT00947323|Simvastatin|simvastatin|mesh-list
2448108|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2448109|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2448110|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
2448111|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448112|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2448113|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2448114|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448115|NCT00947336|Norfloxacin|norfloxacin|mesh-list
2448116|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2448117|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448118|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2448119|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2448120|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448121|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448122|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448123|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2448124|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2448125|NCT00947375|Lamotrigine|lamotrigine|mesh-list
2448126|NCT00947375|Haloperidol|haloperidol|mesh-list
2448127|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
2448128|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
2448129|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
2448130|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448131|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448132|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2448133|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2448134|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2448135|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2448136|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2448137|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2448138|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
2448139|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2448140|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448141|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2448142|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
2448143|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2448144|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2448145|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2448146|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2448147|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2448148|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
2448149|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2448150|NCT00947388|Antibodies|antibodies|mesh-list
2448151|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
2448152|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2448153|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
2448154|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448155|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448156|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2448157|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
2448158|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448159|NCT00947453|Montelukast|montelukast|mesh-list
2448160|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2448161|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
2448162|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2448163|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
2448164|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2448165|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448166|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2448167|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2448168|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448169|NCT00947466|Buprenorphine|buprenorphine|mesh-list
2448170|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2208263|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208264|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
2208265|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208266|NCT00010075|Leucovorin|leucovorin|mesh-list
2208267|NCT00010075|Fluorouracil|fluorouracil|mesh-list
2208268|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
2208269|NCT00010075|Calcium|calcium|mesh-list
2208270|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
2208271|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2208272|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208273|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
2208274|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208275|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208276|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208277|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208278|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
2208279|NCT00010075|Antidotes|antidotes|mesh-ancestor
2208280|NCT00010075|Protective Agents|protective agents|mesh-ancestor
2208281|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
2208282|NCT00010075|Vitamins|vitamins|mesh-ancestor
2208283|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
2208284|NCT00010075|Analgesics|analgesics|mesh-ancestor
2208285|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
2208286|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2208287|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2208288|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2208289|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208290|NCT00010088|Leucovorin|leucovorin|mesh-list
2208291|NCT00010088|Gemcitabine|gemcitabine|mesh-list
2208292|NCT00010088|Fluorouracil|fluorouracil|mesh-list
2208293|NCT00010088|Calcium|calcium|mesh-list
2208294|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
2208295|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208296|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
2208297|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208298|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208299|NCT00010088|Antiviral Agents|antiviral agents|mesh-ancestor
2208300|NCT00010088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208301|NCT00010088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208302|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208303|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
2208304|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208305|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2208306|NCT00010088|Antidotes|antidotes|mesh-ancestor
2208307|NCT00010088|Protective Agents|protective agents|mesh-ancestor
2208308|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
2208309|NCT00010088|Vitamins|vitamins|mesh-ancestor
2208310|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
2208311|NCT00010140|Tamoxifen|tamoxifen|mesh-list
2208312|NCT00010140|Docetaxel|docetaxel|mesh-list
2208313|NCT00010140|Epirubicin|epirubicin|mesh-list
2208314|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448171|NCT00947466|Narcotics|narcotics|mesh-ancestor
2448172|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2448173|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448174|NCT00947466|Analgesics|analgesics|mesh-ancestor
2448175|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
2448176|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448177|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2448178|NCT00947596|Atropine|atropine|mesh-list
2448179|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2448180|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2448181|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2448182|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
2448183|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448184|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448185|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2448186|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
2448187|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
2448188|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
2448189|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2448190|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2448191|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
2208315|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
2208316|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
2448192|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2448193|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448194|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2448195|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2448196|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448197|NCT00947739|Camptothecin|camptothecin|mesh-list
2448198|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2448199|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448200|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2448201|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2448202|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448203|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448204|NCT00947843|Aspirin|aspirin|mesh-list
2448205|NCT00947843|Clopidogrel|clopidogrel|mesh-list
2448206|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2448207|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2448208|NCT00947843|Analgesics|analgesics|mesh-ancestor
2448209|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
2448210|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448211|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448212|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2448213|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2448214|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2448215|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2448216|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448217|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2448218|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2448219|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448220|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
2448221|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2448222|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2448223|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2448224|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
2448225|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2448226|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
2448227|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2448228|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2448229|NCT00947895|Prednisolone|prednisolone|mesh-list
2448230|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
2448231|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2448232|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
2448233|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2448234|NCT00947895|Hormones|hormones|mesh-ancestor
2448235|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2448236|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448237|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2448238|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
2448239|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
2448240|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448241|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2448242|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
2448243|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2448244|NCT00947895|Protective Agents|protective agents|mesh-ancestor
2448245|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2448246|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448247|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
2448248|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
2448249|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2448250|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448251|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
2448252|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2448253|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
2448254|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
2448255|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2448256|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448257|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2448258|NCT00948103|Analgesics|analgesics|mesh-ancestor
2448259|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
2448260|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448261|NCT00948142|Linezolid|linezolid|mesh-list
2448262|NCT00948142|Fusidic Acid|fusidic acid|mesh-list
2448263|NCT00948142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2448264|NCT00948142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448265|NCT00948142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2448266|NCT00948142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448267|NCT00948142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448268|NCT00948168|Exenatide|exenatide|mesh-list
2448269|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2448270|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448271|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2448272|NCT00948168|Incretins|incretins|mesh-ancestor
2448273|NCT00948168|Hormones|hormones|mesh-ancestor
2448274|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2448275|NCT00948220|Ribavirin|ribavirin|mesh-list
2448276|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2448277|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
2448278|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448279|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
2448280|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448281|NCT00948272|Vaccines|vaccines|mesh-list
2448282|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
2448283|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448284|NCT00948402|Metformin|metformin|mesh-list
2448285|NCT00948402|Biguanides|biguanides|mesh-list
2448286|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
2448287|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
2448288|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2448289|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448290|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2448291|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2448292|NCT00948480|Sargramostim|sargramostim|mesh-list
2448293|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
2448294|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448295|NCT00948493|Insulin|insulin|mesh-list
2448296|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2448297|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2448298|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448299|NCT00948584|Insulin|insulin|mesh-list
2448300|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2448301|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
2448302|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2448303|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448304|NCT00948649|Varenicline|varenicline|mesh-list
2448305|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2448306|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2448307|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
2448308|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2448309|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448310|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448311|NCT00948662|Ketoconazole|ketoconazole|mesh-list
2448312|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
2448313|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448314|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2448315|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2448316|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448317|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448318|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2448319|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
2448320|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2448321|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448322|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2448323|NCT00948727|Cyclosporine|cyclosporine|mesh-list
2448324|NCT00948727|Cyclosporins|cyclosporins|mesh-list
2448325|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448326|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448327|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2448328|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
2448329|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448330|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
2448331|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448332|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
2448333|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2448334|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2448335|NCT00948740|Vitamin D|vitamin d|mesh-list
2448336|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
2448337|NCT00948740|Vitamins|vitamins|mesh-ancestor
2448338|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
2448339|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448340|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2448341|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2448342|NCT00948753|Maraviroc|maraviroc|mesh-list
2448343|NCT00948753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2448344|NCT00948753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2448345|NCT00948753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448346|NCT00948753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2448347|NCT00948753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2448348|NCT00948753|Antiviral Agents|antiviral agents|mesh-ancestor
2448349|NCT00948753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448350|NCT00948753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2448351|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2448352|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2448353|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448354|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
2448355|NCT00948805|Goserelin|goserelin|mesh-list
2448356|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2448357|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2448358|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448359|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2448360|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448361|NCT00948909|Donepezil|donepezil|mesh-list
2448362|NCT00948909|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2448363|NCT00948909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448364|NCT00948909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448365|NCT00948909|Cholinergic Agents|cholinergic agents|mesh-ancestor
2448366|NCT00948909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2448367|NCT00948909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448368|NCT00948909|Nootropic Agents|nootropic agents|mesh-ancestor
2448369|NCT00948961|Poly I-C|poly i-c|mesh-list
2448370|NCT00948961|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2448371|NCT00948961|Poly ICLC|poly iclc|mesh-list
2448372|NCT00948961|Interferon Inducers|interferon inducers|mesh-ancestor
2448373|NCT00948961|Immunologic Factors|immunologic factors|mesh-ancestor
2448374|NCT00948961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448375|NCT00948961|Laxatives|laxatives|mesh-ancestor
2448376|NCT00948961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2448377|NCT00948961|Antiviral Agents|antiviral agents|mesh-ancestor
2448378|NCT00948961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448379|NCT00948987|Aspirin|aspirin|mesh-list
2448380|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2448381|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2448382|NCT00948987|Analgesics|analgesics|mesh-ancestor
2448383|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
2448384|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448385|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448386|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2448387|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2448388|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2448389|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2448390|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448391|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2448392|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2448393|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448394|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
2448395|NCT00949026|Sirolimus|sirolimus|mesh-list
2448396|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2448397|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448398|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2448399|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448400|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
2448401|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2448402|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
2448403|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448404|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
2448405|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2448406|NCT00949065|Antibodies|antibodies|mesh-list
2448407|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
2448408|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2448409|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
2448410|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448411|NCT00949130|Linezolid|linezolid|mesh-list
2448412|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2448413|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448414|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2448415|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448416|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448417|NCT00949182|Doxorubicin|doxorubicin|mesh-list
2448418|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2448419|NCT00949182|Mitomycins|mitomycins|mesh-list
2448420|NCT00949182|Mitomycin|mitomycin|mesh-list
2448421|NCT00949182|Sorafenib|sorafenib|mesh-list
2448422|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2448423|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448424|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2448425|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2448426|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448427|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448428|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2448429|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
2448430|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2448431|NCT00949247|Bevacizumab|bevacizumab|mesh-list
2448432|NCT00949247|Trastuzumab|trastuzumab|mesh-list
2448433|NCT00949247|Carboplatin|carboplatin|mesh-list
2448434|NCT00949247|Docetaxel|docetaxel|mesh-list
2448435|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2448436|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448437|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2448438|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2448439|NCT00949247|Growth Substances|growth substances|mesh-ancestor
2448440|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448441|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
2448442|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
2448443|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
2448444|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
2448445|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448446|NCT00949299|Buprenorphine|buprenorphine|mesh-list
2448447|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2448448|NCT00949299|Narcotics|narcotics|mesh-ancestor
2448449|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2448450|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448451|NCT00949299|Analgesics|analgesics|mesh-ancestor
2448452|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
2448453|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448454|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2448455|NCT00949364|Pomalidomide|pomalidomide|mesh-list
2448456|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
2448457|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448458|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2448459|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2448460|NCT00949364|Growth Substances|growth substances|mesh-ancestor
2448461|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
2448462|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448463|NCT00949377|Bromides|bromides|mesh-list
2448464|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
2448465|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
2448466|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2448467|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448468|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
2208317|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208318|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208319|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2208320|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2208321|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2208322|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208323|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2208324|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
2448469|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448470|NCT00949442|Insulin|insulin|mesh-list
2448471|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2448472|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
2448473|NCT00949442|Glimepiride|glimepiride|mesh-list
2448474|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2448475|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448476|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2448477|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2448478|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
2448479|NCT00949455|Lapatinib|lapatinib|mesh-list
2448480|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448481|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2448482|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448483|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448484|NCT00949494|Hylan|hylan|mesh-list
2448485|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
2448486|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
2448487|NCT00949494|Protective Agents|protective agents|mesh-ancestor
2448488|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448489|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2448490|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
2448491|NCT00949546|Etanercept|etanercept|mesh-list
2448492|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2448493|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2448494|NCT00949546|Analgesics|analgesics|mesh-ancestor
2448495|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
2448496|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448497|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448498|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2448499|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2448500|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2448501|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2448502|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
2448503|NCT00949572|Vaccines|vaccines|mesh-list
2448504|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
2448505|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
2448506|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448507|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2448508|NCT00949598|Tamoxifen|tamoxifen|mesh-list
2448509|NCT00949598|Letrozole|letrozole|mesh-list
2448510|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448511|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448512|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2448513|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2448514|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448515|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2448516|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
2448517|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2448518|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448519|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2448520|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2448521|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2448522|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2448523|NCT00949624|Docetaxel|docetaxel|mesh-list
2448524|NCT00949624|Axitinib|axitinib|mesh-list
2448525|NCT00949624|Crenolanib|crenolanib|mesh-list
2448526|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448527|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
2448528|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
2448529|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
2448530|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448531|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2448532|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448533|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
2448534|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2448535|NCT00949663|Incretins|incretins|mesh-ancestor
2448536|NCT00949663|Hormones|hormones|mesh-ancestor
2448537|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2448538|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448539|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2448540|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
2448541|NCT00949728|Coagulants|coagulants|mesh-ancestor
2448542|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
2448543|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2448544|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2448545|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448546|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
2448547|NCT00949832|Vitamin D|vitamin d|mesh-list
2448548|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
2448549|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
2448550|NCT00949832|Vitamins|vitamins|mesh-list
2448551|NCT00949832|Calcium|calcium|mesh-list
2448552|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
2448553|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448554|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2448555|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2448556|NCT00949949|Gemcitabine|gemcitabine|mesh-list
2448557|NCT00949949|Everolimus|everolimus|mesh-list
2448558|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448559|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2448560|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
2448561|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448562|NCT00949949|Antiviral Agents|antiviral agents|mesh-ancestor
2448563|NCT00949949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448564|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448565|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2448566|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
2448567|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448568|NCT00949962|Leuprolide|leuprolide|mesh-list
2448569|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
2448570|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2448571|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
2448572|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2448573|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448574|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2448575|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448576|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
2448577|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2448578|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
2448579|NCT00950027|Povidone|povidone|mesh-list
2448580|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
2448581|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
2448582|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2448583|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448584|NCT00950066|Amlodipine|amlodipine|mesh-list
2448585|NCT00950066|Irbesartan|irbesartan|mesh-list
2448586|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2448587|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2448588|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2448589|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448590|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2448591|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448592|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
2448593|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2448594|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2448595|NCT00950105|Semapimod|semapimod|mesh-list
2448596|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2448597|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2448598|NCT00950105|Analgesics|analgesics|mesh-ancestor
2448599|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
2448600|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448601|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448602|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2448603|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2448604|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2448605|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
2448606|NCT00950196|Amantadine|amantadine|mesh-list
2448607|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2448608|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2448609|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
2448610|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448611|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
2448612|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2448613|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448614|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448615|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2448616|NCT00950196|Analgesics|analgesics|mesh-ancestor
2448617|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
2448618|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448619|NCT00950209|Heparin|heparin|mesh-list
2448620|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
2448621|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2448622|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2448623|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448624|NCT00950222|Imipenem|imipenem|mesh-list
2448625|NCT00950222|Amikacin|amikacin|mesh-list
2448626|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2448627|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448628|NCT00950261|Cisplatin|cisplatin|mesh-list
2448629|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448630|NCT00950339|Omeprazole|omeprazole|mesh-list
2448631|NCT00950339|Pantoprazole|pantoprazole|mesh-list
2448632|NCT00950339|Famotidine|famotidine|mesh-list
2448633|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2448634|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2448635|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2448636|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448637|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448638|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2448639|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
2448640|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
2448641|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2448642|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448643|NCT00950391|Tacrolimus|tacrolimus|mesh-list
2448644|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2448645|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
2448646|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448647|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2448648|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448649|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448650|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
2448651|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
2448652|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2448653|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2448654|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448655|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448656|NCT00950404|Urological Agents|urological agents|mesh-ancestor
2448657|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
2448658|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2448659|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448660|NCT00950430|Corticosterone|corticosterone|mesh-list
2448661|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2448662|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
2448663|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2448664|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448665|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
2448666|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
2448667|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
2448668|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2448669|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2448670|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2448671|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448672|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448673|NCT00950625|Lidocaine|lidocaine|mesh-list
2448674|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
2448675|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
2448676|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2448677|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448678|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
2448679|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448680|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2448681|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2448682|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2448683|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2448684|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448685|NCT00950677|Exenatide|exenatide|mesh-list
2448686|NCT00950677|Pramlintide|pramlintide|mesh-list
2448687|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2448688|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448689|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2448690|NCT00950677|Incretins|incretins|mesh-ancestor
2448691|NCT00950677|Hormones|hormones|mesh-ancestor
2208325|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208326|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208327|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2208328|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2208329|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2208330|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2208331|NCT00010153|Fulvestrant|fulvestrant|mesh-list
2208332|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2208333|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208334|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2208335|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2448692|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2448693|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
2448694|NCT00950794|Tulobuterol|tulobuterol|mesh-list
2448695|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2448696|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
2448697|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448698|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448699|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2448700|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
2448701|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2448702|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2448703|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2448704|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
2448705|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2448706|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448707|NCT00950820|Capecitabine|capecitabine|mesh-list
2448708|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
2448709|NCT00950820|Panitumumab|panitumumab|mesh-list
2448710|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2448711|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
2448712|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448713|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448714|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2448715|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
2448716|NCT00950846|Busulfan|busulfan|mesh-list
2448717|NCT00950846|Fludarabine|fludarabine|mesh-list
2448718|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2448719|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
2448720|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448721|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2448722|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2448723|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
2448724|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448725|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448726|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2448727|NCT00950885|Melatonin|melatonin|mesh-list
2448728|NCT00950885|Antioxidants|antioxidants|mesh-ancestor
2448729|NCT00950885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448730|NCT00950885|Protective Agents|protective agents|mesh-ancestor
2448731|NCT00950885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448732|NCT00950885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2448733|NCT00950898|Caffeine|caffeine|mesh-list
2448734|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2448735|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448736|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2448737|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448738|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448739|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2448740|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2448741|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
2448742|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2448761|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
2448762|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2448763|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
2448764|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2448765|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2448766|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448767|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2448768|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448769|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448770|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2448771|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2448772|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2448773|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
2448774|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448775|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2448776|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2448777|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448778|NCT00951223|Interferons|interferons|mesh-list
2448779|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
2448780|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448781|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
2448782|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448783|NCT00951236|Cortisone|cortisone|mesh-list
2448784|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2448785|NCT00951431|Esomeprazole|esomeprazole|mesh-list
2448786|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2448787|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2448788|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2448789|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448790|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448791|NCT00951444|Gemcitabine|gemcitabine|mesh-list
2448792|NCT00951444|Carboplatin|carboplatin|mesh-list
2448793|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448794|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2448795|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
2448796|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448797|NCT00951444|Antiviral Agents|antiviral agents|mesh-ancestor
2448798|NCT00951444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448799|NCT00951444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448800|NCT00951444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2448801|NCT00951444|Immunologic Factors|immunologic factors|mesh-ancestor
2448802|NCT00951444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448803|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2448804|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2448805|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
2448806|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448807|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448808|NCT00951574|Nadroparin|nadroparin|mesh-list
2448809|NCT00951574|Calcium|calcium|mesh-list
2448810|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2448811|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448812|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
2448813|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2448814|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2448815|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448816|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
2448817|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
2448818|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2448819|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2448820|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2448821|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448822|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2448823|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2448824|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2448825|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
2448826|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448827|NCT00951834|Protective Agents|protective agents|mesh-ancestor
2448828|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448829|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2448830|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2448831|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448832|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2448833|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
2448834|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
2448835|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2448836|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2448837|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2448838|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448839|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2448840|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2448841|NCT00952003|Bevacizumab|bevacizumab|mesh-list
2448842|NCT00952003|Docetaxel|docetaxel|mesh-list
2448843|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
2448844|NCT00952003|Irinotecan|irinotecan|mesh-list
2448845|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2448846|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448847|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2448848|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2448849|NCT00952003|Growth Substances|growth substances|mesh-ancestor
2448850|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448851|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
2448852|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
2448853|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
2448854|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
2448855|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448856|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2448857|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2448858|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448859|NCT00952016|Methotrexate|methotrexate|mesh-list
2448860|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2448861|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
2448862|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2448863|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448864|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2448865|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
2448866|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448867|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448868|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
2448869|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448870|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2448871|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2448872|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
2448873|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2448874|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2448875|NCT00952029|Leucovorin|leucovorin|mesh-list
2448876|NCT00952029|Bevacizumab|bevacizumab|mesh-list
2448877|NCT00952029|Fluorouracil|fluorouracil|mesh-list
2448878|NCT00952029|Irinotecan|irinotecan|mesh-list
2448879|NCT00952029|Calcium|calcium|mesh-list
2448880|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
2448881|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2448882|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448883|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2448884|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2448885|NCT00952029|Growth Substances|growth substances|mesh-ancestor
2448886|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448887|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
2448888|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2448889|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
2448890|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448891|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2448892|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2448893|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
2448894|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2448895|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2448896|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448897|NCT00952029|Antidotes|antidotes|mesh-ancestor
2448898|NCT00952029|Protective Agents|protective agents|mesh-ancestor
2448899|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
2448900|NCT00952029|Vitamins|vitamins|mesh-ancestor
2448901|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
2448902|NCT00952094|Cinacalcet|cinacalcet|mesh-list
2448903|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2448904|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448905|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2448906|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
2448907|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2448908|NCT00952159|Tramadol|tramadol|mesh-list
2448909|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
2448910|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2448911|NCT00952159|Narcotics|narcotics|mesh-ancestor
2448912|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2448913|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448914|NCT00952159|Analgesics|analgesics|mesh-ancestor
2448915|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
2448916|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448917|NCT00952185|Antibodies|antibodies|mesh-list
2448918|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
2448919|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448920|NCT00952302|Iron|iron|mesh-list
2448921|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2448922|NCT00952302|Trace Elements|trace elements|mesh-ancestor
2448923|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
2448924|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448925|NCT00952302|Hematinics|hematinics|mesh-ancestor
2448926|NCT00952432|Carbamazepine|carbamazepine|mesh-list
2448927|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
2448928|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
2448929|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2448930|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2448931|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448932|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2448933|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2448934|NCT00952432|Analgesics|analgesics|mesh-ancestor
2448935|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
2448936|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2448937|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2448938|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2448939|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448940|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2448941|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2448942|NCT00952497|Capecitabine|capecitabine|mesh-list
2448943|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448944|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2448945|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
2448946|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448947|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
2448948|NCT00952562|Vitamins|vitamins|mesh-ancestor
2448949|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
2448950|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448951|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2448952|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2448953|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
2448954|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2448955|NCT00952575|Antibodies|antibodies|mesh-list
2448956|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
2448957|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
2448958|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
2448959|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448960|NCT00952627|Pycnogenols|pycnogenols|mesh-list
2448961|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2448962|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
2448963|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448964|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
2448965|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448966|NCT00952627|Protective Agents|protective agents|mesh-ancestor
2448967|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2448968|NCT00952640|Vitamin A|vitamin a|mesh-list
2448969|NCT00952640|Vitamins|vitamins|mesh-ancestor
2448970|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
2448971|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2448977|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
2448978|NCT00952796|Ampicillin|ampicillin|mesh-list
2448979|NCT00952796|Sulbactam|sulbactam|mesh-list
2448980|NCT00952796|Sultamicillin|sultamicillin|mesh-list
2448981|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2448982|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448983|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2448984|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2448985|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2448986|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2448987|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2448988|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2448989|NCT00952861|Doxycycline|doxycycline|mesh-list
2448990|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2448991|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2448992|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
2448993|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2448994|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2448995|NCT00952913|Lansoprazole|lansoprazole|mesh-list
2448996|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
2448997|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2448998|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2448999|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2449000|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449001|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449002|NCT00952952|Mesalamine|mesalamine|mesh-list
2449003|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2449004|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2449005|NCT00952952|Analgesics|analgesics|mesh-ancestor
2449006|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
2449007|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449008|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449009|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2449010|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2449011|NCT00952978|Omeprazole|omeprazole|mesh-list
2449012|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2449013|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449014|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2449015|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449016|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449017|NCT00952991|Vildagliptin|vildagliptin|mesh-list
2449018|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2449019|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449020|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2449021|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
2449022|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449023|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449024|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2449025|NCT00953108|Citalopram|citalopram|mesh-list
2449026|NCT00953108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2449027|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2449028|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2449029|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449030|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449031|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
2449032|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449033|NCT00953108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2449034|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
2449035|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2449036|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2449037|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2449038|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2449039|NCT00953134|Folic Acid|folic acid|mesh-list
2449040|NCT00953134|Micronutrients|micronutrients|mesh-list
2449041|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
2449042|NCT00953134|Trace Elements|trace elements|mesh-list
2449043|NCT00953134|Hematinics|hematinics|mesh-ancestor
2449044|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
2449045|NCT00953134|Vitamins|vitamins|mesh-ancestor
2449046|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449047|NCT00953303|Dexamethasone|dexamethasone|mesh-list
2449048|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
2449049|NCT00953303|Prednisone|prednisone|mesh-list
2449050|NCT00953303|Torsemide|torsemide|mesh-list
2449051|NCT00953303|Dobutamine|dobutamine|mesh-list
2449052|NCT00953303|Dopamine|dopamine|mesh-list
2449053|NCT00953303|Furosemide|furosemide|mesh-list
2449054|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
2449055|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
2449056|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2449057|NCT00953303|BB 1101|bb 1101|mesh-list
2449058|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2449059|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
2449060|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
2449061|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449062|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449063|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449064|NCT00953303|Hormones|hormones|mesh-ancestor
2449065|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2449066|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2449067|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449068|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
2449069|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449070|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449071|NCT00953303|Diuretics|diuretics|mesh-ancestor
2449072|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
2449073|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2449074|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2449075|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
2449076|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2449077|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
2449078|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2449079|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2449080|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2449081|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
2449082|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449083|NCT00953303|Protective Agents|protective agents|mesh-ancestor
2449084|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
2449085|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2449086|NCT00953355|Metformin|metformin|mesh-list
2449087|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2449088|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449089|NCT00953381|Omeprazole|omeprazole|mesh-list
2449090|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2449091|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449092|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2449093|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449094|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449095|NCT00953394|Octreotide|octreotide|mesh-list
2449096|NCT00953394|Fluorouracil|fluorouracil|mesh-list
2449097|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449098|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2449099|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449100|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
2449101|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449102|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2449103|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2449104|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
2449105|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449106|NCT00953420|Dexamethasone|dexamethasone|mesh-list
2449107|NCT00953420|Carboplatin|carboplatin|mesh-list
2449108|NCT00953420|Docetaxel|docetaxel|mesh-list
2449109|NCT00953420|Lenograstim|lenograstim|mesh-list
2449110|NCT00953420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2449111|NCT00953420|Antiemetics|antiemetics|mesh-ancestor
2449112|NCT00953420|Autonomic Agents|autonomic agents|mesh-ancestor
2449113|NCT00953420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449114|NCT00953420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449115|NCT00953420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449116|NCT00953420|Glucocorticoids|glucocorticoids|mesh-ancestor
2449117|NCT00953420|Hormones|hormones|mesh-ancestor
2449118|NCT00953420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2449119|NCT00953420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2449120|NCT00953420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449121|NCT00953420|Tubulin Modulators|tubulin modulators|mesh-ancestor
2449122|NCT00953420|Antimitotic Agents|antimitotic agents|mesh-ancestor
2449123|NCT00953420|Mitosis Modulators|mitosis modulators|mesh-ancestor
2449124|NCT00953420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449125|NCT00953420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2449126|NCT00953420|Immunologic Factors|immunologic factors|mesh-ancestor
2449127|NCT00953459|Sunitinib|sunitinib|mesh-list
2449128|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2449129|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449130|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2449131|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2449132|NCT00953459|Growth Substances|growth substances|mesh-ancestor
2449133|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449134|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
2449135|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2449136|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449137|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449138|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2449139|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2449140|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
2449141|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449142|NCT00953498|Pioglitazone|pioglitazone|mesh-list
2449143|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
2449144|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2449145|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449146|NCT00953537|Capecitabine|capecitabine|mesh-list
2449147|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2449148|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
2449149|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449150|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449151|NCT00953550|Rocuronium|rocuronium|mesh-list
2449152|NCT00953550|Succinylcholine|succinylcholine|mesh-list
2449153|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2449154|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2449155|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2449156|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449157|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449158|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
2449159|NCT00953589|Ribavirin|ribavirin|mesh-list
2449160|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
2449161|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449162|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
2449163|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449164|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2449165|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2449166|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449167|NCT00953641|Misoprostol|misoprostol|mesh-list
2449168|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2449169|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
2449170|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2449171|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449172|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2449173|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449174|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
2449175|NCT00953771|Danazol|danazol|mesh-list
2449176|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2449177|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
2449178|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2449179|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449180|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
2449181|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2449182|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449183|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449184|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
2449185|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449186|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449187|NCT00954005|Gemcitabine|gemcitabine|mesh-list
2449188|NCT00954005|Rituximab|rituximab|mesh-list
2449189|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
2449190|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2449191|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449192|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
2449193|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449194|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2449195|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2449196|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
2449197|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449198|NCT00954005|Antiviral Agents|antiviral agents|mesh-ancestor
2449199|NCT00954005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449200|NCT00954005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449201|NCT00954005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2449202|NCT00954096|Nicotine|nicotine|mesh-list
2449203|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2449204|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
2449205|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449206|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449207|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2449208|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2449209|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
2449210|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449211|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449212|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
2449213|NCT00954135|Sorafenib|sorafenib|mesh-list
2449214|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2449215|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
2449216|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449217|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2449218|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2449219|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
2449220|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449221|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449222|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2449223|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2449224|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449225|NCT00954200|Ibuprofen|ibuprofen|mesh-list
2449226|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2449227|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2449228|NCT00954200|Analgesics|analgesics|mesh-ancestor
2449229|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
2449230|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449231|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449232|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2449233|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2449234|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2449235|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449236|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449237|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2449238|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449239|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2449240|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449241|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449242|NCT00954252|Flurbiprofen|flurbiprofen|mesh-list
2449243|NCT00954252|Analgesics|analgesics|mesh-ancestor
2449244|NCT00954252|Sensory System Agents|sensory system agents|mesh-ancestor
2449245|NCT00954252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449246|NCT00954252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449247|NCT00954252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2449248|NCT00954252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2449249|NCT00954252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2449250|NCT00954252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2449251|NCT00954252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2449252|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449253|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449254|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2449255|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2449256|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449257|NCT00954278|Sorafenib|sorafenib|mesh-list
2449258|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449259|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2449260|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449261|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449262|NCT00954304|Loperamide|loperamide|mesh-list
2449263|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
2449264|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449265|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
2449266|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
2449267|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2449268|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2449269|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449270|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
2449271|NCT00954395|Coagulants|coagulants|mesh-ancestor
2449272|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
2449273|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
2449274|NCT00954486|Hematinics|hematinics|mesh-ancestor
2449275|NCT00954525|Ascorbic Acid|ascorbic acid|mesh-list
2449276|NCT00954525|Gemcitabine|gemcitabine|mesh-list
2449277|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2449278|NCT00954525|Vitamins|vitamins|mesh-ancestor
2449279|NCT00954525|Micronutrients|micronutrients|mesh-ancestor
2449280|NCT00954525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449281|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2449282|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
2449283|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449284|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449285|NCT00954525|Antiviral Agents|antiviral agents|mesh-ancestor
2449286|NCT00954525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449287|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449288|NCT00954525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2449289|NCT00954525|Immunologic Factors|immunologic factors|mesh-ancestor
2449290|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2449291|NCT00954525|Antioxidants|antioxidants|mesh-ancestor
2449292|NCT00954525|Protective Agents|protective agents|mesh-ancestor
2449293|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2449294|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2449295|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449296|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449297|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2449298|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
2449299|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2449300|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449301|NCT00954603|Haloperidol|haloperidol|mesh-list
2449302|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2449303|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
2449304|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
2449305|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2449306|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2449307|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2449308|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2449309|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449310|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
2449311|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
2449312|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449313|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449314|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2449315|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
2449316|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449317|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449318|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2449319|NCT00954642|Paclitaxel|paclitaxel|mesh-list
2449320|NCT00954642|Bevacizumab|bevacizumab|mesh-list
2449321|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2449322|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449323|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
2449324|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
2449325|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
2449326|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449327|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2449328|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2449329|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2449330|NCT00954642|Growth Substances|growth substances|mesh-ancestor
2449331|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449332|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
2449333|NCT00954785|Diclofenac|diclofenac|mesh-list
2449334|NCT00954785|Etoricoxib|etoricoxib|mesh-list
2449335|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2449336|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2449337|NCT00954785|Analgesics|analgesics|mesh-ancestor
2449338|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
2449339|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449340|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449341|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2449342|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2449343|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2449344|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449345|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449346|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2449347|NCT00954798|Vaccines|vaccines|mesh-list
2449348|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
2449349|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449350|NCT00954811|Progesterone|progesterone|mesh-list
2449351|NCT00954811|Progestins|progestins|mesh-ancestor
2449352|NCT00954811|Hormones|hormones|mesh-ancestor
2449353|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2449354|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449355|NCT00954876|Capecitabine|capecitabine|mesh-list
2449356|NCT00954876|Cetuximab|cetuximab|mesh-list
2449357|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2449358|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
2449359|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449360|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449361|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2449362|NCT00954889|Tamsulosin|tamsulosin|mesh-list
2449363|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2449364|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2449365|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2449366|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
2449367|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449368|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449369|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449370|NCT00954889|Urological Agents|urological agents|mesh-ancestor
2449371|NCT00954902|Antioxidants|antioxidants|mesh-list
2449372|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449373|NCT00954902|Protective Agents|protective agents|mesh-ancestor
2449374|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449375|NCT00955045|Istradefylline|istradefylline|mesh-list
2449376|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2449377|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2449378|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2449379|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
2449380|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449381|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449382|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449383|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2449384|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449385|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2449386|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449387|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449388|NCT00955162|Buprenorphine|buprenorphine|mesh-list
2449389|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2449390|NCT00955162|Naloxone|naloxone|mesh-list
2449391|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2449392|NCT00955162|Narcotics|narcotics|mesh-ancestor
2449393|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2449394|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449395|NCT00955162|Analgesics|analgesics|mesh-ancestor
2449396|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
2449397|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449398|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2449399|NCT00955214|Paclitaxel|paclitaxel|mesh-list
2449400|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2449401|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449402|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
2449403|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
2449404|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
2449405|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449406|NCT00955227|Ezetimibe|ezetimibe|mesh-list
2449407|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2449408|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2449409|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
2449410|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449411|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2449412|NCT00955240|Fluorouracil|fluorouracil|mesh-list
2449413|NCT00955240|Cetuximab|cetuximab|mesh-list
2449414|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449415|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
2449416|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449417|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2449418|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2449419|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
2449420|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449421|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2449422|NCT00955318|Apomorphine|apomorphine|mesh-list
2449423|NCT00955318|Emetics|emetics|mesh-ancestor
2449424|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449425|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
2449426|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449427|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449428|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
2449429|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
2449430|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449431|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449432|NCT00955526|Istradefylline|istradefylline|mesh-list
2449433|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2449434|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2449435|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2449436|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
2449437|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449438|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449439|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449440|NCT00955604|Rasagiline|rasagiline|mesh-list
2449441|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
2449442|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2449443|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2449444|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449445|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449446|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2449447|NCT00955604|Protective Agents|protective agents|mesh-ancestor
2449448|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449449|NCT00955630|Ranibizumab|ranibizumab|mesh-list
2449450|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2449451|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2449452|NCT00955630|Growth Substances|growth substances|mesh-ancestor
2449453|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449454|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
2449455|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449456|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2449457|NCT00955695|Gefitinib|gefitinib|mesh-list
2449458|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449459|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2449460|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449461|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449462|NCT00955773|Everolimus|everolimus|mesh-list
2449463|NCT00955773|Trametinib|trametinib|mesh-list
2449464|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449465|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2449466|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
2449467|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449468|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2449469|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449470|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449471|NCT00955851|Vaccines|vaccines|mesh-list
2449472|NCT00955851|Immunologic Factors|immunologic factors|mesh-ancestor
2449473|NCT00955851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449474|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
2449475|NCT00955890|Razoxane|razoxane|mesh-list
2449476|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449477|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2449478|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2449479|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2449480|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449481|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449482|NCT00955890|Protective Agents|protective agents|mesh-ancestor
2449483|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449484|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
2449485|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
2449486|NCT00955981|Lesinurad|lesinurad|mesh-list
2449487|NCT00955981|Gout Suppressants|gout suppressants|mesh-ancestor
2449488|NCT00955981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2449489|NCT00955981|Uricosuric Agents|uricosuric agents|mesh-ancestor
2449490|NCT00955981|Renal Agents|renal agents|mesh-ancestor
2449491|NCT00956007|Cetuximab|cetuximab|mesh-list
2449492|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2449493|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449494|NCT00956046|Vaccines|vaccines|mesh-list
2449495|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
2449496|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449497|NCT00956059|Prednisone|prednisone|mesh-list
2449498|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2449499|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
2449500|NCT00956059|Hormones|hormones|mesh-ancestor
2449501|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2449502|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449503|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2449504|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449505|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
2449506|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449507|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2449508|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449509|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449510|NCT00956098|Oltipraz|oltipraz|mesh-list
2449511|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
2449512|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449513|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
2449514|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2449515|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
2449516|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2449517|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2449518|NCT00956098|Protective Agents|protective agents|mesh-ancestor
2449519|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449520|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449521|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2449522|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2449523|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449524|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449525|NCT00956111|Vaccines|vaccines|mesh-list
2449526|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
2449527|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449528|NCT00956150|Rifaximin|rifaximin|mesh-list
2449529|NCT00956150|Lactulose|lactulose|mesh-list
2449530|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2449531|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449532|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449533|NCT00956163|Diphosphonates|diphosphonates|mesh-list
2449534|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
2449535|NCT00956163|Listerine|listerine|mesh-list
2449536|NCT00956163|Fluorides|fluorides|mesh-list
2449537|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
2449538|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
2449539|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
2449540|NCT00956163|Protective Agents|protective agents|mesh-ancestor
2449541|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449542|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2449543|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449544|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2449545|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449546|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2449547|NCT00956176|Cidofovir|cidofovir|mesh-list
2449548|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
2449549|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449550|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449551|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449552|NCT00956189|Aripiprazole|aripiprazole|mesh-list
2449553|NCT00956189|Amisulpride|amisulpride|mesh-list
2449554|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
2449555|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2449556|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2449557|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2449558|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2449559|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449560|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
2449561|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
2449562|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449563|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449564|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2449565|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2449566|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
2449567|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2449568|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2449569|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2449570|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2449571|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2449572|NCT00956202|Vaccines|vaccines|mesh-list
2449573|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
2449574|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449575|NCT00956215|Aprepitant|aprepitant|mesh-list
2449576|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
2449577|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
2449578|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
2449579|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449580|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449581|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449582|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2449583|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449584|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449585|NCT00956267|Letrozole|letrozole|mesh-list
2449586|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449587|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2449588|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2449589|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449590|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449591|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2449592|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
2449593|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2449594|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449595|NCT00956306|Udenafil|udenafil|mesh-list
2449596|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2449597|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2449598|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449599|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449600|NCT00956319|Estazolam|estazolam|mesh-list
2449601|NCT00956319|Zolpidem|zolpidem|mesh-list
2449602|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2449603|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2449604|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2449605|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449606|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2449607|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
2449608|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
2449609|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449610|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208336|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
2208337|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208338|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208339|NCT00010166|Gemcitabine|gemcitabine|mesh-list
2208340|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208341|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
2208342|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208343|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208344|NCT00010166|Antiviral Agents|antiviral agents|mesh-ancestor
2208345|NCT00010166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208346|NCT00010166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208347|NCT00010166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208348|NCT00010166|Immunologic Factors|immunologic factors|mesh-ancestor
2208349|NCT00010166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208350|NCT00010179|Lurtotecan|lurtotecan|mesh-list
2449611|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
2449612|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2449613|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2449614|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2449615|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
2449616|NCT00956397|Rifaximin|rifaximin|mesh-list
2449617|NCT00956397|Lactulose|lactulose|mesh-list
2449618|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2449619|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449620|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449621|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2449622|NCT00956436|Sorafenib|sorafenib|mesh-list
2449623|NCT00956436|Liver Extracts|liver extracts|mesh-list
2449624|NCT00956436|Antibodies|antibodies|mesh-list
2449625|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
2449626|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2449627|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
2449628|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449629|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449630|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2449631|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449632|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449633|NCT00956436|Hematinics|hematinics|mesh-ancestor
2449634|NCT00956462|Dexamethasone|dexamethasone|mesh-list
2449635|NCT00956462|Ketorolac|ketorolac|mesh-list
2449636|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2449637|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2449638|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
2449639|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
2449640|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449641|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449642|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449643|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
2449644|NCT00956462|Hormones|hormones|mesh-ancestor
2449645|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2449646|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2449647|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449648|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2449649|NCT00956462|Analgesics|analgesics|mesh-ancestor
2449650|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
2449651|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2449652|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2449653|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449654|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449655|NCT00956644|Amlodipine|amlodipine|mesh-list
2449656|NCT00956644|Irbesartan|irbesartan|mesh-list
2449657|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2449658|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2449659|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2449660|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449661|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2449662|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449663|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
2449664|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2449665|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2449666|NCT00956696|Topiramate|topiramate|mesh-list
2449667|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
2449668|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2449669|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449670|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
2449671|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
2449672|NCT00956748|Dexamethasone|dexamethasone|mesh-list
2449673|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2449674|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
2449675|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
2449676|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449677|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449678|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449679|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
2449680|NCT00956748|Hormones|hormones|mesh-ancestor
2449681|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2449682|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2449683|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449684|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449685|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449686|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
2449687|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449688|NCT00956748|Expectorants|expectorants|mesh-ancestor
2449689|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
2449690|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2449691|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
2449692|NCT00956748|Protective Agents|protective agents|mesh-ancestor
2449693|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2449694|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2449695|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2449696|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2449697|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2449698|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
2449699|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2449700|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449701|NCT00956982|Interferons|interferons|mesh-list
2449702|NCT00956982|Ribavirin|ribavirin|mesh-list
2449703|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
2449704|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
2449705|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2449706|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449707|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
2449708|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449709|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
2449710|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449711|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
2449712|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449713|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2449714|NCT00957060|Glimepiride|glimepiride|mesh-list
2449715|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2449716|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449717|NCT00957060|Incretins|incretins|mesh-ancestor
2449718|NCT00957060|Hormones|hormones|mesh-ancestor
2449719|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2449720|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2449721|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
2449722|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449723|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449724|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2449725|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2449726|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
2449727|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
2449728|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2449729|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449730|NCT00957125|Bevacizumab|bevacizumab|mesh-list
2449731|NCT00957125|Docetaxel|docetaxel|mesh-list
2449732|NCT00957125|Epirubicin|epirubicin|mesh-list
2449733|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2449734|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449735|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2449736|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2449737|NCT00957125|Growth Substances|growth substances|mesh-ancestor
2449738|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449739|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
2449740|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
2449741|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
2449742|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
2449743|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449744|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2449745|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2449746|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2449747|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449748|NCT00957177|Pregabalin|pregabalin|mesh-list
2449749|NCT00957177|Analgesics|analgesics|mesh-ancestor
2449750|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
2449751|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449752|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449753|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
2449754|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2449755|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2449756|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449757|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2449758|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2449759|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2449760|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2449761|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2449762|NCT00957190|Timolol|timolol|mesh-list
2449763|NCT00957190|Dorzolamide|dorzolamide|mesh-list
2449764|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2449765|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2449766|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
2449767|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449768|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449769|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449770|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2449771|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2449772|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2449773|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449774|NCT00957203|Istradefylline|istradefylline|mesh-list
2449775|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2449776|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2449777|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2449778|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
2449779|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449780|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449781|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449782|NCT00957216|Ubiquinone|ubiquinone|mesh-list
2449783|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
2449784|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
2449785|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449786|NCT00957216|Vitamins|vitamins|mesh-ancestor
2449787|NCT00957320|Sirolimus|sirolimus|mesh-list
2449788|NCT00957320|Asparaginase|asparaginase|mesh-list
2449789|NCT00957320|Pegaspargase|pegaspargase|mesh-list
2449790|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2449791|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449792|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2449793|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449794|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
2449795|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2449796|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
2449797|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449798|NCT00957346|Misoprostol|misoprostol|mesh-list
2449799|NCT00957346|Mifepristone|mifepristone|mesh-list
2449800|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2449801|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
2449802|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2449803|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449804|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2449805|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2449806|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
2449807|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2449808|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2449809|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2449810|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2449811|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
2449812|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2449813|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2449814|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
2449815|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2449816|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
2449817|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2449818|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2449819|NCT00957385|Lenalidomide|lenalidomide|mesh-list
2449820|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
2449821|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449822|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2449823|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2449824|NCT00957385|Growth Substances|growth substances|mesh-ancestor
2449825|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
2449826|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449827|NCT00957411|Cetuximab|cetuximab|mesh-list
2449828|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449829|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2449830|NCT00957554|Amlodipine|amlodipine|mesh-list
2449831|NCT00957554|Irbesartan|irbesartan|mesh-list
2449832|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2449833|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2449834|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2449835|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449836|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2449837|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449838|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
2449839|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2449840|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2449841|NCT00957866|Interferons|interferons|mesh-list
2449842|NCT00957866|Ribavirin|ribavirin|mesh-list
2449843|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449844|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
2449845|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449846|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
2449847|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449848|NCT00957879|Calcitriol|calcitriol|mesh-list
2449849|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
2449850|NCT00957879|Vitamin D|vitamin d|mesh-list
2449851|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2449852|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449853|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2449854|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2449855|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449856|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2449857|NCT00957879|Vitamins|vitamins|mesh-ancestor
2449858|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
2449859|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2449860|NCT00957918|Nicotine|nicotine|mesh-list
2449861|NCT00957918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2449862|NCT00957918|Autonomic Agents|autonomic agents|mesh-ancestor
2449863|NCT00957918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2449864|NCT00957918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449865|NCT00957918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2449866|NCT00957918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2449867|NCT00957918|Cholinergic Agents|cholinergic agents|mesh-ancestor
2449868|NCT00957918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449869|NCT00957918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449870|NCT00958022|Carboplatin|carboplatin|mesh-list
2449871|NCT00958022|Etoposide|etoposide|mesh-list
2449872|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
2449873|NCT00958022|Panobinostat|panobinostat|mesh-list
2449874|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
2449875|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449876|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2449877|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2449878|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2449879|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449880|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449881|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2449882|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
2449883|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
2449884|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
2449885|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
2449886|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
2449887|NCT00958100|Tenofovir|tenofovir|mesh-list
2449888|NCT00958100|Lamivudine|lamivudine|mesh-list
2449889|NCT00958100|Emtricitabine|emtricitabine|mesh-list
2449890|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
2449891|NCT00958100|Abacavir|abacavir|mesh-list
2449892|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
2449893|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
2449894|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449895|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2449896|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2449897|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449898|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449899|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2449900|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2449901|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2449902|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2449903|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
2449904|NCT00958139|Permethrin|permethrin|mesh-list
2449905|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449906|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449907|NCT00958204|Fluoxetine|fluoxetine|mesh-list
2449908|NCT00958204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2449909|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2449910|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2449911|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449912|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449913|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
2449914|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449915|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2449916|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
2449917|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2449918|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2449919|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2449920|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449921|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2449922|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2449923|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449924|NCT00958269|Incretins|incretins|mesh-ancestor
2449925|NCT00958269|Hormones|hormones|mesh-ancestor
2449926|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2449927|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2449928|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
2449929|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449930|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449931|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2449932|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2449933|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449934|NCT00958386|Irinotecan|irinotecan|mesh-list
2449935|NCT00958386|Panitumumab|panitumumab|mesh-list
2449936|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2449937|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2449938|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449939|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449940|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2449941|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2449942|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
2449943|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2449944|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
2449945|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449946|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
2449947|NCT00958425|Protective Agents|protective agents|mesh-ancestor
2449948|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
2449949|NCT00958451|Vitamin D|vitamin d|mesh-list
2449950|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2449951|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449952|NCT00958451|Vitamins|vitamins|mesh-ancestor
2449953|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
2449954|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2449955|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
2449956|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2449957|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2449958|NCT00958633|Citalopram|citalopram|mesh-list
2449959|NCT00958633|Bupropion|bupropion|mesh-list
2449960|NCT00958633|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2449961|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2449962|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2449963|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2449964|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2449965|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
2449966|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2449967|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2449968|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
2449969|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2449970|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2449971|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
2449972|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2449973|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2449974|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2449994|NCT00958750|Minoxidil|minoxidil|mesh-list
2449995|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2449996|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
2449997|NCT00958854|Thalidomide|thalidomide|mesh-list
2449998|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
2449999|NCT00958854|Fludarabine|fludarabine|mesh-list
2450000|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
2450001|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208351|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208352|NCT00010192|Aldesleukin|aldesleukin|mesh-list
2208353|NCT00010192|Rituximab|rituximab|mesh-list
2208354|NCT00010192|Interleukin-2|interleukin-2|mesh-list
2208355|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2208356|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208357|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
2208358|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208359|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2208360|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2208361|NCT00010192|Analgesics|analgesics|mesh-ancestor
2208362|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
2208363|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2208364|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2208365|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2450002|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
2450003|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450004|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450005|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2450006|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
2450007|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450008|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450009|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2450010|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2450011|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
2450012|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
2450013|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2450014|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450015|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2450016|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2450017|NCT00958854|Growth Substances|growth substances|mesh-ancestor
2450018|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
2450019|NCT00958906|Infliximab|infliximab|mesh-list
2450020|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
2450021|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2450022|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450023|NCT00959036|Methotrexate|methotrexate|mesh-list
2450024|NCT00959036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2450025|NCT00959036|Abortifacient Agents|abortifacient agents|mesh-ancestor
2450026|NCT00959036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2450027|NCT00959036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450028|NCT00959036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2450029|NCT00959036|Antimetabolites|antimetabolites|mesh-ancestor
2450030|NCT00959036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450031|NCT00959036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450032|NCT00959036|Dermatologic Agents|dermatologic agents|mesh-ancestor
2450033|NCT00959036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450034|NCT00959036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2450035|NCT00959036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2450036|NCT00959036|Immunologic Factors|immunologic factors|mesh-ancestor
2450037|NCT00959036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450038|NCT00959036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2450039|NCT00959062|Clonidine|clonidine|mesh-list
2450040|NCT00959062|Analgesics|analgesics|mesh-ancestor
2450041|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
2450042|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450043|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450044|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2450045|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
2450046|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
2450047|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2450048|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2450049|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2450050|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
2450051|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450052|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450053|NCT00959075|Thiamine|thiamine|mesh-list
2450054|NCT00959075|Vitamins|vitamins|mesh-ancestor
2450055|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
2450056|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450057|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
2450058|NCT00959101|Metformin|metformin|mesh-list
2450059|NCT00959101|Repaglinide|repaglinide|mesh-list
2450060|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2450061|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450062|NCT00959218|Dronabinol|dronabinol|mesh-list
2450063|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
2450064|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450065|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2450066|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2450067|NCT00959218|Analgesics|analgesics|mesh-ancestor
2450068|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
2450069|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450070|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2450071|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2450072|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450073|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450074|NCT00959218|Hormones|hormones|mesh-ancestor
2450075|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450076|NCT00959231|Cyclosporine|cyclosporine|mesh-list
2450077|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
2450078|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
2450079|NCT00959231|Fludarabine|fludarabine|mesh-list
2450080|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
2450081|NCT00959231|Cyclosporins|cyclosporins|mesh-list
2450082|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2450083|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
2450084|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450085|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450086|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2450087|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
2450088|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450089|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450090|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2450091|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2450092|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
2450093|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450094|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
2450095|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450096|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
2450097|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2450098|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2450099|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2450100|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
2450101|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2450102|NCT00959335|Bicalutamide|bicalutamide|mesh-list
2450103|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
2450104|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
2450105|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450106|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450107|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450108|NCT00959387|Paclitaxel|paclitaxel|mesh-list
2450109|NCT00959387|Cisplatin|cisplatin|mesh-list
2450110|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2450111|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450112|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
2450113|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
2450114|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
2450115|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450116|NCT00959400|Fentanyl|fentanyl|mesh-list
2450117|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2450118|NCT00959400|Narcotics|narcotics|mesh-ancestor
2450119|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2450120|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450121|NCT00959400|Analgesics|analgesics|mesh-ancestor
2450122|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
2450123|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450124|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2450125|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2450126|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
2450127|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
2450128|NCT00959439|Naproxen|naproxen|mesh-list
2450129|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2450130|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2450131|NCT00959439|Analgesics|analgesics|mesh-ancestor
2450132|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
2450133|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450134|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450135|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2450136|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450137|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
2450138|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2450139|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450140|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450141|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
2450142|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
2450143|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450144|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
2450145|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450146|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450147|NCT00959517|Artesunate|artesunate|mesh-list
2450148|NCT00959517|Chloroquine|chloroquine|mesh-list
2450149|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
2450150|NCT00959517|Primaquine|primaquine|mesh-list
2450151|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
2450152|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2450153|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
2450154|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2450155|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2450156|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450157|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450158|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
2450159|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
2450160|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2450161|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
2450162|NCT00959517|Amebicides|amebicides|mesh-ancestor
2450163|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450164|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2450165|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450166|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450167|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2450168|NCT00959517|Renal Agents|renal agents|mesh-ancestor
2450169|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2450170|NCT00959569|Esmolol|esmolol|mesh-list
2450171|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2450172|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
2450173|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450174|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450175|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450176|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2450177|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2450178|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2450179|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450180|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
2450181|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
2450182|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
2450183|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2450184|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450185|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
2450186|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450187|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
2450188|NCT00959621|Aspirin|aspirin|mesh-list
2450189|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2450190|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2450191|NCT00959621|Analgesics|analgesics|mesh-ancestor
2450192|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
2450193|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450194|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450195|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2450196|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450197|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2450198|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2450199|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450200|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2450201|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2450202|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450203|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
2450204|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2450205|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2450206|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
2450207|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450208|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450209|NCT00959725|Infliximab|infliximab|mesh-list
2450210|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
2450211|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2450212|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450213|NCT00959777|Lenograstim|lenograstim|mesh-list
2450214|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2450215|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
2450216|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450217|NCT00959881|Donepezil|donepezil|mesh-list
2450218|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2450219|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450220|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450221|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
2450222|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450223|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450224|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
2450225|NCT00959933|Ribavirin|ribavirin|mesh-list
2450226|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
2450227|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450228|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
2450229|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450230|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
2450231|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450232|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450233|NCT00959972|Nicotine|nicotine|mesh-list
2450234|NCT00959972|Varenicline|varenicline|mesh-list
2450235|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2450236|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
2450237|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450238|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450239|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2450240|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2450241|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
2450242|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450243|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450244|NCT00960037|Vitamin D|vitamin d|mesh-list
2450245|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
2450246|NCT00960037|Vitamins|vitamins|mesh-ancestor
2450247|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
2450248|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450249|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2450250|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2450251|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
2450252|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2450253|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450254|NCT00960232|Vitamins|vitamins|mesh-ancestor
2450255|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
2450256|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2450257|NCT00960245|Nadolol|nadolol|mesh-list
2450258|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2450259|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2450260|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
2450261|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450262|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450263|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450264|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2450265|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2450266|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
2450267|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
2450268|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450269|NCT00960284|Gemcitabine|gemcitabine|mesh-list
2450270|NCT00960284|Fluorouracil|fluorouracil|mesh-list
2450271|NCT00960284|Capecitabine|capecitabine|mesh-list
2450272|NCT00960284|Epirubicin|epirubicin|mesh-list
2450273|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450274|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2450275|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
2450276|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450277|NCT00960284|Antiviral Agents|antiviral agents|mesh-ancestor
2450278|NCT00960284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450279|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450280|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2450281|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
2450282|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450283|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2450284|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2450285|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2450286|NCT00960310|Bicalutamide|bicalutamide|mesh-list
2450287|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
2450288|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
2450289|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450290|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450291|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450292|NCT00960336|Doxorubicin|doxorubicin|mesh-list
2450293|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2450294|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2450295|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450296|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2450297|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2450298|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450299|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450300|NCT00960349|Cisplatin|cisplatin|mesh-list
2450301|NCT00960349|Capecitabine|capecitabine|mesh-list
2450302|NCT00960349|Cediranib|cediranib|mesh-list
2450303|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450304|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2450305|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
2450306|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450307|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2450308|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450309|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2450310|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2450311|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450312|NCT00960453|Incretins|incretins|mesh-ancestor
2450313|NCT00960453|Hormones|hormones|mesh-ancestor
2450314|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450315|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2450316|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
2450317|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450318|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450319|NCT00960479|Ribavirin|ribavirin|mesh-list
2450320|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
2450321|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450322|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
2450323|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450324|NCT00960492|Temozolomide|temozolomide|mesh-list
2450325|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2450326|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
2450327|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450328|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450329|NCT00960518|Adefovir|adefovir|mesh-list
2450330|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
2450331|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450332|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2450333|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2450334|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450335|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450336|NCT00960544|Capecitabine|capecitabine|mesh-list
2450337|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2450338|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
2450339|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450340|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450341|NCT00960557|Combretastatin|combretastatin|mesh-list
2450342|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2450343|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450344|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
2450345|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
2450346|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
2450347|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450348|NCT00960635|Vitamin D|vitamin d|mesh-list
2450349|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
2450350|NCT00960635|Calcitriol|calcitriol|mesh-list
2450351|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
2450352|NCT00960635|Vitamins|vitamins|mesh-ancestor
2450353|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
2450354|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450355|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2450356|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2450357|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2450358|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2450359|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450360|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2450361|NCT00960713|Rituximab|rituximab|mesh-list
2450362|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2450363|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450364|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
2450365|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450366|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450367|NCT00960739|Topotecan|topotecan|mesh-list
2450368|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2450369|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2450370|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2450371|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450372|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450373|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450374|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2450375|NCT00960817|Aspirin|aspirin|mesh-list
2450376|NCT00960817|Dipyridamole|dipyridamole|mesh-list
2450377|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2450378|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2450379|NCT00960817|Analgesics|analgesics|mesh-ancestor
2450380|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
2450381|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450382|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450383|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2450384|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450385|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2450386|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2450387|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450388|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2450389|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2450390|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450391|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
2450392|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2450393|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
2450394|NCT00960830|Mirtazapine|mirtazapine|mesh-list
2450395|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
2450396|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2450397|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2450398|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
2450399|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
2450400|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450401|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450402|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450403|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2450404|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2450405|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2450406|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2450407|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2450408|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2450409|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
2450410|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2450411|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2450412|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
2450413|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2450414|NCT00960921|Iron|iron|mesh-list
2450415|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2450416|NCT00960921|Trace Elements|trace elements|mesh-ancestor
2450417|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
2450418|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450419|NCT00960921|Hematinics|hematinics|mesh-ancestor
2450420|NCT00960960|Paclitaxel|paclitaxel|mesh-list
2450421|NCT00960960|Bevacizumab|bevacizumab|mesh-list
2450422|NCT00960960|Trastuzumab|trastuzumab|mesh-list
2450423|NCT00960960|Letrozole|letrozole|mesh-list
2450424|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2450425|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450426|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
2450427|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
2450428|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
2450429|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450430|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2450431|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2450432|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2450433|NCT00960960|Growth Substances|growth substances|mesh-ancestor
2450434|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450435|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
2450436|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2450437|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2450438|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450439|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2450440|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
2450441|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450442|NCT00960973|Menatetrenone|menatetrenone|mesh-list
2450443|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
2450444|NCT00960973|Coagulants|coagulants|mesh-ancestor
2450445|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
2450446|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2450447|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450448|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2450449|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2450450|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450451|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450452|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450453|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2450454|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2450455|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
2450456|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450457|NCT00961090|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2450458|NCT00961090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2450459|NCT00961090|Dermatologic Agents|dermatologic agents|mesh-ancestor
2450460|NCT00961142|Fludarabine|fludarabine|mesh-list
2450461|NCT00961142|Melphalan|melphalan|mesh-list
2450462|NCT00961142|Thiotepa|thiotepa|mesh-list
2450463|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
2450464|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450465|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450466|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2450467|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
2450468|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450469|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2450470|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
2450471|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2450472|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
2450473|NCT00961155|Montelukast|montelukast|mesh-list
2450474|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2450475|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
2450476|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450477|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450478|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2450479|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
2450480|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2450481|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2450482|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2450483|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
2450484|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450485|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450486|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2450487|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
2450488|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450489|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2450490|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2450491|NCT00961194|Ketamine|ketamine|mesh-list
2450492|NCT00961194|Analgesics|analgesics|mesh-ancestor
2450493|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
2450494|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450495|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450496|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2450497|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2450498|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
2450499|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
2450500|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2450501|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2450502|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2450503|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450504|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450505|NCT00961324|Insulin|insulin|mesh-list
2450506|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2450507|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
2450508|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2450509|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450510|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2450511|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2450512|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450513|NCT00961363|Incretins|incretins|mesh-ancestor
2450514|NCT00961363|Hormones|hormones|mesh-ancestor
2450515|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450516|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2450517|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
2450518|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450519|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450520|NCT00961467|Thalidomide|thalidomide|mesh-list
2450521|NCT00961467|Prednisone|prednisone|mesh-list
2450522|NCT00961467|Melphalan|melphalan|mesh-list
2450523|NCT00961467|Lenalidomide|lenalidomide|mesh-list
2450524|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2450525|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
2450526|NCT00961467|Hormones|hormones|mesh-ancestor
2450527|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450528|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450529|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2450530|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450531|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2450532|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
2450533|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450534|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2450535|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2450536|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
2450537|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2450538|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2450539|NCT00961467|Growth Substances|growth substances|mesh-ancestor
2450540|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
2450541|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
2450542|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2450543|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450544|NCT00961480|Metformin|metformin|mesh-list
2450545|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2450546|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2450547|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450548|NCT00961480|Incretins|incretins|mesh-ancestor
2450549|NCT00961480|Hormones|hormones|mesh-ancestor
2450550|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450551|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2450552|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
2450553|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450554|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450555|NCT00961675|Ciprofloxacin|ciprofloxacin|mesh-list
2450556|NCT00961675|Povidone-Iodine|povidone-iodine|mesh-list
2450557|NCT00961675|Dexamethasone|dexamethasone|mesh-list
2450558|NCT00961675|Dexamethasone acetate|dexamethasone acetate|mesh-list
2450559|NCT00961675|Povidone|povidone|mesh-list
2450560|NCT00961675|BB 1101|bb 1101|mesh-list
2450561|NCT00961675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2450562|NCT00961675|Antiemetics|antiemetics|mesh-ancestor
2450563|NCT00961675|Autonomic Agents|autonomic agents|mesh-ancestor
2450564|NCT00961675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450565|NCT00961675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450566|NCT00961675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2450567|NCT00961675|Glucocorticoids|glucocorticoids|mesh-ancestor
2450568|NCT00961675|Hormones|hormones|mesh-ancestor
2450569|NCT00961675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450570|NCT00961675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2450571|NCT00961675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450572|NCT00961675|Protease Inhibitors|protease inhibitors|mesh-ancestor
2450573|NCT00961675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450574|NCT00961675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450575|NCT00961675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2450576|NCT00961675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450577|NCT00961675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2450578|NCT00961675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2450579|NCT00961675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2450580|NCT00961675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2450581|NCT00961675|Plasma Substitutes|plasma substitutes|mesh-ancestor
2450582|NCT00961675|Blood Substitutes|blood substitutes|mesh-ancestor
2450583|NCT00961675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2450584|NCT00961753|Ibuprofen|ibuprofen|mesh-list
2450585|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2450586|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2450587|NCT00961753|Analgesics|analgesics|mesh-ancestor
2450588|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
2450589|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450590|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450591|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2450592|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450593|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2450594|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450595|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450596|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
2450597|NCT00961792|Promethazine|promethazine|mesh-list
2450598|NCT00961792|Ethanol|ethanol|mesh-list
2450599|NCT00961792|Caffeine|caffeine|mesh-list
2450600|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2450601|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450602|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2450603|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450604|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450605|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2450606|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2450607|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
2450608|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450609|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2450610|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450611|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2450612|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2450613|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2450614|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
2450615|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
2450616|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
2450617|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450618|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
2450619|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
2450620|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2450621|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2450622|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
2450623|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
2450624|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2450625|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
2450626|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
2450627|NCT00961844|Temozolomide|temozolomide|mesh-list
2450628|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2450629|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
2450630|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450631|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450632|NCT00961857|Metformin|metformin|mesh-list
2450633|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2450634|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2450635|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450636|NCT00961857|Incretins|incretins|mesh-ancestor
2450637|NCT00961857|Hormones|hormones|mesh-ancestor
2450638|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450639|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2450640|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
2450641|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450642|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450643|NCT00961909|Metformin|metformin|mesh-list
2450644|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2450645|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450646|NCT00962026|Rilonacept|rilonacept|mesh-list
2450647|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2450648|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2450649|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
2450650|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
2450651|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
2450652|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450653|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2450654|NCT00962234|Protective Agents|protective agents|mesh-ancestor
2450655|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450656|NCT00962286|Furosemide|furosemide|mesh-list
2450657|NCT00962286|Diuretics|diuretics|mesh-ancestor
2450658|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
2450659|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450660|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2450661|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2450662|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450663|NCT00962299|Beclomethasone|beclomethasone|mesh-list
2450664|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2450665|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
2450666|NCT00962299|Hormones|hormones|mesh-ancestor
2450667|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450668|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450669|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2450670|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
2450671|NCT00962312|Capecitabine|capecitabine|mesh-list
2450672|NCT00962312|Lapatinib|lapatinib|mesh-list
2450673|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2450674|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
2450675|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450676|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450677|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2450678|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450679|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
2450680|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2450681|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
2450682|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450683|NCT00962442|Expectorants|expectorants|mesh-ancestor
2450684|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
2450685|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2450686|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
2450687|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450688|NCT00962442|Protective Agents|protective agents|mesh-ancestor
2450689|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450690|NCT00962442|Antidotes|antidotes|mesh-ancestor
2450691|NCT00962507|Everolimus|everolimus|mesh-list
2450692|NCT00962507|Panobinostat|panobinostat|mesh-list
2450693|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450694|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2450695|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
2450696|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450697|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2450698|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450699|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450700|NCT00962533|Telbivudine|telbivudine|mesh-list
2450701|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
2450702|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450703|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2450704|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450705|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450706|NCT00962624|Vaccines|vaccines|mesh-list
2450707|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
2450708|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450709|NCT00962637|Citric Acid|citric acid|mesh-list
2450710|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
2450711|NCT00962637|Enclomiphene|enclomiphene|mesh-list
2450712|NCT00962637|Clomiphene|clomiphene|mesh-list
2450713|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
2450714|NCT00962637|Testosterone|testosterone|mesh-list
2450715|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
2450716|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2450717|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
2450718|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
2450719|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450720|NCT00962637|Androgens|androgens|mesh-ancestor
2450721|NCT00962637|Hormones|hormones|mesh-ancestor
2450722|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450723|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450724|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2450725|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
2450726|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2450727|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
2450728|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2450729|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2450730|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2450731|NCT00962663|Ibuprofen|ibuprofen|mesh-list
2450732|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2450733|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2450734|NCT00962663|Analgesics|analgesics|mesh-ancestor
2450735|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
2450736|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450737|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450738|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2450739|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450740|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2450741|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450742|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450743|NCT00962715|Interferons|interferons|mesh-list
2450744|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
2450745|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
2450746|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2450747|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450748|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
2450749|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450750|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
2450751|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450752|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
2450753|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2450754|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450755|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
2450756|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
2450757|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2450758|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2450759|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450760|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450761|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450762|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450763|NCT00962936|Pidilizumab|pidilizumab|mesh-list
2450764|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2450765|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450766|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2450767|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
2450768|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450769|NCT00962988|Bupropion|bupropion|mesh-list
2450770|NCT00962988|Nicotine|nicotine|mesh-list
2450771|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2450772|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
2450773|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450774|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450775|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2450776|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2450777|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
2450778|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450779|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450780|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2450781|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
2450782|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2450783|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2450784|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2450785|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2450786|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
2450787|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2450788|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2450789|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450790|NCT00963001|Treprostinil|treprostinil|mesh-list
2450791|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2450792|NCT00963027|Treprostinil|treprostinil|mesh-list
2450793|NCT00963027|Esomeprazole|esomeprazole|mesh-list
2450794|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2450795|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2450796|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2450797|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450798|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450799|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2450800|NCT00963040|Oxytocin|oxytocin|mesh-list
2450801|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
2450802|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2450803|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450804|NCT00963131|Antioxidants|antioxidants|mesh-list
2450805|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450806|NCT00963131|Protective Agents|protective agents|mesh-ancestor
2450807|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450808|NCT00963209|Tamoxifen|tamoxifen|mesh-list
2450809|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2450810|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
2450811|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450812|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450813|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2450814|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450815|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2450816|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2450817|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2450818|NCT00963222|Vitamin A|vitamin a|mesh-list
2450819|NCT00963222|Vitamins|vitamins|mesh-ancestor
2450820|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
2450821|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450822|NCT00963274|Bortezomib|bortezomib|mesh-list
2450823|NCT00963274|Romidepsin|romidepsin|mesh-list
2450824|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450825|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2450826|NCT00963313|Adalimumab|adalimumab|mesh-list
2450827|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2450828|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450829|NCT00963443|Aspirin|aspirin|mesh-list
2450830|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
2450831|NCT00963443|Ephedrine|ephedrine|mesh-list
2450832|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2450833|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2450834|NCT00963443|Analgesics|analgesics|mesh-ancestor
2450835|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
2450836|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450837|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450838|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2450839|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450840|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2450841|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2450842|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450843|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2450844|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2450845|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450846|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
2450847|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2450848|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
2450849|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2450850|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
2450851|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
2450852|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2450853|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2450854|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
2450855|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
2450856|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450857|NCT00963534|Rituximab|rituximab|mesh-list
2450858|NCT00963534|Lenalidomide|lenalidomide|mesh-list
2450859|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2450860|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2450861|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450862|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
2450863|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450864|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450865|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2450866|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2450867|NCT00963534|Growth Substances|growth substances|mesh-ancestor
2450868|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
2450869|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2450870|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
2450871|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450872|NCT00963573|Loratadine|loratadine|mesh-list
2450873|NCT00963573|Betamethasone|betamethasone|mesh-list
2450874|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2450875|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
2450876|NCT00963573|Hormones|hormones|mesh-ancestor
2450877|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450878|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450879|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2450880|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
2450881|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
2450882|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
2450883|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2450884|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2450885|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2450886|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
2450887|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
2450888|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450889|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450890|NCT00963664|Interferons|interferons|mesh-list
2450891|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
2450892|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
2450893|NCT00963664|Lovastatin|lovastatin|mesh-list
2450894|NCT00963664|L 647318|l 647318|mesh-list
2450895|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
2450896|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450897|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
2450898|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450899|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
2450900|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450901|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2450902|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2450903|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
2450904|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450905|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2450906|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2450907|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450908|NCT00963690|Hemostatics|hemostatics|mesh-list
2450909|NCT00963690|Coagulants|coagulants|mesh-ancestor
2450910|NCT00963703|Rituximab|rituximab|mesh-list
2450911|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2450912|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450913|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
2450914|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450915|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450916|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
2450917|NCT00963729|Docetaxel|docetaxel|mesh-list
2450918|NCT00963729|Fluorouracil|fluorouracil|mesh-list
2450919|NCT00963729|Letrozole|letrozole|mesh-list
2450920|NCT00963729|Epirubicin|epirubicin|mesh-list
2450921|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2450922|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
2450923|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450924|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2450925|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2450926|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
2450927|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450928|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450929|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2450930|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
2450931|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
2450932|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
2450933|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
2450934|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2450935|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2450936|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2450937|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450938|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2450939|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
2450940|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2450941|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2450942|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2450943|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2450944|NCT00963768|Canagliflozin|canagliflozin|mesh-list
2450945|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2450946|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450947|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2450948|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450949|NCT00963833|Interferons|interferons|mesh-list
2450950|NCT00963833|Interferon-beta|interferon-beta|mesh-list
2450951|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
2450952|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2450953|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
2450954|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450955|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
2450956|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450957|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2450958|NCT00963846|Huperzine A|huperzine a|mesh-list
2450959|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2450960|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450961|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450962|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
2450963|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450964|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450965|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2450966|NCT00963846|Protective Agents|protective agents|mesh-ancestor
2450967|NCT00963885|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2450968|NCT00963885|Lactams|lactams|mesh-list
2450969|NCT00963885|Antiviral Agents|antiviral agents|mesh-ancestor
2450970|NCT00963885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450971|NCT00963885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2450972|NCT00963976|Enalapril|enalapril|mesh-list
2450973|NCT00963976|Hydralazine|hydralazine|mesh-list
2450974|NCT00963976|Labetalol|labetalol|mesh-list
2450975|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2450976|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
2450977|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450978|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450979|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2450980|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
2450981|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2450982|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2450983|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
2450984|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2450985|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2450986|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
2450987|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
2450988|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2450989|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2450990|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2450991|NCT00964002|Efavirenz|efavirenz|mesh-list
2450992|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2450993|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2450994|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2450995|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2450996|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
2450997|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2450998|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2450999|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2451000|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2451001|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2451002|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2451003|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2451004|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2451005|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
2451006|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
2451007|NCT00964041|Cycloserine|cycloserine|mesh-list
2451008|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2451009|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451010|NCT00964041|Renal Agents|renal agents|mesh-ancestor
2451011|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2451012|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
2451013|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2451014|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
2451015|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451016|NCT00964080|Leucovorin|leucovorin|mesh-list
2451017|NCT00964080|Fluorouracil|fluorouracil|mesh-list
2451018|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
2451019|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
2451020|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451021|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2451022|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451023|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2451024|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
2451025|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451026|NCT00964080|Antidotes|antidotes|mesh-ancestor
2451027|NCT00964080|Protective Agents|protective agents|mesh-ancestor
2451028|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
2451029|NCT00964080|Vitamins|vitamins|mesh-ancestor
2451030|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
2451031|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
2451032|NCT00964106|Rifampin|rifampin|mesh-list
2451033|NCT00964106|Fluconazole|fluconazole|mesh-list
2451034|NCT00964106|Ketoconazole|ketoconazole|mesh-list
2451035|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
2451036|NCT00964106|Midazolam|midazolam|mesh-list
2451037|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
2451038|NCT00964106|Caffeine|caffeine|mesh-list
2451039|NCT00964106|Omeprazole|omeprazole|mesh-list
2451040|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2451041|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2451042|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2451043|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2451044|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451045|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2451046|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2451047|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2451048|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2451049|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
2451050|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
2451051|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
2451052|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
2451053|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451054|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451055|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2451056|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2451057|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
2451058|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2451059|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2451060|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451061|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2451062|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2451063|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2451064|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2451065|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2451066|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2451067|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2451068|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
2451069|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2451070|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
2451071|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2451072|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451073|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
2451074|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2451075|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2451076|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2451077|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2451078|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2451079|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2451080|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2451081|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2451082|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
2451083|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2451084|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2451085|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2451086|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
2451087|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2451088|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2451089|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2451090|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2451091|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
2451092|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
2451093|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2451094|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2451095|NCT00964106|Analgesics|analgesics|mesh-ancestor
2451096|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
2451097|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451098|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2451099|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2451100|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2451101|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2451102|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2451103|NCT00964171|Efavirenz|efavirenz|mesh-list
2451104|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2451105|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2451106|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451107|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451108|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
2451109|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451110|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2451111|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2451112|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2451113|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2451114|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2451115|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2451116|NCT00964184|Metformin|metformin|mesh-list
2451117|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2451118|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451119|NCT00964262|Exenatide|exenatide|mesh-list
2451120|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2451121|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451122|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2451123|NCT00964262|Incretins|incretins|mesh-ancestor
2451124|NCT00964262|Hormones|hormones|mesh-ancestor
2451125|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2451126|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2451127|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2451128|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451129|NCT00964288|Lidocaine|lidocaine|mesh-list
2451130|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
2451131|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
2451132|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2451133|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451134|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
2451135|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451136|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2451137|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2451138|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2451139|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2451140|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451141|NCT00964327|Darunavir|darunavir|mesh-list
2451142|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2451143|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2451144|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
2451145|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451146|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451147|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2451148|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2451149|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
2451150|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451151|NCT00964418|Insulin|insulin|mesh-list
2451152|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2451153|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
2451154|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2451155|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451156|NCT00964457|Cetuximab|cetuximab|mesh-list
2451157|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2451158|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451159|NCT00964535|Budesonide|budesonide|mesh-list
2451160|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
2451161|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2451162|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2451163|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2451164|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
2451165|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451166|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451167|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2451168|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
2451169|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
2451170|NCT00964535|Hormones|hormones|mesh-ancestor
2451171|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2451172|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2451173|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2451174|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2451175|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
2451176|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451177|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451178|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2451179|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
2451180|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2451181|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451182|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
2451183|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2451184|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2451185|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451186|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451187|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451188|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2451189|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2451190|NCT00964574|Insulin|insulin|mesh-list
2451191|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2451192|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
2451193|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
2451194|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2451195|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451196|NCT00964626|Paclitaxel|paclitaxel|mesh-list
2451197|NCT00964626|Cisplatin|cisplatin|mesh-list
2451198|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2451199|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451200|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
2451201|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
2451202|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
2451203|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451204|NCT00964639|Ropivacaine|ropivacaine|mesh-list
2451205|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
2451206|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
2451207|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2451208|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451209|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
2451210|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451211|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2451212|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
2451213|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
2451214|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451215|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
2451216|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451217|NCT00964691|Chloroquine|chloroquine|mesh-list
2451218|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
2451219|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
2451220|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
2451221|NCT00964691|Amebicides|amebicides|mesh-ancestor
2451222|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2451223|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2451224|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451225|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
2451226|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2451227|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2451228|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451229|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451230|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2451231|NCT00964691|Renal Agents|renal agents|mesh-ancestor
2451232|NCT00964704|Bevacizumab|bevacizumab|mesh-list
2451233|NCT00964704|Trastuzumab|trastuzumab|mesh-list
2451234|NCT00964704|Docetaxel|docetaxel|mesh-list
2451235|NCT00964704|Capecitabine|capecitabine|mesh-list
2451236|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2451237|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451238|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2451239|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2451240|NCT00964704|Growth Substances|growth substances|mesh-ancestor
2451241|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451242|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
2451243|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
2451244|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
2451245|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
2451246|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451247|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2451248|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
2451249|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
2451250|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2451251|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451252|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2451253|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2451254|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451255|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451256|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451257|NCT00964756|Ganciclovir|ganciclovir|mesh-list
2451258|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2451259|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
2451260|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451261|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2451262|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451263|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451264|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2451265|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
2451266|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451267|NCT00964808|Oxycodone|oxycodone|mesh-list
2451268|NCT00964808|Buprenorphine|buprenorphine|mesh-list
2451269|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2451270|NCT00964808|Narcotics|narcotics|mesh-ancestor
2451271|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2451272|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451273|NCT00964808|Analgesics|analgesics|mesh-ancestor
2451274|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
2451275|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451276|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2451277|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2451278|NCT00964834|Doxycycline|doxycycline|mesh-list
2451279|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2451280|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451281|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
2451282|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
2451283|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2451284|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2451285|NCT00964964|Insulin|insulin|mesh-list
2451286|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2451287|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
2451288|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2451289|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451290|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
2451291|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2451292|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2451293|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451294|NCT00965107|Thiopental|thiopental|mesh-list
2451295|NCT00965107|Propofol|propofol|mesh-list
2451296|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2451297|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2451298|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451299|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2451300|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
2451301|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
2451302|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
2451303|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
2451304|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
2451305|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451306|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451307|NCT00965120|Bradykinin|bradykinin|mesh-list
2451308|NCT00965120|Kininogens|kininogens|mesh-list
2451309|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
2451310|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
2451311|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2451312|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
2451313|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451314|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451315|NCT00965172|Calcium|calcium|mesh-list
2451316|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2451317|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451318|NCT00965224|Vaccines|vaccines|mesh-list
2451319|NCT00965224|Immunologic Factors|immunologic factors|mesh-ancestor
2451320|NCT00965224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451321|NCT00965289|Rituximab|rituximab|mesh-list
2451322|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2451323|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451324|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
2451325|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451326|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2451327|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2451328|NCT00965315|Fenofibrate|fenofibrate|mesh-list
2451329|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2451330|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2451331|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
2451332|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451333|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2451334|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2451335|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451336|NCT00965393|Bradykinin|bradykinin|mesh-list
2451337|NCT00965393|Kininogens|kininogens|mesh-list
2451338|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
2451339|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
2451340|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2451341|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
2451342|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451343|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451344|NCT00965406|Insulin|insulin|mesh-list
2451345|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2451346|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451347|NCT00965549|Insulin|insulin|mesh-list
2451348|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2451349|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
2451350|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
2451351|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
2451352|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2451353|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451354|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
2451355|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2451356|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2451357|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451358|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
2451359|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451360|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451361|NCT00965653|Folic Acid|folic acid|mesh-list
2451362|NCT00965653|Methotrexate|methotrexate|mesh-list
2451363|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2451364|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
2451365|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2451366|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451367|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2451368|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
2451369|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451370|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451371|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
2451372|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451373|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2451374|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2451375|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
2451376|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2451377|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2451378|NCT00965653|Hematinics|hematinics|mesh-ancestor
2451379|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
2451380|NCT00965653|Vitamins|vitamins|mesh-ancestor
2451381|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
2451382|NCT00965666|Etanercept|etanercept|mesh-list
2451383|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2451384|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2451385|NCT00965666|Analgesics|analgesics|mesh-ancestor
2451386|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
2451387|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451388|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451389|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2451390|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2451391|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2451392|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2451393|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
2451394|NCT00965796|Lidocaine|lidocaine|mesh-list
2451395|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
2451396|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
2451397|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2451398|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451399|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
2451400|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451401|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2451402|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2451403|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2451404|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2451405|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451406|NCT00965809|Dronabinol|dronabinol|mesh-list
2451407|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
2451408|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451409|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2451410|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2451411|NCT00965809|Analgesics|analgesics|mesh-ancestor
2451412|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
2451413|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451414|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
2451415|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2451416|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451417|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451418|NCT00965809|Hormones|hormones|mesh-ancestor
2451419|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2451420|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
2451421|NCT00965874|Analgesics|analgesics|mesh-ancestor
2451422|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
2451423|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451424|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451425|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
2451426|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2451427|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2451428|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
2451429|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2451430|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2451431|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451432|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2451433|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
2451434|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2451435|NCT00965900|Propranolol|propranolol|mesh-list
2451436|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2451437|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2451438|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
2451439|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451440|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451441|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451442|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2451443|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2451444|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
2451445|NCT00965913|Nicotine|nicotine|mesh-list
2451446|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2451447|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
2451448|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451449|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451450|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2451451|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2451452|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
2451453|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451454|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451455|NCT00965926|Mirabegron|mirabegron|mesh-list
2451456|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2451457|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2451458|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2451459|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
2208366|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
2208367|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208368|NCT00010231|Calcitriol|calcitriol|mesh-list
2208369|NCT00010231|Dexamethasone|dexamethasone|mesh-list
2208370|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2208371|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
2208372|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
2208373|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2208374|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208375|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2208376|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
2208377|NCT00010231|Hormones|hormones|mesh-ancestor
2208378|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208379|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2208380|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208381|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2208382|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2451460|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451461|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451462|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451463|NCT00965926|Urological Agents|urological agents|mesh-ancestor
2451464|NCT00965991|Metformin|metformin|mesh-list
2451465|NCT00965991|Glyburide|glyburide|mesh-list
2451466|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2451467|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451468|NCT00966004|Mirabegron|mirabegron|mesh-list
2451469|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2451470|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2451471|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2451472|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2451473|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
2451474|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451475|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451476|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451477|NCT00966004|Urological Agents|urological agents|mesh-ancestor
2451478|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2451479|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2451480|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
2451481|NCT00966056|Mitomycins|mitomycins|mesh-list
2451482|NCT00966056|Mitomycin|mitomycin|mesh-list
2451483|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2451484|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451485|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
2451486|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451487|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2451488|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451489|NCT00966082|Propranolol|propranolol|mesh-list
2451490|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2451491|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2451492|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
2451493|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451494|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451495|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451496|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2451497|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2451498|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
2451499|NCT00966121|Propranolol|propranolol|mesh-list
2451500|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2451501|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2451502|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
2451503|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451504|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451505|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451506|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2451507|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2451508|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
2451509|NCT00966160|Ritonavir|ritonavir|mesh-list
2451510|NCT00966160|Lopinavir|lopinavir|mesh-list
2451511|NCT00966160|Lamivudine|lamivudine|mesh-list
2451512|NCT00966160|Zidovudine|zidovudine|mesh-list
2451513|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
2451514|NCT00966160|Efavirenz|efavirenz|mesh-list
2451515|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2451516|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2451517|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
2451518|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451519|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451520|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2451521|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2451522|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
2451523|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451524|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2451525|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2451526|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2451527|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2451528|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
2451529|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2451530|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2451531|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2451532|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2451533|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2451534|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
2451535|NCT00966251|Pidilizumab|pidilizumab|mesh-list
2451536|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2451537|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451538|NCT00966290|Warfarin|warfarin|mesh-list
2451539|NCT00966290|Anticoagulants|anticoagulants|mesh-list
2451540|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
2451541|NCT00966290|Fluindione|fluindione|mesh-list
2451542|NCT00966290|Phenindione|phenindione|mesh-list
2451543|NCT00966316|Aspirin|aspirin|mesh-list
2451544|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2451545|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2451546|NCT00966316|Analgesics|analgesics|mesh-ancestor
2451547|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
2451548|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451549|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451550|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2451551|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2451552|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2451553|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2451554|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451555|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2451556|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2451557|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451558|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
2451559|NCT00966329|Maraviroc|maraviroc|mesh-list
2451560|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2451561|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2451562|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451563|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2451564|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2451565|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
2451566|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451567|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2451568|NCT00966368|Insulin|insulin|mesh-list
2451569|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2451570|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
2451571|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2451572|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451573|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2451574|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2451575|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451576|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2451577|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451578|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451579|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2451580|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2451581|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
2451582|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2451583|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2451584|NCT00966576|Timolol|timolol|mesh-list
2451585|NCT00966576|Brinzolamide|brinzolamide|mesh-list
2451586|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2451587|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2451588|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
2451589|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451590|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451591|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451592|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2451593|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2451594|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451595|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2451596|NCT00966602|Ivacaftor|ivacaftor|mesh-list
2451597|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2451598|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2451599|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451600|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
2451601|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2451602|NCT00966680|Anesthetics|anesthetics|mesh-list
2451603|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2451604|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451605|NCT00966706|Gemcitabine|gemcitabine|mesh-list
2451606|NCT00966706|Docetaxel|docetaxel|mesh-list
2451607|NCT00966706|Capecitabine|capecitabine|mesh-list
2451608|NCT00966706|Epirubicin|epirubicin|mesh-list
2451609|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451610|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2451611|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
2451612|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451613|NCT00966706|Antiviral Agents|antiviral agents|mesh-ancestor
2451614|NCT00966706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451615|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451616|NCT00966706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2451617|NCT00966706|Immunologic Factors|immunologic factors|mesh-ancestor
2451618|NCT00966706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451619|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
2451620|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
2451621|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
2451622|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2451623|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2451624|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2451625|NCT00966745|Milrinone|milrinone|mesh-list
2451626|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2451627|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2451628|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
2451629|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2451630|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2451631|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451632|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451633|NCT00966745|Protective Agents|protective agents|mesh-ancestor
2451634|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451635|NCT00966771|Copper|copper|mesh-list
2451636|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
2451637|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2451638|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
2451639|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2451640|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451641|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2451642|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2451643|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2451644|NCT00966771|Trace Elements|trace elements|mesh-ancestor
2451645|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
2451646|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
2451647|NCT00966836|Valganciclovir|valganciclovir|mesh-list
2451648|NCT00966836|Everolimus|everolimus|mesh-list
2451649|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451650|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2451651|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
2451652|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451653|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2451654|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2451655|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
2451656|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2451657|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451658|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451659|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451660|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
2451661|NCT00966901|Nicotine|nicotine|mesh-list
2451662|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2451663|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
2451664|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451665|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451666|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2451667|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2451668|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
2451669|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451670|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451671|NCT00966914|Paclitaxel|paclitaxel|mesh-list
2451672|NCT00966914|Docetaxel|docetaxel|mesh-list
2451673|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2451674|NCT00966914|Cisplatin|cisplatin|mesh-list
2451675|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
2451676|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2451677|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451678|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
2451679|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
2451680|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
2451681|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451682|NCT00966914|Protective Agents|protective agents|mesh-ancestor
2451683|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451684|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
2451685|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2451686|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
2451687|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451688|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2451689|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2451690|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2451691|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451692|NCT00967031|Capecitabine|capecitabine|mesh-list
2451693|NCT00967031|Lapatinib|lapatinib|mesh-list
2451694|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2451695|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
2451696|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451697|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451698|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2451699|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451700|NCT00967057|Dexamethasone|dexamethasone|mesh-list
2451701|NCT00967057|Methotrexate|methotrexate|mesh-list
2451702|NCT00967057|Vincristine|vincristine|mesh-list
2451703|NCT00967057|Asparaginase|asparaginase|mesh-list
2451704|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
2451705|NCT00967057|Idarubicin|idarubicin|mesh-list
2451706|NCT00967057|Pegaspargase|pegaspargase|mesh-list
2451707|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2451708|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
2451709|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
2451710|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451711|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451712|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2451713|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
2451714|NCT00967057|Hormones|hormones|mesh-ancestor
2451715|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2451716|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2451717|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451718|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2451719|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
2451720|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2451721|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2451722|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
2451723|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451724|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
2451725|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451726|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2451727|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2451728|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
2451729|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2451730|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2451731|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2451732|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
2451733|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
2451734|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
2451735|NCT00967057|Analgesics|analgesics|mesh-ancestor
2451736|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
2451737|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2451738|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2451739|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2451740|NCT00967070|Nicotine|nicotine|mesh-list
2451741|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2451742|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
2451743|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451744|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451745|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2451746|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2451747|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
2451748|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451749|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451750|NCT00967096|Rifaximin|rifaximin|mesh-list
2451751|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2451752|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451753|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2451754|NCT00967135|Pregabalin|pregabalin|mesh-list
2451755|NCT00967135|Analgesics|analgesics|mesh-ancestor
2451756|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
2451757|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451758|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451759|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
2451760|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2451761|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2451762|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451763|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2451764|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2451765|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2451766|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2451767|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2451768|NCT00967148|Tinzaparin|tinzaparin|mesh-list
2451769|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2451770|NCT00967148|Dalteparin|dalteparin|mesh-list
2451771|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
2451772|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2451773|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2451774|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451775|NCT00967174|Nicotine|nicotine|mesh-list
2451776|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2451777|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
2451778|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451779|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451780|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2451781|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2451782|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
2451783|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451784|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451785|NCT00967213|Ranibizumab|ranibizumab|mesh-list
2451786|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2451787|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2451788|NCT00967213|Growth Substances|growth substances|mesh-ancestor
2451789|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451790|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
2451791|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451792|NCT00967252|Atorvastatin|atorvastatin|mesh-list
2451793|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2451794|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2451795|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
2451796|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451797|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2451798|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2451799|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451800|NCT00967291|Ifosfamide|ifosfamide|mesh-list
2451801|NCT00967291|Mitomycins|mitomycins|mesh-list
2451802|NCT00967291|Mitomycin|mitomycin|mesh-list
2451803|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2451804|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
2451805|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451806|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451807|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2451808|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2451809|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451810|NCT00967382|Dalteparin|dalteparin|mesh-list
2451811|NCT00967382|Tinzaparin|tinzaparin|mesh-list
2451812|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2451813|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
2451814|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2451815|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2451816|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451817|NCT00967408|Citalopram|citalopram|mesh-list
2451818|NCT00967408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2451819|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2451820|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2451821|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451822|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451823|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
2451824|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451825|NCT00967408|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2451826|NCT00967408|Antidepressive Agents|antidepressive agents|mesh-ancestor
2451827|NCT00967408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2451828|NCT00967421|Ethanol|ethanol|mesh-list
2451829|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2451830|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451831|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2451832|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451833|NCT00967434|Atorvastatin|atorvastatin|mesh-list
2451834|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2451835|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2451836|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
2451837|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451838|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2451839|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2451840|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451841|NCT00967512|Cytarabine|cytarabine|mesh-list
2451842|NCT00967512|Idarubicin|idarubicin|mesh-list
2451843|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2451844|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
2451845|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451846|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451847|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
2451848|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2451849|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2451850|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
2451851|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451852|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2451853|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2451854|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2451855|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451856|NCT00967538|Etanercept|etanercept|mesh-list
2451857|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2451858|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2451859|NCT00967538|Analgesics|analgesics|mesh-ancestor
2451860|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
2451861|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451862|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451863|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2451864|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2451865|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2451866|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2451867|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
2451868|NCT00967603|Sunitinib|sunitinib|mesh-list
2451869|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451870|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2451871|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2451872|NCT00967603|Growth Substances|growth substances|mesh-ancestor
2451873|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451874|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
2451875|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2451876|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451877|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451878|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
2451879|NCT00967629|Calcium|calcium|mesh-list
2451880|NCT00967629|Sevelamer|sevelamer|mesh-list
2451881|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2451882|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451883|NCT00967629|Antacids|antacids|mesh-ancestor
2451884|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451885|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2451886|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
2451887|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
2451888|NCT00967642|Insulin|insulin|mesh-list
2451889|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2451890|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451891|NCT00967655|Capecitabine|capecitabine|mesh-list
2451892|NCT00967655|Irinotecan|irinotecan|mesh-list
2451893|NCT00967655|Panitumumab|panitumumab|mesh-list
2451894|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2451895|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
2451896|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451897|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451898|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2451899|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2451900|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451901|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2451902|NCT00967707|Gabapentin|gabapentin|mesh-list
2451903|NCT00967707|Donepezil|donepezil|mesh-list
2451904|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2451905|NCT00967707|Analgesics|analgesics|mesh-ancestor
2451906|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
2451907|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2451908|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451909|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
2451910|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2451911|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2451912|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2451913|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2451914|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2451915|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2451916|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451917|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451918|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
2451919|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2451920|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451921|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
2451922|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
2451923|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2451924|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2451925|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2451926|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2451927|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
2451928|NCT00967746|Etonogestrel|etonogestrel|mesh-list
2451929|NCT00967746|Desogestrel|desogestrel|mesh-list
2451930|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2451931|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
2451932|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2451933|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451934|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2451935|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2451936|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2451937|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2451938|NCT00967746|Progestins|progestins|mesh-ancestor
2451939|NCT00967746|Hormones|hormones|mesh-ancestor
2451940|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2451941|NCT00967772|Naftopidil|naftopidil|mesh-list
2451942|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2451943|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2451944|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
2451945|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451946|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451947|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451948|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2451949|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2451950|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2451951|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2451952|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2451958|NCT00967837|Insulin|insulin|mesh-list
2451959|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2451960|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2451961|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451962|NCT00967850|Verteporfin|verteporfin|mesh-list
2451963|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2451964|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
2451965|NCT00967928|Everolimus|everolimus|mesh-list
2451966|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2451967|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2451968|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
2451969|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451970|NCT00967954|Hormones|hormones|mesh-list
2451971|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
2451972|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2451973|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451974|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
2451975|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
2451976|NCT00967967|Desloratadine|desloratadine|mesh-list
2451977|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2451978|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
2451979|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2451980|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2451981|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
2451982|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2451983|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451984|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451985|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2451986|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2451987|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
2451988|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
2451989|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2451990|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2451991|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2451992|NCT00968006|Incretins|incretins|mesh-ancestor
2451993|NCT00968006|Hormones|hormones|mesh-ancestor
2451994|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2451995|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2451996|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
2451997|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2451998|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2451999|NCT00968110|Omalizumab|omalizumab|mesh-list
2452000|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2452001|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2452002|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
2452003|NCT00968162|Fludarabine|fludarabine|mesh-list
2452004|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452005|NCT00968240|Bevacizumab|bevacizumab|mesh-list
2738617|NCT04551482|Oxytocin|oxytocin|mesh-list
2452006|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2452007|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452008|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2452009|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2452010|NCT00968240|Growth Substances|growth substances|mesh-ancestor
2452011|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452012|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
2452013|NCT00968331|Rituximab|rituximab|mesh-list
2452014|NCT00968331|Lenalidomide|lenalidomide|mesh-list
2452015|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2452016|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452017|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
2452018|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452019|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2452020|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2452021|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2452022|NCT00968331|Growth Substances|growth substances|mesh-ancestor
2452023|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
2452024|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
2452025|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2452026|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
2452027|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
2452028|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2452029|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
2452030|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452031|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452032|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452033|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452034|NCT00968396|Melphalan|melphalan|mesh-list
2452035|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2452036|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
2452037|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452038|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452039|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2452040|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2452041|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
2452042|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452043|NCT00968435|Bevacizumab|bevacizumab|mesh-list
2452044|NCT00968435|Cetuximab|cetuximab|mesh-list
2452045|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2452046|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452047|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2452048|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2452049|NCT00968435|Growth Substances|growth substances|mesh-ancestor
2452050|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452051|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
2452052|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
2452053|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452054|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452055|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2452056|NCT00968461|Protective Agents|protective agents|mesh-ancestor
2452057|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452058|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452059|NCT00968565|Citric Acid|citric acid|mesh-list
2452060|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
2452061|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
2452062|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2452063|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
2452064|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
2452065|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452066|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
2452067|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2452068|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2452069|NCT00968578|Prednisolone|prednisolone|mesh-list
2452070|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
2452071|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2452072|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
2452073|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2452074|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
2452075|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
2452076|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452077|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452078|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2452079|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
2452080|NCT00968578|Hormones|hormones|mesh-ancestor
2452081|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452082|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2452083|NCT00968578|Protective Agents|protective agents|mesh-ancestor
2452084|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2452085|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452086|NCT00968591|Everolimus|everolimus|mesh-list
2452087|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452088|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2452089|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
2452090|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452091|NCT00968682|Trastuzumab|trastuzumab|mesh-list
2452092|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2452093|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452094|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
2452095|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2452096|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452097|NCT00968734|Vitamins|vitamins|mesh-ancestor
2452098|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
2452099|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2452100|NCT00968760|Cytarabine|cytarabine|mesh-list
2452101|NCT00968760|Etoposide|etoposide|mesh-list
2452102|NCT00968760|Melphalan|melphalan|mesh-list
2452103|NCT00968760|Interleukin-2|interleukin-2|mesh-list
2452104|NCT00968760|Carmustine|carmustine|mesh-list
2452105|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2452106|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452107|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2452108|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2452109|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452110|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452111|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2452112|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
2452113|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
2452114|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2452115|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2452116|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
2452117|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452118|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2452119|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
2452120|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2452121|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2452122|NCT00968760|Analgesics|analgesics|mesh-ancestor
2452123|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
2452124|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452125|NCT00968825|Botulinum Toxins|botulinum toxins|mesh-list
2452126|NCT00968825|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2452127|NCT00968825|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2452128|NCT00968825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2452129|NCT00968825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2452130|NCT00968825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452131|NCT00968825|Cholinergic Agents|cholinergic agents|mesh-ancestor
2452132|NCT00968825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452133|NCT00968825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452134|NCT00968825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2452135|NCT00968825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452136|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
2452137|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2452138|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452139|NCT00968877|Vitamins|vitamins|mesh-ancestor
2452140|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
2452141|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2452142|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
2452143|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2452144|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2452145|NCT00968903|Prednisolone|prednisolone|mesh-list
2452146|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
2452147|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2452148|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
2452149|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2452150|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
2452151|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
2452152|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452153|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452154|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2452155|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
2452156|NCT00968903|Hormones|hormones|mesh-ancestor
2452157|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452158|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2452159|NCT00968903|Protective Agents|protective agents|mesh-ancestor
2452160|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2452161|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452162|NCT00968929|Streptokinase|streptokinase|mesh-list
2452163|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2452164|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2452165|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452166|NCT00968942|Botulinum Toxins|botulinum toxins|mesh-list
2452167|NCT00968942|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2452168|NCT00968942|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2452169|NCT00968942|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2452170|NCT00968942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2452171|NCT00968942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452172|NCT00968942|Cholinergic Agents|cholinergic agents|mesh-ancestor
2452173|NCT00968942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452174|NCT00968942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452175|NCT00968942|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2452176|NCT00968942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452177|NCT00968955|Ropivacaine|ropivacaine|mesh-list
2452178|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
2452179|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
2452180|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2452181|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452182|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
2452183|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452184|NCT00968994|Petrolatum|petrolatum|mesh-list
2452185|NCT00968994|Emollients|emollients|mesh-ancestor
2452186|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
2452187|NCT00969033|Irinotecan|irinotecan|mesh-list
2452188|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2452189|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2452190|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452191|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452192|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452193|NCT00969046|Epothilone B|epothilone b|mesh-list
2452194|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452195|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
2452196|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
2452197|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
2452198|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452199|NCT00969072|Dutasteride|dutasteride|mesh-list
2452200|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2452201|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2452202|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452203|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452204|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
2452205|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452206|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452207|NCT00969085|Curcumin|curcumin|mesh-list
2452208|NCT00969085|Turmeric extract|turmeric extract|mesh-list
2452209|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2452210|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2452211|NCT00969085|Analgesics|analgesics|mesh-ancestor
2452212|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
2452213|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452214|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452215|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2452216|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2452217|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452218|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452219|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452220|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
2452221|NCT00969085|Protective Agents|protective agents|mesh-ancestor
2452222|NCT00969137|Nicotine|nicotine|mesh-list
2452223|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2452224|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
2452225|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452226|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452227|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2452228|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2452229|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
2452230|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452231|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452232|NCT00969163|Testosterone|testosterone|mesh-list
2452233|NCT00969163|Androgens|androgens|mesh-ancestor
2452234|NCT00969163|Hormones|hormones|mesh-ancestor
2452235|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452236|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452237|NCT00969176|Acetaminophen|acetaminophen|mesh-list
2452238|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2452239|NCT00969176|Analgesics|analgesics|mesh-ancestor
2452240|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
2452241|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452242|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452243|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
2452244|NCT00969293|Ecallantide|ecallantide|mesh-list
2452245|NCT00969293|Analgesics|analgesics|mesh-ancestor
2452246|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
2452247|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452248|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452249|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2452250|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2452251|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2452252|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2452253|NCT00969306|Chloroquine|chloroquine|mesh-list
2452254|NCT00969306|Amebicides|amebicides|mesh-ancestor
2452255|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2452256|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2452257|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2452258|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
2452259|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2452260|NCT00969319|Factor VIII|factor viii|mesh-list
2452261|NCT00969319|Coagulants|coagulants|mesh-ancestor
2452262|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
2452263|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2452264|NCT00969397|Growth Substances|growth substances|mesh-ancestor
2452265|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452266|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
2452267|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452268|NCT00969449|Naproxen|naproxen|mesh-list
2452269|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2452270|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2452271|NCT00969449|Analgesics|analgesics|mesh-ancestor
2452272|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
2452273|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452274|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452275|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2452276|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2452277|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
2452278|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2452279|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452280|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452281|NCT00969462|Doxorubicin|doxorubicin|mesh-list
2452282|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2452283|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452284|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2452285|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2452286|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452287|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452288|NCT00969566|Metformin|metformin|mesh-list
2452289|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2452290|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2452291|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452292|NCT00969566|Incretins|incretins|mesh-ancestor
2452293|NCT00969566|Hormones|hormones|mesh-ancestor
2452294|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452295|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2452296|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
2452297|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452298|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452299|NCT00969592|Insulin|insulin|mesh-list
2452300|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2452301|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
2452302|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
2452303|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2452304|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
2452305|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2738618|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
2452306|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452307|NCT00969631|Metformin|metformin|mesh-list
2452308|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2452309|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452310|NCT00969696|Galantamine|galantamine|mesh-list
2452311|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2452312|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452313|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452314|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
2452315|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452316|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452317|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2452318|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
2452319|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452320|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
2452321|NCT00969722|Tretinoin|tretinoin|mesh-list
2452322|NCT00969722|Molgramostim|molgramostim|mesh-list
2452323|NCT00969722|Isotretinoin|isotretinoin|mesh-list
2452324|NCT00969722|Sargramostim|sargramostim|mesh-list
2452325|NCT00969722|Immunologic Factors|immunologic factors|mesh-ancestor
2452326|NCT00969722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452327|NCT00969722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452328|NCT00969722|Keratolytic Agents|keratolytic agents|mesh-ancestor
2452329|NCT00969722|Dermatologic Agents|dermatologic agents|mesh-ancestor
2452330|NCT00969813|Tofacitinib|tofacitinib|mesh-list
2452331|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2452332|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452333|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452334|NCT00969852|Sertraline|sertraline|mesh-list
2452335|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
2452336|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2452337|NCT00969852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2452338|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2452339|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2452340|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452341|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452342|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
2452343|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452344|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
2452345|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2452346|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
2452347|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2452348|NCT00969904|Expectorants|expectorants|mesh-ancestor
2452349|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
2452350|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2452351|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
2452352|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452353|NCT00969904|Protective Agents|protective agents|mesh-ancestor
2452354|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452355|NCT00969904|Antidotes|antidotes|mesh-ancestor
2452356|NCT00969982|Misoprostol|misoprostol|mesh-list
2452357|NCT00969982|Mifepristone|mifepristone|mesh-list
2452358|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2452359|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
2452360|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2452361|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452362|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2452363|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2452364|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
2452365|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2452366|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2452367|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2452368|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2452369|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
2452370|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2452371|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2452372|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
2452373|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452374|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
2452375|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2452376|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2452377|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
2452378|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
2452379|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2452380|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
2452381|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452382|NCT00970086|Bupivacaine|bupivacaine|mesh-list
2452383|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
2452384|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
2452385|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
2452386|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2452387|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452388|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
2452389|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452390|NCT00970138|Apatinib|apatinib|mesh-list
2452391|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452392|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2452393|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452394|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452395|NCT00970450|Acetaminophen|acetaminophen|mesh-list
2452396|NCT00970450|Tropisetron|tropisetron|mesh-list
2452397|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2452398|NCT00970450|Analgesics|analgesics|mesh-ancestor
2452399|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
2452400|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452401|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452402|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
2452403|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
2452404|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
2452405|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2452406|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2452407|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2452408|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
2452409|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452410|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452411|NCT00970528|Acarbose|acarbose|mesh-list
2452412|NCT00970528|Voglibose|voglibose|mesh-list
2452413|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2452414|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452415|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452416|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2452417|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452418|NCT00970567|Insulin|insulin|mesh-list
2452419|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2452420|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452421|NCT00970580|Paclitaxel|paclitaxel|mesh-list
2452422|NCT00970580|Carboplatin|carboplatin|mesh-list
2452423|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
2452424|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2452425|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452426|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
2452427|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
2452428|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
2452429|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452430|NCT00970697|Becaplermin|becaplermin|mesh-list
2452431|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
2452432|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
2452433|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2452434|NCT00970697|Growth Substances|growth substances|mesh-ancestor
2452435|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452436|NCT00970762|Rocuronium|rocuronium|mesh-list
2452437|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
2452438|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2452439|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2452440|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2452441|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452442|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452443|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2452444|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2452445|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
2452446|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452447|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452448|NCT00970866|Folic Acid|folic acid|mesh-list
2452449|NCT00970866|Micronutrients|micronutrients|mesh-list
2452450|NCT00970866|Trace Elements|trace elements|mesh-list
2452451|NCT00970866|Hematinics|hematinics|mesh-ancestor
2452452|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
2452453|NCT00970866|Vitamins|vitamins|mesh-ancestor
2452454|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452455|NCT00970879|Mefloquine|mefloquine|mesh-list
2452456|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2452457|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
2452458|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2452459|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2452460|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2452461|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2452462|NCT00970879|Renal Agents|renal agents|mesh-ancestor
2452463|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2452464|NCT00970892|Warfarin|warfarin|mesh-list
2452465|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
2452466|NCT00970905|Ondansetron|ondansetron|mesh-list
2452467|NCT00970905|Aprepitant|aprepitant|mesh-list
2452468|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
2452469|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
2452470|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452471|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452472|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2452473|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
2452474|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
2452475|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2452476|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
2452477|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452478|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452479|NCT00970905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2452480|NCT00970905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2452481|NCT00970905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2452482|NCT00970905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2452483|NCT00970905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2452484|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2452485|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
2452486|NCT00970931|Amiloride|amiloride|mesh-list
2452487|NCT00970931|Diuretics|diuretics|mesh-list
2452488|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
2452489|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452490|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2452491|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2452492|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2452493|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452494|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2452495|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2452496|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2452497|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2452498|NCT00970957|Bevacizumab|bevacizumab|mesh-list
2452499|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2452500|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452501|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2452502|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2452503|NCT00970957|Growth Substances|growth substances|mesh-ancestor
2452504|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452505|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
2452506|NCT00970970|Bevacizumab|bevacizumab|mesh-list
2452507|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
2452508|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2452509|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452510|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2452511|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2452512|NCT00970970|Growth Substances|growth substances|mesh-ancestor
2452513|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452514|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
2452515|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2452516|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452517|NCT00970996|Interferons|interferons|mesh-list
2452518|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
2452519|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
2452520|NCT00970996|Paclitaxel|paclitaxel|mesh-list
2452521|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2452522|NCT00970996|Cisplatin|cisplatin|mesh-list
2452523|NCT00970996|Temozolomide|temozolomide|mesh-list
2452524|NCT00970996|Interleukin-2|interleukin-2|mesh-list
2452525|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2452526|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452527|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
2452528|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
2452529|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
2452530|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452531|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
2452532|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2452533|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2452534|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
2452535|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
2452536|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452537|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2452538|NCT00970996|Analgesics|analgesics|mesh-ancestor
2452539|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
2452540|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452541|NCT00971035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2452542|NCT00971035|Immunologic Factors|immunologic factors|mesh-ancestor
2452543|NCT00971035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452544|NCT00971074|Hylan|hylan|mesh-list
2452545|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
2452546|NCT00971074|Protective Agents|protective agents|mesh-ancestor
2452547|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452548|NCT00971126|Thalidomide|thalidomide|mesh-list
2452549|NCT00971126|Sorafenib|sorafenib|mesh-list
2452550|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452551|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2452552|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452553|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452554|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2452555|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
2452556|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452557|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
2452558|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2452559|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2452560|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2452561|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2452562|NCT00971126|Growth Substances|growth substances|mesh-ancestor
2452563|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
2452564|NCT00971152|Menotropins|menotropins|mesh-list
2452565|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2452566|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
2452567|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2452568|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452569|NCT00971165|Losartan|losartan|mesh-list
2452570|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
2452571|NCT00971165|Amiloride|amiloride|mesh-list
2452572|NCT00971165|Diuretics|diuretics|mesh-list
2452573|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2452574|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2452575|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2452576|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2452577|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452578|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
2452579|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452580|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2452581|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2452582|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2452583|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2452584|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2452585|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2452586|NCT00971399|Ondansetron|ondansetron|mesh-list
2452587|NCT00971399|Ramosetron|ramosetron|mesh-list
2452588|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
2452589|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
2452590|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452591|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452592|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2452593|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
2452594|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
2452595|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2452596|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
2452597|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452598|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452599|NCT00971399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2452600|NCT00971399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2452601|NCT00971399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2452602|NCT00971399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2452603|NCT00971399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2452604|NCT00971581|Ketoprofen|ketoprofen|mesh-list
2452605|NCT00971581|Omeprazole|omeprazole|mesh-list
2452606|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2452607|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2452608|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2452609|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452610|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452611|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2452612|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2452613|NCT00971581|Analgesics|analgesics|mesh-ancestor
2452614|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
2452615|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452616|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452617|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2452618|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2452619|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2452620|NCT00971607|Sevoflurane|sevoflurane|mesh-list
2452621|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2452622|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2452623|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
2452624|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
2452625|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2452626|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452627|NCT00971659|Insulin|insulin|mesh-list
2452628|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2452629|NCT00971659|Metformin|metformin|mesh-list
2452630|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
2452631|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2452632|NCT00971659|Exenatide|exenatide|mesh-list
2452633|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2452634|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452635|NCT00971659|Incretins|incretins|mesh-ancestor
2452636|NCT00971659|Hormones|hormones|mesh-ancestor
2452637|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452638|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2452639|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
2452640|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452641|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452642|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2452643|NCT00971685|Dexamethasone|dexamethasone|mesh-list
2452644|NCT00971685|Lenalidomide|lenalidomide|mesh-list
2452645|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2452646|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
2452647|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
2452648|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452649|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452650|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2452651|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
2452652|NCT00971685|Hormones|hormones|mesh-ancestor
2452653|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452654|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2452655|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452656|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
2452657|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2452658|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2452659|NCT00971685|Growth Substances|growth substances|mesh-ancestor
2452660|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
2452661|NCT00971724|Prednisolone|prednisolone|mesh-list
2452662|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2452663|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
2452664|NCT00971724|Hormones|hormones|mesh-ancestor
2452665|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452666|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452667|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2452668|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452669|NCT00971763|Gemcitabine|gemcitabine|mesh-list
2452670|NCT00971763|Prednisolone|prednisolone|mesh-list
2452671|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
2452672|NCT00971763|Rituximab|rituximab|mesh-list
2452673|NCT00971763|Vincristine|vincristine|mesh-list
2452674|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2452675|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
2452676|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452677|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2452678|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2452679|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
2452680|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452681|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452682|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2452683|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2452684|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2452685|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
2452686|NCT00971763|Antiviral Agents|antiviral agents|mesh-ancestor
2452687|NCT00971763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2452688|NCT00971763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452689|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2452690|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
2452691|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
2452692|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
2452693|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2452694|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
2452695|NCT00971763|Hormones|hormones|mesh-ancestor
2452696|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452697|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2452698|NCT00971815|Dexetimide|dexetimide|mesh-list
2452699|NCT00971815|Citalopram|citalopram|mesh-list
2452700|NCT00971815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2452701|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2452702|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2452703|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452704|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452705|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
2452706|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452707|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2452708|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
2452709|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2452710|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2452711|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2452712|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
2452713|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
2452714|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452715|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2452716|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2452717|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
2452718|NCT00971867|Paclitaxel|paclitaxel|mesh-list
2452719|NCT00971867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2452720|NCT00971867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452721|NCT00971867|Tubulin Modulators|tubulin modulators|mesh-ancestor
2452722|NCT00971867|Antimitotic Agents|antimitotic agents|mesh-ancestor
2452723|NCT00971867|Mitosis Modulators|mitosis modulators|mesh-ancestor
2452724|NCT00971867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452725|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
2452726|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2452727|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2452728|NCT00971893|Prednisolone|prednisolone|mesh-list
2452729|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
2452730|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2452731|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
2452732|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2452733|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
2452734|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
2452735|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452736|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452737|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2452738|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
2452739|NCT00971893|Hormones|hormones|mesh-ancestor
2452740|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452741|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2452742|NCT00971893|Protective Agents|protective agents|mesh-ancestor
2452743|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2452744|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452745|NCT00972075|Melatonin|melatonin|mesh-list
2452746|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
2452747|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452748|NCT00972075|Protective Agents|protective agents|mesh-ancestor
2452749|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452750|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2452751|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
2452752|NCT00972101|Rituximab|rituximab|mesh-list
2452753|NCT00972101|Fludarabine|fludarabine|mesh-list
2452754|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
2452755|NCT00972101|Etoposide|etoposide|mesh-list
2452756|NCT00972101|Melphalan|melphalan|mesh-list
2452757|NCT00972101|Thiotepa|thiotepa|mesh-list
2452758|NCT00972101|Tacrolimus|tacrolimus|mesh-list
2452759|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2452760|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2452761|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452762|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
2452763|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452764|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2452765|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2452766|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
2452767|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452768|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2452769|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2452770|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2452771|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2452772|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2452773|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452774|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2452775|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2452776|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2452777|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
2452778|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2452779|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2452780|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
2452781|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2452782|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
2452783|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2452784|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
2452785|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452786|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452787|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2452788|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
2452789|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2452790|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2452791|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2452792|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
2452793|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452794|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452795|NCT00972218|Adalimumab|adalimumab|mesh-list
2452796|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2452797|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2452798|NCT00972257|Timolol|timolol|mesh-list
2452799|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2452800|NCT00972257|Dorzolamide|dorzolamide|mesh-list
2452801|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2452802|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2452803|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
2452804|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452805|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452806|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452807|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2452808|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2452809|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2452810|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2452811|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2452812|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2452813|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452814|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
2452815|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2452816|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2452820|NCT00972387|Prednisone|prednisone|mesh-list
2452821|NCT00972387|Prednisolone|prednisolone|mesh-list
2452822|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
2452823|NCT00972387|Doxorubicin|doxorubicin|mesh-list
2452824|NCT00972387|Vincristine|vincristine|mesh-list
2452825|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2452826|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
2452827|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452828|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2452829|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2452830|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
2452831|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452832|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452833|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2452834|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2452835|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2452836|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2452837|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452838|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2452839|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
2452840|NCT00972387|Hormones|hormones|mesh-ancestor
2452841|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452842|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2452843|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2452844|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
2452845|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
2452846|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
2452847|NCT00972426|Timolol|timolol|mesh-list
2452848|NCT00972426|Carteolol|carteolol|mesh-list
2452849|NCT00972426|Latanoprost|latanoprost|mesh-list
2452850|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2452851|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2452852|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
2452853|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452854|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452855|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452856|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2452857|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2452858|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2452859|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2452860|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
2452861|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
2452862|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452863|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
2452864|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2452865|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452866|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
2452867|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
2452868|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452869|NCT00972660|Cyclosporine|cyclosporine|mesh-list
2452870|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
2452871|NCT00972660|Prednisone|prednisone|mesh-list
2452872|NCT00972660|Cyclosporins|cyclosporins|mesh-list
2452873|NCT00972660|Tacrolimus|tacrolimus|mesh-list
2452874|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2452875|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
2452876|NCT00972660|Hormones|hormones|mesh-ancestor
2452877|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452878|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452879|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2452880|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452881|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452882|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452883|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2452884|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
2452885|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
2452886|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2452887|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
2452888|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2452889|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2452890|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2452891|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2452892|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
2452893|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2452894|NCT00972712|Bortezomib|bortezomib|mesh-list
2452895|NCT00972712|Tipifarnib|tipifarnib|mesh-list
2452896|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452897|NCT00972790|Bupivacaine|bupivacaine|mesh-list
2452898|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
2452899|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
2452900|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2452901|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452902|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
2452903|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452904|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
2452905|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2452906|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2452907|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
2452908|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2452909|NCT00972829|Ezetimibe|ezetimibe|mesh-list
2452910|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2452911|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2452912|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
2452913|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452914|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2452915|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2452916|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452917|NCT00972842|Lenalidomide|lenalidomide|mesh-list
2452918|NCT00972842|Vorinostat|vorinostat|mesh-list
2452919|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
2452920|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452921|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2452922|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2452923|NCT00972842|Growth Substances|growth substances|mesh-ancestor
2452924|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
2452925|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452926|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2452927|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452928|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452929|NCT00972855|Bicalutamide|bicalutamide|mesh-list
2452930|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
2452931|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
2452932|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452933|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452934|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452935|NCT00972881|Capecitabine|capecitabine|mesh-list
2452936|NCT00972881|Irinotecan|irinotecan|mesh-list
2452937|NCT00972881|Cetuximab|cetuximab|mesh-list
2452938|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2452939|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
2452940|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452941|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452942|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2452943|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2452944|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2452945|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2452946|NCT00972907|Nifedipine|nifedipine|mesh-list
2452947|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2452948|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2452949|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452950|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2452951|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452952|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
2452953|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
2452954|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2452955|NCT00972933|Ipilimumab|ipilimumab|mesh-list
2452956|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2452957|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452958|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2452959|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452960|NCT00972946|Dextrans|dextrans|mesh-list
2452961|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
2452962|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
2452963|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
2452964|NCT00972985|Lorazepam|lorazepam|mesh-list
2452965|NCT00972985|Methylphenidate|methylphenidate|mesh-list
2452966|NCT00972985|Modafinil|modafinil|mesh-list
2452967|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2452968|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452969|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2452970|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2452971|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2452972|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2452973|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
2452974|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2452975|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2452976|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2452977|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2452978|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
2452979|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
2452980|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
2452981|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2452982|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2452983|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2452984|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2452985|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2452986|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2452987|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2452988|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
2452989|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
2452990|NCT00973037|Tamoxifen|tamoxifen|mesh-list
2452991|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2452992|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
2452993|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2452994|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2452995|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2452996|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2452997|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2452998|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2452999|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2453000|NCT00973050|Bicalutamide|bicalutamide|mesh-list
2453001|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
2453002|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
2453003|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2453004|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453005|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453006|NCT00973115|Simvastatin|simvastatin|mesh-list
2453007|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2453008|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2453009|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
2453010|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453011|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2453012|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2453013|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453014|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2453015|NCT00973128|Sargramostim|sargramostim|mesh-list
2453016|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
2453017|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453018|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2453019|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2453020|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453021|NCT00973154|Prednisone|prednisone|mesh-list
2453022|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2453023|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
2453024|NCT00973154|Hormones|hormones|mesh-ancestor
2453025|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2453026|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453027|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2453028|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453029|NCT00973193|Panitumumab|panitumumab|mesh-list
2453030|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2453031|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453032|NCT00973219|Interferons|interferons|mesh-list
2453033|NCT00973219|Tenofovir|tenofovir|mesh-list
2453034|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
2453035|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
2453036|NCT00973219|Adefovir|adefovir|mesh-list
2453037|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
2453038|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2453039|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453040|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
2453041|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453042|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2453043|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2453044|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453045|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453046|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2453047|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2453048|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
2453049|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453050|NCT00973232|Acetaminophen|acetaminophen|mesh-list
2453051|NCT00973232|Tramadol|tramadol|mesh-list
2453052|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2453053|NCT00973232|Analgesics|analgesics|mesh-ancestor
2453054|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
2453055|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453056|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453057|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
2453058|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2453059|NCT00973232|Narcotics|narcotics|mesh-ancestor
2453060|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2453061|NCT00973245|Warfarin|warfarin|mesh-list
2453062|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
2453063|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
2453064|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2453065|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
2453066|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2453067|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
2453068|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453069|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453070|NCT00973271|Atorvastatin|atorvastatin|mesh-list
2453071|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
2453072|NCT00973271|Fenofibrate|fenofibrate|mesh-list
2453073|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2453074|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2453075|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
2453076|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453077|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2453078|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2453079|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453080|NCT00973284|Mannitol|mannitol|mesh-list
2453081|NCT00973284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2453082|NCT00973284|Diuretics|diuretics|mesh-ancestor
2453083|NCT00973284|Natriuretic Agents|natriuretic agents|mesh-ancestor
2453084|NCT00973284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453085|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2453086|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453087|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2453088|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453089|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453090|NCT00973323|Warfarin|warfarin|mesh-list
2453091|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
2453092|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
2453093|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2453094|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
2453095|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2453096|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
2453097|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453098|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453099|NCT00973336|Vitamin D|vitamin d|mesh-list
2453100|NCT00973336|Calcium|calcium|mesh-list
2453101|NCT00973336|Vitamins|vitamins|mesh-ancestor
2453102|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
2453103|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453104|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2453105|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2453106|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
2453107|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2453108|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453109|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2453110|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2453111|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453112|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453113|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453114|NCT00973401|Insulin|insulin|mesh-list
2453115|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2453116|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453117|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
2453118|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453119|NCT00973505|Anastrozole|anastrozole|mesh-list
2453120|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
2453121|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453122|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2453123|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453124|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453125|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2453126|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
2453127|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2453128|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453129|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2453130|NCT00973583|Vitamin D|vitamin d|mesh-list
2453131|NCT00973583|Vitamins|vitamins|mesh-ancestor
2453132|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
2453133|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453134|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2453135|NCT00973609|Folic Acid|folic acid|mesh-list
2453136|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
2453137|NCT00973609|Bevacizumab|bevacizumab|mesh-list
2453138|NCT00973609|Fluorouracil|fluorouracil|mesh-list
2453139|NCT00973609|Capecitabine|capecitabine|mesh-list
2453140|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2453141|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453142|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2453143|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2453144|NCT00973609|Growth Substances|growth substances|mesh-ancestor
2453145|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453146|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
2453147|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
2453148|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453149|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2453150|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2453151|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
2453152|NCT00973609|Hematinics|hematinics|mesh-ancestor
2453153|NCT00973609|Vitamins|vitamins|mesh-ancestor
2453154|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
2453155|NCT00973687|Dexamethasone|dexamethasone|mesh-list
2453156|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2453157|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
2453158|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
2453159|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453160|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453161|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2453162|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
2453163|NCT00973687|Hormones|hormones|mesh-ancestor
2453164|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2453165|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2453166|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453167|NCT00973713|Everolimus|everolimus|mesh-list
2453168|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453169|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2453170|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
2453171|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453172|NCT00973778|Capecitabine|capecitabine|mesh-list
2453173|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2453174|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
2453175|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453176|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453177|NCT00973804|Sirolimus|sirolimus|mesh-list
2453178|NCT00973804|Tacrolimus|tacrolimus|mesh-list
2453179|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2453180|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
2453181|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453182|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2453183|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453184|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453185|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2453186|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453187|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2453188|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453189|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
2453190|NCT00973869|Curcumin|curcumin|mesh-list
2453191|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2453192|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2453193|NCT00973869|Analgesics|analgesics|mesh-ancestor
2453194|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
2453195|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453196|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453197|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2453198|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2453199|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453200|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453201|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453202|NCT00973882|Carboplatin|carboplatin|mesh-list
2453203|NCT00973882|Etoposide|etoposide|mesh-list
2453204|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453205|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2453206|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2453207|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2453208|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453209|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453210|NCT00973986|Atorvastatin|atorvastatin|mesh-list
2453211|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2453212|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2453213|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
2453214|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453215|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2453216|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2453217|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453218|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
2453219|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2453220|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2453221|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453222|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
2453223|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453224|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453225|NCT00974012|Valproic Acid|valproic acid|mesh-list
2453226|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
2453227|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453228|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453229|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
2453230|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453231|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453232|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
2453233|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2453234|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2453235|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2453236|NCT00974025|Ascorbic Acid|ascorbic acid|mesh-list
2453237|NCT00974025|Vitamins|vitamins|mesh-ancestor
2453238|NCT00974025|Micronutrients|micronutrients|mesh-ancestor
2453239|NCT00974025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453240|NCT00974025|Antioxidants|antioxidants|mesh-ancestor
2453241|NCT00974025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453242|NCT00974025|Protective Agents|protective agents|mesh-ancestor
2453243|NCT00974155|Dexetimide|dexetimide|mesh-list
2453244|NCT00974155|Citalopram|citalopram|mesh-list
2453245|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2453246|NCT00974155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2453247|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2453248|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2453249|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453250|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453251|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
2453252|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453253|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2453254|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
2453255|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2453256|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2453257|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2453258|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
2453259|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
2453260|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453261|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2453262|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2453263|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
2453264|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2453265|NCT00974181|Paclitaxel|paclitaxel|mesh-list
2453266|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2453267|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2453268|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453269|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
2453270|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
2453271|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
2453272|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453273|NCT00974272|Exenatide|exenatide|mesh-list
2453274|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2453275|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453276|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2453277|NCT00974272|Incretins|incretins|mesh-ancestor
2453278|NCT00974272|Hormones|hormones|mesh-ancestor
2453279|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2453280|NCT00974324|Endostar protein|endostar protein|mesh-list
2453281|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2453282|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2453283|NCT00974324|Growth Substances|growth substances|mesh-ancestor
2453284|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453285|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
2453286|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453287|NCT00974389|Bevacizumab|bevacizumab|mesh-list
2453288|NCT00974389|Tegafur|tegafur|mesh-list
2453289|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2453290|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453291|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2453292|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2453293|NCT00974389|Growth Substances|growth substances|mesh-ancestor
2453294|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453295|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
2453296|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2453297|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
2453298|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453299|NCT00974428|Wobenzym|wobenzym|mesh-list
2453300|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2453301|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
2453302|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453303|NCT00974441|Valproic Acid|valproic acid|mesh-list
2453304|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
2453305|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453306|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453307|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
2453308|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453309|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453310|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
2453311|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2453312|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2453313|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2453314|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
2453315|NCT00974532|Calcium|calcium|mesh-list
2453316|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2453317|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453318|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2453319|NCT00974584|Paclitaxel|paclitaxel|mesh-list
2453320|NCT00974584|Bevacizumab|bevacizumab|mesh-list
2453321|NCT00974584|Carboplatin|carboplatin|mesh-list
2453322|NCT00974584|Pemetrexed|pemetrexed|mesh-list
2453323|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2453324|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453325|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
2453326|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
2453327|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
2453328|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453329|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2453330|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2453331|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2453332|NCT00974584|Growth Substances|growth substances|mesh-ancestor
2453333|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453334|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
2453335|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453336|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2453337|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2453338|NCT00974740|Atorvastatin|atorvastatin|mesh-list
2453339|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2453340|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2453341|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
2453342|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453343|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2453344|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2453345|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453346|NCT00974753|Ketorolac|ketorolac|mesh-list
2453347|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2453348|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2453349|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2453350|NCT00974753|Analgesics|analgesics|mesh-ancestor
2453351|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
2453352|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453353|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453354|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2453355|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2453356|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2453357|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453358|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453359|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
2453360|NCT00974766|Hormones|hormones|mesh-ancestor
2453361|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2453362|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453363|NCT00974792|Leucovorin|leucovorin|mesh-list
2453364|NCT00974792|Cytarabine|cytarabine|mesh-list
2453365|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
2453366|NCT00974792|Ifosfamide|ifosfamide|mesh-list
2453367|NCT00974792|Rituximab|rituximab|mesh-list
2453368|NCT00974792|Doxorubicin|doxorubicin|mesh-list
2453369|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2453370|NCT00974792|Methotrexate|methotrexate|mesh-list
2453371|NCT00974792|Etoposide|etoposide|mesh-list
2453372|NCT00974792|Vincristine|vincristine|mesh-list
2453373|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
2453374|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
2453375|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2453376|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
2453377|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453378|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2453379|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2453380|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
2453381|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453382|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453383|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2453384|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2453385|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2453386|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2453387|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2453388|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453389|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2453390|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
2453391|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2453392|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2453393|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
2453394|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
2453395|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2453396|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2453397|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2453398|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
2453399|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453400|NCT00974792|Antidotes|antidotes|mesh-ancestor
2453401|NCT00974792|Protective Agents|protective agents|mesh-ancestor
2453402|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
2453403|NCT00974792|Vitamins|vitamins|mesh-ancestor
2453404|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
2453405|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
2453406|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
2453407|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
2453408|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2453409|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2453410|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
2453411|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453412|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453413|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2453414|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
2453415|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
2453416|NCT00974805|Hormones|hormones|mesh-ancestor
2453417|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2453418|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
2453419|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2453420|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2453421|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
2453422|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453423|NCT00974935|Antacids|antacids|mesh-ancestor
2453424|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453425|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2453426|NCT00974961|Bupivacaine|bupivacaine|mesh-list
2453427|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
2453428|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
2453429|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
2453430|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2453431|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453432|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
2453433|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453434|NCT00974987|Temozolomide|temozolomide|mesh-list
2453435|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2453436|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
2453437|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453438|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453439|NCT00975052|Metformin|metformin|mesh-list
2453440|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2453441|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2453442|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453443|NCT00975052|Incretins|incretins|mesh-ancestor
2453444|NCT00975052|Hormones|hormones|mesh-ancestor
2453445|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2453446|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2453447|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
2453448|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453449|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453450|NCT00975065|Metformin|metformin|mesh-list
2453451|NCT00975065|Vildagliptin|vildagliptin|mesh-list
2453452|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2453453|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453454|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2453455|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
2453456|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453457|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453458|NCT00975078|Prednisone|prednisone|mesh-list
2453459|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2453460|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
2453461|NCT00975078|Hormones|hormones|mesh-ancestor
2453462|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2453463|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453464|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2453465|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453466|NCT00975091|Entecavir|entecavir|mesh-list
2453467|NCT00975091|Antiviral Agents|antiviral agents|mesh-ancestor
2453468|NCT00975091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453469|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2453470|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
2453471|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453472|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2453473|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453474|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2453475|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453476|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453477|NCT00975299|Bombesin|bombesin|mesh-list
2453478|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453479|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453480|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453481|NCT00975312|Tretinoin|tretinoin|mesh-list
2453482|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453483|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
2453484|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
2453485|NCT00975325|Yohimbine|yohimbine|mesh-list
2453486|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
2453487|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
2453488|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453489|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453490|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2453491|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2453492|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2453493|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
2453494|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453495|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453496|NCT00975325|Urological Agents|urological agents|mesh-ancestor
2453497|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
2453498|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453499|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
2453500|NCT00975351|Vitamins|vitamins|mesh-ancestor
2453501|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
2453502|NCT00975390|Caffeine|caffeine|mesh-list
2453503|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2453504|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453505|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2453506|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453507|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453508|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2453509|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2453510|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
2453511|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453512|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
2453513|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
2453514|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2453515|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2453516|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453517|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453518|NCT00975494|Urological Agents|urological agents|mesh-ancestor
2453519|NCT00975533|Insulin|insulin|mesh-list
2453520|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2453521|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453522|NCT00975572|Vaccines|vaccines|mesh-list
2453523|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
2453524|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453525|NCT00975663|Tacrolimus|tacrolimus|mesh-list
2453526|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2453527|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
2453528|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453529|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2453530|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453531|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453532|NCT00975728|Antioxidants|antioxidants|mesh-list
2453533|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453534|NCT00975728|Protective Agents|protective agents|mesh-ancestor
2453535|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453536|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
2453537|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2453538|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
2453539|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2453540|NCT00975754|Budesonide|budesonide|mesh-list
2453541|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2453542|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2453543|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
2453544|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453545|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453546|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2453547|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
2453548|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
2453549|NCT00975754|Hormones|hormones|mesh-ancestor
2453550|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2453551|NCT00975767|Docetaxel|docetaxel|mesh-list
2453552|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2453553|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453554|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
2453555|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
2453556|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
2453557|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453558|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2453559|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453560|NCT00975819|Sirolimus|sirolimus|mesh-list
2453561|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2453562|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453563|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2453564|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453565|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
2453566|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2453567|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
2453568|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453569|NCT00975897|Leucovorin|leucovorin|mesh-list
2453570|NCT00975897|Bevacizumab|bevacizumab|mesh-list
2453571|NCT00975897|Cetuximab|cetuximab|mesh-list
2453572|NCT00975897|Fluorouracil|fluorouracil|mesh-list
2453573|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
2453574|NCT00975897|Irinotecan|irinotecan|mesh-list
2453575|NCT00975897|Calcium|calcium|mesh-list
2453576|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
2453577|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2453578|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453579|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2453580|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2453581|NCT00975897|Growth Substances|growth substances|mesh-ancestor
2453582|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453583|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
2453584|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2453585|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
2453586|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453587|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2453588|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2453589|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
2453590|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2453591|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2453592|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453593|NCT00975897|Antidotes|antidotes|mesh-ancestor
2453594|NCT00975897|Protective Agents|protective agents|mesh-ancestor
2453595|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
2453596|NCT00975897|Vitamins|vitamins|mesh-ancestor
2453597|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
2453598|NCT00975910|Lidocaine|lidocaine|mesh-list
2453599|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
2453600|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
2453601|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2453602|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453603|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
2453604|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453605|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2453606|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2453607|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2453608|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2453609|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453610|NCT00975936|Ketoconazole|ketoconazole|mesh-list
2453611|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
2453612|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453613|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2453614|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2453615|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453616|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453617|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2453618|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
2453619|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2453620|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453621|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2453622|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2453623|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2453624|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2453625|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453626|NCT00975988|Lapatinib|lapatinib|mesh-list
2453627|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453628|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2453629|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453630|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453631|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2453632|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
2453633|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453634|NCT00976066|Naltrexone|naltrexone|mesh-list
2453635|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2453636|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2453637|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453638|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
2453639|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453640|NCT00976092|Heparin|heparin|mesh-list
2453641|NCT00976092|Calcium heparin|calcium heparin|mesh-list
2453642|NCT00976092|Bivalirudin|bivalirudin|mesh-list
2453643|NCT00976092|Clopidogrel|clopidogrel|mesh-list
2453644|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
2453645|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2453646|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2453647|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2453648|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2453649|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
2453650|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453651|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453652|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453653|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
2453654|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2453655|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2453656|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
2453657|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2453658|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
2453659|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453660|NCT00976105|Zolpidem|zolpidem|mesh-list
2453661|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2453662|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2453663|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2453664|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453665|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2453666|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
2453667|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
2453668|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453669|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453670|NCT00976131|Ubiquinone|ubiquinone|mesh-list
2453671|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
2453672|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
2453673|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453674|NCT00976131|Vitamins|vitamins|mesh-ancestor
2453675|NCT00976170|Sorafenib|sorafenib|mesh-list
2453676|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453677|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2453678|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453679|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453680|NCT00976222|Ranibizumab|ranibizumab|mesh-list
2453681|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2453682|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2453683|NCT00976222|Growth Substances|growth substances|mesh-ancestor
2453684|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453685|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
2453686|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453687|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2453688|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2453689|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453690|NCT00976261|Incretins|incretins|mesh-ancestor
2453691|NCT00976261|Hormones|hormones|mesh-ancestor
2453692|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2453693|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2453694|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
2453695|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453696|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453697|NCT00976300|Cyclosporine|cyclosporine|mesh-list
2453698|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
2453699|NCT00976300|Cyclosporins|cyclosporins|mesh-list
2453700|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2453701|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
2453702|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453703|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2453704|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2453705|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
2453706|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453707|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453708|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2453709|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453710|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
2453711|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453712|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
2453713|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2453714|NCT00976326|Insulin|insulin|mesh-list
2453715|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2453716|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453717|NCT00976469|Vaccines|vaccines|mesh-list
2453718|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
2453719|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453720|NCT00976651|Menotropins|menotropins|mesh-list
2453721|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2453722|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
2453723|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2453724|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453725|NCT00976690|Mesalamine|mesalamine|mesh-list
2453726|NCT00976690|Azathioprine|azathioprine|mesh-list
2453727|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
2453728|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453729|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2453730|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453731|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2453732|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
2453733|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453734|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2453735|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2453736|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2453737|NCT00976690|Analgesics|analgesics|mesh-ancestor
2453738|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
2453739|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453740|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2453741|NCT00976755|Everolimus|everolimus|mesh-list
2453742|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453743|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2453744|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
2453745|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453746|NCT00976768|Fluorouracil|fluorouracil|mesh-list
2453747|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
2453748|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
2453749|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453750|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2453751|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453752|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2453753|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
2453754|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453755|NCT00976794|Carbamazepine|carbamazepine|mesh-list
2453756|NCT00976794|Valproic Acid|valproic acid|mesh-list
2453757|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
2453758|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
2453759|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2453760|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453761|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453762|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
2453763|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2453764|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2453765|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453766|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
2453767|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
2453768|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453769|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2453770|NCT00976794|Analgesics|analgesics|mesh-ancestor
2453771|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
2453772|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453773|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2453774|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2453775|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2453776|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2453777|NCT00976963|Fosfomycin|fosfomycin|mesh-list
2453778|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2453779|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453780|NCT00976976|Cisplatin|cisplatin|mesh-list
2453781|NCT00976976|Docetaxel|docetaxel|mesh-list
2453782|NCT00976976|Capecitabine|capecitabine|mesh-list
2453783|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453784|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
2453785|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
2453786|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
2453787|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453788|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2453789|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
2453790|NCT00977028|Lidocaine|lidocaine|mesh-list
2453791|NCT00977028|Epinephrine|epinephrine|mesh-list
2453792|NCT00977028|Racepinephrine|racepinephrine|mesh-list
2453793|NCT00977028|Anesthetics|anesthetics|mesh-list
2453794|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
2453795|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
2453796|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2453797|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453798|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
2453799|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453800|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2453801|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2453802|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2453803|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2453804|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453805|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2453806|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2453807|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
2453808|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453809|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2453810|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2453811|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
2453812|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2453813|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
2453814|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
2453815|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
2453816|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2453817|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2453818|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
2453819|NCT00977054|Ribavirin|ribavirin|mesh-list
2453820|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
2453821|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2453822|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
2453823|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453824|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
2453825|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453826|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
2453827|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453828|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453829|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
2453830|NCT00977093|Antidotes|antidotes|mesh-ancestor
2453831|NCT00977093|Protective Agents|protective agents|mesh-ancestor
2453832|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453833|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
2453834|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
2453835|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453836|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2453837|NCT00977132|Lenalidomide|lenalidomide|mesh-list
2453838|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
2453839|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453840|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2453841|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2453842|NCT00977132|Growth Substances|growth substances|mesh-ancestor
2453843|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
2453844|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453845|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
2453846|NCT00977145|Vaccines|vaccines|mesh-list
2453847|NCT00977145|Immunologic Factors|immunologic factors|mesh-ancestor
2453848|NCT00977145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453849|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
2453850|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453851|NCT00977223|Aprepitant|aprepitant|mesh-list
2453852|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
2453853|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
2453854|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
2453855|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453856|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453857|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2453858|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2453859|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453860|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453861|NCT00977249|Varenicline|varenicline|mesh-list
2453862|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2453863|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2453864|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
2453865|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453866|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453867|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453868|NCT00977288|Atorvastatin|atorvastatin|mesh-list
2453869|NCT00977288|Anacetrapib|anacetrapib|mesh-list
2453870|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2453871|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2453872|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
2453873|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453874|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2453875|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2453876|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453877|NCT00977301|Ritonavir|ritonavir|mesh-list
2453878|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
2453879|NCT00977301|Olanzapine|olanzapine|mesh-list
2453880|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2453881|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2453882|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
2453883|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453884|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453885|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2453886|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2453887|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
2453888|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453889|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2453890|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2453891|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
2453892|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
2453893|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453894|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453895|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2453896|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2453897|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2453898|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2453899|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2453900|NCT00977301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2453901|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2453902|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2453903|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453904|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
2453905|NCT00977353|Citalopram|citalopram|mesh-list
2453906|NCT00977353|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2453907|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2453908|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2453909|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453910|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2453911|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
2453912|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453913|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2453914|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
2453915|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2453916|NCT00977405|Gentamicins|gentamicins|mesh-list
2453917|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2453918|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453919|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2453920|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453921|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453922|NCT00977444|Prednisolone|prednisolone|mesh-list
2453923|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2453924|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
2453925|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2453926|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
2453927|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2453928|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
2453929|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2453930|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
2453931|NCT00977444|Hormones|hormones|mesh-ancestor
2453932|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2453933|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453934|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2453935|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453936|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
2453937|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
2453938|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2453939|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2453940|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2453941|NCT00977444|Protective Agents|protective agents|mesh-ancestor
2453942|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
2453943|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
2453944|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453945|NCT00977483|Protective Agents|protective agents|mesh-ancestor
2453946|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453947|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
2453948|NCT00977483|Vitamins|vitamins|mesh-ancestor
2453949|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
2453950|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2453951|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2453952|NCT00977756|Ritonavir|ritonavir|mesh-list
2453953|NCT00977756|Lopinavir|lopinavir|mesh-list
2453954|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2453955|NCT00977756|Darunavir|darunavir|mesh-list
2453956|NCT00977756|Tenofovir|tenofovir|mesh-list
2453957|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
2453958|NCT00977756|Maraviroc|maraviroc|mesh-list
2453959|NCT00977756|Etravirine|etravirine|mesh-list
2453960|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2453961|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2453962|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
2453963|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2453964|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2453965|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2453966|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2453967|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
2453968|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2453969|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2453970|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2453971|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2453972|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2453973|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2453974|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2453975|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2453976|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2453977|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2453978|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2453979|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2453980|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
2453981|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
2453982|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2453983|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2453984|NCT00977873|Vitamins|vitamins|mesh-ancestor
2453985|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
2453986|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2453987|NCT00977964|Caseins|caseins|mesh-list
2453988|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
2453989|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
2453990|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454006|NCT00978016|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
2454007|NCT00978016|Baclofen|baclofen|mesh-list
2454008|NCT00978016|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2454009|NCT00978016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454010|NCT00978016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454011|NCT00978016|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2454012|NCT00978016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454013|NCT00978016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2454014|NCT00978016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454015|NCT00978016|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2454016|NCT00978016|GABA Agonists|gaba agonists|mesh-ancestor
2454017|NCT00978016|GABA Agents|gaba agents|mesh-ancestor
2454018|NCT00978016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454019|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2454020|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2454021|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
2454022|NCT00978107|Flucytosine|flucytosine|mesh-list
2454023|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
2454024|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454025|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
2454026|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454027|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
2454028|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454029|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
2454030|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454031|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454032|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2454033|NCT00978159|Esomeprazole|esomeprazole|mesh-list
2454034|NCT00978159|Famotidine|famotidine|mesh-list
2454035|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2454036|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2454037|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2454038|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454039|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454040|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2454041|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
2454042|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
2454043|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454044|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454045|NCT00978172|Artesunate|artesunate|mesh-list
2454046|NCT00978172|Mefloquine|mefloquine|mesh-list
2454047|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
2454048|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2454049|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2454050|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454051|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454052|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
2454053|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
2454054|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2454055|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
2454056|NCT00978211|Octreotide|octreotide|mesh-list
2454057|NCT00978211|Somatostatin|somatostatin|mesh-list
2454058|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2454059|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2454060|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454061|NCT00978211|Hormones|hormones|mesh-ancestor
2454062|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2454063|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454064|NCT00978263|Metformin|metformin|mesh-list
2454065|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2454066|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454067|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
2454068|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2454069|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454070|NCT00978315|Vitamins|vitamins|mesh-ancestor
2454071|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
2454072|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2454073|NCT00978328|Oxycodone|oxycodone|mesh-list
2454074|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2454075|NCT00978328|Narcotics|narcotics|mesh-ancestor
2454076|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2454077|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454078|NCT00978328|Analgesics|analgesics|mesh-ancestor
2454079|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
2454080|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454081|NCT00978354|Furosemide|furosemide|mesh-list
2454082|NCT00978354|Diuretics|diuretics|mesh-ancestor
2454083|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
2454084|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454085|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2454086|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2454087|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454088|NCT00978393|Liraglutide|liraglutide|mesh-list
2454089|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2454090|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454091|NCT00978393|Incretins|incretins|mesh-ancestor
2454092|NCT00978393|Hormones|hormones|mesh-ancestor
2454093|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2454099|NCT00978471|Thiotepa|thiotepa|mesh-list
2454100|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2454101|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
2454102|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454103|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454104|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2454105|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2454106|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
2454107|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454108|NCT00978497|Ribavirin|ribavirin|mesh-list
2454109|NCT00978497|Antimetabolites|antimetabolites|mesh-ancestor
2454110|NCT00978497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454111|NCT00978497|Antiviral Agents|antiviral agents|mesh-ancestor
2454112|NCT00978497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454113|NCT00978549|Docetaxel|docetaxel|mesh-list
2454114|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454115|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
2454116|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
2454117|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
2454118|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454119|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2454120|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
2454121|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
2454122|NCT00978601|Analgesics|analgesics|mesh-list
2454123|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
2454124|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454125|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454126|NCT00978653|Allopurinol|allopurinol|mesh-list
2454127|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
2454128|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454129|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454130|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
2454131|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2454132|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2454133|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
2454134|NCT00978653|Protective Agents|protective agents|mesh-ancestor
2454135|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454136|NCT00978718|Selenium|selenium|mesh-list
2454137|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
2454138|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454139|NCT00978718|Protective Agents|protective agents|mesh-ancestor
2454140|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454141|NCT00978718|Trace Elements|trace elements|mesh-ancestor
2454142|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
2454143|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2454144|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2454145|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454146|NCT00978796|Incretins|incretins|mesh-ancestor
2454147|NCT00978796|Hormones|hormones|mesh-ancestor
2454148|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2454149|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2454150|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
2454151|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454152|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454153|NCT00978822|Clevidipine|clevidipine|mesh-list
2454154|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2454155|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2454156|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454157|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2454158|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454159|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2454160|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2454161|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454162|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
2454163|NCT00978913|Vaccines|vaccines|mesh-list
2454164|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
2454165|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454166|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2454167|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2454168|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2454169|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
2454170|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454171|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454172|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2454173|NCT00978978|Fentanyl|fentanyl|mesh-list
2454174|NCT00978978|Midazolam|midazolam|mesh-list
2454175|NCT00978978|Propofol|propofol|mesh-list
2454176|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2454177|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2454178|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454179|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2454180|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
2454181|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
2454182|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2454183|NCT00978978|Narcotics|narcotics|mesh-ancestor
2454184|NCT00978978|Analgesics|analgesics|mesh-ancestor
2454185|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
2454186|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454187|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2454188|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2454189|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2454190|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2454191|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
2454192|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
2454193|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454194|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454195|NCT00979056|Rifaximin|rifaximin|mesh-list
2454196|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2454197|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454198|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2454199|NCT00979160|Dasatinib|dasatinib|mesh-list
2454200|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454201|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2454202|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454203|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454204|NCT00979186|Hemostatics|hemostatics|mesh-list
2454205|NCT00979186|Coagulants|coagulants|mesh-ancestor
2454206|NCT00979251|Oseltamivir|oseltamivir|mesh-list
2454207|NCT00979251|Amantadine|amantadine|mesh-list
2454208|NCT00979251|Antiviral Agents|antiviral agents|mesh-ancestor
2454209|NCT00979251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454210|NCT00979251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454211|NCT00979251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454212|NCT00979251|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2454213|NCT00979251|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2454214|NCT00979251|Dopamine Agents|dopamine agents|mesh-ancestor
2454215|NCT00979251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454216|NCT00979251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454217|NCT00979251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2454218|NCT00979251|Analgesics|analgesics|mesh-ancestor
2454219|NCT00979251|Sensory System Agents|sensory system agents|mesh-ancestor
2454220|NCT00979251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454221|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
2454222|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2454223|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454224|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2454225|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2454226|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454227|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454228|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454229|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
2454230|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2454231|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2454232|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
2454233|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454234|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454235|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454236|NCT00979472|Urological Agents|urological agents|mesh-ancestor
2454237|NCT00979537|Nisoldipine|nisoldipine|mesh-list
2454238|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2454239|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2454240|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2454241|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454242|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2454243|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454244|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
2454245|NCT00979563|Irinotecan|irinotecan|mesh-list
2454246|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2454247|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2454248|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454249|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454250|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454251|NCT00979589|Aspirin|aspirin|mesh-list
2454252|NCT00979589|Clopidogrel|clopidogrel|mesh-list
2454253|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2454254|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2454255|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2454256|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2454257|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
2454258|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454259|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454260|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454261|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2454262|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2454263|NCT00979589|Analgesics|analgesics|mesh-ancestor
2454264|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
2454265|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454266|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2454267|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2454268|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2454269|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2454270|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2454271|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454272|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
2454273|NCT00979641|Docetaxel|docetaxel|mesh-list
2454274|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454275|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
2454276|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
2454277|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
2454278|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454279|NCT00979667|Oseltamivir|oseltamivir|mesh-list
2454280|NCT00979667|Zanamivir|zanamivir|mesh-list
2454281|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
2454282|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454283|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454284|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454285|NCT00979693|Psilocybin|psilocybin|mesh-list
2454286|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
2454287|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454288|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2454289|NCT00979706|Cyclosporine|cyclosporine|mesh-list
2454290|NCT00979706|Interleukin-2|interleukin-2|mesh-list
2454291|NCT00979706|Cyclosporins|cyclosporins|mesh-list
2454292|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454293|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454294|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2454295|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
2454296|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454297|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
2454298|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454299|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
2454300|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2454301|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2454302|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454303|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2454304|NCT00979706|Analgesics|analgesics|mesh-ancestor
2454305|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
2454306|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454307|NCT00979758|Atorvastatin|atorvastatin|mesh-list
2454308|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2454309|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2454310|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
2454311|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454312|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2454313|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2454314|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454315|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
2454316|NCT00979836|Calcium|calcium|mesh-list
2454317|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2454318|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454319|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
2454320|NCT00979836|Coagulants|coagulants|mesh-ancestor
2454321|NCT00979862|Cediranib|cediranib|mesh-list
2454322|NCT00979862|Maleic acid|maleic acid|mesh-list
2454323|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454324|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454325|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454326|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2454327|NCT00979966|Sirolimus|sirolimus|mesh-list
2454328|NCT00979966|Sunitinib|sunitinib|mesh-list
2454329|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454330|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2454331|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2454332|NCT00979966|Growth Substances|growth substances|mesh-ancestor
2454333|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454334|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
2454335|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2454336|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454337|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454338|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2454339|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454340|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2454341|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
2454342|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2454343|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
2454344|NCT00980031|Eplerenone|eplerenone|mesh-list
2454345|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2454346|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
2454347|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2454348|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454349|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2454350|NCT00980031|Diuretics|diuretics|mesh-ancestor
2454351|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
2454352|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2454353|NCT00980109|Oseltamivir|oseltamivir|mesh-list
2454354|NCT00980109|Zanamivir|zanamivir|mesh-list
2454355|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
2454356|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454357|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454358|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454359|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
2454360|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2454361|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2454362|NCT00980187|Indapamide|indapamide|mesh-list
2454363|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2454364|NCT00980187|Diuretics|diuretics|mesh-ancestor
2454365|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
2454366|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454367|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2454368|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2454369|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454370|NCT00980213|Sunitinib|sunitinib|mesh-list
2454371|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454372|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2454373|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2454374|NCT00980213|Growth Substances|growth substances|mesh-ancestor
2454375|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454376|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
2454377|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2454378|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454379|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454380|NCT00980239|Bevacizumab|bevacizumab|mesh-list
2454381|NCT00980239|Cetuximab|cetuximab|mesh-list
2454382|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
2454383|NCT00980239|Irinotecan|irinotecan|mesh-list
2454384|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2454385|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454386|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2454387|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2454388|NCT00980239|Growth Substances|growth substances|mesh-ancestor
2454389|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454390|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
2454391|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2454392|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2454393|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454394|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454395|NCT00980304|Rituximab|rituximab|mesh-list
2454396|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2454397|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454398|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
2454399|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454400|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2454401|NCT00980356|Vildagliptin|vildagliptin|mesh-list
2454402|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2454403|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454404|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2454405|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
2454406|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454407|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454408|NCT00980382|Docetaxel|docetaxel|mesh-list
2454409|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454410|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
2454411|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
2454412|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
2454413|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454414|NCT00980408|Cycloserine|cycloserine|mesh-list
2454415|NCT00980408|Memantine|memantine|mesh-list
2454416|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2454417|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2454418|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
2454419|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454420|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454421|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454422|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2454423|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2454424|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2454425|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454426|NCT00980408|Renal Agents|renal agents|mesh-ancestor
2454427|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2454428|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
2454429|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2454430|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
2454465|NCT00980473|Timolol|timolol|mesh-list
2454466|NCT00980473|Travoprost|travoprost|mesh-list
2454467|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2454468|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2454469|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
2454470|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454471|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454472|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454473|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2454474|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2454482|NCT00980551|Carboplatin|carboplatin|mesh-list
2454483|NCT00980551|Vincristine|vincristine|mesh-list
2454484|NCT00980551|Topotecan|topotecan|mesh-list
2454485|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454486|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2454487|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
2454488|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
2454489|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
2454490|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454491|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2454492|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2454493|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454494|NCT00980603|Docetaxel|docetaxel|mesh-list
2454495|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454496|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
2454497|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
2454498|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
2454499|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454500|NCT00980616|Ropivacaine|ropivacaine|mesh-list
2454501|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
2454502|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
2454503|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2454504|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454505|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
2454506|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454507|NCT00980707|Fluticasone|fluticasone|mesh-list
2454508|NCT00980707|Xhance|xhance|mesh-list
2454509|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2454510|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2454511|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
2454512|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454513|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454514|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2454515|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
2454516|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
2454517|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2454518|NCT00980850|Vaccines|vaccines|mesh-list
2454519|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
2454520|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454521|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
2454522|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
2454523|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2454524|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2454525|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454526|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2454527|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2454528|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454529|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454530|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454531|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2454532|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2454533|NCT00981006|Mitogens|mitogens|mesh-list
2454534|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
2454535|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454536|NCT00981162|Everolimus|everolimus|mesh-list
2454537|NCT00981162|Sorafenib|sorafenib|mesh-list
2454538|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454539|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2454540|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
2454541|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454542|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2454543|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454544|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454545|NCT00981201|Celecoxib|celecoxib|mesh-list
2454546|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2454547|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2454548|NCT00981201|Analgesics|analgesics|mesh-ancestor
2454549|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
2454550|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454551|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454552|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2454553|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2454554|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2454555|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2454556|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454557|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454558|NCT00981318|Ritonavir|ritonavir|mesh-list
2454559|NCT00981318|Lopinavir|lopinavir|mesh-list
2454560|NCT00981318|Maraviroc|maraviroc|mesh-list
2454561|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2454562|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2454563|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
2454564|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454565|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454566|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2454567|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2454568|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
2454569|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454570|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2454571|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2454572|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2454573|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2454574|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2454575|NCT00981357|Naproxen|naproxen|mesh-list
2454576|NCT00981357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2454577|NCT00981357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2454578|NCT00981357|Analgesics|analgesics|mesh-ancestor
2454579|NCT00981357|Sensory System Agents|sensory system agents|mesh-ancestor
2454580|NCT00981357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454581|NCT00981357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454582|NCT00981357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2454583|NCT00981357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2454584|NCT00981357|Gout Suppressants|gout suppressants|mesh-ancestor
2454585|NCT00981357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2454586|NCT00981357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454587|NCT00981357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454588|NCT00981487|Ondansetron|ondansetron|mesh-list
2454589|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
2454590|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
2454591|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454592|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454593|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2454594|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
2454595|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
2454596|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2454597|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
2454598|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454599|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454600|NCT00981487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2454601|NCT00981487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2454602|NCT00981487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2454603|NCT00981487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2454604|NCT00981487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2454605|NCT00981513|Vaccines|vaccines|mesh-list
2454606|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
2454607|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454608|NCT00981591|Iloprost|iloprost|mesh-list
2454609|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2454610|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
2454611|NCT00981617|ALKS-33|alks-33|mesh-list
2454612|NCT00981617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2454613|NCT00981617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454614|NCT00981617|Sensory System Agents|sensory system agents|mesh-ancestor
2454615|NCT00981617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454616|NCT00981656|Fluorouracil|fluorouracil|mesh-list
2454617|NCT00981656|Mitomycins|mitomycins|mesh-list
2454618|NCT00981656|Mitomycin|mitomycin|mesh-list
2454619|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454620|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
2454621|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454622|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2454623|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2454624|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
2454625|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454626|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2454627|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
2454628|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2454629|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454630|NCT00981708|Dexamethasone|dexamethasone|mesh-list
2454631|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
2454632|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
2454633|NCT00981708|Lenalidomide|lenalidomide|mesh-list
2454634|NCT00981708|BB 1101|bb 1101|mesh-list
2454635|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2454636|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
2454637|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454638|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2454639|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2454640|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
2454641|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454642|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454643|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2454644|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2454645|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
2454646|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
2454647|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454648|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2454649|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
2454650|NCT00981708|Hormones|hormones|mesh-ancestor
2454651|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2454652|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2454653|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
2454654|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454655|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2454656|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2454657|NCT00981708|Growth Substances|growth substances|mesh-ancestor
2454658|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
2454659|NCT00981721|Cediranib|cediranib|mesh-list
2454660|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454661|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2454662|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454663|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454664|NCT00981773|Maraviroc|maraviroc|mesh-list
2454665|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2454666|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2454667|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454668|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2454669|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2454670|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
2454671|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454672|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2454673|NCT00981786|Timolol|timolol|mesh-list
2454674|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2454675|NCT00981786|Travoprost|travoprost|mesh-list
2454676|NCT00981786|Brinzolamide|brinzolamide|mesh-list
2454677|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2454678|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2454679|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
2454680|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454681|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454682|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454683|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2454684|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2454685|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2454686|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2454687|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2454688|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2454689|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454690|NCT00981838|Rituximab|rituximab|mesh-list
2454691|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2454692|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454693|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
2454694|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454695|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2454696|NCT00981851|Albuterol|albuterol|mesh-list
2454697|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
2454698|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2454699|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
2454700|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454701|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454702|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2454703|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
2454704|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
2454705|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2454706|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
2454707|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454708|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454709|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
2454710|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2454711|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2454712|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2454713|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2454714|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
2454715|NCT00981890|Sunitinib|sunitinib|mesh-list
2454716|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454717|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2454718|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2454719|NCT00981890|Growth Substances|growth substances|mesh-ancestor
2454720|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454721|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
2454722|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2454723|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454724|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454725|NCT00981903|Tinzaparin|tinzaparin|mesh-list
2454726|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2454727|NCT00981903|Dalteparin|dalteparin|mesh-list
2454728|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
2454729|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2454730|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2454731|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454732|NCT00981929|Losartan|losartan|mesh-list
2454733|NCT00981929|Tramadol|tramadol|mesh-list
2454734|NCT00981929|Caffeine|caffeine|mesh-list
2454735|NCT00981929|Omeprazole|omeprazole|mesh-list
2454736|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2454737|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2454738|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2454739|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2454740|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454741|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2454742|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2454743|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2454744|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454745|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2454746|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454747|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2454748|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2454749|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2454750|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
2454751|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454752|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2454753|NCT00981929|Narcotics|narcotics|mesh-ancestor
2454754|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2454755|NCT00981929|Analgesics|analgesics|mesh-ancestor
2454756|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
2454757|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454758|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
2454759|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454760|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2454761|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454762|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454763|NCT00981955|Caffeine|caffeine|mesh-list
2454764|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2454765|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454766|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2454767|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454768|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454769|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2454770|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2454771|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
2454772|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454773|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
2454774|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2454775|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454776|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2454777|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
2454778|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2454779|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454780|NCT00982202|Pioglitazone|pioglitazone|mesh-list
2454781|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2454782|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454783|NCT00982215|Acetaminophen|acetaminophen|mesh-list
2454784|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2454785|NCT00982215|Analgesics|analgesics|mesh-ancestor
2454786|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
2454787|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454788|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454789|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
2454790|NCT00982254|Insulin|insulin|mesh-list
2454791|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2454792|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2454793|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454794|NCT00982332|Betamethasone|betamethasone|mesh-list
2454795|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
2454796|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2454797|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
2454798|NCT00982332|Hormones|hormones|mesh-ancestor
2454799|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2454800|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454801|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2454802|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
2454803|NCT00982358|Valsartan|valsartan|mesh-list
2454804|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2454805|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2454806|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2454807|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454808|NCT00982436|Carboplatin|carboplatin|mesh-list
2454809|NCT00982436|Docetaxel|docetaxel|mesh-list
2454810|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454811|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
2454812|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
2454813|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
2454814|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454815|NCT00982449|Fialuridine|fialuridine|mesh-list
2454816|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
2454817|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454818|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2454819|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454820|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454821|NCT00982527|Fenoldopam|fenoldopam|mesh-list
2454822|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2454823|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
2454824|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
2454825|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
2454826|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454827|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454828|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454829|NCT00982540|Caspofungin|caspofungin|mesh-list
2454830|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
2454831|NCT00982540|Clotrimazole|clotrimazole|mesh-list
2454832|NCT00982540|Miconazole|miconazole|mesh-list
2454833|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454834|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454835|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454836|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2454837|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2454838|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2454839|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2454840|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
2454841|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2454842|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454843|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2454844|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2454845|NCT00982566|Navitoclax|navitoclax|mesh-list
2454846|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454847|NCT00982618|Lidocaine|lidocaine|mesh-list
2454848|NCT00982618|Morphine|morphine|mesh-list
2454849|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
2454850|NCT00982618|Anesthetics|anesthetics|mesh-list
2454851|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2454852|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454853|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
2454854|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454855|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2454856|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2454857|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2454858|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2454859|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454860|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2454861|NCT00982618|Narcotics|narcotics|mesh-ancestor
2454862|NCT00982618|Analgesics|analgesics|mesh-ancestor
2454863|NCT00982631|Sirolimus|sirolimus|mesh-list
2454864|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2454865|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454866|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2454867|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454868|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
2454869|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2454870|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
2454871|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454872|NCT00982696|Analgesics, Opioid|analgesics, opioid|mesh-list
2454873|NCT00982696|Mitogens|mitogens|mesh-list
2454874|NCT00982696|Enkephalin, Methionine|enkephalin, methionine|mesh-list
2454875|NCT00982696|Enkephalins|enkephalins|mesh-list
2454876|NCT00982696|Opioid Peptides|opioid peptides|mesh-list
2454877|NCT00982696|Narcotics|narcotics|mesh-ancestor
2454878|NCT00982696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2454879|NCT00982696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454880|NCT00982696|Analgesics|analgesics|mesh-ancestor
2454881|NCT00982696|Sensory System Agents|sensory system agents|mesh-ancestor
2454882|NCT00982696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454883|NCT00982696|Mitosis Modulators|mitosis modulators|mesh-ancestor
2454884|NCT00982696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454885|NCT00982696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454886|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
2454887|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
2454888|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
2454889|NCT00982722|Calcium|calcium|mesh-list
2454890|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2454891|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454892|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2454893|NCT00982722|Vitamins|vitamins|mesh-ancestor
2454894|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
2454895|NCT00982722|Antacids|antacids|mesh-ancestor
2454896|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454897|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2454898|NCT00982800|Gabapentin|gabapentin|mesh-list
2454899|NCT00982800|Analgesics|analgesics|mesh-ancestor
2454900|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
2454901|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454902|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454903|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
2454904|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2454905|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2454906|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2454907|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2454908|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2454909|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2454910|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454911|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454912|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
2454913|NCT00982891|Morphine|morphine|mesh-list
2454914|NCT00982891|Hydromorphone|hydromorphone|mesh-list
2454915|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2454916|NCT00982891|Narcotics|narcotics|mesh-ancestor
2454917|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2454918|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454919|NCT00982891|Analgesics|analgesics|mesh-ancestor
2454920|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
2454921|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454922|NCT00983021|Insulin|insulin|mesh-list
2454923|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2454924|NCT00983021|Liraglutide|liraglutide|mesh-list
2454925|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
2454926|NCT00983021|Xultophy|xultophy|mesh-list
2454927|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2454928|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454929|NCT00983021|Incretins|incretins|mesh-ancestor
2454930|NCT00983021|Hormones|hormones|mesh-ancestor
2454931|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2454932|NCT00983034|Amoxicillin|amoxicillin|mesh-list
2454933|NCT00983034|Clarithromycin|clarithromycin|mesh-list
2454934|NCT00983034|Lansoprazole|lansoprazole|mesh-list
2454935|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
2454936|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2454937|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2454938|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2454939|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2454940|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454941|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2454942|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2454943|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2454944|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2454945|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2454946|NCT00983047|Docetaxel|docetaxel|mesh-list
2454947|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
2454948|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454949|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
2454950|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
2454951|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
2454952|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454953|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2454954|NCT00983112|Thrombin|thrombin|mesh-list
2454955|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
2454956|NCT00983112|Coagulants|coagulants|mesh-ancestor
2454957|NCT00983125|Clonidine|clonidine|mesh-list
2454958|NCT00983125|Analgesics|analgesics|mesh-ancestor
2454959|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
2454960|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454961|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454962|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2454963|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
2454964|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
2454965|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2454966|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2454967|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2454968|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
2454969|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2454970|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454971|NCT00983138|Asparaginase|asparaginase|mesh-list
2454972|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454973|NCT00983151|Tramadol|tramadol|mesh-list
2454974|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2454975|NCT00983151|Narcotics|narcotics|mesh-ancestor
2454976|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2454977|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454978|NCT00983151|Analgesics|analgesics|mesh-ancestor
2454979|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
2454980|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2454981|NCT00983164|Antioxidants|antioxidants|mesh-list
2454982|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454983|NCT00983164|Protective Agents|protective agents|mesh-ancestor
2454984|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2454985|NCT00983177|Colchicine|colchicine|mesh-list
2454986|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
2454987|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2454988|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
2454989|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
2454990|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
2454991|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2454992|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2454993|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2454994|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
2454995|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2454996|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
2454997|NCT00983255|Tedizolid|tedizolid|mesh-list
2454998|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
2454999|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2455000|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455001|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2455002|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455003|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455004|NCT00983268|Capecitabine|capecitabine|mesh-list
2455005|NCT00983268|Vorinostat|vorinostat|mesh-list
2455006|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2455007|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
2455008|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455009|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455010|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2455011|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455012|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2455013|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
2455014|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2455015|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2455016|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2455017|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2455018|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455019|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
2455020|NCT00983398|Carboplatin|carboplatin|mesh-list
2455021|NCT00983398|Melphalan|melphalan|mesh-list
2455022|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
2455023|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2455024|NCT00983398|Mannitol|mannitol|mesh-list
2455025|NCT00983398|Antidotes|antidotes|mesh-list
2455026|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455027|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2455028|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
2455029|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455030|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2455031|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2455032|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
2455033|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455034|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2455035|NCT00983398|Diuretics|diuretics|mesh-ancestor
2455036|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
2455037|NCT00983398|Protective Agents|protective agents|mesh-ancestor
2455038|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
2455039|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
2455040|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2455041|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455042|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
2455043|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
2455044|NCT00983424|Cyclosporine|cyclosporine|mesh-list
2455045|NCT00983424|Paclitaxel|paclitaxel|mesh-list
2455046|NCT00983424|Cyclosporins|cyclosporins|mesh-list
2455047|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2455048|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455049|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
2455050|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
2455051|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
2455052|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455053|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455054|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2455055|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
2455056|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455057|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
2455058|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455059|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
2455060|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2455061|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2455062|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2455063|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2455064|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
2455065|NCT00983450|Hormones|hormones|mesh-ancestor
2455066|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2455067|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455068|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2455069|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455070|NCT00983554|Anastrozole|anastrozole|mesh-list
2455071|NCT00983554|Testosterone|testosterone|mesh-list
2455072|NCT00983554|Dutasteride|dutasteride|mesh-list
2455073|NCT00983554|Androgens|androgens|mesh-ancestor
2455074|NCT00983554|Hormones|hormones|mesh-ancestor
2455075|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2455076|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455077|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2455078|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455079|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2455080|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2455081|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455082|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455083|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
2455084|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2455085|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2455086|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2455087|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2455088|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455089|NCT00983736|Tramadol|tramadol|mesh-list
2208383|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2208384|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208385|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2208386|NCT00010231|Vitamins|vitamins|mesh-ancestor
2208387|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
2208388|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2208389|NCT00010270|Immunotoxins|immunotoxins|mesh-list
2208390|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
2208391|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208392|NCT00010283|Beclomethasone|beclomethasone|mesh-list
2455090|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2455091|NCT00983736|Narcotics|narcotics|mesh-ancestor
2455092|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2455093|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455094|NCT00983736|Analgesics|analgesics|mesh-ancestor
2455095|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
2455096|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2455097|NCT00983788|Bezafibrate|bezafibrate|mesh-list
2455098|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2455099|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
2455100|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455101|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2455102|NCT00983814|Carbidopa|carbidopa|mesh-list
2455103|NCT00983814|Droxidopa|droxidopa|mesh-list
2455104|NCT00983814|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2455105|NCT00983814|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2455106|NCT00983814|Dopamine Agents|dopamine agents|mesh-ancestor
2455107|NCT00983814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2455108|NCT00983814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455109|NCT00983814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455110|NCT00983814|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2455111|NCT00983814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455112|NCT00983944|Prednisone|prednisone|mesh-list
2455113|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
2455114|NCT00983944|Rituximab|rituximab|mesh-list
2455115|NCT00983944|Doxorubicin|doxorubicin|mesh-list
2455116|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2455117|NCT00983944|Etoposide|etoposide|mesh-list
2455118|NCT00983944|Vincristine|vincristine|mesh-list
2455119|NCT00983944|Bleomycin|bleomycin|mesh-list
2455120|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2455121|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
2455122|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455123|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2455124|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2455125|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
2455126|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455127|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455128|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2455129|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2455130|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2455131|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2455132|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2455133|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455134|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2455135|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
2455136|NCT00983944|Hormones|hormones|mesh-ancestor
2455137|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2455138|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2455139|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2455140|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
2455141|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
2455142|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
2455143|NCT00983996|Alendronate|alendronate|mesh-list
2455144|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2455145|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455146|NCT00984152|Efavirenz|efavirenz|mesh-list
2455147|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2455148|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
2455149|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2455150|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2455151|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455152|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455153|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
2455154|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455155|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2455156|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2455157|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2455158|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2455159|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2455160|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2455161|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2455162|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2455163|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2455164|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2455165|NCT00984178|Sargramostim|sargramostim|mesh-list
2455166|NCT00984178|Immunologic Factors|immunologic factors|mesh-ancestor
2455167|NCT00984178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455168|NCT00984217|Panitumumab|panitumumab|mesh-list
2455169|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2455170|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455171|NCT00984230|Lactoferrin|lactoferrin|mesh-list
2455172|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455173|NCT00984347|Oxytocin|oxytocin|mesh-list
2455174|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
2455175|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2455176|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455177|NCT00984360|Naltrexone|naltrexone|mesh-list
2455178|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2455179|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2455180|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455181|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
2455182|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2455183|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2455184|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2455185|NCT00984386|Estradiol|estradiol|mesh-list
2455186|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2455187|NCT00984386|Estrogens|estrogens|mesh-ancestor
2455188|NCT00984386|Hormones|hormones|mesh-ancestor
2455189|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2455190|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455191|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2455192|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
2455193|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2455194|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2455195|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2455196|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2455197|NCT00984399|Estradiol|estradiol|mesh-list
2455198|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2455199|NCT00984399|Estrogens|estrogens|mesh-ancestor
2455200|NCT00984399|Hormones|hormones|mesh-ancestor
2455201|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2455202|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455203|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2455204|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
2455205|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2455206|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2455207|NCT00984425|Sorafenib|sorafenib|mesh-list
2455208|NCT00984425|Lapatinib|lapatinib|mesh-list
2455209|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455210|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2455211|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455212|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455213|NCT00984438|Bevacizumab|bevacizumab|mesh-list
2455214|NCT00984438|Irinotecan|irinotecan|mesh-list
2455215|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2455216|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455217|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2455218|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2455219|NCT00984438|Growth Substances|growth substances|mesh-ancestor
2455220|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455221|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
2455222|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2455223|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2455224|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455225|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455226|NCT00984451|Vaccines|vaccines|mesh-list
2208393|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2208394|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
2208395|NCT00010283|Hormones|hormones|mesh-ancestor
2208396|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208397|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208398|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2208399|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
2208400|NCT00010322|Toremifene|toremifene|mesh-list
2208401|NCT00010322|Atamestane|atamestane|mesh-list
2208402|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2208403|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208404|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2208405|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2455227|NCT00984451|Immunologic Factors|immunologic factors|mesh-ancestor
2455228|NCT00984451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455229|NCT00984464|Paclitaxel|paclitaxel|mesh-list
2455230|NCT00984464|Carboplatin|carboplatin|mesh-list
2455231|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2455232|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455233|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
2455234|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
2455235|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
2455236|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455237|NCT00984633|Bromides|bromides|mesh-list
2455238|NCT00984633|Propofol|propofol|mesh-list
2455239|NCT00984633|Sevoflurane|sevoflurane|mesh-list
2455240|NCT00984633|Rocuronium|rocuronium|mesh-list
2455241|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2455242|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2455243|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455244|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2455245|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
2455246|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
2455247|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2455248|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2455249|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
2455250|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2455251|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2455252|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2455253|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2455254|NCT00984724|Nicotine|nicotine|mesh-list
2455255|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2455256|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
2455257|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2455258|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455259|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2455260|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2455261|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
2455262|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2455263|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455264|NCT00984737|Insulin|insulin|mesh-list
2455265|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2455266|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455267|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
2455268|NCT00984750|Simvastatin|simvastatin|mesh-list
2455269|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2455270|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2455271|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
2455272|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455273|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2455274|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2455275|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455276|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
2455277|NCT00984750|Vitamins|vitamins|mesh-ancestor
2455278|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
2455279|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455280|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
2455281|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
2455282|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2455283|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
2455284|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455285|NCT00984763|Antacids|antacids|mesh-ancestor
2455286|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455287|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2455288|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2455289|NCT00984789|Gestodene|gestodene|mesh-list
2455290|NCT00984789|Norelgestromin|norelgestromin|mesh-list
2455291|NCT00984789|Femovan|femovan|mesh-list
2455292|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2455293|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2455294|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2455295|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
2455296|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2455297|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455298|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2455299|NCT00984789|Estrogens|estrogens|mesh-ancestor
2455300|NCT00984789|Hormones|hormones|mesh-ancestor
2455301|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2455302|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2455303|NCT00984789|Progestins|progestins|mesh-ancestor
2455304|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2455305|NCT00984828|Bortezomib|bortezomib|mesh-list
2455306|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455307|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
2455308|NCT00984893|Diphosphonates|diphosphonates|mesh-list
2455309|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2455310|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455311|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2455312|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2455313|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2455314|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
2455315|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455316|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2455317|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2455318|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455319|NCT00984945|Vaccines|vaccines|mesh-list
2455320|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
2455321|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455322|NCT00984971|Tenofovir|tenofovir|mesh-list
2455323|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
2455324|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455325|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2455326|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2455327|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455328|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455329|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2455330|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2455331|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
2455332|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2455333|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2455334|NCT00984984|Prednisolone|prednisolone|mesh-list
2455335|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
2455336|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2455337|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
2455338|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2455339|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
2455340|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
2455341|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2455342|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455343|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2455344|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
2455345|NCT00984984|Hormones|hormones|mesh-ancestor
2455346|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2455347|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2455348|NCT00984984|Protective Agents|protective agents|mesh-ancestor
2455349|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2455350|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455351|NCT00984997|Etoposide|etoposide|mesh-list
2455352|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455353|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2455354|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2455355|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2455356|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455357|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455358|NCT00985244|Azithromycin|azithromycin|mesh-list
2455359|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2455360|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455361|NCT00985270|Rifampin|rifampin|mesh-list
2455362|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2455363|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
2455364|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2455365|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455366|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
2455367|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2455368|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455369|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455370|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2455371|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2455372|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2455373|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2455374|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2455375|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2455376|NCT00985322|Ramipril|ramipril|mesh-list
2455377|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
2455378|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2455379|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
2455380|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455381|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455382|NCT00985348|Levetiracetam|levetiracetam|mesh-list
2455383|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
2455384|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
2455385|NCT00985361|Vitamin D|vitamin d|mesh-list
2455386|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
2455387|NCT00985361|Vitamins|vitamins|mesh-list
2455388|NCT00985361|Ascorbic Acid|ascorbic acid|mesh-list
2455389|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
2455390|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455391|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2455392|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2455393|NCT00985361|Antioxidants|antioxidants|mesh-ancestor
2455394|NCT00985361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455395|NCT00985361|Protective Agents|protective agents|mesh-ancestor
2455396|NCT00985374|Everolimus|everolimus|mesh-list
2455397|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455398|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2455399|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
2455400|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455401|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
2455402|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2455403|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2455404|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
2455405|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2455406|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455407|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455408|NCT00985387|Urological Agents|urological agents|mesh-ancestor
2455409|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
2455410|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455411|NCT00985556|Capecitabine|capecitabine|mesh-list
2455412|NCT00985556|Tegafur|tegafur|mesh-list
2455413|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
2455414|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2455415|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
2455416|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455417|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455418|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2455419|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2455420|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455421|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
2455422|NCT00985647|Lamivudine|lamivudine|mesh-list
2455423|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2455424|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2455425|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455426|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455427|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
2455428|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455429|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2455430|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2455431|NCT00985660|Nisoldipine|nisoldipine|mesh-list
2455432|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2455433|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2455434|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2455435|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455436|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2455437|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455438|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
2455439|NCT00985777|Vitamin E|vitamin e|mesh-list
2455440|NCT00985777|Tocopherols|tocopherols|mesh-list
2455441|NCT00985777|Tocotrienols|tocotrienols|mesh-list
2455442|NCT00985777|Vitamins|vitamins|mesh-ancestor
2455443|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
2455444|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455445|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
2455446|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455447|NCT00985777|Protective Agents|protective agents|mesh-ancestor
2455448|NCT00985855|Etoposide|etoposide|mesh-list
2455449|NCT00985855|Cetuximab|cetuximab|mesh-list
2455450|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455451|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2455452|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2455453|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2455454|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455455|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455456|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2455457|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
2455458|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2455459|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2455460|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455461|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
2455462|NCT00985920|Coagulants|coagulants|mesh-ancestor
2455463|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
2455464|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2455465|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455466|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2455467|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
2455468|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455469|NCT00986050|Sirolimus|sirolimus|mesh-list
2455470|NCT00986050|Abciximab|abciximab|mesh-list
2455471|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2455472|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455473|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2455474|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455475|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
2455476|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2455477|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
2455478|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455479|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
2455480|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2455481|NCT00986076|Enoxaparin|enoxaparin|mesh-list
2455482|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
2455483|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2455484|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2455485|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455486|NCT00986115|Memantine|memantine|mesh-list
2455487|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2455488|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2455489|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
2455490|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2455491|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455492|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455493|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2455494|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2455495|NCT00986128|Topiramate|topiramate|mesh-list
2455496|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
2455497|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2455498|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455499|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2455500|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
2455501|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2455502|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2455503|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2455504|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2455505|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455506|NCT00986284|Gefitinib|gefitinib|mesh-list
2455507|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455508|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2455509|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455510|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455511|NCT00986336|Topiramate|topiramate|mesh-list
2455512|NCT00986336|Risperidone|risperidone|mesh-list
2455513|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2455514|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
2455515|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2455516|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455517|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455518|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2455519|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2455520|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2455521|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2455522|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2455523|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
2455524|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
2455525|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2455526|NCT00986466|Vitamin D|vitamin d|mesh-list
2455527|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
2455528|NCT00986466|Vitamins|vitamins|mesh-list
2455529|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
2455530|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455531|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2455532|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2455533|NCT00986505|Lidocaine|lidocaine|mesh-list
2455534|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
2455535|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
2455536|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2455537|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455538|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
2455539|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2455540|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2455541|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2455542|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2455543|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2455544|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455545|NCT00986557|Ganciclovir|ganciclovir|mesh-list
2455546|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2455547|NCT00986557|Foscarnet|foscarnet|mesh-list
2455548|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
2455549|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
2455550|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2455551|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455552|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
2455553|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455554|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2455555|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455556|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455557|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2455558|NCT00986596|Vitamin D|vitamin d|mesh-list
2455559|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
2455560|NCT00986596|Vitamins|vitamins|mesh-ancestor
2455561|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
2455562|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455563|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2455564|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2455565|NCT00986609|Poly I-C|poly i-c|mesh-list
2455566|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2455567|NCT00986609|Vaccines|vaccines|mesh-list
2455568|NCT00986609|Poly ICLC|poly iclc|mesh-list
2455569|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
2455570|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455571|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
2455572|NCT00986609|Laxatives|laxatives|mesh-ancestor
2455573|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2455574|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
2455575|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455576|NCT00986713|Amphotericin B|amphotericin b|mesh-list
2455577|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2455578|NCT00986713|Amebicides|amebicides|mesh-ancestor
2455579|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2455580|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2455581|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455582|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2455583|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
2455584|NCT00986765|Aspirin|aspirin|mesh-list
2455585|NCT00986765|Enoxaparin|enoxaparin|mesh-list
2455586|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2455587|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2455588|NCT00986765|Analgesics|analgesics|mesh-ancestor
2455589|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
2455590|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2455591|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455592|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2455593|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2455594|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2455595|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2455596|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455597|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2455598|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2455599|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455600|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
2455601|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
2455602|NCT00986778|Lamivudine|lamivudine|mesh-list
2455603|NCT00986778|Adefovir|adefovir|mesh-list
2455604|NCT00986778|Entecavir|entecavir|mesh-list
2455605|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2455606|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2455607|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455608|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455609|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
2455610|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455611|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2455612|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2455613|NCT00986804|Decitabine|decitabine|mesh-list
2455614|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2455615|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
2455616|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455617|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455618|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455619|NCT00986817|Terlipressin|terlipressin|mesh-list
2455620|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2455621|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2455622|NCT00986843|Irinotecan|irinotecan|mesh-list
2455623|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2455624|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2455625|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455626|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455627|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455628|NCT00986882|Ibuprofen|ibuprofen|mesh-list
2455629|NCT00986882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2455630|NCT00986882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2455631|NCT00986882|Analgesics|analgesics|mesh-ancestor
2455632|NCT00986882|Sensory System Agents|sensory system agents|mesh-ancestor
2455633|NCT00986882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2455634|NCT00986882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455635|NCT00986882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2455636|NCT00986882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2455637|NCT00986882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2455638|NCT00986882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455639|NCT00986882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455640|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2455641|NCT00986960|Hormones|hormones|mesh-ancestor
2455642|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2455643|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455644|NCT00987038|Midazolam|midazolam|mesh-list
2455645|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2455646|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2455647|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2455648|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455649|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2455650|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2455651|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2455652|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2455653|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
2455654|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
2455655|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
2455656|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
2455657|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2455658|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455659|NCT00987103|Tacrolimus|tacrolimus|mesh-list
2455660|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2455661|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
2455662|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455663|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2455664|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455665|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455666|NCT00987116|Prednisone|prednisone|mesh-list
2455667|NCT00987116|Azathioprine|azathioprine|mesh-list
2455668|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2455669|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
2455670|NCT00987116|Hormones|hormones|mesh-ancestor
2455671|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2455672|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455673|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2455674|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455675|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
2455676|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455677|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2455678|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2455679|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
2455680|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2455681|NCT00987168|Octreotide|octreotide|mesh-list
2455682|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2455683|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2455684|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455685|NCT00987207|Cyclosporine|cyclosporine|mesh-list
2455686|NCT00987207|Cyclosporins|cyclosporins|mesh-list
2455687|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455688|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455689|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2455690|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
2455691|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455692|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
2455693|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455694|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
2455695|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2455696|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2455697|NCT00987220|Donepezil|donepezil|mesh-list
2455698|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2455699|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455700|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455701|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
2455702|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2455703|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455704|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
2455705|NCT00987233|Triamcinolone|triamcinolone|mesh-list
2455706|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2455707|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2455708|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2455709|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2455710|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
2455711|NCT00987233|Hormones|hormones|mesh-ancestor
2455712|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2455713|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455714|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2455715|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
2455716|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455717|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455718|NCT00987272|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2455719|NCT00987272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2455720|NCT00987272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2455721|NCT00987272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2455722|NCT00987272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2455723|NCT00987272|Analgesics|analgesics|mesh-ancestor
2455724|NCT00987272|Sensory System Agents|sensory system agents|mesh-ancestor
2455725|NCT00987272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2455726|NCT00987272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455727|NCT00987272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2455728|NCT00987272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2455729|NCT00987272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2455730|NCT00987272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2455731|NCT00987272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2455732|NCT00987272|Histamine Antagonists|histamine antagonists|mesh-ancestor
2455733|NCT00987272|Histamine Agents|histamine agents|mesh-ancestor
2455734|NCT00987272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2455735|NCT00987272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455736|NCT00987376|Choline|choline|mesh-list
2455737|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
2455738|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2455739|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
2455740|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455741|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2455742|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2455743|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
2455744|NCT00987441|Sufentanil|sufentanil|mesh-list
2455745|NCT00987441|Dsuvia|dsuvia|mesh-list
2455746|NCT00987441|Ropivacaine|ropivacaine|mesh-list
2455747|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
2455748|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
2455749|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2455750|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455751|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
2455752|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2455753|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2455754|NCT00987441|Narcotics|narcotics|mesh-ancestor
2455755|NCT00987441|Analgesics|analgesics|mesh-ancestor
2455756|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2455757|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2455758|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
2455759|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
2455760|NCT00987454|Hematinics|hematinics|mesh-ancestor
2455761|NCT00987493|Rituximab|rituximab|mesh-list
2455762|NCT00987493|Lenalidomide|lenalidomide|mesh-list
2455763|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2455764|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2455765|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455766|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
2455767|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455768|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2455769|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2455770|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2455771|NCT00987493|Growth Substances|growth substances|mesh-ancestor
2455772|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
2455773|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2455774|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
2455775|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455776|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
2455777|NCT00987636|Diphosphonates|diphosphonates|mesh-list
2455778|NCT00987636|Busulfan|busulfan|mesh-list
2455779|NCT00987636|Treosulfan|treosulfan|mesh-list
2455780|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
2455781|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455782|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2455783|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
2455784|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455785|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2455786|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455787|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2455788|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2455789|NCT00987662|Amlodipine|amlodipine|mesh-list
2455790|NCT00987662|Irbesartan|irbesartan|mesh-list
2455791|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2455792|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2455793|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2455794|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455795|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2455796|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455797|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
2455798|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2455799|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2455800|NCT00987766|Gemcitabine|gemcitabine|mesh-list
2455801|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
2455802|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2455803|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2455804|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
2455805|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455806|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455807|NCT00987766|Antiviral Agents|antiviral agents|mesh-ancestor
2455808|NCT00987766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455809|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455810|NCT00987766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2455811|NCT00987766|Immunologic Factors|immunologic factors|mesh-ancestor
2455812|NCT00987766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455813|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2455814|NCT00987779|Gabapentin|gabapentin|mesh-list
2208406|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
2208407|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208408|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208409|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2208410|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455815|NCT00987779|Analgesics|analgesics|mesh-ancestor
2208411|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208412|NCT00010361|Cyclosporine|cyclosporine|mesh-list
2208413|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
2208414|NCT00010361|Fludarabine|fludarabine|mesh-list
2208415|NCT00010361|Cyclosporins|cyclosporins|mesh-list
2208416|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208417|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208418|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208419|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
2208420|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455816|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
2455817|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2455818|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455819|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
2455820|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2455821|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2455822|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2455823|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2455824|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2455825|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2455826|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2455827|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455828|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
2455829|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
2455830|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2455831|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2455832|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455833|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2455834|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2455835|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455836|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455837|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455838|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2455839|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
2455840|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2455841|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455842|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2455843|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2455844|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2455845|NCT00987844|Prucalopride|prucalopride|mesh-list
2455846|NCT00987844|Laxatives|laxatives|mesh-ancestor
2455847|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2455848|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2455849|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2455850|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
2455851|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2455852|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455853|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455854|NCT00987870|Betamethasone|betamethasone|mesh-list
2455855|NCT00987870|Calcipotriene|calcipotriene|mesh-list
2455856|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2455857|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
2455858|NCT00987870|Hormones|hormones|mesh-ancestor
2455859|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2455860|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455861|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2455862|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
2455863|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
2455864|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
2455865|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455866|NCT00987974|Atorvastatin|atorvastatin|mesh-list
2455867|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2455868|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2455869|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2455870|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
2455871|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455872|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2455873|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2455874|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208421|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208422|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
2208423|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208424|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
2208425|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2208426|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2208427|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2208428|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2208429|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
2208430|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2208431|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
2208432|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208433|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
2455875|NCT00988026|Minocycline|minocycline|mesh-list
2455876|NCT00988026|Lymecycline|lymecycline|mesh-list
2455877|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2455878|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455879|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
2455880|NCT00988039|Lopinavir|lopinavir|mesh-list
2455881|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2455882|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2455883|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
2455884|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455885|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2455886|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2455887|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455888|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455889|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2455890|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2455891|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
2455892|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2455893|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2455894|NCT00988078|Metformin|metformin|mesh-list
2455895|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2455896|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455897|NCT00988195|Doxorubicin|doxorubicin|mesh-list
2455898|NCT00988195|BCT-100|bct-100|mesh-list
2455899|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2455900|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455901|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2455902|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2455903|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455904|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455905|NCT00988260|Ganirelix|ganirelix|mesh-list
2455906|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
2455907|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2455908|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455909|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
2455910|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
2455911|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455912|NCT00988364|Simvastatin|simvastatin|mesh-list
2455913|NCT00988364|Ezetimibe|ezetimibe|mesh-list
2455914|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
2455915|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2455916|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2455917|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
2455918|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455919|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2455920|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2455921|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455922|NCT00988403|Levan|levan|mesh-list
2455923|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455924|NCT00988481|Topiramate|topiramate|mesh-list
2455925|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
2455926|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2455927|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455928|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2455929|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2455930|NCT00988507|Artesunate|artesunate|mesh-list
2455931|NCT00988507|Ferroquine|ferroquine|mesh-list
2455932|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
2455933|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2455934|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2455935|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455936|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455937|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
2455938|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
2455939|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2455940|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
2455941|NCT00988520|Bromides|bromides|mesh-list
2455942|NCT00988520|Propofol|propofol|mesh-list
2455943|NCT00988520|Sevoflurane|sevoflurane|mesh-list
2455944|NCT00988520|Rocuronium|rocuronium|mesh-list
2455945|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2455946|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2455947|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455948|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2455949|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
2455950|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
2455951|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2455952|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2455953|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
2455954|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2455955|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2455956|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2455957|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2455958|NCT00988663|Memantine|memantine|mesh-list
2455959|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2455960|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2455961|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
2455962|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2455963|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455964|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455965|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2455966|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2455967|NCT00988715|Cyclosporine|cyclosporine|mesh-list
2455968|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
2455969|NCT00988715|Fludarabine|fludarabine|mesh-list
2455970|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
2455971|NCT00988715|Cyclosporins|cyclosporins|mesh-list
2455972|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2455973|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2455974|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
2455975|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2455976|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2455977|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
2455978|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455979|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2455980|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
2455981|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2455982|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
2455983|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2455984|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2455985|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2455986|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2455987|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
2455988|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2455989|NCT00988728|Olanzapine|olanzapine|mesh-list
2455990|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
2455991|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
2455992|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2455993|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2455994|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2455995|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2455996|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2455997|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2455998|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2455999|NCT00988728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2456000|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2456001|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2456002|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456003|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456004|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
2456005|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2456006|NCT00988780|Efavirenz|efavirenz|mesh-list
2456007|NCT00988780|Maraviroc|maraviroc|mesh-list
2456008|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2456009|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2456010|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456011|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456012|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
2456013|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456014|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2456015|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2456016|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2456017|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2456018|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2456019|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2456020|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2456021|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2456022|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2456023|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2456024|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2456025|NCT00988806|Simendan|simendan|mesh-list
2456026|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2456027|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
2456028|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2456029|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2456030|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456031|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456032|NCT00988806|Protective Agents|protective agents|mesh-ancestor
2456033|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456034|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
2456035|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2456036|NCT00988845|Protective Agents|protective agents|mesh-ancestor
2456037|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456038|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456039|NCT00988897|Leucovorin|leucovorin|mesh-list
2456040|NCT00988897|Bevacizumab|bevacizumab|mesh-list
2456041|NCT00988897|Fluorouracil|fluorouracil|mesh-list
2456042|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
2456043|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2456044|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456045|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2456046|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2456047|NCT00988897|Growth Substances|growth substances|mesh-ancestor
2456048|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456049|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
2456050|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
2456051|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456052|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2456053|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2456054|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
2456055|NCT00988897|Antidotes|antidotes|mesh-ancestor
2456056|NCT00988897|Protective Agents|protective agents|mesh-ancestor
2456057|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
2456058|NCT00988897|Vitamins|vitamins|mesh-ancestor
2456059|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
2456060|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
2456061|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
2456062|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
2456063|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2456064|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456065|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2456066|NCT00988949|Spiradoline|spiradoline|mesh-list
2456067|NCT00988949|Analgesics|analgesics|mesh-ancestor
2456068|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
2456069|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456070|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456071|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2456072|NCT00988949|Diuretics|diuretics|mesh-ancestor
2456073|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
2456074|NCT00989027|Oxytocin|oxytocin|mesh-list
2456075|NCT00989027|Ergonovine|ergonovine|mesh-list
2456076|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
2456077|NCT00989027|Carboprost|carboprost|mesh-list
2456078|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
2456079|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2456080|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208434|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208435|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2208436|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2208437|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
2456081|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2456082|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
2456083|NCT00989053|Citalopram|citalopram|mesh-list
2456084|NCT00989053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2456085|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2456086|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2208438|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208439|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208440|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2208441|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
2208442|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208443|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
2456087|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456088|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456089|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
2208444|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208445|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2456090|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456091|NCT00989053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2456092|NCT00989053|Antidepressive Agents|antidepressive agents|mesh-ancestor
2456093|NCT00989053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2456094|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
2456095|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2456096|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456097|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2456098|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456099|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
2456100|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2456101|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2456102|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2456103|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2456104|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456105|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
2456106|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456107|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456108|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2456109|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456110|NCT00989274|Vaccines|vaccines|mesh-list
2456111|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
2456112|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456113|NCT00989300|Omeprazole|omeprazole|mesh-list
2456114|NCT00989300|Rabeprazole|rabeprazole|mesh-list
2456115|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2456116|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2456117|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2456118|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456119|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456120|NCT00989352|Rituximab|rituximab|mesh-list
2456121|NCT00989352|Methotrexate|methotrexate|mesh-list
2456122|NCT00989352|Lomustine|lomustine|mesh-list
2456123|NCT00989352|Procarbazine|procarbazine|mesh-list
2456124|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2456125|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456126|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
2456127|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456128|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2456129|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2456130|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
2456131|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2456132|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2456133|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
2456134|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456135|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
2456136|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456137|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2456138|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2456139|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2456140|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2456141|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
2456142|NCT00989404|Zanamivir|zanamivir|mesh-list
2456143|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
2456144|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456145|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456146|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456147|NCT00989443|Cidofovir|cidofovir|mesh-list
2456148|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
2456149|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456150|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456151|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456152|NCT00989469|Irinotecan|irinotecan|mesh-list
2456153|NCT00989469|Sorafenib|sorafenib|mesh-list
2456154|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2456155|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2456156|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456157|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456158|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456159|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2456160|NCT00989508|Perhexiline|perhexiline|mesh-list
2456161|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2456162|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2456163|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456164|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2456165|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456166|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
2456167|NCT00989625|Naproxen|naproxen|mesh-list
2456168|NCT00989625|Sumatriptan|sumatriptan|mesh-list
2456169|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2456170|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2456171|NCT00989625|Analgesics|analgesics|mesh-ancestor
2456172|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
2456173|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456174|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456175|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2456176|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2456177|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
2456178|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2456179|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456180|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456181|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2456182|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2456183|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2456184|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
2456185|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456186|NCT00989651|Paclitaxel|paclitaxel|mesh-list
2456187|NCT00989651|Bevacizumab|bevacizumab|mesh-list
2456188|NCT00989651|Cisplatin|cisplatin|mesh-list
2456189|NCT00989651|Carboplatin|carboplatin|mesh-list
2456190|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2456191|NCT00989651|Veliparib|veliparib|mesh-list
2456192|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2456193|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
2456194|NCT00989651|Antibodies|antibodies|mesh-list
2456195|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
2456196|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2456197|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
2456198|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2456199|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456200|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
2456201|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
2456202|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
2456203|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456204|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2456205|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2456206|NCT00989651|Growth Substances|growth substances|mesh-ancestor
2456207|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456208|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
2456209|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
2456210|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2456211|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456212|NCT00989690|Docetaxel|docetaxel|mesh-list
2456213|NCT00989690|Pemetrexed|pemetrexed|mesh-list
2456214|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2456215|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456216|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
2456217|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
2456218|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
2456219|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456220|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456221|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2456222|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2456223|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2456224|NCT00989703|Methotrexate|methotrexate|mesh-list
2456225|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2456226|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
2456227|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2456228|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456229|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2456230|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
2456231|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456232|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456233|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
2456234|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456235|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2456236|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2456237|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
2456238|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2456239|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2456240|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
2456241|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
2456242|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
2456243|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
2456244|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2456245|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2456246|NCT00989729|Prednisolone|prednisolone|mesh-list
2456247|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
2456248|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2456249|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
2456250|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2456251|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
2456252|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
2456253|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456254|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456255|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2456256|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
2456257|NCT00989729|Hormones|hormones|mesh-ancestor
2456258|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2456259|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2456260|NCT00989729|Protective Agents|protective agents|mesh-ancestor
2456261|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2208446|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2208447|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
2208448|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208449|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208450|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2208451|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
2208452|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208453|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
2208454|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208455|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2208456|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2208457|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
2208458|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456262|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456263|NCT00989742|Doxycycline|doxycycline|mesh-list
2456264|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2456265|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456266|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
2456267|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2456268|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2456269|NCT00989807|Aztreonam|aztreonam|mesh-list
2456270|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2456271|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456272|NCT00989820|Coal Tar|coal tar|mesh-list
2456273|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
2456274|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
2456275|NCT00989898|Insulin|insulin|mesh-list
2456276|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2456277|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456278|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2456279|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2456280|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2456281|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
2456282|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456283|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2456284|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2456285|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456286|NCT00990054|Plerixafor|plerixafor|mesh-list
2456287|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2456288|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2456289|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
2456290|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456291|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2456292|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2456293|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2456294|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2456295|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2456296|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456297|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456298|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456299|NCT00990067|Analgesics|analgesics|mesh-ancestor
2456300|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
2456301|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456302|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
2456303|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2456304|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
2456305|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
2456306|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
2456307|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2456308|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
2456309|NCT00990158|Vitamin K|vitamin k|mesh-list
2456310|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
2456311|NCT00990158|Vitamins|vitamins|mesh-ancestor
2456312|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
2456313|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456314|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2456315|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2456316|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456317|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
2456318|NCT00990158|Coagulants|coagulants|mesh-ancestor
2456319|NCT00990197|Nicotine|nicotine|mesh-list
2456320|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2456321|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
2456322|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456323|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456324|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2456325|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2456326|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
2456327|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456328|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456329|NCT00990223|Eplerenone|eplerenone|mesh-list
2456330|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2456331|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
2456332|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2456333|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456334|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2456335|NCT00990223|Diuretics|diuretics|mesh-ancestor
2456336|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
2456337|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2456338|NCT00990275|Ethanol|ethanol|mesh-list
2456339|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2456340|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456341|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2456342|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456343|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2456344|NCT00990301|Moexipril|moexipril|mesh-list
2456345|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2456346|NCT00990301|Diuretics|diuretics|mesh-ancestor
2456347|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
2456348|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456349|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2456350|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2456351|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456352|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2456353|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
2456354|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456355|NCT00990327|Adenosine|adenosine|mesh-list
2456356|NCT00990327|Analgesics|analgesics|mesh-ancestor
2456357|NCT00990327|Sensory System Agents|sensory system agents|mesh-ancestor
2456358|NCT00990327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456359|NCT00990327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456360|NCT00990327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2456361|NCT00990327|Vasodilator Agents|vasodilator agents|mesh-ancestor
2456362|NCT00990327|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2456363|NCT00990327|Purinergic Agonists|purinergic agonists|mesh-ancestor
2456364|NCT00990327|Purinergic Agents|purinergic agents|mesh-ancestor
2456365|NCT00990327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456366|NCT00990327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456367|NCT00990392|Polymyxins|polymyxins|mesh-list
2456368|NCT00990392|Bacitracin|bacitracin|mesh-list
2456369|NCT00990392|Polymyxin B|polymyxin b|mesh-list
2456370|NCT00990392|Gramicidin|gramicidin|mesh-list
2456371|NCT00990392|Petrolatum|petrolatum|mesh-list
2456372|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2456373|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456374|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2456375|NCT00990392|Emollients|emollients|mesh-ancestor
2456376|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
2456377|NCT00990405|Amoxicillin|amoxicillin|mesh-list
2456378|NCT00990405|Clarithromycin|clarithromycin|mesh-list
2456379|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2456380|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456381|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2456382|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456383|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456384|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2456385|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2456386|NCT00990418|Fentanyl|fentanyl|mesh-list
2456387|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2456388|NCT00990418|Narcotics|narcotics|mesh-ancestor
2456389|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2456390|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456391|NCT00990418|Analgesics|analgesics|mesh-ancestor
2456392|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
2456393|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456394|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2456395|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2456396|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
2456397|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
2456398|NCT00990444|Insulin|insulin|mesh-list
2456399|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2456400|NCT00990444|Dextrans|dextrans|mesh-list
2456401|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2456402|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456403|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
2456404|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
2456405|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
2456406|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
2456407|NCT00990496|Fludarabine|fludarabine|mesh-list
2456408|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2456409|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
2456410|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456411|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2456412|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2456413|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
2456414|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456415|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456416|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2456417|NCT00990535|Octreotide|octreotide|mesh-list
2456418|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2208459|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208460|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2208461|NCT00010426|Cysteamine|cysteamine|mesh-list
2456419|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2456420|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456421|NCT00990574|Anesthetics|anesthetics|mesh-list
2456422|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2456423|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456424|NCT00990587|Ciclopirox|ciclopirox|mesh-list
2456425|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
2456426|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456427|NCT00990600|Tenofovir|tenofovir|mesh-list
2456428|NCT00990600|Emtricitabine|emtricitabine|mesh-list
2456429|NCT00990600|Efavirenz|efavirenz|mesh-list
2456430|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
2456431|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456432|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2456433|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2456434|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456435|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456436|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2456437|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2456438|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2456439|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2456440|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2456441|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2208462|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
2208463|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208464|NCT00010452|Picibanil|picibanil|mesh-list
2208465|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208466|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
2208467|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2208468|NCT00010686|Estrogens|estrogens|mesh-ancestor
2208469|NCT00010686|Hormones|hormones|mesh-ancestor
2456442|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2456443|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2456444|NCT00990639|Candesartan|candesartan|mesh-list
2456445|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2456446|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2456447|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2456448|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456449|NCT00990678|Vitamin D|vitamin d|mesh-list
2456450|NCT00990678|Calcitriol|calcitriol|mesh-list
2456451|NCT00990678|Calcium|calcium|mesh-list
2456452|NCT00990678|Vitamins|vitamins|mesh-ancestor
2456453|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
2456454|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456455|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2456456|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2456457|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2456458|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2456459|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456460|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2456461|NCT00990691|Desipramine|desipramine|mesh-list
2456462|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2456463|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
2456464|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2456465|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456466|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456467|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2456468|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2456469|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2456470|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
2208470|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208471|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208472|NCT00010699|Vitamin E|vitamin e|mesh-list
2208473|NCT00010699|Vitamins|vitamins|mesh-ancestor
2208474|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
2208475|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456471|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456472|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456473|NCT00990795|Cyclosporine|cyclosporine|mesh-list
2456474|NCT00990795|Cyclosporins|cyclosporins|mesh-list
2456475|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456476|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456477|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2456478|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
2456479|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456480|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
2456481|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456482|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
2456483|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2456484|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2456485|NCT00990808|Atorvastatin|atorvastatin|mesh-list
2456486|NCT00990808|Anacetrapib|anacetrapib|mesh-list
2456487|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2456488|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2456489|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
2456490|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456491|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2456492|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2456493|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456494|NCT00990834|Simvastatin|simvastatin|mesh-list
2456495|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2456496|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2456497|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
2456498|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456499|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2456500|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2456501|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456502|NCT00990847|Procaterol|procaterol|mesh-list
2208476|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
2208477|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208478|NCT00010699|Protective Agents|protective agents|mesh-ancestor
2208479|NCT00010725|Vitamins|vitamins|mesh-list
2208480|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
2208481|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208482|NCT00010842|Vitamin E|vitamin e|mesh-list
2456503|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2456504|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
2456505|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456506|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456507|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2456508|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
2456509|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
2456510|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2456511|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2456512|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2456513|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
2456514|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456515|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456516|NCT00990860|Doxorubicin|doxorubicin|mesh-list
2456517|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2456518|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456519|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2456520|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2456521|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456522|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456523|NCT00990886|Oxybutynin|oxybutynin|mesh-list
2456524|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
2456525|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
2456526|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456527|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456528|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2456529|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2456530|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
2456531|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456532|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456533|NCT00990886|Urological Agents|urological agents|mesh-ancestor
2456534|NCT00990912|Carboplatin|carboplatin|mesh-list
2456535|NCT00990912|Irinotecan|irinotecan|mesh-list
2456536|NCT00990912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456537|NCT00990912|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2456538|NCT00990912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2456539|NCT00990912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456540|NCT00990912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456541|NCT00990990|Linezolid|linezolid|mesh-list
2456542|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
2456543|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2456544|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456545|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2456546|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456547|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456548|NCT00991055|Pioglitazone|pioglitazone|mesh-list
2456549|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2456550|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456551|NCT00991068|Lidocaine|lidocaine|mesh-list
2456552|NCT00991068|Tetracaine|tetracaine|mesh-list
2456553|NCT00991068|Anesthetics, Local|anesthetics, local|mesh-ancestor
2456554|NCT00991068|Anesthetics|anesthetics|mesh-ancestor
2456555|NCT00991068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2456556|NCT00991068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456557|NCT00991068|Sensory System Agents|sensory system agents|mesh-ancestor
2456558|NCT00991068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456559|NCT00991068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2456560|NCT00991068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2456561|NCT00991068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2456562|NCT00991068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2456563|NCT00991068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456564|NCT00991133|Clofarabine|clofarabine|mesh-list
2456565|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456566|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456567|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2456568|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
2456569|NCT00991159|Bococizumab|bococizumab|mesh-list
2456570|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2456571|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2456572|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
2456573|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456574|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2456575|NCT00991172|Fasinumab|fasinumab|mesh-list
2456576|NCT00991172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2456577|NCT00991172|Analgesics|analgesics|mesh-ancestor
2456578|NCT00991172|Sensory System Agents|sensory system agents|mesh-ancestor
2456579|NCT00991172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456580|NCT00991172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456581|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
2456582|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2456583|NCT00991211|Doxorubicin|doxorubicin|mesh-list
2456584|NCT00991211|Vincristine|vincristine|mesh-list
2456585|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2456586|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
2456587|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456588|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2456589|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2456590|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
2456591|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456592|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456593|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2456594|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2456595|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2456596|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2456597|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456598|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2456599|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
2456600|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
2456601|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
2456602|NCT00991250|Temozolomide|temozolomide|mesh-list
2456603|NCT00991250|Dacarbazine|dacarbazine|mesh-list
2456604|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2456605|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
2456606|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456607|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456608|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
2456609|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2456610|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2456611|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456612|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2456613|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
2456614|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
2456615|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
2456616|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456617|NCT00991627|Atropine|atropine|mesh-list
2456618|NCT00991627|Ephedrine|ephedrine|mesh-list
2456619|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
2456620|NCT00991627|Morphine|morphine|mesh-list
2456621|NCT00991627|Bupivacaine|bupivacaine|mesh-list
2456622|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
2456623|NCT00991627|Anesthetics|anesthetics|mesh-list
2456624|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2456625|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456626|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
2456627|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456628|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2456629|NCT00991627|Narcotics|narcotics|mesh-ancestor
2456630|NCT00991627|Analgesics|analgesics|mesh-ancestor
2456631|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2456632|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2456633|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2456634|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
2456635|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2456636|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
2456637|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
2456638|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
2456639|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2456640|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2456641|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
2456642|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456643|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456644|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2456645|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
2456646|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2456647|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
2456648|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
2456649|NCT00991705|Atorvastatin|atorvastatin|mesh-list
2456650|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2456651|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2456652|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
2456653|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456654|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2456655|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2456656|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456657|NCT00991744|Cytarabine|cytarabine|mesh-list
2456658|NCT00991744|Cortisone|cortisone|mesh-list
2456659|NCT00991744|Prednisolone|prednisolone|mesh-list
2456660|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2456661|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
2456662|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2456663|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
2456664|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2456665|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
2456666|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2456667|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
2456668|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456669|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456670|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
2456671|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456672|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2456673|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
2456674|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456675|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2456676|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
2456677|NCT00991744|Hormones|hormones|mesh-ancestor
2456678|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2456679|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2456680|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
2456681|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
2456682|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456683|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2456684|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2456685|NCT00991744|Protective Agents|protective agents|mesh-ancestor
2456686|NCT00991783|Digoxin|digoxin|mesh-list
2456687|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2456688|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2456689|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456690|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456691|NCT00991783|Protective Agents|protective agents|mesh-ancestor
2456692|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456693|NCT00991796|Paclitaxel|paclitaxel|mesh-list
2456694|NCT00991796|Carboplatin|carboplatin|mesh-list
2456695|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2456696|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456697|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
2456698|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
2456699|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
2456700|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456701|NCT00991822|Timolol|timolol|mesh-list
2456702|NCT00991822|Dorzolamide|dorzolamide|mesh-list
2456703|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2456704|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2208483|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
2208484|NCT00010842|Selenium|selenium|mesh-list
2208485|NCT00010842|Vitamins|vitamins|mesh-ancestor
2208486|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
2208487|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208488|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
2208489|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208490|NCT00010842|Protective Agents|protective agents|mesh-ancestor
2208491|NCT00010842|Trace Elements|trace elements|mesh-ancestor
2208492|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
2208493|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2208494|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2208495|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456705|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
2456706|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456707|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456708|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456709|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2456710|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2456711|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2456712|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456713|NCT00991848|Lidocaine|lidocaine|mesh-list
2456714|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
2456715|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
2208496|NCT00010881|Antioxidants|antioxidants|mesh-list
2208497|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208498|NCT00010881|Protective Agents|protective agents|mesh-ancestor
2208499|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208500|NCT00011076|Pirfenidone|pirfenidone|mesh-list
2208501|NCT00011076|Analgesics|analgesics|mesh-ancestor
2208502|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
2208503|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2208504|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208505|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2208506|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2208507|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2208508|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2208509|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208510|NCT00011089|Tenofovir|tenofovir|mesh-list
2208511|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
2208512|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208513|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2208514|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2208515|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208516|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208517|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2208518|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2208519|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2208520|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
2208521|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208522|NCT00011297|Gabapentin|gabapentin|mesh-list
2208523|NCT00011297|Lorazepam|lorazepam|mesh-list
2208524|NCT00011297|Analgesics|analgesics|mesh-ancestor
2208525|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
2208526|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2208527|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208528|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
2208529|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2208530|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2208531|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2208532|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2208533|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2208534|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2208535|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2208536|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208537|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
2208538|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
2208539|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
2208540|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2208541|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2208542|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
2208543|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
2208544|NCT00011362|Dexamethasone|dexamethasone|mesh-list
2208545|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
2208546|NCT00011362|BB 1101|bb 1101|mesh-list
2208547|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2208548|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
2208549|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
2208550|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2208551|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208552|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2208553|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
2208554|NCT00011362|Hormones|hormones|mesh-ancestor
2208555|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208556|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2208557|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208558|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
2208559|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208560|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208561|NCT00011375|Rolipram|rolipram|mesh-list
2208562|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
2208563|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2208564|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2208565|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2208566|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208567|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208568|NCT00011479|Abacavir|abacavir|mesh-list
2208569|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2208570|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2208571|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208572|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208573|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
2208574|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208575|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2208576|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2208577|NCT00011635|Silymarin|silymarin|mesh-list
2208578|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
2208579|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208580|NCT00011635|Protective Agents|protective agents|mesh-ancestor
2208581|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208582|NCT00011765|Fluoxetine|fluoxetine|mesh-list
2208583|NCT00011765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2208584|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2208585|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2208586|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208587|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2208588|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
2208589|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208590|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2208591|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
2208592|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2208593|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2208594|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2208595|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208596|NCT00011778|Bortezomib|bortezomib|mesh-list
2208597|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208598|NCT00011804|Topiramate|topiramate|mesh-list
2208599|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
2208600|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2208601|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208602|NCT00011895|Lamivudine|lamivudine|mesh-list
2208603|NCT00011895|Zidovudine|zidovudine|mesh-list
2208604|NCT00011895|Efavirenz|efavirenz|mesh-list
2208605|NCT00011895|Abacavir|abacavir|mesh-list
2208606|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2208607|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2208608|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208609|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208610|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
2208611|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208612|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2208613|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2208614|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
2208615|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2208616|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2208617|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2208618|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2208619|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2208620|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2208621|NCT00011908|Epratuzumab|epratuzumab|mesh-list
2208622|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2208623|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208624|NCT00011921|Paclitaxel|paclitaxel|mesh-list
2208625|NCT00011921|Etoposide|etoposide|mesh-list
2208626|NCT00011921|Carboplatin|carboplatin|mesh-list
2208627|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
2208628|NCT00011921|Epirubicin|epirubicin|mesh-list
2208629|NCT00011921|Ifosfamide|ifosfamide|mesh-list
2208630|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208631|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208632|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
2208633|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
2208634|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208635|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208636|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2208637|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2208638|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208639|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2208640|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2208641|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
2208642|NCT00011934|Interferons|interferons|mesh-list
2208643|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
2208644|NCT00011934|Sargramostim|sargramostim|mesh-list
2208645|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208646|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
2208647|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208648|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
2208649|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208650|NCT00011960|Paclitaxel|paclitaxel|mesh-list
2208651|NCT00011960|Cisplatin|cisplatin|mesh-list
2208652|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208653|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208654|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
2208655|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
2208656|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208657|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208658|NCT00011973|Fenretinide|fenretinide|mesh-list
2208659|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208660|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2208661|NCT00011973|Protective Agents|protective agents|mesh-ancestor
2208662|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208663|NCT00011999|Paclitaxel|paclitaxel|mesh-list
2208664|NCT00011999|Cisplatin|cisplatin|mesh-list
2208665|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208666|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208667|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
2208668|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
2208669|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208670|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208671|NCT00012025|Fulvestrant|fulvestrant|mesh-list
2208672|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2208673|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208674|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2208675|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2208676|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
2208677|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208678|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208679|NCT00012038|Irofulven|irofulven|mesh-list
2208680|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2208681|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
2208682|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208683|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208684|NCT00012051|Cytarabine|cytarabine|mesh-list
2208685|NCT00012051|Dexamethasone|dexamethasone|mesh-list
2208686|NCT00012051|Rituximab|rituximab|mesh-list
2208687|NCT00012051|Methotrexate|methotrexate|mesh-list
2208688|NCT00012051|Etoposide|etoposide|mesh-list
2208689|NCT00012051|Melphalan|melphalan|mesh-list
2208690|NCT00012051|Ifosfamide|ifosfamide|mesh-list
2208691|NCT00012051|Carmustine|carmustine|mesh-list
2208692|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208693|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2208694|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
2208695|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
2208696|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2208697|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208698|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2208699|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
2208700|NCT00012051|Hormones|hormones|mesh-ancestor
2208701|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208702|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2208703|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2208704|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
2208705|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2208706|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2208707|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
2208708|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2208709|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208710|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
2208711|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208712|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
2208713|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208714|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2208715|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208716|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2208717|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208718|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2208719|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2208720|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
2208721|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208722|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2208723|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
2208724|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2208725|NCT00012090|Goserelin|goserelin|mesh-list
2208726|NCT00012090|Bicalutamide|bicalutamide|mesh-list
2208727|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2208728|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208729|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
2208730|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
2208731|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208732|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208733|NCT00012116|Temozolomide|temozolomide|mesh-list
2208734|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2208735|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
2208736|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208737|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208738|NCT00012129|Annamycin|annamycin|mesh-list
2208739|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2208740|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208741|NCT00012142|Sirolimus|sirolimus|mesh-list
2208742|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2208743|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208744|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2208745|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208746|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
2208747|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208748|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
2208749|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208750|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
2208751|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2208752|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208753|NCT00012181|Alvocidib|alvocidib|mesh-list
2208754|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208755|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
2208756|NCT00012181|Growth Substances|growth substances|mesh-ancestor
2208757|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208758|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2208759|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208760|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208761|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
2208762|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208763|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2208764|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208765|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208766|NCT00012207|Aldesleukin|aldesleukin|mesh-list
2208767|NCT00012207|Prednisone|prednisone|mesh-list
2208768|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
2208769|NCT00012207|Vincristine|vincristine|mesh-list
2208770|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208771|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
2208772|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208773|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2208774|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2208775|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
2208776|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208777|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208778|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2208779|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2208780|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
2208781|NCT00012207|Hormones|hormones|mesh-ancestor
2208782|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208783|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2208784|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208785|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
2208786|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
2208787|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
2456716|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2208788|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2208789|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2208790|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
2208791|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208792|NCT00012220|Gemcitabine|gemcitabine|mesh-list
2208793|NCT00012220|Docetaxel|docetaxel|mesh-list
2208794|NCT00012220|Irinotecan|irinotecan|mesh-list
2208795|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208796|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208797|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
2208798|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208799|NCT00012220|Antiviral Agents|antiviral agents|mesh-ancestor
2208800|NCT00012220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208801|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208802|NCT00012220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208803|NCT00012220|Immunologic Factors|immunologic factors|mesh-ancestor
2208804|NCT00012220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208805|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
2208806|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
2208807|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208808|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2208809|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2208810|NCT00012246|Sargramostim|sargramostim|mesh-list
2208811|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
2208812|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
2208813|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208814|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2208815|NCT00012259|Troxacitabine|troxacitabine|mesh-list
2208816|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208817|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2208818|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2208819|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
2208820|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208821|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
2208822|NCT00012311|Ifosfamide|ifosfamide|mesh-list
2208823|NCT00012311|Thiotepa|thiotepa|mesh-list
2208824|NCT00012311|Carboplatin|carboplatin|mesh-list
2208825|NCT00012311|Docetaxel|docetaxel|mesh-list
2208826|NCT00012311|Doxorubicin|doxorubicin|mesh-list
2208827|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2208828|NCT00012311|Fluorouracil|fluorouracil|mesh-list
2208829|NCT00012311|Methotrexate|methotrexate|mesh-list
2208830|NCT00012311|Etoposide|etoposide|mesh-list
2208831|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208832|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
2208833|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208834|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2208835|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2208836|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
2208837|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208838|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208839|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2208840|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
2208841|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
2208842|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
2208843|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2208844|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2208845|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2208846|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208847|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
2208848|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208849|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2208850|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
2208851|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2208852|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
2208853|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2208854|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2208855|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2208856|NCT00012324|Doxorubicin|doxorubicin|mesh-list
2208857|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2208858|NCT00012324|Nolatrexed|nolatrexed|mesh-list
2208859|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2208860|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208861|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2208862|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2208863|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208864|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208865|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208866|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
2208867|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2208868|NCT00012337|Gefitinib|gefitinib|mesh-list
2208869|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208870|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2208871|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208872|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208873|NCT00012350|Tipifarnib|tipifarnib|mesh-list
2208874|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208875|NCT00012363|Gemcitabine|gemcitabine|mesh-list
2208876|NCT00012363|Irinotecan|irinotecan|mesh-list
2208877|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2208878|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
2208879|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208880|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208881|NCT00012363|Antiviral Agents|antiviral agents|mesh-ancestor
2208882|NCT00012363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208883|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208884|NCT00012363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208885|NCT00012363|Immunologic Factors|immunologic factors|mesh-ancestor
2208886|NCT00012363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208887|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2208888|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2208889|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
2208890|NCT00012376|Sargramostim|sargramostim|mesh-list
2208891|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
2208892|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208893|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208894|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2208895|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
2208896|NCT00012389|Irinotecan|irinotecan|mesh-list
2208897|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208898|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2208899|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2208900|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208901|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208902|NCT00012467|Interferons|interferons|mesh-list
2208903|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
2208904|NCT00012467|Itraconazole|itraconazole|mesh-list
2208905|NCT00012467|Fluconazole|fluconazole|mesh-list
2208906|NCT00012467|Amphotericin B|amphotericin b|mesh-list
2208907|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2208908|NCT00012467|Flucytosine|flucytosine|mesh-list
2208909|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2208910|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
2208911|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208912|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
2208913|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2208914|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2208915|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208916|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208917|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2208918|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
2208919|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2208920|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208921|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2208922|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2208923|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2208924|NCT00012467|Amebicides|amebicides|mesh-ancestor
2208925|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2208926|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2208927|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2208928|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
2208929|NCT00012506|Etanercept|etanercept|mesh-list
2208930|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2208931|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2208932|NCT00012506|Analgesics|analgesics|mesh-ancestor
2208933|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
2208934|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2208935|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208936|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2208937|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2208938|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2208939|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2208940|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
2208941|NCT00012519|Ritonavir|ritonavir|mesh-list
2208942|NCT00012519|Indinavir|indinavir|mesh-list
2208943|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2208944|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2208945|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
2208946|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208947|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208948|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2208949|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2208950|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
2208951|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2208952|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2208953|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2208954|NCT00012558|Inositol|inositol|mesh-list
2208955|NCT00012558|Lamotrigine|lamotrigine|mesh-list
2208956|NCT00012558|Valproic Acid|valproic acid|mesh-list
2208957|NCT00012558|Risperidone|risperidone|mesh-list
2208958|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
2208959|NCT00012558|Bupropion|bupropion|mesh-list
2208960|NCT00012558|Paroxetine|paroxetine|mesh-list
2208961|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2208962|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
2208963|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2208964|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2208965|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208966|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2208967|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2208968|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2208969|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2208970|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2208971|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
2208972|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2208973|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
2208974|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2208975|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2208976|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2208977|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2208978|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2208979|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2208980|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
2208981|NCT00012558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2208982|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
2208983|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2208984|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2208985|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2208986|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
2208987|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
2208988|NCT00012558|Vitamins|vitamins|mesh-ancestor
2208989|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
2208990|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2208991|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2208992|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
2208993|NCT00012584|Methylphenidate|methylphenidate|mesh-list
2208994|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2208995|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2208996|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2208997|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2208998|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2208999|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2209000|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
2209001|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2209002|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2209003|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2209004|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2209005|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2209006|NCT00012584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2209007|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
2209008|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2209009|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
2456717|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456718|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
2456719|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456720|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2456721|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2456722|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2456723|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2456724|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456725|NCT00991926|Orlistat|orlistat|mesh-list
2456726|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456727|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456728|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2456729|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2456730|NCT00991978|Bevacizumab|bevacizumab|mesh-list
2456731|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
2456732|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2456733|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456734|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2456735|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2456736|NCT00991978|Growth Substances|growth substances|mesh-ancestor
2456737|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456738|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
2456739|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2456740|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456741|NCT00992004|Turmeric extract|turmeric extract|mesh-list
2456742|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
2456743|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456744|NCT00992004|Protective Agents|protective agents|mesh-ancestor
2456745|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456746|NCT00992030|Rituximab|rituximab|mesh-list
2456747|NCT00992030|Doxorubicin|doxorubicin|mesh-list
2456748|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2456749|NCT00992030|Dacarbazine|dacarbazine|mesh-list
2456750|NCT00992030|Bleomycin|bleomycin|mesh-list
2456751|NCT00992030|Vinblastine|vinblastine|mesh-list
2456752|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2456753|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456754|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
2456755|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456756|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2456757|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2456758|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2456759|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2456760|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456761|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456762|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2456763|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
2456764|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2456765|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
2456766|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
2456767|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
2456768|NCT00992069|Efavirenz|efavirenz|mesh-list
2456769|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2456770|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2456771|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456772|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456773|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
2456774|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209010|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2209011|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2209012|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2209013|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2209014|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
2209015|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2209016|NCT00012688|Doxycycline|doxycycline|mesh-list
2209017|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2209018|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2209019|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
2209020|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
2209021|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2209022|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
2209023|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2209024|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2456775|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2456776|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2456777|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2456778|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2456779|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2456780|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2456781|NCT00992082|Ketorolac|ketorolac|mesh-list
2456782|NCT00992082|Epinephrine|epinephrine|mesh-list
2456783|NCT00992082|Morphine|morphine|mesh-list
2456784|NCT00992082|Ropivacaine|ropivacaine|mesh-list
2456785|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2456786|NCT00992082|Narcotics|narcotics|mesh-ancestor
2456787|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2456788|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456789|NCT00992082|Analgesics|analgesics|mesh-ancestor
2456790|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
2456791|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456792|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
2456793|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
2456794|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2456795|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2456796|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
2456797|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456798|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456799|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2456800|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2456801|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
2456802|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2456803|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
2456804|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
2456805|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
2456806|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2456807|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2456808|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2456809|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2456810|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2456811|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2456812|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456813|NCT00992095|Buprenorphine|buprenorphine|mesh-list
2456814|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2456815|NCT00992095|Narcotics|narcotics|mesh-ancestor
2456816|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2456817|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456818|NCT00992095|Analgesics|analgesics|mesh-ancestor
2456819|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
2456820|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456821|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2456822|NCT00992121|Bevacizumab|bevacizumab|mesh-list
2456823|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2456824|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456825|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2456826|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2456827|NCT00992121|Growth Substances|growth substances|mesh-ancestor
2456828|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456829|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
2456830|NCT00992134|Cytarabine|cytarabine|mesh-list
2456831|NCT00992134|Rituximab|rituximab|mesh-list
2456832|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2456833|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2456834|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456835|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
2456836|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456837|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2456838|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2456839|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
2456840|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456841|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
2456842|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456843|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2456844|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2456845|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
2456846|NCT00992160|Vestipitant|vestipitant|mesh-list
2456847|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2456848|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456849|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456850|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456851|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2456852|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456853|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456854|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456855|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2456856|NCT00992199|Fluorouracil|fluorouracil|mesh-list
2456857|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456858|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
2456859|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456860|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2456861|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2456862|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
2456863|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456864|NCT00992238|Flavoxate|flavoxate|mesh-list
2456865|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
2456866|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
2456867|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456868|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456869|NCT00992238|Urological Agents|urological agents|mesh-ancestor
2456870|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
2456871|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2456872|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456873|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2456874|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2456875|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456876|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456877|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456878|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2456879|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2456880|NCT00992355|Tobramycin|tobramycin|mesh-list
2456881|NCT00992355|Dexamethasone|dexamethasone|mesh-list
2456882|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
2456883|NCT00992355|Ketorolac|ketorolac|mesh-list
2456884|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2456885|NCT00992355|BB 1101|bb 1101|mesh-list
2456886|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2456887|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
2456888|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
2456889|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456890|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456891|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2456892|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
2456893|NCT00992355|Hormones|hormones|mesh-ancestor
2456894|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2456895|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2456896|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456897|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
2456898|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456899|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456900|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2456901|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2456902|NCT00992355|Analgesics|analgesics|mesh-ancestor
2456903|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
2456904|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2456905|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2456906|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2456907|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456908|NCT00992381|Naproxen|naproxen|mesh-list
2456909|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2456910|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2456911|NCT00992381|Analgesics|analgesics|mesh-ancestor
2456912|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
2456913|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456914|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456915|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2456916|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2456917|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
2456918|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2456919|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456920|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456921|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
2456922|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
2456923|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
2456924|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456925|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456926|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2456927|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2456928|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2456929|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2456930|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2456931|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2456932|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
2456933|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2456934|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456935|NCT00992524|Misoprostol|misoprostol|mesh-list
2456936|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2456937|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
2456938|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2456939|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456940|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2456941|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2456942|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
2456943|NCT00992537|Insulin|insulin|mesh-list
2456944|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2456945|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
2456946|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
2456947|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2456948|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2456949|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456950|NCT00992563|Ranibizumab|ranibizumab|mesh-list
2456951|NCT00992563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2456952|NCT00992563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2456953|NCT00992563|Growth Substances|growth substances|mesh-ancestor
2456954|NCT00992563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456955|NCT00992563|Growth Inhibitors|growth inhibitors|mesh-ancestor
2456956|NCT00992563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456957|NCT00992576|Hydromorphone|hydromorphone|mesh-list
2456958|NCT00992576|Naloxone|naloxone|mesh-list
2456959|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2456960|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456961|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
2456962|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456963|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2456964|NCT00992576|Narcotics|narcotics|mesh-ancestor
2456965|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2456966|NCT00992576|Analgesics|analgesics|mesh-ancestor
2456967|NCT00992654|Maraviroc|maraviroc|mesh-list
2456968|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2456969|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2456970|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456971|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2456972|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2456973|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
2456974|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456975|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2456976|NCT00992667|Acetovanillone|acetovanillone|mesh-list
2456977|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2456978|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2456979|NCT00992667|Analgesics|analgesics|mesh-ancestor
2456980|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
2456981|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2456982|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2456983|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2456984|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2456985|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
2456986|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456987|NCT00992667|Protective Agents|protective agents|mesh-ancestor
2456988|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2456989|NCT00992693|Ribavirin|ribavirin|mesh-list
2456990|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
2456991|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2456992|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
2456993|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2456994|NCT00992706|Doxorubicin|doxorubicin|mesh-list
2456995|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2456996|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2456997|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2456998|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2456999|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2457000|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457001|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457002|NCT00992732|Valganciclovir|valganciclovir|mesh-list
2457003|NCT00992732|Ganciclovir|ganciclovir|mesh-list
2457004|NCT00992732|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
2457005|NCT00992732|Arginine butyrate|arginine butyrate|mesh-list
2457006|NCT00992732|Antiviral Agents|antiviral agents|mesh-ancestor
2457007|NCT00992732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457008|NCT00992732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2457009|NCT00992732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457010|NCT00992732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457011|NCT00992732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457012|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
2457013|NCT00992758|Antibodies|antibodies|mesh-list
2457014|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
2457015|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457016|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457017|NCT00992771|Varenicline|varenicline|mesh-list
2457018|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2457019|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2457020|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
2457021|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2457022|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457023|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457024|NCT00992797|Vitamin D|vitamin d|mesh-list
2457025|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
2457026|NCT00992797|Vitamins|vitamins|mesh-ancestor
2457027|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
2457028|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457029|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2457030|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2457031|NCT00992823|Iron|iron|mesh-list
2457032|NCT00992823|Trace Elements|trace elements|mesh-ancestor
2457033|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
2457034|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457035|NCT00992849|Bevacizumab|bevacizumab|mesh-list
2457036|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2457037|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457038|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2457039|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2457040|NCT00992849|Growth Substances|growth substances|mesh-ancestor
2457041|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457042|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
2457043|NCT00992862|Moexipril|moexipril|mesh-list
2457044|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2457045|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
2457046|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457047|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457048|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2457049|NCT00992901|Atropine|atropine|mesh-list
2457050|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2457051|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2457052|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2457053|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2457054|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
2457055|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457056|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457057|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2457058|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
2457059|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
2457060|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
2457061|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2457062|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2457063|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
2457064|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2457065|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457066|NCT00992901|Incretins|incretins|mesh-ancestor
2457067|NCT00992901|Hormones|hormones|mesh-ancestor
2457068|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2457069|NCT00992914|Lidocaine|lidocaine|mesh-list
2457070|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
2457071|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
2457072|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2457073|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457074|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
2457075|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457076|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2457077|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2457078|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2457079|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2457080|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457081|NCT00993057|Insulin|insulin|mesh-list
2457082|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2457083|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457084|NCT00993070|Capsaicin|capsaicin|mesh-list
2457085|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
2457086|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
2457087|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
2457088|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457089|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457090|NCT00993096|Insulin|insulin|mesh-list
2457091|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2457092|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
2457093|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
2457094|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2457095|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
2457096|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2457097|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
2457098|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2457099|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457100|NCT00993109|Valsartan|valsartan|mesh-list
2457101|NCT00993109|Nifedipine|nifedipine|mesh-list
2457102|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2457103|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2457104|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2457105|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457106|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2457107|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2457108|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2457109|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457110|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
2457111|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
2457112|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2457113|NCT00993122|Ribavirin|ribavirin|mesh-list
2457114|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
2457115|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457116|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
2457117|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457118|NCT00993135|Methotrexate|methotrexate|mesh-list
2457119|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2457120|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
2457121|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2457122|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457123|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2457124|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
2457125|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457126|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457127|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
2457128|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457129|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2457130|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2457131|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
2457132|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2457133|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2457134|NCT00993304|Liraglutide|liraglutide|mesh-list
2457135|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2457136|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457137|NCT00993304|Incretins|incretins|mesh-ancestor
2457138|NCT00993304|Hormones|hormones|mesh-ancestor
2457139|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2457140|NCT00993343|Cyclosporine|cyclosporine|mesh-list
2457141|NCT00993343|Sirolimus|sirolimus|mesh-list
2457142|NCT00993343|Methotrexate|methotrexate|mesh-list
2457143|NCT00993343|Tacrolimus|tacrolimus|mesh-list
2457144|NCT00993343|Cyclosporins|cyclosporins|mesh-list
2457145|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2457146|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
2457147|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2457148|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457149|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2457150|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
2457151|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457152|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457153|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
2457154|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457155|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2457156|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2457157|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
2457158|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2457159|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2457160|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2457161|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
2457162|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457163|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2457164|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2457165|NCT00993356|Lanreotide|lanreotide|mesh-list
2457166|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457167|NCT00993382|Amiodarone|amiodarone|mesh-list
2457168|NCT00993382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2457169|NCT00993382|Vasodilator Agents|vasodilator agents|mesh-ancestor
2457170|NCT00993382|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2457171|NCT00993382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2457172|NCT00993382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457173|NCT00993382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2457174|NCT00993382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2457175|NCT00993382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2457176|NCT00993382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457177|NCT00993382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2457178|NCT00993382|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2457179|NCT00993382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2457180|NCT00993408|Selexipag|selexipag|mesh-list
2457181|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2457182|NCT00993512|Bleomycin|bleomycin|mesh-list
2457183|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2457184|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457185|NCT00993525|Ranibizumab|ranibizumab|mesh-list
2457186|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2457187|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2457188|NCT00993525|Growth Substances|growth substances|mesh-ancestor
2457189|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457190|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
2457191|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457192|NCT00993642|Panobinostat|panobinostat|mesh-list
2457193|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457194|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2457195|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457196|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457197|NCT00993681|Vaccines|vaccines|mesh-list
2457198|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
2457199|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457200|NCT00993694|Dapsone|dapsone|mesh-list
2457201|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457202|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
2457203|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2457204|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2457205|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2457206|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457207|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457208|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
2457209|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2457210|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
2457211|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2457212|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
2457213|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457214|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
2457215|NCT00993707|Protective Agents|protective agents|mesh-ancestor
2457216|NCT00993720|Liraglutide|liraglutide|mesh-list
2457217|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2457218|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457219|NCT00993720|Incretins|incretins|mesh-ancestor
2457220|NCT00993720|Hormones|hormones|mesh-ancestor
2457221|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2457222|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
2457223|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2457224|NCT00993746|Lidocaine|lidocaine|mesh-list
2457225|NCT00993746|Bupivacaine|bupivacaine|mesh-list
2457226|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
2457227|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
2457228|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2457229|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457230|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
2457231|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457232|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2457233|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2457234|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2457235|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2457236|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457237|NCT00993863|Ibuprofen|ibuprofen|mesh-list
2457238|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2457239|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2457240|NCT00993863|Analgesics|analgesics|mesh-ancestor
2457241|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
2457242|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457243|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457244|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2457245|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2457246|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2457247|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457248|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457249|NCT00993876|Citalopram|citalopram|mesh-list
2457250|NCT00993876|Reboxetine|reboxetine|mesh-list
2457251|NCT00993876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2457252|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2457253|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2457254|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457255|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2457256|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
2457257|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457258|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2457259|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
2457260|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2457261|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2457262|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
2457263|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
2457264|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
2457265|NCT00994006|Levulinic acid|levulinic acid|mesh-list
2457266|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457267|NCT00994006|Cathartics|cathartics|mesh-ancestor
2457268|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2457269|NCT00994006|Antacids|antacids|mesh-ancestor
2457270|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457271|NCT00994071|Temozolomide|temozolomide|mesh-list
2457272|NCT00994071|Veliparib|veliparib|mesh-list
2457273|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2457274|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
2457275|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457276|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457277|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2457278|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457279|NCT00994097|Gemcitabine|gemcitabine|mesh-list
2457280|NCT00994097|Pemetrexed|pemetrexed|mesh-list
2457281|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457282|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2457283|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
2457284|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457285|NCT00994097|Antiviral Agents|antiviral agents|mesh-ancestor
2457286|NCT00994097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457287|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457288|NCT00994097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2457289|NCT00994097|Immunologic Factors|immunologic factors|mesh-ancestor
2457290|NCT00994097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457291|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2457292|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2457293|NCT00994149|Diazoxide|diazoxide|mesh-list
2457294|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2457295|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
2457296|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2457297|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2457298|NCT00994253|Diuretics|diuretics|mesh-ancestor
2457299|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
2457300|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457301|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2457302|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2457303|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457304|NCT00994292|Darexaban|darexaban|mesh-list
2457305|NCT00994292|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2457306|NCT00994292|Antithrombins|antithrombins|mesh-ancestor
2457307|NCT00994292|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2457308|NCT00994292|Protease Inhibitors|protease inhibitors|mesh-ancestor
2457309|NCT00994292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457310|NCT00994292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457311|NCT00994292|Anticoagulants|anticoagulants|mesh-ancestor
2457312|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
2457313|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2457314|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
2457315|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457316|NCT00994305|Expectorants|expectorants|mesh-ancestor
2457317|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
2457318|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2457319|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
2457320|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457321|NCT00994305|Protective Agents|protective agents|mesh-ancestor
2457322|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457323|NCT00994305|Antidotes|antidotes|mesh-ancestor
2457324|NCT00994344|Ritonavir|ritonavir|mesh-list
2457325|NCT00994344|Lopinavir|lopinavir|mesh-list
2457326|NCT00994344|Darunavir|darunavir|mesh-list
2457327|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2457328|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2457329|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
2457330|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457331|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457332|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2457333|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2457334|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
2457335|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457336|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2457337|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2457338|NCT00994383|Morphine|morphine|mesh-list
2457339|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2457340|NCT00994383|Narcotics|narcotics|mesh-ancestor
2457341|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2457342|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457343|NCT00994383|Analgesics|analgesics|mesh-ancestor
2457344|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
2457345|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457346|NCT00994396|Vitamin D|vitamin d|mesh-list
2457347|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
2457348|NCT00994396|Vitamins|vitamins|mesh-ancestor
2457349|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
2457350|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457351|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2457352|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2457353|NCT00994500|Bortezomib|bortezomib|mesh-list
2457354|NCT00994500|Vorinostat|vorinostat|mesh-list
2457355|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457356|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2457357|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457358|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457359|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
2457360|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
2457361|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457362|NCT00994513|Protective Agents|protective agents|mesh-ancestor
2457363|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457364|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
2457365|NCT00994513|Vitamins|vitamins|mesh-ancestor
2457366|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
2457367|NCT00994526|Vitamin E|vitamin e|mesh-list
2457368|NCT00994526|Calcium|calcium|mesh-list
2457369|NCT00994526|Vitamins|vitamins|mesh-ancestor
2457370|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
2457371|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457372|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2457373|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
2457374|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457375|NCT00994526|Protective Agents|protective agents|mesh-ancestor
2457376|NCT00994539|Morphine|morphine|mesh-list
2457377|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2457378|NCT00994539|Narcotics|narcotics|mesh-ancestor
2457379|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2457380|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457381|NCT00994539|Analgesics|analgesics|mesh-ancestor
2457382|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
2457383|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457384|NCT00994617|Losartan|losartan|mesh-list
2457385|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2457386|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2457387|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2457388|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2457389|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2457390|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457391|NCT00994617|Diuretics|diuretics|mesh-ancestor
2457392|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
2457393|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457394|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2457395|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2457396|NCT00994695|Vaccines|vaccines|mesh-list
2457397|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
2457398|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457399|NCT00994708|Esomeprazole|esomeprazole|mesh-list
2457400|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2457401|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2457402|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2457403|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457404|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457405|NCT00994734|Mifepristone|mifepristone|mesh-list
2457406|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2457407|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
2457408|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2457409|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457410|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2457411|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2457412|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2457413|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
2457414|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2457415|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2457416|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
2457417|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2457418|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
2457419|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2457420|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2457421|NCT00994773|Tenofovir|tenofovir|mesh-list
2457422|NCT00994773|Entecavir|entecavir|mesh-list
2457423|NCT00994773|Simvastatin|simvastatin|mesh-list
2457424|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
2457425|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457426|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2457427|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2457428|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457429|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457430|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2457431|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2457432|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2457433|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2457434|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
2457435|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2457436|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2457437|NCT00994786|Pregabalin|pregabalin|mesh-list
2457438|NCT00994786|Analgesics|analgesics|mesh-ancestor
2457439|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
2457440|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457441|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457442|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
2457443|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2457444|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2457445|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457446|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2457447|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2457448|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2457449|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2457450|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2457451|NCT00994799|Ranibizumab|ranibizumab|mesh-list
2457452|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2457453|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2457454|NCT00994799|Growth Substances|growth substances|mesh-ancestor
2457455|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457456|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
2457457|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457458|NCT00994812|Metformin|metformin|mesh-list
2457459|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2457460|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457461|NCT00994825|Simendan|simendan|mesh-list
2457462|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2457463|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
2457464|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2457465|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2457466|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457467|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457468|NCT00994825|Protective Agents|protective agents|mesh-ancestor
2457469|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457470|NCT00994903|Simvastatin|simvastatin|mesh-list
2457471|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2457472|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2457473|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
2457474|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457475|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2457476|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2457477|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457478|NCT00994916|Amifampridine|amifampridine|mesh-list
2457479|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2457480|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457481|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457482|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
2457483|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2457484|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457485|NCT00994942|Morphine|morphine|mesh-list
2457486|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2457487|NCT00994942|Narcotics|narcotics|mesh-ancestor
2457488|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2457489|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457490|NCT00994942|Analgesics|analgesics|mesh-ancestor
2457491|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
2457492|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457493|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
2457494|NCT00994968|Docetaxel|docetaxel|mesh-list
2457495|NCT00994968|Doxorubicin|doxorubicin|mesh-list
2457496|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2457497|NCT00994968|Tegafur|tegafur|mesh-list
2457498|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2457499|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
2457500|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457501|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2457502|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2457503|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
2457504|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457505|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457506|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2457507|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
2457508|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
2457509|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
2457510|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2457511|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2457512|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2457513|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457514|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2457515|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
2457516|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
2457517|NCT00994981|Analgesics|analgesics|mesh-ancestor
2457518|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
2457519|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457520|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457521|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
2457522|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2457523|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2457524|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
2457525|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2457526|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2457527|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457528|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2457529|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
2457530|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2457531|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
2457532|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
2457533|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
2457534|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2457535|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457536|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
2457537|NCT00994994|Coagulants|coagulants|mesh-ancestor
2457538|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
2457539|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2457540|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2457541|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457542|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2457543|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2457544|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2457545|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457546|NCT00995033|Varenicline|varenicline|mesh-list
2457547|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2457548|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2457549|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
2457550|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2457551|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457552|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457553|NCT00995046|Factor VIII|factor viii|mesh-list
2457554|NCT00995046|Coagulants|coagulants|mesh-ancestor
2457555|NCT00995059|Sirolimus|sirolimus|mesh-list
2457556|NCT00995059|Bortezomib|bortezomib|mesh-list
2457557|NCT00995059|Melphalan|melphalan|mesh-list
2457558|NCT00995059|Tacrolimus|tacrolimus|mesh-list
2457559|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
2457560|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2457561|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
2457562|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2457563|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
2457564|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457565|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2457566|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457567|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457568|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457569|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2457570|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457571|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2457572|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
2457573|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2457574|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
2457575|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2457576|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2457577|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
2457578|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2457579|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
2457580|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2457581|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457582|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2457583|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2457584|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2457585|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
2457586|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2457587|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2457588|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
2457589|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457590|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2457591|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2457592|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457593|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457594|NCT00995293|Docetaxel|docetaxel|mesh-list
2457595|NCT00995293|Fluorouracil|fluorouracil|mesh-list
2457596|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457597|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
2457598|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
2457599|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
2457600|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457601|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
2457602|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2457603|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2457604|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
2457605|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457606|NCT00995306|Capsaicin|capsaicin|mesh-list
2457607|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
2457608|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
2457609|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
2457610|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457611|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457612|NCT00995332|Cytarabine|cytarabine|mesh-list
2457613|NCT00995332|Tretinoin|tretinoin|mesh-list
2457614|NCT00995332|Valproic Acid|valproic acid|mesh-list
2457615|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2457616|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
2457617|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457618|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457619|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
2457620|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457621|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2457622|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
2457623|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457624|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
2457625|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
2457626|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
2457627|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457628|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
2457629|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2457630|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
2457631|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2457632|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2457633|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2457634|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
2457635|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
2457636|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2457637|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
2457638|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
2457639|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2457640|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457641|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457642|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
2457643|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
2457644|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2457645|NCT00995423|Paclitaxel|paclitaxel|mesh-list
2457646|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2457647|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457648|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
2457649|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
2457650|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
2457651|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457652|NCT00995618|Tranilast|tranilast|mesh-list
2457653|NCT00995618|Febuxostat|febuxostat|mesh-list
2457654|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
2457655|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2457656|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2457657|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2457658|NCT00995618|Analgesics|analgesics|mesh-ancestor
2457659|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
2457660|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457661|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457662|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2457663|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2457664|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2457665|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457666|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2457667|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2457668|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
2457669|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
2457670|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2457671|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2457672|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2457673|NCT00995657|Fluticasone|fluticasone|mesh-list
2457674|NCT00995657|Xhance|xhance|mesh-list
2457675|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2457676|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2457677|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
2457678|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457679|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457680|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2457681|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
2457682|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
2457683|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2457684|NCT00995800|Fluticasone|fluticasone|mesh-list
2457685|NCT00995800|Xhance|xhance|mesh-list
2457686|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
2457687|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2457688|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2457689|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
2457690|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457691|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457692|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2457693|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
2457694|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
2457695|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2457696|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2457697|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2457698|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2457699|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
2457700|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2457701|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457702|NCT00995826|Laninamivir|laninamivir|mesh-list
2457703|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
2457704|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457705|NCT00995839|Terlipressin|terlipressin|mesh-list
2457706|NCT00995839|Vasopressins|vasopressins|mesh-list
2457707|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
2457708|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
2457709|NCT00995839|Coagulants|coagulants|mesh-ancestor
2457710|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2457711|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2457712|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
2457713|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457714|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2457715|NCT00995917|Vitamin K|vitamin k|mesh-list
2457716|NCT00995917|Vitamins|vitamins|mesh-ancestor
2457717|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
2457718|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457719|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2457720|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2457721|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457722|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
2457723|NCT00995917|Coagulants|coagulants|mesh-ancestor
2457724|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
2457725|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2457726|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457727|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
2457728|NCT00996021|Dolutegravir|dolutegravir|mesh-list
2457729|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2457730|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2457731|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457732|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2457733|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2457734|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457735|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457736|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457737|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2457738|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
2457739|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2457740|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457741|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2457742|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2457743|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2457744|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2457745|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2457746|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2457747|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2457748|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
2457749|NCT00996060|Hydralazine|hydralazine|mesh-list
2457750|NCT00996060|Valproic Acid|valproic acid|mesh-list
2457751|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
2457752|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457753|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457754|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
2457755|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2457756|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457757|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
2457758|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2457759|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2457760|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2457761|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2457762|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
2457763|NCT00996099|Insulin|insulin|mesh-list
2457764|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2457765|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2457766|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457767|NCT00996151|Testosterone|testosterone|mesh-list
2457768|NCT00996151|Androgens|androgens|mesh-ancestor
2457769|NCT00996151|Hormones|hormones|mesh-ancestor
2457770|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2457771|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457772|NCT00996177|Fentanyl|fentanyl|mesh-list
2457773|NCT00996177|Morphine|morphine|mesh-list
2457774|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2457775|NCT00996177|Narcotics|narcotics|mesh-ancestor
2457776|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2457777|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457778|NCT00996177|Analgesics|analgesics|mesh-ancestor
2457779|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
2457780|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457781|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2457782|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2457783|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
2457784|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
2457785|NCT00996190|Phenylephrine|phenylephrine|mesh-list
2457786|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
2457787|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2457788|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
2457789|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
2457790|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457791|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457792|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
2457793|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2457794|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
2457795|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
2457796|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2457797|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2457798|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2457799|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
2457800|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2457801|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457802|NCT00996190|Protective Agents|protective agents|mesh-ancestor
2457803|NCT00996229|Resveratrol|resveratrol|mesh-list
2457804|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
2457805|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457806|NCT00996229|Protective Agents|protective agents|mesh-ancestor
2457807|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457808|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457809|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2457810|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
2457811|NCT00996385|Bortezomib|bortezomib|mesh-list
2457812|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457813|NCT00996411|Salvinorin A|salvinorin a|mesh-list
2457814|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
2457815|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457816|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2457817|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
2457818|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2457819|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
2457820|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457821|NCT00996424|Expectorants|expectorants|mesh-ancestor
2457822|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
2457823|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2457824|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
2457825|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457826|NCT00996424|Protective Agents|protective agents|mesh-ancestor
2457827|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457828|NCT00996424|Antidotes|antidotes|mesh-ancestor
2457829|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
2457830|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2457831|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2457832|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2457833|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
2457834|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2457835|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
2457836|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2457837|NCT00996515|Azacitidine|azacitidine|mesh-list
2457838|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457839|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2457840|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457841|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457842|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2457843|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
2457844|NCT00996567|Cetuximab|cetuximab|mesh-list
2457845|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2457846|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457847|NCT00996684|Plasminogen|plasminogen|mesh-list
2457848|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2457849|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2457850|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457851|NCT00996697|Budesonide|budesonide|mesh-list
2457852|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
2457853|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
2457854|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
2457855|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2457856|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2457857|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
2457858|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457859|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457860|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2457861|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
2457862|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
2457863|NCT00996697|Hormones|hormones|mesh-ancestor
2457864|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2457865|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2457866|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2457867|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2457868|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
2457869|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2457870|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457871|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
2457872|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2457873|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
2457874|NCT00996723|Dasatinib|dasatinib|mesh-list
2457875|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457876|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2457877|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457878|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457879|NCT00996762|Lapatinib|lapatinib|mesh-list
2457880|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457881|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2457882|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457883|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457884|NCT00996788|Rebamipide|rebamipide|mesh-list
2457885|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2457886|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2457887|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
2457888|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457889|NCT00996788|Protective Agents|protective agents|mesh-ancestor
2457890|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457891|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457892|NCT00996866|Vitamin D|vitamin d|mesh-list
2457893|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
2457894|NCT00996866|Vitamins|vitamins|mesh-ancestor
2457895|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
2457896|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457897|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2457898|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2457899|NCT00996879|Midazolam|midazolam|mesh-list
2457900|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2457901|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2457902|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2457903|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457904|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2457905|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2457906|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2457907|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2457908|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
2457909|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
2457910|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
2457911|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
2457912|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2457913|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457914|NCT00996983|Ziconotide|ziconotide|mesh-list
2457915|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2457916|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2457917|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457918|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2457919|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457920|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2457921|NCT00996983|Protective Agents|protective agents|mesh-ancestor
2457922|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2457923|NCT00996983|Analgesics|analgesics|mesh-ancestor
2457924|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
2457925|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457926|NCT00997009|Paclitaxel|paclitaxel|mesh-list
2457927|NCT00997009|Carboplatin|carboplatin|mesh-list
2457928|NCT00997009|Cetuximab|cetuximab|mesh-list
2457929|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2457930|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457931|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
2457932|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
2457933|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
2457934|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457935|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2457936|NCT00997022|Sorafenib|sorafenib|mesh-list
2457937|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457938|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2457939|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457940|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457941|NCT00997061|Topotecan|topotecan|mesh-list
2457942|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2457943|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2457944|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457945|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457946|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457947|NCT00997074|Ibuprofen|ibuprofen|mesh-list
2457948|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
2457949|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2457950|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2457951|NCT00997074|Analgesics|analgesics|mesh-ancestor
2457952|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
2457953|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2457954|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457955|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2457956|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2457957|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2457958|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457959|NCT00997087|Flumazenil|flumazenil|mesh-list
2457960|NCT00997087|Antidotes|antidotes|mesh-ancestor
2457961|NCT00997087|Protective Agents|protective agents|mesh-ancestor
2457962|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457963|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
2457964|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
2457965|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2457966|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2457967|NCT00997191|Triamcinolone|triamcinolone|mesh-list
2457968|NCT00997191|Bevacizumab|bevacizumab|mesh-list
2457969|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2457970|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2457971|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2457972|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2457973|NCT00997191|Growth Substances|growth substances|mesh-ancestor
2457974|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457975|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
2457976|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2457977|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
2457978|NCT00997191|Hormones|hormones|mesh-ancestor
2457979|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2457980|NCT00997269|Ubiquinone|ubiquinone|mesh-list
2457981|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
2457982|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
2457983|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457984|NCT00997269|Vitamins|vitamins|mesh-ancestor
2457985|NCT00997347|Misoprostol|misoprostol|mesh-list
2457986|NCT00997347|Mifepristone|mifepristone|mesh-list
2457987|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2457988|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
2457989|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2457990|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2457991|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2457992|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2457993|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
2457994|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
2457995|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2457996|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2457997|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2457998|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
2457999|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
2458000|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
2458001|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
2458002|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2458003|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
2458004|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2458005|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
2458006|NCT00997399|Panobinostat|panobinostat|mesh-list
2458007|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458008|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2458009|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458010|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458011|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
2458012|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2458013|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458014|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2458015|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
2458016|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2458017|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458018|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458019|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458020|NCT00997477|Budesonide|budesonide|mesh-list
2458021|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
2458022|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458023|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2458024|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
2458025|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458026|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458027|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2458028|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
2458029|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
2458030|NCT00997477|Hormones|hormones|mesh-ancestor
2458031|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2458032|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2458033|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2458034|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2458035|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
2458036|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458037|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458038|NCT00997542|Allopurinol|allopurinol|mesh-list
2458039|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
2458040|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458041|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458042|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
2458043|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2458044|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2458045|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
2458046|NCT00997542|Protective Agents|protective agents|mesh-ancestor
2458047|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458048|NCT00997581|Apremilast|apremilast|mesh-list
2458049|NCT00997581|Indomethacin|indomethacin|mesh-list
2458050|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2458051|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2458052|NCT00997581|Analgesics|analgesics|mesh-ancestor
2458053|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
2458054|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458055|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458056|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458057|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2458058|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2458059|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2458060|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458061|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458062|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
2458063|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
2458064|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2458065|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2458066|NCT00997607|Vaccines|vaccines|mesh-list
2458067|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
2458068|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458069|NCT00997659|Chromium|chromium|mesh-list
2458070|NCT00997659|Picolinic acid|picolinic acid|mesh-list
2458071|NCT00997659|Trace Elements|trace elements|mesh-ancestor
2458072|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
2458073|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458074|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2458075|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
2458076|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
2458077|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458078|NCT00997685|Capecitabine|capecitabine|mesh-list
2458079|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
2458080|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2458081|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
2458082|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458083|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458084|NCT00997711|Sirolimus|sirolimus|mesh-list
2458085|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2458086|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458087|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2458088|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458089|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
2458090|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2458091|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
2458092|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458093|NCT00997750|Lornoxicam|lornoxicam|mesh-list
2458094|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2458095|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2458096|NCT00997750|Analgesics|analgesics|mesh-ancestor
2458097|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
2458098|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458099|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458100|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458101|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2458102|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
2458103|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2458104|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2458105|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2458106|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2458107|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458108|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
2458109|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458110|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458111|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2458112|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458113|NCT00997828|Everolimus|everolimus|mesh-list
2458114|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458115|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2458116|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
2458117|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458118|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
2458119|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2458120|NCT00997880|Calcium|calcium|mesh-list
2458121|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2458122|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458123|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2458124|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2458125|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2458126|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
2458127|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458128|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2458129|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2458130|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458131|NCT00997906|Gemcitabine|gemcitabine|mesh-list
2458132|NCT00997906|Paclitaxel|paclitaxel|mesh-list
2458133|NCT00997906|Carboplatin|carboplatin|mesh-list
2458134|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2458135|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458136|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
2458137|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
2458138|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
2458139|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458140|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2458141|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
2458142|NCT00997906|Antiviral Agents|antiviral agents|mesh-ancestor
2458143|NCT00997906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458144|NCT00997906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458145|NCT00997906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2458146|NCT00997906|Immunologic Factors|immunologic factors|mesh-ancestor
2458147|NCT00997906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458148|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2458149|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
2458150|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458151|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
2458152|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2458153|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458154|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2458155|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
2458156|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2458157|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458158|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458159|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458160|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
2458161|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2458162|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2458163|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458164|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2458165|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2458166|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458167|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458168|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458169|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2458170|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
2458171|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2458172|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458173|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2458174|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2458175|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2458176|NCT00998036|Sirolimus|sirolimus|mesh-list
2458177|NCT00998036|Cisplatin|cisplatin|mesh-list
2458178|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2458179|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458180|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2458181|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458182|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458183|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2458184|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458185|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2458186|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
2458187|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2458188|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
2458189|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458190|NCT00998075|Aspirin|aspirin|mesh-list
2458191|NCT00998075|Esomeprazole|esomeprazole|mesh-list
2458192|NCT00998075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2458193|NCT00998075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2458194|NCT00998075|Analgesics|analgesics|mesh-ancestor
2458195|NCT00998075|Sensory System Agents|sensory system agents|mesh-ancestor
2458196|NCT00998075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458197|NCT00998075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458198|NCT00998075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458199|NCT00998075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2458200|NCT00998075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2458201|NCT00998075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2458202|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458203|NCT00998075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2458204|NCT00998075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2458205|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458206|NCT00998075|Antipyretics|antipyretics|mesh-ancestor
2458207|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2458208|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2458209|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2458210|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
2458211|NCT00998088|Hematinics|hematinics|mesh-ancestor
2458212|NCT00998101|Carboplatin|carboplatin|mesh-list
2458213|NCT00998101|Cetuximab|cetuximab|mesh-list
2458214|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458215|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2458216|NCT00998166|Bevacizumab|bevacizumab|mesh-list
2458217|NCT00998166|Pemetrexed|pemetrexed|mesh-list
2458218|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2458219|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458220|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2458221|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2458222|NCT00998166|Growth Substances|growth substances|mesh-ancestor
2458223|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458224|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
2458225|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458226|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458227|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2458228|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2458229|NCT00998192|Paclitaxel|paclitaxel|mesh-list
2458230|NCT00998192|Carboplatin|carboplatin|mesh-list
2458231|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2458232|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458233|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
2458234|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
2458235|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
2458236|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458237|NCT00998218|Ranolazine|ranolazine|mesh-list
2458238|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2458239|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2458240|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458241|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
2458242|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
2458243|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458244|NCT00998322|Gemcitabine|gemcitabine|mesh-list
2458245|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2458246|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
2458247|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458248|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458249|NCT00998322|Antiviral Agents|antiviral agents|mesh-ancestor
2458250|NCT00998322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458251|NCT00998322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458252|NCT00998322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2458253|NCT00998322|Immunologic Factors|immunologic factors|mesh-ancestor
2458254|NCT00998322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458255|NCT00998439|Paclitaxel|paclitaxel|mesh-list
2458256|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2458257|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458258|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
2458259|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
2458260|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
2458261|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458262|NCT00998504|Resveratrol|resveratrol|mesh-list
2458263|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
2458264|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458265|NCT00998504|Protective Agents|protective agents|mesh-ancestor
2458266|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458267|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458268|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2458269|NCT00998556|Bromocriptine|bromocriptine|mesh-list
2458270|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2458271|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2458272|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
2458273|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2458274|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458275|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
2458276|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
2458277|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458278|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458279|NCT00998608|Risperidone|risperidone|mesh-list
2458280|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2458281|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
2458282|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458283|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458284|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458285|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2458286|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2458287|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2458288|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2458289|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2458290|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
2458291|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
2458292|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
2458293|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2458294|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458295|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458296|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
2458297|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2458298|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2458299|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458300|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2458301|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2458302|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458303|NCT00998686|Incretins|incretins|mesh-ancestor
2458304|NCT00998686|Hormones|hormones|mesh-ancestor
2458305|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2458306|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2458307|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
2458308|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458309|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458310|NCT00998816|Pregabalin|pregabalin|mesh-list
2458311|NCT00998816|Analgesics|analgesics|mesh-ancestor
2458312|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
2458313|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458314|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458315|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
2458316|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2458317|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2458318|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458319|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2458320|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2458321|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2458322|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2458323|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2458324|NCT00998920|Equol|equol|mesh-list
2458325|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
2458326|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
2458327|NCT00998920|Estrogens|estrogens|mesh-ancestor
2458328|NCT00998920|Hormones|hormones|mesh-ancestor
2458329|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2458330|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458331|NCT00998933|Testosterone|testosterone|mesh-list
2458332|NCT00998933|Androgens|androgens|mesh-ancestor
2458333|NCT00998933|Hormones|hormones|mesh-ancestor
2458334|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2458335|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458336|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
2458337|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2458338|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
2458339|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458340|NCT00998972|Expectorants|expectorants|mesh-ancestor
2458341|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
2458342|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2458343|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
2458344|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458345|NCT00998972|Protective Agents|protective agents|mesh-ancestor
2458346|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458347|NCT00998972|Antidotes|antidotes|mesh-ancestor
2458348|NCT00999128|Rabeprazole|rabeprazole|mesh-list
2458349|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2458350|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2458351|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2458352|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458353|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458354|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
2458355|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2458356|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2458357|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2458358|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2458359|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458360|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
2458361|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458362|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458363|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2458364|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458365|NCT00999206|Vaccines|vaccines|mesh-list
2458366|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
2458367|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458368|NCT00999219|Zolpidem|zolpidem|mesh-list
2458369|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2458370|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2458371|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2458372|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458373|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2458374|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
2458375|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
2458376|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458377|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458378|NCT00999232|Erythromycin|erythromycin|mesh-list
2458379|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
2458380|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2458381|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
2458382|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2458383|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458384|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2458385|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2458386|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458387|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458388|NCT00999258|Sirolimus|sirolimus|mesh-list
2458389|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2458390|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458391|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2458392|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458393|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
2458394|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2458395|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
2458396|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458397|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
2458398|NCT00999271|Hormones|hormones|mesh-list
2458399|NCT00999271|Incretins|incretins|mesh-list
2458400|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2458401|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458402|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2458403|NCT00999297|Capsaicin|capsaicin|mesh-list
2458404|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
2458405|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
2458406|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
2458407|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458408|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458409|NCT00999336|Betrixaban|betrixaban|mesh-list
2458410|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2458411|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
2458412|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2458413|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
2458414|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458415|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458416|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
2458417|NCT00999349|Silymarin|silymarin|mesh-list
2458418|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
2458419|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458420|NCT00999349|Protective Agents|protective agents|mesh-ancestor
2458421|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458430|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
2458431|NCT00999427|Povidone|povidone|mesh-list
2458432|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
2458433|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
2458434|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2458435|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458436|NCT00999440|Methadone|methadone|mesh-list
2458437|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2458438|NCT00999440|Narcotics|narcotics|mesh-ancestor
2458439|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2458440|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458441|NCT00999440|Analgesics|analgesics|mesh-ancestor
2458442|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
2458443|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458444|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
2458445|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
2458446|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
2458447|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2458448|NCT00999479|Norethindrone|norethindrone|mesh-list
2458449|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
2458450|NCT00999479|Estradiol|estradiol|mesh-list
2458451|NCT00999479|Estrogens|estrogens|mesh-ancestor
2458452|NCT00999479|Hormones|hormones|mesh-ancestor
2458453|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2458454|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458455|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2458456|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
2458457|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2458458|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2458459|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2458460|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2458461|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2458462|NCT00999479|Trace Elements|trace elements|mesh-ancestor
2458463|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
2458464|NCT00999505|Amantadine|amantadine|mesh-list
2458465|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2458466|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2458467|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
2458468|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458469|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
2458470|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458471|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458472|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458473|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2458474|NCT00999505|Analgesics|analgesics|mesh-ancestor
2458475|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
2458476|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458477|NCT00999557|Bimatoprost|bimatoprost|mesh-list
2458478|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2458479|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2458480|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2458481|NCT00999700|Cisplatin|cisplatin|mesh-list
2458482|NCT00999700|Docetaxel|docetaxel|mesh-list
2458483|NCT00999700|Fluorouracil|fluorouracil|mesh-list
2458484|NCT00999700|Cetuximab|cetuximab|mesh-list
2458485|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458486|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
2458487|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
2458488|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
2458489|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458490|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
2458491|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2458492|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2458493|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
2458494|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458495|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2458496|NCT00999739|Vaccines|vaccines|mesh-list
2458497|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2458498|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
2458499|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458500|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2458501|NCT00999752|Nebivolol|nebivolol|mesh-list
2458502|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2458503|NCT00999752|Diuretics|diuretics|mesh-ancestor
2458504|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
2458505|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458506|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2458507|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2458508|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458509|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
2458510|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2458511|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2458512|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2458513|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
2458514|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458515|NCT00999791|Diclofenac|diclofenac|mesh-list
2458516|NCT00999791|Bevacizumab|bevacizumab|mesh-list
2458517|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2458518|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458519|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2458520|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2458521|NCT00999791|Growth Substances|growth substances|mesh-ancestor
2458522|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458523|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
2458524|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2458525|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2458526|NCT00999791|Analgesics|analgesics|mesh-ancestor
2458527|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
2458528|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458529|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458530|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2458531|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2458532|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458533|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458534|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
2458535|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
2458536|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
2458537|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2458538|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2458539|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458540|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458541|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458542|NCT00999843|Sorafenib|sorafenib|mesh-list
2458543|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458544|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2458545|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458546|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458547|NCT00999869|Triamcinolone|triamcinolone|mesh-list
2458548|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2458549|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2458550|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
2458551|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2458552|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2458553|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2458554|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2458555|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2458556|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458557|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
2458558|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458559|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458560|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458561|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
2458562|NCT00999869|Hormones|hormones|mesh-ancestor
2458563|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2458564|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2458565|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
2458566|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458567|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2458568|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458569|NCT00999973|Mitomycins|mitomycins|mesh-list
2458570|NCT00999973|Mitomycin|mitomycin|mesh-list
2458571|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2458572|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458573|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
2458574|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458575|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2458576|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458577|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
2458578|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2458579|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
2458580|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458581|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2458582|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2458583|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
2458584|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458585|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458586|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2458587|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2458588|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
2458589|NCT01000116|Coagulants|coagulants|mesh-ancestor
2458590|NCT01000220|Omeprazole|omeprazole|mesh-list
2458591|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2458592|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2458593|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2458594|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458595|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458596|NCT01000233|Inositol|inositol|mesh-list
2458597|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
2458598|NCT01000233|Vitamins|vitamins|mesh-ancestor
2458599|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
2458600|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458601|NCT01000298|Amoxicillin|amoxicillin|mesh-list
2458602|NCT01000298|Cefdinir|cefdinir|mesh-list
2458603|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2458604|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458605|NCT01000415|Cisplatin|cisplatin|mesh-list
2458606|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458607|NCT01000441|Adalimumab|adalimumab|mesh-list
2458608|NCT01000441|Etanercept|etanercept|mesh-list
2458609|NCT01000441|Rituximab|rituximab|mesh-list
2458610|NCT01000441|Abatacept|abatacept|mesh-list
2458611|NCT01000441|Infliximab|infliximab|mesh-list
2458612|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2458613|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458614|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
2458615|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458616|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2458617|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458618|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2458619|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2458620|NCT01000441|Analgesics|analgesics|mesh-ancestor
2458621|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
2458622|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458623|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2458624|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2458625|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
2458626|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2458627|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458628|NCT01000467|Probucol|probucol|mesh-list
2458629|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2458630|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2458631|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
2458632|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458633|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2458634|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
2458635|NCT01000467|Protective Agents|protective agents|mesh-ancestor
2458636|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458637|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
2458638|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
2458639|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2458640|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
2458641|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458642|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2458643|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2458644|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2458645|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2458646|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458647|NCT01000597|Fluticasone|fluticasone|mesh-list
2458648|NCT01000597|Xhance|xhance|mesh-list
2458649|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458650|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2458651|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
2458652|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458653|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458654|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2458655|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
2458656|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
2458657|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2458658|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2458659|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2458660|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2458661|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2458662|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458663|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458664|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458665|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2458666|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
2458667|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2458668|NCT01000688|Vildagliptin|vildagliptin|mesh-list
2458669|NCT01000688|Acarbose|acarbose|mesh-list
2458670|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2458671|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458672|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2458673|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
2458674|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458675|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458676|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2458677|NCT01000779|Propranolol|propranolol|mesh-list
2458678|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2458679|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2458680|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
2458681|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458682|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458683|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458684|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2458685|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2458686|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
2458687|NCT01000792|Cetirizine|cetirizine|mesh-list
2458688|NCT01000792|Levocetirizine|levocetirizine|mesh-list
2458689|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2458690|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2458691|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
2458692|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
2458693|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458694|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458695|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458696|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2458697|NCT01000831|Vaccines|vaccines|mesh-list
2458698|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
2458699|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458700|NCT01000857|Paroxetine|paroxetine|mesh-list
2458701|NCT01000857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2458702|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2458703|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2458704|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458705|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458706|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
2458707|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458708|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2458709|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
2458710|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2458711|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2458712|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2458713|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458714|NCT01000896|Paclitaxel|paclitaxel|mesh-list
2458715|NCT01000896|Carboplatin|carboplatin|mesh-list
2458716|NCT01000896|Saracatinib|saracatinib|mesh-list
2458717|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2458718|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458719|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
2458720|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
2458721|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
2458722|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458723|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458724|NCT01000922|Insulin|insulin|mesh-list
2458725|NCT01000922|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2458726|NCT01000922|Insulin Glargine|insulin glargine|mesh-list
2458727|NCT01000922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2458728|NCT01000922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458729|NCT01001013|Pioglitazone|pioglitazone|mesh-list
2458730|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2458731|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458732|NCT01001091|Dexamethasone|dexamethasone|mesh-list
2458733|NCT01001091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2458734|NCT01001091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2458735|NCT01001091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458736|NCT01001091|Antiemetics|antiemetics|mesh-ancestor
2458737|NCT01001091|Autonomic Agents|autonomic agents|mesh-ancestor
2458738|NCT01001091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458739|NCT01001091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458740|NCT01001091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2458741|NCT01001091|Glucocorticoids|glucocorticoids|mesh-ancestor
2458742|NCT01001091|Hormones|hormones|mesh-ancestor
2458743|NCT01001091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2458744|NCT01001091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2458745|NCT01001091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458746|NCT01001130|Fluticasone|fluticasone|mesh-list
2458747|NCT01001130|Xhance|xhance|mesh-list
2458748|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458749|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2458750|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
2458751|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458752|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458753|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2458754|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
2458755|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
2458756|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2458757|NCT01001143|Decitabine|decitabine|mesh-list
2458758|NCT01001143|Bexarotene|bexarotene|mesh-list
2458759|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2458760|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
2458761|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458762|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458763|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458764|NCT01001247|Rilpivirine|rilpivirine|mesh-list
2458765|NCT01001247|Omeprazole|omeprazole|mesh-list
2458766|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2458767|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2458768|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2458769|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458770|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458771|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2458772|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2458773|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
2458774|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458775|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2458776|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2458777|NCT01001260|Aspirin|aspirin|mesh-list
2458778|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2458779|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2458780|NCT01001260|Analgesics|analgesics|mesh-ancestor
2458781|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
2458782|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458783|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458784|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458785|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2458786|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2458787|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2458788|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458789|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2458790|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2458791|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458792|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
2458793|NCT01001338|Allopurinol|allopurinol|mesh-list
2458794|NCT01001338|Lesinurad|lesinurad|mesh-list
2458795|NCT01001338|Antimetabolites|antimetabolites|mesh-ancestor
2458796|NCT01001338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458797|NCT01001338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458798|NCT01001338|Gout Suppressants|gout suppressants|mesh-ancestor
2458799|NCT01001338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2458800|NCT01001338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2458801|NCT01001338|Antioxidants|antioxidants|mesh-ancestor
2458802|NCT01001338|Protective Agents|protective agents|mesh-ancestor
2458803|NCT01001338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458804|NCT01001338|Uricosuric Agents|uricosuric agents|mesh-ancestor
2458805|NCT01001338|Renal Agents|renal agents|mesh-ancestor
2458806|NCT01001364|Budesonide|budesonide|mesh-list
2458807|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
2458808|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458809|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2458810|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
2458811|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458812|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458813|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2458814|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
2458815|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
2458816|NCT01001364|Hormones|hormones|mesh-ancestor
2458817|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2458818|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2458819|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2458820|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2458821|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
2458822|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2458823|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458824|NCT01001585|Sevoflurane|sevoflurane|mesh-list
2458825|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2458826|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2458827|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
2458828|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
2458829|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2458830|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458831|NCT01001624|Hydroquinone|hydroquinone|mesh-list
2458832|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
2458833|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458834|NCT01001624|Protective Agents|protective agents|mesh-ancestor
2458835|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458836|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2458837|NCT01001637|Curcumin|curcumin|mesh-list
2458838|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2458839|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2458840|NCT01001637|Analgesics|analgesics|mesh-ancestor
2458841|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
2458842|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458843|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458844|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458845|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2458846|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458847|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458848|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458849|NCT01001676|Paclitaxel|paclitaxel|mesh-list
2458850|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2458851|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458852|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
2458853|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
2458854|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
2458855|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458856|NCT01001715|Fasinumab|fasinumab|mesh-list
2458857|NCT01001715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2458858|NCT01001715|Analgesics|analgesics|mesh-ancestor
2458859|NCT01001715|Sensory System Agents|sensory system agents|mesh-ancestor
2458860|NCT01001715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458861|NCT01001715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458862|NCT01001754|Ribavirin|ribavirin|mesh-list
2458863|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2458864|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
2458865|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458866|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
2458867|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458868|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
2458869|NCT01001780|Rituximab|rituximab|mesh-list
2458870|NCT01001780|Pentostatin|pentostatin|mesh-list
2458871|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2458872|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
2458873|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458874|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2458875|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2458876|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
2458877|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458878|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458879|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2458880|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2458881|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
2458882|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458883|NCT01001845|Vitamin E|vitamin e|mesh-list
2458884|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
2458885|NCT01001845|Tocopherols|tocopherols|mesh-list
2458886|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
2458887|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458888|NCT01001845|Protective Agents|protective agents|mesh-ancestor
2458889|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458890|NCT01001845|Vitamins|vitamins|mesh-ancestor
2458891|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
2458892|NCT01001871|Vitamins|vitamins|mesh-list
2458893|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
2458894|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458895|NCT01001897|Misoprostol|misoprostol|mesh-list
2458896|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2458897|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
2458898|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2458899|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458900|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2458901|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2458902|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
2458903|NCT01001923|Fasinumab|fasinumab|mesh-list
2458904|NCT01001923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2458905|NCT01001923|Analgesics|analgesics|mesh-ancestor
2458906|NCT01001923|Sensory System Agents|sensory system agents|mesh-ancestor
2458907|NCT01001923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458908|NCT01001923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458909|NCT01001962|Metformin|metformin|mesh-list
2458910|NCT01001962|Empagliflozin|empagliflozin|mesh-list
2458911|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2458912|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458913|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2458914|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458915|NCT01002079|Rifampin|rifampin|mesh-list
2458916|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2458917|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
2458918|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2458919|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458920|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
2458921|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2458922|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458923|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458924|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2458925|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2458926|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2458927|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2458928|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2458929|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2458930|NCT01002092|Endostar protein|endostar protein|mesh-list
2458931|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2458932|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2458933|NCT01002092|Growth Substances|growth substances|mesh-ancestor
2458934|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458935|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
2458936|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458937|NCT01002157|Vitamin K|vitamin k|mesh-list
2458938|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
2458939|NCT01002157|Vitamin MK 7|vitamin mk 7|mesh-list
2458940|NCT01002157|Vitamins|vitamins|mesh-ancestor
2458941|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
2458942|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458943|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2458944|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2458945|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458946|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
2458947|NCT01002157|Coagulants|coagulants|mesh-ancestor
2458948|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
2458949|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2458950|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2458951|NCT01002248|Dexamethasone|dexamethasone|mesh-list
2458952|NCT01002248|Bortezomib|bortezomib|mesh-list
2458953|NCT01002248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458954|NCT01002248|Antiemetics|antiemetics|mesh-ancestor
2458955|NCT01002248|Autonomic Agents|autonomic agents|mesh-ancestor
2458956|NCT01002248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458957|NCT01002248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458958|NCT01002248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2458959|NCT01002248|Glucocorticoids|glucocorticoids|mesh-ancestor
2458960|NCT01002248|Hormones|hormones|mesh-ancestor
2458961|NCT01002248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2458962|NCT01002248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2458963|NCT01002248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458964|NCT01002300|Oxytocin|oxytocin|mesh-list
2458965|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
2458966|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2458967|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458968|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2458969|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
2458970|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2458971|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2458972|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458973|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458974|NCT01002534|Urological Agents|urological agents|mesh-ancestor
2458975|NCT01002690|Etoricoxib|etoricoxib|mesh-list
2458976|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2458977|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2458978|NCT01002690|Analgesics|analgesics|mesh-ancestor
2458979|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
2458980|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2458981|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458982|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458983|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2458984|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2458985|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2458986|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2458987|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2458988|NCT01002703|Prednisone|prednisone|mesh-list
2458989|NCT01002703|Lenalidomide|lenalidomide|mesh-list
2458990|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2458991|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2458992|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
2458993|NCT01002703|Hormones|hormones|mesh-ancestor
2458994|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2458995|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2458996|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2458997|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2458998|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
2458999|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2459000|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2459001|NCT01002703|Growth Substances|growth substances|mesh-ancestor
2459002|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
2459003|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2459004|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
2459005|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459006|NCT01002716|Vaccines|vaccines|mesh-list
2459007|NCT01002716|Immunologic Factors|immunologic factors|mesh-ancestor
2459008|NCT01002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459009|NCT01002729|Oseltamivir|oseltamivir|mesh-list
2459010|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
2459011|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459012|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459013|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459014|NCT01002768|Insulin|insulin|mesh-list
2459015|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2459016|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
2459017|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2459018|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459019|NCT01002807|Metformin|metformin|mesh-list
2459020|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
2459021|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2459022|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459023|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2459024|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459025|NCT01002820|Ganaxolone|ganaxolone|mesh-list
2459026|NCT01002820|Neurosteroids|neurosteroids|mesh-ancestor
2459027|NCT01002820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459028|NCT01002820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459029|NCT01002820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459030|NCT01002820|GABA Modulators|gaba modulators|mesh-ancestor
2459031|NCT01002820|GABA Agents|gaba agents|mesh-ancestor
2459032|NCT01002898|Ritonavir|ritonavir|mesh-list
2459033|NCT01002898|Lopinavir|lopinavir|mesh-list
2459034|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2459035|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2459036|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
2459037|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459038|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459039|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2459040|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2459041|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
2459042|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459043|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2459044|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2459045|NCT01002911|Cefazolin|cefazolin|mesh-list
2459046|NCT01002911|Cephalexin|cephalexin|mesh-list
2459047|NCT01002911|Bacitracin|bacitracin|mesh-list
2459048|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2459049|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459050|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2459051|NCT01003002|Levodopa|levodopa|mesh-list
2459052|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2459053|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2459054|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
2459055|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459056|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459057|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459058|NCT01003028|Remifentanil|remifentanil|mesh-list
2459059|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2459060|NCT01003028|Narcotics|narcotics|mesh-ancestor
2459061|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459062|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459063|NCT01003028|Analgesics|analgesics|mesh-ancestor
2459064|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
2459065|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459066|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
2459067|NCT01003054|Busulfan|busulfan|mesh-list
2459068|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
2459069|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2459070|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
2459071|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459072|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2459073|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2459074|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
2459075|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459076|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459077|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2459078|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2459079|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459080|NCT01003158|Paclitaxel|paclitaxel|mesh-list
2459081|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2459082|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459083|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
2459084|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
2459085|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
2459086|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459087|NCT01003314|Vaccines|vaccines|mesh-list
2459088|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
2459089|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459090|NCT01003483|Orlistat|orlistat|mesh-list
2459091|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459092|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459093|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2459094|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2459095|NCT01003522|Anesthetics|anesthetics|mesh-list
2459096|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
2459097|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459098|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459099|NCT01003561|Anesthetics|anesthetics|mesh-list
2459100|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459101|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459102|NCT01003613|Tranilast|tranilast|mesh-list
2459103|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2459104|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2459105|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2459106|NCT01003613|Analgesics|analgesics|mesh-ancestor
2459107|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
2459108|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459109|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459110|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2459111|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2459112|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2459113|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2459114|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459115|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2459116|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2459117|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
2459118|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
2459119|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459120|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2459121|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2459122|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
2459123|NCT01003613|Coagulants|coagulants|mesh-ancestor
2459124|NCT01003678|Clofarabine|clofarabine|mesh-list
2459125|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2459126|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
2459127|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459128|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459129|NCT01003847|Fenofibrate|fenofibrate|mesh-list
2459130|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2459131|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
2459132|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459133|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2459134|NCT01003964|Gemcitabine|gemcitabine|mesh-list
2459135|NCT01003964|Docetaxel|docetaxel|mesh-list
2459136|NCT01003964|Irinotecan|irinotecan|mesh-list
2459137|NCT01003964|Pemetrexed|pemetrexed|mesh-list
2459138|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459139|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2459140|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
2459141|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459142|NCT01003964|Antiviral Agents|antiviral agents|mesh-ancestor
2459143|NCT01003964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459144|NCT01003964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459145|NCT01003964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2459146|NCT01003964|Immunologic Factors|immunologic factors|mesh-ancestor
2459147|NCT01003964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459148|NCT01003964|Tubulin Modulators|tubulin modulators|mesh-ancestor
2459149|NCT01003964|Antimitotic Agents|antimitotic agents|mesh-ancestor
2459150|NCT01003964|Mitosis Modulators|mitosis modulators|mesh-ancestor
2459151|NCT01003964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2459152|NCT01003964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2459153|NCT01003964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2459154|NCT01003964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2459155|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
2459156|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2459157|NCT01004068|Clomiphene|clomiphene|mesh-list
2459158|NCT01004068|Enclomiphene|enclomiphene|mesh-list
2459159|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
2459160|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2459161|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
2459162|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2459163|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459164|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2459165|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
2459166|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2459167|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2459168|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2459169|NCT01004081|Exemestane|exemestane|mesh-list
2459170|NCT01004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459171|NCT01004081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2459172|NCT01004081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2459173|NCT01004081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459174|NCT01004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459175|NCT01004081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2459176|NCT01004081|Hormone Antagonists|hormone antagonists|mesh-ancestor
2459177|NCT01004081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2459178|NCT01004081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459179|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2459180|NCT01004224|Infigratinib|infigratinib|mesh-list
2459181|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459182|NCT01004237|Valsartan|valsartan|mesh-list
2459183|NCT01004237|Pravastatin|pravastatin|mesh-list
2459184|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2459185|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2459186|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2459187|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459188|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2459189|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2459190|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
2459191|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2459192|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2459193|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459194|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2459195|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2459196|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2459197|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
2459198|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459199|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459200|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459201|NCT01004315|Urological Agents|urological agents|mesh-ancestor
2459202|NCT01004380|Carboplatin|carboplatin|mesh-list
2459203|NCT01004380|Farletuzumab|farletuzumab|mesh-list
2459204|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459205|NCT01004419|Fulvestrant|fulvestrant|mesh-list
2459206|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2459207|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459208|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2459209|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2459210|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
2459211|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2459212|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459213|NCT01004445|Amikacin|amikacin|mesh-list
2459214|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2459215|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459216|NCT01004497|Cytarabine|cytarabine|mesh-list
2459217|NCT01004497|Dexamethasone|dexamethasone|mesh-list
2459218|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
2459219|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
2459220|NCT01004497|Vincristine|vincristine|mesh-list
2459221|NCT01004497|Daunorubicin|daunorubicin|mesh-list
2459222|NCT01004497|Dasatinib|dasatinib|mesh-list
2459223|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
2459224|NCT01004497|BB 1101|bb 1101|mesh-list
2459225|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2459226|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
2459227|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459228|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2459229|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2459230|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
2459231|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459232|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459233|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2459234|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2459235|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
2459236|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
2459237|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459238|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2459239|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
2459240|NCT01004497|Hormones|hormones|mesh-ancestor
2459241|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2459242|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2459243|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
2459244|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459245|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2459246|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
2459247|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
2459248|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459249|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2459250|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
2459251|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
2459252|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
2459253|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2459254|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2459255|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2459256|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2459257|NCT01004497|Analgesics|analgesics|mesh-ancestor
2459258|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
2459259|NCT01004575|Cobalt|cobalt|mesh-list
2459260|NCT01004575|Chromium|chromium|mesh-list
2459261|NCT01004575|Trace Elements|trace elements|mesh-ancestor
2459262|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
2459263|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459264|NCT01004601|Docetaxel|docetaxel|mesh-list
2459265|NCT01004601|Pemetrexed|pemetrexed|mesh-list
2459266|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459267|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
2459268|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
2459269|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
2459270|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459271|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459272|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2459273|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2459274|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
2459275|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459276|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
2459277|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
2459278|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
2459279|NCT01004731|Gemcitabine|gemcitabine|mesh-list
2459280|NCT01004731|Carboplatin|carboplatin|mesh-list
2459281|NCT01004731|Cetuximab|cetuximab|mesh-list
2459282|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459283|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2459284|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
2459285|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459286|NCT01004731|Antiviral Agents|antiviral agents|mesh-ancestor
2459287|NCT01004731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459288|NCT01004731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459289|NCT01004731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2459290|NCT01004731|Immunologic Factors|immunologic factors|mesh-ancestor
2459291|NCT01004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459292|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2459293|NCT01004809|Dutasteride|dutasteride|mesh-list
2459294|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2459295|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2459296|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459297|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459298|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
2459299|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2459300|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459301|NCT01004900|Timolol|timolol|mesh-list
2459302|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
2459303|NCT01004900|Travoprost|travoprost|mesh-list
2459304|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2459305|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2459306|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
2459307|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459308|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459309|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459310|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2459311|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2459312|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2459313|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2459314|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2459315|NCT01004978|Cisplatin|cisplatin|mesh-list
2459316|NCT01004978|Doxorubicin|doxorubicin|mesh-list
2459317|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2459318|NCT01004978|Sorafenib|sorafenib|mesh-list
2459319|NCT01004978|Mitomycins|mitomycins|mesh-list
2459320|NCT01004978|Mitomycin|mitomycin|mesh-list
2459321|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459322|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2459323|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2459324|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2459325|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459326|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459327|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2459328|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
2459329|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2459330|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2459331|NCT01005056|Desogestrel|desogestrel|mesh-list
2459332|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2459333|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2459334|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2459335|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
2459336|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2459337|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459338|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2459339|NCT01005056|Estrogens|estrogens|mesh-ancestor
2459340|NCT01005056|Hormones|hormones|mesh-ancestor
2459341|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2459342|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2459343|NCT01005056|Progestins|progestins|mesh-ancestor
2459344|NCT01005095|Vitamin D|vitamin d|mesh-list
2459345|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
2459346|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
2459347|NCT01005095|Vitamins|vitamins|mesh-list
2459348|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
2459349|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459350|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2459351|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2459352|NCT01005108|Gabapentin|gabapentin|mesh-list
2459353|NCT01005108|Analgesics|analgesics|mesh-ancestor
2459354|NCT01005108|Sensory System Agents|sensory system agents|mesh-ancestor
2459355|NCT01005108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459356|NCT01005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459357|NCT01005108|Anticonvulsants|anticonvulsants|mesh-ancestor
2459358|NCT01005108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2459359|NCT01005108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2459360|NCT01005108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459361|NCT01005108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2459362|NCT01005108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2459363|NCT01005108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2459364|NCT01005108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459365|NCT01005108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459366|NCT01005108|Antimanic Agents|antimanic agents|mesh-ancestor
2459367|NCT01005121|Colchicine|colchicine|mesh-list
2459368|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
2459369|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2459370|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
2459371|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
2459372|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
2459373|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459374|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459375|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
2459376|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2459377|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2459378|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459379|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
2459380|NCT01005147|Coagulants|coagulants|mesh-ancestor
2459381|NCT01005160|Metformin|metformin|mesh-list
2459382|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2459383|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459384|NCT01005199|Everolimus|everolimus|mesh-list
2459385|NCT01005199|Sorafenib|sorafenib|mesh-list
2459386|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459387|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2459388|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
2459389|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459390|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2459391|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459392|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459393|NCT01005238|Lamivudine|lamivudine|mesh-list
2459394|NCT01005238|Telbivudine|telbivudine|mesh-list
2459395|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2459396|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2459397|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459398|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459399|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
2459400|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459401|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2459402|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2459403|NCT01005303|Vitamin D|vitamin d|mesh-list
2459404|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
2459405|NCT01005303|Vitamins|vitamins|mesh-ancestor
2459406|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
2459407|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459408|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2459409|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2459410|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
2459411|NCT01005381|Vitamin D|vitamin d|mesh-list
2459412|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
2459413|NCT01005381|Calcium|calcium|mesh-list
2459414|NCT01005381|Vitamins|vitamins|mesh-ancestor
2459415|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
2459416|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459417|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2459418|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2459419|NCT01005381|Antacids|antacids|mesh-ancestor
2459420|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459421|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2459422|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
2459423|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2459424|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459425|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459426|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2459427|NCT01005433|Analgesics|analgesics|mesh-ancestor
2459428|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
2459429|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459430|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2459431|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2459432|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2459433|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
2459434|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459435|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459436|NCT01005472|Temozolomide|temozolomide|mesh-list
2459437|NCT01005472|Sunitinib|sunitinib|mesh-list
2459438|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2459439|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
2459440|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459441|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459442|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2459443|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2459444|NCT01005472|Growth Substances|growth substances|mesh-ancestor
2459445|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459446|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
2459447|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2459448|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459449|NCT01005537|Aldesleukin|aldesleukin|mesh-list
2459450|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
2459451|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2459452|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
2459453|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459454|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2459455|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2459456|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
2459457|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459458|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459459|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2459460|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2459461|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2459462|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
2459463|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459464|NCT01005550|Ropivacaine|ropivacaine|mesh-list
2459465|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
2459466|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
2459467|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459468|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459469|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
2459470|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459471|NCT01005628|Bortezomib|bortezomib|mesh-list
2459472|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459473|NCT01005641|Lapatinib|lapatinib|mesh-list
2459474|NCT01005641|Exemestane|exemestane|mesh-list
2459475|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459476|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2459477|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459478|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459479|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2459480|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2459481|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2459482|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
2459483|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2459484|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459485|NCT01005758|Cytarabine|cytarabine|mesh-list
2459486|NCT01005758|Dexamethasone|dexamethasone|mesh-list
2459487|NCT01005758|Prednisone|prednisone|mesh-list
2459488|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
2459489|NCT01005758|Prednisolone|prednisolone|mesh-list
2459490|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
2459491|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2459492|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2459493|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2459494|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
2459495|NCT01005758|Doxorubicin|doxorubicin|mesh-list
2459496|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2459497|NCT01005758|Methotrexate|methotrexate|mesh-list
2459498|NCT01005758|Etoposide|etoposide|mesh-list
2459499|NCT01005758|Vincristine|vincristine|mesh-list
2459500|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
2459501|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
2459502|NCT01005758|Pegaspargase|pegaspargase|mesh-list
2459503|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
2459504|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2459505|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
2459506|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459507|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2459508|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2459509|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
2459510|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459511|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459512|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2459513|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2459514|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
2459515|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
2459516|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459517|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2459518|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
2459519|NCT01005758|Hormones|hormones|mesh-ancestor
2459520|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2459521|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2459522|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2459523|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2459524|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2459525|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459526|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2459527|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
2459528|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2459529|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2459530|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
2459531|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
2459532|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2459533|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2459534|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2459535|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
2459536|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459537|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
2459538|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
2459539|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
2459540|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2459541|NCT01005758|Protective Agents|protective agents|mesh-ancestor
2459542|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2459543|NCT01005784|Cetrorelix|cetrorelix|mesh-list
2459544|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2459545|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
2459546|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2459547|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459548|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
2459549|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2459550|NCT01005797|Sorafenib|sorafenib|mesh-list
2459551|NCT01005797|Panobinostat|panobinostat|mesh-list
2459552|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459553|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2459554|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459555|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459556|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2459557|NCT01005927|Calcium|calcium|mesh-list
2459558|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2459559|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459560|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
2459561|NCT01005979|Rituximab|rituximab|mesh-list
2459562|NCT01005979|Lenalidomide|lenalidomide|mesh-list
2459563|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2459564|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
2459565|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459566|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2459567|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2459568|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
2459569|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459570|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459571|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2459572|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2459573|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2459574|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2459575|NCT01005979|Growth Substances|growth substances|mesh-ancestor
2459576|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
2459577|NCT01006031|Interferons|interferons|mesh-list
2459578|NCT01006031|Ribavirin|ribavirin|mesh-list
2459579|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
2459580|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
2459581|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2459582|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459583|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
2459584|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459585|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
2459586|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459587|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
2459588|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459589|NCT01006057|Insulin|insulin|mesh-list
2459590|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2459591|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
2459592|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2459593|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459594|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2459595|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459596|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2459597|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459598|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459599|NCT01006187|Lidocaine|lidocaine|mesh-list
2459600|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
2459601|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
2459602|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459603|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459604|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
2459605|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459606|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2459607|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2459608|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2459609|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2459610|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459611|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
2459612|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2459613|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459614|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
2459615|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2459616|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459617|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459618|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2459619|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2459620|NCT01006499|Protective Agents|protective agents|mesh-ancestor
2459621|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459622|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
2459623|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2459624|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
2459625|NCT01006525|Zolpidem|zolpidem|mesh-list
2459626|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2459627|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2459628|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459629|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459630|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2459631|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
2459632|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
2459633|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459634|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459635|NCT01006551|Ziprasidone|ziprasidone|mesh-list
2459636|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2459637|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
2459638|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459639|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459640|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459641|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2459642|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2459643|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459644|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2459645|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2459646|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
2459647|NCT01006668|Propofol|propofol|mesh-list
2459648|NCT01006668|Sevoflurane|sevoflurane|mesh-list
2459649|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2459650|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459651|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459652|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2459653|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
2459654|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
2459655|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2459656|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2459657|NCT01006681|Vaccines|vaccines|mesh-list
2459658|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
2459659|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
2459660|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459661|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2459662|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
2459663|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2459664|NCT01006720|Neostigmine|neostigmine|mesh-list
2459665|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2459666|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459667|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459668|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
2459669|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459670|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459671|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2459672|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
2459673|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459674|NCT01006798|Vaccines|vaccines|mesh-list
2459675|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
2459676|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459677|NCT01006863|Phenylephrine|phenylephrine|mesh-list
2459678|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
2459679|NCT01006863|Ephedrine|ephedrine|mesh-list
2459680|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2459681|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
2459682|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
2459683|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459684|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459685|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
2459686|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2459687|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
2459688|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
2459689|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2459690|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2459691|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2459692|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
2459693|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459694|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459695|NCT01006863|Protective Agents|protective agents|mesh-ancestor
2459696|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2459697|NCT01006876|Warfarin|warfarin|mesh-list
2459698|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
2459699|NCT01007019|Esomeprazole|esomeprazole|mesh-list
2459700|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2459701|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2459702|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2459703|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459704|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459705|NCT01007084|Propranolol|propranolol|mesh-list
2459706|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2459707|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2459708|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
2459709|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459710|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459711|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459712|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2459713|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2459714|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
2459715|NCT01007097|Glimepiride|glimepiride|mesh-list
2459716|NCT01007097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2459717|NCT01007097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2459718|NCT01007097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459719|NCT01007097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2459720|NCT01007097|Immunologic Factors|immunologic factors|mesh-ancestor
2459721|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2459722|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2459723|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2459724|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
2459725|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459726|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2459727|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2459728|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459729|NCT01007292|Rituximab|rituximab|mesh-list
2459730|NCT01007292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2459731|NCT01007292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459732|NCT01007292|Immunologic Factors|immunologic factors|mesh-ancestor
2459733|NCT01007292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459734|NCT01007292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2459735|NCT01007500|Dexamethasone|dexamethasone|mesh-list
2459736|NCT01007500|Ondansetron|ondansetron|mesh-list
2459737|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2459738|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
2459739|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
2459740|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459741|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459742|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2459743|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
2459744|NCT01007500|Hormones|hormones|mesh-ancestor
2459745|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2459746|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2459747|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459748|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
2459749|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
2459750|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2459751|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
2459752|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459753|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459754|NCT01007500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2459755|NCT01007500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2459756|NCT01007500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459757|NCT01007500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2459758|NCT01007500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2459759|NCT01007539|Choline|choline|mesh-list
2459760|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
2459761|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
2459762|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2459763|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
2459764|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459765|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2459766|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2459767|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
2459768|NCT01007565|Anesthetics|anesthetics|mesh-list
2459769|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459770|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459771|NCT01007578|Paclitaxel|paclitaxel|mesh-list
2459772|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2459773|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459774|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
2459775|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
2459776|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
2459777|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459778|NCT01007630|Rasagiline|rasagiline|mesh-list
2459779|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2459780|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459781|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459782|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2459783|NCT01007630|Protective Agents|protective agents|mesh-ancestor
2459784|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459785|NCT01007695|Valproic Acid|valproic acid|mesh-list
2459786|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
2459787|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459788|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459789|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
2459790|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459791|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459792|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
2459793|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2459794|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459795|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2459796|NCT01007721|Fluticasone|fluticasone|mesh-list
2459797|NCT01007721|Xhance|xhance|mesh-list
2459798|NCT01007721|Montelukast|montelukast|mesh-list
2459799|NCT01007721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2459800|NCT01007721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2459801|NCT01007721|Autonomic Agents|autonomic agents|mesh-ancestor
2459802|NCT01007721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459803|NCT01007721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459804|NCT01007721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2459805|NCT01007721|Respiratory System Agents|respiratory system agents|mesh-ancestor
2459806|NCT01007721|Dermatologic Agents|dermatologic agents|mesh-ancestor
2459807|NCT01007721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2459808|NCT01007721|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2459809|NCT01007721|Hormone Antagonists|hormone antagonists|mesh-ancestor
2459810|NCT01007721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2459811|NCT01007721|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2459812|NCT01007721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2459813|NCT01007721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459814|NCT01007773|Fentanyl|fentanyl|mesh-list
2459815|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
2459816|NCT01007773|Propofol|propofol|mesh-list
2459817|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2459818|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2459819|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459820|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2459821|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
2459822|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
2459823|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2459824|NCT01007773|Analgesics|analgesics|mesh-ancestor
2459825|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
2459826|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459827|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2459828|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2459829|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2459830|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
2459831|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459832|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459833|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2459834|NCT01007773|Narcotics|narcotics|mesh-ancestor
2459835|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2459836|NCT01007799|Vitamin D|vitamin d|mesh-list
2459837|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
2459838|NCT01007799|Vitamins|vitamins|mesh-list
2459839|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
2459840|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459841|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2459842|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2459843|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
2459844|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
2459845|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2459846|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
2459847|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2459848|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459849|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2459850|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2459851|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459852|NCT01007864|Pramipexole|pramipexole|mesh-list
2459853|NCT01007864|Ropinirole|ropinirole|mesh-list
2459854|NCT01007864|Piribedil|piribedil|mesh-list
2459855|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
2459856|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459857|NCT01007864|Protective Agents|protective agents|mesh-ancestor
2459858|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459859|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2459860|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2459861|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
2459862|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
2459863|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459864|NCT01007968|Panobinostat|panobinostat|mesh-list
2459865|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459866|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2459867|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459868|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459869|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2459870|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
2459871|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459872|NCT01008020|Protective Agents|protective agents|mesh-ancestor
2459873|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459874|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2459875|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2459876|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459877|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2459878|NCT01008046|Metformin|metformin|mesh-list
2459879|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
2459880|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2459881|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2459882|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459883|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
2459884|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459885|NCT01008046|Expectorants|expectorants|mesh-ancestor
2459886|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
2459887|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2459888|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
2459889|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459890|NCT01008046|Protective Agents|protective agents|mesh-ancestor
2459891|NCT01008046|Antidotes|antidotes|mesh-ancestor
2459892|NCT01008098|Citalopram|citalopram|mesh-list
2459893|NCT01008098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2459894|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2459895|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2459896|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459897|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459898|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
2459899|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459900|NCT01008098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2459901|NCT01008098|Antidepressive Agents|antidepressive agents|mesh-ancestor
2459902|NCT01008098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2459903|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
2459904|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2459905|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459906|NCT01008137|Vaccines|vaccines|mesh-list
2459907|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
2459908|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459909|NCT01008293|Lactulose|lactulose|mesh-list
2459910|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2459911|NCT01008345|Ezetimibe|ezetimibe|mesh-list
2459912|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2459913|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2459914|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
2459915|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459916|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2459917|NCT01008358|Tremelimumab|tremelimumab|mesh-list
2459918|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459919|NCT01008384|Vitamin D|vitamin d|mesh-list
2459920|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
2459921|NCT01008384|Vitamins|vitamins|mesh-ancestor
2459922|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
2459923|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459924|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2459925|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2459926|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2459927|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459928|NCT01008527|Poly ICLC|poly iclc|mesh-list
2459929|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
2459930|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
2459931|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459932|NCT01008566|Sorafenib|sorafenib|mesh-list
2459933|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2459934|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459935|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2459936|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459937|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459938|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
2459939|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459940|NCT01008592|Levocetirizine|levocetirizine|mesh-list
2459941|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2459942|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2459943|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
2459944|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
2459945|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459946|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459947|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459948|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
2459949|NCT01008631|Antidotes|antidotes|mesh-ancestor
2459950|NCT01008631|Protective Agents|protective agents|mesh-ancestor
2459951|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459952|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
2459953|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459954|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
2459955|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2459956|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459957|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
2459958|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
2459959|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2459960|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2459961|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
2459962|NCT01008709|Hormones|hormones|mesh-ancestor
2459963|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2459964|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459965|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2459966|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459967|NCT01008761|Azithromycin|azithromycin|mesh-list
2459968|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2459969|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459970|NCT01008813|Vaccines|vaccines|mesh-list
2459971|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
2459972|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459973|NCT01008917|Sirolimus|sirolimus|mesh-list
2459974|NCT01008917|Sorafenib|sorafenib|mesh-list
2459975|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2459976|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2459977|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2459978|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2459979|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2459980|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2459981|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2459982|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
2459983|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2459984|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
2459985|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459986|NCT01008982|Belimumab|belimumab|mesh-list
2459987|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2459988|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
2459989|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459990|NCT01009021|Diclofenac|diclofenac|mesh-list
2459991|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2459992|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2459993|NCT01009021|Analgesics|analgesics|mesh-ancestor
2459994|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
2459995|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2459996|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2459997|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2459998|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2459999|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2460000|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460001|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460002|NCT01009073|Irinotecan|irinotecan|mesh-list
2460003|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2460004|NCT01009073|Navitoclax|navitoclax|mesh-list
2460005|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2460006|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2460007|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460008|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460009|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460010|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2460011|NCT01009177|Bosentan|bosentan|mesh-list
2460012|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2460013|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2460014|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460015|NCT01009190|Carboplatin|carboplatin|mesh-list
2460016|NCT01009190|Rucaparib|rucaparib|mesh-list
2460017|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460018|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2460019|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460020|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460021|NCT01009242|Methotrexate|methotrexate|mesh-list
2460022|NCT01009242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2460023|NCT01009242|Abortifacient Agents|abortifacient agents|mesh-ancestor
2460024|NCT01009242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2460025|NCT01009242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460026|NCT01009242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2460027|NCT01009242|Antimetabolites|antimetabolites|mesh-ancestor
2460028|NCT01009242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460029|NCT01009242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460030|NCT01009242|Dermatologic Agents|dermatologic agents|mesh-ancestor
2460031|NCT01009242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460032|NCT01009242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2460033|NCT01009242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2460034|NCT01009242|Immunologic Factors|immunologic factors|mesh-ancestor
2460035|NCT01009242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2460036|NCT01009242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2460037|NCT01009437|Ritonavir|ritonavir|mesh-list
2460038|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2460039|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2460040|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
2460041|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460042|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460043|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2460044|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2460045|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
2460046|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460047|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2460048|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2460049|NCT01009476|Nicergoline|nicergoline|mesh-list
2460050|NCT01009476|Piracetam|piracetam|mesh-list
2460051|NCT01009476|Galantamine|galantamine|mesh-list
2460052|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
2460053|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2460054|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460055|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460056|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
2460057|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460058|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460059|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2460060|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
2460061|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460062|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2460063|NCT01009476|Protective Agents|protective agents|mesh-ancestor
2460064|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2460065|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2460066|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
2460067|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
2460068|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
2460069|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2460070|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2460071|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460072|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
2460073|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2460074|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
2460075|NCT01009541|Pregabalin|pregabalin|mesh-list
2460076|NCT01009541|Analgesics|analgesics|mesh-ancestor
2460077|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
2460078|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460079|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460080|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
2460081|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2460082|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2460083|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460084|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2460085|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2460086|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2460087|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2460088|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2460089|NCT01009567|Cabergoline|cabergoline|mesh-list
2460090|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2460091|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2460092|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
2460093|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
2460094|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460095|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460096|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460097|NCT01009593|Sorafenib|sorafenib|mesh-list
2460098|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460099|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2460100|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460101|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460102|NCT01009697|Codeine|codeine|mesh-list
2460103|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2460104|NCT01009697|Narcotics|narcotics|mesh-ancestor
2460105|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2460106|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460107|NCT01009697|Analgesics|analgesics|mesh-ancestor
2460108|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
2460109|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460110|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
2460111|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
2460112|NCT01009775|Docetaxel|docetaxel|mesh-list
2460113|NCT01009775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460114|NCT01009775|Tubulin Modulators|tubulin modulators|mesh-ancestor
2460115|NCT01009775|Antimitotic Agents|antimitotic agents|mesh-ancestor
2460116|NCT01009775|Mitosis Modulators|mitosis modulators|mesh-ancestor
2460117|NCT01009775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460118|NCT01009788|Temozolomide|temozolomide|mesh-list
2460119|NCT01009788|Veliparib|veliparib|mesh-list
2460120|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2460121|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
2460122|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460123|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460124|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2460125|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460126|NCT01009801|Doxorubicin|doxorubicin|mesh-list
2460127|NCT01009801|Everolimus|everolimus|mesh-list
2460128|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2460129|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460130|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2460131|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2460132|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460133|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460134|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2460135|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
2460136|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460137|NCT01009853|Codeine|codeine|mesh-list
2460138|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2460139|NCT01009853|Narcotics|narcotics|mesh-ancestor
2460140|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2460141|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460142|NCT01009853|Analgesics|analgesics|mesh-ancestor
2460143|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
2460144|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460145|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
2460146|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
2460147|NCT01009879|Etanercept|etanercept|mesh-list
2460148|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2460149|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2460150|NCT01009879|Analgesics|analgesics|mesh-ancestor
2460151|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
2460152|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460153|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460154|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2460155|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2460156|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2460157|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2460158|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
2460159|NCT01009892|Codeine|codeine|mesh-list
2460160|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2460161|NCT01009892|Narcotics|narcotics|mesh-ancestor
2460162|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2460163|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460164|NCT01009892|Analgesics|analgesics|mesh-ancestor
2460165|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
2460166|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460167|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
2460168|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
2460169|NCT01009944|Atenolol|atenolol|mesh-list
2460170|NCT01009944|Lisinopril|lisinopril|mesh-list
2460171|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2460172|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
2460173|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460174|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460175|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2460176|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2460177|NCT01009944|Protective Agents|protective agents|mesh-ancestor
2460178|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460179|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2460180|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
2460181|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
2460182|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460183|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2460184|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2460185|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2460186|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
2460187|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460188|NCT01009957|Everolimus|everolimus|mesh-list
2460189|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460190|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2460191|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
2460192|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460193|NCT01009970|Prednisone|prednisone|mesh-list
2460194|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
2460195|NCT01009970|Rituximab|rituximab|mesh-list
2460196|NCT01009970|Doxorubicin|doxorubicin|mesh-list
2460197|NCT01009970|Vincristine|vincristine|mesh-list
2460198|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2460199|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
2460200|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460201|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2460202|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2460203|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
2460204|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460205|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460206|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2460207|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2460208|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2460209|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2460210|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2460211|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460212|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2460213|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
2460214|NCT01009970|Hormones|hormones|mesh-ancestor
2460215|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2460216|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2460217|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2460218|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
2460219|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
2460220|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
2460221|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
2460222|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
2460223|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
2460224|NCT01010048|Nifedipine|nifedipine|mesh-list
2460225|NCT01010048|Bromides|bromides|mesh-list
2460226|NCT01010048|Propantheline|propantheline|mesh-list
2460227|NCT01010048|Tamsulosin|tamsulosin|mesh-list
2460228|NCT01010048|Progesterone|progesterone|mesh-list
2460229|NCT01010048|Progestins|progestins|mesh-ancestor
2460230|NCT01010048|Hormones|hormones|mesh-ancestor
2460231|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2460232|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460233|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
2460234|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2460235|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2460236|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2460237|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
2460238|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460239|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460240|NCT01010048|Urological Agents|urological agents|mesh-ancestor
2460241|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2460242|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2460243|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2460244|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
2460245|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
2460246|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2460247|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2460248|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2460249|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2460250|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2460251|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
2460252|NCT01010087|Oseltamivir|oseltamivir|mesh-list
2460253|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
2460254|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460255|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460256|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460257|NCT01010100|Acarbose|acarbose|mesh-list
2460258|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2460259|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460260|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460261|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2460262|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460263|NCT01010139|Codeine|codeine|mesh-list
2460264|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2460265|NCT01010139|Narcotics|narcotics|mesh-ancestor
2460266|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2460267|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460268|NCT01010139|Analgesics|analgesics|mesh-ancestor
2460269|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
2460270|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460271|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
2460272|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
2460273|NCT01010152|Codeine|codeine|mesh-list
2460274|NCT01010152|Analgesics|analgesics|mesh-ancestor
2460275|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
2460276|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460277|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460278|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2460279|NCT01010152|Narcotics|narcotics|mesh-ancestor
2460280|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2460281|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
2460282|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
2460283|NCT01010178|Theophylline|theophylline|mesh-list
2460284|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2460285|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
2460286|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460287|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460288|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2460289|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
2460290|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2460291|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460292|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460293|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
2460294|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2460295|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2460296|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
2460297|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460298|NCT01010243|Pioglitazone|pioglitazone|mesh-list
2460299|NCT01010243|Dexamethasone|dexamethasone|mesh-list
2460300|NCT01010243|Lenalidomide|lenalidomide|mesh-list
2460301|NCT01010243|Treosulfan|treosulfan|mesh-list
2460302|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2460303|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
2460304|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
2460305|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460306|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460307|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2460308|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
2460309|NCT01010243|Hormones|hormones|mesh-ancestor
2460310|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2460311|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2460312|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460313|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
2460314|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2460315|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2460316|NCT01010243|Growth Substances|growth substances|mesh-ancestor
2460317|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
2460318|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2460319|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2460320|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
2460321|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460322|NCT01010295|Doxycycline|doxycycline|mesh-list
2460323|NCT01010295|Tetracycline|tetracycline|mesh-list
2460324|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2460325|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460326|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
2460327|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2460328|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2460329|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2460330|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460331|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460332|NCT01010308|Nadolol|nadolol|mesh-list
2460333|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2460334|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2460335|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
2460336|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460337|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460338|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460339|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2460340|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2460341|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
2460342|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
2460343|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460344|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
2460345|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2460346|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
2460347|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460348|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460349|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2460350|NCT01010373|Protective Agents|protective agents|mesh-ancestor
2460351|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2460352|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2460353|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460354|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460355|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
2460356|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460357|NCT01010425|Hormones|hormones|mesh-list
2460358|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2460359|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460360|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
2460361|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2460362|NCT01010451|Calcium|calcium|mesh-list
2460363|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2460364|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460365|NCT01010490|Dipivefrin|dipivefrin|mesh-list
2460366|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2460367|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
2460368|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460369|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460370|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460371|NCT01010516|Niacin|niacin|mesh-list
2460372|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2460373|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
2460374|NCT01010516|Fenofibrate|fenofibrate|mesh-list
2460375|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2460376|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2460377|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
2460378|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460379|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2460380|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460381|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
2460382|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
2460383|NCT01010516|Vitamins|vitamins|mesh-ancestor
2460384|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
2460385|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460386|NCT01010581|Folic Acid|folic acid|mesh-list
2460387|NCT01010581|Methotrexate|methotrexate|mesh-list
2460388|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2460389|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
2460390|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2460391|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460392|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2460393|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
2460394|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460395|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460396|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
2460397|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460398|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2460399|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2460400|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
2460401|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2460402|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2460403|NCT01010581|Hematinics|hematinics|mesh-ancestor
2460404|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
2460405|NCT01010581|Vitamins|vitamins|mesh-ancestor
2460406|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
2460407|NCT01010646|Ribavirin|ribavirin|mesh-list
2460408|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
2460409|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
2460410|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
2460411|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
2460412|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460413|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
2460414|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460415|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
2460416|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460417|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460418|NCT01010672|Sirolimus|sirolimus|mesh-list
2460419|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2460420|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460421|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2460422|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460423|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
2460424|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2460425|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
2460426|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460427|NCT01010698|Acyclovir|acyclovir|mesh-list
2460428|NCT01010698|Cimetidine|cimetidine|mesh-list
2460429|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
2460430|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460431|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2460432|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2460433|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2460434|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
2460435|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
2460436|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460437|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460438|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460439|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2460440|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2460441|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460442|NCT01010789|Modafinil|modafinil|mesh-list
2460443|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2460444|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460445|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2460446|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2460447|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2460448|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460449|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
2460450|NCT01010802|Hematinics|hematinics|mesh-ancestor
2460451|NCT01010893|Vaccines|vaccines|mesh-list
2460452|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
2460453|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460454|NCT01010945|Gemcitabine|gemcitabine|mesh-list
2460455|NCT01010945|Paclitaxel|paclitaxel|mesh-list
2460456|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2460457|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2460458|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460459|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
2460460|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
2460461|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
2460462|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460463|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2460464|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
2460465|NCT01010945|Antiviral Agents|antiviral agents|mesh-ancestor
2460466|NCT01010945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460467|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460468|NCT01010945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2460469|NCT01010945|Immunologic Factors|immunologic factors|mesh-ancestor
2460470|NCT01010945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460471|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2460472|NCT01010958|Valproic Acid|valproic acid|mesh-list
2460473|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
2460474|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460475|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460476|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
2460477|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460478|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460479|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
2460480|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2460481|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2460482|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2460483|NCT01011010|Doxorubicin|doxorubicin|mesh-list
2460484|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2460485|NCT01011010|Mitomycins|mitomycins|mesh-list
2460486|NCT01011010|Mitomycin|mitomycin|mesh-list
2460487|NCT01011010|Sorafenib|sorafenib|mesh-list
2460488|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2460489|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460490|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2460491|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2460492|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460493|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460494|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2460495|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
2460496|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2460497|NCT01011036|Clonazepam|clonazepam|mesh-list
2460498|NCT01011036|Clobazam|clobazam|mesh-list
2460499|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2460500|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2460501|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2460502|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
2460503|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460504|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460505|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460506|NCT01011036|Urological Agents|urological agents|mesh-ancestor
2460507|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
2460508|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
2460509|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
2460510|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2460511|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2460512|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2460513|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2460514|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2460515|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
2460516|NCT01011062|Losartan|losartan|mesh-list
2460517|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2460518|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2460519|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2460520|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2460521|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460522|NCT01011114|Cinacalcet|cinacalcet|mesh-list
2460523|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2460524|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460525|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2460526|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
2460527|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2460528|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2460529|NCT01011127|Pravastatin|pravastatin|mesh-list
2460530|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2460531|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2460532|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
2460533|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460534|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2460535|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2460536|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460537|NCT01011166|Ribavirin|ribavirin|mesh-list
2460538|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2460539|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
2460540|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460541|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
2460542|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460543|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
2460544|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
2460545|NCT01011205|Tacrolimus|tacrolimus|mesh-list
2460546|NCT01011205|Basiliximab|basiliximab|mesh-list
2460547|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2460548|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
2460549|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460550|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2460551|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460552|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460553|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2460554|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460555|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2460556|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
2460557|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2460558|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460559|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2460560|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
2460561|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
2460562|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460563|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2460564|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
2460565|NCT01011205|Hormones|hormones|mesh-ancestor
2460566|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2460567|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2460568|NCT01011205|Protective Agents|protective agents|mesh-ancestor
2460569|NCT01011257|Clopidogrel|clopidogrel|mesh-list
2460570|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2460571|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2460572|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2460573|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2460574|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
2460575|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460576|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460577|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460578|NCT01011348|Ubiquinone|ubiquinone|mesh-list
2460579|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
2460580|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
2460581|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460582|NCT01011348|Vitamins|vitamins|mesh-ancestor
2460583|NCT01011374|Ranibizumab|ranibizumab|mesh-list
2460584|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2460585|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2460586|NCT01011374|Growth Substances|growth substances|mesh-ancestor
2460587|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460588|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
2460589|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460590|NCT01011426|Bisacodyl|bisacodyl|mesh-list
2460591|NCT01011426|Cathartics|cathartics|mesh-ancestor
2460592|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2460593|NCT01011426|Laxatives|laxatives|mesh-ancestor
2460594|NCT01011452|Montelukast|montelukast|mesh-list
2460595|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2460596|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
2460597|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2460598|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
2460599|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2460600|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460601|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2460602|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2460603|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460604|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2460605|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2460606|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2460607|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
2460608|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460609|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2460610|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2460611|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460612|NCT01011530|Pevonedistat|pevonedistat|mesh-list
2460613|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460614|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460615|NCT01011621|Prednisolone|prednisolone|mesh-list
2460616|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2460617|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
2460618|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2460619|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
2460620|NCT01011621|Betamethasone|betamethasone|mesh-list
2460621|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
2460622|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2460623|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
2460624|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2460625|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
2460626|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2460627|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2460628|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
2460629|NCT01011621|Hormones|hormones|mesh-ancestor
2460630|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2460631|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460632|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2460633|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460634|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
2460635|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
2460636|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460637|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2460638|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2460639|NCT01011621|Protective Agents|protective agents|mesh-ancestor
2460640|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2460641|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
2460642|NCT01011660|Amlodipine|amlodipine|mesh-list
2460643|NCT01011660|Telmisartan|telmisartan|mesh-list
2460644|NCT01011660|Amiloride|amiloride|mesh-list
2460645|NCT01011660|Simvastatin|simvastatin|mesh-list
2460646|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2460647|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2460648|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2460649|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460650|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2460651|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460652|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
2460653|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2460654|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2460655|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
2460656|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2460657|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2460658|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460659|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2460660|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2460661|NCT01011660|Diuretics|diuretics|mesh-ancestor
2460662|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
2460663|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
2460664|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2460665|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
2460666|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2460667|NCT01011699|Niacinamide|niacinamide|mesh-list
2460668|NCT01011699|Niacin|niacin|mesh-list
2460669|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
2460670|NCT01011699|Sevelamer|sevelamer|mesh-list
2460671|NCT01011699|Cinacalcet|cinacalcet|mesh-list
2460672|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
2460673|NCT01011699|Vitamins|vitamins|mesh-ancestor
2460674|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
2460675|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460676|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2460677|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
2460678|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460679|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2460680|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
2460681|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
2460682|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
2460683|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2460684|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
2460685|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
2460686|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2460687|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2460688|NCT01011751|Leuprolide|leuprolide|mesh-list
2460689|NCT01011751|Flutamide|flutamide|mesh-list
2460690|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
2460691|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2460692|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
2460693|NCT01011751|Cyproterone|cyproterone|mesh-list
2460694|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2460695|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2460696|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2460697|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460698|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460699|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460700|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2460701|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
2460702|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2460703|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2460704|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2460705|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2460706|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
2460707|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2460708|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2460709|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2460710|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2460711|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2460712|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460713|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2460714|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
2460715|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
2460716|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
2460717|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2460718|NCT01011920|Cytarabine|cytarabine|mesh-list
2460719|NCT01011920|Rituximab|rituximab|mesh-list
2460720|NCT01011920|Methotrexate|methotrexate|mesh-list
2460721|NCT01011920|Thiotepa|thiotepa|mesh-list
2460722|NCT01011920|Carmustine|carmustine|mesh-list
2460723|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2460724|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460725|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
2460726|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460727|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2460728|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2460729|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
2460730|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2460731|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2460732|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
2460733|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460734|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
2460735|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460736|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2460737|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2460738|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2460739|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
2460740|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460741|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2460742|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
2460743|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2460744|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
2460745|NCT01011998|Valproic Acid|valproic acid|mesh-list
2460746|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460747|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2460748|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460749|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460750|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
2460751|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
2460752|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460753|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460754|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
2460755|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2460756|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2460757|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2460758|NCT01012011|Sorafenib|sorafenib|mesh-list
2460759|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460760|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2460761|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460762|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460763|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
2460764|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2460765|NCT01012063|Hematinics|hematinics|mesh-ancestor
2460766|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
2460767|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2460768|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
2460769|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460770|NCT01012141|Docetaxel|docetaxel|mesh-list
2460771|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460772|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
2460773|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
2460774|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
2460775|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460776|NCT01012193|Cilostazol|cilostazol|mesh-list
2460777|NCT01012193|Clopidogrel|clopidogrel|mesh-list
2460778|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2460779|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2460780|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2460781|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2460782|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
2460783|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460784|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460785|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460786|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2460787|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
2460788|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460789|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2460790|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
2460791|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2460792|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2460793|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
2460794|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2460795|NCT01012193|Protective Agents|protective agents|mesh-ancestor
2460796|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2460797|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2460798|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460799|NCT01012232|Ropivacaine|ropivacaine|mesh-list
2460800|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
2460801|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
2460802|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2460803|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460804|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
2460805|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460806|NCT01012284|Bedaquiline|bedaquiline|mesh-list
2460807|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
2460808|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2460809|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460810|NCT01012349|Aspirin|aspirin|mesh-list
2460811|NCT01012349|Citric Acid|citric acid|mesh-list
2460812|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
2460813|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2460814|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2460815|NCT01012349|Analgesics|analgesics|mesh-ancestor
2460816|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
2460817|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460818|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460819|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2460820|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2460821|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2460822|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2460823|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460824|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2460825|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2460826|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460827|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
2460828|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
2460829|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2460830|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
2460831|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
2460832|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2460833|NCT01012479|Candesartan|candesartan|mesh-list
2460834|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
2460835|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2460836|NCT01012479|Diuretics|diuretics|mesh-ancestor
2460837|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
2460838|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460839|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2460840|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2460841|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460842|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2460843|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2460844|NCT01012544|Clopidogrel|clopidogrel|mesh-list
2460845|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2460846|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2460847|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2460848|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2460849|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
2460850|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460851|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460852|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460853|NCT01012570|Adalimumab|adalimumab|mesh-list
2460854|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2460855|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2460856|NCT01012687|Perindopril|perindopril|mesh-list
2460857|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2460858|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
2460859|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460860|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460861|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2460862|NCT01012700|Poly ICLC|poly iclc|mesh-list
2460863|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
2460864|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
2460865|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460866|NCT01012817|Topotecan|topotecan|mesh-list
2460867|NCT01012817|Veliparib|veliparib|mesh-list
2460868|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2460869|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2460870|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460871|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460872|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460873|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2460874|NCT01012830|Huperzine A|huperzine a|mesh-list
2460875|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2460876|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460877|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460878|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
2460879|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460880|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460881|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2460882|NCT01012830|Protective Agents|protective agents|mesh-ancestor
2460883|NCT01012843|Amoxicillin|amoxicillin|mesh-list
2460884|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
2460885|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
2460886|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2460887|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2460888|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460889|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2460890|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460891|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460892|NCT01012869|Everolimus|everolimus|mesh-list
2460893|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460894|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2460895|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
2460896|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460897|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
2460898|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460899|NCT01012895|Interferons|interferons|mesh-list
2460900|NCT01012895|Ribavirin|ribavirin|mesh-list
2460901|NCT01012895|Interferon-alpha|interferon-alpha|mesh-list
2460902|NCT01012895|Interferon alpha-2|interferon alpha-2|mesh-list
2460903|NCT01012895|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2460904|NCT01012895|Asunaprevir|asunaprevir|mesh-list
2460905|NCT01012895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460906|NCT01012895|Antiviral Agents|antiviral agents|mesh-ancestor
2460907|NCT01012895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460908|NCT01012895|Antimetabolites|antimetabolites|mesh-ancestor
2460909|NCT01012895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460910|NCT01012895|Immunologic Factors|immunologic factors|mesh-ancestor
2460911|NCT01012895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460912|NCT01012895|Protease Inhibitors|protease inhibitors|mesh-ancestor
2460913|NCT01012895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460914|NCT01012934|Alendronate|alendronate|mesh-list
2460915|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2460916|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460917|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
2460918|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2460919|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460920|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
2460921|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460922|NCT01013012|Dexamethasone|dexamethasone|mesh-list
2460923|NCT01013012|Ramosetron|ramosetron|mesh-list
2460924|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2460925|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
2460926|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
2460927|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460928|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460929|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2460930|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
2460931|NCT01013012|Hormones|hormones|mesh-ancestor
2460932|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2460933|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2460934|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460935|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2460936|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
2460937|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460938|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460939|NCT01013103|Atorvastatin|atorvastatin|mesh-list
2460940|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2460941|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2460942|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
2460943|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460944|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2460945|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2460946|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460947|NCT01013155|Perindopril|perindopril|mesh-list
2460948|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2460949|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
2460950|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460951|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460952|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2460953|NCT01013272|Lamivudine|lamivudine|mesh-list
2460954|NCT01013272|Entecavir|entecavir|mesh-list
2460955|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2460956|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2460957|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2460958|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460959|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
2460960|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2460961|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2460962|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2460963|NCT01013402|Insulin|insulin|mesh-list
2460964|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2460965|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2460966|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460967|NCT01013454|Varenicline|varenicline|mesh-list
2460968|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2460969|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2460970|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
2460971|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460972|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460973|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460974|NCT01013480|Baclofen|baclofen|mesh-list
2460975|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2460976|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460977|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2460978|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2460979|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2460980|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
2460981|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
2460982|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2460983|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460984|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2460985|NCT01013506|Letrozole|letrozole|mesh-list
2460986|NCT01013506|Goserelin|goserelin|mesh-list
2460987|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2460988|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2460989|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2738619|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2460990|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2460991|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2460992|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2460993|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2460994|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
2460995|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2460996|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2460997|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2460998|NCT01013532|Aspirin|aspirin|mesh-list
2460999|NCT01013532|Cilostazol|cilostazol|mesh-list
2461000|NCT01013532|Probucol|probucol|mesh-list
2461001|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2461002|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2461003|NCT01013532|Analgesics|analgesics|mesh-ancestor
2461004|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
2461005|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461006|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461007|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2461008|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2461009|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2461010|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2461011|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461012|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2461013|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2461014|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461015|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
2461016|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2461017|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
2461018|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2461019|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
2461020|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
2461021|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2461022|NCT01013532|Protective Agents|protective agents|mesh-ancestor
2461023|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2461024|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2461025|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2461026|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2461027|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
2461028|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2461029|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
2461030|NCT01013558|Remifentanil|remifentanil|mesh-list
2461031|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2461032|NCT01013558|Narcotics|narcotics|mesh-ancestor
2461033|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461034|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461035|NCT01013558|Analgesics|analgesics|mesh-ancestor
2461036|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
2461037|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461038|NCT01013571|Insulin|insulin|mesh-list
2461039|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2461040|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
2461041|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
2461042|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2461043|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461044|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
2461045|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2461046|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461047|NCT01013584|Vitamins|vitamins|mesh-ancestor
2461048|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
2461049|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2461050|NCT01013649|Gemcitabine|gemcitabine|mesh-list
2461051|NCT01013649|Fluorouracil|fluorouracil|mesh-list
2461052|NCT01013649|Capecitabine|capecitabine|mesh-list
2461053|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2461054|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2461055|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
2461056|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461057|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461058|NCT01013649|Antiviral Agents|antiviral agents|mesh-ancestor
2461059|NCT01013649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461060|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461061|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2461062|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
2461063|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461064|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2461065|NCT01013675|Vaccines|vaccines|mesh-list
2461066|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
2461067|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461068|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
2461069|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2461070|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461071|NCT01013779|Carboplatin|carboplatin|mesh-list
2461072|NCT01013779|Etoposide|etoposide|mesh-list
2461073|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461074|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2461075|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2461076|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2461077|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461078|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461079|NCT01013805|Leucovorin|leucovorin|mesh-list
2461080|NCT01013805|Fluorouracil|fluorouracil|mesh-list
2461081|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
2461082|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
2461083|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461084|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2461085|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461086|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2461087|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
2461088|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461089|NCT01013805|Antidotes|antidotes|mesh-ancestor
2461090|NCT01013805|Protective Agents|protective agents|mesh-ancestor
2461091|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
2461092|NCT01013805|Vitamins|vitamins|mesh-ancestor
2461093|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
2461094|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2461095|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461096|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2461097|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461098|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461099|NCT01013909|Terbinafine|terbinafine|mesh-list
2461100|NCT01013909|Bifonazole|bifonazole|mesh-list
2461101|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
2461102|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461103|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461104|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461105|NCT01013987|Ritonavir|ritonavir|mesh-list
2461106|NCT01013987|Darunavir|darunavir|mesh-list
2461107|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
2461108|NCT01013987|Maraviroc|maraviroc|mesh-list
2461109|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2461110|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2461111|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
2461112|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461113|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461114|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2461115|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2461116|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
2461117|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461118|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2461119|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2461120|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2461121|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2461122|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2461123|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2461124|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2461125|NCT01014052|Retinol acetate|retinol acetate|mesh-list
2461126|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2461127|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
2461128|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461129|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2461130|NCT01014052|Protective Agents|protective agents|mesh-ancestor
2461131|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461132|NCT01014078|Azithromycin|azithromycin|mesh-list
2461133|NCT01014078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2461134|NCT01014078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2461135|NCT01014078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2461136|NCT01014078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461137|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
2461138|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2461139|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2461140|NCT01014104|Prednisolone|prednisolone|mesh-list
2461141|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
2461142|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2461143|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
2461144|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2461145|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
2461146|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
2461147|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461148|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461149|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2461150|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
2461151|NCT01014104|Hormones|hormones|mesh-ancestor
2461152|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2461153|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2461154|NCT01014104|Protective Agents|protective agents|mesh-ancestor
2461155|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2461156|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461157|NCT01014156|Epoprostenol|epoprostenol|mesh-list
2461158|NCT01014156|Tezosentan|tezosentan|mesh-list
2461159|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2461160|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2461161|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
2461162|NCT01014221|Prednisolone|prednisolone|mesh-list
2461163|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2461164|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
2461165|NCT01014221|Hormones|hormones|mesh-ancestor
2461166|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2461167|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461168|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2461169|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461170|NCT01014234|Cyclosporine|cyclosporine|mesh-list
2461171|NCT01014234|Sirolimus|sirolimus|mesh-list
2461172|NCT01014234|Cyclosporins|cyclosporins|mesh-list
2461173|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461174|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461175|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2461176|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
2461177|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461178|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
2461179|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461180|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
2461181|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2461182|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2461183|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2461184|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2461185|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461186|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
2461187|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2461188|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2461189|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461190|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2461191|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2461192|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461193|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461194|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461195|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2461196|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
2461197|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2461198|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461199|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2461200|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2461201|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2461202|NCT01014260|Doxycycline|doxycycline|mesh-list
2461203|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2461204|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461205|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
2461206|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2461207|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2461208|NCT01014338|Fosinopril|fosinopril|mesh-list
2461209|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2461210|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
2461211|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461212|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461213|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2461214|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
2461215|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2461216|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2461217|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2461218|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2461219|NCT01014416|Tolvaptan|tolvaptan|mesh-list
2461220|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2461221|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461222|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
2461223|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461224|NCT01014468|Bevacizumab|bevacizumab|mesh-list
2461225|NCT01014468|Ranibizumab|ranibizumab|mesh-list
2461226|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2461227|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461228|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2461229|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2461230|NCT01014468|Growth Substances|growth substances|mesh-ancestor
2461231|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461232|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
2461233|NCT01014481|Tenofovir|tenofovir|mesh-list
2461234|NCT01014481|Lamivudine|lamivudine|mesh-list
2461235|NCT01014481|Efavirenz|efavirenz|mesh-list
2461236|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
2461237|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461238|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2461239|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2461240|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461241|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461242|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2461243|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2461244|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2461245|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2461246|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2461247|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2461248|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2461249|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2461250|NCT01014507|Goserelin|goserelin|mesh-list
2461251|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
2461252|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
2461253|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2461254|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461255|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2461256|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461257|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2461258|NCT01014520|Gabapentin|gabapentin|mesh-list
2461259|NCT01014520|Amitriptyline|amitriptyline|mesh-list
2461260|NCT01014520|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2461261|NCT01014520|Analgesics|analgesics|mesh-ancestor
2461262|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
2461263|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461264|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461265|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
2461266|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2461267|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2461268|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461269|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2461270|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2461271|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2461272|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461273|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461274|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
2461275|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2461276|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
2461277|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2461278|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2461279|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2461280|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2461281|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
2461282|NCT01014520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2461283|NCT01014546|Vitamins|vitamins|mesh-list
2461284|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
2461285|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
2461286|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
2461287|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461288|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
2461289|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461290|NCT01014546|Protective Agents|protective agents|mesh-ancestor
2461291|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461292|NCT01014559|Oxycodone|oxycodone|mesh-list
2461293|NCT01014559|Naloxone|naloxone|mesh-list
2461294|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2461295|NCT01014559|Narcotics|narcotics|mesh-ancestor
2461296|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461297|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461298|NCT01014559|Analgesics|analgesics|mesh-ancestor
2461299|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
2461300|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461301|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2461302|NCT01014598|Cisplatin|cisplatin|mesh-list
2461303|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461304|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
2461305|NCT01014637|Clotrimazole|clotrimazole|mesh-list
2461306|NCT01014637|Miconazole|miconazole|mesh-list
2461307|NCT01014637|Amorolfine|amorolfine|mesh-list
2461308|NCT01014637|Ciclopirox|ciclopirox|mesh-list
2461309|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
2461310|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461311|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2461312|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2461313|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2461314|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461315|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461316|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2461317|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
2461318|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2461319|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461320|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2461321|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2461322|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
2461323|NCT01014650|Glycine|glycine|mesh-list
2461324|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
2461325|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461326|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461327|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461328|NCT01014793|Cabergoline|cabergoline|mesh-list
2461329|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2461330|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2461331|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
2461332|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
2461333|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461334|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461335|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461336|NCT01014832|Insulin|insulin|mesh-list
2461337|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2461338|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2461339|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461340|NCT01014845|Vaccines|vaccines|mesh-list
2461341|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
2461342|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461343|NCT01014858|Donepezil|donepezil|mesh-list
2461344|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2461345|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461346|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461347|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
2461348|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461349|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461350|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
2461351|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
2461352|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2461353|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2461354|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
2461355|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461356|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461357|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461358|NCT01015040|Urological Agents|urological agents|mesh-ancestor
2461359|NCT01015053|Ropivacaine|ropivacaine|mesh-list
2461360|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
2461361|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
2461362|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461363|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461364|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
2461365|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461366|NCT01015066|Naltrexone|naltrexone|mesh-list
2461367|NCT01015066|Buprenorphine|buprenorphine|mesh-list
2461368|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2461369|NCT01015066|Naloxone|naloxone|mesh-list
2461370|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2461371|NCT01015066|Narcotics|narcotics|mesh-ancestor
2461372|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461373|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461374|NCT01015066|Analgesics|analgesics|mesh-ancestor
2461375|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
2461376|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461377|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2461378|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2461379|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
2461380|NCT01015183|Astringents|astringents|mesh-ancestor
2461381|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461382|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
2461383|NCT01015196|Daunorubicin|daunorubicin|mesh-list
2461384|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2461385|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461386|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2461387|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2461388|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461389|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461390|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
2461391|NCT01015209|Chitosan|chitosan|mesh-list
2461392|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2461393|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2461394|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2461395|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
2461396|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461397|NCT01015209|Expectorants|expectorants|mesh-ancestor
2461398|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
2461399|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2461400|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
2461401|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461402|NCT01015209|Protective Agents|protective agents|mesh-ancestor
2461403|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461404|NCT01015209|Antidotes|antidotes|mesh-ancestor
2461405|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2461406|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2461407|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
2461408|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2461409|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
2461410|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
2461411|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
2461412|NCT01015209|Coagulants|coagulants|mesh-ancestor
2461413|NCT01015222|Paclitaxel|paclitaxel|mesh-list
2461414|NCT01015222|Bevacizumab|bevacizumab|mesh-list
2461415|NCT01015222|Dasatinib|dasatinib|mesh-list
2461416|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2461417|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461418|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
2461419|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
2461420|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
2461421|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461422|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2461423|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2461424|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2461425|NCT01015222|Growth Substances|growth substances|mesh-ancestor
2461426|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461427|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
2461428|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2461429|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461430|NCT01015235|Ketorolac|ketorolac|mesh-list
2461431|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
2461432|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2461433|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2461434|NCT01015235|Analgesics|analgesics|mesh-ancestor
2461435|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
2461436|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461437|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461438|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2461439|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2461440|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2461441|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461442|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461443|NCT01015248|Rituximab|rituximab|mesh-list
2461444|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2461445|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2461446|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461447|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
2461448|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461449|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2461450|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2461451|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
2461452|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461453|NCT01015300|Bevacizumab|bevacizumab|mesh-list
2461454|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2461455|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461456|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2461457|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2461458|NCT01015300|Growth Substances|growth substances|mesh-ancestor
2461459|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461460|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
2461461|NCT01015339|Paclitaxel|paclitaxel|mesh-list
2461462|NCT01015339|Capecitabine|capecitabine|mesh-list
2461463|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2461464|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461465|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
2461466|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
2461467|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
2461468|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461469|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2461470|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
2461471|NCT01015352|Azacitidine|azacitidine|mesh-list
2461472|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
2461473|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2461474|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
2461475|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461476|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461477|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461478|NCT01015352|Hematinics|hematinics|mesh-ancestor
2461479|NCT01015391|Azathioprine|azathioprine|mesh-list
2461480|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
2461481|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461482|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2461483|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461484|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2461485|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
2461486|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461487|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2461488|NCT01015417|Amoxicillin|amoxicillin|mesh-list
2461489|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
2461490|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
2461491|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
2461492|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2461493|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461494|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2461495|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461496|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461497|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
2461498|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
2461499|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2461500|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
2461501|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461502|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2461503|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2461504|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
2461505|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461506|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461507|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2461508|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2461509|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2461510|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
2461511|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2461512|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461513|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461514|NCT01015482|Midazolam|midazolam|mesh-list
2461515|NCT01015482|Remifentanil|remifentanil|mesh-list
2461516|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2461517|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2461518|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461519|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461520|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2461521|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2461522|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2461523|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2461524|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
2461525|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
2461526|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
2461527|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
2461528|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461529|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461530|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2461531|NCT01015482|Narcotics|narcotics|mesh-ancestor
2461532|NCT01015482|Analgesics|analgesics|mesh-ancestor
2461533|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
2461534|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461535|NCT01015495|Ranibizumab|ranibizumab|mesh-list
2461536|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2461537|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2461538|NCT01015495|Growth Substances|growth substances|mesh-ancestor
2461539|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461540|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
2461541|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461542|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
2461543|NCT01015547|Methotrexate|methotrexate|mesh-list
2461544|NCT01015547|Infliximab|infliximab|mesh-list
2461545|NCT01015547|Naltrexone|naltrexone|mesh-list
2461546|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2461547|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
2461548|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2461549|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461550|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2461551|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
2461552|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461553|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461554|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
2461555|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461556|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2461557|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2461558|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
2461559|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2461560|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2461561|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2461562|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461563|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2461564|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2461565|NCT01015547|Analgesics|analgesics|mesh-ancestor
2461566|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
2461567|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461568|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2461569|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2461570|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2461571|NCT01015651|Remifentanil|remifentanil|mesh-list
2461572|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2461573|NCT01015651|Narcotics|narcotics|mesh-ancestor
2461574|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461575|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461576|NCT01015651|Analgesics|analgesics|mesh-ancestor
2461577|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
2461578|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461579|NCT01015664|Sirolimus|sirolimus|mesh-list
2461580|NCT01015664|Cetuximab|cetuximab|mesh-list
2461581|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461582|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2461583|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2461584|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461585|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2461586|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
2461587|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2461588|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
2461589|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461590|NCT01015729|Aspirin|aspirin|mesh-list
2461591|NCT01015729|Esomeprazole|esomeprazole|mesh-list
2461592|NCT01015729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2461593|NCT01015729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2461594|NCT01015729|Analgesics|analgesics|mesh-ancestor
2461595|NCT01015729|Sensory System Agents|sensory system agents|mesh-ancestor
2461596|NCT01015729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461597|NCT01015729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461598|NCT01015729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2461599|NCT01015729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2461600|NCT01015729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2461601|NCT01015729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2461602|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461603|NCT01015729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2461604|NCT01015729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2461605|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461606|NCT01015729|Antipyretics|antipyretics|mesh-ancestor
2461607|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2461608|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2461609|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2461610|NCT01015794|Ephedrine|ephedrine|mesh-list
2461611|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
2461612|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2461613|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461614|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
2461615|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
2461616|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461617|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2461618|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
2461619|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461620|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461621|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2461622|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2461623|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
2461624|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
2461625|NCT01015937|Losartan|losartan|mesh-list
2461626|NCT01015937|Enalapril|enalapril|mesh-list
2461627|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
2461628|NCT01015937|Giapreza|giapreza|mesh-list
2461629|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2461630|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
2461631|NCT01015937|Turmeric extract|turmeric extract|mesh-list
2461632|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2461633|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2461634|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2461635|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2461636|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461637|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
2461638|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461639|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
2461640|NCT01015937|Protective Agents|protective agents|mesh-ancestor
2461641|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461642|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2461643|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2461644|NCT01016002|Temoporfin|temoporfin|mesh-list
2461645|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461646|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2461647|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
2461648|NCT01016041|Paclitaxel|paclitaxel|mesh-list
2461649|NCT01016041|Everolimus|everolimus|mesh-list
2461650|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2461651|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461652|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
2461653|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
2461654|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
2461655|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461656|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2461657|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
2461658|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461659|NCT01016054|Gemcitabine|gemcitabine|mesh-list
2461660|NCT01016054|Carboplatin|carboplatin|mesh-list
2461661|NCT01016054|Doxorubicin|doxorubicin|mesh-list
2461662|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2461663|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461664|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2461665|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
2461666|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461667|NCT01016054|Antiviral Agents|antiviral agents|mesh-ancestor
2461668|NCT01016054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461669|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461670|NCT01016054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2461671|NCT01016054|Immunologic Factors|immunologic factors|mesh-ancestor
2461672|NCT01016054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461673|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2461674|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2461675|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2461676|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
2461677|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2461678|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461679|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
2461680|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2461681|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2461682|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461683|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461684|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2461685|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2461686|NCT01016184|Vitamin D|vitamin d|mesh-list
2461687|NCT01016184|Vitamins|vitamins|mesh-ancestor
2461688|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
2461689|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461690|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2461691|NCT01016223|Beclomethasone|beclomethasone|mesh-list
2461692|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2461693|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
2461694|NCT01016223|Hormones|hormones|mesh-ancestor
2461695|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2461696|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461697|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2461698|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
2461699|NCT01016249|Epinephrine|epinephrine|mesh-list
2461700|NCT01016249|Racepinephrine|racepinephrine|mesh-list
2461701|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
2461702|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2461703|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2461704|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
2461705|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461706|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461707|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461708|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2461709|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2461710|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
2461711|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461712|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2461713|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
2461714|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
2461715|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
2461716|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2461717|NCT01016509|Insulin|insulin|mesh-list
2461718|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2461719|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2461720|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461721|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
2461722|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2461723|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461724|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2461725|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
2461726|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2461727|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461728|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461729|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461730|NCT01016639|Capecitabine|capecitabine|mesh-list
2461731|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
2461732|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2461733|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
2461734|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461735|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461736|NCT01016665|Anastrozole|anastrozole|mesh-list
2461737|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2461738|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461739|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2461740|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2461741|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461742|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461743|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2461744|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
2738620|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461745|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2461746|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461747|NCT01016717|Omeprazole|omeprazole|mesh-list
2461748|NCT01016717|Pantoprazole|pantoprazole|mesh-list
2461749|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2461750|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2461751|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2461752|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461753|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461754|NCT01016730|Bortezomib|bortezomib|mesh-list
2461755|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461756|NCT01016795|Lenograstim|lenograstim|mesh-list
2461757|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2461758|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
2461759|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461760|NCT01016808|Morphine|morphine|mesh-list
2461761|NCT01016808|Oxycodone|oxycodone|mesh-list
2461762|NCT01016808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2461763|NCT01016808|Narcotics|narcotics|mesh-ancestor
2461764|NCT01016808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461765|NCT01016808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461766|NCT01016808|Analgesics|analgesics|mesh-ancestor
2461767|NCT01016808|Sensory System Agents|sensory system agents|mesh-ancestor
2461768|NCT01016808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461769|NCT01016821|Oxycodone|oxycodone|mesh-list
2461770|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2461771|NCT01016821|Narcotics|narcotics|mesh-ancestor
2461772|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461773|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461774|NCT01016821|Analgesics|analgesics|mesh-ancestor
2461775|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
2461776|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461777|NCT01016860|Irinotecan|irinotecan|mesh-list
2461778|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2461779|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2461780|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461781|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461782|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461783|NCT01016886|Bisoprolol|bisoprolol|mesh-list
2461784|NCT01016886|Perindopril|perindopril|mesh-list
2461785|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2461786|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
2461787|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
2461788|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461789|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461790|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2461791|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2461792|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2461793|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
2461794|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461795|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461796|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2461797|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
2461798|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461799|NCT01016990|Valproic Acid|valproic acid|mesh-list
2461800|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
2461801|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461802|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461803|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
2461804|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461805|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461806|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
2461807|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2461808|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461809|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2461810|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
2461811|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2461812|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461813|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
2461814|NCT01017107|Protein C|protein c|mesh-list
2461815|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
2461816|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2461817|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2461818|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461819|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461820|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
2461821|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2461822|NCT01017133|Fluorides|fluorides|mesh-list
2461823|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2461824|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461825|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
2461826|NCT01017133|Protective Agents|protective agents|mesh-ancestor
2461827|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461828|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
2461829|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
2461830|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461831|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
2461832|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2461833|NCT01017159|Antibodies|antibodies|mesh-list
2461834|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
2461835|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461836|NCT01017198|Antacids|antacids|mesh-list
2461837|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461838|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2461839|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
2461840|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2461841|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461842|NCT01017354|Calcifediol|calcifediol|mesh-list
2461843|NCT01017354|Vitamins|vitamins|mesh-ancestor
2461844|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
2461845|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461846|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2461847|NCT01017367|Antibodies|antibodies|mesh-list
2461848|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
2461849|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461850|NCT01017380|Celecoxib|celecoxib|mesh-list
2461851|NCT01017380|Etoricoxib|etoricoxib|mesh-list
2461852|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2461853|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2461854|NCT01017380|Analgesics|analgesics|mesh-ancestor
2461855|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
2461856|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461857|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461858|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2461859|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2461860|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2461861|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2461862|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461863|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461864|NCT01017393|Ketamine|ketamine|mesh-list
2461865|NCT01017393|Analgesics|analgesics|mesh-ancestor
2461866|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
2461867|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461868|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461869|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2461870|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2461871|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
2461872|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
2461873|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461874|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2461875|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2461876|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461877|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461878|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
2461879|NCT01017458|Testosterone|testosterone|mesh-list
2461880|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
2461881|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
2461882|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2461883|NCT01017458|Androgens|androgens|mesh-ancestor
2461884|NCT01017458|Hormones|hormones|mesh-ancestor
2461885|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2461886|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461887|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2461888|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461889|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
2461890|NCT01017640|Mitomycins|mitomycins|mesh-list
2461891|NCT01017640|Mitomycin|mitomycin|mesh-list
2461892|NCT01017640|Veliparib|veliparib|mesh-list
2461893|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2461894|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461895|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
2461896|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461897|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2461898|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461899|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2461900|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
2461901|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2461902|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2461903|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2461904|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
2461905|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461906|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461907|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461908|NCT01017679|Gefitinib|gefitinib|mesh-list
2461909|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461910|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2461911|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461912|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461913|NCT01017744|Anesthetics|anesthetics|mesh-list
2461914|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461915|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461916|NCT01017770|Artesunate|artesunate|mesh-list
2461917|NCT01017770|Lumefantrine|lumefantrine|mesh-list
2461918|NCT01017770|Artemether|artemether|mesh-list
2461919|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2461920|NCT01017770|Amodiaquine|amodiaquine|mesh-list
2461921|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
2461922|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2461923|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2461924|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461925|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461926|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
2461927|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
2461928|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2461929|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
2461930|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
2461931|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
2461932|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2461933|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
2461934|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461935|NCT01017796|Expectorants|expectorants|mesh-ancestor
2461936|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
2461937|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2461938|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
2461939|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461940|NCT01017796|Protective Agents|protective agents|mesh-ancestor
2461941|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461942|NCT01017796|Antidotes|antidotes|mesh-ancestor
2461943|NCT01017796|Vitamins|vitamins|mesh-ancestor
2461944|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
2461945|NCT01017809|Aprepitant|aprepitant|mesh-list
2461946|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
2461947|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
2461948|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2461949|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461950|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2461951|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2461952|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461953|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461954|NCT01017822|Gemcitabine|gemcitabine|mesh-list
2461955|NCT01017822|Capecitabine|capecitabine|mesh-list
2461956|NCT01017822|Conatumumab|conatumumab|mesh-list
2461957|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2461958|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
2461959|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461960|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461961|NCT01017822|Antiviral Agents|antiviral agents|mesh-ancestor
2461962|NCT01017822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2461963|NCT01017822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461964|NCT01017822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2461965|NCT01017822|Immunologic Factors|immunologic factors|mesh-ancestor
2461966|NCT01017822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461967|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2461968|NCT01017926|Triazolam|triazolam|mesh-list
2461969|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2461970|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2461971|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2461972|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2461973|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461974|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2461975|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
2461976|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
2461977|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2461978|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461979|NCT01017939|Prednisone|prednisone|mesh-list
2461980|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
2461981|NCT01017939|Theophylline|theophylline|mesh-list
2461982|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
2461983|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2461984|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
2461985|NCT01017939|Hormones|hormones|mesh-ancestor
2461986|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2461987|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2461988|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2461989|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2461990|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2461991|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2461992|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2461993|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
2461994|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2461995|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
2461996|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
2461997|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2461998|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2461999|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462000|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2462001|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
2462002|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462003|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2462004|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2462005|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
2462006|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2462007|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2462008|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
2462009|NCT01018160|Rabeprazole|rabeprazole|mesh-list
2462010|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2462011|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2462012|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2462013|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462014|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462015|NCT01018225|Darifenacin|darifenacin|mesh-list
2462016|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2462017|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2462018|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
2462019|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462020|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462021|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462022|NCT01018225|Urological Agents|urological agents|mesh-ancestor
2462023|NCT01018251|Alovudine|alovudine|mesh-list
2462024|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
2462025|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462026|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
2462027|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2462028|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462029|NCT01018342|Renal Agents|renal agents|mesh-ancestor
2462030|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2462031|NCT01018368|Rifampin|rifampin|mesh-list
2462032|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2462033|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
2462034|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2462035|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462036|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
2462037|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2462038|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462039|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462040|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2462041|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2462042|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2462043|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2462044|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2462045|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2462046|NCT01018381|Ethanol|ethanol|mesh-list
2462047|NCT01018381|Entecavir|entecavir|mesh-list
2462048|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2462049|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462050|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2462051|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462052|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
2462053|NCT01018446|Busulfan|busulfan|mesh-list
2462054|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
2462055|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462056|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2462057|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
2462058|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462059|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2462060|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462061|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2462062|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
2462063|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2462064|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2462065|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2462066|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2462067|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462068|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
2462069|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462070|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462071|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2462072|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462075|NCT01018602|Vildagliptin|vildagliptin|mesh-list
2462076|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2462077|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462078|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2462079|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
2462080|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462081|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462082|NCT01018615|Silymarin|silymarin|mesh-list
2462083|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
2462084|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462085|NCT01018615|Protective Agents|protective agents|mesh-ancestor
2462086|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462087|NCT01018758|Palonosetron|palonosetron|mesh-list
2462088|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
2462089|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
2462090|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462091|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462092|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2462093|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2462094|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2462095|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
2462096|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462097|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462098|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
2462099|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2462100|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462101|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2462102|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462103|NCT01018836|Riluzole|riluzole|mesh-list
2462104|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
2462105|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2462106|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2462107|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462108|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462109|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462110|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2462111|NCT01018836|Protective Agents|protective agents|mesh-ancestor
2462112|NCT01018849|Vitamin D|vitamin d|mesh-list
2462113|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
2462114|NCT01018849|Vitamins|vitamins|mesh-ancestor
2462115|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
2462116|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462117|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2738621|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
2738622|NCT04523922|Oxytocin|oxytocin|mesh-list
2738623|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
2462118|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2462119|NCT01018875|Donepezil|donepezil|mesh-list
2462120|NCT01018875|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2462121|NCT01018875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462122|NCT01018875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462123|NCT01018875|Cholinergic Agents|cholinergic agents|mesh-ancestor
2462124|NCT01018875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462125|NCT01018875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462126|NCT01018875|Nootropic Agents|nootropic agents|mesh-ancestor
2462127|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
2462128|NCT01018914|Tacrolimus|tacrolimus|mesh-list
2462129|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2462130|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
2462131|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462132|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2462133|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462134|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462135|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2462136|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462137|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2462138|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
2462139|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2462140|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462141|NCT01019070|Asunaprevir|asunaprevir|mesh-list
2462142|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
2462143|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462144|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462145|NCT01019083|Zinc|zinc|mesh-list
2462146|NCT01019083|Albendazole|albendazole|mesh-list
2462147|NCT01019083|Secnidazole|secnidazole|mesh-list
2462148|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
2462149|NCT01019083|Trace Elements|trace elements|mesh-ancestor
2462150|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
2462151|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462152|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
2462153|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2462154|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462155|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
2462156|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2462157|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2462158|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
2462159|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
2462160|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
2462161|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462162|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462163|NCT01019083|Astringents|astringents|mesh-ancestor
2462164|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
2462165|NCT01019109|Cobalt|cobalt|mesh-list
2462166|NCT01019109|Trace Elements|trace elements|mesh-ancestor
2462167|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
2462168|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462169|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
2462170|NCT01019174|Lenalidomide|lenalidomide|mesh-list
2462171|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2462172|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
2462173|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462174|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2462175|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2462176|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
2462177|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462178|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462179|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2462180|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2462181|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2462182|NCT01019174|Growth Substances|growth substances|mesh-ancestor
2462183|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
2462184|NCT01019187|Modafinil|modafinil|mesh-list
2462185|NCT01019187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2462186|NCT01019187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462187|NCT01019187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2462188|NCT01019187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2462189|NCT01019187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2462190|NCT01019187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462191|NCT01019265|Buprenorphine|buprenorphine|mesh-list
2462192|NCT01019265|Tramadol|tramadol|mesh-list
2462193|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2462194|NCT01019265|Narcotics|narcotics|mesh-ancestor
2462195|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2462196|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462197|NCT01019265|Analgesics|analgesics|mesh-ancestor
2462198|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
2462199|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462200|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2462201|NCT01019278|Cisplatin|cisplatin|mesh-list
2462202|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462203|NCT01019291|Formaldehyde|formaldehyde|mesh-list
2462204|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
2462205|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462213|NCT01019382|Gemcitabine|gemcitabine|mesh-list
2462214|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2462215|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
2462216|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462217|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462218|NCT01019382|Antiviral Agents|antiviral agents|mesh-ancestor
2462219|NCT01019382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462220|NCT01019382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462221|NCT01019382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2462222|NCT01019382|Immunologic Factors|immunologic factors|mesh-ancestor
2462223|NCT01019382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462224|NCT01019395|Daptomycin|daptomycin|mesh-list
2462225|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2462226|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462227|NCT01019408|Chloroquine|chloroquine|mesh-list
2462228|NCT01019408|Amebicides|amebicides|mesh-ancestor
2462229|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2462230|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2462231|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462232|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
2462233|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2462234|NCT01019434|Sirolimus|sirolimus|mesh-list
2462235|NCT01019434|Temozolomide|temozolomide|mesh-list
2462236|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2462237|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
2462238|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462239|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462240|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2462241|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462242|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2462243|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
2462244|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2462245|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
2462246|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462247|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
2462248|NCT01019447|Triclosan|triclosan|mesh-list
2462249|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2462250|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2462251|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2462252|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2462253|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
2462254|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462255|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2462256|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2462257|NCT01019590|Olmesartan|olmesartan|mesh-list
2462258|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2462259|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2462260|NCT01019590|Diuretics|diuretics|mesh-ancestor
2462261|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
2462262|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462263|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2462264|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2462265|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462266|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2462267|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2462268|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
2462269|NCT01019603|Tazarotene|tazarotene|mesh-list
2462270|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
2462271|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
2462272|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
2462273|NCT01019603|Vitamins|vitamins|mesh-ancestor
2462274|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
2462275|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462276|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
2462277|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2462278|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462279|NCT01019642|Vitamins|vitamins|mesh-ancestor
2462280|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
2462281|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2462282|NCT01019655|Nadroparin|nadroparin|mesh-list
2462283|NCT01019655|Calcium|calcium|mesh-list
2462284|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2462285|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462286|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
2462287|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2462288|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2462289|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462290|NCT01019668|Verteporfin|verteporfin|mesh-list
2462291|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2462292|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
2462293|NCT01019746|Propofol|propofol|mesh-list
2462294|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2462295|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2462296|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462297|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2462298|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
2462299|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
2462300|NCT01019772|Vaccines|vaccines|mesh-list
2462301|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
2462302|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462303|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
2462304|NCT01019785|Vitamin D|vitamin d|mesh-list
2462305|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2462306|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462307|NCT01019785|Vitamins|vitamins|mesh-ancestor
2462308|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
2462309|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2462310|NCT01019798|Docetaxel|docetaxel|mesh-list
2462311|NCT01019798|Sunitinib|sunitinib|mesh-list
2462312|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462313|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
2462314|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
2462315|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
2462316|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462317|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2462318|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2462319|NCT01019798|Growth Substances|growth substances|mesh-ancestor
2462320|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462321|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
2462322|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2462323|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462324|NCT01019850|Vorinostat|vorinostat|mesh-list
2462325|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2462326|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462327|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2462328|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462329|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462330|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2462331|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
2462332|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462333|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
2462334|NCT01019876|Fludarabine|fludarabine|mesh-list
2462335|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2462336|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
2462337|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462338|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2462339|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2462340|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
2462341|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462342|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462343|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2462344|NCT01019941|Docetaxel|docetaxel|mesh-list
2462345|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462346|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
2462347|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
2462348|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
2462349|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462350|NCT01020097|Fluorides|fluorides|mesh-list
2462351|NCT01020097|Cariostatic Agents|cariostatic agents|mesh-ancestor
2462352|NCT01020097|Protective Agents|protective agents|mesh-ancestor
2462353|NCT01020097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462354|NCT01020136|Axitinib|axitinib|mesh-list
2462355|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462356|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2462357|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462358|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462359|NCT01020162|Gabapentin|gabapentin|mesh-list
2462360|NCT01020162|Amitriptyline|amitriptyline|mesh-list
2462361|NCT01020162|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2462362|NCT01020162|Analgesics|analgesics|mesh-ancestor
2462363|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
2462364|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462365|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462366|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
2462367|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2462368|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2462369|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2462370|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2462371|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2462372|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2462373|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462374|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462375|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
2462376|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2462377|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
2462378|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2462379|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2462380|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2462381|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2462382|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
2462383|NCT01020162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2462384|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2462385|NCT01020214|Olmesartan|olmesartan|mesh-list
2462386|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2462387|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2462388|NCT01020214|Diuretics|diuretics|mesh-ancestor
2462389|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
2462390|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462391|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2462392|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2462393|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462394|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2462395|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2462396|NCT01020253|Alendronate|alendronate|mesh-list
2462397|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
2462398|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2462399|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2462400|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462401|NCT01020253|Vitamins|vitamins|mesh-ancestor
2462402|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
2462403|NCT01020279|Celecoxib|celecoxib|mesh-list
2462404|NCT01020279|Ketoprofen|ketoprofen|mesh-list
2462405|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2462406|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2462407|NCT01020279|Analgesics|analgesics|mesh-ancestor
2462408|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
2462409|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462410|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462411|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2462412|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2462413|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2462414|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2462415|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462416|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462417|NCT01020292|Nelfinavir|nelfinavir|mesh-list
2462418|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2462419|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2462420|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
2462421|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462422|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462423|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2462424|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2462425|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
2462426|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462427|NCT01020331|Memantine|memantine|mesh-list
2462428|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2462429|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2462430|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
2462431|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462432|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462433|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462434|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2462435|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2462436|NCT01020357|Caffeine|caffeine|mesh-list
2462437|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
2462438|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462439|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2462440|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462441|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2462442|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462443|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2462444|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2462445|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
2462446|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462447|NCT01020383|Abciximab|abciximab|mesh-list
2462448|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
2462449|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2462450|NCT01020396|Metronidazole|metronidazole|mesh-list
2462451|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462452|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2462453|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2462454|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2462455|NCT01020539|Fludarabine|fludarabine|mesh-list
2462456|NCT01020539|Busulfan|busulfan|mesh-list
2462457|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
2462458|NCT01020539|Isotretinoin|isotretinoin|mesh-list
2462459|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
2462460|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2462461|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462462|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462463|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2462464|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
2462465|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462466|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
2462467|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2462468|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2462469|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
2462470|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2462471|NCT01020565|Entecavir|entecavir|mesh-list
2462472|NCT01020565|Antiviral Agents|antiviral agents|mesh-ancestor
2462473|NCT01020565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462474|NCT01020630|Sunitinib|sunitinib|mesh-list
2462475|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462476|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2462477|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2462478|NCT01020630|Growth Substances|growth substances|mesh-ancestor
2462479|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462480|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
2462481|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2462482|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462483|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462484|NCT01020643|Propofol|propofol|mesh-list
2462485|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2462486|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2462487|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462488|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2462489|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
2462490|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
2462491|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
2462492|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
2462493|NCT01020708|Mesalamine|mesalamine|mesh-list
2462494|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2462495|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
2462496|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462497|NCT01020708|Expectorants|expectorants|mesh-ancestor
2462498|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
2462499|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2462500|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
2462501|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462502|NCT01020708|Protective Agents|protective agents|mesh-ancestor
2462503|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462504|NCT01020708|Antidotes|antidotes|mesh-ancestor
2462505|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2462506|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2462507|NCT01020708|Analgesics|analgesics|mesh-ancestor
2462508|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
2462509|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462510|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2462511|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2462512|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
2462513|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2462514|NCT01020734|Cyclosporine|cyclosporine|mesh-list
2462515|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
2462516|NCT01020734|Busulfan|busulfan|mesh-list
2462517|NCT01020734|Methotrexate|methotrexate|mesh-list
2462518|NCT01020734|Fludarabine|fludarabine|mesh-list
2462519|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
2462520|NCT01020734|Cyclosporins|cyclosporins|mesh-list
2462521|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2462522|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2462523|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
2462524|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462525|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2462526|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2462527|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
2462528|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462529|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462530|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2462531|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2462532|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
2462533|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2462534|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2462535|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
2462536|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
2462537|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462538|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2462539|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2462540|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
2462541|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462542|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2462543|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2462544|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
2462545|NCT01020825|Coagulants|coagulants|mesh-ancestor
2462546|NCT01020864|Carboplatin|carboplatin|mesh-list
2462547|NCT01020864|Cetuximab|cetuximab|mesh-list
2462548|NCT01020864|Vinorelbine|vinorelbine|mesh-list
2462549|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462550|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2462551|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2462552|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
2462553|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
2462554|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
2462555|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462556|NCT01020955|Mecasermin|mecasermin|mesh-list
2462557|NCT01020955|Growth Substances|growth substances|mesh-ancestor
2462558|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462559|NCT01021150|Cisplatin|cisplatin|mesh-list
2462560|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462561|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
2462562|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2462563|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
2462564|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462565|NCT01021163|Expectorants|expectorants|mesh-ancestor
2462566|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
2462567|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2462568|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
2462569|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462570|NCT01021163|Protective Agents|protective agents|mesh-ancestor
2462571|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462572|NCT01021163|Antidotes|antidotes|mesh-ancestor
2462573|NCT01021176|Diltiazem|diltiazem|mesh-list
2462574|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2462575|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2462576|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2462577|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462578|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2462579|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462580|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
2462581|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
2462582|NCT01021267|Urological Agents|urological agents|mesh-ancestor
2462583|NCT01021358|Ketoconazole|ketoconazole|mesh-list
2462584|NCT01021358|Navitoclax|navitoclax|mesh-list
2462585|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
2462586|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462587|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2462588|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2462589|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462590|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462591|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2462592|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
2462593|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2462594|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462595|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2462596|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462597|NCT01021436|Amikacin|amikacin|mesh-list
2462598|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2462599|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462600|NCT01021475|Domperidone|domperidone|mesh-list
2462601|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
2462602|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
2462603|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462604|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462605|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2462606|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2462607|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
2462608|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462609|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462610|NCT01021488|Enoxaparin|enoxaparin|mesh-list
2462611|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2462612|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2462613|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2462614|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
2462615|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462616|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2462617|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2462618|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462619|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
2462620|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2462621|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2462622|NCT01021501|Nifedipine|nifedipine|mesh-list
2462623|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2462624|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2462625|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462626|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2462627|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462628|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
2462629|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
2462630|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2462631|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2462632|NCT01021540|Hormones|hormones|mesh-ancestor
2462633|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2462634|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462635|NCT01021566|Methadone|methadone|mesh-list
2462636|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2462637|NCT01021566|Narcotics|narcotics|mesh-ancestor
2462638|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2462639|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462640|NCT01021566|Analgesics|analgesics|mesh-ancestor
2462641|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
2462642|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462643|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
2462644|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
2462645|NCT01021579|Metformin|metformin|mesh-list
2462646|NCT01021579|Simvastatin|simvastatin|mesh-list
2462647|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2462648|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462649|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2462650|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2462651|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
2462652|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462653|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2462654|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2462655|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462656|NCT01021592|Bortezomib|bortezomib|mesh-list
2462657|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462658|NCT01021696|Acetaminophen|acetaminophen|mesh-list
2462659|NCT01021696|Pregabalin|pregabalin|mesh-list
2462660|NCT01021696|Morphine|morphine|mesh-list
2462661|NCT01021696|Buprenorphine|buprenorphine|mesh-list
2462662|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2462663|NCT01021696|Narcotics|narcotics|mesh-ancestor
2462664|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2462665|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462666|NCT01021696|Analgesics|analgesics|mesh-ancestor
2462667|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
2462668|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462669|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
2462670|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2462671|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2462672|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462673|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2462674|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2462675|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2462676|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2462677|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2462678|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
2462679|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2462680|NCT01021735|Adalimumab|adalimumab|mesh-list
2462681|NCT01021735|Etanercept|etanercept|mesh-list
2462682|NCT01021735|Rituximab|rituximab|mesh-list
2462683|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2462684|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462685|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
2462686|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462687|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2462688|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2462689|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2462690|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2462691|NCT01021735|Analgesics|analgesics|mesh-ancestor
2462692|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
2462693|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462694|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2462695|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2462696|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
2462697|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
2462698|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2462699|NCT01021787|Protective Agents|protective agents|mesh-ancestor
2462700|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462701|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
2462702|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2462703|NCT01021865|Glucagon|glucagon|mesh-list
2462704|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2462705|NCT01021865|Regadenoson|regadenoson|mesh-list
2462706|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2462707|NCT01021865|Hormones|hormones|mesh-ancestor
2462708|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2462709|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462710|NCT01021865|Incretins|incretins|mesh-ancestor
2462711|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
2462712|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2462713|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
2462714|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
2462715|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462716|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462717|NCT01021891|Insulin|insulin|mesh-list
2462718|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2462719|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462720|NCT01021930|Sirolimus|sirolimus|mesh-list
2462721|NCT01021930|Paclitaxel|paclitaxel|mesh-list
2462722|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2462723|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462724|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
2462725|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
2462726|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
2462727|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462728|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2462729|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462730|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2462731|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
2462732|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2462733|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
2462734|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462735|NCT01021943|Spironolactone|spironolactone|mesh-list
2462736|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2462737|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
2462738|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2462739|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462740|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2462741|NCT01021943|Diuretics|diuretics|mesh-ancestor
2462742|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
2462743|NCT01022021|Rituximab|rituximab|mesh-list
2462744|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2462745|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2462746|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462747|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
2462748|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462749|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2462750|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2462751|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
2462752|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462753|NCT01022047|Budesonide|budesonide|mesh-list
2462754|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2462755|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2462756|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
2462757|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462758|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462759|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2462760|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
2462761|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
2462762|NCT01022047|Hormones|hormones|mesh-ancestor
2462763|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2462764|NCT01022125|Simeprevir|simeprevir|mesh-list
2462765|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
2462766|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462767|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
2462768|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462769|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462770|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
2462771|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2462772|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
2462773|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462774|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2462775|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2462776|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
2462777|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462778|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462779|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2462780|NCT01022151|Aminophylline|aminophylline|mesh-list
2462781|NCT01022151|Doxapram|doxapram|mesh-list
2462782|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2462783|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
2462784|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462785|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462786|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2462787|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
2462788|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2462789|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2462790|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462791|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462792|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2462793|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2462794|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
2462795|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462796|NCT01022151|Protective Agents|protective agents|mesh-ancestor
2462797|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2462798|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
2462799|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
2462800|NCT01022164|Coagulants|coagulants|mesh-ancestor
2462801|NCT01022229|Vitamins|vitamins|mesh-list
2462802|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
2462803|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
2462804|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462805|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
2462806|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
2462807|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2462808|NCT01022333|Protective Agents|protective agents|mesh-ancestor
2462809|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462810|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462811|NCT01022463|Atenolol|atenolol|mesh-list
2462812|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2462813|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2462814|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
2462815|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
2462816|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462817|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462818|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2462819|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2462820|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2462821|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
2462822|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462823|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462824|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
2462825|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2462826|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2462827|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
2462828|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462829|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2462830|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2462831|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462832|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462833|NCT01022528|Dexamethasone|dexamethasone|mesh-list
2462834|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
2462835|NCT01022528|BB 1101|bb 1101|mesh-list
2462836|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2462837|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
2462838|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
2462839|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462840|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462841|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2462842|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
2462843|NCT01022528|Hormones|hormones|mesh-ancestor
2462844|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2462845|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2462846|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462847|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
2462848|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462849|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462850|NCT01022541|Bevacizumab|bevacizumab|mesh-list
2462851|NCT01022541|Capecitabine|capecitabine|mesh-list
2462852|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
2462853|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2462854|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462855|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2462856|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2462857|NCT01022541|Growth Substances|growth substances|mesh-ancestor
2462858|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462859|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
2462860|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2462861|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
2462862|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462863|NCT01022632|Curcumin|curcumin|mesh-list
2462864|NCT01022632|Fluoxetine|fluoxetine|mesh-list
2462865|NCT01022632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2462866|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2462867|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2462868|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462869|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462870|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
2462871|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462872|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2462873|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
2462874|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2462875|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2462876|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2462877|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462878|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2462879|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2462880|NCT01022632|Analgesics|analgesics|mesh-ancestor
2462881|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
2462882|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462883|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2462884|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2462885|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462886|NCT01022645|Copper|copper|mesh-list
2462887|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
2462888|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2462889|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
2462890|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2462891|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462892|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2462893|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2462894|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2462895|NCT01022645|Trace Elements|trace elements|mesh-ancestor
2462896|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
2462897|NCT01022658|Insulin|insulin|mesh-list
2462898|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
2462899|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
2462900|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2462901|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462902|NCT01022671|Belotecan|belotecan|mesh-list
2462903|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2462904|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2462905|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462906|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462907|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462908|NCT01022736|Gabapentin|gabapentin|mesh-list
2462909|NCT01022736|Analgesics|analgesics|mesh-ancestor
2462910|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
2462911|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462912|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462913|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
2462914|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2462915|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2462916|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2462917|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2462918|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2462919|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2462920|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462921|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462922|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
2462923|NCT01022749|Vaccines|vaccines|mesh-list
2462924|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
2462925|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462926|NCT01022801|Entecavir|entecavir|mesh-list
2462927|NCT01022801|Antiviral Agents|antiviral agents|mesh-ancestor
2462928|NCT01022801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462929|NCT01022840|Ketamine|ketamine|mesh-list
2462930|NCT01022840|Esketamine|esketamine|mesh-list
2462931|NCT01022840|Analgesics|analgesics|mesh-ancestor
2462932|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
2462933|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2462934|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462935|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2462936|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2462937|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
2462938|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
2462939|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2462940|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2462941|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2462942|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2462943|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462944|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
2462945|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2462946|NCT01022918|Bevacizumab|bevacizumab|mesh-list
2462947|NCT01022918|Temozolomide|temozolomide|mesh-list
2462948|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2462949|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462950|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2462951|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2462952|NCT01022918|Growth Substances|growth substances|mesh-ancestor
2462953|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462954|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
2462955|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2462956|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
2462957|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462958|NCT01022983|Simendan|simendan|mesh-list
2462959|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2462960|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
2462961|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2462962|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2462963|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462964|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462965|NCT01022983|Protective Agents|protective agents|mesh-ancestor
2462966|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462967|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2462968|NCT01023087|Colistin|colistin|mesh-list
2462969|NCT01023087|Polymyxins|polymyxins|mesh-list
2462970|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2462971|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462972|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
2462973|NCT01023100|Tofacitinib|tofacitinib|mesh-list
2462974|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2462975|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2462976|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462977|NCT01023139|Sibutramine|sibutramine|mesh-list
2462978|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
2462979|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2462980|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
2462981|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2462982|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
2462983|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
2462984|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2462985|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2462986|NCT01023204|Paclitaxel|paclitaxel|mesh-list
2462987|NCT01023204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2462988|NCT01023204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2462989|NCT01023204|Tubulin Modulators|tubulin modulators|mesh-ancestor
2462990|NCT01023204|Antimitotic Agents|antimitotic agents|mesh-ancestor
2462991|NCT01023204|Mitosis Modulators|mitosis modulators|mesh-ancestor
2462992|NCT01023204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2462993|NCT01023230|Entecavir|entecavir|mesh-list
2462994|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
2462995|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2462996|NCT01023243|Aspirin|aspirin|mesh-list
2462997|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2462998|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2462999|NCT01023243|Analgesics|analgesics|mesh-ancestor
2463000|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
2463001|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463002|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463003|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2463004|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2463005|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2463006|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2463007|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463008|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2463009|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2463010|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463011|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
2463012|NCT01023295|Fosbretabulin|fosbretabulin|mesh-list
2463013|NCT01023295|Combretastatin|combretastatin|mesh-list
2463014|NCT01023295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2463015|NCT01023295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463016|NCT01023295|Tubulin Modulators|tubulin modulators|mesh-ancestor
2463017|NCT01023295|Antimitotic Agents|antimitotic agents|mesh-ancestor
2463018|NCT01023295|Mitosis Modulators|mitosis modulators|mesh-ancestor
2463019|NCT01023295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463020|NCT01023334|Lidocaine|lidocaine|mesh-list
2463021|NCT01023334|Anesthetics|anesthetics|mesh-list
2463022|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
2463023|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463024|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463025|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
2463026|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463027|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2463028|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2463029|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2463030|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2463031|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463032|NCT01023347|Paclitaxel|paclitaxel|mesh-list
2463033|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2463034|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2463035|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463036|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
2463037|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
2463038|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
2463039|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463040|NCT01023360|Esomeprazole|esomeprazole|mesh-list
2463041|NCT01023360|Rabeprazole|rabeprazole|mesh-list
2463042|NCT01023360|Pantoprazole|pantoprazole|mesh-list
2463043|NCT01023360|Clopidogrel|clopidogrel|mesh-list
2463044|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
2463045|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2463046|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2463047|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2463048|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2463049|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
2463050|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463051|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463052|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463053|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2463054|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2463055|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463056|NCT01023399|Artesunate|artesunate|mesh-list
2463057|NCT01023399|Amodiaquine|amodiaquine|mesh-list
2463058|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
2463059|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2463060|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2463061|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463062|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463063|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
2463064|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
2463065|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2463066|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
2463067|NCT01023425|Donepezil|donepezil|mesh-list
2463068|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2463069|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463070|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463071|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
2463072|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463073|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463074|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
2463075|NCT01023464|Emollients|emollients|mesh-list
2463076|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2463077|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2463078|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
2463079|NCT01023490|Vitamin D|vitamin d|mesh-list
2463080|NCT01023490|Vitamins|vitamins|mesh-ancestor
2463081|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
2463082|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463083|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2463084|NCT01023542|Everolimus|everolimus|mesh-list
2463085|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463086|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2463087|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
2463088|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463089|NCT01023607|Atorvastatin|atorvastatin|mesh-list
2463090|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2463091|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2463092|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2463093|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
2463094|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463095|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2463096|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2463097|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463098|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
2463099|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463111|NCT01023750|Fenofibrate|fenofibrate|mesh-list
2463112|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2463113|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
2463114|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463115|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2463116|NCT01023867|Donepezil|donepezil|mesh-list
2463117|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2463118|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463119|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463120|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
2463121|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463122|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463123|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
2463124|NCT01023880|Delanzomib|delanzomib|mesh-list
2463125|NCT01023880|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
2463126|NCT01023880|Protease Inhibitors|protease inhibitors|mesh-ancestor
2463127|NCT01023880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463128|NCT01023880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463129|NCT01023919|Sirolimus|sirolimus|mesh-list
2463130|NCT01023919|Paclitaxel|paclitaxel|mesh-list
2463131|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2463132|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463133|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
2463134|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
2463135|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
2463136|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463137|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2463138|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463139|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2463140|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
2463141|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2463142|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
2463143|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463144|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
2463145|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2463146|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463147|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2463148|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463149|NCT01024062|Paclitaxel|paclitaxel|mesh-list
2463150|NCT01024062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2463151|NCT01024062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463152|NCT01024062|Tubulin Modulators|tubulin modulators|mesh-ancestor
2463153|NCT01024062|Antimitotic Agents|antimitotic agents|mesh-ancestor
2463154|NCT01024062|Mitosis Modulators|mitosis modulators|mesh-ancestor
2463155|NCT01024062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463156|NCT01024075|Dexamethasone|dexamethasone|mesh-list
2463157|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2463158|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
2463159|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
2463160|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463161|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463162|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2463163|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
2463164|NCT01024075|Hormones|hormones|mesh-ancestor
2463165|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2463166|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2463167|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463168|NCT01024101|Paclitaxel|paclitaxel|mesh-list
2463169|NCT01024101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2463170|NCT01024101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463171|NCT01024101|Tubulin Modulators|tubulin modulators|mesh-ancestor
2463172|NCT01024101|Antimitotic Agents|antimitotic agents|mesh-ancestor
2463173|NCT01024101|Mitosis Modulators|mitosis modulators|mesh-ancestor
2463174|NCT01024101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463175|NCT01024140|Citalopram|citalopram|mesh-list
2463176|NCT01024140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2463177|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2463178|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2463179|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463180|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463181|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
2463182|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463183|NCT01024140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2463184|NCT01024140|Antidepressive Agents|antidepressive agents|mesh-ancestor
2463185|NCT01024140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2463186|NCT01024179|Sirolimus|sirolimus|mesh-list
2463187|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2463188|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463189|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2463190|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463191|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
2463192|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2463193|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
2463194|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463195|NCT01024192|Zolpidem|zolpidem|mesh-list
2463196|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2463197|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2463198|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463199|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463200|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
2463201|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
2463202|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
2463203|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463204|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463205|NCT01024205|Sunitinib|sunitinib|mesh-list
2463206|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463207|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2463208|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2463209|NCT01024205|Growth Substances|growth substances|mesh-ancestor
2463210|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463211|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
2463212|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2463213|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463214|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463215|NCT01024270|Misoprostol|misoprostol|mesh-list
2463216|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2463217|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
2463218|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2463219|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463220|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2463221|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2463222|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
2463223|NCT01024322|Diclofenac|diclofenac|mesh-list
2463224|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
2463225|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2463226|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
2463227|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2463228|NCT01024322|Prednisolone|prednisolone|mesh-list
2463229|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2463230|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
2463231|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2463232|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2463233|NCT01024322|Analgesics|analgesics|mesh-ancestor
2463234|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
2463235|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463236|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463237|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2463238|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2463239|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2463240|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463241|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463242|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
2463243|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
2463244|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2463245|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
2463246|NCT01024322|Hormones|hormones|mesh-ancestor
2463247|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2463248|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2463249|NCT01024322|Protective Agents|protective agents|mesh-ancestor
2463250|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2463251|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463252|NCT01024348|Acetaminophen|acetaminophen|mesh-list
2463253|NCT01024348|Tramadol|tramadol|mesh-list
2463254|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2463255|NCT01024348|Analgesics|analgesics|mesh-ancestor
2463256|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
2463257|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463258|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463259|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
2463260|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2463261|NCT01024348|Narcotics|narcotics|mesh-ancestor
2463262|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463263|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2463264|NCT01024413|Gefitinib|gefitinib|mesh-list
2463265|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463266|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2463267|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463268|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463269|NCT01024491|Paroxetine|paroxetine|mesh-list
2463270|NCT01024491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2463271|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2463272|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2463273|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463274|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463275|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
2463276|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463277|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2463278|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
2463279|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2463280|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2463281|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2463282|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463283|NCT01024504|Bevacizumab|bevacizumab|mesh-list
2463284|NCT01024504|Capecitabine|capecitabine|mesh-list
2463285|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
2463286|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2463287|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463288|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2463289|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2463290|NCT01024504|Growth Substances|growth substances|mesh-ancestor
2463291|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463292|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
2463293|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2463294|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
2463295|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463296|NCT01024543|Phenylephrine|phenylephrine|mesh-list
2463297|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
2463298|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
2463299|NCT01024543|Giapreza|giapreza|mesh-list
2463300|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
2463301|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2463302|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
2463303|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
2463304|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463305|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463306|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
2463307|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2463308|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
2463309|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
2463310|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2463311|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2463312|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2463313|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
2463314|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463315|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463316|NCT01024543|Protective Agents|protective agents|mesh-ancestor
2463317|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2463318|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
2463319|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463320|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
2463321|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2463322|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
2463323|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463324|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2463325|NCT01024660|Donepezil|donepezil|mesh-list
2463326|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2463327|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463328|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463329|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
2463330|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463331|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463332|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
2463333|NCT01024712|Paclitaxel|paclitaxel|mesh-list
2463334|NCT01024712|Carboplatin|carboplatin|mesh-list
2463335|NCT01024712|Gefitinib|gefitinib|mesh-list
2463336|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2463337|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463338|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
2463339|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
2463340|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
2463341|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463342|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2463343|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463344|NCT01024777|Vitamin D|vitamin d|mesh-list
2463345|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
2463346|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
2463347|NCT01024777|Vitamins|vitamins|mesh-list
2463348|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
2463349|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463350|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2463351|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2463352|NCT01024868|Ropivacaine|ropivacaine|mesh-list
2463353|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
2463354|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
2463355|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463356|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463357|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
2463358|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463359|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
2463360|NCT01025089|Doxorubicin|doxorubicin|mesh-list
2463361|NCT01025089|Cetuximab|cetuximab|mesh-list
2463362|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2463363|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
2463364|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463365|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2463366|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2463367|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
2463368|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463369|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463370|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2463371|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2463372|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2463373|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2463374|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463375|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2463376|NCT01025102|Sufentanil|sufentanil|mesh-list
2463377|NCT01025102|Ropivacaine|ropivacaine|mesh-list
2463378|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2463379|NCT01025102|Narcotics|narcotics|mesh-ancestor
2463380|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463381|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463382|NCT01025102|Analgesics|analgesics|mesh-ancestor
2463383|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
2463384|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463385|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2463386|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2463387|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
2463388|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
2463389|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
2463390|NCT01025128|Vitamin D|vitamin d|mesh-list
2463391|NCT01025128|Vitamins|vitamins|mesh-ancestor
2463392|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
2463393|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463394|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2463395|NCT01025245|Remifentanil|remifentanil|mesh-list
2463396|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2463397|NCT01025245|Narcotics|narcotics|mesh-ancestor
2463398|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463399|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463400|NCT01025245|Analgesics|analgesics|mesh-ancestor
2463401|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
2463402|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463403|NCT01025349|Bevacizumab|bevacizumab|mesh-list
2463404|NCT01025349|Docetaxel|docetaxel|mesh-list
2463405|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2463406|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463407|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2463408|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2463409|NCT01025349|Growth Substances|growth substances|mesh-ancestor
2463410|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463411|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
2463412|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
2463413|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
2463414|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
2463415|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463416|NCT01025466|Memantine|memantine|mesh-list
2463417|NCT01025466|Rivastigmine|rivastigmine|mesh-list
2463418|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2463419|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2463420|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
2463421|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463422|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463423|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463424|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2463425|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2463426|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2463427|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463428|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
2463429|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2463430|NCT01025466|Protective Agents|protective agents|mesh-ancestor
2463431|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
2463432|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463433|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2463434|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463435|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463436|NCT01025544|Vaccines|vaccines|mesh-list
2463437|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
2463438|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463439|NCT01025570|Gemcitabine|gemcitabine|mesh-list
2463440|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2463441|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
2463442|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463443|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463444|NCT01025570|Antiviral Agents|antiviral agents|mesh-ancestor
2463445|NCT01025570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463446|NCT01025570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463447|NCT01025570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2463448|NCT01025570|Immunologic Factors|immunologic factors|mesh-ancestor
2463449|NCT01025570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463450|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2463451|NCT01025648|Epinephrine|epinephrine|mesh-list
2463452|NCT01025648|Racepinephrine|racepinephrine|mesh-list
2463453|NCT01025648|Epinephryl borate|epinephryl borate|mesh-list
2463454|NCT01025648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2463455|NCT01025648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2463456|NCT01025648|Adrenergic Agents|adrenergic agents|mesh-ancestor
2463457|NCT01025648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463458|NCT01025648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463459|NCT01025648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463460|NCT01025648|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2463461|NCT01025648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2463462|NCT01025648|Autonomic Agents|autonomic agents|mesh-ancestor
2463463|NCT01025648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463464|NCT01025648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2463465|NCT01025648|Respiratory System Agents|respiratory system agents|mesh-ancestor
2463466|NCT01025648|Mydriatics|mydriatics|mesh-ancestor
2463467|NCT01025648|Sympathomimetics|sympathomimetics|mesh-ancestor
2463468|NCT01025648|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2463469|NCT01025700|Nabilone|nabilone|mesh-list
2463470|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
2463471|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
2463472|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463473|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463474|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2463475|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2463476|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2463477|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463478|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2463479|NCT01025765|Metformin|metformin|mesh-list
2463480|NCT01025765|Pioglitazone|pioglitazone|mesh-list
2463481|NCT01025765|Acarbose|acarbose|mesh-list
2463482|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2463483|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463484|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
2463485|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463486|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463487|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
2463488|NCT01025778|Thiotepa|thiotepa|mesh-list
2463489|NCT01025778|Etoposide|etoposide|mesh-list
2463490|NCT01025778|Clofarabine|clofarabine|mesh-list
2463491|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2463492|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
2463493|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463494|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2463495|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2463496|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
2463497|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463498|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463499|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2463500|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2463501|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2463502|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2463503|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463504|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2463505|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
2463506|NCT01025882|Gemcitabine|gemcitabine|mesh-list
2463507|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2463508|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
2463509|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463510|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463511|NCT01025882|Antiviral Agents|antiviral agents|mesh-ancestor
2463512|NCT01025882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463513|NCT01025882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463514|NCT01025882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2463515|NCT01025882|Immunologic Factors|immunologic factors|mesh-ancestor
2463516|NCT01025882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463517|NCT01025921|Colistin|colistin|mesh-list
2463518|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2463519|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463520|NCT01025934|Bevacizumab|bevacizumab|mesh-list
2463521|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2463522|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463523|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2463524|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2463525|NCT01025934|Growth Substances|growth substances|mesh-ancestor
2463526|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463527|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
2463528|NCT01026064|Azithromycin|azithromycin|mesh-list
2463529|NCT01026064|Cantharidin|cantharidin|mesh-list
2463530|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2463531|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463532|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463533|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463534|NCT01026090|Dronedarone|dronedarone|mesh-list
2463535|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2463536|NCT01026116|Paclitaxel|paclitaxel|mesh-list
2463537|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
2463538|NCT01026116|Epirubicin|epirubicin|mesh-list
2463539|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2463540|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463541|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
2463542|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
2463543|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
2463544|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463545|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2463546|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
2463547|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463548|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2463549|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2463550|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
2463551|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2463552|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2463553|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2463554|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2463555|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463556|NCT01026129|Lidocaine|lidocaine|mesh-list
2463557|NCT01026129|Remifentanil|remifentanil|mesh-list
2463558|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
2463559|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
2463560|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463561|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463562|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
2463563|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463564|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2463565|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2463566|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2463567|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2463568|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463569|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2463570|NCT01026129|Narcotics|narcotics|mesh-ancestor
2463571|NCT01026129|Analgesics|analgesics|mesh-ancestor
2463572|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2463573|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2463574|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463575|NCT01026285|Risperidone|risperidone|mesh-list
2463576|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
2463577|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2463578|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
2463579|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463580|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463581|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463582|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2463583|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463584|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2463585|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2463586|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
2463587|NCT01026311|Ubiquinone|ubiquinone|mesh-list
2463588|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
2463589|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
2463590|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463591|NCT01026311|Vitamins|vitamins|mesh-ancestor
2463592|NCT01026337|Sunitinib|sunitinib|mesh-list
2463593|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463594|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2463595|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2463596|NCT01026337|Growth Substances|growth substances|mesh-ancestor
2463597|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463598|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
2463599|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2463600|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463601|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463602|NCT01026350|Antibodies|antibodies|mesh-list
2463603|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
2463604|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463605|NCT01026363|Vitamin D|vitamin d|mesh-list
2463606|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
2463607|NCT01026363|Calcitriol|calcitriol|mesh-list
2463608|NCT01026363|Vitamins|vitamins|mesh-list
2463609|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
2463610|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463611|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2463612|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2463613|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2463614|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2463615|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463616|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2463617|NCT01026376|Decitabine|decitabine|mesh-list
2463618|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2463619|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
2463620|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463621|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463622|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463623|NCT01026415|Rifampin|rifampin|mesh-list
2463624|NCT01026415|Ketoconazole|ketoconazole|mesh-list
2463625|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2463626|NCT01026415|Midazolam|midazolam|mesh-list
2463627|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2463628|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2463629|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2463630|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463631|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463632|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2463633|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2463634|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2463635|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2463636|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
2463637|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
2463638|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
2463639|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
2463640|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463641|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463642|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2463643|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
2463644|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2463645|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463646|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
2463647|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2463648|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463649|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2463650|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2463651|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2463652|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2463653|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2463654|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2463655|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2463656|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463657|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
2463658|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
2463659|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2463660|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2463661|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2463662|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
2463663|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2463664|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2463665|NCT01026428|Levodopa|levodopa|mesh-list
2463666|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2463667|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2463668|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
2463669|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463670|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463671|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463672|NCT01026467|Carboplatin|carboplatin|mesh-list
2463673|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463674|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
2463675|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2463676|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2463677|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463678|NCT01026584|Aripiprazole|aripiprazole|mesh-list
2463679|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
2463680|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2463681|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2463682|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2463683|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463684|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463685|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
2463686|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
2463687|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463688|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463689|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2463690|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2463691|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
2463692|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2463693|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2463694|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2463695|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2463696|NCT01026610|Entecavir|entecavir|mesh-list
2463697|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
2463698|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463699|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
2463700|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2463701|NCT01026636|Cephalosporins|cephalosporins|mesh-list
2463702|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2463703|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463704|NCT01026701|Bortezomib|bortezomib|mesh-list
2463705|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463706|NCT01026714|Fluconazole|fluconazole|mesh-list
2463707|NCT01026714|Rifampin|rifampin|mesh-list
2463708|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
2463709|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
2463710|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463711|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2463712|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2463713|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463714|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463715|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2463716|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
2463717|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2463718|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463719|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2463720|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2463721|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2463722|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
2463723|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2463724|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
2463725|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2463726|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2463727|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2463728|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2463729|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2463730|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2463731|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2463732|NCT01026714|Analgesics|analgesics|mesh-ancestor
2463733|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
2463734|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463735|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2463736|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2463737|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2463738|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2463739|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2463740|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2463741|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
2463742|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463743|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
2463744|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2463745|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2463746|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463747|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
2463748|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2463749|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
2463750|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2463751|NCT01026961|Acetaminophen|acetaminophen|mesh-list
2463752|NCT01026961|Dimethindene|dimethindene|mesh-list
2463753|NCT01026961|Phenylephrine|phenylephrine|mesh-list
2463754|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
2463755|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2463756|NCT01026961|Analgesics|analgesics|mesh-ancestor
2463757|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
2463758|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463759|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463760|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
2463761|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463762|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2463763|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
2463764|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
2463765|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
2463766|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2463767|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
2463768|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
2463769|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2463770|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2463771|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2463772|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
2463773|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463774|NCT01026961|Protective Agents|protective agents|mesh-ancestor
2463775|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
2463776|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
2463777|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2463778|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
2463779|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
2463780|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2463781|NCT01026987|Plerixafor|plerixafor|mesh-list
2463782|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2463783|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2463784|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
2463785|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463786|NCT01027013|Rebamipide|rebamipide|mesh-list
2463787|NCT01027013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2463788|NCT01027013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2463789|NCT01027013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2463790|NCT01027013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2463791|NCT01027013|Antioxidants|antioxidants|mesh-ancestor
2463792|NCT01027013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463793|NCT01027013|Protective Agents|protective agents|mesh-ancestor
2463794|NCT01027013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463795|NCT01027013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463796|NCT01027065|Tenofovir|tenofovir|mesh-list
2463797|NCT01027065|Entecavir|entecavir|mesh-list
2463798|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
2463799|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463800|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2463801|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2463802|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463803|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463804|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2463805|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2463806|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
2463807|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
2463808|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2463809|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2463810|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463811|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463812|NCT01027117|Urological Agents|urological agents|mesh-ancestor
2463813|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
2463814|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2463815|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2463816|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
2463817|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463818|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2463819|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2463820|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463821|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463822|NCT01027377|Factor VIII|factor viii|mesh-list
2463823|NCT01027377|Coagulants|coagulants|mesh-ancestor
2463824|NCT01027429|Amoxicillin|amoxicillin|mesh-list
2463825|NCT01027429|Gentamicins|gentamicins|mesh-list
2463826|NCT01027429|Penicillins|penicillins|mesh-list
2463827|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
2463828|NCT01027429|Penicillin G|penicillin g|mesh-list
2463829|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
2463830|NCT01027429|Procaine|procaine|mesh-list
2463831|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2463832|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463833|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2463834|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463835|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463836|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
2463837|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
2463838|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463839|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463840|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
2463841|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463842|NCT01027481|Ranibizumab|ranibizumab|mesh-list
2463843|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2463844|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2463845|NCT01027481|Growth Substances|growth substances|mesh-ancestor
2463846|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463847|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
2463848|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463849|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
2463850|NCT01027494|Dexamethasone|dexamethasone|mesh-list
2463851|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2463852|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
2463853|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
2463854|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463855|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463856|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2463857|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
2463858|NCT01027494|Hormones|hormones|mesh-ancestor
2463859|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2463860|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2463861|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463862|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2463863|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463864|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2463865|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2463866|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463867|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463868|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2463869|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2463870|NCT01027520|Monensin|monensin|mesh-list
2463871|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
2463872|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463873|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2463874|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2463875|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
2463876|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
2463877|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
2463878|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463879|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463880|NCT01027520|Ionophores|ionophores|mesh-ancestor
2463881|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2463882|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
2463883|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
2463884|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2463885|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2463886|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463887|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
2463888|NCT01027546|Coagulants|coagulants|mesh-ancestor
2463889|NCT01027611|Lidocaine|lidocaine|mesh-list
2463890|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
2463891|NCT01027611|Propoxycaine|propoxycaine|mesh-list
2463892|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
2463893|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
2463894|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463895|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463896|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
2463897|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463898|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2463899|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2463900|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2463901|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2463902|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463903|NCT01027689|Alprazolam|alprazolam|mesh-list
2463904|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2463905|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2463906|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463907|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2463908|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2463909|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2463910|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
2463911|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
2463912|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2463913|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463914|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
2463915|NCT01027832|Tazobactam|tazobactam|mesh-list
2463916|NCT01027832|Piperacillin|piperacillin|mesh-list
2463917|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
2463918|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2463919|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463920|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2463921|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463922|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463923|NCT01027923|Cytarabine|cytarabine|mesh-list
2463924|NCT01027923|Plerixafor|plerixafor|mesh-list
2463925|NCT01027923|Etoposide|etoposide|mesh-list
2463926|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
2463927|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2463928|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463929|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2463930|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2463931|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463932|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463933|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2463934|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
2463935|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
2463936|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463937|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2463938|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
2463939|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463940|NCT01027923|Analgesics|analgesics|mesh-ancestor
2463941|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
2463942|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463943|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2463944|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2463945|NCT01028079|Aspirin|aspirin|mesh-list
2463946|NCT01028079|Ibuprofen|ibuprofen|mesh-list
2463947|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2463948|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2463949|NCT01028079|Analgesics|analgesics|mesh-ancestor
2463950|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
2463951|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463952|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463953|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2463954|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2463955|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2463956|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2463957|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463958|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2463959|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2463960|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463961|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
2463962|NCT01028092|Cyclosporine|cyclosporine|mesh-list
2463963|NCT01028092|Everolimus|everolimus|mesh-list
2463964|NCT01028092|Interleukin-2|interleukin-2|mesh-list
2463965|NCT01028092|Cyclosporins|cyclosporins|mesh-list
2463966|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
2463967|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2463968|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463969|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2463970|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
2463971|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463972|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
2463973|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2463974|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
2463975|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2463976|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2463977|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463978|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2463979|NCT01028092|Analgesics|analgesics|mesh-ancestor
2463980|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
2463981|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2463982|NCT01028170|Furosemide|furosemide|mesh-list
2463983|NCT01028170|Diuretics|diuretics|mesh-ancestor
2463984|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
2463985|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463986|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2463987|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2463988|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2463989|NCT01028248|Ranibizumab|ranibizumab|mesh-list
2463990|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2463991|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2463992|NCT01028248|Growth Substances|growth substances|mesh-ancestor
2463993|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2463994|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
2463995|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2463996|NCT01028261|CKD732|ckd732|mesh-list
2463997|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2463998|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2463999|NCT01028261|Growth Substances|growth substances|mesh-ancestor
2464000|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464001|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
2464002|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464003|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
2464004|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
2464005|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
2464006|NCT01028287|Hormones|hormones|mesh-ancestor
2464007|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2464008|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464009|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464010|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464011|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
2464012|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2464013|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2464014|NCT01028313|Prednisolone|prednisolone|mesh-list
2464015|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
2464016|NCT01028313|Panobinostat|panobinostat|mesh-list
2464017|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2464018|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
2464019|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2464020|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
2464021|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
2464022|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464023|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464024|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2464025|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
2464026|NCT01028313|Hormones|hormones|mesh-ancestor
2464027|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2464028|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2464029|NCT01028313|Protective Agents|protective agents|mesh-ancestor
2464030|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2464031|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464032|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2464033|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464034|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464035|NCT01028339|Mannitol|mannitol|mesh-list
2464036|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2464037|NCT01028339|Diuretics|diuretics|mesh-ancestor
2464038|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
2464039|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464040|NCT01028404|Insulin|insulin|mesh-list
2464041|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2464042|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
2464043|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
2464044|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2464045|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2464046|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464047|NCT01028443|Cyclosporine|cyclosporine|mesh-list
2464048|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
2464049|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464050|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
2464051|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464052|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464053|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464054|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
2464055|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464056|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464057|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2464058|NCT01028482|Sertraline|sertraline|mesh-list
2464059|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
2464060|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2464061|NCT01028482|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2464062|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2464063|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2464064|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464065|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464066|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
2464067|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464068|NCT01028495|Gemcitabine|gemcitabine|mesh-list
2464069|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2464070|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
2464071|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464072|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464073|NCT01028495|Antiviral Agents|antiviral agents|mesh-ancestor
2464074|NCT01028495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464075|NCT01028495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464076|NCT01028495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464077|NCT01028495|Immunologic Factors|immunologic factors|mesh-ancestor
2464078|NCT01028495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464079|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
2464080|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
2464081|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2464082|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464083|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464084|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2464085|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2464086|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2464087|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464088|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2464089|NCT01028534|Olmesartan|olmesartan|mesh-list
2464090|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
2464091|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
2464092|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
2464093|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
2464094|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2464095|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464096|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2464097|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2464098|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464099|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2464100|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2464101|NCT01028547|Dexamethasone|dexamethasone|mesh-list
2464102|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2464103|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
2464104|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
2464105|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464106|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464107|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2464108|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
2464109|NCT01028547|Hormones|hormones|mesh-ancestor
2464110|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2464111|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2464112|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464113|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
2464114|NCT01028573|Laxatives|laxatives|mesh-ancestor
2464115|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2464116|NCT01028638|Bevacizumab|bevacizumab|mesh-list
2464117|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
2464118|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2464119|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464120|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2464121|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2464122|NCT01028638|Growth Substances|growth substances|mesh-ancestor
2464123|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464124|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
2464125|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2464126|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464127|NCT01028716|Vidarabine|vidarabine|mesh-list
2464128|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
2464129|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
2464130|NCT01028716|Fludarabine|fludarabine|mesh-list
2464131|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
2464132|NCT01028716|Tacrolimus|tacrolimus|mesh-list
2464133|NCT01028716|Lenograstim|lenograstim|mesh-list
2464134|NCT01028716|Sargramostim|sargramostim|mesh-list
2464135|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464136|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
2464137|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464138|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464139|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2464140|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
2464141|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464142|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464143|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2464144|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2464145|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
2464146|NCT01028716|Antiviral Agents|antiviral agents|mesh-ancestor
2464147|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464148|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2464149|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2464150|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464151|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2464152|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2464153|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
2464154|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2464155|NCT01028729|Gemcitabine|gemcitabine|mesh-list
2464156|NCT01028729|Endostar protein|endostar protein|mesh-list
2464157|NCT01028729|Endostatins|endostatins|mesh-list
2464158|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464159|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2464160|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
2464161|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464162|NCT01028729|Antiviral Agents|antiviral agents|mesh-ancestor
2464163|NCT01028729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464164|NCT01028729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464165|NCT01028729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464166|NCT01028729|Immunologic Factors|immunologic factors|mesh-ancestor
2464167|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464168|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2464169|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2464170|NCT01028729|Growth Substances|growth substances|mesh-ancestor
2464171|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
2464172|NCT01028768|Teduglutide|teduglutide|mesh-list
2464173|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2464174|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2464175|NCT01028768|Protective Agents|protective agents|mesh-ancestor
2464176|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464177|NCT01028781|Thalidomide|thalidomide|mesh-list
2464178|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464179|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
2464180|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464181|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
2464182|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2464183|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464184|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2464185|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2464186|NCT01028781|Growth Substances|growth substances|mesh-ancestor
2464187|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
2464188|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464189|NCT01028846|Diazoxide|diazoxide|mesh-list
2464190|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2464191|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
2464192|NCT01028924|Teduglutide|teduglutide|mesh-list
2464193|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2464194|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2464195|NCT01028924|Protective Agents|protective agents|mesh-ancestor
2464196|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464197|NCT01028950|Darexaban|darexaban|mesh-list
2464198|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2464199|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
2464200|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2464201|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
2464202|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464203|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464204|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
2464205|NCT01028963|Pioglitazone|pioglitazone|mesh-list
2464206|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2464207|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464208|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
2464209|NCT01028976|Vitamins|vitamins|mesh-ancestor
2464210|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
2464211|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464212|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
2464213|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464214|NCT01028976|Protective Agents|protective agents|mesh-ancestor
2464215|NCT01029002|Vitamin D|vitamin d|mesh-list
2464216|NCT01029002|Vitamins|vitamins|mesh-ancestor
2464217|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
2464218|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464219|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2464220|NCT01029132|Galantamine|galantamine|mesh-list
2464221|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2464222|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464223|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464224|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
2464225|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464226|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464227|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2464228|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
2464229|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464230|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
2464231|NCT01029223|Metoprolol|metoprolol|mesh-list
2464232|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2464233|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2464234|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
2464235|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
2464236|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464237|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464238|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2464239|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2464240|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2464241|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
2464242|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464243|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464244|NCT01029275|Octreotide|octreotide|mesh-list
2464245|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2464246|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2464247|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464248|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2464249|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464250|NCT01029418|Sorafenib|sorafenib|mesh-list
2464251|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464252|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2464253|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464254|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464255|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
2464256|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2464257|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464258|NCT01029522|Atorvastatin|atorvastatin|mesh-list
2464259|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2464260|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2464261|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
2464262|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464263|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2464264|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2464265|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464266|NCT01029613|Adalimumab|adalimumab|mesh-list
2464267|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2464268|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464269|NCT01029639|Insulin|insulin|mesh-list
2464270|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
2464271|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2464272|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2464273|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464274|NCT01029678|Vinorelbine|vinorelbine|mesh-list
2464275|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464276|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2464277|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
2464278|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
2464279|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
2464280|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464281|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2464282|NCT01029717|Minocycline|minocycline|mesh-list
2464283|NCT01029717|Rifampin|rifampin|mesh-list
2464284|NCT01029717|Heparin|heparin|mesh-list
2464285|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464286|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2464287|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
2464288|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
2464289|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2464290|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2464291|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464292|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
2464293|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2464294|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464295|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2464296|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2464297|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2464298|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2464299|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2464300|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2464301|NCT01029743|Aspirin|aspirin|mesh-list
2464302|NCT01029743|PENTA|penta|mesh-list
2464303|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
2464304|NCT01029743|Fondaparinux|fondaparinux|mesh-list
2464305|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2464306|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2464307|NCT01029743|Analgesics|analgesics|mesh-ancestor
2464308|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
2464309|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464310|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464311|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2464312|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464313|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2464314|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2464315|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464316|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2464317|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2464318|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464319|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
2464320|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2464321|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
2464322|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2464323|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
2464324|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
2464325|NCT01029769|Olanzapine|olanzapine|mesh-list
2464326|NCT01029769|Amisulpride|amisulpride|mesh-list
2464327|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
2464328|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
2464329|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464330|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464331|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2464332|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2464333|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2464334|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2464335|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2464336|NCT01029769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2464337|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2464338|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2464339|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464340|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464341|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
2464342|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2464343|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
2464344|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2464345|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
2464346|NCT01029821|Heparin|heparin|mesh-list
2464347|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2464348|NCT01029821|Tinzaparin|tinzaparin|mesh-list
2464349|NCT01029821|Dalteparin|dalteparin|mesh-list
2464350|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
2464351|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2464352|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2464353|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464354|NCT01029847|Adalimumab|adalimumab|mesh-list
2464355|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2464356|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464357|NCT01029873|Cisplatin|cisplatin|mesh-list
2464358|NCT01029873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464359|NCT01030016|Atenolol|atenolol|mesh-list
2464360|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2464361|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2464362|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
2464363|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
2464364|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464365|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464366|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2464367|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2464368|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2464369|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
2464370|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464371|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464372|NCT01030042|Leucovorin|leucovorin|mesh-list
2464373|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
2464374|NCT01030042|Irinotecan|irinotecan|mesh-list
2464375|NCT01030042|Cetuximab|cetuximab|mesh-list
2464376|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464377|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2464378|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2464379|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464380|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464381|NCT01030042|Antidotes|antidotes|mesh-ancestor
2464382|NCT01030042|Protective Agents|protective agents|mesh-ancestor
2464383|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464384|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
2464385|NCT01030042|Vitamins|vitamins|mesh-ancestor
2464386|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
2464387|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2464388|NCT01030081|Amlodipine|amlodipine|mesh-list
2464389|NCT01030081|Nifedipine|nifedipine|mesh-list
2464390|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2464391|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2464392|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2464393|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464394|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2464395|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464396|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
2464397|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
2464398|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2464399|NCT01030094|Topiramate|topiramate|mesh-list
2464400|NCT01030094|Carbamazepine|carbamazepine|mesh-list
2464401|NCT01030094|Valproic Acid|valproic acid|mesh-list
2464402|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
2464403|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2464404|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464405|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464406|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464407|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
2464408|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464409|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
2464410|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2464411|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2464412|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2464413|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2464414|NCT01030094|Analgesics|analgesics|mesh-ancestor
2464415|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
2464416|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464417|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2464418|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2464419|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2464420|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2464421|NCT01030120|Etanercept|etanercept|mesh-list
2464422|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2464423|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2464424|NCT01030120|Analgesics|analgesics|mesh-ancestor
2464425|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
2464426|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464427|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464428|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2464429|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464430|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2464431|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464432|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
2464433|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2464434|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
2464435|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2464436|NCT01030302|Bortezomib|bortezomib|mesh-list
2464437|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464438|NCT01030328|Fenofibrate|fenofibrate|mesh-list
2464439|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2464440|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
2464441|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464442|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2464443|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2464444|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2464445|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464446|NCT01030432|Ribavirin|ribavirin|mesh-list
2464447|NCT01030432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2464448|NCT01030432|Interferon-alpha|interferon-alpha|mesh-list
2464449|NCT01030432|Asunaprevir|asunaprevir|mesh-list
2464450|NCT01030432|Antimetabolites|antimetabolites|mesh-ancestor
2464451|NCT01030432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464452|NCT01030432|Antiviral Agents|antiviral agents|mesh-ancestor
2464453|NCT01030432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464454|NCT01030432|Immunologic Factors|immunologic factors|mesh-ancestor
2464455|NCT01030432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464456|NCT01030432|Protease Inhibitors|protease inhibitors|mesh-ancestor
2464457|NCT01030432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464458|NCT01030510|Rocuronium|rocuronium|mesh-list
2464459|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2464460|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2464461|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2464462|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464463|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464464|NCT01030601|Dexamethasone|dexamethasone|mesh-list
2464465|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
2464466|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2464467|NCT01030601|BB 1101|bb 1101|mesh-list
2464468|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2464469|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
2464470|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
2464471|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464472|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464473|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2464474|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
2464475|NCT01030601|Hormones|hormones|mesh-ancestor
2464476|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2464477|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2464478|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464479|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
2464480|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464481|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464482|NCT01030614|Dexamethasone|dexamethasone|mesh-list
2464483|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2464484|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
2464485|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
2464486|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464487|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464488|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2464489|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
2464490|NCT01030614|Hormones|hormones|mesh-ancestor
2464491|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2464492|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2464493|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464494|NCT01030640|Tanezumab|tanezumab|mesh-list
2464495|NCT01030640|Analgesics|analgesics|mesh-ancestor
2464496|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
2464497|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464498|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464499|NCT01030692|Rivastigmine|rivastigmine|mesh-list
2464500|NCT01030692|Huperzine A|huperzine a|mesh-list
2464501|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2464502|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464503|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464504|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
2464505|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464506|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464507|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2464508|NCT01030692|Protective Agents|protective agents|mesh-ancestor
2464509|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
2464510|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
2464511|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2464512|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464513|NCT01030770|Ranibizumab|ranibizumab|mesh-list
2464514|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2464515|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2464516|NCT01030770|Growth Substances|growth substances|mesh-ancestor
2464517|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464518|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
2464519|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464520|NCT01030796|Caffeine|caffeine|mesh-list
2464521|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2464522|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464523|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2464524|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464525|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464526|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2464527|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2464528|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
2464529|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464530|NCT01030900|Rituximab|rituximab|mesh-list
2464531|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
2464532|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2464533|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464534|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
2464535|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464536|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464537|NCT01030926|Insulin|insulin|mesh-list
2464538|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2464539|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
2464540|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2464541|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464542|NCT01031017|Progesterone|progesterone|mesh-list
2464543|NCT01031017|Progestins|progestins|mesh-ancestor
2464544|NCT01031017|Hormones|hormones|mesh-ancestor
2464545|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2464546|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464547|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
2464548|NCT01031030|Fluorouracil|fluorouracil|mesh-list
2464549|NCT01031030|Methotrexate|methotrexate|mesh-list
2464550|NCT01031030|Epirubicin|epirubicin|mesh-list
2464551|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464552|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
2464553|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464554|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464555|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2464556|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
2464557|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464558|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464559|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2464560|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
2464561|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2464562|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2464563|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
2464564|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2464565|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
2464566|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464567|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2464568|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2464569|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2464570|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2464571|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2464572|NCT01031212|Acetic Acid|acetic acid|mesh-list
2464573|NCT01031212|Paclitaxel|paclitaxel|mesh-list
2464574|NCT01031212|Carboplatin|carboplatin|mesh-list
2464575|NCT01031212|Cetuximab|cetuximab|mesh-list
2464576|NCT01031212|Vadimezan|vadimezan|mesh-list
2464577|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2464578|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464579|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
2464580|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
2464581|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
2464582|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464583|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2464584|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2464585|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464586|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
2464587|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
2464588|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2464589|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2464590|NCT01031355|Calcium|calcium|mesh-list
2464591|NCT01031355|Estradiol|estradiol|mesh-list
2464592|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2464593|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2464594|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464595|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2464596|NCT01031355|Estrogens|estrogens|mesh-ancestor
2464597|NCT01031355|Hormones|hormones|mesh-ancestor
2464598|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2464599|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2464600|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
2464601|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2464602|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2464603|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
2464604|NCT01031355|Vitamins|vitamins|mesh-ancestor
2464605|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
2464606|NCT01031368|Cytarabine|cytarabine|mesh-list
2464607|NCT01031368|Clofarabine|clofarabine|mesh-list
2464608|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
2464609|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464610|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2464611|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
2464612|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464613|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464614|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
2464615|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464616|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464617|NCT01031459|Interferons|interferons|mesh-list
2464618|NCT01031459|Interferon-beta|interferon-beta|mesh-list
2464619|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
2464620|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464621|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
2464622|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464623|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
2464624|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464625|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2464626|NCT01031589|Rilpivirine|rilpivirine|mesh-list
2464627|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2464628|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2464629|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464630|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464631|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
2464632|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464633|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2464634|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2464635|NCT01031667|Cilostazol|cilostazol|mesh-list
2464636|NCT01031667|Probucol|probucol|mesh-list
2464637|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2464638|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
2464639|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464640|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464641|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2464642|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
2464643|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2464644|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2464645|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464646|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2464647|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
2464648|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2464649|NCT01031667|Protective Agents|protective agents|mesh-ancestor
2464650|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2464651|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2464652|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464653|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2464654|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2464655|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
2464656|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2464657|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
2464658|NCT01031719|Vaccines|vaccines|mesh-list
2464659|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
2464660|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464661|NCT01031732|Tacrine|tacrine|mesh-list
2464662|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2464663|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464664|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464665|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
2464666|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464667|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464668|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2464669|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
2464670|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464671|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
2464672|NCT01031849|Lopinavir|lopinavir|mesh-list
2464673|NCT01031849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2464674|NCT01031849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2464675|NCT01031849|Protease Inhibitors|protease inhibitors|mesh-ancestor
2464676|NCT01031849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464677|NCT01031849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464678|NCT01031849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2464679|NCT01031849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2464680|NCT01031849|Antiviral Agents|antiviral agents|mesh-ancestor
2464681|NCT01031849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464682|NCT01031849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2464683|NCT01031849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2464684|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
2464685|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2464686|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464687|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2464688|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2464689|NCT01031901|Sirolimus|sirolimus|mesh-list
2464690|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2464691|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464692|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2464693|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464694|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
2464695|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464696|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
2464697|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464698|NCT01031927|Glycine|glycine|mesh-list
2464699|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
2464700|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464701|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464702|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464703|NCT01031966|Thymalfasin|thymalfasin|mesh-list
2464704|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2464705|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
2464706|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464707|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
2464708|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2464709|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2464710|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464711|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
2464712|NCT01031992|Coagulants|coagulants|mesh-ancestor
2464713|NCT01032031|Ascorbic Acid|ascorbic acid|mesh-list
2464714|NCT01032031|Vitamins|vitamins|mesh-ancestor
2464715|NCT01032031|Micronutrients|micronutrients|mesh-ancestor
2464716|NCT01032031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464717|NCT01032031|Antioxidants|antioxidants|mesh-ancestor
2464718|NCT01032031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464719|NCT01032031|Protective Agents|protective agents|mesh-ancestor
2464720|NCT01032057|Gemcitabine|gemcitabine|mesh-list
2464721|NCT01032057|Capecitabine|capecitabine|mesh-list
2464722|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2464723|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
2464724|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464725|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464726|NCT01032057|Antiviral Agents|antiviral agents|mesh-ancestor
2464727|NCT01032057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464728|NCT01032057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464729|NCT01032057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464730|NCT01032057|Immunologic Factors|immunologic factors|mesh-ancestor
2464731|NCT01032057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464732|NCT01032083|Citalopram|citalopram|mesh-list
2464733|NCT01032083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2464734|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2464735|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2464736|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464737|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464738|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
2464739|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464740|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2464741|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
2464742|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2464743|NCT01032109|Bevacizumab|bevacizumab|mesh-list
2464744|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2464745|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464746|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2464747|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2464748|NCT01032109|Growth Substances|growth substances|mesh-ancestor
2464749|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464750|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
2464751|NCT01032122|Rituximab|rituximab|mesh-list
2464752|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2464753|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464754|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
2464755|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464756|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464757|NCT01032148|Panobinostat|panobinostat|mesh-list
2464758|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464759|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2464760|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464761|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464762|NCT01032187|Amphotericin B|amphotericin b|mesh-list
2464763|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2464764|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
2464765|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2464766|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
2464767|NCT01032187|Amebicides|amebicides|mesh-ancestor
2464768|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2464769|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2464770|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464771|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2464772|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
2464773|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2464774|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2464775|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
2464776|NCT01032213|Analgesics|analgesics|mesh-ancestor
2464777|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
2464778|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464779|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464780|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
2464781|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2464782|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2464783|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
2464784|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2464785|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2464786|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464787|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2464788|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
2464789|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2464790|NCT01032304|Erdosteine|erdosteine|mesh-list
2464791|NCT01032304|Expectorants|expectorants|mesh-ancestor
2464792|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
2464793|NCT01032434|Sertraline|sertraline|mesh-list
2464794|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
2464795|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2464796|NCT01032434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2464797|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2464798|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2464799|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464800|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464801|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
2464802|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464803|NCT01032486|Rasagiline|rasagiline|mesh-list
2464804|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2464805|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464806|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464807|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2464808|NCT01032486|Protective Agents|protective agents|mesh-ancestor
2464809|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464810|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
2464811|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2464812|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464813|NCT01032668|Clopidogrel|clopidogrel|mesh-list
2464814|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2464815|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2464816|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2464817|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2464818|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
2464819|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464820|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464821|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464822|NCT01032798|Mepivacaine|mepivacaine|mesh-list
2464823|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
2464824|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
2464825|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2464826|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464827|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
2464828|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464829|NCT01033058|Atorvastatin|atorvastatin|mesh-list
2464830|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2464831|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2464832|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
2464833|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464834|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2464835|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2464836|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464837|NCT01033084|Sertraline|sertraline|mesh-list
2464838|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
2464839|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2464840|NCT01033084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2464841|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2464842|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2464843|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464844|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464845|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
2464846|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464847|NCT01033097|Betamethasone|betamethasone|mesh-list
2464848|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2464849|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
2464850|NCT01033097|Hormones|hormones|mesh-ancestor
2464851|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2464852|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464853|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2464854|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
2464855|NCT01033123|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2464856|NCT01033123|Iniparib|iniparib|mesh-list
2464857|NCT01033123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464858|NCT01033123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464859|NCT01033123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464860|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
2464861|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2464862|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
2464863|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464864|NCT01033149|Expectorants|expectorants|mesh-ancestor
2464865|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
2464866|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2464867|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
2464868|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464869|NCT01033149|Protective Agents|protective agents|mesh-ancestor
2464870|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464871|NCT01033149|Antidotes|antidotes|mesh-ancestor
2464872|NCT01033279|Warfarin|warfarin|mesh-list
2464873|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
2464874|NCT01033292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
2464875|NCT01033292|Iniparib|iniparib|mesh-list
2464876|NCT01033292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464877|NCT01033292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464878|NCT01033292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464879|NCT01033305|Cyclosporine|cyclosporine|mesh-list
2464880|NCT01033305|Cyclosporins|cyclosporins|mesh-list
2464881|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464882|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464883|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464884|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
2464885|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464886|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
2464887|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464888|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
2464889|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464890|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2464891|NCT01033318|Losartan|losartan|mesh-list
2464892|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2464893|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2464894|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2464895|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2464896|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464897|NCT01033370|Clevidipine|clevidipine|mesh-list
2464898|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2464899|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2464900|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464901|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2464902|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464903|NCT01033396|Fexofenadine|fexofenadine|mesh-list
2464904|NCT01033396|Terfenadine|terfenadine|mesh-list
2464905|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2464906|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2464907|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2464908|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
2464909|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
2464910|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2464911|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464912|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464913|NCT01033409|Vaccines|vaccines|mesh-list
2464914|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
2464915|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464916|NCT01033461|Calcium|calcium|mesh-list
2464917|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2464918|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464919|NCT01033500|Abatacept|abatacept|mesh-list
2464920|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2464921|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464922|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464923|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464924|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
2464925|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464926|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464927|NCT01033526|Aspirin|aspirin|mesh-list
2464928|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2464929|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2464930|NCT01033526|Analgesics|analgesics|mesh-ancestor
2464931|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
2464932|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2464933|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464934|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2464935|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464936|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2464937|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2464938|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464939|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2464940|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2464941|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464942|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
2464943|NCT01033552|Cyclosporine|cyclosporine|mesh-list
2464944|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
2464945|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
2464946|NCT01033552|Fludarabine|fludarabine|mesh-list
2464947|NCT01033552|Cyclosporins|cyclosporins|mesh-list
2464948|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2464949|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464950|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
2464951|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464952|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464953|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2464954|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
2464955|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464956|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464957|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2464958|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464959|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
2464960|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2464961|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
2464962|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2464963|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2464964|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2464965|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
2464966|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2464967|NCT01033656|Methotrexate|methotrexate|mesh-list
2464968|NCT01033656|Azathioprine|azathioprine|mesh-list
2464969|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2464970|NCT01033656|Leflunomide|leflunomide|mesh-list
2464971|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2464972|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
2464973|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2464974|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2464975|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2464976|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
2464977|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464978|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2464979|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
2464980|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464981|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2464982|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2464983|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
2464984|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2464985|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2464986|NCT01033760|Ritonavir|ritonavir|mesh-list
2464987|NCT01033760|Darunavir|darunavir|mesh-list
2464988|NCT01033760|Tenofovir|tenofovir|mesh-list
2464989|NCT01033760|Emtricitabine|emtricitabine|mesh-list
2464990|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
2464991|NCT01033760|Maraviroc|maraviroc|mesh-list
2464992|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2464993|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2464994|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
2464995|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2464996|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2464997|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2464998|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2464999|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
2465000|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465001|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2465002|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2465003|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2465004|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2465005|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2465006|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2465007|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2465008|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2465009|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2465010|NCT01033877|Vaccines|vaccines|mesh-list
2465011|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
2465012|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465013|NCT01033903|Misoprostol|misoprostol|mesh-list
2465014|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2465015|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
2465016|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2465017|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465018|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2465019|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2465020|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
2465021|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2465022|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2465023|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2465024|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
2465025|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465026|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2465027|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2465028|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465029|NCT01033981|Sunitinib|sunitinib|mesh-list
2465030|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465031|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2465032|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2465033|NCT01033981|Growth Substances|growth substances|mesh-ancestor
2465034|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465035|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
2465036|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2465037|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465038|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465039|NCT01033994|Mitogens|mitogens|mesh-list
2465040|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
2465041|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465042|NCT01034020|Nicotine|nicotine|mesh-list
2465043|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2465044|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
2465045|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465046|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465047|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2465048|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2465049|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
2465050|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465051|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465052|NCT01034124|Vitamin K|vitamin k|mesh-list
2465053|NCT01034124|Midazolam|midazolam|mesh-list
2465054|NCT01034124|Warfarin|warfarin|mesh-list
2465055|NCT01034124|Vitamins|vitamins|mesh-ancestor
2465056|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
2465057|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465058|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2465059|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2465060|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2465061|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2465062|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2465063|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2465064|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2465065|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
2465066|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
2465067|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
2465068|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
2465069|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465070|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465071|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
2465072|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2465073|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2465074|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
2465075|NCT01034124|Coagulants|coagulants|mesh-ancestor
2465076|NCT01034189|Paclitaxel|paclitaxel|mesh-list
2465077|NCT01034189|Cetuximab|cetuximab|mesh-list
2465078|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2465079|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465080|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
2465081|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
2465082|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
2465083|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465084|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2465085|NCT01034345|Sirolimus|sirolimus|mesh-list
2465086|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
2465087|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2465088|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465089|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2465090|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465091|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
2465092|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2465093|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
2465094|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465095|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465096|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465097|NCT01034410|Cytarabine|cytarabine|mesh-list
2465098|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2465099|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
2465100|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465101|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465102|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
2465103|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465104|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2465105|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
2465106|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465107|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
2465108|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2465109|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465110|NCT01034683|Leucovorin|leucovorin|mesh-list
2465111|NCT01034683|Antidotes|antidotes|mesh-ancestor
2465112|NCT01034683|Protective Agents|protective agents|mesh-ancestor
2465113|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465114|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
2465115|NCT01034683|Vitamins|vitamins|mesh-ancestor
2465116|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
2465117|NCT01034787|Tremelimumab|tremelimumab|mesh-list
2465118|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465119|NCT01034878|Sunitinib|sunitinib|mesh-list
2465120|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465121|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2465122|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2465123|NCT01034878|Growth Substances|growth substances|mesh-ancestor
2465124|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465125|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
2465126|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2465127|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465128|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465129|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2465130|NCT01034917|Etravirine|etravirine|mesh-list
2465131|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
2465132|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465133|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2465134|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2465135|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465136|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465137|NCT01034956|Calcium|calcium|mesh-list
2465138|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
2465139|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2465140|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465141|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2465142|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
2465143|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
2465144|NCT01034956|Protective Agents|protective agents|mesh-ancestor
2465145|NCT01034995|Citalopram|citalopram|mesh-list
2465146|NCT01034995|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2465147|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2465148|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2465149|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465150|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465151|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
2465152|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465153|NCT01034995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2465154|NCT01034995|Antidepressive Agents|antidepressive agents|mesh-ancestor
2465155|NCT01034995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2465156|NCT01035021|Rocuronium|rocuronium|mesh-list
2465157|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
2465158|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
2465159|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2465160|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465161|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465162|NCT01035190|Budesonide|budesonide|mesh-list
2465163|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2465164|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2465165|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
2465166|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465167|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465168|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2465169|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
2465170|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
2465171|NCT01035190|Hormones|hormones|mesh-ancestor
2465172|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2465173|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
2465174|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2465175|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
2465176|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465177|NCT01035281|Nabilone|nabilone|mesh-list
2465178|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
2465179|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
2465180|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465181|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465182|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2465183|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2465184|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2465185|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2465186|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2465187|NCT01035320|Simvastatin|simvastatin|mesh-list
2465188|NCT01035320|Ezetimibe|ezetimibe|mesh-list
2465189|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2465190|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2465191|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
2465192|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465193|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2465194|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2465195|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465196|NCT01035450|Sirolimus|sirolimus|mesh-list
2465197|NCT01035450|Everolimus|everolimus|mesh-list
2465198|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465199|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2465200|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
2465201|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465202|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2465203|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465204|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2465205|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
2465206|NCT01035502|Idarubicin|idarubicin|mesh-list
2465207|NCT01035502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2465208|NCT01035502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465209|NCT01035502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2465210|NCT01035502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2465211|NCT01035502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465212|NCT01035502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465213|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
2465214|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
2465215|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2465216|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2465217|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
2465218|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465219|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465220|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465221|NCT01035528|Metformin|metformin|mesh-list
2465222|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
2465223|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2465224|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465225|NCT01035580|Curcumin|curcumin|mesh-list
2465226|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2465227|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2465228|NCT01035580|Analgesics|analgesics|mesh-ancestor
2465229|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
2465230|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465231|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465232|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2465233|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2465234|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465235|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465236|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465237|NCT01035619|Moxidectin|moxidectin|mesh-list
2465238|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
2465239|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2465240|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465241|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
2465242|NCT01035671|Vitamin E|vitamin e|mesh-list
2465243|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
2465244|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
2465245|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2465246|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
2465247|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465248|NCT01035671|Protective Agents|protective agents|mesh-ancestor
2465249|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465250|NCT01035671|Vitamins|vitamins|mesh-ancestor
2465251|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
2465252|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
2465253|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2465254|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465255|NCT01035853|Colistin|colistin|mesh-list
2465256|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2465257|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465258|NCT01035879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2465259|NCT01035879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2465260|NCT01035879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465261|NCT01035879|Incretins|incretins|mesh-ancestor
2465262|NCT01035879|Hormones|hormones|mesh-ancestor
2465263|NCT01035879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2465264|NCT01035879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2465265|NCT01035879|Protease Inhibitors|protease inhibitors|mesh-ancestor
2465266|NCT01035879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465267|NCT01035879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465268|NCT01035983|Frovatriptan|frovatriptan|mesh-list
2465269|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2465270|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
2465271|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465272|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465273|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465274|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2465275|NCT01036035|Pilocarpine|pilocarpine|mesh-list
2465276|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2465277|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2465278|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
2465279|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465280|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465281|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465282|NCT01036035|Urological Agents|urological agents|mesh-ancestor
2465283|NCT01036035|Miotics|miotics|mesh-ancestor
2465284|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
2465285|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465286|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2465287|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2465288|NCT01036087|Paclitaxel|paclitaxel|mesh-list
2465289|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2465290|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
2465291|NCT01036087|Carboplatin|carboplatin|mesh-list
2465292|NCT01036087|Fluorouracil|fluorouracil|mesh-list
2465293|NCT01036087|Epirubicin|epirubicin|mesh-list
2465294|NCT01036087|Panitumumab|panitumumab|mesh-list
2465295|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2465296|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465297|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
2465298|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
2465299|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
2465300|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465301|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2465302|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
2465303|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465304|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2465305|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2465306|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
2465307|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2465308|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
2465309|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2465310|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2465311|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2465312|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2465313|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465314|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2465315|NCT01036399|Lenalidomide|lenalidomide|mesh-list
2465316|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
2465317|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465318|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2465319|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2465320|NCT01036399|Growth Substances|growth substances|mesh-ancestor
2465321|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
2465322|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465323|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
2465324|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2465325|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2465326|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465327|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
2465328|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
2465329|NCT01036659|Ecallantide|ecallantide|mesh-list
2465330|NCT01036659|Bradykinin|bradykinin|mesh-list
2465331|NCT01036659|Kallikreins|kallikreins|mesh-list
2465332|NCT01036659|Kininogens|kininogens|mesh-list
2465333|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
2465334|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
2465335|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
2465336|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465337|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465338|NCT01036659|Analgesics|analgesics|mesh-ancestor
2465339|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
2465340|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465341|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465342|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2465343|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2465344|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2465345|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2465346|NCT01036659|Coagulants|coagulants|mesh-ancestor
2465347|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
2465348|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
2465349|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2465350|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
2465351|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
2465352|NCT01036841|Coagulants|coagulants|mesh-ancestor
2465353|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
2465354|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
2465355|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465356|NCT01036854|Ondansetron|ondansetron|mesh-list
2465357|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
2465358|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
2465359|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465360|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465361|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2465362|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
2465363|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
2465364|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2465365|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
2465366|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465367|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465368|NCT01036854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2465369|NCT01036854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2465370|NCT01036854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2465371|NCT01036854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2465372|NCT01036854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2465373|NCT01036893|Prucalopride|prucalopride|mesh-list
2465374|NCT01036893|Laxatives|laxatives|mesh-ancestor
2465375|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2465376|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2465377|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2465378|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
2465379|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465380|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465381|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465382|NCT01036932|Sargramostim|sargramostim|mesh-list
2465383|NCT01036932|Lenograstim|lenograstim|mesh-list
2465384|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
2465385|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465386|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2465387|NCT01037023|Topotecan|topotecan|mesh-list
2465388|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2465389|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2465390|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465391|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465392|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465393|NCT01037036|Latanoprost|latanoprost|mesh-list
2465394|NCT01037036|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2465395|NCT01037036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2465396|NCT01037062|Entecavir|entecavir|mesh-list
2465397|NCT01037062|Antiviral Agents|antiviral agents|mesh-ancestor
2465398|NCT01037062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465399|NCT01037101|Cycloserine|cycloserine|mesh-list
2465400|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2465401|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465402|NCT01037101|Renal Agents|renal agents|mesh-ancestor
2465403|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2465404|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
2465405|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2465406|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
2465407|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465408|NCT01037140|Vitamin D|vitamin d|mesh-list
2465409|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
2465410|NCT01037140|Vitamins|vitamins|mesh-ancestor
2465411|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
2465412|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465413|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2465414|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2465415|NCT01037166|Entecavir|entecavir|mesh-list
2465416|NCT01037166|Antiviral Agents|antiviral agents|mesh-ancestor
2465417|NCT01037166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465418|NCT01037179|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2465419|NCT01037179|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2465420|NCT01037179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2465421|NCT01037179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2465422|NCT01037179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2465423|NCT01037179|Analgesics|analgesics|mesh-ancestor
2465424|NCT01037179|Sensory System Agents|sensory system agents|mesh-ancestor
2465425|NCT01037179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465426|NCT01037179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465427|NCT01037179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2465428|NCT01037179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2465429|NCT01037179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2465430|NCT01037179|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2465431|NCT01037179|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2465432|NCT01037179|Histamine Antagonists|histamine antagonists|mesh-ancestor
2465433|NCT01037179|Histamine Agents|histamine agents|mesh-ancestor
2465434|NCT01037179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465435|NCT01037179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465436|NCT01037322|Cannabidiol|cannabidiol|mesh-list
2465437|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
2465438|NCT01037335|Morphine|morphine|mesh-list
2465439|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2465440|NCT01037335|Narcotics|narcotics|mesh-ancestor
2465441|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2465442|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465443|NCT01037335|Analgesics|analgesics|mesh-ancestor
2465444|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
2465445|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465446|NCT01037348|Ranibizumab|ranibizumab|mesh-list
2465447|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2465448|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2465449|NCT01037348|Growth Substances|growth substances|mesh-ancestor
2465450|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465451|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
2465452|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465453|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
2465454|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
2465455|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465456|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465457|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2465458|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
2465459|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
2465460|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2465461|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
2465462|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465463|NCT01037465|Expectorants|expectorants|mesh-ancestor
2465464|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
2465465|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2465466|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
2465467|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465468|NCT01037465|Protective Agents|protective agents|mesh-ancestor
2465469|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465470|NCT01037465|Antidotes|antidotes|mesh-ancestor
2465471|NCT01037491|Aspirin|aspirin|mesh-list
2465472|NCT01037491|Rabeprazole|rabeprazole|mesh-list
2465473|NCT01037491|Clopidogrel|clopidogrel|mesh-list
2465474|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2465475|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2465476|NCT01037491|Analgesics|analgesics|mesh-ancestor
2465477|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
2465478|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465479|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465480|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2465481|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2465482|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2465483|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2465484|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465485|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2465486|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2465487|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465488|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
2465489|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2465490|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2465491|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2465492|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
2465493|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465494|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2465495|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2465496|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2465497|NCT01037517|Plerixafor|plerixafor|mesh-list
2465498|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2465499|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2465500|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
2465501|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465502|NCT01037530|Ramipril|ramipril|mesh-list
2465503|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2465504|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
2465505|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465506|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465507|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2465508|NCT01037595|Turmeric extract|turmeric extract|mesh-list
2465509|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
2465510|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465511|NCT01037595|Protective Agents|protective agents|mesh-ancestor
2465512|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465513|NCT01037608|Nabiximols|nabiximols|mesh-list
2465514|NCT01037608|Analgesics|analgesics|mesh-ancestor
2465515|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
2465516|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465517|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465518|NCT01037621|Valacyclovir|valacyclovir|mesh-list
2465519|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
2465520|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465521|NCT01037634|Oseltamivir|oseltamivir|mesh-list
2465522|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
2465523|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465524|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465525|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465526|NCT01037660|Metformin|metformin|mesh-list
2465527|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2465528|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465529|NCT01037699|Hormones|hormones|mesh-list
2465530|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2465531|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2465532|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465533|NCT01037712|Valacyclovir|valacyclovir|mesh-list
2465534|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
2465535|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465536|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
2465537|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465538|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2465539|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465540|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465541|NCT01037842|Mitiglinide|mitiglinide|mesh-list
2465542|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2465543|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465544|NCT01037959|Norfloxacin|norfloxacin|mesh-list
2465545|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2465546|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465547|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2465548|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2465549|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465550|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465551|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465552|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2465553|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2465554|NCT01037998|Gefitinib|gefitinib|mesh-list
2465555|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465556|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2465557|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465558|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465559|NCT01038024|Antioxidants|antioxidants|mesh-list
2465560|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465561|NCT01038024|Protective Agents|protective agents|mesh-ancestor
2465562|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465563|NCT01038037|Carboplatin|carboplatin|mesh-list
2465564|NCT01038037|Vinorelbine|vinorelbine|mesh-list
2465565|NCT01038037|Panitumumab|panitumumab|mesh-list
2465566|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465567|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2465568|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
2465569|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
2465570|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
2465571|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465572|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2465573|NCT01038063|Lumefantrine|lumefantrine|mesh-list
2465574|NCT01038063|Artemether|artemether|mesh-list
2465575|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2465576|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
2465577|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2465578|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2465579|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465580|NCT01038089|Resveratrol|resveratrol|mesh-list
2465581|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
2465582|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465583|NCT01038089|Protective Agents|protective agents|mesh-ancestor
2465584|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465585|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465586|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2465587|NCT01038154|Pravastatin|pravastatin|mesh-list
2465588|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2465589|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2465590|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
2465591|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465592|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2465593|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2465594|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465595|NCT01038167|Cyclosporine|cyclosporine|mesh-list
2465596|NCT01038167|Tacrolimus|tacrolimus|mesh-list
2465597|NCT01038167|Cyclosporins|cyclosporins|mesh-list
2465598|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2465599|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
2465600|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465601|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2465602|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465603|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465604|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
2465605|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465606|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
2465607|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2465608|NCT01038349|Methotrexate|methotrexate|mesh-list
2465609|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2465610|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
2465611|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2465612|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465613|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2465614|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
2465615|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465616|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465617|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
2465618|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465619|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2465620|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2465621|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
2465622|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2465623|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2465624|NCT01038388|Dexamethasone|dexamethasone|mesh-list
2465625|NCT01038388|Lenalidomide|lenalidomide|mesh-list
2465626|NCT01038388|Bortezomib|bortezomib|mesh-list
2465627|NCT01038388|Vorinostat|vorinostat|mesh-list
2465628|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2465629|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
2465630|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
2465631|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465632|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465633|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2465634|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
2465635|NCT01038388|Hormones|hormones|mesh-ancestor
2465636|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2465637|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2465638|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465639|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
2465640|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2465641|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2465642|NCT01038388|Growth Substances|growth substances|mesh-ancestor
2465643|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
2465644|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2465645|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465646|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465647|NCT01038453|Vitamin D|vitamin d|mesh-list
2465648|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
2465649|NCT01038453|Vitamins|vitamins|mesh-ancestor
2465650|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
2465651|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465652|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2465653|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2465654|NCT01038505|Sirolimus|sirolimus|mesh-list
2465655|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
2465656|NCT01038505|Tacrolimus|tacrolimus|mesh-list
2465657|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2465658|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
2465659|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465660|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2465661|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465662|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465663|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2465664|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465665|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2465666|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465667|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
2465668|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2465669|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
2465670|NCT01038570|Oxytocin|oxytocin|mesh-list
2465671|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
2465672|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2465673|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465674|NCT01038583|Aspirin|aspirin|mesh-list
2465675|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2465676|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2465677|NCT01038583|Analgesics|analgesics|mesh-ancestor
2465678|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
2465679|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465680|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465681|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2465682|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2465683|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2465684|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2465685|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465686|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2465687|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2465688|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465689|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
2465690|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2465691|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2465692|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465693|NCT01038648|Incretins|incretins|mesh-ancestor
2465694|NCT01038648|Hormones|hormones|mesh-ancestor
2465695|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2465696|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2465697|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
2465698|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465699|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465700|NCT01038661|Docetaxel|docetaxel|mesh-list
2465701|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465702|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
2465703|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
2465704|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
2465705|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465706|NCT01038739|Mesalamine|mesalamine|mesh-list
2465707|NCT01038739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2465708|NCT01038739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2465709|NCT01038739|Analgesics|analgesics|mesh-ancestor
2465710|NCT01038739|Sensory System Agents|sensory system agents|mesh-ancestor
2465711|NCT01038739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465712|NCT01038739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465713|NCT01038739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2465714|NCT01038739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2465715|NCT01038804|Docetaxel|docetaxel|mesh-list
2465716|NCT01038804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465717|NCT01038804|Tubulin Modulators|tubulin modulators|mesh-ancestor
2465718|NCT01038804|Antimitotic Agents|antimitotic agents|mesh-ancestor
2465719|NCT01038804|Mitosis Modulators|mitosis modulators|mesh-ancestor
2465720|NCT01038804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465721|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
2465722|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
2465723|NCT01038817|Protective Agents|protective agents|mesh-ancestor
2465724|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465725|NCT01038882|Midazolam|midazolam|mesh-list
2465726|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2465727|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2465728|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2465729|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465730|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2465731|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2465732|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2465733|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2465734|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
2465735|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
2465736|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
2465737|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
2465738|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465739|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465740|NCT01038895|Ramipril|ramipril|mesh-list
2465741|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2465742|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
2465743|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465744|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465745|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2465746|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
2465747|NCT01039025|Melphalan|melphalan|mesh-list
2465748|NCT01039025|Topotecan|topotecan|mesh-list
2465749|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2465750|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
2465751|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465752|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2465753|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2465754|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
2465755|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465756|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465757|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2465758|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2465759|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2465760|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465761|NCT01039090|Dopamine|dopamine|mesh-list
2465762|NCT01039090|Apomorphine|apomorphine|mesh-list
2465763|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
2465764|NCT01039090|Emetics|emetics|mesh-ancestor
2465765|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465766|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
2465767|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465768|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2465769|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
2465770|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465771|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465772|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2465773|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
2465774|NCT01039090|Protective Agents|protective agents|mesh-ancestor
2465775|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
2465776|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2465777|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2465778|NCT01039103|Prednisolone|prednisolone|mesh-list
2465779|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
2465780|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2465781|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
2465782|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2465783|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
2465784|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
2465785|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465786|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465787|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2465788|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
2465789|NCT01039103|Hormones|hormones|mesh-ancestor
2465790|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2465791|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2465792|NCT01039103|Protective Agents|protective agents|mesh-ancestor
2465793|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2465794|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465795|NCT01039142|Acitretin|acitretin|mesh-list
2465796|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
2465797|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
2465798|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
2465799|NCT01039155|Azacitidine|azacitidine|mesh-list
2465800|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465801|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2465802|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
2465803|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465804|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465805|NCT01039181|Vitamin D|vitamin d|mesh-list
2465806|NCT01039181|Calcitriol|calcitriol|mesh-list
2465807|NCT01039181|Vitamins|vitamins|mesh-ancestor
2465808|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
2465809|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465810|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2465811|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2465812|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
2465813|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2465814|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465815|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2465816|NCT01039194|Galantamine|galantamine|mesh-list
2465817|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2465818|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465819|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465820|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
2465821|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465822|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465823|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2465824|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
2465825|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465826|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
2465827|NCT01039233|Bicalutamide|bicalutamide|mesh-list
2465828|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
2465829|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
2465830|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2465831|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465832|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465833|NCT01039285|Poractant alfa|poractant alfa|mesh-list
2465834|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
2465835|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
2465836|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
2465837|NCT01039350|Hematinics|hematinics|mesh-ancestor
2465838|NCT01039363|Cytarabine|cytarabine|mesh-list
2465839|NCT01039363|Vorinostat|vorinostat|mesh-list
2465840|NCT01039363|Idarubicin|idarubicin|mesh-list
2465841|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
2465842|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2465843|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
2465844|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465845|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465846|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
2465847|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465848|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2465849|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
2465850|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465851|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2465852|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465853|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2465854|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2465855|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2465856|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2465857|NCT01039441|Bupivacaine|bupivacaine|mesh-list
2465858|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
2465859|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
2465860|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2465861|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465862|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
2465863|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465864|NCT01039506|Irinotecan|irinotecan|mesh-list
2465865|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2465866|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2465867|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465868|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465869|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465870|NCT01039545|Norfloxacin|norfloxacin|mesh-list
2465871|NCT01039545|Diclofenac|diclofenac|mesh-list
2465872|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2465873|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2465874|NCT01039545|Analgesics|analgesics|mesh-ancestor
2465875|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
2465876|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2465877|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465878|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2465879|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2465880|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2465881|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465882|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465883|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2465884|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465885|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2465886|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2465887|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465888|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2465889|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2465890|NCT01039558|Ecabet|ecabet|mesh-list
2465891|NCT01039558|Lansoprazole|lansoprazole|mesh-list
2465892|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
2465893|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2465894|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2465895|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2465896|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465897|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465898|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465899|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
2465900|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
2465901|NCT01039558|Protective Agents|protective agents|mesh-ancestor
2465902|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465903|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465904|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
2465905|NCT01039610|Linezolid|linezolid|mesh-list
2465906|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2465907|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465908|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2465909|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2465910|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465911|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465912|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465913|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2465914|NCT01039740|Mirtazapine|mirtazapine|mesh-list
2465915|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
2465916|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2465917|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2465918|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
2465919|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
2465920|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2465921|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465922|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465923|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2465924|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2465925|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2465926|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2465927|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2465928|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2465929|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
2465930|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2465931|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2465932|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
2465933|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2465934|NCT01039766|Oxytocin|oxytocin|mesh-list
2465935|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
2465936|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2465937|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465938|NCT01039844|Paclitaxel|paclitaxel|mesh-list
2465939|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2465940|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465941|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
2465942|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
2465943|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
2465944|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465945|NCT01039883|Albaconazole|albaconazole|mesh-list
2465946|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
2465947|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465948|NCT01039948|Gefitinib|gefitinib|mesh-list
2465949|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465950|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2465951|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465952|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465953|NCT01039974|Ketoconazole|ketoconazole|mesh-list
2465954|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
2465955|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465956|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2465957|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2465958|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465959|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465960|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2465961|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
2465962|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2465963|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465964|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2465965|NCT01040078|Vaccines|vaccines|mesh-list
2465966|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
2465967|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465968|NCT01040091|Tenofovir|tenofovir|mesh-list
2465969|NCT01040091|Emtricitabine|emtricitabine|mesh-list
2465970|NCT01040091|Efavirenz|efavirenz|mesh-list
2465971|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
2465972|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
2465973|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2465974|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2465975|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2465976|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465977|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465978|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2465979|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2465980|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2465981|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2465982|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2465983|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2465984|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2465985|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2465986|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
2465987|NCT01040195|Methotrexate|methotrexate|mesh-list
2465988|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2465989|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
2465990|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2465991|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2465992|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2465993|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
2465994|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2465995|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2465996|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
2465997|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2465998|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2465999|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2466000|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
2466001|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2466002|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2466003|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
2466004|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2466005|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2466006|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466007|NCT01040234|Bupivacaine|bupivacaine|mesh-list
2466008|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
2466009|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
2466010|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2466011|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466012|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
2466013|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466014|NCT01040273|Bupivacaine|bupivacaine|mesh-list
2466015|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
2466016|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
2466017|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2466018|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466019|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
2466020|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466021|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
2466022|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
2466023|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2466024|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466025|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
2466026|NCT01040286|Analgesics|analgesics|mesh-ancestor
2466027|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
2466028|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466029|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466030|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2466031|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2466032|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2466033|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2466034|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2466035|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466036|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466037|NCT01040312|Cisplatin|cisplatin|mesh-list
1659301|NCT05076461|Ondansetron|ondansetron|mesh-list
2466038|NCT01040312|Carboplatin|carboplatin|mesh-list
2466039|NCT01040312|Nedaplatin|nedaplatin|mesh-list
2466040|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466041|NCT01040325|Vaccines|vaccines|mesh-list
2466042|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
2466043|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466044|NCT01040338|Nicotine|nicotine|mesh-list
2466045|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2466046|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
2466047|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466048|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466049|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2466050|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2466051|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
2466052|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466053|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466054|NCT01040429|Clonidine|clonidine|mesh-list
2466055|NCT01040429|Analgesics|analgesics|mesh-ancestor
2466056|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
2466057|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466058|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466059|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2466060|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
2466061|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
2466062|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2466063|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2466064|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2466065|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
2466066|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466067|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466068|NCT01040455|Lansoprazole|lansoprazole|mesh-list
2466069|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
2466070|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2466071|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2466072|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2466073|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466074|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466075|NCT01040559|Idarubicin|idarubicin|mesh-list
2466076|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2466077|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466078|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2466079|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2466080|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466081|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466082|NCT01040585|Linezolid|linezolid|mesh-list
2466083|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2466084|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466085|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2466086|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466087|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466088|NCT01040598|Omalizumab|omalizumab|mesh-list
2466089|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2466090|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2466091|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
2466092|NCT01040702|Methylphenidate|methylphenidate|mesh-list
2466093|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2466094|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466095|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2466096|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2466097|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2466098|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466099|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
2466100|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466101|NCT01040936|Atorvastatin|atorvastatin|mesh-list
2466102|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2466103|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2466104|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
2466105|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466106|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2466107|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2466108|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466109|NCT01041027|Paclitaxel|paclitaxel|mesh-list
2466110|NCT01041027|Carboplatin|carboplatin|mesh-list
2466111|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2466112|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466113|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
2466114|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
2466115|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
2466116|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466117|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
2466118|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2466119|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466120|NCT01041066|Labetalol|labetalol|mesh-list
2466121|NCT01041066|Nicardipine|nicardipine|mesh-list
2466122|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2466123|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2466124|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
2466125|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466126|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466127|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466128|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2466129|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
2466130|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
2466131|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466132|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2466133|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2466134|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2466135|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2466136|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2466137|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
2466138|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2466139|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2466140|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
2466141|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2466142|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466143|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2466144|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2466145|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2466146|NCT01041170|Rimonabant|rimonabant|mesh-list
2466147|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2466148|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
2466149|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
2466150|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466151|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466152|NCT01041170|Hormones|hormones|mesh-ancestor
2466153|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2466154|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466155|NCT01041183|Ramosetron|ramosetron|mesh-list
2466156|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
2466157|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
2466158|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466159|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466160|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2466161|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2466162|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
2466163|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466164|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466165|NCT01041235|Docetaxel|docetaxel|mesh-list
2466166|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466167|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
2466168|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
2466169|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
2466170|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466171|NCT01041313|Memantine|memantine|mesh-list
2466172|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2466173|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2466174|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
2466175|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466176|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466177|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466178|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2466179|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2466180|NCT01041378|Dexamethasone|dexamethasone|mesh-list
2466181|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2466182|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
2466183|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
2466184|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466185|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466186|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2466187|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
2466188|NCT01041378|Hormones|hormones|mesh-ancestor
2466189|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2466190|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2466191|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466192|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
2466193|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
2466194|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466195|NCT01041482|Sorafenib|sorafenib|mesh-list
2466196|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466197|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2466198|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466199|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466200|NCT01041508|Cyclosporine|cyclosporine|mesh-list
2466201|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
2466202|NCT01041508|Clofarabine|clofarabine|mesh-list
2466203|NCT01041508|Cyclosporins|cyclosporins|mesh-list
2466204|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466205|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466206|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2466207|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
2466208|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466209|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
2466210|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466211|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
2466212|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2466213|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2466214|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2466215|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466216|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2466217|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
2466218|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2466219|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2466220|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
2466221|NCT01041625|Apremilast|apremilast|mesh-list
2466222|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2466223|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2466224|NCT01041625|Analgesics|analgesics|mesh-ancestor
2466225|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
2466226|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466227|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466228|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2466229|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2466230|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
2466231|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2466232|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466233|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466234|NCT01041690|Bevacizumab|bevacizumab|mesh-list
2466235|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2466236|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466237|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2466238|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2466239|NCT01041690|Growth Substances|growth substances|mesh-ancestor
2466240|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466241|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
2466242|NCT01041729|Atorvastatin|atorvastatin|mesh-list
2466243|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2466244|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2466245|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
2466246|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466247|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2466248|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2466249|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466250|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
2466251|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
2466252|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2466253|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466254|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466255|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466256|NCT01041807|Losartan|losartan|mesh-list
2466257|NCT01041807|Amlodipine|amlodipine|mesh-list
2466258|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2466259|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2466260|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2466261|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466262|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2466263|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466264|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
2466265|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2466266|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2466267|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2466268|NCT01041872|Lidocaine|lidocaine|mesh-list
2466269|NCT01041872|Propofol|propofol|mesh-list
2466270|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
2466271|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
2466272|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2466273|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466274|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
2466275|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466276|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2466277|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2466278|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2466279|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2466280|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466281|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2466282|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2466283|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
2466284|NCT01041963|Losartan|losartan|mesh-list
2466285|NCT01041963|Enalapril|enalapril|mesh-list
2466286|NCT01041963|Enalaprilat|enalaprilat|mesh-list
2466287|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2466288|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2466289|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2466290|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2466291|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466292|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2466293|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
2466294|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466295|NCT01042028|Capecitabine|capecitabine|mesh-list
2466296|NCT01042028|Irinotecan|irinotecan|mesh-list
2466297|NCT01042028|Everolimus|everolimus|mesh-list
2466298|NCT01042028|Cetuximab|cetuximab|mesh-list
2466299|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
2466300|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2466301|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
2466302|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466303|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466304|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2466305|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2466306|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466307|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2466308|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
2466309|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466310|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2466311|NCT01042041|Doxorubicin|doxorubicin|mesh-list
2466312|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2466313|NCT01042041|Sorafenib|sorafenib|mesh-list
2466314|NCT01042041|Mitomycins|mitomycins|mesh-list
2466315|NCT01042041|Mitomycin|mitomycin|mesh-list
2466316|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466317|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2466318|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2466319|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2466320|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466321|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466322|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2466323|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
2466324|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2466325|NCT01042314|Donepezil|donepezil|mesh-list
2466326|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2466327|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466328|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466329|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
2466330|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466331|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466332|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
2466333|NCT01042379|Metformin|metformin|mesh-list
2466334|NCT01042379|Paclitaxel|paclitaxel|mesh-list
2466335|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
2466336|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2466337|NCT01042379|Carboplatin|carboplatin|mesh-list
2466338|NCT01042379|Doxorubicin|doxorubicin|mesh-list
2466339|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
2466340|NCT01042379|Trastuzumab|trastuzumab|mesh-list
2466341|NCT01042379|Irinotecan|irinotecan|mesh-list
2466342|NCT01042379|Durvalumab|durvalumab|mesh-list
2466343|NCT01042379|Letrozole|letrozole|mesh-list
2466344|NCT01042379|Olaparib|olaparib|mesh-list
2466345|NCT01042379|Pertuzumab|pertuzumab|mesh-list
2466346|NCT01042379|Veliparib|veliparib|mesh-list
2466347|NCT01042379|Talazoparib|talazoparib|mesh-list
2466348|NCT01042379|Cemiplimab|cemiplimab|mesh-list
2466349|NCT01042379|Trebananib|trebananib|mesh-list
2466350|NCT01042379|Tucatinib|tucatinib|mesh-list
2466351|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2466352|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466353|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
2466354|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
2466355|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
2466356|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466357|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2466358|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466359|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2466360|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2466361|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2466362|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466363|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2466364|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2466365|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2466366|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2466367|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2466368|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
2466369|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2466370|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2466371|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2466372|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2466373|NCT01042379|Growth Substances|growth substances|mesh-ancestor
2466374|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
2466375|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2466376|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
2466377|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2466378|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466379|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2466380|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
2466381|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2466382|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466383|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466384|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466402|NCT01042561|Vitamin D|vitamin d|mesh-list
2466403|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
2466404|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
2466405|NCT01042561|Vitamins|vitamins|mesh-list
2466406|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
2466407|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466408|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2466409|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2466410|NCT01042574|Clevidipine|clevidipine|mesh-list
2466411|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2466412|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2466413|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466414|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2466415|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466416|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
2466417|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2466418|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2466419|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
2466420|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466421|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2466422|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2466423|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466424|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466425|NCT01042665|Latanoprost|latanoprost|mesh-list
2466426|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
2466427|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2466428|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
2466429|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466430|NCT01042704|Aspirin|aspirin|mesh-list
2466431|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2466432|NCT01042704|Dexamethasone|dexamethasone|mesh-list
2466433|NCT01042704|Lenalidomide|lenalidomide|mesh-list
2466434|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2466435|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2466436|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
2466437|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
2466438|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466439|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466440|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2466441|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
2466442|NCT01042704|Hormones|hormones|mesh-ancestor
2466443|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2466444|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2466445|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466446|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2466447|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2466448|NCT01042704|Analgesics|analgesics|mesh-ancestor
2466449|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
2466450|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2466451|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2466452|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2466453|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466454|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2466455|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2466456|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466457|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
2466458|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
2466459|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2466460|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2466461|NCT01042704|Growth Substances|growth substances|mesh-ancestor
2466462|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
2466463|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466464|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2466465|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
2466466|NCT01042717|Plerixafor|plerixafor|mesh-list
2466467|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2466468|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2466469|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
2466470|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466471|NCT01042730|Pitavastatin|pitavastatin|mesh-list
2466472|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2466473|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2466474|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2466475|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
2466476|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466477|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466478|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2466479|NCT01042782|Everolimus|everolimus|mesh-list
2466480|NCT01042782|Mitomycin|mitomycin|mesh-list
2466481|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466482|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2466483|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
2466484|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466485|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
2466486|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466487|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2466488|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2466489|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466490|NCT01042873|Dobutamine|dobutamine|mesh-list
2466491|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2466492|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
2466493|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
2466494|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466495|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466496|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2466497|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2466498|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2466499|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
2466500|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466501|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466502|NCT01042873|Protective Agents|protective agents|mesh-ancestor
2466503|NCT01042925|Paclitaxel|paclitaxel|mesh-list
2466504|NCT01042925|Trastuzumab|trastuzumab|mesh-list
2466505|NCT01042925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2466506|NCT01042925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466507|NCT01042925|Tubulin Modulators|tubulin modulators|mesh-ancestor
2466508|NCT01042925|Antimitotic Agents|antimitotic agents|mesh-ancestor
2466509|NCT01042925|Mitosis Modulators|mitosis modulators|mesh-ancestor
2466510|NCT01042925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466511|NCT01042925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2466512|NCT01042951|Vaccines|vaccines|mesh-list
2466513|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
2466514|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466515|NCT01043029|Pioglitazone|pioglitazone|mesh-list
2466516|NCT01043029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2466517|NCT01043029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466518|NCT01043172|Gemcitabine|gemcitabine|mesh-list
2466519|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2466520|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
2466521|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466522|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466523|NCT01043172|Antiviral Agents|antiviral agents|mesh-ancestor
2466524|NCT01043172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466525|NCT01043172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466526|NCT01043172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2466527|NCT01043172|Immunologic Factors|immunologic factors|mesh-ancestor
2466528|NCT01043172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466529|NCT01043211|Lidocaine|lidocaine|mesh-list
2466530|NCT01043211|Epinephrine|epinephrine|mesh-list
2466531|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
2466532|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
2466533|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2466534|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466535|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
2466536|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466537|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2466538|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2466539|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2466540|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2466541|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466542|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2466543|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2466544|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
2466545|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466546|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2466547|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2466548|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
2466549|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2466550|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
2466551|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
2466552|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
2466553|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2466554|NCT01043224|Clobetasol|clobetasol|mesh-list
2466555|NCT01043224|Calcipotriene|calcipotriene|mesh-list
2466556|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2466557|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
2466558|NCT01043224|Hormones|hormones|mesh-ancestor
2466559|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2466560|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466561|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
2466562|NCT01043341|Vaccines|vaccines|mesh-list
2466563|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
2466564|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466565|NCT01043380|Atorvastatin|atorvastatin|mesh-list
2466566|NCT01043380|Ezetimibe|ezetimibe|mesh-list
2466567|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2466568|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2466569|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
2466570|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466571|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2466572|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2466573|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466574|NCT01043419|Xenon|xenon|mesh-list
2466575|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2466576|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
2466577|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
2466578|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2466579|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466580|NCT01043445|Glycerol|glycerol|mesh-list
2466581|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2466582|NCT01043445|Protective Agents|protective agents|mesh-ancestor
2466583|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466584|NCT01043484|Bevacizumab|bevacizumab|mesh-list
2466585|NCT01043484|Capecitabine|capecitabine|mesh-list
2466586|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2466587|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466588|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2466589|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2466590|NCT01043484|Growth Substances|growth substances|mesh-ancestor
2466591|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466592|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
2466593|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2466594|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
2466595|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466596|NCT01043510|Insulin|insulin|mesh-list
2466597|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2466598|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
2466599|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2466600|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466601|NCT01043536|Temozolomide|temozolomide|mesh-list
2466602|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2466603|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
2466604|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466605|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466606|NCT01043575|Rifampin|rifampin|mesh-list
2466607|NCT01043575|Rifapentine|rifapentine|mesh-list
2466608|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2466609|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
2466610|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2466611|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466612|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
2466613|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2466614|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466615|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466616|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2466617|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2466618|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2466619|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2466620|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2466621|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2466622|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
2466623|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2466624|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
2466625|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466626|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466627|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2466628|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
2466629|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2466630|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2466631|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2466632|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
2466633|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466634|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466635|NCT01043666|Mirabegron|mirabegron|mesh-list
2466636|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
2466637|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
2466638|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2466639|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2466640|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
2466641|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466642|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466643|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466644|NCT01043666|Urological Agents|urological agents|mesh-ancestor
2466645|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2466646|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2466647|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
2466648|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2466649|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
2466650|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2466651|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2466652|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2466653|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2466654|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466655|NCT01043744|Lumefantrine|lumefantrine|mesh-list
2466656|NCT01043744|Artemether|artemether|mesh-list
2466657|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2466658|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
2466659|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2466660|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2466661|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466662|NCT01043952|Remifentanil|remifentanil|mesh-list
2466663|NCT01043952|Propofol|propofol|mesh-list
2466664|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2466665|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2466666|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466667|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2466668|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
2466669|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
2466670|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2466671|NCT01043952|Narcotics|narcotics|mesh-ancestor
2466672|NCT01043952|Analgesics|analgesics|mesh-ancestor
2466673|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
2466674|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466675|NCT01043965|Metformin|metformin|mesh-list
2466676|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2466677|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466678|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
2466679|NCT01043991|Hematinics|hematinics|mesh-ancestor
2466680|NCT01044004|Modafinil|modafinil|mesh-list
2466681|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2466682|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466683|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2466684|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2466685|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2466686|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466687|NCT01044095|Vaccines|vaccines|mesh-list
2466688|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
2466689|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466690|NCT01044186|Deferasirox|deferasirox|mesh-list
2466691|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2466692|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
2466693|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
2466694|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466695|NCT01044199|Vaccines|vaccines|mesh-list
2466696|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
2466697|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466698|NCT01044225|Cetuximab|cetuximab|mesh-list
2466699|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2466700|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466701|NCT01044238|Methylphenidate|methylphenidate|mesh-list
2466702|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2466703|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466704|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2466705|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2466706|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2466707|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466708|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
2466709|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466710|NCT01044251|Frovatriptan|frovatriptan|mesh-list
2466711|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2466712|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
2466713|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466714|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466715|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466716|NCT01044329|Triamcinolone|triamcinolone|mesh-list
2466717|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2466718|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2466719|NCT01044329|Bevacizumab|bevacizumab|mesh-list
2466720|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2466721|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2466722|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466723|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2466724|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2466725|NCT01044329|Growth Substances|growth substances|mesh-ancestor
2466726|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466727|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
2466728|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2466729|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
2466730|NCT01044329|Hormones|hormones|mesh-ancestor
2466731|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2466732|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2466733|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
2466734|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466735|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466736|NCT01044342|Donepezil|donepezil|mesh-list
2466737|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2466738|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466739|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466740|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
2466741|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466742|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466743|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
2466744|NCT01044381|Luliconazole|luliconazole|mesh-list
2466745|NCT01044381|Antifungal Agents|antifungal agents|mesh-ancestor
2466746|NCT01044381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466747|NCT01044394|Bisacodyl|bisacodyl|mesh-list
2466748|NCT01044394|Cathartics|cathartics|mesh-ancestor
2466749|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2466750|NCT01044394|Laxatives|laxatives|mesh-ancestor
2466751|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
2466752|NCT01044446|Icodextrin|icodextrin|mesh-list
2466753|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2466754|NCT01044485|Docetaxel|docetaxel|mesh-list
2466755|NCT01044485|Lapatinib|lapatinib|mesh-list
2466756|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466757|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
2466758|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
2466759|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
2466760|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466761|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2466762|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466763|NCT01044719|Meropenem|meropenem|mesh-list
2466764|NCT01044719|Tobramycin|tobramycin|mesh-list
2466765|NCT01044719|Ceftazidime|ceftazidime|mesh-list
2466766|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2466767|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466768|NCT01044810|Efavirenz|efavirenz|mesh-list
2466769|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2466770|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2466771|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466772|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466773|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
2466774|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466775|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2466776|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2466777|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2466778|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2466779|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2466780|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2466781|NCT01044888|Heparin|heparin|mesh-list
2466782|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
2466783|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2466784|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2466785|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466786|NCT01044992|Levodopa|levodopa|mesh-list
2466787|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2466788|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2466789|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
2466790|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466791|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466792|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466793|NCT01045018|Mesalamine|mesalamine|mesh-list
2466794|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2466795|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2466796|NCT01045018|Analgesics|analgesics|mesh-ancestor
2466797|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
2466798|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466799|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466800|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2466801|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2466802|NCT01045083|Methylphenidate|methylphenidate|mesh-list
2466803|NCT01045083|Citalopram|citalopram|mesh-list
2466804|NCT01045083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2466805|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2466806|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2466807|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466808|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2466809|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
2466810|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466811|NCT01045083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2466812|NCT01045083|Antidepressive Agents|antidepressive agents|mesh-ancestor
2466813|NCT01045083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2466814|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2466815|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2466816|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
2466817|NCT01045109|Vitamin D|vitamin d|mesh-list
2466818|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
2466819|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
2466820|NCT01045109|Vitamins|vitamins|mesh-list
2466821|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
2466822|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466823|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2466824|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2466825|NCT01045278|Interferons|interferons|mesh-list
2466826|NCT01045278|Ribavirin|ribavirin|mesh-list
2466827|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
2466828|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
2466829|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2466830|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466831|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
2466832|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466833|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
2466834|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466835|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
2466836|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466837|NCT01045304|Gemcitabine|gemcitabine|mesh-list
2466838|NCT01045304|Carboplatin|carboplatin|mesh-list
2466839|NCT01045304|Iniparib|iniparib|mesh-list
2466840|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466841|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2466842|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
2466843|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466844|NCT01045304|Antiviral Agents|antiviral agents|mesh-ancestor
2466845|NCT01045304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466846|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466847|NCT01045304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2466848|NCT01045304|Immunologic Factors|immunologic factors|mesh-ancestor
2466849|NCT01045304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466850|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2466851|NCT01045369|Etravirine|etravirine|mesh-list
2466852|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466853|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466854|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
2466855|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466856|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2466857|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2466858|NCT01045434|Omeprazole|omeprazole|mesh-list
2466859|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2466860|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2466861|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2466862|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466863|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466864|NCT01045538|Capecitabine|capecitabine|mesh-list
2466865|NCT01045538|Vorinostat|vorinostat|mesh-list
2466866|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466867|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2466868|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
2466869|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466870|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2466871|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466872|NCT01045642|Omeprazole|omeprazole|mesh-list
2466873|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2466874|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2466875|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2466876|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466877|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466878|NCT01045681|Dexamethasone|dexamethasone|mesh-list
2466879|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
2466880|NCT01045681|Bortezomib|bortezomib|mesh-list
2466881|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2466882|NCT01045681|BB 1101|bb 1101|mesh-list
2466883|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2466884|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
2466885|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
2466886|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466887|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466888|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2466889|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
2466890|NCT01045681|Hormones|hormones|mesh-ancestor
2466891|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2466892|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2466893|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466894|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
2466895|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466896|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466897|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2466898|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
2466899|NCT01045772|Rilonacept|rilonacept|mesh-list
2466900|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2466901|NCT01045837|Prednisolone|prednisolone|mesh-list
2466902|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2466903|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
2466904|NCT01045837|Hormones|hormones|mesh-ancestor
2466905|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2466906|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466907|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2466908|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466909|NCT01045876|Dexamethasone|dexamethasone|mesh-list
2466910|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2466911|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
2466912|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
2466913|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2466914|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466915|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2466916|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
2466917|NCT01045876|Hormones|hormones|mesh-ancestor
2466918|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2466919|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2466920|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466921|NCT01045889|Prednisone|prednisone|mesh-list
2466922|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
2466923|NCT01045889|Melphalan|melphalan|mesh-list
2466924|NCT01045889|Rituximab|rituximab|mesh-list
2466925|NCT01045889|Etoposide|etoposide|mesh-list
2466926|NCT01045889|Vincristine|vincristine|mesh-list
2466927|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2466928|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
2466929|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466930|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2466931|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2466932|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
2466933|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466934|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466935|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2466936|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2466937|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2466938|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
2466939|NCT01045889|Hormones|hormones|mesh-ancestor
2466940|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2466941|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2466942|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2466943|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2466944|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2466945|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466946|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
2466947|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
2466948|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
2466949|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
2466950|NCT01045902|Ampicillin|ampicillin|mesh-list
2466951|NCT01045902|Sulbactam|sulbactam|mesh-list
2466952|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2466953|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2466954|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466955|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2466956|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2466957|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466958|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466959|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466960|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2466961|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
2466962|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2466963|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466964|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2466965|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2466966|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2466967|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2466968|NCT01045928|Rituximab|rituximab|mesh-list
2466969|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2466970|NCT01045928|Lenalidomide|lenalidomide|mesh-list
2466971|NCT01045928|Antibodies|antibodies|mesh-list
2466972|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
2466973|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2466974|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
2466975|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466976|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466977|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2466978|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2466979|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2466980|NCT01045928|Growth Substances|growth substances|mesh-ancestor
2466981|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
2466982|NCT01045941|Gemcitabine|gemcitabine|mesh-list
2466983|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2466984|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
2466985|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2466986|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2466987|NCT01045941|Antiviral Agents|antiviral agents|mesh-ancestor
2466988|NCT01045941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2466989|NCT01045941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2466990|NCT01045941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2466991|NCT01045941|Immunologic Factors|immunologic factors|mesh-ancestor
2466992|NCT01045941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466993|NCT01045954|Insulin|insulin|mesh-list
2466994|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
2466995|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
2466996|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2466997|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2466998|NCT01045980|Vitamin D|vitamin d|mesh-list
2466999|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
2467000|NCT01045980|Vitamins|vitamins|mesh-list
2467001|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
2467002|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467003|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2467004|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2467005|NCT01046006|Dexamethasone|dexamethasone|mesh-list
2467006|NCT01046006|Rituximab|rituximab|mesh-list
2467007|NCT01046006|Bortezomib|bortezomib|mesh-list
2467008|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2467009|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
2467010|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
2467011|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467012|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467013|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2467014|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
2467015|NCT01046006|Hormones|hormones|mesh-ancestor
2467016|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2467017|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2467018|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467019|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2467020|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
2467021|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2467022|NCT01046032|Metformin|metformin|mesh-list
2467023|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2467024|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467025|NCT01046045|Everolimus|everolimus|mesh-list
2467026|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467027|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2467028|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
2467029|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467030|NCT01046058|Simeprevir|simeprevir|mesh-list
2467031|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
2467032|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467033|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
2467034|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467035|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467036|NCT01046162|Alprazolam|alprazolam|mesh-list
2467037|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2467038|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2467039|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467040|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2467041|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2467042|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2467043|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
2467044|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
2467045|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467046|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467047|NCT01046214|Bupropion|bupropion|mesh-list
2467048|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2467049|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
2467050|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2467051|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2467052|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2467053|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2467054|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467055|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
2467056|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467057|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467058|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2467059|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2467060|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467061|NCT01046227|Vaccines|vaccines|mesh-list
2467062|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
2467063|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467064|NCT01046240|Palonosetron|palonosetron|mesh-list
2467065|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
2467066|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
2467067|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467068|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467069|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2467070|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2467071|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2467072|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
2467073|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467074|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467075|NCT01046266|Cetuximab|cetuximab|mesh-list
2467076|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2467077|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467078|NCT01046279|Bevacizumab|bevacizumab|mesh-list
2467079|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2467080|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467081|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2467082|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2467083|NCT01046279|Growth Substances|growth substances|mesh-ancestor
2467084|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467085|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
2467086|NCT01046383|Caseins|caseins|mesh-list
2467087|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
2467088|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
2467089|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467090|NCT01046422|Metformin|metformin|mesh-list
2467091|NCT01046422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2467092|NCT01046422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467093|NCT01046435|Amoxicillin|amoxicillin|mesh-list
2467094|NCT01046435|Metronidazole|metronidazole|mesh-list
2467095|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2467096|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467097|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2467098|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2467099|NCT01046461|Dexamethasone|dexamethasone|mesh-list
2467100|NCT01046461|Aprepitant|aprepitant|mesh-list
2467101|NCT01046461|Ramosetron|ramosetron|mesh-list
2467102|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2467103|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
2467104|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
2467105|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467106|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467107|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2467108|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
2467109|NCT01046461|Hormones|hormones|mesh-ancestor
2467110|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2467111|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2467112|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467113|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2467114|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467115|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467116|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2467117|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
2467118|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
2467119|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
2467120|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2467121|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
2467122|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467123|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2467124|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2467125|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
2467126|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467127|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467128|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2467129|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2467130|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467131|NCT01046500|Inositol|inositol|mesh-list
2467132|NCT01046500|Metformin|metformin|mesh-list
2467133|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2467134|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467135|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
2467136|NCT01046500|Vitamins|vitamins|mesh-ancestor
2467137|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
2467138|NCT01046539|Buprenorphine|buprenorphine|mesh-list
2467139|NCT01046539|ALKS-33|alks-33|mesh-list
2467140|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2467141|NCT01046539|Narcotics|narcotics|mesh-ancestor
2467142|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2467143|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467144|NCT01046539|Analgesics|analgesics|mesh-ancestor
2467145|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
2467146|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467147|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2467148|NCT01046578|Letrozole|letrozole|mesh-list
2467149|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467150|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2467151|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2467152|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467153|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467154|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2467155|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
2467156|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2467157|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467158|NCT01046630|Ketamine|ketamine|mesh-list
2467159|NCT01046630|Analgesics|analgesics|mesh-ancestor
2467160|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
2467161|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467162|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467163|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2467164|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2467165|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
2467166|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
2467167|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2467168|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2467169|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2467170|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467171|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467172|NCT01046708|Progesterone|progesterone|mesh-list
2467173|NCT01046708|Progestins|progestins|mesh-ancestor
2467174|NCT01046708|Hormones|hormones|mesh-ancestor
2467175|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2467176|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467177|NCT01046721|Exenatide|exenatide|mesh-list
2467178|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2467179|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467180|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2467181|NCT01046721|Incretins|incretins|mesh-ancestor
2467182|NCT01046721|Hormones|hormones|mesh-ancestor
2467183|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2467184|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
2467185|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2467186|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467187|NCT01046773|Vitamins|vitamins|mesh-ancestor
2467188|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
2467189|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2467190|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
2467191|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2467192|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2467193|NCT01046786|Prednisolone|prednisolone|mesh-list
2467194|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
2467195|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2467196|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
2467197|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2467198|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
2467199|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
2467200|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467201|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467202|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2467203|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
2467204|NCT01046786|Hormones|hormones|mesh-ancestor
2467205|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2467206|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2467207|NCT01046786|Protective Agents|protective agents|mesh-ancestor
2467208|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2467209|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467210|NCT01046799|Entecavir|entecavir|mesh-list
2467211|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
2467212|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467255|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
2467256|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
2467257|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2467258|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2467259|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467260|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467261|NCT01046838|Urological Agents|urological agents|mesh-ancestor
2467262|NCT01046864|Leucovorin|leucovorin|mesh-list
2467263|NCT01046864|Fluorouracil|fluorouracil|mesh-list
2467264|NCT01046864|Irinotecan|irinotecan|mesh-list
2467265|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
2467266|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467267|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2467268|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467269|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2467270|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
2467271|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467272|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2467273|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2467274|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467275|NCT01046864|Antidotes|antidotes|mesh-ancestor
2467276|NCT01046864|Protective Agents|protective agents|mesh-ancestor
2467277|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
2467278|NCT01046864|Vitamins|vitamins|mesh-ancestor
2467279|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
2467280|NCT01046942|Aspirin|aspirin|mesh-list
2467281|NCT01046942|Clopidogrel|clopidogrel|mesh-list
2467282|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2467283|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2467284|NCT01046942|Analgesics|analgesics|mesh-ancestor
2467285|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
2467286|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467287|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467288|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2467289|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2467290|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2467291|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2467292|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467293|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2467294|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2467295|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467296|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
2467297|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2467298|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2467299|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2467300|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
2467301|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467302|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
2467303|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
2467304|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2467305|NCT01046955|Daclizumab|daclizumab|mesh-list
2467306|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
2467307|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467308|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2467309|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2467310|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467311|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2467312|NCT01046981|Metronidazole|metronidazole|mesh-list
2467313|NCT01046981|Cefazolin|cefazolin|mesh-list
2467314|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2467315|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467316|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
2467317|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2467318|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2467319|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2467320|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467321|NCT01047059|Bevacizumab|bevacizumab|mesh-list
2467322|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2467323|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2467324|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467325|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2467326|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2467327|NCT01047059|Growth Substances|growth substances|mesh-ancestor
2467328|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467329|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
2467330|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2467331|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467332|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467333|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
2467334|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
2467335|NCT01047072|Rituximab|rituximab|mesh-list
2467336|NCT01047072|Fludarabine|fludarabine|mesh-list
2467337|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
2467338|NCT01047072|Tacrolimus|tacrolimus|mesh-list
2467339|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2467340|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
2467341|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467342|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2467343|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2467344|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
2467345|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467346|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467347|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2467348|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2467349|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2467350|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
2467351|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2467352|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467353|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2467354|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2467355|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
2467356|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2467357|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467358|NCT01047098|Iron|iron|mesh-list
2467359|NCT01047098|Trace Elements|trace elements|mesh-ancestor
2467360|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
2467361|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467362|NCT01047202|Vaccines|vaccines|mesh-list
2467363|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
2467364|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467365|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2467366|NCT01047215|Aripiprazole|aripiprazole|mesh-list
2467367|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
2467368|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2467369|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2467370|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2467371|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2467372|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467373|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
2467374|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
2467375|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467376|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467377|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2467378|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2467379|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
2467380|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2467381|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2467382|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2467383|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2467384|NCT01047423|Simvastatin|simvastatin|mesh-list
2467385|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2467386|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2467387|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
2467388|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467389|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2467390|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2467391|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467392|NCT01047488|Pregabalin|pregabalin|mesh-list
2467393|NCT01047488|Imipramine|imipramine|mesh-list
2467394|NCT01047488|Analgesics|analgesics|mesh-ancestor
2467395|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
2467396|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467397|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467398|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
2467399|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2467400|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2467401|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467402|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2467403|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2467404|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2467405|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2467406|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2467407|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2467408|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
2467409|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2467410|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2467411|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
2467412|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467413|NCT01047501|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2467414|NCT01047501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2467415|NCT01047501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2467416|NCT01047540|Pritelivir|pritelivir|mesh-list
2467417|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
2467418|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467419|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467420|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467421|NCT01047566|Digoxin|digoxin|mesh-list
2467422|NCT01047566|Dronedarone|dronedarone|mesh-list
2467423|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
2467424|NCT01047566|Calcium|calcium|mesh-list
2467425|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
2467426|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2467427|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467428|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2467429|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2467430|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467431|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467432|NCT01047566|Protective Agents|protective agents|mesh-ancestor
2467433|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2467434|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
2467435|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467436|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2467437|NCT01047579|Rivastigmine|rivastigmine|mesh-list
2467438|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2467439|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467440|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467441|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
2467442|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467443|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467444|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2467445|NCT01047579|Protective Agents|protective agents|mesh-ancestor
2467446|NCT01047657|Orlistat|orlistat|mesh-list
2467447|NCT01047657|Sibutramine|sibutramine|mesh-list
2467448|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467449|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467450|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2467451|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2467452|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
2467453|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2467454|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
2467455|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
2467456|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2467457|NCT01047683|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
2467458|NCT01047683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2467459|NCT01047683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2467460|NCT01047722|Aspirin|aspirin|mesh-list
2467461|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2467462|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2467463|NCT01047722|Analgesics|analgesics|mesh-ancestor
2467464|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
2467465|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467466|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467467|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2467468|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2467469|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2467470|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2467471|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467472|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2467473|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2467474|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467475|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
2467476|NCT01047748|Digoxin|digoxin|mesh-list
2467477|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2467478|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2467479|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467480|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467481|NCT01047748|Protective Agents|protective agents|mesh-ancestor
2467482|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467483|NCT01047774|Caseins|caseins|mesh-list
2467484|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
2467485|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
2467486|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467487|NCT01047891|Sorafenib|sorafenib|mesh-list
2467488|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467489|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2467490|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467491|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467492|NCT01047956|Methadone|methadone|mesh-list
2467493|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2467494|NCT01047956|Narcotics|narcotics|mesh-ancestor
2467495|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2467496|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467497|NCT01047956|Analgesics|analgesics|mesh-ancestor
2467498|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
2467499|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467500|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
2467501|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
2467502|NCT01047982|Folic Acid|folic acid|mesh-list
2467503|NCT01047982|Inositol|inositol|mesh-list
2467504|NCT01047982|Hematinics|hematinics|mesh-ancestor
2467505|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
2467506|NCT01047982|Vitamins|vitamins|mesh-ancestor
2467507|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
2467508|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467509|NCT01047995|Ritonavir|ritonavir|mesh-list
2467510|NCT01047995|Darunavir|darunavir|mesh-list
2467511|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
2467512|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2467513|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2467514|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
2467515|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467516|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467517|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2467518|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2467519|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
2467520|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467521|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2467522|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2467523|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2467524|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2467525|NCT01048034|Azacitidine|azacitidine|mesh-list
2467526|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
2467527|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2467528|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
2467529|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467530|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467531|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467532|NCT01048034|Hematinics|hematinics|mesh-ancestor
2467533|NCT01048047|Amlodipine|amlodipine|mesh-list
2467534|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2467535|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2467536|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2467537|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467538|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2467539|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467540|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
2467541|NCT01048086|Tretinoin|tretinoin|mesh-list
2467542|NCT01048086|Isotretinoin|isotretinoin|mesh-list
2467543|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467544|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
2467545|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
2467546|NCT01048138|Biperiden|biperiden|mesh-list
2467547|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
2467548|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2467549|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2467550|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
2467551|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
2467552|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467553|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467554|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2467555|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2467556|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
2467557|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467558|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467559|NCT01048177|Lidocaine|lidocaine|mesh-list
2467560|NCT01048177|Heparin|heparin|mesh-list
2467561|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
2467562|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
2467563|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2467564|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467565|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
2467566|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467567|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2467568|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2467569|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2467570|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2467571|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467572|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
2467573|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2467574|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2467575|NCT01048190|Vaccines|vaccines|mesh-list
2467576|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
2467577|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467578|NCT01048229|Pramipexole|pramipexole|mesh-list
2467579|NCT01048229|Rasagiline|rasagiline|mesh-list
2467580|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
2467581|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467582|NCT01048229|Protective Agents|protective agents|mesh-ancestor
2467583|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467584|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2467585|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2467586|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
2467587|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
2467588|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467589|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2467590|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467591|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2467592|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
2467593|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2467594|NCT01048268|Incretins|incretins|mesh-ancestor
2467595|NCT01048268|Hormones|hormones|mesh-ancestor
2467596|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2467597|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467598|NCT01048307|Polihexanide|polihexanide|mesh-list
2467599|NCT01048307|Betaine|betaine|mesh-list
2467600|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2467601|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2467602|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
2467603|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2467604|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
2467605|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467606|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2467607|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
2467608|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467609|NCT01048320|Gemcitabine|gemcitabine|mesh-list
2467610|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
2467611|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
2467612|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2467613|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
2467614|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467615|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467616|NCT01048320|Antiviral Agents|antiviral agents|mesh-ancestor
2467617|NCT01048320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467618|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467619|NCT01048320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2467620|NCT01048320|Immunologic Factors|immunologic factors|mesh-ancestor
2467621|NCT01048320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467622|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2467623|NCT01048385|Ubiquinone|ubiquinone|mesh-list
2467624|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
2467625|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
2467626|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467627|NCT01048385|Vitamins|vitamins|mesh-ancestor
2467628|NCT01048398|Acetaminophen|acetaminophen|mesh-list
2467629|NCT01048398|Remifentanil|remifentanil|mesh-list
2467630|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2467631|NCT01048398|Analgesics|analgesics|mesh-ancestor
2467632|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
2467633|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467634|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467635|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
2467636|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2467637|NCT01048398|Narcotics|narcotics|mesh-ancestor
2467638|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2467639|NCT01048515|Caffeine|caffeine|mesh-list
2467640|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2467641|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467642|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2467643|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467644|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467645|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2467646|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2467647|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
2467648|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467649|NCT01048554|Bevacizumab|bevacizumab|mesh-list
2467650|NCT01048554|Temozolomide|temozolomide|mesh-list
2467651|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2467652|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467653|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2467654|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2467655|NCT01048554|Growth Substances|growth substances|mesh-ancestor
2467656|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467657|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
2467658|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2467659|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
2467660|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467661|NCT01048580|Capecitabine|capecitabine|mesh-list
2467662|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2467663|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
2467664|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467665|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467666|NCT01048619|ON 01910|on 01910|mesh-list
2467667|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467668|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2467669|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467670|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467671|NCT01048632|Oxandrolone|oxandrolone|mesh-list
2467672|NCT01048632|Androgens|androgens|mesh-ancestor
2467673|NCT01048632|Hormones|hormones|mesh-ancestor
2467674|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2467675|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467676|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
2467677|NCT01048684|Mannitol|mannitol|mesh-list
2467678|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2467679|NCT01048684|Diuretics|diuretics|mesh-ancestor
2467680|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
2467681|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467682|NCT01048827|Busulfan|busulfan|mesh-list
2467683|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
2467684|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467685|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2467686|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
2467687|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467688|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2467689|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467690|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2467691|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
2467692|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2467693|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
2467694|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467695|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2467696|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2467697|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
2467698|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467699|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467700|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2467701|NCT01048983|Minocycline|minocycline|mesh-list
2467702|NCT01048983|Curcumin|curcumin|mesh-list
2467703|NCT01048983|Modafinil|modafinil|mesh-list
2467704|NCT01048983|Bupropion|bupropion|mesh-list
2467705|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2467706|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
2467707|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2467708|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2467709|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2467710|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2467711|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467712|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
2467713|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467714|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467715|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2467716|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2467717|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467718|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2467719|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467720|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2467721|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2467722|NCT01048983|Analgesics|analgesics|mesh-ancestor
2467723|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
2467724|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467725|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2467726|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2467727|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467728|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2467729|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2467730|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2467731|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2467732|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
2467733|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2467734|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2467735|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467736|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2467737|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2467738|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467739|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467740|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467741|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2467742|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
2467743|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2467744|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467745|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2467746|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2467747|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2467748|NCT01049035|Vaccines|vaccines|mesh-list
2467749|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2467750|NCT01049035|Immunoglobulins|immunoglobulins|mesh-list
2467751|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
2467752|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467753|NCT01049048|Vitamin D|vitamin d|mesh-list
2467754|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
2467755|NCT01049048|Vitamins|vitamins|mesh-ancestor
2467756|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
2467757|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467758|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2467759|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2467760|NCT01049061|Farletuzumab|farletuzumab|mesh-list
2467761|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467762|NCT01049178|Silymarin|silymarin|mesh-list
2467763|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
2467764|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467765|NCT01049178|Protective Agents|protective agents|mesh-ancestor
2467766|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467767|NCT01049204|Maraviroc|maraviroc|mesh-list
2467768|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2467769|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2467770|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467771|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2467772|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2467773|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
2467774|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467775|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1659155|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1659156|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1659157|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659158|NCT05076955|Vancomycin|vancomycin|mesh-list
1659159|NCT05076955|Tobramycin|tobramycin|mesh-list
1659160|NCT05076955|Itraconazole|itraconazole|mesh-list
1659161|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1659162|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1659163|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
1659164|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1659165|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1659166|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1659167|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659168|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1659169|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
1659170|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1659171|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659172|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1659173|NCT05076942|Cisplatin|cisplatin|mesh-list
1659174|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467776|NCT01049347|Amitriptyline|amitriptyline|mesh-list
2467777|NCT01049347|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2467778|NCT01049347|Paroxetine|paroxetine|mesh-list
2467779|NCT01049347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2467780|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2467781|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2467782|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467783|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2467784|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
2467785|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467786|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2467787|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
2467788|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2467789|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2467790|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2467791|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467792|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2467793|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2467794|NCT01049347|Analgesics|analgesics|mesh-ancestor
2467795|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
2467796|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467797|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2467798|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
2467799|NCT01049347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2467800|NCT01049347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2467801|NCT01049347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2467802|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
2467803|NCT01049425|Docetaxel|docetaxel|mesh-list
2467804|NCT01049425|Epirubicin|epirubicin|mesh-list
2467805|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2467806|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
2467807|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467808|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2467809|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2467810|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
2467811|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467812|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467813|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2467814|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
2467815|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
2467816|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
2467817|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2467818|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2467819|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2467820|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467821|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2467822|NCT01049438|Doxycycline|doxycycline|mesh-list
1659223|NCT05076799|Lactulose|lactulose|mesh-list
1659224|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2467823|NCT01049438|Minocycline|minocycline|mesh-list
2467824|NCT01049438|Mupirocin|mupirocin|mesh-list
2467825|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2467826|NCT01049438|Trimethoprim|trimethoprim|mesh-list
2467827|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
2467828|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
1659233|NCT05076773|Morphine|morphine|mesh-list
1659234|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1659235|NCT05076773|Narcotics|narcotics|mesh-ancestor
1659236|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1659237|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659238|NCT05076773|Analgesics|analgesics|mesh-ancestor
1659239|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
1659240|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1659241|NCT05076695|Trastuzumab|trastuzumab|mesh-list
1659242|NCT05076695|Fulvestrant|fulvestrant|mesh-list
1659243|NCT05076695|Palbociclib|palbociclib|mesh-list
1659244|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1659245|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1659246|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1659247|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1659248|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1659249|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
1659250|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1659251|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659252|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1659253|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1659254|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659255|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
1659256|NCT05076682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1659257|NCT05076682|Choline|choline|mesh-list
1659258|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
1659259|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1659260|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
1659261|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659262|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1659263|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1659264|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
1659265|NCT05076682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1659266|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
1659267|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
1659268|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659269|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1659270|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1659271|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
1659283|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
1659284|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1659285|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
1659286|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1659287|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
1659288|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659289|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
1659290|NCT05076526|Protective Agents|protective agents|mesh-ancestor
2467829|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467830|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
2467831|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2467832|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2467833|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1659296|NCT05076474|Orlistat|orlistat|mesh-list
1659297|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1659298|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659299|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1659300|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2467834|NCT01049438|Renal Agents|renal agents|mesh-ancestor
2467835|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1659302|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
1659303|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
1659304|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1659305|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659306|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1659307|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
1659308|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
1659309|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1659310|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
1659311|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1659312|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659313|NCT05076461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1659314|NCT05076461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1659315|NCT05076461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1659316|NCT05076461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1659317|NCT05076461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2467836|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467837|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467838|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2467839|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2467840|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2467841|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2467842|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2467843|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
2467844|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2467845|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2467846|NCT01049451|Prednisolone|prednisolone|mesh-list
2467847|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
2467848|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2467849|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
2467850|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1659333|NCT05076292|Glucagon|glucagon|mesh-list
1659334|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1659335|NCT05076292|Hormones|hormones|mesh-ancestor
1659336|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1659337|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659341|NCT05076227|Vaccines|vaccines|mesh-list
1659342|NCT05076227|Immunologic Factors|immunologic factors|mesh-ancestor
1659343|NCT05076227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659344|NCT05076175|Ozanimod|ozanimod|mesh-list
1659345|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1659346|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659347|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1659348|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
1659349|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467851|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
2467852|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
2467853|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467854|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467855|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2467856|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
2467857|NCT01049451|Hormones|hormones|mesh-ancestor
2467858|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2467859|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2467860|NCT01049451|Protective Agents|protective agents|mesh-ancestor
2467861|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2467862|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467863|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
2467864|NCT01049464|Analgesics|analgesics|mesh-ancestor
2467865|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
2467866|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467867|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467868|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
2467869|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2467870|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2467871|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
2467872|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2467873|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2467874|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467875|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2467876|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
2467877|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2467878|NCT01049542|Astressin|astressin|mesh-list
2467879|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2467880|NCT01049542|Protective Agents|protective agents|mesh-ancestor
2467881|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467882|NCT01049620|Capecitabine|capecitabine|mesh-list
2467883|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
2467884|NCT01049620|Everolimus|everolimus|mesh-list
2467885|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2467886|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
2467887|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467888|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467889|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2467890|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
2467891|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467892|NCT01049633|Aspirin|aspirin|mesh-list
2467893|NCT01049633|Sirolimus|sirolimus|mesh-list
2467894|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2467895|NCT01049633|Clotrimazole|clotrimazole|mesh-list
1659396|NCT05076019|Atorvastatin|atorvastatin|mesh-list
1659397|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1659398|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1659399|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
1659400|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659401|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1659402|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1659403|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1659404|NCT05076006|PF-06700841|pf-06700841|mesh-list
1659405|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1659406|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1659407|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467896|NCT01049633|Miconazole|miconazole|mesh-list
2467897|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
2467898|NCT01049633|Trimethoprim|trimethoprim|mesh-list
2467899|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
2467900|NCT01049633|Valganciclovir|valganciclovir|mesh-list
2467901|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
2467902|NCT01049633|Heparin|heparin|mesh-list
2467903|NCT01049633|Enoxaparin|enoxaparin|mesh-list
2467904|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
2467905|NCT01049633|Tacrolimus|tacrolimus|mesh-list
2467906|NCT01049633|Basiliximab|basiliximab|mesh-list
2467907|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2467908|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2467909|NCT01049633|Analgesics|analgesics|mesh-ancestor
2467910|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
2467911|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467912|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467913|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2467914|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2467915|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2467916|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2467917|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467918|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2467919|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2467920|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467921|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
2467922|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2467923|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
2467924|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2467925|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467926|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2467927|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467928|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
2467929|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2467930|NCT01049633|Renal Agents|renal agents|mesh-ancestor
2467931|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
2467932|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2467933|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2467934|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2467935|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2467936|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2467937|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2467938|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2467939|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2467940|NCT01049633|Protective Agents|protective agents|mesh-ancestor
2467941|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
2467942|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2467943|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
2467944|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2467945|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1659455|NCT05069857|Apatinib|apatinib|mesh-list
1659456|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1659457|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1659458|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1659459|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1659460|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467946|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2467947|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
2467948|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2467949|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2467950|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1659474|NCT05063136|Capecitabine|capecitabine|mesh-list
1659475|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1659476|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
1659477|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659478|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467951|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
2467952|NCT01049646|Giapreza|giapreza|mesh-list
2467953|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
2467954|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2467955|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2467956|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
2467957|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467958|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467959|NCT01049672|Alfentanil|alfentanil|mesh-list
2467960|NCT01049672|Heroin|heroin|mesh-list
2467961|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2467962|NCT01049672|Narcotics|narcotics|mesh-ancestor
2467963|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2467964|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467965|NCT01049672|Analgesics|analgesics|mesh-ancestor
2467966|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
2467967|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2467968|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2467969|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
2467970|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
2467971|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1659508|NCT05034809|Melatonin|melatonin|mesh-list
1659509|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
1659510|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659511|NCT05034809|Protective Agents|protective agents|mesh-ancestor
1659512|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659513|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2467972|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
2467973|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467974|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
2467975|NCT01049711|Hematinics|hematinics|mesh-ancestor
2467976|NCT01049763|Oseltamivir|oseltamivir|mesh-list
2467977|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
2467978|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467979|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2467980|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467981|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
2467982|NCT01049815|Calcium|calcium|mesh-list
2467983|NCT01049815|Sevelamer|sevelamer|mesh-list
2467984|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2467985|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2467986|NCT01049815|Antacids|antacids|mesh-ancestor
2467987|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2467988|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2467989|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
2467990|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
2467991|NCT01049841|Sirolimus|sirolimus|mesh-list
2467992|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2467993|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2467994|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2467995|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2467996|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
2467997|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2467998|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
2467999|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468000|NCT01049854|Vidarabine|vidarabine|mesh-list
2468001|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
2468002|NCT01049854|Thiotepa|thiotepa|mesh-list
2468003|NCT01049854|Busulfan|busulfan|mesh-list
2468004|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
2468005|NCT01049854|Fludarabine|fludarabine|mesh-list
2468006|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2468007|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2468008|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
2468009|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468010|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2468011|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2468012|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
2468013|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468014|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468015|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2468016|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2468017|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
2468018|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
2468019|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468020|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
2468021|NCT01049880|Gemcitabine|gemcitabine|mesh-list
2468022|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2468023|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
2468024|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468025|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468026|NCT01049880|Antiviral Agents|antiviral agents|mesh-ancestor
2468027|NCT01049880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468028|NCT01049880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468029|NCT01049880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2468030|NCT01049880|Immunologic Factors|immunologic factors|mesh-ancestor
2468031|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468032|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
2468033|NCT01049880|Protective Agents|protective agents|mesh-ancestor
2468034|NCT01049880|Vitamins|vitamins|mesh-ancestor
2468035|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
2468036|NCT01049932|Rilpivirine|rilpivirine|mesh-list
2468037|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2468038|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2468039|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468040|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468041|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
2468042|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468043|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2468044|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2468045|NCT01050036|Busulfan|busulfan|mesh-list
2468046|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
2468047|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468048|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2468049|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
2468050|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468051|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2468052|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468053|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2468054|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2468055|NCT01050114|Oxybutynin|oxybutynin|mesh-list
2468056|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2468057|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2468058|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468059|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468060|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2468061|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2468062|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468063|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
2468064|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468065|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
2468066|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
2468067|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2468068|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2468069|NCT01050114|Urological Agents|urological agents|mesh-ancestor
2468070|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
2468071|NCT01050270|Ondansetron|ondansetron|mesh-list
2468072|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2468073|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
2468074|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
2468075|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468076|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468077|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1659620|NCT04998032|Metformin|metformin|mesh-list
1659621|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1659622|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659623|NCT04993924|Cetrorelix|cetrorelix|mesh-list
1659624|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1659625|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
1659626|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1659627|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659628|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
1659629|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1659630|NCT04982614|Vaccines|vaccines|mesh-list
1659631|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
1659632|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659633|NCT04978259|Remdesivir|remdesivir|mesh-list
1659634|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
1659635|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659636|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
1659637|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468078|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
2468079|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
2468080|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2468081|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
2468082|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468083|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468084|NCT01050270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2468085|NCT01050270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2468086|NCT01050270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468087|NCT01050270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2468088|NCT01050270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2468089|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
2468090|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468091|NCT01050270|Expectorants|expectorants|mesh-ancestor
2468092|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
2468093|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2468094|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
2468095|NCT01050270|Protective Agents|protective agents|mesh-ancestor
2468096|NCT01050270|Antidotes|antidotes|mesh-ancestor
2468097|NCT01050322|Gemcitabine|gemcitabine|mesh-list
2468098|NCT01050322|Capecitabine|capecitabine|mesh-list
2468099|NCT01050322|Vinorelbine|vinorelbine|mesh-list
2468100|NCT01050322|Lapatinib|lapatinib|mesh-list
2468101|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2468102|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
2468103|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468104|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468105|NCT01050322|Antiviral Agents|antiviral agents|mesh-ancestor
2468106|NCT01050322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468107|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468108|NCT01050322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2468109|NCT01050322|Immunologic Factors|immunologic factors|mesh-ancestor
2468110|NCT01050322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468111|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2468112|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
2468113|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
2468114|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
2468115|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2468116|NCT01050348|Atorvastatin|atorvastatin|mesh-list
2468117|NCT01050348|Calcium|calcium|mesh-list
2468118|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2468119|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468120|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2468121|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2468122|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
2468123|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659681|NCT04956042|Cytarabine|cytarabine|mesh-list
1659682|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1659683|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
1659684|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659685|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1659686|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
1659687|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1659688|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1659689|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
1659690|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659691|NCT04951323|Vaccines|vaccines|mesh-list
1659692|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
1659693|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468124|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2468125|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2468126|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468127|NCT01050374|Albendazole|albendazole|mesh-list
2468128|NCT01050374|Praziquantel|praziquantel|mesh-list
2468129|NCT01050374|Mebendazole|mebendazole|mesh-list
2468130|NCT01050374|Piperazine|piperazine|mesh-list
2468131|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
2468132|NCT01050374|DMP 777|dmp 777|mesh-list
2468133|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
2468134|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2468135|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468136|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
2468137|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2468138|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2468139|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
2468140|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
2468141|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
2468142|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468143|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468144|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
2468145|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468146|NCT01050387|Vitamin D|vitamin d|mesh-list
2468147|NCT01050387|Vitamins|vitamins|mesh-ancestor
2468148|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
2468149|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468150|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2468151|NCT01050426|Leucovorin|leucovorin|mesh-list
2468152|NCT01050426|Cetuximab|cetuximab|mesh-list
2468153|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
2468154|NCT01050426|Antidotes|antidotes|mesh-ancestor
2468155|NCT01050426|Protective Agents|protective agents|mesh-ancestor
2468156|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468157|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
2468158|NCT01050426|Vitamins|vitamins|mesh-ancestor
2468159|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
2468160|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2468161|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468162|NCT01050452|Ivermectin|ivermectin|mesh-list
2468163|NCT01050452|Albendazole|albendazole|mesh-list
2468164|NCT01050452|Mebendazole|mebendazole|mesh-list
2468165|NCT01050452|Piperazine|piperazine|mesh-list
2468166|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
2468167|NCT01050452|DMP 777|dmp 777|mesh-list
2468168|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2468169|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468170|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
2468171|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
2468172|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2468173|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2468174|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
2468175|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
2468176|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
2468177|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468178|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468179|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
2468180|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468181|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2468182|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2468183|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2468184|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468185|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468186|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2468187|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2468188|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2468189|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
2468190|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468191|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468192|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2468193|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2468194|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
2468195|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
2468196|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2468197|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468198|NCT01050517|Ivermectin|ivermectin|mesh-list
2468199|NCT01050517|Albendazole|albendazole|mesh-list
2468200|NCT01050517|Praziquantel|praziquantel|mesh-list
2468201|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2468202|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468203|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
2468204|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
2468205|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2468206|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2468207|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
2468208|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
2468209|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
2468210|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659775|NCT04905446|Niacinamide|niacinamide|mesh-list
1659776|NCT04905446|Niacin|niacin|mesh-list
1659777|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
1659778|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
1659779|NCT04905446|Vitamins|vitamins|mesh-ancestor
1659780|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
1659781|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659782|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1659783|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
1659784|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659785|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1659786|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
2468211|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468212|NCT01050556|Folic Acid|folic acid|mesh-list
2468213|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
2468214|NCT01050556|Hematinics|hematinics|mesh-ancestor
2468215|NCT01050556|Vitamins|vitamins|mesh-ancestor
2468216|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
2468217|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468218|NCT01050595|Naltrexone|naltrexone|mesh-list
2468219|NCT01050595|Bromides|bromides|mesh-list
2468220|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
2468221|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
2468222|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2468223|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468224|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
2468225|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468226|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2468227|NCT01050608|Ethanol|ethanol|mesh-list
2468228|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2468229|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468230|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468231|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468232|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
2468233|NCT01050621|Vitamins|vitamins|mesh-ancestor
2468234|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
2468235|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468236|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
2468237|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468238|NCT01050621|Protective Agents|protective agents|mesh-ancestor
2468239|NCT01050699|Fentanyl|fentanyl|mesh-list
2468240|NCT01050699|Midazolam|midazolam|mesh-list
2468241|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
2468242|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1659819|NCT04893785|Temozolomide|temozolomide|mesh-list
1659820|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1659821|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
1659822|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659823|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468243|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468244|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468245|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2468246|NCT01050699|Analgesics|analgesics|mesh-ancestor
2468247|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
2468248|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468249|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2468250|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2468251|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2468252|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
2468253|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468254|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468255|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2468256|NCT01050699|Narcotics|narcotics|mesh-ancestor
2468257|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2468258|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2468259|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
2468260|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
2468261|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2468262|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1659850|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
1659851|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1659852|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1659853|NCT04875364|Eszopiclone|eszopiclone|mesh-list
1659854|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1659855|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1659856|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468263|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2468264|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
2468265|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
2468266|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
2468267|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
2468268|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468269|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
2468270|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468271|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468272|NCT01050777|Paromomycin|paromomycin|mesh-list
2468273|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
2468274|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2468275|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468276|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2468277|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2468278|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
2468279|NCT01050842|Bicalutamide|bicalutamide|mesh-list
2468280|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
2468281|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
2468282|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1659877|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
1659878|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1659879|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1659880|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1659881|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1659882|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1659883|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659884|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468283|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468284|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468285|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2468286|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2468287|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1659930|NCT04850495|Prednisone|prednisone|mesh-list
1659931|NCT04850495|Cortisone|cortisone|mesh-list
1659932|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
1659933|NCT04850495|Rituximab|rituximab|mesh-list
1659934|NCT04850495|Doxorubicin|doxorubicin|mesh-list
1659935|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1659936|NCT04850495|Vincristine|vincristine|mesh-list
1659937|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
1659938|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1659939|NCT04850495|Antibodies|antibodies|mesh-list
1659940|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
1659941|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1659942|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1659943|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
1659944|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1659945|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1659946|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1659947|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
1659948|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1659949|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1659950|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1659951|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1659952|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1659953|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1659954|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1659955|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1659956|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
1659957|NCT04850495|Hormones|hormones|mesh-ancestor
1659958|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1659959|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1659960|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1659961|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
1659962|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
1659963|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
1659964|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1659965|NCT04848714|Antivenins|antivenins|mesh-list
1659966|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
1659967|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468288|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2468289|NCT01050855|Busulfan|busulfan|mesh-list
2468290|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
2468291|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
2468292|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468293|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2468294|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
2468295|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468296|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2468297|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468298|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2468299|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2468300|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
2468301|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
2468302|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468303|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
2468304|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468305|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468306|NCT01050985|Sirolimus|sirolimus|mesh-list
2468307|NCT01050985|Capecitabine|capecitabine|mesh-list
2468308|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2468309|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
2468310|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468311|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468312|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2468313|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468314|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2468315|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
2468316|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2468317|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
2468318|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468319|NCT01051011|Metformin|metformin|mesh-list
2468320|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
2468321|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
1660004|NCT04805541|Tropicamide|tropicamide|mesh-list
1660005|NCT04805541|Mydriatics|mydriatics|mesh-list
1660006|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
1660007|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1660008|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660009|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1660010|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1660011|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
1660012|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1660013|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660014|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
1660015|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1660016|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1660017|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660018|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
1660019|NCT04803591|Coagulants|coagulants|mesh-ancestor
2468322|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2468323|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468324|NCT01051011|Incretins|incretins|mesh-ancestor
2468325|NCT01051011|Hormones|hormones|mesh-ancestor
2468326|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2468327|NCT01051102|Insulin|insulin|mesh-list
2468328|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2468329|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
2468330|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
2468331|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
2468332|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
2468333|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2468334|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2468335|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468336|NCT01051115|Dasatinib|dasatinib|mesh-list
2468337|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1660036|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
1660037|NCT04767984|Atorvastatin|atorvastatin|mesh-list
1660038|NCT04767984|Calcium|calcium|mesh-list
1660039|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1660040|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660041|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1660042|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1660043|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1660044|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
1660045|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660046|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1660047|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1660048|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468338|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2468339|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468340|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468341|NCT01051167|Cetuximab|cetuximab|mesh-list
2468342|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2468343|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468344|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
2468345|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
2468346|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2468347|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2468348|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2468349|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468350|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2468351|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2468352|NCT01051219|Losartan|losartan|mesh-list
2468353|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2468354|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2468355|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2468356|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2468357|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468358|NCT01051271|Midazolam|midazolam|mesh-list
2468359|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2468360|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2468361|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468362|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468363|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2468364|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2468365|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2468366|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2468367|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
2468368|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
2468369|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
2468370|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
2468371|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468372|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468373|NCT01051284|Gemcitabine|gemcitabine|mesh-list
2468374|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2468375|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
2468376|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468377|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468378|NCT01051284|Antiviral Agents|antiviral agents|mesh-ancestor
2468379|NCT01051284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468380|NCT01051284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468381|NCT01051284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2468382|NCT01051284|Immunologic Factors|immunologic factors|mesh-ancestor
2468383|NCT01051284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468384|NCT01051362|Carboplatin|carboplatin|mesh-list
2468385|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468386|NCT01051388|Rabeprazole|rabeprazole|mesh-list
2468387|NCT01051388|Gefarnate|gefarnate|mesh-list
2468388|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2468389|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2468390|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2468391|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468392|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468393|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2468394|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2468395|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2468396|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
2468397|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468398|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2468399|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2468400|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1660119|NCT04746547|Dolutegravir|dolutegravir|mesh-list
1660120|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1660121|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1660122|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1660123|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660124|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1660125|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1660126|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
1660127|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468401|NCT01051414|Asunaprevir|asunaprevir|mesh-list
2468402|NCT01051414|Protease Inhibitors|protease inhibitors|mesh-ancestor
2468403|NCT01051414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468404|NCT01051414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468405|NCT01051427|Hemostatics|hemostatics|mesh-list
2468406|NCT01051427|Surgiflo|surgiflo|mesh-list
2468407|NCT01051427|Coagulants|coagulants|mesh-ancestor
2468408|NCT01051479|Choline|choline|mesh-list
2468409|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
2468410|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2468411|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
2468412|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468413|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2468414|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2468415|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
2468416|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2468417|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1660148|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1660149|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
1660150|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1660151|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
1660152|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1660153|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660154|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1660155|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1660156|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468418|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2468419|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468420|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468421|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2468422|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2468423|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2468424|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
2468425|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468426|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468427|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2468428|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2468429|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
2468430|NCT01051544|Factor VIII|factor viii|mesh-list
2468431|NCT01051544|Coagulants|coagulants|mesh-ancestor
2468432|NCT01051583|Bevacizumab|bevacizumab|mesh-list
2468433|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2468434|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468435|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1660175|NCT04713709|Naloxone|naloxone|mesh-list
1660176|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1660177|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660178|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
1660179|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1660180|NCT04711356|Vaccines|vaccines|mesh-list
1660181|NCT04711356|Immunologic Factors|immunologic factors|mesh-ancestor
1660182|NCT04711356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468436|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2468437|NCT01051583|Growth Substances|growth substances|mesh-ancestor
2468438|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468439|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
2468440|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
2468441|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2468442|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468443|NCT01051648|Triamcinolone|triamcinolone|mesh-list
1660191|NCT04696822|Epinephrine|epinephrine|mesh-list
1660192|NCT04696822|Racepinephrine|racepinephrine|mesh-list
1660193|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
1660194|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1660195|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1660196|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
1660197|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1660198|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660199|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660200|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1660201|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1660202|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
1660203|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1660204|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1660205|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
2468444|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1660206|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
1660207|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
1660208|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2468445|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2468446|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2468447|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2468448|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
2468449|NCT01051648|Hormones|hormones|mesh-ancestor
2468450|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2468451|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468452|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2468453|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
2468454|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468455|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468456|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
2468457|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2468458|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2468459|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2468460|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2468461|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468462|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
2468463|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468464|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468465|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2468466|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468467|NCT01051765|Irinotecan|irinotecan|mesh-list
2468468|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468469|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2468470|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2468471|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468472|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468473|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2468474|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
2468475|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2468476|NCT01051934|Paclitaxel|paclitaxel|mesh-list
2468477|NCT01051934|Bevacizumab|bevacizumab|mesh-list
2468478|NCT01051934|Carboplatin|carboplatin|mesh-list
2468479|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2468480|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468481|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
2468482|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
2468483|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
2468484|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468485|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2468486|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2468487|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2468488|NCT01051934|Growth Substances|growth substances|mesh-ancestor
2468489|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468490|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
2468491|NCT01051947|Metoprolol|metoprolol|mesh-list
1660259|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
1660260|NCT04608487|Fludarabine|fludarabine|mesh-list
1660261|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1660262|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
1660263|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660264|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1660265|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1660266|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
1660267|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660268|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1660269|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2468492|NCT01051947|Nebivolol|nebivolol|mesh-list
2468493|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2468494|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2468495|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
2468496|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
1660275|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
1660276|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1660277|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468497|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468498|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468499|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2468500|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2468501|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2468502|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
2468503|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468504|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468505|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
2468506|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2468507|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2468508|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2468509|NCT01052025|Curcumin|curcumin|mesh-list
2468510|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2468511|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2468512|NCT01052025|Analgesics|analgesics|mesh-ancestor
2468513|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
2468514|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1660297|NCT04565730|Anesthetics|anesthetics|mesh-list
1660298|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1660299|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468515|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468516|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2468517|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2468518|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468519|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468520|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468521|NCT01052051|Vitamin D|vitamin d|mesh-list
2468522|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
2468523|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
2468524|NCT01052051|Calcium|calcium|mesh-list
2468525|NCT01052051|Vitamins|vitamins|mesh-ancestor
2468526|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
2468527|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468528|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2468529|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2468530|NCT01052051|Antacids|antacids|mesh-ancestor
2468531|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468532|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2468533|NCT01052129|Naproxen|naproxen|mesh-list
2468534|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2468535|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2468536|NCT01052129|Analgesics|analgesics|mesh-ancestor
2468537|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
2468538|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468539|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468540|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2468541|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2468542|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
2468543|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2468544|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468545|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468546|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
2468547|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2468548|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468549|NCT01052181|Vitamins|vitamins|mesh-ancestor
2468550|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
2468551|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2468552|NCT01052246|Clindamycin|clindamycin|mesh-list
2468553|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
2468554|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
2468555|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
2468556|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2468557|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468558|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2468559|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468560|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468561|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
2468562|NCT01052259|Gusperimus|gusperimus|mesh-list
2468563|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2468564|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468565|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2468566|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468567|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2468568|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
2468569|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2468570|NCT01052259|Protective Agents|protective agents|mesh-ancestor
2468571|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
2468572|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2468573|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468574|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2468575|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2468576|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468577|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468578|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468579|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2468580|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2468581|NCT01052311|Niacin|niacin|mesh-list
2468582|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2468583|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
1660381|NCT04501861|Vasopressins|vasopressins|mesh-list
1660382|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
1660383|NCT04501861|Norepinephrine|norepinephrine|mesh-list
1660384|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1660385|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1660386|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
1660387|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1660388|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660389|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660390|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
1660391|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
1660392|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1660393|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1660394|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
1660395|NCT04501861|Coagulants|coagulants|mesh-ancestor
1660396|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1660397|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
2468584|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468585|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2468586|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
2468587|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
2468588|NCT01052311|Vitamins|vitamins|mesh-ancestor
2468589|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
1660404|NCT04498741|Midazolam|midazolam|mesh-list
1660405|NCT04498741|Dabigatran|dabigatran|mesh-list
1660406|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1660407|NCT04498741|Tacrolimus|tacrolimus|mesh-list
1660408|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1660409|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
1660410|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660411|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1660412|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1660413|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660414|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1660415|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1660416|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1660417|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1660418|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1660419|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1660420|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1660421|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
1660422|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
1660423|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
1660424|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
1660425|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1660426|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1660427|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1660428|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
1660429|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1660430|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1660431|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
1660432|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1660433|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
1660434|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
2468590|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468591|NCT01052324|Remifentanil|remifentanil|mesh-list
2468592|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2468593|NCT01052324|Narcotics|narcotics|mesh-ancestor
2468594|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468595|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468596|NCT01052324|Analgesics|analgesics|mesh-ancestor
2468597|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
2468598|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468599|NCT01052337|Anesthetics|anesthetics|mesh-list
2468600|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1660456|NCT04455815|Camostat|camostat|mesh-list
1660457|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
1660458|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1660459|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660460|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1660461|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2468601|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468602|NCT01052363|Bevacizumab|bevacizumab|mesh-list
2468603|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2468604|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468605|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2468606|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2468607|NCT01052363|Growth Substances|growth substances|mesh-ancestor
2468608|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468609|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
2468610|NCT01052389|Haloperidol|haloperidol|mesh-list
2468611|NCT01052389|Olanzapine|olanzapine|mesh-list
2468612|NCT01052389|Aripiprazole|aripiprazole|mesh-list
2468613|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
2468614|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
2468615|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
2468616|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468617|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468618|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2468619|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2468620|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2468621|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468622|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2468623|NCT01052389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2468624|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2468625|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2468626|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468627|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468628|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
1660490|NCT04407988|Letrozole|letrozole|mesh-list
1660491|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1660492|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1660493|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1660494|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1660495|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660496|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1660497|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
1660498|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1660499|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468629|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
2468630|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
2468631|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
2468632|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2468633|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2468634|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2468635|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2468636|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1660509|NCT04379635|Paclitaxel|paclitaxel|mesh-list
1660510|NCT04379635|Carboplatin|carboplatin|mesh-list
1660511|NCT04379635|Pemetrexed|pemetrexed|mesh-list
1660512|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1660513|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1660514|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
1660515|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
1660516|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
1660517|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660518|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1660519|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1660520|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2468637|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2468638|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2468639|NCT01052584|Chloroquine|chloroquine|mesh-list
2468640|NCT01052584|Lumefantrine|lumefantrine|mesh-list
2468641|NCT01052584|Artemether|artemether|mesh-list
2468642|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2468643|NCT01052584|Amebicides|amebicides|mesh-ancestor
2468644|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2468645|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2468646|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468647|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
2468648|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2468649|NCT01052597|Curcumin|curcumin|mesh-list
2468650|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1660535|NCT04342078|Vitamin D|vitamin d|mesh-list
1660536|NCT04342078|Vitamins|vitamins|mesh-ancestor
1660537|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
1660538|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660539|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2468651|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2468652|NCT01052597|Analgesics|analgesics|mesh-ancestor
2468653|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
2468654|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468655|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468656|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2468657|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2468658|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468659|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468660|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468661|NCT01052623|Clonidine|clonidine|mesh-list
2468662|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
2468663|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
2468664|NCT01052623|Estradiol|estradiol|mesh-list
2468665|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
2468666|NCT01052623|Hormones|hormones|mesh-ancestor
2468667|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2468668|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468669|NCT01052623|Estrogens|estrogens|mesh-ancestor
2468670|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2468671|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
2468672|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2468673|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2468674|NCT01052623|Analgesics|analgesics|mesh-ancestor
2468675|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
2468676|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468677|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2468678|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
2468679|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
2468680|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2468681|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2468682|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2468683|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
2468684|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468685|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468686|NCT01052792|Naproxen|naproxen|mesh-list
2468687|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2468688|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2468689|NCT01052792|Analgesics|analgesics|mesh-ancestor
2468690|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
2468691|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468692|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660582|NCT04242173|Cemiplimab|cemiplimab|mesh-list
1660583|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1660584|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468693|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2468694|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2468695|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
2468696|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2468697|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468698|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468699|NCT01052870|Finasteride|finasteride|mesh-list
2468700|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
2468701|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2468702|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468703|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468704|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
2468705|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2468706|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468707|NCT01052870|Urological Agents|urological agents|mesh-ancestor
2468708|NCT01052896|Gabapentin|gabapentin|mesh-list
1660602|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
1660603|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1660604|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
1660605|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1660606|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660607|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1660608|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
1660609|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1660610|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
1660611|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660612|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1660613|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1660614|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
1660615|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
1660616|NCT04231760|Protective Agents|protective agents|mesh-ancestor
1660617|NCT04218266|Apixaban|apixaban|mesh-list
1660618|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1660619|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
1660620|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1660621|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
1660622|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1660623|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660624|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
2468709|NCT01052896|Analgesics|analgesics|mesh-ancestor
2468710|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
2468711|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468712|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468713|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
2468714|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2468715|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2468716|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468717|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2468718|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2468719|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2468720|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468721|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468722|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
2468723|NCT01052909|Glimepiride|glimepiride|mesh-list
2468724|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2468725|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2468726|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468727|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2468728|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
2468729|NCT01052961|Oseltamivir|oseltamivir|mesh-list
2468730|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
2468731|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468732|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468733|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468734|NCT01052974|Ropivacaine|ropivacaine|mesh-list
2468735|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
2468736|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
2468737|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468738|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468739|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
2468740|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468741|NCT01052987|Tranilast|tranilast|mesh-list
2468742|NCT01052987|Allopurinol|allopurinol|mesh-list
2468743|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
2468744|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468745|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468746|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
2468747|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2468748|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2468749|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
2468750|NCT01052987|Protective Agents|protective agents|mesh-ancestor
2468751|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468752|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2468753|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2468754|NCT01052987|Analgesics|analgesics|mesh-ancestor
2468755|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
2468756|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468757|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2468758|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2468759|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2468760|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2468761|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2468762|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
2468763|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
2468764|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468765|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2468766|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2468767|NCT01053026|Olmesartan|olmesartan|mesh-list
2468768|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2468769|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2468770|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2468771|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468772|NCT01053039|Morphine|morphine|mesh-list
2468773|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1660690|NCT04102241|Hemay005|hemay005|mesh-list
1660691|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
1660692|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1660693|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1660694|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1660695|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468774|NCT01053039|Narcotics|narcotics|mesh-ancestor
2468775|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468776|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468777|NCT01053039|Analgesics|analgesics|mesh-ancestor
2468778|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
2468779|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468780|NCT01053065|Atorvastatin|atorvastatin|mesh-list
2468781|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
2468782|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
2468783|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2468784|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2468785|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
2468786|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468787|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2468788|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2468789|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468790|NCT01053169|Thrombin|thrombin|mesh-list
2468791|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
2468792|NCT01053169|Coagulants|coagulants|mesh-ancestor
2468793|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
2468794|NCT01053208|Promethazine|promethazine|mesh-list
2468795|NCT01053208|Ibuprofen|ibuprofen|mesh-list
2468796|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468797|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2468798|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2468799|NCT01053208|Analgesics|analgesics|mesh-ancestor
2468800|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
2468801|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468802|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468803|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2468804|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2468805|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2468806|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1660729|NCT04083014|Bortezomib|bortezomib|mesh-list
1660730|NCT04083014|Antibodies|antibodies|mesh-list
1660731|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
1660732|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660733|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468807|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2468808|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1660742|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1660743|NCT04039750|Clindamycin|clindamycin|mesh-list
1660744|NCT04039750|Gentamicins|gentamicins|mesh-list
1660745|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1660746|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1660747|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1660748|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660749|NCT04026945|Lidocaine|lidocaine|mesh-list
1660750|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
1660751|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
1660752|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1660753|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660754|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
1660755|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1660756|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1660757|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1660758|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1660759|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1660760|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660761|NCT04007991|Ecopipam|ecopipam|mesh-list
1660762|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1660763|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1660764|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1660765|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660766|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1660767|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1660768|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
1660769|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1660770|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468809|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468810|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
2468811|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
2468812|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
2468813|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
2468814|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2468815|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2468816|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
2468817|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
2468818|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468819|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2468820|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
2468821|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
2468822|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
2468823|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
2468824|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2468825|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1660788|NCT03990467|Tazobactam|tazobactam|mesh-list
1660789|NCT03990467|Piperacillin|piperacillin|mesh-list
1660790|NCT03990467|Amikacin|amikacin|mesh-list
1660791|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1660792|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1660793|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1660794|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1660795|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660796|NCT03980561|Varenicline|varenicline|mesh-list
1660797|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1660798|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1660799|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
1660800|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1660801|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660802|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660803|NCT03978767|Acetaminophen|acetaminophen|mesh-list
1660804|NCT03978767|Ibuprofen|ibuprofen|mesh-list
1660805|NCT03978767|Ketorolac|ketorolac|mesh-list
1660806|NCT03978767|Oxycodone|oxycodone|mesh-list
1660807|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1660808|NCT03978767|Analgesics|analgesics|mesh-ancestor
1660809|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
1660810|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1660811|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660812|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
1660813|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1660814|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1660815|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1660816|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1660817|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1660818|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660819|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1660820|NCT03978767|Narcotics|narcotics|mesh-ancestor
1660821|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1660822|NCT03971669|Vaccines|vaccines|mesh-list
1660823|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
1660824|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468826|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468827|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2468828|NCT01053325|Renal Agents|renal agents|mesh-ancestor
2468829|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2468830|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
2468831|NCT01053338|Promethazine|promethazine|mesh-list
2468832|NCT01053338|Ibuprofen|ibuprofen|mesh-list
2468833|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660833|NCT03970993|Vaccines|vaccines|mesh-list
1660834|NCT03970993|Immunologic Factors|immunologic factors|mesh-ancestor
1660835|NCT03970993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468834|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2468835|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2468836|NCT01053338|Analgesics|analgesics|mesh-ancestor
2468837|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
2468838|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468839|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468840|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2468841|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1660860|NCT03936309|Lidocaine|lidocaine|mesh-list
1660861|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
1660862|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
1660863|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1660864|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1660865|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
1660866|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1660867|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1660868|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1660869|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1660870|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1660871|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468842|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2468843|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468844|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2468845|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2468846|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468847|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
2468848|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
2468849|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
2468850|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
2468851|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2468852|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2468853|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
2468854|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
2468855|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468856|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2468857|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
2468858|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
2468859|NCT01053377|Oseltamivir|oseltamivir|mesh-list
2468860|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
2468861|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2468862|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468863|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468864|NCT01053390|Leucovorin|leucovorin|mesh-list
2468865|NCT01053390|Fluorouracil|fluorouracil|mesh-list
2468866|NCT01053390|Epirubicin|epirubicin|mesh-list
2468867|NCT01053390|Somatostatin|somatostatin|mesh-list
2468868|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468869|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
2468870|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468871|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2468872|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2468873|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
2468874|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468875|NCT01053390|Antidotes|antidotes|mesh-ancestor
2468876|NCT01053390|Protective Agents|protective agents|mesh-ancestor
2468877|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
2468878|NCT01053390|Vitamins|vitamins|mesh-ancestor
2468879|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
2468880|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2468881|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2468882|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2468883|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468884|NCT01053390|Hormones|hormones|mesh-ancestor
2468885|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2468886|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2468887|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
2468888|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468889|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2468890|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
2468891|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468892|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468893|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2468894|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2468895|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2468896|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
2468897|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
2468898|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
2468899|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
2468900|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
2468901|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468902|NCT01053481|Vitamin D|vitamin d|mesh-list
2468903|NCT01053481|Vitamins|vitamins|mesh-ancestor
2468904|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
2468905|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468906|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2468907|NCT01053520|Navitoclax|navitoclax|mesh-list
2468908|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468909|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
2468910|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2468911|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
2468912|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468913|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2468914|NCT01053585|Baclofen|baclofen|mesh-list
1660957|NCT03838692|Ponatinib|ponatinib|mesh-list
1660958|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1660959|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1660960|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1660961|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660962|NCT03838042|Nivolumab|nivolumab|mesh-list
1660963|NCT03838042|Entinostat|entinostat|mesh-list
1660964|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1660965|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1660966|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2468915|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1660967|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1660968|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1660969|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468916|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468917|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2468918|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468919|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2468920|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
2468921|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
2468922|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2468923|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468924|NCT01053611|Remifentanil|remifentanil|mesh-list
2468925|NCT01053611|Propofol|propofol|mesh-list
2468926|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2468927|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468928|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468929|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2468930|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
2468931|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
2468932|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2468933|NCT01053611|Narcotics|narcotics|mesh-ancestor
2468934|NCT01053611|Analgesics|analgesics|mesh-ancestor
2468935|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
2468936|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468937|NCT01053637|Acetaminophen|acetaminophen|mesh-list
1660998|NCT03774186|Pancrelipase|pancrelipase|mesh-list
1660999|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2468938|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2468939|NCT01053637|Hydrocodone|hydrocodone|mesh-list
2468940|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2468941|NCT01053637|Analgesics|analgesics|mesh-ancestor
2468942|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
2468943|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468944|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468945|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
2468946|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2468947|NCT01053637|Narcotics|narcotics|mesh-ancestor
2468948|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468949|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
1661012|NCT03770260|Ixazomib|ixazomib|mesh-list
1661013|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
1661014|NCT03770260|Pevonedistat|pevonedistat|mesh-list
1661015|NCT03770260|Glycine|glycine|mesh-list
1661016|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661017|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661018|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
1661019|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
1661020|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1661021|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661022|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
1661023|NCT03760718|Procaine|procaine|mesh-list
1661024|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
1661025|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
1661026|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1661027|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661028|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
1661029|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1661030|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1661031|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1661032|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661033|NCT03739268|Sevelamer|sevelamer|mesh-list
1661034|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
1661035|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
1661036|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468950|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
2468951|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2468952|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2468953|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1661041|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
2468954|NCT01053650|Acetaminophen|acetaminophen|mesh-list
1661042|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468955|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2468956|NCT01053650|Analgesics|analgesics|mesh-ancestor
2468957|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
2468958|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468959|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468960|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
2468961|NCT01053689|Glimepiride|glimepiride|mesh-list
2468962|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1661051|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
1661052|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1661053|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1661054|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661055|NCT03729362|Miglustat|miglustat|mesh-list
1661056|NCT03729362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1661057|NCT03729362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661058|NCT03729362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1661059|NCT03729362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1661060|NCT03729362|Antiviral Agents|antiviral agents|mesh-ancestor
1661061|NCT03729362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1661062|NCT03729362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
1661063|NCT03729362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1661064|NCT03729362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661068|NCT03672630|Azithromycin|azithromycin|mesh-list
1661069|NCT03672630|Rifampin|rifampin|mesh-list
1661070|NCT03672630|Ethambutol|ethambutol|mesh-list
1661071|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1661072|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1661073|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1661074|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
1661075|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
1661076|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1661077|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1661078|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661079|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1661080|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1661081|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1661082|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1661083|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1661084|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1661085|NCT03671525|Nimodipine|nimodipine|mesh-list
1661086|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1661087|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1661088|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1661089|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661090|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1661091|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661092|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
2468963|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2468964|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468965|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2468966|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
2468967|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
2468968|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2468969|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468970|NCT01053806|Lenalidomide|lenalidomide|mesh-list
2468971|NCT01053806|Azacitidine|azacitidine|mesh-list
2468972|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
2468973|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468974|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2468975|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2468976|NCT01053806|Growth Substances|growth substances|mesh-ancestor
2468977|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
2468978|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2468979|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2468980|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
1661111|NCT03660553|Insulin|insulin|mesh-list
1661112|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1661113|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
1661114|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
1661115|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
1661116|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1661117|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468981|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2468982|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2468983|NCT01053871|Fentanyl|fentanyl|mesh-list
2468984|NCT01053871|Midazolam|midazolam|mesh-list
2468985|NCT01053871|Propofol|propofol|mesh-list
2468986|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2468987|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2468988|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2468989|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2468990|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
2468991|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
2468992|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2468993|NCT01053871|Narcotics|narcotics|mesh-ancestor
2468994|NCT01053871|Analgesics|analgesics|mesh-ancestor
2468995|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
2468996|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2468997|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2468998|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2468999|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2469000|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2469001|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
2469002|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
2469003|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469004|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469005|NCT01053884|Anidulafungin|anidulafungin|mesh-list
2469006|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
2469007|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469008|NCT01053910|Ramipril|ramipril|mesh-list
2469009|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2469010|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
2469011|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469012|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469013|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2469014|NCT01053949|Thalidomide|thalidomide|mesh-list
2469015|NCT01053949|Pomalidomide|pomalidomide|mesh-list
2469016|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
2469017|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469018|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2469019|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2469020|NCT01053949|Growth Substances|growth substances|mesh-ancestor
2469021|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
2469022|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469023|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2469024|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
2469025|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2469026|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469027|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
2469028|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
2469029|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2469030|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2469031|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469032|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469033|NCT01054001|Urological Agents|urological agents|mesh-ancestor
2469034|NCT01054027|Phenylephrine|phenylephrine|mesh-list
2469035|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
2469036|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
2469037|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2469038|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
2469039|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
2469040|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469041|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661179|NCT03576443|Idelalisib|idelalisib|mesh-list
1661180|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661181|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1661182|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469042|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
2469043|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2469044|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
2469045|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
2469046|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2469047|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2469048|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2469049|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
2469050|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469051|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469052|NCT01054027|Protective Agents|protective agents|mesh-ancestor
2469053|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
2469054|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2469055|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2469056|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
2469057|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
2469058|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2469059|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661205|NCT03505944|Venetoclax|venetoclax|mesh-list
1661206|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661207|NCT03480776|Aspirin|aspirin|mesh-list
1661208|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1661209|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1661210|NCT03480776|Analgesics|analgesics|mesh-ancestor
1661211|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
1661212|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1661213|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661214|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1661215|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1661216|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1661217|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1661218|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661219|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1661220|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1661221|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1661222|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
1661223|NCT03466294|Azacitidine|azacitidine|mesh-list
1661224|NCT03466294|Venetoclax|venetoclax|mesh-list
1661225|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1661226|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
1661227|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661228|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661229|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469060|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2469061|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469062|NCT01054105|Iloprost|iloprost|mesh-list
2469063|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2469064|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
2469065|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2469066|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2469067|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469068|NCT01054118|Incretins|incretins|mesh-ancestor
2469069|NCT01054118|Hormones|hormones|mesh-ancestor
2469070|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469071|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2469072|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
2469073|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469074|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469075|NCT01054196|Lenalidomide|lenalidomide|mesh-list
2469076|NCT01054196|Melphalan|melphalan|mesh-list
2469077|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
2469078|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469079|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2469080|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2469081|NCT01054196|Growth Substances|growth substances|mesh-ancestor
2469082|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
2469083|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469084|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2469085|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
2469086|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661259|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
1661260|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1661261|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1661262|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661263|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
1661264|NCT03353259|Coagulants|coagulants|mesh-ancestor
1661265|NCT03247569|Edoxaban|edoxaban|mesh-list
1661266|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1661267|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
1661268|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1661269|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
1661270|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1661271|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661272|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
1661273|NCT03245840|Budesonide|budesonide|mesh-list
1661274|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1661275|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1661276|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
1661277|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1661278|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661279|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1661280|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
1661281|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
1661282|NCT03245840|Hormones|hormones|mesh-ancestor
1661283|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469087|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2469088|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2469089|NCT01054248|Artesunate|artesunate|mesh-list
2469090|NCT01054248|Piperaquine|piperaquine|mesh-list
2469091|NCT01054248|Artenimol|artenimol|mesh-list
2469092|NCT01054248|Mefloquine|mefloquine|mesh-list
2469093|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
2469094|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2469095|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2469096|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469097|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469098|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
2469099|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
2469100|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2469101|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
2469102|NCT01054313|Sirolimus|sirolimus|mesh-list
2469103|NCT01054313|Prednisone|prednisone|mesh-list
2469104|NCT01054313|Docetaxel|docetaxel|mesh-list
2469105|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469106|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
2469107|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
2469108|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
1661306|NCT03174184|Amoxicillin|amoxicillin|mesh-list
1661307|NCT03174184|Rifampin|rifampin|mesh-list
1661308|NCT03174184|Meropenem|meropenem|mesh-list
1661309|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
1661310|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
1661311|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1661312|NCT03174184|Rifamycins|rifamycins|mesh-list
1661313|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1661314|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1661315|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1661316|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
1661317|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
1661318|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1661319|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1661320|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661321|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1661322|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1661323|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1661324|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1661325|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1661326|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1661327|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2469109|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469110|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2469111|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
2469112|NCT01054313|Hormones|hormones|mesh-ancestor
2469113|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469114|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469115|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2469116|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2469117|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469118|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1661338|NCT03128905|Prednisone|prednisone|mesh-list
1661339|NCT03128905|Colchicine|colchicine|mesh-list
1661340|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1661341|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
1661342|NCT03128905|Hormones|hormones|mesh-ancestor
1661343|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469119|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
1661344|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661345|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1661346|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661347|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
1661348|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1661349|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
1661350|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
1661351|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
1661352|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661353|NCT03121586|Pimavanserin|pimavanserin|mesh-list
1661354|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1661355|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1661356|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1661357|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1661358|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1661359|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661360|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1661361|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1661362|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1661363|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
1661364|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1661365|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661366|NCT03110926|Leucovorin|leucovorin|mesh-list
1661367|NCT03110926|Paclitaxel|paclitaxel|mesh-list
1661368|NCT03110926|Carboplatin|carboplatin|mesh-list
1661369|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
1661370|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1661371|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661372|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
1661373|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
1661374|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
1661375|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661376|NCT03110926|Antidotes|antidotes|mesh-ancestor
1661377|NCT03110926|Protective Agents|protective agents|mesh-ancestor
1661378|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661379|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
1661380|NCT03110926|Vitamins|vitamins|mesh-ancestor
1661381|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
2469120|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2469121|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
2469122|NCT01054469|Ropivacaine|ropivacaine|mesh-list
2469123|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
2469124|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
2469125|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2469126|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661398|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
1661399|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1661400|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661401|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1661402|NCT02997761|Blinatumomab|blinatumomab|mesh-list
1661403|NCT02997761|Antibodies|antibodies|mesh-list
1661404|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
1661405|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1661406|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
1661407|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
1661408|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
1661409|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661410|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661411|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2469127|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
2469128|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469129|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
2469130|NCT01054508|Niacin|niacin|mesh-list
2469131|NCT01054508|Niacinamide|niacinamide|mesh-list
2469132|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
2469133|NCT01054508|Vitamins|vitamins|mesh-ancestor
2469134|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
2469135|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469136|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2469137|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
2469138|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469139|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2469140|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
2469141|NCT01054547|Anesthetics|anesthetics|mesh-list
2469142|NCT01054547|Ropivacaine|ropivacaine|mesh-list
2469143|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2469144|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469145|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
2469146|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
2469147|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469148|NCT01054651|Artesunate|artesunate|mesh-list
2469149|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
2469150|NCT01054651|Sulfalene|sulfalene|mesh-list
2469151|NCT01054651|Praziquantel|praziquantel|mesh-list
2469152|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
2469153|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2469154|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2469155|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469156|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469157|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
2469158|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
2469159|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2469160|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
1661446|NCT02913495|Progesterone|progesterone|mesh-list
1661447|NCT02913495|Progestins|progestins|mesh-ancestor
1661448|NCT02913495|Hormones|hormones|mesh-ancestor
1661449|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1661450|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469161|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2469162|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469163|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469164|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2469165|NCT01054651|Renal Agents|renal agents|mesh-ancestor
2469166|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2469167|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469168|NCT01054781|Rituximab|rituximab|mesh-list
2469169|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2469170|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469171|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
2469172|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469173|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2469174|NCT01054872|Vaccines|vaccines|mesh-list
2469175|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
2469176|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469177|NCT01055015|Morphine|morphine|mesh-list
2469178|NCT01055015|Oxycodone|oxycodone|mesh-list
2469179|NCT01055015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2469180|NCT01055015|Narcotics|narcotics|mesh-ancestor
2469181|NCT01055015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2469182|NCT01055015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469183|NCT01055015|Analgesics|analgesics|mesh-ancestor
2469184|NCT01055015|Sensory System Agents|sensory system agents|mesh-ancestor
2469185|NCT01055015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469186|NCT01055041|Budesonide|budesonide|mesh-list
2469187|NCT01055041|Doxofylline|doxofylline|mesh-list
2469188|NCT01055041|Montelukast|montelukast|mesh-list
2469189|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2469190|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2469191|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
2469192|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469193|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469194|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2469195|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
2469196|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
2469197|NCT01055041|Hormones|hormones|mesh-ancestor
2469198|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469199|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
2469200|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
2469201|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
2469202|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2469203|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469204|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
2469205|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2469206|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469207|NCT01055106|Metronidazole|metronidazole|mesh-list
2469208|NCT01055106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469209|NCT01055106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2469210|NCT01055106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2469211|NCT01055106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2469212|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
2469213|NCT01055145|Levofloxacin|levofloxacin|mesh-list
2469214|NCT01055145|Ofloxacin|ofloxacin|mesh-list
2469215|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2469216|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1661508|NCT02823990|Nivolumab|nivolumab|mesh-list
1661509|NCT02823990|Interleukin-2|interleukin-2|mesh-list
1661510|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661511|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1661512|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661513|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1661514|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661515|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1661516|NCT02823990|Analgesics|analgesics|mesh-ancestor
1661517|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
1661518|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469217|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2469218|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2469219|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469220|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469221|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469222|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2469223|NCT01055145|Renal Agents|renal agents|mesh-ancestor
2469224|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2469225|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2469226|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
2469227|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
2469228|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
2469229|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2469230|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
2469231|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
2469232|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469233|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469234|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469235|NCT01055249|Ibuprofen|ibuprofen|mesh-list
1661538|NCT02633098|Artesunate|artesunate|mesh-list
1661539|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
1661540|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1661541|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1661542|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1661543|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661544|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
1661545|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
1661546|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1661547|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
2469236|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
2469237|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2469238|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2469239|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2469240|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2469241|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2469242|NCT01055249|Analgesics|analgesics|mesh-ancestor
2469243|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
2469244|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469245|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469246|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2469247|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2469248|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2469249|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469250|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469251|NCT01055301|Thalidomide|thalidomide|mesh-list
2469252|NCT01055301|Dexamethasone|dexamethasone|mesh-list
2469253|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
2469254|NCT01055301|Melphalan|melphalan|mesh-list
2469255|NCT01055301|Doxorubicin|doxorubicin|mesh-list
2469256|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2469257|NCT01055301|Etoposide|etoposide|mesh-list
2469258|NCT01055301|Lenalidomide|lenalidomide|mesh-list
2469259|NCT01055301|Bortezomib|bortezomib|mesh-list
2469260|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2469261|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
2469262|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469263|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2469264|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2469265|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
2469266|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469267|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469268|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1661577|NCT02624128|Cetuximab|cetuximab|mesh-list
1661578|NCT02624128|Valproic Acid|valproic acid|mesh-list
1661579|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661580|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1661581|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
1661582|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1661583|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661584|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
1661585|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1661586|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661587|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
1661588|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1661589|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1661590|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1661591|NCT02592707|Dexamethasone|dexamethasone|mesh-list
1661592|NCT02592707|Ondansetron|ondansetron|mesh-list
1661593|NCT02592707|Antiemetics|antiemetics|mesh-list
1661594|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
1661595|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1661596|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
1661597|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1661598|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661599|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1661600|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
1661601|NCT02592707|Hormones|hormones|mesh-ancestor
1661602|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1661603|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1661604|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661605|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661606|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
1661607|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
1661608|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1661609|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
1661610|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1661611|NCT02592707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1661612|NCT02592707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1661613|NCT02592707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1661614|NCT02592707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1661615|NCT02592707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1661616|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
1661617|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
1661618|NCT02578069|Sirolimus|sirolimus|mesh-list
1661619|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1661620|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1661621|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1661622|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661623|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
1661624|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1661625|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
1661626|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469269|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2469270|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
2469271|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
2469272|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469273|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2469274|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
2469275|NCT01055301|Hormones|hormones|mesh-ancestor
2469276|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469277|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2469278|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2469279|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2469280|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2469281|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469282|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2469283|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2469284|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2469285|NCT01055301|Growth Substances|growth substances|mesh-ancestor
2469286|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
2469287|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
2469288|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2469289|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469290|NCT01055327|Lamotrigine|lamotrigine|mesh-list
2469291|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
2469292|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2469293|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2469294|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469295|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2469296|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469297|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2469298|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2469299|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2469300|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2469301|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2469302|NCT01055379|Rasagiline|rasagiline|mesh-list
2469303|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2469304|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469305|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469306|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2469307|NCT01055379|Protective Agents|protective agents|mesh-ancestor
2469308|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469309|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
2469310|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
2469311|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2469312|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469313|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469314|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
2469315|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2469316|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2469317|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469318|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
2469319|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
2469320|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2469321|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1661680|NCT02514031|Gemcitabine|gemcitabine|mesh-list
1661681|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
1661682|NCT02514031|Paclitaxel|paclitaxel|mesh-list
1661683|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1661684|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661685|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
1661686|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
1661687|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
1661688|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661689|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1661690|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
1661691|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
1661692|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1661693|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1661694|NCT02514031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1661695|NCT02514031|Immunologic Factors|immunologic factors|mesh-ancestor
1661696|NCT02514031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661697|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1661698|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2469322|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469323|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469324|NCT01055405|Urological Agents|urological agents|mesh-ancestor
2469325|NCT01055418|Ascorbic Acid|ascorbic acid|mesh-list
2469326|NCT01055418|Vitamins|vitamins|mesh-ancestor
2469327|NCT01055418|Micronutrients|micronutrients|mesh-ancestor
2469328|NCT01055418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469329|NCT01055418|Antioxidants|antioxidants|mesh-ancestor
2469330|NCT01055418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469331|NCT01055418|Protective Agents|protective agents|mesh-ancestor
2469332|NCT01055431|Iron|iron|mesh-list
2469333|NCT01055431|Trace Elements|trace elements|mesh-ancestor
2469334|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
2469335|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469336|NCT01055444|Lidocaine|lidocaine|mesh-list
2469337|NCT01055444|Tetracaine|tetracaine|mesh-list
2469338|NCT01055444|Anesthetics, Local|anesthetics, local|mesh-ancestor
2469339|NCT01055444|Anesthetics|anesthetics|mesh-ancestor
2469340|NCT01055444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2469341|NCT01055444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469342|NCT01055444|Sensory System Agents|sensory system agents|mesh-ancestor
2469343|NCT01055444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469344|NCT01055444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2738624|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2469345|NCT01055444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2469346|NCT01055444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2469347|NCT01055444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2469348|NCT01055444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469349|NCT01055470|Diclofenac|diclofenac|mesh-list
2469350|NCT01055470|Lornoxicam|lornoxicam|mesh-list
2469351|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2469352|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2469353|NCT01055470|Analgesics|analgesics|mesh-ancestor
2469354|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
2469355|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469356|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469357|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2469358|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2469359|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2469360|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469361|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469362|NCT01055483|Panobinostat|panobinostat|mesh-list
2469363|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469364|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2469365|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469366|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469367|NCT01055522|Interleukin-2|interleukin-2|mesh-list
2469368|NCT01055522|Dacarbazine|dacarbazine|mesh-list
2469369|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469370|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2469371|NCT01055522|Analgesics|analgesics|mesh-ancestor
2469372|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
2469373|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469374|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469375|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2469376|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
2469377|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469378|NCT01055535|Plasminogen|plasminogen|mesh-list
2469379|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2469380|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2469381|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469382|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
2469383|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2469384|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469385|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2469386|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469387|NCT01055691|Metformin|metformin|mesh-list
2469388|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
2469389|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2469390|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469391|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2469392|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469393|NCT01055743|Fluorouracil|fluorouracil|mesh-list
2469394|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
2469395|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469396|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2469397|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469398|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2469399|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
2469400|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469401|NCT01055756|Loratadine|loratadine|mesh-list
2469402|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
2469403|NCT01055756|Ephedrine|ephedrine|mesh-list
2469404|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2469405|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
2469406|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469407|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469408|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2469409|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
2469410|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
2469411|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2469412|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2469413|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
2469414|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
2469415|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469416|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469417|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
2469418|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
2469419|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1661808|NCT02427126|Aspirin|aspirin|mesh-list
1661809|NCT02427126|Apixaban|apixaban|mesh-list
1661810|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1661811|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1661812|NCT02427126|Analgesics|analgesics|mesh-ancestor
1661813|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
1661814|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1661815|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661816|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1661817|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1661818|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1661819|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1661820|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661821|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1661822|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1661823|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1661824|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
1661825|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1661826|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
1661827|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1661828|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
1661829|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
2469420|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2469421|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2469422|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
2469423|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
2469424|NCT01055795|Bevacizumab|bevacizumab|mesh-list
2469425|NCT01055795|Everolimus|everolimus|mesh-list
2469426|NCT01055795|Panobinostat|panobinostat|mesh-list
2469427|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2469428|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469429|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2469430|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2469431|NCT01055795|Growth Substances|growth substances|mesh-ancestor
2469432|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469433|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
2469434|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2469435|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
2469436|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2469437|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469438|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469439|NCT01055808|Insulin|insulin|mesh-list
2469440|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2469441|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469442|NCT01055821|Interferons|interferons|mesh-list
2469443|NCT01055821|Ribavirin|ribavirin|mesh-list
2469444|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469445|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
1661856|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
1661857|NCT02394834|Leucovorin|leucovorin|mesh-list
1661858|NCT02394834|Bevacizumab|bevacizumab|mesh-list
1661859|NCT02394834|Panitumumab|panitumumab|mesh-list
1661860|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
1661861|NCT02394834|Fluorouracil|fluorouracil|mesh-list
1661862|NCT02394834|Calcium|calcium|mesh-list
1661863|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
1661864|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1661865|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661866|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1661867|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1661868|NCT02394834|Growth Substances|growth substances|mesh-ancestor
1661869|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661870|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
1661871|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1661872|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1661873|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
1661874|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661875|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1661876|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1661877|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
1661878|NCT02394834|Antidotes|antidotes|mesh-ancestor
1661879|NCT02394834|Protective Agents|protective agents|mesh-ancestor
1661880|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
1661881|NCT02394834|Vitamins|vitamins|mesh-ancestor
1661882|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
1661883|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
1661884|NCT02394795|Leucovorin|leucovorin|mesh-list
1661885|NCT02394795|Bevacizumab|bevacizumab|mesh-list
1661886|NCT02394795|Panitumumab|panitumumab|mesh-list
1661887|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
1661888|NCT02394795|Fluorouracil|fluorouracil|mesh-list
1661889|NCT02394795|Calcium|calcium|mesh-list
1661890|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
1661891|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1661892|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1661893|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1661894|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1661895|NCT02394795|Growth Substances|growth substances|mesh-ancestor
1661896|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1661897|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
1661898|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1661899|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1661900|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
1661901|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1661902|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1661903|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1661904|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
1661905|NCT02394795|Antidotes|antidotes|mesh-ancestor
1661906|NCT02394795|Protective Agents|protective agents|mesh-ancestor
1661907|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
1661908|NCT02394795|Vitamins|vitamins|mesh-ancestor
1661909|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
2469446|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469447|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
2469448|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469449|NCT01055847|Aztreonam|aztreonam|mesh-list
2469450|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2469451|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469452|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2469453|NCT01055925|Laxatives|laxatives|mesh-ancestor
2469454|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2469455|NCT01055938|Valproic Acid|valproic acid|mesh-list
2469456|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
2469457|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469458|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469459|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
2469460|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469461|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469462|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
2469463|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2469464|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2469465|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2469466|NCT01055964|Tacrolimus|tacrolimus|mesh-list
2469467|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2469468|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
2469469|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469470|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2469471|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469472|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469473|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2469474|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2469475|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
2469476|NCT01056042|Gestodene|gestodene|mesh-list
2469477|NCT01056042|Estradiol|estradiol|mesh-list
2469478|NCT01056042|Estrogens|estrogens|mesh-ancestor
2469479|NCT01056042|Hormones|hormones|mesh-ancestor
2469480|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469481|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469482|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2469483|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
2469484|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2469485|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2469486|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2469487|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2469488|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2469489|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2469490|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2469491|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469492|NCT01056042|Progestins|progestins|mesh-ancestor
2469493|NCT01056159|Albuterol|albuterol|mesh-list
2469494|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2469495|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
2469496|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469497|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469498|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2469499|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
2469500|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
2469501|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2469502|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2469503|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2469504|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2469505|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
2469506|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469507|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469508|NCT01056172|Ribavirin|ribavirin|mesh-list
2469509|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2469510|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
2469511|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
2469512|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469513|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
2469514|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469515|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
2469516|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469517|NCT01056224|Remifentanil|remifentanil|mesh-list
2469518|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2469519|NCT01056224|Narcotics|narcotics|mesh-ancestor
2469520|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2469521|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469522|NCT01056224|Analgesics|analgesics|mesh-ancestor
2469523|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
2469524|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469525|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
2469526|NCT01056237|Azathioprine|azathioprine|mesh-list
2469527|NCT01056237|Tacrolimus|tacrolimus|mesh-list
2469528|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2469529|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
2469530|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469531|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2469532|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469533|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469534|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2469535|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469536|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2469537|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
2469538|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2469539|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469540|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
2469541|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2469542|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2469543|NCT01056393|Ibalizumab|ibalizumab|mesh-list
2469544|NCT01056393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2469545|NCT01056393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2469546|NCT01056393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2469547|NCT01056393|Antiviral Agents|antiviral agents|mesh-ancestor
2469548|NCT01056393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469549|NCT01056393|Immunologic Factors|immunologic factors|mesh-ancestor
2469550|NCT01056393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469551|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
2469552|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
2469553|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469554|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
2469555|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
2469556|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469557|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469558|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
2469559|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
2469560|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469561|NCT01056497|Protective Agents|protective agents|mesh-ancestor
2469562|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469563|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
2469564|NCT01056497|Vitamins|vitamins|mesh-ancestor
2469565|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
2469566|NCT01056549|Exenatide|exenatide|mesh-list
2469567|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2469568|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469569|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2469570|NCT01056549|Incretins|incretins|mesh-ancestor
2469571|NCT01056549|Hormones|hormones|mesh-ancestor
2469572|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469573|NCT01056614|Methotrexate|methotrexate|mesh-list
2469574|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
2469575|NCT01056614|Fludarabine|fludarabine|mesh-list
2469576|NCT01056614|Busulfan|busulfan|mesh-list
2469577|NCT01056614|Tacrolimus|tacrolimus|mesh-list
2469578|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
2469579|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
2469580|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
2469581|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2469582|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
2469583|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2469584|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469585|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2469586|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
2738625|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469587|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469588|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469589|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
2469590|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469591|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2469592|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2469593|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
2469594|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2469595|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2469596|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2469597|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
2469598|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2469599|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2469600|NCT01056627|Valproic Acid|valproic acid|mesh-list
2469601|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
2469602|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469603|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469604|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
2469605|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469606|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469607|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
2469608|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2469609|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2469610|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2469611|NCT01056679|Doxorubicin|doxorubicin|mesh-list
2469612|NCT01056679|Lenalidomide|lenalidomide|mesh-list
2469613|NCT01056679|Vinblastine|vinblastine|mesh-list
2469614|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2469615|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469616|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2469617|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2469618|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469619|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469620|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
2469621|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469622|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2469623|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2469624|NCT01056679|Growth Substances|growth substances|mesh-ancestor
2469625|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
2469626|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2469627|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
2469628|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
2469629|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
2469630|NCT01056705|Vaccines|vaccines|mesh-list
2469631|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
2469632|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469633|NCT01056757|Ribavirin|ribavirin|mesh-list
2469634|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
2469635|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469636|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
2469637|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469638|NCT01056835|Epoprostenol|epoprostenol|mesh-list
2469639|NCT01056835|Tezosentan|tezosentan|mesh-list
2469640|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2469641|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2469642|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
2469643|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
2469644|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2469645|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2469646|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2469647|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2469648|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469649|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
2469650|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469651|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469652|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2469653|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469654|NCT01056874|Maraviroc|maraviroc|mesh-list
2469655|NCT01056874|Digoxin|digoxin|mesh-list
2469656|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2469657|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2469658|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469659|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2469660|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2469661|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
2469662|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469663|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2469664|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2738639|NCT04514497|Irinotecan|irinotecan|mesh-list
2738640|NCT04514497|Topotecan|topotecan|mesh-list
2738641|NCT04514497|Camptothecin|camptothecin|mesh-list
2738642|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2738643|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2738644|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2738645|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738646|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738647|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2738648|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
2738649|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738650|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2738651|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738652|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2738653|NCT04507204|Methylphenidate|methylphenidate|mesh-list
2738654|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2738655|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738656|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2738657|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2738658|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2738659|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738660|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
2738661|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2738662|NCT04496596|Suramin|suramin|mesh-list
2738663|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
2738664|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
2738665|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2469665|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2469666|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469667|NCT01056874|Protective Agents|protective agents|mesh-ancestor
2469668|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469669|NCT01056926|Nicotine|nicotine|mesh-list
2469670|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2738666|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2738667|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738668|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2469671|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
2469672|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469673|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469674|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2469675|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2469676|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
2469677|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469678|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469679|NCT01057069|Paclitaxel|paclitaxel|mesh-list
2469680|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2469681|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
2469682|NCT01057069|Carboplatin|carboplatin|mesh-list
2738669|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2738670|NCT04487067|Bevacizumab|bevacizumab|mesh-list
2738671|NCT04487067|Atezolizumab|atezolizumab|mesh-list
2738672|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2738673|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738674|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2738675|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2738676|NCT04487067|Growth Substances|growth substances|mesh-ancestor
2738677|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738678|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
2738683|NCT04458922|Atezolizumab|atezolizumab|mesh-list
2738684|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2738685|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738686|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
2738687|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738688|NCT04447846|Cannabidiol|cannabidiol|mesh-list
2738689|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
2738690|NCT04447053|Belimumab|belimumab|mesh-list
2738691|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2738692|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
2738693|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662393|NCT05080569|Progesterone|progesterone|mesh-list
1662394|NCT05080569|Progestins|progestins|mesh-ancestor
1662395|NCT05080569|Hormones|hormones|mesh-ancestor
1662396|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1662397|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662398|NCT05080556|Carboplatin|carboplatin|mesh-list
1662399|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1662400|NCT05080543|Terlipressin|terlipressin|mesh-list
1662401|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1662402|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1662403|NCT05080530|Vitamin D|vitamin d|mesh-list
1662404|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
1662405|NCT05080530|Vitamins|vitamins|mesh-ancestor
1662406|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
1662407|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662408|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1662409|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1662410|NCT05080478|Clopidogrel|clopidogrel|mesh-list
1662411|NCT05080478|Ticagrelor|ticagrelor|mesh-list
1662412|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1662413|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1662414|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1662415|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1662416|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
1662417|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1662418|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662419|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662420|NCT05080348|Ropivacaine|ropivacaine|mesh-list
1662421|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
1662422|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
1662423|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1662424|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662425|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
1662426|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1662427|NCT05080322|Fluticasone|fluticasone|mesh-list
1662428|NCT05080322|Xhance|xhance|mesh-list
1662429|NCT05080322|Azelastine|azelastine|mesh-list
1662430|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1662431|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1662432|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
1662433|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1662434|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662435|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1662436|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
1662437|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
1662438|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1662439|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1662440|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1662441|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662442|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1662443|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1662444|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
1662445|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
1662446|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469683|NCT01057069|Doxorubicin|doxorubicin|mesh-list
2469684|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2469685|NCT01057069|Thiotepa|thiotepa|mesh-list
2469686|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2469687|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469688|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
2469689|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
2469690|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
2469691|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469692|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2469693|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
2469694|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469695|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2469696|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2469697|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
2469698|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2469699|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2469700|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2469701|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2469702|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469703|NCT01057147|Rebamipide|rebamipide|mesh-list
2469704|NCT01057147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2469705|NCT01057147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2469706|NCT01057147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1662471|NCT05080192|Fenofibrate|fenofibrate|mesh-list
1662472|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1662473|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
1662474|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662475|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1662476|NCT05080140|Ezetimibe|ezetimibe|mesh-list
1662477|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1662478|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1662479|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
1662480|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662481|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1662482|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
1662483|NCT05080049|Hematinics|hematinics|mesh-ancestor
1662484|NCT05080010|Carboplatin|carboplatin|mesh-list
1662485|NCT05080010|Etoposide|etoposide|mesh-list
1662486|NCT05080010|Vincristine|vincristine|mesh-list
1662487|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1662488|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1662489|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1662490|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1662491|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1662492|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662493|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
1662494|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
1662495|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
1662496|NCT05079880|Caffeine|caffeine|mesh-list
1662497|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
1662498|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662499|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1662500|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662501|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1662502|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1662503|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1662504|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1662505|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
1662506|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469707|NCT01057147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2469708|NCT01057147|Antioxidants|antioxidants|mesh-ancestor
2469709|NCT01057147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469710|NCT01057147|Protective Agents|protective agents|mesh-ancestor
2469711|NCT01057147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469712|NCT01057147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469713|NCT01057160|Rizatriptan|rizatriptan|mesh-list
2469714|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2469715|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
2469716|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469717|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469718|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662519|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1662520|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1662521|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469719|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
2469720|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
2469721|NCT01057186|Sevelamer|sevelamer|mesh-list
2469722|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
2469723|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
2469724|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469725|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2469726|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469727|NCT01057186|Vitamins|vitamins|mesh-ancestor
2469728|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
2469729|NCT01057212|Bevacizumab|bevacizumab|mesh-list
2469730|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2469731|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469732|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1662536|NCT05079789|Amiloride|amiloride|mesh-list
1662537|NCT05079789|Furosemide|furosemide|mesh-list
1662538|NCT05079789|Diuretics|diuretics|mesh-ancestor
1662539|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
1662540|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662541|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1662542|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1662543|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662544|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
1662545|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1662546|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
1662547|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1662548|NCT05079763|Monolaurin|monolaurin|mesh-list
1662549|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
1662550|NCT05079763|Protective Agents|protective agents|mesh-ancestor
1662551|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469733|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2469734|NCT01057212|Growth Substances|growth substances|mesh-ancestor
2469735|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469736|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
2469737|NCT01057264|Gemcitabine|gemcitabine|mesh-list
2469738|NCT01057264|Paclitaxel|paclitaxel|mesh-list
2469739|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2469740|NCT01057264|Bevacizumab|bevacizumab|mesh-list
2469741|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2469742|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469743|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
2469744|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
2469745|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
2469746|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469747|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2469748|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2469749|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2469750|NCT01057264|Growth Substances|growth substances|mesh-ancestor
2469751|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469752|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
2469753|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2469754|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
2469755|NCT01057264|Antiviral Agents|antiviral agents|mesh-ancestor
2469756|NCT01057264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469757|NCT01057264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469758|NCT01057264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2469759|NCT01057264|Immunologic Factors|immunologic factors|mesh-ancestor
2469760|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2469761|NCT01057329|Olanzapine|olanzapine|mesh-list
2469762|NCT01057329|Aripiprazole|aripiprazole|mesh-list
2469763|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2469764|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
2469765|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
2469766|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469767|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469768|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2469769|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2469770|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2469771|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2469772|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2469773|NCT01057329|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2469774|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2469775|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2469776|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469777|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469778|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
2469779|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
2469780|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
2469781|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
1662626|NCT05079087|Midazolam|midazolam|mesh-list
1662627|NCT05079087|Ketamine|ketamine|mesh-list
1662628|NCT05079087|Analgesics|analgesics|mesh-ancestor
1662629|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
1662630|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1662631|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662632|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1662633|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1662634|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
1662635|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
1662636|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1662637|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1662638|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1662639|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1662640|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662641|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1662642|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1662643|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1662644|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1662645|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1662646|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
1662647|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
2469782|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2469783|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2469784|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2469785|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2469786|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2469787|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2469788|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2469789|NCT01057329|Analgesics|analgesics|mesh-ancestor
2469790|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
2469791|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2469792|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
1662659|NCT05079061|Misoprostol|misoprostol|mesh-list
1662660|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1662661|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
1662662|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1662663|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662664|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1662665|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1662666|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
1662667|NCT05079022|Aflutinib|aflutinib|mesh-list
1662668|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1662669|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1662670|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662671|NCT05078944|Donepezil|donepezil|mesh-list
1662672|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1662673|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1662674|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662675|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
1662676|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1662677|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662678|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
2469793|NCT01057342|Paclitaxel|paclitaxel|mesh-list
2469794|NCT01057342|Carboplatin|carboplatin|mesh-list
2469795|NCT01057342|Vadimezan|vadimezan|mesh-list
2469796|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2469797|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469798|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
2469799|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
2469800|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
2469801|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469802|NCT01057355|Ethanol|ethanol|mesh-list
2469803|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2469804|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469805|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2469806|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469807|NCT01057407|Sevelamer|sevelamer|mesh-list
1662694|NCT05078827|Fluorouracil|fluorouracil|mesh-list
1662695|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
1662696|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662697|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1662698|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1662699|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1662700|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
1662701|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662702|NCT05078788|Triamcinolone|triamcinolone|mesh-list
1662703|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1662704|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
1662705|NCT05078788|Hormones|hormones|mesh-ancestor
1662706|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1662707|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662708|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
1662709|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
1662710|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469808|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
2469809|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
2469810|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469811|NCT01057498|RNS60|rns60|mesh-list
2469812|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2469813|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2469814|NCT01057498|Analgesics|analgesics|mesh-ancestor
2469815|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
2469816|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469817|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469818|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2469819|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1662746|NCT05078372|Midazolam|midazolam|mesh-list
1662747|NCT05078372|Ropivacaine|ropivacaine|mesh-list
1662748|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
1662749|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
1662750|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1662751|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662752|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
1662753|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1662754|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1662755|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1662756|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1662757|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1662758|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1662759|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1662760|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
1662761|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
1662762|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
1662763|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1662764|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662765|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
1662766|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1662767|NCT05078255|Incretins|incretins|mesh-ancestor
1662768|NCT05078255|Hormones|hormones|mesh-ancestor
1662769|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1662770|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662771|NCT05078177|Rituximab|rituximab|mesh-list
1662772|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1662773|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1662774|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
1662775|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662776|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1662777|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
1662778|NCT05078138|Hematinics|hematinics|mesh-ancestor
2469820|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2469821|NCT01057511|Progesterone|progesterone|mesh-list
2469822|NCT01057511|Progestins|progestins|mesh-ancestor
2469823|NCT01057511|Hormones|hormones|mesh-ancestor
2469824|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469825|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469826|NCT01057563|Paclitaxel|paclitaxel|mesh-list
2469827|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2469828|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2469829|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469830|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
2469831|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
2469832|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
2469833|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469834|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
1662825|NCT05077813|Vitamin D|vitamin d|mesh-list
1662826|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
1662827|NCT05077813|Vitamins|vitamins|mesh-list
1662828|NCT05077813|Minocycline|minocycline|mesh-list
1662829|NCT05077813|Tretinoin|tretinoin|mesh-list
1662830|NCT05077813|Alitretinoin|alitretinoin|mesh-list
1662831|NCT05077813|Isotretinoin|isotretinoin|mesh-list
1662832|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
1662833|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662834|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1662835|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1662836|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1662837|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1662838|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1662839|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
1662840|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
2469835|NCT01057615|Vitamins|vitamins|mesh-ancestor
2469836|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
2469837|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469838|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
2469839|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469840|NCT01057615|Protective Agents|protective agents|mesh-ancestor
2469841|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
2469842|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2469843|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469844|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2469845|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662858|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
1662859|NCT05077592|Povidone|povidone|mesh-list
1662860|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
1662861|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
1662862|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1662863|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469846|NCT01057654|Pravastatin|pravastatin|mesh-list
2469847|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2469848|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2469849|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
2469850|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469851|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2469852|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1662873|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
1662874|NCT05077527|Fludarabine|fludarabine|mesh-list
1662875|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1662876|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
1662877|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662878|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1662879|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1662880|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
1662881|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662882|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1662883|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2469853|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469854|NCT01057667|Ribavirin|ribavirin|mesh-list
2469855|NCT01057667|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2469856|NCT01057667|Antimetabolites|antimetabolites|mesh-ancestor
2469857|NCT01057667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469858|NCT01057667|Antiviral Agents|antiviral agents|mesh-ancestor
2469859|NCT01057667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469860|NCT01057758|Simvastatin|simvastatin|mesh-list
2469861|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2469862|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2469863|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
2469864|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662896|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
1662897|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
1662898|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
1662899|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662900|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1662901|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
1662902|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
1662903|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
1662904|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662905|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469865|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2469866|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2469867|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469868|NCT01057849|Olanzapine|olanzapine|mesh-list
2469869|NCT01057849|Risperidone|risperidone|mesh-list
2469870|NCT01057849|Aripiprazole|aripiprazole|mesh-list
2469871|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2469872|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
2469873|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469874|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469875|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469876|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2469877|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2469878|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2469879|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2469880|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1662949|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
1662950|NCT05077215|Lenvatinib|lenvatinib|mesh-list
1662951|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1662952|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1662953|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1662954|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1662955|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662956|NCT05077137|Vaccines|vaccines|mesh-list
1662957|NCT05077137|Immunologic Factors|immunologic factors|mesh-ancestor
1662958|NCT05077137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662959|NCT05077111|Anesthetics|anesthetics|mesh-list
1662960|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1662961|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662962|NCT05075863|Letrozole|letrozole|mesh-list
1662963|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1662964|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1662965|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1662966|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1662967|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1662968|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1662969|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
1662970|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1662971|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469881|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
2469882|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
2469883|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
2469884|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469885|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1662985|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
1662986|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1662987|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1662988|NCT05069740|Analgesics|analgesics|mesh-ancestor
1662989|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
1662990|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1662991|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1662992|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1662993|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1662994|NCT05068141|Paclitaxel|paclitaxel|mesh-list
1662995|NCT05068141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1662996|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1662997|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1662998|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
1662999|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
1663000|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
1663001|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663002|NCT05068037|Antiemetics|antiemetics|mesh-list
1663003|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
1663004|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1663005|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663006|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1663007|NCT05065424|Atropine|atropine|mesh-list
1663008|NCT05065424|Fentanyl|fentanyl|mesh-list
1663009|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1663010|NCT05065424|Narcotics|narcotics|mesh-ancestor
1663011|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1663012|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663013|NCT05065424|Analgesics|analgesics|mesh-ancestor
1663014|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
1663015|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1663016|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1663017|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1663018|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
1663019|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
1663020|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663021|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1663022|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1663023|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
1663024|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1663025|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
1663026|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
1663027|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
1663028|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1663029|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1663030|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
1663031|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469886|NCT01057849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2469887|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2469888|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2469889|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
2469890|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
1663054|NCT05062356|Ketorolac|ketorolac|mesh-list
1663055|NCT05062356|Epinephrine|epinephrine|mesh-list
1663056|NCT05062356|Bupivacaine|bupivacaine|mesh-list
1663057|NCT05062356|Prilocaine|prilocaine|mesh-list
1663058|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1663059|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
1663060|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
1663061|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1663062|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663063|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
1663064|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1663065|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1663066|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1663067|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
1663068|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1663069|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663070|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1663071|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1663072|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
1663073|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1663074|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
1663075|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
1663076|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
1663077|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1663078|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1663079|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1663080|NCT05062356|Analgesics|analgesics|mesh-ancestor
1663081|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1663082|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1663083|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1663084|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1663085|NCT05062317|Leucovorin|leucovorin|mesh-list
1663086|NCT05062317|Bevacizumab|bevacizumab|mesh-list
1663087|NCT05062317|Fluorouracil|fluorouracil|mesh-list
1663088|NCT05062317|Capecitabine|capecitabine|mesh-list
1663089|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
1663090|NCT05062317|Irinotecan|irinotecan|mesh-list
1663091|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1663092|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1663093|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1663094|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1663095|NCT05062317|Growth Substances|growth substances|mesh-ancestor
1663096|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663097|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
1663098|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
1663099|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663100|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1663101|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1663102|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
1663103|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1663104|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1663105|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1663106|NCT05062317|Antidotes|antidotes|mesh-ancestor
1663107|NCT05062317|Protective Agents|protective agents|mesh-ancestor
1663108|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
1663109|NCT05062317|Vitamins|vitamins|mesh-ancestor
1663110|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
1663111|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
1663112|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663113|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
1663114|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1663115|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1663116|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1663117|NCT05061368|Urological Agents|urological agents|mesh-ancestor
1663130|NCT05053425|Cytarabine|cytarabine|mesh-list
1663131|NCT05053425|Azacitidine|azacitidine|mesh-list
1663132|NCT05053425|Venetoclax|venetoclax|mesh-list
1663133|NCT05053425|Idarubicin|idarubicin|mesh-list
1663134|NCT05053425|Cladribine|cladribine|mesh-list
1663135|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1663136|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
1663137|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663138|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1663139|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
1663140|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1663141|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1663142|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
1663143|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663144|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1663145|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1663146|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1663147|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2469891|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2469892|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2469893|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2469894|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2469895|NCT01057875|Caffeine|caffeine|mesh-list
1663153|NCT05044871|Paclitaxel|paclitaxel|mesh-list
1663154|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1663155|NCT05044871|Bevacizumab|bevacizumab|mesh-list
1663156|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1663157|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1663158|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
1663159|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
1663160|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
1663161|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663162|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1663163|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1663164|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1663165|NCT05044871|Growth Substances|growth substances|mesh-ancestor
1663166|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663167|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
2469896|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2469897|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469898|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2469899|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469900|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469901|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2469902|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2469903|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
2469904|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469905|NCT01057966|Vitamins|vitamins|mesh-list
2469906|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
2469907|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469908|NCT01058057|Atorvastatin|atorvastatin|mesh-list
2469909|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2469910|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2469911|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
2469912|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469913|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2469914|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2469915|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469916|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
2469917|NCT01058109|Calcium|calcium|mesh-list
2469918|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2469919|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469920|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2469921|NCT01058174|Fluconazole|fluconazole|mesh-list
2469922|NCT01058174|Amphotericin B|amphotericin b|mesh-list
2469923|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2469924|NCT01058174|Caspofungin|caspofungin|mesh-list
2469925|NCT01058174|Micafungin|micafungin|mesh-list
2469926|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
2469927|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2469928|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2469929|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2469930|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469931|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469932|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2469933|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
2469934|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469935|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469936|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2469937|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2469938|NCT01058174|Amebicides|amebicides|mesh-ancestor
2469939|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2469940|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2469941|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1663219|NCT05021562|Niraparib|niraparib|mesh-list
1663220|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1663221|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1663222|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663223|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469942|NCT01058252|Indomethacin|indomethacin|mesh-list
2469943|NCT01058252|Letrozole|letrozole|mesh-list
2469944|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469945|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2469946|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2469947|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2469948|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469949|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2469950|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
2469951|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469952|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469953|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2469954|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2469955|NCT01058252|Analgesics|analgesics|mesh-ancestor
2469956|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
2469957|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469958|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2469959|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2469960|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
2469961|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
2469962|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2469963|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2469964|NCT01058291|Apomorphine|apomorphine|mesh-list
2469965|NCT01058291|Emetics|emetics|mesh-ancestor
2469966|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469967|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
1663251|NCT05015686|Vaccines|vaccines|mesh-list
1663252|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
1663253|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469968|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2469969|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2469970|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
2469971|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
2469972|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469973|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469974|NCT01058317|Propranolol|propranolol|mesh-list
2469975|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2469976|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2469977|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
2469978|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2469979|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2469980|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469981|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2469982|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2469983|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
2469984|NCT01058382|Progesterone|progesterone|mesh-list
2469985|NCT01058382|Progestins|progestins|mesh-ancestor
2469986|NCT01058382|Hormones|hormones|mesh-ancestor
2469987|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469988|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469989|NCT01058408|Cisplatin|cisplatin|mesh-list
2469990|NCT01058408|Everolimus|everolimus|mesh-list
2469991|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2469992|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2469993|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
2469994|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469995|NCT01058577|Somatostatin|somatostatin|mesh-list
2469996|NCT01058577|Hormones|hormones|mesh-ancestor
2469997|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2469998|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2469999|NCT01058720|Vitamin D|vitamin d|mesh-list
2470000|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
2470001|NCT01058720|Vitamins|vitamins|mesh-ancestor
2470002|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
2470003|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470004|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1663291|NCT05005260|Bupivacaine|bupivacaine|mesh-list
1663292|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
1663293|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
1663294|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1663295|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663296|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
1663297|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470005|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2470006|NCT01058759|Enoxaparin|enoxaparin|mesh-list
2470007|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
2470008|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
2470009|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2470010|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2470011|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470012|NCT01058824|Lincomycin|lincomycin|mesh-list
2470013|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2470014|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470015|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1663311|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
1663312|NCT05000450|Fludarabine|fludarabine|mesh-list
1663313|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1663314|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
1663315|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663316|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1663317|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1663318|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
1663319|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663320|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1663321|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2470016|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470017|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470018|NCT01058850|Rindopepimut|rindopepimut|mesh-list
2470019|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2470020|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470021|NCT01058876|Nicotine|nicotine|mesh-list
2470022|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2470023|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
2470024|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470025|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470026|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2470027|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2470028|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
2470029|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2470030|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470031|NCT01058902|Aspirin|aspirin|mesh-list
2470032|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2470033|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2470034|NCT01058902|Analgesics|analgesics|mesh-ancestor
2470035|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
2470036|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470037|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470038|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2470039|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1663347|NCT04997941|Tamoxifen|tamoxifen|mesh-list
1663348|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1663349|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
1663350|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1663351|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663352|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1663353|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1663354|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1663355|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1663356|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1663357|NCT04996199|Zileuton|zileuton|mesh-list
1663358|NCT04996199|Carbamazepine|carbamazepine|mesh-list
1663359|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
1663360|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
1663361|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
1663362|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1663363|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1663364|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663365|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1663366|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1663367|NCT04996199|Analgesics|analgesics|mesh-ancestor
1663368|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
1663369|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1663370|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1663371|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1663372|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663373|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1663374|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1663375|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1663376|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1663377|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1663378|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1663379|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1663380|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1663381|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1663382|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
1663383|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2470040|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2470041|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2470042|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470043|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2470044|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2470045|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470046|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
2470047|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
2470048|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2470049|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1663415|NCT04990284|Levodopa|levodopa|mesh-list
1663416|NCT04990284|Opicapone|opicapone|mesh-list
1663417|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1663418|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1663419|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
1663420|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1663421|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663422|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663423|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1663424|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1663425|NCT04988971|Corticosterone|corticosterone|mesh-list
1663426|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
1663427|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1663428|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1663429|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
1663430|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
1663431|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1663432|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470050|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
2470051|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470052|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2470053|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2470054|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470055|NCT01059058|Fluorides|fluorides|mesh-list
2470056|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
2470057|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
2470058|NCT01059058|Protective Agents|protective agents|mesh-ancestor
2470059|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470060|NCT01059084|Valacyclovir|valacyclovir|mesh-list
1663449|NCT04984733|Nivolumab|nivolumab|mesh-list
1663450|NCT04984733|Temozolomide|temozolomide|mesh-list
1663451|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1663452|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1663453|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1663454|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663455|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1663456|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
2470061|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
2470062|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470063|NCT01059110|Salicylates|salicylates|mesh-list
2470064|NCT01059110|Imiquimod|imiquimod|mesh-list
2470065|NCT01059110|Fluorouracil|fluorouracil|mesh-list
2470066|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2470067|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
2470068|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470069|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470070|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
2470071|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
2470072|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470073|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2470074|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1663484|NCT04973826|Aztreonam|aztreonam|mesh-list
1663485|NCT04973826|Avibactam|avibactam|mesh-list
1663486|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1663487|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1663488|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1663489|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1663490|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470075|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2470076|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2470077|NCT01059110|Analgesics|analgesics|mesh-ancestor
2470078|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
2470079|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470080|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2470081|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2470082|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2470083|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470084|NCT01059123|Amoxicillin|amoxicillin|mesh-list
2470085|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2470086|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470087|NCT01059136|Spironolactone|spironolactone|mesh-list
2470088|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2470089|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
2470090|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2470091|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470092|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2470093|NCT01059136|Diuretics|diuretics|mesh-ancestor
2470094|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
2470095|NCT01059331|Pregabalin|pregabalin|mesh-list
2470096|NCT01059331|Analgesics|analgesics|mesh-ancestor
2470097|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
2470098|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470099|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470100|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
2470101|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2470102|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2470103|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470104|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2470105|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2470106|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2470107|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2470108|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2470109|NCT01059383|Esomeprazole|esomeprazole|mesh-list
2470110|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2470111|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2470112|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2470113|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470114|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470115|NCT01059396|Propranolol|propranolol|mesh-list
2470116|NCT01059396|Carvedilol|carvedilol|mesh-list
2470117|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2470118|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2470119|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
2470120|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2470121|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470122|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470123|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2470124|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2470125|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
2470126|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
2470127|NCT01059396|Protective Agents|protective agents|mesh-ancestor
2470128|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2470129|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2470130|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2470131|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2470132|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2470133|NCT01059422|Lamivudine|lamivudine|mesh-list
2470134|NCT01059422|Abacavir|abacavir|mesh-list
1663560|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
1663561|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1663562|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1663563|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
2470135|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
2470136|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2470137|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2470138|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470139|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470140|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
2470141|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470142|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2470143|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2470144|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2470145|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2470146|NCT01059448|Brodalumab|brodalumab|mesh-list
2470147|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
2470148|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
2470149|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2470150|NCT01059461|Protective Agents|protective agents|mesh-ancestor
2470151|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470152|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
2470153|NCT01059552|Vorinostat|vorinostat|mesh-list
2470154|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470155|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2470156|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470157|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470158|NCT01059604|Naproxen|naproxen|mesh-list
2470159|NCT01059604|Sumatriptan|sumatriptan|mesh-list
2470160|NCT01059604|Naratriptan|naratriptan|mesh-list
2470161|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2470162|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2470163|NCT01059604|Analgesics|analgesics|mesh-ancestor
2470164|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
2470165|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470166|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470167|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2470168|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2470169|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
2470170|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2470171|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470172|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470173|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2470174|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2470175|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2470176|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
2470177|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1663616|NCT04940637|Niraparib|niraparib|mesh-list
1663617|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1663618|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1663619|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663620|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470191|NCT01059890|Metronidazole|metronidazole|mesh-list
2470192|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
2470193|NCT01059890|Cefotaxime|cefotaxime|mesh-list
2470194|NCT01059890|Cefoxitin|cefoxitin|mesh-list
2470195|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470196|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2470197|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2470198|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2470199|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2470200|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2470201|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470202|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470203|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470204|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2470205|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2470206|NCT01059955|Dexamethasone|dexamethasone|mesh-list
2470207|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
2470208|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2470209|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2470210|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
2470211|NCT01059955|BB 1101|bb 1101|mesh-list
2470212|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2470213|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
2470214|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
2470215|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470216|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470217|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2470218|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
2470219|NCT01059955|Hormones|hormones|mesh-ancestor
2470220|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2470221|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2470222|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470223|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
2470224|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470225|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470226|NCT01060137|Fentanyl|fentanyl|mesh-list
2470227|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2470228|NCT01060137|Narcotics|narcotics|mesh-ancestor
2470229|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2470230|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470231|NCT01060137|Analgesics|analgesics|mesh-ancestor
2470232|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
2470233|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470234|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2470235|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2470236|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
2470237|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
2470238|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
2470239|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2470240|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2470241|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470242|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
2470243|NCT01060163|Coagulants|coagulants|mesh-ancestor
2470244|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
2470245|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2470246|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2470247|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470248|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
2470249|NCT01060176|Coagulants|coagulants|mesh-ancestor
2470250|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
2470251|NCT01060189|Urinastatin|urinastatin|mesh-list
2470252|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2470253|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2470254|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470255|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
2470256|NCT01060189|Coagulants|coagulants|mesh-ancestor
2470257|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2470258|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2470259|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
2470260|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470261|NCT01060228|Valproic Acid|valproic acid|mesh-list
2470262|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
2470263|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2470264|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2470265|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2470266|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470267|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2470268|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2470269|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2470270|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
2470271|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2470272|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470273|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2470274|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2470275|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
2470276|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
2470277|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470278|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
2470279|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
2470280|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2470281|NCT01060267|Erythromycin|erythromycin|mesh-list
2470282|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
2470283|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
2470284|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
2470285|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470286|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2470287|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2470288|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470289|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663725|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
1663726|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1663727|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
1663728|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663729|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1663730|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1663731|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
1663732|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663733|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1663734|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2470290|NCT01060293|Dopamine|dopamine|mesh-list
2470291|NCT01060293|Furosemide|furosemide|mesh-list
2470292|NCT01060293|Diuretics|diuretics|mesh-ancestor
2470293|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
2470294|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663740|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
1663741|NCT04926454|Bupivacaine|bupivacaine|mesh-list
1663742|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
1663743|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
1663744|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1663745|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663746|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
1663747|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1663748|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1663749|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1663750|NCT04926454|Analgesics|analgesics|mesh-ancestor
1663751|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1663752|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1663753|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1663754|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
1663755|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1663756|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663757|NCT04925427|Naloxone|naloxone|mesh-list
1663758|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1663759|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663760|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
1663761|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470295|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2470296|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2470297|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470298|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2470299|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
2470300|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
2470301|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470302|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
2470303|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2470304|NCT01060293|Protective Agents|protective agents|mesh-ancestor
2470305|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
2470306|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2470307|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
2470308|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470309|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2470310|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2470311|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
2470312|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470313|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470314|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2470315|NCT01060423|Irinotecan|irinotecan|mesh-list
2470316|NCT01060423|Cetuximab|cetuximab|mesh-list
2470317|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2470318|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2470319|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1663829|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
1663830|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1663831|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
1663832|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663833|NCT04915768|Antacids|antacids|mesh-ancestor
1663834|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1663835|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2470320|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470321|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470322|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2470323|NCT01060475|Tacrolimus|tacrolimus|mesh-list
2470324|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2470325|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
2470326|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470327|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1663844|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
1663845|NCT04913025|Nivolumab|nivolumab|mesh-list
1663846|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1663847|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1663848|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1663849|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470328|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470329|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470330|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
2470331|NCT01060488|Hormones|hormones|mesh-ancestor
2470332|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2470333|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470334|NCT01060501|Leucovorin|leucovorin|mesh-list
2470335|NCT01060501|Folic Acid|folic acid|mesh-list
2470336|NCT01060501|Interferons|interferons|mesh-list
2470337|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
2470338|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
2470339|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470340|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
2470341|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470342|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
2470343|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470344|NCT01060501|Antidotes|antidotes|mesh-ancestor
2470345|NCT01060501|Protective Agents|protective agents|mesh-ancestor
2470346|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
2470347|NCT01060501|Vitamins|vitamins|mesh-ancestor
2470348|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
2470349|NCT01060501|Hematinics|hematinics|mesh-ancestor
2470350|NCT01060514|Vinorelbine|vinorelbine|mesh-list
2470351|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2470352|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470353|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
2470354|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
2470355|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
2470356|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470357|NCT01060566|Ivacaftor|ivacaftor|mesh-list
2470358|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2470359|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2470360|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470361|NCT01060579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2470362|NCT01060579|Latanoprost|latanoprost|mesh-list
2470363|NCT01060579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1663895|NCT04905654|Cromakalim|cromakalim|mesh-list
1663896|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1663897|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1663898|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
1663899|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1663900|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1663901|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1663902|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
1663903|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
1663904|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
2470364|NCT01060605|Sirolimus|sirolimus|mesh-list
2470365|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2470366|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470367|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2470368|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470369|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
2470370|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2470371|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
2470372|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470373|NCT01060618|Maraviroc|maraviroc|mesh-list
2470374|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
2470375|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
2470376|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470377|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2470378|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2470379|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
2470380|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470381|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
2470382|NCT01060631|Propofol|propofol|mesh-list
2470383|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2470384|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2470385|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470386|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2470387|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
2470388|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
2470389|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
2470390|NCT01060696|Scopolamine|scopolamine|mesh-list
2470391|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
2470392|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2470393|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
2470394|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
2470395|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470396|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470397|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2470398|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
2470399|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2470400|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
2470401|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2470402|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470403|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2470404|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
2470405|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2470406|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2470407|NCT01060696|Analgesics|analgesics|mesh-ancestor
2470408|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
2470409|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2470410|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1663948|NCT04859608|Eculizumab|eculizumab|mesh-list
1663949|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1663950|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1663951|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
1663952|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470411|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2470412|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470413|NCT01060735|Vitamin D|vitamin d|mesh-list
2470414|NCT01060735|Vitamins|vitamins|mesh-ancestor
2470415|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
2470416|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470417|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2470418|NCT01060774|Lidocaine|lidocaine|mesh-list
2470419|NCT01060774|Bupivacaine|bupivacaine|mesh-list
2470420|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
2470421|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
2470422|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2470423|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470424|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
2470425|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470426|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2470427|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2470428|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2470429|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2470430|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470431|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
2470432|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2470433|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
2470434|NCT01060787|Hormones|hormones|mesh-ancestor
2470435|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2470436|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470437|NCT01060826|Somatostatin|somatostatin|mesh-list
2470438|NCT01060826|Hormones|hormones|mesh-ancestor
2470439|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2470440|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470441|NCT01060891|Colistin|colistin|mesh-list
2470442|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2470443|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470444|NCT01060904|Doxorubicin|doxorubicin|mesh-list
2470445|NCT01060904|Bleomycin|bleomycin|mesh-list
2470446|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2470447|NCT01060904|Dacarbazine|dacarbazine|mesh-list
2470448|NCT01060904|Vinblastine|vinblastine|mesh-list
2470449|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2470450|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2470451|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470452|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2470453|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2470454|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470455|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470456|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2470457|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
2470458|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470459|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2470460|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
2470461|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2470462|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
2470463|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
2470464|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
2470465|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
2470466|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470467|NCT01060930|Epinephrine|epinephrine|mesh-list
2470468|NCT01060930|Norepinephrine|norepinephrine|mesh-list
2470469|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2470470|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2470471|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2470472|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
2470473|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2470474|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1664019|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1664020|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1664021|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1664022|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
1664023|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1664024|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1664025|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1664026|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1664027|NCT04824131|Tenofovir|tenofovir|mesh-list
1664028|NCT04824131|Emtricitabine|emtricitabine|mesh-list
1664029|NCT04824131|Cabotegravir|cabotegravir|mesh-list
1664030|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
1664031|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1664032|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1664033|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1664034|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1664035|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1664036|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1664037|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1664038|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1664039|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2470475|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470476|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2470477|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2470478|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
2470479|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470480|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2470481|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
2470482|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
2470483|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
2470484|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2470485|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470486|NCT01060969|Acetazolamide|acetazolamide|mesh-list
2470487|NCT01060969|Tadalafil|tadalafil|mesh-list
2470488|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
2470489|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2470490|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2470491|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1664057|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1664058|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1664059|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1664060|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1664061|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664062|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1664063|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1664064|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1664065|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
1664066|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2470492|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470493|NCT01060969|Urological Agents|urological agents|mesh-ancestor
2470494|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
2470495|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
2470496|NCT01060969|Diuretics|diuretics|mesh-ancestor
2470497|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
2470498|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470499|NCT01061060|Epoprostenol|epoprostenol|mesh-list
2470500|NCT01061060|Beraprost|beraprost|mesh-list
2470501|NCT01061060|Tezosentan|tezosentan|mesh-list
2470502|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2470503|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
2470504|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2470505|NCT01061112|Tolbutamide|tolbutamide|mesh-list
2470506|NCT01061112|Fluconazole|fluconazole|mesh-list
2470507|NCT01061112|Ketoprofen|ketoprofen|mesh-list
2470508|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
2470509|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
2470510|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470511|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2470512|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2470513|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470514|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470515|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2470516|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
1664110|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
1664111|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1664112|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1664113|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664114|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1664115|NCT04798482|Analgesics|analgesics|mesh-ancestor
1664116|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
1664117|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1664118|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1664119|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1664120|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1664121|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
1664122|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1664123|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470517|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2470518|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470519|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2470520|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2470521|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2470522|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1664130|NCT04797312|Sufentanil|sufentanil|mesh-list
1664131|NCT04797312|Remifentanil|remifentanil|mesh-list
1664132|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
1664133|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
1664134|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1664135|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664136|NCT04797312|Narcotics|narcotics|mesh-ancestor
1664137|NCT04797312|Analgesics|analgesics|mesh-ancestor
1664138|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
1664139|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1664140|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1664141|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1664142|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
2470523|NCT01061112|Analgesics|analgesics|mesh-ancestor
2470524|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
2470525|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470526|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2470527|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2470528|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2470529|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2470530|NCT01061190|Propranolol|propranolol|mesh-list
2470531|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2470532|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2470533|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
2470534|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2470535|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470536|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470537|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2470538|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2470539|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
2470540|NCT01061216|Insulin|insulin|mesh-list
2470541|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2470542|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2470543|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470544|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2470545|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
2470546|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2470547|NCT01061320|Tocopherols|tocopherols|mesh-list
2470548|NCT01061320|Vitamin E|vitamin e|mesh-list
2470549|NCT01061320|Tocotrienols|tocotrienols|mesh-list
2470550|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
2470551|NCT01061320|Vitamins|vitamins|mesh-ancestor
2470552|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
2470553|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470554|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
2470555|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470556|NCT01061320|Protective Agents|protective agents|mesh-ancestor
2470557|NCT01061372|Pregabalin|pregabalin|mesh-list
2470558|NCT01061372|Analgesics|analgesics|mesh-ancestor
2470559|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
2470560|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470561|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470562|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
2470563|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2470564|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2470565|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470566|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2470567|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1664202|NCT04771156|Ketorolac|ketorolac|mesh-list
1664203|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1664204|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1664205|NCT04771156|Analgesics|analgesics|mesh-ancestor
1664206|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
1664207|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1664208|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664209|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1664210|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1664211|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1664212|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1664213|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470568|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2470569|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2470570|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2470571|NCT01061411|Sunitinib|sunitinib|mesh-list
2470572|NCT01061411|Dalteparin|dalteparin|mesh-list
2470573|NCT01061411|Tinzaparin|tinzaparin|mesh-list
2470574|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2470575|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470576|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2470577|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2470578|NCT01061411|Growth Substances|growth substances|mesh-ancestor
2470579|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470580|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
2470581|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2470582|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470583|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470584|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
2470585|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2470586|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2470587|NCT01061437|Lansoprazole|lansoprazole|mesh-list
2470588|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
2470589|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2470590|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2470591|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2470592|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470593|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470594|NCT01061450|Simvastatin|simvastatin|mesh-list
2470595|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2470596|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2470597|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
2470598|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470599|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2470600|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2470601|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470602|NCT01061658|Vaccines|vaccines|mesh-list
2470603|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
2470604|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470605|NCT01061697|Pregabalin|pregabalin|mesh-list
2470606|NCT01061697|Analgesics|analgesics|mesh-ancestor
2470607|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
2470608|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470609|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470610|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
2470611|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2470612|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2470613|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470614|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2470615|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2470616|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2470617|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2470618|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2470619|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2470620|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
2470621|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470622|NCT01061788|Everolimus|everolimus|mesh-list
2470623|NCT01061788|Panitumumab|panitumumab|mesh-list
2470624|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470625|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2470626|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
2470627|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470628|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2470629|NCT01061814|Mipomersen|mipomersen|mesh-list
2470630|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2470631|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2470632|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
2470633|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470634|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2470635|NCT01061840|Molgramostim|molgramostim|mesh-list
2470636|NCT01061840|Modafinil|modafinil|mesh-list
2470637|NCT01061840|Vaccines|vaccines|mesh-list
2470638|NCT01061840|Sargramostim|sargramostim|mesh-list
2470639|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
2470640|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470641|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470642|NCT01061840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2470643|NCT01061840|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2470644|NCT01061840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2470645|NCT01061840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2470646|NCT01061840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470647|NCT01061853|Sirolimus|sirolimus|mesh-list
2470648|NCT01061853|Betamethasone|betamethasone|mesh-list
2470649|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2470650|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470651|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2470652|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470653|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
2470654|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2470655|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
2470656|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664304|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1664305|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1664306|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
1664307|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1664308|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
1664309|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470657|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2470658|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
2470659|NCT01061853|Hormones|hormones|mesh-ancestor
2470660|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2470661|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2470662|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
2470663|NCT01061996|Basiliximab|basiliximab|mesh-list
2470664|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1664321|NCT04738942|Vedolizumab|vedolizumab|mesh-list
1664322|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2470665|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
2470666|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664325|NCT04735861|Bevacizumab|bevacizumab|mesh-list
1664326|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1664327|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1664328|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1664329|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1664330|NCT04735861|Growth Substances|growth substances|mesh-ancestor
1664331|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664332|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
1664333|NCT04735263|Atorvastatin|atorvastatin|mesh-list
1664334|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1664335|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1664336|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
1664337|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1664338|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1664339|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1664340|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1664341|NCT04734886|Vitamin D|vitamin d|mesh-list
1664342|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
1664343|NCT04734886|Vitamins|vitamins|mesh-list
1664344|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
1664345|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664346|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1664347|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2470667|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2470668|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2470669|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470670|NCT01062048|Incretins|incretins|mesh-ancestor
2470671|NCT01062048|Hormones|hormones|mesh-ancestor
2470672|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2470673|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2470674|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
2470675|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470676|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470677|NCT01062087|Lidocaine|lidocaine|mesh-list
2470678|NCT01062087|Bupivacaine|bupivacaine|mesh-list
2470679|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
2470680|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
2470681|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2470682|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470683|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
2470684|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470685|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2470686|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2470687|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2470688|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2470689|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470690|NCT01062139|Cetirizine|cetirizine|mesh-list
2470691|NCT01062139|Levocetirizine|levocetirizine|mesh-list
2470692|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2470693|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2470694|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
2470695|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
2470696|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2470697|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470698|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470699|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1664382|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
1664383|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1664384|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
1664385|NCT04696731|Fludarabine|fludarabine|mesh-list
1664386|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1664387|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
1664388|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664389|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1664390|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1664391|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
1664392|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1664393|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1664394|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2470700|NCT01062152|Lenalidomide|lenalidomide|mesh-list
2470701|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
2470702|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470703|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2470704|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2470705|NCT01062152|Growth Substances|growth substances|mesh-ancestor
2470706|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
2470707|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470708|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2470709|NCT01062191|Laxatives|laxatives|mesh-ancestor
2470710|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2470711|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
2470712|NCT01062204|Laxatives|laxatives|mesh-ancestor
2470713|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2470714|NCT01062282|Iloprost|iloprost|mesh-list
2470715|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2470716|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
2470717|NCT01062360|Aspirin|aspirin|mesh-list
2470718|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
2470719|NCT01062360|Ephedrine|ephedrine|mesh-list
2470720|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2470721|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2470722|NCT01062360|Analgesics|analgesics|mesh-ancestor
2470723|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
2470724|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2470725|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470726|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2470727|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2470728|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2470729|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1664438|NCT04670679|Cetuximab|cetuximab|mesh-list
1664439|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1664440|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1664441|NCT04669288|Azithromycin|azithromycin|mesh-list
1664442|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1664443|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1664444|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1664445|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1664446|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1664447|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1664448|NCT04664959|Denosumab|denosumab|mesh-list
1664449|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1664450|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470730|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470731|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2470732|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2470733|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470734|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
2470735|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2470736|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
2470737|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1664459|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
1664460|NCT04662723|Empagliflozin|empagliflozin|mesh-list
1664461|NCT04662723|Canagliflozin|canagliflozin|mesh-list
1664462|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
1664463|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
1664464|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1664465|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1664466|NCT04662723|Prednisolone|prednisolone|mesh-list
1664467|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
1664468|NCT04662723|Losartan|losartan|mesh-list
1664469|NCT04662723|Ramipril|ramipril|mesh-list
1664470|NCT04662723|Lisinopril|lisinopril|mesh-list
1664471|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1664472|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
1664473|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1664474|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
1664475|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
1664476|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1664477|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664478|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1664479|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
1664480|NCT04662723|Hormones|hormones|mesh-ancestor
1664481|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1664482|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1664483|NCT04662723|Protective Agents|protective agents|mesh-ancestor
1664484|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1664485|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1664486|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1664487|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1664488|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1664489|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1664490|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1664491|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1664492|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1664493|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
1664494|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1664495|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2470738|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
2470739|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
2470740|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2470741|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2470742|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
2470743|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
2470744|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2470745|NCT01062451|Candesartan|candesartan|mesh-list
2470746|NCT01062451|Perindopril|perindopril|mesh-list
2470747|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2470748|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2470749|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2470750|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470751|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2470752|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
2470753|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470754|NCT01062477|Vaccines|vaccines|mesh-list
2470755|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
2470756|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470757|NCT01062490|Treosulfan|treosulfan|mesh-list
2470758|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2470759|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
2470760|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470761|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470762|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
2470763|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2470764|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470765|NCT01062516|Esomeprazole|esomeprazole|mesh-list
1664546|NCT04654429|Ondansetron|ondansetron|mesh-list
1664547|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
1664548|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
1664549|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1664550|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664551|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1664552|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
1664553|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
1664554|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1664555|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
1664556|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1664557|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1664558|NCT04654429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1664559|NCT04654429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1664560|NCT04654429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1664561|NCT04654429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1664562|NCT04654429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1664563|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
1664564|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1664565|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1664566|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1664567|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
1664568|NCT04650698|Coagulants|coagulants|mesh-ancestor
2470766|NCT01062516|Famotidine|famotidine|mesh-list
2470767|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2470768|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2470769|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2470770|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470771|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470772|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2470773|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
2470774|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
2470775|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2470776|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470777|NCT01062529|Somatostatin|somatostatin|mesh-list
2470778|NCT01062529|Hormones|hormones|mesh-ancestor
2470779|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2470780|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470781|NCT01062633|Erythritol|erythritol|mesh-list
2470782|NCT01062633|Sorbitol|sorbitol|mesh-list
2470783|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
2470784|NCT01062633|Cathartics|cathartics|mesh-ancestor
2470785|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2470786|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
2470787|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2470788|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2470789|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470790|NCT01062776|Furosemide|furosemide|mesh-list
2470791|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2470792|NCT01062776|Diuretics|diuretics|mesh-ancestor
2470793|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
2470794|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470795|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2470796|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2470797|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470798|NCT01062802|Atorvastatin|atorvastatin|mesh-list
2470799|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2470800|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2470801|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
2470802|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470803|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2470804|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2470805|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470806|NCT01062906|Lidocaine|lidocaine|mesh-list
2470807|NCT01062906|Fentanyl|fentanyl|mesh-list
2470808|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
2470809|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
2470810|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2470811|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470812|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
2470813|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1664617|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
1664618|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1664619|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664620|NCT04629534|Vitamins|vitamins|mesh-ancestor
1664621|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
1664622|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2470814|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2470815|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2470816|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2470817|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2470818|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470819|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2470820|NCT01062906|Narcotics|narcotics|mesh-ancestor
2470821|NCT01062906|Analgesics|analgesics|mesh-ancestor
2470822|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2470823|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2470824|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
2470825|NCT01062932|Cycloserine|cycloserine|mesh-list
2470826|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2470827|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470828|NCT01062932|Renal Agents|renal agents|mesh-ancestor
2470829|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2470830|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
2470831|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2470832|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
2470833|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470834|NCT01062945|Doxazosin|doxazosin|mesh-list
2470835|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1664645|NCT04617457|Leucovorin|leucovorin|mesh-list
1664646|NCT04617457|Folic Acid|folic acid|mesh-list
1664647|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
1664648|NCT04617457|Irinotecan|irinotecan|mesh-list
1664649|NCT04617457|Fluorouracil|fluorouracil|mesh-list
1664650|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
1664651|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1664652|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1664653|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1664654|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1664655|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1664656|NCT04617457|Antidotes|antidotes|mesh-ancestor
1664657|NCT04617457|Protective Agents|protective agents|mesh-ancestor
1664658|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664659|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
1664660|NCT04617457|Vitamins|vitamins|mesh-ancestor
1664661|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
1664662|NCT04617457|Hematinics|hematinics|mesh-ancestor
1664663|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
1664664|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1664665|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1664666|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
2470836|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2470837|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2470838|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2470839|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
2470840|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2470841|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470842|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470843|NCT01062958|Vitamins|vitamins|mesh-list
2470844|NCT01062958|Folic Acid|folic acid|mesh-list
2470845|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
2470846|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
2470847|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
2470848|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664680|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
1664681|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1664682|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
1664683|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470849|NCT01062958|Hematinics|hematinics|mesh-ancestor
2470850|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
2470851|NCT01063010|Bevacizumab|bevacizumab|mesh-list
2470852|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2470853|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470854|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1664690|NCT04593563|Psilocybin|psilocybin|mesh-list
1664691|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
1664692|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664693|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2470855|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2470856|NCT01063010|Growth Substances|growth substances|mesh-ancestor
2470857|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470858|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
2470859|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
2470860|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1664702|NCT04581343|Gemcitabine|gemcitabine|mesh-list
1664703|NCT04581343|Paclitaxel|paclitaxel|mesh-list
1664704|NCT04581343|Spartalizumab|spartalizumab|mesh-list
1664705|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1664706|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1664707|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
1664708|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
1664709|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
1664710|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1664711|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1664712|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
1664713|NCT04581343|Antiviral Agents|antiviral agents|mesh-ancestor
1664714|NCT04581343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1664715|NCT04581343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1664716|NCT04581343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1664717|NCT04581343|Immunologic Factors|immunologic factors|mesh-ancestor
1664718|NCT04581343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664719|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2470861|NCT01063023|Asunaprevir|asunaprevir|mesh-list
2470862|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
2470863|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470864|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470865|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2470866|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
2470867|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2470868|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470869|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2470870|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2470871|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2470872|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2470873|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470874|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2470875|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2470876|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470877|NCT01063101|Fucoidan|fucoidan|mesh-list
2470878|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2470879|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2470880|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
2470881|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470882|NCT01063127|Insulin|insulin|mesh-list
2470883|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2470884|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470885|NCT01063140|Vaccines|vaccines|mesh-list
2470886|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
2470887|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470888|NCT01063179|Thalidomide|thalidomide|mesh-list
2470889|NCT01063179|Prednisone|prednisone|mesh-list
2470890|NCT01063179|Bortezomib|bortezomib|mesh-list
2470891|NCT01063179|Melphalan|melphalan|mesh-list
2470892|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2470893|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
2470894|NCT01063179|Hormones|hormones|mesh-ancestor
2470895|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2470896|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470897|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2470898|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470899|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2470900|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
2470901|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470902|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2470903|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2470904|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
2470905|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
2470906|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2470907|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470908|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2470909|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2470910|NCT01063179|Growth Substances|growth substances|mesh-ancestor
2470911|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
2470912|NCT01063192|Leucovorin|leucovorin|mesh-list
2470913|NCT01063192|Gemcitabine|gemcitabine|mesh-list
2470914|NCT01063192|Fluorouracil|fluorouracil|mesh-list
2470915|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
2470916|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2470917|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
2470918|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470919|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470920|NCT01063192|Antiviral Agents|antiviral agents|mesh-ancestor
2470921|NCT01063192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470922|NCT01063192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470923|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2470924|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
2470925|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470926|NCT01063192|Antidotes|antidotes|mesh-ancestor
2470927|NCT01063192|Protective Agents|protective agents|mesh-ancestor
2470928|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
2470929|NCT01063192|Vitamins|vitamins|mesh-ancestor
2470930|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
2470931|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
2470932|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1664793|NCT04579120|Corticosterone|corticosterone|mesh-list
1664794|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2470933|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
2470934|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470935|NCT01063205|Expectorants|expectorants|mesh-ancestor
2470936|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
2470937|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2470938|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
2470939|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470940|NCT01063205|Protective Agents|protective agents|mesh-ancestor
2470941|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470942|NCT01063205|Antidotes|antidotes|mesh-ancestor
2470943|NCT01063218|Emollients|emollients|mesh-list
2470944|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
2470945|NCT01063257|Clofarabine|clofarabine|mesh-list
2470946|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2470947|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
2470948|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470949|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1664826|NCT04554836|Cetuximab|cetuximab|mesh-list
1664827|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1664828|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1664829|NCT04551911|Calcifediol|calcifediol|mesh-list
1664830|NCT04551911|Vitamins|vitamins|mesh-ancestor
1664831|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
1664832|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664833|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2470950|NCT01063270|Rifampin|rifampin|mesh-list
2470951|NCT01063270|Clindamycin|clindamycin|mesh-list
2470952|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
2470953|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
2470954|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2470955|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
2470956|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2470957|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470958|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
2470959|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2470960|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470961|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470962|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2470963|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2470964|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2470965|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2470966|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2470967|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2470968|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2470969|NCT01063426|Enoxaparin|enoxaparin|mesh-list
2470970|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
2470971|NCT01063426|Atorvastatin|atorvastatin|mesh-list
2470972|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2470973|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2470974|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
2470975|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470976|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2470977|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2470978|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470979|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
2470980|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2470981|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2470982|NCT01063439|Cytarabine|cytarabine|mesh-list
2470983|NCT01063439|Etoposide|etoposide|mesh-list
2470984|NCT01063439|Melphalan|melphalan|mesh-list
2470985|NCT01063439|Busulfan|busulfan|mesh-list
2470986|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2470987|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2470988|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2470989|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2470990|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2470991|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2470992|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2470993|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
2470994|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
2470995|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2470996|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2470997|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
2470998|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1664901|NCT04536272|Heparin|heparin|mesh-list
1664902|NCT04536272|Calcium heparin|calcium heparin|mesh-list
1664903|NCT04536272|Enoxaparin|enoxaparin|mesh-list
1664904|NCT04536272|Nadroparin|nadroparin|mesh-list
1664905|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
1664906|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1664907|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1664908|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1664909|NCT04533880|Calcium|calcium|mesh-list
1664910|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1664911|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2470999|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2471000|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
2471001|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2471002|NCT01063478|Everolimus|everolimus|mesh-list
1664916|NCT04529460|Antibodies|antibodies|mesh-list
1664917|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
1664918|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471003|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471004|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2471005|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
2471006|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471007|NCT01063504|Teriparatide|teriparatide|mesh-list
2471008|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2471009|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471010|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2471011|NCT01063530|Fluorides|fluorides|mesh-list
2471012|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
2471013|NCT01063530|Protective Agents|protective agents|mesh-ancestor
2471014|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471015|NCT01063556|Donepezil|donepezil|mesh-list
2471016|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2471017|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471018|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471019|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
2471020|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471021|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471022|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
2471023|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
2471024|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
2471025|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
2471026|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2471027|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2471028|NCT01063621|Apomorphine|apomorphine|mesh-list
2471029|NCT01063621|Emetics|emetics|mesh-ancestor
2471030|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471031|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
2471032|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471033|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2471034|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
2471035|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
2471036|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471037|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471038|NCT01063647|Treosulfan|treosulfan|mesh-list
2471039|NCT01063647|Busulfan|busulfan|mesh-list
2471040|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2471041|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
2471042|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471043|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471044|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2471045|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
2471046|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471047|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2471048|NCT01063660|Treosulfan|treosulfan|mesh-list
2471049|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2471050|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
2471051|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471052|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471053|NCT01063816|Gemcitabine|gemcitabine|mesh-list
2471054|NCT01063816|Carboplatin|carboplatin|mesh-list
2471055|NCT01063816|Veliparib|veliparib|mesh-list
2471056|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471057|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2471058|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
2471059|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471060|NCT01063816|Antiviral Agents|antiviral agents|mesh-ancestor
2471061|NCT01063816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471062|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471063|NCT01063816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2471064|NCT01063816|Immunologic Factors|immunologic factors|mesh-ancestor
2471065|NCT01063816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471066|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2471067|NCT01063842|Acetaminophen|acetaminophen|mesh-list
2471068|NCT01063842|Tramadol|tramadol|mesh-list
2471069|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2471070|NCT01063842|Analgesics|analgesics|mesh-ancestor
1665005|NCT04478721|Meropenem|meropenem|mesh-list
1665006|NCT04478721|Temocillin|temocillin|mesh-list
1665007|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1665008|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471071|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
2471072|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471073|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471074|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
2471075|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2471076|NCT01063842|Narcotics|narcotics|mesh-ancestor
2471077|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2471078|NCT01063920|Naproxen|naproxen|mesh-list
2471079|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2471080|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2471081|NCT01063920|Analgesics|analgesics|mesh-ancestor
2471082|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
2471083|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471084|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471085|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2471086|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2471087|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
2471088|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2471089|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471090|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471091|NCT01063933|Peramivir|peramivir|mesh-list
2471092|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
2471093|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471094|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471095|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471096|NCT01064102|Cetirizine|cetirizine|mesh-list
2471097|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2471098|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2471099|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2471100|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
2471101|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
2471102|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471103|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471104|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471105|NCT01064115|Cetirizine|cetirizine|mesh-list
2471106|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2471107|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2471108|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2471109|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
2471110|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
2471111|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471112|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471113|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471114|NCT01064141|Vaccines|vaccines|mesh-list
2471115|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
2471116|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471117|NCT01064154|Carvedilol|carvedilol|mesh-list
2471118|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2471119|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2471120|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
2471121|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471122|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471123|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471124|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2471125|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
2471126|NCT01064154|Protective Agents|protective agents|mesh-ancestor
2471127|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2471128|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2471129|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2471130|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
2471131|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2471132|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2471133|NCT01064180|Carvedilol|carvedilol|mesh-list
2471134|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2471135|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2471136|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
2471137|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471138|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471139|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471140|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2471141|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
2471142|NCT01064180|Protective Agents|protective agents|mesh-ancestor
2471143|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2471144|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2471145|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2471146|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
2471147|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2471148|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2471149|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2471150|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1665095|NCT04428203|Cannabidiol|cannabidiol|mesh-list
1665096|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
1665097|NCT04427956|Riboflavin|riboflavin|mesh-list
1665098|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
1665099|NCT04427956|Vitamins|vitamins|mesh-ancestor
1665100|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
1665101|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665102|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1665103|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
2471151|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471152|NCT01064232|Risperidone|risperidone|mesh-list
2471153|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2471154|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
2471155|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471156|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471157|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471158|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2471159|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2471160|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2471161|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2471162|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2471163|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
2471164|NCT01064245|Mannitol|mannitol|mesh-list
1665118|NCT04417062|Olaparib|olaparib|mesh-list
1665119|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1665120|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1665121|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665122|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665123|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
1665124|NCT04416984|Fludarabine|fludarabine|mesh-list
1665125|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1665126|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
1665127|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665128|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1665129|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1665130|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
1665131|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665132|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665133|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2471165|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
2471166|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2471167|NCT01064245|Diuretics|diuretics|mesh-ancestor
2471168|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
2471169|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471170|NCT01064245|Miotics|miotics|mesh-ancestor
2471171|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
2471172|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471173|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
2471174|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
2471175|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
2471176|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
2471177|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2471178|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
2471179|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471180|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471181|NCT01064271|Risperidone|risperidone|mesh-list
2471182|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2471183|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
2471184|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471185|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471186|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471187|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1665180|NCT04397107|Aldesleukin|aldesleukin|mesh-list
1665181|NCT04397107|Interleukin-2|interleukin-2|mesh-list
1665182|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665183|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1665184|NCT04397107|Analgesics|analgesics|mesh-ancestor
1665185|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
1665186|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1665187|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665188|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1665189|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1665190|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
1665191|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471188|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2471189|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2471190|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2471191|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2471192|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
2471193|NCT01064349|Trastuzumab|trastuzumab|mesh-list
2471194|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2471195|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471196|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
1665201|NCT04387942|Aldesleukin|aldesleukin|mesh-list
1665202|NCT04387942|Interleukin-2|interleukin-2|mesh-list
1665203|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665204|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1665205|NCT04387942|Analgesics|analgesics|mesh-ancestor
1665206|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
1665207|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1665208|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665209|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1665210|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1665211|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
1665212|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1665213|NCT04386317|Terazosin|terazosin|mesh-list
1665214|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1665215|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1665216|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1665217|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
1665218|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1665219|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665220|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665221|NCT04386317|Urological Agents|urological agents|mesh-ancestor
2471197|NCT01064375|Molgramostim|molgramostim|mesh-list
2471198|NCT01064375|Sargramostim|sargramostim|mesh-list
2471199|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2471200|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
2471201|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471202|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2471203|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2471204|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
2471205|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471206|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471207|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2471208|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
2471209|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2471210|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471211|NCT01064466|Etoposide|etoposide|mesh-list
2471212|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
2471213|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2471214|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471215|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2471216|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2471217|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471218|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471230|NCT01064518|Botulinum Toxins|botulinum toxins|mesh-list
2471231|NCT01064518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1665258|NCT04380142|Levodopa|levodopa|mesh-list
1665259|NCT04380142|Carbidopa|carbidopa|mesh-list
1665260|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1665261|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1665262|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
1665263|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1665264|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665265|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665266|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1665267|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471232|NCT01064518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2471233|NCT01064518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2471234|NCT01064518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2471235|NCT01064518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471236|NCT01064518|Cholinergic Agents|cholinergic agents|mesh-ancestor
2471237|NCT01064518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471238|NCT01064518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471239|NCT01064518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2471240|NCT01064518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471241|NCT01064557|Tretinoin|tretinoin|mesh-list
2471242|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471243|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
2471244|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
2471245|NCT01064570|Tretinoin|tretinoin|mesh-list
1665282|NCT04342572|Melphalan|melphalan|mesh-list
1665283|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1665284|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
1665285|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665286|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665287|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1665288|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1665289|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
1665290|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471246|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471247|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
2471248|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
2471249|NCT01064635|Letrozole|letrozole|mesh-list
2471250|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471251|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2471252|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2471253|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471254|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471255|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2471256|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
2471257|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2471258|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471259|NCT01064726|Fluticasone|fluticasone|mesh-list
2471260|NCT01064726|Xhance|xhance|mesh-list
2471261|NCT01064726|Ibuprofen|ibuprofen|mesh-list
2471262|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2471263|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2471264|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
2471265|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471266|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471267|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2471268|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
2471269|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
2471270|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2471271|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2471272|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2471273|NCT01064726|Analgesics|analgesics|mesh-ancestor
2471274|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
2471275|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2471276|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2471277|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471278|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471279|NCT01064752|Minocycline|minocycline|mesh-list
2471280|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2471281|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471282|NCT01064791|Mycophenolic Acid|mycophenolic acid|mesh-list
2471283|NCT01064791|Tacrolimus|tacrolimus|mesh-list
2471284|NCT01064791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2471285|NCT01064791|Immunologic Factors|immunologic factors|mesh-ancestor
2471286|NCT01064791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471287|NCT01064791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2471288|NCT01064791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471289|NCT01064791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471290|NCT01064791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2471291|NCT01064791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471292|NCT01064791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2471293|NCT01064791|Antitubercular Agents|antitubercular agents|mesh-ancestor
2471294|NCT01064791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2471295|NCT01064791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471296|NCT01064921|Vorinostat|vorinostat|mesh-list
2471297|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471298|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2471299|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471300|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471301|NCT01064973|Baclofen|baclofen|mesh-list
2471302|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2471303|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471304|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2471305|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471306|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
2471307|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
2471308|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
2471309|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471310|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471311|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
2471312|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
2471313|NCT01064986|Epinephrine|epinephrine|mesh-list
2471314|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2471315|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2471316|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
2471317|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471318|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471319|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471320|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2471321|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2471322|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
2471323|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471324|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2471325|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
2471326|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
2471327|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
2471328|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1665383|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
1665384|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
1665385|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471329|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2471330|NCT01064999|Capecitabine|capecitabine|mesh-list
2471331|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
2471332|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2471333|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
2471334|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471335|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471336|NCT01065012|Udenafil|udenafil|mesh-list
2471337|NCT01065012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2471338|NCT01065012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2471339|NCT01065012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471340|NCT01065012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471341|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
1665399|NCT04278573|Vitamin D|vitamin d|mesh-list
1665400|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
1665401|NCT04278573|Vitamins|vitamins|mesh-ancestor
1665402|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
1665403|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665404|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1665405|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1665406|NCT04273737|Amantadine|amantadine|mesh-list
1665407|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1665408|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1665409|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
1665410|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1665411|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
1665412|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1665413|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665414|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665415|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1665416|NCT04273737|Analgesics|analgesics|mesh-ancestor
1665417|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
1665418|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471342|NCT01065038|Anagrelide|anagrelide|mesh-list
2471343|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471344|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
2471345|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471346|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471347|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2471348|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2471349|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2471350|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2471351|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2471352|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
2471353|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2471354|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2471355|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471356|NCT01065129|Plerixafor|plerixafor|mesh-list
2471357|NCT01065129|Azacitidine|azacitidine|mesh-list
2471358|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2471359|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
2471360|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471361|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471362|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471363|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2471364|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2471365|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
2471366|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471367|NCT01065194|Simendan|simendan|mesh-list
2471368|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2471369|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
2471370|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2471371|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2471372|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471373|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471374|NCT01065194|Protective Agents|protective agents|mesh-ancestor
2471375|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471376|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
2471377|NCT01065220|Testolactone|testolactone|mesh-list
2471378|NCT01065220|Lynestrenol|lynestrenol|mesh-list
2471379|NCT01065220|Estradiol|estradiol|mesh-list
2471380|NCT01065220|Cyproterone|cyproterone|mesh-list
2471381|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
2471382|NCT01065220|Estrogens|estrogens|mesh-ancestor
2471383|NCT01065220|Hormones|hormones|mesh-ancestor
2471384|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2471385|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471386|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2471387|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
2471388|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2471389|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2471390|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
2471391|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
2471392|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665472|NCT04266795|Azacitidine|azacitidine|mesh-list
1665473|NCT04266795|Venetoclax|venetoclax|mesh-list
1665474|NCT04266795|Pevonedistat|pevonedistat|mesh-list
1665475|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1665476|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
1665477|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665478|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665479|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1665480|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
1665481|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1665482|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665483|NCT04259944|Capecitabine|capecitabine|mesh-list
1665484|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1665485|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
1665486|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665487|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471393|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
2471394|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2471395|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471396|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471397|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2471398|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2471399|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2471400|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2471401|NCT01065246|Catumaxomab|catumaxomab|mesh-list
2471402|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2471403|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
2471404|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2471405|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2471406|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2471407|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471408|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
2471409|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471410|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471411|NCT01065272|Dexamethasone|dexamethasone|mesh-list
1665508|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
1665509|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1665510|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
1665511|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1665512|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665513|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1665514|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
1665515|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1665516|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
1665517|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665518|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1665519|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1665520|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
1665521|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
1665522|NCT04231773|Protective Agents|protective agents|mesh-ancestor
2471412|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2471413|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
1665539|NCT04217278|Cytarabine|cytarabine|mesh-list
1665540|NCT04217278|Fludarabine|fludarabine|mesh-list
1665541|NCT04217278|Busulfan|busulfan|mesh-list
1665542|NCT04217278|Thiotepa|thiotepa|mesh-list
1665543|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665544|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1665545|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
1665546|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665547|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1665548|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
1665549|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665550|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
1665551|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1665552|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
1665553|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1665554|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2471414|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
2471415|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471416|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471417|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2471418|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
2471419|NCT01065272|Hormones|hormones|mesh-ancestor
2471420|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2471421|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2471422|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471423|NCT01065285|Vaccines|vaccines|mesh-list
2471424|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
2471425|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471426|NCT01065376|Cabergoline|cabergoline|mesh-list
2471427|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2471428|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2471429|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
2471430|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
2471431|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471432|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471433|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471434|NCT01065467|Panobinostat|panobinostat|mesh-list
2471435|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471436|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2471437|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471438|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471439|NCT01065519|Umirolimus|umirolimus|mesh-list
2471440|NCT01065519|Everolimus|everolimus|mesh-list
2471441|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471442|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2471443|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
2471444|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471445|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2471446|NCT01065532|Paclitaxel|paclitaxel|mesh-list
2471447|NCT01065532|Everolimus|everolimus|mesh-list
2471448|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2471449|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471450|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
2471451|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
2471452|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
2471453|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471454|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2471455|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
2471456|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471457|NCT01065545|Clofarabine|clofarabine|mesh-list
2471458|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1665603|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1665604|NCT04205266|Hematinics|hematinics|mesh-ancestor
1665605|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1665606|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1665618|NCT04202263|Minocycline|minocycline|mesh-list
1665619|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1665620|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471459|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
2471460|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471461|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471462|NCT01065610|Oxytocin|oxytocin|mesh-list
2471463|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
2471464|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2471465|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471466|NCT01065649|Nortriptyline|nortriptyline|mesh-list
2471467|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2471468|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
2471469|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2471470|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2471471|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2471472|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2471473|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471474|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
2471475|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471476|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471477|NCT01065662|Sirolimus|sirolimus|mesh-list
2471478|NCT01065662|Cediranib|cediranib|mesh-list
2471479|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2471480|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471481|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2471482|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471483|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
2471484|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2471485|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
2471486|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471487|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2471488|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471489|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471490|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
2471491|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2471492|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2471493|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471494|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2471495|NCT01065701|Analgesics|analgesics|mesh-ancestor
2471496|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
2471497|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471498|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2471499|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2471500|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2471501|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
2471502|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471503|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471504|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
2471505|NCT01065727|Natalizumab|natalizumab|mesh-list
2471506|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
2471507|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
2471508|NCT01065727|Analgesics|analgesics|mesh-ancestor
2471509|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
2471510|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471511|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471512|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471513|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2471514|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2471515|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1665692|NCT04192955|Salicylates|salicylates|mesh-list
1665693|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1665694|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1665695|NCT04192955|Analgesics|analgesics|mesh-ancestor
1665696|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
1665697|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1665698|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665699|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1665700|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1665701|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1665702|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1665703|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471516|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471517|NCT01065805|Alovudine|alovudine|mesh-list
2471518|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
2471519|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471520|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
2471521|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
2471522|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
2471523|NCT01065857|Citric Acid|citric acid|mesh-list
2471524|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
2471525|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
2471526|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2471527|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
2471528|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
2471529|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471530|NCT01065857|Cathartics|cathartics|mesh-ancestor
2471531|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2471532|NCT01065857|Antacids|antacids|mesh-ancestor
2471533|NCT01065870|Gemcitabine|gemcitabine|mesh-list
2471534|NCT01065870|Capecitabine|capecitabine|mesh-list
2471535|NCT01065870|Docetaxel|docetaxel|mesh-list
2471536|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2471537|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
2471538|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471539|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471540|NCT01065870|Antiviral Agents|antiviral agents|mesh-ancestor
2471541|NCT01065870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471542|NCT01065870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471543|NCT01065870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2471544|NCT01065870|Immunologic Factors|immunologic factors|mesh-ancestor
2471545|NCT01065870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471546|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
2471547|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
2471548|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
2471549|NCT01065961|Dexamethasone|dexamethasone|mesh-list
2471550|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
2471551|NCT01065961|BB 1101|bb 1101|mesh-list
2471552|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2471553|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
2471554|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
2471555|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471556|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471557|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2471558|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
2471559|NCT01065961|Hormones|hormones|mesh-ancestor
2471560|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2471561|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2471562|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471563|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
2471564|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471565|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471566|NCT01065987|Tizanidine|tizanidine|mesh-list
2471567|NCT01065987|Analgesics|analgesics|mesh-ancestor
2471568|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
2471569|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471570|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471571|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
2471572|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2471573|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2471574|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
2471575|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
2471576|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2471577|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2471578|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2471579|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
2471580|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471581|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471582|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
2471583|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2471584|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
2471585|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471586|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471587|NCT01066169|Lactitol|lactitol|mesh-list
2471588|NCT01066169|Cathartics|cathartics|mesh-ancestor
2471589|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2471590|NCT01066195|Pemetrexed|pemetrexed|mesh-list
2471591|NCT01066195|Gefitinib|gefitinib|mesh-list
2471592|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471593|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471594|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471595|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2471596|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2471597|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2471598|NCT01066247|Midazolam|midazolam|mesh-list
2471599|NCT01066247|Morphine|morphine|mesh-list
2471600|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2471601|NCT01066247|Narcotics|narcotics|mesh-ancestor
2471602|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2471603|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471604|NCT01066247|Analgesics|analgesics|mesh-ancestor
2471605|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
2471606|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471607|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2471608|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2471609|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2471610|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2471611|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2471612|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2471613|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
2471614|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
2471615|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
2471616|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
2471617|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471618|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471619|NCT01066299|Oxytocin|oxytocin|mesh-list
2471620|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
2471621|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2471622|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471623|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
2471624|NCT01066351|Hematinics|hematinics|mesh-ancestor
2471625|NCT01066377|Sulfalene|sulfalene|mesh-list
2471626|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471627|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2471628|NCT01066377|Renal Agents|renal agents|mesh-ancestor
1665817|NCT04170517|Progesterone|progesterone|mesh-list
1665818|NCT04170517|Progestins|progestins|mesh-ancestor
1665819|NCT04170517|Hormones|hormones|mesh-ancestor
1665820|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1665821|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471629|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
2471630|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2471631|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2471632|NCT01066403|Pergolide|pergolide|mesh-list
2471633|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
2471634|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
2471635|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471636|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471637|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471638|NCT01066429|Dexamethasone|dexamethasone|mesh-list
2471639|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
2471640|NCT01066429|BB 1101|bb 1101|mesh-list
2471641|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2471642|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
2471643|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
2471644|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471645|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471646|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2471647|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
2471648|NCT01066429|Hormones|hormones|mesh-ancestor
2471649|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2471650|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2471651|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471652|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
2471653|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471654|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471655|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
2471656|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471657|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2471658|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471659|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665850|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
1665851|NCT04162756|Fludarabine|fludarabine|mesh-list
1665852|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1665853|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
1665854|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665855|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1665856|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1665857|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
1665858|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665859|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665860|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1665861|NCT04156581|Dexamethasone|dexamethasone|mesh-list
1665862|NCT04156581|Bupivacaine|bupivacaine|mesh-list
1665863|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1665864|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
1665865|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
1665866|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1665867|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665868|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1665869|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
1665870|NCT04156581|Hormones|hormones|mesh-ancestor
1665871|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1665872|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1665873|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665874|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
1665875|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
1665876|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1665877|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
1665878|NCT04153136|Valsartan|valsartan|mesh-list
1665879|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1665880|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1665881|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1665882|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1665883|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471660|NCT01066494|Cytarabine|cytarabine|mesh-list
2471661|NCT01066494|Amonafide|amonafide|mesh-list
2471662|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2471663|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
2471664|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471665|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471666|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
2471667|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471668|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1665894|NCT04149990|Valsartan|valsartan|mesh-list
1665895|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1665896|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1665897|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1665898|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665899|NCT04149964|Acetaminophen|acetaminophen|mesh-list
1665900|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
1665901|NCT04149964|Oxycodone|oxycodone|mesh-list
1665902|NCT04149964|Hydrocodone|hydrocodone|mesh-list
1665903|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1665904|NCT04149964|Analgesics|analgesics|mesh-ancestor
1665905|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
1665906|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1665907|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665908|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
1665909|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1665910|NCT04149964|Narcotics|narcotics|mesh-ancestor
1665911|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1665912|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
1665913|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
1665914|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1665915|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1665916|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2471669|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
2471670|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471671|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471672|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
2471673|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
2471674|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2471675|NCT01066559|Protective Agents|protective agents|mesh-ancestor
2471676|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471677|NCT01066572|Lisinopril|lisinopril|mesh-list
2471678|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
2471679|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
2471680|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471681|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471682|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2471683|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2471684|NCT01066572|Protective Agents|protective agents|mesh-ancestor
2471685|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471686|NCT01066598|Rituximab|rituximab|mesh-list
2471687|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2471688|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471689|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
2471690|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665939|NCT04123561|Dexamethasone|dexamethasone|mesh-list
1665940|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
1665941|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1665942|NCT04123561|BB 1101|bb 1101|mesh-list
1665943|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1665944|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
1665945|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
1665946|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1665947|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665948|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1665949|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
1665950|NCT04123561|Hormones|hormones|mesh-ancestor
1665951|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1665952|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1665953|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665954|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
1665955|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1665956|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665957|NCT04123379|Nivolumab|nivolumab|mesh-list
1665958|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1665959|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665960|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1665961|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471691|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2471692|NCT01066650|Everolimus|everolimus|mesh-list
2471693|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471694|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2471695|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
2471696|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471697|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
2471698|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
2471699|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2471700|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2471701|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471702|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2471703|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471704|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471705|NCT01066676|Ibuprofen|ibuprofen|mesh-list
2471706|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2471707|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2471708|NCT01066676|Analgesics|analgesics|mesh-ancestor
2471709|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
2471710|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1665989|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
1665990|NCT04093596|Fludarabine|fludarabine|mesh-list
1665991|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1665992|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
1665993|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1665994|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1665995|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1665996|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
1665997|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1665998|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1665999|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2471711|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471712|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2471713|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2471714|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2471715|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471716|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471717|NCT01066689|Rituximab|rituximab|mesh-list
2471718|NCT01066689|Citric Acid|citric acid|mesh-list
2471719|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
2471720|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2471721|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471722|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
2471723|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471724|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2471725|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
2471726|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2471727|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
2471728|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
2471729|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471730|NCT01066728|Theophylline|theophylline|mesh-list
2471731|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2471732|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
2471733|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471734|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471735|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2471736|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
2471737|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2471738|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471739|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471740|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
2471741|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2471742|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2471743|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
1666033|NCT04066491|Gemcitabine|gemcitabine|mesh-list
1666034|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666035|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1666036|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
1666037|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666038|NCT04066491|Antiviral Agents|antiviral agents|mesh-ancestor
1666039|NCT04066491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1666040|NCT04066491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1666041|NCT04066491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1666042|NCT04066491|Immunologic Factors|immunologic factors|mesh-ancestor
1666043|NCT04066491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471744|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471745|NCT01066754|Fexofenadine|fexofenadine|mesh-list
2471746|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2471747|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2471748|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2471749|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
2471750|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
2471751|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471752|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471753|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471754|NCT01066767|Fexofenadine|fexofenadine|mesh-list
2471755|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2471756|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2471757|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2471758|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
2471759|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
2471760|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471761|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471762|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666079|NCT04039464|Bosentan|bosentan|mesh-list
1666080|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
1666081|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
1666082|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1666083|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1666084|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1666085|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666086|NCT04039464|Urological Agents|urological agents|mesh-ancestor
1666087|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1666088|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1666089|NCT04037605|Ketoconazole|ketoconazole|mesh-list
1666090|NCT04037605|Dexamethasone|dexamethasone|mesh-list
1666091|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
1666092|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
1666093|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1666094|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1666095|NCT04037605|Hormones|hormones|mesh-list
1666096|NCT04037605|Cosyntropin|cosyntropin|mesh-list
1666097|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
1666098|NCT04037605|BB 1101|bb 1101|mesh-list
1666099|NCT04037605|Ganirelix|ganirelix|mesh-list
1666100|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1666101|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
1666102|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
1666103|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1666104|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666105|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1666106|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
1666107|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1666108|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1666109|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666110|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
1666111|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1666112|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666113|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
1666114|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1666115|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1666116|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1666117|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1666118|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
1666119|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2471763|NCT01066806|Calcium|calcium|mesh-list
2471764|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2471765|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471766|NCT01066832|Paclitaxel|paclitaxel|mesh-list
2471767|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2471768|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471769|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
2471770|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
2471771|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
2471772|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471773|NCT01066845|Tadalafil|tadalafil|mesh-list
2471774|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
2471775|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2471776|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2471777|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471778|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471779|NCT01066845|Urological Agents|urological agents|mesh-ancestor
2471780|NCT01066858|Tenofovir|tenofovir|mesh-list
2471781|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
2471782|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471783|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2471784|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2471785|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471786|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666155|NCT04022967|Ritonavir|ritonavir|mesh-list
1666156|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1666157|NCT04022967|Tenofovir|tenofovir|mesh-list
1666158|NCT04022967|Lamivudine|lamivudine|mesh-list
1666159|NCT04022967|Dolutegravir|dolutegravir|mesh-list
1666160|NCT04022967|Efavirenz|efavirenz|mesh-list
1666161|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1666162|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1666163|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
1666164|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1666165|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666166|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1666167|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1666168|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
1666169|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1666170|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1666171|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1666172|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1666173|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1666174|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1666175|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1666176|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1666177|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1666178|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1666179|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1666180|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2471787|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2471788|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2471789|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2471790|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471791|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2471792|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471793|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471794|NCT01066962|Ritonavir|ritonavir|mesh-list
1666189|NCT04006210|Levodopa|levodopa|mesh-list
1666190|NCT04006210|Carbidopa|carbidopa|mesh-list
1666191|NCT04006210|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1666192|NCT04006210|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1666193|NCT04006210|Dopamine Agents|dopamine agents|mesh-ancestor
1666194|NCT04006210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1666195|NCT04006210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666196|NCT04006210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666197|NCT04006210|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1666198|NCT04006210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471795|NCT01066962|Darunavir|darunavir|mesh-list
2471796|NCT01066962|Tenofovir|tenofovir|mesh-list
2471797|NCT01066962|Emtricitabine|emtricitabine|mesh-list
2471798|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
2471799|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1666206|NCT03998488|Psyllium|psyllium|mesh-list
1666207|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
1666208|NCT03998488|Cathartics|cathartics|mesh-ancestor
1666209|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1666210|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
1666211|NCT03995004|Dexamethasone|dexamethasone|mesh-list
1666212|NCT03995004|Melatonin|melatonin|mesh-list
1666213|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
1666214|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1666215|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
1666216|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
1666217|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1666218|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666219|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1666220|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
1666221|NCT03995004|Hormones|hormones|mesh-ancestor
1666222|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1666223|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1666224|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666225|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
1666226|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666227|NCT03995004|Protective Agents|protective agents|mesh-ancestor
1666228|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1666229|NCT03995004|Cathartics|cathartics|mesh-ancestor
2471800|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2471801|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
2471802|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471803|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471804|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2471805|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2471806|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
2471807|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471808|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2471809|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2471810|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2471811|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2471812|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2471813|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
2471814|NCT01066988|Emollients|emollients|mesh-list
2471815|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2471816|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2471817|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
2471818|NCT01067053|Bevacizumab|bevacizumab|mesh-list
2471819|NCT01067053|Capecitabine|capecitabine|mesh-list
2471820|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
2471821|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2471822|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471823|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2471824|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2471825|NCT01067053|Growth Substances|growth substances|mesh-ancestor
2471826|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471827|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
2471828|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2471829|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
2471830|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471831|NCT01067066|Temozolomide|temozolomide|mesh-list
2471832|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2471833|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
2471834|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471835|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471836|NCT01067118|Insulin|insulin|mesh-list
2471837|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2471838|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
1666294|NCT03980769|Vidarabine|vidarabine|mesh-list
1666295|NCT03980769|Fludarabine|fludarabine|mesh-list
1666296|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
1666297|NCT03980769|Thiotepa|thiotepa|mesh-list
1666298|NCT03980769|Treosulfan|treosulfan|mesh-list
1666299|NCT03980769|Busulfan|busulfan|mesh-list
1666300|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1666301|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
1666302|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666303|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1666304|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
1666305|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666306|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1666307|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
1666308|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666309|NCT03980769|Antiviral Agents|antiviral agents|mesh-ancestor
1666310|NCT03980769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1666311|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1666312|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
1666313|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2471839|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2471840|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471841|NCT01067222|Modafinil|modafinil|mesh-list
2471842|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2471843|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471844|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2471845|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2471846|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2471847|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471848|NCT01067235|Modafinil|modafinil|mesh-list
2471849|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2471850|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666328|NCT03971474|Gemcitabine|gemcitabine|mesh-list
1666329|NCT03971474|Docetaxel|docetaxel|mesh-list
1666330|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
1666331|NCT03971474|Pemetrexed|pemetrexed|mesh-list
1666332|NCT03971474|Ramucirumab|ramucirumab|mesh-list
1666333|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1666334|NCT03971474|Antibodies|antibodies|mesh-list
1666335|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
1666336|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1666337|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
1666338|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666339|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1666340|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
1666341|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666342|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666343|NCT03971474|Antiviral Agents|antiviral agents|mesh-ancestor
1666344|NCT03971474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1666345|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1666346|NCT03971474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1666347|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
1666348|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
1666349|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
1666350|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1666351|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1666352|NCT03970655|Dexamethasone|dexamethasone|mesh-list
1666353|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
1666354|NCT03970655|Epinephrine|epinephrine|mesh-list
1666355|NCT03970655|Racepinephrine|racepinephrine|mesh-list
1666356|NCT03970655|Bupivacaine|bupivacaine|mesh-list
1666357|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
1666358|NCT03970655|BB 1101|bb 1101|mesh-list
1666359|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1666360|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
1666361|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
1666362|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1666363|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666364|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1666365|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
1666366|NCT03970655|Hormones|hormones|mesh-ancestor
1666367|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1666368|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1666369|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666370|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
1666371|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1666372|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666373|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
1666374|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
1666375|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1666376|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
1666377|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1666378|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1666379|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
1666380|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1666381|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1666382|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1666383|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1666384|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
1666385|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
1666386|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
1666387|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2471851|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2471852|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2471853|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2471854|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471855|NCT01067274|Cytarabine|cytarabine|mesh-list
2471856|NCT01067274|Azacitidine|azacitidine|mesh-list
2471857|NCT01067274|Tretinoin|tretinoin|mesh-list
2471858|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2471859|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
1666397|NCT03970096|Cyclosporine|cyclosporine|mesh-list
1666398|NCT03970096|Sirolimus|sirolimus|mesh-list
1666399|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
1666400|NCT03970096|Busulfan|busulfan|mesh-list
1666401|NCT03970096|Thiotepa|thiotepa|mesh-list
1666402|NCT03970096|Methotrexate|methotrexate|mesh-list
1666403|NCT03970096|Fludarabine|fludarabine|mesh-list
1666404|NCT03970096|Tacrolimus|tacrolimus|mesh-list
1666405|NCT03970096|Cyclosporins|cyclosporins|mesh-list
1666406|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1666407|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
1666408|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666409|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1666410|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1666411|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
1666412|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666413|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666414|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1666415|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1666416|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
1666417|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1666418|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1666419|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
1666420|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
1666421|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1666422|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1666423|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1666424|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1666425|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
1666426|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1666427|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1666428|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1666435|NCT03968822|Lidocaine|lidocaine|mesh-list
1666436|NCT03968822|Bupivacaine|bupivacaine|mesh-list
1666437|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1666438|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
1666439|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
1666440|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1666441|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666442|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
1666443|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1666444|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1666445|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1666446|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1666447|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1666448|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666449|NCT03968562|Doxycycline|doxycycline|mesh-list
1666450|NCT03968562|Petrolatum|petrolatum|mesh-list
1666451|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1666452|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1666453|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
1666454|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1666455|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1666456|NCT03968562|Emollients|emollients|mesh-ancestor
1666457|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
1666458|NCT03959488|Palivizumab|palivizumab|mesh-list
1666459|NCT03959488|Antiviral Agents|antiviral agents|mesh-ancestor
1666460|NCT03959488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471860|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471861|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471862|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
2471863|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471864|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2471865|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
2471866|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471867|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471868|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
2471869|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
2471870|NCT01067287|Pidilizumab|pidilizumab|mesh-list
2471871|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2471872|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471873|NCT01067365|Citric Acid|citric acid|mesh-list
2471874|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
2471875|NCT01067365|Enclomiphene|enclomiphene|mesh-list
2471876|NCT01067365|Clomiphene|clomiphene|mesh-list
2471877|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
2471878|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
2471879|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2471880|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
1666482|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
1666483|NCT03939026|Fludarabine|fludarabine|mesh-list
1666484|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1666485|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
1666486|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666487|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1666488|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1666489|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
1666490|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666491|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666492|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1666493|NCT03934541|Vaccines|vaccines|mesh-list
1666494|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
1666495|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471881|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
2471882|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471883|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2471884|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
2471885|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2471886|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471887|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2471888|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
2471889|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2471890|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1666506|NCT03915613|Insulin|insulin|mesh-list
1666507|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1666508|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1666509|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471891|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2471892|NCT01067391|Tadalafil|tadalafil|mesh-list
2471893|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
2471894|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2471895|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2471896|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471897|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471898|NCT01067391|Urological Agents|urological agents|mesh-ancestor
2471899|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
2471900|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
2471901|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2471902|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2471903|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471904|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471905|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471906|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2471907|NCT01067430|Diclofenac|diclofenac|mesh-list
2471908|NCT01067430|Etoricoxib|etoricoxib|mesh-list
2471909|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2471910|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2471911|NCT01067430|Analgesics|analgesics|mesh-ancestor
2471912|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
2471913|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471914|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471915|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2471916|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2471917|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2471918|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2471919|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471920|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2471921|NCT01067443|Amphotericin B|amphotericin b|mesh-list
2471922|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
2471923|NCT01067443|Miltefosine|miltefosine|mesh-list
2471924|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
2471925|NCT01067443|Amebicides|amebicides|mesh-ancestor
2471926|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2471927|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2471928|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2471929|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2471930|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
2471931|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2471932|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
2471933|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2471934|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
2471935|NCT01067534|Albuterol|albuterol|mesh-list
2471936|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2471937|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
2471938|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471939|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471940|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2471941|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
2471942|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
2471943|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2471944|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2471945|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2471946|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2471947|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
2471948|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471949|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471950|NCT01067547|Iron|iron|mesh-list
2471951|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2471952|NCT01067547|Trace Elements|trace elements|mesh-ancestor
2471953|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
2471954|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471955|NCT01067547|Hematinics|hematinics|mesh-ancestor
2471956|NCT01067599|Nicotine|nicotine|mesh-list
2471957|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2471958|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
2471959|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471960|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471961|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2471962|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2471963|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
2471964|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471965|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471966|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
2471967|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2471968|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2471969|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471970|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
2471971|NCT01067638|Coagulants|coagulants|mesh-ancestor
1666593|NCT03868150|Amiodarone|amiodarone|mesh-list
1666594|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1666595|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
1666596|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1666597|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1666598|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666599|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1666600|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1666601|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1666602|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1666603|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1666604|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1666605|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2471972|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
2471973|NCT01067677|Promethazine|promethazine|mesh-list
2471974|NCT01067677|Ondansetron|ondansetron|mesh-list
2471975|NCT01067677|Metoclopramide|metoclopramide|mesh-list
2471976|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
2471977|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
2471978|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1666612|NCT03864276|Propofol|propofol|mesh-list
1666613|NCT03864276|Desflurane|desflurane|mesh-list
1666614|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
1666615|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1666616|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666617|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1666618|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1666619|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
1666620|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1666621|NCT03856788|Bupivacaine|bupivacaine|mesh-list
1666622|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
1666623|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
1666624|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1666625|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666626|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
1666627|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2471979|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2471980|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2471981|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
2471982|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
2471983|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2471984|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
2471985|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2471986|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2471987|NCT01067677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2471988|NCT01067677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2471989|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2471990|NCT01067677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2471991|NCT01067677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2471992|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2471993|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2471994|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
2471995|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
2471996|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
2471997|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1666647|NCT03840902|Paclitaxel|paclitaxel|mesh-list
1666648|NCT03840902|Etoposide|etoposide|mesh-list
1666649|NCT03840902|Carboplatin|carboplatin|mesh-list
1666650|NCT03840902|Pemetrexed|pemetrexed|mesh-list
1666651|NCT03840902|Durvalumab|durvalumab|mesh-list
1666652|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1666653|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666654|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
1666655|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
1666656|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
1666657|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666658|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1666659|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1666660|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1666661|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1666662|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1666663|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2471998|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
2471999|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
2472000|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2472001|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2472002|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2472003|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
2472004|NCT01067690|Indinavir|indinavir|mesh-list
2472005|NCT01067690|Bleomycin|bleomycin|mesh-list
2472006|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2472007|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2472008|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
2472009|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472010|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472011|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2472012|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2472013|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
2472014|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472015|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2472016|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472017|NCT01067898|Vitamin D|vitamin d|mesh-list
2472018|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
2472019|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
1666684|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
1666685|NCT03821610|Melphalan|melphalan|mesh-list
1666686|NCT03821610|Fludarabine|fludarabine|mesh-list
1666687|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
1666688|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1666689|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
1666690|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666691|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1666692|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1666693|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
1666694|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666695|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666696|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1666697|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2472020|NCT01067898|Vitamins|vitamins|mesh-list
2472021|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
2472022|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
2472023|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472024|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1666711|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1666712|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1666713|NCT03815929|Estradiol|estradiol|mesh-list
1666714|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1666715|NCT03815929|Estrogens|estrogens|mesh-ancestor
1666716|NCT03815929|Hormones|hormones|mesh-ancestor
1666717|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1666718|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666719|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1666720|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
1666721|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1666722|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1666723|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
1666724|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1666725|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666726|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
1666727|NCT03811756|Vitamins|vitamins|mesh-ancestor
1666728|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
1666729|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472025|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2472026|NCT01067898|Antacids|antacids|mesh-ancestor
2472027|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472028|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2472029|NCT01067950|Pancrelipase|pancrelipase|mesh-list
2472030|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2472031|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
2472032|NCT01067989|Pamidronate|pamidronate|mesh-list
2472033|NCT01067989|Celecoxib|celecoxib|mesh-list
2472034|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
2472035|NCT01067989|Capecitabine|capecitabine|mesh-list
2472036|NCT01067989|Methotrexate|methotrexate|mesh-list
2472037|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472038|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
2472039|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472040|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2472041|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2472042|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
2472043|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472044|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472045|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2472046|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2472047|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
2472048|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2472049|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
2472050|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2472051|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
2472052|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472053|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2472054|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2472055|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2472056|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2472057|NCT01067989|Analgesics|analgesics|mesh-ancestor
2472058|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
2472059|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472060|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2472061|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
2472062|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2472063|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2472064|NCT01068054|Cyclosporine|cyclosporine|mesh-list
2472065|NCT01068054|Tacrolimus|tacrolimus|mesh-list
2472066|NCT01068054|Cyclosporins|cyclosporins|mesh-list
2472067|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472068|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
2472069|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472070|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2472071|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472072|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666787|NCT03792516|Artesunate|artesunate|mesh-list
1666788|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
1666789|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1666790|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1666791|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1666792|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666793|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
1666794|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
1666795|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1666796|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
2472073|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
2472074|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1666799|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
1666800|NCT03781934|Lenvatinib|lenvatinib|mesh-list
1666801|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1666802|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666803|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1666804|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1666805|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472075|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
2472076|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2472077|NCT01068067|Tacrolimus|tacrolimus|mesh-list
2472078|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472079|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
2472080|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472081|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2472082|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472083|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472084|NCT01068093|Ezetimibe|ezetimibe|mesh-list
2472085|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2472086|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2472087|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
2472088|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472089|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2472090|NCT01068132|Cetuximab|cetuximab|mesh-list
2472091|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2472092|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472093|NCT01068223|Cetirizine|cetirizine|mesh-list
2472094|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2472095|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2472096|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2472097|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
2472098|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
2472099|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472100|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472101|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472102|NCT01068249|Everolimus|everolimus|mesh-list
2472103|NCT01068249|Letrozole|letrozole|mesh-list
2472104|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472105|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472106|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
2472107|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472108|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2472109|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2472110|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472111|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472112|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1666845|NCT03768414|Gemcitabine|gemcitabine|mesh-list
1666846|NCT03768414|Paclitaxel|paclitaxel|mesh-list
1666847|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1666848|NCT03768414|Cisplatin|cisplatin|mesh-list
1666849|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1666850|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666851|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
1666852|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
1666853|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
1666854|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666855|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1666856|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
1666857|NCT03768414|Antiviral Agents|antiviral agents|mesh-ancestor
1666858|NCT03768414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1666859|NCT03768414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1666860|NCT03768414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1666861|NCT03768414|Immunologic Factors|immunologic factors|mesh-ancestor
1666862|NCT03768414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472113|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
2472114|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2472115|NCT01068301|Plerixafor|plerixafor|mesh-list
2472116|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2472117|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2472118|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
1666869|NCT03764137|Panitumumab|panitumumab|mesh-list
1666870|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1666871|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666872|NCT03757130|Liraglutide|liraglutide|mesh-list
1666873|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1666874|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666875|NCT03757130|Incretins|incretins|mesh-ancestor
1666876|NCT03757130|Hormones|hormones|mesh-ancestor
1666877|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2472119|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472120|NCT01068327|Leucovorin|leucovorin|mesh-list
2472121|NCT01068327|Gemcitabine|gemcitabine|mesh-list
2472122|NCT01068327|Nelfinavir|nelfinavir|mesh-list
2472123|NCT01068327|Fluorouracil|fluorouracil|mesh-list
2472124|NCT01068327|Calcium|calcium|mesh-list
2472125|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
2472126|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2472127|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
2472128|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472129|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666889|NCT03733418|Vitamin D|vitamin d|mesh-list
1666890|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
1666891|NCT03733418|Vitamins|vitamins|mesh-ancestor
1666892|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
1666893|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666894|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1666895|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2472130|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
2472131|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472132|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472133|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472134|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
2472135|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472136|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2472137|NCT01068327|Antidotes|antidotes|mesh-ancestor
1666904|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
1666905|NCT03732664|Nivolumab|nivolumab|mesh-list
1666906|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1666907|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666908|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1666909|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472138|NCT01068327|Protective Agents|protective agents|mesh-ancestor
2472139|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
2472140|NCT01068327|Vitamins|vitamins|mesh-ancestor
2472141|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
2472142|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2472143|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2472144|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
2472145|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2472146|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2472147|NCT01068353|Etanercept|etanercept|mesh-list
2472148|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2472149|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2472150|NCT01068353|Analgesics|analgesics|mesh-ancestor
2472151|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
2472152|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472153|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472154|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2472155|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2472156|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2472157|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472158|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
2472159|NCT01068392|Prednisolone|prednisolone|mesh-list
2472160|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
2472161|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472162|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2472163|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
1666947|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
1666948|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1666949|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472164|NCT01068392|Hormones|hormones|mesh-ancestor
2472165|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2472166|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666953|NCT03675256|Vaccines|vaccines|mesh-list
1666954|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
1666955|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472167|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2472168|NCT01068405|Methotrexate|methotrexate|mesh-list
2472169|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2472170|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
2472171|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2472172|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666962|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
1666963|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
1666964|NCT03670966|Fludarabine|fludarabine|mesh-list
1666965|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
1666966|NCT03670966|Tacrolimus|tacrolimus|mesh-list
1666967|NCT03670966|Antibodies|antibodies|mesh-list
1666968|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1666969|NCT03670966|Sargramostim|sargramostim|mesh-list
1666970|NCT03670966|Lenograstim|lenograstim|mesh-list
1666971|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1666972|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
1666973|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1666974|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1666975|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1666976|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
1666977|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1666978|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1666979|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1666980|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1666981|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
1666982|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1666983|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1666984|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1666985|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1666986|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2472173|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1666987|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
1666988|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1666989|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2472174|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
2472175|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472176|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472177|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
2472178|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472179|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2472180|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472181|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
2472182|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2472183|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2472184|NCT01068444|Pioglitazone|pioglitazone|mesh-list
2472185|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2472186|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472187|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2472188|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472189|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2472190|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472191|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472192|NCT01068613|Tiotropium Bromide|tiotropium bromide|mesh-list
2472193|NCT01068613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2472194|NCT01068613|Autonomic Agents|autonomic agents|mesh-ancestor
2472195|NCT01068613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472196|NCT01068613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472197|NCT01068613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2472198|NCT01068613|Respiratory System Agents|respiratory system agents|mesh-ancestor
2472199|NCT01068613|Parasympatholytics|parasympatholytics|mesh-ancestor
2472200|NCT01068613|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2472201|NCT01068613|Cholinergic Agents|cholinergic agents|mesh-ancestor
2472202|NCT01068613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472203|NCT01068613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472204|NCT01068704|Letrozole|letrozole|mesh-list
2472205|NCT01068704|Lapatinib|lapatinib|mesh-list
2472206|NCT01068704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472207|NCT01068704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2472208|NCT01068704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1667025|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
1667026|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1667027|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472209|NCT01068704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472210|NCT01068704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472211|NCT01068704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2472212|NCT01068704|Hormone Antagonists|hormone antagonists|mesh-ancestor
2472213|NCT01068704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2472214|NCT01068704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472215|NCT01068704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2472216|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
2472217|NCT01068756|Rifampin|rifampin|mesh-list
2472218|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2472219|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472220|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2472221|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472222|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2472223|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
2472224|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2472225|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472226|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
1667059|NCT03620201|Atezolizumab|atezolizumab|mesh-list
1667060|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667061|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1667062|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1667216|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1667063|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1667064|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1667065|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667066|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1667067|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667068|NCT03618225|Analgesics|analgesics|mesh-ancestor
1667069|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
1667070|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1667071|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
1667072|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1667073|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
2472227|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2472228|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472229|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2472230|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2472231|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2472232|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2472233|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
2472234|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2472235|NCT01068795|Enoxaparin|enoxaparin|mesh-list
2472236|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
2472237|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2472238|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2472239|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667120|NCT03587272|Sirolimus|sirolimus|mesh-list
1667121|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
1667122|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1667123|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1667124|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1667125|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667126|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
1667127|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1667128|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
1667129|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667130|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2472240|NCT01068847|Cycloserine|cycloserine|mesh-list
2472241|NCT01068847|Verapamil|verapamil|mesh-list
2472242|NCT01068847|Nifedipine|nifedipine|mesh-list
2472243|NCT01068847|Tizanidine|tizanidine|mesh-list
2472244|NCT01068847|Naloxone|naloxone|mesh-list
2472245|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1667137|NCT03566199|Panobinostat|panobinostat|mesh-list
1667138|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667139|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1667140|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1667141|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667142|NCT03561831|Propofol|propofol|mesh-list
1667143|NCT03561831|Sevoflurane|sevoflurane|mesh-list
1667144|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1667145|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1667146|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667147|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1667148|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
1667149|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
1667150|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1667151|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1667157|NCT03551626|Trametinib|trametinib|mesh-list
1667158|NCT03551626|Dabrafenib|dabrafenib|mesh-list
1667159|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667160|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1667161|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1667162|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667163|NCT03544736|Paclitaxel|paclitaxel|mesh-list
1667164|NCT03544736|Carboplatin|carboplatin|mesh-list
1667165|NCT03544736|Nivolumab|nivolumab|mesh-list
1667166|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1667167|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667168|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
1667169|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
1667170|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
1667171|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667172|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1667173|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2472246|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472247|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
2472248|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472249|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2472250|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2472251|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472252|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2472253|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
2472254|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
2472255|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2472256|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2472257|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472258|NCT01068847|Renal Agents|renal agents|mesh-ancestor
2472259|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2472260|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
2472261|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2472262|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
2472263|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2472264|NCT01068847|Analgesics|analgesics|mesh-ancestor
1667198|NCT03508232|Doxycycline|doxycycline|mesh-list
1667199|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1667200|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1667201|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
1667202|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1667203|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2472265|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
2472266|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2472267|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1667207|NCT03501979|Capecitabine|capecitabine|mesh-list
1667208|NCT03501979|Trastuzumab|trastuzumab|mesh-list
1667209|NCT03501979|Tucatinib|tucatinib|mesh-list
1667210|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1667211|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
1667212|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667213|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667214|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1667215|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2472268|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
2472269|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
2472270|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1667220|NCT03491059|Nicotine|nicotine|mesh-list
1667221|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1667222|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
1667223|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1667224|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667225|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1667226|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1667227|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
1667228|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1667229|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472271|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2472272|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2472273|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
2472274|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472275|NCT01068925|Dolutegravir|dolutegravir|mesh-list
2472276|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
2472277|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1667237|NCT03473574|Gemcitabine|gemcitabine|mesh-list
1667238|NCT03473574|Durvalumab|durvalumab|mesh-list
1667239|NCT03473574|Tremelimumab|tremelimumab|mesh-list
1667240|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667241|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1667242|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
1667243|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667244|NCT03473574|Antiviral Agents|antiviral agents|mesh-ancestor
1667245|NCT03473574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1667246|NCT03473574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1667247|NCT03473574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1667248|NCT03473574|Immunologic Factors|immunologic factors|mesh-ancestor
1667249|NCT03473574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667250|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1667251|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
1667252|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1667253|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1667254|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1667255|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1667256|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667257|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
1667258|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1667259|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667260|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1667261|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1667262|NCT03466151|Sirolimus|sirolimus|mesh-list
1667263|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1667264|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1667265|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1667266|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667267|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
1667268|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1667269|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
1667270|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472278|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472279|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472280|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2472281|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2472282|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
2472283|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472284|NCT01068977|Bevacizumab|bevacizumab|mesh-list
2472285|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2472286|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2472287|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472288|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2472289|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2472290|NCT01068977|Growth Substances|growth substances|mesh-ancestor
2472291|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472292|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
2472293|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
2472294|NCT01069042|Enalapril|enalapril|mesh-list
2472295|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2472296|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
2472297|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472298|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472299|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2472300|NCT01069055|Acetaminophen|acetaminophen|mesh-list
2472301|NCT01069055|Lornoxicam|lornoxicam|mesh-list
2472302|NCT01069055|Piroxicam|piroxicam|mesh-list
2472303|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2472304|NCT01069055|Analgesics|analgesics|mesh-ancestor
2472305|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
2472306|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472307|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472308|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
2472309|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2472310|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2472311|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2472312|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2472313|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472314|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472315|NCT01069081|Cisplatin|cisplatin|mesh-list
2472316|NCT01069081|Docetaxel|docetaxel|mesh-list
2472317|NCT01069081|Esomeprazole|esomeprazole|mesh-list
2472318|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472319|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
2472320|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
2472321|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
2472322|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472323|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2472324|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2472325|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2472326|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472327|NCT01069094|Leuprolide|leuprolide|mesh-list
2472328|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2472329|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
2472330|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2472331|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472332|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2472333|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472334|NCT01069133|Rifaximin|rifaximin|mesh-list
2472335|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2472336|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472337|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2472338|NCT01069159|Propranolol|propranolol|mesh-list
2472339|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2472340|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2472341|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
2472342|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472343|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472344|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472345|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2472346|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2472347|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
2472348|NCT01069198|Vitamin A|vitamin a|mesh-list
2472349|NCT01069198|Albendazole|albendazole|mesh-list
2472350|NCT01069198|Vitamins|vitamins|mesh-ancestor
2472351|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
2472352|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472353|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472354|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472355|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
2472356|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2472357|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472358|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
1667366|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
1667367|NCT03391466|Fludarabine|fludarabine|mesh-list
1667368|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472359|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2472360|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2472361|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
1667369|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
1667370|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667371|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1667372|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1667373|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
1667374|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667375|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667376|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2472362|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
2472363|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
2472364|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2472365|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2472366|NCT01069263|Protective Agents|protective agents|mesh-ancestor
2472367|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472368|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2472369|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
2472370|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472371|NCT01069302|Clopidogrel|clopidogrel|mesh-list
2472372|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2472373|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2472374|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2472375|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2472376|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
2472377|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472378|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472379|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472380|NCT01069328|Paclitaxel|paclitaxel|mesh-list
2472381|NCT01069328|Bevacizumab|bevacizumab|mesh-list
2472382|NCT01069328|Carboplatin|carboplatin|mesh-list
2472383|NCT01069328|Sorafenib|sorafenib|mesh-list
2472384|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2472385|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472386|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
2472387|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
2472388|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
2472389|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472390|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2472391|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2472392|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2472393|NCT01069328|Growth Substances|growth substances|mesh-ancestor
2472394|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472395|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
2472396|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2472397|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472398|NCT01069536|Metoclopramide|metoclopramide|mesh-list
2472399|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
2472400|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
2472401|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472402|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472403|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2472404|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2472405|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2472406|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
2472407|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472408|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472409|NCT01069692|Ferric Compounds|ferric compounds|mesh-list
2472410|NCT01069692|Hematinics|hematinics|mesh-ancestor
2472411|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2472412|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472413|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2472414|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472415|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472416|NCT01069770|Sunitinib|sunitinib|mesh-list
2472417|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472418|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1667755|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
2472419|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2472420|NCT01069770|Growth Substances|growth substances|mesh-ancestor
2472421|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472422|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
2472423|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2472424|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472425|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472426|NCT01069796|Paclitaxel|paclitaxel|mesh-list
2472427|NCT01069796|Bevacizumab|bevacizumab|mesh-list
2472428|NCT01069796|Capecitabine|capecitabine|mesh-list
2472429|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2472430|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472431|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
2472432|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
1667467|NCT03370263|Belimumab|belimumab|mesh-list
1667468|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1667469|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
1667470|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472433|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
2472434|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667473|NCT03352427|Everolimus|everolimus|mesh-list
1667474|NCT03352427|Dasatinib|dasatinib|mesh-list
1667475|NCT03352427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667476|NCT03352427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1667477|NCT03352427|Immunologic Factors|immunologic factors|mesh-ancestor
1667478|NCT03352427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667479|NCT03352427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1667480|NCT03352427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1667481|NCT03352427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667482|NCT03351439|Celecoxib|celecoxib|mesh-list
1667483|NCT03351439|Naproxen|naproxen|mesh-list
1667484|NCT03351439|Gabapentin|gabapentin|mesh-list
1667485|NCT03351439|Zopiclone|zopiclone|mesh-list
1667486|NCT03351439|Analgesics|analgesics|mesh-ancestor
1667487|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
1667488|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1667489|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667490|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
1667491|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1667492|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1667493|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1667494|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1667495|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1667496|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1667497|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1667498|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667499|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
1667500|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1667501|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1667502|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1667503|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1667504|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1667505|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1667506|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1667507|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
1667508|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2472435|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2472436|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2472437|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2472438|NCT01069796|Growth Substances|growth substances|mesh-ancestor
2472439|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472440|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
2472441|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2472442|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
2472443|NCT01069822|Midazolam|midazolam|mesh-list
2472444|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2472445|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2472446|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2472447|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472448|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2472449|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2472450|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2472451|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2472452|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
2472453|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
2472454|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
2472455|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
2472456|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472457|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472458|NCT01069874|Vitamin D|vitamin d|mesh-list
2472459|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
2472460|NCT01069874|Vitamins|vitamins|mesh-ancestor
2472461|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
2472462|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472463|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2472464|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2472465|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
2472466|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
2472467|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472468|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
2472469|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472470|NCT01069965|BGP 15|bgp 15|mesh-list
2472471|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472472|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472473|NCT01070030|Amlodipine|amlodipine|mesh-list
1667560|NCT03330847|Olaparib|olaparib|mesh-list
1667561|NCT03330847|Adavosertib|adavosertib|mesh-list
1667562|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1667563|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1667564|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667565|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472474|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2472475|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2472476|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1667569|NCT03319667|Acetaminophen|acetaminophen|mesh-list
1667570|NCT03319667|Diphenhydramine|diphenhydramine|mesh-list
1667571|NCT03319667|Promethazine|promethazine|mesh-list
1667572|NCT03319667|Dexamethasone|dexamethasone|mesh-list
1667573|NCT03319667|Lenalidomide|lenalidomide|mesh-list
1667574|NCT03319667|Bortezomib|bortezomib|mesh-list
1667575|NCT03319667|Ranitidine|ranitidine|mesh-list
1667576|NCT03319667|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
1667577|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1667578|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
1667579|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
1667580|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1667581|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667582|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1667583|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
1667584|NCT03319667|Hormones|hormones|mesh-ancestor
1667585|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1667586|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1667587|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667588|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
1667589|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1667590|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1667591|NCT03319667|Growth Substances|growth substances|mesh-ancestor
1667592|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
1667593|NCT03319667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1667594|NCT03319667|Analgesics|analgesics|mesh-ancestor
1667595|NCT03319667|Sensory System Agents|sensory system agents|mesh-ancestor
1667596|NCT03319667|Antipyretics|antipyretics|mesh-ancestor
1667597|NCT03319667|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1667598|NCT03319667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1667599|NCT03319667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1667600|NCT03319667|Anesthetics, Local|anesthetics, local|mesh-ancestor
1667601|NCT03319667|Anesthetics|anesthetics|mesh-ancestor
1667602|NCT03319667|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1667603|NCT03319667|Histamine Antagonists|histamine antagonists|mesh-ancestor
1667604|NCT03319667|Histamine Agents|histamine agents|mesh-ancestor
1667605|NCT03319667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1667606|NCT03319667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667607|NCT03319667|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1667608|NCT03319667|Antipruritics|antipruritics|mesh-ancestor
1667609|NCT03319667|Dermatologic Agents|dermatologic agents|mesh-ancestor
1667610|NCT03319667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1667611|NCT03319667|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1667612|NCT03316274|Nivolumab|nivolumab|mesh-list
1667613|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1667614|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667615|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1667616|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472477|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2472478|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472479|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2472480|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472481|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
2472482|NCT01070030|Diuretics|diuretics|mesh-ancestor
2472483|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
2472484|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2472485|NCT01070108|Ketamine|ketamine|mesh-list
2472486|NCT01070108|Analgesics|analgesics|mesh-ancestor
2472487|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
2472488|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472489|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472490|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2472491|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2472492|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
2472493|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
2472494|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2472495|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2472496|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2472497|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472498|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472499|NCT01070160|Metformin|metformin|mesh-list
2472500|NCT01070160|Progesterone|progesterone|mesh-list
2472501|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2472502|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472503|NCT01070160|Progestins|progestins|mesh-ancestor
2472504|NCT01070160|Hormones|hormones|mesh-ancestor
2472505|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2472506|NCT01070186|Sunitinib|sunitinib|mesh-list
2472507|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472508|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2472509|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2472510|NCT01070186|Growth Substances|growth substances|mesh-ancestor
2472511|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472512|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
2472513|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2472514|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472515|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472516|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
2472517|NCT01070225|Propranolol|propranolol|mesh-list
2472518|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2472519|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2472520|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2472521|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
2472522|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472523|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472524|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472525|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2472526|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1667754|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472527|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
2472528|NCT01070277|Albendazole|albendazole|mesh-list
2472529|NCT01070277|Tinidazole|tinidazole|mesh-list
2472530|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
2472531|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2472532|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472533|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
2472534|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2472535|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2472536|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
2472537|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
2472538|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
2472539|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472540|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472541|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
2472542|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2472543|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
2472544|NCT01070290|Capecitabine|capecitabine|mesh-list
2472545|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
2472546|NCT01070290|Irinotecan|irinotecan|mesh-list
2472547|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2472548|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
2472549|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472550|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472551|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2472552|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2472553|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472554|NCT01070407|Cloricromen|cloricromen|mesh-list
2472555|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2472556|NCT01070446|Choline|choline|mesh-list
2472557|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
2472558|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2472559|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
2472560|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472561|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2472562|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2472563|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
2472564|NCT01070472|Misoprostol|misoprostol|mesh-list
2472565|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2472566|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
2472567|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2472568|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472569|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2472570|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2472571|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
1667722|NCT03252626|Alprostadil|alprostadil|mesh-list
1667723|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1667724|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
1667725|NCT03252626|Urological Agents|urological agents|mesh-ancestor
1667726|NCT03246906|Cyclosporine|cyclosporine|mesh-list
1667727|NCT03246906|Sirolimus|sirolimus|mesh-list
1667728|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
1667729|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
1667730|NCT03246906|Cyclosporins|cyclosporins|mesh-list
1667731|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1667732|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
1667733|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667734|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1667735|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1667736|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
1667737|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667738|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667739|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1667740|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1667741|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
1667742|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1667743|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
1667744|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1667745|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1667746|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1667747|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
1667748|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1667749|NCT03245008|Fasinumab|fasinumab|mesh-list
1667750|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1667751|NCT03245008|Analgesics|analgesics|mesh-ancestor
1667752|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
1667753|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472572|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
1667756|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1667757|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
1667758|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1667759|NCT03238300|Expectorants|expectorants|mesh-ancestor
1667760|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
1667761|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1667762|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
1667763|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667764|NCT03238300|Protective Agents|protective agents|mesh-ancestor
1667765|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667766|NCT03238300|Antidotes|antidotes|mesh-ancestor
1667767|NCT03237377|Durvalumab|durvalumab|mesh-list
1667768|NCT03237377|Tremelimumab|tremelimumab|mesh-list
1667769|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1667770|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667771|NCT03236545|Estradiol|estradiol|mesh-list
1667772|NCT03236545|Estrogens|estrogens|mesh-list
1667773|NCT03236545|Hormones|hormones|mesh-ancestor
1667774|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1667775|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472573|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472574|NCT01070511|Tadalafil|tadalafil|mesh-list
2472575|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
2472576|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2472577|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2472578|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472579|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472580|NCT01070511|Urological Agents|urological agents|mesh-ancestor
2472581|NCT01070524|Budesonide|budesonide|mesh-list
2472582|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
2472583|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2472584|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2472585|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
2472586|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472587|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472588|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2472589|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
2472590|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
2472591|NCT01070524|Hormones|hormones|mesh-ancestor
2472592|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2472593|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
2472594|NCT01070615|Prucalopride|prucalopride|mesh-list
2472595|NCT01070615|Laxatives|laxatives|mesh-ancestor
2472596|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2472597|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
2472598|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2472599|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
2472600|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472601|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472602|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472603|NCT01070628|Levodopa|levodopa|mesh-list
2472604|NCT01070628|Carbidopa|carbidopa|mesh-list
2472605|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2472606|NCT01070628|Entacapone|entacapone|mesh-list
2472607|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2472608|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2472609|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
2472610|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472611|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472612|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472613|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2472614|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472615|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2472616|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
2472617|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
2472618|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
2472619|NCT01070641|Carvedilol|carvedilol|mesh-list
2472620|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2472621|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2472622|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
2472623|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472624|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472625|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472626|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2472627|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
2472628|NCT01070641|Protective Agents|protective agents|mesh-ancestor
2472629|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2472630|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2472631|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2472632|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
2472633|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2472634|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2472635|NCT01070667|Dronedarone|dronedarone|mesh-list
2472636|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2472637|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
2472638|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2472639|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2472640|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472641|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2472642|NCT01070680|Analgesics|analgesics|mesh-ancestor
2472643|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
2472644|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472645|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2472646|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2472647|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2472648|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
2472649|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472650|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472651|NCT01070706|Gemcitabine|gemcitabine|mesh-list
2472652|NCT01070706|Paclitaxel|paclitaxel|mesh-list
2472653|NCT01070706|Sunitinib|sunitinib|mesh-list
2472654|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2472655|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472656|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
2472657|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
2472658|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
2472659|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472660|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2472661|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
2472662|NCT01070706|Antiviral Agents|antiviral agents|mesh-ancestor
2472663|NCT01070706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472664|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472665|NCT01070706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472666|NCT01070706|Immunologic Factors|immunologic factors|mesh-ancestor
2472667|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472668|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2472669|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2472670|NCT01070706|Growth Substances|growth substances|mesh-ancestor
2472671|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
2472672|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2472673|NCT01070732|Acetaminophen|acetaminophen|mesh-list
2472674|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2472675|NCT01070732|Analgesics|analgesics|mesh-ancestor
2472676|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
1667902|NCT03199755|Lumefantrine|lumefantrine|mesh-list
1667903|NCT03199755|Artemether|artemether|mesh-list
1667904|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1667905|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
1667906|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1667907|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1667908|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1667920|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
1667921|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1667922|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472677|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472678|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472679|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
2472680|NCT01070745|Ibuprofen|ibuprofen|mesh-list
2472681|NCT01070745|Indomethacin|indomethacin|mesh-list
2472682|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2472683|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2472684|NCT01070745|Analgesics|analgesics|mesh-ancestor
2472685|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
2472686|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1667933|NCT03181126|Venetoclax|venetoclax|mesh-list
1667934|NCT03181126|Navitoclax|navitoclax|mesh-list
1667935|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472687|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472688|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2472689|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2472690|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2472691|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1667941|NCT03174405|Avelumab|avelumab|mesh-list
1667942|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1667943|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472692|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472693|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
2472694|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
2472695|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2472696|NCT01070758|Lanreotide|lanreotide|mesh-list
2472697|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472698|NCT01070823|Natalizumab|natalizumab|mesh-list
1667951|NCT03139747|Everolimus|everolimus|mesh-list
1667952|NCT03139747|Lenvatinib|lenvatinib|mesh-list
1667953|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667954|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1667955|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
1667956|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667957|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1667958|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1667959|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667960|NCT03128619|Letrozole|letrozole|mesh-list
1667961|NCT03128619|Palbociclib|palbociclib|mesh-list
1667962|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1667963|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1667964|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1667965|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1667966|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1667967|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1667968|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
1667969|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1667970|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1667971|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2472699|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
2472700|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472701|NCT01070836|Natalizumab|natalizumab|mesh-list
2472702|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
2472703|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472704|NCT01070862|Thalidomide|thalidomide|mesh-list
2472705|NCT01070862|Dexamethasone|dexamethasone|mesh-list
2472706|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
2472707|NCT01070862|Doxorubicin|doxorubicin|mesh-list
2472708|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2472709|NCT01070862|Melphalan|melphalan|mesh-list
2472710|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
2472711|NCT01070862|Vincristine|vincristine|mesh-list
2472712|NCT01070862|BB 1101|bb 1101|mesh-list
2472713|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2472714|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
2472715|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
2472716|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472717|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1668015|NCT03066648|Azacitidine|azacitidine|mesh-list
1668016|NCT03066648|Decitabine|decitabine|mesh-list
1668017|NCT03066648|Spartalizumab|spartalizumab|mesh-list
1668018|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1668019|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
1668020|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1668021|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1668022|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1668023|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1668038|NCT03059498|Bupivacaine|bupivacaine|mesh-list
1668039|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
1668040|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
1668041|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1668042|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1668043|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
1668044|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472718|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2472719|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
2472720|NCT01070862|Hormones|hormones|mesh-ancestor
2472721|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2472722|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2472723|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472724|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
2472725|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472726|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472727|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2472728|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2472729|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2472730|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2472731|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
2472732|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2472733|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472734|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
2472735|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
2472736|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2472737|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472738|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2472739|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2472740|NCT01070862|Growth Substances|growth substances|mesh-ancestor
2472741|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
2472742|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2472743|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2472744|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
2472745|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
2472746|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
2472747|NCT01070875|Heparin|heparin|mesh-list
2472748|NCT01070875|Calcium heparin|calcium heparin|mesh-list
2472749|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
2472750|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2472751|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2472752|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472753|NCT01070927|R04929097|r04929097|mesh-list
2472754|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472755|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472756|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
2472757|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472758|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472759|NCT01071005|Leuprolide|leuprolide|mesh-list
2472760|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
2472761|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
2472762|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2472763|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472764|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2472765|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472766|NCT01071057|Morphine|morphine|mesh-list
2472767|NCT01071057|Naloxone|naloxone|mesh-list
2472768|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2472769|NCT01071057|Narcotics|narcotics|mesh-ancestor
2472770|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2472771|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1668098|NCT02943590|Atorvastatin|atorvastatin|mesh-list
1668099|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1668100|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1668101|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
1668102|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1668103|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1668104|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1668105|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1668106|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
1668107|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
1668108|NCT02918292|Fludarabine|fludarabine|mesh-list
1668109|NCT02918292|Tacrolimus|tacrolimus|mesh-list
1668110|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
1668111|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1668112|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1668113|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
1668114|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1668115|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1668116|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1668117|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
1668118|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1668119|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1668120|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1668121|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1668122|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1668123|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1668124|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1668125|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
1668126|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1668127|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472772|NCT01071057|Analgesics|analgesics|mesh-ancestor
2472773|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
2472774|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472775|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2472776|NCT01071122|Valsartan|valsartan|mesh-list
2472777|NCT01071122|Nifedipine|nifedipine|mesh-list
2472778|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2472779|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2472780|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2472781|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472782|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2472783|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2472784|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2472785|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472786|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
2472787|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
2472788|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2472789|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
2472790|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
2472791|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2472792|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2472793|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1668152|NCT02902120|Grazoprevir|grazoprevir|mesh-list
1668153|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
1668154|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1668155|NCT02896712|Modafinil|modafinil|mesh-list
1668156|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1668157|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1668158|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1668159|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1668160|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1668161|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1668162|NCT02880020|Nivolumab|nivolumab|mesh-list
1668163|NCT02880020|Ipilimumab|ipilimumab|mesh-list
1668164|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1668165|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1668166|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1668167|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1668168|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
1668169|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1668170|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1668171|NCT02855944|Gemcitabine|gemcitabine|mesh-list
1668172|NCT02855944|Paclitaxel|paclitaxel|mesh-list
1668173|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1668174|NCT02855944|Cisplatin|cisplatin|mesh-list
1668175|NCT02855944|Carboplatin|carboplatin|mesh-list
1668176|NCT02855944|Rucaparib|rucaparib|mesh-list
1668177|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1668178|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1668179|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
1668180|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
1668181|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
1668182|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1668183|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1668184|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
1668185|NCT02855944|Antiviral Agents|antiviral agents|mesh-ancestor
1668186|NCT02855944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1668187|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1668188|NCT02855944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1668189|NCT02855944|Immunologic Factors|immunologic factors|mesh-ancestor
1668190|NCT02855944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1668191|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2472794|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2472795|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472796|NCT01071161|Azithromycin|azithromycin|mesh-list
2472797|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2472798|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472799|NCT01071174|Dapivirine|dapivirine|mesh-list
2472800|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2472801|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2472802|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
2472803|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472804|NCT01071187|Varenicline|varenicline|mesh-list
2472805|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2472806|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2472807|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
2472808|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472809|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472810|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472811|NCT01071239|Cyclophosphamide|cyclophosphamide|mesh-list
2472812|NCT01071239|Busulfan|busulfan|mesh-list
2472813|NCT01071239|Fludarabine|fludarabine|mesh-list
2472814|NCT01071239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472815|NCT01071239|Immunologic Factors|immunologic factors|mesh-ancestor
2472816|NCT01071239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472817|NCT01071239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2472818|NCT01071239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2472819|NCT01071239|Alkylating Agents|alkylating agents|mesh-ancestor
2472820|NCT01071239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472821|NCT01071239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472822|NCT01071239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2472823|NCT01071291|Niacin|niacin|mesh-list
2472824|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
2472825|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2472826|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
2472827|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472828|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2472829|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
2472830|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
2472831|NCT01071291|Vitamins|vitamins|mesh-ancestor
2472832|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
2472833|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472834|NCT01071304|Midazolam|midazolam|mesh-list
2472835|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2472836|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2472837|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2472838|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472839|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2472840|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2472841|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2472842|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2472843|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
2472844|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
2472845|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
2472846|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
2472847|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472848|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472849|NCT01071369|Betamethasone|betamethasone|mesh-list
2472850|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
2472851|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
2472852|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
2472853|NCT01071369|Lidocaine|lidocaine|mesh-list
2472854|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
2472855|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
2472856|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
2472857|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2472858|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472859|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
2472860|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472861|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2472862|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2472863|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2472864|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2472865|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472866|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2472867|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
2472868|NCT01071369|Hormones|hormones|mesh-ancestor
2472869|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2472870|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2472871|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
2472872|NCT01071499|Morphine|morphine|mesh-list
2472873|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2472874|NCT01071499|Narcotics|narcotics|mesh-ancestor
2472875|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2472876|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472877|NCT01071499|Analgesics|analgesics|mesh-ancestor
2472878|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
2472879|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472880|NCT01071525|Niacin|niacin|mesh-list
2472881|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1668304|NCT02654080|Vaccines|vaccines|mesh-list
1668305|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
1668306|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472882|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
2472883|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472884|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2472885|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
2472886|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
2472887|NCT01071525|Vitamins|vitamins|mesh-ancestor
2472888|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
1668314|NCT02639026|Durvalumab|durvalumab|mesh-list
1668315|NCT02639026|Tremelimumab|tremelimumab|mesh-list
1668316|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1668317|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472889|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472890|NCT01071564|R04929097|r04929097|mesh-list
2472891|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472892|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472893|NCT01071655|Fluorouracil|fluorouracil|mesh-list
2472894|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
2472895|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472896|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2472897|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472898|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472899|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
2472900|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472901|NCT01071681|Telmisartan|telmisartan|mesh-list
2472902|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2472903|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2472904|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2472905|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472906|NCT01071694|Interferons|interferons|mesh-list
1668354|NCT02618148|Estrogens|estrogens|mesh-list
1668355|NCT02618148|Hormones|hormones|mesh-ancestor
1668356|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1668357|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472907|NCT01071694|Interferon-beta|interferon-beta|mesh-list
2472908|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
2472909|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472910|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
2472911|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472912|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
2472913|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472914|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2472915|NCT01071772|Insulin|insulin|mesh-list
2472916|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2472917|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472918|NCT01071850|Metformin|metformin|mesh-list
2472919|NCT01071850|Ipragliflozin|ipragliflozin|mesh-list
2472920|NCT01071850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2472921|NCT01071850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472922|NCT01071850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2472923|NCT01071850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472924|NCT01071889|Flumazenil|flumazenil|mesh-list
2472925|NCT01071889|Antidotes|antidotes|mesh-ancestor
2472926|NCT01071889|Protective Agents|protective agents|mesh-ancestor
2472927|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472928|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
1668380|NCT02601014|Nivolumab|nivolumab|mesh-list
1668381|NCT02601014|Ipilimumab|ipilimumab|mesh-list
1668382|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1668383|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1668384|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1668385|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472929|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
2472930|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472931|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472932|NCT01071902|Moxifloxacin|moxifloxacin|mesh-list
2472933|NCT01071902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2472934|NCT01071902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2472935|NCT01071902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2472936|NCT01071902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2472937|NCT01071902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2472938|NCT01071902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472939|NCT01071902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472940|NCT01071902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472941|NCT01071928|Docetaxel|docetaxel|mesh-list
2472942|NCT01071928|Vadimezan|vadimezan|mesh-list
2472943|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472944|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
2472945|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
2472946|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
2472947|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472948|NCT01072045|Prednisone|prednisone|mesh-list
2472949|NCT01072045|Propranolol|propranolol|mesh-list
2472950|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2472951|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
2472952|NCT01072045|Hormones|hormones|mesh-ancestor
2472953|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2472954|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472955|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2472956|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472957|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2472958|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2472959|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
2472960|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2472961|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472962|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2472963|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2472964|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
2472965|NCT01072058|Adalimumab|adalimumab|mesh-list
2472966|NCT01072058|Etanercept|etanercept|mesh-list
2472967|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
2472968|NCT01072058|Infliximab|infliximab|mesh-list
2472969|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2472970|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1668428|NCT02553447|Vitamin D|vitamin d|mesh-list
1668429|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
1668430|NCT02553447|Vitamins|vitamins|mesh-ancestor
1668431|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
1668432|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1668433|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1668434|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2472971|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2472972|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2472973|NCT01072058|Analgesics|analgesics|mesh-ancestor
2472974|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
2472975|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2472976|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472977|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2472978|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2472979|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
2472980|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
2472981|NCT01072071|Furosemide|furosemide|mesh-list
2472982|NCT01072071|Diuretics|diuretics|mesh-ancestor
2472983|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
2472984|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2472985|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2472986|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2472987|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1668464|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
1668465|NCT02499003|Pixantrone|pixantrone|mesh-list
1668466|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1668467|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1668468|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1668469|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1668470|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1668471|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1668472|NCT02486666|Enoxaparin|enoxaparin|mesh-list
1668473|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
1668474|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
1668475|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1668476|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1668477|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472988|NCT01072097|Atorvastatin|atorvastatin|mesh-list
2472989|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2472990|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2472991|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
2472992|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2472993|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2472994|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2472995|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2472996|NCT01072175|Trametinib|trametinib|mesh-list
2472997|NCT01072175|Dabrafenib|dabrafenib|mesh-list
2472998|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2472999|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2473000|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473001|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473002|NCT01072240|Rituximab|rituximab|mesh-list
2473003|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2473004|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473005|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
2473006|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473007|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2473008|NCT01072318|Letrozole|letrozole|mesh-list
2473009|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473010|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2473011|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2473012|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473013|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473014|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2473015|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
2473016|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2473017|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473018|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
2473019|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2473020|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1668517|NCT02431767|Interleukin-12|interleukin-12|mesh-list
1668518|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1668519|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
1668520|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1668521|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1668522|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1668523|NCT02431767|Growth Substances|growth substances|mesh-ancestor
1668524|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
1668525|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1668526|NCT02390284|Timolol|timolol|mesh-list
1668527|NCT02390284|Bimatoprost|bimatoprost|mesh-list
1668528|NCT02390284|Travoprost|travoprost|mesh-list
1668529|NCT02390284|Dorzolamide|dorzolamide|mesh-list
1668530|NCT02390284|Acetazolamide|acetazolamide|mesh-list
1668531|NCT02390284|Methazolamide|methazolamide|mesh-list
1668532|NCT02390284|Latanoprost|latanoprost|mesh-list
1668533|NCT02390284|Brinzolamide|brinzolamide|mesh-list
1668534|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1668535|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1668536|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
1668537|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1668538|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1668539|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1668540|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1668541|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1668542|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1668543|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1668544|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
1668545|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1668546|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1668547|NCT02390284|Diuretics|diuretics|mesh-ancestor
1668548|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
1668549|NCT02389517|Dexamethasone|dexamethasone|mesh-list
1668550|NCT02389517|Lenalidomide|lenalidomide|mesh-list
1668551|NCT02389517|Ixazomib|ixazomib|mesh-list
1668552|NCT02389517|Glycine|glycine|mesh-list
1668553|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
1668554|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1668555|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
1668556|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
1668557|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1668558|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1668559|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1668560|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
1668561|NCT02389517|Hormones|hormones|mesh-ancestor
1668562|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1668563|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1668564|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1668565|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
1668566|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1668567|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1668568|NCT02389517|Growth Substances|growth substances|mesh-ancestor
1668569|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
1668570|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1668571|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
1668572|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1668573|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
1668574|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473021|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2473022|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473023|NCT01072604|Aspirin|aspirin|mesh-list
2473024|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2473025|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2473026|NCT01072604|Analgesics|analgesics|mesh-ancestor
2473027|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
2473028|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473029|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473030|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2473031|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2473032|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2473033|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2473034|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473035|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2473036|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2473037|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473038|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
2473039|NCT01072695|Ribavirin|ribavirin|mesh-list
2473040|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2473041|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
2473042|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473043|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
2473044|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473045|NCT01072734|Vaccines|vaccines|mesh-list
2473046|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
2473047|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473048|NCT01072747|Heparin|heparin|mesh-list
2473049|NCT01072747|Calcium heparin|calcium heparin|mesh-list
2473050|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
2473051|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2473052|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2473053|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473054|NCT01072786|Vaccines|vaccines|mesh-list
2473055|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
2473056|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473057|NCT01072812|Phenserine|phenserine|mesh-list
2473058|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2473059|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473060|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473061|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
2473062|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473063|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473064|NCT01072890|Sirolimus|sirolimus|mesh-list
2473065|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2473066|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473067|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2473068|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473069|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
2473070|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2473071|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
2473072|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473073|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
2473074|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2473075|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473076|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2473077|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2473078|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473079|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473080|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473081|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2473082|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2473083|NCT01072955|Heparin|heparin|mesh-list
2473084|NCT01072955|Calcium heparin|calcium heparin|mesh-list
2473085|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
2473086|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2473087|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2473088|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473089|NCT01072981|Gemcitabine|gemcitabine|mesh-list
2473090|NCT01072981|Fluorouracil|fluorouracil|mesh-list
2473091|NCT01072981|Pancrelipase|pancrelipase|mesh-list
2473092|NCT01072981|Immunologic Factors|immunologic factors|mesh-list
2473093|NCT01072981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2473094|NCT01072981|Antimetabolites|antimetabolites|mesh-ancestor
2473095|NCT01072981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473096|NCT01072981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473097|NCT01072981|Antiviral Agents|antiviral agents|mesh-ancestor
2473098|NCT01072981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473099|NCT01072981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473100|NCT01072981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2473101|NCT01072981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473102|NCT01072981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2473103|NCT01073007|Simvastatin|simvastatin|mesh-list
2473104|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2473105|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2473106|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
2473107|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473108|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2473109|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2473110|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473111|NCT01073059|Ertapenem|ertapenem|mesh-list
2473112|NCT01073059|Valproic Acid|valproic acid|mesh-list
2473113|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
2473114|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473115|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473116|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
2473117|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473118|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473119|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
2473120|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2473121|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2473122|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2473123|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2473124|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473125|NCT01073111|Sirolimus|sirolimus|mesh-list
2473126|NCT01073111|Everolimus|everolimus|mesh-list
2473127|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473128|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2473129|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
2473130|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473131|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2473132|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473133|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2473134|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
2473135|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
2473136|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2473137|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473138|NCT01073189|Fenoldopam|fenoldopam|mesh-list
2473139|NCT01073189|Furosemide|furosemide|mesh-list
2473140|NCT01073189|Diuretics|diuretics|mesh-ancestor
2473141|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
2473142|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473143|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2473144|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2473145|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473146|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2473147|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
2473148|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
2473149|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
2473150|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473151|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
2473152|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
2473153|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2473154|NCT01073319|Rivastigmine|rivastigmine|mesh-list
2473155|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
2473156|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473157|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473158|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
2473159|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473160|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473161|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2473162|NCT01073319|Protective Agents|protective agents|mesh-ancestor
2473163|NCT01073332|Antioxidants|antioxidants|mesh-list
2473164|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473165|NCT01073332|Protective Agents|protective agents|mesh-ancestor
2473166|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473167|NCT01073371|Prilocaine|prilocaine|mesh-list
2473168|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
2473169|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
2473170|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2473171|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473172|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
2473173|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473174|NCT01073384|Beclomethasone|beclomethasone|mesh-list
2473175|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2473176|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
2473177|NCT01073384|Hormones|hormones|mesh-ancestor
2473178|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2473179|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473180|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2473181|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
2473182|NCT01073501|Pregabalin|pregabalin|mesh-list
2473183|NCT01073501|Analgesics|analgesics|mesh-ancestor
2473184|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
2473185|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473186|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473187|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
2473188|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2473189|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2473190|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473191|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2473192|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2473193|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2473194|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2473195|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2473196|NCT01073527|Adenosine|adenosine|mesh-list
2473197|NCT01073527|Albuterol|albuterol|mesh-list
2473198|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2473199|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
2473200|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473201|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473202|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2473203|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
2473204|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
2473205|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2473206|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2473207|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2473208|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2473209|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
2473210|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473211|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473212|NCT01073527|Analgesics|analgesics|mesh-ancestor
2473213|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
2473214|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2473215|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
2473216|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
2473217|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
2473218|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
2473219|NCT01073540|Cephalexin|cephalexin|mesh-list
2473220|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2473221|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473222|NCT01073553|Cephalexin|cephalexin|mesh-list
2473223|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2473224|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473225|NCT01073579|Vigabatrin|vigabatrin|mesh-list
2473226|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
2473227|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473228|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473229|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
2473230|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473231|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473232|NCT01073644|Sunitinib|sunitinib|mesh-list
2473233|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473234|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2473235|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2473236|NCT01073644|Growth Substances|growth substances|mesh-ancestor
2473237|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473238|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
2473239|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2473240|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473241|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473242|NCT01073670|Acetaminophen|acetaminophen|mesh-list
2473243|NCT01073670|Indomethacin|indomethacin|mesh-list
2473244|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2473245|NCT01073670|Analgesics|analgesics|mesh-ancestor
2473246|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
2473247|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473248|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473249|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
2473250|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2473251|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2473252|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2473253|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
2473254|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
2473255|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2473256|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2473257|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473258|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473259|NCT01073683|Docetaxel|docetaxel|mesh-list
2473260|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473261|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
2473262|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
2473263|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
2473264|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473265|NCT01073696|Granisetron|granisetron|mesh-list
2473266|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
2473267|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
2473268|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473269|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473270|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2473271|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2473272|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
2473273|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473274|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473275|NCT01073709|Acetaminophen|acetaminophen|mesh-list
2473276|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2473277|NCT01073709|Analgesics|analgesics|mesh-ancestor
2473278|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
2473279|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473280|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473281|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
2473282|NCT01073748|Acetaminophen|acetaminophen|mesh-list
2473283|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2473284|NCT01073748|Analgesics|analgesics|mesh-ancestor
2473285|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
2473286|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473287|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473288|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
2473289|NCT01073761|Ritonavir|ritonavir|mesh-list
2473290|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
2473291|NCT01073761|Darunavir|darunavir|mesh-list
2473292|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2473293|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2473294|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
2473295|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473296|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473297|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2473298|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2473299|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
2473300|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473301|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2473302|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2473303|NCT01073800|Atorvastatin|atorvastatin|mesh-list
2473304|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2473305|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2473306|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
2473307|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473308|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2473309|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2473310|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473311|NCT01073813|Minocycline|minocycline|mesh-list
2473312|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2473313|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473314|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
2473315|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2473316|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473317|NCT01073826|Incretins|incretins|mesh-ancestor
2473318|NCT01073826|Hormones|hormones|mesh-ancestor
2473319|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2473320|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2473321|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
2473322|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473323|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473324|NCT01073839|Gemcitabine|gemcitabine|mesh-list
2473325|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473326|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2473327|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
2473328|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473329|NCT01073839|Antiviral Agents|antiviral agents|mesh-ancestor
2473330|NCT01073839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473331|NCT01073839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473332|NCT01073839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2473333|NCT01073839|Immunologic Factors|immunologic factors|mesh-ancestor
2473334|NCT01073839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473335|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
2473336|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
2473337|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2473338|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2473339|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473340|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473341|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473342|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2473343|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
2473344|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
2473345|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2473346|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473347|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2473348|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2473349|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473350|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473351|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473352|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2473353|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
2473354|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2473355|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473356|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2473357|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2473358|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2473359|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
2473360|NCT01073904|Norgestrel|norgestrel|mesh-list
2473361|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2473362|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
2473363|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2473364|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738706|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
2738707|NCT04421196|Analgesics|analgesics|mesh-list
2738708|NCT04421196|Narcotics|narcotics|mesh-ancestor
2738709|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2738710|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738711|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
2738712|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2738717|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
2738718|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
2738719|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2738720|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738721|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
2738722|NCT04410042|Coagulants|coagulants|mesh-ancestor
2473365|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2473366|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2473367|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2473368|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2473369|NCT01073995|Triamcinolone|triamcinolone|mesh-list
2473370|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2473371|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2473372|NCT01073995|Bupivacaine|bupivacaine|mesh-list
2473373|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2473374|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
2473375|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
2473376|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2473377|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473378|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
2473379|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473380|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2473381|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
2473382|NCT01073995|Hormones|hormones|mesh-ancestor
2473383|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2473384|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2473385|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
2473386|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473387|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473388|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
2473389|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2473390|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473391|NCT01074060|Plerixafor|plerixafor|mesh-list
2473392|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
2473393|NCT01074060|Lenograstim|lenograstim|mesh-list
2473394|NCT01074060|Sargramostim|sargramostim|mesh-list
2473395|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2473396|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
2473397|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473398|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2473399|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2473400|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
2473401|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473402|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473403|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2473404|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2473405|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2473406|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2473407|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
2473408|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473409|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2473410|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2473411|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2473412|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2473413|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738744|NCT04393311|Urinastatin|urinastatin|mesh-list
2738745|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2473414|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2473415|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2473416|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2473417|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2473418|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
2473419|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473420|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473421|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2473422|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2473423|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
2473424|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2738746|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2738747|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
2738748|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473425|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2473426|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
2473427|NCT01074086|Everolimus|everolimus|mesh-list
2473428|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473429|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2473430|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
2473431|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473432|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
2473433|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473434|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473435|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2738749|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738750|NCT04393298|Leucovorin|leucovorin|mesh-list
2738751|NCT04393298|Trifluridine|trifluridine|mesh-list
2738752|NCT04393298|Fluorouracil|fluorouracil|mesh-list
2738753|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738754|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
2738755|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738756|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2738757|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2738758|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2738759|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
2473436|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2473437|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2473438|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2473439|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473440|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2738760|NCT04393298|Antidotes|antidotes|mesh-ancestor
2738761|NCT04393298|Protective Agents|protective agents|mesh-ancestor
2738762|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
2738763|NCT04393298|Vitamins|vitamins|mesh-ancestor
2738764|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
2738765|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
2738766|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473441|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473442|NCT01074151|Analgesics|analgesics|mesh-ancestor
2473443|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
2473444|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473445|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
2473446|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2473447|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
2473448|NCT01074190|Fentanyl|fentanyl|mesh-list
2473449|NCT01074190|Bupivacaine|bupivacaine|mesh-list
2473450|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
2473451|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
2473452|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2473453|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473454|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
2473455|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473456|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2473457|NCT01074190|Narcotics|narcotics|mesh-ancestor
2473458|NCT01074190|Analgesics|analgesics|mesh-ancestor
2473459|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2473460|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2473461|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
2473462|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
2473463|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2473464|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473465|NCT01074281|Enalapril|enalapril|mesh-list
2473466|NCT01074281|Enalaprilat|enalaprilat|mesh-list
2473467|NCT01074281|Nitrendipine|nitrendipine|mesh-list
2473468|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473469|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473470|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2473471|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
2473472|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2473473|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2473474|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2473475|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2473476|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473477|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
2473478|NCT01074294|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
2473479|NCT01074294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473480|NCT01074333|Cetuximab|cetuximab|mesh-list
2473481|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2473482|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473483|NCT01074346|Interferons|interferons|mesh-list
2473484|NCT01074346|Interferon-beta|interferon-beta|mesh-list
2473485|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
2473486|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473487|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
2473488|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473489|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
2473490|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473491|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2473492|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
2473493|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
2473494|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2473495|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
2473496|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473497|NCT01074359|Protective Agents|protective agents|mesh-ancestor
2473498|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473499|NCT01074411|Carboplatin|carboplatin|mesh-list
2473500|NCT01074411|Bortezomib|bortezomib|mesh-list
2473501|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473502|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
2473503|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
2473504|NCT01074567|Protective Agents|protective agents|mesh-ancestor
2473505|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473506|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2473507|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
2473508|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473509|NCT01074593|Interferons|interferons|mesh-list
2473510|NCT01074593|Interferon-beta|interferon-beta|mesh-list
2473511|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
2473512|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473513|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
2473514|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473515|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
2473516|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473517|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2473518|NCT01074619|Memantine|memantine|mesh-list
2473519|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1669278|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
1669279|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1669280|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1669281|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669282|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
1669283|NCT05082142|Coagulants|coagulants|mesh-ancestor
1669284|NCT05082025|Fulvestrant|fulvestrant|mesh-list
1669285|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1669286|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473520|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1669287|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1669288|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1669289|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
1669290|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1669291|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669292|NCT05081986|Cycloserine|cycloserine|mesh-list
1669293|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1669294|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1669295|NCT05081986|Renal Agents|renal agents|mesh-ancestor
1669296|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1669297|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
1669298|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1669299|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
1669300|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669301|NCT05081765|Olaparib|olaparib|mesh-list
1669302|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1669303|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1669304|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669305|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473521|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
2473522|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473523|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669309|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
1669310|NCT05081687|Irinotecan|irinotecan|mesh-list
1669311|NCT05081687|Folfirinox|folfirinox|mesh-list
1669312|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1669313|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1669314|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1669315|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1669316|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669317|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
1669318|NCT05081674|Nivolumab|nivolumab|mesh-list
1669319|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1669320|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1669321|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1669322|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1669323|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669324|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1669325|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473524|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473525|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2473526|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2473527|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2473528|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2473529|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2473530|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2473531|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473532|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2473533|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2473534|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2473535|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2473536|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
2473537|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473538|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473539|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2473540|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2473541|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
2473542|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2473543|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2473544|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
2473545|NCT01074645|Tenofovir|tenofovir|mesh-list
2473546|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
2473547|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473548|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2473549|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2473550|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1669360|NCT05081466|Vitamin D|vitamin d|mesh-list
1669361|NCT05081466|Calcium|calcium|mesh-list
1669362|NCT05081466|Vitamins|vitamins|mesh-ancestor
1669363|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
1669364|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669365|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1669366|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1669367|NCT05081375|Enoxaparin|enoxaparin|mesh-list
1669368|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
1669369|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1669370|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1669371|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473551|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473552|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2473553|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2473554|NCT01074697|Dexamethasone|dexamethasone|mesh-list
2473555|NCT01074697|Palonosetron|palonosetron|mesh-list
2473556|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
2473557|NCT01074697|Aprepitant|aprepitant|mesh-list
2473558|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2473559|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
2473560|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
2473561|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473562|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473563|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2473564|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
2473565|NCT01074697|Hormones|hormones|mesh-ancestor
2473566|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2473567|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2473568|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473569|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473570|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
2473571|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2473572|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
2473573|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473574|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
2473575|NCT01074723|Carotenoids|carotenoids|mesh-list
2473576|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
1669417|NCT05081102|Ibuprofen|ibuprofen|mesh-list
1669418|NCT05081102|Oxycodone|oxycodone|mesh-list
1669419|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1669420|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1669421|NCT05081102|Analgesics|analgesics|mesh-ancestor
1669422|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
1669423|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1669424|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669425|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1669426|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1669427|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1669428|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1669429|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669430|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1669431|NCT05081102|Narcotics|narcotics|mesh-ancestor
1669432|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2473577|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473578|NCT01074723|Protective Agents|protective agents|mesh-ancestor
2473579|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473580|NCT01074801|Insulin|insulin|mesh-list
2473581|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2473582|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2473583|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473584|NCT01074853|Propranolol|propranolol|mesh-list
2473585|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2473586|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2473587|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
2473588|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473589|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473590|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473591|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2473592|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2473593|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
2473594|NCT01074879|Caseins|caseins|mesh-list
1669451|NCT05080985|Bupivacaine|bupivacaine|mesh-list
1669452|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
1669453|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
1669454|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1669455|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669456|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
1669457|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473595|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
2473596|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
2473597|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473598|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
2473599|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
2473600|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
2473601|NCT01074892|Progestins|progestins|mesh-list
2473602|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2473603|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
2473604|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2473605|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473606|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2473607|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2473608|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2473609|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2473610|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1669481|NCT05080803|Bevacizumab|bevacizumab|mesh-list
1669482|NCT05080803|Ranibizumab|ranibizumab|mesh-list
1669483|NCT05080803|Aflibercept|aflibercept|mesh-list
1669484|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1669485|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1669486|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1669487|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1669488|NCT05080803|Growth Substances|growth substances|mesh-ancestor
1669489|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669490|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
2473611|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2473612|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473613|NCT01074892|Hormones|hormones|mesh-ancestor
2473614|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2473615|NCT01074905|Artesunate|artesunate|mesh-list
2473616|NCT01074905|Chloroquine|chloroquine|mesh-list
2473617|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2473618|NCT01074905|Primaquine|primaquine|mesh-list
2473619|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
2473620|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2473621|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2473622|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473623|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473624|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
2473625|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
1669519|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
1669520|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1669521|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473626|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2473627|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
2473628|NCT01074905|Amebicides|amebicides|mesh-ancestor
2473629|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2473630|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2473631|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2473632|NCT01074905|Analgesics|analgesics|mesh-ancestor
2473633|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
2473634|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473635|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473636|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2473637|NCT01074905|Filaricides|filaricides|mesh-ancestor
2473638|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
2473639|NCT01074970|Cisplatin|cisplatin|mesh-list
2473640|NCT01074970|Rucaparib|rucaparib|mesh-list
2473641|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473642|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2473643|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473644|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473645|NCT01074996|Leucovorin|leucovorin|mesh-list
2473646|NCT01074996|Antidotes|antidotes|mesh-ancestor
2473647|NCT01074996|Protective Agents|protective agents|mesh-ancestor
2473648|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473649|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
2473650|NCT01074996|Vitamins|vitamins|mesh-ancestor
2473651|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
2473652|NCT01075022|Vitamin D|vitamin d|mesh-list
2473653|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
2473654|NCT01075022|Vitamins|vitamins|mesh-ancestor
2473655|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
2473656|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473657|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2473658|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2473659|NCT01075113|Sorafenib|sorafenib|mesh-list
2473660|NCT01075113|Vorinostat|vorinostat|mesh-list
2473661|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473662|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2473663|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473664|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669561|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
1669562|NCT05062278|Vinblastine|vinblastine|mesh-list
1669563|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1669564|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
1669565|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1669566|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669567|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1669568|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1669569|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
1669570|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
1669571|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
1669572|NCT05059873|Prednisone|prednisone|mesh-list
1669573|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1669574|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
1669575|NCT05059873|Hormones|hormones|mesh-ancestor
1669576|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1669577|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669578|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1669579|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1669580|NCT05055830|Acetaminophen|acetaminophen|mesh-list
1669581|NCT05055830|Methadone|methadone|mesh-list
1669582|NCT05055830|Caffeine|caffeine|mesh-list
1669583|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1669584|NCT05055830|Analgesics|analgesics|mesh-ancestor
1669585|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
1669586|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1669587|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669588|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
1669589|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2473665|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2473666|NCT01075126|Valproic Acid|valproic acid|mesh-list
1669590|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1669591|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1669592|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669593|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1669594|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1669595|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
1669596|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1669597|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1669598|NCT05055830|Narcotics|narcotics|mesh-ancestor
1669599|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1669600|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
1669601|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
2473667|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2473668|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473669|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473670|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
2473671|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1669607|NCT05048212|Nivolumab|nivolumab|mesh-list
1669608|NCT05048212|Ipilimumab|ipilimumab|mesh-list
1669609|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1669610|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1669611|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1669612|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473672|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2473673|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473674|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
2473675|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
2473676|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473677|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
2473678|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473679|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473680|NCT01075425|Bortezomib|bortezomib|mesh-list
2473681|NCT01075425|Belinostat|belinostat|mesh-list
2473682|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473683|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2473684|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473685|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473686|NCT01075438|Vaccines|vaccines|mesh-list
2473687|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2473688|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
2473689|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473690|NCT01075464|Paclitaxel|paclitaxel|mesh-list
2473691|NCT01075464|Bevacizumab|bevacizumab|mesh-list
2473692|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2473693|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473694|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
2473695|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
2473696|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
2473697|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473698|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2473699|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2473700|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2473701|NCT01075464|Growth Substances|growth substances|mesh-ancestor
2473702|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473703|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
2473704|NCT01075477|Rituximab|rituximab|mesh-list
2473705|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2473706|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473707|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
2473708|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473709|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2473710|NCT01075490|Clonidine|clonidine|mesh-list
2473711|NCT01075490|Analgesics|analgesics|mesh-ancestor
2473712|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
2473713|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473714|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473715|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2473716|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
2473717|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
2473718|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2473719|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2473720|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2473721|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
2473722|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473723|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473724|NCT01075503|Ropivacaine|ropivacaine|mesh-list
2473725|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
2473726|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
2473727|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2473728|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473729|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
2473730|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473731|NCT01075529|Fluoxetine|fluoxetine|mesh-list
2473732|NCT01075529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2473733|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2473734|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2473735|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473736|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473737|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
2473738|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473739|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2473740|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
2473741|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2473742|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
2473743|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2473744|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473745|NCT01075555|Sorafenib|sorafenib|mesh-list
2473746|NCT01075555|Pravastatin|pravastatin|mesh-list
2473747|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473748|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2473749|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473750|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473751|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2473752|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2473753|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
2473754|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1669707|NCT05010629|Carboplatin|carboplatin|mesh-list
1669708|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473755|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2473756|NCT01075581|Epinephrine|epinephrine|mesh-list
2473757|NCT01075581|Racepinephrine|racepinephrine|mesh-list
2473758|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
2473759|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2473760|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2473761|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
2473762|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473763|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473764|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473765|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2473766|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2473767|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
2473768|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1669723|NCT04997239|Vaccines|vaccines|mesh-list
1669724|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
1669725|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669726|NCT04997174|Celecoxib|celecoxib|mesh-list
1669727|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1669728|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1669729|NCT04997174|Analgesics|analgesics|mesh-ancestor
1669730|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
1669731|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1669732|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669733|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1669734|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1669735|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1669736|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1669737|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1669738|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473769|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2473770|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
2473771|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
2473772|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
2473773|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2473774|NCT01075659|Nicotine|nicotine|mesh-list
2473775|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2473776|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
2473777|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473778|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473779|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2473780|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2473781|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
2473782|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473783|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473784|NCT01075698|Telmisartan|telmisartan|mesh-list
2473785|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2473786|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2473787|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2473788|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473789|NCT01075711|Prednisone|prednisone|mesh-list
2473790|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2473791|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
2473792|NCT01075711|Hormones|hormones|mesh-ancestor
2473793|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2473794|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473795|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1669768|NCT04981509|Bevacizumab|bevacizumab|mesh-list
1669769|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1669770|NCT04981509|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1669771|NCT04981509|Atezolizumab|atezolizumab|mesh-list
1669772|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
1669773|NCT04981509|Antibodies|antibodies|mesh-list
1669774|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
1669775|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1669776|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
1669777|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1669778|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1669779|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1669780|NCT04981509|Growth Substances|growth substances|mesh-ancestor
1669781|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669782|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
1669783|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
1669784|NCT04981509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1669785|NCT04981509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1669786|NCT04981509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669787|NCT04976387|Acetaminophen|acetaminophen|mesh-list
1669788|NCT04976387|Ibuprofen|ibuprofen|mesh-list
1669789|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
1669790|NCT04976387|Hydrocodone|hydrocodone|mesh-list
1669791|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1669792|NCT04976387|Analgesics|analgesics|mesh-ancestor
1669793|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
1669794|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1669795|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669796|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
1669797|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1669798|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1669799|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1669800|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1669801|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1669802|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669803|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1669804|NCT04976387|Narcotics|narcotics|mesh-ancestor
1669805|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1669806|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
1669807|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
2473796|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473797|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
2473798|NCT01075776|Acetylcholine|acetylcholine|mesh-list
2473799|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
2473800|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2473801|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
2473802|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473803|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473804|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473805|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
2473806|NCT01075789|Lidocaine|lidocaine|mesh-list
2473807|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
2473808|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
2473809|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2473810|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473811|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
2473812|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473813|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2473814|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1669856|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
1669857|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1669858|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
1669859|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1669860|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669861|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1669862|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1669863|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1669864|NCT04964050|Diuretics|diuretics|mesh-ancestor
1669865|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
1669866|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669867|NCT04949633|Oxytocin|oxytocin|mesh-list
1669868|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
1669869|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1669870|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473815|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2473816|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2473817|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473818|NCT01075802|Tamoxifen|tamoxifen|mesh-list
2473819|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2473820|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
2473821|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2473822|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473823|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2473824|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473825|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
2473826|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2473827|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2473828|NCT01075828|Cetuximab|cetuximab|mesh-list
2473829|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2473830|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473831|NCT01075841|Cetuximab|cetuximab|mesh-list
2473832|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2473833|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473834|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2473835|NCT01075854|Hormones|hormones|mesh-ancestor
2473836|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2473837|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473838|NCT01075880|Interferons|interferons|mesh-list
2473839|NCT01075880|Interferon-beta|interferon-beta|mesh-list
2473840|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
2473841|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473842|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
2473843|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473844|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
2473845|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473846|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2473847|NCT01075906|Colchicine|colchicine|mesh-list
2473848|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
2473849|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2473850|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
2473851|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
2473852|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
2473853|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473854|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473855|NCT01075945|Lumefantrine|lumefantrine|mesh-list
2473856|NCT01075945|Artemether|artemether|mesh-list
2473857|NCT01075945|Piperaquine|piperaquine|mesh-list
2473858|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2473859|NCT01075945|Artenimol|artenimol|mesh-list
2473860|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
2473861|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2473862|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2473863|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473864|NCT01076062|Misoprostol|misoprostol|mesh-list
2473865|NCT01076062|Oxytocin|oxytocin|mesh-list
2473866|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
2473867|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2473868|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473869|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2473870|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
2473871|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2473872|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2473873|NCT01076140|Lisinopril|lisinopril|mesh-list
2473874|NCT01076140|Nebivolol|nebivolol|mesh-list
2473875|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
2473876|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
2473877|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473878|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473879|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2473880|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2473881|NCT01076140|Protective Agents|protective agents|mesh-ancestor
2473882|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473883|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
2473884|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2473885|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2473886|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2473887|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
2473888|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473889|NCT01076322|Albuterol|albuterol|mesh-list
2473890|NCT01076322|Procaterol|procaterol|mesh-list
2473891|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2473892|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
1669952|NCT04912505|Aspirin|aspirin|mesh-list
1669953|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1669954|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1669955|NCT04912505|Analgesics|analgesics|mesh-ancestor
1669956|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
1669957|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1669958|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669959|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1669960|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1669961|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1669962|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1669963|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1669964|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1669965|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1669966|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473893|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473894|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1669967|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
1669968|NCT04908956|Osimertinib|osimertinib|mesh-list
1669969|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1669970|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1669971|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1669972|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473895|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2473896|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
2473897|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
2473898|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2473899|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2473900|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2473901|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2473902|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
2473903|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473904|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473905|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
2473906|NCT01076439|Fluticasone|fluticasone|mesh-list
2473907|NCT01076439|Xhance|xhance|mesh-list
2473908|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
2473909|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2473910|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2473911|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
2473912|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473913|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473914|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2473915|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
2473916|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
2473917|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2473918|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1669997|NCT04895488|Vortioxetine|vortioxetine|mesh-list
1669998|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
1669999|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
1670000|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1670001|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1670002|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1670003|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1670004|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670005|NCT04895488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1670006|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1670007|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1670008|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670009|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1670010|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
1670011|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1670012|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1670013|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1670014|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2473919|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2473920|NCT01076439|Analgesics|analgesics|mesh-ancestor
2473921|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
2473922|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2473923|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2473924|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2473925|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
2473926|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
2473927|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2473928|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473929|NCT01076478|Cilostazol|cilostazol|mesh-list
2473930|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2473931|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
2473932|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2473933|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473934|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2473935|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
2473936|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2473937|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2473938|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473939|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2473940|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
2473941|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2473942|NCT01076478|Protective Agents|protective agents|mesh-ancestor
2473943|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
2473944|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2473945|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473946|NCT01076491|Mannitol|mannitol|mesh-list
2473947|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2473948|NCT01076491|Diuretics|diuretics|mesh-ancestor
2473949|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
2473950|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473951|NCT01076530|Temozolomide|temozolomide|mesh-list
2473952|NCT01076530|Vorinostat|vorinostat|mesh-list
2473953|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2473954|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
2473955|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473956|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473957|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2473958|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473959|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
2473960|NCT01076556|Rituximab|rituximab|mesh-list
2473961|NCT01076556|Alvocidib|alvocidib|mesh-list
2473962|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2473963|NCT01076556|Antibodies|antibodies|mesh-list
2473964|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
2473965|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2473966|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2473967|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
2473968|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473969|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2473970|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2473971|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
2473972|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2473973|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473974|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2473975|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
2473976|NCT01076556|Growth Substances|growth substances|mesh-ancestor
2473977|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2473978|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2473979|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
2473980|NCT01076582|Desogestrel|desogestrel|mesh-list
2473981|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2473982|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2473983|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2473984|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
2473985|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2473986|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2473987|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2473988|NCT01076582|Estrogens|estrogens|mesh-ancestor
2473989|NCT01076582|Hormones|hormones|mesh-ancestor
2473990|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2473991|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2473992|NCT01076582|Progestins|progestins|mesh-ancestor
2473993|NCT01076595|Interferons|interferons|mesh-list
2473994|NCT01076595|Interferon-beta|interferon-beta|mesh-list
2473995|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
2473996|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2473997|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
2473998|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2473999|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
2474000|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474001|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2474002|NCT01076621|Norethindrone|norethindrone|mesh-list
2474003|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
2474004|NCT01076621|Estradiol|estradiol|mesh-list
2474005|NCT01076621|Estrogens|estrogens|mesh-ancestor
2474006|NCT01076621|Hormones|hormones|mesh-ancestor
2474007|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2474008|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474009|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2474010|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
2474011|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2474012|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2474013|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2474014|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2474015|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1670125|NCT04830735|Dasatinib|dasatinib|mesh-list
1670126|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1670127|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1670128|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1670129|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474016|NCT01076634|Insulin|insulin|mesh-list
2474017|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2474018|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
2474019|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2474020|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474021|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
2474022|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2474023|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
2474024|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474025|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
2474026|NCT01076673|Protective Agents|protective agents|mesh-ancestor
2474027|NCT01076764|Heparin|heparin|mesh-list
2474028|NCT01076764|Calcium heparin|calcium heparin|mesh-list
2474029|NCT01076764|Otamixaban|otamixaban|mesh-list
2474030|NCT01076764|Eptifibatide|eptifibatide|mesh-list
2474031|NCT01076764|Anticoagulants|anticoagulants|mesh-ancestor
2474032|NCT01076764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2474033|NCT01076764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2474034|NCT01076764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474035|NCT01076764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2474036|NCT01076764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2474037|NCT01076764|Antithrombins|antithrombins|mesh-ancestor
2474038|NCT01076764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2474039|NCT01076764|Protease Inhibitors|protease inhibitors|mesh-ancestor
2474040|NCT01076764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474041|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
2474042|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2474043|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474044|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474045|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2474046|NCT01076790|Analgesics|analgesics|mesh-ancestor
2474047|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
2474048|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474049|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1670164|NCT04800692|Verapamil|verapamil|mesh-list
1670165|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1670166|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1670167|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1670168|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670169|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1670170|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670171|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
2474050|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2474051|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2474052|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
2474053|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1670176|NCT04745026|Cannabidiol|cannabidiol|mesh-list
1670177|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
2474054|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474055|NCT01076803|Lanreotide|lanreotide|mesh-list
2474056|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474057|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
2474058|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2474059|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1670205|NCT04704661|Trastuzumab|trastuzumab|mesh-list
1670206|NCT04704661|Camptothecin|camptothecin|mesh-list
1670207|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
1670208|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1670209|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1670210|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1670211|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1670212|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1670213|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1670214|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670215|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
1670216|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670217|NCT04700527|Butyric Acid|butyric acid|mesh-list
1670218|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
1670219|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
1670220|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1670221|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670222|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474060|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474061|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2474062|NCT01076816|Analgesics|analgesics|mesh-ancestor
2474063|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
2474064|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474065|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2474066|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1670230|NCT04665739|Everolimus|everolimus|mesh-list
1670231|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
1670232|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1670233|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1670234|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
1670235|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670236|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670237|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2474067|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2474068|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
2474069|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2474070|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474071|NCT01076842|Insulin|insulin|mesh-list
2474072|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2474073|NCT01076842|Exenatide|exenatide|mesh-list
2474074|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
2474075|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2474076|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474077|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
2474078|NCT01076842|Incretins|incretins|mesh-ancestor
2474079|NCT01076842|Hormones|hormones|mesh-ancestor
2474080|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2474081|NCT01076868|Primaquine|primaquine|mesh-list
2474082|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
2474083|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2474084|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2474085|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474086|NCT01076894|Anesthetics|anesthetics|mesh-list
2474087|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474088|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474089|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2474090|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
2474091|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2474092|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2474093|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
2474094|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2474095|NCT01077206|Simvastatin|simvastatin|mesh-list
2474096|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2474097|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2474098|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
2474099|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474100|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2474101|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2474102|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474103|NCT01077297|Tezosentan|tezosentan|mesh-list
2474104|NCT01077297|Vasodilator Agents|vasodilator agents|mesh-ancestor
2474105|NCT01077427|Gemcitabine|gemcitabine|mesh-list
2474106|NCT01077427|Capecitabine|capecitabine|mesh-list
2474107|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474108|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2474109|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
2474110|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474111|NCT01077427|Antiviral Agents|antiviral agents|mesh-ancestor
2474112|NCT01077427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474113|NCT01077427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474114|NCT01077427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474115|NCT01077427|Immunologic Factors|immunologic factors|mesh-ancestor
2474116|NCT01077427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474117|NCT01077453|Letrozole|letrozole|mesh-list
1670322|NCT04585724|Palbociclib|palbociclib|mesh-list
1670323|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1670324|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1670325|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1670326|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474118|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474119|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2474120|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2474121|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474122|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474123|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2474124|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
2474125|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2474126|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670337|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
1670338|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1670339|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1670340|NCT04571697|Methotrexate|methotrexate|mesh-list
1670341|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1670342|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
1670343|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1670344|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670345|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1670346|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
1670347|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670348|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1670349|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
1670350|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1670351|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1670352|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1670353|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
1670354|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1670355|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2474127|NCT01077466|Natalizumab|natalizumab|mesh-list
2474128|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
2474129|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474130|NCT01077479|Metformin|metformin|mesh-list
2474131|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2474132|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474133|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
2474134|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
2474135|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
2474136|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
2474137|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2474138|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474139|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2474140|NCT01077505|Incretins|incretins|mesh-ancestor
2474141|NCT01077505|Hormones|hormones|mesh-ancestor
2474142|NCT01077505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2474143|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
2474144|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2474145|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2474146|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
2474147|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2474148|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
2474149|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
2474150|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474151|NCT01077570|Repaglinide|repaglinide|mesh-list
2474152|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2474153|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474154|NCT01077609|Fluticasone|fluticasone|mesh-list
2474155|NCT01077609|Xhance|xhance|mesh-list
2474156|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2474157|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2474158|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
1670422|NCT04531982|Pimavanserin|pimavanserin|mesh-list
1670423|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1670424|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1670425|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1670426|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1670427|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1670428|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670429|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1670430|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1670431|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1670432|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
1670433|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1670434|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474159|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474160|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474161|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2474162|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
2474163|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
2474164|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2474165|NCT01077648|Trastuzumab|trastuzumab|mesh-list
2474166|NCT01077648|Lapatinib|lapatinib|mesh-list
2474167|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2474168|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474169|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2474170|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474171|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474172|NCT01077661|Nebivolol|nebivolol|mesh-list
2474173|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2474174|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
2474175|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
2474176|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2474177|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2474178|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
2474179|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2474180|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474181|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474182|NCT01077726|Capecitabine|capecitabine|mesh-list
2474183|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2474184|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
2474185|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474186|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474187|NCT01077752|Acetaminophen|acetaminophen|mesh-list
2474188|NCT01077752|Lidocaine|lidocaine|mesh-list
2474189|NCT01077752|Morphine|morphine|mesh-list
1670466|NCT04455100|Itraconazole|itraconazole|mesh-list
1670467|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
1670468|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1670469|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1670470|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1670471|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1670472|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670473|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1670474|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
1670475|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1670476|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670477|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2474190|NCT01077752|Ropivacaine|ropivacaine|mesh-list
2474191|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
2474192|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
2474193|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1670482|NCT04439578|Rifampin|rifampin|mesh-list
1670483|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1670484|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
1670485|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1670486|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1670487|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
1670488|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1670489|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1670490|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670491|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1670492|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1670493|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1670494|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1670495|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1670496|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1670497|NCT04439266|Crizotinib|crizotinib|mesh-list
1670498|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1670499|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1670500|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1670501|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670519|NCT04423601|Itraconazole|itraconazole|mesh-list
1670520|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
1670521|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1670522|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1670523|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1670524|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1670525|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670526|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1670527|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
1670528|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1670529|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670530|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2474194|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474195|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
2474196|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474197|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2474198|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2474199|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2474200|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2474201|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474202|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2474203|NCT01077752|Narcotics|narcotics|mesh-ancestor
2474204|NCT01077752|Analgesics|analgesics|mesh-ancestor
2474205|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2474206|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
2474207|NCT01077843|Etoricoxib|etoricoxib|mesh-list
2474208|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
2474209|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
2474210|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2474211|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2474212|NCT01077843|Analgesics|analgesics|mesh-ancestor
2474213|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
2474214|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474215|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474216|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2474217|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2474218|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474219|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474220|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
2474221|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474222|NCT01077947|Anesthetics|anesthetics|mesh-list
2474223|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474224|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670570|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1670571|NCT04387071|Antibodies|antibodies|mesh-list
1670572|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
1670573|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1670574|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
1670575|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670576|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474225|NCT01077986|Capecitabine|capecitabine|mesh-list
2474226|NCT01077986|Everolimus|everolimus|mesh-list
2474227|NCT01077986|Cetuximab|cetuximab|mesh-list
2474228|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2474229|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
2474230|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474231|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474232|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474233|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
2474234|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474235|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2474236|NCT01077999|Paclitaxel|paclitaxel|mesh-list
2474237|NCT01077999|Carboplatin|carboplatin|mesh-list
2474238|NCT01077999|Panitumumab|panitumumab|mesh-list
2474239|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2474240|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474241|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
2474242|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
2474243|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
2474244|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474245|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2474246|NCT01078038|Sirolimus|sirolimus|mesh-list
2474247|NCT01078038|Everolimus|everolimus|mesh-list
1670600|NCT04357457|Almitrine|almitrine|mesh-list
1670601|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
1670611|NCT04355858|Paclitaxel|paclitaxel|mesh-list
1670612|NCT04355858|Capecitabine|capecitabine|mesh-list
1670613|NCT04355858|Everolimus|everolimus|mesh-list
1670614|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1670615|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1670616|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
1670617|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
1670618|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
1670619|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670620|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1670621|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
1670622|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1670623|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
1670624|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474248|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474249|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474250|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
2474251|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474252|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2474253|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474254|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2474255|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
2474256|NCT01078142|Sirolimus|sirolimus|mesh-list
2474257|NCT01078142|Rituximab|rituximab|mesh-list
2474258|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2474259|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2474260|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474261|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
1670660|NCT04315701|Cemiplimab|cemiplimab|mesh-list
1670661|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1670662|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474262|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474263|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2474264|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2474265|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
2474266|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474267|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2474268|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474269|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2474270|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
2474271|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474272|NCT01078428|Petrolatum|petrolatum|mesh-list
2474273|NCT01078428|Emollients|emollients|mesh-ancestor
2474274|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
2474275|NCT01078519|Anesthetics|anesthetics|mesh-list
2474276|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
2474277|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474278|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474279|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
2474280|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474281|NCT01078610|Adalimumab|adalimumab|mesh-list
2474282|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2474283|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2474284|NCT01078714|Bumetanide|bumetanide|mesh-list
2474285|NCT01078714|Diuretics|diuretics|mesh-ancestor
2474286|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
2474287|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474288|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
2474289|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2474290|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474291|NCT01078779|Chloroquine|chloroquine|mesh-list
2474292|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
2474293|NCT01078779|Amebicides|amebicides|mesh-ancestor
2474294|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2474295|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2474296|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474297|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
2474298|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2474299|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2474300|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2474301|NCT01078779|Analgesics|analgesics|mesh-ancestor
2474302|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
2474303|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474304|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474305|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2474306|NCT01078779|Filaricides|filaricides|mesh-ancestor
2474307|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
2474308|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
2474309|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
2474310|NCT01078818|Trace Elements|trace elements|mesh-ancestor
2474311|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
2474312|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474313|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2474314|NCT01078870|Citalopram|citalopram|mesh-list
2474315|NCT01078870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2474316|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2474317|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2474318|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474319|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2474320|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
2474321|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474322|NCT01078870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1670727|NCT04249076|Clobetasol|clobetasol|mesh-list
1670728|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1670729|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
1670730|NCT04249076|Hormones|hormones|mesh-ancestor
1670731|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1670732|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670733|NCT04246801|Clobetasol|clobetasol|mesh-list
1670734|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1670735|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
1670736|NCT04246801|Hormones|hormones|mesh-ancestor
1670737|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1670738|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474323|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
2474324|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2474325|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474326|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2474327|NCT01078870|Analgesics|analgesics|mesh-ancestor
2474328|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
2474329|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
2474330|NCT01078961|Bortezomib|bortezomib|mesh-list
2474331|NCT01078961|Sorafenib|sorafenib|mesh-list
2474332|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474333|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2474334|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474335|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474336|NCT01079013|Treosulfan|treosulfan|mesh-list
2474337|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2474338|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
2474339|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474340|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474341|NCT01079052|Famotidine|famotidine|mesh-list
1670758|NCT04173533|Azacitidine|azacitidine|mesh-list
1670759|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1670760|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
1670761|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670762|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1670763|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1670764|NCT04167033|Hormones|hormones|mesh-list
1670765|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1670766|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474342|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2474343|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2474344|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2474345|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
2474346|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
2474347|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2474348|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474349|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474350|NCT01079065|Famotidine|famotidine|mesh-list
2474351|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2474352|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2474353|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2474354|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
2474355|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
2474356|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2474357|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474358|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474359|NCT01079078|Acetaminophen|acetaminophen|mesh-list
2474360|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2474361|NCT01079078|Analgesics|analgesics|mesh-ancestor
2474362|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
2474363|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474364|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474365|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
2474366|NCT01079117|Morphine|morphine|mesh-list
2474367|NCT01079117|Methadone|methadone|mesh-list
2474368|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2474369|NCT01079117|Narcotics|narcotics|mesh-ancestor
2474370|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474371|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474372|NCT01079117|Analgesics|analgesics|mesh-ancestor
2474373|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
2474374|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474375|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
2474376|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
2474377|NCT01079286|Sirolimus|sirolimus|mesh-list
2474378|NCT01079286|Nelfinavir|nelfinavir|mesh-list
2474379|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2474380|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474381|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2474382|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474383|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
2474384|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474385|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
2474386|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474387|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2474388|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2474389|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
2474390|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474391|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474392|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2474393|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2474394|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
2474395|NCT01079312|Fentanyl|fentanyl|mesh-list
2474396|NCT01079312|Remifentanil|remifentanil|mesh-list
2474397|NCT01079312|Propofol|propofol|mesh-list
2474398|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
2474399|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474400|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474401|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2474402|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
2474403|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
2474404|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2474405|NCT01079312|Narcotics|narcotics|mesh-ancestor
2474406|NCT01079312|Analgesics|analgesics|mesh-ancestor
2474407|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
2474408|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474409|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2474410|NCT01079338|Caffeine|caffeine|mesh-list
2474411|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2474412|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474413|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2474414|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474415|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474416|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
2474417|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2474418|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
2474419|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2474420|NCT01079351|Carbamazepine|carbamazepine|mesh-list
2474421|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
2474422|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
2474423|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2474424|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474425|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474426|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2474427|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2474428|NCT01079351|Analgesics|analgesics|mesh-ancestor
2474429|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
2474430|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1671018|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
2474431|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2474432|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2474433|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474434|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2474435|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2474436|NCT01079364|Insulin|insulin|mesh-list
2474437|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2474438|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
2474439|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
2474440|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
2474441|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
2474442|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2474443|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474444|NCT01079455|Corticosterone|corticosterone|mesh-list
2474445|NCT01079455|Bupivacaine|bupivacaine|mesh-list
2474446|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
2474447|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
2474448|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
2474449|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474450|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474451|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
2474452|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1670908|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1670909|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1670910|NCT04010539|Azithromycin|azithromycin|mesh-list
1670911|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
1670912|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1670913|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474453|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2474454|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
2474455|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
2474456|NCT01079455|Protective Agents|protective agents|mesh-ancestor
2474457|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2474458|NCT01079481|Everolimus|everolimus|mesh-list
2474459|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474460|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474461|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
1670925|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1670926|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1670927|NCT03971929|Diuretics|diuretics|mesh-ancestor
1670928|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
1670929|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670930|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1670931|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1670932|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670933|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
1670934|NCT03971084|Caseins|caseins|mesh-list
1670935|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1670936|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
1670937|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1670938|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670939|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1670940|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
1670941|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
1671168|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
1670948|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1670949|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1670950|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1670951|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1670952|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
1670953|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474462|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474463|NCT01079559|Tobramycin|tobramycin|mesh-list
2474464|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2474465|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474466|NCT01079624|Glucagon|glucagon|mesh-list
2474467|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
2474468|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2474469|NCT01079624|Hormones|hormones|mesh-ancestor
2474470|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2474471|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474472|NCT01079624|Incretins|incretins|mesh-ancestor
2474473|NCT01079676|Lenograstim|lenograstim|mesh-list
2474474|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2474475|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
2474476|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474477|NCT01079702|Capecitabine|capecitabine|mesh-list
2474478|NCT01079702|Everolimus|everolimus|mesh-list
2474479|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2474480|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
1670973|NCT03916263|Metformin|metformin|mesh-list
1670974|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1670975|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474481|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474482|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474483|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474484|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
2474485|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474486|NCT01079715|Propranolol|propranolol|mesh-list
2474487|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2474488|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2474489|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
2474490|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2474491|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474492|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474493|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2474494|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2474495|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
2474496|NCT01079754|Morphine|morphine|mesh-list
2474497|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
2474498|NCT01079754|Narcotics|narcotics|mesh-ancestor
2474499|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474500|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671006|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
1671007|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1671008|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671009|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
1671010|NCT03832647|Salicylates|salicylates|mesh-list
1671011|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1671012|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
1671013|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
1671014|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
1671015|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1671016|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1671017|NCT03832647|Analgesics|analgesics|mesh-ancestor
1671019|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1671020|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671021|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1671022|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1671023|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1671024|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1671025|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474501|NCT01079754|Analgesics|analgesics|mesh-ancestor
2474502|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
2474503|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474504|NCT01079767|Sirolimus|sirolimus|mesh-list
2474505|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2474506|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474507|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1671033|NCT03778671|Fentanyl|fentanyl|mesh-list
1671034|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
1671035|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
1671036|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1671037|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1671038|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671039|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1671040|NCT03778671|Analgesics|analgesics|mesh-ancestor
1671041|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
1671042|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1671043|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1671044|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1671045|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1671046|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
1671047|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1671048|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671049|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1671050|NCT03778671|Narcotics|narcotics|mesh-ancestor
1671051|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1671052|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1671053|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
1671054|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
1671055|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
2474508|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474509|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
2474510|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474511|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
2474512|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474513|NCT01079780|Irinotecan|irinotecan|mesh-list
2474514|NCT01079780|Cetuximab|cetuximab|mesh-list
2474515|NCT01079780|Ramucirumab|ramucirumab|mesh-list
2474516|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2474517|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2474518|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474519|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474520|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474521|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2474522|NCT01079884|Esomeprazole|esomeprazole|mesh-list
2474523|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2474524|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2474525|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2474526|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474527|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474528|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
2474529|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2474530|NCT01079910|Fluorides|fluorides|mesh-list
2474531|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
2474532|NCT01079910|Protective Agents|protective agents|mesh-ancestor
2474533|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474534|NCT01079923|Vitamin D|vitamin d|mesh-list
2474535|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
2474536|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
2474537|NCT01079923|Vitamins|vitamins|mesh-list
2474538|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
2474539|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474540|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2474541|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2474542|NCT01080027|Interferons|interferons|mesh-list
2474543|NCT01080027|Interferon-beta|interferon-beta|mesh-list
2474544|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
2474545|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474546|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
2474547|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474548|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
2474549|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474550|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2474551|NCT01080066|Cetuximab|cetuximab|mesh-list
2474552|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2474553|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474554|NCT01080079|Terbinafine|terbinafine|mesh-list
2474555|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
1671102|NCT03698162|Bevacizumab|bevacizumab|mesh-list
1671103|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1671104|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671105|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1671106|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1671107|NCT03698162|Growth Substances|growth substances|mesh-ancestor
1671108|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671109|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
2474556|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474557|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474558|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474559|NCT01080222|Ribavirin|ribavirin|mesh-list
2474560|NCT01080222|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
2474561|NCT01080222|Antimetabolites|antimetabolites|mesh-ancestor
1671116|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
1671117|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1671118|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1671119|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1671120|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1671121|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1671122|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671123|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671124|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1671125|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2474562|NCT01080222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474563|NCT01080222|Antiviral Agents|antiviral agents|mesh-ancestor
2474564|NCT01080222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474565|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
2474566|NCT01080352|Vitamins|vitamins|mesh-ancestor
2474567|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
2474568|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474569|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
2474570|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474571|NCT01080352|Protective Agents|protective agents|mesh-ancestor
2474572|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
2474573|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2474574|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474575|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2474576|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
2474577|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2474578|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474579|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474580|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474581|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
2474582|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2474583|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474584|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2474585|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
2474586|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1671151|NCT03644186|Paclitaxel|paclitaxel|mesh-list
1671152|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1671153|NCT03644186|Trastuzumab|trastuzumab|mesh-list
1671154|NCT03644186|Letrozole|letrozole|mesh-list
1671155|NCT03644186|Palbociclib|palbociclib|mesh-list
1671156|NCT03644186|Pertuzumab|pertuzumab|mesh-list
1671157|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1671158|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671159|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
1671160|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
1671161|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
1671162|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671163|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1671164|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1671165|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1671166|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1671167|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2474587|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1671169|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1671170|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671171|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2474588|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474589|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474590|NCT01080456|Tacrolimus|tacrolimus|mesh-list
2474591|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474592|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
2474593|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474594|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2474595|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474596|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474597|NCT01080469|Tacrolimus|tacrolimus|mesh-list
2474598|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474599|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
2474600|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474601|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2474602|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474603|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474604|NCT01080482|Tacrolimus|tacrolimus|mesh-list
2474605|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474606|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
2474607|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474608|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2474609|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474610|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474611|NCT01080534|Tacrolimus|tacrolimus|mesh-list
2474612|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474613|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
2474614|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474615|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2474616|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474617|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474618|NCT01080547|Capecitabine|capecitabine|mesh-list
1671206|NCT03563066|Benralizumab|benralizumab|mesh-list
1671207|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1671208|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
1671209|NCT03558789|Lactoferrin|lactoferrin|mesh-list
1671210|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474619|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
2474620|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2474621|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
2474622|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474623|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474624|NCT01080560|Cyclosporine|cyclosporine|mesh-list
2474625|NCT01080560|Cyclosporins|cyclosporins|mesh-list
2474626|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474627|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474628|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474629|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
2474630|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474631|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
2474632|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474633|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
2474634|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2474635|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2474636|NCT01080586|Cyclosporine|cyclosporine|mesh-list
2474637|NCT01080586|Cyclosporins|cyclosporins|mesh-list
2474638|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474639|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474640|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474641|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
2474642|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474643|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
2474644|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474645|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
2474646|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2474647|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2474648|NCT01080612|Pregabalin|pregabalin|mesh-list
2474649|NCT01080612|Analgesics|analgesics|mesh-ancestor
2474650|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
2474651|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474652|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474653|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
2474654|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2474655|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2474656|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474657|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2474658|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2474659|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2474660|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474661|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2474662|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
2474663|NCT01080638|Abciximab|abciximab|mesh-list
2474664|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
2474665|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2474666|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2474667|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
2474668|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474669|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2474670|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474671|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
2474672|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474673|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
2474674|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2474675|NCT01080638|Protective Agents|protective agents|mesh-ancestor
2474676|NCT01080651|Voriconazole|voriconazole|mesh-list
2474677|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
2474678|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474679|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
2474680|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2474681|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474682|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474683|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2474684|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
2474685|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2474686|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474687|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2474688|NCT01080729|Hormones|hormones|mesh-list
2474689|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2474690|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2474691|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474692|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
2474693|NCT01080742|Bisoprolol|bisoprolol|mesh-list
1671286|NCT03495921|Irinotecan|irinotecan|mesh-list
1671287|NCT03495921|Camptothecin|camptothecin|mesh-list
1671288|NCT03495921|Temozolomide|temozolomide|mesh-list
1671289|NCT03495921|Immunologic Factors|immunologic factors|mesh-list
1671290|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1671291|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1671292|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1671293|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671294|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671295|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1671296|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
1671297|NCT03495921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671298|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2474694|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2474695|NCT01080742|Diuretics|diuretics|mesh-ancestor
2474696|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
2474697|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474698|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2474699|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2474700|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474701|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
2474702|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
2474703|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474704|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
2474705|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2474706|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2474707|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
2474708|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2474709|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
2474710|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
2474711|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474712|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2474713|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2474714|NCT01080846|Misoprostol|misoprostol|mesh-list
2474715|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2474716|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
2474717|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2474718|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474719|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2474720|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2474721|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
2474722|NCT01080911|Morphine|morphine|mesh-list
2474723|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
2474724|NCT01080911|Narcotics|narcotics|mesh-ancestor
1671333|NCT03414983|Leucovorin|leucovorin|mesh-list
1671334|NCT03414983|Bevacizumab|bevacizumab|mesh-list
1671335|NCT03414983|Nivolumab|nivolumab|mesh-list
1671336|NCT03414983|Fluorouracil|fluorouracil|mesh-list
1671337|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
1671338|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1671339|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671340|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1671341|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1671342|NCT03414983|Growth Substances|growth substances|mesh-ancestor
1671343|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671344|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
1671345|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
1671346|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671347|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1671348|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1671349|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
1671350|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1671351|NCT03414983|Antidotes|antidotes|mesh-ancestor
1671352|NCT03414983|Protective Agents|protective agents|mesh-ancestor
1671353|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
1671354|NCT03414983|Vitamins|vitamins|mesh-ancestor
1671355|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
2474725|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474726|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474727|NCT01080911|Analgesics|analgesics|mesh-ancestor
1671359|NCT03383458|Nivolumab|nivolumab|mesh-list
1671360|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1671361|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671362|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1671363|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671364|NCT03330821|Cytarabine|cytarabine|mesh-list
1671365|NCT03330821|Idarubicin|idarubicin|mesh-list
1671366|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
1671367|NCT03330821|Pevonedistat|pevonedistat|mesh-list
1671368|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1671369|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
1671370|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671371|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671372|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
1671373|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1671374|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1671375|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
1671376|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671377|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1671378|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1671379|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1671380|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
1671381|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1671382|NCT03322280|Estrogens|estrogens|mesh-ancestor
1671383|NCT03322280|Hormones|hormones|mesh-ancestor
1671384|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1671385|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671386|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1671387|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671388|NCT03317223|Amoxicillin|amoxicillin|mesh-list
1671389|NCT03317223|Clarithromycin|clarithromycin|mesh-list
1671390|NCT03317223|Lansoprazole|lansoprazole|mesh-list
1671391|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1671392|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1671393|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1671394|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474728|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
2474729|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1671395|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671396|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1671397|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1671398|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1671399|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1671400|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1671401|NCT03304821|Sargramostim|sargramostim|mesh-list
1671402|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
1671403|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474730|NCT01080963|Daptomycin|daptomycin|mesh-list
2474731|NCT01080963|Cefuroxime|cefuroxime|mesh-list
2474732|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
2474733|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2474734|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474735|NCT01081002|Lidocaine|lidocaine|mesh-list
2474736|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
2474737|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
2474738|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474739|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474740|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
2474741|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474742|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2474743|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2474744|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2474745|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2474746|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474747|NCT01081158|Ritonavir|ritonavir|mesh-list
2474748|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
2474749|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
2474750|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2474751|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2474752|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
2474753|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474754|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671438|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
1671439|NCT03154749|Carboplatin|carboplatin|mesh-list
1671440|NCT03154749|Docetaxel|docetaxel|mesh-list
1671441|NCT03154749|Epirubicin|epirubicin|mesh-list
1671442|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1671443|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
1671444|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671445|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1671446|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1671447|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
1671448|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671449|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671450|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1671451|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
1671452|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
1671453|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
1671454|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1671455|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1671456|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1671457|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1671458|NCT03141177|Nivolumab|nivolumab|mesh-list
1671459|NCT03141177|Ipilimumab|ipilimumab|mesh-list
1671460|NCT03141177|Sunitinib|sunitinib|mesh-list
1671461|NCT03141177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1671462|NCT03141177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671463|NCT03141177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1671464|NCT03141177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671465|NCT03141177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1671466|NCT03141177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1671467|NCT03141177|Growth Substances|growth substances|mesh-ancestor
1671468|NCT03141177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671469|NCT03141177|Growth Inhibitors|growth inhibitors|mesh-ancestor
1671470|NCT03141177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1671471|NCT03141177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474755|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2474756|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2474757|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
2474758|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474759|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2474760|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1671478|NCT03136731|Antibodies|antibodies|mesh-list
1671479|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
1671480|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474761|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
2474762|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474763|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
2474764|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
2474765|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474766|NCT01081353|Aspirin|aspirin|mesh-list
2474767|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2474768|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2474769|NCT01081353|Analgesics|analgesics|mesh-ancestor
2474770|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
2474771|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474772|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474773|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2474774|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2474775|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2474776|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2474777|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474778|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1671499|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1671500|NCT03084523|Hematinics|hematinics|mesh-ancestor
1671501|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1671502|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2474779|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2474780|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474781|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
2474782|NCT01081431|Lenalidomide|lenalidomide|mesh-list
2474783|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
2474784|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474785|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2474786|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2474787|NCT01081431|Growth Substances|growth substances|mesh-ancestor
2474788|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
2474789|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474790|NCT01081535|Ketorolac|ketorolac|mesh-list
2474791|NCT01081535|Fentanyl|fentanyl|mesh-list
2474792|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2474793|NCT01081535|Narcotics|narcotics|mesh-ancestor
2474794|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474795|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474796|NCT01081535|Analgesics|analgesics|mesh-ancestor
2474797|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
2474798|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474799|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2474800|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2474801|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
2474802|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
2474803|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2474804|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2474805|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2474806|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2474807|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2474808|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1671535|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
1671536|NCT02992743|Fludarabine|fludarabine|mesh-list
1671537|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1671538|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
1671539|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671540|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1671541|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1671542|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
1671543|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671544|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671545|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1671559|NCT02983006|Nivolumab|nivolumab|mesh-list
1671560|NCT02983006|DS-8273a|ds-8273a|mesh-list
1671561|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1671562|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671563|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1671564|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474809|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474810|NCT01081548|Atorvastatin|atorvastatin|mesh-list
2474811|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
2474812|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2474813|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
2474814|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474815|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2474816|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
2474817|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474818|NCT01081561|Riboflavin|riboflavin|mesh-list
2474819|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
2474820|NCT01081561|Vitamins|vitamins|mesh-ancestor
2474821|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
2474822|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474823|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2474824|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
2474825|NCT01081600|Trastuzumab|trastuzumab|mesh-list
1671582|NCT02936687|Ambrisentan|ambrisentan|mesh-list
1671583|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2474826|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2474827|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474828|NCT01081613|Bevacizumab|bevacizumab|mesh-list
2474829|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
2474830|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2474831|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474832|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2474833|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2474834|NCT01081613|Growth Substances|growth substances|mesh-ancestor
2474835|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474836|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
2474837|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2474838|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474839|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
2474840|NCT01081639|Hormones|hormones|mesh-ancestor
2474841|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2474842|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474843|NCT01081652|Progesterone|progesterone|mesh-list
2474844|NCT01081652|Progestins|progestins|mesh-ancestor
2474845|NCT01081652|Hormones|hormones|mesh-ancestor
2474846|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2474847|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474848|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2474849|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
1671608|NCT02787590|Simvastatin|simvastatin|mesh-list
1671609|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1671610|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1671611|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
1671612|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671613|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1671614|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1671615|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474850|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474851|NCT01081704|Ustekinumab|ustekinumab|mesh-list
2474852|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
2474853|NCT01081717|Golimumab|golimumab|mesh-list
2474854|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2474855|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2474856|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474857|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
2474858|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474859|NCT01081730|Ustekinumab|ustekinumab|mesh-list
2474860|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
2474861|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
2474862|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2474863|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474864|NCT01081782|Ceralifimod|ceralifimod|mesh-list
2474865|NCT01081782|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2474866|NCT01081782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474867|NCT01081782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2474868|NCT01081782|Immunologic Factors|immunologic factors|mesh-ancestor
2474869|NCT01081782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474870|NCT01081847|Mannitol|mannitol|mesh-list
2474871|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
2474872|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2474873|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
2474874|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474875|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
2474876|NCT01081847|Diuretics|diuretics|mesh-ancestor
2474877|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
1671645|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
1671646|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
1671647|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1671648|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
1671649|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671650|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1671651|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1671652|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
1671653|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671654|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671655|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1671656|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2474878|NCT01081938|Insulin|insulin|mesh-list
2474879|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2474880|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
2474881|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
2474882|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2474883|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474884|NCT01081964|Levofloxacin|levofloxacin|mesh-list
2474885|NCT01081964|Ofloxacin|ofloxacin|mesh-list
2474886|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
2474887|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2474888|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2474889|NCT01081964|Renal Agents|renal agents|mesh-ancestor
2474890|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2474891|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2474892|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2474893|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474894|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671674|NCT02734004|Bevacizumab|bevacizumab|mesh-list
1671675|NCT02734004|Durvalumab|durvalumab|mesh-list
1671676|NCT02734004|Olaparib|olaparib|mesh-list
1671677|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1671678|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671679|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1671680|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1671681|NCT02734004|Growth Substances|growth substances|mesh-ancestor
1671682|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671683|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
1671684|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1671685|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1671686|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671687|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
1671688|NCT02678143|Sirolimus|sirolimus|mesh-list
1671689|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
1671690|NCT02678143|Fludarabine|fludarabine|mesh-list
1671691|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
1671692|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1671693|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
1671694|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671695|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1671696|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1671697|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
1671698|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671699|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671700|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1671701|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1671702|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1671703|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
1671704|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1671705|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1671706|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1671707|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
1671708|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1671709|NCT02659813|Copper|copper|mesh-list
1671710|NCT02659813|Nickel|nickel|mesh-list
1671711|NCT02659813|Trace Elements|trace elements|mesh-ancestor
1671712|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
1671713|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671714|NCT02658890|Nivolumab|nivolumab|mesh-list
1671715|NCT02658890|Ipilimumab|ipilimumab|mesh-list
1671716|NCT02658890|Linrodostat|linrodostat|mesh-list
1671717|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1671718|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671719|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1671720|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671721|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474895|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474896|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
2474897|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2474898|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2474899|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
2474900|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2474901|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
2474902|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2474903|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
2474904|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474905|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2474906|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2474907|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2474908|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474909|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
2474910|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2474911|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474912|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671740|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
1671741|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
1671742|NCT02621021|Fludarabine|fludarabine|mesh-list
1671743|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1671744|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
1671745|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671746|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1671747|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1671748|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
1671749|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671750|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671751|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1671752|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2474913|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2474914|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
2474915|NCT01082003|Protective Agents|protective agents|mesh-ancestor
2474916|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474917|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
2474918|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2474919|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
1671776|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
1671777|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1671778|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1671779|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671780|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1671781|NCT02566863|Analgesics|analgesics|mesh-ancestor
1671782|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
1671783|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1671784|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1671785|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1671786|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1671787|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
1671788|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1671789|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474920|NCT01082029|Lansoprazole|lansoprazole|mesh-list
2474921|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
2474922|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2474923|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2474924|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1671795|NCT02488408|Cytarabine|cytarabine|mesh-list
1671796|NCT02488408|Decitabine|decitabine|mesh-list
1671797|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1671798|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
1671799|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671800|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671801|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
1671802|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1671803|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1671804|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
1671805|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671806|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474925|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474926|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474927|NCT01082068|Letrozole|letrozole|mesh-list
2474928|NCT01082068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474929|NCT01082068|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2474930|NCT01082068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2474931|NCT01082068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2474932|NCT01082068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474933|NCT01082068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2474934|NCT01082068|Hormone Antagonists|hormone antagonists|mesh-ancestor
2474935|NCT01082068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2474936|NCT01082068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1671819|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1671820|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1671821|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1671822|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1671823|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1671824|NCT02346747|Immunologic Factors|immunologic factors|mesh-list
1671825|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474937|NCT01082120|Pioglitazone|pioglitazone|mesh-list
2474938|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2474939|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474940|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2474941|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2474942|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2474943|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474944|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474945|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2474946|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2474947|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2474948|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2474949|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
2474950|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2474951|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474952|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2474953|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2474954|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
2474955|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2474956|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2474957|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
2474958|NCT01082198|Vaccines|vaccines|mesh-list
2474959|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
2474960|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
2474961|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474962|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2474963|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
2474964|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2474965|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2474966|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
2474967|NCT01082237|Citalopram|citalopram|mesh-list
2474968|NCT01082237|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
2474969|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2474970|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2474971|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474972|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2474973|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
2474974|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474975|NCT01082237|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
2474976|NCT01082237|Antidepressive Agents|antidepressive agents|mesh-ancestor
2474977|NCT01082237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2474978|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2474979|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2474980|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2474981|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2474982|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2474983|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2474984|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2474985|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2474986|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2474987|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
2474988|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2474989|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2474990|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2474991|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2474992|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
2474993|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2474994|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2474995|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
2474996|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2474997|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2474998|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2474999|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475000|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475001|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2475002|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2475003|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2475004|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2475005|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
2475006|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475007|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475008|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2475009|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2475010|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
2475011|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2475012|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2475013|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
2475014|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2475015|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2475016|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2475017|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475018|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475019|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2475020|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2475021|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2475022|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2475023|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
2475024|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475025|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475026|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2475027|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2475028|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
2475029|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2475030|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2475031|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
2475032|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
2475033|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2475034|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2475035|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475036|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475037|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2475038|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
2475039|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2475040|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2475041|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
2475042|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475043|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475044|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2475045|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2475046|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
2475047|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2475048|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2475049|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
2475050|NCT01082315|Cetuximab|cetuximab|mesh-list
2475051|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2475052|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475053|NCT01082341|Vaccines|vaccines|mesh-list
2475054|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
2475055|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475056|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
2475057|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
2475058|NCT01082393|Tacrolimus|tacrolimus|mesh-list
2475059|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2475060|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
2475061|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475062|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2475063|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475064|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475065|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2475066|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
2475067|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2475068|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2475069|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2475070|NCT01082393|Analgesics|analgesics|mesh-ancestor
2475071|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
2475072|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475073|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2475074|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
2475075|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2475076|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
2475077|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475078|NCT01082445|Expectorants|expectorants|mesh-ancestor
2475079|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
2475080|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2475081|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
2475082|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475083|NCT01082445|Protective Agents|protective agents|mesh-ancestor
2475084|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475085|NCT01082445|Antidotes|antidotes|mesh-ancestor
2475086|NCT01082458|Lidocaine|lidocaine|mesh-list
2475087|NCT01082458|Remifentanil|remifentanil|mesh-list
2475088|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
2475089|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
2475090|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475091|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475092|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
2475093|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475094|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2475095|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2475096|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2475097|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2475098|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475099|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2475100|NCT01082458|Narcotics|narcotics|mesh-ancestor
2475101|NCT01082458|Analgesics|analgesics|mesh-ancestor
2475102|NCT01082471|Morphine|morphine|mesh-list
2475103|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2475104|NCT01082471|Narcotics|narcotics|mesh-ancestor
2475105|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475106|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475107|NCT01082471|Analgesics|analgesics|mesh-ancestor
2475108|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
2475109|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475110|NCT01082484|Treprostinil|treprostinil|mesh-list
2475111|NCT01082484|Iloprost|iloprost|mesh-list
2475112|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2475113|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2475114|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
2475115|NCT01082510|Tegafur|tegafur|mesh-list
2475116|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2475117|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
2475118|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475119|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475120|NCT01082549|Gemcitabine|gemcitabine|mesh-list
2475121|NCT01082549|Carboplatin|carboplatin|mesh-list
2475122|NCT01082549|Iniparib|iniparib|mesh-list
2475123|NCT01082549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475124|NCT01082549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2475125|NCT01082549|Antimetabolites|antimetabolites|mesh-ancestor
2475126|NCT01082549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475127|NCT01082549|Antiviral Agents|antiviral agents|mesh-ancestor
2475128|NCT01082549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475129|NCT01082549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475130|NCT01082549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2475131|NCT01082549|Immunologic Factors|immunologic factors|mesh-ancestor
2475132|NCT01082549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475133|NCT01082549|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2475134|NCT01082627|Somatostatin|somatostatin|mesh-list
2475135|NCT01082627|Hormones|hormones|mesh-ancestor
2475136|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2475137|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475138|NCT01082679|Buprenorphine|buprenorphine|mesh-list
2475139|NCT01082679|Methadone|methadone|mesh-list
2475140|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
2475141|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2475142|NCT01082679|Narcotics|narcotics|mesh-ancestor
2475143|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475144|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475145|NCT01082679|Analgesics|analgesics|mesh-ancestor
2475146|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
2475147|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475148|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2475149|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
2475150|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
2475151|NCT01082705|Lumefantrine|lumefantrine|mesh-list
2475152|NCT01082705|Artemether|artemether|mesh-list
2475153|NCT01082705|Piperaquine|piperaquine|mesh-list
2475154|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2475155|NCT01082705|Artenimol|artenimol|mesh-list
2475156|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
2475157|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2475158|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2475159|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475160|NCT01082718|Artesunate|artesunate|mesh-list
2475161|NCT01082718|Mefloquine|mefloquine|mesh-list
2475162|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
2475163|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2475164|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2475165|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475166|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475167|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
2475168|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
2475169|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2475170|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
2475171|NCT01082731|Artesunate|artesunate|mesh-list
2475172|NCT01082731|Lumefantrine|lumefantrine|mesh-list
2475173|NCT01082731|Artemether|artemether|mesh-list
2475174|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2475175|NCT01082731|Mefloquine|mefloquine|mesh-list
2475176|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
2475177|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2475178|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2475179|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475180|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475181|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
2475182|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
2475183|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
2475184|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
2475185|NCT01082744|Sufentanil|sufentanil|mesh-list
2475186|NCT01082744|Ropivacaine|ropivacaine|mesh-list
2475187|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
2475188|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
2475189|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475190|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475191|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
2475192|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475193|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2475194|NCT01082744|Narcotics|narcotics|mesh-ancestor
2475195|NCT01082744|Analgesics|analgesics|mesh-ancestor
2475196|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2475197|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2475198|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
2475199|NCT01082796|Glipizide|glipizide|mesh-list
2475200|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2475201|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475202|NCT01082809|Sunitinib|sunitinib|mesh-list
2475203|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475204|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2475205|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2475206|NCT01082809|Growth Substances|growth substances|mesh-ancestor
2475207|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475208|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
2475209|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2475210|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475211|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475212|NCT01082848|Aripiprazole|aripiprazole|mesh-list
2475213|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
2475214|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2475215|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2475216|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2475217|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475218|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475219|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
2475220|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
2475221|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475222|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475223|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2475224|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2475225|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
2475226|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2475227|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2475228|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2475229|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2475230|NCT01082926|Aldesleukin|aldesleukin|mesh-list
2475231|NCT01082926|Interleukin-2|interleukin-2|mesh-list
2475232|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475233|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2475234|NCT01082926|Analgesics|analgesics|mesh-ancestor
2475235|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
2475236|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475237|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475238|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2475239|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2475240|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
2475241|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475242|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
2475243|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
2475244|NCT01083017|Diuretics|diuretics|mesh-ancestor
2475245|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
2475246|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475247|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
2475248|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2475249|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475250|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
2475251|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2475252|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
2475253|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475254|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2475255|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
2475256|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2475257|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475258|NCT01083251|Vitamin D|vitamin d|mesh-list
2475259|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
2475260|NCT01083251|Vitamins|vitamins|mesh-list
2475261|NCT01083251|Entecavir|entecavir|mesh-list
2475262|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
2475263|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475264|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2475265|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2475266|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
2475267|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475268|NCT01083264|Gestodene|gestodene|mesh-list
2475269|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
2475270|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
2475271|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2475272|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
2475273|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2475274|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475275|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2475276|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2475277|NCT01083264|Progestins|progestins|mesh-ancestor
2475278|NCT01083264|Hormones|hormones|mesh-ancestor
2475279|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2475280|NCT01083290|Spironolactone|spironolactone|mesh-list
2475281|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2475282|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
2475283|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2475284|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475285|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2475286|NCT01083290|Diuretics|diuretics|mesh-ancestor
2475287|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
2475288|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
2475289|NCT01083329|Niacin|niacin|mesh-list
2475290|NCT01083329|Niacinamide|niacinamide|mesh-list
2475291|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
2475292|NCT01083329|Vitamins|vitamins|mesh-ancestor
2475293|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
2475294|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475295|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2475296|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
2475297|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475298|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2475299|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
2475300|NCT01083381|Risperidone|risperidone|mesh-list
2475301|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2475302|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
2475303|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475304|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475305|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475306|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2475307|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2475308|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475309|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2475310|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
2475311|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
2475312|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
2475313|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
2475314|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
2475315|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475316|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
2475317|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
2475318|NCT01083420|Minocycline|minocycline|mesh-list
2475319|NCT01083420|Dexamethasone|dexamethasone|mesh-list
2475320|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2475321|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
2475322|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
2475323|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475324|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475325|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2475326|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
2475327|NCT01083420|Hormones|hormones|mesh-ancestor
2475328|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2475329|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2475330|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475331|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2475332|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475333|NCT01083537|Paclitaxel|paclitaxel|mesh-list
2475334|NCT01083537|Cisplatin|cisplatin|mesh-list
1672432|NCT05084456|Docetaxel|docetaxel|mesh-list
1672433|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1672434|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
1672435|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
1672436|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
1672437|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475335|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2475336|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475337|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
2475338|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
2475339|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
2475340|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475341|NCT01083589|Docetaxel|docetaxel|mesh-list
2475342|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
2475343|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1672447|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1672448|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
1672449|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
1672450|NCT05084378|Povidone|povidone|mesh-list
1672451|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1672452|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1672453|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1672454|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
1672455|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
1672456|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
1672457|NCT05084365|Sulforaphane|sulforaphane|mesh-list
1672458|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1672459|NCT05084365|Protective Agents|protective agents|mesh-ancestor
2475344|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
2475345|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
1672460|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672461|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475346|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
2475347|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475348|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2475349|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475350|NCT01083615|Prednisone|prednisone|mesh-list
2475351|NCT01083615|Docetaxel|docetaxel|mesh-list
2475352|NCT01083615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1672469|NCT05084235|Empagliflozin|empagliflozin|mesh-list
1672470|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1672471|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672472|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1672473|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672474|NCT05084222|Budesonide|budesonide|mesh-list
1672475|NCT05084222|Albuterol|albuterol|mesh-list
1672476|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
1672477|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1672478|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1672479|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
1672480|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1672481|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672482|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1672483|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
1672484|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
1672485|NCT05084222|Hormones|hormones|mesh-ancestor
1672486|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1672487|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1672488|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1672489|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1672490|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
1672491|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1672492|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672493|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
1672494|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1672495|NCT05084196|Melatonin|melatonin|mesh-list
1672496|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
1672497|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672498|NCT05084196|Protective Agents|protective agents|mesh-ancestor
1672499|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672500|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475353|NCT01083615|Tubulin Modulators|tubulin modulators|mesh-ancestor
2475354|NCT01083615|Antimitotic Agents|antimitotic agents|mesh-ancestor
2475355|NCT01083615|Mitosis Modulators|mitosis modulators|mesh-ancestor
2475356|NCT01083615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475357|NCT01083615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2475358|NCT01083615|Glucocorticoids|glucocorticoids|mesh-ancestor
2475359|NCT01083615|Hormones|hormones|mesh-ancestor
2475360|NCT01083615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1672509|NCT05084079|Insulin|insulin|mesh-list
1672510|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1672511|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1672512|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475361|NCT01083615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475362|NCT01083615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2475363|NCT01083784|Valproic Acid|valproic acid|mesh-list
2475364|NCT01083784|Clonazepam|clonazepam|mesh-list
2475365|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
2475366|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475367|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475368|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
2475369|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475370|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475371|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
1672527|NCT05084001|Listerine|listerine|mesh-list
1672528|NCT05084001|Fluorides|fluorides|mesh-list
1672529|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
1672530|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
1672531|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
1672532|NCT05084001|Protective Agents|protective agents|mesh-ancestor
1672533|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672534|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1672535|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475372|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2475373|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475374|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2475375|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
2475376|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
2475377|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
2475378|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2475379|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475380|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475381|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2475382|NCT01083797|Analgesics|analgesics|mesh-ancestor
2475383|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
1672564|NCT05083793|Pregabalin|pregabalin|mesh-list
1672565|NCT05083793|Analgesics|analgesics|mesh-ancestor
1672566|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
1672567|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1672568|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672569|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
1672570|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1672571|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1672572|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672573|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1672574|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1672575|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1672576|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1672577|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2475384|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475385|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2475386|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2475387|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2475388|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
2475389|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2475390|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475391|NCT01083875|Amlexanox|amlexanox|mesh-list
2475392|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2475393|NCT01083953|Sevoflurane|sevoflurane|mesh-list
2475394|NCT01083953|Desflurane|desflurane|mesh-list
2475395|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2475396|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2475397|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
2475398|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
2475399|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475400|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475401|NCT01083966|Bevacizumab|bevacizumab|mesh-list
1672596|NCT05083689|Bevacizumab|bevacizumab|mesh-list
1672597|NCT05083689|Timolol|timolol|mesh-list
1672598|NCT05083689|Dorzolamide|dorzolamide|mesh-list
1672599|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
1672600|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1672601|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1672602|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1672603|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1672604|NCT05083689|Growth Substances|growth substances|mesh-ancestor
1672605|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672606|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
1672607|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1672608|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1672609|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
2475402|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1672610|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1672611|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672612|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1672613|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1672614|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1672615|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1672616|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1672617|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1672618|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1672619|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1672620|NCT05083572|Rifaximin|rifaximin|mesh-list
1672621|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1672622|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1672623|NCT05083455|Enoxaparin|enoxaparin|mesh-list
1672624|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
1672625|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1672626|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
1672627|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1672628|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
1672629|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1672630|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672631|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
1672632|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1672633|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1672634|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
1672635|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1672636|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1672637|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
1672638|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1672639|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672640|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1672641|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
1672642|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
1672643|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1672644|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
1672645|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1672646|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672647|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1672648|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1672649|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1672650|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
2475403|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475404|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2475405|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2475406|NCT01083966|Growth Substances|growth substances|mesh-ancestor
2475407|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475408|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
2475409|NCT01083992|Vitamin D|vitamin d|mesh-list
2475410|NCT01083992|Vildagliptin|vildagliptin|mesh-list
2475411|NCT01083992|Vitamins|vitamins|mesh-ancestor
2475412|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
2475413|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475414|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2475415|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2475416|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
2475417|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
2475418|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1672667|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
1672668|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1672669|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1672670|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672671|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1672672|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1672673|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
1672674|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1672675|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475419|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475420|NCT01084031|Propofol|propofol|mesh-list
2475421|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2475422|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475423|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475424|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2475425|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
2475426|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
2475427|NCT01084044|Urinastatin|urinastatin|mesh-list
2475428|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2475429|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1672686|NCT05083247|Gemcitabine|gemcitabine|mesh-list
1672687|NCT05083247|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1672688|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1672689|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
1672690|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672691|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1672692|NCT05083247|Antiviral Agents|antiviral agents|mesh-ancestor
1672693|NCT05083247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1672694|NCT05083247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1672695|NCT05083247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1672696|NCT05083247|Immunologic Factors|immunologic factors|mesh-ancestor
1672697|NCT05083247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475430|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
2475431|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475432|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475433|NCT01084057|Vorinostat|vorinostat|mesh-list
2475434|NCT01084057|Epothilone B|epothilone b|mesh-list
2475435|NCT01084057|Epothilones|epothilones|mesh-list
2475436|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475437|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2475438|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475439|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475440|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
2475441|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
2475442|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
2475443|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
2475444|NCT01084122|Hematinics|hematinics|mesh-ancestor
2475445|NCT01084161|Morphine|morphine|mesh-list
2475446|NCT01084161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2475447|NCT01084161|Narcotics|narcotics|mesh-ancestor
2475448|NCT01084161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475449|NCT01084161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475450|NCT01084161|Analgesics|analgesics|mesh-ancestor
2475451|NCT01084161|Sensory System Agents|sensory system agents|mesh-ancestor
1672722|NCT05083026|Antibodies|antibodies|mesh-list
1672723|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
1672724|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
1672725|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475452|NCT01084161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475453|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2475454|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
2475455|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2475456|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1672732|NCT05082974|Varenicline|varenicline|mesh-list
1672733|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1672734|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1672735|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
1672736|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1672737|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672738|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672739|NCT05082909|Probenecid|probenecid|mesh-list
1672740|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
1672741|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
1672742|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1672743|NCT05082909|Renal Agents|renal agents|mesh-ancestor
1672744|NCT05082896|Anesthetics|anesthetics|mesh-list
1672745|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1672746|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672747|NCT05082753|Ivermectin|ivermectin|mesh-list
1672748|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1672749|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1672753|NCT05082662|Diclofenac|diclofenac|mesh-list
1672754|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1672755|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1672756|NCT05082662|Analgesics|analgesics|mesh-ancestor
1672757|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
1672758|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1672759|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672760|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1672761|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1672762|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1672763|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1672764|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672768|NCT05082441|Bupivacaine|bupivacaine|mesh-list
1672769|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
1672770|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
1672771|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1672772|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672773|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
1672774|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2475457|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475458|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475459|NCT01084187|Urological Agents|urological agents|mesh-ancestor
2475460|NCT01084200|Propofol|propofol|mesh-list
2475461|NCT01084200|Sevoflurane|sevoflurane|mesh-list
2475462|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2475463|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2475464|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475465|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2475466|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
2475467|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
2475468|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2475469|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2475470|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
2475471|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
2475472|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2475473|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1672792|NCT05075941|Vaccines|vaccines|mesh-list
1672793|NCT05075941|Immunologic Factors|immunologic factors|mesh-ancestor
1672794|NCT05075941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475474|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2475475|NCT01084291|Vaccines|vaccines|mesh-list
2475476|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
2475477|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475478|NCT01084330|Docetaxel|docetaxel|mesh-list
2475479|NCT01084330|Irinotecan|irinotecan|mesh-list
2475480|NCT01084330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475481|NCT01084330|Tubulin Modulators|tubulin modulators|mesh-ancestor
2475482|NCT01084330|Antimitotic Agents|antimitotic agents|mesh-ancestor
2475483|NCT01084330|Mitosis Modulators|mitosis modulators|mesh-ancestor
2475484|NCT01084330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475485|NCT01084330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2475486|NCT01084330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2475487|NCT01084330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1672821|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1672822|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1672823|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672824|NCT05072054|Atorvastatin|atorvastatin|mesh-list
1672825|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1672826|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1672827|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1672828|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
1672829|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672830|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1672831|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1672832|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475488|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
2475489|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
2475490|NCT01084369|Testosterone|testosterone|mesh-list
2475491|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
2475492|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
2475493|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
2475494|NCT01084369|Androgens|androgens|mesh-ancestor
2475495|NCT01084369|Hormones|hormones|mesh-ancestor
2475496|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2475497|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2475498|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2475499|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2475500|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
2475501|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
2475502|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
2475503|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2475504|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2475505|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2475506|NCT01084369|Urological Agents|urological agents|mesh-ancestor
1672870|NCT05049902|Amoxicillin|amoxicillin|mesh-list
1672871|NCT05049902|Metronidazole|metronidazole|mesh-list
1672872|NCT05049902|Clarithromycin|clarithromycin|mesh-list
1672873|NCT05049902|Tetracycline|tetracycline|mesh-list
1672874|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
1672875|NCT05049902|Bismuth|bismuth|mesh-list
1672876|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672877|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1672878|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1672879|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1672880|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1672881|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1672882|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1672883|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1672884|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1672885|NCT05049902|Antacids|antacids|mesh-ancestor
1672886|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1672887|NCT05049902|Diuretics|diuretics|mesh-ancestor
1672888|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
1672889|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672890|NCT05049902|Expectorants|expectorants|mesh-ancestor
1672891|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
2738806|NCT04361799|Insulin|insulin|mesh-list
1672895|NCT05048069|Rebamipide|rebamipide|mesh-list
1672896|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1672897|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1672898|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
1672899|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672900|NCT05048069|Protective Agents|protective agents|mesh-ancestor
1672901|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672902|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2738807|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2738808|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672930|NCT05036577|Dexamethasone|dexamethasone|mesh-list
1672931|NCT05036577|Rituximab|rituximab|mesh-list
1672932|NCT05036577|Methotrexate|methotrexate|mesh-list
1672933|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1672934|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
1672935|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
1672936|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1672937|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1672938|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1672939|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
1672940|NCT05036577|Hormones|hormones|mesh-ancestor
1672941|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1672942|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1672943|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1672944|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1672945|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
1672946|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1672947|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1672948|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
1672949|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1672950|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1672951|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
1672952|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1672953|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
1672954|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1672955|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1672956|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1672957|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1673021|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
1673022|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1673023|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673024|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1673025|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2738869|NCT04309916|Esomeprazole|esomeprazole|mesh-list
2738870|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2738871|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2738872|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2738873|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2738874|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738875|NCT04306510|Antibodies|antibodies|mesh-list
2738876|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
2738877|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
2738878|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
2738879|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673079|NCT04994132|Dactinomycin|dactinomycin|mesh-list
1673080|NCT04994132|Cactinomycin|cactinomycin|mesh-list
1673081|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
1673082|NCT04994132|Vincristine|vincristine|mesh-list
1673083|NCT04994132|Vinorelbine|vinorelbine|mesh-list
1673084|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1673085|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
1673086|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673087|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1673088|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1673089|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
1673090|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673091|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1673092|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1673093|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1673094|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
1673095|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
1673096|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
1673097|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1673098|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1673099|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1673100|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1673101|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1673102|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1673105|NCT04962230|Ritonavir|ritonavir|mesh-list
1673106|NCT04962230|Carbamazepine|carbamazepine|mesh-list
1673107|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1673108|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1673109|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
1673110|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1673111|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673112|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1673113|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1673114|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
1673115|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1673116|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1673117|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1673118|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
1673119|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
1673120|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1673121|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1673122|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673123|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1673124|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1673125|NCT04962230|Analgesics|analgesics|mesh-ancestor
1673126|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
1673127|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1673128|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1673129|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1673130|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1673131|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1673144|NCT04943341|Triamcinolone|triamcinolone|mesh-list
1673145|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1673146|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1673147|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1673148|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1673149|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
1673150|NCT04943341|Hormones|hormones|mesh-ancestor
1673151|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1673152|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673153|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1673154|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
1673155|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1673156|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673157|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
1673158|NCT04941040|Anesthetics|anesthetics|mesh-list
1673159|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1673160|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673161|NCT04941040|Narcotics|narcotics|mesh-ancestor
1673162|NCT04941040|Analgesics|analgesics|mesh-ancestor
1673163|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
1673164|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2738924|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
2738925|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1673168|NCT04934410|Midazolam|midazolam|mesh-list
1673169|NCT04934410|Etomidate|etomidate|mesh-list
1673170|NCT04934410|Sevoflurane|sevoflurane|mesh-list
1673171|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1673172|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1673173|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1673174|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673175|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1673176|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1673177|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1673178|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1673179|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
1673180|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
1673181|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
1673182|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
1673183|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1673184|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673185|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1673186|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2738926|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2738927|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2738928|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738929|NCT04275999|Ivermectin|ivermectin|mesh-list
2738930|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2738931|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1673367|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
1673229|NCT04923620|Cetuximab|cetuximab|mesh-list
1673230|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1673231|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1673235|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
1673236|NCT04918927|Favipiravir|favipiravir|mesh-list
1673237|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1673238|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1673239|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
1673264|NCT04896645|Albuterol|albuterol|mesh-list
1673265|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1673266|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
1673267|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1673268|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673269|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1673270|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
1673271|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
1673272|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1673273|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1673274|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1673275|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1673276|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
1673277|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1673278|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2738997|NCT04197986|Infigratinib|infigratinib|mesh-list
2738998|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739012|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2739013|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
1673294|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1673295|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2739014|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
2739015|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2739016|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1673299|NCT04873297|Metoclopramide|metoclopramide|mesh-list
1673300|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
1673301|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
1673302|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1673303|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673304|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1673305|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1673306|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1673307|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
1673308|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1673309|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673310|NCT04871607|Cytarabine|cytarabine|mesh-list
1673311|NCT04871607|Etoposide|etoposide|mesh-list
1673312|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
1673313|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
1673314|NCT04871607|Carmustine|carmustine|mesh-list
1673315|NCT04871607|Basiliximab|basiliximab|mesh-list
1673316|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1673317|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1673318|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1673319|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1673320|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1673321|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673322|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1673323|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
1673324|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
1673325|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1673326|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1673327|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
1673328|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673329|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1673330|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
1673331|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
1673332|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
1673333|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
1673334|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
1673335|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
2739017|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2739018|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739025|NCT04164732|Valsartan|valsartan|mesh-list
2739026|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1673346|NCT04858711|Lidocaine|lidocaine|mesh-list
1673347|NCT04858711|Fentanyl|fentanyl|mesh-list
1673348|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
1673349|NCT04858711|Ketamine|ketamine|mesh-list
1673350|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
1673351|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
1673352|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1673353|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673354|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
1673355|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1673356|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1673357|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1673358|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1673359|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1673360|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673361|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1673362|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1673363|NCT04858711|Analgesics|analgesics|mesh-ancestor
1673364|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1673365|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1673366|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2739027|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1673368|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1673369|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1673370|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1673371|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
1673372|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1673373|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1673374|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1673375|NCT04858711|Narcotics|narcotics|mesh-ancestor
1673376|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2739028|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2739029|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2739030|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673382|NCT04852224|Leuprolide|leuprolide|mesh-list
1673383|NCT04852224|Goserelin|goserelin|mesh-list
1673384|NCT04852224|Androgens|androgens|mesh-list
1673385|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1673386|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
1673387|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1673388|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673389|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1673390|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1673391|NCT04852224|Hormones|hormones|mesh-ancestor
1673392|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2739052|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2739053|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
2739054|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673427|NCT04826484|Bupivacaine|bupivacaine|mesh-list
1673428|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
1673429|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
1673430|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1673431|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673432|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
1673433|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1673449|NCT04810793|Amoxicillin|amoxicillin|mesh-list
1673450|NCT04810793|Levofloxacin|levofloxacin|mesh-list
1673451|NCT04810793|Ofloxacin|ofloxacin|mesh-list
1673452|NCT04810793|Tetracycline|tetracycline|mesh-list
1673453|NCT04810793|Furazolidone|furazolidone|mesh-list
1673454|NCT04810793|Esomeprazole|esomeprazole|mesh-list
1673455|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1673456|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1673457|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1673458|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1673459|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1673460|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1673461|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673462|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1673463|NCT04810793|Renal Agents|renal agents|mesh-ancestor
1673464|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1673465|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1673466|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1673467|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1673468|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1673469|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1673470|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1673471|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
1673472|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1673473|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1673474|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
2739093|NCT04136353|Hormones|hormones|mesh-list
2739094|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
2739095|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2739096|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739097|NCT04132817|Paclitaxel|paclitaxel|mesh-list
2739098|NCT04132817|Nivolumab|nivolumab|mesh-list
2739099|NCT04132817|Ipilimumab|ipilimumab|mesh-list
2739100|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2739101|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739102|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
2739103|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
2739104|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
2739105|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739106|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2739107|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2739108|NCT04126031|Ceftazidime|ceftazidime|mesh-list
2739109|NCT04126031|Avibactam|avibactam|mesh-list
2739110|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
2739111|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2739112|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2739113|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2739114|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2739115|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739130|NCT04101890|Allantoin|allantoin|mesh-list
2739131|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
2739132|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
2739133|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
2739134|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1673532|NCT04791228|Doxorubicin|doxorubicin|mesh-list
1673533|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1673534|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1673535|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1673536|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1673537|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1673538|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1673539|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739135|NCT04101890|Protective Agents|protective agents|mesh-ancestor
2739136|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739161|NCT04069156|Aspirin|aspirin|mesh-list
2739162|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2739163|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2739164|NCT04069156|Analgesics|analgesics|mesh-ancestor
2739165|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
2739166|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2739167|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739168|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2739169|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2739170|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2739171|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2739172|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739173|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2739174|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2739175|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2739176|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
2739180|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
2739181|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
2739182|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2739183|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739184|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2739185|NCT04028050|Carboplatin|carboplatin|mesh-list
2739186|NCT04028050|Etoposide|etoposide|mesh-list
2739187|NCT04028050|Atezolizumab|atezolizumab|mesh-list
2739188|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739189|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2739190|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2739191|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2739192|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2739193|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739194|NCT04017442|Morphine|morphine|mesh-list
2739195|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2739196|NCT04017442|Narcotics|narcotics|mesh-ancestor
2739197|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2739198|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739199|NCT04017442|Analgesics|analgesics|mesh-ancestor
2739200|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
2739201|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2739215|NCT03993314|Bupivacaine|bupivacaine|mesh-list
2739216|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
2739217|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
2739218|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
2739219|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2739220|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673630|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
1673631|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
1673632|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1673633|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
1673634|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739221|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
2739222|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1673645|NCT04728633|Carmustine|carmustine|mesh-list
1673646|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
1673647|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1673648|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
1673649|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673650|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1673651|NCT04725864|Progesterone|progesterone|mesh-list
1673652|NCT04725864|Progestins|progestins|mesh-ancestor
1673653|NCT04725864|Hormones|hormones|mesh-ancestor
1673654|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1673655|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673672|NCT04684368|Carboplatin|carboplatin|mesh-list
1673673|NCT04684368|Etoposide|etoposide|mesh-list
1673674|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
1673675|NCT04684368|Ifosfamide|ifosfamide|mesh-list
1673676|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
1673677|NCT04684368|Thiotepa|thiotepa|mesh-list
1673678|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
1673679|NCT04684368|Lenograstim|lenograstim|mesh-list
1673680|NCT04684368|Mesna|mesna|mesh-list
1673681|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1673682|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1673683|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1673684|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1673685|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1673686|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673687|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1673688|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
1673689|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673690|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1673691|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
1673692|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1673693|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1673694|NCT04684368|Protective Agents|protective agents|mesh-ancestor
1673695|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
1673696|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
1673697|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
1673698|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
1673699|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
2739251|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
2739252|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2739253|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
2739254|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2739255|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
2739256|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2739257|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739258|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
2739259|NCT03955471|Niraparib|niraparib|mesh-list
2739260|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2739261|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2739262|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739263|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739270|NCT03949894|Tolvaptan|tolvaptan|mesh-list
2739271|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2739272|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739273|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
2739274|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739275|NCT03942224|Dexamethasone|dexamethasone|mesh-list
2739276|NCT03942224|Bortezomib|bortezomib|mesh-list
2739277|NCT03942224|Daratumumab|daratumumab|mesh-list
2739278|NCT03942224|Ixazomib|ixazomib|mesh-list
2739279|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2739280|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
2739281|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
2739282|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2739283|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739284|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1673737|NCT04631393|Alfentanil|alfentanil|mesh-list
1673738|NCT04631393|Propofol|propofol|mesh-list
1673739|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1673740|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1673741|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673742|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1673743|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
1673744|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
1673745|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1673746|NCT04631393|Narcotics|narcotics|mesh-ancestor
1673747|NCT04631393|Analgesics|analgesics|mesh-ancestor
1673748|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
1673749|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2739285|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
2739286|NCT03942224|Hormones|hormones|mesh-ancestor
2739287|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2739288|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2739289|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739290|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
2739291|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2739292|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739295|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
2739296|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
2739297|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739298|NCT03928847|Protective Agents|protective agents|mesh-ancestor
2739299|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739300|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
2739301|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1673769|NCT04575857|Atorvastatin|atorvastatin|mesh-list
1673770|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1673771|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1673772|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
1673773|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673774|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1673775|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1673776|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2739302|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739303|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1673795|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
1673796|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
1673797|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
1673798|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
1673799|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1673800|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1673801|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1673802|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673803|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1673804|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2739320|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
2739321|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2739322|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739323|NCT03922997|Atezolizumab|atezolizumab|mesh-list
2739324|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1673823|NCT04537923|Insulin|insulin|mesh-list
1673824|NCT04537923|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1673825|NCT04537923|Insulin Glargine|insulin glargine|mesh-list
1673826|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
1673827|NCT04537923|Tirzepatide|tirzepatide|mesh-list
1673828|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1673829|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673830|NCT04537923|Incretins|incretins|mesh-ancestor
1673831|NCT04537923|Hormones|hormones|mesh-ancestor
1673832|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1673833|NCT04530747|Metformin|metformin|mesh-list
1673834|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1673835|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673848|NCT04513314|Valproic Acid|valproic acid|mesh-list
1673849|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1673850|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
1673851|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1673852|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1673853|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1673854|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1673855|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673856|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
1673857|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1673858|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673859|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
1673860|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1673861|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
1673873|NCT04497584|Prednisone|prednisone|mesh-list
1673874|NCT04497584|Afatinib|afatinib|mesh-list
1673875|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1673876|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
1673877|NCT04497584|Hormones|hormones|mesh-ancestor
1673878|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1673879|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673880|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1673881|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1673882|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1673883|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1673884|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673937|NCT04447118|Docetaxel|docetaxel|mesh-list
1673938|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1673939|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
1673940|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
1673941|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
1673942|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673943|NCT04443062|177Lu-PSMA-617|177lu-psma-617|mesh-list
1673944|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1673945|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673956|NCT04409002|Niraparib|niraparib|mesh-list
1673957|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1673958|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1673959|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673960|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1673961|NCT04406415|Nafamostat|nafamostat|mesh-list
1673962|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1673963|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1673964|NCT04406415|Analgesics|analgesics|mesh-ancestor
1673965|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
1673966|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1673967|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1673968|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1673969|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1673970|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
1673971|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
1673972|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1673973|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1673974|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1673975|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1673976|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1673977|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1673978|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
1674036|NCT04385277|Vitamin A|vitamin a|mesh-list
1674037|NCT04385277|Irinotecan|irinotecan|mesh-list
1674038|NCT04385277|Temozolomide|temozolomide|mesh-list
1674039|NCT04385277|Tretinoin|tretinoin|mesh-list
1674040|NCT04385277|Dinutuximab|dinutuximab|mesh-list
1674041|NCT04385277|Isotretinoin|isotretinoin|mesh-list
1674042|NCT04385277|Sargramostim|sargramostim|mesh-list
1674043|NCT04385277|Vitamins|vitamins|mesh-ancestor
1674044|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
1674045|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674046|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1674047|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1674048|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1674049|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1674050|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674051|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1674052|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
1674053|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
1674054|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
1674055|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
2739453|NCT03879109|Folfirinox|folfirinox|mesh-list
2739454|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739461|NCT03856359|Rifaximin|rifaximin|mesh-list
2739462|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2739463|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2739464|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2739474|NCT03846505|Oxytocin|oxytocin|mesh-list
2739475|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
2739476|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2739477|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739478|NCT03837015|Estradiol|estradiol|mesh-list
2739479|NCT03837015|Estrogens|estrogens|mesh-ancestor
2739480|NCT03837015|Hormones|hormones|mesh-ancestor
2739481|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2739482|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674113|NCT04293562|Cytarabine|cytarabine|mesh-list
1674114|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
1674115|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1674116|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1674117|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1674118|NCT04293562|Methotrexate|methotrexate|mesh-list
1674119|NCT04293562|Etoposide|etoposide|mesh-list
1674120|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
1674121|NCT04293562|Daunorubicin|daunorubicin|mesh-list
1674122|NCT04293562|Asparaginase|asparaginase|mesh-list
1674123|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
1674124|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
1674125|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
1674126|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
1674127|NCT04293562|Razoxane|razoxane|mesh-list
1674128|NCT04293562|Calicheamicins|calicheamicins|mesh-list
1674129|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1674130|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
1674131|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1674132|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674133|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1674134|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
1674135|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1674136|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674137|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
1674138|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1674139|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1674140|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1674141|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
1674142|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1674143|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1674144|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1674145|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1674146|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1674147|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
1674148|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1674149|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1674150|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1674151|NCT04293562|Analgesics|analgesics|mesh-ancestor
1674152|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
1674153|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1674154|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
1674155|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
1674156|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
1674157|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
1674158|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1674159|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1674160|NCT04293562|Protective Agents|protective agents|mesh-ancestor
1674161|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
1674162|NCT04277975|Narcotics|narcotics|mesh-ancestor
1674163|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1674164|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674165|NCT04277975|Analgesics|analgesics|mesh-ancestor
1674166|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
1674167|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1674168|NCT04275531|Anesthetics|anesthetics|mesh-list
1674169|NCT04275531|Propofol|propofol|mesh-list
1674170|NCT04275531|Sevoflurane|sevoflurane|mesh-list
1674171|NCT04275531|Isoflurane|isoflurane|mesh-list
1674172|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1674173|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674174|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1674175|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1674176|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
1674177|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1674178|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
2739509|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
2739510|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
2739511|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
2739512|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2739513|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2739514|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2739515|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1674203|NCT04262479|Vitamin D|vitamin d|mesh-list
1674204|NCT04262479|Vitamins|vitamins|mesh-ancestor
1674205|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
1674206|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674207|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1674259|NCT04239716|Anesthetics|anesthetics|mesh-list
1674260|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1674261|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674283|NCT04215848|Budesonide|budesonide|mesh-list
1674284|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
1674285|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1674286|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1674287|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
1674288|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1674289|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674290|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1674291|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
1674292|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
1674293|NCT04215848|Hormones|hormones|mesh-ancestor
1674294|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1674295|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1674296|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1674297|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1674298|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
1674299|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1674300|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739588|NCT03690011|Cyclophosphamide|cyclophosphamide|mesh-list
2739589|NCT03690011|Fludarabine|fludarabine|mesh-list
2739590|NCT03690011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2739591|NCT03690011|Immunologic Factors|immunologic factors|mesh-ancestor
2739592|NCT03690011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739593|NCT03690011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2739594|NCT03690011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2739595|NCT03690011|Alkylating Agents|alkylating agents|mesh-ancestor
2739596|NCT03690011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739597|NCT03690011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674317|NCT04200534|Nicotine|nicotine|mesh-list
1674318|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1674319|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
1674320|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1674321|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674322|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1674323|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1674324|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
1674325|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1674326|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739598|NCT03690011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2739603|NCT03674827|Vaccines|vaccines|mesh-list
1674333|NCT04195399|Imidazole|imidazole|mesh-list
1674334|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1674335|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739604|NCT03674827|Immunologic Factors|immunologic factors|mesh-list
2739605|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739606|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
2739607|NCT03654729|Edetic Acid|edetic acid|mesh-list
2739608|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
2739609|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
2739610|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
2739611|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
2739612|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739613|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
2739614|NCT03654729|Vitamins|vitamins|mesh-ancestor
2739615|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
2739616|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739635|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
2739636|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2739637|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739651|NCT03582176|Ketotifen|ketotifen|mesh-list
2739652|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
2739653|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
2739654|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2739655|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
2739656|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
2739657|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2739658|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739659|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674409|NCT04107051|Nalmefene|nalmefene|mesh-list
1674410|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1674411|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674412|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
1674413|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2739660|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2739667|NCT03560466|Prednisone|prednisone|mesh-list
2739668|NCT03560466|Prednisolone|prednisolone|mesh-list
2739669|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2739670|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
2739671|NCT03560466|Hormones|hormones|mesh-ancestor
2739672|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2739673|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739674|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2739675|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674442|NCT04090710|Nivolumab|nivolumab|mesh-list
1674443|NCT04090710|Ipilimumab|ipilimumab|mesh-list
1674444|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1674445|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674446|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1674447|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1674448|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
1674449|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
1674450|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1674451|NCT04088591|Protective Agents|protective agents|mesh-ancestor
1674452|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674453|NCT04088591|Vitamins|vitamins|mesh-ancestor
1674454|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
2739687|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
2739688|NCT03547973|Avelumab|avelumab|mesh-list
2739689|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739690|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1674473|NCT04028388|Docetaxel|docetaxel|mesh-list
1674474|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674475|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
1674476|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
1674477|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
1674478|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1674493|NCT04003506|Bupivacaine|bupivacaine|mesh-list
1674494|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
1674495|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
1674496|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1674497|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674498|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
1674499|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2739729|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
2739730|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2739731|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739732|NCT03484923|Spartalizumab|spartalizumab|mesh-list
2739733|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2739734|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739735|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739736|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
2739737|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2739738|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2739739|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2739740|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2739741|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739742|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
2739743|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2739744|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739745|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2739746|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2739747|NCT03406286|Tolvaptan|tolvaptan|mesh-list
2739748|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
2739749|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739750|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
2739751|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739752|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
2739753|NCT03393845|Fulvestrant|fulvestrant|mesh-list
2739754|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2739755|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739756|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2739757|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2739758|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2739759|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
2739760|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2739761|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739762|NCT03376763|Aripiprazole|aripiprazole|mesh-list
2739763|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
2739764|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2739765|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2739766|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2739767|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2739768|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739769|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
2739770|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
2739771|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2739772|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739773|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
2739774|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2739775|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
2739776|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
2739777|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2739778|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
2739779|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1674564|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
1674565|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1674566|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674579|NCT03955640|Olaparib|olaparib|mesh-list
1674580|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1674581|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1674582|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1674583|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674584|NCT03954782|Nintedanib|nintedanib|mesh-list
1674585|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674586|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1674587|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1674588|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739817|NCT03336203|Allopurinol|allopurinol|mesh-list
2739818|NCT03336203|Febuxostat|febuxostat|mesh-list
2739819|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
1674618|NCT03934905|Sulforaphane|sulforaphane|mesh-list
1674619|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1674620|NCT03934905|Protective Agents|protective agents|mesh-ancestor
1674621|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674622|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739820|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739821|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2739822|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
2739823|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2739824|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2739825|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
2739826|NCT03336203|Protective Agents|protective agents|mesh-ancestor
2739827|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674640|NCT03919292|Valproic Acid|valproic acid|mesh-list
1674641|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
1674642|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1674643|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1674644|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
1674645|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1674646|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674647|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
1674648|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1674649|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1674650|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2739835|NCT03296033|Enoxaparin|enoxaparin|mesh-list
2739836|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
2739837|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
2739838|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2739839|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2739840|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739841|NCT03237286|Ketamine|ketamine|mesh-list
2739842|NCT03237286|Analgesics|analgesics|mesh-ancestor
2739843|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
2739844|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2739845|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739846|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2739847|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2739848|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
2739849|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
2739850|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2739851|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2739852|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2739853|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2739854|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1674697|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
1674698|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1674699|NCT03910738|Testosterone|testosterone|mesh-list
1674700|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
1674701|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
1674702|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1674703|NCT03910738|Androgens|androgens|mesh-ancestor
1674704|NCT03910738|Hormones|hormones|mesh-ancestor
1674705|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1674706|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674707|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1674708|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674709|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
1674745|NCT03890744|Docetaxel|docetaxel|mesh-list
1674746|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674747|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
1674748|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
1674749|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
1674750|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1674751|NCT03885037|Infliximab|infliximab|mesh-list
1674752|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
1674753|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1674754|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1674769|NCT03860038|Dexamethasone|dexamethasone|mesh-list
1674770|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1674771|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
1674772|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
1674773|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1674774|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674775|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1674776|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
1674777|NCT03860038|Hormones|hormones|mesh-ancestor
1674778|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1674779|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1674780|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674796|NCT03831503|Antibodies|antibodies|mesh-list
1674797|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
1674798|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674799|NCT03823300|Aflibercept|aflibercept|mesh-list
1674800|NCT03823300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1674801|NCT03823300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1674802|NCT03823300|Growth Substances|growth substances|mesh-ancestor
1674803|NCT03823300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674804|NCT03823300|Growth Inhibitors|growth inhibitors|mesh-ancestor
1674805|NCT03823300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674806|NCT03823287|Aflibercept|aflibercept|mesh-list
1674807|NCT03823287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1674808|NCT03823287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1674809|NCT03823287|Growth Substances|growth substances|mesh-ancestor
1674810|NCT03823287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674811|NCT03823287|Growth Inhibitors|growth inhibitors|mesh-ancestor
1674812|NCT03823287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674813|NCT03820817|Rifaximin|rifaximin|mesh-list
1674814|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1674815|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1674816|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2739920|NCT03171025|Nivolumab|nivolumab|mesh-list
2739921|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2739922|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739923|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2739924|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739925|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
2739926|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
2739927|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2739928|NCT03155061|Nivolumab|nivolumab|mesh-list
2739929|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2739930|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739931|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2739932|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739933|NCT03141424|Fluticasone|fluticasone|mesh-list
2739934|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
2739935|NCT03141424|Ciclesonide|ciclesonide|mesh-list
2739936|NCT03141424|Budesonide|budesonide|mesh-list
2739937|NCT03141424|Beclomethasone|beclomethasone|mesh-list
2739938|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2739939|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2739940|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
2739941|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2739942|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739943|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2739944|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
2739945|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
2739946|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2739947|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
2739948|NCT03141424|Hormones|hormones|mesh-ancestor
2739949|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2739950|NCT03106688|Carfentanil|carfentanil|mesh-list
2739951|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2739952|NCT03106688|Narcotics|narcotics|mesh-ancestor
2739953|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2739954|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739955|NCT03106688|Analgesics|analgesics|mesh-ancestor
2739956|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
2739957|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2739958|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
2739959|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739960|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
2739961|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
2739962|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2739963|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2739964|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
2739965|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2739966|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
2739967|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2739968|NCT03032601|Expectorants|expectorants|mesh-ancestor
2739969|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
2739970|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2739971|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
2739972|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2739973|NCT03032601|Protective Agents|protective agents|mesh-ancestor
2739974|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739975|NCT03032601|Antidotes|antidotes|mesh-ancestor
2739976|NCT03032328|Vitamin D|vitamin d|mesh-list
2739977|NCT03032328|Vitamins|vitamins|mesh-ancestor
2739978|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
2739979|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2739980|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1674908|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
1674909|NCT03789097|Poly ICLC|poly iclc|mesh-list
1674910|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1674911|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674912|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
1674913|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
1674914|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674954|NCT03745430|Ramucirumab|ramucirumab|mesh-list
1674955|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1674956|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
1674957|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1674958|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1674959|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1674960|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
1674961|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1674962|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1674963|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740007|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
2740008|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2740009|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
2740010|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2740011|NCT02966873|Expectorants|expectorants|mesh-ancestor
2740012|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
2740013|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2740014|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
2740015|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740016|NCT02966873|Protective Agents|protective agents|mesh-ancestor
1674978|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
1674979|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1674980|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
1674981|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1674982|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1674983|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1674984|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
1674985|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1674986|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
1674987|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1674988|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1674989|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1674990|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
1674991|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
1674992|NCT03718793|Protective Agents|protective agents|mesh-ancestor
2740017|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740018|NCT02966873|Antidotes|antidotes|mesh-ancestor
2740019|NCT02951767|Atezolizumab|atezolizumab|mesh-list
2740020|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675000|NCT03708549|Metformin|metformin|mesh-list
1675001|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1675002|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740026|NCT02685735|Gabapentin|gabapentin|mesh-list
2740027|NCT02685735|Analgesics|analgesics|mesh-ancestor
2740028|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
2740029|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740030|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740031|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
2740032|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2740033|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2740034|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2740035|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2740036|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2740037|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2740038|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2740039|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740040|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
2740041|NCT02657434|Carboplatin|carboplatin|mesh-list
1675021|NCT03671967|Meropenem|meropenem|mesh-list
1675022|NCT03671967|Tazobactam|tazobactam|mesh-list
1675023|NCT03671967|Piperacillin|piperacillin|mesh-list
1675024|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
1675025|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1675026|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1675027|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1675028|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1675029|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740042|NCT02657434|Pemetrexed|pemetrexed|mesh-list
2740043|NCT02657434|Atezolizumab|atezolizumab|mesh-list
2740044|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740045|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2740046|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740047|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2740048|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2740066|NCT02631070|Luspatercept|luspatercept|mesh-list
2740067|NCT02631070|Hematinics|hematinics|mesh-ancestor
2740068|NCT02630641|Hormones|hormones|mesh-list
2740069|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2740070|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740071|NCT02616185|Tremelimumab|tremelimumab|mesh-list
2740072|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740073|NCT02606305|Bevacizumab|bevacizumab|mesh-list
2740074|NCT02606305|Pembrolizumab|pembrolizumab|mesh-list
2740075|NCT02606305|Carboplatin|carboplatin|mesh-list
2740076|NCT02606305|Doxorubicin|doxorubicin|mesh-list
1675067|NCT03622593|Aflibercept|aflibercept|mesh-list
1675068|NCT03622593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1675069|NCT03622593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1675070|NCT03622593|Growth Substances|growth substances|mesh-ancestor
1675071|NCT03622593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675072|NCT03622593|Growth Inhibitors|growth inhibitors|mesh-ancestor
1675073|NCT03622593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740077|NCT02606305|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2740078|NCT02606305|Maytansine|maytansine|mesh-list
2740079|NCT02606305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2740080|NCT02606305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740081|NCT02606305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2740082|NCT02606305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2740083|NCT02606305|Growth Substances|growth substances|mesh-ancestor
2740084|NCT02606305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740085|NCT02606305|Growth Inhibitors|growth inhibitors|mesh-ancestor
2740086|NCT02606305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2740087|NCT02606305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2740088|NCT02606305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2740089|NCT02606305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2740090|NCT02606305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675121|NCT03524326|Cetuximab|cetuximab|mesh-list
1675122|NCT03524326|Lenvatinib|lenvatinib|mesh-list
1675123|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1675124|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675125|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1675126|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1675127|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740091|NCT02606305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1675203|NCT03426254|Talazoparib|talazoparib|mesh-list
2740092|NCT02606305|Tubulin Modulators|tubulin modulators|mesh-ancestor
2740093|NCT02606305|Antimitotic Agents|antimitotic agents|mesh-ancestor
2740094|NCT02606305|Mitosis Modulators|mitosis modulators|mesh-ancestor
1675144|NCT03512223|Dexamethasone|dexamethasone|mesh-list
1675145|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1675146|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
1675147|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
1675148|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1675149|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675150|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1675151|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
1675152|NCT03512223|Hormones|hormones|mesh-ancestor
1675153|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1675154|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1675155|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675169|NCT03441139|Analgesics|analgesics|mesh-list
1675170|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
1675171|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1675172|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740125|NCT02513667|Ceritinib|ceritinib|mesh-list
2740126|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740127|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2740128|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2740129|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740130|NCT02513329|Bupivacaine|bupivacaine|mesh-list
2740131|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
2740132|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
2740133|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2740134|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740135|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
2740136|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740137|NCT02486042|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2740138|NCT02486042|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
2740139|NCT02486042|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2740140|NCT02486042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1675193|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
1675194|NCT03426891|Temozolomide|temozolomide|mesh-list
1675195|NCT03426891|Vorinostat|vorinostat|mesh-list
1675196|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
1675197|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1675198|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675199|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1675200|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
1675201|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675202|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1675204|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1675205|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1675206|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675207|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675221|NCT03359460|Lenalidomide|lenalidomide|mesh-list
1675222|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
1675223|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675224|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1675225|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1675226|NCT03359460|Growth Substances|growth substances|mesh-ancestor
1675227|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
1675228|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675229|NCT03351348|Bupivacaine|bupivacaine|mesh-list
1675230|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
1675231|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
1675232|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1675233|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675234|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
1675235|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1675236|NCT03339128|Eluxadoline|eluxadoline|mesh-list
1675237|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2740156|NCT02307812|Paclitaxel|paclitaxel|mesh-list
2740157|NCT02307812|Ramucirumab|ramucirumab|mesh-list
2740158|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2740159|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740160|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
2740161|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
2740162|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
2740163|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740164|NCT02297139|Dasatinib|dasatinib|mesh-list
2740165|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740166|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2740167|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2740168|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740169|NCT02281955|Cisplatin|cisplatin|mesh-list
2740170|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740171|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
2740172|NCT02245230|Trimethaphan|trimethaphan|mesh-list
2740173|NCT02245230|Phenylephrine|phenylephrine|mesh-list
2740174|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
2740175|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
2740176|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
2740177|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
2740178|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
2740179|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740180|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740181|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
2740182|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2740183|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
2740184|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
2740185|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
2740186|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2740187|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2740188|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
2740189|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2740190|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740191|NCT02245230|Protective Agents|protective agents|mesh-ancestor
2740192|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2740193|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
2740194|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2740195|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
2740196|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
2740197|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2740198|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
2740199|NCT02152982|Temozolomide|temozolomide|mesh-list
2740200|NCT02152982|Veliparib|veliparib|mesh-list
2740201|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2740202|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
2740203|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740204|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740205|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
2740206|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2740207|NCT02108652|Atezolizumab|atezolizumab|mesh-list
2740208|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740209|NCT02097134|Melphalan|melphalan|mesh-list
1675310|NCT03227263|Bevacizumab|bevacizumab|mesh-list
1675311|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1675312|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675313|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1675314|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1675315|NCT03227263|Growth Substances|growth substances|mesh-ancestor
1675316|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675317|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
1675318|NCT03222570|Serotonin|serotonin|mesh-list
1675319|NCT03222570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1675320|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1675321|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
1675322|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1675323|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675324|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675325|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1675326|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2740210|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
2740211|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
2740212|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2740213|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
2740214|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740215|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740216|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2740217|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2740218|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
2740219|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675347|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
1675348|NCT03211416|Sorafenib|sorafenib|mesh-list
1675349|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1675350|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675351|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1675352|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1675353|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740231|NCT02065765|Ramucirumab|ramucirumab|mesh-list
2740232|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740248|NCT01588431|Bevacizumab|bevacizumab|mesh-list
2740249|NCT01588431|Cetuximab|cetuximab|mesh-list
2740250|NCT01588431|Cisplatin|cisplatin|mesh-list
2740251|NCT01588431|Docetaxel|docetaxel|mesh-list
2740252|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2740253|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740254|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2740255|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2740256|NCT01588431|Growth Substances|growth substances|mesh-ancestor
2740257|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740258|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
2740259|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
2740260|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
2740261|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
2740262|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740263|NCT01564537|Dexamethasone|dexamethasone|mesh-list
2740264|NCT01564537|Lenalidomide|lenalidomide|mesh-list
2740265|NCT01564537|Ixazomib|ixazomib|mesh-list
2740266|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2740267|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
2740268|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
2740269|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740270|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740271|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2740272|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
2740273|NCT01564537|Hormones|hormones|mesh-ancestor
2740274|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2740275|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2740276|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740277|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
2740278|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2740279|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2740280|NCT01564537|Growth Substances|growth substances|mesh-ancestor
2740281|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
2740282|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
2740283|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2740284|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740285|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
2740286|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2740287|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
2740288|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2740289|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740290|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2740291|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
2740292|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1675423|NCT03150368|Docetaxel|docetaxel|mesh-list
1675424|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675425|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
1675426|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
1675427|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
1675428|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675429|NCT03147378|Docetaxel|docetaxel|mesh-list
1675430|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675431|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
1675432|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
1675433|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
1675434|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675435|NCT03147040|Carboplatin|carboplatin|mesh-list
1675436|NCT03147040|Atezolizumab|atezolizumab|mesh-list
1675437|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675443|NCT03136640|Docetaxel|docetaxel|mesh-list
1675444|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675445|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
1675446|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
1675447|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
1675448|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740319|NCT00983437|Modafinil|modafinil|mesh-list
2740320|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2740321|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740322|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2740323|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2740324|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2740325|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740329|NCT00893789|Modafinil|modafinil|mesh-list
1675484|NCT03067181|Cisplatin|cisplatin|mesh-list
1675485|NCT03067181|Carboplatin|carboplatin|mesh-list
1675486|NCT03067181|Etoposide|etoposide|mesh-list
1675487|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
1675488|NCT03067181|Bleomycin|bleomycin|mesh-list
1675489|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
1675490|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675491|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1675492|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1675493|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1675494|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1675495|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675496|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1675497|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
1675498|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
1675499|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
1675500|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
1675501|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
2740330|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2740331|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740332|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
2740333|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2740334|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2740335|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740336|NCT00805129|Everolimus|everolimus|mesh-list
2740337|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740338|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2740339|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
2740340|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740341|NCT00708448|Bevacizumab|bevacizumab|mesh-list
2740342|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
2740343|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2740344|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740345|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2740346|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2740347|NCT00708448|Growth Substances|growth substances|mesh-ancestor
2740348|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740349|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
2740350|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2740351|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2740352|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740353|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
2740354|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
2740355|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2740356|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2740357|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740358|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2740359|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740360|NCT00071708|Analgesics|analgesics|mesh-ancestor
2740361|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
2740362|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740363|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
2740364|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2740365|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
1675580|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
1675581|NCT02981628|Leucovorin|leucovorin|mesh-list
1675582|NCT02981628|Folic Acid|folic acid|mesh-list
1675583|NCT02981628|Cytarabine|cytarabine|mesh-list
1675584|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
1675585|NCT02981628|Methotrexate|methotrexate|mesh-list
1675586|NCT02981628|Vincristine|vincristine|mesh-list
1675587|NCT02981628|Asparaginase|asparaginase|mesh-list
1675588|NCT02981628|Mercaptopurine|mercaptopurine|mesh-list
1675589|NCT02981628|Pegaspargase|pegaspargase|mesh-list
1675590|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
1675591|NCT02981628|Calcium|calcium|mesh-list
1675592|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
1675593|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1675594|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
1675595|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675596|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1675597|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1675598|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
1675599|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675600|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675601|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1675602|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1675603|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1675604|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1675605|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
1675606|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1675607|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1675608|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
1675609|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
1675610|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1675611|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1675612|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1675613|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
1675614|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1675615|NCT02981628|Antidotes|antidotes|mesh-ancestor
1675616|NCT02981628|Protective Agents|protective agents|mesh-ancestor
1675617|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
1675618|NCT02981628|Vitamins|vitamins|mesh-ancestor
1675619|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
1675620|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1675621|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
1675622|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
1675623|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
1675624|NCT02981628|Hematinics|hematinics|mesh-ancestor
1675625|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1675626|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2740375|NCT05164614|Teriparatide|teriparatide|mesh-list
2740376|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2740377|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740378|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2740379|NCT05164549|Buprenorphine|buprenorphine|mesh-list
2740380|NCT05164549|Methadone|methadone|mesh-list
2740381|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2740382|NCT05164549|Narcotics|narcotics|mesh-ancestor
2740383|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1675636|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
1675637|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1675638|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
1675639|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1675640|NCT02972398|Expectorants|expectorants|mesh-ancestor
1675641|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
1675642|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1675643|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
1675644|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675645|NCT02972398|Protective Agents|protective agents|mesh-ancestor
1675646|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675647|NCT02972398|Antidotes|antidotes|mesh-ancestor
2740384|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740385|NCT05164549|Analgesics|analgesics|mesh-ancestor
2740386|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
2740387|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740388|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2740389|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
2740390|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
1675655|NCT02914470|Atezolizumab|atezolizumab|mesh-list
1675656|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740391|NCT05164367|Atropine|atropine|mesh-list
2740392|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2740393|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2740394|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2740395|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
2740396|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740397|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740398|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2740399|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
2740400|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
2740401|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
2740402|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
2740403|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
2740404|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
2740405|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2740406|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740412|NCT05164198|Adalimumab|adalimumab|mesh-list
2740413|NCT05164198|Etanercept|etanercept|mesh-list
2740414|NCT05164198|Golimumab|golimumab|mesh-list
2740415|NCT05164198|Infliximab|infliximab|mesh-list
2740416|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2740417|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2740418|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2740419|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2740420|NCT05164198|Analgesics|analgesics|mesh-ancestor
2740421|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
2740422|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740423|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740424|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2740425|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2740426|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
2740427|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
2740428|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
2740429|NCT05164159|Propofol|propofol|mesh-list
2740430|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2740431|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2740432|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740433|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2740434|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
2740435|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
1675726|NCT02826512|Niraparib|niraparib|mesh-list
1675727|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1675728|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1675729|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675730|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740436|NCT05164146|Propofol|propofol|mesh-list
2740437|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2740438|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2740439|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740440|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2740441|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
2740442|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
2740443|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2740444|NCT05164081|Clindamycin|clindamycin|mesh-list
2740445|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
1675816|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
2740446|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
2740447|NCT05164081|Gentamicins|gentamicins|mesh-list
2740448|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2740449|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2740450|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
2740451|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
2740452|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2740453|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740454|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2740455|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
2740456|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740457|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
1675758|NCT02810743|Olaparib|olaparib|mesh-list
1675759|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1675760|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1675761|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675762|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740458|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2740459|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2740460|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740461|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2740462|NCT05163704|Analgesics|analgesics|mesh-ancestor
2740463|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
2740464|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740465|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2740466|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2740467|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1675773|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
1675774|NCT02724579|Lomustine|lomustine|mesh-list
1675775|NCT02724579|Cisplatin|cisplatin|mesh-list
1675776|NCT02724579|Vincristine|vincristine|mesh-list
1675777|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1675778|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
1675779|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675780|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1675781|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1675782|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
1675783|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675784|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675785|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1675786|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1675787|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
1675788|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
1675789|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
1675790|NCT02660710|Rituximab|rituximab|mesh-list
1675791|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1675792|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675793|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
1675794|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675795|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2740468|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
2740469|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2740470|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740471|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
2740472|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
1675801|NCT02609828|Tanezumab|tanezumab|mesh-list
1675802|NCT02609828|Analgesics|analgesics|mesh-ancestor
1675803|NCT02609828|Sensory System Agents|sensory system agents|mesh-ancestor
1675804|NCT02609828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1675805|NCT02609828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740473|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740474|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2740475|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2740476|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
2740477|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2740478|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740479|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1675814|NCT02521493|Cytarabine|cytarabine|mesh-list
1675815|NCT02521493|Etoposide|etoposide|mesh-list
1675817|NCT02521493|Daunorubicin|daunorubicin|mesh-list
1675818|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
1675819|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
1675820|NCT02521493|Asparaginase|asparaginase|mesh-list
1675821|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
1675822|NCT02521493|Thioguanine|thioguanine|mesh-list
1675823|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
1675824|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1675825|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675826|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1675827|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1675828|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1675829|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675830|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1675831|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
1675832|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
1675833|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1675834|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1675835|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
1675836|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675837|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1675838|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1675839|NCT02521493|Analgesics|analgesics|mesh-ancestor
1675840|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
1675841|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1675842|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
1675843|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
1675844|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
1675845|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
1675846|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
2740487|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1675854|NCT02492711|Gemcitabine|gemcitabine|mesh-list
1675855|NCT02492711|Capecitabine|capecitabine|mesh-list
1675856|NCT02492711|Trastuzumab|trastuzumab|mesh-list
1675857|NCT02492711|Vinorelbine|vinorelbine|mesh-list
1675858|NCT02492711|Margetuximab|margetuximab|mesh-list
1675859|NCT02492711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1675860|NCT02492711|Antimetabolites|antimetabolites|mesh-ancestor
1675861|NCT02492711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675862|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1675863|NCT02492711|Antiviral Agents|antiviral agents|mesh-ancestor
1675864|NCT02492711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1675865|NCT02492711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1675866|NCT02492711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1675867|NCT02492711|Immunologic Factors|immunologic factors|mesh-ancestor
1675868|NCT02492711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675869|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1675870|NCT02492711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1675871|NCT02492711|Tubulin Modulators|tubulin modulators|mesh-ancestor
1675872|NCT02492711|Antimitotic Agents|antimitotic agents|mesh-ancestor
1675873|NCT02492711|Mitosis Modulators|mitosis modulators|mesh-ancestor
1675874|NCT02484716|Timolol|timolol|mesh-list
1675875|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1675876|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1675877|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
1675878|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1675879|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1675880|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675881|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1675882|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2740488|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740489|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740490|NCT05163405|Bortezomib|bortezomib|mesh-list
2740491|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740492|NCT05163366|Morphine|morphine|mesh-list
2740493|NCT05163366|Ketamine|ketamine|mesh-list
2740494|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2740495|NCT05163366|Narcotics|narcotics|mesh-ancestor
2740496|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2740497|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740498|NCT05163366|Analgesics|analgesics|mesh-ancestor
2740499|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
2740500|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740501|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2740502|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2740503|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
2740504|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
2740505|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2740506|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2740507|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2740508|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740509|NCT05163249|Osimertinib|osimertinib|mesh-list
2740510|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740511|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2740512|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2740513|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740514|NCT05163223|Capecitabine|capecitabine|mesh-list
2740515|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
2740516|NCT05163223|Sargramostim|sargramostim|mesh-list
2740517|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2740518|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
2740519|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740520|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740521|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2740522|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
2740523|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740524|NCT05163106|Letrozole|letrozole|mesh-list
2740525|NCT05163106|Goserelin|goserelin|mesh-list
2740526|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740527|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2740528|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2740529|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2740530|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740531|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2740532|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
2740533|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2740534|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740535|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2740541|NCT05162976|Nivolumab|nivolumab|mesh-list
2740542|NCT05162976|Azacitidine|azacitidine|mesh-list
2740543|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2740544|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740545|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2740546|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740547|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2740548|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
2740549|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2740550|NCT05162937|Antibodies|antibodies|mesh-list
2740551|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
2740552|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740553|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
2740554|NCT05161611|Astringents|astringents|mesh-ancestor
2740555|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740556|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
2740557|NCT05160727|Irinotecan|irinotecan|mesh-list
2740558|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2740559|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1675961|NCT02418195|Ketamine|ketamine|mesh-list
1675962|NCT02418195|Analgesics|analgesics|mesh-ancestor
1675963|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
1675964|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1675965|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1675966|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1675967|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1675968|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
1675969|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
1675970|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1675971|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1675972|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1675973|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1675974|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740560|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2740561|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740562|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740600|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
2740601|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
2740602|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
2740603|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740604|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740605|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
2740606|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2740607|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740608|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
2740609|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2740616|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
2740617|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
2740618|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740619|NCT05141422|Efavirenz|efavirenz|mesh-list
2740620|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
2740621|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2740622|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2740623|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740624|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
2740625|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2740626|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
2740627|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2740628|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2740629|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2740630|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2740631|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2740632|NCT05140148|Amantadine|amantadine|mesh-list
2740633|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2740634|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2740635|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
2740636|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2740637|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
2740638|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2740639|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740640|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740641|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2740642|NCT05140148|Analgesics|analgesics|mesh-ancestor
2740643|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
2740644|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740663|NCT05137678|Glyburide|glyburide|mesh-list
2740664|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2740665|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740675|NCT05101018|Denosumab|denosumab|mesh-list
2740676|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2740677|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740678|NCT05097651|Cannabidiol|cannabidiol|mesh-list
2740679|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
2740686|NCT05093959|Metformin|metformin|mesh-list
2740687|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2740688|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740698|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
2740699|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2740700|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740701|NCT05088980|Lidocaine|lidocaine|mesh-list
2740702|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
2740703|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
2740704|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2740705|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740706|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
2740707|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740708|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2740709|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2740710|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2740711|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2740712|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740713|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
2740714|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
2740715|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
2740725|NCT05061134|Durvalumab|durvalumab|mesh-list
2740726|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2740727|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740760|NCT05045378|Midazolam|midazolam|mesh-list
2740761|NCT05045378|Ketamine|ketamine|mesh-list
2740762|NCT05045378|Analgesics|analgesics|mesh-ancestor
2740763|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
2740764|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740765|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740766|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2740767|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2740768|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
2740769|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
2740770|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2740771|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2740772|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2740773|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2740774|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740775|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2740776|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2740777|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2740778|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2740779|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2740780|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
2740781|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
2740782|NCT05040360|Capecitabine|capecitabine|mesh-list
2740783|NCT05040360|Temozolomide|temozolomide|mesh-list
2740784|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2740785|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
2740786|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740787|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740788|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2740789|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
2740890|NCT04965064|Capecitabine|capecitabine|mesh-list
2740891|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2740892|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
2740893|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740894|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2740895|NCT04959760|Antibodies|antibodies|mesh-list
2740896|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
2740897|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
2740898|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
2740899|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740944|NCT04956575|Vaccines|vaccines|mesh-list
2740945|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
2740946|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740953|NCT04939597|Memantine|memantine|mesh-list
2740954|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2740955|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2740956|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
2740957|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2740958|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740959|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740960|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2740961|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2740962|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
2740963|NCT04938765|Analgesics|analgesics|mesh-ancestor
2740964|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
2740965|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2740966|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2740967|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
2740968|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2740969|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2740970|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
2740971|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2740972|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2740973|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2740974|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2740975|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
2740976|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2741058|NCT04917861|Vaccines|vaccines|mesh-list
2741059|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
2741060|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741106|NCT04895202|Siponimod|siponimod|mesh-list
2741107|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2741108|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741109|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2741110|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
2741111|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1676711|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
1676712|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1676713|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1676714|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
1676715|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1676716|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1676717|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1676718|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
1676719|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1676720|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
1676721|NCT05088369|Protective Agents|protective agents|mesh-ancestor
2741134|NCT04845035|Cytarabine|cytarabine|mesh-list
2741135|NCT04845035|Methotrexate|methotrexate|mesh-list
2741136|NCT04845035|Dasatinib|dasatinib|mesh-list
2741137|NCT04845035|Ponatinib|ponatinib|mesh-list
1676748|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1676749|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1676750|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1676751|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
1676752|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1676753|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1676754|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1676755|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1676756|NCT05088330|Daratumumab|daratumumab|mesh-list
1676757|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741138|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2741139|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
2741140|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2741141|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741142|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2741143|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
2741144|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741145|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741146|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
1676767|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1676768|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1676769|NCT05088174|Cyclosporine|cyclosporine|mesh-list
1676770|NCT05088174|Cyclosporins|cyclosporins|mesh-list
1676771|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1676772|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1676773|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1676774|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
1676775|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1676776|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
1676777|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1676778|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
1676779|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1676780|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1676781|NCT05088083|Paclitaxel|paclitaxel|mesh-list
1676782|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1676783|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1676784|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
1676785|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
1676786|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
1676787|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1676788|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
1676789|NCT05088057|Docetaxel|docetaxel|mesh-list
1676790|NCT05088057|Doxorubicin|doxorubicin|mesh-list
1676791|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1676792|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
1676793|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1676794|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1676795|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1676796|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
1676797|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1676798|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1676799|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1676800|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
1676801|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
1676802|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
1676803|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1676804|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1676805|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1676806|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741147|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741148|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2741149|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2741150|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
2741151|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2741152|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2741153|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
2741154|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2741155|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2741179|NCT04820179|Atezolizumab|atezolizumab|mesh-list
2741180|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741181|NCT04809051|Metronidazole|metronidazole|mesh-list
2741182|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2741183|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2741184|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1676845|NCT05087797|Nicorandil|nicorandil|mesh-list
1676846|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1676847|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1676848|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
1676849|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
1676850|NCT05087797|Vitamins|vitamins|mesh-ancestor
1676851|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
1676852|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1676853|NCT05087771|Naltrexone|naltrexone|mesh-list
1676854|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1676855|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1676856|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1676857|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
1676858|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2741185|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1676871|NCT05087706|Bicalutamide|bicalutamide|mesh-list
1676872|NCT05087706|Leuprolide|leuprolide|mesh-list
1676873|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
1676874|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
1676875|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1676876|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1676877|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1676878|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1676879|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
1676880|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1676881|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1676882|NCT05087693|Albuterol|albuterol|mesh-list
1676883|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1676884|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
1676885|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1676886|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1676887|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1676888|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
1676889|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
1676890|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1676891|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1676892|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1676893|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1676894|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
1676895|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1676896|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741235|NCT04760730|Vaccines|vaccines|mesh-list
2741236|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
2741237|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1676960|NCT05087368|Vaccines|vaccines|mesh-list
1676961|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
1676962|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1676974|NCT05087134|Choline|choline|mesh-list
1676975|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
1676976|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1676977|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
1676978|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1676979|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1676980|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1676981|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
1676991|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
1676992|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1676993|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1676994|NCT05086874|Protective Agents|protective agents|mesh-ancestor
1676995|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1676996|NCT05086848|Leucovorin|leucovorin|mesh-list
1676997|NCT05086848|Fluorouracil|fluorouracil|mesh-list
1676998|NCT05086848|Irinotecan|irinotecan|mesh-list
1676999|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
1677000|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677001|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1677002|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677003|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1677004|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
1677005|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677006|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1677007|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1677008|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1677009|NCT05086848|Antidotes|antidotes|mesh-ancestor
1677010|NCT05086848|Protective Agents|protective agents|mesh-ancestor
1677011|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
1677012|NCT05086848|Vitamins|vitamins|mesh-ancestor
1677013|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
1677014|NCT05086822|Irinotecan|irinotecan|mesh-list
1677015|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1677016|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1677017|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1677018|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677019|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677027|NCT05086627|Capecitabine|capecitabine|mesh-list
1677028|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
1677029|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1677030|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
1677031|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677032|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677033|NCT05086614|Thymalfasin|thymalfasin|mesh-list
1677034|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1677035|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
1677036|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741294|NCT04750954|Peposertib|peposertib|mesh-list
2741295|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2741296|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741297|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2741298|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741299|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1677064|NCT05086224|Lidocaine|lidocaine|mesh-list
1677065|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
1677066|NCT05086224|Anesthetics|anesthetics|mesh-list
1677067|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1677068|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677069|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
1677070|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1677071|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1677072|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1677073|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1677074|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1677075|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677076|NCT05086107|Rifabutin|rifabutin|mesh-list
1677077|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1677078|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1677079|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1677080|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
1677081|NCT05086081|Ticagrelor|ticagrelor|mesh-list
1677082|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1677083|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1677084|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1677085|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1677086|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1677087|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
1677088|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1677089|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677090|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677091|NCT05085912|Ethanol|ethanol|mesh-list
1677092|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1677093|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1677094|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1677095|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741331|NCT04735367|Letrozole|letrozole|mesh-list
1677112|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1677113|NCT05085808|Trazodone|trazodone|mesh-list
1677114|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
1677115|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1677116|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1677117|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1677118|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2741332|NCT04735367|Palbociclib|palbociclib|mesh-list
2741333|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677119|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677120|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1677121|NCT05085808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1677122|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1677123|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1677124|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677125|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1677126|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
1677127|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1677128|NCT05085782|Propranolol|propranolol|mesh-list
1677129|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1677130|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1677131|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
1677132|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1677133|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677134|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677135|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1677136|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1677137|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
1677138|NCT05085665|Ivermectin|ivermectin|mesh-list
1677139|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1677140|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1677141|NCT05085652|Anesthetics|anesthetics|mesh-list
1677142|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1677143|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677144|NCT05085587|Fluticasone|fluticasone|mesh-list
1677145|NCT05085587|Xhance|xhance|mesh-list
1677146|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1677147|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1677148|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1677149|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1677150|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
1677151|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1677152|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677153|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1677154|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
1677155|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
1677156|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1677157|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1677158|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1677159|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1677160|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
1677161|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1677162|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677163|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
1677164|NCT05085587|Hormones|hormones|mesh-ancestor
1677165|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1677166|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
2741334|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2741335|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2741336|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741337|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741338|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2741339|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
2741340|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2741341|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741342|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1677209|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1677210|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1677211|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
1677212|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1677213|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
1677214|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677215|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
1677216|NCT05085067|Protective Agents|protective agents|mesh-ancestor
1677222|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
1677223|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1677224|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741367|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
2741368|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
2741369|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741370|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1677238|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
1677239|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
1677240|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1677241|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1677242|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1677243|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1677244|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677245|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2741371|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
2741372|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
2741373|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2741374|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741375|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
2741401|NCT04663997|Docetaxel|docetaxel|mesh-list
2741402|NCT04663997|177Lu-PSMA-617|177lu-psma-617|mesh-list
1677279|NCT05084599|Metaraminol|metaraminol|mesh-list
1677280|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
1677281|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
1677282|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1677283|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677284|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1677285|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1677286|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1677287|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1677288|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
1677289|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1677290|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677299|NCT05084573|Bupivacaine|bupivacaine|mesh-list
1677300|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
1677301|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
1677302|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1677303|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677304|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
1677305|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1677306|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
1677307|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1677308|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1677309|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677310|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1677311|NCT05079672|Analgesics|analgesics|mesh-ancestor
1677312|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
1677313|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1677314|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1677315|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1677316|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1677317|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
1677318|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1677319|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741403|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741404|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
2741405|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
2741406|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
2741407|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741408|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2741409|NCT04662086|Camostat|camostat|mesh-list
2741410|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
2741411|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741412|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741413|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2741414|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2741415|NCT04662073|Camostat|camostat|mesh-list
2741416|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
2741417|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741418|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741419|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
2741420|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2741421|NCT04658173|Alfentanil|alfentanil|mesh-list
2741422|NCT04658173|Propofol|propofol|mesh-list
1677340|NCT05074823|Ketamine|ketamine|mesh-list
2741423|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2741424|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1677341|NCT05074823|Analgesics|analgesics|mesh-ancestor
1677342|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
1677343|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1677344|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677345|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1677346|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1677347|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
1677348|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
1677349|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1677350|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1677351|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1677352|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1677353|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677354|NCT05073939|Oxytocin|oxytocin|mesh-list
1677355|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
1677356|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1677357|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677358|NCT05069597|Pancrelipase|pancrelipase|mesh-list
1677359|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2741425|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741426|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1677362|NCT05068206|Bevacizumab|bevacizumab|mesh-list
1677363|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1677364|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677365|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1677366|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1677367|NCT05068206|Growth Substances|growth substances|mesh-ancestor
1677368|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677369|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
1677370|NCT05063370|Simendan|simendan|mesh-list
1677371|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1677372|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
1677373|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1677374|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1677375|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1677376|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677377|NCT05063370|Protective Agents|protective agents|mesh-ancestor
1677378|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677379|NCT05063006|Methamphetamine|methamphetamine|mesh-list
1677380|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1677381|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677382|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
1677383|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
1677384|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1677385|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
1677386|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1677387|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677388|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
1677389|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1677390|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1677391|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1677392|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2741427|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
2741428|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
2741429|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2741430|NCT04658173|Narcotics|narcotics|mesh-ancestor
2741431|NCT04658173|Analgesics|analgesics|mesh-ancestor
2741432|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
2741433|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2741464|NCT04627285|Lacosamide|lacosamide|mesh-list
2741465|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
2741466|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2741467|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2741468|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2741469|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677456|NCT05032820|Lenalidomide|lenalidomide|mesh-list
1677457|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
1677458|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677459|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1677460|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1677461|NCT05032820|Growth Substances|growth substances|mesh-ancestor
1677462|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
1677463|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677475|NCT05028257|Vaccines|vaccines|mesh-list
1677476|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
1677477|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741496|NCT04612751|Carboplatin|carboplatin|mesh-list
2741497|NCT04612751|Durvalumab|durvalumab|mesh-list
2741498|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741499|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1677571|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
2741510|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
2741511|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741512|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2741513|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741514|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741515|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2741516|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2741517|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2741518|NCT04587687|Antibodies|antibodies|mesh-list
2741519|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
2741520|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2741521|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
2741522|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
2741523|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677511|NCT05020392|Vidarabine|vidarabine|mesh-list
1677512|NCT05020392|Cyclophosphamide|cyclophosphamide|mesh-list
1677513|NCT05020392|Fludarabine|fludarabine|mesh-list
1677514|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
1677515|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1677516|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
1677517|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677518|NCT05020392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1677519|NCT05020392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1677520|NCT05020392|Alkylating Agents|alkylating agents|mesh-ancestor
1677521|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677522|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677523|NCT05020392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1677524|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1677525|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
1677526|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
1677527|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1677528|NCT05018221|Vitamins|vitamins|mesh-list
1677529|NCT05018221|Vitamin K|vitamin k|mesh-list
1677530|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
1677531|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
1677532|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
1677533|NCT05018221|Citric Acid|citric acid|mesh-list
1677534|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
1677535|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
1677536|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677537|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
1677538|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1677539|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
1677540|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
1677541|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677542|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1677543|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1677544|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
1677545|NCT05018221|Coagulants|coagulants|mesh-ancestor
1677546|NCT05018221|Antidotes|antidotes|mesh-ancestor
1677547|NCT05018221|Protective Agents|protective agents|mesh-ancestor
1677548|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
1677549|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
1677550|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1677551|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1677552|NCT05018221|Cathartics|cathartics|mesh-ancestor
1677553|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2741524|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741525|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2741526|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
2741527|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677562|NCT05016947|Dexamethasone|dexamethasone|mesh-list
1677563|NCT05016947|Venetoclax|venetoclax|mesh-list
1677564|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
1677565|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1677566|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
1677567|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
1677568|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1677569|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677570|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1677572|NCT05016947|Hormones|hormones|mesh-ancestor
1677573|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1677574|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1677575|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677576|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1677577|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2741547|NCT04578600|Lenalidomide|lenalidomide|mesh-list
2741548|NCT04578600|Azacitidine|azacitidine|mesh-list
1677596|NCT05013242|Goserelin|goserelin|mesh-list
1677597|NCT05013242|Dienogest|dienogest|mesh-list
1677598|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1677599|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677600|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1677601|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
1677602|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1677603|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677604|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1677605|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1677606|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1677607|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1677608|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
1677609|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2741549|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
2741550|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
2741551|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677613|NCT05008510|Camptothecin|camptothecin|mesh-list
1677614|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
1677615|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1677616|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677617|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1677618|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1677619|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1677620|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677621|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
1677622|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741552|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2741553|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2741554|NCT04578600|Growth Substances|growth substances|mesh-ancestor
2741555|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
2741556|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741557|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2741558|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
2741559|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741560|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741561|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2741573|NCT04565392|Famotidine|famotidine|mesh-list
2741574|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2741575|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2741576|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2741577|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
2741578|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
2741579|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2741580|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741581|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741582|NCT04560179|Tobramycin|tobramycin|mesh-list
2741583|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2741584|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2741597|NCT04509050|Ivacaftor|ivacaftor|mesh-list
2741598|NCT04509050|Elexacaftor|elexacaftor|mesh-list
2741599|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2741600|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2741601|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741602|NCT04504669|Durvalumab|durvalumab|mesh-list
2741603|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2741604|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741623|NCT04478942|Misoprostol|misoprostol|mesh-list
1677696|NCT04978298|Phenelzine|phenelzine|mesh-list
1677697|NCT04978298|Ozanimod|ozanimod|mesh-list
1677698|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1677699|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677700|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1677701|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
1677702|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677703|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
1677704|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1677705|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1677706|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741624|NCT04478942|Oxytocin|oxytocin|mesh-list
2741625|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
2741626|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2741627|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741628|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
2741629|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
2741630|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2741631|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2741632|NCT04467593|Gemcitabine|gemcitabine|mesh-list
2741633|NCT04467593|Paclitaxel|paclitaxel|mesh-list
2741634|NCT04467593|Folfirinox|folfirinox|mesh-list
2741635|NCT04467593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2741636|NCT04467593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741637|NCT04467593|Tubulin Modulators|tubulin modulators|mesh-ancestor
2741638|NCT04467593|Antimitotic Agents|antimitotic agents|mesh-ancestor
2741639|NCT04467593|Mitosis Modulators|mitosis modulators|mesh-ancestor
2741640|NCT04467593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741641|NCT04467593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2741642|NCT04467593|Antimetabolites|antimetabolites|mesh-ancestor
2741643|NCT04467593|Antiviral Agents|antiviral agents|mesh-ancestor
1677724|NCT04976595|Testosterone|testosterone|mesh-list
1677725|NCT04976595|Androgens|androgens|mesh-ancestor
1677726|NCT04976595|Hormones|hormones|mesh-ancestor
1677727|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1677728|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677732|NCT04973891|Metformin|metformin|mesh-list
1677733|NCT04973891|Canagliflozin|canagliflozin|mesh-list
1677734|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1677735|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677736|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1677737|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741644|NCT04467593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2741645|NCT04467593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741646|NCT04467593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2741647|NCT04467593|Immunologic Factors|immunologic factors|mesh-ancestor
1677752|NCT04965272|Cariprazine|cariprazine|mesh-list
1677753|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1677754|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1677755|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1677756|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677757|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2741648|NCT04467593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741649|NCT04463693|Etonogestrel|etonogestrel|mesh-list
2741650|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
2741651|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
2741652|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2741653|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741654|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
2741655|NCT04463680|Rifampin|rifampin|mesh-list
2741656|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
2741657|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
2741658|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2741659|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2741660|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
2741661|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2741662|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741663|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741664|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
2741665|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
2741666|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
2741667|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
2741668|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1677779|NCT04951050|Sirolimus|sirolimus|mesh-list
1677780|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1677781|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1677782|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1677783|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677784|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
1677785|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1677786|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
1677787|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741669|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
2741670|NCT04463498|Methamphetamine|methamphetamine|mesh-list
2741671|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2741672|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678021|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
2741673|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
2741674|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
2741675|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2741676|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
2741677|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2741678|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741679|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
2741680|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2741681|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2741682|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2741683|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2741684|NCT04453137|Adalimumab|adalimumab|mesh-list
2741685|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2741686|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1677847|NCT04934072|Denosumab|denosumab|mesh-list
1677848|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1677849|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741726|NCT04382898|Cemiplimab|cemiplimab|mesh-list
2741727|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2741728|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741729|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
2741730|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2741731|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741732|NCT04373707|Enoxaparin|enoxaparin|mesh-list
2741733|NCT04373707|Dalteparin|dalteparin|mesh-list
2741734|NCT04373707|Tinzaparin|tinzaparin|mesh-list
2741735|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
2741736|NCT04373707|Nadroparin|nadroparin|mesh-list
2741737|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
2741738|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
2741739|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2741740|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2741741|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741742|NCT04372628|Ritonavir|ritonavir|mesh-list
2741743|NCT04372628|Lopinavir|lopinavir|mesh-list
2741744|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
2741745|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
2741746|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
2741747|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741748|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741749|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
2741750|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2741751|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
2741752|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2741753|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
2741754|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1677892|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
1677893|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1677894|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677895|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1677896|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677897|NCT04928846|Docetaxel|docetaxel|mesh-list
1677898|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677899|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
1677900|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
1677901|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
1677902|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677903|NCT04925648|Dasatinib|dasatinib|mesh-list
1677904|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677905|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1677906|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1677907|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677908|NCT04916002|Cemiplimab|cemiplimab|mesh-list
1677909|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1677910|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677911|NCT04915755|Niraparib|niraparib|mesh-list
1677912|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1677913|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1677914|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677915|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741769|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
2741770|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2741771|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741772|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2741773|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677936|NCT04912856|Ezogabine|ezogabine|mesh-list
1677937|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
1677938|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1677939|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677940|NCT04911517|Capecitabine|capecitabine|mesh-list
1677941|NCT04911517|Antibodies|antibodies|mesh-list
1677942|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1677943|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
1677944|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677945|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1677946|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
1677947|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1677948|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677949|NCT04907968|Carboplatin|carboplatin|mesh-list
1677950|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1677985|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
1677986|NCT04899843|Astringents|astringents|mesh-ancestor
1677987|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1677988|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
1677999|NCT04894123|Trifluridine|trifluridine|mesh-list
1678000|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
1678001|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1678002|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
1678003|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678004|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
1678005|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2741798|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
2741799|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2741800|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1678016|NCT04880863|Docetaxel|docetaxel|mesh-list
1678017|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
1678018|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1678019|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
1678020|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
1678022|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678023|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1678024|NCT04880577|Tenofovir|tenofovir|mesh-list
1678025|NCT04880577|Rituximab|rituximab|mesh-list
1678026|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
1678027|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1678028|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1678029|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
1678030|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678031|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1678032|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
1678033|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1678034|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1678035|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1678036|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1678037|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678038|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1678039|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1678050|NCT04861558|Fluorouracil|fluorouracil|mesh-list
1678051|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
1678052|NCT04861558|Irinotecan|irinotecan|mesh-list
1678053|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
1678054|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678055|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1678056|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1678057|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1678058|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
1678059|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678060|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1678061|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1678062|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1678065|NCT04859296|Dronabinol|dronabinol|mesh-list
1678066|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
1678067|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678068|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1678069|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1678070|NCT04859296|Analgesics|analgesics|mesh-ancestor
1678071|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
1678072|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1678073|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1678074|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1678075|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1678076|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678077|NCT04859296|Hormones|hormones|mesh-ancestor
1678078|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2741817|NCT04292470|Amitriptyline|amitriptyline|mesh-list
2741818|NCT04292470|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
2741819|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
2741820|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
2741821|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2741822|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2741823|NCT04292470|Analgesics|analgesics|mesh-ancestor
2741824|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
2741825|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2741826|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741827|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2741828|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2741829|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2741830|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741831|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
2741832|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2741833|NCT04292470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
2741834|NCT04292470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2741835|NCT04292470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2741836|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
2741837|NCT04287816|Antithrombins|antithrombins|mesh-list
2741838|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2741839|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
2741840|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741841|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741842|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
2741849|NCT04220489|Ketamine|ketamine|mesh-list
2741850|NCT04220489|Analgesics|analgesics|mesh-ancestor
2741851|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
2741852|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2741853|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741854|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
2741855|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2741856|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
2741857|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
2741858|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2741859|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
2741860|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
2741861|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1678135|NCT04837235|Hemay005|hemay005|mesh-list
1678136|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
1678137|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1678138|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1678139|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1678140|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741862|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741863|NCT04218786|Colchicine|colchicine|mesh-list
2741864|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
2741865|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2741866|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
2741867|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
2741868|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
2741869|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741870|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741903|NCT04206813|Vaccines|vaccines|mesh-list
2741904|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
2741905|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678208|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
1678209|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1678210|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
1678211|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1678212|NCT04793646|Expectorants|expectorants|mesh-ancestor
1678213|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
1678214|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1678215|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
1678216|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678217|NCT04793646|Protective Agents|protective agents|mesh-ancestor
1678218|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678219|NCT04793646|Antidotes|antidotes|mesh-ancestor
2741938|NCT04133376|Nicotine|nicotine|mesh-list
2741939|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2741940|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
2741941|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2741942|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741943|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2741944|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2741945|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
2741946|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2741947|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678245|NCT04775550|Dexamethasone|dexamethasone|mesh-list
1678246|NCT04775550|Lenalidomide|lenalidomide|mesh-list
1678247|NCT04775550|Bortezomib|bortezomib|mesh-list
1678248|NCT04775550|Daratumumab|daratumumab|mesh-list
1678249|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1678250|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
1678251|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
1678252|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1678253|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678254|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1678255|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
1678256|NCT04775550|Hormones|hormones|mesh-ancestor
1678257|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1678258|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1678259|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1678260|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
1678261|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1678262|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1678263|NCT04775550|Growth Substances|growth substances|mesh-ancestor
1678264|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
1678265|NCT04771962|Sevoflurane|sevoflurane|mesh-list
1678266|NCT04771962|Desflurane|desflurane|mesh-list
1678267|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1678268|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1678269|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
1678270|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
1678271|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1678272|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678273|NCT04767022|Paclitaxel|paclitaxel|mesh-list
1678274|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1678275|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1678276|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1678277|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
1678278|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
1678279|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
1678280|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678281|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
1678282|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1678283|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678284|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1678285|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741964|NCT04050085|Nivolumab|nivolumab|mesh-list
2741965|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2741966|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2741967|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2741968|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741969|NCT04029480|Metformin|metformin|mesh-list
2741970|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
2741971|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2741972|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741973|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2741974|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2741978|NCT04002362|Triamcinolone|triamcinolone|mesh-list
2741979|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
2741980|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
2741981|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
2741982|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2741983|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
2741984|NCT04002362|Hormones|hormones|mesh-ancestor
2741985|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2741986|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2741987|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2741988|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
2741989|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2741990|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742007|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2742008|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742009|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742042|NCT03940690|Bevacizumab|bevacizumab|mesh-list
2742043|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742044|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742045|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2742046|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2742047|NCT03940690|Growth Substances|growth substances|mesh-ancestor
2742048|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742049|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
2742050|NCT03933449|Paclitaxel|paclitaxel|mesh-list
2742051|NCT03933449|Docetaxel|docetaxel|mesh-list
2742052|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
2742053|NCT03933449|Irinotecan|irinotecan|mesh-list
2742054|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2742055|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742056|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
2742057|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
2742058|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
2742059|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742060|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742061|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2742062|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2742063|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1678417|NCT04738149|Bimatoprost|bimatoprost|mesh-list
1678418|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1678426|NCT04727138|Midazolam|midazolam|mesh-list
1678427|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1678428|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1678429|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1678430|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678431|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1678432|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1678433|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1678434|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1678435|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
1678436|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
1678437|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
1678438|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
1678439|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1678440|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678441|NCT04726098|Dexamethasone|dexamethasone|mesh-list
1678442|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
1678443|NCT04726098|BB 1101|bb 1101|mesh-list
1678444|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1678445|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
1678446|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
1678447|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1678448|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678449|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1678450|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
1678451|NCT04726098|Hormones|hormones|mesh-ancestor
1678452|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1678453|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1678454|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1678455|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
1678456|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1678457|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678486|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
1678487|NCT04699071|Lenvatinib|lenvatinib|mesh-list
1678488|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1678489|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1678490|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1678491|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1678492|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678498|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1678499|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1678500|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678556|NCT04648189|Cetuximab|cetuximab|mesh-list
1678557|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1678558|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742164|NCT03901144|Glycerol|glycerol|mesh-list
2742165|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1678571|NCT04643249|Repaglinide|repaglinide|mesh-list
1678572|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
1678573|NCT04643249|Midazolam|midazolam|mesh-list
1678574|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
1678575|NCT04643249|Caffeine|caffeine|mesh-list
1678576|NCT04643249|Bupropion|bupropion|mesh-list
1678577|NCT04643249|Omeprazole|omeprazole|mesh-list
1678578|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1678579|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1678580|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1678581|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678582|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1678583|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1678584|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1678585|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1678586|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
1678587|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
1678588|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
1678589|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
1678590|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1678591|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678592|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1678593|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1678594|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1678595|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1678596|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1678597|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1678598|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1678599|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1678600|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
1678601|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1678602|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
1678603|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1678604|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1678605|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1678606|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
1678607|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1678608|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1678609|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
1678610|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
1678611|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1678612|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1678613|NCT04643249|Analgesics|analgesics|mesh-ancestor
1678614|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
1678615|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1678616|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1678617|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1678618|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1678619|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1678620|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1678621|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2742166|NCT03901144|Protective Agents|protective agents|mesh-ancestor
2742167|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742183|NCT03891355|Dexamethasone|dexamethasone|mesh-list
2742184|NCT03891355|Lenalidomide|lenalidomide|mesh-list
2742185|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2742186|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
2742187|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
2742188|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2742189|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742190|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2742191|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
2742192|NCT03891355|Hormones|hormones|mesh-ancestor
2742193|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2742194|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2742195|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742196|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
2742197|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2742198|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2742199|NCT03891355|Growth Substances|growth substances|mesh-ancestor
2742200|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
2742204|NCT03850067|Carboplatin|carboplatin|mesh-list
2742205|NCT03850067|Nivolumab|nivolumab|mesh-list
2742206|NCT03850067|Etoposide|etoposide|mesh-list
2742207|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
2742208|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742209|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742210|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2742211|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742212|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2742213|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2742214|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2742215|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2742262|NCT03781986|Carboplatin|carboplatin|mesh-list
2742263|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742278|NCT03765632|Busulfan|busulfan|mesh-list
2742279|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
2742280|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742281|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2742282|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
2742283|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742284|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2742285|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742286|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2742287|NCT03761173|Anticoagulants|anticoagulants|mesh-list
1678784|NCT04583618|Vaccines|vaccines|mesh-list
1678785|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1678786|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
1678787|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678843|NCT04560595|Caffeine|caffeine|mesh-list
1678844|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1678845|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678846|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1678847|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1678848|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678849|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1678850|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1678851|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
1678852|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1678862|NCT04558294|Ketanserin|ketanserin|mesh-list
1678863|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
1678864|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
1678865|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678866|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1678867|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1678868|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
1678869|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1678870|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678871|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1678872|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1678873|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1678878|NCT04551222|Probenecid|probenecid|mesh-list
1678879|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
1678880|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
1678881|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1678882|NCT04551222|Renal Agents|renal agents|mesh-ancestor
1678899|NCT04537897|Midazolam|midazolam|mesh-list
1678900|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1678901|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1678902|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1678903|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678904|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1678905|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1678906|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1678907|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1678908|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
1678909|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
1678910|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
1678911|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
1678912|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1678913|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742347|NCT03703297|Durvalumab|durvalumab|mesh-list
2742348|NCT03703297|Tremelimumab|tremelimumab|mesh-list
2742349|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742350|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742351|NCT03695250|Nivolumab|nivolumab|mesh-list
2742352|NCT03695250|Linrodostat|linrodostat|mesh-list
2742353|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742354|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742355|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2742356|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742357|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2742383|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
2742384|NCT03645928|Nivolumab|nivolumab|mesh-list
2742385|NCT03645928|Ipilimumab|ipilimumab|mesh-list
2742386|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742387|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742388|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2742389|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742390|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
2742391|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742392|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1678967|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
1678968|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1678969|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1678970|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678971|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
1678972|NCT04521881|Coagulants|coagulants|mesh-ancestor
2742399|NCT03603912|Metformin|metformin|mesh-list
2742400|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2742401|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678985|NCT04507581|Anesthetics|anesthetics|mesh-list
1678986|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1678987|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678988|NCT04507438|Donepezil|donepezil|mesh-list
1678989|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1678990|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1678991|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1678992|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
1678993|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1678994|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1678995|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
1678996|NCT04505670|Donepezil|donepezil|mesh-list
1678997|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
1678998|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1678999|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1679000|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679001|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
1679002|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1679003|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679004|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
1679005|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
1679006|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
1679007|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1679008|NCT04505670|Protective Agents|protective agents|mesh-ancestor
1679012|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
1679013|NCT04474002|Cathartics|cathartics|mesh-ancestor
1679014|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1679015|NCT04470622|Aprepitant|aprepitant|mesh-list
1679016|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
1679017|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
1679018|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1679019|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679020|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1679021|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1679022|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1679023|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742424|NCT03558152|Vedolizumab|vedolizumab|mesh-list
2742425|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2742426|NCT03549000|Spartalizumab|spartalizumab|mesh-list
2742427|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2742428|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679038|NCT04439253|Crizotinib|crizotinib|mesh-list
1679039|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1679040|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1679041|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1679042|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679043|NCT04434040|Atezolizumab|atezolizumab|mesh-list
1679044|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742429|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742430|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
2742431|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
2742432|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
2742433|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2742434|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742435|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2742436|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1679053|NCT04405063|Paclitaxel|paclitaxel|mesh-list
1679054|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1679055|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1679056|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
1679057|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
1679058|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
1679059|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742437|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742438|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
2742439|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2742440|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742441|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1679068|NCT04396873|11C-PS13|11c-ps13|mesh-list
1679069|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1679070|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742450|NCT03519295|Atezolizumab|atezolizumab|mesh-list
2742451|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1679101|NCT04393753|Avelumab|avelumab|mesh-list
1679102|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1679103|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742467|NCT03462459|Vancomycin|vancomycin|mesh-list
2742468|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2742469|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2742470|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
2742471|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
2742472|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742473|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742474|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2742475|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742476|NCT03396445|Paclitaxel|paclitaxel|mesh-list
2742477|NCT03396445|Carboplatin|carboplatin|mesh-list
2742478|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
2742479|NCT03396445|Pemetrexed|pemetrexed|mesh-list
2742480|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2742481|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742482|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
2742483|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
2742484|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
2742485|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742486|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742487|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2742488|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2742489|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1679207|NCT04373317|Pimavanserin|pimavanserin|mesh-list
1679208|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1679209|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
1679210|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1679211|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1679212|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1679213|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1679214|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679215|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1679216|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1679217|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1679218|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1679219|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
1679220|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1679221|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742529|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
2742530|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742531|NCT03323398|Durvalumab|durvalumab|mesh-list
2742532|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742533|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742539|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
2742540|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
2742541|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742542|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2742543|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
1679269|NCT04362566|Bupivacaine|bupivacaine|mesh-list
1679270|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
1679271|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
1679272|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1679273|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679274|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
1679275|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1679282|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
1679283|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
1679284|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1679285|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1679286|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1679287|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1679288|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679289|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1679290|NCT04348864|Antibodies|antibodies|mesh-list
1679291|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
1679292|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742544|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2742545|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742546|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
2742547|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2742548|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2742549|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
2742552|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
2742553|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1679316|NCT04335084|Vitamin D|vitamin d|mesh-list
1679317|NCT04335084|Vitamins|vitamins|mesh-list
1679318|NCT04335084|Ascorbic Acid|ascorbic acid|mesh-list
1679319|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
1679320|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
1679321|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679322|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1679323|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
1679324|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1679325|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1679326|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1679327|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1679328|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679329|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1679330|NCT04335084|Antioxidants|antioxidants|mesh-ancestor
1679331|NCT04335084|Protective Agents|protective agents|mesh-ancestor
1679332|NCT04318704|Ifenprodil|ifenprodil|mesh-list
1679333|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1679334|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1679335|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
1679336|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1679337|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679338|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679339|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
1679340|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1679341|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1679348|NCT04316871|Morphine|morphine|mesh-list
1679349|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1679350|NCT04316871|Narcotics|narcotics|mesh-ancestor
1679351|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1679352|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679353|NCT04316871|Analgesics|analgesics|mesh-ancestor
1679354|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
1679355|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2742573|NCT03166085|Paclitaxel|paclitaxel|mesh-list
2742574|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
2742575|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2742576|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742577|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
2742578|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
2742579|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
2742580|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742581|NCT03161054|Prednisone|prednisone|mesh-list
2742582|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
2742583|NCT03161054|Rituximab|rituximab|mesh-list
2742584|NCT03161054|Etoposide|etoposide|mesh-list
2742585|NCT03161054|Vinorelbine|vinorelbine|mesh-list
2742586|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2742587|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
2742588|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742589|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2742590|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2742591|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
2742592|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742593|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742594|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2742595|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742596|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2742597|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
2742598|NCT03161054|Hormones|hormones|mesh-ancestor
2742599|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2742600|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2742601|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2742602|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2742603|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2742604|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2742605|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
2742606|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
2742607|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
1679419|NCT04295941|Trazodone|trazodone|mesh-list
1679420|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1679421|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1679422|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1679423|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679424|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1679425|NCT04295941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1679426|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1679427|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1679428|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679429|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1679430|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
1679431|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1679432|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
1679433|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
1679434|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
1679435|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
1679436|NCT04280692|Lumefantrine|lumefantrine|mesh-list
1679437|NCT04280692|Artemether|artemether|mesh-list
1679438|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
1679439|NCT04280692|Piperaquine|piperaquine|mesh-list
1679440|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
1679441|NCT04280692|Primaquine|primaquine|mesh-list
1679442|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1679443|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
1679444|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
1679445|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1679446|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1679447|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1679448|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1679449|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1679450|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679451|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1679452|NCT04280692|Renal Agents|renal agents|mesh-ancestor
1679453|NCT04276233|Prednisone|prednisone|mesh-list
1679454|NCT04276233|Prednisolone|prednisolone|mesh-list
1679455|NCT04276233|Albuterol|albuterol|mesh-list
1679456|NCT04276233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1679457|NCT04276233|Glucocorticoids|glucocorticoids|mesh-ancestor
1679458|NCT04276233|Hormones|hormones|mesh-ancestor
1679459|NCT04276233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1679460|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679461|NCT04276233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1679462|NCT04276233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1679463|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
1679464|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1679465|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1679466|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1679467|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
1679468|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
1679469|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1679470|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1679471|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1679472|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1679473|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
1679474|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1679475|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742655|NCT03050814|Leucovorin|leucovorin|mesh-list
2742656|NCT03050814|Bevacizumab|bevacizumab|mesh-list
2742657|NCT03050814|Avelumab|avelumab|mesh-list
2742658|NCT03050814|Fluorouracil|fluorouracil|mesh-list
2742659|NCT03050814|Capecitabine|capecitabine|mesh-list
2742660|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
2742661|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742662|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742663|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2742664|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2742665|NCT03050814|Growth Substances|growth substances|mesh-ancestor
2742666|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742667|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
2742668|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
2742669|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742670|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2742671|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2742672|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
2742673|NCT03050814|Antidotes|antidotes|mesh-ancestor
2742674|NCT03050814|Protective Agents|protective agents|mesh-ancestor
2742675|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
2742676|NCT03050814|Vitamins|vitamins|mesh-ancestor
2742677|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
1679528|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1679529|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1679530|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1679531|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
1679542|NCT04233034|Verapamil|verapamil|mesh-list
1679543|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1679544|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1679545|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1679546|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679547|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1679548|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679549|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
2742694|NCT02916316|Doxorubicin|doxorubicin|mesh-list
2742695|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2742696|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2742697|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742698|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2742699|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2742700|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2742701|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742748|NCT02827838|Durvalumab|durvalumab|mesh-list
2742749|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
2742750|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2742751|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
2742752|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742753|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742754|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
2742755|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742756|NCT02803203|Bevacizumab|bevacizumab|mesh-list
2742757|NCT02803203|Osimertinib|osimertinib|mesh-list
2742758|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742759|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742760|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2742761|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2742762|NCT02803203|Growth Substances|growth substances|mesh-ancestor
2742763|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742764|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
2742765|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2742766|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2742767|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742773|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
2742774|NCT02791568|Hematinics|hematinics|mesh-ancestor
2742775|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2742776|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2742777|NCT02724241|Nicotine|nicotine|mesh-list
2742778|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
2742779|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
2742780|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2742781|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742782|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2742783|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2742784|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
2742785|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2742786|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679707|NCT04126083|Lofexidine|lofexidine|mesh-list
1679708|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1679709|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1679710|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679711|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
1679712|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1679713|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1679714|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1679715|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1679716|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
1679717|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1679718|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679719|NCT04122196|Pregabalin|pregabalin|mesh-list
1679720|NCT04122196|Analgesics|analgesics|mesh-ancestor
1679721|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
1679722|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1679723|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679724|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
1679725|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1679726|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1679727|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679728|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1679729|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1679730|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1679731|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1679732|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1679733|NCT04102436|Aldesleukin|aldesleukin|mesh-list
1679734|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
1679735|NCT04102436|Fludarabine|fludarabine|mesh-list
1679736|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1679737|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
1679738|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679739|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1679740|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1679741|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
1679742|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679743|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1679744|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1679745|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1679746|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1679747|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
1679748|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1679749|NCT04094012|Isoniazid|isoniazid|mesh-list
1679750|NCT04094012|Rifapentine|rifapentine|mesh-list
1679751|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
1679752|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1679753|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1679754|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1679755|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1679756|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
1679757|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679758|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1679759|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1679760|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
2742787|NCT02639910|Venetoclax|venetoclax|mesh-list
2742788|NCT02639910|Idelalisib|idelalisib|mesh-list
2742789|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742790|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2742791|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742829|NCT02618980|Hemostatics|hemostatics|mesh-list
2742830|NCT02618980|Coagulants|coagulants|mesh-ancestor
2742831|NCT02613598|Bortezomib|bortezomib|mesh-list
2742832|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742840|NCT02598557|Exemestane|exemestane|mesh-list
2742841|NCT02598557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742842|NCT02598557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2742843|NCT02598557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2742844|NCT02598557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2742845|NCT02598557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742846|NCT02598557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1679821|NCT04076761|Trifluridine|trifluridine|mesh-list
1679822|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
1679823|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679824|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
1679825|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1679826|NCT04062266|Azacitidine|azacitidine|mesh-list
1679827|NCT04062266|Venetoclax|venetoclax|mesh-list
1679828|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1679829|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
1679830|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679831|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1679832|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2742847|NCT02598557|Hormone Antagonists|hormone antagonists|mesh-ancestor
2742848|NCT02598557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1679836|NCT04044001|Isoniazid|isoniazid|mesh-list
1679837|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
1679838|NCT04044001|Ethambutol|ethambutol|mesh-list
1679839|NCT04044001|Dolutegravir|dolutegravir|mesh-list
1679840|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
1679841|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1679842|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1679843|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1679844|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679845|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1679846|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1679847|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
1679848|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1679849|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1679850|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1679851|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1679852|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1679853|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
2742849|NCT02598557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742850|NCT02595320|Capecitabine|capecitabine|mesh-list
2742851|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2742852|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
2742853|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742854|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742855|NCT02594384|Rituximab|rituximab|mesh-list
2742856|NCT02594384|Atezolizumab|atezolizumab|mesh-list
1679863|NCT04022980|Nivolumab|nivolumab|mesh-list
1679864|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1679865|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1679866|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1679867|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679868|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
1679869|NCT04021381|Cathartics|cathartics|mesh-ancestor
1679870|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1679878|NCT04012996|Meloxicam|meloxicam|mesh-list
1679879|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1679880|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1679881|NCT04012996|Analgesics|analgesics|mesh-ancestor
1679882|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
1679883|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1679884|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679885|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1679886|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1679887|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1679888|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1679889|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1679890|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1679891|NCT04004442|Avelumab|avelumab|mesh-list
1679892|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1679893|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742857|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742858|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742859|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
2742860|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742861|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2742862|NCT02586623|Droxidopa|droxidopa|mesh-list
2742863|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2742864|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2742912|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
2742913|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742914|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742915|NCT02492867|Paclitaxel|paclitaxel|mesh-list
2742916|NCT02492867|Carboplatin|carboplatin|mesh-list
1679958|NCT03970304|Vaccines|vaccines|mesh-list
1679959|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
1679960|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679961|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
1679962|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
1679963|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
1679964|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1679965|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1679966|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1679967|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1679968|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1679969|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1679970|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1679971|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1679972|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
1679973|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1679974|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742917|NCT02492867|Durvalumab|durvalumab|mesh-list
2742918|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2742919|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742920|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
2742921|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
2742922|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
2742923|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742924|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742962|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
2742963|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
2742964|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
2742965|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
2742966|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2742967|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742968|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742969|NCT02426892|Nivolumab|nivolumab|mesh-list
1680026|NCT03944902|Niraparib|niraparib|mesh-list
1680027|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1680028|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1680029|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1680030|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680031|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1680032|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2742970|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742971|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742972|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2742973|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742974|NCT02409368|Nivolumab|nivolumab|mesh-list
2742975|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2742976|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742977|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2742978|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2742984|NCT02375555|Dexamethasone|dexamethasone|mesh-list
2742985|NCT02375555|Lenalidomide|lenalidomide|mesh-list
2742986|NCT02375555|Bortezomib|bortezomib|mesh-list
2742987|NCT02375555|Elotuzumab|elotuzumab|mesh-list
2742988|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2742989|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
2742990|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
2742991|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2742992|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2742993|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2742994|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
2742995|NCT02375555|Hormones|hormones|mesh-ancestor
2742996|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2742997|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2742998|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2742999|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
2743000|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2743001|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2743002|NCT02375555|Growth Substances|growth substances|mesh-ancestor
2743003|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
2743004|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
2743005|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743006|NCT02230891|Carvedilol|carvedilol|mesh-list
2743007|NCT02230891|Spironolactone|spironolactone|mesh-list
2743008|NCT02230891|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
2743009|NCT02230891|Hormone Antagonists|hormone antagonists|mesh-ancestor
2743010|NCT02230891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2743011|NCT02230891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743012|NCT02230891|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
2743013|NCT02230891|Diuretics|diuretics|mesh-ancestor
2743014|NCT02230891|Natriuretic Agents|natriuretic agents|mesh-ancestor
2743015|NCT02230891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2743016|NCT02230891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2743017|NCT02230891|Adrenergic Agents|adrenergic agents|mesh-ancestor
2743018|NCT02230891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2743019|NCT02230891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743020|NCT02230891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2743021|NCT02230891|Antioxidants|antioxidants|mesh-ancestor
2743022|NCT02230891|Protective Agents|protective agents|mesh-ancestor
2743023|NCT02230891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2743024|NCT02230891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2743025|NCT02230891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2743026|NCT02230891|Vasodilator Agents|vasodilator agents|mesh-ancestor
2743027|NCT02230891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
2743028|NCT02230891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
2743029|NCT02220894|Paclitaxel|paclitaxel|mesh-list
2743030|NCT02220894|Carboplatin|carboplatin|mesh-list
2743031|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
2743032|NCT02220894|Pemetrexed|pemetrexed|mesh-list
2743033|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2743034|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743035|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
2743036|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
2743037|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
2743038|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743039|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2743040|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743041|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2743042|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2743043|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
2743044|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2743045|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
2743046|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743060|NCT02066636|Nivolumab|nivolumab|mesh-list
2743061|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2743062|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743063|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2743064|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743077|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
2743078|NCT01936831|Pyridoxal|pyridoxal|mesh-list
2743079|NCT01936831|Pyridoxine|pyridoxine|mesh-list
1680156|NCT03911505|Miglustat|miglustat|mesh-list
1680157|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1680158|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1680159|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1680160|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1680161|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
1680162|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1680163|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
1680164|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1680165|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1680166|NCT03910387|Gemcitabine|gemcitabine|mesh-list
1680167|NCT03910387|Paclitaxel|paclitaxel|mesh-list
1680168|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1680169|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1680170|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680171|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
1680172|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
1680173|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
1680174|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1680175|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1680176|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
1680177|NCT03910387|Antiviral Agents|antiviral agents|mesh-ancestor
1680178|NCT03910387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1680179|NCT03910387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1680180|NCT03910387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1680181|NCT03910387|Immunologic Factors|immunologic factors|mesh-ancestor
1680182|NCT03910387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743080|NCT01936831|Isoniazid|isoniazid|mesh-list
2743081|NCT01936831|Vitamins|vitamins|mesh-ancestor
2743082|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
2743083|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743084|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
2743085|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
2743086|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2743087|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2743088|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
2743089|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
2743090|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
2743091|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743092|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
2743108|NCT01772004|Avelumab|avelumab|mesh-list
1680234|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
1680235|NCT03898180|Lenvatinib|lenvatinib|mesh-list
1680236|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1680237|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680238|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1680239|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1680240|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1680241|NCT03898154|Dexamethasone|dexamethasone|mesh-list
1680242|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
1680243|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1680244|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1680245|NCT03898154|Prednisolone|prednisolone|mesh-list
1680246|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
1680247|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1680248|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
1680249|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1680250|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
1680251|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
1680252|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1680253|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1680254|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1680255|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
1680256|NCT03898154|Hormones|hormones|mesh-ancestor
1680257|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1680258|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1680259|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680260|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1680261|NCT03898154|Protective Agents|protective agents|mesh-ancestor
2743109|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2743110|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743111|NCT01750567|Metformin|metformin|mesh-list
2743112|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2743113|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743114|NCT01748149|Vemurafenib|vemurafenib|mesh-list
2743115|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743116|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2743117|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743118|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743119|NCT01721759|Nivolumab|nivolumab|mesh-list
2743120|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2743121|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743122|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2743123|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743124|NCT01633541|Carboplatin|carboplatin|mesh-list
2743125|NCT01633541|Docetaxel|docetaxel|mesh-list
2743126|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743127|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
2743128|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
2743129|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
2743130|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743131|NCT01539447|Naproxen|naproxen|mesh-list
2743132|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2743133|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2743134|NCT01539447|Analgesics|analgesics|mesh-ancestor
2743135|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
2743136|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2743137|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743138|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2743139|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2743140|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
1680294|NCT03857087|Edetic Acid|edetic acid|mesh-list
1680295|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1680296|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
1680297|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
1680298|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1680299|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
1680300|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1680301|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
2743141|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2743142|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743143|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1680305|NCT03845140|Praziquantel|praziquantel|mesh-list
1680306|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
1680307|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1680308|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1680312|NCT03827447|Vancomycin|vancomycin|mesh-list
1680313|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1680314|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1680315|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
1680316|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1680317|NCT03821857|Corticosterone|corticosterone|mesh-list
1680318|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1680341|NCT03814590|Vaccines|vaccines|mesh-list
1680342|NCT03814590|Immunologic Factors|immunologic factors|mesh-ancestor
1680343|NCT03814590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743155|NCT01322971|Metronidazole|metronidazole|mesh-list
2743156|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2743157|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2743158|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2743159|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2743160|NCT01285102|Irinotecan|irinotecan|mesh-list
2743161|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2743162|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2743163|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743164|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743165|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680385|NCT03792750|Nivolumab|nivolumab|mesh-list
1680386|NCT03792750|Linrodostat|linrodostat|mesh-list
1680387|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1680388|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680389|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1680390|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1680391|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1680397|NCT03740737|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1680398|NCT03740737|Hormones|hormones|mesh-ancestor
1680399|NCT03740737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1680400|NCT03740737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1680412|NCT03727724|Cetuximab|cetuximab|mesh-list
1680413|NCT03727724|Afatinib|afatinib|mesh-list
1680414|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1680415|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680416|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1680417|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1680418|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743207|NCT01026220|Prednisone|prednisone|mesh-list
2743208|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
2743209|NCT01026220|Ifosfamide|ifosfamide|mesh-list
1680425|NCT03722966|Nicotine|nicotine|mesh-list
1680426|NCT03722966|Varenicline|varenicline|mesh-list
1680427|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1680428|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
1680429|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1680430|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1680431|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1680432|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1680433|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
1680434|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1680435|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743210|NCT01026220|Doxorubicin|doxorubicin|mesh-list
2743211|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
2743212|NCT01026220|Etoposide|etoposide|mesh-list
2743213|NCT01026220|Vincristine|vincristine|mesh-list
2743214|NCT01026220|Vinorelbine|vinorelbine|mesh-list
2743215|NCT01026220|Bleomycin|bleomycin|mesh-list
2743216|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
2743217|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2743218|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
2743219|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743220|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2743221|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2743222|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
2743223|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743224|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743225|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2743226|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2743227|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2743228|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2743229|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743230|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2743231|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
2743232|NCT01026220|Hormones|hormones|mesh-ancestor
2743233|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2743234|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2743235|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2743236|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
2743237|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
2743238|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
2743242|NCT00952692|Lapatinib|lapatinib|mesh-list
2743243|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743244|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2743245|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743246|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743247|NCT00424099|Methylphenidate|methylphenidate|mesh-list
2743248|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
2743249|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743250|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
2743251|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
2743252|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2743253|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743254|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
2743255|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2743256|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
2743257|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
2743258|NCT00001521|Letrozole|letrozole|mesh-list
2743259|NCT00001521|Flutamide|flutamide|mesh-list
2743260|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743261|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
2743262|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
2743263|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743264|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743265|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2743266|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
2743267|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2743268|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743269|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2743270|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
2743271|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1680505|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1680506|NCT03697031|Hormones|hormones|mesh-ancestor
1680507|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1680508|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1680513|NCT03672487|Benzonidazole|benzonidazole|mesh-list
1680514|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1680515|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
1680516|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1680517|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1680518|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1680519|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1680520|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1680521|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
1680522|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1680523|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743278|NCT05166343|Epinephrine|epinephrine|mesh-list
2743279|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2743280|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2743281|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
2743282|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2743283|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1680549|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
1680550|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680551|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
1680552|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1680553|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1680554|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1680555|NCT03637764|Atezolizumab|atezolizumab|mesh-list
1680556|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680587|NCT03630835|Annexin A5|annexin a5|mesh-list
1680588|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1680589|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743284|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743285|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2743286|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2743287|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
2743288|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2743289|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2743290|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
2743291|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
2743292|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
2743293|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
2743294|NCT05166304|Rebamipide|rebamipide|mesh-list
2743295|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2743296|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2743297|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
2743298|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743299|NCT05166304|Protective Agents|protective agents|mesh-ancestor
2743300|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743301|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743310|NCT05166096|Aspirin|aspirin|mesh-list
2743311|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2743312|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2743313|NCT05166096|Analgesics|analgesics|mesh-ancestor
2743314|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
2743315|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2743316|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1680639|NCT03564340|Cemiplimab|cemiplimab|mesh-list
1680640|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1680641|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743317|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2743318|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2743319|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
2743320|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
2743321|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743322|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2743323|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2743324|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743325|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
2743326|NCT05166083|Testosterone|testosterone|mesh-list
2743327|NCT05166083|Androgens|androgens|mesh-ancestor
2743328|NCT05166083|Hormones|hormones|mesh-ancestor
1680667|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
1680668|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
1680669|NCT03541850|Hormones|hormones|mesh-list
1680670|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1680671|NCT03541850|Androgens|androgens|mesh-list
1680672|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
1680673|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1680674|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1680675|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
1680676|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1680677|NCT03541850|Protective Agents|protective agents|mesh-ancestor
1680678|NCT03541850|Vitamins|vitamins|mesh-ancestor
1680679|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
1680680|NCT03541850|Estrogens|estrogens|mesh-ancestor
1680681|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1680682|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680683|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
1680684|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
2743329|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2743330|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743331|NCT05166005|Vitamin D|vitamin d|mesh-list
2743332|NCT05166005|Vitamins|vitamins|mesh-ancestor
2743333|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
2743334|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743335|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2743348|NCT05165966|Vaccines|vaccines|mesh-list
2743349|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
2743350|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743351|NCT05165914|Midazolam|midazolam|mesh-list
2743352|NCT05165914|Anesthetics|anesthetics|mesh-list
2743353|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2743354|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743355|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
2743356|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2743357|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
2743358|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
2743359|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2743360|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2743361|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
2743362|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
2743363|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
2743364|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2743365|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1680733|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
1680734|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1680735|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680739|NCT03469050|Rifaximin|rifaximin|mesh-list
1680740|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1680741|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1680742|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2743380|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
2743381|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2743382|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2743383|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743384|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2743385|NCT05165836|Analgesics|analgesics|mesh-ancestor
2743386|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
2743387|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2743388|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2743389|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2743390|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2743391|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
2743392|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1680785|NCT03415061|Insulin|insulin|mesh-list
1680786|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1680787|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1680788|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1680789|NCT03414684|Carboplatin|carboplatin|mesh-list
1680790|NCT03414684|Nivolumab|nivolumab|mesh-list
1680791|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680792|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1680793|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1680794|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743393|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743394|NCT05165771|Tofacitinib|tofacitinib|mesh-list
2743395|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2743396|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743397|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743398|NCT05165732|Vaccines|vaccines|mesh-list
2743399|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
1680802|NCT03403621|Pentamidine|pentamidine|mesh-list
1680803|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
1680804|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1680805|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1680806|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1680807|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
2743400|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743401|NCT05165641|Anesthetics|anesthetics|mesh-list
2743402|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2743403|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743404|NCT05165615|Insulin|insulin|mesh-list
1680813|NCT03367819|Cemiplimab|cemiplimab|mesh-list
1680814|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1680815|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743405|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2743406|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1680847|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
1680848|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1680849|NCT03327844|Metronidazole|metronidazole|mesh-list
1680850|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
1680851|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1680852|NCT03327844|Calcium|calcium|mesh-list
1680853|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1680854|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1680855|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1680856|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1680857|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
1680858|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1680859|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1680860|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1680861|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1680862|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1680863|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1680864|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680865|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1680866|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
2743424|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
2743425|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2743426|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743427|NCT05165303|Lidocaine|lidocaine|mesh-list
2743428|NCT05165303|Propofol|propofol|mesh-list
2743429|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
2743430|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
2743431|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2743432|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743433|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
2743434|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2743435|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2743436|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2743437|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2743438|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2743439|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743440|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2743441|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
2743442|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
2743443|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2743444|NCT05165290|Latanoprost|latanoprost|mesh-list
2743445|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2743446|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2743482|NCT05165212|Amoxicillin|amoxicillin|mesh-list
2743483|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2743484|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2743485|NCT05165082|Timolol|timolol|mesh-list
2743486|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2743487|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2743488|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2743489|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2743490|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
2743491|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2743492|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743493|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743494|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2743495|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2743496|NCT05164978|Antibodies|antibodies|mesh-list
2743497|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
2743498|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743499|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
2743500|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2743501|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743502|NCT05164848|Afatinib|afatinib|mesh-list
2743503|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743504|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2743505|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743506|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743507|NCT05164770|Prednisone|prednisone|mesh-list
2743508|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
2743509|NCT05164770|Vincristine|vincristine|mesh-list
2743510|NCT05164770|Rituximab|rituximab|mesh-list
2743511|NCT05164770|Doxorubicin|doxorubicin|mesh-list
2743512|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
2743513|NCT05164770|Etoposide|etoposide|mesh-list
2743514|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2743515|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
2743516|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743517|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2743518|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1680984|NCT03239340|Osimertinib|osimertinib|mesh-list
1680985|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1680986|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1680987|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1680988|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743519|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
2743520|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743521|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743522|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2743523|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2743524|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
2743525|NCT05164770|Hormones|hormones|mesh-ancestor
2743526|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2743527|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2743528|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2743529|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
2743530|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
2743531|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
2743532|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2743533|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2743534|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2743535|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2743536|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743537|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2743549|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
2743550|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
1681023|NCT03189706|Irinotecan|irinotecan|mesh-list
1681024|NCT03189706|Temozolomide|temozolomide|mesh-list
1681025|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1681026|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1681027|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1681028|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681029|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681030|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1681031|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
1681032|NCT03158883|Avelumab|avelumab|mesh-list
1681033|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1681034|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681035|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
1681036|NCT03113994|Vitamin D|vitamin d|mesh-list
1681037|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
1681038|NCT03113994|Ubiquinone|ubiquinone|mesh-list
1681039|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
1681040|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1681041|NCT03113994|Calcium|calcium|mesh-list
1681042|NCT03113994|Vitamins|vitamins|mesh-ancestor
1681043|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
1681044|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681045|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1681046|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1681047|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1681048|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1681049|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
1681050|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681051|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1681052|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1681053|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1681054|NCT03113994|Antacids|antacids|mesh-ancestor
1681055|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1681056|NCT03082209|Bevacizumab|bevacizumab|mesh-list
1681057|NCT03082209|Venetoclax|venetoclax|mesh-list
1681058|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1681059|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681060|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1681061|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1681062|NCT03082209|Growth Substances|growth substances|mesh-ancestor
1681063|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681064|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
2743551|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2743552|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2743553|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743554|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2743555|NCT05164627|Analgesics|analgesics|mesh-ancestor
2743556|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
2743557|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2743558|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
2743559|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
2743560|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2743561|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
2743562|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2743563|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743564|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
2743565|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2743566|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
2743567|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2743568|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2743569|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2743570|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
2743571|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2743572|NCT05164263|Empagliflozin|empagliflozin|mesh-list
2743573|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2743574|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743575|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2743576|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743577|NCT05161741|Insulin|insulin|mesh-list
2743578|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2743579|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743588|NCT05153590|Liraglutide|liraglutide|mesh-list
2743589|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1681124|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1681125|NCT03008278|Olaparib|olaparib|mesh-list
1681126|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1681127|NCT03008278|Ramucirumab|ramucirumab|mesh-list
1681128|NCT03008278|Antibodies|antibodies|mesh-list
1681129|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
1681130|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1681131|NCT03008278|Lexatumumab|lexatumumab|mesh-list
1681132|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
1681133|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681134|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681135|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1681136|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681137|NCT03000179|Avelumab|avelumab|mesh-list
1681138|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1681139|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743590|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743591|NCT05153590|Incretins|incretins|mesh-ancestor
2743592|NCT05153590|Hormones|hormones|mesh-ancestor
2743593|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2743594|NCT05153135|Palbociclib|palbociclib|mesh-list
2743595|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743596|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2743597|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743598|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743599|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
2743600|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
2743601|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
2743602|NCT05150704|Prednisolone|prednisolone|mesh-list
2743603|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
2743604|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
2743605|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
2743606|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2743607|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
2743608|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
2743609|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2743610|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743611|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2743612|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
2743613|NCT05150704|Hormones|hormones|mesh-ancestor
2743614|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2743615|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2743616|NCT05150704|Protective Agents|protective agents|mesh-ancestor
2743617|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2743618|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743625|NCT05146479|Fluorides|fluorides|mesh-list
2743626|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
2743627|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
2743628|NCT05146479|Protective Agents|protective agents|mesh-ancestor
2743629|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743630|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
2743631|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
2743632|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681197|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
1681198|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1681199|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743633|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1681208|NCT02960568|Primaquine|primaquine|mesh-list
1681209|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
1681210|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1681211|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1681212|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1681213|NCT02958865|PF-06700841|pf-06700841|mesh-list
1681214|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1681215|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1681216|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681217|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1681218|NCT02954510|Hematinics|hematinics|mesh-ancestor
1681219|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1681220|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1681221|NCT02953665|Liraglutide|liraglutide|mesh-list
1681222|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1681223|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681224|NCT02953665|Incretins|incretins|mesh-ancestor
1681225|NCT02953665|Hormones|hormones|mesh-ancestor
1681226|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1681227|NCT02944071|Paclitaxel|paclitaxel|mesh-list
1681228|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1681229|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681230|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
1681231|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
1681232|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
1681233|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743634|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
2743635|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743679|NCT05110209|Bevacizumab|bevacizumab|mesh-list
2743680|NCT05110209|Ranibizumab|ranibizumab|mesh-list
2743681|NCT05110209|Aflibercept|aflibercept|mesh-list
2743682|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2743683|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743684|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2743685|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2743686|NCT05110209|Growth Substances|growth substances|mesh-ancestor
2743687|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743688|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
2743700|NCT05096143|Valsartan|valsartan|mesh-list
2743701|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2743702|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
2743703|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
2743704|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743705|NCT05056974|UB-421|ub-421|mesh-list
2743706|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
2743707|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
2743708|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1681363|NCT02864004|Apomorphine|apomorphine|mesh-list
1681364|NCT02864004|Emetics|emetics|mesh-ancestor
1681365|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681366|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
1681367|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1681368|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1681369|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
1681370|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
1681371|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1681372|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743729|NCT05053659|Venetoclax|venetoclax|mesh-list
2743730|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
2743731|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743732|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2743733|NCT05051566|Esomeprazole|esomeprazole|mesh-list
2743734|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2743735|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2743736|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2743737|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743738|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743744|NCT05042648|Buprenorphine|buprenorphine|mesh-list
2743745|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2743746|NCT05042648|Narcotics|narcotics|mesh-ancestor
2743747|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2743748|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743749|NCT05042648|Analgesics|analgesics|mesh-ancestor
2743750|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
2743751|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2743752|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
2743753|NCT05039944|Irinotecan|irinotecan|mesh-list
2743754|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2743755|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1681423|NCT02834403|Aspirin|aspirin|mesh-list
1681424|NCT02834403|Docetaxel|docetaxel|mesh-list
1681425|NCT02834403|Amlodipine|amlodipine|mesh-list
1681426|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
1681427|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681428|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
1681429|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
1681430|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
1681431|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681432|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1681433|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1681434|NCT02834403|Analgesics|analgesics|mesh-ancestor
1681435|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
1681436|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1681437|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681438|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1681439|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1681440|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1681441|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1681442|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1681443|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1681444|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1681445|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
1681446|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1681447|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1681448|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1681449|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1681450|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
2743756|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743757|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743758|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681513|NCT02770040|Infliximab|infliximab|mesh-list
1681514|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
1681515|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1681516|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1681517|NCT02766465|Sirolimus|sirolimus|mesh-list
1681518|NCT02766465|Methotrexate|methotrexate|mesh-list
1681519|NCT02766465|Fludarabine|fludarabine|mesh-list
1681520|NCT02766465|Melphalan|melphalan|mesh-list
1681521|NCT02766465|Busulfan|busulfan|mesh-list
1681522|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
1681523|NCT02766465|Tacrolimus|tacrolimus|mesh-list
1681524|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1681525|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
1681526|NCT02766465|Lenograstim|lenograstim|mesh-list
1681527|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1681528|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
1681529|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1681530|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681531|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1681532|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
1681533|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681534|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681535|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
1681536|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1681537|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1681538|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1681539|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
1681540|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1681541|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1681542|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1681543|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1681544|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1681545|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1681546|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
1681547|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1681548|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
1681549|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1681550|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1681551|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2743796|NCT05023343|Ropivacaine|ropivacaine|mesh-list
2743797|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
2743798|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
2743799|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2743800|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743801|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
2743802|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2743803|NCT05022654|Irinotecan|irinotecan|mesh-list
2743804|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
2743805|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2743806|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743807|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743808|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743809|NCT05020769|Osimertinib|osimertinib|mesh-list
2743810|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743811|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2743812|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1681572|NCT02761694|Paclitaxel|paclitaxel|mesh-list
1681573|NCT02761694|Fulvestrant|fulvestrant|mesh-list
1681574|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1681575|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681576|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
1681577|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
1681578|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
1681579|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681580|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1681581|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1681582|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1681583|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
1681584|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1681585|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681594|NCT02748018|Insulin|insulin|mesh-list
1681595|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1681596|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681597|NCT02741128|Vaccines|vaccines|mesh-list
1681598|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
1681599|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681600|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
1681601|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1681602|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2743813|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743814|NCT05020457|Paclitaxel|paclitaxel|mesh-list
2743815|NCT05020457|Docetaxel|docetaxel|mesh-list
2743816|NCT05020457|Cisplatin|cisplatin|mesh-list
2743817|NCT05020457|Pemetrexed|pemetrexed|mesh-list
2743818|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2743819|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743820|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
2743821|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
2743822|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
1681613|NCT02720185|Dasatinib|dasatinib|mesh-list
1681614|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681615|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1681616|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743823|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681617|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681618|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
1681619|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681620|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1681621|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1681622|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681623|NCT02701088|Mitomycins|mitomycins|mesh-list
1681624|NCT02701088|Mitomycin|mitomycin|mesh-list
1681625|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1681626|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681627|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
1681628|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681629|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1681630|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743824|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743825|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2743826|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2743836|NCT05007145|Paclitaxel|paclitaxel|mesh-list
2743837|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2743838|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
2743839|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2743840|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743841|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
2743842|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
2743843|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
2743844|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743845|NCT04990388|Acetaminophen|acetaminophen|mesh-list
2743846|NCT04990388|Antipyretics|antipyretics|mesh-list
2743847|NCT04990388|Cetirizine|cetirizine|mesh-list
2743848|NCT04990388|Ibuprofen|ibuprofen|mesh-list
2743849|NCT04990388|Famotidine|famotidine|mesh-list
2743850|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2743851|NCT04990388|Analgesics|analgesics|mesh-ancestor
2743852|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
2743853|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2743854|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743855|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2743856|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2743857|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2743858|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2743859|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2743860|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743861|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2743862|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2743863|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
2743864|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
2743865|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
1681673|NCT02675465|Miglustat|miglustat|mesh-list
1681674|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1681675|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681676|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1681677|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1681678|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
1681679|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1681680|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
1681681|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1681682|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681683|NCT02663908|Leuprolide|leuprolide|mesh-list
1681684|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1681685|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
1681686|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1681687|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681688|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1681689|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743866|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1681693|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1681694|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1681695|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1681696|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
2743867|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
2743868|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
2743869|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
2743878|NCT04968951|Metronidazole|metronidazole|mesh-list
2743879|NCT04968951|Vancomycin|vancomycin|mesh-list
2743880|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2743881|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2743882|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2743883|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1681718|NCT02624765|Digoxin|digoxin|mesh-list
1681719|NCT02624765|Sotalol|sotalol|mesh-list
1681720|NCT02624765|Flecainide|flecainide|mesh-list
1681721|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1681722|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1681723|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1681724|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681725|NCT02624765|Protective Agents|protective agents|mesh-ancestor
1681726|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681727|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1681728|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1681729|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
1681730|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1681731|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
1681732|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
1681733|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1681734|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1681735|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1681736|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1681745|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
1681746|NCT02619253|Vorinostat|vorinostat|mesh-list
1681747|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1681748|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681749|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1681750|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1681751|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1681760|NCT02554383|Amoxicillin|amoxicillin|mesh-list
1681761|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
1681762|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
1681763|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1681764|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1681765|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1681766|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1681767|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1681768|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743900|NCT04952857|Vitamin D|vitamin d|mesh-list
2743901|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
2743902|NCT04952857|Vitamins|vitamins|mesh-ancestor
2743903|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
2743904|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743905|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
2743906|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2743914|NCT04943445|Paclitaxel|paclitaxel|mesh-list
2743915|NCT04943445|Carboplatin|carboplatin|mesh-list
2743916|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
2743917|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
2743918|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2743919|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743920|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
2743921|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
2743922|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
2743923|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743924|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2743925|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2743970|NCT04928261|Trastuzumab|trastuzumab|mesh-list
2743971|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2743972|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2743973|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
2743974|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
2743975|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2743976|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2743977|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1681895|NCT02408861|Nivolumab|nivolumab|mesh-list
1681896|NCT02408861|Ipilimumab|ipilimumab|mesh-list
1681897|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1681898|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1681899|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1681900|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744027|NCT04899232|Antithrombins|antithrombins|mesh-list
2744028|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
2744029|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2744030|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
2744031|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2744032|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744033|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
2744092|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
2744093|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2744094|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
2744095|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744096|NCT04825262|Tacrolimus|tacrolimus|mesh-list
2744097|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2744098|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
2744099|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744100|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2744101|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2744102|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744103|NCT04821830|Levodopa|levodopa|mesh-list
2744104|NCT04821830|Carbidopa|carbidopa|mesh-list
2744105|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
2744106|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2744107|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2744108|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
2744109|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2744110|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744111|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744112|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
2744113|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2744114|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
2744115|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
2744116|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
2744117|NCT04821310|Pantoprazole|pantoprazole|mesh-list
2744118|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
2744119|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2744120|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
2744121|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2744122|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744145|NCT04803994|Bevacizumab|bevacizumab|mesh-list
2744146|NCT04803994|Atezolizumab|atezolizumab|mesh-list
2744147|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2744148|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2744149|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2744150|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2744151|NCT04803994|Growth Substances|growth substances|mesh-ancestor
2744152|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744153|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
2744240|NCT04739761|Trastuzumab|trastuzumab|mesh-list
2744241|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2744242|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2744243|NCT04708782|Treprostinil|treprostinil|mesh-list
2744244|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2744257|NCT04693507|Antarelix|antarelix|mesh-list
2744258|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
2744259|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2744260|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744261|NCT04692467|Amlodipine|amlodipine|mesh-list
2744262|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2744263|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
2744264|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2744265|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744266|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
2744267|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744268|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
2744378|NCT04618016|Vitamins|vitamins|mesh-list
2744379|NCT04618016|Vitamin E|vitamin e|mesh-list
2744380|NCT04618016|Tocopherols|tocopherols|mesh-list
2744381|NCT04618016|Tocotrienols|tocotrienols|mesh-list
2744382|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
2744383|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
2744384|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744385|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
2744386|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744387|NCT04618016|Protective Agents|protective agents|mesh-ancestor
2744388|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
2744389|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
2744390|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2744391|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
2744392|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
2744393|NCT04613596|Adagrasib|adagrasib|mesh-list
2744394|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2744395|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2744424|NCT04604132|Paclitaxel|paclitaxel|mesh-list
2744425|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2744426|NCT04604132|Atezolizumab|atezolizumab|mesh-list
2744427|NCT04604132|Ramucirumab|ramucirumab|mesh-list
2744428|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2744429|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2744430|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2744431|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
2744432|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
2744433|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
2744434|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744435|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
2744436|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744442|NCT04597671|Durvalumab|durvalumab|mesh-list
2744443|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2744444|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2744509|NCT04571944|Suvorexant|suvorexant|mesh-list
2744510|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
2744511|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
2744512|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2744513|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744514|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
2744515|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2744516|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744567|NCT04527289|Amantadine|amantadine|mesh-list
2744568|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2744569|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2744570|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
2744571|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2744572|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
2744573|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2744574|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744575|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744576|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2744577|NCT04527289|Analgesics|analgesics|mesh-ancestor
2744578|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
2744579|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2744580|NCT04525898|Methadone|methadone|mesh-list
2744581|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2744582|NCT04525898|Narcotics|narcotics|mesh-ancestor
2744583|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2744584|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744585|NCT04525898|Analgesics|analgesics|mesh-ancestor
2744586|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
2744587|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2744588|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
2744589|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
2744590|NCT04518124|Propranolol|propranolol|mesh-list
2744591|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
2744592|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
2744593|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
2744594|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2744595|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744596|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744597|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2744598|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
2744599|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
2744600|NCT04511052|Carotenoids|carotenoids|mesh-list
2744601|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
2744602|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744603|NCT04511052|Protective Agents|protective agents|mesh-ancestor
2744604|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744624|NCT04460326|Insulin|insulin|mesh-list
2744625|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
2744626|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
2744627|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
2744628|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2744629|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744630|NCT04451772|Upadacitinib|upadacitinib|mesh-list
2744631|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
2744632|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2744633|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2744634|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744635|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2744648|NCT04433858|Psilocybin|psilocybin|mesh-list
2744649|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
2744650|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744651|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
2744682|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
2744683|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
2744684|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
1682799|NCT05090449|Losartan|losartan|mesh-list
1682800|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
1682801|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1682802|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1682803|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1682804|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1682805|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1682806|NCT05090449|Diuretics|diuretics|mesh-ancestor
1682807|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
1682808|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1682809|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1682810|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1682811|NCT05090384|Prednisone|prednisone|mesh-list
1682812|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1682813|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
1682814|NCT05090384|Hormones|hormones|mesh-ancestor
1682815|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1682816|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1682817|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1682818|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1682821|NCT05090358|Canagliflozin|canagliflozin|mesh-list
1682822|NCT05090358|Fulvestrant|fulvestrant|mesh-list
1682823|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1682824|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1682825|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1682826|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1682827|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
1682828|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1682829|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1682830|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1682831|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1682832|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2744685|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2744686|NCT04381897|Expectorants|expectorants|mesh-ancestor
2744687|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
2744688|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2744689|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
2744690|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744691|NCT04381897|Protective Agents|protective agents|mesh-ancestor
2744692|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744693|NCT04381897|Antidotes|antidotes|mesh-ancestor
1682854|NCT05090176|Povidone|povidone|mesh-list
1682855|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
1682856|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
1682857|NCT05090137|Diuretics|diuretics|mesh-list
1682858|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
1682859|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1682860|NCT05090124|Adalimumab|adalimumab|mesh-list
1682861|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1682862|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2744713|NCT04339270|Azithromycin|azithromycin|mesh-list
1682872|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
1682873|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1682874|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
1682875|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1682876|NCT05089981|Expectorants|expectorants|mesh-ancestor
1682877|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
1682878|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1682879|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
1682880|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1682881|NCT05089981|Protective Agents|protective agents|mesh-ancestor
1682882|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1682883|NCT05089981|Antidotes|antidotes|mesh-ancestor
2744714|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2744715|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2744728|NCT04282070|Gemcitabine|gemcitabine|mesh-list
2744729|NCT04282070|Paclitaxel|paclitaxel|mesh-list
2744730|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
2744731|NCT04282070|Cisplatin|cisplatin|mesh-list
2744732|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2744733|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2744734|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
2744735|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
2744736|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
2744737|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744738|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2744739|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
2744740|NCT04282070|Antiviral Agents|antiviral agents|mesh-ancestor
2744741|NCT04282070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2744742|NCT04282070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2744743|NCT04282070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2744744|NCT04282070|Immunologic Factors|immunologic factors|mesh-ancestor
2744745|NCT04282070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1682924|NCT05089604|Tacrolimus|tacrolimus|mesh-list
1682925|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1682926|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
1682927|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1682928|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1682929|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1682930|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1682940|NCT05089539|Valsartan|valsartan|mesh-list
1682941|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1682942|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1682943|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1682944|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744755|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
2744756|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2744757|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2744758|NCT04259255|Edaravone|edaravone|mesh-list
2744759|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
2744760|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
2744761|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744762|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
2744763|NCT04259255|Protective Agents|protective agents|mesh-ancestor
2744764|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744770|NCT04246554|Acetaminophen|acetaminophen|mesh-list
2744771|NCT04246554|Ketorolac|ketorolac|mesh-list
2744772|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
2744773|NCT04246554|Oxycodone|oxycodone|mesh-list
2744774|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2744775|NCT04246554|Analgesics|analgesics|mesh-ancestor
2744776|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
2744777|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2744778|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1682976|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
1682977|NCT05089461|Analgesics|analgesics|mesh-ancestor
1682978|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
1682979|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1682980|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1682981|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1682982|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1682983|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1682984|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1682985|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1682986|NCT05089448|Amlodipine|amlodipine|mesh-list
1682987|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1682988|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1682989|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1682990|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1682991|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1682992|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1682993|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
1682994|NCT05089383|Progesterone|progesterone|mesh-list
1682995|NCT05089383|Progestins|progestins|mesh-ancestor
1682996|NCT05089383|Hormones|hormones|mesh-ancestor
1682997|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1682998|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744779|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
2744780|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
2744781|NCT04246554|Narcotics|narcotics|mesh-ancestor
2744782|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2744783|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
2744784|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2744785|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2744786|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
2744787|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1683008|NCT05089344|Clomiphene|clomiphene|mesh-list
1683009|NCT05089344|Enclomiphene|enclomiphene|mesh-list
1683010|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
1683011|NCT05089344|Hormones|hormones|mesh-list
1683012|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1683013|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683014|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1683015|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
1683016|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1683017|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
1683018|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1683019|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1683020|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
2744788|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683060|NCT05088889|Nivolumab|nivolumab|mesh-list
1683061|NCT05088889|Ipilimumab|ipilimumab|mesh-list
1683062|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1683063|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1683064|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1683065|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683066|NCT05088876|Acetaminophen|acetaminophen|mesh-list
1683067|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1683068|NCT05088876|Analgesics|analgesics|mesh-ancestor
1683069|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
1683070|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1683071|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683072|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
1683073|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
1683074|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
1683075|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1683076|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683077|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683078|NCT05088720|Misoprostol|misoprostol|mesh-list
1683079|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1683080|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
1683081|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1683082|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683083|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1683084|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1683085|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
1683086|NCT05088707|Misoprostol|misoprostol|mesh-list
1683087|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1683088|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
1683089|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1683090|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683091|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1683092|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1683093|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
1683094|NCT05084118|Landiolol|landiolol|mesh-list
1683095|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1683096|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1683097|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
1683098|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1683099|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683100|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683101|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1683106|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
1683107|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1683108|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
1683109|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1683110|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683111|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1683131|NCT05077540|Misoprostol|misoprostol|mesh-list
1683132|NCT05077540|Oxytocin|oxytocin|mesh-list
1683133|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
1683134|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1683135|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683136|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1683137|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
1683138|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1683139|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1683140|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
1683141|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1683153|NCT05064878|Fenfluramine|fenfluramine|mesh-list
1683154|NCT05064878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1683155|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1683156|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1683157|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683158|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1683159|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
1683160|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744855|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
2744856|NCT04108858|Trastuzumab|trastuzumab|mesh-list
2744857|NCT04108858|Pertuzumab|pertuzumab|mesh-list
2744858|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
2744859|NCT04108858|Antibodies|antibodies|mesh-list
2744860|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
2744861|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2744862|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
2744863|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744864|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2744865|NCT04101721|Aflibercept|aflibercept|mesh-list
2744866|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
2744867|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
2744868|NCT04101721|Growth Substances|growth substances|mesh-ancestor
2744869|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744870|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
2744871|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1683198|NCT05057468|Cyclosporine|cyclosporine|mesh-list
1683199|NCT05057468|Rituximab|rituximab|mesh-list
1683200|NCT05057468|Cyclosporins|cyclosporins|mesh-list
1683201|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1683202|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1683203|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
1683204|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683205|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1683206|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1683207|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683208|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1683209|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
1683210|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1683211|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
1683212|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
2744888|NCT04093570|Decitabine|decitabine|mesh-list
2744889|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2744890|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
2744891|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744892|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2744893|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2744906|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
2744907|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
2744908|NCT04083495|Fludarabine|fludarabine|mesh-list
2744909|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2744910|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
2744911|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744912|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2744913|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1683253|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
1683254|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1683255|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1683256|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1683257|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1683258|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1683259|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683260|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1683261|NCT05043077|Phenylephrine|phenylephrine|mesh-list
1683262|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
1683263|NCT05043077|Tropicamide|tropicamide|mesh-list
1683264|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1683265|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
1683266|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
1683267|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1683268|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683269|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
1683270|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1683271|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
1683272|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
1683273|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1683274|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1683275|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1683276|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
1683277|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1683278|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683279|NCT05043077|Protective Agents|protective agents|mesh-ancestor
1683280|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1683281|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1683282|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
2744914|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
2744915|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744916|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2744917|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2744918|NCT04078906|SMOFlipid|smoflipid|mesh-list
2744919|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
2744920|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2744921|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2744922|NCT04057898|Ibudilast|ibudilast|mesh-list
2744923|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2744924|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
2744925|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2744926|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744927|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2744928|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
2744929|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
2744930|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2744931|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744932|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2744933|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
2744957|NCT04035486|Carboplatin|carboplatin|mesh-list
2744958|NCT04035486|Pemetrexed|pemetrexed|mesh-list
2744959|NCT04035486|Osimertinib|osimertinib|mesh-list
2744960|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2744961|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2744962|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744963|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
2744964|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
2744965|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
2744966|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-list
2744967|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2744968|NCT04026113|Linaclotide|linaclotide|mesh-list
2744969|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
2744970|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
2744971|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2744972|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2744989|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
2744990|NCT04024462|Docetaxel|docetaxel|mesh-list
1683362|NCT05009992|Panobinostat|panobinostat|mesh-list
1683363|NCT05009992|TIC10 compound|tic10 compound|mesh-list
1683364|NCT05009992|Dopamine|dopamine|mesh-list
1683365|NCT05009992|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
1683366|NCT05009992|GDC-0084|gdc-0084|mesh-list
1683367|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1683368|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1683369|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683370|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1683371|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
1683372|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
1683373|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1683374|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683375|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
1683376|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1683377|NCT05009992|Protective Agents|protective agents|mesh-ancestor
2744991|NCT04024462|Doxorubicin|doxorubicin|mesh-list
2744992|NCT04024462|Trastuzumab|trastuzumab|mesh-list
2744993|NCT04024462|Pertuzumab|pertuzumab|mesh-list
2744994|NCT04024462|Hormones|hormones|mesh-list
2744995|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2744996|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
2744997|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2744998|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2744999|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2745000|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
2745001|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745002|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745003|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2745004|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
2745005|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
2745006|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
2745007|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1683395|NCT04991103|Dexamethasone|dexamethasone|mesh-list
1683396|NCT04991103|Lenalidomide|lenalidomide|mesh-list
1683397|NCT04991103|Bortezomib|bortezomib|mesh-list
1683398|NCT04991103|Daratumumab|daratumumab|mesh-list
1683399|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1683400|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
1683401|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
1683402|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1683403|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683404|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1683405|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
1683406|NCT04991103|Hormones|hormones|mesh-ancestor
1683407|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1683408|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1683409|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1683410|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
1683411|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1683412|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1683413|NCT04991103|Growth Substances|growth substances|mesh-ancestor
1683414|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
2745008|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2745009|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2745010|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745011|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745012|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2745013|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
2745018|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
2745019|NCT03978624|Entinostat|entinostat|mesh-list
2745020|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745021|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745022|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2745023|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745024|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745025|NCT03976310|Benralizumab|benralizumab|mesh-list
2745026|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2745027|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
1683438|NCT04961593|Caspofungin|caspofungin|mesh-list
1683439|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
1683440|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1683441|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1683442|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683443|NCT04961580|Ceftazidime|ceftazidime|mesh-list
1683444|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1683445|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2745049|NCT03941132|Ustekinumab|ustekinumab|mesh-list
2745050|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
2745051|NCT03934671|Antioxidants|antioxidants|mesh-list
2745052|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745053|NCT03934671|Protective Agents|protective agents|mesh-ancestor
2745054|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745055|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
2745056|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745057|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1683500|NCT04945213|Biperiden|biperiden|mesh-list
1683501|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1683502|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1683503|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
1683504|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
1683505|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1683506|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683507|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1683508|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1683509|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
1683510|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1683511|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683822|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
2745092|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
2745093|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745094|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745095|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
2745096|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745097|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745107|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
2745108|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
2745109|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745110|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
2745111|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745112|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745113|NCT03803761|Fulvestrant|fulvestrant|mesh-list
2745114|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2745115|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745116|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
2745117|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
2745118|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
2745119|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2745120|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745147|NCT03739931|Durvalumab|durvalumab|mesh-list
1683823|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
2745148|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1683596|NCT04932915|Niclosamide|niclosamide|mesh-list
1683597|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
1683598|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1683599|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
1683600|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1683601|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1683602|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
2745149|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745150|NCT03737461|Lidocaine|lidocaine|mesh-list
2745151|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
2745152|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
2745153|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2745154|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745155|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
2745156|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2745157|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
2745158|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
2745159|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
2745160|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2745161|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745178|NCT03712098|Liraglutide|liraglutide|mesh-list
2745179|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
2745180|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745181|NCT03712098|Incretins|incretins|mesh-ancestor
2745182|NCT03712098|Hormones|hormones|mesh-ancestor
2745183|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2745184|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
2745185|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1683675|NCT04908592|Dexamethasone|dexamethasone|mesh-list
1683676|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1683677|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
1683678|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
1683679|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1683680|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683681|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1683682|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
1683683|NCT04908592|Hormones|hormones|mesh-ancestor
1683684|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1683685|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1683686|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745186|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745187|NCT03679091|Clopidogrel|clopidogrel|mesh-list
2745188|NCT03679091|Ticagrelor|ticagrelor|mesh-list
2745189|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
2745190|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
2745191|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
2745192|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
2745193|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
2745194|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2745195|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745196|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745197|NCT03677141|Prednisone|prednisone|mesh-list
2745198|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
2745199|NCT03677141|Doxorubicin|doxorubicin|mesh-list
2745200|NCT03677141|Vincristine|vincristine|mesh-list
2745201|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
2745202|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
1683711|NCT04895930|Aflutinib|aflutinib|mesh-list
1683712|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1683713|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1683714|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745203|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745204|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2745205|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
2745206|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
2745207|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745208|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745209|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
2745210|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
2745211|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
2745212|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
2745213|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745214|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2745215|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
2745216|NCT03677141|Hormones|hormones|mesh-ancestor
2745217|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2745218|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2745219|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
2745220|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
2745221|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
2745222|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
2745226|NCT03651518|Rituximab|rituximab|mesh-list
2745227|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
2745228|NCT03651518|Ustekinumab|ustekinumab|mesh-list
2745229|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745230|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745231|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
2745232|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745233|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
2745234|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
2745235|NCT03624517|Octreotide|octreotide|mesh-list
2745236|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2745237|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2745238|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745239|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
2745240|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
2745241|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
2745242|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
2745243|NCT03592212|Albuterol|albuterol|mesh-list
2745244|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
2745245|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
2745246|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2745247|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745248|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
2745249|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
2745250|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
2745251|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
2745252|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
2745253|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
2745254|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
2745255|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
2745256|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2745257|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683775|NCT04870424|Colchicine|colchicine|mesh-list
1683776|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
1683777|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1683778|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
1683779|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
1683780|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
1683781|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683782|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1683783|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
1683784|NCT04862585|Promethazine|promethazine|mesh-list
1683785|NCT04862585|Dexamethasone|dexamethasone|mesh-list
1683786|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
1683787|NCT04862585|Paclitaxel|paclitaxel|mesh-list
1683788|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1683789|NCT04862585|Famotidine|famotidine|mesh-list
1683790|NCT04862585|Ranitidine|ranitidine|mesh-list
1683791|NCT04862585|Cimetidine|cimetidine|mesh-list
1683792|NCT04862585|BB 1101|bb 1101|mesh-list
1683793|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1683794|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1683795|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
1683796|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
1683797|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
1683798|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683799|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1683800|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
1683801|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
1683802|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1683803|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683804|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1683805|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
1683806|NCT04862585|Hormones|hormones|mesh-ancestor
1683807|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1683808|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1683809|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
1683810|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1683811|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1683812|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1683813|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1683814|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
1683815|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
1683816|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
1683817|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1683818|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
1683819|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
1683820|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1683821|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1683824|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1683825|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1683826|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1683827|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1683836|NCT04850651|Fluconazole|fluconazole|mesh-list
1683837|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
1683838|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1683839|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1683840|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1683841|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1683842|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683843|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1683844|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
1683845|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1683846|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683847|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1683848|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
2745278|NCT03475381|Ivacaftor|ivacaftor|mesh-list
2745279|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
2745280|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
2745281|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1683885|NCT04828005|Naloxone|naloxone|mesh-list
1683886|NCT04828005|Nalmefene|nalmefene|mesh-list
1683887|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1683888|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683889|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
1683890|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2745311|NCT03465540|Dexamethasone|dexamethasone|mesh-list
2745312|NCT03465540|Azacitidine|azacitidine|mesh-list
2745313|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2745314|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
2745315|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
2745316|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2745317|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745318|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
2745319|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
2745320|NCT03465540|Hormones|hormones|mesh-ancestor
2745321|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2745322|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2745323|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745324|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
2745325|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
2745326|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745327|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745328|NCT03436199|Amantadine|amantadine|mesh-list
2745329|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
2745330|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
2745331|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
2745332|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2745333|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
2745334|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
2745335|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745336|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745337|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
2745338|NCT03436199|Analgesics|analgesics|mesh-ancestor
2745339|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
2745340|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
2745350|NCT03353233|Ropivacaine|ropivacaine|mesh-list
2745351|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
2745352|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
2745353|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
2745354|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745355|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
2745356|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1683976|NCT04788550|Listerine|listerine|mesh-list
1683977|NCT04788550|Fluorides|fluorides|mesh-list
1683978|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
1683979|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
1683980|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
1683981|NCT04788550|Protective Agents|protective agents|mesh-ancestor
1683982|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1683983|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1683984|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2745367|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
2745368|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745369|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745372|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
2745373|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
2745374|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
2745375|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
2745376|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
2745377|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745378|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745379|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
2745416|NCT03255252|Cisplatin|cisplatin|mesh-list
2745417|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745418|NCT03250273|Nivolumab|nivolumab|mesh-list
2745419|NCT03250273|Entinostat|entinostat|mesh-list
2745420|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745421|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745422|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1684044|NCT04759768|Naltrexone|naltrexone|mesh-list
1684045|NCT04759768|Nalmefene|nalmefene|mesh-list
1684046|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1684047|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684048|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
1684049|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1684050|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
2745423|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745424|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
2745425|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745426|NCT03217136|Metronidazole|metronidazole|mesh-list
2745427|NCT03217136|Meropenem|meropenem|mesh-list
2745428|NCT03217136|Tazobactam|tazobactam|mesh-list
2745429|NCT03217136|Ceftolozane|ceftolozane|mesh-list
2745430|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
2745431|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
2745432|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
2745433|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
2745434|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
2745435|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
2745436|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
2745437|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745438|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
2745439|NCT03217136|Renal Agents|renal agents|mesh-ancestor
2745467|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
2745468|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745469|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1684107|NCT04757493|Prucalopride|prucalopride|mesh-list
1684108|NCT04757493|Laxatives|laxatives|mesh-ancestor
1684109|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1684110|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
1684111|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1684112|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
1684113|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1684114|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684115|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684116|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
1684117|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1684118|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1684119|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1684120|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1684121|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684122|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
1684123|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1684124|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684125|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1684126|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1684134|NCT04731467|Paclitaxel|paclitaxel|mesh-list
1684135|NCT04731467|Nivolumab|nivolumab|mesh-list
1684136|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1684137|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1684138|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
1684139|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
1684140|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
1684141|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684142|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1684143|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1684144|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
1684145|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1684146|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1684147|NCT04723134|Leucovorin|leucovorin|mesh-list
1684148|NCT04723134|Folic Acid|folic acid|mesh-list
1684149|NCT04723134|Calcium|calcium|mesh-list
1684150|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
1684151|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1684152|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684153|NCT04723134|Antidotes|antidotes|mesh-ancestor
1684154|NCT04723134|Protective Agents|protective agents|mesh-ancestor
1684155|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
1684156|NCT04723134|Vitamins|vitamins|mesh-ancestor
1684157|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
1684158|NCT04723134|Hematinics|hematinics|mesh-ancestor
1684165|NCT04713319|Calcium|calcium|mesh-list
1684166|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1684167|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684174|NCT04705662|Lactulose|lactulose|mesh-list
1684175|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1684190|NCT04691986|Niacinamide|niacinamide|mesh-list
1684191|NCT04691986|Niacin|niacin|mesh-list
1684192|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
1684193|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
1684194|NCT04691986|Vitamins|vitamins|mesh-ancestor
1684195|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
1684196|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684197|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1684198|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
1684199|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684200|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1684201|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
2745519|NCT02985957|Prednisone|prednisone|mesh-list
2745520|NCT02985957|Nivolumab|nivolumab|mesh-list
2745521|NCT02985957|Ipilimumab|ipilimumab|mesh-list
2745522|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
2745523|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
2745524|NCT02985957|Hormones|hormones|mesh-ancestor
2745525|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
2745526|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
2745527|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
2745528|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
2745529|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745530|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
2745531|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
2745532|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
2745533|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
2745534|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1684254|NCT04605081|Naltrexone|naltrexone|mesh-list
1684255|NCT04605081|Bupropion|bupropion|mesh-list
1684256|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1684257|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1684258|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684259|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
1684260|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1684261|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1684262|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
1684263|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1684264|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1684265|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1684266|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1684267|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684268|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
1684269|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1684270|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1684271|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1684272|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1684278|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1684279|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1684280|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684281|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1684282|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1684283|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1684284|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684285|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
1684286|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1684287|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
1684288|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1684289|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1684290|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684291|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
1684292|NCT04595786|Coagulants|coagulants|mesh-ancestor
1684311|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
1684312|NCT04569461|Androgens|androgens|mesh-list
1684313|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1684314|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1684315|NCT04569461|Hormones|hormones|mesh-ancestor
1684316|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1684317|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684335|NCT04565483|Benralizumab|benralizumab|mesh-list
1684336|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1684337|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
1684343|NCT04544007|Poly ICLC|poly iclc|mesh-list
1684344|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
1684345|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
1684346|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684347|NCT04536194|Dopamine|dopamine|mesh-list
1684348|NCT04536194|Norepinephrine|norepinephrine|mesh-list
1684349|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1684350|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1684351|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
1684352|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1684353|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684354|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684355|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
1684356|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
1684357|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1684358|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1684359|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1684360|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
1684361|NCT04536194|Protective Agents|protective agents|mesh-ancestor
1684362|NCT04535505|Erythromycin|erythromycin|mesh-list
1684363|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
1684364|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
1684365|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
1684366|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1684367|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1684368|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1684369|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1684370|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1684371|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684413|NCT04484025|Ebselen|ebselen|mesh-list
1684414|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1684415|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1684416|NCT04484025|Analgesics|analgesics|mesh-ancestor
1684417|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
1684418|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1684419|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684420|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1684421|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1684422|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1684423|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1684424|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
1684425|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684426|NCT04484025|Protective Agents|protective agents|mesh-ancestor
1684427|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1684428|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1684429|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1684430|NCT04483973|Ebselen|ebselen|mesh-list
1684431|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1684432|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1684433|NCT04483973|Analgesics|analgesics|mesh-ancestor
1684434|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
1684435|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1684436|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684437|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1684438|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1684439|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1684440|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1684441|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
1684442|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684443|NCT04483973|Protective Agents|protective agents|mesh-ancestor
1684444|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1684445|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1684446|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1684457|NCT04449042|Anesthetics|anesthetics|mesh-list
1684458|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1684459|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684463|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
1684464|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1684465|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1684504|NCT04341090|Apatinib|apatinib|mesh-list
1684505|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1684506|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1684507|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1684508|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684525|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
1684526|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
1684527|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1684528|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684529|NCT04338529|Vitamins|vitamins|mesh-ancestor
1684530|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
1684531|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1684532|NCT04338529|Antacids|antacids|mesh-ancestor
1684533|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684534|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1684549|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
1684550|NCT04263896|Laxatives|laxatives|mesh-ancestor
1684551|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1684552|NCT04254731|Methadone|methadone|mesh-list
1684553|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1684554|NCT04254731|Narcotics|narcotics|mesh-ancestor
1684555|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1684556|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684557|NCT04254731|Analgesics|analgesics|mesh-ancestor
1684558|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
1684559|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1684560|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
1684561|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
1684562|NCT04254627|Etanercept|etanercept|mesh-list
1684563|NCT04254627|Mifepristone|mifepristone|mesh-list
1684564|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1684565|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1684566|NCT04254627|Analgesics|analgesics|mesh-ancestor
1684567|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
1684568|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1684569|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684570|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1684571|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1684572|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1684573|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1684574|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
1684575|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1684576|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
1684577|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1684578|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1684579|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1684580|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1684581|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
1684582|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1684583|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1684584|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
1684585|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1684586|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
1684587|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1684588|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1684617|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
1684618|NCT04223570|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1684619|NCT04223570|Levulinic acid|levulinic acid|mesh-list
1684620|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1684621|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
1684622|NCT04223570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1684623|NCT04223570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684657|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
1684658|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1684659|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1684710|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
1684711|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1684712|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1684747|NCT04089150|Leucovorin|leucovorin|mesh-list
1684748|NCT04089150|Gemcitabine|gemcitabine|mesh-list
1684749|NCT04089150|Paclitaxel|paclitaxel|mesh-list
1684750|NCT04089150|Fluorouracil|fluorouracil|mesh-list
1684751|NCT04089150|Capecitabine|capecitabine|mesh-list
1684752|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
1684753|NCT04089150|Irinotecan|irinotecan|mesh-list
1684754|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1684755|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1684756|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
1684757|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
1684758|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
1684759|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684760|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1684761|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
1684762|NCT04089150|Antiviral Agents|antiviral agents|mesh-ancestor
1684763|NCT04089150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1684764|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1684765|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1684766|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
1684767|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684768|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1684769|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1684770|NCT04089150|Antidotes|antidotes|mesh-ancestor
1684771|NCT04089150|Protective Agents|protective agents|mesh-ancestor
1684772|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
1684773|NCT04089150|Vitamins|vitamins|mesh-ancestor
1684774|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
1684780|NCT04082780|Rifamycins|rifamycins|mesh-list
1684781|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
1684782|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1684783|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1684784|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1684798|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
1684799|NCT04036929|Estrogens|estrogens|mesh-list
1684800|NCT04036929|Hormones|hormones|mesh-ancestor
1684801|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1684802|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1684803|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1684804|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1684805|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
1684806|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1684885|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1684886|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1684887|NCT03925350|Niraparib|niraparib|mesh-list
1684888|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1684889|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1684890|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1684891|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1684999|NCT03906526|Nivolumab|nivolumab|mesh-list
1685000|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1685001|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685002|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1685003|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685021|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
1685022|NCT03829332|Lenvatinib|lenvatinib|mesh-list
1685023|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1685024|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685025|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1685026|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1685027|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685035|NCT03798626|Leucovorin|leucovorin|mesh-list
1685036|NCT03798626|Paclitaxel|paclitaxel|mesh-list
1685037|NCT03798626|Bevacizumab|bevacizumab|mesh-list
1685038|NCT03798626|Fluorouracil|fluorouracil|mesh-list
1685039|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
1685040|NCT03798626|Irinotecan|irinotecan|mesh-list
1685041|NCT03798626|Ramucirumab|ramucirumab|mesh-list
1685042|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
1685043|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1685044|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685045|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
1685046|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
1685047|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
1685048|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685049|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1685050|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1685051|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1685052|NCT03798626|Growth Substances|growth substances|mesh-ancestor
1685053|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685054|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
1685055|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
1685056|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1685057|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1685058|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
1685059|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1685060|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1685061|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1685062|NCT03798626|Antidotes|antidotes|mesh-ancestor
1685063|NCT03798626|Protective Agents|protective agents|mesh-ancestor
1685064|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
1685065|NCT03798626|Vitamins|vitamins|mesh-ancestor
1685066|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
1685070|NCT03789604|Antibodies|antibodies|mesh-list
1685071|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1685072|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
1685073|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685144|NCT03633058|Ketamine|ketamine|mesh-list
1685145|NCT03633058|Analgesics|analgesics|mesh-ancestor
1685146|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
1685147|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1685148|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685149|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1685150|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1685151|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
1685152|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
1685153|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1685154|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1685155|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1685156|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1685157|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685174|NCT03575208|Interferons|interferons|mesh-list
1685175|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
1685176|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
1685177|NCT03575208|Antibodies|antibodies|mesh-list
1685178|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
1685179|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1685180|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1685181|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685182|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
1685183|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1685184|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
1685185|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685186|NCT03568994|Cytarabine|cytarabine|mesh-list
1685187|NCT03568994|Atovaquone|atovaquone|mesh-list
1685188|NCT03568994|Etoposide|etoposide|mesh-list
1685189|NCT03568994|Daunorubicin|daunorubicin|mesh-list
1685190|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
1685191|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1685192|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685193|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1685194|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1685195|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1685196|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685197|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1685198|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
1685199|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
1685200|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1685201|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1685202|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
1685203|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685204|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1685205|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1685206|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
1685207|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1685208|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1685213|NCT03542175|Rucaparib|rucaparib|mesh-list
1685214|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1685215|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1685216|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685217|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685218|NCT03522064|Carboplatin|carboplatin|mesh-list
1685219|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
1685220|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1685221|NCT03522064|Testosterone|testosterone|mesh-list
1685222|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
1685223|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
1685224|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1685225|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685226|NCT03522064|Androgens|androgens|mesh-ancestor
1685227|NCT03522064|Hormones|hormones|mesh-ancestor
1685228|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1685229|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685230|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1685231|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
1685237|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
1685238|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1685239|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685240|NCT03451006|Metformin|metformin|mesh-list
1685241|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1685242|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685256|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
1685257|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1685258|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685259|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
1685260|NCT03408652|Denosumab|denosumab|mesh-list
1685261|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1685262|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685271|NCT03372941|Dalbavancin|dalbavancin|mesh-list
1685272|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1685273|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1685296|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
1685297|NCT03292861|Sirolimus|sirolimus|mesh-list
1685298|NCT03292861|Tacrolimus|tacrolimus|mesh-list
1685299|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
1685300|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1685301|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
1685302|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685303|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1685304|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1685305|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685306|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1685307|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685308|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1685309|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
1685310|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1685311|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1685312|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
1685327|NCT03263117|Anesthetics|anesthetics|mesh-list
1685328|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1685329|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685338|NCT03215030|Dexamethasone|dexamethasone|mesh-list
1685339|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1685340|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
1685341|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
1685342|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1685343|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685344|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1685345|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
1685346|NCT03215030|Hormones|hormones|mesh-ancestor
1685347|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1685348|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1685349|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685355|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
1685356|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1685357|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685361|NCT03165994|Paclitaxel|paclitaxel|mesh-list
1685362|NCT03165994|Carboplatin|carboplatin|mesh-list
1685363|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1685364|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685365|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
1685366|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
1685367|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
1685368|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685373|NCT03056755|Letrozole|letrozole|mesh-list
1685374|NCT03056755|Fulvestrant|fulvestrant|mesh-list
1685375|NCT03056755|Leuprolide|leuprolide|mesh-list
1685376|NCT03056755|Goserelin|goserelin|mesh-list
1685377|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685378|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1685379|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1685380|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1685381|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685382|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1685383|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
1685384|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1685385|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685386|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1685387|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1685388|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1685389|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
1685390|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1685391|NCT03030261|Dexamethasone|dexamethasone|mesh-list
1685392|NCT03030261|Pomalidomide|pomalidomide|mesh-list
1685393|NCT03030261|Elotuzumab|elotuzumab|mesh-list
1685394|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1685395|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
1685396|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
1685397|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1685398|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685399|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1685400|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
1685401|NCT03030261|Hormones|hormones|mesh-ancestor
1685402|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1685403|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1685404|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685405|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
1685406|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1685407|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1685408|NCT03030261|Growth Substances|growth substances|mesh-ancestor
1685409|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
1685444|NCT02969850|Vitamin D|vitamin d|mesh-list
1685445|NCT02969850|Calcium|calcium|mesh-list
1685446|NCT02969850|Vitamins|vitamins|mesh-ancestor
1685447|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
1685448|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685449|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1685450|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1685451|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
1685452|NCT02955290|Nivolumab|nivolumab|mesh-list
1685453|NCT02955290|Vaccines|vaccines|mesh-list
1685454|NCT02955290|Mitogens|mitogens|mesh-list
1685455|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
1685456|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685457|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1685458|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685459|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1685460|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685461|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
1685478|NCT02947386|Nivolumab|nivolumab|mesh-list
1685479|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
1685480|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1685481|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685482|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1685483|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685484|NCT02939989|Ribavirin|ribavirin|mesh-list
1685485|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
1685486|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
1685487|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685488|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
1685489|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1685511|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
1685512|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1685513|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1685514|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1685515|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1685613|NCT02603328|Atorvastatin|atorvastatin|mesh-list
1685614|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1685615|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1685616|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
1685617|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685618|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1685619|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1685620|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1685670|NCT02349867|Gemcitabine|gemcitabine|mesh-list
1685671|NCT02349867|Sorafenib|sorafenib|mesh-list
1685672|NCT02349867|Vorinostat|vorinostat|mesh-list
1685673|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1685674|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
1685675|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1685676|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1685677|NCT02349867|Antiviral Agents|antiviral agents|mesh-ancestor
1685678|NCT02349867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1685679|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1685680|NCT02349867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1685681|NCT02349867|Immunologic Factors|immunologic factors|mesh-ancestor
1685682|NCT02349867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685683|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1685684|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1685685|NCT02339766|Morphine|morphine|mesh-list
1685686|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1685687|NCT02339766|Narcotics|narcotics|mesh-ancestor
1685688|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1685689|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1685690|NCT02339766|Analgesics|analgesics|mesh-ancestor
1685691|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
1685692|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1686169|NCT05092386|Vaccines|vaccines|mesh-list
1686170|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
1686171|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686416|NCT05081583|Midazolam|midazolam|mesh-list
1686233|NCT05091866|Progesterone|progesterone|mesh-list
1686234|NCT05091866|Progestins|progestins|mesh-list
1686235|NCT05091866|Hormones|hormones|mesh-ancestor
1686236|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1686237|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686238|NCT05091775|Mesalamine|mesalamine|mesh-list
1686239|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1686240|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1686241|NCT05091775|Analgesics|analgesics|mesh-ancestor
1686242|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
1686243|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1686244|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686245|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1686246|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1686250|NCT05091606|Anesthetics|anesthetics|mesh-list
1686251|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1686252|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686272|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
1686273|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1686274|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
1686275|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686284|NCT05091359|Calcium|calcium|mesh-list
1686285|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1686286|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686310|NCT05091203|Vitamin D|vitamin d|mesh-list
1686311|NCT05091203|Vitamins|vitamins|mesh-ancestor
1686312|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
1686313|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686314|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1686315|NCT05091177|Acetylcholine|acetylcholine|mesh-list
1686316|NCT05091177|Antibodies|antibodies|mesh-list
1686317|NCT05091177|Neostigmine|neostigmine|mesh-list
1686318|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
1686319|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686320|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1686321|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1686322|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686323|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
1686324|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1686325|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1686326|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
1686327|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1686328|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
1686329|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1686330|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
1686331|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1686332|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1686333|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686334|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1686335|NCT05091151|Analgesics|analgesics|mesh-ancestor
1686336|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
1686337|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1686338|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1686339|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1686340|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1686341|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
1686342|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1686343|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686344|NCT05091138|Buprenorphine|buprenorphine|mesh-list
1686345|NCT05091138|Bupivacaine|bupivacaine|mesh-list
1686346|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
1686347|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
1686348|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1686349|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686350|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
1686351|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1686352|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1686353|NCT05091138|Narcotics|narcotics|mesh-ancestor
1686354|NCT05091138|Analgesics|analgesics|mesh-ancestor
1686355|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1686356|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
1686357|NCT05091099|Alendronate|alendronate|mesh-list
1686358|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1686359|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686360|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
1686361|NCT05091086|Denosumab|denosumab|mesh-list
1686362|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1686363|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686364|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
1686365|NCT05091008|Ledipasvir|ledipasvir|mesh-list
1686366|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
1686367|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
1686368|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1686369|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
1686370|NCT05090761|Buprenorphine|buprenorphine|mesh-list
1686371|NCT05090761|Bupivacaine|bupivacaine|mesh-list
1686372|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1686373|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
1686374|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
1686375|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1686376|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686377|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
1686378|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1686379|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1686380|NCT05090761|Narcotics|narcotics|mesh-ancestor
1686381|NCT05090761|Analgesics|analgesics|mesh-ancestor
1686382|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1686383|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1686384|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
1686385|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1686386|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1686387|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686388|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1686389|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
1686390|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1686400|NCT05090592|Atropine|atropine|mesh-list
1686401|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1686402|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1686403|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1686404|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
1686405|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1686406|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686407|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1686408|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
1686409|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
1686410|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
1686411|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1686412|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1686413|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
1686414|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1686415|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686417|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1686418|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1686419|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1686420|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686421|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1686422|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1686423|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1686424|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1686425|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
1686426|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
1686427|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
1686428|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
1686429|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1686430|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686431|NCT05081336|Ezetimibe|ezetimibe|mesh-list
1686432|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1686433|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1686434|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
1686435|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686436|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1686453|NCT05079217|Vaccines|vaccines|mesh-list
1686454|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
1686455|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686468|NCT05077839|Trifluridine|trifluridine|mesh-list
1686469|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
1686470|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686471|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
1686472|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1686473|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
1686474|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1686475|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
1686476|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1686477|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
1686478|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1686479|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686480|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
1686481|NCT05077085|Vancomycin|vancomycin|mesh-list
1686482|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1686483|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1686522|NCT05069129|Vaccines|vaccines|mesh-list
1686523|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
1686524|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686525|NCT05067985|Anesthetics|anesthetics|mesh-list
1686526|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1686527|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686575|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1686576|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1686577|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686634|NCT05044117|Capecitabine|capecitabine|mesh-list
1686635|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1686636|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
1686637|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686638|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1686765|NCT05004896|Midazolam|midazolam|mesh-list
1686766|NCT05004896|Ketamine|ketamine|mesh-list
1686767|NCT05004896|Analgesics|analgesics|mesh-ancestor
1686768|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
1686769|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1686770|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686771|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1686772|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1686773|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
1686774|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
1686775|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1686776|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1686777|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1686778|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1686779|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686780|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1686781|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1686782|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1686783|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1686784|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1686785|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
1686786|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
1686808|NCT04997993|Leflunomide|leflunomide|mesh-list
1686809|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1686810|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686811|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1686812|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
1686813|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686814|NCT04988841|Nivolumab|nivolumab|mesh-list
1686815|NCT04988841|Ipilimumab|ipilimumab|mesh-list
1686816|NCT04988841|Laxatives|laxatives|mesh-list
1686817|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1686818|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1686819|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1686820|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1686821|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686822|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1686828|NCT04985136|Sorafenib|sorafenib|mesh-list
1686829|NCT04985136|Apatinib|apatinib|mesh-list
1686830|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1686831|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1686832|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1686833|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686857|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
1686858|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1686859|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
1686860|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1686861|NCT04964843|Expectorants|expectorants|mesh-ancestor
1686862|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
1686863|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1686864|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
1686865|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686866|NCT04964843|Protective Agents|protective agents|mesh-ancestor
1686867|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686868|NCT04964843|Antidotes|antidotes|mesh-ancestor
1686869|NCT04955236|Fentanyl|fentanyl|mesh-list
1686870|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1686871|NCT04955236|Narcotics|narcotics|mesh-ancestor
1686872|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1686873|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686874|NCT04955236|Analgesics|analgesics|mesh-ancestor
1686875|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
1686876|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1686877|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1686878|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1686879|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
1686880|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
1686881|NCT04952350|Atorvastatin|atorvastatin|mesh-list
1686882|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1686883|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1686884|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
1686885|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1686886|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1686887|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1686888|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1686892|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1686893|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1686938|NCT04928664|Bupivacaine|bupivacaine|mesh-list
1686939|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
1686940|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
1686941|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1686942|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1686943|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
1686944|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1687003|NCT04899492|Nicotine|nicotine|mesh-list
1687004|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1687005|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
1687006|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1687007|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687008|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1687009|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1687010|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
1687011|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1687012|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687026|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
1687027|NCT04895735|Pemetrexed|pemetrexed|mesh-list
1687028|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1687029|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1687030|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1687031|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687032|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1687033|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1687082|NCT04866017|Durvalumab|durvalumab|mesh-list
1687083|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1687084|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1687090|NCT04850144|Bromides|bromides|mesh-list
1687091|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
1687092|NCT04850144|Charcoal|charcoal|mesh-list
1687093|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1687094|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
1687095|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1687096|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687097|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1687098|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
1687099|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
1687100|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1687101|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
1687102|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1687103|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687104|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
1687105|NCT04850144|Antidotes|antidotes|mesh-ancestor
1687106|NCT04850144|Protective Agents|protective agents|mesh-ancestor
1687110|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
1687111|NCT04847063|Doxorubicin|doxorubicin|mesh-list
1687112|NCT04847063|Fluorouracil|fluorouracil|mesh-list
1687113|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
1687114|NCT04847063|Mitomycins|mitomycins|mesh-list
1687115|NCT04847063|Mitomycin|mitomycin|mesh-list
1687116|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1687117|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1687118|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1687119|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1687120|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1687121|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687122|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
1687123|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1687124|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1687125|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
1687126|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687127|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
1687128|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1687129|NCT04847063|Antidotes|antidotes|mesh-ancestor
1687130|NCT04847063|Protective Agents|protective agents|mesh-ancestor
1687131|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
1687132|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
1687133|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1687134|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1687135|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
1687136|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
1687137|NCT04840602|Rituximab|rituximab|mesh-list
1687138|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1687139|NCT04840602|Venetoclax|venetoclax|mesh-list
1687140|NCT04840602|Antibodies|antibodies|mesh-list
1687141|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
1687142|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1687143|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
1687144|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687145|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1687146|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1687147|NCT04840472|Panitumumab|panitumumab|mesh-list
1687148|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1687149|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1687176|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
1687177|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1687178|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1687179|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
1687180|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1687181|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687182|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1687242|NCT04762199|Osimertinib|osimertinib|mesh-list
1687243|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1687244|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1687245|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1687246|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687308|NCT04759144|Insulin|insulin|mesh-list
1687309|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1687310|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
1687311|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
1687312|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1687313|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1687314|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687321|NCT04741139|Acetaminophen|acetaminophen|mesh-list
1687322|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
1687323|NCT04741139|Promethazine|promethazine|mesh-list
1687324|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1687325|NCT04741139|Analgesics|analgesics|mesh-ancestor
1687326|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
1687327|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1687328|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687329|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
1687330|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1687331|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1687332|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1687333|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
1687334|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
1687335|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
1687336|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
1687337|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1687338|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1687339|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
1687340|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
1687341|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1687342|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687343|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1687344|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
1687345|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
1687401|NCT04730635|Donepezil|donepezil|mesh-list
1687402|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1687403|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1687404|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687405|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
1687406|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1687407|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687408|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
1687419|NCT04710199|Maraviroc|maraviroc|mesh-list
1687420|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1687421|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1687422|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687423|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1687424|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1687425|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
1687426|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1687427|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1687431|NCT04708067|Atezolizumab|atezolizumab|mesh-list
1687432|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1687441|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1687442|NCT04648696|Vancomycin|vancomycin|mesh-list
1687443|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1687444|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1687445|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
1687458|NCT04639310|Ezogabine|ezogabine|mesh-list
1687459|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
1687460|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1687461|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687481|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
1687482|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
1687483|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687484|NCT04604548|Protective Agents|protective agents|mesh-ancestor
1687485|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687486|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
1687487|NCT04602845|Fentanyl|fentanyl|mesh-list
1687488|NCT04602845|Midazolam|midazolam|mesh-list
1687489|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1687490|NCT04602845|Narcotics|narcotics|mesh-ancestor
1687491|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1687492|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687493|NCT04602845|Analgesics|analgesics|mesh-ancestor
1687494|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
1687495|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1687496|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1687497|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1687498|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
1687499|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
1687500|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1687501|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1687502|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1687503|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1687504|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
1687505|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
1687506|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1687507|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687508|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1687509|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1687510|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1687511|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1687512|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1687513|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1687522|NCT04590794|Plasminogen|plasminogen|mesh-list
1687523|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1687524|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1687525|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687571|NCT04573478|Atrasentan|atrasentan|mesh-list
1687572|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1687573|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
1687574|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1687575|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687606|NCT04543643|Carvedilol|carvedilol|mesh-list
1687607|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1687608|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1687609|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
1687610|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1687611|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687612|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687613|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1687614|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
1687615|NCT04543643|Protective Agents|protective agents|mesh-ancestor
1687616|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1687617|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1687618|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1687619|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
1687620|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1687621|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1687682|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
1687683|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1687684|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1687685|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687686|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1687687|NCT04526652|Analgesics|analgesics|mesh-ancestor
1687688|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
1687689|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1687690|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1687691|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1687692|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1687693|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
1687694|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1687695|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687696|NCT04516993|Tenecteplase|tenecteplase|mesh-list
1687697|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1687698|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1687699|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687719|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1687720|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1687724|NCT04448834|Vincristine|vincristine|mesh-list
1687725|NCT04448834|Blinatumomab|blinatumomab|mesh-list
1687726|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1687727|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1687728|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
1687729|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
1687730|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
1687731|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687767|NCT04401800|Lenvatinib|lenvatinib|mesh-list
1687768|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1687769|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1687770|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1687771|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687811|NCT04341467|Olanzapine|olanzapine|mesh-list
1687812|NCT04341467|Amisulpride|amisulpride|mesh-list
1687813|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
1687814|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
1687815|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1687816|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687817|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1687818|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1687819|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1687820|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1687821|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1687822|NCT04341467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1687823|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1687824|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1687825|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687826|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1687827|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
1687828|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1687829|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
1687830|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1687831|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
1687850|NCT04287660|Clarithromycin|clarithromycin|mesh-list
1687851|NCT04287660|Dexamethasone|dexamethasone|mesh-list
1687852|NCT04287660|Lenalidomide|lenalidomide|mesh-list
1687853|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1687854|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
1687855|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
1687856|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1687857|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687858|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1687859|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
1687860|NCT04287660|Hormones|hormones|mesh-ancestor
1687861|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1687862|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1687863|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1687864|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
1687865|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1687866|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1687867|NCT04287660|Growth Substances|growth substances|mesh-ancestor
1687868|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
1687869|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1687870|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1687871|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1687872|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1687873|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687874|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1687875|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1687906|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
1687907|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
1687908|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1687909|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
1687910|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
1687911|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
1687912|NCT04255277|Charcoal|charcoal|mesh-list
1687913|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1687914|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1687915|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1687916|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1687917|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1687918|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1687919|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1687920|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1687921|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1687922|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687923|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1687924|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1687925|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1687926|NCT04255277|Estrogens|estrogens|mesh-ancestor
1687927|NCT04255277|Hormones|hormones|mesh-ancestor
1687928|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1687929|NCT04255277|Antidotes|antidotes|mesh-ancestor
1687930|NCT04255277|Protective Agents|protective agents|mesh-ancestor
1687936|NCT04218539|Psilocybin|psilocybin|mesh-list
1687937|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
1687938|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1687939|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1688018|NCT04149587|Brodalumab|brodalumab|mesh-list
1688019|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
1688054|NCT04086147|Tenecteplase|tenecteplase|mesh-list
1688055|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1688056|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1688057|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688064|NCT04058158|Eculizumab|eculizumab|mesh-list
1688065|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1688066|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1688067|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
1688068|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688082|NCT04012177|Niacinamide|niacinamide|mesh-list
1688083|NCT04012177|Niacin|niacin|mesh-list
1688084|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
1688085|NCT04012177|Azithromycin|azithromycin|mesh-list
1688086|NCT04012177|Choline|choline|mesh-list
1688087|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1688088|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1688089|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
1688090|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1688091|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
1688092|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688093|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1688094|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1688095|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
1688096|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
1688097|NCT04012177|Vitamins|vitamins|mesh-ancestor
1688098|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
1688099|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688100|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
1688108|NCT03979742|Lithium Carbonate|lithium carbonate|mesh-list
1688109|NCT03979742|Antidepressive Agents|antidepressive agents|mesh-ancestor
1688110|NCT03979742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1688111|NCT03979742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1688112|NCT03979742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688113|NCT03979742|Antimanic Agents|antimanic agents|mesh-ancestor
1688114|NCT03979742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1688115|NCT03979742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1688116|NCT03979742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688117|NCT03966807|Nicotine|nicotine|mesh-list
1688118|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1688119|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
1688120|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1688121|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688122|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1688123|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1688124|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
1688125|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1688126|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688136|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
1688137|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1688138|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
1688139|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688140|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1688141|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1688142|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
1688143|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688144|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688145|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1688153|NCT03924986|Gemcitabine|gemcitabine|mesh-list
1688154|NCT03924986|Cisplatin|cisplatin|mesh-list
1688155|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688156|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1688157|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
1688158|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688159|NCT03924986|Antiviral Agents|antiviral agents|mesh-ancestor
1688160|NCT03924986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1688161|NCT03924986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1688162|NCT03924986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1688163|NCT03924986|Immunologic Factors|immunologic factors|mesh-ancestor
1688164|NCT03924986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688165|NCT03922620|Bupivacaine|bupivacaine|mesh-list
1688166|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
1688167|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
1688168|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1688169|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688170|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
1688171|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1688243|NCT03901573|Atezolizumab|atezolizumab|mesh-list
1688244|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688267|NCT03853187|Durvalumab|durvalumab|mesh-list
1688268|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1688269|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1688270|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688271|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
1688272|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688285|NCT03841110|Aldesleukin|aldesleukin|mesh-list
1688286|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
1688287|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
1688288|NCT03841110|Nivolumab|nivolumab|mesh-list
1688289|NCT03841110|Fludarabine|fludarabine|mesh-list
1688290|NCT03841110|Atezolizumab|atezolizumab|mesh-list
1688291|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1688292|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
1688293|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688294|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1688295|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1688296|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
1688297|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688298|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688299|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1688300|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1688301|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1688302|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1688303|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1688304|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
1688305|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1688375|NCT03783403|Rituximab|rituximab|mesh-list
1688376|NCT03783403|Cetuximab|cetuximab|mesh-list
1688377|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1688378|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688379|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
1688380|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688381|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1688394|NCT03713294|Dexamethasone|dexamethasone|mesh-list
1688395|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
1688396|NCT03713294|Pomalidomide|pomalidomide|mesh-list
1688397|NCT03713294|Elotuzumab|elotuzumab|mesh-list
1688398|NCT03713294|Ichthammol|ichthammol|mesh-list
1688399|NCT03713294|BB 1101|bb 1101|mesh-list
1688400|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1688401|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
1688402|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
1688403|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1688404|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688405|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1688406|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
1688407|NCT03713294|Hormones|hormones|mesh-ancestor
1688408|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1688409|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1688410|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688411|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
1688412|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1688413|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688414|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
1688415|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1688416|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1688417|NCT03713294|Growth Substances|growth substances|mesh-ancestor
1688418|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
1688419|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
1688450|NCT03663205|Cisplatin|cisplatin|mesh-list
1688451|NCT03663205|Carboplatin|carboplatin|mesh-list
1688452|NCT03663205|Pemetrexed|pemetrexed|mesh-list
1688453|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688454|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1688455|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688456|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1688457|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1688501|NCT03621696|Cisplatin|cisplatin|mesh-list
1688502|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688536|NCT03597581|Bevacizumab|bevacizumab|mesh-list
1688537|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1688538|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688539|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1688540|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1688541|NCT03597581|Growth Substances|growth substances|mesh-ancestor
1688542|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688543|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
1688552|NCT03593915|Azacitidine|azacitidine|mesh-list
1688553|NCT03593915|Decitabine|decitabine|mesh-list
1688554|NCT03593915|Alvocidib|alvocidib|mesh-list
1688555|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1688556|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
1688557|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688558|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688559|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1688560|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
1688561|NCT03593915|Growth Substances|growth substances|mesh-ancestor
1688562|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688563|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1688593|NCT03472586|Nivolumab|nivolumab|mesh-list
1688594|NCT03472586|Ipilimumab|ipilimumab|mesh-list
1688595|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1688596|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688597|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1688598|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688842|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
1688615|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
1688616|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1688617|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688618|NCT03423680|Aripiprazole|aripiprazole|mesh-list
1688619|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
1688620|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1688621|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1688622|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1688623|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1688624|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688625|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
1688626|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
1688627|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1688628|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688629|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1688630|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1688631|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
1688632|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1688633|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1688634|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1688635|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1688639|NCT03393468|Dapivirine|dapivirine|mesh-list
1688640|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1688641|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1688642|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
1688643|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1688689|NCT03371667|Methotrexate|methotrexate|mesh-list
1688690|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1688691|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
1688692|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1688693|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688694|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1688695|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
1688696|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688697|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688698|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
1688699|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1688700|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1688701|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1688702|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
1688703|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1688704|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1688724|NCT03342937|Capecitabine|capecitabine|mesh-list
1688725|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
1688726|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
1688727|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1688728|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
1688729|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688730|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688731|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1688732|NCT03318900|Aldesleukin|aldesleukin|mesh-list
1688733|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
1688734|NCT03318900|Interleukin-2|interleukin-2|mesh-list
1688735|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1688736|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
1688737|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1688738|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
1688739|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688740|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1688741|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1688742|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
1688743|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688744|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688745|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1688746|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1688747|NCT03318900|Analgesics|analgesics|mesh-ancestor
1688748|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
1688749|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1688750|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1688751|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1688752|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
1688753|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1688760|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
1688761|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1688762|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688843|NCT03121001|Sirolimus|sirolimus|mesh-list
1688844|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
1688845|NCT03121001|Fludarabine|fludarabine|mesh-list
1688846|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
1688847|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1688848|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
1688849|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688850|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1688851|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1688852|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
1688853|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688854|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688855|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1688856|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1688857|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1688858|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
1688859|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1688860|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1688861|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1688862|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
1688863|NCT03073525|Atezolizumab|atezolizumab|mesh-list
1688864|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688865|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
1688866|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1688867|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688916|NCT02965898|Vitamin D|vitamin d|mesh-list
1688917|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
1688918|NCT02965898|Vitamins|vitamins|mesh-list
1688919|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
1689985|NCT05092945|Niacin|niacin|mesh-list
1688920|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688921|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1688922|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1688923|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
1688924|NCT02952222|Propofol|propofol|mesh-list
1688925|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1688926|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1688927|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1688928|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1688929|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
1688930|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
1688931|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1688932|NCT02952222|Analgesics|analgesics|mesh-ancestor
1688933|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
1688934|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1688935|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1688936|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1688937|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1688938|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
1688939|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1688940|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688941|NCT02922764|Carboplatin|carboplatin|mesh-list
1688942|NCT02922764|Docetaxel|docetaxel|mesh-list
1688943|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
1688944|NCT02922764|Nivolumab|nivolumab|mesh-list
1688945|NCT02922764|Pemetrexed|pemetrexed|mesh-list
1688946|NCT02922764|Ipilimumab|ipilimumab|mesh-list
1688947|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1688948|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
1688949|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
1688950|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
1688951|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1688952|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1688953|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1688954|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1688955|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1688956|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1689101|NCT02667587|Nivolumab|nivolumab|mesh-list
1689102|NCT02667587|Temozolomide|temozolomide|mesh-list
1689103|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1689104|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1689105|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1689106|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1689107|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1689108|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
1689109|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1689110|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1689111|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
1689140|NCT02563015|Vitamin D|vitamin d|mesh-list
1689141|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
1689142|NCT02563015|Vitamins|vitamins|mesh-ancestor
1689143|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
1689144|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689145|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1689146|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1689147|NCT02543255|Prednisone|prednisone|mesh-list
1689148|NCT02543255|Leuprolide|leuprolide|mesh-list
1689149|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
1689150|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1689151|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
1689152|NCT02543255|Hormones|hormones|mesh-ancestor
1689153|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1689154|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689155|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1689156|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1689157|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1689158|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
1689159|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1689160|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1689161|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1689162|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1689163|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
1689164|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1689165|NCT02531932|Carboplatin|carboplatin|mesh-list
1689166|NCT02531932|Everolimus|everolimus|mesh-list
1689167|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1689168|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1689169|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
1689170|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689240|NCT02344290|Pitavastatin|pitavastatin|mesh-list
1689241|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1689242|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1689243|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1689244|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
1689245|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1689246|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1689247|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1689719|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
1689720|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1689721|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
1689722|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1689723|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1689724|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689725|NCT05094804|Pembrolizumab|pembrolizumab|mesh-list
1689726|NCT05094804|Nivolumab|nivolumab|mesh-list
1689727|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1689728|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1689729|NCT05094804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1689730|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1689731|NCT05094596|Montelukast|montelukast|mesh-list
1689732|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1689733|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
1689734|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1689735|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
1689736|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1689737|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689738|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1689739|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1689740|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1689741|NCT05094492|Fluorides|fluorides|mesh-list
1689742|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
1689743|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
1689744|NCT05094492|Protective Agents|protective agents|mesh-ancestor
1689745|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689746|NCT05094427|Anesthetics|anesthetics|mesh-list
1689747|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
1689748|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1689749|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689750|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
1689751|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1689752|NCT05094414|Valacyclovir|valacyclovir|mesh-list
1689753|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
1689754|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1689755|NCT05094375|Misoprostol|misoprostol|mesh-list
1689756|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1689757|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
1689758|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1689759|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689760|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1689761|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1689762|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
1689797|NCT05093907|Capecitabine|capecitabine|mesh-list
1689798|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1689799|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
1689800|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1689801|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1689802|NCT05093790|Aspirin|aspirin|mesh-list
1689803|NCT05093790|Ticagrelor|ticagrelor|mesh-list
1689804|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1689805|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1689806|NCT05093790|Analgesics|analgesics|mesh-ancestor
1689807|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
1689808|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1689809|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689810|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1689811|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1689812|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1689813|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1689814|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1689815|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1689816|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1689817|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1689818|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
1689819|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1689820|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1689821|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1689822|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
1689823|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1689833|NCT05093608|Bevacizumab|bevacizumab|mesh-list
1689834|NCT05093608|Atezolizumab|atezolizumab|mesh-list
1689835|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1689836|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1689837|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1689838|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1689839|NCT05093608|Growth Substances|growth substances|mesh-ancestor
1689840|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689841|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
1689855|NCT05093478|Lidocaine|lidocaine|mesh-list
1689856|NCT05093478|Capsaicin|capsaicin|mesh-list
1689857|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
1689858|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
1689859|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1689860|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689861|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
1689862|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1689863|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1689864|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1689865|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1689866|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1689867|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1689868|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
1689869|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
1689870|NCT05093387|Carboplatin|carboplatin|mesh-list
1689871|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
1689872|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1689873|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1689874|NCT05093374|Bevacizumab|bevacizumab|mesh-list
1689875|NCT05093374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1689876|NCT05093374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1689877|NCT05093374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1689878|NCT05093374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1689879|NCT05093374|Growth Substances|growth substances|mesh-ancestor
1689880|NCT05093374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689881|NCT05093374|Growth Inhibitors|growth inhibitors|mesh-ancestor
1689882|NCT05093322|Gemcitabine|gemcitabine|mesh-list
1689883|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1689884|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
1689885|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1689886|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1689887|NCT05093322|Antiviral Agents|antiviral agents|mesh-ancestor
1689888|NCT05093322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1689889|NCT05093322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1689890|NCT05093322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1689891|NCT05093322|Immunologic Factors|immunologic factors|mesh-ancestor
1689892|NCT05093322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689902|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
1689903|NCT05093231|Olaparib|olaparib|mesh-list
1689904|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1689905|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1689906|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1689907|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1689908|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1689944|NCT05093140|Prednisone|prednisone|mesh-list
1689945|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
1689946|NCT05093140|Vincristine|vincristine|mesh-list
1689947|NCT05093140|Doxorubicin|doxorubicin|mesh-list
1689948|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1689949|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1689950|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
1689951|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689952|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1689953|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1689954|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
1689955|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1689956|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1689957|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1689958|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1689959|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
1689960|NCT05093140|Hormones|hormones|mesh-ancestor
1689961|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1689962|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1689963|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1689964|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
1689965|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
1689966|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
1689967|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1689968|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1689969|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1689970|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1689971|NCT05092984|Spironolactone|spironolactone|mesh-list
1689972|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1689973|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
1689974|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1689975|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689976|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1689977|NCT05092984|Diuretics|diuretics|mesh-ancestor
1689978|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
1689979|NCT05092958|Avelumab|avelumab|mesh-list
1689980|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1689981|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1689982|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1689983|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
1689984|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689986|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
1689987|NCT05092945|Niacinamide|niacinamide|mesh-list
1689988|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1689989|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
1689990|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1689991|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1689992|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
1689993|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
1689994|NCT05092945|Vitamins|vitamins|mesh-ancestor
1689995|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
1689996|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1689997|NCT05092841|Naltrexone|naltrexone|mesh-list
1689998|NCT05092841|Baclofen|baclofen|mesh-list
1689999|NCT05092841|Sorbitol|sorbitol|mesh-list
1690000|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1690001|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1690002|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690003|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
1690004|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1690005|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1690006|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1690007|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
1690008|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
1690009|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
1690010|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1690011|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690012|NCT05092841|Cathartics|cathartics|mesh-ancestor
1690013|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1690039|NCT05090085|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
1690040|NCT05090085|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1690041|NCT05090085|Protective Agents|protective agents|mesh-ancestor
1690042|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690043|NCT05090085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1690044|NCT05090085|Antioxidants|antioxidants|mesh-ancestor
1690045|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690046|NCT05089526|Lidocaine|lidocaine|mesh-list
1690047|NCT05089526|Fentanyl|fentanyl|mesh-list
1690048|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
1690049|NCT05089526|Ketamine|ketamine|mesh-list
1690050|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
1690051|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
1690052|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1690053|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690054|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
1690055|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1690056|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1690057|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1690058|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1690059|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1690060|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690061|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1690062|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1690063|NCT05089526|Analgesics|analgesics|mesh-ancestor
1690064|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1690065|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1690066|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1690067|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
1690068|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1690069|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1690070|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1690071|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
1690072|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1690073|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1690074|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1690075|NCT05089526|Narcotics|narcotics|mesh-ancestor
1690076|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1690077|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
1690078|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1690079|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
1690080|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690081|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
1690082|NCT05082480|Protective Agents|protective agents|mesh-ancestor
1690083|NCT05080218|Adalimumab|adalimumab|mesh-list
1690084|NCT05080218|Etanercept|etanercept|mesh-list
1690085|NCT05080218|Golimumab|golimumab|mesh-list
1690086|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
1690087|NCT05080218|Abatacept|abatacept|mesh-list
1690088|NCT05080218|Upadacitinib|upadacitinib|mesh-list
1690089|NCT05080218|Tofacitinib|tofacitinib|mesh-list
1690090|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1690091|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1690092|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1690093|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1690094|NCT05080218|Analgesics|analgesics|mesh-ancestor
1690095|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
1690096|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1690097|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690098|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1690099|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1690100|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
1690101|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1690102|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690103|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1690104|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1690105|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1690106|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
1690112|NCT05078606|Anesthetics|anesthetics|mesh-list
1690113|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1690114|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690115|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
1690116|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1690117|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1690143|NCT05049616|Nifedipine|nifedipine|mesh-list
1690144|NCT05049616|Diuretics|diuretics|mesh-list
1690145|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1690146|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1690147|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1690148|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690149|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1690150|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690151|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
1690152|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
1690153|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1690154|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
1690155|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
1690156|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1690159|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
1690160|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1690161|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690205|NCT05025787|Celecoxib|celecoxib|mesh-list
1690206|NCT05025787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1690207|NCT05025787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1690208|NCT05025787|Analgesics|analgesics|mesh-ancestor
1690209|NCT05025787|Sensory System Agents|sensory system agents|mesh-ancestor
1690210|NCT05025787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1690211|NCT05025787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690212|NCT05025787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1690213|NCT05025787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1690214|NCT05025787|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1690215|NCT05025787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1690216|NCT05025787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1690217|NCT05025787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690221|NCT05022810|Acetaminophen|acetaminophen|mesh-list
1690222|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1690223|NCT05022810|Analgesics|analgesics|mesh-ancestor
1690224|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
1690225|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1690226|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690227|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
1690278|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
1690279|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1690280|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
1690281|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
1690282|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
1690283|NCT04993560|Vaccines|vaccines|mesh-list
1690284|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
1690285|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690367|NCT04947085|Ketamine|ketamine|mesh-list
1690368|NCT04947085|Analgesics|analgesics|mesh-ancestor
1690369|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
1690370|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1690371|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690372|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1690373|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1690374|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
1690375|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
1690376|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1690377|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1690378|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1690379|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1690380|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690495|NCT04898309|Complement C1s|complement c1s|mesh-list
1690496|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1690497|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
1690498|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
1690499|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690500|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1690501|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1690517|NCT04885816|Sirolimus|sirolimus|mesh-list
1690518|NCT04885816|Everolimus|everolimus|mesh-list
1690519|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1690520|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1690521|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
1690522|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690523|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1690524|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1690525|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1690526|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
1690556|NCT04865614|Sevoflurane|sevoflurane|mesh-list
1690557|NCT04865614|Etomidate|etomidate|mesh-list
1690558|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1690559|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1690560|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
1690561|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
1690562|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1690563|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690564|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1690565|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1690573|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
1690574|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1690575|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1690576|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690679|NCT04770454|Buspirone|buspirone|mesh-list
1690680|NCT04770454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1690681|NCT04770454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1690682|NCT04770454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1690683|NCT04770454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690684|NCT04770454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1690685|NCT04770454|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1690686|NCT04770454|Serotonin Agents|serotonin agents|mesh-ancestor
1690687|NCT04770454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1690688|NCT04770454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690689|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
1690690|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1690691|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1690709|NCT04761861|Vildagliptin|vildagliptin|mesh-list
1690710|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1690711|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690712|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1690713|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
1690714|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1690715|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690808|NCT04731025|Vancomycin|vancomycin|mesh-list
1690809|NCT04731025|Gentamicins|gentamicins|mesh-list
1690810|NCT04731025|Cefazolin|cefazolin|mesh-list
1690811|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1690812|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1690813|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1690814|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1690815|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690832|NCT04711824|Gemcitabine|gemcitabine|mesh-list
1690833|NCT04711824|Paclitaxel|paclitaxel|mesh-list
1690834|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1690835|NCT04711824|Cisplatin|cisplatin|mesh-list
1690836|NCT04711824|Carboplatin|carboplatin|mesh-list
1690837|NCT04711824|Capecitabine|capecitabine|mesh-list
1690838|NCT04711824|Durvalumab|durvalumab|mesh-list
1690839|NCT04711824|Olaparib|olaparib|mesh-list
1690840|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1690841|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1690842|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
1690843|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
1690844|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
1690845|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690846|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1690847|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
1690848|NCT04711824|Antiviral Agents|antiviral agents|mesh-ancestor
1690849|NCT04711824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1690850|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1690851|NCT04711824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1690852|NCT04711824|Immunologic Factors|immunologic factors|mesh-ancestor
1690853|NCT04711824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690854|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1690855|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1690889|NCT04691128|Anesthetics|anesthetics|mesh-list
1690890|NCT04691128|Propofol|propofol|mesh-list
1690891|NCT04691128|Desflurane|desflurane|mesh-list
1690892|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1690893|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690894|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1690895|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1690896|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
1690897|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1690898|NCT04682522|Metronidazole|metronidazole|mesh-list
1690899|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1690900|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1690901|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1690902|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1690910|NCT04657809|Insulin|insulin|mesh-list
1690911|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1690912|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690940|NCT04628988|Prednisone|prednisone|mesh-list
1690941|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
1690942|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1690943|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
1690944|NCT04628988|Hormones|hormones|mesh-ancestor
1690945|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1690946|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690947|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1690948|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1690949|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1690950|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690951|NCT04619680|Nintedanib|nintedanib|mesh-list
1690952|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1690953|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1690954|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1690955|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690960|NCT04601584|Antibodies|antibodies|mesh-list
1690961|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
1690962|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
1690963|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690980|NCT04585854|Caffeine|caffeine|mesh-list
1690981|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1690982|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1690983|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1690984|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1690985|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690986|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1690987|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1690988|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
1690989|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1690995|NCT04582981|Raltitrexed|raltitrexed|mesh-list
1690996|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1690997|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
1690998|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1690999|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691000|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1691001|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691062|NCT04551495|Letrozole|letrozole|mesh-list
1691063|NCT04551495|Goserelin|goserelin|mesh-list
1691064|NCT04551495|Entrectinib|entrectinib|mesh-list
1691065|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691066|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1691067|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1691068|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691069|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691070|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1691071|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
1691072|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1691073|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691074|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1691075|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1691083|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
1691084|NCT04548661|Povidone|povidone|mesh-list
1691085|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
1691086|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
1691087|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1691088|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1691161|NCT04504240|Famotidine|famotidine|mesh-list
1691162|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1691163|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1691164|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1691165|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
1691166|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
1691167|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1691168|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691169|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691175|NCT04499248|Bimatoprost|bimatoprost|mesh-list
1691176|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1691177|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
1691178|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1691179|NCT04492306|Protective Agents|protective agents|mesh-ancestor
1691180|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691181|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1691182|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
1691183|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691184|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
1691185|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1691186|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
1691187|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691188|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
1691189|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1691190|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
1691191|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691208|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
1691209|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1691210|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
1691211|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1691212|NCT04459052|Expectorants|expectorants|mesh-ancestor
1691213|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
1691214|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1691215|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
1691216|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691217|NCT04459052|Protective Agents|protective agents|mesh-ancestor
1691218|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691219|NCT04459052|Antidotes|antidotes|mesh-ancestor
1691220|NCT04454476|Trametinib|trametinib|mesh-list
1691221|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691222|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1691223|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691224|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691237|NCT04430036|Gemcitabine|gemcitabine|mesh-list
1691238|NCT04430036|Cisplatin|cisplatin|mesh-list
1691239|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691240|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1691241|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
1691242|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691243|NCT04430036|Antiviral Agents|antiviral agents|mesh-ancestor
1691244|NCT04430036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1691245|NCT04430036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691246|NCT04430036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1691247|NCT04430036|Immunologic Factors|immunologic factors|mesh-ancestor
1691248|NCT04430036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691249|NCT04429802|Prucalopride|prucalopride|mesh-list
1691250|NCT04429802|Laxatives|laxatives|mesh-ancestor
1691251|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1691252|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
1691253|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1691254|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
1691255|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1691256|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691257|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691284|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
1691285|NCT04387760|Favipiravir|favipiravir|mesh-list
1691286|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
1691287|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1691288|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1691289|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1691290|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691291|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691292|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1691293|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
1691294|NCT04374903|Sirolimus|sirolimus|mesh-list
1691295|NCT04374903|Azithromycin|azithromycin|mesh-list
1691296|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
1691297|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1691298|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1691299|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1691300|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691301|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
1691302|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1691303|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
1691304|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691305|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
1691306|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1691307|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1691308|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691309|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691310|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1691325|NCT04356534|Antibodies|antibodies|mesh-list
1691326|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
1691327|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691345|NCT04331756|Anesthetics|anesthetics|mesh-list
1691346|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1691347|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691348|NCT04320342|Beclomethasone|beclomethasone|mesh-list
1691349|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
1691350|NCT04320342|Bromides|bromides|mesh-list
1691351|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
1691352|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1691353|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
1691354|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1691355|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691356|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1691357|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
1691358|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1691359|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1691360|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1691361|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
1691362|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1691363|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691364|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
1691365|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1691366|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
1691367|NCT04320342|Hormones|hormones|mesh-ancestor
1691368|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1691369|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1691370|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1691371|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1691372|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
1691397|NCT04300244|Nivolumab|nivolumab|mesh-list
1691398|NCT04300244|Ipilimumab|ipilimumab|mesh-list
1691399|NCT04300244|Sargramostim|sargramostim|mesh-list
1691400|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1691401|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691402|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1691403|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691404|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
1691405|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691406|NCT04298203|Topiramate|topiramate|mesh-list
1691407|NCT04298203|Phentermine|phentermine|mesh-list
1691408|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
1691409|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1691410|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691411|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1691412|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
1691413|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1691414|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
1691415|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
1691416|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1691417|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
1691418|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1691419|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691458|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
1691459|NCT04214418|Atezolizumab|atezolizumab|mesh-list
1691460|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691461|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
1691462|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1691463|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1691464|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1691465|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691466|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691467|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1691497|NCT04204967|Fentanyl|fentanyl|mesh-list
1691498|NCT04204967|Remifentanil|remifentanil|mesh-list
1691499|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1691500|NCT04204967|Narcotics|narcotics|mesh-ancestor
1691501|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1691502|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691503|NCT04204967|Analgesics|analgesics|mesh-ancestor
1691504|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
1691505|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1691506|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1691507|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1691508|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
1691509|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
1691527|NCT04182672|Triamcinolone|triamcinolone|mesh-list
1691528|NCT04182672|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1691529|NCT04182672|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1691530|NCT04182672|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1691531|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1691532|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
1691533|NCT04182672|Hormones|hormones|mesh-ancestor
1691534|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1691535|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691536|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1691537|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
1691538|NCT04182672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691539|NCT04182672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691547|NCT04169373|Upadacitinib|upadacitinib|mesh-list
1691548|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
1691549|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1691550|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691551|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691552|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1691622|NCT04085445|Paclitaxel|paclitaxel|mesh-list
1691623|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1691624|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691625|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
1691626|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
1691627|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
1691628|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691629|NCT04080804|Nivolumab|nivolumab|mesh-list
1691630|NCT04080804|Ipilimumab|ipilimumab|mesh-list
1691631|NCT04080804|Antibodies|antibodies|mesh-list
1691632|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
1691633|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
1691634|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691635|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1691636|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691637|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1691638|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691639|NCT04069273|Paclitaxel|paclitaxel|mesh-list
1691640|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
1691641|NCT04069273|Ramucirumab|ramucirumab|mesh-list
1691642|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1691643|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691644|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
1691645|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
1691646|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
1691647|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691648|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1691652|NCT04052568|Psilocybin|psilocybin|mesh-list
1691653|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
1691654|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691655|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1691659|NCT03976362|Paclitaxel|paclitaxel|mesh-list
1691660|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1691661|NCT03976362|Carboplatin|carboplatin|mesh-list
1691662|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
1691663|NCT03976362|Olaparib|olaparib|mesh-list
1691664|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1691665|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691666|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
1691667|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
1691668|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
1691669|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691670|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1691671|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1691672|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691705|NCT03920267|BMS-986165|bms-986165|mesh-list
1691706|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
1691707|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1691708|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691709|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691714|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
1691715|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1691716|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691781|NCT03854032|Nivolumab|nivolumab|mesh-list
1691782|NCT03854032|Linrodostat|linrodostat|mesh-list
1691783|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1691784|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691785|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1691786|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691787|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691790|NCT03840967|Niraparib|niraparib|mesh-list
1691791|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1691792|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691793|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691794|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691804|NCT03818763|Factor VIII|factor viii|mesh-list
1691805|NCT03818763|Coagulants|coagulants|mesh-ancestor
1691889|NCT03710876|Gemcitabine|gemcitabine|mesh-list
1691890|NCT03710876|Celecoxib|celecoxib|mesh-list
1691891|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1691892|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
1691893|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691894|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1691895|NCT03710876|Antiviral Agents|antiviral agents|mesh-ancestor
1691896|NCT03710876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1691897|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691898|NCT03710876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1691899|NCT03710876|Immunologic Factors|immunologic factors|mesh-ancestor
1691900|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691901|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1691902|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1691903|NCT03710876|Analgesics|analgesics|mesh-ancestor
1691904|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
1691905|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1691906|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1691907|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1691908|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1691909|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1691925|NCT03688828|Amoxicillin|amoxicillin|mesh-list
1691926|NCT03688828|Clarithromycin|clarithromycin|mesh-list
1691927|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
1691928|NCT03688828|Esomeprazole|esomeprazole|mesh-list
1691929|NCT03688828|Bismuth|bismuth|mesh-list
1691930|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1691931|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1691932|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1691933|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1691934|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1691935|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1691936|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1691937|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1691938|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1691939|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1691940|NCT03688828|Antacids|antacids|mesh-ancestor
1691941|NCT03688828|Diuretics|diuretics|mesh-ancestor
1691942|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
1691943|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691944|NCT03688828|Expectorants|expectorants|mesh-ancestor
1691945|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
1691986|NCT03643822|Dexamethasone|dexamethasone|mesh-list
1691987|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
1691988|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
1691989|NCT03643822|BB 1101|bb 1101|mesh-list
1691990|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1691991|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
1691992|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
1691993|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1691994|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1691995|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1691996|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
1691997|NCT03643822|Hormones|hormones|mesh-ancestor
1691998|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1691999|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1692000|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692001|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
1692002|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1692003|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692004|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1692005|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1692006|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1692007|NCT03643822|Analgesics|analgesics|mesh-ancestor
1692008|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
1692009|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1692010|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1692011|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1692012|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
1692013|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1692014|NCT03634150|Doxorubicin|doxorubicin|mesh-list
1692015|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1692016|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692017|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1692018|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1692019|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1692020|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692039|NCT03593759|Prednisone|prednisone|mesh-list
1692040|NCT03593759|Prednisolone|prednisolone|mesh-list
1692041|NCT03593759|Methotrexate|methotrexate|mesh-list
1692042|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1692043|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
1692044|NCT03593759|Hormones|hormones|mesh-ancestor
1692045|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1692046|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1692047|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1692048|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692049|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1692050|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
1692051|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1692052|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1692053|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
1692054|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692055|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
1692056|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1692057|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1692058|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1692059|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
1692060|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1692061|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1692083|NCT03564821|Ivosidenib|ivosidenib|mesh-list
1692084|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692085|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1692086|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692108|NCT03367741|Nivolumab|nivolumab|mesh-list
1692109|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1692110|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692111|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1692112|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692113|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1692114|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
1692115|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1692116|NCT03329378|Paclitaxel|paclitaxel|mesh-list
1692117|NCT03329378|Docetaxel|docetaxel|mesh-list
1692118|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1692119|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
1692120|NCT03329378|Carboplatin|carboplatin|mesh-list
1692121|NCT03329378|Doxorubicin|doxorubicin|mesh-list
1692122|NCT03329378|Trastuzumab|trastuzumab|mesh-list
1692123|NCT03329378|Pertuzumab|pertuzumab|mesh-list
1692124|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1692125|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692126|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
1692127|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
1692128|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
1692129|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692130|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1692131|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
1692132|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1692133|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1692134|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1692135|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
1692136|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1692137|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1692138|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1692139|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1692140|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1692141|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1692165|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1692166|NCT03270059|Hematinics|hematinics|mesh-ancestor
1692167|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1692168|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1692169|NCT03268083|Vaccines|vaccines|mesh-list
1692170|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
1692171|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1692190|NCT03206047|Poly I-C|poly i-c|mesh-list
1692191|NCT03206047|Atezolizumab|atezolizumab|mesh-list
1692192|NCT03206047|Guadecitabine|guadecitabine|mesh-list
1692193|NCT03206047|Azacitidine|azacitidine|mesh-list
1692194|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1692195|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1692196|NCT03206047|Poly ICLC|poly iclc|mesh-list
1692197|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692198|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
1692199|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1692200|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
1692201|NCT03206047|Laxatives|laxatives|mesh-ancestor
1692202|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1692203|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
1692204|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1692205|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1692206|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
1692207|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692208|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1692209|NCT03170817|Regadenoson|regadenoson|mesh-list
1692210|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1692211|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1692212|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
1692213|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
1692214|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1692215|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692216|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1692248|NCT03148275|Trametinib|trametinib|mesh-list
1692249|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692250|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1692251|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1692252|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692253|NCT03117309|Nivolumab|nivolumab|mesh-list
1692254|NCT03117309|Ipilimumab|ipilimumab|mesh-list
1692255|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1692256|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692257|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1692258|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692308|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
1692309|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1692310|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1692311|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
1692312|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1692313|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692314|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1692315|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
1692316|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
1692317|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1692318|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
1692319|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1692320|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
1692321|NCT02960659|Metformin|metformin|mesh-list
1692322|NCT02960659|Liraglutide|liraglutide|mesh-list
1692323|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1692324|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1692325|NCT02960659|Incretins|incretins|mesh-ancestor
1692326|NCT02960659|Hormones|hormones|mesh-ancestor
1692327|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1692333|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
1692334|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1692335|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1692336|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692337|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
1692338|NCT02926651|Coagulants|coagulants|mesh-ancestor
1692363|NCT02896335|Palbociclib|palbociclib|mesh-list
1692364|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692365|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1692366|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1692367|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692376|NCT02843074|Dexamethasone|dexamethasone|mesh-list
1692377|NCT02843074|Lenalidomide|lenalidomide|mesh-list
1692378|NCT02843074|Elotuzumab|elotuzumab|mesh-list
1692379|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1692380|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
1692381|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
1692382|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1692383|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1692384|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1692385|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
1692386|NCT02843074|Hormones|hormones|mesh-ancestor
1692387|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1692388|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1692389|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692390|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
1692391|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1692392|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1692393|NCT02843074|Growth Substances|growth substances|mesh-ancestor
1692394|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
1692499|NCT02817633|Carboplatin|carboplatin|mesh-list
1692500|NCT02817633|Docetaxel|docetaxel|mesh-list
1692501|NCT02817633|Nivolumab|nivolumab|mesh-list
1692502|NCT02817633|Pemetrexed|pemetrexed|mesh-list
1692503|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692504|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
1692505|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
1692506|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
1692507|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692508|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1692509|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1692510|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1692511|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1692512|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1692513|NCT02805504|Bupivacaine|bupivacaine|mesh-list
1692514|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
1692515|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
1692516|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1692517|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1692518|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
1692519|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1692520|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1692521|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1692558|NCT02715609|Copper|copper|mesh-list
1692559|NCT02715609|Temozolomide|temozolomide|mesh-list
1692560|NCT02715609|Disulfiram|disulfiram|mesh-list
1692561|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1692562|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
1692563|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692564|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692565|NCT02715609|Trace Elements|trace elements|mesh-ancestor
1692566|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
1692567|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1692568|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1692569|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
1692570|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1692571|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
1692572|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692573|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1692574|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692624|NCT02605148|Vitamin D|vitamin d|mesh-list
1692625|NCT02605148|Vitamins|vitamins|mesh-ancestor
1692626|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
1692627|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1692628|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1692638|NCT02505750|Capecitabine|capecitabine|mesh-list
1692639|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1692640|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
1692641|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692642|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692694|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
1692695|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1692696|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692697|NCT02395640|Capecitabine|capecitabine|mesh-list
1692698|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
1692699|NCT02395640|Epirubicin|epirubicin|mesh-list
1692700|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1692701|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
1692702|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1692703|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1692704|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1692705|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1692706|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1692707|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1692708|NCT02381535|Cisplatin|cisplatin|mesh-list
1692709|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693239|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
1693240|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1693241|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1693242|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1693243|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1693244|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693245|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
1693246|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1693247|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693248|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1693249|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1693281|NCT05096715|Bevacizumab|bevacizumab|mesh-list
1693282|NCT05096715|Atezolizumab|atezolizumab|mesh-list
1693283|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1693284|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693285|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1693286|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1693287|NCT05096715|Growth Substances|growth substances|mesh-ancestor
1693288|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693289|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
1693290|NCT05096702|Primaquine|primaquine|mesh-list
1693291|NCT05096702|Tafenoquine|tafenoquine|mesh-list
1693292|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
1693293|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1693294|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1693295|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1693296|NCT05096676|Oxytocin|oxytocin|mesh-list
1693297|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
1693298|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1693299|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693300|NCT05096663|Vitamins|vitamins|mesh-list
1693301|NCT05096663|Folic Acid|folic acid|mesh-list
1693302|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
1693303|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
1693304|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
1693305|NCT05096663|Gemcitabine|gemcitabine|mesh-list
1693306|NCT05096663|Dexamethasone|dexamethasone|mesh-list
1693307|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
1693308|NCT05096663|Docetaxel|docetaxel|mesh-list
1693309|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
1693310|NCT05096663|Pemetrexed|pemetrexed|mesh-list
1693311|NCT05096663|Ramucirumab|ramucirumab|mesh-list
1693312|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1693313|NCT05096663|Antibodies|antibodies|mesh-list
1693314|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
1693315|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1693316|NCT05096663|BB 1101|bb 1101|mesh-list
1693317|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
1693318|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693319|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
1693320|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1693321|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
1693322|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
1693323|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1693324|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1693325|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
1693326|NCT05096663|Hormones|hormones|mesh-ancestor
1693327|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1693328|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1693329|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693330|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
1693331|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1693332|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693333|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1693334|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
1693335|NCT05096663|Antiviral Agents|antiviral agents|mesh-ancestor
1693336|NCT05096663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1693337|NCT05096663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1693338|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
1693339|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
1693340|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
1693341|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1693342|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1693343|NCT05096663|Hematinics|hematinics|mesh-ancestor
1693344|NCT05096520|Lidocaine|lidocaine|mesh-list
1693345|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
1693346|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
1693347|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1693348|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693349|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
1693350|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1693351|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1693352|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1693353|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1693354|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1693355|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693385|NCT05096442|Paclitaxel|paclitaxel|mesh-list
1693386|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1693387|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1693388|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693389|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
1693390|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
1693391|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
1693392|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693393|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
1693394|NCT05096390|Axitinib|axitinib|mesh-list
1693395|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1693396|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693397|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1693398|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1693399|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693403|NCT05096312|Zinc|zinc|mesh-list
1693404|NCT05096312|Adapalene|adapalene|mesh-list
1693405|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
1693406|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1693407|NCT05096312|Trace Elements|trace elements|mesh-ancestor
1693408|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
1693409|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693410|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
1693411|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1693412|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1693413|NCT05096312|Analgesics|analgesics|mesh-ancestor
1693414|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
1693415|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1693416|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1693417|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1693418|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
1693419|NCT05096195|Vitamin D|vitamin d|mesh-list
1693420|NCT05096195|Denosumab|denosumab|mesh-list
1693421|NCT05096195|Calcium|calcium|mesh-list
1693422|NCT05096195|Vitamins|vitamins|mesh-ancestor
1693423|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
1693424|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693425|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1693426|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1693500|NCT05095714|Liver Extracts|liver extracts|mesh-list
1693501|NCT05095714|Hematinics|hematinics|mesh-ancestor
1693502|NCT05095636|Apatinib|apatinib|mesh-list
1693503|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693504|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1693505|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1693506|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693507|NCT05095571|Niacinamide|niacinamide|mesh-list
1693508|NCT05095571|Niacin|niacin|mesh-list
1693509|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
1693510|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
1693511|NCT05095571|Vitamins|vitamins|mesh-ancestor
1693512|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
1693513|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693514|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1693515|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
1693516|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693517|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1693518|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
1693519|NCT05095480|Red yeast rice|red yeast rice|mesh-list
1693520|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1693521|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1693522|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1693523|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
1693524|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693525|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1693526|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1693527|NCT05095467|Paclitaxel|paclitaxel|mesh-list
1693528|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1693529|NCT05095467|Tegafur|tegafur|mesh-list
1693530|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1693531|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693532|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
1693533|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
1693534|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
1693535|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693536|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1693537|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
1693538|NCT05095376|Temozolomide|temozolomide|mesh-list
1693539|NCT05095376|Lomustine|lomustine|mesh-list
1693540|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1693541|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
1693542|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693543|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693544|NCT05095311|Cetirizine|cetirizine|mesh-list
1693545|NCT05095311|Nedocromil|nedocromil|mesh-list
1693546|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1693547|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1693548|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1693549|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
1693550|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
1693551|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1693552|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693553|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693554|NCT05095311|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
1693555|NCT05095311|Immunologic Factors|immunologic factors|mesh-ancestor
1693556|NCT05095311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1693557|NCT05095311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1693558|NCT05095311|Respiratory System Agents|respiratory system agents|mesh-ancestor
1693559|NCT05095259|Insulin|insulin|mesh-list
1693560|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1693561|NCT05095259|Epinephrine|epinephrine|mesh-list
1693562|NCT05095259|Glucagon|glucagon|mesh-list
1693563|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1693564|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693565|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1693566|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1693567|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
1693568|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1693569|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693570|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1693571|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1693572|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
1693573|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1693574|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1693575|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
1693576|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
1693577|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
1693578|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1693579|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1693580|NCT05095259|Hormones|hormones|mesh-ancestor
1693581|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1693582|NCT05095207|Bicalutamide|bicalutamide|mesh-list
1693583|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
1693584|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
1693585|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1693586|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693587|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693588|NCT05095116|Fluticasone|fluticasone|mesh-list
1693589|NCT05095116|Xhance|xhance|mesh-list
1693590|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1693591|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1693592|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
1693593|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1693594|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693595|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1693596|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
1693597|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
1693598|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1693599|NCT05095077|Tadalafil|tadalafil|mesh-list
1693600|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
1693601|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1693602|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1693603|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1693604|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693605|NCT05095077|Urological Agents|urological agents|mesh-ancestor
1693612|NCT05095025|Bupivacaine|bupivacaine|mesh-list
1693613|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
1693614|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
1693615|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1693616|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693617|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
1693618|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1693619|NCT05091619|Vaccines|vaccines|mesh-list
1693620|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
1693621|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693630|NCT05086770|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
1693631|NCT05086770|Hemostatics|hemostatics|mesh-ancestor
1693632|NCT05086770|Coagulants|coagulants|mesh-ancestor
1693689|NCT05084027|Fludarabine|fludarabine|mesh-list
1693690|NCT05084027|Melphalan|melphalan|mesh-list
1693691|NCT05084027|Venetoclax|venetoclax|mesh-list
1693692|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693693|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693694|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1693695|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
1693696|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693697|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1693698|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
1693699|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1693700|NCT05083312|Fluticasone|fluticasone|mesh-list
1693701|NCT05083312|Xhance|xhance|mesh-list
1693702|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1693703|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1693704|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
1693705|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1693706|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693707|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1693708|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
1693709|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
1693710|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1693711|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1693712|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1693713|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1693714|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1693715|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693716|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1693717|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1693718|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693719|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
1693720|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1693721|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
1693722|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1693723|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693724|NCT05079074|Fulvestrant|fulvestrant|mesh-list
1693725|NCT05079074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1693726|NCT05079074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
1693727|NCT05079074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1693728|NCT05079074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693729|NCT05079074|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1693730|NCT05079074|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1693731|NCT05079074|Hormone Antagonists|hormone antagonists|mesh-ancestor
1693732|NCT05079074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1693733|NCT05079074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693734|NCT05079074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1693735|NCT05079074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693772|NCT05065372|Metformin|metformin|mesh-list
1693773|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1693774|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693811|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
1693812|NCT05057481|Rituximab|rituximab|mesh-list
1693813|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1693814|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693815|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
1693816|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1693817|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1693818|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1693819|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1693820|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
1693821|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1693822|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1693823|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1693824|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1693991|NCT05001360|Nivolumab|nivolumab|mesh-list
1693992|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1693993|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1693994|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1693995|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1694002|NCT04986839|Acetaminophen|acetaminophen|mesh-list
1694003|NCT04986839|Ibuprofen|ibuprofen|mesh-list
1694004|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1694005|NCT04986839|Analgesics|analgesics|mesh-ancestor
1694006|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
1694007|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1694008|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694009|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
1694010|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1694011|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1694012|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1694013|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1694014|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1694015|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1694188|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1694201|NCT04901299|Fulvestrant|fulvestrant|mesh-list
1694202|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1694203|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1694204|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1694205|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1694206|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
1694207|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1694208|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694214|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
1694215|NCT04895761|Letrozole|letrozole|mesh-list
1694216|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1694217|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
1694218|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694219|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1694220|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1694221|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
1694222|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1694223|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1694224|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1694225|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1694226|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1694227|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1694228|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1694229|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
1694230|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1694231|NCT04895046|Niraparib|niraparib|mesh-list
1694232|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1694233|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1694234|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1694235|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1694277|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
1694278|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1694322|NCT04839042|Cloricromen|cloricromen|mesh-list
1694323|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1694324|NCT04829383|Bevacizumab|bevacizumab|mesh-list
1694325|NCT04829383|Atezolizumab|atezolizumab|mesh-list
1694326|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1694327|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1694328|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1694329|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1694330|NCT04829383|Growth Substances|growth substances|mesh-ancestor
1694331|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694332|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
1694475|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1694406|NCT04793100|Aflibercept|aflibercept|mesh-list
1694407|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1694408|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1694409|NCT04793100|Growth Substances|growth substances|mesh-ancestor
1694410|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694411|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
1694412|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1694445|NCT04762979|Fulvestrant|fulvestrant|mesh-list
1694446|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1694447|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1694448|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1694449|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1694450|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1694451|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
1694452|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1694453|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694454|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1694455|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1694456|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1694474|NCT04760028|Anesthetics|anesthetics|mesh-list
1694476|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694491|NCT04756505|Interleukin-12|interleukin-12|mesh-list
1694492|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
1694493|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1694494|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
1694495|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694496|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1694497|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1694498|NCT04756505|Growth Substances|growth substances|mesh-ancestor
1694499|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
1694500|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1694538|NCT04737109|Androgens|androgens|mesh-list
1694539|NCT04737109|Hormones|hormones|mesh-ancestor
1694540|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1694541|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694542|NCT04735354|Valsartan|valsartan|mesh-list
1694543|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1694544|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1694545|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1694546|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1694559|NCT04699838|Carboplatin|carboplatin|mesh-list
1694560|NCT04699838|Etoposide|etoposide|mesh-list
1694561|NCT04699838|Durvalumab|durvalumab|mesh-list
1694562|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1694563|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1694564|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1694565|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1694566|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1694567|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1694568|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1694572|NCT04677569|Azithromycin|azithromycin|mesh-list
1694573|NCT04677569|Amikacin|amikacin|mesh-list
1694574|NCT04677569|Ethambutol|ethambutol|mesh-list
1694575|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1694576|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1694577|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
1694596|NCT04675788|Ibutilide|ibutilide|mesh-list
1694597|NCT04675788|Testosterone|testosterone|mesh-list
1694598|NCT04675788|Progesterone|progesterone|mesh-list
1694599|NCT04675788|Androgens|androgens|mesh-ancestor
1694600|NCT04675788|Hormones|hormones|mesh-ancestor
1694601|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1694602|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694603|NCT04675788|Progestins|progestins|mesh-ancestor
1694604|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1694667|NCT04603365|Temozolomide|temozolomide|mesh-list
1694668|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1694669|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1694670|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
1694671|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1694672|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1694673|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1694708|NCT04593680|Tenofovir|tenofovir|mesh-list
1694709|NCT04593680|Emtricitabine|emtricitabine|mesh-list
1694710|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
1694711|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1694712|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1694713|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1694714|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1694715|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1694716|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1694717|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1694718|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
1694719|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1694720|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1694721|NCT04590417|Estradiol|estradiol|mesh-list
1694722|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1694723|NCT04590417|Cyproterone|cyproterone|mesh-list
1694724|NCT04590417|Estrogens|estrogens|mesh-ancestor
1694725|NCT04590417|Hormones|hormones|mesh-ancestor
1694726|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1694727|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694728|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1694729|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
1694730|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1694731|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1694732|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
1694733|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
1694734|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1694735|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1694793|NCT04549168|Lemborexant|lemborexant|mesh-list
1694794|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1694795|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1694796|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1694797|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1694798|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1694799|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1694800|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694871|NCT04530383|Metformin|metformin|mesh-list
1694872|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1694873|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694928|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
1694929|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1694930|NCT04514302|Antibodies|antibodies|mesh-list
1694931|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
1694932|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694938|NCT04492891|Cyclosporine|cyclosporine|mesh-list
1694939|NCT04492891|Cyclosporins|cyclosporins|mesh-list
1694940|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1694941|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1694942|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1694943|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
1694944|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1694945|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
1694946|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1694947|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
1694948|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1694949|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1694985|NCT04478734|Thiamine|thiamine|mesh-list
1694986|NCT04478734|Biotin|biotin|mesh-list
1694987|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
1694988|NCT04478734|Vitamins|vitamins|mesh-ancestor
1694989|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
1694990|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695010|NCT04452136|Edetic Acid|edetic acid|mesh-list
1695011|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1695012|NCT04452136|Anticoagulants|anticoagulants|mesh-ancestor
1695013|NCT04452136|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1695014|NCT04452136|Chelating Agents|chelating agents|mesh-ancestor
1695015|NCT04452136|Sequestering Agents|sequestering agents|mesh-ancestor
1695016|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695017|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1695034|NCT04431635|Rituximab|rituximab|mesh-list
1695035|NCT04431635|Nivolumab|nivolumab|mesh-list
1695036|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1695037|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695038|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
1695039|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695040|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1695041|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1695042|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695043|NCT04430985|Leucovorin|leucovorin|mesh-list
1695044|NCT04430985|Fluorouracil|fluorouracil|mesh-list
1695045|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
1695046|NCT04430985|Nivolumab|nivolumab|mesh-list
1695047|NCT04430985|Ipilimumab|ipilimumab|mesh-list
1695048|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
1695049|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695050|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1695051|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695052|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1695053|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
1695054|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695055|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1695056|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1695057|NCT04430985|Antidotes|antidotes|mesh-ancestor
1695058|NCT04430985|Protective Agents|protective agents|mesh-ancestor
1695059|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
1695060|NCT04430985|Vitamins|vitamins|mesh-ancestor
1695061|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
1695089|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
1695090|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1695091|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1695092|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
1695093|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695117|NCT04367311|Docetaxel|docetaxel|mesh-list
1695118|NCT04367311|Pemetrexed|pemetrexed|mesh-list
1695119|NCT04367311|Atezolizumab|atezolizumab|mesh-list
1695120|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695121|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
1695122|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
1695123|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
1695124|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695125|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1695126|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1695127|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1695239|NCT04262869|Paclitaxel|paclitaxel|mesh-list
1695240|NCT04262869|Carboplatin|carboplatin|mesh-list
1695241|NCT04262869|Pemetrexed|pemetrexed|mesh-list
1695242|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1695243|NCT04262869|Durvalumab|durvalumab|mesh-list
1695244|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
1695245|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1695246|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
1695247|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1695248|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695249|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
1695250|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
1695251|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
1695252|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695253|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1695254|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1695255|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1695256|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1695257|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
1695258|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695259|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
1695260|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1695261|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695282|NCT04189952|Rituximab|rituximab|mesh-list
1695283|NCT04189952|Carboplatin|carboplatin|mesh-list
1695284|NCT04189952|Etoposide|etoposide|mesh-list
1695285|NCT04189952|Ifosfamide|ifosfamide|mesh-list
1695286|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
1695287|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1695288|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695289|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
1695290|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695291|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1695292|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1695293|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1695294|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1695295|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1695296|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695297|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1695298|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
1695312|NCT04182360|Carbetocin|carbetocin|mesh-list
1695313|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
1695314|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1695315|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695348|NCT04088786|Irinotecan|irinotecan|mesh-list
1695349|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1695350|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1695351|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1695352|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695353|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695363|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
1695364|NCT04064814|Flunarizine|flunarizine|mesh-list
1695365|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
1695366|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695367|NCT04064814|Protective Agents|protective agents|mesh-ancestor
1695368|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695369|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
1695370|NCT04064814|Vitamins|vitamins|mesh-ancestor
1695371|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
1695372|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
1695373|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1695374|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1695375|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1695376|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1695377|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
1695378|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
1695379|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1695380|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
1695388|NCT04039230|Talazoparib|talazoparib|mesh-list
1695389|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1695390|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1695391|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695392|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695402|NCT03998735|Lobeline|lobeline|mesh-list
1695403|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1695404|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
1695405|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1695406|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695407|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1695408|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1695409|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
1695410|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1695411|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695412|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
1695413|NCT03981952|Vaccines|vaccines|mesh-list
1695414|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
1695415|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695421|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
1695422|NCT03968939|Promethazine|promethazine|mesh-list
1695423|NCT03968939|Melatonin|melatonin|mesh-list
1695424|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
1695425|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695426|NCT03968939|Protective Agents|protective agents|mesh-ancestor
1695427|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695428|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1695429|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1695430|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1695431|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
1695432|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
1695433|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
1695434|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1695435|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
1695436|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
1695437|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1695438|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1695439|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
1695440|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
1695441|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1695442|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1695443|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
1695444|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
1695445|NCT03959891|Letrozole|letrozole|mesh-list
1695446|NCT03959891|Fulvestrant|fulvestrant|mesh-list
1695447|NCT03959891|Palbociclib|palbociclib|mesh-list
1695448|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1695449|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695450|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1695451|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1695452|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695453|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1695454|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
1695455|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1695456|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695457|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1695458|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1695459|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1695460|NCT03950609|Everolimus|everolimus|mesh-list
1695461|NCT03950609|Lenvatinib|lenvatinib|mesh-list
1695462|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695463|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1695464|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
1695465|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695466|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1695467|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1695468|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695469|NCT03943875|Vaccines|vaccines|mesh-list
1695470|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
1695471|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695472|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
1695473|NCT03942653|Goserelin|goserelin|mesh-list
1695474|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1695475|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695476|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1695682|NCT03866538|Budesonide|budesonide|mesh-list
1695683|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1695684|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1695685|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
1695686|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1695687|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695688|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1695689|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
1695690|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
1695691|NCT03866538|Hormones|hormones|mesh-ancestor
1695692|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1695693|NCT03861702|Irinotecan|irinotecan|mesh-list
1695694|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1695695|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1695696|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1695697|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695698|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695699|NCT03856619|Teriflunomide|teriflunomide|mesh-list
1695700|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1695701|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1695702|NCT03856619|Analgesics|analgesics|mesh-ancestor
1695703|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
1695704|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1695705|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695706|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1695707|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1695708|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1695709|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
1695721|NCT03821272|Vaccines|vaccines|mesh-list
1695722|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
1695723|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695764|NCT03806309|Leucovorin|leucovorin|mesh-list
1695765|NCT03806309|Fluorouracil|fluorouracil|mesh-list
1695766|NCT03806309|Irinotecan|irinotecan|mesh-list
1695767|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
1695768|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695769|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1695770|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695771|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1695772|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
1695773|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695774|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1695775|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1695776|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1695777|NCT03806309|Antidotes|antidotes|mesh-ancestor
1695778|NCT03806309|Protective Agents|protective agents|mesh-ancestor
1695779|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
1695780|NCT03806309|Vitamins|vitamins|mesh-ancestor
1695781|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
1695793|NCT03782532|Prednisone|prednisone|mesh-list
1695794|NCT03782532|Prednisolone|prednisolone|mesh-list
1695795|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1695796|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
1695797|NCT03782532|Hormones|hormones|mesh-ancestor
1695798|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1695799|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695800|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1695801|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695818|NCT03714815|Macitentan|macitentan|mesh-list
1695819|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
1695820|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1695821|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695822|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
1695856|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
1695857|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1695858|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1695859|NCT03636165|Prednisolone|prednisolone|mesh-list
1695860|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
1695861|NCT03636165|Ropivacaine|ropivacaine|mesh-list
1695862|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1695863|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
1695864|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
1695865|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
1695866|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1695867|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695868|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
1695869|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1695870|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1695871|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
1695872|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
1695873|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1695874|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
1695875|NCT03636165|Hormones|hormones|mesh-ancestor
1695876|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1695877|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1695878|NCT03636165|Protective Agents|protective agents|mesh-ancestor
1695879|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1695880|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695924|NCT03564873|Azacitidine|azacitidine|mesh-list
1695925|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
1695926|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1695927|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
1695928|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695929|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695930|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1695931|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1695932|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1695942|NCT03557619|Venetoclax|venetoclax|mesh-list
1695943|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
1695944|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1695945|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
1695946|NCT03557619|Estradiol|estradiol|mesh-list
1695947|NCT03557619|Estrogens|estrogens|mesh-ancestor
1695948|NCT03557619|Hormones|hormones|mesh-ancestor
1695949|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1695950|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1695951|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1695952|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
1695953|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1695954|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1695955|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695956|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1695957|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1695958|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1695959|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1695973|NCT03539822|Durvalumab|durvalumab|mesh-list
1695974|NCT03539822|Tremelimumab|tremelimumab|mesh-list
1695975|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1695976|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1695977|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1695978|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1695998|NCT03538899|Busulfan|busulfan|mesh-list
1695999|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
1696000|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696001|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1696002|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
1696003|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696004|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1696005|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696006|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1696007|NCT03528408|Nivolumab|nivolumab|mesh-list
1696008|NCT03528408|Ipilimumab|ipilimumab|mesh-list
1696009|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1696010|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696011|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1696012|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696013|NCT03523312|Capecitabine|capecitabine|mesh-list
1696014|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1696015|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
1696016|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696017|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696018|NCT03521037|Rucaparib|rucaparib|mesh-list
1696019|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1696020|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1696021|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696022|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696030|NCT03422094|Nivolumab|nivolumab|mesh-list
1696031|NCT03422094|Ipilimumab|ipilimumab|mesh-list
1696032|NCT03422094|Poly ICLC|poly iclc|mesh-list
1696033|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1696034|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696035|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1696036|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696037|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
1696038|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
1696039|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696070|NCT03391869|Nivolumab|nivolumab|mesh-list
1696071|NCT03391869|Ipilimumab|ipilimumab|mesh-list
1696072|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1696073|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696074|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1696075|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696092|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
1696093|NCT03384836|Propranolol|propranolol|mesh-list
1696094|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1696095|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696096|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1696097|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1696098|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
1696099|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1696100|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696101|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696102|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1696103|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1696104|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
1696105|NCT03311555|Docetaxel|docetaxel|mesh-list
1696106|NCT03311555|Androgens|androgens|mesh-list
1696107|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696108|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
1696109|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
1696110|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
1696111|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696112|NCT03311555|Hormones|hormones|mesh-ancestor
1696113|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1696114|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696122|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
1696123|NCT03264404|Azacitidine|azacitidine|mesh-list
1696124|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1696125|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696126|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1696127|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
1696128|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696129|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1696130|NCT03246074|Paclitaxel|paclitaxel|mesh-list
1696131|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1696132|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696133|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
1696134|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
1696135|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
1696136|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696137|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
1696138|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
1696139|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1696140|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696141|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696142|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
1696143|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
1696161|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
1696162|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1696163|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1696164|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1696165|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1696166|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696167|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
1696168|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1696169|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696170|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1696171|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1696205|NCT03198078|Aripiprazole|aripiprazole|mesh-list
1696206|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
1696207|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
1696208|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1696209|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1696210|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1696211|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1696212|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696213|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
1696214|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
1696215|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1696216|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696217|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1696218|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1696219|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
1696220|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1696221|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1696222|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1696223|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1696246|NCT03148327|Durvalumab|durvalumab|mesh-list
1696247|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1696248|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696293|NCT03059173|Inositol|inositol|mesh-list
1696294|NCT03059173|Clomiphene|clomiphene|mesh-list
1696295|NCT03059173|Enclomiphene|enclomiphene|mesh-list
1696296|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
1696297|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1696298|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
1696299|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1696300|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696301|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1696302|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
1696303|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1696304|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1696305|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1696306|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
1696307|NCT03059173|Vitamins|vitamins|mesh-ancestor
1696308|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
1696309|NCT03046862|Gemcitabine|gemcitabine|mesh-list
1696310|NCT03046862|Durvalumab|durvalumab|mesh-list
1696311|NCT03046862|Tremelimumab|tremelimumab|mesh-list
1696312|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696313|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1696314|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
1696315|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696316|NCT03046862|Antiviral Agents|antiviral agents|mesh-ancestor
1696317|NCT03046862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1696318|NCT03046862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1696319|NCT03046862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1696320|NCT03046862|Immunologic Factors|immunologic factors|mesh-ancestor
1696321|NCT03046862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696322|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1696358|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1696359|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
1696360|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1696361|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1696362|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
1696363|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696371|NCT02925234|Bevacizumab|bevacizumab|mesh-list
1696372|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
1696373|NCT02925234|Nivolumab|nivolumab|mesh-list
1696374|NCT02925234|Trastuzumab|trastuzumab|mesh-list
1696375|NCT02925234|Ipilimumab|ipilimumab|mesh-list
1696376|NCT02925234|Durvalumab|durvalumab|mesh-list
1696377|NCT02925234|Panitumumab|panitumumab|mesh-list
1696378|NCT02925234|Pertuzumab|pertuzumab|mesh-list
1696379|NCT02925234|Sunitinib|sunitinib|mesh-list
1696380|NCT02925234|Atezolizumab|atezolizumab|mesh-list
1696381|NCT02925234|Olaparib|olaparib|mesh-list
1696382|NCT02925234|Palbociclib|palbociclib|mesh-list
1696383|NCT02925234|Lenvatinib|lenvatinib|mesh-list
1696384|NCT02925234|Trametinib|trametinib|mesh-list
1696385|NCT02925234|Axitinib|axitinib|mesh-list
1696386|NCT02925234|Afatinib|afatinib|mesh-list
1696387|NCT02925234|Vemurafenib|vemurafenib|mesh-list
1696388|NCT02925234|Dabrafenib|dabrafenib|mesh-list
1696389|NCT02925234|Crizotinib|crizotinib|mesh-list
1696390|NCT02925234|Talazoparib|talazoparib|mesh-list
1696391|NCT02925234|Rucaparib|rucaparib|mesh-list
1696392|NCT02925234|Entrectinib|entrectinib|mesh-list
1696393|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1696394|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696395|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1696396|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1696397|NCT02925234|Growth Substances|growth substances|mesh-ancestor
1696398|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696399|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
1696400|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1696401|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696402|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1696403|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1696404|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1696429|NCT02784288|Paclitaxel|paclitaxel|mesh-list
1696430|NCT02784288|Carboplatin|carboplatin|mesh-list
1696431|NCT02784288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1696432|NCT02784288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696433|NCT02784288|Tubulin Modulators|tubulin modulators|mesh-ancestor
1696434|NCT02784288|Antimitotic Agents|antimitotic agents|mesh-ancestor
1696435|NCT02784288|Mitosis Modulators|mitosis modulators|mesh-ancestor
1696436|NCT02784288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696451|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
1696452|NCT02758431|Anastrozole|anastrozole|mesh-list
1696453|NCT02758431|Testosterone|testosterone|mesh-list
1696454|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
1696455|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
1696456|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1696457|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1696458|NCT02758431|Acyline|acyline|mesh-list
1696459|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
1696460|NCT02758431|Hormones|hormones|mesh-ancestor
1696461|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1696462|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696463|NCT02758431|Androgens|androgens|mesh-ancestor
1696464|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1696465|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696466|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
1696467|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1696468|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1696469|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696470|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1696480|NCT02698293|Vitamin D|vitamin d|mesh-list
1696481|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
1696482|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
1696483|NCT02698293|Vitamins|vitamins|mesh-list
1696484|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
1696485|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696486|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1696487|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1696544|NCT02643056|Panitumumab|panitumumab|mesh-list
1696545|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1696546|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696563|NCT02513186|Dexamethasone|dexamethasone|mesh-list
1696564|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
1696565|NCT02513186|Lenalidomide|lenalidomide|mesh-list
1696566|NCT02513186|Bortezomib|bortezomib|mesh-list
1696567|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1696568|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
1696569|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696570|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1696571|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1696572|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
1696573|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696574|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696575|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1696576|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1696577|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
1696578|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
1696579|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1696580|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1696581|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
1696582|NCT02513186|Hormones|hormones|mesh-ancestor
1696583|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1696584|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1696585|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1696586|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1696587|NCT02513186|Growth Substances|growth substances|mesh-ancestor
1696588|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
1696598|NCT02471118|Adalimumab|adalimumab|mesh-list
1696599|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1696600|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1696628|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
1696629|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1696630|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696636|NCT02398396|Lactitol|lactitol|mesh-list
1696637|NCT02398396|Cathartics|cathartics|mesh-ancestor
1696638|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1696639|NCT02359968|Paclitaxel|paclitaxel|mesh-list
1696640|NCT02359968|Fluorouracil|fluorouracil|mesh-list
1696641|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
1696642|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1696643|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1696644|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
1696645|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
1696646|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
1696647|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696648|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
1696649|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1696650|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1696651|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
1696652|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696963|NCT05098704|Clopidogrel|clopidogrel|mesh-list
1696964|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1696965|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1696966|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1696967|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1696968|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
1696969|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1696970|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1696971|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696972|NCT05098574|Drospirenone|drospirenone|mesh-list
1696973|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1696974|NCT05098574|Estradiol|estradiol|mesh-list
1696975|NCT05098574|Estrogens|estrogens|mesh-ancestor
1696976|NCT05098574|Hormones|hormones|mesh-ancestor
1696977|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1696978|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696979|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1696980|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
1696981|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1696982|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1696983|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1696984|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1696985|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1696986|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
1696987|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1696988|NCT05098574|Diuretics|diuretics|mesh-ancestor
1696989|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
1696990|NCT05098470|Metformin|metformin|mesh-list
1696991|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
1696992|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1696993|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696994|NCT05098457|Lidocaine|lidocaine|mesh-list
1696995|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
1696996|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
1696997|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1696998|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1696999|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
1697000|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1697001|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1697002|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1697003|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1697004|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1697005|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697006|NCT05098366|Furosemide|furosemide|mesh-list
1697007|NCT05098366|Diuretics|diuretics|mesh-ancestor
1697008|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
1697009|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697010|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1697011|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1697012|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697013|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1697014|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
1697015|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1697016|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1697017|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1697018|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1697019|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697020|NCT05098327|Pioglitazone|pioglitazone|mesh-list
1697021|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1697022|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697041|NCT05098119|Paclitaxel|paclitaxel|mesh-list
1697042|NCT05098119|Carboplatin|carboplatin|mesh-list
1697043|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1697044|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1697045|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
1697046|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
1697047|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
1697048|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697049|NCT05098067|Ondansetron|ondansetron|mesh-list
1697050|NCT05098067|Metoclopramide|metoclopramide|mesh-list
1697051|NCT05098067|Capsaicin|capsaicin|mesh-list
1697052|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
1697053|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
1697054|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1697055|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697056|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1697057|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
1697058|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
1697059|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1697060|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
1697061|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1697062|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697063|NCT05098067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1697064|NCT05098067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1697065|NCT05098067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1697066|NCT05098067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1697067|NCT05098067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1697068|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
1697069|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1697070|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1697071|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
1697087|NCT05098028|Rifaximin|rifaximin|mesh-list
1697088|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1697089|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1697090|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1697111|NCT05097950|Acetaminophen|acetaminophen|mesh-list
1697112|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1697113|NCT05097950|Analgesics|analgesics|mesh-ancestor
1697114|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
1697115|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1697116|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697117|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
1697118|NCT05097911|Bevacizumab|bevacizumab|mesh-list
1697119|NCT05097911|Atezolizumab|atezolizumab|mesh-list
1697120|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1697121|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1697122|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1697123|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1697124|NCT05097911|Growth Substances|growth substances|mesh-ancestor
1697125|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697126|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
1697156|NCT05097781|Antibodies|antibodies|mesh-list
1697157|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
1697158|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
1697159|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697189|NCT05097599|Talazoparib|talazoparib|mesh-list
1697190|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1697191|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1697192|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697193|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1697194|NCT05097508|Bromides|bromides|mesh-list
1697195|NCT05097508|Rocuronium|rocuronium|mesh-list
1697196|NCT05097508|Atracurium|atracurium|mesh-list
1697197|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
1697198|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1697199|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1697200|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1697201|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1697202|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697203|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
1697204|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1697205|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
1697206|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1697207|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697237|NCT05097365|Folic Acid|folic acid|mesh-list
1697238|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
1697239|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
1697240|NCT05097365|Vitamins|vitamins|mesh-ancestor
1697241|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
1697242|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697243|NCT05097365|Hematinics|hematinics|mesh-ancestor
1697244|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
1697261|NCT05097274|Choline|choline|mesh-list
1697262|NCT05097274|Lipotropic Agents|lipotropic agents|mesh-ancestor
1697263|NCT05097274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1697264|NCT05097274|Antimetabolites|antimetabolites|mesh-ancestor
1697265|NCT05097274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697266|NCT05097274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1697267|NCT05097274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1697268|NCT05097274|Nootropic Agents|nootropic agents|mesh-ancestor
1697269|NCT05097261|Ketamine|ketamine|mesh-list
1697270|NCT05097261|Analgesics|analgesics|mesh-ancestor
1697271|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
1697272|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1697273|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697274|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1697275|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1697276|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
1697277|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
1697278|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1697279|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1697280|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1697281|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1697282|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697283|NCT05097248|Doxorubicin|doxorubicin|mesh-list
1697284|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1697285|NCT05097248|Losartan|losartan|mesh-list
1697286|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1697287|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1697288|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1697289|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1697290|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1697291|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697292|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1697293|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1697294|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1697295|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1697296|NCT05097209|Gemcitabine|gemcitabine|mesh-list
1697297|NCT05097209|Cisplatin|cisplatin|mesh-list
1697298|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1697299|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1697300|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
1697301|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697302|NCT05097209|Antiviral Agents|antiviral agents|mesh-ancestor
1697303|NCT05097209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1697304|NCT05097209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1697305|NCT05097209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1697306|NCT05097209|Immunologic Factors|immunologic factors|mesh-ancestor
1697307|NCT05097209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697308|NCT05092269|Ustekinumab|ustekinumab|mesh-list
1697309|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
1697310|NCT05090280|Nafamostat|nafamostat|mesh-list
1697311|NCT05090280|Naltrexone|naltrexone|mesh-list
1697312|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1697313|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1697314|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697315|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
1697316|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1697317|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1697318|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1697319|NCT05090280|Analgesics|analgesics|mesh-ancestor
1697320|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1697321|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1697322|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
1697323|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
1697324|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1697325|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697326|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1697327|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1697328|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1697329|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1697330|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
1697331|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
1697332|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
1697333|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1697334|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1697335|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1697336|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1697337|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697338|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
1697339|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1697340|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697341|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1697342|NCT05089851|Protective Agents|protective agents|mesh-ancestor
1697343|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
1697344|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1697345|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1697355|NCT05087940|Diuretics|diuretics|mesh-list
1697356|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
1697357|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
1697358|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697359|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1697360|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697361|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
1697362|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1697363|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
1697364|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697365|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
1697366|NCT05086939|Protective Agents|protective agents|mesh-ancestor
1697367|NCT05083325|Oseltamivir|oseltamivir|mesh-list
1697368|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
1697369|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1697370|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1697371|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697396|NCT05060484|Vaccines|vaccines|mesh-list
1697397|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
1697398|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697399|NCT05057572|Carvedilol|carvedilol|mesh-list
1697400|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1697401|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1697402|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
1697403|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1697404|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697405|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697406|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1697407|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
1697408|NCT05057572|Protective Agents|protective agents|mesh-ancestor
1697409|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1697410|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1697411|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1697412|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
1697413|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1697414|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1697415|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1697416|NCT05055713|Somatostatin|somatostatin|mesh-list
1697417|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1697418|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
1697419|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1697420|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697421|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697422|NCT05055713|Hormones|hormones|mesh-ancestor
1697423|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1697506|NCT05026801|Azithromycin|azithromycin|mesh-list
1697507|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
1697508|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1697509|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1697510|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
1697511|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1697512|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1697513|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1697514|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697515|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1697516|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1697517|NCT05025423|Venetoclax|venetoclax|mesh-list
1697518|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1697519|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1697520|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
1697521|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697535|NCT05019885|Ketamine|ketamine|mesh-list
1697536|NCT05019885|Analgesics|analgesics|mesh-ancestor
1697537|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
1697538|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1697539|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697540|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1697541|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1697542|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
1697543|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
1697544|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1697545|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1697546|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1697547|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1697548|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697574|NCT05011357|Phenylephrine|phenylephrine|mesh-list
1697575|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
1697576|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1697577|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
1697578|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
1697579|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1697580|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697581|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
1697582|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1697583|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
1697584|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
1697585|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1697586|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1697587|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1697588|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
1697589|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1697590|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697591|NCT05011357|Protective Agents|protective agents|mesh-ancestor
1697627|NCT04999631|Ethanol|ethanol|mesh-list
1697628|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
1697629|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1697630|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1697631|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1697632|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697633|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1697634|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
1697650|NCT04985955|Tofacitinib|tofacitinib|mesh-list
1697651|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1697652|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1697653|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697715|NCT04950660|Caffeine|caffeine|mesh-list
1697716|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1697717|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697718|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1697719|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1697720|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697721|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1697722|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1697723|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
1697724|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1697804|NCT04919369|Vitamins|vitamins|mesh-list
1697805|NCT04919369|Vitamin A|vitamin a|mesh-list
1697806|NCT04919369|Atezolizumab|atezolizumab|mesh-list
1697807|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
1697808|NCT04919369|Tretinoin|tretinoin|mesh-list
1697809|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1697810|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
1697811|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697812|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1697813|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
1697814|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
1697815|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697816|NCT04919369|Protective Agents|protective agents|mesh-ancestor
1697817|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1697818|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
1697819|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
1697831|NCT04912791|Anesthetics|anesthetics|mesh-list
1697832|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1697833|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697847|NCT04908293|Listerine|listerine|mesh-list
1697848|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
1697849|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
1697850|NCT04908293|Protective Agents|protective agents|mesh-ancestor
1697851|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697852|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1697853|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1697856|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1697857|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1697858|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1697859|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
1697860|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1697861|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1697862|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1697863|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1697948|NCT04858854|Sulforaphane|sulforaphane|mesh-list
1697949|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1697950|NCT04858854|Protective Agents|protective agents|mesh-ancestor
1697951|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697952|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1697953|NCT04853004|Antibodies|antibodies|mesh-list
1697954|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
1697955|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697966|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1697967|NCT04839185|Hematinics|hematinics|mesh-ancestor
1697968|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1697969|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1697981|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1697982|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1697983|NCT04814940|Menotropins|menotropins|mesh-list
1697984|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1697985|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
1697986|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1697987|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697988|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
1697989|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1697990|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1697991|NCT04801368|Anesthetics|anesthetics|mesh-list
1697992|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
1697993|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1697994|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1697995|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
1697996|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1697997|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
1697998|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
1697999|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698000|NCT04796636|Protective Agents|protective agents|mesh-ancestor
1698001|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698002|NCT04796636|Vitamins|vitamins|mesh-ancestor
1698003|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
1698036|NCT04759274|Diuretics|diuretics|mesh-list
1698037|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
1698038|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698039|NCT04756271|Antibodies|antibodies|mesh-list
1698040|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
1698041|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
1698042|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698110|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
1698111|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
1698112|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1698113|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
1698114|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1698115|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698116|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1698117|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1698118|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1698119|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1698120|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1698121|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1698122|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1698123|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1698124|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698125|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1698129|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
1698130|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1698131|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698132|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1698133|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698155|NCT04689945|Morphine|morphine|mesh-list
1698156|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1698157|NCT04689945|Narcotics|narcotics|mesh-ancestor
1698158|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1698159|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698160|NCT04689945|Analgesics|analgesics|mesh-ancestor
1698161|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
1698162|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1698178|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
1698179|NCT04676412|Lenvatinib|lenvatinib|mesh-list
1698180|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1698181|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1698182|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1698183|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1698184|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698222|NCT04655755|Decitabine|decitabine|mesh-list
1698223|NCT04655755|Venetoclax|venetoclax|mesh-list
1698224|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1698225|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
1698226|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698227|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1698228|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1698241|NCT04644796|Bupivacaine|bupivacaine|mesh-list
1698242|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
1698243|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
1698244|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1698245|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698246|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
1698247|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1698303|NCT04616924|Clarithromycin|clarithromycin|mesh-list
1698304|NCT04616924|Rifabutin|rifabutin|mesh-list
1698305|NCT04616924|Clofazimine|clofazimine|mesh-list
1698306|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1698307|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1698308|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1698309|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1698310|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698311|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1698312|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1698313|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1698314|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
1698315|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1698316|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
1698317|NCT04616274|Venetoclax|venetoclax|mesh-list
1698318|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1698321|NCT04613622|Venetoclax|venetoclax|mesh-list
1698322|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1698401|NCT04562792|Daunorubicin|daunorubicin|mesh-list
1698402|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1698403|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1698404|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1698405|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1698406|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1698407|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698430|NCT04546620|Prednisolone|prednisolone|mesh-list
1698431|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1698432|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
1698433|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1698434|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
1698435|NCT04546620|Prednisone|prednisone|mesh-list
1698436|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
1698437|NCT04546620|Rituximab|rituximab|mesh-list
1698438|NCT04546620|Doxorubicin|doxorubicin|mesh-list
1698439|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1698440|NCT04546620|Vincristine|vincristine|mesh-list
1698441|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
1698442|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1698443|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
1698444|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1698445|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
1698446|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698447|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1698448|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1698449|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
1698450|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698451|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1698452|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1698453|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1698454|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1698455|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1698456|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1698457|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1698458|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1698459|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
1698460|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
1698461|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
1698462|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1698463|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
1698464|NCT04546620|Hormones|hormones|mesh-ancestor
1698465|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1698466|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1698467|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
1698468|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
1698469|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1698470|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1698471|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1698472|NCT04546620|Protective Agents|protective agents|mesh-ancestor
1698609|NCT04523935|Topiramate|topiramate|mesh-list
1698610|NCT04523935|Lamotrigine|lamotrigine|mesh-list
1698611|NCT04523935|Diazepam|diazepam|mesh-list
1698612|NCT04523935|Gabapentin|gabapentin|mesh-list
1698613|NCT04523935|Amitriptyline|amitriptyline|mesh-list
1698614|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
1698615|NCT04523935|Clonazepam|clonazepam|mesh-list
1698616|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
1698617|NCT04523935|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
1698618|NCT04523935|Baclofen|baclofen|mesh-list
1698619|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
1698620|NCT04523935|Analgesics|analgesics|mesh-ancestor
1698621|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
1698622|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1698623|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698624|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1698625|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1698626|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1698627|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1698628|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1698629|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1698630|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1698631|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698632|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
1698633|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1698634|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1698635|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1698636|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1698637|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1698638|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1698639|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1698640|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1698641|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
1698642|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
1698643|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
1698644|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1698645|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
1698646|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1698647|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1698648|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1698649|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
1698650|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1698651|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
1698652|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
1698653|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1698654|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1698655|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1698656|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
1698657|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
1698658|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
1698659|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1698660|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1698661|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1698662|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1698663|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
1698664|NCT04515186|Miltefosine|miltefosine|mesh-list
1698665|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
1698666|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
1698667|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1698668|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1698669|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1698670|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1698688|NCT04507841|Niraparib|niraparib|mesh-list
1698689|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1698690|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1698691|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698692|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1698729|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
1698730|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
1698731|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1698732|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1698733|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1698734|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1698735|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698736|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1698737|NCT04399356|Niclosamide|niclosamide|mesh-list
1698738|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
1698739|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1698740|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
1698741|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1698742|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1698743|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
1698744|NCT04395222|Fludarabine|fludarabine|mesh-list
1698745|NCT04395222|Melphalan|melphalan|mesh-list
1698746|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
1698747|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1698748|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1698749|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698750|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1698751|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
1698752|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698753|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1698754|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
1698755|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1698764|NCT04389775|Glucagon|glucagon|mesh-list
1698765|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
1698766|NCT04389775|Incretins|incretins|mesh-ancestor
1698767|NCT04389775|Hormones|hormones|mesh-ancestor
1698768|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1698769|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698770|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1698813|NCT04368455|Vaccines|vaccines|mesh-list
1698814|NCT04368455|Immunologic Factors|immunologic factors|mesh-ancestor
1698815|NCT04368455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698826|NCT04345887|Spironolactone|spironolactone|mesh-list
1698827|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1698828|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
1698829|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1698830|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698831|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1698832|NCT04345887|Diuretics|diuretics|mesh-ancestor
1698833|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
1698859|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
1698860|NCT04316169|Letrozole|letrozole|mesh-list
1698861|NCT04316169|Fulvestrant|fulvestrant|mesh-list
1698862|NCT04316169|Anastrozole|anastrozole|mesh-list
1698863|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1698864|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1698865|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1698866|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1698867|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698868|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1698869|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
1698870|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1698871|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698872|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
1698873|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1698874|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1698875|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1698876|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1698877|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1698878|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1698883|NCT04305145|Prednisone|prednisone|mesh-list
1698884|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
1698885|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1698886|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1698887|NCT04305145|Prednisolone|prednisolone|mesh-list
1698888|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
1698889|NCT04305145|Infliximab|infliximab|mesh-list
1698890|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1698891|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
1698892|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1698893|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
1698894|NCT04305145|Hormones|hormones|mesh-ancestor
1698895|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1698896|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698897|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1698898|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1698899|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
1698900|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
1698901|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1698902|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1698903|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1698904|NCT04305145|Protective Agents|protective agents|mesh-ancestor
1698905|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
1698906|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1698928|NCT04286529|Calcitriol|calcitriol|mesh-list
1698929|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1698930|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698931|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1698932|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1698933|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1698934|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1698935|NCT04286529|Vitamins|vitamins|mesh-ancestor
1698936|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
1698937|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1698938|NCT04281108|Fluticasone|fluticasone|mesh-list
1698939|NCT04281108|Xhance|xhance|mesh-list
1698940|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1698941|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1698942|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
1698943|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1698944|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698945|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1698946|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
1698947|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
1698948|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1698949|NCT04249596|Tianeptine|tianeptine|mesh-list
1698950|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1698951|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
1698952|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1698982|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1698983|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1698984|NCT04234360|Prednisone|prednisone|mesh-list
1698985|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1698986|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
1698987|NCT04234360|Hormones|hormones|mesh-ancestor
1698988|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1698989|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1698990|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1698991|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699062|NCT04188405|Decitabine|decitabine|mesh-list
1699063|NCT04188405|Venetoclax|venetoclax|mesh-list
1699064|NCT04188405|Ponatinib|ponatinib|mesh-list
1699065|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1699066|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
1699067|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699068|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699069|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1699070|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1699071|NCT04188145|Bevacizumab|bevacizumab|mesh-list
1699072|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1699073|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699074|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1699075|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1699076|NCT04188145|Growth Substances|growth substances|mesh-ancestor
1699077|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699078|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
1699079|NCT04181606|Esmolol|esmolol|mesh-list
1699080|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1699081|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1699082|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1699083|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
1699084|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1699085|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699086|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699101|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
1699102|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
1699103|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1699104|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1699105|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1699106|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1699107|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699108|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1699109|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1699110|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
1699111|NCT04138394|Vitamins|vitamins|mesh-ancestor
1699112|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
1699113|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699114|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
1699115|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699116|NCT04138394|Protective Agents|protective agents|mesh-ancestor
1699117|NCT04128774|Dexamethasone|dexamethasone|mesh-list
1699118|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
1699119|NCT04128774|BB 1101|bb 1101|mesh-list
1699120|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1699121|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
1699122|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
1699123|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1699124|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699125|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1699126|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
1699127|NCT04128774|Hormones|hormones|mesh-ancestor
1699128|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1699129|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1699130|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699131|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
1699132|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1699133|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699148|NCT04088123|Ticagrelor|ticagrelor|mesh-list
1699149|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1699150|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1699151|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1699152|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1699153|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
1699154|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1699155|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699156|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699209|NCT03945721|Niraparib|niraparib|mesh-list
1699210|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1699211|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1699212|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699213|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699235|NCT03921242|Metformin|metformin|mesh-list
1699236|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
1699237|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
1699238|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1699239|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699240|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699241|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
1699242|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1699254|NCT03891706|Interleukin-2|interleukin-2|mesh-list
1699255|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699256|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1699257|NCT03891706|Analgesics|analgesics|mesh-ancestor
1699258|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
1699259|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1699260|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699261|NCT03880019|Temozolomide|temozolomide|mesh-list
1699262|NCT03880019|Olaparib|olaparib|mesh-list
1699263|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1699264|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1699265|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
1699266|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699267|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699268|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1699306|NCT03847181|Vitamin K|vitamin k|mesh-list
1699307|NCT03847181|Warfarin|warfarin|mesh-list
1699308|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
1699309|NCT03847181|Apixaban|apixaban|mesh-list
1699310|NCT03847181|Anticoagulants|anticoagulants|mesh-list
1699311|NCT03847181|Vitamins|vitamins|mesh-ancestor
1699312|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
1699313|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699314|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1699315|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
1699316|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1699317|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
1699318|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1699319|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699320|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1699321|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1699322|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
1699323|NCT03847181|Coagulants|coagulants|mesh-ancestor
1699324|NCT03825796|Cytarabine|cytarabine|mesh-list
1699325|NCT03825796|Daunorubicin|daunorubicin|mesh-list
1699326|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1699327|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
1699328|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699329|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699330|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
1699331|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1699332|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1699333|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
1699334|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699335|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1699336|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1699337|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1699338|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1699406|NCT03753204|Furosemide|furosemide|mesh-list
1699407|NCT03753204|Diuretics|diuretics|mesh-ancestor
1699408|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
1699409|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699410|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1699411|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1699412|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699500|NCT03679611|Neostigmine|neostigmine|mesh-list
1699501|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1699502|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1699503|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699504|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
1699505|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1699506|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699507|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1699508|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
1699509|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1699510|NCT03677934|Ranibizumab|ranibizumab|mesh-list
1699511|NCT03677934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1699512|NCT03677934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1699513|NCT03677934|Growth Substances|growth substances|mesh-ancestor
1699514|NCT03677934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699515|NCT03677934|Growth Inhibitors|growth inhibitors|mesh-ancestor
1699516|NCT03677934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699539|NCT03640754|Lenograstim|lenograstim|mesh-list
1699540|NCT03640754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1699541|NCT03640754|Immunologic Factors|immunologic factors|mesh-ancestor
1699542|NCT03640754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699543|NCT03608436|Bromides|bromides|mesh-list
1699544|NCT03608436|Rocuronium|rocuronium|mesh-list
1699545|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
1699546|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1699547|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1699548|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1699549|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1699550|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699592|NCT03557385|Adenosine|adenosine|mesh-list
1699593|NCT03557385|Analgesics|analgesics|mesh-ancestor
1699594|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
1699595|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1699596|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699597|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1699598|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
1699599|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1699600|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
1699601|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
1699602|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1699603|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699604|NCT03556904|Docetaxel|docetaxel|mesh-list
1699605|NCT03556904|Hormones|hormones|mesh-list
1699606|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699607|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
1699608|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
1699609|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
1699610|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699611|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1699612|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699613|NCT03540758|Niacin|niacin|mesh-list
1699614|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
1699615|NCT03540758|Niacinamide|niacinamide|mesh-list
1699616|NCT03540758|Diazoxide|diazoxide|mesh-list
1699617|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1699618|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
1699619|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699620|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1699621|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
1699622|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
1699623|NCT03540758|Vitamins|vitamins|mesh-ancestor
1699624|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
1699625|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699626|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1699669|NCT03477851|Tramadol|tramadol|mesh-list
1699670|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1699671|NCT03477851|Narcotics|narcotics|mesh-ancestor
1699672|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1699673|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699674|NCT03477851|Analgesics|analgesics|mesh-ancestor
1699675|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
1699676|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1699677|NCT03476330|Quercetin|quercetin|mesh-list
1699678|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
1699679|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699680|NCT03476330|Protective Agents|protective agents|mesh-ancestor
1699681|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699713|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1699714|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
1699715|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699716|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
1699717|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699718|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1699719|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
1699720|NCT03412188|Hormones|hormones|mesh-ancestor
1699721|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1699722|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1699723|NCT03412188|Protective Agents|protective agents|mesh-ancestor
1699724|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1699773|NCT03388632|Nivolumab|nivolumab|mesh-list
1699774|NCT03388632|Ipilimumab|ipilimumab|mesh-list
1699775|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1699776|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699777|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1699778|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699788|NCT03363035|Enoxaparin|enoxaparin|mesh-list
1699789|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
1699790|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1699791|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
1699792|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1699793|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
1699794|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1699795|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699796|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
1699797|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1699798|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1699847|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
1699848|NCT03298945|Laxatives|laxatives|mesh-ancestor
1699849|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1699864|NCT03250975|Azithromycin|azithromycin|mesh-list
1699865|NCT03250975|Budesonide|budesonide|mesh-list
1699866|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1699867|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1699868|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
1699869|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1699870|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699871|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1699872|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
1699873|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
1699874|NCT03250975|Hormones|hormones|mesh-ancestor
1699875|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1699876|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1699877|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1699878|NCT03219268|Margetuximab|margetuximab|mesh-list
1699879|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699882|NCT03218137|Adenosine|adenosine|mesh-list
1699883|NCT03218137|Verapamil|verapamil|mesh-list
1699884|NCT03218137|Analgesics|analgesics|mesh-ancestor
1699885|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
1699886|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1699887|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699888|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1699889|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
1699890|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1699891|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
1699892|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
1699893|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1699894|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699895|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1699896|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1699897|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1699942|NCT03117816|Interferons|interferons|mesh-list
1699943|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
1699944|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
1699945|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1699946|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
1699947|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1699948|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
1699949|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699953|NCT03079999|Aspirin|aspirin|mesh-list
1699954|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1699955|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1699956|NCT03079999|Analgesics|analgesics|mesh-ancestor
1699957|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
1699958|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1699959|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1699960|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1699961|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1699962|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1699963|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1699964|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699965|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1699966|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1699967|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1699968|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
1699983|NCT02958709|Rifampin|rifampin|mesh-list
1699984|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1699985|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
1699986|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1699987|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1699988|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
1699989|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1699990|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1699991|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1699992|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1699993|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1699994|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1699995|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1699996|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1699997|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1699998|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
1699999|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1700000|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
1700001|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1700002|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1700003|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1700004|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1700005|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1700012|NCT02947581|Albendazole|albendazole|mesh-list
1700013|NCT02947581|Praziquantel|praziquantel|mesh-list
1700014|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
1700015|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1700016|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1700017|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
1700018|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1700019|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1700020|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
1700021|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
1700022|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
1700023|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1700024|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1700045|NCT02861898|Cetuximab|cetuximab|mesh-list
1700046|NCT02861898|Mannitol|mannitol|mesh-list
1700047|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1700048|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1700049|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1700050|NCT02861898|Diuretics|diuretics|mesh-ancestor
1700051|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
1700052|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1700101|NCT02806687|Gemcitabine|gemcitabine|mesh-list
1700102|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1700103|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
1700104|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1700105|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1700106|NCT02806687|Antiviral Agents|antiviral agents|mesh-ancestor
1700107|NCT02806687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1700108|NCT02806687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1700109|NCT02806687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1700110|NCT02806687|Immunologic Factors|immunologic factors|mesh-ancestor
1700111|NCT02806687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1700123|NCT02722525|Pentetic Acid|pentetic acid|mesh-list
1700124|NCT02722525|Antidotes|antidotes|mesh-ancestor
1700125|NCT02722525|Protective Agents|protective agents|mesh-ancestor
1700126|NCT02722525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1700127|NCT02722525|Chelating Agents|chelating agents|mesh-ancestor
1700128|NCT02722525|Sequestering Agents|sequestering agents|mesh-ancestor
1700129|NCT02722525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1700130|NCT02722525|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1700143|NCT02632396|Rituximab|rituximab|mesh-list
1700144|NCT02632396|Ixazomib|ixazomib|mesh-list
1700145|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1700146|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1700147|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
1700148|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1700149|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1700150|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1700151|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
1700152|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1700164|NCT02595060|Molgramostim|molgramostim|mesh-list
1700165|NCT02595060|Sargramostim|sargramostim|mesh-list
1700166|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1700167|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
1700168|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1700207|NCT02525757|Paclitaxel|paclitaxel|mesh-list
1700208|NCT02525757|Carboplatin|carboplatin|mesh-list
1700209|NCT02525757|Atezolizumab|atezolizumab|mesh-list
1700210|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1700211|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1700212|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
1700213|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
1700214|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
1700215|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1700274|NCT02404155|Clozapine|clozapine|mesh-list
1700275|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1700276|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
1700277|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1700278|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1700279|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1700280|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1700281|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1700282|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1700283|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1700284|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
1700285|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
1700292|NCT02339922|Rituximab|rituximab|mesh-list
1700293|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1700294|NCT02339922|Ixazomib|ixazomib|mesh-list
1700295|NCT02339922|Antibodies|antibodies|mesh-list
1700296|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
1700297|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1700298|NCT02339922|Glycine|glycine|mesh-list
1700299|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
1700300|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1700301|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1700302|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1700303|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1700304|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
1700305|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1700306|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
1700307|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1701418|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
1701387|NCT05101005|Sirolimus|sirolimus|mesh-list
1701388|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1701389|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1701390|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1701391|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1701392|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
1701393|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1701394|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
1701395|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701396|NCT05100862|Rituximab|rituximab|mesh-list
1701397|NCT05100862|Lenalidomide|lenalidomide|mesh-list
1701398|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
1701399|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1701400|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1701401|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
1701402|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701403|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1701404|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1701405|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1701406|NCT05100862|Growth Substances|growth substances|mesh-ancestor
1701407|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
1701408|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1701409|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1701410|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701411|NCT05100719|Mebeverine|mebeverine|mesh-list
1701412|NCT05100719|Simethicone|simethicone|mesh-list
1701413|NCT05100719|Citric Acid|citric acid|mesh-list
1701414|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
1701415|NCT05100719|Alverine|alverine|mesh-list
1701416|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
1701417|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1701419|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
1701420|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701421|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
1701422|NCT05100719|Emollients|emollients|mesh-ancestor
1701423|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
1701424|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
1701425|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
1701426|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701427|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701428|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
1701455|NCT05100563|Naltrexone|naltrexone|mesh-list
1701456|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1701457|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1701458|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701459|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
1701460|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701465|NCT05100446|Amoxicillin|amoxicillin|mesh-list
1701466|NCT05100446|Esomeprazole|esomeprazole|mesh-list
1701467|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1701468|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1701469|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1701470|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1701471|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1701472|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1701473|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701474|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
1701475|NCT05100329|Analgesics|analgesics|mesh-ancestor
1701476|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
1701477|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701478|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701479|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1701480|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1701481|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1701482|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1701483|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701484|NCT05100303|Cytarabine|cytarabine|mesh-list
1701485|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
1701486|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1701487|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
1701488|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701489|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1701490|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
1701491|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1701492|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1701493|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
1701494|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701495|NCT05100303|Analgesics|analgesics|mesh-ancestor
1701496|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
1701497|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701498|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1701499|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1701500|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1701521|NCT05100186|Dexamethasone|dexamethasone|mesh-list
1701522|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1701523|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
1701524|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
1701525|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701526|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701527|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1701528|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
1701529|NCT05100186|Hormones|hormones|mesh-ancestor
1701530|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1701531|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1701532|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1701533|NCT05100160|Gabapentin|gabapentin|mesh-list
1701534|NCT05100160|Analgesics|analgesics|mesh-ancestor
1701535|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
1701536|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701537|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701538|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
1701539|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1701540|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1701541|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1701542|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1701543|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1701544|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1701545|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1701546|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701547|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
1701553|NCT05100017|Methocarbamol|methocarbamol|mesh-list
1701554|NCT05100017|Oxybutynin|oxybutynin|mesh-list
1701555|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
1701556|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
1701557|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701558|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701559|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1701560|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1701561|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
1701562|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1701563|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701564|NCT05100017|Urological Agents|urological agents|mesh-ancestor
1701565|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1701566|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1701567|NCT05099913|Flupenthixol|flupenthixol|mesh-list
1701568|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1701569|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1701570|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1701571|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701572|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1701573|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1701574|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
1701575|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1701576|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701577|NCT05099848|Leucovorin|leucovorin|mesh-list
1701578|NCT05099848|Fluorouracil|fluorouracil|mesh-list
1701579|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
1701580|NCT05099848|Apatinib|apatinib|mesh-list
1701581|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
1701582|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701583|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1701584|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1701585|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1701586|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
1701587|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701588|NCT05099848|Antidotes|antidotes|mesh-ancestor
1701589|NCT05099848|Protective Agents|protective agents|mesh-ancestor
1701590|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
1701591|NCT05099848|Vitamins|vitamins|mesh-ancestor
1701592|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
1701593|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1701594|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1701595|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
1701596|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1701597|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
1701598|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701599|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
1701600|NCT05099718|Protective Agents|protective agents|mesh-ancestor
1701601|NCT05099666|Doxorubicin|doxorubicin|mesh-list
1701602|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1701603|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1701604|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1701605|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1701606|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1701607|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701608|NCT05099614|Naloxone|naloxone|mesh-list
1701609|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1701610|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701611|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
1701612|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701613|NCT05099601|Silymarin|silymarin|mesh-list
1701614|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
1701615|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701616|NCT05099601|Protective Agents|protective agents|mesh-ancestor
1701617|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701618|NCT05099575|Oxytocin|oxytocin|mesh-list
1701619|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
1701620|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1701621|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701622|NCT05099471|Dexamethasone|dexamethasone|mesh-list
1701623|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
1701624|NCT05099471|Rituximab|rituximab|mesh-list
1701625|NCT05099471|Venetoclax|venetoclax|mesh-list
1701626|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1701627|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
1701628|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701629|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1701630|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1701631|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
1701632|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701633|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1701634|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1701635|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1701636|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
1701637|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
1701638|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701639|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1701640|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
1701641|NCT05099471|Hormones|hormones|mesh-ancestor
1701642|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1701643|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1701644|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1701668|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1701669|NCT05099198|Glimepiride|glimepiride|mesh-list
1701670|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1701671|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701672|NCT05099198|Incretins|incretins|mesh-ancestor
1701673|NCT05099198|Hormones|hormones|mesh-ancestor
1701674|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1701675|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1701676|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
1701677|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1701678|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701679|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1701680|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1701681|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
1701682|NCT05099185|Trace Elements|trace elements|mesh-list
1701683|NCT05099185|Micronutrients|micronutrients|mesh-list
1701684|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701700|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
1701701|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
1701702|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1701703|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
1701704|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1701705|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1701706|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701707|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1701708|NCT05099055|Analgesics|analgesics|mesh-ancestor
1701709|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
1701710|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701711|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1701712|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1701713|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1701714|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
1701715|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1701716|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701728|NCT05092165|Methylene Blue|methylene blue|mesh-list
1701729|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1701730|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701731|NCT05092152|Propofol|propofol|mesh-list
1701732|NCT05092152|Esketamine|esketamine|mesh-list
1701733|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1701734|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1701735|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701736|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1701737|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
1701738|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
1701739|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
1701740|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1701741|NCT05091905|Ropivacaine|ropivacaine|mesh-list
1701742|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
1701743|NCT05091905|Anesthetics|anesthetics|mesh-list
1701744|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1701745|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701746|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
1701747|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701748|NCT05091294|Anesthetics|anesthetics|mesh-list
1701749|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
1701750|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1701751|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701752|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
1701753|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701754|NCT05088928|Apixaban|apixaban|mesh-list
1701755|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1701756|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
1701757|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1701758|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
1701759|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1701760|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701761|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
1701762|NCT05088356|Plerixafor|plerixafor|mesh-list
1701763|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
1701764|NCT05088356|Melphalan|melphalan|mesh-list
1701765|NCT05088356|Fludarabine|fludarabine|mesh-list
1701766|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
1701767|NCT05088356|Tacrolimus|tacrolimus|mesh-list
1701768|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
1701769|NCT05088356|Lenograstim|lenograstim|mesh-list
1701770|NCT05088356|Sargramostim|sargramostim|mesh-list
1701771|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1701772|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
1701773|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701774|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1701775|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1701776|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701777|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1701778|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1701779|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1701780|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
1701781|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
1701782|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1701783|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1701784|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1701785|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1701786|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1701787|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1701788|NCT05087615|Ondansetron|ondansetron|mesh-list
1701789|NCT05087615|Metoclopramide|metoclopramide|mesh-list
1701790|NCT05087615|Granisetron|granisetron|mesh-list
1701791|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
1701792|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
1701793|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701794|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701795|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1701796|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
1701797|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
1701798|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1701799|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
1701800|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1701801|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701802|NCT05087615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1701803|NCT05087615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1701804|NCT05087615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1701805|NCT05087615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1701806|NCT05087615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1701807|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1701808|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1701809|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
1701823|NCT05082155|Bupivacaine|bupivacaine|mesh-list
1701824|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
1701825|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
1701826|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1701827|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701828|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
1701829|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701830|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
1701831|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
1701832|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701838|NCT05078502|Vitamin D|vitamin d|mesh-list
1701839|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
1701840|NCT05078502|Vitamins|vitamins|mesh-ancestor
1701841|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
1701842|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701843|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1701844|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1701852|NCT05057949|Itraconazole|itraconazole|mesh-list
1701853|NCT05057949|Rifampin|rifampin|mesh-list
1701854|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
1701855|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1701856|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1701857|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1701858|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1701859|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1701860|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1701861|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
1701862|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1701863|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701864|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1701865|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1701866|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
1701867|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1701868|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
1701869|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1701870|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1701871|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1701872|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1701873|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1701874|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1701875|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1701955|NCT05036408|Coal Tar|coal tar|mesh-list
1701956|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
1701957|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
1701974|NCT05033041|Metoclopramide|metoclopramide|mesh-list
1701975|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
1701976|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
1701977|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1701978|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1701979|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1701980|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1701981|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1701982|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
1701983|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1701984|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702006|NCT05025397|Propofol|propofol|mesh-list
1702007|NCT05025397|Sevoflurane|sevoflurane|mesh-list
1702008|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1702009|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1702010|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702011|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1702012|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
1702013|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
1702014|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1702015|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1702016|NCT05024214|Sunitinib|sunitinib|mesh-list
1702017|NCT05024214|Lenvatinib|lenvatinib|mesh-list
1702018|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702019|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1702020|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1702021|NCT05024214|Growth Substances|growth substances|mesh-ancestor
1702022|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702023|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
1702024|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1702025|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1702026|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702027|NCT05018091|Dexamethasone|dexamethasone|mesh-list
1702028|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
1702029|NCT05018091|BB 1101|bb 1101|mesh-list
1702030|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1702031|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
1702032|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
1702033|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1702034|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702035|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1702036|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
1702037|NCT05018091|Hormones|hormones|mesh-ancestor
1702038|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1702039|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1702040|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702041|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
1702042|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1702043|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702055|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
1702056|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1702057|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
1702058|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702136|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
1702137|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1702138|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702139|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1702140|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702143|NCT04939467|Pirfenidone|pirfenidone|mesh-list
1702144|NCT04939467|Nintedanib|nintedanib|mesh-list
1702145|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702146|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1702147|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1702148|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702149|NCT04939467|Analgesics|analgesics|mesh-ancestor
1702150|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
1702151|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1702152|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702153|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1702154|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1702155|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1702156|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1702239|NCT04911660|Empagliflozin|empagliflozin|mesh-list
1702240|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1702241|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702242|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1702243|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702279|NCT04877093|Clonidine|clonidine|mesh-list
1702280|NCT04877093|Analgesics|analgesics|mesh-ancestor
1702281|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
1702282|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1702283|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702284|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1702285|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
1702286|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
1702287|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1702288|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1702289|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1702290|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
1702291|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1702292|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702293|NCT04857931|Colchicine|colchicine|mesh-list
1702294|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
1702295|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1702296|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
1702297|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
1702298|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
1702299|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702300|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702301|NCT04856566|Ethanol|ethanol|mesh-list
1702302|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1702303|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1702304|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1702305|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702320|NCT04825704|Bupivacaine|bupivacaine|mesh-list
1702321|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
1702322|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
1702323|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1702324|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702325|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
1702326|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1702352|NCT04770493|Lamotrigine|lamotrigine|mesh-list
1702353|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
1702354|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1702355|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1702356|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702357|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1702358|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702359|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1702360|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1702361|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1702362|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1702363|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1702425|NCT04733040|Felzartamab|felzartamab|mesh-list
1702426|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702427|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
1702428|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702429|NCT04731974|Melatonin|melatonin|mesh-list
1702430|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
1702431|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702432|NCT04731974|Protective Agents|protective agents|mesh-ancestor
1702433|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702434|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1702435|NCT04730232|Paclitaxel|paclitaxel|mesh-list
1702436|NCT04730232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1702437|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1702438|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702439|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
1702440|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
1702441|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
1702442|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702443|NCT04721353|Prazosin|prazosin|mesh-list
1702444|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1702445|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1702446|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1702447|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1702448|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
1702449|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1702450|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702451|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702470|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
1702471|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1702472|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702494|NCT04659174|Xanomeline|xanomeline|mesh-list
1702495|NCT04659174|Trospium chloride|trospium chloride|mesh-list
1702496|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
1702497|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
1702498|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1702499|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702500|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1702501|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1702502|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
1702503|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1702504|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702505|NCT04659174|Urological Agents|urological agents|mesh-ancestor
1702506|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1702507|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1702508|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
1702509|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1702510|NCT04658277|Clarithromycin|clarithromycin|mesh-list
1702511|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1702512|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1702513|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1702514|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1702515|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702516|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1702517|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1702592|NCT04602117|Paclitaxel|paclitaxel|mesh-list
1702593|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1702594|NCT04602117|Trastuzumab|trastuzumab|mesh-list
1702595|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1702596|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702597|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
1702598|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
1702599|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
1702600|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702601|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1702626|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
1702627|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
1702628|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702629|NCT04573322|Protective Agents|protective agents|mesh-ancestor
1702630|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702631|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1702632|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702651|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1702652|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1702653|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1702654|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1702655|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702656|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
1702657|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1702658|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702691|NCT04540848|Bupivacaine|bupivacaine|mesh-list
1702692|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
1702693|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
1702694|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1702695|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702696|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
1702697|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1702708|NCT04531592|Valproic Acid|valproic acid|mesh-list
1702709|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
1702710|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1702711|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702712|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
1702713|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1702714|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702715|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
1702716|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1702717|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1702718|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1702719|NCT04531579|Valproic Acid|valproic acid|mesh-list
1702720|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1702721|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
1702722|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1702723|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702724|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
1702725|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1702726|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702727|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
1702728|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1702729|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1702730|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1702734|NCT04517357|Apatinib|apatinib|mesh-list
1702735|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702736|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1702737|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1702738|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702739|NCT04510584|Bevacizumab|bevacizumab|mesh-list
1702740|NCT04510584|Atezolizumab|atezolizumab|mesh-list
1702741|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1702742|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702743|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1702744|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1702745|NCT04510584|Growth Substances|growth substances|mesh-ancestor
1702746|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702747|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
1702783|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
1702784|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1702785|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
1702786|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1702787|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
1702788|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1702789|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702790|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
1702798|NCT04469764|Letrozole|letrozole|mesh-list
1702799|NCT04469764|Anastrozole|anastrozole|mesh-list
1702800|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702801|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1702802|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1702803|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1702804|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702805|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1702806|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
1702807|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1702808|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702809|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1702838|NCT04420624|Colchicine|colchicine|mesh-list
1702839|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
1702840|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1702841|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
1702842|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
1702843|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
1702844|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702845|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702874|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
1702875|NCT04379024|Estrogens|estrogens|mesh-list
1702876|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1702877|NCT04379024|Hormones|hormones|mesh-ancestor
1702878|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1702879|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702880|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1702881|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1702882|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
1702883|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1702916|NCT04336982|Azacitidine|azacitidine|mesh-list
1702917|NCT04336982|Venetoclax|venetoclax|mesh-list
1702918|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1702919|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
1702920|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702921|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702922|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1702957|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1702958|NCT04272008|Estradiol|estradiol|mesh-list
1702959|NCT04272008|Estrogens|estrogens|mesh-ancestor
1702960|NCT04272008|Hormones|hormones|mesh-ancestor
1702961|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1702962|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702963|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1702964|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
1702965|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1702966|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1702967|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1702968|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1702973|NCT04269213|Cytarabine|cytarabine|mesh-list
1702974|NCT04269213|Daunorubicin|daunorubicin|mesh-list
1702975|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1702976|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
1702977|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1702978|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1702979|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
1702980|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1702981|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1702982|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
1702983|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702984|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1702985|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1702986|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1702987|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1702988|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1702989|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
1702990|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1702994|NCT04243122|Aspirin|aspirin|mesh-list
1702995|NCT04243122|Apixaban|apixaban|mesh-list
1702996|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1702997|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1702998|NCT04243122|Analgesics|analgesics|mesh-ancestor
1702999|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
1703000|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1703001|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703002|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1703003|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1703004|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1703005|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1703006|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703007|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1703008|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1703009|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703010|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
1703011|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1703012|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
1703013|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1703014|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
1703015|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
1703016|NCT04229095|Suvorexant|suvorexant|mesh-list
1703017|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1703018|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1703019|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1703020|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703021|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1703022|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1703023|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703044|NCT04183205|Sertraline|sertraline|mesh-list
1703045|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
1703046|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1703047|NCT04183205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1703048|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1703049|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1703050|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703051|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1703052|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
1703053|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703054|NCT04176718|Dexamethasone|dexamethasone|mesh-list
1703055|NCT04176718|Pomalidomide|pomalidomide|mesh-list
1703056|NCT04176718|Daratumumab|daratumumab|mesh-list
1703057|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1703058|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
1703059|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
1703060|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1703061|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703062|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1703063|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
1703064|NCT04176718|Hormones|hormones|mesh-ancestor
1703065|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1703066|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1703067|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703068|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
1703069|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1703070|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1703071|NCT04176718|Growth Substances|growth substances|mesh-ancestor
1703072|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
1703086|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
1703087|NCT04163406|Trace Elements|trace elements|mesh-ancestor
1703088|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
1703089|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703104|NCT04120246|Acetic Acid|acetic acid|mesh-list
1703105|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1703106|NCT04120246|Trastuzumab|trastuzumab|mesh-list
1703107|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
1703108|NCT04120246|Antibodies|antibodies|mesh-list
1703109|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
1703110|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1703111|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
1703112|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703113|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703114|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1703115|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1703128|NCT04099355|Dronabinol|dronabinol|mesh-list
1703129|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
1703130|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703131|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1703132|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1703133|NCT04099355|Analgesics|analgesics|mesh-ancestor
1703134|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
1703135|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1703136|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1703137|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1703138|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1703139|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703140|NCT04099355|Hormones|hormones|mesh-ancestor
1703141|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1703205|NCT04001504|Vaccines|vaccines|mesh-list
1703206|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
1703207|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703208|NCT03965845|Palbociclib|palbociclib|mesh-list
1703209|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703210|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1703211|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703212|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703325|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
1703326|NCT03825289|Trametinib|trametinib|mesh-list
1703327|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
1703328|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1703329|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1703330|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1703331|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703332|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703333|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1703334|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703335|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1703356|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
1703357|NCT03809533|Velpatasvir|velpatasvir|mesh-list
1703358|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
1703359|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1703395|NCT03759366|Eculizumab|eculizumab|mesh-list
1703396|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1703397|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1703398|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
1703399|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703438|NCT03662659|Nivolumab|nivolumab|mesh-list
1703439|NCT03662659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1703440|NCT03662659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703441|NCT03662659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1703442|NCT03662659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703461|NCT03649321|Gemcitabine|gemcitabine|mesh-list
1703462|NCT03649321|Paclitaxel|paclitaxel|mesh-list
1703463|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1703464|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1703465|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703466|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
1703467|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
1703468|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
1703469|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703470|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1703471|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
1703472|NCT03649321|Antiviral Agents|antiviral agents|mesh-ancestor
1703473|NCT03649321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1703474|NCT03649321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703475|NCT03649321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1703476|NCT03649321|Immunologic Factors|immunologic factors|mesh-ancestor
1703477|NCT03649321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703478|NCT03619551|Busulfan|busulfan|mesh-list
1703479|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
1703480|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703481|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1703482|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
1703483|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703484|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1703485|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703486|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1703496|NCT03581292|Temozolomide|temozolomide|mesh-list
1703497|NCT03581292|Veliparib|veliparib|mesh-list
1703498|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1703499|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
1703500|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703501|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703502|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1703503|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703512|NCT03572530|Azacitidine|azacitidine|mesh-list
1703513|NCT03572530|Decitabine|decitabine|mesh-list
1703514|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1703515|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
1703516|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703517|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703518|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703519|NCT03549715|Durvalumab|durvalumab|mesh-list
1703520|NCT03549715|Tremelimumab|tremelimumab|mesh-list
1703521|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1703522|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703531|NCT03532295|Bevacizumab|bevacizumab|mesh-list
1703532|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1703533|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703534|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1703535|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1703536|NCT03532295|Growth Substances|growth substances|mesh-ancestor
1703537|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703538|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
1703544|NCT03481842|Axitinib|axitinib|mesh-list
1703545|NCT03481842|Afatinib|afatinib|mesh-list
1703546|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703547|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1703548|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703549|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703558|NCT03466346|Fluoxetine|fluoxetine|mesh-list
1703559|NCT03466346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1703560|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1703561|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1703562|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703563|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1703564|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
1703565|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703566|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1703567|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
1703568|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1703569|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1703570|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1703571|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703572|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1703573|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
1703574|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1703585|NCT03403634|Interferons|interferons|mesh-list
1703586|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
1703587|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
1703588|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
1703589|NCT03403634|Celecoxib|celecoxib|mesh-list
1703590|NCT03403634|Benzenesulfonamide|benzenesulfonamide|mesh-list
1703591|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703592|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
1703593|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1703594|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
1703595|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703596|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1703597|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1703598|NCT03403634|Analgesics|analgesics|mesh-ancestor
1703599|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
1703600|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1703601|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1703602|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1703603|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1703604|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1703605|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703606|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703607|NCT03403634|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1703608|NCT03381274|Osimertinib|osimertinib|mesh-list
1703609|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703610|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1703611|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703612|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703618|NCT03341962|Calcium|calcium|mesh-list
1703619|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1703620|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703660|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
1703661|NCT03237819|Analgesics|analgesics|mesh-ancestor
1703662|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
1703663|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1703664|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703665|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
1703666|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1703667|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1703668|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
1703669|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1703670|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1703671|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703672|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1703673|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
1703674|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1703696|NCT03207958|Belimumab|belimumab|mesh-list
1703697|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1703698|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
1703699|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703700|NCT03205956|Levodopa|levodopa|mesh-list
1703701|NCT03205956|Carbidopa|carbidopa|mesh-list
1703702|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1703703|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1703704|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
1703705|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1703706|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703707|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703708|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1703709|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703729|NCT03186209|Benralizumab|benralizumab|mesh-list
1703730|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1703731|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
1703794|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
1703795|NCT03149029|Trametinib|trametinib|mesh-list
1703796|NCT03149029|Dabrafenib|dabrafenib|mesh-list
1703797|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1703798|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703799|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1703800|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703801|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703802|NCT03139916|Temozolomide|temozolomide|mesh-list
1703803|NCT03139916|Bavituximab|bavituximab|mesh-list
1703804|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1703805|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
1703806|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703807|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703808|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1703854|NCT03019003|Durvalumab|durvalumab|mesh-list
1703855|NCT03019003|Decitabine|decitabine|mesh-list
1703856|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1703857|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703858|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1703859|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
1703860|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703861|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703883|NCT03003962|Gemcitabine|gemcitabine|mesh-list
1703884|NCT03003962|Paclitaxel|paclitaxel|mesh-list
1703885|NCT03003962|Cisplatin|cisplatin|mesh-list
1703886|NCT03003962|Carboplatin|carboplatin|mesh-list
1703887|NCT03003962|Pemetrexed|pemetrexed|mesh-list
1703888|NCT03003962|Durvalumab|durvalumab|mesh-list
1703889|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1703890|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703891|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
1703892|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
1703893|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
1703894|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703895|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1703896|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
1703897|NCT03003962|Antiviral Agents|antiviral agents|mesh-ancestor
1703898|NCT03003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1703899|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703900|NCT03003962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1703901|NCT03003962|Immunologic Factors|immunologic factors|mesh-ancestor
1703902|NCT03003962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703903|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1703904|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1703905|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1703936|NCT02951130|Milrinone|milrinone|mesh-list
1703937|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1703938|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1703939|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
1703940|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1703941|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1703942|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703943|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703944|NCT02951130|Protective Agents|protective agents|mesh-ancestor
1703945|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703946|NCT02921893|Dexamethasone|dexamethasone|mesh-list
1703947|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
1703948|NCT02921893|Lenalidomide|lenalidomide|mesh-list
1703949|NCT02921893|Ixazomib|ixazomib|mesh-list
1703950|NCT02921893|Ichthammol|ichthammol|mesh-list
1703951|NCT02921893|BB 1101|bb 1101|mesh-list
1703952|NCT02921893|Glycine|glycine|mesh-list
1703953|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1703954|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
1703955|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
1703956|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1703957|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703958|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1703959|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
1703960|NCT02921893|Hormones|hormones|mesh-ancestor
1703961|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1703962|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1703963|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703964|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
1703965|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703966|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703967|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
1703968|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1703969|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1703970|NCT02921893|Growth Substances|growth substances|mesh-ancestor
1703971|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
1703972|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
1703973|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
1703974|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1703975|NCT02905110|Methotrexate|methotrexate|mesh-list
1703976|NCT02905110|Etoposide|etoposide|mesh-list
1703977|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1703978|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
1703979|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1703980|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1703981|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1703982|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
1703983|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1703984|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1703985|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
1703986|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1703987|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1703988|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1703989|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
1703990|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1703991|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1703992|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1703993|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1703994|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1704017|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
1704018|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1704019|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1704054|NCT02813655|Cosyntropin|cosyntropin|mesh-list
1704055|NCT02813655|Hormones|hormones|mesh-ancestor
1704056|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1704057|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1704082|NCT02747407|Vaccines|vaccines|mesh-list
1704083|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
1704084|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1704094|NCT02718833|Dexamethasone|dexamethasone|mesh-list
1704095|NCT02718833|Bortezomib|bortezomib|mesh-list
1704096|NCT02718833|Pomalidomide|pomalidomide|mesh-list
1704097|NCT02718833|Elotuzumab|elotuzumab|mesh-list
1704098|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1704099|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
1704100|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
1704101|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1704102|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1704103|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1704104|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
1704105|NCT02718833|Hormones|hormones|mesh-ancestor
1704106|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1704107|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1704108|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1704109|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
1704110|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1704111|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1704112|NCT02718833|Growth Substances|growth substances|mesh-ancestor
1704113|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
1704114|NCT02700841|Melphalan|melphalan|mesh-list
1704115|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
1704116|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1704117|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
1704118|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1704119|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1704120|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1704121|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1704122|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
1704123|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1704156|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
1704157|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1704158|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
1704159|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1704160|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1704161|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1704162|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
1704163|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
1704164|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1704165|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
1704166|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1704167|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1704209|NCT02369458|Mitomycins|mitomycins|mesh-list
1704210|NCT02369458|Mitomycin|mitomycin|mesh-list
1704211|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1704212|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1704213|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
1704214|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1704215|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1704216|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1705902|NCT05102591|Ketorolac|ketorolac|mesh-list
1705903|NCT05102591|Metoclopramide|metoclopramide|mesh-list
1705904|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1705905|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1705906|NCT05102591|Analgesics|analgesics|mesh-ancestor
1705907|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
1705908|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1705909|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1705910|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1705911|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1705912|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1705913|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1705914|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1705915|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
1705916|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
1705917|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1705918|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1705919|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1705920|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
1705921|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1705922|NCT05102552|Huperzine A|huperzine a|mesh-list
1705923|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1705924|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1705925|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1705926|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
1705927|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1705928|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1705929|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1705930|NCT05102552|Protective Agents|protective agents|mesh-ancestor
1705931|NCT05102448|Methotrexate|methotrexate|mesh-list
1705932|NCT05102448|Tofacitinib|tofacitinib|mesh-list
1705933|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1705934|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
1705935|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1705936|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1705937|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1705938|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
1705939|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1705940|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1705941|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
1705942|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1705943|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1705944|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1705945|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
1705946|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1705947|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1705948|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1705949|NCT05102422|Propofol|propofol|mesh-list
1705950|NCT05102422|Sevoflurane|sevoflurane|mesh-list
1705951|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1705952|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1705953|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1705954|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1705955|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
1705956|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
1705957|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1705958|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1705962|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
1705963|NCT05102396|Oxybutynin|oxybutynin|mesh-list
1705964|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
1705965|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
1705966|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1705967|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1705968|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1705969|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1705970|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
1705971|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1705972|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1705973|NCT05102396|Urological Agents|urological agents|mesh-ancestor
1705974|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1705975|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1705976|NCT05102396|Renal Agents|renal agents|mesh-ancestor
1706000|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
1706001|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1706002|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1706003|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706004|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1706005|NCT05102058|Analgesics|analgesics|mesh-ancestor
1706006|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
1706007|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1706008|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1706009|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1706010|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1706011|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
1706012|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1706013|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706014|NCT05102045|Memantine|memantine|mesh-list
1706015|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
1706016|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1706017|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1706018|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
1706019|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1706020|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706021|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706022|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1706023|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1706024|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1706025|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
1706026|NCT05101954|Mitogens|mitogens|mesh-list
1706027|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
1706028|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706029|NCT05101928|Prednisone|prednisone|mesh-list
1706030|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1706031|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
1706032|NCT05101928|Hormones|hormones|mesh-ancestor
1706033|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1706034|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706035|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1706036|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1706037|NCT05101811|Vitamin D|vitamin d|mesh-list
1706038|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
1706039|NCT05101811|Vitamins|vitamins|mesh-list
1706040|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
1706041|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706042|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1706043|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1706044|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1706045|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1706046|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
1706047|NCT05101785|Lidocaine|lidocaine|mesh-list
1706048|NCT05101785|Epinephrine|epinephrine|mesh-list
1706049|NCT05101785|Racepinephrine|racepinephrine|mesh-list
1706050|NCT05101785|Carticaine|carticaine|mesh-list
1706051|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
1706052|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
1706053|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
1706054|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1706055|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706056|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
1706057|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1706058|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1706059|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1706060|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1706061|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1706062|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706063|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1706064|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1706065|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
1706066|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1706067|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1706068|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1706069|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
1706070|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1706071|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
1706072|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
1706073|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
1706074|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1706075|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
1706076|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1706077|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
1706078|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1706079|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706080|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1706081|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
1706082|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1706083|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
1706084|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706085|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1706086|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1706087|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
1706088|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
1706089|NCT05101746|Protective Agents|protective agents|mesh-ancestor
1706113|NCT05101551|Gemcitabine|gemcitabine|mesh-list
1706114|NCT05101551|Topotecan|topotecan|mesh-list
1706115|NCT05101551|Talazoparib|talazoparib|mesh-list
1706116|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1706117|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
1706118|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706119|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1706120|NCT05101551|Antiviral Agents|antiviral agents|mesh-ancestor
1706121|NCT05101551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1706122|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1706123|NCT05101551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1706124|NCT05101551|Immunologic Factors|immunologic factors|mesh-ancestor
1706125|NCT05101551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706126|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1706127|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1706128|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1706129|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
1706130|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1706131|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1706132|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1706133|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
1706134|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1706135|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1706136|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1706137|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706143|NCT05101291|Bupivacaine|bupivacaine|mesh-list
1706144|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
1706145|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
1706146|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1706147|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706148|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
1706149|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1706150|NCT05101187|Amphotericin B|amphotericin b|mesh-list
1706151|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
1706152|NCT05101187|Olorofim|olorofim|mesh-list
1706153|NCT05101187|Amebicides|amebicides|mesh-ancestor
1706154|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1706155|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1706156|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1706157|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1706158|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
1706159|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1706160|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1706161|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1706162|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1706163|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706164|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
1706165|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1706166|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706173|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
1706174|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1706175|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1706176|NCT05097976|Prednisolone|prednisolone|mesh-list
1706177|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
1706178|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1706179|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
1706180|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1706181|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
1706182|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
1706183|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1706184|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706185|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1706186|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
1706187|NCT05097976|Hormones|hormones|mesh-ancestor
1706188|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1706189|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1706190|NCT05097976|Protective Agents|protective agents|mesh-ancestor
1706191|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1706192|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1706201|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
1706202|NCT05092074|Velpatasvir|velpatasvir|mesh-list
1706203|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
1706204|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1706214|NCT05091372|Lenalidomide|lenalidomide|mesh-list
1706215|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
1706216|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706217|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1706218|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1706219|NCT05091372|Growth Substances|growth substances|mesh-ancestor
1706220|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
1706221|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1706233|NCT05083949|Metformin|metformin|mesh-list
1706234|NCT05083949|Empagliflozin|empagliflozin|mesh-list
1706235|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1706236|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706237|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1706238|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706279|NCT05058417|Empagliflozin|empagliflozin|mesh-list
1706280|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1706281|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706282|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1706283|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706288|NCT05051449|Ketamine|ketamine|mesh-list
1706289|NCT05051449|Analgesics|analgesics|mesh-ancestor
1706290|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
1706291|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1706292|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706293|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1706294|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1706295|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
1706296|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
1706297|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1706298|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1706299|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1706300|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1706301|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706307|NCT05050318|Vaccines|vaccines|mesh-list
1706308|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
1706309|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706316|NCT05037617|Oxytocin|oxytocin|mesh-list
1706317|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
1706318|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1706319|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706320|NCT05036473|Levodopa|levodopa|mesh-list
1706321|NCT05036473|Carbidopa|carbidopa|mesh-list
1706322|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1706323|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1706324|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1706325|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
1706326|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1706327|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706328|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706329|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1706330|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1706331|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1706332|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
1706333|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
1706406|NCT05020574|Cephalexin|cephalexin|mesh-list
1706407|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1706408|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1706409|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
1706410|NCT05020444|Fludarabine|fludarabine|mesh-list
1706411|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1706412|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
1706413|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706414|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1706415|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1706416|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
1706417|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706418|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1706419|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1706468|NCT04990128|Triamcinolone|triamcinolone|mesh-list
1706469|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1706470|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
1706471|NCT04990128|Hormones|hormones|mesh-ancestor
1706472|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1706473|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706479|NCT04982354|Fludarabine|fludarabine|mesh-list
1706480|NCT04982354|Melphalan|melphalan|mesh-list
1706481|NCT04982354|Busulfan|busulfan|mesh-list
1706482|NCT04982354|Midostaurin|midostaurin|mesh-list
1706483|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1706484|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706485|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1706486|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
1706487|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706488|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1706489|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
1706490|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1706491|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1706492|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1706493|NCT04971746|Pirfenidone|pirfenidone|mesh-list
1706494|NCT04971746|Nintedanib|nintedanib|mesh-list
1706495|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1706496|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1706497|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1706498|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706499|NCT04971746|Analgesics|analgesics|mesh-ancestor
1706500|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
1706501|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1706502|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706503|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1706504|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1706505|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1706506|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1706525|NCT04964466|Becaplermin|becaplermin|mesh-list
1706526|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
1706527|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
1706528|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1706529|NCT04964466|Growth Substances|growth substances|mesh-ancestor
1706530|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706534|NCT04945616|Aspirin|aspirin|mesh-list
1706535|NCT04945616|Clopidogrel|clopidogrel|mesh-list
1706536|NCT04945616|Ticagrelor|ticagrelor|mesh-list
1706537|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1706538|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1706539|NCT04945616|Analgesics|analgesics|mesh-ancestor
1706540|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
1706541|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1706542|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706543|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1706544|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1706545|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1706546|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1706547|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706548|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1706549|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1706550|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1706551|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
1706552|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1706553|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1706554|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1706555|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
1706556|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1706563|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
1706564|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1706565|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
1706566|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
1706567|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1706568|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706569|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706570|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1706571|NCT04940390|Analgesics|analgesics|mesh-ancestor
1706572|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
1706573|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1706576|NCT04940013|Misoprostol|misoprostol|mesh-list
1706577|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1706578|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
1706579|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1706580|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706581|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1706582|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1706583|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
1706633|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1706634|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1706635|NCT04923867|Estradiol|estradiol|mesh-list
1706636|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1706637|NCT04923867|Estrogens|estrogens|mesh-ancestor
1706638|NCT04923867|Hormones|hormones|mesh-ancestor
1706639|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1706640|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706641|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1706642|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
1706643|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1706644|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1706694|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
1706695|NCT04894864|Anesthetics|anesthetics|mesh-list
1706696|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1706697|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706698|NCT04894864|Narcotics|narcotics|mesh-ancestor
1706699|NCT04894864|Analgesics|analgesics|mesh-ancestor
1706700|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
1706701|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1706740|NCT04862650|Paclitaxel|paclitaxel|mesh-list
1706741|NCT04862650|Carboplatin|carboplatin|mesh-list
1706742|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1706743|NCT04862650|Cemiplimab|cemiplimab|mesh-list
1706744|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1706745|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1706746|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
1706747|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
1706748|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
1706749|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706750|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1706817|NCT04796220|Gemcitabine|gemcitabine|mesh-list
1706818|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1706819|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
1706820|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706821|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1706822|NCT04796220|Antiviral Agents|antiviral agents|mesh-ancestor
1706823|NCT04796220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1706824|NCT04796220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1706825|NCT04796220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1706826|NCT04796220|Immunologic Factors|immunologic factors|mesh-ancestor
1706827|NCT04796220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706828|NCT04787991|Gemcitabine|gemcitabine|mesh-list
1706829|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
1706830|NCT04787991|Paclitaxel|paclitaxel|mesh-list
1706831|NCT04787991|Nivolumab|nivolumab|mesh-list
1706832|NCT04787991|Ipilimumab|ipilimumab|mesh-list
1706833|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1706834|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1706835|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
1706836|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
1706837|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
1706838|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706839|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1706840|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
1706841|NCT04787991|Antiviral Agents|antiviral agents|mesh-ancestor
1706842|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1706843|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1706844|NCT04787991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1706845|NCT04787991|Immunologic Factors|immunologic factors|mesh-ancestor
1706846|NCT04787991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706847|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1706848|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1706849|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
1706850|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1706851|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1706852|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1706892|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
1706893|NCT04719065|Analgesics|analgesics|mesh-ancestor
1706894|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
1706895|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1706896|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706897|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1706898|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1706899|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1706900|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1706901|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706948|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
1706949|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1706950|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1706959|NCT04645966|Acetaminophen|acetaminophen|mesh-list
1706960|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1706961|NCT04645966|Analgesics|analgesics|mesh-ancestor
1706962|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
1706963|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1706964|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1706965|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
1706984|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
1706985|NCT04642430|Apixaban|apixaban|mesh-list
1706986|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1706987|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
1706988|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1706989|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
1706990|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1706991|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1706992|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
1707008|NCT04622735|Acetaminophen|acetaminophen|mesh-list
1707009|NCT04622735|Nefopam|nefopam|mesh-list
1707010|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1707011|NCT04622735|Analgesics|analgesics|mesh-ancestor
1707012|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
1707013|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1707014|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707015|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
1707020|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
1707021|NCT04610476|Prednisolone|prednisolone|mesh-list
1707022|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1707023|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
1707024|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1707025|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
1707026|NCT04610476|Adalimumab|adalimumab|mesh-list
1707027|NCT04610476|Etanercept|etanercept|mesh-list
1707028|NCT04610476|Apremilast|apremilast|mesh-list
1707029|NCT04610476|Golimumab|golimumab|mesh-list
1707030|NCT04610476|Methotrexate|methotrexate|mesh-list
1707031|NCT04610476|Abatacept|abatacept|mesh-list
1707032|NCT04610476|Infliximab|infliximab|mesh-list
1707033|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
1707034|NCT04610476|Ustekinumab|ustekinumab|mesh-list
1707035|NCT04610476|Ixekizumab|ixekizumab|mesh-list
1707036|NCT04610476|Tofacitinib|tofacitinib|mesh-list
1707037|NCT04610476|Leflunomide|leflunomide|mesh-list
1707038|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1707039|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
1707040|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1707041|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
1707042|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1707043|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707044|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1707045|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
1707046|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707047|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707048|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
1707049|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1707050|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1707051|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1707052|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
1707053|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1707054|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1707055|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1707056|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
1707057|NCT04610476|Hormones|hormones|mesh-ancestor
1707058|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1707059|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1707060|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
1707061|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
1707062|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1707063|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1707064|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1707065|NCT04610476|Protective Agents|protective agents|mesh-ancestor
1707066|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1707067|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1707068|NCT04610476|Analgesics|analgesics|mesh-ancestor
1707069|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
1707070|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1707071|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1707072|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1707073|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1707074|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1707075|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1707148|NCT04565574|Rifampin|rifampin|mesh-list
1707149|NCT04565574|Rabeprazole|rabeprazole|mesh-list
1707150|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1707151|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1707152|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1707153|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1707154|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707155|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1707156|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
1707157|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1707158|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1707159|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
1707160|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1707161|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1707162|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1707163|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1707164|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1707165|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1707166|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1707169|NCT04560634|Norepinephrine|norepinephrine|mesh-list
1707170|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1707171|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1707172|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
1707173|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1707174|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707175|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707176|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
1707177|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
1707178|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1707179|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1707214|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1707215|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1707216|NCT04521920|Narcotics|narcotics|mesh-ancestor
1707217|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1707218|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707219|NCT04521920|Analgesics|analgesics|mesh-ancestor
1707220|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
1707221|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1707222|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1707230|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
1707231|NCT04483544|Olaparib|olaparib|mesh-list
1707232|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1707233|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707234|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1707235|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1707236|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707237|NCT04474353|Temozolomide|temozolomide|mesh-list
1707238|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1707239|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
1707240|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707241|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707274|NCT04433845|Psilocybin|psilocybin|mesh-list
1707275|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
1707276|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707277|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1707355|NCT04367233|Anesthetics|anesthetics|mesh-list
1707356|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1707357|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707358|NCT04364776|Durvalumab|durvalumab|mesh-list
1707359|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1707360|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707361|NCT04357587|Capecitabine|capecitabine|mesh-list
1707362|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
1707363|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1707364|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
1707365|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707366|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707367|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1707368|NCT04351295|Chloroquine|chloroquine|mesh-list
1707369|NCT04351295|Favipiravir|favipiravir|mesh-list
1707370|NCT04351295|Amebicides|amebicides|mesh-ancestor
1707371|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1707372|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1707373|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1707374|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
1707375|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1707376|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
1707400|NCT04337177|Temozolomide|temozolomide|mesh-list
1707401|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1707402|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
1707403|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707404|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707408|NCT04316143|Zamicastat|zamicastat|mesh-list
1707409|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1707410|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707411|NCT04315233|Belinostat|belinostat|mesh-list
1707412|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707413|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1707414|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1707415|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707416|NCT04313244|Vaccines|vaccines|mesh-list
1707417|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
1707418|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707444|NCT04308330|Vorinostat|vorinostat|mesh-list
1707445|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707446|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1707447|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1707448|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707468|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
1707469|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
1707470|NCT04300985|Anesthetics|anesthetics|mesh-list
1707471|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1707472|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707473|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1707474|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1707475|NCT04300985|Analgesics|analgesics|mesh-ancestor
1707476|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
1707477|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1707478|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1707479|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1707480|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1707481|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
1707482|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1707483|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707484|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1707485|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
1707486|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1707487|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1707488|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1707489|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
1707490|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1707491|NCT04288089|Palbociclib|palbociclib|mesh-list
1707492|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707493|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1707494|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1707495|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707496|NCT04271293|Edoxaban|edoxaban|mesh-list
1707497|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1707498|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
1707499|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1707500|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
1707501|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1707502|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707503|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
1707504|NCT04260477|Rifampin|rifampin|mesh-list
1707505|NCT04260477|Isoniazid|isoniazid|mesh-list
1707506|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
1707507|NCT04260477|Ethambutol|ethambutol|mesh-list
1707508|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1707509|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
1707510|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1707511|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1707512|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
1707513|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1707514|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1707515|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707516|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1707517|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1707518|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1707519|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1707520|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1707521|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1707522|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1707523|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1707524|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
1707525|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1707526|NCT04259138|Vedolizumab|vedolizumab|mesh-list
1707527|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1707530|NCT04246762|Vitamin K|vitamin k|mesh-list
1707531|NCT04246762|Midazolam|midazolam|mesh-list
1707532|NCT04246762|Caffeine|caffeine|mesh-list
1707533|NCT04246762|Omeprazole|omeprazole|mesh-list
1707534|NCT04246762|Warfarin|warfarin|mesh-list
1707535|NCT04246762|Vitamins|vitamins|mesh-ancestor
1707536|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
1707537|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707538|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1707539|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1707540|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1707541|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1707542|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1707543|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1707544|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1707545|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
1707546|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
1707547|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
1707548|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
1707549|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1707550|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707551|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
1707552|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1707553|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1707554|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1707555|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1707556|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1707557|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1707558|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1707559|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1707560|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
1707561|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1707562|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1707563|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
1707564|NCT04246762|Coagulants|coagulants|mesh-ancestor
1707565|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
1707566|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1707567|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1707568|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
1707569|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
1707570|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1707571|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707572|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
1707573|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1707630|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1707631|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1707632|NCT04150042|Vitamins|vitamins|mesh-list
1707633|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
1707634|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
1707635|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
1707636|NCT04150042|Ethanol|ethanol|mesh-list
1707637|NCT04150042|Melphalan|melphalan|mesh-list
1707638|NCT04150042|Carmustine|carmustine|mesh-list
1707639|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
1707640|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707641|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1707642|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
1707643|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707644|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707645|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1707646|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1707647|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
1707648|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
1707649|NCT04150042|Protective Agents|protective agents|mesh-ancestor
1707650|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
1707651|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1707652|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1707653|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1707654|NCT04150042|Hematinics|hematinics|mesh-ancestor
1707678|NCT04141020|Sirolimus|sirolimus|mesh-list
1707679|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1707680|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1707681|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1707682|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707683|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
1707684|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1707685|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
1707686|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707687|NCT04140721|Moxonidine|moxonidine|mesh-list
1707688|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1707689|NCT04138875|Rituximab|rituximab|mesh-list
1707690|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1707691|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1707692|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1707693|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707694|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
1707695|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707696|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1707697|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1707698|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
1707699|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707705|NCT04117763|Empagliflozin|empagliflozin|mesh-list
1707706|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1707707|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707708|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1707709|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707737|NCT04059562|Irinotecan|irinotecan|mesh-list
1707738|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1707739|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1707740|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1707741|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707742|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707753|NCT04046107|Cemiplimab|cemiplimab|mesh-list
1707754|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1707755|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707774|NCT04019834|Bupivacaine|bupivacaine|mesh-list
1707775|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
1707776|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
1707777|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1707778|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707779|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
1707780|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1707788|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
1707789|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
1707790|NCT03959241|Methotrexate|methotrexate|mesh-list
1707791|NCT03959241|Tacrolimus|tacrolimus|mesh-list
1707792|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1707793|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
1707794|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707795|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1707796|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1707797|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
1707798|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707799|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1707800|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1707801|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1707802|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
1707803|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1707804|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1707805|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
1707806|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
1707807|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1707808|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1707809|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1707810|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1707811|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1707812|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1707813|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
1707814|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1707815|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1707970|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
1707971|NCT03882177|Pyridoxal|pyridoxal|mesh-list
1707972|NCT03882177|Pyridoxine|pyridoxine|mesh-list
1707973|NCT03882177|Pravastatin|pravastatin|mesh-list
1707974|NCT03882177|Vitamins|vitamins|mesh-ancestor
1707975|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
1707976|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707977|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
1707978|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1707979|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1707980|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
1707981|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1707982|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1707983|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1707984|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1707985|NCT03874897|Antibodies|antibodies|mesh-list
1707986|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1707987|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
1707988|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1707997|NCT03863184|Rituximab|rituximab|mesh-list
1707998|NCT03863184|Lenalidomide|lenalidomide|mesh-list
1707999|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
1708000|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1708001|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708002|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
1708003|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708004|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1708005|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1708006|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1708007|NCT03863184|Growth Substances|growth substances|mesh-ancestor
1708008|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
1708018|NCT03838744|Olaparib|olaparib|mesh-list
1708019|NCT03838744|Trabectedin|trabectedin|mesh-list
1708020|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1708021|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708022|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708023|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708024|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1708025|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
1708078|NCT03736629|Azithromycin|azithromycin|mesh-list
1708079|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1708080|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1708099|NCT03682770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1708100|NCT03682770|Immunologic Factors|immunologic factors|mesh-ancestor
1708101|NCT03682770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708131|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
1708132|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1708133|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
1708134|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1708135|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708136|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1708137|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1708138|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1708151|NCT03620669|Durvalumab|durvalumab|mesh-list
1708152|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1708153|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708157|NCT03600701|Atezolizumab|atezolizumab|mesh-list
1708158|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1708159|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708160|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
1708161|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708187|NCT03524898|Gemcitabine|gemcitabine|mesh-list
1708188|NCT03524898|Paclitaxel|paclitaxel|mesh-list
1708189|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1708190|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708191|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
1708192|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
1708193|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
1708194|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708195|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1708196|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
1708197|NCT03524898|Antiviral Agents|antiviral agents|mesh-ancestor
1708198|NCT03524898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1708199|NCT03524898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708200|NCT03524898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1708201|NCT03524898|Immunologic Factors|immunologic factors|mesh-ancestor
1708202|NCT03524898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708203|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
1708204|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
1708205|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
1708206|NCT03522753|Hormones|hormones|mesh-ancestor
1708207|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1708208|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708209|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1708210|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708265|NCT03459222|Nivolumab|nivolumab|mesh-list
1708266|NCT03459222|Ipilimumab|ipilimumab|mesh-list
1708267|NCT03459222|Linrodostat|linrodostat|mesh-list
1708268|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1708269|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708270|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1708271|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708272|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708273|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
1708274|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1708275|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708276|NCT03435939|Losartan|losartan|mesh-list
1708277|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1708278|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1708279|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1708280|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1708281|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708287|NCT03430791|Nivolumab|nivolumab|mesh-list
1708288|NCT03430791|Ipilimumab|ipilimumab|mesh-list
1708289|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1708290|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708291|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1708292|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708293|NCT03383224|Nicotine|nicotine|mesh-list
1708294|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1708295|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
1708296|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1708297|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708298|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1708299|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1708300|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
1708301|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1708302|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708342|NCT03244059|Belimumab|belimumab|mesh-list
1708343|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1708344|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
1708345|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708346|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
1708347|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708348|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
1708349|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1708350|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1708351|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708352|NCT03229512|Urological Agents|urological agents|mesh-ancestor
1708353|NCT03180502|Temozolomide|temozolomide|mesh-list
1708354|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1708355|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
1708356|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708357|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708361|NCT03164057|Cytarabine|cytarabine|mesh-list
1708362|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
1708363|NCT03164057|Methotrexate|methotrexate|mesh-list
1708364|NCT03164057|Azacitidine|azacitidine|mesh-list
1708365|NCT03164057|Decitabine|decitabine|mesh-list
1708366|NCT03164057|Fludarabine|fludarabine|mesh-list
1708367|NCT03164057|Etoposide|etoposide|mesh-list
1708368|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
1708369|NCT03164057|Sorafenib|sorafenib|mesh-list
1708370|NCT03164057|Daunorubicin|daunorubicin|mesh-list
1708371|NCT03164057|Asparaginase|asparaginase|mesh-list
1708372|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
1708373|NCT03164057|Idarubicin|idarubicin|mesh-list
1708374|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
1708375|NCT03164057|Razoxane|razoxane|mesh-list
1708376|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1708377|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
1708378|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1708379|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708380|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1708381|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
1708382|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708383|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708384|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
1708385|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708386|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1708387|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1708388|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
1708389|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1708390|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1708391|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1708392|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1708393|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1708394|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
1708395|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1708396|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1708397|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1708398|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1708399|NCT03164057|Analgesics|analgesics|mesh-ancestor
1708400|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
1708401|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1708402|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1708403|NCT03164057|Protective Agents|protective agents|mesh-ancestor
1708404|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
1708405|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
1708411|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1708412|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1708413|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
1708426|NCT03033914|Doxorubicin|doxorubicin|mesh-list
1708427|NCT03033914|Bleomycin|bleomycin|mesh-list
1708428|NCT03033914|Nivolumab|nivolumab|mesh-list
1708429|NCT03033914|Dacarbazine|dacarbazine|mesh-list
1708430|NCT03033914|Vinblastine|vinblastine|mesh-list
1708431|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1708432|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708433|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1708434|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1708435|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708436|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708437|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1708438|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1708439|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1708440|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
1708441|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1708442|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
1708443|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
1708444|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
1708445|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
1708446|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
1708447|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1708448|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1708449|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1708450|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708451|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708452|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1708457|NCT03023124|Doxorubicin|doxorubicin|mesh-list
1708458|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1708459|NCT03023124|Dacarbazine|dacarbazine|mesh-list
1708460|NCT03023124|Trabectedin|trabectedin|mesh-list
1708461|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1708462|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708463|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1708464|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1708465|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708466|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708467|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1708468|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
1708506|NCT02957968|Paclitaxel|paclitaxel|mesh-list
1708507|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
1708508|NCT02957968|Carboplatin|carboplatin|mesh-list
1708509|NCT02957968|Doxorubicin|doxorubicin|mesh-list
1708510|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
1708511|NCT02957968|Decitabine|decitabine|mesh-list
1708512|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1708513|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708514|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
1708515|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
1708516|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
1708517|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708518|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1708519|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
1708520|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708521|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1708522|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1708523|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
1708524|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1708525|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1708526|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1708527|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1708528|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708529|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1708530|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1708531|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
1708581|NCT02788591|Esomeprazole|esomeprazole|mesh-list
1708582|NCT02788591|Omeprazole|omeprazole|mesh-list
1708583|NCT02788591|Pantoprazole|pantoprazole|mesh-list
1708584|NCT02788591|Lansoprazole|lansoprazole|mesh-list
1708585|NCT02788591|Sucralfate|sucralfate|mesh-list
1708586|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
1708587|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1708588|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1708589|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708590|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708591|NCT02740985|Docetaxel|docetaxel|mesh-list
1708592|NCT02740985|Durvalumab|durvalumab|mesh-list
1708593|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
1708594|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708595|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
1708596|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
1708597|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
1708598|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708599|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1708600|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1708601|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708602|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
1708603|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1708604|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708605|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1708608|NCT02733614|SRX246|srx246|mesh-list
1708609|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1708610|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708611|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
1708612|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708613|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
1708614|NCT02727387|Temozolomide|temozolomide|mesh-list
1708615|NCT02727387|Melphalan|melphalan|mesh-list
1708616|NCT02727387|Busulfan|busulfan|mesh-list
1708617|NCT02727387|Ifosfamide|ifosfamide|mesh-list
1708618|NCT02727387|Irinotecan|irinotecan|mesh-list
1708619|NCT02727387|Etoposide|etoposide|mesh-list
1708620|NCT02727387|Vincristine|vincristine|mesh-list
1708621|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1708622|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
1708623|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708624|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1708625|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1708626|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
1708627|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708628|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708629|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1708630|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1708631|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1708632|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708633|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1708634|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1708635|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
1708636|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
1708637|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
1708640|NCT02683018|Dronabinol|dronabinol|mesh-list
1708641|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
1708642|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708643|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1708644|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1708645|NCT02683018|Analgesics|analgesics|mesh-ancestor
1708646|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
1708647|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1708648|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1708649|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1708650|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1708651|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708652|NCT02683018|Hormones|hormones|mesh-ancestor
1708653|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1708654|NCT02675842|Dronabinol|dronabinol|mesh-list
1708655|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
1708656|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708657|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1708658|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1708659|NCT02675842|Analgesics|analgesics|mesh-ancestor
1708660|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
1708661|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1708662|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1708663|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1708664|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1708665|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708666|NCT02675842|Hormones|hormones|mesh-ancestor
1708667|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1708668|NCT02615119|Isoproterenol|isoproterenol|mesh-list
1708669|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1708670|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1708671|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
1708672|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1708673|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708674|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708675|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1708676|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
1708677|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1708678|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1708679|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
1708680|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1708681|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
1708682|NCT02615119|Protective Agents|protective agents|mesh-ancestor
1708683|NCT02605486|Palbociclib|palbociclib|mesh-list
1708684|NCT02605486|Bicalutamide|bicalutamide|mesh-list
1708685|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708686|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1708687|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708688|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708689|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
1708690|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
1708691|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1708692|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708693|NCT02598349|Capecitabine|capecitabine|mesh-list
1708694|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1708695|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
1708696|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708697|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708701|NCT02574728|Sirolimus|sirolimus|mesh-list
1708702|NCT02574728|Celecoxib|celecoxib|mesh-list
1708703|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
1708704|NCT02574728|Etoposide|etoposide|mesh-list
1708705|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1708706|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
1708707|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708708|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1708709|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1708710|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
1708711|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708712|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708713|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1708714|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1708715|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1708716|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1708717|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1708718|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1708719|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1708720|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1708721|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
1708722|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1708723|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1708724|NCT02574728|Analgesics|analgesics|mesh-ancestor
1708725|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
1708726|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1708727|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1708728|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1708729|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1708733|NCT02555293|Rifaximin|rifaximin|mesh-list
1708734|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1708735|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1708736|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1708760|NCT02494921|Prednisone|prednisone|mesh-list
1708761|NCT02494921|Docetaxel|docetaxel|mesh-list
1708762|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708763|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
1708764|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
1708765|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
1708766|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708767|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1708768|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
1708769|NCT02494921|Hormones|hormones|mesh-ancestor
1708770|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1708771|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708772|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1708783|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
1708784|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
1708785|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1708786|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
1708787|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1708788|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1708789|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1708790|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
1708791|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1708792|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1708793|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1708794|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1710549|NCT05104255|Anesthetics|anesthetics|mesh-list
1710550|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1710551|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710552|NCT05104229|Aspirin|aspirin|mesh-list
1710553|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1710554|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1710555|NCT05104229|Analgesics|analgesics|mesh-ancestor
1710556|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
1710557|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1710558|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710559|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1710560|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1710561|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1710562|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1710563|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1710564|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1710565|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1710566|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1710567|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
1710568|NCT05104138|Eplerenone|eplerenone|mesh-list
1710569|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1710570|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
1710571|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1710572|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710573|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1710574|NCT05104138|Diuretics|diuretics|mesh-ancestor
1710575|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
1710576|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1710591|NCT05103904|Lenvatinib|lenvatinib|mesh-list
1710592|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1710593|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1710594|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1710595|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1710596|NCT05103813|Beraprost|beraprost|mesh-list
1710597|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1710598|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
1710612|NCT05103696|Propofol|propofol|mesh-list
1710613|NCT05103696|Etomidate|etomidate|mesh-list
1710614|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1710615|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1710763|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
1710616|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710617|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1710618|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
1710619|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
1710647|NCT05103501|Fluorouracil|fluorouracil|mesh-list
1710648|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
1710649|NCT05103501|Cisplatin|cisplatin|mesh-list
1710650|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1710651|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
1710652|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1710653|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1710654|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1710655|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1710656|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
1710657|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710658|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1710659|NCT05103410|Aripiprazole|aripiprazole|mesh-list
1710660|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
1710661|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1710662|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1710663|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1710664|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1710665|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710666|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
1710667|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
1710668|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1710669|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1710670|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1710671|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1710672|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
1710673|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1710674|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1710675|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1710676|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1710677|NCT05103397|Prednisolone|prednisolone|mesh-list
1710678|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1710679|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
1710680|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1710681|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
1710682|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1710683|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
1710684|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1710685|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
1710686|NCT05103397|Hormones|hormones|mesh-ancestor
1710687|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1710688|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710689|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1710690|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1710691|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
1710692|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
1710693|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1710694|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1710695|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1710696|NCT05103397|Protective Agents|protective agents|mesh-ancestor
1710726|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
1710727|NCT05103254|Ezetimibe|ezetimibe|mesh-list
1710728|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1710729|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1710730|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
1710731|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1710732|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1710733|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1710734|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1710735|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710736|NCT05103228|Menotropins|menotropins|mesh-list
1710737|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1710738|NCT05103228|Hormones|hormones|mesh-ancestor
1710739|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1710740|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710741|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1710742|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
1710743|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1710756|NCT05103098|Misoprostol|misoprostol|mesh-list
1710757|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1710758|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
1710759|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1710760|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710761|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1710762|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1710764|NCT05103020|Bevacizumab|bevacizumab|mesh-list
1710765|NCT05103020|Cetuximab|cetuximab|mesh-list
1710766|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
1710767|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1710768|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1710769|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1710770|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1710771|NCT05103020|Growth Substances|growth substances|mesh-ancestor
1710772|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710773|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
1710774|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
1710775|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1710776|NCT05103007|Estrogens|estrogens|mesh-ancestor
1710777|NCT05103007|Hormones|hormones|mesh-ancestor
1710778|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1710779|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710780|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1710781|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1710794|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
1710795|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1710796|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1710797|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1710798|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
1710799|NCT05092555|Coagulants|coagulants|mesh-ancestor
1710800|NCT05092451|Vidarabine|vidarabine|mesh-list
1710801|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
1710802|NCT05092451|Fludarabine|fludarabine|mesh-list
1710803|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
1710804|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1710805|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
1710806|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710807|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1710808|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1710809|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
1710810|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1710811|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1710812|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1710813|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1710814|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
1710815|NCT05092451|Antiviral Agents|antiviral agents|mesh-ancestor
1710816|NCT05092451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1710817|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
1710818|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1710819|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1710820|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1710821|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
1710822|NCT05087199|Coagulants|coagulants|mesh-ancestor
1710858|NCT05060666|Ivermectin|ivermectin|mesh-list
1710859|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1710860|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1710866|NCT05048134|Trametinib|trametinib|mesh-list
1710867|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1710868|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1710869|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1710870|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1710936|NCT05021900|Tenalisib|tenalisib|mesh-list
1710937|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
1710938|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1710939|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1710940|NCT05019846|Bicalutamide|bicalutamide|mesh-list
1710941|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1710942|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
1710943|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
1710944|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1710945|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1710946|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1710947|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
1710948|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1710949|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
1710950|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1710951|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1710952|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1711032|NCT04985851|Durvalumab|durvalumab|mesh-list
1711033|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1711034|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1711035|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1711036|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
1711037|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711038|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
1711039|NCT04976374|Gabapentin|gabapentin|mesh-list
1711040|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1711041|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1711042|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711043|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1711044|NCT04976374|Analgesics|analgesics|mesh-ancestor
1711045|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
1711046|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1711047|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1711048|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1711049|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1711050|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
1711051|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1711052|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711053|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
1711054|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1711055|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1711056|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1711057|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1711058|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1711059|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
1711096|NCT04949412|Vitamin D|vitamin d|mesh-list
1711097|NCT04949412|Vitamins|vitamins|mesh-ancestor
1711098|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
1711099|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711100|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1711101|NCT04947020|Metformin|metformin|mesh-list
1711102|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1711103|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711146|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
1711147|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
1711148|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
1711149|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
1711150|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711151|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1711152|NCT04929392|Paclitaxel|paclitaxel|mesh-list
1711153|NCT04929392|Carboplatin|carboplatin|mesh-list
1711154|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
1711155|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1711156|NCT04929392|Lenvatinib|lenvatinib|mesh-list
1711157|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1711158|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1711159|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
1711160|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
1711161|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
1711162|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711163|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1711164|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1711165|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1711174|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1711175|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1711176|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1711177|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711178|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1711179|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1711180|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711181|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
1711182|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1711183|NCT04904614|Letermovir|letermovir|mesh-list
1711184|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1711185|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1711186|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711187|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1711188|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
1711189|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1711267|NCT04874935|Lansoprazole|lansoprazole|mesh-list
1711268|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
1711269|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1711270|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1711271|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1711272|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1711273|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711288|NCT04834063|Selenium|selenium|mesh-list
1711289|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
1711290|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711291|NCT04834063|Protective Agents|protective agents|mesh-ancestor
1711292|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711293|NCT04834063|Trace Elements|trace elements|mesh-ancestor
1711294|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
1711301|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1711325|NCT04794205|Caryophyllene|caryophyllene|mesh-list
1711326|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1711327|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1711328|NCT04794205|Analgesics|analgesics|mesh-ancestor
1711329|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
1711330|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1711331|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711332|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1711333|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1711334|NCT04790474|Dexamethasone|dexamethasone|mesh-list
1711335|NCT04790474|Pomalidomide|pomalidomide|mesh-list
1711336|NCT04790474|Ixazomib|ixazomib|mesh-list
1711337|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1711338|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
1711339|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
1711340|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1711341|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711342|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1711343|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
1711344|NCT04790474|Hormones|hormones|mesh-ancestor
1711345|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1711346|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1711347|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1711348|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
1711349|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1711350|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1711351|NCT04790474|Growth Substances|growth substances|mesh-ancestor
1711352|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
1711353|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
1711354|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1711355|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711433|NCT04725032|Propofol|propofol|mesh-list
1711434|NCT04725032|Sevoflurane|sevoflurane|mesh-list
1711435|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1711436|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1711437|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711438|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1711439|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
1711440|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
1711441|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1711442|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1711447|NCT04716114|Cytarabine|cytarabine|mesh-list
1711448|NCT04716114|Fludarabine|fludarabine|mesh-list
1711449|NCT04716114|Azacitidine|azacitidine|mesh-list
1711450|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
1711451|NCT04716114|Aclarubicin|aclarubicin|mesh-list
1711452|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1711453|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1711454|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
1711455|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711456|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1711457|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
1711458|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711459|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
1711460|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1711461|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1711462|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1711463|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1711464|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1711465|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1711466|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1711467|NCT04701281|Capecitabine|capecitabine|mesh-list
1711468|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1711469|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
1711470|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711471|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1711504|NCT04677816|Vitamin D|vitamin d|mesh-list
1711505|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
1711506|NCT04677816|Vitamins|vitamins|mesh-ancestor
1711507|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
1711508|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711509|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1711510|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1711511|NCT04667780|Colchicine|colchicine|mesh-list
1711512|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
1711513|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1711514|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
1711515|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
1711516|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
1711517|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711518|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1711522|NCT04655222|Interferons|interferons|mesh-list
1711523|NCT04655222|Interferon-beta|interferon-beta|mesh-list
1711524|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1711525|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
1711526|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1711527|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
1711528|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711555|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
1711556|NCT04633148|Fludarabine|fludarabine|mesh-list
1711557|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1711558|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
1711559|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711560|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1711561|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1711562|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
1711563|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711564|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1711565|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1711566|NCT04620746|Penicillins|penicillins|mesh-list
1711567|NCT04620746|Penicillin G|penicillin g|mesh-list
1711568|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1711569|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1711644|NCT04552327|Diclofenac|diclofenac|mesh-list
1711645|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1711646|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1711647|NCT04552327|Analgesics|analgesics|mesh-ancestor
1711648|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
1711649|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1711650|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711651|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1711652|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1711653|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1711654|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1711655|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711735|NCT04519905|Paclitaxel|paclitaxel|mesh-list
1711736|NCT04519905|Carboplatin|carboplatin|mesh-list
1711737|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1711738|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1711739|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
1711740|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
1711741|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
1711742|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711777|NCT04482686|Vitamin D|vitamin d|mesh-list
1711778|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
1711779|NCT04482686|Vitamins|vitamins|mesh-list
1711780|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
1711781|NCT04482686|Zinc|zinc|mesh-list
1711782|NCT04482686|Doxycycline|doxycycline|mesh-list
1711783|NCT04482686|Ivermectin|ivermectin|mesh-list
1711784|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
1711785|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
1711786|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711787|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1711788|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1711789|NCT04482686|Trace Elements|trace elements|mesh-ancestor
1711790|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
1711791|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711792|NCT04482686|Protective Agents|protective agents|mesh-ancestor
1711793|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1711794|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1711795|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
1711796|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1711797|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1711798|NCT04482686|Astringents|astringents|mesh-ancestor
1711799|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
1711816|NCT04459286|Ritonavir|ritonavir|mesh-list
1711817|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1711818|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
1711819|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1711820|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1711821|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
1711822|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1711823|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711824|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1711825|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1711826|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
1711827|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1711828|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1711829|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1711830|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1711861|NCT04450407|Insulin|insulin|mesh-list
1711862|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1711863|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711945|NCT04423341|Cannabidiol|cannabidiol|mesh-list
1711946|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
1711967|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
1711968|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1711969|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
1711970|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1711971|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1711972|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1711973|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
1711974|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1711975|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1711976|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1712002|NCT04323462|Insulin|insulin|mesh-list
1712003|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1712004|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
1712005|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1712006|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712007|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
1712008|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
1712009|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712010|NCT04279535|Protective Agents|protective agents|mesh-ancestor
1712011|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712012|NCT04279535|Vitamins|vitamins|mesh-ancestor
1712013|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
1712014|NCT04255927|Triclosan|triclosan|mesh-list
1712015|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1712016|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1712017|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1712018|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1712019|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
1712020|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712021|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1712061|NCT04166669|Itraconazole|itraconazole|mesh-list
1712062|NCT04166669|Rifampin|rifampin|mesh-list
1712063|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
1712064|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1712065|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1712066|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1712067|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1712068|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712069|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1712070|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
1712071|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1712072|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712073|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1712074|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1712075|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
1712076|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1712077|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
1712078|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1712079|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1712080|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1712081|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1712082|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1712083|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1712084|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1712102|NCT04150770|Infliximab|infliximab|mesh-list
1712103|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
1712104|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1712105|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1712112|NCT04125771|Diclofenac|diclofenac|mesh-list
1712113|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1712114|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1712115|NCT04125771|Analgesics|analgesics|mesh-ancestor
1712116|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
1712117|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1712118|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712119|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1712120|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1712121|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1712122|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1712123|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712160|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
1712161|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
1712162|NCT04026438|Protective Agents|protective agents|mesh-ancestor
1712163|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712178|NCT03983993|Panitumumab|panitumumab|mesh-list
1712179|NCT03983993|Niraparib|niraparib|mesh-list
1712180|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1712181|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712182|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1712183|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1712184|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712185|NCT03964532|Avelumab|avelumab|mesh-list
1712186|NCT03964532|Talazoparib|talazoparib|mesh-list
1712187|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1712188|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712189|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1712190|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1712191|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712192|NCT03961971|Spartalizumab|spartalizumab|mesh-list
1712193|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1712194|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712195|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712223|NCT03943147|Mycophenolic Acid|mycophenolic acid|mesh-list
1712224|NCT03943147|BMS-986165|bms-986165|mesh-list
1712225|NCT03943147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1712226|NCT03943147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712227|NCT03943147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1712228|NCT03943147|Antitubercular Agents|antitubercular agents|mesh-ancestor
1712229|NCT03943147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1712230|NCT03943147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1712231|NCT03943147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1712232|NCT03943147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712233|NCT03943147|Dermatologic Agents|dermatologic agents|mesh-ancestor
1712234|NCT03943147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1712293|NCT03897998|Naloxone|naloxone|mesh-list
1712294|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1712295|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712296|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
1712297|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1712304|NCT03864406|Darunavir|darunavir|mesh-list
1712305|NCT03864406|Cobicistat|cobicistat|mesh-list
1712306|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
1712307|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
1712308|NCT03864406|Apixaban|apixaban|mesh-list
1712309|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1712310|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
1712311|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1712312|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
1712313|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1712314|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712315|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
1712316|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1712317|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1712318|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1712319|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1712320|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
1712321|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1712322|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1712323|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1712353|NCT03765359|Metformin|metformin|mesh-list
1712354|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1712355|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712356|NCT03759041|Vancomycin|vancomycin|mesh-list
1712357|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1712358|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1712391|NCT03711604|Tenalisib|tenalisib|mesh-list
1712392|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
1712393|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1712394|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712435|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
1712436|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1712437|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1712438|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712439|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1712440|NCT03645603|Analgesics|analgesics|mesh-ancestor
1712441|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
1712442|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1712443|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1712444|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1712445|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1712446|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
1712447|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1712448|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712449|NCT03634228|Cytarabine|cytarabine|mesh-list
1712450|NCT03634228|Venetoclax|venetoclax|mesh-list
1712451|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1712452|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
1712453|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712454|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712455|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
1712456|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1712457|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1712458|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
1712459|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712463|NCT03615742|Budesonide|budesonide|mesh-list
1712464|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1712465|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1712466|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
1712467|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1712468|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712469|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1712470|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
1712471|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
1712472|NCT03615742|Hormones|hormones|mesh-ancestor
1712473|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1712490|NCT03587584|Bupivacaine|bupivacaine|mesh-list
1712491|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
1712492|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
1712493|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1712494|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712495|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
1712496|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1712519|NCT03581487|Durvalumab|durvalumab|mesh-list
1712520|NCT03581487|Ipilimumab|ipilimumab|mesh-list
1712521|NCT03581487|Tremelimumab|tremelimumab|mesh-list
1712522|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
1712523|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1712524|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
1712525|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1712526|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712527|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
1712528|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712529|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1712530|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712537|NCT03542695|Alendronate|alendronate|mesh-list
1712538|NCT03542695|Copper|copper|mesh-list
1712539|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1712540|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712541|NCT03542695|Trace Elements|trace elements|mesh-ancestor
1712542|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
1712543|NCT03521102|Acetaminophen|acetaminophen|mesh-list
1712544|NCT03521102|Hydromorphone|hydromorphone|mesh-list
1712545|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1712546|NCT03521102|Analgesics|analgesics|mesh-ancestor
1712547|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
1712548|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1712549|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712550|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
1712551|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1712552|NCT03521102|Narcotics|narcotics|mesh-ancestor
1712553|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1712554|NCT03481634|Aflibercept|aflibercept|mesh-list
1712555|NCT03481634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1712556|NCT03481634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1712557|NCT03481634|Growth Substances|growth substances|mesh-ancestor
1712558|NCT03481634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712559|NCT03481634|Growth Inhibitors|growth inhibitors|mesh-ancestor
1712560|NCT03481634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712619|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
1712620|NCT03414502|Minocycline|minocycline|mesh-list
1712621|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
1712622|NCT03414502|Adalimumab|adalimumab|mesh-list
1712623|NCT03414502|Etanercept|etanercept|mesh-list
1712624|NCT03414502|Golimumab|golimumab|mesh-list
1712625|NCT03414502|Rituximab|rituximab|mesh-list
1712626|NCT03414502|Methotrexate|methotrexate|mesh-list
1712627|NCT03414502|Abatacept|abatacept|mesh-list
1712628|NCT03414502|Azathioprine|azathioprine|mesh-list
1712629|NCT03414502|Infliximab|infliximab|mesh-list
1712630|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
1712631|NCT03414502|Leflunomide|leflunomide|mesh-list
1712632|NCT03414502|Tofacitinib|tofacitinib|mesh-list
1712633|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1712634|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712635|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
1712636|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712637|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1712638|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1712639|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
1712640|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1712641|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1712642|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
1712643|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712644|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
1712645|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1712646|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1712647|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1712648|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1712649|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1712650|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
1712651|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1712652|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1712653|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1712654|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1712655|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1712656|NCT03414502|Analgesics|analgesics|mesh-ancestor
1712657|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
1712658|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1712659|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1712660|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1712661|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1712662|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1712663|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1712707|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
1712708|NCT03266783|Apixaban|apixaban|mesh-list
1712709|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1712710|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
1712711|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1712712|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
1712713|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1712714|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712715|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
1712716|NCT03246828|Gliclazide|gliclazide|mesh-list
1712717|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1712718|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712719|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
1712720|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
1712721|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1712722|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1712723|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1712724|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712725|NCT03199612|Urological Agents|urological agents|mesh-ancestor
1712726|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
1712727|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1712728|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1712729|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712730|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
1712731|NCT03182751|Coagulants|coagulants|mesh-ancestor
1712740|NCT03113643|Azacitidine|azacitidine|mesh-list
1712741|NCT03113643|Venetoclax|venetoclax|mesh-list
1712742|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1712743|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
1712744|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712745|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712746|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1712769|NCT03055013|Nivolumab|nivolumab|mesh-list
1712770|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1712771|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712772|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1712773|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712774|NCT03054519|Metformin|metformin|mesh-list
1712775|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1712776|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712788|NCT02943733|Temozolomide|temozolomide|mesh-list
1712789|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1712790|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
1712791|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712792|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712828|NCT02876302|Paclitaxel|paclitaxel|mesh-list
1712829|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
1712830|NCT02876302|Doxorubicin|doxorubicin|mesh-list
1712831|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1712832|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712833|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
1712834|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
1712835|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
1712836|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712837|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1712838|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
1712839|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712840|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1712841|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1712842|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
1712843|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1712844|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1712845|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1712846|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1712847|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1712851|NCT02850263|Bevacizumab|bevacizumab|mesh-list
1712852|NCT02850263|Aflibercept|aflibercept|mesh-list
1712853|NCT02850263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1712854|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712855|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1712856|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1712857|NCT02850263|Growth Substances|growth substances|mesh-ancestor
1712858|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1712859|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
1712898|NCT02668770|Ipilimumab|ipilimumab|mesh-list
1712899|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1712900|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1712901|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1712902|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712918|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
1712919|NCT02559856|Apixaban|apixaban|mesh-list
1712920|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1712921|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
1712922|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1712923|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
1712924|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1712925|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1712926|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
1713010|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
1713011|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1713012|NCT02427451|Venetoclax|venetoclax|mesh-list
1713013|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
1713014|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1713015|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1713016|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
1713017|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1713018|NCT02398240|Rituximab|rituximab|mesh-list
1713019|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1713020|NCT02398240|Doxorubicin|doxorubicin|mesh-list
1713021|NCT02398240|Vincristine|vincristine|mesh-list
1713022|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1713023|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1713024|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
1713025|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1713026|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1713027|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1713028|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1713029|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1713030|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1713031|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1713032|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1713033|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
1713034|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
1713035|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
1713061|NCT02330562|Bevacizumab|bevacizumab|mesh-list
1713062|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1713063|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1713064|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1713065|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1713066|NCT02330562|Growth Substances|growth substances|mesh-ancestor
1713067|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1713068|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
1713768|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
1713769|NCT05106517|Denosumab|denosumab|mesh-list
1713770|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1713771|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1713772|NCT05106400|Lidocaine|lidocaine|mesh-list
1713773|NCT05106400|Menthol|menthol|mesh-list
1713774|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
1713775|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
1713776|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1713777|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1713778|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
1713779|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1713780|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1713781|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1713782|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1713783|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1713784|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1713785|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
1713786|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
1713793|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
1713794|NCT05106296|Etoposide|etoposide|mesh-list
1713795|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1713796|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
1713797|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1713798|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1713799|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1713800|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
1713801|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1713802|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1713803|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1713804|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1713805|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1713806|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1713807|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1713827|NCT05106179|Propranolol|propranolol|mesh-list
1713828|NCT05106179|Atenolol|atenolol|mesh-list
1713829|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1713830|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1713831|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
1713832|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1713833|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1713834|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1713835|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1713836|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1713837|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
1713838|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
1713839|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
1713840|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1713841|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1713854|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
1713855|NCT05106127|Lenvatinib|lenvatinib|mesh-list
1713856|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1713857|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1713858|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1713859|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1713860|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1713861|NCT05106023|Temozolomide|temozolomide|mesh-list
1713862|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1713863|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
1713864|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1713865|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1713866|NCT05105997|Dexamethasone|dexamethasone|mesh-list
1713867|NCT05105997|Bupivacaine|bupivacaine|mesh-list
1713868|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1713869|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
1713870|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
1713871|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1713872|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1713873|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1713874|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
1713875|NCT05105997|Hormones|hormones|mesh-ancestor
1713876|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1713877|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1713878|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1713879|NCT05105997|Anesthetics, Local|anesthetics, local|mesh-ancestor
1713880|NCT05105997|Anesthetics|anesthetics|mesh-ancestor
1713881|NCT05105997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1713882|NCT05105997|Sensory System Agents|sensory system agents|mesh-ancestor
1713920|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
1713921|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
1713922|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
1713923|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1713924|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1713925|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1713926|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
1713927|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1713938|NCT05105412|Gemcitabine|gemcitabine|mesh-list
1713939|NCT05105412|Lenalidomide|lenalidomide|mesh-list
1713940|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1713941|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
1713942|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1713943|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1713944|NCT05105412|Antiviral Agents|antiviral agents|mesh-ancestor
1713945|NCT05105412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1713946|NCT05105412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1713947|NCT05105412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1713948|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
1713949|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1713950|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1713951|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1713952|NCT05105412|Growth Substances|growth substances|mesh-ancestor
1713953|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
1713954|NCT05105347|Prednisone|prednisone|mesh-list
1713955|NCT05105347|Adalimumab|adalimumab|mesh-list
1713956|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1713957|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
1713958|NCT05105347|Hormones|hormones|mesh-ancestor
1713959|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1713960|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1713961|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1713962|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1713963|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1713970|NCT05105256|Prednisolone|prednisolone|mesh-list
1713971|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1713972|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
1713973|NCT05105256|Hormones|hormones|mesh-ancestor
1713974|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1713975|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1713976|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1713977|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1713990|NCT05105074|Morphine|morphine|mesh-list
1713991|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1713992|NCT05105074|Narcotics|narcotics|mesh-ancestor
1713993|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1713994|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1713995|NCT05105074|Analgesics|analgesics|mesh-ancestor
1713996|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
1713997|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1713998|NCT05105061|Ketamine|ketamine|mesh-list
1713999|NCT05105061|Analgesics|analgesics|mesh-ancestor
1714000|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
1714001|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1714002|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714003|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1714004|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1714005|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
1714006|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
1714007|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1714008|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1714009|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1714010|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1714011|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714012|NCT05105035|Meropenem|meropenem|mesh-list
1714013|NCT05105035|Ceftazidime|ceftazidime|mesh-list
1714014|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1714015|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1714016|NCT05105022|Propofol|propofol|mesh-list
1714017|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1714018|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1714019|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714020|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1714021|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
1714022|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
1714023|NCT05105009|Furosemide|furosemide|mesh-list
1714024|NCT05105009|Diuretics|diuretics|mesh-ancestor
1714025|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
1714026|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714027|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1714028|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1714029|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714045|NCT05104931|Piroxicam|piroxicam|mesh-list
1714046|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1714047|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1714048|NCT05104931|Analgesics|analgesics|mesh-ancestor
1714049|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
1714050|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1714051|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714052|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1714053|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1714054|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1714055|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1714056|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714094|NCT05104788|Carboplatin|carboplatin|mesh-list
1714095|NCT05104788|Pemetrexed|pemetrexed|mesh-list
1714096|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714097|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1714098|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714099|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1714100|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1714101|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
1714102|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1714103|NCT05104762|Antibodies|antibodies|mesh-list
1714104|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
1714105|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1714106|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
1714107|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714123|NCT05104437|Vaccines|vaccines|mesh-list
1714124|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
1714125|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714126|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
1714127|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1714128|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714129|NCT05104333|Vaccines|vaccines|mesh-list
1714130|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
1714131|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714132|NCT05104281|Osimertinib|osimertinib|mesh-list
1714133|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714134|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1714135|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1714136|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714154|NCT05087732|Lidocaine|lidocaine|mesh-list
1714155|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
1714156|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
1714157|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1714158|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714159|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
1714160|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1714161|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1714162|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1714163|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1714164|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1714165|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714223|NCT05076786|Carboplatin|carboplatin|mesh-list
1714224|NCT05076786|Etoposide|etoposide|mesh-list
1714225|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714226|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1714227|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1714228|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1714229|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1714230|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714231|NCT05068752|Sorafenib|sorafenib|mesh-list
1714232|NCT05068752|Vemurafenib|vemurafenib|mesh-list
1714233|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714234|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1714235|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1714236|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714250|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1714251|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
1714252|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1714309|NCT05023967|Metformin|metformin|mesh-list
1714310|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1714311|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714330|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
1714331|NCT05012735|Provitamins|provitamins|mesh-list
1714332|NCT05012735|Vitamins|vitamins|mesh-ancestor
1714333|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
1714334|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714335|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
1714342|NCT05004987|Dexetimide|dexetimide|mesh-list
1714343|NCT05004987|Citalopram|citalopram|mesh-list
1714344|NCT05004987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1714345|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1714346|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1714347|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714348|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1714349|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
1714350|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714351|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1714352|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
1714353|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1714354|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1714355|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1714356|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
1714357|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
1714358|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1714359|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1714360|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1714361|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
1714373|NCT04999215|Choline|choline|mesh-list
1714374|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
1714375|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1714376|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
1714377|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714378|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1714379|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1714380|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
1714398|NCT04978428|Cannabidiol|cannabidiol|mesh-list
1714399|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
1714403|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
1714404|NCT04955743|Lenvatinib|lenvatinib|mesh-list
1714405|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1714406|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714407|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1714408|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1714409|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714417|NCT04941443|Ibuprofen|ibuprofen|mesh-list
1714418|NCT04941443|Methadone|methadone|mesh-list
1714419|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1714420|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1714421|NCT04941443|Analgesics|analgesics|mesh-ancestor
1714422|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
1714423|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1714424|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714425|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1714426|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1714427|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1714428|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1714429|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714430|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1714431|NCT04941443|Narcotics|narcotics|mesh-ancestor
1714432|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1714433|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
1714434|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
1714500|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
1714501|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1714502|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714564|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
1714565|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1714566|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1714567|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
1714568|NCT04893148|Dulaglutide|dulaglutide|mesh-list
1714569|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1714570|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714581|NCT04887792|Acetazolamide|acetazolamide|mesh-list
1714582|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
1714583|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1714584|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1714585|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714586|NCT04887792|Diuretics|diuretics|mesh-ancestor
1714587|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
1714588|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714589|NCT04884763|Erenumab|erenumab|mesh-list
1714590|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1714591|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714592|NCT04884763|Analgesics|analgesics|mesh-ancestor
1714593|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
1714594|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1714595|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714596|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
1714597|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
1714598|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
1714599|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1714600|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714601|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
1714602|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1714603|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
1714604|NCT04849364|Capecitabine|capecitabine|mesh-list
1714605|NCT04849364|Atezolizumab|atezolizumab|mesh-list
1714606|NCT04849364|Talazoparib|talazoparib|mesh-list
1714607|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1714608|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
1714609|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714610|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714611|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1714612|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1714613|NCT04847596|Ofatumumab|ofatumumab|mesh-list
1714614|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714654|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
1714655|NCT04813016|Tramadol|tramadol|mesh-list
1714656|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1714657|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1714658|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714659|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1714660|NCT04813016|Analgesics|analgesics|mesh-ancestor
1714661|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
1714662|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1714663|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1714664|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1714665|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1714666|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
1714667|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1714668|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714669|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1714670|NCT04813016|Narcotics|narcotics|mesh-ancestor
1714671|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
1714672|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1714673|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714720|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1714721|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1714722|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1714723|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
1714724|NCT04777422|Defibrotide|defibrotide|mesh-list
1714725|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1714726|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1714727|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714728|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1714787|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
1714788|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1714789|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714797|NCT04731844|Curcumin|curcumin|mesh-list
1714798|NCT04731844|Piperine|piperine|mesh-list
1714799|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1714800|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1714801|NCT04731844|Analgesics|analgesics|mesh-ancestor
1714802|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
1714803|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1714804|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714805|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1714806|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1714807|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714808|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1714809|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714810|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1714846|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
1714847|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1714848|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714849|NCT04681105|Acetaminophen|acetaminophen|mesh-list
1714850|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
1714851|NCT04681105|Promethazine|promethazine|mesh-list
1714852|NCT04681105|Dexamethasone|dexamethasone|mesh-list
1714853|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
1714854|NCT04681105|Ibuprofen|ibuprofen|mesh-list
1714855|NCT04681105|Ranitidine|ranitidine|mesh-list
1714856|NCT04681105|Antibodies|antibodies|mesh-list
1714857|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
1714858|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
1714859|NCT04681105|BB 1101|bb 1101|mesh-list
1714860|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
1714861|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714862|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1714863|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
1714864|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
1714865|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1714866|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1714867|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
1714868|NCT04681105|Hormones|hormones|mesh-ancestor
1714869|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1714870|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1714871|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714872|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
1714873|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1714874|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714875|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1714876|NCT04681105|Analgesics|analgesics|mesh-ancestor
1714877|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
1714878|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
1714879|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1714880|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1714881|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1714882|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1714883|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1714884|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1714885|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
1714886|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
1714887|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1714888|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
1714889|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
1714890|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1714891|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1714892|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
1714893|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
1714894|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1714895|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1714896|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1714897|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1714898|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714899|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1714900|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
1714901|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714902|NCT04663347|Gemcitabine|gemcitabine|mesh-list
1714903|NCT04663347|Cytarabine|cytarabine|mesh-list
1714904|NCT04663347|Dexamethasone|dexamethasone|mesh-list
1714905|NCT04663347|Prednisone|prednisone|mesh-list
1714906|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
1714907|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1714908|NCT04663347|Rituximab|rituximab|mesh-list
1714909|NCT04663347|Carboplatin|carboplatin|mesh-list
1714910|NCT04663347|Doxorubicin|doxorubicin|mesh-list
1714911|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
1714912|NCT04663347|Vincristine|vincristine|mesh-list
1714913|NCT04663347|Lenalidomide|lenalidomide|mesh-list
1714914|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1714915|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
1714916|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1714917|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1714918|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1714919|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
1714920|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1714921|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1714922|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1714923|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1714924|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
1714925|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
1714926|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1714927|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1714928|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
1714929|NCT04663347|Hormones|hormones|mesh-ancestor
1714930|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1714931|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1714932|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1714933|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1714934|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
1714935|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
1714936|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1714937|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1714938|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1714939|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1714940|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1714941|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1714942|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
1714943|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
1714944|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
1714945|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1714946|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1714947|NCT04663347|Growth Substances|growth substances|mesh-ancestor
1714948|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
1715002|NCT04642950|Sargramostim|sargramostim|mesh-list
1715003|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
1715004|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715094|NCT04593914|Protective Agents|protective agents|mesh-list
1715095|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715101|NCT04578015|Metronidazole|metronidazole|mesh-list
1715102|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1715103|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1715104|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1715105|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1715106|NCT04573504|Clindamycin|clindamycin|mesh-list
1715107|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
1715108|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
1715109|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1715110|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1715111|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1715112|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1715113|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1715114|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715115|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1715116|NCT04570644|Ibuprofen|ibuprofen|mesh-list
1715117|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
1715118|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1715119|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1715120|NCT04570644|Analgesics|analgesics|mesh-ancestor
1715121|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
1715122|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1715123|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715124|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1715125|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1715126|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1715127|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1715128|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715129|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
1715130|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
1715131|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1715132|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
1715186|NCT04546230|Anesthetics|anesthetics|mesh-list
1715187|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1715188|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715252|NCT04528667|Abivertinib|abivertinib|mesh-list
1715253|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1715254|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715255|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1715256|NCT04525014|Irinotecan|irinotecan|mesh-list
1715257|NCT04525014|Temozolomide|temozolomide|mesh-list
1715258|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1715259|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1715260|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1715261|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715262|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1715263|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1715264|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
1715288|NCT04495257|Nivolumab|nivolumab|mesh-list
1715289|NCT04495257|Ipilimumab|ipilimumab|mesh-list
1715290|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1715291|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1715292|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1715293|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715312|NCT04468776|Zolpidem|zolpidem|mesh-list
1715313|NCT04468776|Trazodone|trazodone|mesh-list
1715314|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1715315|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1715316|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1715317|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715318|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1715319|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
1715320|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
1715321|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1715322|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715323|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1715324|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1715325|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1715326|NCT04468776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1715327|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1715328|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1715329|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
1715330|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1715331|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
1715332|NCT04459611|Paclitaxel|paclitaxel|mesh-list
1715333|NCT04459611|Carboplatin|carboplatin|mesh-list
1715334|NCT04459611|Pemetrexed|pemetrexed|mesh-list
1715335|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1715336|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1715337|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1715338|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
1715339|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
1715340|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
1715494|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1715341|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715342|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1715343|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1715344|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1715369|NCT04440007|Abivertinib|abivertinib|mesh-list
1715370|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1715371|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715372|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1715373|NCT04434001|Thrombin|thrombin|mesh-list
1715374|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
1715375|NCT04434001|Coagulants|coagulants|mesh-ancestor
1715380|NCT04426591|Biotin|biotin|mesh-list
1715381|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
1715382|NCT04426591|Vitamins|vitamins|mesh-ancestor
1715383|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
1715384|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715390|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1715391|NCT04401553|Vancomycin|vancomycin|mesh-list
1715392|NCT04401553|Cephalosporins|cephalosporins|mesh-list
1715393|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1715406|NCT04374240|Tretazicar|tretazicar|mesh-list
1715407|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1715462|NCT04280328|Daratumumab|daratumumab|mesh-list
1715463|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1715471|NCT04239222|Ibuprofen|ibuprofen|mesh-list
1715472|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1715473|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1715474|NCT04239222|Analgesics|analgesics|mesh-ancestor
1715475|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
1715476|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1715477|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715478|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1715479|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1715480|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1715481|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1715482|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715486|NCT04230746|Trimethoprim|trimethoprim|mesh-list
1715487|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1715488|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
1715489|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1715490|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1715491|NCT04230746|Renal Agents|renal agents|mesh-ancestor
1715492|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
1715493|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1715495|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1715496|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1715497|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715498|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1715499|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1715500|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1715501|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1715512|NCT04201834|Risperidone|risperidone|mesh-list
1715513|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1715514|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
1715515|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1715516|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715517|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715518|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1715519|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1715520|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1715521|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1715522|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1715523|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
1715528|NCT04194775|Lenvatinib|lenvatinib|mesh-list
1715529|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1715530|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1715531|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1715532|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715562|NCT04147013|Celecoxib|celecoxib|mesh-list
1715563|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1715564|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1715565|NCT04147013|Analgesics|analgesics|mesh-ancestor
1715566|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
1715567|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1715568|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715569|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1715570|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1715571|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1715572|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1715573|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1715574|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715575|NCT04141644|Ipilimumab|ipilimumab|mesh-list
1715576|NCT04141644|Osimertinib|osimertinib|mesh-list
1715577|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1715578|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1715579|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1715580|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715581|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1715582|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1715630|NCT04115384|Insulin|insulin|mesh-list
1715631|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1715632|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1715633|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715634|NCT04104139|Trifluridine|trifluridine|mesh-list
1715635|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
1715636|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715637|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
1715638|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1715668|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
1715669|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
1715670|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715671|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1715672|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
1715673|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1715674|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715675|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1715676|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1715677|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1715678|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
1715681|NCT04058756|Spartalizumab|spartalizumab|mesh-list
1715682|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1715683|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715684|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1715722|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
1715723|NCT04025216|Fludarabine|fludarabine|mesh-list
1715724|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1715725|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
1715726|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715727|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1715728|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1715729|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
1715730|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715731|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1715732|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1715742|NCT03991741|Interleukin-2|interleukin-2|mesh-list
1715743|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1715744|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1715745|NCT03991741|Analgesics|analgesics|mesh-ancestor
1715746|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
1715747|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1715748|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715951|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
1715899|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1715900|NCT03903692|Laxatives|laxatives|mesh-ancestor
1715901|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1715936|NCT03781817|Ketamine|ketamine|mesh-list
1715937|NCT03781817|Analgesics|analgesics|mesh-ancestor
1715938|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
1715939|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1715940|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715941|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1715942|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1715943|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
1715944|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
1715945|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1715946|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1715947|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1715948|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1715949|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715950|NCT03777982|Prednisone|prednisone|mesh-list
1715952|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1715953|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
1715954|NCT03777982|Hormones|hormones|mesh-ancestor
1715955|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1715956|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1715957|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1715958|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1715959|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1715960|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1715961|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715962|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
1715963|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1715984|NCT03769688|Metronidazole|metronidazole|mesh-list
1715985|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1715986|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1715987|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1715988|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1715989|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
1715990|NCT03760575|Pemetrexed|pemetrexed|mesh-list
1715991|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1715992|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1715993|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1715994|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1715995|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1715996|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1715997|NCT03751709|Blinatumomab|blinatumomab|mesh-list
1715998|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1715999|NCT03748953|Ixazomib|ixazomib|mesh-list
1716000|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716001|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
1716002|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716003|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716004|NCT03748810|Metformin|metformin|mesh-list
1716005|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
1716006|NCT03748810|Empagliflozin|empagliflozin|mesh-list
1716007|NCT03748810|Glimepiride|glimepiride|mesh-list
1716008|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
1716009|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1716010|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1716011|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1716012|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716013|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1716014|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1716015|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
1716016|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
1716017|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716043|NCT03726879|Paclitaxel|paclitaxel|mesh-list
1716044|NCT03726879|Maytansine|maytansine|mesh-list
1716045|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1716046|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
1716047|NCT03726879|Doxorubicin|doxorubicin|mesh-list
1716048|NCT03726879|Trastuzumab|trastuzumab|mesh-list
1716049|NCT03726879|Atezolizumab|atezolizumab|mesh-list
1716050|NCT03726879|Pertuzumab|pertuzumab|mesh-list
1716051|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1716052|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716053|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
1716054|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
1716055|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
1716056|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716057|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1716058|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
1716059|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1716060|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1716061|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1716062|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
1716063|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1716064|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1716065|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1716066|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1716067|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716068|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1716091|NCT03691311|Denosumab|denosumab|mesh-list
1716092|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1716093|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1716094|NCT03690453|Ivermectin|ivermectin|mesh-list
1716095|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1716096|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1716119|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
1716120|NCT03650764|Ramucirumab|ramucirumab|mesh-list
1716121|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1716122|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716138|NCT03620643|Fulvestrant|fulvestrant|mesh-list
1716139|NCT03620643|Crizotinib|crizotinib|mesh-list
1716140|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1716141|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716142|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1716143|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1716144|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
1716145|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1716146|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1716147|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1716148|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716149|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716166|NCT03593655|Tenofovir|tenofovir|mesh-list
1716167|NCT03593655|Emtricitabine|emtricitabine|mesh-list
1716168|NCT03593655|Dapivirine|dapivirine|mesh-list
1716169|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
1716170|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1716171|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1716172|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1716173|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716174|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716175|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1716176|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1716199|NCT03582774|Edetic Acid|edetic acid|mesh-list
1716200|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1716201|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
1716202|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
1716203|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716204|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
1716205|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1716206|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1716207|NCT03572413|Bromides|bromides|mesh-list
1716208|NCT03572413|Rocuronium|rocuronium|mesh-list
1716209|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
1716210|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1716211|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1716212|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1716213|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1716214|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1716240|NCT03533946|Rucaparib|rucaparib|mesh-list
1716241|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1716242|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716243|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716244|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716280|NCT03500484|Liraglutide|liraglutide|mesh-list
1716281|NCT03500484|Glucagon|glucagon|mesh-list
1716282|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
1716283|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1716284|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1716285|NCT03500484|Incretins|incretins|mesh-ancestor
1716286|NCT03500484|Hormones|hormones|mesh-ancestor
1716287|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1716288|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1716289|NCT03496662|Gemcitabine|gemcitabine|mesh-list
1716290|NCT03496662|Paclitaxel|paclitaxel|mesh-list
1716291|NCT03496662|Nivolumab|nivolumab|mesh-list
1716292|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1716293|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716294|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
1716295|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
1716296|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
1716297|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716298|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1716299|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
1716300|NCT03496662|Antiviral Agents|antiviral agents|mesh-ancestor
1716301|NCT03496662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1716302|NCT03496662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716303|NCT03496662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1716304|NCT03496662|Immunologic Factors|immunologic factors|mesh-ancestor
1716305|NCT03496662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1716306|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1716307|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1716359|NCT03425201|Niraparib|niraparib|mesh-list
1716360|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1716361|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716362|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716363|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716364|NCT03416244|Nivolumab|nivolumab|mesh-list
1716365|NCT03416244|Ipilimumab|ipilimumab|mesh-list
1716366|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1716367|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716368|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1716369|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716373|NCT03386578|Tenofovir|tenofovir|mesh-list
1716374|NCT03386578|Emtricitabine|emtricitabine|mesh-list
1716375|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1716376|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
1716377|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1716378|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1716379|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1716380|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716381|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716382|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1716383|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1716415|NCT03349281|Cytarabine|cytarabine|mesh-list
1716416|NCT03349281|Dexamethasone|dexamethasone|mesh-list
1716417|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
1716418|NCT03349281|Doxorubicin|doxorubicin|mesh-list
1716419|NCT03349281|Methotrexate|methotrexate|mesh-list
1716420|NCT03349281|Vincristine|vincristine|mesh-list
1716421|NCT03349281|Asparaginase|asparaginase|mesh-list
1716422|NCT03349281|Pegaspargase|pegaspargase|mesh-list
1716423|NCT03349281|Pevonedistat|pevonedistat|mesh-list
1716424|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1716425|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
1716426|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
1716427|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1716428|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1716429|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1716430|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
1716431|NCT03349281|Hormones|hormones|mesh-ancestor
1716432|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1716433|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1716434|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716435|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1716436|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1716437|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1716438|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716439|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716440|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1716441|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
1716442|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1716443|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1716444|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
1716445|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
1716446|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1716447|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1716448|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
1716449|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1716450|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1716451|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
1716452|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1716453|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1716454|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
1716455|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
1716456|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
1716513|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
1716514|NCT03299088|Trametinib|trametinib|mesh-list
1716515|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1716516|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716517|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1716518|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716519|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716520|NCT03292666|Warfarin|warfarin|mesh-list
1716521|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
1716522|NCT03292666|Dabigatran|dabigatran|mesh-list
1716523|NCT03292666|Apixaban|apixaban|mesh-list
1716524|NCT03292666|Edoxaban|edoxaban|mesh-list
1716525|NCT03292666|Anticoagulants|anticoagulants|mesh-list
1716526|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1716527|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
1716528|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1716529|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
1716530|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716531|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716539|NCT03286842|Olaparib|olaparib|mesh-list
1716540|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1716541|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716542|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716543|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716544|NCT03283605|Durvalumab|durvalumab|mesh-list
1716545|NCT03283605|Tremelimumab|tremelimumab|mesh-list
1716546|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1716547|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716563|NCT03262779|Nivolumab|nivolumab|mesh-list
1716564|NCT03262779|Ipilimumab|ipilimumab|mesh-list
1716565|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1716566|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716567|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1716568|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716577|NCT03236428|Daratumumab|daratumumab|mesh-list
1716578|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716586|NCT03219775|Nivolumab|nivolumab|mesh-list
1716587|NCT03219775|Ipilimumab|ipilimumab|mesh-list
1716588|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1716589|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716590|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1716591|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716642|NCT03164564|Tenofovir|tenofovir|mesh-list
1716643|NCT03164564|Emtricitabine|emtricitabine|mesh-list
1716644|NCT03164564|Cabotegravir|cabotegravir|mesh-list
1716645|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
1716646|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1716647|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1716648|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1716649|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716650|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716651|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1716652|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1716653|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1716654|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1716673|NCT03143270|Nivolumab|nivolumab|mesh-list
1716674|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1716675|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716676|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1716677|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716678|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
1716679|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
1716680|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1716681|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1716682|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1716683|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716684|NCT03142568|Urological Agents|urological agents|mesh-ancestor
1716700|NCT03100045|Artesunate|artesunate|mesh-list
1716701|NCT03100045|Artemisinins|artemisinins|mesh-list
1716702|NCT03100045|Artemisinin|artemisinin|mesh-list
1716703|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
1716704|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1716705|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1716706|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1716707|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716708|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
1716709|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
1716710|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1716711|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
1716898|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
1716899|NCT02660281|Melphalan|melphalan|mesh-list
1716900|NCT02660281|Busulfan|busulfan|mesh-list
1716901|NCT02660281|Thiotepa|thiotepa|mesh-list
1716902|NCT02660281|Fludarabine|fludarabine|mesh-list
1716903|NCT02660281|Mesna|mesna|mesh-list
1716904|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1716905|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
1716906|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1716907|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1716908|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1716909|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
1716910|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1716911|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716912|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1716913|NCT02660281|Protective Agents|protective agents|mesh-ancestor
1716933|NCT02571530|Trastuzumab|trastuzumab|mesh-list
1716934|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1716935|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1716994|NCT02489903|Gemcitabine|gemcitabine|mesh-list
1716995|NCT02489903|Paclitaxel|paclitaxel|mesh-list
1716996|NCT02489903|Etoposide|etoposide|mesh-list
1716997|NCT02489903|Vinorelbine|vinorelbine|mesh-list
1716998|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1716999|NCT02489903|Carboplatin|carboplatin|mesh-list
1717000|NCT02489903|Irinotecan|irinotecan|mesh-list
1717001|NCT02489903|Pemetrexed|pemetrexed|mesh-list
1717002|NCT02489903|Taxane|taxane|mesh-list
1717003|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1717004|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1717005|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
1717006|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
1717007|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
1717008|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1717009|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1717010|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
1717011|NCT02489903|Antiviral Agents|antiviral agents|mesh-ancestor
1717012|NCT02489903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1717013|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1717014|NCT02489903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1717015|NCT02489903|Immunologic Factors|immunologic factors|mesh-ancestor
1717016|NCT02489903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1717017|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1717018|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1717019|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1717020|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1717021|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1717054|NCT02438995|Cetuximab|cetuximab|mesh-list
1717055|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1717056|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1718478|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1718428|NCT05108389|Hemostatics|hemostatics|mesh-list
1718429|NCT05108389|Coagulants|coagulants|mesh-ancestor
1718430|NCT05108350|Metformin|metformin|mesh-list
1718431|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1718432|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718433|NCT05108259|Adalimumab|adalimumab|mesh-list
1718434|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1718435|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1718436|NCT05108220|Cannabidiol|cannabidiol|mesh-list
1718437|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
1718449|NCT05108051|Oseltamivir|oseltamivir|mesh-list
1718450|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
1718451|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1718452|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1718453|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1718454|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
1718455|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
1718456|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1718457|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1718458|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718459|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
1718460|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1718461|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1718462|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1718463|NCT05107921|Bromfenac|bromfenac|mesh-list
1718464|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1718465|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1718466|NCT05107921|Analgesics|analgesics|mesh-ancestor
1718467|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
1718468|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1718469|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718470|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1718471|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1718472|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1718473|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1718477|NCT05107765|Pioglitazone|pioglitazone|mesh-list
1718479|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718490|NCT05107427|Avelumab|avelumab|mesh-list
1718491|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1718492|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1718493|NCT05107375|Vaccines|vaccines|mesh-list
1718494|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
1718495|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718507|NCT05107063|Pravastatin|pravastatin|mesh-list
1718508|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1718509|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1718510|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
1718511|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1718512|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1718513|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1718514|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1718517|NCT05106803|Amoxicillin|amoxicillin|mesh-list
1718518|NCT05106803|Vancomycin|vancomycin|mesh-list
1718519|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
1718520|NCT05106803|Clindamycin|clindamycin|mesh-list
1718521|NCT05106803|Gentamicins|gentamicins|mesh-list
1718522|NCT05106803|Tetracycline|tetracycline|mesh-list
1718523|NCT05106803|Erythromycin|erythromycin|mesh-list
1718524|NCT05106803|Penicillins|penicillins|mesh-list
1718525|NCT05106803|Ampicillin|ampicillin|mesh-list
1718526|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
1718527|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
1718528|NCT05106803|Cefepime|cefepime|mesh-list
1718529|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1718530|NCT05106803|Norfloxacin|norfloxacin|mesh-list
1718531|NCT05106803|Oxacillin|oxacillin|mesh-list
1718532|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
1718533|NCT05106803|Trimethoprim|trimethoprim|mesh-list
1718534|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
1718535|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1718536|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1718537|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1718538|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1718539|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1718540|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1718541|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1718542|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1718543|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1718544|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1718545|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1718546|NCT05106803|Renal Agents|renal agents|mesh-ancestor
1718547|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
1718548|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1718549|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1718550|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1718551|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1718552|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1718553|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1718554|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1718555|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
1718556|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1718557|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
1718558|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718559|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
1718560|NCT05106751|Protective Agents|protective agents|mesh-ancestor
1718561|NCT05106712|Vitamin D|vitamin d|mesh-list
1718562|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
1718563|NCT05106712|Letrozole|letrozole|mesh-list
1718564|NCT05106712|Clomiphene|clomiphene|mesh-list
1718565|NCT05106712|Enclomiphene|enclomiphene|mesh-list
1718566|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
1718567|NCT05106712|Vitamins|vitamins|mesh-ancestor
1718568|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
1718569|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718570|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1718571|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1718572|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1718573|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1718574|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1718575|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1718576|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1718577|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1718578|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
1718579|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1718580|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1718581|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
1718582|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1718583|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1718584|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1718589|NCT05104047|Lobeline|lobeline|mesh-list
1718590|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1718591|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
1718592|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1718593|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718594|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1718595|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1718596|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
1718597|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1718598|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1718599|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
1718600|NCT05097846|Amoxicillin|amoxicillin|mesh-list
1718601|NCT05097846|Doxycycline|doxycycline|mesh-list
1718602|NCT05097846|Furazolidone|furazolidone|mesh-list
1718603|NCT05097846|Esomeprazole|esomeprazole|mesh-list
1718604|NCT05097846|Bismuth|bismuth|mesh-list
1718605|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1718606|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1718607|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1718608|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1718609|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1718610|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1718611|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1718612|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
1718613|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1718614|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1718615|NCT05097846|Antacids|antacids|mesh-ancestor
1718616|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1718617|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1718618|NCT05097846|Renal Agents|renal agents|mesh-ancestor
1718619|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
1718620|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1718637|NCT05093621|Torsemide|torsemide|mesh-list
1718638|NCT05093621|Furosemide|furosemide|mesh-list
1718639|NCT05093621|Diuretics|diuretics|mesh-ancestor
1718640|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
1718641|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718642|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1718643|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1718644|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1718645|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1718646|NCT05093296|Naltrexone|naltrexone|mesh-list
1718647|NCT05093296|Oxytocin|oxytocin|mesh-list
1718648|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
1718649|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1718650|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718651|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1718652|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1718653|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
1718654|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1718672|NCT05083000|Topotecan|topotecan|mesh-list
1718673|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1718674|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1718675|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1718676|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1718677|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1718702|NCT05075980|Cisplatin|cisplatin|mesh-list
1718703|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1718704|NCT05074290|Taxane|taxane|mesh-list
1718705|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1718706|NCT05069896|Mirikizumab|mirikizumab|mesh-list
1718707|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1718708|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1718709|NCT05069896|Analgesics|analgesics|mesh-ancestor
1718710|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
1718711|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1718712|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718713|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1718714|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1718715|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1718716|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1718717|NCT05057273|Adalimumab|adalimumab|mesh-list
1718718|NCT05057273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1718719|NCT05057273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1718764|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
1718765|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
1718766|NCT05031897|Melphalan|melphalan|mesh-list
1718767|NCT05031897|Fludarabine|fludarabine|mesh-list
1718768|NCT05031897|Tacrolimus|tacrolimus|mesh-list
1718769|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1718770|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
1718771|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718772|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1718773|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1718774|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
1718775|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1718776|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1718777|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1718778|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1718779|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1718780|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1718781|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1718782|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
1718783|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1718784|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1718785|NCT05030298|Temozolomide|temozolomide|mesh-list
1718786|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1718787|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
1718788|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1718789|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1718811|NCT05023369|Dexamethasone|dexamethasone|mesh-list
1718812|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1718813|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
1718814|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
1718815|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1718816|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718817|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1718818|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
1718819|NCT05023369|Hormones|hormones|mesh-ancestor
1718820|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1718821|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1718822|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1718845|NCT05010421|Clobetasol|clobetasol|mesh-list
1718846|NCT05010421|Emollients|emollients|mesh-list
1718847|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1718848|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
1718849|NCT05010421|Hormones|hormones|mesh-ancestor
1718850|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1718851|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718852|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
1718897|NCT05004077|Amiodarone|amiodarone|mesh-list
1718898|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1718899|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
1718900|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1718901|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1718902|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1718903|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1718904|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1718905|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1718906|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1718907|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1718908|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1718909|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1718961|NCT04977024|Vaccines|vaccines|mesh-list
1718962|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
1718963|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1718989|NCT04962126|Atezolizumab|atezolizumab|mesh-list
1718990|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
1718991|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1718992|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1718993|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1719113|NCT04930042|Ustekinumab|ustekinumab|mesh-list
1719114|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
1719123|NCT04903093|Famotidine|famotidine|mesh-list
1719124|NCT04903093|Abrocitinib|abrocitinib|mesh-list
1719125|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1719126|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1719127|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1719128|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
1719129|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
1719130|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1719131|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1719132|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1719133|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1719134|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1719203|NCT04833413|Insulin|insulin|mesh-list
1719204|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1719205|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
1719206|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1719258|NCT04781426|Tenofovir|tenofovir|mesh-list
1719259|NCT04781426|Lamivudine|lamivudine|mesh-list
1719260|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
1719261|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1719262|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1719263|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1719264|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1719265|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1719266|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1719267|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1719282|NCT04771689|Buprenorphine|buprenorphine|mesh-list
1719283|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1719284|NCT04771689|Naloxone|naloxone|mesh-list
1719285|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1719286|NCT04771689|Narcotics|narcotics|mesh-ancestor
1719287|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1719288|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1719289|NCT04771689|Analgesics|analgesics|mesh-ancestor
1719290|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
1719291|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1719292|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1719363|NCT04751877|Dexamethasone|dexamethasone|mesh-list
1719364|NCT04751877|Lenalidomide|lenalidomide|mesh-list
1719365|NCT04751877|Bortezomib|bortezomib|mesh-list
1719366|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1719367|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
1719368|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
1719369|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1719370|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1719371|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1719372|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
1719373|NCT04751877|Hormones|hormones|mesh-ancestor
1719374|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1719375|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1719376|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1719377|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
1719378|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1719379|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1719380|NCT04751877|Growth Substances|growth substances|mesh-ancestor
1719381|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
1719403|NCT04722978|Gemcitabine|gemcitabine|mesh-list
1719404|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
1719405|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1719406|NCT04722978|Carboplatin|carboplatin|mesh-list
1719407|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1719408|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1719409|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1719410|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
1719411|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1719412|NCT04722978|Antiviral Agents|antiviral agents|mesh-ancestor
1719413|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1719414|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1719415|NCT04722978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1719416|NCT04722978|Immunologic Factors|immunologic factors|mesh-ancestor
1719417|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1719418|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1719419|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1719420|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1719421|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
1719422|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1719423|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1719424|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1719425|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1719455|NCT04695106|Aspirin|aspirin|mesh-list
1719456|NCT04695106|Dabigatran|dabigatran|mesh-list
1719457|NCT04695106|Clopidogrel|clopidogrel|mesh-list
1719458|NCT04695106|Ticagrelor|ticagrelor|mesh-list
1719459|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1719460|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1719461|NCT04695106|Analgesics|analgesics|mesh-ancestor
1719462|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
1719463|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1719464|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1719465|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1719466|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1719467|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1719468|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1719469|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1719470|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1719471|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1719472|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1719473|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
1719474|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1719475|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1719476|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1719477|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
1719478|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1719479|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
1719480|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1719481|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
1719482|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
1719483|NCT04681677|Bevacizumab|bevacizumab|mesh-list
1719484|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1719485|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1719486|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1719487|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1719488|NCT04681677|Growth Substances|growth substances|mesh-ancestor
1719489|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1719490|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
1719543|NCT04658147|Nivolumab|nivolumab|mesh-list
1719544|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1719545|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1719546|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1719547|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1719634|NCT04617002|TIC10 compound|tic10 compound|mesh-list
1719635|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1719636|NCT04614974|Famotidine|famotidine|mesh-list
1719637|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1719638|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1719639|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1719640|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
1719641|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
1719642|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1719643|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1719644|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1719686|NCT04576767|Anesthetics|anesthetics|mesh-list
1719687|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1719688|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1719700|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1719701|NCT04561206|Nivolumab|nivolumab|mesh-list
1719702|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1719703|NCT04561206|Antibodies|antibodies|mesh-list
1719704|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
1719705|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1719706|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
1719707|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
1719708|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1719709|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1719710|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1719711|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1719712|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
1719714|NCT04537286|Paclitaxel|paclitaxel|mesh-list
1719715|NCT04537286|Cisplatin|cisplatin|mesh-list
1719716|NCT04537286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1719717|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1719718|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1719719|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
1719720|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
1719721|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
1719722|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1719735|NCT04527887|Dexamethasone|dexamethasone|mesh-list
1719736|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1719737|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
1719738|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
1719739|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1719740|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1719741|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1719742|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
1719743|NCT04527887|Hormones|hormones|mesh-ancestor
1719744|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1719745|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1719746|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1719766|NCT04486625|Aztreonam|aztreonam|mesh-list
1719767|NCT04486625|Avibactam|avibactam|mesh-list
1719768|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1719769|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1719770|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1719771|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1719772|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1719831|NCT04449861|Durvalumab|durvalumab|mesh-list
1719832|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1719833|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1719949|NCT04316364|Paclitaxel|paclitaxel|mesh-list
1719950|NCT04316364|Carboplatin|carboplatin|mesh-list
1719951|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1719952|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1719953|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
1719954|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
1719955|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
1719956|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720082|NCT04235686|Amphetamine|amphetamine|mesh-list
1720083|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
1720084|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1720085|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720086|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
1720087|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
1720088|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1720089|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
1720090|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1720091|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720092|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
1720093|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1720094|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1720095|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1720096|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1720153|NCT04210141|Antivenins|antivenins|mesh-list
1720154|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
1720155|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720156|NCT04199767|Insulin|insulin|mesh-list
1720157|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1720158|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
1720159|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1720160|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720225|NCT04168710|Bupivacaine|bupivacaine|mesh-list
1720226|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
1720227|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
1720228|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1720229|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720230|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
1720231|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1720246|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1720247|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1720248|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720256|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
1720257|NCT04119024|Fludarabine|fludarabine|mesh-list
1720258|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
1720259|NCT04119024|Interleukin-2|interleukin-2|mesh-list
1720260|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1720261|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
1720262|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720263|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1720264|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1720265|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
1720266|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720267|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1720268|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1720269|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1720270|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
1720271|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1720272|NCT04119024|Analgesics|analgesics|mesh-ancestor
1720273|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
1720274|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1720306|NCT04084951|Nivolumab|nivolumab|mesh-list
1720307|NCT04084951|Ipilimumab|ipilimumab|mesh-list
1720308|NCT04084951|Atezolizumab|atezolizumab|mesh-list
1720309|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1720310|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1720311|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1720312|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720346|NCT04018872|Itraconazole|itraconazole|mesh-list
1720347|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
1720348|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1720349|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1720350|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1720351|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1720352|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720353|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1720354|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
1720355|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1720356|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720357|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1720358|NCT04001777|Osimertinib|osimertinib|mesh-list
1720359|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1720360|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1720361|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1720362|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720366|NCT03997786|Etanercept|etanercept|mesh-list
1720367|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1720368|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1720369|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1720370|NCT03997786|Analgesics|analgesics|mesh-ancestor
1720371|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
1720372|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1720373|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720374|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1720375|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1720376|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1720377|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1720378|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
1720393|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1720394|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
1720395|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720396|NCT03982576|Nicotine|nicotine|mesh-list
1720397|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1720398|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
1720399|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1720400|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720401|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1720402|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1720403|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
1720404|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1720405|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720406|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1720407|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1720408|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720415|NCT03969641|Vaccines|vaccines|mesh-list
1720416|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
1720417|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720418|NCT03965923|Tenofovir|tenofovir|mesh-list
1720419|NCT03965923|Emtricitabine|emtricitabine|mesh-list
1720420|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1720421|NCT03965923|Dapivirine|dapivirine|mesh-list
1720422|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
1720423|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1720424|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1720425|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1720426|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1720427|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720428|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1720429|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1720442|NCT03942328|Vaccines|vaccines|mesh-list
1720443|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
1720444|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720445|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
1720446|NCT03933813|Hematinics|hematinics|mesh-ancestor
1720453|NCT03930615|Letermovir|letermovir|mesh-list
1720454|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1720455|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1720456|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720457|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1720458|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
1720459|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1720522|NCT03918850|Buprenorphine|buprenorphine|mesh-list
1720523|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1720524|NCT03918850|Narcotics|narcotics|mesh-ancestor
1720525|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1720526|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720527|NCT03918850|Analgesics|analgesics|mesh-ancestor
1720528|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
1720529|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1720530|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1720759|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1720627|NCT03911739|Buprenorphine|buprenorphine|mesh-list
1720628|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1720629|NCT03911739|Narcotics|narcotics|mesh-ancestor
1720630|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1720631|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720632|NCT03911739|Analgesics|analgesics|mesh-ancestor
1720633|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
1720634|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1720635|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1720636|NCT03911466|Buprenorphine|buprenorphine|mesh-list
1720637|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1720638|NCT03911466|Narcotics|narcotics|mesh-ancestor
1720639|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1720640|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720641|NCT03911466|Analgesics|analgesics|mesh-ancestor
1720642|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
1720643|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1720644|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1720674|NCT03875144|Cisplatin|cisplatin|mesh-list
1720675|NCT03875144|Doxorubicin|doxorubicin|mesh-list
1720676|NCT03875144|Pemetrexed|pemetrexed|mesh-list
1720677|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1720678|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1720679|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1720680|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1720681|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1720760|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
1720682|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720683|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1720684|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1720761|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1720832|NCT03814005|Paclitaxel|paclitaxel|mesh-list
1720833|NCT03814005|Docetaxel|docetaxel|mesh-list
1720834|NCT03814005|Carboplatin|carboplatin|mesh-list
1720835|NCT03814005|Azacitidine|azacitidine|mesh-list
1720836|NCT03814005|Pevonedistat|pevonedistat|mesh-list
1720837|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1720838|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1720839|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
1720840|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
1720841|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
1720842|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720843|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1720844|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
1720845|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1720886|NCT03773302|Gemcitabine|gemcitabine|mesh-list
1720887|NCT03773302|Infigratinib|infigratinib|mesh-list
1720888|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1720889|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1720890|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
1720891|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720892|NCT03773302|Antiviral Agents|antiviral agents|mesh-ancestor
1720893|NCT03773302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1720894|NCT03773302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1720895|NCT03773302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1720896|NCT03773302|Immunologic Factors|immunologic factors|mesh-ancestor
1720897|NCT03773302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720910|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1720911|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1720912|NCT03740204|Estradiol|estradiol|mesh-list
1720913|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1720914|NCT03740204|Progesterone|progesterone|mesh-list
1720915|NCT03740204|Estrogens|estrogens|mesh-ancestor
1720916|NCT03740204|Hormones|hormones|mesh-ancestor
1720917|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1720918|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1720919|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1720920|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
1720921|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1720922|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1720923|NCT03740204|Progestins|progestins|mesh-ancestor
1720943|NCT03726671|Choline|choline|mesh-list
1720944|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
1720945|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1720946|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
1720947|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1720948|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1720949|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1720950|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
1721003|NCT03701711|Lenalidomide|lenalidomide|mesh-list
1721004|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
1721005|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721006|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1721007|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1721008|NCT03701711|Growth Substances|growth substances|mesh-ancestor
1721009|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
1721010|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721011|NCT03685773|Niacin|niacin|mesh-list
1721012|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
1721013|NCT03685773|Niacinamide|niacinamide|mesh-list
1721014|NCT03685773|Diazoxide|diazoxide|mesh-list
1721015|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1721016|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
1721017|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721018|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1721019|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
1721020|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
1721021|NCT03685773|Vitamins|vitamins|mesh-ancestor
1721022|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
1721023|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721024|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1721028|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
1721029|NCT03643796|Ketamine|ketamine|mesh-list
1721030|NCT03643796|Remifentanil|remifentanil|mesh-list
1721031|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1721032|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1721033|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721034|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1721035|NCT03643796|Analgesics|analgesics|mesh-ancestor
1721036|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
1721037|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1721038|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1721039|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1721040|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1721041|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
1721042|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1721043|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721044|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1721045|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1721046|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
1721047|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
1721048|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1721049|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1721050|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1721051|NCT03643796|Narcotics|narcotics|mesh-ancestor
1721078|NCT03596073|Calcipotriene|calcipotriene|mesh-list
1721079|NCT03596073|Petrolatum|petrolatum|mesh-list
1721080|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
1721081|NCT03596073|Emollients|emollients|mesh-ancestor
1721087|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1721088|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1721089|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1721090|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721091|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
1721092|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721115|NCT03579914|Metoprolol|metoprolol|mesh-list
1721116|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1721117|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1721118|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
1721119|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
1721120|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1721121|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721122|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1721123|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1721124|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1721125|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
1721126|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1721127|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721128|NCT03560258|Vaccines|vaccines|mesh-list
1721129|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
1721130|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721131|NCT03535363|Osimertinib|osimertinib|mesh-list
1721132|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721133|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1721134|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1721135|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721152|NCT03518086|Mirikizumab|mirikizumab|mesh-list
1721153|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1721154|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1721155|NCT03518086|Analgesics|analgesics|mesh-ancestor
1721156|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
1721157|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1721158|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721159|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1721160|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1721161|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1721162|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1721195|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
1721196|NCT03467386|Tacrolimus|tacrolimus|mesh-list
1721197|NCT03467386|Lenograstim|lenograstim|mesh-list
1721198|NCT03467386|Sargramostim|sargramostim|mesh-list
1721199|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1721200|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
1721201|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721202|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1721203|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1721204|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
1721205|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721206|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721207|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1721208|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1721209|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1721210|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1721239|NCT03384784|Galantamine|galantamine|mesh-list
1721240|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1721241|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1721242|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721243|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
1721244|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1721245|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721246|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1721247|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
1721248|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1721249|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
1721250|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
1721251|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1721252|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721253|NCT03367572|Dexamethasone|dexamethasone|mesh-list
1721254|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
1721255|NCT03367572|Olanzapine|olanzapine|mesh-list
1721256|NCT03367572|Palonosetron|palonosetron|mesh-list
1721257|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
1721258|NCT03367572|Ichthammol|ichthammol|mesh-list
1721259|NCT03367572|BB 1101|bb 1101|mesh-list
1721260|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1721261|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
1721262|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
1721263|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1721264|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721265|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1721266|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
1721267|NCT03367572|Hormones|hormones|mesh-ancestor
1721268|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1721269|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1721270|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721271|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1721272|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1721273|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1721274|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1721275|NCT03367572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1721276|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1721277|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1721278|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721279|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1721280|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
1721281|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
1721282|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1721283|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1721284|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1721285|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
1721286|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1721287|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
1721288|NCT03338920|Sumatriptan|sumatriptan|mesh-list
1721289|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1721290|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1721291|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1721292|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
1721293|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1721294|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721295|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721296|NCT03293017|Diazepam|diazepam|mesh-list
1721297|NCT03293017|Baclofen|baclofen|mesh-list
1721298|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1721299|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721300|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1721301|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1721302|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
1721303|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
1721304|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
1721305|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1721306|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721307|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1721308|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
1721309|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
1721310|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
1721311|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1721312|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1721313|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1721314|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1721315|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1721316|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1721317|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1721318|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
1721319|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
1721320|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
1721321|NCT03288545|Gemcitabine|gemcitabine|mesh-list
1721322|NCT03288545|Carboplatin|carboplatin|mesh-list
1721323|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
1721324|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721325|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1721326|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
1721327|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721328|NCT03288545|Antiviral Agents|antiviral agents|mesh-ancestor
1721329|NCT03288545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1721330|NCT03288545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1721331|NCT03288545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1721332|NCT03288545|Immunologic Factors|immunologic factors|mesh-ancestor
1721333|NCT03288545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721334|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1721437|NCT03198559|Vorinostat|vorinostat|mesh-list
1721438|NCT03198559|Disulfiram|disulfiram|mesh-list
1721439|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721440|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1721441|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1721442|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721443|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1721444|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
1721445|NCT03179943|Atezolizumab|atezolizumab|mesh-list
1721446|NCT03179943|Guadecitabine|guadecitabine|mesh-list
1721447|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721467|NCT03136263|Oxytocin|oxytocin|mesh-list
1721468|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
1721469|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1721470|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721474|NCT03129113|Metformin|metformin|mesh-list
1721475|NCT03129113|Maraviroc|maraviroc|mesh-list
1721476|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1721477|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721478|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1721479|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1721480|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721481|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1721482|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1721483|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
1721484|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1721485|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1721486|NCT03122522|Nivolumab|nivolumab|mesh-list
1721487|NCT03122522|Ipilimumab|ipilimumab|mesh-list
1721488|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1721489|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721490|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1721491|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721504|NCT03102125|Regadenoson|regadenoson|mesh-list
1721505|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1721506|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1721507|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
1721508|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
1721509|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1721510|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721511|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721534|NCT03033225|Verteporfin|verteporfin|mesh-list
1721535|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1721536|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
1721599|NCT02982668|Metoclopramide|metoclopramide|mesh-list
1721600|NCT02982668|Mosapride|mosapride|mesh-list
1721601|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
1721602|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
1721603|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1721604|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721605|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1721606|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1721607|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1721608|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
1721609|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1721610|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721611|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1721612|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
1721613|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
1721614|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1721615|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721616|NCT02924441|Lidocaine|lidocaine|mesh-list
1721617|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
1721618|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
1721619|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1721620|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721621|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
1721622|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1721623|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1721624|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1721625|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1721626|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1721627|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721628|NCT02917096|Vidarabine|vidarabine|mesh-list
1721629|NCT02917096|Sirolimus|sirolimus|mesh-list
1721630|NCT02917096|Fludarabine|fludarabine|mesh-list
1721631|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
1721632|NCT02917096|Melphalan|melphalan|mesh-list
1721633|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
1721634|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1721635|NCT02917096|Tacrolimus|tacrolimus|mesh-list
1721636|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721637|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1721638|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
1721639|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721640|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1721641|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
1721642|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721643|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
1721644|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1721645|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1721646|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1721647|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1721648|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1721649|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
1721650|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1721651|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
1721652|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1721653|NCT02917083|Cyclophosphamide|cyclophosphamide|mesh-list
1721654|NCT02917083|Fludarabine|fludarabine|mesh-list
1721655|NCT02917083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1721656|NCT02917083|Immunologic Factors|immunologic factors|mesh-ancestor
1721657|NCT02917083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721658|NCT02917083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1721659|NCT02917083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1721660|NCT02917083|Alkylating Agents|alkylating agents|mesh-ancestor
1721661|NCT02917083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721662|NCT02917083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721663|NCT02917083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1721664|NCT02913274|Paclitaxel|paclitaxel|mesh-list
1721665|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1721666|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721667|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
1721668|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
1721669|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
1721670|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721695|NCT02908477|Docetaxel|docetaxel|mesh-list
1721696|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721697|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
1721698|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
1721699|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
1721700|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721701|NCT02906007|Bedaquiline|bedaquiline|mesh-list
1721702|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
1721703|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1721704|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1721723|NCT02775812|Cisplatin|cisplatin|mesh-list
1721724|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
1721725|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721726|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1721727|NCT02757859|Pancrelipase|pancrelipase|mesh-list
1721728|NCT02757859|Pancreatin|pancreatin|mesh-list
1721729|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1721730|NCT02749513|Itraconazole|itraconazole|mesh-list
1721731|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
1721732|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1721733|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1721734|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1721735|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1721736|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721737|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1721738|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
1721739|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1721740|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721741|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1721754|NCT02684227|Paclitaxel|paclitaxel|mesh-list
1721755|NCT02684227|Carboplatin|carboplatin|mesh-list
1721756|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1721757|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1721758|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721759|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
1721760|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
1721761|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
1721762|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721763|NCT02682641|Rituximab|rituximab|mesh-list
1721764|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1721765|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721766|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
1721767|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721768|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1721791|NCT02648477|Doxorubicin|doxorubicin|mesh-list
1721792|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1721793|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
1721794|NCT02648477|Letrozole|letrozole|mesh-list
1721795|NCT02648477|Anastrozole|anastrozole|mesh-list
1721796|NCT02648477|Exemestane|exemestane|mesh-list
1721797|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1721798|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1721799|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1721800|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1721801|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1721802|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1721803|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1721804|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1721805|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1721806|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1721807|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
1721808|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1721809|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1721810|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1723908|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
1723909|NCT05110339|Ropivacaine|ropivacaine|mesh-list
1723910|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1723911|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1723912|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1723913|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1723914|NCT05110339|Analgesics|analgesics|mesh-ancestor
1723915|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
1723916|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1723917|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1723918|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1723919|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1723920|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
1723921|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1723922|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1723923|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
1723924|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
1723925|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1723926|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
1723927|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1723947|NCT05110170|Goserelin|goserelin|mesh-list
1723948|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1723949|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1723950|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1723951|NCT05110144|Amitriptyline|amitriptyline|mesh-list
1723952|NCT05110144|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
1723953|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1723954|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1723955|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1723956|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1723957|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1723958|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1723959|NCT05110144|Analgesics|analgesics|mesh-ancestor
1723960|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
1723961|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1723962|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
1723963|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1723964|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
1723965|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1723966|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1723967|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1723968|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
1723969|NCT05110144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1723970|NCT05110144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1723971|NCT05110144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1723972|NCT05110118|Bevacizumab|bevacizumab|mesh-list
1723973|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
1723974|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1723975|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1723976|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1723977|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1723978|NCT05110118|Growth Substances|growth substances|mesh-ancestor
1723979|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1723980|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
1724017|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1724018|NCT05109650|Antibodies|antibodies|mesh-list
1724019|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
1724020|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
1724021|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724037|NCT05109585|Antibodies|antibodies|mesh-list
1724038|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
1724039|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
1724040|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
1724041|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724045|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
1724046|NCT05109455|Procyanidin|procyanidin|mesh-list
1724047|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
1724048|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724049|NCT05109455|Protective Agents|protective agents|mesh-ancestor
1724050|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724051|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1724052|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1724053|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1724074|NCT05109390|Cyclosporine|cyclosporine|mesh-list
1724075|NCT05109390|Simethicone|simethicone|mesh-list
1724076|NCT05109390|Omeprazole|omeprazole|mesh-list
1724077|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
1724078|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
1724079|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
1724080|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
1724081|NCT05109390|Antacids|antacids|mesh-list
1724082|NCT05109390|Tacrolimus|tacrolimus|mesh-list
1724083|NCT05109390|Cyclosporins|cyclosporins|mesh-list
1724084|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724085|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1724086|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
1724087|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1724088|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1724089|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724090|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
1724091|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1724092|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
1724093|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1724094|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1724095|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1724096|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
1724097|NCT05109390|Emollients|emollients|mesh-ancestor
1724098|NCT05109377|Tadalafil|tadalafil|mesh-list
1724099|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
1724100|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1724101|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1724102|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1724103|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724104|NCT05109377|Urological Agents|urological agents|mesh-ancestor
1724114|NCT05109312|Acetaminophen|acetaminophen|mesh-list
1724115|NCT05109312|Ibuprofen|ibuprofen|mesh-list
1724116|NCT05109312|Bupivacaine|bupivacaine|mesh-list
1724117|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
1724118|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
1724119|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1724120|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724121|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
1724122|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1724123|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1724124|NCT05109312|Analgesics|analgesics|mesh-ancestor
1724125|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
1724126|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1724127|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1724128|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1724129|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1724130|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1724131|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724132|NCT05109299|Fluorides|fluorides|mesh-list
1724133|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
1724134|NCT05109299|Protective Agents|protective agents|mesh-ancestor
1724135|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724138|NCT05109143|Indomethacin|indomethacin|mesh-list
1724139|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1724140|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1724141|NCT05109143|Analgesics|analgesics|mesh-ancestor
1724142|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
1724143|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1724144|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724145|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1724146|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1724147|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
1724148|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
1724149|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1724150|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1724151|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1724152|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724158|NCT05109052|Bevacizumab|bevacizumab|mesh-list
1724159|NCT05109052|Atezolizumab|atezolizumab|mesh-list
1724160|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1724161|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724162|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1724163|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1724164|NCT05109052|Growth Substances|growth substances|mesh-ancestor
1724165|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724166|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
1724195|NCT05108870|Paclitaxel|paclitaxel|mesh-list
1724196|NCT05108870|Carboplatin|carboplatin|mesh-list
1724197|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1724198|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724199|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
1724200|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
1724201|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
1724202|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724208|NCT05108714|Lidocaine|lidocaine|mesh-list
1724209|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
1724210|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
1724211|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1724212|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724213|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
1724214|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1724215|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1724216|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1724217|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1724218|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1724219|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724254|NCT05108597|Misoprostol|misoprostol|mesh-list
1724255|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1724256|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
1724257|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1724258|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724259|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1724260|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1724261|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
1724262|NCT05108545|Amphotericin B|amphotericin b|mesh-list
1724263|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
1724264|NCT05108545|Amebicides|amebicides|mesh-ancestor
1724265|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1724266|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1724267|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1724268|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1724269|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
1724273|NCT05108428|Capecitabine|capecitabine|mesh-list
1724274|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1724275|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
1724276|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724277|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724282|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
1724283|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1724284|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1724285|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724286|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
1724287|NCT05102695|Coagulants|coagulants|mesh-ancestor
1724298|NCT05098847|Lenvatinib|lenvatinib|mesh-list
1724299|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724300|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1724301|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1724302|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724303|NCT05097118|Ketamine|ketamine|mesh-list
1724304|NCT05097118|Bupivacaine|bupivacaine|mesh-list
1724305|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
1724306|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
1724307|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1724308|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724309|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
1724310|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1724311|NCT05097118|Analgesics|analgesics|mesh-ancestor
1724312|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1724313|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1724314|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
1724315|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1724316|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1724317|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1724318|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724319|NCT05096065|Leuprolide|leuprolide|mesh-list
1724320|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1724321|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
1724322|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1724323|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724324|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1724325|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724326|NCT05093920|Doxorubicin|doxorubicin|mesh-list
1724327|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1724328|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1724329|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724330|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1724331|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1724332|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1724333|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724334|NCT05092373|Paclitaxel|paclitaxel|mesh-list
1724335|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1724336|NCT05092373|Atezolizumab|atezolizumab|mesh-list
1724337|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1724338|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724339|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
1724340|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
1724341|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
1724342|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724380|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
1724381|NCT05077254|Vaccines|vaccines|mesh-list
1724382|NCT05077254|Tacrolimus|tacrolimus|mesh-list
1724383|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
1724384|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724385|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1724386|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1724387|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1724388|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724389|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1724390|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724391|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1724392|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
1724393|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1724394|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1724421|NCT05073003|Vaccines|vaccines|mesh-list
1724422|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
1724423|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724437|NCT05053737|Atezolizumab|atezolizumab|mesh-list
1724438|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724454|NCT05041062|Nivolumab|nivolumab|mesh-list
1724455|NCT05041062|Ipilimumab|ipilimumab|mesh-list
1724456|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1724457|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724458|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1724459|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724515|NCT05013502|Empagliflozin|empagliflozin|mesh-list
1724516|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1724517|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724518|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1724519|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724528|NCT05007769|Atezolizumab|atezolizumab|mesh-list
1724529|NCT05007769|Ramucirumab|ramucirumab|mesh-list
1724530|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724542|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
1724543|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1724544|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724592|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
1724593|NCT04977453|Lenvatinib|lenvatinib|mesh-list
1724594|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1724595|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724596|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1724597|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1724598|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724618|NCT04961801|Methotrexate|methotrexate|mesh-list
1724619|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
1724620|NCT04961801|Tacrolimus|tacrolimus|mesh-list
1724621|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1724622|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
1724623|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1724624|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724625|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1724626|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
1724627|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724628|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724629|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
1724630|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1724631|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1724632|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1724633|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
1724634|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1724635|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1724636|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1725036|NCT04707222|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1724690|NCT04928950|Charcoal|charcoal|mesh-list
1724691|NCT04928950|Antidotes|antidotes|mesh-ancestor
1724692|NCT04928950|Protective Agents|protective agents|mesh-ancestor
1724693|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724789|NCT04836910|Metformin|metformin|mesh-list
1724790|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
1724791|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
1724792|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
1724793|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1724794|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724795|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1724796|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1724840|NCT04789928|Gentamicins|gentamicins|mesh-list
1724841|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1724842|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1724843|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1724844|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1724845|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724846|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
1724847|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1724848|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1724849|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1724850|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1724851|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1724852|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724853|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724862|NCT04772300|Sirolimus|sirolimus|mesh-list
1724863|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1724864|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1724865|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1724866|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724867|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
1724868|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1724869|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
1724870|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724876|NCT04762771|Colchicine|colchicine|mesh-list
1724877|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
1724878|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1724879|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
1724880|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
1724881|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
1724882|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1724883|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1724884|NCT04760041|Midazolam|midazolam|mesh-list
1724885|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1724886|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1724887|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1724888|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1724889|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1724890|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1724891|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1724892|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1724893|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
1724894|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
1724895|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
1724896|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
1724897|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1724898|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725025|NCT04707222|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1725026|NCT04707222|Metronidazole|metronidazole|mesh-list
1725027|NCT04707222|Ciprofloxacin|ciprofloxacin|mesh-list
1725028|NCT04707222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1725029|NCT04707222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1725030|NCT04707222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1725031|NCT04707222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1725032|NCT04707222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1725033|NCT04707222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725034|NCT04707222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725035|NCT04707222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725037|NCT04707222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1725038|NCT04701060|Apatinib|apatinib|mesh-list
1725039|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725040|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1725041|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725042|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725071|NCT04677543|Azithromycin|azithromycin|mesh-list
1725072|NCT04677543|Amikacin|amikacin|mesh-list
1725073|NCT04677543|Ethambutol|ethambutol|mesh-list
1725074|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1725075|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1725076|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
1725077|NCT04676477|Osimertinib|osimertinib|mesh-list
1725078|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
1725079|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1725080|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725081|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1725082|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725083|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725084|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
1725085|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725086|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1725087|NCT04674462|Vaccines|vaccines|mesh-list
1725088|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
1725089|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725126|NCT04626141|Abaloparatide|abaloparatide|mesh-list
1725127|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1725128|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725145|NCT04595864|Leucovorin|leucovorin|mesh-list
1725146|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
1725147|NCT04595864|Calcium|calcium|mesh-list
1725148|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
1725149|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1725150|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725151|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725152|NCT04595864|Antidotes|antidotes|mesh-ancestor
1725153|NCT04595864|Protective Agents|protective agents|mesh-ancestor
1725154|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
1725155|NCT04595864|Vitamins|vitamins|mesh-ancestor
1725156|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
1725159|NCT04583462|Metformin|metformin|mesh-list
1725160|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1725161|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725182|NCT04569383|Vaccines|vaccines|mesh-list
1725183|NCT04569383|Immunologic Factors|immunologic factors|mesh-ancestor
1725184|NCT04569383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725213|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
1725214|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1725215|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1725216|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725217|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
1725218|NCT04555343|Coagulants|coagulants|mesh-ancestor
1725219|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
1725220|NCT04545411|Volagidemab|volagidemab|mesh-list
1725221|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1725222|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725223|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1725224|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725245|NCT04495088|Leucovorin|leucovorin|mesh-list
1725246|NCT04495088|Folic Acid|folic acid|mesh-list
1725247|NCT04495088|Capecitabine|capecitabine|mesh-list
1725248|NCT04495088|Fluorouracil|fluorouracil|mesh-list
1725249|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
1725250|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
1725251|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1725252|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
1725253|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725254|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725255|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1725256|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
1725257|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725258|NCT04495088|Antidotes|antidotes|mesh-ancestor
1725259|NCT04495088|Protective Agents|protective agents|mesh-ancestor
1725260|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
1725261|NCT04495088|Vitamins|vitamins|mesh-ancestor
1725262|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
1725263|NCT04495088|Hematinics|hematinics|mesh-ancestor
1725272|NCT04472494|Abatacept|abatacept|mesh-list
1725273|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1725274|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725275|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725276|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1725277|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
1725278|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725279|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1725280|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1725281|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1725282|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1725283|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
1725284|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725285|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725286|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1725287|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1725288|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
1725289|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1725290|NCT04464408|Favipiravir|favipiravir|mesh-list
1725291|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
1725292|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1725293|NCT04456322|Cisplatin|cisplatin|mesh-list
1725294|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
1725295|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725296|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1725312|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
1725313|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
1725314|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
1725315|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725316|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1725317|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1725318|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
1725319|NCT04405167|Dexamethasone|dexamethasone|mesh-list
1725320|NCT04405167|Lenalidomide|lenalidomide|mesh-list
1725321|NCT04405167|Ixazomib|ixazomib|mesh-list
1725322|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1725323|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
1725324|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
1725325|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1725326|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725327|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1725328|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
1725329|NCT04405167|Hormones|hormones|mesh-ancestor
1725330|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1725331|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1725332|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725333|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
1725334|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725335|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725336|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
1725337|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1725338|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1725339|NCT04405167|Growth Substances|growth substances|mesh-ancestor
1725340|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
1725352|NCT04383119|Gemcitabine|gemcitabine|mesh-list
1725353|NCT04383119|Trabectedin|trabectedin|mesh-list
1725354|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1725355|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
1725356|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725357|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725358|NCT04383119|Antiviral Agents|antiviral agents|mesh-ancestor
1725359|NCT04383119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1725360|NCT04383119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725361|NCT04383119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1725362|NCT04383119|Immunologic Factors|immunologic factors|mesh-ancestor
1725363|NCT04383119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725364|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1725365|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
1725389|NCT04349124|Antihypertensive Agents|antihypertensive agents|mesh-list
1725390|NCT04349124|Nifedipine|nifedipine|mesh-list
1725391|NCT04349124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1725392|NCT04349124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1725393|NCT04349124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725394|NCT04349124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1725395|NCT04349124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725396|NCT04349124|Vasodilator Agents|vasodilator agents|mesh-ancestor
1725397|NCT04349124|Tocolytic Agents|tocolytic agents|mesh-ancestor
1725398|NCT04349124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1725404|NCT04339218|Carboplatin|carboplatin|mesh-list
1725405|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
1725406|NCT04339218|Pemetrexed|pemetrexed|mesh-list
1725407|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725408|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1725409|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725410|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725411|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1725412|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1725418|NCT04309877|Theophylline|theophylline|mesh-list
1725419|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1725420|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
1725421|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1725422|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725423|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1725424|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
1725425|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1725426|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725427|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725428|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
1725429|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1725430|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1725431|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
1725432|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1725433|NCT04305548|Trabectedin|trabectedin|mesh-list
1725434|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1725435|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
1725436|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725437|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725442|NCT04281420|Niacin|niacin|mesh-list
1725443|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1725444|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
1725445|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725446|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1725447|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
1725448|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
1725449|NCT04281420|Vitamins|vitamins|mesh-ancestor
1725450|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
1725451|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725466|NCT04244552|Doxorubicin|doxorubicin|mesh-list
1725467|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1725468|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
1725469|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1725470|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725471|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1725472|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1725473|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725474|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725475|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1725476|NCT04239339|Citalopram|citalopram|mesh-list
1725477|NCT04239339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1725478|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1725479|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1725480|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725481|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1725482|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
1725483|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725484|NCT04239339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1725485|NCT04239339|Antidepressive Agents|antidepressive agents|mesh-ancestor
1725486|NCT04239339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1725500|NCT04200443|Temozolomide|temozolomide|mesh-list
1725501|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1725502|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
1725503|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725504|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725505|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
1725506|NCT04195256|Ketamine|ketamine|mesh-list
1725507|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1725508|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1725509|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725510|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1725511|NCT04195256|Analgesics|analgesics|mesh-ancestor
1725512|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
1725513|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1725514|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1725515|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1725516|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1725517|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
1725518|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1725519|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725520|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1725521|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1725522|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
1725523|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
1725524|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1725525|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1725562|NCT04165135|Factor VIII|factor viii|mesh-list
1725563|NCT04165135|Coagulants|coagulants|mesh-ancestor
1725629|NCT04122443|Acetaminophen|acetaminophen|mesh-list
1725630|NCT04122443|Oxycodone|oxycodone|mesh-list
1725631|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1725632|NCT04122443|Analgesics|analgesics|mesh-ancestor
1725633|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
1725634|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1725635|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725636|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
1725637|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1725638|NCT04122443|Narcotics|narcotics|mesh-ancestor
1725639|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1725648|NCT04121299|Amlodipine|amlodipine|mesh-list
1725649|NCT04121299|Carvedilol|carvedilol|mesh-list
1725650|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1725651|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1725652|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1725653|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725654|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1725655|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725656|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
1725657|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1725658|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1725659|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
1725660|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1725661|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
1725662|NCT04121299|Protective Agents|protective agents|mesh-ancestor
1725663|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1725664|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1725680|NCT04105270|Carboplatin|carboplatin|mesh-list
1725681|NCT04105270|Pemetrexed|pemetrexed|mesh-list
1725682|NCT04105270|Durvalumab|durvalumab|mesh-list
1725683|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725684|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725685|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725686|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1725687|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1725688|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1725697|NCT04097912|Aspirin|aspirin|mesh-list
1725698|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1725699|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1725700|NCT04097912|Analgesics|analgesics|mesh-ancestor
1725701|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
1725702|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1725703|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725704|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1725705|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1725706|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1725707|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1725708|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725709|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1725710|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1725711|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725712|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
1725781|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
1725782|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1725783|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
1725784|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1725785|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725786|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1725787|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1725788|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1725807|NCT04040738|Anesthetics|anesthetics|mesh-list
1725808|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1725809|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725850|NCT04008082|Lenvatinib|lenvatinib|mesh-list
1725851|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725852|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1725853|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725854|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725855|NCT04007224|Oxytocin|oxytocin|mesh-list
1725856|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
1725857|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1725858|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725862|NCT04005339|Leucovorin|leucovorin|mesh-list
1725863|NCT04005339|Fluorouracil|fluorouracil|mesh-list
1725864|NCT04005339|Irinotecan|irinotecan|mesh-list
1725865|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
1725866|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725867|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1725868|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725869|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1725870|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
1725871|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1725872|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1725873|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1725874|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725875|NCT04005339|Antidotes|antidotes|mesh-ancestor
1725876|NCT04005339|Protective Agents|protective agents|mesh-ancestor
1725877|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
1725878|NCT04005339|Vitamins|vitamins|mesh-ancestor
1725879|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
1725880|NCT04003649|Nivolumab|nivolumab|mesh-list
1725881|NCT04003649|Ipilimumab|ipilimumab|mesh-list
1725882|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1725883|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725884|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1725885|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725886|NCT03981796|Paclitaxel|paclitaxel|mesh-list
1725887|NCT03981796|Carboplatin|carboplatin|mesh-list
1725888|NCT03981796|Niraparib|niraparib|mesh-list
1725889|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1725890|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725891|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
1725892|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
1725893|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
1725894|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725895|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1725896|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1725897|NCT03973333|Atezolizumab|atezolizumab|mesh-list
1725898|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725899|NCT03943342|Venetoclax|venetoclax|mesh-list
1725900|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1725981|NCT03783351|Clopidogrel|clopidogrel|mesh-list
1725982|NCT03783351|Ticagrelor|ticagrelor|mesh-list
1725983|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1725984|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1725985|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1725986|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1725987|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
1725988|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1725989|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1725990|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726013|NCT03739203|Cariprazine|cariprazine|mesh-list
1726014|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1726015|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1726016|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1726017|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726018|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1726019|NCT03738215|Cariprazine|cariprazine|mesh-list
1726020|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1726021|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1726022|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1726023|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726024|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1726056|NCT03682224|Epinephrine|epinephrine|mesh-list
1726057|NCT03682224|Bupivacaine|bupivacaine|mesh-list
1726058|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
1726059|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
1726060|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1726061|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726062|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
1726063|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1726064|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1726065|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1726066|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
1726067|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1726068|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726069|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1726070|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1726071|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
1726072|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1726073|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
1726074|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
1726075|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
1726076|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1726103|NCT03621748|Anesthetics|anesthetics|mesh-list
1726104|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1726105|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726111|NCT03579693|Niacinamide|niacinamide|mesh-list
1726112|NCT03579693|Niacin|niacin|mesh-list
1726113|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
1726114|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
1726115|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
1726116|NCT03579693|Vitamins|vitamins|mesh-ancestor
1726117|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
1726118|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726119|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1726120|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
1726121|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726122|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1726123|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
1726127|NCT03557359|Nivolumab|nivolumab|mesh-list
1726128|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1726129|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1726130|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1726131|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726132|NCT03540901|Acetazolamide|acetazolamide|mesh-list
1726133|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
1726134|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1726135|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1726136|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726137|NCT03540901|Diuretics|diuretics|mesh-ancestor
1726138|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
1726139|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726140|NCT03540875|Remifentanil|remifentanil|mesh-list
1726141|NCT03540875|Propofol|propofol|mesh-list
1726142|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
1726143|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1726144|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726145|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1726146|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1726147|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
1726148|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1726149|NCT03540875|Narcotics|narcotics|mesh-ancestor
1726150|NCT03540875|Analgesics|analgesics|mesh-ancestor
1726151|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
1726152|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1726153|NCT03536507|Acetazolamide|acetazolamide|mesh-list
1726154|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
1726155|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1726156|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1726157|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726158|NCT03536507|Diuretics|diuretics|mesh-ancestor
1726159|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
1726160|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726166|NCT03522246|Nivolumab|nivolumab|mesh-list
1726167|NCT03522246|Rucaparib|rucaparib|mesh-list
1726168|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1726169|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1726170|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1726171|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726172|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1726173|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1726174|NCT03517735|Remifentanil|remifentanil|mesh-list
1726175|NCT03517735|Propofol|propofol|mesh-list
1726176|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1726177|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1726178|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726179|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1726180|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
1726181|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
1726182|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1726183|NCT03517735|Narcotics|narcotics|mesh-ancestor
1726184|NCT03517735|Analgesics|analgesics|mesh-ancestor
1726185|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
1726186|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1726187|NCT03513562|Venetoclax|venetoclax|mesh-list
1726188|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1726189|NCT03507491|Gemcitabine|gemcitabine|mesh-list
1726190|NCT03507491|Paclitaxel|paclitaxel|mesh-list
1726191|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1726192|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1726193|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
1726194|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
1726195|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
1726196|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726197|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1726198|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
1726199|NCT03507491|Antiviral Agents|antiviral agents|mesh-ancestor
1726200|NCT03507491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1726201|NCT03507491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1726202|NCT03507491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1726203|NCT03507491|Immunologic Factors|immunologic factors|mesh-ancestor
1726204|NCT03507491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726217|NCT03450343|Azacitidine|azacitidine|mesh-list
1726218|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1726219|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
1726220|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726221|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1726222|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1726305|NCT03400501|Insulin|insulin|mesh-list
1726306|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1726307|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
1726308|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1726309|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726310|NCT03395314|Midazolam|midazolam|mesh-list
1726311|NCT03395314|Ketamine|ketamine|mesh-list
1726312|NCT03395314|Analgesics|analgesics|mesh-ancestor
1726313|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
1726314|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1726315|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726316|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1726317|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1726318|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
1726319|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
1726320|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1726321|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1726322|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1726323|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1726324|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726325|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1726326|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1726327|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1726328|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1726329|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1726330|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
1726331|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
1726385|NCT03347838|Nivolumab|nivolumab|mesh-list
1726386|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1726387|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1726388|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1726389|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726480|NCT03197194|Aspirin|aspirin|mesh-list
1726481|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1726482|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1726483|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1726484|NCT03197194|Analgesics|analgesics|mesh-ancestor
1726485|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
1726486|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1726487|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726488|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1726489|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1726490|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1726491|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1726492|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726493|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1726494|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1726495|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1726496|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
1726502|NCT03186638|Ibuprofen|ibuprofen|mesh-list
1726503|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1726504|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1726505|NCT03186638|Analgesics|analgesics|mesh-ancestor
1726506|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
1726507|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1726508|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726509|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1726510|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1726511|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1726512|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1726513|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726553|NCT03087773|Empagliflozin|empagliflozin|mesh-list
1726554|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1726555|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726556|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1726557|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726577|NCT03034200|TIC10 compound|tic10 compound|mesh-list
1726578|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1726606|NCT02991807|Everolimus|everolimus|mesh-list
1726607|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1726608|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1726609|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
1726610|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726616|NCT02944799|Vitamin D|vitamin d|mesh-list
1726617|NCT02944799|Alendronate|alendronate|mesh-list
1726618|NCT02944799|Calcium|calcium|mesh-list
1726619|NCT02944799|Vitamins|vitamins|mesh-ancestor
1726620|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
1726621|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726622|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1726623|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1726641|NCT02859064|Lanreotide|lanreotide|mesh-list
1726642|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1726643|NCT02854436|Niraparib|niraparib|mesh-list
1726644|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1726645|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1726646|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726647|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1726648|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
1726649|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1726650|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1726651|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1726652|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1726653|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726654|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
1726655|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1726656|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726657|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1726658|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1726676|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
1726677|NCT02722668|Sirolimus|sirolimus|mesh-list
1726678|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
1726679|NCT02722668|Fludarabine|fludarabine|mesh-list
1726680|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1726681|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1726682|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
1726683|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726684|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1726685|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1726686|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
1726687|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726688|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1726689|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1726690|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1726691|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1726692|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
1726693|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1726694|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1726695|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1726696|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
1726697|NCT02633293|Treprostinil|treprostinil|mesh-list
1726698|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1726720|NCT02599363|Paclitaxel|paclitaxel|mesh-list
1726721|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1726722|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1726723|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
1726724|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
1726725|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
1726726|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726733|NCT02570672|Metformin|metformin|mesh-list
1726734|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1726735|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726800|NCT02521311|Clemastine|clemastine|mesh-list
1726801|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
1726802|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
1726803|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1726804|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
1726805|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
1726806|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1726807|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1726808|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1726809|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1727560|NCT05112471|Erythritol|erythritol|mesh-list
1727561|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
1727582|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
1727583|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1727584|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1727585|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1727586|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1727587|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727588|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
1727589|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1727590|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727591|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1727592|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1727602|NCT05111860|Bevacizumab|bevacizumab|mesh-list
1727603|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1727604|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1727605|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1727606|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1727607|NCT05111860|Growth Substances|growth substances|mesh-ancestor
1727608|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727609|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
1727615|NCT05111808|Methylene Blue|methylene blue|mesh-list
1727616|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1727617|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727618|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1727619|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
1727620|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727783|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
1727638|NCT05111444|Paclitaxel|paclitaxel|mesh-list
1727639|NCT05111444|Capecitabine|capecitabine|mesh-list
1727640|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
1727641|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1727642|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1727643|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
1727644|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
1727645|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
1727646|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727647|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1727648|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
1727663|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1727687|NCT05111145|Ivacaftor|ivacaftor|mesh-list
1727688|NCT05111145|Elexacaftor|elexacaftor|mesh-list
1727689|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1727690|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1727691|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727699|NCT05110911|Vaccines|vaccines|mesh-list
1727700|NCT05110911|Immunologic Factors|immunologic factors|mesh-ancestor
1727701|NCT05110911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727702|NCT05110898|Olmesartan|olmesartan|mesh-list
1727703|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1727704|NCT05110898|Indapamide|indapamide|mesh-list
1727705|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1727706|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1727707|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1727708|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727709|NCT05110898|Diuretics|diuretics|mesh-ancestor
1727710|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
1727711|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727712|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1727713|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1727719|NCT05110742|Vidarabine|vidarabine|mesh-list
1727720|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
1727721|NCT05110742|Fludarabine|fludarabine|mesh-list
1727722|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
1727723|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1727724|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
1727725|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727726|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1727727|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1727728|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
1727729|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727730|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1727731|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1727732|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1727733|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
1727734|NCT05110742|Antiviral Agents|antiviral agents|mesh-ancestor
1727735|NCT05110742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1727736|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
1727737|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
1727738|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1727739|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1727740|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1727741|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1727742|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727743|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1727744|NCT05110638|Luliconazole|luliconazole|mesh-list
1727745|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
1727746|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1727747|NCT05110482|Oxytocin|oxytocin|mesh-list
1727748|NCT05110482|Carbetocin|carbetocin|mesh-list
1727749|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
1727750|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1727751|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727752|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
1727753|NCT05110469|Meperidine|meperidine|mesh-list
1727754|NCT05110469|Analgesics|analgesics|mesh-ancestor
1727755|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
1727756|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1727757|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727758|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
1727759|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1727760|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1727761|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
1727762|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1727763|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1727764|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727765|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1727766|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
1727767|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1727768|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1727769|NCT05110469|Narcotics|narcotics|mesh-ancestor
1727770|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1727771|NCT05110417|Bromides|bromides|mesh-list
1727772|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
1727773|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
1727774|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1727775|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1727776|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727777|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
1727778|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1727779|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727780|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1727781|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1727782|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727784|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1727785|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
1727786|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1727787|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727788|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1727789|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
1727790|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1727791|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
1727792|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727793|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1727794|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1727795|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
1727796|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
1727797|NCT05109611|Protective Agents|protective agents|mesh-ancestor
1727808|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
1727809|NCT05103735|Remifentanil|remifentanil|mesh-list
1727810|NCT05103735|Propofol|propofol|mesh-list
1727811|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1727812|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1727813|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727814|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1727815|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
1727816|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
1727817|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1727818|NCT05103735|Analgesics|analgesics|mesh-ancestor
1727819|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
1727820|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1727821|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1727822|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1727823|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1727824|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
1727825|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1727826|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727827|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1727828|NCT05103735|Narcotics|narcotics|mesh-ancestor
1727829|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
1727830|NCT05101356|Vaccines|vaccines|mesh-list
1727831|NCT05101356|Sargramostim|sargramostim|mesh-list
1727832|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
1727833|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727834|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
1727835|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
1727836|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727837|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
1727838|NCT05099250|Bupivacaine|bupivacaine|mesh-list
1727839|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
1727840|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
1727841|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1727842|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727843|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
1727844|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1727845|NCT05099250|Analgesics|analgesics|mesh-ancestor
1727846|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1727847|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
1727848|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1727849|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1727850|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727851|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1727852|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
1727853|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1727860|NCT05094323|Bupivacaine|bupivacaine|mesh-list
1727861|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
1727862|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
1727863|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1727864|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727865|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
1727866|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1727867|NCT05092828|Morphine|morphine|mesh-list
1727868|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1727869|NCT05092828|Narcotics|narcotics|mesh-ancestor
1727870|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1727871|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1727872|NCT05092828|Analgesics|analgesics|mesh-ancestor
1727873|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
1727874|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1727875|NCT05083754|Temozolomide|temozolomide|mesh-list
1727876|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1727877|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
1727878|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727879|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1727880|NCT05083052|Propolis|propolis|mesh-list
1727881|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1727882|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1727883|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1727884|NCT05079802|Chitosan|chitosan|mesh-list
1727885|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1727886|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
1727887|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1727888|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1727889|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
1727890|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1727891|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1727892|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
1727893|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
1727894|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
1727895|NCT05079802|Coagulants|coagulants|mesh-ancestor
1727938|NCT05032794|Bisacodyl|bisacodyl|mesh-list
1727939|NCT05032794|Cathartics|cathartics|mesh-ancestor
1727940|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1727941|NCT05032794|Laxatives|laxatives|mesh-ancestor
1727987|NCT05006599|Insulin|insulin|mesh-list
1727988|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1727989|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1727990|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728065|NCT04974879|Osimertinib|osimertinib|mesh-list
1728066|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728067|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1728068|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1728069|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728080|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
1728081|NCT04947553|Bupropion|bupropion|mesh-list
1728082|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1728083|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
1728084|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1728085|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1728086|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1728087|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1728088|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728089|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
1728090|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1728091|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728092|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1728093|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1728094|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1728095|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
1728096|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
1728097|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1728098|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1728195|NCT04926324|Niraparib|niraparib|mesh-list
1728196|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1728197|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1728198|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728199|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728220|NCT04910230|Niacinamide|niacinamide|mesh-list
1728221|NCT04910230|Niacin|niacin|mesh-list
1728222|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
1728223|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
1728224|NCT04910230|Vitamins|vitamins|mesh-ancestor
1728225|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
1728226|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728227|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1728228|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
1728229|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728230|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1728231|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
1728282|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
1728283|NCT04887870|Nivolumab|nivolumab|mesh-list
1728284|NCT04887870|Ipilimumab|ipilimumab|mesh-list
1728285|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1728286|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728287|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1728288|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728289|NCT04851301|Naloxone|naloxone|mesh-list
1728290|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1728291|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728292|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
1728293|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1728318|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
1728319|NCT04796779|Trace Elements|trace elements|mesh-ancestor
1728320|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
1728321|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728346|NCT04783857|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1728347|NCT04783857|Medroxyprogesterone|medroxyprogesterone|mesh-list
1728348|NCT04783857|Progesterone|progesterone|mesh-list
1728349|NCT04783857|Progestins|progestins|mesh-ancestor
1728350|NCT04783857|Hormones|hormones|mesh-ancestor
1728351|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1728352|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728353|NCT04783857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1728354|NCT04783857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1728355|NCT04783857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1728356|NCT04783857|Contraceptive Agents|contraceptive agents|mesh-ancestor
1728357|NCT04783857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1728358|NCT04783857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1728359|NCT04783857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1728360|NCT04783857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1728361|NCT04783857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1728362|NCT04783857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728372|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
1728373|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1728374|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1728375|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
1728376|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1728377|NCT04774237|Carbachol|carbachol|mesh-list
1728378|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1728379|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1728380|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1728381|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1728382|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
1728383|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1728384|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728385|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728386|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1728387|NCT04774237|Miotics|miotics|mesh-ancestor
1728388|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
1728389|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1728390|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1728391|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
1728392|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1728393|NCT04774237|Analgesics|analgesics|mesh-ancestor
1728394|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
1728395|NCT04774237|Protective Agents|protective agents|mesh-ancestor
1728396|NCT04768010|Misoprostol|misoprostol|mesh-list
1728397|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1728398|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
1728399|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1728400|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728401|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1728402|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1728403|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
1728404|NCT04764942|Dexamethasone|dexamethasone|mesh-list
1728405|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
1728406|NCT04764942|Pomalidomide|pomalidomide|mesh-list
1728407|NCT04764942|Ichthammol|ichthammol|mesh-list
1728408|NCT04764942|BB 1101|bb 1101|mesh-list
1728409|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1728410|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
1728411|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
1728412|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1728413|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728414|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1728415|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
1728416|NCT04764942|Hormones|hormones|mesh-ancestor
1728417|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1728418|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1728419|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728420|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
1728421|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1728422|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728423|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
1728424|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1728425|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1728426|NCT04764942|Growth Substances|growth substances|mesh-ancestor
1728427|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
1728428|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
1728515|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
1728516|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1728517|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1728518|NCT04685772|Prednisolone|prednisolone|mesh-list
1728519|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
1728520|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1728521|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
1728522|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1728523|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
1728524|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
1728525|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1728526|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728527|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1728528|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
1728529|NCT04685772|Hormones|hormones|mesh-ancestor
1728530|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1728531|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1728532|NCT04685772|Protective Agents|protective agents|mesh-ancestor
1728533|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1728534|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728535|NCT04674345|Sorafenib|sorafenib|mesh-list
1728536|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728537|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1728538|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1728539|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728540|NCT04672512|Prednisone|prednisone|mesh-list
1728541|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1728542|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
1728543|NCT04672512|Hormones|hormones|mesh-ancestor
1728544|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1728545|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728546|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1728547|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728592|NCT04634604|Bevacizumab|bevacizumab|mesh-list
1728593|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1728594|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728595|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1728596|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1728597|NCT04634604|Growth Substances|growth substances|mesh-ancestor
1728598|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728599|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
1728600|NCT04634578|Bevacizumab|bevacizumab|mesh-list
1728601|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1728602|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728603|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1728604|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1728605|NCT04634578|Growth Substances|growth substances|mesh-ancestor
1728606|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728607|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
1728634|NCT04615936|Methylene Blue|methylene blue|mesh-list
1728635|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1728636|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728645|NCT04597697|Insulin|insulin|mesh-list
1728646|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1728647|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728677|NCT04564612|Itraconazole|itraconazole|mesh-list
1728678|NCT04564612|Rabeprazole|rabeprazole|mesh-list
1728679|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
1728680|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1728681|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1728682|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1728683|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1728684|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728685|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1728686|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
1728687|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1728688|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728689|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1728690|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1728691|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1728692|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1728693|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
1728694|NCT04550832|Bedaquiline|bedaquiline|mesh-list
1728695|NCT04550832|Delpazolid|delpazolid|mesh-list
1728696|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1728697|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1728698|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1728699|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1728700|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1728701|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728702|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728703|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
1728704|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1728748|NCT04484818|Leuprolide|leuprolide|mesh-list
1728749|NCT04484818|Goserelin|goserelin|mesh-list
1728750|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1728751|NCT04484818|Tryptophan|tryptophan|mesh-list
1728752|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
1728753|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1728754|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728755|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1728756|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
1728757|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1728758|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1728759|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728760|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
1728761|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1728762|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
1728763|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1728764|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1728765|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
1728766|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1728767|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
1728770|NCT04461028|Dexamethasone|dexamethasone|mesh-list
1728771|NCT04461028|Bupivacaine|bupivacaine|mesh-list
1728772|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1728773|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
1728774|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
1728775|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1728776|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728777|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1728778|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
1728779|NCT04461028|Hormones|hormones|mesh-ancestor
1728780|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1728781|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1728782|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728783|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
1728784|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
1728785|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1728786|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
1728817|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
1728818|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
1728819|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
1728820|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728821|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1728822|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1728823|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
1728834|NCT04416737|Insulin|insulin|mesh-list
1728835|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1728836|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728881|NCT04380740|Abatacept|abatacept|mesh-list
1728882|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1728883|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728884|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728885|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1728886|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
1728887|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728888|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1728903|NCT04367909|Carboplatin|carboplatin|mesh-list
1728904|NCT04367909|Docetaxel|docetaxel|mesh-list
1728905|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
1728906|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1728907|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
1728908|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
1728909|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
1728910|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728911|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1728912|NCT04346394|Yohimbine|yohimbine|mesh-list
1728913|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
1728914|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
1728915|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1728916|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728917|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1728918|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1728919|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1728920|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
1728921|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1728922|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1728923|NCT04346394|Urological Agents|urological agents|mesh-ancestor
1728924|NCT04342039|Budesonide|budesonide|mesh-list
1728925|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1728926|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1728927|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
1728928|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1728929|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728930|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1728931|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
1728932|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
1728933|NCT04342039|Hormones|hormones|mesh-ancestor
1728934|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1728940|NCT04335058|Iron|iron|mesh-list
1728941|NCT04335058|Lactoferrin|lactoferrin|mesh-list
1728942|NCT04335058|Trace Elements|trace elements|mesh-ancestor
1728943|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
1728944|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728945|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1728946|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
1728947|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
1728948|NCT04329975|Coagulants|coagulants|mesh-ancestor
1728949|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1728950|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
1728951|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728956|NCT04315311|Pancrelipase|pancrelipase|mesh-list
1728957|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1728987|NCT04285255|Lidocaine|lidocaine|mesh-list
1728988|NCT04285255|Fentanyl|fentanyl|mesh-list
1728989|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
1728990|NCT04285255|Ketamine|ketamine|mesh-list
1728991|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
1728992|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
1728993|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1728994|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1728995|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
1728996|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1728997|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1728998|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1728999|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1729000|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1729001|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729002|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1729003|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1729004|NCT04285255|Analgesics|analgesics|mesh-ancestor
1729005|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1729006|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1729007|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1729008|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
1729009|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1729010|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1729011|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1729012|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
1729013|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1729014|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1729015|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1729016|NCT04285255|Narcotics|narcotics|mesh-ancestor
1729017|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1729018|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
1729019|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
1729020|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1729021|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1729022|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729023|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
1729024|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1729025|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1729026|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729046|NCT04196075|Andrographolide|andrographolide|mesh-list
1729047|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1729048|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1729049|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1729050|NCT04196075|Analgesics|analgesics|mesh-ancestor
1729051|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
1729052|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1729053|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729054|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1729055|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1729056|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1729057|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1729058|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
1729059|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1729060|NCT04169828|Leucovorin|leucovorin|mesh-list
1729061|NCT04169828|Folic Acid|folic acid|mesh-list
1729062|NCT04169828|Methotrexate|methotrexate|mesh-list
1729063|NCT04169828|Ondansetron|ondansetron|mesh-list
1729064|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
1729065|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1729066|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
1729067|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1729068|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729069|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1729070|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
1729071|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729072|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729073|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
1729074|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1729075|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1729076|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1729077|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
1729078|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1729079|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1729080|NCT04169828|Antidotes|antidotes|mesh-ancestor
1729081|NCT04169828|Protective Agents|protective agents|mesh-ancestor
1729082|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
1729083|NCT04169828|Vitamins|vitamins|mesh-ancestor
1729084|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
1729085|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
1729086|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
1729087|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1729088|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1729089|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
1729090|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1729091|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
1729092|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1729093|NCT04169828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1729094|NCT04169828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1729095|NCT04169828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1729096|NCT04169828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1729097|NCT04169828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1729098|NCT04169828|Hematinics|hematinics|mesh-ancestor
1729099|NCT04165824|Edaravone|edaravone|mesh-list
1729100|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1729101|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
1729102|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729103|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1729104|NCT04165824|Protective Agents|protective agents|mesh-ancestor
1729105|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729106|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
1729107|NCT04163107|Dexamethasone|dexamethasone|mesh-list
1729108|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1729109|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
1729110|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
1729111|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1729112|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729113|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1729114|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
1729115|NCT04163107|Hormones|hormones|mesh-ancestor
1729116|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1729117|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1729118|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729119|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
1729120|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1729121|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1729122|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1729123|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1729124|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729125|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1729126|NCT04161898|Prednisolone|prednisolone|mesh-list
1729127|NCT04161898|Upadacitinib|upadacitinib|mesh-list
1729128|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1729129|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
1729130|NCT04161898|Hormones|hormones|mesh-ancestor
1729131|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1729132|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729133|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1729134|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729135|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
1729136|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1729137|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1729138|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729139|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1729140|NCT04158141|Cisplatin|cisplatin|mesh-list
1729141|NCT04158141|Carboplatin|carboplatin|mesh-list
1729142|NCT04158141|Pemetrexed|pemetrexed|mesh-list
1729143|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729144|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1729145|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729146|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1729147|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1729179|NCT04053322|Durvalumab|durvalumab|mesh-list
1729180|NCT04053322|Olaparib|olaparib|mesh-list
1729181|NCT04053322|Fulvestrant|fulvestrant|mesh-list
1729182|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1729183|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729184|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1729185|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1729186|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729187|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1729188|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1729189|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1729190|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
1729191|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1729192|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729193|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
1729194|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1729195|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1729196|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729197|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1729198|NCT04040439|Analgesics|analgesics|mesh-ancestor
1729199|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
1729200|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1729201|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1729202|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1729203|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1729204|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
1729205|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1729206|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729217|NCT04030182|Vitamin D|vitamin d|mesh-list
1729218|NCT04030182|Vitamins|vitamins|mesh-ancestor
1729219|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
1729220|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729221|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1729222|NCT04000555|Vancomycin|vancomycin|mesh-list
1729223|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1729224|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1729225|NCT03988933|Rifampin|rifampin|mesh-list
1729226|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1729227|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
1729228|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1729229|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1729230|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
1729231|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1729232|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1729233|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729234|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1729235|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1729236|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1729237|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1729238|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1729239|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1729240|NCT03978520|Upadacitinib|upadacitinib|mesh-list
1729241|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
1729242|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1729243|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1729244|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729245|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1729284|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
1729285|NCT03958565|Denosumab|denosumab|mesh-list
1729286|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1729287|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1729288|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729340|NCT03878459|Pioglitazone|pioglitazone|mesh-list
1729341|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1729342|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729343|NCT03875378|Estrogens|estrogens|mesh-list
1729344|NCT03875378|Hormones|hormones|mesh-ancestor
1729345|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1729346|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729382|NCT03865212|Interferons|interferons|mesh-list
1729383|NCT03865212|Interferon-beta|interferon-beta|mesh-list
1729384|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729385|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
1729386|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1729387|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
1729388|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729389|NCT03863483|Docetaxel|docetaxel|mesh-list
1729390|NCT03863483|Pemetrexed|pemetrexed|mesh-list
1729391|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729392|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
1729393|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
1729394|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
1729395|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729396|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1729397|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1729398|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1729399|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1729400|NCT03854500|Tenecteplase|tenecteplase|mesh-list
1729401|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1729402|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1729403|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729404|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
1729405|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1729406|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729423|NCT03830411|Docetaxel|docetaxel|mesh-list
1729424|NCT03830411|Pemetrexed|pemetrexed|mesh-list
1729425|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729426|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
1729427|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
1729428|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
1729429|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729430|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1729431|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1729432|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1729461|NCT03802305|Anesthetics|anesthetics|mesh-list
1729462|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1729463|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729497|NCT03733119|TIC10 compound|tic10 compound|mesh-list
1729498|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729524|NCT03661632|Nivolumab|nivolumab|mesh-list
1729525|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1729526|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729527|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1729528|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729575|NCT03512262|Abaloparatide|abaloparatide|mesh-list
1729576|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
1729577|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1729578|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729579|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1729694|NCT03456882|RNS60|rns60|mesh-list
1729695|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1729696|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1729697|NCT03456882|Analgesics|analgesics|mesh-ancestor
1729698|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
1729699|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1729700|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729701|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1729702|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1729703|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1729704|NCT03418649|Eplerenone|eplerenone|mesh-list
1729705|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1729706|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
1729707|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1729708|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729709|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1729710|NCT03418649|Diuretics|diuretics|mesh-ancestor
1729711|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
1729712|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1729729|NCT03374956|Liraglutide|liraglutide|mesh-list
1729730|NCT03374956|Topiramate|topiramate|mesh-list
1729731|NCT03374956|Phentermine|phentermine|mesh-list
1729732|NCT03374956|Naltrexone|naltrexone|mesh-list
1729733|NCT03374956|Bupropion|bupropion|mesh-list
1729734|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1729735|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1729736|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729737|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
1729738|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1729739|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1729740|NCT03374956|Incretins|incretins|mesh-ancestor
1729741|NCT03374956|Hormones|hormones|mesh-ancestor
1729742|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1729743|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1729744|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
1729745|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1729746|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1729747|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1729748|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1729749|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729750|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
1729751|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1729752|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1729753|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1729754|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1729755|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
1729756|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1729757|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
1729758|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1729759|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
1729760|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
1729761|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
1729762|NCT03366103|Navitoclax|navitoclax|mesh-list
1729763|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729792|NCT03334253|Atropine|atropine|mesh-list
1729793|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1729794|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1729795|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1729796|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1729797|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
1729798|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1729799|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729800|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1729801|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
1729802|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
1729803|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
1729804|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1729805|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1729806|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
1729807|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1729808|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729809|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1729832|NCT03300479|Urapidil|urapidil|mesh-list
1729833|NCT03300479|Clevidipine|clevidipine|mesh-list
1729834|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1729835|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1729836|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729837|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1729838|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729839|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1729840|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
1729841|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1729842|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
1729843|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1729844|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1729845|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1729846|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1729847|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
1729848|NCT03272464|Trametinib|trametinib|mesh-list
1729849|NCT03272464|Dabrafenib|dabrafenib|mesh-list
1729850|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729851|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1729852|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1729853|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729854|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1729855|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1729856|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1729857|NCT03245151|Everolimus|everolimus|mesh-list
1729858|NCT03245151|Lenvatinib|lenvatinib|mesh-list
1729859|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1729860|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1729861|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
1729862|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729863|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1729864|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1729865|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729945|NCT03070184|Metoprolol|metoprolol|mesh-list
1729946|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1729947|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1729948|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
1729949|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
1729950|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1729951|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1729952|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1729953|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1729954|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1729955|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
1729956|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1729957|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1729980|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
1729981|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1730081|NCT02911142|Prednisone|prednisone|mesh-list
1730082|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
1730083|NCT02911142|Rituximab|rituximab|mesh-list
1730084|NCT02911142|Doxorubicin|doxorubicin|mesh-list
1730085|NCT02911142|Vincristine|vincristine|mesh-list
1730086|NCT02911142|Lenalidomide|lenalidomide|mesh-list
1730087|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1730088|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
1730089|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730090|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1730091|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1730092|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
1730093|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730094|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730095|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1730096|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1730097|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1730098|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1730099|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1730100|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1730101|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1730102|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
1730103|NCT02911142|Hormones|hormones|mesh-ancestor
1730104|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1730105|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1730106|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1730107|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
1730108|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
1730109|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
1730110|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1730111|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1730112|NCT02911142|Growth Substances|growth substances|mesh-ancestor
1730113|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
1730117|NCT02781090|Nicotine|nicotine|mesh-list
1730118|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1730119|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
1730120|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1730121|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730122|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1730123|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1730124|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
1730125|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1730126|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730127|NCT02758847|Paclitaxel|paclitaxel|mesh-list
1730128|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1730129|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1730130|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730131|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
1730132|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
1730133|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
1730134|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730178|NCT02718066|Nivolumab|nivolumab|mesh-list
1730179|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1730180|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730181|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1730182|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730231|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
1730232|NCT02443324|Ramucirumab|ramucirumab|mesh-list
1730233|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1730234|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730235|NCT02390531|Bevacizumab|bevacizumab|mesh-list
1730236|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1730237|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730238|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1730239|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1730240|NCT02390531|Growth Substances|growth substances|mesh-ancestor
1730241|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730242|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
1730243|NCT02369653|Apixaban|apixaban|mesh-list
1730244|NCT02369653|Anticoagulants|anticoagulants|mesh-list
1730245|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1730246|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
1730247|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1730248|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
1730249|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1730250|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730519|NCT05116254|AZD7648|azd7648|mesh-list
1730520|NCT05116254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1730521|NCT05116254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1730522|NCT05116254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730526|NCT05116228|Rituximab|rituximab|mesh-list
1730527|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1730528|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730529|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
1730530|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730531|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1730555|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
1730556|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1730557|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730558|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
1730559|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730560|NCT05116150|Protective Agents|protective agents|mesh-ancestor
1730561|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730562|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
1730563|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
1730564|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730565|NCT05116098|Protective Agents|protective agents|mesh-ancestor
1730566|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730567|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
1730568|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1730569|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730570|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1730579|NCT05116007|Carboplatin|carboplatin|mesh-list
1730580|NCT05116007|Etoposide|etoposide|mesh-list
1730581|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730582|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1730583|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1730584|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1730585|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1730586|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730587|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
1730588|NCT05115903|Adalimumab|adalimumab|mesh-list
1730589|NCT05115903|Etanercept|etanercept|mesh-list
1730590|NCT05115903|Golimumab|golimumab|mesh-list
1730591|NCT05115903|Infliximab|infliximab|mesh-list
1730592|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
1730593|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1730594|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1730595|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1730596|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1730597|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1730598|NCT05115903|Analgesics|analgesics|mesh-ancestor
1730599|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
1730600|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1730601|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730602|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1730603|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1730604|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
1730605|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
1730606|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1730645|NCT05115578|Midazolam|midazolam|mesh-list
1730646|NCT05115578|Remifentanil|remifentanil|mesh-list
1730647|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1730648|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1730649|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1730650|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730651|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1730652|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1730653|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1730654|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1730655|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
1730656|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
1730657|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
1730658|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
1730659|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1730660|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730661|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1730662|NCT05115578|Narcotics|narcotics|mesh-ancestor
1730663|NCT05115578|Analgesics|analgesics|mesh-ancestor
1730664|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
1730665|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1730680|NCT05115409|Rituximab|rituximab|mesh-list
1730681|NCT05115409|Antibodies|antibodies|mesh-list
1730682|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
1730683|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730684|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1730685|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730686|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1730689|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
1730690|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
1730691|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730692|NCT05115149|Protective Agents|protective agents|mesh-ancestor
1730693|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730694|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1730695|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730696|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
1730697|NCT05115136|Promethazine|promethazine|mesh-list
1730698|NCT05115136|Doxepin|doxepin|mesh-list
1730699|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1730700|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1730701|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1730702|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730703|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
1730704|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
1730705|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
1730706|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1730707|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
1730708|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
1730709|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1730710|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1730711|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
1730712|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
1730713|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1730714|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730715|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1730716|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
1730717|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
1730718|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1730719|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
1730720|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1730721|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1730722|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1730723|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1730724|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1730725|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730726|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1730727|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730728|NCT05115123|Analgesics|analgesics|mesh-ancestor
1730729|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
1730730|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1730731|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
1730732|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1730733|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
1730738|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
1730739|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1730740|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730792|NCT05114499|Donepezil|donepezil|mesh-list
1730793|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1730794|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1730795|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730796|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
1730797|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1730798|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730799|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
1730815|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
1730816|NCT05114421|Lenvatinib|lenvatinib|mesh-list
1730817|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1730818|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730819|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1730820|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1730821|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730822|NCT05114239|Timolol|timolol|mesh-list
1730823|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1730824|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1730825|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1730826|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1730827|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
1730828|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1730829|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730830|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730831|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1730832|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1730833|NCT05114096|Betamethasone|betamethasone|mesh-list
1730834|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
1730835|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
1730836|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
1730837|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
1730838|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1730839|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
1730840|NCT05114096|Hormones|hormones|mesh-ancestor
1730841|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1730842|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730843|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1730844|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
1730860|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
1730861|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1730862|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1730863|NCT05113901|Prednisolone|prednisolone|mesh-list
1730864|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
1730865|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1730866|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
1730867|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1730868|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
1730869|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
1730870|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1730871|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730872|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1730873|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
1730874|NCT05113901|Hormones|hormones|mesh-ancestor
1730875|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1730876|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1730877|NCT05113901|Protective Agents|protective agents|mesh-ancestor
1730878|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1730879|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730890|NCT05113628|Methylene Blue|methylene blue|mesh-list
1730891|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1730892|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730893|NCT05113615|Bromides|bromides|mesh-list
1730894|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
1730895|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1730896|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
1730897|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1730898|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730899|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1730900|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
1730901|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
1730902|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1730903|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
1730904|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1730905|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730906|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
1730907|NCT05113537|177Lu-PSMA-617|177lu-psma-617|mesh-list
1730908|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730909|NCT05113537|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1730910|NCT05113511|Bevacizumab|bevacizumab|mesh-list
1730911|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1730912|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730913|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1730914|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1730915|NCT05113511|Growth Substances|growth substances|mesh-ancestor
1730916|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730917|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
1730920|NCT05113368|Fulvestrant|fulvestrant|mesh-list
1730921|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1730922|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730923|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1730924|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1730925|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
1730926|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1730927|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730956|NCT05113186|Lenvatinib|lenvatinib|mesh-list
1730957|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730958|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1730959|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1730960|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730961|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
1730962|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
1730963|NCT05113004|Leflunomide|leflunomide|mesh-list
1730964|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1730965|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730966|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1730967|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
1730968|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1730969|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1730970|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1730971|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1730972|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
1730973|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1730974|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1730975|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1730976|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1730977|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
1730978|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1730979|NCT05112991|Lenvatinib|lenvatinib|mesh-list
1730980|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1730981|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1730982|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1730983|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731013|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1731014|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1731015|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1731016|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1731017|NCT05112692|Cetrorelix|cetrorelix|mesh-list
1731018|NCT05112692|Menotropins|menotropins|mesh-list
1731019|NCT05112692|Estradiol|estradiol|mesh-list
1731020|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1731021|NCT05112692|Progesterone|progesterone|mesh-list
1731022|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
1731023|NCT05112692|Estrogens|estrogens|mesh-ancestor
1731024|NCT05112692|Hormones|hormones|mesh-ancestor
1731025|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1731026|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731027|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1731028|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
1731029|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1731030|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1731031|NCT05112692|Progestins|progestins|mesh-ancestor
1731032|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
1731033|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1731034|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731035|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1731036|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
1731037|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
1731094|NCT05105919|Aspirin|aspirin|mesh-list
1731095|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1731096|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1731097|NCT05105919|Analgesics|analgesics|mesh-ancestor
1731098|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
1731099|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1731100|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731101|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1731102|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1731103|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1731104|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1731105|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731106|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1731107|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1731108|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731109|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
1731110|NCT05105685|Hormones|hormones|mesh-list
1731111|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1731112|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731142|NCT05103306|Empagliflozin|empagliflozin|mesh-list
1731143|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1731144|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731145|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1731146|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731147|NCT05102669|Antibodies|antibodies|mesh-list
1731148|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
1731149|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731150|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
1731151|NCT05101629|Lenvatinib|lenvatinib|mesh-list
1731152|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1731153|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731154|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1731155|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731156|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731157|NCT05100472|Androgens|androgens|mesh-list
1731158|NCT05100472|Hormones|hormones|mesh-ancestor
1731159|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1731160|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731161|NCT05096962|Antibodies|antibodies|mesh-list
1731162|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
1731163|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731164|NCT05091242|Clonidine|clonidine|mesh-list
1731165|NCT05091242|Analgesics|analgesics|mesh-ancestor
1731166|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
1731167|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1731168|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731169|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1731170|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
1731171|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
1731172|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1731173|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1731174|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1731175|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
1731176|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1731177|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731178|NCT05089916|Osimertinib|osimertinib|mesh-list
1731179|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731180|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1731181|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731182|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731189|NCT05088252|Propofol|propofol|mesh-list
1731190|NCT05088252|Desflurane|desflurane|mesh-list
1731191|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1731192|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1731193|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731194|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1731195|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
1731196|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
1731197|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1731257|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
1731258|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1731259|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1731260|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1731261|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1731262|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731263|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731264|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731282|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
1731283|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
1731284|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
1731285|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731286|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1731287|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1731288|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
1731311|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
1731312|NCT05073822|Tacrolimus|tacrolimus|mesh-list
1731313|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1731314|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
1731315|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731316|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1731317|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731318|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731319|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1731320|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731321|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1731322|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
1731323|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1731324|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1731325|NCT05068336|Anesthetics|anesthetics|mesh-list
1731326|NCT05068336|Sevoflurane|sevoflurane|mesh-list
1731327|NCT05068336|Desflurane|desflurane|mesh-list
1731328|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1731329|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731330|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1731331|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1731332|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
1731431|NCT05036109|Analgesics|analgesics|mesh-ancestor
1731356|NCT05062785|Insulin|insulin|mesh-list
1731357|NCT05062785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1731358|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1731359|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731394|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
1731395|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1731396|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731408|NCT05040126|Linezolid|linezolid|mesh-list
1731409|NCT05040126|Bedaquiline|bedaquiline|mesh-list
1731410|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1731411|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1731412|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1731413|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731414|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731415|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
1731423|NCT05036109|Aspirin|aspirin|mesh-list
1731424|NCT05036109|Vitamin D|vitamin d|mesh-list
1731425|NCT05036109|Vitamins|vitamins|mesh-ancestor
1731426|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
1731427|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731428|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1731429|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1731430|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1731432|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
1731433|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1731434|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1731435|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1731436|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1731437|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1731438|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731439|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1731440|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1731441|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731442|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
1731490|NCT05024747|Nicotine|nicotine|mesh-list
1731491|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1731492|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
1731493|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1731494|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731495|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1731496|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1731497|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
1731498|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1731499|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731531|NCT05015335|Adalimumab|adalimumab|mesh-list
1731532|NCT05015335|Methotrexate|methotrexate|mesh-list
1731533|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1731534|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
1731535|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1731536|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731537|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1731538|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
1731539|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731540|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731541|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
1731542|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731543|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1731544|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1731545|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
1731546|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1731547|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1731548|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1731572|NCT05012865|Avelumab|avelumab|mesh-list
1731573|NCT05012865|Axitinib|axitinib|mesh-list
1731574|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1731575|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731576|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1731577|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731578|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731579|NCT05011266|Buprenorphine|buprenorphine|mesh-list
1731580|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1731581|NCT05011266|Naloxone|naloxone|mesh-list
1731582|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1731583|NCT05011266|Narcotics|narcotics|mesh-ancestor
1731584|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1731585|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731586|NCT05011266|Analgesics|analgesics|mesh-ancestor
1731587|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
1731588|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1731589|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1731604|NCT05003102|Fentanyl|fentanyl|mesh-list
1731605|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
1731606|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1731607|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1731608|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731609|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1731610|NCT05003102|Analgesics|analgesics|mesh-ancestor
1731611|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
1731612|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1731613|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1731614|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1731615|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1731616|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
1731617|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1731618|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731619|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1731620|NCT05003102|Narcotics|narcotics|mesh-ancestor
1731621|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1731622|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1731623|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
1731624|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
1731625|NCT05001880|Bevacizumab|bevacizumab|mesh-list
1731626|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1731627|NCT05001880|Carboplatin|carboplatin|mesh-list
1731628|NCT05001880|Pemetrexed|pemetrexed|mesh-list
1731629|NCT05001880|Atezolizumab|atezolizumab|mesh-list
1731630|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
1731631|NCT05001880|Antibodies|antibodies|mesh-list
1731632|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
1731633|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1731634|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
1731635|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731636|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1731637|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1731638|NCT05001880|Growth Substances|growth substances|mesh-ancestor
1731639|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731640|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
1731641|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
1731642|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731643|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731644|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1731645|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1731653|NCT04989283|Paclitaxel|paclitaxel|mesh-list
1731654|NCT04989283|Etoposide|etoposide|mesh-list
1731655|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
1731656|NCT04989283|Cisplatin|cisplatin|mesh-list
1731657|NCT04989283|Carboplatin|carboplatin|mesh-list
1731658|NCT04989283|Pemetrexed|pemetrexed|mesh-list
1731659|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1731660|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
1731661|NCT04989283|Atezolizumab|atezolizumab|mesh-list
1731662|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1731663|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1731664|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731665|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
1731666|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
1731667|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
1731668|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731669|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1731670|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1731671|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731672|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1731673|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1731674|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
1731675|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731676|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
1731677|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
1731683|NCT04984811|Atezolizumab|atezolizumab|mesh-list
1731684|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731685|NCT04982796|Psilocybin|psilocybin|mesh-list
1731686|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
1731687|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731688|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1731689|NCT04979806|Meropenem|meropenem|mesh-list
1731690|NCT04979806|Cefepime|cefepime|mesh-list
1731691|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1731692|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1731713|NCT04973345|Terbutaline|terbutaline|mesh-list
1731714|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1731715|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
1731716|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1731717|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731718|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1731719|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
1731720|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
1731721|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
1731722|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1731723|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1731724|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1731725|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1731726|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
1731727|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1731728|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731737|NCT04964622|Ibuprofen|ibuprofen|mesh-list
1731738|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1731739|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1731740|NCT04964622|Analgesics|analgesics|mesh-ancestor
1731741|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
1731742|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1731743|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731744|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1731745|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1731746|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1731747|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731748|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731749|NCT04963816|Dexamethasone|dexamethasone|mesh-list
1731750|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
1731751|NCT04963816|Bupivacaine|bupivacaine|mesh-list
1731752|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1731753|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1731754|NCT04963816|BB 1101|bb 1101|mesh-list
1731755|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1731756|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
1731757|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
1731758|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1731759|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731760|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1731761|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
1731762|NCT04963816|Hormones|hormones|mesh-ancestor
1731763|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1731764|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1731765|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731766|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
1731767|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731768|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731769|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
1731770|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
1731771|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1731772|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
1731773|NCT04954339|Bevacizumab|bevacizumab|mesh-list
1731774|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1731775|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731776|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1731777|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1731778|NCT04954339|Growth Substances|growth substances|mesh-ancestor
1731779|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731780|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
1731781|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
1731782|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731783|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1731784|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731785|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731786|NCT04951804|Bupivacaine|bupivacaine|mesh-list
1731787|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
1731788|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
1731789|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1731790|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731791|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
1731792|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1731793|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
1731794|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1731795|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1731796|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731797|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
1731798|NCT04947514|Coagulants|coagulants|mesh-ancestor
1731806|NCT04944771|Rabeprazole|rabeprazole|mesh-list
1731807|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1731808|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1731809|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1731810|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731811|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731820|NCT04939753|Sevoflurane|sevoflurane|mesh-list
1731821|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1731822|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1731823|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
1731824|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
1731825|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1731826|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1731827|NCT04937413|Evolocumab|evolocumab|mesh-list
1731828|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1731829|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1731830|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
1731831|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731832|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1731901|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
1731902|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1731903|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731912|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
1731913|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731947|NCT04899206|Antihypertensive Agents|antihypertensive agents|mesh-list
1731948|NCT04899206|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1731949|NCT04899206|Protease Inhibitors|protease inhibitors|mesh-ancestor
1731950|NCT04899206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731951|NCT04899206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731985|NCT04871529|Gemcitabine|gemcitabine|mesh-list
1731986|NCT04871529|Carboplatin|carboplatin|mesh-list
1731987|NCT04871529|Avelumab|avelumab|mesh-list
1731988|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
1731989|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
1731990|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1731991|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1731992|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1731993|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
1731994|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1731995|NCT04871529|Antiviral Agents|antiviral agents|mesh-ancestor
1731996|NCT04871529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1731997|NCT04871529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1731998|NCT04871529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1731999|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
1732000|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732001|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1732012|NCT04869449|Ketoconazole|ketoconazole|mesh-list
1732013|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
1732014|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1732015|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1732016|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1732017|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1732018|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732019|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1732020|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
1732021|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1732022|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732023|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1732027|NCT04862468|Dexamethasone|dexamethasone|mesh-list
1732028|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1732029|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
1732030|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
1732031|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1732032|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732033|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1732034|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
1732035|NCT04862468|Hormones|hormones|mesh-ancestor
1732036|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1732037|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1732038|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732039|NCT04858776|Dexamethasone|dexamethasone|mesh-list
1732040|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1732041|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
1732042|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
1732043|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1732044|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732045|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1732046|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
1732047|NCT04858776|Hormones|hormones|mesh-ancestor
1732048|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1732049|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1732050|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732053|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
1732054|NCT04851522|Eusol|eusol|mesh-list
1732055|NCT04851522|Petrolatum|petrolatum|mesh-list
1732056|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
1732057|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1732058|NCT04851522|Emollients|emollients|mesh-ancestor
1732059|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
1732074|NCT04847453|Dexamethasone|dexamethasone|mesh-list
1732075|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
1732076|NCT04847453|Venetoclax|venetoclax|mesh-list
1732077|NCT04847453|Ixazomib|ixazomib|mesh-list
1732078|NCT04847453|Ichthammol|ichthammol|mesh-list
1732079|NCT04847453|BB 1101|bb 1101|mesh-list
1732080|NCT04847453|Glycine|glycine|mesh-list
1732081|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1732082|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
1732083|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
1732084|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1732085|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732086|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1732087|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
1732088|NCT04847453|Hormones|hormones|mesh-ancestor
1732089|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1732090|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1732091|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732092|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
1732093|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1732094|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732095|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
1732096|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
1732097|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1732139|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
1732140|NCT04828486|Futibatinib|futibatinib|mesh-list
1732141|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1732142|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732163|NCT04820686|Tenofovir|tenofovir|mesh-list
1732164|NCT04820686|Entecavir|entecavir|mesh-list
1732165|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
1732166|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1732167|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1732168|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1732169|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1732170|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732171|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1732172|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1732189|NCT04819568|Terlipressin|terlipressin|mesh-list
1732190|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1732191|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1732192|NCT04818489|Colchicine|colchicine|mesh-list
1732193|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
1732194|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1732195|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
1732196|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
1732197|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
1732198|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732199|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732222|NCT04812366|Prednisone|prednisone|mesh-list
1732223|NCT04812366|Docetaxel|docetaxel|mesh-list
1732224|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
1732225|NCT04812366|Niraparib|niraparib|mesh-list
1732226|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732227|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
1732228|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
1732229|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
1732230|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732231|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1732232|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
1732233|NCT04812366|Hormones|hormones|mesh-ancestor
1732234|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1732235|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732236|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1732237|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1732238|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1732239|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
1732240|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1732241|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1732250|NCT04802408|Listerine|listerine|mesh-list
1732251|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
1732252|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1732253|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1732254|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
1732255|NCT04802408|Protective Agents|protective agents|mesh-ancestor
1732256|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732257|NCT04796467|Edetic Acid|edetic acid|mesh-list
1732258|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1732259|NCT04796467|Anticoagulants|anticoagulants|mesh-ancestor
1732260|NCT04796467|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1732261|NCT04796467|Chelating Agents|chelating agents|mesh-ancestor
1732262|NCT04796467|Sequestering Agents|sequestering agents|mesh-ancestor
1732263|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732264|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1732288|NCT04781647|Interferons|interferons|mesh-list
1732289|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
1732290|NCT04781647|Entecavir|entecavir|mesh-list
1732291|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732292|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
1732293|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1732294|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
1732295|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732321|NCT04765787|Acetaminophen|acetaminophen|mesh-list
1732322|NCT04765787|Orphenadrine|orphenadrine|mesh-list
1732323|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1732324|NCT04765787|Analgesics|analgesics|mesh-ancestor
1732325|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
1732326|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1732327|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732328|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
1732329|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1732330|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1732331|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1732332|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1732333|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
1732334|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
1732335|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1732336|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1732337|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
1732338|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1732339|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732340|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
1732341|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1732342|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1732413|NCT04756791|Anesthetics|anesthetics|mesh-list
1732414|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1732415|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732426|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
1732427|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1732428|NCT04748250|Estrogens|estrogens|mesh-ancestor
1732429|NCT04748250|Hormones|hormones|mesh-ancestor
1732430|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1732431|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732439|NCT04726878|Acetaminophen|acetaminophen|mesh-list
1732440|NCT04726878|Oxycodone|oxycodone|mesh-list
1732441|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1732442|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732443|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1732444|NCT04726878|Analgesics|analgesics|mesh-ancestor
1732445|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
1732446|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1732447|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
1732448|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1732449|NCT04726878|Narcotics|narcotics|mesh-ancestor
1732455|NCT04718727|Olanzapine|olanzapine|mesh-list
1732456|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
1732457|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
1732458|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1732459|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732460|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1732461|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1732462|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1732463|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1732464|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1732465|NCT04718727|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1732466|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1732467|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1732468|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732469|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1732470|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
1732473|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
1732474|NCT04714372|Fludarabine|fludarabine|mesh-list
1732475|NCT04714372|Daratumumab|daratumumab|mesh-list
1732476|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1732477|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
1732478|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732479|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1732480|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1732481|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
1732482|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732483|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732484|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1732515|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1732516|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
1732517|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1732518|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
1732519|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1732520|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732521|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1732522|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1732523|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1732524|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732525|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1732526|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1732527|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1732528|NCT04669002|Olaparib|olaparib|mesh-list
1732529|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1732530|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1732531|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732532|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732568|NCT04647916|Camptothecin|camptothecin|mesh-list
1732569|NCT04647916|Irinotecan|irinotecan|mesh-list
1732570|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
1732571|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
1732572|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732573|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1732574|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732575|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1732576|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1732577|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1732578|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732613|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
1732614|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732615|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
1732616|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1732617|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
1732675|NCT04605614|Copper|copper|mesh-list
1732676|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
1732677|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1732678|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732679|NCT04605614|Trace Elements|trace elements|mesh-ancestor
1732680|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
1732681|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732693|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
1732698|NCT04585295|Betaine|betaine|mesh-list
1732699|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1732700|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
1732701|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1732702|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
1732703|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732704|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1732715|NCT04583488|Docetaxel|docetaxel|mesh-list
1732716|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732717|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
1732718|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
1732719|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
1732720|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732763|NCT04568616|Letrozole|letrozole|mesh-list
1732764|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732765|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1732766|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1732767|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1732768|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732769|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1732770|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
1732771|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1732772|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732784|NCT04560868|Nicotine|nicotine|mesh-list
1732785|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1732786|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
1732787|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1732788|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732789|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1732790|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1732791|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
1732792|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1732793|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732794|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
1732795|NCT04557215|Rifaximin|rifaximin|mesh-list
1732796|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1732797|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
1732798|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1732799|NCT04557215|Expectorants|expectorants|mesh-ancestor
1732800|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
1732801|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1732802|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
1732803|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732804|NCT04557215|Protective Agents|protective agents|mesh-ancestor
1732805|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732806|NCT04557215|Antidotes|antidotes|mesh-ancestor
1732807|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1732808|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1732809|NCT04551521|Trastuzumab|trastuzumab|mesh-list
1732810|NCT04551521|Pertuzumab|pertuzumab|mesh-list
1732811|NCT04551521|Atezolizumab|atezolizumab|mesh-list
1732812|NCT04551521|Vemurafenib|vemurafenib|mesh-list
1732813|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1732814|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1732815|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732816|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
1732817|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732818|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1732819|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1732820|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732828|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
1732829|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1732830|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1732831|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732832|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1732833|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1732907|NCT04526197|Celecoxib|celecoxib|mesh-list
1732908|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
1732909|NCT04526197|Choline|choline|mesh-list
1732910|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1732911|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1732912|NCT04526197|Analgesics|analgesics|mesh-ancestor
1732913|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
1732914|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1732915|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732916|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1732917|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1732918|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1732919|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1732920|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1732921|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732922|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
1732923|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1732924|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
1732925|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1732926|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1732927|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
1732928|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
1732929|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
1732930|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1732931|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1732932|NCT04526197|Growth Substances|growth substances|mesh-ancestor
1732933|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
1732934|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732940|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
1732941|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1732942|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732943|NCT04511013|Nivolumab|nivolumab|mesh-list
1732944|NCT04511013|Ipilimumab|ipilimumab|mesh-list
1732945|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1732946|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1732947|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1732948|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732977|NCT04481919|Diuretics|diuretics|mesh-list
1732978|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
1732979|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732980|NCT04479579|Apixaban|apixaban|mesh-list
1732981|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1732982|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
1732983|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1732984|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
1732985|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1732986|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732987|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
1732988|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
1732989|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
1732990|NCT04479566|Calcium|calcium|mesh-list
1732991|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1732992|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1732993|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
1732994|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1732995|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1732996|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1732997|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
1732998|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1732999|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1733000|NCT04479566|Antacids|antacids|mesh-ancestor
1733001|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1733013|NCT04477512|Prednisone|prednisone|mesh-list
1733014|NCT04477512|Nivolumab|nivolumab|mesh-list
1733015|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
1733016|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1733017|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
1733018|NCT04477512|Hormones|hormones|mesh-ancestor
1733019|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1733020|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733021|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1733022|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733023|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1733024|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1733025|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733026|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1733027|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1733028|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
1733029|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1733049|NCT04468230|Nicotine|nicotine|mesh-list
1733050|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1733051|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
1733052|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1733053|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733054|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1733055|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1733056|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
1733057|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1733058|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733087|NCT04438382|Prednisone|prednisone|mesh-list
1733088|NCT04438382|Cortisone|cortisone|mesh-list
1733089|NCT04438382|Infliximab|infliximab|mesh-list
1733090|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
1733091|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1733092|NCT04438382|Antibodies|antibodies|mesh-list
1733093|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
1733094|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1733095|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
1733096|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1733097|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
1733098|NCT04438382|Hormones|hormones|mesh-ancestor
1733099|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1733100|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733101|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1733102|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733103|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
1733104|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
1733105|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1733106|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1733118|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
1733119|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1733120|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733132|NCT04424225|Niacin|niacin|mesh-list
1733133|NCT04424225|Psilocybin|psilocybin|mesh-list
1733134|NCT04424225|Vitamins|vitamins|mesh-ancestor
1733135|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
1733136|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733137|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
1733138|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1733139|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
1733140|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733141|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1733142|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
1733143|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
1733144|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1733145|NCT04418895|Leucovorin|leucovorin|mesh-list
1733146|NCT04418895|Fluorouracil|fluorouracil|mesh-list
1733147|NCT04418895|Capecitabine|capecitabine|mesh-list
1733148|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
1733149|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
1733150|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733151|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
1733152|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733153|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1733154|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733155|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1733156|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
1733157|NCT04418895|Antidotes|antidotes|mesh-ancestor
1733158|NCT04418895|Protective Agents|protective agents|mesh-ancestor
1733159|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
1733160|NCT04418895|Vitamins|vitamins|mesh-ancestor
1733161|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
1733162|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1733163|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1733164|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1733165|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
1733166|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733191|NCT04398134|Entecavir|entecavir|mesh-list
1733192|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
1733193|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1733203|NCT04396535|Docetaxel|docetaxel|mesh-list
1733204|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733205|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
1733206|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
1733207|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
1733208|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733226|NCT04390763|Gemcitabine|gemcitabine|mesh-list
1733227|NCT04390763|Paclitaxel|paclitaxel|mesh-list
1733228|NCT04390763|Spartalizumab|spartalizumab|mesh-list
1733229|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1733230|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733231|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
1733232|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
1733233|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
1733234|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733235|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1733236|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
1733237|NCT04390763|Antiviral Agents|antiviral agents|mesh-ancestor
1733238|NCT04390763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1733239|NCT04390763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1733240|NCT04390763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1733241|NCT04390763|Immunologic Factors|immunologic factors|mesh-ancestor
1733242|NCT04390763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733243|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1733244|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1733245|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
1733255|NCT04378426|Midazolam|midazolam|mesh-list
1733256|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
1733257|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1733258|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1733259|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1733260|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733261|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1733262|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1733263|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1733264|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1733265|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
1733266|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
1733267|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
1733268|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
1733269|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1733270|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733271|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1733272|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1733273|NCT04378426|Analgesics|analgesics|mesh-ancestor
1733274|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
1733275|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1733276|NCT04376281|Norepinephrine|norepinephrine|mesh-list
1733277|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1733278|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1733279|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
1733280|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1733281|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733282|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733283|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
1733284|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
1733285|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1733286|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1733322|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
1733323|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1733324|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
1733325|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733326|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
1733327|NCT04332445|Protective Agents|protective agents|mesh-ancestor
1733328|NCT04331067|Paclitaxel|paclitaxel|mesh-list
1733329|NCT04331067|Carboplatin|carboplatin|mesh-list
1733330|NCT04331067|Nivolumab|nivolumab|mesh-list
1733331|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1733332|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733333|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
1733334|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
1733335|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
1733336|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733337|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1733338|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1733339|NCT04316910|Anesthetics|anesthetics|mesh-list
1733340|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
1733341|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1733342|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733343|NCT04315272|Azithromycin|azithromycin|mesh-list
1733344|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1733345|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1733346|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
1733347|NCT04314050|Tramadol|tramadol|mesh-list
1733348|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1733349|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1733350|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733351|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1733352|NCT04314050|Analgesics|analgesics|mesh-ancestor
1733353|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
1733354|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1733355|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1733356|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1733357|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1733358|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
1733359|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1733360|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733361|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1733362|NCT04314050|Narcotics|narcotics|mesh-ancestor
1733405|NCT04299490|Analgesics|analgesics|mesh-list
1733406|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733407|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
1733408|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1733409|NCT04299373|Ethanol|ethanol|mesh-list
1733410|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1733411|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1733564|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
1733412|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1733413|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733423|NCT04282109|Paclitaxel|paclitaxel|mesh-list
1733424|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1733425|NCT04282109|Nivolumab|nivolumab|mesh-list
1733426|NCT04282109|Cetuximab|cetuximab|mesh-list
1733427|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1733428|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733429|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
1733430|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
1733431|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
1733432|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733433|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1733434|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1733435|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
1733436|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1733437|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733466|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
1733467|NCT04267120|Lenvatinib|lenvatinib|mesh-list
1733468|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1733469|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733470|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1733471|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1733472|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733473|NCT04265534|Folic Acid|folic acid|mesh-list
1733474|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
1733475|NCT04265534|Hydroxocobalamin|hydroxocobalamin|mesh-list
1733476|NCT04265534|Dexamethasone|dexamethasone|mesh-list
1733477|NCT04265534|Carboplatin|carboplatin|mesh-list
1733478|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
1733479|NCT04265534|Pemetrexed|pemetrexed|mesh-list
1733480|NCT04265534|Vitamins|vitamins|mesh-ancestor
1733481|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
1733482|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733483|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1733484|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
1733485|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
1733486|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1733487|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1733488|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
1733489|NCT04265534|Hormones|hormones|mesh-ancestor
1733490|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1733491|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1733492|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733493|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1733494|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1733495|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733496|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1733497|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1733498|NCT04265534|Hematinics|hematinics|mesh-ancestor
1733499|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
1733500|NCT04261075|Durvalumab|durvalumab|mesh-list
1733501|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1733502|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733510|NCT04240054|Dexamethasone|dexamethasone|mesh-list
1733511|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
1733512|NCT04240054|Bortezomib|bortezomib|mesh-list
1733513|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1733514|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
1733515|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733516|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1733517|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1733518|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
1733519|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733520|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733521|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1733522|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1733523|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
1733524|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
1733525|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1733526|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1733527|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
1733528|NCT04240054|Hormones|hormones|mesh-ancestor
1733529|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1733530|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1733543|NCT04236141|Rituximab|rituximab|mesh-list
1733544|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1733545|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1733546|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733547|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
1733548|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733549|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1733550|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1733551|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
1733552|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733553|NCT04233190|Budesonide|budesonide|mesh-list
1733554|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
1733555|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1733556|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
1733557|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1733558|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733559|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1733560|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
1733561|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1733562|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1733563|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1733565|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1733566|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733567|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1733568|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
1733569|NCT04233190|Hormones|hormones|mesh-ancestor
1733570|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1733609|NCT04210037|Paclitaxel|paclitaxel|mesh-list
1733610|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1733611|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733612|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
1733613|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
1733614|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
1733615|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733624|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
1733625|NCT04205968|Leucovorin|leucovorin|mesh-list
1733626|NCT04205968|Folic Acid|folic acid|mesh-list
1733627|NCT04205968|Paclitaxel|paclitaxel|mesh-list
1733628|NCT04205968|Camptothecin|camptothecin|mesh-list
1733629|NCT04205968|Fluorouracil|fluorouracil|mesh-list
1733630|NCT04205968|Irinotecan|irinotecan|mesh-list
1733631|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1733632|NCT04205968|Ramucirumab|ramucirumab|mesh-list
1733633|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1733634|NCT04205968|Antibodies|antibodies|mesh-list
1733635|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
1733636|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1733637|NCT04205968|Calcium|calcium|mesh-list
1733638|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
1733639|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1733640|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1733641|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
1733642|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
1733643|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
1733644|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733645|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
1733646|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733647|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1733648|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1733649|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
1733650|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1733651|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1733652|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1733653|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1733654|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1733655|NCT04205968|Antidotes|antidotes|mesh-ancestor
1733656|NCT04205968|Protective Agents|protective agents|mesh-ancestor
1733657|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
1733658|NCT04205968|Vitamins|vitamins|mesh-ancestor
1733659|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
1733660|NCT04205968|Hematinics|hematinics|mesh-ancestor
1733661|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
1733662|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
1733663|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1733664|NCT04205786|Vitamins|vitamins|mesh-ancestor
1733665|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
1733666|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733667|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
1733668|NCT04205786|Hematinics|hematinics|mesh-ancestor
1733669|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1733670|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1733671|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733672|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1733673|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
1733674|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1733679|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
1733680|NCT04198961|Narcotics|narcotics|mesh-ancestor
1733681|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1733682|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733683|NCT04198961|Analgesics|analgesics|mesh-ancestor
1733684|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
1733685|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1733686|NCT04198623|Montelukast|montelukast|mesh-list
1733687|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1733688|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
1733689|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1733690|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
1733691|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1733692|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733693|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1733694|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1733695|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733705|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
1733706|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1733707|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
1733708|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733709|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
1733710|NCT04192630|Protective Agents|protective agents|mesh-ancestor
1733714|NCT04189510|Pancrelipase|pancrelipase|mesh-list
1733715|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1733724|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
1733725|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
1733726|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1733727|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1733728|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733729|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
1733730|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
1733837|NCT04134845|Dantrolene|dantrolene|mesh-list
1733838|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1733839|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733840|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1733841|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1733846|NCT04123067|Pioglitazone|pioglitazone|mesh-list
1733847|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1733848|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733910|NCT04094558|Lactulose|lactulose|mesh-list
1733911|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1733991|NCT04071457|Lenalidomide|lenalidomide|mesh-list
1733992|NCT04071457|Daratumumab|daratumumab|mesh-list
1733993|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
1733994|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1733995|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1733996|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1733997|NCT04071457|Growth Substances|growth substances|mesh-ancestor
1733998|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
1733999|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734013|NCT04050462|Nivolumab|nivolumab|mesh-list
1734014|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1734015|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734016|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1734017|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734018|NCT04038346|Acetaminophen|acetaminophen|mesh-list
1734019|NCT04038346|Naproxen|naproxen|mesh-list
1734020|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1734021|NCT04038346|Analgesics|analgesics|mesh-ancestor
1734022|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
1734023|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1734024|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734025|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
1734026|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1734027|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1734028|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1734029|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
1734030|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1734031|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1734032|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734033|NCT04034927|Olaparib|olaparib|mesh-list
1734034|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1734035|NCT04034927|Tremelimumab|tremelimumab|mesh-list
1734036|NCT04034927|Ipilimumab|ipilimumab|mesh-list
1734037|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1734038|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734039|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734040|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1734041|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1734044|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1734045|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1734046|NCT03996265|Bupropion|bupropion|mesh-list
1734047|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1734048|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
1734049|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1734050|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1734051|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1734052|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1734053|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734054|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
1734055|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1734056|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734057|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1734058|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1734059|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1734074|NCT03980483|Methotrexate|methotrexate|mesh-list
1734075|NCT03980483|Tofacitinib|tofacitinib|mesh-list
1734076|NCT03980483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1734077|NCT03980483|Abortifacient Agents|abortifacient agents|mesh-ancestor
1734078|NCT03980483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1734079|NCT03980483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734080|NCT03980483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1734081|NCT03980483|Antimetabolites|antimetabolites|mesh-ancestor
1734082|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734083|NCT03980483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734084|NCT03980483|Dermatologic Agents|dermatologic agents|mesh-ancestor
1734085|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1734086|NCT03980483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1734087|NCT03980483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1734088|NCT03980483|Immunologic Factors|immunologic factors|mesh-ancestor
1734089|NCT03980483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1734090|NCT03980483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1734091|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1734100|NCT03957590|Paclitaxel|paclitaxel|mesh-list
1734101|NCT03957590|Cisplatin|cisplatin|mesh-list
1734102|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1734103|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734104|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
1734105|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
1734106|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
1734107|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734120|NCT03943901|Prednisone|prednisone|mesh-list
1734121|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
1734122|NCT03943901|Rituximab|rituximab|mesh-list
1734123|NCT03943901|Doxorubicin|doxorubicin|mesh-list
1734124|NCT03943901|Vincristine|vincristine|mesh-list
1734125|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1734126|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
1734127|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734128|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1734129|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1734130|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
1734131|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734132|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734133|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1734134|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1734135|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1734136|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1734137|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1734138|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1734139|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1734140|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
1734141|NCT03943901|Hormones|hormones|mesh-ancestor
1734142|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1734143|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1734144|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1734145|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
1734146|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
1734147|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
1734193|NCT03932136|Sulforaphane|sulforaphane|mesh-list
1734194|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1734195|NCT03932136|Protective Agents|protective agents|mesh-ancestor
1734196|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734197|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734218|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1734219|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1734238|NCT03904199|Insulin|insulin|mesh-list
1734239|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1734240|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1734241|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734251|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1734252|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
1734253|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734254|NCT03891849|Octreotide|octreotide|mesh-list
1734255|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1734256|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1734257|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734273|NCT03890133|Pregabalin|pregabalin|mesh-list
1734274|NCT03890133|Analgesics|analgesics|mesh-ancestor
1734275|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
1734276|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1734277|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734278|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
1734279|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1734280|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1734281|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734282|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1734283|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1734284|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1734285|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1734286|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1734314|NCT03875638|Levetiracetam|levetiracetam|mesh-list
1734315|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
1734316|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
1734317|NCT03874234|GSK3186899|gsk3186899|mesh-list
1734318|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1734319|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1734320|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734321|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1734322|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1734323|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
1734324|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1734325|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734326|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734358|NCT03811886|Natalizumab|natalizumab|mesh-list
1734359|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
1734360|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734479|NCT03783923|Deflazacort|deflazacort|mesh-list
1734480|NCT03783923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1734481|NCT03783923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1734482|NCT03783923|Immunologic Factors|immunologic factors|mesh-ancestor
1734483|NCT03783923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734558|NCT03742414|Fluticasone|fluticasone|mesh-list
1734559|NCT03742414|Xhance|xhance|mesh-list
1734560|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1734561|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1734562|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
1734563|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1734564|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734565|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1734566|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
1734567|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
1734568|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1734598|NCT03727139|Rasagiline|rasagiline|mesh-list
1734599|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1734600|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1734601|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734602|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1734603|NCT03727139|Protective Agents|protective agents|mesh-ancestor
1734604|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734605|NCT03723772|Insulin|insulin|mesh-list
1734606|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1734607|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1734608|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734624|NCT03713580|Venetoclax|venetoclax|mesh-list
1734625|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734626|NCT03709758|Cytarabine|cytarabine|mesh-list
1734627|NCT03709758|Daunorubicin|daunorubicin|mesh-list
1734628|NCT03709758|Venetoclax|venetoclax|mesh-list
1734629|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1734630|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
1734631|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734632|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734633|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
1734634|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1734635|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1734636|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
1734637|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734638|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1734639|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1734640|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1734641|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1734677|NCT03678025|Prednisone|prednisone|mesh-list
1734678|NCT03678025|Cortisone|cortisone|mesh-list
1734679|NCT03678025|Docetaxel|docetaxel|mesh-list
1734680|NCT03678025|Leuprolide|leuprolide|mesh-list
1734681|NCT03678025|Goserelin|goserelin|mesh-list
1734682|NCT03678025|Bicalutamide|bicalutamide|mesh-list
1734683|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1734684|NCT03678025|Flutamide|flutamide|mesh-list
1734685|NCT03678025|Nilutamide|nilutamide|mesh-list
1734686|NCT03678025|Tryptophan|tryptophan|mesh-list
1734687|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734688|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
1734689|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
1734690|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
1734691|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734692|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1734693|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
1734694|NCT03678025|Hormones|hormones|mesh-ancestor
1734695|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1734696|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734697|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1734698|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1734699|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
1734700|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1734701|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
1734702|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
1734703|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
1734704|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1734705|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
1734706|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1734707|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1734708|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
1734709|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1734735|NCT03669523|Denosumab|denosumab|mesh-list
1734736|NCT03669523|Nivolumab|nivolumab|mesh-list
1734737|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1734738|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734739|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1734740|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734741|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1734742|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734743|NCT03631784|Paclitaxel|paclitaxel|mesh-list
1734744|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1734745|NCT03631784|Carboplatin|carboplatin|mesh-list
1734746|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
1734747|NCT03631784|Pemetrexed|pemetrexed|mesh-list
1734748|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1734749|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734750|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
1734751|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
1734752|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
1734753|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734754|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1734755|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1734756|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1734757|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1734758|NCT03625986|Nicotine|nicotine|mesh-list
1734759|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1734760|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
1734761|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1734762|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734763|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1734764|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1734765|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
1734766|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1734767|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734786|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
1734787|NCT03610490|Fludarabine|fludarabine|mesh-list
1734788|NCT03610490|Interleukin-2|interleukin-2|mesh-list
1734789|NCT03610490|Mitogens|mitogens|mesh-list
1734790|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1734791|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
1734792|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734793|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1734794|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1734795|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
1734796|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734797|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734798|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1734799|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1734800|NCT03610490|Analgesics|analgesics|mesh-ancestor
1734801|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
1734802|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1734803|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
1734804|NCT03608163|Diazoxide|diazoxide|mesh-list
1734805|NCT03608163|Naloxone|naloxone|mesh-list
1734806|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1734807|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734808|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
1734809|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1734810|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1734811|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
1734825|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
1734826|NCT03580473|Dexamethasone|dexamethasone|mesh-list
1734827|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1734828|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1734829|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
1734830|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
1734831|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1734832|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734833|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1734834|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
1734835|NCT03580473|Hormones|hormones|mesh-ancestor
1734836|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1734837|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1734838|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734839|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1734840|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734841|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1734842|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1734843|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1734844|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1734845|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1734846|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
1734847|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1734848|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1734849|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1734850|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1734877|NCT03567642|Etoposide|etoposide|mesh-list
1734878|NCT03567642|Osimertinib|osimertinib|mesh-list
1734879|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1734880|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734881|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1734882|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1734883|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1734884|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734885|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1734906|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
1734907|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1734908|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734914|NCT03526900|Atezolizumab|atezolizumab|mesh-list
1734915|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734954|NCT03504410|Cytarabine|cytarabine|mesh-list
1734955|NCT03504410|Fludarabine|fludarabine|mesh-list
1734956|NCT03504410|Etoposide|etoposide|mesh-list
1734957|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
1734958|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1734959|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1734960|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
1734961|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1734962|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1734963|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
1734964|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1734965|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1734966|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1734967|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1734968|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1734969|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
1734970|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1734971|NCT03504410|Analgesics|analgesics|mesh-ancestor
1734972|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
1734973|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1735019|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1735020|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1735021|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1735022|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
1735027|NCT03418961|Carvedilol|carvedilol|mesh-list
1735028|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1735029|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1735030|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
1735031|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1735032|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735033|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735034|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1735035|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
1735036|NCT03418961|Protective Agents|protective agents|mesh-ancestor
1735037|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1735038|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1735039|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1735040|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
1735041|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1735042|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1735043|NCT03416855|Insulin|insulin|mesh-list
1735044|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
1735045|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1735046|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735051|NCT03409718|Cimetidine|cimetidine|mesh-list
1735052|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1735053|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1735054|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1735055|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
1735056|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
1735057|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1735058|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735059|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735060|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1735061|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1735062|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1735063|NCT03404778|Cimetidine|cimetidine|mesh-list
1735064|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1735065|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1735066|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1735067|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
1735068|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
1735069|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1735070|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735071|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735072|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1735073|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1735074|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1735075|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
1735076|NCT03404180|Propofol|propofol|mesh-list
1735077|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
1735078|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1735079|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735080|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1735081|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
1735082|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
1735083|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1735084|NCT03404180|Analgesics|analgesics|mesh-ancestor
1735085|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
1735086|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1735087|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1735088|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1735089|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1735090|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
1735091|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1735092|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735093|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
1735094|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1735095|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1735096|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735097|NCT03347617|Hematinics|hematinics|mesh-ancestor
1735098|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1735099|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1735100|NCT03345784|Cisplatin|cisplatin|mesh-list
1735101|NCT03345784|Adavosertib|adavosertib|mesh-list
1735102|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735103|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1735104|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735105|NCT03342417|Nivolumab|nivolumab|mesh-list
1735106|NCT03342417|Ipilimumab|ipilimumab|mesh-list
1735107|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1735108|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735109|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1735110|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735111|NCT03328026|Interferons|interferons|mesh-list
1735112|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
1735113|NCT03328026|Vaccines|vaccines|mesh-list
1735114|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1735115|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
1735116|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735117|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1735118|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1735119|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
1735120|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735121|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735122|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1735123|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
1735124|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1735151|NCT03297606|Nivolumab|nivolumab|mesh-list
1735152|NCT03297606|Trastuzumab|trastuzumab|mesh-list
1735153|NCT03297606|Ipilimumab|ipilimumab|mesh-list
1735154|NCT03297606|Pertuzumab|pertuzumab|mesh-list
1735155|NCT03297606|Sunitinib|sunitinib|mesh-list
1735156|NCT03297606|Dasatinib|dasatinib|mesh-list
1735157|NCT03297606|Olaparib|olaparib|mesh-list
1735158|NCT03297606|Palbociclib|palbociclib|mesh-list
1735159|NCT03297606|Axitinib|axitinib|mesh-list
1735160|NCT03297606|Vemurafenib|vemurafenib|mesh-list
1735161|NCT03297606|Crizotinib|crizotinib|mesh-list
1735162|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1735163|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735164|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1735165|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735166|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1735167|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1735168|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1735169|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1735170|NCT03297606|Growth Substances|growth substances|mesh-ancestor
1735171|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735172|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
1735173|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1735174|NCT03293784|Nivolumab|nivolumab|mesh-list
1735175|NCT03293784|Ipilimumab|ipilimumab|mesh-list
1735176|NCT03293784|Infliximab|infliximab|mesh-list
1735177|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
1735178|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1735179|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735180|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1735181|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735182|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
1735183|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1735184|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1735185|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1735186|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
1735187|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735205|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1735206|NCT03234309|Hematinics|hematinics|mesh-ancestor
1735207|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1735208|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1735209|NCT03222609|Navitoclax|navitoclax|mesh-list
1735210|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735262|NCT03204396|Dulaglutide|dulaglutide|mesh-list
1735263|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1735264|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735318|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1735319|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1735320|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735321|NCT03107871|Valganciclovir|valganciclovir|mesh-list
1735322|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
1735323|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1735324|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
1735325|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735326|NCT03096041|Analgesics|analgesics|mesh-list
1735327|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
1735328|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1735329|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735340|NCT03080883|Apixaban|apixaban|mesh-list
1735341|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1735342|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
1735343|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1735344|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
1735345|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1735346|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735347|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
1735359|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
1735360|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1735361|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
1735362|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1735363|NCT03069300|Expectorants|expectorants|mesh-ancestor
1735364|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
1735365|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1735366|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
1735367|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735368|NCT03069300|Protective Agents|protective agents|mesh-ancestor
1735369|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735370|NCT03069300|Antidotes|antidotes|mesh-ancestor
1735371|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
1735372|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1735373|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735374|NCT03063450|Nivolumab|nivolumab|mesh-list
1735375|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1735376|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735377|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1735378|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735425|NCT03039036|Misoprostol|misoprostol|mesh-list
1735426|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1735427|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
1735428|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1735429|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735430|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1735431|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1735432|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
1735445|NCT03036930|Vaccines|vaccines|mesh-list
1735446|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
1735447|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735531|NCT02962297|Vitamin E|vitamin e|mesh-list
1735532|NCT02962297|Vitamins|vitamins|mesh-ancestor
1735533|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
1735534|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735535|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
1735536|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735537|NCT02962297|Protective Agents|protective agents|mesh-ancestor
1735538|NCT02942355|Palbociclib|palbociclib|mesh-list
1735539|NCT02942355|Anastrozole|anastrozole|mesh-list
1735540|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735541|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1735542|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1735543|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735544|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1735545|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1735546|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1735547|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1735548|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
1735628|NCT02879695|Blinatumomab|blinatumomab|mesh-list
1735549|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1735550|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735557|NCT02936388|Cisplatin|cisplatin|mesh-list
1735558|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735611|NCT02893241|Cafedrine|cafedrine|mesh-list
1735612|NCT02893241|Theodrenaline|theodrenaline|mesh-list
1735613|NCT02893241|Ephedrine|ephedrine|mesh-list
1735614|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1735615|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735616|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
1735617|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
1735618|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1735619|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1735620|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
1735621|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1735622|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735623|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1735624|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
1735625|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1735626|NCT02879695|Nivolumab|nivolumab|mesh-list
1735627|NCT02879695|Ipilimumab|ipilimumab|mesh-list
1735629|NCT02879695|Antibodies|antibodies|mesh-list
1735630|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
1735631|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1735632|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
1735633|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
1735634|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
1735635|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735636|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735637|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1735638|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735639|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1735674|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
1735675|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1735676|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
1735677|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735678|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1735679|NCT02839265|Protective Agents|protective agents|mesh-ancestor
1735686|NCT02807779|Dexamethasone|dexamethasone|mesh-list
1735687|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1735688|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
1735689|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
1735690|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1735691|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735692|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1735693|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
1735694|NCT02807779|Hormones|hormones|mesh-ancestor
1735695|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1735696|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1735697|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735705|NCT02688309|Dexamethasone|dexamethasone|mesh-list
1735706|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1735707|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
1735708|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
1735709|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1735710|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735711|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1735712|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
1735713|NCT02688309|Hormones|hormones|mesh-ancestor
1735714|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1735715|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1735716|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735717|NCT02684578|Metformin|metformin|mesh-list
1735718|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1735719|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735720|NCT02680561|Fluticasone|fluticasone|mesh-list
1735721|NCT02680561|Xhance|xhance|mesh-list
1735722|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1735723|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1735724|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1735725|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1735726|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
1735727|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1735728|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735729|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1735730|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
1735731|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
1735732|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1735733|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1735734|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1735735|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1735736|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
1735737|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1735738|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735739|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
1735740|NCT02680561|Hormones|hormones|mesh-ancestor
1735741|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1735742|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
1735750|NCT02664935|Docetaxel|docetaxel|mesh-list
1735751|NCT02664935|Durvalumab|durvalumab|mesh-list
1735752|NCT02664935|Palbociclib|palbociclib|mesh-list
1735753|NCT02664935|Osimertinib|osimertinib|mesh-list
1735754|NCT02664935|Crizotinib|crizotinib|mesh-list
1735755|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735756|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
1735757|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
1735758|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
1735759|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735760|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1735761|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1735762|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1735790|NCT02636036|Nivolumab|nivolumab|mesh-list
1735791|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1735792|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735793|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1735794|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735795|NCT02631733|Irinotecan|irinotecan|mesh-list
1735796|NCT02631733|Veliparib|veliparib|mesh-list
1735797|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1735798|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1735799|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1735800|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1735801|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735802|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735803|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1735804|NCT02631733|Hematinics|hematinics|mesh-ancestor
1735805|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1735806|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1735821|NCT02619682|Lenalidomide|lenalidomide|mesh-list
1735822|NCT02619682|Ixazomib|ixazomib|mesh-list
1735823|NCT02619682|Glycine|glycine|mesh-list
1735824|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
1735825|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735826|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1735827|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1735828|NCT02619682|Growth Substances|growth substances|mesh-ancestor
1735829|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
1735830|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735831|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735832|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
1735833|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1735834|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
1735835|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1735856|NCT02592031|Goserelin|goserelin|mesh-list
1735857|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1735858|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1735884|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
1735885|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1735886|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1735887|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735888|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
1735889|NCT02568124|Coagulants|coagulants|mesh-ancestor
1735890|NCT02547818|Ibuprofen|ibuprofen|mesh-list
1735891|NCT02547818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1735892|NCT02547818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1735893|NCT02547818|Analgesics|analgesics|mesh-ancestor
1735894|NCT02547818|Sensory System Agents|sensory system agents|mesh-ancestor
1735895|NCT02547818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1735896|NCT02547818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735897|NCT02547818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1735898|NCT02547818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1735899|NCT02547818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1735900|NCT02547818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1735901|NCT02547818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1735922|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
1735923|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1735924|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735935|NCT02487108|Acetaminophen|acetaminophen|mesh-list
1735936|NCT02487108|Hydrocodone|hydrocodone|mesh-list
1735937|NCT02487108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1735938|NCT02487108|Analgesics|analgesics|mesh-ancestor
1735939|NCT02487108|Sensory System Agents|sensory system agents|mesh-ancestor
1735940|NCT02487108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1735941|NCT02487108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1735942|NCT02487108|Antipyretics|antipyretics|mesh-ancestor
1735943|NCT02487108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1735944|NCT02487108|Narcotics|narcotics|mesh-ancestor
1735945|NCT02487108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1735946|NCT02487108|Antitussive Agents|antitussive agents|mesh-ancestor
1735947|NCT02487108|Respiratory System Agents|respiratory system agents|mesh-ancestor
1736004|NCT02437604|Fluticasone|fluticasone|mesh-list
1736005|NCT02437604|Xhance|xhance|mesh-list
1736006|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1736007|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1736008|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1736009|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1736010|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
1736011|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1736012|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736013|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1736014|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
1736015|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
1736016|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1736017|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1736018|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1736019|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1736020|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
1736021|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1736022|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736023|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
1736024|NCT02437604|Hormones|hormones|mesh-ancestor
1736025|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1736026|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
1736068|NCT02404935|Cetuximab|cetuximab|mesh-list
1736069|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1736070|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736071|NCT02390427|Paclitaxel|paclitaxel|mesh-list
1736072|NCT02390427|Maytansine|maytansine|mesh-list
1736073|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1736074|NCT02390427|Trastuzumab|trastuzumab|mesh-list
1736075|NCT02390427|Pertuzumab|pertuzumab|mesh-list
1736076|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1736077|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736078|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
1736079|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
1736080|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
1736081|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736082|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1736083|NCT02384577|Budesonide|budesonide|mesh-list
1736084|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
1736085|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1736086|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1736087|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
1736088|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1736089|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736090|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1736091|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
1736092|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
1736093|NCT02384577|Hormones|hormones|mesh-ancestor
1736094|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1736095|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1736096|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1736097|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1736098|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
1736099|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1736100|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736142|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
1736143|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1736144|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
1736145|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1736146|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736147|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1736148|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
1736149|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
1736150|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1736151|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
1736152|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1736153|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736250|NCT02150967|Infigratinib|infigratinib|mesh-list
1736251|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736331|NCT02092571|Progesterone|progesterone|mesh-list
1736332|NCT02092571|Progestins|progestins|mesh-ancestor
1736333|NCT02092571|Hormones|hormones|mesh-ancestor
1736334|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1736335|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736336|NCT02092077|Hormones|hormones|mesh-list
1736337|NCT02092077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1736338|NCT02092077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736362|NCT02062463|Budesonide|budesonide|mesh-list
1736363|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
1736364|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1736365|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1736366|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1736367|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
1736368|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1736369|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736370|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1736371|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
1736372|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
1736373|NCT02062463|Hormones|hormones|mesh-ancestor
1736374|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1736375|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1736376|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1736377|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1736378|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
1736379|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1736380|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736441|NCT02030457|Beclomethasone|beclomethasone|mesh-list
1736442|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1736443|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
1736444|NCT02030457|Hormones|hormones|mesh-ancestor
1736445|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1736446|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736447|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1736448|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
1736612|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
1736465|NCT01975298|Interferons|interferons|mesh-list
1736466|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
1736467|NCT01975298|Interferon-beta|interferon-beta|mesh-list
1736468|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736469|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
1736470|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1736471|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1736472|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
1736473|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736474|NCT01953926|Trastuzumab|trastuzumab|mesh-list
1736475|NCT01953926|Fulvestrant|fulvestrant|mesh-list
1736476|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1736477|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736478|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1736479|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1736480|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1736481|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
1736482|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1736483|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736494|NCT01889199|Flutamide|flutamide|mesh-list
1736495|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
1736496|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
1736497|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1736498|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736499|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1736500|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736558|NCT01729091|Lenalidomide|lenalidomide|mesh-list
1736559|NCT01729091|Melphalan|melphalan|mesh-list
1736560|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
1736561|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1736562|NCT01729091|Elotuzumab|elotuzumab|mesh-list
1736563|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
1736564|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736565|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1736566|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1736567|NCT01729091|Growth Substances|growth substances|mesh-ancestor
1736568|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
1736569|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736570|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1736571|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
1736572|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736573|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1736574|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1736582|NCT01624480|Modafinil|modafinil|mesh-list
1736583|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1736584|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736585|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1736586|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1736587|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1736588|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736589|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1736590|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1736591|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
1736592|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736593|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736608|NCT01446133|Rituximab|rituximab|mesh-list
1736609|NCT01446133|Lenalidomide|lenalidomide|mesh-list
1736610|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1736611|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736613|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736614|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1736615|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1736616|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1736617|NCT01446133|Growth Substances|growth substances|mesh-ancestor
1736618|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
1736621|NCT01349881|Eflornithine|eflornithine|mesh-list
1736622|NCT01349881|Sulindac|sulindac|mesh-list
1736623|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736624|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1736625|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1736626|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1736627|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1736628|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
1736629|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1736630|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736631|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1736632|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1736633|NCT01349881|Analgesics|analgesics|mesh-ancestor
1736634|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
1736635|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1736636|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736637|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1736638|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1736639|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1736640|NCT01342952|Ambrisentan|ambrisentan|mesh-list
1736641|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1736661|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
1736662|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1736663|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
1736664|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736665|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1736666|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1736667|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
1736668|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736669|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736670|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1736693|NCT01120249|Everolimus|everolimus|mesh-list
1736694|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736695|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1736696|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
1736697|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736698|NCT01061515|Bevacizumab|bevacizumab|mesh-list
1736699|NCT01061515|Capecitabine|capecitabine|mesh-list
1736700|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
1736701|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1736702|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736703|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1736704|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1736705|NCT01061515|Growth Substances|growth substances|mesh-ancestor
1736706|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736707|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
1736708|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1736709|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
1736710|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736736|NCT00980954|Paclitaxel|paclitaxel|mesh-list
1736737|NCT00980954|Carboplatin|carboplatin|mesh-list
1736738|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1736739|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736740|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
1736741|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
1736742|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
1736743|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736764|NCT00790010|Bevacizumab|bevacizumab|mesh-list
1736765|NCT00790010|Ipilimumab|ipilimumab|mesh-list
1736766|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1736767|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736768|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1736769|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1736770|NCT00790010|Growth Substances|growth substances|mesh-ancestor
1736771|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736772|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
1736773|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1736774|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736775|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
1736776|NCT00712881|Docetaxel|docetaxel|mesh-list
1736777|NCT00712881|Doxorubicin|doxorubicin|mesh-list
1736778|NCT00712881|Trastuzumab|trastuzumab|mesh-list
1736779|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1736780|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
1736781|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736782|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1736783|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1736784|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
1736785|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736786|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1736787|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1736788|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
1736789|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
1736790|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
1736791|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1736792|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1736793|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1736794|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1736795|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1736814|NCT00672412|Lamivudine|lamivudine|mesh-list
1736815|NCT00672412|Zidovudine|zidovudine|mesh-list
1736816|NCT00672412|Nevirapine|nevirapine|mesh-list
1736817|NCT00672412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1736818|NCT00672412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1736819|NCT00672412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1736820|NCT00672412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736821|NCT00672412|Antiviral Agents|antiviral agents|mesh-ancestor
1736822|NCT00672412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1736823|NCT00672412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1736824|NCT00672412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1736825|NCT00672412|Antimetabolites|antimetabolites|mesh-ancestor
1736826|NCT00672412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1736827|NCT00672412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1736828|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1736829|NCT00659126|Hematinics|hematinics|mesh-ancestor
1736830|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1736831|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1736847|NCT00530062|Albuterol|albuterol|mesh-list
1736848|NCT00530062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1736849|NCT00530062|Autonomic Agents|autonomic agents|mesh-ancestor
1736850|NCT00530062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1736851|NCT00530062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736852|NCT00530062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1736853|NCT00530062|Respiratory System Agents|respiratory system agents|mesh-ancestor
1736854|NCT00530062|Tocolytic Agents|tocolytic agents|mesh-ancestor
1736855|NCT00530062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1736856|NCT00530062|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1736857|NCT00530062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1736858|NCT00530062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1736859|NCT00530062|Adrenergic Agents|adrenergic agents|mesh-ancestor
1736860|NCT00530062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1736861|NCT00530062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736893|NCT00308685|Albuterol|albuterol|mesh-list
1736894|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1736895|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
1736896|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1736897|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736898|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1736899|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
1736900|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
1736901|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1736902|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1736903|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1736904|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1736905|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
1736906|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1736907|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736908|NCT00260078|Ritonavir|ritonavir|mesh-list
1736909|NCT00260078|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1736910|NCT00260078|Darunavir|darunavir|mesh-list
1736911|NCT00260078|Tenofovir|tenofovir|mesh-list
1736912|NCT00260078|Nevirapine|nevirapine|mesh-list
1736913|NCT00260078|Efavirenz|efavirenz|mesh-list
1736914|NCT00260078|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1736915|NCT00260078|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1736916|NCT00260078|Protease Inhibitors|protease inhibitors|mesh-ancestor
1736917|NCT00260078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1736918|NCT00260078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1736919|NCT00260078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1736920|NCT00260078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1736921|NCT00260078|Antiviral Agents|antiviral agents|mesh-ancestor
1736922|NCT00260078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1736923|NCT00260078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1736924|NCT00260078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1736925|NCT00260078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1736926|NCT00260078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1736927|NCT00260078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1736928|NCT00260078|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1736929|NCT00260078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1736930|NCT00260078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1736931|NCT00260078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1736962|NCT00080106|Vaccines|vaccines|mesh-list
1736963|NCT00080106|Immunologic Factors|immunologic factors|mesh-ancestor
1736964|NCT00080106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1736997|NCT00001309|Ascorbic Acid|ascorbic acid|mesh-list
1736998|NCT00001309|Vitamins|vitamins|mesh-ancestor
1736999|NCT00001309|Micronutrients|micronutrients|mesh-ancestor
1737000|NCT00001309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737001|NCT00001309|Antioxidants|antioxidants|mesh-ancestor
1737002|NCT00001309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737003|NCT00001309|Protective Agents|protective agents|mesh-ancestor
1737016|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
1737017|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1737018|NCT05117957|Sorafenib|sorafenib|mesh-list
1737019|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737020|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1737021|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1737022|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737023|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1737024|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1737025|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
1737026|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1737027|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737028|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
1737029|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737030|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1737031|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1737032|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737055|NCT05117489|Cortisone|cortisone|mesh-list
1737056|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1737057|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
1737058|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1737059|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737065|NCT05117398|Dalbavancin|dalbavancin|mesh-list
1737066|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1737067|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1737085|NCT05117125|Heparin|heparin|mesh-list
1737086|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
1737087|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1737088|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1737089|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737098|NCT05117021|Bupivacaine|bupivacaine|mesh-list
1737099|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
1737100|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
1737101|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1737102|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737103|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
1737104|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1737105|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
1737106|NCT05116995|Ticagrelor|ticagrelor|mesh-list
1737107|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1737108|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1737109|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1737110|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1737111|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
1737112|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1737113|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737114|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737115|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1737116|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
1737117|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1737118|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
1737119|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1737120|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
1737141|NCT05116917|Nivolumab|nivolumab|mesh-list
1737142|NCT05116917|Ipilimumab|ipilimumab|mesh-list
1737143|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1737144|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737145|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1737146|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737147|NCT05116891|Leucovorin|leucovorin|mesh-list
1737148|NCT05116891|Gemcitabine|gemcitabine|mesh-list
1737149|NCT05116891|Cisplatin|cisplatin|mesh-list
1737150|NCT05116891|Docetaxel|docetaxel|mesh-list
1737151|NCT05116891|Fluorouracil|fluorouracil|mesh-list
1737152|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
1737153|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737154|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1737155|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
1737156|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737157|NCT05116891|Antiviral Agents|antiviral agents|mesh-ancestor
1737158|NCT05116891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1737159|NCT05116891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1737160|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1737161|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
1737162|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737163|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
1737164|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
1737165|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
1737166|NCT05116891|Antidotes|antidotes|mesh-ancestor
1737167|NCT05116891|Protective Agents|protective agents|mesh-ancestor
1737168|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
1737169|NCT05116891|Vitamins|vitamins|mesh-ancestor
1737170|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
1737195|NCT05116462|Gemcitabine|gemcitabine|mesh-list
1737196|NCT05116462|Paclitaxel|paclitaxel|mesh-list
1737197|NCT05116462|Docetaxel|docetaxel|mesh-list
1737198|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1737199|NCT05116462|Carboplatin|carboplatin|mesh-list
1737200|NCT05116462|Pemetrexed|pemetrexed|mesh-list
1737201|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1737202|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737203|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
1737204|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
1737205|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
1737206|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737207|NCT05116462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1737208|NCT05116462|Antimetabolites|antimetabolites|mesh-ancestor
1737209|NCT05116462|Antiviral Agents|antiviral agents|mesh-ancestor
1737210|NCT05116462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1737211|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1737212|NCT05116462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1737213|NCT05116462|Immunologic Factors|immunologic factors|mesh-ancestor
1737214|NCT05116462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737215|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1737216|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1737217|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
1737218|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1737219|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
1737220|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
1737221|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
1737222|NCT05116371|Estradiol|estradiol|mesh-list
1737223|NCT05116371|Estrogens|estrogens|mesh-ancestor
1737224|NCT05116371|Hormones|hormones|mesh-ancestor
1737225|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1737226|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737227|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1737228|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1737229|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1737230|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1737231|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1737232|NCT05116345|Dexamethasone|dexamethasone|mesh-list
1737233|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
1737234|NCT05116345|BB 1101|bb 1101|mesh-list
1737235|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1737236|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
1737237|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
1737238|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1737239|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737240|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1737241|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
1737242|NCT05116345|Hormones|hormones|mesh-ancestor
1737243|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1737244|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1737245|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737246|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
1737247|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1737248|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737249|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
1737250|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1737251|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
1737252|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737253|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
1737254|NCT05116306|Protective Agents|protective agents|mesh-ancestor
1737255|NCT05116293|Acetaminophen|acetaminophen|mesh-list
1737256|NCT05116293|Digoxin|digoxin|mesh-list
1737257|NCT05116293|Midazolam|midazolam|mesh-list
1737258|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1737259|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1737260|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1737261|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737262|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1737263|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1737264|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1737265|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1737266|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
1737267|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
1737268|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
1737269|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
1737270|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1737271|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737272|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1737273|NCT05116293|Analgesics|analgesics|mesh-ancestor
1737274|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
1737275|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1737276|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
1737277|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1737278|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1737279|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1737280|NCT05116293|Protective Agents|protective agents|mesh-ancestor
1737281|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
1737282|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1737283|NCT05114941|Antibodies|antibodies|mesh-list
1737284|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
1737285|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1737286|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
1737287|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737294|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
1737295|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
1737296|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
1737297|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1737298|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737299|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
1737300|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1737301|NCT05104970|Cholecalciferol|cholecalciferol|mesh-list
1737302|NCT05104970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1737303|NCT05104970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737304|NCT05104970|Vitamins|vitamins|mesh-ancestor
1737305|NCT05104970|Micronutrients|micronutrients|mesh-ancestor
1737306|NCT05104970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1737365|NCT05076110|Acetaminophen|acetaminophen|mesh-list
1737366|NCT05076110|Ibuprofen|ibuprofen|mesh-list
1737367|NCT05076110|Oxycodone|oxycodone|mesh-list
1737368|NCT05076110|Gabapentin|gabapentin|mesh-list
1737369|NCT05076110|Methocarbamol|methocarbamol|mesh-list
1737370|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1737371|NCT05076110|Analgesics|analgesics|mesh-ancestor
1737372|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
1737373|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1737374|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737375|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
1737376|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1737377|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1737378|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1737379|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1737380|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1737381|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737382|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1737383|NCT05076110|Narcotics|narcotics|mesh-ancestor
1737384|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1737385|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
1737386|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1737387|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1737388|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1737389|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1737390|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1737391|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1737392|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
1737393|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1737394|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1737395|NCT05076097|Rituximab|rituximab|mesh-list
1737396|NCT05076097|Lenalidomide|lenalidomide|mesh-list
1737397|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1737398|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737399|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
1737400|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737401|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1737402|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1737403|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1737404|NCT05076097|Growth Substances|growth substances|mesh-ancestor
1737405|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
1737427|NCT05063786|Capecitabine|capecitabine|mesh-list
1737428|NCT05063786|Trastuzumab|trastuzumab|mesh-list
1737429|NCT05063786|Vinorelbine|vinorelbine|mesh-list
1737430|NCT05063786|Fulvestrant|fulvestrant|mesh-list
1737431|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1737432|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
1737433|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737434|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737435|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1737436|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1737437|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
1737438|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
1737439|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
1737440|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1737441|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1737442|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1737443|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
1737444|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1737445|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737456|NCT05053152|Relugolix|relugolix|mesh-list
1737457|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
1737458|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
1737459|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1737460|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737530|NCT05023980|Rituximab|rituximab|mesh-list
1737531|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1737532|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1737533|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737534|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
1737535|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737536|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1737537|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1737538|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
1737539|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737540|NCT05016895|Azithromycin|azithromycin|mesh-list
1737541|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1737542|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1737609|NCT05005403|Pembrolizumab|pembrolizumab|mesh-list
1737610|NCT05005403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1737611|NCT05005403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737623|NCT05002530|Vitamin D|vitamin d|mesh-list
1737624|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
1737625|NCT05002530|Vitamins|vitamins|mesh-list
1737626|NCT05002530|Tretinoin|tretinoin|mesh-list
1737627|NCT05002530|Isotretinoin|isotretinoin|mesh-list
1737628|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
1737629|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737630|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1737631|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1737632|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737633|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
1737634|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
1737667|NCT04940286|Gemcitabine|gemcitabine|mesh-list
1737668|NCT04940286|Paclitaxel|paclitaxel|mesh-list
1737669|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1737670|NCT04940286|Durvalumab|durvalumab|mesh-list
1737671|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
1737672|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1737673|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
1737674|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1737675|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737676|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
1737677|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
1737678|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
1737679|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737680|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1737681|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
1737682|NCT04940286|Antiviral Agents|antiviral agents|mesh-ancestor
1737683|NCT04940286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1737684|NCT04940286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1737685|NCT04940286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1737686|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
1737687|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737688|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1737753|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
1737754|NCT04930237|Bisacodyl|bisacodyl|mesh-list
1737755|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
1737756|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
1737757|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
1737758|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
1737759|NCT04930237|Calcium|calcium|mesh-list
1737760|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1737761|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737762|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737763|NCT04930237|Cathartics|cathartics|mesh-ancestor
1737764|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1737765|NCT04930237|Laxatives|laxatives|mesh-ancestor
1737766|NCT04930237|Antacids|antacids|mesh-ancestor
1737767|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1737768|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
1737769|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1737770|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
1737874|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
1737875|NCT04889703|Salicylates|salicylates|mesh-list
1737876|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1737877|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
1737878|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
1737879|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
1737880|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1737881|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1737882|NCT04889703|Analgesics|analgesics|mesh-ancestor
1737883|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
1737884|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1737885|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1737886|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1737887|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1737888|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1737889|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1737890|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1737983|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
1737984|NCT04836429|Trioxsalen|trioxsalen|mesh-list
1737985|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1737986|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
1737987|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1738119|NCT04768504|Tofacitinib|tofacitinib|mesh-list
1738120|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1738121|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1738122|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738196|NCT04753437|Amoxicillin|amoxicillin|mesh-list
1738197|NCT04753437|Clarithromycin|clarithromycin|mesh-list
1738198|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
1738199|NCT04753437|Esomeprazole|esomeprazole|mesh-list
1738200|NCT04753437|Bismuth|bismuth|mesh-list
1738201|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738202|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1738203|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1738204|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1738205|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1738206|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1738207|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1738208|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1738209|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1738210|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1738211|NCT04753437|Antacids|antacids|mesh-ancestor
1738212|NCT04753437|Diuretics|diuretics|mesh-ancestor
1738213|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
1738214|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738215|NCT04753437|Expectorants|expectorants|mesh-ancestor
1738216|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
1738229|NCT04742777|Sirolimus|sirolimus|mesh-list
1738230|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1738231|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1738232|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1738233|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738234|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
1738235|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1738236|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
1738237|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738255|NCT04695847|Antibodies|antibodies|mesh-list
1738256|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
1738257|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
1738258|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
1738259|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
1738260|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738261|NCT04690504|Melatonin|melatonin|mesh-list
1738262|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
1738263|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738264|NCT04690504|Protective Agents|protective agents|mesh-ancestor
1738265|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738266|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1738267|NCT04683575|Selenium|selenium|mesh-list
1738268|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
1738269|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738270|NCT04683575|Protective Agents|protective agents|mesh-ancestor
1738271|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738272|NCT04683575|Trace Elements|trace elements|mesh-ancestor
1738273|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
1738274|NCT04675333|Carboplatin|carboplatin|mesh-list
1738275|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
1738276|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738277|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1738278|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
1738279|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1738280|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738284|NCT04671953|Metformin|metformin|mesh-list
1738285|NCT04671953|BMS-986165|bms-986165|mesh-list
1738286|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1738287|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738288|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
1738289|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1738290|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1738291|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738303|NCT04650217|Levodopa|levodopa|mesh-list
1738304|NCT04650217|Carbidopa|carbidopa|mesh-list
1738305|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1738306|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1738307|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1738308|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
1738309|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1738310|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738311|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738312|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1738313|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1738314|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1738315|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
1738316|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
1738329|NCT04630964|Niacin|niacin|mesh-list
1738330|NCT04630964|Psilocybin|psilocybin|mesh-list
1738331|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1738332|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
1738333|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738334|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1738335|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
1738336|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
1738337|NCT04630964|Vitamins|vitamins|mesh-ancestor
1738338|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
1738339|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738340|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
1738341|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1738364|NCT04585061|Lidocaine|lidocaine|mesh-list
1738365|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
1738366|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
1738367|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1738368|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738369|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
1738370|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1738371|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1738372|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1738373|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1738374|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1738375|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738396|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1738397|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1738398|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
1738399|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1738400|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738401|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738402|NCT04564157|Paclitaxel|paclitaxel|mesh-list
1738403|NCT04564157|Carboplatin|carboplatin|mesh-list
1738404|NCT04564157|Nivolumab|nivolumab|mesh-list
1738405|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1738406|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738407|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
1738408|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
1738409|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
1738410|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738411|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1738412|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1738416|NCT04553133|Letrozole|letrozole|mesh-list
1738417|NCT04553133|Fulvestrant|fulvestrant|mesh-list
1738418|NCT04553133|Palbociclib|palbociclib|mesh-list
1738419|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738420|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1738421|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1738422|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1738423|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738424|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1738425|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
1738426|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1738427|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738428|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1738429|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1738430|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1738450|NCT04539236|Lenalidomide|lenalidomide|mesh-list
1738451|NCT04539236|Luspatercept|luspatercept|mesh-list
1738452|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
1738453|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738454|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1738455|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1738456|NCT04539236|Growth Substances|growth substances|mesh-ancestor
1738457|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
1738458|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738459|NCT04539236|Hematinics|hematinics|mesh-ancestor
1738460|NCT04530838|Vaccines|vaccines|mesh-list
1738461|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1738462|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
1738463|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738477|NCT04521803|Rifampin|rifampin|mesh-list
1738478|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1738479|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
1738480|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1738481|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1738482|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
1738483|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1738484|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1738485|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738486|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1738487|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1738488|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1738489|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1738490|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1738491|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1738492|NCT04514653|Ranibizumab|ranibizumab|mesh-list
1738493|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1738494|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1738495|NCT04514653|Growth Substances|growth substances|mesh-ancestor
1738496|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738497|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
1738498|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738499|NCT04512430|Bevacizumab|bevacizumab|mesh-list
1738500|NCT04512430|Carboplatin|carboplatin|mesh-list
1738501|NCT04512430|Pemetrexed|pemetrexed|mesh-list
1738502|NCT04512430|Atezolizumab|atezolizumab|mesh-list
1738503|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1738504|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738505|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1738506|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1738507|NCT04512430|Growth Substances|growth substances|mesh-ancestor
1738508|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738509|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
1738510|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1738511|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738512|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1738513|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1738542|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1738543|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
1738544|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738547|NCT04450498|Vaccines|vaccines|mesh-list
1738548|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
1738549|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738550|NCT04443569|Lidocaine|lidocaine|mesh-list
1738551|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
1738552|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
1738553|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1738554|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738555|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
1738556|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1738557|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1738558|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1738559|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1738560|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1738561|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738562|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1738563|NCT04425174|Anesthetics|anesthetics|mesh-list
1738564|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1738565|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738566|NCT04423211|Leuprolide|leuprolide|mesh-list
1738567|NCT04423211|Goserelin|goserelin|mesh-list
1738568|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1738569|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
1738570|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1738571|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738572|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1738573|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738574|NCT04418479|Aspirin|aspirin|mesh-list
1738575|NCT04418479|Clopidogrel|clopidogrel|mesh-list
1738576|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1738577|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1738578|NCT04418479|Analgesics|analgesics|mesh-ancestor
1738579|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
1738580|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1738581|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738582|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1738583|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1738584|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1738585|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1738586|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738587|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1738894|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
1738588|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1738589|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1738590|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
1738591|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1738592|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1738593|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1738594|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
1738595|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1738612|NCT04379713|Vaccines|vaccines|mesh-list
1738613|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1738614|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
1738615|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738630|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1738631|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
1738649|NCT04370379|Aflibercept|aflibercept|mesh-list
1738650|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1738651|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1738652|NCT04370379|Growth Substances|growth substances|mesh-ancestor
1738653|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738654|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
1738655|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738699|NCT04305899|BMS-986165|bms-986165|mesh-list
1738700|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
1738701|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1738702|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1738703|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738704|NCT04298606|Vaccines|vaccines|mesh-list
1738705|NCT04298606|Mitogens|mitogens|mesh-list
1738706|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
1738707|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738708|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
1738709|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738710|NCT04279847|INCB057643|incb057643|mesh-list
1738711|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738717|NCT04256941|Letrozole|letrozole|mesh-list
1738718|NCT04256941|Fulvestrant|fulvestrant|mesh-list
1738719|NCT04256941|Palbociclib|palbociclib|mesh-list
1738720|NCT04256941|Anastrozole|anastrozole|mesh-list
1738721|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738722|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1738723|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1738724|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1738725|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738726|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1738727|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
1738728|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1738729|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738730|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1738731|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1738732|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1739268|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
1738740|NCT04250883|Iodine|iodine|mesh-list
1738741|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1738742|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1738743|NCT04250883|Trace Elements|trace elements|mesh-ancestor
1738744|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
1738745|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738765|NCT04238624|Trametinib|trametinib|mesh-list
1738766|NCT04238624|Dabrafenib|dabrafenib|mesh-list
1738767|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738768|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1738769|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1738770|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738882|NCT04153604|Doxycycline|doxycycline|mesh-list
1738883|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1738884|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1738885|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
1738886|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1738887|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1738888|NCT04140162|Dexamethasone|dexamethasone|mesh-list
1738889|NCT04140162|Lenalidomide|lenalidomide|mesh-list
1738890|NCT04140162|Bortezomib|bortezomib|mesh-list
1738891|NCT04140162|Daratumumab|daratumumab|mesh-list
1738892|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1738893|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
1738895|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1738896|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738897|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1738898|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
1738899|NCT04140162|Hormones|hormones|mesh-ancestor
1738900|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1738901|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1738902|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738903|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
1738904|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1738905|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1738906|NCT04140162|Growth Substances|growth substances|mesh-ancestor
1738907|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
1738908|NCT04129398|Letermovir|letermovir|mesh-list
1738909|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1738910|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1738911|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738912|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738913|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
1738914|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1738915|NCT04126278|Dexamethasone|dexamethasone|mesh-list
1738916|NCT04126278|Cortisone|cortisone|mesh-list
1738917|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1738918|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
1738919|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
1738920|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1738921|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738922|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1738923|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
1738924|NCT04126278|Hormones|hormones|mesh-ancestor
1738925|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1738926|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1738927|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1738951|NCT04074161|Liraglutide|liraglutide|mesh-list
1738952|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1738953|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738954|NCT04074161|Incretins|incretins|mesh-ancestor
1738955|NCT04074161|Hormones|hormones|mesh-ancestor
1738956|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1738987|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
1738988|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
1738989|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1738990|NCT04042935|Protective Agents|protective agents|mesh-ancestor
1738991|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1738992|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
1738993|NCT04042935|Vitamins|vitamins|mesh-ancestor
1738994|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
1738995|NCT04036435|BMS-986165|bms-986165|mesh-list
1738996|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
1738997|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1738998|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1738999|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739000|NCT04016714|Vaccines|vaccines|mesh-list
1739001|NCT04016714|Immunoglobulins|immunoglobulins|mesh-list
1739002|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
1739003|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739004|NCT04014803|Aspirin|aspirin|mesh-list
1739005|NCT04014803|Clopidogrel|clopidogrel|mesh-list
1739006|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1739007|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1739008|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1739009|NCT04014803|Analgesics|analgesics|mesh-ancestor
1739010|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
1739011|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1739012|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739013|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1739014|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1739015|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1739016|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1739017|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739018|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1739019|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1739020|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1739021|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
1739022|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1739023|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1739024|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1739025|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
1739026|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1739027|NCT04006119|Cemiplimab|cemiplimab|mesh-list
1739028|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1739029|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739038|NCT03971500|Aspirin|aspirin|mesh-list
1739039|NCT03971500|Ticagrelor|ticagrelor|mesh-list
1739040|NCT03971500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1739041|NCT03971500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1739042|NCT03971500|Analgesics|analgesics|mesh-ancestor
1739043|NCT03971500|Sensory System Agents|sensory system agents|mesh-ancestor
1739044|NCT03971500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1739045|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739046|NCT03971500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1739047|NCT03971500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1739048|NCT03971500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1739049|NCT03971500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1739050|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739051|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1739052|NCT03971500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1739053|NCT03971500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1739054|NCT03971500|Antipyretics|antipyretics|mesh-ancestor
1739055|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1739056|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1739057|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1739058|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
1739059|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1739072|NCT03954132|Cholinergic Agents|cholinergic agents|mesh-list
1739073|NCT03954132|Muscarinic Antagonists|muscarinic antagonists|mesh-list
1739074|NCT03954132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1739075|NCT03954132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739076|NCT03954132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739077|NCT03954132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1739106|NCT03929029|Nivolumab|nivolumab|mesh-list
1739107|NCT03929029|Ipilimumab|ipilimumab|mesh-list
1739108|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1739109|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739110|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1739111|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739131|NCT03913104|Mifepristone|mifepristone|mesh-list
1739132|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1739133|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
1739134|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1739135|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739136|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1739137|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1739138|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1739139|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
1739140|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1739141|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1739142|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
1739143|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1739144|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
1739145|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1739146|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1739155|NCT03901339|Gemcitabine|gemcitabine|mesh-list
1739156|NCT03901339|Capecitabine|capecitabine|mesh-list
1739157|NCT03901339|Vinorelbine|vinorelbine|mesh-list
1739158|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1739159|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
1739160|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739161|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739162|NCT03901339|Antiviral Agents|antiviral agents|mesh-ancestor
1739163|NCT03901339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1739164|NCT03901339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1739165|NCT03901339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1739166|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
1739167|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739168|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1739169|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
1739170|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
1739171|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
1739187|NCT03890887|Itraconazole|itraconazole|mesh-list
1739188|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
1739189|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1739190|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1739191|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1739192|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1739193|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739194|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1739195|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
1739196|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1739197|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739198|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1739244|NCT03838159|Paclitaxel|paclitaxel|mesh-list
1739245|NCT03838159|Carboplatin|carboplatin|mesh-list
1739246|NCT03838159|Nivolumab|nivolumab|mesh-list
1739247|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1739248|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739249|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
1739250|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
1739251|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
1739252|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739253|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1739254|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1739260|NCT03836066|Bevacizumab|bevacizumab|mesh-list
1739261|NCT03836066|Atezolizumab|atezolizumab|mesh-list
1739262|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1739263|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739264|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1739265|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1739266|NCT03836066|Growth Substances|growth substances|mesh-ancestor
1739267|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739275|NCT03830866|Carboplatin|carboplatin|mesh-list
1739276|NCT03830866|Durvalumab|durvalumab|mesh-list
1739277|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739278|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1739279|NCT03827213|Bupivacaine|bupivacaine|mesh-list
1739280|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
1739281|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
1739282|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1739283|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739284|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
1739285|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1739286|NCT03797469|Niacinamide|niacinamide|mesh-list
1739287|NCT03797469|Vitamins|vitamins|mesh-ancestor
1739288|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
1739289|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739290|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
1739291|NCT03795701|Liraglutide|liraglutide|mesh-list
1739292|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1739293|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739294|NCT03795701|Incretins|incretins|mesh-ancestor
1739295|NCT03795701|Hormones|hormones|mesh-ancestor
1739296|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1739314|NCT03771313|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
1739315|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1739316|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1739348|NCT03722108|Irinotecan|irinotecan|mesh-list
1739349|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1739350|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1739351|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1739352|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739353|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739354|NCT03717129|Tenofovir|tenofovir|mesh-list
1739355|NCT03717129|Emtricitabine|emtricitabine|mesh-list
1739356|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1739357|NCT03717129|Cobicistat|cobicistat|mesh-list
1739358|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
1739359|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1739360|NCT03717129|Elvitegravir|elvitegravir|mesh-list
1739361|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
1739362|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1739363|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1739364|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1739365|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1739366|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739367|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1739368|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1739369|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1739370|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1739371|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1739390|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1739391|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
1739392|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739396|NCT03651128|Dexamethasone|dexamethasone|mesh-list
1739397|NCT03651128|Lenalidomide|lenalidomide|mesh-list
1739398|NCT03651128|Bortezomib|bortezomib|mesh-list
1739399|NCT03651128|Pomalidomide|pomalidomide|mesh-list
1739400|NCT03651128|Daratumumab|daratumumab|mesh-list
1739401|NCT03651128|Ixazomib|ixazomib|mesh-list
1739402|NCT03651128|Elotuzumab|elotuzumab|mesh-list
1739403|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1739404|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
1739405|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
1739406|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1739407|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739408|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1739409|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
1739410|NCT03651128|Hormones|hormones|mesh-ancestor
1739411|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1739412|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1739413|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739414|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
1739415|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1739416|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1739417|NCT03651128|Growth Substances|growth substances|mesh-ancestor
1739418|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
1739419|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
1739420|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1739421|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739434|NCT03636295|Warfarin|warfarin|mesh-list
1739435|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
1739436|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
1739437|NCT03622788|Fludarabine|fludarabine|mesh-list
1739438|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1739439|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1739440|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
1739441|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739442|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1739443|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1739444|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
1739445|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739446|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739447|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1739448|NCT03579446|Oxymorphone|oxymorphone|mesh-list
1739449|NCT03579446|Morphine|morphine|mesh-list
1739450|NCT03579446|Oxycodone|oxycodone|mesh-list
1739451|NCT03579446|Hydromorphone|hydromorphone|mesh-list
1739452|NCT03579446|Hydrocodone|hydrocodone|mesh-list
1739453|NCT03579446|Levorphanol|levorphanol|mesh-list
1739454|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1739455|NCT03579446|Narcotics|narcotics|mesh-ancestor
1739456|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1739457|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739458|NCT03579446|Analgesics|analgesics|mesh-ancestor
1739459|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
1739460|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1739461|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
1739462|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
1739463|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1739464|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
1739465|NCT03573700|Fludarabine|fludarabine|mesh-list
1739466|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1739467|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
1739468|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739469|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1739470|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1739471|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
1739472|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739473|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739474|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1739486|NCT03534284|Trazodone|trazodone|mesh-list
1739487|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1739488|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1739489|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1739490|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739491|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1739492|NCT03534284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1739493|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1739494|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1739495|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739496|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1739497|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
1739498|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1739499|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
1739500|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
1739501|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
1739502|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739503|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
1739504|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1739505|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1739506|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1739507|NCT03525873|Methylphenidate|methylphenidate|mesh-list
1739508|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1739509|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739510|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1739511|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1739512|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1739513|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739514|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
1739515|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1739528|NCT03489525|Antibodies|antibodies|mesh-list
1739529|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
1739530|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
1739531|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
1739532|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739533|NCT03463408|Nivolumab|nivolumab|mesh-list
1739534|NCT03463408|Ipilimumab|ipilimumab|mesh-list
1739535|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1739536|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739537|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1739538|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739539|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
1739540|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1739541|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
1739542|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739543|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
1739544|NCT03460158|Protective Agents|protective agents|mesh-ancestor
1739567|NCT03246347|Docetaxel|docetaxel|mesh-list
1739568|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739569|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
1739570|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
1739571|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
1739572|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739612|NCT03178149|Tacrolimus|tacrolimus|mesh-list
1739613|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1739614|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
1739615|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739616|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1739617|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1739618|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739619|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1739620|NCT03169985|Ezetimibe|ezetimibe|mesh-list
1739621|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1739622|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1739623|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
1739624|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739625|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1739626|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1739627|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1739628|NCT03140670|Rucaparib|rucaparib|mesh-list
1739629|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1739630|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1739631|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739632|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739633|NCT03129360|Levetiracetam|levetiracetam|mesh-list
1739634|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
1739635|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
1739724|NCT02774590|Timolol|timolol|mesh-list
1739674|NCT02989597|Methadone|methadone|mesh-list
1739675|NCT02989597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1739676|NCT02989597|Narcotics|narcotics|mesh-ancestor
1739677|NCT02989597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1739678|NCT02989597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739679|NCT02989597|Analgesics|analgesics|mesh-ancestor
1739680|NCT02989597|Sensory System Agents|sensory system agents|mesh-ancestor
1739681|NCT02989597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1739682|NCT02989597|Antitussive Agents|antitussive agents|mesh-ancestor
1739683|NCT02989597|Respiratory System Agents|respiratory system agents|mesh-ancestor
1739684|NCT02968810|Simvastatin|simvastatin|mesh-list
1739685|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1739686|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1739687|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
1739688|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739689|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1739690|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1739691|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1739692|NCT02934282|HBOC 201|hboc 201|mesh-list
1739693|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
1739725|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1739726|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1739727|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
1739728|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1739729|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739730|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739731|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1739732|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1739747|NCT02624596|Midazolam|midazolam|mesh-list
1739748|NCT02624596|Ketamine|ketamine|mesh-list
1739749|NCT02624596|Analgesics|analgesics|mesh-ancestor
1739750|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
1739751|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1739752|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739753|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1739754|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1739755|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
1739756|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
1739757|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1739758|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1739759|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1739760|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1739761|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739762|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1739763|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1739764|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1739765|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1739766|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1739767|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
1739768|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
1739775|NCT02582125|Nivolumab|nivolumab|mesh-list
1739776|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1739777|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739778|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1739779|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739830|NCT02356159|Rituximab|rituximab|mesh-list
1739831|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1739832|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739833|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
1739834|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739835|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1739850|NCT02195947|Hormones|hormones|mesh-list
1739851|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1739852|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739881|NCT02175173|Rufinamide|rufinamide|mesh-list
1739882|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
1739883|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1739884|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1739885|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1739886|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739887|NCT02037048|Leucovorin|leucovorin|mesh-list
1739888|NCT02037048|Paclitaxel|paclitaxel|mesh-list
1739889|NCT02037048|Carboplatin|carboplatin|mesh-list
1739890|NCT02037048|Fluorouracil|fluorouracil|mesh-list
1739891|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
1739892|NCT02037048|Calcium|calcium|mesh-list
1739893|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
1739894|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1739895|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739896|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
1739897|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
1739898|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
1739899|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739900|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1739901|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739902|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
1739903|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1739904|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1739905|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
1739906|NCT02037048|Antidotes|antidotes|mesh-ancestor
1739907|NCT02037048|Protective Agents|protective agents|mesh-ancestor
1739908|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
1739909|NCT02037048|Vitamins|vitamins|mesh-ancestor
1739910|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
1739911|NCT02023905|Everolimus|everolimus|mesh-list
1739912|NCT02023905|Temozolomide|temozolomide|mesh-list
1739913|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739914|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1739915|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
1739916|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739917|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1739918|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
1739919|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739948|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1739949|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1739950|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1739951|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
1739952|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1739953|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739954|NCT01972919|Gemcitabine|gemcitabine|mesh-list
1739955|NCT01972919|Capecitabine|capecitabine|mesh-list
1739956|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1739957|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
1739958|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1739959|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1739960|NCT01972919|Antiviral Agents|antiviral agents|mesh-ancestor
1739961|NCT01972919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1739962|NCT01972919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1739963|NCT01972919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1739964|NCT01972919|Immunologic Factors|immunologic factors|mesh-ancestor
1739965|NCT01972919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739966|NCT01909414|Vaccines|vaccines|mesh-list
1739967|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
1739968|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1739969|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1739982|NCT01698307|Adalimumab|adalimumab|mesh-list
1739983|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1739984|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1740065|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
1740066|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1740067|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740068|NCT05119101|Analgesics|analgesics|mesh-ancestor
1740069|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
1740070|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1740071|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740072|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
1740073|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1740074|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
1740075|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1740076|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1740077|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1740078|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
1740079|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1740091|NCT05118984|Azithromycin|azithromycin|mesh-list
1740092|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1740093|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1740094|NCT05118945|Insulin|insulin|mesh-list
1740095|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1740096|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1740097|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740098|NCT05118854|Cisplatin|cisplatin|mesh-list
1740099|NCT05118854|Carboplatin|carboplatin|mesh-list
1740100|NCT05118854|Pemetrexed|pemetrexed|mesh-list
1740101|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1740102|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1740103|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740104|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1740105|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1740121|NCT05118672|Acetaminophen|acetaminophen|mesh-list
1740122|NCT05118672|Fexofenadine|fexofenadine|mesh-list
1740123|NCT05118672|Phenylephrine|phenylephrine|mesh-list
1740124|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
1740125|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1740126|NCT05118672|Analgesics|analgesics|mesh-ancestor
1740127|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
1740128|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1740129|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740130|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
1740131|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1740132|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
1740133|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
1740134|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
1740135|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1740136|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
1740137|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
1740138|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1740139|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1740140|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1740141|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
1740142|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1740143|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740144|NCT05118672|Protective Agents|protective agents|mesh-ancestor
1740145|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1740146|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1740147|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1740148|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
1740149|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
1740157|NCT05118542|Methimazole|methimazole|mesh-list
1740158|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
1740159|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
1740160|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
1740161|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1740162|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740163|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
1740164|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740165|NCT05118490|Isoniazid|isoniazid|mesh-list
1740166|NCT05118490|Rifapentine|rifapentine|mesh-list
1740167|NCT05118490|Rifampin|rifampin|mesh-list
1740168|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
1740169|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1740170|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1740171|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1740172|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1740173|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
1740174|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740175|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1740176|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1740177|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
1740178|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1740179|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1740180|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1740181|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1740182|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1740183|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1740184|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1740185|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1740228|NCT05103358|Sirolimus|sirolimus|mesh-list
1740229|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1740230|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1740231|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1740232|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1740233|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
1740234|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1740235|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
1740236|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740250|NCT05094154|Penicillins|penicillins|mesh-list
1740251|NCT05094154|Cephalosporins|cephalosporins|mesh-list
1740252|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1740253|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1740254|NCT05093205|Midazolam|midazolam|mesh-list
1740255|NCT05093205|Atorvastatin|atorvastatin|mesh-list
1740256|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
1740257|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1740258|NCT05093205|Estradiol|estradiol|mesh-list
1740259|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1740260|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1740261|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
1740262|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740263|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1740264|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1740265|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1740266|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1740267|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1740268|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1740269|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740270|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1740271|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1740272|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1740273|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1740274|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
1740275|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
1740276|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
1740277|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
1740278|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1740279|NCT05093205|Estrogens|estrogens|mesh-ancestor
1740280|NCT05093205|Hormones|hormones|mesh-ancestor
1740281|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1740282|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1740283|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
1740284|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1740285|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1740286|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1740287|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1740288|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1740289|NCT05084534|Midodrine|midodrine|mesh-list
1740290|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
1740291|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
1740292|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1740293|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740294|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1740295|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1740296|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1740297|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1740298|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
1740299|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1740300|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740301|NCT05081219|Insulin|insulin|mesh-list
1740302|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1740303|NCT05081219|Empagliflozin|empagliflozin|mesh-list
1740304|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1740305|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740306|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1740307|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740350|NCT05038475|Antibodies|antibodies|mesh-list
1740351|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
1740352|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740360|NCT05036226|Metformin|metformin|mesh-list
1740361|NCT05036226|Sirolimus|sirolimus|mesh-list
1740362|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
1740363|NCT05036226|Nelfinavir|nelfinavir|mesh-list
1740364|NCT05036226|Dasatinib|dasatinib|mesh-list
1740365|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1740366|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740367|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1740368|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1740369|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1740370|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1740371|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
1740372|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1740373|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
1740374|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
1740375|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1740376|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1740377|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1740378|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740379|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1740380|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1740381|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1740382|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1740383|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
1740384|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1740385|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1740386|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
1740430|NCT05025163|Fluorides|fluorides|mesh-list
1740431|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
1740432|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
1740433|NCT05025163|Protective Agents|protective agents|mesh-ancestor
1740434|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740441|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1740442|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1740443|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1740444|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1740445|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740446|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1740447|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740448|NCT05018013|Analgesics|analgesics|mesh-ancestor
1740449|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
1740450|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1740451|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
1740452|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1740453|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
1740490|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
1740491|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1740583|NCT04908800|Itraconazole|itraconazole|mesh-list
1740584|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
1740585|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1740586|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1740587|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1740588|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1740589|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740590|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1740591|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
1740592|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1740593|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740594|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1740649|NCT04872582|Bevacizumab|bevacizumab|mesh-list
1740650|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1740651|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1740652|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1740653|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1740654|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1740655|NCT04872582|Growth Substances|growth substances|mesh-ancestor
1740656|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740657|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
1740658|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740706|NCT04818372|Dexamethasone|dexamethasone|mesh-list
1740707|NCT04818372|Lenalidomide|lenalidomide|mesh-list
1740708|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1740709|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
1740710|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
1740711|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1740712|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740713|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1740714|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
1740715|NCT04818372|Hormones|hormones|mesh-ancestor
1740716|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1740717|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1740718|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1740719|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
1740720|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1740721|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1740722|NCT04818372|Growth Substances|growth substances|mesh-ancestor
1740723|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
1740747|NCT04784299|Lidocaine|lidocaine|mesh-list
1740748|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
1740749|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
1740750|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1740751|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740752|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
1740753|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1740754|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1740755|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1740756|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1740757|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1740758|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740854|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
1740855|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
1740856|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740857|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1740858|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1740859|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
1740860|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1740861|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740862|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1740866|NCT04706507|Ganciclovir|ganciclovir|mesh-list
1740867|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
1740868|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
1740869|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1740870|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1740871|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1740872|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740905|NCT04692077|Tenofovir|tenofovir|mesh-list
1740906|NCT04692077|Emtricitabine|emtricitabine|mesh-list
1740907|NCT04692077|Cabotegravir|cabotegravir|mesh-list
1740908|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
1740909|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1740910|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1740911|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1740912|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1740913|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740914|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1740915|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1740916|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1740917|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1740918|NCT04682158|Paclitaxel|paclitaxel|mesh-list
1740919|NCT04682158|Carboplatin|carboplatin|mesh-list
1740920|NCT04682158|Propranolol|propranolol|mesh-list
1740921|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1740922|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1740923|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
1740924|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
1740925|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
1740926|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740927|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1740928|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1740929|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
1740930|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1740931|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740932|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1740933|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1740934|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
1740955|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
1740956|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
1740957|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1740958|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1740959|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1740960|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1740961|NCT04645316|Propofol|propofol|mesh-list
1740962|NCT04645316|Sevoflurane|sevoflurane|mesh-list
1740963|NCT04645316|Desflurane|desflurane|mesh-list
1740964|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1740965|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1740966|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1740967|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1740968|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
1740969|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
1740970|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1740971|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1741029|NCT04620382|Midodrine|midodrine|mesh-list
1741030|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
1741031|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
1741032|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1741033|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741034|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1741035|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1741036|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1741037|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1741038|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
1741039|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1741040|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741041|NCT04602533|Durvalumab|durvalumab|mesh-list
1741042|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1741043|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1741049|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
1741050|NCT04594382|Narcotics|narcotics|mesh-ancestor
1741051|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1741052|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741053|NCT04594382|Analgesics|analgesics|mesh-ancestor
1741054|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
1741055|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1741087|NCT04530604|Defibrotide|defibrotide|mesh-list
1741088|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1741089|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1741090|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741091|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1741134|NCT04451863|Caryophyllene|caryophyllene|mesh-list
1741135|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741136|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1741137|NCT04451863|Analgesics|analgesics|mesh-ancestor
1741138|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
1741139|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1741140|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1741141|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1741142|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1741143|NCT04450394|Insulin|insulin|mesh-list
1741144|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1741145|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741179|NCT04413201|Afatinib|afatinib|mesh-list
1741180|NCT04413201|Osimertinib|osimertinib|mesh-list
1741181|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1741182|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1741183|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1741184|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741280|NCT04303325|Esketamine|esketamine|mesh-list
1741281|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
1741282|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1741290|NCT04293393|Paclitaxel|paclitaxel|mesh-list
1741291|NCT04293393|Docetaxel|docetaxel|mesh-list
1741292|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
1741293|NCT04293393|Doxorubicin|doxorubicin|mesh-list
1741294|NCT04293393|Letrozole|letrozole|mesh-list
1741295|NCT04293393|Leuprolide|leuprolide|mesh-list
1741296|NCT04293393|Goserelin|goserelin|mesh-list
1741297|NCT04293393|Taxane|taxane|mesh-list
1741298|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1741299|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1741300|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
1741301|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
1741302|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
1741303|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741304|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1741305|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
1741306|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741307|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1741308|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1741309|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
1741310|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1741311|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1741312|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1741313|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1741314|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1741315|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1741316|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1741317|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1741318|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
1741319|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1741320|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1741321|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
1741322|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1741323|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1741328|NCT04247750|Sirolimus|sirolimus|mesh-list
1741329|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1741330|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1741331|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1741332|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1741333|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
1741334|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1741335|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
1741336|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741354|NCT04230408|Paclitaxel|paclitaxel|mesh-list
1741355|NCT04230408|Carboplatin|carboplatin|mesh-list
1741356|NCT04230408|Durvalumab|durvalumab|mesh-list
1741357|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1741358|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1741359|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
1741360|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
1741361|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
1741362|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741363|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1741449|NCT04169698|Denosumab|denosumab|mesh-list
1741450|NCT04169698|Alendronate|alendronate|mesh-list
1741451|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1741452|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741453|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
1741454|NCT04155203|Mupirocin|mupirocin|mesh-list
1741455|NCT04155203|Calcium|calcium|mesh-list
1741456|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1741457|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741458|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1741459|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1741460|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1741461|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1741462|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1741463|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741464|NCT04128956|Aspirin|aspirin|mesh-list
1741465|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1741466|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1741467|NCT04128956|Analgesics|analgesics|mesh-ancestor
1741468|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
1741469|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1741470|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741471|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1741472|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1741473|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1741474|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1741475|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741476|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1741477|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1741478|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1741479|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
1741851|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
1741579|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
1741580|NCT04042701|Trastuzumab|trastuzumab|mesh-list
1741581|NCT04042701|Camptothecin|camptothecin|mesh-list
1741582|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
1741583|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1741584|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1741585|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1741586|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1741587|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1741588|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1741589|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741590|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
1741591|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742153|NCT03386721|Antiviral Agents|antiviral agents|mesh-ancestor
1741677|NCT03906617|Dexamethasone|dexamethasone|mesh-list
1741678|NCT03906617|Epinephrine|epinephrine|mesh-list
1741679|NCT03906617|Bupivacaine|bupivacaine|mesh-list
1741680|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1741681|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
1741682|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
1741683|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1741684|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741685|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1741686|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
1741687|NCT03906617|Hormones|hormones|mesh-ancestor
1741688|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1741689|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1741690|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1741691|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
1741692|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
1741693|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1741694|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
1741695|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1741696|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1741697|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
1741698|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1741699|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741700|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1741701|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1741702|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1741703|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
1741704|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
1741705|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
1741706|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1741707|NCT03897673|Iron|iron|mesh-list
1741708|NCT03897673|Trace Elements|trace elements|mesh-ancestor
1741709|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
1741710|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741735|NCT03886649|Venetoclax|venetoclax|mesh-list
1741736|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1741737|NCT03874494|Aripiprazole|aripiprazole|mesh-list
1741738|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
1741739|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
1741740|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1741741|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1741742|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1741743|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1741744|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741745|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
1741746|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
1741747|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1741748|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741749|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1741750|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1741751|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
1741752|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1741753|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1741754|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1741755|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1741762|NCT03862859|Warfarin|warfarin|mesh-list
1741763|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
1741764|NCT03807817|Ethanol|ethanol|mesh-list
1741765|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1741766|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1741767|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1741768|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741769|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
1741770|NCT03797326|Lenvatinib|lenvatinib|mesh-list
1741771|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1741772|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1741773|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1741774|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1741775|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741782|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
1741783|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1741784|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1741826|NCT03739710|Docetaxel|docetaxel|mesh-list
1741827|NCT03739710|Ipilimumab|ipilimumab|mesh-list
1741828|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1741829|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
1741830|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
1741831|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
1741832|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741833|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1741834|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1741847|NCT03709446|Leflunomide|leflunomide|mesh-list
1741848|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1741849|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741850|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1741852|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741859|NCT03683069|Amlodipine|amlodipine|mesh-list
1741860|NCT03683069|Eplerenone|eplerenone|mesh-list
1741861|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1741862|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1741863|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1741864|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741865|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1741866|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741867|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
1741868|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1741869|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
1741870|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1741871|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1741872|NCT03683069|Diuretics|diuretics|mesh-ancestor
1741873|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
1741874|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
1741875|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1741876|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1741877|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741878|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1741879|NCT03677115|Analgesics|analgesics|mesh-ancestor
1741880|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
1741881|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1741882|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1741883|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1741884|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1741885|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
1741886|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1741887|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741891|NCT03673228|Nicotine|nicotine|mesh-list
1741892|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1741893|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
1741894|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1741895|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741896|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1741897|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1741898|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
1741899|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1741900|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741957|NCT03589326|Cytarabine|cytarabine|mesh-list
1741958|NCT03589326|Dexamethasone|dexamethasone|mesh-list
1741959|NCT03589326|Prednisone|prednisone|mesh-list
1741960|NCT03589326|Methotrexate|methotrexate|mesh-list
1741961|NCT03589326|Vincristine|vincristine|mesh-list
1741962|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
1741963|NCT03589326|Ponatinib|ponatinib|mesh-list
1741964|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1741965|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
1741966|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
1741967|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1741968|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741969|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1741970|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
1741971|NCT03589326|Hormones|hormones|mesh-ancestor
1741972|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1741973|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1741974|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1741975|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1741976|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
1741977|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1741978|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1741979|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
1741980|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1741981|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
1741982|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1741983|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1741984|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1741985|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
1741986|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1741987|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1741988|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
1741989|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1741990|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1741991|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
1741992|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
1741993|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
1741994|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1741995|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1741996|NCT03575403|Methylphenidate|methylphenidate|mesh-list
1741997|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1741998|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1741999|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1742000|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1742001|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1742002|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742003|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
1742004|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1742005|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1742006|NCT03575403|Analgesics|analgesics|mesh-ancestor
1742007|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
1742008|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1742009|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
1742010|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1742011|NCT03564691|Paclitaxel|paclitaxel|mesh-list
1742012|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1742013|NCT03564691|Cisplatin|cisplatin|mesh-list
1742014|NCT03564691|Carboplatin|carboplatin|mesh-list
1742015|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
1742016|NCT03564691|Pemetrexed|pemetrexed|mesh-list
1742017|NCT03564691|Lenvatinib|lenvatinib|mesh-list
1742018|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1742019|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742020|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
1742021|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
1742022|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
1742023|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742024|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1742025|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742026|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1742027|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1742028|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1742029|NCT03554174|Psilocybin|psilocybin|mesh-list
1742030|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
1742031|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742032|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1742058|NCT03482297|Midodrine|midodrine|mesh-list
1742059|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
1742060|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
1742061|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1742062|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742063|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1742064|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1742065|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1742066|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1742067|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
1742068|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1742069|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742143|NCT03386721|Gemcitabine|gemcitabine|mesh-list
1742144|NCT03386721|Atezolizumab|atezolizumab|mesh-list
1742145|NCT03386721|Vinorelbine|vinorelbine|mesh-list
1742146|NCT03386721|Antibodies|antibodies|mesh-list
1742147|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
1742148|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742149|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1742150|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
1742151|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742152|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742154|NCT03386721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1742155|NCT03386721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742156|NCT03386721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1742157|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1742158|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
1742159|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
1742160|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
1742178|NCT03314935|Leucovorin|leucovorin|mesh-list
1742179|NCT03314935|Gemcitabine|gemcitabine|mesh-list
1742180|NCT03314935|Paclitaxel|paclitaxel|mesh-list
1742181|NCT03314935|Fluorouracil|fluorouracil|mesh-list
1742182|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
1742183|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1742184|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742185|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
1742186|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
1742187|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
1742188|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742189|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1742190|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
1742191|NCT03314935|Antiviral Agents|antiviral agents|mesh-ancestor
1742192|NCT03314935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1742193|NCT03314935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742194|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1742195|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
1742196|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742197|NCT03314935|Antidotes|antidotes|mesh-ancestor
1742198|NCT03314935|Protective Agents|protective agents|mesh-ancestor
1742199|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
1742200|NCT03314935|Vitamins|vitamins|mesh-ancestor
1742201|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
1742208|NCT03278717|Olaparib|olaparib|mesh-list
1742209|NCT03278717|Cediranib|cediranib|mesh-list
1742210|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1742211|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742212|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742213|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742214|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1742228|NCT03235505|Nicotine|nicotine|mesh-list
1742229|NCT03235505|Varenicline|varenicline|mesh-list
1742230|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1742231|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
1742232|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1742233|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742234|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1742235|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1742236|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
1742237|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1742238|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742294|NCT03159897|Doxorubicin|doxorubicin|mesh-list
1742295|NCT03159897|Bleomycin|bleomycin|mesh-list
1742296|NCT03159897|Dacarbazine|dacarbazine|mesh-list
1742297|NCT03159897|Vinblastine|vinblastine|mesh-list
1742298|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1742299|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742300|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1742301|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1742302|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742303|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742304|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1742305|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
1742306|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1742307|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
1742308|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
1742309|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
1742310|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
1742311|NCT03025035|Olaparib|olaparib|mesh-list
1742312|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1742313|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742314|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1742315|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742316|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742317|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
1742318|NCT03018288|Temozolomide|temozolomide|mesh-list
1742319|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1742320|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742321|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1742322|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
1742323|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742324|NCT03003325|Aspirin|aspirin|mesh-list
1742325|NCT03003325|Interferons|interferons|mesh-list
1742326|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742327|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
1742328|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1742329|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1742330|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1742331|NCT03003325|Analgesics|analgesics|mesh-ancestor
1742332|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
1742333|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1742334|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742335|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1742336|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1742337|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1742338|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1742339|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742340|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1742341|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1742342|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742343|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
1742371|NCT02955823|Dexamethasone|dexamethasone|mesh-list
1742372|NCT02955823|Rituximab|rituximab|mesh-list
1742373|NCT02955823|Lenalidomide|lenalidomide|mesh-list
1742374|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1742375|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
1742376|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
1742377|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1742378|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742379|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1742380|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
1742381|NCT02955823|Hormones|hormones|mesh-ancestor
1742382|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1742383|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1742384|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742385|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1742386|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
1742387|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1742388|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1742389|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1742390|NCT02955823|Growth Substances|growth substances|mesh-ancestor
1742391|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
1742401|NCT02917993|Osimertinib|osimertinib|mesh-list
1742402|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742403|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1742404|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742405|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742433|NCT02862132|Vedolizumab|vedolizumab|mesh-list
1742434|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1742462|NCT02772081|Poractant alfa|poractant alfa|mesh-list
1742463|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
1742464|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
1742495|NCT02728050|Cytarabine|cytarabine|mesh-list
1742496|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
1742497|NCT02728050|Sorafenib|sorafenib|mesh-list
1742498|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
1742499|NCT02728050|Cladribine|cladribine|mesh-list
1742500|NCT02728050|Lenograstim|lenograstim|mesh-list
1742501|NCT02728050|Sargramostim|sargramostim|mesh-list
1742502|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1742503|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
1742504|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742505|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1742506|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
1742507|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742508|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742509|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
1742510|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1742511|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1742512|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1742513|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742514|NCT02728050|Analgesics|analgesics|mesh-ancestor
1742515|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
1742516|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1742517|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1742518|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1742534|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
1742535|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1742536|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1742537|NCT02578394|Prednisolone|prednisolone|mesh-list
1742538|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
1742539|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1742540|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1742541|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
1742542|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1742543|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
1742544|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
1742545|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1742546|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742547|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1742548|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
1742549|NCT02578394|Hormones|hormones|mesh-ancestor
1742550|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1742551|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1742552|NCT02578394|Protective Agents|protective agents|mesh-ancestor
1742553|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1742554|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742555|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1742655|NCT02341989|Carboplatin|carboplatin|mesh-list
1742656|NCT02341989|Etoposide|etoposide|mesh-list
1742657|NCT02341989|Bleomycin|bleomycin|mesh-list
1742658|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742659|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1742660|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1742661|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1742662|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742663|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742664|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1742665|NCT02184767|Loxapine|loxapine|mesh-list
1742666|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1742667|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1742668|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1742669|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742670|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1742671|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1742672|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
1742673|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1742674|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742706|NCT02122718|Allopurinol|allopurinol|mesh-list
1742707|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
1742708|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742709|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742710|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
1742711|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1742712|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1742713|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
1742714|NCT02122718|Protective Agents|protective agents|mesh-ancestor
1742715|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742716|NCT02078427|BAX 855|bax 855|mesh-list
1742717|NCT02078427|Coagulants|coagulants|mesh-ancestor
1742736|NCT01882816|Doxorubicin|doxorubicin|mesh-list
1742737|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1742738|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742739|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1742740|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1742741|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742742|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742758|NCT01758614|Aspirin|aspirin|mesh-list
1742759|NCT01758614|Clopidogrel|clopidogrel|mesh-list
1742760|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1742761|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1742762|NCT01758614|Analgesics|analgesics|mesh-ancestor
1742763|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
1742764|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1742765|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742766|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1742767|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1742768|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1742769|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1742770|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742771|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1742772|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1742773|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742774|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
1742775|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1742776|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1742777|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1742778|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
1742779|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1742780|NCT01593241|Carboplatin|carboplatin|mesh-list
1742781|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742794|NCT01515527|Cytarabine|cytarabine|mesh-list
1742795|NCT01515527|Decitabine|decitabine|mesh-list
1742796|NCT01515527|Cladribine|cladribine|mesh-list
1742797|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1742798|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
1742799|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742800|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742801|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
1742802|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1742803|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1742804|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
1742805|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742806|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742807|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1742808|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1742809|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742822|NCT01097746|Paclitaxel|paclitaxel|mesh-list
1742823|NCT01097746|Bevacizumab|bevacizumab|mesh-list
1742824|NCT01097746|Carboplatin|carboplatin|mesh-list
1742825|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1742826|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1742827|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
1742828|NCT01097746|Antibodies|antibodies|mesh-list
1742829|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
1742830|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1742831|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
1742832|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1742833|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742834|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
1742835|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
1742836|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
1742837|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742838|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1742839|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1742840|NCT01097746|Growth Substances|growth substances|mesh-ancestor
1742841|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742842|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
1742843|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
1742877|NCT00307242|Adefovir|adefovir|mesh-list
1742878|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
1742879|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
1742880|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1742881|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1742882|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1742883|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742884|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742885|NCT05120895|Pravastatin|pravastatin|mesh-list
1742886|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1742887|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1742888|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
1742889|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742890|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1742891|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1742892|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742893|NCT05120687|Cyclosporine|cyclosporine|mesh-list
1742894|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
1742895|NCT05120687|Adalimumab|adalimumab|mesh-list
1742896|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
1742897|NCT05120687|Methotrexate|methotrexate|mesh-list
1742898|NCT05120687|Cyclosporins|cyclosporins|mesh-list
1742899|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1742900|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
1742901|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742902|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1742903|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1742904|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
1742905|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742906|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742907|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1742908|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1742909|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
1742910|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1742911|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1742912|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
1742913|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
1742914|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742915|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1742916|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1742917|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
1742918|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1742919|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1742920|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1742921|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1742922|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
1742923|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1742924|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1742925|NCT05120622|Tremelimumab|tremelimumab|mesh-list
1742926|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742927|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
1742928|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1742929|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742930|NCT05120505|Metformin|metformin|mesh-list
1742931|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1742932|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742942|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
1742943|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1742944|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1742945|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1742946|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
1742947|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
1742951|NCT05120076|Dexamethasone|dexamethasone|mesh-list
1742952|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
1742953|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1742954|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
1742955|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
1742956|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1742957|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1742958|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1742959|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
1742960|NCT05120076|Hormones|hormones|mesh-ancestor
1742961|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1742962|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1742963|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1742984|NCT05119712|Terbinafine|terbinafine|mesh-list
1742985|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
1742986|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1742987|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1742988|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1742989|NCT05119452|Adalimumab|adalimumab|mesh-list
1742990|NCT05119452|Etanercept|etanercept|mesh-list
1742991|NCT05119452|Golimumab|golimumab|mesh-list
1742992|NCT05119452|Infliximab|infliximab|mesh-list
1742993|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
1742994|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
1742995|NCT05119452|Tofacitinib|tofacitinib|mesh-list
1742996|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1742997|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1742998|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1742999|NCT05119452|Analgesics|analgesics|mesh-ancestor
1743000|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
1743001|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1743002|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743003|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1743004|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1743005|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
1743006|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
1743007|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1743008|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1743009|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743010|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1743011|NCT05119439|Misoprostol|misoprostol|mesh-list
1743012|NCT05119439|Mifepristone|mifepristone|mesh-list
1743013|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1743014|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
1743015|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1743016|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743017|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1743018|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1743019|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
1743020|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1743021|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1743022|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1743023|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1743024|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
1743025|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1743026|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1743027|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
1743028|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1743029|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
1743030|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1743031|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1743035|NCT05119257|Antibodies|antibodies|mesh-list
1743036|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
1743037|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
1743038|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743055|NCT05112263|Cyclosporine|cyclosporine|mesh-list
1743056|NCT05112263|Cyclosporins|cyclosporins|mesh-list
1743057|NCT05112263|Tofacitinib|tofacitinib|mesh-list
1743058|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1743059|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743060|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1743061|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
1743062|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743063|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
1743064|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1743065|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
1743066|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1743067|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1743068|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1743080|NCT05108155|Tacrine|tacrine|mesh-list
1743081|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1743082|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1743083|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743084|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
1743085|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1743086|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743087|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1743088|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
1743089|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1743090|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
1743091|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
1743092|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1743093|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743094|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743106|NCT05085873|Midazolam|midazolam|mesh-list
1743107|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
1743108|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1743109|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1743110|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1743111|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743112|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1743113|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1743114|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1743115|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1743116|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
1743117|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
1743118|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
1743119|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
1743120|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1743121|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743139|NCT05065918|Ethanol|ethanol|mesh-list
1743140|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1743141|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1743142|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1743143|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743144|NCT05061992|Lactulose|lactulose|mesh-list
1743145|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1743146|NCT05056883|Ivermectin|ivermectin|mesh-list
1743147|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1743148|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1743196|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
1743197|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1743198|NCT05021861|Estradiol|estradiol|mesh-list
1743199|NCT05021861|Cyproterone|cyproterone|mesh-list
1743200|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
1743201|NCT05021861|Estrogens|estrogens|mesh-ancestor
1743202|NCT05021861|Hormones|hormones|mesh-ancestor
1743203|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1743204|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743205|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1743206|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
1743207|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1743208|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1743209|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1743210|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1743211|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
1743212|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
1743213|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1743214|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1743234|NCT05014282|Nicotine|nicotine|mesh-list
1743235|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1743236|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
1743237|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1743238|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743239|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1743240|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1743241|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
1743242|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1743243|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743295|NCT04995874|Micronutrients|micronutrients|mesh-list
1743296|NCT04995874|Trace Elements|trace elements|mesh-list
1743297|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743298|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
1743299|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1743300|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1743355|NCT04961281|Triamcinolone|triamcinolone|mesh-list
1743356|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
1743357|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1743358|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1743359|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743360|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1743361|NCT04961281|Analgesics|analgesics|mesh-ancestor
1743362|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
1743363|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1743364|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1743365|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1743366|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1743367|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
1743368|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1743369|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743370|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1743371|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
1743372|NCT04961281|Hormones|hormones|mesh-ancestor
1743373|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1743374|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
1743375|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1743376|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743377|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1743378|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743379|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
1743380|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1743381|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1743382|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
1743383|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
1743384|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
1743385|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1743386|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743387|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
1743388|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1743512|NCT04920331|Erenumab|erenumab|mesh-list
1743513|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1743514|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743515|NCT04920331|Analgesics|analgesics|mesh-ancestor
1743516|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
1743517|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1743518|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743519|NCT04918186|Durvalumab|durvalumab|mesh-list
1743520|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1743521|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1743530|NCT04908371|Lidocaine|lidocaine|mesh-list
1743531|NCT04908371|Epinephrine|epinephrine|mesh-list
1743532|NCT04908371|Racepinephrine|racepinephrine|mesh-list
1743533|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
1743534|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
1743535|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
1743536|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
1743537|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1743538|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743539|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
1743540|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1743541|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1743542|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1743543|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1743544|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1743545|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743546|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1743547|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1743548|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
1743549|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1743550|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1743551|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1743552|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
1743553|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1743554|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
1743555|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
1743556|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
1743557|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1743624|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
1743625|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1743626|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1743627|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743628|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1743629|NCT04824144|Analgesics|analgesics|mesh-ancestor
1743630|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
1743631|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1743632|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1743633|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1743634|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1743635|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
1743636|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1743637|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743644|NCT04814745|Morphine|morphine|mesh-list
1743645|NCT04814745|Tramadol|tramadol|mesh-list
1743646|NCT04814745|Ropivacaine|ropivacaine|mesh-list
1743647|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1743648|NCT04814745|Narcotics|narcotics|mesh-ancestor
1743649|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1743650|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743651|NCT04814745|Analgesics|analgesics|mesh-ancestor
1743652|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
1743653|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1743654|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
1743655|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
1743752|NCT04755244|Azacitidine|azacitidine|mesh-list
1743753|NCT04755244|Venetoclax|venetoclax|mesh-list
1743754|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1743755|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
1743756|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743757|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1743758|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1743759|NCT04752527|Sorafenib|sorafenib|mesh-list
1743760|NCT04752527|Decitabine|decitabine|mesh-list
1743761|NCT04752527|Venetoclax|venetoclax|mesh-list
1743762|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1743763|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1743764|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1743765|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743766|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1743767|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
1743792|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1743807|NCT04738422|Glycine|glycine|mesh-list
1743808|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
1743809|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1743810|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743811|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743834|NCT04716335|Harmine|harmine|mesh-list
1743835|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
1743836|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743837|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1743838|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1743839|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1743840|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743847|NCT04675151|Phentolamine|phentolamine|mesh-list
1743848|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1743849|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1743850|NCT04675151|Pilocarpine|pilocarpine|mesh-list
1743851|NCT04675151|Miotics|miotics|mesh-ancestor
1743852|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
1743853|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1743854|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743855|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
1743856|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1743857|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
1743858|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1743859|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743860|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1743861|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1743862|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
1743863|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1743864|NCT04666961|Tamoxifen|tamoxifen|mesh-list
1743865|NCT04666961|Anastrozole|anastrozole|mesh-list
1743866|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1743867|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
1743868|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1743869|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743870|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1743871|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1743872|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1743873|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1743874|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1743875|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1743876|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1743877|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1743878|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743882|NCT04663308|Volixibat|volixibat|mesh-list
1743883|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1743892|NCT04640571|Metformin|metformin|mesh-list
1743893|NCT04640571|Valacyclovir|valacyclovir|mesh-list
1743894|NCT04640571|Enalaprilat|enalaprilat|mesh-list
1743895|NCT04640571|Enalapril|enalapril|mesh-list
1743896|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
1743897|NCT04640571|Pravastatin|pravastatin|mesh-list
1743898|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1743899|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743900|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1743901|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1743902|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
1743903|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743904|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1743905|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1743906|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1743907|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
1743908|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1743909|NCT04640571|Cathartics|cathartics|mesh-ancestor
1743910|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1743911|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1743912|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
1743913|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1743926|NCT04638660|Phentolamine|phentolamine|mesh-list
1743927|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1743928|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1743929|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1743930|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1743931|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
1743932|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1743933|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1743934|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1743935|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1743998|NCT04576455|Fulvestrant|fulvestrant|mesh-list
1743999|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1744000|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1744001|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744002|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1744003|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1744004|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
1744005|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1744006|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744007|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1744008|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1744009|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744010|NCT04572100|Paclitaxel|paclitaxel|mesh-list
1744011|NCT04572100|Carboplatin|carboplatin|mesh-list
1744012|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1744013|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744014|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
1744015|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
1744016|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
1744017|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744025|NCT04567407|Ropivacaine|ropivacaine|mesh-list
1744026|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
1744027|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
1744028|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1744029|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744030|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
1744031|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1744043|NCT04564885|Meloxicam|meloxicam|mesh-list
1744044|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1744045|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1744046|NCT04564885|Analgesics|analgesics|mesh-ancestor
1744047|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
1744048|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1744049|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744050|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1744051|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1744052|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1744053|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1744054|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1744055|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744056|NCT04551885|Aldesleukin|aldesleukin|mesh-list
1744057|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
1744058|NCT04551885|Fludarabine|fludarabine|mesh-list
1744059|NCT04551885|Avelumab|avelumab|mesh-list
1744060|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1744061|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
1744062|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744063|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1744064|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1744065|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
1744066|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744067|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744068|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1744069|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1744070|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1744071|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
1744072|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1744073|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1744074|NCT04533451|Carboplatin|carboplatin|mesh-list
1744075|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
1744076|NCT04533451|Pemetrexed|pemetrexed|mesh-list
1744077|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744078|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1744079|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1744080|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744081|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1744082|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1744083|NCT04520776|Meloxicam|meloxicam|mesh-list
1744084|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1744085|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1744086|NCT04520776|Analgesics|analgesics|mesh-ancestor
1744087|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
1744088|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1744089|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744090|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1744091|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1744092|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1744093|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1744094|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1744095|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744111|NCT04497870|Peppermint oil|peppermint oil|mesh-list
1744112|NCT04497870|Menthol|menthol|mesh-list
1744113|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
1744114|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
1744115|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
1744116|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
1744117|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1744118|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744119|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1744120|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
1744121|NCT04487041|Vaccines|vaccines|mesh-list
1744122|NCT04487041|Immunologic Factors|immunologic factors|mesh-ancestor
1744123|NCT04487041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744142|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
1744143|NCT04456296|Testosterone|testosterone|mesh-list
1744144|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
1744145|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
1744146|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1744147|NCT04456296|Androgens|androgens|mesh-ancestor
1744148|NCT04456296|Hormones|hormones|mesh-ancestor
1744149|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1744150|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744151|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1744152|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744153|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
1744170|NCT04431141|Empagliflozin|empagliflozin|mesh-list
1744171|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1744172|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744173|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1744174|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744175|NCT04412395|Lactoferrin|lactoferrin|mesh-list
1744176|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1744207|NCT04382326|Vaccines|vaccines|mesh-list
1744208|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1744209|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
1744210|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744249|NCT04327024|Allopurinol|allopurinol|mesh-list
1744250|NCT04327024|Verinurad|verinurad|mesh-list
1744251|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
1744252|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744253|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1744254|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
1744255|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1744256|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1744257|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
1744258|NCT04327024|Protective Agents|protective agents|mesh-ancestor
1744259|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744260|NCT04310748|Anesthetics|anesthetics|mesh-list
1744261|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1744262|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744266|NCT04304768|Vaccines|vaccines|mesh-list
1744267|NCT04304768|Immunologic Factors|immunologic factors|mesh-ancestor
1744268|NCT04304768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744269|NCT04294498|Entecavir|entecavir|mesh-list
1744270|NCT04294498|Durvalumab|durvalumab|mesh-list
1744271|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1744272|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744273|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
1744274|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1744281|NCT04276493|Docetaxel|docetaxel|mesh-list
1744282|NCT04276493|Capecitabine|capecitabine|mesh-list
1744283|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
1744284|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744285|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
1744286|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
1744287|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
1744288|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744289|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1744290|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
1744355|NCT04235634|Alprostadil|alprostadil|mesh-list
1744356|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1744357|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
1744358|NCT04235634|Urological Agents|urological agents|mesh-ancestor
1744401|NCT04206488|Digoxin|digoxin|mesh-list
1744402|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1744403|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1744404|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1744405|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744406|NCT04206488|Protective Agents|protective agents|mesh-ancestor
1744407|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744420|NCT04188418|Fentanyl|fentanyl|mesh-list
1744421|NCT04188418|Morphine|morphine|mesh-list
1744422|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1744423|NCT04188418|Narcotics|narcotics|mesh-ancestor
1744424|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1744425|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744426|NCT04188418|Analgesics|analgesics|mesh-ancestor
1744427|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
1744428|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1744429|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1744430|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1744431|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
1744432|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
1744464|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
1744465|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
1744466|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1744467|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
1744468|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744469|NCT04177355|Antacids|antacids|mesh-ancestor
1744470|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744471|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1744472|NCT04161066|Psilocybin|psilocybin|mesh-list
1744473|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
1744474|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744475|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1744571|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1744620|NCT03946969|Paclitaxel|paclitaxel|mesh-list
1744621|NCT03946969|Cisplatin|cisplatin|mesh-list
1744622|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1744623|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744624|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
1744625|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
1744626|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
1744627|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744646|NCT03912363|Insulin|insulin|mesh-list
1744647|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1744648|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744649|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1744650|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1744651|NCT03901131|Norethindrone|norethindrone|mesh-list
1744652|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
1744653|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
1744654|NCT03901131|Estradiol|estradiol|mesh-list
1744655|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1744656|NCT03901131|Estrogens|estrogens|mesh-ancestor
1744657|NCT03901131|Hormones|hormones|mesh-ancestor
1744658|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1744659|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744660|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1744661|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
1744662|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1744663|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1744664|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1744665|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1744666|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1744667|NCT03814317|Treprostinil|treprostinil|mesh-list
1744668|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1744675|NCT03744026|Carboplatin|carboplatin|mesh-list
1744676|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744677|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
1744678|NCT03737955|Calicheamicins|calicheamicins|mesh-list
1744679|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1744680|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744681|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1744707|NCT03688633|Candesartan|candesartan|mesh-list
1744708|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1744709|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1744710|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1744711|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744719|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
1744720|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1744721|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744727|NCT03613116|Vitamin D|vitamin d|mesh-list
1744728|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
1744729|NCT03613116|Vitamins|vitamins|mesh-ancestor
1744730|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
1744731|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744732|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1744733|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1744765|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1744766|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
1744767|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744768|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
1744769|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1744770|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
1744771|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744772|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1744773|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1744774|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
1744775|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744776|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744777|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1744804|NCT03441750|Metformin|metformin|mesh-list
1744805|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1744806|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744819|NCT03423264|Gabapentin|gabapentin|mesh-list
1744820|NCT03423264|Analgesics|analgesics|mesh-ancestor
1744821|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
1744822|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1744823|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744824|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
1744825|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1744826|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1744827|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1744828|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1744829|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1744830|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1744831|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1744832|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744833|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
1744834|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
1744835|NCT03399773|Thiotepa|thiotepa|mesh-list
1744836|NCT03399773|Fludarabine|fludarabine|mesh-list
1744837|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1744838|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
1744839|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744840|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1744841|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1744842|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
1744843|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744844|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744845|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1744860|NCT03367715|Nivolumab|nivolumab|mesh-list
1744861|NCT03367715|Ipilimumab|ipilimumab|mesh-list
1744862|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1744863|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744864|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1744865|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744869|NCT03360890|Docetaxel|docetaxel|mesh-list
1744870|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
1744871|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744872|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
1744873|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
1744874|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
1744875|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744876|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1744880|NCT03332797|Palbociclib|palbociclib|mesh-list
1744881|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744882|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1744883|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1744884|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1744899|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
1744900|NCT03225547|Mifepristone|mifepristone|mesh-list
1744901|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1744902|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1744903|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1744904|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
1744905|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1744906|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1744907|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1744908|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1744909|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1744910|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
1744911|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1744912|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1744913|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
1744914|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1744915|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
1744916|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1744917|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1745028|NCT03132454|Dexamethasone|dexamethasone|mesh-list
1745029|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
1745030|NCT03132454|Sorafenib|sorafenib|mesh-list
1745031|NCT03132454|Decitabine|decitabine|mesh-list
1745032|NCT03132454|Palbociclib|palbociclib|mesh-list
1745033|NCT03132454|Ichthammol|ichthammol|mesh-list
1745034|NCT03132454|BB 1101|bb 1101|mesh-list
1745035|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1745036|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
1745037|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
1745038|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1745039|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745040|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1745041|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
1745042|NCT03132454|Hormones|hormones|mesh-ancestor
1745043|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1745044|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1745045|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745046|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
1745047|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745048|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745049|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1745050|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1745051|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
1745052|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
1745053|NCT03126968|Epinephrine|epinephrine|mesh-list
1745054|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1745055|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1745056|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
1745057|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1745058|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745059|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745060|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1745061|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1745062|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
1745063|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1745064|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1745065|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
1745066|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
1745067|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
1745068|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1745074|NCT03121677|Poly I-C|poly i-c|mesh-list
1745075|NCT03121677|Rituximab|rituximab|mesh-list
1745076|NCT03121677|Nivolumab|nivolumab|mesh-list
1745077|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1745078|NCT03121677|Poly ICLC|poly iclc|mesh-list
1745079|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1745080|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745081|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
1745082|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745083|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1745084|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1745085|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745086|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
1745087|NCT03121677|Laxatives|laxatives|mesh-ancestor
1745088|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1745089|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
1745090|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1745093|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
1745094|NCT03107182|Promethazine|promethazine|mesh-list
1745095|NCT03107182|Dexamethasone|dexamethasone|mesh-list
1745096|NCT03107182|Paclitaxel|paclitaxel|mesh-list
1745097|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1745098|NCT03107182|Carboplatin|carboplatin|mesh-list
1745099|NCT03107182|Nivolumab|nivolumab|mesh-list
1745100|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
1745101|NCT03107182|Famotidine|famotidine|mesh-list
1745102|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1745103|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745104|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
1745105|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
1745106|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
1745107|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745108|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1745109|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
1745110|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
1745111|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1745112|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745113|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1745114|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
1745115|NCT03107182|Hormones|hormones|mesh-ancestor
1745116|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1745117|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1745118|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1745119|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1745120|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
1745121|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745122|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1745123|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1745124|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1745125|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1745126|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
1745127|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
1745128|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
1745129|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1745130|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
1745131|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
1745132|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1745133|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1745134|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
1745135|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
1745136|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1745137|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1745193|NCT02969837|Dexamethasone|dexamethasone|mesh-list
1745194|NCT02969837|Lenalidomide|lenalidomide|mesh-list
1745195|NCT02969837|Elotuzumab|elotuzumab|mesh-list
1745196|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1745197|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
1745198|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
1745199|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1745200|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745201|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1745202|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
1745203|NCT02969837|Hormones|hormones|mesh-ancestor
1745204|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1745205|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1745206|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745207|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
1745208|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1745209|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1745210|NCT02969837|Growth Substances|growth substances|mesh-ancestor
1745211|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
1745223|NCT02870738|Triamcinolone|triamcinolone|mesh-list
1745224|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1745225|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
1745226|NCT02870738|Hormones|hormones|mesh-ancestor
1745227|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1745228|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745237|NCT02802852|Lenograstim|lenograstim|mesh-list
1745238|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1745239|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
1745240|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745241|NCT02789020|Rasagiline|rasagiline|mesh-list
1745242|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1745243|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745244|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745245|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1745246|NCT02789020|Protective Agents|protective agents|mesh-ancestor
1745247|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745289|NCT02524275|Docetaxel|docetaxel|mesh-list
1745290|NCT02524275|Capecitabine|capecitabine|mesh-list
1745291|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745292|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
1745293|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
1745294|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
1745295|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745296|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1745297|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
1745311|NCT02473042|Promethazine|promethazine|mesh-list
1745312|NCT02473042|Dexamethasone|dexamethasone|mesh-list
1745313|NCT02473042|Ondansetron|ondansetron|mesh-list
1745314|NCT02473042|Famotidine|famotidine|mesh-list
1745315|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1745316|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
1745317|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
1745318|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1745319|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745320|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1745321|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
1745322|NCT02473042|Hormones|hormones|mesh-ancestor
1745323|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1745324|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1745325|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745326|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
1745327|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
1745328|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1745329|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
1745330|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1745331|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745332|NCT02473042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1745333|NCT02473042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1745334|NCT02473042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1745335|NCT02473042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1745336|NCT02473042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1745337|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1745338|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1745339|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
1745340|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
1745341|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1745342|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1745418|NCT02333149|Melatonin|melatonin|mesh-list
1745419|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
1745420|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745421|NCT02333149|Protective Agents|protective agents|mesh-ancestor
1745422|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745423|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1745513|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
1745437|NCT02320435|Trastuzumab|trastuzumab|mesh-list
1745438|NCT02320435|Pertuzumab|pertuzumab|mesh-list
1745439|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1745440|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745441|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
1745442|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1745443|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745444|NCT02213575|Minocycline|minocycline|mesh-list
1745445|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1745446|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1745475|NCT02192021|Doxorubicin|doxorubicin|mesh-list
1745476|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1745477|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1745478|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745479|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1745480|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1745481|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745482|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745483|NCT02144857|Cyclosporine|cyclosporine|mesh-list
1745484|NCT02144857|Etanercept|etanercept|mesh-list
1745485|NCT02144857|Apremilast|apremilast|mesh-list
1745486|NCT02144857|Ustekinumab|ustekinumab|mesh-list
1745487|NCT02144857|Cyclosporins|cyclosporins|mesh-list
1745488|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745489|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745490|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1745491|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
1745492|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745493|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
1745494|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1745495|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
1745496|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1745497|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1745498|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1745499|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1745500|NCT02144857|Analgesics|analgesics|mesh-ancestor
1745501|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
1745502|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1745503|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1745504|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1745505|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1745506|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1745507|NCT02133872|Minocycline|minocycline|mesh-list
1745508|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1745509|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1745514|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1745515|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745529|NCT01462578|Azacitidine|azacitidine|mesh-list
1745530|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1745531|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
1745532|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745533|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745534|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745538|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
1745539|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1745540|NCT01219075|Estrogens|estrogens|mesh-ancestor
1745541|NCT01219075|Hormones|hormones|mesh-ancestor
1745542|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1745543|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745555|NCT00876031|Etoposide|etoposide|mesh-list
1745556|NCT00876031|Idarubicin|idarubicin|mesh-list
1745557|NCT00876031|Trofosfamide|trofosfamide|mesh-list
1745558|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1745559|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745560|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1745561|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1745562|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745563|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745564|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1745565|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1745566|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
1745567|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745568|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1745569|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
1745622|NCT05122494|Capecitabine|capecitabine|mesh-list
1745623|NCT05122494|Lapatinib|lapatinib|mesh-list
1745624|NCT05122494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1745625|NCT05122494|Antimetabolites|antimetabolites|mesh-ancestor
1745626|NCT05122494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745627|NCT05122494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745628|NCT05122494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1745629|NCT05122494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745630|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
1745631|NCT05122481|Vitamins|vitamins|mesh-ancestor
1745632|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
1745633|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745634|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
1745635|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745636|NCT05122481|Protective Agents|protective agents|mesh-ancestor
1745637|NCT05122455|Edoxaban|edoxaban|mesh-list
1745638|NCT05122455|Clopidogrel|clopidogrel|mesh-list
1745639|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1745640|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1745641|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1745642|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1745643|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
1745644|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1745645|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745646|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745647|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1745648|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
1745649|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1745650|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
1745651|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745652|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
1745653|NCT05122377|Goserelin|goserelin|mesh-list
1745654|NCT05122377|Leuprolide|leuprolide|mesh-list
1745655|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1745656|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745657|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1745658|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
1745659|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1745660|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745661|NCT05122351|Acetaminophen|acetaminophen|mesh-list
1745662|NCT05122351|Bupivacaine|bupivacaine|mesh-list
1745663|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
1745664|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
1745665|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1745666|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745667|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
1745668|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1745669|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1745670|NCT05122351|Analgesics|analgesics|mesh-ancestor
1745671|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
1745672|NCT05122338|Lidocaine|lidocaine|mesh-list
1745673|NCT05122338|Ropivacaine|ropivacaine|mesh-list
1745674|NCT05122338|Esketamine|esketamine|mesh-list
1745675|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
1745676|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
1745677|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1745678|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745679|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
1745680|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1745681|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1745682|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1745683|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1745684|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1745685|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745686|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
1745687|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1745688|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
1745689|NCT05122221|Fludarabine|fludarabine|mesh-list
1745690|NCT05122221|Interleukin-2|interleukin-2|mesh-list
1745691|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1745692|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
1745693|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745694|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1745695|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1745696|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
1745697|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745698|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745699|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1745700|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1745701|NCT05122221|Analgesics|analgesics|mesh-ancestor
1745702|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
1745703|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1745704|NCT05122208|Famotidine|famotidine|mesh-list
1745705|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1745706|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1745707|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1745708|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
1745709|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
1745710|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1745711|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745712|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745744|NCT05122117|Methylene Blue|methylene blue|mesh-list
1745745|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745746|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745747|NCT05122026|Isoniazid|isoniazid|mesh-list
1745748|NCT05122026|Rifapentine|rifapentine|mesh-list
1745749|NCT05122026|Rifampin|rifampin|mesh-list
1745750|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
1745751|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1745752|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1745753|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1745754|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1745755|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
1745756|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745757|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1745758|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1745759|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
1745760|NCT05122026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1745761|NCT05122026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745762|NCT05122026|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1745763|NCT05122026|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1745764|NCT05122026|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1745765|NCT05122026|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1745766|NCT05122026|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1745767|NCT05122026|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1745772|NCT05121909|Listerine|listerine|mesh-list
1745773|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
1745774|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
1745775|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
1745776|NCT05121909|Protective Agents|protective agents|mesh-ancestor
1745777|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745778|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1745779|NCT05121883|Edaravone|edaravone|mesh-list
1745780|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1745781|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
1745782|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745783|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1745784|NCT05121883|Protective Agents|protective agents|mesh-ancestor
1745785|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745786|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1745787|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1745788|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745819|NCT05121324|Midazolam|midazolam|mesh-list
1745820|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1745821|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1745822|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1745823|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745824|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1745825|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1745826|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1745827|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1745828|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
1745829|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
1745830|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
1745831|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
1745832|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1745833|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745843|NCT05121233|Diclofenac|diclofenac|mesh-list
1745844|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1745845|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1745846|NCT05121233|Analgesics|analgesics|mesh-ancestor
1745847|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
1745848|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1745849|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745850|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1745851|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1745852|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1745853|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745854|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745855|NCT05121168|Bupivacaine|bupivacaine|mesh-list
1745856|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
1745857|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
1745858|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1745859|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745860|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
1745861|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1745884|NCT05120960|Osimertinib|osimertinib|mesh-list
1745885|NCT05120960|Tepotinib|tepotinib|mesh-list
1745886|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745887|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1745888|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745889|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745890|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1745891|NCT05120934|Amitriptyline|amitriptyline|mesh-list
1745892|NCT05120934|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
1745893|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1745894|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1745895|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1745896|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745897|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1745898|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745899|NCT05120934|Analgesics|analgesics|mesh-ancestor
1745900|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
1745901|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1745902|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
1745903|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1745904|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
1745905|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1745906|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1745907|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1745908|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
1745909|NCT05120934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1745910|NCT05120934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1745911|NCT05120934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1745912|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1745913|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
1745914|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
1745915|NCT05114720|Docetaxel|docetaxel|mesh-list
1745916|NCT05114720|Doxorubicin|doxorubicin|mesh-list
1745917|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1745918|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1745919|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1745920|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
1745921|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745922|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1745923|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1745924|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
1745925|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745926|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745927|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1745928|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
1745929|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
1745930|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
1745931|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1745932|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1745933|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1745934|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745935|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1745936|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1745937|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
1745938|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1745939|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1745940|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1745941|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1745942|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
1745943|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745944|NCT05112211|Doxycycline|doxycycline|mesh-list
1745945|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1745946|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1745947|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
1745948|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1745949|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1745950|NCT05111717|Desflurane|desflurane|mesh-list
1745951|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1745952|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
1745953|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
1745954|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1745955|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745956|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
1745957|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
1745958|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1745978|NCT05095064|Irinotecan|irinotecan|mesh-list
1745979|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1745980|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1745981|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745982|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1745983|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1745984|NCT05087589|Tofacitinib|tofacitinib|mesh-list
1745985|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1745986|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1745987|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746031|NCT05077488|Lidocaine|lidocaine|mesh-list
1746032|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
1746033|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
1746034|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1746035|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746036|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
1746037|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1746038|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1746039|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1746040|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1746041|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1746042|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746065|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
1746066|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1746067|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1746068|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746069|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
1746070|NCT05075200|Coagulants|coagulants|mesh-ancestor
1746071|NCT05073484|Antibodies|antibodies|mesh-list
1746072|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
1746073|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
1746074|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746083|NCT05065970|Felzartamab|felzartamab|mesh-list
1746084|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1746085|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
1746086|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746087|NCT05064319|Gabapentin|gabapentin|mesh-list
1746088|NCT05064319|Analgesics|analgesics|mesh-ancestor
1746089|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
1746090|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1746091|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746092|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
1746093|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1746094|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1746095|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1746096|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1746097|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1746098|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1746099|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1746100|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746101|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
1746129|NCT05037994|Prednisolone|prednisolone|mesh-list
1746130|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1746131|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
1746132|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1746133|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
1746134|NCT05037994|Gabapentin|gabapentin|mesh-list
1746135|NCT05037994|Bupivacaine|bupivacaine|mesh-list
1746136|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1746137|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
1746138|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1746139|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
1746140|NCT05037994|Hormones|hormones|mesh-ancestor
1746141|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1746142|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746143|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1746144|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1746145|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
1746146|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
1746147|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1746148|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1746149|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1746150|NCT05037994|Protective Agents|protective agents|mesh-ancestor
1746151|NCT05037994|Analgesics|analgesics|mesh-ancestor
1746152|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
1746153|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
1746154|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1746155|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1746156|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1746157|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1746158|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1746159|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1746160|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1746161|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746162|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
1746163|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
1746164|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
1746165|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
1746166|NCT05036434|Lenvatinib|lenvatinib|mesh-list
1746167|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1746168|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1746169|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1746170|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1746171|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746229|NCT05018117|Nicotine|nicotine|mesh-list
1746230|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1746231|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
1746232|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1746233|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746234|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1746235|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1746236|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
1746237|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1746238|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746259|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1746260|NCT05002738|Desogestrel|desogestrel|mesh-list
1746261|NCT05002738|Estradiol|estradiol|mesh-list
1746262|NCT05002738|Estrogens|estrogens|mesh-ancestor
1746263|NCT05002738|Hormones|hormones|mesh-ancestor
1746264|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1746265|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746266|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1746267|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
1746268|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1746269|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1746270|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1746271|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1746272|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1746273|NCT05002738|Progestins|progestins|mesh-ancestor
1746274|NCT05000294|Atezolizumab|atezolizumab|mesh-list
1746275|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1746276|NCT04984616|Atorvastatin|atorvastatin|mesh-list
1746277|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1746278|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1746279|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
1746280|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746281|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1746282|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1746283|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1746292|NCT04972396|Metformin|metformin|mesh-list
1746293|NCT04972396|Digoxin|digoxin|mesh-list
1746294|NCT04972396|Warfarin|warfarin|mesh-list
1746295|NCT04972396|Atorvastatin|atorvastatin|mesh-list
1746296|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
1746297|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1746298|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1746299|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746300|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1746301|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1746302|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
1746303|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746304|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1746305|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1746306|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1746307|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
1746308|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1746309|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
1746310|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1746311|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1746312|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1746313|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1746314|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1746315|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1746316|NCT04972396|Protective Agents|protective agents|mesh-ancestor
1746317|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1746318|NCT04972396|Estrogens|estrogens|mesh-ancestor
1746319|NCT04972396|Hormones|hormones|mesh-ancestor
1746320|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1746331|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
1746332|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1746333|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1746334|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1746335|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1746336|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746337|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
1746338|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1746339|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746340|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1746341|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1746446|NCT04915144|Edotreotide|edotreotide|mesh-list
1746447|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1746448|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746459|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
1746460|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1746461|NCT04910269|Antibodies|antibodies|mesh-list
1746462|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
1746463|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746464|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
1746465|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1746466|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
1746467|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1746468|NCT04904952|Expectorants|expectorants|mesh-ancestor
1746469|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
1746470|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1746471|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
1746472|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746473|NCT04904952|Protective Agents|protective agents|mesh-ancestor
1746474|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746475|NCT04904952|Antidotes|antidotes|mesh-ancestor
1746530|NCT04853147|Dexamethasone|dexamethasone|mesh-list
1746531|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
1746532|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
1746533|NCT04853147|Aprepitant|aprepitant|mesh-list
1746534|NCT04853147|BB 1101|bb 1101|mesh-list
1746535|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1746536|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
1746537|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
1746538|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1746539|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746540|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1746541|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
1746542|NCT04853147|Hormones|hormones|mesh-ancestor
1746543|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1746544|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1746545|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1746546|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
1746547|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1746548|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746549|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1746550|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1746551|NCT04852887|Tamoxifen|tamoxifen|mesh-list
1746552|NCT04852887|Letrozole|letrozole|mesh-list
1746553|NCT04852887|Exemestane|exemestane|mesh-list
1746554|NCT04852887|Anastrozole|anastrozole|mesh-list
1746555|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1746556|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1746557|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1746558|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1746559|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746560|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1746561|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
1746562|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1746563|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746564|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1746565|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1746566|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1746567|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1746606|NCT04810910|Molgramostim|molgramostim|mesh-list
1746607|NCT04810910|Sargramostim|sargramostim|mesh-list
1746608|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
1746609|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746610|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1746726|NCT04746989|Allopurinol|allopurinol|mesh-list
1746727|NCT04746989|Probenecid|probenecid|mesh-list
1746728|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
1746729|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746730|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1746731|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
1746732|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1746733|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1746734|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
1746735|NCT04746989|Protective Agents|protective agents|mesh-ancestor
1746736|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746737|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
1746738|NCT04746989|Renal Agents|renal agents|mesh-ancestor
1746770|NCT04729049|Morphine|morphine|mesh-list
1746771|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1746772|NCT04729049|Narcotics|narcotics|mesh-ancestor
1746773|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1746774|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746775|NCT04729049|Analgesics|analgesics|mesh-ancestor
1746776|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
1746777|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1746778|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
1746779|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1746780|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1746781|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
1746782|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1746783|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1746784|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
1746785|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
1746795|NCT04688931|Mitomycins|mitomycins|mesh-list
1746796|NCT04688931|Mitomycin|mitomycin|mesh-list
1746797|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1746872|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1746798|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1746799|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
1746800|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746801|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1746802|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1746803|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1746804|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1746805|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746809|NCT04663711|Anesthetics|anesthetics|mesh-list
1746810|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1746811|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746833|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
1746834|NCT04639245|Fludarabine|fludarabine|mesh-list
1746835|NCT04639245|Atezolizumab|atezolizumab|mesh-list
1746836|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1746837|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1746838|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1746839|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
1746840|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746841|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1746842|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1746843|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
1746844|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746845|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1746846|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1746865|NCT04618523|Artesunate|artesunate|mesh-list
1746866|NCT04618523|Lumefantrine|lumefantrine|mesh-list
1746867|NCT04618523|Artemether|artemether|mesh-list
1746868|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1746869|NCT04618523|Amodiaquine|amodiaquine|mesh-list
1746870|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
1746871|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1746873|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1746874|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1746875|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
1746876|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
1746877|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1746878|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
1746879|NCT04616534|Gemcitabine|gemcitabine|mesh-list
1746880|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1746881|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
1746882|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746883|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1746884|NCT04616534|Antiviral Agents|antiviral agents|mesh-ancestor
1746885|NCT04616534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1746886|NCT04616534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1746887|NCT04616534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1746888|NCT04616534|Immunologic Factors|immunologic factors|mesh-ancestor
1746889|NCT04616534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746905|NCT04588259|Insulin|insulin|mesh-list
1746906|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1746907|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
1746908|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
1746909|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1746910|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1746911|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746927|NCT04582448|Insulin|insulin|mesh-list
1746928|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1746929|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746930|NCT04582435|Insulin|insulin|mesh-list
1746931|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1746932|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746956|NCT04562558|Leucovorin|leucovorin|mesh-list
1746957|NCT04562558|Dactinomycin|dactinomycin|mesh-list
1746958|NCT04562558|Methotrexate|methotrexate|mesh-list
1746959|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746960|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1746961|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
1746962|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1746963|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1746964|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
1746965|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1746966|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1746967|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
1746968|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1746969|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1746970|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1746971|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
1746972|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1746973|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1746974|NCT04562558|Antidotes|antidotes|mesh-ancestor
1746975|NCT04562558|Protective Agents|protective agents|mesh-ancestor
1746976|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
1746977|NCT04562558|Vitamins|vitamins|mesh-ancestor
1746978|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
1746979|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1746980|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1746981|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1746982|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1746983|NCT04547166|Bevacizumab|bevacizumab|mesh-list
1746984|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1746985|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1746986|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1746987|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1746988|NCT04547166|Growth Substances|growth substances|mesh-ancestor
1746989|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1746990|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
1747059|NCT04529876|Abatacept|abatacept|mesh-list
1747060|NCT04529876|Tofacitinib|tofacitinib|mesh-list
1747061|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1747062|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747063|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747064|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1747065|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
1747066|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747067|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1747068|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1747069|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1747070|NCT04529863|Abatacept|abatacept|mesh-list
1747071|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1747072|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747073|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747074|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1747075|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
1747076|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747077|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1747078|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1747079|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1747080|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1747081|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1747082|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747083|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1747084|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1747085|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747086|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
1747087|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1747097|NCT04522323|Lenvatinib|lenvatinib|mesh-list
1747098|NCT04522323|Axitinib|axitinib|mesh-list
1747099|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747100|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1747101|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1747102|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747118|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1747119|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
1747120|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1747121|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
1747122|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747147|NCT04465487|Cemiplimab|cemiplimab|mesh-list
1747148|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1747149|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747150|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
1747151|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1747152|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1747153|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1747154|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1747155|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747156|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
1747157|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1747158|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747159|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1747160|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1747161|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
1747162|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1747163|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747173|NCT04421092|Lidocaine|lidocaine|mesh-list
1747174|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
1747175|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
1747176|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1747327|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
1747177|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747178|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
1747179|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1747180|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1747181|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1747182|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1747183|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1747184|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747190|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
1747191|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1747192|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747198|NCT04402385|Aspirin|aspirin|mesh-list
1747199|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1747200|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1747201|NCT04402385|Analgesics|analgesics|mesh-ancestor
1747202|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
1747203|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1747204|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747205|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1747206|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1747207|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1747208|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1747209|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747210|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1747211|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1747212|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1747213|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
1747223|NCT04393103|Atropine|atropine|mesh-list
1747224|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1747225|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1747226|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1747227|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1747228|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
1747229|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1747230|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747231|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1747232|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
1747233|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
1747234|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
1747235|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1747236|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1747237|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
1747238|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1747239|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747240|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1747241|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1747242|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1747289|NCT04347616|Aldesleukin|aldesleukin|mesh-list
1747290|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747291|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1747292|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1747293|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
1747294|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1747311|NCT04333706|Capecitabine|capecitabine|mesh-list
1747312|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1747313|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
1747314|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747315|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747322|NCT04331002|Triamcinolone|triamcinolone|mesh-list
1747323|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1747324|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1747325|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1747326|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1747328|NCT04331002|Hormones|hormones|mesh-ancestor
1747329|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1747330|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747331|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1747332|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
1747333|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1747334|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747403|NCT04273139|Venetoclax|venetoclax|mesh-list
1747404|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747441|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
1747442|NCT04245839|Fludarabine|fludarabine|mesh-list
1747443|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1747444|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
1747445|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747446|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1747447|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1747448|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
1747449|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747450|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747451|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1747452|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
1747453|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1747454|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1747455|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
1747456|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747457|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1747458|NCT04218409|Oxycodone|oxycodone|mesh-list
1747459|NCT04218409|Oxytocin|oxytocin|mesh-list
1747460|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
1747461|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1747462|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747463|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1747464|NCT04218409|Narcotics|narcotics|mesh-ancestor
1747465|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1747466|NCT04218409|Analgesics|analgesics|mesh-ancestor
1747467|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
1747468|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1747469|NCT04209868|Bupivacaine|bupivacaine|mesh-list
1747470|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
1747471|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
1747472|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
1747473|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1747474|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747475|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
1747476|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1747477|NCT04209504|Bupivacaine|bupivacaine|mesh-list
1747478|NCT04209504|Ropivacaine|ropivacaine|mesh-list
1747479|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
1747480|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
1747481|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1747482|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747483|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
1747484|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1747514|NCT04167176|Lidocaine|lidocaine|mesh-list
1747515|NCT04167176|Bupivacaine|bupivacaine|mesh-list
1747516|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
1747517|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
1747518|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1747519|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747520|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
1747521|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1747522|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1747523|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1747524|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1747525|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1747526|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747535|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
1747536|NCT04164069|Leucovorin|leucovorin|mesh-list
1747537|NCT04164069|Folic Acid|folic acid|mesh-list
1747538|NCT04164069|Bevacizumab|bevacizumab|mesh-list
1747539|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1747540|NCT04164069|Fluorouracil|fluorouracil|mesh-list
1747541|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
1747542|NCT04164069|Dasatinib|dasatinib|mesh-list
1747543|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
1747544|NCT04164069|Antibodies|antibodies|mesh-list
1747545|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
1747546|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1747547|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
1747548|NCT04164069|Calcium|calcium|mesh-list
1747549|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
1747550|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747551|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1747552|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1747553|NCT04164069|Growth Substances|growth substances|mesh-ancestor
1747554|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747555|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
1747556|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
1747557|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1747558|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1747559|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
1747637|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
1747560|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747561|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1747562|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1747563|NCT04164069|Antidotes|antidotes|mesh-ancestor
1747564|NCT04164069|Protective Agents|protective agents|mesh-ancestor
1747565|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
1747566|NCT04164069|Vitamins|vitamins|mesh-ancestor
1747567|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
1747568|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1747569|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1747570|NCT04164069|Hematinics|hematinics|mesh-ancestor
1747571|NCT04143711|Paclitaxel|paclitaxel|mesh-list
1747572|NCT04143711|Nivolumab|nivolumab|mesh-list
1747573|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1747574|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747575|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
1747576|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
1747577|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
1747578|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747579|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1747580|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1747581|NCT04129151|Palbociclib|palbociclib|mesh-list
1747582|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747583|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1747584|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1747585|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747586|NCT04115059|Dasatinib|dasatinib|mesh-list
1747587|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747588|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1747589|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1747590|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747599|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
1747600|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1747601|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747635|NCT04083950|Aspirin|aspirin|mesh-list
1747636|NCT04083950|Vaccines|vaccines|mesh-list
1747638|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747639|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1747640|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1747641|NCT04083950|Analgesics|analgesics|mesh-ancestor
1747642|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
1747643|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1747644|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1747645|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1747646|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1747647|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1747648|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747649|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1747650|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1747651|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1747652|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
1747653|NCT04083365|Capecitabine|capecitabine|mesh-list
1747654|NCT04083365|Durvalumab|durvalumab|mesh-list
1747655|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1747656|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
1747657|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747658|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747659|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1747660|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
1747661|NCT04068103|Leucovorin|leucovorin|mesh-list
1747662|NCT04068103|Folic Acid|folic acid|mesh-list
1747663|NCT04068103|Fluorouracil|fluorouracil|mesh-list
1747664|NCT04068103|Capecitabine|capecitabine|mesh-list
1747665|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
1747666|NCT04068103|Calcium|calcium|mesh-list
1747667|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
1747668|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1747669|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747670|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1747671|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
1747672|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747673|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1747674|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747675|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1747676|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
1747677|NCT04068103|Antidotes|antidotes|mesh-ancestor
1747678|NCT04068103|Protective Agents|protective agents|mesh-ancestor
1747679|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
1747680|NCT04068103|Vitamins|vitamins|mesh-ancestor
1747681|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
1747682|NCT04068103|Hematinics|hematinics|mesh-ancestor
1747694|NCT04012827|Doxorubicin|doxorubicin|mesh-list
1747695|NCT04012827|Apatinib|apatinib|mesh-list
1747696|NCT04012827|Ifosfamide|ifosfamide|mesh-list
1747697|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1747698|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747699|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1747700|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1747701|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1747702|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747703|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1747704|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1747705|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
1747706|NCT04008797|Lenvatinib|lenvatinib|mesh-list
1747707|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747708|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1747709|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1747710|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747711|NCT03992456|Trifluridine|trifluridine|mesh-list
1747712|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1747713|NCT03992456|Panitumumab|panitumumab|mesh-list
1747714|NCT03992456|Antibodies|antibodies|mesh-list
1747715|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
1747716|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1747717|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
1747718|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747719|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747720|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
1747721|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747722|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
1747723|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1747724|NCT03977194|Paclitaxel|paclitaxel|mesh-list
1747725|NCT03977194|Carboplatin|carboplatin|mesh-list
1747726|NCT03977194|Atezolizumab|atezolizumab|mesh-list
1747727|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1747728|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1747729|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
1747730|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
1747731|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
1747732|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747798|NCT03874091|Epinephrine|epinephrine|mesh-list
1747799|NCT03874091|Racepinephrine|racepinephrine|mesh-list
1747800|NCT03874091|Morphine|morphine|mesh-list
1747801|NCT03874091|Bupivacaine|bupivacaine|mesh-list
1747802|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
1747803|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
1747804|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
1747805|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1747806|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747807|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
1747808|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1747809|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1747810|NCT03874091|Narcotics|narcotics|mesh-ancestor
1747811|NCT03874091|Analgesics|analgesics|mesh-ancestor
1747812|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1747813|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1747814|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
1747815|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1747816|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747817|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1747818|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1747819|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
1747820|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1747821|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
1747822|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
1747823|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
1747824|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1747833|NCT03843008|Melatonin|melatonin|mesh-list
1747834|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
1747835|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747836|NCT03843008|Protective Agents|protective agents|mesh-ancestor
1747837|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747838|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1747968|NCT03773276|Norepinephrine|norepinephrine|mesh-list
1747969|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1747970|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1747971|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
1747972|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1747973|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1747974|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1747975|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
1747976|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
1747977|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1747978|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1748010|NCT03738696|Bupivacaine|bupivacaine|mesh-list
1748011|NCT03738696|Ropivacaine|ropivacaine|mesh-list
1748012|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
1748013|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
1748014|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1748015|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748016|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
1748017|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1748032|NCT03719768|Avelumab|avelumab|mesh-list
1748033|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1748034|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748035|NCT03712787|Tilavonemab|tilavonemab|mesh-list
1748036|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
1748037|NCT03708003|Venetoclax|venetoclax|mesh-list
1748038|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748039|NCT03704610|Infliximab|infliximab|mesh-list
1748040|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
1748041|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1748042|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1748058|NCT03679650|Decitabine|decitabine|mesh-list
1748059|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1748060|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
1748061|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748062|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748063|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1748064|NCT03667482|Cetuximab|cetuximab|mesh-list
1748065|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1748066|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748067|NCT03662815|Molgramostim|molgramostim|mesh-list
1748068|NCT03662815|Sargramostim|sargramostim|mesh-list
1748069|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
1748070|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748071|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748087|NCT03645148|Molgramostim|molgramostim|mesh-list
1748088|NCT03645148|Sargramostim|sargramostim|mesh-list
1748089|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
1748090|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748091|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748104|NCT03612921|Amantadine|amantadine|mesh-list
1748105|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1748106|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1748107|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
1748108|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1748109|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
1748110|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1748111|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748112|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748113|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1748114|NCT03612921|Analgesics|analgesics|mesh-ancestor
1748115|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
1748116|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1748120|NCT03611738|Docetaxel|docetaxel|mesh-list
1748121|NCT03611738|Ceritinib|ceritinib|mesh-list
1748122|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748123|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
1748124|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
1748125|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
1748126|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748127|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1748128|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1748129|NCT03603808|Vaccines|vaccines|mesh-list
1748130|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
1748131|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748140|NCT03568383|Pyridoxine|pyridoxine|mesh-list
1748141|NCT03568383|Pyridoxal|pyridoxal|mesh-list
1748142|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
1748143|NCT03568383|Isoniazid|isoniazid|mesh-list
1748144|NCT03568383|Vitamins|vitamins|mesh-ancestor
1748145|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
1748146|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748147|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
1748148|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
1748149|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1748150|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1748151|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1748152|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1748153|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
1748154|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748155|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1748156|NCT03534453|Olaparib|olaparib|mesh-list
1748157|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1748158|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1748159|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748160|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748166|NCT03512197|Midostaurin|midostaurin|mesh-list
1748167|NCT03512197|Staurosporine|staurosporine|mesh-list
1748168|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748169|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1748170|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1748171|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748172|NCT03501576|Vaccines|vaccines|mesh-list
1748173|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
1748174|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748180|NCT03490903|Fentanyl|fentanyl|mesh-list
1748181|NCT03490903|Midazolam|midazolam|mesh-list
1748182|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1748183|NCT03490903|Narcotics|narcotics|mesh-ancestor
1748184|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1748185|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748186|NCT03490903|Analgesics|analgesics|mesh-ancestor
1748187|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
1748188|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1748189|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1748190|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1748191|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
1748192|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
1748193|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1748194|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1748195|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1748196|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1748197|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
1748198|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
1748199|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1748200|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748201|NCT03457701|Iron|iron|mesh-list
1748202|NCT03457701|Trace Elements|trace elements|mesh-ancestor
1748203|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
1748204|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748234|NCT03411031|Thalidomide|thalidomide|mesh-list
1748235|NCT03411031|Dexamethasone|dexamethasone|mesh-list
1748236|NCT03411031|Lenalidomide|lenalidomide|mesh-list
1748237|NCT03411031|Elotuzumab|elotuzumab|mesh-list
1748238|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1748239|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
1748240|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
1748241|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1748242|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748243|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1748244|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
1748245|NCT03411031|Hormones|hormones|mesh-ancestor
1748246|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1748247|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1748248|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748249|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
1748250|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1748251|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1748252|NCT03411031|Growth Substances|growth substances|mesh-ancestor
1748253|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
1748254|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1748255|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
1748256|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1748257|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1748258|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
1748259|NCT03405792|Temozolomide|temozolomide|mesh-list
1748260|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1748261|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748262|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1748263|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
1748264|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748265|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
1748266|NCT03396575|Fludarabine|fludarabine|mesh-list
1748267|NCT03396575|Vaccines|vaccines|mesh-list
1748268|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
1748269|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748270|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1748271|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1748272|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1748273|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
1748274|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748275|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748276|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1748277|NCT03377023|Nivolumab|nivolumab|mesh-list
1748278|NCT03377023|Ipilimumab|ipilimumab|mesh-list
1748279|NCT03377023|Nintedanib|nintedanib|mesh-list
1748280|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1748281|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748282|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1748283|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748284|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1748285|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1748470|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
1748471|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1748472|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
1748473|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748474|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
1748475|NCT03200288|Protective Agents|protective agents|mesh-ancestor
1748495|NCT03164772|Durvalumab|durvalumab|mesh-list
1748496|NCT03164772|Tremelimumab|tremelimumab|mesh-list
1748497|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1748498|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748509|NCT03132532|Paclitaxel|paclitaxel|mesh-list
1748510|NCT03132532|Carboplatin|carboplatin|mesh-list
1748511|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1748512|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748513|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
1748514|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
1748515|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
1748516|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748517|NCT03129776|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1748518|NCT03129776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1748519|NCT03129776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748520|NCT03122496|Durvalumab|durvalumab|mesh-list
1748521|NCT03122496|Tremelimumab|tremelimumab|mesh-list
1748522|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1748523|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748538|NCT03066739|Remifentanil|remifentanil|mesh-list
1748539|NCT03066739|Naloxone|naloxone|mesh-list
1748540|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1748541|NCT03066739|Narcotics|narcotics|mesh-ancestor
1748542|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1748543|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748544|NCT03066739|Analgesics|analgesics|mesh-ancestor
1748545|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
1748546|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1748547|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1748548|NCT03061474|Niacinamide|niacinamide|mesh-list
1748549|NCT03061474|Niacin|niacin|mesh-list
1748550|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
1748551|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
1748552|NCT03061474|Vitamins|vitamins|mesh-ancestor
1748553|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
1748554|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748555|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1748556|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
1748557|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748558|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1748559|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
1748617|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
1748618|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1748619|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748620|NCT02963831|Durvalumab|durvalumab|mesh-list
1748621|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1748622|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748633|NCT02929485|Bromocriptine|bromocriptine|mesh-list
1748634|NCT02929485|Tolcapone|tolcapone|mesh-list
1748635|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1748636|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1748637|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
1748638|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1748639|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748640|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
1748641|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
1748642|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1748643|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748644|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1748645|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1748670|NCT02906761|Aspirin|aspirin|mesh-list
1748671|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1748672|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1748673|NCT02906761|Analgesics|analgesics|mesh-ancestor
1748674|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
1748675|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1748676|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748677|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1748678|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1748679|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1748680|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1748681|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748682|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1748683|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1748684|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1748685|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
1748686|NCT02884908|Pregabalin|pregabalin|mesh-list
1748687|NCT02884908|Analgesics|analgesics|mesh-ancestor
1748688|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
1748689|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1748690|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748691|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
1748692|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1748693|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1748694|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748695|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1748696|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1748697|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1748698|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1748699|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1748700|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
1748701|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1748702|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1748703|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1748704|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
1748705|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1748706|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748707|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748708|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
1748709|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1748710|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
1748711|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1748712|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748713|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1748714|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1748715|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1748716|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
1748717|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1748718|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
1748719|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1748720|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748721|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1748727|NCT02849639|Scopolamine|scopolamine|mesh-list
1748728|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
1748729|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1748730|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
1748731|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
1748732|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1748733|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748734|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1748735|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
1748736|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1748737|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
1748738|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1748739|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748740|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1748741|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
1748748|NCT02829502|Exenatide|exenatide|mesh-list
1748749|NCT02829502|Glucagon|glucagon|mesh-list
1748750|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
1748751|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1748752|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748753|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1748754|NCT02829502|Incretins|incretins|mesh-ancestor
1748755|NCT02829502|Hormones|hormones|mesh-ancestor
1748756|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1748757|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1748762|NCT02815592|Carboplatin|carboplatin|mesh-list
1748763|NCT02815592|Etoposide|etoposide|mesh-list
1748764|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748765|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1748766|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1748767|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1748768|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1748769|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748770|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
1748771|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
1748772|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1748773|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1748774|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1748775|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748776|NCT02795351|Urological Agents|urological agents|mesh-ancestor
1748785|NCT02735239|Leucovorin|leucovorin|mesh-list
1748786|NCT02735239|Paclitaxel|paclitaxel|mesh-list
1748787|NCT02735239|Docetaxel|docetaxel|mesh-list
1748788|NCT02735239|Carboplatin|carboplatin|mesh-list
1748789|NCT02735239|Fluorouracil|fluorouracil|mesh-list
1748790|NCT02735239|Capecitabine|capecitabine|mesh-list
1748791|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
1748792|NCT02735239|Durvalumab|durvalumab|mesh-list
1748793|NCT02735239|Tremelimumab|tremelimumab|mesh-list
1748794|NCT02735239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1748795|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748796|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
1748797|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
1748798|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
1748799|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748800|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
1748801|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1748802|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1748803|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
1748804|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748805|NCT02735239|Antidotes|antidotes|mesh-ancestor
1748806|NCT02735239|Protective Agents|protective agents|mesh-ancestor
1748807|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
1748808|NCT02735239|Vitamins|vitamins|mesh-ancestor
1748809|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
1748810|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1748811|NCT02733133|Testosterone|testosterone|mesh-list
1748812|NCT02733133|Androgens|androgens|mesh-ancestor
1748813|NCT02733133|Hormones|hormones|mesh-ancestor
1748814|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1748815|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748816|NCT02721459|Vemurafenib|vemurafenib|mesh-list
1748817|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748818|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1748819|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1748820|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748821|NCT02697383|Dexamethasone|dexamethasone|mesh-list
1748822|NCT02697383|Ixazomib|ixazomib|mesh-list
1748823|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1748824|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
1748825|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
1748826|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1748827|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748828|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1748829|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
1748830|NCT02697383|Hormones|hormones|mesh-ancestor
1748831|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1748832|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1748833|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748834|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
1748835|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1748836|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748837|NCT02683265|Methylphenidate|methylphenidate|mesh-list
1748838|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1748839|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748840|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1748841|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1748842|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1748843|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748844|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
1748845|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1748846|NCT02652455|Aldesleukin|aldesleukin|mesh-list
1748847|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
1748848|NCT02652455|Nivolumab|nivolumab|mesh-list
1748849|NCT02652455|Fludarabine|fludarabine|mesh-list
1748850|NCT02652455|Interleukin-2|interleukin-2|mesh-list
1748851|NCT02652455|Antibodies|antibodies|mesh-list
1748852|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
1748853|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
1748854|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1748855|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
1748856|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748857|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1748858|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1748859|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
1748860|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748861|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748862|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1748863|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1748864|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1748865|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1748866|NCT02652455|Analgesics|analgesics|mesh-ancestor
1748867|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
1748868|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1748869|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1748870|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1748871|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
1748872|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1748873|NCT02643303|Durvalumab|durvalumab|mesh-list
1748874|NCT02643303|Tremelimumab|tremelimumab|mesh-list
1748875|NCT02643303|Poly ICLC|poly iclc|mesh-list
1748876|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1748877|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748878|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
1748879|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
1748880|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748897|NCT02604446|Oxycodone|oxycodone|mesh-list
1748898|NCT02604446|Tapentadol|tapentadol|mesh-list
1748899|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1748900|NCT02604446|Narcotics|narcotics|mesh-ancestor
1748901|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1748902|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748903|NCT02604446|Analgesics|analgesics|mesh-ancestor
1748904|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
1748905|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1748906|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1748907|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1748908|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1748909|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748910|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
1748911|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1748912|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
1748913|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1748914|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
1748915|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1748916|NCT02586831|Exenatide|exenatide|mesh-list
1748917|NCT02586831|Aldesleukin|aldesleukin|mesh-list
1748918|NCT02586831|Adalimumab|adalimumab|mesh-list
1748919|NCT02586831|Interleukin-2|interleukin-2|mesh-list
1748920|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
1748921|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1748922|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1748923|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1748924|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748925|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1748926|NCT02586831|Analgesics|analgesics|mesh-ancestor
1748927|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
1748928|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1748929|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748930|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1748931|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1748932|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
1748933|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1748934|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1748935|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1748936|NCT02586831|Incretins|incretins|mesh-ancestor
1748937|NCT02586831|Hormones|hormones|mesh-ancestor
1748938|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1748939|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
1748940|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1748941|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1748942|NCT02581787|Antibodies|antibodies|mesh-list
1748943|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
1748944|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1748945|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
1748946|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
1748947|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748948|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748979|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
1748980|NCT02529813|Fludarabine|fludarabine|mesh-list
1748981|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
1748982|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1748983|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
1748984|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1748985|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1748986|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1748987|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
1748988|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748989|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1748990|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1748991|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1748992|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
1748993|NCT02519777|Maraviroc|maraviroc|mesh-list
1748994|NCT02519777|Dolutegravir|dolutegravir|mesh-list
1748995|NCT02519777|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1748996|NCT02519777|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1748997|NCT02519777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1748998|NCT02519777|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1748999|NCT02519777|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1749000|NCT02519777|Antiviral Agents|antiviral agents|mesh-ancestor
1749001|NCT02519777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1749002|NCT02519777|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1749003|NCT02519777|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1749004|NCT02519777|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1749005|NCT02519777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1749027|NCT02488967|Paclitaxel|paclitaxel|mesh-list
1749028|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
1749029|NCT02488967|Carboplatin|carboplatin|mesh-list
1749030|NCT02488967|Doxorubicin|doxorubicin|mesh-list
1749031|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1749032|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1749033|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1749034|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1749035|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
1749036|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
1749037|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
1749038|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749039|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1749040|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
1749041|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749042|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1749043|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1749044|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
1749045|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1749046|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1749047|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1749048|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1749049|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1749120|NCT02403310|Cytarabine|cytarabine|mesh-list
1749121|NCT02403310|Daunorubicin|daunorubicin|mesh-list
1749122|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1749123|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
1749124|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749125|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1749126|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
1749127|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1749128|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1749129|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
1749130|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749131|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1749132|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1749133|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1749134|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1749135|NCT02341625|Nivolumab|nivolumab|mesh-list
1749136|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1749137|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1749138|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1749139|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749153|NCT02297698|Trastuzumab|trastuzumab|mesh-list
1749154|NCT02297698|Sargramostim|sargramostim|mesh-list
1749155|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1749156|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1749157|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
1749158|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749207|NCT02117076|Gabapentin|gabapentin|mesh-list
1749208|NCT02117076|Analgesics|analgesics|mesh-ancestor
1749209|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
1749210|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1749211|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749212|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
1749213|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1749214|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1749215|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1749216|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1749217|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1749218|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1749219|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1749220|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749221|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
1749236|NCT02099591|Naloxegol|naloxegol|mesh-list
1749237|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1749238|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749239|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
1749240|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1749264|NCT01710176|Gemcitabine|gemcitabine|mesh-list
1749265|NCT01710176|Docetaxel|docetaxel|mesh-list
1749266|NCT01710176|Etoposide|etoposide|mesh-list
1749267|NCT01710176|Epirubicin|epirubicin|mesh-list
1749268|NCT01710176|Ifosfamide|ifosfamide|mesh-list
1749269|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
1749270|NCT01710176|Dacarbazine|dacarbazine|mesh-list
1749271|NCT01710176|Trabectedin|trabectedin|mesh-list
1749272|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1749273|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
1749274|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749275|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1749276|NCT01710176|Antiviral Agents|antiviral agents|mesh-ancestor
1749277|NCT01710176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1749278|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1749279|NCT01710176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1749280|NCT01710176|Immunologic Factors|immunologic factors|mesh-ancestor
1749281|NCT01710176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749282|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
1749283|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
1749284|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
1749285|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1749286|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1749287|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1749288|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1749289|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1749290|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
1749330|NCT01176461|Nivolumab|nivolumab|mesh-list
1749331|NCT01176461|Vaccines|vaccines|mesh-list
1749332|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
1749333|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749334|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1749335|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1749336|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1749337|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749341|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1749342|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1749343|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749344|NCT00584246|Pregabalin|pregabalin|mesh-list
1749345|NCT00584246|Analgesics|analgesics|mesh-ancestor
1749346|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
1749347|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1749348|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749349|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
1749350|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1749351|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1749352|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749353|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1749354|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1749355|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1749356|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1749357|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1749358|NCT00584025|Levetiracetam|levetiracetam|mesh-list
1749359|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
1749360|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
1749375|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
1749376|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1749377|NCT05124353|Protective Agents|protective agents|mesh-ancestor
1749378|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749379|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
1749383|NCT05124314|Misoprostol|misoprostol|mesh-list
1749384|NCT05124314|Mifepristone|mifepristone|mesh-list
1749385|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1749386|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
1749387|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1749388|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749389|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1749390|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1749391|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
1749392|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1749393|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1749394|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1749395|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1749396|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
1749397|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1749398|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1749399|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
1749400|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1749401|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
1749402|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1749403|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1749454|NCT05123976|Olanzapine|olanzapine|mesh-list
1749455|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
1749456|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
1749457|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1749458|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749459|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1749460|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1749461|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1749462|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1749463|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1749464|NCT05123976|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1749465|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1749466|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1749467|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749468|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1749469|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
1749490|NCT05123781|Metformin|metformin|mesh-list
1749491|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1749492|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749521|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1749522|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749523|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1749925|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
1749564|NCT05123092|Morphine|morphine|mesh-list
1749565|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1749566|NCT05123092|Narcotics|narcotics|mesh-ancestor
1749567|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1749568|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749569|NCT05123092|Analgesics|analgesics|mesh-ancestor
1749570|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
1749571|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1749572|NCT05123053|Amifampridine|amifampridine|mesh-list
1749573|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1749574|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1749575|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749576|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1749577|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1749578|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749579|NCT05123040|Prednisone|prednisone|mesh-list
1749580|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
1749581|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1749582|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
1749583|NCT05123040|Hormones|hormones|mesh-ancestor
1749584|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1749585|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749586|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1749587|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1749588|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
1749589|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
1749590|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1749591|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1749592|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1749593|NCT05123040|Protective Agents|protective agents|mesh-ancestor
1749594|NCT05122884|Milrinone|milrinone|mesh-list
1749595|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1749596|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1749597|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
1749598|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1749599|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1749600|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1749601|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749602|NCT05122884|Protective Agents|protective agents|mesh-ancestor
1749603|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749604|NCT05122819|Anesthetics|anesthetics|mesh-list
1749605|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1749606|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749607|NCT05122780|Acetylcholine|acetylcholine|mesh-list
1749608|NCT05122780|Anticoagulants|anticoagulants|mesh-list
1749609|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
1749610|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1749611|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1749612|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
1749613|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1749614|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749615|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749616|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
1749617|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1749618|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
1749619|NCT05122767|Dolutegravir|dolutegravir|mesh-list
1749620|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1749621|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1749622|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1749623|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749624|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1749625|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1749626|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
1749627|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1749628|NCT05122741|Aspirin|aspirin|mesh-list
1749629|NCT05122741|Clopidogrel|clopidogrel|mesh-list
1749630|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1749631|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1749632|NCT05122741|Analgesics|analgesics|mesh-ancestor
1749633|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
1749634|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1749635|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749636|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1749637|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1749638|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1749639|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1749640|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749641|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1749642|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1749643|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1749644|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
1749645|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1749646|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1749647|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1749648|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
1749649|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1749650|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
1749651|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749652|NCT05115773|Anesthetics|anesthetics|mesh-list
1749653|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1749654|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749669|NCT05097326|Mifepristone|mifepristone|mesh-list
1749670|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1749671|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
1749672|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1749673|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749674|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1749675|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1749676|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1749677|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
1749678|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1749679|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1749680|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
1749681|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1749682|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
1749683|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1749684|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1749685|NCT05089630|Vaccines|vaccines|mesh-list
1749686|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
1749687|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749701|NCT05084404|Guanabenz|guanabenz|mesh-list
1749702|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1749703|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1749704|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1749705|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1749706|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
1749707|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1749708|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749709|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749710|NCT05081492|Antibodies|antibodies|mesh-list
1749711|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
1749712|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
1749713|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749734|NCT05073718|Aspirin|aspirin|mesh-list
1749735|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1749736|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1749737|NCT05073718|Analgesics|analgesics|mesh-ancestor
1749738|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
1749739|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1749740|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749741|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1749742|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1749743|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1749744|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1749745|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749746|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1749747|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1749748|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1749749|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
1749750|NCT05069974|Linezolid|linezolid|mesh-list
1749751|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1749752|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1749753|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1749754|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1749755|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749756|NCT05062031|Atropine|atropine|mesh-list
1749757|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1749758|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1749759|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1749760|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1749761|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
1749762|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1749763|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749764|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1749765|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
1749766|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
1749767|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
1749768|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1749769|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1749770|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
1749771|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1749772|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749773|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1749774|NCT05052099|Bevacizumab|bevacizumab|mesh-list
1749775|NCT05052099|Atezolizumab|atezolizumab|mesh-list
1749776|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1749777|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1749778|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1749779|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1749780|NCT05052099|Growth Substances|growth substances|mesh-ancestor
1749781|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749782|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
1749788|NCT05041920|Omeprazole|omeprazole|mesh-list
1749789|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1749790|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1749791|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1749792|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1749793|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749794|NCT05036317|Empagliflozin|empagliflozin|mesh-list
1749795|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1749796|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749797|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1749798|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749846|NCT05023993|Niacinamide|niacinamide|mesh-list
1749847|NCT05023993|Niacin|niacin|mesh-list
1749848|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
1749849|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
1749850|NCT05023993|Vitamins|vitamins|mesh-ancestor
1749851|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
1749852|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749853|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1749854|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
1749855|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749856|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1749857|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
1749881|NCT05001802|Ropivacaine|ropivacaine|mesh-list
1749882|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
1749883|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
1749884|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1749885|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749886|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
1749887|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1749898|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
1749899|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1749900|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1749901|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1749902|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1749903|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749904|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
1749905|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1749906|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749907|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1749908|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1749909|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1749910|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1749911|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1749912|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1749913|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749914|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1749915|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749916|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1749917|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
1749918|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1749919|NCT04975958|Atezolizumab|atezolizumab|mesh-list
1749920|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1749921|NCT04965493|Rituximab|rituximab|mesh-list
1749922|NCT04965493|Venetoclax|venetoclax|mesh-list
1749923|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1749924|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1749926|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749927|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1749928|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1749929|NCT04942210|Vaccines|vaccines|mesh-list
1749930|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
1749931|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749986|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
1749987|NCT04921189|Thiamine|thiamine|mesh-list
1749988|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
1749989|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
1749990|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1749991|NCT04921189|Protective Agents|protective agents|mesh-ancestor
1749992|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1749993|NCT04921189|Vitamins|vitamins|mesh-ancestor
1749994|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
1749995|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
1749996|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1750058|NCT04875871|Copper|copper|mesh-list
1750059|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1750060|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1750061|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750062|NCT04875871|Trace Elements|trace elements|mesh-ancestor
1750063|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
1750064|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750098|NCT04840199|Letermovir|letermovir|mesh-list
1750099|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1750100|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1750101|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750102|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750103|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
1750104|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1750111|NCT04828538|Vitamin D|vitamin d|mesh-list
1750112|NCT04828538|Vitamins|vitamins|mesh-list
1750113|NCT04828538|Ascorbic Acid|ascorbic acid|mesh-list
1750114|NCT04828538|Folic Acid|folic acid|mesh-list
1750115|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
1750116|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
1750117|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750118|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1750119|NCT04828538|Antioxidants|antioxidants|mesh-ancestor
1750120|NCT04828538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750121|NCT04828538|Protective Agents|protective agents|mesh-ancestor
1750122|NCT04828538|Hematinics|hematinics|mesh-ancestor
1750123|NCT04827056|Ethanol|ethanol|mesh-list
1750124|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
1750125|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1750126|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1750127|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750128|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1750129|NCT04827056|Analgesics|analgesics|mesh-ancestor
1750130|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
1750131|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1750132|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1750133|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1750134|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1750135|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
1750136|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1750137|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750138|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1750139|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1750140|NCT04827030|Ropivacaine|ropivacaine|mesh-list
1750141|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
1750142|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
1750143|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1750144|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750145|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
1750146|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1750169|NCT04791514|Treprostinil|treprostinil|mesh-list
1750170|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1750171|NCT04781725|Cisplatin|cisplatin|mesh-list
1750172|NCT04781725|Vinblastine|vinblastine|mesh-list
1750173|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750174|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1750175|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
1750176|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
1750177|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
1750178|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750179|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
1750180|NCT04767776|Charcoal|charcoal|mesh-list
1750181|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1750182|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
1750183|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1750184|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
1750185|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1750186|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750187|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
1750188|NCT04767776|Antidotes|antidotes|mesh-ancestor
1750189|NCT04767776|Protective Agents|protective agents|mesh-ancestor
1750190|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750191|NCT04767191|Lumefantrine|lumefantrine|mesh-list
1750192|NCT04767191|Artemether|artemether|mesh-list
1750193|NCT04767191|Piperaquine|piperaquine|mesh-list
1750194|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1750195|NCT04767191|Artenimol|artenimol|mesh-list
1750196|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
1750197|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1750198|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1750199|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1750315|NCT04737603|Buprenorphine|buprenorphine|mesh-list
1750316|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1750317|NCT04737603|Naloxone|naloxone|mesh-list
1750318|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1750319|NCT04737603|Narcotics|narcotics|mesh-ancestor
1750320|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1750321|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750322|NCT04737603|Analgesics|analgesics|mesh-ancestor
1750323|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
1750324|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1750325|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1750326|NCT04655976|Docetaxel|docetaxel|mesh-list
1750327|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750328|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
1750329|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
1750330|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
1750331|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750332|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
1750333|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1750334|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1750335|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750336|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
1750337|NCT04651166|Coagulants|coagulants|mesh-ancestor
1750338|NCT04640168|Remdesivir|remdesivir|mesh-list
1750339|NCT04640168|Dexamethasone|dexamethasone|mesh-list
1750340|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1750341|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
1750342|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
1750343|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1750344|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750345|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1750346|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
1750347|NCT04640168|Hormones|hormones|mesh-ancestor
1750348|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1750349|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1750350|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750351|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
1750352|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750353|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
1750354|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1750367|NCT04637620|Sertraline|sertraline|mesh-list
1750368|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
1750369|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1750370|NCT04637620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1750371|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1750372|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1750373|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750374|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1750375|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
1750376|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750411|NCT04595994|Gemcitabine|gemcitabine|mesh-list
1750412|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1750413|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
1750414|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750415|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750416|NCT04595994|Antiviral Agents|antiviral agents|mesh-ancestor
1750417|NCT04595994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1750418|NCT04595994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1750419|NCT04595994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1750420|NCT04595994|Immunologic Factors|immunologic factors|mesh-ancestor
1750421|NCT04595994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750422|NCT04595565|Carboplatin|carboplatin|mesh-list
1750423|NCT04595565|Capecitabine|capecitabine|mesh-list
1750424|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750425|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1750426|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
1750427|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750428|NCT04592809|Midazolam|midazolam|mesh-list
1750429|NCT04592809|Ketamine|ketamine|mesh-list
1750430|NCT04592809|Analgesics|analgesics|mesh-ancestor
1750431|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
1750432|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1750433|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750434|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1750435|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1750436|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
1750437|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
1750438|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1750439|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1750440|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1750441|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1750442|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750443|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1750444|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1750445|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1750446|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1750447|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1750448|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
1750449|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
1750472|NCT04584255|Niraparib|niraparib|mesh-list
1750473|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1750474|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1750475|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750476|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750512|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
1750513|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1750514|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1750515|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1750516|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1750517|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1750518|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750519|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750520|NCT04563559|Prednisolone|prednisolone|mesh-list
1750521|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1750522|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
1750523|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1750524|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
1750525|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1750526|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
1750527|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1750528|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
1750529|NCT04563559|Hormones|hormones|mesh-ancestor
1750530|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1750531|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750532|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1750533|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750534|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
1750535|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
1750536|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1750537|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1750538|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1750539|NCT04563559|Protective Agents|protective agents|mesh-ancestor
1750540|NCT04562090|Mirabegron|mirabegron|mesh-list
1750541|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
1750542|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1750543|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1750544|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
1750545|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1750546|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750547|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750548|NCT04562090|Urological Agents|urological agents|mesh-ancestor
1750549|NCT04551430|Nivolumab|nivolumab|mesh-list
1750550|NCT04551430|Ipilimumab|ipilimumab|mesh-list
1750551|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1750552|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750553|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1750554|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750734|NCT04393285|Letrozole|letrozole|mesh-list
1750735|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750736|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1750737|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1750738|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1750739|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750740|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1750741|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
1750742|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1750743|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750758|NCT04359017|Lidocaine|lidocaine|mesh-list
1750759|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
1750760|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
1750761|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1750762|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750763|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
1750764|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1750765|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1750766|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1750767|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1750768|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1750769|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750770|NCT04353310|Curcumin|curcumin|mesh-list
1750771|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1750772|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1750773|NCT04353310|Analgesics|analgesics|mesh-ancestor
1750774|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
1750775|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1750776|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750777|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1750778|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1750779|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750780|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1750781|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750788|NCT04345341|Bupivacaine|bupivacaine|mesh-list
1750789|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
1750790|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
1750791|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1750792|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750793|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
1750794|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1750811|NCT04330625|Volagidemab|volagidemab|mesh-list
1750812|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1750813|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750877|NCT04234022|Pomalidomide|pomalidomide|mesh-list
1750878|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
1750879|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750880|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1750881|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1750882|NCT04234022|Growth Substances|growth substances|mesh-ancestor
1750883|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
1750884|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750885|NCT04230499|Sirolimus|sirolimus|mesh-list
1750886|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1750887|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1750888|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1750889|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750890|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
1750891|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1750892|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
1750893|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750899|NCT04200066|Tamoxifen|tamoxifen|mesh-list
1750900|NCT04200066|Temozolomide|temozolomide|mesh-list
1750901|NCT04200066|Maprotiline|maprotiline|mesh-list
1750902|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1750903|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
1750904|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750905|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750906|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1750907|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
1750908|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1750909|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750910|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1750911|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1750912|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1750913|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1750914|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1750915|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
1750916|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1750917|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1750918|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1750919|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1750920|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
1750921|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1750922|NCT04199117|Nicotine|nicotine|mesh-list
1750923|NCT04199117|Varenicline|varenicline|mesh-list
1750924|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1750925|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
1750926|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1750927|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750928|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1750929|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1750930|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
1750931|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1750932|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750952|NCT04167462|BMS-986165|bms-986165|mesh-list
1750953|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
1750954|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1750955|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1750956|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750965|NCT04165993|Docetaxel|docetaxel|mesh-list
1750966|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750967|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
1750968|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
1750969|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
1750970|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750971|NCT04158635|Gemcitabine|gemcitabine|mesh-list
1750972|NCT04158635|Paclitaxel|paclitaxel|mesh-list
1750973|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1750974|NCT04158635|Bosentan|bosentan|mesh-list
1750975|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1750976|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1750977|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
1750978|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
1750979|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
1750980|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1750981|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1750982|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
1750983|NCT04158635|Antiviral Agents|antiviral agents|mesh-ancestor
1750984|NCT04158635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1750985|NCT04158635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1750986|NCT04158635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1750987|NCT04158635|Immunologic Factors|immunologic factors|mesh-ancestor
1750988|NCT04158635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1750989|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1750990|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1751032|NCT04123262|Tamoxifen|tamoxifen|mesh-list
1751033|NCT04123262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1751034|NCT04123262|Hormone Antagonists|hormone antagonists|mesh-ancestor
1751035|NCT04123262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1751036|NCT04123262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751037|NCT04123262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1751038|NCT04123262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751039|NCT04123262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1751040|NCT04123262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1751041|NCT04123262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1751132|NCT04070378|Daratumumab|daratumumab|mesh-list
1751133|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751134|NCT04064294|Levodopa|levodopa|mesh-list
1751135|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1751136|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1751137|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
1751138|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1751139|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751140|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751162|NCT03991988|Montelukast|montelukast|mesh-list
1751163|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1751164|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
1751165|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1751166|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
1751167|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1751168|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751169|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1751170|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1751171|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751172|NCT03984045|Lidocaine|lidocaine|mesh-list
1751173|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
1751174|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
1751175|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
1751176|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1751177|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751178|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
1751179|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1751180|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1751181|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1751182|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1751183|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1751184|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751185|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
1751186|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
1751187|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1751188|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1751189|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1751190|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1751191|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1751192|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
1751193|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1751214|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
1751215|NCT03967223|Fludarabine|fludarabine|mesh-list
1751216|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1751217|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
1751218|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751219|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1751220|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1751221|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
1751222|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751223|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751224|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1751239|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
1751240|NCT03930602|BMS-986165|bms-986165|mesh-list
1751241|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1751242|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1751243|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1751244|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751245|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1751246|NCT03930602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1751247|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1751248|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1751249|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751250|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1751251|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
1751252|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1751253|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
1751254|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1751255|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1751256|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1751257|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1751258|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
1751259|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1751260|NCT03927144|Erenumab|erenumab|mesh-list
1751261|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1751262|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751263|NCT03927144|Analgesics|analgesics|mesh-ancestor
1751264|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
1751265|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1751266|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751308|NCT03905265|Moxidectin|moxidectin|mesh-list
1751309|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
1751310|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1751311|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1751312|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
1751313|NCT03889795|Metformin|metformin|mesh-list
1751314|NCT03889795|Digoxin|digoxin|mesh-list
1751315|NCT03889795|Simvastatin|simvastatin|mesh-list
1751316|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1751317|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751318|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1751319|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1751320|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
1751321|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751322|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1751323|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1751324|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1751325|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1751326|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1751327|NCT03889795|Protective Agents|protective agents|mesh-ancestor
1751333|NCT03872791|Paclitaxel|paclitaxel|mesh-list
1751334|NCT03872791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1751335|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1751336|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751337|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
1751338|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
1751339|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
1751340|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751355|NCT03843151|Itraconazole|itraconazole|mesh-list
1751356|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
1751357|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1751358|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1751359|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1751360|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1751361|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751362|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1751363|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
1751364|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1751365|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751366|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1751369|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
1751370|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1751371|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1751372|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751373|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
1751374|NCT03822793|Coagulants|coagulants|mesh-ancestor
1751413|NCT03748134|Paclitaxel|paclitaxel|mesh-list
1751414|NCT03748134|Fluorouracil|fluorouracil|mesh-list
1751415|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1751416|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751417|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
1751418|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
1751419|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
1751420|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751421|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
1751422|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1751423|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1751424|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
1751425|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751454|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
1751455|NCT03710421|Fludarabine|fludarabine|mesh-list
1751456|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1751457|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
1751458|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751459|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1751460|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1751461|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
1751462|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751463|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751464|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1751465|NCT03706521|Lorecivivint|lorecivivint|mesh-list
1751466|NCT03706521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1751481|NCT03703492|Estradiol|estradiol|mesh-list
1751482|NCT03703492|Estrogens|estrogens|mesh-ancestor
1751483|NCT03703492|Hormones|hormones|mesh-ancestor
1751484|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1751485|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751517|NCT03664024|Carboplatin|carboplatin|mesh-list
1751518|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
1751519|NCT03664024|Pemetrexed|pemetrexed|mesh-list
1751520|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751521|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1751522|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1751523|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751524|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1751525|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1751526|NCT03663166|Nivolumab|nivolumab|mesh-list
1751527|NCT03663166|Ipilimumab|ipilimumab|mesh-list
1751528|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1751529|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751530|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1751531|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751532|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
1751533|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1751534|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1751580|NCT03554317|Nivolumab|nivolumab|mesh-list
1751581|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
1751582|NCT03554317|Testosterone|testosterone|mesh-list
1751583|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
1751584|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
1751585|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1751586|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1751587|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751588|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1751589|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751590|NCT03554317|Androgens|androgens|mesh-ancestor
1751591|NCT03554317|Hormones|hormones|mesh-ancestor
1751592|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1751593|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751594|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1751595|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
1751694|NCT03434418|Osimertinib|osimertinib|mesh-list
1751695|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751696|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1751697|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1751698|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751699|NCT03430063|Ipilimumab|ipilimumab|mesh-list
1751700|NCT03430063|Cemiplimab|cemiplimab|mesh-list
1751701|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1751702|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751703|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1751704|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751705|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
1751706|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1751707|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751708|NCT03422731|Alovudine|alovudine|mesh-list
1751709|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
1751710|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1751711|NCT03377699|Insulin|insulin|mesh-list
1751712|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1751713|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
1751714|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
1751715|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1751716|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751734|NCT03306394|Trifluridine|trifluridine|mesh-list
1751735|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
1751736|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751737|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
1751738|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1751739|NCT03290950|Dexamethasone|dexamethasone|mesh-list
1751740|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
1751741|NCT03290950|Lenalidomide|lenalidomide|mesh-list
1751742|NCT03290950|Daratumumab|daratumumab|mesh-list
1751743|NCT03290950|BB 1101|bb 1101|mesh-list
1751744|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1751745|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
1751746|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
1751747|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1751748|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751749|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1751750|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
1751751|NCT03290950|Hormones|hormones|mesh-ancestor
1751752|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1751753|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1751754|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751755|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
1751756|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1751757|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751758|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
1751759|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1751760|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1751761|NCT03290950|Growth Substances|growth substances|mesh-ancestor
1751762|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
1751780|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
1751781|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1751782|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1751783|NCT03249844|Prednisolone|prednisolone|mesh-list
1751784|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
1751785|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1751786|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
1751787|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1751788|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
1751789|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
1751790|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1751791|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751792|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1751793|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
1751794|NCT03249844|Hormones|hormones|mesh-ancestor
1751795|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1751796|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1751797|NCT03249844|Protective Agents|protective agents|mesh-ancestor
1751798|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1751799|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751818|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
1751819|NCT03221257|Pirfenidone|pirfenidone|mesh-list
1751820|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1751821|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751822|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1751823|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
1751824|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1751825|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1751826|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1751827|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751828|NCT03221257|Analgesics|analgesics|mesh-ancestor
1751829|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
1751830|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1751831|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751832|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1751833|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1751834|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1751835|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1751846|NCT03208231|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1751847|NCT03208231|Antiviral Agents|antiviral agents|mesh-ancestor
1751848|NCT03208231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1751849|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
1751850|NCT03204188|Fludarabine|fludarabine|mesh-list
1751851|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1751852|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751888|NCT03172754|Nivolumab|nivolumab|mesh-list
1751889|NCT03172754|Axitinib|axitinib|mesh-list
1751890|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1751891|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751892|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1751893|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751894|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1751895|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1751932|NCT03044977|Octreotide|octreotide|mesh-list
1751933|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1751934|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1751935|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1751958|NCT03009019|Celecoxib|celecoxib|mesh-list
1751959|NCT03009019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1751960|NCT03009019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1751961|NCT03009019|Analgesics|analgesics|mesh-ancestor
1751962|NCT03009019|Sensory System Agents|sensory system agents|mesh-ancestor
1751963|NCT03009019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1751964|NCT03009019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751965|NCT03009019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1751966|NCT03009019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1751967|NCT03009019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1751968|NCT03009019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1751969|NCT03009019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1751970|NCT03009019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1751971|NCT03006276|Celecoxib|celecoxib|mesh-list
1751972|NCT03006276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1751973|NCT03006276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1751974|NCT03006276|Analgesics|analgesics|mesh-ancestor
1751975|NCT03006276|Sensory System Agents|sensory system agents|mesh-ancestor
1751976|NCT03006276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1751977|NCT03006276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1751978|NCT03006276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1751979|NCT03006276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1751980|NCT03006276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1751981|NCT03006276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1751982|NCT03006276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1751983|NCT03006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752011|NCT02977156|Ipilimumab|ipilimumab|mesh-list
1752012|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1752013|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752014|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1752015|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752016|NCT02913313|Nivolumab|nivolumab|mesh-list
1752017|NCT02913313|Ipilimumab|ipilimumab|mesh-list
1752018|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1752019|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752020|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1752021|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752201|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752071|NCT02755272|Gemcitabine|gemcitabine|mesh-list
1752072|NCT02755272|Carboplatin|carboplatin|mesh-list
1752073|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
1752074|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752075|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1752076|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
1752077|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752078|NCT02755272|Antiviral Agents|antiviral agents|mesh-ancestor
1752079|NCT02755272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1752080|NCT02755272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752081|NCT02755272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1752082|NCT02755272|Immunologic Factors|immunologic factors|mesh-ancestor
1752083|NCT02755272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752084|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1752085|NCT02707042|Amoxicillin|amoxicillin|mesh-list
1752086|NCT02707042|Azithromycin|azithromycin|mesh-list
1752087|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1752088|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1752089|NCT02664155|Vitamin K|vitamin k|mesh-list
1752090|NCT02664155|Heparin|heparin|mesh-list
1752091|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
1752092|NCT02664155|Apixaban|apixaban|mesh-list
1752093|NCT02664155|Vitamins|vitamins|mesh-ancestor
1752094|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
1752095|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752096|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
1752097|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1752098|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1752099|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752100|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1752101|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
1752102|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1752103|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
1752104|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752105|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1752106|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
1752107|NCT02664155|Coagulants|coagulants|mesh-ancestor
1752130|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
1752131|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
1752132|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1752133|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1752134|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1752135|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752136|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752137|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1752182|NCT02542657|Clarithromycin|clarithromycin|mesh-list
1752183|NCT02542657|Dexamethasone|dexamethasone|mesh-list
1752184|NCT02542657|Pomalidomide|pomalidomide|mesh-list
1752185|NCT02542657|Ixazomib|ixazomib|mesh-list
1752186|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1752187|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
1752188|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
1752189|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1752190|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752191|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1752192|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
1752193|NCT02542657|Hormones|hormones|mesh-ancestor
1752194|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1752195|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1752196|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752197|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752198|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1752199|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1752200|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1752202|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1752203|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1752204|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
1752205|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1752206|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1752207|NCT02542657|Growth Substances|growth substances|mesh-ancestor
1752208|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
1752209|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
1752322|NCT02359513|Fluoxetine|fluoxetine|mesh-list
1752323|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
1752324|NCT02359513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1752325|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1752326|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1752327|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752328|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1752329|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
1752330|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752331|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1752332|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1752333|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1752334|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1752335|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752357|NCT02267343|Nivolumab|nivolumab|mesh-list
1752358|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1752359|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752360|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1752361|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752362|NCT02261285|Nivolumab|nivolumab|mesh-list
1752363|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1752364|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752365|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1752366|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752367|NCT02256800|Leucovorin|leucovorin|mesh-list
1752368|NCT02256800|Bevacizumab|bevacizumab|mesh-list
1752369|NCT02256800|Irinotecan|irinotecan|mesh-list
1752370|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1752371|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752372|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1752373|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1752374|NCT02256800|Growth Substances|growth substances|mesh-ancestor
1752375|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752376|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
1752377|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1752378|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1752379|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752380|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752381|NCT02256800|Antidotes|antidotes|mesh-ancestor
1752382|NCT02256800|Protective Agents|protective agents|mesh-ancestor
1752383|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
1752384|NCT02256800|Vitamins|vitamins|mesh-ancestor
1752385|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
1752413|NCT02203682|Doxycycline|doxycycline|mesh-list
1752414|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1752415|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1752416|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
1752417|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1752418|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1752447|NCT02157051|Vaccines|vaccines|mesh-list
1752448|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
1752449|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752450|NCT02116335|Bosentan|bosentan|mesh-list
1752451|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1752452|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1752453|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752483|NCT01903486|Prednisone|prednisone|mesh-list
1752484|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1752485|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
1752486|NCT01903486|Hormones|hormones|mesh-ancestor
1752487|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1752488|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752489|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1752490|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752529|NCT01811368|Cyclosporine|cyclosporine|mesh-list
1752530|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
1752531|NCT01811368|Rituximab|rituximab|mesh-list
1752532|NCT01811368|Cyclosporins|cyclosporins|mesh-list
1752533|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
1752534|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1752535|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
1752536|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1752537|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752538|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
1752539|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752540|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1752541|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752542|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752543|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1752544|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
1752545|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1752546|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
1752547|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1752548|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1752549|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1752550|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
1752551|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1752552|NCT01611116|Sirolimus|sirolimus|mesh-list
1752553|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1752554|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1752555|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1752556|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752557|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
1752558|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1752559|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
1752560|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752563|NCT01303341|Sorafenib|sorafenib|mesh-list
1752564|NCT01303341|Riluzole|riluzole|mesh-list
1752565|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752566|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1752567|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752568|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752569|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
1752570|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1752571|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1752572|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1752573|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752574|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1752575|NCT01303341|Protective Agents|protective agents|mesh-ancestor
1752576|NCT01288625|Amifostine|amifostine|mesh-list
1752577|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1752578|NCT01288625|Protective Agents|protective agents|mesh-ancestor
1752579|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752605|NCT00848328|Rituximab|rituximab|mesh-list
1752606|NCT00848328|Lenalidomide|lenalidomide|mesh-list
1752607|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1752608|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752609|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
1752610|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752611|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1752612|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1752613|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1752614|NCT00848328|Growth Substances|growth substances|mesh-ancestor
1752615|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
1752616|NCT00599170|Rituximab|rituximab|mesh-list
1752617|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1752618|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752619|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
1752620|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752621|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1752678|NCT05128292|Selenium|selenium|mesh-list
1752679|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
1752680|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752681|NCT05128292|Protective Agents|protective agents|mesh-ancestor
1752682|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752683|NCT05128292|Trace Elements|trace elements|mesh-ancestor
1752684|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
1752685|NCT05128175|Levodopa|levodopa|mesh-list
1752686|NCT05128175|Carbidopa|carbidopa|mesh-list
1752687|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1752688|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1752689|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1752690|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
1752691|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1752692|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752693|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752694|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1752695|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752696|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1752697|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
1752698|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
1752699|NCT05128162|Psilocybin|psilocybin|mesh-list
1752700|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
1752701|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752702|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1752703|NCT05128071|Progesterone|progesterone|mesh-list
1752704|NCT05128071|Progestins|progestins|mesh-ancestor
1752705|NCT05128071|Hormones|hormones|mesh-ancestor
1752706|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1752707|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752708|NCT05127980|Antibodies|antibodies|mesh-list
1752709|NCT05127980|Autoantibodies|autoantibodies|mesh-list
1752710|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
1752711|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752712|NCT05127928|Vitamins|vitamins|mesh-list
1752713|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
1752714|NCT05127928|Vitamin E|vitamin e|mesh-list
1752715|NCT05127928|Tocopherols|tocopherols|mesh-list
1752716|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
1752717|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752718|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
1752719|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752720|NCT05127928|Protective Agents|protective agents|mesh-ancestor
1752748|NCT05127746|Donepezil|donepezil|mesh-list
1752749|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1752750|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752751|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752752|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
1752753|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1752754|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752755|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
1752756|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
1752757|NCT05127707|Narcotics|narcotics|mesh-ancestor
1752758|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1752759|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752760|NCT05127707|Analgesics|analgesics|mesh-ancestor
1752761|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
1752762|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1752766|NCT05127395|Acyclovir|acyclovir|mesh-list
1752767|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
1752768|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1752769|NCT05127369|Fluoxetine|fluoxetine|mesh-list
1752770|NCT05127369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1752771|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1752772|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1752773|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752774|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1752775|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
1752776|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752777|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1752778|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
1752779|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1752780|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1752781|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1752782|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752811|NCT05126901|Ferric maltol|ferric maltol|mesh-list
1752812|NCT05126901|Hematinics|hematinics|mesh-ancestor
1752813|NCT05126836|Cilostazol|cilostazol|mesh-list
1752814|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1752815|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
1752816|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1752817|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752818|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1752819|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
1752820|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1752821|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1752822|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752823|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1752824|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
1752825|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1752826|NCT05126836|Protective Agents|protective agents|mesh-ancestor
1752827|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1752828|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1752829|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752833|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
1752834|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1752835|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1752836|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752837|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
1752838|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1752839|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752840|NCT05126602|Vitamin D|vitamin d|mesh-list
1752841|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
1752842|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
1752843|NCT05126602|Vitamins|vitamins|mesh-list
1752844|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
1752845|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752846|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1752847|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1752856|NCT05126342|Niraparib|niraparib|mesh-list
1752857|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1752858|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752859|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752860|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752882|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
1752883|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
1752884|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1752885|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1752886|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1752887|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752888|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752889|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1752918|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
1752919|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1752920|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752921|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
1752922|NCT05126004|Azacitidine|azacitidine|mesh-list
1752923|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1752924|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1752925|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
1752926|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1752927|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1752928|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752929|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
1752930|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1752931|NCT05126004|Expectorants|expectorants|mesh-ancestor
1752932|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
1752933|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1752934|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
1752935|NCT05126004|Protective Agents|protective agents|mesh-ancestor
1752936|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752937|NCT05126004|Antidotes|antidotes|mesh-ancestor
1752975|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
1752976|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1752977|NCT05125640|Progesterone|progesterone|mesh-list
1752978|NCT05125640|Progestins|progestins|mesh-ancestor
1752979|NCT05125640|Hormones|hormones|mesh-ancestor
1752980|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1752981|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752982|NCT05125627|Progesterone|progesterone|mesh-list
1752983|NCT05125627|Progestins|progestins|mesh-ancestor
1752984|NCT05125627|Hormones|hormones|mesh-ancestor
1752985|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1752986|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752987|NCT05125588|Meloxicam|meloxicam|mesh-list
1752988|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1752989|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1752990|NCT05125588|Analgesics|analgesics|mesh-ancestor
1752991|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
1752992|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1752993|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1752994|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1752995|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1752996|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1752997|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1752998|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1752999|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753000|NCT05125575|Metformin|metformin|mesh-list
1753001|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1753002|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753003|NCT05125549|Clopidogrel|clopidogrel|mesh-list
1753004|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1753005|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1753006|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1753007|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1753008|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
1753009|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1753010|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753011|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753021|NCT05125380|Acetic Acid|acetic acid|mesh-list
1753022|NCT05125380|Retinol acetate|retinol acetate|mesh-list
1753023|NCT05125380|Lugol's solution|lugol's solution|mesh-list
1753024|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1753025|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1753026|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1753027|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
1753028|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753029|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1753030|NCT05125380|Protective Agents|protective agents|mesh-ancestor
1753031|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753032|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
1753033|NCT05125380|Coagulants|coagulants|mesh-ancestor
1753034|NCT05125328|Remifentanil|remifentanil|mesh-list
1753035|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1753036|NCT05125328|Narcotics|narcotics|mesh-ancestor
1753037|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1753038|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753039|NCT05125328|Analgesics|analgesics|mesh-ancestor
1753040|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
1753041|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1753042|NCT05125276|Aspirin|aspirin|mesh-list
1753043|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1753044|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1753045|NCT05125276|Analgesics|analgesics|mesh-ancestor
1753046|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
1753047|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1753048|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753049|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1753050|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1753051|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1753052|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1753053|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753054|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1753055|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1753056|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1753057|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
1753058|NCT05125237|Amiloride|amiloride|mesh-list
1753059|NCT05125237|Triamterene|triamterene|mesh-list
1753060|NCT05125237|Diuretics|diuretics|mesh-ancestor
1753061|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
1753062|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753063|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
1753064|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1753065|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1753066|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753067|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
1753068|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1753069|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1753070|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
1753071|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
1753072|NCT05125224|Calcium|calcium|mesh-list
1753073|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1753074|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753075|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1753076|NCT05125224|Diuretics|diuretics|mesh-ancestor
1753077|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
1753078|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1753079|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1753080|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753098|NCT05125055|Paclitaxel|paclitaxel|mesh-list
1753099|NCT05125055|Docetaxel|docetaxel|mesh-list
1753100|NCT05125055|Fluorouracil|fluorouracil|mesh-list
1753101|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1753102|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753103|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
1753104|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
1753105|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
1753106|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753107|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
1753108|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1753109|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1753110|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
1753111|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753112|NCT05125042|Amiodarone|amiodarone|mesh-list
1753113|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1753114|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
1753115|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1753116|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1753117|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753118|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1753119|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1753120|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1753121|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1753122|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1753123|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1753124|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1753135|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
1753136|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1753137|NCT05124951|Carboplatin|carboplatin|mesh-list
1753138|NCT05124951|Etoposide|etoposide|mesh-list
1753139|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
1753140|NCT05124951|Ifosfamide|ifosfamide|mesh-list
1753141|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753142|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1753143|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1753144|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1753145|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1753146|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753147|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1753148|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
1753149|NCT05124938|Hormones|hormones|mesh-list
1753150|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1753151|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753157|NCT05124730|Metformin|metformin|mesh-list
1753158|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1753159|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753160|NCT05124717|Metformin|metformin|mesh-list
1753161|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1753162|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753163|NCT05124704|Ropivacaine|ropivacaine|mesh-list
1753164|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
1753165|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
1753166|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1753167|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753168|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
1753169|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1753170|NCT05124691|Ivermectin|ivermectin|mesh-list
1753171|NCT05124691|Albendazole|albendazole|mesh-list
1753172|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1753173|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1753174|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
1753175|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
1753176|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1753177|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1753178|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
1753179|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
1753180|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
1753181|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753182|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753195|NCT05124457|Insulin|insulin|mesh-list
1753196|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1753197|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
1753198|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
1753199|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
1753200|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
1753201|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1753202|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753203|NCT05124431|Everolimus|everolimus|mesh-list
1753204|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753205|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1753206|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
1753207|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753208|NCT05120349|Osimertinib|osimertinib|mesh-list
1753209|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753210|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1753211|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1753212|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753231|NCT05118620|Bupivacaine|bupivacaine|mesh-list
1753232|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
1753233|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
1753234|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1753235|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753236|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
1753237|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1753278|NCT05115591|Anesthetics|anesthetics|mesh-list
1753279|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1753280|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753281|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1753282|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1753303|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
1753304|NCT05109949|Empagliflozin|empagliflozin|mesh-list
1753305|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1753306|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753307|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1753308|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753342|NCT05104918|Vortioxetine|vortioxetine|mesh-list
1753343|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1753344|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1753345|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1753346|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1753347|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753348|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1753349|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753350|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1753351|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
1753352|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1753353|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1753354|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1753355|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1753356|NCT05104918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1753357|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
1753358|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1753359|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1753360|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1753361|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1753377|NCT05092412|Carboplatin|carboplatin|mesh-list
1753378|NCT05092412|Etoposide|etoposide|mesh-list
1753379|NCT05092412|Durvalumab|durvalumab|mesh-list
1753380|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753381|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1753382|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1753383|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1753384|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1753385|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753386|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1753387|NCT05089942|Insulin|insulin|mesh-list
1753388|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1753389|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1753390|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753391|NCT05087914|Naproxen|naproxen|mesh-list
1753392|NCT05087914|Levodopa|levodopa|mesh-list
1753393|NCT05087914|Carbidopa|carbidopa|mesh-list
1753394|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1753395|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1753396|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1753397|NCT05087914|Analgesics|analgesics|mesh-ancestor
1753398|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
1753399|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1753400|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753401|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1753402|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1753403|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
1753404|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1753405|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1753406|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753407|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1753408|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1753409|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
1753410|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1753411|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1753412|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1753413|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
1753414|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
1753415|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1753416|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1753417|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1753418|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1753419|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753420|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1753421|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753422|NCT05086393|Analgesics|analgesics|mesh-ancestor
1753423|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
1753424|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1753425|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
1753426|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1753427|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
1753436|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
1753437|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
1753438|NCT05073172|Petrolatum|petrolatum|mesh-list
1753439|NCT05073172|Mineral Oil|mineral oil|mesh-list
1753440|NCT05073172|Emollients|emollients|mesh-ancestor
1753441|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
1753442|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1753443|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1753444|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1753445|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1753446|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
1753447|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1753461|NCT05067634|Cenobamate|cenobamate|mesh-list
1753462|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
1753511|NCT05055323|Pyrvinium|pyrvinium|mesh-list
1753512|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
1753513|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1753514|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1753526|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
1753527|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1753528|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753540|NCT05047718|Vaccines|vaccines|mesh-list
1753541|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
1753542|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753555|NCT05044936|Cannabidiol|cannabidiol|mesh-list
1753556|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
1753557|NCT05044611|Amiloride|amiloride|mesh-list
1753558|NCT05044611|Diuretics|diuretics|mesh-ancestor
1753559|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
1753560|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753561|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
1753562|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1753563|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1753564|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753565|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
1753566|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1753621|NCT05017571|Colchicine|colchicine|mesh-list
1753622|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
1753623|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1753624|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
1753625|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
1753626|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
1753627|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753628|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753673|NCT05004025|Nivolumab|nivolumab|mesh-list
1753674|NCT05004025|Ipilimumab|ipilimumab|mesh-list
1753675|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1753676|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753677|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1753678|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753726|NCT04979910|Ixekizumab|ixekizumab|mesh-list
1753727|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
1753765|NCT04971187|Cisplatin|cisplatin|mesh-list
1753766|NCT04971187|Carboplatin|carboplatin|mesh-list
1753767|NCT04971187|Pemetrexed|pemetrexed|mesh-list
1753768|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753769|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1753770|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753771|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1753772|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1753789|NCT04960709|Durvalumab|durvalumab|mesh-list
1753790|NCT04960709|Tremelimumab|tremelimumab|mesh-list
1753791|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1753792|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753815|NCT04943627|Gemcitabine|gemcitabine|mesh-list
1753816|NCT04943627|Irinotecan|irinotecan|mesh-list
1753817|NCT04943627|Pemetrexed|pemetrexed|mesh-list
1753818|NCT04943627|Topotecan|topotecan|mesh-list
1753819|NCT04943627|Vinorelbine|vinorelbine|mesh-list
1753820|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1753821|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
1753822|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753823|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753824|NCT04943627|Antiviral Agents|antiviral agents|mesh-ancestor
1753825|NCT04943627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1753826|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1753827|NCT04943627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1753828|NCT04943627|Immunologic Factors|immunologic factors|mesh-ancestor
1753829|NCT04943627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753830|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1753831|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1753832|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1753833|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1753834|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1753835|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
1753836|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
1753837|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
1753838|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1753839|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1753840|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
1753841|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753842|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1753843|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
1753844|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1753845|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1753846|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753847|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1753848|NCT04941508|Analgesics|analgesics|mesh-ancestor
1753849|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
1753850|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1753851|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1753852|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1753853|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1753854|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
1753855|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1753856|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753908|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
1753909|NCT04933331|Fluorides|fluorides|mesh-list
1753910|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
1753911|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
1753912|NCT04933331|Protective Agents|protective agents|mesh-ancestor
1753913|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753914|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1753915|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1753916|NCT04932213|Tropicamide|tropicamide|mesh-list
1753917|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
1753918|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
1753919|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1753920|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1753921|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1753922|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1753923|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
1753924|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1753925|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1753997|NCT04909853|Ritonavir|ritonavir|mesh-list
1753998|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1753999|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1754000|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
1754001|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1754002|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754003|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1754004|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1754005|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
1754006|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1754007|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1754008|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1754243|NCT04833582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1754023|NCT04901988|Nivolumab|nivolumab|mesh-list
1754024|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1754025|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754026|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1754027|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754125|NCT04880876|Eluxadoline|eluxadoline|mesh-list
1754126|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1754136|NCT04874831|Avelumab|avelumab|mesh-list
1754137|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1754138|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754139|NCT04869358|Ofatumumab|ofatumumab|mesh-list
1754140|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754144|NCT04863248|Docetaxel|docetaxel|mesh-list
1754145|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754146|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
1754147|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
1754148|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
1754149|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754150|NCT04862260|Atorvastatin|atorvastatin|mesh-list
1754151|NCT04862260|Ezetimibe|ezetimibe|mesh-list
1754152|NCT04862260|Evolocumab|evolocumab|mesh-list
1754153|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1754154|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1754155|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
1754156|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754157|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1754158|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1754159|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1754197|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1754198|NCT04846218|Progesterone|progesterone|mesh-list
1754199|NCT04846218|Progestins|progestins|mesh-ancestor
1754200|NCT04846218|Hormones|hormones|mesh-ancestor
1754201|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1754202|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754203|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
1754204|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1754205|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
1754206|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1754207|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1754208|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1754209|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754213|NCT04841499|Niacinamide|niacinamide|mesh-list
1754214|NCT04841499|Niacin|niacin|mesh-list
1754215|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
1754216|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
1754217|NCT04841499|Vitamins|vitamins|mesh-ancestor
1754218|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
1754219|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754220|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1754221|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
1754222|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754223|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1754224|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
1754231|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
1754232|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754233|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1754234|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1754235|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754236|NCT04833582|Gemcitabine|gemcitabine|mesh-list
1754237|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1754238|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
1754239|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754240|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754241|NCT04833582|Antiviral Agents|antiviral agents|mesh-ancestor
1754242|NCT04833582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1754244|NCT04833582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1754245|NCT04833582|Immunologic Factors|immunologic factors|mesh-ancestor
1754246|NCT04833582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754258|NCT04825678|Erenumab|erenumab|mesh-list
1754259|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1754260|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754261|NCT04825678|Analgesics|analgesics|mesh-ancestor
1754262|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
1754263|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1754264|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754265|NCT04822337|Dexamethasone|dexamethasone|mesh-list
1754266|NCT04822337|Lenalidomide|lenalidomide|mesh-list
1754267|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1754268|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
1754269|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
1754270|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1754271|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754272|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1754273|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
1754274|NCT04822337|Hormones|hormones|mesh-ancestor
1754275|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1754276|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1754277|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754278|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
1754279|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1754280|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1754281|NCT04822337|Growth Substances|growth substances|mesh-ancestor
1754282|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
1754339|NCT04798027|Vaccines|vaccines|mesh-list
1754340|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
1754341|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754342|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
1754343|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1754344|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754403|NCT04773405|Lidocaine|lidocaine|mesh-list
1754404|NCT04773405|Epinephrine|epinephrine|mesh-list
1754405|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
1754406|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
1754407|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
1754408|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1754409|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754410|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
1754411|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1754412|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1754413|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1754414|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1754415|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1754416|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754417|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1754418|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1754419|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
1754420|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1754421|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1754422|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1754423|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
1754424|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1754425|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
1754426|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
1754427|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
1754428|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1754429|NCT04766996|Aspirin|aspirin|mesh-list
1754430|NCT04766996|Acetaminophen|acetaminophen|mesh-list
1754431|NCT04766996|Prednisone|prednisone|mesh-list
1754432|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1754433|NCT04766996|Meloxicam|meloxicam|mesh-list
1754434|NCT04766996|Diclofenac|diclofenac|mesh-list
1754435|NCT04766996|Lidocaine|lidocaine|mesh-list
1754436|NCT04766996|Pregabalin|pregabalin|mesh-list
1754437|NCT04766996|Tramadol|tramadol|mesh-list
1754438|NCT04766996|Bupivacaine|bupivacaine|mesh-list
1754439|NCT04766996|Propofol|propofol|mesh-list
1754440|NCT04766996|Omeprazole|omeprazole|mesh-list
1754441|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
1754442|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
1754443|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
1754444|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1754445|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754446|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
1754447|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1754448|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1754449|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1754450|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1754451|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1754452|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754453|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1754454|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
1754455|NCT04766996|Hormones|hormones|mesh-ancestor
1754456|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1754457|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1754458|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754459|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1754460|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1754461|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
1754462|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1754463|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1754464|NCT04766996|Analgesics|analgesics|mesh-ancestor
1754465|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1754466|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1754467|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1754468|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1754469|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1754470|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1754471|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
1754472|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1754473|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
1754474|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1754475|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1754476|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1754477|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1754478|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1754479|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1754480|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
1754481|NCT04766996|Coagulants|coagulants|mesh-ancestor
1754482|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1754483|NCT04766996|Narcotics|narcotics|mesh-ancestor
1754484|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1754485|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1754486|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1754504|NCT04761094|Insulin|insulin|mesh-list
1754505|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1754506|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754568|NCT04754061|Psilocybin|psilocybin|mesh-list
1754569|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
1754570|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754571|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1754572|NCT04752475|Furosemide|furosemide|mesh-list
1754573|NCT04752475|Diuretics|diuretics|mesh-ancestor
1754574|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
1754575|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754576|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1754577|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1754578|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754653|NCT04732260|Letermovir|letermovir|mesh-list
1754654|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1754655|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1754656|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754657|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754658|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
1754659|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1754688|NCT04722601|Azacitidine|azacitidine|mesh-list
1754689|NCT04722601|Venetoclax|venetoclax|mesh-list
1754690|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
1754691|NCT04722601|Cc-486|cc-486|mesh-list
1754692|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1754693|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
1754694|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754695|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754696|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1754697|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1754931|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
1754718|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
1754719|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1754720|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1754721|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754722|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1754723|NCT04700514|Analgesics|analgesics|mesh-ancestor
1754724|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
1754725|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1754726|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1754727|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1754728|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1754729|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
1754730|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1754731|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754753|NCT04693468|Palbociclib|palbociclib|mesh-list
1754754|NCT04693468|Axitinib|axitinib|mesh-list
1754755|NCT04693468|Crizotinib|crizotinib|mesh-list
1754756|NCT04693468|Talazoparib|talazoparib|mesh-list
1754757|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754758|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1754759|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1754760|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754761|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1754766|NCT04684420|Metformin|metformin|mesh-list
1754767|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1754768|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754932|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
1754846|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1754847|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1754848|NCT04654312|Diuretics|diuretics|mesh-ancestor
1754849|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
1754850|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754851|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1754852|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1754853|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754873|NCT04635644|Morphine|morphine|mesh-list
1754874|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1754875|NCT04635644|Narcotics|narcotics|mesh-ancestor
1754876|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1754877|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754878|NCT04635644|Analgesics|analgesics|mesh-ancestor
1754879|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
1754880|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1754893|NCT04633226|Vaccines|vaccines|mesh-list
1754894|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
1754895|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754921|NCT04623931|Temozolomide|temozolomide|mesh-list
1754922|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1754923|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
1754924|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754925|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754926|NCT04617067|Gemcitabine|gemcitabine|mesh-list
1754927|NCT04617067|Paclitaxel|paclitaxel|mesh-list
1754928|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1754929|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754930|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
1754933|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754934|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1754935|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
1754936|NCT04617067|Antiviral Agents|antiviral agents|mesh-ancestor
1754937|NCT04617067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1754938|NCT04617067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1754939|NCT04617067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1754940|NCT04617067|Immunologic Factors|immunologic factors|mesh-ancestor
1754941|NCT04617067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1754942|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
1754943|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1754944|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754945|NCT04610684|Carboplatin|carboplatin|mesh-list
1754946|NCT04610684|Etoposide|etoposide|mesh-list
1754947|NCT04610684|Atezolizumab|atezolizumab|mesh-list
1754948|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1754949|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1754950|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1754951|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1754952|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1754953|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1754995|NCT04584567|Doxycycline|doxycycline|mesh-list
1754996|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1754997|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1754998|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
1754999|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1755000|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1755041|NCT04578886|Guanfacine|guanfacine|mesh-list
1755042|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1755043|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1755044|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1755045|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1755046|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
1755047|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1755048|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755049|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755050|NCT04576325|Voriconazole|voriconazole|mesh-list
1755051|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
1755052|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1755053|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1755054|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1755055|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1755056|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755057|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1755058|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
1755059|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1755060|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755061|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1755062|NCT04572828|Naproxen|naproxen|mesh-list
1755063|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1755064|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1755065|NCT04572828|Analgesics|analgesics|mesh-ancestor
1755066|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
1755067|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1755068|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755069|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1755070|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1755071|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
1755072|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1755073|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1755074|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755107|NCT04564625|Vitamin D|vitamin d|mesh-list
1755108|NCT04564625|Vitamins|vitamins|mesh-ancestor
1755109|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
1755110|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755111|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1755112|NCT04558112|Levodopa|levodopa|mesh-list
1755113|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1755114|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1755115|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
1755116|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1755117|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755118|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755119|NCT04557189|Ondansetron|ondansetron|mesh-list
1755120|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
1755121|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
1755122|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1755123|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755124|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1755125|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
1755126|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
1755127|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1755128|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
1755129|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1755130|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755131|NCT04557189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1755132|NCT04557189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1755133|NCT04557189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1755134|NCT04557189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1755135|NCT04557189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1755160|NCT04555577|Temozolomide|temozolomide|mesh-list
1755161|NCT04555577|Peposertib|peposertib|mesh-list
1755162|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1755163|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
1755164|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755165|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755166|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1755167|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1755168|NCT04552080|Amoxicillin|amoxicillin|mesh-list
1755169|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1755170|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1755171|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1755172|NCT04549311|Amoxicillin|amoxicillin|mesh-list
1755173|NCT04549311|Metronidazole|metronidazole|mesh-list
1755174|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
1755175|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
1755176|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
1755177|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1755178|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1755179|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1755180|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
1755181|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1755182|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1755183|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1755184|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1755185|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1755186|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755187|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755188|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1755189|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1755190|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1755303|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
1755304|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1755305|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755319|NCT04516278|Bevacizumab|bevacizumab|mesh-list
1755320|NCT04516278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1755321|NCT04516278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755322|NCT04516278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1755323|NCT04516278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1755324|NCT04516278|Growth Substances|growth substances|mesh-ancestor
1755325|NCT04516278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755326|NCT04516278|Growth Inhibitors|growth inhibitors|mesh-ancestor
1755409|NCT04500665|Colchicine|colchicine|mesh-list
1755410|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
1755411|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1755412|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
1755413|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
1755414|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
1755415|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755416|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755417|NCT04493138|Azacitidine|azacitidine|mesh-list
1755418|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1755419|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
1755420|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755421|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755422|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1755438|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
1755439|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1755440|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755441|NCT04473716|Paclitaxel|paclitaxel|mesh-list
1755442|NCT04473716|Cisplatin|cisplatin|mesh-list
1755443|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1755444|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755445|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
1755446|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
1755447|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
1755448|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755451|NCT04471233|Pregabalin|pregabalin|mesh-list
1755452|NCT04471233|Analgesics|analgesics|mesh-ancestor
1755453|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
1755454|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1755455|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755456|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
1755457|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1755458|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1755459|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755460|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1755461|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1755462|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1755463|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1755464|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1755514|NCT04435691|Azacitidine|azacitidine|mesh-list
1755515|NCT04435691|Venetoclax|venetoclax|mesh-list
1755516|NCT04435691|Magrolimab|magrolimab|mesh-list
1755517|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1755518|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
1755519|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755520|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755521|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1755522|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1755529|NCT04422743|Tramiprosate|tramiprosate|mesh-list
1755530|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
1755531|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
1755532|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
1755533|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
1755534|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
1755535|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1755536|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755537|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755538|NCT04421378|Bevacizumab|bevacizumab|mesh-list
1755539|NCT04421378|Temozolomide|temozolomide|mesh-list
1755540|NCT04421378|Carmustine|carmustine|mesh-list
1755541|NCT04421378|Lomustine|lomustine|mesh-list
1755542|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1755543|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755544|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1755545|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1755546|NCT04421378|Growth Substances|growth substances|mesh-ancestor
1755547|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755548|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
1755549|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1755550|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
1755551|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755552|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
1755553|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1755554|NCT04413526|Estrogens|estrogens|mesh-ancestor
1755555|NCT04413526|Hormones|hormones|mesh-ancestor
1755556|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1755557|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755558|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1755559|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755603|NCT04385368|Durvalumab|durvalumab|mesh-list
1755604|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1755605|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755632|NCT04375813|Sirolimus|sirolimus|mesh-list
1755633|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1755634|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1755635|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1755636|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755637|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
1755638|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1755639|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
1755640|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755641|NCT04373733|Favipiravir|favipiravir|mesh-list
1755642|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
1755643|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1755658|NCT04357795|Cyclosporine|cyclosporine|mesh-list
1755659|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1755660|NCT04357795|Cyclosporins|cyclosporins|mesh-list
1755661|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1755662|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755663|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1755664|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
1755665|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755666|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
1755667|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1755668|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
1755669|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1755670|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1755671|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1755672|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
1755673|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
1755674|NCT04355130|Vitamins|vitamins|mesh-ancestor
1755675|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
1755676|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755677|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
1755678|NCT04355130|Hematinics|hematinics|mesh-ancestor
1755695|NCT04334070|Clofazimine|clofazimine|mesh-list
1755696|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1755697|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
1755698|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1755699|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1755705|NCT04317807|Levetiracetam|levetiracetam|mesh-list
1755706|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
1755707|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
1755713|NCT04305405|Benralizumab|benralizumab|mesh-list
1755714|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1755715|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
1755739|NCT04302324|Clarithromycin|clarithromycin|mesh-list
1755740|NCT04302324|Dexamethasone|dexamethasone|mesh-list
1755741|NCT04302324|Pomalidomide|pomalidomide|mesh-list
1755742|NCT04302324|Daratumumab|daratumumab|mesh-list
1755743|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1755744|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
1755745|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
1755746|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1755747|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755748|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1755749|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
1755750|NCT04302324|Hormones|hormones|mesh-ancestor
1755751|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1755752|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1755753|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755754|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1755755|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1755756|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1755757|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1755758|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755759|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1755760|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1755761|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
1755762|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1755763|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1755764|NCT04302324|Growth Substances|growth substances|mesh-ancestor
1755765|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
1756147|NCT04061330|Ketamine|ketamine|mesh-list
1755770|NCT04266912|Avelumab|avelumab|mesh-list
1755771|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1755772|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1755773|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755774|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
1755775|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755782|NCT04264663|Tinidazole|tinidazole|mesh-list
1755783|NCT04264663|Furazolidone|furazolidone|mesh-list
1755784|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
1755785|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755786|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1755787|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1755788|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
1755789|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1755790|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1755791|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1755792|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1755793|NCT04264663|Renal Agents|renal agents|mesh-ancestor
1755794|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1755795|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1755796|NCT04256434|Nalbuphine|nalbuphine|mesh-list
1755797|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1755798|NCT04256434|Narcotics|narcotics|mesh-ancestor
1755799|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1755800|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755801|NCT04256434|Analgesics|analgesics|mesh-ancestor
1755802|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
1755803|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1755811|NCT04253262|Rucaparib|rucaparib|mesh-list
1755812|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1755813|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1755814|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755815|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755875|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
1755876|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1755877|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755878|NCT04227366|Methotrexate|methotrexate|mesh-list
1755879|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1755880|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
1755881|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1755882|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755883|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1755884|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
1755885|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755886|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1755887|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
1755888|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1755889|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1755890|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1755891|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
1755892|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1755893|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1755923|NCT04219774|Aspirin|aspirin|mesh-list
1755924|NCT04219774|Clopidogrel|clopidogrel|mesh-list
1755925|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1755926|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1755927|NCT04219774|Analgesics|analgesics|mesh-ancestor
1755928|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
1755929|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1755930|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1755931|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1755932|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1755933|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1755934|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1755935|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1755936|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1755937|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1755938|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1755939|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
1755940|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1755941|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1755942|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1755943|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
1755944|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1755971|NCT04185012|Benralizumab|benralizumab|mesh-list
1755972|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1755973|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
1756032|NCT04139655|Colchicine|colchicine|mesh-list
1756033|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
1756034|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1756035|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
1756036|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
1756037|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
1756038|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756039|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756066|NCT04122287|Levofloxacin|levofloxacin|mesh-list
1756067|NCT04122287|Ofloxacin|ofloxacin|mesh-list
1756068|NCT04122287|Tinidazole|tinidazole|mesh-list
1756069|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1756070|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1756071|NCT04122287|Renal Agents|renal agents|mesh-ancestor
1756072|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1756073|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1756074|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1756075|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756076|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756077|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756078|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1756079|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1756080|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
1756081|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
1756082|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1756083|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1756084|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1756085|NCT04117945|Cetuximab|cetuximab|mesh-list
1756086|NCT04117945|Panitumumab|panitumumab|mesh-list
1756087|NCT04117945|Irinotecan|irinotecan|mesh-list
1756088|NCT04117945|Antibodies|antibodies|mesh-list
1756089|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
1756090|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1756091|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
1756092|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756093|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756094|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1756095|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1756096|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756097|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756114|NCT04095858|Methotrexate|methotrexate|mesh-list
1756115|NCT04095858|Tacrolimus|tacrolimus|mesh-list
1756116|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1756117|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
1756118|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1756119|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756120|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1756121|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
1756122|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756123|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756124|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
1756125|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756126|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1756127|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1756128|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
1756129|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1756130|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1756131|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1756146|NCT04061330|Morphine|morphine|mesh-list
1756148|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1756149|NCT04061330|Narcotics|narcotics|mesh-ancestor
1756150|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1756151|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756152|NCT04061330|Analgesics|analgesics|mesh-ancestor
1756153|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
1756154|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1756155|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1756156|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1756157|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
1756158|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
1756159|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1756160|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1756161|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1756162|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756163|NCT04060394|Prednisone|prednisone|mesh-list
1756164|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1756165|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
1756166|NCT04060394|Hormones|hormones|mesh-ancestor
1756167|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1756168|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756169|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1756170|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756174|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
1756175|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1756176|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
1756177|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756178|NCT04040621|Ceftazidime|ceftazidime|mesh-list
1756179|NCT04040621|Avibactam|avibactam|mesh-list
1756180|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
1756181|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1756182|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1756183|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1756184|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756185|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756193|NCT04030000|Paclitaxel|paclitaxel|mesh-list
1756194|NCT04030000|Carboplatin|carboplatin|mesh-list
1756195|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1756196|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756197|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
1756198|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
1756199|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
1756200|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756207|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
1756208|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
1756209|NCT04028115|Ixazomib|ixazomib|mesh-list
1756210|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756211|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
1756212|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756213|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756219|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
1756220|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1756221|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1756222|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
1756223|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
1756224|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1756225|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756261|NCT03965234|Cisplatin|cisplatin|mesh-list
1756262|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756275|NCT03959423|Insulin|insulin|mesh-list
1756276|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1756277|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756278|NCT03958474|Remifentanil|remifentanil|mesh-list
1756279|NCT03958474|Oxycodone|oxycodone|mesh-list
1756280|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1756281|NCT03958474|Narcotics|narcotics|mesh-ancestor
1756282|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1756283|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756284|NCT03958474|Analgesics|analgesics|mesh-ancestor
1756285|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
1756286|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1756287|NCT03952091|Dexamethasone|dexamethasone|mesh-list
1756288|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
1756289|NCT03952091|Lenalidomide|lenalidomide|mesh-list
1756290|NCT03952091|BB 1101|bb 1101|mesh-list
1756291|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1756292|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
1756293|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
1756294|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1756295|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756296|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1756297|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
1756298|NCT03952091|Hormones|hormones|mesh-ancestor
1756374|NCT03912337|Analgesics|analgesics|mesh-ancestor
1756299|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1756300|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1756301|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756302|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
1756303|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756304|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756305|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
1756306|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1756307|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1756308|NCT03952091|Growth Substances|growth substances|mesh-ancestor
1756309|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
1756316|NCT03946527|Lanreotide|lanreotide|mesh-list
1756317|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756318|NCT03943173|Olaparib|olaparib|mesh-list
1756319|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1756320|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756321|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756322|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756329|NCT03933904|Sirolimus|sirolimus|mesh-list
1756330|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1756331|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1756332|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1756333|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756334|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
1756335|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1756336|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
1756337|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756338|NCT03933163|Resveratrol|resveratrol|mesh-list
1756339|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
1756340|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756341|NCT03933163|Protective Agents|protective agents|mesh-ancestor
1756342|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756343|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756344|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1756345|NCT03927443|Bimatoprost|bimatoprost|mesh-list
1756346|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1756366|NCT03913247|Metronidazole|metronidazole|mesh-list
1756367|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1756368|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1756369|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1756370|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1756371|NCT03912337|Erenumab|erenumab|mesh-list
1756372|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1756373|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756375|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
1756376|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1756377|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756427|NCT03895099|Desogestrel|desogestrel|mesh-list
1756428|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1756429|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1756430|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1756431|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
1756432|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1756433|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756434|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1756435|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1756436|NCT03895099|Progestins|progestins|mesh-ancestor
1756437|NCT03895099|Hormones|hormones|mesh-ancestor
1756438|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1756456|NCT03866200|Resveratrol|resveratrol|mesh-list
1756457|NCT03866200|Antioxidants|antioxidants|mesh-ancestor
1756458|NCT03866200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756459|NCT03866200|Protective Agents|protective agents|mesh-ancestor
1756460|NCT03866200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756461|NCT03866200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756462|NCT03866200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1756463|NCT03864042|Losartan|losartan|mesh-list
1756464|NCT03864042|Midazolam|midazolam|mesh-list
1756465|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
1756466|NCT03864042|Caffeine|caffeine|mesh-list
1756467|NCT03864042|Modafinil|modafinil|mesh-list
1756468|NCT03864042|Bupropion|bupropion|mesh-list
1756469|NCT03864042|Omeprazole|omeprazole|mesh-list
1756470|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1756471|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1756472|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1756473|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1756474|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756475|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1756476|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1756477|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1756478|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1756479|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
1756480|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
1756481|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
1756482|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
1756483|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1756484|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756485|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1756486|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1756487|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
1756488|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1756489|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1756490|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756491|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1756492|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1756493|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1756494|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1756495|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1756496|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1756497|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1756498|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1756499|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1756500|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1756501|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1756502|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
1756503|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1756504|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
1756505|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1756506|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1756507|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1756508|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
1756509|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1756510|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1756511|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1756512|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1756513|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1756514|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
1756515|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
1756516|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1756517|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1756527|NCT03835949|Atezolizumab|atezolizumab|mesh-list
1756528|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756529|NCT03834753|Bevacizumab|bevacizumab|mesh-list
1756530|NCT03834753|Ranibizumab|ranibizumab|mesh-list
1756531|NCT03834753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1756532|NCT03834753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756533|NCT03834753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1756534|NCT03834753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1756535|NCT03834753|Growth Substances|growth substances|mesh-ancestor
1756536|NCT03834753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756537|NCT03834753|Growth Inhibitors|growth inhibitors|mesh-ancestor
1756544|NCT03828045|Apremilast|apremilast|mesh-list
1756545|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1756546|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1756547|NCT03828045|Analgesics|analgesics|mesh-ancestor
1756548|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
1756549|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1756550|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756551|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1756552|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1756553|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1756554|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1756555|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756556|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756557|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1756558|NCT03825874|Amikacin|amikacin|mesh-list
1756559|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1756572|NCT03822351|Durvalumab|durvalumab|mesh-list
1756573|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1756574|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1756575|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756576|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
1756577|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756606|NCT03805841|Bromides|bromides|mesh-list
1756607|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
1756608|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
1756609|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1756610|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756611|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756629|NCT03777436|Apremilast|apremilast|mesh-list
1756630|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1756631|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1756632|NCT03777436|Analgesics|analgesics|mesh-ancestor
1756633|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
1756634|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1756635|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756636|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1756637|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1756638|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1756639|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1756640|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756641|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756662|NCT03772925|Belinostat|belinostat|mesh-list
1756663|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
1756664|NCT03772925|Pevonedistat|pevonedistat|mesh-list
1756665|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756666|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756667|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1756681|NCT03745729|Allopurinol|allopurinol|mesh-list
1756682|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
1756683|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756684|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756685|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
1756686|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1756687|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1756688|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
1756689|NCT03745729|Protective Agents|protective agents|mesh-ancestor
1756690|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756691|NCT03744793|Pemetrexed|pemetrexed|mesh-list
1756692|NCT03744793|Avelumab|avelumab|mesh-list
1756693|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1756694|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756695|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756696|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756697|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1756698|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1756699|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1756700|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
1756701|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756707|NCT03738618|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1756708|NCT03738618|Hormones|hormones|mesh-ancestor
1756709|NCT03738618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1756710|NCT03738618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756744|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
1756745|NCT03725384|Iron|iron|mesh-list
1756746|NCT03725384|Vitamins|vitamins|mesh-ancestor
1756747|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
1756748|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756749|NCT03725384|Trace Elements|trace elements|mesh-ancestor
1756750|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
1756827|NCT03635632|Immunologic Factors|immunologic factors|mesh-ancestor
1756751|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756752|NCT03725384|Protective Agents|protective agents|mesh-ancestor
1756753|NCT03719430|Doxorubicin|doxorubicin|mesh-list
1756754|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1756755|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756756|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1756757|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1756758|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756759|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756767|NCT03693807|Gemcitabine|gemcitabine|mesh-list
1756768|NCT03693807|Fluorouracil|fluorouracil|mesh-list
1756769|NCT03693807|Floxuridine|floxuridine|mesh-list
1756770|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
1756771|NCT03693807|Irinotecan|irinotecan|mesh-list
1756772|NCT03693807|Cetuximab|cetuximab|mesh-list
1756773|NCT03693807|Panitumumab|panitumumab|mesh-list
1756774|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1756775|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
1756776|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756777|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756778|NCT03693807|Antiviral Agents|antiviral agents|mesh-ancestor
1756779|NCT03693807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1756780|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756781|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1756782|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
1756783|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756784|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1756785|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1756786|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1756787|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
1756788|NCT03693014|Nivolumab|nivolumab|mesh-list
1756789|NCT03693014|Ipilimumab|ipilimumab|mesh-list
1756790|NCT03693014|Atezolizumab|atezolizumab|mesh-list
1756791|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1756792|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756793|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1756794|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756795|NCT03692403|Quinagolide|quinagolide|mesh-list
1756796|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
1756797|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
1756798|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1756799|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756800|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756801|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
1756802|NCT03678350|Trioxsalen|trioxsalen|mesh-list
1756803|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756804|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
1756805|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1756819|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
1756820|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756821|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756822|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756823|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1756824|NCT03635632|Cyclophosphamide|cyclophosphamide|mesh-list
1756825|NCT03635632|Fludarabine|fludarabine|mesh-list
1756826|NCT03635632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1756828|NCT03635632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756829|NCT03635632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1756830|NCT03635632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1756831|NCT03635632|Alkylating Agents|alkylating agents|mesh-ancestor
1756832|NCT03635632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756833|NCT03635632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756834|NCT03635632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1756835|NCT03631043|Lenalidomide|lenalidomide|mesh-list
1756836|NCT03631043|Vaccines|vaccines|mesh-list
1756837|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
1756838|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756839|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1756840|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1756841|NCT03631043|Growth Substances|growth substances|mesh-ancestor
1756842|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
1756843|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756844|NCT03608657|Apremilast|apremilast|mesh-list
1756845|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1756846|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1756847|NCT03608657|Analgesics|analgesics|mesh-ancestor
1756848|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
1756849|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1756850|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756851|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1756852|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1756853|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1756854|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1756855|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756856|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756870|NCT03595592|Paclitaxel|paclitaxel|mesh-list
1756871|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1756872|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
1756873|NCT03595592|Carboplatin|carboplatin|mesh-list
1756874|NCT03595592|Doxorubicin|doxorubicin|mesh-list
1756875|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1756876|NCT03595592|Trastuzumab|trastuzumab|mesh-list
1756877|NCT03595592|Atezolizumab|atezolizumab|mesh-list
1756878|NCT03595592|Pertuzumab|pertuzumab|mesh-list
1756879|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1756880|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756881|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
1756882|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
1756883|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
1756884|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756885|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1756886|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
1756887|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756888|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1756889|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1756890|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
1756891|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1756892|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1756893|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1756894|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1756895|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756896|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1756902|NCT03582033|Dexamethasone|dexamethasone|mesh-list
1756903|NCT03582033|Pomalidomide|pomalidomide|mesh-list
1756904|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1756905|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
1756906|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
1756907|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1756908|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756909|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1756910|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
1756911|NCT03582033|Hormones|hormones|mesh-ancestor
1756912|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1756913|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1756914|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756915|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
1756916|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1756917|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1756918|NCT03582033|Growth Substances|growth substances|mesh-ancestor
1756919|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
1756920|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
1756921|NCT03577431|Everolimus|everolimus|mesh-list
1756922|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1756923|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
1756924|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756925|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1756926|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1756927|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
1756928|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756929|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756930|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1756931|NCT03568929|Idelalisib|idelalisib|mesh-list
1756932|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756933|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756934|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756935|NCT03557294|Varenicline|varenicline|mesh-list
1756936|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1756937|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1756938|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
1756939|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1756940|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756941|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1756962|NCT03537690|Paclitaxel|paclitaxel|mesh-list
1756963|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1756964|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1756965|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756966|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
1756967|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
1756968|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
1756969|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1756970|NCT03536728|Eflornithine|eflornithine|mesh-list
1756971|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1756972|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1756973|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1756974|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1756975|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1756976|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
1756977|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1756978|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757002|NCT03510390|Metformin|metformin|mesh-list
1757003|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1757004|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757042|NCT03459846|Durvalumab|durvalumab|mesh-list
1757043|NCT03459846|Olaparib|olaparib|mesh-list
1757044|NCT03459846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757045|NCT03459846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757046|NCT03459846|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1757047|NCT03459846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757048|NCT03459846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757049|NCT03449108|Aldesleukin|aldesleukin|mesh-list
1757050|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
1757051|NCT03449108|Nivolumab|nivolumab|mesh-list
1757052|NCT03449108|Fludarabine|fludarabine|mesh-list
1757053|NCT03449108|Ipilimumab|ipilimumab|mesh-list
1757054|NCT03449108|Interleukin-2|interleukin-2|mesh-list
1757055|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1757056|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
1757057|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757058|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1757059|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1757060|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
1757061|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757062|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757063|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1757064|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757065|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1757066|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1757067|NCT03449108|Analgesics|analgesics|mesh-ancestor
1757068|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
1757069|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1757070|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1757071|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1757072|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
1757073|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1757074|NCT03442088|Apremilast|apremilast|mesh-list
1757075|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1757076|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1757077|NCT03442088|Analgesics|analgesics|mesh-ancestor
1757078|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
1757079|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1757080|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757081|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1757082|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1757083|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1757084|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1757085|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757086|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757092|NCT03436654|Prednisone|prednisone|mesh-list
1757093|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
1757094|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1757095|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
1757096|NCT03436654|Hormones|hormones|mesh-ancestor
1757097|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1757098|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757099|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1757100|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757101|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1757102|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757103|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757104|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
1757105|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1757173|NCT03401320|Letrozole|letrozole|mesh-list
1757174|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757175|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1757176|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1757177|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757178|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757179|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1757180|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
1757181|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1757182|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757231|NCT03291990|Temozolomide|temozolomide|mesh-list
1757232|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1757233|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
1757234|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757235|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757243|NCT03277924|Doxorubicin|doxorubicin|mesh-list
1757244|NCT03277924|Methotrexate|methotrexate|mesh-list
1757245|NCT03277924|Nivolumab|nivolumab|mesh-list
1757246|NCT03277924|Sunitinib|sunitinib|mesh-list
1757247|NCT03277924|Ifosfamide|ifosfamide|mesh-list
1757248|NCT03277924|Epirubicin|epirubicin|mesh-list
1757249|NCT03277924|Dacarbazine|dacarbazine|mesh-list
1757250|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757251|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1757252|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1757253|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1757254|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757255|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757256|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1757257|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
1757258|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1757259|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757260|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1757261|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
1757262|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
1757263|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1757264|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1757265|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
1757266|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1757267|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1757268|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757269|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1757270|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1757271|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1757272|NCT03277924|Growth Substances|growth substances|mesh-ancestor
1757273|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
1757274|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1757275|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1757276|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
1757277|NCT03258853|Pancrelipase|pancrelipase|mesh-list
1757278|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1757289|NCT03257267|Cemiplimab|cemiplimab|mesh-list
1757290|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757291|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757292|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
1757293|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
1757294|NCT03247088|Busulfan|busulfan|mesh-list
1757295|NCT03247088|Fludarabine|fludarabine|mesh-list
1757296|NCT03247088|Sorafenib|sorafenib|mesh-list
1757297|NCT03247088|Tacrolimus|tacrolimus|mesh-list
1757298|NCT03247088|Lenograstim|lenograstim|mesh-list
1757299|NCT03247088|Sargramostim|sargramostim|mesh-list
1757300|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1757301|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
1757302|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757303|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1757304|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1757305|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
1757306|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757307|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757308|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1757309|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1757310|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1757311|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757312|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1757313|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1757314|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
1757315|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1757316|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1757317|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1757325|NCT03217747|Avelumab|avelumab|mesh-list
1757326|NCT03217747|Antibodies|antibodies|mesh-list
1757327|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1757328|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
1757329|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
1757330|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757331|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757332|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757333|NCT03206151|Leucovorin|leucovorin|mesh-list
1757334|NCT03206151|Folic Acid|folic acid|mesh-list
1757335|NCT03206151|Fluorouracil|fluorouracil|mesh-list
1757336|NCT03206151|Irinotecan|irinotecan|mesh-list
1757337|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
1757338|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
1757339|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757340|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1757341|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757342|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1757343|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
1757344|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757345|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1757346|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1757347|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757348|NCT03206151|Antidotes|antidotes|mesh-ancestor
1757349|NCT03206151|Protective Agents|protective agents|mesh-ancestor
1757350|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
1757351|NCT03206151|Vitamins|vitamins|mesh-ancestor
1757352|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
1757353|NCT03206151|Hematinics|hematinics|mesh-ancestor
1757373|NCT03193190|Leucovorin|leucovorin|mesh-list
1757374|NCT03193190|Gemcitabine|gemcitabine|mesh-list
1757375|NCT03193190|Paclitaxel|paclitaxel|mesh-list
1757376|NCT03193190|Bevacizumab|bevacizumab|mesh-list
1757377|NCT03193190|Fluorouracil|fluorouracil|mesh-list
1757378|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
1757379|NCT03193190|Atezolizumab|atezolizumab|mesh-list
1757380|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1757381|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757382|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
1757383|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
1757384|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
1757385|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757386|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757387|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1757388|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1757389|NCT03193190|Growth Substances|growth substances|mesh-ancestor
1757390|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757391|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
1757392|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1757393|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
1757394|NCT03193190|Antiviral Agents|antiviral agents|mesh-ancestor
1757395|NCT03193190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1757396|NCT03193190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757397|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1757398|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
1757399|NCT03193190|Antidotes|antidotes|mesh-ancestor
1757400|NCT03193190|Protective Agents|protective agents|mesh-ancestor
1757401|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
1757402|NCT03193190|Vitamins|vitamins|mesh-ancestor
1757403|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
1757404|NCT03191786|Gemcitabine|gemcitabine|mesh-list
1757405|NCT03191786|Atezolizumab|atezolizumab|mesh-list
1757406|NCT03191786|Vinorelbine|vinorelbine|mesh-list
1757407|NCT03191786|Antibodies|antibodies|mesh-list
1757408|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1757409|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
1757410|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757411|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1757412|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
1757413|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757414|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757415|NCT03191786|Antiviral Agents|antiviral agents|mesh-ancestor
1757416|NCT03191786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1757417|NCT03191786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757418|NCT03191786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1757419|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1757420|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
1757421|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
1757422|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
1757460|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
1757461|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
1757462|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1757463|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1757464|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1757465|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757466|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757467|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1757493|NCT03151057|Idelalisib|idelalisib|mesh-list
1757494|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757495|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757496|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757499|NCT03131726|Simvastatin|simvastatin|mesh-list
1757500|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1757501|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1757502|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
1757503|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757504|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1757505|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1757506|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757518|NCT03110978|Nivolumab|nivolumab|mesh-list
1757519|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757520|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757521|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1757522|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757537|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
1757538|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757539|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757540|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
1757541|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757542|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757548|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
1757549|NCT03070327|Lenalidomide|lenalidomide|mesh-list
1757550|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1757551|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
1757552|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757553|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1757554|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1757555|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
1757556|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757557|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757558|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1757559|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1757560|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1757561|NCT03070327|Growth Substances|growth substances|mesh-ancestor
1757562|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
1757563|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
1757564|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757565|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757572|NCT03031821|Metformin|metformin|mesh-list
1757573|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1757574|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757575|NCT03023631|Vaccines|vaccines|mesh-list
1757576|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
1757577|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757578|NCT03023462|Droperidol|droperidol|mesh-list
1757579|NCT03023462|Oxycodone|oxycodone|mesh-list
1757580|NCT03023462|Ondansetron|ondansetron|mesh-list
1757581|NCT03023462|Ropivacaine|ropivacaine|mesh-list
1757582|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
1757583|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
1757584|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1757585|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757586|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
1757587|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1757588|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1757589|NCT03023462|Narcotics|narcotics|mesh-ancestor
1757590|NCT03023462|Analgesics|analgesics|mesh-ancestor
1757591|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
1757592|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
1757593|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1757594|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
1757595|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
1757596|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1757597|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
1757598|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1757599|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757600|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1757601|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1757602|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1757603|NCT03023462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1757604|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1757605|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1757606|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1757607|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
1757608|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
1757609|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1757610|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
1757611|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1757612|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757613|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1757614|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
1757615|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1757616|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
1757617|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757618|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1757619|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1757620|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
1757621|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
1757622|NCT03023449|Protective Agents|protective agents|mesh-ancestor
1757654|NCT02994069|Cisplatin|cisplatin|mesh-list
1757655|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757656|NCT02987686|Infliximab|infliximab|mesh-list
1757657|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
1757658|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1757659|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1757669|NCT02970318|Rituximab|rituximab|mesh-list
1757670|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1757671|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
1757672|NCT02970318|Idelalisib|idelalisib|mesh-list
1757673|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757674|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757675|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
1757676|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757677|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1757678|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1757679|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
1757680|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757681|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757695|NCT02963064|Antibodies|antibodies|mesh-list
1757696|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1757697|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
1757698|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757725|NCT02960230|Nivolumab|nivolumab|mesh-list
1757726|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757727|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757728|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1757729|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757754|NCT02909686|Curcumin|curcumin|mesh-list
1757755|NCT02909686|Resveratrol|resveratrol|mesh-list
1757756|NCT02909686|Pycnogenols|pycnogenols|mesh-list
1757757|NCT02909686|Turmeric extract|turmeric extract|mesh-list
1757758|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1757759|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1757760|NCT02909686|Analgesics|analgesics|mesh-ancestor
1757761|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
1757762|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1757763|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757764|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1757765|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1757766|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757767|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757768|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757769|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
1757770|NCT02909686|Protective Agents|protective agents|mesh-ancestor
1757771|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1757772|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1757773|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
1757774|NCT02867813|Evolocumab|evolocumab|mesh-list
1757775|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1757776|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1757777|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
1757778|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757779|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1757780|NCT02865928|Bupivacaine|bupivacaine|mesh-list
1757781|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
1757782|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
1757783|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1757784|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757785|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
1757786|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1757821|NCT02860091|Ropivacaine|ropivacaine|mesh-list
1757822|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
1757823|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
1757824|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1757825|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757826|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
1757827|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1757915|NCT02825641|Oxytocin|oxytocin|mesh-list
1757916|NCT02825641|Dinoprostone|dinoprostone|mesh-list
1757917|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
1757918|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1757919|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757920|NCT02824952|Osimertinib|osimertinib|mesh-list
1757921|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757922|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1757923|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1757924|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757929|NCT02812420|Durvalumab|durvalumab|mesh-list
1757930|NCT02812420|Ipilimumab|ipilimumab|mesh-list
1757931|NCT02812420|Tremelimumab|tremelimumab|mesh-list
1757932|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
1757933|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1757934|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
1757935|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757936|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757937|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
1757938|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757939|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1757940|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757941|NCT02780609|Dexamethasone|dexamethasone|mesh-list
1757942|NCT02780609|Melphalan|melphalan|mesh-list
1757943|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
1757944|NCT02780609|Aprepitant|aprepitant|mesh-list
1757945|NCT02780609|Antiemetics|antiemetics|mesh-list
1757946|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1757947|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
1757948|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1757949|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757950|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1757951|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
1757952|NCT02780609|Hormones|hormones|mesh-ancestor
1757953|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1757954|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1757955|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1757956|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1757957|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
1757958|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1757959|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1757960|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1757961|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
1757962|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1757963|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1757973|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
1757974|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1757975|NCT02730325|Antibodies|antibodies|mesh-list
1757976|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
1757977|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1757986|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
1757987|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1757988|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758007|NCT02532257|Rituximab|rituximab|mesh-list
1758008|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1758009|NCT02532257|Lenalidomide|lenalidomide|mesh-list
1758010|NCT02532257|Antibodies|antibodies|mesh-list
1758011|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
1758012|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1758013|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
1758014|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758015|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758016|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1758017|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1758018|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1758019|NCT02532257|Growth Substances|growth substances|mesh-ancestor
1758020|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
1758021|NCT02514382|Dexamethasone|dexamethasone|mesh-list
1758022|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
1758023|NCT02514382|Bortezomib|bortezomib|mesh-list
1758024|NCT02514382|Ichthammol|ichthammol|mesh-list
1758025|NCT02514382|BB 1101|bb 1101|mesh-list
1758026|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1758027|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
1758028|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
1758029|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1758030|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758031|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1758032|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
1758033|NCT02514382|Hormones|hormones|mesh-ancestor
1758034|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1758035|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1758036|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758037|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
1758038|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758039|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758040|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
1758041|NCT02512692|Gemcitabine|gemcitabine|mesh-list
1758042|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758043|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1758044|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
1758045|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758046|NCT02512692|Antiviral Agents|antiviral agents|mesh-ancestor
1758047|NCT02512692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1758048|NCT02512692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758049|NCT02512692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1758050|NCT02512692|Immunologic Factors|immunologic factors|mesh-ancestor
1758051|NCT02512692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758089|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
1758090|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1758091|NCT02460445|Cyproterone|cyproterone|mesh-list
1758092|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1758093|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1758094|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1758095|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
1758096|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1758097|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758098|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1758099|NCT02460445|Estrogens|estrogens|mesh-ancestor
1758100|NCT02460445|Hormones|hormones|mesh-ancestor
1758101|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1758102|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
1758103|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
1758104|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758105|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1758106|NCT02432404|NuvaRing|nuvaring|mesh-list
1758107|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1758108|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
1758109|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1758110|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758126|NCT02429557|Midodrine|midodrine|mesh-list
1758127|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
1758128|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
1758129|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1758130|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758131|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1758132|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1758133|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1758134|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1758135|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
1758136|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1758137|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758138|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
1758139|NCT02419495|Leucovorin|leucovorin|mesh-list
1758140|NCT02419495|Folic Acid|folic acid|mesh-list
1758141|NCT02419495|Paclitaxel|paclitaxel|mesh-list
1758142|NCT02419495|Camptothecin|camptothecin|mesh-list
1758143|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
1758144|NCT02419495|Carboplatin|carboplatin|mesh-list
1758145|NCT02419495|Doxorubicin|doxorubicin|mesh-list
1758146|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1758147|NCT02419495|Fluorouracil|fluorouracil|mesh-list
1758148|NCT02419495|Capecitabine|capecitabine|mesh-list
1758149|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
1758150|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
1758151|NCT02419495|Nivolumab|nivolumab|mesh-list
1758152|NCT02419495|Irinotecan|irinotecan|mesh-list
1758153|NCT02419495|Pemetrexed|pemetrexed|mesh-list
1758154|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1758155|NCT02419495|Ipilimumab|ipilimumab|mesh-list
1758156|NCT02419495|Topotecan|topotecan|mesh-list
1758157|NCT02419495|Daunorubicin|daunorubicin|mesh-list
1758158|NCT02419495|Olaparib|olaparib|mesh-list
1758159|NCT02419495|Calcium|calcium|mesh-list
1758160|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
1758161|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1758162|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758163|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
1758164|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
1758165|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
1758166|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758167|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1758168|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
1758169|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758170|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1758171|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1758172|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
1758173|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1758174|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1758175|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1758176|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1758177|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758178|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1758179|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1758180|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
1758181|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1758182|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1758183|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1758184|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1758185|NCT02419495|Antidotes|antidotes|mesh-ancestor
1758186|NCT02419495|Protective Agents|protective agents|mesh-ancestor
1758187|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
1758188|NCT02419495|Vitamins|vitamins|mesh-ancestor
1758189|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
1758190|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1758191|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1758192|NCT02419495|Hematinics|hematinics|mesh-ancestor
1758193|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1758194|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
1758195|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1758196|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758232|NCT02247349|Nivolumab|nivolumab|mesh-list
1758233|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1758234|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758235|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1758236|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758237|NCT02214407|Decitabine|decitabine|mesh-list
1758238|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
1758239|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1758240|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
1758241|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758242|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758243|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758244|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
1758245|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1758246|NCT02142803|Bevacizumab|bevacizumab|mesh-list
1758247|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1758248|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
1758249|NCT02142803|Antibodies|antibodies|mesh-list
1758250|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
1758251|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1758252|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
1758253|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758254|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1758255|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1758256|NCT02142803|Growth Substances|growth substances|mesh-ancestor
1758257|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758258|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
1758259|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
1758273|NCT02101775|Gemcitabine|gemcitabine|mesh-list
1758274|NCT02101775|Adavosertib|adavosertib|mesh-list
1758275|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1758276|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
1758277|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758278|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758279|NCT02101775|Antiviral Agents|antiviral agents|mesh-ancestor
1758280|NCT02101775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1758281|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758282|NCT02101775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1758283|NCT02101775|Immunologic Factors|immunologic factors|mesh-ancestor
1758284|NCT02101775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758287|NCT02017717|Bevacizumab|bevacizumab|mesh-list
1758288|NCT02017717|Nivolumab|nivolumab|mesh-list
1758289|NCT02017717|Ipilimumab|ipilimumab|mesh-list
1758290|NCT02017717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1758291|NCT02017717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758292|NCT02017717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1758293|NCT02017717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1758294|NCT02017717|Growth Substances|growth substances|mesh-ancestor
1758295|NCT02017717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758296|NCT02017717|Growth Inhibitors|growth inhibitors|mesh-ancestor
1758297|NCT02017717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1758298|NCT02017717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758299|NCT02008656|Leucovorin|leucovorin|mesh-list
1758300|NCT02008656|Fluorouracil|fluorouracil|mesh-list
1758301|NCT02008656|Capecitabine|capecitabine|mesh-list
1758302|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
1758303|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
1758304|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758305|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1758306|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758307|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1758308|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
1758309|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758310|NCT02008656|Antidotes|antidotes|mesh-ancestor
1758311|NCT02008656|Protective Agents|protective agents|mesh-ancestor
1758312|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
1758313|NCT02008656|Vitamins|vitamins|mesh-ancestor
1758314|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
1758322|NCT01982630|Liraglutide|liraglutide|mesh-list
1758323|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1758324|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758325|NCT01982630|Incretins|incretins|mesh-ancestor
1758326|NCT01982630|Hormones|hormones|mesh-ancestor
1758327|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1758352|NCT01899989|Carboplatin|carboplatin|mesh-list
1758353|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758354|NCT01869114|Sirolimus|sirolimus|mesh-list
1758355|NCT01869114|Azacitidine|azacitidine|mesh-list
1758356|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1758357|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
1758358|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758359|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758360|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758361|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1758362|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1758363|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1758364|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
1758365|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1758366|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
1758367|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758400|NCT01786265|Prednisone|prednisone|mesh-list
1758401|NCT01786265|Cortisone|cortisone|mesh-list
1758402|NCT01786265|Leuprolide|leuprolide|mesh-list
1758403|NCT01786265|Goserelin|goserelin|mesh-list
1758404|NCT01786265|Flutamide|flutamide|mesh-list
1758405|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
1758406|NCT01786265|Bicalutamide|bicalutamide|mesh-list
1758407|NCT01786265|Nilutamide|nilutamide|mesh-list
1758408|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1758409|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
1758410|NCT01786265|Hormones|hormones|mesh-ancestor
1758411|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1758412|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758413|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1758414|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758415|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1758416|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
1758417|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1758418|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1758419|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758420|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758421|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
1758422|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1758423|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
1758437|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1758466|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1758467|NCT01594398|Exemestane|exemestane|mesh-list
1758468|NCT01594398|Entinostat|entinostat|mesh-list
1758469|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758470|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1758471|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758472|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758473|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1758474|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1758475|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1758476|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
1758477|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1758478|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758479|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1758489|NCT01573429|Bisphenol A|bisphenol a|mesh-list
1758490|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1758491|NCT01573429|Estrogens|estrogens|mesh-ancestor
1758492|NCT01573429|Hormones|hormones|mesh-ancestor
1758493|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1758494|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758495|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1758496|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
1758497|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758498|NCT01573429|Protective Agents|protective agents|mesh-ancestor
1758513|NCT01478542|Rituximab|rituximab|mesh-list
1758514|NCT01478542|Vincristine|vincristine|mesh-list
1758515|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1758516|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758517|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
1758518|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758519|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1758520|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1758521|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
1758522|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
1758523|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
1758524|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758544|NCT01408082|Azithromycin|azithromycin|mesh-list
1758545|NCT01408082|Dexamethasone|dexamethasone|mesh-list
1758546|NCT01408082|Dexamethasone acetate|dexamethasone acetate|mesh-list
1758547|NCT01408082|BB 1101|bb 1101|mesh-list
1758548|NCT01408082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1758549|NCT01408082|Antiemetics|antiemetics|mesh-ancestor
1758550|NCT01408082|Autonomic Agents|autonomic agents|mesh-ancestor
1758551|NCT01408082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1758552|NCT01408082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758553|NCT01408082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1758554|NCT01408082|Glucocorticoids|glucocorticoids|mesh-ancestor
1758555|NCT01408082|Hormones|hormones|mesh-ancestor
1758556|NCT01408082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1758557|NCT01408082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1758558|NCT01408082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758559|NCT01408082|Protease Inhibitors|protease inhibitors|mesh-ancestor
1758560|NCT01408082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758561|NCT01408082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758562|NCT01408082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1758563|NCT01408082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1758608|NCT00819221|Doxorubicin|doxorubicin|mesh-list
1758609|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1758610|NCT00819221|Olaparib|olaparib|mesh-list
1758611|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1758612|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758613|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1758614|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1758615|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758616|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758617|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1758618|NCT00807651|Insulin|insulin|mesh-list
1758619|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1758620|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1758621|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758631|NCT00700791|Vitamins|vitamins|mesh-list
1758632|NCT00700791|Vitamin E|vitamin e|mesh-list
1758633|NCT00700791|Tocopherols|tocopherols|mesh-list
1758634|NCT00700791|Tocotrienols|tocotrienols|mesh-list
1758635|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
1758636|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
1758637|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758638|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
1758639|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758640|NCT00700791|Protective Agents|protective agents|mesh-ancestor
1758641|NCT00578955|Azithromycin|azithromycin|mesh-list
1758642|NCT00578955|Dexamethasone|dexamethasone|mesh-list
1758643|NCT00578955|Dexamethasone acetate|dexamethasone acetate|mesh-list
1758644|NCT00578955|BB 1101|bb 1101|mesh-list
1758645|NCT00578955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1758646|NCT00578955|Antiemetics|antiemetics|mesh-ancestor
1758647|NCT00578955|Autonomic Agents|autonomic agents|mesh-ancestor
1758648|NCT00578955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1758649|NCT00578955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758650|NCT00578955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1758651|NCT00578955|Glucocorticoids|glucocorticoids|mesh-ancestor
1758652|NCT00578955|Hormones|hormones|mesh-ancestor
1758653|NCT00578955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1758654|NCT00578955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1758655|NCT00578955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758656|NCT00578955|Protease Inhibitors|protease inhibitors|mesh-ancestor
1758657|NCT00578955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758658|NCT00578955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758659|NCT00578955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1758660|NCT00578955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1758684|NCT00452023|Interferons|interferons|mesh-list
1758685|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
1758686|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
1758687|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1758688|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758689|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
1758690|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1758691|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
1758692|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758786|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
1758787|NCT05129748|Mannitol|mannitol|mesh-list
1758788|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1758789|NCT05129748|Diuretics|diuretics|mesh-ancestor
1758790|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
1758791|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758792|NCT05129748|Antidotes|antidotes|mesh-ancestor
1758793|NCT05129748|Protective Agents|protective agents|mesh-ancestor
1758794|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
1758795|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758796|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
1758797|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1758798|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1758799|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
1758800|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
1758801|NCT05129722|Empagliflozin|empagliflozin|mesh-list
1758802|NCT05129722|Eplerenone|eplerenone|mesh-list
1758803|NCT05129722|Bumetanide|bumetanide|mesh-list
1758804|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1758805|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758806|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1758807|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758808|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1758809|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
1758810|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1758811|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1758812|NCT05129722|Diuretics|diuretics|mesh-ancestor
1758813|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
1758814|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1758815|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1758816|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1758817|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
1758818|NCT05129670|Antacids|antacids|mesh-ancestor
1758819|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758820|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1758836|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
1758837|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1758838|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758839|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1758840|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
1758841|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1758842|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1758843|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758844|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758845|NCT05129332|Vitamin E|vitamin e|mesh-list
1758846|NCT05129332|Vitamins|vitamins|mesh-ancestor
1758847|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
1758848|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758849|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
1758850|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758851|NCT05129332|Protective Agents|protective agents|mesh-ancestor
1758868|NCT05129137|Acetaminophen|acetaminophen|mesh-list
1758869|NCT05129137|Nefopam|nefopam|mesh-list
1758870|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1758871|NCT05129137|Analgesics|analgesics|mesh-ancestor
1758872|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
1758873|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1758874|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758875|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
1758876|NCT05129085|Dexamethasone|dexamethasone|mesh-list
1758877|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1758878|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
1758879|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
1758880|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1758881|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758882|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1758883|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
1758884|NCT05129085|Hormones|hormones|mesh-ancestor
1758885|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1758886|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1758887|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758888|NCT05129033|Omalizumab|omalizumab|mesh-list
1758889|NCT05129033|Itraconazole|itraconazole|mesh-list
1758890|NCT05129033|Prednisone|prednisone|mesh-list
1758891|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1758892|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
1758893|NCT05129033|Hormones|hormones|mesh-ancestor
1758894|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1758895|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758896|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1758897|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758898|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
1758899|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1758900|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1758901|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1758902|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758903|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758904|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1758905|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
1758906|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1758907|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1758908|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1758909|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
1758910|NCT05128916|Terbinafine|terbinafine|mesh-list
1758911|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
1758912|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1758913|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758914|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758925|NCT05128734|Temozolomide|temozolomide|mesh-list
1758926|NCT05128734|Olaparib|olaparib|mesh-list
1758927|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1758928|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
1758929|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758930|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758931|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1758932|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758933|NCT05128721|Vaccines|vaccines|mesh-list
1758934|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
1758935|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758936|NCT05128630|Durvalumab|durvalumab|mesh-list
1758937|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1758938|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758977|NCT05126784|Denosumab|denosumab|mesh-list
1758978|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1758979|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758980|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
1758981|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
1758982|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
1758983|NCT05126511|Hormones|hormones|mesh-ancestor
1758984|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1758985|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1758986|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1758987|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1758988|NCT05121350|Epirubicin|epirubicin|mesh-list
1758989|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1758990|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1758991|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1758992|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1758993|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1758994|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759000|NCT05117736|Valsartan|valsartan|mesh-list
1759001|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1759002|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1759003|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1759004|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759012|NCT05097794|Indapamide|indapamide|mesh-list
1759013|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1759014|NCT05097794|Diuretics|diuretics|mesh-ancestor
1759015|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
1759016|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759017|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1759018|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1759019|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759031|NCT05086692|Interleukin-2|interleukin-2|mesh-list
1759032|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759033|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1759034|NCT05086692|Analgesics|analgesics|mesh-ancestor
1759035|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
1759036|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1759037|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759047|NCT05073562|Folic Acid|folic acid|mesh-list
1759048|NCT05073562|Mebendazole|mebendazole|mesh-list
1759049|NCT05073562|Piperazine|piperazine|mesh-list
1759050|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
1759051|NCT05073562|DMP 777|dmp 777|mesh-list
1759052|NCT05073562|Hematinics|hematinics|mesh-ancestor
1759053|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
1759054|NCT05073562|Vitamins|vitamins|mesh-ancestor
1759055|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
1759056|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759057|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
1759058|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
1759059|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1759060|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1759061|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
1759062|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
1759063|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
1759064|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759065|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759066|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1759125|NCT05032807|Cannabidiol|cannabidiol|mesh-list
1759126|NCT05032807|Anticonvulsants|anticonvulsants|mesh-ancestor
1759152|NCT05023070|Cannabidiol|cannabidiol|mesh-list
1759153|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
1759216|NCT04975997|Dexamethasone|dexamethasone|mesh-list
1759217|NCT04975997|Dexamethasone acetate|dexamethasone acetate|mesh-list
1759218|NCT04975997|Bortezomib|bortezomib|mesh-list
1759219|NCT04975997|Daratumumab|daratumumab|mesh-list
1759220|NCT04975997|BB 1101|bb 1101|mesh-list
1759221|NCT04975997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1759222|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1759223|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
1759224|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
1759225|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1759226|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759227|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1759228|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
1759229|NCT04975997|Hormones|hormones|mesh-ancestor
1759230|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1759231|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1759232|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759233|NCT04975997|Protease Inhibitors|protease inhibitors|mesh-ancestor
1759234|NCT04975997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1759235|NCT04975997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759236|NCT04975997|Immunologic Factors|immunologic factors|mesh-ancestor
1759237|NCT04969731|Gemcitabine|gemcitabine|mesh-list
1759238|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1759239|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
1759240|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759241|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759242|NCT04969731|Antiviral Agents|antiviral agents|mesh-ancestor
1759243|NCT04969731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1759244|NCT04969731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1759245|NCT04969731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1759246|NCT04969731|Immunologic Factors|immunologic factors|mesh-ancestor
1759247|NCT04969731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759248|NCT04965155|Dexamethasone|dexamethasone|mesh-list
1759249|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1759250|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
1759251|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
1759252|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1759253|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759254|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1759255|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
1759256|NCT04965155|Hormones|hormones|mesh-ancestor
1759257|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1759258|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1759259|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759649|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
1759289|NCT04955938|Ivosidenib|ivosidenib|mesh-list
1759290|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759291|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1759292|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759296|NCT04945655|Vaccines|vaccines|mesh-list
1759297|NCT04945655|Immunologic Factors|immunologic factors|mesh-ancestor
1759298|NCT04945655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759349|NCT04930991|Omeprazole|omeprazole|mesh-list
1759350|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1759351|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1759352|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1759353|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1759354|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759355|NCT04928222|Doxorubicin|doxorubicin|mesh-list
1759356|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1759357|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759358|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1759359|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1759360|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1759361|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759391|NCT04898894|Vidarabine|vidarabine|mesh-list
1759392|NCT04898894|Cytarabine|cytarabine|mesh-list
1759393|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
1759394|NCT04898894|Methotrexate|methotrexate|mesh-list
1759395|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
1759396|NCT04898894|Fludarabine|fludarabine|mesh-list
1759397|NCT04898894|Venetoclax|venetoclax|mesh-list
1759398|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1759399|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
1759400|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1759401|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759402|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1759403|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
1759404|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759405|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759406|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
1759407|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1759408|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1759409|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1759410|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
1759411|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1759412|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1759413|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
1759414|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1759415|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1759423|NCT04892043|Nivolumab|nivolumab|mesh-list
1759424|NCT04892043|Ipilimumab|ipilimumab|mesh-list
1759425|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1759426|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759427|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1759428|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759453|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
1759454|NCT04862221|Promethazine|promethazine|mesh-list
1759455|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
1759456|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1759457|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1759458|NCT04862221|Prednisolone|prednisolone|mesh-list
1759459|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
1759460|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1759461|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
1759462|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1759463|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1759464|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
1759465|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
1759466|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1759467|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759468|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1759469|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
1759470|NCT04862221|Hormones|hormones|mesh-ancestor
1759471|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1759472|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1759473|NCT04862221|Protective Agents|protective agents|mesh-ancestor
1759474|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1759475|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759476|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
1759477|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1759478|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1759479|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1759480|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1759481|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
1759482|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
1759483|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
1759484|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1759485|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
1759486|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
1759487|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1759488|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759489|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1759490|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
1759491|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
1759492|NCT04862143|Fulvestrant|fulvestrant|mesh-list
1759493|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1759494|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759495|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1759496|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1759497|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
1759498|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1759499|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759574|NCT04794790|Buprenorphine|buprenorphine|mesh-list
1759575|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1759576|NCT04794790|Naloxone|naloxone|mesh-list
1759577|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1759578|NCT04794790|Narcotics|narcotics|mesh-ancestor
1759579|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1759580|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759581|NCT04794790|Analgesics|analgesics|mesh-ancestor
1759582|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
1759583|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1759584|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1759585|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1759586|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759587|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759608|NCT04779216|Alendronate|alendronate|mesh-list
1759609|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1759610|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759619|NCT04773184|Capsaicin|capsaicin|mesh-list
1759620|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
1759621|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
1759622|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
1759623|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1759624|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759637|NCT04765371|Dexamethasone|dexamethasone|mesh-list
1759638|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
1759639|NCT04765371|Prednisolone|prednisolone|mesh-list
1759640|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1759641|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
1759642|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1759643|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
1759644|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1759645|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
1759646|NCT04765371|BB 1101|bb 1101|mesh-list
1759647|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1759648|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
1759650|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1759651|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759652|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1759653|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
1759654|NCT04765371|Hormones|hormones|mesh-ancestor
1759655|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1759656|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1759657|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759658|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
1759659|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1759660|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759661|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1759662|NCT04765371|Protective Agents|protective agents|mesh-ancestor
1759726|NCT04739995|Naltrexone|naltrexone|mesh-list
1759727|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1759728|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1759729|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759730|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
1759731|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1759789|NCT04710641|Sorafenib|sorafenib|mesh-list
1759790|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759791|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1759792|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1759793|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759809|NCT04660812|Bevacizumab|bevacizumab|mesh-list
1759810|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1759811|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759812|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1759813|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1759814|NCT04660812|Growth Substances|growth substances|mesh-ancestor
1759815|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759816|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
1759869|NCT04591431|Nivolumab|nivolumab|mesh-list
1759870|NCT04591431|Trastuzumab|trastuzumab|mesh-list
1759871|NCT04591431|Ipilimumab|ipilimumab|mesh-list
1759872|NCT04591431|Pertuzumab|pertuzumab|mesh-list
1759873|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1759874|NCT04591431|Everolimus|everolimus|mesh-list
1759875|NCT04591431|Atezolizumab|atezolizumab|mesh-list
1759876|NCT04591431|Lapatinib|lapatinib|mesh-list
1759877|NCT04591431|Palbociclib|palbociclib|mesh-list
1759878|NCT04591431|Vemurafenib|vemurafenib|mesh-list
1759879|NCT04591431|Maytansine|maytansine|mesh-list
1759880|NCT04591431|Ponatinib|ponatinib|mesh-list
1759881|NCT04591431|Entrectinib|entrectinib|mesh-list
1759882|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1759883|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759884|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1759885|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759886|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1759887|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
1759888|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759889|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1759890|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1759891|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1759892|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
1759893|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
1759894|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
1759932|NCT04562129|Aldesleukin|aldesleukin|mesh-list
1759933|NCT04562129|Nivolumab|nivolumab|mesh-list
1759934|NCT04562129|Ipilimumab|ipilimumab|mesh-list
1759935|NCT04562129|Interleukin-2|interleukin-2|mesh-list
1759936|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1759937|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759938|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1759939|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1759940|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1759941|NCT04562129|Analgesics|analgesics|mesh-ancestor
1759942|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
1759943|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1759944|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1759945|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1759946|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1759947|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
1759948|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1759949|NCT04548648|Isavuconazole|isavuconazole|mesh-list
1759950|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
1759951|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759952|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
1759953|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1759971|NCT04477759|Atezolizumab|atezolizumab|mesh-list
1759972|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1759995|NCT04437888|Ketamine|ketamine|mesh-list
1759996|NCT04437888|Analgesics|analgesics|mesh-ancestor
1759997|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
1759998|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1759999|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760000|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1760001|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1760002|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
1760003|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
1760004|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1760005|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1760006|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1760007|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1760008|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760009|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1760010|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1760011|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1760012|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760064|NCT04405674|Paclitaxel|paclitaxel|mesh-list
1760065|NCT04405674|Bevacizumab|bevacizumab|mesh-list
1760066|NCT04405674|Carboplatin|carboplatin|mesh-list
1760067|NCT04405674|Pemetrexed|pemetrexed|mesh-list
1760068|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1760069|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760070|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
1760071|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
1760072|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
1760073|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760074|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1760075|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1760076|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1760077|NCT04405674|Growth Substances|growth substances|mesh-ancestor
1760078|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760079|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
1760080|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1760081|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1760082|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1760122|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
1760123|NCT04370509|Axitinib|axitinib|mesh-list
1760124|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1760125|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760126|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1760127|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1760128|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760129|NCT04366518|Scopolamine|scopolamine|mesh-list
1760130|NCT04366518|Rivastigmine|rivastigmine|mesh-list
1760131|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
1760132|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1760133|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1760134|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760135|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
1760136|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1760137|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760138|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1760139|NCT04366518|Protective Agents|protective agents|mesh-ancestor
1760140|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1760141|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
1760142|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
1760143|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1760144|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1760145|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
1760146|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1760147|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1760148|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
1760149|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
1760150|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1760151|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1760152|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760153|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
1760154|NCT04360629|Coagulants|coagulants|mesh-ancestor
1760183|NCT04330664|Adagrasib|adagrasib|mesh-list
1760184|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760252|NCT04237649|Spartalizumab|spartalizumab|mesh-list
1760253|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1760254|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760255|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760256|NCT04230148|Triclabendazole|triclabendazole|mesh-list
1760257|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1760258|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
1760259|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1760260|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1760261|NCT04227314|Apremilast|apremilast|mesh-list
1760262|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1760413|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
1760263|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1760264|NCT04227314|Analgesics|analgesics|mesh-ancestor
1760265|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
1760266|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1760267|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760268|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1760269|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1760270|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1760271|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1760272|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1760273|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760274|NCT04223648|Nivolumab|nivolumab|mesh-list
1760275|NCT04223648|Ipilimumab|ipilimumab|mesh-list
1760276|NCT04223648|Durvalumab|durvalumab|mesh-list
1760277|NCT04223648|Tremelimumab|tremelimumab|mesh-list
1760278|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1760279|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760280|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1760281|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760282|NCT04220775|Atezolizumab|atezolizumab|mesh-list
1760283|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760284|NCT04218708|Nicotine|nicotine|mesh-list
1760285|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1760286|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
1760287|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1760288|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760289|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1760290|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1760291|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
1760292|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1760293|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760294|NCT04215146|Paclitaxel|paclitaxel|mesh-list
1760295|NCT04215146|Avelumab|avelumab|mesh-list
1760296|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1760297|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760298|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
1760299|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
1760300|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
1760301|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760302|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1760308|NCT04212013|Rituximab|rituximab|mesh-list
1760309|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1760310|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760311|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
1760312|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760313|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1760397|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
1760398|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
1760399|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1760400|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1760401|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760402|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1760403|NCT04113720|Analgesics|analgesics|mesh-ancestor
1760404|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
1760405|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1760406|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1760407|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1760408|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1760409|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
1760410|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1760411|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760412|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
1760423|NCT04094675|Sirolimus|sirolimus|mesh-list
1760424|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1760425|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1760426|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1760427|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760428|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
1760429|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1760430|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
1760431|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760460|NCT04092270|Doxorubicin|doxorubicin|mesh-list
1760461|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1760462|NCT04092270|Peposertib|peposertib|mesh-list
1760463|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1760464|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760465|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1760466|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1760467|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1760468|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760469|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1760485|NCT04076748|Sufentanil|sufentanil|mesh-list
1760486|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1760487|NCT04076748|Narcotics|narcotics|mesh-ancestor
1760488|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1760489|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760490|NCT04076748|Analgesics|analgesics|mesh-ancestor
1760491|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
1760492|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1760493|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1760494|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1760495|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
1760496|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
1760497|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
1760498|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1760499|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1760500|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1760501|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1760502|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1760503|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760504|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
1760505|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1760506|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760507|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1760508|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1760517|NCT04047862|Paclitaxel|paclitaxel|mesh-list
1760518|NCT04047862|Etoposide|etoposide|mesh-list
1760519|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1760520|NCT04047862|Carboplatin|carboplatin|mesh-list
1760521|NCT04047862|Fluorouracil|fluorouracil|mesh-list
1760522|NCT04047862|Capecitabine|capecitabine|mesh-list
1760523|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
1760524|NCT04047862|Pemetrexed|pemetrexed|mesh-list
1760525|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1760526|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760527|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
1760528|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
1760529|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
1760530|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760531|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
1760532|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1760533|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1760534|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
1760535|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760536|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1760537|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1760538|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1760539|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1760540|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1760549|NCT04040790|Phenylephrine|phenylephrine|mesh-list
1760550|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
1760551|NCT04040790|Tropicamide|tropicamide|mesh-list
1760552|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1760553|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
1760554|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
1760555|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1760556|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760557|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
1760558|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1760559|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
1760560|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
1760561|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1760562|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1760563|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1760564|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
1760565|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1760566|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760567|NCT04040790|Protective Agents|protective agents|mesh-ancestor
1760568|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1760569|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1760570|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
1760571|NCT04038489|Aspirin|aspirin|mesh-list
1760572|NCT04038489|Tamoxifen|tamoxifen|mesh-list
1760573|NCT04038489|Paclitaxel|paclitaxel|mesh-list
1760574|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
1760575|NCT04038489|Doxorubicin|doxorubicin|mesh-list
1760576|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1760577|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760578|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
1760579|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
1760580|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
1760581|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760582|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1760583|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
1760584|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760585|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1760586|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1760587|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
1760588|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1760589|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1760590|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1760591|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1760592|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1760593|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1760594|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1760595|NCT04038489|Analgesics|analgesics|mesh-ancestor
1760596|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
1760597|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1760598|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1760599|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1760600|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1760601|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1760602|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1760603|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
1760604|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1760605|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
1760606|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1760607|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1760608|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1760609|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1760610|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1760685|NCT03956368|Atorvastatin|atorvastatin|mesh-list
1760686|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1760687|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1760688|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
1760689|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760690|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1760691|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1760692|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1760704|NCT03933007|Fexofenadine|fexofenadine|mesh-list
1760705|NCT03933007|Colchicine|colchicine|mesh-list
1760706|NCT03933007|Midazolam|midazolam|mesh-list
1760707|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1760708|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1760709|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1760710|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760711|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1760712|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1760713|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1760714|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1760715|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
1760716|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
1760717|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
1760718|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
1760719|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1760720|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760721|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
1760722|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1760723|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
1760724|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
1760725|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
1760726|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760727|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1760728|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1760729|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1760730|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
1760731|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
1760734|NCT03923270|Durvalumab|durvalumab|mesh-list
1760735|NCT03923270|Olaparib|olaparib|mesh-list
1760736|NCT03923270|Tremelimumab|tremelimumab|mesh-list
1760737|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1760738|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1760739|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760740|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1760741|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1760742|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760743|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
1760744|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760765|NCT03921060|Denosumab|denosumab|mesh-list
1760766|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1760767|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760828|NCT03875287|Decitabine|decitabine|mesh-list
1760829|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1760830|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
1760831|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760832|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760833|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1760877|NCT03805581|Defibrotide|defibrotide|mesh-list
1760878|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1760879|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1760880|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760881|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1760896|NCT03791593|Evolocumab|evolocumab|mesh-list
1760897|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1760898|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1760899|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
1760900|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760901|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1760932|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
1760933|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1760934|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1760939|NCT03715465|Melatonin|melatonin|mesh-list
1760940|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
1760941|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760942|NCT03715465|Protective Agents|protective agents|mesh-ancestor
1760943|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1760944|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1760987|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
1760988|NCT03682536|Luspatercept|luspatercept|mesh-list
1760989|NCT03682536|Hematinics|hematinics|mesh-ancestor
1760994|NCT03665506|Trifluridine|trifluridine|mesh-list
1760995|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
1760996|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1760997|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
1760998|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1761063|NCT03630809|Vaccines|vaccines|mesh-list
1761064|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
1761065|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761079|NCT03598309|Curcumin|curcumin|mesh-list
1761080|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1761081|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1761082|NCT03598309|Analgesics|analgesics|mesh-ancestor
1761083|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
1761084|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1761085|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761086|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1761087|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1761088|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761089|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1761090|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761111|NCT03559647|Atezolizumab|atezolizumab|mesh-list
1761112|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761113|NCT03528694|Durvalumab|durvalumab|mesh-list
1761114|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
1761115|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1761116|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761117|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1761118|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
1761119|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761120|NCT03519971|Paclitaxel|paclitaxel|mesh-list
1761121|NCT03519971|Etoposide|etoposide|mesh-list
1761122|NCT03519971|Cisplatin|cisplatin|mesh-list
1761123|NCT03519971|Carboplatin|carboplatin|mesh-list
1761124|NCT03519971|Pemetrexed|pemetrexed|mesh-list
1761125|NCT03519971|Durvalumab|durvalumab|mesh-list
1761126|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1761127|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761128|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
1761129|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
1761130|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
1761131|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761132|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1761133|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1761134|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1761135|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1761136|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1761137|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1761172|NCT03481556|Dexamethasone|dexamethasone|mesh-list
1761173|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
1761174|NCT03481556|Bortezomib|bortezomib|mesh-list
1761175|NCT03481556|Melphalan|melphalan|mesh-list
1761176|NCT03481556|Daratumumab|daratumumab|mesh-list
1761177|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1761178|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
1761179|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
1761180|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1761181|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761182|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1761183|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
1761184|NCT03481556|Hormones|hormones|mesh-ancestor
1761185|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1761186|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1761187|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761188|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1761189|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
1761190|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761191|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1761192|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1761193|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
1761204|NCT03452137|Atezolizumab|atezolizumab|mesh-list
1761205|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761206|NCT03442556|Carboplatin|carboplatin|mesh-list
1761207|NCT03442556|Docetaxel|docetaxel|mesh-list
1761208|NCT03442556|Rucaparib|rucaparib|mesh-list
1761209|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761210|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
1761211|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
1761212|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
1761213|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761214|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1761215|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1761216|NCT03412643|Paclitaxel|paclitaxel|mesh-list
1761217|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
1761218|NCT03412643|Doxorubicin|doxorubicin|mesh-list
1761219|NCT03412643|Trastuzumab|trastuzumab|mesh-list
1761220|NCT03412643|Pertuzumab|pertuzumab|mesh-list
1761221|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1761222|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761223|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
1761224|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
1761225|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
1761226|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761227|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1761228|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
1761229|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761230|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1761231|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1761232|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
1761233|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1761234|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1761235|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1761236|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1761237|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1761238|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1761239|NCT03397004|Doxycycline|doxycycline|mesh-list
1761240|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1761241|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1761242|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
1761243|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1761244|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1761245|NCT03389022|Ketamine|ketamine|mesh-list
1761246|NCT03389022|Analgesics|analgesics|mesh-ancestor
1761247|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
1761248|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1761249|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761250|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1761251|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1761252|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
1761253|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
1761254|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1761255|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1761256|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1761257|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1761258|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761259|NCT03381183|Durvalumab|durvalumab|mesh-list
1761260|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1761261|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761262|NCT03344159|Spironolactone|spironolactone|mesh-list
1761263|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1761264|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
1761265|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1761266|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761267|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1761268|NCT03344159|Diuretics|diuretics|mesh-ancestor
1761269|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
1761270|NCT03336333|Rituximab|rituximab|mesh-list
1761271|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1761272|NCT03336333|Venetoclax|venetoclax|mesh-list
1761273|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
1761274|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1761275|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761276|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
1761277|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761278|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1761279|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1761280|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
1761281|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761282|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1761283|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1761284|NCT03319459|Trastuzumab|trastuzumab|mesh-list
1761285|NCT03319459|Cetuximab|cetuximab|mesh-list
1761286|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1761287|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761288|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
1761289|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1761290|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
1761291|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761292|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
1761293|NCT03318874|Protective Agents|protective agents|mesh-ancestor
1761309|NCT03310619|Nivolumab|nivolumab|mesh-list
1761310|NCT03310619|Durvalumab|durvalumab|mesh-list
1761311|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1761312|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761313|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1761314|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761318|NCT03269136|Thalidomide|thalidomide|mesh-list
1761319|NCT03269136|Dexamethasone|dexamethasone|mesh-list
1761320|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
1761321|NCT03269136|Lenalidomide|lenalidomide|mesh-list
1761322|NCT03269136|Pomalidomide|pomalidomide|mesh-list
1761323|NCT03269136|Antibodies|antibodies|mesh-list
1761324|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
1761325|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
1761326|NCT03269136|BB 1101|bb 1101|mesh-list
1761327|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
1761328|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761329|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1761330|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
1761331|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
1761332|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1761333|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1761334|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
1761335|NCT03269136|Hormones|hormones|mesh-ancestor
1761336|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1761337|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1761338|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761339|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
1761340|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1761341|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761342|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1761343|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1761344|NCT03269136|Growth Substances|growth substances|mesh-ancestor
1761345|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
1761346|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1761347|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
1761348|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1761349|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1761350|NCT03259698|Tenofovir|tenofovir|mesh-list
1761351|NCT03259698|Emtricitabine|emtricitabine|mesh-list
1761352|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
1761353|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
1761354|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1761355|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1761356|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1761357|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1761358|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761359|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1761360|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1761366|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
1761367|NCT03222531|Velpatasvir|velpatasvir|mesh-list
1761368|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
1761369|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1761410|NCT03137771|Gemcitabine|gemcitabine|mesh-list
1761411|NCT03137771|Docetaxel|docetaxel|mesh-list
1761412|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
1761413|NCT03137771|Pemetrexed|pemetrexed|mesh-list
1761414|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1761415|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1761416|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
1761417|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761418|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761419|NCT03137771|Antiviral Agents|antiviral agents|mesh-ancestor
1761420|NCT03137771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1761421|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1761422|NCT03137771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1761423|NCT03137771|Immunologic Factors|immunologic factors|mesh-ancestor
1761424|NCT03137771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761425|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
1761426|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
1761427|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
1761428|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1761429|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1761430|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1761431|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1761432|NCT03124355|Bromides|bromides|mesh-list
1761433|NCT03124355|Galantamine|galantamine|mesh-list
1761434|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
1761435|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
1761436|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1761437|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1761438|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761439|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
1761440|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1761441|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761442|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1761443|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
1761444|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1761445|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
1761456|NCT03056339|Vidarabine|vidarabine|mesh-list
1761457|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
1761458|NCT03056339|Fludarabine|fludarabine|mesh-list
1761459|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
1761460|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1761461|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
1761462|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761463|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1761464|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1761465|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
1761466|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761467|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761468|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1761469|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1761470|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
1761471|NCT03056339|Antiviral Agents|antiviral agents|mesh-ancestor
1761472|NCT03056339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1761473|NCT03038100|Paclitaxel|paclitaxel|mesh-list
1761474|NCT03038100|Bevacizumab|bevacizumab|mesh-list
1761475|NCT03038100|Carboplatin|carboplatin|mesh-list
1761476|NCT03038100|Atezolizumab|atezolizumab|mesh-list
1761477|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1761478|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1761479|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761480|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
1761481|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
1761482|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
1761483|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761484|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1761485|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1761486|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1761487|NCT03038100|Growth Substances|growth substances|mesh-ancestor
1761488|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761489|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
1761490|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
1761572|NCT02937571|Dexamethasone|dexamethasone|mesh-list
1761573|NCT02937571|Lenalidomide|lenalidomide|mesh-list
1761574|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1761575|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
1761576|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
1761577|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1761578|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761579|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1761580|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
1761581|NCT02937571|Hormones|hormones|mesh-ancestor
1761582|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1761583|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1761584|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761585|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
1761586|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1761587|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1761588|NCT02937571|Growth Substances|growth substances|mesh-ancestor
1761589|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
1761651|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
1761652|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
1761653|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1761663|NCT02648581|Ustekinumab|ustekinumab|mesh-list
1761664|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
1761683|NCT02609815|Metformin|metformin|mesh-list
1761684|NCT02609815|Glimepiride|glimepiride|mesh-list
1761685|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1761686|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761687|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1761688|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1761689|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
1761731|NCT02506959|Gemcitabine|gemcitabine|mesh-list
1761732|NCT02506959|Melphalan|melphalan|mesh-list
1761733|NCT02506959|Busulfan|busulfan|mesh-list
1761734|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
1761735|NCT02506959|Panobinostat|panobinostat|mesh-list
1761736|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1761737|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1761738|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
1761739|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761740|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761741|NCT02506959|Antiviral Agents|antiviral agents|mesh-ancestor
1761742|NCT02506959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1761743|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1761744|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1761745|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
1761746|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761747|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1761748|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
1761749|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1761750|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1761751|NCT02502786|Antibodies|antibodies|mesh-list
1761752|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
1761753|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761793|NCT02464878|Etanercept|etanercept|mesh-list
1761794|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
1761795|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1761796|NCT02464878|Basiliximab|basiliximab|mesh-list
1761797|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1761798|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
1761799|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1761800|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1761801|NCT02464878|Analgesics|analgesics|mesh-ancestor
1761802|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
1761803|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1761804|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761805|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1761806|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1761807|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1761808|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1761809|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
1761810|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1761811|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1761812|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
1761813|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1761814|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761895|NCT02250937|Fludarabine|fludarabine|mesh-list
1761896|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
1761897|NCT02250937|Busulfan|busulfan|mesh-list
1761898|NCT02250937|Venetoclax|venetoclax|mesh-list
1761899|NCT02250937|Cladribine|cladribine|mesh-list
1761900|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
1761901|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761902|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1761903|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
1761904|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761905|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1761906|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
1761907|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761908|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
1761909|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1761910|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1761967|NCT02010606|Bevacizumab|bevacizumab|mesh-list
1761968|NCT02010606|Temozolomide|temozolomide|mesh-list
1761969|NCT02010606|Vaccines|vaccines|mesh-list
1761970|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1761971|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1761972|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1761973|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1761974|NCT02010606|Growth Substances|growth substances|mesh-ancestor
1761975|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761976|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
1761977|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1761978|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
1761979|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761980|NCT02010606|Immunologic Factors|immunologic factors|mesh-ancestor
1761986|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
1761987|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
1761988|NCT02002130|Butyric Acid|butyric acid|mesh-list
1761989|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1761990|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
1761991|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1761992|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
1761993|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1761994|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1761995|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
1761996|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
1762024|NCT01794520|Dexamethasone|dexamethasone|mesh-list
1762025|NCT01794520|Venetoclax|venetoclax|mesh-list
1762026|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1762027|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
1762028|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
1762029|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1762030|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762031|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1762032|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
1762033|NCT01794520|Hormones|hormones|mesh-ancestor
1762034|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1762035|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1762036|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762037|NCT01746836|Ponatinib|ponatinib|mesh-list
1762038|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762039|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1762040|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762041|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762042|NCT01737502|Sirolimus|sirolimus|mesh-list
1762043|NCT01737502|Auranofin|auranofin|mesh-list
1762044|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1762045|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1762046|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1762047|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762048|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
1762049|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1762050|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
1762051|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762052|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1762053|NCT01701986|Gemcitabine|gemcitabine|mesh-list
1762054|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
1762055|NCT01701986|Rituximab|rituximab|mesh-list
1762056|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1762057|NCT01701986|Busulfan|busulfan|mesh-list
1762058|NCT01701986|Clofarabine|clofarabine|mesh-list
1762059|NCT01701986|Antibodies|antibodies|mesh-list
1762060|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
1762061|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1762062|NCT01701986|Tacrolimus|tacrolimus|mesh-list
1762063|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
1762064|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1762065|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
1762066|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762067|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762068|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1762069|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1762070|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
1762071|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762072|NCT01701986|Antiviral Agents|antiviral agents|mesh-ancestor
1762073|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1762074|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762075|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1762076|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1762077|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1762078|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1762079|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
1762080|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1762081|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
1762082|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1762083|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1762131|NCT00754949|Azithromycin|azithromycin|mesh-list
1762132|NCT00754949|Dexamethasone|dexamethasone|mesh-list
1762133|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
1762134|NCT00754949|BB 1101|bb 1101|mesh-list
1762135|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1762136|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
1762137|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
1762138|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1762139|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762140|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1762141|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
1762142|NCT00754949|Hormones|hormones|mesh-ancestor
1762143|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1762144|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1762145|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762146|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
1762147|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762148|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762149|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1762150|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1762233|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
1762234|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1762235|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
1762236|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762237|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1762238|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1762239|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
1762240|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762241|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762242|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1762254|NCT05132023|Metformin|metformin|mesh-list
1762255|NCT05132023|Empagliflozin|empagliflozin|mesh-list
1762256|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1762257|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762258|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1762259|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762269|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
1762270|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
1762271|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762272|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
1762273|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1762274|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762275|NCT05131893|Tamoxifen|tamoxifen|mesh-list
1762276|NCT05131893|Docetaxel|docetaxel|mesh-list
1762277|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
1762278|NCT05131893|Capecitabine|capecitabine|mesh-list
1762279|NCT05131893|Trastuzumab|trastuzumab|mesh-list
1762280|NCT05131893|Letrozole|letrozole|mesh-list
1762281|NCT05131893|Epirubicin|epirubicin|mesh-list
1762282|NCT05131893|Goserelin|goserelin|mesh-list
1762283|NCT05131893|Pertuzumab|pertuzumab|mesh-list
1762284|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762285|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
1762286|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
1762287|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
1762288|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762289|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1762290|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
1762291|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762292|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1762293|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1762294|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
1762295|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1762296|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1762297|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
1762298|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1762299|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1762300|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1762301|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762302|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1762303|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
1762304|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1762305|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1762306|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1762307|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1762308|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1762309|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1762310|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1762311|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1762312|NCT05131867|Nimodipine|nimodipine|mesh-list
1762313|NCT05131867|Milrinone|milrinone|mesh-list
1762314|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1762315|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1762316|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
1762317|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1762318|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1762319|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762320|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762321|NCT05131867|Protective Agents|protective agents|mesh-ancestor
1762322|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762323|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1762324|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1762325|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1762326|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1762327|NCT05131841|Vinorelbine|vinorelbine|mesh-list
1762328|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1762329|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762330|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
1762331|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
1762332|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
1762333|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762334|NCT05131828|Metformin|metformin|mesh-list
1762335|NCT05131828|Clemastine|clemastine|mesh-list
1762336|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1762337|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762338|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
1762339|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
1762340|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1762341|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
1762342|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
1762343|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1762344|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762345|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1762351|NCT05131646|Axitinib|axitinib|mesh-list
1762352|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762353|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1762354|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762355|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762356|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
1762357|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
1762358|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762359|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
1762360|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
1762361|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1762362|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762368|NCT05131295|Dapsone|dapsone|mesh-list
1762369|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
1762370|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1762371|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
1762372|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1762373|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1762374|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1762375|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762376|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762377|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
1762378|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1762379|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1762380|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
1762381|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762382|NCT05131295|Antacids|antacids|mesh-ancestor
1762383|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1762384|NCT05131204|Eculizumab|eculizumab|mesh-list
1762385|NCT05131204|Ravulizumab|ravulizumab|mesh-list
1762386|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1762387|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1762388|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
1762389|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762390|NCT05131178|Bupivacaine|bupivacaine|mesh-list
1762391|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
1762392|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
1762393|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1762394|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762395|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
1762396|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1762417|NCT05130892|Tranilast|tranilast|mesh-list
1762418|NCT05130892|Colchicine|colchicine|mesh-list
1762419|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
1762420|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1762421|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
1762422|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
1762423|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
1762424|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762425|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762426|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1762427|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1762428|NCT05130892|Analgesics|analgesics|mesh-ancestor
1762429|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
1762430|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1762431|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762432|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1762433|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1762434|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1762435|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1762436|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1762437|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
1762438|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
1762439|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1762440|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1762441|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1762442|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
1762443|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1762444|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
1762445|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762446|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
1762447|NCT05130814|Protective Agents|protective agents|mesh-ancestor
1762458|NCT05130684|Paclitaxel|paclitaxel|mesh-list
1762459|NCT05130684|Cisplatin|cisplatin|mesh-list
1762460|NCT05130684|Nivolumab|nivolumab|mesh-list
1762461|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1762462|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762463|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
1762464|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
1762465|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
1762466|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762467|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1762468|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1762469|NCT05130619|Ethanol|ethanol|mesh-list
1762470|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1762471|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1762472|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1762473|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762474|NCT05130515|Niraparib|niraparib|mesh-list
1762475|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1762476|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762477|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762478|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762491|NCT05130398|Vaccines|vaccines|mesh-list
1762492|NCT05130398|Immunologic Factors|immunologic factors|mesh-ancestor
1762493|NCT05130398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762496|NCT05107557|Vaccines|vaccines|mesh-list
1762497|NCT05107557|Immunologic Factors|immunologic factors|mesh-ancestor
1762498|NCT05107557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762528|NCT05069831|Abrocitinib|abrocitinib|mesh-list
1762529|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1762530|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762531|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762548|NCT05065554|Rituximab|rituximab|mesh-list
1762549|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
1762550|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1762551|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762552|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
1762553|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762554|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1762555|NCT05060913|Lidocaine|lidocaine|mesh-list
1762556|NCT05060913|Prilocaine|prilocaine|mesh-list
1762557|NCT05060913|Benzocaine|benzocaine|mesh-list
1762558|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
1762559|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
1762560|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
1762561|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1762562|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762563|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
1762564|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1762565|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1762566|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1762567|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1762568|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1762569|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762570|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
1762594|NCT05049980|Mifepristone|mifepristone|mesh-list
1762595|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1762596|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
1762597|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1762598|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762599|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1762600|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1762601|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1762602|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
1762603|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1762604|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1762605|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
1762606|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1762607|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
1762608|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1762609|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1762610|NCT05045950|Memantine|memantine|mesh-list
1762611|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1762612|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1762613|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
1762614|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1762615|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762616|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762617|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1762618|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1762619|NCT05045703|Vitamin A|vitamin a|mesh-list
1762620|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
1762621|NCT05045703|Vitamins|vitamins|mesh-ancestor
1762622|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
1762623|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762624|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
1762625|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762626|NCT05045703|Protective Agents|protective agents|mesh-ancestor
1762627|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1762628|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762629|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1762630|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1762631|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1762632|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
1762633|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762634|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1762635|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1762636|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762637|NCT05041101|Halichondrin B|halichondrin b|mesh-list
1762638|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
1762639|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
1762640|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
1762641|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762642|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762643|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
1762644|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
1762645|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1762646|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762647|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762648|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1762649|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762650|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762651|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762652|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1762653|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762654|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762671|NCT05034562|Edetic Acid|edetic acid|mesh-list
1762672|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1762673|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
1762674|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
1762675|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762676|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
1762677|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1762678|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1762679|NCT05028725|Lugol's solution|lugol's solution|mesh-list
1762680|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
1762681|NCT05028725|Coagulants|coagulants|mesh-ancestor
1762703|NCT05027204|Docetaxel|docetaxel|mesh-list
1762704|NCT05027204|Nivolumab|nivolumab|mesh-list
1762705|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762706|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
1762707|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
1762708|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
1762709|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762710|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1762711|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1762712|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
1762713|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1762714|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1762715|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762716|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
1762717|NCT05024253|Coagulants|coagulants|mesh-ancestor
1762740|NCT05008536|Fludarabine|fludarabine|mesh-list
1762741|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
1762742|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762743|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762744|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1762745|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
1762746|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762747|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1762748|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1762749|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
1762750|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1762768|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
1762769|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1762770|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762771|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1762772|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762773|NCT04983901|Vancomycin|vancomycin|mesh-list
1762774|NCT04983901|Meropenem|meropenem|mesh-list
1762775|NCT04983901|Tazobactam|tazobactam|mesh-list
1762776|NCT04983901|Linezolid|linezolid|mesh-list
1762777|NCT04983901|Piperacillin|piperacillin|mesh-list
1762778|NCT04983901|Daptomycin|daptomycin|mesh-list
1762779|NCT04983901|Imipenem|imipenem|mesh-list
1762780|NCT04983901|Cefepime|cefepime|mesh-list
1762781|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
1762782|NCT04983901|Relebactam|relebactam|mesh-list
1762783|NCT04983901|Cilastatin|cilastatin|mesh-list
1762784|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1762785|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1762786|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1762787|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762788|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762789|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1762790|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
1762791|NCT04982848|Talazoparib|talazoparib|mesh-list
1762792|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1762793|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762794|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762795|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762798|NCT04968899|Dexamethasone|dexamethasone|mesh-list
1762799|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
1762800|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1762801|NCT04968899|Antibodies|antibodies|mesh-list
1762802|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
1762803|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1762804|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1762805|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
1762806|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
1762807|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1762808|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762809|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1762810|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
1762811|NCT04968899|Hormones|hormones|mesh-ancestor
1762812|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1762813|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1762814|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762815|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
1762816|NCT04966663|Gemcitabine|gemcitabine|mesh-list
1762817|NCT04966663|Carboplatin|carboplatin|mesh-list
1762818|NCT04966663|Nivolumab|nivolumab|mesh-list
1762819|NCT04966663|Pemetrexed|pemetrexed|mesh-list
1762820|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762821|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1762822|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
1762823|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762824|NCT04966663|Antiviral Agents|antiviral agents|mesh-ancestor
1762825|NCT04966663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1762826|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1762827|NCT04966663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1762828|NCT04966663|Immunologic Factors|immunologic factors|mesh-ancestor
1762829|NCT04966663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762830|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1762831|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1762832|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1762833|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1762834|NCT04964063|Listerine|listerine|mesh-list
1762835|NCT04964063|Fluorides|fluorides|mesh-list
1762836|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
1762837|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
1762838|NCT04964063|Protective Agents|protective agents|mesh-ancestor
1762839|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762840|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1762841|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1762890|NCT04937738|Leucovorin|leucovorin|mesh-list
1762891|NCT04937738|Docetaxel|docetaxel|mesh-list
1762892|NCT04937738|Fluorouracil|fluorouracil|mesh-list
1762893|NCT04937738|Capecitabine|capecitabine|mesh-list
1762894|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
1762895|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1762896|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
1762897|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
1762898|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
1762899|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762900|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
1762901|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1762902|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1762903|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
1762904|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762905|NCT04937738|Antidotes|antidotes|mesh-ancestor
1762906|NCT04937738|Protective Agents|protective agents|mesh-ancestor
1762907|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
1762908|NCT04937738|Vitamins|vitamins|mesh-ancestor
1762909|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
1762968|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1762969|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1762970|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1762971|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1762972|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1762973|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1762974|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1762975|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1762976|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
1762977|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1762978|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1762979|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1762980|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1762981|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
1763087|NCT04887857|Azacitidine|azacitidine|mesh-list
1763088|NCT04887857|Venetoclax|venetoclax|mesh-list
1763089|NCT04887857|Cc-486|cc-486|mesh-list
1763090|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1763091|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
1763092|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763093|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763094|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763095|NCT04884412|Anesthetics|anesthetics|mesh-list
1763096|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1763097|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763108|NCT04868409|Rocuronium|rocuronium|mesh-list
1763109|NCT04868409|Succinylcholine|succinylcholine|mesh-list
1763110|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1763111|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1763112|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1763113|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1763114|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763115|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
1763116|NCT04862975|Tenofovir|tenofovir|mesh-list
1763117|NCT04862975|Emtricitabine|emtricitabine|mesh-list
1763118|NCT04862975|Efavirenz|efavirenz|mesh-list
1763119|NCT04862975|Dolutegravir|dolutegravir|mesh-list
1763120|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
1763121|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1763122|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1763123|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1763124|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763125|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763126|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1763127|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1763128|NCT04862975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1763129|NCT04862975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1763130|NCT04862975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1763131|NCT04862975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1763132|NCT04862975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1763133|NCT04862975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1763134|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1763135|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1763136|NCT04860960|Betadex|betadex|mesh-list
1763137|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
1763138|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763139|NCT04859465|Doxorubicin|doxorubicin|mesh-list
1763140|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1763141|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1763142|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1763143|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763144|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1763145|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1763146|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763147|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763156|NCT04849715|Rituximab|rituximab|mesh-list
1763157|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1763158|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1763159|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763160|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
1763161|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763162|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1763163|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1763164|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
1763165|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763221|NCT04798755|Adalimumab|adalimumab|mesh-list
1763222|NCT04798755|Methotrexate|methotrexate|mesh-list
1763223|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1763224|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
1763225|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1763226|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763227|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1763228|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
1763229|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763230|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763231|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
1763232|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763233|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1763234|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1763235|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
1763236|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1763237|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1763238|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1763280|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
1763281|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1763282|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763374|NCT04756427|Citric Acid|citric acid|mesh-list
1763375|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
1763376|NCT04756427|Anticoagulants|anticoagulants|mesh-list
1763377|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1763378|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
1763379|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
1763380|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763381|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
1763382|NCT04691505|Methotrexate|methotrexate|mesh-list
1763383|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1763384|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
1763385|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1763386|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763387|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1763388|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
1763389|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763390|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763391|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
1763392|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763393|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1763394|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1763395|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
1763396|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1763397|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1763398|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
1763399|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1763400|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1763401|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1763402|NCT04682405|Melphalan|melphalan|mesh-list
1763403|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1763404|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
1763405|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763406|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763407|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1763408|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1763409|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
1763410|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763411|NCT04682366|Tamsulosin|tamsulosin|mesh-list
1763412|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1763413|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1763414|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1763415|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
1763416|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1763417|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763418|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763419|NCT04682366|Urological Agents|urological agents|mesh-ancestor
1763422|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
1763423|NCT04678401|Thiotepa|thiotepa|mesh-list
1763424|NCT04678401|Fludarabine|fludarabine|mesh-list
1763425|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1763426|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
1763427|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763428|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1763429|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1763430|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
1763431|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763432|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763433|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1763445|NCT04661280|Donepezil|donepezil|mesh-list
1763446|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1763447|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763448|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763449|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
1763450|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1763451|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763452|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
1763453|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
1763454|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763470|NCT04635826|Adderall|adderall|mesh-list
1763471|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1763472|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763524|NCT04596579|Antibodies|antibodies|mesh-list
1763525|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
1763526|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763527|NCT04590586|Thalidomide|thalidomide|mesh-list
1763528|NCT04590586|Apremilast|apremilast|mesh-list
1763529|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1763530|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1763531|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1763532|NCT04590586|Analgesics|analgesics|mesh-ancestor
1763533|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
1763534|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1763535|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763536|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1763537|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1763538|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1763539|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1763540|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763541|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763542|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1763543|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
1763544|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
1763545|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1763546|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1763547|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1763548|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1763549|NCT04590586|Growth Substances|growth substances|mesh-ancestor
1763550|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
1763551|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763552|NCT04589754|Ifosfamide|ifosfamide|mesh-list
1763553|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763554|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763555|NCT04589754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1763556|NCT04589754|Alkylating Agents|alkylating agents|mesh-ancestor
1763568|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
1763569|NCT04579523|Fludarabine|fludarabine|mesh-list
1763570|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
1763571|NCT04579523|Daratumumab|daratumumab|mesh-list
1763572|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1763573|NCT04579523|Antibodies|antibodies|mesh-list
1763574|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
1763575|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1763576|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1763577|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
1763578|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763579|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1763580|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1763581|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
1763582|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763583|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763584|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1763585|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1763586|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
1763587|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1763588|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1763589|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763613|NCT04543071|Gemcitabine|gemcitabine|mesh-list
1763614|NCT04543071|Paclitaxel|paclitaxel|mesh-list
1763615|NCT04543071|Cemiplimab|cemiplimab|mesh-list
1763616|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1763617|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763618|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
1763619|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
1763620|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
1763621|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763622|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1763623|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
1763624|NCT04543071|Antiviral Agents|antiviral agents|mesh-ancestor
1763625|NCT04543071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1763626|NCT04543071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763627|NCT04543071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1763628|NCT04543071|Immunologic Factors|immunologic factors|mesh-ancestor
1763629|NCT04543071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763630|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1763639|NCT04535141|Olanzapine|olanzapine|mesh-list
1763640|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
1763641|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
1763642|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1763643|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763644|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1763645|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1763646|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1763647|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1763648|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1763649|NCT04535141|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1763650|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1763651|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1763652|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763653|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1763654|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
1763655|NCT04530630|Emtricitabine|emtricitabine|mesh-list
1763656|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
1763657|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1763658|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1763659|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1763660|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763661|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763662|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1763663|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1763664|NCT04530149|Acetaminophen|acetaminophen|mesh-list
1763665|NCT04530149|Bupivacaine|bupivacaine|mesh-list
1763666|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
1763667|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
1763668|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1763669|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763670|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
1763671|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1763672|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1763673|NCT04530149|Analgesics|analgesics|mesh-ancestor
1763674|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
1763675|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
1763676|NCT04529902|Abatacept|abatacept|mesh-list
1763677|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1763678|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763679|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763680|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1763681|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
1763682|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763683|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1763684|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1763685|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
1763686|NCT04515615|Tegafur|tegafur|mesh-list
1763687|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763688|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1763689|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
1763690|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763737|NCT04486118|Lisinopril|lisinopril|mesh-list
1763738|NCT04486118|Benazepril|benazepril|mesh-list
1763739|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1763740|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
1763741|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763742|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763743|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1763744|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1763745|NCT04486118|Protective Agents|protective agents|mesh-ancestor
1763746|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763811|NCT04417621|Trametinib|trametinib|mesh-list
1763812|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763813|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1763814|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763815|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763816|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
1763817|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
1763818|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1763819|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1763820|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763821|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
1763822|NCT04373603|Coagulants|coagulants|mesh-ancestor
1763823|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1763824|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
1763825|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763826|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
1763827|NCT04373603|Protective Agents|protective agents|mesh-ancestor
1763828|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
1763829|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1763830|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1763831|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763832|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
1763833|NCT04372940|Coagulants|coagulants|mesh-ancestor
1763848|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
1763849|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
1763850|NCT04370301|Melphalan|melphalan|mesh-list
1763851|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
1763852|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
1763853|NCT04370301|Fludarabine|fludarabine|mesh-list
1763854|NCT04370301|Tacrolimus|tacrolimus|mesh-list
1763855|NCT04370301|Sargramostim|sargramostim|mesh-list
1763856|NCT04370301|Lenograstim|lenograstim|mesh-list
1763857|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
1763858|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1763859|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
1763860|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763861|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1763862|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1763863|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
1763864|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763865|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763866|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1763867|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1763868|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763869|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1763870|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1763871|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
1763872|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1763873|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1763874|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1763875|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1763876|NCT04353128|Melatonin|melatonin|mesh-list
1763877|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
1763878|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763879|NCT04353128|Protective Agents|protective agents|mesh-ancestor
1763880|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763881|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1763882|NCT04340076|Ixekizumab|ixekizumab|mesh-list
1763883|NCT04340076|Brodalumab|brodalumab|mesh-list
1763884|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
1763896|NCT04325880|Tamsulosin|tamsulosin|mesh-list
1763897|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
1763898|NCT04325880|Mirabegron|mirabegron|mesh-list
1763899|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1763900|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1763901|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1763902|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
1763903|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1763904|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763905|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763906|NCT04325880|Urological Agents|urological agents|mesh-ancestor
1763907|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1763908|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1763909|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
1763910|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
1763911|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1763912|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1763913|NCT04299880|Leucovorin|leucovorin|mesh-list
1763914|NCT04299880|Gemcitabine|gemcitabine|mesh-list
1763915|NCT04299880|Paclitaxel|paclitaxel|mesh-list
1763916|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1763917|NCT04299880|Bevacizumab|bevacizumab|mesh-list
1763918|NCT04299880|Fluorouracil|fluorouracil|mesh-list
1763919|NCT04299880|Nivolumab|nivolumab|mesh-list
1763920|NCT04299880|Irinotecan|irinotecan|mesh-list
1763921|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1763922|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763923|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
1763924|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
1763925|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
1763926|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763927|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1763928|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1763929|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1763930|NCT04299880|Growth Substances|growth substances|mesh-ancestor
1763931|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763932|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
1763933|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1763934|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
1763935|NCT04299880|Antiviral Agents|antiviral agents|mesh-ancestor
1763936|NCT04299880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1763937|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763938|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1763939|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
1763940|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1763941|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1763942|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1763943|NCT04299880|Antidotes|antidotes|mesh-ancestor
1763944|NCT04299880|Protective Agents|protective agents|mesh-ancestor
1763945|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
1763946|NCT04299880|Vitamins|vitamins|mesh-ancestor
1763947|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
1763948|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
1763949|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1763950|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
1763951|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763952|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1763953|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
1763954|NCT04263350|Cobicistat|cobicistat|mesh-list
1763955|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1763956|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1763957|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
1763958|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1763959|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1763960|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1763961|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1763962|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
1763963|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1763964|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1763965|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1763966|NCT04227028|Bevacizumab|bevacizumab|mesh-list
1763967|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1763968|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
1763969|NCT04227028|Antibodies|antibodies|mesh-list
1763970|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
1763971|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1763972|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
1763973|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763974|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1763975|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1763976|NCT04227028|Growth Substances|growth substances|mesh-ancestor
1763977|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1763978|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
1763979|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
1763984|NCT04214288|Fulvestrant|fulvestrant|mesh-list
1763985|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1763986|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1763987|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1763988|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1763989|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
1763990|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1763991|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764013|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
1764014|NCT04207086|Lenvatinib|lenvatinib|mesh-list
1764015|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1764016|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764017|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1764018|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1764019|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764020|NCT04202458|Tenecteplase|tenecteplase|mesh-list
1764021|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1764022|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1764023|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764035|NCT04184453|Deferiprone|deferiprone|mesh-list
1764036|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1764037|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
1764038|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
1764039|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764053|NCT04147494|Edetic Acid|edetic acid|mesh-list
1764054|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1764055|NCT04147494|FAPI-46|fapi-46|mesh-list
1764056|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
1764057|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
1764058|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764059|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
1764060|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1764061|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1764095|NCT04108481|Durvalumab|durvalumab|mesh-list
1764096|NCT04108481|Methamphetamine|methamphetamine|mesh-list
1764097|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1764098|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1764099|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764100|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
1764101|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764102|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1764103|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
1764104|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
1764105|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1764106|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
1764107|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1764108|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764109|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
1764110|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1764111|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1764112|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1764113|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1764114|NCT04101643|Evolocumab|evolocumab|mesh-list
1764115|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1764116|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1764117|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
1764118|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764119|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1764139|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
1764140|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1764141|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1764142|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764143|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1764144|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1764145|NCT04094207|Protective Agents|protective agents|mesh-ancestor
1764146|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764147|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
1764148|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1764149|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
1764164|NCT04069312|Azithromycin|azithromycin|mesh-list
1764165|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1764166|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1764186|NCT04009681|Antibodies|antibodies|mesh-list
1764187|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
1764188|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764194|NCT03978611|Ipilimumab|ipilimumab|mesh-list
1764195|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1764196|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764197|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1764198|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764220|NCT03891953|Spartalizumab|spartalizumab|mesh-list
1764221|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1764222|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764223|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764224|NCT03873493|Venetoclax|venetoclax|mesh-list
1764225|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764226|NCT03844048|Venetoclax|venetoclax|mesh-list
1764227|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764258|NCT03741530|Glyburide|glyburide|mesh-list
1764259|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1764260|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764284|NCT03667846|Topiramate|topiramate|mesh-list
1764285|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
1764286|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1764287|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764366|NCT03580928|Venetoclax|venetoclax|mesh-list
1764367|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
1764368|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
1764369|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764370|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1764384|NCT03534323|Venetoclax|venetoclax|mesh-list
1764385|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764386|NCT03520231|Vitamin D|vitamin d|mesh-list
1764387|NCT03520231|Denosumab|denosumab|mesh-list
1764388|NCT03520231|Gemcitabine|gemcitabine|mesh-list
1764389|NCT03520231|Carboplatin|carboplatin|mesh-list
1764390|NCT03520231|Calcium|calcium|mesh-list
1764391|NCT03520231|Vitamins|vitamins|mesh-ancestor
1764392|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
1764393|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764394|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764395|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1764396|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
1764397|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764398|NCT03520231|Antiviral Agents|antiviral agents|mesh-ancestor
1764399|NCT03520231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1764400|NCT03520231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1764401|NCT03520231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1764402|NCT03520231|Immunologic Factors|immunologic factors|mesh-ancestor
1764403|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1764404|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1764408|NCT03464097|Ozanimod|ozanimod|mesh-list
1764409|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1764410|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764411|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1764412|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
1764413|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764414|NCT03451578|alpha-MSH|alpha-msh|mesh-list
1764415|NCT03451578|Hormones|hormones|mesh-ancestor
1764416|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1764417|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764418|NCT03440385|Ozanimod|ozanimod|mesh-list
1764419|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1764420|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764421|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1764422|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
1764423|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764424|NCT03440372|Ozanimod|ozanimod|mesh-list
1764425|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1764426|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764427|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1764428|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
1764429|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764432|NCT03425331|Nivolumab|nivolumab|mesh-list
1764433|NCT03425331|Ipilimumab|ipilimumab|mesh-list
1764434|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1764435|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764436|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1764437|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764454|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
1764455|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1764456|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1764457|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1764458|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1764517|NCT03171805|Propranolol|propranolol|mesh-list
1764518|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1764519|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1764520|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
1764521|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1764522|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764523|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764524|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1764525|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1764526|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
1764527|NCT03107416|Bumetanide|bumetanide|mesh-list
1764528|NCT03107416|Diuretics|diuretics|mesh-ancestor
1764529|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
1764530|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764531|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1764532|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1764533|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764536|NCT03094234|Propranolol|propranolol|mesh-list
1764537|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1764538|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1764539|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
1764540|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1764541|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764542|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764543|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1764544|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1764545|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
1764557|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1764558|NCT03042468|177Lu-PSMA-617|177lu-psma-617|mesh-list
1764559|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1764560|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764561|NCT03034564|Droxidopa|droxidopa|mesh-list
1764562|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1764563|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1764564|NCT03034538|Zonisamide|zonisamide|mesh-list
1764565|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
1764566|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1764567|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1764568|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764569|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1764570|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764571|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1764572|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1764573|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
1764604|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
1764605|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1764606|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764622|NCT02819518|Gemcitabine|gemcitabine|mesh-list
1764623|NCT02819518|Paclitaxel|paclitaxel|mesh-list
1764624|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1764625|NCT02819518|Carboplatin|carboplatin|mesh-list
1764626|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
1764627|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1764628|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764629|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
1764630|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
1764631|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
1764632|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764633|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1764634|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
1764635|NCT02819518|Antiviral Agents|antiviral agents|mesh-ancestor
1764636|NCT02819518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1764637|NCT02819518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1764638|NCT02819518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1764639|NCT02819518|Immunologic Factors|immunologic factors|mesh-ancestor
1764640|NCT02819518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764641|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1764775|NCT02549833|Poly I-C|poly i-c|mesh-list
1764776|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1764777|NCT02549833|Poly ICLC|poly iclc|mesh-list
1764778|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
1764779|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
1764780|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764781|NCT02549833|Laxatives|laxatives|mesh-ancestor
1764782|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1764783|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
1764784|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1764793|NCT02468180|Polidocanol|polidocanol|mesh-list
1764794|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
1764795|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1764886|NCT02207465|Paclitaxel|paclitaxel|mesh-list
1764887|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1764888|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1764889|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764890|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
1764891|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
1764892|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
1764893|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764922|NCT02158507|Lapatinib|lapatinib|mesh-list
1764923|NCT02158507|Veliparib|veliparib|mesh-list
1764924|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1764925|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1764926|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1764927|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764928|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1764951|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
1764952|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
1764953|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
1764954|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1764955|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1764956|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1764957|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1764958|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
1764959|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
1764960|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1764961|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764991|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
1764992|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1764993|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1764994|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1764995|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1764996|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1764997|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
1764998|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1765067|NCT01308190|Capecitabine|capecitabine|mesh-list
1765068|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1765069|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
1765070|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765071|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765072|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
1765073|NCT01210768|Doxorubicin|doxorubicin|mesh-list
1765074|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1765075|NCT01210768|Epirubicin|epirubicin|mesh-list
1765076|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1765077|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
1765078|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765079|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1765080|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1765081|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
1765082|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765083|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765084|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1765085|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1765086|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1765087|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1765088|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765141|NCT00782574|Olaparib|olaparib|mesh-list
1765142|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765143|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1765144|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765145|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765146|NCT00719225|Abatacept|abatacept|mesh-list
1765147|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1765148|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765149|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765150|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1765151|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
1765152|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765153|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1765176|NCT00516724|Paclitaxel|paclitaxel|mesh-list
1765177|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1765178|NCT00516724|Carboplatin|carboplatin|mesh-list
1765179|NCT00516724|Olaparib|olaparib|mesh-list
1765180|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1765181|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1765182|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765183|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
1765184|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
1765185|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
1765186|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765187|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765188|NCT00516373|Olaparib|olaparib|mesh-list
1765189|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1765190|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765191|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765192|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765242|NCT00094016|Beclomethasone|beclomethasone|mesh-list
1765243|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1765244|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
1765245|NCT00094016|Hormones|hormones|mesh-ancestor
1765246|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1765247|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765248|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1765249|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
1765250|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
1765251|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1765252|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1765253|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765254|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1765255|NCT05134363|Analgesics|analgesics|mesh-ancestor
1765256|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
1765257|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1765258|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1765259|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1765260|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1765261|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
1765262|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1765263|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765264|NCT05134350|Omeprazole|omeprazole|mesh-list
1765265|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1765266|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1765267|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1765268|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765269|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765270|NCT05134337|Itraconazole|itraconazole|mesh-list
1765271|NCT05134337|Rifampin|rifampin|mesh-list
1765272|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
1765273|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1765274|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1765275|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1765276|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765277|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765278|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1765279|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
1765280|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1765281|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765282|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1765283|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1765284|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
1765285|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1765286|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
1765287|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1765288|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1765289|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1765290|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1765291|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1765292|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1765293|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1765294|NCT05134298|Meropenem|meropenem|mesh-list
1765295|NCT05134298|Tazobactam|tazobactam|mesh-list
1765296|NCT05134298|Piperacillin|piperacillin|mesh-list
1765297|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
1765298|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1765299|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1765300|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1765301|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765302|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765303|NCT05134220|Calcium|calcium|mesh-list
1765304|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1765305|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765306|NCT05134194|Gemcitabine|gemcitabine|mesh-list
1765307|NCT05134194|Capecitabine|capecitabine|mesh-list
1765308|NCT05134194|Vinorelbine|vinorelbine|mesh-list
1765309|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1765310|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
1765311|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765312|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765313|NCT05134194|Antiviral Agents|antiviral agents|mesh-ancestor
1765314|NCT05134194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1765315|NCT05134194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765316|NCT05134194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1765317|NCT05134194|Immunologic Factors|immunologic factors|mesh-ancestor
1765318|NCT05134194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765319|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1765320|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
1765321|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
1765322|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
1765323|NCT05133895|Prednisone|prednisone|mesh-list
1765324|NCT05133895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1765325|NCT05133895|Glucocorticoids|glucocorticoids|mesh-ancestor
1765326|NCT05133895|Hormones|hormones|mesh-ancestor
1765327|NCT05133895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1765328|NCT05133895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765329|NCT05133895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1765330|NCT05133895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765361|NCT05133791|Annexin A5|annexin a5|mesh-list
1765362|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765363|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765364|NCT05133687|Bupivacaine|bupivacaine|mesh-list
1765365|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
1765366|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
1765367|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1765368|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765369|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
1765370|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1765371|NCT05133674|Tamoxifen|tamoxifen|mesh-list
1765372|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1765373|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
1765374|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1765375|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765376|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1765377|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765378|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1765379|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1765380|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1765381|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
1765382|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1765383|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1765384|NCT05133635|Prednisolone|prednisolone|mesh-list
1765385|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
1765386|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1765387|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
1765388|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1765389|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
1765390|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
1765391|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1765392|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765393|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1765394|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
1765395|NCT05133635|Hormones|hormones|mesh-ancestor
1765396|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1765397|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1765398|NCT05133635|Protective Agents|protective agents|mesh-ancestor
1765399|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1765400|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765450|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
1765451|NCT05133258|Dexamethasone|dexamethasone|mesh-list
1765452|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1765453|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
1765454|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
1765455|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1765456|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765457|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1765458|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
1765459|NCT05133258|Hormones|hormones|mesh-ancestor
1765460|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1765461|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1765462|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765463|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1765464|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1765465|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1765466|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1765467|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765468|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765469|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1765470|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1765475|NCT05133050|Ramipril|ramipril|mesh-list
1765476|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1765477|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
1765478|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765479|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765480|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1765503|NCT05132829|Azithromycin|azithromycin|mesh-list
1765504|NCT05132829|Cefazolin|cefazolin|mesh-list
1765505|NCT05132829|Indomethacin|indomethacin|mesh-list
1765506|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1765507|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1765508|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1765509|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1765510|NCT05132829|Analgesics|analgesics|mesh-ancestor
1765511|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
1765512|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1765513|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765514|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1765515|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1765516|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
1765517|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
1765518|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1765519|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1765520|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765521|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765522|NCT05132777|Osimertinib|osimertinib|mesh-list
1765523|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765524|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1765525|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765526|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765527|NCT05132712|Losartan|losartan|mesh-list
1765528|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1765529|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1765530|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1765531|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1765532|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765533|NCT05132699|Cannabidiol|cannabidiol|mesh-list
1765534|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1765535|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
1765547|NCT05132595|Ketorolac|ketorolac|mesh-list
1765548|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1765549|NCT05132595|Esketamine|esketamine|mesh-list
1765550|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1765551|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1765552|NCT05132595|Analgesics|analgesics|mesh-ancestor
1765553|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
1765554|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1765555|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765556|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1765557|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1765558|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1765559|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765560|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765561|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
1765562|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1765571|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
1765572|NCT05132504|Folfirinox|folfirinox|mesh-list
1765573|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1765574|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765578|NCT05132413|Bevacizumab|bevacizumab|mesh-list
1765579|NCT05132413|Cisplatin|cisplatin|mesh-list
1765580|NCT05132413|Carboplatin|carboplatin|mesh-list
1765581|NCT05132413|Pemetrexed|pemetrexed|mesh-list
1765582|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1765583|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765584|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1765585|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1765586|NCT05132413|Growth Substances|growth substances|mesh-ancestor
1765587|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765588|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
1765589|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765590|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765591|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1765592|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1765593|NCT05132270|Thalidomide|thalidomide|mesh-list
1765594|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
1765595|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1765596|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
1765597|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765598|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
1765599|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1765600|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1765601|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1765602|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1765603|NCT05132270|Growth Substances|growth substances|mesh-ancestor
1765604|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
1765605|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765606|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
1765607|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765608|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765609|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1765616|NCT05132166|Sirolimus|sirolimus|mesh-list
1765617|NCT05132166|Everolimus|everolimus|mesh-list
1765618|NCT05132166|Vedolizumab|vedolizumab|mesh-list
1765619|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1765620|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765621|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1765622|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
1765623|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765624|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1765625|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1765626|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1765627|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
1765628|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1765629|NCT05132153|Milrinone|milrinone|mesh-list
1765630|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1765631|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1765632|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
1765633|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1765634|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1765635|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765636|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765637|NCT05132153|Protective Agents|protective agents|mesh-ancestor
1765638|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765642|NCT05132101|Palbociclib|palbociclib|mesh-list
1765643|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765644|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1765645|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765646|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765647|NCT05132075|Docetaxel|docetaxel|mesh-list
1765648|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765649|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
1765650|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
1765651|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
1765652|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765653|NCT05129176|Metronidazole|metronidazole|mesh-list
1765654|NCT05129176|Levofloxacin|levofloxacin|mesh-list
1765655|NCT05129176|Ofloxacin|ofloxacin|mesh-list
1765656|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1765657|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1765658|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1765659|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1765660|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1765661|NCT05129176|Renal Agents|renal agents|mesh-ancestor
1765662|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1765663|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1765664|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765665|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765666|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765667|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1765668|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1765678|NCT05122546|Nivolumab|nivolumab|mesh-list
1765679|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1765680|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765681|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1765682|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765683|NCT05121038|Leucovorin|leucovorin|mesh-list
1765684|NCT05121038|Fluorouracil|fluorouracil|mesh-list
1765685|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
1765686|NCT05121038|Irinotecan|irinotecan|mesh-list
1765687|NCT05121038|Panitumumab|panitumumab|mesh-list
1765688|NCT05121038|Folfirinox|folfirinox|mesh-list
1765689|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
1765690|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765691|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1765692|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765693|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1765694|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
1765695|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765696|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1765697|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1765698|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765699|NCT05121038|Antidotes|antidotes|mesh-ancestor
1765700|NCT05121038|Protective Agents|protective agents|mesh-ancestor
1765701|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
1765702|NCT05121038|Vitamins|vitamins|mesh-ancestor
1765703|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
1765704|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1765734|NCT05071937|Talazoparib|talazoparib|mesh-list
1765735|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1765736|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765737|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765738|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765759|NCT05062837|Apatinib|apatinib|mesh-list
1765760|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765761|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1765762|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765763|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765787|NCT05043714|Nivolumab|nivolumab|mesh-list
1765788|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1765789|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765790|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1765791|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765792|NCT05039736|Nivolumab|nivolumab|mesh-list
1765793|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1765794|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765795|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1765796|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765797|NCT05039632|Nivolumab|nivolumab|mesh-list
1765798|NCT05039632|Ipilimumab|ipilimumab|mesh-list
1765799|NCT05039632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1765800|NCT05039632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765801|NCT05039632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1765802|NCT05039632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765803|NCT05039281|Atezolizumab|atezolizumab|mesh-list
1765804|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1765805|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765806|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
1765807|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765808|NCT05038592|Decitabine|decitabine|mesh-list
1765809|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1765810|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
1765811|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765812|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765813|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765830|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
1765831|NCT05033756|Olaparib|olaparib|mesh-list
1765832|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1765833|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765834|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1765835|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765836|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765842|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
1765843|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
1765844|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
1765845|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1765846|NCT05031442|Protective Agents|protective agents|mesh-ancestor
1765847|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765860|NCT05030857|Midazolam|midazolam|mesh-list
1765861|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1765862|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1765863|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1765864|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765865|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1765866|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1765867|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1765868|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1765869|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
1765870|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
1765871|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
1765872|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
1765873|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1765874|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765898|NCT05027360|Nitroprusside|nitroprusside|mesh-list
1765899|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1765900|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
1765901|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
1765902|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765903|NCT05027100|Irinotecan|irinotecan|mesh-list
1765904|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1765905|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1765906|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765907|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765908|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765909|NCT05026606|Nivolumab|nivolumab|mesh-list
1765910|NCT05026606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1765911|NCT05026606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765912|NCT05026606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1765913|NCT05026606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765914|NCT05025800|Rituximab|rituximab|mesh-list
1765915|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1765916|NCT05025800|Lenalidomide|lenalidomide|mesh-list
1765917|NCT05025800|Antibodies|antibodies|mesh-list
1765918|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
1765919|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1765920|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
1765921|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1765922|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765923|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1765924|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1765925|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1765926|NCT05025800|Growth Substances|growth substances|mesh-ancestor
1765927|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
1765937|NCT05017025|Osimertinib|osimertinib|mesh-list
1765938|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765939|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1765940|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765941|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765942|NCT05010772|Decitabine|decitabine|mesh-list
1765943|NCT05010772|Venetoclax|venetoclax|mesh-list
1765944|NCT05010772|Ivosidenib|ivosidenib|mesh-list
1765945|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1765946|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
1765947|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765948|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765949|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765971|NCT05004116|Irinotecan|irinotecan|mesh-list
1765972|NCT05004116|Temozolomide|temozolomide|mesh-list
1765973|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1765974|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1765975|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1765976|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1765977|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1765978|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1765979|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
1766082|NCT04974528|Insulin|insulin|mesh-list
1766083|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1766084|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
1766085|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
1766086|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
1766087|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
1766088|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1766089|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766172|NCT04939272|Venetoclax|venetoclax|mesh-list
1766173|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766242|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
1766243|NCT04924374|Atezolizumab|atezolizumab|mesh-list
1766244|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1766245|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1766246|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766247|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
1766248|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766257|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
1766258|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1766259|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1766260|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766261|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1766262|NCT04912518|Analgesics|analgesics|mesh-ancestor
1766263|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
1766264|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1766265|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1766266|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1766267|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1766268|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
1766269|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1766270|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1766271|NCT04909021|Vaccines|vaccines|mesh-list
1766272|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
1766273|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766274|NCT04906395|Tamoxifen|tamoxifen|mesh-list
1766275|NCT04906395|Letrozole|letrozole|mesh-list
1766276|NCT04906395|Anastrozole|anastrozole|mesh-list
1766277|NCT04906395|Exemestane|exemestane|mesh-list
1766278|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766279|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1766280|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1766281|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1766282|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1766283|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1766284|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
1766285|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1766286|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766287|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1766288|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1766289|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1766290|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1766303|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
1766304|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1766305|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
1766306|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1766360|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
1766361|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1766362|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1766363|NCT04873583|Prednisolone|prednisolone|mesh-list
1766364|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
1766365|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1766366|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
1766367|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1766368|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
1766369|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
1766370|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1766371|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766372|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1766373|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
1766374|NCT04873583|Hormones|hormones|mesh-ancestor
1766375|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1766376|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1766377|NCT04873583|Protective Agents|protective agents|mesh-ancestor
1766378|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1766379|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766393|NCT04847440|Tenofovir|tenofovir|mesh-list
1766394|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
1766395|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1766396|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1766397|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1766398|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1766399|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1766400|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1766401|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1766405|NCT04831398|Melatonin|melatonin|mesh-list
1766406|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
1766407|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1766408|NCT04831398|Protective Agents|protective agents|mesh-ancestor
1766409|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766410|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1766430|NCT04818320|Favipiravir|favipiravir|mesh-list
1766431|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
1766432|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1766439|NCT04816513|Ustekinumab|ustekinumab|mesh-list
1766440|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
1766457|NCT04793906|Iron|iron|mesh-list
1766458|NCT04793906|Trace Elements|trace elements|mesh-ancestor
1766459|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
1766460|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766461|NCT04789070|Sirolimus|sirolimus|mesh-list
1766462|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1766463|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1766464|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1766465|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766466|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
1766467|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1766468|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
1766469|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766542|NCT04741204|Metformin|metformin|mesh-list
1766543|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1766544|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766545|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
1766546|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
1766547|NCT04740645|Coagulants|coagulants|mesh-ancestor
1766548|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1766549|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
1766550|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766551|NCT04738318|Dexamethasone|dexamethasone|mesh-list
1766552|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
1766553|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
1766554|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1766555|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
1766556|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
1766557|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1766558|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766559|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1766560|NCT04738318|Hormones|hormones|mesh-ancestor
1766637|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
1766561|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1766562|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1766563|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766564|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1766565|NCT04738318|Protective Agents|protective agents|mesh-ancestor
1766566|NCT04688788|Fexofenadine|fexofenadine|mesh-list
1766567|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
1766568|NCT04688788|Rituximab|rituximab|mesh-list
1766569|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
1766570|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1766571|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766572|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
1766573|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766574|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1766575|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1766576|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
1766577|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
1766578|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1766579|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1766580|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
1766581|NCT04688788|Hormones|hormones|mesh-ancestor
1766582|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1766583|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1766584|NCT04688788|Protective Agents|protective agents|mesh-ancestor
1766585|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1766586|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1766587|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1766588|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
1766589|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
1766590|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1766591|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1766602|NCT04673448|Niraparib|niraparib|mesh-list
1766603|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
1766604|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
1766605|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
1766606|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766607|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1766608|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1766609|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1766610|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766628|NCT04656964|Midazolam|midazolam|mesh-list
1766629|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1766630|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1766631|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1766632|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766633|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1766634|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1766635|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1766636|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1766638|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
1766639|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
1766640|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
1766641|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1766642|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1766693|NCT04605796|Bevacizumab|bevacizumab|mesh-list
1766694|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1766695|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766696|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1766697|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1766698|NCT04605796|Growth Substances|growth substances|mesh-ancestor
1766699|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766700|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
1766701|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
1766702|NCT04599868|Analgesics|analgesics|mesh-ancestor
1766703|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
1766704|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1766705|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766706|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
1766707|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1766708|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1766709|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
1766710|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1766711|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1766712|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1766713|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1766714|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
1766715|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1766770|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
1766771|NCT04535401|Leucovorin|leucovorin|mesh-list
1766772|NCT04535401|Folic Acid|folic acid|mesh-list
1766773|NCT04535401|Fluorouracil|fluorouracil|mesh-list
1766774|NCT04535401|Irinotecan|irinotecan|mesh-list
1766775|NCT04535401|Camptothecin|camptothecin|mesh-list
1766776|NCT04535401|Calcium|calcium|mesh-list
1766777|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
1766778|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1766779|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766780|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1766781|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
1766782|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1766783|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1766784|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766785|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1766786|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
1766787|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1766788|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1766789|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1766790|NCT04535401|Antidotes|antidotes|mesh-ancestor
1766791|NCT04535401|Protective Agents|protective agents|mesh-ancestor
1766792|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
1766793|NCT04535401|Vitamins|vitamins|mesh-ancestor
1766794|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
1766795|NCT04535401|Hematinics|hematinics|mesh-ancestor
1766796|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1766823|NCT04515394|Cetuximab|cetuximab|mesh-list
1766824|NCT04515394|Tepotinib|tepotinib|mesh-list
1766825|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1766826|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766827|NCT04513951|Leucovorin|leucovorin|mesh-list
1766828|NCT04513951|Fluorouracil|fluorouracil|mesh-list
1766829|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
1766830|NCT04513951|Irinotecan|irinotecan|mesh-list
1766831|NCT04513951|Cetuximab|cetuximab|mesh-list
1766832|NCT04513951|Avelumab|avelumab|mesh-list
1766833|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
1766834|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
1766835|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1766836|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1766837|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766838|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1766839|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
1766840|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766841|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1766842|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1766843|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1766844|NCT04513951|Antidotes|antidotes|mesh-ancestor
1766845|NCT04513951|Protective Agents|protective agents|mesh-ancestor
1766846|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
1766847|NCT04513951|Vitamins|vitamins|mesh-ancestor
1766848|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
1766849|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1766869|NCT04436133|Vaccines|vaccines|mesh-list
1766870|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
1766871|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766877|NCT04414475|Dexamethasone|dexamethasone|mesh-list
1766878|NCT04414475|Bortezomib|bortezomib|mesh-list
1766879|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1766880|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
1766881|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
1766882|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1766883|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766884|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1766885|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
1766886|NCT04414475|Hormones|hormones|mesh-ancestor
1766887|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1766888|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1766889|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766894|NCT04401995|Nivolumab|nivolumab|mesh-list
1766895|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1766896|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766897|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1766898|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767023|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1766964|NCT04340947|Nicotine|nicotine|mesh-list
1766965|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1766966|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
1766967|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1766968|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1766969|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1766970|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1766971|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
1766972|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1766973|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767006|NCT04313608|Gemcitabine|gemcitabine|mesh-list
1767007|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
1767008|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
1767009|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1767010|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
1767011|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767012|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767013|NCT04313608|Antiviral Agents|antiviral agents|mesh-ancestor
1767014|NCT04313608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1767015|NCT04313608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1767016|NCT04313608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1767017|NCT04313608|Immunologic Factors|immunologic factors|mesh-ancestor
1767018|NCT04313608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767019|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767020|NCT04311710|Nivolumab|nivolumab|mesh-list
1767021|NCT04311710|Ipilimumab|ipilimumab|mesh-list
1767022|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767024|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1767025|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767026|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
1767027|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767028|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767029|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1767034|NCT04305327|Ustekinumab|ustekinumab|mesh-list
1767035|NCT04305327|Brodalumab|brodalumab|mesh-list
1767036|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
1767050|NCT04245865|Leucovorin|leucovorin|mesh-list
1767051|NCT04245865|Tocotrienols|tocotrienols|mesh-list
1767052|NCT04245865|Vitamin E|vitamin e|mesh-list
1767053|NCT04245865|Tocopherols|tocopherols|mesh-list
1767054|NCT04245865|Bevacizumab|bevacizumab|mesh-list
1767055|NCT04245865|Fluorouracil|fluorouracil|mesh-list
1767056|NCT04245865|Capecitabine|capecitabine|mesh-list
1767057|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
1767058|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
1767059|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767060|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767061|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1767062|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1767063|NCT04245865|Growth Substances|growth substances|mesh-ancestor
1767064|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767065|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
1767066|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
1767067|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767068|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1767069|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1767070|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
1767071|NCT04245865|Antidotes|antidotes|mesh-ancestor
1767072|NCT04245865|Protective Agents|protective agents|mesh-ancestor
1767073|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
1767074|NCT04245865|Vitamins|vitamins|mesh-ancestor
1767075|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
1767076|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
1767077|NCT04244877|Rifaximin|rifaximin|mesh-list
1767078|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1767079|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1767080|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1767081|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
1767082|NCT04215120|Hematinics|hematinics|mesh-ancestor
1767193|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
1767194|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1767195|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1767196|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1767197|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1767198|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767199|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
1767200|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1767201|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767202|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1767203|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1767219|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
1767220|NCT04012957|Hematinics|hematinics|mesh-ancestor
1767232|NCT03991884|Prednisone|prednisone|mesh-list
1767233|NCT03991884|Cortisone|cortisone|mesh-list
1767234|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
1767235|NCT03991884|Doxorubicin|doxorubicin|mesh-list
1767236|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1767237|NCT03991884|Etoposide|etoposide|mesh-list
1767238|NCT03991884|Vincristine|vincristine|mesh-list
1767239|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
1767240|NCT03991884|Daunorubicin|daunorubicin|mesh-list
1767241|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
1767242|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
1767243|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1767244|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
1767245|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767246|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1767247|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1767248|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
1767249|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767250|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767251|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1767252|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1767253|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1767254|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1767255|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1767256|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1767257|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
1767258|NCT03991884|Hormones|hormones|mesh-ancestor
1767259|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1767260|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1767261|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1767262|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
1767263|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
1767264|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
1767265|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
1767266|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
1767267|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767268|NCT03989362|Ipilimumab|ipilimumab|mesh-list
1767269|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767270|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767271|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1767272|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767339|NCT03883581|Quinidine|quinidine|mesh-list
1767340|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
1767341|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
1767342|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
1767343|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
1767344|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1767345|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1767346|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1767347|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767348|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767349|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1767350|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1767351|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
1767352|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1767353|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
1767354|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1767355|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1767356|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1767357|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1767358|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1767359|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1767360|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
1767361|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1767362|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1767363|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1767364|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1767365|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1767366|NCT03854578|Citalopram|citalopram|mesh-list
1767367|NCT03854578|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1767368|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1767369|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1767370|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767371|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1767372|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
1767373|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767374|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1767375|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
1767376|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1767381|NCT03844412|Lidocaine|lidocaine|mesh-list
1767382|NCT03844412|Nortriptyline|nortriptyline|mesh-list
1767383|NCT03844412|Estradiol|estradiol|mesh-list
1767384|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
1767385|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
1767386|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1767387|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767388|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
1767389|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1767390|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1767391|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1767392|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1767393|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1767394|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767395|NCT03844412|Estrogens|estrogens|mesh-ancestor
1767396|NCT03844412|Hormones|hormones|mesh-ancestor
1767397|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1767398|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1767399|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
1767400|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1767401|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1767402|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1767403|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
1767404|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1767405|NCT03821246|Atezolizumab|atezolizumab|mesh-list
1767406|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1767407|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767408|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
1767409|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767432|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
1767433|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
1767434|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1767440|NCT03769155|Nivolumab|nivolumab|mesh-list
1767441|NCT03769155|Ipilimumab|ipilimumab|mesh-list
1767442|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767443|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767444|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1767445|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767446|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
1767447|NCT03747484|Avelumab|avelumab|mesh-list
1767448|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
1767449|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
1767450|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1767451|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767452|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767453|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
1767454|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767475|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
1767476|NCT03709680|Temozolomide|temozolomide|mesh-list
1767477|NCT03709680|Irinotecan|irinotecan|mesh-list
1767478|NCT03709680|Topotecan|topotecan|mesh-list
1767479|NCT03709680|Palbociclib|palbociclib|mesh-list
1767480|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1767481|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
1767482|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767483|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1767484|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1767485|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
1767486|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767487|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767488|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1767489|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1767490|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1767491|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1767492|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1767519|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
1767520|NCT03660059|Peficitinib|peficitinib|mesh-list
1767521|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1767522|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767523|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1767524|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
1767525|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767573|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1767574|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1767575|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1767576|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1767577|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767578|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
1767579|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1767580|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1767581|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1767582|NCT03512119|Ivacaftor|ivacaftor|mesh-list
1767583|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1767584|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1767585|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767586|NCT03505762|Prednisone|prednisone|mesh-list
1767587|NCT03505762|Cortisone|cortisone|mesh-list
1767588|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
1767589|NCT03505762|Rituximab|rituximab|mesh-list
1767590|NCT03505762|Doxorubicin|doxorubicin|mesh-list
1767591|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1767592|NCT03505762|Vincristine|vincristine|mesh-list
1767593|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1767594|NCT03505762|Antibodies|antibodies|mesh-list
1767595|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
1767596|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1767597|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1767598|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
1767599|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767600|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1767601|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1767602|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
1767603|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767604|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767605|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1767606|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1767607|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1767608|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1767609|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1767610|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1767611|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
1767612|NCT03505762|Hormones|hormones|mesh-ancestor
1767613|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1767614|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1767615|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1767616|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
1767617|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
1767618|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
1767619|NCT03502148|Cisplatin|cisplatin|mesh-list
1767620|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767636|NCT03450772|Pancrelipase|pancrelipase|mesh-list
1767637|NCT03450772|Pancreatin|pancreatin|mesh-list
1767638|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1767639|NCT03445728|Nicorandil|nicorandil|mesh-list
1767640|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1767641|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1767642|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
1767643|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
1767644|NCT03445728|Vitamins|vitamins|mesh-ancestor
1767645|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
1767646|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767647|NCT03424460|Hemostatics|hemostatics|mesh-list
1767648|NCT03424460|Coagulants|coagulants|mesh-ancestor
1767654|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
1767655|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767656|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767678|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
1767679|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767680|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767681|NCT03278691|Ketorolac|ketorolac|mesh-list
1767682|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1767683|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1767684|NCT03278691|Analgesics|analgesics|mesh-ancestor
1767685|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
1767686|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1767687|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767688|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1767689|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1767690|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1767691|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1767692|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767693|NCT03274375|Rituximab|rituximab|mesh-list
1767694|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767695|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767696|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
1767697|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767698|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1767709|NCT03257761|Durvalumab|durvalumab|mesh-list
1767710|NCT03257761|Guadecitabine|guadecitabine|mesh-list
1767711|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767712|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767724|NCT03218826|Docetaxel|docetaxel|mesh-list
1767725|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767726|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
1767727|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
1767728|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
1767729|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767732|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
1767733|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767734|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767748|NCT03110107|Nivolumab|nivolumab|mesh-list
1767749|NCT03110107|Ipilimumab|ipilimumab|mesh-list
1767750|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1767751|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767752|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1767753|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767759|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1767760|NCT03057795|Nivolumab|nivolumab|mesh-list
1767761|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1767762|NCT03057795|Antibodies|antibodies|mesh-list
1767763|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
1767764|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1767765|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
1767766|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
1767767|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767768|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767769|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1767770|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767799|NCT03014648|Atezolizumab|atezolizumab|mesh-list
1767800|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767861|NCT02959619|Ensartinib|ensartinib|mesh-list
1767862|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767863|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1767864|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1767865|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767916|NCT02908750|Fexofenadine|fexofenadine|mesh-list
1767917|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1767918|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1767919|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1767920|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
1767921|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
1767922|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1767923|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1767924|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767927|NCT02862275|Atezolizumab|atezolizumab|mesh-list
1767928|NCT02862275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1767929|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1767930|NCT02862275|Immunologic Factors|immunologic factors|mesh-ancestor
1767931|NCT02862275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1767932|NCT02795520|OTS167|ots167|mesh-list
1767933|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1767934|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1767935|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1768022|NCT02645149|Trametinib|trametinib|mesh-list
1768023|NCT02645149|Ceritinib|ceritinib|mesh-list
1768024|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1768025|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1768026|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1768027|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1768028|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
1768029|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1768030|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1768046|NCT02620579|Propranolol|propranolol|mesh-list
1768047|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1768048|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1768049|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
1768050|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1768051|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1768052|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1768053|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1768054|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1768055|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
1768056|NCT02598661|Imetelstat|imetelstat|mesh-list
1768057|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
1768058|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1768059|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1768060|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1768091|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1768092|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1768093|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1768094|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1768095|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1768225|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
1768226|NCT02420314|Paclitaxel|paclitaxel|mesh-list
1768227|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1768228|NCT02420314|Carboplatin|carboplatin|mesh-list
1768229|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1768230|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1768231|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
1768232|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
1768233|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
1768234|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1768235|NCT02420314|Vitamins|vitamins|mesh-ancestor
1768236|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
1768237|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1768238|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
1768239|NCT02420314|Protective Agents|protective agents|mesh-ancestor
1768242|NCT02370589|Vaccines|vaccines|mesh-list
1768243|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
1768244|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1768257|NCT02313194|Buspirone|buspirone|mesh-list
1768258|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1768259|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1768260|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1768261|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1768262|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1768263|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1768264|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
1768265|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1768266|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1768355|NCT02100956|Oxytocin|oxytocin|mesh-list
1768356|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
1768357|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1768358|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1768373|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
1768374|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
1768375|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1768376|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
1768377|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1768423|NCT01752049|Timolol|timolol|mesh-list
1768424|NCT01752049|Maleic acid|maleic acid|mesh-list
1768425|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1768426|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1768427|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
1768428|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1768429|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1768430|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1768431|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1768432|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1768433|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1768450|NCT01316523|Rituximab|rituximab|mesh-list
1768451|NCT01316523|Lenalidomide|lenalidomide|mesh-list
1768452|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1768453|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1768454|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
1768455|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1768456|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1768457|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1768458|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1768459|NCT01316523|Growth Substances|growth substances|mesh-ancestor
1768460|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
1768538|NCT00085774|Albuterol|albuterol|mesh-list
1768539|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1768540|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
1768541|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1768542|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1768543|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1768544|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
1768545|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
1768546|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1768547|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1768548|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1768549|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1768550|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
1768551|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1768552|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1768553|NCT00071552|Fluticasone|fluticasone|mesh-list
1768554|NCT00071552|Xhance|xhance|mesh-list
1768555|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1768556|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1768557|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
1768558|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1768559|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1768560|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1768561|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
1768562|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
1768563|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1768564|NCT05136066|Peppermint oil|peppermint oil|mesh-list
1768565|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
1768566|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
1768567|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1768568|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1768569|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1768570|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
1768787|NCT05125146|Trazodone|trazodone|mesh-list
1768788|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1768789|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1768790|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1768791|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1768792|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1768793|NCT05125146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1768794|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1768795|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1768796|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1768797|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1768798|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
1768799|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1768800|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
1771101|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1771102|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
1771103|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1771114|NCT05136677|Carboplatin|carboplatin|mesh-list
1771115|NCT05136677|Nivolumab|nivolumab|mesh-list
1771116|NCT05136677|Pemetrexed|pemetrexed|mesh-list
1771117|NCT05136677|Ipilimumab|ipilimumab|mesh-list
1771118|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1771119|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1771120|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1771121|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771122|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771123|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1771124|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1771142|NCT05136534|Anesthetics|anesthetics|mesh-list
1771143|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1771144|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771145|NCT05136521|Trazodone|trazodone|mesh-list
1771146|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1771147|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1771148|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1771149|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771150|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1771151|NCT05136521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1771152|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1771153|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1771154|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771155|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1771156|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
1771157|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1771158|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
1771159|NCT05136508|Propofol|propofol|mesh-list
1771160|NCT05136508|Sevoflurane|sevoflurane|mesh-list
1771161|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1771162|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1771163|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771164|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1771165|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
1771166|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
1771167|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1771168|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1771184|NCT05136157|Insulin|insulin|mesh-list
1771185|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1771186|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
1771187|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1771188|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771194|NCT05135858|Methotrexate|methotrexate|mesh-list
1771195|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1771196|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
1771197|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1771198|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771199|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1771200|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
1771201|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771202|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1771203|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
1771204|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771205|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1771206|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1771207|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
1771208|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1771209|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1771210|NCT05135845|Spartalizumab|spartalizumab|mesh-list
1771211|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1771212|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771213|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1771221|NCT05135637|Vaccines|vaccines|mesh-list
1771222|NCT05135637|Immunologic Factors|immunologic factors|mesh-ancestor
1771223|NCT05135637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771224|NCT05135442|Bortezomib|bortezomib|mesh-list
1771225|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1771238|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1771239|NCT05135286|Carbachol|carbachol|mesh-list
1771240|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1771241|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1771242|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1771243|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1771244|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
1771245|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1771246|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771247|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771248|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1771249|NCT05135286|Miotics|miotics|mesh-ancestor
1771250|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
1771251|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1771252|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1771253|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
1771254|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1771255|NCT05135286|Analgesics|analgesics|mesh-ancestor
1771256|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
1771257|NCT05135286|Protective Agents|protective agents|mesh-ancestor
1771258|NCT05135273|Vaccines|vaccines|mesh-list
1771259|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
1771260|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771278|NCT05135104|Palbociclib|palbociclib|mesh-list
1771279|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1771280|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1771281|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771282|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771283|NCT05135039|Canagliflozin|canagliflozin|mesh-list
1771284|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1771285|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771286|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1771287|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771288|NCT05135013|Drospirenone|drospirenone|mesh-list
1771289|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1771290|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1771291|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1771292|NCT05135013|Norethindrone|norethindrone|mesh-list
1771293|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
1771294|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
1771295|NCT05135013|Estradiol|estradiol|mesh-list
1771296|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1771297|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
1771298|NCT05135013|Estrogens|estrogens|mesh-ancestor
1771299|NCT05135013|Hormones|hormones|mesh-ancestor
1771300|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1771301|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771302|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1771303|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
1771304|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1771305|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1771306|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1771307|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1771308|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1771309|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
1771310|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1771311|NCT05135013|Diuretics|diuretics|mesh-ancestor
1771312|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
1771313|NCT05135013|Progestins|progestins|mesh-ancestor
1771314|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1771328|NCT05134922|Gedatolisib|gedatolisib|mesh-list
1771329|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1771330|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771331|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771339|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
1771340|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1771341|NCT05134792|Antibodies|antibodies|mesh-list
1771342|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
1771343|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1771344|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
1771345|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771346|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
1771347|NCT05134688|Analgesics|analgesics|mesh-ancestor
1771348|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
1771349|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1771350|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771351|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
1771352|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1771353|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1771354|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
1771355|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1771356|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1771357|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771358|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1771359|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
1771360|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1771367|NCT05134558|Xenon|xenon|mesh-list
1771368|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1771369|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
1771370|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
1771371|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1771372|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771373|NCT05134519|Trastuzumab|trastuzumab|mesh-list
1771374|NCT05134519|Antibodies|antibodies|mesh-list
1771375|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1771376|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
1771377|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771378|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1771379|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1771386|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1771387|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1771388|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1771389|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
1771409|NCT05122169|Iodine|iodine|mesh-list
1771410|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
1771411|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1771412|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
1771413|NCT05122169|Povidone|povidone|mesh-list
1771414|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1771415|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1771416|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
1771417|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
1771418|NCT05122169|Trace Elements|trace elements|mesh-ancestor
1771419|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
1771420|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771421|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
1771422|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
1771423|NCT05121571|Sorafenib|sorafenib|mesh-list
1771424|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1771425|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1771426|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771427|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771428|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
1771429|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1771430|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771431|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771432|NCT05120141|Listerine|listerine|mesh-list
1771433|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1771434|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1771435|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
1771436|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1771437|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1771473|NCT05098041|Rifampin|rifampin|mesh-list
1771474|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1771475|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
1771476|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1771477|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1771478|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
1771479|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1771480|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771481|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771482|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1771483|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1771484|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1771485|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1771486|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1771487|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1771491|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
1771492|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1771493|NCT05090657|Methylene Blue|methylene blue|mesh-list
1771494|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1771495|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1771496|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
1771497|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
1771498|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771499|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771500|NCT05087862|Anesthetics|anesthetics|mesh-list
1771501|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
1771502|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1771503|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771504|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
1771505|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1771565|NCT05060523|Tolvaptan|tolvaptan|mesh-list
1771566|NCT05060523|Midodrine|midodrine|mesh-list
1771567|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1771568|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771569|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
1771570|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771571|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
1771572|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
1771573|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1771574|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1771575|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1771576|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1771577|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1771578|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
1771579|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1771580|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
1771581|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
1771582|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1771583|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1771584|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
1771585|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771586|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
1771587|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1771588|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1771612|NCT05049525|Itraconazole|itraconazole|mesh-list
1771613|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
1771614|NCT05049525|Terbinafine|terbinafine|mesh-list
1771615|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
1771616|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1771617|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1771618|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1771619|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771620|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771621|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1771622|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
1771623|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1771624|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771625|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1771759|NCT05024773|Paclitaxel|paclitaxel|mesh-list
1771760|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
1771761|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1771762|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1771763|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
1771764|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
1771765|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
1771766|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771767|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1771768|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
1771769|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771770|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
1771771|NCT05024773|Protective Agents|protective agents|mesh-ancestor
1771772|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
1771773|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1771774|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
1771775|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771776|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771777|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1771797|NCT05014334|Amoxicillin|amoxicillin|mesh-list
1771798|NCT05014334|Clarithromycin|clarithromycin|mesh-list
1771799|NCT05014334|Rabeprazole|rabeprazole|mesh-list
1771800|NCT05014334|Bismuth|bismuth|mesh-list
1771801|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1771802|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1771803|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1771804|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771805|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771806|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1771807|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1771808|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1771809|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1771810|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1771811|NCT05014334|Antacids|antacids|mesh-ancestor
1771812|NCT05014087|Digoxin|digoxin|mesh-list
1771813|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1771814|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1771815|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771816|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771817|NCT05014087|Protective Agents|protective agents|mesh-ancestor
1771818|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771856|NCT05007522|Ketotifen|ketotifen|mesh-list
1771857|NCT05007522|Indomethacin|indomethacin|mesh-list
1771858|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1771859|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1771860|NCT05007522|Analgesics|analgesics|mesh-ancestor
1771861|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
1771862|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1771863|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771864|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1771865|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1771866|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
1771867|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
1771868|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1771869|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1771870|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771871|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771872|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
1771873|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
1771874|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1771875|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
1771876|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
1771877|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1771878|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1771902|NCT05002192|Eucalyptol|eucalyptol|mesh-list
1771903|NCT05002192|Ambroxol|ambroxol|mesh-list
1771904|NCT05002192|Expectorants|expectorants|mesh-list
1771905|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
1771906|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1771907|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
1771908|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
1771909|NCT05002192|Protective Agents|protective agents|mesh-ancestor
1771910|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771917|NCT04986605|Methoxsalen|methoxsalen|mesh-list
1771918|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1771919|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
1771936|NCT04976777|Dexamethasone|dexamethasone|mesh-list
1771937|NCT04976777|Dexamethasone acetate|dexamethasone acetate|mesh-list
1771938|NCT04976777|BB 1101|bb 1101|mesh-list
1771939|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1771940|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
1771941|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
1771942|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1771943|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771944|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1771945|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
1771946|NCT04976777|Hormones|hormones|mesh-ancestor
1771947|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1771948|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1771949|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1771950|NCT04976777|Protease Inhibitors|protease inhibitors|mesh-ancestor
1771951|NCT04976777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771952|NCT04976777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771953|NCT04975347|Naloxone|naloxone|mesh-list
1771954|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771955|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1771956|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
1771957|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1771958|NCT04975334|Naloxone|naloxone|mesh-list
1771959|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
1771960|NCT04975334|Hormones|hormones|mesh-ancestor
1771961|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1771962|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1771963|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1771964|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
1771965|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1771966|NCT04973020|Efavirenz|efavirenz|mesh-list
1771967|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1771968|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1771969|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1771970|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1771971|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
1771972|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1771973|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1771974|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1771975|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1771976|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1771977|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1771978|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1772032|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
1772033|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1772034|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1772035|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772036|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1772037|NCT04955249|Analgesics|analgesics|mesh-ancestor
1772038|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
1772039|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1772040|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1772041|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1772042|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1772043|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
1772044|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1772045|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772142|NCT04910503|Dexamethasone|dexamethasone|mesh-list
1772143|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
1772144|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1772145|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
1772146|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
1772147|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1772148|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772149|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1772150|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
1772151|NCT04910503|Hormones|hormones|mesh-ancestor
1772152|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1772153|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1772154|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1772155|NCT04908787|Paclitaxel|paclitaxel|mesh-list
1772156|NCT04908787|Doxorubicin|doxorubicin|mesh-list
1772157|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1772158|NCT04908787|Topotecan|topotecan|mesh-list
1772159|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1772160|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1772161|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
1772162|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
1772163|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
1772164|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772165|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1772166|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1772167|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1772168|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1772169|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1772170|NCT04908449|Bupivacaine|bupivacaine|mesh-list
1772171|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
1772172|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
1772173|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1772174|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772175|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
1772176|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1772193|NCT04904549|Vaccines|vaccines|mesh-list
1772194|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
1772195|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772208|NCT04897217|Megestrol|megestrol|mesh-list
1772209|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
1772210|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
1772211|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1772212|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
1772213|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1772214|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772215|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1772216|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1772217|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1772218|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1772219|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1772220|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1772221|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
1772222|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1772257|NCT04886453|Morphine|morphine|mesh-list
1772258|NCT04886453|Anesthetics|anesthetics|mesh-list
1772259|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1772260|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772261|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1772262|NCT04886453|Narcotics|narcotics|mesh-ancestor
1772263|NCT04886453|Analgesics|analgesics|mesh-ancestor
1772264|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
1772265|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1772266|NCT04883346|Liraglutide|liraglutide|mesh-list
1772267|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1772268|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772269|NCT04883346|Incretins|incretins|mesh-ancestor
1772270|NCT04883346|Hormones|hormones|mesh-ancestor
1772271|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1772278|NCT04877522|Niacinamide|niacinamide|mesh-list
1772279|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
1772280|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1772281|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1772282|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1772283|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772284|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
1772285|NCT04877522|Vitamins|vitamins|mesh-ancestor
1772286|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
1772287|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772295|NCT04874480|Decitabine|decitabine|mesh-list
1772296|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1772297|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
1772298|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772299|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1772300|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1772311|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
1772312|NCT04865887|Lenvatinib|lenvatinib|mesh-list
1772313|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1772314|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1772315|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1772316|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1772317|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772334|NCT04849832|Fesoterodine|fesoterodine|mesh-list
1772335|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1772336|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1772337|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
1772338|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1772339|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772340|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772341|NCT04849832|Urological Agents|urological agents|mesh-ancestor
1772436|NCT04781192|Durvalumab|durvalumab|mesh-list
1772437|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1772438|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1772439|NCT04780932|Macitentan|macitentan|mesh-list
1772440|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
1772441|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1772442|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772443|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
1772467|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
1772468|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1772469|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
1772470|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772471|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
1772472|NCT04769453|Protective Agents|protective agents|mesh-ancestor
1772569|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
1772570|NCT04745988|Lenvatinib|lenvatinib|mesh-list
1772571|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1772572|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1772573|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1772574|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1772575|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772576|NCT04745910|Rasburicase|rasburicase|mesh-list
1772577|NCT04745910|Uric Acid|uric acid|mesh-list
1772578|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
1772579|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1772580|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
1772581|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772582|NCT04745910|Protective Agents|protective agents|mesh-ancestor
1772583|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772654|NCT04720612|Omalizumab|omalizumab|mesh-list
1772655|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1772656|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1772657|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
1772662|NCT04717154|Nivolumab|nivolumab|mesh-list
1772663|NCT04717154|Ipilimumab|ipilimumab|mesh-list
1772664|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1772665|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1772666|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1772667|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772692|NCT04702464|Fluconazole|fluconazole|mesh-list
1772693|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
1772694|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1772695|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1772696|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1772697|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1772698|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772699|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1772700|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
1772701|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1772702|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772703|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1772704|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1772705|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
1772706|NCT04700072|Lenvatinib|lenvatinib|mesh-list
1772707|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1772708|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1772709|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1772710|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1772711|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772712|NCT04698057|Amoxicillin|amoxicillin|mesh-list
1772713|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
1772714|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
1772715|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
1772716|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1772717|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1772718|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1772719|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1772720|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1772721|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1772722|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772723|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1772724|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1772725|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1772726|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1772749|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
1772750|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
1772751|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1772752|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1772753|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1772754|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1772755|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772756|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1772813|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
1772814|NCT04664972|Docetaxel|docetaxel|mesh-list
1772815|NCT04664972|Doxorubicin|doxorubicin|mesh-list
1772816|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1772817|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
1772818|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772819|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1772820|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1772821|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
1772822|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772823|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1772824|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1772825|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
1772826|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
1772827|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
1772828|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1772829|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1772830|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1772831|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1772884|NCT04652544|Vitamin D|vitamin d|mesh-list
1772885|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
1772886|NCT04652544|Vitamins|vitamins|mesh-ancestor
1772887|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
1772888|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772889|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1772890|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1772894|NCT04644705|Niclosamide|niclosamide|mesh-list
1772895|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
1772896|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1772897|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
1772898|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1772899|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1772900|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
1772928|NCT04637555|Valsartan|valsartan|mesh-list
1772929|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1772930|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1772931|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1772932|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1772933|NCT04636034|Anesthetics|anesthetics|mesh-list
1772934|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
1772935|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1772936|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1772937|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
1772938|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1773029|NCT04607122|Landiolol|landiolol|mesh-list
1773030|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1773031|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1773032|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
1773033|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1773034|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773035|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773036|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1773037|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
1773038|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1773039|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773095|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
1773096|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
1773097|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773098|NCT04576663|Phenylephrine|phenylephrine|mesh-list
1773099|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
1773100|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1773101|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
1773102|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
1773103|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1773104|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773105|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
1773106|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1773107|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
1773108|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
1773109|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1773110|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1773111|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1773112|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
1773113|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1773114|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773115|NCT04576663|Protective Agents|protective agents|mesh-ancestor
1773146|NCT04556357|Phenylephrine|phenylephrine|mesh-list
1773147|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
1773148|NCT04556357|Norepinephrine|norepinephrine|mesh-list
1773149|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
1773150|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1773151|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
1773152|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
1773153|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1773154|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773155|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
1773156|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
1773157|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
1773158|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1773159|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1773160|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1773161|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
1773162|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1773163|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773164|NCT04556357|Protective Agents|protective agents|mesh-ancestor
1773165|NCT04553939|Gemcitabine|gemcitabine|mesh-list
1773166|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1773167|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
1773168|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773169|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773170|NCT04553939|Antiviral Agents|antiviral agents|mesh-ancestor
1773171|NCT04553939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1773172|NCT04553939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1773173|NCT04553939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1773174|NCT04553939|Immunologic Factors|immunologic factors|mesh-ancestor
1773175|NCT04553939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773195|NCT04547946|Trametinib|trametinib|mesh-list
1773196|NCT04547946|Dabrafenib|dabrafenib|mesh-list
1773197|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773198|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1773199|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1773200|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773230|NCT04515901|Lidocaine|lidocaine|mesh-list
1773231|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
1773232|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
1773233|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1773234|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773235|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
1773236|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1773237|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1773238|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1773239|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1773240|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1773241|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773246|NCT04504175|Ketamine|ketamine|mesh-list
1773247|NCT04504175|Analgesics|analgesics|mesh-ancestor
1773248|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
1773249|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1773250|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773251|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1773252|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1773253|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
1773254|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
1773255|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1773256|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1773257|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1773258|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1773259|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773260|NCT04501939|Venetoclax|venetoclax|mesh-list
1773261|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773314|NCT04468425|Tofacitinib|tofacitinib|mesh-list
1773315|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773316|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1773317|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1773355|NCT04434326|Vorolanib|vorolanib|mesh-list
1773356|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1773357|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1773358|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773376|NCT04426968|Interferons|interferons|mesh-list
1773377|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773378|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
1773379|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1773390|NCT04400695|Paclitaxel|paclitaxel|mesh-list
1773391|NCT04400695|Vinorelbine|vinorelbine|mesh-list
1773392|NCT04400695|Docetaxel|docetaxel|mesh-list
1773393|NCT04400695|Capecitabine|capecitabine|mesh-list
1773394|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1773395|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773396|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
1773397|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
1773398|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
1773399|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773552|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
1773400|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1773401|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
1773402|NCT04398706|Vaccines|vaccines|mesh-list
1773403|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1773404|NCT04398706|Immunoglobulins|immunoglobulins|mesh-list
1773405|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
1773406|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773444|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
1773445|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1773446|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773461|NCT04359329|Estradiol|estradiol|mesh-list
1773462|NCT04359329|Estrogens|estrogens|mesh-ancestor
1773463|NCT04359329|Hormones|hormones|mesh-ancestor
1773464|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1773465|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773491|NCT04328506|Vorolanib|vorolanib|mesh-list
1773492|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1773493|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1773494|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773535|NCT04303689|Colchicine|colchicine|mesh-list
1773536|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
1773537|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1773538|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
1773539|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
1773540|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
1773541|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773542|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773548|NCT04287855|Dexamethasone|dexamethasone|mesh-list
1773549|NCT04287855|Pomalidomide|pomalidomide|mesh-list
1773550|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1773551|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
1773553|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1773554|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773555|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1773556|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
1773557|NCT04287855|Hormones|hormones|mesh-ancestor
1773558|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1773559|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1773560|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773561|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
1773562|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1773563|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1773564|NCT04287855|Growth Substances|growth substances|mesh-ancestor
1773565|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
1773622|NCT04264897|Metformin|metformin|mesh-list
1773623|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1773624|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773625|NCT04253964|Paclitaxel|paclitaxel|mesh-list
1773626|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1773627|NCT04253964|Carboplatin|carboplatin|mesh-list
1773628|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
1773629|NCT04253964|Pemetrexed|pemetrexed|mesh-list
1773630|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1773631|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773632|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
1773633|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
1773634|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
1773635|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773636|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1773637|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1773638|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1773639|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1773649|NCT04246060|Cysteamine|cysteamine|mesh-list
1773650|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
1773651|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773674|NCT04235140|Ivacaftor|ivacaftor|mesh-list
1773675|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1773676|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1773677|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773780|NCT04203875|Abatacept|abatacept|mesh-list
1773781|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1773782|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773783|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773784|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1773785|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
1773786|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773787|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1773795|NCT04199026|Sirolimus|sirolimus|mesh-list
1773796|NCT04199026|Doxorubicin|doxorubicin|mesh-list
1773797|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1773798|NCT04199026|Daunorubicin|daunorubicin|mesh-list
1773799|NCT04199026|Irinotecan|irinotecan|mesh-list
1773800|NCT04199026|Vincristine|vincristine|mesh-list
1773801|NCT04199026|Everolimus|everolimus|mesh-list
1773802|NCT04199026|Temozolomide|temozolomide|mesh-list
1773803|NCT04199026|Ifosfamide|ifosfamide|mesh-list
1773804|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
1773805|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1773806|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1773807|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773808|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1773809|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1773810|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1773811|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773812|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1773813|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1773814|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
1773815|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
1773816|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
1773817|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1773818|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
1773819|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773820|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1773821|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
1773822|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1773823|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1773824|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
1773938|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
1774167|NCT03976934|Urological Agents|urological agents|mesh-ancestor
1773939|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1773940|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773952|NCT04115956|Dexamethasone|dexamethasone|mesh-list
1773953|NCT04115956|Melphalan|melphalan|mesh-list
1773954|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1773955|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
1773956|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
1773957|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1773958|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773959|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1773960|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
1773961|NCT04115956|Hormones|hormones|mesh-ancestor
1773962|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1773963|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1773964|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1773965|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1773966|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
1773967|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1773968|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1773969|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1773970|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
1773971|NCT04114539|Ecopipam|ecopipam|mesh-list
1773972|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1773973|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1773974|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1773975|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1773976|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1773977|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1773978|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
1773979|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1773980|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774001|NCT04094298|FX006|fx006|mesh-list
1774002|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1774003|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
1774004|NCT04094298|Hormones|hormones|mesh-ancestor
1774005|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1774006|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774007|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1774008|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
1774055|NCT04046549|Abatacept|abatacept|mesh-list
1774056|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1774057|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774058|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774059|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1774060|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
1774061|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774062|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1774093|NCT04003636|Gemcitabine|gemcitabine|mesh-list
1774094|NCT04003636|Cisplatin|cisplatin|mesh-list
1774095|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
1774096|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774097|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1774098|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
1774099|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774100|NCT04003636|Antiviral Agents|antiviral agents|mesh-ancestor
1774101|NCT04003636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1774102|NCT04003636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1774103|NCT04003636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1774104|NCT04003636|Immunologic Factors|immunologic factors|mesh-ancestor
1774105|NCT04003636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774106|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1774159|NCT03976934|Tamsulosin|tamsulosin|mesh-list
1774160|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1774161|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1774162|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1774163|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
1774164|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1774165|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774166|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774182|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
1774183|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1774184|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
1774185|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774195|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
1774196|NCT03969446|Decitabine|decitabine|mesh-list
1774197|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1774198|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774199|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1774200|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
1774201|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774202|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1774224|NCT03939897|Fulvestrant|fulvestrant|mesh-list
1774225|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1774226|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774227|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1774228|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1774229|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
1774230|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1774231|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774251|NCT03909217|Dexetimide|dexetimide|mesh-list
1774252|NCT03909217|Citalopram|citalopram|mesh-list
1774253|NCT03909217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1774254|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1774255|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1774256|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774257|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1774258|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
1774259|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774260|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1774261|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
1774262|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1774263|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1774264|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1774265|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
1774266|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
1774267|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1774268|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1774269|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1774270|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
1774271|NCT03909165|Atropine|atropine|mesh-list
1774272|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
1774273|NCT03909165|Neostigmine|neostigmine|mesh-list
1774274|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1774275|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1774276|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1774277|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
1774278|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1774279|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774280|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1774281|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
1774282|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
1774283|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
1774284|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1774285|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1774286|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
1774287|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1774288|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774289|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1774290|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1774291|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1774330|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
1774331|NCT03890289|Idelalisib|idelalisib|mesh-list
1774332|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1774333|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774334|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1774335|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774344|NCT03870529|Vitamins|vitamins|mesh-list
1774345|NCT03870529|Vitamin A|vitamin a|mesh-list
1774346|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
1774347|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
1774348|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
1774349|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774350|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
1774351|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774352|NCT03870529|Protective Agents|protective agents|mesh-ancestor
1774353|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1774354|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774364|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
1774365|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1774366|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1774367|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774368|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1774369|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774370|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1774371|NCT03856047|Liraglutide|liraglutide|mesh-list
1774372|NCT03856047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1774373|NCT03856047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774374|NCT03856047|Incretins|incretins|mesh-ancestor
1774375|NCT03856047|Hormones|hormones|mesh-ancestor
1774376|NCT03856047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1774519|NCT03770546|Betamethasone|betamethasone|mesh-list
1774520|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1774521|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
1774522|NCT03770546|Hormones|hormones|mesh-ancestor
1774523|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1774524|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774525|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1774526|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
1774531|NCT03763643|Rituximab|rituximab|mesh-list
1774532|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1774533|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774534|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
1774535|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774536|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1774537|NCT03749187|Temozolomide|temozolomide|mesh-list
1774538|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1774539|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1774540|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
1774541|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774542|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774543|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1774577|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
1774578|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1774579|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774603|NCT03721341|Hormones|hormones|mesh-list
1774604|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1774605|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774609|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1774610|NCT03712202|Nivolumab|nivolumab|mesh-list
1774611|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1774612|NCT03712202|Doxorubicin|doxorubicin|mesh-list
1774613|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1774614|NCT03712202|Daunorubicin|daunorubicin|mesh-list
1774615|NCT03712202|Bleomycin|bleomycin|mesh-list
1774616|NCT03712202|Dacarbazine|dacarbazine|mesh-list
1774617|NCT03712202|Vinblastine|vinblastine|mesh-list
1774618|NCT03712202|Antibodies|antibodies|mesh-list
1774619|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
1774620|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1774621|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
1774622|NCT03712202|Imidazole|imidazole|mesh-list
1774623|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
1774624|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774625|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774626|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1774627|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1774628|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1774629|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1774630|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774631|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1774632|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1774633|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
1774634|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1774635|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
1774636|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
1774637|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
1774647|NCT03689374|Insulin|insulin|mesh-list
1774648|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1774649|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
1774650|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
1774651|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1774652|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774671|NCT03672773|Temozolomide|temozolomide|mesh-list
1774672|NCT03672773|Talazoparib|talazoparib|mesh-list
1774673|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1774674|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
1774675|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774676|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774677|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1774678|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1774694|NCT03659539|Propofol|propofol|mesh-list
1774695|NCT03659539|Desflurane|desflurane|mesh-list
1774696|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1774697|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1774698|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774699|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1774700|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
1774701|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
1774702|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1774718|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
1774719|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1774720|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1774721|NCT03627858|Beclomethasone|beclomethasone|mesh-list
1774722|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
1774723|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
1774724|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1774725|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
1774726|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1774727|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774728|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1774729|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
1774730|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1774731|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1774732|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1774733|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
1774734|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1774735|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774736|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1774737|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
1774738|NCT03627858|Hormones|hormones|mesh-ancestor
1774739|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1774740|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1774741|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1774742|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1774743|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
1774758|NCT03620123|Docetaxel|docetaxel|mesh-list
1774759|NCT03620123|Nivolumab|nivolumab|mesh-list
1774760|NCT03620123|Ipilimumab|ipilimumab|mesh-list
1774761|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774762|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
1774763|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
1774764|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
1774765|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774766|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1774767|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1774781|NCT03601637|Ivacaftor|ivacaftor|mesh-list
1774782|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1774783|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1774784|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774808|NCT03586999|Nivolumab|nivolumab|mesh-list
1774809|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1774810|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774811|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1774812|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774818|NCT03552692|Venetoclax|venetoclax|mesh-list
1774819|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774885|NCT03467958|Ozanimod|ozanimod|mesh-list
1774886|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1774887|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774888|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1774889|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
1774890|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774920|NCT03430843|Paclitaxel|paclitaxel|mesh-list
1774921|NCT03430843|Docetaxel|docetaxel|mesh-list
1774922|NCT03430843|Irinotecan|irinotecan|mesh-list
1774923|NCT03430843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1774924|NCT03430843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774925|NCT03430843|Tubulin Modulators|tubulin modulators|mesh-ancestor
1774926|NCT03430843|Antimitotic Agents|antimitotic agents|mesh-ancestor
1774927|NCT03430843|Mitosis Modulators|mitosis modulators|mesh-ancestor
1774928|NCT03430843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774929|NCT03430843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1774930|NCT03430843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1774931|NCT03430843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1774932|NCT03425643|Gemcitabine|gemcitabine|mesh-list
1774933|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
1774934|NCT03425643|Pemetrexed|pemetrexed|mesh-list
1774935|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774936|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1774937|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
1774938|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774939|NCT03425643|Antiviral Agents|antiviral agents|mesh-ancestor
1774940|NCT03425643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1774941|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1774942|NCT03425643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1774943|NCT03425643|Immunologic Factors|immunologic factors|mesh-ancestor
1774944|NCT03425643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1774945|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1774946|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1774947|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1774950|NCT03398655|Paclitaxel|paclitaxel|mesh-list
1774951|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1774952|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1774953|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1774954|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
1774955|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
1774956|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
1774957|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1774972|NCT03370172|Factor VIII|factor viii|mesh-list
1774973|NCT03370172|Coagulants|coagulants|mesh-ancestor
1775044|NCT03292146|Denosumab|denosumab|mesh-list
1775045|NCT03292146|Alendronate|alendronate|mesh-list
1775046|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1775047|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775048|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
1775049|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1775050|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1775051|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775052|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1775053|NCT03289325|Analgesics|analgesics|mesh-ancestor
1775054|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
1775055|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1775056|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1775057|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1775058|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1775059|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
1775060|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1775061|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775064|NCT03274492|Prednisone|prednisone|mesh-list
1775065|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
1775066|NCT03274492|Rituximab|rituximab|mesh-list
1775067|NCT03274492|Doxorubicin|doxorubicin|mesh-list
1775068|NCT03274492|Vincristine|vincristine|mesh-list
1775069|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1775070|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
1775071|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1775072|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
1775073|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775074|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1775075|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1775076|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
1775077|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775078|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775079|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1775080|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1775081|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1775082|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1775083|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1775084|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1775085|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1775086|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
1775087|NCT03274492|Hormones|hormones|mesh-ancestor
1775088|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1775089|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1775090|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1775091|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
1775092|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
1775093|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
1775094|NCT03270501|Golimumab|golimumab|mesh-list
1775095|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1775096|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1775097|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1775098|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
1775099|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775149|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
1775150|NCT03251651|Propofol|propofol|mesh-list
1775151|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1775152|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1775153|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775154|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1775155|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
1775156|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
1775157|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1775158|NCT03251651|Analgesics|analgesics|mesh-ancestor
1775159|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
1775160|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1775161|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1775162|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1775163|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1775164|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
1775165|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1775166|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775167|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
1775168|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1775169|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775238|NCT03159000|Lidocaine|lidocaine|mesh-list
1775239|NCT03159000|Bupivacaine|bupivacaine|mesh-list
1775240|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
1775241|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
1775242|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1775243|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775244|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
1775245|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1775246|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1775247|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1775248|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1775249|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1775250|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775251|NCT03126643|Nivolumab|nivolumab|mesh-list
1775252|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1775253|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775254|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1775255|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775265|NCT03126617|Elotuzumab|elotuzumab|mesh-list
1775266|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775269|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
1775270|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1775271|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775283|NCT03016819|Dacarbazine|dacarbazine|mesh-list
1775284|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1775285|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
1775286|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775287|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775339|NCT02978625|Nivolumab|nivolumab|mesh-list
1775340|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
1775341|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1775342|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775343|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1775344|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775367|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
1775368|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
1775369|NCT02951364|Ledipasvir|ledipasvir|mesh-list
1775370|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
1775371|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1775372|NCT02927067|Valganciclovir|valganciclovir|mesh-list
1775373|NCT02927067|Maribavir|maribavir|mesh-list
1775374|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
1775375|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1775376|NCT02923947|Osimertinib|osimertinib|mesh-list
1775377|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775378|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1775379|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1775380|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775381|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
1775382|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1775383|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1775384|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775385|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
1775386|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
1775387|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1775388|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
1775389|NCT02889237|Vitamin D|vitamin d|mesh-list
1775390|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
1775391|NCT02889237|Vitamins|vitamins|mesh-list
1775392|NCT02889237|Calcium|calcium|mesh-list
1775393|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
1775394|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775395|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1775396|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1775397|NCT02873962|Bevacizumab|bevacizumab|mesh-list
1775398|NCT02873962|Nivolumab|nivolumab|mesh-list
1775399|NCT02873962|Rucaparib|rucaparib|mesh-list
1775400|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1775401|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775402|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1775403|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1775404|NCT02873962|Growth Substances|growth substances|mesh-ancestor
1775405|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775406|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
1775407|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1775408|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775409|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1775410|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1775411|NCT02856438|Dexamethasone|dexamethasone|mesh-list
1775412|NCT02856438|Lenalidomide|lenalidomide|mesh-list
1775413|NCT02856438|Elotuzumab|elotuzumab|mesh-list
1775414|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1775415|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
1775416|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
1775417|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1775418|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775419|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1775420|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
1775421|NCT02856438|Hormones|hormones|mesh-ancestor
1775422|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1775423|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1775424|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775425|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
1775426|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1775427|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1775428|NCT02856438|Growth Substances|growth substances|mesh-ancestor
1775429|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
1775430|NCT02844816|Atezolizumab|atezolizumab|mesh-list
1775431|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1775432|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775433|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
1775434|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775441|NCT02814916|Dalbavancin|dalbavancin|mesh-list
1775442|NCT02814916|Teicoplanin|teicoplanin|mesh-list
1775443|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1775444|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1775450|NCT02808182|Niacin|niacin|mesh-list
1775451|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
1775452|NCT02808182|Niacinamide|niacinamide|mesh-list
1775453|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1775454|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
1775455|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775456|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1775457|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
1775458|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
1775459|NCT02808182|Vitamins|vitamins|mesh-ancestor
1775460|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
1775461|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775465|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
1775466|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1775467|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
1775468|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1775469|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775470|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1775471|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
1775472|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1775473|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
1775474|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775475|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1775476|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1775477|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
1775478|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
1775479|NCT02760329|Protective Agents|protective agents|mesh-ancestor
1775508|NCT02689167|Sunitinib|sunitinib|mesh-list
1775509|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775510|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1775511|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1775512|NCT02689167|Growth Substances|growth substances|mesh-ancestor
1775513|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775514|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
1775515|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1775516|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1775517|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775570|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1775571|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
1775572|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1775573|NCT02582697|Cisplatin|cisplatin|mesh-list
1775574|NCT02582697|Etoposide|etoposide|mesh-list
1775575|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
1775576|NCT02582697|Bleomycin|bleomycin|mesh-list
1775577|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775578|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1775579|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1775580|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1775581|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1775582|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775583|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1775614|NCT02535221|Epirubicin|epirubicin|mesh-list
1775615|NCT02535221|Goserelin|goserelin|mesh-list
1775616|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1775617|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775618|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1775619|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1775620|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1775621|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775622|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1775623|NCT02529904|Vaccines|vaccines|mesh-list
1775624|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
1775625|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775626|NCT02525796|Eplerenone|eplerenone|mesh-list
1775627|NCT02525796|Amiloride|amiloride|mesh-list
1775628|NCT02525796|Cinacalcet|cinacalcet|mesh-list
1775629|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1775630|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
1775631|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1775632|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775633|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1775634|NCT02525796|Diuretics|diuretics|mesh-ancestor
1775635|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
1775636|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1775637|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1775638|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1775639|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
1775640|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1775641|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1775642|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775643|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
1775705|NCT02386839|Mecasermin|mecasermin|mesh-list
1775706|NCT02386839|Growth Substances|growth substances|mesh-ancestor
1775707|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775734|NCT02217345|Hormones|hormones|mesh-list
1775735|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1775736|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775805|NCT02101944|Dexamethasone|dexamethasone|mesh-list
1775806|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
1775807|NCT02101944|Ichthammol|ichthammol|mesh-list
1775808|NCT02101944|BB 1101|bb 1101|mesh-list
1775809|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1775810|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
1775811|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
1775812|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1775813|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775814|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1775815|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
1775816|NCT02101944|Hormones|hormones|mesh-ancestor
1775817|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1775818|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1775819|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775820|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
1775821|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1775822|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775823|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
1775835|NCT01996605|Oxytocin|oxytocin|mesh-list
1775836|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
1775837|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1775838|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775890|NCT01729455|Belimumab|belimumab|mesh-list
1775891|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1775892|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
1775893|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775899|NCT01669915|Vitamin D|vitamin d|mesh-list
1775900|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
1775901|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
1775902|NCT01669915|Vitamins|vitamins|mesh-list
1775903|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
1775904|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775905|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1775906|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1775941|NCT01529593|Metformin|metformin|mesh-list
1775942|NCT01529593|Sirolimus|sirolimus|mesh-list
1775943|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1775944|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775945|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1775946|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1775947|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1775948|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775949|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
1775950|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1775951|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
1775952|NCT01503489|Norepinephrine|norepinephrine|mesh-list
1775953|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
1775954|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
1775955|NCT01503489|Serotonin|serotonin|mesh-list
1775956|NCT01503489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1775957|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1775958|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1775959|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
1775960|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1775961|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775962|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1775963|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
1775964|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
1775965|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1775966|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1775967|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1775968|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1775969|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
1775970|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1775971|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1775982|NCT01059188|Docetaxel|docetaxel|mesh-list
1775983|NCT01059188|Cetuximab|cetuximab|mesh-list
1775984|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775985|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
1775986|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
1775987|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
1775988|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775989|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1775990|NCT01019616|Paclitaxel|paclitaxel|mesh-list
1775991|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1775992|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1775993|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
1775994|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
1775995|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
1775996|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1775997|NCT00777582|Olaparib|olaparib|mesh-list
1775998|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1775999|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1776000|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776001|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776023|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
1776024|NCT00000587|Hematinics|hematinics|mesh-ancestor
1776025|NCT05138146|Doxorubicin|doxorubicin|mesh-list
1776026|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1776027|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1776028|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776029|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1776030|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1776031|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1776032|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776033|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
1776034|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
1776035|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776036|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1776037|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
1776038|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1776039|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776040|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1776041|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1776042|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1776043|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
1776066|NCT05137964|Vitamin D|vitamin d|mesh-list
1776067|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
1776068|NCT05137964|Vitamins|vitamins|mesh-ancestor
1776069|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
1776070|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776071|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1776095|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
1776096|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776106|NCT05137626|Digoxin|digoxin|mesh-list
1776107|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1776108|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1776109|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1776110|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776111|NCT05137626|Protective Agents|protective agents|mesh-ancestor
1776112|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776135|NCT05137587|Ketamine|ketamine|mesh-list
1776136|NCT05137587|Propofol|propofol|mesh-list
1776137|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1776138|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1776139|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776140|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1776141|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
1776142|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
1776143|NCT05137587|Analgesics|analgesics|mesh-ancestor
1776144|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
1776145|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776146|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1776147|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1776148|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1776149|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1776150|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776151|NCT05137574|Ketamine|ketamine|mesh-list
1776152|NCT05137574|Propofol|propofol|mesh-list
1776153|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1776154|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1776155|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776156|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1776157|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
1776158|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
1776159|NCT05137574|Analgesics|analgesics|mesh-ancestor
1776160|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
1776161|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776162|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1776163|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1776164|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1776165|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1776166|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776176|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
1776177|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1776178|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1776179|NCT05137522|Prednisolone|prednisolone|mesh-list
1776180|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
1776181|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1776182|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
1776183|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1776184|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
1776185|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
1776186|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776187|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776188|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1776189|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
1776190|NCT05137522|Hormones|hormones|mesh-ancestor
1776191|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1776192|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1776193|NCT05137522|Protective Agents|protective agents|mesh-ancestor
1776194|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1776195|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776196|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
1776197|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1776198|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1776199|NCT05137496|Prednisolone|prednisolone|mesh-list
1776200|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
1776201|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1776202|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
1776203|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1776204|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
1776205|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
1776206|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776207|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776208|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1776209|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
1776210|NCT05137496|Hormones|hormones|mesh-ancestor
1776211|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1776212|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1776213|NCT05137496|Protective Agents|protective agents|mesh-ancestor
1776214|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1776215|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776216|NCT05137288|Atropine|atropine|mesh-list
1776217|NCT05137288|Ondansetron|ondansetron|mesh-list
1776218|NCT05137288|Bupivacaine|bupivacaine|mesh-list
1776219|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
1776220|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
1776221|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1776222|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776223|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
1776224|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776225|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
1776226|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
1776227|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1776228|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
1776229|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
1776230|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1776231|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
1776232|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1776233|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776234|NCT05137288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1776235|NCT05137288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1776236|NCT05137288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1776237|NCT05137288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1776238|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1776239|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1776240|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1776241|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1776242|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
1776243|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
1776244|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
1776245|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1776246|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1776247|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
1776248|NCT05137262|Cisplatin|cisplatin|mesh-list
1776249|NCT05137262|Doxorubicin|doxorubicin|mesh-list
1776250|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1776251|NCT05137262|Methotrexate|methotrexate|mesh-list
1776252|NCT05137262|Durvalumab|durvalumab|mesh-list
1776253|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
1776254|NCT05137262|Vinblastine|vinblastine|mesh-list
1776255|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776256|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1776257|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1776258|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1776259|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1776260|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776261|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1776262|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
1776263|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1776264|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776265|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1776266|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
1776267|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
1776268|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1776269|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1776270|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
1776271|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1776272|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1776273|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1776274|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1776275|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
1776276|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1776277|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1776278|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1776279|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
1776280|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
1776281|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
1776282|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
1776283|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1776284|NCT05137184|Fentanyl|fentanyl|mesh-list
1776285|NCT05137184|Morphine|morphine|mesh-list
1776286|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
1776287|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1776288|NCT05137184|Narcotics|narcotics|mesh-ancestor
1776289|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1776290|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776291|NCT05137184|Analgesics|analgesics|mesh-ancestor
1776292|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
1776293|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776294|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1776295|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1776296|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
1776297|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
1776298|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1776299|NCT05137145|Linaclotide|linaclotide|mesh-list
1776300|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
1776301|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
1776302|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776303|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1776304|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1776305|NCT05137119|Vancomycin|vancomycin|mesh-list
1776306|NCT05137119|Clindamycin|clindamycin|mesh-list
1776307|NCT05137119|Cefazolin|cefazolin|mesh-list
1776308|NCT05137119|Daptomycin|daptomycin|mesh-list
1776309|NCT05137119|Penicillins|penicillins|mesh-list
1776310|NCT05137119|Penicillin G|penicillin g|mesh-list
1776311|NCT05137119|Lincomycin|lincomycin|mesh-list
1776312|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1776313|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1776314|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1776315|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776335|NCT05137054|Dexamethasone|dexamethasone|mesh-list
1776336|NCT05137054|Lenalidomide|lenalidomide|mesh-list
1776337|NCT05137054|Bortezomib|bortezomib|mesh-list
1776338|NCT05137054|Daratumumab|daratumumab|mesh-list
1776339|NCT05137054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1776340|NCT05137054|Antiemetics|antiemetics|mesh-ancestor
1776341|NCT05137054|Autonomic Agents|autonomic agents|mesh-ancestor
1776342|NCT05137054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776343|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776344|NCT05137054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1776345|NCT05137054|Glucocorticoids|glucocorticoids|mesh-ancestor
1776346|NCT05137054|Hormones|hormones|mesh-ancestor
1776347|NCT05137054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1776348|NCT05137054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1776349|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776350|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
1776351|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1776352|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1776353|NCT05137054|Growth Substances|growth substances|mesh-ancestor
1776354|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
1776355|NCT05136976|Rituximab|rituximab|mesh-list
1776356|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1776357|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776358|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
1776359|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776360|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1776361|NCT05136924|Varenicline|varenicline|mesh-list
1776362|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1776363|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1776364|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
1776365|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1776366|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776367|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776381|NCT05135715|Trastuzumab|trastuzumab|mesh-list
1776382|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1776383|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776384|NCT05135182|Metronidazole|metronidazole|mesh-list
1776385|NCT05135182|Furazolidone|furazolidone|mesh-list
1776386|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1776387|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1776388|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1776389|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1776390|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1776391|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1776392|NCT05135182|Renal Agents|renal agents|mesh-ancestor
1776393|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
1776394|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1776395|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1776396|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776397|NCT05135143|Antioxidants|antioxidants|mesh-list
1776398|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776399|NCT05135143|Protective Agents|protective agents|mesh-ancestor
1776400|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776401|NCT05133453|Pirfenidone|pirfenidone|mesh-list
1776402|NCT05133453|Analgesics|analgesics|mesh-ancestor
1776403|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
1776404|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776405|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776406|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1776407|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1776408|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1776409|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1776410|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776441|NCT05125978|Dipyrone|dipyrone|mesh-list
1776442|NCT05125978|Tramadol|tramadol|mesh-list
1776443|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1776444|NCT05125978|Narcotics|narcotics|mesh-ancestor
1776445|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1776446|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776447|NCT05125978|Analgesics|analgesics|mesh-ancestor
1776448|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
1776449|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776450|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1776451|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1776452|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1776453|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1776454|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
1776455|NCT05125796|Acetaminophen|acetaminophen|mesh-list
1776456|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
1776457|NCT05125796|Ketoprofen|ketoprofen|mesh-list
1776458|NCT05125796|Lidocaine|lidocaine|mesh-list
1776459|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
1776460|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
1776461|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1776462|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776463|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
1776464|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776465|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1776466|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1776467|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1776468|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1776469|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776470|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1776471|NCT05125796|Analgesics|analgesics|mesh-ancestor
1776472|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
1776473|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1776474|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1776475|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1776476|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1776477|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1776478|NCT05125185|Insulin|insulin|mesh-list
1776479|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1776480|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776481|NCT05124067|Dexamethasone|dexamethasone|mesh-list
1776482|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
1776483|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
1776484|NCT05124067|Ondansetron|ondansetron|mesh-list
1776485|NCT05124067|BB 1101|bb 1101|mesh-list
1776486|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1776487|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
1776488|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
1776489|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776490|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776491|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1776492|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
1776493|NCT05124067|Hormones|hormones|mesh-ancestor
1776494|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1776495|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1776496|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776497|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
1776498|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1776499|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776500|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1776501|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1776502|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1776503|NCT05124067|Analgesics|analgesics|mesh-ancestor
1776504|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
1776505|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1776506|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1776507|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1776508|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
1776509|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1776510|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
1776511|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
1776512|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1776513|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
1776514|NCT05124067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1776515|NCT05124067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1776516|NCT05124067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1776517|NCT05124067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1776538|NCT05118477|Caffeine|caffeine|mesh-list
1776539|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1776540|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776541|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1776542|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1776543|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776544|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1776545|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1776546|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
1776547|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1776563|NCT05108974|Choline|choline|mesh-list
1776564|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
1776565|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1776566|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
1776567|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776568|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1776569|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1776570|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
1776575|NCT05105139|Triclosan|triclosan|mesh-list
1776576|NCT05105139|Coal Tar|coal tar|mesh-list
1776577|NCT05105139|Allantoin|allantoin|mesh-list
1776578|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1776579|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1776580|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1776581|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1776582|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
1776583|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776584|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1776585|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
1776586|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
1776591|NCT05103215|Lidocaine|lidocaine|mesh-list
1776592|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
1776593|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
1776594|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1776595|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776596|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
1776597|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776598|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1776599|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1776600|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1776601|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1776602|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776622|NCT05042700|Melatonin|melatonin|mesh-list
1776623|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
1776624|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776625|NCT05042700|Protective Agents|protective agents|mesh-ancestor
1776626|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776627|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1776628|NCT05035862|Interferons|interferons|mesh-list
1776629|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
1776630|NCT05035862|Prednisone|prednisone|mesh-list
1776631|NCT05035862|Albuterol|albuterol|mesh-list
1776632|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1776633|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
1776634|NCT05035862|Hormones|hormones|mesh-ancestor
1776635|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1776636|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776637|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1776638|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776639|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
1776640|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1776641|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1776642|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
1776643|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776644|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1776645|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
1776646|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
1776647|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1776648|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1776649|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1776650|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1776651|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
1776652|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1776653|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776670|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
1776671|NCT05033483|Trace Elements|trace elements|mesh-ancestor
1776672|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
1776673|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776674|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
1776675|NCT05030506|Lenvatinib|lenvatinib|mesh-list
1776676|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1776677|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776678|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1776679|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1776680|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776714|NCT05027919|Lofexidine|lofexidine|mesh-list
1776715|NCT05027919|Clonidine|clonidine|mesh-list
1776716|NCT05027919|Morphine|morphine|mesh-list
1776717|NCT05027919|Naloxone|naloxone|mesh-list
1776718|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1776719|NCT05027919|Narcotics|narcotics|mesh-ancestor
1776720|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1776721|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776722|NCT05027919|Analgesics|analgesics|mesh-ancestor
1776723|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
1776724|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776725|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1776726|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1776727|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1776728|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1776729|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1776730|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
1776731|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1776732|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776733|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
1776734|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
1776748|NCT05015608|Carboplatin|carboplatin|mesh-list
1776749|NCT05015608|Pemetrexed|pemetrexed|mesh-list
1776750|NCT05015608|Osimertinib|osimertinib|mesh-list
1776751|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776752|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1776753|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776754|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1776755|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1776756|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1776771|NCT05001815|Insulin|insulin|mesh-list
1776772|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1776773|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1776774|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776775|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
1776776|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776777|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1776778|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1776779|NCT05001555|Analgesics|analgesics|mesh-ancestor
1776780|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
1776781|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776782|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1776783|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1776784|NCT04998669|Rituximab|rituximab|mesh-list
1776785|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
1776786|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1776787|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776788|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
1776789|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776790|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1776827|NCT04975555|Siltuximab|siltuximab|mesh-list
1776828|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776844|NCT04968158|Acetaminophen|acetaminophen|mesh-list
1776845|NCT04968158|Etoricoxib|etoricoxib|mesh-list
1776846|NCT04968158|Tramadol|tramadol|mesh-list
1776847|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1776848|NCT04968158|Analgesics|analgesics|mesh-ancestor
1776849|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
1776850|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1776851|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1776852|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
1776853|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1776854|NCT04968158|Narcotics|narcotics|mesh-ancestor
1776855|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1776856|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1776857|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1776858|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1776859|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1776860|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1776861|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1776862|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776893|NCT04956146|Carboplatin|carboplatin|mesh-list
1776894|NCT04956146|Pemetrexed|pemetrexed|mesh-list
1776895|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1776896|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1776897|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1776898|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1776899|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1777016|NCT04905251|Misoprostol|misoprostol|mesh-list
1777017|NCT04905251|Mifepristone|mifepristone|mesh-list
1777018|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1777019|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
1777020|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1777021|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777022|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1777023|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1777024|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
1777025|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1777026|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1777027|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1777028|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1777029|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
1777030|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1777031|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1777032|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
1777033|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1777034|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
1777035|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1777036|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1777057|NCT04895098|Ezetimibe|ezetimibe|mesh-list
1777058|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1777059|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1777060|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1777061|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
1777062|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777063|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1777064|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1777075|NCT04889066|Durvalumab|durvalumab|mesh-list
1777076|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1777077|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777120|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1777121|NCT04862962|Ezetimibe|ezetimibe|mesh-list
1777122|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1777123|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1777124|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
1777125|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777126|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1777127|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1777128|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1777129|NCT04849325|Sirolimus|sirolimus|mesh-list
1777130|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1777131|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1777132|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1777133|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777134|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
1777135|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1777136|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
1777137|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777143|NCT04848454|Vinorelbine|vinorelbine|mesh-list
1777144|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777145|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1777146|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
1777147|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
1777148|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
1777149|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777156|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
1777157|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1777158|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1777159|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1777160|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1777161|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1777162|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1777163|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777164|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777165|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1777166|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
1777167|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1777168|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777169|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1777170|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1777171|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1777186|NCT04810559|Antibodies|antibodies|mesh-list
1777187|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
1777188|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777230|NCT04799236|Amphotericin B|amphotericin b|mesh-list
1777231|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
1777232|NCT04799236|Miltefosine|miltefosine|mesh-list
1777233|NCT04799236|Amebicides|amebicides|mesh-ancestor
1777234|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1777235|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1777236|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1777237|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1777238|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
1777239|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777266|NCT04785326|Ustekinumab|ustekinumab|mesh-list
1777267|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
1777272|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
1777273|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1777274|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1777275|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777276|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1777277|NCT04771637|Analgesics|analgesics|mesh-ancestor
1777278|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
1777279|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1777280|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1777281|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1777282|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1777283|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
1777284|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1777285|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777329|NCT04737343|Azathioprine|azathioprine|mesh-list
1777330|NCT04737343|Leflunomide|leflunomide|mesh-list
1777331|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
1777332|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777333|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1777334|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777335|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1777336|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
1777337|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777338|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1777339|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1777340|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
1777341|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1777342|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
1777343|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1777344|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777345|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1777346|NCT04714710|Diuretics|diuretics|mesh-ancestor
1777347|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
1777348|NCT04696445|Morphine|morphine|mesh-list
1777349|NCT04696445|Oxycodone|oxycodone|mesh-list
1777350|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1777351|NCT04696445|Narcotics|narcotics|mesh-ancestor
1777352|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1777353|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777354|NCT04696445|Analgesics|analgesics|mesh-ancestor
1777355|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
1777356|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1777382|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
1777383|NCT04638881|Analgesics|analgesics|mesh-ancestor
1777384|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
1777385|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1777386|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777387|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
1777388|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1777389|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1777390|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
1777391|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1777392|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1777393|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777394|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1777395|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
1777396|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1777397|NCT04635683|Lenalidomide|lenalidomide|mesh-list
1777398|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
1777399|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777400|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1777401|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1777402|NCT04635683|Growth Substances|growth substances|mesh-ancestor
1777403|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
1777404|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777405|NCT04633252|Prednisone|prednisone|mesh-list
1777406|NCT04633252|Docetaxel|docetaxel|mesh-list
1777407|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777408|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
1777409|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
1777410|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
1777411|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777412|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1777413|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
1777414|NCT04633252|Hormones|hormones|mesh-ancestor
1777415|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1777416|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777417|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1777503|NCT04591808|Perindopril|perindopril|mesh-list
1777504|NCT04591808|Atorvastatin|atorvastatin|mesh-list
1777505|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1777506|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1777507|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
1777508|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777509|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1777510|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1777511|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1777512|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1777513|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
1777514|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1777529|NCT04563338|Bevacizumab|bevacizumab|mesh-list
1777530|NCT04563338|Atezolizumab|atezolizumab|mesh-list
1777531|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1777532|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777533|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1777534|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1777535|NCT04563338|Growth Substances|growth substances|mesh-ancestor
1777536|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777537|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
1777560|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
1777561|NCT04499495|Mesalamine|mesalamine|mesh-list
1777562|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1777563|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1777564|NCT04499495|Analgesics|analgesics|mesh-ancestor
1777565|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
1777566|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1777567|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777568|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1777569|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1777570|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
1777571|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1777572|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1777573|NCT04498273|Aspirin|aspirin|mesh-list
1777574|NCT04498273|Apixaban|apixaban|mesh-list
1777575|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1777576|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1777577|NCT04498273|Analgesics|analgesics|mesh-ancestor
1777578|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
1777579|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1777580|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777581|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1777582|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1777583|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1777584|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1777585|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777586|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1777587|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1777588|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1777589|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
1777590|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1777591|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
1777592|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1777593|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
1777594|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
1777634|NCT04460885|Insulin|insulin|mesh-list
1777635|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1777636|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
1777637|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1777638|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777639|NCT04450953|Eplerenone|eplerenone|mesh-list
1777640|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1777641|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
1777642|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1777643|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777644|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1777645|NCT04450953|Diuretics|diuretics|mesh-ancestor
1777646|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
1777647|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1777660|NCT04409834|Heparin|heparin|mesh-list
1777661|NCT04409834|Calcium heparin|calcium heparin|mesh-list
1777662|NCT04409834|Enoxaparin|enoxaparin|mesh-list
1777663|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
1777664|NCT04409834|Clopidogrel|clopidogrel|mesh-list
1777665|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1777666|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1777667|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1777668|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1777669|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
1777670|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1777671|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777672|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777673|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
1777674|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1777675|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1777704|NCT04326283|Trametinib|trametinib|mesh-list
1777705|NCT04326283|Riluzole|riluzole|mesh-list
1777706|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777707|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1777708|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1777709|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777710|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
1777711|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1777712|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1777713|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1777714|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777715|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1777716|NCT04326283|Protective Agents|protective agents|mesh-ancestor
1777717|NCT04314895|Paclitaxel|paclitaxel|mesh-list
1777718|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1777719|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1777720|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777721|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
1777722|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
1777723|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
1777724|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777738|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1777739|NCT04268498|Acetaminophen|acetaminophen|mesh-list
1777740|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
1777741|NCT04268498|Promethazine|promethazine|mesh-list
1777742|NCT04268498|Dexamethasone|dexamethasone|mesh-list
1777743|NCT04268498|Lenalidomide|lenalidomide|mesh-list
1777744|NCT04268498|Bortezomib|bortezomib|mesh-list
1777745|NCT04268498|Daratumumab|daratumumab|mesh-list
1777746|NCT04268498|Montelukast|montelukast|mesh-list
1777747|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1777748|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
1777749|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
1777750|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1777751|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777752|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1777753|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
1777754|NCT04268498|Hormones|hormones|mesh-ancestor
1777755|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1777756|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1777757|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777758|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
1777759|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1777760|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1777761|NCT04268498|Growth Substances|growth substances|mesh-ancestor
1777762|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
1777763|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1777764|NCT04268498|Analgesics|analgesics|mesh-ancestor
1777765|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
1777766|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
1777767|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1777768|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
1777769|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1777770|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
1777771|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1777772|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1777773|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777774|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1777775|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1777776|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1777777|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
1777778|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
1777779|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1777780|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
1777781|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
1777782|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1777783|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1777784|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
1777785|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
1777786|NCT04248465|Ravulizumab|ravulizumab|mesh-list
1777787|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1777788|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1777789|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
1777790|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777791|NCT04231565|Tenofovir|tenofovir|mesh-list
1777792|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
1777793|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1777794|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1777795|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1777796|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1777797|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777798|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1777799|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1777848|NCT04189445|Futibatinib|futibatinib|mesh-list
1777849|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777876|NCT04123444|Iloprost|iloprost|mesh-list
1777877|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1777878|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
1777879|NCT04116502|Interferons|interferons|mesh-list
1777880|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
1777881|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
1777882|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
1777883|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777884|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
1777885|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1777886|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
1777887|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777888|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
1777889|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1777890|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777891|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1777892|NCT04116047|Durvalumab|durvalumab|mesh-list
1777893|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777894|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1777911|NCT04095845|Tacrine|tacrine|mesh-list
1777912|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1777913|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1777914|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777915|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
1777916|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1777917|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777918|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1777919|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
1777920|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1777921|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
1777922|NCT04092179|Venetoclax|venetoclax|mesh-list
1777923|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777932|NCT04046900|Metronidazole|metronidazole|mesh-list
1777933|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1777934|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1777935|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1777936|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1777937|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
1777938|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1777939|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1777940|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
1777941|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777942|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1777943|NCT04038099|Lidocaine|lidocaine|mesh-list
1777944|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
1777945|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
1777946|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1777947|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777948|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
1777949|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1777950|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1777951|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1777952|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1777953|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1777954|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777955|NCT03991832|Durvalumab|durvalumab|mesh-list
1777956|NCT03991832|Olaparib|olaparib|mesh-list
1777957|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1777958|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1777959|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1777960|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1777961|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777962|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
1777963|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1777964|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777965|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
1777966|NCT03965741|Apixaban|apixaban|mesh-list
1777967|NCT03965741|Dabigatran|dabigatran|mesh-list
1777968|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1777969|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
1777970|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1777971|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
1777972|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1777973|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1777974|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
1777975|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
1777976|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1777977|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
1777978|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777985|NCT03945812|Lenograstim|lenograstim|mesh-list
1777986|NCT03945812|Sargramostim|sargramostim|mesh-list
1777987|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1777988|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
1777989|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1777990|NCT03920007|Trimethoprim|trimethoprim|mesh-list
1777991|NCT03920007|Polymyxins|polymyxins|mesh-list
1777992|NCT03920007|Polymyxin B|polymyxin b|mesh-list
1777993|NCT03920007|Prednisone|prednisone|mesh-list
1777994|NCT03920007|Prednisolone|prednisolone|mesh-list
1777995|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1777996|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
1777997|NCT03920007|Hormones|hormones|mesh-ancestor
1777998|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1777999|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778000|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1778001|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778002|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1778003|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1778004|NCT03920007|Renal Agents|renal agents|mesh-ancestor
1778005|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
1778006|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1778007|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1778008|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1778009|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1778010|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778011|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1778012|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1778013|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1778014|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1778135|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
1778111|NCT03913845|Lidocaine|lidocaine|mesh-list
1778112|NCT03913845|Epinephrine|epinephrine|mesh-list
1778113|NCT03913845|Racepinephrine|racepinephrine|mesh-list
1778114|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
1778115|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
1778116|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
1778117|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1778118|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778119|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
1778120|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1778121|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1778122|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1778123|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1778124|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1778125|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778126|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1778127|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1778128|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
1778129|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1778130|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1778131|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1778132|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
1778133|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1778134|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
1778136|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
1778137|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1778138|NCT03903939|Iloprost|iloprost|mesh-list
1778139|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1778140|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
1778141|NCT03870438|Lamivudine|lamivudine|mesh-list
1778142|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1778143|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1778144|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1778145|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778146|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
1778147|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1778148|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1778149|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1778150|NCT03834363|Fentanyl|fentanyl|mesh-list
1778151|NCT03834363|Morphine|morphine|mesh-list
1778152|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1778153|NCT03834363|Narcotics|narcotics|mesh-ancestor
1778154|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1778155|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778156|NCT03834363|Analgesics|analgesics|mesh-ancestor
1778157|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
1778158|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1778159|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1778160|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1778161|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
1778162|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
1778171|NCT03818776|Durvalumab|durvalumab|mesh-list
1778172|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1778173|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778194|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
1778195|NCT03809884|Diuretics|diuretics|mesh-ancestor
1778196|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
1778197|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778198|NCT03809884|Expectorants|expectorants|mesh-ancestor
1778199|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
1778200|NCT03792958|Vorolanib|vorolanib|mesh-list
1778201|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1778202|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1778203|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778204|NCT03785210|Vancomycin|vancomycin|mesh-list
1778205|NCT03785210|Nivolumab|nivolumab|mesh-list
1778206|NCT03785210|Tadalafil|tadalafil|mesh-list
1778207|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1778208|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778209|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1778210|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778211|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1778212|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1778213|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
1778214|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1778215|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1778216|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1778217|NCT03785210|Urological Agents|urological agents|mesh-ancestor
1778218|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
1778219|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1778220|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1778221|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778222|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
1778223|NCT03782350|Coagulants|coagulants|mesh-ancestor
1778237|NCT03767933|Acetaminophen|acetaminophen|mesh-list
1778238|NCT03767933|Ibuprofen|ibuprofen|mesh-list
1778239|NCT03767933|Hydromorphone|hydromorphone|mesh-list
1778240|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1778241|NCT03767933|Analgesics|analgesics|mesh-ancestor
1778242|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
1778243|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1778244|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778245|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
1778246|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1778247|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1778248|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1778249|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1778250|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1778251|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778252|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1778253|NCT03767933|Narcotics|narcotics|mesh-ancestor
1778254|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1778282|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
1778283|NCT03734731|Narcotics|narcotics|mesh-ancestor
1778284|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1778285|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778286|NCT03734731|Analgesics|analgesics|mesh-ancestor
1778287|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
1778288|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1778297|NCT03691714|Cetuximab|cetuximab|mesh-list
1778298|NCT03691714|Durvalumab|durvalumab|mesh-list
1778299|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1778300|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778350|NCT03636256|Docetaxel|docetaxel|mesh-list
1778351|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778352|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
1778353|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
1778354|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
1778355|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778384|NCT03578965|Cefazolin|cefazolin|mesh-list
1778385|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1778386|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1778404|NCT03559400|Gentamicins|gentamicins|mesh-list
1778405|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1778406|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1778407|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1778408|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1778409|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778410|NCT03558087|Gemcitabine|gemcitabine|mesh-list
1778411|NCT03558087|Nivolumab|nivolumab|mesh-list
1778412|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778413|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1778414|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
1778415|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778416|NCT03558087|Antiviral Agents|antiviral agents|mesh-ancestor
1778417|NCT03558087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1778418|NCT03558087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1778419|NCT03558087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1778420|NCT03558087|Immunologic Factors|immunologic factors|mesh-ancestor
1778421|NCT03558087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778422|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1778423|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1778429|NCT03519984|Cytarabine|cytarabine|mesh-list
1778430|NCT03519984|Vincristine|vincristine|mesh-list
1778431|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1778432|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
1778433|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778434|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778435|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
1778436|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1778437|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1778438|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
1778439|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778440|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1778441|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
1778442|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
1778443|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
1778486|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
1778487|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1778488|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778524|NCT03363893|Fulvestrant|fulvestrant|mesh-list
1778525|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1778526|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778527|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1778528|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1778529|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
1778530|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1778531|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778535|NCT03287778|Pyridoxine|pyridoxine|mesh-list
1778536|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
1778537|NCT03287778|Vitamins|vitamins|mesh-ancestor
1778538|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
1778539|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778540|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
1778544|NCT03277170|Montelukast|montelukast|mesh-list
1778545|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1778546|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
1778547|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1778548|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
1778549|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1778550|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778551|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1778552|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1778553|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778554|NCT03271372|Avelumab|avelumab|mesh-list
1778555|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1778556|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1778557|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778558|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
1778559|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778560|NCT03238196|Fulvestrant|fulvestrant|mesh-list
1778561|NCT03238196|Palbociclib|palbociclib|mesh-list
1778562|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1778563|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778564|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1778565|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1778566|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
1778567|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1778568|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778569|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1778570|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1778571|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778585|NCT03192345|Cemiplimab|cemiplimab|mesh-list
1778586|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1778587|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778588|NCT03126331|Nivolumab|nivolumab|mesh-list
1778589|NCT03126331|Ipilimumab|ipilimumab|mesh-list
1778590|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1778591|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778592|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1778593|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778597|NCT03077685|Paclitaxel|paclitaxel|mesh-list
1778598|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1778599|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778600|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
1778601|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
1778602|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
1778603|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778604|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
1778605|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
1778606|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1778607|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
1778608|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778609|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1778610|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1778611|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
1778612|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778613|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778614|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1778615|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1778652|NCT02989636|Nivolumab|nivolumab|mesh-list
1778653|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1778654|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778655|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1778656|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778706|NCT02762669|Oxytocin|oxytocin|mesh-list
1778707|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
1778708|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1778709|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778710|NCT02716948|Nivolumab|nivolumab|mesh-list
1778711|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1778712|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778713|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1778714|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778717|NCT02681237|Olaparib|olaparib|mesh-list
1778718|NCT02681237|Cediranib|cediranib|mesh-list
1778719|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1778720|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1778721|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778722|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778723|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1778778|NCT02431897|Estrogens|estrogens|mesh-list
1778779|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1778780|NCT02431897|Hormones|hormones|mesh-ancestor
1778781|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1778782|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778831|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1778832|NCT02154490|Nivolumab|nivolumab|mesh-list
1778833|NCT02154490|Ipilimumab|ipilimumab|mesh-list
1778834|NCT02154490|Durvalumab|durvalumab|mesh-list
1778835|NCT02154490|Rilotumumab|rilotumumab|mesh-list
1778836|NCT02154490|Docetaxel|docetaxel|mesh-list
1778837|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1778838|NCT02154490|Palbociclib|palbociclib|mesh-list
1778839|NCT02154490|Tremelimumab|tremelimumab|mesh-list
1778840|NCT02154490|Talazoparib|talazoparib|mesh-list
1778841|NCT02154490|Antibodies|antibodies|mesh-list
1778842|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
1778843|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1778844|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
1778845|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
1778846|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778847|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778848|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
1778849|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
1778850|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
1778851|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1778852|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1778853|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1778854|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1778855|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1778886|NCT02069730|Androgens|androgens|mesh-list
1778887|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
1778888|NCT02069730|Hormones|hormones|mesh-ancestor
1778889|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1778890|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1778891|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
1778961|NCT01641107|Ponatinib|ponatinib|mesh-list
1778962|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1778963|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1778964|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1778965|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779006|NCT00843037|Sunitinib|sunitinib|mesh-list
1779007|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779008|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1779009|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1779010|NCT00843037|Growth Substances|growth substances|mesh-ancestor
1779011|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779012|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
1779013|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1779014|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779015|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779044|NCT00054964|Albuterol|albuterol|mesh-list
1779045|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1779046|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
1779047|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779048|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779049|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1779050|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
1779051|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
1779052|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1779053|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1779054|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1779055|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1779056|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
1779057|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1779058|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779059|NCT00045201|Irinotecan|irinotecan|mesh-list
1779060|NCT00045201|Camptothecin|camptothecin|mesh-list
1779061|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
1779062|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1779063|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1779064|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779065|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779066|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779067|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1779068|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1779082|NCT05073692|Liraglutide|liraglutide|mesh-list
1779083|NCT05073692|Empagliflozin|empagliflozin|mesh-list
1779084|NCT05073692|Exenatide|exenatide|mesh-list
1779085|NCT05073692|Glimepiride|glimepiride|mesh-list
1779086|NCT05073692|Linagliptin|linagliptin|mesh-list
1779087|NCT05073692|Saxagliptin|saxagliptin|mesh-list
1779088|NCT05073692|Alogliptin|alogliptin|mesh-list
1779089|NCT05073692|Glipizide|glipizide|mesh-list
1779090|NCT05073692|Glucagon|glucagon|mesh-list
1779091|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
1779092|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1779093|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779094|NCT05073692|Incretins|incretins|mesh-ancestor
1779095|NCT05073692|Hormones|hormones|mesh-ancestor
1779096|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779097|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1779098|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779099|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1779100|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1779101|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1779102|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
1779103|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1779104|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
1779105|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779106|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1779107|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
1779108|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1779109|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779110|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779111|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1779112|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1779113|NCT05073640|Protective Agents|protective agents|mesh-ancestor
1779114|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779115|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
1779116|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1779117|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
1779130|NCT05073744|Morphine|morphine|mesh-list
1779131|NCT05073744|Nalbuphine|nalbuphine|mesh-list
1779132|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1779133|NCT05073744|Narcotics|narcotics|mesh-ancestor
1779134|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779135|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779136|NCT05073744|Analgesics|analgesics|mesh-ancestor
1779137|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
1779138|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779139|NCT05073250|Rituximab|rituximab|mesh-list
1779140|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1779141|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779142|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
1779143|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779144|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1779145|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
1779146|NCT05073237|Estrogens|estrogens|mesh-list
1779147|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1779148|NCT05073237|Hormones|hormones|mesh-ancestor
1779149|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779150|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779151|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1779152|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1779153|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
1779154|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1779155|NCT05073094|Esmolol|esmolol|mesh-list
1779156|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1779157|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1779158|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1779159|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
1779160|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1779161|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779162|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779163|NCT05073055|Anesthetics|anesthetics|mesh-list
1779164|NCT05073055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779165|NCT05073055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779166|NCT05073029|Vitamin D|vitamin d|mesh-list
1779167|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
1779168|NCT05073029|Vitamins|vitamins|mesh-ancestor
1779169|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
1779170|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779171|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1779172|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1779173|NCT05072938|Nizatidine|nizatidine|mesh-list
1779174|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1779175|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1779176|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1779177|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
1779178|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
1779179|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1779180|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779181|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779182|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
1779183|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1779184|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
1779185|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779186|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
1779187|NCT05072899|Protective Agents|protective agents|mesh-ancestor
1779188|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
1779189|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1779190|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1779191|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779192|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
1779193|NCT05072860|Coagulants|coagulants|mesh-ancestor
1779194|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
1779195|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1779196|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1779197|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779198|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
1779199|NCT05072873|Coagulants|coagulants|mesh-ancestor
1779200|NCT05072782|Methotrexate|methotrexate|mesh-list
1779201|NCT05072782|Infliximab|infliximab|mesh-list
1779202|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1779203|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
1779204|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1779205|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779206|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1779207|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
1779208|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779209|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779210|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
1779211|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779212|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1779213|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1779214|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
1779215|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1779216|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1779217|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1779218|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
1779219|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1779220|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1779221|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1779222|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1779223|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779224|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
1779225|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1779226|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779227|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1779228|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779229|NCT05072704|Sufentanil|sufentanil|mesh-list
1779230|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
1779231|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1779232|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779233|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779234|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1779235|NCT05072704|Analgesics|analgesics|mesh-ancestor
1779236|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
1779237|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779238|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1779239|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1779240|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1779241|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
1779242|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1779243|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779244|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1779245|NCT05072704|Narcotics|narcotics|mesh-ancestor
1779246|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1779247|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1779248|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
1779249|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
1779250|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
1779251|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1779252|NCT05072691|Antibodies|antibodies|mesh-list
1779253|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
1779254|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779260|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1779261|NCT05072405|Simvastatin|simvastatin|mesh-list
1779262|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1779263|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1779264|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
1779265|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779266|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1779267|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1779268|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779269|NCT05072249|Naloxone|naloxone|mesh-list
1779270|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1779271|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779272|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
1779273|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779274|NCT05072262|Dexamethasone|dexamethasone|mesh-list
1779275|NCT05072262|Nepafenac|nepafenac|mesh-list
1779276|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1779277|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
1779278|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
1779279|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779280|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779281|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1779282|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
1779283|NCT05072262|Hormones|hormones|mesh-ancestor
1779284|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779285|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1779286|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779287|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1779288|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1779289|NCT05072262|Analgesics|analgesics|mesh-ancestor
1779290|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
1779291|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1779295|NCT05072314|Lidocaine|lidocaine|mesh-list
1779296|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
1779297|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
1779298|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779299|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779300|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
1779301|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779302|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1779303|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1779304|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1779305|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1779306|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779307|NCT05072106|Bosentan|bosentan|mesh-list
1779308|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1779309|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1779310|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779311|NCT05071794|Propofol|propofol|mesh-list
1779312|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1779313|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779314|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779315|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1779316|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
1779317|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
1779318|NCT05071716|Rifaximin|rifaximin|mesh-list
1779319|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1779320|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1779321|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1779322|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
1779323|NCT05071482|HH-GV-678|hh-gv-678|mesh-list
1779324|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779325|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1779326|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779327|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779328|NCT05071703|Carboplatin|carboplatin|mesh-list
1779329|NCT05071703|Etoposide|etoposide|mesh-list
1779330|NCT05071703|Topotecan|topotecan|mesh-list
1779331|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779332|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1779333|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1779334|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1779335|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779336|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779337|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1779346|NCT05071781|Hormones|hormones|mesh-list
1779347|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
1779348|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779349|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779350|NCT05071352|Nefopam|nefopam|mesh-list
1779351|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1779352|NCT05071352|Analgesics|analgesics|mesh-ancestor
1779353|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
1779354|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779355|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779356|NCT05071339|Ganirelix|ganirelix|mesh-list
1779357|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
1779358|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779359|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779360|NCT05071118|Pregabalin|pregabalin|mesh-list
1779361|NCT05071118|Analgesics|analgesics|mesh-ancestor
1779362|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
1779363|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779364|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779365|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
1779366|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1779367|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1779368|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779369|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1779370|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1779371|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1779372|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779373|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1779382|NCT05070520|Lumefantrine|lumefantrine|mesh-list
1779383|NCT05070520|Artemether|artemether|mesh-list
1779384|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1779385|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
1779386|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1779387|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1779388|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1779420|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
1779421|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
1779422|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1779423|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779424|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779425|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
1779426|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1779427|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779428|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779429|NCT05070403|Afatinib|afatinib|mesh-list
1779430|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779431|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1779432|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779433|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779434|NCT05070468|Dexamethasone|dexamethasone|mesh-list
1779435|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1779436|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
1779437|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
1779438|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779439|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779440|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1779441|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
1779442|NCT05070468|Hormones|hormones|mesh-ancestor
1779443|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779444|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1779445|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779446|NCT05070598|Paclitaxel|paclitaxel|mesh-list
1779447|NCT05070598|Tegafur|tegafur|mesh-list
1779448|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1779449|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779450|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
1779451|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
1779452|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
1779453|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779454|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1779455|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
1779456|NCT05070260|Glenzocimab|glenzocimab|mesh-list
1779457|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
1779458|NCT05070195|Midazolam|midazolam|mesh-list
1779459|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1779460|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1779461|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779462|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779463|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1779464|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1779465|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1779466|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1779467|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
1779468|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
1779469|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
1779470|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
1779471|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1779472|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779476|NCT05070221|Axitinib|axitinib|mesh-list
1779477|NCT05070221|Antibodies|antibodies|mesh-list
1779478|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1779479|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
1779480|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779481|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779482|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1779483|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779484|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779488|NCT05069870|Itraconazole|itraconazole|mesh-list
1779489|NCT05069870|Rifampin|rifampin|mesh-list
1779490|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
1779491|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
1779492|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1779493|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1779494|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1779495|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779496|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779497|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1779498|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
1779499|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779500|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779501|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1779502|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1779503|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
1779504|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1779505|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
1779506|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1779507|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1779508|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1779509|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1779510|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1779511|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1779512|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1779513|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1779514|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
1779515|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1779516|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1779517|NCT05070104|Bevacizumab|bevacizumab|mesh-list
1779518|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1779519|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779520|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1779521|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1779522|NCT05070104|Growth Substances|growth substances|mesh-ancestor
1779523|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779524|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
1779525|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
1779526|NCT05069935|Fludarabine|fludarabine|mesh-list
1779527|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1779528|NCT05069935|Antibodies|antibodies|mesh-list
1779529|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
1779530|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1779531|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1779532|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
1779533|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779534|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1779535|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1779536|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
1779537|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779538|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779539|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1779556|NCT05069779|Diazepam|diazepam|mesh-list
1779557|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1779558|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
1779559|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
1779560|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
1779561|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779562|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779563|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1779564|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1779565|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779566|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1779567|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1779568|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1779569|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1779570|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1779571|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1779572|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
1779573|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
1779574|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
1779575|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
1779576|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1779577|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779578|NCT05069454|Vaccines|vaccines|mesh-list
1779579|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
1779580|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779581|NCT05069688|Rifampin|rifampin|mesh-list
1779582|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1779583|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
1779584|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1779585|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1779586|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
1779587|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1779588|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779589|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779590|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1779591|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1779592|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1779593|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1779594|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1779595|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1779601|NCT05069350|Bupivacaine|bupivacaine|mesh-list
1779602|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
1779603|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
1779604|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779605|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779606|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
1779607|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779608|NCT05069298|Silybin|silybin|mesh-list
1779609|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1779610|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779611|NCT05069298|Protective Agents|protective agents|mesh-ancestor
1779612|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779613|NCT05069038|Palbociclib|palbociclib|mesh-list
1779614|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779615|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1779616|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779617|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779618|NCT05069051|Belimumab|belimumab|mesh-list
1779619|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1779620|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
1779621|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779622|NCT05068960|Bupivacaine|bupivacaine|mesh-list
1779623|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
1779624|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
1779625|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779626|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779627|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
1779628|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779629|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
1779630|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1779631|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1779632|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
1779633|NCT05068609|Nivolumab|nivolumab|mesh-list
1779634|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1779635|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779636|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1779637|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779638|NCT05068401|Mycophenolic Acid|mycophenolic acid|mesh-list
1779639|NCT05068401|Sirolimus|sirolimus|mesh-list
1779640|NCT05068401|Cyclophosphamide|cyclophosphamide|mesh-list
1779641|NCT05068401|Busulfan|busulfan|mesh-list
1779642|NCT05068401|Fludarabine|fludarabine|mesh-list
1779643|NCT05068401|Sargramostim|sargramostim|mesh-list
1779644|NCT05068401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1779645|NCT05068401|Immunologic Factors|immunologic factors|mesh-ancestor
1779646|NCT05068401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779647|NCT05068401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1779648|NCT05068401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1779649|NCT05068401|Alkylating Agents|alkylating agents|mesh-ancestor
1779650|NCT05068401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779651|NCT05068401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779652|NCT05068401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1779653|NCT05068401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1779654|NCT05068401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1779655|NCT05068401|Antitubercular Agents|antitubercular agents|mesh-ancestor
1779656|NCT05068401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1779657|NCT05068401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1779658|NCT05068401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779659|NCT05068401|Antifungal Agents|antifungal agents|mesh-ancestor
1779660|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
1779661|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779662|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1779663|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779664|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779665|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
1779666|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1779667|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1779668|NCT05068349|Protective Agents|protective agents|mesh-ancestor
1779669|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779670|NCT05068453|Antibodies|antibodies|mesh-list
1779671|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1779672|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
1779673|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779680|NCT05067621|Liraglutide|liraglutide|mesh-list
1779681|NCT05067621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1779682|NCT05067621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779683|NCT05067621|Incretins|incretins|mesh-ancestor
1779684|NCT05067621|Hormones|hormones|mesh-ancestor
1779685|NCT05067621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779686|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
1779687|NCT05067699|Calcifediol|calcifediol|mesh-list
1779688|NCT05067699|Vitamins|vitamins|mesh-ancestor
1779689|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
1779690|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779691|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1779692|NCT05067530|Paclitaxel|paclitaxel|mesh-list
1779693|NCT05067530|Carboplatin|carboplatin|mesh-list
1779694|NCT05067530|Palbociclib|palbociclib|mesh-list
1779695|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1779696|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779697|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
1779698|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
1779699|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
1779700|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779701|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1779702|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779703|NCT05067387|Dronabinol|dronabinol|mesh-list
1779704|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
1779705|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779706|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1779707|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1779708|NCT05067387|Analgesics|analgesics|mesh-ancestor
1779709|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
1779710|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779711|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1779712|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1779713|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1779714|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779715|NCT05067387|Hormones|hormones|mesh-ancestor
1779716|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779717|NCT05067517|Nintedanib|nintedanib|mesh-list
1779718|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779719|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1779720|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780094|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1779721|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779722|NCT05067153|Heparin|heparin|mesh-list
1779723|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1779724|NCT05067153|Tinzaparin|tinzaparin|mesh-list
1779725|NCT05067153|Dalteparin|dalteparin|mesh-list
1779726|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
1779727|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1779728|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1779729|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779730|NCT05067309|Letrozole|letrozole|mesh-list
1779731|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779732|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1779733|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1779734|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779735|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779736|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1779737|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
1779738|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779739|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779757|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
1779758|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1779759|NCT05066802|Folfirinox|folfirinox|mesh-list
1779760|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779761|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
1779762|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779763|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779764|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
1779765|NCT05066516|Linagliptin|linagliptin|mesh-list
1779766|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1779767|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779768|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1779769|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779770|NCT05066516|Incretins|incretins|mesh-ancestor
1779771|NCT05066516|Hormones|hormones|mesh-ancestor
1779772|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779773|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1779774|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
1779775|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779776|NCT05066633|Metoprolol|metoprolol|mesh-list
1779777|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1779778|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1779779|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
1779780|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
1779781|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779782|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779783|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1779784|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1779785|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1779786|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
1779787|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1779788|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779789|NCT05066607|Dexamethasone|dexamethasone|mesh-list
1779790|NCT05066607|Pomalidomide|pomalidomide|mesh-list
1779791|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1779792|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
1779793|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
1779794|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780323|NCT05061654|Renal Agents|renal agents|mesh-ancestor
1779795|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779796|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1779797|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
1779798|NCT05066607|Hormones|hormones|mesh-ancestor
1779799|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779800|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1779801|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779802|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
1779803|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1779804|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1779805|NCT05066607|Growth Substances|growth substances|mesh-ancestor
1779806|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
1779809|NCT05066360|Hormones|hormones|mesh-list
1779810|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779811|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779814|NCT05066061|Analgesics|analgesics|mesh-list
1779815|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
1779816|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
1779817|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779818|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779819|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1779820|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779821|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1779822|NCT05065866|Azacitidine|azacitidine|mesh-list
1779823|NCT05065866|Cc-486|cc-486|mesh-list
1779824|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1779825|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
1779826|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779827|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779828|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779829|NCT05065736|Clofarabine|clofarabine|mesh-list
1779830|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1779831|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
1779832|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779833|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779834|NCT05065957|Capecitabine|capecitabine|mesh-list
1779835|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1779836|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
1779837|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779838|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779839|NCT05065658|Posaconazole|posaconazole|mesh-list
1779840|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
1779841|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1779842|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1779843|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1779844|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1779845|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1779846|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1779847|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779848|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779849|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1779850|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
1779851|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1779852|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779853|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1779854|NCT05065671|Tolcapone|tolcapone|mesh-list
1779855|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1779856|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1779857|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1779858|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779859|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1779860|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779861|NCT05065671|Analgesics|analgesics|mesh-ancestor
1779862|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
1779863|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779864|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
1779865|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1779866|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
1779867|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1779868|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1779869|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1779870|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779871|NCT05065905|Interferons|interferons|mesh-list
1779872|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
1779873|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779874|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
1779875|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1779876|NCT05066035|Neostigmine|neostigmine|mesh-list
1779877|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1779878|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779879|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779880|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
1779881|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1779882|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779883|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1779884|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
1779885|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779886|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1779899|NCT05065164|Denosumab|denosumab|mesh-list
1779900|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1779901|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779902|NCT05065177|Vaccines|vaccines|mesh-list
1779903|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
1779904|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779905|NCT05065567|Droperidol|droperidol|mesh-list
1779906|NCT05065567|Haloperidol|haloperidol|mesh-list
1779907|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
1779908|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
1779909|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
1779910|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1779911|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779912|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1779913|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1779914|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1779915|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779916|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1779917|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1779918|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
1779919|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1779920|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779921|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1779922|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1779923|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1779924|NCT05065021|Paclitaxel|paclitaxel|mesh-list
1779925|NCT05065021|Bevacizumab|bevacizumab|mesh-list
1779926|NCT05065021|Niraparib|niraparib|mesh-list
1779927|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1779928|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779929|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
1779930|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
1779931|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
1779932|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779933|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1779934|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1779935|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1779936|NCT05065021|Growth Substances|growth substances|mesh-ancestor
1779937|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779938|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
1779939|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1779940|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779941|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
1779942|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1779943|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
1779944|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779957|NCT05064020|Tenofovir|tenofovir|mesh-list
1779958|NCT05064020|Emtricitabine|emtricitabine|mesh-list
1779959|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
1779960|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
1779961|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1779962|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1779963|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1779964|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1779965|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779966|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1779967|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1779968|NCT05064137|Listerine|listerine|mesh-list
1779969|NCT05064137|Fluorides|fluorides|mesh-list
1779970|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
1779971|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
1779972|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
1779973|NCT05064137|Protective Agents|protective agents|mesh-ancestor
1779974|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1779975|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1779976|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1779982|NCT05064085|Capecitabine|capecitabine|mesh-list
1779983|NCT05064085|Cemiplimab|cemiplimab|mesh-list
1779984|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1779985|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
1779986|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1779987|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1779988|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1779989|NCT05063838|Anesthetics|anesthetics|mesh-list
1779990|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1779991|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780024|NCT05063578|Lidocaine|lidocaine|mesh-list
1780025|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
1780026|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
1780027|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1780028|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780029|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
1780030|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780031|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1780032|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1780033|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1780034|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1780035|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780056|NCT05063604|Citalopram|citalopram|mesh-list
1780057|NCT05063604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1780058|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1780059|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1780060|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780061|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1780062|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
1780063|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780064|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1780065|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
1780066|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1780067|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
1780068|NCT05063513|Rituximab|rituximab|mesh-list
1780069|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1780070|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780071|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
1780072|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780073|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1780074|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1780075|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1780076|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
1780077|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1780078|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780079|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780080|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780081|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
1780082|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1780083|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
1780084|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780085|NCT05063422|Trimethoprim|trimethoprim|mesh-list
1780086|NCT05063422|Polymyxins|polymyxins|mesh-list
1780087|NCT05063422|Polymyxin B|polymyxin b|mesh-list
1780088|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1780089|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1780090|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780091|NCT05063422|Renal Agents|renal agents|mesh-ancestor
1780092|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
1780093|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1780095|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1780096|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780097|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780098|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1780099|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1780100|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1780101|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1780102|NCT05063422|Laxatives|laxatives|mesh-ancestor
1780103|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1780104|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
1780105|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
1780106|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780107|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
1780108|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1780109|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780110|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
1780111|NCT05063396|Anesthetics|anesthetics|mesh-list
1780112|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1780113|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780114|NCT05063396|Narcotics|narcotics|mesh-ancestor
1780115|NCT05063396|Analgesics|analgesics|mesh-ancestor
1780116|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
1780117|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780118|NCT05062980|Docetaxel|docetaxel|mesh-list
1780119|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
1780120|NCT05062980|Ramucirumab|ramucirumab|mesh-list
1780121|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780122|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
1780123|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
1780124|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
1780125|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780126|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1780127|NCT05063318|Itraconazole|itraconazole|mesh-list
1780128|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
1780129|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780130|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1780131|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1780132|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780133|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780134|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1780135|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
1780136|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1780137|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780138|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1780139|NCT05063071|Tenofovir|tenofovir|mesh-list
1780140|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
1780141|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780142|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1780143|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1780144|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780145|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780146|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1780147|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1780148|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
1780149|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1780150|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1780151|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780152|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
1780153|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1780154|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780179|NCT05062681|Dexamethasone|dexamethasone|mesh-list
1780180|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
1780181|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1780182|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1780183|NCT05062681|Prednisolone|prednisolone|mesh-list
1780184|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
1780185|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1780186|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
1780187|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780188|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
1780189|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
1780190|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780191|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780192|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1780193|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
1780194|NCT05062681|Hormones|hormones|mesh-ancestor
1780195|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1780196|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1780197|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780198|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1780199|NCT05062681|Protective Agents|protective agents|mesh-ancestor
1780200|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
1780201|NCT05062954|Procyanidin|procyanidin|mesh-list
1780202|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
1780203|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780204|NCT05062954|Protective Agents|protective agents|mesh-ancestor
1780205|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780206|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1780207|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1780208|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780209|NCT05062486|Curcumin|curcumin|mesh-list
1780210|NCT05062486|Resveratrol|resveratrol|mesh-list
1780211|NCT05062486|Quercetin|quercetin|mesh-list
1780212|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1780213|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1780214|NCT05062486|Analgesics|analgesics|mesh-ancestor
1780215|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
1780216|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780217|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780218|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780219|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1780220|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780221|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780222|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780223|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
1780224|NCT05062486|Protective Agents|protective agents|mesh-ancestor
1780225|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1780226|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
1780227|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1780228|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1780229|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780230|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
1780231|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
1780232|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780233|NCT05062174|Mifepristone|mifepristone|mesh-list
1780234|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1780235|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
1780236|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1780237|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780238|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1780239|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1780240|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1780241|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
1780242|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1780243|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1780244|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
1780322|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1780245|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1780246|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
1780247|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1780248|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1780249|NCT05062304|Fluticasone|fluticasone|mesh-list
1780250|NCT05062304|Xhance|xhance|mesh-list
1780251|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780252|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1780253|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
1780254|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780255|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780256|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1780257|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
1780258|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
1780259|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1780267|NCT05061732|Amoxicillin|amoxicillin|mesh-list
1780268|NCT05061732|Metronidazole|metronidazole|mesh-list
1780269|NCT05061732|Clarithromycin|clarithromycin|mesh-list
1780270|NCT05061732|Doxycycline|doxycycline|mesh-list
1780271|NCT05061732|Levofloxacin|levofloxacin|mesh-list
1780272|NCT05061732|Tetracycline|tetracycline|mesh-list
1780273|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
1780274|NCT05061732|Rabeprazole|rabeprazole|mesh-list
1780275|NCT05061732|Bismuth|bismuth|mesh-list
1780276|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780277|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1780278|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780279|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1780280|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1780281|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1780282|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780283|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1780284|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1780285|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
1780286|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1780287|NCT05061732|Renal Agents|renal agents|mesh-ancestor
1780288|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1780289|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1780290|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780291|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1780292|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1780293|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1780294|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1780295|NCT05061732|Antacids|antacids|mesh-ancestor
1780296|NCT05061732|Diuretics|diuretics|mesh-ancestor
1780297|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
1780298|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780299|NCT05061732|Expectorants|expectorants|mesh-ancestor
1780300|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
1780301|NCT05061901|Lisinopril|lisinopril|mesh-list
1780302|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1780303|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
1780304|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780305|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780306|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1780307|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1780308|NCT05061901|Protective Agents|protective agents|mesh-ancestor
1780309|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780314|NCT05061654|Tazobactam|tazobactam|mesh-list
1780315|NCT05061654|Ceftolozane|ceftolozane|mesh-list
1780316|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
1780317|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1780318|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780319|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1780320|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780321|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780324|NCT05061641|Progesterone|progesterone|mesh-list
1780325|NCT05061641|Progestins|progestins|mesh-ancestor
1780326|NCT05061641|Hormones|hormones|mesh-ancestor
1780327|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1780328|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780329|NCT05061147|Azacitidine|azacitidine|mesh-list
1780330|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1780331|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
1780332|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780333|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780334|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780345|NCT05060822|Pirfenidone|pirfenidone|mesh-list
1780346|NCT05060822|Analgesics|analgesics|mesh-ancestor
1780347|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
1780348|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780349|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780350|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1780351|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1780352|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780353|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1780354|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780355|NCT05060991|Antimetabolites|antimetabolites|mesh-list
1780356|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780357|NCT05060809|Vitamin K|vitamin k|mesh-list
1780358|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
1780359|NCT05060809|Vitamins|vitamins|mesh-ancestor
1780360|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
1780361|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780362|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1780363|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1780364|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780365|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
1780366|NCT05060809|Coagulants|coagulants|mesh-ancestor
1780367|NCT05060731|Iron|iron|mesh-list
1780368|NCT05060731|Trace Elements|trace elements|mesh-ancestor
1780369|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
1780370|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780371|NCT05060588|Valsartan|valsartan|mesh-list
1780372|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1780373|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1780374|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1780375|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780376|NCT05060419|Meropenem|meropenem|mesh-list
1780377|NCT05060419|Tazobactam|tazobactam|mesh-list
1780378|NCT05060419|Piperacillin|piperacillin|mesh-list
1780379|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
1780380|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1780381|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780382|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1780383|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780384|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780391|NCT05060744|Antacids|antacids|mesh-list
1780392|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
1780393|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780394|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1780395|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
1780396|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1780397|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780405|NCT05060198|Lumefantrine|lumefantrine|mesh-list
1780406|NCT05060198|Artemether|artemether|mesh-list
1780407|NCT05060198|Piperaquine|piperaquine|mesh-list
1780408|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1780409|NCT05060198|Artenimol|artenimol|mesh-list
1780410|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
1780411|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1780412|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1780413|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780417|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
1780418|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
1780419|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780420|NCT05059535|Acetaminophen|acetaminophen|mesh-list
1780421|NCT05059535|Analgesics|analgesics|mesh-list
1780422|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1780423|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
1780424|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780425|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780426|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
1780427|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1780428|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1780429|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780430|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780431|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1780432|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1780433|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780434|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
1780435|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1780436|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
1780437|NCT05059626|Simvastatin|simvastatin|mesh-list
1780438|NCT05059626|Estrogens|estrogens|mesh-list
1780439|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1780440|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1780441|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
1780442|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780443|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1780444|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1780445|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780446|NCT05059626|Hormones|hormones|mesh-ancestor
1780447|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1780448|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780449|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1780450|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1780451|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
1780452|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1780453|NCT05059782|Coal Tar|coal tar|mesh-list
1780454|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
1780455|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
1780456|NCT05059860|Insulin|insulin|mesh-list
1780457|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1780458|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780459|NCT05059418|Clonazepam|clonazepam|mesh-list
1780460|NCT05059418|Capsaicin|capsaicin|mesh-list
1780461|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
1780462|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
1780463|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
1780464|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780465|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780466|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
1780467|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
1780468|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
1780469|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1780470|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780471|NCT05059028|Oxytocin|oxytocin|mesh-list
1780472|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
1780473|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1780474|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780475|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
1780476|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1780477|NCT05059145|Fluconazole|fluconazole|mesh-list
1780478|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1780479|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780480|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
1780481|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
1780482|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
1780483|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1780484|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1780485|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780486|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780487|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1780488|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
1780489|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1780490|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780491|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1780492|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1780493|NCT05058976|Vitamin D|vitamin d|mesh-list
1780494|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
1780495|NCT05058976|Calcium|calcium|mesh-list
1780496|NCT05058976|Vitamins|vitamins|mesh-ancestor
1780497|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
1780498|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780499|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1780500|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1780501|NCT05058924|Aspirin|aspirin|mesh-list
1780502|NCT05058924|Heparin|heparin|mesh-list
1780503|NCT05058924|Calcium heparin|calcium heparin|mesh-list
1780504|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1780505|NCT05058924|Tinzaparin|tinzaparin|mesh-list
1780506|NCT05058924|Dalteparin|dalteparin|mesh-list
1780507|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1780508|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1780509|NCT05058924|Analgesics|analgesics|mesh-ancestor
1780510|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
1780511|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780512|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780513|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780514|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1780515|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1780516|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1780517|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780518|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1780519|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1780520|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780521|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
1780522|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
1780523|NCT05058677|Lidocaine|lidocaine|mesh-list
1780524|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
1780525|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
1780526|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1780527|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780528|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
1780529|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780530|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1780531|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1780532|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1780533|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1780534|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780535|NCT05058612|Midodrine|midodrine|mesh-list
1780536|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
1780537|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
1780538|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780539|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780540|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1780541|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1780542|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1780543|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1780544|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
1780545|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1780546|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780547|NCT05058443|Denosumab|denosumab|mesh-list
1780548|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1780549|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780550|NCT05058755|Etoposide|etoposide|mesh-list
1780551|NCT05058755|Lenalidomide|lenalidomide|mesh-list
1780552|NCT05058755|Azacitidine|azacitidine|mesh-list
1780553|NCT05058755|Pegaspargase|pegaspargase|mesh-list
1780554|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1780555|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780556|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1780557|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1780558|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780559|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780560|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
1780561|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780562|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1780563|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1780564|NCT05058755|Growth Substances|growth substances|mesh-ancestor
1780565|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
1780566|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1780567|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
1780568|NCT05058404|Prednisone|prednisone|mesh-list
1780569|NCT05058404|Rituximab|rituximab|mesh-list
1780570|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1780571|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
1780572|NCT05058404|Vincristine|vincristine|mesh-list
1780573|NCT05058404|Doxorubicin|doxorubicin|mesh-list
1780574|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1780575|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780576|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
1780577|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780578|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1780579|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1780580|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
1780581|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780582|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1780583|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1780584|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780585|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
1780586|NCT05058404|Hormones|hormones|mesh-ancestor
1780587|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1780588|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1780589|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1780590|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
1780591|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
1780592|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
1780593|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1780594|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1780595|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1780596|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780597|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
1780598|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1780599|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780600|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1780601|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780602|NCT05058209|Triamcinolone|triamcinolone|mesh-list
1780603|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1780604|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1780605|NCT05058209|Betamethasone|betamethasone|mesh-list
1780606|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
1780607|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
1780608|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
1780609|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
1780610|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
1780611|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1780612|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780613|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
1780614|NCT05058209|Hormones|hormones|mesh-ancestor
1780615|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1780616|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780617|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1780618|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
1780619|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780620|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780621|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1780622|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
1780623|NCT05058105|Meropenem|meropenem|mesh-list
1780624|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1780625|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780626|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
1780627|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1780628|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1780629|NCT05058287|Prednisolone|prednisolone|mesh-list
1780630|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
1780631|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1780632|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
1780633|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780634|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
1780635|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
1780636|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780637|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780638|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1780639|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
1780640|NCT05058287|Hormones|hormones|mesh-ancestor
1780641|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1780642|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1780643|NCT05058287|Protective Agents|protective agents|mesh-ancestor
1780644|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1780645|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780646|NCT05057767|Midazolam|midazolam|mesh-list
1780647|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1780648|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1780649|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1780650|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780651|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1780652|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1780653|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1780654|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1780655|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
1780656|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
1780657|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
1780658|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
1780659|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1780660|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780675|NCT05057845|Lenvatinib|lenvatinib|mesh-list
1780676|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780677|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1780678|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780679|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780707|NCT05057663|Fluorouracil|fluorouracil|mesh-list
1780708|NCT05057663|Bleomycin|bleomycin|mesh-list
1780709|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
1780710|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780711|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1780712|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780713|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1780714|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
1780715|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780716|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1780717|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
1780718|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1780719|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1780720|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1780721|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780722|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
1780723|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1780724|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780725|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1780726|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780727|NCT05057247|Docetaxel|docetaxel|mesh-list
1780728|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780729|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
1780730|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
1780731|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
1780732|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780733|NCT05057351|Glycerol|glycerol|mesh-list
1780734|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1780735|NCT05057351|Protective Agents|protective agents|mesh-ancestor
1780736|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780737|NCT05057130|Cisplatin|cisplatin|mesh-list
1780738|NCT05057130|Doxorubicin|doxorubicin|mesh-list
1780739|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1780740|NCT05057130|Methotrexate|methotrexate|mesh-list
1780741|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780742|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1780743|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1780744|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1780745|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780746|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780747|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1780748|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
1780749|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1780750|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780751|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1780752|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
1780753|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
1780754|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1780755|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1780756|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
1780757|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1780758|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1780759|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
1780760|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1780761|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1780762|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1780763|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1780764|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780765|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
1780766|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1780767|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780768|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1780769|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780774|NCT05056896|Aspirin|aspirin|mesh-list
1780775|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
1780776|NCT05056896|Salicylates|salicylates|mesh-list
1780777|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1780778|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1780779|NCT05056896|Analgesics|analgesics|mesh-ancestor
1780780|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
1780781|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780782|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780783|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780784|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1780785|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1780786|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1780787|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780788|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1780789|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1780790|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780791|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
1780792|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780793|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
1780794|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
1780795|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
1780796|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
1780797|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780798|NCT05056402|Vaccines|vaccines|mesh-list
1780799|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
1780800|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780801|NCT05056142|Anesthetics|anesthetics|mesh-list
1780802|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1780803|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780807|NCT05056584|Glucagon|glucagon|mesh-list
1780808|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1780809|NCT05056584|Hormones|hormones|mesh-ancestor
1780810|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1780811|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780812|NCT05056519|Vaccines|vaccines|mesh-list
1780813|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
1780814|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780815|NCT05056337|Lenvatinib|lenvatinib|mesh-list
1780816|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780817|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1780818|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780819|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780822|NCT05055752|Aspirin|aspirin|mesh-list
1780823|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1780824|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1780825|NCT05055752|Analgesics|analgesics|mesh-ancestor
1780826|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
1780827|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780828|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780829|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780830|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1780831|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1780832|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1780833|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780834|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1780835|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1780836|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780837|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
1780838|NCT05056025|Vitamins|vitamins|mesh-list
1780839|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
1780840|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780843|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
1780844|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
1780845|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1780846|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780847|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780850|NCT05055726|Benzydamine|benzydamine|mesh-list
1780851|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780852|NCT05055544|Fosfomycin|fosfomycin|mesh-list
1780853|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1780854|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780855|NCT05054868|Ketorolac|ketorolac|mesh-list
1780856|NCT05054868|Oxycodone|oxycodone|mesh-list
1780857|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1780858|NCT05054868|Narcotics|narcotics|mesh-ancestor
1780859|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1780860|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780861|NCT05054868|Analgesics|analgesics|mesh-ancestor
1780862|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
1780863|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780864|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1780865|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1780866|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780867|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1780868|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1780869|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780870|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780877|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
1780878|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1780879|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1780880|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780881|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
1780882|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
1780883|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780884|NCT05054842|Metformin|metformin|mesh-list
1780885|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1780886|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780893|NCT05054465|Venetoclax|venetoclax|mesh-list
1780894|NCT05054465|Navitoclax|navitoclax|mesh-list
1780895|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780896|NCT05054439|Paclitaxel|paclitaxel|mesh-list
1780897|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1780898|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780899|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
1780900|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
1780901|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
1780902|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780903|NCT05054478|Daratumumab|daratumumab|mesh-list
1780904|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780905|NCT05054426|Methotrexate|methotrexate|mesh-list
1780906|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1780907|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
1780908|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1780909|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780910|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1780911|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
1780912|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780913|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780914|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
1780915|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780916|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1780917|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1780918|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
1780919|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1780920|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1780921|NCT05054751|Fulvestrant|fulvestrant|mesh-list
1780922|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1780923|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780924|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1780925|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1780926|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
1781001|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1780927|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1780928|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780929|NCT05054322|Fluticasone|fluticasone|mesh-list
1780930|NCT05054322|Xhance|xhance|mesh-list
1780931|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780932|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1780933|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
1780934|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780935|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780936|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1780937|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
1780938|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
1780939|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1780940|NCT05054361|Mannitol|mannitol|mesh-list
1780941|NCT05054361|Lactulose|lactulose|mesh-list
1780942|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1780943|NCT05054361|Diuretics|diuretics|mesh-ancestor
1780944|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
1780945|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780946|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1780947|NCT05054114|Interferons|interferons|mesh-list
1780948|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
1780949|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780950|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
1780951|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1780952|NCT05054023|Piroxicam|piroxicam|mesh-list
1780953|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1780954|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1780955|NCT05054023|Analgesics|analgesics|mesh-ancestor
1780956|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
1780957|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780958|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780959|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1780960|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1780961|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1780962|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780963|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780971|NCT05053854|Talazoparib|talazoparib|mesh-list
1780972|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1780973|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780974|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780975|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780976|NCT05053633|Anesthetics|anesthetics|mesh-list
1780977|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1780978|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780979|NCT05053750|Paclitaxel|paclitaxel|mesh-list
1780980|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1780981|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1780982|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1780983|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
1780984|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
1780985|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
1780986|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780987|NCT05053594|Neostigmine|neostigmine|mesh-list
1780988|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1780989|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1780990|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1780991|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
1780992|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1780993|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1780994|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1780995|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
1780996|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1780997|NCT05053893|Valsartan|valsartan|mesh-list
1780998|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1780999|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1781000|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1781002|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781007|NCT05053841|Metformin|metformin|mesh-list
1781008|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1781009|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781019|NCT05053503|Lofexidine|lofexidine|mesh-list
1781020|NCT05053503|Naltrexone|naltrexone|mesh-list
1781021|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1781022|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1781023|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781024|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
1781025|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781026|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1781027|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1781028|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1781029|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1781030|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
1781031|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1781032|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781056|NCT05053126|Pregabalin|pregabalin|mesh-list
1781057|NCT05053126|Oxycodone|oxycodone|mesh-list
1781058|NCT05053126|Analgesics|analgesics|mesh-ancestor
1781059|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
1781060|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781061|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781062|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
1781063|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1781064|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1781065|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781066|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1781067|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1781068|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1781069|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1781070|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1781071|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1781072|NCT05053126|Narcotics|narcotics|mesh-ancestor
1781073|NCT05053009|Ibuprofen|ibuprofen|mesh-list
1781074|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1781075|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1781076|NCT05053009|Analgesics|analgesics|mesh-ancestor
1781077|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
1781078|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781079|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781080|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1781081|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1781082|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1781083|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781084|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781089|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
1781090|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1781091|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781105|NCT05053386|Epirubicin|epirubicin|mesh-list
1781106|NCT05053386|Idarubicin|idarubicin|mesh-list
1781107|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1781108|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781109|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1781110|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1781111|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781112|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781113|NCT05052827|Caseins|caseins|mesh-list
1781114|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
1781115|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
1781116|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781117|NCT05052879|Tadalafil|tadalafil|mesh-list
1781118|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
1781119|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1781120|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1781121|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781122|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781123|NCT05052879|Urological Agents|urological agents|mesh-ancestor
1781124|NCT05052515|Ascorbic Acid|ascorbic acid|mesh-list
1781125|NCT05052515|Choline|choline|mesh-list
1781126|NCT05052515|Vitamins|vitamins|mesh-ancestor
1781127|NCT05052515|Micronutrients|micronutrients|mesh-ancestor
1781128|NCT05052515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781129|NCT05052515|Antioxidants|antioxidants|mesh-ancestor
1781130|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781131|NCT05052515|Protective Agents|protective agents|mesh-ancestor
1781132|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
1781133|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1781134|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
1781135|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1781136|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1781137|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
1781138|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1781139|NCT05052619|Cefmetazole|cefmetazole|mesh-list
1781140|NCT05052619|Sulperazone|sulperazone|mesh-list
1781141|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1781142|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1781143|NCT05052619|Renal Agents|renal agents|mesh-ancestor
1781144|NCT05052931|Paclitaxel|paclitaxel|mesh-list
1781145|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
1781146|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1781147|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781148|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
1781149|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
1781150|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
1781151|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781152|NCT05052437|Capecitabine|capecitabine|mesh-list
1781153|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1781154|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
1781155|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781156|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781157|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
1781158|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1781159|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1781160|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
1781161|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
1781162|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1781163|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
1781164|NCT05052814|Calcium|calcium|mesh-list
1781165|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1781166|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781167|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1781168|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1781169|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
1781170|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
1781171|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
1781172|NCT05052541|Dronabinol|dronabinol|mesh-list
1781173|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
1781174|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781175|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1781176|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1781177|NCT05052541|Analgesics|analgesics|mesh-ancestor
1781178|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
1781179|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781180|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1781181|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1781182|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1781183|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781184|NCT05052541|Hormones|hormones|mesh-ancestor
1781185|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1781186|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
1781187|NCT05052528|Rituximab|rituximab|mesh-list
1781188|NCT05052528|Fludarabine|fludarabine|mesh-list
1781189|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
1781190|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1781191|NCT05052528|Antibodies|antibodies|mesh-list
1781192|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
1781193|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1781194|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1781195|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
1781196|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781197|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1781198|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1781199|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
1781200|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781201|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781202|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1781203|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1781204|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
1781223|NCT05052008|Erenumab|erenumab|mesh-list
1781224|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1781225|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781226|NCT05052008|Analgesics|analgesics|mesh-ancestor
1781227|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
1781228|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781229|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781230|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
1781231|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1781232|NCT05052359|Lectins|lectins|mesh-list
1781233|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
1781234|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
1781235|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781236|NCT05052359|Coagulants|coagulants|mesh-ancestor
1781265|NCT05051956|Palbociclib|palbociclib|mesh-list
1781266|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781267|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1781268|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781269|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781290|NCT05051007|Lidocaine|lidocaine|mesh-list
1781291|NCT05051007|Fentanyl|fentanyl|mesh-list
1781292|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
1781293|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
1781294|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1781295|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781296|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
1781297|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781298|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1781299|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1781300|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1781301|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1781302|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781303|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1781304|NCT05051007|Narcotics|narcotics|mesh-ancestor
1781305|NCT05051007|Analgesics|analgesics|mesh-ancestor
1781306|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1781307|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1781308|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
1781309|NCT05051150|Epinephrine|epinephrine|mesh-list
1781310|NCT05051150|Racepinephrine|racepinephrine|mesh-list
1781311|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
1781312|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1781313|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1781314|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
1781315|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1781316|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781317|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781318|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1781319|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1781320|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
1781321|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781322|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1781323|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
1781324|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
1781325|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
1781326|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1781327|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
1781328|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
1781329|NCT05051137|Infliximab|infliximab|mesh-list
1781330|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
1781331|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1781332|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1781333|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1781334|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781335|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781336|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1781337|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
1781338|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1781339|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1781340|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1781341|NCT05051137|Analgesics|analgesics|mesh-ancestor
1781342|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
1781343|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781344|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781345|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1781358|NCT05051163|Gentamicins|gentamicins|mesh-list
1781359|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
1781360|NCT05051163|Ampicillin|ampicillin|mesh-list
1781361|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1781362|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1781363|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1781364|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781365|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781366|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1781367|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1781368|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1781369|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1781370|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781371|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1781372|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781373|NCT05050656|Analgesics|analgesics|mesh-ancestor
1781374|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
1781375|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781376|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
1781377|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1781378|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
1781379|NCT05050604|Choline|choline|mesh-list
1781380|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
1781381|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1781382|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
1781383|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781384|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1781385|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1781386|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
1781398|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
1781399|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1781400|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781401|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1781402|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781403|NCT05050357|Norethindrone|norethindrone|mesh-list
1781404|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
1781405|NCT05050357|Progestins|progestins|mesh-list
1781406|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1781407|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1781408|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1781409|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
1781410|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1781411|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781412|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1781413|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1781414|NCT05050357|Hormones|hormones|mesh-ancestor
1781415|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1781416|NCT05050188|Lansoprazole|lansoprazole|mesh-list
1781417|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
1781418|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1781419|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1781420|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1781421|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781422|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781423|NCT05050305|Dexamethasone|dexamethasone|mesh-list
1781424|NCT05050305|Pomalidomide|pomalidomide|mesh-list
1781425|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1781426|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
1781427|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
1781428|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781429|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781430|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1781431|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
1781432|NCT05050305|Hormones|hormones|mesh-ancestor
1781433|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1781434|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1781435|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781436|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
1781437|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1781438|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1781439|NCT05050305|Growth Substances|growth substances|mesh-ancestor
1781440|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
1781441|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
1781442|NCT05050071|Calcium|calcium|mesh-list
1781443|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1781444|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781445|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1781446|NCT05050448|Diclofenac|diclofenac|mesh-list
1781447|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1781448|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1781449|NCT05050448|Analgesics|analgesics|mesh-ancestor
1781450|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
1781451|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781452|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781453|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1781454|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1781455|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1781456|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781457|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781483|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
1781484|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1781485|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781489|NCT05049603|Atorvastatin|atorvastatin|mesh-list
1781490|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1781491|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1781492|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
1781493|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781494|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1781495|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1781496|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781497|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
1781498|NCT05049863|Irinotecan|irinotecan|mesh-list
1781499|NCT05049863|Allopurinol|allopurinol|mesh-list
1781500|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1781501|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1781502|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781503|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781504|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781505|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1781506|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1781507|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
1781508|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1781509|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1781510|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
1781511|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
1781512|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1781513|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1781514|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
1781515|NCT05049863|Protective Agents|protective agents|mesh-ancestor
1781516|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781517|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
1781518|NCT05049707|Analgesics|analgesics|mesh-ancestor
1781519|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
1781520|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781521|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781522|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
1781523|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1781524|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1781525|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
1781526|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1781527|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1781528|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781529|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1781530|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
1781531|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1781532|NCT05049473|Cytarabine|cytarabine|mesh-list
1781533|NCT05049473|Dexamethasone|dexamethasone|mesh-list
1781534|NCT05049473|Prednisone|prednisone|mesh-list
1781535|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
1781536|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
1781537|NCT05049473|Rituximab|rituximab|mesh-list
1781538|NCT05049473|Doxorubicin|doxorubicin|mesh-list
1781539|NCT05049473|Methotrexate|methotrexate|mesh-list
1781540|NCT05049473|Etoposide|etoposide|mesh-list
1781541|NCT05049473|Vincristine|vincristine|mesh-list
1781542|NCT05049473|Vindesine|vindesine|mesh-list
1781543|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1781544|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
1781545|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781546|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1781547|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1781548|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
1781549|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781550|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781551|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1781552|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1781553|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
1781554|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
1781555|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781556|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1781557|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
1781558|NCT05049473|Hormones|hormones|mesh-ancestor
1781559|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1781560|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1781561|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1781562|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1781563|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1781564|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1781565|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781566|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1781567|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
1781568|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1781569|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1781570|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
1781571|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
1781572|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1781573|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1781574|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1781575|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
1781576|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1781577|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
1781578|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
1781579|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
1781580|NCT05049278|Phenylephrine|phenylephrine|mesh-list
1781581|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
1781582|NCT05049278|Norepinephrine|norepinephrine|mesh-list
1781583|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1781584|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
1781585|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
1781586|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781587|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781588|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
1781589|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1781590|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
1781591|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
1781592|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1781593|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1781594|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1781595|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
1781596|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1781597|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781598|NCT05049278|Protective Agents|protective agents|mesh-ancestor
1781599|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
1781600|NCT05049213|Povidone|povidone|mesh-list
1781601|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
1781602|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
1781603|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1781604|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1781605|NCT05049681|Apatinib|apatinib|mesh-list
1781606|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781607|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1781608|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781609|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781610|NCT05049057|Erenumab|erenumab|mesh-list
1781611|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1781612|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781613|NCT05049057|Analgesics|analgesics|mesh-ancestor
1781614|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
1781615|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781616|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781617|NCT05048914|Acetaminophen|acetaminophen|mesh-list
1781618|NCT05048914|Dipyrone|dipyrone|mesh-list
1781619|NCT05048914|Ibuprofen|ibuprofen|mesh-list
1781620|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1781621|NCT05048914|Analgesics|analgesics|mesh-ancestor
1781622|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
1781623|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781624|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781625|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
1781626|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1781627|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1781628|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1781629|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1781630|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781631|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781632|NCT05048940|Vaccines|vaccines|mesh-list
1781633|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
1781634|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781635|NCT05048901|Lanreotide|lanreotide|mesh-list
1781636|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781637|NCT05048615|Itraconazole|itraconazole|mesh-list
1781638|NCT05048615|Azacitidine|azacitidine|mesh-list
1781639|NCT05048615|Venetoclax|venetoclax|mesh-list
1781640|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1781641|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
1781642|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781643|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781644|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781645|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
1781646|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1781647|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1781648|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1781649|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1781650|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
1781651|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1781652|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781653|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1781654|NCT05048511|Vitamin D|vitamin d|mesh-list
1781655|NCT05048511|Vitamins|vitamins|mesh-ancestor
1781656|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
1781657|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781658|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1781659|NCT05048589|Vaccines|vaccines|mesh-list
1781660|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
1781661|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781662|NCT05048524|Leucovorin|leucovorin|mesh-list
1781663|NCT05048524|Gemcitabine|gemcitabine|mesh-list
1781664|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
1781665|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1781666|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
1781667|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781668|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781669|NCT05048524|Antiviral Agents|antiviral agents|mesh-ancestor
1781670|NCT05048524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1781671|NCT05048524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781672|NCT05048524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1781673|NCT05048524|Immunologic Factors|immunologic factors|mesh-ancestor
1781674|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781675|NCT05048524|Antidotes|antidotes|mesh-ancestor
1781676|NCT05048524|Protective Agents|protective agents|mesh-ancestor
1781677|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
1781678|NCT05048524|Vitamins|vitamins|mesh-ancestor
1781679|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
1781684|NCT05048498|Azacitidine|azacitidine|mesh-list
1781685|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1781686|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
1781687|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781688|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781689|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781722|NCT05047952|Vortioxetine|vortioxetine|mesh-list
1781723|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
1781724|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1781725|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1781726|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1781727|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1781728|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781729|NCT05047952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1781730|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1781731|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1781732|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781733|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1781734|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
1781735|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1781736|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1781737|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1781738|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1781739|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
1781740|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1781741|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1781742|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781743|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781744|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
1781745|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1781746|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1781747|NCT05047874|Prednisolone|prednisolone|mesh-list
1781748|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
1781749|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1781750|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
1781751|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1781752|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
1781753|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
1781754|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781755|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781756|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1781757|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
1781758|NCT05047874|Hormones|hormones|mesh-ancestor
1781759|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1781760|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1781761|NCT05047874|Protective Agents|protective agents|mesh-ancestor
1781762|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1781763|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781771|NCT05047848|Fulvestrant|fulvestrant|mesh-list
1781772|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1781773|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781774|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1781775|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1781776|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
1781777|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1781778|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781779|NCT05047991|Leucovorin|leucovorin|mesh-list
1781780|NCT05047991|Gemcitabine|gemcitabine|mesh-list
1781781|NCT05047991|Paclitaxel|paclitaxel|mesh-list
1781782|NCT05047991|Fluorouracil|fluorouracil|mesh-list
1781783|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
1781784|NCT05047991|Irinotecan|irinotecan|mesh-list
1781785|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1781786|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781787|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
1781788|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
1781789|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
1781790|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781791|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1781792|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
1781793|NCT05047991|Antiviral Agents|antiviral agents|mesh-ancestor
1781794|NCT05047991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1781795|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781796|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1781797|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
1781798|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781799|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1781800|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1781801|NCT05047991|Antidotes|antidotes|mesh-ancestor
1781802|NCT05047991|Protective Agents|protective agents|mesh-ancestor
1781803|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
1781804|NCT05047991|Vitamins|vitamins|mesh-ancestor
1781805|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
1781806|NCT05047978|Caseins|caseins|mesh-list
1781807|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
1781808|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
1781809|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781810|NCT05047328|Inolimomab|inolimomab|mesh-list
1781811|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1781812|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
1781813|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781814|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
1781815|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1781816|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1781817|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781818|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
1781819|NCT05047133|Coagulants|coagulants|mesh-ancestor
1781820|NCT05047393|Vitamin D|vitamin d|mesh-list
1781821|NCT05047393|Vitamins|vitamins|mesh-ancestor
1781822|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
1781823|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781824|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1781854|NCT05047211|Dextrans|dextrans|mesh-list
1781855|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
1781856|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
1781857|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
1781858|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
1781859|NCT05047211|Hematinics|hematinics|mesh-ancestor
1781872|NCT05046860|Dalbavancin|dalbavancin|mesh-list
1781873|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1781874|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1781876|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
1781877|NCT05047055|Rifampin|rifampin|mesh-list
1781878|NCT05047055|Isoniazid|isoniazid|mesh-list
1781879|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
1781880|NCT05047055|Ethambutol|ethambutol|mesh-list
1781881|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1781882|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1781883|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1781884|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1781885|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781886|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781887|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781888|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1781889|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
1781890|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
1781891|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1781892|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1781893|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1781894|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1781895|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1781896|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1781897|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1781898|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1781899|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1781900|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
1781901|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1781919|NCT05046535|Nicotine|nicotine|mesh-list
1781920|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1781921|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
1781922|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781923|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781924|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1781925|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1781926|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
1781927|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1781928|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781929|NCT05046431|Golimumab|golimumab|mesh-list
1781930|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1781931|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1781932|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1781933|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
1781934|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781935|NCT05046262|Calcium|calcium|mesh-list
1781936|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1781937|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781938|NCT05046314|Vincristine|vincristine|mesh-list
1781939|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1781940|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1781941|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
1781942|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
1781943|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
1781944|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781945|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
1781946|NCT05046457|Provitamins|provitamins|mesh-ancestor
1781947|NCT05046457|Vitamins|vitamins|mesh-ancestor
1781948|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
1781949|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781972|NCT05045937|Vitamin D|vitamin d|mesh-list
1781973|NCT05045937|Vitamins|vitamins|mesh-list
1781974|NCT05045937|Ivermectin|ivermectin|mesh-list
1781975|NCT05045937|Remdesivir|remdesivir|mesh-list
1781976|NCT05045937|Ibuprofen|ibuprofen|mesh-list
1781977|NCT05045937|Budesonide|budesonide|mesh-list
1781978|NCT05045937|Melatonin|melatonin|mesh-list
1781979|NCT05045937|Albuterol|albuterol|mesh-list
1781980|NCT05045937|Quercetin|quercetin|mesh-list
1781981|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1781982|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
1781983|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1781984|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1781985|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1781986|NCT05045937|Analgesics|analgesics|mesh-ancestor
1781987|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
1781988|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1781989|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1781990|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1781991|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1781992|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1781993|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1781994|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1781995|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
1781996|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1781997|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
1781998|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
1781999|NCT05045937|Hormones|hormones|mesh-ancestor
1782000|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1782001|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
1782002|NCT05045937|Protective Agents|protective agents|mesh-ancestor
1782003|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782004|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
1782005|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1782006|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1782007|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1782008|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1782009|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
1782010|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782011|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1782012|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1782013|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
1782014|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
1782015|NCT05046041|Misoprostol|misoprostol|mesh-list
1782016|NCT05046041|Mifepristone|mifepristone|mesh-list
1782017|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1782018|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
1782019|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1782020|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782021|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1782022|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1782023|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
1782024|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1782025|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1782026|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1782027|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1782028|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
1782029|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1782030|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1782031|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
1782032|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1782033|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
1782034|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1782035|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1782038|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
1782039|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1782040|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1782041|NCT05045794|Liver Extracts|liver extracts|mesh-list
1782042|NCT05045794|Hematinics|hematinics|mesh-ancestor
1782043|NCT05045651|Cimetidine|cimetidine|mesh-list
1782044|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1782045|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1782046|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1782047|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
1782048|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
1782049|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782050|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782051|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782052|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1782053|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1782054|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782069|NCT05045508|Varenicline|varenicline|mesh-list
1782070|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1782071|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1782072|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
1782073|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782074|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782075|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782076|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
1782077|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1782078|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782079|NCT05045248|Apraclonidine|apraclonidine|mesh-list
1782080|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1782081|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1782082|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1782083|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
1782084|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782085|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782086|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782087|NCT05045274|Aspirin|aspirin|mesh-list
1782088|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
1782089|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
1782090|NCT05045274|Giapreza|giapreza|mesh-list
1782091|NCT05045274|Clopidogrel|clopidogrel|mesh-list
1782092|NCT05045274|Ticagrelor|ticagrelor|mesh-list
1782093|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1782094|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
1782095|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
1782096|NCT05045274|Diuretics|diuretics|mesh-list
1782097|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1782098|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1782099|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
1782100|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
1782101|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
1782102|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1782103|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1782104|NCT05045274|Analgesics|analgesics|mesh-ancestor
1782105|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
1782106|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782107|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782108|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1782109|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1782110|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1782111|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1782112|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782113|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1782114|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1782115|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
1782116|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1782117|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1782118|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1782119|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
1782120|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782121|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1782122|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1782123|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1782124|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1782125|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
1782126|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1782127|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
1782128|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1782129|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
1782130|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1782131|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1782132|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
1782133|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
1782134|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1782135|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1782136|NCT05045274|Hormones|hormones|mesh-ancestor
1782137|NCT05045443|Curcumin|curcumin|mesh-list
1782138|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1782139|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1782140|NCT05045443|Analgesics|analgesics|mesh-ancestor
1782141|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
1782142|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782143|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782144|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1782145|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1782146|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782147|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782148|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782156|NCT05044962|Rilpivirine|rilpivirine|mesh-list
1782157|NCT05044962|Cabotegravir|cabotegravir|mesh-list
1782158|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1782159|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
1782160|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
1782161|NCT05044962|Etonogestrel|etonogestrel|mesh-list
1782162|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1782163|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
1782164|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1782165|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782166|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1782167|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1782168|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1782169|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1782170|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1782171|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1782172|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782173|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1782174|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1782175|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782176|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782177|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
1782178|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1782179|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1782180|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1782181|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1782182|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1782183|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1782184|NCT05045053|Lifitegrast|lifitegrast|mesh-list
1782185|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1782186|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
1782187|NCT05045170|Propofol|propofol|mesh-list
1782188|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
1782189|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782190|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782191|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1782192|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1782193|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
1782194|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1782195|NCT05045170|Analgesics|analgesics|mesh-ancestor
1782196|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
1782197|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782198|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1782199|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1782200|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1782201|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
1782202|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782203|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782204|NCT05044819|Cannabidiol|cannabidiol|mesh-list
1782205|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
1782206|NCT05044728|Paclitaxel|paclitaxel|mesh-list
1782207|NCT05044728|Carboplatin|carboplatin|mesh-list
1782208|NCT05044728|Antibodies|antibodies|mesh-list
1782209|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1782210|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782211|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
1782212|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
1782213|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
1782214|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782215|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
1782216|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782217|NCT05044637|Primaquine|primaquine|mesh-list
1782218|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
1782219|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1782220|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1782221|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1782222|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
1782223|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1782224|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
1782225|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782226|NCT05044429|Lidocaine|lidocaine|mesh-list
1782227|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
1782228|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
1782229|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782230|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782231|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
1782232|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782233|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1782234|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1782235|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1782236|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1782237|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782238|NCT05044468|Lidocaine|lidocaine|mesh-list
1782239|NCT05044468|Bupivacaine|bupivacaine|mesh-list
1782240|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
1782241|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
1782242|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782243|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782244|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
1782245|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782246|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1782247|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1782248|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1782249|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1782250|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782251|NCT05044364|Clevidipine|clevidipine|mesh-list
1782252|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1782253|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1782254|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782255|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1782256|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782257|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
1782258|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1782259|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1782260|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782261|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782262|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782263|NCT05043766|Naltrexone|naltrexone|mesh-list
1782264|NCT05043766|Oxycodone|oxycodone|mesh-list
1782265|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1782266|NCT05043766|Narcotics|narcotics|mesh-ancestor
1782267|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782268|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782269|NCT05043766|Analgesics|analgesics|mesh-ancestor
1782270|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
1782271|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782272|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1782273|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1782274|NCT05043740|Evolocumab|evolocumab|mesh-list
1782275|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1782276|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1782277|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
1782278|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782279|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1782280|NCT05043896|Tadalafil|tadalafil|mesh-list
1782281|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
1782282|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1782283|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1782284|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782285|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782286|NCT05043896|Urological Agents|urological agents|mesh-ancestor
1782287|NCT05043506|Palbociclib|palbociclib|mesh-list
1782288|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1782289|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782290|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1782291|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782292|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782293|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1782294|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1782295|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
1782296|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1782297|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782298|NCT05043688|Paclitaxel|paclitaxel|mesh-list
1782299|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1782300|NCT05043688|Carboplatin|carboplatin|mesh-list
1782301|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1782302|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782303|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
1782304|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
1782305|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
1782306|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782307|NCT05043350|Loratadine|loratadine|mesh-list
1782308|NCT05043350|Famotidine|famotidine|mesh-list
1782309|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1782310|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1782311|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1782312|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
1782313|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
1782314|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782315|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782316|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782317|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
1782318|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
1782319|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1782320|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1782321|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1782322|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1782323|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1782324|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1782325|NCT05043233|Methimazole|methimazole|mesh-list
1782326|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
1782327|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
1782328|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1782329|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782330|NCT05043129|Vaccines|vaccines|mesh-list
1782331|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
1782332|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782333|NCT05043142|Antibodies|antibodies|mesh-list
1782334|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
1782335|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782336|NCT05043116|Vitamin D|vitamin d|mesh-list
1782337|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
1782338|NCT05043116|Vitamins|vitamins|mesh-ancestor
1782339|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
1782340|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782341|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1782342|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1782343|NCT05042973|Empagliflozin|empagliflozin|mesh-list
1782344|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1782345|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782346|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1782347|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782356|NCT05042817|Sufentanil|sufentanil|mesh-list
1782357|NCT05042817|Morphine|morphine|mesh-list
1782358|NCT05042817|Prilocaine|prilocaine|mesh-list
1782359|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1782360|NCT05042817|Narcotics|narcotics|mesh-ancestor
1782361|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782362|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782363|NCT05042817|Analgesics|analgesics|mesh-ancestor
1782364|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
1782365|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782366|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1782367|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1782368|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
1782369|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
1782370|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
1782371|NCT05042934|Irinotecan|irinotecan|mesh-list
1782372|NCT05042934|Camptothecin|camptothecin|mesh-list
1782373|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1782374|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1782375|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782376|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782377|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782378|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1782379|NCT05042674|Ergothioneine|ergothioneine|mesh-list
1782380|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
1782381|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782382|NCT05042674|Protective Agents|protective agents|mesh-ancestor
1782383|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782384|NCT05042791|Capecitabine|capecitabine|mesh-list
1782385|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1782386|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
1782387|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782388|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782389|NCT05042635|Ixekizumab|ixekizumab|mesh-list
1782390|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
1782395|NCT05042531|Azacitidine|azacitidine|mesh-list
1782396|NCT05042531|Dasatinib|dasatinib|mesh-list
1782397|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1782398|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
1782399|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782400|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782401|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782402|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1782418|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
1782419|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1782420|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782421|NCT05042336|Lenvatinib|lenvatinib|mesh-list
1782422|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782423|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1782424|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782425|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782426|NCT05042271|Meropenem|meropenem|mesh-list
1782427|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1782428|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1782429|NCT05042245|Silymarin|silymarin|mesh-list
1782430|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
1782431|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
1782432|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782433|NCT05042245|Protective Agents|protective agents|mesh-ancestor
1782434|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782435|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
1782436|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1782437|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782438|NCT05041985|Diazepam|diazepam|mesh-list
1782439|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1782440|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
1782441|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
1782442|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
1782443|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782444|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782445|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1782446|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1782447|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782448|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1782449|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1782450|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1782451|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1782452|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1782453|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1782454|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
1782455|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
1782456|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
1782457|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
1782458|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782459|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782469|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
1782470|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
1782471|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1782472|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782473|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782474|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782503|NCT05042102|Donepezil|donepezil|mesh-list
1782504|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1782505|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782506|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782507|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
1782508|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782509|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782510|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
1782511|NCT05041647|Dronabinol|dronabinol|mesh-list
1782512|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
1782513|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782514|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1782515|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1782516|NCT05041647|Analgesics|analgesics|mesh-ancestor
1782517|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
1782518|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782519|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1782520|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1782521|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782522|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782523|NCT05041647|Hormones|hormones|mesh-ancestor
1782524|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1782539|NCT05041582|Citalopram|citalopram|mesh-list
1782540|NCT05041582|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1782541|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1782542|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1782543|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782544|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782545|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
1782546|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782547|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1782548|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
1782549|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1782550|NCT05041426|Valganciclovir|valganciclovir|mesh-list
1782551|NCT05041426|Letermovir|letermovir|mesh-list
1782552|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
1782553|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1782554|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1782555|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782556|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782557|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782558|NCT05041790|Choline|choline|mesh-list
1782559|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
1782560|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1782561|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
1782562|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782563|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1782564|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1782565|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
1782576|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
1782577|NCT05041153|Lenvatinib|lenvatinib|mesh-list
1782578|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1782579|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782580|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1782581|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782582|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782583|NCT05041335|Heparin|heparin|mesh-list
1782584|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
1782585|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1782586|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1782660|NCT05040594|Lidocaine|lidocaine|mesh-list
1782587|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782588|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1782589|NCT05041127|Cetuximab|cetuximab|mesh-list
1782590|NCT05041127|Antibodies|antibodies|mesh-list
1782591|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
1782592|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1782593|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
1782594|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782595|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782596|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
1782597|NCT05041270|Nalbuphine|nalbuphine|mesh-list
1782598|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1782599|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782600|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782601|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1782602|NCT05041270|Analgesics|analgesics|mesh-ancestor
1782603|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
1782604|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782605|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1782606|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1782607|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1782608|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
1782609|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782610|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782611|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1782612|NCT05041270|Narcotics|narcotics|mesh-ancestor
1782613|NCT05040906|Rituximab|rituximab|mesh-list
1782614|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1782615|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782616|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
1782617|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782618|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1782619|NCT05040880|Telmisartan|telmisartan|mesh-list
1782620|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1782621|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1782622|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1782623|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782631|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
1782632|NCT05040984|Mirabegron|mirabegron|mesh-list
1782633|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1782634|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1782635|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
1782636|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782637|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782638|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782639|NCT05040984|Urological Agents|urological agents|mesh-ancestor
1782640|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
1782641|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1782642|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1782643|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
1782644|NCT05040828|Montelukast|montelukast|mesh-list
1782645|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1782646|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
1782647|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1782648|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
1782649|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1782650|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782651|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1782652|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1782653|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782657|NCT05040724|Ivermectin|ivermectin|mesh-list
1782658|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1782659|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1782661|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
1782662|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
1782663|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782664|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782665|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
1782666|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782667|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1782668|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1782669|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1782670|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1782671|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782672|NCT05040217|Mitogens|mitogens|mesh-list
1782673|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
1782674|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782675|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1782676|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1782685|NCT05040282|Etonogestrel|etonogestrel|mesh-list
1782686|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1782687|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
1782688|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1782689|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782690|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1782710|NCT05039801|Pembrolizumab|pembrolizumab|mesh-list
1782711|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1782712|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782719|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1782720|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1782721|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782722|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782723|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1782724|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1782725|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782726|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
1782727|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782728|NCT05039580|Dexamethasone|dexamethasone|mesh-list
1782729|NCT05039580|Antibodies|antibodies|mesh-list
1782730|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1782731|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
1782732|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782733|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1782734|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
1782735|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
1782736|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782737|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1782738|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
1782739|NCT05039580|Hormones|hormones|mesh-ancestor
1782740|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1782741|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1782742|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782743|NCT05039606|Nedaplatin|nedaplatin|mesh-list
1782744|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782745|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
1782746|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1782747|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1782748|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
1782749|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
1782750|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1782751|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782752|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782753|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1782754|NCT05039476|Vitamin A|vitamin a|mesh-list
1782755|NCT05039476|Vitamins|vitamins|mesh-ancestor
1782756|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
1782757|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782762|NCT05038969|Esomeprazole|esomeprazole|mesh-list
1782763|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1782764|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1782765|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1782766|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782767|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782768|NCT05038605|Metronidazole|metronidazole|mesh-list
1782769|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1782770|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1782771|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1782772|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1782773|NCT05038657|Atezolizumab|atezolizumab|mesh-list
1782774|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782775|NCT05038462|Lactoferrin|lactoferrin|mesh-list
1782776|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1782777|NCT05038072|Triamcinolone|triamcinolone|mesh-list
1782778|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1782779|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1782780|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1782781|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1782782|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
1782783|NCT05038072|Hormones|hormones|mesh-ancestor
1782784|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1782785|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782786|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1782787|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
1782788|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782789|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782790|NCT05038007|Bupivacaine|bupivacaine|mesh-list
1782791|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
1782792|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
1782793|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782794|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782795|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
1782796|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782797|NCT05038410|Wobenzym|wobenzym|mesh-list
1782798|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1782799|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
1782800|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782801|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
1782802|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1782803|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782804|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782805|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1782806|NCT05038111|Analgesics|analgesics|mesh-ancestor
1782807|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
1782808|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782809|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1782810|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1782811|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1782812|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
1782813|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782814|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782815|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
1782816|NCT05038202|Bromides|bromides|mesh-list
1782817|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
1782818|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1782819|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
1782820|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1782821|NCT05038228|Vitamin K|vitamin k|mesh-list
1782822|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
1782823|NCT05038228|Apixaban|apixaban|mesh-list
1782824|NCT05038228|Dabigatran|dabigatran|mesh-list
1782825|NCT05038228|Vitamins|vitamins|mesh-ancestor
1782826|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
1782827|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782828|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1782829|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
1782830|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1782831|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
1782832|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782833|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782834|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
1782835|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1782836|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1782837|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
1782838|NCT05038228|Coagulants|coagulants|mesh-ancestor
1782839|NCT05038449|Colchicine|colchicine|mesh-list
1782840|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
1782841|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1782842|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
1782843|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
1782844|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
1782845|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782846|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782847|NCT05038059|Acetic Acid|acetic acid|mesh-list
1782848|NCT05038059|Retinol acetate|retinol acetate|mesh-list
1782849|NCT05038059|Ethylene|ethylene|mesh-list
1782850|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1782851|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1782852|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1782853|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
1782854|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782855|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1782856|NCT05038059|Protective Agents|protective agents|mesh-ancestor
1782857|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782858|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
1782859|NCT05038059|Growth Substances|growth substances|mesh-ancestor
1782860|NCT05037812|Ketorolac|ketorolac|mesh-list
1782861|NCT05037812|Clonidine|clonidine|mesh-list
1782862|NCT05037812|Epinephrine|epinephrine|mesh-list
1782863|NCT05037812|Morphine|morphine|mesh-list
1782864|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1782865|NCT05037812|Narcotics|narcotics|mesh-ancestor
1782866|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782867|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782868|NCT05037812|Analgesics|analgesics|mesh-ancestor
1782869|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
1782870|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782871|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1782872|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1782873|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
1782874|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782875|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782876|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1782877|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1782878|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
1782879|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1782880|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
1782881|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
1782882|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
1782883|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1782884|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1782885|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1782886|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1782887|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1782888|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1782889|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782890|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1782891|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
1782892|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1782893|NCT05037695|Empagliflozin|empagliflozin|mesh-list
1782894|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1782895|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782896|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1782897|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782898|NCT05037487|Dronabinol|dronabinol|mesh-list
1782899|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
1782900|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782901|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1782902|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1782903|NCT05037487|Analgesics|analgesics|mesh-ancestor
1782904|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
1782905|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782906|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1782907|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1782908|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782909|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782910|NCT05037487|Hormones|hormones|mesh-ancestor
1782911|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1782912|NCT05037539|Fentanyl|fentanyl|mesh-list
1782913|NCT05037539|Morphine|morphine|mesh-list
1782914|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1782915|NCT05037539|Narcotics|narcotics|mesh-ancestor
1782916|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782917|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782918|NCT05037539|Analgesics|analgesics|mesh-ancestor
1782919|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
1782920|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782921|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1782922|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1782923|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
1782924|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
1782925|NCT05037032|Naltrexone|naltrexone|mesh-list
1782926|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1782927|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1782928|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782929|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
1782930|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782931|NCT05037253|Vitamin D|vitamin d|mesh-list
1782932|NCT05037253|Vitamins|vitamins|mesh-ancestor
1782933|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
1782934|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782935|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1782936|NCT05037240|Quercetin|quercetin|mesh-list
1782937|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
1782938|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782939|NCT05037240|Protective Agents|protective agents|mesh-ancestor
1782940|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782941|NCT05037123|Ketamine|ketamine|mesh-list
1782942|NCT05037123|Analgesics|analgesics|mesh-ancestor
1782943|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
1782944|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782945|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782946|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1782947|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1782948|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
1782949|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
1782950|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782951|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1782952|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1782953|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782954|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782955|NCT05037006|Anesthetics|anesthetics|mesh-list
1782956|NCT05037006|Sevoflurane|sevoflurane|mesh-list
1782957|NCT05037006|Neostigmine|neostigmine|mesh-list
1782958|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1782959|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782960|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1782961|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1782962|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
1782963|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1782964|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1782965|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782966|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
1782967|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1782968|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1782969|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
1782970|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1782971|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
1782972|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1782973|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1782974|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782975|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
1782976|NCT05037162|Coagulants|coagulants|mesh-ancestor
1782977|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
1782978|NCT05037045|Incretins|incretins|mesh-ancestor
1782979|NCT05037045|Hormones|hormones|mesh-ancestor
1782980|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1782981|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782982|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
1782983|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1782984|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
1782985|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1782986|NCT05036824|Tinzaparin|tinzaparin|mesh-list
1782987|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1782988|NCT05036824|Dalteparin|dalteparin|mesh-list
1782989|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
1782990|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1782991|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1782992|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1782997|NCT05036798|Lenvatinib|lenvatinib|mesh-list
1782998|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1782999|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1783000|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783001|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783002|NCT05036421|Empagliflozin|empagliflozin|mesh-list
1783003|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1783004|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783005|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1783006|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783007|NCT05036005|Pertuzumab|pertuzumab|mesh-list
1783008|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1783009|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783014|NCT05035953|Edaravone|edaravone|mesh-list
1783015|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1783016|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
1783017|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783018|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1783019|NCT05035953|Protective Agents|protective agents|mesh-ancestor
1783020|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783021|NCT05036018|Anesthetics|anesthetics|mesh-list
1783022|NCT05036018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1783023|NCT05036018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783024|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
1783025|NCT05036174|Promethazine|promethazine|mesh-list
1783026|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1783027|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1783028|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1783029|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783030|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
1783031|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
1783032|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
1783033|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783034|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
1783035|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
1783036|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1783037|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1783038|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
1783039|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
1783040|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783041|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783042|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1783043|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
1783044|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
1783045|NCT05035888|Phenylephrine|phenylephrine|mesh-list
1783046|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
1783047|NCT05035888|Norepinephrine|norepinephrine|mesh-list
1783048|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
1783049|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1783050|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
1783051|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
1783052|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783053|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783054|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
1783055|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
1783056|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
1783057|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1783058|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1783059|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1783060|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
1783061|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783062|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783063|NCT05035888|Protective Agents|protective agents|mesh-ancestor
1783064|NCT05035745|Talazoparib|talazoparib|mesh-list
1783065|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1783066|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783067|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783068|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783069|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1783070|NCT05035849|Acarbose|acarbose|mesh-list
1783071|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1783072|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783073|NCT05035849|Incretins|incretins|mesh-ancestor
1783074|NCT05035849|Hormones|hormones|mesh-ancestor
1783075|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1783076|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1783077|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
1783078|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783079|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783080|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
1783096|NCT05035381|Leucovorin|leucovorin|mesh-list
1783097|NCT05035381|Bevacizumab|bevacizumab|mesh-list
1783098|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
1783099|NCT05035381|Fluorouracil|fluorouracil|mesh-list
1783100|NCT05035381|Irinotecan|irinotecan|mesh-list
1783101|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1783102|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1783103|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783104|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1783105|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1783106|NCT05035381|Growth Substances|growth substances|mesh-ancestor
1783107|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783108|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
1783109|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
1783110|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783111|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1783112|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1783113|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
1783114|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1783115|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1783116|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783117|NCT05035381|Antidotes|antidotes|mesh-ancestor
1783118|NCT05035381|Protective Agents|protective agents|mesh-ancestor
1783119|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
1783120|NCT05035381|Vitamins|vitamins|mesh-ancestor
1783121|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
1783122|NCT05035680|Vaccines|vaccines|mesh-list
1783123|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
1783124|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783125|NCT05035498|Phenylephrine|phenylephrine|mesh-list
1783126|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
1783127|NCT05035498|Norepinephrine|norepinephrine|mesh-list
1783128|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
1783129|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1783130|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
1783131|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
1783132|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783133|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783134|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
1783135|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
1783136|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
1783137|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1783138|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1783139|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1783140|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
1783141|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783142|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783143|NCT05035498|Protective Agents|protective agents|mesh-ancestor
1783144|NCT05035485|Phenylephrine|phenylephrine|mesh-list
1783145|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
1783146|NCT05035485|Norepinephrine|norepinephrine|mesh-list
1783147|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
1783148|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1783149|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
1783150|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
1783151|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783152|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783153|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
1783154|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
1783155|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
1783156|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1783157|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1783158|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1783159|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
1783160|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783161|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783162|NCT05035485|Protective Agents|protective agents|mesh-ancestor
1783163|NCT05035472|Phenylephrine|phenylephrine|mesh-list
1783164|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
1783165|NCT05035472|Norepinephrine|norepinephrine|mesh-list
1783166|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
1783167|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1783168|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
1783169|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
1783170|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783171|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783172|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
1783173|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
1783174|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
1783175|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1783176|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1783177|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1783178|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
1783179|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783180|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783181|NCT05035472|Protective Agents|protective agents|mesh-ancestor
1783182|NCT05035316|Aspirin|aspirin|mesh-list
1783183|NCT05035316|Calcium|calcium|mesh-list
1783184|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1783185|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783186|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1783187|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1783188|NCT05035316|Analgesics|analgesics|mesh-ancestor
1783189|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
1783190|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783191|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1783192|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1783193|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1783194|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1783195|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783196|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1783197|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1783198|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783199|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
1783200|NCT05035238|Vaccines|vaccines|mesh-list
1783201|NCT05035238|Immunologic Factors|immunologic factors|mesh-ancestor
1783202|NCT05035238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783203|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
1783204|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1783205|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
1783206|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783207|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
1783208|NCT05034965|Protective Agents|protective agents|mesh-ancestor
1783233|NCT05035069|Propofol|propofol|mesh-list
1783234|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1783235|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1783236|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783237|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1783238|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
1783239|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
1783240|NCT05035147|Gemcitabine|gemcitabine|mesh-list
1783241|NCT05035147|Paclitaxel|paclitaxel|mesh-list
1783242|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1783243|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1783244|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783245|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
1783246|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
1783247|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
1783248|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783249|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1783250|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
1783251|NCT05035147|Antiviral Agents|antiviral agents|mesh-ancestor
1783252|NCT05035147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1783253|NCT05035147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783254|NCT05035147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1783255|NCT05035147|Immunologic Factors|immunologic factors|mesh-ancestor
1783256|NCT05035147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783273|NCT05034783|Exenatide|exenatide|mesh-list
1783274|NCT05034783|Edetic Acid|edetic acid|mesh-list
1783275|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
1783276|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
1783277|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783278|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
1783279|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1783280|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1783281|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783282|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1783283|NCT05034783|Incretins|incretins|mesh-ancestor
1783284|NCT05034783|Hormones|hormones|mesh-ancestor
1783285|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1783286|NCT05034887|Trastuzumab|trastuzumab|mesh-list
1783287|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1783288|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783289|NCT05034627|Asparaginase|asparaginase|mesh-list
1783290|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783291|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
1783292|NCT05034536|Infliximab|infliximab|mesh-list
1783293|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1783294|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783295|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
1783296|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1783297|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1783298|NCT05034406|Lidocaine|lidocaine|mesh-list
1783299|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
1783300|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
1783301|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
1783302|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1783303|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783304|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
1783305|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783306|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1783307|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1783308|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1783309|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1783310|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783319|NCT05033808|Epirubicin|epirubicin|mesh-list
1783320|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1783321|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783322|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1783323|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1783324|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783325|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783326|NCT05034055|Atezolizumab|atezolizumab|mesh-list
1783327|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783328|NCT05033665|Benzocaine|benzocaine|mesh-list
1783329|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
1783330|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
1783331|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1783332|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783333|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
1783334|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783335|NCT05033769|Paclitaxel|paclitaxel|mesh-list
1783336|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1783337|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1783338|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783339|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
1783340|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
1783341|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
1783342|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783343|NCT05034133|Cisplatin|cisplatin|mesh-list
1783344|NCT05034133|Etoposide|etoposide|mesh-list
1783345|NCT05034133|Durvalumab|durvalumab|mesh-list
1783346|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783347|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1783348|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1783349|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1783350|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783351|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783352|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1783353|NCT05033743|Secnidazole|secnidazole|mesh-list
1783354|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1783355|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1783356|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1783357|NCT05033860|Vaccines|vaccines|mesh-list
1783358|NCT05033860|Immunologic Factors|immunologic factors|mesh-ancestor
1783359|NCT05033860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783360|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
1783361|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1783362|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
1783363|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1783364|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
1783365|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783366|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783367|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
1783368|NCT05033574|Hormones|hormones|mesh-list
1783369|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1783370|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783371|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
1783372|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
1783373|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
1783374|NCT05033535|Olmesartan|olmesartan|mesh-list
1783375|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1783376|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1783377|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1783378|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1783379|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783380|NCT05033106|Bevacizumab|bevacizumab|mesh-list
1783381|NCT05033106|Ranibizumab|ranibizumab|mesh-list
1783382|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1783383|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783384|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1783385|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1783386|NCT05033106|Growth Substances|growth substances|mesh-ancestor
1783387|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783388|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
1783389|NCT05032781|Minocycline|minocycline|mesh-list
1783390|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1783391|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1783392|NCT05032261|Norepinephrine|norepinephrine|mesh-list
1783393|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1783394|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1783395|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
1783396|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783397|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783398|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783399|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
1783400|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
1783401|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783402|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1783403|NCT05032287|Tamsulosin|tamsulosin|mesh-list
1783404|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1783405|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1783406|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1783407|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
1783408|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783409|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783410|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783411|NCT05032287|Urological Agents|urological agents|mesh-ancestor
1783412|NCT05032508|Lidocaine|lidocaine|mesh-list
1783413|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
1783414|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
1783415|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1783416|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783417|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
1783418|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783419|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1783420|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1783421|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1783422|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1783423|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783482|NCT05032248|Tacrolimus|tacrolimus|mesh-list
1783483|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1783484|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
1783485|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783486|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1783487|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783488|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783489|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
1783490|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1783491|NCT05031936|Ropivacaine|ropivacaine|mesh-list
1783492|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
1783493|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
1783494|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1783495|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783496|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
1783497|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783498|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
1783499|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
1783500|NCT05032001|Biguanides|biguanides|mesh-list
1783501|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783502|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1783503|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783504|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
1783505|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783506|NCT05032118|Ketamine|ketamine|mesh-list
1783507|NCT05032118|Propofol|propofol|mesh-list
1783508|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1783509|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1783510|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783511|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1783512|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
1783513|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
1783514|NCT05032118|Analgesics|analgesics|mesh-ancestor
1783515|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
1783516|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783517|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1783518|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1783519|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1783520|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783521|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783522|NCT05031975|Irinotecan|irinotecan|mesh-list
1783523|NCT05031975|Temozolomide|temozolomide|mesh-list
1783524|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1783525|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1783526|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783527|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783528|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783529|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1783530|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
1783531|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
1783532|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1783533|NCT05031689|Protective Agents|protective agents|mesh-ancestor
1783534|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783535|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
1783536|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
1783537|NCT05031676|Anesthetics|anesthetics|mesh-list
1783538|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1783539|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783540|NCT05031676|Narcotics|narcotics|mesh-ancestor
1783541|NCT05031676|Analgesics|analgesics|mesh-ancestor
1783542|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
1783543|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783544|NCT05031481|Butoconazole|butoconazole|mesh-list
1783545|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
1783546|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1783563|NCT05031520|Metoprolol|metoprolol|mesh-list
1783564|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
1783565|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1783566|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1783567|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
1783568|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
1783569|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783570|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783571|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1783572|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1783573|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1783574|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
1783575|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783576|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783577|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
1783578|NCT05031234|Morphine|morphine|mesh-list
1783579|NCT05031234|Anesthetics|anesthetics|mesh-list
1783580|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1783581|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783582|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1783583|NCT05031234|Narcotics|narcotics|mesh-ancestor
1783584|NCT05031234|Analgesics|analgesics|mesh-ancestor
1783585|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
1783586|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783587|NCT05031143|Triamcinolone|triamcinolone|mesh-list
1783588|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1783589|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1783590|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1783591|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1783592|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
1783593|NCT05031143|Hormones|hormones|mesh-ancestor
1783594|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1783595|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783596|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1783597|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
1783598|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783599|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783600|NCT05030818|Aspirin|aspirin|mesh-list
1783601|NCT05030818|Ramipril|ramipril|mesh-list
1783602|NCT05030818|Atorvastatin|atorvastatin|mesh-list
1783603|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1783604|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1783605|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
1783606|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783607|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1783608|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1783609|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783610|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1783611|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1783612|NCT05030818|Analgesics|analgesics|mesh-ancestor
1783613|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
1783614|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783615|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783616|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1783617|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1783618|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1783619|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1783620|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1783621|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1783622|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
1783623|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1783624|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
1783625|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1783626|NCT05030623|Tadalafil|tadalafil|mesh-list
1783627|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
1783628|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1783629|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1783630|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783631|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783632|NCT05030623|Urological Agents|urological agents|mesh-ancestor
1783643|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
1783644|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1783645|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1783646|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783647|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1783648|NCT05031026|Analgesics|analgesics|mesh-ancestor
1783649|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
1783650|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783651|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1783652|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1783653|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1783654|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
1783655|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783656|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783657|NCT05030545|Eplerenone|eplerenone|mesh-list
1783658|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
1783659|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
1783660|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
1783661|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1783662|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783663|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1783664|NCT05030545|Diuretics|diuretics|mesh-ancestor
1783665|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
1783666|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1783667|NCT05030545|Hormones|hormones|mesh-ancestor
1783672|NCT05030415|Ixekizumab|ixekizumab|mesh-list
1783673|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
1783674|NCT05030194|Nicotine|nicotine|mesh-list
1783675|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1783676|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
1783677|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783678|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783679|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1783680|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1783681|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
1783682|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783683|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783684|NCT05030493|Bevacizumab|bevacizumab|mesh-list
1783685|NCT05030493|Panitumumab|panitumumab|mesh-list
1783686|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1783687|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783688|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1783689|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1783690|NCT05030493|Growth Substances|growth substances|mesh-ancestor
1783691|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783692|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
1783693|NCT05030116|Domperidone|domperidone|mesh-list
1783694|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
1783695|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
1783696|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783697|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783698|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1783699|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1783700|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
1783701|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783702|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783703|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
1783704|NCT05030155|Azathioprine|azathioprine|mesh-list
1783705|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1783706|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
1783707|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783708|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1783709|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1783710|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
1783711|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783712|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783713|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1783714|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
1783715|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1783724|NCT05029726|Clonidine|clonidine|mesh-list
1783725|NCT05029726|Epinephrine|epinephrine|mesh-list
1783726|NCT05029726|Bupivacaine|bupivacaine|mesh-list
1783727|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
1783728|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
1783729|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1783730|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783731|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
1783732|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783733|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1783734|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1783735|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
1783736|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783737|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783738|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1783739|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1783740|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
1783741|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1783742|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
1783743|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
1783744|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
1783745|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1783746|NCT05029726|Analgesics|analgesics|mesh-ancestor
1783747|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1783748|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
1783749|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1783750|NCT05030025|Lamivudine|lamivudine|mesh-list
1783751|NCT05030025|Abacavir|abacavir|mesh-list
1783752|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
1783753|NCT05030025|Dolutegravir|dolutegravir|mesh-list
1783754|NCT05030025|Triumeq|triumeq|mesh-list
1783755|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1783756|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1783757|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783758|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783759|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
1783760|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1783761|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1783762|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1783763|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
1783764|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1783765|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1783766|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
1783767|NCT05030129|Pyridoxal|pyridoxal|mesh-list
1783768|NCT05030129|Pyridoxine|pyridoxine|mesh-list
1783769|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
1783770|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
1783771|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
1783772|NCT05030129|Vitamins|vitamins|mesh-ancestor
1783773|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
1783774|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783775|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
1783776|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1783777|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
1783778|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1783779|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1783780|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1783781|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
1783782|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783783|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783784|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
1783785|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
1783786|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
1783787|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
1783788|NCT05030077|Gemcitabine|gemcitabine|mesh-list
1783789|NCT05030077|Carboplatin|carboplatin|mesh-list
1783790|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783791|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1783792|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
1783793|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783794|NCT05030077|Antiviral Agents|antiviral agents|mesh-ancestor
1783795|NCT05030077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1783796|NCT05030077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783797|NCT05030077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1783798|NCT05030077|Immunologic Factors|immunologic factors|mesh-ancestor
1783799|NCT05030077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783802|NCT05029453|Apatinib|apatinib|mesh-list
1783803|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783804|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1783805|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783806|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783807|NCT05029596|Heparin|heparin|mesh-list
1783808|NCT05029596|Calcium heparin|calcium heparin|mesh-list
1783809|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
1783810|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1783811|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1783812|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783813|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
1783814|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783815|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1783816|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783817|NCT05029076|Liraglutide|liraglutide|mesh-list
1783818|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1783819|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783820|NCT05029076|Incretins|incretins|mesh-ancestor
1783821|NCT05029076|Hormones|hormones|mesh-ancestor
1783822|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1783823|NCT05029401|Ibogaine|ibogaine|mesh-list
1783824|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
1783825|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783826|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1783827|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1783828|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1783829|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1783830|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783849|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
1783850|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
1783851|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783852|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1783853|NCT05029297|Capsaicin|capsaicin|mesh-list
1783854|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
1783855|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
1783856|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
1783857|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783858|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783859|NCT05029037|Ascorbic Acid|ascorbic acid|mesh-list
1783860|NCT05029037|Vitamins|vitamins|mesh-ancestor
1783861|NCT05029037|Micronutrients|micronutrients|mesh-ancestor
1783862|NCT05029037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783863|NCT05029037|Antioxidants|antioxidants|mesh-ancestor
1783864|NCT05029037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783865|NCT05029037|Protective Agents|protective agents|mesh-ancestor
1783866|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
1783867|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1783868|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
1783869|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1783870|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
1783871|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783872|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783873|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
1783874|NCT05028907|Tocopherols|tocopherols|mesh-list
1783875|NCT05028907|Vitamin E|vitamin e|mesh-list
1783876|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
1783877|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
1783878|NCT05028907|Dexamethasone|dexamethasone|mesh-list
1783879|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
1783880|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
1783881|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1783882|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
1783883|NCT05028907|BB 1101|bb 1101|mesh-list
1783884|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1783885|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
1783886|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
1783887|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783888|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783889|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1783890|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
1783891|NCT05028907|Hormones|hormones|mesh-ancestor
1783892|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1783893|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1783894|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783895|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1783896|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
1783897|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
1783898|NCT05028907|Protective Agents|protective agents|mesh-ancestor
1783899|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
1783900|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783901|NCT05028907|Vitamins|vitamins|mesh-ancestor
1783902|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
1783903|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
1783904|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783905|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1783906|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1783907|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1783908|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1783909|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1783910|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
1783911|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
1783912|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1783913|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
1783922|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
1783923|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783924|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
1783925|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1783926|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1783927|NCT05028322|Imiquimod|imiquimod|mesh-list
1783928|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1783929|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
1783930|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783931|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783932|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
1783937|NCT05028348|Dexamethasone|dexamethasone|mesh-list
1783938|NCT05028348|Pomalidomide|pomalidomide|mesh-list
1783939|NCT05028348|Elotuzumab|elotuzumab|mesh-list
1783940|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1783941|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
1783942|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
1783943|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783944|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783945|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1783946|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
1783947|NCT05028348|Hormones|hormones|mesh-ancestor
1783948|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1783949|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1783950|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783951|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
1783952|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1783953|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1783954|NCT05028348|Growth Substances|growth substances|mesh-ancestor
1783955|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
1783962|NCT05028049|Sufentanil|sufentanil|mesh-list
1783963|NCT05028049|Remifentanil|remifentanil|mesh-list
1783964|NCT05028049|Dsuvia|dsuvia|mesh-list
1783965|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1783966|NCT05028049|Narcotics|narcotics|mesh-ancestor
1783967|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1783968|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783969|NCT05028049|Analgesics|analgesics|mesh-ancestor
1783970|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
1783971|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783972|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1783973|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1783974|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
1783975|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
1783976|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
1783977|NCT05027893|Cefixime|cefixime|mesh-list
1783978|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1783979|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1783980|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1783981|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1783982|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1783983|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783984|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1783985|NCT05028153|Azithromycin|azithromycin|mesh-list
1783986|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1783987|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1783988|NCT05028140|Pioglitazone|pioglitazone|mesh-list
1783989|NCT05028140|Empagliflozin|empagliflozin|mesh-list
1783990|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1783991|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1783992|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1783993|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1783994|NCT05027594|Dexamethasone|dexamethasone|mesh-list
1783995|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1783996|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
1783997|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
1783998|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1783999|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784000|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1784001|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
1784002|NCT05027594|Hormones|hormones|mesh-ancestor
1784003|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1784004|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1784005|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784010|NCT05027646|Granisetron|granisetron|mesh-list
1784011|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
1784012|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
1784013|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784014|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784015|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1784016|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1784017|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
1784018|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784019|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784029|NCT05027516|Azithromycin|azithromycin|mesh-list
1784030|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
1784031|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1784032|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1784033|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
1784034|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1784035|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
1784036|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784037|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
1784038|NCT05027581|Protective Agents|protective agents|mesh-ancestor
1784044|NCT05027295|Riboflavin|riboflavin|mesh-list
1784045|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1784046|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1784047|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
1784048|NCT05027295|Vitamins|vitamins|mesh-ancestor
1784049|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
1784050|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784051|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1784052|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
1784053|NCT05027126|Folic Acid|folic acid|mesh-list
1784054|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
1784055|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
1784056|NCT05027126|Vitamins|vitamins|mesh-ancestor
1784057|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
1784058|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784059|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1784060|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1784061|NCT05027126|Analgesics|analgesics|mesh-ancestor
1784062|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
1784063|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784064|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1784065|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1784066|NCT05027126|Hematinics|hematinics|mesh-ancestor
1784067|NCT05027386|Irinotecan|irinotecan|mesh-list
1784068|NCT05027386|Temozolomide|temozolomide|mesh-list
1784069|NCT05027386|Apatinib|apatinib|mesh-list
1784070|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1784071|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1784072|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784073|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784074|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784075|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1784076|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
1784077|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1784078|NCT05027048|Calcium|calcium|mesh-list
1784079|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1784080|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784081|NCT05027191|Sevoflurane|sevoflurane|mesh-list
1784082|NCT05027191|Desflurane|desflurane|mesh-list
1784083|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1784084|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1784085|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
1784086|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
1784087|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1784088|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784089|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1784090|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1784091|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784092|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784093|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1784094|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1784095|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784096|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
1784097|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784128|NCT05026398|Fenfluramine|fenfluramine|mesh-list
1784129|NCT05026398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1784130|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1784131|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1784132|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784133|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784134|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
1784135|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784136|NCT05026593|Carboplatin|carboplatin|mesh-list
1784137|NCT05026593|Etoposide|etoposide|mesh-list
1784138|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784139|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1784140|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1784141|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1784142|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784143|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784144|NCT05026567|Midazolam|midazolam|mesh-list
1784145|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1784146|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1784147|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1784148|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784149|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1784150|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1784151|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1784152|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1784153|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
1784154|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
1784155|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
1784156|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
1784157|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784158|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784159|NCT05026125|Remifentanil|remifentanil|mesh-list
1784160|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1784161|NCT05026125|Narcotics|narcotics|mesh-ancestor
1784162|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1784163|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784164|NCT05026125|Analgesics|analgesics|mesh-ancestor
1784165|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
1784166|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784167|NCT05026229|Cytarabine|cytarabine|mesh-list
1784168|NCT05026229|Prednisone|prednisone|mesh-list
1784169|NCT05026229|Methotrexate|methotrexate|mesh-list
1784170|NCT05026229|Vincristine|vincristine|mesh-list
1784171|NCT05026229|Dasatinib|dasatinib|mesh-list
1784172|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1784173|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
1784174|NCT05026229|Hormones|hormones|mesh-ancestor
1784175|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1784176|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784177|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1784178|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784179|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1784180|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
1784181|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1784182|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1784183|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
1784184|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784185|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
1784186|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784187|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1784188|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1784189|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
1784190|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1784191|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1784192|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
1784193|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1784194|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1784195|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
1784196|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
1784197|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
1784198|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1784199|NCT05026203|Midazolam|midazolam|mesh-list
1784200|NCT05026203|Ketamine|ketamine|mesh-list
1784201|NCT05026203|Analgesics|analgesics|mesh-ancestor
1784202|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
1784203|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784204|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784205|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1784206|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1784207|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
1784208|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
1784209|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1784210|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1784211|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1784212|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784213|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784214|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1784215|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1784216|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1784217|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1784218|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1784219|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
1784220|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
1784221|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
1784222|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1784223|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1784224|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784225|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1784226|NCT05025605|Analgesics|analgesics|mesh-ancestor
1784227|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
1784228|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784229|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1784230|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1784231|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1784232|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
1784233|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784234|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784235|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
1784236|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1784237|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784238|NCT05025644|Dobutamine|dobutamine|mesh-list
1784239|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1784240|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
1784241|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
1784242|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784243|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784244|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1784245|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1784246|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1784247|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
1784248|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784249|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784250|NCT05025644|Protective Agents|protective agents|mesh-ancestor
1784251|NCT05025488|Poly ICLC|poly iclc|mesh-list
1784252|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
1784253|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
1784254|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784255|NCT05025228|Acetaminophen|acetaminophen|mesh-list
1784256|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1784257|NCT05025228|Analgesics|analgesics|mesh-ancestor
1784258|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
1784259|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784260|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784261|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
1784262|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
1784263|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784264|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
1784265|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784266|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784267|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1784268|NCT05025033|Paclitaxel|paclitaxel|mesh-list
1784269|NCT05025033|Irinotecan|irinotecan|mesh-list
1784270|NCT05025033|Apatinib|apatinib|mesh-list
1784271|NCT05025033|Antibodies|antibodies|mesh-list
1784272|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
1784273|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1784274|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784275|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
1784276|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
1784277|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
1784278|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784279|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
1784280|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784281|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1784282|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1784283|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784284|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1784285|NCT05025098|Azacitidine|azacitidine|mesh-list
1784286|NCT05025098|Venetoclax|venetoclax|mesh-list
1784287|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1784288|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
1784289|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784290|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784291|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784292|NCT05024799|Fentanyl|fentanyl|mesh-list
1784293|NCT05024799|Butorphanol|butorphanol|mesh-list
1784294|NCT05024799|Propofol|propofol|mesh-list
1784295|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1784296|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1784297|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784298|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1784299|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
1784300|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
1784301|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1784302|NCT05024799|Narcotics|narcotics|mesh-ancestor
1784303|NCT05024799|Analgesics|analgesics|mesh-ancestor
1784304|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
1784305|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784306|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1784307|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
1784308|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
1784309|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1784310|NCT05024825|Acetaminophen|acetaminophen|mesh-list
1784311|NCT05024825|Ibuprofen|ibuprofen|mesh-list
1784312|NCT05024825|Gabapentin|gabapentin|mesh-list
1784313|NCT05024825|Hydrocodone|hydrocodone|mesh-list
1784314|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1784315|NCT05024825|Analgesics|analgesics|mesh-ancestor
1784316|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
1784317|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784318|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784319|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
1784320|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1784321|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1784322|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1784323|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1784324|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784325|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784326|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
1784327|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1784328|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1784329|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1784330|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1784331|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1784332|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1784333|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784334|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
1784335|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1784336|NCT05024825|Narcotics|narcotics|mesh-ancestor
1784337|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
1784338|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
1784339|NCT05024734|Gemcitabine|gemcitabine|mesh-list
1784340|NCT05024734|Docetaxel|docetaxel|mesh-list
1784341|NCT05024734|Epirubicin|epirubicin|mesh-list
1784342|NCT05024734|Mitomycins|mitomycins|mesh-list
1784343|NCT05024734|Mitomycin|mitomycin|mesh-list
1784344|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1784345|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
1784346|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784347|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784348|NCT05024734|Antiviral Agents|antiviral agents|mesh-ancestor
1784349|NCT05024734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1784350|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784351|NCT05024734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1784352|NCT05024734|Immunologic Factors|immunologic factors|mesh-ancestor
1784353|NCT05024734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784354|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
1784355|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
1784356|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
1784357|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1784358|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1784359|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1784360|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
1784361|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1784362|NCT05024604|Progesterone|progesterone|mesh-list
1784363|NCT05024604|Progestins|progestins|mesh-ancestor
1784364|NCT05024604|Hormones|hormones|mesh-ancestor
1784365|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1784366|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784367|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1784368|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
1784369|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
1784370|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1784371|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1784372|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1784373|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
1784374|NCT05024448|Prednisone|prednisone|mesh-list
1784375|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1784376|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
1784377|NCT05024448|Hormones|hormones|mesh-ancestor
1784378|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1784379|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784380|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1784381|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784397|NCT05024877|Stanozolol|stanozolol|mesh-list
1784398|NCT05024877|Androgens|androgens|mesh-ancestor
1784399|NCT05024877|Hormones|hormones|mesh-ancestor
1784400|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1784401|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784402|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
1784403|NCT05024526|Edaravone|edaravone|mesh-list
1784404|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1784405|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
1784406|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784407|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1784408|NCT05024526|Protective Agents|protective agents|mesh-ancestor
1784409|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784410|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1784411|NCT05024565|Lactams|lactams|mesh-list
1784412|NCT05024565|beta-Lactams|beta-lactams|mesh-list
1784413|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1784414|NCT05024422|Pyridoxine|pyridoxine|mesh-list
1784415|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
1784416|NCT05024422|Cabergoline|cabergoline|mesh-list
1784417|NCT05024422|Vitamins|vitamins|mesh-ancestor
1784418|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
1784419|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784420|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
1784421|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1784422|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1784423|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
1784424|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
1784425|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784426|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784427|NCT05024357|Dasatinib|dasatinib|mesh-list
1784428|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784429|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1784430|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784431|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784432|NCT05024344|Dexamethasone|dexamethasone|mesh-list
1784433|NCT05024344|Ropivacaine|ropivacaine|mesh-list
1784434|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1784435|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
1784436|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
1784437|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784438|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784439|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1784440|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
1784441|NCT05024344|Hormones|hormones|mesh-ancestor
1784442|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1784443|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1784444|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784445|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
1784446|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
1784447|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1784448|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
1784449|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
1784450|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1784451|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784465|NCT05023915|Dexamethasone|dexamethasone|mesh-list
1784466|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
1784467|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1784468|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
1784469|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
1784470|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784471|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784472|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1784473|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
1784474|NCT05023915|Hormones|hormones|mesh-ancestor
1784475|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1784476|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1784477|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784478|NCT05024006|Interferons|interferons|mesh-list
1784479|NCT05024006|Ritonavir|ritonavir|mesh-list
1784480|NCT05024006|Lopinavir|lopinavir|mesh-list
1784481|NCT05024006|Interferon-beta|interferon-beta|mesh-list
1784482|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
1784483|NCT05024006|Remdesivir|remdesivir|mesh-list
1784484|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
1784485|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
1784486|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784487|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
1784488|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1784489|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1784490|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1784491|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
1784492|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784493|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784494|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1784495|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1784496|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1784497|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1784498|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
1784499|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1784500|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1784501|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1784502|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
1784503|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784504|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1784505|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
1784506|NCT05023941|Acetazolamide|acetazolamide|mesh-list
1784507|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
1784508|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1784509|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784510|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784511|NCT05023941|Diuretics|diuretics|mesh-ancestor
1784512|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
1784513|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784514|NCT05024266|Paclitaxel|paclitaxel|mesh-list
1784515|NCT05024266|Carboplatin|carboplatin|mesh-list
1784516|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1784517|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784518|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
1784519|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
1784520|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
1784521|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784522|NCT05024084|Anesthetics|anesthetics|mesh-list
1784523|NCT05024084|Sevoflurane|sevoflurane|mesh-list
1784524|NCT05024084|Desflurane|desflurane|mesh-list
1784525|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1784526|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784527|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1784528|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1784529|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
1784530|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
1784531|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1784532|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784536|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
1784537|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1784538|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
1784539|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784540|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784541|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784542|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
1784543|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
1784544|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784545|NCT05023863|Protective Agents|protective agents|mesh-ancestor
1784546|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784547|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
1784548|NCT05023863|Vitamins|vitamins|mesh-ancestor
1784549|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
1784550|NCT05023382|Teduglutide|teduglutide|mesh-list
1784551|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1784552|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1784553|NCT05023382|Protective Agents|protective agents|mesh-ancestor
1784554|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784558|NCT05023473|Morphine|morphine|mesh-list
1784559|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1784560|NCT05023473|Narcotics|narcotics|mesh-ancestor
1784561|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1784562|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784563|NCT05023473|Analgesics|analgesics|mesh-ancestor
1784564|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
1784565|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784566|NCT05023408|Bleomycin|bleomycin|mesh-list
1784567|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1784568|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784569|NCT05023304|Prednisolone|prednisolone|mesh-list
1784570|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1784571|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
1784572|NCT05023304|Hormones|hormones|mesh-ancestor
1784573|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1784574|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784575|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1784576|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784577|NCT05023759|Cannabidiol|cannabidiol|mesh-list
1784578|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
1784579|NCT05023577|Metronidazole|metronidazole|mesh-list
1784580|NCT05023577|Clarithromycin|clarithromycin|mesh-list
1784581|NCT05023577|Levofloxacin|levofloxacin|mesh-list
1784582|NCT05023577|Ofloxacin|ofloxacin|mesh-list
1784583|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
1784584|NCT05023577|Rabeprazole|rabeprazole|mesh-list
1784585|NCT05023577|Bismuth|bismuth|mesh-list
1784586|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784587|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1784588|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1784589|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1784590|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1784591|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1784592|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784593|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1784594|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1784595|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1784596|NCT05023577|Renal Agents|renal agents|mesh-ancestor
1784597|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1784598|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1784599|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784600|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1784601|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1784602|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1784603|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1784604|NCT05023577|Antacids|antacids|mesh-ancestor
1784605|NCT05023577|Diuretics|diuretics|mesh-ancestor
1784606|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
1784607|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784608|NCT05023577|Expectorants|expectorants|mesh-ancestor
1784609|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
1784610|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1784611|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1784612|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1784613|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1784614|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784615|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784616|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784617|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1784618|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
1784619|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1784627|NCT05023122|Vitamin D|vitamin d|mesh-list
1784628|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
1784629|NCT05023122|Calcium|calcium|mesh-list
1784630|NCT05023122|Vitamins|vitamins|mesh-ancestor
1784631|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
1784632|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784633|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1784634|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1784635|NCT05022901|Melphalan|melphalan|mesh-list
1784636|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1784637|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
1784638|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784639|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784640|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1784641|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1784642|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
1784643|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784653|NCT05022524|Acetic Acid|acetic acid|mesh-list
1784654|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1784655|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1784671|NCT05022394|Nivolumab|nivolumab|mesh-list
1784672|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1784673|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784674|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1784675|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784676|NCT05022030|Cetuximab|cetuximab|mesh-list
1784677|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1784678|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784713|NCT05021887|Fluticasone|fluticasone|mesh-list
1784714|NCT05021887|Xhance|xhance|mesh-list
1784715|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1784716|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1784717|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
1784718|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784719|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784720|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1784721|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
1784722|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
1784723|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1784724|NCT05022186|Cannabidiol|cannabidiol|mesh-list
1784725|NCT05022186|Tramiprosate|tramiprosate|mesh-list
1784726|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
1784727|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
1784728|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
1784729|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784730|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784731|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784743|NCT05021770|Thiotepa|thiotepa|mesh-list
1784744|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1784745|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
1784746|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784747|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784748|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1784749|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1784750|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
1784751|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784752|NCT05021809|Calcium|calcium|mesh-list
1784753|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1784754|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784755|NCT05021588|Anticoagulants|anticoagulants|mesh-list
1784756|NCT05021406|Carvedilol|carvedilol|mesh-list
1784757|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1784758|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1784759|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
1784760|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784761|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784762|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784763|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1784764|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
1784765|NCT05021406|Protective Agents|protective agents|mesh-ancestor
1784766|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1784767|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1784768|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1784769|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
1784770|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1784771|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1784772|NCT05021484|Felzartamab|felzartamab|mesh-list
1784773|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784774|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
1784775|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784776|NCT05021731|Rifampin|rifampin|mesh-list
1784777|NCT05021731|Rifapentine|rifapentine|mesh-list
1784778|NCT05021731|Isoniazid|isoniazid|mesh-list
1784779|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1784780|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
1784781|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1784782|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1784783|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
1784784|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1784785|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784786|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784787|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1784788|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1784789|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1784790|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1784791|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1784792|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1784793|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1784794|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1784795|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
1784796|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1784797|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1784798|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1784799|NCT05021094|Estradiol|estradiol|mesh-list
1784800|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1784801|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
1784802|NCT05021094|Estrogens|estrogens|mesh-ancestor
1784803|NCT05021094|Hormones|hormones|mesh-ancestor
1784804|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1784805|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784806|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1784807|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
1784808|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1784809|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1784810|NCT05021094|Progestins|progestins|mesh-ancestor
1784811|NCT05021263|GABA Agonists|gaba agonists|mesh-list
1784812|NCT05021263|GABA Agents|gaba agents|mesh-ancestor
1784813|NCT05021263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784814|NCT05021263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784815|NCT05021263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784816|NCT05021276|Basiliximab|basiliximab|mesh-list
1784817|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1784818|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
1784819|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784820|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
1784821|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784822|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
1784823|NCT05021315|Povidone|povidone|mesh-list
1784824|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
1784825|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
1784826|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1784827|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1784828|NCT05020964|Trastuzumab|trastuzumab|mesh-list
1784829|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1784830|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784831|NCT05020860|Paclitaxel|paclitaxel|mesh-list
1784832|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
1784833|NCT05020860|Carboplatin|carboplatin|mesh-list
1784834|NCT05020860|Doxorubicin|doxorubicin|mesh-list
1784835|NCT05020860|Trastuzumab|trastuzumab|mesh-list
1784836|NCT05020860|Pertuzumab|pertuzumab|mesh-list
1784837|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1784838|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784839|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
1784840|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
1784841|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
1784842|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784843|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1784844|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
1784845|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784846|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1784847|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1784848|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
1784849|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1784850|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1784851|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1784852|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1784853|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784854|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1784855|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
1784856|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1784857|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1784858|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784859|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1784860|NCT05020821|Analgesics|analgesics|mesh-ancestor
1784861|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
1784862|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784863|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1784864|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1784865|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1784866|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
1784867|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784868|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784869|NCT05020704|Empagliflozin|empagliflozin|mesh-list
1784870|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1784871|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784872|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1784873|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784874|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
1784875|NCT05020483|Coagulants|coagulants|mesh-ancestor
1784876|NCT05020782|Belimumab|belimumab|mesh-list
1784877|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1784878|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
1784879|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784880|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1784881|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1784882|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1784883|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1784884|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784885|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784886|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784887|NCT05020600|Analgesics|analgesics|mesh-ancestor
1784888|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
1784889|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784890|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
1784891|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1784892|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
1784893|NCT05020522|Phenobarbital|phenobarbital|mesh-list
1784894|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
1784895|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1784896|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1784897|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784898|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1784899|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1784900|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784901|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784902|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
1784903|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
1784904|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1784905|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1784906|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1784907|NCT05020028|Cannabidiol|cannabidiol|mesh-list
1784908|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
1784909|NCT05020184|Cimetidine|cimetidine|mesh-list
1784910|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1784911|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1784912|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1784913|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
1784914|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
1784915|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784916|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784917|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784918|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1784919|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1784920|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784921|NCT05020210|Sivelestat|sivelestat|mesh-list
1784922|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1784923|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
1784924|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784925|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784932|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
1784933|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
1784934|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784935|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784936|NCT05019794|Infigratinib|infigratinib|mesh-list
1784937|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784945|NCT05019534|Cetuximab|cetuximab|mesh-list
1784946|NCT05019534|Vemurafenib|vemurafenib|mesh-list
1784947|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1784948|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784949|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1784950|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784951|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784952|NCT05019586|Amoxicillin|amoxicillin|mesh-list
1784953|NCT05019586|Clarithromycin|clarithromycin|mesh-list
1784954|NCT05019586|Levofloxacin|levofloxacin|mesh-list
1784955|NCT05019586|Ofloxacin|ofloxacin|mesh-list
1784956|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1784957|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1784958|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1784959|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1784960|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784961|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1784962|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1784963|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1784964|NCT05019586|Renal Agents|renal agents|mesh-ancestor
1784965|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1784966|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1784967|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1784968|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1784969|NCT05019638|Ketorolac|ketorolac|mesh-list
1784970|NCT05019638|Epinephrine|epinephrine|mesh-list
1784971|NCT05019638|Racepinephrine|racepinephrine|mesh-list
1784972|NCT05019638|Morphine|morphine|mesh-list
1784973|NCT05019638|Bupivacaine|bupivacaine|mesh-list
1784974|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
1784975|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
1784976|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
1784977|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1784978|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1784979|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
1784980|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1784981|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1784982|NCT05019638|Narcotics|narcotics|mesh-ancestor
1784983|NCT05019638|Analgesics|analgesics|mesh-ancestor
1784984|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1784985|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1784986|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
1784987|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1784988|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1784989|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1784990|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1784991|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
1784992|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1784993|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
1784994|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
1784995|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
1784996|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1784997|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1784998|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1784999|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1785000|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1785001|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1785002|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785003|NCT05019690|Paclitaxel|paclitaxel|mesh-list
1785004|NCT05019690|Apatinib|apatinib|mesh-list
1785005|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1785006|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1785007|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785008|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
1785009|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
1785010|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
1785011|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785012|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1785013|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785014|NCT05019703|Atezolizumab|atezolizumab|mesh-list
1785015|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1785016|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785017|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
1785018|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785019|NCT05019716|Cisplatin|cisplatin|mesh-list
1785020|NCT05019716|Etoposide|etoposide|mesh-list
1785021|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
1785022|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
1785023|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785024|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1785025|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1785026|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1785027|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785028|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785029|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
1785030|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
1785031|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
1785032|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
1785033|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
1785034|NCT05019222|Anesthetics|anesthetics|mesh-list
1785035|NCT05019222|Sevoflurane|sevoflurane|mesh-list
1785036|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785037|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785038|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1785039|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1785040|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
1785041|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
1785042|NCT05019417|Glycerol|glycerol|mesh-list
1785043|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1785044|NCT05019417|Protective Agents|protective agents|mesh-ancestor
1785045|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785046|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785053|NCT05018923|Metronidazole|metronidazole|mesh-list
1785054|NCT05018923|Doxycycline|doxycycline|mesh-list
1785055|NCT05018923|Tetracycline|tetracycline|mesh-list
1785056|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
1785057|NCT05018923|Rabeprazole|rabeprazole|mesh-list
1785058|NCT05018923|Bismuth|bismuth|mesh-list
1785059|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785060|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785061|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1785062|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1785063|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1785064|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
1785065|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1785066|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1785067|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1785068|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785069|NCT05018923|Antacids|antacids|mesh-ancestor
1785070|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1785071|NCT05018923|Diuretics|diuretics|mesh-ancestor
1785072|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
1785073|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785074|NCT05018923|Expectorants|expectorants|mesh-ancestor
1785075|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
1785076|NCT05019326|Andrographolide|andrographolide|mesh-list
1785077|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1785078|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1785079|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1785080|NCT05019326|Analgesics|analgesics|mesh-ancestor
1785081|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
1785082|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785083|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785084|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1785085|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1785086|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1785087|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785088|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
1785089|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1785090|NCT05018988|Vitamin D|vitamin d|mesh-list
1785091|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
1785092|NCT05018988|Vitamins|vitamins|mesh-list
1785093|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
1785094|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785095|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1785096|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1785097|NCT05018962|Paclitaxel|paclitaxel|mesh-list
1785098|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1785099|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785100|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
1785101|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
1785102|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
1785103|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785104|NCT05018520|Prednisone|prednisone|mesh-list
1785105|NCT05018520|Rituximab|rituximab|mesh-list
1785106|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
1785107|NCT05018520|Vincristine|vincristine|mesh-list
1785108|NCT05018520|Doxorubicin|doxorubicin|mesh-list
1785109|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1785110|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785111|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
1785112|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785113|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1785114|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1785115|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1785116|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
1785117|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785118|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1785119|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1785120|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
1785121|NCT05018520|Hormones|hormones|mesh-ancestor
1785122|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1785123|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1785124|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1785125|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
1785126|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
1785127|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
1785128|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1785129|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1785130|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1785131|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785132|NCT05018637|Teriparatide|teriparatide|mesh-list
1785133|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1785134|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785135|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1785136|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
1785137|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
1785138|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1785139|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
1785140|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785141|NCT05018585|Antacids|antacids|mesh-ancestor
1785142|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785143|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1785144|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1785145|NCT05018585|Vitamins|vitamins|mesh-ancestor
1785146|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
1785147|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1785148|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
1785149|NCT05018364|Hematinics|hematinics|mesh-ancestor
1785150|NCT05018182|Leucovorin|leucovorin|mesh-list
1785151|NCT05018182|Folic Acid|folic acid|mesh-list
1785152|NCT05018182|Fluorouracil|fluorouracil|mesh-list
1785153|NCT05018182|Capecitabine|capecitabine|mesh-list
1785154|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
1785155|NCT05018182|Irinotecan|irinotecan|mesh-list
1785156|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
1785157|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
1785158|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785159|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1785160|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785161|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1785162|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
1785163|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785164|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1785165|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1785166|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785167|NCT05018182|Antidotes|antidotes|mesh-ancestor
1785168|NCT05018182|Protective Agents|protective agents|mesh-ancestor
1785169|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
1785170|NCT05018182|Vitamins|vitamins|mesh-ancestor
1785171|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
1785172|NCT05018182|Hematinics|hematinics|mesh-ancestor
1785175|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
1785176|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785177|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1785178|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1785179|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1785180|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
1785181|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1785182|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
1785183|NCT05017454|Valproic Acid|valproic acid|mesh-list
1785184|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1785185|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
1785186|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1785187|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
1785188|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785189|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785190|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
1785191|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1785192|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785193|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
1785194|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1785195|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785196|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1785197|NCT05017311|Citalopram|citalopram|mesh-list
1785198|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
1785199|NCT05017311|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1785200|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1785201|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1785202|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785203|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1785204|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
1785205|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785206|NCT05017311|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1785207|NCT05017311|Antidepressive Agents|antidepressive agents|mesh-ancestor
1785208|NCT05017311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1785209|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
1785210|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
1785211|NCT05017610|Lomustine|lomustine|mesh-list
1785212|NCT05017610|Methimazole|methimazole|mesh-list
1785213|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1785214|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
1785215|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785216|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785217|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
1785218|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
1785219|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1785220|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785245|NCT05017428|Niacinamide|niacinamide|mesh-list
1785246|NCT05017428|Niacin|niacin|mesh-list
1785247|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
1785248|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
1785249|NCT05017428|Vitamins|vitamins|mesh-ancestor
1785250|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
1785251|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785252|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1785253|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
1785254|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785255|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1785256|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
1785257|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
1785258|NCT05017272|Narcotics|narcotics|mesh-ancestor
1785259|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785260|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785261|NCT05017272|Analgesics|analgesics|mesh-ancestor
1785262|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
1785263|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785264|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1785265|NCT05017103|Antibodies|antibodies|mesh-list
1785266|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
1785267|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1785268|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
1785269|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785270|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785271|NCT05017155|Mexiletine|mexiletine|mesh-list
1785272|NCT05017155|Lamotrigine|lamotrigine|mesh-list
1785273|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
1785274|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1785275|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1785276|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785277|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1785278|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785279|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1785280|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1785281|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785282|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1785283|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1785284|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1785285|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1785286|NCT05017116|Entecavir|entecavir|mesh-list
1785287|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
1785288|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785289|NCT05017194|Emodepside|emodepside|mesh-list
1785290|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1785291|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785292|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
1785293|NCT05016609|Velpatasvir|velpatasvir|mesh-list
1785294|NCT05016609|Antibodies|antibodies|mesh-list
1785295|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
1785296|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
1785297|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785298|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
1785299|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785300|NCT05016869|Capecitabine|capecitabine|mesh-list
1785301|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1785302|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
1785303|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785304|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785305|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
1785306|NCT05016713|Fluorides|fluorides|mesh-list
1785307|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
1785308|NCT05016713|Protective Agents|protective agents|mesh-ancestor
1785309|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785310|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1785311|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785312|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
1785313|NCT05016128|Ketamine|ketamine|mesh-list
1785314|NCT05016128|Esketamine|esketamine|mesh-list
1785315|NCT05016128|Analgesics|analgesics|mesh-ancestor
1785316|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
1785317|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785318|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785319|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1785320|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1785321|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
1785322|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
1785323|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785324|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1785325|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1785326|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1785327|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785328|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
1785329|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1785330|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
1785331|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1785332|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1785333|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785334|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1785335|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1785336|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785337|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785338|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785339|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1785340|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
1785341|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1785342|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785343|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1785344|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1785345|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1785346|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
1785347|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
1785348|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1785349|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1785350|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785351|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785352|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785353|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1785354|NCT05016310|Vitamin D|vitamin d|mesh-list
1785355|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
1785356|NCT05016310|Vitamins|vitamins|mesh-list
1785357|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
1785358|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785359|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1785360|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1785361|NCT05016440|Lisinopril|lisinopril|mesh-list
1785362|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1785363|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
1785364|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785365|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785366|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1785367|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1785368|NCT05016440|Protective Agents|protective agents|mesh-ancestor
1785369|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785370|NCT05016349|Tamoxifen|tamoxifen|mesh-list
1785371|NCT05016349|Tocopherols|tocopherols|mesh-list
1785372|NCT05016349|Tretinoin|tretinoin|mesh-list
1785373|NCT05016349|Alitretinoin|alitretinoin|mesh-list
1785374|NCT05016349|Cannabidiol|cannabidiol|mesh-list
1785375|NCT05016349|Isotretinoin|isotretinoin|mesh-list
1785376|NCT05016349|Mifepristone|mifepristone|mesh-list
1785377|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1785378|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
1785379|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1785380|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785381|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1785382|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785383|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1785384|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1785385|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1785386|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
1785387|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
1785388|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
1785389|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1785390|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
1785391|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1785392|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1785393|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1785394|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1785395|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
1785396|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1785397|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1785398|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
1785399|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1785400|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1785401|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
1785402|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785403|NCT05016349|Protective Agents|protective agents|mesh-ancestor
1785404|NCT05016349|Vitamins|vitamins|mesh-ancestor
1785405|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
1785406|NCT05016180|Ropivacaine|ropivacaine|mesh-list
1785407|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
1785408|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
1785409|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785410|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785411|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
1785412|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785413|NCT05016063|Fludarabine|fludarabine|mesh-list
1785414|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
1785415|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785416|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785417|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1785418|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
1785419|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785420|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1785421|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1785422|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
1785423|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1785424|NCT05016076|Dexamethasone|dexamethasone|mesh-list
1785425|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1785426|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
1785427|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
1785428|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785429|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785430|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1785431|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
1785432|NCT05016076|Hormones|hormones|mesh-ancestor
1785433|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1785434|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1785435|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785436|NCT05016518|Propofol|propofol|mesh-list
1785437|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1785438|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785439|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785440|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1785441|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
1785442|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
1785443|NCT05015907|Ropivacaine|ropivacaine|mesh-list
1785444|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
1785445|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
1785446|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785447|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785448|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
1785449|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785450|NCT05015595|Memantine|memantine|mesh-list
1785451|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1785452|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1785453|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
1785454|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1785455|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785456|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785457|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1785458|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1785459|NCT05015621|Leucovorin|leucovorin|mesh-list
1785460|NCT05015621|Fluorouracil|fluorouracil|mesh-list
1785461|NCT05015621|Irinotecan|irinotecan|mesh-list
1785462|NCT05015621|Calcium|calcium|mesh-list
1785463|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
1785464|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1785465|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785466|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
1785467|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785468|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1785469|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785470|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1785471|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
1785472|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1785473|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1785474|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785475|NCT05015621|Antidotes|antidotes|mesh-ancestor
1785476|NCT05015621|Protective Agents|protective agents|mesh-ancestor
1785477|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
1785478|NCT05015621|Vitamins|vitamins|mesh-ancestor
1785479|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
1785480|NCT05015829|Dobutamine|dobutamine|mesh-list
1785481|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1785482|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
1785483|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
1785484|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785485|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785486|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1785487|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1785488|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1785489|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
1785490|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1785491|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785492|NCT05015829|Protective Agents|protective agents|mesh-ancestor
1785493|NCT05015361|Propofol|propofol|mesh-list
1785494|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1785495|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785496|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785497|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1785498|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
1785499|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
1785502|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
1785503|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1785504|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1785505|NCT05015322|Prednisolone|prednisolone|mesh-list
1785506|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
1785507|NCT05015322|Bupivacaine|bupivacaine|mesh-list
1785508|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1785509|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
1785510|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
1785511|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
1785512|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785513|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785514|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
1785515|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785516|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1785517|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
1785518|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
1785519|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1785520|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
1785521|NCT05015322|Hormones|hormones|mesh-ancestor
1785522|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1785523|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1785524|NCT05015322|Protective Agents|protective agents|mesh-ancestor
1785525|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1785526|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785527|NCT05014711|Fentanyl|fentanyl|mesh-list
1785528|NCT05014711|Remifentanil|remifentanil|mesh-list
1785529|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1785530|NCT05014711|Narcotics|narcotics|mesh-ancestor
1785531|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785532|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785533|NCT05014711|Analgesics|analgesics|mesh-ancestor
1785534|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
1785535|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785536|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1785537|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1785538|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
1785539|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
1785540|NCT05014685|Amoxicillin|amoxicillin|mesh-list
1785541|NCT05014685|Metronidazole|metronidazole|mesh-list
1785542|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
1785543|NCT05014685|Rabeprazole|rabeprazole|mesh-list
1785544|NCT05014685|Bismuth|bismuth|mesh-list
1785545|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785546|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1785547|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785548|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1785549|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1785550|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1785551|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1785552|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1785553|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785554|NCT05014685|Antacids|antacids|mesh-ancestor
1785555|NCT05014685|Diuretics|diuretics|mesh-ancestor
1785556|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
1785557|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785558|NCT05014685|Expectorants|expectorants|mesh-ancestor
1785559|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
1785560|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
1785561|NCT05014646|Leflunomide|leflunomide|mesh-list
1785562|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785563|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785564|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1785565|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
1785566|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785567|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1785568|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1785569|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
1785570|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1785583|NCT05014906|Minocycline|minocycline|mesh-list
1785584|NCT05014906|Azelaic acid|azelaic acid|mesh-list
1785585|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1785586|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785587|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785588|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
1785589|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
1785590|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1785591|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
1785592|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785593|NCT05014828|Lenvatinib|lenvatinib|mesh-list
1785594|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785595|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1785596|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785597|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785598|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
1785599|NCT05015387|Procyanidin|procyanidin|mesh-list
1785600|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
1785601|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785602|NCT05015387|Protective Agents|protective agents|mesh-ancestor
1785603|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785604|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1785605|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1785606|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785607|NCT05014464|Crizotinib|crizotinib|mesh-list
1785608|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785609|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1785610|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785611|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785612|NCT05014490|Etoricoxib|etoricoxib|mesh-list
1785613|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1785614|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1785615|NCT05014490|Analgesics|analgesics|mesh-ancestor
1785616|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
1785617|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785618|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785619|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1785620|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1785621|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1785622|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1785623|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785624|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785629|NCT05014516|Xenon|xenon|mesh-list
1785630|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1785631|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
1785632|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
1785633|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785634|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785635|NCT05014581|Norepinephrine|norepinephrine|mesh-list
1785636|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1785637|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1785638|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
1785639|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1785640|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785641|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785642|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
1785643|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
1785644|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785645|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1785646|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
1785647|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1785648|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785649|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1785650|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785651|NCT05014373|Favipiravir|favipiravir|mesh-list
1785652|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
1785653|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785654|NCT05014100|Lenalidomide|lenalidomide|mesh-list
1785655|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
1785656|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785657|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1785658|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1785659|NCT05014100|Growth Substances|growth substances|mesh-ancestor
1785660|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
1785661|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785662|NCT05014048|Vitamin D|vitamin d|mesh-list
1785663|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
1785664|NCT05014048|Vitamins|vitamins|mesh-ancestor
1785665|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
1785666|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785667|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1785668|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1785676|NCT05013892|Memantine|memantine|mesh-list
1785677|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1785678|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1785679|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
1785680|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1785681|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785682|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785683|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1785684|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1785685|NCT05013801|Hydroquinone|hydroquinone|mesh-list
1785686|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
1785687|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785688|NCT05013801|Protective Agents|protective agents|mesh-ancestor
1785689|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785690|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1785691|NCT05013697|Paclitaxel|paclitaxel|mesh-list
1785692|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1785693|NCT05013697|Cisplatin|cisplatin|mesh-list
1785694|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1785695|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785696|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
1785697|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
1785698|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
1785699|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785700|NCT05013567|Ibuprofen|ibuprofen|mesh-list
1785701|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1785702|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1785703|NCT05013567|Analgesics|analgesics|mesh-ancestor
1785704|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
1785705|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785706|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785707|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1785708|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1785709|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1785710|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785788|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
1785711|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785712|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
1785713|NCT05013463|Indapamide|indapamide|mesh-list
1785714|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
1785715|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1785716|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1785717|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785718|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785719|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785720|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1785721|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1785722|NCT05013463|Diuretics|diuretics|mesh-ancestor
1785723|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
1785724|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785725|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1785726|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1785777|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1785778|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1785779|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1785780|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785781|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785782|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1785783|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1785784|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785785|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
1785786|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1785787|NCT05013060|Butyric Acid|butyric acid|mesh-list
1785789|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
1785790|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1785791|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785792|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785793|NCT05013112|Metformin|metformin|mesh-list
1785794|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
1785795|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1785796|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785797|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785798|NCT05013164|Leucovorin|leucovorin|mesh-list
1785799|NCT05013164|Folic Acid|folic acid|mesh-list
1785800|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
1785801|NCT05013164|Antidotes|antidotes|mesh-ancestor
1785802|NCT05013164|Protective Agents|protective agents|mesh-ancestor
1785803|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785804|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
1785805|NCT05013164|Vitamins|vitamins|mesh-ancestor
1785806|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
1785807|NCT05013164|Hematinics|hematinics|mesh-ancestor
1785808|NCT05013034|Basiliximab|basiliximab|mesh-list
1785809|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1785810|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
1785811|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785812|NCT05013151|Castor Oil|castor oil|mesh-list
1785813|NCT05013151|Cathartics|cathartics|mesh-ancestor
1785814|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1785815|NCT05013268|Paclitaxel|paclitaxel|mesh-list
1785816|NCT05013268|Docetaxel|docetaxel|mesh-list
1785817|NCT05013268|Carboplatin|carboplatin|mesh-list
1785818|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1785819|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785820|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
1785821|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
1785822|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
1785823|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785824|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
1785825|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
1785826|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1785827|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785828|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785829|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1785830|NCT05013320|Analgesics|analgesics|mesh-ancestor
1785831|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
1785832|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785833|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1785834|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1785835|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1785836|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
1785837|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1785838|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785839|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1785840|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1785841|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1785842|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
1785864|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
1785865|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1785866|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
1785867|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1785868|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1785869|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785870|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
1785871|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1785872|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785873|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1785874|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
1785875|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
1785876|NCT05012566|Protective Agents|protective agents|mesh-ancestor
1785877|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1785878|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785879|NCT05012787|Vaccines|vaccines|mesh-list
1785880|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
1785881|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
1785882|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785883|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1785884|NCT05012371|Everolimus|everolimus|mesh-list
1785885|NCT05012371|Lenvatinib|lenvatinib|mesh-list
1785886|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785887|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1785888|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
1785889|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785890|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1785891|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785892|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785893|NCT05012137|Ropivacaine|ropivacaine|mesh-list
1785894|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
1785895|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
1785896|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785897|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785898|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
1785899|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785900|NCT05012033|Prednisolone|prednisolone|mesh-list
1785901|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1785902|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
1785903|NCT05012033|Hormones|hormones|mesh-ancestor
1785904|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1785905|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785906|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1785907|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785934|NCT05012189|Oseltamivir|oseltamivir|mesh-list
1785935|NCT05012189|Baloxavir|baloxavir|mesh-list
1785936|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
1785937|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1785938|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785939|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785940|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1785941|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1785942|NCT05011760|Amphetamine|amphetamine|mesh-list
1785943|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
1785944|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1785945|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785946|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
1785947|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
1785948|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1785949|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
1785950|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1785951|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785952|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
1785953|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1785954|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1785955|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1785956|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1785957|NCT05011487|Pemetrexed|pemetrexed|mesh-list
1785958|NCT05011487|Osimertinib|osimertinib|mesh-list
1785959|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1785960|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1785961|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785962|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1785963|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1785964|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1785977|NCT05011617|Anesthetics|anesthetics|mesh-list
1785978|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785979|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785980|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
1785981|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1785982|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1785983|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1785984|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1785985|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1785986|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1785987|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1785988|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1785989|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
1785990|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1785991|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1785992|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1785993|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1785994|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
1785995|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1785996|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1785997|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
1785998|NCT05011383|Testosterone|testosterone|mesh-list
1785999|NCT05011383|Androgens|androgens|mesh-list
1786000|NCT05011383|Hormones|hormones|mesh-ancestor
1786001|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1786002|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786015|NCT05011214|Ketamine|ketamine|mesh-list
1786016|NCT05011214|Sevoflurane|sevoflurane|mesh-list
1786017|NCT05011214|Esketamine|esketamine|mesh-list
1786018|NCT05011214|Analgesics|analgesics|mesh-ancestor
1786019|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
1786020|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786021|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786022|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1786023|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1786024|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
1786025|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
1786026|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786027|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1786028|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1786029|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1786030|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786031|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1786032|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1786033|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
1786034|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1786035|NCT05011058|Valganciclovir|valganciclovir|mesh-list
1786036|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
1786037|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1786041|NCT05010954|Lansoprazole|lansoprazole|mesh-list
1786042|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
1786043|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1786044|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1786045|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1786046|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786047|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786048|NCT05010876|Icatibant|icatibant|mesh-list
1786049|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1786050|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1786051|NCT05010876|Analgesics|analgesics|mesh-ancestor
1786052|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
1786053|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786054|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786055|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1786056|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1786057|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
1786058|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
1786059|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786060|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1786061|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1786062|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
1786063|NCT05010707|Spironolactone|spironolactone|mesh-list
1786064|NCT05010707|Hormones|hormones|mesh-list
1786065|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1786066|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786067|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1786068|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
1786069|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1786070|NCT05010707|Diuretics|diuretics|mesh-ancestor
1786071|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
1786072|NCT05010668|Lenvatinib|lenvatinib|mesh-list
1786073|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786074|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1786075|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786076|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786077|NCT05010681|Lenvatinib|lenvatinib|mesh-list
1786078|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786079|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1786080|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786081|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786082|NCT05010538|Sarecycline|sarecycline|mesh-list
1786083|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1786084|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1786085|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
1786086|NCT05010499|Bupivacaine|bupivacaine|mesh-list
1786087|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
1786088|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
1786089|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
1786090|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786091|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786092|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
1786093|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786094|NCT05010434|Bevacizumab|bevacizumab|mesh-list
1786095|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1786096|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786097|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1786098|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1786099|NCT05010434|Growth Substances|growth substances|mesh-ancestor
1786100|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786101|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
1786102|NCT05010356|Insulin|insulin|mesh-list
1786103|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1786104|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786105|NCT05010590|Denosumab|denosumab|mesh-list
1786106|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1786107|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786115|NCT05010200|Poly ICLC|poly iclc|mesh-list
1786116|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
1786117|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
1786118|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786119|NCT05010148|Lidocaine|lidocaine|mesh-list
1786120|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
1786121|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
1786122|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786123|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786124|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
1786125|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786126|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1786127|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1786128|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1786129|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1786130|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786153|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
1786154|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
1786155|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786156|NCT05009901|Protective Agents|protective agents|mesh-ancestor
1786157|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786158|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
1786159|NCT05009901|Vitamins|vitamins|mesh-ancestor
1786160|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
1786161|NCT05009953|Leucovorin|leucovorin|mesh-list
1786162|NCT05009953|Fluorouracil|fluorouracil|mesh-list
1786163|NCT05009953|Irinotecan|irinotecan|mesh-list
1786164|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
1786165|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786166|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1786167|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786168|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1786169|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
1786170|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786171|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1786172|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1786173|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786174|NCT05009953|Antidotes|antidotes|mesh-ancestor
1786175|NCT05009953|Protective Agents|protective agents|mesh-ancestor
1786176|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
1786177|NCT05009953|Vitamins|vitamins|mesh-ancestor
1786178|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
1786179|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
1786180|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786181|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1786182|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786183|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786184|NCT05009342|Calpastatin|calpastatin|mesh-list
1786185|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
1786186|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
1786187|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786188|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786189|NCT05009498|Vitamin D|vitamin d|mesh-list
1786190|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
1786191|NCT05009498|Vitamins|vitamins|mesh-ancestor
1786192|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
1786193|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786194|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1786195|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1786196|NCT05009355|Ascorbic Acid|ascorbic acid|mesh-list
1786197|NCT05009355|Vitamins|vitamins|mesh-ancestor
1786198|NCT05009355|Micronutrients|micronutrients|mesh-ancestor
1786199|NCT05009355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786200|NCT05009355|Antioxidants|antioxidants|mesh-ancestor
1786201|NCT05009355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786202|NCT05009355|Protective Agents|protective agents|mesh-ancestor
1786203|NCT05008887|Fluorouracil|fluorouracil|mesh-list
1786204|NCT05008887|Methotrexate|methotrexate|mesh-list
1786205|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
1786206|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786207|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1786208|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786209|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1786210|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
1786211|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786212|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1786213|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
1786214|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1786215|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
1786216|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786217|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1786218|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1786219|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1786220|NCT05009017|Bevacizumab|bevacizumab|mesh-list
1786221|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1786222|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786223|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1786224|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1786225|NCT05009017|Growth Substances|growth substances|mesh-ancestor
1786226|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786227|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
1786228|NCT05009082|Paclitaxel|paclitaxel|mesh-list
1786229|NCT05009082|Bevacizumab|bevacizumab|mesh-list
1786230|NCT05009082|Carboplatin|carboplatin|mesh-list
1786231|NCT05009082|Niraparib|niraparib|mesh-list
1786232|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1786233|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786234|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
1786235|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
1786236|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
1786237|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786238|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1786239|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1786240|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1786241|NCT05009082|Growth Substances|growth substances|mesh-ancestor
1786242|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786243|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
1786244|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1786245|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786246|NCT05008939|Sevoflurane|sevoflurane|mesh-list
1786247|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1786248|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1786249|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
1786250|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
1786251|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786252|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786253|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
1786254|NCT05008861|Nivolumab|nivolumab|mesh-list
1786255|NCT05008861|Durvalumab|durvalumab|mesh-list
1786256|NCT05008861|Antibodies|antibodies|mesh-list
1786257|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1786258|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
1786259|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786260|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1786261|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786262|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1786263|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786270|NCT05008926|Naloxegol|naloxegol|mesh-list
1786271|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1786272|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786273|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
1786274|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786275|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
1786276|NCT05008523|Narcotics|narcotics|mesh-ancestor
1786277|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786278|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786279|NCT05008523|Analgesics|analgesics|mesh-ancestor
1786280|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
1786281|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786282|NCT05008679|Oseltamivir|oseltamivir|mesh-list
1786283|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
1786284|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1786285|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786286|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786292|NCT05008666|Azacitidine|azacitidine|mesh-list
1786293|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1786294|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
1786295|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786296|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786297|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786298|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
1786299|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
1786300|NCT05008458|Coagulants|coagulants|mesh-ancestor
1786301|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1786302|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1786303|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
1786304|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786305|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
1786306|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1786307|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1786308|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786309|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
1786310|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1786311|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786312|NCT05008367|Dexamethasone|dexamethasone|mesh-list
1786313|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1786314|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
1786315|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
1786316|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786317|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786318|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1786319|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
1786320|NCT05008367|Hormones|hormones|mesh-ancestor
1786321|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1786322|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1786323|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786335|NCT05008029|Anesthetics|anesthetics|mesh-list
1786336|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786337|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786338|NCT05008068|Simvastatin|simvastatin|mesh-list
1786339|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1786340|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1786341|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
1786342|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786343|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1786344|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1786345|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786346|NCT05008263|Liver Extracts|liver extracts|mesh-list
1786347|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
1786348|NCT05008263|Hematinics|hematinics|mesh-ancestor
1786349|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1786350|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786351|NCT05008237|Docetaxel|docetaxel|mesh-list
1786352|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786353|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
1786354|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
1786355|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
1786356|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786361|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
1786362|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1786363|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1786364|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1786365|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1786385|NCT05008354|Pyridoxine|pyridoxine|mesh-list
1786386|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
1786387|NCT05008354|Vitamins|vitamins|mesh-ancestor
1786388|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
1786389|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786390|NCT05008250|Metoprolol|metoprolol|mesh-list
1786391|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1786392|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1786393|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
1786394|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
1786395|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786396|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786397|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1786398|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1786399|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1786400|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
1786401|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1786402|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786403|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
1786404|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1786405|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
1786406|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
1786407|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
1786408|NCT05007678|Leflunomide|leflunomide|mesh-list
1786409|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786410|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786411|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1786412|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
1786413|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786414|NCT05007587|Leucovorin|leucovorin|mesh-list
1786415|NCT05007587|Fluorouracil|fluorouracil|mesh-list
1786416|NCT05007587|Raltitrexed|raltitrexed|mesh-list
1786417|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
1786418|NCT05007587|Lenvatinib|lenvatinib|mesh-list
1786419|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
1786420|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786421|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1786422|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786423|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1786424|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
1786425|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786426|NCT05007587|Antidotes|antidotes|mesh-ancestor
1786427|NCT05007587|Protective Agents|protective agents|mesh-ancestor
1786428|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
1786429|NCT05007587|Vitamins|vitamins|mesh-ancestor
1786430|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
1786431|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1786432|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786433|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1786434|NCT05007860|Vaccines|vaccines|mesh-list
1786435|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
1786436|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786437|NCT05007561|Naltrexone|naltrexone|mesh-list
1786438|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1786439|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1786440|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786441|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
1786442|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786443|NCT05007652|Plerixafor|plerixafor|mesh-list
1786444|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1786445|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1786446|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
1786447|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1786448|NCT05007392|Febuxostat|febuxostat|mesh-list
1786449|NCT05007392|Dotinurad|dotinurad|mesh-list
1786450|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
1786451|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1786452|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
1786453|NCT05007392|Renal Agents|renal agents|mesh-ancestor
1786454|NCT05007613|Atezolizumab|atezolizumab|mesh-list
1786455|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786456|NCT05007509|Vaccines|vaccines|mesh-list
1786457|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
1786458|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786459|NCT05006911|Bromfenac|bromfenac|mesh-list
1786460|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1786461|NCT05006911|Phenylephrine|phenylephrine|mesh-list
1786462|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
1786463|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
1786464|NCT05006911|Pilocarpine|pilocarpine|mesh-list
1786465|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1786466|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
1786467|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786468|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
1786469|NCT05006911|Protective Agents|protective agents|mesh-ancestor
1786470|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1786471|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1786472|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1786473|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1786474|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
1786475|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1786476|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786477|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
1786478|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
1786479|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786480|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
1786481|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1786482|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
1786483|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1786484|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
1786485|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1786486|NCT05006911|Miotics|miotics|mesh-ancestor
1786487|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
1786488|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1786489|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
1786490|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1786491|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1786492|NCT05006911|Analgesics|analgesics|mesh-ancestor
1786493|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
1786494|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1786495|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1786496|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1786497|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
1786498|NCT05006898|Pilocarpine|pilocarpine|mesh-list
1786499|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1786500|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1786501|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1786502|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1786503|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
1786504|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1786505|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786506|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786507|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
1786508|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
1786509|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786510|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
1786511|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1786512|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
1786513|NCT05006898|Miotics|miotics|mesh-ancestor
1786514|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
1786515|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1786516|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
1786517|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
1786518|NCT05007262|Calcium|calcium|mesh-list
1786519|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1786520|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786521|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
1786522|NCT05007262|Coagulants|coagulants|mesh-ancestor
1786523|NCT05007041|Vaccines|vaccines|mesh-list
1786524|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
1786525|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786526|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
1786527|NCT05006846|Narcotics|narcotics|mesh-ancestor
1786528|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786529|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786530|NCT05006846|Analgesics|analgesics|mesh-ancestor
1786531|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
1786532|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786542|NCT05007223|Doxycycline|doxycycline|mesh-list
1786543|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1786544|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1786545|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
1786546|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1786547|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1786548|NCT05007132|Trifluridine|trifluridine|mesh-list
1786549|NCT05007132|Bevacizumab|bevacizumab|mesh-list
1786550|NCT05007132|Panitumumab|panitumumab|mesh-list
1786551|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1786552|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786553|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1786554|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1786555|NCT05007132|Growth Substances|growth substances|mesh-ancestor
1786556|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786557|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
1786558|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
1786559|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786560|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
1786561|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1786562|NCT05006469|Dexamethasone|dexamethasone|mesh-list
1786563|NCT05006469|Doxorubicin|doxorubicin|mesh-list
1786564|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1786565|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1786566|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1786567|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
1786568|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
1786569|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786570|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786571|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1786572|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
1786573|NCT05006469|Hormones|hormones|mesh-ancestor
1786574|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1786575|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1786576|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786577|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786578|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786579|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1786580|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1786581|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1786582|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1786583|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
1786584|NCT05006664|Prednisone|prednisone|mesh-list
1786585|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
1786586|NCT05006664|Doxorubicin|doxorubicin|mesh-list
1786587|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1786588|NCT05006664|Etoposide|etoposide|mesh-list
1786589|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
1786590|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1786591|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1786592|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
1786593|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786594|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1786595|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1786596|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
1786597|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786598|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786599|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1786600|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1786601|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1786602|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1786603|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786604|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1786605|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
1786606|NCT05006664|Hormones|hormones|mesh-ancestor
1786607|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1786608|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1786609|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1786610|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1786611|NCT05006677|Vitamin K|vitamin k|mesh-list
1786612|NCT05006677|Anticoagulants|anticoagulants|mesh-list
1786613|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
1786614|NCT05006677|Vitamins|vitamins|mesh-ancestor
1786615|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
1786616|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786617|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1786618|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1786619|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786620|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
1786621|NCT05006677|Coagulants|coagulants|mesh-ancestor
1786622|NCT05006287|Warfarin|warfarin|mesh-list
1786623|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
1786624|NCT05006287|Dabigatran|dabigatran|mesh-list
1786625|NCT05006287|Apixaban|apixaban|mesh-list
1786626|NCT05006287|Edoxaban|edoxaban|mesh-list
1786627|NCT05006287|Anticoagulants|anticoagulants|mesh-list
1786628|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1786629|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
1786630|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1786631|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
1786632|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786633|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786634|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1786635|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1786636|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786637|NCT05006638|Atropine|atropine|mesh-list
1786638|NCT05006638|Ondansetron|ondansetron|mesh-list
1786639|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
1786640|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
1786641|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
1786642|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
1786643|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786644|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786645|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1786646|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
1786647|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
1786648|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1786649|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
1786650|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1786651|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786652|NCT05006638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1786653|NCT05006638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1786654|NCT05006638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786655|NCT05006638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1786656|NCT05006638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1786657|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1786658|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1786659|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1786660|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1786661|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
1786662|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
1786663|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
1786664|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1786665|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1786666|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
1786667|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1786668|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1786669|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
1786670|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
1786671|NCT05006001|Colchicine|colchicine|mesh-list
1786672|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
1786673|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1786674|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
1786675|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
1786676|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
1786677|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786678|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786679|NCT05006209|Calcium|calcium|mesh-list
1786680|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1786681|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786699|NCT05006235|Epinephrine|epinephrine|mesh-list
1786700|NCT05006235|Albuterol|albuterol|mesh-list
1786701|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1786702|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1786703|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
1786704|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1786705|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786706|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786707|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1786708|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1786709|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
1786710|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786711|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1786712|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
1786713|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
1786714|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
1786715|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1786716|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
1786717|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1786718|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1786726|NCT05005689|Fluorides|fluorides|mesh-list
1786727|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
1786728|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786729|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
1786730|NCT05005689|Protective Agents|protective agents|mesh-ancestor
1786731|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
1786732|NCT05005494|Analgesics|analgesics|mesh-ancestor
1786733|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
1786734|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786735|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786736|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
1786737|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786738|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1786739|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
1786740|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1786741|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1786742|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786743|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1786744|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
1786745|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1786746|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
1786747|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1786748|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786749|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786750|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1786751|NCT05005715|Analgesics|analgesics|mesh-ancestor
1786752|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
1786753|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786754|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1786755|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1786756|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1786757|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
1786758|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1786759|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786760|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
1786761|NCT05005637|Prednisone|prednisone|mesh-list
1786762|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1786763|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
1786764|NCT05005637|Hormones|hormones|mesh-ancestor
1786765|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1786766|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786767|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1786768|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786769|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1786770|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1786771|NCT05005455|Bevacizumab|bevacizumab|mesh-list
1786772|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1786773|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786774|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1786775|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1786776|NCT05005455|Growth Substances|growth substances|mesh-ancestor
1786777|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786778|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
1786779|NCT05005741|Dulaglutide|dulaglutide|mesh-list
1786780|NCT05005741|Glucagon|glucagon|mesh-list
1786781|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
1786782|NCT05005741|Incretins|incretins|mesh-ancestor
1786783|NCT05005741|Hormones|hormones|mesh-ancestor
1786784|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1786785|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786786|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1786787|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1786792|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
1786793|NCT05005299|Fludarabine|fludarabine|mesh-list
1786794|NCT05005299|Venetoclax|venetoclax|mesh-list
1786795|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1786796|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
1786797|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786798|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1786799|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1786800|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
1786801|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786802|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786803|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1786810|NCT05004909|Tretinoin|tretinoin|mesh-list
1786811|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786812|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
1786813|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
1786825|NCT05005000|Triamcinolone|triamcinolone|mesh-list
1786826|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1786827|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1786828|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1786829|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1786830|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
1786831|NCT05005000|Hormones|hormones|mesh-ancestor
1786832|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1786833|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786834|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1786835|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
1786836|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786837|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786838|NCT05004753|Artemisinins|artemisinins|mesh-list
1786839|NCT05004753|Artemisinin|artemisinin|mesh-list
1786840|NCT05004753|Dexamethasone|dexamethasone|mesh-list
1786841|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1786842|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
1786843|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
1786844|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786845|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786846|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1786847|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
1786848|NCT05004753|Hormones|hormones|mesh-ancestor
1786849|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1786850|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1786851|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786852|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
1786853|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1786854|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1786855|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1786856|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
1786857|NCT05004519|Remifentanil|remifentanil|mesh-list
1786858|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1786859|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786860|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786861|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1786862|NCT05004519|Analgesics|analgesics|mesh-ancestor
1786863|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
1786864|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786865|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1786866|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1786867|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1786868|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
1786869|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1786870|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786871|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1786872|NCT05004519|Narcotics|narcotics|mesh-ancestor
1786873|NCT05004545|Propofol|propofol|mesh-list
1786874|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1786875|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786876|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786877|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1786878|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
1786879|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
1786880|NCT05004350|Fluorouracil|fluorouracil|mesh-list
1786881|NCT05004350|Irinotecan|irinotecan|mesh-list
1786882|NCT05004350|Cetuximab|cetuximab|mesh-list
1786883|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
1786884|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786885|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1786886|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786887|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1786888|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
1786889|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786890|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1786891|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1786892|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786893|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1786894|NCT05004064|Rituximab|rituximab|mesh-list
1786895|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
1786896|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1786897|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786898|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
1786899|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786900|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1786901|NCT05004207|Lactulose|lactulose|mesh-list
1786902|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1786903|NCT05004142|Letrozole|letrozole|mesh-list
1786904|NCT05004142|Fulvestrant|fulvestrant|mesh-list
1786905|NCT05004142|Goserelin|goserelin|mesh-list
1786906|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786907|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1786908|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1786909|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1786910|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786911|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1786912|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
1786913|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1786914|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786915|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1786916|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1786917|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
1786918|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1786919|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
1786920|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786921|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
1786922|NCT05003765|Buprenorphine|buprenorphine|mesh-list
1786923|NCT05003765|Bupivacaine|bupivacaine|mesh-list
1786924|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1786925|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
1786926|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
1786927|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786928|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786929|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
1786930|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786931|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1786932|NCT05003765|Narcotics|narcotics|mesh-ancestor
1786933|NCT05003765|Analgesics|analgesics|mesh-ancestor
1786934|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1786935|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1786936|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
1786937|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1786938|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1786939|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786940|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1786941|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
1786942|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1786943|NCT05003570|Fentanyl|fentanyl|mesh-list
1786944|NCT05003570|Remifentanil|remifentanil|mesh-list
1786945|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1786946|NCT05003570|Narcotics|narcotics|mesh-ancestor
1786947|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1786948|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786949|NCT05003570|Analgesics|analgesics|mesh-ancestor
1786950|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
1786951|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1786952|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1786953|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1786954|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
1786955|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
1786956|NCT05003713|Prednisone|prednisone|mesh-list
1786957|NCT05003713|Cortisone|cortisone|mesh-list
1786958|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1786959|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
1786960|NCT05003713|Hormones|hormones|mesh-ancestor
1786961|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1786962|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786963|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1786964|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786982|NCT05003752|Goserelin|goserelin|mesh-list
1786983|NCT05003752|Androgens|androgens|mesh-list
1786984|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1786985|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1786986|NCT05003752|Hormones|hormones|mesh-ancestor
1786987|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1786988|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786989|NCT05003648|Pramipexole|pramipexole|mesh-list
1786990|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
1786991|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1786992|NCT05003648|Protective Agents|protective agents|mesh-ancestor
1786993|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1786994|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1786995|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1786996|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
1786997|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
1786998|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1786999|NCT05003258|Dexamethasone|dexamethasone|mesh-list
1787000|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1787001|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
1787002|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
1787003|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787004|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787005|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1787006|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
1787007|NCT05003258|Hormones|hormones|mesh-ancestor
1787008|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1787009|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1787010|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787011|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
1787012|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1787013|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1787014|NCT05003596|Prednisolone|prednisolone|mesh-list
1787015|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
1787016|NCT05003596|Narcotics|narcotics|mesh-list
1787017|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1787018|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
1787019|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1787020|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
1787021|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
1787022|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787023|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787024|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1787025|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
1787026|NCT05003596|Hormones|hormones|mesh-ancestor
1787027|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1787028|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1787029|NCT05003596|Protective Agents|protective agents|mesh-ancestor
1787030|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1787031|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787032|NCT05003596|Analgesics|analgesics|mesh-ancestor
1787033|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
1787034|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1787035|NCT05003700|Lenvatinib|lenvatinib|mesh-list
1787036|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787037|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1787038|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787039|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787068|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
1787069|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1787070|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787071|NCT05002946|Naltrexone|naltrexone|mesh-list
1787072|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1787073|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1787074|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787075|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
1787076|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787088|NCT05002725|Lidocaine|lidocaine|mesh-list
1787089|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
1787090|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
1787091|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1787092|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787093|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
1787094|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787095|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1787096|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1787097|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1787098|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1787099|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787100|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1787101|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1787102|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787103|NCT05002673|Anesthetics|anesthetics|mesh-list
1787104|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1787105|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787106|NCT05002569|Nivolumab|nivolumab|mesh-list
1787107|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1787108|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787109|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1787110|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787111|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
1787112|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1787113|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1787114|NCT05002517|Prednisolone|prednisolone|mesh-list
1787115|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
1787116|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1787117|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
1787118|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1787119|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
1787120|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
1787121|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787122|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787123|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1787124|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
1787125|NCT05002517|Hormones|hormones|mesh-ancestor
1787126|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1787127|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1787128|NCT05002517|Protective Agents|protective agents|mesh-ancestor
1787129|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1787130|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787142|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
1787143|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1787144|NCT05002270|Cetuximab|cetuximab|mesh-list
1787145|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1787146|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787147|NCT05002361|Dexamethasone|dexamethasone|mesh-list
1787148|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1787149|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
1787150|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
1787151|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787152|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787153|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1787154|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
1787155|NCT05002361|Hormones|hormones|mesh-ancestor
1787156|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1787157|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1787158|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787159|NCT05002686|Paclitaxel|paclitaxel|mesh-list
1787160|NCT05002686|Capecitabine|capecitabine|mesh-list
1787161|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
1787162|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1787163|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787164|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
1787165|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
1787166|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
1787167|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787168|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1787169|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
1787170|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1787171|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1787172|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1787173|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1787174|NCT05002101|Zinc|zinc|mesh-list
1787175|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
1787176|NCT05002101|Trace Elements|trace elements|mesh-ancestor
1787177|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
1787178|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787179|NCT05002101|Astringents|astringents|mesh-ancestor
1787180|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
1787181|NCT05001919|Mitogens|mitogens|mesh-list
1787182|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
1787183|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787184|NCT05001763|Prucalopride|prucalopride|mesh-list
1787185|NCT05001763|Laxatives|laxatives|mesh-ancestor
1787186|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1787187|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
1787188|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1787189|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
1787190|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787191|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787192|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787193|NCT05002114|Cannabidiol|cannabidiol|mesh-list
1787194|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
1787195|NCT05001724|Docetaxel|docetaxel|mesh-list
1787196|NCT05001724|Lenvatinib|lenvatinib|mesh-list
1787197|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787198|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
1787199|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
1787200|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
1787201|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787202|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1787203|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787204|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1787205|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1787206|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1787207|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
1787208|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
1787209|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1787210|NCT05001828|Azacitidine|azacitidine|mesh-list
1787211|NCT05001828|Venetoclax|venetoclax|mesh-list
1787212|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1787213|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
1787214|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787215|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787216|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787217|NCT05001672|Tenofovir|tenofovir|mesh-list
1787218|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
1787219|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1787220|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1787221|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1787222|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787223|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787224|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1787225|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1787226|NCT05002127|Paclitaxel|paclitaxel|mesh-list
1787227|NCT05002127|Trastuzumab|trastuzumab|mesh-list
1787228|NCT05002127|Ramucirumab|ramucirumab|mesh-list
1787229|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1787230|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787231|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
1787232|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
1787233|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
1787234|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787235|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1787239|NCT05001412|Carboplatin|carboplatin|mesh-list
1787240|NCT05001412|Etoposide|etoposide|mesh-list
1787241|NCT05001412|Apatinib|apatinib|mesh-list
1787242|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787243|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1787244|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1787245|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1787246|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787247|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787248|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1787249|NCT05001776|PENTA|penta|mesh-list
1787250|NCT05001776|Fondaparinux|fondaparinux|mesh-list
1787251|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1787252|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
1787253|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1787254|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
1787255|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787256|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787257|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
1787258|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1787259|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1787260|NCT05001529|Antibodies|antibodies|mesh-list
1787261|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
1787262|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787263|NCT05001243|Bromfenac|bromfenac|mesh-list
1787264|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1787265|NCT05001243|Phenylephrine|phenylephrine|mesh-list
1787266|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
1787267|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
1787268|NCT05001243|Pilocarpine|pilocarpine|mesh-list
1787269|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1787270|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
1787271|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787272|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
1787273|NCT05001243|Protective Agents|protective agents|mesh-ancestor
1787274|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1787275|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1787276|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1787277|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1787278|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
1787279|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787280|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787281|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
1787282|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
1787283|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787284|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
1787285|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1787286|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
1787287|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1787288|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
1787289|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1787290|NCT05001243|Miotics|miotics|mesh-ancestor
1787291|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
1787292|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1787293|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
1787294|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1787295|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1787296|NCT05001243|Analgesics|analgesics|mesh-ancestor
1787297|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
1787298|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1787299|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1787300|NCT05001061|Misoprostol|misoprostol|mesh-list
1787301|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1787302|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
1787303|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1787304|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787305|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1787306|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1787307|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
1787308|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
1787309|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1787384|NCT05000281|Ibuprofen|ibuprofen|mesh-list
1787310|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787311|NCT05001152|Ozanimod|ozanimod|mesh-list
1787312|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1787313|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787314|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1787315|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
1787316|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787317|NCT05001074|Tacrolimus|tacrolimus|mesh-list
1787318|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1787319|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
1787320|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787321|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1787322|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787323|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787324|NCT05001048|Phenylephrine|phenylephrine|mesh-list
1787325|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
1787326|NCT05001048|Synephrine|synephrine|mesh-list
1787327|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1787328|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
1787329|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
1787330|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787331|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787332|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
1787333|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1787334|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
1787335|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
1787336|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1787337|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1787338|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1787339|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
1787340|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787341|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787342|NCT05001048|Protective Agents|protective agents|mesh-ancestor
1787343|NCT05000892|Paclitaxel|paclitaxel|mesh-list
1787344|NCT05000892|Carboplatin|carboplatin|mesh-list
1787345|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1787346|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787347|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
1787348|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
1787349|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
1787350|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787351|NCT05000658|Dexamethasone|dexamethasone|mesh-list
1787352|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1787353|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1787354|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
1787355|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
1787356|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787357|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787358|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1787359|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
1787360|NCT05000658|Hormones|hormones|mesh-ancestor
1787361|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1787362|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1787363|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787364|NCT05000736|Fulvestrant|fulvestrant|mesh-list
1787365|NCT05000736|Palbociclib|palbociclib|mesh-list
1787366|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1787367|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1787368|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787369|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1787370|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1787371|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
1787372|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1787373|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787374|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1787375|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787376|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787377|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1787378|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
1787379|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787380|NCT05000086|Diphosphonates|diphosphonates|mesh-list
1787381|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
1787382|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1787383|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787385|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1787386|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1787387|NCT05000281|Analgesics|analgesics|mesh-ancestor
1787388|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
1787389|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787390|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787391|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1787392|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1787393|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1787394|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787395|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787396|NCT05000047|Silicon|silicon|mesh-list
1787397|NCT05000047|Trace Elements|trace elements|mesh-ancestor
1787398|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
1787399|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787418|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1787419|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1787420|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
1787421|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1787422|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787423|NCT04999878|Gemcitabine|gemcitabine|mesh-list
1787424|NCT04999878|Dexamethasone|dexamethasone|mesh-list
1787425|NCT04999878|Etoposide|etoposide|mesh-list
1787426|NCT04999878|Cisplatin|cisplatin|mesh-list
1787427|NCT04999878|Pegaspargase|pegaspargase|mesh-list
1787428|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1787429|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
1787430|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
1787431|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787432|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787433|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1787434|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
1787435|NCT04999878|Hormones|hormones|mesh-ancestor
1787436|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1787437|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1787438|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787439|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1787440|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
1787441|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787442|NCT04999878|Antiviral Agents|antiviral agents|mesh-ancestor
1787443|NCT04999878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1787444|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787445|NCT04999878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1787446|NCT04999878|Immunologic Factors|immunologic factors|mesh-ancestor
1787447|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1787448|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1787449|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1787450|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
1787451|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1787452|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
1787453|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787454|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787455|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1787456|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
1787457|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
1787458|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1787459|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
1787460|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787461|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787462|NCT04999540|Fulvestrant|fulvestrant|mesh-list
1787463|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1787464|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787465|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1787466|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1787467|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
1787468|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1787469|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787470|NCT04999228|Mesalamine|mesalamine|mesh-list
1787471|NCT04999228|Infliximab|infliximab|mesh-list
1787472|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
1787473|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1787474|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1787475|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1787476|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1787477|NCT04999228|Analgesics|analgesics|mesh-ancestor
1787478|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
1787479|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787480|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787481|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1787482|NCT04999293|Clopidogrel|clopidogrel|mesh-list
1787483|NCT04999293|Ticagrelor|ticagrelor|mesh-list
1787484|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1787485|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1787486|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1787487|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1787488|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
1787489|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787490|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787491|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787492|NCT04999332|Leucovorin|leucovorin|mesh-list
1787493|NCT04999332|Docetaxel|docetaxel|mesh-list
1787494|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
1787495|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
1787496|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787497|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
1787498|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
1787499|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
1787500|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787501|NCT04999332|Antidotes|antidotes|mesh-ancestor
1787502|NCT04999332|Protective Agents|protective agents|mesh-ancestor
1787503|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787504|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
1787505|NCT04999332|Vitamins|vitamins|mesh-ancestor
1787506|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
1787507|NCT04999449|Scopolamine|scopolamine|mesh-list
1787508|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
1787509|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1787510|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
1787511|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
1787512|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787513|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787514|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1787515|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
1787516|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1787517|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
1787518|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787519|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787520|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1787521|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
1787522|NCT04999241|Mesalamine|mesalamine|mesh-list
1787523|NCT04999241|Infliximab|infliximab|mesh-list
1787524|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
1787525|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1787526|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1787527|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1787528|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1787529|NCT04999241|Analgesics|analgesics|mesh-ancestor
1787530|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
1787531|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787532|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787533|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1787534|NCT04999176|Enoxaparin|enoxaparin|mesh-list
1787535|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
1787536|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1787537|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
1787538|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1787539|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
1787540|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787541|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787542|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
1787543|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1787544|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1787550|NCT04999137|Vitamins|vitamins|mesh-list
1787551|NCT04999137|Ascorbic Acid|ascorbic acid|mesh-list
1787552|NCT04999137|Thiamine|thiamine|mesh-list
1787553|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
1787554|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787555|NCT04999137|Antioxidants|antioxidants|mesh-ancestor
1787556|NCT04999137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787557|NCT04999137|Protective Agents|protective agents|mesh-ancestor
1787558|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
1787591|NCT04998279|Lenograstim|lenograstim|mesh-list
1787592|NCT04998279|Sargramostim|sargramostim|mesh-list
1787593|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1787594|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
1787595|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787596|NCT04998838|Tenofovir|tenofovir|mesh-list
1787597|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
1787598|NCT04998838|Antibodies|antibodies|mesh-list
1787599|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
1787600|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1787601|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1787602|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
1787603|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1787604|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1787605|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1787606|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787607|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787608|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1787609|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1787610|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
1787611|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787612|NCT04998071|Bupivacaine|bupivacaine|mesh-list
1787613|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
1787614|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
1787615|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1787616|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787617|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
1787618|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787619|NCT04998344|Vaccines|vaccines|mesh-list
1787620|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
1787621|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787622|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1787623|NCT04998253|Propofol|propofol|mesh-list
1787624|NCT04998253|Sevoflurane|sevoflurane|mesh-list
1787625|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1787626|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1787627|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787628|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1787629|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
1787630|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
1787631|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1787632|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1787633|NCT04998500|Hormones|hormones|mesh-list
1787634|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1787635|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787636|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
1787637|NCT04998240|Paraproteins|paraproteins|mesh-list
1787638|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
1787639|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787640|NCT04998214|Thrombin|thrombin|mesh-list
1787641|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
1787642|NCT04998214|Coagulants|coagulants|mesh-ancestor
1787643|NCT04998006|Ethanol|ethanol|mesh-list
1787644|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1787645|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1787646|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1787647|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787648|NCT04997967|Ketamine|ketamine|mesh-list
1787649|NCT04997967|Propofol|propofol|mesh-list
1787650|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1787651|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1787652|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787653|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1787654|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
1787655|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
1787656|NCT04997967|Analgesics|analgesics|mesh-ancestor
1787657|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
1787658|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787659|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1787660|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1787661|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1787662|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787663|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787664|NCT04997980|Amiodarone|amiodarone|mesh-list
1787665|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1787666|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
1787667|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1787668|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1787669|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787670|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1787671|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1787672|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1787673|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787674|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1787675|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1787676|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1787677|NCT04997837|Capecitabine|capecitabine|mesh-list
1787678|NCT04997837|Tegafur|tegafur|mesh-list
1787679|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
1787680|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1787681|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1787682|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
1787683|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787684|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787685|NCT04997850|Lenvatinib|lenvatinib|mesh-list
1787686|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787687|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1787688|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787764|NCT04997291|Protective Agents|protective agents|mesh-ancestor
1787689|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787690|NCT04997759|Neostigmine|neostigmine|mesh-list
1787691|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1787692|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787693|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787694|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
1787695|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787696|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787697|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1787698|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
1787699|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787700|NCT04997707|Propofol|propofol|mesh-list
1787701|NCT04997707|Sevoflurane|sevoflurane|mesh-list
1787702|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1787703|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1787704|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787705|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1787706|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
1787707|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
1787708|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1787709|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1787710|NCT04997798|Trastuzumab|trastuzumab|mesh-list
1787711|NCT04997798|Letrozole|letrozole|mesh-list
1787712|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1787713|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787714|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1787715|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1787716|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787717|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787718|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1787719|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
1787720|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1787721|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787722|NCT04997564|Tenofovir|tenofovir|mesh-list
1787723|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
1787724|NCT04997564|Velpatasvir|velpatasvir|mesh-list
1787725|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
1787726|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1787727|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1787728|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1787729|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787730|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787731|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1787732|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1787733|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1787734|NCT04997525|Estradiol|estradiol|mesh-list
1787735|NCT04997525|Progesterone|progesterone|mesh-list
1787736|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1787737|NCT04997525|Estrogens|estrogens|mesh-ancestor
1787738|NCT04997525|Hormones|hormones|mesh-ancestor
1787739|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1787740|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787741|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1787742|NCT04997525|Progestins|progestins|mesh-ancestor
1787745|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
1787746|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
1787747|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
1787748|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787749|NCT04996979|Ropivacaine|ropivacaine|mesh-list
1787750|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
1787751|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
1787752|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1787753|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787754|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
1787755|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787756|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
1787757|NCT04997291|Razoxane|razoxane|mesh-list
1787758|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787759|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1787760|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1787761|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1787762|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787763|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787765|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787766|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
1787767|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
1787768|NCT04997304|Albuterol|albuterol|mesh-list
1787769|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1787770|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
1787771|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787772|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787773|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1787774|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
1787775|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1787776|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1787777|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1787778|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
1787779|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787780|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787781|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
1787782|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1787792|NCT04996550|Metoprolol|metoprolol|mesh-list
1787793|NCT04996550|Carvedilol|carvedilol|mesh-list
1787794|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1787795|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1787796|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
1787797|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
1787798|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787799|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787800|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1787801|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1787802|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1787803|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
1787804|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787805|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787806|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
1787807|NCT04996550|Protective Agents|protective agents|mesh-ancestor
1787808|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1787809|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1787810|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1787811|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
1787812|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1787813|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1787822|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
1787823|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1787824|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
1787825|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787826|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787827|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1787828|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
1787829|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1787830|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
1787831|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787832|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787833|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1787834|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
1787835|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
1787836|NCT04996667|Protective Agents|protective agents|mesh-ancestor
1787837|NCT04996602|177Lu-PSMA-617|177lu-psma-617|mesh-list
1787838|NCT04996602|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
1787839|NCT04996602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1787840|NCT04996602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787841|NCT04996485|Ustekinumab|ustekinumab|mesh-list
1787842|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
1787843|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
1787844|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1787845|NCT04996290|Ropivacaine|ropivacaine|mesh-list
1787846|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
1787847|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
1787848|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1787849|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787850|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
1787851|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787852|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
1787853|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
1787854|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787855|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787862|NCT04996134|Domperidone|domperidone|mesh-list
1787863|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
1787864|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
1787865|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787866|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787867|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1787868|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1787869|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
1787870|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787871|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787872|NCT04996251|Bupivacaine|bupivacaine|mesh-list
1787873|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
1787874|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
1787875|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1787876|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787877|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
1787878|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787879|NCT04996498|Oxytocin|oxytocin|mesh-list
1787880|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
1787881|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1787882|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787883|NCT04996238|Vaccines|vaccines|mesh-list
1787884|NCT04996238|Immunologic Factors|immunologic factors|mesh-ancestor
1787885|NCT04996238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787886|NCT04996004|Doxorubicin|doxorubicin|mesh-list
1787887|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1787888|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787889|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1787890|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1787891|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787892|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787893|NCT04996160|Dexamethasone|dexamethasone|mesh-list
1787894|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
1787895|NCT04996160|Doxorubicin|doxorubicin|mesh-list
1787896|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1787897|NCT04996160|Bortezomib|bortezomib|mesh-list
1787898|NCT04996160|Palbociclib|palbociclib|mesh-list
1787899|NCT04996160|BB 1101|bb 1101|mesh-list
1787900|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1787901|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
1787902|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
1787903|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787904|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787905|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1787906|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
1787907|NCT04996160|Hormones|hormones|mesh-ancestor
1787908|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1787909|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1787910|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787911|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
1787912|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787913|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787914|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1787915|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1787916|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1787917|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1787918|NCT04996017|Atezolizumab|atezolizumab|mesh-list
1787919|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1787920|NCT04995653|Vancomycin|vancomycin|mesh-list
1787921|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1787922|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1787926|NCT04995354|Mitogens|mitogens|mesh-list
1787927|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
1787928|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787929|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
1787930|NCT04995263|Caffeine|caffeine|mesh-list
1787931|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1787932|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787933|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1787934|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1787935|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787936|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1787937|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1787938|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
1787939|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787940|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1787941|NCT04995497|Lidocaine|lidocaine|mesh-list
1787942|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
1787943|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
1787944|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1787945|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787946|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
1787947|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787948|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1787949|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1787950|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1787951|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1787952|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787961|NCT04995133|Colistin|colistin|mesh-list
1787962|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1787963|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1787978|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1787979|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1787980|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1787981|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1787982|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1787983|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
1787984|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1787985|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787986|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1787987|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1787988|NCT04994951|Triamcinolone|triamcinolone|mesh-list
1787989|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1787990|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1787991|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1787992|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1787993|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
1787994|NCT04994951|Hormones|hormones|mesh-ancestor
1787995|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1787996|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1787997|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1787998|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
1787999|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788000|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788001|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
1788002|NCT04995016|Axitinib|axitinib|mesh-list
1788003|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1788004|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788005|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1788006|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788007|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788008|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
1788009|NCT04994860|Zamicastat|zamicastat|mesh-list
1788010|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
1788011|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1788012|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1788013|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788014|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788015|NCT04994860|Urological Agents|urological agents|mesh-ancestor
1788016|NCT04994626|Rituximab|rituximab|mesh-list
1788017|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1788018|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788019|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
1788020|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788021|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1788022|NCT04994743|Cortisone|cortisone|mesh-list
1788023|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1788024|NCT04994431|Tamsulosin|tamsulosin|mesh-list
1788025|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1788026|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1788027|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1788028|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
1788029|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1788030|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788031|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788032|NCT04994431|Urological Agents|urological agents|mesh-ancestor
1788033|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1788051|NCT04994444|Nicotine|nicotine|mesh-list
1788052|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1788053|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
1788054|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788055|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788056|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1788057|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1788058|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
1788059|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1788060|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788061|NCT04994314|Fluorides|fluorides|mesh-list
1788062|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788063|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
1788064|NCT04994314|Protective Agents|protective agents|mesh-ancestor
1788065|NCT04994262|Menthol|menthol|mesh-list
1788066|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
1788067|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
1788068|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
1788069|NCT04994574|Olodaterol|olodaterol|mesh-list
1788070|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1788071|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
1788072|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788073|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788074|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1788075|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
1788076|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
1788077|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1788078|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
1788079|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1788080|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788081|NCT04994236|Leucovorin|leucovorin|mesh-list
1788082|NCT04994236|Fluorouracil|fluorouracil|mesh-list
1788083|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
1788084|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
1788085|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788086|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1788087|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788088|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1788089|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
1788090|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788091|NCT04994236|Antidotes|antidotes|mesh-ancestor
1788092|NCT04994236|Protective Agents|protective agents|mesh-ancestor
1788093|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
1788094|NCT04994236|Vitamins|vitamins|mesh-ancestor
1788095|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
1788096|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
1788097|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1788098|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
1788099|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1788100|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
1788101|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788102|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788103|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
1788104|NCT04994119|Warfarin|warfarin|mesh-list
1788105|NCT04994119|Zamicastat|zamicastat|mesh-list
1788106|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
1788107|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788108|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788109|NCT04993209|Vaccines|vaccines|mesh-list
1788110|NCT04993209|Immunologic Factors|immunologic factors|mesh-ancestor
1788111|NCT04993209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788112|NCT04993365|Vaccines|vaccines|mesh-list
1788113|NCT04993365|Immunologic Factors|immunologic factors|mesh-ancestor
1788114|NCT04993365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788115|NCT04993352|Antibodies|antibodies|mesh-list
1788116|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1788117|NCT04993352|Mitogens|mitogens|mesh-list
1788118|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
1788119|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
1788120|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788121|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
1788122|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788123|NCT04993352|Growth Substances|growth substances|mesh-ancestor
1788124|NCT04993222|Amphotericin B|amphotericin b|mesh-list
1788125|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
1788126|NCT04993222|Amebicides|amebicides|mesh-ancestor
1788127|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1788128|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1788129|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1788130|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1788131|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
1788132|NCT04993014|Trastuzumab|trastuzumab|mesh-list
1788133|NCT04993014|Pertuzumab|pertuzumab|mesh-list
1788134|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1788135|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788136|NCT04993040|Paclitaxel|paclitaxel|mesh-list
1788137|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1788138|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788139|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
1788140|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
1788141|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
1788142|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788143|NCT04993027|Vancomycin|vancomycin|mesh-list
1788144|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1788145|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1788146|NCT04992507|Anesthetics|anesthetics|mesh-list
1788147|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1788148|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788149|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
1788150|NCT04992468|Hormones|hormones|mesh-ancestor
1788151|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1788152|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788153|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
1788154|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1788155|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1788156|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
1788157|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1788158|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788159|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788160|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
1788161|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
1788162|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788163|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
1788164|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1788165|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
1788166|NCT04992481|Fluorides|fluorides|mesh-list
1788167|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
1788168|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
1788169|NCT04992481|Protective Agents|protective agents|mesh-ancestor
1788170|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788171|NCT04992572|Lidocaine|lidocaine|mesh-list
1788172|NCT04992572|Propofol|propofol|mesh-list
1788173|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
1788174|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
1788175|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1788176|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788177|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
1788178|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788179|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1788180|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1788181|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1788182|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1788183|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788184|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1788185|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1788186|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
1788203|NCT04992156|Palbociclib|palbociclib|mesh-list
1788204|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788205|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1788206|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788207|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788208|NCT04992182|Vaccines|vaccines|mesh-list
1788209|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
1788210|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788211|NCT04992052|Bone wax|bone wax|mesh-list
1788212|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
1788213|NCT04992052|Coagulants|coagulants|mesh-ancestor
1788214|NCT04992143|Sorafenib|sorafenib|mesh-list
1788215|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788216|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1788217|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788218|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788219|NCT04992026|Prednisone|prednisone|mesh-list
1788220|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
1788221|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1788222|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
1788223|NCT04992026|Hormones|hormones|mesh-ancestor
1788224|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1788225|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788226|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1788227|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788228|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1788229|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788230|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788231|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
1788232|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1788238|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
1788250|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
1788251|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1788252|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788253|NCT04991597|Lidocaine|lidocaine|mesh-list
1788254|NCT04991597|Epinephrine|epinephrine|mesh-list
1788255|NCT04991597|Racepinephrine|racepinephrine|mesh-list
1788256|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
1788257|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
1788258|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
1788259|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1788260|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788261|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
1788262|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788263|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1788264|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1788265|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1788266|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1788267|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788268|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1788269|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1788270|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
1788271|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1788272|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1788273|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1788274|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
1788275|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1788276|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
1788277|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
1788278|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
1788279|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1788280|NCT04991584|Amoxicillin|amoxicillin|mesh-list
1788281|NCT04991584|Levofloxacin|levofloxacin|mesh-list
1788282|NCT04991584|Ofloxacin|ofloxacin|mesh-list
1788283|NCT04991584|Tetracycline|tetracycline|mesh-list
1788284|NCT04991584|Furazolidone|furazolidone|mesh-list
1788285|NCT04991584|Esomeprazole|esomeprazole|mesh-list
1788286|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1788287|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1788288|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1788289|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1788290|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1788291|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788292|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788293|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1788294|NCT04991584|Renal Agents|renal agents|mesh-ancestor
1788295|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1788296|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1788297|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788298|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1788299|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1788300|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1788301|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1788302|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
1788303|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1788304|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1788305|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1788306|NCT04991896|Metoprolol|metoprolol|mesh-list
1788307|NCT04991896|Sotalol|sotalol|mesh-list
1788308|NCT04991896|Flecainide|flecainide|mesh-list
1788309|NCT04991896|Bisoprolol|bisoprolol|mesh-list
1788310|NCT04991896|Betaxolol|betaxolol|mesh-list
1788311|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1788312|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1788313|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
1788314|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
1788315|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788316|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788317|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1788318|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1788319|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1788320|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
1788321|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1788322|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788323|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1788324|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1788325|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1788326|NCT04991181|Zamicastat|zamicastat|mesh-list
1788327|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788328|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788329|NCT04991324|Vitamin D|vitamin d|mesh-list
1788330|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
1788331|NCT04991324|Vitamins|vitamins|mesh-ancestor
1788332|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
1788333|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788334|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1788335|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1788336|NCT04991402|Dolutegravir|dolutegravir|mesh-list
1788337|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1788338|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1788339|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1788340|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788341|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788342|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1788343|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
1788344|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1788354|NCT04991493|Tramadol|tramadol|mesh-list
1788355|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1788356|NCT04991493|Narcotics|narcotics|mesh-ancestor
1788357|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1788358|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788359|NCT04991493|Analgesics|analgesics|mesh-ancestor
1788360|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
1788361|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788362|NCT04991207|Bosentan|bosentan|mesh-list
1788363|NCT04991207|Zamicastat|zamicastat|mesh-list
1788364|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1788365|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1788366|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788367|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788368|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
1788369|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
1788370|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1788371|NCT04991064|Protective Agents|protective agents|mesh-ancestor
1788372|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788373|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
1788374|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1788375|NCT04991155|Zamicastat|zamicastat|mesh-list
1788376|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788377|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788378|NCT04991298|Fentanyl|fentanyl|mesh-list
1788379|NCT04991298|Midazolam|midazolam|mesh-list
1788380|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1788381|NCT04991298|Narcotics|narcotics|mesh-ancestor
1788382|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1788383|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788384|NCT04991298|Analgesics|analgesics|mesh-ancestor
1788385|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
1788386|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788387|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1788388|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1788389|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
1788390|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
1788391|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1788392|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1788393|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1788394|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1788395|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
1788396|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
1788397|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1788398|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788399|NCT04991194|Zamicastat|zamicastat|mesh-list
1788400|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788401|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788402|NCT04991012|Triamcinolone|triamcinolone|mesh-list
1788403|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1788404|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1788405|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1788406|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1788407|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
1788408|NCT04991012|Hormones|hormones|mesh-ancestor
1788409|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1788410|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788411|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1788412|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
1788413|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788414|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788415|NCT04990830|Heparin|heparin|mesh-list
1788416|NCT04990830|Enoxaparin|enoxaparin|mesh-list
1788417|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1788418|NCT04990830|Tinzaparin|tinzaparin|mesh-list
1788419|NCT04990830|Dalteparin|dalteparin|mesh-list
1788420|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
1788421|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
1788422|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1788423|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1788424|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788425|NCT04990869|Niacinamide|niacinamide|mesh-list
1788426|NCT04990869|Niacin|niacin|mesh-list
1788427|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
1788428|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
1788429|NCT04990869|Vitamins|vitamins|mesh-ancestor
1788430|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
1788431|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788432|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1788433|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
1788434|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788435|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1788436|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
1788437|NCT04990713|Ropivacaine|ropivacaine|mesh-list
1788438|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
1788439|NCT04990713|Anesthetics|anesthetics|mesh-list
1788440|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1788441|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788442|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
1788443|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788444|NCT04990791|Aspirin|aspirin|mesh-list
1788445|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
1788446|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1788447|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1788448|NCT04990791|Analgesics|analgesics|mesh-ancestor
1788449|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
1788450|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788451|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788452|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1788453|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1788454|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1788455|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1788456|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788457|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1788458|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1788459|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788460|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
1788461|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1788462|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
1788463|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1788464|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
1788465|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
1788466|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
1788467|NCT04990804|Analgesics|analgesics|mesh-list
1788468|NCT04990804|Narcotics|narcotics|mesh-ancestor
1788469|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1788470|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788471|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
1788472|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788473|NCT04990778|Venetoclax|venetoclax|mesh-list
1788474|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788475|NCT04990752|Urinastatin|urinastatin|mesh-list
1788476|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1788477|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1788478|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
1788479|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788480|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788481|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1788482|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1788483|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
1788484|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788508|NCT04990037|Folfirinox|folfirinox|mesh-list
1788509|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788510|NCT04990258|Infliximab|infliximab|mesh-list
1788511|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
1788512|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1788513|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1788514|NCT04990167|Bromides|bromides|mesh-list
1788515|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
1788516|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1788517|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
1788518|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788519|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788520|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1788521|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
1788522|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
1788523|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1788524|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
1788525|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1788526|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788527|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
1788541|NCT04989660|Phenol|phenol|mesh-list
1788542|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1788543|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1788544|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
1788545|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
1788546|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1788553|NCT04989621|Rituximab|rituximab|mesh-list
1788554|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1788555|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788556|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
1788557|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788558|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1788559|NCT04989413|Dronabinol|dronabinol|mesh-list
1788560|NCT04989413|Cannabidiol|cannabidiol|mesh-list
1788561|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
1788562|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
1788563|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788564|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1788565|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1788566|NCT04989413|Analgesics|analgesics|mesh-ancestor
1788567|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
1788568|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788569|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1788570|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1788571|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1788572|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788573|NCT04989413|Hormones|hormones|mesh-ancestor
1788574|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1788586|NCT04989335|Fludarabine|fludarabine|mesh-list
1788587|NCT04989335|Clofarabine|clofarabine|mesh-list
1788588|NCT04989335|Bisantrene|bisantrene|mesh-list
1788589|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788590|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1788591|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
1788592|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788593|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1788594|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
1788595|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1788596|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
1788597|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788598|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
1788599|NCT04989361|Protective Agents|protective agents|mesh-ancestor
1788600|NCT04989400|Misoprostol|misoprostol|mesh-list
1788601|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
1788602|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1788603|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
1788604|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1788605|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788606|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1788607|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1788608|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
1788609|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1788610|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
1788611|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1788612|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1788613|NCT04989127|Penicillins|penicillins|mesh-list
1788614|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1788615|NCT04989127|Analgesics|analgesics|mesh-list
1788616|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1788617|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
1788618|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
1788619|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788620|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788621|NCT04989166|Curcumin|curcumin|mesh-list
1788622|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1788623|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1788624|NCT04989166|Analgesics|analgesics|mesh-ancestor
1788625|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
1788626|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788627|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788628|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1788629|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1788630|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788631|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788632|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788633|NCT04989140|Dexamethasone|dexamethasone|mesh-list
1788634|NCT04989140|Pomalidomide|pomalidomide|mesh-list
1788635|NCT04989140|Ixazomib|ixazomib|mesh-list
1788636|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1788637|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
1788638|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
1788639|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788640|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788641|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1788642|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
1788643|NCT04989140|Hormones|hormones|mesh-ancestor
1788644|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1788645|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1788646|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788647|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
1788648|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1788649|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1788650|NCT04989140|Growth Substances|growth substances|mesh-ancestor
1788651|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
1788652|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
1788653|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788654|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788655|NCT04989218|Gemcitabine|gemcitabine|mesh-list
1788656|NCT04989218|Cisplatin|cisplatin|mesh-list
1788657|NCT04989218|Durvalumab|durvalumab|mesh-list
1788658|NCT04989218|Tremelimumab|tremelimumab|mesh-list
1788659|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788660|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1788661|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
1788662|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788663|NCT04989218|Antiviral Agents|antiviral agents|mesh-ancestor
1788664|NCT04989218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1788665|NCT04989218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788666|NCT04989218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1788667|NCT04989218|Immunologic Factors|immunologic factors|mesh-ancestor
1788668|NCT04989218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788669|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1788670|NCT04988945|Durvalumab|durvalumab|mesh-list
1788671|NCT04988945|Tremelimumab|tremelimumab|mesh-list
1788672|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1788673|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788674|NCT04989270|Anesthetics|anesthetics|mesh-list
1788675|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1788676|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788677|NCT04989257|Clopidogrel|clopidogrel|mesh-list
1788678|NCT04989257|Ticagrelor|ticagrelor|mesh-list
1788679|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1788680|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1788681|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1788682|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1788683|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
1788684|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1788685|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788686|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788687|NCT04989049|Folic Acid|folic acid|mesh-list
1788688|NCT04989049|Hematinics|hematinics|mesh-ancestor
1788689|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
1788690|NCT04989049|Vitamins|vitamins|mesh-ancestor
1788691|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
1788692|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788693|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
1788694|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1788695|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
1788696|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788697|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788698|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1788699|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
1788700|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1788701|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
1788702|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788703|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1788704|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1788705|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
1788706|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
1788707|NCT04988932|Protective Agents|protective agents|mesh-ancestor
1788708|NCT04989348|Hormones|hormones|mesh-list
1788709|NCT04989348|Progestins|progestins|mesh-list
1788710|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
1788711|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1788712|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788713|NCT04988685|Sirolimus|sirolimus|mesh-list
1788714|NCT04988685|Paclitaxel|paclitaxel|mesh-list
1788715|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1788716|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788717|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
1788718|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
1788719|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
1788720|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788721|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1788722|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1788723|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1788724|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
1788725|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1788726|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
1788727|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788728|NCT04988776|Bupivacaine|bupivacaine|mesh-list
1788729|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
1788730|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
1788731|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1788732|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788733|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
1788734|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788735|NCT04988789|Paclitaxel|paclitaxel|mesh-list
1788736|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1788737|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788738|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
1788739|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
1788740|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
1788741|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788742|NCT04988607|Bevacizumab|bevacizumab|mesh-list
1788743|NCT04988607|Osimertinib|osimertinib|mesh-list
1788744|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1788745|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788746|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1788747|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1788748|NCT04988607|Growth Substances|growth substances|mesh-ancestor
1788749|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788750|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
1788751|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1788752|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788753|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788754|NCT04988646|Acyclovir|acyclovir|mesh-list
1788755|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
1788756|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1788757|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
1788758|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1788759|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1788760|NCT04988425|Prednisolone|prednisolone|mesh-list
1788761|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
1788762|NCT04988425|Antibodies|antibodies|mesh-list
1788763|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1788764|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1788765|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
1788766|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
1788767|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788768|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1788769|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
1788770|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
1788771|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788772|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1788773|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
1788774|NCT04988425|Hormones|hormones|mesh-ancestor
1788775|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1788776|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1788777|NCT04988425|Protective Agents|protective agents|mesh-ancestor
1788778|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1788779|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788780|NCT04988217|Interferons|interferons|mesh-list
1788781|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
1788782|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
1788783|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788784|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
1788785|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1788786|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
1788787|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788788|NCT04988191|Bevacizumab|bevacizumab|mesh-list
1788789|NCT04988191|Irinotecan|irinotecan|mesh-list
1788790|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1788791|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788792|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1788793|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1788794|NCT04988191|Growth Substances|growth substances|mesh-ancestor
1788795|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788796|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
1788797|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1788798|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1788799|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788800|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788801|NCT04988048|Vaccines|vaccines|mesh-list
1788802|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
1788803|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788804|NCT04988256|Cyclosporine|cyclosporine|mesh-list
1788805|NCT04988256|Prednisone|prednisone|mesh-list
1788806|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
1788807|NCT04988256|Cyclosporins|cyclosporins|mesh-list
1788808|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1788809|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
1788810|NCT04988256|Hormones|hormones|mesh-ancestor
1788811|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1788812|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788813|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1788814|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788815|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788816|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788817|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1788818|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
1788819|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
1788820|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1788821|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
1788822|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1788823|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1788824|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
1788825|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
1788826|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788827|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1788828|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1788829|NCT04988256|Protective Agents|protective agents|mesh-ancestor
1788830|NCT04987892|Tamsulosin|tamsulosin|mesh-list
1788831|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1788832|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1788833|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1788834|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
1788835|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1788836|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788837|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788838|NCT04987892|Urological Agents|urological agents|mesh-ancestor
1788844|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
1788845|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1788846|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788847|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
1788848|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1788849|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1788850|NCT04988282|Prednisolone|prednisolone|mesh-list
1788851|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
1788852|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1788853|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
1788854|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1788855|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
1788856|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
1788857|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788858|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788859|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1788860|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
1788861|NCT04988282|Hormones|hormones|mesh-ancestor
1788862|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1788863|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1788864|NCT04988282|Protective Agents|protective agents|mesh-ancestor
1788865|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1788866|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788867|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
1788868|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1788869|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
1788870|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1788871|NCT04987775|Expectorants|expectorants|mesh-ancestor
1788872|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
1788873|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1788874|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
1788875|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788876|NCT04987775|Protective Agents|protective agents|mesh-ancestor
1788877|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788878|NCT04987775|Antidotes|antidotes|mesh-ancestor
1788879|NCT04987632|Letrozole|letrozole|mesh-list
1788880|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788881|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1788882|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1788883|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788884|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788885|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1788886|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
1788887|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1788888|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788889|NCT04987463|Sirolimus|sirolimus|mesh-list
1788890|NCT04987463|Vigabatrin|vigabatrin|mesh-list
1788891|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1788892|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1788893|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1788894|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788895|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
1788896|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1788897|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
1788898|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788899|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
1788900|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788901|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788902|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
1788903|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1788904|NCT04987450|Prednisone|prednisone|mesh-list
1788905|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
1788906|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1788907|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1788908|NCT04987450|Prednisolone|prednisolone|mesh-list
1788909|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
1788910|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1788911|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
1788912|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1788913|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
1788914|NCT04987450|Hormones|hormones|mesh-ancestor
1788915|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1788916|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788917|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1788918|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1788919|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
1788920|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
1788921|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1788922|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1788923|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1788924|NCT04987450|Protective Agents|protective agents|mesh-ancestor
1788925|NCT04987567|Antioxidants|antioxidants|mesh-list
1788926|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788927|NCT04987567|Protective Agents|protective agents|mesh-ancestor
1788928|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788929|NCT04987554|Immunoferon|immunoferon|mesh-list
1788930|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1788931|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
1788932|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1788970|NCT04987242|Rasburicase|rasburicase|mesh-list
1788971|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
1788972|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1789058|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
1788986|NCT04986982|Opicapone|opicapone|mesh-list
1788987|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1788988|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788989|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788990|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1788991|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1788992|NCT04986995|Opicapone|opicapone|mesh-list
1788993|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1788994|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1788995|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1788996|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1788997|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1788998|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1788999|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
1789000|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1789001|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1789002|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789003|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
1789004|NCT04986813|Coagulants|coagulants|mesh-ancestor
1789005|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
1789006|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1789007|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789008|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
1789009|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1789010|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
1789011|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789012|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
1789013|NCT04986644|Protective Agents|protective agents|mesh-ancestor
1789014|NCT04986735|Empagliflozin|empagliflozin|mesh-list
1789015|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1789016|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789017|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1789018|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789019|NCT04986371|Niraparib|niraparib|mesh-list
1789020|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1789021|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789022|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789023|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789024|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1789025|NCT04986254|Meropenem|meropenem|mesh-list
1789026|NCT04986254|Tazobactam|tazobactam|mesh-list
1789027|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
1789028|NCT04986254|Piperacillin|piperacillin|mesh-list
1789029|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
1789030|NCT04986254|Penicillin G|penicillin g|mesh-list
1789031|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
1789032|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
1789033|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789034|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1789035|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789036|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789037|NCT04986319|Vitamin D|vitamin d|mesh-list
1789038|NCT04986319|Vitamins|vitamins|mesh-ancestor
1789039|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
1789040|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789041|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1789045|NCT04986631|Topiramate|topiramate|mesh-list
1789046|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
1789047|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1789048|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789049|NCT04986072|Nitroprusside|nitroprusside|mesh-list
1789050|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1789051|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
1789052|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
1789053|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789054|NCT04985890|UB-421|ub-421|mesh-list
1789055|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1789056|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
1789057|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789059|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
1789060|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1789061|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1789062|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789063|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789064|NCT04985929|Urological Agents|urological agents|mesh-ancestor
1789065|NCT04986098|Paclitaxel|paclitaxel|mesh-list
1789066|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1789067|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789068|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
1789069|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
1789070|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
1789071|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789072|NCT04985656|Decitabine|decitabine|mesh-list
1789073|NCT04985656|Pevonedistat|pevonedistat|mesh-list
1789074|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1789075|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
1789076|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789077|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789078|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789079|NCT04985435|Adalimumab|adalimumab|mesh-list
1789080|NCT04985435|Etanercept|etanercept|mesh-list
1789081|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1789082|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1789083|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1789084|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1789085|NCT04985435|Analgesics|analgesics|mesh-ancestor
1789086|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
1789087|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789088|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789089|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1789090|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1789091|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
1789092|NCT04985344|Propranolol|propranolol|mesh-list
1789093|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1789094|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1789095|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
1789096|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1789097|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789098|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789099|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1789100|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1789101|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
1789102|NCT04985526|Octenidine|octenidine|mesh-list
1789103|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789104|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1789105|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
1789106|NCT04985760|Vaccines|vaccines|mesh-list
1789107|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
1789108|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
1789109|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789110|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1789111|NCT04985760|Antacids|antacids|mesh-ancestor
1789112|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789113|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1789114|NCT04985669|Prucalopride|prucalopride|mesh-list
1789115|NCT04985669|Laxatives|laxatives|mesh-ancestor
1789116|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1789117|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
1789118|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1789119|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
1789120|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1789121|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789122|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789123|NCT04985500|Bupivacaine|bupivacaine|mesh-list
1789124|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
1789125|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
1789126|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1789127|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789128|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
1789129|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789130|NCT04985266|Tamoxifen|tamoxifen|mesh-list
1789131|NCT04985266|Letrozole|letrozole|mesh-list
1789132|NCT04985266|Fulvestrant|fulvestrant|mesh-list
1789133|NCT04985266|Palbociclib|palbociclib|mesh-list
1789134|NCT04985266|Anastrozole|anastrozole|mesh-list
1789135|NCT04985266|Exemestane|exemestane|mesh-list
1789136|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789137|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1789138|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1789139|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789140|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789141|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1789142|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
1789143|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789144|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789145|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1789146|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1789147|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1789148|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1789149|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1789150|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1789151|NCT04985201|Irinotecan|irinotecan|mesh-list
1789152|NCT04985201|Simvastatin|simvastatin|mesh-list
1789153|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1789154|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1789155|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789156|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789157|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789158|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1789159|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1789160|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
1789161|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1789162|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1789175|NCT04984759|Primaquine|primaquine|mesh-list
1789176|NCT04984759|Tafenoquine|tafenoquine|mesh-list
1789177|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
1789178|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1789179|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1789180|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789181|NCT04984980|Gemcitabine|gemcitabine|mesh-list
1789182|NCT04984980|Bevacizumab|bevacizumab|mesh-list
1789183|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
1789184|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1789185|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789186|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1789187|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1789188|NCT04984980|Growth Substances|growth substances|mesh-ancestor
1789189|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789190|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
1789191|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1789192|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
1789193|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789194|NCT04984980|Antiviral Agents|antiviral agents|mesh-ancestor
1789195|NCT04984980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789196|NCT04984980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789197|NCT04984980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1789198|NCT04984980|Immunologic Factors|immunologic factors|mesh-ancestor
1789199|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1789200|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1789201|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789202|NCT04985110|Renal Agents|renal agents|mesh-ancestor
1789203|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1789204|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
1789205|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1789206|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1789207|NCT04984993|Tadalafil|tadalafil|mesh-list
1789208|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
1789209|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1789210|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1789211|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789212|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789213|NCT04984993|Urological Agents|urological agents|mesh-ancestor
1789214|NCT04984798|Vitamin E|vitamin e|mesh-list
1789215|NCT04984798|Tocopherols|tocopherols|mesh-list
1789216|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
1789217|NCT04984798|Vitamins|vitamins|mesh-ancestor
1789218|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
1789219|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789220|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
1789221|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789222|NCT04984798|Protective Agents|protective agents|mesh-ancestor
1789223|NCT04984408|Vaccines|vaccines|mesh-list
1789224|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
1789225|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789226|NCT04984200|Mydriatics|mydriatics|mesh-list
1789227|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
1789228|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789229|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789233|NCT04984577|Edaravone|edaravone|mesh-list
1789234|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1789235|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
1789236|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789237|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1789238|NCT04984577|Protective Agents|protective agents|mesh-ancestor
1789239|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789240|NCT04984278|Nabiximols|nabiximols|mesh-list
1789241|NCT04984278|Analgesics|analgesics|mesh-ancestor
1789242|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
1789243|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789244|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789252|NCT04983836|Anesthetics|anesthetics|mesh-list
1789253|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1789254|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789255|NCT04984070|Metformin|metformin|mesh-list
1789256|NCT04984070|Drospirenone|drospirenone|mesh-list
1789257|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
1789258|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1789259|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
1789260|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
1789261|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
1789262|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1789263|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789264|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1789265|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1789266|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1789267|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1789268|NCT04984070|Estrogens|estrogens|mesh-ancestor
1789269|NCT04984070|Hormones|hormones|mesh-ancestor
1789270|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789271|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1789272|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
1789273|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1789274|NCT04984070|Diuretics|diuretics|mesh-ancestor
1789275|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
1789276|NCT04983849|Metronidazole|metronidazole|mesh-list
1789277|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789278|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1789279|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1789280|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1789281|NCT04983966|Desflurane|desflurane|mesh-list
1789282|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1789283|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
1789284|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
1789285|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1789286|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789287|NCT04984083|Vitamin K|vitamin k|mesh-list
1789288|NCT04984083|Vitamins|vitamins|mesh-ancestor
1789289|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
1789290|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789291|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1789292|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1789293|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789294|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
1789295|NCT04984083|Coagulants|coagulants|mesh-ancestor
1789313|NCT04983550|Doxorubicin|doxorubicin|mesh-list
1789314|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1789315|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1789316|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789317|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1789318|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1789319|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789320|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789321|NCT04983524|Propolis|propolis|mesh-list
1789322|NCT04983524|Calcium|calcium|mesh-list
1789323|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1789324|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789325|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789326|NCT04983615|Fentanyl|fentanyl|mesh-list
1789327|NCT04983615|Midazolam|midazolam|mesh-list
1789328|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1789329|NCT04983615|Narcotics|narcotics|mesh-ancestor
1789330|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1789331|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789332|NCT04983615|Analgesics|analgesics|mesh-ancestor
1789333|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
1789334|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789335|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1789336|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1789337|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
1789338|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
1789339|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1789340|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1789341|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1789342|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1789343|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
1789344|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
1789345|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1789346|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789361|NCT04983095|Hormones|hormones|mesh-list
1789362|NCT04983095|Androgens|androgens|mesh-list
1789363|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
1789439|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789364|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789365|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789366|NCT04983121|Antibodies|antibodies|mesh-list
1789367|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
1789368|NCT04983121|Mitogens|mitogens|mesh-list
1789369|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
1789370|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789371|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
1789372|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789373|NCT04983160|Allopurinol|allopurinol|mesh-list
1789374|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
1789375|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789376|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789377|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
1789378|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1789379|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1789380|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
1789381|NCT04983160|Protective Agents|protective agents|mesh-ancestor
1789382|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789383|NCT04982861|Cefixime|cefixime|mesh-list
1789384|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1789385|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789386|NCT04982874|Furosemide|furosemide|mesh-list
1789387|NCT04982874|Diuretics|diuretics|mesh-ancestor
1789388|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
1789389|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789390|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1789391|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1789392|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789393|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1789394|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1789395|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789396|NCT04982705|Incretins|incretins|mesh-ancestor
1789397|NCT04982705|Hormones|hormones|mesh-ancestor
1789398|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789399|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1789400|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
1789401|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789402|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789403|NCT04982809|Dexamethasone|dexamethasone|mesh-list
1789404|NCT04982809|Prednisolone|prednisolone|mesh-list
1789405|NCT04982809|Betamethasone|betamethasone|mesh-list
1789406|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1789407|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
1789408|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
1789409|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789410|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789411|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1789412|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
1789413|NCT04982809|Hormones|hormones|mesh-ancestor
1789414|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789415|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1789416|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789417|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1789418|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
1789419|NCT04982900|Aflutinib|aflutinib|mesh-list
1789420|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1789421|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789422|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789423|NCT04982913|Oseltamivir|oseltamivir|mesh-list
1789424|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
1789425|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789426|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789427|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789428|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
1789429|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789430|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
1789431|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1789432|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
1789433|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789434|NCT04982549|Paclitaxel|paclitaxel|mesh-list
1789435|NCT04982549|Carboplatin|carboplatin|mesh-list
1789436|NCT04982549|Pemetrexed|pemetrexed|mesh-list
1789437|NCT04982549|Durvalumab|durvalumab|mesh-list
1789438|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1789440|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
1789441|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
1789442|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
1789443|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789444|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789445|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1789446|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1789447|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1789464|NCT04981912|Rituximab|rituximab|mesh-list
1789465|NCT04981912|Venetoclax|venetoclax|mesh-list
1789466|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1789467|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789468|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
1789469|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789470|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1789471|NCT04982016|Methamphetamine|methamphetamine|mesh-list
1789472|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1789473|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789474|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
1789475|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
1789476|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789477|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
1789478|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1789479|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789480|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
1789481|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1789482|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1789483|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1789484|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1789487|NCT04981899|Carboplatin|carboplatin|mesh-list
1789488|NCT04981899|Nivolumab|nivolumab|mesh-list
1789489|NCT04981899|Etoposide|etoposide|mesh-list
1789490|NCT04981899|Ifosfamide|ifosfamide|mesh-list
1789491|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789492|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1789493|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1789494|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789495|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1789496|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1789497|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1789498|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789499|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1789500|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
1789501|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
1789502|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1789503|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1789504|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789505|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1789506|NCT04981951|Analgesics|analgesics|mesh-ancestor
1789507|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
1789508|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789509|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1789510|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1789511|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1789512|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
1789513|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1789514|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789515|NCT04982237|Paclitaxel|paclitaxel|mesh-list
1789516|NCT04982237|Bevacizumab|bevacizumab|mesh-list
1789517|NCT04982237|Carboplatin|carboplatin|mesh-list
1789518|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1789519|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789520|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
1789521|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
1789522|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
1789523|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789524|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1789525|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1789526|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1789527|NCT04982237|Growth Substances|growth substances|mesh-ancestor
1789528|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789529|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
1789530|NCT04981886|Bimatoprost|bimatoprost|mesh-list
1789531|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1789532|NCT04982055|Nadroparin|nadroparin|mesh-list
1789533|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
1789534|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1789535|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1789536|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789537|NCT04981743|Vitamin D|vitamin d|mesh-list
1789538|NCT04981743|Vitamins|vitamins|mesh-ancestor
1789539|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
1789540|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789541|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1789542|NCT04982172|Infliximab|infliximab|mesh-list
1789543|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
1789544|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1789545|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1789546|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
1789547|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1789548|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
1789549|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789550|NCT04982146|Expectorants|expectorants|mesh-ancestor
1789551|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
1789552|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1789553|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
1789554|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789555|NCT04982146|Protective Agents|protective agents|mesh-ancestor
1789556|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789557|NCT04982146|Antidotes|antidotes|mesh-ancestor
1789558|NCT04981457|Misoprostol|misoprostol|mesh-list
1789559|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1789560|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
1789561|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1789562|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789563|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1789564|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1789565|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
1789566|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
1789567|NCT04981860|Povidone|povidone|mesh-list
1789568|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
1789569|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
1789570|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1789571|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789572|NCT04981327|Apixaban|apixaban|mesh-list
1789573|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1789574|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
1789575|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1789576|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
1789577|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789578|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789579|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
1789580|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
1789581|NCT04981379|Favipiravir|favipiravir|mesh-list
1789582|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
1789583|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1789584|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1789585|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789586|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789587|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789588|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1789589|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
1789590|NCT04981392|Vaccines|vaccines|mesh-list
1789591|NCT04981392|Immunologic Factors|immunologic factors|mesh-ancestor
1789592|NCT04981392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789593|NCT04981704|Itraconazole|itraconazole|mesh-list
1789594|NCT04981704|Phenytoin|phenytoin|mesh-list
1789595|NCT04981704|Paroxetine|paroxetine|mesh-list
1789596|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
1789597|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789598|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1789599|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1789600|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789601|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789602|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1789603|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
1789604|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789605|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789606|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1789607|NCT04981704|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1789608|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1789609|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1789610|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1789611|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
1789612|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1789613|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
1789614|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1789615|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1789616|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
1789617|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1789618|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1789619|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1789620|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1789621|NCT04981067|Ropivacaine|ropivacaine|mesh-list
1789622|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
1789623|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
1789624|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1789625|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789626|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
1789627|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789628|NCT04982211|Propranolol|propranolol|mesh-list
1789629|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1789630|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1789631|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
1789632|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1789633|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789634|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789635|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1789636|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1789637|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
1789638|NCT04981093|Dexamethasone|dexamethasone|mesh-list
1789639|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
1789640|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1789641|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
1789642|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
1789643|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789644|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789645|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1789646|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
1789647|NCT04981093|Hormones|hormones|mesh-ancestor
1789648|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789649|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1789650|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789651|NCT04981158|Anesthetics|anesthetics|mesh-list
1789652|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
1789653|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1789654|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789655|NCT04981041|Clopidogrel|clopidogrel|mesh-list
1789656|NCT04981041|Ticagrelor|ticagrelor|mesh-list
1789657|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1789658|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1789659|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1789660|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1789661|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1789662|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
1789663|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1789664|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789665|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789666|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
1789667|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
1789668|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1789669|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1789670|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789671|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789672|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789673|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1789674|NCT04980885|Azacitidine|azacitidine|mesh-list
1789675|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1789676|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
1789677|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789678|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789679|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789690|NCT04980404|Decitabine|decitabine|mesh-list
1789691|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1789692|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
1789693|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789694|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789695|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789696|NCT04980170|Amoxicillin|amoxicillin|mesh-list
1789697|NCT04980170|Clindamycin|clindamycin|mesh-list
1789698|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
1789699|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
1789700|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1789701|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
1789702|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
1789703|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1789704|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789705|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1789706|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789707|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789708|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1789709|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
1789710|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1789711|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1789712|NCT04980105|Prednisolone|prednisolone|mesh-list
1789713|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
1789714|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1789715|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
1789716|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
1789717|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1789718|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
1789719|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
1789720|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789721|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789722|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1789723|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
1789724|NCT04980105|Hormones|hormones|mesh-ancestor
1789725|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789726|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1789727|NCT04980105|Protective Agents|protective agents|mesh-ancestor
1789728|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1789729|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789730|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1789731|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
1789732|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
1789733|NCT04980040|Alogliptin|alogliptin|mesh-list
1789734|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1789735|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789736|NCT04980040|Incretins|incretins|mesh-ancestor
1789737|NCT04980040|Hormones|hormones|mesh-ancestor
1789738|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789739|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1789740|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
1789741|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789742|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789743|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
1789744|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1789745|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1789749|NCT04979663|Gemcitabine|gemcitabine|mesh-list
1789750|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
1789751|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1789752|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
1789753|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789754|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789755|NCT04979663|Antiviral Agents|antiviral agents|mesh-ancestor
1789756|NCT04979663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789757|NCT04979663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789758|NCT04979663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1789759|NCT04979663|Immunologic Factors|immunologic factors|mesh-ancestor
1789760|NCT04979663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789761|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
1789762|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1789763|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1789764|NCT04979650|Prednisolone|prednisolone|mesh-list
1789765|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
1789766|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1789767|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
1789768|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1789769|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
1789770|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
1789771|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789772|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789773|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1789774|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
1789775|NCT04979650|Hormones|hormones|mesh-ancestor
1789776|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789777|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1789778|NCT04979650|Protective Agents|protective agents|mesh-ancestor
1789779|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1789780|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789781|NCT04979611|Exenatide|exenatide|mesh-list
1789782|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1789783|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789784|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1789785|NCT04979611|Incretins|incretins|mesh-ancestor
1789786|NCT04979611|Hormones|hormones|mesh-ancestor
1789787|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789788|NCT04979585|Paclitaxel|paclitaxel|mesh-list
1789789|NCT04979585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1789790|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1789791|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789792|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
1789793|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
1789794|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
1789795|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789796|NCT04979884|Cyclosporine|cyclosporine|mesh-list
1789797|NCT04979884|Interleukin-2|interleukin-2|mesh-list
1789798|NCT04979884|Cyclosporins|cyclosporins|mesh-list
1789799|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789800|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789801|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1789802|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
1789803|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789804|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
1789805|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789806|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
1789807|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1789808|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1789809|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789810|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1789811|NCT04979884|Analgesics|analgesics|mesh-ancestor
1789812|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
1789813|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789814|NCT04979832|Metronidazole|metronidazole|mesh-list
1789815|NCT04979832|Fosfomycin|fosfomycin|mesh-list
1789816|NCT04979832|Molgramostim|molgramostim|mesh-list
1789817|NCT04979832|Sargramostim|sargramostim|mesh-list
1789818|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789819|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1789820|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1789821|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1789822|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
1789823|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789824|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789825|NCT04979923|Lidocaine|lidocaine|mesh-list
1789826|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
1789827|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
1789828|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1789829|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789830|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
1789831|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789832|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1789833|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1789834|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1789835|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1789836|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789837|NCT04979468|Lamivudine|lamivudine|mesh-list
1789838|NCT04979468|Dolutegravir|dolutegravir|mesh-list
1789839|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1789840|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1789841|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789842|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789843|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
1789844|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789845|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1789846|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1789847|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1789848|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1789849|NCT04979520|Brodalumab|brodalumab|mesh-list
1789850|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
1789851|NCT04979273|Epinephrine|epinephrine|mesh-list
1789852|NCT04979273|Racepinephrine|racepinephrine|mesh-list
1789853|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
1789854|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1789855|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1789856|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
1789857|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1789858|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789859|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789860|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1789861|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1789862|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
1789863|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789864|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1789865|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
1789866|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
1789867|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
1789868|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1789869|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
1789870|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
1789871|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
1789872|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1789873|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1789874|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
1789875|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
1789876|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1789877|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789878|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789879|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1789880|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
1789881|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1789882|NCT04979091|Hormones|hormones|mesh-list
1789883|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789884|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789885|NCT04979338|Bupivacaine|bupivacaine|mesh-list
1789886|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
1789887|NCT04979338|Anesthetics|anesthetics|mesh-list
1789888|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1789889|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789890|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
1789891|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1789892|NCT04979377|Insulin|insulin|mesh-list
1789893|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1789894|NCT04979377|Hormones|hormones|mesh-list
1789895|NCT04979377|Testosterone|testosterone|mesh-list
1789896|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
1789897|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1789898|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789899|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789900|NCT04979377|Androgens|androgens|mesh-ancestor
1789901|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1789902|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
1789903|NCT04979065|Vitamin D|vitamin d|mesh-list
1789904|NCT04979065|Vitamins|vitamins|mesh-ancestor
1789905|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
1789906|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789907|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1789913|NCT04978675|Fluorides|fluorides|mesh-list
1789914|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
1789915|NCT04978675|Protective Agents|protective agents|mesh-ancestor
1789916|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789917|NCT04978688|Relugolix|relugolix|mesh-list
1789918|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
1789919|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
1789920|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789921|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789922|NCT04978649|Amlodipine|amlodipine|mesh-list
1789923|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1789924|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1789925|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1789926|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789927|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1789928|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789929|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
1789930|NCT04978597|Opicapone|opicapone|mesh-list
1789931|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1789932|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789933|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789934|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1789935|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1789936|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
1789937|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1789938|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789939|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
1789940|NCT04978584|Prednisone|prednisone|mesh-list
1789941|NCT04978584|Cortisone|cortisone|mesh-list
1789942|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
1789943|NCT04978584|Rituximab|rituximab|mesh-list
1789944|NCT04978584|Doxorubicin|doxorubicin|mesh-list
1789945|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1789946|NCT04978584|Vincristine|vincristine|mesh-list
1789947|NCT04978584|Lenalidomide|lenalidomide|mesh-list
1789948|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
1789949|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1789950|NCT04978584|Antibodies|antibodies|mesh-list
1789951|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
1789952|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1789953|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1789954|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
1789955|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789956|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1789957|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1789958|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
1789959|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789960|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1789961|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1789962|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1789963|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1789964|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1789965|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789966|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1789967|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
1789968|NCT04978584|Hormones|hormones|mesh-ancestor
1789969|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789970|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1790048|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1789971|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1789972|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
1789973|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
1789974|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
1789975|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1789976|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1789977|NCT04978584|Growth Substances|growth substances|mesh-ancestor
1789978|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
1789979|NCT04978272|Piperaquine|piperaquine|mesh-list
1789980|NCT04978272|Artenimol|artenimol|mesh-list
1789981|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
1789982|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1789983|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1789984|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1789985|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1789986|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1789987|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1789988|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1789989|NCT04977960|Canrenone|canrenone|mesh-list
1789990|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
1789991|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1789992|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
1789993|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1789994|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1789995|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1789996|NCT04977960|Diuretics|diuretics|mesh-ancestor
1789997|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
1789998|NCT04978155|Anesthetics|anesthetics|mesh-list
1789999|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1790000|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790001|NCT04978038|Vaccines|vaccines|mesh-list
1790002|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1790003|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
1790004|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790005|NCT04977778|Fluorides|fluorides|mesh-list
1790006|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
1790007|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
1790008|NCT04977778|Protective Agents|protective agents|mesh-ancestor
1790009|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790010|NCT04977674|Naltrexone|naltrexone|mesh-list
1790011|NCT04977674|Ketamine|ketamine|mesh-list
1790012|NCT04977674|Analgesics|analgesics|mesh-ancestor
1790013|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
1790014|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790015|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790016|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1790017|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1790018|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
1790019|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
1790020|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1790021|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1790022|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1790023|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790024|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790025|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1790026|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1790027|NCT04977908|Insulin|insulin|mesh-list
1790028|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1790029|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790030|NCT04977830|Xenon|xenon|mesh-list
1790031|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1790032|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
1790033|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
1790034|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1790035|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790036|NCT04977661|Vitamin E|vitamin e|mesh-list
1790037|NCT04977661|Tocopherols|tocopherols|mesh-list
1790038|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
1790039|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
1790040|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1790041|NCT04977661|Vitamins|vitamins|mesh-ancestor
1790042|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
1790043|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790044|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
1790045|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790046|NCT04977661|Protective Agents|protective agents|mesh-ancestor
1790047|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1790049|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1790050|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1790051|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
1790052|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1790053|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1790054|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1790055|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1790056|NCT04977791|Antibodies|antibodies|mesh-list
1790057|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1790058|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
1790059|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790060|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790061|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790062|NCT04978051|Icatibant|icatibant|mesh-list
1790063|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1790064|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1790065|NCT04978051|Analgesics|analgesics|mesh-ancestor
1790066|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
1790067|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790068|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790069|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1790070|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1790071|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
1790072|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
1790073|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790074|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1790075|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1790076|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
1790077|NCT04977427|Prednisolone|prednisolone|mesh-list
1790078|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1790079|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
1790080|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1790081|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
1790082|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1790083|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
1790084|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1790085|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
1790086|NCT04977427|Hormones|hormones|mesh-ancestor
1790087|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1790088|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790089|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1790090|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790091|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
1790092|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
1790093|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790094|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1790095|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1790096|NCT04977427|Protective Agents|protective agents|mesh-ancestor
1790097|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
1790098|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1790099|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790100|NCT04977336|Acetaminophen|acetaminophen|mesh-list
1790101|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1790102|NCT04977336|Analgesics|analgesics|mesh-ancestor
1790103|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
1790104|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790105|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790106|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
1790107|NCT04977544|Sertraline|sertraline|mesh-list
1790108|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
1790109|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1790110|NCT04977544|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1790111|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1790112|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1790113|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790114|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790115|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
1790116|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790128|NCT04977401|Glycerol|glycerol|mesh-list
1790129|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1790130|NCT04977401|Protective Agents|protective agents|mesh-ancestor
1790131|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790132|NCT04977557|Thiamine|thiamine|mesh-list
1790133|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
1790134|NCT04977557|Vitamins|vitamins|mesh-ancestor
1790135|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
1790136|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790137|NCT04977167|Antibodies|antibodies|mesh-list
1790138|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
1790139|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790140|NCT04977388|Droxidopa|droxidopa|mesh-list
1790141|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1790142|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1790143|NCT04976816|Triamcinolone|triamcinolone|mesh-list
1790144|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1790145|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1790146|NCT04976816|Betamethasone|betamethasone|mesh-list
1790147|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
1790148|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
1790149|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
1790150|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
1790151|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1790152|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1790153|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
1790154|NCT04976816|Hormones|hormones|mesh-ancestor
1790155|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1790156|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790157|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1790158|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
1790159|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790160|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790161|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1790162|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
1790163|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
1790164|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1790165|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1790166|NCT04976868|Analgesics|analgesics|mesh-ancestor
1790167|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
1790168|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790169|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790170|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1790171|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1790172|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
1790173|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1790174|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
1790175|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1790176|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790177|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790190|NCT04976673|Triamcinolone|triamcinolone|mesh-list
1790191|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1790192|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1790193|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1790194|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1790195|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
1790196|NCT04976673|Hormones|hormones|mesh-ancestor
1790197|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1790198|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790199|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1790200|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
1790201|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790202|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790203|NCT04976543|Heparin|heparin|mesh-list
1790204|NCT04976543|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1790205|NCT04976543|Tinzaparin|tinzaparin|mesh-list
1790206|NCT04976543|Dalteparin|dalteparin|mesh-list
1790207|NCT04976543|Warfarin|warfarin|mesh-list
1790208|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
1790209|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1790210|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1790211|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790212|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1790213|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1790214|NCT04976855|Buprenorphine|buprenorphine|mesh-list
1790215|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1790216|NCT04976855|Naloxone|naloxone|mesh-list
1790217|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1790218|NCT04976855|Narcotics|narcotics|mesh-ancestor
1790219|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1790220|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790221|NCT04976855|Analgesics|analgesics|mesh-ancestor
1790222|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
1790223|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790224|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1790225|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
1790226|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1790227|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790228|NCT04976088|Diclofenac|diclofenac|mesh-list
1790229|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
1790230|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1790231|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1790232|NCT04976088|Analgesics|analgesics|mesh-ancestor
1790233|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
1790234|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790235|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790236|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1790237|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1790238|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1790239|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790240|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790245|NCT04976036|Nintedanib|nintedanib|mesh-list
1790246|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790247|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1790248|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790249|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790250|NCT04976283|Pioglitazone|pioglitazone|mesh-list
1790251|NCT04976283|Empagliflozin|empagliflozin|mesh-list
1790252|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1790253|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790254|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1790255|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790256|NCT04975802|Caffeine|caffeine|mesh-list
1790257|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1790258|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790259|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1790260|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790261|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790262|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1790263|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1790264|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
1790265|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790266|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
1790267|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1790268|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1790276|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
1790277|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1790278|NCT04975932|Estrogens|estrogens|mesh-ancestor
1790279|NCT04975932|Hormones|hormones|mesh-ancestor
1790280|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1790281|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790282|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1790283|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790287|NCT04975971|Dexamethasone|dexamethasone|mesh-list
1790288|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1790289|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
1790290|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
1790291|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790292|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790293|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1790294|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
1790295|NCT04975971|Hormones|hormones|mesh-ancestor
1790296|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1790297|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1790298|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790299|NCT04975724|Citalopram|citalopram|mesh-list
1790300|NCT04975724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1790301|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1790302|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1790303|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790304|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790305|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
1790306|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790307|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1790308|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
1790309|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1790310|NCT04975269|Acetazolamide|acetazolamide|mesh-list
1790311|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
1790312|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1790313|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790314|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790315|NCT04975269|Diuretics|diuretics|mesh-ancestor
1790316|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
1790317|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790318|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
1790319|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1790320|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
1790321|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790322|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
1790323|NCT04975373|Protective Agents|protective agents|mesh-ancestor
1790324|NCT04975360|Caffeine|caffeine|mesh-list
1790325|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1790326|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790327|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1790328|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790329|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790330|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1790331|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1790332|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
1790333|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790336|NCT04975022|Insulin|insulin|mesh-list
1790337|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1790338|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790342|NCT04975074|Iron|iron|mesh-list
1790343|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
1790344|NCT04975074|Trace Elements|trace elements|mesh-ancestor
1790345|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
1790346|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790347|NCT04975074|Hematinics|hematinics|mesh-ancestor
1790348|NCT04974827|Carboplatin|carboplatin|mesh-list
1790349|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790350|NCT04974723|Teriparatide|teriparatide|mesh-list
1790351|NCT04974723|Abaloparatide|abaloparatide|mesh-list
1790352|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1790353|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790354|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1790355|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
1790356|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
1790357|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790358|NCT04974944|Paclitaxel|paclitaxel|mesh-list
1790359|NCT04974944|Bevacizumab|bevacizumab|mesh-list
1790360|NCT04974944|Carboplatin|carboplatin|mesh-list
1790361|NCT04974944|Apatinib|apatinib|mesh-list
1790362|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1790363|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790364|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
1790365|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
1790366|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
1790367|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790368|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1790369|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1790370|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1790371|NCT04974944|Growth Substances|growth substances|mesh-ancestor
1790372|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790373|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
1790374|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1790375|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790376|NCT04974580|Nicotine|nicotine|mesh-list
1790377|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1790378|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
1790379|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790380|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790381|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1790382|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1790383|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
1790384|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790385|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790386|NCT04974814|Atorvastatin|atorvastatin|mesh-list
1790387|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1790388|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1790389|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1790390|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
1790391|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790392|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1790393|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1790394|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790395|NCT04974684|Apixaban|apixaban|mesh-list
1790396|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1790397|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
1790398|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1790399|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
1790400|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790401|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790402|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
1790403|NCT04974281|Lenvatinib|lenvatinib|mesh-list
1790404|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790405|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1790406|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790407|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790408|NCT04974385|Bupivacaine|bupivacaine|mesh-list
1790409|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
1790410|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
1790411|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1790412|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790413|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
1790414|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790415|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1790416|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
1790417|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790418|NCT04974398|Gemcitabine|gemcitabine|mesh-list
1790419|NCT04974398|Cisplatin|cisplatin|mesh-list
1790420|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790421|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1790422|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
1790423|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790424|NCT04974398|Antiviral Agents|antiviral agents|mesh-ancestor
1790425|NCT04974398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1790426|NCT04974398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790427|NCT04974398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1790428|NCT04974398|Immunologic Factors|immunologic factors|mesh-ancestor
1790429|NCT04974398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790430|NCT04974151|Folic Acid|folic acid|mesh-list
1790431|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-list
1790432|NCT04974151|Amlodipine|amlodipine|mesh-list
1790433|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1790434|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1790435|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1790436|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790437|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1790438|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790439|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
1790440|NCT04974151|Hematinics|hematinics|mesh-ancestor
1790441|NCT04974151|Vitamins|vitamins|mesh-ancestor
1790442|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
1790443|NCT04974060|Remifentanil|remifentanil|mesh-list
1790444|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1790445|NCT04974060|Narcotics|narcotics|mesh-ancestor
1790446|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1790447|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790448|NCT04974060|Analgesics|analgesics|mesh-ancestor
1790449|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
1790450|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790451|NCT04974138|Folic Acid|folic acid|mesh-list
1790452|NCT04974138|Amlodipine|amlodipine|mesh-list
1790453|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1790454|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1790455|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1790456|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790457|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1790458|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790459|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
1790460|NCT04974138|Hematinics|hematinics|mesh-ancestor
1790461|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
1790462|NCT04974138|Vitamins|vitamins|mesh-ancestor
1790463|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
1790475|NCT04973982|Tacrolimus|tacrolimus|mesh-list
1790476|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1790477|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
1790478|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790479|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1790480|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790481|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790482|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1790483|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
1790484|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1790485|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
1790486|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1790487|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790488|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1790489|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1790490|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790491|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
1790572|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1790500|NCT04973904|Paclitaxel|paclitaxel|mesh-list
1790501|NCT04973904|Bevacizumab|bevacizumab|mesh-list
1790502|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1790503|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790504|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
1790505|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
1790506|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
1790507|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790508|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1790509|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1790510|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1790511|NCT04973904|Growth Substances|growth substances|mesh-ancestor
1790512|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790513|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
1790514|NCT04973605|Dexamethasone|dexamethasone|mesh-list
1790515|NCT04973605|Dexamethasone acetate|dexamethasone acetate|mesh-list
1790516|NCT04973605|BB 1101|bb 1101|mesh-list
1790517|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1790518|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
1790519|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
1790520|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790521|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790522|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1790523|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
1790524|NCT04973605|Hormones|hormones|mesh-ancestor
1790525|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1790526|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1790527|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790528|NCT04973605|Protease Inhibitors|protease inhibitors|mesh-ancestor
1790529|NCT04973605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790530|NCT04973605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790531|NCT04973462|Oseltamivir|oseltamivir|mesh-list
1790532|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
1790533|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1790534|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790535|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790536|NCT04973722|Denosumab|denosumab|mesh-list
1790537|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1790538|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790539|NCT04973579|Anesthetics|anesthetics|mesh-list
1790540|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1790541|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790545|NCT04973033|Tofacitinib|tofacitinib|mesh-list
1790546|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1790547|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790548|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790549|NCT04973319|Trastuzumab|trastuzumab|mesh-list
1790550|NCT04973319|Pertuzumab|pertuzumab|mesh-list
1790551|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1790552|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790553|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
1790554|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1790555|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1790556|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790557|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1790558|NCT04973124|Analgesics|analgesics|mesh-ancestor
1790559|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
1790560|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790561|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1790562|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1790563|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1790564|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
1790565|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790566|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790567|NCT04972942|Daratumumab|daratumumab|mesh-list
1790568|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790569|NCT04973293|Bevacizumab|bevacizumab|mesh-list
1790570|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1790571|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790573|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1790574|NCT04973293|Growth Substances|growth substances|mesh-ancestor
1790575|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790576|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
1790577|NCT04972656|Ambrisentan|ambrisentan|mesh-list
1790578|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1790579|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
1790580|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1790581|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
1790582|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790583|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
1790584|NCT04972383|Protective Agents|protective agents|mesh-ancestor
1790585|NCT04972617|Furosemide|furosemide|mesh-list
1790586|NCT04972617|Diuretics|diuretics|mesh-ancestor
1790587|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
1790588|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790589|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1790590|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1790591|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790592|NCT04972292|Dipyrone|dipyrone|mesh-list
1790593|NCT04972292|Codeine|codeine|mesh-list
1790594|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1790595|NCT04972292|Narcotics|narcotics|mesh-ancestor
1790596|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1790597|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790598|NCT04972292|Analgesics|analgesics|mesh-ancestor
1790599|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
1790600|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790601|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
1790602|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
1790603|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1790604|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1790605|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1790606|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1790607|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
1790608|NCT04972123|Phenylephrine|phenylephrine|mesh-list
1790609|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
1790610|NCT04972123|Caffeine|caffeine|mesh-list
1790611|NCT04972123|Capsaicin|capsaicin|mesh-list
1790612|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1790613|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790614|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1790615|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790616|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790617|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1790618|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1790619|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
1790620|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790621|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1790622|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
1790623|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
1790624|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790625|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
1790626|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1790627|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
1790628|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
1790629|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1790630|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1790631|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1790632|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
1790633|NCT04972123|Protective Agents|protective agents|mesh-ancestor
1790634|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
1790635|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
1790636|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
1790637|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
1790638|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1790639|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790640|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
1790641|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1790642|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
1790643|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790644|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790645|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1790646|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
1790647|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1790648|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
1791167|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
1790649|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790650|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790651|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1790652|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
1790653|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
1790654|NCT04972513|Protective Agents|protective agents|mesh-ancestor
1790655|NCT04972552|Ubiquinone|ubiquinone|mesh-list
1790656|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
1790657|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
1790658|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790659|NCT04972552|Vitamins|vitamins|mesh-ancestor
1790660|NCT04972032|Estrogens|estrogens|mesh-list
1790661|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
1790662|NCT04972032|Hormones|hormones|mesh-ancestor
1790663|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1790664|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790665|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1790666|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
1790667|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
1790668|NCT04972032|Protective Agents|protective agents|mesh-ancestor
1790669|NCT04971954|Nicotine|nicotine|mesh-list
1790670|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1790671|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
1790672|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790673|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790674|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1790675|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1790676|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
1790677|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790678|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790679|NCT04972045|Curcumin|curcumin|mesh-list
1790680|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1790681|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1790682|NCT04972045|Analgesics|analgesics|mesh-ancestor
1790683|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
1790684|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790685|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790686|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1790687|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1790688|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790689|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790690|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790693|NCT04971759|Fentanyl|fentanyl|mesh-list
1790694|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
1790695|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
1790696|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1790697|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1790698|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790699|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1790700|NCT04971759|Analgesics|analgesics|mesh-ancestor
1790701|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
1790702|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790703|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1790704|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1790705|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1790706|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
1790707|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790708|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790709|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1790710|NCT04971759|Narcotics|narcotics|mesh-ancestor
1790711|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1790712|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1790713|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
1790714|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
1790715|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
1790721|NCT04971343|Antibodies|antibodies|mesh-list
1790722|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
1790723|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
1790724|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791168|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1790731|NCT04971356|Aspirin|aspirin|mesh-list
1790732|NCT04971356|Ticagrelor|ticagrelor|mesh-list
1790733|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1790734|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1790735|NCT04971356|Analgesics|analgesics|mesh-ancestor
1790736|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
1790737|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790738|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790739|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1790740|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1790741|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1790742|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1790743|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790744|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1790745|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1790746|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790747|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
1790748|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1790749|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1790750|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1790751|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
1790752|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790753|NCT04971382|Curcumin|curcumin|mesh-list
1790754|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1790755|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1790756|NCT04971382|Analgesics|analgesics|mesh-ancestor
1790757|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
1790758|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790759|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790760|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1790761|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1790762|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790763|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790764|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790768|NCT04971577|Simvastatin|simvastatin|mesh-list
1790769|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1790770|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1790771|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
1790772|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790773|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1790774|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1790775|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790776|NCT04971304|Sargramostim|sargramostim|mesh-list
1790777|NCT04971304|Lenograstim|lenograstim|mesh-list
1790778|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
1790779|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790780|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1790781|NCT04971291|Bupropion|bupropion|mesh-list
1790782|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1790783|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
1790784|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1790785|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1790786|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1790787|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1790788|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790789|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
1790790|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790791|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790792|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1790793|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1790794|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790795|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
1790796|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
1790797|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1790798|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790799|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
1790800|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790803|NCT04971239|Methotrexate|methotrexate|mesh-list
1790804|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1790805|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
1790806|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1790807|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790808|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1790809|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
1790810|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790811|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790812|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
1790813|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790814|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1790815|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1790816|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
1790817|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1790818|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1790819|NCT04970719|Remdesivir|remdesivir|mesh-list
1790820|NCT04970719|Dexamethasone|dexamethasone|mesh-list
1790821|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
1790822|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1790823|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
1790824|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
1790825|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790826|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790827|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1790828|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
1790829|NCT04970719|Hormones|hormones|mesh-ancestor
1790830|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1790831|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1790832|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790833|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
1790834|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790835|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
1790836|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1790837|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1790838|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790839|NCT04970576|Warfarin|warfarin|mesh-list
1790840|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
1790841|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
1790842|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1790843|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
1790844|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1790845|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
1790846|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790847|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790848|NCT04970667|Flupenthixol|flupenthixol|mesh-list
1790849|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
1790850|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1790851|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1790852|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1790853|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790854|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1790855|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1790856|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
1790857|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790858|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790859|NCT04970602|Methylene Blue|methylene blue|mesh-list
1790860|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790861|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790862|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1790863|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1790864|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
1790865|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1790866|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1790867|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1790868|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1790869|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1790870|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790871|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
1790872|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790873|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790874|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1790875|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790876|NCT04970251|Aflibercept|aflibercept|mesh-list
1790877|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1790878|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1790879|NCT04970251|Growth Substances|growth substances|mesh-ancestor
1790880|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790881|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
1790882|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790883|NCT04970069|Analgesics|analgesics|mesh-list
1790884|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
1790885|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790886|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790894|NCT04970303|Methylphenidate|methylphenidate|mesh-list
1790895|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1790896|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790897|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1790898|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1790899|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1790900|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790901|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
1790902|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790903|NCT04970108|Empagliflozin|empagliflozin|mesh-list
1790904|NCT04970108|Telmisartan|telmisartan|mesh-list
1790905|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1790906|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1790907|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1790908|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790909|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1790910|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1790911|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790912|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1790913|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1790914|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1790915|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1790916|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790917|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790918|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790919|NCT04970121|Analgesics|analgesics|mesh-ancestor
1790920|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
1790921|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790922|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
1790923|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1790924|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
1790925|NCT04970329|Dextrans|dextrans|mesh-list
1790926|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
1790927|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
1790928|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
1790929|NCT04970238|Simendan|simendan|mesh-list
1790930|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1790931|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
1790932|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1790933|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1790934|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790935|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790936|NCT04970238|Protective Agents|protective agents|mesh-ancestor
1790937|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790938|NCT04970342|Alprazolam|alprazolam|mesh-list
1790939|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790940|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1790941|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790942|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790943|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1791245|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
1790944|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1790945|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1790946|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1790947|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
1790948|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
1790949|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
1790950|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1790951|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
1790952|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1790953|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
1790954|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790955|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790956|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
1790957|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
1790958|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
1790959|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790960|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790961|NCT04970043|Pemetrexed|pemetrexed|mesh-list
1790962|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1790963|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1790964|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790965|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1790966|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1790967|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
1790968|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1790969|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1790970|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790971|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1790972|NCT04969705|Analgesics|analgesics|mesh-ancestor
1790973|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
1790974|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1790975|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1790976|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1790977|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1790978|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
1790979|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1790980|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1790981|NCT04969627|Metformin|metformin|mesh-list
1790982|NCT04969627|Exenatide|exenatide|mesh-list
1790983|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1790984|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790985|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1790986|NCT04969627|Incretins|incretins|mesh-ancestor
1790987|NCT04969627|Hormones|hormones|mesh-ancestor
1790988|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1790989|NCT04969263|Vaccines|vaccines|mesh-list
1790990|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
1790991|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790992|NCT04969237|Vitamin D|vitamin d|mesh-list
1790993|NCT04969237|Vitamins|vitamins|mesh-ancestor
1790994|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
1790995|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1790996|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1790997|NCT04969211|Iloperidone|iloperidone|mesh-list
1790998|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1790999|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1791000|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791001|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791002|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1791003|NCT04969276|Vaccines|vaccines|mesh-list
1791004|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
1791005|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791006|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
1791007|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1791008|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1791009|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
1791010|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791011|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791012|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791013|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
1791014|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
1791015|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
1791016|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791017|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791018|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
1791019|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1791037|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
1791038|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1791039|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
1791040|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791041|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791042|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
1791043|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791044|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791050|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
1791051|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
1791052|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1791053|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791054|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791055|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1791056|NCT04968392|Analgesics|analgesics|mesh-ancestor
1791057|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
1791058|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1791059|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1791060|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1791061|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1791062|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
1791063|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791064|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791065|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
1791066|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
1791067|NCT04968522|Methylphenidate|methylphenidate|mesh-list
1791068|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
1791069|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1791070|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791071|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1791072|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1791073|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1791074|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791075|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
1791076|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791077|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1791078|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1791079|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1791080|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
1791081|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791082|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791083|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1791084|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
1791085|NCT04968132|Narcotics|narcotics|mesh-ancestor
1791086|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791087|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791088|NCT04968132|Analgesics|analgesics|mesh-ancestor
1791089|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
1791090|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1791091|NCT04968002|Apatinib|apatinib|mesh-list
1791092|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791093|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1791094|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791095|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791096|NCT04967859|Gentamicins|gentamicins|mesh-list
1791097|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1791098|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791099|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1791100|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791101|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791102|NCT04968015|Cytarabine|cytarabine|mesh-list
1791103|NCT04968015|Venetoclax|venetoclax|mesh-list
1791104|NCT04968015|Idarubicin|idarubicin|mesh-list
1791105|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1791106|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
1791107|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791108|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791109|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
1791110|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791111|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1791112|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
1791113|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791114|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1791115|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1791116|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1791117|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791118|NCT04968054|Propofol|propofol|mesh-list
1791119|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1791120|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791121|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791122|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1791123|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
1791124|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
1791125|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
1791126|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1791127|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
1791128|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1791129|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
1791130|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791131|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791132|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
1791141|NCT04967469|Calcitriol|calcitriol|mesh-list
1791142|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
1791143|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
1791144|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1791145|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791146|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1791147|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1791148|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791149|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1791150|NCT04967469|Vitamins|vitamins|mesh-ancestor
1791151|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
1791152|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1791153|NCT04967950|Methotrexate|methotrexate|mesh-list
1791154|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1791155|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1791156|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
1791157|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1791158|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791159|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1791160|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
1791161|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791162|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791163|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
1791164|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791165|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1791166|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1791169|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1791170|NCT04967326|Carbamazepine|carbamazepine|mesh-list
1791171|NCT04967326|Phenytoin|phenytoin|mesh-list
1791172|NCT04967326|Valproic Acid|valproic acid|mesh-list
1791173|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
1791174|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791175|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791176|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
1791177|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791178|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791179|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
1791180|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1791181|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791182|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1791183|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1791184|NCT04967326|Analgesics|analgesics|mesh-ancestor
1791185|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
1791186|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1791187|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1791188|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1791189|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1791190|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1791191|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1791192|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1791193|NCT04967417|Paclitaxel|paclitaxel|mesh-list
1791194|NCT04967417|Carboplatin|carboplatin|mesh-list
1791195|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
1791196|NCT04967417|Pemetrexed|pemetrexed|mesh-list
1791197|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1791198|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791199|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
1791200|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
1791201|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
1791202|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791203|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1791204|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791205|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1791206|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1791207|NCT04967196|Nivolumab|nivolumab|mesh-list
1791208|NCT04967196|Ipilimumab|ipilimumab|mesh-list
1791209|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1791210|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791211|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1791212|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791213|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
1791215|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
1791216|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
1791222|NCT04967495|Sorafenib|sorafenib|mesh-list
1791223|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
1791224|NCT04967495|Lenvatinib|lenvatinib|mesh-list
1791225|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791226|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1791227|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791228|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791229|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1791230|NCT04967495|Estrogens|estrogens|mesh-ancestor
1791231|NCT04967495|Hormones|hormones|mesh-ancestor
1791232|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1791233|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791234|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1791235|NCT04966702|Ivermectin|ivermectin|mesh-list
1791236|NCT04966702|Albendazole|albendazole|mesh-list
1791237|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1791238|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791239|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
1791240|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
1791241|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1791242|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1791243|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
1791244|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
1791246|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791247|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791248|NCT04966676|Nivolumab|nivolumab|mesh-list
1791249|NCT04966676|Ipilimumab|ipilimumab|mesh-list
1791250|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1791251|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791252|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1791253|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791254|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
1791255|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
1791256|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791257|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
1791258|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791259|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791260|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
1791261|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1791262|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791263|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791264|NCT04966585|Posaconazole|posaconazole|mesh-list
1791265|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
1791266|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791267|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1791268|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1791269|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1791270|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1791271|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1791272|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791273|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791274|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1791275|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
1791276|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1791277|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791278|NCT04966546|Memantine|memantine|mesh-list
1791279|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1791280|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1791281|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
1791282|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791283|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791284|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791285|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1791286|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1791295|NCT04966507|Listerine|listerine|mesh-list
1791296|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
1791297|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791306|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
1791307|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
1791308|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791309|NCT04966299|Erythritol|erythritol|mesh-list
1791310|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
1791311|NCT04966234|Posaconazole|posaconazole|mesh-list
1791312|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
1791313|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791314|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1791315|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1791316|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1791317|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1791318|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1791319|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791320|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791321|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1791322|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
1791323|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1791324|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791325|NCT04966429|Maraviroc|maraviroc|mesh-list
1791326|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1791327|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1791328|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791329|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1791330|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1791331|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
1791332|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791333|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1791334|NCT04965870|Trifluridine|trifluridine|mesh-list
1791335|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
1791336|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791337|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
1791338|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791339|NCT04965818|Futibatinib|futibatinib|mesh-list
1791340|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791341|NCT04965831|Aflutinib|aflutinib|mesh-list
1791342|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1791343|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791344|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791345|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
1791346|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1791347|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791348|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1791349|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791353|NCT04965545|Copper|copper|mesh-list
1791354|NCT04965545|Trace Elements|trace elements|mesh-ancestor
1791355|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
1791356|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791357|NCT04965532|Anesthetics|anesthetics|mesh-list
1791358|NCT04965532|Propofol|propofol|mesh-list
1791359|NCT04965532|Sevoflurane|sevoflurane|mesh-list
1791360|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791361|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791362|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1791363|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1791364|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
1791365|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1791366|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1791367|NCT04965714|Nivolumab|nivolumab|mesh-list
1791368|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1791369|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791370|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1791371|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791372|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
1791373|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1791374|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791375|NCT04965701|Osimertinib|osimertinib|mesh-list
1791376|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791377|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1791378|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791379|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791380|NCT04965662|Tenofovir|tenofovir|mesh-list
1791381|NCT04965662|Emtricitabine|emtricitabine|mesh-list
1791382|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1791383|NCT04965662|Maraviroc|maraviroc|mesh-list
1791384|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
1791385|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791386|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1791387|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1791388|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791389|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791390|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1791391|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1791392|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1791393|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1791394|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1791395|NCT04965220|Trametinib|trametinib|mesh-list
1791396|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791397|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1791398|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791399|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791400|NCT04965181|Nicotine|nicotine|mesh-list
1791401|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1791402|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
1791403|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1791404|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791405|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1791406|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1791407|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
1791408|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791409|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791410|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
1791411|NCT04965116|Progestins|progestins|mesh-list
1791412|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1791413|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791414|NCT04965116|Hormones|hormones|mesh-ancestor
1791415|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1791416|NCT04965298|Lansoprazole|lansoprazole|mesh-list
1791417|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
1791418|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1791419|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1791420|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1791421|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791422|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791423|NCT04965324|Anesthetics|anesthetics|mesh-list
1791424|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791425|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791426|NCT04965051|Insulin|insulin|mesh-list
1791427|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1791428|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
1791429|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1791430|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791431|NCT04965077|Antibodies|antibodies|mesh-list
1791432|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1791433|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
1791434|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791435|NCT04965090|Lazertinib|lazertinib|mesh-list
1791436|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1791437|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791438|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791443|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
1791444|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1791445|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1791446|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1791447|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1791448|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1791449|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791450|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
1791451|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791452|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791453|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1791454|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1791475|NCT04964869|Epinephrine|epinephrine|mesh-list
1791476|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1791477|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1791478|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
1791479|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791480|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791481|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791482|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1791483|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1791484|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
1791485|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1791486|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1791487|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
1791488|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
1791489|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
1791490|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1791491|NCT04964947|Tobramycin|tobramycin|mesh-list
1791492|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1791493|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791494|NCT04964583|Azithromycin|azithromycin|mesh-list
1791495|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
1791496|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1791497|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791498|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
1791499|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1791500|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1791501|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791502|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791503|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1791507|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
1791508|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1791509|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791510|NCT04964505|Azacitidine|azacitidine|mesh-list
1791511|NCT04964505|Venetoclax|venetoclax|mesh-list
1791512|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1791513|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
1791514|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791515|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791516|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791520|NCT04964180|Indomethacin|indomethacin|mesh-list
1791521|NCT04964180|Lidocaine|lidocaine|mesh-list
1791522|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
1791523|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
1791524|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791525|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791526|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
1791527|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1791528|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1791529|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1791530|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1791531|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1791532|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791533|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1791534|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1791535|NCT04964180|Analgesics|analgesics|mesh-ancestor
1791536|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1791537|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1791538|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
1791539|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
1791540|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1791541|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1791542|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791546|NCT04964427|Methylphenidate|methylphenidate|mesh-list
1791547|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1791548|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791549|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1791550|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1791551|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1791552|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791553|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
1791554|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791555|NCT04964414|Budesonide|budesonide|mesh-list
1791556|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
1791557|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1791558|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1791559|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
1791560|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1791561|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791562|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1791563|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
1791564|NCT04964414|Hormones|hormones|mesh-ancestor
1791565|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1791584|NCT04964219|Ketamine|ketamine|mesh-list
1791585|NCT04964219|Esketamine|esketamine|mesh-list
1791586|NCT04964219|Analgesics|analgesics|mesh-ancestor
1791587|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
1791588|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1791589|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791590|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1791591|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1791592|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
1791593|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
1791594|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791595|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1791596|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1791597|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791598|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791599|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
1791600|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1791601|NCT04964089|Aflibercept|aflibercept|mesh-list
1791602|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1791603|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1791604|NCT04964089|Growth Substances|growth substances|mesh-ancestor
1791605|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791606|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
1791607|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791608|NCT04964024|Antibodies|antibodies|mesh-list
1791609|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
1791610|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791611|NCT04963998|Copper|copper|mesh-list
1791612|NCT04963998|Trace Elements|trace elements|mesh-ancestor
1791613|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
1791614|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791615|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
1791616|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791617|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791618|NCT04963764|Amoxicillin|amoxicillin|mesh-list
1791619|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1791620|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791621|NCT04963712|Thymalfasin|thymalfasin|mesh-list
1791622|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1791623|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
1791624|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791625|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
1791626|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
1791627|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1791628|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791629|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791630|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
1791631|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1791632|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791633|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791634|NCT04963881|Antibodies|antibodies|mesh-list
1791635|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
1791636|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791637|NCT04963595|Vinorelbine|vinorelbine|mesh-list
1791638|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1791639|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791640|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
1791641|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
1791642|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
1791643|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791644|NCT04963257|Aripiprazole|aripiprazole|mesh-list
1791645|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
1791646|NCT04963257|Sertraline|sertraline|mesh-list
1791647|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
1791648|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1791649|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1791650|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1791651|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791652|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791653|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
1791654|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
1791655|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791656|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791657|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1791658|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1791659|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
1791660|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1791661|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1791662|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1791663|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1791664|NCT04963257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1791665|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1791666|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1791667|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1791668|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1791669|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1791670|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1791671|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791672|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1791683|NCT04963088|Capecitabine|capecitabine|mesh-list
1791684|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
1791685|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1791686|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
1791687|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791688|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791689|NCT04963036|Anesthetics|anesthetics|mesh-list
1791690|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791691|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791692|NCT04962672|Anesthetics|anesthetics|mesh-list
1791693|NCT04962672|Propofol|propofol|mesh-list
1791694|NCT04962672|Sevoflurane|sevoflurane|mesh-list
1791695|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791696|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791697|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1791698|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1791699|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
1791700|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1791701|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1791702|NCT04962893|Vaccines|vaccines|mesh-list
1791703|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
1791704|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791705|NCT04962958|Leucovorin|leucovorin|mesh-list
1791706|NCT04962958|Fluorouracil|fluorouracil|mesh-list
1791707|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
1791708|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
1791709|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791710|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1791711|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791712|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1791713|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
1791714|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791715|NCT04962958|Antidotes|antidotes|mesh-ancestor
1791716|NCT04962958|Protective Agents|protective agents|mesh-ancestor
1791717|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
1791718|NCT04962958|Vitamins|vitamins|mesh-ancestor
1791719|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
1791720|NCT04962841|Metformin|metformin|mesh-list
1791721|NCT04962841|Amlodipine|amlodipine|mesh-list
1791722|NCT04962841|Ramipril|ramipril|mesh-list
1791723|NCT04962841|Nebivolol|nebivolol|mesh-list
1791724|NCT04962841|Rivastigmine|rivastigmine|mesh-list
1791725|NCT04962841|Sertraline|sertraline|mesh-list
1791726|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1791727|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791728|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1791729|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1791730|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1791731|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791732|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1791733|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
1791734|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
1791735|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1791736|NCT04962841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1791737|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1791738|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791739|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
1791740|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1791741|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
1791742|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791743|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1791744|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1791745|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1791746|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
1791747|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1791748|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
1791749|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1791750|NCT04962841|Protective Agents|protective agents|mesh-ancestor
1791751|NCT04962425|Trastuzumab|trastuzumab|mesh-list
1791752|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1791753|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791754|NCT04962451|Ticagrelor|ticagrelor|mesh-list
1791755|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1791756|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1791757|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1791758|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1791759|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
1791760|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791761|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791762|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791765|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1791766|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1791767|NCT04962386|Hormones|hormones|mesh-list
1791768|NCT04962386|Estradiol|estradiol|mesh-list
1791769|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1791770|NCT04962386|Progesterone|progesterone|mesh-list
1791771|NCT04962386|Estrogens|estrogens|mesh-list
1791772|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1791773|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791774|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1791775|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
1791776|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1791777|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1791778|NCT04962386|Progestins|progestins|mesh-ancestor
1791779|NCT04962308|Vaccines|vaccines|mesh-list
1791780|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
1791781|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791782|NCT04962438|Bevacizumab|bevacizumab|mesh-list
1791783|NCT04962438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1791784|NCT04962438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791785|NCT04962438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1791786|NCT04962438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1791787|NCT04962438|Growth Substances|growth substances|mesh-ancestor
1791788|NCT04962438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791789|NCT04962438|Growth Inhibitors|growth inhibitors|mesh-ancestor
1791790|NCT04962152|Nalbuphine|nalbuphine|mesh-list
1791791|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1791792|NCT04962152|Narcotics|narcotics|mesh-ancestor
1791793|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791794|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791795|NCT04962152|Analgesics|analgesics|mesh-ancestor
1791796|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
1791797|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1791798|NCT04961970|Leucovorin|leucovorin|mesh-list
1791799|NCT04961970|Gemcitabine|gemcitabine|mesh-list
1791800|NCT04961970|Fluorouracil|fluorouracil|mesh-list
1791801|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
1791802|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791803|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1791804|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
1791805|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791806|NCT04961970|Antiviral Agents|antiviral agents|mesh-ancestor
1791807|NCT04961970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791808|NCT04961970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791809|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1791810|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
1791811|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791812|NCT04961970|Antidotes|antidotes|mesh-ancestor
1791813|NCT04961970|Protective Agents|protective agents|mesh-ancestor
1791814|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
1791815|NCT04961970|Vitamins|vitamins|mesh-ancestor
1791816|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
1791817|NCT04961684|Amorolfine|amorolfine|mesh-list
1791818|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
1791819|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791820|NCT04961918|Durvalumab|durvalumab|mesh-list
1791821|NCT04961918|Lenvatinib|lenvatinib|mesh-list
1791822|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1791823|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791824|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1791825|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791826|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791827|NCT04961931|Empagliflozin|empagliflozin|mesh-list
1791828|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1791829|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791830|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1791831|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791832|NCT04961788|Antibodies|antibodies|mesh-list
1791833|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
1791834|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791835|NCT04961632|Tamoxifen|tamoxifen|mesh-list
1791836|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1791837|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
1791838|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1791839|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791840|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1791841|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791842|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1791843|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1791844|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1791845|NCT04961359|Vaccines|vaccines|mesh-list
1791846|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
1791847|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791848|NCT04961268|Acetaminophen|acetaminophen|mesh-list
1791849|NCT04961268|Ibuprofen|ibuprofen|mesh-list
1791850|NCT04961268|Tramadol|tramadol|mesh-list
1791851|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1791852|NCT04961268|Analgesics|analgesics|mesh-ancestor
1791853|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
1791854|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1791855|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791856|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
1791857|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1791858|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1791859|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1791860|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1791861|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791862|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791863|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1791864|NCT04961268|Narcotics|narcotics|mesh-ancestor
1791865|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791866|NCT04961554|Anesthetics|anesthetics|mesh-list
1791867|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791868|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791869|NCT04961502|Vaccines|vaccines|mesh-list
1791870|NCT04961502|Immunologic Factors|immunologic factors|mesh-ancestor
1791871|NCT04961502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791872|NCT04961307|Trastuzumab|trastuzumab|mesh-list
1791873|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1791874|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791875|NCT04961528|Terlipressin|terlipressin|mesh-list
1791876|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
1791877|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1791878|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1791879|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791880|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
1791881|NCT04961528|Coagulants|coagulants|mesh-ancestor
1791882|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1791883|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1791890|NCT04961138|Lenvatinib|lenvatinib|mesh-list
1791891|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791892|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1791893|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791894|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791895|NCT04960943|Trastuzumab|trastuzumab|mesh-list
1791896|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1791897|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791917|NCT04960618|Gemcitabine|gemcitabine|mesh-list
1791918|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
1791919|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1791920|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
1791921|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791922|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1791923|NCT04960618|Antiviral Agents|antiviral agents|mesh-ancestor
1791924|NCT04960618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791925|NCT04960618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791926|NCT04960618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1791927|NCT04960618|Immunologic Factors|immunologic factors|mesh-ancestor
1791928|NCT04960618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791929|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1791930|NCT04960657|Glyburide|glyburide|mesh-list
1791931|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
1791932|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1791933|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791934|NCT04960657|Growth Substances|growth substances|mesh-ancestor
1791935|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
1791936|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1791937|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791943|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
1791944|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
1791945|NCT04960293|Coagulants|coagulants|mesh-ancestor
1791951|NCT04959721|Triamcinolone|triamcinolone|mesh-list
1791952|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1791953|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1791954|NCT04959721|Bupivacaine|bupivacaine|mesh-list
1791955|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1791956|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
1791957|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
1791958|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791959|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791960|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
1791961|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1791962|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1791963|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
1791964|NCT04959721|Hormones|hormones|mesh-ancestor
1791965|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1791966|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1791967|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
1791968|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1791969|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791970|NCT04959825|Melatonin|melatonin|mesh-list
1791971|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
1791972|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791973|NCT04959825|Protective Agents|protective agents|mesh-ancestor
1791974|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791975|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791981|NCT04959786|Ribavirin|ribavirin|mesh-list
1791982|NCT04959786|Ivermectin|ivermectin|mesh-list
1791983|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
1791984|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
1791985|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1791986|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
1791987|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791988|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1791989|NCT04959799|Dalbavancin|dalbavancin|mesh-list
1791990|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1791991|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1791992|NCT04959812|Sufentanil|sufentanil|mesh-list
1791993|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1791994|NCT04959812|Narcotics|narcotics|mesh-ancestor
1791995|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1791996|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1791997|NCT04959812|Analgesics|analgesics|mesh-ancestor
1791998|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
1791999|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792000|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1792001|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1792002|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
1792003|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
1792004|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
1792005|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
1792006|NCT04959578|Hematinics|hematinics|mesh-ancestor
1792007|NCT04959591|Acetaminophen|acetaminophen|mesh-list
1792008|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1792009|NCT04959591|Analgesics|analgesics|mesh-ancestor
1792010|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
1792011|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792012|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792013|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
1792014|NCT04959331|Fosfomycin|fosfomycin|mesh-list
1792015|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
1792016|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
1792017|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1792018|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792019|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1792020|NCT04959331|Renal Agents|renal agents|mesh-ancestor
1792021|NCT04959253|Psilocybin|psilocybin|mesh-list
1792022|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
1792023|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792024|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1792025|NCT04959500|Temozolomide|temozolomide|mesh-list
1792026|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1792027|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
1792028|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792029|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792050|NCT04959409|Tetracaine|tetracaine|mesh-list
1792051|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
1792052|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
1792053|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1792054|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792055|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
1792056|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792057|NCT04959006|Antioxidants|antioxidants|mesh-list
1792058|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792059|NCT04959006|Protective Agents|protective agents|mesh-ancestor
1792060|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792061|NCT04958772|Lenograstim|lenograstim|mesh-list
1792062|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1792063|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
1792064|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792074|NCT04958746|Propofol|propofol|mesh-list
1792075|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1792076|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1792077|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792078|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1792079|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
1792080|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
1792081|NCT04958538|Methotrexate|methotrexate|mesh-list
1792082|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1792083|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
1792084|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1792085|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792086|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1792087|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
1792088|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792089|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792090|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
1792091|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792092|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1792093|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1792094|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
1792095|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1792096|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1792097|NCT04958486|Trastuzumab|trastuzumab|mesh-list
1792098|NCT04958486|Azacitidine|azacitidine|mesh-list
1792099|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1792100|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792101|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1792102|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
1792103|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792104|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792108|NCT04958187|Mitogens|mitogens|mesh-list
1792109|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
1792110|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792111|NCT04958473|Axitinib|axitinib|mesh-list
1792112|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792113|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1792114|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792115|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792116|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
1792117|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1792118|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792119|NCT04957940|SMOFlipid|smoflipid|mesh-list
1792120|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1792121|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1792122|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1792123|NCT04958122|Penicillins|penicillins|mesh-list
1792124|NCT04958122|Cefixime|cefixime|mesh-list
1792125|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
1792126|NCT04958122|Penicillin G|penicillin g|mesh-list
1792127|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
1792128|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1792129|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792130|NCT04957927|Fluticasone|fluticasone|mesh-list
1792131|NCT04957927|Xhance|xhance|mesh-list
1792132|NCT04957927|Montelukast|montelukast|mesh-list
1792133|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1792134|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1792135|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
1792136|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792137|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792138|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1792139|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
1792140|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
1792141|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1792142|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1792143|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
1792144|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1792145|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1792146|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1792147|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792155|NCT04957615|Nivolumab|nivolumab|mesh-list
1792156|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1792157|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792158|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1792159|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792160|NCT04957420|Rotigotine|rotigotine|mesh-list
1792161|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
1792162|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
1792163|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792164|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792165|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792187|NCT04957329|Latanoprost|latanoprost|mesh-list
1792188|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1792189|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1792190|NCT04957212|Carboplatin|carboplatin|mesh-list
1792191|NCT04957212|Docetaxel|docetaxel|mesh-list
1792192|NCT04957212|Trastuzumab|trastuzumab|mesh-list
1792193|NCT04957212|Pertuzumab|pertuzumab|mesh-list
1792194|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792195|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
1792196|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
1792197|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
1792198|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792199|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1792224|NCT04956939|Levodopa|levodopa|mesh-list
1792225|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1792226|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1792227|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
1792228|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792229|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792230|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792231|NCT04956432|Allopurinol|allopurinol|mesh-list
1792232|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
1792233|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792234|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792235|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
1792236|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1792237|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1792238|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
1792239|NCT04956432|Protective Agents|protective agents|mesh-ancestor
1792240|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792241|NCT04956419|Fluconazole|fluconazole|mesh-list
1792242|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
1792243|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792244|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1792245|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1792246|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792247|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792248|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1792249|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
1792250|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1792251|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792252|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1792253|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1792254|NCT04956705|Vitamin D|vitamin d|mesh-list
1792255|NCT04956705|Calcium|calcium|mesh-list
1792256|NCT04956705|Vitamins|vitamins|mesh-ancestor
1792257|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
1792258|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792259|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1792260|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1792261|NCT04956484|Belimumab|belimumab|mesh-list
1792262|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1792263|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
1792264|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792293|NCT04956094|Uric Acid|uric acid|mesh-list
1792294|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
1792295|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792296|NCT04956094|Protective Agents|protective agents|mesh-ancestor
1792297|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792298|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
1792299|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1792300|NCT04955678|Sorbitol|sorbitol|mesh-list
1792301|NCT04955678|Calcium|calcium|mesh-list
1792302|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1792303|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792304|NCT04955678|Cathartics|cathartics|mesh-ancestor
1792305|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1792306|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1792307|NCT04955574|Metronidazole|metronidazole|mesh-list
1792308|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1792309|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792310|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
1792311|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1792312|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1792313|NCT04955834|Insulin|insulin|mesh-list
1792314|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1792315|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792316|NCT04955470|Midazolam|midazolam|mesh-list
1792317|NCT04955470|Ketamine|ketamine|mesh-list
1792318|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1792319|NCT04955470|Analgesics|analgesics|mesh-ancestor
1792320|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
1792321|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792322|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792323|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1792324|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1792325|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
1792326|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
1792327|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1792328|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1792329|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1792330|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792331|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792332|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1792333|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1792334|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1792335|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1792336|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1792337|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
1792338|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
1792339|NCT04955262|Nivolumab|nivolumab|mesh-list
1792340|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1792341|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792342|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1792343|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792344|NCT04955366|Abatacept|abatacept|mesh-list
1792345|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1792346|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792347|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792348|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1792349|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
1792350|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792351|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1792352|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
1792353|NCT04954989|Hematinics|hematinics|mesh-ancestor
1792354|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
1792355|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
1792356|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
1792357|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792358|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792359|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1792360|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1792361|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
1792362|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
1792363|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792364|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792365|NCT04954742|Riociguat|riociguat|mesh-list
1792366|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
1792367|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792371|NCT04954560|Losartan|losartan|mesh-list
1792372|NCT04954560|Eprosartan|eprosartan|mesh-list
1792373|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1792374|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1792375|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1792376|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1792377|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792378|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
1792379|NCT04954599|Carboplatin|carboplatin|mesh-list
1792380|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
1792381|NCT04954599|Nivolumab|nivolumab|mesh-list
1792382|NCT04954599|Ipilimumab|ipilimumab|mesh-list
1792383|NCT04954599|Durvalumab|durvalumab|mesh-list
1792384|NCT04954599|Atezolizumab|atezolizumab|mesh-list
1792385|NCT04954599|Avelumab|avelumab|mesh-list
1792386|NCT04954599|Cemiplimab|cemiplimab|mesh-list
1792387|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1792388|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792389|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1792390|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792391|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
1792392|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
1792393|NCT04954638|Eusol|eusol|mesh-list
1792394|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
1792395|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792396|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
1792397|NCT04954365|Amisulpride|amisulpride|mesh-list
1792398|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1792399|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1792400|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1792401|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792402|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1792403|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1792404|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
1792405|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792406|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792407|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1792408|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
1792423|NCT04953754|Melatonin|melatonin|mesh-list
1792424|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
1792425|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792426|NCT04953754|Protective Agents|protective agents|mesh-ancestor
1792427|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792428|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1792429|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
1792430|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1792431|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792432|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1792433|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1792434|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792435|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792436|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792437|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
1792438|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1792439|NCT04953741|Fluticasone|fluticasone|mesh-list
1792440|NCT04953741|Xhance|xhance|mesh-list
1792441|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1792442|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1792443|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
1792444|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792445|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792446|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1792447|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
1792448|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
1792449|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1792450|NCT04954014|Bevacizumab|bevacizumab|mesh-list
1792451|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1792452|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792453|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1792454|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1792455|NCT04954014|Growth Substances|growth substances|mesh-ancestor
1792456|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792457|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
1792458|NCT04954040|Azithromycin|azithromycin|mesh-list
1792459|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
1792460|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1792461|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792462|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
1792463|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1792464|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1792465|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792466|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792467|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1792474|NCT04953325|Vaccines|vaccines|mesh-list
1792475|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1792476|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
1792477|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792478|NCT04953117|Paclitaxel|paclitaxel|mesh-list
1792479|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1792480|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792481|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
1792482|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
1792483|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
1792484|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792485|NCT04953130|Vaccines|vaccines|mesh-list
1792486|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
1792487|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792488|NCT04953104|Nivolumab|nivolumab|mesh-list
1792489|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1792490|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792491|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1792492|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792493|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
1792494|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
1792495|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1792496|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1792497|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792498|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1792499|NCT04953156|Analgesics|analgesics|mesh-ancestor
1792500|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
1792501|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792502|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1792503|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1792504|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1792505|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
1792506|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792507|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792508|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
1792509|NCT04952727|Vaccines|vaccines|mesh-list
1792510|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
1792511|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792519|NCT04952792|Apixaban|apixaban|mesh-list
1792520|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1792521|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
1792522|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1792523|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
1792524|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792525|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792526|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
1792537|NCT04952571|Bevacizumab|bevacizumab|mesh-list
1792538|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1792539|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792540|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1792541|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1792542|NCT04952571|Growth Substances|growth substances|mesh-ancestor
1792543|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792544|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
1792545|NCT04952519|Amantadine|amantadine|mesh-list
1792546|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1792547|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1792548|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
1792549|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792550|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
1792551|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792552|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792553|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792554|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1792555|NCT04952519|Analgesics|analgesics|mesh-ancestor
1792556|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
1792557|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792566|NCT04952194|Levodopa|levodopa|mesh-list
1792567|NCT04952194|Carbidopa|carbidopa|mesh-list
1792568|NCT04952194|Entacapone|entacapone|mesh-list
1792569|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1792570|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1792571|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
1792572|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792573|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792574|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792575|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1792576|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792577|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
1792578|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
1792579|NCT04952207|Grazoprevir|grazoprevir|mesh-list
1792580|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
1792581|NCT04952207|Ledipasvir|ledipasvir|mesh-list
1792582|NCT04952207|Velpatasvir|velpatasvir|mesh-list
1792583|NCT04952207|Asunaprevir|asunaprevir|mesh-list
1792584|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792585|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
1792586|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792587|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792588|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
1792589|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1792590|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
1792591|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792592|NCT04951986|Levofloxacin|levofloxacin|mesh-list
1792593|NCT04951986|Ofloxacin|ofloxacin|mesh-list
1792594|NCT04951986|Rifampin|rifampin|mesh-list
1792595|NCT04951986|Isoniazid|isoniazid|mesh-list
1792596|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
1792597|NCT04951986|Ethambutol|ethambutol|mesh-list
1792598|NCT04951986|Prednisone|prednisone|mesh-list
1792599|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1792600|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
1792601|NCT04951986|Hormones|hormones|mesh-ancestor
1792602|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1792603|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792604|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1792605|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792606|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1792607|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792608|NCT04951986|Renal Agents|renal agents|mesh-ancestor
1792609|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1792610|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1792611|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1792612|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792613|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792614|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1792615|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1792616|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1792617|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
1792618|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
1792619|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1792620|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1792621|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1792622|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1792623|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1792624|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1792625|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1792626|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1792627|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1792628|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
1792629|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1792630|NCT04951947|Lenvatinib|lenvatinib|mesh-list
1792631|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792632|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1792633|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792634|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792635|NCT04951856|Evolocumab|evolocumab|mesh-list
1792636|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1792637|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1792638|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
1792639|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792640|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1792641|NCT04952129|Selenium|selenium|mesh-list
1792642|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
1792643|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
1792644|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792645|NCT04952129|Protective Agents|protective agents|mesh-ancestor
1792646|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792647|NCT04952129|Trace Elements|trace elements|mesh-ancestor
1792648|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
1792649|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1792650|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792651|NCT04952051|Folic Acid|folic acid|mesh-list
1792652|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
1792653|NCT04952051|Amlodipine|amlodipine|mesh-list
1792654|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1792655|NCT04952051|Enalapril|enalapril|mesh-list
1792656|NCT04952051|Enalaprilat|enalaprilat|mesh-list
1792657|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1792658|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1792659|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1792660|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792661|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1792662|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792663|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
1792664|NCT04952051|Diuretics|diuretics|mesh-ancestor
1792665|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
1792666|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1792667|NCT04952051|Hematinics|hematinics|mesh-ancestor
1792668|NCT04952051|Vitamins|vitamins|mesh-ancestor
1792669|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
1792670|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1792671|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
1792672|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792673|NCT04951791|SMOFlipid|smoflipid|mesh-list
1792674|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1792675|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1792676|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1792677|NCT04951713|Clarithromycin|clarithromycin|mesh-list
1792678|NCT04951713|Rifampin|rifampin|mesh-list
1792679|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1792680|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792681|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1792682|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792683|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792684|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1792685|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1792686|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1792687|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
1792688|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
1792689|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1792690|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1792691|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1792692|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1792693|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1792694|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1792695|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1792696|NCT04951752|Ropivacaine|ropivacaine|mesh-list
1792697|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
1792698|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
1792699|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1792700|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792701|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
1792702|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792703|NCT04951505|Cefepime|cefepime|mesh-list
1792704|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1792705|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792711|NCT04951362|Ivermectin|ivermectin|mesh-list
1792712|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1792713|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792714|NCT04951726|Neostigmine|neostigmine|mesh-list
1792715|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1792716|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792717|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792718|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
1792719|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792720|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792721|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1792722|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
1792723|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792724|NCT04951349|Petrolatum|petrolatum|mesh-list
1792725|NCT04951349|Emollients|emollients|mesh-ancestor
1792726|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
1792727|NCT04951167|Norepinephrine|norepinephrine|mesh-list
1792728|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1792729|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1792730|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
1792731|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792732|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792733|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792734|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
1792735|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
1792736|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792737|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1792738|NCT04950933|Riluzole|riluzole|mesh-list
1792739|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
1792740|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1792741|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1792742|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792743|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792744|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792745|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1792746|NCT04950933|Protective Agents|protective agents|mesh-ancestor
1792828|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
1792754|NCT04951128|Anesthetics|anesthetics|mesh-list
1792755|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
1792756|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
1792757|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1792758|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792759|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1792760|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1792761|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792762|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
1792763|NCT04951128|Coagulants|coagulants|mesh-ancestor
1792764|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
1792765|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792766|NCT04951232|Cinepazide|cinepazide|mesh-list
1792767|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
1792768|NCT04951115|Carboplatin|carboplatin|mesh-list
1792769|NCT04951115|Etoposide|etoposide|mesh-list
1792770|NCT04951115|Durvalumab|durvalumab|mesh-list
1792771|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792772|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1792773|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1792774|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1792775|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792776|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792777|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1792778|NCT04951206|Clobetasol|clobetasol|mesh-list
1792779|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1792780|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
1792781|NCT04951206|Hormones|hormones|mesh-ancestor
1792782|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1792783|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792784|NCT04950569|Simendan|simendan|mesh-list
1792785|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1792786|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
1792787|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1792788|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1792789|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792790|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792791|NCT04950569|Protective Agents|protective agents|mesh-ancestor
1792792|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792793|NCT04950465|Fluorides|fluorides|mesh-list
1792794|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
1792795|NCT04950465|Protective Agents|protective agents|mesh-ancestor
1792796|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792797|NCT04950621|Propofol|propofol|mesh-list
1792798|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1792799|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1792800|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792801|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1792802|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
1792803|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
1792808|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
1792809|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792810|NCT04950205|Sevoflurane|sevoflurane|mesh-list
1792811|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1792812|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1792813|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
1792814|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
1792815|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1792816|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792827|NCT04950049|Dexamethasone|dexamethasone|mesh-list
1792829|NCT04950049|BB 1101|bb 1101|mesh-list
1792830|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1792831|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
1792832|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
1792833|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792834|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792835|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1792836|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
1792837|NCT04950049|Hormones|hormones|mesh-ancestor
1792838|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1792839|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1792840|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792841|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
1792842|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792843|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792844|NCT04950400|Apatinib|apatinib|mesh-list
1792845|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792846|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1792847|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792848|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792849|NCT04950530|Emtricitabine|emtricitabine|mesh-list
1792850|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
1792851|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792852|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1792853|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1792854|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792855|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792856|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1792857|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1792858|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
1792859|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
1792860|NCT04950270|Coagulants|coagulants|mesh-ancestor
1792861|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1792862|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1792863|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
1792864|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792880|NCT04949867|Glucagon|glucagon|mesh-list
1792881|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1792882|NCT04949867|Hormones|hormones|mesh-ancestor
1792883|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1792884|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792885|NCT04949932|Turmeric extract|turmeric extract|mesh-list
1792886|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
1792887|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792888|NCT04949932|Protective Agents|protective agents|mesh-ancestor
1792889|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792890|NCT04949464|Nicotine|nicotine|mesh-list
1792891|NCT04949464|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1792892|NCT04949464|Autonomic Agents|autonomic agents|mesh-ancestor
1792893|NCT04949464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792894|NCT04949464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792895|NCT04949464|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1792896|NCT04949464|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1792897|NCT04949464|Cholinergic Agents|cholinergic agents|mesh-ancestor
1792898|NCT04949464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792899|NCT04949464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792900|NCT04949516|Aspirin|aspirin|mesh-list
1792901|NCT04949516|Colchicine|colchicine|mesh-list
1792902|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1792903|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1792904|NCT04949516|Analgesics|analgesics|mesh-ancestor
1792905|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
1792906|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792907|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792908|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1792909|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1792910|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1792911|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1792912|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792913|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1792914|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1792915|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792916|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
1792917|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
1792918|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
1792919|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
1792920|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
1792921|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792922|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
1792923|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1792924|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792925|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
1792926|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1792927|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792928|NCT04949113|Nivolumab|nivolumab|mesh-list
1792929|NCT04949113|Ipilimumab|ipilimumab|mesh-list
1792930|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1792931|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792932|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1792933|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792934|NCT04949269|BMS-986165|bms-986165|mesh-list
1792935|NCT04949269|Famotidine|famotidine|mesh-list
1792936|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1792937|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1792938|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1792939|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
1792940|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
1792941|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792942|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792943|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792944|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
1792945|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1792946|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792947|NCT04949347|Glycerol|glycerol|mesh-list
1792948|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1792949|NCT04949347|Protective Agents|protective agents|mesh-ancestor
1792950|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792951|NCT04949477|Acetaminophen|acetaminophen|mesh-list
1792952|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
1792953|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1792954|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1792955|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792956|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1792957|NCT04949477|Analgesics|analgesics|mesh-ancestor
1792958|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
1792959|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1792960|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1792961|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1792962|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1792963|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
1792964|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1792965|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792966|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
1792967|NCT04948814|Vancomycin|vancomycin|mesh-list
1792968|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1792969|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792970|NCT04948749|Sirolimus|sirolimus|mesh-list
1792971|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1792972|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792973|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1792974|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792975|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
1792976|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1792977|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
1792978|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1792982|NCT04948788|Gemcitabine|gemcitabine|mesh-list
1792983|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
1792984|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1792985|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
1792986|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1792987|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1792988|NCT04948788|Antiviral Agents|antiviral agents|mesh-ancestor
1792989|NCT04948788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1792990|NCT04948788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1792991|NCT04948788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1792992|NCT04948788|Immunologic Factors|immunologic factors|mesh-ancestor
1792993|NCT04948788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793011|NCT04948697|Bevacizumab|bevacizumab|mesh-list
1793012|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1793013|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793014|NCT04948697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1793015|NCT04948697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1793016|NCT04948697|Growth Substances|growth substances|mesh-ancestor
1793017|NCT04948697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793018|NCT04948697|Growth Inhibitors|growth inhibitors|mesh-ancestor
1793019|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
1793020|NCT04948957|Esmolol|esmolol|mesh-list
1793021|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
1793022|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1793023|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1793024|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1793025|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
1793026|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1793027|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793028|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793029|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
1793030|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
1793031|NCT04948801|Velpatasvir|velpatasvir|mesh-list
1793032|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
1793033|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793034|NCT04948489|Norethindrone|norethindrone|mesh-list
1793035|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
1793036|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1793037|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1793038|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1793039|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
1793040|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1793041|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793042|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1793043|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1793044|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
1793045|NCT04948567|Analgesics|analgesics|mesh-ancestor
1793046|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
1793047|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793048|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793049|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
1793050|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1793051|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1793052|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
1793053|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1793054|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1793055|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793056|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1793057|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
1793058|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1793059|NCT04948203|Sirolimus|sirolimus|mesh-list
1793060|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1793061|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793062|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1793063|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793064|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
1793065|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1793066|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
1793067|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793068|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
1793069|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
1793070|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
1793071|NCT04948125|Apatinib|apatinib|mesh-list
1793072|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793073|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1793074|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793075|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793076|NCT04948385|Propofol|propofol|mesh-list
1793077|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1793078|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1793079|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793080|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1793081|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
1793082|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
1793083|NCT04948372|Terlipressin|terlipressin|mesh-list
1793084|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1793085|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1793086|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1793087|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793088|NCT04948164|Naproxen|naproxen|mesh-list
1793089|NCT04948164|Sumatriptan|sumatriptan|mesh-list
1793090|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1793091|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1793092|NCT04948164|Analgesics|analgesics|mesh-ancestor
1793093|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
1793094|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793095|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793096|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1793097|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793098|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
1793099|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1793100|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793101|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793102|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1793103|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1793104|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1793105|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
1793106|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1793107|NCT04947956|Apatinib|apatinib|mesh-list
1793108|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793109|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1793110|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793111|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793112|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
1793113|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
1793114|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1793115|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1793116|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793117|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793118|NCT04948151|Urological Agents|urological agents|mesh-ancestor
1793119|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
1793120|NCT04947501|Ifosfamide|ifosfamide|mesh-list
1793121|NCT04947501|Carboplatin|carboplatin|mesh-list
1793122|NCT04947501|Doxorubicin|doxorubicin|mesh-list
1793123|NCT04947501|Etoposide|etoposide|mesh-list
1793124|NCT04947501|Vincristine|vincristine|mesh-list
1793125|NCT04947501|Topotecan|topotecan|mesh-list
1793126|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1793127|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
1793128|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793129|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793130|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1793131|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
1793283|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
1793132|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793133|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793134|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1793135|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1793136|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1793137|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1793138|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793139|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1793140|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
1793141|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
1793142|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
1793143|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1793144|NCT04947826|Antibodies|antibodies|mesh-list
1793145|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
1793146|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
1793147|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793148|NCT04947566|Ibuprofen|ibuprofen|mesh-list
1793149|NCT04947566|Naproxen|naproxen|mesh-list
1793150|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1793151|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1793152|NCT04947566|Analgesics|analgesics|mesh-ancestor
1793153|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
1793154|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793155|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793156|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1793157|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793158|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1793159|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793160|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793161|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
1793162|NCT04947423|Scopolamine|scopolamine|mesh-list
1793163|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1793164|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
1793165|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
1793166|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793167|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793168|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1793169|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
1793170|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1793171|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
1793172|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1793173|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793174|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1793201|NCT04947527|Fluorides|fluorides|mesh-list
1793202|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
1793203|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
1793204|NCT04947527|Protective Agents|protective agents|mesh-ancestor
1793205|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793206|NCT04947267|Epinephrine|epinephrine|mesh-list
1793207|NCT04947267|Mepivacaine|mepivacaine|mesh-list
1793208|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1793209|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1793210|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
1793211|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1793212|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793213|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793214|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1793215|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1793216|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
1793217|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793218|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1793219|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
1793220|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
1793221|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
1793222|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1793223|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
1793224|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
1793225|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1793226|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
1793227|NCT04947111|Antibodies|antibodies|mesh-list
1793228|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
1793229|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
1793230|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793231|NCT04946929|Heparin|heparin|mesh-list
1793232|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1793233|NCT04946929|Tinzaparin|tinzaparin|mesh-list
1793234|NCT04946929|Dalteparin|dalteparin|mesh-list
1793235|NCT04946929|Ticagrelor|ticagrelor|mesh-list
1793236|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
1793237|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1793238|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1793239|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793240|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1793241|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1793242|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1793243|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1793244|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
1793245|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1793246|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793247|NCT04947345|Propofol|propofol|mesh-list
1793248|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1793249|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1793250|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793251|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1793252|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
1793253|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
1793254|NCT04947189|Dexamethasone|dexamethasone|mesh-list
1793255|NCT04947189|Docetaxel|docetaxel|mesh-list
1793256|NCT04947189|Seviteronel|seviteronel|mesh-list
1793257|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1793258|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
1793259|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
1793260|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793261|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793262|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1793263|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
1793264|NCT04947189|Hormones|hormones|mesh-ancestor
1793265|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1793266|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1793267|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793268|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
1793269|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
1793270|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
1793271|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793272|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1793273|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793274|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
1793275|NCT04947254|Prednisone|prednisone|mesh-list
1793276|NCT04947254|Cortisone|cortisone|mesh-list
1793277|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
1793278|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
1793279|NCT04947254|Niraparib|niraparib|mesh-list
1793280|NCT04947254|Hormones|hormones|mesh-list
1793281|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
1793282|NCT04947254|Androgens|androgens|mesh-list
1793284|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1793285|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
1793286|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1793287|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793288|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1793289|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793290|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1793291|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793292|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793293|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
1793294|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1793295|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
1793296|NCT04947254|Protective Agents|protective agents|mesh-ancestor
1793297|NCT04947254|Vitamins|vitamins|mesh-ancestor
1793298|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
1793299|NCT04947254|Estrogens|estrogens|mesh-ancestor
1793300|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
1793301|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1793302|NCT04947241|Gemcitabine|gemcitabine|mesh-list
1793303|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1793304|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793305|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1793306|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
1793307|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793308|NCT04947241|Antiviral Agents|antiviral agents|mesh-ancestor
1793309|NCT04947241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793310|NCT04947241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793311|NCT04947241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1793312|NCT04947241|Immunologic Factors|immunologic factors|mesh-ancestor
1793313|NCT04947241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793314|NCT04946825|Nicotine|nicotine|mesh-list
1793315|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1793316|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
1793317|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793318|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793319|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1793320|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1793321|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
1793322|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1793323|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793339|NCT04946864|Palbociclib|palbociclib|mesh-list
1793340|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793341|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1793342|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793343|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793347|NCT04946734|Aspirin|aspirin|mesh-list
1793348|NCT04946734|Clopidogrel|clopidogrel|mesh-list
1793349|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1793350|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1793351|NCT04946734|Analgesics|analgesics|mesh-ancestor
1793352|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
1793353|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793354|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793355|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1793356|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793357|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1793358|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1793359|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793360|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1793361|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1793362|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793363|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
1793364|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1793365|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1793366|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1793367|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
1793368|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1793374|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1793375|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
1793376|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1793377|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793378|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1793379|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1793380|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1793381|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793382|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
1793383|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1793384|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1793385|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1793386|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
1793387|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793388|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793389|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1793390|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
1793391|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
1793392|NCT04946630|Hormones|hormones|mesh-ancestor
1793393|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1793394|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
1793395|NCT04946669|Abatacept|abatacept|mesh-list
1793396|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1793397|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793398|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793399|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1793400|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
1793401|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793402|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793420|NCT04946383|Dasatinib|dasatinib|mesh-list
1793421|NCT04946383|Quercetin|quercetin|mesh-list
1793422|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793423|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1793424|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793425|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793426|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
1793427|NCT04946383|Protective Agents|protective agents|mesh-ancestor
1793428|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793429|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
1793430|NCT04946370|Edetic Acid|edetic acid|mesh-list
1793431|NCT04946370|Androgens|androgens|mesh-list
1793432|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1793433|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1793434|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793435|NCT04946370|Hormones|hormones|mesh-ancestor
1793436|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1793437|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793438|NCT04946370|Anticoagulants|anticoagulants|mesh-ancestor
1793439|NCT04946370|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1793440|NCT04946370|Chelating Agents|chelating agents|mesh-ancestor
1793441|NCT04946370|Sequestering Agents|sequestering agents|mesh-ancestor
1793442|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793443|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1793444|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
1793445|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1793446|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
1793447|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793448|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793449|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1793450|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
1793451|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793452|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793453|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1793454|NCT04946162|Tadalafil|tadalafil|mesh-list
1793455|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
1793456|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1793457|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1793458|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793459|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793460|NCT04946162|Urological Agents|urological agents|mesh-ancestor
1793465|NCT04946227|Paclitaxel|paclitaxel|mesh-list
1793466|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
1793467|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1793468|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793469|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
1793470|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
1793471|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
1793472|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793473|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1793474|NCT04946123|Selenium|selenium|mesh-list
1793475|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
1793476|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793477|NCT04946123|Protective Agents|protective agents|mesh-ancestor
1793478|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793479|NCT04946123|Trace Elements|trace elements|mesh-ancestor
1793480|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
1793481|NCT04945824|Dexamethasone|dexamethasone|mesh-list
1793482|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1793483|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
1793484|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
1793485|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793486|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793487|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1793488|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
1793489|NCT04945824|Hormones|hormones|mesh-ancestor
1793490|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1793491|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1793492|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793493|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1793494|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
1793495|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793496|NCT04945694|Fentanyl|fentanyl|mesh-list
1793497|NCT04945694|Propofol|propofol|mesh-list
1793498|NCT04945694|Sevoflurane|sevoflurane|mesh-list
1793499|NCT04945694|Atracurium|atracurium|mesh-list
1793500|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1793501|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1793502|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793503|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1793504|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
1793505|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
1793506|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1793507|NCT04945694|Narcotics|narcotics|mesh-ancestor
1793508|NCT04945694|Analgesics|analgesics|mesh-ancestor
1793509|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
1793510|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793511|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1793512|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1793513|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1793514|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1793515|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1793516|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1793517|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
1793518|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1793519|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
1793520|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1793521|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793522|NCT04945577|Vitamin D|vitamin d|mesh-list
1793523|NCT04945577|Vitamins|vitamins|mesh-ancestor
1793524|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
1793525|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793526|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1793527|NCT04945226|Finasteride|finasteride|mesh-list
1793528|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1793529|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1793530|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793531|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793532|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
1793533|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1793534|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793535|NCT04945226|Urological Agents|urological agents|mesh-ancestor
1793536|NCT04945434|Methamphetamine|methamphetamine|mesh-list
1793537|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1793538|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793539|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
1793540|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
1793541|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793542|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
1793543|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1793544|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793545|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
1793546|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1793547|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1793548|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1793549|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1793550|NCT04945122|Atorvastatin|atorvastatin|mesh-list
1793551|NCT04945122|Pitavastatin|pitavastatin|mesh-list
1793552|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1793553|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1793554|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
1793555|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793556|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1793557|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1793558|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793559|NCT04945070|Insulin|insulin|mesh-list
1793560|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1793561|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793562|NCT04945096|Cytarabine|cytarabine|mesh-list
1793563|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
1793564|NCT04945096|Cyclosporine|cyclosporine|mesh-list
1793565|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
1793566|NCT04945096|Busulfan|busulfan|mesh-list
1793567|NCT04945096|Semustine|semustine|mesh-list
1793568|NCT04945096|Decitabine|decitabine|mesh-list
1793569|NCT04945096|Cyclosporins|cyclosporins|mesh-list
1793570|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
1793571|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1793572|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1793573|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
1793574|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793575|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793576|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1793577|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
1793578|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793579|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793580|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1793581|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1793582|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
1793583|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
1793584|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793585|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793586|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
1793587|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
1793588|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1793589|NCT04945096|Expectorants|expectorants|mesh-ancestor
1793590|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
1793591|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1793592|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
1793593|NCT04945096|Protective Agents|protective agents|mesh-ancestor
1793594|NCT04944836|Clomiphene|clomiphene|mesh-list
1793595|NCT04944836|Enclomiphene|enclomiphene|mesh-list
1793596|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
1793597|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1793598|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
1793599|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1793600|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793601|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1793602|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
1793603|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1793604|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1793605|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1793606|NCT04944966|Lumefantrine|lumefantrine|mesh-list
1793607|NCT04944966|Artemether|artemether|mesh-list
1793608|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1793609|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
1793610|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1793611|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1793612|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793613|NCT04944381|Vaccines|vaccines|mesh-list
1793614|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
1793615|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793625|NCT04944602|Omalizumab|omalizumab|mesh-list
1793626|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1793627|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1793628|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
1793641|NCT04944524|Methotrexate|methotrexate|mesh-list
1793642|NCT04944524|Tofacitinib|tofacitinib|mesh-list
1793643|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1793644|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
1793645|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1793646|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793647|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1793648|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
1793649|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793650|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793651|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
1793652|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793653|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1793654|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1793655|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
1793656|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793657|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1793658|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1793663|NCT04943952|Asparaginase|asparaginase|mesh-list
1793664|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793665|NCT04944069|Bevacizumab|bevacizumab|mesh-list
1793666|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1793667|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793668|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1793669|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1793670|NCT04944069|Growth Substances|growth substances|mesh-ancestor
1793671|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793672|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
1793673|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
1793674|NCT04944082|Ivermectin|ivermectin|mesh-list
1793675|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1793676|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793677|NCT04944095|Antibodies|antibodies|mesh-list
1793678|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
1793679|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793680|NCT04944134|Vaccines|vaccines|mesh-list
1793681|NCT04944134|Immunologic Factors|immunologic factors|mesh-ancestor
1793682|NCT04944134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793697|NCT04944212|Vitamin D|vitamin d|mesh-list
1793698|NCT04944212|Vitamins|vitamins|mesh-ancestor
1793699|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
1793700|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793701|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1793702|NCT04943900|Nivolumab|nivolumab|mesh-list
1793703|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1793704|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793705|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1793706|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793707|NCT04943692|Metformin|metformin|mesh-list
1793708|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1793709|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793710|NCT04944173|Durvalumab|durvalumab|mesh-list
1793711|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1793712|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793713|NCT04943588|Antibodies|antibodies|mesh-list
1793714|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
1793715|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
1793716|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793725|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
1793726|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1793727|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1793728|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
1793729|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793730|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793731|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1793732|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
1793733|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793734|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793735|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1793736|NCT04943653|Paclitaxel|paclitaxel|mesh-list
1793737|NCT04943653|Capecitabine|capecitabine|mesh-list
1793738|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
1793739|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1793740|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793741|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
1793742|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
1793743|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
1793744|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793745|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1793746|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
1793747|NCT04943536|Bicalutamide|bicalutamide|mesh-list
1793748|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
1793749|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
1793750|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1793751|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793752|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793760|NCT04943783|Atorvastatin|atorvastatin|mesh-list
1793761|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1793762|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1793763|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
1793764|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793765|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1793766|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1793767|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793768|NCT04943679|Interferons|interferons|mesh-list
1793769|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
1793770|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793771|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
1793772|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793773|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
1793774|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793775|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1793776|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1793777|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793778|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
1793779|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1793780|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793781|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1793782|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1793783|NCT04943237|Analgesics|analgesics|mesh-ancestor
1793784|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
1793785|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793786|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793787|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793788|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1793789|NCT04943029|Paclitaxel|paclitaxel|mesh-list
1793790|NCT04943029|Carboplatin|carboplatin|mesh-list
1793791|NCT04943029|Pemetrexed|pemetrexed|mesh-list
1793792|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1793793|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793794|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
1793795|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
1793796|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
1793797|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793798|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793799|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1793800|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1793801|NCT04943198|Vemurafenib|vemurafenib|mesh-list
1793802|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793803|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1793804|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793805|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793806|NCT04942899|Capecitabine|capecitabine|mesh-list
1793807|NCT04942899|Letrozole|letrozole|mesh-list
1793808|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1793809|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
1793810|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793811|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793812|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1793813|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1793814|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793815|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1793816|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
1793817|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1793818|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793819|NCT04943146|Aspirin|aspirin|mesh-list
1793820|NCT04943146|Prednisone|prednisone|mesh-list
1793821|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1793822|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
1793823|NCT04943146|Hormones|hormones|mesh-ancestor
1793824|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1793825|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793826|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1793827|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793828|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1793829|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1793830|NCT04943146|Analgesics|analgesics|mesh-ancestor
1793831|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
1793832|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793833|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793834|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1793835|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1793836|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793837|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1793838|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1793839|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793840|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
1793841|NCT04943224|Trametinib|trametinib|mesh-list
1793842|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793843|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1793844|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793845|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793846|NCT04942886|Entecavir|entecavir|mesh-list
1793847|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
1793848|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793849|NCT04942626|Capecitabine|capecitabine|mesh-list
1793850|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1793851|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1793852|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
1793853|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793854|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793855|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793856|NCT04942860|Methotrexate|methotrexate|mesh-list
1793857|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1793858|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
1793859|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1793860|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793861|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1793862|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
1793863|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793864|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793865|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
1793866|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793867|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1793868|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1793869|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
1793870|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793871|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1793872|NCT04942834|Amiodarone|amiodarone|mesh-list
1793873|NCT04942834|Sotalol|sotalol|mesh-list
1793874|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
1793875|NCT04942834|Dronedarone|dronedarone|mesh-list
1793876|NCT04942834|Propafenone|propafenone|mesh-list
1793877|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
1793878|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1793879|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1793880|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793881|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1793882|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1793883|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1793884|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793885|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1793886|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1793887|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1793888|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1793889|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1793890|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
1793891|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1793892|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793893|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
1793894|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
1793895|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793896|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1793897|NCT04942652|Itraconazole|itraconazole|mesh-list
1793898|NCT04942652|Esomeprazole|esomeprazole|mesh-list
1793899|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1793900|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1793901|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1793902|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793903|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793904|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
1793905|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793906|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1793907|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1793908|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1793909|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
1793910|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1793911|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793912|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1793913|NCT04942769|Selenium|selenium|mesh-list
1793914|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
1793915|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793916|NCT04942769|Protective Agents|protective agents|mesh-ancestor
1793917|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793918|NCT04942769|Trace Elements|trace elements|mesh-ancestor
1793919|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
1793920|NCT04942470|Propolis|propolis|mesh-list
1793921|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793922|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
1793923|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
1793924|NCT04942730|Busulfan|busulfan|mesh-list
1793925|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1793926|NCT04942730|Fludarabine|fludarabine|mesh-list
1793927|NCT04942730|Tacrolimus|tacrolimus|mesh-list
1793928|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1793929|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
1793930|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793931|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1793932|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1793933|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
1793934|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793935|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793936|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1793937|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1793938|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793939|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1793940|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1793941|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
1793942|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1793943|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793944|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
1793945|NCT04942340|Caffeine|caffeine|mesh-list
1793946|NCT04942340|Atipamezole|atipamezole|mesh-list
1793947|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1793948|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1793949|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793950|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1793951|NCT04942340|Analgesics|analgesics|mesh-ancestor
1793952|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
1793953|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793954|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1793955|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1793956|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1793957|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
1793958|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1793959|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1793960|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1793961|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1793962|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1793963|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1793964|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1793965|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
1793966|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1793967|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1793968|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1793969|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
1793970|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1793971|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1793972|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1793973|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
1793974|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
1793975|NCT04942301|Endostar protein|endostar protein|mesh-list
1793976|NCT04942301|Endostatins|endostatins|mesh-list
1793977|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1793978|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1793979|NCT04942301|Growth Substances|growth substances|mesh-ancestor
1793980|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793981|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
1793982|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1793983|NCT04941976|Benzydamine|benzydamine|mesh-list
1793984|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1793985|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
1793986|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1793987|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1793988|NCT04942002|Prednisolone|prednisolone|mesh-list
1793989|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
1793990|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1793991|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
1793992|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1793993|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
1793994|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
1793995|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1793996|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1793997|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1793998|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
1793999|NCT04942002|Hormones|hormones|mesh-ancestor
1794000|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1794001|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1794002|NCT04942002|Protective Agents|protective agents|mesh-ancestor
1794003|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1794004|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794005|NCT04941872|FAPI-46|fapi-46|mesh-list
1794006|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1794007|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794033|NCT04941898|Factor VIII|factor viii|mesh-list
1794034|NCT04941898|BAX 855|bax 855|mesh-list
1794035|NCT04941898|Coagulants|coagulants|mesh-ancestor
1794036|NCT04941937|Thalidomide|thalidomide|mesh-list
1794037|NCT04941937|Dexamethasone|dexamethasone|mesh-list
1794038|NCT04941937|Lenalidomide|lenalidomide|mesh-list
1794039|NCT04941937|Pomalidomide|pomalidomide|mesh-list
1794040|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1794041|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
1794042|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
1794043|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794044|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794045|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1794046|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
1794047|NCT04941937|Hormones|hormones|mesh-ancestor
1794048|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1794049|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1794050|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794051|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
1794052|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1794053|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1794054|NCT04941937|Growth Substances|growth substances|mesh-ancestor
1794055|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
1794056|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1794057|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
1794058|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1794059|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794063|NCT04941833|Desogestrel|desogestrel|mesh-list
1794064|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1794065|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1794066|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1794067|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
1794068|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1794069|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794070|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1794071|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1794072|NCT04941833|Progestins|progestins|mesh-ancestor
1794073|NCT04941833|Hormones|hormones|mesh-ancestor
1794074|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1794075|NCT04941911|Octreotide|octreotide|mesh-list
1794076|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1794077|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1794078|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794079|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
1794080|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1794081|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
1794082|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794083|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1794084|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1794085|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
1794086|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794087|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794088|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1794089|NCT04941846|Nimodipine|nimodipine|mesh-list
1794090|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1794091|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1794092|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1794093|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794094|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1794095|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794096|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
1794109|NCT04941521|Exenatide|exenatide|mesh-list
1794110|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1794111|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794112|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1794113|NCT04941521|Incretins|incretins|mesh-ancestor
1794114|NCT04941521|Hormones|hormones|mesh-ancestor
1794115|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1794116|NCT04941625|Cystatins|cystatins|mesh-list
1794117|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
1794118|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
1794119|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1794120|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794121|NCT04941573|Xenon|xenon|mesh-list
1794122|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1794123|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
1794124|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
1794125|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794126|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794127|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1794128|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794129|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794130|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
1794131|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1794132|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
1794133|NCT04941131|Povidone|povidone|mesh-list
1794134|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1794135|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794136|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
1794137|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
1794138|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
1794139|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
1794140|NCT04941196|Ticagrelor|ticagrelor|mesh-list
1794141|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1794142|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1794143|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1794144|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1794145|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
1794146|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794147|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794148|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794149|NCT04941105|Evolocumab|evolocumab|mesh-list
1794150|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1794151|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1794152|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
1794153|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794154|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1794155|NCT04941170|Bupivacaine|bupivacaine|mesh-list
1794156|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
1794157|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
1794158|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794159|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794160|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
1794161|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794162|NCT04941118|Anesthetics|anesthetics|mesh-list
1794163|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
1794164|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794165|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794166|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
1794167|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794168|NCT04941144|Vaccines|vaccines|mesh-list
1794169|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
1794170|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794174|NCT04940689|Lidocaine|lidocaine|mesh-list
1794175|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
1794176|NCT04940689|Remifentanil|remifentanil|mesh-list
1794177|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
1794178|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
1794179|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794180|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794181|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
1794182|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794183|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1794184|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1794185|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1794186|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1794187|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794188|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1794189|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1794190|NCT04940689|Analgesics|analgesics|mesh-ancestor
1794191|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1794192|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1794193|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1794194|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
1794195|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794196|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1794197|NCT04940689|Narcotics|narcotics|mesh-ancestor
1794198|NCT04940767|Minocycline|minocycline|mesh-list
1794199|NCT04940767|Isotretinoin|isotretinoin|mesh-list
1794200|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1794201|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794202|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
1794203|NCT04940845|Denosumab|denosumab|mesh-list
1794204|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1794205|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794206|NCT04940871|Favipiravir|favipiravir|mesh-list
1794207|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
1794208|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794220|NCT04940546|Bevacizumab|bevacizumab|mesh-list
1794221|NCT04940546|Capecitabine|capecitabine|mesh-list
1794222|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
1794223|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1794224|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794225|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1794226|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1794227|NCT04940546|Growth Substances|growth substances|mesh-ancestor
1794228|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794229|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
1794230|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1794231|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
1794232|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794233|NCT04940273|Remifentanil|remifentanil|mesh-list
1794234|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1794235|NCT04940273|Narcotics|narcotics|mesh-ancestor
1794236|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794237|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794238|NCT04940273|Analgesics|analgesics|mesh-ancestor
1794239|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
1794240|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794241|NCT04940299|Nivolumab|nivolumab|mesh-list
1794242|NCT04940299|Ipilimumab|ipilimumab|mesh-list
1794243|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
1794244|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
1794245|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1794246|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794247|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1794248|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794249|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
1794250|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794276|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
1794277|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1794278|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1794279|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1794280|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1794281|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794282|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
1794283|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794284|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794285|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1794286|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794287|NCT04939935|Metformin|metformin|mesh-list
1794288|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1794289|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794290|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
1794291|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1794292|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1794293|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1794294|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1794295|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794296|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
1794297|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794298|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794299|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1794300|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794301|NCT04939883|Carvedilol|carvedilol|mesh-list
1794302|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1794303|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1794304|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
1794305|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794306|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794307|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794308|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1794309|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
1794310|NCT04939883|Protective Agents|protective agents|mesh-ancestor
1794311|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1794312|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1794313|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1794314|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
1794315|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1794316|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1794317|NCT04939844|Lenalidomide|lenalidomide|mesh-list
1794318|NCT04939844|Bortezomib|bortezomib|mesh-list
1794319|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
1794320|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794321|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1794322|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1794323|NCT04939844|Growth Substances|growth substances|mesh-ancestor
1794324|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
1794325|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794333|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
1794334|NCT04939623|Probenecid|probenecid|mesh-list
1794335|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
1794336|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
1794337|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1794338|NCT04939623|Renal Agents|renal agents|mesh-ancestor
1794339|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
1794340|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794341|NCT04939662|Bevacizumab|bevacizumab|mesh-list
1794342|NCT04939662|Olaparib|olaparib|mesh-list
1794343|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1794344|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794345|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1794346|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1794347|NCT04939662|Growth Substances|growth substances|mesh-ancestor
1794348|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794349|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
1794350|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1794351|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1794352|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794353|NCT04939857|Trimetazidine|trimetazidine|mesh-list
1794354|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
1794355|NCT04939779|Delpazolid|delpazolid|mesh-list
1794356|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
1794357|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1794358|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794359|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1794360|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1794361|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794370|NCT04939675|Lamotrigine|lamotrigine|mesh-list
1794371|NCT04939675|Zonisamide|zonisamide|mesh-list
1794372|NCT04939675|Levetiracetam|levetiracetam|mesh-list
1794373|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
1794374|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
1794375|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1794376|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1794377|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794378|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1794379|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794380|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1794381|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1794382|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794383|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1794384|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1794385|NCT04939766|Insulin|insulin|mesh-list
1794386|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1794387|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794397|NCT04939649|Midazolam|midazolam|mesh-list
1794398|NCT04939649|Ketamine|ketamine|mesh-list
1794399|NCT04939649|Analgesics|analgesics|mesh-ancestor
1794400|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
1794401|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794402|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794403|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1794404|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1794405|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
1794406|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
1794407|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794408|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1794409|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1794410|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794411|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794412|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1794413|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1794414|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1794415|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1794416|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1794417|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
1794418|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
1794419|NCT04939480|Atezolizumab|atezolizumab|mesh-list
1794420|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794425|NCT04939441|Tenofovir|tenofovir|mesh-list
1794426|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
1794427|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794428|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1794429|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1794430|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1794431|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794432|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1794433|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1794434|NCT04938882|Lidocaine|lidocaine|mesh-list
1794435|NCT04938882|Ropivacaine|ropivacaine|mesh-list
1794436|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
1794437|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
1794438|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794439|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794440|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
1794441|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794442|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1794443|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1794444|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1794445|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1794446|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794447|NCT04938583|Paclitaxel|paclitaxel|mesh-list
1794448|NCT04938583|Bevacizumab|bevacizumab|mesh-list
1794449|NCT04938583|Carboplatin|carboplatin|mesh-list
1794450|NCT04938583|Oregovomab|oregovomab|mesh-list
1794451|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1794452|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794453|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
1794454|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
1794455|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
1794456|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794457|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1794458|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1794459|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1794460|NCT04938583|Growth Substances|growth substances|mesh-ancestor
1794461|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794462|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
1794466|NCT04938713|Ketamine|ketamine|mesh-list
1794467|NCT04938713|Esketamine|esketamine|mesh-list
1794468|NCT04938713|Analgesics|analgesics|mesh-ancestor
1794469|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
1794470|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794471|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794472|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1794473|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1794474|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
1794475|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
1794476|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794477|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1794478|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1794479|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794480|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794481|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
1794482|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1794483|NCT04938856|Lamotrigine|lamotrigine|mesh-list
1794484|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
1794485|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1794486|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1794561|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1794487|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794488|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1794489|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794490|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1794491|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1794492|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794493|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1794494|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1794495|NCT04938557|Insulin|insulin|mesh-list
1794496|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1794497|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1794498|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794499|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
1794500|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1794501|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
1794502|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794503|NCT04938453|Nintedanib|nintedanib|mesh-list
1794504|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794505|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1794506|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1794507|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794523|NCT04938232|Nivolumab|nivolumab|mesh-list
1794524|NCT04938232|Ipilimumab|ipilimumab|mesh-list
1794525|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1794526|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794527|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1794528|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794529|NCT04938466|Hormones|hormones|mesh-list
1794530|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1794531|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794532|NCT04938297|Rituximab|rituximab|mesh-list
1794533|NCT04938297|Lenalidomide|lenalidomide|mesh-list
1794534|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
1794535|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1794536|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794537|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
1794538|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794539|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1794540|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1794541|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1794542|NCT04938297|Growth Substances|growth substances|mesh-ancestor
1794543|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
1794544|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1794545|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1794546|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794547|NCT04938011|Progesterone|progesterone|mesh-list
1794548|NCT04938011|Progestins|progestins|mesh-ancestor
1794549|NCT04938011|Hormones|hormones|mesh-ancestor
1794550|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1794551|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794559|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
1794560|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1794562|NCT04938037|Prednisolone|prednisolone|mesh-list
1794563|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
1794564|NCT04938037|Bupivacaine|bupivacaine|mesh-list
1794565|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1794566|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
1794567|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
1794568|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
1794569|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794570|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794571|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
1794572|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794573|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1794574|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
1794575|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
1794576|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1794577|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
1794578|NCT04938037|Hormones|hormones|mesh-ancestor
1794579|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1794580|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1794581|NCT04938037|Protective Agents|protective agents|mesh-ancestor
1794582|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1794583|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794584|NCT04937946|Fentanyl|fentanyl|mesh-list
1794585|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1794586|NCT04937946|Narcotics|narcotics|mesh-ancestor
1794587|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794588|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794589|NCT04937946|Analgesics|analgesics|mesh-ancestor
1794590|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
1794591|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794592|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1794593|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1794594|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
1794595|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
1794596|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
1794597|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1794598|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1794599|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1794600|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1794601|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794602|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
1794603|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794604|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794605|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1794606|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794612|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
1794613|NCT04937907|Benazepril|benazepril|mesh-list
1794614|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
1794615|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1794616|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1794617|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794618|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1794619|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794620|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1794621|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1794622|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
1794623|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1794624|NCT04937699|Aspirin|aspirin|mesh-list
1794625|NCT04937699|Ticagrelor|ticagrelor|mesh-list
1794626|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1794627|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1794628|NCT04937699|Analgesics|analgesics|mesh-ancestor
1794629|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
1794630|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794631|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794632|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1794633|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1794634|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1794635|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1794636|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794637|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1794638|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1794639|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1794640|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
1794641|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1794642|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1794643|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1794644|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
1794645|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794646|NCT04937673|Paclitaxel|paclitaxel|mesh-list
1794647|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1794648|NCT04937673|Cisplatin|cisplatin|mesh-list
1794649|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1794650|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794651|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
1794652|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
1794653|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
1794654|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794655|NCT04937894|Tigecycline|tigecycline|mesh-list
1794656|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1794657|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794658|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1794659|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1794660|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794661|NCT04937569|Ivermectin|ivermectin|mesh-list
1794662|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1794663|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794664|NCT04937634|Melphalan|melphalan|mesh-list
1794665|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1794666|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
1794667|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794668|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794669|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1794670|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1794671|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
1794672|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794673|NCT04937543|Beclomethasone|beclomethasone|mesh-list
1794674|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
1794675|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
1794676|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1794677|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
1794678|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794679|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794680|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1794681|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
1794682|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1794683|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1794684|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1794685|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
1794686|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794687|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794688|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1794689|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
1794690|NCT04937543|Hormones|hormones|mesh-ancestor
1794691|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1794692|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1794693|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1794694|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1794695|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
1794696|NCT04937881|Tenofovir|tenofovir|mesh-list
1794697|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
1794698|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794699|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1794700|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1794701|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1794702|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794703|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1794704|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1794705|NCT04937452|Rotigotine|rotigotine|mesh-list
1794706|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
1794707|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
1794708|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794709|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794710|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794711|NCT04937140|Antibodies|antibodies|mesh-list
1794712|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
1794713|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794714|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
1794715|NCT04937101|Codeine|codeine|mesh-list
1794716|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1794717|NCT04937101|Narcotics|narcotics|mesh-ancestor
1794718|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794719|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794720|NCT04937101|Analgesics|analgesics|mesh-ancestor
1794721|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
1794722|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794723|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
1794724|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
1794725|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
1794726|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
1794727|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1794728|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
1794729|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
1794730|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794731|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794732|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1794740|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1794741|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1794742|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1794743|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
1794744|NCT04937062|Glycerol|glycerol|mesh-list
1794745|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1794746|NCT04937062|Protective Agents|protective agents|mesh-ancestor
1794747|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794748|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794754|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
1794755|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1794756|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
1794757|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794758|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
1794759|NCT04936763|Protective Agents|protective agents|mesh-ancestor
1794760|NCT04936711|Bupivacaine|bupivacaine|mesh-list
1794761|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
1794762|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
1794763|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794764|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794765|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
1794766|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794770|NCT04936854|Sirolimus|sirolimus|mesh-list
1794771|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
1794772|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1794773|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1794774|NCT04936854|Prednisolone|prednisolone|mesh-list
1794775|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
1794776|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1794777|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
1794778|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1794779|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794780|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1794781|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794782|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
1794783|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1794784|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
1794785|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794786|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1794787|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
1794788|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
1794789|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794790|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1794791|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
1794792|NCT04936854|Hormones|hormones|mesh-ancestor
1794793|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1794794|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1794795|NCT04936854|Protective Agents|protective agents|mesh-ancestor
1794796|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1794797|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
1794798|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1794799|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794800|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1794801|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1794802|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794803|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
1794804|NCT04936971|Everolimus|everolimus|mesh-list
1794805|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794806|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1794807|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
1794808|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794809|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1794810|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1794811|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
1794812|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1794813|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794814|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1794815|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794816|NCT04936282|Tacrolimus|tacrolimus|mesh-list
1794817|NCT04936282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1794818|NCT04936282|Immunologic Factors|immunologic factors|mesh-ancestor
1794819|NCT04936282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794820|NCT04936282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1794821|NCT04936282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1794822|NCT04936282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794823|NCT04936399|Nivolumab|nivolumab|mesh-list
1794824|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1794825|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794826|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1794827|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794828|NCT04936295|Fulvestrant|fulvestrant|mesh-list
1794829|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1794830|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794831|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1794832|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1794833|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
1794834|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1794835|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794836|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
1794837|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1794838|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
1794839|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794840|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
1794841|NCT04936204|Protective Agents|protective agents|mesh-ancestor
1794842|NCT04936126|Amantadine|amantadine|mesh-list
1794843|NCT04936126|Pramipexole|pramipexole|mesh-list
1794844|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1794845|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
1794846|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1794847|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1794848|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1794849|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794850|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794851|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
1794852|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794853|NCT04936126|Protective Agents|protective agents|mesh-ancestor
1794854|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1794855|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1794856|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
1794857|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
1794858|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794859|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
1794860|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794861|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1794862|NCT04936126|Analgesics|analgesics|mesh-ancestor
1794863|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
1794864|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794865|NCT04935814|Vasopressins|vasopressins|mesh-list
1794866|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
1794867|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
1794868|NCT04935814|Coagulants|coagulants|mesh-ancestor
1794869|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1794870|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1794871|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
1794872|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794873|NCT04935931|Naltrexone|naltrexone|mesh-list
1794874|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1794875|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1794876|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794877|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
1794878|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794879|NCT04935788|Caseins|caseins|mesh-list
1794880|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
1794881|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
1794882|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794883|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
1794884|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794885|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794892|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1794893|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1794894|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1794895|NCT04935515|Anticoagulants|anticoagulants|mesh-list
1794896|NCT04935515|Coagulants|coagulants|mesh-list
1794897|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
1794898|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
1794899|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1794900|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
1794901|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
1794902|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794903|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794904|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794905|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
1794906|NCT04935541|Remifentanil|remifentanil|mesh-list
1794907|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1794908|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794909|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794910|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1794911|NCT04935541|Analgesics|analgesics|mesh-ancestor
1794912|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
1794913|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1794914|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1794915|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1794916|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1794917|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
1794918|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1794919|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794920|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1794921|NCT04935541|Narcotics|narcotics|mesh-ancestor
1794922|NCT04935034|Vitamin D|vitamin d|mesh-list
1794923|NCT04935034|Vitamins|vitamins|mesh-ancestor
1794924|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
1794925|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794926|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1794939|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1794940|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
1794941|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1794942|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
1794943|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794944|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794945|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1794946|NCT04935073|Cetrorelix|cetrorelix|mesh-list
1794947|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1794948|NCT04935073|Hormones|hormones|mesh-ancestor
1794949|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1794950|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794951|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1794952|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
1794953|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1794954|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
1794955|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
1794956|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
1794957|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1794958|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794959|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1794960|NCT04934683|Propofol|propofol|mesh-list
1794961|NCT04934683|Etomidate|etomidate|mesh-list
1794962|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1794963|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1794964|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794965|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1794966|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
1794967|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
1794968|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
1794969|NCT04934722|Androgens|androgens|mesh-list
1794970|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1794971|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794972|NCT04934722|Hormones|hormones|mesh-ancestor
1794973|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1794974|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794975|NCT04934579|Rituximab|rituximab|mesh-list
1794976|NCT04934579|Methotrexate|methotrexate|mesh-list
1794977|NCT04934579|Lenalidomide|lenalidomide|mesh-list
1794978|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1794979|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1794980|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
1794981|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1794982|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1794983|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1794984|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
1794985|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1794986|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1794987|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
1794988|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1794989|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
1794990|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1794991|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1794992|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1794993|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1794994|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1794995|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1794996|NCT04934579|Growth Substances|growth substances|mesh-ancestor
1794997|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
1794998|NCT04934852|Ephedrine|ephedrine|mesh-list
1794999|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
1795000|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1795001|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795002|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
1795003|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
1795004|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795005|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1795006|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
1795007|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795008|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795009|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1795010|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1795011|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
1795012|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
1795018|NCT04934618|Irinotecan|irinotecan|mesh-list
1795019|NCT04934618|Apatinib|apatinib|mesh-list
1795020|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1795021|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1795022|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795023|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795024|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795025|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1795026|NCT04934904|Ropivacaine|ropivacaine|mesh-list
1795027|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
1795028|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
1795029|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795030|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795031|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
1795032|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795033|NCT04934514|Gemcitabine|gemcitabine|mesh-list
1795034|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795035|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1795036|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
1795037|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795038|NCT04934514|Antiviral Agents|antiviral agents|mesh-ancestor
1795039|NCT04934514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1795040|NCT04934514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795041|NCT04934514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1795042|NCT04934514|Immunologic Factors|immunologic factors|mesh-ancestor
1795043|NCT04934514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795044|NCT04934748|Phenylephrine|phenylephrine|mesh-list
1795045|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
1795046|NCT04934748|Norepinephrine|norepinephrine|mesh-list
1795047|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1795048|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
1795049|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
1795050|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795051|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795052|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
1795053|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1795054|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
1795055|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
1795056|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1795057|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1795058|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1795059|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
1795060|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795061|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795062|NCT04934748|Protective Agents|protective agents|mesh-ancestor
1795063|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1795064|NCT04934228|Clonidine|clonidine|mesh-list
1795065|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1795066|NCT04934228|Diuretics|diuretics|mesh-ancestor
1795067|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
1795068|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795069|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1795070|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1795071|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795072|NCT04934228|Analgesics|analgesics|mesh-ancestor
1795073|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
1795074|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795075|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
1795076|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
1795077|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1795078|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1795079|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1795080|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
1795081|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795082|NCT04934475|Lenalidomide|lenalidomide|mesh-list
1795083|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
1795084|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795085|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1795086|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1795087|NCT04934475|Growth Substances|growth substances|mesh-ancestor
1795088|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
1795089|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795090|NCT04933942|Lomustine|lomustine|mesh-list
1795091|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1795092|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
1795093|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795094|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795120|NCT04933630|Norepinephrine|norepinephrine|mesh-list
1795121|NCT04933630|Serotonin|serotonin|mesh-list
1795122|NCT04933630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1795123|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1795124|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1795125|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
1795126|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795127|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795128|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795129|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
1795130|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
1795131|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795132|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1795133|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1795134|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
1795135|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1795136|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1795137|NCT04933903|Nivolumab|nivolumab|mesh-list
1795138|NCT04933903|Ipilimumab|ipilimumab|mesh-list
1795139|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1795140|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795141|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1795142|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795143|NCT04933864|Methylene Blue|methylene blue|mesh-list
1795144|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795145|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795146|NCT04933721|Berotralstat|berotralstat|mesh-list
1795147|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795148|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795149|NCT04933526|Dasatinib|dasatinib|mesh-list
1795150|NCT04933526|HH-GV-678|hh-gv-678|mesh-list
1795151|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795152|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1795153|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795154|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795155|NCT04933383|Budesonide|budesonide|mesh-list
1795156|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1795157|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1795158|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
1795159|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795160|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795161|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1795162|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
1795163|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
1795164|NCT04933383|Hormones|hormones|mesh-ancestor
1795165|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1795166|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1795167|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1795168|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
1795169|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
1795170|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1795171|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1795172|NCT04933292|Prednisolone|prednisolone|mesh-list
1795173|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
1795174|NCT04933292|Azathioprine|azathioprine|mesh-list
1795175|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1795176|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
1795177|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1795178|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795179|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1795180|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
1795181|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1795182|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1795183|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795184|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795185|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1795186|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
1795187|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
1795188|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795189|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795190|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1795191|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
1795192|NCT04933292|Hormones|hormones|mesh-ancestor
1795193|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1795194|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1795195|NCT04933292|Protective Agents|protective agents|mesh-ancestor
1795196|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1795197|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
1795198|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1795199|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1795200|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
1795201|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1795205|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
1795206|NCT04933084|Narcotics|narcotics|mesh-ancestor
1795207|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795208|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795209|NCT04933084|Analgesics|analgesics|mesh-ancestor
1795210|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
1795211|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795212|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
1795213|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
1795214|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
1795215|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795216|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795217|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
1795218|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795219|NCT04933279|Iodine|iodine|mesh-list
1795220|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
1795221|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1795222|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1795223|NCT04933279|Trace Elements|trace elements|mesh-ancestor
1795224|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
1795225|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795226|NCT04932980|Aflibercept|aflibercept|mesh-list
1795227|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1795228|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1795229|NCT04932980|Growth Substances|growth substances|mesh-ancestor
1795230|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795231|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
1795232|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795233|NCT04932564|Leflunomide|leflunomide|mesh-list
1795234|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795235|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795236|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1795237|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
1795238|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795239|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
1795240|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1795241|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795242|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795243|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1795244|NCT04932746|Analgesics|analgesics|mesh-ancestor
1795245|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
1795246|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795247|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1795248|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1795249|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1795250|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
1795251|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795252|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795253|NCT04932434|Psilocybin|psilocybin|mesh-list
1795254|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
1795255|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
1795256|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795257|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1795258|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1795259|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
1795260|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795261|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795262|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1795263|NCT04932135|Hormones|hormones|mesh-list
1795264|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1795265|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795266|NCT04932096|Melatonin|melatonin|mesh-list
1795267|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
1795268|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795269|NCT04932096|Protective Agents|protective agents|mesh-ancestor
1795270|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795271|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795272|NCT04932382|Misoprostol|misoprostol|mesh-list
1795273|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1795274|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
1795275|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1795276|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795277|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1795278|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1795279|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
1795280|NCT04932187|Capecitabine|capecitabine|mesh-list
1795281|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1795282|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
1795283|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795284|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795285|NCT04932083|Fentanyl|fentanyl|mesh-list
1795286|NCT04932083|Midazolam|midazolam|mesh-list
1795287|NCT04932083|Nalbuphine|nalbuphine|mesh-list
1795288|NCT04932083|Bupivacaine|bupivacaine|mesh-list
1795289|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
1795290|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
1795291|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795292|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795293|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
1795294|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795295|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1795296|NCT04932083|Narcotics|narcotics|mesh-ancestor
1795297|NCT04932083|Analgesics|analgesics|mesh-ancestor
1795298|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1795299|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1795300|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
1795301|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1795302|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1795303|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1795304|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1795305|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
1795306|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
1795307|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795308|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795309|NCT04931602|Vitamin D|vitamin d|mesh-list
1795310|NCT04931602|Vitamins|vitamins|mesh-ancestor
1795311|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
1795312|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795313|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1795314|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
1795315|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1795316|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795321|NCT04931693|Acetaminophen|acetaminophen|mesh-list
1795322|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1795323|NCT04931693|Analgesics|analgesics|mesh-ancestor
1795324|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
1795325|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795326|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795327|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
1795346|NCT04931368|Rituximab|rituximab|mesh-list
1795347|NCT04931368|Methotrexate|methotrexate|mesh-list
1795348|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1795349|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795350|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
1795351|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795352|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1795353|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1795354|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
1795355|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1795356|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1795357|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
1795358|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795359|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
1795360|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795361|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1795362|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1795363|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1795364|NCT04931433|Lidocaine|lidocaine|mesh-list
1795365|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
1795366|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
1795367|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795368|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795369|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
1795370|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795371|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1795372|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1795373|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1795374|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1795375|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795376|NCT04931524|Mitogens|mitogens|mesh-list
1795377|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
1795378|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795379|NCT04931355|Cetrorelix|cetrorelix|mesh-list
1795380|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1795381|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795382|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1795383|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
1795384|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1795385|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
1795386|NCT04930952|Ethanol|ethanol|mesh-list
1795387|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1795388|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1795389|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795390|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795391|NCT04931225|Landiolol|landiolol|mesh-list
1795392|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1795393|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1795394|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
1795395|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795396|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795397|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795398|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1795402|NCT04931108|Atenolol|atenolol|mesh-list
1795403|NCT04931108|Nitrendipine|nitrendipine|mesh-list
1795404|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1795405|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1795406|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
1795407|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
1795408|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795409|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795410|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1795411|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1795412|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1795413|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
1795414|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795415|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795416|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1795417|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1795418|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1795419|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
1795420|NCT04931121|Viscosupplements|viscosupplements|mesh-list
1795421|NCT04931121|Protective Agents|protective agents|mesh-ancestor
1795422|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795423|NCT04930900|Epinephrine|epinephrine|mesh-list
1795424|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1795425|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1795426|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
1795427|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795428|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795429|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795430|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1795431|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1795432|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
1795433|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795434|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1795435|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
1795436|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
1795437|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
1795438|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1795439|NCT04930744|Metformin|metformin|mesh-list
1795440|NCT04930744|Rifampin|rifampin|mesh-list
1795441|NCT04930744|Isoniazid|isoniazid|mesh-list
1795442|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
1795443|NCT04930744|Ethambutol|ethambutol|mesh-list
1795444|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1795445|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795446|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1795447|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
1795448|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1795449|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1795450|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
1795451|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1795452|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795453|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795454|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1795455|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1795456|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1795457|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1795458|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1795459|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1795460|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1795461|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1795462|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
1795463|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1795469|NCT04930627|Empagliflozin|empagliflozin|mesh-list
1795470|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1795471|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795472|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1795473|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795474|NCT04930887|Bupivacaine|bupivacaine|mesh-list
1795475|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
1795476|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
1795477|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795478|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795479|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
1795480|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795486|NCT04930458|Listerine|listerine|mesh-list
1795487|NCT04930458|Calcium|calcium|mesh-list
1795488|NCT04930458|Fluorides|fluorides|mesh-list
1795489|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
1795490|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
1795491|NCT04930458|Caseins|caseins|mesh-list
1795492|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1795493|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795494|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
1795495|NCT04930458|Protective Agents|protective agents|mesh-ancestor
1795496|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1795497|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1795498|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
1795499|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
1795500|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795501|NCT04930471|Metformin|metformin|mesh-list
1795502|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1795503|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795504|NCT04930211|Dexamethasone|dexamethasone|mesh-list
1795505|NCT04930211|Lidocaine|lidocaine|mesh-list
1795506|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1795507|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
1795508|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
1795509|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795510|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795511|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1795512|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
1795513|NCT04930211|Hormones|hormones|mesh-ancestor
1795514|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1795515|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1795516|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795517|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
1795518|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
1795519|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795520|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
1795521|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1795522|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1795523|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1795524|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1795525|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795526|NCT04930185|Vaccines|vaccines|mesh-list
1795527|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
1795528|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795529|NCT04930055|Vaccines|vaccines|mesh-list
1795530|NCT04930055|Immunologic Factors|immunologic factors|mesh-ancestor
1795531|NCT04930055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795532|NCT04930107|Fluconazole|fluconazole|mesh-list
1795533|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
1795534|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1795535|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1795536|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1795537|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795538|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795539|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1795540|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
1795541|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1795542|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795543|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1795544|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1795545|NCT04930133|Afatinib|afatinib|mesh-list
1795546|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795547|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1795548|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795549|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795550|NCT04929652|Irinotecan|irinotecan|mesh-list
1795551|NCT04929652|Molgramostim|molgramostim|mesh-list
1795552|NCT04929652|Sargramostim|sargramostim|mesh-list
1795553|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1795554|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1795555|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795556|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795557|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795558|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
1795559|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795563|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
1795564|NCT04929626|Albuterol|albuterol|mesh-list
1795565|NCT04929626|Analgesics|analgesics|mesh-ancestor
1795566|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
1795567|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795568|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795569|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
1795570|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795571|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1795572|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
1795573|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1795574|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1795575|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795576|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1795577|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
1795578|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1795579|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1795580|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
1795581|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1795582|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
1795583|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1795584|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1795585|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1795586|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
1795587|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795604|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1795605|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1795606|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1795607|NCT04929522|Anesthetics|anesthetics|mesh-list
1795608|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795609|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795610|NCT04929509|Listerine|listerine|mesh-list
1795611|NCT04929509|Fluorides|fluorides|mesh-list
1795612|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
1795613|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
1795614|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
1795615|NCT04929509|Protective Agents|protective agents|mesh-ancestor
1795616|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795617|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1795618|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1795637|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1795638|NCT04929080|Antibodies|antibodies|mesh-list
1795639|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
1795640|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1795641|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
1795642|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
1795643|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795644|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795652|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
1795653|NCT04928391|Nalbuphine|nalbuphine|mesh-list
1795654|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1795655|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795656|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795657|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1795658|NCT04928391|Analgesics|analgesics|mesh-ancestor
1795659|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
1795660|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795661|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1795662|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1795663|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1795664|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
1795665|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795666|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795667|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1795668|NCT04928391|Narcotics|narcotics|mesh-ancestor
1795669|NCT04928365|Antibodies|antibodies|mesh-list
1795670|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1795671|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
1795672|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795673|NCT04928352|Bupivacaine|bupivacaine|mesh-list
1795674|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
1795675|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
1795676|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795677|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795678|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
1795679|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795680|NCT04928495|Ascorbic Acid|ascorbic acid|mesh-list
1795681|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
1795682|NCT04928495|Bromhexine|bromhexine|mesh-list
1795683|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1795684|NCT04928495|Vitamins|vitamins|mesh-ancestor
1795685|NCT04928495|Micronutrients|micronutrients|mesh-ancestor
1795686|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795687|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
1795688|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795689|NCT04928495|Protective Agents|protective agents|mesh-ancestor
1795690|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
1795691|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1795692|NCT04928495|Expectorants|expectorants|mesh-ancestor
1795693|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
1795694|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1795695|NCT04928495|Antidotes|antidotes|mesh-ancestor
1795696|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
1795697|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
1795698|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1795699|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
1795700|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795701|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1795702|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1795703|NCT04928183|Nitroprusside|nitroprusside|mesh-list
1795704|NCT04928183|Phenylephrine|phenylephrine|mesh-list
1795705|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
1795706|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
1795707|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1795708|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
1795709|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
1795710|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795711|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795712|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
1795713|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1795714|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
1795715|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
1795716|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1795717|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1795718|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1795719|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
1795720|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795721|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795722|NCT04928183|Protective Agents|protective agents|mesh-ancestor
1795723|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
1795724|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
1795725|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1795726|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
1795727|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
1795728|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
1795729|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1795730|NCT04928066|Prednisone|prednisone|mesh-list
1795731|NCT04928066|Tofacitinib|tofacitinib|mesh-list
1795732|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1795733|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
1795734|NCT04928066|Hormones|hormones|mesh-ancestor
1795735|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1795736|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795737|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1795738|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795739|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1795740|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795741|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795742|NCT04927936|Vaccines|vaccines|mesh-list
1795743|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
1795744|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795745|NCT04927949|Cangrelor|cangrelor|mesh-list
1795746|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1795747|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1795748|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1795749|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1795750|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
1795751|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795752|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795753|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795754|NCT04928586|Pirfenidone|pirfenidone|mesh-list
1795755|NCT04928586|Analgesics|analgesics|mesh-ancestor
1795756|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
1795757|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795758|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795759|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1795760|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1795761|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1795762|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1795763|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795764|NCT04928651|Clonidine|clonidine|mesh-list
1795765|NCT04928651|Analgesics|analgesics|mesh-ancestor
1795766|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
1795767|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795768|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795769|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1795770|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
1795771|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
1795772|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1795773|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1795774|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1795775|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
1795776|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795777|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795778|NCT04928820|Edetic Acid|edetic acid|mesh-list
1795779|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1795780|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
1795781|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
1795782|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795783|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
1795784|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1795785|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1795789|NCT04928703|Ketamine|ketamine|mesh-list
1795790|NCT04928703|Analgesics|analgesics|mesh-ancestor
1795791|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
1795792|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795793|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795794|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1795795|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1795796|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
1795797|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
1795798|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795799|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1795800|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1795801|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795802|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795803|NCT04927858|Empagliflozin|empagliflozin|mesh-list
1795804|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1795805|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795806|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1795807|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795808|NCT04927585|Vaccines|vaccines|mesh-list
1795809|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
1795810|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795811|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
1795812|NCT04927481|Analgesics|analgesics|mesh-ancestor
1795813|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
1795814|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795815|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795816|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795817|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1795818|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1795819|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795820|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795830|NCT04927299|Losartan|losartan|mesh-list
1795831|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1795832|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
1795833|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1795834|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1795835|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1795836|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1795837|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795838|NCT04927299|Diuretics|diuretics|mesh-ancestor
1795839|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
1795840|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795841|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1795842|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1795843|NCT04926844|Midazolam|midazolam|mesh-list
1795844|NCT04926844|Levetiracetam|levetiracetam|mesh-list
1795845|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1795846|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1795847|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795848|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795849|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1795850|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1795851|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1795852|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1795853|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
1795854|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
1795855|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
1795856|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
1795857|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1795858|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795859|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
1795860|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
1795861|NCT04927000|Tofacitinib|tofacitinib|mesh-list
1795862|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1795863|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795864|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795865|NCT04927052|Lidocaine|lidocaine|mesh-list
1795866|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
1795867|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
1795868|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795869|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795870|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
1795871|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795872|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1795873|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1795874|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1795875|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1795876|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795877|NCT04926753|Fluorouracil|fluorouracil|mesh-list
1795878|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795879|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
1795880|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795881|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1795882|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1795883|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
1795884|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795885|NCT04926480|Anesthetics|anesthetics|mesh-list
1795886|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795887|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795888|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1795889|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1795890|NCT04927039|Iloprost|iloprost|mesh-list
1795891|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1795892|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
1795893|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
1795894|NCT04926545|Fluorouracil|fluorouracil|mesh-list
1795895|NCT04926545|Irinotecan|irinotecan|mesh-list
1795896|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
1795897|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795898|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1795899|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795900|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1795901|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
1795902|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795903|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1795904|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1795905|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795906|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1795907|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
1795908|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1795909|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1795910|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1795911|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1795912|NCT04926532|Sorafenib|sorafenib|mesh-list
1795913|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795914|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1795915|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795916|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795917|NCT04926571|Dexamethasone|dexamethasone|mesh-list
1795918|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1795919|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
1795920|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
1795921|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795922|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795923|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1795924|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
1795925|NCT04926571|Hormones|hormones|mesh-ancestor
1795926|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1795927|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1795928|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795929|NCT04925973|Tofacitinib|tofacitinib|mesh-list
1795930|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1795931|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795932|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795933|NCT04926155|Metformin|metformin|mesh-list
1795934|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1795935|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795939|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1795940|NCT04925531|Ampicillin|ampicillin|mesh-list
1795941|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1795942|NCT04925505|Anesthetics|anesthetics|mesh-list
1795943|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795944|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795945|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
1795946|NCT04925557|Siponimod|siponimod|mesh-list
1795947|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
1795948|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795949|NCT04925557|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1795950|NCT04925557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795951|NCT04925557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1795952|NCT04925375|Abatacept|abatacept|mesh-list
1795953|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1795954|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795955|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795956|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1795957|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
1795958|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795959|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1795960|NCT04925141|Dasatinib|dasatinib|mesh-list
1795961|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1795962|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1795963|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795964|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795965|NCT04925063|Metformin|metformin|mesh-list
1795966|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1795967|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795968|NCT04925076|Ethanol|ethanol|mesh-list
1795969|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1795970|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1795971|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1795972|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795973|NCT04925167|Heparin|heparin|mesh-list
1795974|NCT04925167|Calcium heparin|calcium heparin|mesh-list
1795975|NCT04925167|Argatroban|argatroban|mesh-list
1795976|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
1795977|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1795978|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1795979|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1795980|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
1795981|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1795982|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
1795983|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1795984|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1795985|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1795986|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1795987|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1795988|NCT04924647|Dexamethasone|dexamethasone|mesh-list
1795989|NCT04924647|Lenalidomide|lenalidomide|mesh-list
1795990|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1795991|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
1795992|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
1795993|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1795994|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1795995|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1795996|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
1795997|NCT04924647|Hormones|hormones|mesh-ancestor
1795998|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1795999|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1796000|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796001|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
1796002|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1796003|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1796004|NCT04924647|Growth Substances|growth substances|mesh-ancestor
1796005|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
1796006|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
1796007|NCT04924192|Irinotecan|irinotecan|mesh-list
1796008|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1796009|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1796010|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796011|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796012|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796013|NCT04924322|Enoxaparin|enoxaparin|mesh-list
1796014|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
1796015|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1796016|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1796017|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796020|NCT04924257|Esketamine|esketamine|mesh-list
1796021|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
1796022|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1796023|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
1796024|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1796025|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1796026|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1796027|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
1796028|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796029|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796030|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796045|NCT04923776|Carboplatin|carboplatin|mesh-list
1796046|NCT04923776|Etoposide|etoposide|mesh-list
1796047|NCT04923776|Atezolizumab|atezolizumab|mesh-list
1796048|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796049|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1796050|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1796051|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1796052|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796053|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796054|NCT04923659|Nimodipine|nimodipine|mesh-list
1796055|NCT04923659|Carbamazepine|carbamazepine|mesh-list
1796056|NCT04923659|Lorazepam|lorazepam|mesh-list
1796057|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
1796058|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
1796059|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
1796060|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1796061|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1796062|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796212|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
1796063|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796064|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796065|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
1796066|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
1796067|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
1796068|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796069|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796070|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1796071|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1796072|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1796073|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1796074|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1796075|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
1796076|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
1796077|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
1796078|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1796079|NCT04923659|Analgesics|analgesics|mesh-ancestor
1796080|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
1796081|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1796082|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1796083|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1796084|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1796085|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1796086|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1796087|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1796088|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
1796089|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
1796090|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1796091|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1796092|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796093|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1796094|NCT04923737|Analgesics|analgesics|mesh-ancestor
1796095|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
1796096|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796097|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1796098|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1796099|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1796100|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
1796101|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796102|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796108|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1796109|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1796110|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1796111|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
1796112|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796113|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796114|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1796115|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
1796116|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1796117|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1796118|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1796119|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1796120|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796121|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
1796122|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796123|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796124|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1796125|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796126|NCT04922944|Vaccines|vaccines|mesh-list
1796127|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
1796128|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796129|NCT04922827|Infliximab|infliximab|mesh-list
1796130|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
1796131|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796132|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1796133|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
1796134|NCT04922996|Calcium|calcium|mesh-list
1796135|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1796136|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796137|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
1796138|NCT04922996|Coagulants|coagulants|mesh-ancestor
1796139|NCT04923113|Amoxicillin|amoxicillin|mesh-list
1796140|NCT04923113|Minocycline|minocycline|mesh-list
1796141|NCT04923113|Rabeprazole|rabeprazole|mesh-list
1796142|NCT04923113|Bismuth|bismuth|mesh-list
1796143|NCT04923113|Antibodies|antibodies|mesh-list
1796144|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
1796145|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796146|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1796147|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796148|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1796149|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796150|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1796151|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796152|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796153|NCT04923113|Antacids|antacids|mesh-ancestor
1796154|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1796155|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1796156|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
1796157|NCT04922359|Lidocaine|lidocaine|mesh-list
1796158|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
1796159|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
1796160|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1796161|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796162|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
1796163|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796164|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1796165|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1796166|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1796167|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1796168|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796169|NCT04922567|Prednisone|prednisone|mesh-list
1796170|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
1796171|NCT04922567|Doxorubicin|doxorubicin|mesh-list
1796172|NCT04922567|Vincristine|vincristine|mesh-list
1796173|NCT04922567|Lenalidomide|lenalidomide|mesh-list
1796174|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1796175|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
1796176|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796177|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1796178|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1796179|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
1796180|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796181|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796182|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1796183|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1796184|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1796185|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1796186|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796187|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1796188|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
1796189|NCT04922567|Hormones|hormones|mesh-ancestor
1796190|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1796191|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1796192|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1796193|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
1796194|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
1796195|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
1796196|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1796197|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1796198|NCT04922567|Growth Substances|growth substances|mesh-ancestor
1796199|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
1796200|NCT04922450|Paclitaxel|paclitaxel|mesh-list
1796201|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1796202|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1796203|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796204|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
1796205|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
1796206|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
1796207|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796208|NCT04922658|Vinorelbine|vinorelbine|mesh-list
1796209|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1796210|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796211|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
1796213|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
1796214|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796215|NCT04922723|Daratumumab|daratumumab|mesh-list
1796216|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796217|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
1796218|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1796219|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1796220|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796221|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1796222|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796223|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1796224|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1796225|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796226|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796227|NCT04922034|Amoxicillin|amoxicillin|mesh-list
1796228|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1796229|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796230|NCT04921943|Azithromycin|azithromycin|mesh-list
1796231|NCT04921943|Rifampin|rifampin|mesh-list
1796232|NCT04921943|Ethambutol|ethambutol|mesh-list
1796233|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1796234|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796235|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1796236|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
1796237|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
1796238|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1796239|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796240|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796241|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1796242|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1796243|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1796244|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1796245|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1796246|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1796247|NCT04922008|Capecitabine|capecitabine|mesh-list
1796248|NCT04922008|Trastuzumab|trastuzumab|mesh-list
1796249|NCT04922008|Vinorelbine|vinorelbine|mesh-list
1796250|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1796251|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
1796252|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796253|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796254|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1796255|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1796256|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
1796257|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
1796258|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
1796259|NCT04922151|Ranibizumab|ranibizumab|mesh-list
1796260|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1796261|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1796262|NCT04922151|Growth Substances|growth substances|mesh-ancestor
1796263|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796264|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
1796265|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796266|NCT04921930|Artesunate|artesunate|mesh-list
1796267|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
1796268|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1796269|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1796270|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796271|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796272|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
1796273|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
1796274|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1796275|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
1796281|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
1796282|NCT04921878|Analgesics|analgesics|mesh-ancestor
1796283|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
1796284|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796285|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796286|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796287|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1796288|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1796289|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796290|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796291|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1796292|NCT04921657|Simvastatin|simvastatin|mesh-list
1796293|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1796294|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1796295|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
1796296|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796297|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1796298|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1796299|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796300|NCT04921670|Infliximab|infliximab|mesh-list
1796301|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
1796302|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796303|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1796304|NCT04922424|Atorvastatin|atorvastatin|mesh-list
1796305|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1796306|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1796307|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
1796308|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796309|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1796310|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1796311|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796312|NCT04921904|Ramucirumab|ramucirumab|mesh-list
1796313|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796314|NCT04921982|Propranolol|propranolol|mesh-list
1796315|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1796316|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1796317|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
1796318|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796319|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796320|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796321|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1796322|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1796323|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
1796324|NCT04921566|Torsemide|torsemide|mesh-list
1796325|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1796326|NCT04921566|Diuretics|diuretics|mesh-ancestor
1796327|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
1796328|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796329|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1796330|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1796331|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796332|NCT04921527|Paclitaxel|paclitaxel|mesh-list
1796333|NCT04921527|Chiauranib|chiauranib|mesh-list
1796334|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1796335|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796336|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
1796337|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
1796338|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
1796339|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796340|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1796341|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796342|NCT04921306|Clenbuterol|clenbuterol|mesh-list
1796343|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1796344|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1796345|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
1796346|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796347|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796348|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796349|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1796350|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
1796351|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796352|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1796353|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
1796354|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
1796355|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
1796356|NCT04921111|Vaccines|vaccines|mesh-list
1796357|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
1796358|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796359|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1796360|NCT04921111|Antacids|antacids|mesh-ancestor
1796437|NCT04920838|Hormones|hormones|mesh-ancestor
1796361|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796362|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796363|NCT04921358|Docetaxel|docetaxel|mesh-list
1796364|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796365|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
1796366|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
1796367|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
1796368|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796369|NCT04921371|Listerine|listerine|mesh-list
1796370|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1796371|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796372|NCT04921124|Teriparatide|teriparatide|mesh-list
1796373|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1796374|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796375|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1796383|NCT04921046|Lidocaine|lidocaine|mesh-list
1796384|NCT04921046|Midazolam|midazolam|mesh-list
1796385|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1796386|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1796387|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1796388|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796389|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1796390|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1796391|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1796392|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1796393|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
1796394|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
1796395|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
1796396|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
1796397|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796398|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796399|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
1796400|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
1796401|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796402|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1796403|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1796404|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1796405|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1796406|NCT04920968|Rituximab|rituximab|mesh-list
1796407|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
1796408|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1796409|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796410|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
1796411|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796412|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1796420|NCT04920981|Atezolizumab|atezolizumab|mesh-list
1796421|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796422|NCT04920838|Acetaminophen|acetaminophen|mesh-list
1796423|NCT04920838|Ciclesonide|ciclesonide|mesh-list
1796424|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
1796425|NCT04920838|Telmisartan|telmisartan|mesh-list
1796426|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1796427|NCT04920838|Analgesics|analgesics|mesh-ancestor
1796428|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
1796429|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796430|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796431|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
1796432|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1796433|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1796434|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1796435|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796436|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
1796438|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1796439|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1796440|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1796441|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796442|NCT04920747|Taxane|taxane|mesh-list
1796443|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796444|NCT04920760|Vitamin A|vitamin a|mesh-list
1796445|NCT04920760|Vitamins|vitamins|mesh-ancestor
1796446|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
1796447|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796448|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
1796449|NCT04920669|Bupivacaine|bupivacaine|mesh-list
1796450|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
1796451|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
1796452|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1796453|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796454|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
1796455|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796456|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1796457|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1796458|NCT04920669|Analgesics|analgesics|mesh-ancestor
1796459|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1796460|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1796461|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1796462|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
1796463|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796464|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796465|NCT04920604|Anesthetics|anesthetics|mesh-list
1796466|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1796467|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796468|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
1796469|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1796470|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
1796471|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796472|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796473|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1796474|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
1796475|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1796476|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
1796477|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796478|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796479|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1796480|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
1796481|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
1796482|NCT04920695|Protective Agents|protective agents|mesh-ancestor
1796483|NCT04920708|Fulvestrant|fulvestrant|mesh-list
1796484|NCT04920708|Palbociclib|palbociclib|mesh-list
1796485|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1796486|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796487|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1796488|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1796489|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
1796490|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1796491|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796492|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1796493|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796494|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796495|NCT04920565|Polymyxins|polymyxins|mesh-list
1796496|NCT04920565|Polymyxin B|polymyxin b|mesh-list
1796497|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1796498|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796499|NCT04920682|Iodine|iodine|mesh-list
1796500|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1796501|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796502|NCT04920682|Trace Elements|trace elements|mesh-ancestor
1796503|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
1796504|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796505|NCT04921033|Prednisolone|prednisolone|mesh-list
1796506|NCT04921033|Budesonide|budesonide|mesh-list
1796507|NCT04921033|Azathioprine|azathioprine|mesh-list
1796508|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1796509|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
1796510|NCT04921033|Hormones|hormones|mesh-ancestor
1796511|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1796512|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796589|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
1796513|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1796514|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796515|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
1796516|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796517|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1796518|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1796519|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
1796520|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
1796521|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796522|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1796523|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1796524|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
1796525|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1796526|NCT04920357|Vaccines|vaccines|mesh-list
1796527|NCT04920357|Immunologic Factors|immunologic factors|mesh-ancestor
1796528|NCT04920357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796529|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
1796530|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1796531|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
1796532|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796533|NCT04920448|Expectorants|expectorants|mesh-ancestor
1796534|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
1796535|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1796536|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
1796537|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796538|NCT04920448|Protective Agents|protective agents|mesh-ancestor
1796539|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796540|NCT04920448|Antidotes|antidotes|mesh-ancestor
1796541|NCT04920539|Dronabinol|dronabinol|mesh-list
1796542|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
1796543|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796544|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1796545|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1796546|NCT04920539|Analgesics|analgesics|mesh-ancestor
1796547|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
1796548|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796549|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1796550|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1796551|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796552|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796553|NCT04920539|Hormones|hormones|mesh-ancestor
1796554|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1796555|NCT04920500|Cytarabine|cytarabine|mesh-list
1796556|NCT04920500|Daunorubicin|daunorubicin|mesh-list
1796557|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1796558|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
1796559|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796560|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796561|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
1796562|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796563|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1796564|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
1796565|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796566|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1796567|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1796568|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1796569|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796570|NCT04920344|Cisplatin|cisplatin|mesh-list
1796571|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796572|NCT04920032|Irinotecan|irinotecan|mesh-list
1796573|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1796574|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1796575|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796576|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796577|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796578|NCT04920149|Mesalamine|mesalamine|mesh-list
1796579|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1796580|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1796581|NCT04920149|Analgesics|analgesics|mesh-ancestor
1796582|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
1796583|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796584|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796585|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1796586|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1796587|NCT04919564|Furosemide|furosemide|mesh-list
1796588|NCT04919564|Diuretics|diuretics|mesh-ancestor
1796590|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796591|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1796592|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1796593|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796594|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
1796595|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
1796596|NCT04919460|Coagulants|coagulants|mesh-ancestor
1796597|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
1796598|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796599|NCT04919317|Dexamethasone|dexamethasone|mesh-list
1796600|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1796601|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
1796602|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
1796603|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796604|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796605|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796606|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
1796607|NCT04919317|Hormones|hormones|mesh-ancestor
1796608|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1796609|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1796610|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796646|NCT04919252|Vedolizumab|vedolizumab|mesh-list
1796647|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796648|NCT04919096|Aflibercept|aflibercept|mesh-list
1796649|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1796650|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1796651|NCT04919096|Growth Substances|growth substances|mesh-ancestor
1796652|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796653|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
1796654|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796655|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
1796656|NCT04919174|Remifentanil|remifentanil|mesh-list
1796657|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1796658|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1796659|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796660|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1796661|NCT04919174|Analgesics|analgesics|mesh-ancestor
1796662|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
1796663|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796664|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1796665|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1796666|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1796667|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
1796668|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796669|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796670|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1796671|NCT04919174|Narcotics|narcotics|mesh-ancestor
1796672|NCT04918914|Dapsone|dapsone|mesh-list
1796673|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796674|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
1796675|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1796676|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1796677|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1796678|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796679|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796680|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
1796681|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1796682|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
1796683|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1796684|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1796685|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796686|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
1796687|NCT04918589|Coagulants|coagulants|mesh-ancestor
1796688|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
1796689|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1796690|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1796691|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796692|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
1796693|NCT04918576|Coagulants|coagulants|mesh-ancestor
1796694|NCT04918823|Cyclosporine|cyclosporine|mesh-list
1796695|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1796696|NCT04918823|Cyclosporins|cyclosporins|mesh-list
1796697|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796698|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796699|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1796700|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
1796701|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796702|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
1796703|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796704|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
1796705|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1796706|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1796707|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1796708|NCT04918758|Sucralfate|sucralfate|mesh-list
1796709|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1796710|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796711|NCT04918524|Aspirin|aspirin|mesh-list
1796712|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
1796713|NCT04918524|Prednisone|prednisone|mesh-list
1796714|NCT04918524|Heparin|heparin|mesh-list
1796715|NCT04918524|Enoxaparin|enoxaparin|mesh-list
1796716|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1796717|NCT04918524|Tinzaparin|tinzaparin|mesh-list
1796718|NCT04918524|Dalteparin|dalteparin|mesh-list
1796719|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1796720|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
1796721|NCT04918524|Hormones|hormones|mesh-ancestor
1796722|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1796723|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796724|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1796725|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796726|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1796727|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1796728|NCT04918524|Analgesics|analgesics|mesh-ancestor
1796729|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
1796730|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796731|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1796732|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1796733|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1796734|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796735|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1796736|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1796737|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796738|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
1796739|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
1796740|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
1796741|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1796742|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1796743|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796744|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
1796745|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1796746|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
1796747|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796748|NCT04918719|Expectorants|expectorants|mesh-ancestor
1796749|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
1796750|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1796751|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
1796752|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796753|NCT04918719|Protective Agents|protective agents|mesh-ancestor
1796754|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796755|NCT04918719|Antidotes|antidotes|mesh-ancestor
1796756|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
1796757|NCT04918563|Acetylcholine|acetylcholine|mesh-list
1796758|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
1796759|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1796760|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
1796761|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796762|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796763|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796764|NCT04918862|Granisetron|granisetron|mesh-list
1796765|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796766|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
1796767|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
1796768|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796769|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796770|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1796771|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
1796772|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796773|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796774|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
1796775|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1796776|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1796777|NCT04918953|Prednisolone|prednisolone|mesh-list
1796778|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
1796779|NCT04918953|Budesonide|budesonide|mesh-list
1796780|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1796781|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
1796782|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1796783|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
1796784|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
1796785|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796786|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796787|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796788|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
1796789|NCT04918953|Hormones|hormones|mesh-ancestor
1796790|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1796791|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1796792|NCT04918953|Protective Agents|protective agents|mesh-ancestor
1796793|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1796794|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796795|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1796796|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1796797|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
1796798|NCT04918810|Docetaxel|docetaxel|mesh-list
1796799|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796800|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
1796801|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
1796802|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
1796803|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796804|NCT04918069|Capsaicin|capsaicin|mesh-list
1796805|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
1796806|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
1796807|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
1796808|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796809|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796810|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
1796811|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
1796812|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1796813|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
1796814|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796815|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796816|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
1796817|NCT04918433|Anesthetics|anesthetics|mesh-list
1796818|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1796819|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796820|NCT04918264|Capecitabine|capecitabine|mesh-list
1796821|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1796822|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
1796823|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796824|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796825|NCT04918407|Empagliflozin|empagliflozin|mesh-list
1796826|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1796827|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796828|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1796829|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796830|NCT04917679|Diacetylrhein|diacetylrhein|mesh-list
1796831|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1796832|NCT04917718|Tacrolimus|tacrolimus|mesh-list
1796833|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1796834|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
1796835|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796836|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1796837|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796838|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796839|NCT04917692|Empagliflozin|empagliflozin|mesh-list
1796840|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1796841|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796842|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1796843|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796844|NCT04917627|Vancomycin|vancomycin|mesh-list
1796845|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1796846|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796847|NCT04917900|Paclitaxel|paclitaxel|mesh-list
1796848|NCT04917900|Trastuzumab|trastuzumab|mesh-list
1796849|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1796850|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1796851|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796852|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
1796853|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
1796854|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
1796855|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796856|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1796857|NCT04917757|Dexamethasone|dexamethasone|mesh-list
1796858|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1796859|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
1796860|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
1796861|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796862|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796863|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796864|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
1796865|NCT04917757|Hormones|hormones|mesh-ancestor
1796866|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1796867|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1796868|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796869|NCT04917588|Lidocaine|lidocaine|mesh-list
1796870|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
1796871|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
1796872|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1796873|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796874|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
1796875|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796876|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1796877|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1796878|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1796879|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1796880|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796881|NCT04917497|Simendan|simendan|mesh-list
1796882|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1796883|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
1796884|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1796885|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1796886|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796887|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796888|NCT04917497|Protective Agents|protective agents|mesh-ancestor
1796889|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796890|NCT04917458|Vitamin D|vitamin d|mesh-list
1796891|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
1796892|NCT04917458|Vitamins|vitamins|mesh-ancestor
1796893|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
1797193|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
1796894|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796895|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1796896|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1796897|NCT04917484|Octreotide|octreotide|mesh-list
1796898|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
1796899|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796900|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1796901|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796902|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1796903|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796904|NCT04917406|Dexamethasone|dexamethasone|mesh-list
1796905|NCT04917406|Lidocaine|lidocaine|mesh-list
1796906|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1796907|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
1796908|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
1796909|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796910|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796911|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796912|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
1796913|NCT04917406|Hormones|hormones|mesh-ancestor
1796914|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1796915|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1796916|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796917|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
1796918|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
1796919|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1796920|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
1796921|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1796922|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1796923|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1796924|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1796925|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796943|NCT04917055|Dexamethasone|dexamethasone|mesh-list
1796944|NCT04917055|Epinephrine|epinephrine|mesh-list
1796945|NCT04917055|Ropivacaine|ropivacaine|mesh-list
1796946|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1796947|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
1796948|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
1796949|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796950|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796951|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796952|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
1796953|NCT04917055|Hormones|hormones|mesh-ancestor
1796954|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1796955|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1796956|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796957|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
1796958|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
1796959|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1796960|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
1796961|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1796962|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1796963|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
1796964|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1796965|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796966|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1796967|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1796968|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1796969|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
1796970|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
1796971|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
1796972|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1796973|NCT04917250|Gemcitabine|gemcitabine|mesh-list
1796974|NCT04917250|Dexamethasone|dexamethasone|mesh-list
1796975|NCT04917250|Etoposide|etoposide|mesh-list
1796976|NCT04917250|Pegaspargase|pegaspargase|mesh-list
1796977|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1796978|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
1796979|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
1796980|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1796981|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1796982|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1796983|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
1796984|NCT04917250|Hormones|hormones|mesh-ancestor
1796985|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1796986|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1796987|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1796988|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1796989|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
1796990|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1796991|NCT04917250|Antiviral Agents|antiviral agents|mesh-ancestor
1796992|NCT04917250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1796993|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1796994|NCT04917250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1796995|NCT04917250|Immunologic Factors|immunologic factors|mesh-ancestor
1796996|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1796997|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1796998|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1796999|NCT04916925|Vitamin D|vitamin d|mesh-list
1797000|NCT04916925|Vitamins|vitamins|mesh-ancestor
1797001|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
1797002|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797003|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1797004|NCT04916951|Amoxicillin|amoxicillin|mesh-list
1797005|NCT04916951|Cephalexin|cephalexin|mesh-list
1797006|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1797007|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797008|NCT04916899|Rifampin|rifampin|mesh-list
1797009|NCT04916899|Isoniazid|isoniazid|mesh-list
1797010|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
1797011|NCT04916899|Ethambutol|ethambutol|mesh-list
1797012|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1797013|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
1797014|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1797015|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797016|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
1797017|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1797018|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797019|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797020|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1797021|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1797022|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1797023|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1797024|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1797025|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1797026|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1797027|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1797028|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
1797029|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1797031|NCT04916886|Vaccines|vaccines|mesh-list
1797032|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
1797033|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797034|NCT04916821|Propolis|propolis|mesh-list
1797035|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797036|NCT04916522|Colchicine|colchicine|mesh-list
1797037|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
1797038|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1797039|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
1797040|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
1797041|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
1797042|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797043|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797044|NCT04916665|Teduglutide|teduglutide|mesh-list
1797420|NCT04913389|Acetazolamide|acetazolamide|mesh-list
1797045|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1797046|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1797047|NCT04916665|Protective Agents|protective agents|mesh-ancestor
1797048|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797049|NCT04916509|Fulvestrant|fulvestrant|mesh-list
1797050|NCT04916509|Palbociclib|palbociclib|mesh-list
1797051|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
1797052|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1797053|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797054|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1797055|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1797056|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
1797057|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1797058|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797059|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1797060|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797061|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797062|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1797063|NCT04916548|Ketamine|ketamine|mesh-list
1797064|NCT04916548|Analgesics|analgesics|mesh-ancestor
1797065|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
1797066|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797067|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797068|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1797069|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1797070|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
1797071|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
1797072|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1797073|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1797074|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1797075|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1797076|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797077|NCT04916613|Androgens|androgens|mesh-list
1797078|NCT04916613|Hormones|hormones|mesh-ancestor
1797079|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1797080|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797081|NCT04916574|Antibodies|antibodies|mesh-list
1797082|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
1797083|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797084|NCT04916418|Ropivacaine|ropivacaine|mesh-list
1797085|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
1797086|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
1797087|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1797088|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797089|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
1797090|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797091|NCT04916392|Bupivacaine|bupivacaine|mesh-list
1797092|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
1797093|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
1797094|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1797095|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797096|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
1797097|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797098|NCT04916353|Triamcinolone|triamcinolone|mesh-list
1797099|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1797100|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1797101|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1797102|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1797103|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
1797104|NCT04916353|Hormones|hormones|mesh-ancestor
1797105|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1797106|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797107|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1797108|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
1797109|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797110|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797111|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
1797112|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1797113|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1797114|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797115|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1797116|NCT04916197|Analgesics|analgesics|mesh-ancestor
1797117|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
1797118|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797119|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1797120|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1797121|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1797122|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
1797123|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1797124|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797125|NCT04916691|Ropivacaine|ropivacaine|mesh-list
1797126|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
1797127|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
1797128|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1797129|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797130|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
1797131|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797132|NCT04916327|Antioxidants|antioxidants|mesh-list
1797133|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797134|NCT04916327|Protective Agents|protective agents|mesh-ancestor
1797135|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797136|NCT04916093|Metformin|metformin|mesh-list
1797137|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1797138|NCT04916093|Vildagliptin|vildagliptin|mesh-list
1797139|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1797140|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797141|NCT04916093|Incretins|incretins|mesh-ancestor
1797142|NCT04916093|Hormones|hormones|mesh-ancestor
1797143|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1797144|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1797145|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
1797146|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797147|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797148|NCT04915846|Tamoxifen|tamoxifen|mesh-list
1797149|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1797150|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
1797151|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1797152|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797153|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1797154|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797155|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1797156|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1797157|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1797158|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
1797159|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1797160|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797161|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
1797162|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1797163|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
1797164|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797165|NCT04916080|Expectorants|expectorants|mesh-ancestor
1797166|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
1797167|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1797168|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
1797169|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797170|NCT04916080|Protective Agents|protective agents|mesh-ancestor
1797171|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797172|NCT04916080|Antidotes|antidotes|mesh-ancestor
1797180|NCT04915963|Vitamin D|vitamin d|mesh-list
1797181|NCT04915963|Vitamins|vitamins|mesh-ancestor
1797182|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
1797183|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797184|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1797185|NCT04915807|Paclitaxel|paclitaxel|mesh-list
1797186|NCT04915807|Irinotecan|irinotecan|mesh-list
1797187|NCT04915807|Ramucirumab|ramucirumab|mesh-list
1797188|NCT04915807|Taxane|taxane|mesh-list
1797189|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1797190|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797191|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
1797192|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
1797194|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797195|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1797196|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1797197|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797198|NCT04915508|Hormones|hormones|mesh-list
1797199|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1797200|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797201|NCT04915612|Cytarabine|cytarabine|mesh-list
1797202|NCT04915612|Daunorubicin|daunorubicin|mesh-list
1797203|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
1797204|NCT04915612|Calicheamicins|calicheamicins|mesh-list
1797205|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1797206|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
1797207|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797208|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797209|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
1797210|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797211|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1797212|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
1797213|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797214|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1797215|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1797216|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1797217|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797218|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1797219|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1797220|NCT04915586|Plasminogen|plasminogen|mesh-list
1797221|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1797222|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1797223|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797224|NCT04915482|Rituximab|rituximab|mesh-list
1797225|NCT04915482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1797226|NCT04915482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797227|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
1797228|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797229|NCT04915482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1797230|NCT04915365|Acetazolamide|acetazolamide|mesh-list
1797231|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
1797232|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1797233|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797234|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797235|NCT04915365|Diuretics|diuretics|mesh-ancestor
1797236|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
1797237|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797254|NCT04915287|Maleic acid|maleic acid|mesh-list
1797255|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797256|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797257|NCT04915456|Prednisolone|prednisolone|mesh-list
1797258|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1797259|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
1797260|NCT04915456|Hormones|hormones|mesh-ancestor
1797261|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1797262|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797263|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1797264|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797265|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
1797266|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
1797267|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1797268|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797269|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797270|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
1797271|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1797272|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1797273|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797274|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
1797275|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1797276|NCT04914910|Insulin|insulin|mesh-list
1797277|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1797278|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797279|NCT04914936|Rifampin|rifampin|mesh-list
1797280|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
1797281|NCT04914936|Omeprazole|omeprazole|mesh-list
1797282|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
1797283|NCT04914936|Calcium|calcium|mesh-list
1797284|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1797285|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797286|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1797287|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1797288|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1797289|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797290|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797291|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1797292|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
1797293|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1797294|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797295|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
1797296|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1797297|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1797298|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1797299|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1797300|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1797301|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1797302|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1797303|NCT04914936|Antacids|antacids|mesh-ancestor
1797304|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797333|NCT04914390|Paclitaxel|paclitaxel|mesh-list
1797334|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1797335|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797336|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
1797337|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
1797338|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
1797339|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797340|NCT04914598|Cisplatin|cisplatin|mesh-list
1797341|NCT04914598|Endostar protein|endostar protein|mesh-list
1797342|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797343|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1797344|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1797345|NCT04914598|Growth Substances|growth substances|mesh-ancestor
1797346|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797347|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
1797355|NCT04913987|Cimetidine|cimetidine|mesh-list
1797356|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1797357|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1797358|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1797359|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
1797360|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
1797361|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1797362|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797363|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797364|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1797365|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1797366|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797367|NCT04914247|Selexipag|selexipag|mesh-list
1797368|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1797383|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
1797384|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1797385|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797386|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797387|NCT04913714|Vaccines|vaccines|mesh-list
1797388|NCT04913714|Immunologic Factors|immunologic factors|mesh-ancestor
1797389|NCT04913714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797390|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
1797391|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1797392|NCT04913831|Protective Agents|protective agents|mesh-ancestor
1797393|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797394|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
1797395|NCT04913610|Ivermectin|ivermectin|mesh-list
1797396|NCT04913610|Albendazole|albendazole|mesh-list
1797397|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1797398|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797399|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
1797400|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
1797401|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1797402|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1797403|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
1797404|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
1797405|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
1797406|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797407|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797408|NCT04913480|Durvalumab|durvalumab|mesh-list
1797409|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1797410|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797411|NCT04913922|Nivolumab|nivolumab|mesh-list
1797412|NCT04913922|Azacitidine|azacitidine|mesh-list
1797413|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1797414|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797415|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1797416|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797417|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1797418|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
1797419|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797421|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
1797422|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1797423|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797424|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797425|NCT04913389|Diuretics|diuretics|mesh-ancestor
1797426|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
1797427|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797431|NCT04913402|Sufentanil|sufentanil|mesh-list
1797432|NCT04913402|Dsuvia|dsuvia|mesh-list
1797433|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1797434|NCT04913402|Narcotics|narcotics|mesh-ancestor
1797435|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1797436|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797437|NCT04913402|Analgesics|analgesics|mesh-ancestor
1797438|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
1797439|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797440|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1797441|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1797442|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
1797443|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
1797444|NCT04913103|Rituximab|rituximab|mesh-list
1797445|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1797446|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1797447|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797448|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
1797449|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797450|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1797451|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1797452|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
1797453|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797454|NCT04912934|Insulin|insulin|mesh-list
1797455|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1797456|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797457|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1797458|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797459|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797460|NCT04912700|Vaccines|vaccines|mesh-list
1797461|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
1797462|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797463|NCT04912765|Nivolumab|nivolumab|mesh-list
1797464|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1797465|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797466|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1797467|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797485|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
1797486|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
1797487|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1797488|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1797489|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797490|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797491|NCT04912726|Urological Agents|urological agents|mesh-ancestor
1797492|NCT04912596|Albuterol|albuterol|mesh-list
1797493|NCT04912596|Procaterol|procaterol|mesh-list
1797494|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
1797495|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1797496|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
1797497|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797498|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797499|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1797500|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
1797501|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
1797502|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1797503|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1797504|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1797505|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1797506|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
1797507|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1797508|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797509|NCT04912596|Miotics|miotics|mesh-ancestor
1797510|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1797511|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
1797512|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
1797513|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1797514|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
1797515|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
1797529|NCT04912167|Valsartan|valsartan|mesh-list
1797530|NCT04912167|Enalapril|enalapril|mesh-list
1797531|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1797532|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1797533|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1797534|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1797535|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797536|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1797537|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
1797538|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797539|NCT04912271|Dexamethasone|dexamethasone|mesh-list
1797540|NCT04912271|Aprepitant|aprepitant|mesh-list
1797541|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
1797542|NCT04912271|Palonosetron|palonosetron|mesh-list
1797543|NCT04912271|Granisetron|granisetron|mesh-list
1797544|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1797545|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
1797546|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
1797547|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797548|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797549|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1797550|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
1797551|NCT04912271|Hormones|hormones|mesh-ancestor
1797552|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1797553|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1797554|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797555|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1797556|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1797557|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797558|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1797559|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1797560|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
1797561|NCT04912193|Antithrombins|antithrombins|mesh-list
1797562|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
1797563|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1797564|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
1797565|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797566|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797567|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
1797568|NCT04912258|Irinotecan|irinotecan|mesh-list
1797569|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1797570|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1797571|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797572|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797573|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797574|NCT04912492|Ethanol|ethanol|mesh-list
1797575|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1797576|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797577|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1797578|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797579|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1797580|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
1797581|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797582|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
1797583|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1797584|NCT04912128|Growth Substances|growth substances|mesh-ancestor
1797585|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797586|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
1797587|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797588|NCT04911959|Lenvatinib|lenvatinib|mesh-list
1797589|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797590|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1797591|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797592|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797593|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1797594|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1797595|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1797596|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
1797597|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797598|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
1797599|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1797600|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
1797601|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1797602|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797603|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1797604|NCT04912011|Diuretics|diuretics|mesh-ancestor
1797605|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
1797606|NCT04911621|Temozolomide|temozolomide|mesh-list
1797607|NCT04911621|Vaccines|vaccines|mesh-list
1797608|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1797609|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
1797610|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797611|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797612|NCT04911621|Immunologic Factors|immunologic factors|mesh-ancestor
1797613|NCT04911621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797614|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
1797615|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
1797616|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1797617|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1797618|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797619|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797620|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797621|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1797622|NCT04911127|Cannabidiol|cannabidiol|mesh-list
1797623|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
1797624|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
1797625|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1797626|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1797627|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797628|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
1797629|NCT04911413|Coagulants|coagulants|mesh-ancestor
1797663|NCT04910711|Dolutegravir|dolutegravir|mesh-list
1797664|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1797665|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
1797666|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
1797667|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1797668|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
1797669|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1797670|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797671|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1797672|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1797673|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1797674|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1797675|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1797676|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797677|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797678|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1797679|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1797680|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
1797681|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797682|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1797683|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1797684|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1797685|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797686|NCT04910815|Rifaximin|rifaximin|mesh-list
1797687|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1797688|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797689|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1797690|NCT04910477|Atropine|atropine|mesh-list
1797691|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
1797692|NCT04910477|Neostigmine|neostigmine|mesh-list
1797693|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1797694|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1797695|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797696|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1797697|NCT04910477|Analgesics|analgesics|mesh-ancestor
1797698|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
1797699|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797700|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1797701|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1797702|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1797703|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
1797704|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1797705|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797706|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1797707|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1797708|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1797709|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
1797710|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1797711|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
1797712|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
1797713|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
1797714|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1797715|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1797716|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
1797717|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1797718|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797719|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1797720|NCT04910347|Nivolumab|nivolumab|mesh-list
1797721|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1797722|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797723|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1797724|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797725|NCT04910386|Gemcitabine|gemcitabine|mesh-list
1797726|NCT04910386|Cisplatin|cisplatin|mesh-list
1797727|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797728|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1797729|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
1797730|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797731|NCT04910386|Antiviral Agents|antiviral agents|mesh-ancestor
1797732|NCT04910386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797733|NCT04910386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797734|NCT04910386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1797735|NCT04910386|Immunologic Factors|immunologic factors|mesh-ancestor
1797736|NCT04910386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797737|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
1797738|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1797739|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1797740|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797741|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
1797742|NCT04910464|Coagulants|coagulants|mesh-ancestor
1797743|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1797744|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797745|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
1797746|NCT04910594|Hematinics|hematinics|mesh-ancestor
1797747|NCT04910425|Fluorides|fluorides|mesh-list
1797748|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
1797749|NCT04910425|Protective Agents|protective agents|mesh-ancestor
1797750|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797751|NCT04910022|Lomustine|lomustine|mesh-list
1797752|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1797753|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
1797754|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797755|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797756|NCT04910100|Timolol|timolol|mesh-list
1797757|NCT04910100|Nebivolol|nebivolol|mesh-list
1797758|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1797759|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1797760|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1797761|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1797762|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
1797763|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1797764|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797765|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797766|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1797767|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1797768|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
1797769|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1797770|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1797771|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1797772|NCT04910126|Doxorubicin|doxorubicin|mesh-list
1797773|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1797774|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1797775|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797776|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1797777|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1797778|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797779|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797780|NCT04910178|Empagliflozin|empagliflozin|mesh-list
1797781|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
1797782|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1797783|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1797784|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797785|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1797786|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797787|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1797788|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797789|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1797790|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1797791|NCT04910178|Protective Agents|protective agents|mesh-ancestor
1797792|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
1797793|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1797794|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
1797795|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1797796|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1797797|NCT04910165|Ropivacaine|ropivacaine|mesh-list
1797798|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
1797799|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
1797800|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1797801|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797802|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
1797803|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797816|NCT04909931|Vitamin D|vitamin d|mesh-list
1797817|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
1797818|NCT04909931|Vitamins|vitamins|mesh-ancestor
1797819|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
1797820|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797821|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1797822|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1797823|NCT04909918|Dexamethasone|dexamethasone|mesh-list
1797824|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
1797825|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1797826|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1797827|NCT04909918|Prednisolone|prednisolone|mesh-list
1797828|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
1797829|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1797830|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
1797831|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1797832|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
1797833|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
1797834|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797835|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797836|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1797837|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
1797838|NCT04909918|Hormones|hormones|mesh-ancestor
1797839|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1797840|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1797841|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797842|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1797843|NCT04909918|Protective Agents|protective agents|mesh-ancestor
1797844|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
1797845|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1797846|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797847|NCT04909697|Sivelestat|sivelestat|mesh-list
1797848|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1797849|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
1797850|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797851|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797852|NCT04909619|Anesthetics|anesthetics|mesh-list
1797853|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
1797854|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1797855|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797856|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
1797857|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797862|NCT04909775|Gemcitabine|gemcitabine|mesh-list
1797863|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797864|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1797865|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
1797866|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797867|NCT04909775|Antiviral Agents|antiviral agents|mesh-ancestor
1797868|NCT04909775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1797869|NCT04909775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797870|NCT04909775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1797871|NCT04909775|Immunologic Factors|immunologic factors|mesh-ancestor
1797872|NCT04909775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797873|NCT04909333|Exenatide|exenatide|mesh-list
1797874|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1797875|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1797876|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797877|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1797878|NCT04909333|Incretins|incretins|mesh-ancestor
1797879|NCT04909333|Hormones|hormones|mesh-ancestor
1797880|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1797881|NCT04908982|Aspirin|aspirin|mesh-list
1797882|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1797883|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1797884|NCT04908982|Analgesics|analgesics|mesh-ancestor
1797885|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
1797886|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797887|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797888|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1797889|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1797890|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1797891|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1797892|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797893|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1797894|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1797895|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797896|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
1797897|NCT04909073|Afatinib|afatinib|mesh-list
1797898|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797899|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1797900|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797901|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797902|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
1797903|NCT04909255|Mirabegron|mirabegron|mesh-list
1797904|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
1797905|NCT04909255|Oxybutynin|oxybutynin|mesh-list
1797906|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1797907|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1797908|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
1797909|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1797910|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797911|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797912|NCT04909255|Urological Agents|urological agents|mesh-ancestor
1797913|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
1797914|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1797915|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1797916|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
1797917|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
1797918|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
1797919|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797920|NCT04909151|Methamphetamine|methamphetamine|mesh-list
1797921|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1797922|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797923|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
1797924|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
1797925|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1797926|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
1797927|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1797928|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797929|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
1797930|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1797931|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1797932|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1797933|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1797934|NCT04908865|Belimumab|belimumab|mesh-list
1797935|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1797936|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
1797937|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797938|NCT04908566|Folfirinox|folfirinox|mesh-list
1797939|NCT04908566|Antibodies|antibodies|mesh-list
1797940|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
1797941|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
1797942|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1797943|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797960|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
1797961|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
1797962|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1797963|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1797964|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1797965|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797966|NCT04908657|Urological Agents|urological agents|mesh-ancestor
1797990|NCT04908813|Capecitabine|capecitabine|mesh-list
1797991|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
1797992|NCT04908813|Trastuzumab|trastuzumab|mesh-list
1797993|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1797994|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
1797995|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1797996|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1797997|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1797998|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
1797999|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1798000|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798001|NCT04908345|Fentanyl|fentanyl|mesh-list
1798002|NCT04908345|Methadone|methadone|mesh-list
1798003|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1798004|NCT04908345|Narcotics|narcotics|mesh-ancestor
1798005|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798006|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798007|NCT04908345|Analgesics|analgesics|mesh-ancestor
1798008|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
1798009|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798010|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1798011|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1798012|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
1798013|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
1798014|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
1798015|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
1798016|NCT04908176|Midazolam|midazolam|mesh-list
1798017|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1798018|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1798019|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798020|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798021|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1798022|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1798023|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1798024|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1798025|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
1798026|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
1798027|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
1798028|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
1798029|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798030|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798031|NCT04907708|Metformin|metformin|mesh-list
1798032|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1798033|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798034|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
1798035|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1798036|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1798037|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798038|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
1798039|NCT04907812|Coagulants|coagulants|mesh-ancestor
1798040|NCT04907864|Ibuprofen|ibuprofen|mesh-list
1798041|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1798042|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1798043|NCT04907864|Analgesics|analgesics|mesh-ancestor
1798044|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
1798045|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798046|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798047|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1798048|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1798049|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1798050|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798051|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798052|NCT04907721|Glucagon|glucagon|mesh-list
1798053|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
1798054|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1798055|NCT04907721|Hormones|hormones|mesh-ancestor
1798056|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1798057|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798058|NCT04907721|Incretins|incretins|mesh-ancestor
1798059|NCT04907825|Warfarin|warfarin|mesh-list
1798060|NCT04907825|Anticoagulants|anticoagulants|mesh-list
1798061|NCT04907682|Ribavirin|ribavirin|mesh-list
1798062|NCT04907682|Favipiravir|favipiravir|mesh-list
1798063|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
1798064|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798065|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
1798066|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798067|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
1798068|NCT04907838|BQ 788|bq 788|mesh-list
1798069|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1798070|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1798071|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798072|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
1798081|NCT04907474|Phenylephrine|phenylephrine|mesh-list
1798082|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
1798083|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1798084|NCT04907474|Tropicamide|tropicamide|mesh-list
1798085|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1798086|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1798087|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
1798088|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
1798089|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798090|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798091|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
1798092|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1798093|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
1798094|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
1798095|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1798096|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1798097|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1798098|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
1798099|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798100|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798101|NCT04907474|Protective Agents|protective agents|mesh-ancestor
1798102|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1798103|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1798104|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
1798105|NCT04907747|Amoxicillin|amoxicillin|mesh-list
1798106|NCT04907747|Furazolidone|furazolidone|mesh-list
1798107|NCT04907747|Esomeprazole|esomeprazole|mesh-list
1798108|NCT04907747|Bismuth|bismuth|mesh-list
1798109|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1798110|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798111|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1798112|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1798113|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1798114|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798115|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798116|NCT04907747|Antacids|antacids|mesh-ancestor
1798117|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1798118|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1798119|NCT04907747|Renal Agents|renal agents|mesh-ancestor
1798120|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
1798121|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1798122|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1798123|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1798124|NCT04907851|Denosumab|denosumab|mesh-list
1798125|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1798126|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798127|NCT04907279|Aripiprazole|aripiprazole|mesh-list
1798128|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
1798129|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1798130|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1798131|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1798132|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798133|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798134|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
1798135|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
1798136|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798137|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798138|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1798139|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1798140|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
1798141|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1798142|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1798143|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1798144|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1798145|NCT04907253|Quercetin|quercetin|mesh-list
1798146|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
1798147|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798148|NCT04907253|Protective Agents|protective agents|mesh-ancestor
1798149|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798150|NCT04907123|Diuretics|diuretics|mesh-list
1798151|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
1798152|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798153|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1798154|NCT04907084|Fenofibrate|fenofibrate|mesh-list
1798155|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1798156|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
1798157|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798158|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1798159|NCT04907370|Gemcitabine|gemcitabine|mesh-list
1798160|NCT04907370|Cisplatin|cisplatin|mesh-list
1798161|NCT04907370|Antibodies|antibodies|mesh-list
1798162|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
1798163|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798164|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
1798165|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798166|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1798167|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
1798168|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798169|NCT04907370|Antiviral Agents|antiviral agents|mesh-ancestor
1798170|NCT04907370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798171|NCT04907370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798172|NCT04907370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1798173|NCT04907110|Niacinamide|niacinamide|mesh-list
1798174|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
1798175|NCT04907110|Vitamins|vitamins|mesh-ancestor
1798176|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
1798177|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798178|NCT04907071|Coal Tar|coal tar|mesh-list
1798179|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
1798180|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
1798195|NCT04907227|Dexamethasone|dexamethasone|mesh-list
1798196|NCT04907227|Prednisone|prednisone|mesh-list
1798197|NCT04907227|Docetaxel|docetaxel|mesh-list
1798198|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
1798199|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1798200|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
1798201|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
1798202|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798203|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798204|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1798205|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
1798206|NCT04907227|Hormones|hormones|mesh-ancestor
1798207|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1798208|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1798209|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798210|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
1798211|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
1798212|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
1798213|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798214|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1798215|NCT04907344|Paclitaxel|paclitaxel|mesh-list
1798216|NCT04907344|Carboplatin|carboplatin|mesh-list
1798217|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1798218|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798219|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
1798220|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
1798221|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
1798222|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798223|NCT04907019|Rifampin|rifampin|mesh-list
1798224|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1798225|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
1798226|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1798227|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798228|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
1798229|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1798230|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798231|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798232|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1798233|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1798234|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1798235|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1798236|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1798237|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1798238|NCT04906889|Lidocaine|lidocaine|mesh-list
1798239|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
1798240|NCT04906889|Remifentanil|remifentanil|mesh-list
1798241|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
1798242|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
1798243|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798244|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798245|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
1798246|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798247|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1798473|NCT04905108|Vitamins|vitamins|mesh-ancestor
1798248|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1798249|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1798250|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1798251|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798252|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1798253|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1798254|NCT04906889|Analgesics|analgesics|mesh-ancestor
1798255|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1798256|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1798257|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1798258|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
1798259|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798260|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1798261|NCT04906889|Narcotics|narcotics|mesh-ancestor
1798262|NCT04906876|Gemcitabine|gemcitabine|mesh-list
1798263|NCT04906876|Docetaxel|docetaxel|mesh-list
1798264|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1798265|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
1798266|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798267|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798268|NCT04906876|Antiviral Agents|antiviral agents|mesh-ancestor
1798269|NCT04906876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798270|NCT04906876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798271|NCT04906876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1798272|NCT04906876|Immunologic Factors|immunologic factors|mesh-ancestor
1798273|NCT04906876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798274|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
1798275|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
1798276|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
1798277|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
1798278|NCT04906772|Ketamine|ketamine|mesh-list
1798279|NCT04906772|Propofol|propofol|mesh-list
1798280|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1798281|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798282|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798283|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1798284|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
1798285|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
1798286|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1798287|NCT04906772|Analgesics|analgesics|mesh-ancestor
1798288|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
1798289|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798290|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1798291|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1798292|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1798293|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
1798294|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798295|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798296|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1798297|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1798298|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1798299|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
1798300|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1798301|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1798302|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1798303|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
1798304|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798305|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798306|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798307|NCT04906915|Ketamine|ketamine|mesh-list
1798308|NCT04906915|Analgesics|analgesics|mesh-ancestor
1798309|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
1798310|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798311|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798312|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1798313|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1798314|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
1798315|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
1798316|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798317|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1798318|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1798319|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798320|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798323|NCT04906720|Colchicine|colchicine|mesh-list
1798324|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
1798325|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1798326|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
1798327|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
1798328|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
1798329|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798330|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798331|NCT04906317|Midazolam|midazolam|mesh-list
1798332|NCT04906317|Dezocine|dezocine|mesh-list
1798333|NCT04906317|Propofol|propofol|mesh-list
1798334|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1798335|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798336|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798337|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1798338|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
1798339|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
1798340|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1798341|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1798342|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1798343|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1798344|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
1798345|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
1798346|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798347|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798348|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1798349|NCT04906317|Narcotics|narcotics|mesh-ancestor
1798350|NCT04906317|Analgesics|analgesics|mesh-ancestor
1798351|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
1798352|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798353|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
1798354|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1798355|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1798356|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798357|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
1798358|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1798359|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
1798360|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
1798361|NCT04906304|Cyclosporine|cyclosporine|mesh-list
1798362|NCT04906304|Everolimus|everolimus|mesh-list
1798363|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798364|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1798365|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
1798366|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798367|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1798368|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1798369|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
1798370|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1798371|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798372|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798373|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798374|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
1798375|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
1798376|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1798377|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1798378|NCT04906096|GDC-0084|gdc-0084|mesh-list
1798379|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798380|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798381|NCT04906083|Mitogens|mitogens|mesh-list
1798382|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
1798383|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798389|NCT04906161|Vitamin D|vitamin d|mesh-list
1798390|NCT04906161|Calcium|calcium|mesh-list
1798391|NCT04906161|Vitamins|vitamins|mesh-ancestor
1798392|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
1798393|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798394|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1798395|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1798396|NCT04906382|Paclitaxel|paclitaxel|mesh-list
1798397|NCT04906382|Carboplatin|carboplatin|mesh-list
1798398|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1798474|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
1798399|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1798400|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798401|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
1798402|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
1798403|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
1798404|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798405|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1798406|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1798407|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1798408|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1798409|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798410|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
1798411|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798412|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798417|NCT04905953|Neostigmine|neostigmine|mesh-list
1798418|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1798419|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798420|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798421|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
1798422|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798423|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798424|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1798425|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
1798426|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798427|NCT04905667|Trastuzumab|trastuzumab|mesh-list
1798428|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1798429|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798430|NCT04905693|Treprostinil|treprostinil|mesh-list
1798431|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1798432|NCT04905862|Antipyretics|antipyretics|mesh-list
1798433|NCT04905862|Analgesics|analgesics|mesh-list
1798434|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798435|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
1798436|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798437|NCT04905563|Acetaminophen|acetaminophen|mesh-list
1798438|NCT04905563|Ibuprofen|ibuprofen|mesh-list
1798439|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
1798440|NCT04905563|Hydrocodone|hydrocodone|mesh-list
1798441|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1798442|NCT04905563|Analgesics|analgesics|mesh-ancestor
1798443|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
1798444|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798445|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798446|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
1798447|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1798448|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1798449|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1798450|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1798451|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798452|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798453|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1798454|NCT04905563|Narcotics|narcotics|mesh-ancestor
1798455|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798456|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
1798457|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
1798458|NCT04905277|Atenolol|atenolol|mesh-list
1798459|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1798460|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1798461|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
1798462|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
1798463|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798464|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798465|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1798466|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1798467|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1798468|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
1798469|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798470|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798471|NCT04905108|Riboflavin|riboflavin|mesh-list
1798472|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
1798475|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798476|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1798477|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
1798481|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
1798482|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798487|NCT04904965|Propofol|propofol|mesh-list
1798488|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1798489|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798490|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798491|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1798492|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
1798493|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
1798494|NCT04905147|Mosapride|mosapride|mesh-list
1798495|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1798496|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1798497|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
1798498|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798499|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798500|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798501|NCT04904536|Atorvastatin|atorvastatin|mesh-list
1798502|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1798503|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1798504|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
1798505|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798506|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1798507|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1798508|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798509|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
1798510|NCT04904562|Giapreza|giapreza|mesh-list
1798511|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
1798512|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1798513|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1798514|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
1798515|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798516|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798517|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
1798518|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1798519|NCT04904341|Protective Agents|protective agents|mesh-ancestor
1798520|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798521|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
1798522|NCT04904302|Nivolumab|nivolumab|mesh-list
1798523|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1798524|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798525|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1798526|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798527|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
1798528|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
1798529|NCT04904185|Fludarabine|fludarabine|mesh-list
1798530|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
1798531|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1798532|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
1798533|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798534|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1798535|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1798536|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
1798537|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798538|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798539|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1798540|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1798541|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1798542|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
1798543|NCT04904406|Lamivudine|lamivudine|mesh-list
1798544|NCT04904406|Abacavir|abacavir|mesh-list
1798545|NCT04904406|Dolutegravir|dolutegravir|mesh-list
1798546|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1798547|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1798548|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798549|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798550|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
1798551|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798552|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1798553|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1798554|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1798555|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1798556|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
1798557|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1798558|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798559|NCT04903847|Tenofovir|tenofovir|mesh-list
1798560|NCT04903847|Lamivudine|lamivudine|mesh-list
1798561|NCT04903847|Dolutegravir|dolutegravir|mesh-list
1798562|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
1798563|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798564|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1798565|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1798566|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798567|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798568|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1798569|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1798570|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1798571|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1798572|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
1798573|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
1798574|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798575|NCT04903808|Protective Agents|protective agents|mesh-ancestor
1798576|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798577|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1798578|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798579|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1798580|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798581|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
1798582|NCT04903743|Bupivacaine|bupivacaine|mesh-list
1798583|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
1798584|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
1798585|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798586|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798587|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
1798588|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798589|NCT04903743|Analgesics|analgesics|mesh-ancestor
1798590|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1798591|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
1798592|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1798593|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1798594|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798595|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1798596|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
1798597|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1798598|NCT04903652|Vinorelbine|vinorelbine|mesh-list
1798599|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1798600|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798601|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
1798602|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
1798603|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
1798604|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798605|NCT04903483|Anesthetics|anesthetics|mesh-list
1798606|NCT04903483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798607|NCT04903483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798608|NCT04903470|Bisacodyl|bisacodyl|mesh-list
1798609|NCT04903470|Cathartics|cathartics|mesh-ancestor
1798610|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1798611|NCT04903470|Laxatives|laxatives|mesh-ancestor
1798631|NCT04903678|Melphalan|melphalan|mesh-list
1798632|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1798633|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
1798634|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798635|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798636|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1798637|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1798638|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
1798639|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798640|NCT04903366|Timolol|timolol|mesh-list
1798641|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1798642|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1798643|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
1798644|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798645|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798646|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798647|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1798648|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1798661|NCT04903275|Fluorides|fluorides|mesh-list
1798662|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
1798663|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
1798664|NCT04903275|Protective Agents|protective agents|mesh-ancestor
1798665|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798666|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
1798667|NCT04903054|Prednisone|prednisone|mesh-list
1798668|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
1798669|NCT04903054|Tacrolimus|tacrolimus|mesh-list
1798670|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
1798671|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1798672|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1798673|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
1798674|NCT04903054|Hormones|hormones|mesh-ancestor
1798675|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1798676|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798677|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1798678|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798679|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1798680|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
1798681|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1798682|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798683|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798684|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1798685|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1798686|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
1798687|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1798688|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798689|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
1798690|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
1798691|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798692|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1798693|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1798694|NCT04903054|Protective Agents|protective agents|mesh-ancestor
1798695|NCT04902911|Antibodies|antibodies|mesh-list
1798696|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
1798697|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
1798698|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798699|NCT04902885|Carboplatin|carboplatin|mesh-list
1798700|NCT04902885|Etoposide|etoposide|mesh-list
1798701|NCT04902885|Topotecan|topotecan|mesh-list
1798702|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798703|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1798704|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1798705|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1798706|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798707|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798708|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1798709|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
1798710|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1798711|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1798712|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798713|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
1798714|NCT04902950|Coagulants|coagulants|mesh-ancestor
1798715|NCT04903002|Oxytocin|oxytocin|mesh-list
1798716|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
1798717|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1798718|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798719|NCT04902859|Clonidine|clonidine|mesh-list
1798720|NCT04902859|Analgesics|analgesics|mesh-ancestor
1798721|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
1798722|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798723|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798724|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1798725|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
1798726|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
1798727|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1798728|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1798729|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1798730|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
1798731|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798732|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798733|NCT04902625|Naltrexone|naltrexone|mesh-list
1798734|NCT04902625|Bupropion|bupropion|mesh-list
1798735|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1798736|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1798737|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798738|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
1798739|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798740|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1798741|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
1798742|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1798743|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1798744|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1798745|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1798746|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798747|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
1798748|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798749|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1798750|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1798751|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798752|NCT04902729|Oxytocin|oxytocin|mesh-list
1798753|NCT04902729|Carbetocin|carbetocin|mesh-list
1798754|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
1798755|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1798756|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798757|NCT04902638|Dexamethasone|dexamethasone|mesh-list
1798758|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1798759|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
1798760|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
1798761|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798762|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798763|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1798764|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
1798765|NCT04902638|Hormones|hormones|mesh-ancestor
1798766|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1798767|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1798768|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798769|NCT04902261|Gemcitabine|gemcitabine|mesh-list
1798770|NCT04902261|Paclitaxel|paclitaxel|mesh-list
1798771|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1798772|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798773|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
1798774|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
1798775|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
1798776|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798777|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1798778|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
1798779|NCT04902261|Antiviral Agents|antiviral agents|mesh-ancestor
1798780|NCT04902261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798781|NCT04902261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798782|NCT04902261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1798783|NCT04902261|Immunologic Factors|immunologic factors|mesh-ancestor
1798784|NCT04902261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798785|NCT04902495|Pemetrexed|pemetrexed|mesh-list
1798786|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798787|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798788|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798789|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1798790|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1798791|NCT04902222|Morphine|morphine|mesh-list
1798792|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1798793|NCT04902222|Narcotics|narcotics|mesh-ancestor
1798794|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798795|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798796|NCT04902222|Analgesics|analgesics|mesh-ancestor
1798797|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
1798798|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798799|NCT04901975|Spironolactone|spironolactone|mesh-list
1798800|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1798801|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
1798802|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1798803|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798804|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1798805|NCT04901975|Diuretics|diuretics|mesh-ancestor
1798806|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
1798807|NCT04902378|Insulin|insulin|mesh-list
1798808|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1798809|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798810|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
1798811|NCT04902027|Analgesics|analgesics|mesh-ancestor
1798812|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
1798813|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798814|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798815|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798816|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1798817|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1798818|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798819|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798820|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
1798821|NCT04902105|Valproic Acid|valproic acid|mesh-list
1798822|NCT04902105|Ecopipam|ecopipam|mesh-list
1798823|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
1798824|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798825|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798826|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
1798827|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798828|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798829|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
1798830|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1798831|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798832|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1798833|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1798834|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1798835|NCT04902105|Analgesics|analgesics|mesh-ancestor
1798836|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
1798837|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798838|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1798839|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1798840|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1798841|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1798842|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1798843|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
1798844|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
1798845|NCT04902040|Nivolumab|nivolumab|mesh-list
1798846|NCT04902040|Durvalumab|durvalumab|mesh-list
1798847|NCT04902040|Avelumab|avelumab|mesh-list
1798848|NCT04902040|Atezolizumab|atezolizumab|mesh-list
1798849|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
1798850|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1798851|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
1798852|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1798853|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798854|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1798927|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798855|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798856|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
1798857|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798858|NCT04901923|Itraconazole|itraconazole|mesh-list
1798859|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
1798860|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
1798861|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798862|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1798863|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1798864|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798865|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798866|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1798867|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
1798868|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1798869|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798870|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1798871|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1798877|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1798878|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1798879|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798903|NCT04901494|Serotonin|serotonin|mesh-list
1798904|NCT04901494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1798905|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1798906|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
1798907|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798908|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798909|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798910|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1798911|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1798912|NCT04901663|Amoxicillin|amoxicillin|mesh-list
1798913|NCT04901663|Clarithromycin|clarithromycin|mesh-list
1798914|NCT04901663|Omeprazole|omeprazole|mesh-list
1798915|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1798916|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798917|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1798918|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1798919|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1798920|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798921|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798922|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1798923|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1798924|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1798925|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
1798926|NCT04901312|Narcotics|narcotics|mesh-ancestor
1798928|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798929|NCT04901312|Analgesics|analgesics|mesh-ancestor
1798930|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
1798931|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798932|NCT04901117|Amoxicillin|amoxicillin|mesh-list
1798933|NCT04901117|Metronidazole|metronidazole|mesh-list
1798934|NCT04901117|Clarithromycin|clarithromycin|mesh-list
1798935|NCT04901117|Tetracycline|tetracycline|mesh-list
1798936|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
1798937|NCT04901117|Bismuth|bismuth|mesh-list
1798938|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798939|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1798940|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1798941|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1798942|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1798943|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1798944|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798945|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1798946|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1798947|NCT04901117|Antacids|antacids|mesh-ancestor
1798948|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1798949|NCT04901117|Diuretics|diuretics|mesh-ancestor
1798950|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
1798951|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798952|NCT04901117|Expectorants|expectorants|mesh-ancestor
1798953|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
1798954|NCT04901065|Lidocaine|lidocaine|mesh-list
1798955|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
1798956|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
1798957|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1798958|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798959|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
1798960|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798961|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1798962|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1798963|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1798964|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1798965|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798966|NCT04901208|Nicotine|nicotine|mesh-list
1798967|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1798968|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
1798969|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798970|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798971|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1798972|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1798973|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
1798974|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1798975|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798976|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
1798977|NCT04901169|Giapreza|giapreza|mesh-list
1798978|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
1798979|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1798980|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1798981|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
1798982|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1798983|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1798984|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
1798985|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1798986|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1798987|NCT04900948|Prednisolone|prednisolone|mesh-list
1798988|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
1798989|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
1798990|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
1798991|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1798992|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
1798993|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1798994|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
1798995|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
1798996|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1798997|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1798998|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1798999|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
1799000|NCT04900948|Hormones|hormones|mesh-ancestor
1799001|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1799002|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1799003|NCT04900948|Protective Agents|protective agents|mesh-ancestor
1799004|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1799005|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799006|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1799007|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1799008|NCT04900948|Analgesics|analgesics|mesh-ancestor
1799009|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
1799010|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1799011|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
1799012|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1799013|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
1799014|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1799015|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799016|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799017|NCT04901104|Thymalfasin|thymalfasin|mesh-list
1799018|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1799019|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
1799020|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799021|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
1799022|NCT04900792|Temozolomide|temozolomide|mesh-list
1799023|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
1799024|NCT04900792|Vitamins|vitamins|mesh-ancestor
1799025|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
1799026|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799027|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1799028|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
1799029|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799030|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799031|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
1799032|NCT04900792|Protective Agents|protective agents|mesh-ancestor
1799033|NCT04900792|Hematinics|hematinics|mesh-ancestor
1799034|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1799035|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1799036|NCT04900532|Tocotrienols|tocotrienols|mesh-list
1799037|NCT04900532|Vitamin E|vitamin e|mesh-list
1799038|NCT04900532|Tocopherols|tocopherols|mesh-list
1799039|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
1799040|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799041|NCT04900532|Protective Agents|protective agents|mesh-ancestor
1799042|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799043|NCT04900532|Vitamins|vitamins|mesh-ancestor
1799044|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
1799045|NCT04900415|Vitamin A|vitamin a|mesh-list
1799046|NCT04900415|Vitamins|vitamins|mesh-ancestor
1799047|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
1799048|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799049|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
1799050|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1799051|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799052|NCT04900571|Renal Agents|renal agents|mesh-ancestor
1799053|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1799054|NCT04900623|Paclitaxel|paclitaxel|mesh-list
1799055|NCT04900623|Cisplatin|cisplatin|mesh-list
1799056|NCT04900623|Carboplatin|carboplatin|mesh-list
1799057|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1799058|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799059|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
1799060|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
1799061|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
1799062|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799063|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
1799064|NCT04900766|Analgesics|analgesics|mesh-ancestor
1799065|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
1799066|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799067|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799068|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799069|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1799070|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1799071|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799072|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799073|NCT04900311|Paclitaxel|paclitaxel|mesh-list
1799074|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1799075|NCT04900311|Trastuzumab|trastuzumab|mesh-list
1799076|NCT04900311|Pertuzumab|pertuzumab|mesh-list
1799077|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1799078|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799079|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
1799080|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
1799081|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
1799082|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799083|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1799084|NCT04900350|Azacitidine|azacitidine|mesh-list
1799085|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1799086|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
1799087|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799088|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799089|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799097|NCT04899921|Nivolumab|nivolumab|mesh-list
1799098|NCT04899921|Ipilimumab|ipilimumab|mesh-list
1799099|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1799100|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799101|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1799102|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799115|NCT04900155|Atorvastatin|atorvastatin|mesh-list
1799116|NCT04900155|Ezetimibe|ezetimibe|mesh-list
1799117|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1799118|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1799119|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
1799120|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799121|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1799122|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1799123|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799124|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
1799125|NCT04900129|Diclofenac|diclofenac|mesh-list
1799126|NCT04900129|Salicylates|salicylates|mesh-list
1799127|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
1799128|NCT04900129|Menthol|menthol|mesh-list
1799129|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1799130|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1799131|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1799132|NCT04900129|Analgesics|analgesics|mesh-ancestor
1799133|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
1799134|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799135|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799136|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1799137|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1799138|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1799139|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799140|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799141|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
1799142|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
1799143|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
1799144|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799145|NCT04900129|Expectorants|expectorants|mesh-ancestor
1799146|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
1799147|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1799148|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
1799149|NCT04900129|Protective Agents|protective agents|mesh-ancestor
1799150|NCT04900129|Antidotes|antidotes|mesh-ancestor
1799151|NCT04899765|Vaccines|vaccines|mesh-list
1799152|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
1799153|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
1799154|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799155|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1799156|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
1799157|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799158|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
1799159|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799160|NCT04899791|Protective Agents|protective agents|mesh-ancestor
1799161|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799162|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1799163|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
1799164|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1799165|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1799166|NCT04900220|Prednisolone|prednisolone|mesh-list
1799167|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
1799168|NCT04900220|Betamethasone|betamethasone|mesh-list
1799169|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1799170|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
1799171|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1799172|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
1799173|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
1799174|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799175|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799176|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1799177|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
1799178|NCT04900220|Hormones|hormones|mesh-ancestor
1799179|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1799180|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1799181|NCT04900220|Protective Agents|protective agents|mesh-ancestor
1799182|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1799183|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799184|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1799185|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
1799186|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
1799187|NCT04899687|Fluoxetine|fluoxetine|mesh-list
1799188|NCT04899687|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1799189|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1799190|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1799191|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799192|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1799193|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
1799194|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799195|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1799196|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
1799197|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1799198|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1799199|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1799200|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799201|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
1799202|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
1799203|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1799204|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1799205|NCT04899570|Prednisone|prednisone|mesh-list
1799206|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
1799207|NCT04899570|Rituximab|rituximab|mesh-list
1799208|NCT04899570|Epirubicin|epirubicin|mesh-list
1799209|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
1799210|NCT04899570|Vindesine|vindesine|mesh-list
1799211|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1799212|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
1799213|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799214|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1799215|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1799216|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
1799217|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799218|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799219|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1799220|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1799221|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1799222|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
1799223|NCT04899570|Hormones|hormones|mesh-ancestor
1799224|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1799225|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1799226|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1799227|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1799228|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1799229|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799230|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1799231|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1799232|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
1799233|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
1799234|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
1799235|NCT04899453|Rituximab|rituximab|mesh-list
1799236|NCT04899453|Methotrexate|methotrexate|mesh-list
1799237|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
1799238|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1799239|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799240|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
1799241|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799242|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1799243|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1799244|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
1799245|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1799246|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1799247|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
1799248|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799249|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
1799250|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799251|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1799252|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1799253|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1799254|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1799270|NCT04899817|Granisetron|granisetron|mesh-list
1799271|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
1799272|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
1799273|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799274|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799275|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1799276|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1799277|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
1799278|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1799279|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799280|NCT04899674|Bupropion|bupropion|mesh-list
1799281|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1799282|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
1799283|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1799284|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1799285|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1799286|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1799287|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799288|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
1799289|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1799290|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799291|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1799292|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1799293|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799294|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
1799295|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799296|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1799297|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799298|NCT04899414|Dexamethasone|dexamethasone|mesh-list
1799299|NCT04899414|Azacitidine|azacitidine|mesh-list
1799300|NCT04899414|Pegaspargase|pegaspargase|mesh-list
1799301|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1799302|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
1799303|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
1799304|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799305|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799306|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1799307|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
1799308|NCT04899414|Hormones|hormones|mesh-ancestor
1799309|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1799310|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1799311|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799312|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1799313|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
1799314|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799315|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799316|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
1799317|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
1799318|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
1799319|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1799320|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799321|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1799346|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1799347|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1799348|NCT04899388|Fentanyl|fentanyl|mesh-list
1799349|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1799350|NCT04899388|Narcotics|narcotics|mesh-ancestor
1799351|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1799352|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799353|NCT04899388|Analgesics|analgesics|mesh-ancestor
1799354|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
1799355|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799356|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1799357|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1799358|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
1799359|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
1799360|NCT04899115|Vancomycin|vancomycin|mesh-list
1799361|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1799362|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799363|NCT04898920|Dexamethasone|dexamethasone|mesh-list
1799364|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1799365|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
1799366|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
1799367|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799368|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799369|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1799370|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
1799371|NCT04898920|Hormones|hormones|mesh-ancestor
1799372|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1799373|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1799374|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799375|NCT04898946|Vaccines|vaccines|mesh-list
1799376|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
1799377|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799378|NCT04899050|Cannabidiol|cannabidiol|mesh-list
1799379|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
1799380|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
1799381|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1799382|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799383|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
1799384|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
1799385|NCT04898751|Nivolumab|nivolumab|mesh-list
1799386|NCT04898751|Ipilimumab|ipilimumab|mesh-list
1799387|NCT04898751|Durvalumab|durvalumab|mesh-list
1799388|NCT04898751|Avelumab|avelumab|mesh-list
1799389|NCT04898751|Cemiplimab|cemiplimab|mesh-list
1799390|NCT04898751|Atezolizumab|atezolizumab|mesh-list
1799391|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1799392|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1799393|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799394|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799395|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
1799396|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1799397|NCT04898907|Mitogens|mitogens|mesh-list
1799398|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1799399|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799400|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1799401|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1799402|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799403|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799404|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799405|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1799406|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
1799407|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1799408|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799409|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1799410|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1799411|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1799412|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
1799413|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1799414|NCT04898699|Tenofovir|tenofovir|mesh-list
1799415|NCT04898699|Emtricitabine|emtricitabine|mesh-list
1799416|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1799417|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
1799418|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799419|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1799420|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1799421|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799422|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799423|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1799424|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1799425|NCT04898725|Vitamin D|vitamin d|mesh-list
1799426|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
1799427|NCT04898725|Vitamins|vitamins|mesh-ancestor
1799428|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
1799429|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799430|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1799431|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1799432|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
1799433|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1799434|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1799435|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799436|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
1799437|NCT04898712|Coagulants|coagulants|mesh-ancestor
1799438|NCT04898387|Timolol|timolol|mesh-list
1799439|NCT04898387|Bimatoprost|bimatoprost|mesh-list
1799440|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1799441|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1799442|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
1799443|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1799444|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799445|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799446|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1799447|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1799448|NCT04898374|Gemcitabine|gemcitabine|mesh-list
1799449|NCT04898374|Cisplatin|cisplatin|mesh-list
1799450|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799451|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1799452|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
1799453|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799454|NCT04898374|Antiviral Agents|antiviral agents|mesh-ancestor
1799455|NCT04898374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799456|NCT04898374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799457|NCT04898374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1799458|NCT04898374|Immunologic Factors|immunologic factors|mesh-ancestor
1799459|NCT04898374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799460|NCT04898348|Vancomycin|vancomycin|mesh-list
1799461|NCT04898348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1799462|NCT04898348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799463|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
1799464|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799465|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
1799466|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1799467|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
1799468|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799469|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
1799470|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
1799471|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799472|NCT04898023|Protective Agents|protective agents|mesh-ancestor
1799473|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799474|NCT04898023|Vitamins|vitamins|mesh-ancestor
1799475|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
1799476|NCT04898504|Floxuridine|floxuridine|mesh-list
1799477|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1799478|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
1799479|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799480|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799481|NCT04898075|Nicotine|nicotine|mesh-list
1799482|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1799483|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
1799484|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799485|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799486|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1799487|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1799488|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
1799489|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1799490|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799491|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
1799492|NCT04898478|Narcotics|narcotics|mesh-ancestor
1799493|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1799494|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799495|NCT04898478|Analgesics|analgesics|mesh-ancestor
1799496|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
1799497|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799498|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
1799499|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
1799500|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799501|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
1799502|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1799503|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1799504|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799505|NCT04898114|Urological Agents|urological agents|mesh-ancestor
1799506|NCT04898114|Analgesics|analgesics|mesh-ancestor
1799507|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
1799508|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799509|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799510|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
1799511|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1799512|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1799513|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
1799514|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1799515|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1799516|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1799517|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
1799518|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1799519|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
1799520|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1799521|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1799522|NCT04898231|Prednisolone|prednisolone|mesh-list
1799523|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
1799524|NCT04898231|Infliximab|infliximab|mesh-list
1799525|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1799526|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1799527|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
1799528|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1799529|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
1799530|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
1799531|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799532|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799533|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1799534|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
1799535|NCT04898231|Hormones|hormones|mesh-ancestor
1799536|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1799537|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1799538|NCT04898231|Protective Agents|protective agents|mesh-ancestor
1799539|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1799540|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799541|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
1799542|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1799543|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
1799544|NCT04898270|Flupenthixol|flupenthixol|mesh-list
1799545|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
1799546|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1799547|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1799548|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799549|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1799550|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1799551|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
1799552|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1799553|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799554|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
1799555|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1799556|NCT04897971|Antibodies|antibodies|mesh-list
1799557|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
1799558|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799559|NCT04897958|Leuprolide|leuprolide|mesh-list
1799560|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1799561|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
1799562|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1799563|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799564|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1799565|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799566|NCT04897854|Folfirinox|folfirinox|mesh-list
1799567|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799568|NCT04897802|Exenatide|exenatide|mesh-list
1799569|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1799570|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799571|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1799572|NCT04897802|Incretins|incretins|mesh-ancestor
1799573|NCT04897802|Hormones|hormones|mesh-ancestor
1799574|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1799575|NCT04897880|Panobinostat|panobinostat|mesh-list
1799576|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799577|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1799578|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799579|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799580|NCT04897919|Piperaquine|piperaquine|mesh-list
1799581|NCT04897919|Artenimol|artenimol|mesh-list
1799582|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
1799583|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1799584|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1799585|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799586|NCT04897737|Tenofovir|tenofovir|mesh-list
1799587|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
1799588|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799589|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1799590|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1799591|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799592|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799593|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1799594|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1799595|NCT04897516|Benzonidazole|benzonidazole|mesh-list
1799596|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1799597|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
1799598|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799599|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1799600|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1799601|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1799602|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799603|NCT04897503|Riboflavin|riboflavin|mesh-list
1799604|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
1799605|NCT04897503|Vitamins|vitamins|mesh-ancestor
1799606|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
1799607|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799608|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1799609|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
1799610|NCT04897386|Pemetrexed|pemetrexed|mesh-list
1799611|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799612|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799613|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799614|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1799615|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1799616|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
1799617|NCT04897321|Fludarabine|fludarabine|mesh-list
1799618|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1799619|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
1799620|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799621|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1799622|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1799623|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
1799624|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799625|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799626|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1799627|NCT04897477|Azacitidine|azacitidine|mesh-list
1799628|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1799629|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1799630|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
1799631|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799632|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799633|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799634|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1799635|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
1799639|NCT04897269|Progesterone|progesterone|mesh-list
1799640|NCT04897269|Progestins|progestins|mesh-ancestor
1799641|NCT04897269|Hormones|hormones|mesh-ancestor
1799642|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1799643|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799664|NCT04896359|Ascorbic Acid|ascorbic acid|mesh-list
1799665|NCT04896359|Vitamins|vitamins|mesh-ancestor
1799666|NCT04896359|Micronutrients|micronutrients|mesh-ancestor
1799667|NCT04896359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799668|NCT04896359|Antioxidants|antioxidants|mesh-ancestor
1799669|NCT04896359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799670|NCT04896359|Protective Agents|protective agents|mesh-ancestor
1799671|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
1799672|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1799673|NCT04896177|Sirolimus|sirolimus|mesh-list
1799674|NCT04896177|Paclitaxel|paclitaxel|mesh-list
1799675|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1799676|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799677|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
1799678|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
1799679|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
1799680|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799681|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1799682|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799683|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1799684|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
1799836|NCT04895007|Vaccines|vaccines|mesh-list
1799685|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1799686|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
1799687|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799688|NCT04896125|Bimatoprost|bimatoprost|mesh-list
1799689|NCT04896125|Latanoprost|latanoprost|mesh-list
1799690|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1799691|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1799692|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1799693|NCT04896164|Curcumin|curcumin|mesh-list
1799694|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1799695|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1799696|NCT04896164|Analgesics|analgesics|mesh-ancestor
1799697|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
1799698|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799699|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799700|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1799701|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1799702|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799703|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799704|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799710|NCT04895917|Daratumumab|daratumumab|mesh-list
1799711|NCT04895917|Pomalidomide|pomalidomide|mesh-list
1799712|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799713|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
1799714|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799715|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1799716|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1799717|NCT04895917|Growth Substances|growth substances|mesh-ancestor
1799718|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
1799719|NCT04895657|Tazobactam|tazobactam|mesh-list
1799720|NCT04895657|Piperacillin|piperacillin|mesh-list
1799721|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
1799722|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1799723|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799724|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1799725|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799726|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799727|NCT04895423|Cyclosporine|cyclosporine|mesh-list
1799728|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
1799729|NCT04895423|Methotrexate|methotrexate|mesh-list
1799730|NCT04895423|Cyclosporins|cyclosporins|mesh-list
1799731|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1799732|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
1799733|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1799734|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799735|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1799736|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
1799737|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799738|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799739|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
1799740|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799741|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1799742|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1799743|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
1799744|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1799745|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1799746|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
1799747|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799748|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1799749|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1799750|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1799751|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
1799752|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1799757|NCT04895800|Caffeine|caffeine|mesh-list
1799758|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1799759|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799837|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
1799760|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1799761|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799762|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799763|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1799764|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1799765|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
1799766|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1799767|NCT04895579|Durvalumab|durvalumab|mesh-list
1799768|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1799769|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799770|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
1799771|NCT04895306|Testosterone|testosterone|mesh-list
1799772|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
1799773|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
1799774|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1799775|NCT04895306|Androgens|androgens|mesh-ancestor
1799776|NCT04895306|Hormones|hormones|mesh-ancestor
1799777|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1799778|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799779|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1799780|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799781|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
1799782|NCT04895592|Dexamethasone|dexamethasone|mesh-list
1799783|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
1799784|NCT04895592|Ichthammol|ichthammol|mesh-list
1799785|NCT04895592|BB 1101|bb 1101|mesh-list
1799786|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1799787|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
1799788|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
1799789|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799790|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799791|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1799792|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
1799793|NCT04895592|Hormones|hormones|mesh-ancestor
1799794|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1799795|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1799796|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799797|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
1799798|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799799|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799800|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
1799820|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1799821|NCT04895566|Antibodies|antibodies|mesh-list
1799822|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
1799823|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1799824|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
1799825|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799826|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799827|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1799828|NCT04895059|Ezetimibe|ezetimibe|mesh-list
1799829|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1799830|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1799831|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
1799832|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799833|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1799834|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1799835|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799838|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799839|NCT04895137|Bevacizumab|bevacizumab|mesh-list
1799840|NCT04895137|Antibodies|antibodies|mesh-list
1799841|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1799842|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1799843|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799844|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1799845|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1799846|NCT04895137|Growth Substances|growth substances|mesh-ancestor
1799847|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799848|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
1799849|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
1799875|NCT04894994|Ipilimumab|ipilimumab|mesh-list
1799876|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1799877|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799878|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1799879|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799880|NCT04894643|Gemcitabine|gemcitabine|mesh-list
1799881|NCT04894643|Paclitaxel|paclitaxel|mesh-list
1799882|NCT04894643|Capecitabine|capecitabine|mesh-list
1799883|NCT04894643|Pancrelipase|pancrelipase|mesh-list
1799884|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1799885|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799886|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
1799887|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
1799888|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
1799889|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799890|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1799891|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
1799892|NCT04894643|Antiviral Agents|antiviral agents|mesh-ancestor
1799893|NCT04894643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799894|NCT04894643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1799895|NCT04894643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1799896|NCT04894643|Immunologic Factors|immunologic factors|mesh-ancestor
1799897|NCT04894643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799898|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1799899|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
1799900|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1799904|NCT04894617|Amantadine|amantadine|mesh-list
1799905|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1799906|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1799907|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
1799908|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799909|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
1799910|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1799911|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799912|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799913|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1799914|NCT04894617|Analgesics|analgesics|mesh-ancestor
1799915|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
1799916|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799917|NCT04894682|Vaccines|vaccines|mesh-list
1799918|NCT04894682|Immunologic Factors|immunologic factors|mesh-ancestor
1799919|NCT04894682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799923|NCT04894253|Vaccines|vaccines|mesh-list
1799924|NCT04894253|Immunologic Factors|immunologic factors|mesh-ancestor
1799925|NCT04894253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799926|NCT04894188|Goserelin|goserelin|mesh-list
1799927|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1799928|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799929|NCT04893993|Thiamine|thiamine|mesh-list
1799930|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
1799931|NCT04893993|Vitamins|vitamins|mesh-ancestor
1799932|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
1799933|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799934|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1799935|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
1799936|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1799937|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1799938|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1799939|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
1799940|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1799941|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799942|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1799943|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1799944|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1799945|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1799946|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799963|NCT04893980|Aldesleukin|aldesleukin|mesh-list
1799964|NCT04893980|Interleukin-2|interleukin-2|mesh-list
1799965|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1799966|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1799967|NCT04893980|Analgesics|analgesics|mesh-ancestor
1799968|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
1799969|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799970|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799971|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1799972|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1799973|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
1799974|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1799975|NCT04893655|Dobutamine|dobutamine|mesh-list
1799976|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1799977|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
1799978|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
1799979|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1799980|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799981|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1799982|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1799983|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1799984|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
1799985|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1799986|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1799987|NCT04893655|Protective Agents|protective agents|mesh-ancestor
1799988|NCT04893616|Vaccines|vaccines|mesh-list
1799989|NCT04893616|Immunologic Factors|immunologic factors|mesh-ancestor
1799990|NCT04893616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799991|NCT04893733|Folic Acid|folic acid|mesh-list
1799992|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
1799993|NCT04893733|Vitamins|vitamins|mesh-ancestor
1799994|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
1799995|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1799996|NCT04893733|Hematinics|hematinics|mesh-ancestor
1799997|NCT04893629|Digoxin|digoxin|mesh-list
1799998|NCT04893629|Captopril|captopril|mesh-list
1799999|NCT04893629|Furosemide|furosemide|mesh-list
1800000|NCT04893629|Diuretics|diuretics|mesh-ancestor
1800001|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
1800002|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800003|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1800004|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1800005|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800006|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1800007|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1800008|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800009|NCT04893629|Protective Agents|protective agents|mesh-ancestor
1800010|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1800011|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
1800012|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1800013|NCT04893525|Buprenorphine|buprenorphine|mesh-list
1800014|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1800015|NCT04893525|Naloxone|naloxone|mesh-list
1800016|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1800017|NCT04893525|Narcotics|narcotics|mesh-ancestor
1800018|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1800019|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800020|NCT04893525|Analgesics|analgesics|mesh-ancestor
1800021|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
1800022|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800023|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1800024|NCT04893356|Dacarbazine|dacarbazine|mesh-list
1800025|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1800026|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
1800027|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800028|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800033|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
1800034|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1800035|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
1800036|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800037|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
1800038|NCT04893174|Protective Agents|protective agents|mesh-ancestor
1800039|NCT04892953|Gemcitabine|gemcitabine|mesh-list
1800040|NCT04892953|Paclitaxel|paclitaxel|mesh-list
1800041|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1800042|NCT04892953|Carboplatin|carboplatin|mesh-list
1800043|NCT04892953|Pemetrexed|pemetrexed|mesh-list
1800044|NCT04892953|Durvalumab|durvalumab|mesh-list
1800045|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
1800046|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1800047|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
1800048|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1800049|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800050|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
1800051|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
1800052|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
1800053|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800054|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1800055|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
1800056|NCT04892953|Antiviral Agents|antiviral agents|mesh-ancestor
1800057|NCT04892953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800058|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800059|NCT04892953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1800060|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
1800061|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800062|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1800063|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1800064|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1800069|NCT04892940|Analgesics|analgesics|mesh-list
1800070|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
1800071|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800072|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800077|NCT04893252|Durvalumab|durvalumab|mesh-list
1800078|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1800079|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800080|NCT04892888|Vaccines|vaccines|mesh-list
1800081|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
1800082|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800083|NCT04892732|Budesonide|budesonide|mesh-list
1800084|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
1800085|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1800086|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1800087|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
1800088|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800089|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800090|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1800091|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
1800092|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
1800093|NCT04892732|Hormones|hormones|mesh-ancestor
1800094|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1800095|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1800096|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1800097|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1800098|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
1800099|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800100|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800101|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
1800102|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
1800103|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1800104|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
1800105|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800106|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800107|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1800108|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
1800109|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1800110|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1800111|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1800112|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
1800113|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800114|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800115|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1800116|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
1800117|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1800153|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
1800154|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1800155|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1800156|NCT04892706|Analgesics|analgesics|mesh-ancestor
1800157|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
1800158|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800159|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800160|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1800161|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1800162|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
1800163|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1800164|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800165|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800166|NCT04892511|Nitroprusside|nitroprusside|mesh-list
1800167|NCT04892511|Labetalol|labetalol|mesh-list
1800168|NCT04892511|Urapidil|urapidil|mesh-list
1800169|NCT04892511|Phenylephrine|phenylephrine|mesh-list
1800170|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1800171|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
1800172|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
1800173|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800174|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800175|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
1800176|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1800177|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
1800178|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
1800179|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1800180|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1800181|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1800182|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
1800183|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800184|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800185|NCT04892511|Protective Agents|protective agents|mesh-ancestor
1800186|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1800187|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
1800188|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
1800189|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1800190|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1800191|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1800192|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1800193|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1800194|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
1800195|NCT04892693|Talazoparib|talazoparib|mesh-list
1800196|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1800197|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800198|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800199|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800200|NCT04892654|Dolutegravir|dolutegravir|mesh-list
1800201|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1800202|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1800203|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800204|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800205|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1800206|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1800207|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
1800208|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800209|NCT04892459|Vaccines|vaccines|mesh-list
1800210|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
1800211|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800212|NCT04892563|Morphine|morphine|mesh-list
1800213|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1800214|NCT04892563|Narcotics|narcotics|mesh-ancestor
1800215|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1800216|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800217|NCT04892563|Analgesics|analgesics|mesh-ancestor
1800218|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
1800219|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800220|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
1800221|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800222|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
1800223|NCT04892277|Fludarabine|fludarabine|mesh-list
1800224|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1800225|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
1800226|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800227|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1800228|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1800229|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
1800230|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800231|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800232|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1800233|NCT04892212|Sirolimus|sirolimus|mesh-list
1800234|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1800235|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800236|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1800237|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800238|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
1800239|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1800240|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
1800241|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800242|NCT04892264|Dexamethasone|dexamethasone|mesh-list
1800243|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
1800244|NCT04892264|Lenalidomide|lenalidomide|mesh-list
1800245|NCT04892264|Daratumumab|daratumumab|mesh-list
1800246|NCT04892264|Ichthammol|ichthammol|mesh-list
1800247|NCT04892264|BB 1101|bb 1101|mesh-list
1800248|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1800249|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
1800250|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
1800251|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800252|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800253|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1800254|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
1800255|NCT04892264|Hormones|hormones|mesh-ancestor
1800256|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1800257|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1800258|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800259|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
1800260|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800261|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800262|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
1800263|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1800264|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1800265|NCT04892264|Growth Substances|growth substances|mesh-ancestor
1800266|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
1800267|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
1800268|NCT04892069|Insulin|insulin|mesh-list
1800269|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
1800270|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1800271|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800272|NCT04892017|Trametinib|trametinib|mesh-list
1800273|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800274|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1800275|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800276|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800277|NCT04892186|Inositol|inositol|mesh-list
1800278|NCT04892186|Metformin|metformin|mesh-list
1800279|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1800280|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800281|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
1800282|NCT04892186|Vitamins|vitamins|mesh-ancestor
1800283|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
1800284|NCT04892173|Cetuximab|cetuximab|mesh-list
1800285|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1800286|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800287|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
1800288|NCT04891861|Apixaban|apixaban|mesh-list
1800289|NCT04891861|Edoxaban|edoxaban|mesh-list
1800290|NCT04891861|Dabigatran|dabigatran|mesh-list
1800291|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1800292|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
1800293|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1800294|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
1800295|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800296|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800297|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
1800298|NCT04891744|Thalidomide|thalidomide|mesh-list
1800299|NCT04891744|Dexamethasone|dexamethasone|mesh-list
1800300|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1800301|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
1800302|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
1800303|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800304|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800305|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1800306|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
1800307|NCT04891744|Hormones|hormones|mesh-ancestor
1800308|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1800309|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1800310|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800311|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1800312|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
1800313|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
1800314|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1800315|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800316|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1800317|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1800318|NCT04891744|Growth Substances|growth substances|mesh-ancestor
1800319|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
1800324|NCT04891900|Capecitabine|capecitabine|mesh-list
1800325|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
1800326|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1800327|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1800328|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
1800329|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800330|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800331|NCT04891484|Ondansetron|ondansetron|mesh-list
1800332|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
1800333|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
1800334|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800335|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800336|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1800337|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
1800338|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
1800339|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1800340|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
1800341|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800342|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800343|NCT04891484|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1800344|NCT04891484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1800345|NCT04891484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1800346|NCT04891484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1800347|NCT04891484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1800348|NCT04891588|Timolol|timolol|mesh-list
1800349|NCT04891588|Latanoprost|latanoprost|mesh-list
1800350|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1800351|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1800352|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1800353|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1800354|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
1800355|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800356|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800357|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800358|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1800359|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1800360|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
1800361|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
1800362|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1800363|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
1800364|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800365|NCT04891679|Misoprostol|misoprostol|mesh-list
1800366|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1800367|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
1800368|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1800369|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800370|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1800371|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1800372|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
1800373|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
1800374|NCT04891458|Anesthetics|anesthetics|mesh-list
1800375|NCT04891458|Propofol|propofol|mesh-list
1800376|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1800377|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800378|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1800379|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1800380|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
1800381|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1800382|NCT04891458|Analgesics|analgesics|mesh-ancestor
1800383|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
1800384|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800385|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1800386|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1800387|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1800388|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
1800389|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800390|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800403|NCT04891289|Gemcitabine|gemcitabine|mesh-list
1800404|NCT04891289|Dexamethasone|dexamethasone|mesh-list
1800405|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
1800406|NCT04891289|Floxuridine|floxuridine|mesh-list
1800407|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1800408|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
1800409|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
1800410|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800411|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800412|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1800413|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
1800414|NCT04891289|Hormones|hormones|mesh-ancestor
1800415|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1800416|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1800417|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800418|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1800419|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
1800420|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800421|NCT04891289|Antiviral Agents|antiviral agents|mesh-ancestor
1800422|NCT04891289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800423|NCT04891289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800424|NCT04891289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1800425|NCT04891289|Immunologic Factors|immunologic factors|mesh-ancestor
1800426|NCT04891718|Nivolumab|nivolumab|mesh-list
1800427|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1800428|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800429|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1800430|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800431|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
1800432|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1800433|NCT04891172|Antibodies|antibodies|mesh-list
1800434|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
1800435|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1800436|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
1800437|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800438|NCT04891250|Ivermectin|ivermectin|mesh-list
1800439|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1800440|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800441|NCT04891302|Clevudine|clevudine|mesh-list
1800442|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
1800443|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800444|NCT04891211|Vitamin D|vitamin d|mesh-list
1800445|NCT04891211|Vitamins|vitamins|mesh-ancestor
1800446|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
1800447|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800448|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1800449|NCT04890626|Tenofovir|tenofovir|mesh-list
1800450|NCT04890626|Emtricitabine|emtricitabine|mesh-list
1800451|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1800452|NCT04890626|Dexamethasone|dexamethasone|mesh-list
1800453|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
1800454|NCT04890626|BB 1101|bb 1101|mesh-list
1800455|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1800456|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
1800457|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
1800458|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800459|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800460|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1800461|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
1800462|NCT04890626|Hormones|hormones|mesh-ancestor
1800463|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1800464|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1800465|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800466|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
1800467|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800468|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800469|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
1800470|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800471|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1800472|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1800473|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1800474|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1800475|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
1800476|NCT04890873|Antacids|antacids|mesh-ancestor
1800477|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800478|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1800479|NCT04890522|Gemcitabine|gemcitabine|mesh-list
1800480|NCT04890522|Fluorouracil|fluorouracil|mesh-list
1800481|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800482|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1800483|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
1800484|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800485|NCT04890522|Antiviral Agents|antiviral agents|mesh-ancestor
1800486|NCT04890522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800487|NCT04890522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800488|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1800489|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
1800490|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800491|NCT04890561|Lemborexant|lemborexant|mesh-list
1800492|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1800493|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800494|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800495|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1800496|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1800497|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1800498|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800499|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
1800500|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
1800501|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1800502|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
1800503|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800504|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
1800505|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
1800506|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1800507|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
1800508|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800513|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
1800514|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
1800515|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1800516|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
1800517|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800518|NCT04890418|Ketamine|ketamine|mesh-list
1800519|NCT04890418|Analgesics|analgesics|mesh-ancestor
1800520|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
1800521|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800522|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800523|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1800524|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1800525|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
1800526|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
1800527|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1800528|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1800529|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1800530|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800531|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800532|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
1800533|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1800534|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800535|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800536|NCT04890470|Vasopressins|vasopressins|mesh-list
1800537|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
1800538|NCT04890470|Oxytocin|oxytocin|mesh-list
1800539|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
1800540|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1800541|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800542|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
1800543|NCT04890470|Coagulants|coagulants|mesh-ancestor
1800544|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1800545|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1800546|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
1800547|NCT04889768|Antibodies|antibodies|mesh-list
1800548|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
1800549|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800550|NCT04889781|Dexamethasone|dexamethasone|mesh-list
1800551|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
1800552|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1800553|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
1800554|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
1800555|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800556|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800557|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1800558|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
1800559|NCT04889781|Hormones|hormones|mesh-ancestor
1800560|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1800561|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1800562|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800563|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
1800564|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800565|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1800566|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800567|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800568|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
1800569|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1800570|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800571|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1800572|NCT04889547|Dexamethasone|dexamethasone|mesh-list
1800573|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
1800574|NCT04889547|BB 1101|bb 1101|mesh-list
1800575|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1800576|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
1800577|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
1800578|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800579|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800580|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1800581|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
1800582|NCT04889547|Hormones|hormones|mesh-ancestor
1800583|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1800584|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1800585|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800586|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
1800587|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800588|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800589|NCT04889664|Ketamine|ketamine|mesh-list
1800590|NCT04889664|Analgesics|analgesics|mesh-ancestor
1800591|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
1800592|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800593|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800594|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1800595|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1800596|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
1800597|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
1800598|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1800599|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1800600|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1800601|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800602|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800616|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
1800617|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1800618|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800619|NCT04889196|Fluorides|fluorides|mesh-list
1800620|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
1800621|NCT04889196|Protective Agents|protective agents|mesh-ancestor
1800622|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800623|NCT04888663|Paclitaxel|paclitaxel|mesh-list
1800624|NCT04888663|Trastuzumab|trastuzumab|mesh-list
1800625|NCT04888663|Ramucirumab|ramucirumab|mesh-list
1800626|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1800627|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800628|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
1800629|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
1800630|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
1800631|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800632|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1800633|NCT04888728|Nebivolol|nebivolol|mesh-list
1800634|NCT04888728|Paroxetine|paroxetine|mesh-list
1800635|NCT04888728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1800636|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1800637|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1800638|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800639|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800640|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
1800641|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800642|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1800643|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
1800644|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1800645|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1800646|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1800647|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800648|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1800649|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
1800650|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1800651|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1800652|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1800653|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
1800654|NCT04888858|Fentanyl|fentanyl|mesh-list
1800655|NCT04888858|Bupivacaine|bupivacaine|mesh-list
1800656|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
1800657|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
1800658|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1800659|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800660|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
1800661|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800662|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1800663|NCT04888858|Narcotics|narcotics|mesh-ancestor
1800664|NCT04888858|Analgesics|analgesics|mesh-ancestor
1800665|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1800666|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1800667|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
1800668|NCT04888741|Cyclosporine|cyclosporine|mesh-list
1800669|NCT04888741|Sirolimus|sirolimus|mesh-list
1800670|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
1800671|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
1800672|NCT04888741|Cyclosporins|cyclosporins|mesh-list
1800673|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
1800674|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1800675|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
1800676|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800677|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1800678|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1800679|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
1800680|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800681|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800682|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1800683|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800684|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
1800685|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800686|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
1800687|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1800688|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1800689|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1800690|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
1800691|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1800692|NCT04888715|Pirfenidone|pirfenidone|mesh-list
1800693|NCT04888715|Nintedanib|nintedanib|mesh-list
1800694|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800695|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1800696|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800697|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800698|NCT04888715|Analgesics|analgesics|mesh-ancestor
1800699|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
1800700|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800701|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800702|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1800703|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1800704|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1800705|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1800706|NCT04888403|Paclitaxel|paclitaxel|mesh-list
1800707|NCT04888403|Nedaplatin|nedaplatin|mesh-list
1800708|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1800709|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800710|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
1800711|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
1800712|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
1800713|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800714|NCT04887818|Lidocaine|lidocaine|mesh-list
1800715|NCT04887818|Diltiazem|diltiazem|mesh-list
1800716|NCT04887818|Nifedipine|nifedipine|mesh-list
1800717|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
1800718|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
1800719|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1800720|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800721|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
1800722|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800723|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1800724|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1800725|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1800726|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1800727|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800728|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1800729|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1800730|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
1800731|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
1800732|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1800733|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1800737|NCT04887961|Trabectedin|trabectedin|mesh-list
1800738|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1800739|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
1800740|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800741|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800742|NCT04887649|Morphine|morphine|mesh-list
1800743|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1800744|NCT04887649|Narcotics|narcotics|mesh-ancestor
1800745|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1800746|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800747|NCT04887649|Analgesics|analgesics|mesh-ancestor
1800748|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
1800749|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800750|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
1800751|NCT04887805|Lenvatinib|lenvatinib|mesh-list
1800752|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1800753|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800754|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1800755|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800756|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800757|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
1800758|NCT04887844|Lidocaine|lidocaine|mesh-list
1800759|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
1800760|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
1800761|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1800762|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800763|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
1800764|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800765|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1800766|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1800767|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1800768|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1800769|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800770|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1800771|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
1800772|NCT04887844|Hormones|hormones|mesh-ancestor
1800773|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1800774|NCT04887467|Apomorphine|apomorphine|mesh-list
1800775|NCT04887467|Emetics|emetics|mesh-ancestor
1800776|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800777|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
1800778|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800779|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1800780|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
1800781|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
1800782|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800783|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800789|NCT04887493|Alprostadil|alprostadil|mesh-list
1800790|NCT04887493|Misoprostol|misoprostol|mesh-list
1800791|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1800792|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
1800793|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1800794|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800795|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1800796|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1800797|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
1800798|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1800799|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
1800800|NCT04887493|Urological Agents|urological agents|mesh-ancestor
1800801|NCT04887298|Annamycin|annamycin|mesh-list
1800802|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1800803|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800810|NCT04887389|Listerine|listerine|mesh-list
1800811|NCT04887389|Fluorides|fluorides|mesh-list
1800812|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
1800813|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
1800814|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
1800815|NCT04887389|Protective Agents|protective agents|mesh-ancestor
1800816|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800817|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1800818|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800819|NCT04887311|Tempol|tempol|mesh-list
1800820|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
1800821|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800822|NCT04887311|Protective Agents|protective agents|mesh-ancestor
1800823|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800824|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1800825|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800826|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1800827|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1800828|NCT04887402|Clomiphene|clomiphene|mesh-list
1800829|NCT04887402|Enclomiphene|enclomiphene|mesh-list
1800830|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
1800831|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1800832|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
1800833|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1800834|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800835|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1800836|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
1800837|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1800838|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1800839|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1800840|NCT04887194|Nivolumab|nivolumab|mesh-list
1800841|NCT04887194|Digoxin|digoxin|mesh-list
1800842|NCT04887194|Midazolam|midazolam|mesh-list
1800843|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
1800844|NCT04887194|Warfarin|warfarin|mesh-list
1800845|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1800846|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1800847|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800848|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1800849|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800850|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1800851|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1800852|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1800853|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800854|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1800855|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1800856|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1800857|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1800858|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
1800859|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
1800860|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
1800861|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
1800862|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800863|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1800864|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1800865|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
1800866|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1800867|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1800868|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800869|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
1800870|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1800871|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1800872|NCT04887194|Protective Agents|protective agents|mesh-ancestor
1800873|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
1800874|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
1800875|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1800876|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1800877|NCT04886986|Edetic Acid|edetic acid|mesh-list
1800878|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1800879|NCT04886986|Anticoagulants|anticoagulants|mesh-ancestor
1800880|NCT04886986|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1800881|NCT04886986|Chelating Agents|chelating agents|mesh-ancestor
1800882|NCT04886986|Sequestering Agents|sequestering agents|mesh-ancestor
1800883|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800884|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1800885|NCT04886869|Caffeine|caffeine|mesh-list
1800886|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1800887|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800888|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1800889|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800890|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800891|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1800892|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1800893|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
1800894|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800895|NCT04886752|Vitamins|vitamins|mesh-list
1800896|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
1800897|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
1800898|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
1800899|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800900|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
1800901|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800902|NCT04886752|Protective Agents|protective agents|mesh-ancestor
1800917|NCT04886323|Ketoconazole|ketoconazole|mesh-list
1800918|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
1800919|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800920|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1800921|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1800922|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800923|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800924|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1800925|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
1800926|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1800927|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800928|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1800929|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
1800930|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1800931|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800932|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
1800936|NCT04886297|Resveratrol|resveratrol|mesh-list
1800937|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
1800938|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800939|NCT04886297|Protective Agents|protective agents|mesh-ancestor
1800940|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800941|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800942|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1800943|NCT04886362|Ivermectin|ivermectin|mesh-list
1800944|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1800945|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1800946|NCT04886193|Leucovorin|leucovorin|mesh-list
1800947|NCT04886193|Docetaxel|docetaxel|mesh-list
1800948|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
1800949|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1800950|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
1800951|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
1800952|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
1800953|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800954|NCT04886193|Antidotes|antidotes|mesh-ancestor
1800955|NCT04886193|Protective Agents|protective agents|mesh-ancestor
1800956|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800957|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
1800958|NCT04886193|Vitamins|vitamins|mesh-ancestor
1800959|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
1800960|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1800961|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1800962|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1800963|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1800964|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800965|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
1800966|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1800967|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800968|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1800969|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1800970|NCT04885972|Triamcinolone|triamcinolone|mesh-list
1800971|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1801124|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
1800972|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1800973|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1800974|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1800975|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
1800976|NCT04885972|Hormones|hormones|mesh-ancestor
1800977|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1800978|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800979|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1800980|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
1800981|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1800982|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1800983|NCT04885907|Vaccines|vaccines|mesh-list
1800984|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
1800985|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1800998|NCT04885764|Vaccines|vaccines|mesh-list
1800999|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
1801000|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801001|NCT04885777|Lidocaine|lidocaine|mesh-list
1801002|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
1801003|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
1801004|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1801005|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801006|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
1801007|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801008|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1801009|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1801010|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1801011|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1801012|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801013|NCT04885712|Metformin|metformin|mesh-list
1801014|NCT04885712|Pioglitazone|pioglitazone|mesh-list
1801015|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
1801016|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1801017|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801018|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1801019|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801020|NCT04885660|Lisinopril|lisinopril|mesh-list
1801021|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1801022|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
1801023|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801024|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801025|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1801026|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1801027|NCT04885660|Protective Agents|protective agents|mesh-ancestor
1801028|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801029|NCT04885686|Formaldehyde|formaldehyde|mesh-list
1801030|NCT04885686|Thymol|thymol|mesh-list
1801031|NCT04885686|Dexamethasone|dexamethasone|mesh-list
1801032|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
1801033|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1801034|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
1801035|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
1801036|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801037|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801038|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1801039|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
1801040|NCT04885686|Hormones|hormones|mesh-ancestor
1801041|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1801042|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1801043|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801044|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
1801045|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801046|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1801047|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
1801048|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
1801049|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
1801050|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801051|NCT04885751|Rebamipide|rebamipide|mesh-list
1801052|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1801053|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1801054|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
1801055|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801056|NCT04885751|Protective Agents|protective agents|mesh-ancestor
1801057|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801058|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801059|NCT04885803|Vitamin D|vitamin d|mesh-list
1801060|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
1801061|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
1801062|NCT04885803|Vitamins|vitamins|mesh-list
1801063|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
1801064|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801065|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1801066|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1801067|NCT04885270|Cisplatin|cisplatin|mesh-list
1801068|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801069|NCT04885426|Metformin|metformin|mesh-list
1801070|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1801071|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801072|NCT04885413|Niraparib|niraparib|mesh-list
1801073|NCT04885413|Antibodies|antibodies|mesh-list
1801074|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
1801075|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801076|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1801077|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801078|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801079|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801080|NCT04885153|Fenofibrate|fenofibrate|mesh-list
1801081|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1801082|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
1801083|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801084|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1801085|NCT04884997|Temozolomide|temozolomide|mesh-list
1801086|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1801087|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
1801088|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801089|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801090|NCT04884906|Paclitaxel|paclitaxel|mesh-list
1801091|NCT04884906|Cisplatin|cisplatin|mesh-list
1801092|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1801093|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801094|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
1801095|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
1801096|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
1801097|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801098|NCT04885075|Midazolam|midazolam|mesh-list
1801099|NCT04885075|Diazepam|diazepam|mesh-list
1801100|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1801101|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1801102|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1801103|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801104|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1801105|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1801106|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1801107|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1801108|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
1801109|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
1801110|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
1801111|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
1801112|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1801113|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801114|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
1801115|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
1801116|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
1801117|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801118|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1801119|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1801120|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1801121|NCT04884919|Chitosan|chitosan|mesh-list
1801122|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1801123|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1801125|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801126|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1801127|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
1801128|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
1801129|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
1801130|NCT04884919|Coagulants|coagulants|mesh-ancestor
1801131|NCT04885049|Racecadotril|racecadotril|mesh-list
1801132|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
1801133|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1801134|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
1801135|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801136|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801147|NCT04884802|Phenylephrine|phenylephrine|mesh-list
1801148|NCT04884802|Norepinephrine|norepinephrine|mesh-list
1801149|NCT04884802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
1801150|NCT04884802|Propofol|propofol|mesh-list
1801151|NCT04884802|Etomidate|etomidate|mesh-list
1801152|NCT04884802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1801153|NCT04884802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1801154|NCT04884802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801155|NCT04884802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1801156|NCT04884802|Anesthetics, General|anesthetics, general|mesh-ancestor
1801157|NCT04884802|Anesthetics|anesthetics|mesh-ancestor
1801158|NCT04884802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1801159|NCT04884802|Mydriatics|mydriatics|mesh-ancestor
1801160|NCT04884802|Autonomic Agents|autonomic agents|mesh-ancestor
1801161|NCT04884802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801162|NCT04884802|Sympathomimetics|sympathomimetics|mesh-ancestor
1801163|NCT04884802|Nasal Decongestants|nasal decongestants|mesh-ancestor
1801164|NCT04884802|Respiratory System Agents|respiratory system agents|mesh-ancestor
1801165|NCT04884802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1801166|NCT04884802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1801167|NCT04884802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1801168|NCT04884802|Adrenergic Agents|adrenergic agents|mesh-ancestor
1801169|NCT04884802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1801170|NCT04884802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801171|NCT04884802|Protective Agents|protective agents|mesh-ancestor
1801172|NCT04884750|Vaccines|vaccines|mesh-list
1801173|NCT04884750|Immunologic Factors|immunologic factors|mesh-ancestor
1801174|NCT04884750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801175|NCT04884503|Clonazepam|clonazepam|mesh-list
1801176|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
1801177|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
1801178|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
1801179|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1801180|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801181|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801182|NCT04884516|Vitamin A|vitamin a|mesh-list
1801183|NCT04884516|Vitamins|vitamins|mesh-ancestor
1801184|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
1801185|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801186|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1801187|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1801188|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801189|NCT04884490|Renal Agents|renal agents|mesh-ancestor
1801190|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1801191|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
1801192|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1801193|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1801194|NCT04884399|Ranibizumab|ranibizumab|mesh-list
1801195|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1801196|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1801197|NCT04884399|Growth Substances|growth substances|mesh-ancestor
1801198|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801199|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
1801200|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801205|NCT04884139|Tenofovir|tenofovir|mesh-list
1801206|NCT04884139|Lamivudine|lamivudine|mesh-list
1801207|NCT04884139|Emtricitabine|emtricitabine|mesh-list
1801208|NCT04884139|Dolutegravir|dolutegravir|mesh-list
1801209|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
1801210|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801211|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1801212|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1801213|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801214|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801215|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1801216|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1801217|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1801218|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1801219|NCT04884282|Docetaxel|docetaxel|mesh-list
1801220|NCT04884282|Nivolumab|nivolumab|mesh-list
1801221|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801222|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
1801223|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
1801224|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
1801225|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801226|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1801227|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1801228|NCT04883996|Pilocarpine|pilocarpine|mesh-list
1801229|NCT04883996|Miotics|miotics|mesh-ancestor
1801230|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
1801231|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801232|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801233|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
1801234|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1801235|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
1801236|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1801237|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801238|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
1801239|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1801240|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
1801241|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1801242|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801243|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
1801244|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
1801245|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1801246|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
1801247|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801248|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
1801249|NCT04884464|Protective Agents|protective agents|mesh-ancestor
1801250|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1801251|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1801252|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1801253|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
1801254|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801255|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1801256|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1801257|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801258|NCT04883736|Tretinoin|tretinoin|mesh-list
1801259|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801260|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
1801261|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
1801262|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
1801263|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1801264|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
1801265|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801266|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
1801267|NCT04883892|Protective Agents|protective agents|mesh-ancestor
1801268|NCT04883528|Valsartan|valsartan|mesh-list
1801269|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1801270|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1801271|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1801272|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1801273|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801274|NCT04883632|Lidocaine|lidocaine|mesh-list
1801275|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
1801276|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
1801277|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1801278|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801279|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
1801280|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801281|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1801282|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1801283|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1801284|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1801285|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801286|NCT04883255|Dronabinol|dronabinol|mesh-list
1801287|NCT04883255|Cannabidiol|cannabidiol|mesh-list
1801288|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
1801289|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
1801290|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801291|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1801292|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1801293|NCT04883255|Analgesics|analgesics|mesh-ancestor
1801294|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
1801295|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801296|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1801297|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1801298|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1801299|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801300|NCT04883255|Hormones|hormones|mesh-ancestor
1801301|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1801302|NCT04883645|Imiquimod|imiquimod|mesh-list
1801303|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1801304|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
1801305|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801306|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801307|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
1801308|NCT04883164|Antibodies|antibodies|mesh-list
1801309|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
1801310|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801317|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1801318|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
1801319|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1801320|NCT04883034|Analgesics|analgesics|mesh-list
1801321|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
1801322|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801323|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801350|NCT04882839|Psilocybin|psilocybin|mesh-list
1801351|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
1801352|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801353|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1801354|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
1801355|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
1801356|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1801357|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1801358|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801359|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801360|NCT04882826|Urological Agents|urological agents|mesh-ancestor
1801361|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1801362|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
1801363|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1801364|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801365|NCT04882813|Incretins|incretins|mesh-ancestor
1801366|NCT04882813|Hormones|hormones|mesh-ancestor
1801367|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1801368|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1801369|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
1801370|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801371|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801372|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1801373|NCT04883125|Pioglitazone|pioglitazone|mesh-list
1801374|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1801375|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801376|NCT04882774|Treprostinil|treprostinil|mesh-list
1801377|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1801378|NCT04882540|Brivaracetam|brivaracetam|mesh-list
1801379|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
1801380|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
1801381|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
1801382|NCT04882332|Vitamins|vitamins|mesh-ancestor
1801383|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
1801384|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801385|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
1801386|NCT04882332|Hematinics|hematinics|mesh-ancestor
1801387|NCT04882241|Leucovorin|leucovorin|mesh-list
1801388|NCT04882241|Docetaxel|docetaxel|mesh-list
1801389|NCT04882241|Fluorouracil|fluorouracil|mesh-list
1801390|NCT04882241|Capecitabine|capecitabine|mesh-list
1801391|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
1801392|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
1801393|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801394|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
1801395|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
1801396|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
1801397|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801398|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
1801399|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1801400|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1801401|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
1801402|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801403|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1801404|NCT04882241|Antidotes|antidotes|mesh-ancestor
1801405|NCT04882241|Protective Agents|protective agents|mesh-ancestor
1801406|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
1801407|NCT04882241|Vitamins|vitamins|mesh-ancestor
1801408|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
1801409|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
1801410|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1801411|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801412|NCT04882683|Prednisone|prednisone|mesh-list
1801413|NCT04882683|Adalimumab|adalimumab|mesh-list
1801414|NCT04882683|Azathioprine|azathioprine|mesh-list
1801415|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1801416|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
1801417|NCT04882683|Hormones|hormones|mesh-ancestor
1801418|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1801419|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801420|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1801421|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801422|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1801423|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
1801424|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801425|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1801426|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1801427|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
1801428|NCT04882293|Atorvastatin|atorvastatin|mesh-list
1801429|NCT04882293|Fenofibrate|fenofibrate|mesh-list
1801430|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1801431|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1801432|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
1801433|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801434|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1801435|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1801436|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801437|NCT04882202|Acetaminophen|acetaminophen|mesh-list
1801438|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1801439|NCT04882202|Analgesics|analgesics|mesh-ancestor
1801440|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
1801441|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801442|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801443|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
1801444|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
1801445|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
1801446|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801447|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1801448|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801449|NCT04882163|Gemcitabine|gemcitabine|mesh-list
1801450|NCT04882163|Dexamethasone|dexamethasone|mesh-list
1801451|NCT04882163|Rituximab|rituximab|mesh-list
1801452|NCT04882163|Lenalidomide|lenalidomide|mesh-list
1801453|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1801454|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801455|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1801456|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
1801457|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
1801458|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801459|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801460|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1801461|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
1801462|NCT04882163|Hormones|hormones|mesh-ancestor
1801463|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1801464|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1801465|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1801466|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
1801467|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1801468|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1801469|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
1801470|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801471|NCT04882163|Antiviral Agents|antiviral agents|mesh-ancestor
1801472|NCT04882163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801473|NCT04882163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801474|NCT04882163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1801475|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1801476|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1801477|NCT04882163|Growth Substances|growth substances|mesh-ancestor
1801478|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
1801479|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1801480|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
1801481|NCT04881942|Menthol|menthol|mesh-list
1801482|NCT04881942|Nicotine|nicotine|mesh-list
1801483|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1801484|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
1801485|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801486|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801487|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1801488|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1801489|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
1801490|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1801491|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801492|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
1801493|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
1801494|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
1801495|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1801496|NCT04881929|Docetaxel|docetaxel|mesh-list
1801497|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801498|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
1801499|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
1801500|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
1801501|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801512|NCT04881799|Topiramate|topiramate|mesh-list
1801513|NCT04881799|Phentermine|phentermine|mesh-list
1801514|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
1801515|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1801516|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801517|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1801518|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
1801519|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1801520|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
1801521|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
1801522|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801523|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
1801524|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1801525|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801526|NCT04881747|Lasmiditan|lasmiditan|mesh-list
1801527|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1801528|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
1801529|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1801530|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801531|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801532|NCT04881539|Cannabidiol|cannabidiol|mesh-list
1801533|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
1801534|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
1801535|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1801536|NCT04881682|Antibodies|antibodies|mesh-list
1801537|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
1801538|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801539|NCT04881474|Ibuprofen|ibuprofen|mesh-list
1801540|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1801541|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1801542|NCT04881474|Analgesics|analgesics|mesh-ancestor
1801543|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
1801544|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801545|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801546|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1801547|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1801548|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1801549|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801550|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801551|NCT04881851|Folic Acid|folic acid|mesh-list
1801552|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
1801553|NCT04881851|Inositol|inositol|mesh-list
1801554|NCT04881851|Hematinics|hematinics|mesh-ancestor
1801555|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
1801556|NCT04881851|Vitamins|vitamins|mesh-ancestor
1801557|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
1801558|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801559|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
1801560|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801561|NCT04881851|Protective Agents|protective agents|mesh-ancestor
1801562|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
1801563|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1801564|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801565|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1801566|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801567|NCT04881110|Liraglutide|liraglutide|mesh-list
1801568|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1801569|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801570|NCT04881110|Incretins|incretins|mesh-ancestor
1801571|NCT04881110|Hormones|hormones|mesh-ancestor
1801572|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1801578|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
1801579|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1801580|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801581|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1801582|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801583|NCT04880746|Cladribine|cladribine|mesh-list
1801584|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801585|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1801586|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
1801587|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801588|NCT04880980|Itraconazole|itraconazole|mesh-list
1801589|NCT04880980|Terbinafine|terbinafine|mesh-list
1801590|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
1801591|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801592|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1801593|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1801594|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801595|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801596|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1801597|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
1801598|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1801599|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801600|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1801601|NCT04880811|Afatinib|afatinib|mesh-list
1801602|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801603|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1801604|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801605|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801606|NCT04880785|Lamivudine|lamivudine|mesh-list
1801607|NCT04880785|Dolutegravir|dolutegravir|mesh-list
1801608|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1801609|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1801610|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801611|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801612|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
1801613|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801614|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1801615|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1801616|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1801617|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1801624|NCT04880655|Bacitracin|bacitracin|mesh-list
1801625|NCT04880655|Petrolatum|petrolatum|mesh-list
1801626|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1801627|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801628|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1801629|NCT04880655|Emollients|emollients|mesh-ancestor
1801630|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
1801631|NCT04880499|Folic Acid|folic acid|mesh-list
1801632|NCT04880499|Riboflavin|riboflavin|mesh-list
1801633|NCT04880499|Vitamins|vitamins|mesh-ancestor
1801634|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
1801635|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801636|NCT04880499|Hematinics|hematinics|mesh-ancestor
1801637|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
1801638|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1801639|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
1801640|NCT04880395|Lamivudine|lamivudine|mesh-list
1801641|NCT04880395|Emtricitabine|emtricitabine|mesh-list
1801642|NCT04880395|Dolutegravir|dolutegravir|mesh-list
1801643|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1801644|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1801645|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801646|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801647|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
1801648|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801649|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1801650|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1801651|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1801652|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1801653|NCT04879823|Acetaminophen|acetaminophen|mesh-list
1801654|NCT04879823|Dexamethasone|dexamethasone|mesh-list
1801655|NCT04879823|Ibuprofen|ibuprofen|mesh-list
1801656|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1801657|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
1801658|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
1801659|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801890|NCT04878497|Apixaban|apixaban|mesh-list
1801660|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801661|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1801662|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
1801663|NCT04879823|Hormones|hormones|mesh-ancestor
1801664|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1801665|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1801666|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801667|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1801668|NCT04879823|Analgesics|analgesics|mesh-ancestor
1801669|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
1801670|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
1801671|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1801672|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1801673|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1801674|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801675|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801676|NCT04879992|Amoxicillin|amoxicillin|mesh-list
1801677|NCT04879992|Metronidazole|metronidazole|mesh-list
1801678|NCT04879992|Tetracycline|tetracycline|mesh-list
1801679|NCT04879992|Rifabutin|rifabutin|mesh-list
1801680|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
1801681|NCT04879992|Esomeprazole|esomeprazole|mesh-list
1801682|NCT04879992|Bismuth|bismuth|mesh-list
1801683|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801684|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1801685|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801686|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1801687|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1801688|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1801689|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1801690|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1801691|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801692|NCT04879992|Antacids|antacids|mesh-ancestor
1801693|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1801694|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1801695|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
1801696|NCT04879992|Diuretics|diuretics|mesh-ancestor
1801697|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
1801698|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801699|NCT04879992|Expectorants|expectorants|mesh-ancestor
1801700|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
1801701|NCT04879966|Infliximab|infliximab|mesh-list
1801702|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
1801703|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1801704|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1801705|NCT04879446|Mitogens|mitogens|mesh-list
1801706|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
1801707|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801708|NCT04879511|Metformin|metformin|mesh-list
1801709|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1801710|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801711|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
1801712|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1801713|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1801714|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801715|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
1801716|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1801717|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801718|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
1801719|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801720|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1801721|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801722|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801723|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
1801724|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1801725|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801726|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1801727|NCT04879420|Teriparatide|teriparatide|mesh-list
1801728|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
1801729|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1801730|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801731|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1801732|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1801733|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1801891|NCT04878497|Edoxaban|edoxaban|mesh-list
1801734|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801735|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1801736|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1801737|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1801738|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801758|NCT04879550|Antithrombins|antithrombins|mesh-list
1801759|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
1801760|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1801761|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
1801762|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801763|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801764|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
1801765|NCT04879407|Warfarin|warfarin|mesh-list
1801766|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
1801767|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
1801768|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1801769|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
1801770|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1801771|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
1801772|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801773|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801774|NCT04879225|Menthol|menthol|mesh-list
1801775|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
1801776|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
1801777|NCT04879004|Ropivacaine|ropivacaine|mesh-list
1801778|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
1801779|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
1801780|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1801781|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801782|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
1801783|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801784|NCT04879134|Apomorphine|apomorphine|mesh-list
1801785|NCT04879134|Emetics|emetics|mesh-ancestor
1801786|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801787|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
1801788|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801789|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1801790|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
1801791|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
1801792|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1801793|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801794|NCT04878926|Midazolam|midazolam|mesh-list
1801795|NCT04878926|Propofol|propofol|mesh-list
1801796|NCT04878926|Anesthetics|anesthetics|mesh-list
1801797|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
1801798|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1801799|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1801800|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801801|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1801802|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
1801803|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1801804|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1801805|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1801806|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1801807|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
1801808|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
1801809|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1801810|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801811|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
1801812|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801813|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
1801814|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
1801815|NCT04879030|Levofloxacin|levofloxacin|mesh-list
1801816|NCT04879030|Meropenem|meropenem|mesh-list
1801817|NCT04879030|Tazobactam|tazobactam|mesh-list
1801818|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
1801819|NCT04879030|Piperacillin|piperacillin|mesh-list
1801820|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
1801821|NCT04879030|Imipenem|imipenem|mesh-list
1801822|NCT04879030|Ceftazidime|ceftazidime|mesh-list
1801823|NCT04879030|Ertapenem|ertapenem|mesh-list
1801824|NCT04879030|Lactams|lactams|mesh-list
1801825|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
1801826|NCT04879030|Cefotaxime|cefotaxime|mesh-list
1801827|NCT04879030|beta-Lactams|beta-lactams|mesh-list
1801828|NCT04879030|Cefixime|cefixime|mesh-list
1801829|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
1801830|NCT04879030|Ticarcillin|ticarcillin|mesh-list
1801831|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1801832|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801833|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1801834|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1801835|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801836|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801837|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801838|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1801839|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1801840|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1801841|NCT04879030|Renal Agents|renal agents|mesh-ancestor
1801842|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1801843|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1801844|NCT04878835|Ranibizumab|ranibizumab|mesh-list
1801845|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1801846|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1801847|NCT04878835|Growth Substances|growth substances|mesh-ancestor
1801848|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801849|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
1801850|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801851|NCT04878770|Cyclosporine|cyclosporine|mesh-list
1801852|NCT04878770|Cyclosporins|cyclosporins|mesh-list
1801853|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801854|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801855|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1801856|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
1801857|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801858|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
1801859|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801860|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
1801861|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1801862|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1801863|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
1801864|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1801865|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1801866|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801867|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1801868|NCT04878510|Analgesics|analgesics|mesh-ancestor
1801869|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
1801870|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801871|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1801872|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1801873|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1801874|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
1801875|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1801876|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801884|NCT04878718|Vancomycin|vancomycin|mesh-list
1801885|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1801886|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801887|NCT04878497|Warfarin|warfarin|mesh-list
1801888|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
1801889|NCT04878497|Dabigatran|dabigatran|mesh-list
1801892|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
1801893|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1801894|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
1801895|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1801896|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
1801897|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801898|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801899|NCT04878198|Melatonin|melatonin|mesh-list
1801900|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
1801901|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801902|NCT04878198|Protective Agents|protective agents|mesh-ancestor
1801903|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801904|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1801905|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1801906|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1801907|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801908|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
1801909|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
1801910|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801911|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
1801912|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1801913|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1801914|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801915|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1801916|NCT04877639|Analgesics|analgesics|mesh-ancestor
1801917|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
1801918|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1801919|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1801920|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1801921|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1801922|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
1801923|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1801924|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801925|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
1801926|NCT04877613|Fludarabine|fludarabine|mesh-list
1801927|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1801928|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
1801929|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801930|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1801931|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1801932|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
1801933|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801934|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801935|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1801936|NCT04878016|Carboplatin|carboplatin|mesh-list
1801937|NCT04878016|Etoposide|etoposide|mesh-list
1801938|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801939|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1801940|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1801941|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1801942|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801943|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801944|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
1801945|NCT04877834|Lansoprazole|lansoprazole|mesh-list
1801946|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1801947|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1801948|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1801949|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1801950|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801951|NCT04877626|Artesunate|artesunate|mesh-list
1801952|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
1801953|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1801954|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1801955|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1801956|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801957|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
1801958|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
1801959|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1801960|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
1801972|NCT04877509|Vitamin D|vitamin d|mesh-list
1801973|NCT04877509|Vitamin A|vitamin a|mesh-list
1801974|NCT04877509|Selenium|selenium|mesh-list
1801975|NCT04877509|Copper|copper|mesh-list
1801976|NCT04877509|Vitamins|vitamins|mesh-ancestor
1801977|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
1801978|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801979|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
1801980|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801981|NCT04877509|Protective Agents|protective agents|mesh-ancestor
1801982|NCT04877509|Trace Elements|trace elements|mesh-ancestor
1801983|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1801984|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
1801985|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
1801986|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801987|NCT04877275|Dexamethasone|dexamethasone|mesh-list
1801988|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
1801989|NCT04877275|Doxorubicin|doxorubicin|mesh-list
1801990|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1801991|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1801992|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
1801993|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1801994|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1801995|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1801996|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
1801997|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1801998|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1801999|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1802000|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1802001|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
1802002|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
1802003|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802004|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1802005|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
1802006|NCT04877275|Hormones|hormones|mesh-ancestor
1802007|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802008|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1802009|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1802010|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1802011|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1802012|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802013|NCT04877210|Insulin|insulin|mesh-list
1802014|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1802015|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1802016|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802020|NCT04877106|Metformin|metformin|mesh-list
1802021|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1802022|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1802023|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802024|NCT04877106|Incretins|incretins|mesh-ancestor
1802025|NCT04877106|Hormones|hormones|mesh-ancestor
1802026|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802027|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1802028|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
1802029|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802030|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802031|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
1802032|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1802033|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802034|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802035|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1802036|NCT04876937|Analgesics|analgesics|mesh-ancestor
1802037|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
1802038|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802039|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1802040|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1802041|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1802042|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
1802043|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802044|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802045|NCT04877288|Cyclosporine|cyclosporine|mesh-list
1802046|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
1802047|NCT04877288|Abatacept|abatacept|mesh-list
1802048|NCT04877288|Tacrolimus|tacrolimus|mesh-list
1802049|NCT04877288|Cyclosporins|cyclosporins|mesh-list
1802050|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1802051|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
1802052|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802053|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1802054|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802055|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802056|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
1802057|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802058|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
1802059|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1802060|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1802061|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802062|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1802063|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
1802064|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1802065|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1802066|NCT04876781|Tofacitinib|tofacitinib|mesh-list
1802067|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1802068|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802069|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802070|NCT04876716|Voriconazole|voriconazole|mesh-list
1802071|NCT04876716|Posaconazole|posaconazole|mesh-list
1802072|NCT04876716|Isavuconazole|isavuconazole|mesh-list
1802073|NCT04876716|Anidulafungin|anidulafungin|mesh-list
1802074|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
1802075|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802076|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1802077|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1802078|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802079|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802080|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1802081|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
1802082|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802083|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802084|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1802085|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1802086|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1802087|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1802111|NCT04876638|Minocycline|minocycline|mesh-list
1802112|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1802113|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802114|NCT04876859|Anesthetics|anesthetics|mesh-list
1802115|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802116|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802117|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
1802118|NCT04876807|Omeprazole|omeprazole|mesh-list
1802119|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1802120|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1802121|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1802122|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802123|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802124|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802125|NCT04876430|Meropenem|meropenem|mesh-list
1802126|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1802127|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802128|NCT04876313|Paclitaxel|paclitaxel|mesh-list
1802129|NCT04876313|Nivolumab|nivolumab|mesh-list
1802130|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1802131|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802132|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
1802133|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
1802134|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
1802135|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802136|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1802137|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1802138|NCT04876755|TEMPO|tempo|mesh-list
1802139|NCT04876755|TEMPOL-H|tempol-h|mesh-list
1802140|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
1802141|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802142|NCT04876755|Protective Agents|protective agents|mesh-ancestor
1802143|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802144|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1802145|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
1802146|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
1802147|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
1802148|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1802149|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1802150|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
1802151|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
1802152|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802153|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802154|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802155|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1802156|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
1802157|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1802158|NCT04876521|Olanzapine|olanzapine|mesh-list
1802159|NCT04876521|Amisulpride|amisulpride|mesh-list
1802160|NCT04876521|Fluoxetine|fluoxetine|mesh-list
1802161|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
1802162|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
1802163|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802164|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802165|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1802166|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1802167|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1802168|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802169|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1802170|NCT04876521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1802171|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1802172|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1802173|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802174|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802175|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
1802176|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1802177|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
1802178|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1802179|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1802180|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802181|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1802182|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
1802183|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
1802184|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1802185|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1802186|NCT04876534|Prednisolone|prednisolone|mesh-list
1802187|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
1802188|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1802189|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1802190|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
1802191|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1802192|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
1802193|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
1802194|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802195|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802196|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1802197|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
1802198|NCT04876534|Hormones|hormones|mesh-ancestor
1802199|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802200|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1802201|NCT04876534|Protective Agents|protective agents|mesh-ancestor
1802202|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1802203|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802204|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
1802205|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802206|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
1802207|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802208|NCT04876261|Protective Agents|protective agents|mesh-ancestor
1802209|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802210|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1802211|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1802212|NCT04876131|Gentamicins|gentamicins|mesh-list
1802213|NCT04876131|Cephalexin|cephalexin|mesh-list
1802214|NCT04876131|Penicillin G|penicillin g|mesh-list
1802215|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
1802216|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
1802217|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802218|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1802219|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802220|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802221|NCT04875819|Vaccines|vaccines|mesh-list
1802222|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1802223|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
1802224|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802225|NCT04876066|Ketamine|ketamine|mesh-list
1802226|NCT04876066|Analgesics|analgesics|mesh-ancestor
1802227|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
1802228|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802229|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802230|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1802231|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1802232|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
1802233|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
1802234|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802235|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1802236|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1802237|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802238|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802239|NCT04876079|Insulin|insulin|mesh-list
1802240|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1802241|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802242|NCT04876027|Dulaglutide|dulaglutide|mesh-list
1802243|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1802244|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802245|NCT04875715|Hydroquinone|hydroquinone|mesh-list
1802246|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
1802247|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802248|NCT04875715|Protective Agents|protective agents|mesh-ancestor
1802249|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802250|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1802251|NCT04875767|Coal Tar|coal tar|mesh-list
1802252|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
1802253|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
1802254|NCT04875728|Cefazolin|cefazolin|mesh-list
1802255|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1802256|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802257|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1802258|NCT04875702|Allopurinol|allopurinol|mesh-list
1802259|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
1802260|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802261|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802262|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
1802263|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1802264|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1802265|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
1802266|NCT04875702|Protective Agents|protective agents|mesh-ancestor
1802267|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802268|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
1802269|NCT04875585|Lenvatinib|lenvatinib|mesh-list
1802270|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1802271|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802272|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1802273|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802274|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802275|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1802276|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
1802277|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802278|NCT04875611|Nivolumab|nivolumab|mesh-list
1802279|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1802280|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802281|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1802282|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802283|NCT04875026|Fluorouracil|fluorouracil|mesh-list
1802284|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
1802285|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802286|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1802287|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802288|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1802289|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
1802290|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802291|NCT04874844|Antibodies|antibodies|mesh-list
1802292|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1802293|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
1802294|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802295|NCT04875039|Dexamethasone|dexamethasone|mesh-list
1802296|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
1802297|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
1802298|NCT04875039|BB 1101|bb 1101|mesh-list
1802299|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1802300|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
1802301|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
1802302|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802303|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802304|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1802305|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
1802306|NCT04875039|Hormones|hormones|mesh-ancestor
1802307|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802308|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1802309|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802310|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
1802311|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802312|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802313|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1802314|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802315|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1802316|NCT04875039|Analgesics|analgesics|mesh-ancestor
1802317|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
1802318|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1802319|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1802320|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1802321|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
1802322|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802323|NCT04874688|Provitamins|provitamins|mesh-list
1802324|NCT04874688|Beta Carotene|beta carotene|mesh-list
1802325|NCT04874688|Vitamins|vitamins|mesh-ancestor
1802326|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
1802327|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802328|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
1802329|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1802330|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1802331|NCT04874610|Prednisolone|prednisolone|mesh-list
1802332|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
1802333|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1802334|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
1802335|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1802336|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
1802337|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
1802338|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802339|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802340|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1802341|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
1802342|NCT04874610|Hormones|hormones|mesh-ancestor
1802343|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802344|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1802345|NCT04874610|Protective Agents|protective agents|mesh-ancestor
1802346|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1802347|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802348|NCT04874675|Acetaminophen|acetaminophen|mesh-list
1802349|NCT04874675|Ibuprofen|ibuprofen|mesh-list
1802350|NCT04874675|Diclofenac|diclofenac|mesh-list
1802351|NCT04874675|Codeine|codeine|mesh-list
1802352|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1802353|NCT04874675|Analgesics|analgesics|mesh-ancestor
1802354|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
1802355|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802356|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802357|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
1802358|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1802359|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1802360|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1802361|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1802362|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802363|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802364|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1802365|NCT04874675|Narcotics|narcotics|mesh-ancestor
1802366|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802367|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
1802368|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
1802369|NCT04874506|TEMPO|tempo|mesh-list
1802370|NCT04874506|TEMPOL-H|tempol-h|mesh-list
1802371|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
1802372|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802373|NCT04874506|Protective Agents|protective agents|mesh-ancestor
1802374|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802375|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1802386|NCT04874246|Vasopressins|vasopressins|mesh-list
1802387|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
1802388|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
1802389|NCT04874246|Coagulants|coagulants|mesh-ancestor
1802390|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1802391|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1802392|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
1802393|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802394|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
1802395|NCT04874428|Apixaban|apixaban|mesh-list
1802396|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1802397|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
1802398|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1802399|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
1802400|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802401|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802402|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
1802403|NCT04874025|Palbociclib|palbociclib|mesh-list
1802404|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802405|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1802406|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802407|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802408|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
1802409|NCT04873895|Axitinib|axitinib|mesh-list
1802410|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
1802411|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1802412|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1802413|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802414|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802415|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802416|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1802417|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802418|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1802419|NCT04874038|Lidocaine|lidocaine|mesh-list
1802420|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
1802421|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
1802422|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802423|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802424|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
1802425|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802426|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1802427|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1802428|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1802429|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1802430|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802438|NCT04873531|Neostigmine|neostigmine|mesh-list
1802439|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1802440|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802441|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802442|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
1802443|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802444|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802445|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1802446|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
1802447|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802448|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
1802449|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
1802450|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802451|NCT04873440|Manganese|manganese|mesh-list
1802452|NCT04873440|Trace Elements|trace elements|mesh-ancestor
1802453|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
1802454|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802455|NCT04873596|Midazolam|midazolam|mesh-list
1802456|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
1802457|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1802458|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802459|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802460|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1802461|NCT04873596|Analgesics|analgesics|mesh-ancestor
1802462|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
1802463|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802464|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1802465|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1802466|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1802467|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
1802468|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802469|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802470|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1802471|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1802472|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1802473|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1802474|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1802475|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
1802476|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
1802477|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
1802478|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
1802479|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
1802480|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1802481|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802482|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1802483|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1802484|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802485|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802486|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802487|NCT04873557|Copper|copper|mesh-list
1802488|NCT04873557|Trace Elements|trace elements|mesh-ancestor
1802489|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
1802490|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802491|NCT04873362|Trastuzumab|trastuzumab|mesh-list
1802492|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1802493|NCT04873362|Atezolizumab|atezolizumab|mesh-list
1802494|NCT04873362|Maytansine|maytansine|mesh-list
1802495|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1802496|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802497|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1802498|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
1802499|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
1802500|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
1802501|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802502|NCT04873479|Ketamine|ketamine|mesh-list
1802503|NCT04873479|Esketamine|esketamine|mesh-list
1802504|NCT04873479|Analgesics|analgesics|mesh-ancestor
1802505|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
1802506|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802507|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802508|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1802509|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1802510|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
1802511|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
1802512|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802513|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1802514|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1802515|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802516|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802517|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
1802518|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1802519|NCT04873349|Oleuropein|oleuropein|mesh-list
1802520|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802521|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1802522|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
1802523|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1802524|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802525|NCT04873284|Dexamethasone|dexamethasone|mesh-list
1802526|NCT04873284|Aprepitant|aprepitant|mesh-list
1802527|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
1802528|NCT04873284|Granisetron|granisetron|mesh-list
1802529|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1802530|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
1802531|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
1802532|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802533|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802534|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1802535|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
1802536|NCT04873284|Hormones|hormones|mesh-ancestor
1802537|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802538|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1802539|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802540|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1802541|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802542|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802543|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1802544|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
1802545|NCT04873375|Cemiplimab|cemiplimab|mesh-list
1802546|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1802547|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802548|NCT04873102|Danazol|danazol|mesh-list
1802549|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1802550|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
1802551|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802552|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802553|NCT04873011|Quinine|quinine|mesh-list
1802554|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
1802555|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1802556|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1802557|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802558|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1802559|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802560|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1802561|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802562|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1802563|NCT04873011|Analgesics|analgesics|mesh-ancestor
1802564|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
1802565|NCT04872985|Paclitaxel|paclitaxel|mesh-list
1802566|NCT04872985|Docetaxel|docetaxel|mesh-list
1802567|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
1802568|NCT04872985|Doxorubicin|doxorubicin|mesh-list
1802569|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1802570|NCT04872985|Epirubicin|epirubicin|mesh-list
1802571|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1802572|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802573|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
1802574|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
1802575|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
1802576|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802577|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1802578|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
1802579|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802580|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1802581|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1802582|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
1802583|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1802584|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1802585|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1802586|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1802587|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802588|NCT04873063|Beclomethasone|beclomethasone|mesh-list
1802589|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1802590|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
1802591|NCT04873063|Hormones|hormones|mesh-ancestor
1802592|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802593|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802594|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1802595|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
1802596|NCT04872907|Fluorides|fluorides|mesh-list
1802597|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
1802598|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
1802599|NCT04872907|Protective Agents|protective agents|mesh-ancestor
1802600|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802601|NCT04872608|Letrozole|letrozole|mesh-list
1802602|NCT04872608|Palbociclib|palbociclib|mesh-list
1802603|NCT04872608|Onapristone|onapristone|mesh-list
1802604|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802605|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1802606|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1802607|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802608|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802609|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1802610|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
1802611|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802612|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802613|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1802614|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1802615|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
1802616|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1802617|NCT04872881|Fentanyl|fentanyl|mesh-list
1802618|NCT04872881|Propofol|propofol|mesh-list
1802619|NCT04872881|Rocuronium|rocuronium|mesh-list
1802620|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1802621|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802622|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802623|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1802624|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
1802625|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
1802626|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1802627|NCT04872881|Narcotics|narcotics|mesh-ancestor
1802628|NCT04872881|Analgesics|analgesics|mesh-ancestor
1802629|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
1802630|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802631|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1802632|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1802633|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1802634|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1802669|NCT04872634|Cetuximab|cetuximab|mesh-list
1802670|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1802671|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802686|NCT04873453|Cannabidiol|cannabidiol|mesh-list
1802687|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
1802691|NCT04872270|Caffeine|caffeine|mesh-list
1802692|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1802693|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802694|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1802695|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802696|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802697|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1802698|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1802699|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
1802700|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802701|NCT04872218|Abatacept|abatacept|mesh-list
1802702|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1802703|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802704|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802705|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1802706|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
1802707|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802708|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1802709|NCT04872400|Vancomycin|vancomycin|mesh-list
1802710|NCT04872400|Tobramycin|tobramycin|mesh-list
1802711|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1802712|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802713|NCT04872192|Anesthetics|anesthetics|mesh-list
1802714|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802715|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802716|NCT04872231|Voriconazole|voriconazole|mesh-list
1802717|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
1802718|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802719|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1802720|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1802721|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802722|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802723|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1802724|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
1802725|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802726|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803025|NCT04870541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1802727|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1802728|NCT04872283|Aspirin|aspirin|mesh-list
1802729|NCT04872283|Acetaminophen|acetaminophen|mesh-list
1802730|NCT04872283|Ketorolac|ketorolac|mesh-list
1802731|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1802732|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
1802733|NCT04872283|Oxycodone|oxycodone|mesh-list
1802734|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1802735|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1802736|NCT04872283|Analgesics|analgesics|mesh-ancestor
1802737|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
1802738|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802739|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802740|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1802741|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1802742|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1802743|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1802744|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802745|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1802746|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1802747|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802748|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
1802749|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1802750|NCT04872283|Narcotics|narcotics|mesh-ancestor
1802751|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802752|NCT04872257|Vitamin D|vitamin d|mesh-list
1802753|NCT04872257|Vitamins|vitamins|mesh-ancestor
1802754|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
1802755|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802756|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1802757|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
1802758|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1802759|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
1802760|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1802761|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802762|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1802763|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1802764|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1802765|NCT04872322|Ropivacaine|ropivacaine|mesh-list
1802766|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1802767|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
1802768|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
1802769|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802770|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802771|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
1802772|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802773|NCT04871958|Insulin|insulin|mesh-list
1802774|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1802775|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802776|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
1802777|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
1802778|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802779|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802780|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1802781|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
1802782|NCT04871724|Fluconazole|fluconazole|mesh-list
1802783|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
1802784|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802785|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1802786|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1802787|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802788|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802789|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1802790|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
1802791|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802792|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802793|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1802794|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1802795|NCT04871802|Taxifolin|taxifolin|mesh-list
1802796|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1802797|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1802798|NCT04871802|Analgesics|analgesics|mesh-ancestor
1802799|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
1803177|NCT04869306|Protective Agents|protective agents|mesh-ancestor
1802800|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802801|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802802|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1802803|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1802804|NCT04871633|Azithromycin|azithromycin|mesh-list
1802805|NCT04871633|Remdesivir|remdesivir|mesh-list
1802806|NCT04871633|Dexamethasone|dexamethasone|mesh-list
1802807|NCT04871633|Prednisolone|prednisolone|mesh-list
1802808|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1802809|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1802810|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
1802811|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
1802812|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802813|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802814|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1802815|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
1802816|NCT04871633|Hormones|hormones|mesh-ancestor
1802817|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802818|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1802819|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802820|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802821|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1802822|NCT04871633|Protective Agents|protective agents|mesh-ancestor
1802823|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1802824|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802825|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
1802826|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
1802827|NCT04871750|Caseins|caseins|mesh-list
1802828|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
1802829|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
1802830|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802831|NCT04871932|Vaccines|vaccines|mesh-list
1802832|NCT04871932|Immunologic Factors|immunologic factors|mesh-ancestor
1802833|NCT04871932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802834|NCT04871594|Nivolumab|nivolumab|mesh-list
1802835|NCT04871594|Ipilimumab|ipilimumab|mesh-list
1802836|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1802837|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802838|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1802839|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802840|NCT04871425|Fentanyl|fentanyl|mesh-list
1802841|NCT04871425|Ketamine|ketamine|mesh-list
1802842|NCT04871425|Analgesics|analgesics|mesh-ancestor
1802843|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
1802844|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802845|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802846|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1802847|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1802848|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
1802849|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
1802850|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802851|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1802852|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1802853|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802854|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802855|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1802856|NCT04871425|Narcotics|narcotics|mesh-ancestor
1802857|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1802858|NCT04871321|Gemcitabine|gemcitabine|mesh-list
1802859|NCT04871321|Paclitaxel|paclitaxel|mesh-list
1802860|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1802861|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802862|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
1802863|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
1802864|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
1802865|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802866|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1802867|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
1802868|NCT04871321|Antiviral Agents|antiviral agents|mesh-ancestor
1802869|NCT04871321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802870|NCT04871321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802871|NCT04871321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1802872|NCT04871321|Immunologic Factors|immunologic factors|mesh-ancestor
1802873|NCT04871321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802874|NCT04871191|Rituximab|rituximab|mesh-list
1802875|NCT04871191|Abatacept|abatacept|mesh-list
1802876|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1802877|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802878|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
1802879|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802880|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1802881|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1802882|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802883|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1802884|NCT04871412|Vitamin D|vitamin d|mesh-list
1802885|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
1802886|NCT04871412|Vitamins|vitamins|mesh-list
1802887|NCT04871412|Curcumin|curcumin|mesh-list
1802888|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
1802889|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802890|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1802891|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1802892|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1802893|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1802894|NCT04871412|Analgesics|analgesics|mesh-ancestor
1802895|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
1802896|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802897|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1802898|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1802899|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802900|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802901|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802902|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
1802903|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1802904|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802905|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802906|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1802907|NCT04871308|Analgesics|analgesics|mesh-ancestor
1802908|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
1802909|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802910|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1802911|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1802912|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1802913|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
1802914|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802915|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802916|NCT04871204|Octreotide|octreotide|mesh-list
1802917|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1802918|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1802919|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1802923|NCT04871269|Dronabinol|dronabinol|mesh-list
1802924|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
1802925|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802926|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1802927|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1802928|NCT04871269|Analgesics|analgesics|mesh-ancestor
1802929|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
1802930|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802931|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1802932|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1802933|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802934|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802935|NCT04871269|Hormones|hormones|mesh-ancestor
1802936|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1802937|NCT04871061|Fentanyl|fentanyl|mesh-list
1802938|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1802939|NCT04871061|Narcotics|narcotics|mesh-ancestor
1802940|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1802941|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802942|NCT04871061|Analgesics|analgesics|mesh-ancestor
1802943|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
1802944|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802945|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1802946|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1802947|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
1802948|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
1802949|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1802950|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1802951|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1802952|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1802953|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802954|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802955|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802956|NCT04870957|Analgesics|analgesics|mesh-ancestor
1802957|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
1802958|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802959|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
1802960|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1802961|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
1802962|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1802963|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1802964|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1802965|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1802966|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802967|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1802968|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1802969|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802970|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
1802971|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1802977|NCT04870372|Selegiline|selegiline|mesh-list
1802978|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
1802979|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1802980|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1802981|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1802982|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1802983|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802984|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802985|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1802986|NCT04870372|Protective Agents|protective agents|mesh-ancestor
1802987|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1802988|NCT04870671|Tenofovir|tenofovir|mesh-list
1802989|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
1802990|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1802991|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1802992|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1802993|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1802994|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1802995|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1802996|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1802997|NCT04870866|Niacinamide|niacinamide|mesh-list
1802998|NCT04870866|Niacin|niacin|mesh-list
1802999|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
1803000|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
1803001|NCT04870866|Vitamins|vitamins|mesh-ancestor
1803002|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
1803003|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803004|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1803005|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
1803006|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803007|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1803008|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
1803009|NCT04870489|Isotretinoin|isotretinoin|mesh-list
1803010|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
1803011|NCT04870541|Nefopam|nefopam|mesh-list
1803012|NCT04870541|Ondansetron|ondansetron|mesh-list
1803013|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
1803014|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
1803015|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803016|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803017|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1803018|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
1803019|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
1803020|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1803021|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
1803022|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1803023|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803024|NCT04870541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1803026|NCT04870541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803027|NCT04870541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1803028|NCT04870541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1803029|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1803030|NCT04870541|Analgesics|analgesics|mesh-ancestor
1803031|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
1803032|NCT04870502|Clomiphene|clomiphene|mesh-list
1803033|NCT04870502|Enclomiphene|enclomiphene|mesh-list
1803034|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
1803035|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1803036|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
1803037|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1803038|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803039|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1803040|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
1803041|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1803042|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1803043|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1803044|NCT04870359|Prednisolone|prednisolone|mesh-list
1803045|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
1803046|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1803047|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
1803048|NCT04870359|Hormones|hormones|mesh-ancestor
1803049|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1803050|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803051|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1803052|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803053|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
1803054|NCT04870333|Niclosamide|niclosamide|mesh-list
1803055|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
1803056|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1803057|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
1803058|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1803059|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803060|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
1803061|NCT04870203|Adalimumab|adalimumab|mesh-list
1803062|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1803063|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1803076|NCT04870190|Osimertinib|osimertinib|mesh-list
1803077|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803078|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1803079|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803080|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803087|NCT04870021|Vaccines|vaccines|mesh-list
1803088|NCT04870021|Immunologic Factors|immunologic factors|mesh-ancestor
1803089|NCT04870021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803090|NCT04870060|Curcumin|curcumin|mesh-list
1803091|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1803092|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1803093|NCT04870060|Analgesics|analgesics|mesh-ancestor
1803094|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
1803095|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803096|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803097|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1803098|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1803099|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803100|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803252|NCT04868552|Naloxone|naloxone|mesh-list
1803101|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803102|NCT04870073|Mannitol|mannitol|mesh-list
1803103|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1803104|NCT04870073|Diuretics|diuretics|mesh-ancestor
1803105|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
1803106|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803107|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1803108|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
1803109|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803110|NCT04869592|Vaccines|vaccines|mesh-list
1803111|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
1803112|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803113|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
1803114|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803115|NCT04869501|Atezolizumab|atezolizumab|mesh-list
1803116|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803133|NCT04869579|Selenium|selenium|mesh-list
1803134|NCT04869579|Selenious Acid|selenious acid|mesh-list
1803135|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
1803136|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803137|NCT04869579|Protective Agents|protective agents|mesh-ancestor
1803138|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803139|NCT04869579|Trace Elements|trace elements|mesh-ancestor
1803140|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
1803160|NCT04869709|Betamethasone|betamethasone|mesh-list
1803161|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
1803162|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
1803163|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
1803164|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
1803165|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1803166|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
1803167|NCT04869709|Hormones|hormones|mesh-ancestor
1803168|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1803169|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803170|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1803171|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
1803172|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
1803173|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1803174|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
1803175|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803176|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
1803183|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
1803184|NCT04869137|Lenvatinib|lenvatinib|mesh-list
1803185|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1803186|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803187|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1803188|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803189|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803190|NCT04869176|Caffeine|caffeine|mesh-list
1803191|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
1803192|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803193|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1803194|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803195|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1803196|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803197|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1803198|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1803199|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
1803200|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1803201|NCT04869046|Acetaminophen|acetaminophen|mesh-list
1803202|NCT04869046|Ibuprofen|ibuprofen|mesh-list
1803203|NCT04869046|Analgesics|analgesics|mesh-list
1803204|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
1803205|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1803206|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
1803207|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803208|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803209|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
1803210|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1803211|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1803212|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1803213|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1803214|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803215|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803216|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
1803217|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
1803218|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803219|NCT04868903|Vitamin D|vitamin d|mesh-list
1803220|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
1803221|NCT04868903|Vitamins|vitamins|mesh-ancestor
1803222|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
1803223|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803224|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1803225|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1803226|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
1803227|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1803228|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803229|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1803230|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
1803231|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1803232|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803233|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803234|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803235|NCT04868760|Ipilimumab|ipilimumab|mesh-list
1803236|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1803237|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803238|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1803239|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803240|NCT04868747|Lidocaine|lidocaine|mesh-list
1803241|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
1803242|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
1803243|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803244|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803245|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
1803246|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803247|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1803248|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1803249|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1803250|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1803251|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803253|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1803254|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803255|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
1803256|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803257|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
1803258|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1803259|NCT04868513|Fluorides|fluorides|mesh-list
1803260|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
1803261|NCT04868513|Protective Agents|protective agents|mesh-ancestor
1803262|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803263|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1803264|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803265|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
1803266|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
1803267|NCT04868838|Daratumumab|daratumumab|mesh-list
1803268|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803269|NCT04868773|Trifluridine|trifluridine|mesh-list
1803270|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
1803271|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803272|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
1803273|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803274|NCT04868708|Paclitaxel|paclitaxel|mesh-list
1803275|NCT04868708|Bevacizumab|bevacizumab|mesh-list
1803276|NCT04868708|Carboplatin|carboplatin|mesh-list
1803277|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1803278|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803279|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
1803280|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
1803281|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
1803282|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803283|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1803284|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1803285|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1803286|NCT04868708|Growth Substances|growth substances|mesh-ancestor
1803287|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803288|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
1803289|NCT04868175|Timolol|timolol|mesh-list
1803290|NCT04868175|Travoprost|travoprost|mesh-list
1803291|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1803292|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1803293|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
1803294|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1803295|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803296|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803297|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1803298|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1803299|NCT04868227|Vitamin D|vitamin d|mesh-list
1803300|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
1803301|NCT04868227|Vitamins|vitamins|mesh-ancestor
1803302|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
1803303|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803304|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1803305|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1803306|NCT04868461|Caseins|caseins|mesh-list
1803307|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
1803308|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
1803309|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803310|NCT04868019|Fenofibrate|fenofibrate|mesh-list
1803311|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1803312|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
1803313|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803314|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1803315|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
1803316|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
1803317|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1803318|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803319|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1803320|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1803321|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803322|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803323|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803324|NCT04868253|Oxazepam|oxazepam|mesh-list
1803325|NCT04868253|Metyrapone|metyrapone|mesh-list
1803326|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
1803327|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803328|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803329|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1803330|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803331|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803332|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1803333|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1803334|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1803335|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
1803336|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
1803337|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1803338|NCT04867993|Amikacin|amikacin|mesh-list
1803339|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1803340|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803341|NCT04868058|Ropivacaine|ropivacaine|mesh-list
1803342|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
1803343|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
1803344|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803345|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803346|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
1803347|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803348|NCT04868565|Caffeine|caffeine|mesh-list
1803349|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
1803350|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803351|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1803352|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803353|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1803354|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803355|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1803356|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1803357|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
1803358|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1803359|NCT04868045|Hormones|hormones|mesh-list
1803360|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
1803361|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1803362|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803370|NCT04867720|Everolimus|everolimus|mesh-list
1803371|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803372|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1803373|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
1803374|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803375|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
1803376|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803387|NCT04867707|Zanamivir|zanamivir|mesh-list
1803388|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
1803389|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803390|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803391|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803392|NCT04867343|Fentanyl|fentanyl|mesh-list
1803393|NCT04867343|Remifentanil|remifentanil|mesh-list
1803394|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1803395|NCT04867343|Narcotics|narcotics|mesh-ancestor
1803396|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803397|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803398|NCT04867343|Analgesics|analgesics|mesh-ancestor
1803399|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
1803400|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803401|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1803402|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1803403|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
1803404|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
1803405|NCT04867226|Colchicine|colchicine|mesh-list
1803406|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
1803407|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1803408|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
1803409|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
1803410|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
1803411|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803412|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803413|NCT04867135|Amikacin|amikacin|mesh-list
1803414|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1803415|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803416|NCT04867252|Inositol|inositol|mesh-list
1803417|NCT04867252|Metformin|metformin|mesh-list
1803418|NCT04867252|Pioglitazone|pioglitazone|mesh-list
1803419|NCT04867252|Resveratrol|resveratrol|mesh-list
1803420|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1803421|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803422|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
1803423|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803424|NCT04867252|Protective Agents|protective agents|mesh-ancestor
1803425|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803426|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1803427|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
1803428|NCT04867252|Vitamins|vitamins|mesh-ancestor
1803429|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
1803430|NCT04866498|Analgesics|analgesics|mesh-list
1803431|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
1803432|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803433|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803434|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
1803435|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1803436|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
1803437|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803438|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
1803439|NCT04866706|Protective Agents|protective agents|mesh-ancestor
1803440|NCT04866654|Nivolumab|nivolumab|mesh-list
1803441|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1803442|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803443|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1803444|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803450|NCT04866355|Ibuprofen|ibuprofen|mesh-list
1803451|NCT04866355|Scopolamine|scopolamine|mesh-list
1803452|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1803453|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1803454|NCT04866355|Analgesics|analgesics|mesh-ancestor
1803455|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
1803456|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803457|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803458|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1803459|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1803460|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1803461|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803462|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803463|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1803464|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
1803465|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
1803466|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1803467|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
1803468|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1803469|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
1803470|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1803471|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1803472|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
1803473|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1803474|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803475|NCT04866108|Capecitabine|capecitabine|mesh-list
1803476|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1803477|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
1803478|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803479|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803480|NCT04866056|Azacitidine|azacitidine|mesh-list
1803481|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1803482|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
1803559|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1803483|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803484|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803485|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803486|NCT04865900|Antibodies|antibodies|mesh-list
1803487|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
1803488|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803489|NCT04865848|Anesthetics|anesthetics|mesh-list
1803490|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803491|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803494|NCT04865705|Paclitaxel|paclitaxel|mesh-list
1803495|NCT04865705|Cisplatin|cisplatin|mesh-list
1803496|NCT04865705|Carboplatin|carboplatin|mesh-list
1803497|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1803498|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803499|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
1803500|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
1803501|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
1803502|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803506|NCT04865991|Propofol|propofol|mesh-list
1803507|NCT04865991|Sevoflurane|sevoflurane|mesh-list
1803508|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1803509|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803510|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803511|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1803512|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
1803513|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
1803514|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1803515|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1803522|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
1803523|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1803524|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
1803525|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803526|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1803527|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1803528|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
1803529|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1803530|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803531|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1803535|NCT04865510|Heparin|heparin|mesh-list
1803536|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
1803537|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803538|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1803539|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1803540|NCT04865211|Bupivacaine|bupivacaine|mesh-list
1803541|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
1803542|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
1803543|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803544|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803545|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
1803546|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803547|NCT04865237|Remdesivir|remdesivir|mesh-list
1803548|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
1803549|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803550|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
1803551|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803552|NCT04865445|Midazolam|midazolam|mesh-list
1803553|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1803554|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1803555|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803556|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803557|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1803558|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1803560|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1803561|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
1803562|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
1803563|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
1803564|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
1803565|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1803566|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803567|NCT04865250|Paclitaxel|paclitaxel|mesh-list
1803568|NCT04865250|Carboplatin|carboplatin|mesh-list
1803569|NCT04865250|Atezolizumab|atezolizumab|mesh-list
1803570|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1803571|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803572|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
1803573|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
1803574|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
1803575|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803576|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
1803577|NCT04865562|Testosterone|testosterone|mesh-list
1803578|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
1803579|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
1803580|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1803581|NCT04865562|Androgens|androgens|mesh-ancestor
1803582|NCT04865562|Hormones|hormones|mesh-ancestor
1803583|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1803584|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803585|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1803586|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803587|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
1803588|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
1803589|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1803590|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1803591|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803592|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
1803593|NCT04865380|Coagulants|coagulants|mesh-ancestor
1803594|NCT04865185|Ethanol|ethanol|mesh-list
1803595|NCT04865185|Lidocaine|lidocaine|mesh-list
1803596|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1803597|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803598|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803599|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803600|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
1803601|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
1803602|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
1803603|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803604|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1803605|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1803606|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1803607|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1803608|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803609|NCT04865159|Tipifarnib|tipifarnib|mesh-list
1803610|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803611|NCT04864977|Insulin|insulin|mesh-list
1803612|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1803613|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803614|NCT04864743|Factor VIII|factor viii|mesh-list
1803615|NCT04864743|Coagulants|coagulants|mesh-ancestor
1803616|NCT04864782|Paclitaxel|paclitaxel|mesh-list
1803617|NCT04864782|Carboplatin|carboplatin|mesh-list
1803618|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1803619|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803620|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
1803621|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
1803622|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
1803623|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803624|NCT04864717|Doxycycline|doxycycline|mesh-list
1803625|NCT04864717|Isotretinoin|isotretinoin|mesh-list
1803626|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1803627|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803628|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
1803629|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1803630|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1803631|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
1803632|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1803633|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1803634|NCT04865029|Estradiol|estradiol|mesh-list
1803635|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1803636|NCT04865029|Progesterone|progesterone|mesh-list
1803637|NCT04865029|Estrogens|estrogens|mesh-ancestor
1803638|NCT04865029|Hormones|hormones|mesh-ancestor
1803639|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1803640|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803641|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1803642|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
1803643|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1803644|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1803645|NCT04865029|Progestins|progestins|mesh-ancestor
1803646|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1803647|NCT04864379|Molgramostim|molgramostim|mesh-list
1803648|NCT04864379|Sargramostim|sargramostim|mesh-list
1803649|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
1803650|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803651|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803652|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803653|NCT04864431|Vitamin D|vitamin d|mesh-list
1803654|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
1803655|NCT04864431|Vitamins|vitamins|mesh-ancestor
1803656|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
1803657|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803658|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1803659|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1803660|NCT04864210|Bupivacaine|bupivacaine|mesh-list
1803661|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
1803662|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
1803663|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803664|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803665|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
1803666|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803667|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
1803668|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1803669|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
1803670|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803671|NCT04864314|Protective Agents|protective agents|mesh-ancestor
1803672|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803673|NCT04864366|Tenofovir|tenofovir|mesh-list
1803674|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
1803675|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803676|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1803677|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1803678|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803679|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803680|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1803681|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1803682|NCT04864444|Piperaquine|piperaquine|mesh-list
1803683|NCT04864444|Primaquine|primaquine|mesh-list
1803684|NCT04864444|Artenimol|artenimol|mesh-list
1803685|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
1803686|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1803687|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1803688|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803689|NCT04864067|Leucovorin|leucovorin|mesh-list
1803690|NCT04864067|Capecitabine|capecitabine|mesh-list
1803691|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
1803692|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1803693|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
1803694|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803695|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803696|NCT04864067|Antidotes|antidotes|mesh-ancestor
1803697|NCT04864067|Protective Agents|protective agents|mesh-ancestor
1803698|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803699|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
1803700|NCT04864067|Vitamins|vitamins|mesh-ancestor
1803701|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
1803702|NCT04864509|Melatonin|melatonin|mesh-list
1803703|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
1803704|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803705|NCT04864509|Protective Agents|protective agents|mesh-ancestor
1803706|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803707|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803708|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
1803709|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1803710|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
1803711|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803712|NCT04864496|Expectorants|expectorants|mesh-ancestor
1803713|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
1803714|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1803715|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
1803716|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803717|NCT04864496|Protective Agents|protective agents|mesh-ancestor
1803718|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803719|NCT04864496|Antidotes|antidotes|mesh-ancestor
1803720|NCT04863742|Prednisolone|prednisolone|mesh-list
1803721|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1803722|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
1803723|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1803724|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
1803725|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1803726|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
1803727|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1803728|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
1803729|NCT04863742|Hormones|hormones|mesh-ancestor
1803730|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1803731|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803732|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1803733|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803734|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
1803735|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
1803736|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803737|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1803738|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1803739|NCT04863742|Protective Agents|protective agents|mesh-ancestor
1803740|NCT04863716|Fentanyl|fentanyl|mesh-list
1803741|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1803742|NCT04863716|Narcotics|narcotics|mesh-ancestor
1803743|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803744|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803745|NCT04863716|Analgesics|analgesics|mesh-ancestor
1803746|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
1803747|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803748|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1803749|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1803750|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
1803751|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
1803752|NCT04863807|Anesthetics|anesthetics|mesh-list
1803753|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803754|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803755|NCT04863638|Vaccines|vaccines|mesh-list
1803756|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
1803757|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803758|NCT04863885|Nivolumab|nivolumab|mesh-list
1803759|NCT04863885|Ipilimumab|ipilimumab|mesh-list
1803760|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1803761|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803762|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1803763|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803764|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
1803765|NCT04863430|Apatinib|apatinib|mesh-list
1803766|NCT04863430|Tegafur|tegafur|mesh-list
1803767|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803768|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1803769|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803770|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803771|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1803772|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
1803773|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
1803774|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1803775|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1803776|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803777|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
1803778|NCT04863339|Coagulants|coagulants|mesh-ancestor
1803779|NCT04863183|Triamcinolone|triamcinolone|mesh-list
1803780|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1803781|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1803782|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1803783|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1803784|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
1803785|NCT04863183|Hormones|hormones|mesh-ancestor
1803786|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1803787|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803788|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1803789|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
1803790|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803791|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803792|NCT04863274|Atorvastatin|atorvastatin|mesh-list
1803793|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1803794|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1803795|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
1803796|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803797|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1803798|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1803799|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803800|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1803801|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1803802|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
1803803|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1803804|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803805|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
1803806|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
1803807|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803808|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1803809|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803810|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803811|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
1803812|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1803813|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803814|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1803815|NCT04862949|Bevacizumab|bevacizumab|mesh-list
1803816|NCT04862949|Atezolizumab|atezolizumab|mesh-list
1803817|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1803818|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803819|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1803820|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1803821|NCT04862949|Growth Substances|growth substances|mesh-ancestor
1803822|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803823|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
1803824|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
1803825|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1803826|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803827|NCT04862767|Aldesleukin|aldesleukin|mesh-list
1803828|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803829|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1803830|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1803831|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
1803832|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803833|NCT04862845|Pregabalin|pregabalin|mesh-list
1803834|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1803835|NCT04862845|Analgesics|analgesics|mesh-ancestor
1803836|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
1803837|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803838|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803839|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
1803840|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1803841|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1803842|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803843|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1803844|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1803845|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1803846|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803847|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1803848|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1803849|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1803850|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1803851|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
1803852|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
1803865|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
1803866|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803867|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1803868|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803869|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803870|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
1803871|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1803872|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803873|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1803874|NCT04862377|Budesonide|budesonide|mesh-list
1803875|NCT04862377|Poractant alfa|poractant alfa|mesh-list
1803876|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1803877|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1803878|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
1803879|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803880|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803881|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1803882|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
1803883|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
1803884|NCT04862377|Hormones|hormones|mesh-ancestor
1803885|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1803886|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
1803887|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1803888|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
1803889|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803890|NCT04862234|Dulaglutide|dulaglutide|mesh-list
1803891|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1803892|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803893|NCT04861948|Bevacizumab|bevacizumab|mesh-list
1803894|NCT04861948|Carboplatin|carboplatin|mesh-list
1803895|NCT04861948|Pemetrexed|pemetrexed|mesh-list
1803896|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1803897|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803898|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1803899|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1803900|NCT04861948|Growth Substances|growth substances|mesh-ancestor
1803901|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803902|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
1803903|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803904|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803905|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1803906|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1803907|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1803908|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
1803909|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1803910|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803911|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803912|NCT04861922|Heparin|heparin|mesh-list
1803913|NCT04861922|Calcium heparin|calcium heparin|mesh-list
1803914|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
1803915|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1803916|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1803917|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803918|NCT04861987|Capecitabine|capecitabine|mesh-list
1803919|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1803920|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
1803921|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803922|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803923|NCT04861298|Quercetin|quercetin|mesh-list
1803924|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
1803925|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803926|NCT04861298|Protective Agents|protective agents|mesh-ancestor
1803927|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803928|NCT04861584|Gemcitabine|gemcitabine|mesh-list
1803929|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803930|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1803931|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
1803932|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803933|NCT04861584|Antiviral Agents|antiviral agents|mesh-ancestor
1803934|NCT04861584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803935|NCT04861584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803936|NCT04861584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1803937|NCT04861584|Immunologic Factors|immunologic factors|mesh-ancestor
1804767|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1803938|NCT04861584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803939|NCT04861181|Niraparib|niraparib|mesh-list
1803940|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1803941|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1803942|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803943|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803944|NCT04861064|Sirolimus|sirolimus|mesh-list
1803945|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1803946|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1803947|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1803948|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1803949|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
1803950|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1803951|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
1803952|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803953|NCT04861142|Denosumab|denosumab|mesh-list
1803954|NCT04861142|Alendronate|alendronate|mesh-list
1803955|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1803956|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803957|NCT04861051|Ketamine|ketamine|mesh-list
1803958|NCT04861051|Analgesics|analgesics|mesh-ancestor
1803959|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
1803960|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1803961|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1803962|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1803963|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1803964|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
1803965|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
1803966|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1803967|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1803968|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1803969|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1803970|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1803971|NCT04860661|Esketamine|esketamine|mesh-list
1803972|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
1803973|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1803974|NCT04860739|Vaccines|vaccines|mesh-list
1803975|NCT04860739|Immunologic Factors|immunologic factors|mesh-ancestor
1803976|NCT04860739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804002|NCT04861103|Enoxaparin|enoxaparin|mesh-list
1804003|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
1804004|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1804005|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1804006|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804007|NCT04860674|Carboplatin|carboplatin|mesh-list
1804008|NCT04860674|Etoposide|etoposide|mesh-list
1804009|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1804010|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804011|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1804012|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1804013|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1804014|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804015|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804016|NCT04860856|Ropivacaine|ropivacaine|mesh-list
1804017|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
1804018|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
1804019|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804020|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804021|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
1804022|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804023|NCT04860505|Doxycycline|doxycycline|mesh-list
1804024|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1804025|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804026|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
1804027|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1804028|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1804029|NCT04861207|Cladribine|cladribine|mesh-list
1804030|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804031|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1804032|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
1804033|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804034|NCT04860531|Betamethasone|betamethasone|mesh-list
1804035|NCT04860531|Lidocaine|lidocaine|mesh-list
1804036|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
1804037|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
1804038|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804039|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804040|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
1804041|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804042|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1804043|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1804044|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1804045|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1804046|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804047|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1804048|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
1804049|NCT04860531|Hormones|hormones|mesh-ancestor
1804050|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1804051|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1804052|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
1804053|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
1804054|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
1804055|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1804056|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1804057|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804058|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804059|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804060|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1804061|NCT04860635|Celecoxib|celecoxib|mesh-list
1804062|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1804063|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1804064|NCT04860635|Analgesics|analgesics|mesh-ancestor
1804065|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
1804066|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804067|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804068|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1804069|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1804070|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1804071|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1804072|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804073|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804074|NCT04860141|Gabapentin|gabapentin|mesh-list
1804075|NCT04860141|Analgesics|analgesics|mesh-ancestor
1804076|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
1804077|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804078|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804079|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
1804080|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1804081|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1804082|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804083|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1804084|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1804085|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1804086|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1804087|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804088|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
1804089|NCT04860167|Diclofenac|diclofenac|mesh-list
1804090|NCT04860167|Lidocaine|lidocaine|mesh-list
1804091|NCT04860167|Propofol|propofol|mesh-list
1804092|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1804093|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804094|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804095|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1804096|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
1804097|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
1804098|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1804099|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1804100|NCT04860167|Analgesics|analgesics|mesh-ancestor
1804101|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
1804102|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804103|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1804104|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1804105|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1804106|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804107|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804108|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
1804109|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1804110|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1804111|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1804112|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1804113|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
1804114|NCT04860076|Nivolumab|nivolumab|mesh-list
1804115|NCT04860076|Ipilimumab|ipilimumab|mesh-list
1804116|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1804117|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804118|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1804119|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804120|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
1804121|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1804122|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
1804123|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
1804124|NCT04860011|Metolazone|metolazone|mesh-list
1804125|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1804126|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804127|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1804128|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804129|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1804130|NCT04860011|Diuretics|diuretics|mesh-ancestor
1804131|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
1804132|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1804133|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1804134|NCT04859738|Lidocaine|lidocaine|mesh-list
1804135|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
1804136|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
1804137|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804138|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804139|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
1804140|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804141|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1804142|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1804143|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1804144|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1804145|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804146|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
1804147|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1804148|NCT04859829|Antibodies|antibodies|mesh-list
1804149|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
1804150|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1804151|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
1804152|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804153|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
1804154|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1804155|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804156|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
1804157|NCT04859946|Busulfan|busulfan|mesh-list
1804158|NCT04859946|Thiotepa|thiotepa|mesh-list
1804159|NCT04859946|Fludarabine|fludarabine|mesh-list
1804160|NCT04859946|Tacrolimus|tacrolimus|mesh-list
1804161|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1804162|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
1804163|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804164|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1804165|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1804166|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
1804167|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804168|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804169|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1804170|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1804171|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804172|NCT04860219|Lactoferrin|lactoferrin|mesh-list
1804173|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804174|NCT04859660|Tamsulosin|tamsulosin|mesh-list
1804175|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1804176|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1804177|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1804178|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
1804179|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1804180|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804181|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804182|NCT04859660|Urological Agents|urological agents|mesh-ancestor
1804183|NCT04859621|Vitamin D|vitamin d|mesh-list
1804184|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
1804185|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
1804186|NCT04859621|Vitamins|vitamins|mesh-list
1804187|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1804188|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
1804189|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804190|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1804191|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1804192|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804193|NCT04859556|Dipivefrin|dipivefrin|mesh-list
1804194|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1804195|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
1804196|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1804197|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804198|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804199|NCT04859569|Denosumab|denosumab|mesh-list
1804200|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1804201|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804202|NCT04859530|Lugol's solution|lugol's solution|mesh-list
1804203|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
1804204|NCT04859530|Coagulants|coagulants|mesh-ancestor
1804205|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
1804206|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1804207|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804208|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804209|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1804210|NCT04859283|Analgesics|analgesics|mesh-ancestor
1804211|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
1804212|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804213|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1804214|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1804215|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1804216|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
1804217|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1804218|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804219|NCT04859452|Metformin|metformin|mesh-list
1804220|NCT04859452|Glyburide|glyburide|mesh-list
1804221|NCT04859452|Valsartan|valsartan|mesh-list
1804222|NCT04859452|Simvastatin|simvastatin|mesh-list
1804223|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1804224|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804225|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1804226|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1804227|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
1804228|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804229|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1804230|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1804231|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804232|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1804233|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1804234|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1804235|NCT04859361|Imiquimod|imiquimod|mesh-list
1804236|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1804237|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
1804238|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804239|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804240|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
1804241|NCT04859322|Glucagon|glucagon|mesh-list
1804242|NCT04859322|Somatostatin|somatostatin|mesh-list
1804243|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804244|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1804245|NCT04859322|Hormones|hormones|mesh-ancestor
1804246|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1804259|NCT04859244|Remdesivir|remdesivir|mesh-list
1804260|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
1804261|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804262|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
1804263|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804264|NCT04858997|Palbociclib|palbociclib|mesh-list
1804265|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804266|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1804267|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804268|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804269|NCT04859062|Lidocaine|lidocaine|mesh-list
1804270|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
1804271|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
1804272|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804273|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804274|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
1804275|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804276|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1804277|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1804278|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1804279|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1804280|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804281|NCT04858841|Levetiracetam|levetiracetam|mesh-list
1804282|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
1804283|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
1804284|NCT04858529|Carboplatin|carboplatin|mesh-list
1804285|NCT04858529|Docetaxel|docetaxel|mesh-list
1804286|NCT04858529|Trastuzumab|trastuzumab|mesh-list
1804287|NCT04858529|Pertuzumab|pertuzumab|mesh-list
1804288|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804289|NCT04858529|Tubulin Modulators|tubulin modulators|mesh-ancestor
1804290|NCT04858529|Antimitotic Agents|antimitotic agents|mesh-ancestor
1804291|NCT04858529|Mitosis Modulators|mitosis modulators|mesh-ancestor
1804292|NCT04858529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804293|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1804294|NCT04858516|Trastuzumab|trastuzumab|mesh-list
1804295|NCT04858516|Palbociclib|palbociclib|mesh-list
1804296|NCT04858516|Exemestane|exemestane|mesh-list
1804297|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1804298|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804299|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1804300|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804301|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804302|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1804303|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1804304|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1804305|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
1804306|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1804307|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804330|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
1804331|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
1804332|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1804333|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1804334|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804335|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804336|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804337|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1804348|NCT04858087|Lumefantrine|lumefantrine|mesh-list
1804349|NCT04858087|Artemether|artemether|mesh-list
1804350|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1804351|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
1804352|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1804353|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1804354|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804364|NCT04858048|Anesthetics|anesthetics|mesh-list
1804365|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804366|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804367|NCT04857983|Memantine|memantine|mesh-list
1804368|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1804369|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1804370|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
1804371|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1804372|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804373|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804374|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1804375|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1804376|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1804377|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
1804378|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1804379|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1804380|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1804381|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1804382|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804383|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
1804384|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1804385|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804386|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1804387|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804388|NCT04857801|Teduglutide|teduglutide|mesh-list
1804389|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1804390|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1804391|NCT04857801|Protective Agents|protective agents|mesh-ancestor
1804392|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804393|NCT04857840|Firibastat|firibastat|mesh-list
1804394|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1804395|NCT04857684|Bevacizumab|bevacizumab|mesh-list
1804396|NCT04857684|Atezolizumab|atezolizumab|mesh-list
1804397|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1804398|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804399|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1804400|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1804401|NCT04857684|Growth Substances|growth substances|mesh-ancestor
1804402|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804403|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
1804404|NCT04857320|Insulin|insulin|mesh-list
1804405|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1804406|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1804407|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804408|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1804409|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804410|NCT04857450|Ketamine|ketamine|mesh-list
1804411|NCT04857450|Etomidate|etomidate|mesh-list
1804412|NCT04857450|Analgesics|analgesics|mesh-ancestor
1804413|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
1804414|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804415|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804416|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1804417|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1804418|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
1804419|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
1804420|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804421|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1804422|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1804423|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1804424|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804425|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1804426|NCT04857177|Ranibizumab|ranibizumab|mesh-list
1804427|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1804428|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1804429|NCT04857177|Growth Substances|growth substances|mesh-ancestor
1804430|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804431|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
1804432|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804433|NCT04857203|Vitamin D|vitamin d|mesh-list
1804434|NCT04857203|Vitamins|vitamins|mesh-ancestor
1804435|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
1804436|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804437|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1804438|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
1804439|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1804440|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804441|NCT04856761|Capecitabine|capecitabine|mesh-list
1804442|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1804443|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
1804444|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804445|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804446|NCT04856852|Iodine|iodine|mesh-list
1804447|NCT04856852|Temozolomide|temozolomide|mesh-list
1804448|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1804449|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
1804450|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804451|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804452|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1804453|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804454|NCT04856852|Trace Elements|trace elements|mesh-ancestor
1804455|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
1804456|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804457|NCT04856878|Vancomycin|vancomycin|mesh-list
1804458|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1804459|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804460|NCT04856787|Fluorouracil|fluorouracil|mesh-list
1804461|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
1804462|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804463|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1804464|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804465|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1804466|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
1804467|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804470|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
1804471|NCT04856969|Olmesartan|olmesartan|mesh-list
1804472|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1804473|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804474|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1804475|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804476|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1804477|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1804478|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1804479|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
1804480|NCT04856644|Rifapentine|rifapentine|mesh-list
1804481|NCT04856644|Rifampin|rifampin|mesh-list
1804482|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1804483|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804484|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1804485|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1804486|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804487|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804488|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804489|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1804490|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
1804491|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
1804492|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1804493|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1804494|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1804495|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1804496|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1804497|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1804498|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1804503|NCT04856631|Cetuximab|cetuximab|mesh-list
1804504|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1804505|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804506|NCT04856371|Letrozole|letrozole|mesh-list
1804507|NCT04856371|Fulvestrant|fulvestrant|mesh-list
1804508|NCT04856371|Palbociclib|palbociclib|mesh-list
1804509|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804510|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1804511|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1804512|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804513|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804514|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1804515|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
1804516|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1804517|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804518|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1804519|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1804520|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1804525|NCT04856137|Paclitaxel|paclitaxel|mesh-list
1804526|NCT04856137|Rituximab|rituximab|mesh-list
1804527|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1804528|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804529|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
1804530|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
1804531|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
1804532|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804533|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1804534|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
1804535|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804536|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1804537|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
1804538|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1804539|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804540|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
1804541|NCT04856098|Bromides|bromides|mesh-list
1804542|NCT04856098|Maleic acid|maleic acid|mesh-list
1804543|NCT04856098|Charcoal|charcoal|mesh-list
1804544|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
1804545|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804546|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804547|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1804548|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1804549|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1804550|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
1804551|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1804552|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804553|NCT04856098|Antidotes|antidotes|mesh-ancestor
1804554|NCT04856098|Protective Agents|protective agents|mesh-ancestor
1804557|NCT04856228|Lidocaine|lidocaine|mesh-list
1804558|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
1804559|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
1804560|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804561|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804562|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
1804563|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804564|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1804565|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1804566|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1804567|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1804568|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804569|NCT04856111|Pirfenidone|pirfenidone|mesh-list
1804570|NCT04856111|Nintedanib|nintedanib|mesh-list
1804571|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804572|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1804573|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804574|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804575|NCT04856111|Analgesics|analgesics|mesh-ancestor
1804576|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
1804577|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804578|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804579|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1804580|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1804581|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1804582|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1804601|NCT04855968|Analgesics|analgesics|mesh-list
1804602|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
1804603|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804604|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804605|NCT04856124|Ketamine|ketamine|mesh-list
1804606|NCT04856124|Esketamine|esketamine|mesh-list
1804607|NCT04856124|Analgesics|analgesics|mesh-ancestor
1804608|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
1804609|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804610|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804611|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1804612|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1804613|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
1804614|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
1804768|NCT04854252|Narcotics|narcotics|mesh-ancestor
1804615|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804616|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1804617|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1804618|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1804619|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804620|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
1804621|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1804622|NCT04856007|Metformin|metformin|mesh-list
1804623|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
1804624|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1804625|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804626|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1804627|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804628|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
1804629|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
1804630|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804631|NCT04855513|Metformin|metformin|mesh-list
1804632|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1804633|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804634|NCT04855279|Listerine|listerine|mesh-list
1804635|NCT04855279|Fluorides|fluorides|mesh-list
1804636|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
1804637|NCT04855279|Glycerol|glycerol|mesh-list
1804638|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
1804639|NCT04855279|Protective Agents|protective agents|mesh-ancestor
1804640|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804641|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1804642|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804643|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
1804644|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
1804645|NCT04855266|Hematinics|hematinics|mesh-ancestor
1804646|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1804647|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1804648|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804649|NCT04855695|Venetoclax|venetoclax|mesh-list
1804650|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
1804651|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
1804652|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804653|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1804654|NCT04855110|Warfarin|warfarin|mesh-list
1804655|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
1804656|NCT04854837|Remdesivir|remdesivir|mesh-list
1804657|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
1804658|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804659|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
1804660|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804661|NCT04854889|Decitabine|decitabine|mesh-list
1804662|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1804663|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
1804664|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804665|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804666|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804667|NCT04854759|Amantadine|amantadine|mesh-list
1804668|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1804669|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1804670|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
1804671|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804672|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
1804673|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1804674|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804675|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804676|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1804677|NCT04854759|Analgesics|analgesics|mesh-ancestor
1804678|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
1804679|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804680|NCT04855136|Dexamethasone|dexamethasone|mesh-list
1804681|NCT04855136|Bortezomib|bortezomib|mesh-list
1804682|NCT04855136|Pomalidomide|pomalidomide|mesh-list
1804683|NCT04855136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1804684|NCT04855136|Antiemetics|antiemetics|mesh-ancestor
1804685|NCT04855136|Autonomic Agents|autonomic agents|mesh-ancestor
1804686|NCT04855136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804687|NCT04855136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804688|NCT04855136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1804689|NCT04855136|Glucocorticoids|glucocorticoids|mesh-ancestor
1804690|NCT04855136|Hormones|hormones|mesh-ancestor
1804691|NCT04855136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1804692|NCT04855136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1804693|NCT04855136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804694|NCT04855136|Immunologic Factors|immunologic factors|mesh-ancestor
1804695|NCT04855136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1804696|NCT04855136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1804697|NCT04855136|Growth Substances|growth substances|mesh-ancestor
1804698|NCT04855136|Growth Inhibitors|growth inhibitors|mesh-ancestor
1804699|NCT04854668|Bevacizumab|bevacizumab|mesh-list
1804700|NCT04854668|Capecitabine|capecitabine|mesh-list
1804701|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
1804702|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1804703|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804704|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1804705|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1804706|NCT04854668|Growth Substances|growth substances|mesh-ancestor
1804707|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804708|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
1804709|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1804710|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
1804711|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804712|NCT04854434|Trifluridine|trifluridine|mesh-list
1804713|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
1804714|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1804715|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804716|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
1804717|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804718|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
1804719|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804720|NCT04854460|Ivermectin|ivermectin|mesh-list
1804721|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1804722|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804723|NCT04854551|Naltrexone|naltrexone|mesh-list
1804724|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1804725|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1804726|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804727|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
1804728|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804729|NCT04854577|Anesthetics|anesthetics|mesh-list
1804730|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804731|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804732|NCT04854538|Budesonide|budesonide|mesh-list
1804733|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1804734|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1804735|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
1804736|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804737|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804738|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1804739|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
1804740|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
1804741|NCT04854538|Hormones|hormones|mesh-ancestor
1804742|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1804743|NCT04854395|Bupivacaine|bupivacaine|mesh-list
1804744|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
1804745|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
1804746|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804747|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804748|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
1804749|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804750|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1804751|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1804752|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804753|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
1804754|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
1804755|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
1804756|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804757|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804758|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1804759|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1804760|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1804761|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
1804762|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804763|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1804764|NCT04854044|TIC10 compound|tic10 compound|mesh-list
1804765|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804766|NCT04854252|Fentanyl|fentanyl|mesh-list
1804769|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804770|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804771|NCT04854252|Analgesics|analgesics|mesh-ancestor
1804772|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
1804773|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804774|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1804775|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1804776|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
1804777|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
1804778|NCT04853758|Valsartan|valsartan|mesh-list
1804779|NCT04853758|Enalapril|enalapril|mesh-list
1804780|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1804781|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1804782|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
1804783|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1804784|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1804785|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1804786|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804787|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
1804788|NCT04853797|Calcium|calcium|mesh-list
1804789|NCT04853797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1804790|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804791|NCT04853875|Amoxicillin|amoxicillin|mesh-list
1804792|NCT04853875|Metronidazole|metronidazole|mesh-list
1804793|NCT04853875|Clarithromycin|clarithromycin|mesh-list
1804794|NCT04853875|Tetracycline|tetracycline|mesh-list
1804795|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
1804796|NCT04853875|Bismuth|bismuth|mesh-list
1804797|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1804798|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804799|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1804800|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1804801|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1804802|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804803|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804804|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1804805|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1804806|NCT04853875|Antacids|antacids|mesh-ancestor
1804807|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1804808|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1804809|NCT04853615|Empagliflozin|empagliflozin|mesh-list
1804810|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
1804811|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804812|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1804813|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804814|NCT04853446|Dexamethasone|dexamethasone|mesh-list
1804815|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
1804816|NCT04853446|BB 1101|bb 1101|mesh-list
1804817|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1804818|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
1804819|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
1804820|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804821|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804822|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1804823|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
1804824|NCT04853446|Hormones|hormones|mesh-ancestor
1804825|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1804826|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1804827|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804828|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
1804829|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804830|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804831|NCT04853719|Aspirin|aspirin|mesh-list
1804832|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
1804833|NCT04853719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1804834|NCT04853719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1804835|NCT04853719|Analgesics|analgesics|mesh-ancestor
1804836|NCT04853719|Sensory System Agents|sensory system agents|mesh-ancestor
1804837|NCT04853719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804838|NCT04853719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804839|NCT04853719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1804840|NCT04853719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1804841|NCT04853719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1804842|NCT04853719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1805141|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
1804843|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804844|NCT04853719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1804845|NCT04853719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1804846|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804847|NCT04853719|Antipyretics|antipyretics|mesh-ancestor
1804848|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1804849|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
1804850|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1804851|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
1804852|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
1804853|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
1804854|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1804855|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
1804856|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804857|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
1804858|NCT04853589|Protective Agents|protective agents|mesh-ancestor
1804859|NCT04853628|Ethanol|ethanol|mesh-list
1804860|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1804861|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804862|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804863|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804864|NCT04853524|Tenofovir|tenofovir|mesh-list
1804865|NCT04853524|Emtricitabine|emtricitabine|mesh-list
1804866|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
1804867|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804868|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1804869|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1804870|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804871|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804872|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1804873|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1804874|NCT04853901|Remdesivir|remdesivir|mesh-list
1804875|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1804876|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804877|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
1804878|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
1804879|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1804880|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1804881|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804882|NCT04853199|Quercetin|quercetin|mesh-list
1804883|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
1804884|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804885|NCT04853199|Protective Agents|protective agents|mesh-ancestor
1804886|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804887|NCT04853069|Estradiol|estradiol|mesh-list
1804888|NCT04853069|Estrogens|estrogens|mesh-ancestor
1804889|NCT04853069|Hormones|hormones|mesh-ancestor
1804890|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1804891|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804892|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
1804893|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1804894|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804895|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
1804896|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1804897|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1804900|NCT04852510|Metformin|metformin|mesh-list
1804901|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1804902|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804903|NCT04852315|Caffeine|caffeine|mesh-list
1804904|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1804905|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804906|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1804907|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804908|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804909|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1804910|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1804911|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
1804912|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1804913|NCT04852484|Morphine|morphine|mesh-list
1804914|NCT04852484|Ketamine|ketamine|mesh-list
1804915|NCT04852484|Anesthetics|anesthetics|mesh-list
1804916|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
1804917|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1804918|NCT04852484|Narcotics|narcotics|mesh-ancestor
1805142|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
1804919|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804920|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804921|NCT04852484|Analgesics|analgesics|mesh-ancestor
1804922|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
1804923|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804924|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1804925|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1804926|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
1804927|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1804928|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1804929|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1804930|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804931|NCT04852367|Doxorubicin|doxorubicin|mesh-list
1804932|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1804933|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804934|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1804935|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1804936|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804937|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804938|NCT04852003|Morphine|morphine|mesh-list
1804939|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1804940|NCT04852003|Narcotics|narcotics|mesh-ancestor
1804941|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804942|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804943|NCT04852003|Analgesics|analgesics|mesh-ancestor
1804944|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
1804945|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1804946|NCT04852068|Vaccines|vaccines|mesh-list
1804947|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
1804948|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804949|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1804950|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1804951|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1804952|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
1804953|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804954|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804955|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1804956|NCT04851821|Quercetin|quercetin|mesh-list
1804957|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
1804958|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804959|NCT04851821|Protective Agents|protective agents|mesh-ancestor
1804960|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804961|NCT04851977|Vaccines|vaccines|mesh-list
1804962|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
1804963|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804972|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
1804973|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1804974|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
1804975|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804976|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
1804977|NCT04851548|Protective Agents|protective agents|mesh-ancestor
1804978|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
1804979|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1804980|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804981|NCT04852081|Tamoxifen|tamoxifen|mesh-list
1804982|NCT04852081|Letrozole|letrozole|mesh-list
1804983|NCT04852081|Fulvestrant|fulvestrant|mesh-list
1804984|NCT04852081|Palbociclib|palbociclib|mesh-list
1804985|NCT04852081|Anastrozole|anastrozole|mesh-list
1804986|NCT04852081|Exemestane|exemestane|mesh-list
1804987|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1804988|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1804989|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1804990|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1804991|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1804992|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1804993|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
1804994|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1804995|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1804996|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1804997|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1804998|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1804999|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1805000|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1805001|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1805009|NCT04851457|Tirofiban|tirofiban|mesh-list
1805010|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1805011|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1805012|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805013|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1805014|NCT04851392|Dronabinol|dronabinol|mesh-list
1805015|NCT04851392|Cannabidiol|cannabidiol|mesh-list
1805016|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
1805017|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
1805018|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805019|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1805020|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1805021|NCT04851392|Analgesics|analgesics|mesh-ancestor
1805022|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
1805023|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805024|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1805025|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1805026|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1805027|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805028|NCT04851392|Hormones|hormones|mesh-ancestor
1805029|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1805030|NCT04851015|Trimethoprim|trimethoprim|mesh-list
1805031|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1805032|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
1805033|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1805034|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805035|NCT04851015|Renal Agents|renal agents|mesh-ancestor
1805036|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
1805037|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1805038|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1805039|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1805040|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805041|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805042|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1805043|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1805044|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1805045|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1805046|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1805047|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1805048|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805049|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
1805050|NCT04851002|Mitogens|mitogens|mesh-list
1805051|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
1805052|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805053|NCT04850911|Ketamine|ketamine|mesh-list
1805054|NCT04850911|Analgesics|analgesics|mesh-ancestor
1805055|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
1805056|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805057|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805058|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1805059|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1805060|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
1805061|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
1805062|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1805063|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1805064|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1805065|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1805293|NCT04849455|Narcotics|narcotics|mesh-ancestor
1805066|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805067|NCT04851132|Durvalumab|durvalumab|mesh-list
1805068|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1805069|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805070|NCT04850885|Dexamethasone|dexamethasone|mesh-list
1805071|NCT04850885|Lidocaine|lidocaine|mesh-list
1805072|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1805073|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
1805074|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
1805075|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805076|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805077|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1805078|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
1805079|NCT04850885|Hormones|hormones|mesh-ancestor
1805080|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1805081|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1805082|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805083|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
1805084|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
1805085|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1805086|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
1805087|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1805088|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1805089|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1805090|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1805091|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805092|NCT04850950|Tenofovir|tenofovir|mesh-list
1805093|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
1805094|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805095|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1805096|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1805097|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805098|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805099|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1805100|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1805101|NCT04850846|Metformin|metformin|mesh-list
1805102|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1805103|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805104|NCT04850937|Esketamine|esketamine|mesh-list
1805105|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
1805106|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1805107|NCT04850638|Furosemide|furosemide|mesh-list
1805108|NCT04850638|Diuretics|diuretics|mesh-ancestor
1805109|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
1805110|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805111|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1805112|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1805113|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805114|NCT04850755|Nivolumab|nivolumab|mesh-list
1805115|NCT04850755|Ipilimumab|ipilimumab|mesh-list
1805116|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1805117|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805118|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1805119|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805120|NCT04850378|Dalteparin|dalteparin|mesh-list
1805121|NCT04850378|Tinzaparin|tinzaparin|mesh-list
1805122|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1805123|NCT04850378|Apixaban|apixaban|mesh-list
1805124|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1805125|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
1805126|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1805127|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
1805128|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805129|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805130|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
1805131|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1805132|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1805133|NCT04850560|Decitabine|decitabine|mesh-list
1805134|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1805135|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
1805136|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805137|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805138|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805139|NCT04850404|Ropivacaine|ropivacaine|mesh-list
1805140|NCT04850404|Rocuronium|rocuronium|mesh-list
1805143|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1805144|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805145|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
1805146|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805147|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1805148|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1805149|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1805150|NCT04850417|Aspirin|aspirin|mesh-list
1805151|NCT04850417|Clopidogrel|clopidogrel|mesh-list
1805152|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1805153|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1805154|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1805155|NCT04850417|Analgesics|analgesics|mesh-ancestor
1805156|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
1805157|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805158|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805159|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1805160|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1805161|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1805162|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1805163|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805164|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1805165|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1805166|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805167|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
1805168|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1805169|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1805170|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1805171|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
1805172|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1805173|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1805174|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
1805191|NCT04850235|Paclitaxel|paclitaxel|mesh-list
1805192|NCT04850235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1805193|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1805194|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805195|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
1805196|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
1805197|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
1805198|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805199|NCT04850261|Nafarelin|nafarelin|mesh-list
1805200|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1805201|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
1805202|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1805203|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805204|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
1805205|NCT04850040|Apatinib|apatinib|mesh-list
1805206|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805207|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1805208|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805209|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805210|NCT04850001|Aspirin|aspirin|mesh-list
1805211|NCT04850001|Clopidogrel|clopidogrel|mesh-list
1805212|NCT04850001|Atorvastatin|atorvastatin|mesh-list
1805213|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1805214|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1805215|NCT04850001|Analgesics|analgesics|mesh-ancestor
1805216|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
1805217|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805218|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805219|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1805220|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1805221|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1805222|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1805223|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805224|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1805225|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1805226|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805227|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
1805228|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1805229|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1805230|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
1805231|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1805232|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1805233|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1805234|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1805235|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1805236|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
1805237|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1805238|NCT04849845|Insulin|insulin|mesh-list
1805239|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1805240|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1805241|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805242|NCT04849858|Bupivacaine|bupivacaine|mesh-list
1805243|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
1805244|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
1805245|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1805246|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805247|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
1805248|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805249|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
1805250|NCT04849533|Prednisone|prednisone|mesh-list
1805251|NCT04849533|Everolimus|everolimus|mesh-list
1805252|NCT04849533|Abatacept|abatacept|mesh-list
1805253|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
1805254|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1805255|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1805256|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
1805257|NCT04849533|Hormones|hormones|mesh-ancestor
1805258|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1805259|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805260|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1805261|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805262|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1805263|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
1805264|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1805265|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1805266|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
1805267|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1805268|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805269|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805270|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805271|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1805272|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1805285|NCT04849377|Cisplatin|cisplatin|mesh-list
1805286|NCT04849377|Carboplatin|carboplatin|mesh-list
1805287|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805288|NCT04849455|Morphine|morphine|mesh-list
1805289|NCT04849455|Ropivacaine|ropivacaine|mesh-list
1805290|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
1805291|NCT04849455|Anesthetics|anesthetics|mesh-list
1805292|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1805294|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1805295|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805296|NCT04849455|Analgesics|analgesics|mesh-ancestor
1805297|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
1805298|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805299|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
1805300|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1805301|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
1805302|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1805303|NCT04849013|Ketanserin|ketanserin|mesh-list
1805304|NCT04849013|Mescaline|mescaline|mesh-list
1805305|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1805306|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1805307|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1805308|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
1805309|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1805310|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805311|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805312|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
1805313|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1805314|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1805315|NCT04849026|Clozapine|clozapine|mesh-list
1805316|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1805317|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
1805318|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1805319|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805320|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805321|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1805322|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1805323|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1805324|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1805325|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
1805326|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
1805327|NCT04849299|Cyclosporine|cyclosporine|mesh-list
1805328|NCT04849299|Cyclosporins|cyclosporins|mesh-list
1805329|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805330|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805331|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1805332|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
1805333|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805334|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
1805335|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805336|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
1805337|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1805338|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1805339|NCT04848974|Cytarabine|cytarabine|mesh-list
1805340|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
1805341|NCT04848974|Cladribine|cladribine|mesh-list
1805342|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1805343|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
1805344|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805345|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805346|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
1805347|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805348|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1805349|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
1805350|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805351|NCT04848857|Colchicine|colchicine|mesh-list
1805352|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
1805353|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1805354|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
1805355|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
1805356|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
1805357|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805358|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805359|NCT04848792|Sulforaphane|sulforaphane|mesh-list
1805360|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1805361|NCT04848792|Protective Agents|protective agents|mesh-ancestor
1805362|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805363|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805364|NCT04848662|Budesonide|budesonide|mesh-list
1805365|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1805366|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1805367|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
1805368|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805369|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805522|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1805370|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1805371|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
1805372|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
1805373|NCT04848662|Hormones|hormones|mesh-ancestor
1805374|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1805375|NCT04848597|Paclitaxel|paclitaxel|mesh-list
1805376|NCT04848597|Antibodies|antibodies|mesh-list
1805377|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1805378|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1805379|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805380|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
1805381|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
1805382|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
1805383|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805384|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805385|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
1805395|NCT04848688|Ivermectin|ivermectin|mesh-list
1805396|NCT04848688|Moxidectin|moxidectin|mesh-list
1805397|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1805398|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805399|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
1805400|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
1805401|NCT04848467|Vaccines|vaccines|mesh-list
1805402|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
1805403|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805404|NCT04848584|Vaccines|vaccines|mesh-list
1805405|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
1805406|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805407|NCT04848259|Dexamethasone|dexamethasone|mesh-list
1805408|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
1805409|NCT04848259|BB 1101|bb 1101|mesh-list
1805410|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1805411|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
1805412|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
1805413|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805414|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805415|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1805416|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
1805417|NCT04848259|Hormones|hormones|mesh-ancestor
1805418|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1805419|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1805420|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805421|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
1805422|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805423|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805424|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
1805425|NCT04848519|Propranolol|propranolol|mesh-list
1805426|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1805427|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805428|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1805429|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1805430|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
1805431|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1805432|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805433|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805434|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1805435|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1805436|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
1805437|NCT04848246|Bupropion|bupropion|mesh-list
1805438|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1805439|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
1805440|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1805441|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1805442|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1805443|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1805444|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805445|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
1805446|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1805447|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805448|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1805449|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1805450|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805451|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
1805452|NCT04848181|Finasteride|finasteride|mesh-list
1805453|NCT04848181|Cyproterone|cyproterone|mesh-list
1805454|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1805455|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1805456|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805457|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805458|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
1805459|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1805460|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805461|NCT04848181|Urological Agents|urological agents|mesh-ancestor
1805462|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
1805463|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805464|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1805465|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
1805466|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1805467|NCT04848116|Nivolumab|nivolumab|mesh-list
1805468|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1805469|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805470|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1805471|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805472|NCT04847791|Lactoferrin|lactoferrin|mesh-list
1805473|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805474|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
1805475|NCT04848064|Fludarabine|fludarabine|mesh-list
1805476|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
1805477|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
1805478|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
1805479|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1805480|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
1805481|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805482|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1805483|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1805484|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
1805485|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805486|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805487|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1805488|NCT04847921|Dalbavancin|dalbavancin|mesh-list
1805489|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1805490|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805491|NCT04847895|Ranibizumab|ranibizumab|mesh-list
1805492|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1805493|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1805494|NCT04847895|Growth Substances|growth substances|mesh-ancestor
1805495|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805496|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
1805497|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805498|NCT04847947|Vitamin D|vitamin d|mesh-list
1805499|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
1805500|NCT04847947|Vitamins|vitamins|mesh-ancestor
1805501|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
1805502|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805503|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1805504|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1805505|NCT04847752|Aspirin|aspirin|mesh-list
1805506|NCT04847752|Warfarin|warfarin|mesh-list
1805507|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
1805508|NCT04847752|Dabigatran|dabigatran|mesh-list
1805509|NCT04847752|Anticoagulants|anticoagulants|mesh-list
1805510|NCT04847752|Clopidogrel|clopidogrel|mesh-list
1805511|NCT04847752|Atorvastatin|atorvastatin|mesh-list
1805512|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1805513|NCT04847752|Evolocumab|evolocumab|mesh-list
1805514|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1805515|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1805516|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1805517|NCT04847752|Analgesics|analgesics|mesh-ancestor
1805518|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
1805519|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805520|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805521|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1805523|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1805524|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1805525|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805526|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1805527|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1805528|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805529|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
1805530|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1805531|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1805532|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
1805533|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1805534|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1805535|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1805536|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1805537|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
1805538|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1805539|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1805540|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
1805541|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1805542|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
1805543|NCT04847622|Remdesivir|remdesivir|mesh-list
1805544|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
1805545|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805546|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
1805547|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805548|NCT04847661|Mefloquine|mefloquine|mesh-list
1805549|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
1805550|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1805551|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1805552|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805553|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
1805554|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1805555|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1805556|NCT04847687|Prednisolone|prednisolone|mesh-list
1805557|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
1805558|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1805559|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
1805560|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1805561|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
1805562|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
1805563|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805564|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805565|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1805566|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
1805567|NCT04847687|Hormones|hormones|mesh-ancestor
1805568|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1805569|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1805570|NCT04847687|Protective Agents|protective agents|mesh-ancestor
1805571|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1805572|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805573|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1805574|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
1805587|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
1805588|NCT04847024|Parecoxib|parecoxib|mesh-list
1805589|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1805590|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1805591|NCT04847024|Analgesics|analgesics|mesh-ancestor
1805592|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
1805593|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805594|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805595|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1805596|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1805597|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1805598|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1805599|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805600|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805601|NCT04847245|Pregabalin|pregabalin|mesh-list
1805602|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1805603|NCT04847245|Esketamine|esketamine|mesh-list
1805604|NCT04847245|Analgesics|analgesics|mesh-ancestor
1805605|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
1805606|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805607|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805608|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
1805609|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1805610|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1805611|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805612|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1805613|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1805614|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1805615|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1805616|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1805617|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1805618|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1805619|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1805620|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
1805621|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
1805622|NCT04847193|Xanthohumol|xanthohumol|mesh-list
1805623|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805624|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1805625|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1805626|NCT04847193|Growth Substances|growth substances|mesh-ancestor
1805627|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805628|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
1805629|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
1805630|NCT04846673|Pregabalin|pregabalin|mesh-list
1805631|NCT04846673|Analgesics|analgesics|mesh-ancestor
1805632|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
1805633|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805634|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805635|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
1805636|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1805637|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1805638|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805639|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1805640|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1805641|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1805642|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1805643|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1805644|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
1805645|NCT04846673|Protective Agents|protective agents|mesh-ancestor
1805646|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
1805647|NCT04846673|Vitamins|vitamins|mesh-ancestor
1805648|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
1805649|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
1805650|NCT04846621|Calcium|calcium|mesh-list
1805651|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1805652|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805653|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1805654|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805655|NCT04846829|Citalopram|citalopram|mesh-list
1805656|NCT04846829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1805657|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1805658|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1805659|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805660|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1805661|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
1805662|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805663|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1805664|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
1805665|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1805666|NCT04846855|Anesthetics|anesthetics|mesh-list
1805667|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
1805668|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1805669|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805670|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
1805671|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805672|NCT04846634|Gemcitabine|gemcitabine|mesh-list
1805673|NCT04846634|Paclitaxel|paclitaxel|mesh-list
1805674|NCT04846634|Docetaxel|docetaxel|mesh-list
1805675|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1805676|NCT04846634|Cisplatin|cisplatin|mesh-list
1805677|NCT04846634|Carboplatin|carboplatin|mesh-list
1805678|NCT04846634|Pemetrexed|pemetrexed|mesh-list
1805679|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1805680|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805681|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
1805682|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
1805683|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
1805684|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805685|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1805686|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
1805687|NCT04846634|Antiviral Agents|antiviral agents|mesh-ancestor
1805688|NCT04846634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805689|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805690|NCT04846634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1805691|NCT04846634|Immunologic Factors|immunologic factors|mesh-ancestor
1805692|NCT04846634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805693|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1805694|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1805695|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
1805696|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
1805697|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
1805698|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805699|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
1805700|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805701|NCT04846452|Paclitaxel|paclitaxel|mesh-list
1805702|NCT04846452|Carboplatin|carboplatin|mesh-list
1805703|NCT04846452|Pemetrexed|pemetrexed|mesh-list
1805704|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1805705|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805706|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
1805707|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
1805708|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
1805709|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805710|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805711|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1805712|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1805713|NCT04846478|Talazoparib|talazoparib|mesh-list
1805714|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1805715|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805716|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805717|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805718|NCT04846335|Doxycycline|doxycycline|mesh-list
1805719|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1805720|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805721|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
1805722|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1805723|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1805724|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
1805725|NCT04846348|Promethazine|promethazine|mesh-list
1805726|NCT04846348|Salicylates|salicylates|mesh-list
1805727|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
1805728|NCT04846348|Emollients|emollients|mesh-list
1805729|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1805730|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1805731|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1805732|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805733|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
1805734|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
1805735|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
1805736|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805737|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
1805738|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
1805739|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1805740|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1805741|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
1805742|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
1805743|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1805744|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805745|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1805746|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
1805747|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
1805748|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1805749|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1805750|NCT04846348|Analgesics|analgesics|mesh-ancestor
1805751|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1805752|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1805753|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1805754|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805755|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
1805756|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
1805757|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1805758|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
1805762|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
1805763|NCT04845880|Paraproteins|paraproteins|mesh-list
1805764|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
1805765|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805766|NCT04845737|Vitamin D|vitamin d|mesh-list
1805767|NCT04845737|Vitamins|vitamins|mesh-ancestor
1805768|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
1805769|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805770|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1805771|NCT04845607|Amiodarone|amiodarone|mesh-list
1805772|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1805773|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
1805774|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1805775|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1805776|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805777|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1805778|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1805779|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1805780|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805781|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1805782|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1805783|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1805784|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
1805785|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1805786|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1805787|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805788|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
1805789|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
1805790|NCT04845646|Itraconazole|itraconazole|mesh-list
1805791|NCT04845646|Phenytoin|phenytoin|mesh-list
1805792|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
1805793|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805794|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1805795|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1805796|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805797|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805798|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1805799|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
1805800|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1805801|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805802|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1805803|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
1805804|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1805805|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1805806|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1805807|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1805808|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1805809|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1805810|NCT04846231|Red yeast rice|red yeast rice|mesh-list
1805811|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1805812|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1805813|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
1805814|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805815|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1805816|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1805817|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805818|NCT04845490|Mitomycins|mitomycins|mesh-list
1805819|NCT04845490|Mitomycin|mitomycin|mesh-list
1805820|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1805821|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805822|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
1805823|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805824|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1805825|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805826|NCT04845399|Factor VIII|factor viii|mesh-list
1805827|NCT04845399|Coagulants|coagulants|mesh-ancestor
1805828|NCT04845217|Peppermint oil|peppermint oil|mesh-list
1805829|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
1805830|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
1805831|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1805832|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805833|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1805834|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
1805835|NCT04845139|Nivolumab|nivolumab|mesh-list
1805836|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1805837|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805838|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1805839|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805840|NCT04844996|Ezetimibe|ezetimibe|mesh-list
1805841|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1805842|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1805843|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
1805844|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805845|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1805846|NCT04845061|Nebivolol|nebivolol|mesh-list
1805847|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1805848|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
1805849|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1805850|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1805851|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1805852|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
1805853|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1805854|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805855|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805878|NCT04844905|Ivermectin|ivermectin|mesh-list
1805879|NCT04844905|Piperaquine|piperaquine|mesh-list
1805880|NCT04844905|Artenimol|artenimol|mesh-list
1805881|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1805882|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805883|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
1805884|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1805885|NCT04844866|Gemcitabine|gemcitabine|mesh-list
1805886|NCT04844866|Rituximab|rituximab|mesh-list
1805887|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
1805888|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1805889|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1805890|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
1805891|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1805892|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805893|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
1805894|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805895|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1805896|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1805897|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
1805898|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805899|NCT04844866|Antiviral Agents|antiviral agents|mesh-ancestor
1805900|NCT04844866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805901|NCT04844866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1805902|NCT04844866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1805903|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1805904|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
1805905|NCT04844814|Prednisone|prednisone|mesh-list
1805906|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1805907|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1805908|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
1805909|NCT04844814|Hormones|hormones|mesh-ancestor
1805910|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1805911|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805912|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1805913|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805914|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1805915|NCT04844957|Vitamin D|vitamin d|mesh-list
1805916|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
1805917|NCT04844957|Vitamins|vitamins|mesh-list
1805918|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
1805919|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805920|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1805921|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1805924|NCT04844762|Menthol|menthol|mesh-list
1805925|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
1805926|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
1805927|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
1805928|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1805929|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
1805930|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805943|NCT04844385|Paclitaxel|paclitaxel|mesh-list
1805944|NCT04844385|Capecitabine|capecitabine|mesh-list
1805945|NCT04844385|Nedaplatin|nedaplatin|mesh-list
1805946|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1805947|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805948|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
1805949|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
1805950|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
1805951|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805952|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1805953|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
1805954|NCT04844489|Vaccines|vaccines|mesh-list
1805955|NCT04844489|Immunologic Factors|immunologic factors|mesh-ancestor
1805956|NCT04844489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805957|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
1805958|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1805959|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805960|NCT04844164|Vitamins|vitamins|mesh-ancestor
1805961|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
1805962|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1805963|NCT04844333|Anesthetics|anesthetics|mesh-list
1805964|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1805965|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805966|NCT04844268|Vaccines|vaccines|mesh-list
1805967|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
1805968|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805969|NCT04844216|Lidocaine|lidocaine|mesh-list
1805970|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
1805971|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
1805972|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
1805973|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1805974|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1805975|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
1805976|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806056|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
1805977|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1805978|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1805979|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1805980|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1805981|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1805982|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1805983|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
1805984|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
1805985|NCT04844216|Protective Agents|protective agents|mesh-ancestor
1805986|NCT04844099|Piperaquine|piperaquine|mesh-list
1805987|NCT04844099|Artenimol|artenimol|mesh-list
1805988|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
1805989|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1805990|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1805991|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1805992|NCT04843982|Esketamine|esketamine|mesh-list
1805993|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
1805994|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1805995|NCT04843943|Bevacizumab|bevacizumab|mesh-list
1805996|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1805997|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1805998|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1805999|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1806000|NCT04843943|Growth Substances|growth substances|mesh-ancestor
1806001|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806002|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
1806003|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
1806004|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1806005|NCT04843917|Antibodies|antibodies|mesh-list
1806006|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
1806007|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
1806008|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806009|NCT04843904|Rituximab|rituximab|mesh-list
1806010|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
1806011|NCT04843904|Venetoclax|venetoclax|mesh-list
1806012|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1806013|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806014|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
1806015|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806016|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1806017|NCT04843839|Nepafenac|nepafenac|mesh-list
1806018|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1806019|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1806020|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
1806021|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1806022|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1806023|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1806024|NCT04843839|Analgesics|analgesics|mesh-ancestor
1806025|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
1806026|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806027|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806028|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1806029|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1806030|NCT04843839|Laxatives|laxatives|mesh-ancestor
1806031|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1806032|NCT04843553|Niacinamide|niacinamide|mesh-list
1806033|NCT04843553|Niacin|niacin|mesh-list
1806034|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
1806035|NCT04843553|Vitamins|vitamins|mesh-ancestor
1806036|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
1806037|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806038|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
1806039|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1806040|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
1806041|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806042|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1806043|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
1806044|NCT04843462|Esketamine|esketamine|mesh-list
1806045|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
1806046|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1806053|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1806054|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806055|NCT04843631|Ustekinumab|ustekinumab|mesh-list
1806057|NCT04843111|Vaccines|vaccines|mesh-list
1806058|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
1806059|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806060|NCT04843449|Itraconazole|itraconazole|mesh-list
1806061|NCT04843449|Rifampin|rifampin|mesh-list
1806062|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
1806063|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806064|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1806065|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1806066|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806067|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806068|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1806069|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
1806070|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1806071|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806072|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1806073|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1806074|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
1806075|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1806076|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
1806077|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1806078|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1806079|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1806080|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1806081|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1806082|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1806083|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1806084|NCT04843644|Propolis|propolis|mesh-list
1806085|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806086|NCT04843280|Coal Tar|coal tar|mesh-list
1806087|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
1806088|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
1806089|NCT04843098|Paclitaxel|paclitaxel|mesh-list
1806090|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1806091|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806092|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
1806093|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
1806094|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
1806095|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806096|NCT04842825|Cetrorelix|cetrorelix|mesh-list
1806097|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1806098|NCT04842825|Hormones|hormones|mesh-ancestor
1806099|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1806100|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806101|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1806102|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
1806103|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1806104|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
1806105|NCT04843046|Pioglitazone|pioglitazone|mesh-list
1806106|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1806107|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806108|NCT04843007|Pemetrexed|pemetrexed|mesh-list
1806109|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806110|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806111|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806112|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1806113|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1806114|NCT04842708|Vaccines|vaccines|mesh-list
1806115|NCT04842708|Immunologic Factors|immunologic factors|mesh-ancestor
1806116|NCT04842708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806117|NCT04842838|Paclitaxel|paclitaxel|mesh-list
1806118|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1806119|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806120|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
1806121|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
1806122|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
1806123|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806130|NCT04842968|Methylene Blue|methylene blue|mesh-list
1806131|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806132|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806133|NCT04842682|Diazepam|diazepam|mesh-list
1806134|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1806135|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
1806136|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
1806137|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
1806138|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806139|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806140|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1806141|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1806142|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1806143|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1806144|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1806145|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1806146|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1806147|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1806148|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1806149|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
1806150|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
1806151|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
1806152|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
1806153|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1806154|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806155|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
1806156|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1806157|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
1806158|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806159|NCT04842487|Prednisone|prednisone|mesh-list
1806160|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
1806161|NCT04842487|Rituximab|rituximab|mesh-list
1806162|NCT04842487|Vincristine|vincristine|mesh-list
1806163|NCT04842487|Lenalidomide|lenalidomide|mesh-list
1806164|NCT04842487|Doxorubicin|doxorubicin|mesh-list
1806165|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1806166|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1806167|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
1806168|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806169|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1806170|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1806171|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
1806172|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806173|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806174|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1806175|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1806176|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1806177|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
1806178|NCT04842487|Hormones|hormones|mesh-ancestor
1806179|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1806180|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1806181|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1806182|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
1806183|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
1806184|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
1806185|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1806186|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1806187|NCT04842487|Growth Substances|growth substances|mesh-ancestor
1806188|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
1806189|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1806190|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1806191|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1806192|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806199|NCT04842292|Heparin|heparin|mesh-list
1806200|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
1806201|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1806202|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1806203|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806204|NCT04842383|Peppermint oil|peppermint oil|mesh-list
1806205|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
1806206|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
1806207|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806208|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806209|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1806210|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
1806214|NCT04842526|Irinotecan|irinotecan|mesh-list
1806215|NCT04842526|Temozolomide|temozolomide|mesh-list
1806216|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1806217|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1806218|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806219|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806220|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806221|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1806222|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
1806223|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
1806224|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1806225|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
1806226|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806227|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806228|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1806229|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
1806230|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1806231|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
1806232|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806233|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1806234|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1806235|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
1806236|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
1806237|NCT04842331|Protective Agents|protective agents|mesh-ancestor
1806238|NCT04841980|Rifaximin|rifaximin|mesh-list
1806239|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1806240|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806241|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1806259|NCT04841720|Metformin|metformin|mesh-list
1806260|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1806261|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806262|NCT04841668|Metformin|metformin|mesh-list
1806263|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1806264|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806265|NCT04842071|Listerine|listerine|mesh-list
1806266|NCT04842071|Fluorides|fluorides|mesh-list
1806267|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
1806268|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
1806269|NCT04842071|Protective Agents|protective agents|mesh-ancestor
1806270|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806271|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1806272|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806273|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
1806274|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1806275|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1806276|NCT04841096|Metformin|metformin|mesh-list
1806277|NCT04841096|Glimepiride|glimepiride|mesh-list
1806278|NCT04841096|Vildagliptin|vildagliptin|mesh-list
1806279|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1806280|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806281|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1806282|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1806283|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
1806284|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1806285|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
1806286|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806287|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806288|NCT04841369|Vaccines|vaccines|mesh-list
1806289|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
1806290|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806291|NCT04841343|Triamcinolone|triamcinolone|mesh-list
1806292|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1806293|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
1806294|NCT04841343|Hormones|hormones|mesh-ancestor
1806295|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1806296|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806297|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
1806298|NCT04841148|Palbociclib|palbociclib|mesh-list
1806299|NCT04841148|Avelumab|avelumab|mesh-list
1806300|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
1806301|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1806302|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1806303|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806304|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806305|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806306|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1806307|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806308|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1806309|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1806310|NCT04841434|Methotrexate|methotrexate|mesh-list
1806311|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1806312|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
1806313|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1806314|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806315|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1806316|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
1806317|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806318|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806319|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
1806320|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806321|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1806322|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1806323|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
1806324|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1806325|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1806326|NCT04841265|Vitamin D|vitamin d|mesh-list
1806327|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
1806328|NCT04841265|Vitamins|vitamins|mesh-ancestor
1806329|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
1806330|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806331|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1806332|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1806333|NCT04840862|Rifabutin|rifabutin|mesh-list
1806334|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1806335|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806336|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1806337|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
1806348|NCT04841018|Dexamethasone|dexamethasone|mesh-list
1806349|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
1806350|NCT04841018|BB 1101|bb 1101|mesh-list
1806351|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1806352|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
1806353|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
1806354|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806355|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806356|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1806357|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
1806358|NCT04841018|Hormones|hormones|mesh-ancestor
1806359|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1806360|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1806361|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806362|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
1806363|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806364|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806365|NCT04840992|Vaccines|vaccines|mesh-list
1806366|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
1806367|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806368|NCT04840550|Lansoprazole|lansoprazole|mesh-list
1806369|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
1806370|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1806371|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1806372|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1806373|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806374|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806375|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
1806376|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
1806377|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1806378|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806431|NCT04840511|Lidocaine|lidocaine|mesh-list
1806432|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
1806433|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
1806434|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1806435|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806436|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
1806437|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806438|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1806439|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1806440|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1806441|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1806442|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806443|NCT04840745|Leuprolide|leuprolide|mesh-list
1806444|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1806445|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
1806446|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1806447|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806448|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1806449|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806450|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
1806451|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1806452|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806453|NCT04840238|Vitamins|vitamins|mesh-ancestor
1806454|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
1806455|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1806456|NCT04840290|Paclitaxel|paclitaxel|mesh-list
1806457|NCT04840290|Carboplatin|carboplatin|mesh-list
1806458|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1806459|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806460|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
1806461|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
1806462|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
1806463|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806464|NCT04840342|Amlodipine|amlodipine|mesh-list
1806465|NCT04840342|Eplerenone|eplerenone|mesh-list
1806466|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1806467|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1806468|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1806469|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806470|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1806471|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806472|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
1806473|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1806474|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
1806475|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1806476|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1806477|NCT04840342|Diuretics|diuretics|mesh-ancestor
1806478|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
1806479|NCT04840264|Docetaxel|docetaxel|mesh-list
1806480|NCT04840264|Fluorouracil|fluorouracil|mesh-list
1806481|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
1806482|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806483|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
1806484|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
1806485|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
1806486|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806487|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
1806488|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1806489|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1806490|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
1806491|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806492|NCT04839913|Antibodies|antibodies|mesh-list
1806493|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
1806494|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806495|NCT04840004|Aprepitant|aprepitant|mesh-list
1806496|NCT04840004|Antiemetics|antiemetics|mesh-ancestor
1806497|NCT04840004|Autonomic Agents|autonomic agents|mesh-ancestor
1806498|NCT04840004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806499|NCT04840004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806500|NCT04840004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1806501|NCT04840004|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1806502|NCT04840004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1806503|NCT04840004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806504|NCT04839666|Propofol|propofol|mesh-list
1806505|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1806506|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1806507|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806508|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1806509|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
1806510|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
1806511|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
1806512|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1806513|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
1806514|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806515|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
1806516|NCT04839692|Protective Agents|protective agents|mesh-ancestor
1806517|NCT04839731|Fluorouracil|fluorouracil|mesh-list
1806518|NCT04839731|Calcipotriene|calcipotriene|mesh-list
1806519|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
1806520|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806521|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1806522|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806523|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1806524|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
1806525|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806526|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
1806527|NCT04839653|Vancomycin|vancomycin|mesh-list
1806528|NCT04839653|Gentamicins|gentamicins|mesh-list
1806529|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
1806530|NCT04839653|Polymyxins|polymyxins|mesh-list
1806531|NCT04839653|Cefotaxime|cefotaxime|mesh-list
1806532|NCT04839653|Cefoxitin|cefoxitin|mesh-list
1806533|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1806534|NCT04839653|Polymyxin B|polymyxin b|mesh-list
1806535|NCT04839653|Amphotericin B|amphotericin b|mesh-list
1806536|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
1806537|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806538|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1806539|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806540|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806541|NCT04839653|Amebicides|amebicides|mesh-ancestor
1806542|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1806543|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1806544|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
1806545|NCT04839536|Sevoflurane|sevoflurane|mesh-list
1806546|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1806547|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1806548|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
1806549|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
1806550|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1806551|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806552|NCT04839549|Fluorometholone|fluorometholone|mesh-list
1806553|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1806554|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806555|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
1806556|NCT04839549|Hormones|hormones|mesh-ancestor
1806557|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1806558|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1806559|NCT04839627|Progesterone|progesterone|mesh-list
1806560|NCT04839627|Progestins|progestins|mesh-ancestor
1806561|NCT04839627|Hormones|hormones|mesh-ancestor
1806562|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1806563|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806564|NCT04839445|Anesthetics|anesthetics|mesh-list
1806565|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1806566|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806567|NCT04839224|Phenylephrine|phenylephrine|mesh-list
1806568|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
1806569|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1806570|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
1806571|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
1806572|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806573|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806574|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
1806575|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1806576|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
1806577|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
1806578|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1806579|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1806580|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1806581|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
1806582|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1806583|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806584|NCT04839224|Protective Agents|protective agents|mesh-ancestor
1806585|NCT04839471|Afatinib|afatinib|mesh-list
1806586|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806587|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1806588|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806589|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806590|NCT04839328|Hemay005|hemay005|mesh-list
1806591|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
1806592|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1806593|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1806594|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806595|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806596|NCT04839198|Nicotine|nicotine|mesh-list
1806597|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1806598|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
1806599|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806600|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806601|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1806602|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1806603|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
1806604|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1806605|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806606|NCT04839237|Metformin|metformin|mesh-list
1806607|NCT04839237|Liraglutide|liraglutide|mesh-list
1806608|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1806609|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806610|NCT04839237|Incretins|incretins|mesh-ancestor
1806611|NCT04839237|Hormones|hormones|mesh-ancestor
1806612|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1806613|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
1806614|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1806615|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806616|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
1806617|NCT04838704|Methotrexate|methotrexate|mesh-list
1806618|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1806619|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
1806620|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1806621|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806622|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1806623|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
1806624|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806625|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806626|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
1806627|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806628|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1806629|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1806630|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
1806631|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1806632|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1806633|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1806634|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1806635|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
1806636|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1806637|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806638|NCT04838665|Phenylephrine|phenylephrine|mesh-list
1806639|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
1806640|NCT04838665|Tropicamide|tropicamide|mesh-list
1806641|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
1806642|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1806643|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
1806644|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
1806645|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806646|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806647|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
1806648|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1806649|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
1806650|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
1806651|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1806652|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1806653|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1806654|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
1806655|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1806656|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806657|NCT04838665|Protective Agents|protective agents|mesh-ancestor
1806658|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1806659|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1806660|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
1806661|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
1806662|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
1806663|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1806664|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
1806665|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1806666|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
1806667|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806668|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806669|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
1806670|NCT04838717|Doxycycline|doxycycline|mesh-list
1806671|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1806672|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806673|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
1806674|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1806675|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1806676|NCT04838860|Siltuximab|siltuximab|mesh-list
1806677|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806678|NCT04838288|Tacrolimus|tacrolimus|mesh-list
1806679|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1806680|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
1806681|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806682|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1806683|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806684|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806685|NCT04838301|Pregnanolone|pregnanolone|mesh-list
1806686|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
1806687|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1806688|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806689|NCT04838145|Ribavirin|ribavirin|mesh-list
1806690|NCT04838145|Pleconaril|pleconaril|mesh-list
1806691|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
1806692|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806693|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
1806694|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806695|NCT04838132|Ropivacaine|ropivacaine|mesh-list
1806696|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
1806697|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
1806698|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1806699|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806700|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
1806701|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806702|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
1806703|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1806704|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806705|NCT04837768|Progesterone|progesterone|mesh-list
1806706|NCT04837768|Progestins|progestins|mesh-ancestor
1806707|NCT04837768|Hormones|hormones|mesh-ancestor
1806708|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1806709|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806710|NCT04837924|Acetaminophen|acetaminophen|mesh-list
1806711|NCT04837924|Tramadol|tramadol|mesh-list
1806712|NCT04837924|Analgesics|analgesics|mesh-list
1806713|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
1806714|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1806715|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
1806716|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806717|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806718|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
1806719|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1806720|NCT04837924|Narcotics|narcotics|mesh-ancestor
1806721|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1806722|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
1806723|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
1806724|NCT04838080|Vaccines|vaccines|mesh-list
1806725|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
1806726|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806727|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
1806728|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
1806729|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
1806730|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806731|NCT04837664|Nystatin|nystatin|mesh-list
1806732|NCT04837664|Curcumin|curcumin|mesh-list
1806733|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1806734|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1806735|NCT04837664|Analgesics|analgesics|mesh-ancestor
1806736|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
1806737|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806738|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806739|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1806740|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1806741|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806742|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806743|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806744|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1806745|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806746|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
1806747|NCT04837664|Ionophores|ionophores|mesh-ancestor
1806748|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1806749|NCT04837716|Bevacizumab|bevacizumab|mesh-list
1806750|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1806751|NCT04837716|Carboplatin|carboplatin|mesh-list
1806752|NCT04837716|Pemetrexed|pemetrexed|mesh-list
1806753|NCT04837716|Ensartinib|ensartinib|mesh-list
1806754|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
1806755|NCT04837716|Antibodies|antibodies|mesh-list
1806756|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
1806757|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1806758|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
1806759|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806760|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1806761|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1806762|NCT04837716|Growth Substances|growth substances|mesh-ancestor
1806763|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806764|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
1806765|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
1806766|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806767|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806768|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1806769|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1806770|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1806771|NCT04837651|Antibodies|antibodies|mesh-list
1806772|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
1806773|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806774|NCT04837209|Niraparib|niraparib|mesh-list
1806775|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1806776|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806777|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806778|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806779|NCT04837131|Ixazomib|ixazomib|mesh-list
1806780|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806781|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
1806782|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806783|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806784|NCT04837014|Acetaminophen|acetaminophen|mesh-list
1806785|NCT04837014|Naproxen|naproxen|mesh-list
1806786|NCT04837014|Hydromorphone|hydromorphone|mesh-list
1806787|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1806788|NCT04837014|Analgesics|analgesics|mesh-ancestor
1806789|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
1806790|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806791|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806792|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
1806793|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1806794|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1806795|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1806796|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
1806797|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1806798|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806799|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806800|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1806801|NCT04837014|Narcotics|narcotics|mesh-ancestor
1806802|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1806803|NCT04837170|Ketamine|ketamine|mesh-list
1806804|NCT04837170|Esketamine|esketamine|mesh-list
1806805|NCT04837170|Analgesics|analgesics|mesh-ancestor
1806806|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
1806807|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806808|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806809|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1806810|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1806811|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
1806812|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
1806813|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1806814|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1806815|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1806816|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1806817|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806818|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
1806819|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1806820|NCT04837066|Imidacloprid|imidacloprid|mesh-list
1806821|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
1806822|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1806823|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806824|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806825|NCT04837261|Propranolol|propranolol|mesh-list
1806826|NCT04837261|Amiodarone|amiodarone|mesh-list
1806827|NCT04837261|Flecainide|flecainide|mesh-list
1806828|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1806829|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1806830|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
1806831|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1806832|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806833|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806834|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1806835|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1806836|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
1806837|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1806838|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1806839|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1806840|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1806841|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1806842|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806843|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1806844|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1806845|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1806846|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1806847|NCT04836962|Dexamethasone|dexamethasone|mesh-list
1806848|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1806849|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
1806850|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
1806851|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806852|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806853|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1806854|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
1806855|NCT04836962|Hormones|hormones|mesh-ancestor
1806856|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1806857|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1806858|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806859|NCT04836806|Cetirizine|cetirizine|mesh-list
1806860|NCT04836806|Famotidine|famotidine|mesh-list
1806861|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1806862|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1806863|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1806864|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
1806865|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
1806866|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1806867|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806868|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806869|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1806870|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1806871|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1806872|NCT04836728|Paclitaxel|paclitaxel|mesh-list
1806873|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1806874|NCT04836728|Carboplatin|carboplatin|mesh-list
1806875|NCT04836728|Pemetrexed|pemetrexed|mesh-list
1806876|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1806877|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1806878|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806879|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
1806880|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
1806881|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
1806882|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806883|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806884|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1806885|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1806886|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
1806887|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1806888|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
1806889|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
1806890|NCT04836637|Calcium|calcium|mesh-list
1806891|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1806892|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806893|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1806894|NCT04836637|Antacids|antacids|mesh-ancestor
1806895|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806896|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1806897|NCT04836819|Lidocaine|lidocaine|mesh-list
1806898|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
1806899|NCT04836819|Ketamine|ketamine|mesh-list
1806900|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
1806901|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
1806902|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1806903|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806904|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
1806905|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806906|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1806907|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1806908|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1806909|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1806910|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806911|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1806912|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1806913|NCT04836819|Analgesics|analgesics|mesh-ancestor
1806914|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1806915|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1806916|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1806917|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
1806918|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1806919|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1806920|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1806921|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
1806922|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1806923|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1806924|NCT04836780|Dexamethasone|dexamethasone|mesh-list
1806925|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1806926|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
1806927|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
1806928|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1806929|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806930|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1806931|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
1806932|NCT04836780|Hormones|hormones|mesh-ancestor
1806933|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1806934|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1806935|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806936|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
1806937|NCT04836507|Fludarabine|fludarabine|mesh-list
1806938|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1806939|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
1806940|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806941|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1806942|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1806943|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
1806944|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806945|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806946|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1806947|NCT04836078|Chitosan|chitosan|mesh-list
1806948|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1806949|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1806950|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
1806951|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806952|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1806953|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
1806954|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
1806955|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
1806956|NCT04836078|Coagulants|coagulants|mesh-ancestor
1806957|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
1806958|NCT04836156|Carboplatin|carboplatin|mesh-list
1806959|NCT04836156|Docetaxel|docetaxel|mesh-list
1806960|NCT04836156|Epirubicin|epirubicin|mesh-list
1806961|NCT04836156|Phenobarbital|phenobarbital|mesh-list
1806962|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1806963|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
1806964|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806965|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1807118|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
1806966|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1806967|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
1806968|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806969|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1806970|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1806971|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
1806972|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
1806973|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
1806974|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1806975|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1806976|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1806977|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1806978|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
1806979|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1806980|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1806981|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1806982|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1806983|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1806984|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
1806985|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
1806986|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1806987|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1806988|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1806989|NCT04836143|Mitogens|mitogens|mesh-list
1806990|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
1806991|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
1806992|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1806993|NCT04836143|Growth Substances|growth substances|mesh-ancestor
1806994|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1806995|NCT04836299|Ivermectin|ivermectin|mesh-list
1806996|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1806997|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1806998|NCT04835870|Prednisone|prednisone|mesh-list
1806999|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
1807000|NCT04835870|Rituximab|rituximab|mesh-list
1807001|NCT04835870|Doxorubicin|doxorubicin|mesh-list
1807002|NCT04835870|Vincristine|vincristine|mesh-list
1807003|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
1807004|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1807005|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
1807006|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807007|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1807008|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1807009|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
1807010|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807011|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807012|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1807013|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1807014|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1807015|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1807016|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1807017|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807018|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1807019|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
1807020|NCT04835870|Hormones|hormones|mesh-ancestor
1807021|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807022|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1807023|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1807024|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
1807025|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
1807026|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
1807027|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1807028|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1807029|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
1807030|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807031|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1807032|NCT04835623|Cyclosporine|cyclosporine|mesh-list
1807033|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1807034|NCT04835623|Cyclosporins|cyclosporins|mesh-list
1807035|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807036|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807037|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1807038|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
1807039|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807040|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
1807041|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807042|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
1807043|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1807044|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1807045|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1807046|NCT04835922|Anesthetics|anesthetics|mesh-list
1807047|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807048|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807049|NCT04835896|Paclitaxel|paclitaxel|mesh-list
1807050|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1807051|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807052|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
1807053|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
1807054|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
1807055|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807056|NCT04835350|Pancrelipase|pancrelipase|mesh-list
1807057|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807058|NCT04835259|Selenium|selenium|mesh-list
1807059|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
1807060|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807061|NCT04835259|Protective Agents|protective agents|mesh-ancestor
1807062|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807063|NCT04835259|Trace Elements|trace elements|mesh-ancestor
1807064|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
1807065|NCT04835584|Dasatinib|dasatinib|mesh-list
1807066|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807067|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1807068|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807069|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807070|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
1807071|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1807072|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807073|NCT04835506|Infliximab|infliximab|mesh-list
1807074|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
1807075|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807076|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1807077|NCT04835233|Methyldopa|methyldopa|mesh-list
1807078|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1807079|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
1807080|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
1807081|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807082|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807083|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1807084|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1807085|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1807086|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
1807087|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807088|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807089|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
1807090|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1807091|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807092|NCT04834986|Lenvatinib|lenvatinib|mesh-list
1807093|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807094|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1807095|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807096|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807097|NCT04835064|Gemcitabine|gemcitabine|mesh-list
1807098|NCT04835064|Paclitaxel|paclitaxel|mesh-list
1807099|NCT04835064|Folfirinox|folfirinox|mesh-list
1807100|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1807101|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807102|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
1807103|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
1807104|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
1807105|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807106|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1807107|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
1807108|NCT04835064|Antiviral Agents|antiviral agents|mesh-ancestor
1807109|NCT04835064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807110|NCT04835064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807111|NCT04835064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1807112|NCT04835064|Immunologic Factors|immunologic factors|mesh-ancestor
1807113|NCT04835064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807114|NCT04835116|Acetaminophen|acetaminophen|mesh-list
1807115|NCT04835116|Tramadol|tramadol|mesh-list
1807116|NCT04835116|Analgesics|analgesics|mesh-list
1807117|NCT04835116|Orphenadrine|orphenadrine|mesh-list
1807119|NCT04835116|Bupivacaine|bupivacaine|mesh-list
1807120|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
1807121|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
1807122|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807123|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807124|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
1807125|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807126|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1807127|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
1807128|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1807129|NCT04835116|Narcotics|narcotics|mesh-ancestor
1807130|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1807131|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1807132|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1807133|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1807134|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
1807135|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
1807136|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1807137|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1807138|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
1807139|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807140|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807141|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
1807142|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1807143|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807144|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
1807145|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807146|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1807147|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
1807148|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
1807149|NCT04834908|Immune Sera|immune sera|mesh-list
1807150|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
1807151|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807152|NCT04834791|Letrozole|letrozole|mesh-list
1807153|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807154|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1807155|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1807156|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807157|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807158|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1807159|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
1807160|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807161|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807162|NCT04834960|Vaccines|vaccines|mesh-list
1807163|NCT04834960|Immunologic Factors|immunologic factors|mesh-ancestor
1807164|NCT04834960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807165|NCT04835129|Dexamethasone|dexamethasone|mesh-list
1807166|NCT04835129|Pomalidomide|pomalidomide|mesh-list
1807167|NCT04835129|Elotuzumab|elotuzumab|mesh-list
1807168|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1807169|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1807170|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
1807171|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
1807172|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807173|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807174|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807175|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
1807176|NCT04835129|Hormones|hormones|mesh-ancestor
1807177|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807178|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1807179|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807180|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
1807181|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1807182|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1807183|NCT04835129|Growth Substances|growth substances|mesh-ancestor
1807184|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
1807185|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1807186|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807187|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807188|NCT04834440|Ropivacaine|ropivacaine|mesh-list
1807189|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
1807190|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
1807191|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807192|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807193|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
1807348|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
1807194|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807195|NCT04834557|Digoxin|digoxin|mesh-list
1807196|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1807197|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1807198|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1807199|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807200|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807201|NCT04834557|Protective Agents|protective agents|mesh-ancestor
1807202|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807203|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1807204|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807205|NCT04834752|Esomeprazole|esomeprazole|mesh-list
1807206|NCT04834752|Omeprazole|omeprazole|mesh-list
1807207|NCT04834752|Rabeprazole|rabeprazole|mesh-list
1807208|NCT04834752|Pantoprazole|pantoprazole|mesh-list
1807209|NCT04834752|Lansoprazole|lansoprazole|mesh-list
1807210|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
1807211|NCT04834752|Famotidine|famotidine|mesh-list
1807212|NCT04834752|Ranitidine|ranitidine|mesh-list
1807213|NCT04834752|Cimetidine|cimetidine|mesh-list
1807214|NCT04834752|Nizatidine|nizatidine|mesh-list
1807215|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1807216|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807217|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1807218|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807219|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807220|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1807221|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
1807222|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
1807223|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807224|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807225|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1807226|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1807227|NCT04834674|Apatinib|apatinib|mesh-list
1807228|NCT04834674|Antibodies|antibodies|mesh-list
1807229|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
1807230|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807231|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807232|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1807233|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807234|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807235|NCT04834427|Ketamine|ketamine|mesh-list
1807236|NCT04834427|Esketamine|esketamine|mesh-list
1807237|NCT04834427|Analgesics|analgesics|mesh-ancestor
1807238|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
1807239|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807240|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807241|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1807242|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1807243|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
1807244|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
1807245|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807246|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1807247|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1807248|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807249|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807250|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
1807251|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1807252|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1807253|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1807254|NCT04834375|Dexamethasone|dexamethasone|mesh-list
1807255|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
1807256|NCT04834375|BB 1101|bb 1101|mesh-list
1807257|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1807258|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
1807259|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
1807260|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807261|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807262|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807263|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
1807264|NCT04834375|Hormones|hormones|mesh-ancestor
1807265|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807266|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1807267|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807268|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
1807269|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807349|NCT04833738|Hormones|hormones|mesh-ancestor
1807270|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807271|NCT04834310|Clindamycin|clindamycin|mesh-list
1807272|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
1807273|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
1807274|NCT04834310|Cefazolin|cefazolin|mesh-list
1807275|NCT04834310|Cephalexin|cephalexin|mesh-list
1807276|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1807277|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807278|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1807279|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807280|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807281|NCT04833946|Andrographolide|andrographolide|mesh-list
1807282|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1807283|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1807284|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1807285|NCT04833946|Analgesics|analgesics|mesh-ancestor
1807286|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
1807287|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807288|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807289|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1807290|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1807291|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1807292|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807293|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
1807294|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1807295|NCT04834024|Antibodies|antibodies|mesh-list
1807296|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1807297|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
1807298|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807299|NCT04833959|Panitumumab|panitumumab|mesh-list
1807300|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1807301|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807302|NCT04834115|Ivermectin|ivermectin|mesh-list
1807303|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1807304|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807305|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
1807306|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1807307|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807308|NCT04834206|Docetaxel|docetaxel|mesh-list
1807309|NCT04834206|Fluorouracil|fluorouracil|mesh-list
1807310|NCT04834206|Nedaplatin|nedaplatin|mesh-list
1807311|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807312|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
1807313|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
1807314|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
1807315|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807316|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
1807317|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1807318|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1807319|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
1807320|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807321|NCT04833907|Prednisolone|prednisolone|mesh-list
1807322|NCT04833907|Levetiracetam|levetiracetam|mesh-list
1807323|NCT04833907|Prednisolone phosphate|prednisolone phosphate|mesh-list
1807324|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1807325|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
1807326|NCT04833907|Hormones|hormones|mesh-ancestor
1807327|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807328|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807329|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1807330|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807331|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
1807332|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
1807339|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
1807340|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1807341|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807342|NCT04833738|Triamcinolone|triamcinolone|mesh-list
1807343|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1807344|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1807345|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
1807346|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1807347|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1807350|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807351|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807352|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1807353|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
1807354|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807355|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807356|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1807357|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
1807358|NCT04833738|Protective Agents|protective agents|mesh-ancestor
1807359|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1807360|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807361|NCT04833777|Lidocaine|lidocaine|mesh-list
1807362|NCT04833777|Bupivacaine|bupivacaine|mesh-list
1807363|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
1807364|NCT04833777|Anesthetics|anesthetics|mesh-list
1807365|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807366|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807367|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
1807368|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807369|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1807370|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1807371|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1807372|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1807373|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807374|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
1807375|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1807376|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807377|NCT04833218|Propranolol|propranolol|mesh-list
1807378|NCT04833218|Clonidine|clonidine|mesh-list
1807379|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1807380|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1807381|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
1807382|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807383|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807384|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807385|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1807386|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1807387|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
1807388|NCT04833218|Analgesics|analgesics|mesh-ancestor
1807389|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
1807390|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807391|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
1807392|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
1807393|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1807394|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1807395|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1807396|NCT04833114|Carboplatin|carboplatin|mesh-list
1807397|NCT04833114|Etoposide|etoposide|mesh-list
1807398|NCT04833114|Rituximab|rituximab|mesh-list
1807399|NCT04833114|Ifosfamide|ifosfamide|mesh-list
1807400|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807401|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1807402|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1807403|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1807404|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807405|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807406|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1807407|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
1807408|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807409|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1807410|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1807411|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
1807412|NCT04833387|Antibodies|antibodies|mesh-list
1807413|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
1807414|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807415|NCT04833374|Prednisone|prednisone|mesh-list
1807416|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
1807417|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1807418|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1807419|NCT04833374|Prednisolone|prednisolone|mesh-list
1807420|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
1807421|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1807422|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
1807423|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1807424|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
1807425|NCT04833374|Hormones|hormones|mesh-ancestor
1807426|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807427|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807428|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1807429|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807430|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
1807431|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
1807432|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807433|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807434|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1807435|NCT04833374|Protective Agents|protective agents|mesh-ancestor
1807441|NCT04833426|Testosterone|testosterone|mesh-list
1807442|NCT04833426|Androgens|androgens|mesh-ancestor
1807443|NCT04833426|Hormones|hormones|mesh-ancestor
1807444|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807445|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807446|NCT04833101|Vaccines|vaccines|mesh-list
1807447|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
1807448|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807449|NCT04833036|Irinotecan|irinotecan|mesh-list
1807450|NCT04833036|Cetuximab|cetuximab|mesh-list
1807451|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1807452|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1807453|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807454|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807455|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807456|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1807457|NCT04833023|Olanzapine|olanzapine|mesh-list
1807458|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
1807459|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
1807460|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807461|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807462|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807463|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1807464|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1807465|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807466|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1807467|NCT04833023|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1807468|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1807469|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1807470|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807471|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807472|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
1807473|NCT04833296|Ropivacaine|ropivacaine|mesh-list
1807474|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
1807475|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
1807476|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807477|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807478|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
1807479|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807480|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
1807481|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1807482|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
1807483|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1807484|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807485|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1807486|NCT04832880|Remdesivir|remdesivir|mesh-list
1807487|NCT04832880|Dexamethasone|dexamethasone|mesh-list
1807488|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1807489|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
1807490|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
1807491|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807492|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807493|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807494|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
1807495|NCT04832880|Hormones|hormones|mesh-ancestor
1807496|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807497|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1807498|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807499|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
1807500|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807501|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
1807502|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807503|NCT04832945|Ivermectin|ivermectin|mesh-list
1807504|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1807505|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807506|NCT04832438|Carboplatin|carboplatin|mesh-list
1807507|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807508|NCT04832776|Bevacizumab|bevacizumab|mesh-list
1807509|NCT04832776|Cetuximab|cetuximab|mesh-list
1807510|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1807511|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807512|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1807513|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1807514|NCT04832776|Growth Substances|growth substances|mesh-ancestor
1807515|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807516|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
1807517|NCT04832399|Natalizumab|natalizumab|mesh-list
1807518|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
1807519|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807520|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
1807521|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1807522|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
1807523|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807524|NCT04832009|Protective Agents|protective agents|mesh-ancestor
1807525|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807526|NCT04832009|Vitamins|vitamins|mesh-ancestor
1807527|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
1807528|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1807529|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1807530|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1807531|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
1807532|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1807533|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1807534|NCT04832269|Prednisolone|prednisolone|mesh-list
1807535|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
1807536|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1807537|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
1807538|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1807539|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
1807540|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
1807541|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807542|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807543|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807544|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
1807545|NCT04832269|Hormones|hormones|mesh-ancestor
1807546|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807547|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1807548|NCT04832269|Protective Agents|protective agents|mesh-ancestor
1807549|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1807550|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807551|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
1807552|NCT04832100|Pregabalin|pregabalin|mesh-list
1807553|NCT04832100|Imipramine|imipramine|mesh-list
1807554|NCT04832100|Analgesics|analgesics|mesh-ancestor
1807555|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
1807556|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807557|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807558|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
1807559|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1807560|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1807561|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807562|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1807563|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1807564|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1807565|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807566|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1807567|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1807568|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
1807569|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1807570|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1807571|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
1807572|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807573|NCT04832204|Apatinib|apatinib|mesh-list
1807574|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807575|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1807576|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807577|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807578|NCT04832087|Teduglutide|teduglutide|mesh-list
1807579|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807580|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1807581|NCT04832087|Protective Agents|protective agents|mesh-ancestor
1807582|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807583|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
1807584|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1807585|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1807586|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807587|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
1807588|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
1807589|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807600|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1807601|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1807602|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807603|NCT04831593|Anesthetics|anesthetics|mesh-list
1807604|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807605|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807606|NCT04831736|Ketamine|ketamine|mesh-list
1807607|NCT04831736|Analgesics|analgesics|mesh-ancestor
1807608|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
1807609|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807610|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807611|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1807612|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1807613|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
1807614|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
1807615|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807616|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1807617|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1807618|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807619|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807620|NCT04831528|Bevacizumab|bevacizumab|mesh-list
1807621|NCT04831528|Trastuzumab|trastuzumab|mesh-list
1807622|NCT04831528|Cetuximab|cetuximab|mesh-list
1807623|NCT04831528|Pertuzumab|pertuzumab|mesh-list
1807624|NCT04831528|Lapatinib|lapatinib|mesh-list
1807625|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1807626|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807627|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1807628|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1807629|NCT04831528|Growth Substances|growth substances|mesh-ancestor
1807630|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807631|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
1807632|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1807633|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807634|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807635|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
1807636|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807637|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
1807638|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
1807639|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807640|NCT04831320|Paclitaxel|paclitaxel|mesh-list
1807641|NCT04831320|Nivolumab|nivolumab|mesh-list
1807642|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1807643|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807644|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
1807645|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
1807646|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
1807647|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807648|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1807649|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1807650|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
1807651|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1807652|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807653|NCT04831047|Phenylephrine|phenylephrine|mesh-list
1807654|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
1807655|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1807656|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1807657|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1807658|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1807659|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
1807660|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807661|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807662|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807663|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
1807664|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
1807665|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807666|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
1807667|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1807668|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
1807669|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1807670|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
1807671|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1807672|NCT04831047|Protective Agents|protective agents|mesh-ancestor
1807673|NCT04831255|Triamcinolone|triamcinolone|mesh-list
1807674|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1807675|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1807676|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1807677|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1807678|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
1807679|NCT04831255|Hormones|hormones|mesh-ancestor
1807680|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807681|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807682|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1807683|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
1807684|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807685|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807686|NCT04831294|Cannabidiol|cannabidiol|mesh-list
1807687|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
1807688|NCT04830982|Diazoxide|diazoxide|mesh-list
1807689|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1807690|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
1807691|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
1807692|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1807693|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1807694|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807695|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
1807696|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
1807697|NCT04830878|Methotrexate|methotrexate|mesh-list
1807698|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1807699|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
1807700|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1807701|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807702|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1807703|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
1807704|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807705|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807706|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
1807707|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807708|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1807709|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1807710|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
1807711|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1807712|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1807713|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
1807714|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1807715|NCT04830943|Protective Agents|protective agents|mesh-ancestor
1807716|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807717|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
1807718|NCT04830813|Chiauranib|chiauranib|mesh-list
1807719|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807720|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1807721|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807722|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807723|NCT04830579|Etoricoxib|etoricoxib|mesh-list
1807724|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1807725|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1807726|NCT04830579|Analgesics|analgesics|mesh-ancestor
1807727|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
1807728|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807729|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807730|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1807731|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1807732|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1807733|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1807734|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807735|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807736|NCT04830397|Timolol|timolol|mesh-list
1807737|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1807738|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1807739|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
1807740|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807741|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807742|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807743|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1807744|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1807745|NCT04830462|Rifampin|rifampin|mesh-list
1807746|NCT04830462|Isoniazid|isoniazid|mesh-list
1807747|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1807748|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
1807749|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1807750|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807751|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
1807752|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1807753|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807754|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807755|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1807756|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1807757|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1807758|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1807759|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1807760|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1807761|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1807762|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1807763|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
1807764|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1807765|NCT04831099|Testosterone|testosterone|mesh-list
1807766|NCT04831099|Androgens|androgens|mesh-ancestor
1807767|NCT04831099|Hormones|hormones|mesh-ancestor
1807768|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807769|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807770|NCT04831229|Menthol|menthol|mesh-list
1807771|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
1807772|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
1807773|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1807774|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
1807775|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807776|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
1807777|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1807778|NCT04830410|Levan|levan|mesh-list
1807779|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807780|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
1807781|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
1807782|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807783|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807784|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807785|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
1807786|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
1807787|NCT04829799|Ketorolac|ketorolac|mesh-list
1807788|NCT04829799|Lidocaine|lidocaine|mesh-list
1807789|NCT04829799|Phenylephrine|phenylephrine|mesh-list
1807790|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
1807791|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
1807792|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
1807793|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807794|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807795|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
1807796|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807797|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1807798|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1807799|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1807953|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
1807800|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1807801|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807802|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1807803|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1807804|NCT04829799|Analgesics|analgesics|mesh-ancestor
1807805|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1807806|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1807807|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1807808|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807809|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1807810|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
1807811|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
1807812|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
1807813|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1807814|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
1807815|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
1807816|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1807817|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1807818|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1807819|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
1807820|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807821|NCT04829799|Protective Agents|protective agents|mesh-ancestor
1807822|NCT04829903|Liraglutide|liraglutide|mesh-list
1807823|NCT04829903|Dulaglutide|dulaglutide|mesh-list
1807824|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1807825|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807826|NCT04829903|Incretins|incretins|mesh-ancestor
1807827|NCT04829903|Hormones|hormones|mesh-ancestor
1807828|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807829|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1807830|NCT04829773|Midazolam|midazolam|mesh-list
1807831|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1807832|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1807833|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807834|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807835|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1807836|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1807837|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1807838|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1807839|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
1807840|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
1807841|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
1807842|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
1807843|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807844|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807845|NCT04829760|Psyllium|psyllium|mesh-list
1807846|NCT04829760|Cathartics|cathartics|mesh-ancestor
1807847|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807848|NCT04829695|Artesunate|artesunate|mesh-list
1807849|NCT04829695|Lumefantrine|lumefantrine|mesh-list
1807850|NCT04829695|Artemether|artemether|mesh-list
1807851|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1807852|NCT04829695|Amodiaquine|amodiaquine|mesh-list
1807853|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
1807854|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1807855|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1807856|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807857|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807858|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
1807859|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
1807860|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1807861|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
1807862|NCT04829435|Rasburicase|rasburicase|mesh-list
1807863|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
1807864|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1807865|NCT04829422|Lazertinib|lazertinib|mesh-list
1807866|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1807867|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807868|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807869|NCT04829487|Vitamin D|vitamin d|mesh-list
1807870|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
1807871|NCT04829487|Vitamins|vitamins|mesh-ancestor
1807872|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
1807873|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807874|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1807875|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1807876|NCT04829344|Carticaine|carticaine|mesh-list
1807877|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
1807878|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
1807879|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807880|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807881|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
1807882|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807883|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
1807884|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1807885|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1807886|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807887|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
1807888|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807889|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807890|NCT04829097|Temozolomide|temozolomide|mesh-list
1807891|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1807892|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
1807893|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807894|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807895|NCT04829019|Osimertinib|osimertinib|mesh-list
1807896|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807897|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1807898|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807899|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807900|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
1807901|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1807902|NCT04828824|Norgestimate|norgestimate|mesh-list
1807903|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1807904|NCT04828824|Estradiol|estradiol|mesh-list
1807905|NCT04828824|Estrogens|estrogens|mesh-ancestor
1807906|NCT04828824|Hormones|hormones|mesh-ancestor
1807907|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807908|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807909|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1807910|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
1807911|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1807912|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1807913|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1807914|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1807915|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1807916|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1807917|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807918|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1807919|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1807920|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1807921|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807922|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807923|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1807924|NCT04828525|Dexamethasone|dexamethasone|mesh-list
1807925|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1807926|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
1807927|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
1807928|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807929|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807930|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1807931|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
1807932|NCT04828525|Hormones|hormones|mesh-ancestor
1807933|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1807934|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1807935|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1807936|NCT04828642|Vitamins|vitamins|mesh-list
1807937|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
1807938|NCT04828642|Vitamin E|vitamin e|mesh-list
1807939|NCT04828642|Tocopherols|tocopherols|mesh-list
1807940|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
1807941|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807942|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
1807943|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807944|NCT04828642|Protective Agents|protective agents|mesh-ancestor
1807945|NCT04828694|Naltrexone|naltrexone|mesh-list
1807946|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1807947|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1807948|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807949|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
1807950|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807951|NCT04828564|Ribavirin|ribavirin|mesh-list
1807952|NCT04828564|Favipiravir|favipiravir|mesh-list
1807954|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807955|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
1807956|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1807957|NCT04828135|Xenon|xenon|mesh-list
1807958|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1807959|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
1807960|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
1807961|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807962|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807963|NCT04828031|Vitamin D|vitamin d|mesh-list
1807964|NCT04828031|Vitamins|vitamins|mesh-ancestor
1807965|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
1807966|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807967|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1807968|NCT04828083|Lidocaine|lidocaine|mesh-list
1807969|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
1807970|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
1807971|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1807972|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807973|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
1807974|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807975|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1807976|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1807977|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1807978|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1807979|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807980|NCT04828057|Timolol|timolol|mesh-list
1807981|NCT04828057|Bimatoprost|bimatoprost|mesh-list
1807982|NCT04828057|Travoprost|travoprost|mesh-list
1807983|NCT04828057|Latanoprost|latanoprost|mesh-list
1807984|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1807985|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1807986|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
1807987|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1807988|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1807989|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807990|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1807991|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1807992|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1807993|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1807994|NCT04828226|Clonidine|clonidine|mesh-list
1807995|NCT04828226|Analgesics|analgesics|mesh-ancestor
1807996|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
1807997|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1807998|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1807999|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1808000|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
1808001|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
1808002|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1808003|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1808004|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1808005|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
1808006|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808007|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808008|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
1808009|NCT04827966|Listerine|listerine|mesh-list
1808010|NCT04827966|Calcium|calcium|mesh-list
1808011|NCT04827966|Fluorides|fluorides|mesh-list
1808012|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
1808013|NCT04827966|Caseins|caseins|mesh-list
1808014|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1808015|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808016|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1808017|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
1808018|NCT04827966|Protective Agents|protective agents|mesh-ancestor
1808019|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1808020|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808021|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
1808022|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
1808023|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808024|NCT04828395|Paclitaxel|paclitaxel|mesh-list
1808025|NCT04828395|Etoposide|etoposide|mesh-list
1808026|NCT04828395|Cisplatin|cisplatin|mesh-list
1808027|NCT04828395|Carboplatin|carboplatin|mesh-list
1808028|NCT04828395|Pemetrexed|pemetrexed|mesh-list
1808029|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1808030|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808031|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
1808032|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
1808033|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
1808034|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808035|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1808036|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1808037|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808038|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1808039|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1808040|NCT04827745|Blinatumomab|blinatumomab|mesh-list
1808041|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808042|NCT04827784|Anesthetics|anesthetics|mesh-list
1808043|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
1808044|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808045|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808046|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
1808047|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808056|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
1808057|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1808058|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808059|NCT04827537|Metronidazole|metronidazole|mesh-list
1808060|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808061|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1808062|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1808063|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1808064|NCT04827446|Methamphetamine|methamphetamine|mesh-list
1808065|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1808066|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808067|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
1808068|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
1808069|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808070|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
1808071|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808072|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808073|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
1808074|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1808075|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1808076|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1808077|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1808078|NCT04827134|Triumeq|triumeq|mesh-list
1808079|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1808080|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1808081|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
1808082|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808083|NCT04827147|Methamphetamine|methamphetamine|mesh-list
1808084|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1808085|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808086|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
1808087|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
1808088|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808089|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
1808090|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808091|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808092|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
1808093|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1808094|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1808095|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1808096|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1808097|NCT04826822|Dexamethasone|dexamethasone|mesh-list
1808098|NCT04826822|Spironolactone|spironolactone|mesh-list
1808099|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1808100|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
1808101|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
1808102|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808103|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808104|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1808105|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
1808106|NCT04826822|Hormones|hormones|mesh-ancestor
1808107|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1808108|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1808109|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808110|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1808111|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
1808112|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1808113|NCT04826822|Diuretics|diuretics|mesh-ancestor
1808114|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
1808115|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1808116|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1808117|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808118|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808119|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1808120|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1808121|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808122|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
1808123|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808124|NCT04826679|Paclitaxel|paclitaxel|mesh-list
1808125|NCT04826679|Cisplatin|cisplatin|mesh-list
1808126|NCT04826679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1808127|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1808128|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808129|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
1808130|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
1808131|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
1808132|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808133|NCT04826692|Metformin|metformin|mesh-list
1808134|NCT04826692|Biguanides|biguanides|mesh-list
1808135|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
1808136|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808137|NCT04826198|Olaparib|olaparib|mesh-list
1808138|NCT04826198|Niraparib|niraparib|mesh-list
1808139|NCT04826198|Rucaparib|rucaparib|mesh-list
1808140|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1808141|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808142|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808143|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808144|NCT04826562|Lamivudine|lamivudine|mesh-list
1808145|NCT04826562|Dolutegravir|dolutegravir|mesh-list
1808146|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1808147|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1808148|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808149|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808150|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
1808151|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808152|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1808153|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1808154|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1808155|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1808156|NCT04826237|Dexamethasone|dexamethasone|mesh-list
1808157|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
1808158|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1808159|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1808160|NCT04826237|Prednisolone|prednisolone|mesh-list
1808161|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
1808162|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1808163|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1808164|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
1808165|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1808166|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
1808167|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
1808168|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808169|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808170|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1808171|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
1808172|NCT04826237|Hormones|hormones|mesh-ancestor
1808173|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1808174|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1808175|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808176|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1808177|NCT04826237|Protective Agents|protective agents|mesh-ancestor
1808178|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1808179|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1808180|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
1808256|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1808181|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808182|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808183|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1808184|NCT04826406|Apatinib|apatinib|mesh-list
1808185|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808186|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1808187|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808188|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808213|NCT04826432|Pasireotide|pasireotide|mesh-list
1808214|NCT04826432|Hormones|hormones|mesh-ancestor
1808215|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1808216|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808217|NCT04826497|Nicorandil|nicorandil|mesh-list
1808218|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1808219|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1808220|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
1808221|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
1808222|NCT04826497|Vitamins|vitamins|mesh-ancestor
1808223|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
1808224|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808225|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
1808226|NCT04826510|Perospirone|perospirone|mesh-list
1808227|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
1808228|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1808229|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808230|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808231|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
1808232|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1808233|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808234|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808235|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1808236|NCT04825938|Paclitaxel|paclitaxel|mesh-list
1808237|NCT04825938|Carboplatin|carboplatin|mesh-list
1808238|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1808239|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808240|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
1808241|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
1808242|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
1808243|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808244|NCT04826016|Paclitaxel|paclitaxel|mesh-list
1808245|NCT04826016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1808246|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1808247|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808248|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
1808249|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
1808250|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
1808251|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808252|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
1808253|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
1808254|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808255|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808257|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808258|NCT04826133|Calcitriol|calcitriol|mesh-list
1808259|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
1808260|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1808261|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808262|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1808263|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1808264|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808265|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1808266|NCT04826133|Vitamins|vitamins|mesh-ancestor
1808267|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
1808268|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1808269|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
1808270|NCT04825990|Olaparib|olaparib|mesh-list
1808271|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1808272|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808273|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1808274|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808275|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808279|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
1808280|NCT04825496|Fludarabine|fludarabine|mesh-list
1808281|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1808282|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
1808283|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808284|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1808285|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1808286|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
1808287|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808288|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808289|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1808290|NCT04825522|Vancomycin|vancomycin|mesh-list
1808291|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1808292|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808303|NCT04824924|Venetoclax|venetoclax|mesh-list
1808304|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808305|NCT04825093|Vitamin D|vitamin d|mesh-list
1808306|NCT04825093|Vitamins|vitamins|mesh-ancestor
1808307|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
1808308|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808309|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1808310|NCT04824638|Vaccines|vaccines|mesh-list
1808311|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
1808312|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808313|NCT04824586|Insulin|insulin|mesh-list
1808314|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1808315|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1808316|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808317|NCT04824599|Ropivacaine|ropivacaine|mesh-list
1808318|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
1808319|NCT04824599|Anesthetics|anesthetics|mesh-list
1808320|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808321|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808322|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
1808323|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808324|NCT04824898|Simvastatin|simvastatin|mesh-list
1808325|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1808326|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1808327|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
1808328|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808329|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1808330|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1808331|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808332|NCT04824937|Talazoparib|talazoparib|mesh-list
1808333|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1808334|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808335|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808336|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808337|NCT04824612|Triamcinolone|triamcinolone|mesh-list
1808338|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1808339|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1808340|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1808341|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1808342|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
1808343|NCT04824612|Hormones|hormones|mesh-ancestor
1808344|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1808345|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808346|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1808347|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
1808348|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808349|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808350|NCT04824911|Aspirin|aspirin|mesh-list
1808351|NCT04824911|Clopidogrel|clopidogrel|mesh-list
1808352|NCT04824911|Atorvastatin|atorvastatin|mesh-list
1808353|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1808354|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1808355|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1808356|NCT04824911|Analgesics|analgesics|mesh-ancestor
1808357|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
1808358|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808359|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808360|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1808361|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1808362|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1808363|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1808364|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808365|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1808366|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1808367|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808368|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
1808369|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1808370|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1808371|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
1808372|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1808373|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1808374|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1808375|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1808376|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1808377|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
1808378|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808379|NCT04824352|Apatinib|apatinib|mesh-list
1808380|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808381|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1808382|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808383|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808384|NCT04824404|Buprenorphine|buprenorphine|mesh-list
1808385|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1808386|NCT04824404|Narcotics|narcotics|mesh-ancestor
1808387|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808388|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808389|NCT04824404|Analgesics|analgesics|mesh-ancestor
1808390|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
1808391|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808392|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1808393|NCT04824261|Clotrimazole|clotrimazole|mesh-list
1808394|NCT04824261|Miconazole|miconazole|mesh-list
1808395|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1808396|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808397|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
1808398|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1808399|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1808400|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808401|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808402|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1808403|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
1808404|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1808405|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808406|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1808407|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1808408|NCT04824391|Vaccines|vaccines|mesh-list
1808409|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
1808410|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808411|NCT04823962|Molgramostim|molgramostim|mesh-list
1808412|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808446|NCT04824053|Selenium|selenium|mesh-list
1808447|NCT04824053|Caseins|caseins|mesh-list
1808448|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
1808449|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808450|NCT04824053|Protective Agents|protective agents|mesh-ancestor
1808451|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808452|NCT04824053|Trace Elements|trace elements|mesh-ancestor
1808453|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
1808454|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
1808455|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
1808456|NCT04823845|Adapalene|adapalene|mesh-list
1808457|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1808458|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1808459|NCT04823845|Analgesics|analgesics|mesh-ancestor
1808460|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
1808461|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808462|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808463|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1808464|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1808465|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
1808466|NCT04824274|Fentanyl|fentanyl|mesh-list
1808467|NCT04824274|Morphine|morphine|mesh-list
1808468|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1808469|NCT04824274|Narcotics|narcotics|mesh-ancestor
1808470|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808471|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808472|NCT04824274|Analgesics|analgesics|mesh-ancestor
1808473|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
1808474|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808475|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1808476|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1808477|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
1808478|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
1808479|NCT04823390|Fentanyl|fentanyl|mesh-list
1808480|NCT04823390|Midazolam|midazolam|mesh-list
1808481|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1808482|NCT04823390|Narcotics|narcotics|mesh-ancestor
1808483|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808484|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808485|NCT04823390|Analgesics|analgesics|mesh-ancestor
1808486|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
1808487|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808488|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1808489|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1808490|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
1808491|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
1808492|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1808493|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1808494|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1808495|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1808496|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
1808497|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
1808498|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808499|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808500|NCT04823442|Bisoprolol|bisoprolol|mesh-list
1808501|NCT04823442|Mirabegron|mirabegron|mesh-list
1808502|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
1808503|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1808504|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1808505|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
1808506|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808507|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808508|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808509|NCT04823442|Urological Agents|urological agents|mesh-ancestor
1808510|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1808511|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
1808512|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
1808513|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808514|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1808515|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1808516|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1808517|NCT04823468|Cisplatin|cisplatin|mesh-list
1808518|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808519|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
1808520|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808521|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808522|NCT04823403|Nivolumab|nivolumab|mesh-list
1808523|NCT04823403|Ipilimumab|ipilimumab|mesh-list
1808524|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1808525|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808526|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1808527|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808528|NCT04823156|Calcium|calcium|mesh-list
1808529|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1808530|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808538|NCT04823260|Niacinamide|niacinamide|mesh-list
1808539|NCT04823260|Niacin|niacin|mesh-list
1808540|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
1808541|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
1808542|NCT04823260|Vitamins|vitamins|mesh-ancestor
1808543|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
1808544|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808545|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1808546|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
1808547|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808548|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1808549|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
1808550|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
1808551|NCT04823091|Fludarabine|fludarabine|mesh-list
1808552|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1808553|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
1808554|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808555|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1808556|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1808557|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
1808633|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1808558|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808559|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808560|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1808561|NCT04822909|Thalidomide|thalidomide|mesh-list
1808562|NCT04822909|Apremilast|apremilast|mesh-list
1808563|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1808564|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1808565|NCT04822909|Analgesics|analgesics|mesh-ancestor
1808566|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
1808567|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808568|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808569|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1808570|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1808571|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1808572|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1808573|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808574|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808575|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1808576|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
1808577|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
1808578|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1808579|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808580|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1808581|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1808582|NCT04822909|Growth Substances|growth substances|mesh-ancestor
1808583|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
1808584|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808585|NCT04823065|Scopolamine|scopolamine|mesh-list
1808586|NCT04823065|Loperamide|loperamide|mesh-list
1808587|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
1808588|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
1808589|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1808590|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1808591|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
1808592|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
1808593|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808594|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808595|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
1808596|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1808597|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
1808598|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808599|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808600|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1808601|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
1808602|NCT04822467|Ethanol|ethanol|mesh-list
1808603|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1808604|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808605|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808606|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808607|NCT04822649|Adenosine|adenosine|mesh-list
1808608|NCT04822649|Analgesics|analgesics|mesh-ancestor
1808609|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
1808610|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808611|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808612|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1808613|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
1808614|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1808615|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
1808616|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
1808617|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808618|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808619|NCT04822415|Mepivacaine|mepivacaine|mesh-list
1808620|NCT04822415|Carticaine|carticaine|mesh-list
1808621|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
1808622|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
1808623|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808624|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808625|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
1808626|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808627|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
1808628|NCT04822064|Ketamine|ketamine|mesh-list
1808629|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
1808630|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1808631|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808632|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808634|NCT04822064|Analgesics|analgesics|mesh-ancestor
1808635|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
1808636|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808637|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1808638|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1808639|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1808640|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
1808641|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808642|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808643|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1808644|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1808645|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
1808646|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
1808647|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1808648|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1808649|NCT04822012|Antibodies|antibodies|mesh-list
1808650|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
1808651|NCT04822012|Progesterone|progesterone|mesh-list
1808652|NCT04822012|Estrogens|estrogens|mesh-list
1808653|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
1808654|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808655|NCT04822012|Progestins|progestins|mesh-ancestor
1808656|NCT04822012|Hormones|hormones|mesh-ancestor
1808657|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1808658|NCT04822363|Aspirin|aspirin|mesh-list
1808659|NCT04822363|Clopidogrel|clopidogrel|mesh-list
1808660|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1808661|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1808662|NCT04822363|Analgesics|analgesics|mesh-ancestor
1808663|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
1808664|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808665|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808666|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1808667|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1808668|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1808669|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1808670|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808671|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1808672|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1808673|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808674|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
1808675|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1808676|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1808677|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1808678|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
1808679|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808680|NCT04822038|Vitamin D|vitamin d|mesh-list
1808681|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
1808682|NCT04822038|Vitamins|vitamins|mesh-ancestor
1808683|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
1808684|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808685|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1808686|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1808702|NCT04821856|Cannabidiol|cannabidiol|mesh-list
1808703|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
1808704|NCT04821947|Bupivacaine|bupivacaine|mesh-list
1808705|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
1808706|NCT04821947|Anesthetics|anesthetics|mesh-list
1808707|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808708|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808785|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1808709|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
1808710|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808711|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
1808712|NCT04822090|Antibodies|antibodies|mesh-list
1808713|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
1808714|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1808715|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1808716|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
1808717|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808721|NCT04821843|Paclitaxel|paclitaxel|mesh-list
1808722|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
1808723|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1808724|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808725|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
1808726|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
1808727|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
1808728|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808729|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1808744|NCT04821817|Rocuronium|rocuronium|mesh-list
1808745|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1808746|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1808747|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1808748|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808749|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808750|NCT04821778|Paclitaxel|paclitaxel|mesh-list
1808751|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
1808752|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1808753|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808754|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
1808755|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
1808756|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
1808757|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808758|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1808759|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
1808760|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1808761|NCT04821765|Paclitaxel|paclitaxel|mesh-list
1808762|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1808763|NCT04821765|Antibodies|antibodies|mesh-list
1808764|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1808765|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808766|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
1808767|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
1808768|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
1808769|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808770|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
1808771|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808772|NCT04821323|Indomethacin|indomethacin|mesh-list
1808773|NCT04821323|Mannitol|mannitol|mesh-list
1808774|NCT04821323|Lactulose|lactulose|mesh-list
1808775|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1808776|NCT04821323|Diuretics|diuretics|mesh-ancestor
1808777|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
1808778|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808779|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1808780|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1808781|NCT04821323|Analgesics|analgesics|mesh-ancestor
1808782|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
1808783|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808784|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1808786|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
1808787|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
1808788|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1808789|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1808790|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808791|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808792|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1808793|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
1808794|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1808795|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
1808796|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808797|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
1808798|NCT04821804|Protective Agents|protective agents|mesh-ancestor
1808799|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
1808800|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808801|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808802|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
1808803|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808804|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808835|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
1808836|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1808837|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
1808838|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1808839|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808840|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1808841|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1808842|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808843|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808844|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808845|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1808846|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
1808847|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1808848|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808849|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1808850|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1808851|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1808852|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1808853|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
1808854|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
1808855|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1808856|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808857|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808858|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
1808859|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1808860|NCT04821193|Disinfectants|disinfectants|mesh-list
1808861|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1808862|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1808863|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808864|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
1808865|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
1808866|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
1808867|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
1808868|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
1808869|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1808870|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1808871|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
1808872|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
1808873|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808874|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808875|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808876|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1808877|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
1808878|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1808879|NCT04820933|Tenofovir|tenofovir|mesh-list
1808880|NCT04820933|Emtricitabine|emtricitabine|mesh-list
1808881|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
1808882|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808883|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1808884|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1808885|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808886|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808887|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1808888|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1808889|NCT04820673|Sarecycline|sarecycline|mesh-list
1808890|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1808891|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808892|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
1808893|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
1808894|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1808895|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808896|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
1808897|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
1808898|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808899|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808902|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
1808903|NCT04820205|Ketamine|ketamine|mesh-list
1808904|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
1808905|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1808906|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808907|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808908|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1808909|NCT04820205|Analgesics|analgesics|mesh-ancestor
1808910|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
1808911|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808912|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1808913|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1808914|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1808915|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
1808916|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808917|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808918|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1808919|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1808920|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
1808921|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
1808922|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1808923|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1808924|NCT04820439|Pertuzumab|pertuzumab|mesh-list
1808925|NCT04820439|Antibodies|antibodies|mesh-list
1808926|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1808927|NCT04820439|Mitogens|mitogens|mesh-list
1808928|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
1808929|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808930|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
1808931|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808932|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1808933|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808934|NCT04820452|Aflibercept|aflibercept|mesh-list
1808935|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1808936|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1808937|NCT04820452|Growth Substances|growth substances|mesh-ancestor
1808938|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808939|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
1808940|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808941|NCT04820023|Cetuximab|cetuximab|mesh-list
1808942|NCT04820023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1808943|NCT04820023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808944|NCT04820036|Insulin|insulin|mesh-list
1808945|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1808946|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808947|NCT04819971|Docetaxel|docetaxel|mesh-list
1808948|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
1808949|NCT04819971|Trastuzumab|trastuzumab|mesh-list
1808950|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808951|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
1808952|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
1808953|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
1808954|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808955|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1808956|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
1808957|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1808958|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808959|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1808960|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1808961|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1808962|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808963|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1808964|NCT04820010|Insulin|insulin|mesh-list
1808965|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1808966|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808967|NCT04819776|Iloperidone|iloperidone|mesh-list
1808968|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1808969|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1808970|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808971|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808972|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1808973|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
1808974|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1808975|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808976|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808977|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1808978|NCT04820101|Analgesics|analgesics|mesh-ancestor
1808979|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
1808980|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808981|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1808982|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1808983|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1808984|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
1808985|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1808986|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1808987|NCT04819867|Propolis|propolis|mesh-list
1808988|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1808989|NCT04819503|Anesthetics|anesthetics|mesh-list
1808990|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1808991|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808992|NCT04819399|Catumaxomab|catumaxomab|mesh-list
1808993|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1808994|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
1808995|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1808996|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1808997|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1808998|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1808999|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1809000|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1809001|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809002|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
1809003|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809004|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1809005|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1809006|NCT04819360|Urological Agents|urological agents|mesh-ancestor
1809007|NCT04819438|Riluzole|riluzole|mesh-list
1809008|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
1809009|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1809010|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1809011|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809012|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809013|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809014|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1809015|NCT04819438|Protective Agents|protective agents|mesh-ancestor
1809016|NCT04819828|Diclofenac|diclofenac|mesh-list
1809017|NCT04819828|Tamsulosin|tamsulosin|mesh-list
1809018|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1809019|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1809020|NCT04819828|Analgesics|analgesics|mesh-ancestor
1809021|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
1809022|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809023|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809024|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1809025|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1809026|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1809027|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809028|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809029|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1809030|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1809031|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1809032|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
1809033|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809034|NCT04819828|Urological Agents|urological agents|mesh-ancestor
1809035|NCT04818931|Cefazolin|cefazolin|mesh-list
1809036|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1809037|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1809043|NCT04818957|Vitamin D|vitamin d|mesh-list
1809044|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
1809045|NCT04818957|Vitamins|vitamins|mesh-ancestor
1809046|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
1809047|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809048|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1809049|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1809050|NCT04819204|Cetrorelix|cetrorelix|mesh-list
1809051|NCT04819204|Testosterone|testosterone|mesh-list
1809052|NCT04819204|Androgens|androgens|mesh-ancestor
1809053|NCT04819204|Hormones|hormones|mesh-ancestor
1809054|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1809055|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809056|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1809057|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
1809058|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1809059|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
1809060|NCT04819217|Charcoal|charcoal|mesh-list
1809061|NCT04819217|Antidotes|antidotes|mesh-ancestor
1809062|NCT04819217|Protective Agents|protective agents|mesh-ancestor
1809063|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809064|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1809065|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1809066|NCT04819243|Atezolizumab|atezolizumab|mesh-list
1809067|NCT04819243|Talazoparib|talazoparib|mesh-list
1809068|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809069|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1809070|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809071|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809072|NCT04818723|Montelukast|montelukast|mesh-list
1809073|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1809074|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
1809075|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1809076|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
1809077|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1809078|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809079|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1809080|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1809081|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809082|NCT04818736|Vaccines|vaccines|mesh-list
1809083|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
1809084|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809094|NCT04818450|Gabapentin|gabapentin|mesh-list
1809095|NCT04818450|Analgesics|analgesics|mesh-ancestor
1809096|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
1809097|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809098|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809099|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
1809100|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1809101|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1809102|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809103|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1809104|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1809105|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1809106|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809107|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809108|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
1809109|NCT04818749|Dexamethasone|dexamethasone|mesh-list
1809110|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
1809111|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
1809112|NCT04818749|BB 1101|bb 1101|mesh-list
1809113|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1809114|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
1809115|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
1809116|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809117|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809118|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1809119|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
1809120|NCT04818749|Hormones|hormones|mesh-ancestor
1809121|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1809122|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1809123|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809124|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
1809125|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809126|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809127|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1809128|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809129|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1809130|NCT04818749|Analgesics|analgesics|mesh-ancestor
1809131|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
1809132|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1809133|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1809134|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1809135|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
1809136|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809154|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
1809155|NCT04818177|Antibodies|antibodies|mesh-list
1809156|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
1809157|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1809158|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1809159|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
1809160|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809174|NCT04818216|Niacinamide|niacinamide|mesh-list
1809175|NCT04818216|Niacin|niacin|mesh-list
1809176|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
1809177|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
1809178|NCT04818216|Vitamins|vitamins|mesh-ancestor
1809179|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
1809180|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809181|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1809182|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
1809183|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809184|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1809185|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
1809186|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
1809187|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1809188|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809189|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1809190|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809191|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1809192|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1809193|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1809194|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
1809195|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809196|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1809197|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1809198|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809199|NCT04817826|Durvalumab|durvalumab|mesh-list
1809200|NCT04817826|Tremelimumab|tremelimumab|mesh-list
1809201|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1809202|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809203|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1809204|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1809205|NCT04817982|Dexamethasone|dexamethasone|mesh-list
1809206|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
1809207|NCT04817982|Lidocaine|lidocaine|mesh-list
1809208|NCT04817982|BB 1101|bb 1101|mesh-list
1809209|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1809210|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
1809211|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
1809212|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809213|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809214|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1809215|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
1809216|NCT04817982|Hormones|hormones|mesh-ancestor
1809217|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1809218|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1809219|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809220|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
1809221|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809222|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809223|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
1809224|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
1809225|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809226|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
1809227|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1809228|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1809229|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1809230|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1809231|NCT04818099|Vortioxetine|vortioxetine|mesh-list
1809232|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
1809233|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1809234|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1809235|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1809236|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809237|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809238|NCT04818099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1809239|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1809240|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1809241|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809242|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809243|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
1809244|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1809245|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1809246|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1809247|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1809248|NCT04817969|Cimetidine|cimetidine|mesh-list
1809249|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1809250|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1809251|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1809252|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
1809253|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
1809254|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809255|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809256|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809257|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1809258|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1809259|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809260|NCT04818151|Warfarin|warfarin|mesh-list
1809261|NCT04818151|Apixaban|apixaban|mesh-list
1809262|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
1809263|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1809264|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
1809265|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1809266|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
1809267|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809268|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809269|NCT04817800|Azelastine|azelastine|mesh-list
1809270|NCT04817800|Beclomethasone|beclomethasone|mesh-list
1809271|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1809272|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
1809273|NCT04817800|Hormones|hormones|mesh-ancestor
1809274|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1809275|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809276|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1809277|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
1809278|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1809279|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
1809280|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809281|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1809282|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809283|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809284|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1809285|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1809286|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1809287|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
1809288|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
1809289|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809290|NCT04817527|Edaravone|edaravone|mesh-list
1809291|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1809292|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
1809293|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809294|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1809295|NCT04817527|Protective Agents|protective agents|mesh-ancestor
1809296|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809297|NCT04817501|Edetic Acid|edetic acid|mesh-list
1809298|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
1809299|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1809300|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
1809301|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
1809302|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809303|NCT04817410|Naltrexone|naltrexone|mesh-list
1809304|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1809305|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1809306|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809307|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
1809308|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809309|NCT04817189|Dexamethasone|dexamethasone|mesh-list
1809310|NCT04817189|Ondansetron|ondansetron|mesh-list
1809311|NCT04817189|Palonosetron|palonosetron|mesh-list
1809312|NCT04817189|Granisetron|granisetron|mesh-list
1809313|NCT04817189|Tropisetron|tropisetron|mesh-list
1809314|NCT04817189|Dolasetron|dolasetron|mesh-list
1809315|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1809316|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
1809317|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
1809318|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809319|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809320|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1809321|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
1809322|NCT04817189|Hormones|hormones|mesh-ancestor
1809323|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1809324|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1809325|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809326|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
1809327|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
1809328|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1809329|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
1809330|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809331|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809332|NCT04817189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1809333|NCT04817189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1809334|NCT04817189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809335|NCT04817189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1809336|NCT04817189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1809337|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1809338|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1809339|NCT04817202|Antibodies|antibodies|mesh-list
1809340|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
1809341|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1809342|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
1809343|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809344|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809345|NCT04816968|Vancomycin|vancomycin|mesh-list
1809346|NCT04816968|Meropenem|meropenem|mesh-list
1809347|NCT04816968|Tazobactam|tazobactam|mesh-list
1809348|NCT04816968|Piperacillin|piperacillin|mesh-list
1809349|NCT04816968|Cefepime|cefepime|mesh-list
1809350|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
1809351|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1809352|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1809353|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1809354|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809355|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809356|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
1809357|NCT04816877|Narcotics|narcotics|mesh-ancestor
1809358|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809359|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809360|NCT04816877|Analgesics|analgesics|mesh-ancestor
1809361|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
1809362|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809363|NCT04816838|Osimertinib|osimertinib|mesh-list
1809364|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809365|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1809366|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809367|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809368|NCT04817033|Midazolam|midazolam|mesh-list
1809369|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
1809370|NCT04817033|Anesthetics|anesthetics|mesh-list
1809371|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809372|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809373|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1809374|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1809375|NCT04817033|Analgesics|analgesics|mesh-ancestor
1809376|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
1809377|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809378|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1809379|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1809380|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1809381|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
1809382|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809383|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809384|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1809385|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1809386|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1809387|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1809388|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1809389|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
1809390|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
1809391|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
1809392|NCT04816682|Silymarin|silymarin|mesh-list
1809393|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
1809394|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809395|NCT04816682|Protective Agents|protective agents|mesh-ancestor
1809396|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809397|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
1809398|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1809399|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809400|NCT04816344|Anesthetics|anesthetics|mesh-list
1809401|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809402|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809403|NCT04816461|Piperaquine|piperaquine|mesh-list
1809404|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
1809405|NCT04816461|Amodiaquine|amodiaquine|mesh-list
1809406|NCT04816461|Artenimol|artenimol|mesh-list
1809407|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
1809408|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1809409|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1809410|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1809411|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1809412|NCT04816461|Renal Agents|renal agents|mesh-ancestor
1809413|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
1809414|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1809415|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1809416|NCT04816253|Prednisolone|prednisolone|mesh-list
1809417|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
1809418|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1809419|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
1809420|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
1809421|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1809422|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
1809423|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
1809424|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809425|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809426|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1809427|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
1809428|NCT04816253|Hormones|hormones|mesh-ancestor
1809429|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1809430|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1809431|NCT04816253|Protective Agents|protective agents|mesh-ancestor
1809432|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1809433|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809434|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1809435|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
1809436|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
1809437|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
1809438|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
1809439|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1809440|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1809441|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1809442|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1809443|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809444|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
1809445|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809446|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809447|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1809448|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809449|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1809450|NCT04816097|Dexamethasone|dexamethasone|mesh-list
1809451|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1809452|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1809453|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
1809454|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
1809455|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809456|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809457|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1809458|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
1809459|NCT04816097|Hormones|hormones|mesh-ancestor
1809460|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1809461|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1809462|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809463|NCT04816240|Midodrine|midodrine|mesh-list
1809464|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
1809465|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
1809466|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809467|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809468|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1809469|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1809470|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1809471|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1809472|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
1809473|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809474|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809497|NCT04815590|Buprenorphine|buprenorphine|mesh-list
1809498|NCT04815590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1809499|NCT04815590|Narcotics|narcotics|mesh-ancestor
1809500|NCT04815590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809501|NCT04815590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809502|NCT04815590|Analgesics|analgesics|mesh-ancestor
1809503|NCT04815590|Sensory System Agents|sensory system agents|mesh-ancestor
1809504|NCT04815590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809505|NCT04815590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1809506|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
1809507|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1809508|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809509|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809510|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1809511|NCT04815265|Analgesics|analgesics|mesh-ancestor
1809512|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
1809513|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809514|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1809515|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1809516|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1809517|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
1809518|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809519|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809520|NCT04815408|Paclitaxel|paclitaxel|mesh-list
1809521|NCT04815408|Carboplatin|carboplatin|mesh-list
1809522|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1809523|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1809524|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809525|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
1809526|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
1809527|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
1809528|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809529|NCT04815395|Oxytocin|oxytocin|mesh-list
1809530|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
1809531|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1809532|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809533|NCT04815187|Montelukast|montelukast|mesh-list
1809534|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1809535|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
1809536|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1809537|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
1809538|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1809539|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809540|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1809844|NCT04812860|Tramadol|tramadol|mesh-list
1809541|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1809542|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809543|NCT04814927|Copper|copper|mesh-list
1809544|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1809545|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
1809546|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
1809547|NCT04814927|Etonogestrel|etonogestrel|mesh-list
1809548|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1809549|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
1809550|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1809551|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809552|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1809553|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1809554|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1809555|NCT04814927|Trace Elements|trace elements|mesh-ancestor
1809556|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
1809557|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1809558|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1809559|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1809560|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809561|NCT04815200|Copper|copper|mesh-list
1809562|NCT04815200|Nickel|nickel|mesh-list
1809563|NCT04815200|Trace Elements|trace elements|mesh-ancestor
1809564|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
1809565|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809566|NCT04814875|Carboplatin|carboplatin|mesh-list
1809567|NCT04814875|Doxorubicin|doxorubicin|mesh-list
1809568|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1809569|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809570|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1809571|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1809572|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1809573|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809574|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809575|NCT04814537|Bupivacaine|bupivacaine|mesh-list
1809576|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
1809577|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
1809578|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809579|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809580|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
1809581|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809582|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
1809583|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
1809584|NCT04814615|Daratumumab|daratumumab|mesh-list
1809585|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809586|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1809587|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1809588|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
1809602|NCT04814433|Lidocaine|lidocaine|mesh-list
1809603|NCT04814433|Epinephrine|epinephrine|mesh-list
1809604|NCT04814433|Racepinephrine|racepinephrine|mesh-list
1809605|NCT04814433|Bupivacaine|bupivacaine|mesh-list
1809606|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
1809607|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
1809608|NCT04814433|Thrombin|thrombin|mesh-list
1809609|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
1809610|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
1809611|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
1809612|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809613|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809614|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
1809615|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809616|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1809617|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1809618|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1809619|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1809620|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809621|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1809622|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1809623|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
1809624|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809625|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1809626|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1809627|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
1809628|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1809629|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
1809630|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
1809631|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
1809632|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1809633|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1809634|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1809635|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
1809636|NCT04814433|Coagulants|coagulants|mesh-ancestor
1809637|NCT04814602|Proglumide|proglumide|mesh-list
1809638|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1809639|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1809640|NCT04814303|Morphine|morphine|mesh-list
1809641|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1809642|NCT04814303|Narcotics|narcotics|mesh-ancestor
1809643|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809644|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809645|NCT04814303|Analgesics|analgesics|mesh-ancestor
1809646|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
1809647|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809648|NCT04814511|Permethrin|permethrin|mesh-list
1809649|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809650|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809651|NCT04814485|Paclitaxel|paclitaxel|mesh-list
1809652|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1809653|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1809654|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809655|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
1809656|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
1809657|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
1809658|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809659|NCT04814043|Lenvatinib|lenvatinib|mesh-list
1809660|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1809661|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809662|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1809663|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809664|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809665|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1809666|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809667|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809668|NCT04814589|Ezetimibe|ezetimibe|mesh-list
1809669|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1809670|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1809671|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
1809672|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809673|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1809674|NCT04813913|Bevacizumab|bevacizumab|mesh-list
1809675|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1809676|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809677|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1809678|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1809679|NCT04813913|Growth Substances|growth substances|mesh-ancestor
1809680|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809681|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
1809682|NCT04813952|Sevoflurane|sevoflurane|mesh-list
1809683|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1809684|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1809685|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
1809686|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
1809687|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809688|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809692|NCT04814056|Afatinib|afatinib|mesh-list
1809693|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809694|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1809695|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809696|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809697|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
1809698|NCT04814381|Ketamine|ketamine|mesh-list
1809699|NCT04814381|Analgesics|analgesics|mesh-ancestor
1809700|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
1809701|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809702|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809703|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1809704|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1809705|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
1809706|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
1809707|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809708|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1809709|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1809710|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809711|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809712|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1809713|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
1809714|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1809715|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1809716|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1809717|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
1809718|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1809719|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
1809720|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1809721|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
1809722|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
1809723|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809724|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809725|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1809726|NCT04813874|Analgesics|analgesics|mesh-ancestor
1809727|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
1809728|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809729|NCT04813848|Fluorides|fluorides|mesh-list
1809730|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
1809731|NCT04813848|Protective Agents|protective agents|mesh-ancestor
1809732|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809733|NCT04813822|Miconazole|miconazole|mesh-list
1809734|NCT04813822|Clotrimazole|clotrimazole|mesh-list
1809735|NCT04813822|Bromides|bromides|mesh-list
1809736|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
1809737|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
1809738|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1809739|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1809740|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1809741|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809742|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809743|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1809744|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
1809745|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1809746|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809747|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1809748|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1809749|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1809750|NCT04813614|Lidocaine|lidocaine|mesh-list
1809751|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
1809752|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
1809753|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809754|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809755|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
1809756|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809757|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1809758|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1809759|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1809760|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1809761|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809762|NCT04813562|Vaccines|vaccines|mesh-list
1809763|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
1809764|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809765|NCT04813523|Cisplatin|cisplatin|mesh-list
1809766|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
1809767|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809768|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1809769|NCT04813471|Folic Acid|folic acid|mesh-list
1809770|NCT04813471|Nicorandil|nicorandil|mesh-list
1809771|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
1809772|NCT04813471|Atorvastatin|atorvastatin|mesh-list
1809773|NCT04813471|Vitamins|vitamins|mesh-ancestor
1809774|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
1809775|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809776|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1809777|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1809778|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
1809779|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809780|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1809781|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1809782|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809783|NCT04813471|Hematinics|hematinics|mesh-ancestor
1809784|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1809785|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1809786|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
1809787|NCT04813653|Cyclosporine|cyclosporine|mesh-list
1809788|NCT04813653|Dexamethasone|dexamethasone|mesh-list
1809789|NCT04813653|Cyclosporins|cyclosporins|mesh-list
1809790|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1809791|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
1809792|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
1809793|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809794|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809795|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1809796|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
1809797|NCT04813653|Hormones|hormones|mesh-ancestor
1809798|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1809799|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1809800|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809801|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809802|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809803|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1809804|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
1809805|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
1809806|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1809807|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
1809808|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1809809|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1809824|NCT04812912|Hormones|hormones|mesh-list
1809825|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1809826|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809827|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
1809828|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1809829|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1809830|NCT04812470|Melphalan|melphalan|mesh-list
1809831|NCT04812470|Interleukin-2|interleukin-2|mesh-list
1809832|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1809833|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
1809834|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809835|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809836|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1809837|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1809838|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
1809839|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809840|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1809841|NCT04812470|Analgesics|analgesics|mesh-ancestor
1809842|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
1809843|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809845|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1809846|NCT04812860|Narcotics|narcotics|mesh-ancestor
1809847|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809848|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809849|NCT04812860|Analgesics|analgesics|mesh-ancestor
1809850|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
1809851|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809852|NCT04812379|Aripiprazole|aripiprazole|mesh-list
1809853|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
1809854|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1809855|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1809856|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1809857|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809858|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809859|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
1809860|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
1809861|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1809862|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809863|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1809864|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1809865|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
1809866|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1809867|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1809868|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1809869|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1809870|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
1809871|NCT04812535|Vilobelimab|vilobelimab|mesh-list
1809872|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1809873|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809874|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1809875|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1809876|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
1809877|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809878|NCT04812509|Denosumab|denosumab|mesh-list
1809879|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1809880|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809881|NCT04812626|Triamcinolone|triamcinolone|mesh-list
1809882|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1809883|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1809884|NCT04812626|Fluorouracil|fluorouracil|mesh-list
1809885|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1809886|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
1809887|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809888|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1809889|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809890|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1809891|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
1809892|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809893|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1809894|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
1809895|NCT04812626|Hormones|hormones|mesh-ancestor
1809896|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1809897|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809908|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
1809909|NCT04812028|Analgesics|analgesics|mesh-ancestor
1809910|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
1809911|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809912|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809913|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
1809914|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809915|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1809916|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
1809917|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1809918|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1809919|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809920|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1809921|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
1809922|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1809923|NCT04811573|Thalidomide|thalidomide|mesh-list
1809924|NCT04811573|Apremilast|apremilast|mesh-list
1809925|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1809926|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1809927|NCT04811573|Analgesics|analgesics|mesh-ancestor
1809928|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
1809929|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809930|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809931|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1809932|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1809933|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1809934|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1809935|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809936|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809937|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1809938|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
1809939|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
1809940|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1809941|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1809942|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1809943|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1809944|NCT04811573|Growth Substances|growth substances|mesh-ancestor
1809945|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
1809946|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809947|NCT04811625|Aspirin|aspirin|mesh-list
1809948|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1809949|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1809950|NCT04811625|Analgesics|analgesics|mesh-ancestor
1809951|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
1809952|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809953|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809954|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1809955|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1809956|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1809957|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1809958|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809959|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1809960|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1809961|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809962|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
1809963|NCT04811911|Methotrexate|methotrexate|mesh-list
1809964|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1809965|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
1809966|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1809967|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809968|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1809969|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
1809970|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1809971|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1809972|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
1809973|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1809974|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1809975|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1809976|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
1809977|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1809978|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1809979|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
1809980|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
1809981|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1809982|NCT04811326|Latanoprost|latanoprost|mesh-list
1809983|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1809984|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1809985|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
1809986|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1809987|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1809988|NCT04811209|Analgesics|analgesics|mesh-list
1809989|NCT04811209|Anesthetics|anesthetics|mesh-list
1809990|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809991|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1809992|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
1809993|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1809994|NCT04811313|Bupivacaine|bupivacaine|mesh-list
1809995|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
1809996|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
1809997|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
1809998|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1809999|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810000|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
1810001|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810002|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1810003|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1810004|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810005|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
1810006|NCT04811313|Coagulants|coagulants|mesh-ancestor
1810007|NCT04811014|Buprenorphine|buprenorphine|mesh-list
1810008|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1810009|NCT04811014|Naloxone|naloxone|mesh-list
1810010|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1810011|NCT04811014|Narcotics|narcotics|mesh-ancestor
1810012|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810013|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810014|NCT04811014|Analgesics|analgesics|mesh-ancestor
1810015|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
1810016|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810017|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1810024|NCT04810949|Vitamin D|vitamin d|mesh-list
1810025|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
1810026|NCT04810949|Vitamins|vitamins|mesh-ancestor
1810027|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
1810028|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810029|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1810030|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1810031|NCT04811001|Osimertinib|osimertinib|mesh-list
1810032|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810033|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1810034|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810035|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810036|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
1810037|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1810038|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1810039|NCT04810819|Prednisolone|prednisolone|mesh-list
1810040|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
1810041|NCT04810819|Dyphylline|dyphylline|mesh-list
1810042|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1810043|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
1810044|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1810045|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
1810046|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
1810047|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810048|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810049|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1810050|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
1810051|NCT04810819|Hormones|hormones|mesh-ancestor
1810052|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1810053|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1810054|NCT04810819|Protective Agents|protective agents|mesh-ancestor
1810055|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1810056|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810057|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1810058|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1810059|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
1810060|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1810061|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810062|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810063|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
1810064|NCT04810754|Daratumumab|daratumumab|mesh-list
1810065|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810066|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1810067|NCT04810507|Anagliptin|anagliptin|mesh-list
1810068|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1810069|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810070|NCT04810507|Incretins|incretins|mesh-ancestor
1810071|NCT04810507|Hormones|hormones|mesh-ancestor
1810072|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1810073|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1810074|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
1810075|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810076|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810079|NCT04810598|Venetoclax|venetoclax|mesh-list
1810080|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810081|NCT04810572|Silymarin|silymarin|mesh-list
1810082|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
1810083|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810084|NCT04810572|Protective Agents|protective agents|mesh-ancestor
1810085|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810086|NCT04810585|Aflibercept|aflibercept|mesh-list
1810087|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1810088|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1810089|NCT04810585|Growth Substances|growth substances|mesh-ancestor
1810090|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810091|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
1810092|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810099|NCT04809818|Aspirin|aspirin|mesh-list
1810100|NCT04809818|Dabigatran|dabigatran|mesh-list
1810101|NCT04809818|Apixaban|apixaban|mesh-list
1810102|NCT04809818|Clopidogrel|clopidogrel|mesh-list
1810103|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1810104|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1810105|NCT04809818|Analgesics|analgesics|mesh-ancestor
1810106|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
1810107|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810108|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810109|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1810110|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1810111|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1810112|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1810113|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810114|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1810115|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1810116|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810117|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
1810118|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1810119|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1810120|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1810121|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
1810122|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810123|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
1810124|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1810125|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
1810126|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
1810127|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1810128|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
1810129|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
1810130|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1810131|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1810132|NCT04810156|Prednisolone|prednisolone|mesh-list
1810133|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
1810134|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1810135|NCT04810156|Tacrolimus|tacrolimus|mesh-list
1810136|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1810137|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
1810138|NCT04810156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1810139|NCT04810156|Immunologic Factors|immunologic factors|mesh-ancestor
1810140|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810141|NCT04810156|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1810142|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810143|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810144|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1810145|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810146|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1810147|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
1810148|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1810149|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810150|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1810151|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
1810152|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
1810153|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810154|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1810155|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
1810156|NCT04810156|Hormones|hormones|mesh-ancestor
1810157|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1810158|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1810159|NCT04810156|Protective Agents|protective agents|mesh-ancestor
1810160|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1810161|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1810162|NCT04809974|Niacinamide|niacinamide|mesh-list
1810163|NCT04809974|Vitamins|vitamins|mesh-ancestor
1810164|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
1810165|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810166|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
1810167|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
1810168|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810169|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
1810170|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
1810171|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
1810172|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
1810173|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810174|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1810175|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
1810176|NCT04809662|Imiquimod|imiquimod|mesh-list
1810177|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1810178|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
1810179|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810180|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810181|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
1810192|NCT04809649|Itraconazole|itraconazole|mesh-list
1810193|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
1810194|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810195|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1810196|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1810197|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810198|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810199|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1810200|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
1810201|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1810202|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810203|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1810204|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
1810205|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
1810206|NCT04809532|Tramadol|tramadol|mesh-list
1810207|NCT04809532|Bupivacaine|bupivacaine|mesh-list
1810208|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
1810209|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
1810210|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810211|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810212|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
1810213|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810214|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1810215|NCT04809532|Narcotics|narcotics|mesh-ancestor
1810216|NCT04809532|Analgesics|analgesics|mesh-ancestor
1810217|NCT04809233|Tipifarnib|tipifarnib|mesh-list
1810218|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810224|NCT04809116|Pimavanserin|pimavanserin|mesh-list
1810225|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1810226|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1810227|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1810228|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1810229|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810230|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810231|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1810232|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1810233|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1810234|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
1810235|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810236|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810237|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
1810238|NCT04809038|Analgesics|analgesics|mesh-ancestor
1810239|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
1810240|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810241|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810242|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
1810243|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810244|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1810245|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
1810246|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1810247|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1810248|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810249|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1810250|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
1810251|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1810252|NCT04808973|Lamivudine|lamivudine|mesh-list
1810253|NCT04808973|Dolutegravir|dolutegravir|mesh-list
1810254|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1810255|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1810256|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810257|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810258|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
1810259|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810260|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1810261|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1810262|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1810263|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1810264|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
1810265|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1810266|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810267|NCT04809103|Cisplatin|cisplatin|mesh-list
1810268|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810269|NCT04808882|Tinzaparin|tinzaparin|mesh-list
1810270|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1810271|NCT04808882|Dalteparin|dalteparin|mesh-list
1810272|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
1810273|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1810274|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1810275|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810276|NCT04809142|Gemcitabine|gemcitabine|mesh-list
1810277|NCT04809142|Capecitabine|capecitabine|mesh-list
1810278|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
1810279|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1810280|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
1810281|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810282|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810283|NCT04809142|Antiviral Agents|antiviral agents|mesh-ancestor
1810284|NCT04809142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810285|NCT04809142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810286|NCT04809142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1810287|NCT04809142|Immunologic Factors|immunologic factors|mesh-ancestor
1810288|NCT04809142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810289|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
1810290|NCT04808934|Apixaban|apixaban|mesh-list
1810291|NCT04808934|Dabigatran|dabigatran|mesh-list
1810292|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1810293|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
1810294|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1810295|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
1810296|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810297|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810298|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
1810299|NCT04809181|Azacitidine|azacitidine|mesh-list
1810300|NCT04809181|Venetoclax|venetoclax|mesh-list
1810301|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1810302|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
1810303|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810304|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810305|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810306|NCT04808739|Adalimumab|adalimumab|mesh-list
1810307|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1810308|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1810309|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
1810310|NCT04808856|Hormones|hormones|mesh-list
1810311|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
1810312|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
1810313|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
1810314|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1810315|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810316|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1810317|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
1810318|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
1810319|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810320|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1810321|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
1810322|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1810323|NCT04808856|Protective Agents|protective agents|mesh-ancestor
1810324|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810325|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810326|NCT04808648|Itraconazole|itraconazole|mesh-list
1810327|NCT04808648|Rifampin|rifampin|mesh-list
1810328|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
1810329|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810330|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1810331|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1810332|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810333|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810334|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1810335|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
1810336|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1810337|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810338|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1810339|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1810340|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
1810341|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1810342|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
1810343|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1810344|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1810345|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1810346|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1810347|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1810348|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1810349|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1810350|NCT04808895|Aspirin|aspirin|mesh-list
1810351|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1810352|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1810353|NCT04808895|Analgesics|analgesics|mesh-ancestor
1810354|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
1810355|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810356|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810357|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1810358|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1810359|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1810360|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1810361|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810362|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1810363|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1810364|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810365|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
1810366|NCT04808791|Trifluridine|trifluridine|mesh-list
1810367|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
1810368|NCT04808791|Irinotecan|irinotecan|mesh-list
1810369|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810370|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1810371|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1810372|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810373|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810374|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
1810375|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
1810376|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810377|NCT04808687|Paclitaxel|paclitaxel|mesh-list
1810378|NCT04808687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1810379|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1810380|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810381|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
1810382|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
1810383|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
1810384|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810385|NCT04808531|Oxycodone|oxycodone|mesh-list
1810386|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1810387|NCT04808531|Narcotics|narcotics|mesh-ancestor
1810388|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810389|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810390|NCT04808531|Analgesics|analgesics|mesh-ancestor
1810391|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
1810392|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810393|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
1810394|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
1810395|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810396|NCT04808622|Protective Agents|protective agents|mesh-ancestor
1810397|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810398|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1810399|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810400|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
1810401|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810402|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
1810403|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810404|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810405|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1810406|NCT04808323|Capecitabine|capecitabine|mesh-list
1810407|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
1810408|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1810409|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
1810410|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810411|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810412|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1810413|NCT04808414|Polymyxins|polymyxins|mesh-list
1810414|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810422|NCT04808466|Paclitaxel|paclitaxel|mesh-list
1810423|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1810424|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810425|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
1810426|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
1810427|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
1810428|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810429|NCT04807816|Gemcitabine|gemcitabine|mesh-list
1810430|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1810431|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
1810432|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810433|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810434|NCT04807816|Antiviral Agents|antiviral agents|mesh-ancestor
1810435|NCT04807816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810436|NCT04807816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810437|NCT04807816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1810438|NCT04807816|Immunologic Factors|immunologic factors|mesh-ancestor
1810439|NCT04807816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810440|NCT04807829|Nabilone|nabilone|mesh-list
1810441|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
1810442|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
1810443|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810444|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810445|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1810446|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1810447|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1810448|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810449|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1810450|NCT04807894|Testosterone|testosterone|mesh-list
1810451|NCT04807894|Androgens|androgens|mesh-ancestor
1810452|NCT04807894|Hormones|hormones|mesh-ancestor
1810453|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1810454|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810455|NCT04807569|Tamsulosin|tamsulosin|mesh-list
1810456|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1810457|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1810458|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1810459|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
1810460|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810461|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810462|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810463|NCT04807569|Urological Agents|urological agents|mesh-ancestor
1810464|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1810465|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
1810466|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1810467|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1810468|NCT04807504|Ropivacaine|ropivacaine|mesh-list
1810469|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
1810470|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
1810471|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810472|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810473|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
1810474|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810475|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
1810476|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1810477|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
1810478|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810479|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810480|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1810481|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
1810482|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1810483|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
1810484|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810485|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810486|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1810487|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
1810488|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
1810489|NCT04807413|Protective Agents|protective agents|mesh-ancestor
1810490|NCT04807673|Paclitaxel|paclitaxel|mesh-list
1810491|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
1810492|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1810493|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810494|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
1810495|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
1810496|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
1810497|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810498|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1810499|NCT04807517|Buspirone|buspirone|mesh-list
1810500|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1810501|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1810502|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810503|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810504|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1810505|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1810506|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
1810507|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810508|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810509|NCT04807543|Castor Oil|castor oil|mesh-list
1810510|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
1810511|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
1810512|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1810513|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
1810514|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1810515|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810516|NCT04807543|Progestins|progestins|mesh-ancestor
1810517|NCT04807543|Hormones|hormones|mesh-ancestor
1810518|NCT04807543|Cathartics|cathartics|mesh-ancestor
1810519|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1810520|NCT04807348|Metformin|metformin|mesh-list
1810521|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1810522|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810523|NCT04807140|Paclitaxel|paclitaxel|mesh-list
1810524|NCT04807140|Carboplatin|carboplatin|mesh-list
1810525|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1810526|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810527|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
1810528|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
1810529|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
1810530|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810531|NCT04807309|Danazol|danazol|mesh-list
1810532|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1810533|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
1810534|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1810535|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810536|NCT04807166|Paclitaxel|paclitaxel|mesh-list
1810537|NCT04807166|Carboplatin|carboplatin|mesh-list
1810538|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1810539|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810540|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
1810541|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
1810542|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
1810543|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810544|NCT04807335|Sufentanil|sufentanil|mesh-list
1810545|NCT04807335|Ketamine|ketamine|mesh-list
1810546|NCT04807335|Analgesics|analgesics|mesh-ancestor
1810547|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
1810548|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810549|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810550|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1810551|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1810552|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
1810553|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
1810554|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810555|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1810556|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1810557|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810558|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810559|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1810560|NCT04807335|Narcotics|narcotics|mesh-ancestor
1810561|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1810562|NCT04807101|Midazolam|midazolam|mesh-list
1810563|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1810564|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1810565|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810566|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810567|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1810568|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1810569|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1810570|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1810571|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
1810572|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
1810573|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
1810574|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
1810575|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810576|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810577|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
1810578|NCT04807127|Durvalumab|durvalumab|mesh-list
1810579|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1810580|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1810581|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810582|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810583|NCT04806945|Paclitaxel|paclitaxel|mesh-list
1810584|NCT04806945|Carboplatin|carboplatin|mesh-list
1810585|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1810586|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810587|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
1810588|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
1810589|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
1810590|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810596|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
1810597|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1810598|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1810599|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810600|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810601|NCT04806737|Teriflunomide|teriflunomide|mesh-list
1810602|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1810603|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1810604|NCT04806737|Analgesics|analgesics|mesh-ancestor
1810605|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
1810606|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810607|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810608|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1810609|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1810610|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1810611|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
1810612|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
1810613|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1810614|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810615|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1810616|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810617|NCT04806906|Azacitidine|azacitidine|mesh-list
1810618|NCT04806906|Cc-486|cc-486|mesh-list
1810619|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1810620|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
1810621|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810622|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810623|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810624|NCT04806386|Psyllium|psyllium|mesh-list
1810625|NCT04806386|Cathartics|cathartics|mesh-ancestor
1810626|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1810627|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1810628|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1810629|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1810630|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1810631|NCT04806438|Lidocaine|lidocaine|mesh-list
1810632|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
1810633|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
1810634|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810635|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810636|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
1810637|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810638|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1810639|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1810640|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1810641|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1810642|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810643|NCT04806230|Mirtazapine|mirtazapine|mesh-list
1810644|NCT04806230|Citalopram|citalopram|mesh-list
1810645|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1810646|NCT04806230|Sertraline|sertraline|mesh-list
1810647|NCT04806230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1810648|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1810649|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1810650|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810651|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810652|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
1810653|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810654|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1810655|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
1810656|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1810657|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1810658|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1810659|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
1810660|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
1810661|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1810662|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1810663|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810664|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1810665|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1810666|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1810667|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
1810668|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1810669|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1810670|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1810671|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1810672|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1810673|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1810674|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810675|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
1810676|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1810677|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
1810678|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810679|NCT04805775|Propofol|propofol|mesh-list
1810680|NCT04805775|Desflurane|desflurane|mesh-list
1810681|NCT04805775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1810682|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810683|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810684|NCT04805775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1810685|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
1810686|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
1810687|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1810688|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
1810689|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
1810690|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810691|NCT04805957|Sulforaphane|sulforaphane|mesh-list
1810692|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1810693|NCT04805957|Protective Agents|protective agents|mesh-ancestor
1810694|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810695|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810696|NCT04805944|Dolutegravir|dolutegravir|mesh-list
1810697|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1810698|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1810699|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810700|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810701|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1810702|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1810703|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
1810704|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810705|NCT04805827|Gabapentin|gabapentin|mesh-list
1810706|NCT04805827|Analgesics|analgesics|mesh-ancestor
1810707|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
1810708|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810709|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810710|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
1810711|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1810712|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1810713|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810714|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1810715|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1810716|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1810717|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810718|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810719|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
1810720|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
1810721|NCT04805710|Clopidogrel|clopidogrel|mesh-list
1810722|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1810723|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1810724|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1810725|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1810726|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
1810727|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810728|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810729|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810730|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1810731|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
1810732|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1810733|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
1810734|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810735|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
1810736|NCT04805515|Nicotine|nicotine|mesh-list
1810737|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1810738|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
1810739|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810740|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810741|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1810742|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1810743|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
1810744|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810745|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810746|NCT04805580|Anesthetics|anesthetics|mesh-list
1810747|NCT04805580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810748|NCT04805580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810749|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
1810750|NCT04805229|Narcotics|narcotics|mesh-ancestor
1810751|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810752|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810753|NCT04805229|Analgesics|analgesics|mesh-ancestor
1810754|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
1810755|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810756|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1810757|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1810758|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810759|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
1810760|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
1810761|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1810762|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810763|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810764|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
1810765|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1810766|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810767|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810768|NCT04805073|Promethazine|promethazine|mesh-list
1810769|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
1810770|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
1810771|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
1810772|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1810773|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
1810774|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
1810775|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810776|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810777|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810778|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1810779|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1810780|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1810781|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810782|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
1810783|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
1810784|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
1810785|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810786|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
1810787|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
1810788|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1810789|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
1810790|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810796|NCT04804696|Paclitaxel|paclitaxel|mesh-list
1810797|NCT04804696|Cisplatin|cisplatin|mesh-list
1810798|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1810799|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810800|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
1810801|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
1810802|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
1810803|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810807|NCT04804423|Listerine|listerine|mesh-list
1810808|NCT04804423|Fluorides|fluorides|mesh-list
1810809|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
1810810|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
1810811|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
1810812|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
1810813|NCT04804423|Protective Agents|protective agents|mesh-ancestor
1810814|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810815|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1810816|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810822|NCT04804735|Anesthetics|anesthetics|mesh-list
1810823|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810824|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810825|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1810826|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1810827|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810837|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
1810838|NCT04804072|Narcotics|narcotics|mesh-ancestor
1810839|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810840|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810841|NCT04804072|Analgesics|analgesics|mesh-ancestor
1810842|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
1810843|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810844|NCT04804007|Etoposide|etoposide|mesh-list
1810845|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1810846|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810847|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1810848|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1810849|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810850|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810851|NCT04804267|Linaclotide|linaclotide|mesh-list
1810852|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
1810853|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
1810854|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810855|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1810856|NCT04803539|Capecitabine|capecitabine|mesh-list
1810857|NCT04803539|Apatinib|apatinib|mesh-list
1810858|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1810859|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
1810860|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810861|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810862|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1810863|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810864|NCT04803734|Albuterol|albuterol|mesh-list
1810865|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1810866|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
1810867|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810868|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810869|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1810870|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
1810871|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
1810872|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1810873|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1810874|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1810875|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1810876|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
1810877|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810878|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810879|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
1810880|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1810881|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1810882|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810883|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
1810884|NCT04803747|Coagulants|coagulants|mesh-ancestor
1810885|NCT04803500|Simvastatin|simvastatin|mesh-list
1810886|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1810887|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1810888|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
1810889|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810890|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1810891|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1810892|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810893|NCT04803318|Everolimus|everolimus|mesh-list
1810894|NCT04803318|Lenvatinib|lenvatinib|mesh-list
1810895|NCT04803318|Trametinib|trametinib|mesh-list
1810896|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1810897|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1810898|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
1810899|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810900|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1810901|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810902|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810903|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1810904|NCT04803422|Amoxicillin|amoxicillin|mesh-list
1810905|NCT04803422|Metronidazole|metronidazole|mesh-list
1810906|NCT04803422|Tazobactam|tazobactam|mesh-list
1810907|NCT04803422|Piperacillin|piperacillin|mesh-list
1810908|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
1810909|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
1810910|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
1810911|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810912|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1810913|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1810914|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1810915|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810916|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810917|NCT04803162|Omeprazole|omeprazole|mesh-list
1810918|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1810919|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1810920|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1810921|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810922|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810923|NCT04803175|Valsartan|valsartan|mesh-list
1810924|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1810925|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1810926|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1810927|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1810928|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810929|NCT04803084|TEMPO|tempo|mesh-list
1810930|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
1810931|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810932|NCT04803084|Protective Agents|protective agents|mesh-ancestor
1810933|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810934|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
1810935|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1810936|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
1810937|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810938|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
1810939|NCT04803240|Protective Agents|protective agents|mesh-ancestor
1810940|NCT04803474|Hormones|hormones|mesh-list
1810941|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1810942|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810943|NCT04803370|Antibodies|antibodies|mesh-list
1810944|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
1810945|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810946|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
1810947|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1810948|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
1810949|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810950|NCT04802967|Ketoprofen|ketoprofen|mesh-list
1810951|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
1810952|NCT04802967|Gabapentin|gabapentin|mesh-list
1810953|NCT04802967|Analgesics|analgesics|mesh-ancestor
1810954|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
1810955|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1810956|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810957|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
1810958|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1810959|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1810960|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810961|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1810962|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1810963|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1810964|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1810965|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810966|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
1810967|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1810968|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1810969|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1810970|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1810971|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1810972|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1810973|NCT04802928|Isoniazid|isoniazid|mesh-list
1810974|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
1810975|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1810976|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1810977|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1810978|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1810979|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
1810980|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810981|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1810982|NCT04802785|Aspirin|aspirin|mesh-list
1810983|NCT04802785|Domperidone|domperidone|mesh-list
1810984|NCT04802785|Melatonin|melatonin|mesh-list
1810985|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
1810986|NCT04802785|Simethicone|simethicone|mesh-list
1810987|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
1810988|NCT04802785|Citric Acid|citric acid|mesh-list
1810989|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
1810990|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
1810991|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1810992|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
1810993|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
1810994|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1810995|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
1810996|NCT04802785|Protective Agents|protective agents|mesh-ancestor
1810997|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1810998|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1810999|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1811000|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1811001|NCT04802785|Analgesics|analgesics|mesh-ancestor
1811002|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
1811003|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811004|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1811005|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1811006|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1811007|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1811008|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1811009|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1811010|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811011|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
1811012|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
1811013|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
1811014|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1811015|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1811016|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
1811017|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1811018|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
1811019|NCT04802785|Emollients|emollients|mesh-ancestor
1811020|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
1811021|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
1811022|NCT04802785|Antacids|antacids|mesh-ancestor
1811023|NCT04802876|Spartalizumab|spartalizumab|mesh-list
1811024|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1811025|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811026|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811027|NCT04802980|Gemcitabine|gemcitabine|mesh-list
1811028|NCT04802980|Paclitaxel|paclitaxel|mesh-list
1811029|NCT04802980|Carboplatin|carboplatin|mesh-list
1811030|NCT04802980|Capecitabine|capecitabine|mesh-list
1811031|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
1811032|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1811033|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811034|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
1811035|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
1811036|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
1811037|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811038|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1811039|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
1811040|NCT04802980|Antiviral Agents|antiviral agents|mesh-ancestor
1811041|NCT04802980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811042|NCT04802980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811043|NCT04802980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1811044|NCT04802980|Immunologic Factors|immunologic factors|mesh-ancestor
1811045|NCT04802980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811055|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
1811056|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1811057|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1811058|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811059|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
1811060|NCT04802382|Coagulants|coagulants|mesh-ancestor
1811061|NCT04802122|Propofol|propofol|mesh-list
1811062|NCT04802122|Sevoflurane|sevoflurane|mesh-list
1811063|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1811064|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811065|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811066|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1811067|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
1811068|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
1811069|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1811070|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1811071|NCT04802083|Eculizumab|eculizumab|mesh-list
1811072|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1811073|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1811074|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
1811075|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811094|NCT04801849|Vitamin E|vitamin e|mesh-list
1811095|NCT04801849|Tocopherols|tocopherols|mesh-list
1811096|NCT04801849|Tocotrienols|tocotrienols|mesh-list
1811097|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
1811098|NCT04801849|Vitamins|vitamins|mesh-ancestor
1811099|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
1811100|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811101|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
1811102|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811103|NCT04801849|Protective Agents|protective agents|mesh-ancestor
1811104|NCT04801953|Nimodipine|nimodipine|mesh-list
1811105|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1811106|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1811107|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1811108|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811109|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1811110|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811111|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
1811112|NCT04801888|Vaccines|vaccines|mesh-list
1811113|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
1811114|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811115|NCT04801940|Apixaban|apixaban|mesh-list
1811116|NCT04801940|Atorvastatin|atorvastatin|mesh-list
1811117|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1811118|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1811119|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
1811120|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811121|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1811122|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1811123|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811124|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1811125|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
1811126|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1811127|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
1811128|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
1811129|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
1811130|NCT04801966|Nivolumab|nivolumab|mesh-list
1811131|NCT04801966|Atezolizumab|atezolizumab|mesh-list
1811132|NCT04801966|Olaparib|olaparib|mesh-list
1811133|NCT04801966|Palbociclib|palbociclib|mesh-list
1811134|NCT04801966|Trametinib|trametinib|mesh-list
1811135|NCT04801966|Vemurafenib|vemurafenib|mesh-list
1811136|NCT04801966|Dabrafenib|dabrafenib|mesh-list
1811137|NCT04801966|Talazoparib|talazoparib|mesh-list
1811138|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1811139|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811140|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1811141|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811142|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1811143|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811144|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1811145|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1811146|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
1811147|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811148|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
1811149|NCT04801511|Vitamins|vitamins|mesh-ancestor
1811150|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
1811151|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811152|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
1811153|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811154|NCT04801511|Protective Agents|protective agents|mesh-ancestor
1811155|NCT04801303|Calcitriol|calcitriol|mesh-list
1811156|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1811157|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811158|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1811159|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1811160|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811161|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1811162|NCT04801303|Vitamins|vitamins|mesh-ancestor
1811163|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
1811164|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1811165|NCT04801589|Midazolam|midazolam|mesh-list
1811166|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
1811167|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1811168|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811169|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811170|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1811171|NCT04801589|Analgesics|analgesics|mesh-ancestor
1811172|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
1811173|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811174|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1811175|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1811176|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1811177|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
1811178|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1811179|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811180|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1811181|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1811182|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1811183|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1811184|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1811185|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
1811186|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
1811187|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
1811188|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
1811189|NCT04801641|Nabilone|nabilone|mesh-list
1811190|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
1811191|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
1811192|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811193|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811194|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1811195|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1811196|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1811197|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811198|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1811199|NCT04801485|Inositol|inositol|mesh-list
1811200|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
1811201|NCT04801485|Vitamins|vitamins|mesh-ancestor
1811202|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
1811203|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811204|NCT04801342|Memantine|memantine|mesh-list
1811205|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1811206|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1811207|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
1811208|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1811209|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811210|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811211|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1811212|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1811213|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1811214|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
1811215|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1811216|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811217|NCT04800978|Durvalumab|durvalumab|mesh-list
1811218|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1811219|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811220|NCT04801017|Artemisinins|artemisinins|mesh-list
1811221|NCT04801017|Artemisinin|artemisinin|mesh-list
1811222|NCT04801017|Trabedersen|trabedersen|mesh-list
1811223|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
1811224|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1811225|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1811226|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811227|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811235|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
1811236|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1811237|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811238|NCT04801199|Incretins|incretins|mesh-ancestor
1811239|NCT04801199|Hormones|hormones|mesh-ancestor
1811240|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1811241|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1811242|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
1811243|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811244|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811245|NCT04800822|Cetuximab|cetuximab|mesh-list
1811246|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1811247|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811248|NCT04800471|Insulin|insulin|mesh-list
1811249|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1811250|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811251|NCT04800367|Denosumab|denosumab|mesh-list
1811252|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1811253|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811260|NCT04800393|Propofol|propofol|mesh-list
1811261|NCT04800393|Sevoflurane|sevoflurane|mesh-list
1811262|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1811263|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811264|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811265|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1811266|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
1811267|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
1811268|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1811269|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1811273|NCT04800107|Curcumin|curcumin|mesh-list
1811274|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1811275|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1811276|NCT04800107|Analgesics|analgesics|mesh-ancestor
1811277|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
1811278|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811279|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811280|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1811281|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1811282|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811283|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811284|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811285|NCT04800302|Morphine|morphine|mesh-list
1811286|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1811287|NCT04800302|Narcotics|narcotics|mesh-ancestor
1811288|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811289|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811290|NCT04800302|Analgesics|analgesics|mesh-ancestor
1811291|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
1811292|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811293|NCT04800224|Propolis|propolis|mesh-list
1811294|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811295|NCT04800081|Valsartan|valsartan|mesh-list
1811296|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1811297|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1811298|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1811299|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811300|NCT04799847|Catumaxomab|catumaxomab|mesh-list
1811301|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1811302|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1811303|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
1811304|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1811305|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1811306|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
1811307|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811308|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811309|NCT04799925|Febuxostat|febuxostat|mesh-list
1811310|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
1811311|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1811312|NCT04799782|Mirtazapine|mirtazapine|mesh-list
1811313|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
1811314|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1811315|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1811316|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
1811317|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
1811318|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1811319|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811320|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811321|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1811322|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1811323|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811324|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1811325|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1811326|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1811327|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
1811328|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1811329|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1811330|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
1811331|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1811332|NCT04799743|Resveratrol|resveratrol|mesh-list
1811333|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
1811334|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811335|NCT04799743|Protective Agents|protective agents|mesh-ancestor
1811336|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811337|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811338|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1811339|NCT04799626|Meropenem|meropenem|mesh-list
1811340|NCT04799626|Tazobactam|tazobactam|mesh-list
1811341|NCT04799626|Piperacillin|piperacillin|mesh-list
1811342|NCT04799626|Tigecycline|tigecycline|mesh-list
1811343|NCT04799626|Biapenem|biapenem|mesh-list
1811344|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1811345|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811346|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1811347|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811348|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811349|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1811360|NCT04799262|Prednisone|prednisone|mesh-list
1811361|NCT04799262|Tofacitinib|tofacitinib|mesh-list
1811362|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1811363|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
1811364|NCT04799262|Hormones|hormones|mesh-ancestor
1811365|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1811366|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811367|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1811368|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811369|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1811370|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811371|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811372|NCT04799639|Paclitaxel|paclitaxel|mesh-list
1811373|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1811374|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811375|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
1811376|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
1811377|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
1811378|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811379|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1811380|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811381|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811382|NCT04799015|Dexamethasone|dexamethasone|mesh-list
1811383|NCT04799015|Metoclopramide|metoclopramide|mesh-list
1811384|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1811385|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
1811386|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
1811387|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811388|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811389|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1811390|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
1811391|NCT04799015|Hormones|hormones|mesh-ancestor
1811392|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1811393|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1811394|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811395|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1811396|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1811397|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
1811398|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1811399|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811400|NCT04799002|Melphalan|melphalan|mesh-list
1811401|NCT04799002|Topotecan|topotecan|mesh-list
1811402|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1811403|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
1811404|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811405|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811406|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1811407|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1811408|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
1811409|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811410|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1811411|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1811412|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811413|NCT04799184|Epinephrine|epinephrine|mesh-list
1811414|NCT04799184|Racepinephrine|racepinephrine|mesh-list
1811415|NCT04799184|Bupivacaine|bupivacaine|mesh-list
1811416|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
1811417|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
1811418|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
1811419|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
1811420|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811421|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811422|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
1811423|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811424|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1811425|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1811426|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
1811427|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1811428|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811429|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1811430|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1811431|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
1811432|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1811433|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
1811434|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
1811435|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
1811436|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1811437|NCT04798703|Paclitaxel|paclitaxel|mesh-list
1811438|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
1811439|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1811440|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811441|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
1811442|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
1811443|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
1811444|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811445|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1811446|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
1811447|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811448|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
1811449|NCT04798703|Protective Agents|protective agents|mesh-ancestor
1811450|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
1811451|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811452|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
1811453|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
1811454|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
1811455|NCT04798638|Osimertinib|osimertinib|mesh-list
1811456|NCT04798638|Complement Factor H|complement factor h|mesh-list
1811457|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811458|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1811459|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811460|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811461|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1811462|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1811463|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
1811464|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811465|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
1811466|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
1811467|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811480|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
1811481|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1811482|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
1811483|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811484|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
1811485|NCT04798443|Protective Agents|protective agents|mesh-ancestor
1811486|NCT04798313|Denosumab|denosumab|mesh-list
1811487|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1811488|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811491|NCT04798287|Adalimumab|adalimumab|mesh-list
1811492|NCT04798287|Etanercept|etanercept|mesh-list
1811493|NCT04798287|Golimumab|golimumab|mesh-list
1811494|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
1811495|NCT04798287|Infliximab|infliximab|mesh-list
1811496|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
1811497|NCT04798287|Tofacitinib|tofacitinib|mesh-list
1811498|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1811499|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1811500|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1811501|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1811502|NCT04798287|Analgesics|analgesics|mesh-ancestor
1811503|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
1811504|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811505|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811506|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1811507|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1811508|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
1811509|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
1811510|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1811511|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811512|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811513|NCT04798391|Dexamethasone|dexamethasone|mesh-list
1811514|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1811515|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
1811516|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
1811517|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811518|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811519|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1811520|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
1811521|NCT04798391|Hormones|hormones|mesh-ancestor
1811522|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1811523|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1811524|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811525|NCT04798001|Vaccines|vaccines|mesh-list
1811526|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
1811527|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811528|NCT04797949|Aspirin|aspirin|mesh-list
1811529|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1811530|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1811531|NCT04797949|Analgesics|analgesics|mesh-ancestor
1811532|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
1811533|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811534|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811535|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1811536|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1811537|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1811538|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1811539|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811540|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1811541|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1811542|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811543|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
1811544|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
1811545|NCT04797832|Hematinics|hematinics|mesh-ancestor
1811546|NCT04797546|Morphine|morphine|mesh-list
1811547|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1811548|NCT04797546|Narcotics|narcotics|mesh-ancestor
1811549|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811550|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811551|NCT04797546|Analgesics|analgesics|mesh-ancestor
1811552|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
1811553|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811554|NCT04797793|Adapalene|adapalene|mesh-list
1811555|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1811556|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1811557|NCT04797793|Analgesics|analgesics|mesh-ancestor
1811558|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
1811559|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811560|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811561|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1811562|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1811563|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
1811564|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
1811565|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811566|NCT04797338|Nafarelin|nafarelin|mesh-list
1811567|NCT04797338|Progesterone|progesterone|mesh-list
1811568|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
1811569|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
1811570|NCT04797338|Estradiol|estradiol|mesh-list
1811571|NCT04797338|Progestins|progestins|mesh-ancestor
1811572|NCT04797338|Hormones|hormones|mesh-ancestor
1811573|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1811574|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811575|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1811576|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
1811577|NCT04797338|Estrogens|estrogens|mesh-ancestor
1811578|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1811579|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1811580|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
1811581|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
1811582|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1811583|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1811584|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811585|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
1811586|NCT04797156|Coagulants|coagulants|mesh-ancestor
1811587|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
1811588|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
1811589|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1811590|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1811591|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811592|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811593|NCT04797286|Urological Agents|urological agents|mesh-ancestor
1811594|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1811595|NCT04797013|Plasminogen|plasminogen|mesh-list
1811596|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1811597|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1811598|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811621|NCT04796857|Lenalidomide|lenalidomide|mesh-list
1811622|NCT04796857|Antibodies|antibodies|mesh-list
1811623|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
1811624|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811625|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1811626|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1811627|NCT04796857|Growth Substances|growth substances|mesh-ancestor
1811628|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
1811629|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811630|NCT04796623|Fulvestrant|fulvestrant|mesh-list
1811631|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1811632|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811633|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1811634|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1811635|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
1811636|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1811637|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811638|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
1811639|NCT04796688|Fludarabine|fludarabine|mesh-list
1811640|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1811641|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
1811642|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811643|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1811644|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1811645|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
1811646|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811647|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811648|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1811649|NCT04796714|Aspirin|aspirin|mesh-list
1811650|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1811651|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1811652|NCT04796714|Analgesics|analgesics|mesh-ancestor
1811653|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
1811654|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811655|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811656|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1811657|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1811658|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1811659|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1811660|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811661|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1811662|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1811663|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811664|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
1811665|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
1811666|NCT04796428|Empagliflozin|empagliflozin|mesh-list
1811667|NCT04796428|Canagliflozin|canagliflozin|mesh-list
1811668|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1811669|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811670|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1811671|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811672|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
1811673|NCT04796675|Fludarabine|fludarabine|mesh-list
1811674|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1811675|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
1811676|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811677|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1811678|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1811679|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
1811680|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811681|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811682|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1811683|NCT04796584|Antibodies|antibodies|mesh-list
1811684|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
1811685|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811689|NCT04796454|Gemcitabine|gemcitabine|mesh-list
1811690|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
1811691|NCT04796454|Temozolomide|temozolomide|mesh-list
1811692|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811693|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1811694|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
1811695|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811696|NCT04796454|Antiviral Agents|antiviral agents|mesh-ancestor
1811697|NCT04796454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811698|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811699|NCT04796454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1811700|NCT04796454|Immunologic Factors|immunologic factors|mesh-ancestor
1811701|NCT04796454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811702|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1811703|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
1811707|NCT04796012|Irinotecan|irinotecan|mesh-list
1811708|NCT04796012|Vincristine|vincristine|mesh-list
1811709|NCT04796012|Temozolomide|temozolomide|mesh-list
1811710|NCT04796012|Atezolizumab|atezolizumab|mesh-list
1811711|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1811712|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1811713|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811714|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811715|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811716|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1811717|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
1811718|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
1811719|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
1811720|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1811721|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
1811722|NCT04796025|Bevacizumab|bevacizumab|mesh-list
1811723|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1811724|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811725|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1811726|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1811727|NCT04796025|Growth Substances|growth substances|mesh-ancestor
1811728|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811729|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
1811730|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1811731|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
1811732|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1811733|NCT04795869|Antibodies|antibodies|mesh-list
1811734|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
1811735|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1811736|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
1811737|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
1811738|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811739|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811741|NCT04795583|Prednisone|prednisone|mesh-list
1811742|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1811743|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
1811744|NCT04795583|Hormones|hormones|mesh-ancestor
1811745|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1811746|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811747|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1811748|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811749|NCT04795752|Cyclosporine|cyclosporine|mesh-list
1811750|NCT04795752|Cyclosporins|cyclosporins|mesh-list
1811751|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811752|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811753|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1811754|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
1811755|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811756|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
1811757|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811758|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
1811759|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1811760|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1811761|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
1811762|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1811763|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811764|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1811765|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1811766|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811767|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811768|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811769|NCT04795336|Melatonin|melatonin|mesh-list
1811770|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
1811771|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811772|NCT04795336|Protective Agents|protective agents|mesh-ancestor
1811773|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811774|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811775|NCT04794738|Morphine|morphine|mesh-list
1811776|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1811777|NCT04794738|Narcotics|narcotics|mesh-ancestor
1811778|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811779|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811780|NCT04794738|Analgesics|analgesics|mesh-ancestor
1811781|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
1811782|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811783|NCT04794842|Phenol|phenol|mesh-list
1811784|NCT04794842|Tetracaine|tetracaine|mesh-list
1811785|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
1811786|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
1811787|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811788|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811789|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
1811790|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811791|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1811792|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811793|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
1811794|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
1811795|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1811801|NCT04794426|Fluorides|fluorides|mesh-list
1811802|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
1811803|NCT04794426|Protective Agents|protective agents|mesh-ancestor
1811804|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811805|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
1811806|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1811807|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1811808|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811809|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
1811810|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
1811811|NCT04794413|Pimavanserin|pimavanserin|mesh-list
1811812|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1811813|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1811814|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1811815|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1811816|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811817|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811818|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1811819|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1811820|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1811821|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
1811822|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1811823|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811824|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1811825|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1811826|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811827|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811828|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1811829|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1811830|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811831|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
1811832|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1811833|NCT04794049|Lactulose|lactulose|mesh-list
1811834|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1811835|NCT04794127|Pioglitazone|pioglitazone|mesh-list
1811836|NCT04794127|Trabectedin|trabectedin|mesh-list
1811837|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1811838|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811839|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1811840|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
1811841|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811842|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811843|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
1811844|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811845|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1811846|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811847|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811848|NCT04793919|Tretinoin|tretinoin|mesh-list
1811849|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
1811850|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
1811851|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811852|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
1811853|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
1811854|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1811855|NCT04793711|Decanoic acid|decanoic acid|mesh-list
1811856|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
1811857|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811858|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
1811859|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1811860|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811861|NCT04793529|Vitamins|vitamins|mesh-ancestor
1811862|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
1811863|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1811864|NCT04793568|Interferons|interferons|mesh-list
1811865|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
1811866|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811867|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
1811868|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811878|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
1811879|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1811880|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811881|NCT04793867|Xenon|xenon|mesh-list
1811882|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1811883|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
1811884|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
1811885|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811886|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811897|NCT04793490|Acetaminophen|acetaminophen|mesh-list
1811898|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1811899|NCT04793490|Analgesics|analgesics|mesh-ancestor
1811900|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
1811901|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811902|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811903|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
1811904|NCT04793256|Listerine|listerine|mesh-list
1811905|NCT04793256|Fluorides|fluorides|mesh-list
1811906|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
1811907|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
1811908|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
1811909|NCT04793256|Protective Agents|protective agents|mesh-ancestor
1811910|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811911|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1811912|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811913|NCT04793243|Vitamin D|vitamin d|mesh-list
1811914|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
1811915|NCT04793243|Vitamins|vitamins|mesh-ancestor
1811916|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
1811917|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811918|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1811919|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1811920|NCT04793399|Atezolizumab|atezolizumab|mesh-list
1811921|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811922|NCT04793152|Vancomycin|vancomycin|mesh-list
1811923|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1811924|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811925|NCT04793022|Anesthetics|anesthetics|mesh-list
1811926|NCT04793022|Propofol|propofol|mesh-list
1811927|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1811928|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811929|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1811930|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1811931|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
1811932|NCT04792723|Aspirin|aspirin|mesh-list
1811933|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1811934|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1811935|NCT04792723|Analgesics|analgesics|mesh-ancestor
1811936|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
1811937|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811938|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811939|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1811940|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1811941|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1811942|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1811943|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811944|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1811945|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1811946|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811947|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
1811948|NCT04792801|Choline|choline|mesh-list
1811949|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
1811950|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1811951|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
1811952|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811953|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1811954|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1811955|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
1811956|NCT04792645|Memantine|memantine|mesh-list
1811957|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1811958|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1811959|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
1811960|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1811961|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811962|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811963|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1811964|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1811965|NCT04792749|Metformin|metformin|mesh-list
1811966|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1811967|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811968|NCT04792710|Metronidazole|metronidazole|mesh-list
1811969|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1811970|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1811971|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1811972|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1811973|NCT04792840|Letrozole|letrozole|mesh-list
1811974|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1811975|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1811976|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1811977|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1811978|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811979|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1811980|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
1811981|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1811982|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811983|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1811984|NCT04792580|Lifitegrast|lifitegrast|mesh-list
1811985|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1811992|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
1811993|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1811994|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1811995|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1811996|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1811997|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1811998|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1811999|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
1812000|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812001|NCT04792333|Firibastat|firibastat|mesh-list
1812002|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1812008|NCT04792385|Drospirenone|drospirenone|mesh-list
1812009|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
1812010|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
1812011|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
1812012|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1812013|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812014|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1812015|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1812016|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
1812017|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1812018|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1812019|NCT04792385|Diuretics|diuretics|mesh-ancestor
1812020|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
1812021|NCT04792320|Charcoal|charcoal|mesh-list
1812022|NCT04792320|Antidotes|antidotes|mesh-ancestor
1812023|NCT04792320|Protective Agents|protective agents|mesh-ancestor
1812024|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812025|NCT04792138|Phenobarbital|phenobarbital|mesh-list
1812026|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
1812027|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1812028|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812029|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812030|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1812031|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1812032|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812033|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812034|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
1812035|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
1812036|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1812037|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1812038|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1812039|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1812040|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
1812041|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1812042|NCT04792502|Lenalidomide|lenalidomide|mesh-list
1812043|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
1812044|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812045|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1812046|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1812047|NCT04792502|Growth Substances|growth substances|mesh-ancestor
1812048|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
1812049|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812050|NCT04792515|Apatinib|apatinib|mesh-list
1812051|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812052|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1812053|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812054|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812058|NCT04792034|Cocaine|cocaine|mesh-list
1812059|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
1812060|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
1812061|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812062|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812063|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
1812064|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812065|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1812066|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1812067|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1812068|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1812069|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812070|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
1812071|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812072|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
1812073|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1812074|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
1812075|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1812076|NCT04792021|Expectorants|expectorants|mesh-ancestor
1812077|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
1812078|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1812079|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
1812080|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812081|NCT04792021|Protective Agents|protective agents|mesh-ancestor
1812082|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812083|NCT04792021|Antidotes|antidotes|mesh-ancestor
1812084|NCT04791969|Naltrexone|naltrexone|mesh-list
1812085|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1812086|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1812087|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812088|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
1812089|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812090|NCT04791761|Acetaminophen|acetaminophen|mesh-list
1812091|NCT04791761|Ibuprofen|ibuprofen|mesh-list
1812092|NCT04791761|Oxycodone|oxycodone|mesh-list
1812093|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
1812094|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1812095|NCT04791761|Analgesics|analgesics|mesh-ancestor
1812096|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
1812097|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812098|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812099|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
1812100|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1812101|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1812102|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1812103|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1812104|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812105|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812106|NCT04791761|Narcotics|narcotics|mesh-ancestor
1812107|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812108|NCT04791943|Melatonin|melatonin|mesh-list
1812109|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
1812110|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812111|NCT04791943|Protective Agents|protective agents|mesh-ancestor
1812112|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812113|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812114|NCT04791774|Caseins|caseins|mesh-list
1812115|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
1812116|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
1812117|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812118|NCT04791345|Dexamethasone|dexamethasone|mesh-list
1812119|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
1812120|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
1812121|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1812122|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1812123|NCT04791345|Prednisolone|prednisolone|mesh-list
1812124|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
1812125|NCT04791345|Deflazacort|deflazacort|mesh-list
1812126|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1812127|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
1812128|NCT04791345|BB 1101|bb 1101|mesh-list
1812129|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1812130|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
1812131|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
1812132|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812133|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812134|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1812135|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
1812136|NCT04791345|Hormones|hormones|mesh-ancestor
1812137|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1812138|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1812139|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812140|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
1812141|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812142|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812143|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1812144|NCT04791345|Protective Agents|protective agents|mesh-ancestor
1812145|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1812146|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
1812147|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
1812148|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1812149|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1812150|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1812151|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1812152|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812153|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812154|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812155|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1812156|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1812157|NCT04791566|Dexamethasone|dexamethasone|mesh-list
1812158|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1812159|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
1812160|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
1812161|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812162|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812163|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1812164|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
1812165|NCT04791566|Hormones|hormones|mesh-ancestor
1812166|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1812167|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1812168|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812169|NCT04791475|Dexamethasone|dexamethasone|mesh-list
1812170|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
1812171|NCT04791475|Bupivacaine|bupivacaine|mesh-list
1812172|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1812173|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
1812174|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
1812175|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812176|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812177|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1812178|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
1812179|NCT04791475|Hormones|hormones|mesh-ancestor
1812180|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1812181|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1812182|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812183|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
1812184|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
1812185|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812186|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
1812187|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1812188|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1812189|NCT04791475|Analgesics|analgesics|mesh-ancestor
1812190|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1812191|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1812192|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1812193|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
1812194|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812195|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812201|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
1812202|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1812203|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1812204|NCT04791202|Prednisolone|prednisolone|mesh-list
1812205|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
1812206|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1812207|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
1812208|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1812209|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
1812210|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
1812211|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812212|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812213|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1812214|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
1812215|NCT04791202|Hormones|hormones|mesh-ancestor
1812216|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1812217|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1812218|NCT04791202|Protective Agents|protective agents|mesh-ancestor
1812219|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1812220|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812221|NCT04790838|Fluticasone|fluticasone|mesh-list
1812222|NCT04790838|Xhance|xhance|mesh-list
1812223|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1812224|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1812225|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1812226|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1812227|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
1812228|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812229|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812230|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1812231|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
1812232|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
1812233|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1812234|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1812235|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1812236|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1812237|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
1812238|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812239|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812240|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
1812241|NCT04790838|Hormones|hormones|mesh-ancestor
1812242|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1812243|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
1812244|NCT04791020|Lidocaine|lidocaine|mesh-list
1812245|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
1812246|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
1812247|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812248|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812249|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
1812250|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812251|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1812252|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1812253|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1812254|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1812255|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812256|NCT04791059|Sufentanil|sufentanil|mesh-list
1812257|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
1812258|NCT04791059|Ketamine|ketamine|mesh-list
1812259|NCT04791059|Esketamine|esketamine|mesh-list
1812260|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1812261|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812262|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812339|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
1812263|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1812264|NCT04791059|Analgesics|analgesics|mesh-ancestor
1812265|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
1812266|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812267|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1812268|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1812269|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1812270|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
1812271|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812272|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812273|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1812274|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1812275|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
1812276|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
1812277|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1812278|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1812279|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1812280|NCT04791059|Narcotics|narcotics|mesh-ancestor
1812281|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1812282|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
1812283|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1812284|NCT04790812|Acetaminophen|acetaminophen|mesh-list
1812285|NCT04790812|Celecoxib|celecoxib|mesh-list
1812286|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1812287|NCT04790812|Analgesics|analgesics|mesh-ancestor
1812288|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
1812289|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812290|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812291|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
1812292|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1812293|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1812294|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1812295|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1812296|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1812297|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812298|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812299|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
1812300|NCT04790734|Remifentanil|remifentanil|mesh-list
1812301|NCT04790734|Propofol|propofol|mesh-list
1812302|NCT04790734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1812303|NCT04790734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812304|NCT04790734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812305|NCT04790734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1812306|NCT04790734|Anesthetics, General|anesthetics, general|mesh-ancestor
1812307|NCT04790734|Anesthetics|anesthetics|mesh-ancestor
1812308|NCT04790734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1812309|NCT04790734|Narcotics|narcotics|mesh-ancestor
1812310|NCT04790734|Analgesics|analgesics|mesh-ancestor
1812311|NCT04790734|Sensory System Agents|sensory system agents|mesh-ancestor
1812312|NCT04790734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812313|NCT04790513|Evolocumab|evolocumab|mesh-list
1812314|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1812315|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1812316|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
1812317|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812318|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1812319|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
1812320|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
1812321|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
1812322|NCT04790383|Protective Agents|protective agents|mesh-ancestor
1812323|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812324|NCT04790708|Octreotide|octreotide|mesh-list
1812325|NCT04790708|Edotreotide|edotreotide|mesh-list
1812326|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1812327|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812328|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1812329|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1812330|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812331|NCT04790409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1812332|NCT04790409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812333|NCT04790409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812334|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
1812335|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
1812336|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
1812337|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1812338|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
1812340|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812341|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812342|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812343|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1812344|NCT04790448|Irinotecan|irinotecan|mesh-list
1812345|NCT04790448|Camptothecin|camptothecin|mesh-list
1812346|NCT04790448|Cetuximab|cetuximab|mesh-list
1812347|NCT04790448|Vemurafenib|vemurafenib|mesh-list
1812348|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1812349|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1812350|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812351|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812352|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812353|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1812354|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1812355|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1812356|NCT04790331|Verapamil|verapamil|mesh-list
1812357|NCT04790331|Diltiazem|diltiazem|mesh-list
1812358|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1812359|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1812360|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1812361|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812362|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1812363|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812364|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
1812365|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1812366|NCT04790136|Cannabidiol|cannabidiol|mesh-list
1812367|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
1812368|NCT04790279|Amlodipine|amlodipine|mesh-list
1812369|NCT04790279|Nifedipine|nifedipine|mesh-list
1812370|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1812371|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1812372|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1812373|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812374|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1812375|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812376|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
1812377|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
1812378|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1812379|NCT04790175|Tolvaptan|tolvaptan|mesh-list
1812380|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1812381|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812382|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
1812383|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812384|NCT04789941|Irinotecan|irinotecan|mesh-list
1812385|NCT04789941|Cisplatin|cisplatin|mesh-list
1812386|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1812387|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1812388|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812389|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812390|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812392|NCT04790045|Venetoclax|venetoclax|mesh-list
1812393|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812394|NCT04789915|Memantine|memantine|mesh-list
1812395|NCT04789915|Amisulpride|amisulpride|mesh-list
1812396|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1812397|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1812398|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
1812399|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812400|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812401|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812402|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1812403|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1812404|NCT04789915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1812405|NCT04789915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1812406|NCT04789915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812407|NCT04789915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1812408|NCT04789915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1812409|NCT04789915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1812410|NCT04789915|Antidepressive Agents|antidepressive agents|mesh-ancestor
1812420|NCT04789668|Atezolizumab|atezolizumab|mesh-list
1812421|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812422|NCT04790032|Cangrelor|cangrelor|mesh-list
1812423|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1812424|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1812425|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1812426|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1812427|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
1812428|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812429|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812430|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812431|NCT04789499|Theophylline|theophylline|mesh-list
1812432|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1812433|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
1812434|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812435|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812436|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1812437|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
1812438|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1812439|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812440|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812441|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
1812442|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1812443|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1812444|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
1812445|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812446|NCT04789837|Cilostazol|cilostazol|mesh-list
1812447|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1812448|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
1812449|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812450|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812451|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1812452|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
1812453|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1812454|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1812455|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812456|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1812457|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
1812458|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1812459|NCT04789837|Protective Agents|protective agents|mesh-ancestor
1812460|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1812461|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1812462|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812463|NCT04789330|Phenylephrine|phenylephrine|mesh-list
1812464|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
1812465|NCT04789330|Norepinephrine|norepinephrine|mesh-list
1812466|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1812467|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
1812468|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
1812469|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812470|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812471|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
1812472|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1812473|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
1812474|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
1812475|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1812476|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1812477|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1812478|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
1812479|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812480|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812481|NCT04789330|Protective Agents|protective agents|mesh-ancestor
1812482|NCT04789005|Phenylephrine|phenylephrine|mesh-list
1812483|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
1812484|NCT04789005|Norepinephrine|norepinephrine|mesh-list
1812485|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1812486|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
1812487|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
1812488|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812489|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812490|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
1812491|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1812492|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
1812493|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
1812494|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1812495|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1812496|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1812497|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
1812498|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812499|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812500|NCT04789005|Protective Agents|protective agents|mesh-ancestor
1812501|NCT04788979|Melatonin|melatonin|mesh-list
1812502|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
1812503|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812504|NCT04788979|Protective Agents|protective agents|mesh-ancestor
1812505|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812506|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812507|NCT04788667|Erenumab|erenumab|mesh-list
1812508|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1812509|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812510|NCT04788667|Analgesics|analgesics|mesh-ancestor
1812511|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
1812512|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812513|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812514|NCT04788641|Cyclosporine|cyclosporine|mesh-list
1812515|NCT04788641|Tacrolimus|tacrolimus|mesh-list
1812516|NCT04788641|Cyclosporins|cyclosporins|mesh-list
1812517|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1812518|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
1812519|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812520|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1812521|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812522|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812523|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
1812524|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1812525|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
1812526|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1812527|NCT04788823|Prednisone|prednisone|mesh-list
1812528|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1812529|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
1812530|NCT04788823|Hormones|hormones|mesh-ancestor
1812531|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1812532|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812533|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1812534|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812535|NCT04788914|Charcoal|charcoal|mesh-list
1812536|NCT04788914|Antidotes|antidotes|mesh-ancestor
1812537|NCT04788914|Protective Agents|protective agents|mesh-ancestor
1812538|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812539|NCT04788654|Acetaminophen|acetaminophen|mesh-list
1812540|NCT04788654|Dexamethasone|dexamethasone|mesh-list
1812541|NCT04788654|Celecoxib|celecoxib|mesh-list
1812542|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1812543|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
1812544|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
1812545|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812546|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812547|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1812548|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
1812549|NCT04788654|Hormones|hormones|mesh-ancestor
1812550|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1812551|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1812552|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812553|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1812554|NCT04788654|Analgesics|analgesics|mesh-ancestor
1812555|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
1812556|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
1812557|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1812558|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1812559|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1812560|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1812561|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812562|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812563|NCT04789096|Capecitabine|capecitabine|mesh-list
1812564|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
1812565|NCT04789096|Trastuzumab|trastuzumab|mesh-list
1812566|NCT04789096|Tucatinib|tucatinib|mesh-list
1812567|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1812568|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
1812569|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812570|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812571|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1812572|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1812573|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812574|NCT04789057|Atorvastatin|atorvastatin|mesh-list
1812575|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1812576|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1812577|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
1812578|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812579|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1812580|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1812581|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812583|NCT04788745|Trimetazidine|trimetazidine|mesh-list
1812584|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
1812585|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
1812586|NCT04788355|Apixaban|apixaban|mesh-list
1812587|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
1812588|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1812589|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1812590|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1812591|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812592|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812593|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1812594|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1812595|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
1812596|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1812597|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
1812598|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
1812599|NCT04788381|Bevacizumab|bevacizumab|mesh-list
1812600|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1812601|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812602|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1812603|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1812604|NCT04788381|Growth Substances|growth substances|mesh-ancestor
1812605|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812606|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
1812607|NCT04788420|Sorafenib|sorafenib|mesh-list
1812608|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812609|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1812610|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812611|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812612|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
1812613|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1812614|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1812615|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1812616|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
1812617|NCT04788043|Magrolimab|magrolimab|mesh-list
1812618|NCT04788043|Antibodies|antibodies|mesh-list
1812619|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
1812620|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1812621|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
1812622|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812623|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812624|NCT04788017|Ziresovir|ziresovir|mesh-list
1812625|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
1812626|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1812627|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
1812628|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1812629|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1812630|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812631|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
1812632|NCT04788121|Coagulants|coagulants|mesh-ancestor
1812633|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1812634|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1812635|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
1812636|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812637|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812638|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812645|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
1812646|NCT04788108|Progestins|progestins|mesh-ancestor
1812647|NCT04788108|Hormones|hormones|mesh-ancestor
1812648|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1812649|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812656|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
1812657|NCT04787692|Narcotics|narcotics|mesh-ancestor
1812658|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812659|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812660|NCT04787692|Analgesics|analgesics|mesh-ancestor
1812661|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
1812662|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812698|NCT04787848|Bromides|bromides|mesh-list
1812699|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
1812700|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
1812701|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1812702|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812703|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
1812704|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812712|NCT04787510|Heparin|heparin|mesh-list
1812713|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1812714|NCT04787510|Tinzaparin|tinzaparin|mesh-list
1812715|NCT04787510|Dalteparin|dalteparin|mesh-list
1812716|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
1812717|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1812718|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1812871|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
1812719|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812720|NCT04787341|Panitumumab|panitumumab|mesh-list
1812721|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1812722|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812723|NCT04787471|Riboflavin|riboflavin|mesh-list
1812724|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
1812725|NCT04787471|Vitamins|vitamins|mesh-ancestor
1812726|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
1812727|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812728|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1812729|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
1812730|NCT04787731|Lidocaine|lidocaine|mesh-list
1812731|NCT04787731|Bupivacaine|bupivacaine|mesh-list
1812732|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
1812733|NCT04787731|Anesthetics|anesthetics|mesh-list
1812734|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812735|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812736|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
1812737|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812738|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1812739|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1812740|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1812741|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1812742|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812743|NCT04787354|Capecitabine|capecitabine|mesh-list
1812744|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
1812745|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1812746|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
1812747|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812748|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812749|NCT04787289|Bevacizumab|bevacizumab|mesh-list
1812750|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1812751|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812752|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1812753|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1812754|NCT04787289|Growth Substances|growth substances|mesh-ancestor
1812755|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812756|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
1812757|NCT04787276|Rifaximin|rifaximin|mesh-list
1812758|NCT04787276|Lactulose|lactulose|mesh-list
1812759|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1812760|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1812761|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1812769|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1812770|NCT04786795|Pancreatin|pancreatin|mesh-list
1812771|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1812772|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1812773|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
1812774|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1812775|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
1812776|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812777|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
1812778|NCT04786613|Protective Agents|protective agents|mesh-ancestor
1812804|NCT04786873|Clonidine|clonidine|mesh-list
1812805|NCT04786873|Analgesics|analgesics|mesh-ancestor
1812806|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
1812807|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812808|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812809|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1812810|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
1812811|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
1812812|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1812813|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1812814|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1812815|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
1812816|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812817|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812818|NCT04786574|Tolvaptan|tolvaptan|mesh-list
1812819|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1812820|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812821|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
1812822|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812823|NCT04786548|Celecoxib|celecoxib|mesh-list
1812824|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1812825|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1812826|NCT04786548|Analgesics|analgesics|mesh-ancestor
1812827|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
1812828|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812829|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812830|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1812831|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1812832|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1812833|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1812834|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812835|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812836|NCT04786275|Fentanyl|fentanyl|mesh-list
1812837|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1812838|NCT04786275|Narcotics|narcotics|mesh-ancestor
1812839|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812840|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812841|NCT04786275|Analgesics|analgesics|mesh-ancestor
1812842|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
1812843|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812844|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1812845|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1812846|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
1812847|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
1812848|NCT04786158|Apomorphine|apomorphine|mesh-list
1812849|NCT04786158|Emetics|emetics|mesh-ancestor
1812850|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812851|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
1812852|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812853|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1812854|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
1812855|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
1812856|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812857|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812858|NCT04786210|Triamcinolone|triamcinolone|mesh-list
1812859|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1812860|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1812861|NCT04786210|Fluorouracil|fluorouracil|mesh-list
1812862|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1812863|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
1812864|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812865|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1812866|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812867|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1812868|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
1812869|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812870|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1812872|NCT04786210|Hormones|hormones|mesh-ancestor
1812873|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1812874|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812875|NCT04786340|Pirenzepine|pirenzepine|mesh-list
1812876|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1812877|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1812878|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1812879|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1812880|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1812881|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
1812882|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812883|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812884|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812885|NCT04786327|Edetic Acid|edetic acid|mesh-list
1812886|NCT04786327|Mitogens|mitogens|mesh-list
1812887|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
1812888|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
1812889|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812890|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
1812891|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1812892|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
1812893|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
1812894|NCT04786327|Antidotes|antidotes|mesh-ancestor
1812895|NCT04786327|Protective Agents|protective agents|mesh-ancestor
1812896|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812897|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1812898|NCT04786470|Ropivacaine|ropivacaine|mesh-list
1812899|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
1812900|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
1812901|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812902|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812903|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
1812904|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812905|NCT04786093|Durvalumab|durvalumab|mesh-list
1812906|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1812907|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812916|NCT04785716|Niraparib|niraparib|mesh-list
1812917|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1812918|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812919|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812920|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812921|NCT04785755|Etilefrine|etilefrine|mesh-list
1812922|NCT04785755|Furosemide|furosemide|mesh-list
1812923|NCT04785755|Spironolactone|spironolactone|mesh-list
1812924|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1812925|NCT04785755|Diuretics|diuretics|mesh-list
1812926|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
1812927|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812928|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1812929|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1812930|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812931|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1812932|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
1812933|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1812934|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1812935|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1812936|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1812937|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
1812938|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812939|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1812940|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
1812941|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
1812942|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812943|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1812944|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1812945|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1812946|NCT04785755|Protective Agents|protective agents|mesh-ancestor
1812947|NCT04786002|Busulfan|busulfan|mesh-list
1812948|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
1812949|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812950|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1812951|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
1812952|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812953|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1812954|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1812955|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1812956|NCT04785924|Imipenem|imipenem|mesh-list
1812957|NCT04785924|Relebactam|relebactam|mesh-list
1812958|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1812959|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1812960|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1812961|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1812962|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812963|NCT04785911|Antiemetics|antiemetics|mesh-list
1812964|NCT04785911|Histamine|histamine|mesh-list
1812965|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
1812966|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
1812967|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1812968|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812969|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812970|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
1812971|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812972|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1812973|NCT04785768|Morphine|morphine|mesh-list
1812974|NCT04785768|Hydromorphone|hydromorphone|mesh-list
1812975|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1812976|NCT04785768|Narcotics|narcotics|mesh-ancestor
1812977|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1812978|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1812979|NCT04785768|Analgesics|analgesics|mesh-ancestor
1812980|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
1812981|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1812982|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
1812983|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1812984|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1812985|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1812986|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
1812987|NCT04785651|Coagulants|coagulants|mesh-ancestor
1813002|NCT04785547|Blinatumomab|blinatumomab|mesh-list
1813003|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813014|NCT04785183|Melatonin|melatonin|mesh-list
1813015|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
1813016|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813017|NCT04785183|Protective Agents|protective agents|mesh-ancestor
1813018|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813019|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813022|NCT04785118|Scopolamine|scopolamine|mesh-list
1813023|NCT04785118|Ondansetron|ondansetron|mesh-list
1813024|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
1813025|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
1813026|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
1813027|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813028|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813029|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1813030|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
1813031|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
1813032|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1813033|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
1813034|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1813035|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813036|NCT04785118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1813037|NCT04785118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1813038|NCT04785118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813039|NCT04785118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1813040|NCT04785118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1813041|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1813042|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
1813043|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1813044|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
1813045|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1813046|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
1813056|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
1813057|NCT04785222|Bupivacaine|bupivacaine|mesh-list
1813058|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
1813059|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
1813060|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813061|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813062|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
1813063|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813064|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1813065|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1813066|NCT04785222|Analgesics|analgesics|mesh-ancestor
1813067|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1813068|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1813069|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1813070|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
1813071|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1813072|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813073|NCT04784754|Melatonin|melatonin|mesh-list
1813074|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
1813075|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813076|NCT04784754|Protective Agents|protective agents|mesh-ancestor
1813077|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813078|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813079|NCT04784988|BAX 855|bax 855|mesh-list
1813080|NCT04784988|Coagulants|coagulants|mesh-ancestor
1813081|NCT04784728|Lidocaine|lidocaine|mesh-list
1813082|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
1813083|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
1813084|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813085|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813086|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
1813087|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813088|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1813089|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1813090|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1813091|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1813092|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813093|NCT04784910|Lansoprazole|lansoprazole|mesh-list
1813094|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
1813095|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1813096|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1813097|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1813098|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813099|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813100|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
1813101|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1813102|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
1813103|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813107|NCT04784481|Ivermectin|ivermectin|mesh-list
1813108|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1813109|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1813110|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
1813111|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1813112|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
1813113|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813114|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1813115|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813116|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1813117|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813118|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
1813119|NCT04784052|Rituximab|rituximab|mesh-list
1813120|NCT04784052|Fludarabine|fludarabine|mesh-list
1813121|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
1813122|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1813123|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1813124|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
1813125|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813126|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1813127|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1813128|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
1813129|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813130|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813131|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1813132|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1813136|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
1813137|NCT04784247|Lenvatinib|lenvatinib|mesh-list
1813138|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1813139|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813140|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1813141|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813142|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813143|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
1813144|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1813145|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1813146|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813147|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
1813148|NCT04784039|Coagulants|coagulants|mesh-ancestor
1813149|NCT04784104|Epinephrine|epinephrine|mesh-list
1813150|NCT04784104|Racepinephrine|racepinephrine|mesh-list
1813151|NCT04784104|Bupivacaine|bupivacaine|mesh-list
1813152|NCT04784104|Prilocaine|prilocaine|mesh-list
1813153|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1813154|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
1813155|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
1813156|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
1813157|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813158|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813159|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
1813160|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813161|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1813162|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1813163|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
1813164|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1813165|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813166|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1813167|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1813168|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
1813169|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1813170|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
1813171|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
1813172|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
1813173|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1813174|NCT04784000|Carbamazepine|carbamazepine|mesh-list
1813175|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
1813176|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
1813177|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1813178|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813179|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813180|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1813181|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1813182|NCT04784000|Analgesics|analgesics|mesh-ancestor
1813183|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
1813184|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813185|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1813186|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1813187|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813188|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1813189|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1813190|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
1813191|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1813192|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813193|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1813194|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813195|NCT04783935|Cladribine|cladribine|mesh-list
1813196|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813197|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1813198|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
1813199|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813200|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
1813201|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
1813202|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813203|NCT04783792|Protective Agents|protective agents|mesh-ancestor
1813204|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813205|NCT04783792|Vitamins|vitamins|mesh-ancestor
1813206|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
1813207|NCT04783753|Itraconazole|itraconazole|mesh-list
1813208|NCT04783753|Quinidine|quinidine|mesh-list
1813209|NCT04783753|Carbamazepine|carbamazepine|mesh-list
1813210|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
1813211|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1813212|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1813213|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1813214|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813215|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813216|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1813217|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
1813218|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1813219|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813220|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1813221|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
1813222|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
1813223|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1813224|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813225|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1813226|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1813227|NCT04783753|Analgesics|analgesics|mesh-ancestor
1813228|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
1813229|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813230|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1813231|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1813232|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1813233|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1813234|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1813235|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1813236|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
1813237|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1813238|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1813239|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
1813240|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1813241|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1813242|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1813243|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1813244|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
1813245|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1813322|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
1813246|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1813253|NCT04783636|Leuprolide|leuprolide|mesh-list
1813254|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1813255|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
1813256|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1813257|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813258|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1813259|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813260|NCT04783610|Ethanol|ethanol|mesh-list
1813261|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1813262|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1813263|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813264|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813265|NCT04783194|Dexamethasone|dexamethasone|mesh-list
1813266|NCT04783194|Bupivacaine|bupivacaine|mesh-list
1813267|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1813268|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
1813269|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
1813270|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813271|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813272|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1813273|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
1813274|NCT04783194|Hormones|hormones|mesh-ancestor
1813275|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1813276|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1813277|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813278|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
1813279|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
1813280|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813281|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
1813282|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
1813283|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813299|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
1813300|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
1813301|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
1813302|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
1813303|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1813304|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1813305|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1813306|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1813307|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813308|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813309|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1813310|NCT04783051|Renal Agents|renal agents|mesh-ancestor
1813311|NCT04782622|Apatinib|apatinib|mesh-list
1813312|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813313|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1813314|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813315|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813316|NCT04782830|Midodrine|midodrine|mesh-list
1813317|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1813318|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1813319|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1813320|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1813321|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813323|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1813324|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813325|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
1813326|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
1813327|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813328|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1813329|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1813330|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1813331|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1813332|NCT04782960|Bupivacaine|bupivacaine|mesh-list
1813333|NCT04782960|Anesthetics|anesthetics|mesh-list
1813334|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
1813335|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813336|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813337|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
1813338|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813339|NCT04782700|Prednisone|prednisone|mesh-list
1813340|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1813341|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
1813342|NCT04782700|Hormones|hormones|mesh-ancestor
1813343|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1813344|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813345|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1813346|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813347|NCT04782804|Capecitabine|capecitabine|mesh-list
1813348|NCT04782804|Antibodies|antibodies|mesh-list
1813349|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
1813350|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813351|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1813352|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
1813353|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813354|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813360|NCT04782778|Bupivacaine|bupivacaine|mesh-list
1813361|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
1813362|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
1813363|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813364|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813365|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
1813366|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813367|NCT04782388|Alprazolam|alprazolam|mesh-list
1813368|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1813369|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813370|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813371|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1813372|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1813373|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1813374|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
1813375|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
1813376|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1813377|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813378|NCT04782076|Dabigatran|dabigatran|mesh-list
1813379|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
1813380|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1813381|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
1813382|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813383|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813384|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
1813385|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1813386|NCT04782089|Antibodies|antibodies|mesh-list
1813387|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
1813388|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813389|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813390|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813391|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813392|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
1813393|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1813394|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813395|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1813396|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813397|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
1813398|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1813399|NCT04782258|Tolvaptan|tolvaptan|mesh-list
1813400|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
1813401|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813402|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
1813403|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813404|NCT04782037|Calcium|calcium|mesh-list
1813405|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1813406|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813407|NCT04782310|Pregabalin|pregabalin|mesh-list
1813408|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1813409|NCT04782310|Analgesics|analgesics|mesh-ancestor
1813410|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
1813411|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813412|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813413|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
1813414|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1813415|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1813416|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813417|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1813418|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1813419|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1813420|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813421|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1813422|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1813423|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1813424|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1813425|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
1813426|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
1813427|NCT04781998|Liraglutide|liraglutide|mesh-list
1813428|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1813429|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813430|NCT04781998|Incretins|incretins|mesh-ancestor
1813431|NCT04781998|Hormones|hormones|mesh-ancestor
1813432|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1813442|NCT04781803|Cyclosporine|cyclosporine|mesh-list
1813443|NCT04781803|Cyclosporins|cyclosporins|mesh-list
1813444|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813445|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813446|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1813447|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
1813448|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813449|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
1813450|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1813451|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
1813452|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1813453|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1813454|NCT04781673|Lidocaine|lidocaine|mesh-list
1813455|NCT04781673|Ketamine|ketamine|mesh-list
1813456|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
1813457|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
1813458|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813459|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813460|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
1813461|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813462|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1813463|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1813464|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1813465|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1813466|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813467|NCT04781673|Analgesics|analgesics|mesh-ancestor
1813468|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1813546|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1813469|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1813470|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
1813471|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1813472|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1813473|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1813474|NCT04781959|Lenograstim|lenograstim|mesh-list
1813475|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1813476|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
1813477|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813478|NCT04781686|Docetaxel|docetaxel|mesh-list
1813479|NCT04781686|Apatinib|apatinib|mesh-list
1813480|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813481|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
1813482|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
1813483|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
1813484|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813485|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1813486|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813493|NCT04781777|Insulin|insulin|mesh-list
1813494|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1813495|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813496|NCT04781751|Insulin|insulin|mesh-list
1813497|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1813498|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813499|NCT04781270|Bevacizumab|bevacizumab|mesh-list
1813500|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1813501|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813502|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1813503|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1813504|NCT04781270|Growth Substances|growth substances|mesh-ancestor
1813505|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813506|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
1813507|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1813508|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1813509|NCT04781075|Bupivacaine|bupivacaine|mesh-list
1813510|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
1813511|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
1813512|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813513|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813514|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
1813515|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813516|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
1813517|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1813518|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1813519|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
1813520|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1813521|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1813522|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1813523|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1813524|NCT04780867|Vaccines|vaccines|mesh-list
1813525|NCT04780867|Immunologic Factors|immunologic factors|mesh-ancestor
1813526|NCT04780867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813527|NCT04780945|Olaparib|olaparib|mesh-list
1813528|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1813529|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813530|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813531|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813536|NCT04780659|Vaccines|vaccines|mesh-list
1813537|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
1813538|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813539|NCT04780750|Docetaxel|docetaxel|mesh-list
1813540|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813541|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
1813542|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
1813543|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
1813544|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813545|NCT04780854|Metformin|metformin|mesh-list
1813547|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813553|NCT04781088|Paclitaxel|paclitaxel|mesh-list
1813554|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
1813555|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1813556|NCT04781088|Lenvatinib|lenvatinib|mesh-list
1813557|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1813558|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813559|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
1813560|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
1813561|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
1813562|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813563|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1813564|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1813565|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813566|NCT04780581|Dexamethasone|dexamethasone|mesh-list
1813567|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
1813568|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1813569|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1813570|NCT04780581|Prednisolone|prednisolone|mesh-list
1813571|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
1813572|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1813573|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
1813574|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1813575|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
1813576|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
1813577|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813578|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813579|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1813580|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
1813581|NCT04780581|Hormones|hormones|mesh-ancestor
1813582|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1813583|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1813584|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813585|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1813586|NCT04780581|Protective Agents|protective agents|mesh-ancestor
1813587|NCT04780958|Vitamin A|vitamin a|mesh-list
1813588|NCT04780958|Vitamins|vitamins|mesh-ancestor
1813589|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
1813590|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813591|NCT04780568|Osimertinib|osimertinib|mesh-list
1813592|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813593|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1813594|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813595|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813596|NCT04780984|Bromides|bromides|mesh-list
1813597|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
1813598|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1813599|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
1813600|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813601|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813602|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1813603|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
1813604|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
1813605|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1813606|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
1813607|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1813608|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813609|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
1813614|NCT04780412|Alprostadil|alprostadil|mesh-list
1813615|NCT04780412|Misoprostol|misoprostol|mesh-list
1813616|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1813617|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
1813618|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1813619|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813620|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1813621|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1813622|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
1813623|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1813624|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
1813625|NCT04780412|Urological Agents|urological agents|mesh-ancestor
1813626|NCT04780347|Paclitaxel|paclitaxel|mesh-list
1813627|NCT04780347|Capecitabine|capecitabine|mesh-list
1813628|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1813629|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1813630|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813631|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
1813632|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
1813633|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
1813634|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813635|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1813636|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
1813637|NCT04780269|Dinoprostone|dinoprostone|mesh-list
1813638|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
1813639|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1813640|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813650|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
1813651|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1813652|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813653|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1813654|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813655|NCT04780217|Pembrolizumab|pembrolizumab|mesh-list
1813656|NCT04780217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1813657|NCT04780217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813658|NCT04779853|Antibodies|antibodies|mesh-list
1813659|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
1813660|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813661|NCT04779892|Infliximab|infliximab|mesh-list
1813662|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
1813663|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1813664|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1813665|NCT04780152|Fluoxetine|fluoxetine|mesh-list
1813666|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
1813667|NCT04780152|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1813668|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1813669|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1813670|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813671|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1813672|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
1813673|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813674|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1813675|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1813676|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1813677|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1813678|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813679|NCT04779762|Ustekinumab|ustekinumab|mesh-list
1813680|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
1813681|NCT04779645|Volagidemab|volagidemab|mesh-list
1813682|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1813683|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813684|NCT04780061|Vitamin D|vitamin d|mesh-list
1813685|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
1813686|NCT04780061|Vitamins|vitamins|mesh-list
1813687|NCT04780061|Vitamin K|vitamin k|mesh-list
1813688|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
1813689|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
1813690|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813691|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1813692|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1813693|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813694|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1813695|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1813696|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
1813697|NCT04780061|Coagulants|coagulants|mesh-ancestor
1813698|NCT04779255|Acetaminophen|acetaminophen|mesh-list
1813699|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813700|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1813701|NCT04779255|Analgesics|analgesics|mesh-ancestor
1813702|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
1813703|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813704|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
1813705|NCT04779567|Acetaminophen|acetaminophen|mesh-list
1813706|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1813707|NCT04779567|Analgesics|analgesics|mesh-ancestor
1813708|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
1813709|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813710|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813711|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
1813712|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
1813713|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1813714|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1813715|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1813716|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
1813717|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
1813718|NCT04779580|Anesthetics|anesthetics|mesh-list
1813719|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
1813720|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813721|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813722|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
1813723|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813724|NCT04779554|Mitomycins|mitomycins|mesh-list
1813725|NCT04779554|Mitomycin|mitomycin|mesh-list
1813726|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1813727|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813728|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
1813729|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813730|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1813731|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813734|NCT04778904|Nivolumab|nivolumab|mesh-list
1813735|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1813736|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813737|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1813738|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813739|NCT04778982|Fulvestrant|fulvestrant|mesh-list
1813740|NCT04778982|Palbociclib|palbociclib|mesh-list
1813741|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1813742|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813743|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1813744|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1813745|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
1813746|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1813747|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813748|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1813749|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813750|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813754|NCT04779151|Niraparib|niraparib|mesh-list
1813755|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1813756|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813757|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813758|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813759|NCT04779060|Dexamethasone|dexamethasone|mesh-list
1813760|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1813761|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
1813762|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
1813763|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813764|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813765|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1813766|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
1813767|NCT04779060|Hormones|hormones|mesh-ancestor
1813768|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1813769|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1813770|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813771|NCT04778917|Heparin|heparin|mesh-list
1813772|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1813773|NCT04778917|Tinzaparin|tinzaparin|mesh-list
1813774|NCT04778917|Dalteparin|dalteparin|mesh-list
1813775|NCT04778917|Calcium heparin|calcium heparin|mesh-list
1813776|NCT04778917|Calcium|calcium|mesh-list
1813777|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1813778|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813779|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
1813780|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1813781|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1813782|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813783|NCT04778865|Vitamin D|vitamin d|mesh-list
1813784|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
1813785|NCT04778865|Vitamins|vitamins|mesh-list
1813786|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
1813787|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813788|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1813789|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1813794|NCT04778839|Paclitaxel|paclitaxel|mesh-list
1813795|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1813796|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1813797|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813798|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
1813799|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
1813800|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
1813801|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813802|NCT04778813|Artesunate|artesunate|mesh-list
1813803|NCT04778813|Lumefantrine|lumefantrine|mesh-list
1813804|NCT04778813|Artemether|artemether|mesh-list
1813805|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1813806|NCT04778813|Artenimol|artenimol|mesh-list
1813807|NCT04778813|Pyronaridine|pyronaridine|mesh-list
1813808|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
1813809|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1813810|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1813811|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1813812|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1813813|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
1813814|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
1813815|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1813816|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
1813817|NCT04779047|Ritonavir|ritonavir|mesh-list
1813818|NCT04779047|Lopinavir|lopinavir|mesh-list
1813819|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
1813820|NCT04779047|Ivermectin|ivermectin|mesh-list
1813821|NCT04779047|Remdesivir|remdesivir|mesh-list
1813822|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1813823|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1813824|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
1813825|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813826|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813827|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1813828|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1813829|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
1813830|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1813831|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1813832|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1813833|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
1813834|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1813835|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1813836|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1813837|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
1813838|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
1813839|NCT04778787|Digoxin|digoxin|mesh-list
1813840|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
1813841|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
1813842|NCT04778787|Diuretics|diuretics|mesh-list
1813843|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
1813844|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1813845|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813846|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1813847|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813848|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1813849|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1813850|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813851|NCT04778787|Protective Agents|protective agents|mesh-ancestor
1813852|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
1813853|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1813854|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
1813855|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
1813856|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
1813857|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1813858|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813859|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1813860|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1813861|NCT04778358|Hormones|hormones|mesh-ancestor
1813862|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1813863|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813864|NCT04778176|Levodopa|levodopa|mesh-list
1813865|NCT04778176|Carbidopa|carbidopa|mesh-list
1813866|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1813867|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1813868|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
1813869|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1813870|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813871|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813872|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1813873|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813892|NCT04778072|Iron|iron|mesh-list
1813893|NCT04778072|Trace Elements|trace elements|mesh-ancestor
1813894|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
1813895|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813896|NCT04778137|Omalizumab|omalizumab|mesh-list
1813897|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1813898|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1813899|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
1813900|NCT04777968|Fluorides|fluorides|mesh-list
1813901|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
1813902|NCT04777968|Protective Agents|protective agents|mesh-ancestor
1813903|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813904|NCT04777929|Progesterone|progesterone|mesh-list
1813905|NCT04777929|Estrogens|estrogens|mesh-list
1813906|NCT04777929|Progestins|progestins|mesh-ancestor
1813907|NCT04777929|Hormones|hormones|mesh-ancestor
1813908|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1813909|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813915|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1813916|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
1813919|NCT04777383|Atropine|atropine|mesh-list
1813920|NCT04777383|Phenylephrine|phenylephrine|mesh-list
1813921|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
1813922|NCT04777383|Norepinephrine|norepinephrine|mesh-list
1813923|NCT04777383|Acetylcholine|acetylcholine|mesh-list
1813924|NCT04777383|Neostigmine|neostigmine|mesh-list
1813925|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1813926|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
1813927|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
1813928|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813929|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813930|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
1813931|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1813932|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
1813933|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
1813934|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1813935|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1813936|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1813937|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
1813938|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1813939|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813940|NCT04777383|Protective Agents|protective agents|mesh-ancestor
1813941|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1813942|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1813943|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1813944|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1813945|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
1813946|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1813947|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1813948|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
1813949|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1813950|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1813951|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1813952|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
1813953|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1813954|NCT04777539|Natalizumab|natalizumab|mesh-list
1813955|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
1813956|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813957|NCT04777838|Amitriptyline|amitriptyline|mesh-list
1813958|NCT04777838|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
1813959|NCT04777838|Citalopram|citalopram|mesh-list
1813960|NCT04777838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1813961|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1813962|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1813963|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1813964|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1813965|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
1813966|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813967|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1813968|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
1813969|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1813970|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813971|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1813972|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1813973|NCT04777838|Analgesics|analgesics|mesh-ancestor
1813974|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
1813975|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1813976|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
1813977|NCT04777838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1813978|NCT04777838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1813979|NCT04777838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813980|NCT04777552|Diazepam|diazepam|mesh-list
1813981|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1813982|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
1813983|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
1813984|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
1813985|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1813986|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1813987|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1813988|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1813989|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1813990|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1813991|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1813992|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1813993|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1813994|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1813995|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1813996|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
1813997|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
1813998|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
1813999|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
1814000|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1814001|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814002|NCT04777591|Bupivacaine|bupivacaine|mesh-list
1814003|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
1814004|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
1814005|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814006|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814007|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
1814008|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814009|NCT04777045|Diltiazem|diltiazem|mesh-list
1814010|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1814011|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1814012|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1814013|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814014|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1814015|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814016|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
1814017|NCT04777227|Lidocaine|lidocaine|mesh-list
1814018|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
1814019|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
1814020|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814021|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814022|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
1814023|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814024|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1814025|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1814026|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1814027|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1814028|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814029|NCT04777071|Edetic Acid|edetic acid|mesh-list
1814030|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1814031|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
1814032|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
1814033|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814034|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
1814035|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1814036|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1814037|NCT04777110|Esketamine|esketamine|mesh-list
1814038|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
1814039|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1814040|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1814041|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1814042|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1814043|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
1814044|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814045|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1814046|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1814047|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814052|NCT04776993|Methimazole|methimazole|mesh-list
1814053|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
1814054|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
1814055|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1814056|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814079|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
1814080|NCT04776850|Dexamethasone|dexamethasone|mesh-list
1814081|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
1814082|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
1814083|NCT04776850|Busulfan|busulfan|mesh-list
1814084|NCT04776850|Rituximab|rituximab|mesh-list
1814085|NCT04776850|Fludarabine|fludarabine|mesh-list
1814086|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
1814087|NCT04776850|Bortezomib|bortezomib|mesh-list
1814088|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1814089|NCT04776850|Tacrolimus|tacrolimus|mesh-list
1814090|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
1814091|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1814092|NCT04776850|Antibodies|antibodies|mesh-list
1814093|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
1814094|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1814095|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
1814096|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1814097|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1814098|NCT04776850|BB 1101|bb 1101|mesh-list
1814099|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1814100|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
1814101|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814102|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1814103|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1814104|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
1814105|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814106|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814107|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1814108|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1814109|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
1814110|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
1814111|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814112|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1814113|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
1814114|NCT04776850|Hormones|hormones|mesh-ancestor
1814115|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1814116|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1814117|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
1814118|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814119|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1814120|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
1814121|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1814122|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1814123|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1814124|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
1814125|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1814126|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814127|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
1814128|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
1814129|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814130|NCT04776512|Bupivacaine|bupivacaine|mesh-list
1814131|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
1814132|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
1814133|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814134|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814135|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
1814136|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814137|NCT04776525|Doxorubicin|doxorubicin|mesh-list
1814138|NCT04776525|Ifosfamide|ifosfamide|mesh-list
1814139|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1814140|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814141|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1814142|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1814143|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814144|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814145|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1814146|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
1814147|NCT04776499|Perphenazine|perphenazine|mesh-list
1814148|NCT04776499|Riociguat|riociguat|mesh-list
1814149|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
1814150|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
1814151|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814152|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1814153|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1814154|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814155|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814156|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1814157|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1814158|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
1814159|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1814160|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
1814161|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
1814162|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
1814163|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1814164|NCT04776655|Leucovorin|leucovorin|mesh-list
1814165|NCT04776655|Bevacizumab|bevacizumab|mesh-list
1814166|NCT04776655|Cetuximab|cetuximab|mesh-list
1814167|NCT04776655|Fluorouracil|fluorouracil|mesh-list
1814168|NCT04776655|Irinotecan|irinotecan|mesh-list
1814169|NCT04776655|Calcium|calcium|mesh-list
1814170|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
1814171|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1814172|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814173|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1814174|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1814175|NCT04776655|Growth Substances|growth substances|mesh-ancestor
1814176|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814177|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
1814178|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1814179|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
1814180|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814181|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1814182|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1814183|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
1814184|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1814185|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1814186|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814187|NCT04776655|Antidotes|antidotes|mesh-ancestor
1814188|NCT04776655|Protective Agents|protective agents|mesh-ancestor
1814189|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
1814190|NCT04776655|Vitamins|vitamins|mesh-ancestor
1814191|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
1814192|NCT04776395|Dexamethasone|dexamethasone|mesh-list
1814193|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
1814194|NCT04776395|Ichthammol|ichthammol|mesh-list
1814195|NCT04776395|BB 1101|bb 1101|mesh-list
1814196|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1814197|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
1814198|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
1814199|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814200|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814201|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1814202|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
1814203|NCT04776395|Hormones|hormones|mesh-ancestor
1814204|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1814205|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1814206|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814207|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
1814208|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814209|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814210|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
1814211|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
1814212|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1814213|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
1814214|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814215|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814216|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1814217|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
1814218|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1814219|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
1814220|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814221|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1814222|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1814223|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
1814224|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
1814225|NCT04776408|Protective Agents|protective agents|mesh-ancestor
1814226|NCT04776369|Lidocaine|lidocaine|mesh-list
1814227|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
1814228|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
1814229|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
1814230|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814231|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814232|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
1814233|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814234|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1814235|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1814236|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1814237|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1814238|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814239|NCT04776369|Analgesics|analgesics|mesh-ancestor
1814240|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
1814241|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1814242|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1814243|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
1814244|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1814245|NCT04776213|Cladribine|cladribine|mesh-list
1814246|NCT04776213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814247|NCT04776213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1814248|NCT04776213|Immunologic Factors|immunologic factors|mesh-ancestor
1814249|NCT04776213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814250|NCT04776135|Edaravone|edaravone|mesh-list
1814251|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1814252|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
1814253|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814254|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1814255|NCT04776135|Protective Agents|protective agents|mesh-ancestor
1814256|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814257|NCT04776226|Citalopram|citalopram|mesh-list
1814258|NCT04776226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1814259|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1814260|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1814261|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814262|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1814263|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
1814264|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814265|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1814266|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
1814267|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1814268|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1814269|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
1814270|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1814271|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1814272|NCT04776096|Analgesics|analgesics|mesh-ancestor
1814273|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
1814274|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814275|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814276|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1814277|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1814278|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1814279|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1814280|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1814281|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
1814282|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
1814283|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1814284|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814285|NCT04775797|Tenofovir|tenofovir|mesh-list
1814286|NCT04775797|Antiviral Agents|antiviral agents|mesh-ancestor
1814287|NCT04775797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814288|NCT04775797|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1814289|NCT04775797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1814290|NCT04775797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814291|NCT04775797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814292|NCT04775797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1814293|NCT04775797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1814294|NCT04775732|Infliximab|infliximab|mesh-list
1814295|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
1814296|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1814297|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1814301|NCT04775563|Vaccines|vaccines|mesh-list
1814302|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
1814303|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814304|NCT04775303|Cyclosporine|cyclosporine|mesh-list
1814305|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1814306|NCT04775303|Cyclosporins|cyclosporins|mesh-list
1814307|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814308|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814309|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1814310|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
1814311|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814312|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
1814313|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814314|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
1814315|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1814316|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1814317|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1814318|NCT04775576|Anesthetics|anesthetics|mesh-list
1814319|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814320|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814321|NCT04775381|Vitamin D|vitamin d|mesh-list
1814322|NCT04775381|Vitamins|vitamins|mesh-ancestor
1814323|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
1814324|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814325|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1814326|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1814327|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
1814328|NCT04775212|Sevoflurane|sevoflurane|mesh-list
1814329|NCT04775212|Desflurane|desflurane|mesh-list
1814330|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1814331|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1814332|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
1814333|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
1814334|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814335|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814336|NCT04775238|Copper|copper|mesh-list
1814337|NCT04775238|Trace Elements|trace elements|mesh-ancestor
1814338|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
1814339|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814340|NCT04775173|Sirolimus|sirolimus|mesh-list
1814341|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1814342|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814343|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1814344|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814345|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
1814346|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1814347|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
1814348|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814349|NCT04775225|Lidocaine|lidocaine|mesh-list
1814350|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
1814351|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
1814352|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814353|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814354|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
1814355|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814356|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1814357|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1814358|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1814359|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1814360|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814361|NCT04774991|Azithromycin|azithromycin|mesh-list
1814362|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1814363|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814364|NCT04774666|Antibodies|antibodies|mesh-list
1814365|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
1814366|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814367|NCT04774822|Mydriatics|mydriatics|mesh-list
1814368|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
1814369|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814370|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814371|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
1814372|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814373|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
1814374|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
1814375|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
1814376|NCT04774627|Olaparib|olaparib|mesh-list
1814377|NCT04774627|Niraparib|niraparib|mesh-list
1814378|NCT04774627|Veliparib|veliparib|mesh-list
1814379|NCT04774627|Talazoparib|talazoparib|mesh-list
1814380|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1814381|NCT04774627|Rucaparib|rucaparib|mesh-list
1814382|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814383|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814384|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814385|NCT04775329|Rifaximin|rifaximin|mesh-list
1814386|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1814387|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814388|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1814396|NCT04774120|Propofol|propofol|mesh-list
1814397|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1814398|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814399|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814400|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1814401|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
1814402|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
1814412|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1814413|NCT04774068|Romidepsin|romidepsin|mesh-list
1814414|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814415|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1814416|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814417|NCT04774029|Lidocaine|lidocaine|mesh-list
1814418|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
1814419|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
1814420|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814421|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814422|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
1814423|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814424|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1814425|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1814426|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1814427|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1814428|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814429|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
1814430|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
1814431|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814432|NCT04773951|Antibodies|antibodies|mesh-list
1814433|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1814434|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
1814435|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814436|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
1814437|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
1814438|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1814439|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814440|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814441|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
1814442|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1814443|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814444|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814445|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
1814446|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
1814447|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814448|NCT04773717|Protective Agents|protective agents|mesh-ancestor
1814449|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814450|NCT04773717|Vitamins|vitamins|mesh-ancestor
1814451|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
1814452|NCT04774159|Colchicine|colchicine|mesh-list
1814453|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
1814454|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1814455|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
1814456|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
1814457|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
1814458|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814459|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814460|NCT04774406|Olaparib|olaparib|mesh-list
1814461|NCT04774406|Niraparib|niraparib|mesh-list
1814462|NCT04774406|Veliparib|veliparib|mesh-list
1814463|NCT04774406|Talazoparib|talazoparib|mesh-list
1814464|NCT04774406|Rucaparib|rucaparib|mesh-list
1814465|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1814466|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814467|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814468|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814469|NCT04773366|Cytarabine|cytarabine|mesh-list
1814470|NCT04773366|Prednisone|prednisone|mesh-list
1814471|NCT04773366|Vincristine|vincristine|mesh-list
1814472|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
1814473|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1814474|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
1814475|NCT04773366|Hormones|hormones|mesh-ancestor
1814476|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1814477|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814478|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1814479|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814480|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1814481|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
1814482|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814483|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
1814484|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814485|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1814486|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
1814487|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1814488|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
1814489|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
1814490|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
1814491|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1814492|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814493|NCT04773301|Ropivacaine|ropivacaine|mesh-list
1814494|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
1814495|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
1814496|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
1814497|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814498|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814499|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
1814500|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814501|NCT04773236|Lidocaine|lidocaine|mesh-list
1814502|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
1814503|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
1814504|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814505|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814506|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
1814507|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814508|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1814509|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1814510|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1814511|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1814512|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814513|NCT04774393|Decitabine|decitabine|mesh-list
1814514|NCT04774393|Venetoclax|venetoclax|mesh-list
1814515|NCT04774393|Ivosidenib|ivosidenib|mesh-list
1814516|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1814517|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
1814518|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814519|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814520|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814521|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
1814522|NCT04773392|Prednisone|prednisone|mesh-list
1814523|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
1814524|NCT04773392|Azathioprine|azathioprine|mesh-list
1814525|NCT04773392|Tacrolimus|tacrolimus|mesh-list
1814526|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
1814527|NCT04773392|Basiliximab|basiliximab|mesh-list
1814528|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1814529|NCT04773392|Antimetabolites|antimetabolites|mesh-list
1814530|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1814531|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
1814532|NCT04773392|Hormones|hormones|mesh-ancestor
1814533|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1814534|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814535|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1814536|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814537|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1814538|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
1814767|NCT04771728|Metronidazole|metronidazole|mesh-list
1814539|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1814540|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814541|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814542|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1814543|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1814544|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
1814545|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1814546|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814547|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
1814548|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
1814549|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814550|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1814551|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1814552|NCT04773392|Protective Agents|protective agents|mesh-ancestor
1814553|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1814554|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1814555|NCT04773093|Lidocaine|lidocaine|mesh-list
1814556|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
1814557|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
1814558|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814559|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814560|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
1814561|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814562|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1814563|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1814564|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1814565|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1814566|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814567|NCT04772781|Ibuprofen|ibuprofen|mesh-list
1814568|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1814569|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1814570|NCT04772781|Analgesics|analgesics|mesh-ancestor
1814571|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
1814572|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814573|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814574|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1814575|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1814576|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1814577|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814578|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814579|NCT04773002|Anesthetics|anesthetics|mesh-list
1814580|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814581|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814582|NCT04772729|Insulin|insulin|mesh-list
1814583|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1814584|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
1814585|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1814586|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814596|NCT04772521|Nicotine|nicotine|mesh-list
1814597|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1814598|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
1814599|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814600|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814601|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1814602|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1814603|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
1814604|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1814605|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814606|NCT04772287|Gemcitabine|gemcitabine|mesh-list
1814607|NCT04772287|Paclitaxel|paclitaxel|mesh-list
1814608|NCT04772287|Vinorelbine|vinorelbine|mesh-list
1814609|NCT04772287|Docetaxel|docetaxel|mesh-list
1814610|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1814611|NCT04772287|Cisplatin|cisplatin|mesh-list
1814612|NCT04772287|Carboplatin|carboplatin|mesh-list
1814613|NCT04772287|Pemetrexed|pemetrexed|mesh-list
1814614|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1814615|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814616|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
1814617|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
1814618|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
1814619|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814620|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1814621|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
1814622|NCT04772287|Antiviral Agents|antiviral agents|mesh-ancestor
1814623|NCT04772287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814624|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814625|NCT04772287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1814626|NCT04772287|Immunologic Factors|immunologic factors|mesh-ancestor
1814627|NCT04772287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814628|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1814629|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1814646|NCT04772196|Vitamin D|vitamin d|mesh-list
1814647|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
1814648|NCT04772196|Vitamins|vitamins|mesh-ancestor
1814649|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
1814650|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814651|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1814652|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1814670|NCT04772248|Adalimumab|adalimumab|mesh-list
1814671|NCT04772248|Etanercept|etanercept|mesh-list
1814672|NCT04772248|Golimumab|golimumab|mesh-list
1814673|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
1814674|NCT04772248|Infliximab|infliximab|mesh-list
1814675|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
1814676|NCT04772248|Tofacitinib|tofacitinib|mesh-list
1814677|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1814678|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1814679|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1814680|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1814681|NCT04772248|Analgesics|analgesics|mesh-ancestor
1814682|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
1814683|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814684|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814685|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1814686|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1814687|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
1814688|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
1814689|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1814690|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814691|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814692|NCT04772352|Febuxostat|febuxostat|mesh-list
1814693|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
1814694|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1814695|NCT04772209|Heparin|heparin|mesh-list
1814696|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
1814697|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1814698|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1814699|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814700|NCT04772235|Osimertinib|osimertinib|mesh-list
1814701|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814702|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1814703|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814704|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814705|NCT04772001|Carboplatin|carboplatin|mesh-list
1814706|NCT04772001|Cisplatin|cisplatin|mesh-list
1814707|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814708|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
1814709|NCT04771715|Nivolumab|nivolumab|mesh-list
1814710|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1814711|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814712|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1814713|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814714|NCT04771871|Paclitaxel|paclitaxel|mesh-list
1814715|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
1814716|NCT04771871|Carboplatin|carboplatin|mesh-list
1814717|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1814718|NCT04771871|Epirubicin|epirubicin|mesh-list
1814719|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1814720|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814721|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
1814722|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
1814723|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
1814724|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814725|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1814726|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
1814727|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814728|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1814729|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1814730|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
1814731|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1814732|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1814733|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1814734|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1814735|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814736|NCT04771741|Acetaminophen|acetaminophen|mesh-list
1814737|NCT04771741|Ketorolac|ketorolac|mesh-list
1814738|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1814739|NCT04771741|Meloxicam|meloxicam|mesh-list
1814740|NCT04771741|Pregabalin|pregabalin|mesh-list
1814741|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
1814742|NCT04771741|Analgesics|analgesics|mesh-ancestor
1814743|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
1814744|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814745|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814746|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
1814747|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1814748|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1814749|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814750|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1814751|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1814752|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1814753|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814754|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1814755|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1814756|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1814757|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1814758|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1814759|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1814760|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814761|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
1814762|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1814763|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1814764|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
1814765|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1814766|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1814768|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814769|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1814770|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1814771|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1814772|NCT04771923|Epinephrine|epinephrine|mesh-list
1814773|NCT04771923|Racepinephrine|racepinephrine|mesh-list
1814774|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
1814775|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
1814776|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1814777|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1814778|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814779|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
1814780|NCT04771923|Coagulants|coagulants|mesh-ancestor
1814781|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1814782|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1814783|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
1814784|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1814785|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814786|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1814787|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1814788|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
1814789|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814790|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1814791|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
1814792|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
1814793|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
1814794|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1814795|NCT04771884|Vancomycin|vancomycin|mesh-list
1814796|NCT04771884|Meropenem|meropenem|mesh-list
1814797|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
1814798|NCT04771884|Linezolid|linezolid|mesh-list
1814799|NCT04771884|Ceftazidime|ceftazidime|mesh-list
1814800|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
1814801|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1814802|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814803|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1814804|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814805|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814806|NCT04771754|Dolutegravir|dolutegravir|mesh-list
1814807|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1814808|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1814809|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814810|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814811|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1814812|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1814813|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
1814814|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814815|NCT04771559|Antibodies|antibodies|mesh-list
1814816|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
1814817|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814818|NCT04771767|Ketamine|ketamine|mesh-list
1814819|NCT04771767|Analgesics|analgesics|mesh-ancestor
1814820|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
1814821|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814822|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814823|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1814824|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1814825|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
1814826|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
1814827|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814828|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1814829|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1814830|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1814831|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814832|NCT04771520|Piperazine|piperazine|mesh-list
1814833|NCT04771520|Mebendazole|mebendazole|mesh-list
1814834|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
1814835|NCT04771520|DMP 777|dmp 777|mesh-list
1814836|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
1814837|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
1814838|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1814839|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814840|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
1814841|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
1814842|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
1814843|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814844|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814845|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814846|NCT04771130|Posaconazole|posaconazole|mesh-list
1814847|NCT04771130|Azacitidine|azacitidine|mesh-list
1814848|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1814849|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
1814850|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814851|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814852|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814853|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
1814854|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814855|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1814856|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1814857|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1814858|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1814859|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1814860|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1814861|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
1814862|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1814863|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814864|NCT04771390|Selitrectinib|selitrectinib|mesh-list
1814865|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814866|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814867|NCT04771481|Metoclopramide|metoclopramide|mesh-list
1814868|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
1814869|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
1814870|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814871|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814872|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1814873|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1814874|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1814875|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
1814876|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1814877|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814878|NCT04771299|Cariprazine|cariprazine|mesh-list
1814879|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1814880|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1814881|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814882|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814883|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1814884|NCT04771026|Dexamethasone|dexamethasone|mesh-list
1814885|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1814886|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
1814887|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
1814888|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814889|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814890|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1814891|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
1814892|NCT04771026|Hormones|hormones|mesh-ancestor
1814893|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1814894|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1814895|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814896|NCT04771000|Ambrisentan|ambrisentan|mesh-list
1814897|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1814898|NCT04770740|Vitamin K|vitamin k|mesh-list
1814899|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
1814900|NCT04770740|Vitamin MK 7|vitamin mk 7|mesh-list
1814901|NCT04770740|Vitamins|vitamins|mesh-ancestor
1814902|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
1814903|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814904|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1814905|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1814906|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814907|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
1814908|NCT04770740|Coagulants|coagulants|mesh-ancestor
1814909|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
1814910|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1814911|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1814912|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1814913|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
1814914|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
1814915|NCT04770623|Docetaxel|docetaxel|mesh-list
1814916|NCT04770623|Irinotecan|irinotecan|mesh-list
1814917|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814918|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
1814919|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
1814920|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
1814921|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814922|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1814923|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1814924|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814925|NCT04770688|Osimertinib|osimertinib|mesh-list
1814926|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814927|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1814928|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814929|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814930|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1814931|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1814932|NCT04770961|Ropivacaine|ropivacaine|mesh-list
1814933|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
1814934|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
1814935|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1814936|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1814937|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
1814938|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1814939|NCT04770155|Bosentan|bosentan|mesh-list
1814940|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
1814941|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
1814942|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1814943|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1814944|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814945|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814946|NCT04770155|Urological Agents|urological agents|mesh-ancestor
1814947|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1814948|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
1814949|NCT04770389|Ezetimibe|ezetimibe|mesh-list
1814950|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
1814951|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1814952|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
1814953|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1814954|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1814978|NCT04769908|Lenvatinib|lenvatinib|mesh-list
1814979|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1814980|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1814981|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1814982|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815005|NCT04769557|Acetaminophen|acetaminophen|mesh-list
1815006|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1815007|NCT04769557|Analgesics|analgesics|mesh-ancestor
1815008|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
1815009|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815010|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815011|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
1815012|NCT04769713|Ropivacaine|ropivacaine|mesh-list
1815013|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
1815014|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
1815015|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815016|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815017|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
1815018|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815019|NCT04769583|Metronidazole|metronidazole|mesh-list
1815020|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1815021|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1815022|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1815023|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1815024|NCT04769778|Valsartan|valsartan|mesh-list
1815025|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1815026|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1815027|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1815028|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815034|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1815035|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1815036|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
1815037|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815038|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815039|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815040|NCT04769414|Gemcitabine|gemcitabine|mesh-list
1815041|NCT04769414|Fluorouracil|fluorouracil|mesh-list
1815042|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1815043|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
1815044|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815045|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815046|NCT04769414|Antiviral Agents|antiviral agents|mesh-ancestor
1815047|NCT04769414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1815048|NCT04769414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815049|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1815050|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
1815051|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815052|NCT04769258|Vaccines|vaccines|mesh-list
1815053|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
1815054|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815055|NCT04769388|Carboplatin|carboplatin|mesh-list
1815056|NCT04769388|Pemetrexed|pemetrexed|mesh-list
1815057|NCT04769388|Osimertinib|osimertinib|mesh-list
1815058|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815059|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815060|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815061|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1815062|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1815063|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1815064|NCT04769297|Ketamine|ketamine|mesh-list
1815065|NCT04769297|Analgesics|analgesics|mesh-ancestor
1815066|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
1815067|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815068|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815069|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1815070|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1815071|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
1815072|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
1815297|NCT04767217|Artemether|artemether|mesh-list
1815073|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815074|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1815075|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1815076|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815077|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815078|NCT04769076|Paclitaxel|paclitaxel|mesh-list
1815079|NCT04769076|Cisplatin|cisplatin|mesh-list
1815080|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1815081|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1815082|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815083|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
1815084|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
1815085|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
1815086|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815087|NCT04769050|Docetaxel|docetaxel|mesh-list
1815088|NCT04769050|Capecitabine|capecitabine|mesh-list
1815089|NCT04769050|Trastuzumab|trastuzumab|mesh-list
1815090|NCT04769050|Pertuzumab|pertuzumab|mesh-list
1815091|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815092|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
1815093|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
1815094|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
1815095|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815096|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1815097|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
1815098|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1815099|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
1815100|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1815101|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1815102|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
1815103|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815104|NCT04768764|Bupivacaine|bupivacaine|mesh-list
1815105|NCT04768764|Anesthetics|anesthetics|mesh-list
1815106|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
1815107|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815108|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815109|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
1815110|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815111|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
1815112|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1815113|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815114|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
1815115|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1815116|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1815124|NCT04768465|Prednisone|prednisone|mesh-list
1815125|NCT04768465|Bromides|bromides|mesh-list
1815126|NCT04768465|Tacrolimus|tacrolimus|mesh-list
1815127|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
1815128|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1815129|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
1815130|NCT04768465|Hormones|hormones|mesh-ancestor
1815131|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1815132|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815133|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1815134|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815135|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1815136|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
1815137|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1815138|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815139|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815140|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
1815141|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1815142|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
1815143|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815144|NCT04768166|Miglustat|miglustat|mesh-list
1815145|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815146|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815147|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1815148|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1815149|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
1815150|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1815151|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
1815152|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1815153|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815154|NCT04768231|Rifampin|rifampin|mesh-list
1815155|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1815156|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
1815157|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1815158|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1815159|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
1815160|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1815161|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815162|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815163|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1815164|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1815165|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1815166|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1815167|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1815168|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1815174|NCT04768075|Paclitaxel|paclitaxel|mesh-list
1815175|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1815176|NCT04768075|Carboplatin|carboplatin|mesh-list
1815177|NCT04768075|Pemetrexed|pemetrexed|mesh-list
1815178|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1815179|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815180|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
1815181|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
1815182|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
1815183|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815184|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815185|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1815186|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1815187|NCT04768439|Vitamin D|vitamin d|mesh-list
1815188|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
1815189|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
1815190|NCT04768439|Calcitriol|calcitriol|mesh-list
1815191|NCT04768439|Vitamins|vitamins|mesh-list
1815192|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
1815193|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815194|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1815195|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1815196|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1815197|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1815198|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815199|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1815200|NCT04767841|Metformin|metformin|mesh-list
1815201|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1815202|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815203|NCT04768023|Vitamin D|vitamin d|mesh-list
1815204|NCT04768023|Vitamins|vitamins|mesh-ancestor
1815205|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
1815206|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815207|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1815208|NCT04767698|Belimumab|belimumab|mesh-list
1815209|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
1815210|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1815211|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
1815212|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815213|NCT04767828|Capecitabine|capecitabine|mesh-list
1815214|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1815215|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
1815216|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815217|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815218|NCT04767711|Prednisolone|prednisolone|mesh-list
1815219|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1815220|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
1815221|NCT04767711|Hormones|hormones|mesh-ancestor
1815222|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1815223|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815224|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1815225|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815226|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
1815227|NCT04767633|Analgesics|analgesics|mesh-ancestor
1815228|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
1815229|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815230|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815231|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
1815232|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815233|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1815234|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
1815235|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1815236|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1815237|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815238|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1815239|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
1815240|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1815241|NCT04767243|Methamphetamine|methamphetamine|mesh-list
1815242|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1815243|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815244|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
1815245|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
1815246|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815247|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
1815248|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815249|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815250|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
1815251|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1815252|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1815253|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1815254|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1815255|NCT04767256|Dexamethasone|dexamethasone|mesh-list
1815256|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
1815257|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1815258|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
1815259|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
1815260|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815261|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815262|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1815263|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
1815264|NCT04767256|Hormones|hormones|mesh-ancestor
1815265|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1815266|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1815267|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815268|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1815269|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815270|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1815271|NCT04767256|Analgesics|analgesics|mesh-ancestor
1815272|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
1815273|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1815274|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1815275|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1815276|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
1815277|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815278|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815279|NCT04767295|Paclitaxel|paclitaxel|mesh-list
1815280|NCT04767295|Carboplatin|carboplatin|mesh-list
1815281|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1815282|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815283|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
1815284|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
1815285|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
1815286|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815287|NCT04767503|Propofol|propofol|mesh-list
1815288|NCT04767503|Desflurane|desflurane|mesh-list
1815289|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1815290|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815291|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815292|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1815293|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
1815294|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
1815295|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1815296|NCT04767217|Lumefantrine|lumefantrine|mesh-list
1815298|NCT04767217|Piperaquine|piperaquine|mesh-list
1815299|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1815300|NCT04767217|Artenimol|artenimol|mesh-list
1815301|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
1815302|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1815303|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1815304|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1815305|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
1815306|NCT04767308|Fludarabine|fludarabine|mesh-list
1815307|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1815308|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
1815309|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815310|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1815311|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1815312|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
1815313|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815314|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815315|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1815316|NCT04767594|Palbociclib|palbociclib|mesh-list
1815317|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815318|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1815319|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815320|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815321|NCT04767178|Acetaminophen|acetaminophen|mesh-list
1815322|NCT04767178|Ibuprofen|ibuprofen|mesh-list
1815323|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1815324|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1815325|NCT04767178|Analgesics|analgesics|mesh-ancestor
1815326|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
1815327|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815328|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815329|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1815330|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1815331|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1815332|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815333|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815334|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
1815335|NCT04767542|Acetaminophen|acetaminophen|mesh-list
1815336|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815337|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1815338|NCT04767542|Analgesics|analgesics|mesh-ancestor
1815339|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
1815340|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815341|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
1815342|NCT04766853|Dexamethasone|dexamethasone|mesh-list
1815343|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
1815344|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1815345|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
1815346|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
1815347|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815348|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815349|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1815350|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
1815351|NCT04766853|Hormones|hormones|mesh-ancestor
1815352|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1815353|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1815354|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815355|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1815356|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
1815357|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
1815358|NCT04766853|Protective Agents|protective agents|mesh-ancestor
1815359|NCT04767035|Midazolam|midazolam|mesh-list
1815360|NCT04767035|Ketamine|ketamine|mesh-list
1815361|NCT04767035|Analgesics|analgesics|mesh-ancestor
1815362|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
1815363|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815364|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815365|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1815366|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1815367|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
1815368|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
1815369|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815370|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1815371|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1815372|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815373|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815374|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1815375|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1815376|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1815377|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1815378|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1815379|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
1815380|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
1815381|NCT04766827|Paclitaxel|paclitaxel|mesh-list
1815382|NCT04766827|Docetaxel|docetaxel|mesh-list
1815383|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1815384|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1815385|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815386|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
1815387|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
1815388|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
1815389|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815390|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
1815391|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1815392|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
1815393|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815394|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
1815395|NCT04766918|Protective Agents|protective agents|mesh-ancestor
1815396|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
1815397|NCT04767074|Guaifenesin|guaifenesin|mesh-list
1815398|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
1815399|NCT04767074|Expectorants|expectorants|mesh-ancestor
1815400|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
1815401|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1815402|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1815403|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
1815404|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815405|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815406|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815407|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
1815408|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1815409|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
1815410|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
1815411|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815412|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
1815413|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1815414|NCT04767061|Propranolol|propranolol|mesh-list
1815415|NCT04767061|Metoprolol|metoprolol|mesh-list
1815416|NCT04767061|Atenolol|atenolol|mesh-list
1815417|NCT04767061|Sotalol|sotalol|mesh-list
1815418|NCT04767061|Nadolol|nadolol|mesh-list
1815419|NCT04767061|Acebutolol|acebutolol|mesh-list
1815420|NCT04767061|Carvedilol|carvedilol|mesh-list
1815421|NCT04767061|Nebivolol|nebivolol|mesh-list
1815422|NCT04767061|Bisoprolol|bisoprolol|mesh-list
1815423|NCT04767061|Labetalol|labetalol|mesh-list
1815424|NCT04767061|Pindolol|pindolol|mesh-list
1815425|NCT04767061|Betaxolol|betaxolol|mesh-list
1815426|NCT04767061|Penbutolol|penbutolol|mesh-list
1815427|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1815428|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1815429|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
1815430|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815431|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815432|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815433|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1815434|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1815435|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
1815436|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
1815437|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
1815438|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815439|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1815440|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
1815441|NCT04767061|Protective Agents|protective agents|mesh-ancestor
1815442|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1815443|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1815444|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1815445|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1815446|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1815447|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1815448|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1815449|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1815450|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
1815451|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1815452|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
1815453|NCT04767113|Heparin|heparin|mesh-list
1815454|NCT04767113|Calcium heparin|calcium heparin|mesh-list
1815455|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
1815456|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1815457|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1815458|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815459|NCT04766775|Fluorides|fluorides|mesh-list
1815460|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
1815461|NCT04766775|Protective Agents|protective agents|mesh-ancestor
1815462|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815463|NCT04766762|Flunarizine|flunarizine|mesh-list
1815464|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
1815465|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1815466|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1815467|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815468|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1815469|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815470|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1815471|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
1815472|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
1815473|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815474|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
1815475|NCT04766736|Antibodies|antibodies|mesh-list
1815476|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
1815477|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815478|NCT04766307|Interleukin-2|interleukin-2|mesh-list
1815479|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815480|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1815481|NCT04766307|Analgesics|analgesics|mesh-ancestor
1815482|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
1815483|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815484|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815485|NCT04766359|Paclitaxel|paclitaxel|mesh-list
1815486|NCT04766359|Cisplatin|cisplatin|mesh-list
1815487|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1815488|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1815489|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815490|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
1815491|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
1815492|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
1815493|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815494|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1815495|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1815496|NCT04766177|Bumetanide|bumetanide|mesh-list
1815497|NCT04766177|Diuretics|diuretics|mesh-ancestor
1815498|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
1815499|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815500|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1815501|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1815502|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815503|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
1815504|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
1815505|NCT04766684|Lidocaine|lidocaine|mesh-list
1815506|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
1815507|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
1815508|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815509|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815510|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
1815511|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815512|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1815513|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1815514|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1815515|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1815516|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815517|NCT04766463|Morphine|morphine|mesh-list
1815518|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1815519|NCT04766463|Narcotics|narcotics|mesh-ancestor
1815520|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815521|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815522|NCT04766463|Analgesics|analgesics|mesh-ancestor
1815523|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
1815524|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815525|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
1815526|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1815527|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
1815528|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1815529|NCT04766450|Expectorants|expectorants|mesh-ancestor
1815530|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
1815531|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1815532|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
1815533|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815534|NCT04766450|Protective Agents|protective agents|mesh-ancestor
1815535|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815536|NCT04766450|Antidotes|antidotes|mesh-ancestor
1815537|NCT04766229|Gabapentin|gabapentin|mesh-list
1815538|NCT04766229|Citalopram|citalopram|mesh-list
1815539|NCT04766229|Analgesics|analgesics|mesh-ancestor
1815540|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
1815541|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815542|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815543|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
1815544|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1815545|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1815546|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815547|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1815548|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1815549|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1815550|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815551|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815552|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
1815553|NCT04766229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1815554|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1815555|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1815556|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
1815557|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1815558|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
1815562|NCT04765904|Fluorides|fluorides|mesh-list
1815563|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
1815564|NCT04765904|Protective Agents|protective agents|mesh-ancestor
1815565|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815566|NCT04765709|Carboplatin|carboplatin|mesh-list
1815567|NCT04765709|Pemetrexed|pemetrexed|mesh-list
1815568|NCT04765709|Durvalumab|durvalumab|mesh-list
1815569|NCT04765709|Vinorelbine|vinorelbine|mesh-list
1815570|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1815571|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815572|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815573|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815574|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1815575|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1815576|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1815577|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
1815578|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815579|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1815580|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
1815581|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
1815582|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
1815583|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
1815584|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1815585|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815586|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815587|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1815588|NCT04766047|Analgesics|analgesics|mesh-ancestor
1815589|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
1815590|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815591|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1815592|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1815593|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1815594|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
1815595|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815596|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815597|NCT04766008|Metformin|metformin|mesh-list
1815598|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1815599|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815600|NCT04766021|Mirabegron|mirabegron|mesh-list
1815601|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
1815602|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1815603|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1815604|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
1815605|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815606|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815607|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815608|NCT04766021|Urological Agents|urological agents|mesh-ancestor
1815609|NCT04765644|Celecoxib|celecoxib|mesh-list
1815610|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1815611|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1815612|NCT04765644|Analgesics|analgesics|mesh-ancestor
1815613|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
1815614|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815615|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815616|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1815617|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1815618|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1815619|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1815620|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815621|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815622|NCT04765267|Vitamin D|vitamin d|mesh-list
1815623|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
1815624|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
1815625|NCT04765267|Vitamins|vitamins|mesh-ancestor
1815626|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
1815627|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815628|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1815629|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1815630|NCT04765267|Astringents|astringents|mesh-ancestor
1815631|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
1815632|NCT04765514|Temozolomide|temozolomide|mesh-list
1815633|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1815634|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
1815635|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815636|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815637|NCT04765527|Turmeric extract|turmeric extract|mesh-list
1815638|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
1815639|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815640|NCT04765527|Protective Agents|protective agents|mesh-ancestor
1815641|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815642|NCT04765228|Doxorubicin|doxorubicin|mesh-list
1815643|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1815644|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1815645|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815646|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1815647|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1815648|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815649|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815658|NCT04765085|Aripiprazole|aripiprazole|mesh-list
1815659|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
1815660|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1815661|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1815662|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1815663|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815664|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815665|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
1815666|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
1815667|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815668|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815669|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1815670|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1815671|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
1815672|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1815673|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1815674|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1815675|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1815676|NCT04765111|Rituximab|rituximab|mesh-list
1815677|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1815678|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
1815679|NCT04765111|Antibodies|antibodies|mesh-list
1815680|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
1815681|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1815682|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
1815683|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815684|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815685|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1815686|NCT04764955|Vitamin D|vitamin d|mesh-list
1815687|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
1815688|NCT04764955|Vitamins|vitamins|mesh-ancestor
1815689|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
1815690|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815691|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1815692|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1815693|NCT04764825|Morphine|morphine|mesh-list
1815694|NCT04764825|Methadone|methadone|mesh-list
1815695|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1815696|NCT04764825|Narcotics|narcotics|mesh-ancestor
1815697|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815698|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815699|NCT04764825|Analgesics|analgesics|mesh-ancestor
1815700|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
1815701|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815702|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
1815703|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
1815704|NCT04765098|Tamoxifen|tamoxifen|mesh-list
1815705|NCT04765098|Etoposide|etoposide|mesh-list
1815706|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1815707|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815708|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1815709|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1815710|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815711|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815712|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1815713|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
1815714|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1815715|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815716|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1815717|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1815718|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1815719|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1815723|NCT04764916|Bupivacaine|bupivacaine|mesh-list
1815724|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
1815725|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
1815726|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815727|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815728|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
1815729|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815730|NCT04764851|Ecopipam|ecopipam|mesh-list
1815731|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1815732|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1815733|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815734|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815735|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1815736|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1815737|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
1815738|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815739|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815740|NCT04764630|Naloxone|naloxone|mesh-list
1815741|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1815742|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815743|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
1815744|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815745|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
1815746|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
1815747|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1815748|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1815749|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
1815750|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1815751|NCT04764643|Expectorants|expectorants|mesh-ancestor
1815752|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
1815753|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1815754|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
1815755|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815756|NCT04764643|Protective Agents|protective agents|mesh-ancestor
1815757|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815758|NCT04764643|Antidotes|antidotes|mesh-ancestor
1815759|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
1815760|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1815761|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
1815762|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
1815763|NCT04764396|Heparin|heparin|mesh-list
1815764|NCT04764396|Calcium heparin|calcium heparin|mesh-list
1815765|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
1815766|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1815767|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1815768|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815769|NCT04764227|Paclitaxel|paclitaxel|mesh-list
1815770|NCT04764227|Carboplatin|carboplatin|mesh-list
1815771|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1815772|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815773|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
1815774|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
1815775|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
1815776|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815777|NCT04764344|Haloperidol|haloperidol|mesh-list
1815778|NCT04764344|Ondansetron|ondansetron|mesh-list
1815779|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
1815780|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
1815781|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
1815782|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815783|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815784|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1815785|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
1815786|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
1815787|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1815788|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
1815789|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815790|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815791|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1815792|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1815793|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815794|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1815795|NCT04764344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1815796|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1815797|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
1815798|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1815799|NCT04764383|Histamine|histamine|mesh-list
1815800|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
1815801|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
1815802|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815803|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815804|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815805|NCT04764084|Niraparib|niraparib|mesh-list
1815806|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1815807|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815808|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815809|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815810|NCT04763759|Antibodies|antibodies|mesh-list
1815811|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1815812|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
1815813|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815814|NCT04764214|Osimertinib|osimertinib|mesh-list
1815815|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815816|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1815817|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815818|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815819|NCT04764045|Ropivacaine|ropivacaine|mesh-list
1815820|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
1815821|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
1815822|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815823|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815824|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
1815825|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815826|NCT04763876|Ketorolac|ketorolac|mesh-list
1815827|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1815828|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1815829|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1815830|NCT04763876|Analgesics|analgesics|mesh-ancestor
1815831|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
1815832|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815833|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815834|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1815835|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1815836|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1815837|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815838|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815839|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
1815840|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1815841|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1815842|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
1815843|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815844|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815852|NCT04764162|Choline|choline|mesh-list
1815853|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
1815854|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1815855|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
1815856|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815857|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1815858|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1815859|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
1815860|NCT04763512|Caseins|caseins|mesh-list
1815861|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
1815862|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
1815863|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815864|NCT04763434|Dexamethasone|dexamethasone|mesh-list
1815865|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
1815866|NCT04763434|Ropivacaine|ropivacaine|mesh-list
1815867|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1815868|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
1815869|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
1815870|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815871|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815872|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1815873|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
1815874|NCT04763434|Hormones|hormones|mesh-ancestor
1815875|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1815876|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1815877|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815878|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1815879|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815880|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1815881|NCT04763434|Analgesics|analgesics|mesh-ancestor
1815882|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
1815883|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1815884|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1815885|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1815886|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
1815887|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815888|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815889|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
1815890|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
1815891|NCT04763226|Furosemide|furosemide|mesh-list
1815892|NCT04763226|Diuretics|diuretics|mesh-ancestor
1815893|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
1815894|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815895|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1815896|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1815897|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815898|NCT04763408|Sorafenib|sorafenib|mesh-list
1815899|NCT04763408|Lenvatinib|lenvatinib|mesh-list
1815900|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815901|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1815902|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815976|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815903|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815904|NCT04763252|Coal Tar|coal tar|mesh-list
1815905|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
1815906|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
1815907|NCT04763486|Cefazolin|cefazolin|mesh-list
1815908|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1815909|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1815924|NCT04763616|Cemiplimab|cemiplimab|mesh-list
1815925|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1815926|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815927|NCT04763135|Mirtazapine|mirtazapine|mesh-list
1815928|NCT04763135|Citalopram|citalopram|mesh-list
1815929|NCT04763135|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1815930|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1815931|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1815932|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815933|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815934|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
1815935|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815936|NCT04763135|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1815937|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
1815938|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1815939|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1815940|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
1815941|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
1815942|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1815943|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1815944|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1815945|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1815946|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1815947|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1815948|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
1815949|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1815950|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1815951|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1815952|NCT04763564|Liraglutide|liraglutide|mesh-list
1815953|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1815954|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815955|NCT04763564|Incretins|incretins|mesh-ancestor
1815956|NCT04763564|Hormones|hormones|mesh-ancestor
1815957|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1815958|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
1815959|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1815960|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1815961|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1815962|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1815963|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815964|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
1815965|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1815966|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815967|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1815968|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1815969|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
1815970|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1815971|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1815972|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1815973|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1815974|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815975|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815977|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1815978|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1815979|NCT04763057|Calcium|calcium|mesh-list
1815980|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1815981|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815982|NCT04763096|Tacrolimus|tacrolimus|mesh-list
1815983|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1815984|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
1815985|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1815986|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1815987|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1815988|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815989|NCT04762953|Leucovorin|leucovorin|mesh-list
1815990|NCT04762953|Paclitaxel|paclitaxel|mesh-list
1815991|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1815992|NCT04762953|Fluorouracil|fluorouracil|mesh-list
1815993|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1815994|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1815995|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
1815996|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
1815997|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
1815998|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1815999|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
1816000|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1816001|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1816002|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
1816003|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816004|NCT04762953|Antidotes|antidotes|mesh-ancestor
1816005|NCT04762953|Protective Agents|protective agents|mesh-ancestor
1816006|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
1816007|NCT04762953|Vitamins|vitamins|mesh-ancestor
1816008|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
1816009|NCT04762992|Enoxaparin|enoxaparin|mesh-list
1816010|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
1816011|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1816012|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1816013|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816014|NCT04762966|Metformin|metformin|mesh-list
1816015|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1816016|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816017|NCT04762888|Edetic Acid|edetic acid|mesh-list
1816018|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1816019|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
1816020|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
1816021|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816022|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
1816023|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1816024|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1816025|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
1816026|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
1816027|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1816028|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
1816029|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816030|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1816031|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1816032|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
1816033|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816034|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816035|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1816036|NCT04762810|Hormones|hormones|mesh-ancestor
1816037|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1816038|NCT04762745|Thalidomide|thalidomide|mesh-list
1816039|NCT04762745|Dexamethasone|dexamethasone|mesh-list
1816040|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
1816041|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1816042|NCT04762745|Pomalidomide|pomalidomide|mesh-list
1816043|NCT04762745|BB 1101|bb 1101|mesh-list
1816044|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1816045|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
1816046|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
1816047|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816048|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816049|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1816050|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
1816051|NCT04762745|Hormones|hormones|mesh-ancestor
1816052|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1816204|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
1816053|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1816054|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816055|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
1816056|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816057|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816058|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1816059|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
1816060|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
1816061|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1816062|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1816063|NCT04762745|Growth Substances|growth substances|mesh-ancestor
1816064|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
1816065|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1816066|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
1816067|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1816068|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1816078|NCT04762381|Dexamethasone|dexamethasone|mesh-list
1816079|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
1816080|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1816081|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1816082|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
1816083|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
1816084|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816085|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816086|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1816087|NCT04762381|Hormones|hormones|mesh-ancestor
1816088|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1816089|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1816090|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816091|NCT04762316|Pyridoxal|pyridoxal|mesh-list
1816092|NCT04762316|Pyridoxine|pyridoxine|mesh-list
1816093|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
1816094|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
1816095|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
1816096|NCT04762316|Vitamins|vitamins|mesh-ancestor
1816097|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
1816098|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816099|NCT04762459|Pemetrexed|pemetrexed|mesh-list
1816100|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816101|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816102|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816103|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1816104|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1816105|NCT04762511|Vaccines|vaccines|mesh-list
1816106|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
1816107|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816108|NCT04762498|Methotrexate|methotrexate|mesh-list
1816109|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1816110|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
1816111|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1816112|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816113|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1816114|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
1816115|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816116|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816117|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
1816118|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816119|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1816120|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1816121|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
1816122|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1816123|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1816124|NCT04762472|Montelukast|montelukast|mesh-list
1816125|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1816126|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
1816127|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1816128|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
1816129|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1816130|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816131|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1816132|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1816133|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816134|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
1816135|NCT04762784|Hormones|hormones|mesh-ancestor
1816136|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1816137|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816138|NCT04762901|Paclitaxel|paclitaxel|mesh-list
1816139|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
1816140|NCT04762901|Carboplatin|carboplatin|mesh-list
1816141|NCT04762901|Doxorubicin|doxorubicin|mesh-list
1816142|NCT04762901|Niraparib|niraparib|mesh-list
1816143|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1816144|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816145|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
1816146|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
1816147|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
1816148|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816149|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1816150|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
1816151|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816152|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1816153|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1816154|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
1816155|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1816156|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1816157|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1816158|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1816159|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816160|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1816174|NCT04761952|Azathioprine|azathioprine|mesh-list
1816175|NCT04761952|Infliximab|infliximab|mesh-list
1816176|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
1816177|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1816178|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1816179|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
1816180|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816181|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1816182|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816183|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1816184|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
1816185|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816189|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
1816190|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1816191|NCT04762030|Paclitaxel|paclitaxel|mesh-list
1816192|NCT04762030|Carboplatin|carboplatin|mesh-list
1816193|NCT04762030|Durvalumab|durvalumab|mesh-list
1816194|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1816195|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816196|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
1816197|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
1816198|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
1816199|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816200|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1816201|NCT04762134|Doxycycline|doxycycline|mesh-list
1816202|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1816203|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1816205|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1816206|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1816207|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1816208|NCT04761705|Latanoprost|latanoprost|mesh-list
1816209|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1816210|NCT04761848|Cilostazol|cilostazol|mesh-list
1816211|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1816212|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
1816213|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816214|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816215|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1816216|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
1816217|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1816218|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1816219|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816220|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1816221|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
1816222|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1816223|NCT04761848|Protective Agents|protective agents|mesh-ancestor
1816224|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1816225|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1816226|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816227|NCT04762082|Tadalafil|tadalafil|mesh-list
1816228|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
1816229|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1816230|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1816231|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816232|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816233|NCT04762082|Urological Agents|urological agents|mesh-ancestor
1816234|NCT04762147|Acetaminophen|acetaminophen|mesh-list
1816235|NCT04762147|Fentanyl|fentanyl|mesh-list
1816236|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1816237|NCT04762147|Narcotics|narcotics|mesh-ancestor
1816238|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1816239|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816240|NCT04762147|Analgesics|analgesics|mesh-ancestor
1816241|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
1816242|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816243|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1816244|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1816245|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
1816246|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
1816247|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1816248|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
1816249|NCT04761744|Nivolumab|nivolumab|mesh-list
1816250|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1816251|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816252|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1816253|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816254|NCT04761731|Tacrolimus|tacrolimus|mesh-list
1816255|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1816256|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
1816257|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816258|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1816259|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816260|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816300|NCT04761601|Gemcitabine|gemcitabine|mesh-list
1816301|NCT04761601|Paclitaxel|paclitaxel|mesh-list
1816302|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1816303|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816304|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
1816305|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
1816306|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
1816307|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816308|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1816309|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
1816310|NCT04761601|Antiviral Agents|antiviral agents|mesh-ancestor
1816311|NCT04761601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1816312|NCT04761601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816313|NCT04761601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1816314|NCT04761601|Immunologic Factors|immunologic factors|mesh-ancestor
1816315|NCT04761601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816316|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1816317|NCT04761185|Raltitrexed|raltitrexed|mesh-list
1816318|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1816319|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
1816320|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816321|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816322|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1816323|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816324|NCT04761159|Ketamine|ketamine|mesh-list
1816325|NCT04761159|Analgesics|analgesics|mesh-ancestor
1816326|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
1816327|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816328|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816329|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1816330|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1816331|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
1816332|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
1816333|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1816334|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1816335|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1816336|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1816337|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816338|NCT04761393|Xenon|xenon|mesh-list
1816339|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1816340|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
1816341|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
1816342|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1816343|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816344|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
1816345|NCT04761133|Povidone|povidone|mesh-list
1816346|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
1816347|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
1816348|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1816349|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1816350|NCT04761198|Nivolumab|nivolumab|mesh-list
1816351|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1816352|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816353|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1816354|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816355|NCT04761029|Tramadol|tramadol|mesh-list
1816356|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1816357|NCT04761029|Narcotics|narcotics|mesh-ancestor
1816510|NCT04759248|Trastuzumab|trastuzumab|mesh-list
1816358|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1816359|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816360|NCT04761029|Analgesics|analgesics|mesh-ancestor
1816361|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
1816362|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816363|NCT04760821|Trimetazidine|trimetazidine|mesh-list
1816364|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
1816365|NCT04760860|Prazosin|prazosin|mesh-list
1816366|NCT04760860|Terazosin|terazosin|mesh-list
1816367|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1816368|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1816369|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1816370|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
1816371|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1816372|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816373|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816374|NCT04760860|Urological Agents|urological agents|mesh-ancestor
1816375|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1816376|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
1816377|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1816378|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
1816379|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816380|NCT04760782|Abaloparatide|abaloparatide|mesh-list
1816381|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1816382|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816383|NCT04760912|Bromides|bromides|mesh-list
1816384|NCT04760912|Anesthetics|anesthetics|mesh-list
1816385|NCT04760912|Rocuronium|rocuronium|mesh-list
1816386|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1816387|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816388|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
1816389|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1816390|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1816391|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1816392|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816393|NCT04760704|Antibodies|antibodies|mesh-list
1816394|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
1816395|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816406|NCT04760691|Tenofovir|tenofovir|mesh-list
1816407|NCT04760691|Emtricitabine|emtricitabine|mesh-list
1816408|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1816409|NCT04760691|Leuprolide|leuprolide|mesh-list
1816410|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1816411|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1816412|NCT04760691|Estradiol|estradiol|mesh-list
1816413|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1816414|NCT04760691|Estrogens|estrogens|mesh-list
1816415|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
1816416|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1816417|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1816418|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1816419|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816420|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816421|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1816422|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1816423|NCT04760691|Hormones|hormones|mesh-ancestor
1816424|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1816425|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816426|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1816427|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
1816428|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1816429|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1816430|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1816431|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
1816432|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1816433|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816434|NCT04760574|Testosterone|testosterone|mesh-list
1816435|NCT04760574|Androgens|androgens|mesh-ancestor
1816436|NCT04760574|Hormones|hormones|mesh-ancestor
1816437|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1816438|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816439|NCT04760327|Cisplatin|cisplatin|mesh-list
1816440|NCT04760327|Bleomycin|bleomycin|mesh-list
1816441|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816442|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1816443|NCT04760496|Oxytocin|oxytocin|mesh-list
1816444|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
1816445|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1816446|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816447|NCT04760431|Paclitaxel|paclitaxel|mesh-list
1816448|NCT04760431|Docetaxel|docetaxel|mesh-list
1816449|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1816450|NCT04760431|Trastuzumab|trastuzumab|mesh-list
1816451|NCT04760431|Pertuzumab|pertuzumab|mesh-list
1816452|NCT04760431|Taxane|taxane|mesh-list
1816453|NCT04760431|Tucatinib|tucatinib|mesh-list
1816454|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1816455|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816456|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
1816457|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
1816458|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
1816459|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816460|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1816461|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1816462|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816463|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
1816464|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1816465|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1816466|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816467|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
1816468|NCT04760301|Coagulants|coagulants|mesh-ancestor
1816469|NCT04760275|Fluoxetine|fluoxetine|mesh-list
1816470|NCT04760275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1816471|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1816472|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1816473|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816474|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1816475|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
1816476|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816477|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1816478|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
1816479|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1816480|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1816481|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1816482|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816483|NCT04760132|Vaccines|vaccines|mesh-list
1816484|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
1816485|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816486|NCT04759703|Pramipexole|pramipexole|mesh-list
1816487|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
1816488|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816489|NCT04759703|Protective Agents|protective agents|mesh-ancestor
1816490|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816491|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1816492|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1816493|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
1816494|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
1816495|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1816496|NCT04759729|Vitamin D|vitamin d|mesh-list
1816497|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
1816498|NCT04759729|Vitamins|vitamins|mesh-list
1816499|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
1816500|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816501|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1816502|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1816503|NCT04759742|Ropivacaine|ropivacaine|mesh-list
1816504|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
1816505|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
1816506|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1816507|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816508|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
1816509|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816511|NCT04759248|Atezolizumab|atezolizumab|mesh-list
1816512|NCT04759248|Vinorelbine|vinorelbine|mesh-list
1816513|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1816514|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816515|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1816516|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
1816517|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
1816518|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
1816519|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816523|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1816524|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1816525|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1816526|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1816527|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816528|NCT04760262|Remifentanil|remifentanil|mesh-list
1816529|NCT04760262|Propofol|propofol|mesh-list
1816530|NCT04760262|Sevoflurane|sevoflurane|mesh-list
1816531|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1816532|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1816533|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816534|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1816535|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
1816536|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
1816537|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1816538|NCT04760262|Narcotics|narcotics|mesh-ancestor
1816539|NCT04760262|Analgesics|analgesics|mesh-ancestor
1816540|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
1816541|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816542|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1816543|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1816544|NCT04758936|Clonidine|clonidine|mesh-list
1816545|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
1816546|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1816547|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1816548|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816549|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1816550|NCT04758936|Analgesics|analgesics|mesh-ancestor
1816551|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
1816552|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816553|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1816554|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1816555|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1816556|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
1816557|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1816558|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816559|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1816560|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
1816561|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
1816562|NCT04758871|Progesterone|progesterone|mesh-list
1816563|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
1816564|NCT04758871|Progestins|progestins|mesh-ancestor
1816565|NCT04758871|Hormones|hormones|mesh-ancestor
1816566|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1816567|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816568|NCT04758858|Glucagon|glucagon|mesh-list
1816569|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816570|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1816571|NCT04758858|Hormones|hormones|mesh-ancestor
1816572|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1816573|NCT04759079|Antiemetics|antiemetics|mesh-list
1816574|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
1816575|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816576|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816577|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1816578|NCT04759196|Topiramate|topiramate|mesh-list
1816579|NCT04759196|Levetiracetam|levetiracetam|mesh-list
1816580|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
1816581|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1816582|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816583|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
1816584|NCT04758975|Rituximab|rituximab|mesh-list
1816585|NCT04758975|Venetoclax|venetoclax|mesh-list
1816586|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1816587|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816588|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
1816589|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816590|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1816591|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1816592|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1816593|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816594|NCT04758689|Methotrexate|methotrexate|mesh-list
1816595|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1816596|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
1816597|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1816598|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816599|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1816600|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
1816601|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816602|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816603|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
1816604|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816605|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1816606|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1816607|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
1816608|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1816609|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1816610|NCT04758728|Epinephrine|epinephrine|mesh-list
1816611|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1816612|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1816613|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
1816614|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1816615|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816616|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816617|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1816618|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1816619|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
1816620|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816621|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1816622|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
1816623|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
1816624|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
1816625|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1816626|NCT04758260|Antioxidants|antioxidants|mesh-list
1816627|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816628|NCT04758260|Protective Agents|protective agents|mesh-ancestor
1816629|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816630|NCT04758286|Anesthetics|anesthetics|mesh-list
1816631|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1816632|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816633|NCT04757883|Antibodies|antibodies|mesh-list
1816634|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
1816635|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816636|NCT04758273|Vaccines|vaccines|mesh-list
1816637|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
1816638|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816639|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
1816640|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1816641|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1816642|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
1816643|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1816644|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
1816645|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1816646|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
1816647|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816648|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816649|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
1816650|NCT04758000|Metformin|metformin|mesh-list
1816651|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1816652|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816653|NCT04757974|Fostemsavir|fostemsavir|mesh-list
1816654|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1816655|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1816656|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
1816657|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1816658|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1816659|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1816660|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816661|NCT04757779|Docetaxel|docetaxel|mesh-list
1816662|NCT04757779|Irinotecan|irinotecan|mesh-list
1816663|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816664|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
1816665|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
1816666|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
1816667|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816668|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1816669|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1816670|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816671|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
1816672|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1816673|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1816674|NCT04757740|Prednisolone|prednisolone|mesh-list
1816675|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
1816676|NCT04757740|Lidocaine|lidocaine|mesh-list
1816677|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1816678|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
1816679|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
1816680|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
1816681|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1816682|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816683|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
1816684|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816685|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1816686|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1816687|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1816688|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1816689|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816690|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1816691|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
1816692|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
1816693|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1816694|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
1816695|NCT04757740|Hormones|hormones|mesh-ancestor
1816696|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1816697|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1816698|NCT04757740|Protective Agents|protective agents|mesh-ancestor
1816699|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1816700|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816701|NCT04757506|Naltrexone|naltrexone|mesh-list
1816702|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1816703|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1816704|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816705|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
1816706|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816707|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
1816708|NCT04757675|Ketamine|ketamine|mesh-list
1816709|NCT04757675|Esketamine|esketamine|mesh-list
1816710|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1816711|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1816712|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816713|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1816714|NCT04757675|Analgesics|analgesics|mesh-ancestor
1816715|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
1816716|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816717|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1816718|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1816719|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1816720|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
1816721|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1816722|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816723|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1816724|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1816725|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
1816726|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
1816727|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1816728|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1816729|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
1816730|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1816731|NCT04757571|Paroxetine|paroxetine|mesh-list
1816732|NCT04757571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1816733|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1816734|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1816735|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816736|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1816737|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
1816738|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816739|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1816740|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
1816741|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1816742|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1816743|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1816744|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816745|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
1816746|NCT04757532|Anastrozole|anastrozole|mesh-list
1816747|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
1816748|NCT04757532|Bupropion|bupropion|mesh-list
1816749|NCT04757532|Testosterone|testosterone|mesh-list
1816750|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
1816751|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
1816752|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1816753|NCT04757532|Danazol|danazol|mesh-list
1816754|NCT04757532|Androgens|androgens|mesh-ancestor
1816755|NCT04757532|Hormones|hormones|mesh-ancestor
1816756|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1816757|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816758|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1816759|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816760|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
1816761|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1816762|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
1816763|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1816764|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1816765|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1816766|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1816767|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816768|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
1816769|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1816770|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1816771|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1816772|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816773|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1816774|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1816775|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1816776|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
1816777|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1816778|NCT04757532|Diuretics|diuretics|mesh-ancestor
1816779|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
1816780|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1816781|NCT04757584|Propranolol|propranolol|mesh-list
1816782|NCT04757584|Metoprolol|metoprolol|mesh-list
1816783|NCT04757584|Atenolol|atenolol|mesh-list
1816784|NCT04757584|Sotalol|sotalol|mesh-list
1816785|NCT04757584|Nadolol|nadolol|mesh-list
1816786|NCT04757584|Acebutolol|acebutolol|mesh-list
1816787|NCT04757584|Carvedilol|carvedilol|mesh-list
1816788|NCT04757584|Nebivolol|nebivolol|mesh-list
1816789|NCT04757584|Bisoprolol|bisoprolol|mesh-list
1816790|NCT04757584|Labetalol|labetalol|mesh-list
1816791|NCT04757584|Pindolol|pindolol|mesh-list
1816792|NCT04757584|Betaxolol|betaxolol|mesh-list
1816793|NCT04757584|Penbutolol|penbutolol|mesh-list
1816794|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1816795|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1816796|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
1816797|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1816798|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816799|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816800|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1816801|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1816802|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
1816803|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
1816804|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
1816805|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816806|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1816807|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
1816808|NCT04757584|Protective Agents|protective agents|mesh-ancestor
1816809|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1816810|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1816811|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1816812|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1816813|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1816814|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1816815|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1816816|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1816817|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
1816818|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1816819|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
1816820|NCT04757662|Tadalafil|tadalafil|mesh-list
1816821|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
1816822|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1816823|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1816824|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816825|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816826|NCT04757662|Urological Agents|urological agents|mesh-ancestor
1816827|NCT04757376|Denosumab|denosumab|mesh-list
1816828|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1816829|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816836|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
1816837|NCT04757337|Doxorubicin|doxorubicin|mesh-list
1816838|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1816839|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
1816840|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816841|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1816842|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1816843|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
1816844|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816845|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816846|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1816847|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1816848|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1816849|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1816850|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816863|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1816864|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1816865|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1816866|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1816867|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816868|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
1816869|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1816870|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816871|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1816872|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816873|NCT04756895|Vancomycin|vancomycin|mesh-list
1816874|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1816875|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1816876|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
1816877|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1816878|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
1816879|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1816880|NCT04756622|Expectorants|expectorants|mesh-ancestor
1816881|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
1816882|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1816883|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
1816884|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816885|NCT04756622|Protective Agents|protective agents|mesh-ancestor
1816886|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816887|NCT04756622|Antidotes|antidotes|mesh-ancestor
1816893|NCT04756492|Cyclosporine|cyclosporine|mesh-list
1816894|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
1816895|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1816896|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
1816897|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816898|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816899|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1816900|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
1816901|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816902|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1816903|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1816904|NCT04756661|Misoprostol|misoprostol|mesh-list
1816905|NCT04756661|Oxytocin|oxytocin|mesh-list
1816906|NCT04756661|Carbetocin|carbetocin|mesh-list
1816907|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
1816908|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1816909|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816910|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1816911|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
1816912|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1816913|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1816914|NCT04756323|Vaccines|vaccines|mesh-list
1816915|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
1816916|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816917|NCT04756557|Fluorides|fluorides|mesh-list
1816918|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
1816919|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
1816920|NCT04756557|Protective Agents|protective agents|mesh-ancestor
1816921|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816942|NCT04756232|Mecamylamine|mecamylamine|mesh-list
1816943|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1816944|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
1816945|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
1816946|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816947|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816948|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
1816949|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1816950|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
1816951|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1816952|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816953|NCT04756206|Dutasteride|dutasteride|mesh-list
1816954|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1816955|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1816956|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816957|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816958|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
1816959|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1816960|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816961|NCT04756128|Colchicine|colchicine|mesh-list
1816962|NCT04756128|Naltrexone|naltrexone|mesh-list
1816963|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1816964|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1816965|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816966|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
1816967|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816968|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
1816969|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1816970|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
1816971|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
1816972|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
1816973|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816974|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816975|NCT04756089|Oxytocin|oxytocin|mesh-list
1816976|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
1816977|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1816978|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816979|NCT04755998|Vaccines|vaccines|mesh-list
1816980|NCT04755998|Immunologic Factors|immunologic factors|mesh-ancestor
1816981|NCT04755998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816982|NCT04755868|Talazoparib|talazoparib|mesh-list
1816983|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1816984|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1816985|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1816986|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1816987|NCT04755712|Sufentanil|sufentanil|mesh-list
1816988|NCT04755712|Morphine|morphine|mesh-list
1816989|NCT04755712|Bupivacaine|bupivacaine|mesh-list
1816990|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
1816991|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
1816992|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1816993|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1816994|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
1816995|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1816996|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1816997|NCT04755712|Narcotics|narcotics|mesh-ancestor
1816998|NCT04755712|Analgesics|analgesics|mesh-ancestor
1816999|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1817000|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1817001|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
1817002|NCT04756050|Epinephrine|epinephrine|mesh-list
1817003|NCT04756050|Racepinephrine|racepinephrine|mesh-list
1817004|NCT04756050|Bupivacaine|bupivacaine|mesh-list
1817005|NCT04756050|Prilocaine|prilocaine|mesh-list
1817006|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1817007|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
1817008|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
1817009|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
1817010|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1817011|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817012|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
1817013|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817014|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1817015|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1817016|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
1817017|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817018|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817019|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1817020|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1817021|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
1817022|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1817023|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
1817024|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
1817025|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
1817026|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1817027|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1817028|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1817029|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1817030|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817031|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817032|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1817033|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1817034|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817035|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
1817036|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817037|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
1817038|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1817039|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1817040|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
1817344|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
1817041|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817042|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817043|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1817044|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
1817045|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1817046|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
1817047|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817048|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817049|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1817050|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
1817051|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
1817052|NCT04755647|Protective Agents|protective agents|mesh-ancestor
1817053|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
1817054|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1817055|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
1817056|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817057|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
1817058|NCT04755634|Protective Agents|protective agents|mesh-ancestor
1817059|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
1817060|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1817061|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
1817062|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1817063|NCT04755972|Expectorants|expectorants|mesh-ancestor
1817064|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
1817065|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1817066|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
1817067|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817068|NCT04755972|Protective Agents|protective agents|mesh-ancestor
1817069|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817070|NCT04755972|Antidotes|antidotes|mesh-ancestor
1817071|NCT04755764|Atenolol|atenolol|mesh-list
1817072|NCT04755764|Labetalol|labetalol|mesh-list
1817073|NCT04755764|Nifedipine|nifedipine|mesh-list
1817074|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1817075|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1817076|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817077|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1817078|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817079|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
1817080|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
1817081|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1817082|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1817083|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1817084|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
1817085|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
1817086|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817087|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1817088|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1817089|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1817090|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
1817091|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817092|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
1817093|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1817094|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1817095|NCT04755543|Fluorouracil|fluorouracil|mesh-list
1817096|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817097|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
1817098|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817099|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1817100|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1817101|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
1817102|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817103|NCT04755322|Aspirin|aspirin|mesh-list
1817104|NCT04755322|Folic Acid|folic acid|mesh-list
1817105|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
1817106|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1817107|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1817108|NCT04755322|Analgesics|analgesics|mesh-ancestor
1817109|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
1817110|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817111|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817112|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1817113|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1817114|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1817115|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1817116|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817117|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1817118|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1817119|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817120|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
1817121|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
1817122|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1817123|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1817124|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1817125|NCT04755322|Hematinics|hematinics|mesh-ancestor
1817126|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
1817127|NCT04755322|Vitamins|vitamins|mesh-ancestor
1817128|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
1817129|NCT04755387|Ticagrelor|ticagrelor|mesh-list
1817130|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1817131|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1817132|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1817133|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1817134|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
1817135|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817136|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817137|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817138|NCT04755062|Micronutrients|micronutrients|mesh-list
1817139|NCT04755062|Trace Elements|trace elements|mesh-list
1817140|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817141|NCT04755218|Misoprostol|misoprostol|mesh-list
1817142|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1817143|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
1817144|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1817145|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817146|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1817147|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1817148|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
1817149|NCT04754815|Paclitaxel|paclitaxel|mesh-list
1817150|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1817151|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
1817152|NCT04754815|Pemetrexed|pemetrexed|mesh-list
1817153|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1817154|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817155|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
1817156|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
1817157|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
1817158|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817159|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1817160|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817161|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1817162|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1817163|NCT04754945|Dexamethasone|dexamethasone|mesh-list
1817164|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
1817165|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
1817166|NCT04754945|Bortezomib|bortezomib|mesh-list
1817167|NCT04754945|Ichthammol|ichthammol|mesh-list
1817168|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1817169|NCT04754945|BB 1101|bb 1101|mesh-list
1817170|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1817171|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
1817172|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817173|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1817174|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1817175|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
1817176|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817177|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817178|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1817179|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1817180|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
1817181|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
1817182|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817183|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1817184|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
1817185|NCT04754945|Hormones|hormones|mesh-ancestor
1817186|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1817187|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1817188|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
1817189|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817190|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
1817191|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1817575|NCT04752384|Narcotics|narcotics|mesh-ancestor
1817192|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1817193|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1817194|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1817195|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1817196|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
1817197|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1817198|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817199|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817200|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1817201|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1817202|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817203|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
1817204|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817205|NCT04754763|Propolis|propolis|mesh-list
1817206|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1817207|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
1817208|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1817209|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1817210|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1817211|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817212|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1817213|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1817214|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1817215|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
1817216|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817217|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817218|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1817219|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1817220|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
1817221|NCT04754789|Aspirin|aspirin|mesh-list
1817222|NCT04754789|Ticagrelor|ticagrelor|mesh-list
1817223|NCT04754789|Atorvastatin|atorvastatin|mesh-list
1817224|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1817225|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1817226|NCT04754789|Analgesics|analgesics|mesh-ancestor
1817227|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
1817228|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817229|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817230|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1817231|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1817232|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1817233|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1817234|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817235|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1817236|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1817237|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817238|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
1817239|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1817240|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1817241|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
1817242|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1817243|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1817244|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1817245|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1817246|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1817247|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
1817248|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817249|NCT04754334|Insulin|insulin|mesh-list
1817250|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1817251|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817252|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
1817253|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1817254|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1817255|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817256|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
1817257|NCT04754230|Coagulants|coagulants|mesh-ancestor
1817261|NCT04754386|Antibodies|antibodies|mesh-list
1817262|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
1817263|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817264|NCT04754399|Cannabidiol|cannabidiol|mesh-list
1817265|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
1817266|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
1817267|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
1817268|NCT04753918|Trioxsalen|trioxsalen|mesh-list
1817269|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817270|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
1817271|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1817296|NCT04754035|Venetoclax|venetoclax|mesh-list
1817297|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817298|NCT04753957|Progesterone|progesterone|mesh-list
1817299|NCT04753957|Progestins|progestins|mesh-ancestor
1817300|NCT04753957|Hormones|hormones|mesh-ancestor
1817301|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1817302|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817303|NCT04753970|Cilostazol|cilostazol|mesh-list
1817304|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1817305|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
1817306|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817307|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817308|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1817309|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
1817310|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1817311|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1817312|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817313|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1817314|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
1817315|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1817316|NCT04753970|Protective Agents|protective agents|mesh-ancestor
1817317|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1817318|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1817319|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817320|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
1817321|NCT04753723|Gentamicins|gentamicins|mesh-list
1817322|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1817323|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1817324|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1817325|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817326|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817327|NCT04753515|Midazolam|midazolam|mesh-list
1817328|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
1817329|NCT04753515|Remifentanil|remifentanil|mesh-list
1817330|NCT04753515|Propofol|propofol|mesh-list
1817331|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1817332|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1817333|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817334|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1817335|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
1817336|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
1817337|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1817338|NCT04753515|Analgesics|analgesics|mesh-ancestor
1817339|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
1817340|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817341|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1817342|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1817343|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1817345|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817346|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817347|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1817348|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1817349|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1817350|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1817351|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
1817352|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
1817353|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1817354|NCT04753515|Narcotics|narcotics|mesh-ancestor
1817355|NCT04753749|Aspirin|aspirin|mesh-list
1817356|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1817357|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1817358|NCT04753749|Analgesics|analgesics|mesh-ancestor
1817359|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
1817360|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817361|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817362|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1817363|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1817364|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1817365|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1817366|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817367|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1817368|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1817369|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817370|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
1817371|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
1817372|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1817373|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
1817374|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1817375|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
1817376|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817377|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817378|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
1817379|NCT04753619|Niclosamide|niclosamide|mesh-list
1817380|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
1817381|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1817382|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
1817383|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1817384|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1817385|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
1817386|NCT04753372|Aspirin|aspirin|mesh-list
1817387|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
1817388|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1817389|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
1817390|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1817391|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
1817392|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817393|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817394|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
1817395|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1817396|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1817397|NCT04753372|Analgesics|analgesics|mesh-ancestor
1817398|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
1817399|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817400|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817401|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1817402|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1817403|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1817404|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1817405|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1817406|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1817407|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
1817408|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
1817409|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1817410|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1817411|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817412|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
1817413|NCT04753151|Coagulants|coagulants|mesh-ancestor
1817414|NCT04753112|Valsartan|valsartan|mesh-list
1817415|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1817416|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1817417|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1817418|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1817419|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817420|NCT04753203|Capecitabine|capecitabine|mesh-list
1817421|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1817422|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
1817423|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817424|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817425|NCT04753177|Paclitaxel|paclitaxel|mesh-list
1817426|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
1817427|NCT04753177|Doxorubicin|doxorubicin|mesh-list
1817428|NCT04753177|Fulvestrant|fulvestrant|mesh-list
1817429|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1817430|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1817431|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817432|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
1817433|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
1817434|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
1817435|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817436|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1817437|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
1817438|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817439|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1817440|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1817441|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
1817442|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1817443|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1817444|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1817445|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1817446|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817447|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1817448|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1817449|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1817450|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
1817451|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1817452|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
1817453|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1817454|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
1817455|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1817456|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1817457|NCT04753008|Dopamine|dopamine|mesh-list
1817458|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1817459|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
1817460|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
1817461|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817462|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817463|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
1817464|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817465|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817466|NCT04753008|Protective Agents|protective agents|mesh-ancestor
1817467|NCT04753216|Bevacizumab|bevacizumab|mesh-list
1817468|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1817469|NCT04753216|Irinotecan|irinotecan|mesh-list
1817470|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
1817471|NCT04753216|Antibodies|antibodies|mesh-list
1817472|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
1817473|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1817474|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
1817475|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817476|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1817477|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1817478|NCT04753216|Growth Substances|growth substances|mesh-ancestor
1817479|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817480|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
1817481|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
1817482|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1817483|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1817484|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817485|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817486|NCT04753294|Diazepam|diazepam|mesh-list
1817487|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1817488|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
1817489|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
1817490|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
1817491|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817492|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817493|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1817494|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1817495|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1817496|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1817497|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1817498|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1817499|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1817500|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1817501|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1817502|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
1817503|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
1817504|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
1817505|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
1817506|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817507|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817511|NCT04752852|Dexamethasone|dexamethasone|mesh-list
1817512|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1817513|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
1817514|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
1817515|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817516|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817517|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1817518|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
1817519|NCT04752852|Hormones|hormones|mesh-ancestor
1817520|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1817521|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1817522|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817523|NCT04752813|Vitamin K|vitamin k|mesh-list
1817524|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
1817525|NCT04752813|Temozolomide|temozolomide|mesh-list
1817526|NCT04752813|Vitamins|vitamins|mesh-ancestor
1817527|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
1817528|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817529|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1817530|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
1817531|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817532|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817533|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1817534|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1817535|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
1817536|NCT04752813|Coagulants|coagulants|mesh-ancestor
1817537|NCT04752631|Tenecteplase|tenecteplase|mesh-list
1817538|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1817539|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1817540|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817561|NCT04752540|Olorofim|olorofim|mesh-list
1817562|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
1817563|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1817564|NCT04752566|Eculizumab|eculizumab|mesh-list
1817565|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1817566|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1817567|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
1817568|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817569|NCT04752267|Clevudine|clevudine|mesh-list
1817570|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
1817571|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1817572|NCT04752384|Buprenorphine|buprenorphine|mesh-list
1817573|NCT04752384|Tramadol|tramadol|mesh-list
1817574|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1817576|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1817577|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817578|NCT04752384|Analgesics|analgesics|mesh-ancestor
1817579|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
1817580|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817581|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1817582|NCT04752163|Leucovorin|leucovorin|mesh-list
1817583|NCT04752163|Cytarabine|cytarabine|mesh-list
1817584|NCT04752163|Voriconazole|voriconazole|mesh-list
1817585|NCT04752163|Posaconazole|posaconazole|mesh-list
1817586|NCT04752163|Dexamethasone|dexamethasone|mesh-list
1817587|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
1817588|NCT04752163|Prednisone|prednisone|mesh-list
1817589|NCT04752163|Cortisone|cortisone|mesh-list
1817590|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
1817591|NCT04752163|Rituximab|rituximab|mesh-list
1817592|NCT04752163|Methotrexate|methotrexate|mesh-list
1817593|NCT04752163|Vincristine|vincristine|mesh-list
1817594|NCT04752163|Azacitidine|azacitidine|mesh-list
1817595|NCT04752163|Venetoclax|venetoclax|mesh-list
1817596|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1817597|NCT04752163|Antibodies|antibodies|mesh-list
1817598|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
1817599|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1817600|NCT04752163|Lenograstim|lenograstim|mesh-list
1817601|NCT04752163|BB 1101|bb 1101|mesh-list
1817602|NCT04752163|Mesna|mesna|mesh-list
1817603|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1817604|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
1817605|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817606|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1817607|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1817608|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
1817609|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817610|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817611|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1817612|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1817613|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
1817614|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
1817615|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817616|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1817617|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
1817618|NCT04752163|Hormones|hormones|mesh-ancestor
1817619|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1817620|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1817621|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
1817622|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817623|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1817624|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
1817625|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1817626|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1817627|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
1817628|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
1817629|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1817630|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1817631|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1817632|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
1817633|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1817634|NCT04752163|Antidotes|antidotes|mesh-ancestor
1817635|NCT04752163|Protective Agents|protective agents|mesh-ancestor
1817636|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
1817637|NCT04752163|Vitamins|vitamins|mesh-ancestor
1817638|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
1817639|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1817640|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
1817641|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
1817642|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
1817643|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
1817644|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1817645|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1817646|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1817647|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
1817648|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1817649|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1817650|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1817651|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1817652|NCT04752059|Trastuzumab|trastuzumab|mesh-list
1817653|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1817654|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817655|NCT04752111|Esmolol|esmolol|mesh-list
1817656|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1817657|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1817658|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1817659|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
1817660|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817661|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817662|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817663|NCT04751994|Sorbitol|sorbitol|mesh-list
1817664|NCT04751994|Cathartics|cathartics|mesh-ancestor
1817665|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1817666|NCT04751955|Capecitabine|capecitabine|mesh-list
1817667|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1817668|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
1817669|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817670|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817671|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
1817672|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1817673|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1817674|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
1817675|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817676|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817677|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817678|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
1817679|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
1817680|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817681|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
1817682|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1817683|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
1817684|NCT04752033|Morphine|morphine|mesh-list
1817685|NCT04752033|Hydromorphone|hydromorphone|mesh-list
1817686|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1817687|NCT04752033|Narcotics|narcotics|mesh-ancestor
1817688|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1817689|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817690|NCT04752033|Analgesics|analgesics|mesh-ancestor
1817691|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
1817692|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817693|NCT04751929|Atezolizumab|atezolizumab|mesh-list
1817694|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817695|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1817696|NCT04751500|Metronidazole|metronidazole|mesh-list
1817697|NCT04751500|Clindamycin|clindamycin|mesh-list
1817698|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1817699|NCT04751500|Misoprostol|misoprostol|mesh-list
1817700|NCT04751500|Mifepristone|mifepristone|mesh-list
1817701|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1817702|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1817703|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1817704|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1817705|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
1817706|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1817707|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817708|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1817709|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1817710|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
1817711|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1817712|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817713|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817714|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1817715|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1817716|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1817717|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1817718|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
1817719|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1817720|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1817721|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
1817722|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1817723|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
1817724|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1817725|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1817726|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1817727|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
1817728|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1817729|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817730|NCT04751812|Narcotics|narcotics|mesh-ancestor
1817731|NCT04751812|Analgesics|analgesics|mesh-ancestor
1817732|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
1817733|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817734|NCT04751669|Trace Elements|trace elements|mesh-list
1817735|NCT04751669|Micronutrients|micronutrients|mesh-list
1817736|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817737|NCT04751344|Bupivacaine|bupivacaine|mesh-list
1817738|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
1817739|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
1817740|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1817741|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817742|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
1817743|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817744|NCT04751227|Modafinil|modafinil|mesh-list
1817745|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1817746|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817747|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
1817748|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1817749|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1817750|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817751|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1817752|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1817753|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1817754|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1817755|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817756|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817757|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817758|NCT04751318|Analgesics|analgesics|mesh-ancestor
1817759|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
1817760|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817761|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
1817762|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1817763|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
1817764|NCT04751604|Niacinamide|niacinamide|mesh-list
1817765|NCT04751604|Niacin|niacin|mesh-list
1817766|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
1817767|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
1817768|NCT04751604|Vitamins|vitamins|mesh-ancestor
1817769|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
1817770|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817771|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1817772|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
1817773|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817774|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1817775|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
1817776|NCT04751175|Dexamethasone|dexamethasone|mesh-list
1817777|NCT04751175|Ketamine|ketamine|mesh-list
1817778|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1817779|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
1817780|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
1817781|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817782|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817783|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1817784|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
1817785|NCT04751175|Hormones|hormones|mesh-ancestor
1817786|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1817787|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1817788|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817789|NCT04751175|Analgesics|analgesics|mesh-ancestor
1817790|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
1817791|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1817792|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1817793|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
1817794|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
1817795|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1817796|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1817797|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1817798|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817799|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817800|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1817801|NCT04751188|Bezafibrate|bezafibrate|mesh-list
1817802|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1817803|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1817804|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1817805|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
1817806|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817807|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1817808|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
1817809|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
1817810|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
1817811|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817812|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817813|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1817814|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1817815|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
1817816|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817817|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817818|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
1817819|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1817820|NCT04751136|Protective Agents|protective agents|mesh-ancestor
1817821|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817822|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
1817823|NCT04750902|Listerine|listerine|mesh-list
1817824|NCT04750902|Fluorides|fluorides|mesh-list
1817825|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
1817826|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
1817827|NCT04750902|Protective Agents|protective agents|mesh-ancestor
1817828|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817829|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1817830|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1817831|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1817832|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1817833|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817834|NCT04750967|Lidocaine|lidocaine|mesh-list
1817835|NCT04750967|Amitriptyline|amitriptyline|mesh-list
1817836|NCT04750967|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
1817837|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
1817838|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
1817839|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1817840|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817841|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
1817842|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817843|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1817844|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1817845|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1817846|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1817847|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817848|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1817849|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
1817850|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1817851|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1817852|NCT04750967|Analgesics|analgesics|mesh-ancestor
1817853|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1817854|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1817855|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
1817856|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817857|NCT04750967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1817858|NCT04750967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1817872|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
1817873|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1817874|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1817875|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1817876|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1817877|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817878|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817879|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817880|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
1817881|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817882|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
1817883|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817884|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817885|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1817886|NCT04750603|Fluticasone|fluticasone|mesh-list
1817887|NCT04750603|Xhance|xhance|mesh-list
1817888|NCT04750603|Albuterol|albuterol|mesh-list
1817889|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1817890|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1817891|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
1817892|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1817893|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817894|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1817895|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
1817896|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
1817897|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1817898|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
1817899|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1817900|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1817901|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1817902|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1817903|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
1817904|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817905|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817906|NCT04750473|Edetic Acid|edetic acid|mesh-list
1817907|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1817908|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
1817909|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
1817910|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817911|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
1817912|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1817913|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1817914|NCT04750460|Teriparatide|teriparatide|mesh-list
1817915|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1817916|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817917|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1817918|NCT04750616|Niacinamide|niacinamide|mesh-list
1817919|NCT04750616|Niacin|niacin|mesh-list
1817920|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
1817921|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
1817922|NCT04750616|Vitamins|vitamins|mesh-ancestor
1817923|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
1817924|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817925|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1817926|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
1817927|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817928|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1817929|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
1817930|NCT04750317|Tofacitinib|tofacitinib|mesh-list
1817931|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1817932|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817933|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817955|NCT04750382|Gemcitabine|gemcitabine|mesh-list
1817956|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817957|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1817958|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
1817959|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817960|NCT04750382|Antiviral Agents|antiviral agents|mesh-ancestor
1817961|NCT04750382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1817962|NCT04750382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817963|NCT04750382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1817964|NCT04750382|Immunologic Factors|immunologic factors|mesh-ancestor
1817965|NCT04750382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817966|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1817967|NCT04749940|Laxatives|laxatives|mesh-ancestor
1817968|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1817969|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1817970|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
1817971|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1817972|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
1817973|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1817974|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817975|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1817976|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1817977|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1817978|NCT04749914|Dabigatran|dabigatran|mesh-list
1817979|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1817980|NCT04749914|Lasmiditan|lasmiditan|mesh-list
1817981|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1817982|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1817983|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
1817984|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1817985|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1817986|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1817987|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1817988|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
1817989|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1817990|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
1817991|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
1817992|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1817993|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
1817994|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1817995|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1817996|NCT04750122|Carboplatin|carboplatin|mesh-list
1817997|NCT04750122|Docetaxel|docetaxel|mesh-list
1817998|NCT04750122|Trastuzumab|trastuzumab|mesh-list
1817999|NCT04750122|Pertuzumab|pertuzumab|mesh-list
1818000|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818001|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
1818002|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
1818003|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
1818004|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818005|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1818006|NCT04750135|Metformin|metformin|mesh-list
1818007|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1818008|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818009|NCT04750005|Listerine|listerine|mesh-list
1818010|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1818011|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818012|NCT04750083|Carboplatin|carboplatin|mesh-list
1818013|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
1818014|NCT04750083|Pemetrexed|pemetrexed|mesh-list
1818015|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818016|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1818017|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818018|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818019|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1818020|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1818106|NCT04749069|Remifentanil|remifentanil|mesh-list
1818043|NCT04749797|Bupivacaine|bupivacaine|mesh-list
1818044|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
1818045|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
1818046|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818047|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818048|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
1818049|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818050|NCT04749810|Eculizumab|eculizumab|mesh-list
1818051|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1818052|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1818053|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
1818054|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818055|NCT04749641|Vaccines|vaccines|mesh-list
1818056|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
1818057|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818058|NCT04749394|Apatinib|apatinib|mesh-list
1818059|NCT04749394|Antibodies|antibodies|mesh-list
1818060|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
1818061|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1818062|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
1818063|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818064|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818065|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1818066|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818067|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818068|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
1818069|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1818070|NCT04749459|Protective Agents|protective agents|mesh-ancestor
1818071|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818072|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
1818073|NCT04749602|Nivolumab|nivolumab|mesh-list
1818074|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1818075|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818076|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1818077|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818078|NCT04749628|Cannabidiol|cannabidiol|mesh-list
1818079|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
1818080|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
1818081|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
1818082|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818083|NCT04748991|Amiodarone|amiodarone|mesh-list
1818084|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1818085|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
1818086|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1818087|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1818088|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818089|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1818090|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1818091|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1818092|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818093|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1818094|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1818095|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1818096|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
1818097|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1818098|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
1818099|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
1818100|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818101|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818102|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1818103|NCT04749043|Analgesics|analgesics|mesh-ancestor
1818104|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
1818105|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818107|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1818108|NCT04749069|Narcotics|narcotics|mesh-ancestor
1818109|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818110|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818111|NCT04749069|Analgesics|analgesics|mesh-ancestor
1818112|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
1818113|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818114|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
1818115|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1818116|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
1818117|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818118|NCT04748887|Protective Agents|protective agents|mesh-ancestor
1818119|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818120|NCT04748562|Progesterone|progesterone|mesh-list
1818121|NCT04748562|Progestins|progestins|mesh-ancestor
1818122|NCT04748562|Hormones|hormones|mesh-ancestor
1818123|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1818124|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818125|NCT04748783|Listerine|listerine|mesh-list
1818126|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
1818127|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1818128|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1818129|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
1818130|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
1818131|NCT04748783|Protective Agents|protective agents|mesh-ancestor
1818132|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818133|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1818134|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818135|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
1818136|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
1818137|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1818138|NCT04748822|Ethanol|ethanol|mesh-list
1818139|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1818140|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818141|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818142|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818143|NCT04748757|Annexin A5|annexin a5|mesh-list
1818144|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818145|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818146|NCT04748523|Mirtazapine|mirtazapine|mesh-list
1818147|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
1818148|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1818149|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1818150|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
1818151|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
1818152|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1818153|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818154|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818155|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1818156|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1818157|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818158|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1818159|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1818160|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1818161|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
1818162|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1818163|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1818164|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
1818165|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1818166|NCT04748796|Landiolol|landiolol|mesh-list
1818167|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1818168|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1818169|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
1818170|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1818171|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818172|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818173|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1818191|NCT04748276|Norepinephrine|norepinephrine|mesh-list
1818192|NCT04748276|Serotonin|serotonin|mesh-list
1818193|NCT04748276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1818194|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1818195|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1818196|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
1818197|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1818198|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818199|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818200|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
1818201|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
1818202|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818203|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1818204|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1818205|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
1818206|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1818207|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1818208|NCT04748341|Benzocaine|benzocaine|mesh-list
1818209|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
1818210|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
1818211|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818212|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818213|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
1818214|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818215|NCT04748419|Durvalumab|durvalumab|mesh-list
1818216|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1818217|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818218|NCT04748042|Prednisone|prednisone|mesh-list
1818219|NCT04748042|Olaparib|olaparib|mesh-list
1818220|NCT04748042|Androgens|androgens|mesh-list
1818221|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1818222|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
1818223|NCT04748042|Hormones|hormones|mesh-ancestor
1818224|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1818225|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818226|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1818227|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818228|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1818229|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818230|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818231|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1818232|NCT04747847|Atorvastatin|atorvastatin|mesh-list
1818233|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1818234|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1818235|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
1818236|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818237|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1818238|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1818239|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818240|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1818241|NCT04747912|Dexamethasone|dexamethasone|mesh-list
1818242|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
1818243|NCT04747912|Methotrexate|methotrexate|mesh-list
1818244|NCT04747912|Vincristine|vincristine|mesh-list
1818245|NCT04747912|Dasatinib|dasatinib|mesh-list
1818246|NCT04747912|Ponatinib|ponatinib|mesh-list
1818247|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
1818248|NCT04747912|BB 1101|bb 1101|mesh-list
1818249|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1818250|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
1818251|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
1818252|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818253|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818254|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1818255|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
1818256|NCT04747912|Hormones|hormones|mesh-ancestor
1818257|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1818258|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1818259|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818260|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
1818261|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818262|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818263|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1818264|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
1818265|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1818266|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1818267|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
1818268|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
1818269|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1818270|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1818271|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
1818272|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1818273|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1818274|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1818275|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
1818276|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
1818277|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
1818278|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1818279|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1818280|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1818281|NCT04747678|Ivermectin|ivermectin|mesh-list
1818282|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1818283|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818284|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
1818285|NCT04747795|Vitamins|vitamins|mesh-ancestor
1818286|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
1818287|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818288|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
1818289|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818290|NCT04747795|Protective Agents|protective agents|mesh-ancestor
1818291|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1818292|NCT04747314|Aripiprazole|aripiprazole|mesh-list
1818293|NCT04747314|Mirtazapine|mirtazapine|mesh-list
1818294|NCT04747314|Citalopram|citalopram|mesh-list
1818295|NCT04747314|Bupropion|bupropion|mesh-list
1818296|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1818297|NCT04747314|Sertraline|sertraline|mesh-list
1818298|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
1818299|NCT04747314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1818300|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1818301|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1818302|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818303|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1818304|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
1818305|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818306|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1818307|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1818308|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818309|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1818310|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
1818311|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1818312|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1818313|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818314|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1818315|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1818316|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818317|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
1818318|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1818319|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1818320|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1818321|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1818322|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1818323|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1818324|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1818325|NCT04747314|Analgesics|analgesics|mesh-ancestor
1818326|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
1818327|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1818328|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
1818329|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
1818330|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1818331|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1818332|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1818333|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1818334|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
1818335|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1818336|NCT04747392|Teriparatide|teriparatide|mesh-list
1818337|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1818338|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818339|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1818340|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1818341|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1818342|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818343|NCT04747301|Dinoprostone|dinoprostone|mesh-list
1818344|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
1818345|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1818346|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818347|NCT04747236|Gemcitabine|gemcitabine|mesh-list
1818348|NCT04747236|Azacitidine|azacitidine|mesh-list
1818349|NCT04747236|Romidepsin|romidepsin|mesh-list
1818350|NCT04747236|Belinostat|belinostat|mesh-list
1818351|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1818352|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
1818353|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818354|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818355|NCT04747236|Antiviral Agents|antiviral agents|mesh-ancestor
1818356|NCT04747236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818357|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818358|NCT04747236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1818359|NCT04747236|Immunologic Factors|immunologic factors|mesh-ancestor
1818360|NCT04747236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818361|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1818362|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1818363|NCT04747015|Oxytocin|oxytocin|mesh-list
1818364|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
1818365|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1818366|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818367|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
1818368|NCT04746937|Norfloxacin|norfloxacin|mesh-list
1818369|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1818370|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818371|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1818372|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1818373|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1818374|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818375|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818376|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818377|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1818378|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1818379|NCT04747080|Dexamethasone|dexamethasone|mesh-list
1818380|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
1818381|NCT04747080|BB 1101|bb 1101|mesh-list
1818382|NCT04747080|Tacrolimus|tacrolimus|mesh-list
1818383|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1818384|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
1818385|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
1818386|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818387|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818388|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1818389|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
1818390|NCT04747080|Hormones|hormones|mesh-ancestor
1818391|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1818392|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1818393|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818394|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
1818395|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818396|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818397|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1818398|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
1818399|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1818403|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
1818404|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1818405|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818406|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818407|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1818408|NCT04747171|Analgesics|analgesics|mesh-ancestor
1818409|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
1818410|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818411|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1818412|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1818413|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1818414|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
1818415|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1818416|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818417|NCT04747145|Temozolomide|temozolomide|mesh-list
1818418|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1818419|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
1818420|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818421|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818422|NCT04746430|Dexamethasone|dexamethasone|mesh-list
1818423|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1818424|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
1818425|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
1818426|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818427|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818428|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1818429|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
1818430|NCT04746430|Hormones|hormones|mesh-ancestor
1818431|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1818432|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1818433|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818434|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
1818435|NCT04746365|Ivermectin|ivermectin|mesh-list
1818436|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
1818437|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1818438|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1818439|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818440|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818441|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818442|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1818443|NCT04746495|Eplerenone|eplerenone|mesh-list
1818444|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1818445|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
1818446|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1818447|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818448|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1818449|NCT04746495|Diuretics|diuretics|mesh-ancestor
1818450|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
1818451|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1818452|NCT04746339|Apixaban|apixaban|mesh-list
1818453|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1818454|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
1818455|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1818456|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
1818457|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818458|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818459|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
1818460|NCT04746235|Decitabine|decitabine|mesh-list
1818461|NCT04746235|Venetoclax|venetoclax|mesh-list
1818462|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1818463|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
1818464|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818465|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818466|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818467|NCT04746209|Blinatumomab|blinatumomab|mesh-list
1818468|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818469|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
1818470|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1818471|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818472|NCT04746040|Fluticasone|fluticasone|mesh-list
1818473|NCT04746040|Xhance|xhance|mesh-list
1818474|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
1818475|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1818476|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1818477|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1818478|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
1818479|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818480|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818481|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1818560|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
1818482|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
1818483|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
1818484|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1818485|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1818486|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1818487|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1818488|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
1818489|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1818490|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818491|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
1818492|NCT04746040|Hormones|hormones|mesh-ancestor
1818493|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1818494|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
1818524|NCT04745780|Inositol|inositol|mesh-list
1818525|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
1818526|NCT04745780|Vitamins|vitamins|mesh-ancestor
1818527|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
1818528|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818529|NCT04745728|Prednisone|prednisone|mesh-list
1818530|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
1818531|NCT04745728|Rituximab|rituximab|mesh-list
1818532|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1818533|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
1818534|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818535|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1818536|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1818537|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
1818538|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818539|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818540|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1818541|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1818542|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1818543|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
1818544|NCT04745728|Hormones|hormones|mesh-ancestor
1818545|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1818546|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1818547|NCT04745949|Prednisone|prednisone|mesh-list
1818548|NCT04745949|Cortisone|cortisone|mesh-list
1818549|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
1818550|NCT04745949|Rituximab|rituximab|mesh-list
1818551|NCT04745949|Doxorubicin|doxorubicin|mesh-list
1818552|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1818553|NCT04745949|Nivolumab|nivolumab|mesh-list
1818554|NCT04745949|Daunorubicin|daunorubicin|mesh-list
1818555|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1818556|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1818557|NCT04745949|Antibodies|antibodies|mesh-list
1818558|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
1818559|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1818561|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1818562|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
1818563|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818564|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1818565|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1818566|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
1818567|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818568|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818569|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1818570|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1818571|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1818572|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1818573|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818574|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1818575|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
1818576|NCT04745949|Hormones|hormones|mesh-ancestor
1818577|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1818578|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1818579|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1818580|NCT04745663|Iodine|iodine|mesh-list
1818581|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
1818582|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
1818583|NCT04745663|Povidone|povidone|mesh-list
1818584|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1818585|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818586|NCT04745663|Trace Elements|trace elements|mesh-ancestor
1818587|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
1818588|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818589|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
1818590|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
1818591|NCT04745260|Fentanyl|fentanyl|mesh-list
1818592|NCT04745260|Midazolam|midazolam|mesh-list
1818593|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1818594|NCT04745260|Narcotics|narcotics|mesh-ancestor
1818595|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818596|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818597|NCT04745260|Analgesics|analgesics|mesh-ancestor
1818598|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
1818599|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818600|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1818601|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1818602|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
1818603|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
1818604|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1818605|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1818606|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1818607|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1818608|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
1818609|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
1818610|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1818611|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818615|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
1818616|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818617|NCT04745286|Ketamine|ketamine|mesh-list
1818618|NCT04745286|Esketamine|esketamine|mesh-list
1818619|NCT04745286|Analgesics|analgesics|mesh-ancestor
1818620|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
1818621|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818622|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818623|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1818624|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1818625|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
1818626|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
1818627|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818628|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1818629|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1818630|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1818631|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818632|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
1818633|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1818634|NCT04745299|Riluzole|riluzole|mesh-list
1818635|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
1818636|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1818637|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1818638|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1818639|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818640|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818641|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1818642|NCT04745299|Protective Agents|protective agents|mesh-ancestor
1818643|NCT04745273|Ondansetron|ondansetron|mesh-list
1818644|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
1818645|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
1818646|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818647|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818648|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1818649|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
1818650|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
1818651|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1818652|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
1818653|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1818654|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818655|NCT04745273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1818656|NCT04745273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1818657|NCT04745273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818658|NCT04745273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1818659|NCT04745273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1818660|NCT04745442|Antithrombins|antithrombins|mesh-list
1818661|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
1818662|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1818663|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
1818664|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818665|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818666|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
1818667|NCT04745377|Antibodies|antibodies|mesh-list
1818668|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
1818669|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818670|NCT04744883|Naloxone|naloxone|mesh-list
1818671|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1818672|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818673|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
1818674|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818675|NCT04745130|Cetuximab|cetuximab|mesh-list
1818676|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1818677|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818678|NCT04744753|Calcium|calcium|mesh-list
1818679|NCT04744753|Ionophores|ionophores|mesh-list
1818680|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
1818681|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1818682|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818683|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1818684|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818685|NCT04744727|Acetaminophen|acetaminophen|mesh-list
1818686|NCT04744727|Meperidine|meperidine|mesh-list
1818687|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1818688|NCT04744727|Analgesics|analgesics|mesh-ancestor
1818689|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
1818690|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818691|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818692|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
1818693|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1818694|NCT04744727|Narcotics|narcotics|mesh-ancestor
1818695|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818696|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1818697|NCT04744649|Fluorouracil|fluorouracil|mesh-list
1818698|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
1818699|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818700|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1818701|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818702|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1818703|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
1818704|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818705|NCT04744675|Triamcinolone|triamcinolone|mesh-list
1818706|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1818707|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1818708|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1818709|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1818710|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
1818711|NCT04744675|Hormones|hormones|mesh-ancestor
1818712|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1818713|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818714|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1818715|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
1818716|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818717|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818718|NCT04744480|Anesthetics|anesthetics|mesh-list
1818719|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818720|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818721|NCT04744545|Curcumin|curcumin|mesh-list
1818722|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1818723|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1818724|NCT04744545|Analgesics|analgesics|mesh-ancestor
1818725|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
1818726|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818727|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818728|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1818729|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1818730|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818731|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818732|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818733|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1818734|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818735|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
1818736|NCT04744623|Dapsone|dapsone|mesh-list
1818737|NCT04744623|Prednisolone|prednisolone|mesh-list
1818738|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1818739|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
1818740|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1818741|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
1818742|NCT04744623|Triamcinolone|triamcinolone|mesh-list
1818743|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1818744|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1818745|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1818746|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1818747|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
1818748|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1818749|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818750|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1818751|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
1818752|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1818753|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818754|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818755|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818756|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1818757|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
1818758|NCT04744623|Hormones|hormones|mesh-ancestor
1818759|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1818760|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818761|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1818762|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
1818763|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
1818764|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818765|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1818766|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1818767|NCT04744623|Protective Agents|protective agents|mesh-ancestor
1818768|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1818769|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
1818770|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
1818771|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1818772|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1818773|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1818774|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
1818775|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1818776|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1818777|NCT04744571|Aspirin|aspirin|mesh-list
1818778|NCT04744571|Metoprolol|metoprolol|mesh-list
1818779|NCT04744571|Clopidogrel|clopidogrel|mesh-list
1818780|NCT04744571|Ticagrelor|ticagrelor|mesh-list
1818781|NCT04744571|Atorvastatin|atorvastatin|mesh-list
1818782|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1818783|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1818784|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1818785|NCT04744571|Analgesics|analgesics|mesh-ancestor
1818786|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
1818787|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1818788|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818789|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1818790|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1818791|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1818792|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1818793|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818794|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1818795|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1818796|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818797|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
1818798|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1818799|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1818800|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
1818801|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1818802|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1818803|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1818804|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1818805|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1818806|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
1818807|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1818808|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1818809|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1818810|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
1818811|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
1818812|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1818813|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1818814|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1818815|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
1818823|NCT04743934|Androgens|androgens|mesh-list
1818824|NCT04743934|Hormones|hormones|mesh-ancestor
1818825|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1818826|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818827|NCT04743739|Cyclosporine|cyclosporine|mesh-list
1818828|NCT04743739|Rituximab|rituximab|mesh-list
1818829|NCT04743739|Cyclosporins|cyclosporins|mesh-list
1818830|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1818831|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818832|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
1818833|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818834|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1818835|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818836|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818837|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1818838|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
1818839|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818840|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
1818841|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1818842|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
1818843|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818844|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1818845|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818846|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818879|NCT04743544|Voriconazole|voriconazole|mesh-list
1818880|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
1818881|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818882|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1818883|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1818884|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818885|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818886|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1818887|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
1818888|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1818889|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818890|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1818896|NCT04743622|Latanoprost|latanoprost|mesh-list
1818897|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1818898|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1818899|NCT04743180|Paclitaxel|paclitaxel|mesh-list
1818900|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1818901|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1818902|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
1818903|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
1818904|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
1818905|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818906|NCT04743011|Heparin|heparin|mesh-list
1818907|NCT04743011|Calcium heparin|calcium heparin|mesh-list
1818908|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1818909|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
1818910|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1818911|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1818912|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818913|NCT04743297|Dinoprostone|dinoprostone|mesh-list
1818914|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
1818915|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1818916|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818917|NCT04743063|Losartan|losartan|mesh-list
1818918|NCT04743063|Valsartan|valsartan|mesh-list
1818919|NCT04743063|Telmisartan|telmisartan|mesh-list
1818920|NCT04743063|Candesartan|candesartan|mesh-list
1818921|NCT04743063|Olmesartan|olmesartan|mesh-list
1818922|NCT04743063|Irbesartan|irbesartan|mesh-list
1818923|NCT04743063|Eprosartan|eprosartan|mesh-list
1818924|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
1818925|NCT04743063|Giapreza|giapreza|mesh-list
1818926|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
1818927|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
1818928|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1818929|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1818930|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818931|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1818932|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1818933|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1818934|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
1818935|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818936|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
1818937|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
1818938|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1818939|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818940|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1818941|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818942|NCT04743193|Sevoflurane|sevoflurane|mesh-list
1818943|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
1818944|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818945|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818946|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1818947|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1818948|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
1818949|NCT04742504|Benralizumab|benralizumab|mesh-list
1818950|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1818951|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
1818961|NCT04742699|Lemborexant|lemborexant|mesh-list
1818962|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1818963|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1818964|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818965|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1818966|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1818967|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1818968|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818969|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
1818970|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1818977|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1818978|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
1818979|NCT04742491|Emtricitabine|emtricitabine|mesh-list
1818980|NCT04742491|Tenofovir|tenofovir|mesh-list
1818981|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1818982|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1818983|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1818984|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818985|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
1818986|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1818987|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1818988|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1818989|NCT04742283|Timolol|timolol|mesh-list
1818990|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1818991|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1818992|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1818993|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1818994|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
1818995|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1818996|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1818997|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1818998|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1818999|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1819005|NCT04742101|Azacitidine|azacitidine|mesh-list
1819006|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1819007|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
1819008|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819009|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819010|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819029|NCT04742348|Levodopa|levodopa|mesh-list
1819030|NCT04742348|Carbidopa|carbidopa|mesh-list
1819031|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1819032|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1819033|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1819034|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
1819035|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1819036|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819037|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819038|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1819039|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819040|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1819041|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
1819042|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
1819043|NCT04741945|Metformin|metformin|mesh-list
1819044|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1819045|NCT04741945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819046|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
1819047|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1819048|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1819049|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819050|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
1819051|NCT04742205|Coagulants|coagulants|mesh-ancestor
1819065|NCT04741880|Lidocaine|lidocaine|mesh-list
1819066|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
1819067|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
1819068|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1819069|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819070|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
1819071|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1819072|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1819073|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1819074|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1819075|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1819076|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819077|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
1819078|NCT04741620|Capsaicin|capsaicin|mesh-list
1819079|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
1819080|NCT04741620|Citric Acid|citric acid|mesh-list
1819081|NCT04741620|Piperine|piperine|mesh-list
1819082|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
1819083|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
1819084|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
1819085|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1819086|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819087|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
1819088|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1819089|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
1819090|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
1819091|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819092|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1819093|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819094|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1819095|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819096|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
1819097|NCT04741620|Protective Agents|protective agents|mesh-ancestor
1819098|NCT04741464|Tinzaparin|tinzaparin|mesh-list
1819099|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1819100|NCT04741464|Dalteparin|dalteparin|mesh-list
1819101|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
1819102|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1819103|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1819104|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819105|NCT04741698|Propranolol|propranolol|mesh-list
1819106|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1819107|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1819108|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
1819109|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1819110|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819111|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819112|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1819113|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1819114|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
1819115|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
1819116|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1819117|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819118|NCT04741334|Anticoagulants|anticoagulants|mesh-list
1819119|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
1819120|NCT04741386|Vaccines|vaccines|mesh-list
1819121|NCT04741386|Immunologic Factors|immunologic factors|mesh-ancestor
1819122|NCT04741386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819123|NCT04741438|Nivolumab|nivolumab|mesh-list
1819124|NCT04741438|Ipilimumab|ipilimumab|mesh-list
1819125|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1819126|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819127|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1819128|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819129|NCT04741295|Heparin|heparin|mesh-list
1819130|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1819131|NCT04741295|Tinzaparin|tinzaparin|mesh-list
1819132|NCT04741295|Dalteparin|dalteparin|mesh-list
1819133|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
1819134|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1819135|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1819136|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819137|NCT04741165|Bevacizumab|bevacizumab|mesh-list
1819138|NCT04741165|Lenvatinib|lenvatinib|mesh-list
1819139|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1819140|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819141|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1819142|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1819143|NCT04741165|Growth Substances|growth substances|mesh-ancestor
1819144|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819145|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
1819146|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1819147|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819148|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819149|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
1819150|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1819151|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819152|NCT04740840|Amlodipine|amlodipine|mesh-list
1819153|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1819154|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1819155|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1819156|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819157|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1819158|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819159|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
1819165|NCT04740593|Methamphetamine|methamphetamine|mesh-list
1819166|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1819167|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819168|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
1819169|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
1819170|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1819171|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
1819172|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1819173|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819174|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
1819175|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1819176|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1819177|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1819178|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1819179|NCT04740697|Tamoxifen|tamoxifen|mesh-list
1819180|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1819181|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
1819182|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1819183|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819184|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1819185|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819186|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1819187|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1819188|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1819189|NCT04740554|Prednisone|prednisone|mesh-list
1819190|NCT04740554|Deflazacort|deflazacort|mesh-list
1819191|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1819192|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
1819193|NCT04740554|Hormones|hormones|mesh-ancestor
1819194|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1819195|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819196|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1819197|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819198|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1819199|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
1819200|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
1819201|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1819202|NCT04740580|Glycine|glycine|mesh-list
1819203|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
1819204|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819205|NCT04740580|Expectorants|expectorants|mesh-ancestor
1819206|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
1819207|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1819208|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
1819209|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819210|NCT04740580|Protective Agents|protective agents|mesh-ancestor
1819211|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819212|NCT04740580|Antidotes|antidotes|mesh-ancestor
1819213|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
1819214|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1819230|NCT04740190|Carboplatin|carboplatin|mesh-list
1819231|NCT04740190|Talazoparib|talazoparib|mesh-list
1819232|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819233|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1819234|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819235|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819236|NCT04740671|Ranibizumab|ranibizumab|mesh-list
1819237|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1819238|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1819239|NCT04740671|Growth Substances|growth substances|mesh-ancestor
1819240|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819241|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
1819242|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819243|NCT04740021|Carboplatin|carboplatin|mesh-list
1819244|NCT04740021|Etoposide|etoposide|mesh-list
1819245|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819246|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1819247|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1819248|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1819249|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819250|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819251|NCT04740099|Naloxone|naloxone|mesh-list
1819252|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1819253|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819254|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
1819255|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1819256|NCT04740008|Nicotine|nicotine|mesh-list
1819257|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1819258|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
1819259|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1819260|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819261|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1819262|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1819263|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
1819264|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1819265|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819266|NCT04739826|HH-GV-678|hh-gv-678|mesh-list
1819267|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1819268|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819269|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819270|NCT04739774|Itraconazole|itraconazole|mesh-list
1819271|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
1819272|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819273|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1819274|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1819275|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819276|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819277|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1819278|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
1819279|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1819280|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819281|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1819282|NCT04740086|Calcium|calcium|mesh-list
1819283|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1819284|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819292|NCT04739670|Gemcitabine|gemcitabine|mesh-list
1819293|NCT04739670|Bevacizumab|bevacizumab|mesh-list
1819294|NCT04739670|Carboplatin|carboplatin|mesh-list
1819295|NCT04739670|Atezolizumab|atezolizumab|mesh-list
1819296|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1819297|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819298|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1819299|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1819300|NCT04739670|Growth Substances|growth substances|mesh-ancestor
1819301|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819302|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
1819303|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1819304|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
1819305|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819306|NCT04739670|Antiviral Agents|antiviral agents|mesh-ancestor
1819307|NCT04739670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819308|NCT04739670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819309|NCT04739670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1819310|NCT04739670|Immunologic Factors|immunologic factors|mesh-ancestor
1819311|NCT04739384|Ticagrelor|ticagrelor|mesh-list
1819312|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1819313|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1819314|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1819315|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1819316|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
1819317|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1819318|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819319|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819320|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
1819321|NCT04739618|Ipilimumab|ipilimumab|mesh-list
1819322|NCT04739618|Sargramostim|sargramostim|mesh-list
1819323|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1819324|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819325|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1819326|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819327|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
1819328|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819331|NCT04739566|Trametinib|trametinib|mesh-list
1819332|NCT04739566|Dabrafenib|dabrafenib|mesh-list
1819333|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819334|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1819335|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819336|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819337|NCT04739592|Vitamin D|vitamin d|mesh-list
1819338|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
1819339|NCT04739592|Alendronate|alendronate|mesh-list
1819340|NCT04739592|Vitamins|vitamins|mesh-ancestor
1819341|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
1819342|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819343|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1819344|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1819345|NCT04739410|Ivermectin|ivermectin|mesh-list
1819346|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1819347|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819352|NCT04739241|Insulin|insulin|mesh-list
1819353|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1819354|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1819355|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819356|NCT04739202|Bevacizumab|bevacizumab|mesh-list
1819357|NCT04739202|Atezolizumab|atezolizumab|mesh-list
1819358|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1819359|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1819360|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819361|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1819362|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1819363|NCT04739202|Growth Substances|growth substances|mesh-ancestor
1819364|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819365|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
1819366|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
1819367|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
1819368|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1819369|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819370|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1819371|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819372|NCT04738955|Micafungin|micafungin|mesh-list
1819373|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
1819374|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819375|NCT04739111|Antibodies|antibodies|mesh-list
1819376|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
1819377|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1819378|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
1819379|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819380|NCT04738981|Basiliximab|basiliximab|mesh-list
1819381|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1819382|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
1819383|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819384|NCT04738695|Antibodies|antibodies|mesh-list
1819385|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
1819386|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819387|NCT04738838|Oxytocin|oxytocin|mesh-list
1819388|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
1819389|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1819390|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819391|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
1819392|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819393|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819401|NCT04738773|Naltrexone|naltrexone|mesh-list
1819402|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1819403|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1819404|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819405|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
1819406|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1819407|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
1819408|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
1819409|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1819410|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819411|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819412|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
1819413|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1819414|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1819415|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819416|NCT04738058|Lactoferrin|lactoferrin|mesh-list
1819417|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819418|NCT04738188|Epirubicin|epirubicin|mesh-list
1819419|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1819420|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819421|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1819422|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1819423|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819424|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819425|NCT04738097|Clopidogrel|clopidogrel|mesh-list
1819426|NCT04738097|Ticagrelor|ticagrelor|mesh-list
1819427|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1819428|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1819429|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1819430|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1819431|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
1819432|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1819433|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819434|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819435|NCT04738045|Ritonavir|ritonavir|mesh-list
1819436|NCT04738045|Lopinavir|lopinavir|mesh-list
1819437|NCT04738045|Remdesivir|remdesivir|mesh-list
1819438|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1819439|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1819440|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
1819441|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819442|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819443|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1819444|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1819445|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
1819446|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819447|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1819448|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1819449|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
1819450|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1819451|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1819452|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
1819453|NCT04737889|Rituximab|rituximab|mesh-list
1819454|NCT04737889|Methotrexate|methotrexate|mesh-list
1819455|NCT04737889|Lenalidomide|lenalidomide|mesh-list
1819456|NCT04737889|Temozolomide|temozolomide|mesh-list
1819457|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1819458|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819459|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
1819460|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819461|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1819687|NCT04736433|Valsartan|valsartan|mesh-list
1819462|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1819463|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
1819464|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1819465|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1819466|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
1819467|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819468|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
1819469|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819470|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1819471|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1819472|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1819473|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1819474|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1819475|NCT04737889|Growth Substances|growth substances|mesh-ancestor
1819476|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
1819477|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1819478|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
1819479|NCT04737928|Latanoprost|latanoprost|mesh-list
1819480|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1819481|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1819482|NCT04737980|Dexamethasone|dexamethasone|mesh-list
1819483|NCT04737980|Bupivacaine|bupivacaine|mesh-list
1819484|NCT04737980|Ropivacaine|ropivacaine|mesh-list
1819485|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1819486|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
1819487|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
1819488|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1819489|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819490|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1819491|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
1819492|NCT04737980|Hormones|hormones|mesh-ancestor
1819493|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1819494|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1819495|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819496|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
1819497|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
1819498|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1819499|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
1819500|NCT04737967|Memantine|memantine|mesh-list
1819501|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1819502|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1819503|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1819504|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
1819505|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1819506|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819507|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819508|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1819509|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1819510|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1819511|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1819512|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1819513|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1819514|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
1819515|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1819516|NCT04737837|Lacosamide|lacosamide|mesh-list
1819517|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
1819518|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1819519|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1819520|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1819521|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819522|NCT04737655|Beclomethasone|beclomethasone|mesh-list
1819523|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
1819524|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
1819525|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1819526|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
1819527|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1819528|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819529|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1819530|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
1819531|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1819532|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1819533|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1819534|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
1819763|NCT04736186|Protective Agents|protective agents|mesh-ancestor
1819535|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1819536|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819537|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1819538|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1819539|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1819540|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
1819541|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1819542|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
1819543|NCT04737655|Hormones|hormones|mesh-ancestor
1819544|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1819545|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1819546|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1819547|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1819548|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
1819549|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819550|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1819551|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1819552|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819553|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
1819554|NCT04737278|Niacin|niacin|mesh-list
1819555|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
1819556|NCT04737278|Vitamins|vitamins|mesh-ancestor
1819557|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
1819558|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819559|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1819560|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
1819561|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819562|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1819563|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
1819577|NCT04737473|Anesthetics|anesthetics|mesh-list
1819578|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1819579|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819580|NCT04736953|Sirolimus|sirolimus|mesh-list
1819581|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1819582|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819583|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1819584|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819585|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
1819586|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1819587|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
1819588|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819589|NCT04737057|Fluorides|fluorides|mesh-list
1819590|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
1819591|NCT04737057|Protective Agents|protective agents|mesh-ancestor
1819592|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819593|NCT04736836|Rifaximin|rifaximin|mesh-list
1819594|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1819595|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819596|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1819597|NCT04736823|Paclitaxel|paclitaxel|mesh-list
1819598|NCT04736823|Docetaxel|docetaxel|mesh-list
1819599|NCT04736823|Carboplatin|carboplatin|mesh-list
1819600|NCT04736823|Pemetrexed|pemetrexed|mesh-list
1819601|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1819602|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819603|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
1819604|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
1819605|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
1819606|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819607|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819608|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1819609|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1819610|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
1819611|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819612|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1819613|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819614|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819615|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1819616|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
1819617|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819618|NCT04736901|Enoxaparin|enoxaparin|mesh-list
1819619|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
1819620|NCT04736901|Apixaban|apixaban|mesh-list
1819621|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
1819622|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1819623|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
1819624|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1819625|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
1819626|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819627|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819628|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
1819629|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1819630|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1819631|NCT04736927|Midazolam|midazolam|mesh-list
1819632|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1819633|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1819634|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1819635|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819636|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1819637|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1819638|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1819639|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1819640|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
1819641|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
1819642|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
1819643|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
1819644|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1819645|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819646|NCT04736979|Amoxicillin|amoxicillin|mesh-list
1819647|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
1819648|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
1819649|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1819650|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1819651|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819652|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1819653|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819654|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819655|NCT04736524|Antibodies|antibodies|mesh-list
1819656|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
1819657|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819658|NCT04736810|Gemcitabine|gemcitabine|mesh-list
1819659|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819660|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1819661|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
1819662|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819663|NCT04736810|Antiviral Agents|antiviral agents|mesh-ancestor
1819664|NCT04736810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819665|NCT04736810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819666|NCT04736810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1819667|NCT04736810|Immunologic Factors|immunologic factors|mesh-ancestor
1819668|NCT04736810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819669|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
1819670|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
1819671|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1819672|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819673|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1819674|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
1819675|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1819676|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1819677|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1819678|NCT04736719|Warfarin|warfarin|mesh-list
1819679|NCT04736719|Apixaban|apixaban|mesh-list
1819680|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
1819681|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1819682|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
1819683|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1819684|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
1819685|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819686|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819688|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1819689|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1819690|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1819691|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1819692|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819693|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
1819694|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819695|NCT04736420|Warfarin|warfarin|mesh-list
1819696|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
1819697|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
1819698|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1819699|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
1819700|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1819701|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
1819702|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819703|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819704|NCT04736589|Sirolimus|sirolimus|mesh-list
1819705|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1819706|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819707|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1819708|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819709|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
1819710|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1819711|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
1819712|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819713|NCT04736329|Telmisartan|telmisartan|mesh-list
1819714|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1819715|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1819716|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1819717|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819718|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
1819719|NCT04736381|Abatacept|abatacept|mesh-list
1819720|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1819721|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819722|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1819723|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
1819724|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1819725|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819726|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819727|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819728|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1819729|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
1819730|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819731|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1819732|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1819733|NCT04736108|Prednisolone|prednisolone|mesh-list
1819734|NCT04736108|Goserelin|goserelin|mesh-list
1819735|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
1819736|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1819737|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
1819738|NCT04736108|Hormones|hormones|mesh-ancestor
1819739|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1819740|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819741|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1819742|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819743|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1819744|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819745|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819746|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
1819747|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1819748|NCT04736225|Insulin|insulin|mesh-list
1819749|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1819750|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819751|NCT04736394|Epirubicin|epirubicin|mesh-list
1819752|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1819753|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819754|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1819755|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1819756|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819757|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819758|NCT04736186|Loperamide|loperamide|mesh-list
1819759|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
1819760|NCT04736186|Bentonite|bentonite|mesh-list
1819761|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1819762|NCT04736186|Antidotes|antidotes|mesh-ancestor
1819764|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819783|NCT04735978|Antibodies|antibodies|mesh-list
1819784|NCT04735978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1819785|NCT04735978|Immunologic Factors|immunologic factors|mesh-ancestor
1819786|NCT04735978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819796|NCT04735926|Calcifediol|calcifediol|mesh-list
1819797|NCT04735926|Vitamins|vitamins|mesh-ancestor
1819798|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
1819799|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819800|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1819801|NCT04735523|Warfarin|warfarin|mesh-list
1819802|NCT04735523|Dabigatran|dabigatran|mesh-list
1819803|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
1819804|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
1819805|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1819806|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
1819807|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819808|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819809|NCT04735445|Liver Extracts|liver extracts|mesh-list
1819810|NCT04735445|Hematinics|hematinics|mesh-ancestor
1819811|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
1819812|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
1819813|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1819814|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819815|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
1819816|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
1819817|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1819818|NCT04735510|Cyclosporine|cyclosporine|mesh-list
1819819|NCT04735510|Cyclosporins|cyclosporins|mesh-list
1819820|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819821|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819822|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1819823|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
1819824|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819825|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
1819826|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819827|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
1819828|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1819829|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1819830|NCT04735549|Hormones|hormones|mesh-list
1819831|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1819832|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819833|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
1819834|NCT04735471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1819835|NCT04735471|Fludarabine|fludarabine|mesh-list
1819836|NCT04735471|Interleukin-2|interleukin-2|mesh-list
1819837|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1819838|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
1819839|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819840|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1819841|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1819842|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
1819843|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819844|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819845|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1819846|NCT04735471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1819847|NCT04735471|Analgesics|analgesics|mesh-ancestor
1819848|NCT04735471|Sensory System Agents|sensory system agents|mesh-ancestor
1819849|NCT04735471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1819850|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1819851|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1819864|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
1819865|NCT04735042|Empagliflozin|empagliflozin|mesh-list
1819866|NCT04735042|Linagliptin|linagliptin|mesh-list
1819867|NCT04735042|Saxagliptin|saxagliptin|mesh-list
1819868|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1819869|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819870|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1819871|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819872|NCT04735042|Incretins|incretins|mesh-ancestor
1819873|NCT04735042|Hormones|hormones|mesh-ancestor
1819874|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1819875|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1819876|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
1819877|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819878|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
1819879|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
1819880|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1819881|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1819882|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819883|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819884|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819885|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1819898|NCT04734652|Tenofovir|tenofovir|mesh-list
1819899|NCT04734652|Lamivudine|lamivudine|mesh-list
1819900|NCT04734652|Dolutegravir|dolutegravir|mesh-list
1819901|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
1819902|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1819903|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1819904|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1819905|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819906|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819907|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1819908|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1819909|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1819910|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1819915|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
1819916|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819917|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819918|NCT04734678|Infliximab|infliximab|mesh-list
1819919|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
1819920|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1819921|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1819922|NCT04734730|Prednisone|prednisone|mesh-list
1819923|NCT04734730|Cortisone|cortisone|mesh-list
1819924|NCT04734730|Leuprolide|leuprolide|mesh-list
1819925|NCT04734730|Goserelin|goserelin|mesh-list
1819926|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
1819927|NCT04734730|Bicalutamide|bicalutamide|mesh-list
1819928|NCT04734730|Talazoparib|talazoparib|mesh-list
1819929|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1819930|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
1819931|NCT04734730|Hormones|hormones|mesh-ancestor
1819932|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1819933|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819934|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1819935|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819936|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1819937|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
1819938|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1819939|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1819940|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819941|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819942|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
1819943|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1819944|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
1819945|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1819946|NCT04734782|Antibodies|antibodies|mesh-list
1819947|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
1819948|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819949|NCT04734665|Bevacizumab|bevacizumab|mesh-list
1819950|NCT04734665|Niraparib|niraparib|mesh-list
1819951|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1819952|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1819953|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1819954|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1819955|NCT04734665|Growth Substances|growth substances|mesh-ancestor
1819956|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819957|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
1819958|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1819959|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1819960|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819961|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
1819962|NCT04734418|Remifentanil|remifentanil|mesh-list
1819963|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1819964|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1819965|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819966|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1819967|NCT04734418|Analgesics|analgesics|mesh-ancestor
1819968|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
1819969|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1819970|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1819971|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1819972|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1819973|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
1819974|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1819975|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1819976|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1819977|NCT04734418|Narcotics|narcotics|mesh-ancestor
1819978|NCT04734210|Betamethasone|betamethasone|mesh-list
1819979|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
1819980|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
1819981|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
1819982|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
1819983|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1819984|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
1819985|NCT04734210|Hormones|hormones|mesh-ancestor
1819986|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1819987|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1819988|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1819989|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
1820013|NCT04734405|Fluconazole|fluconazole|mesh-list
1820014|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
1820015|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820016|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1820017|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1820018|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820019|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820020|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1820021|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
1820022|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1820023|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820024|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1820025|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1820026|NCT04734028|Aspirin|aspirin|mesh-list
1820027|NCT04734028|Clopidogrel|clopidogrel|mesh-list
1820028|NCT04734028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1820029|NCT04734028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1820030|NCT04734028|Analgesics|analgesics|mesh-ancestor
1820031|NCT04734028|Sensory System Agents|sensory system agents|mesh-ancestor
1820032|NCT04734028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820033|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820034|NCT04734028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1820035|NCT04734028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1820036|NCT04734028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1820037|NCT04734028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1820038|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820039|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1820040|NCT04734028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1820041|NCT04734028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820042|NCT04734028|Antipyretics|antipyretics|mesh-ancestor
1820043|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1820044|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1820045|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1820046|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
1820047|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820048|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1820049|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820050|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820051|NCT04734353|Ticagrelor|ticagrelor|mesh-list
1820052|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1820053|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1820054|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1820055|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1820056|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1820057|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
1820058|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820059|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820060|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820061|NCT04734119|Anesthetics|anesthetics|mesh-list
1820062|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820063|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820073|NCT04734080|Dronabinol|dronabinol|mesh-list
1820074|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
1820075|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820076|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1820077|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1820078|NCT04734080|Analgesics|analgesics|mesh-ancestor
1820079|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
1820080|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820081|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1820082|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1820083|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820084|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820085|NCT04734080|Hormones|hormones|mesh-ancestor
1820086|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1820087|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1820088|NCT04733781|Lidocaine|lidocaine|mesh-list
1820089|NCT04733781|Epinephrine|epinephrine|mesh-list
1820090|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
1820091|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
1820092|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820093|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820094|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
1820095|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820096|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1820097|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1820098|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1820099|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1820100|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820101|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1820102|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1820103|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
1820104|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820105|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1820106|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1820107|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
1820108|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1820109|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
1820110|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
1820111|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
1820112|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1820113|NCT04733742|Tenecteplase|tenecteplase|mesh-list
1820114|NCT04733742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1820115|NCT04733742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1820116|NCT04733742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820121|NCT04733625|Vitamin D|vitamin d|mesh-list
1820122|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
1820123|NCT04733625|Vitamins|vitamins|mesh-ancestor
1820124|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
1820125|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820126|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1820127|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1820128|NCT04733326|Ketorolac|ketorolac|mesh-list
1820129|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1820130|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1820131|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1820132|NCT04733326|Analgesics|analgesics|mesh-ancestor
1820133|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
1820134|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820135|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820136|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1820137|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1820138|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1820139|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820140|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820141|NCT04733963|Bevacizumab|bevacizumab|mesh-list
1820142|NCT04733963|Capecitabine|capecitabine|mesh-list
1820143|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1820144|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820145|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1820146|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1820147|NCT04733963|Growth Substances|growth substances|mesh-ancestor
1820148|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820149|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
1820150|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1820151|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
1820152|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820153|NCT04733521|Cisplatin|cisplatin|mesh-list
1820154|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820155|NCT04733508|Exenatide|exenatide|mesh-list
1820156|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1820157|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820158|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1820159|NCT04733508|Incretins|incretins|mesh-ancestor
1820160|NCT04733508|Hormones|hormones|mesh-ancestor
1820161|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1820162|NCT04733235|Progesterone|progesterone|mesh-list
1820163|NCT04733235|Hormones|hormones|mesh-ancestor
1820164|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1820165|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820166|NCT04733235|Progestins|progestins|mesh-ancestor
1820167|NCT04733144|Dexamethasone|dexamethasone|mesh-list
1820168|NCT04733144|Prednisolone|prednisolone|mesh-list
1820169|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1820170|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
1820171|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
1820172|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820173|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820174|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1820175|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
1820176|NCT04733144|Hormones|hormones|mesh-ancestor
1820177|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1820178|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1820179|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820180|NCT04733131|Abatacept|abatacept|mesh-list
1820181|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1820182|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820183|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820184|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1820185|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
1820186|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820187|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1820194|NCT04733066|Teduglutide|teduglutide|mesh-list
1820195|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1820196|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1820197|NCT04733066|Protective Agents|protective agents|mesh-ancestor
1820198|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820199|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
1820200|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820201|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
1820202|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
1820203|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
1820204|NCT04733547|Furosemide|furosemide|mesh-list
1820205|NCT04733547|Diuretics|diuretics|mesh-ancestor
1820206|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
1820207|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820208|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1820209|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1820210|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820211|NCT04732910|Ivacaftor|ivacaftor|mesh-list
1820212|NCT04732910|Elexacaftor|elexacaftor|mesh-list
1820213|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1820214|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1820215|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820216|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
1820217|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820218|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
1820219|NCT04732845|Fludarabine|fludarabine|mesh-list
1820220|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1820221|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
1820222|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820223|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1820224|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1820225|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
1820226|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820227|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820228|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1820229|NCT04733183|Dacarbazine|dacarbazine|mesh-list
1820230|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1820231|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
1820232|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820233|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820234|NCT04733118|Trastuzumab|trastuzumab|mesh-list
1820235|NCT04733118|Pertuzumab|pertuzumab|mesh-list
1820236|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1820237|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820238|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
1820239|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1820240|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1820241|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1820242|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820243|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
1820244|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
1820245|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
1820246|NCT04732390|Bupivacaine|bupivacaine|mesh-list
1820247|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
1820248|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
1820249|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820250|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820251|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
1820252|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820253|NCT04732390|Analgesics|analgesics|mesh-ancestor
1820254|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1820255|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
1820256|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1820257|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1820258|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820259|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1820260|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
1820261|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1820262|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
1820263|NCT04732377|Bupivacaine|bupivacaine|mesh-list
1820264|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
1820265|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
1820266|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820267|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820268|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
1820269|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820270|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1820271|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1820272|NCT04732377|Analgesics|analgesics|mesh-ancestor
1820273|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1820274|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1820275|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1820276|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
1820277|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820278|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820279|NCT04732455|Lidocaine|lidocaine|mesh-list
1820280|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1820281|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
1820282|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
1820283|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820284|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820285|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
1820286|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820287|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1820288|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1820289|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1820290|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1820291|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820292|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1820293|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1820294|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820295|NCT04732455|Analgesics|analgesics|mesh-ancestor
1820296|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
1820297|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1820298|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
1820299|NCT04732364|Bupivacaine|bupivacaine|mesh-list
1820300|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
1820301|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
1820302|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820303|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820304|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
1820305|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820306|NCT04732598|Paclitaxel|paclitaxel|mesh-list
1820307|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1820308|NCT04732598|Bevacizumab|bevacizumab|mesh-list
1820309|NCT04732598|Atezolizumab|atezolizumab|mesh-list
1820310|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1820311|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820312|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
1820313|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
1820314|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
1820315|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820316|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1820317|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1820318|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1820319|NCT04732598|Growth Substances|growth substances|mesh-ancestor
1820320|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820321|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
1820322|NCT04732507|Lidocaine|lidocaine|mesh-list
1820323|NCT04732507|Bupivacaine|bupivacaine|mesh-list
1820324|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
1820325|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
1820326|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820327|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820328|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
1820329|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820330|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1820331|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1820332|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1820333|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1820334|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820343|NCT04732247|Oxytocin|oxytocin|mesh-list
1820344|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
1820345|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1820346|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820347|NCT04732208|Mydriatics|mydriatics|mesh-list
1820348|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
1820349|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820350|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820351|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1820352|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1820353|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1820354|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820355|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820356|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1820357|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1820358|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820359|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
1820360|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820361|NCT04732104|Lidocaine|lidocaine|mesh-list
1820362|NCT04732104|Xylometazoline|xylometazoline|mesh-list
1820363|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
1820364|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
1820365|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
1820366|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820367|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820368|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
1820369|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820370|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1820371|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1820372|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1820373|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1820374|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820375|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1820376|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
1820377|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
1820378|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1820379|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
1820380|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820381|NCT04732000|Expectorants|expectorants|mesh-ancestor
1820382|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
1820383|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1820384|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
1820385|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820386|NCT04732000|Protective Agents|protective agents|mesh-ancestor
1820387|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820388|NCT04732000|Antidotes|antidotes|mesh-ancestor
1820389|NCT04731727|Riboflavin|riboflavin|mesh-list
1820390|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
1820391|NCT04731727|Vitamins|vitamins|mesh-ancestor
1820392|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
1820393|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820394|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1820395|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
1820406|NCT04731779|Cannabidiol|cannabidiol|mesh-list
1820407|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
1820408|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
1820409|NCT04731740|Lenvatinib|lenvatinib|mesh-list
1820410|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1820411|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820412|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1820413|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820414|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820415|NCT04731948|Vitamins|vitamins|mesh-list
1820416|NCT04731948|Folic Acid|folic acid|mesh-list
1820417|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
1820418|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
1820419|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
1820420|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
1820421|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820422|NCT04731948|Hematinics|hematinics|mesh-ancestor
1820423|NCT04731909|Cisplatin|cisplatin|mesh-list
1820424|NCT04731909|Carboplatin|carboplatin|mesh-list
1820425|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820426|NCT04731766|Listerine|listerine|mesh-list
1820427|NCT04731766|Fluorides|fluorides|mesh-list
1820428|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
1820429|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
1820430|NCT04731766|Protective Agents|protective agents|mesh-ancestor
1820431|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820432|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1820433|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820434|NCT04731558|Enoxaparin|enoxaparin|mesh-list
1820435|NCT04731558|Dalteparin|dalteparin|mesh-list
1820436|NCT04731558|Tinzaparin|tinzaparin|mesh-list
1820437|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1820438|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
1820439|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1820440|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1820441|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820442|NCT04731363|Erythritol|erythritol|mesh-list
1820443|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
1820447|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
1820448|NCT04731376|Testosterone|testosterone|mesh-list
1820449|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
1820450|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
1820451|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
1820452|NCT04731376|Androgens|androgens|mesh-ancestor
1820453|NCT04731376|Hormones|hormones|mesh-ancestor
1820454|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1820455|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820456|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1820457|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820458|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
1820459|NCT04731480|Propofol|propofol|mesh-list
1820460|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1820461|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820462|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820463|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1820464|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
1820465|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
1820479|NCT04731116|Cannabidiol|cannabidiol|mesh-list
1820480|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
1820481|NCT04731038|Paclitaxel|paclitaxel|mesh-list
1820482|NCT04731038|Carboplatin|carboplatin|mesh-list
1820483|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1820484|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820485|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
1820486|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
1820487|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
1820488|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820504|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1820505|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
1820506|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1820507|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820508|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
1820509|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1820510|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820511|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820512|NCT04730973|Evolocumab|evolocumab|mesh-list
1820513|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1820514|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1820515|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
1820516|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820517|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1820518|NCT04730856|Tinzaparin|tinzaparin|mesh-list
1820519|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1820520|NCT04730856|Dalteparin|dalteparin|mesh-list
1820521|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
1820522|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1820523|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1820524|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820525|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1820526|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820527|NCT04730895|Tretinoin|tretinoin|mesh-list
1820528|NCT04730895|Isotretinoin|isotretinoin|mesh-list
1820529|NCT04730895|Vaccines|vaccines|mesh-list
1820530|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
1820531|NCT04730895|Paraproteins|paraproteins|mesh-list
1820532|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
1820533|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820534|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820535|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
1820536|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
1820537|NCT04730999|Bevacizumab|bevacizumab|mesh-list
1820538|NCT04730999|Carboplatin|carboplatin|mesh-list
1820539|NCT04730999|Etoposide|etoposide|mesh-list
1820540|NCT04730999|Atezolizumab|atezolizumab|mesh-list
1820541|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1820542|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820543|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1820544|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1820545|NCT04730999|Growth Substances|growth substances|mesh-ancestor
1820546|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820547|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
1820548|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1820549|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1820550|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1820551|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820552|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820553|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
1820554|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1820555|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820556|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1820557|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820563|NCT04730362|Propofol|propofol|mesh-list
1820564|NCT04730362|Sevoflurane|sevoflurane|mesh-list
1820565|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
1820566|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820567|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820568|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1820569|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1820570|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
1820571|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1820572|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1820573|NCT04730622|Mitogens|mitogens|mesh-list
1820574|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
1820575|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820576|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
1820577|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1820578|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820579|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820580|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1820581|NCT04730609|Analgesics|analgesics|mesh-ancestor
1820582|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
1820583|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820584|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1820585|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1820586|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1820587|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
1820588|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820589|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820590|NCT04730544|Nivolumab|nivolumab|mesh-list
1820591|NCT04730544|Ipilimumab|ipilimumab|mesh-list
1820592|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1820593|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820594|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1820595|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820596|NCT04730531|Epinephrine|epinephrine|mesh-list
1820597|NCT04730531|Bupivacaine|bupivacaine|mesh-list
1820598|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
1820599|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
1820600|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820601|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820602|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
1820603|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820604|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1820605|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1820606|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
1820607|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820608|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820609|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1820610|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1820611|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
1820612|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1820613|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
1820614|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
1820615|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
1820616|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1820617|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
1820618|NCT04730596|Ketamine|ketamine|mesh-list
1820619|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1820620|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820621|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820622|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1820623|NCT04730596|Analgesics|analgesics|mesh-ancestor
1820624|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
1820625|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820626|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1820627|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1820628|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1820629|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
1820630|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820631|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820632|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1820633|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1820634|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
1820635|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
1820636|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1820637|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1820638|NCT04730674|Tetracycline|tetracycline|mesh-list
1820639|NCT04730674|Lidocaine|lidocaine|mesh-list
1820640|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
1820641|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
1820642|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820643|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820644|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
1820645|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820646|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1820647|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1820648|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1820649|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1820650|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820651|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1820652|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820653|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1820654|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820655|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
1820656|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1820657|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1820658|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
1820659|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1820660|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820661|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820662|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1820663|NCT04730375|Analgesics|analgesics|mesh-ancestor
1820664|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
1820665|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820666|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1820667|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1820668|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1820669|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
1820670|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820671|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820672|NCT04730245|Rifaximin|rifaximin|mesh-list
1820673|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1820674|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820675|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1820676|NCT04730219|Paclitaxel|paclitaxel|mesh-list
1820677|NCT04730219|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1820678|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1820679|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820680|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
1820681|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
1820682|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
1820683|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820684|NCT04730297|Acetaminophen|acetaminophen|mesh-list
1820685|NCT04730297|Ibuprofen|ibuprofen|mesh-list
1820686|NCT04730297|Codeine|codeine|mesh-list
1820687|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1820688|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1820689|NCT04730297|Analgesics|analgesics|mesh-ancestor
1820690|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
1820691|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820692|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820693|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1820694|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1820695|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1820696|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820697|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820698|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
1820699|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1820700|NCT04730297|Narcotics|narcotics|mesh-ancestor
1820701|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820702|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
1820703|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
1820704|NCT04730258|Azacitidine|azacitidine|mesh-list
1820705|NCT04730258|Decitabine|decitabine|mesh-list
1820706|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1820707|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
1820708|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820709|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820710|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820711|NCT04730206|Camostat|camostat|mesh-list
1820712|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
1820713|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820714|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820715|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1820716|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1820726|NCT04730193|Caffeine|caffeine|mesh-list
1820727|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1820728|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820729|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1820730|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820731|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820732|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1820733|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1820734|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
1820735|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820746|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
1820747|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1820748|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
1820749|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1820750|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
1820751|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820752|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820753|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
1820754|NCT04729556|Chitosan|chitosan|mesh-list
1820755|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1820756|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1820757|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
1820758|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820759|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1820760|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
1820761|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
1820762|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
1820763|NCT04729556|Coagulants|coagulants|mesh-ancestor
1820764|NCT04729543|Azacitidine|azacitidine|mesh-list
1820765|NCT04729543|Interleukin-2|interleukin-2|mesh-list
1820766|NCT04729543|Valproic Acid|valproic acid|mesh-list
1820767|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1820768|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
1820769|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820770|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820771|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820772|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1820773|NCT04729543|Analgesics|analgesics|mesh-ancestor
1820774|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
1820775|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820776|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820777|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
1820778|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
1820779|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820780|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
1820781|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1820782|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820783|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1820784|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
1820785|NCT04729868|Bupivacaine|bupivacaine|mesh-list
1820786|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
1820787|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
1820788|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
1820789|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820790|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820791|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
1820792|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820793|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1820794|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1820795|NCT04729868|Analgesics|analgesics|mesh-ancestor
1820796|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1820797|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1820798|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1820799|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
1820800|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820801|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820802|NCT04729465|Propofol|propofol|mesh-list
1820803|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1820804|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820805|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820806|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1820807|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
1820808|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
1820809|NCT04729491|Azithromycin|azithromycin|mesh-list
1820810|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
1820811|NCT04729491|Dutasteride|dutasteride|mesh-list
1820812|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1820813|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820814|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1820815|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1820816|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820817|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820818|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
1820819|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1820820|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820821|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1820822|NCT04729322|Metronidazole|metronidazole|mesh-list
1820823|NCT04729322|Vancomycin|vancomycin|mesh-list
1820824|NCT04729322|Neomycin|neomycin|mesh-list
1820825|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
1820826|NCT04729322|Nivolumab|nivolumab|mesh-list
1820827|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1820828|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820829|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1820830|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820831|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820832|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1820833|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1820834|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1820835|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1820836|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820837|NCT04729517|Azelastine|azelastine|mesh-list
1820838|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1820839|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
1820840|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820841|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820842|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1820843|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
1820844|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1820845|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820846|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820847|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1820848|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1820849|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1820850|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
1820851|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
1820852|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820853|NCT04729179|Cannabidiol|cannabidiol|mesh-list
1820854|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
1820855|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
1820856|NCT04729348|Lenvatinib|lenvatinib|mesh-list
1820857|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1820858|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820859|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1820860|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820861|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820868|NCT04729101|Lansoprazole|lansoprazole|mesh-list
1820869|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
1820870|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1820871|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1820872|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1820873|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820874|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820875|NCT04728932|Simendan|simendan|mesh-list
1820876|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1820877|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
1820878|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1820879|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1820880|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820881|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820882|NCT04728932|Protective Agents|protective agents|mesh-ancestor
1820883|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820884|NCT04728880|Remdesivir|remdesivir|mesh-list
1820885|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
1820886|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820887|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
1820888|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820889|NCT04728971|Caspofungin|caspofungin|mesh-list
1820890|NCT04728971|Micafungin|micafungin|mesh-list
1820891|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
1820892|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820893|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820894|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820895|NCT04728750|Pancrelipase|pancrelipase|mesh-list
1820896|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1820897|NCT04728516|Amoxicillin|amoxicillin|mesh-list
1820898|NCT04728516|Pantoprazole|pantoprazole|mesh-list
1820899|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1820900|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820901|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1820902|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1820903|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1820904|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820905|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820918|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
1820919|NCT04728581|Mirtazapine|mirtazapine|mesh-list
1820920|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
1820921|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1820922|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1820923|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1820924|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820925|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820926|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1820927|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
1820928|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
1820929|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820930|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820931|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1820932|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1820933|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1820934|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1820935|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
1820936|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1820937|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1820938|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
1820939|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1820940|NCT04728659|Desogestrel|desogestrel|mesh-list
1820941|NCT04728659|Ganirelix|ganirelix|mesh-list
1820942|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1820943|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1820944|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1820945|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
1820946|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1820947|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820948|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1820949|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1820950|NCT04728659|Progestins|progestins|mesh-ancestor
1820951|NCT04728659|Hormones|hormones|mesh-ancestor
1820952|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1820953|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
1820954|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
1820955|NCT04728386|Eusol|eusol|mesh-list
1820956|NCT04728386|Curcumin|curcumin|mesh-list
1820957|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1820958|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1820959|NCT04728386|Analgesics|analgesics|mesh-ancestor
1820960|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
1820961|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1820962|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820963|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1820964|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1820965|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820966|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1820967|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820968|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
1820969|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1820970|NCT04729023|Temazepam|temazepam|mesh-list
1820971|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1820972|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1820973|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820974|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1820975|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1820976|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1820977|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
1820978|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
1820979|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1820980|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820981|NCT04729088|Isosorbide|isosorbide|mesh-list
1820982|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
1820983|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
1820984|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1820985|NCT04729088|Diuretics|diuretics|mesh-ancestor
1820986|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
1820987|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1820988|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
1820989|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
1820990|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820991|NCT04729205|Mitomycins|mitomycins|mesh-list
1820992|NCT04729205|Mitomycin|mitomycin|mesh-list
1820993|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1820994|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1820995|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
1820996|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1820997|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1820998|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821014|NCT04729140|Doxycycline|doxycycline|mesh-list
1821015|NCT04729140|Ivermectin|ivermectin|mesh-list
1821016|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1821017|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821018|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
1821019|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1821020|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1821021|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
1821022|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1821023|NCT04728425|Antibodies|antibodies|mesh-list
1821024|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
1821025|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1821026|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
1821027|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
1821028|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821029|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1821030|NCT04728321|Lenvatinib|lenvatinib|mesh-list
1821031|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821032|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1821033|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821034|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821035|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
1821036|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
1821037|NCT04728087|Coagulants|coagulants|mesh-ancestor
1821038|NCT04728360|Ustekinumab|ustekinumab|mesh-list
1821039|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
1821040|NCT04728308|Bupivacaine|bupivacaine|mesh-list
1821041|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
1821042|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
1821043|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1821044|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821045|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
1821046|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821047|NCT04728217|Factor VIII|factor viii|mesh-list
1821048|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
1821049|NCT04728217|Coagulants|coagulants|mesh-ancestor
1821050|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
1821051|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821052|NCT04728230|Carboplatin|carboplatin|mesh-list
1821053|NCT04728230|Etoposide|etoposide|mesh-list
1821054|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
1821055|NCT04728230|Durvalumab|durvalumab|mesh-list
1821056|NCT04728230|Olaparib|olaparib|mesh-list
1821057|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
1821058|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
1821059|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1821060|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
1821061|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821062|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1821063|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1821064|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1821065|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821066|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821067|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1821068|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
1821069|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821070|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1821071|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
1821072|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
1821073|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
1821074|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
1821075|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
1821076|NCT04728035|Irinotecan|irinotecan|mesh-list
1821077|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1821078|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1821079|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821080|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821081|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821082|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
1821083|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1821084|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821085|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1821086|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1821087|NCT04727671|Cetrorelix|cetrorelix|mesh-list
1821088|NCT04727671|Menotropins|menotropins|mesh-list
1821089|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
1821090|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1821091|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
1821092|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1821093|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821094|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1821095|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1821096|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821097|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1821098|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
1821099|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
1821100|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1821101|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1821102|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1821103|NCT04727684|Cetrorelix|cetrorelix|mesh-list
1821104|NCT04727684|Menotropins|menotropins|mesh-list
1821105|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
1821106|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1821107|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
1821108|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1821109|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821110|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1821111|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1821112|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821113|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1821114|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
1821115|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
1821116|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1821117|NCT04727515|Fentanyl|fentanyl|mesh-list
1821118|NCT04727515|Isoflurane|isoflurane|mesh-list
1821119|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1821120|NCT04727515|Narcotics|narcotics|mesh-ancestor
1821121|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1821122|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821123|NCT04727515|Analgesics|analgesics|mesh-ancestor
1821124|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
1821125|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821126|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1821127|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1821128|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
1821129|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
1821130|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1821131|NCT04727775|Remdesivir|remdesivir|mesh-list
1821132|NCT04727775|Favipiravir|favipiravir|mesh-list
1821133|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
1821134|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821135|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
1821136|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821137|NCT04727853|Irinotecan|irinotecan|mesh-list
1821138|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1821139|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1821140|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821141|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821142|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821143|NCT04727437|Heparin|heparin|mesh-list
1821144|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1821145|NCT04727437|Tinzaparin|tinzaparin|mesh-list
1821146|NCT04727437|Dalteparin|dalteparin|mesh-list
1821147|NCT04727437|Warfarin|warfarin|mesh-list
1821148|NCT04727437|Anticoagulants|anticoagulants|mesh-list
1821149|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1821150|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1821151|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821179|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
1821180|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
1821181|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821182|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1821183|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1821184|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1821185|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1821186|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1821187|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1821188|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821189|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821190|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821191|NCT04727502|Analgesics|analgesics|mesh-ancestor
1821192|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
1821193|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821194|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
1821195|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1821196|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
1821197|NCT04727242|Gemcitabine|gemcitabine|mesh-list
1821198|NCT04727242|Dacarbazine|dacarbazine|mesh-list
1821199|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1821200|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
1821201|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821202|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821203|NCT04727242|Antiviral Agents|antiviral agents|mesh-ancestor
1821204|NCT04727242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821205|NCT04727242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821206|NCT04727242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1821207|NCT04727242|Immunologic Factors|immunologic factors|mesh-ancestor
1821208|NCT04727242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821209|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1821210|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
1821211|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
1821212|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1821213|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821214|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1821215|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1821216|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1821217|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821218|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
1821219|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821220|NCT04727229|Bupivacaine|bupivacaine|mesh-list
1821221|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
1821222|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
1821223|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1821224|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821225|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
1821226|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821227|NCT04727034|Propofol|propofol|mesh-list
1821228|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1821229|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1821230|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821231|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1821232|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
1821233|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
1821234|NCT04726982|Acetazolamide|acetazolamide|mesh-list
1821235|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
1821236|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1821237|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821238|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821239|NCT04726982|Diuretics|diuretics|mesh-ancestor
1821240|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
1821241|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821242|NCT04726657|Insulin|insulin|mesh-list
1821243|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1821244|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
1821245|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
1821246|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
1821247|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1821248|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821249|NCT04727073|Spironolactone|spironolactone|mesh-list
1821250|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1821251|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
1821252|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1821253|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821254|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1821255|NCT04727073|Diuretics|diuretics|mesh-ancestor
1821256|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
1821257|NCT04726631|Insulin|insulin|mesh-list
1821258|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1821259|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
1821260|NCT04726631|Protamines|protamines|mesh-list
1821261|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1821262|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821263|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
1821264|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821265|NCT04726631|Coagulants|coagulants|mesh-ancestor
1821272|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
1821273|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1821274|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
1821275|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1821276|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
1821277|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821278|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821279|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
1821280|NCT04726592|Ketoprofen|ketoprofen|mesh-list
1821281|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
1821282|NCT04726592|Metoclopramide|metoclopramide|mesh-list
1821283|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
1821284|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
1821285|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821286|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821287|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1821288|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1821289|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1821290|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
1821291|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821292|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821293|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1821294|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1821295|NCT04726592|Analgesics|analgesics|mesh-ancestor
1821296|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
1821297|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1821298|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1821299|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1821300|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821301|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
1821302|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1821303|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1821304|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1821305|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1821306|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
1821307|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
1821308|NCT04726332|Prednisone|prednisone|mesh-list
1821309|NCT04726332|Fulvestrant|fulvestrant|mesh-list
1821310|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1821311|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
1821312|NCT04726332|Hormones|hormones|mesh-ancestor
1821313|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1821314|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821315|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1821316|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821317|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1821318|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1821319|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
1821320|NCT04726345|Fexofenadine|fexofenadine|mesh-list
1821321|NCT04726345|Terfenadine|terfenadine|mesh-list
1821322|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1821323|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1821324|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1821325|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
1821326|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
1821327|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821328|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821329|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821330|NCT04726280|Ropivacaine|ropivacaine|mesh-list
1821331|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1821332|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
1821333|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
1821334|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1821335|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821336|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
1821337|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821340|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
1821341|NCT04726553|Antimalarials|antimalarials|mesh-list
1821342|NCT04726553|Methotrexate|methotrexate|mesh-list
1821343|NCT04726553|Azathioprine|azathioprine|mesh-list
1821344|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1821345|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
1821346|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1821347|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821348|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1821349|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
1821350|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821351|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821352|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
1821353|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821354|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1821355|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1821356|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
1821357|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1821358|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1821359|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1821360|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1821361|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
1821362|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1821363|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821364|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1821365|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1821366|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1821367|NCT04726046|Cefotetan|cefotetan|mesh-list
1821368|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821369|NCT04725747|Midazolam|midazolam|mesh-list
1821370|NCT04725747|Ketamine|ketamine|mesh-list
1821371|NCT04725747|Analgesics|analgesics|mesh-ancestor
1821372|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
1821373|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821374|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821375|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1821376|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1821377|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
1821378|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
1821379|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1821380|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1821381|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1821382|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821383|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821384|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1821385|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1821386|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1821387|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1821388|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1821389|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
1821390|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
1821391|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
1821392|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1821393|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821394|NCT04725812|Eculizumab|eculizumab|mesh-list
1821395|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1821396|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1821397|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
1821398|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821405|NCT04725942|Posaconazole|posaconazole|mesh-list
1821406|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
1821407|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821408|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1821409|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1821410|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1821411|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1821412|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1821413|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821414|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821415|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1821416|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
1821417|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1821418|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821419|NCT04726085|Ibuprofen|ibuprofen|mesh-list
1821420|NCT04726085|Indomethacin|indomethacin|mesh-list
1821644|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
1821421|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1821422|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1821423|NCT04726085|Analgesics|analgesics|mesh-ancestor
1821424|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
1821425|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821426|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821427|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1821428|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1821429|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1821430|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821431|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821432|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
1821433|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
1821434|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1821435|NCT04725591|Insulin|insulin|mesh-list
1821436|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1821437|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821438|NCT04725695|Lidocaine|lidocaine|mesh-list
1821439|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
1821440|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
1821441|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1821442|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821443|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
1821444|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821445|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1821446|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1821447|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1821448|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1821449|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821450|NCT04725682|Tacrolimus|tacrolimus|mesh-list
1821451|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1821452|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
1821453|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821454|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1821455|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821456|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821457|NCT04725617|Varenicline|varenicline|mesh-list
1821458|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1821459|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1821460|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
1821461|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821462|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821463|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821464|NCT04725448|Paclitaxel|paclitaxel|mesh-list
1821465|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1821466|NCT04725448|Bevacizumab|bevacizumab|mesh-list
1821467|NCT04725448|Carboplatin|carboplatin|mesh-list
1821468|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1821469|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821470|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
1821471|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
1821472|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
1821473|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821474|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1821475|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1821476|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1821477|NCT04725448|Growth Substances|growth substances|mesh-ancestor
1821478|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821479|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
1821480|NCT04725656|Nicotine|nicotine|mesh-list
1821481|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1821482|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
1821483|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821484|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821485|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1821486|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1821487|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
1821488|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821489|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821490|NCT04725253|Niacinamide|niacinamide|mesh-list
1821491|NCT04725253|Niacin|niacin|mesh-list
1821492|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
1821493|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
1821494|NCT04725253|Vitamins|vitamins|mesh-ancestor
1821495|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
1821496|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821497|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1821498|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
1821499|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821500|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1821501|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
1821502|NCT04725383|Amitriptyline|amitriptyline|mesh-list
1821503|NCT04725383|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
1821504|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1821505|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
1821506|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1821507|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1821508|NCT04725383|Analgesics|analgesics|mesh-ancestor
1821509|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
1821510|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821511|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821512|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1821513|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1821514|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1821515|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821516|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
1821517|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821518|NCT04725383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1821519|NCT04725383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1821520|NCT04725383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1821521|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1821522|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1821523|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1821524|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821525|NCT04725357|Meloxicam|meloxicam|mesh-list
1821526|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1821527|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1821528|NCT04725357|Analgesics|analgesics|mesh-ancestor
1821529|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
1821530|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821531|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821532|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1821533|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1821534|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1821535|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1821536|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821537|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821538|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
1821539|NCT04725422|Pamidronate|pamidronate|mesh-list
1821540|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
1821541|NCT04725422|Adalimumab|adalimumab|mesh-list
1821542|NCT04725422|Etanercept|etanercept|mesh-list
1821543|NCT04725422|Golimumab|golimumab|mesh-list
1821544|NCT04725422|Methotrexate|methotrexate|mesh-list
1821545|NCT04725422|Infliximab|infliximab|mesh-list
1821546|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
1821547|NCT04725422|Leflunomide|leflunomide|mesh-list
1821548|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1821549|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
1821550|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1821551|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821552|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1821553|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
1821554|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821555|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821556|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
1821557|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821558|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1821559|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1821560|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
1821561|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1821562|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1821563|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1821564|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1821565|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1821566|NCT04725422|Analgesics|analgesics|mesh-ancestor
1821567|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
1821568|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821569|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1821570|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1821571|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
1821572|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821573|NCT04725214|Temozolomide|temozolomide|mesh-list
1821574|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1821575|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
1821576|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821577|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821578|NCT04725201|Heparin|heparin|mesh-list
1821579|NCT04725201|Calcium heparin|calcium heparin|mesh-list
1821580|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
1821581|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1821582|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1821583|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821584|NCT04724720|Famotidine|famotidine|mesh-list
1821585|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1821586|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1821587|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1821588|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
1821589|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
1821590|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821591|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821592|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821599|NCT04724655|Mineral Oil|mineral oil|mesh-list
1821600|NCT04724655|Emollients|emollients|mesh-ancestor
1821601|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
1821613|NCT04724759|Lidocaine|lidocaine|mesh-list
1821614|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
1821615|NCT04724759|Ketamine|ketamine|mesh-list
1821616|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
1821617|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
1821618|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1821619|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821620|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
1821621|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821622|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1821623|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1821624|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1821625|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1821626|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821627|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1821628|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1821629|NCT04724759|Analgesics|analgesics|mesh-ancestor
1821630|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1821631|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1821632|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1821633|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
1821634|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821635|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1821636|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1821637|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
1821638|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1821639|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1821640|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
1821641|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1821642|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1821643|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821645|NCT04724772|Coagulants|coagulants|mesh-ancestor
1821646|NCT04724629|Aldesleukin|aldesleukin|mesh-list
1821647|NCT04724629|Colchicine|colchicine|mesh-list
1821648|NCT04724629|Ixekizumab|ixekizumab|mesh-list
1821649|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821650|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1821651|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1821652|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
1821653|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821654|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
1821655|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1821656|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
1821657|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
1821658|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
1821659|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821660|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
1821676|NCT04724447|Valganciclovir|valganciclovir|mesh-list
1821677|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
1821678|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821679|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1821680|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1821681|NCT04724486|Cetrorelix|cetrorelix|mesh-list
1821682|NCT04724486|Menotropins|menotropins|mesh-list
1821683|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
1821684|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1821685|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
1821686|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1821687|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821688|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1821689|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1821690|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821691|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1821692|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
1821693|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
1821694|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1821695|NCT04724473|Tretinoin|tretinoin|mesh-list
1821696|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821697|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
1821698|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
1821699|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
1821700|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1821701|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821702|NCT04724187|Misoprostol|misoprostol|mesh-list
1821703|NCT04724187|Oxytocin|oxytocin|mesh-list
1821704|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
1821705|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1821706|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821707|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1821708|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
1821709|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1821710|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1821711|NCT04724226|Apatinib|apatinib|mesh-list
1821712|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821713|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1821714|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821715|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821716|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1821717|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1821718|NCT04724343|Cetrorelix|cetrorelix|mesh-list
1821719|NCT04724343|Menotropins|menotropins|mesh-list
1821720|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
1821721|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1821722|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
1821723|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1821724|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821725|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1821726|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1821727|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821728|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1821729|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
1821730|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
1821731|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1821732|NCT04724148|Fentanyl|fentanyl|mesh-list
1821733|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1821734|NCT04724148|Narcotics|narcotics|mesh-ancestor
1821735|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1821736|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821737|NCT04724148|Analgesics|analgesics|mesh-ancestor
1821738|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
1821739|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821740|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1821741|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1821742|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
1821743|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
1821744|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
1821745|NCT04724044|Clarithromycin|clarithromycin|mesh-list
1821746|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
1821747|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1821748|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1821749|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821750|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1821751|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1821752|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821753|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821754|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821755|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1821756|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
1821757|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1821758|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821759|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1821760|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1821761|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1821762|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1821763|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1821764|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1821765|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1821766|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821767|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821768|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821769|NCT04723836|Riboflavin|riboflavin|mesh-list
1821770|NCT04723836|Vitamins|vitamins|mesh-ancestor
1821771|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
1821772|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821773|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
1821774|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1821775|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
1821776|NCT04723940|Doxycycline|doxycycline|mesh-list
1821777|NCT04723940|Clindamycin|clindamycin|mesh-list
1821778|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
1821779|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
1821780|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1821781|NCT04723940|Cefadroxil|cefadroxil|mesh-list
1821782|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1821783|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821784|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
1821785|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1821786|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1821787|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1821788|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821789|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821790|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1821791|NCT04723940|Renal Agents|renal agents|mesh-ancestor
1821792|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
1821793|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1821794|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1821795|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821796|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
1821797|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
1821798|NCT04723875|Paclitaxel|paclitaxel|mesh-list
1821799|NCT04723875|Docetaxel|docetaxel|mesh-list
1821800|NCT04723875|Carboplatin|carboplatin|mesh-list
1821801|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1821802|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821803|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
1821804|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
1821805|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
1821806|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821807|NCT04723862|Spironolactone|spironolactone|mesh-list
1821808|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1821809|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
1821810|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1821811|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821812|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1821813|NCT04723862|Diuretics|diuretics|mesh-ancestor
1821814|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
1821815|NCT04723563|Heparin|heparin|mesh-list
1821816|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
1821817|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1821818|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1821819|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821820|NCT04723472|Cefuroxime|cefuroxime|mesh-list
1821821|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
1821822|NCT04723472|Bismuth|bismuth|mesh-list
1821823|NCT04723472|Antacids|antacids|mesh-ancestor
1821824|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821825|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1821826|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1821827|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821828|NCT04723147|Levodopa|levodopa|mesh-list
1821829|NCT04723147|Carbidopa|carbidopa|mesh-list
1821830|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1821831|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1821832|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1821833|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
1821834|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821835|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821836|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821837|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1821838|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821839|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1821840|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
1821841|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
1821842|NCT04723342|Blinatumomab|blinatumomab|mesh-list
1821843|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821844|NCT04723459|Ivermectin|ivermectin|mesh-list
1821845|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1821846|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821847|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1821848|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1821849|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1821850|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1821851|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821852|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821853|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821854|NCT04723238|Analgesics|analgesics|mesh-ancestor
1821855|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
1821856|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821857|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
1821858|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1821859|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
1821860|NCT04723069|Metronidazole|metronidazole|mesh-list
1821861|NCT04723069|Doxycycline|doxycycline|mesh-list
1821862|NCT04723069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1821863|NCT04723069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1821864|NCT04723069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1821865|NCT04723069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1821866|NCT04723069|Antimalarials|antimalarials|mesh-ancestor
1821867|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1821875|NCT04722822|Vaccines|vaccines|mesh-list
1821876|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
1821877|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821878|NCT04722718|Paclitaxel|paclitaxel|mesh-list
1821879|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1821880|NCT04722718|Carboplatin|carboplatin|mesh-list
1821881|NCT04722718|Apatinib|apatinib|mesh-list
1821882|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1821883|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821884|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
1821885|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
1821886|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
1821887|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821888|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1821889|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821890|NCT04723030|Paclitaxel|paclitaxel|mesh-list
1821891|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1821892|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821893|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
1821894|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
1821895|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
1821896|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821897|NCT04722835|Albuterol|albuterol|mesh-list
1821898|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1821899|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
1821900|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821901|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821902|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1821903|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
1821904|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
1821905|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1821906|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1821907|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1821908|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1821909|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
1821910|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821911|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821912|NCT04723004|Bevacizumab|bevacizumab|mesh-list
1821913|NCT04723004|Sorafenib|sorafenib|mesh-list
1821914|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1821915|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821916|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1821917|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1821918|NCT04723004|Growth Substances|growth substances|mesh-ancestor
1821919|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821920|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
1821921|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1821922|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821923|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821924|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
1821925|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1821926|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1821927|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821928|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
1821929|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821930|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821931|NCT04722523|Carboplatin|carboplatin|mesh-list
1821932|NCT04722523|Docetaxel|docetaxel|mesh-list
1821933|NCT04722523|Cetuximab|cetuximab|mesh-list
1821934|NCT04722523|Cemiplimab|cemiplimab|mesh-list
1821935|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821936|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
1821937|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
1821938|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
1821939|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821940|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1821941|NCT04722575|Atezolizumab|atezolizumab|mesh-list
1821942|NCT04722575|Vemurafenib|vemurafenib|mesh-list
1821943|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821944|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1821945|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1821946|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821947|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
1821948|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
1821949|NCT04722354|Growth Substances|growth substances|mesh-ancestor
1821950|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821967|NCT04722471|Progesterone|progesterone|mesh-list
1821968|NCT04722471|Progestins|progestins|mesh-ancestor
1821969|NCT04722471|Hormones|hormones|mesh-ancestor
1821970|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1821971|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821972|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
1821973|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
1821974|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1821975|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1821976|NCT04721873|Topiramate|topiramate|mesh-list
1821977|NCT04721873|Phentermine|phentermine|mesh-list
1821978|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
1821979|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1821980|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821981|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1821982|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
1821983|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1821984|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
1821985|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
1821986|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1821987|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
1821988|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1821989|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1821990|NCT04721899|Vitamin D|vitamin d|mesh-list
1821991|NCT04721899|Vitamins|vitamins|mesh-ancestor
1821992|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
1821993|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1821994|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1821995|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
1821996|NCT04721964|Trace Elements|trace elements|mesh-ancestor
1821997|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
1821998|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822003|NCT04721548|Minoxidil|minoxidil|mesh-list
1822004|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1822005|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
1822022|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
1822023|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1822024|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
1822025|NCT04721626|Tetracycline|tetracycline|mesh-list
1822026|NCT04721626|Doxycycline|doxycycline|mesh-list
1822027|NCT04721626|Povidone|povidone|mesh-list
1822028|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1822029|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822030|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
1822031|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
1822032|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
1822033|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
1822034|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1822035|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1822036|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822037|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822038|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
1822039|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1822040|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1822041|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
1822042|NCT04721795|Atorvastatin|atorvastatin|mesh-list
1822043|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1822044|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1822045|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
1822046|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822047|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1822048|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1822049|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822050|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1822051|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822052|NCT04721704|Amoxicillin|amoxicillin|mesh-list
1822053|NCT04721704|Metronidazole|metronidazole|mesh-list
1822054|NCT04721704|Clarithromycin|clarithromycin|mesh-list
1822055|NCT04721704|Omeprazole|omeprazole|mesh-list
1822056|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1822057|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822058|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1822059|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1822060|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1822061|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1822062|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1822063|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822064|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822065|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1822066|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1822067|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1822068|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1822069|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822070|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822071|NCT04721054|Lidocaine|lidocaine|mesh-list
1822072|NCT04721054|Bupivacaine|bupivacaine|mesh-list
1822073|NCT04721054|Anesthetics|anesthetics|mesh-list
1822074|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
1822075|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822076|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822077|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
1822078|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822079|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1822080|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1822081|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1822082|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1822083|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822084|NCT04721132|Bevacizumab|bevacizumab|mesh-list
1822085|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1822086|NCT04721132|Atezolizumab|atezolizumab|mesh-list
1822087|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
1822088|NCT04721132|Antibodies|antibodies|mesh-list
1822089|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
1822090|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1822091|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
1822092|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822093|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1822094|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1822095|NCT04721132|Growth Substances|growth substances|mesh-ancestor
1822096|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822097|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
1822098|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
1822099|NCT04721691|Cannabidiol|cannabidiol|mesh-list
1822100|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
1822107|NCT04721119|Anesthetics|anesthetics|mesh-list
1822108|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822109|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822110|NCT04721301|Maraviroc|maraviroc|mesh-list
1822111|NCT04721301|Nivolumab|nivolumab|mesh-list
1822112|NCT04721301|Ipilimumab|ipilimumab|mesh-list
1822113|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1822114|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822115|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1822116|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822117|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1822118|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1822119|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1822120|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1822121|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
1822122|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822123|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
1822127|NCT04720807|Letrozole|letrozole|mesh-list
1822128|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822129|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1822130|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1822131|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822132|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822133|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1822134|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
1822135|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1822136|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822137|NCT04720768|Palbociclib|palbociclib|mesh-list
1822138|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822139|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1822140|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822141|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822142|NCT04720833|Vitamin D|vitamin d|mesh-list
1822143|NCT04720833|Calcium|calcium|mesh-list
1822144|NCT04720833|Vitamins|vitamins|mesh-ancestor
1822145|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
1822146|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822147|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1822148|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1822149|NCT04720859|Canagliflozin|canagliflozin|mesh-list
1822150|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1822151|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822152|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1822153|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822165|NCT04720326|Tacrolimus|tacrolimus|mesh-list
1822166|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1822167|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
1822168|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822169|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1822170|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822171|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822172|NCT04720573|Neostigmine|neostigmine|mesh-list
1822173|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1822174|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822175|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822176|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
1822177|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1822178|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822179|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1822180|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
1822181|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822182|NCT04720287|Bupivacaine|bupivacaine|mesh-list
1822183|NCT04720287|Neostigmine|neostigmine|mesh-list
1822184|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
1822185|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
1822186|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822187|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822188|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
1822189|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822190|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1822191|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822192|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822193|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
1822194|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1822195|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1822196|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
1822197|NCT04720547|Zolpidem|zolpidem|mesh-list
1822198|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1822199|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1822200|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822201|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822202|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1822203|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
1822204|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
1822205|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1822206|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822207|NCT04720248|Dipyrone|dipyrone|mesh-list
1822208|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1822209|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1822210|NCT04720248|Analgesics|analgesics|mesh-ancestor
1822211|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
1822212|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822213|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822214|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1822215|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1822216|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
1822217|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
1822218|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822219|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1822220|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1822221|NCT04720183|Analgesics|analgesics|mesh-ancestor
1822222|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
1822223|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822224|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822225|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1822226|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1822227|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1822228|NCT04720131|Capecitabine|capecitabine|mesh-list
1822229|NCT04720131|Apatinib|apatinib|mesh-list
1822230|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1822231|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
1822232|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822233|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822234|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1822235|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822236|NCT04720105|Halobetasol|halobetasol|mesh-list
1822237|NCT04720105|Tazarotene|tazarotene|mesh-list
1822238|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
1822239|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
1822240|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1822241|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
1822242|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1822243|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
1822244|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1822245|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
1822246|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822247|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822248|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
1822249|NCT04719819|Anesthetics|anesthetics|mesh-list
1822250|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822251|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822252|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
1822253|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1822254|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822255|NCT04719507|Meperidine|meperidine|mesh-list
1822256|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1822257|NCT04719507|Narcotics|narcotics|mesh-ancestor
1822258|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822259|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822260|NCT04719507|Analgesics|analgesics|mesh-ancestor
1822261|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
1822262|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822263|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1822264|NCT04719715|Antibodies|antibodies|mesh-list
1822265|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
1822266|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822267|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1822268|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822269|NCT04719585|Analgesics|analgesics|mesh-ancestor
1822270|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
1822271|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822272|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1822273|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1822274|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1822275|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822276|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1822277|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
1822278|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1822279|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
1822280|NCT04719481|Pravastatin|pravastatin|mesh-list
1822281|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1822282|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1822283|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
1822284|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822285|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1822286|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1822287|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822288|NCT04719104|Bilirubin|bilirubin|mesh-list
1822289|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
1822290|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822291|NCT04719104|Protective Agents|protective agents|mesh-ancestor
1822292|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822293|NCT04719221|Evolocumab|evolocumab|mesh-list
1822294|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1822295|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1822296|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
1822297|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822298|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1822299|NCT04719273|Anastrozole|anastrozole|mesh-list
1822300|NCT04719273|Onapristone|onapristone|mesh-list
1822301|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1822302|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822303|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1822304|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1822305|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822306|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822307|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1822308|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
1822309|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1822310|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822311|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1822312|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
1822313|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1822314|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
1822315|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1822316|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1822317|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822318|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
1822319|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
1822320|NCT04718792|Psilocybin|psilocybin|mesh-list
1822321|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
1822322|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822323|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1822324|NCT04718805|Darunavir|darunavir|mesh-list
1822325|NCT04718805|Cobicistat|cobicistat|mesh-list
1822326|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1822327|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1822328|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
1822329|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822330|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822331|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1822332|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1822333|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
1822334|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822335|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1822336|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1822349|NCT04718740|Vitamin K|vitamin k|mesh-list
1822350|NCT04718740|Repaglinide|repaglinide|mesh-list
1822351|NCT04718740|Midazolam|midazolam|mesh-list
1822352|NCT04718740|Caffeine|caffeine|mesh-list
1822353|NCT04718740|Bupropion|bupropion|mesh-list
1822354|NCT04718740|Omeprazole|omeprazole|mesh-list
1822355|NCT04718740|Warfarin|warfarin|mesh-list
1822356|NCT04718740|Vitamins|vitamins|mesh-ancestor
1822357|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
1822358|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822359|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1822360|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1822361|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822362|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1822363|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1822364|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1822365|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1822366|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
1822367|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
1822368|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
1822369|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
1822370|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1822371|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822372|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
1822373|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1822374|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1822375|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1822376|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822377|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1822378|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1822379|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1822380|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1822381|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
1822382|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1822383|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
1822384|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1822385|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1822386|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1822387|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
1822388|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1822389|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1822390|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1822391|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1822392|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
1822393|NCT04718740|Coagulants|coagulants|mesh-ancestor
1822394|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1822395|NCT04718701|Paclitaxel|paclitaxel|mesh-list
1822396|NCT04718701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1822397|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1822398|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822399|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
1822400|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
1822401|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
1822402|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822403|NCT04718389|Benralizumab|benralizumab|mesh-list
1822404|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1822405|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
1822406|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
1822407|NCT04718402|Analgesics|analgesics|mesh-ancestor
1822408|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
1822409|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822410|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822411|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822412|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1822413|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1822414|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822415|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822416|NCT04718350|Simendan|simendan|mesh-list
1822417|NCT04718350|Milrinone|milrinone|mesh-list
1822418|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1822419|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
1822420|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1822421|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1822422|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822423|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822424|NCT04718350|Protective Agents|protective agents|mesh-ancestor
1822425|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822426|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1822427|NCT04718285|Favipiravir|favipiravir|mesh-list
1822428|NCT04718285|Montelukast|montelukast|mesh-list
1822429|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1822430|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
1822431|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1822432|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
1822433|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1822434|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822435|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1822436|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1822437|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822438|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
1822439|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822440|NCT04718311|Tacrolimus|tacrolimus|mesh-list
1822441|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1822442|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
1822443|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822444|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1822445|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822446|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822447|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
1822448|NCT04718376|Analgesics|analgesics|mesh-ancestor
1822449|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
1822450|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822451|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822452|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822453|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1822454|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1822455|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822456|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822457|NCT04718584|Antibodies|antibodies|mesh-list
1822458|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1822459|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
1822460|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822461|NCT04718649|Celecoxib|celecoxib|mesh-list
1822462|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1822463|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1822464|NCT04718649|Analgesics|analgesics|mesh-ancestor
1822465|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
1822466|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822467|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822468|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1822469|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1822470|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1822471|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1822472|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822473|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822474|NCT04718415|Paclitaxel|paclitaxel|mesh-list
1822475|NCT04718415|Carboplatin|carboplatin|mesh-list
1822476|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1822477|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822478|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
1822479|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
1822480|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
1822481|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822482|NCT04718714|Midazolam|midazolam|mesh-list
1822483|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
1822484|NCT04718714|Propofol|propofol|mesh-list
1822485|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1822486|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822487|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822488|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1822489|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
1822490|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
1822491|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1822492|NCT04718714|Analgesics|analgesics|mesh-ancestor
1822493|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
1822494|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822495|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1822496|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1822497|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1822498|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
1822499|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1822500|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822501|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1822502|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1822503|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1822504|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1822505|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
1822506|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
1822507|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
1822508|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1822509|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1822510|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822511|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822512|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1822513|NCT04718480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1822514|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1822515|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1822516|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822517|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1822518|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
1822519|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1822520|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
1822521|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1822522|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1822523|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822524|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1822525|NCT04718038|Cetuximab|cetuximab|mesh-list
1822526|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1822527|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822528|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
1822529|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
1822530|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1822531|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1822532|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822533|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822534|NCT04718233|Urological Agents|urological agents|mesh-ancestor
1822535|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1822536|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1822537|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822538|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1822539|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
1822540|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822541|NCT04718259|Midazolam|midazolam|mesh-list
1822542|NCT04718259|Bupivacaine|bupivacaine|mesh-list
1822543|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
1822544|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
1822545|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822546|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822547|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
1822548|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822549|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1822550|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1822551|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1822552|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1822553|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1822554|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1822555|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
1822556|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
1822557|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
1822558|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1822559|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822568|NCT04717973|Vitamin D|vitamin d|mesh-list
1822569|NCT04717973|Vitamins|vitamins|mesh-list
1822570|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
1822571|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
1822572|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
1822573|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822574|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1822575|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
1822576|NCT04717973|Hematinics|hematinics|mesh-ancestor
1822577|NCT04717908|Cycloserine|cycloserine|mesh-list
1822578|NCT04717908|Linezolid|linezolid|mesh-list
1822579|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
1822580|NCT04717908|Bedaquiline|bedaquiline|mesh-list
1822581|NCT04717908|Clofazimine|clofazimine|mesh-list
1822582|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1822583|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822584|NCT04717908|Renal Agents|renal agents|mesh-ancestor
1822585|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1822586|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
1822587|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1822588|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
1822589|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822590|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1822591|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822592|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1822593|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
1822594|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
1822595|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1822596|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822597|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1822598|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822599|NCT04718025|Aspirin|aspirin|mesh-list
1822600|NCT04718025|Ticagrelor|ticagrelor|mesh-list
1822601|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1822602|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1822603|NCT04718025|Analgesics|analgesics|mesh-ancestor
1822604|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
1822605|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822606|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822607|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1822608|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1822609|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1822610|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1822611|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822612|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1822613|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1822614|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822615|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
1822616|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1822617|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1822618|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1822619|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
1822620|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1822621|NCT04718220|Antibodies|antibodies|mesh-list
1822622|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
1822623|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822624|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1822625|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1822626|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822627|NCT04717765|Vitamin E|vitamin e|mesh-list
1822628|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
1822629|NCT04717765|Tocopherols|tocopherols|mesh-list
1822630|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
1822631|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822632|NCT04717765|Protective Agents|protective agents|mesh-ancestor
1822633|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822634|NCT04717765|Vitamins|vitamins|mesh-ancestor
1822635|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
1822648|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
1822649|NCT04717531|Docetaxel|docetaxel|mesh-list
1822650|NCT04717531|Trastuzumab|trastuzumab|mesh-list
1822651|NCT04717531|Epirubicin|epirubicin|mesh-list
1822652|NCT04717531|Pertuzumab|pertuzumab|mesh-list
1822653|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1822654|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
1822655|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822656|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1822657|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1822658|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
1822659|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822660|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822661|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1822662|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
1822663|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
1822664|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
1822665|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1822666|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1822667|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1822668|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1822669|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822674|NCT04717700|Dexamethasone|dexamethasone|mesh-list
1822675|NCT04717700|Lenalidomide|lenalidomide|mesh-list
1822676|NCT04717700|Bortezomib|bortezomib|mesh-list
1822677|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1822678|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
1822679|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
1822680|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822681|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822682|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1822683|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
1822684|NCT04717700|Hormones|hormones|mesh-ancestor
1822685|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1822686|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1822687|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822688|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
1822689|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1822690|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1822691|NCT04717700|Growth Substances|growth substances|mesh-ancestor
1822692|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
1822693|NCT04717609|Ropivacaine|ropivacaine|mesh-list
1822694|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
1822695|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
1822696|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822697|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822698|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
1822699|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822700|NCT04717102|Desflurane|desflurane|mesh-list
1822701|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1822702|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
1822703|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
1822704|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822705|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822706|NCT04717089|Anesthetics|anesthetics|mesh-list
1822707|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822708|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822712|NCT04716894|Itraconazole|itraconazole|mesh-list
1822713|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
1822714|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822715|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1822716|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1822717|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822718|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822719|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1822720|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
1822721|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1822722|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822723|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1822724|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1822725|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1822726|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822727|NCT04716881|Naltrexone|naltrexone|mesh-list
1822728|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1822729|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1822730|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822731|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
1822732|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822733|NCT04717193|Epinephrine|epinephrine|mesh-list
1822734|NCT04717193|Racepinephrine|racepinephrine|mesh-list
1822735|NCT04717193|Bupivacaine|bupivacaine|mesh-list
1822736|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
1822737|NCT04717193|Anesthetics|anesthetics|mesh-list
1822738|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
1822739|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822740|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822741|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
1822742|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822743|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1822744|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1822745|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
1822746|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1822747|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822748|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1822749|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1822750|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
1822751|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1822752|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
1822753|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
1822754|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
1822755|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1822756|NCT04716569|Ivermectin|ivermectin|mesh-list
1822757|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1822758|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822759|NCT04716868|Levan|levan|mesh-list
1822760|NCT04716868|Psyllium|psyllium|mesh-list
1822761|NCT04716868|Cathartics|cathartics|mesh-ancestor
1822762|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1822763|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822764|NCT04716712|Azithromycin|azithromycin|mesh-list
1822765|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1822766|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822767|NCT04716751|Paclitaxel|paclitaxel|mesh-list
1822768|NCT04716751|Carboplatin|carboplatin|mesh-list
1822769|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1822770|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822771|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
1822772|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
1822773|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
1822774|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822787|NCT04716686|Niraparib|niraparib|mesh-list
1822788|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1822789|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822790|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822791|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822792|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1822793|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1822794|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822795|NCT04716296|Ketamine|ketamine|mesh-list
1822796|NCT04716296|Analgesics|analgesics|mesh-ancestor
1822797|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
1822798|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822799|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822800|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1822801|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1822802|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
1822803|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
1822804|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822805|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1822806|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1822807|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1822808|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822809|NCT04716413|Dsuvia|dsuvia|mesh-list
1822810|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1822811|NCT04716413|Narcotics|narcotics|mesh-ancestor
1822812|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822813|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822814|NCT04716413|Analgesics|analgesics|mesh-ancestor
1822815|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
1822816|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822817|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
1822818|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
1822819|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1822820|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822821|NCT04716426|Tetracycline|tetracycline|mesh-list
1822822|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1822823|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822824|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1822825|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822826|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822827|NCT04716179|Hormones|hormones|mesh-list
1822828|NCT04716179|Testosterone|testosterone|mesh-list
1822829|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1822830|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822831|NCT04716179|Androgens|androgens|mesh-ancestor
1822834|NCT04715763|Telmisartan|telmisartan|mesh-list
1822835|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1822836|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1822837|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1822838|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822839|NCT04715737|Vasopressins|vasopressins|mesh-list
1822840|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
1822841|NCT04715737|Oxytocin|oxytocin|mesh-list
1822842|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
1822843|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1822844|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822845|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
1822846|NCT04715737|Coagulants|coagulants|mesh-ancestor
1822847|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1822848|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1822849|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
1822850|NCT04715633|Apatinib|apatinib|mesh-list
1822851|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1822852|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822853|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1822854|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822855|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822856|NCT04715620|Niraparib|niraparib|mesh-list
1822857|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1822858|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822859|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822860|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822861|NCT04715568|Losartan|losartan|mesh-list
1822862|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
1822863|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
1822864|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
1822865|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1822866|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1822867|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822868|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1822869|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
1822870|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1822871|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
1822872|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822873|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1822874|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1822875|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
1822876|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822877|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822878|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1822879|NCT04715269|Alprazolam|alprazolam|mesh-list
1822880|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1822881|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822882|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822883|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1822884|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1822885|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1822886|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
1822887|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
1822888|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1822889|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822890|NCT04715152|Dexamethasone|dexamethasone|mesh-list
1822891|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
1822892|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
1822893|NCT04715152|BB 1101|bb 1101|mesh-list
1822894|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1822895|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
1822896|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
1822897|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822898|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822899|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1822900|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
1822901|NCT04715152|Hormones|hormones|mesh-ancestor
1822902|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1822903|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1822904|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822905|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
1822906|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822907|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822908|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
1822909|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
1822910|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822911|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
1822912|NCT04715360|Favipiravir|favipiravir|mesh-list
1822913|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
1822914|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822915|NCT04715295|Azithromycin|azithromycin|mesh-list
1822916|NCT04715295|Doxycycline|doxycycline|mesh-list
1822917|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
1822918|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
1822919|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1822920|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822921|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
1822922|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1822923|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1822924|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822925|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822926|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1822927|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1822928|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
1822929|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1822930|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
1822931|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
1822932|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1822933|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1822934|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822935|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
1822936|NCT04715165|Bupivacaine|bupivacaine|mesh-list
1822937|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
1822938|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
1822939|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1822940|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822941|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
1822942|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1822943|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1822944|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1822945|NCT04715165|Analgesics|analgesics|mesh-ancestor
1822946|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1822947|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1822948|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1822949|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
1822950|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1822951|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822952|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
1822953|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
1822954|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822955|NCT04715022|Protective Agents|protective agents|mesh-ancestor
1822956|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822957|NCT04715022|Vitamins|vitamins|mesh-ancestor
1822958|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
1822959|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
1822960|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
1822961|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1822962|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1822963|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822964|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822965|NCT04715113|Urological Agents|urological agents|mesh-ancestor
1822966|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
1822967|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1822968|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
1822969|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822970|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1822971|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1822972|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
1822973|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822974|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1822975|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1822976|NCT04714554|Erythromycin|erythromycin|mesh-list
1822977|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
1822978|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
1822979|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
1822980|NCT04714554|Relugolix|relugolix|mesh-list
1822981|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1822982|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1822983|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1822984|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1822985|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1822986|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822987|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
1822988|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
1822989|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1822990|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822991|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
1822992|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1822993|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
1822994|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1822995|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1822996|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1822997|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
1822998|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1822999|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823000|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1823001|NCT04714242|Ranibizumab|ranibizumab|mesh-list
1823002|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1823003|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1823004|NCT04714242|Growth Substances|growth substances|mesh-ancestor
1823005|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823006|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
1823007|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823008|NCT04714229|Vaccines|vaccines|mesh-list
1823009|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
1823010|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823011|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
1823012|NCT04714515|Ivermectin|ivermectin|mesh-list
1823013|NCT04714515|Montelukast|montelukast|mesh-list
1823014|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
1823015|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1823016|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1823017|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823018|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823019|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823020|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1823021|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1823022|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
1823023|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1823024|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
1823025|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823026|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823027|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1823028|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1823029|NCT04714541|Ketamine|ketamine|mesh-list
1823030|NCT04714541|Analgesics|analgesics|mesh-ancestor
1823031|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
1823032|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823033|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823034|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1823035|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1823036|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
1823037|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
1823038|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823039|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1823040|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1823041|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1823042|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823043|NCT04713969|Pantoprazole|pantoprazole|mesh-list
1823044|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1823045|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1823046|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1823047|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823048|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823049|NCT04714073|Itraconazole|itraconazole|mesh-list
1823050|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
1823051|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823052|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1823053|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1823054|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823055|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823056|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1823057|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
1823058|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823059|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823060|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1823061|NCT04714112|Dexamethasone|dexamethasone|mesh-list
1823062|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
1823063|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1823064|NCT04714112|BB 1101|bb 1101|mesh-list
1823065|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1823066|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
1823067|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
1823068|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823069|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823070|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1823071|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
1823072|NCT04714112|Hormones|hormones|mesh-ancestor
1823073|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823074|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1823075|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823076|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
1823077|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823078|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823079|NCT04714099|Cyclosporine|cyclosporine|mesh-list
1823080|NCT04714099|Cyclosporins|cyclosporins|mesh-list
1823081|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823082|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823083|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1823084|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
1823085|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823086|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
1823087|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823088|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
1823089|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1823090|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1823091|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
1823092|NCT04713956|Busulfan|busulfan|mesh-list
1823093|NCT04713956|Fludarabine|fludarabine|mesh-list
1823094|NCT04713956|Decitabine|decitabine|mesh-list
1823095|NCT04713956|Sargramostim|sargramostim|mesh-list
1823096|NCT04713956|Lenograstim|lenograstim|mesh-list
1823097|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1823098|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
1823099|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823100|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1823101|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1823102|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
1823103|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823104|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823105|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1823106|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1823107|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
1823108|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823109|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1823110|NCT04714177|Edaravone|edaravone|mesh-list
1823111|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1823112|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
1823113|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823114|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1823115|NCT04714177|Protective Agents|protective agents|mesh-ancestor
1823116|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823132|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
1823133|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
1823134|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1823135|NCT04713904|Estradiol|estradiol|mesh-list
1823136|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
1823137|NCT04713904|Estrogens|estrogens|mesh-ancestor
1823138|NCT04713904|Hormones|hormones|mesh-ancestor
1823139|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823140|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823141|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1823142|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
1823143|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1823144|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1823145|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1823146|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1823147|NCT04713891|Atezolizumab|atezolizumab|mesh-list
1823148|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1823149|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823150|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
1823151|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823152|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1823153|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823154|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
1823155|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1823156|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823157|NCT04713657|Propranolol|propranolol|mesh-list
1823235|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
1823158|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1823159|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1823160|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
1823161|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1823162|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823163|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823164|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1823165|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1823166|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
1823167|NCT04713787|Albendazole|albendazole|mesh-list
1823168|NCT04713787|Oxfendazole|oxfendazole|mesh-list
1823169|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
1823170|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1823171|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823172|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
1823173|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1823174|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1823175|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
1823176|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
1823177|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
1823178|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823179|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823180|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
1823181|NCT04713644|Propofol|propofol|mesh-list
1823182|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1823183|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823184|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823185|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1823186|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
1823187|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
1823188|NCT04713488|Vaccines|vaccines|mesh-list
1823189|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
1823190|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823191|NCT04713735|Lactoferrin|lactoferrin|mesh-list
1823192|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823193|NCT04713761|Carboplatin|carboplatin|mesh-list
1823194|NCT04713761|Pemetrexed|pemetrexed|mesh-list
1823195|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823196|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823197|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823198|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1823199|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1823203|NCT04713631|Artesunate|artesunate|mesh-list
1823204|NCT04713631|Curcumin|curcumin|mesh-list
1823205|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1823206|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1823207|NCT04713631|Analgesics|analgesics|mesh-ancestor
1823208|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
1823209|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823210|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823211|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1823212|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1823213|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823214|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823215|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823216|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
1823217|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1823218|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1823219|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823220|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
1823221|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
1823222|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1823223|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
1823224|NCT04713254|Metoprolol|metoprolol|mesh-list
1823225|NCT04713254|Midazolam|midazolam|mesh-list
1823226|NCT04713254|Bupropion|bupropion|mesh-list
1823227|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1823228|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1823229|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823230|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823231|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1823232|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1823233|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1823234|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1823236|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
1823237|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
1823238|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
1823239|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1823240|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823241|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1823242|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
1823243|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1823244|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1823245|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1823246|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
1823247|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1823248|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1823249|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823250|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1823251|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1823252|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
1823253|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
1823254|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823255|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1823256|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1823257|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1823258|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
1823259|NCT04713176|Remdesivir|remdesivir|mesh-list
1823260|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
1823261|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823262|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
1823263|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823264|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
1823265|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
1823266|NCT04713371|Ipilimumab|ipilimumab|mesh-list
1823267|NCT04713371|Sargramostim|sargramostim|mesh-list
1823268|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1823269|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
1823270|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823271|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1823272|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1823273|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
1823274|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823275|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823276|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1823277|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1823278|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1823281|NCT04713410|Prednisolone|prednisolone|mesh-list
1823282|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1823283|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
1823284|NCT04713410|Hormones|hormones|mesh-ancestor
1823285|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823286|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823287|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1823288|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823289|NCT04713189|Fentanyl|fentanyl|mesh-list
1823290|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1823291|NCT04713189|Narcotics|narcotics|mesh-ancestor
1823292|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823293|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823294|NCT04713189|Analgesics|analgesics|mesh-ancestor
1823295|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
1823296|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823297|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1823298|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1823299|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
1823300|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
1823306|NCT04713163|Vaccines|vaccines|mesh-list
1823307|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
1823308|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823309|NCT04713332|Vitamin E|vitamin e|mesh-list
1823310|NCT04713332|Tocopherols|tocopherols|mesh-list
1823311|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
1823312|NCT04713332|Vitamins|vitamins|mesh-ancestor
1823313|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
1823314|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823315|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
1823316|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823317|NCT04713332|Protective Agents|protective agents|mesh-ancestor
1823325|NCT04712929|Fluconazole|fluconazole|mesh-list
1823326|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
1823327|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823328|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1823329|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1823330|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823331|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823332|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1823333|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
1823334|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823335|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823336|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1823337|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1823338|NCT04712734|Iloperidone|iloperidone|mesh-list
1823339|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1823340|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1823341|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823342|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823343|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1823357|NCT04712539|Oseltamivir|oseltamivir|mesh-list
1823358|NCT04712539|Baloxavir|baloxavir|mesh-list
1823359|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
1823360|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823361|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823362|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823363|NCT04712799|Xylometazoline|xylometazoline|mesh-list
1823364|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
1823365|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1823366|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
1823367|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
1823368|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1823369|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
1823370|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823371|NCT04712435|Expectorants|expectorants|mesh-ancestor
1823372|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
1823373|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1823374|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
1823375|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823376|NCT04712435|Protective Agents|protective agents|mesh-ancestor
1823377|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823378|NCT04712435|Antidotes|antidotes|mesh-ancestor
1823379|NCT04712071|Ketamine|ketamine|mesh-list
1823380|NCT04712071|Analgesics|analgesics|mesh-ancestor
1823381|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
1823382|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823383|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823384|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1823385|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1823386|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
1823387|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
1823388|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823389|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1823390|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1823391|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1823392|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823393|NCT04712357|Ascorbic Acid|ascorbic acid|mesh-list
1823394|NCT04712357|Tenofovir|tenofovir|mesh-list
1823395|NCT04712357|Emtricitabine|emtricitabine|mesh-list
1823396|NCT04712357|Vitamins|vitamins|mesh-ancestor
1823397|NCT04712357|Micronutrients|micronutrients|mesh-ancestor
1823398|NCT04712357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823399|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
1823400|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823401|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1823402|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1823403|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823404|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823405|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1823406|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1823407|NCT04712357|Antioxidants|antioxidants|mesh-ancestor
1823408|NCT04712357|Protective Agents|protective agents|mesh-ancestor
1823409|NCT04712396|Itraconazole|itraconazole|mesh-list
1823410|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
1823411|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823412|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1823413|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1823414|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823415|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823416|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1823417|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
1823418|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823419|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823420|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1823421|NCT04712266|Insulin|insulin|mesh-list
1823422|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1823423|NCT04712266|Glucagon|glucagon|mesh-list
1823424|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1823425|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823426|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1823427|NCT04712266|Hormones|hormones|mesh-ancestor
1823428|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823429|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
1823430|NCT04712279|Ivermectin|ivermectin|mesh-list
1823431|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
1823432|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1823433|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1823434|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823435|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823436|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823437|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1823445|NCT04711889|Urinastatin|urinastatin|mesh-list
1823446|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1823447|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1823448|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
1823449|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823450|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823451|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
1823452|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1823453|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1823454|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823455|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823456|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1823457|NCT04711863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1823458|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1823459|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1823460|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823461|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1823462|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
1823463|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1823464|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
1823465|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1823466|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1823467|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823468|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1823469|NCT04712058|Tenofovir|tenofovir|mesh-list
1823470|NCT04712058|Emtricitabine|emtricitabine|mesh-list
1823471|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
1823472|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
1823473|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823474|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1823475|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1823476|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823477|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823478|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1823479|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1823480|NCT04711668|Lidocaine|lidocaine|mesh-list
1823481|NCT04711668|Ketamine|ketamine|mesh-list
1823482|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
1823483|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
1823484|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823485|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823486|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
1823487|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823488|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1823489|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1823490|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1823491|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1823492|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823493|NCT04711668|Analgesics|analgesics|mesh-ancestor
1823494|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1823495|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1823496|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
1823497|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1823498|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1823499|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1823500|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
1823501|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1823502|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
1823503|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823504|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
1823505|NCT04711642|Protective Agents|protective agents|mesh-ancestor
1823506|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1823507|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
1823508|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1823509|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1823510|NCT04711291|Tacrolimus|tacrolimus|mesh-list
1823511|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1823512|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
1823513|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823514|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1823515|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823516|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823517|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
1823518|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1823519|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
1823520|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823521|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
1823522|NCT04711304|Protective Agents|protective agents|mesh-ancestor
1823523|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1823524|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
1823525|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823526|NCT04711265|Vaccines|vaccines|mesh-list
1823527|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
1823528|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823529|NCT04711434|Antibodies|antibodies|mesh-list
1823530|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
1823531|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823532|NCT04711213|Dexamethasone|dexamethasone|mesh-list
1823533|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
1823534|NCT04711213|BB 1101|bb 1101|mesh-list
1823535|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1823536|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
1823537|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
1823538|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823539|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823540|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1823541|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
1823542|NCT04711213|Hormones|hormones|mesh-ancestor
1823543|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823544|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1823545|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823546|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
1823547|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823548|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823549|NCT04711161|Paclitaxel|paclitaxel|mesh-list
1823550|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1823551|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823552|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
1823553|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
1823554|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
1823555|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823559|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1823560|NCT04711122|Cephalosporins|cephalosporins|mesh-list
1823561|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823562|NCT04711096|Bupivacaine|bupivacaine|mesh-list
1823563|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
1823564|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
1823565|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823566|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823567|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
1823568|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823569|NCT04710927|Fluorides|fluorides|mesh-list
1823570|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
1823571|NCT04710927|Protective Agents|protective agents|mesh-ancestor
1823572|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823573|NCT04711109|Denosumab|denosumab|mesh-list
1823574|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1823575|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823576|NCT04710914|Midazolam|midazolam|mesh-list
1823577|NCT04710914|Isoflurane|isoflurane|mesh-list
1823578|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1823579|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1823580|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823581|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823582|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1823583|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1823584|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1823585|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1823586|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
1823587|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
1823588|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
1823589|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
1823590|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1823591|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823592|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1823593|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1823594|NCT04711044|Menthol|menthol|mesh-list
1823595|NCT04711044|Histamine|histamine|mesh-list
1823596|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
1823597|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
1823598|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
1823599|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
1823600|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1823601|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823602|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823603|NCT04710732|Enoxaparin|enoxaparin|mesh-list
1823604|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
1823605|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
1823606|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1823607|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1823608|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823609|NCT04710719|Triamcinolone|triamcinolone|mesh-list
1823610|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1823611|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1823612|NCT04710719|Fluorouracil|fluorouracil|mesh-list
1823613|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1823614|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
1823615|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823616|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1823617|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823618|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1823619|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
1823620|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823621|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1823622|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
1823623|NCT04710719|Hormones|hormones|mesh-ancestor
1823624|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823625|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823626|NCT04710368|Evolocumab|evolocumab|mesh-list
1823627|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1823628|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1823629|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
1823630|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823631|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1823632|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
1823633|NCT04710628|Lenvatinib|lenvatinib|mesh-list
1823634|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1823635|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823636|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1823637|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823638|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823639|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
1823640|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
1823641|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823642|NCT04710329|Protective Agents|protective agents|mesh-ancestor
1823643|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823644|NCT04710329|Vitamins|vitamins|mesh-ancestor
1823645|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
1823646|NCT04710498|Atezolizumab|atezolizumab|mesh-list
1823647|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823648|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
1823649|NCT04710277|Narcotics|narcotics|mesh-ancestor
1823650|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823651|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823652|NCT04710277|Analgesics|analgesics|mesh-ancestor
1823653|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
1823654|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823658|NCT04710134|Reslizumab|reslizumab|mesh-list
1823659|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1823660|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
1823661|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1823662|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
1823663|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
1823664|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1823665|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1823666|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823667|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
1823668|NCT04710017|Coagulants|coagulants|mesh-ancestor
1823669|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1823670|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1823671|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1823672|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
1823673|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1823674|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823675|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1823676|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1823677|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1823678|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1823679|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823680|NCT04710160|Calcium|calcium|mesh-list
1823681|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1823682|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823683|NCT04709770|Simethicone|simethicone|mesh-list
1823684|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823685|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
1823686|NCT04709770|Emollients|emollients|mesh-ancestor
1823687|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
1823688|NCT04709731|Ponatinib|ponatinib|mesh-list
1823689|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823690|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1823691|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823692|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823693|NCT04709471|Nicotine|nicotine|mesh-list
1823694|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1823695|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
1823696|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823697|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823698|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1823699|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1823700|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
1823701|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1823702|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823703|NCT04709744|Vitamin D|vitamin d|mesh-list
1823704|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
1823705|NCT04709744|Vitamins|vitamins|mesh-list
1823706|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
1823707|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823708|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1823709|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1823710|NCT04709380|Sorafenib|sorafenib|mesh-list
1823711|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823712|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1823713|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823714|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823715|NCT04709185|Dexamethasone|dexamethasone|mesh-list
1823716|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1823717|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
1823718|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
1823719|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823720|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823721|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1823722|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
1823723|NCT04709185|Hormones|hormones|mesh-ancestor
1823724|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823725|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1823726|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823727|NCT04709172|Cefditoren|cefditoren|mesh-list
1823728|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
1823729|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1823730|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823731|NCT04709315|Choline|choline|mesh-list
1823732|NCT04709315|Rocuronium|rocuronium|mesh-list
1823733|NCT04709315|Succinylcholine|succinylcholine|mesh-list
1823734|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1823735|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1823736|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1823737|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823738|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823739|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
1823740|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1823741|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
1823742|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823743|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1823744|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1823745|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
1823746|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
1823747|NCT04709250|Bupivacaine|bupivacaine|mesh-list
1823748|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
1823749|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
1823750|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823751|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823752|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
1823753|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823754|NCT04709094|Bupropion|bupropion|mesh-list
1823755|NCT04709094|Warfarin|warfarin|mesh-list
1823756|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
1823757|NCT04709094|Norethindrone|norethindrone|mesh-list
1823758|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
1823759|NCT04709094|Norinyl|norinyl|mesh-list
1823760|NCT04709094|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
1823761|NCT04709094|Estradiol|estradiol|mesh-list
1823762|NCT04709094|Estrogens|estrogens|mesh-ancestor
1823763|NCT04709094|Hormones|hormones|mesh-ancestor
1823764|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823765|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823766|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1823767|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
1823768|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1823769|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1823770|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
1823771|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1823772|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
1823773|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1823774|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1823775|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1823776|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1823777|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823778|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
1823779|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1823780|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1823781|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1823782|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823783|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1823784|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1823785|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1823786|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1823787|NCT04709094|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
1823788|NCT04709211|Bupivacaine|bupivacaine|mesh-list
1823789|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
1823790|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
1823791|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823792|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823793|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
1823794|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823795|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1823796|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1823797|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
1823798|NCT04709081|Itraconazole|itraconazole|mesh-list
1823799|NCT04709081|Digoxin|digoxin|mesh-list
1823800|NCT04709081|Midazolam|midazolam|mesh-list
1823801|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1823802|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1823803|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823804|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823805|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1823806|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1823807|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1823808|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1823809|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
1823810|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
1823811|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
1823812|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
1823813|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1823814|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823815|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
1823816|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823817|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1823818|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1823819|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823820|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1823821|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
1823822|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823823|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1823824|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1823825|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1823826|NCT04709081|Protective Agents|protective agents|mesh-ancestor
1823827|NCT04709276|Carboplatin|carboplatin|mesh-list
1823828|NCT04709276|Nivolumab|nivolumab|mesh-list
1823829|NCT04709276|Ipilimumab|ipilimumab|mesh-list
1823830|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823831|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1823832|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1823833|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823834|NCT04709029|Dexamethasone|dexamethasone|mesh-list
1823835|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
1823836|NCT04709029|BB 1101|bb 1101|mesh-list
1823837|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1823838|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
1823839|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
1823840|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823841|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823842|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1823843|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
1823844|NCT04709029|Hormones|hormones|mesh-ancestor
1823845|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823846|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1823847|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823848|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
1823849|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823850|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823856|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
1823857|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
1823858|NCT04708821|Dexamethasone|dexamethasone|mesh-list
1823859|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1823860|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1823861|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
1823862|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
1823863|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823864|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823865|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1823866|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
1823867|NCT04708821|Hormones|hormones|mesh-ancestor
1823868|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1823869|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1823870|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1823871|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1823872|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1823873|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1823874|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1823875|NCT04708821|Analgesics|analgesics|mesh-ancestor
1823876|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
1823877|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1823878|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1823879|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1823880|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
1823881|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
1823882|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1823883|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823884|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
1823885|NCT04708964|Analgesics|analgesics|mesh-ancestor
1823886|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
1823887|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823888|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823889|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1823890|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1823891|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1823892|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1823893|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1823894|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823895|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823904|NCT04708496|Efavirenz|efavirenz|mesh-list
1823905|NCT04708496|Lumefantrine|lumefantrine|mesh-list
1823906|NCT04708496|Dolutegravir|dolutegravir|mesh-list
1823907|NCT04708496|Artemether|artemether|mesh-list
1823908|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1823909|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1823910|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1823911|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1823912|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823913|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
1823914|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1823915|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1823916|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1823917|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1823918|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1823919|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1823920|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1823921|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
1823922|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1823923|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1823924|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1823925|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1823926|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1823927|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1823928|NCT04708249|Inositol|inositol|mesh-list
1823929|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
1823930|NCT04708249|Vitamins|vitamins|mesh-ancestor
1823931|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
1823932|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823933|NCT04708353|Ascorbic Acid|ascorbic acid|mesh-list
1823934|NCT04708353|Pregabalin|pregabalin|mesh-list
1823935|NCT04708353|Vitamins|vitamins|mesh-ancestor
1823936|NCT04708353|Micronutrients|micronutrients|mesh-ancestor
1823937|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823938|NCT04708353|Analgesics|analgesics|mesh-ancestor
1823939|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
1823940|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1823941|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
1823942|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1823943|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1823944|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823945|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1823946|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1823947|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1823948|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823949|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1823950|NCT04708353|Antioxidants|antioxidants|mesh-ancestor
1823951|NCT04708353|Protective Agents|protective agents|mesh-ancestor
1823959|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
1823960|NCT04707950|Oxytocin|oxytocin|mesh-list
1823961|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
1823962|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1823963|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823964|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1823965|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1823966|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1823967|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
1823968|NCT04707950|Coagulants|coagulants|mesh-ancestor
1823986|NCT04708106|Menthol|menthol|mesh-list
1823987|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
1823988|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
1823989|NCT04708171|Anesthetics|anesthetics|mesh-list
1823990|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823991|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1823992|NCT04707794|Sevoflurane|sevoflurane|mesh-list
1823993|NCT04707794|Desflurane|desflurane|mesh-list
1823994|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1823995|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1823996|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
1823997|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
1823998|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1823999|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824000|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
1824001|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1824002|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
1824003|NCT04707742|Povidone|povidone|mesh-list
1824004|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
1824005|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
1824006|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1824007|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1824008|NCT04707534|Dexamethasone|dexamethasone|mesh-list
1824009|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1824010|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
1824011|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
1824012|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824013|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824014|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1824015|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
1824016|NCT04707534|Hormones|hormones|mesh-ancestor
1824017|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1824018|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1824019|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824020|NCT04707560|Heparin|heparin|mesh-list
1824021|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
1824022|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1824023|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1824024|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824025|NCT04707547|Nivolumab|nivolumab|mesh-list
1824026|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1824027|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824028|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1824029|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824030|NCT04707508|Metformin|metformin|mesh-list
1824031|NCT04707508|Valsartan|valsartan|mesh-list
1824032|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1824033|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824034|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1824035|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1824036|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1824037|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824038|NCT04707703|Isavuconazole|isavuconazole|mesh-list
1824039|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
1824040|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1824041|NCT04707430|Progesterone|progesterone|mesh-list
1824042|NCT04707430|Progestins|progestins|mesh-ancestor
1824043|NCT04707430|Hormones|hormones|mesh-ancestor
1824044|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1824045|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824058|NCT04707209|Sirolimus|sirolimus|mesh-list
1824059|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1824060|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1824061|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1824062|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824063|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
1824064|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1824065|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
1824066|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824067|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1824068|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1824069|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
1824070|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824071|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
1824072|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824073|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824074|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1824075|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
1824076|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1824077|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824078|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1824079|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824092|NCT04707118|Paclitaxel|paclitaxel|mesh-list
1824093|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1824094|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1824095|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824096|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
1824097|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
1824098|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
1824099|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824100|NCT04707027|Aflibercept|aflibercept|mesh-list
1824101|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1824102|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1824103|NCT04707027|Growth Substances|growth substances|mesh-ancestor
1824104|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824105|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
1824106|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824107|NCT04706767|Lidocaine|lidocaine|mesh-list
1824108|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
1824109|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
1824110|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
1824111|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824112|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824113|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
1824114|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824115|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1824116|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1824117|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1824118|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1824119|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824120|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1824121|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1824122|NCT04706767|Analgesics|analgesics|mesh-ancestor
1824123|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1824124|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1824125|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1824126|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
1824127|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824131|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
1824132|NCT04706936|Fludarabine|fludarabine|mesh-list
1824133|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1824134|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
1824135|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824136|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1824137|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1824138|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
1824139|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824140|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824141|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1824142|NCT04706806|Acetic Acid|acetic acid|mesh-list
1824143|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1824144|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1824154|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
1824155|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1824156|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824157|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1824158|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824159|NCT04706910|Furosemide|furosemide|mesh-list
1824160|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
1824161|NCT04706910|Diuretics|diuretics|mesh-ancestor
1824162|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
1824163|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824164|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1824165|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1824166|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824167|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
1824168|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824169|NCT04706949|Carboplatin|carboplatin|mesh-list
1824170|NCT04706949|Pemetrexed|pemetrexed|mesh-list
1824171|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824172|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824173|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824174|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1824175|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1824176|NCT04706897|Lidocaine|lidocaine|mesh-list
1824177|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
1824178|NCT04706897|Ketamine|ketamine|mesh-list
1824179|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
1824180|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
1824181|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824182|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824183|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
1824184|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824185|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1824186|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1824187|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1824188|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1824189|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824190|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1824191|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1824192|NCT04706897|Analgesics|analgesics|mesh-ancestor
1824193|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1824194|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1824195|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1824196|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
1824197|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824198|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1824199|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1824200|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
1824201|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1824202|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1824203|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
1824204|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1824205|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
1824206|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824207|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
1824208|NCT04706455|Protective Agents|protective agents|mesh-ancestor
1824209|NCT04706429|Trientine|trientine|mesh-list
1824210|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
1824211|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
1824212|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824213|NCT04706247|Anesthetics|anesthetics|mesh-list
1824214|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824215|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824216|NCT04706130|Artesunate|artesunate|mesh-list
1824217|NCT04706130|Primaquine|primaquine|mesh-list
1824218|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
1824219|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1824220|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1824221|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1824222|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824223|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
1824224|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
1824225|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1824226|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
1824227|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
1824228|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
1824229|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1824230|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1824231|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824232|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824233|NCT04706546|Urological Agents|urological agents|mesh-ancestor
1824234|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
1824235|NCT04706377|Vitamins|vitamins|mesh-ancestor
1824236|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
1824237|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824238|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
1824239|NCT04706013|Pyridoxal|pyridoxal|mesh-list
1824240|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
1824241|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
1824242|NCT04706013|Vitamins|vitamins|mesh-ancestor
1824243|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
1824244|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824245|NCT04706091|Suvorexant|suvorexant|mesh-list
1824246|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1824247|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1824248|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824249|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824250|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1824251|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824252|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824253|NCT04705844|Adalimumab|adalimumab|mesh-list
1824254|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1824255|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1824256|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
1824257|NCT04705948|Ketamine|ketamine|mesh-list
1824258|NCT04705948|Analgesics|analgesics|mesh-ancestor
1824259|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
1824260|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824261|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824262|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1824263|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1824264|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
1824265|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
1824266|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824267|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1824268|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1824269|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824270|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824271|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1824272|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
1824273|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1824274|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1824275|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1824276|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
1824277|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1824278|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
1824279|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1824280|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1824281|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
1824282|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824283|NCT04705987|Colchicine|colchicine|mesh-list
1824284|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
1824285|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1824286|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
1824287|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
1824288|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
1824289|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824290|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824291|NCT04705909|Pitavastatin|pitavastatin|mesh-list
1824292|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1824293|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1824294|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1824295|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
1824296|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824297|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824298|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1824299|NCT04706026|Anesthetics|anesthetics|mesh-list
1824300|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824301|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824302|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
1824303|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1824304|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
1824305|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824306|NCT04705818|Durvalumab|durvalumab|mesh-list
1824307|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1824308|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824309|NCT04705727|Budesonide|budesonide|mesh-list
1824310|NCT04705727|Terbutaline|terbutaline|mesh-list
1824311|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
1824312|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1824313|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1824314|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1824315|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
1824316|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824317|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824318|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1824319|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
1824320|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
1824321|NCT04705727|Hormones|hormones|mesh-ancestor
1824322|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1824323|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1824324|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1824325|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1824326|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
1824327|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824328|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824329|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
1824330|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
1824331|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1824332|NCT04705584|Cyclosporine|cyclosporine|mesh-list
1824333|NCT04705584|Prednisolone|prednisolone|mesh-list
1824334|NCT04705584|Cyclosporins|cyclosporins|mesh-list
1824335|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824336|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824337|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1824338|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
1824339|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824340|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
1824341|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1824342|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
1824343|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1824344|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1824345|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1824346|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
1824347|NCT04705584|Hormones|hormones|mesh-ancestor
1824348|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1824349|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1824350|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824351|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
1824352|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1824353|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824354|NCT04705337|Simendan|simendan|mesh-list
1824355|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1824356|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
1824357|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1824358|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1824359|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824360|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824361|NCT04705337|Protective Agents|protective agents|mesh-ancestor
1824362|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824363|NCT04705480|Pregabalin|pregabalin|mesh-list
1824364|NCT04705480|Gabapentin|gabapentin|mesh-list
1824365|NCT04705480|Analgesics|analgesics|mesh-ancestor
1824366|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
1824367|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824368|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824369|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
1824370|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1824371|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1824372|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824373|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1824374|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1824375|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1824376|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824377|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1824378|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1824379|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1824380|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824381|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
1824382|NCT04705402|Mannitol|mannitol|mesh-list
1824383|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1824384|NCT04705402|Diuretics|diuretics|mesh-ancestor
1824385|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
1824386|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824387|NCT04705519|Paclitaxel|paclitaxel|mesh-list
1824388|NCT04705519|Bevacizumab|bevacizumab|mesh-list
1824389|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1824390|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824391|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
1824392|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
1824393|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
1824394|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824395|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1824396|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1824397|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1824398|NCT04705519|Growth Substances|growth substances|mesh-ancestor
1824399|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824400|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
1824401|NCT04705428|Fluorides|fluorides|mesh-list
1824402|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
1824403|NCT04705428|Protective Agents|protective agents|mesh-ancestor
1824404|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824405|NCT04705415|Niclosamide|niclosamide|mesh-list
1824406|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
1824407|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1824408|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
1824409|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1824410|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1824411|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
1824412|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
1824413|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824414|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1824415|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824416|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824437|NCT04704921|Ranibizumab|ranibizumab|mesh-list
1824438|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1824439|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1824440|NCT04704921|Growth Substances|growth substances|mesh-ancestor
1824441|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824442|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
1824443|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824444|NCT04704947|Alendronate|alendronate|mesh-list
1824445|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
1824446|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
1824447|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1824448|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824449|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1824450|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
1824451|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824452|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824453|NCT04704622|Midazolam|midazolam|mesh-list
1824454|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
1824455|NCT04704622|Ketamine|ketamine|mesh-list
1824456|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1824457|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824458|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824459|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1824460|NCT04704622|Analgesics|analgesics|mesh-ancestor
1824461|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
1824462|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824463|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1824464|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1824465|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1824466|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
1824467|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824468|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824469|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1824470|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1824471|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
1824472|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
1824473|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1824474|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1824475|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1824476|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1824477|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1824478|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1824479|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
1824480|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
1824487|NCT04704596|Anesthetics|anesthetics|mesh-list
1824488|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824489|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824490|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
1824491|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
1824492|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1824493|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1824494|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824495|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824496|NCT04704440|Urological Agents|urological agents|mesh-ancestor
1824497|NCT04704713|Afamelanotide|afamelanotide|mesh-list
1824498|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
1824499|NCT04704297|Acetaminophen|acetaminophen|mesh-list
1824500|NCT04704297|Ibuprofen|ibuprofen|mesh-list
1824501|NCT04704297|Ketorolac|ketorolac|mesh-list
1824502|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1824503|NCT04704297|Amitriptyline|amitriptyline|mesh-list
1824504|NCT04704297|Bupivacaine|bupivacaine|mesh-list
1824505|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
1824506|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
1824507|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
1824508|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824509|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824510|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
1824511|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824512|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1824513|NCT04704297|Analgesics|analgesics|mesh-ancestor
1824514|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
1824515|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1824516|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1824517|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1824518|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1824519|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824520|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824521|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1824522|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
1824523|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1824524|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1824525|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1824526|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1824527|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1824528|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1824529|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1824530|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
1824531|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824538|NCT04704453|Amitriptyline|amitriptyline|mesh-list
1824539|NCT04704453|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
1824540|NCT04704453|Capsaicin|capsaicin|mesh-list
1824541|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
1824542|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
1824543|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
1824544|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824545|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824546|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1824547|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
1824548|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1824549|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1824550|NCT04704453|Analgesics|analgesics|mesh-ancestor
1824551|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1824552|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1824553|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1824554|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824555|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
1824556|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824557|NCT04704453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1824558|NCT04704453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1824559|NCT04704453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824574|NCT04704245|Petrolatum|petrolatum|mesh-list
1824575|NCT04704245|Mitogens|mitogens|mesh-list
1824576|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
1824577|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824578|NCT04704245|Emollients|emollients|mesh-ancestor
1824579|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
1824580|NCT04704141|Hormones|hormones|mesh-list
1824581|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1824582|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824583|NCT04703868|Rabeprazole|rabeprazole|mesh-list
1824584|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1824585|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1824586|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1824587|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824588|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824589|NCT04704024|Tenofovir|tenofovir|mesh-list
1824590|NCT04704024|Lamivudine|lamivudine|mesh-list
1824591|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
1824592|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1824593|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1824594|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1824595|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824596|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824597|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1824598|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1824599|NCT04703803|Lidocaine|lidocaine|mesh-list
1824600|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
1824601|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
1824602|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824603|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824604|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
1824605|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824606|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1824607|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1824608|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1824609|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1824610|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824611|NCT04703920|Talazoparib|talazoparib|mesh-list
1824612|NCT04703920|Belinostat|belinostat|mesh-list
1824613|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1824614|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824615|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824616|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824617|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
1824618|NCT04704063|Vitamin E|vitamin e|mesh-list
1824619|NCT04704063|Tocopherols|tocopherols|mesh-list
1824620|NCT04704063|Tocotrienols|tocotrienols|mesh-list
1824621|NCT04704063|Tocovid|tocovid|mesh-list
1824622|NCT04704063|Vitamins|vitamins|mesh-ancestor
1824623|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
1824624|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824625|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
1824626|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824627|NCT04704063|Protective Agents|protective agents|mesh-ancestor
1824628|NCT04704050|Dronedarone|dronedarone|mesh-list
1824629|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1824630|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
1824631|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
1824632|NCT04703465|Tenofovir|tenofovir|mesh-list
1824633|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
1824634|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1824635|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1824636|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1824637|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824638|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824639|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1824640|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1824651|NCT04703608|Ivermectin|ivermectin|mesh-list
1824652|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1824653|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1824654|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
1824655|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
1824656|NCT04703673|Ephedrine|ephedrine|mesh-list
1824657|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
1824658|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1824659|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
1824660|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1824661|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824662|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
1824663|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824664|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
1824665|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824666|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824667|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1824668|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1824671|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
1824672|NCT04703426|Sargramostim|sargramostim|mesh-list
1824673|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1824674|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824675|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
1824676|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824677|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
1824678|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1824679|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824680|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
1824681|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1824682|NCT04703257|Dipyrone|dipyrone|mesh-list
1824683|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1824684|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1824685|NCT04703257|Analgesics|analgesics|mesh-ancestor
1824686|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
1824687|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824688|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824689|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1824690|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1824691|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
1824692|NCT04702906|Trimetazidine|trimetazidine|mesh-list
1824693|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
1824705|NCT04703127|Lidocaine|lidocaine|mesh-list
1824706|NCT04703127|Tadalafil|tadalafil|mesh-list
1824707|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
1824708|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
1824709|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824710|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824711|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
1824712|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824713|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1824714|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1824715|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1824716|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1824717|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824718|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
1824719|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1824720|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1824721|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824722|NCT04703127|Urological Agents|urological agents|mesh-ancestor
1824723|NCT04702971|Flunarizine|flunarizine|mesh-list
1824724|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
1824725|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1824726|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1824727|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824728|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1824729|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824730|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1824731|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
1824732|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
1824733|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824734|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
1824735|NCT04703088|Ondansetron|ondansetron|mesh-list
1824736|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
1824737|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
1824738|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824739|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824740|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1824741|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
1824742|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
1824743|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1824744|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
1824745|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824746|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824747|NCT04703088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1824748|NCT04703088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1824749|NCT04703088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824750|NCT04703088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1824751|NCT04703088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1824805|NCT04702698|Peposertib|peposertib|mesh-list
1824806|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1824807|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824808|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824809|NCT04702685|Ropivacaine|ropivacaine|mesh-list
1824810|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
1824811|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
1824812|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824813|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824814|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
1824815|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824841|NCT04702490|Empagliflozin|empagliflozin|mesh-list
1824842|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1824843|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824844|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1824845|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824846|NCT04702048|Aflibercept|aflibercept|mesh-list
1824847|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1824848|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1824849|NCT04702048|Growth Substances|growth substances|mesh-ancestor
1824850|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824851|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
1824852|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824853|NCT04702061|Anesthetics|anesthetics|mesh-list
1824854|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824855|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824856|NCT04702334|Lidocaine|lidocaine|mesh-list
1824857|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
1824858|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
1824859|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
1824860|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1824861|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824862|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
1824863|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1824864|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1824865|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1824866|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1824867|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1824868|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824869|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1824870|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
1824871|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
1824872|NCT04702334|Protective Agents|protective agents|mesh-ancestor
1824909|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1824910|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1824911|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824912|NCT04702360|Ivacaftor|ivacaftor|mesh-list
1824913|NCT04702360|Elexacaftor|elexacaftor|mesh-list
1824914|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1824915|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1824916|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824917|NCT04702204|Denosumab|denosumab|mesh-list
1824918|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1824919|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824920|NCT04702009|Antibodies|antibodies|mesh-list
1824921|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1824922|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
1824923|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824924|NCT04701606|Artesunate|artesunate|mesh-list
1824925|NCT04701606|Pyronaridine|pyronaridine|mesh-list
1824926|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
1824927|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1824928|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1824929|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1824930|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824931|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
1824932|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
1824933|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1824934|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
1824935|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1824936|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
1824937|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824938|NCT04701593|Triamcinolone|triamcinolone|mesh-list
1824939|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1824940|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1824941|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1824942|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1824943|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
1824944|NCT04701593|Hormones|hormones|mesh-ancestor
1824945|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1824946|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824947|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1824948|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
1824949|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824950|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824951|NCT04701710|Ivermectin|ivermectin|mesh-list
1824952|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1824953|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1824954|NCT04701528|Tacrolimus|tacrolimus|mesh-list
1824955|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1824956|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
1824957|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824958|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1824959|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824960|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824961|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
1824962|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1824963|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824964|NCT04701463|Calcium|calcium|mesh-list
1824965|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1824966|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824967|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1824968|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1824969|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824970|NCT04701307|Niraparib|niraparib|mesh-list
1824971|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
1824972|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
1824973|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
1824974|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824975|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1824976|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1824977|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824978|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1824979|NCT04701333|Cabergoline|cabergoline|mesh-list
1824980|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1824981|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1824982|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
1824983|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
1824984|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1824985|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1824986|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1824998|NCT04701242|Ezetimibe|ezetimibe|mesh-list
1824999|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1825000|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1825001|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
1825002|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825003|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1825004|NCT04701320|Methamphetamine|methamphetamine|mesh-list
1825005|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1825006|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825007|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
1825008|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
1825009|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825010|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
1825011|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825012|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825013|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
1825014|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1825015|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1825016|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1825017|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1825018|NCT04701424|Insulin|insulin|mesh-list
1825019|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1825020|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825021|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
1825022|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1825023|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
1825024|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825025|NCT04701034|Prednisolone|prednisolone|mesh-list
1825026|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
1825027|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1825028|NCT04701034|Antibodies|antibodies|mesh-list
1825029|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
1825030|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1825031|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1825032|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
1825033|NCT04701034|Hormones|hormones|mesh-ancestor
1825034|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1825035|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825036|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1825037|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825038|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
1825039|NCT04701008|Ketamine|ketamine|mesh-list
1825040|NCT04701008|Analgesics|analgesics|mesh-ancestor
1825041|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
1825042|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825043|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825044|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1825045|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1825046|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
1825047|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
1825048|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825049|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1825050|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1825051|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825052|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825053|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
1825054|NCT04700826|Apixaban|apixaban|mesh-list
1825055|NCT04700826|Edoxaban|edoxaban|mesh-list
1825056|NCT04700826|Dabigatran|dabigatran|mesh-list
1825057|NCT04700826|Anticoagulants|anticoagulants|mesh-list
1825058|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1825059|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
1825060|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1825061|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
1825062|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825063|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825064|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1825065|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
1825066|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825067|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
1825068|NCT04700670|Coagulants|coagulants|mesh-ancestor
1825069|NCT04700592|Ketamine|ketamine|mesh-list
1825070|NCT04700592|Gabapentin|gabapentin|mesh-list
1825071|NCT04700592|Analgesics|analgesics|mesh-ancestor
1825072|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
1825073|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825074|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825075|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1825076|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1825077|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
1825078|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
1825079|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825080|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1825081|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1825082|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825083|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825084|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
1825085|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1825086|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1825087|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1825088|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
1825089|NCT04700943|Anesthetics|anesthetics|mesh-list
1825090|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825091|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825092|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
1825093|NCT04700696|Narcotics|narcotics|mesh-ancestor
1825094|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825095|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825096|NCT04700696|Analgesics|analgesics|mesh-ancestor
1825097|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
1825098|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825099|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
1825100|NCT04700709|Sirolimus|sirolimus|mesh-list
1825101|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1825102|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825103|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1825104|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
1825105|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1825106|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825107|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825108|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825109|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
1825110|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1825111|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
1825112|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825113|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
1825114|NCT04700761|Anesthetics|anesthetics|mesh-list
1825115|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825116|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825117|NCT04700761|Narcotics|narcotics|mesh-ancestor
1825118|NCT04700761|Analgesics|analgesics|mesh-ancestor
1825119|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
1825120|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825136|NCT04700839|Metformin|metformin|mesh-list
1825137|NCT04700839|Canagliflozin|canagliflozin|mesh-list
1825138|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
1825139|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1825140|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825141|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825142|NCT04700475|Citric Acid|citric acid|mesh-list
1825143|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
1825144|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
1825145|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1825146|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
1825147|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
1825148|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825149|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1825150|NCT04700436|Ezetimibe|ezetimibe|mesh-list
1825151|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1825152|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1825153|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
1825154|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825155|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1825156|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1825157|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825180|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
1825181|NCT04700228|Bupivacaine|bupivacaine|mesh-list
1825182|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
1825183|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
1825184|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825185|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825186|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
1825187|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825188|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1825189|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1825190|NCT04700228|Analgesics|analgesics|mesh-ancestor
1825191|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1825192|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1825193|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1825194|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
1825195|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825196|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825197|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
1825198|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
1825227|NCT04700046|Mexiletine|mexiletine|mesh-list
1825228|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1825229|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1825230|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1825231|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1825232|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825233|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1825234|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1825235|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825236|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
1825237|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
1825238|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1825239|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825240|NCT04699903|Antibodies|antibodies|mesh-list
1825241|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
1825242|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
1825243|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825244|NCT04699734|Lidocaine|lidocaine|mesh-list
1825245|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
1825246|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
1825247|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825248|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825249|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
1825250|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825251|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1825252|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1825253|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1825254|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1825255|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825256|NCT04699721|Paclitaxel|paclitaxel|mesh-list
1825257|NCT04699721|Carboplatin|carboplatin|mesh-list
1825258|NCT04699721|Nivolumab|nivolumab|mesh-list
1825259|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1825260|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825261|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
1825262|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
1825263|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
1825264|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825265|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1825266|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1825348|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
1825275|NCT04699591|Domperidone|domperidone|mesh-list
1825276|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
1825277|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
1825278|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825279|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825280|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1825281|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1825282|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
1825283|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825284|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825309|NCT04699214|Endostar protein|endostar protein|mesh-list
1825310|NCT04699214|Endostatins|endostatins|mesh-list
1825311|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1825312|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1825313|NCT04699214|Growth Substances|growth substances|mesh-ancestor
1825314|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825315|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
1825316|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825321|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
1825322|NCT04699383|Allopurinol|allopurinol|mesh-list
1825323|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
1825324|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825325|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825326|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
1825327|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1825328|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1825329|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
1825330|NCT04699383|Protective Agents|protective agents|mesh-ancestor
1825331|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825332|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1825333|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1825334|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825335|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
1825336|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1825337|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
1825338|NCT04699240|Clotrimazole|clotrimazole|mesh-list
1825339|NCT04699240|Miconazole|miconazole|mesh-list
1825340|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1825341|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825342|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
1825343|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1825344|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1825345|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825346|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825347|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1825349|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1825350|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825351|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1825352|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1825353|NCT04698850|Ranibizumab|ranibizumab|mesh-list
1825354|NCT04698850|Aflibercept|aflibercept|mesh-list
1825355|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1825356|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1825357|NCT04698850|Growth Substances|growth substances|mesh-ancestor
1825358|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825359|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
1825360|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825361|NCT04698941|Paclitaxel|paclitaxel|mesh-list
1825362|NCT04698941|Simvastatin|simvastatin|mesh-list
1825363|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1825364|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825365|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
1825366|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
1825367|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
1825368|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825369|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1825370|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1825371|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
1825372|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1825373|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1825374|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825375|NCT04699058|Antibodies|antibodies|mesh-list
1825376|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
1825377|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825378|NCT04699110|Adenosine|adenosine|mesh-list
1825379|NCT04699110|Epinephrine|epinephrine|mesh-list
1825380|NCT04699110|Racepinephrine|racepinephrine|mesh-list
1825381|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
1825382|NCT04699110|Analgesics|analgesics|mesh-ancestor
1825383|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
1825384|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825385|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825386|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1825387|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
1825388|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1825389|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
1825390|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
1825391|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825392|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825393|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1825394|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1825395|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
1825396|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1825397|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1825398|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
1825399|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1825400|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
1825401|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
1825402|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
1825403|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1825404|NCT04699097|Azithromycin|azithromycin|mesh-list
1825405|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1825406|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825407|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1825408|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1825409|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1825410|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
1825411|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825412|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1825413|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1825414|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825415|NCT04698746|Anesthetics|anesthetics|mesh-list
1825416|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
1825417|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825418|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825419|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
1825420|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825447|NCT04698772|Morphine|morphine|mesh-list
1825448|NCT04698772|Ketamine|ketamine|mesh-list
1825449|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1825450|NCT04698772|Narcotics|narcotics|mesh-ancestor
1825451|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825452|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825453|NCT04698772|Analgesics|analgesics|mesh-ancestor
1825454|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
1825455|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825456|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1825457|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1825458|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
1825459|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
1825460|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1825461|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1825462|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825463|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825464|NCT04698512|Sirolimus|sirolimus|mesh-list
1825465|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1825466|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825467|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1825468|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825469|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
1825470|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1825471|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
1825472|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825473|NCT04698434|Esketamine|esketamine|mesh-list
1825474|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
1825475|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1825476|NCT04698226|Temazepam|temazepam|mesh-list
1825477|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1825478|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825479|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825480|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1825481|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1825482|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1825483|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
1825484|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
1825485|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825486|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825487|NCT04698213|Avelumab|avelumab|mesh-list
1825488|NCT04698213|Axitinib|axitinib|mesh-list
1825489|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1825490|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825491|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1825492|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825493|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825494|NCT04698317|Mitogens|mitogens|mesh-list
1825495|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
1825496|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825497|NCT04697992|Vitamins|vitamins|mesh-list
1825498|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
1825499|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
1825500|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
1825501|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825502|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1825503|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1825504|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825505|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
1825506|NCT04697992|Coagulants|coagulants|mesh-ancestor
1825507|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
1825508|NCT04697992|Protective Agents|protective agents|mesh-ancestor
1825509|NCT04697940|Decitabine|decitabine|mesh-list
1825510|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1825511|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
1825512|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825513|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825514|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825515|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
1825516|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
1825517|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1825518|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1825519|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825520|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825521|NCT04697862|Urological Agents|urological agents|mesh-ancestor
1825522|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
1825523|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1825524|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
1825525|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825526|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
1825527|NCT04697823|Protective Agents|protective agents|mesh-ancestor
1825528|NCT04697602|Colchicine|colchicine|mesh-list
1825529|NCT04697602|Febuxostat|febuxostat|mesh-list
1825530|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
1825531|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1825532|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
1825533|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
1825534|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
1825535|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825536|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825537|NCT04697498|Anesthetics|anesthetics|mesh-list
1825538|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825539|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825540|NCT04697641|Amoxicillin|amoxicillin|mesh-list
1825541|NCT04697641|Clarithromycin|clarithromycin|mesh-list
1825542|NCT04697641|Pantoprazole|pantoprazole|mesh-list
1825543|NCT04697641|Z 338|z 338|mesh-list
1825544|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1825545|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825546|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1825547|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825548|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825549|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1825550|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1825551|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1825552|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1825553|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1825554|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1825555|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
1825556|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825557|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825558|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
1825559|NCT04697693|Citalopram|citalopram|mesh-list
1825560|NCT04697693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1825561|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1825562|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1825563|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825564|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825565|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
1825566|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825567|NCT04697693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1825568|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
1825569|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1825570|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825571|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1825572|NCT04697693|Analgesics|analgesics|mesh-ancestor
1825573|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
1825574|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
1825575|NCT04697732|Anesthetics|anesthetics|mesh-list
1825576|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825577|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825578|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
1825579|NCT04697576|Nivolumab|nivolumab|mesh-list
1825580|NCT04697576|Ipilimumab|ipilimumab|mesh-list
1825581|NCT04697576|Vaccines|vaccines|mesh-list
1825582|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
1825583|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825584|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1825585|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825586|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1825587|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825588|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
1825589|NCT04697537|Ropivacaine|ropivacaine|mesh-list
1825590|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
1825591|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825592|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825593|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1825594|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1825595|NCT04697537|Analgesics|analgesics|mesh-ancestor
1825596|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
1825597|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825598|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1825599|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1825600|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1825601|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
1825602|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825603|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825604|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
1825605|NCT04697719|Aspirin|aspirin|mesh-list
1825606|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1825607|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1825608|NCT04697719|Analgesics|analgesics|mesh-ancestor
1825609|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
1825610|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825611|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825612|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1825613|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1825614|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1825615|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1825616|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825617|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1825618|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1825619|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825620|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
1825621|NCT04697485|Eplerenone|eplerenone|mesh-list
1825622|NCT04697485|Bumetanide|bumetanide|mesh-list
1825623|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1825624|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
1825625|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1825626|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825627|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1825628|NCT04697485|Diuretics|diuretics|mesh-ancestor
1825629|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
1825630|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1825631|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1825632|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1825633|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825634|NCT04697745|Dexamethasone|dexamethasone|mesh-list
1825635|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
1825636|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1825637|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
1825638|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
1825639|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825640|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825641|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1825642|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
1825643|NCT04697745|Hormones|hormones|mesh-ancestor
1825644|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1825645|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1825646|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825647|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1825648|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825649|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1825650|NCT04697745|Analgesics|analgesics|mesh-ancestor
1825651|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
1825652|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1825653|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1825654|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1825655|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
1825656|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825657|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825658|NCT04697511|Midazolam|midazolam|mesh-list
1825659|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1825660|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1825661|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825662|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825663|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1825664|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1825665|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1825666|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1825667|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
1825668|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
1825669|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
1825670|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
1825671|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825672|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825673|NCT04697355|Beta Carotene|beta carotene|mesh-list
1825674|NCT04697355|Naringenin|naringenin|mesh-list
1825675|NCT04697355|Carotenoids|carotenoids|mesh-list
1825676|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
1825677|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825678|NCT04697355|Protective Agents|protective agents|mesh-ancestor
1825679|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825680|NCT04697355|Provitamins|provitamins|mesh-ancestor
1825681|NCT04697355|Vitamins|vitamins|mesh-ancestor
1825682|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
1825683|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1825684|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1825685|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1825686|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
1825687|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1825688|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1825689|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825690|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
1825691|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
1825692|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
1825693|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825694|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825695|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
1825696|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825701|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
1825702|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825703|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
1825704|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
1825705|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
1825706|NCT04696939|Carboplatin|carboplatin|mesh-list
1825707|NCT04696939|Etoposide|etoposide|mesh-list
1825708|NCT04696939|Atezolizumab|atezolizumab|mesh-list
1825709|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825710|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1825711|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1825712|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1825713|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825714|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825715|NCT04697186|Amoxicillin|amoxicillin|mesh-list
1825716|NCT04697186|Clarithromycin|clarithromycin|mesh-list
1825717|NCT04697186|Rabeprazole|rabeprazole|mesh-list
1825718|NCT04697186|Bismuth|bismuth|mesh-list
1825719|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1825720|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825721|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1825722|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825723|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825724|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1825953|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825725|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1825726|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1825727|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1825728|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1825729|NCT04697186|Antacids|antacids|mesh-ancestor
1825730|NCT04696848|Durvalumab|durvalumab|mesh-list
1825731|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1825732|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825733|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
1825734|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1825735|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
1825736|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825737|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
1825738|NCT04696666|Protective Agents|protective agents|mesh-ancestor
1825739|NCT04696783|Esomeprazole|esomeprazole|mesh-list
1825740|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1825741|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1825742|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1825743|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825744|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825745|NCT04696523|Xenon|xenon|mesh-list
1825746|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1825747|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
1825748|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
1825749|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825750|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825751|NCT04696757|Capecitabine|capecitabine|mesh-list
1825752|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1825753|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
1825754|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825755|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825756|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
1825757|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1825758|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1825759|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825760|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
1825761|NCT04696224|Coagulants|coagulants|mesh-ancestor
1825762|NCT04696380|Nicotine|nicotine|mesh-list
1825763|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1825764|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
1825765|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825766|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825767|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1825768|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1825769|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
1825770|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825771|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825772|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
1825773|NCT04696536|Listerine|listerine|mesh-list
1825774|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1825775|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825776|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
1825777|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1825778|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825779|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1825780|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825781|NCT04696575|Lamivudine|lamivudine|mesh-list
1825782|NCT04696575|Carboplatin|carboplatin|mesh-list
1825783|NCT04696575|Etoposide|etoposide|mesh-list
1825784|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
1825785|NCT04696575|Atezolizumab|atezolizumab|mesh-list
1825786|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
1825787|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1825788|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825789|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1825790|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1825791|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1825792|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825793|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825794|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1825795|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1825796|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
1825797|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825798|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1825799|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1825800|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
1825801|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825802|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
1825803|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
1825804|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
1825805|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
1825806|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
1825807|NCT04696042|Lanreotide|lanreotide|mesh-list
1825808|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825809|NCT04696029|Eflornithine|eflornithine|mesh-list
1825810|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825811|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
1825812|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1825813|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1825814|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825815|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
1825816|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825817|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825818|NCT04695925|Carboplatin|carboplatin|mesh-list
1825819|NCT04695925|Pemetrexed|pemetrexed|mesh-list
1825820|NCT04695925|Osimertinib|osimertinib|mesh-list
1825821|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825822|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825823|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825824|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1825825|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1825826|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1825834|NCT04696120|Apixaban|apixaban|mesh-list
1825835|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1825836|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
1825837|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1825838|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
1825839|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825840|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825841|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
1825842|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
1825843|NCT04695613|Analgesics|analgesics|mesh-ancestor
1825844|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
1825845|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825846|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825847|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
1825848|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825849|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1825850|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
1825851|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1825852|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1825853|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825854|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1825855|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
1825856|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1825857|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
1825858|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1825859|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1825860|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1825861|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1825862|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825863|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
1825864|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825865|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825866|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1825867|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825868|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
1825869|NCT04695483|Hormones|hormones|mesh-ancestor
1825870|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1825871|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825872|NCT04695509|Propofol|propofol|mesh-list
1825873|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1825874|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1825875|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825876|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1825877|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
1825878|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
1825879|NCT04695769|Ribavirin|ribavirin|mesh-list
1825880|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
1825881|NCT04695769|Velpatasvir|velpatasvir|mesh-list
1825882|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
1825883|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
1825884|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825885|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
1825886|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825887|NCT04695704|Montelukast|montelukast|mesh-list
1825888|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1825889|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1825890|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
1825891|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
1825892|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1825893|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825894|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1825895|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1825896|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825897|NCT04695197|Artesunate|artesunate|mesh-list
1825898|NCT04695197|Lumefantrine|lumefantrine|mesh-list
1825899|NCT04695197|Artemether|artemether|mesh-list
1825900|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
1825901|NCT04695197|Pyronaridine|pyronaridine|mesh-list
1825902|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
1825903|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1825904|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1825905|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825906|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825907|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
1825908|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
1825909|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1825910|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
1825911|NCT04694976|Vitamin D|vitamin d|mesh-list
1825912|NCT04694976|Vitamins|vitamins|mesh-ancestor
1825913|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
1825914|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825915|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1825916|NCT04695080|Cladribine|cladribine|mesh-list
1825917|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825918|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1825919|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
1825920|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825921|NCT04695340|Psyllium|psyllium|mesh-list
1825922|NCT04695340|Cathartics|cathartics|mesh-ancestor
1825923|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1825932|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
1825933|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1825934|NCT04694612|Remdesivir|remdesivir|mesh-list
1825935|NCT04694612|Favipiravir|favipiravir|mesh-list
1825936|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
1825937|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825938|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
1825939|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825943|NCT04694586|Rifampin|rifampin|mesh-list
1825944|NCT04694586|Isoniazid|isoniazid|mesh-list
1825945|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
1825946|NCT04694586|Ethambutol|ethambutol|mesh-list
1825947|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1825948|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
1825949|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1825950|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1825951|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
1825952|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1825954|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825955|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1825956|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1825957|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1825958|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1825959|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1825960|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1825961|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1825962|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1825963|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
1825964|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1825965|NCT04694846|Bupropion|bupropion|mesh-list
1825966|NCT04694846|Nicotine|nicotine|mesh-list
1825967|NCT04694846|Varenicline|varenicline|mesh-list
1825968|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1825969|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
1825970|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1825971|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825972|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1825973|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1825974|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
1825975|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1825976|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825977|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1825978|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
1825979|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1825980|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1825981|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1825982|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1825983|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
1825984|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1825985|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1825986|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1825987|NCT04694677|Misoprostol|misoprostol|mesh-list
1825988|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
1825989|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1825990|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1825991|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1825992|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
1825993|NCT04694677|Coagulants|coagulants|mesh-ancestor
1825994|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1825995|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
1825996|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1825997|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1825998|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1825999|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1826000|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
1826001|NCT04694183|Paclitaxel|paclitaxel|mesh-list
1826002|NCT04694183|Antibodies|antibodies|mesh-list
1826003|NCT04694183|Immunoglobulins|immunoglobulins|mesh-list
1826004|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1826005|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826006|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
1826007|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
1826008|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
1826009|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826010|NCT04694183|Immunologic Factors|immunologic factors|mesh-ancestor
1826011|NCT04694183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826012|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
1826013|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826036|NCT04694092|Landiolol|landiolol|mesh-list
1826037|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1826038|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1826039|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
1826040|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826041|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826042|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826043|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1826044|NCT04694300|Acetaminophen|acetaminophen|mesh-list
1826045|NCT04694300|Naproxen|naproxen|mesh-list
1826046|NCT04694300|Tramadol|tramadol|mesh-list
1826047|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1826048|NCT04694300|Analgesics|analgesics|mesh-ancestor
1826049|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
1826050|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826051|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826052|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
1826053|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1826054|NCT04694300|Narcotics|narcotics|mesh-ancestor
1826055|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826056|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1826057|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1826058|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1826059|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
1826060|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1826061|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826062|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826063|NCT04694105|Dexamethasone|dexamethasone|mesh-list
1826064|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
1826065|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1826066|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
1826067|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
1826068|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826069|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826070|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1826071|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
1826072|NCT04694105|Hormones|hormones|mesh-ancestor
1826073|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1826074|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1826075|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826076|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1826077|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826078|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1826079|NCT04694105|Analgesics|analgesics|mesh-ancestor
1826080|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
1826081|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1826082|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1826083|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1826084|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
1826085|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826086|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826087|NCT04693715|RNS60|rns60|mesh-list
1826088|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1826089|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1826090|NCT04693715|Analgesics|analgesics|mesh-ancestor
1826091|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
1826092|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826093|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826094|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1826095|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1826096|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1826097|NCT04693689|Vaccines|vaccines|mesh-list
1826098|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
1826099|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826100|NCT04693910|Hormones|hormones|mesh-list
1826101|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1826102|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826103|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
1826104|NCT04693897|Mirabegron|mirabegron|mesh-list
1826105|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1826106|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1826107|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
1826108|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826109|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826110|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826111|NCT04693897|Urological Agents|urological agents|mesh-ancestor
1826112|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
1826113|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1826114|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1826115|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
1826116|NCT04693962|Mitogens|mitogens|mesh-list
1826117|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
1826118|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826123|NCT04693169|Choline|choline|mesh-list
1826124|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
1826125|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1826126|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
1826127|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826128|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1826129|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1826130|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
1826131|NCT04693156|Bupivacaine|bupivacaine|mesh-list
1826132|NCT04693156|Prilocaine|prilocaine|mesh-list
1826133|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
1826134|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
1826135|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826136|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826137|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
1826138|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826139|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
1826140|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1826141|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1826142|NCT04693312|Prednisolone|prednisolone|mesh-list
1826143|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
1826144|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1826145|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
1826146|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1826147|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
1826148|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
1826149|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826150|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826151|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1826152|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
1826153|NCT04693312|Hormones|hormones|mesh-ancestor
1826154|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1826155|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1826156|NCT04693312|Protective Agents|protective agents|mesh-ancestor
1826157|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1826158|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826161|NCT04693026|Remdesivir|remdesivir|mesh-list
1826162|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
1826163|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826164|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
1826165|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1826166|NCT04692831|Pertuzumab|pertuzumab|mesh-list
1826167|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1826168|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826169|NCT04692623|Insulin|insulin|mesh-list
1826170|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1826171|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
1826172|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
1826173|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1826174|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826175|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1826176|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1826177|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1826178|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1826179|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826180|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826181|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826182|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
1826183|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1826184|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
1826185|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826186|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
1826187|NCT04692558|Protective Agents|protective agents|mesh-ancestor
1826188|NCT04692844|Propranolol|propranolol|mesh-list
1826189|NCT04692844|Primidone|primidone|mesh-list
1826190|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1826191|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1826192|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
1826193|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826194|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826195|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826196|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1826197|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1826198|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
1826199|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
1826200|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
1826201|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
1826202|NCT04692896|Lidocaine|lidocaine|mesh-list
1826203|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
1826204|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
1826205|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826206|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826207|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
1826208|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826209|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1826210|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1826211|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1826212|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1826213|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826214|NCT04692740|Chlorambucil|chlorambucil|mesh-list
1826215|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1826216|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
1826217|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826218|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826227|NCT04692285|Zolpidem|zolpidem|mesh-list
1826228|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1826229|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1826230|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826231|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826232|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
1826233|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
1826234|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
1826235|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826236|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826237|NCT04692376|Cyclosporine|cyclosporine|mesh-list
1826238|NCT04692376|Cyclosporins|cyclosporins|mesh-list
1826239|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
1826240|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826241|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826242|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1826243|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
1826244|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826245|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
1826246|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1826247|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
1826248|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1826249|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1826250|NCT04692376|Hormones|hormones|mesh-ancestor
1826251|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1826252|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
1826253|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1826254|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826255|NCT04692051|Gemcitabine|gemcitabine|mesh-list
1826256|NCT04692051|Paclitaxel|paclitaxel|mesh-list
1826257|NCT04692051|Cisplatin|cisplatin|mesh-list
1826258|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1826259|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826260|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
1826261|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
1826262|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
1826263|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826264|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1826265|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
1826266|NCT04692051|Antiviral Agents|antiviral agents|mesh-ancestor
1826267|NCT04692051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1826268|NCT04692051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826269|NCT04692051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1826270|NCT04692051|Immunologic Factors|immunologic factors|mesh-ancestor
1826271|NCT04692051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826272|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1826273|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1826274|NCT04691687|Furosemide|furosemide|mesh-list
1826275|NCT04691687|Diuretics|diuretics|mesh-ancestor
1826276|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
1826277|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826278|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1826279|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1826280|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826281|NCT04691726|Dipyrone|dipyrone|mesh-list
1826282|NCT04691726|Lidocaine|lidocaine|mesh-list
1826283|NCT04691726|Morphine|morphine|mesh-list
1826284|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
1826285|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
1826286|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826287|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826288|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
1826289|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826290|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1826291|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1826292|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1826293|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1826294|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826295|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1826296|NCT04691726|Narcotics|narcotics|mesh-ancestor
1826297|NCT04691726|Analgesics|analgesics|mesh-ancestor
1826298|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1826299|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1826300|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1826301|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1826302|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
1826303|NCT04691817|Atezolizumab|atezolizumab|mesh-list
1826304|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826319|NCT04691856|Acetaminophen|acetaminophen|mesh-list
1826320|NCT04691856|Ibuprofen|ibuprofen|mesh-list
1826321|NCT04691856|Morphine|morphine|mesh-list
1826322|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1826323|NCT04691856|Narcotics|narcotics|mesh-ancestor
1826324|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826325|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826326|NCT04691856|Analgesics|analgesics|mesh-ancestor
1826327|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
1826404|NCT04690686|Atezolizumab|atezolizumab|mesh-list
1826328|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826329|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1826330|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1826331|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1826332|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1826333|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1826334|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826335|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826336|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
1826337|NCT04691934|Anesthetics|anesthetics|mesh-list
1826338|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826339|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826340|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
1826341|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1826342|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826343|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
1826344|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1826345|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1826346|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826347|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
1826348|NCT04691362|Coagulants|coagulants|mesh-ancestor
1826352|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1826353|NCT04690920|Remdesivir|remdesivir|mesh-list
1826354|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1826355|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826356|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
1826357|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
1826358|NCT04691076|Fentanyl|fentanyl|mesh-list
1826359|NCT04691076|Propofol|propofol|mesh-list
1826360|NCT04691076|Esketamine|esketamine|mesh-list
1826361|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1826362|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826363|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826364|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1826365|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
1826366|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
1826367|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1826368|NCT04691076|Narcotics|narcotics|mesh-ancestor
1826369|NCT04691076|Analgesics|analgesics|mesh-ancestor
1826370|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
1826371|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826372|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1826373|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
1826374|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1826375|NCT04691063|Carboplatin|carboplatin|mesh-list
1826376|NCT04691063|Etoposide|etoposide|mesh-list
1826377|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
1826378|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826379|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1826380|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1826381|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1826382|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826383|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826384|NCT04690855|Atezolizumab|atezolizumab|mesh-list
1826385|NCT04690855|Talazoparib|talazoparib|mesh-list
1826386|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826387|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1826388|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826389|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826390|NCT04690608|Triamcinolone|triamcinolone|mesh-list
1826391|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1826392|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1826393|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1826394|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1826395|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
1826396|NCT04690608|Hormones|hormones|mesh-ancestor
1826397|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1826398|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826399|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1826400|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
1826401|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826402|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826403|NCT04690686|Paclitaxel|paclitaxel|mesh-list
1826405|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1826406|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826407|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
1826408|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
1826409|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
1826410|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826411|NCT04690647|Dexamethasone|dexamethasone|mesh-list
1826412|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
1826413|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1826414|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
1826415|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
1826416|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826417|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826418|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1826419|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
1826420|NCT04690647|Hormones|hormones|mesh-ancestor
1826421|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1826422|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1826423|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826424|NCT04690647|Analgesics|analgesics|mesh-ancestor
1826425|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
1826426|NCT04690751|Cenobamate|cenobamate|mesh-list
1826427|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
1826428|NCT04690556|Ranibizumab|ranibizumab|mesh-list
1826429|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1826430|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1826431|NCT04690556|Growth Substances|growth substances|mesh-ancestor
1826432|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826433|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
1826434|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826442|NCT04690270|Sumatriptan|sumatriptan|mesh-list
1826443|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1826444|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
1826445|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1826446|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
1826447|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826448|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826449|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826450|NCT04690322|Factor VIII|factor viii|mesh-list
1826451|NCT04690322|BAX 855|bax 855|mesh-list
1826452|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
1826453|NCT04690322|Coagulants|coagulants|mesh-ancestor
1826454|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
1826455|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826456|NCT04689958|Vitamin D|vitamin d|mesh-list
1826457|NCT04689958|Vitamins|vitamins|mesh-ancestor
1826458|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
1826459|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826460|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1826477|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
1826478|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1826479|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
1826480|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1826481|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
1826482|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826483|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826484|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
1826485|NCT04690231|Etoposide|etoposide|mesh-list
1826486|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
1826487|NCT04690231|Apatinib|apatinib|mesh-list
1826488|NCT04690231|Ifosfamide|ifosfamide|mesh-list
1826489|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
1826490|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1826491|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826492|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1826493|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1826494|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826495|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826496|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1826497|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1826498|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
1826499|NCT04689971|Vitamins|vitamins|mesh-list
1826500|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
1826501|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
1826502|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826510|NCT04690309|Insulin|insulin|mesh-list
1826511|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1826512|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1826513|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826514|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
1826515|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826516|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
1826517|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
1826518|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
1826519|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826520|NCT04689412|Resveratrol|resveratrol|mesh-list
1826521|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
1826522|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826523|NCT04689412|Protective Agents|protective agents|mesh-ancestor
1826524|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826525|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826526|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1826527|NCT04689191|Vaccines|vaccines|mesh-list
1826528|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
1826529|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826530|NCT04689347|Leucovorin|leucovorin|mesh-list
1826531|NCT04689347|Bevacizumab|bevacizumab|mesh-list
1826532|NCT04689347|Fluorouracil|fluorouracil|mesh-list
1826533|NCT04689347|Irinotecan|irinotecan|mesh-list
1826534|NCT04689347|Temozolomide|temozolomide|mesh-list
1826535|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1826536|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826537|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1826538|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1826539|NCT04689347|Growth Substances|growth substances|mesh-ancestor
1826540|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826541|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
1826542|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
1826543|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826544|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1826545|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1826546|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
1826547|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1826548|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1826549|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826550|NCT04689347|Antidotes|antidotes|mesh-ancestor
1826551|NCT04689347|Protective Agents|protective agents|mesh-ancestor
1826552|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
1826553|NCT04689347|Vitamins|vitamins|mesh-ancestor
1826554|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
1826555|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1826556|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
1826557|NCT04689100|Leucovorin|leucovorin|mesh-list
1826558|NCT04689100|Fluorouracil|fluorouracil|mesh-list
1826559|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
1826560|NCT04689100|Irinotecan|irinotecan|mesh-list
1826561|NCT04689100|Calcium|calcium|mesh-list
1826562|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
1826563|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1826564|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826565|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
1826566|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826567|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1826568|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826569|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1826570|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
1826571|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1826572|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1826573|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826574|NCT04689100|Antidotes|antidotes|mesh-ancestor
1826575|NCT04689100|Protective Agents|protective agents|mesh-ancestor
1826576|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
1826577|NCT04689100|Vitamins|vitamins|mesh-ancestor
1826578|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
1826579|NCT04689165|Vaccines|vaccines|mesh-list
1826580|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
1826581|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826582|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
1826583|NCT04688983|Blinatumomab|blinatumomab|mesh-list
1826584|NCT04688983|Ponatinib|ponatinib|mesh-list
1826585|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826586|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1826587|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826588|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826589|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
1826598|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
1826599|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
1826600|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
1826601|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1826602|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
1826603|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
1826604|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826605|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826606|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826607|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1826608|NCT04688723|Dabigatran|dabigatran|mesh-list
1826609|NCT04688723|Clopidogrel|clopidogrel|mesh-list
1826610|NCT04688723|Ticagrelor|ticagrelor|mesh-list
1826611|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1826612|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1826613|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1826614|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1826615|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
1826616|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826617|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826618|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826619|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
1826620|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1826621|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
1826622|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826623|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
1826624|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1826625|NCT04688658|Nivolumab|nivolumab|mesh-list
1826626|NCT04688658|Axitinib|axitinib|mesh-list
1826627|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1826628|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826629|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1826630|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826631|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1826632|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826633|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
1826634|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
1826635|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1826636|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1826637|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1826638|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1826639|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826640|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826641|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826642|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1826643|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
1826644|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1826645|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826646|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
1826647|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1826648|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1826649|NCT04688346|Epinephrine|epinephrine|mesh-list
1826650|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1826651|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1826652|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
1826653|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826654|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826655|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826656|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1826657|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1826658|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
1826659|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826660|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1826661|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
1826662|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
1826663|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
1826664|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1826665|NCT04688294|Valsartan|valsartan|mesh-list
1826666|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1826667|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1826668|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1826669|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1826670|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826671|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1826672|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1826673|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1826674|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826675|NCT04688021|Cytarabine|cytarabine|mesh-list
1826676|NCT04688021|Cyclosporine|cyclosporine|mesh-list
1826677|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
1826678|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
1826679|NCT04688021|Busulfan|busulfan|mesh-list
1826680|NCT04688021|Cyclosporins|cyclosporins|mesh-list
1826681|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
1826682|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
1826683|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1826684|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
1826685|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826686|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1826687|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1826688|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
1826689|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826690|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826691|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1826692|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1826693|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
1826694|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
1826695|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1826696|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826697|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
1826698|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
1826699|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1826700|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1826701|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1826702|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
1826703|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1826717|NCT04688151|Rituximab|rituximab|mesh-list
1826718|NCT04688151|Durvalumab|durvalumab|mesh-list
1826719|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
1826720|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1826721|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826722|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
1826723|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826724|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1826725|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
1826726|NCT04688203|Labetalol|labetalol|mesh-list
1826727|NCT04688203|Analgesics|analgesics|mesh-ancestor
1826728|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
1826729|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826730|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826731|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
1826732|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826733|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1826734|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
1826735|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1826736|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1826737|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826738|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1826739|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
1826740|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1826741|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1826742|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1826743|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
1826744|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826745|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1826746|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
1826747|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
1826748|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1826749|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1826750|NCT04687878|Insulin|insulin|mesh-list
1826751|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1826752|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1826753|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826754|NCT04687800|Dexamethasone|dexamethasone|mesh-list
1826755|NCT04687800|Difluprednate|difluprednate|mesh-list
1826756|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1826757|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
1826758|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
1826759|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826760|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826761|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1826762|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
1826763|NCT04687800|Hormones|hormones|mesh-ancestor
1826764|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1826765|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1826766|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826767|NCT04687566|Memantine|memantine|mesh-list
1826768|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
1826769|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1826770|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1826771|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
1826772|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826773|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826774|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826775|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1826776|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1826777|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
1826778|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
1826779|NCT04687631|Bevacizumab|bevacizumab|mesh-list
1826780|NCT04687631|Cetuximab|cetuximab|mesh-list
1826781|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1826782|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826783|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1826784|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1826785|NCT04687631|Growth Substances|growth substances|mesh-ancestor
1826786|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826787|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
1826788|NCT04687761|Cytarabine|cytarabine|mesh-list
1826789|NCT04687761|Azacitidine|azacitidine|mesh-list
1826790|NCT04687761|Venetoclax|venetoclax|mesh-list
1826791|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1826792|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
1826793|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826794|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826795|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
1826796|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1826797|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1826798|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
1826799|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826800|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826801|NCT04687514|Dulaglutide|dulaglutide|mesh-list
1826802|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1826803|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826804|NCT04687332|Tryptophan|tryptophan|mesh-list
1826805|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1826806|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
1826807|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1826808|NCT04687449|Curcumin|curcumin|mesh-list
1826809|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1826810|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1826811|NCT04687449|Analgesics|analgesics|mesh-ancestor
1826812|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
1826813|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826814|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826815|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1826816|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1826817|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826818|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826819|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826820|NCT04687111|Valsartan|valsartan|mesh-list
1826821|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1826822|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1826823|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1826824|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1826825|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826826|NCT04686890|Acetaminophen|acetaminophen|mesh-list
1826827|NCT04686890|Tramadol|tramadol|mesh-list
1826828|NCT04686890|Analgesics|analgesics|mesh-list
1826829|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1826830|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
1826831|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826832|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826833|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
1826834|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1826835|NCT04686890|Narcotics|narcotics|mesh-ancestor
1826836|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826837|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
1826838|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826839|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
1826840|NCT04687163|Fluorouracil|fluorouracil|mesh-list
1826841|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826842|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
1826843|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826844|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1826845|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1826846|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
1826847|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826857|NCT04686929|Abatacept|abatacept|mesh-list
1826858|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1826859|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826860|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826861|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1826862|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
1826863|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826864|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1826871|NCT04687098|Idarubicin|idarubicin|mesh-list
1826872|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1826873|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1826874|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1826875|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1826876|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826877|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826878|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
1826879|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
1826880|NCT04686448|Fentanyl|fentanyl|mesh-list
1826881|NCT04686448|Ketamine|ketamine|mesh-list
1826882|NCT04686448|Propofol|propofol|mesh-list
1826883|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1826884|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826885|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826886|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1826887|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
1826888|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
1826889|NCT04686448|Analgesics|analgesics|mesh-ancestor
1826890|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
1826891|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826892|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1826893|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1826894|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1826895|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826896|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826897|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1826898|NCT04686448|Narcotics|narcotics|mesh-ancestor
1826899|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1826900|NCT04686825|DA-8010|da-8010|mesh-list
1826901|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1826902|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1826903|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
1826904|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826905|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826906|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826907|NCT04686643|Niacin|niacin|mesh-list
1826908|NCT04686643|Amlodipine|amlodipine|mesh-list
1826909|NCT04686643|Valsartan|valsartan|mesh-list
1826910|NCT04686643|Indapamide|indapamide|mesh-list
1826911|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1826912|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1826913|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1826914|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826915|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1826916|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826917|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
1826918|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1826919|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1826920|NCT04686643|Diuretics|diuretics|mesh-ancestor
1826921|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
1826922|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1826923|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1826924|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
1826925|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1826926|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
1826927|NCT04686643|Vitamins|vitamins|mesh-ancestor
1826928|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
1826929|NCT04686279|Tenofovir|tenofovir|mesh-list
1826930|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
1826931|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1826932|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1826933|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1826934|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826935|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826936|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1826937|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1826938|NCT04685980|Morphine|morphine|mesh-list
1826939|NCT04685980|Anesthetics|anesthetics|mesh-list
1826940|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
1826941|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826942|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826943|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1826944|NCT04685980|Narcotics|narcotics|mesh-ancestor
1826945|NCT04685980|Analgesics|analgesics|mesh-ancestor
1826946|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
1826947|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826948|NCT04686058|Midazolam|midazolam|mesh-list
1826949|NCT04686058|Meperidine|meperidine|mesh-list
1826950|NCT04686058|Propofol|propofol|mesh-list
1826951|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1826952|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826953|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826954|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1826955|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
1826956|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
1826957|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1826958|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1826959|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1826960|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1826961|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
1826962|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
1826963|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1826964|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826965|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1826966|NCT04686058|Narcotics|narcotics|mesh-ancestor
1826967|NCT04686058|Analgesics|analgesics|mesh-ancestor
1826968|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
1826969|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826970|NCT04685876|Bupivacaine|bupivacaine|mesh-list
1826971|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
1826972|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
1826973|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1826974|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1826975|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
1826976|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826977|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1826978|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1826979|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826980|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
1826981|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1826982|NCT04685512|Tenofovir|tenofovir|mesh-list
1826983|NCT04685512|Emtricitabine|emtricitabine|mesh-list
1826984|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
1826985|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1826986|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1826987|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1826988|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1826989|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1826990|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1826991|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1826992|NCT04685642|Aspirin|aspirin|mesh-list
1826993|NCT04685642|Atorvastatin|atorvastatin|mesh-list
1826994|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1826995|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1826996|NCT04685642|Analgesics|analgesics|mesh-ancestor
1826997|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
1826998|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1826999|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827000|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1827001|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1827002|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1827003|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1827004|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827005|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1827006|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1827007|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827008|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
1827009|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1827010|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1827011|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
1827012|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1827013|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1827014|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
1827015|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1827016|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827017|NCT04685616|Doxorubicin|doxorubicin|mesh-list
1827018|NCT04685616|Bleomycin|bleomycin|mesh-list
1827019|NCT04685616|Dacarbazine|dacarbazine|mesh-list
1827020|NCT04685616|Vinblastine|vinblastine|mesh-list
1827021|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
1827022|NCT04685616|Mitogens|mitogens|mesh-list
1827023|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1827024|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827025|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1827026|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1827027|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827028|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827029|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
1827030|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1827031|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
1827032|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1827033|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
1827034|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
1827035|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1827036|NCT04685694|Misoprostol|misoprostol|mesh-list
1827037|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1827038|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
1827039|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1827040|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827041|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1827042|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1827043|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
1827044|NCT04685538|Tetracaine|tetracaine|mesh-list
1827045|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
1827046|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
1827047|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
1827048|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827049|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827050|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
1827051|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827052|NCT04685421|Bupivacaine|bupivacaine|mesh-list
1827053|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
1827054|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
1827055|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827056|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827057|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
1827058|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827059|NCT04685577|Nefopam|nefopam|mesh-list
1827060|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1827061|NCT04685577|Analgesics|analgesics|mesh-ancestor
1827062|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
1827063|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827064|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827065|NCT04685148|Estradiol|estradiol|mesh-list
1827066|NCT04685148|Estrogens|estrogens|mesh-ancestor
1827067|NCT04685148|Hormones|hormones|mesh-ancestor
1827068|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1827069|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827070|NCT04685031|Clobetasol|clobetasol|mesh-list
1827071|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
1827072|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
1827073|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1827074|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
1827075|NCT04685031|Hormones|hormones|mesh-ancestor
1827076|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1827077|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827078|NCT04685005|Caffeine|caffeine|mesh-list
1827079|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1827080|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827081|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1827082|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827083|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827084|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1827085|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1827086|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
1827087|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1827091|NCT04684589|Tadalafil|tadalafil|mesh-list
1827092|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
1827093|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1827094|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1827095|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827096|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827097|NCT04684589|Urological Agents|urological agents|mesh-ancestor
1827098|NCT04684667|Propranolol|propranolol|mesh-list
1827099|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1827100|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1827101|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
1827102|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1827103|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827104|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827105|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1827106|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1827107|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
1827108|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
1827109|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1827110|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827128|NCT04684199|Melatonin|melatonin|mesh-list
1827129|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
1827130|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827131|NCT04684199|Protective Agents|protective agents|mesh-ancestor
1827132|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827133|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827134|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
1827135|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1827136|NCT04684498|Oseltamivir|oseltamivir|mesh-list
1827137|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
1827138|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827139|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827140|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827141|NCT04683965|Bevacizumab|bevacizumab|mesh-list
1827142|NCT04683965|Pemetrexed|pemetrexed|mesh-list
1827143|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1827144|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827145|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1827146|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1827147|NCT04683965|Growth Substances|growth substances|mesh-ancestor
1827148|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827149|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
1827150|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827151|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827152|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1827153|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1827154|NCT04684017|Carboplatin|carboplatin|mesh-list
1827155|NCT04684017|Etoposide|etoposide|mesh-list
1827156|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827157|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1827158|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1827159|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1827160|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827161|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827162|NCT04683458|Paclitaxel|paclitaxel|mesh-list
1827163|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1827164|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1827165|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827166|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
1827167|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
1827168|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
1827169|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827170|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
1827171|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
1827172|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1827173|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827174|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827175|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
1827176|NCT04683445|Trastuzumab|trastuzumab|mesh-list
1827177|NCT04683445|Pertuzumab|pertuzumab|mesh-list
1827178|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1827179|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827180|NCT04683627|Diclofenac|diclofenac|mesh-list
1827181|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1827182|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1827183|NCT04683627|Analgesics|analgesics|mesh-ancestor
1827184|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
1827185|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827186|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827187|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1827188|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1827189|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1827190|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827191|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827203|NCT04683406|Oseltamivir|oseltamivir|mesh-list
1827204|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
1827205|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827206|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827207|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827208|NCT04683341|Tenofovir|tenofovir|mesh-list
1827209|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
1827210|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827211|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1827212|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1827213|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827214|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827215|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1827216|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1827217|NCT04683315|Gemcitabine|gemcitabine|mesh-list
1827218|NCT04683315|Paclitaxel|paclitaxel|mesh-list
1827219|NCT04683315|Fluorouracil|fluorouracil|mesh-list
1827220|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1827221|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827222|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
1827223|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
1827224|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
1827225|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827226|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1827227|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
1827228|NCT04683315|Antiviral Agents|antiviral agents|mesh-ancestor
1827229|NCT04683315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827230|NCT04683315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827231|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1827232|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
1827233|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827234|NCT04683198|Carboplatin|carboplatin|mesh-list
1827235|NCT04683198|Etoposide|etoposide|mesh-list
1827236|NCT04683198|Apatinib|apatinib|mesh-list
1827237|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827238|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1827239|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1827240|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1827241|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827242|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827243|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1827244|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1827245|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1827246|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1827247|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1827248|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1827249|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
1827250|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1827251|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827252|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827253|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
1827254|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1827255|NCT04683146|Propranolol|propranolol|mesh-list
1827256|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1827257|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827258|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
1827259|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
1827260|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1827261|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1827262|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
1827263|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1827264|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827265|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827266|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1827267|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1827268|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
1827269|NCT04683237|Liraglutide|liraglutide|mesh-list
1827270|NCT04683237|Megestrol|megestrol|mesh-list
1827271|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
1827272|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1827273|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827274|NCT04683237|Incretins|incretins|mesh-ancestor
1827275|NCT04683237|Hormones|hormones|mesh-ancestor
1827276|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1827277|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1827278|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1827279|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1827280|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
1827281|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1827282|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1827283|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1827284|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1827285|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827286|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
1827287|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1827288|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
1827289|NCT04683679|Olaparib|olaparib|mesh-list
1827290|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1827291|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827292|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1827293|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827294|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827295|NCT04682782|Esketamine|esketamine|mesh-list
1827296|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
1827297|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1827298|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
1827299|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1827300|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1827305|NCT04682691|Erythromycin|erythromycin|mesh-list
1827306|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
1827307|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
1827308|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
1827309|NCT04682691|Metoclopramide|metoclopramide|mesh-list
1827310|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
1827311|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
1827312|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827313|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827314|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1827315|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1827316|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1827317|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
1827318|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1827319|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827320|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1827321|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827322|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1827323|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827324|NCT04682834|Probenecid|probenecid|mesh-list
1827325|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
1827326|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
1827327|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1827328|NCT04682834|Renal Agents|renal agents|mesh-ancestor
1827344|NCT04682795|Insulin|insulin|mesh-list
1827345|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1827346|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827347|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
1827348|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1827349|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827350|NCT04682626|Vitamins|vitamins|mesh-ancestor
1827351|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
1827352|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1827353|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1827354|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1827355|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827356|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
1827357|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
1827358|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1827359|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827360|NCT04682743|Acetaminophen|acetaminophen|mesh-list
1827361|NCT04682743|Ondansetron|ondansetron|mesh-list
1827362|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1827363|NCT04682743|Analgesics|analgesics|mesh-ancestor
1827364|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
1827365|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827366|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827367|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
1827368|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
1827369|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
1827370|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1827371|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
1827372|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
1827373|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1827374|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
1827375|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1827376|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827377|NCT04682743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1827378|NCT04682743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1827379|NCT04682743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827380|NCT04682743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1827381|NCT04682743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1827382|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
1827383|NCT04682587|Avelumab|avelumab|mesh-list
1827384|NCT04682587|Axitinib|axitinib|mesh-list
1827385|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1827386|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827387|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1827388|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827389|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827391|NCT04682574|Ascorbic Acid|ascorbic acid|mesh-list
1827392|NCT04682574|Vitamins|vitamins|mesh-ancestor
1827393|NCT04682574|Micronutrients|micronutrients|mesh-ancestor
1827394|NCT04682574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827395|NCT04682574|Antioxidants|antioxidants|mesh-ancestor
1827396|NCT04682574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827397|NCT04682574|Protective Agents|protective agents|mesh-ancestor
1827411|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
1827412|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1827413|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1827414|NCT04681937|Prednisolone|prednisolone|mesh-list
1827415|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
1827416|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1827417|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
1827418|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
1827419|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1827420|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
1827421|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
1827422|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827423|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827424|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1827425|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
1827426|NCT04681937|Hormones|hormones|mesh-ancestor
1827427|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1827428|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1827429|NCT04681937|Protective Agents|protective agents|mesh-ancestor
1827430|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1827431|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827432|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1827433|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
1827434|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
1827435|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1827436|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827437|NCT04682249|Apatinib|apatinib|mesh-list
1827438|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827439|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1827440|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827441|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827442|NCT04682184|Propranolol|propranolol|mesh-list
1827443|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
1827444|NCT04682184|Ephedrine|ephedrine|mesh-list
1827445|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1827446|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1827447|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
1827448|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1827449|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827450|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827451|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1827452|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1827453|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
1827454|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1827455|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
1827456|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827457|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1827458|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
1827459|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
1827460|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1827461|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1827462|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
1827463|NCT04682210|Bevacizumab|bevacizumab|mesh-list
1827464|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1827465|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827466|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1827467|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1827468|NCT04682210|Growth Substances|growth substances|mesh-ancestor
1827469|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827470|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
1827471|NCT04682132|Antibodies|antibodies|mesh-list
1827472|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
1827473|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827481|NCT04681820|HH-GV-678|hh-gv-678|mesh-list
1827482|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1827483|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827484|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827485|NCT04681911|Gemcitabine|gemcitabine|mesh-list
1827486|NCT04681911|Paclitaxel|paclitaxel|mesh-list
1827487|NCT04681911|Vinorelbine|vinorelbine|mesh-list
1827488|NCT04681911|Carboplatin|carboplatin|mesh-list
1827489|NCT04681911|Capecitabine|capecitabine|mesh-list
1827490|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1827491|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827492|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
1827493|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
1827494|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
1827495|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827496|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1827497|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
1827498|NCT04681911|Antiviral Agents|antiviral agents|mesh-ancestor
1827499|NCT04681911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827500|NCT04681911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827501|NCT04681911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1827502|NCT04681911|Immunologic Factors|immunologic factors|mesh-ancestor
1827503|NCT04681911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827504|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
1827505|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1827506|NCT04682041|Antibodies|antibodies|mesh-list
1827507|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
1827508|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827509|NCT04681443|Phenol|phenol|mesh-list
1827510|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1827511|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827512|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
1827513|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
1827514|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1827515|NCT04681469|Niraparib|niraparib|mesh-list
1827516|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1827517|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827518|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827519|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827542|NCT04681833|Vaccines|vaccines|mesh-list
1827543|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
1827544|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827545|NCT04680988|Gemcitabine|gemcitabine|mesh-list
1827546|NCT04680988|Paclitaxel|paclitaxel|mesh-list
1827547|NCT04680988|Pemetrexed|pemetrexed|mesh-list
1827548|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1827549|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1827550|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827551|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
1827552|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
1827553|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
1827554|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827555|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1827556|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
1827557|NCT04680988|Antiviral Agents|antiviral agents|mesh-ancestor
1827558|NCT04680988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827559|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827560|NCT04680988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1827561|NCT04680988|Immunologic Factors|immunologic factors|mesh-ancestor
1827562|NCT04680988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827563|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1827564|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1827565|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
1827566|NCT04680884|Clotrimazole|clotrimazole|mesh-list
1827567|NCT04680884|Miconazole|miconazole|mesh-list
1827568|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827569|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1827570|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1827571|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1827572|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827573|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827574|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1827575|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
1827576|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1827577|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827578|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1827579|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1827580|NCT04680962|Rituximab|rituximab|mesh-list
1827581|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1827582|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827583|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
1827584|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827585|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1827586|NCT04681027|Oxymorphone|oxymorphone|mesh-list
1827587|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1827588|NCT04681027|Narcotics|narcotics|mesh-ancestor
1827589|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827590|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827591|NCT04681027|Analgesics|analgesics|mesh-ancestor
1827592|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
1827593|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827594|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1827603|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1827604|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827605|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827606|NCT04681053|Ivermectin|ivermectin|mesh-list
1827607|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1827608|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827609|NCT04681430|Gabexate|gabexate|mesh-list
1827610|NCT04681430|Camostat|camostat|mesh-list
1827611|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
1827612|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827613|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827614|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1827615|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1827616|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
1827617|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1827694|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827618|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827619|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827620|NCT04680923|Bupivacaine|bupivacaine|mesh-list
1827621|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
1827622|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
1827623|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827624|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827625|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
1827626|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827627|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1827628|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1827629|NCT04680819|Propolis|propolis|mesh-list
1827630|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827631|NCT04680650|Anesthetics|anesthetics|mesh-list
1827632|NCT04680650|Propofol|propofol|mesh-list
1827633|NCT04680650|Sevoflurane|sevoflurane|mesh-list
1827634|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827635|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827636|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1827637|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1827638|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
1827639|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1827640|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1827641|NCT04680442|Trastuzumab|trastuzumab|mesh-list
1827642|NCT04680442|Pertuzumab|pertuzumab|mesh-list
1827643|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1827644|NCT04680442|Maytansine|maytansine|mesh-list
1827645|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1827646|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827647|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1827648|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
1827649|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
1827650|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
1827651|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827652|NCT04680221|Bupivacaine|bupivacaine|mesh-list
1827653|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
1827654|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
1827655|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827656|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827657|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
1827658|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827659|NCT04680091|Efavirenz|efavirenz|mesh-list
1827660|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1827661|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1827662|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827663|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827664|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
1827665|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827666|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1827667|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1827668|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1827669|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1827670|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1827671|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1827672|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
1827673|NCT04680143|Hematinics|hematinics|mesh-ancestor
1827685|NCT04680208|Anesthetics|anesthetics|mesh-list
1827686|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827687|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827688|NCT04679948|Midazolam|midazolam|mesh-list
1827689|NCT04679948|Caffeine|caffeine|mesh-list
1827690|NCT04679948|Omeprazole|omeprazole|mesh-list
1827691|NCT04679948|Warfarin|warfarin|mesh-list
1827692|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1827693|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1827695|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827696|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1827697|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1827698|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1827699|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1827700|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
1827701|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
1827702|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
1827703|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
1827704|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1827705|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827706|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
1827707|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1827708|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1827709|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1827710|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827711|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1827712|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1827713|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1827714|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1827715|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
1827716|NCT04680286|Methadone|methadone|mesh-list
1827717|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1827718|NCT04680286|Narcotics|narcotics|mesh-ancestor
1827719|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827720|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827721|NCT04680286|Analgesics|analgesics|mesh-ancestor
1827722|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
1827723|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827724|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
1827725|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
1827726|NCT04679831|Praziquantel|praziquantel|mesh-list
1827727|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
1827728|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1827729|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827730|NCT04679740|Sirolimus|sirolimus|mesh-list
1827731|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1827732|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827733|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1827734|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827735|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
1827736|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1827737|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
1827738|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827739|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
1827740|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1827741|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827742|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
1827749|NCT04679389|Acetazolamide|acetazolamide|mesh-list
1827750|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
1827751|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1827752|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827753|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827754|NCT04679389|Diuretics|diuretics|mesh-ancestor
1827755|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
1827756|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827757|NCT04680195|Thalidomide|thalidomide|mesh-list
1827758|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1827759|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
1827760|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827761|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
1827762|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1827763|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827764|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1827765|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1827766|NCT04680195|Growth Substances|growth substances|mesh-ancestor
1827767|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
1827768|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827769|NCT04679623|Midazolam|midazolam|mesh-list
1827770|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1827771|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1827772|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827773|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827774|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1827775|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1827776|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1827777|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1827778|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
1827779|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
1827780|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
1827781|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
1827782|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1827783|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827784|NCT04679818|Fentanyl|fentanyl|mesh-list
1827785|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
1827786|NCT04679818|Narcotics|narcotics|mesh-ancestor
1827787|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827788|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827789|NCT04679818|Analgesics|analgesics|mesh-ancestor
1827790|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
1827791|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827792|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1827793|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1827794|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
1827795|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
1827796|NCT04679597|Capecitabine|capecitabine|mesh-list
1827797|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
1827798|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1827799|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
1827800|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827801|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827802|NCT04679506|Cytarabine|cytarabine|mesh-list
1827803|NCT04679506|Etoposide|etoposide|mesh-list
1827804|NCT04679506|Cladribine|cladribine|mesh-list
1827805|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1827806|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827807|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1827808|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1827809|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827810|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827811|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1827812|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
1827813|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
1827814|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827815|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1827816|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
1827817|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827818|NCT04679480|Cemiplimab|cemiplimab|mesh-list
1827819|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1827820|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827821|NCT04679376|Atorvastatin|atorvastatin|mesh-list
1827822|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1827823|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1827824|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
1827825|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827826|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1827827|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1827828|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827829|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1827830|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
1827831|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827832|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1827833|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1827834|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827835|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827836|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827837|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1827838|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1827839|NCT04679142|Baclofen|baclofen|mesh-list
1827840|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1827841|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827842|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1827843|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827844|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
1827845|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
1827846|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
1827847|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1827848|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827849|NCT04679064|Gemcitabine|gemcitabine|mesh-list
1827850|NCT04679064|Paclitaxel|paclitaxel|mesh-list
1827851|NCT04679064|Bevacizumab|bevacizumab|mesh-list
1827852|NCT04679064|Doxorubicin|doxorubicin|mesh-list
1827853|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1827854|NCT04679064|Topotecan|topotecan|mesh-list
1827855|NCT04679064|Niraparib|niraparib|mesh-list
1827856|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1827857|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827858|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
1827859|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
1827860|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
1827861|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827862|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1827863|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1827864|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1827865|NCT04679064|Growth Substances|growth substances|mesh-ancestor
1827866|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827867|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
1827868|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1827869|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
1827870|NCT04679064|Antiviral Agents|antiviral agents|mesh-ancestor
1827871|NCT04679064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827872|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827873|NCT04679064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1827874|NCT04679064|Immunologic Factors|immunologic factors|mesh-ancestor
1827875|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1827876|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1827877|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1827878|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1827879|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1827906|NCT04679103|Eculizumab|eculizumab|mesh-list
1827907|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1827908|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1827909|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
1827910|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827917|NCT04678830|Leronlimab|leronlimab|mesh-list
1827918|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1827919|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1827920|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827921|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1827922|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1827923|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
1827924|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827925|NCT04678791|Cisplatin|cisplatin|mesh-list
1827926|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
1827927|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827928|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1827929|NCT04678739|Remdesivir|remdesivir|mesh-list
1827930|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
1827931|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827932|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
1827933|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827934|NCT04678492|Amoxicillin|amoxicillin|mesh-list
1827935|NCT04678492|Tetracycline|tetracycline|mesh-list
1827936|NCT04678492|Furazolidone|furazolidone|mesh-list
1827937|NCT04678492|Esomeprazole|esomeprazole|mesh-list
1827938|NCT04678492|Bismuth|bismuth|mesh-list
1827939|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1827940|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827941|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1827942|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1827943|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1827944|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827945|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827946|NCT04678492|Antacids|antacids|mesh-ancestor
1827947|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1827948|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1827949|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1827950|NCT04678492|Renal Agents|renal agents|mesh-ancestor
1827951|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
1827952|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1827953|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1827954|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1827955|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
1827956|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1827957|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827958|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
1827959|NCT04678336|Fludarabine|fludarabine|mesh-list
1827960|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1827961|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
1827962|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827963|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1827964|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1827965|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
1827966|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827967|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827968|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1827969|NCT04678154|Vancomycin|vancomycin|mesh-list
1827970|NCT04678154|Tobramycin|tobramycin|mesh-list
1827971|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1827972|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1827973|NCT04678076|Ketoprofen|ketoprofen|mesh-list
1827974|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
1827975|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1827976|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1827977|NCT04678076|Analgesics|analgesics|mesh-ancestor
1827978|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
1827979|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1827980|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827981|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1827982|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1827983|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1827984|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1827985|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1827986|NCT04678089|Bortezomib|bortezomib|mesh-list
1827987|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1827988|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
1827989|NCT04678050|Ketamine|ketamine|mesh-list
1827990|NCT04678050|Propofol|propofol|mesh-list
1827991|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1827992|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1827993|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1827994|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1827995|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
1827996|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
1827997|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1827998|NCT04678050|Analgesics|analgesics|mesh-ancestor
1827999|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
1828000|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828001|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1828002|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1828003|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1828004|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
1828005|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1828006|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828007|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1828008|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1828009|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1828010|NCT04678479|Ganaxolone|ganaxolone|mesh-list
1828011|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
1828012|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1828013|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828014|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828015|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
1828016|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
1828017|NCT04678661|Insulin|insulin|mesh-list
1828018|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1828019|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828041|NCT04677985|Analgesics|analgesics|mesh-list
1828042|NCT04677985|Menthol|menthol|mesh-list
1828043|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
1828044|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828045|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828046|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
1828047|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
1828048|NCT04677972|Ebselen|ebselen|mesh-list
1828049|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1828050|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1828051|NCT04677972|Analgesics|analgesics|mesh-ancestor
1828052|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
1828053|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828054|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828055|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1828056|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1828057|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1828058|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1828059|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
1828060|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828061|NCT04677972|Protective Agents|protective agents|mesh-ancestor
1828062|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1828063|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828064|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1828065|NCT04677868|Methotrexate|methotrexate|mesh-list
1828066|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1828067|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
1828068|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1828069|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828070|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1828071|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
1828072|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828073|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828074|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
1828075|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828076|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1828077|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1828078|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
1828079|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1828080|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1828081|NCT04678362|Avelumab|avelumab|mesh-list
1828082|NCT04678362|Talazoparib|talazoparib|mesh-list
1828083|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1828084|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828085|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1828086|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828087|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828088|NCT04677855|Prednisone|prednisone|mesh-list
1828089|NCT04677855|Dutasteride|dutasteride|mesh-list
1828090|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1828091|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
1828092|NCT04677855|Hormones|hormones|mesh-ancestor
1828093|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1828094|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828095|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1828096|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828097|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1828098|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1828099|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828100|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828101|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
1828107|NCT04677439|HH-GV-678|hh-gv-678|mesh-list
1828108|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1828109|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828110|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828111|NCT04677335|Lovastatin|lovastatin|mesh-list
1828112|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1828113|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1828114|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
1828115|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828116|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1828117|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1828118|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828119|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
1828120|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1828121|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828122|NCT04676958|Vitamin K|vitamin k|mesh-list
1828123|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
1828124|NCT04676958|Vitamins|vitamins|mesh-ancestor
1828125|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
1828126|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828127|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1828128|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1828129|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828130|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
1828131|NCT04676958|Coagulants|coagulants|mesh-ancestor
1828132|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1828133|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1828134|NCT04677114|Buprenorphine|buprenorphine|mesh-list
1828135|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
1828136|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1828137|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
1828138|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1828139|NCT04677114|Narcotics|narcotics|mesh-ancestor
1828140|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1828141|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828142|NCT04677114|Analgesics|analgesics|mesh-ancestor
1828143|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
1828144|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828145|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1828146|NCT04677049|Niacin|niacin|mesh-list
1828147|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
1828148|NCT04677049|Vitamins|vitamins|mesh-ancestor
1828149|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
1828150|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828151|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
1828152|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1828153|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
1828154|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828155|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1828156|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
1828157|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
1828158|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1828159|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1828160|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
1828161|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828162|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1828163|NCT04676997|Paclitaxel|paclitaxel|mesh-list
1828164|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
1828165|NCT04676997|Epirubicin|epirubicin|mesh-list
1828166|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1828167|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828168|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
1828169|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
1828170|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
1828171|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828172|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1828173|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
1828174|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828175|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1828176|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1828177|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
1828178|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1828179|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1828180|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1828181|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1828182|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828183|NCT04676763|Histamine|histamine|mesh-list
1828184|NCT04676763|Substance P|substance p|mesh-list
1828185|NCT04676763|Neurokinin A|neurokinin a|mesh-list
1828186|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
1828187|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
1828188|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1828189|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828190|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828198|NCT04676789|Pegaspargase|pegaspargase|mesh-list
1828199|NCT04676789|Antibodies|antibodies|mesh-list
1828200|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1828201|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
1828202|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828203|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828204|NCT04676555|Ofatumumab|ofatumumab|mesh-list
1828205|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
1828206|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828207|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
1828208|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828209|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
1828210|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1828211|NCT04676399|Diuretics|diuretics|mesh-ancestor
1828212|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
1828213|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828214|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
1828215|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1828216|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828217|NCT04676659|Tenecteplase|tenecteplase|mesh-list
1828218|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1828219|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1828220|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828221|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
1828222|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828223|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828229|NCT04676204|Teriflunomide|teriflunomide|mesh-list
1828230|NCT04676204|Cladribine|cladribine|mesh-list
1828231|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
1828232|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1828233|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828234|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1828235|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
1828236|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828237|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1828238|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828239|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
1828240|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1828241|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1828242|NCT04676204|Analgesics|analgesics|mesh-ancestor
1828243|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
1828244|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828245|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1828246|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1828247|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
1828248|NCT04676776|Mifepristone|mifepristone|mesh-list
1828249|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1828250|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
1828251|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1828252|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828253|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1828254|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1828255|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1828256|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1828257|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
1828258|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1828259|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1828260|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
1828261|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1828262|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
1828263|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1828264|NCT04676139|Fluoxetine|fluoxetine|mesh-list
1828265|NCT04676139|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1828266|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1828267|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1828268|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828269|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1828270|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
1828271|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828272|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1828273|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
1828274|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1828275|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1828276|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1828277|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828278|NCT04676061|Norethindrone|norethindrone|mesh-list
1828279|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
1828280|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1828281|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1828282|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1828283|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
1828284|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1828285|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828286|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1828287|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1828288|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
1828289|NCT04676035|Vitamin K|vitamin k|mesh-list
1828290|NCT04676035|Midazolam|midazolam|mesh-list
1828291|NCT04676035|Omeprazole|omeprazole|mesh-list
1828292|NCT04676035|Warfarin|warfarin|mesh-list
1828293|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1828294|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1828295|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1828296|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828297|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1828298|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1828299|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1828300|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1828301|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
1828302|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
1828303|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
1828304|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
1828305|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1828306|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828307|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
1828308|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1828309|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1828310|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1828311|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828312|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1828313|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1828314|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
1828315|NCT04676035|Coagulants|coagulants|mesh-ancestor
1828316|NCT04676035|Vitamins|vitamins|mesh-ancestor
1828317|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
1828318|NCT04675944|Treprostinil|treprostinil|mesh-list
1828319|NCT04675944|Zamicastat|zamicastat|mesh-list
1828320|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1828321|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828322|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828331|NCT04675697|Etoposide|etoposide|mesh-list
1828332|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1828333|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828334|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1828335|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1828336|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828337|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828338|NCT04676126|Dorzolamide|dorzolamide|mesh-list
1828339|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1828340|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1828341|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828342|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828343|NCT04675619|Pirfenidone|pirfenidone|mesh-list
1828344|NCT04675619|Analgesics|analgesics|mesh-ancestor
1828345|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
1828346|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828347|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828348|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1828349|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1828350|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1828351|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1828352|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828353|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
1828354|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
1828355|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
1828356|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
1828357|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828358|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828359|NCT04675827|Trastuzumab|trastuzumab|mesh-list
1828360|NCT04675827|Pertuzumab|pertuzumab|mesh-list
1828361|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
1828362|NCT04675827|Maytansine|maytansine|mesh-list
1828363|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1828364|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828365|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1828366|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
1828367|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
1828368|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
1828369|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828370|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1828371|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1828372|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828373|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1828374|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
1828375|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828376|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
1828377|NCT04675710|Trametinib|trametinib|mesh-list
1828378|NCT04675710|Dabrafenib|dabrafenib|mesh-list
1828379|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1828380|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828381|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1828382|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828383|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828384|NCT04675528|Paclitaxel|paclitaxel|mesh-list
1828385|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1828386|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828387|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
1828388|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
1828389|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
1828390|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828391|NCT04675983|Fluorouracil|fluorouracil|mesh-list
1828392|NCT04675983|Capecitabine|capecitabine|mesh-list
1828393|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
1828394|NCT04675983|Ramucirumab|ramucirumab|mesh-list
1828395|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828396|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
1828397|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828398|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1828399|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1828400|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
1828401|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828402|NCT04675177|Polidocanol|polidocanol|mesh-list
1828403|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
1828404|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1828405|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
1828406|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1828407|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
1828408|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828409|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
1828410|NCT04675385|Protective Agents|protective agents|mesh-ancestor
1828411|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
1828412|NCT04675086|Remdesivir|remdesivir|mesh-list
1828413|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
1828414|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
1828415|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1828416|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
1828417|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828418|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828419|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1828420|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1828421|NCT04675372|Midazolam|midazolam|mesh-list
1828422|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
1828423|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1828424|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1828425|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828426|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1828427|NCT04675372|Analgesics|analgesics|mesh-ancestor
1828428|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
1828429|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828430|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1828431|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1828432|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1828433|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
1828434|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1828435|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828436|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1828437|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1828438|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1828439|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1828440|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1828441|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
1828442|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
1828443|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
1828444|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
1828450|NCT04674956|Gemcitabine|gemcitabine|mesh-list
1828451|NCT04674956|Paclitaxel|paclitaxel|mesh-list
1828452|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1828453|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828454|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
1828455|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
1828456|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
1828457|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828458|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1828459|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
1828460|NCT04674956|Antiviral Agents|antiviral agents|mesh-ancestor
1828461|NCT04674956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1828462|NCT04674956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828463|NCT04674956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1828464|NCT04674956|Immunologic Factors|immunologic factors|mesh-ancestor
1828465|NCT04674956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828466|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1828467|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
1828468|NCT04674813|Fludarabine|fludarabine|mesh-list
1828469|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1828470|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
1828471|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828472|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1828473|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1828474|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
1828475|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828476|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828477|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1828478|NCT04674774|Lansoprazole|lansoprazole|mesh-list
1828479|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
1828480|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1828481|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1828482|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1828483|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828484|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828485|NCT04674670|Naltrexone|naltrexone|mesh-list
1828486|NCT04674670|Bromocriptine|bromocriptine|mesh-list
1828487|NCT04674670|Amisulpride|amisulpride|mesh-list
1828488|NCT04674670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1828489|NCT04674670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1828490|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828491|NCT04674670|Sensory System Agents|sensory system agents|mesh-ancestor
1828492|NCT04674670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828493|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1828494|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1828495|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1828496|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1828497|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1828498|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
1828499|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1828500|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828501|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1828502|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
1828503|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1828504|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1828505|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
1828506|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1828507|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
1828508|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1828509|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1828510|NCT04674423|Tenofovir|tenofovir|mesh-list
1828511|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
1828512|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1828513|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1828514|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1828515|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828516|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828517|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1828518|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1828519|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1828520|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1828521|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
1828522|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1828523|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828524|NCT04674176|Rifaximin|rifaximin|mesh-list
1828525|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1828526|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1828527|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1828528|NCT04674254|Bevacizumab|bevacizumab|mesh-list
1828529|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1828530|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828531|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1828532|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1828533|NCT04674254|Growth Substances|growth substances|mesh-ancestor
1828534|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828535|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
1828536|NCT04674527|Temozolomide|temozolomide|mesh-list
1828537|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1828538|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
1828539|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828540|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828555|NCT04674514|Dexamethasone|dexamethasone|mesh-list
1828556|NCT04674514|Lenalidomide|lenalidomide|mesh-list
1828557|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1828558|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
1828559|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
1828560|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828561|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828562|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1828563|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
1828564|NCT04674514|Hormones|hormones|mesh-ancestor
1828565|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1828566|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1828567|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828568|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
1828569|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1828570|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1828571|NCT04674514|Growth Substances|growth substances|mesh-ancestor
1828572|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
1828573|NCT04673877|Vancomycin|vancomycin|mesh-list
1828574|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1828575|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1828576|NCT04673955|Cetuximab|cetuximab|mesh-list
1828577|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1828578|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828579|NCT04673799|Denosumab|denosumab|mesh-list
1828580|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1828581|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828582|NCT04673812|Fentanyl|fentanyl|mesh-list
1828583|NCT04673812|Bupivacaine|bupivacaine|mesh-list
1828584|NCT04673812|Naloxone|naloxone|mesh-list
1828585|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
1828586|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
1828587|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1828588|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828589|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
1828590|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828591|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1828592|NCT04673812|Narcotics|narcotics|mesh-ancestor
1828593|NCT04673812|Analgesics|analgesics|mesh-ancestor
1828594|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1828595|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1828596|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
1828597|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1828600|NCT04674137|Histamine|histamine|mesh-list
1828601|NCT04674137|Glutarimide|glutarimide|mesh-list
1828602|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
1828603|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
1828604|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1828605|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828606|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828607|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1828608|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828634|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
1828635|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
1828636|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
1828637|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828638|NCT04673461|Xylometazoline|xylometazoline|mesh-list
1828639|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
1828640|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1828641|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
1828642|NCT04673500|Lidocaine|lidocaine|mesh-list
1828643|NCT04673500|Propofol|propofol|mesh-list
1828644|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
1828645|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
1828646|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1828647|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828648|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
1828649|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828650|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1828651|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1828652|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1828653|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1828654|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828655|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1828656|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1828657|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
1828658|NCT04673578|Celecoxib|celecoxib|mesh-list
1828659|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1828660|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1828661|NCT04673578|Analgesics|analgesics|mesh-ancestor
1828662|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
1828663|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828664|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828665|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1828666|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1828667|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1828668|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1828669|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828670|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828671|NCT04673396|Norcantharidin|norcantharidin|mesh-list
1828672|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828673|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828674|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828684|NCT04673422|Montelukast|montelukast|mesh-list
1828685|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1828686|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
1828687|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1828688|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
1828689|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1828690|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828691|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1828692|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1828693|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828694|NCT04672928|Paclitaxel|paclitaxel|mesh-list
1828695|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1828696|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828697|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
1828698|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
1828699|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
1828700|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828711|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
1828712|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1828713|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1828714|NCT04673162|Prednisolone|prednisolone|mesh-list
1828715|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
1828716|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1828717|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
1828718|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1828719|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
1828720|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
1828721|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828722|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828723|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1828724|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
1828725|NCT04673162|Hormones|hormones|mesh-ancestor
1828726|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1828727|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1828728|NCT04673162|Protective Agents|protective agents|mesh-ancestor
1828729|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1828730|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828731|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
1828732|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1828733|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1828734|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1828735|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1828736|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828737|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
1828738|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1828739|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828740|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1828741|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828742|NCT04673214|Acetaminophen|acetaminophen|mesh-list
1828743|NCT04673214|Azithromycin|azithromycin|mesh-list
1828744|NCT04673214|Ivermectin|ivermectin|mesh-list
1828745|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1828746|NCT04673214|Analgesics|analgesics|mesh-ancestor
1828747|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
1828748|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828749|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828750|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
1828751|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1828752|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1828753|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1828754|NCT04672772|Paclitaxel|paclitaxel|mesh-list
1828755|NCT04672772|Cetuximab|cetuximab|mesh-list
1828756|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1828757|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828758|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
1828759|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
1828760|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
1828761|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828762|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1828763|NCT04672759|Durvalumab|durvalumab|mesh-list
1828764|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1828765|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1828766|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828767|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
1828768|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828769|NCT04672499|Cortisone|cortisone|mesh-list
1828770|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1828771|NCT04672525|Rifampin|rifampin|mesh-list
1828772|NCT04672525|Rifabutin|rifabutin|mesh-list
1828773|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1828774|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
1828775|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1828776|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1828777|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
1828778|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1828779|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828780|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828781|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1828782|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1828783|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1828784|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1828785|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1828786|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1828787|NCT04672707|Bromhexine|bromhexine|mesh-list
1828788|NCT04672707|Expectorants|expectorants|mesh-ancestor
1828789|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
1828790|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
1828791|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1828792|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
1828793|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828802|NCT04672213|Tranexamic Acid|tranexamic acid|mesh-list
1828803|NCT04672213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1828804|NCT04672213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1828805|NCT04672213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828806|NCT04672213|Hemostatics|hemostatics|mesh-ancestor
1828807|NCT04672213|Coagulants|coagulants|mesh-ancestor
1828808|NCT04672291|Poly I-C|poly i-c|mesh-list
1828809|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
1828810|NCT04672291|Poly ICLC|poly iclc|mesh-list
1828811|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
1828812|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
1828813|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828814|NCT04672291|Laxatives|laxatives|mesh-ancestor
1828815|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1828816|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
1828817|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1828818|NCT04672005|Leucovorin|leucovorin|mesh-list
1828819|NCT04672005|Gemcitabine|gemcitabine|mesh-list
1828820|NCT04672005|Paclitaxel|paclitaxel|mesh-list
1828821|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1828822|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
1828823|NCT04672005|Irinotecan|irinotecan|mesh-list
1828824|NCT04672005|Folfirinox|folfirinox|mesh-list
1828825|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1828826|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828827|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
1828828|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
1828829|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
1828830|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828831|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1828832|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
1828833|NCT04672005|Antiviral Agents|antiviral agents|mesh-ancestor
1828834|NCT04672005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1828835|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828836|NCT04672005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1828837|NCT04672005|Immunologic Factors|immunologic factors|mesh-ancestor
1828838|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828839|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1828840|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1828841|NCT04672005|Antidotes|antidotes|mesh-ancestor
1828842|NCT04672005|Protective Agents|protective agents|mesh-ancestor
1828843|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
1828844|NCT04672005|Vitamins|vitamins|mesh-ancestor
1828845|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
1828846|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
1828847|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1828848|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
1828849|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828850|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
1828851|NCT04671914|Protective Agents|protective agents|mesh-ancestor
1828852|NCT04671836|Lorazepam|lorazepam|mesh-list
1828853|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
1828854|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
1828855|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
1828856|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828857|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828858|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1828859|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1828860|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1828861|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1828862|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1828863|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1828864|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
1828865|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
1828866|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1828867|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828873|NCT04671966|Cetrorelix|cetrorelix|mesh-list
1828874|NCT04671966|Estradiol|estradiol|mesh-list
1828875|NCT04671966|Estrogens|estrogens|mesh-ancestor
1828876|NCT04671966|Hormones|hormones|mesh-ancestor
1828877|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1828878|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828879|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1828880|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1828881|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
1828882|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
1828888|NCT04671875|Antibodies|antibodies|mesh-list
1828889|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1828890|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
1828891|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828892|NCT04671355|Fluticasone|fluticasone|mesh-list
1828893|NCT04671355|Xhance|xhance|mesh-list
1828894|NCT04671355|Beclomethasone|beclomethasone|mesh-list
1828895|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
1828896|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
1828897|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1828898|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1828899|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
1828900|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828901|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828902|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1828903|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
1828904|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
1828905|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1828906|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1828907|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1828908|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1828909|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
1828910|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1828911|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828912|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1828913|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1828914|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1828915|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
1828916|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
1828917|NCT04671355|Hormones|hormones|mesh-ancestor
1828918|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1828919|NCT04671589|Meropenem|meropenem|mesh-list
1828920|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1828921|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1828922|NCT04671563|Tenofovir|tenofovir|mesh-list
1828923|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
1828924|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1828925|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1828926|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1828927|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828928|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828929|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1828930|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1828931|NCT04671446|Autoantibodies|autoantibodies|mesh-list
1828932|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
1828933|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828934|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1828935|NCT04671160|Dalteparin|dalteparin|mesh-list
1828936|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
1828937|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1828938|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1828939|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828940|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
1828941|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
1828942|NCT04671420|Rituximab|rituximab|mesh-list
1828943|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1828944|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828945|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
1828946|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828947|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1828948|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
1828949|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1828950|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
1828951|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828952|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
1828953|NCT04671108|Protective Agents|protective agents|mesh-ancestor
1828954|NCT04670978|Bevacizumab|bevacizumab|mesh-list
1828955|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1828956|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828957|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1828958|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1828959|NCT04670978|Growth Substances|growth substances|mesh-ancestor
1828960|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828961|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
1828962|NCT04671056|Pioglitazone|pioglitazone|mesh-list
1828963|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1828964|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828979|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
1828980|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1828981|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
1828982|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1828983|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
1828984|NCT04670601|Analgesics|analgesics|mesh-ancestor
1828985|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
1828986|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1828987|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1828988|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1828989|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1828990|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1828991|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1828992|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1828993|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828994|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1828995|NCT04670913|Apatinib|apatinib|mesh-list
1828996|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1828997|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1828998|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1828999|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829000|NCT04671069|Clopidogrel|clopidogrel|mesh-list
1829001|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1829002|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1829003|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1829004|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1829005|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
1829006|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1829007|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829008|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829009|NCT04670796|Trastuzumab|trastuzumab|mesh-list
1829010|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1829011|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829012|NCT04670809|Clevidipine|clevidipine|mesh-list
1829013|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1829014|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1829015|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829016|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1829017|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829018|NCT04670666|Metformin|metformin|mesh-list
1829019|NCT04670666|Empagliflozin|empagliflozin|mesh-list
1829020|NCT04670666|Linagliptin|linagliptin|mesh-list
1829021|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1829022|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829023|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1829024|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829025|NCT04670666|Incretins|incretins|mesh-ancestor
1829026|NCT04670666|Hormones|hormones|mesh-ancestor
1829027|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1829028|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1829029|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
1829030|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829041|NCT04670471|Remifentanil|remifentanil|mesh-list
1829042|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1829043|NCT04670471|Narcotics|narcotics|mesh-ancestor
1829044|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1829045|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829046|NCT04670471|Analgesics|analgesics|mesh-ancestor
1829047|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
1829048|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829049|NCT04670432|Troxerutin|troxerutin|mesh-list
1829050|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
1829051|NCT04670497|Epinephrine|epinephrine|mesh-list
1829052|NCT04670497|Racepinephrine|racepinephrine|mesh-list
1829053|NCT04670497|Bupivacaine|bupivacaine|mesh-list
1829054|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
1829055|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
1829056|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
1829134|NCT04669990|Remdesivir|remdesivir|mesh-list
1829057|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1829058|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829059|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
1829060|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829061|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1829062|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1829063|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
1829064|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1829065|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829066|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1829067|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1829068|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
1829069|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1829070|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
1829071|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
1829072|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
1829073|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1829074|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1829075|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829076|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829077|NCT04670224|Anesthetics|anesthetics|mesh-list
1829078|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1829079|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829080|NCT04669821|Propofol|propofol|mesh-list
1829081|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1829082|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1829083|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829084|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1829085|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
1829086|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
1829087|NCT04670081|Niacinamide|niacinamide|mesh-list
1829088|NCT04670081|Niacin|niacin|mesh-list
1829089|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
1829090|NCT04670081|Psilocybin|psilocybin|mesh-list
1829091|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
1829092|NCT04670081|Vitamins|vitamins|mesh-ancestor
1829093|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
1829094|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829095|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1829096|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
1829097|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829098|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1829099|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
1829100|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
1829101|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1829113|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
1829114|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829115|NCT04669717|Amoxicillin|amoxicillin|mesh-list
1829116|NCT04669717|Azithromycin|azithromycin|mesh-list
1829117|NCT04669717|Metronidazole|metronidazole|mesh-list
1829118|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1829119|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1829120|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1829121|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1829122|NCT04669782|Teriparatide|teriparatide|mesh-list
1829123|NCT04669782|Vitamin K|vitamin k|mesh-list
1829124|NCT04669782|Vitamins|vitamins|mesh-ancestor
1829125|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
1829126|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829127|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1829128|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1829129|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829130|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
1829131|NCT04669782|Coagulants|coagulants|mesh-ancestor
1829132|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1829133|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1829135|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
1829136|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829137|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
1829138|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1829139|NCT04669392|Ethanol|ethanol|mesh-list
1829140|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1829141|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1829142|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1829143|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829144|NCT04669457|Midazolam|midazolam|mesh-list
1829145|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
1829146|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1829147|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1829148|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829149|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1829150|NCT04669457|Analgesics|analgesics|mesh-ancestor
1829151|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
1829152|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829153|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1829154|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1829155|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1829156|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
1829157|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1829158|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829159|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1829160|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1829161|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1829162|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1829163|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1829164|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
1829165|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
1829166|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
1829167|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
1829168|NCT04669587|Palbociclib|palbociclib|mesh-list
1829169|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829170|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1829171|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829172|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829173|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1829174|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
1829175|NCT04669678|Etonogestrel|etonogestrel|mesh-list
1829176|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1829177|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1829178|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1829179|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
1829180|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1829181|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829182|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1829183|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1829184|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1829185|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1829186|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829201|NCT04669158|Idebenone|idebenone|mesh-list
1829202|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
1829203|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829204|NCT04669158|Protective Agents|protective agents|mesh-ancestor
1829205|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829206|NCT04669171|Rituximab|rituximab|mesh-list
1829207|NCT04669171|Lenalidomide|lenalidomide|mesh-list
1829208|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1829209|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829210|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
1829211|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829212|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1829213|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1829214|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1829215|NCT04669171|Growth Substances|growth substances|mesh-ancestor
1829216|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
1829217|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
1829218|NCT04669210|Tacrolimus|tacrolimus|mesh-list
1829219|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1829220|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
1829221|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829222|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1829223|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829224|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829225|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1829226|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829227|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1829228|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
1829229|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1829230|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1829231|NCT04669145|Ropivacaine|ropivacaine|mesh-list
1829232|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
1829233|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
1829234|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1829235|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829236|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
1829237|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829238|NCT04669132|Olanzapine|olanzapine|mesh-list
1829239|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
1829240|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
1829241|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829242|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829243|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1829244|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1829245|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1829246|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1829247|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1829248|NCT04669132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1829249|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1829250|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1829251|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829252|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1829253|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
1829254|NCT04668976|Gemcitabine|gemcitabine|mesh-list
1829255|NCT04668976|Fluorouracil|fluorouracil|mesh-list
1829256|NCT04668976|Floxuridine|floxuridine|mesh-list
1829257|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
1829258|NCT04668976|Irinotecan|irinotecan|mesh-list
1829259|NCT04668976|Cetuximab|cetuximab|mesh-list
1829260|NCT04668976|Panitumumab|panitumumab|mesh-list
1829261|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1829262|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
1829263|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829264|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829265|NCT04668976|Antiviral Agents|antiviral agents|mesh-ancestor
1829266|NCT04668976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1829267|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829268|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1829269|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
1829270|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829271|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1829272|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1829273|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1829274|NCT04669366|Sunitinib|sunitinib|mesh-list
1829275|NCT04669366|Axitinib|axitinib|mesh-list
1829276|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829277|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1829278|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1829279|NCT04669366|Growth Substances|growth substances|mesh-ancestor
1829280|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829281|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
1829282|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1829283|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829284|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829285|NCT04669197|Gemcitabine|gemcitabine|mesh-list
1829286|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
1829287|NCT04669197|Paclitaxel|paclitaxel|mesh-list
1829288|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1829289|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1829290|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829291|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
1829292|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
1829293|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
1829294|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829295|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1829296|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
1829297|NCT04669197|Antiviral Agents|antiviral agents|mesh-ancestor
1829298|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1829299|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829300|NCT04669197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1829301|NCT04669197|Immunologic Factors|immunologic factors|mesh-ancestor
1829302|NCT04669197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829303|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
1829304|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1829305|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1829306|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1829316|NCT04668859|Midodrine|midodrine|mesh-list
1829317|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
1829318|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
1829319|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829320|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829321|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1829322|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1829323|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1829324|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1829325|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
1829326|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1829327|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829346|NCT04668456|Lidocaine|lidocaine|mesh-list
1829347|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
1829348|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
1829349|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
1829350|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1829351|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829352|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
1829353|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829354|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1829355|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1829356|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1829357|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1829436|NCT04668469|Protective Agents|protective agents|mesh-ancestor
1829358|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829359|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1829360|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1829361|NCT04668456|Analgesics|analgesics|mesh-ancestor
1829362|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1829363|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1829364|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1829365|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
1829366|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1829367|NCT04668417|Vaccines|vaccines|mesh-list
1829368|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
1829369|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829400|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
1829401|NCT04668690|Analgesics|analgesics|mesh-ancestor
1829402|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
1829403|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829404|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829405|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829406|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1829407|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1829408|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829409|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829410|NCT04668469|Acetaminophen|acetaminophen|mesh-list
1829411|NCT04668469|Vitamins|vitamins|mesh-list
1829412|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
1829413|NCT04668469|Zinc|zinc|mesh-list
1829414|NCT04668469|Azithromycin|azithromycin|mesh-list
1829415|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
1829416|NCT04668469|Ivermectin|ivermectin|mesh-list
1829417|NCT04668469|Lactoferrin|lactoferrin|mesh-list
1829418|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
1829419|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
1829420|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829421|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1829422|NCT04668469|Analgesics|analgesics|mesh-ancestor
1829423|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
1829424|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829425|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
1829426|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1829427|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1829428|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
1829429|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1829430|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1829431|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829432|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829433|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1829434|NCT04668469|Trace Elements|trace elements|mesh-ancestor
1829435|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
1829437|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1829438|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1829439|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
1829440|NCT04668469|Coagulants|coagulants|mesh-ancestor
1829441|NCT04668352|Dactolisib|dactolisib|mesh-list
1829442|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829443|NCT04668300|Durvalumab|durvalumab|mesh-list
1829444|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
1829445|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1829446|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
1829447|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1829448|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829449|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
1829450|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829451|NCT04668274|Resveratrol|resveratrol|mesh-list
1829452|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
1829453|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829454|NCT04668274|Protective Agents|protective agents|mesh-ancestor
1829455|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829456|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829457|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1829458|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1829459|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
1829460|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1829461|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1829462|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
1829463|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829464|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
1829465|NCT04668131|Protective Agents|protective agents|mesh-ancestor
1829466|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
1829467|NCT04668144|Cangrelor|cangrelor|mesh-list
1829468|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1829469|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1829470|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1829471|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1829472|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
1829473|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1829474|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829475|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829476|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1829477|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1829478|NCT04667663|Dexamethasone|dexamethasone|mesh-list
1829479|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
1829480|NCT04667663|Daratumumab|daratumumab|mesh-list
1829481|NCT04667663|Pomalidomide|pomalidomide|mesh-list
1829482|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1829483|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
1829484|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829485|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1829486|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1829487|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
1829488|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829489|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829490|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1829491|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1829492|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
1829493|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
1829494|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829495|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1829496|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
1829497|NCT04667663|Hormones|hormones|mesh-ancestor
1829498|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1829499|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1829500|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1829501|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1829502|NCT04667663|Growth Substances|growth substances|mesh-ancestor
1829503|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
1829504|NCT04667910|Ranibizumab|ranibizumab|mesh-list
1829505|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1829506|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1829507|NCT04667910|Growth Substances|growth substances|mesh-ancestor
1829508|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829509|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
1829510|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829511|NCT04667897|Ranibizumab|ranibizumab|mesh-list
1829512|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1829513|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1829514|NCT04667897|Growth Substances|growth substances|mesh-ancestor
1829515|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829516|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
1829517|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829525|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
1829526|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1829527|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
1829528|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829529|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
1829530|NCT04667819|Protective Agents|protective agents|mesh-ancestor
1829531|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
1829532|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1829533|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1829534|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1829535|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829536|NCT04667572|Riboflavin|riboflavin|mesh-list
1829537|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
1829538|NCT04667572|Vitamins|vitamins|mesh-ancestor
1829539|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
1829540|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829541|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1829542|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
1829543|NCT04667351|Fluorouracil|fluorouracil|mesh-list
1829544|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
1829545|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829546|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1829547|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829548|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1829549|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
1829550|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829551|NCT04667507|Dexamethasone|dexamethasone|mesh-list
1829552|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1829553|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
1829554|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
1829555|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829556|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829557|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1829558|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
1829559|NCT04667507|Hormones|hormones|mesh-ancestor
1829560|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1829561|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1829562|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829563|NCT04667299|Amoxicillin|amoxicillin|mesh-list
1829564|NCT04667299|Metronidazole|metronidazole|mesh-list
1829565|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
1829566|NCT04667299|Rabeprazole|rabeprazole|mesh-list
1829567|NCT04667299|Bismuth|bismuth|mesh-list
1829568|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829569|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1829570|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1829571|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1829572|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1829573|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1829574|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1829575|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1829576|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829577|NCT04667299|Antacids|antacids|mesh-ancestor
1829578|NCT04667299|Diuretics|diuretics|mesh-ancestor
1829579|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
1829580|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829581|NCT04667299|Expectorants|expectorants|mesh-ancestor
1829582|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
1829583|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
1829584|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
1829594|NCT04667143|Metformin|metformin|mesh-list
1829595|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1829596|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829597|NCT04666948|Vancomycin|vancomycin|mesh-list
1829598|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1829599|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1829600|NCT04666987|Liraglutide|liraglutide|mesh-list
1829601|NCT04666987|Xultophy|xultophy|mesh-list
1829602|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1829603|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829604|NCT04666987|Incretins|incretins|mesh-ancestor
1829605|NCT04666987|Hormones|hormones|mesh-ancestor
1829606|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1829607|NCT04666805|Tamoxifen|tamoxifen|mesh-list
1829608|NCT04666805|Toremifene|toremifene|mesh-list
1829609|NCT04666805|Letrozole|letrozole|mesh-list
1829610|NCT04666805|Anastrozole|anastrozole|mesh-list
1829611|NCT04666805|Exemestane|exemestane|mesh-list
1829612|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829613|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1829614|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1829615|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829616|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829617|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1829618|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
1829619|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1829620|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829621|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1829622|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
1829623|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
1829624|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1829625|NCT04667117|Ofatumumab|ofatumumab|mesh-list
1829626|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829634|NCT04666675|Upadacitinib|upadacitinib|mesh-list
1829635|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
1829636|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1829637|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829638|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829639|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1829640|NCT04666688|Gemcitabine|gemcitabine|mesh-list
1829641|NCT04666688|Paclitaxel|paclitaxel|mesh-list
1829642|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1829643|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829644|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
1829645|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
1829646|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
1829647|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829648|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1829649|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
1829650|NCT04666688|Antiviral Agents|antiviral agents|mesh-ancestor
1829651|NCT04666688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1829652|NCT04666688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829653|NCT04666688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1829654|NCT04666688|Immunologic Factors|immunologic factors|mesh-ancestor
1829655|NCT04666688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829656|NCT04666701|Ketorolac|ketorolac|mesh-list
1829657|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
1829658|NCT04666701|Scopolamine|scopolamine|mesh-list
1829659|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
1829660|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1829661|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1829662|NCT04666701|Analgesics|analgesics|mesh-ancestor
1829663|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
1829664|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829665|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829666|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1829667|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1829668|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1829669|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829670|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829671|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1829672|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
1829673|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
1829674|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1829675|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
1829676|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1829677|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
1829678|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1829679|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1829680|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
1829690|NCT04666623|Esketamine|esketamine|mesh-list
1829691|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
1829692|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1829693|NCT04666714|Pregabalin|pregabalin|mesh-list
1829694|NCT04666714|Analgesics|analgesics|mesh-ancestor
1829695|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
1829696|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829697|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829698|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
1829699|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1829700|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1829701|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829702|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1829703|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1829704|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1829705|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1829706|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1829737|NCT04666324|Simethicone|simethicone|mesh-list
1829738|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
1829739|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829740|NCT04666324|Emollients|emollients|mesh-ancestor
1829741|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
1829742|NCT04666649|Venetoclax|venetoclax|mesh-list
1829743|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829744|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
1829745|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
1829746|NCT04666051|Coagulants|coagulants|mesh-ancestor
1829747|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
1829748|NCT04666168|Fludarabine|fludarabine|mesh-list
1829749|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1829750|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
1829751|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829752|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1829753|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1829754|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
1829755|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829756|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829757|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1829758|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
1829759|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
1829760|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
1829761|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829762|NCT04665895|Fluticasone|fluticasone|mesh-list
1829763|NCT04665895|Xhance|xhance|mesh-list
1829764|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1829765|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1829766|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
1829767|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829768|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829769|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1829770|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
1829771|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
1829772|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1829773|NCT04665986|Docetaxel|docetaxel|mesh-list
1829774|NCT04665986|Vinorelbine|vinorelbine|mesh-list
1829775|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829776|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
1829777|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
1829778|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
1829779|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829780|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1829781|NCT04666038|Rituximab|rituximab|mesh-list
1829782|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1829783|NCT04666038|Idelalisib|idelalisib|mesh-list
1829784|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1829785|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829786|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
1829787|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829788|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1829789|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1829790|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
1829791|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829792|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829793|NCT04666129|Prednisone|prednisone|mesh-list
1829794|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
1829795|NCT04666129|Docetaxel|docetaxel|mesh-list
1829796|NCT04666129|Relugolix|relugolix|mesh-list
1829797|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829798|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
1829799|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
1829800|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
1829801|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829802|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1829803|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
1829804|NCT04666129|Hormones|hormones|mesh-ancestor
1829805|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1829806|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829807|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1829808|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
1829809|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
1829810|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829811|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1829812|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1829813|NCT04666129|Protective Agents|protective agents|mesh-ancestor
1829814|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
1829815|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
1829816|NCT04665830|Evolocumab|evolocumab|mesh-list
1829817|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1829818|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1829819|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
1829820|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829821|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1829822|NCT04665791|Vaccines|vaccines|mesh-list
1829823|NCT04665791|Immunologic Factors|immunologic factors|mesh-ancestor
1829824|NCT04665791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829825|NCT04665531|Ropivacaine|ropivacaine|mesh-list
1829826|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
1829827|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
1829828|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1829829|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829830|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
1829831|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829832|NCT04665765|Rituximab|rituximab|mesh-list
1829833|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1829834|NCT04665765|Carboplatin|carboplatin|mesh-list
1829835|NCT04665765|Etoposide|etoposide|mesh-list
1829836|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
1829837|NCT04665765|Ifosfamide|ifosfamide|mesh-list
1829838|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
1829839|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
1829840|NCT04665765|Antibodies|antibodies|mesh-list
1829841|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
1829842|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1829843|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
1829844|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
1829845|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829846|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829847|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1829848|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1829849|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1829850|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1829851|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829852|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829853|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1829854|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
1829855|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
1829856|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
1829857|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
1829858|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
1829859|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
1829860|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1829861|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
1829862|NCT04665453|Melatonin|melatonin|mesh-list
1829863|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1829864|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1829865|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829866|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1829867|NCT04665453|Analgesics|analgesics|mesh-ancestor
1829868|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
1829869|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1829870|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1829871|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1829872|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1829873|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
1829874|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1829875|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829876|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
1829877|NCT04665453|Protective Agents|protective agents|mesh-ancestor
1829878|NCT04665362|Apatinib|apatinib|mesh-list
1829879|NCT04665362|Antibodies|antibodies|mesh-list
1829880|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
1829881|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829882|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829883|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1829884|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829885|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829886|NCT04665648|Nicorandil|nicorandil|mesh-list
1829887|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1829888|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1829889|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
1829890|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
1829891|NCT04665648|Vitamins|vitamins|mesh-ancestor
1829892|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
1829893|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829894|NCT04665232|Progesterone|progesterone|mesh-list
1829895|NCT04665232|Progestins|progestins|mesh-ancestor
1829896|NCT04665232|Hormones|hormones|mesh-ancestor
1829897|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1829898|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829899|NCT04665141|Omalizumab|omalizumab|mesh-list
1829900|NCT04665141|Benralizumab|benralizumab|mesh-list
1829901|NCT04665141|Reslizumab|reslizumab|mesh-list
1829902|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1829903|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1829904|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
1829905|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
1829906|NCT04665063|Fludarabine|fludarabine|mesh-list
1829907|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1829908|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
1829909|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829910|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1829911|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1829912|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
1829913|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829914|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829915|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1829916|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
1829917|NCT04665076|Fludarabine|fludarabine|mesh-list
1829918|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1829919|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
1829920|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829921|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1829922|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1829923|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
1829924|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829925|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829926|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1829927|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
1829928|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
1829929|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829930|NCT04665284|Empagliflozin|empagliflozin|mesh-list
1829931|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1829932|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829933|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1829934|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829935|NCT04665089|Erythromycin|erythromycin|mesh-list
1829936|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
1829937|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
1829938|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
1829939|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1829940|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1829941|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1829942|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1829943|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829944|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829945|NCT04665310|Tacrolimus|tacrolimus|mesh-list
1829946|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1829947|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
1829948|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829949|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1829950|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829951|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829952|NCT04664894|Ribavirin|ribavirin|mesh-list
1829953|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
1829954|NCT04664894|Velpatasvir|velpatasvir|mesh-list
1829955|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
1829956|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829957|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
1829958|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1829962|NCT04664803|Cefdinir|cefdinir|mesh-list
1829963|NCT04664803|Cefetamet|cefetamet|mesh-list
1829964|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1829965|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1829966|NCT04664725|Repaglinide|repaglinide|mesh-list
1829967|NCT04664725|Bupropion|bupropion|mesh-list
1829968|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1829969|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
1829970|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1829971|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1829972|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1829973|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1829974|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829975|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
1829976|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1829977|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829978|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1829979|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1829980|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1829981|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1829982|NCT04664829|Capecitabine|capecitabine|mesh-list
1829983|NCT04664829|Bexarotene|bexarotene|mesh-list
1829984|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1829985|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
1829986|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1829987|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1829988|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
1829989|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
1829990|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
1829991|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1829992|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1829996|NCT04664595|Propofol|propofol|mesh-list
1829997|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1829998|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1829999|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830000|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1830001|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
1830002|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
1830003|NCT04664530|Esketamine|esketamine|mesh-list
1830004|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
1830005|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1830006|NCT04664361|Niacinamide|niacinamide|mesh-list
1830007|NCT04664361|Niacin|niacin|mesh-list
1830008|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
1830009|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
1830010|NCT04664361|Vitamins|vitamins|mesh-ancestor
1830011|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
1830012|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830013|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1830014|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
1830015|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830016|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1830017|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
1830018|NCT04664517|Anesthetics|anesthetics|mesh-list
1830019|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830020|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830021|NCT04664010|Vitamins|vitamins|mesh-list
1830022|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
1830023|NCT04664010|Interferons|interferons|mesh-list
1830024|NCT04664010|Ribavirin|ribavirin|mesh-list
1830025|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
1830026|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
1830027|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
1830028|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830029|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830030|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
1830031|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830032|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
1830033|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830034|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
1830035|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
1830036|NCT04664010|Protective Agents|protective agents|mesh-ancestor
1830037|NCT04664127|Valacyclovir|valacyclovir|mesh-list
1830038|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
1830039|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830040|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1830041|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1830042|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1830043|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1830044|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830045|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830046|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830047|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1830048|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
1830049|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1830050|NCT04663763|Capecitabine|capecitabine|mesh-list
1830051|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
1830052|NCT04663763|Antibodies|antibodies|mesh-list
1830053|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
1830054|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830055|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1830056|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
1830057|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830058|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830059|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
1830060|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1830061|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830062|NCT04663750|Aflibercept|aflibercept|mesh-list
1830063|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
1830064|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1830065|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1830066|NCT04663750|Growth Substances|growth substances|mesh-ancestor
1830067|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830068|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
1830069|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830070|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1830071|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1830072|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830073|NCT04664023|Vaccines|vaccines|mesh-list
1830074|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
1830075|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830081|NCT04663555|Dexamethasone|dexamethasone|mesh-list
1830082|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1830083|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
1830084|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
1830085|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830086|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830087|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1830088|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
1830089|NCT04663555|Hormones|hormones|mesh-ancestor
1830090|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830091|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1830092|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830093|NCT04663386|Budesonide|budesonide|mesh-list
1830094|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
1830095|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1830096|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1830097|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
1830098|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830099|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830100|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1830101|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
1830102|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
1830103|NCT04663386|Hormones|hormones|mesh-ancestor
1830104|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830105|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1830106|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1830107|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1830108|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
1830109|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830110|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830111|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
1830112|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
1830113|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1830114|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
1830115|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1830116|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830117|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1830118|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1830119|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1830120|NCT04663295|Insulin|insulin|mesh-list
1830121|NCT04663295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1830122|NCT04663295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830123|NCT04663269|Dexamethasone|dexamethasone|mesh-list
1830124|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1830125|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
1830126|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
1830127|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830128|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830129|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1830130|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
1830131|NCT04663269|Hormones|hormones|mesh-ancestor
1830132|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830133|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1830134|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830135|NCT04662788|Antibodies|antibodies|mesh-list
1830136|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1830137|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
1830138|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830139|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1830140|NCT04662736|Tedizolid|tedizolid|mesh-list
1830141|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830142|NCT04662840|Anesthetics|anesthetics|mesh-list
1830143|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
1830144|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830145|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830146|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
1830147|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830148|NCT04662866|Metformin|metformin|mesh-list
1830149|NCT04662866|Pioglitazone|pioglitazone|mesh-list
1830150|NCT04662866|Empagliflozin|empagliflozin|mesh-list
1830151|NCT04662866|Linagliptin|linagliptin|mesh-list
1830152|NCT04662866|Biguanides|biguanides|mesh-list
1830153|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
1830154|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1830155|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830156|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1830157|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830158|NCT04662866|Incretins|incretins|mesh-ancestor
1830159|NCT04662866|Hormones|hormones|mesh-ancestor
1830160|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830161|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1830162|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830163|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
1830164|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1830165|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
1830166|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1830167|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
1830168|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830169|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830170|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
1830171|NCT04662476|Vitamin D|vitamin d|mesh-list
1830172|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
1830173|NCT04662476|Vitamins|vitamins|mesh-ancestor
1830174|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
1830175|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830176|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1830177|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1830178|NCT04662567|Acetaminophen|acetaminophen|mesh-list
1830179|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1830180|NCT04662567|Analgesics|analgesics|mesh-ancestor
1830181|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
1830182|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830183|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830184|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
1830185|NCT04662658|Xenon|xenon|mesh-list
1830186|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1830187|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
1830188|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
1830189|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830190|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830191|NCT04662515|Warfarin|warfarin|mesh-list
1830192|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
1830193|NCT04662515|Dabigatran|dabigatran|mesh-list
1830194|NCT04662515|Apixaban|apixaban|mesh-list
1830195|NCT04662515|Edoxaban|edoxaban|mesh-list
1830196|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
1830197|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1830198|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
1830199|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1830200|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
1830201|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830202|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830203|NCT04662385|Listerine|listerine|mesh-list
1830204|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
1830205|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
1830206|NCT04662385|Protective Agents|protective agents|mesh-ancestor
1830207|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830208|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1830209|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830222|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
1830223|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1830224|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830225|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830226|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1830227|NCT04662177|Analgesics|analgesics|mesh-ancestor
1830228|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
1830229|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830230|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1830231|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1830232|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1830233|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
1830234|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830235|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830236|NCT04662125|Acetaminophen|acetaminophen|mesh-list
1830237|NCT04662125|Prednisolone|prednisolone|mesh-list
1830238|NCT04662125|Pregabalin|pregabalin|mesh-list
1830239|NCT04662125|Caffeine|caffeine|mesh-list
1830240|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1830241|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
1830242|NCT04662125|Hormones|hormones|mesh-ancestor
1830243|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830244|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830245|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1830246|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830247|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830248|NCT04662125|Analgesics|analgesics|mesh-ancestor
1830249|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
1830250|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
1830251|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1830252|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1830253|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830254|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1830255|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1830256|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1830257|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830258|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1830259|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1830260|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
1830261|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1830262|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1830263|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830264|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1830265|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1830266|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
1830267|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830268|NCT04661930|Fenofibrate|fenofibrate|mesh-list
1830269|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1830270|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
1830271|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830272|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1830273|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
1830274|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830275|NCT04662242|Selenium|selenium|mesh-list
1830276|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
1830277|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830278|NCT04662242|Protective Agents|protective agents|mesh-ancestor
1830279|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830280|NCT04662242|Trace Elements|trace elements|mesh-ancestor
1830281|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
1830282|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
1830283|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830284|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
1830285|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
1830286|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
1830287|NCT04661709|Aspirin|aspirin|mesh-list
1830288|NCT04661709|Metoprolol|metoprolol|mesh-list
1830289|NCT04661709|Isosorbide|isosorbide|mesh-list
1830290|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
1830291|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
1830292|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
1830293|NCT04661709|Trimetazidine|trimetazidine|mesh-list
1830294|NCT04661709|Clopidogrel|clopidogrel|mesh-list
1830295|NCT04661709|Atorvastatin|atorvastatin|mesh-list
1830296|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830297|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1830298|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1830299|NCT04661709|Analgesics|analgesics|mesh-ancestor
1830300|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
1830301|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830302|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1830303|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1830304|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1830305|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1830306|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830307|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1830308|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1830309|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830310|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
1830311|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1830312|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1830313|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
1830314|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1830315|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1830316|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1830317|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1830318|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1830319|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
1830320|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830321|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1830322|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1830323|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
1830324|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
1830325|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1830326|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1830327|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1830328|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
1830329|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
1830330|NCT04661709|Diuretics|diuretics|mesh-ancestor
1830331|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
1830332|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
1830333|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
1830334|NCT04661696|Paclitaxel|paclitaxel|mesh-list
1830335|NCT04661696|Carboplatin|carboplatin|mesh-list
1830336|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1830337|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830338|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
1830339|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
1830340|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
1830341|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830342|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
1830343|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1830344|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830345|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830346|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1830347|NCT04661475|Analgesics|analgesics|mesh-ancestor
1830348|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
1830349|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830350|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1830351|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1830352|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1830353|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
1830354|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830355|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830356|NCT04661514|Psilocybin|psilocybin|mesh-list
1830357|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
1830358|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830359|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1830360|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
1830361|NCT04661852|Topotecan|topotecan|mesh-list
1830362|NCT04661852|Mitogens|mitogens|mesh-list
1830363|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1830364|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
1830365|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830366|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1830367|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1830368|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
1830369|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830370|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830371|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1830372|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1830373|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1830374|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830375|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
1830376|NCT04661137|Dexamethasone|dexamethasone|mesh-list
1830377|NCT04661137|Daratumumab|daratumumab|mesh-list
1830378|NCT04661137|Pomalidomide|pomalidomide|mesh-list
1830379|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1830380|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
1830381|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
1830382|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830383|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830384|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1830385|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
1830386|NCT04661137|Hormones|hormones|mesh-ancestor
1830387|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830388|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1830389|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830390|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
1830391|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1830392|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1830393|NCT04661137|Growth Substances|growth substances|mesh-ancestor
1830394|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
1830395|NCT04661345|Coagulase|coagulase|mesh-list
1830396|NCT04661345|Coagulants|coagulants|mesh-ancestor
1830397|NCT04661397|Tenofovir|tenofovir|mesh-list
1830398|NCT04661397|Emtricitabine|emtricitabine|mesh-list
1830399|NCT04661397|Darunavir|darunavir|mesh-list
1830400|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
1830401|NCT04661397|Cobicistat|cobicistat|mesh-list
1830402|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
1830403|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
1830404|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830405|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1830406|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1830407|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830408|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830409|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1830410|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1830411|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
1830412|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
1830413|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
1830414|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1830415|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1830424|NCT04660773|Pregabalin|pregabalin|mesh-list
1830425|NCT04660773|Analgesics|analgesics|mesh-ancestor
1830426|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
1830427|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830428|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830429|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
1830430|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1830431|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1830432|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830433|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1830434|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1830435|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1830436|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830437|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1830438|NCT04660916|Isotretinoin|isotretinoin|mesh-list
1830439|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
1830440|NCT04660747|Anticoagulants|anticoagulants|mesh-list
1830441|NCT04660786|Vitamin D|vitamin d|mesh-list
1830442|NCT04660786|Triamcinolone|triamcinolone|mesh-list
1830443|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1830444|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1830445|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1830446|NCT04660786|Vitamins|vitamins|mesh-ancestor
1830447|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
1830448|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830449|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1830450|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1830451|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
1830452|NCT04660786|Hormones|hormones|mesh-ancestor
1830453|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830454|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1830455|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
1830456|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830457|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830474|NCT04660643|Tirzepatide|tirzepatide|mesh-list
1830475|NCT04660643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1830476|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830477|NCT04660643|Incretins|incretins|mesh-ancestor
1830478|NCT04660643|Hormones|hormones|mesh-ancestor
1830479|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830480|NCT04660240|Sirolimus|sirolimus|mesh-list
1830481|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1830482|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830483|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1830484|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830485|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
1830486|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1830487|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
1830488|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830489|NCT04660461|Lansoprazole|lansoprazole|mesh-list
1830490|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
1830491|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1830492|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1830493|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1830494|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830495|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830496|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
1830497|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1830498|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830499|NCT04660565|Prednisone|prednisone|mesh-list
1830500|NCT04660565|Belimumab|belimumab|mesh-list
1830501|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1830502|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
1830503|NCT04660565|Hormones|hormones|mesh-ancestor
1830504|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830505|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830506|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1830507|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830508|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1830509|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
1830510|NCT04660097|Etoposide|etoposide|mesh-list
1830511|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
1830512|NCT04660097|Durvalumab|durvalumab|mesh-list
1830513|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1830514|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1830515|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830516|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1830517|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1830518|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830519|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830520|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1830521|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
1830522|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830523|NCT04660110|Piperaquine|piperaquine|mesh-list
1830524|NCT04660110|Artenimol|artenimol|mesh-list
1830525|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
1830526|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1830527|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1830528|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830529|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1830530|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1830531|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830532|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
1830533|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1830534|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
1830535|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830536|NCT04659915|Metformin|metformin|mesh-list
1830537|NCT04659915|Prednisone|prednisone|mesh-list
1830538|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1830539|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830540|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1830541|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
1830542|NCT04659915|Hormones|hormones|mesh-ancestor
1830543|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830544|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1830545|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830546|NCT04660123|Bismuth|bismuth|mesh-list
1830547|NCT04660123|Antacids|antacids|mesh-ancestor
1830548|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830549|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1830550|NCT04659785|Apatinib|apatinib|mesh-list
1830551|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830552|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1830553|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830554|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830555|NCT04659369|Nivolumab|nivolumab|mesh-list
1830556|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1830557|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830558|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1830559|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830560|NCT04659525|Ezetimibe|ezetimibe|mesh-list
1830561|NCT04659525|Evolocumab|evolocumab|mesh-list
1830562|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1830563|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1830564|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
1830565|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830566|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1830567|NCT04659382|Bevacizumab|bevacizumab|mesh-list
1830568|NCT04659382|Atezolizumab|atezolizumab|mesh-list
1830569|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1830570|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830571|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1830572|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1830573|NCT04659382|Growth Substances|growth substances|mesh-ancestor
1830574|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830575|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
1830584|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
1830585|NCT04659551|Nivolumab|nivolumab|mesh-list
1830586|NCT04659551|Epirubicin|epirubicin|mesh-list
1830587|NCT04659551|Exemestane|exemestane|mesh-list
1830588|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1830589|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1830590|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
1830591|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830592|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1830593|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1830594|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
1830595|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830596|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830597|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1830598|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1830599|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1830600|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1830601|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1830602|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1830603|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830604|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1830605|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1830606|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1830607|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
1830608|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830609|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
1830610|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1830611|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
1830612|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1830613|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1830614|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1830615|NCT04659616|Cytarabine|cytarabine|mesh-list
1830616|NCT04659616|Daunorubicin|daunorubicin|mesh-list
1830617|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1830618|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
1830619|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830620|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830621|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
1830622|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830623|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1830624|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
1830625|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830626|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1830627|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1830628|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1830629|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830630|NCT04659499|Paclitaxel|paclitaxel|mesh-list
1830631|NCT04659499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1830632|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1830633|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830634|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
1830635|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
1830636|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
1830637|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830638|NCT04659642|Fentanyl|fentanyl|mesh-list
1830639|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
1830640|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1830641|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830642|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830643|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1830644|NCT04659642|Analgesics|analgesics|mesh-ancestor
1830645|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
1830646|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830647|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1830648|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1830649|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1830650|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
1830727|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
1830651|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830652|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830653|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1830654|NCT04659642|Narcotics|narcotics|mesh-ancestor
1830655|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1830656|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1830657|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
1830658|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
1830659|NCT04659278|Peppermint oil|peppermint oil|mesh-list
1830660|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
1830661|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
1830662|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830663|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830664|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1830665|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
1830680|NCT04659109|Glenzocimab|glenzocimab|mesh-list
1830681|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
1830682|NCT04659070|Telmisartan|telmisartan|mesh-list
1830683|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1830684|NCT04659070|Ezetimibe|ezetimibe|mesh-list
1830685|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1830686|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1830687|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
1830688|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830689|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1830690|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1830691|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830692|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1830693|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1830694|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1830695|NCT04658927|Dexamethasone|dexamethasone|mesh-list
1830696|NCT04658927|Prednisone|prednisone|mesh-list
1830697|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1830698|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
1830699|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
1830700|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830701|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830702|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1830703|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
1830704|NCT04658927|Hormones|hormones|mesh-ancestor
1830705|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830706|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1830707|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830708|NCT04659057|Lidocaine|lidocaine|mesh-list
1830709|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
1830710|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
1830711|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
1830712|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830713|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830714|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
1830715|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830716|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1830717|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1830718|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1830719|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1830720|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830721|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1830722|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1830723|NCT04659057|Analgesics|analgesics|mesh-ancestor
1830724|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1830725|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1830726|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1830728|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830729|NCT04658823|Vitamin E|vitamin e|mesh-list
1830730|NCT04658823|Tocopherols|tocopherols|mesh-list
1830731|NCT04658823|Tocotrienols|tocotrienols|mesh-list
1830732|NCT04658823|Tocovid|tocovid|mesh-list
1830733|NCT04658823|Vitamins|vitamins|mesh-ancestor
1830734|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
1830735|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830736|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
1830737|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830738|NCT04658823|Protective Agents|protective agents|mesh-ancestor
1830739|NCT04658836|Triamcinolone|triamcinolone|mesh-list
1830740|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1830741|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1830742|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1830743|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1830744|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
1830745|NCT04658836|Hormones|hormones|mesh-ancestor
1830746|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830747|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830748|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1830749|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
1830750|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830751|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830768|NCT04658784|Cyclopropane|cyclopropane|mesh-list
1830769|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
1830770|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830771|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830772|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
1830773|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1830774|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830775|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830776|NCT04658680|Vaccines|vaccines|mesh-list
1830777|NCT04658680|Immunologic Factors|immunologic factors|mesh-ancestor
1830778|NCT04658680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830779|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
1830780|NCT04658732|Gabapentin|gabapentin|mesh-list
1830781|NCT04658732|Alprazolam|alprazolam|mesh-list
1830782|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1830783|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830784|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830785|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1830786|NCT04658732|Analgesics|analgesics|mesh-ancestor
1830787|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
1830788|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830789|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1830790|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1830791|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1830792|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
1830793|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830794|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830795|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
1830796|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1830797|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1830798|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1830799|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1830800|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1830801|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
1830802|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
1830803|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
1830804|NCT04658420|Ketamine|ketamine|mesh-list
1830805|NCT04658420|Analgesics|analgesics|mesh-ancestor
1830806|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
1830807|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830808|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830809|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1830810|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1830811|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
1830812|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
1830813|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830814|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1830815|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1830816|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830817|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830818|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
1830819|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
1830820|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830821|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
1830822|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1830823|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
1830824|NCT04658355|Povidone|povidone|mesh-list
1830825|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1830826|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830827|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
1830828|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
1830829|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
1830830|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
1830831|NCT04658160|Imidacloprid|imidacloprid|mesh-list
1830832|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
1830833|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830834|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830835|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830849|NCT04658134|Glycine|glycine|mesh-list
1830850|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
1830851|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830852|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830853|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830854|NCT04657939|Pioglitazone|pioglitazone|mesh-list
1830855|NCT04657939|Liraglutide|liraglutide|mesh-list
1830856|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1830857|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830858|NCT04657939|Incretins|incretins|mesh-ancestor
1830859|NCT04657939|Hormones|hormones|mesh-ancestor
1830860|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830861|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
1830862|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1830863|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830864|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
1830873|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
1830874|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1830875|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830876|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1830877|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
1830878|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830879|NCT04657666|Nabiximols|nabiximols|mesh-list
1830880|NCT04657666|Analgesics|analgesics|mesh-ancestor
1830881|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
1830882|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830883|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830884|NCT04657497|Camostat|camostat|mesh-list
1830885|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
1830886|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830887|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830888|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1830889|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1830890|NCT04657692|Anesthetics|anesthetics|mesh-list
1830891|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830892|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830893|NCT04657484|Prednisolone|prednisolone|mesh-list
1830894|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1830895|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
1830896|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1830897|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
1830898|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1830899|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
1830900|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1830901|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
1830902|NCT04657484|Hormones|hormones|mesh-ancestor
1830903|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830904|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830905|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1830906|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830907|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
1830908|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
1830909|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830910|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1830911|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1830912|NCT04657484|Protective Agents|protective agents|mesh-ancestor
1830913|NCT04657562|Tacrolimus|tacrolimus|mesh-list
1830914|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1830915|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
1830916|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830917|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1830918|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830919|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830920|NCT04657068|Gemcitabine|gemcitabine|mesh-list
1830921|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1830922|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
1830923|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830924|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830925|NCT04657068|Antiviral Agents|antiviral agents|mesh-ancestor
1830926|NCT04657068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1830927|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1830928|NCT04657068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1830929|NCT04657068|Immunologic Factors|immunologic factors|mesh-ancestor
1830930|NCT04657068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830931|NCT04656951|Daratumumab|daratumumab|mesh-list
1830932|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830933|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
1830934|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1830935|NCT04657107|Ketamine|ketamine|mesh-list
1830936|NCT04657107|Esketamine|esketamine|mesh-list
1830937|NCT04657107|Analgesics|analgesics|mesh-ancestor
1830938|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
1830939|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830940|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830941|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1830942|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1830943|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
1830944|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
1830945|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830946|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1830947|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1830948|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830949|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830950|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
1830951|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1830952|NCT04657016|Tirzepatide|tirzepatide|mesh-list
1830953|NCT04657016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1830954|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830955|NCT04657016|Incretins|incretins|mesh-ancestor
1830956|NCT04657016|Hormones|hormones|mesh-ancestor
1830957|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1830958|NCT04657172|Pilocarpine|pilocarpine|mesh-list
1830959|NCT04657172|Miotics|miotics|mesh-ancestor
1830960|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
1830961|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830962|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830963|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
1830964|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1830965|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
1830966|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830967|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830975|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
1830976|NCT04656470|Ketamine|ketamine|mesh-list
1830977|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1830978|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1830979|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1830980|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1830981|NCT04656470|Analgesics|analgesics|mesh-ancestor
1830982|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
1830983|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1830984|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1830985|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1830986|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1830987|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
1830988|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1830989|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1830990|NCT04656470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1830991|NCT04656470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1830992|NCT04656470|Anesthetics, General|anesthetics, general|mesh-ancestor
1830993|NCT04656470|Anesthetics|anesthetics|mesh-ancestor
1830994|NCT04656470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1830995|NCT04656470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1830996|NCT04656665|Aspirin|aspirin|mesh-list
1830997|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1830998|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1830999|NCT04656665|Analgesics|analgesics|mesh-ancestor
1831000|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
1831001|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831002|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831003|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831004|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831005|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1831006|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1831007|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831008|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1831009|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1831010|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831011|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
1831012|NCT04656301|Psilocybin|psilocybin|mesh-list
1831013|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
1831014|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831015|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1831016|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
1831017|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1831018|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1831019|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1831020|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
1831021|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
1831022|NCT04656041|Paclitaxel|paclitaxel|mesh-list
1831023|NCT04656041|Carboplatin|carboplatin|mesh-list
1831024|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1831025|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831026|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
1831027|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
1831028|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
1831029|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831030|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1831031|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1831032|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831033|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
1831034|NCT04656262|Doxorubicin|doxorubicin|mesh-list
1831035|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1831036|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
1831037|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831038|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831039|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1831040|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
1831041|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831042|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831043|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1831044|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1831045|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1831046|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1831047|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831048|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
1831049|NCT04656067|Ethamsylate|ethamsylate|mesh-list
1831050|NCT04656067|Oxytocin|oxytocin|mesh-list
1831051|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
1831052|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1831053|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831054|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1831055|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1831056|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831057|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
1831058|NCT04656067|Coagulants|coagulants|mesh-ancestor
1831059|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1831060|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
1831061|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1831062|NCT04656184|Antibodies|antibodies|mesh-list
1831063|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
1831064|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1831065|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
1831066|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831067|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831068|NCT04656249|Lenvatinib|lenvatinib|mesh-list
1831069|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831070|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1831071|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831072|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831073|NCT04655482|Aflibercept|aflibercept|mesh-list
1831074|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1831075|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1831076|NCT04655482|Growth Substances|growth substances|mesh-ancestor
1831077|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831078|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
1831079|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831080|NCT04655807|Adalimumab|adalimumab|mesh-list
1831081|NCT04655807|Ustekinumab|ustekinumab|mesh-list
1831082|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831083|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831084|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
1831085|NCT04655664|Vitamin D|vitamin d|mesh-list
1831086|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
1831087|NCT04655664|Vitamins|vitamins|mesh-list
1831088|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
1831089|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831090|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1831091|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1831092|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
1831093|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
1831094|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1831095|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
1831096|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1831097|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
1831098|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831099|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831100|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1831101|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
1831102|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
1831103|NCT04655508|Hormones|hormones|mesh-ancestor
1831104|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831105|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
1831106|NCT04655729|Infliximab|infliximab|mesh-list
1831107|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
1831108|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1831109|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831110|NCT04655391|Decitabine|decitabine|mesh-list
1831111|NCT04655391|Venetoclax|venetoclax|mesh-list
1831112|NCT04655391|Ivosidenib|ivosidenib|mesh-list
1831113|NCT04655391|Maleic acid|maleic acid|mesh-list
1831114|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1831115|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
1831116|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831117|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831118|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831119|NCT04655157|Nivolumab|nivolumab|mesh-list
1831120|NCT04655157|Ipilimumab|ipilimumab|mesh-list
1831121|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1831122|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831123|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1831124|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831125|NCT04655144|Dexamethasone|dexamethasone|mesh-list
1831126|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831127|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
1831128|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
1831129|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831130|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831131|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1831132|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
1831133|NCT04655144|Hormones|hormones|mesh-ancestor
1831134|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831135|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1831136|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831137|NCT04655170|Albuterol|albuterol|mesh-list
1831138|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
1831139|NCT04655170|Ipratropium|ipratropium|mesh-list
1831140|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
1831141|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1831142|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
1831143|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831144|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831145|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1831146|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
1831147|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1831148|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1831149|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1831150|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
1831151|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1831152|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831153|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
1831154|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1831155|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
1831156|NCT04655183|Niraparib|niraparib|mesh-list
1831157|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1831158|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831159|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831160|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831161|NCT04655040|Caffeine|caffeine|mesh-list
1831162|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1831163|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831164|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1831165|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831166|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831167|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1831168|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1831169|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
1831170|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1831171|NCT04654988|Prednisone|prednisone|mesh-list
1831172|NCT04654988|Azathioprine|azathioprine|mesh-list
1831173|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831174|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
1831175|NCT04654988|Hormones|hormones|mesh-ancestor
1831176|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831177|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831178|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1831179|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831180|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
1831181|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831182|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1831183|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1831184|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
1831185|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831186|NCT04654962|Anesthetics|anesthetics|mesh-list
1831187|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1831188|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831189|NCT04654507|Dexamethasone|dexamethasone|mesh-list
1831190|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831191|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
1831192|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
1831193|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831194|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831195|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1831196|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
1831197|NCT04654507|Hormones|hormones|mesh-ancestor
1831198|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831199|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1831200|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831201|NCT04654416|Colchicine|colchicine|mesh-list
1831202|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
1831203|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831204|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
1831205|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
1831206|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
1831207|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831208|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831209|NCT04654676|Vildagliptin|vildagliptin|mesh-list
1831210|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1831211|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831212|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
1831213|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
1831214|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831215|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831216|NCT04654819|Anesthetics|anesthetics|mesh-list
1831217|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1831218|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831219|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
1831220|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
1831221|NCT04654741|Ganirelix|ganirelix|mesh-list
1831222|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1831223|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1831224|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1831225|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
1831226|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1831227|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831228|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1831229|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1831230|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
1831231|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1831232|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831233|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
1831234|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831235|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
1831236|NCT04654195|Doxorubicin|doxorubicin|mesh-list
1831237|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1831238|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
1831239|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831240|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831241|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1831242|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
1831243|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831244|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831245|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1831246|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1831247|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1831248|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1831249|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831250|NCT04654351|Icatibant|icatibant|mesh-list
1831251|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1831252|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1831253|NCT04654351|Analgesics|analgesics|mesh-ancestor
1831254|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
1831255|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831256|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831332|NCT04653623|Coagulants|coagulants|mesh-ancestor
1831257|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831258|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831259|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
1831260|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
1831261|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831262|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1831263|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1831264|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
1831265|NCT04654208|Palbociclib|palbociclib|mesh-list
1831266|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831267|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1831268|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831269|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831270|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
1831271|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1831272|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1831273|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1831274|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
1831275|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
1831276|NCT04654026|Aspirin|aspirin|mesh-list
1831277|NCT04654026|Clopidogrel|clopidogrel|mesh-list
1831278|NCT04654026|Ticagrelor|ticagrelor|mesh-list
1831279|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1831280|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1831281|NCT04654026|Analgesics|analgesics|mesh-ancestor
1831282|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
1831283|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831284|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831285|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831286|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831287|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1831288|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1831289|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831290|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1831291|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1831292|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831293|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
1831294|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1831295|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1831296|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1831297|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
1831298|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1831299|NCT04653831|Pirfenidone|pirfenidone|mesh-list
1831300|NCT04653831|Analgesics|analgesics|mesh-ancestor
1831301|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
1831302|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831303|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831304|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1831305|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1831306|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831307|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831308|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831309|NCT04653506|Acetaminophen|acetaminophen|mesh-list
1831310|NCT04653506|Ibuprofen|ibuprofen|mesh-list
1831311|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1831312|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1831313|NCT04653506|Analgesics|analgesics|mesh-ancestor
1831314|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
1831315|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831316|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831317|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831318|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831319|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1831320|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831321|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831322|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
1831327|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
1831328|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1831329|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1831330|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831331|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
1831333|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
1831334|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1831335|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1831336|NCT04653792|Pregabalin|pregabalin|mesh-list
1831337|NCT04653792|Analgesics|analgesics|mesh-ancestor
1831338|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
1831339|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831340|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831341|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
1831342|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1831343|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1831344|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831345|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1831346|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1831347|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1831348|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1831349|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1831350|NCT04653779|Metformin|metformin|mesh-list
1831351|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1831352|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831353|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
1831354|NCT04653493|Fludarabine|fludarabine|mesh-list
1831355|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1831356|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
1831357|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831358|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831359|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1831360|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
1831361|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831362|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831363|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1831364|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
1831365|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1831366|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1831367|NCT04653415|Prednisolone|prednisolone|mesh-list
1831368|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
1831369|NCT04653415|Gabapentin|gabapentin|mesh-list
1831370|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1831371|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
1831372|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831373|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
1831374|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
1831375|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831376|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831377|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1831378|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
1831379|NCT04653415|Hormones|hormones|mesh-ancestor
1831380|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831381|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1831382|NCT04653415|Protective Agents|protective agents|mesh-ancestor
1831383|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1831384|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831385|NCT04653415|Analgesics|analgesics|mesh-ancestor
1831386|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
1831387|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
1831388|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1831389|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1831390|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1831391|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1831392|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1831393|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1831394|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1831395|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831396|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
1831398|NCT04653246|Dexamethasone|dexamethasone|mesh-list
1831399|NCT04653246|Lenalidomide|lenalidomide|mesh-list
1831400|NCT04653246|Bortezomib|bortezomib|mesh-list
1831401|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831402|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
1831403|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
1831404|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831405|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831406|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1831407|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
1831408|NCT04653246|Hormones|hormones|mesh-ancestor
1831409|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831410|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1831411|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831412|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
1831413|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1831414|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1831415|NCT04653246|Growth Substances|growth substances|mesh-ancestor
1831416|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
1831417|NCT04653337|Norepinephrine|norepinephrine|mesh-list
1831418|NCT04653337|Serotonin|serotonin|mesh-list
1831419|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
1831420|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1831421|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1831422|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
1831423|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1831424|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831425|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831426|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
1831427|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
1831428|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831429|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1831430|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1831431|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
1831432|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1831433|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1831434|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
1831435|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
1831436|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1831437|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1831438|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1831439|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831440|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831441|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831442|NCT04652739|Prednisolone|prednisolone|mesh-list
1831443|NCT04652739|Lycopene|lycopene|mesh-list
1831444|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831445|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
1831446|NCT04652739|Hormones|hormones|mesh-ancestor
1831447|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831448|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831449|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1831450|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831451|NCT04652739|Protective Agents|protective agents|mesh-ancestor
1831452|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
1831453|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831454|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1831455|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1831456|NCT04652661|Midazolam|midazolam|mesh-list
1831457|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
1831458|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1831459|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1831460|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831461|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1831462|NCT04652661|Analgesics|analgesics|mesh-ancestor
1831463|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
1831464|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831465|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1831466|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1831467|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1831468|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
1831469|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1831470|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831471|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1831472|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1831473|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1831474|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1831475|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1831476|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
1831477|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
1831478|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
1831479|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
1831480|NCT04652414|Prednisone|prednisone|mesh-list
1831481|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831482|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
1831483|NCT04652414|Hormones|hormones|mesh-ancestor
1831484|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831485|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831486|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1831487|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831488|NCT04652765|Bicalutamide|bicalutamide|mesh-list
1831489|NCT04652765|Camostat|camostat|mesh-list
1831490|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
1831491|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
1831492|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831493|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831494|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831495|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
1831496|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831497|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831498|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1831499|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1831500|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
1831501|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1831502|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1831503|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831504|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1831505|NCT04652427|Analgesics|analgesics|mesh-ancestor
1831506|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
1831507|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831508|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1831509|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1831510|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1831511|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
1831512|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1831513|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831514|NCT04652440|Antibodies|antibodies|mesh-list
1831515|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1831516|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
1831517|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831535|NCT04652284|Amoxicillin|amoxicillin|mesh-list
1831536|NCT04652284|Clarithromycin|clarithromycin|mesh-list
1831537|NCT04652284|Rifabutin|rifabutin|mesh-list
1831538|NCT04652284|Tinidazole|tinidazole|mesh-list
1831539|NCT04652284|Esomeprazole|esomeprazole|mesh-list
1831540|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1831541|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1831542|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1831543|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1831544|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1831545|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831546|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831547|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1831548|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1831549|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1831550|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1831551|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
1831552|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
1831553|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
1831554|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1831555|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1831556|NCT04652323|Calcium|calcium|mesh-list
1831557|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1831558|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831559|NCT04651959|Favipiravir|favipiravir|mesh-list
1831560|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
1831561|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1831562|NCT04652011|Analgesics|analgesics|mesh-list
1831563|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
1831564|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831565|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831566|NCT04652193|Anesthetics|anesthetics|mesh-list
1831567|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1831568|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831569|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
1831570|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1831571|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831572|NCT04652115|Defibrotide|defibrotide|mesh-list
1831573|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1831574|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1831575|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831576|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1831577|NCT04652076|Paclitaxel|paclitaxel|mesh-list
1831578|NCT04652076|Carboplatin|carboplatin|mesh-list
1831579|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
1831580|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1831581|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831582|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
1831583|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
1831584|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
1831585|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831586|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1831587|NCT04652245|Fluticasone|fluticasone|mesh-list
1831588|NCT04652245|Xhance|xhance|mesh-list
1831589|NCT04652245|Azelastine|azelastine|mesh-list
1831590|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831591|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1831592|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
1831593|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831594|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831595|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1831596|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
1831597|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
1831598|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1831599|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1831600|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831601|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831602|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1831603|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1831604|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
1831605|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
1831606|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1831607|NCT04651842|Insulin|insulin|mesh-list
1831608|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1831609|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831610|NCT04652089|Simvastatin|simvastatin|mesh-list
1831611|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1831612|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1831613|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
1831614|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831615|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1831616|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1831617|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831618|NCT04651595|Morphine|morphine|mesh-list
1831619|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1831620|NCT04651595|Narcotics|narcotics|mesh-ancestor
1831621|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1831622|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831623|NCT04651595|Analgesics|analgesics|mesh-ancestor
1831624|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
1831625|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831626|NCT04651556|Acetaminophen|acetaminophen|mesh-list
1831627|NCT04651556|Ketorolac|ketorolac|mesh-list
1831628|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
1831629|NCT04651556|Bupivacaine|bupivacaine|mesh-list
1831630|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
1831631|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
1831632|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1831633|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831634|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
1831635|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831636|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1831637|NCT04651556|Analgesics|analgesics|mesh-ancestor
1831638|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
1831639|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1831640|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831641|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831642|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1831643|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831644|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831645|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1831646|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
1831647|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1831648|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1831649|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1831650|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
1831651|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1831652|NCT04651439|Lenograstim|lenograstim|mesh-list
1831653|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1831654|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
1831655|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831656|NCT04651348|Antibodies|antibodies|mesh-list
1831657|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1831658|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
1831659|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831667|NCT04650984|Doxorubicin|doxorubicin|mesh-list
1831668|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1831669|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831670|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1831671|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1831672|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831673|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831674|NCT04651049|Propranolol|propranolol|mesh-list
1831675|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1831676|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1831677|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
1831678|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1831679|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831680|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831681|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1831682|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1831683|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
1831684|NCT04651205|Thiamine|thiamine|mesh-list
1831685|NCT04651205|Vitamins|vitamins|mesh-ancestor
1831686|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
1831687|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831688|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
1831689|NCT04650893|Dexamethasone|dexamethasone|mesh-list
1831690|NCT04650893|Ketorolac|ketorolac|mesh-list
1831691|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831692|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
1831693|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
1831694|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831695|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831696|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1831697|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
1831698|NCT04650893|Hormones|hormones|mesh-ancestor
1831699|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831700|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1831701|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831702|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1831703|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1831704|NCT04650893|Analgesics|analgesics|mesh-ancestor
1831705|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
1831706|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1831707|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1831708|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831709|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831710|NCT04650841|Naloxone|naloxone|mesh-list
1831711|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1831712|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831713|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
1831714|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831715|NCT04650880|Vitamin D|vitamin d|mesh-list
1831716|NCT04650880|Vitamins|vitamins|mesh-ancestor
1831717|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
1831718|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831719|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1831720|NCT04650828|Tenofovir|tenofovir|mesh-list
1831721|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
1831722|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1831723|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1831724|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1831725|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831726|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831727|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1831728|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1831729|NCT04650555|Genistein|genistein|mesh-list
1831730|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
1831731|NCT04650555|Protective Agents|protective agents|mesh-ancestor
1831732|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831733|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831734|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1831735|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831736|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831737|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
1831738|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
1831739|NCT04650555|Estrogens|estrogens|mesh-ancestor
1831740|NCT04650555|Hormones|hormones|mesh-ancestor
1831741|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831742|NCT04650542|Paroxetine|paroxetine|mesh-list
1831743|NCT04650542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1831744|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1831745|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1831746|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831747|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1831748|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
1831749|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831750|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1831751|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
1831752|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1831753|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1831754|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1831755|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831800|NCT04650269|Emtricitabine|emtricitabine|mesh-list
1831801|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
1831802|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1831803|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1831804|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1831805|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831806|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831807|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1831808|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1831809|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1831810|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1831811|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1831812|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
1831813|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
1831814|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831815|NCT04650074|Lidocaine|lidocaine|mesh-list
1831816|NCT04650074|Ketamine|ketamine|mesh-list
1831817|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
1831818|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
1831819|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1831820|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831821|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
1831822|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831823|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1831824|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1831825|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1831826|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1831827|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831828|NCT04650074|Analgesics|analgesics|mesh-ancestor
1831829|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1831830|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1831831|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
1831832|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1831833|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1831834|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1831847|NCT04649892|Naltrexone|naltrexone|mesh-list
1831848|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1831849|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1831850|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831851|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
1831852|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831858|NCT04649723|Rifampin|rifampin|mesh-list
1831859|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1831860|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
1831861|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1831862|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1831863|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
1831864|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1831865|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831866|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831867|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1831868|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1831869|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1831870|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1831871|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1831872|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1831873|NCT04649645|Nicotine|nicotine|mesh-list
1831874|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1831875|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
1831876|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831877|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831878|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1831879|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1831880|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
1831881|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1831882|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831883|NCT04649229|Aprepitant|aprepitant|mesh-list
1831884|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1831885|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
1831886|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
1831887|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831888|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831889|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1831890|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1831891|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1831892|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831893|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1831894|NCT04649697|Clobetasol|clobetasol|mesh-list
1831895|NCT04649697|Rebamipide|rebamipide|mesh-list
1831896|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1831897|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
1831898|NCT04649697|Hormones|hormones|mesh-ancestor
1831899|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831900|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831901|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1831902|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1831903|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
1831904|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831905|NCT04649697|Protective Agents|protective agents|mesh-ancestor
1831906|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1831922|NCT04649502|Metformin|metformin|mesh-list
1831923|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1831924|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831925|NCT04649476|Cisplatin|cisplatin|mesh-list
1831926|NCT04649476|Docetaxel|docetaxel|mesh-list
1831927|NCT04649476|Fluorouracil|fluorouracil|mesh-list
1831928|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831929|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
1831930|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
1831931|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
1831932|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831933|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
1831934|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1831935|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1831936|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
1831937|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831938|NCT04649398|Nimodipine|nimodipine|mesh-list
1831939|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1831940|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1831941|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1831942|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831943|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1831944|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831945|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
1831966|NCT04649489|Bevacizumab|bevacizumab|mesh-list
1831967|NCT04649489|Atezolizumab|atezolizumab|mesh-list
1831968|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1831969|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1831970|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1831971|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1831972|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1831973|NCT04649489|Growth Substances|growth substances|mesh-ancestor
1831974|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831975|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
1831976|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
1831977|NCT04648891|Lidocaine|lidocaine|mesh-list
1831978|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
1831979|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
1831980|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1831981|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831982|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
1831983|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831984|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1831985|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1831986|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1831987|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1831988|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1831989|NCT04648969|Hormones|hormones|mesh-list
1831990|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1831991|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831992|NCT04648813|Bromides|bromides|mesh-list
1831993|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
1831994|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1831995|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
1831996|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1831997|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1831998|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1831999|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
1832000|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
1832001|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1832002|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
1832003|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832004|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832005|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
1832010|NCT04648358|Dexamethasone|dexamethasone|mesh-list
1832011|NCT04648358|Bupivacaine|bupivacaine|mesh-list
1832012|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1832013|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
1832014|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
1832015|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832016|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832017|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1832018|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
1832019|NCT04648358|Hormones|hormones|mesh-ancestor
1832020|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1832021|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1832022|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832023|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
1832024|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
1832025|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832026|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
1832027|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
1832028|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1832029|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1832030|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
1832031|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
1832032|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832033|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832034|NCT04648540|Acetaminophen|acetaminophen|mesh-list
1832035|NCT04648540|Celecoxib|celecoxib|mesh-list
1832036|NCT04648540|Ketorolac|ketorolac|mesh-list
1832037|NCT04648540|Lidocaine|lidocaine|mesh-list
1832038|NCT04648540|Pregabalin|pregabalin|mesh-list
1832039|NCT04648540|Fentanyl|fentanyl|mesh-list
1832040|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
1832041|NCT04648540|Morphine|morphine|mesh-list
1832042|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
1832043|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
1832044|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832045|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832046|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
1832047|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832048|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1832049|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1832050|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1832051|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1832052|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832053|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1832054|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1832055|NCT04648540|Analgesics|analgesics|mesh-ancestor
1832056|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1832057|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1832058|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1832059|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
1832060|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832061|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1832062|NCT04648540|Narcotics|narcotics|mesh-ancestor
1832063|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1832064|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1832065|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
1832066|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
1832067|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
1832068|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1832069|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1832070|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1832071|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1832072|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1832073|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1832074|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1832075|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1832076|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1832077|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1832078|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832079|NCT04648917|Caffeic acid|caffeic acid|mesh-list
1832080|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
1832081|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832082|NCT04648917|Protective Agents|protective agents|mesh-ancestor
1832083|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832084|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1832085|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
1832086|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
1832087|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
1832088|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832089|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1832090|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
1832091|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832092|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832093|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1832094|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1832095|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1832096|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
1832097|NCT04648332|Bupivacaine|bupivacaine|mesh-list
1832098|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
1832099|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
1832100|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832101|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832102|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
1832103|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832104|NCT04648020|Clonidine|clonidine|mesh-list
1832105|NCT04648020|Analgesics|analgesics|mesh-ancestor
1832106|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
1832107|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832108|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832109|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1832110|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
1832111|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
1832112|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1832113|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1832114|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1832115|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
1832116|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832117|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832118|NCT04648280|Fostemsavir|fostemsavir|mesh-list
1832119|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1832120|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1832121|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
1832122|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1832123|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
1832124|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
1832125|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832126|NCT04648319|Nivolumab|nivolumab|mesh-list
1832127|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1832128|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832129|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1832130|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832131|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
1832132|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1832133|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
1832134|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832135|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1832136|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1832137|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
1832138|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832139|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832140|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1832141|NCT04648241|Vaccines|vaccines|mesh-list
1832142|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
1832143|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832158|NCT04647669|Interferons|interferons|mesh-list
1832159|NCT04647669|Interferon-beta|interferon-beta|mesh-list
1832160|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
1832161|NCT04647669|Remdesivir|remdesivir|mesh-list
1832162|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
1832163|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832164|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
1832165|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1832166|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
1832167|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832168|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1832169|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
1832170|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832171|NCT04647877|Phenytoin|phenytoin|mesh-list
1832172|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
1832173|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1832174|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1832175|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1832176|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832177|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1832178|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1832179|NCT04647838|Tepotinib|tepotinib|mesh-list
1832180|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832181|NCT04647773|Pregabalin|pregabalin|mesh-list
1832182|NCT04647773|Analgesics|analgesics|mesh-ancestor
1832183|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
1832184|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832185|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832186|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
1832187|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1832188|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1832189|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832190|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1832191|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1832192|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1832193|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832194|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1832195|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1832196|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1832197|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1832198|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1832199|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1832200|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1832201|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1832202|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
1832203|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832204|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832205|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832206|NCT04647643|Paclitaxel|paclitaxel|mesh-list
1832207|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1832208|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832209|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
1832210|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
1832211|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
1832212|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832213|NCT04647695|Interferons|interferons|mesh-list
1832214|NCT04647695|Interferon-beta|interferon-beta|mesh-list
1832215|NCT04647695|Remdesivir|remdesivir|mesh-list
1832216|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
1832217|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832218|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
1832219|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1832220|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
1832221|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832222|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
1832223|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832224|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1832225|NCT04647500|Methylphenidate|methylphenidate|mesh-list
1832226|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1832227|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832228|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1832229|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1832230|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1832231|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832232|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
1832233|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832234|NCT04647435|Tramadol|tramadol|mesh-list
1832235|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1832236|NCT04647435|Narcotics|narcotics|mesh-ancestor
1832237|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832238|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832239|NCT04647435|Analgesics|analgesics|mesh-ancestor
1832240|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
1832241|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832242|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
1832243|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1832244|NCT04647344|Paclitaxel|paclitaxel|mesh-list
1832245|NCT04647344|Carboplatin|carboplatin|mesh-list
1832246|NCT04647344|Pemetrexed|pemetrexed|mesh-list
1832247|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1832248|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832249|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
1832250|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
1832251|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
1832252|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832253|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832254|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1832255|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1832268|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
1832269|NCT04646967|Acetaminophen|acetaminophen|mesh-list
1832270|NCT04646967|Ibuprofen|ibuprofen|mesh-list
1832271|NCT04646967|Ketorolac|ketorolac|mesh-list
1832272|NCT04646967|Bupivacaine|bupivacaine|mesh-list
1832273|NCT04646967|Sevoflurane|sevoflurane|mesh-list
1832274|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
1832275|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
1832276|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832277|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832278|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
1832279|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832280|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1832281|NCT04646967|Analgesics|analgesics|mesh-ancestor
1832282|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
1832283|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1832284|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1832285|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1832286|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1832287|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832288|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832289|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1832290|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1832291|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
1832292|NCT04646837|Paclitaxel|paclitaxel|mesh-list
1832293|NCT04646837|Carboplatin|carboplatin|mesh-list
1832294|NCT04646837|Durvalumab|durvalumab|mesh-list
1832295|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1832296|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832297|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
1832298|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
1832299|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
1832300|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832301|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1832302|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
1832303|NCT04646876|Analgesics|analgesics|mesh-ancestor
1832304|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
1832305|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832306|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832307|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
1832308|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832309|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1832310|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
1832311|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1832312|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1832313|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832314|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1832315|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
1832316|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1832317|NCT04647110|Crizotinib|crizotinib|mesh-list
1832318|NCT04647110|Ceritinib|ceritinib|mesh-list
1832319|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832320|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1832321|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832322|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832323|NCT04646824|Pemetrexed|pemetrexed|mesh-list
1832324|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832325|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832326|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832327|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1832328|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1832329|NCT04646707|Lidocaine|lidocaine|mesh-list
1832330|NCT04646707|Bupivacaine|bupivacaine|mesh-list
1832331|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
1832332|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
1832333|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832334|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832335|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
1832336|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832337|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1832338|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1832339|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1832340|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1832341|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832342|NCT04646759|Capecitabine|capecitabine|mesh-list
1832343|NCT04646759|Fulvestrant|fulvestrant|mesh-list
1832344|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1832345|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
1832346|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832347|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832348|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1832349|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
1832350|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1832351|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
1832352|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1832353|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832354|NCT04646655|Enoxaparin|enoxaparin|mesh-list
1832355|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
1832356|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1832357|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1832358|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832359|NCT04646694|Ketamine|ketamine|mesh-list
1832360|NCT04646694|Analgesics|analgesics|mesh-ancestor
1832361|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
1832362|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832363|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832364|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1832365|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1832366|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
1832367|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
1832368|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832369|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1832370|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1832371|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832372|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832376|NCT04646356|Tacrolimus|tacrolimus|mesh-list
1832377|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1832378|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
1832379|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832380|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1832381|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832382|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832383|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
1832384|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1832385|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832386|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832387|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1832388|NCT04646317|Analgesics|analgesics|mesh-ancestor
1832389|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
1832390|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832391|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1832392|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1832393|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1832394|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
1832395|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832396|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832397|NCT04646161|Misoprostol|misoprostol|mesh-list
1832398|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1832399|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
1832400|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1832401|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832402|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1832403|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1832404|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
1832405|NCT04646135|Lorazepam|lorazepam|mesh-list
1832406|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
1832407|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
1832408|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
1832409|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832410|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832411|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1832412|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1832413|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832414|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1832415|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1832416|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1832417|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
1832418|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
1832419|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832420|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832421|NCT04645914|Nicotine|nicotine|mesh-list
1832422|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1832423|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
1832424|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832425|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832426|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1832427|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1832428|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
1832429|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832430|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832431|NCT04645823|Lidocaine|lidocaine|mesh-list
1832432|NCT04645823|Fentanyl|fentanyl|mesh-list
1832433|NCT04645823|Citric Acid|citric acid|mesh-list
1832434|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
1832435|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
1832436|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
1832437|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832438|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832439|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
1832440|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832441|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1832442|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1832443|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1832444|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1832445|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832446|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1832447|NCT04645823|Narcotics|narcotics|mesh-ancestor
1832448|NCT04645823|Analgesics|analgesics|mesh-ancestor
1832449|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1832450|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1832451|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
1832452|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
1832453|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
1832454|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
1832455|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
1832456|NCT04646109|Azithromycin|azithromycin|mesh-list
1832457|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
1832458|NCT04646109|Ivermectin|ivermectin|mesh-list
1832459|NCT04646109|Favipiravir|favipiravir|mesh-list
1832460|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1832461|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1832462|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
1832463|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1832464|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1832465|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832466|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832467|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1832468|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
1832469|NCT04645940|Rabeprazole|rabeprazole|mesh-list
1832470|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1832471|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1832472|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1832473|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832474|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832475|NCT04646187|Adalimumab|adalimumab|mesh-list
1832476|NCT04646187|Infliximab|infliximab|mesh-list
1832477|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1832478|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1832479|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
1832480|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1832481|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
1832482|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1832483|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832484|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1832485|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
1832486|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1832487|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1832488|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832489|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832497|NCT04645550|Aspirin|aspirin|mesh-list
1832498|NCT04645550|Heparin|heparin|mesh-list
1832499|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1832500|NCT04645550|Tinzaparin|tinzaparin|mesh-list
1832501|NCT04645550|Dalteparin|dalteparin|mesh-list
1832502|NCT04645550|Dipyridamole|dipyridamole|mesh-list
1832503|NCT04645550|Warfarin|warfarin|mesh-list
1832504|NCT04645550|Apixaban|apixaban|mesh-list
1832505|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1832506|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1832507|NCT04645550|Analgesics|analgesics|mesh-ancestor
1832508|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
1832509|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832510|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832511|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1832512|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1832513|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1832514|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1832515|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832516|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1832517|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1832518|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832519|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
1832520|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
1832521|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1832522|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
1832523|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1832524|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
1832525|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1832526|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
1832534|NCT04645745|Folic Acid|folic acid|mesh-list
1832535|NCT04645745|Inositol|inositol|mesh-list
1832536|NCT04645745|Hematinics|hematinics|mesh-ancestor
1832537|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
1832538|NCT04645745|Vitamins|vitamins|mesh-ancestor
1832539|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
1832540|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832541|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
1832542|NCT04645719|Analgesics|analgesics|mesh-ancestor
1832543|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
1832544|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832545|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832546|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
1832547|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832548|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1832549|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
1832550|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1832551|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1832552|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832553|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1832554|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
1832555|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1832563|NCT04645004|Aspirin|aspirin|mesh-list
1832564|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1832565|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1832566|NCT04645004|Analgesics|analgesics|mesh-ancestor
1832567|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
1832568|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832569|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832570|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1832571|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1832572|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1832573|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1832574|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832575|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1832576|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1832577|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832578|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
1832579|NCT04645303|Triamcinolone|triamcinolone|mesh-list
1832580|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1832581|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1832582|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
1832583|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1832584|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1832585|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
1832586|NCT04645303|Hormones|hormones|mesh-ancestor
1832587|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1832588|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832589|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1832590|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
1832591|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832592|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832593|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1832594|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
1832595|NCT04645303|Protective Agents|protective agents|mesh-ancestor
1832602|NCT04644627|Gentamicins|gentamicins|mesh-list
1832603|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1832604|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1832605|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1832606|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832607|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832608|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
1832609|NCT04644484|Vaccines|vaccines|mesh-list
1832610|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
1832611|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
1832612|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832613|NCT04644354|Nifedipine|nifedipine|mesh-list
1832614|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1832615|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1832616|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832617|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1832618|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832619|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
1832620|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
1832621|NCT04644354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1832622|NCT04644237|Trastuzumab|trastuzumab|mesh-list
1832623|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1832624|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832625|NCT04644250|Paclitaxel|paclitaxel|mesh-list
1832626|NCT04644250|Carboplatin|carboplatin|mesh-list
1832627|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1832628|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832629|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
1832630|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
1832631|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
1832632|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832633|NCT04644289|Durvalumab|durvalumab|mesh-list
1832634|NCT04644289|Olaparib|olaparib|mesh-list
1832635|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1832636|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832637|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1832638|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832639|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832640|NCT04644094|Dexamethasone|dexamethasone|mesh-list
1832641|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1832642|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
1832643|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
1832644|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832645|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832646|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1832647|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
1832648|NCT04644094|Hormones|hormones|mesh-ancestor
1832649|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1832650|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1832651|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832652|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1832653|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1832654|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832655|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
1832656|NCT04644185|Paraproteins|paraproteins|mesh-list
1832657|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
1832658|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832667|NCT04644406|Trastuzumab|trastuzumab|mesh-list
1832668|NCT04644406|Pertuzumab|pertuzumab|mesh-list
1832669|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1832670|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832671|NCT04643821|Calcitriol|calcitriol|mesh-list
1832672|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
1832673|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
1832674|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
1832675|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1832676|NCT04643821|Expectorants|expectorants|mesh-ancestor
1832677|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
1832678|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1832679|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
1832680|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832681|NCT04643821|Protective Agents|protective agents|mesh-ancestor
1832682|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832683|NCT04643821|Antidotes|antidotes|mesh-ancestor
1832684|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1832685|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1832686|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1832687|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1832688|NCT04643821|Vitamins|vitamins|mesh-ancestor
1832689|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
1832690|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1832691|NCT04644016|Cyclosporine|cyclosporine|mesh-list
1832692|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
1832693|NCT04644016|Fludarabine|fludarabine|mesh-list
1832694|NCT04644016|Busulfan|busulfan|mesh-list
1832695|NCT04644016|Clofarabine|clofarabine|mesh-list
1832696|NCT04644016|Cyclosporins|cyclosporins|mesh-list
1832697|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832698|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1832699|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
1832700|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832701|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1832702|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
1832703|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832704|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832705|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
1832706|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1832707|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
1832708|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1832709|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1832710|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1832711|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1832712|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
1832713|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1832714|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
1832715|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1832716|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1832717|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
1832718|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832719|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1832720|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832721|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832722|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
1832723|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1832724|NCT04643691|Losartan|losartan|mesh-list
1832725|NCT04643691|Spironolactone|spironolactone|mesh-list
1832726|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1832727|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1832728|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1832729|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1832730|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832731|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1832732|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
1832733|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1832734|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832735|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1832736|NCT04643691|Diuretics|diuretics|mesh-ancestor
1832737|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
1832738|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
1832739|NCT04643574|Fludarabine|fludarabine|mesh-list
1832740|NCT04643574|Interleukin-2|interleukin-2|mesh-list
1832741|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1832742|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
1832743|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832744|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1832745|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1832746|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
1832747|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832748|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832749|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1832750|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1832751|NCT04643574|Analgesics|analgesics|mesh-ancestor
1832752|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
1832753|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832778|NCT04643483|Adalimumab|adalimumab|mesh-list
1832779|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
1832780|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1832781|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1832782|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1832783|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
1832784|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832785|NCT04643327|Levetiracetam|levetiracetam|mesh-list
1832786|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
1832787|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
1832788|NCT04643132|Ketamine|ketamine|mesh-list
1832789|NCT04643132|Esketamine|esketamine|mesh-list
1832790|NCT04643132|Analgesics|analgesics|mesh-ancestor
1832791|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
1832792|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832793|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832794|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1832795|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1832796|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
1832797|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
1832798|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832799|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1832800|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1832801|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832802|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832803|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
1832804|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1832805|NCT04643301|Liraglutide|liraglutide|mesh-list
1832806|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1832807|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832808|NCT04643301|Incretins|incretins|mesh-ancestor
1832809|NCT04643301|Hormones|hormones|mesh-ancestor
1832810|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1832811|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1832812|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1832813|NCT04643093|Ezetimibe|ezetimibe|mesh-list
1832814|NCT04643093|Pitavastatin|pitavastatin|mesh-list
1832815|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1832816|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1832817|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
1832818|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832819|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1832820|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1832821|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832822|NCT04643106|Hemostatics|hemostatics|mesh-list
1832823|NCT04643106|Coagulants|coagulants|mesh-ancestor
1832838|NCT04642846|Fluorides|fluorides|mesh-list
1832839|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
1832840|NCT04642846|Protective Agents|protective agents|mesh-ancestor
1832841|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832842|NCT04642664|Apatinib|apatinib|mesh-list
1832843|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832844|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1832845|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832846|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832847|NCT04642807|Calpastatin|calpastatin|mesh-list
1832848|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
1832849|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
1832850|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832851|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832852|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
1832853|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1832854|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1832855|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832856|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1832857|NCT04642651|Analgesics|analgesics|mesh-ancestor
1832858|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
1832859|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832860|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1832861|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1832862|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1832863|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
1832864|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832865|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832880|NCT04642547|Gefitinib|gefitinib|mesh-list
1832881|NCT04642547|Lenvatinib|lenvatinib|mesh-list
1832882|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832883|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1832884|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832885|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832886|NCT04642287|Fluorouracil|fluorouracil|mesh-list
1832887|NCT04642287|Calcipotriene|calcipotriene|mesh-list
1832888|NCT04642287|Petrolatum|petrolatum|mesh-list
1832889|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
1832890|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832891|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1832892|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1832893|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1832894|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
1832895|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832896|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
1832897|NCT04642287|Emollients|emollients|mesh-ancestor
1832898|NCT04642261|Empagliflozin|empagliflozin|mesh-list
1832899|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1832900|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832901|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1832902|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832903|NCT04642391|Cosyntropin|cosyntropin|mesh-list
1832904|NCT04642391|Hormones|hormones|mesh-ancestor
1832905|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1832906|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832907|NCT04642404|Cannabidiol|cannabidiol|mesh-list
1832908|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
1832909|NCT04642131|Caffeine|caffeine|mesh-list
1832910|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1832911|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832912|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1832913|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832914|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832915|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
1832916|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1832917|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
1832918|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832919|NCT04642001|Listerine|listerine|mesh-list
1832920|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
1832921|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
1832922|NCT04642001|Protective Agents|protective agents|mesh-ancestor
1832923|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832924|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1832925|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1832926|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
1832927|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
1832928|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832929|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832930|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832931|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
1832932|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
1832933|NCT04641507|Tadalafil|tadalafil|mesh-list
1832934|NCT04641507|Tamsulosin|tamsulosin|mesh-list
1832935|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
1832936|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1832937|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1832938|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1832939|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1832940|NCT04641507|Urological Agents|urological agents|mesh-ancestor
1832941|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
1832942|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1832943|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1832944|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
1832945|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1832946|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832970|NCT04641195|Vitamin D|vitamin d|mesh-list
1832971|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
1832972|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
1832973|NCT04641195|Vitamins|vitamins|mesh-list
1832974|NCT04641195|Zinc|zinc|mesh-list
1832975|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
1832976|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832977|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1832978|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1832979|NCT04641195|Trace Elements|trace elements|mesh-ancestor
1832980|NCT04641104|Thiamine|thiamine|mesh-list
1832981|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
1832982|NCT04641104|Vitamins|vitamins|mesh-ancestor
1832983|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
1832984|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832985|NCT04641338|Dipyrone|dipyrone|mesh-list
1832986|NCT04641338|Codeine|codeine|mesh-list
1832987|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1832988|NCT04641338|Narcotics|narcotics|mesh-ancestor
1832989|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833064|NCT04640636|Analgesics|analgesics|mesh-ancestor
1832990|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1832991|NCT04641338|Analgesics|analgesics|mesh-ancestor
1832992|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
1832993|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1832994|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
1832995|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
1832996|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1832997|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1832998|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1832999|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1833000|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
1833001|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
1833002|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833003|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1833004|NCT04641026|Protective Agents|protective agents|mesh-ancestor
1833005|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833006|NCT04641234|Aflibercept|aflibercept|mesh-list
1833007|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1833008|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1833009|NCT04641234|Growth Substances|growth substances|mesh-ancestor
1833010|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833011|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
1833012|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833013|NCT04641351|Triamcinolone|triamcinolone|mesh-list
1833014|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1833015|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1833016|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1833017|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1833018|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
1833019|NCT04641351|Hormones|hormones|mesh-ancestor
1833020|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1833021|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833022|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1833023|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
1833024|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833025|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833026|NCT04641247|Niraparib|niraparib|mesh-list
1833027|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1833028|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833029|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833030|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833031|NCT04640870|Afatinib|afatinib|mesh-list
1833032|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833033|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1833034|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833035|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833036|NCT04640896|Lidocaine|lidocaine|mesh-list
1833037|NCT04640896|Bupivacaine|bupivacaine|mesh-list
1833038|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
1833039|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
1833040|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833041|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833042|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
1833043|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833044|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1833045|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1833046|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1833047|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1833048|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833049|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
1833050|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833051|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
1833052|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833053|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
1833054|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
1833055|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833056|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1833057|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1833058|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
1833059|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1833060|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833061|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1833062|NCT04640636|Midazolam|midazolam|mesh-list
1833063|NCT04640636|Ketamine|ketamine|mesh-list
1833065|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
1833066|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833067|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833068|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1833069|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1833070|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
1833071|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
1833072|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833073|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1833074|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1833075|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1833076|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833077|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1833078|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1833079|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1833080|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1833081|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1833082|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
1833083|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
1833084|NCT04640779|Salicylates|salicylates|mesh-list
1833085|NCT04640779|Choline|choline|mesh-list
1833086|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
1833087|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1833088|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
1833089|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833090|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1833091|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1833092|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
1833093|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1833094|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1833095|NCT04640779|Analgesics|analgesics|mesh-ancestor
1833096|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
1833097|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833098|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833099|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1833100|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1833101|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1833102|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833103|NCT04640818|Rituximab|rituximab|mesh-list
1833104|NCT04640818|Cladribine|cladribine|mesh-list
1833105|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
1833106|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1833107|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833108|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
1833109|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833110|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1833111|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1833112|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
1833113|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1833114|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833115|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1833116|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833117|NCT04640376|Acetaminophen|acetaminophen|mesh-list
1833118|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1833119|NCT04640376|Analgesics|analgesics|mesh-ancestor
1833120|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
1833121|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833122|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833123|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
1833124|NCT04640181|Enoxaparin|enoxaparin|mesh-list
1833125|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
1833126|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1833127|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
1833128|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1833129|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
1833130|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833131|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833132|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
1833133|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1833134|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1833135|NCT04639986|Gemcitabine|gemcitabine|mesh-list
1833136|NCT04639986|Capecitabine|capecitabine|mesh-list
1833137|NCT04639986|Vinorelbine|vinorelbine|mesh-list
1833138|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1833139|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
1833140|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833141|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833142|NCT04639986|Antiviral Agents|antiviral agents|mesh-ancestor
1833143|NCT04639986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833144|NCT04639986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833145|NCT04639986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1833146|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
1833147|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833148|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1833149|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
1833150|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
1833151|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
1833152|NCT04640129|Interferons|interferons|mesh-list
1833153|NCT04640129|Tenofovir|tenofovir|mesh-list
1833154|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
1833155|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833156|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
1833157|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833158|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1833159|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1833160|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833161|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833162|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1833163|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1833164|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
1833165|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833166|NCT04640324|Vitamin D|vitamin d|mesh-list
1833167|NCT04640324|Vitamins|vitamins|mesh-list
1833168|NCT04640324|Vitamin E|vitamin e|mesh-list
1833169|NCT04640324|Silybin|silybin|mesh-list
1833170|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
1833171|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833172|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1833173|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
1833174|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833175|NCT04640324|Protective Agents|protective agents|mesh-ancestor
1833176|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1833177|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833178|NCT04640285|Menthol|menthol|mesh-list
1833179|NCT04640285|Nicotine|nicotine|mesh-list
1833180|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1833181|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
1833182|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833183|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833184|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1833185|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1833186|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
1833187|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1833188|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833189|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
1833190|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
1833191|NCT04640402|Vaccines|vaccines|mesh-list
1833192|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
1833193|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833194|NCT04639960|Risperidone|risperidone|mesh-list
1833195|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1833196|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
1833197|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1833198|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833199|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833200|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1833201|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1833202|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833203|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1833204|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1833205|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
1833206|NCT04639817|Levofloxacin|levofloxacin|mesh-list
1833207|NCT04639817|Ofloxacin|ofloxacin|mesh-list
1833208|NCT04639817|Trimethoprim|trimethoprim|mesh-list
1833209|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
1833210|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
1833211|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1833212|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833213|NCT04639817|Renal Agents|renal agents|mesh-ancestor
1833214|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1833215|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1833216|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1833217|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833218|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833219|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833220|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1833221|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1833222|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
1833223|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1833224|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1833225|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1833226|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1833227|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1833228|NCT04639804|Celecoxib|celecoxib|mesh-list
1833229|NCT04639804|Naproxen|naproxen|mesh-list
1833230|NCT04639804|Aceclofenac|aceclofenac|mesh-list
1833231|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1833232|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1833233|NCT04639804|Analgesics|analgesics|mesh-ancestor
1833234|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
1833235|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833236|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833237|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1833238|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1833239|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1833240|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1833241|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833242|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833243|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
1833244|NCT04639362|Venetoclax|venetoclax|mesh-list
1833245|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
1833246|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833247|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1833248|NCT04639232|Probenecid|probenecid|mesh-list
1833249|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
1833250|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
1833251|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1833252|NCT04639232|Renal Agents|renal agents|mesh-ancestor
1833258|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
1833259|NCT04639284|Antibodies|antibodies|mesh-list
1833260|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
1833261|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833262|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1833263|NCT04639284|Growth Substances|growth substances|mesh-ancestor
1833264|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
1833265|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833266|NCT04639271|Trastuzumab|trastuzumab|mesh-list
1833267|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1833268|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1833269|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833270|NCT04639180|Apatinib|apatinib|mesh-list
1833271|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833272|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1833273|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833274|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833275|NCT04638816|Lidocaine|lidocaine|mesh-list
1833276|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
1833277|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
1833278|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
1833279|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833280|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833281|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
1833282|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833283|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1833284|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1833285|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1833286|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1833287|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833288|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1833289|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
1833290|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
1833291|NCT04638816|Protective Agents|protective agents|mesh-ancestor
1833292|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
1833293|NCT04639193|Acetazolamide|acetazolamide|mesh-list
1833294|NCT04639193|Eszopiclone|eszopiclone|mesh-list
1833295|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
1833296|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
1833297|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1833298|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1833299|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833300|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1833301|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833302|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1833303|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
1833304|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1833305|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
1833306|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1833307|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833308|NCT04639193|Diuretics|diuretics|mesh-ancestor
1833309|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
1833310|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1833311|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833312|NCT04638686|Lamivudine|lamivudine|mesh-list
1833313|NCT04638686|Dolutegravir|dolutegravir|mesh-list
1833314|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1833315|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1833316|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833317|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833318|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
1833319|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833320|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1833321|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1833322|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1833323|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1833324|NCT04638790|Dexamethasone|dexamethasone|mesh-list
1833325|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
1833326|NCT04638790|Dacarbazine|dacarbazine|mesh-list
1833327|NCT04638790|Doxorubicin|doxorubicin|mesh-list
1833328|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1833329|NCT04638790|Etoposide|etoposide|mesh-list
1833330|NCT04638790|Vincristine|vincristine|mesh-list
1833331|NCT04638790|Bleomycin|bleomycin|mesh-list
1833332|NCT04638790|Vinblastine|vinblastine|mesh-list
1833333|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1833334|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
1833335|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833336|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1833337|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1833338|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
1833339|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833340|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833341|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1833342|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1833343|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
1833344|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
1833345|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833346|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1833347|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
1833348|NCT04638790|Hormones|hormones|mesh-ancestor
1833349|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1833350|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1833351|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1833352|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1833353|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1833354|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833355|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1833356|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
1833357|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
1833358|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
1833359|NCT04639115|Ozanimod|ozanimod|mesh-list
1833360|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
1833361|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833362|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1833363|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
1833364|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833365|NCT04638582|Paclitaxel|paclitaxel|mesh-list
1833366|NCT04638582|Carboplatin|carboplatin|mesh-list
1833367|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
1833368|NCT04638582|Pemetrexed|pemetrexed|mesh-list
1833369|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1833370|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833371|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
1833372|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
1833373|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
1833374|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833375|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1833376|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833377|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1833378|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1833382|NCT04638751|Pembrolizumab|pembrolizumab|mesh-list
1833383|NCT04638751|Nivolumab|nivolumab|mesh-list
1833384|NCT04638751|Ipilimumab|ipilimumab|mesh-list
1833385|NCT04638751|Durvalumab|durvalumab|mesh-list
1833386|NCT04638751|Avelumab|avelumab|mesh-list
1833387|NCT04638751|Cemiplimab|cemiplimab|mesh-list
1833388|NCT04638751|Atezolizumab|atezolizumab|mesh-list
1833389|NCT04638751|Antineoplastic Agents|antineoplastic agents|mesh-list
1833390|NCT04638751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1833391|NCT04638751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1833392|NCT04638751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833393|NCT04638517|Danazol|danazol|mesh-list
1833394|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1833395|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
1833396|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1833397|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833404|NCT04638400|Simvastatin|simvastatin|mesh-list
1833405|NCT04638400|Ezetimibe|ezetimibe|mesh-list
1833406|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1833407|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1833408|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
1833409|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833410|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1833411|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1833412|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833413|NCT04638465|Cisplatin|cisplatin|mesh-list
1833414|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833415|NCT04638439|Entecavir|entecavir|mesh-list
1833416|NCT04638439|Nivolumab|nivolumab|mesh-list
1833417|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1833418|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833419|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1833420|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833421|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
1833422|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833423|NCT04638036|Cetuximab|cetuximab|mesh-list
1833424|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1833425|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833426|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
1833427|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1833428|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1833429|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
1833430|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1833431|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
1833432|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833433|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1833434|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833435|NCT04637152|Valsartan|valsartan|mesh-list
1833436|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
1833437|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1833438|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1833439|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1833440|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833441|NCT04636918|Cyclosporine|cyclosporine|mesh-list
1833442|NCT04636918|Cyclosporins|cyclosporins|mesh-list
1833443|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833444|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833445|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1833446|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
1833447|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833448|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
1833449|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833450|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
1833451|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1833452|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1833453|NCT04637204|Axitinib|axitinib|mesh-list
1833454|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833455|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1833456|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833457|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833458|NCT04637529|Ibuprofen|ibuprofen|mesh-list
1833459|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1833460|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1833461|NCT04637529|Analgesics|analgesics|mesh-ancestor
1833462|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
1833463|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833464|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833465|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1833466|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1833467|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1833468|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833469|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833470|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
1833471|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
1833472|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1833473|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1833474|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833475|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1833476|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1833477|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833478|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833479|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833480|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1833481|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1833482|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1833483|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
1833484|NCT04636957|Hormones|hormones|mesh-ancestor
1833485|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1833486|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833487|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
1833488|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1833489|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
1833490|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833491|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1833492|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
1833493|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1833494|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833495|NCT04637360|Calcitriol|calcitriol|mesh-list
1833496|NCT04637360|Cinacalcet|cinacalcet|mesh-list
1833497|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1833498|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833499|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
1833500|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1833501|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833502|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1833503|NCT04637360|Vitamins|vitamins|mesh-ancestor
1833504|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
1833505|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1833506|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
1833507|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
1833508|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1833509|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
1833510|NCT04636632|Aprepitant|aprepitant|mesh-list
1833511|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
1833512|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
1833513|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833514|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833515|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1833516|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1833517|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1833518|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833519|NCT04636671|Dexamethasone|dexamethasone|mesh-list
1833520|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
1833521|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1833522|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1833523|NCT04636671|Prednisolone|prednisolone|mesh-list
1833524|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
1833525|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1833526|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
1833527|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1833528|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
1833529|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
1833530|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833531|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833532|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1833533|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
1833534|NCT04636671|Hormones|hormones|mesh-ancestor
1833535|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1833536|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1833537|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833538|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1833539|NCT04636671|Protective Agents|protective agents|mesh-ancestor
1833540|NCT04636437|Tenofovir|tenofovir|mesh-list
1833541|NCT04636437|Lamivudine|lamivudine|mesh-list
1833542|NCT04636437|Emtricitabine|emtricitabine|mesh-list
1833543|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
1833544|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
1833545|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833546|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1833547|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1833548|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833549|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833550|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1833551|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1833552|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
1833553|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1833554|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833555|NCT04636086|Vitamins|vitamins|mesh-ancestor
1833556|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
1833557|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1833558|NCT04636125|Doxycycline|doxycycline|mesh-list
1833559|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1833560|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833561|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
1833562|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1833563|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1833564|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1833565|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1833566|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
1833567|NCT04636255|Calcium|calcium|mesh-list
1833568|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1833569|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833570|NCT04636333|Vaccines|vaccines|mesh-list
1833571|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
1833572|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833573|NCT04635774|Insulin|insulin|mesh-list
1833574|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1833575|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833576|NCT04635852|Fentanyl|fentanyl|mesh-list
1833577|NCT04635852|Morphine|morphine|mesh-list
1833578|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1833579|NCT04635852|Narcotics|narcotics|mesh-ancestor
1833580|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833581|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833582|NCT04635852|Analgesics|analgesics|mesh-ancestor
1833583|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
1833584|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833585|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1833586|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1833587|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
1833588|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
1833602|NCT04635839|Heparin|heparin|mesh-list
1833603|NCT04635839|Calcium heparin|calcium heparin|mesh-list
1833604|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
1833605|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1833606|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1833607|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833608|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
1833609|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
1833610|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
1833611|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833612|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833613|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
1833614|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833615|NCT04635605|Methylene Blue|methylene blue|mesh-list
1833616|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833617|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833618|NCT04635280|Pancrelipase|pancrelipase|mesh-list
1833619|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1833620|NCT04635176|Dexamethasone|dexamethasone|mesh-list
1833621|NCT04635176|Epinephrine|epinephrine|mesh-list
1833622|NCT04635176|Bupivacaine|bupivacaine|mesh-list
1833623|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1833624|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
1833625|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
1833626|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833627|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833628|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1833629|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
1833630|NCT04635176|Hormones|hormones|mesh-ancestor
1833631|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1833632|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1833633|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833634|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
1833635|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
1833636|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833637|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
1833638|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1833639|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1833640|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
1833641|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1833642|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833643|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1833644|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1833645|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1833646|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
1833647|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
1833648|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
1833649|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1833650|NCT04635566|Mebeverine|mebeverine|mesh-list
1833651|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
1833652|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
1833653|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
1833654|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833655|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833656|NCT04635293|Simendan|simendan|mesh-list
1833657|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1833658|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
1833659|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1833660|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1833661|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833662|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833663|NCT04635293|Protective Agents|protective agents|mesh-ancestor
1833664|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833671|NCT04635241|Heparin|heparin|mesh-list
1833672|NCT04635241|Calcium heparin|calcium heparin|mesh-list
1833673|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
1833674|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1833675|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1833676|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833677|NCT04635007|Misoprostol|misoprostol|mesh-list
1833678|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
1833679|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1833680|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1833681|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833682|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
1833683|NCT04635007|Coagulants|coagulants|mesh-ancestor
1833684|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1833685|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
1833686|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1833687|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833688|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1833689|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1833690|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
1833691|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
1833692|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1833693|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833694|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833695|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1833696|NCT04635098|Analgesics|analgesics|mesh-ancestor
1833697|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
1833698|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833699|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1833700|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1833701|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1833702|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
1833703|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1833704|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833705|NCT04635553|Praziquantel|praziquantel|mesh-list
1833706|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
1833707|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1833708|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833709|NCT04635189|Dexamethasone|dexamethasone|mesh-list
1833710|NCT04635189|Lenalidomide|lenalidomide|mesh-list
1833711|NCT04635189|Daratumumab|daratumumab|mesh-list
1833712|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1833713|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
1833714|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
1833715|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833716|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833717|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1833718|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
1833719|NCT04635189|Hormones|hormones|mesh-ancestor
1833720|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1833721|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1833722|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833723|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
1833724|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1833725|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1833726|NCT04635189|Growth Substances|growth substances|mesh-ancestor
1833727|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
1833728|NCT04634799|Plasminogen|plasminogen|mesh-list
1833729|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
1833730|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
1833731|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1833732|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1833733|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833734|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1833735|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
1833736|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833737|NCT04634838|Copper|copper|mesh-list
1833738|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1833739|NCT04634838|Trace Elements|trace elements|mesh-ancestor
1833740|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
1833741|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833742|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833743|NCT04634981|Anesthetics|anesthetics|mesh-list
1833744|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833745|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833746|NCT04634656|Lidocaine|lidocaine|mesh-list
1833747|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
1833748|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
1833749|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833750|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833751|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
1833752|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833753|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1833754|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1833755|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1833756|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1833757|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833758|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
1833759|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1833760|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833761|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1833762|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833763|NCT04634721|Bupivacaine|bupivacaine|mesh-list
1833764|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
1833765|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
1833766|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833767|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833768|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
1833769|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833770|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
1833771|NCT04634669|Bupropion|bupropion|mesh-list
1833772|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1833773|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
1833774|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1833775|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1833776|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1833777|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1833778|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833779|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
1833780|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1833781|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833782|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1833783|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1833784|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833785|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
1833786|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
1833787|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1833788|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1833789|NCT04634539|Gemcitabine|gemcitabine|mesh-list
1833790|NCT04634539|Paclitaxel|paclitaxel|mesh-list
1833791|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1833792|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833793|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
1833794|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
1833795|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
1833796|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833797|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1833798|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
1833799|NCT04634539|Antiviral Agents|antiviral agents|mesh-ancestor
1833800|NCT04634539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833801|NCT04634539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833802|NCT04634539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1833803|NCT04634539|Immunologic Factors|immunologic factors|mesh-ancestor
1833804|NCT04634539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833805|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
1833806|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1833807|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833808|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
1833809|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1833810|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1833811|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1833812|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1833813|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
1833814|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1833815|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833816|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833817|NCT04634058|Antibodies|antibodies|mesh-list
1833818|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
1833819|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
1833820|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833821|NCT04634071|Bupropion|bupropion|mesh-list
1833822|NCT04634071|Nicotine|nicotine|mesh-list
1833823|NCT04634071|Varenicline|varenicline|mesh-list
1833824|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1833825|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
1833826|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833827|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833828|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1833829|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1833830|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
1833831|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1833832|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833833|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1833834|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
1833835|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1833836|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1833837|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1833838|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1833839|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
1833840|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1833841|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1833842|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833843|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
1833844|NCT04633902|Olaparib|olaparib|mesh-list
1833845|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1833846|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833847|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1833848|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833849|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833850|NCT04633889|Deferoxamine|deferoxamine|mesh-list
1833851|NCT04633889|Siderophores|siderophores|mesh-ancestor
1833852|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
1833853|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
1833854|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
1833855|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833859|NCT04633850|Dexamethasone|dexamethasone|mesh-list
1833860|NCT04633850|Bupivacaine|bupivacaine|mesh-list
1833861|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1833862|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
1833863|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
1833864|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833865|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833866|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1833867|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
1833868|NCT04633850|Hormones|hormones|mesh-ancestor
1833869|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1833870|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1833871|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833872|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
1833873|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
1833874|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833875|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
1833876|NCT04633746|Endostatins|endostatins|mesh-list
1833877|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833878|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1833879|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1833880|NCT04633746|Growth Substances|growth substances|mesh-ancestor
1833881|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833882|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
1833883|NCT04633733|Tacrolimus|tacrolimus|mesh-list
1833884|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1833885|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
1833886|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833887|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1833888|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833889|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833890|NCT04633577|Lidocaine|lidocaine|mesh-list
1833891|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
1833892|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
1834044|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
1833893|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1833894|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833895|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
1833896|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1833897|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1833898|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1833899|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1833900|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1833901|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833902|NCT04633564|Bevacizumab|bevacizumab|mesh-list
1833903|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1833904|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833905|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1833906|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1833907|NCT04633564|Growth Substances|growth substances|mesh-ancestor
1833908|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833909|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
1833910|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1833911|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1833912|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1833915|NCT04633044|Betaine|betaine|mesh-list
1833916|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1833917|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
1833918|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1833919|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
1833920|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833921|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1833922|NCT04633122|Sunitinib|sunitinib|mesh-list
1833923|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833924|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1833925|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1833926|NCT04633122|Growth Substances|growth substances|mesh-ancestor
1833927|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833928|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
1833929|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1833930|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833931|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833932|NCT04632693|Ascorbic Acid|ascorbic acid|mesh-list
1833933|NCT04632693|Vitamins|vitamins|mesh-ancestor
1833934|NCT04632693|Micronutrients|micronutrients|mesh-ancestor
1833935|NCT04632693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833936|NCT04632693|Antioxidants|antioxidants|mesh-ancestor
1833937|NCT04632693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833938|NCT04632693|Protective Agents|protective agents|mesh-ancestor
1833939|NCT04632589|Losartan|losartan|mesh-list
1833940|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1833941|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1833942|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1833943|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1833944|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833945|NCT04632758|Crizotinib|crizotinib|mesh-list
1833946|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833947|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1833948|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1833949|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833953|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
1833954|NCT04632316|Fludarabine|fludarabine|mesh-list
1833955|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1833956|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
1833957|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833958|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1833959|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1833960|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
1833961|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833962|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833963|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1833964|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
1833965|NCT04632459|Ramucirumab|ramucirumab|mesh-list
1833966|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1833967|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833968|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
1833969|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1833970|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
1833971|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833972|NCT04632433|Cemiplimab|cemiplimab|mesh-list
1833973|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1833974|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1833975|NCT04632238|Metronidazole|metronidazole|mesh-list
1833976|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1833977|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1833978|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1833979|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1833980|NCT04632121|Nicorandil|nicorandil|mesh-list
1833981|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1833982|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1833983|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
1833984|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
1833985|NCT04632121|Vitamins|vitamins|mesh-ancestor
1833986|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
1833987|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833988|NCT04631874|Varenicline|varenicline|mesh-list
1833989|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1833990|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1833991|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
1833992|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1833993|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1833994|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1833995|NCT04631822|Dexamethasone|dexamethasone|mesh-list
1833996|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1833997|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
1833998|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
1833999|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834000|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834001|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1834002|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
1834003|NCT04631822|Hormones|hormones|mesh-ancestor
1834004|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1834005|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1834006|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834007|NCT04631627|Aspirin|aspirin|mesh-list
1834008|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1834009|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1834010|NCT04631627|Analgesics|analgesics|mesh-ancestor
1834011|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
1834012|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834013|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834014|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1834015|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1834016|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1834017|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1834018|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834019|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1834020|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1834021|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834022|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
1834035|NCT04631315|Prednisolone|prednisolone|mesh-list
1834036|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1834037|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
1834038|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1834039|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
1834040|NCT04631315|Phenylephrine|phenylephrine|mesh-list
1834041|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
1834042|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1834043|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1834045|NCT04631315|Difluprednate|difluprednate|mesh-list
1834046|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1834047|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1834048|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
1834049|NCT04631315|Hormones|hormones|mesh-ancestor
1834050|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1834051|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834052|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1834053|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834054|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
1834055|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
1834056|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834057|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1834058|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1834059|NCT04631315|Protective Agents|protective agents|mesh-ancestor
1834060|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1834061|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
1834062|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
1834063|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1834064|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
1834065|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
1834066|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1834067|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1834068|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1834069|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
1834070|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834071|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834072|NCT04631536|Folic Acid|folic acid|mesh-list
1834073|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
1834074|NCT04631536|Nicorandil|nicorandil|mesh-list
1834075|NCT04631536|Nebivolol|nebivolol|mesh-list
1834076|NCT04631536|Atorvastatin|atorvastatin|mesh-list
1834077|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1834078|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1834079|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
1834080|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834081|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1834082|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1834083|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834084|NCT04631536|Hematinics|hematinics|mesh-ancestor
1834085|NCT04631536|Vitamins|vitamins|mesh-ancestor
1834086|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
1834087|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834088|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1834089|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
1834090|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1834091|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1834092|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1834093|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
1834094|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834095|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1834108|NCT04631341|Melatonin|melatonin|mesh-list
1834109|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
1834110|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834111|NCT04631341|Protective Agents|protective agents|mesh-ancestor
1834112|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834113|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834114|NCT04631484|Riboflavin|riboflavin|mesh-list
1834115|NCT04631484|Niacinamide|niacinamide|mesh-list
1834116|NCT04631484|Niacin|niacin|mesh-list
1834117|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
1834118|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
1834119|NCT04631484|Vitamins|vitamins|mesh-ancestor
1834120|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
1834121|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834122|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1834123|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
1834124|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1834125|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
1834126|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834127|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1834128|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
1834129|NCT04631510|Gabapentin|gabapentin|mesh-list
1834130|NCT04631510|Analgesics|analgesics|mesh-ancestor
1834131|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
1834132|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834133|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834134|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
1834135|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1834136|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1834137|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834138|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1834139|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1834140|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1834141|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834142|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834143|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
1834144|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
1834145|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1834146|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
1834147|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
1834148|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1834149|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
1834150|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834151|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
1834152|NCT04631263|Protective Agents|protective agents|mesh-ancestor
1834174|NCT04630808|Latanoprost|latanoprost|mesh-list
1834175|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
1834176|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1834177|NCT04630769|Interleukin-2|interleukin-2|mesh-list
1834178|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834179|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1834180|NCT04630769|Analgesics|analgesics|mesh-ancestor
1834181|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
1834182|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834183|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834184|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
1834185|NCT04630821|Eusol|eusol|mesh-list
1834186|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
1834187|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1834202|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
1834203|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1834204|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1834205|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834206|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
1834207|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834208|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834209|NCT04630834|Acetaminophen|acetaminophen|mesh-list
1834210|NCT04630834|Ibuprofen|ibuprofen|mesh-list
1834211|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1834212|NCT04630834|Analgesics|analgesics|mesh-ancestor
1834213|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
1834214|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834215|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834216|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
1834217|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1834218|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1834219|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1834220|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1834221|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834222|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834223|NCT04630886|Lidocaine|lidocaine|mesh-list
1834224|NCT04630886|Epinephrine|epinephrine|mesh-list
1834225|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
1834226|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
1834227|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
1834228|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834229|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834230|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
1834231|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834232|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1834233|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1834234|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1834235|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1834236|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834237|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1834238|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1834239|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
1834240|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834241|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1834242|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1834243|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
1834244|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1834245|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
1834246|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
1834247|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
1834248|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1834249|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1834250|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1834251|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
1834252|NCT04630886|Coagulants|coagulants|mesh-ancestor
1834255|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1834256|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
1834257|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1834258|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
1834259|NCT04630938|Lidocaine|lidocaine|mesh-list
1834260|NCT04630938|Morphine|morphine|mesh-list
1834261|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
1834262|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
1834263|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834264|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834265|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
1834266|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834267|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1834268|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1834269|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1834270|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1834271|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834272|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1834273|NCT04630938|Narcotics|narcotics|mesh-ancestor
1834274|NCT04630938|Analgesics|analgesics|mesh-ancestor
1834275|NCT04630522|Vitamin D|vitamin d|mesh-list
1834276|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
1834277|NCT04630522|Calcium|calcium|mesh-list
1834278|NCT04630522|Vitamins|vitamins|mesh-ancestor
1834279|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
1834280|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834281|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1834282|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1834283|NCT04630444|Riluzole|riluzole|mesh-list
1834284|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
1834285|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1834286|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1834287|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834288|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834289|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834290|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1834291|NCT04630444|Protective Agents|protective agents|mesh-ancestor
1834292|NCT04630548|Copper|copper|mesh-list
1834293|NCT04630548|Trace Elements|trace elements|mesh-ancestor
1834294|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
1834295|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834296|NCT04630288|Clopidogrel|clopidogrel|mesh-list
1834297|NCT04630288|Ticagrelor|ticagrelor|mesh-list
1834298|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1834299|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1834300|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1834301|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1834302|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
1834303|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834304|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834305|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834306|NCT04630171|Anesthetics|anesthetics|mesh-list
1834307|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834308|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834309|NCT04629885|Oxytocin|oxytocin|mesh-list
1834310|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
1834311|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1834312|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834313|NCT04629976|Tenofovir|tenofovir|mesh-list
1834314|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
1834315|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1834316|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1834317|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1834318|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834319|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834320|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1834321|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1834322|NCT04630210|Letrozole|letrozole|mesh-list
1834323|NCT04630210|Atezolizumab|atezolizumab|mesh-list
1834324|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834325|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1834326|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1834327|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834328|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834329|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1834330|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
1834331|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1834332|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834355|NCT04629547|Suvorexant|suvorexant|mesh-list
1834356|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1834357|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1834358|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834359|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834360|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
1834361|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834362|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834363|NCT04629495|Sirolimus|sirolimus|mesh-list
1834364|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1834365|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1834366|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1834367|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834368|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
1834369|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1834370|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
1834371|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834372|NCT04629846|Docetaxel|docetaxel|mesh-list
1834373|NCT04629846|Trastuzumab|trastuzumab|mesh-list
1834374|NCT04629846|Pertuzumab|pertuzumab|mesh-list
1834375|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834376|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
1834377|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
1834378|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
1834379|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834380|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1834387|NCT04629573|Anesthetics|anesthetics|mesh-list
1834388|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834389|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834396|NCT04629443|Azacitidine|azacitidine|mesh-list
1834397|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1834398|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
1834399|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834400|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834401|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834402|NCT04629612|Anesthetics|anesthetics|mesh-list
1834403|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834404|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834405|NCT04629144|Belimumab|belimumab|mesh-list
1834406|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1834407|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
1834408|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834409|NCT04629209|TIC10 compound|tic10 compound|mesh-list
1834410|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834411|NCT04629248|Acetaminophen|acetaminophen|mesh-list
1834412|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
1834413|NCT04629248|Promethazine|promethazine|mesh-list
1834414|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
1834415|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
1834416|NCT04629248|Tacrolimus|tacrolimus|mesh-list
1834417|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1834418|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
1834419|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834420|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1834421|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834422|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834423|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1834424|NCT04629248|Analgesics|analgesics|mesh-ancestor
1834425|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
1834426|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834427|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
1834428|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1834429|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
1834430|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
1834431|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1834432|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
1834433|NCT04629248|Hormones|hormones|mesh-ancestor
1834434|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1834435|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1834436|NCT04629248|Protective Agents|protective agents|mesh-ancestor
1834437|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834438|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1834439|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1834440|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1834441|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834442|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
1834443|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
1834444|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1834445|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
1834446|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
1834447|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834448|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1834449|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
1834450|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
1834464|NCT04629196|Ustekinumab|ustekinumab|mesh-list
1834465|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
1834466|NCT04628884|Heparin|heparin|mesh-list
1834467|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
1834468|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1834469|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1834470|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834471|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1834472|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834473|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834474|NCT04629118|Sirolimus|sirolimus|mesh-list
1834475|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1834476|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1834477|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1834478|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834479|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
1834480|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1834481|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
1834482|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834483|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
1834484|NCT04628559|Ketamine|ketamine|mesh-list
1834485|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1834486|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834487|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834488|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1834489|NCT04628559|Analgesics|analgesics|mesh-ancestor
1834490|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
1834491|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834492|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1834493|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1834494|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1834495|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
1834496|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834497|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834498|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1834499|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1834500|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
1834501|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
1834502|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1834503|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1834504|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
1834505|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1834506|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834507|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834508|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1834509|NCT04628663|Analgesics|analgesics|mesh-ancestor
1834510|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
1834511|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834512|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1834513|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1834514|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1834515|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
1834516|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834517|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834518|NCT04628676|Epinephrine|epinephrine|mesh-list
1834519|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
1834520|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
1834521|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1834522|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1834523|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
1834524|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834525|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834526|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834527|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1834528|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1834529|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
1834530|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834531|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1834532|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
1834533|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
1834534|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
1834535|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1834536|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1834537|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1834538|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
1834539|NCT04628676|Coagulants|coagulants|mesh-ancestor
1834540|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
1834541|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1834542|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1834543|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834544|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1834545|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1834546|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834552|NCT04628429|Erenumab|erenumab|mesh-list
1834553|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1834554|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834555|NCT04628429|Analgesics|analgesics|mesh-ancestor
1834556|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
1834557|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834558|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834559|NCT04628325|Furosemide|furosemide|mesh-list
1834560|NCT04628325|Diuretics|diuretics|mesh-ancestor
1834561|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
1834562|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834563|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1834564|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1834565|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834574|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
1834575|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1834576|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1834577|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
1834578|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834579|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834580|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834581|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
1834582|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
1834583|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834584|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
1834585|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1834586|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
1834587|NCT04628624|Antioxidants|antioxidants|mesh-list
1834588|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834589|NCT04628624|Protective Agents|protective agents|mesh-ancestor
1834590|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834603|NCT04628000|Vitamin D|vitamin d|mesh-list
1834604|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
1834605|NCT04628000|Vitamins|vitamins|mesh-list
1834606|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
1834607|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834608|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1834609|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1834610|NCT04628026|Venetoclax|venetoclax|mesh-list
1834611|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834612|NCT04627870|Paclitaxel|paclitaxel|mesh-list
1834613|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1834614|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834615|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
1834616|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
1834617|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
1834618|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834619|NCT04628143|Nafamostat|nafamostat|mesh-list
1834620|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1834621|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1834622|NCT04628143|Analgesics|analgesics|mesh-ancestor
1834623|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
1834624|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834625|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834626|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1834627|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1834628|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
1834629|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
1834630|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834631|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834632|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1834633|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1834634|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1834635|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1834636|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
1834637|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
1834638|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
1834639|NCT04627779|Analgesics|analgesics|mesh-ancestor
1834640|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
1834641|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834642|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834643|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1834644|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1834645|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1834646|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1834647|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1834648|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834649|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834650|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1834651|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1834652|NCT04627467|Chloroquine|chloroquine|mesh-list
1834653|NCT04627467|Amebicides|amebicides|mesh-ancestor
1834654|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1834655|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1834656|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1834657|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
1834658|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1834659|NCT04627623|Antibodies|antibodies|mesh-list
1834660|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
1834661|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
1834662|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834663|NCT04627753|Rituximab|rituximab|mesh-list
1834664|NCT04627753|Lenalidomide|lenalidomide|mesh-list
1834665|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1834666|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834667|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
1834668|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834669|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1834670|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1834671|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1834672|NCT04627753|Growth Substances|growth substances|mesh-ancestor
1834673|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
1834674|NCT04627363|Bevacizumab|bevacizumab|mesh-list
1834675|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1834676|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834677|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1834678|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1834679|NCT04627363|Growth Substances|growth substances|mesh-ancestor
1834680|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834681|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
1834682|NCT04627298|Vaccines|vaccines|mesh-list
1834683|NCT04627298|Immunologic Factors|immunologic factors|mesh-ancestor
1834684|NCT04627298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834685|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
1834686|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
1834687|NCT04627181|Hematinics|hematinics|mesh-ancestor
1834688|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
1834689|NCT04627181|Vitamins|vitamins|mesh-ancestor
1834690|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
1834691|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834692|NCT04627246|Vaccines|vaccines|mesh-list
1834693|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
1834694|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834695|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
1834696|NCT04627012|Lenvatinib|lenvatinib|mesh-list
1834697|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1834698|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834699|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834700|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1834701|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834702|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
1834703|NCT04626739|Fludarabine|fludarabine|mesh-list
1834704|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1834705|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
1834706|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834707|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1834708|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1834709|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
1834710|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834711|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834712|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1834713|NCT04627129|Itraconazole|itraconazole|mesh-list
1834714|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
1834715|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1834716|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1834717|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1834718|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834719|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834720|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1834721|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
1834722|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1834723|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834724|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1834725|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1834726|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1834727|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1834728|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
1834729|NCT04626765|Fludarabine|fludarabine|mesh-list
1834730|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1834731|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
1834732|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834733|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1834734|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1834735|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
1834736|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834737|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834738|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1834739|NCT04626791|Cytarabine|cytarabine|mesh-list
1834740|NCT04626791|Prednisone|prednisone|mesh-list
1834741|NCT04626791|Cortisone|cortisone|mesh-list
1834742|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
1834743|NCT04626791|Rituximab|rituximab|mesh-list
1834744|NCT04626791|Doxorubicin|doxorubicin|mesh-list
1834745|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1834746|NCT04626791|Bortezomib|bortezomib|mesh-list
1834747|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
1834748|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
1834749|NCT04626791|Antibodies|antibodies|mesh-list
1834750|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
1834751|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1834752|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1834753|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
1834754|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834755|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1834756|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1834757|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
1834758|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834759|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834760|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1834761|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1834762|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1834763|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1834764|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834765|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1834766|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
1834767|NCT04626791|Hormones|hormones|mesh-ancestor
1834768|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1834769|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1834770|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1834771|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
1834772|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
1834773|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1834774|NCT04626973|Ezetimibe|ezetimibe|mesh-list
1834775|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1834776|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1834777|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1834778|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
1834779|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834780|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1834781|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834782|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
1834783|NCT04626752|Fludarabine|fludarabine|mesh-list
1834784|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1834785|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
1834786|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834787|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1834788|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1834789|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
1834790|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834791|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834792|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1834793|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
1834794|NCT04626726|Fludarabine|fludarabine|mesh-list
1834795|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1834796|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
1834797|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834798|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1834799|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1834800|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
1834801|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834802|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834803|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1834804|NCT04626414|Ferric maltol|ferric maltol|mesh-list
1834805|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
1834806|NCT04626414|Hematinics|hematinics|mesh-ancestor
1834807|NCT04626089|Metformin|metformin|mesh-list
1834808|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1834809|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834810|NCT04626193|Amoxicillin|amoxicillin|mesh-list
1834811|NCT04626193|Doxycycline|doxycycline|mesh-list
1834812|NCT04626193|Levofloxacin|levofloxacin|mesh-list
1834813|NCT04626193|Ofloxacin|ofloxacin|mesh-list
1834814|NCT04626193|Esomeprazole|esomeprazole|mesh-list
1834815|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1834816|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1834817|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1834818|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1834819|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1834820|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834821|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834822|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
1834823|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1834824|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1834825|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
1834826|NCT04626193|Renal Agents|renal agents|mesh-ancestor
1834827|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1834828|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1834829|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834830|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1834831|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1834832|NCT04626258|Fluconazole|fluconazole|mesh-list
1834833|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
1834834|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1834835|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1834836|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1834837|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834838|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834839|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1834840|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
1834841|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1834842|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834843|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1834844|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1834856|NCT04626063|Acetaminophen|acetaminophen|mesh-list
1834857|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
1834858|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1834859|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1834860|NCT04626063|Analgesics|analgesics|mesh-ancestor
1834861|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
1834862|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834863|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834864|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
1834865|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1834877|NCT04625985|Metformin|metformin|mesh-list
1834878|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1834879|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834883|NCT04625777|Vaccines|vaccines|mesh-list
1834884|NCT04625777|Immunologic Factors|immunologic factors|mesh-ancestor
1834885|NCT04625777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834886|NCT04625907|Dactinomycin|dactinomycin|mesh-list
1834887|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
1834888|NCT04625907|Temozolomide|temozolomide|mesh-list
1834889|NCT04625907|Ifosfamide|ifosfamide|mesh-list
1834890|NCT04625907|Doxorubicin|doxorubicin|mesh-list
1834891|NCT04625907|Irinotecan|irinotecan|mesh-list
1834892|NCT04625907|Vincristine|vincristine|mesh-list
1834893|NCT04625907|Vinorelbine|vinorelbine|mesh-list
1834894|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1834895|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
1834896|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834897|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1834898|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1834899|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
1834900|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834901|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834902|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1834903|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1834904|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1834905|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1834906|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1834907|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1834908|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1834909|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
1834910|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
1834911|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
1834912|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1834913|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1834914|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1834915|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1834916|NCT04625699|Durvalumab|durvalumab|mesh-list
1834917|NCT04625699|Tremelimumab|tremelimumab|mesh-list
1834918|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1834919|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834920|NCT04625608|Acetaminophen|acetaminophen|mesh-list
1834921|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1834922|NCT04625608|Analgesics|analgesics|mesh-ancestor
1834923|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
1834924|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834925|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834926|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
1834927|NCT04625595|Methyldopa|methyldopa|mesh-list
1834928|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1834929|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
1834930|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
1834931|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834932|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834933|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1834934|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1834935|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1834936|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
1834937|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834938|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834939|NCT04625283|Ketamine|ketamine|mesh-list
1834940|NCT04625283|Analgesics|analgesics|mesh-ancestor
1834941|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
1834942|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834943|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834944|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1834945|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1834946|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
1834947|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
1834948|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834949|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1834950|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1834951|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1834952|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834953|NCT04625257|Antibodies|antibodies|mesh-list
1834954|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
1834955|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834956|NCT04625543|Paclitaxel|paclitaxel|mesh-list
1834957|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1834958|NCT04625543|Cisplatin|cisplatin|mesh-list
1834959|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1834960|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1834961|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
1834962|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
1834963|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
1834964|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834965|NCT04625426|Protective Agents|protective agents|mesh-list
1834966|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834967|NCT04625179|Melatonin|melatonin|mesh-list
1834968|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
1834969|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
1834970|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834971|NCT04625179|Protective Agents|protective agents|mesh-ancestor
1834972|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834973|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1834974|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1834975|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
1834976|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
1834977|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
1834978|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
1834979|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1834980|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1834981|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1834982|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
1834983|NCT04625530|Coagulants|coagulants|mesh-ancestor
1834984|NCT04625530|Hematinics|hematinics|mesh-ancestor
1834985|NCT04625088|Atropine|atropine|mesh-list
1834986|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1834987|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1834988|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1834989|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
1834990|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1834991|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1834992|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1834993|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
1834994|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
1834995|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
1834996|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1834997|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1834998|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
1834999|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835000|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835001|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1835002|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
1835003|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
1835004|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835005|NCT04624958|Rituximab|rituximab|mesh-list
1835006|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
1835007|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1835008|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835009|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
1835010|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835011|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1835012|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1835013|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835014|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835015|NCT04624984|Gemcitabine|gemcitabine|mesh-list
1835016|NCT04624984|Doxorubicin|doxorubicin|mesh-list
1835017|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
1835018|NCT04624984|Vinorelbine|vinorelbine|mesh-list
1835019|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1835020|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1835021|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
1835022|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835023|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835024|NCT04624984|Antiviral Agents|antiviral agents|mesh-ancestor
1835025|NCT04624984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835026|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835027|NCT04624984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1835028|NCT04624984|Immunologic Factors|immunologic factors|mesh-ancestor
1835029|NCT04624984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835030|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1835031|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1835032|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1835033|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1835034|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
1835035|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
1835036|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
1835037|NCT04624906|Rituximab|rituximab|mesh-list
1835038|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1835039|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
1835040|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1835041|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835042|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
1835043|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835044|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1835045|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1835046|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
1835047|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835048|NCT04625114|Gabexate|gabexate|mesh-list
1835049|NCT04625114|Camostat|camostat|mesh-list
1835050|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
1835051|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835052|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835053|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1835054|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1835055|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
1835059|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
1835060|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1835061|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1835062|NCT04624776|Prednisolone|prednisolone|mesh-list
1835063|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
1835064|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1835065|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
1835066|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1835067|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
1835068|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
1835069|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835070|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835071|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1835072|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
1835073|NCT04624776|Hormones|hormones|mesh-ancestor
1835074|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1835075|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1835076|NCT04624776|Protective Agents|protective agents|mesh-ancestor
1835077|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1835078|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835079|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
1835080|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835081|NCT04624750|Mexiletine|mexiletine|mesh-list
1835082|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1835083|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1835084|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1835085|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1835086|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835087|NCT04624828|Androgens|androgens|mesh-list
1835088|NCT04624828|Hormones|hormones|mesh-ancestor
1835089|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1835090|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835091|NCT04624295|Aspirin|aspirin|mesh-list
1835092|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1835093|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1835094|NCT04624295|Analgesics|analgesics|mesh-ancestor
1835095|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
1835096|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835097|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835098|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1835099|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1835100|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1835101|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1835102|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835103|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1835104|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1835105|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835106|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
1835107|NCT04624399|Atezolizumab|atezolizumab|mesh-list
1835108|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835109|NCT04624178|Nivolumab|nivolumab|mesh-list
1835110|NCT04624178|Rucaparib|rucaparib|mesh-list
1835111|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1835112|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835113|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1835114|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835115|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1835116|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835117|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
1835118|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
1835119|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1835120|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1835121|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835122|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835123|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835124|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1835125|NCT04624360|Dexamethasone|dexamethasone|mesh-list
1835126|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1835127|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
1835128|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
1835129|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835130|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835131|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1835132|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
1835133|NCT04624360|Hormones|hormones|mesh-ancestor
1835134|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1835135|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1835136|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835137|NCT04624451|Dalbavancin|dalbavancin|mesh-list
1835138|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1835139|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835140|NCT04623879|Ivacaftor|ivacaftor|mesh-list
1835141|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1835142|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1835143|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835144|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
1835145|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1835146|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835147|NCT04624217|Gemcitabine|gemcitabine|mesh-list
1835148|NCT04624217|Paclitaxel|paclitaxel|mesh-list
1835149|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1835150|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835151|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
1835152|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
1835153|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
1835154|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835155|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1835156|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
1835157|NCT04624217|Antiviral Agents|antiviral agents|mesh-ancestor
1835158|NCT04624217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835159|NCT04624217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835160|NCT04624217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1835161|NCT04624217|Immunologic Factors|immunologic factors|mesh-ancestor
1835162|NCT04624217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835163|NCT04623866|Valsartan|valsartan|mesh-list
1835164|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1835165|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1835166|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1835167|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835168|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
1835169|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
1835170|NCT04623619|Vitamins|vitamins|mesh-ancestor
1835171|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
1835172|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835173|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
1835188|NCT04623684|Phenylephrine|phenylephrine|mesh-list
1835189|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
1835190|NCT04623684|Tropicamide|tropicamide|mesh-list
1835191|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1835192|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
1835193|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
1835194|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835195|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835196|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
1835197|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1835198|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
1835199|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
1835200|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1835201|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1835202|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1835203|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
1835204|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835205|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835206|NCT04623684|Protective Agents|protective agents|mesh-ancestor
1835207|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1835208|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1835209|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
1835210|NCT04623840|Tadalafil|tadalafil|mesh-list
1835211|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
1835212|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
1835213|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1835214|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835215|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835216|NCT04623840|Urological Agents|urological agents|mesh-ancestor
1835226|NCT04623086|Insulin|insulin|mesh-list
1835227|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1835228|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
1835229|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1835230|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835231|NCT04623385|Tretinoin|tretinoin|mesh-list
1835232|NCT04623385|Isotretinoin|isotretinoin|mesh-list
1835233|NCT04623385|Testosterone|testosterone|mesh-list
1835234|NCT04623385|Androgens|androgens|mesh-ancestor
1835235|NCT04623385|Hormones|hormones|mesh-ancestor
1835236|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1835237|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835238|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835239|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
1835240|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
1835247|NCT04623242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1835248|NCT04623242|Immunologic Factors|immunologic factors|mesh-ancestor
1835249|NCT04623242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835250|NCT04623099|Citalopram|citalopram|mesh-list
1835251|NCT04623099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1835252|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1835253|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1835254|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835255|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835256|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
1835257|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835258|NCT04623099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1835259|NCT04623099|Antidepressive Agents|antidepressive agents|mesh-ancestor
1835260|NCT04623099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1835261|NCT04623021|Nafamostat|nafamostat|mesh-list
1835262|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1835263|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1835264|NCT04623021|Analgesics|analgesics|mesh-ancestor
1835265|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
1835266|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835267|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835268|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1835269|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1835270|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
1835271|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
1835272|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835273|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835274|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1835275|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1835276|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
1835277|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1835278|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
1835279|NCT04622618|Gabapentin|gabapentin|mesh-list
1835280|NCT04622618|Analgesics|analgesics|mesh-ancestor
1835281|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
1835282|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835283|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835284|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
1835285|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1835286|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1835287|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1835288|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1835289|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1835290|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1835291|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835292|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835293|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
1835294|NCT04622865|Quercetin|quercetin|mesh-list
1835295|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
1835296|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835297|NCT04622865|Protective Agents|protective agents|mesh-ancestor
1835298|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835299|NCT04622995|Diazepam|diazepam|mesh-list
1835300|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1835301|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
1835302|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
1835303|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
1835304|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835305|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835306|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1835307|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1835308|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1835309|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
1835310|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1835311|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1835312|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1835313|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1835314|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1835315|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
1835316|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
1835317|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
1835318|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
1835319|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835320|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835321|NCT04622904|Lidocaine|lidocaine|mesh-list
1835322|NCT04622904|Ketamine|ketamine|mesh-list
1835323|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
1835324|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
1835325|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1835326|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835327|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
1835328|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835329|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1835330|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1835331|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1835332|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1835333|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835334|NCT04622904|Analgesics|analgesics|mesh-ancestor
1835335|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1835336|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1835337|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
1835338|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1835339|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1835340|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835341|NCT04622709|Furosemide|furosemide|mesh-list
1835342|NCT04622709|Diuretics|diuretics|mesh-list
1835343|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
1835344|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
1835345|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835346|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1835347|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835348|NCT04622956|Methotrexate|methotrexate|mesh-list
1835349|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1835350|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
1835351|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1835352|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835353|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1835354|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
1835355|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835356|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835357|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
1835358|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835359|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1835360|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1835361|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
1835362|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1835363|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1835364|NCT04622891|Azithromycin|azithromycin|mesh-list
1835365|NCT04622891|Clarithromycin|clarithromycin|mesh-list
1835366|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1835367|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835368|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1835369|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835370|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835371|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1835372|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1835373|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
1835374|NCT04622566|Lenvatinib|lenvatinib|mesh-list
1835375|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1835376|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835377|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1835378|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835379|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835380|NCT04622813|Acetaminophen|acetaminophen|mesh-list
1835381|NCT04622813|Ketoprofen|ketoprofen|mesh-list
1835382|NCT04622813|Nefopam|nefopam|mesh-list
1835383|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1835384|NCT04622813|Analgesics|analgesics|mesh-ancestor
1835385|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
1835386|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835387|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835388|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
1835389|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1835390|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1835391|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1835392|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1835393|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835394|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835395|NCT04622579|Rituximab|rituximab|mesh-list
1835396|NCT04622579|Lenalidomide|lenalidomide|mesh-list
1835397|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1835398|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835399|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
1835400|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835401|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1835402|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1835403|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1835404|NCT04622579|Growth Substances|growth substances|mesh-ancestor
1835405|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
1835406|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
1835407|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1835408|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1835409|NCT04622917|Prednisolone|prednisolone|mesh-list
1835410|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
1835411|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1835412|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
1835413|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1835414|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
1835415|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
1835416|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835417|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835418|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1835419|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
1835420|NCT04622917|Hormones|hormones|mesh-ancestor
1835421|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1835422|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1835423|NCT04622917|Protective Agents|protective agents|mesh-ancestor
1835424|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1835425|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835426|NCT04622982|Vitamin D|vitamin d|mesh-list
1835427|NCT04622982|Vitamins|vitamins|mesh-ancestor
1835428|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
1835429|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835430|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1835446|NCT04622488|Diclofenac|diclofenac|mesh-list
1835447|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1835448|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1835449|NCT04622488|Analgesics|analgesics|mesh-ancestor
1835450|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
1835451|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835452|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835453|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1835454|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1835455|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1835456|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835457|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835458|NCT04622202|Pregabalin|pregabalin|mesh-list
1835459|NCT04622202|Analgesics|analgesics|mesh-ancestor
1835460|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
1835461|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835462|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835463|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
1835464|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1835465|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1835466|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835467|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1835468|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1835469|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1835470|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1835471|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1835472|NCT04622358|Rabeprazole|rabeprazole|mesh-list
1835473|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1835474|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1835475|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1835476|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835477|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835484|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
1835485|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1835486|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1835487|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835488|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
1835489|NCT04622397|Coagulants|coagulants|mesh-ancestor
1835490|NCT04622111|Metformin|metformin|mesh-list
1835491|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1835492|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835495|NCT04621929|Topiramate|topiramate|mesh-list
1835496|NCT04621929|Phentermine|phentermine|mesh-list
1835497|NCT04621929|Allopurinol|allopurinol|mesh-list
1835498|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835499|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
1835500|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1835501|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835502|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
1835503|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835504|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
1835505|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1835506|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1835507|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
1835508|NCT04621929|Protective Agents|protective agents|mesh-ancestor
1835509|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1835510|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
1835511|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1835512|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
1835513|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
1835514|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835515|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
1835516|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835517|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1835518|NCT04622020|Anesthetics|anesthetics|mesh-list
1835519|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1835520|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835521|NCT04622033|Brodalumab|brodalumab|mesh-list
1835522|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
1835523|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
1835524|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
1835525|NCT04621799|Coagulants|coagulants|mesh-ancestor
1835533|NCT04621370|Capecitabine|capecitabine|mesh-list
1835534|NCT04621370|Durvalumab|durvalumab|mesh-list
1835535|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1835536|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
1835537|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835538|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835539|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1835540|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
1835541|NCT04621461|Astringents|astringents|mesh-ancestor
1835542|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835543|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
1835544|NCT04621487|Amoxicillin|amoxicillin|mesh-list
1835545|NCT04621487|Metronidazole|metronidazole|mesh-list
1835546|NCT04621487|Clarithromycin|clarithromycin|mesh-list
1835547|NCT04621487|Pantoprazole|pantoprazole|mesh-list
1835548|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1835549|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835550|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1835551|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1835552|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1835553|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835554|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835555|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1835556|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1835557|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1835558|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1835559|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1835560|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
1835561|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1835562|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1835563|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1835564|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1835565|NCT04621617|Midodrine|midodrine|mesh-list
1835566|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
1835567|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
1835568|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835569|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835570|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1835571|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1835572|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1835573|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1835574|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
1835575|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835576|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835577|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
1835578|NCT04621526|Ketamine|ketamine|mesh-list
1835579|NCT04621526|Propofol|propofol|mesh-list
1835580|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1835581|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1835582|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835583|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1835584|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
1835585|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
1835586|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1835587|NCT04621526|Analgesics|analgesics|mesh-ancestor
1835588|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
1835589|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835590|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1835591|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1835592|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1835593|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
1835594|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835595|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835596|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1835597|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1835598|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1835599|NCT04621669|Metformin|metformin|mesh-list
1835600|NCT04621669|Digoxin|digoxin|mesh-list
1835601|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1835602|NCT04621669|Calcium|calcium|mesh-list
1835603|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1835604|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835605|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1835606|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1835607|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1835608|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
1835609|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835610|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1835611|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1835612|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835613|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1835614|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1835615|NCT04621669|Protective Agents|protective agents|mesh-ancestor
1835616|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
1835617|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1835618|NCT04621318|Denosumab|denosumab|mesh-list
1835619|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1835620|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835621|NCT04621227|Midazolam|midazolam|mesh-list
1835622|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1835623|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1835624|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1835625|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1835626|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835627|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1835628|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1835629|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1835630|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1835631|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
1835632|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
1835633|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
1835634|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
1835635|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835636|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835637|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1835638|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1835639|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
1835640|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1835641|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1835642|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835643|NCT04621513|Montelukast|montelukast|mesh-list
1835644|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1835645|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
1835646|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1835647|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
1835648|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1835649|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835650|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1835651|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1835652|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835653|NCT04621149|Lactoferrin|lactoferrin|mesh-list
1835654|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
1835655|NCT04621149|Famotidine|famotidine|mesh-list
1835656|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1835657|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1835658|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1835659|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
1835660|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
1835661|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835662|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835663|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835664|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835665|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
1835666|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
1835667|NCT04620954|Nivolumab|nivolumab|mesh-list
1835668|NCT04620954|Oregovomab|oregovomab|mesh-list
1835669|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1835670|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835671|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1835672|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835673|NCT04621253|Dipyrone|dipyrone|mesh-list
1835674|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1835675|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1835676|NCT04621253|Analgesics|analgesics|mesh-ancestor
1835677|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
1835678|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835679|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835680|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1835681|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1835682|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
1835683|NCT04621058|Vitamin D|vitamin d|mesh-list
1835684|NCT04621058|Vitamins|vitamins|mesh-list
1835685|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
1835686|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835687|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1835688|NCT04621110|Fentanyl|fentanyl|mesh-list
1835689|NCT04621110|Midazolam|midazolam|mesh-list
1835690|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
1835691|NCT04621110|Ketamine|ketamine|mesh-list
1835692|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1835693|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1835694|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835695|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1835696|NCT04621110|Analgesics|analgesics|mesh-ancestor
1835697|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
1835698|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835699|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1835700|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1835701|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1835702|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
1835703|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835704|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835705|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1835706|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1835707|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
1835708|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
1835784|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
1835709|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1835710|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1835711|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1835712|NCT04621110|Narcotics|narcotics|mesh-ancestor
1835713|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1835714|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1835715|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1835716|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1835717|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
1835718|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
1835719|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1835720|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1835721|NCT04620967|Insulin|insulin|mesh-list
1835722|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1835723|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
1835724|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
1835725|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
1835726|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1835727|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835731|NCT04620785|Methylene Blue|methylene blue|mesh-list
1835732|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835733|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835734|NCT04620720|Gabapentin|gabapentin|mesh-list
1835735|NCT04620720|Analgesics|analgesics|mesh-ancestor
1835736|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
1835737|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835738|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835739|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
1835740|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1835741|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1835742|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1835743|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1835744|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1835745|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1835746|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835747|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835748|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
1835749|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
1835750|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1835751|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835752|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1835753|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835754|NCT04620603|Nivolumab|nivolumab|mesh-list
1835755|NCT04620603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1835756|NCT04620603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835757|NCT04620603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1835758|NCT04620603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835759|NCT04620616|Menthol|menthol|mesh-list
1835760|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
1835761|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
1835762|NCT04620473|Oxaliplatin|oxaliplatin|mesh-list
1835763|NCT04620473|Capecitabine|capecitabine|mesh-list
1835764|NCT04620473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835765|NCT04620473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1835766|NCT04620473|Antimetabolites|antimetabolites|mesh-ancestor
1835767|NCT04620473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835768|NCT04620759|Psilocybin|psilocybin|mesh-list
1835769|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
1835770|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
1835771|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835772|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1835773|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1835774|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
1835775|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835776|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835777|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1835778|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
1835779|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1835780|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
1835781|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835782|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1835783|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1835785|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835786|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835787|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1835788|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1835789|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835790|NCT04620018|Amoxicillin|amoxicillin|mesh-list
1835791|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1835792|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835793|NCT04620031|Propofol|propofol|mesh-list
1835794|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1835795|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1835796|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835797|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1835798|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
1835799|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
1835800|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1835801|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1835802|NCT04620200|Nivolumab|nivolumab|mesh-list
1835803|NCT04620200|Ipilimumab|ipilimumab|mesh-list
1835804|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
1835805|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1835806|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835807|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1835808|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835809|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835810|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1835811|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1835823|NCT04620343|Anesthetics|anesthetics|mesh-list
1835824|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1835825|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835826|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
1835827|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
1835828|NCT04620252|Calcium|calcium|mesh-list
1835829|NCT04620252|Fluorides|fluorides|mesh-list
1835830|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1835831|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835832|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1835833|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835834|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
1835835|NCT04620252|Protective Agents|protective agents|mesh-ancestor
1835836|NCT04620252|Antacids|antacids|mesh-ancestor
1835837|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1835838|NCT04620291|UB-421|ub-421|mesh-list
1835839|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1835840|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
1835841|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835842|NCT04620304|UB-421|ub-421|mesh-list
1835843|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1835844|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
1835845|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835846|NCT04620213|Phentolamine|phentolamine|mesh-list
1835847|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1835848|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1835849|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1835850|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1835851|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
1835852|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835853|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835854|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835855|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1835856|NCT04619758|Emollients|emollients|mesh-list
1835857|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
1835858|NCT04619706|Palmidrol|palmidrol|mesh-list
1835859|NCT04619706|Analgesics|analgesics|mesh-ancestor
1835860|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
1835861|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835862|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835863|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1835864|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1835865|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1835866|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1835867|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
1835868|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835869|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1835870|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1835871|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835872|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835873|NCT04619706|Hormones|hormones|mesh-ancestor
1835874|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1835875|NCT04619914|Letrozole|letrozole|mesh-list
1835876|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835877|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1835878|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1835879|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835880|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835881|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1835882|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
1835883|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1835884|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835885|NCT04619875|Lactulose|lactulose|mesh-list
1835886|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1835887|NCT04619862|Gabapentin|gabapentin|mesh-list
1835888|NCT04619862|Analgesics|analgesics|mesh-ancestor
1835889|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
1835890|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835891|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835892|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
1835893|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1835894|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1835895|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1835896|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1835897|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1835898|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1835899|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835900|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835901|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
1835902|NCT04619290|Methylene Blue|methylene blue|mesh-list
1835903|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835904|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835905|NCT04619303|Dexamethasone|dexamethasone|mesh-list
1835906|NCT04619303|Bevacizumab|bevacizumab|mesh-list
1835907|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1835908|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835909|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1835910|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1835911|NCT04619303|Growth Substances|growth substances|mesh-ancestor
1835912|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835913|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
1835914|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1835915|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
1835916|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
1835917|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835918|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1835919|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
1835920|NCT04619303|Hormones|hormones|mesh-ancestor
1835921|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1835922|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1835923|NCT04619537|Docetaxel|docetaxel|mesh-list
1835924|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835925|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
1835926|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
1835927|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
1835928|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835929|NCT04619563|Docetaxel|docetaxel|mesh-list
1835930|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835931|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
1835932|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
1835933|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
1835934|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835935|NCT04619316|Trametinib|trametinib|mesh-list
1835936|NCT04619316|Dabrafenib|dabrafenib|mesh-list
1835937|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1835938|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1835939|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835940|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835941|NCT04619251|Itraconazole|itraconazole|mesh-list
1835942|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
1835943|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835944|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1835945|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1835946|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835947|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835948|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1835949|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
1835950|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1835951|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835952|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1835953|NCT04619381|Clopidogrel|clopidogrel|mesh-list
1835954|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1835955|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
1835956|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
1835957|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
1835958|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
1835959|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835960|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835961|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835962|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
1835963|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1835964|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1835965|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1835966|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1835967|NCT04618965|Analgesics|analgesics|mesh-ancestor
1835968|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
1835969|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1835970|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1835971|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1835972|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1835973|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
1835974|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1835975|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835976|NCT04619095|Psyllium|psyllium|mesh-list
1835977|NCT04619095|Cathartics|cathartics|mesh-ancestor
1835978|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1835979|NCT04619082|Tenofovir|tenofovir|mesh-list
1835980|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
1835981|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1835982|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1835983|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1835984|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835985|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835986|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1835987|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1835988|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
1835989|NCT04618913|Apixaban|apixaban|mesh-list
1835990|NCT04618913|Edoxaban|edoxaban|mesh-list
1835991|NCT04618913|Dabigatran|dabigatran|mesh-list
1835992|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1835993|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
1835994|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1835995|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
1835996|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1835997|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1835998|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
1835999|NCT04618952|Calcium|calcium|mesh-list
1836000|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1836001|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836002|NCT04619433|Carboplatin|carboplatin|mesh-list
1836003|NCT04619433|Pemetrexed|pemetrexed|mesh-list
1836004|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836005|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836006|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836007|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1836008|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1836009|NCT04619160|Propofol|propofol|mesh-list
1836010|NCT04619160|Sevoflurane|sevoflurane|mesh-list
1836011|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1836012|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836013|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836014|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1836015|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
1836016|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
1836017|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1836018|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1836019|NCT04619069|Hormones|hormones|mesh-list
1836020|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1836021|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836022|NCT04618497|Ketorolac|ketorolac|mesh-list
1836023|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
1836024|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1836025|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1836026|NCT04618497|Analgesics|analgesics|mesh-ancestor
1836027|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
1836028|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836029|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836030|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1836031|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1836032|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1836033|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836034|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836035|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1836036|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
1836037|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
1836038|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836039|NCT04618367|Lenvatinib|lenvatinib|mesh-list
1836040|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836041|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1836042|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836043|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836044|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1836045|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1836046|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1836047|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
1836048|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1836049|NCT04618536|Protective Agents|protective agents|mesh-ancestor
1836050|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836051|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
1836052|NCT04618601|Spironolactone|spironolactone|mesh-list
1836053|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
1836054|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
1836055|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1836056|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836057|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
1836058|NCT04618601|Diuretics|diuretics|mesh-ancestor
1836059|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
1836064|NCT04618107|Anesthetics|anesthetics|mesh-list
1836065|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836066|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836067|NCT04618146|Morphine|morphine|mesh-list
1836068|NCT04618146|Bupivacaine|bupivacaine|mesh-list
1836069|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
1836070|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
1836071|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836072|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836073|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
1836074|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836075|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1836076|NCT04618146|Narcotics|narcotics|mesh-ancestor
1836077|NCT04618146|Analgesics|analgesics|mesh-ancestor
1836078|NCT04618289|Vitamin D|vitamin d|mesh-list
1836079|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
1836080|NCT04618289|Vitamins|vitamins|mesh-ancestor
1836081|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
1836082|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836083|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1836084|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1836085|NCT04618328|Tretinoin|tretinoin|mesh-list
1836086|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836087|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
1836088|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
1836089|NCT04617782|Donepezil|donepezil|mesh-list
1836090|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1836091|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836092|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836093|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
1836094|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1836095|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836096|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
1836124|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
1836125|NCT04617938|Narcotics|narcotics|mesh-ancestor
1836126|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836127|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836128|NCT04617938|Analgesics|analgesics|mesh-ancestor
1836129|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
1836130|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836131|NCT04617613|Amoxicillin|amoxicillin|mesh-list
1836132|NCT04617613|Metronidazole|metronidazole|mesh-list
1836133|NCT04617613|Clarithromycin|clarithromycin|mesh-list
1836134|NCT04617613|Omeprazole|omeprazole|mesh-list
1836135|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1836136|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1836137|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1836138|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1836139|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1836140|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1836141|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
1836142|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836143|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836144|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1836145|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1836146|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1836147|NCT04617626|Azithromycin|azithromycin|mesh-list
1836148|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1836149|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1836150|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
1836151|NCT04617652|Analgesics|analgesics|mesh-ancestor
1836152|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
1836153|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836154|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836155|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
1836156|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836157|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1836158|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
1836159|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1836160|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1836161|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836162|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1836163|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
1836164|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1836165|NCT04617795|Insulin|insulin|mesh-list
1836166|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1836167|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836168|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
1836169|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1836170|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1836171|NCT04617561|Prednisolone|prednisolone|mesh-list
1836172|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
1836173|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
1836174|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1836175|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
1836176|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
1836177|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1836178|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
1836179|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
1836180|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836181|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836182|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1836183|NCT04617561|Hormones|hormones|mesh-ancestor
1836184|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1836185|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1836186|NCT04617561|Protective Agents|protective agents|mesh-ancestor
1836187|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1836188|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836189|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
1836190|NCT04617483|Vaccines|vaccines|mesh-list
1836191|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
1836192|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836193|NCT04617249|Anesthetics|anesthetics|mesh-list
1836194|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836195|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836196|NCT04617171|Benralizumab|benralizumab|mesh-list
1836197|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1836198|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
1836210|NCT04616872|Methotrexate|methotrexate|mesh-list
1836211|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1836212|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
1836213|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1836214|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836215|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1836216|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
1836217|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836218|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836219|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
1836220|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836221|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1836222|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1836223|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
1836224|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1836225|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1836226|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
1836227|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
1836228|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1836229|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
1836230|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1836231|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836232|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1836233|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1836234|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836235|NCT04616807|Mexiletine|mexiletine|mesh-list
1836236|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1836237|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1836238|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1836239|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1836240|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836241|NCT04617015|Bromides|bromides|mesh-list
1836242|NCT04617015|Ipratropium|ipratropium|mesh-list
1836243|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
1836244|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1836245|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
1836246|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836247|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836248|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1836249|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
1836250|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1836251|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
1836252|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1836253|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836254|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
1836255|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836256|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
1836257|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836258|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836259|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1836260|NCT04616859|Ethanol|ethanol|mesh-list
1836261|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1836262|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1836263|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836264|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836265|NCT04616586|Siltuximab|siltuximab|mesh-list
1836266|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836267|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
1836268|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1836269|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
1836270|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836271|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836272|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1836273|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
1836274|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1836275|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1836276|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1836277|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
1836278|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1836279|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836280|NCT04616352|Cefuroxime|cefuroxime|mesh-list
1836281|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
1836282|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1836283|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1836284|NCT04616313|Xenon|xenon|mesh-list
1836285|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1836286|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
1836287|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
1836288|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836289|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836290|NCT04616391|Insulin|insulin|mesh-list
1836291|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1836292|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836320|NCT04615910|Exenatide|exenatide|mesh-list
1836321|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1836322|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836323|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1836324|NCT04615910|Incretins|incretins|mesh-ancestor
1836325|NCT04615910|Hormones|hormones|mesh-ancestor
1836326|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1836327|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
1836328|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
1836329|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1836330|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1836331|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1836332|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1836333|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
1836334|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1836335|NCT04615767|Inositol|inositol|mesh-list
1836336|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
1836337|NCT04615767|Vitamins|vitamins|mesh-ancestor
1836338|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
1836339|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836340|NCT04615702|Acetaminophen|acetaminophen|mesh-list
1836341|NCT04615702|Metronidazole|metronidazole|mesh-list
1836342|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
1836343|NCT04615702|Imipenem|imipenem|mesh-list
1836344|NCT04615702|Diclofenac|diclofenac|mesh-list
1836345|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
1836346|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
1836347|NCT04615702|Secretin|secretin|mesh-list
1836348|NCT04615702|Bilirubin|bilirubin|mesh-list
1836349|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836350|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1836351|NCT04615702|Analgesics|analgesics|mesh-ancestor
1836352|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
1836353|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836354|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
1836355|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1836356|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1836357|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1836358|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1836359|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1836360|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1836361|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1836362|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836363|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836364|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1836365|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1836366|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836367|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1836368|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1836369|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1836370|NCT04615702|Narcotics|narcotics|mesh-ancestor
1836371|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836372|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1836373|NCT04615702|Hormones|hormones|mesh-ancestor
1836374|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1836375|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
1836376|NCT04615702|Protective Agents|protective agents|mesh-ancestor
1836377|NCT04615611|Albuterol|albuterol|mesh-list
1836378|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1836379|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
1836380|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836381|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836382|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1836383|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
1836384|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
1836385|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1836386|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1836387|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1836388|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1836389|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
1836390|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1836391|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836399|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1836400|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1836401|NCT04615481|Metronidazole|metronidazole|mesh-list
1836402|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1836403|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1836404|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1836405|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1836406|NCT04615403|Travoprost|travoprost|mesh-list
1836407|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1836408|NCT04615351|Metformin|metformin|mesh-list
1836409|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1836410|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836411|NCT04615013|Leucovorin|leucovorin|mesh-list
1836412|NCT04615013|Paclitaxel|paclitaxel|mesh-list
1836413|NCT04615013|Docetaxel|docetaxel|mesh-list
1836414|NCT04615013|Carboplatin|carboplatin|mesh-list
1836415|NCT04615013|Fluorouracil|fluorouracil|mesh-list
1836416|NCT04615013|Capecitabine|capecitabine|mesh-list
1836417|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
1836418|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1836419|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1836420|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836421|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
1836422|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
1836423|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
1836424|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836425|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
1836426|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1836427|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1836428|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
1836429|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836430|NCT04615013|Antidotes|antidotes|mesh-ancestor
1836431|NCT04615013|Protective Agents|protective agents|mesh-ancestor
1836432|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
1836433|NCT04615013|Vitamins|vitamins|mesh-ancestor
1836434|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
1836435|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
1836436|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
1836437|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
1836438|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836439|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
1836440|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1836441|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1836450|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
1836451|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836452|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1836457|NCT04614727|Calcium|calcium|mesh-list
1836458|NCT04614727|Fluorides|fluorides|mesh-list
1836459|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1836460|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836461|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
1836462|NCT04614727|Protective Agents|protective agents|mesh-ancestor
1836463|NCT04614714|Niacinamide|niacinamide|mesh-list
1836464|NCT04614714|Niacin|niacin|mesh-list
1836465|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
1836466|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
1836467|NCT04614714|Vitamins|vitamins|mesh-ancestor
1836468|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
1836469|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836470|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1836471|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
1836472|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836473|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1836474|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
1836475|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
1836476|NCT04614636|Fludarabine|fludarabine|mesh-list
1836477|NCT04614636|Daratumumab|daratumumab|mesh-list
1836478|NCT04614636|Elotuzumab|elotuzumab|mesh-list
1836479|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1836480|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
1836481|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836482|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1836483|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1836484|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
1836485|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836486|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836487|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1836488|NCT04614545|Phentermine|phentermine|mesh-list
1836489|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1836490|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836491|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
1836492|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1836493|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
1836494|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
1836495|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836496|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
1836497|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1836498|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836499|NCT04614493|Temozolomide|temozolomide|mesh-list
1836500|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1836501|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
1836502|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836503|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836504|NCT04614610|Lidocaine|lidocaine|mesh-list
1836505|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
1836506|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
1836507|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836508|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836509|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
1836510|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836511|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1836512|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1836513|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1836514|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1836515|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836524|NCT04614584|Mirtazapine|mirtazapine|mesh-list
1836525|NCT04614584|Methamphetamine|methamphetamine|mesh-list
1836526|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
1836527|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1836528|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1836529|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
1836530|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
1836531|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1836532|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836533|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836534|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1836535|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1836536|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836537|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
1836538|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
1836539|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1836540|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
1836541|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
1836542|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1836543|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
1836544|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1836545|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1836546|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
1836547|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
1836548|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836549|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
1836550|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1836551|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1836552|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1836553|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1836554|NCT04614311|Triamcinolone|triamcinolone|mesh-list
1836555|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1836556|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1836557|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1836558|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1836559|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
1836560|NCT04614311|Hormones|hormones|mesh-ancestor
1836561|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1836562|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836563|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1836564|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
1836565|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836566|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836567|NCT04614298|Brodalumab|brodalumab|mesh-list
1836568|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
1836574|NCT04614259|Bupivacaine|bupivacaine|mesh-list
1836575|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
1836576|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
1836577|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836578|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836579|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
1836580|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836581|NCT04614194|Letrozole|letrozole|mesh-list
1836582|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836583|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1836584|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1836585|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836586|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836587|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1836588|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
1836589|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1836590|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836591|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
1836592|NCT04613960|Analgesics|analgesics|mesh-ancestor
1836593|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
1836594|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836595|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836596|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
1836597|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836598|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1836599|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
1836600|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1836601|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1836602|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836603|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1836604|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
1836605|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1836606|NCT04613609|Nicotine|nicotine|mesh-list
1836607|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1836608|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
1836609|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836610|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836611|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1836612|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1836613|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
1836614|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1836615|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836616|NCT04613700|Secretin|secretin|mesh-list
1836617|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1836618|NCT04613700|Hormones|hormones|mesh-ancestor
1836619|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1836620|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836626|NCT04613869|Hydromorphone|hydromorphone|mesh-list
1836627|NCT04613869|Esketamine|esketamine|mesh-list
1836628|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1836629|NCT04613869|Narcotics|narcotics|mesh-ancestor
1836630|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836631|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836632|NCT04613869|Analgesics|analgesics|mesh-ancestor
1836633|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
1836634|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836635|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
1836636|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1836637|NCT04613726|Ondansetron|ondansetron|mesh-list
1836638|NCT04613726|Granisetron|granisetron|mesh-list
1836639|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
1836640|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
1836641|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836642|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836643|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1836644|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
1836645|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
1836646|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1836647|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
1836648|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1836649|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836650|NCT04613726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1836651|NCT04613726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1836652|NCT04613726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836653|NCT04613726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1836654|NCT04613726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1836655|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
1836656|NCT04613557|Fludarabine|fludarabine|mesh-list
1836657|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
1836658|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1836659|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
1836660|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836661|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1836662|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1836663|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
1836664|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836665|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836666|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1836667|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1836668|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
1836669|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1836670|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836671|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836672|NCT04613830|Tramadol|tramadol|mesh-list
1836673|NCT04613830|Bupivacaine|bupivacaine|mesh-list
1836674|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
1836675|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
1836676|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836677|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836678|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
1836679|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836680|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1836681|NCT04613830|Narcotics|narcotics|mesh-ancestor
1836682|NCT04613830|Analgesics|analgesics|mesh-ancestor
1836683|NCT04613102|Cannabidiol|cannabidiol|mesh-list
1836684|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
1836685|NCT04613219|Tofacitinib|tofacitinib|mesh-list
1836686|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1836687|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836688|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836689|NCT04613167|Evolocumab|evolocumab|mesh-list
1836690|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1836691|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1836692|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
1836922|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1836693|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836694|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1836695|NCT04613271|Azithromycin|azithromycin|mesh-list
1836696|NCT04613271|Favipiravir|favipiravir|mesh-list
1836697|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1836698|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1836699|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
1836700|NCT04613206|Vaccines|vaccines|mesh-list
1836701|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
1836702|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836703|NCT04613284|Durvalumab|durvalumab|mesh-list
1836704|NCT04613284|Endostar protein|endostar protein|mesh-list
1836705|NCT04613284|Endostatins|endostatins|mesh-list
1836706|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1836707|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836708|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1836709|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1836710|NCT04613284|Growth Substances|growth substances|mesh-ancestor
1836711|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836712|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
1836713|NCT04613024|Topiramate|topiramate|mesh-list
1836714|NCT04613024|Gabapentin|gabapentin|mesh-list
1836715|NCT04613024|Analgesics|analgesics|mesh-ancestor
1836716|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
1836717|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836718|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836719|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
1836720|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1836721|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1836722|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836723|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1836724|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1836725|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1836726|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1836727|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836728|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
1836729|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1836730|NCT04612998|Atropine|atropine|mesh-list
1836731|NCT04612998|Ephedrine|ephedrine|mesh-list
1836732|NCT04612998|Metoclopramide|metoclopramide|mesh-list
1836733|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1836734|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1836735|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1836736|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
1836737|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836738|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836739|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1836740|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
1836741|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
1836742|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
1836743|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1836744|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1836745|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
1836746|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1836747|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836748|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
1836749|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1836750|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
1836751|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1836752|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
1836753|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1836754|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
1836755|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1836756|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
1836757|NCT04612920|Acetaminophen|acetaminophen|mesh-list
1836758|NCT04612920|Ibuprofen|ibuprofen|mesh-list
1836759|NCT04612920|Oxycodone|oxycodone|mesh-list
1836760|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1836761|NCT04612920|Analgesics|analgesics|mesh-ancestor
1836762|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
1836763|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836764|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836765|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
1836766|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1836767|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1836768|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1836769|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1836770|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836771|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836772|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1836773|NCT04612920|Narcotics|narcotics|mesh-ancestor
1836774|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836775|NCT04613180|Montelukast|montelukast|mesh-list
1836776|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1836777|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
1836778|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
1836779|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
1836780|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1836781|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836782|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
1836783|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1836784|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836785|NCT04612894|Apatinib|apatinib|mesh-list
1836786|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836787|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1836788|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836789|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836790|NCT04612634|Vaccines|vaccines|mesh-list
1836791|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
1836792|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836793|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
1836794|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
1836795|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
1836796|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1836797|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836798|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836799|NCT04612556|Vaccines|vaccines|mesh-list
1836800|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
1836801|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836808|NCT04612582|Thalidomide|thalidomide|mesh-list
1836809|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
1836810|NCT04612582|Bortezomib|bortezomib|mesh-list
1836811|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1836812|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
1836813|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836814|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1836815|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1836816|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
1836817|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836818|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836819|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1836820|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
1836821|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1836822|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1836823|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1836824|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1836825|NCT04612582|Growth Substances|growth substances|mesh-ancestor
1836826|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
1836827|NCT04612530|Nivolumab|nivolumab|mesh-list
1836828|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1836829|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836830|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1836831|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836832|NCT04612504|Atezolizumab|atezolizumab|mesh-list
1836833|NCT04612504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836834|NCT04612179|Sirolimus|sirolimus|mesh-list
1836835|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1836836|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1836837|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1836838|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836839|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
1836840|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1836841|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
1836842|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836843|NCT04612257|Insulin|insulin|mesh-list
1836844|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1836845|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836846|NCT04611958|Bupivacaine|bupivacaine|mesh-list
1836847|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
1836848|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
1836849|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836850|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836851|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
1836852|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836853|NCT04611971|Belimumab|belimumab|mesh-list
1836854|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1836855|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
1836856|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836857|NCT04611724|Folfirinox|folfirinox|mesh-list
1836858|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836862|NCT04611438|Cannabidiol|cannabidiol|mesh-list
1836863|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
1836864|NCT04611529|Ibuprofen|ibuprofen|mesh-list
1836865|NCT04611529|Diclofenac|diclofenac|mesh-list
1836866|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1836867|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1836868|NCT04611529|Analgesics|analgesics|mesh-ancestor
1836869|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
1836870|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836871|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836872|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1836873|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1836874|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1836875|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836876|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836877|NCT04611711|Decitabine|decitabine|mesh-list
1836878|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1836879|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
1836880|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836881|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836882|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836883|NCT04611685|Parecoxib|parecoxib|mesh-list
1836884|NCT04611685|Loxoprofen|loxoprofen|mesh-list
1836885|NCT04611685|Tramadol|tramadol|mesh-list
1836886|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1836887|NCT04611685|Narcotics|narcotics|mesh-ancestor
1836888|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836889|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836890|NCT04611685|Analgesics|analgesics|mesh-ancestor
1836891|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
1836892|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1836893|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
1836894|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1836895|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836896|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836897|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1836898|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1836899|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1836900|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1836901|NCT04611373|Levamisole|levamisole|mesh-list
1836902|NCT04611373|Acetazolamide|acetazolamide|mesh-list
1836903|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
1836904|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
1836905|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836906|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836907|NCT04611373|Diuretics|diuretics|mesh-ancestor
1836908|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
1836909|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836910|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1836911|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
1836912|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
1836913|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
1836914|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1836915|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1836916|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1836917|NCT04611464|Misoprostol|misoprostol|mesh-list
1836918|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1836919|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
1836920|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1836921|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836923|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1836924|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
1836938|NCT04611776|Gemcitabine|gemcitabine|mesh-list
1836939|NCT04611776|Paclitaxel|paclitaxel|mesh-list
1836940|NCT04611776|Carboplatin|carboplatin|mesh-list
1836941|NCT04611776|Pemetrexed|pemetrexed|mesh-list
1836942|NCT04611776|Atezolizumab|atezolizumab|mesh-list
1836943|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1836944|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836945|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
1836946|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
1836947|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
1836948|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836949|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1836950|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
1836951|NCT04611776|Antiviral Agents|antiviral agents|mesh-ancestor
1836952|NCT04611776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1836953|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1836954|NCT04611776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1836955|NCT04611776|Immunologic Factors|immunologic factors|mesh-ancestor
1836956|NCT04611776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836957|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1836958|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1836959|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
1836960|NCT04611126|Nivolumab|nivolumab|mesh-list
1836961|NCT04611126|Fludarabine|fludarabine|mesh-list
1836962|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
1836963|NCT04611126|Ipilimumab|ipilimumab|mesh-list
1836964|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1836965|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
1836966|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836967|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1836968|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1836969|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
1836970|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836971|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836972|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1836973|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1836974|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1836975|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1836976|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
1836977|NCT04611152|Aflibercept|aflibercept|mesh-list
1836978|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1836979|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1836980|NCT04611152|Growth Substances|growth substances|mesh-ancestor
1836981|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836982|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
1836983|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836984|NCT04611165|Nivolumab|nivolumab|mesh-list
1836985|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1836986|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1836987|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1836988|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1836989|NCT04610879|Carbamazepine|carbamazepine|mesh-list
1836990|NCT04610879|Levetiracetam|levetiracetam|mesh-list
1836991|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
1836992|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
1836993|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
1836994|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1836995|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1836996|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1836997|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1836998|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1836999|NCT04610879|Analgesics|analgesics|mesh-ancestor
1837000|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
1837001|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837002|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1837003|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1837004|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837005|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1837006|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1837007|NCT04611243|Vaccines|vaccines|mesh-list
1837008|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
1837009|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837010|NCT04610736|Temozolomide|temozolomide|mesh-list
1837011|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1837012|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
1837013|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837014|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837015|NCT04610567|Methotrexate|methotrexate|mesh-list
1837016|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1837017|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
1837018|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1837019|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837020|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1837021|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
1837022|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837023|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837024|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
1837025|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837026|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1837027|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1837028|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
1837029|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1837030|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1837031|NCT04610541|Remdesivir|remdesivir|mesh-list
1837032|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
1837033|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837034|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
1837035|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1837036|NCT04610671|Nivolumab|nivolumab|mesh-list
1837037|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1837038|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837039|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1837040|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837050|NCT04610320|Daratumumab|daratumumab|mesh-list
1837051|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837052|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
1837053|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1837054|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1837055|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837056|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
1837057|NCT04610164|Coagulants|coagulants|mesh-ancestor
1837058|NCT04610307|Anesthetics|anesthetics|mesh-list
1837059|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1837060|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837061|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
1837062|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1837063|NCT04610502|Antibodies|antibodies|mesh-list
1837064|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
1837065|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837066|NCT04610398|Dexamethasone|dexamethasone|mesh-list
1837067|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
1837068|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1837069|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
1837070|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
1837071|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837072|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837073|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1837074|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
1837075|NCT04610398|Hormones|hormones|mesh-ancestor
1837076|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1837077|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1837078|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837079|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
1837080|NCT04610125|Fludarabine|fludarabine|mesh-list
1837081|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1837082|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
1837083|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837084|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1837085|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1837086|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
1837087|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837088|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837089|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1837090|NCT04609865|Lidocaine|lidocaine|mesh-list
1837091|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
1837092|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
1837093|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1837094|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837095|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
1837096|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837097|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1837098|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1837099|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1837100|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1837101|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837102|NCT04609748|Nimesulide|nimesulide|mesh-list
1837103|NCT04609748|Cannabidiol|cannabidiol|mesh-list
1837104|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
1837105|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1837106|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1837107|NCT04609748|Analgesics|analgesics|mesh-ancestor
1837108|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
1837109|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837110|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837111|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1837112|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1837113|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1837114|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837115|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837119|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
1837120|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1837121|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837122|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
1837123|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837124|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
1837125|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
1837126|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1837127|NCT04609761|Antibodies|antibodies|mesh-list
1837128|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
1837129|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
1837130|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
1837131|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837132|NCT04609514|Nicotine|nicotine|mesh-list
1837133|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1837134|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
1837135|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837136|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837137|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1837138|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1837139|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
1837140|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1837141|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837142|NCT04609540|Trastuzumab|trastuzumab|mesh-list
1837143|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1837144|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837145|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
1837146|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
1837153|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1837154|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1837155|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1837156|NCT04609254|Acetaminophen|acetaminophen|mesh-list
1837157|NCT04609254|Ibuprofen|ibuprofen|mesh-list
1837158|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
1837159|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1837160|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1837161|NCT04609254|Analgesics|analgesics|mesh-ancestor
1837162|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
1837163|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837164|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837165|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1837166|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1837167|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1837168|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837169|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837170|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
1837171|NCT04609293|Apatinib|apatinib|mesh-list
1837172|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837173|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1837174|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837175|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837176|NCT04609189|Vitamin D|vitamin d|mesh-list
1837177|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
1837178|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
1837179|NCT04609189|Calcium|calcium|mesh-list
1837180|NCT04609189|Vitamins|vitamins|mesh-ancestor
1837181|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
1837182|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837183|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1837184|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1837185|NCT04609189|Antacids|antacids|mesh-ancestor
1837186|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837187|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1837188|NCT04609111|Aspirin|aspirin|mesh-list
1837189|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1837190|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1837191|NCT04609111|Analgesics|analgesics|mesh-ancestor
1837192|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
1837193|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837194|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837195|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1837196|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1837197|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1837198|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1837199|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837200|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1837201|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1837202|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837203|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
1837204|NCT04609176|Apatinib|apatinib|mesh-list
1837205|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837206|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1837207|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837208|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837209|NCT04609397|Hemay005|hemay005|mesh-list
1837210|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
1837211|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
1837212|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1837213|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837214|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837215|NCT04609098|Piperaquine|piperaquine|mesh-list
1837216|NCT04609098|Artenimol|artenimol|mesh-list
1837217|NCT04609098|Tafenoquine|tafenoquine|mesh-list
1837218|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
1837219|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1837220|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1837221|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1837227|NCT04608734|Midazolam|midazolam|mesh-list
1837228|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1837229|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1837230|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1837231|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837232|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1837233|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1837234|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1837235|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1837236|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
1837237|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
1837238|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
1837239|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
1837240|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1837241|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837242|NCT04609033|Morphine|morphine|mesh-list
1837243|NCT04609033|Ketamine|ketamine|mesh-list
1837244|NCT04609033|Bupivacaine|bupivacaine|mesh-list
1837245|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
1837246|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
1837247|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1837248|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837249|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
1837250|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837251|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1837252|NCT04609033|Narcotics|narcotics|mesh-ancestor
1837253|NCT04609033|Analgesics|analgesics|mesh-ancestor
1837254|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1837255|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1837256|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
1837257|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1837258|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1837259|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1837260|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837261|NCT04608981|Prednisolone|prednisolone|mesh-list
1837262|NCT04608981|Diclofenac|diclofenac|mesh-list
1837263|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1837264|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
1837265|NCT04608981|Hormones|hormones|mesh-ancestor
1837266|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1837267|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837268|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1837269|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837270|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837271|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1837272|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1837273|NCT04608981|Analgesics|analgesics|mesh-ancestor
1837274|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
1837275|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1837276|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1837277|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837278|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837288|NCT04608669|Acetaminophen|acetaminophen|mesh-list
1837289|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1837290|NCT04608669|Analgesics|analgesics|mesh-ancestor
1837291|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
1837292|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837293|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837294|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
1837295|NCT04608448|Sirolimus|sirolimus|mesh-list
1837296|NCT04608448|Petrolatum|petrolatum|mesh-list
1837297|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1837298|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1837299|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1837300|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837301|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
1837302|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1837303|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
1837304|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837305|NCT04608448|Emollients|emollients|mesh-ancestor
1837306|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
1837307|NCT04608474|Evolocumab|evolocumab|mesh-list
1837308|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
1837309|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1837310|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1837311|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
1837312|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837313|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1837314|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837315|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
1837316|NCT04608630|Denosumab|denosumab|mesh-list
1837317|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1837318|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837329|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
1837330|NCT04608539|Hematinics|hematinics|mesh-ancestor
1837331|NCT04608253|Choline|choline|mesh-list
1837332|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
1837333|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1837334|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
1837335|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837336|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1837337|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1837338|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
1837339|NCT04608500|Minocycline|minocycline|mesh-list
1837340|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1837341|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1837342|NCT04608201|Nicotine|nicotine|mesh-list
1837343|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1837344|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
1837345|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837346|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837347|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1837348|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1837349|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
1837350|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1837351|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837352|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1837353|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1837370|NCT04607772|Gemcitabine|gemcitabine|mesh-list
1837371|NCT04607772|Rituximab|rituximab|mesh-list
1837372|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
1837373|NCT04607772|Lenalidomide|lenalidomide|mesh-list
1837374|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
1837375|NCT04607772|Venetoclax|venetoclax|mesh-list
1837376|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1837377|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837378|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
1837379|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837380|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1837381|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1837382|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
1837383|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837384|NCT04607772|Antiviral Agents|antiviral agents|mesh-ancestor
1837385|NCT04607772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1837386|NCT04607772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837387|NCT04607772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1837388|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1837389|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1837390|NCT04607772|Growth Substances|growth substances|mesh-ancestor
1837391|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
1837392|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1837393|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
1837394|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
1837395|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1837396|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1837397|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837398|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1837399|NCT04608331|Analgesics|analgesics|mesh-ancestor
1837400|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
1837401|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837402|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1837403|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1837404|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1837405|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
1837406|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1837407|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837408|NCT04608266|Camostat|camostat|mesh-list
1837409|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
1837410|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837411|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837412|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
1837413|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1837414|NCT04608006|Fentanyl|fentanyl|mesh-list
1837415|NCT04608006|Bupivacaine|bupivacaine|mesh-list
1837416|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
1837417|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
1837418|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1837419|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837420|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
1837421|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837422|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1837423|NCT04608006|Narcotics|narcotics|mesh-ancestor
1837424|NCT04608006|Analgesics|analgesics|mesh-ancestor
1837425|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1837426|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1837427|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
1837453|NCT04607733|Mirikizumab|mirikizumab|mesh-list
1837454|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1837455|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1837456|NCT04607733|Analgesics|analgesics|mesh-ancestor
1837457|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
1837458|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837459|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837460|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1837461|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1837462|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1837463|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1837464|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
1837465|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1837466|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1837467|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1837468|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
1837469|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
1837470|NCT04607629|Omalizumab|omalizumab|mesh-list
1837471|NCT04607629|Budesonide|budesonide|mesh-list
1837472|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
1837473|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
1837474|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1837475|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1837476|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1837477|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
1837478|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837479|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837480|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1837481|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
1837482|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
1837483|NCT04607629|Hormones|hormones|mesh-ancestor
1837484|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1837485|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1837486|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1837487|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1837488|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
1837489|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1837490|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837491|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1837492|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
1837493|NCT04607603|Cannabidiol|cannabidiol|mesh-list
1837494|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
1837495|NCT04607447|Dexamethasone|dexamethasone|mesh-list
1837496|NCT04607447|Atorvastatin|atorvastatin|mesh-list
1837497|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1837498|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
1837499|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
1837500|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837501|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837502|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1837503|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
1837504|NCT04607447|Hormones|hormones|mesh-ancestor
1837505|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1837506|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1837507|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837508|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1837509|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1837510|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
1837511|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837512|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1837513|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1837514|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837515|NCT04607252|Metformin|metformin|mesh-list
1837516|NCT04607252|Megestrol|megestrol|mesh-list
1837517|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
1837518|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1837519|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837520|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
1837521|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1837522|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1837523|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
1837524|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1837525|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1837526|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1837527|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1837528|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837529|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
1837530|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1837531|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
1837532|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1837533|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1837534|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837535|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1837536|NCT04607525|Analgesics|analgesics|mesh-ancestor
1837537|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
1837538|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837539|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1837540|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1837541|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1837542|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
1837543|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1837544|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837545|NCT04607460|Coal Tar|coal tar|mesh-list
1837546|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
1837547|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
1837548|NCT04607642|Manganese|manganese|mesh-list
1837549|NCT04607642|Trace Elements|trace elements|mesh-ancestor
1837550|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
1837551|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837552|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
1837553|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1837554|NCT04606914|Maytansine|maytansine|mesh-list
1837555|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1837556|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837557|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
1837558|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
1837559|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
1837560|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837571|NCT04606836|Bupivacaine|bupivacaine|mesh-list
1837572|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
1837573|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
1837574|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1837575|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837576|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
1837577|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837578|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
1837579|NCT04606901|Neostigmine|neostigmine|mesh-list
1837580|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
1837581|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837582|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837583|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
1837584|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1837585|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837586|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
1837587|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
1837588|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837589|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1837590|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1837591|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1837592|NCT04606563|Losartan|losartan|mesh-list
1837593|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1837594|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1837595|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1837596|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1837597|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837598|NCT04606537|Itraconazole|itraconazole|mesh-list
1837599|NCT04606537|Rifampin|rifampin|mesh-list
1837600|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
1837601|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1837602|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1837603|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1837604|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837605|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837606|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1837607|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
1837608|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1837609|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837610|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1837611|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1837612|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
1837613|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1837614|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
1837615|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1837616|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1837617|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1837618|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1837619|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1837620|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1837621|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1837626|NCT04606212|Losartan|losartan|mesh-list
1837627|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1837628|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1837629|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1837630|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1837631|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837638|NCT04606225|Losartan|losartan|mesh-list
1837639|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1837640|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1837641|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1837642|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1837643|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837644|NCT04606264|Lidocaine|lidocaine|mesh-list
1837645|NCT04606264|Morphine|morphine|mesh-list
1837646|NCT04606264|Hydromorphone|hydromorphone|mesh-list
1837647|NCT04606264|Ketamine|ketamine|mesh-list
1837648|NCT04606264|Gabapentin|gabapentin|mesh-list
1837649|NCT04606264|Aprepitant|aprepitant|mesh-list
1837650|NCT04606264|Anesthetics|anesthetics|mesh-list
1837651|NCT04606264|Perphenazine|perphenazine|mesh-list
1837652|NCT04606264|Anesthetics, Local|anesthetics, local|mesh-ancestor
1837653|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1837654|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837655|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
1837656|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837657|NCT04606264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1837658|NCT04606264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1837659|NCT04606264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1837660|NCT04606264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1837661|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837662|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1837663|NCT04606264|Narcotics|narcotics|mesh-ancestor
1837664|NCT04606264|Analgesics|analgesics|mesh-ancestor
1837665|NCT04606264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1837666|NCT04606264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1837667|NCT04606264|Anesthetics, General|anesthetics, general|mesh-ancestor
1837668|NCT04606264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1837669|NCT04606264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1837670|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1837671|NCT04606264|Anticonvulsants|anticonvulsants|mesh-ancestor
1837672|NCT04606264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1837673|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1837674|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1837675|NCT04606264|Antimanic Agents|antimanic agents|mesh-ancestor
1837676|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
1837677|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
1837678|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1837679|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
1837680|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1837681|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1837682|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
1837683|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1837684|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1837685|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837686|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
1837687|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837688|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837697|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
1837698|NCT04606017|Antacids|antacids|mesh-ancestor
1837699|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837700|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1837701|NCT04605770|Pemetrexed|pemetrexed|mesh-list
1837702|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837703|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837704|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837705|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1837706|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1837707|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1837708|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
1837709|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1837710|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
1837711|NCT04605952|Antibodies|antibodies|mesh-list
1837712|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
1837713|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
1837714|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837730|NCT04605861|Liraglutide|liraglutide|mesh-list
1837731|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1837732|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837733|NCT04605861|Incretins|incretins|mesh-ancestor
1837734|NCT04605861|Hormones|hormones|mesh-ancestor
1837735|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1837736|NCT04605562|Palbociclib|palbociclib|mesh-list
1837737|NCT04605562|Antibodies|antibodies|mesh-list
1837738|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
1837739|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
1837740|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837741|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837742|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1837743|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837744|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837745|NCT04605419|Calcium|calcium|mesh-list
1837746|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1837747|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837748|NCT04605588|Ribavirin|ribavirin|mesh-list
1837749|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
1837750|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
1837751|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
1837752|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837753|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
1837754|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1837755|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
1837756|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1837757|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1837758|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837759|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1837760|NCT04605575|Vinorelbine|vinorelbine|mesh-list
1837761|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1837762|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837763|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
1837764|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
1837765|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
1837766|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837767|NCT04605393|Dronabinol|dronabinol|mesh-list
1837768|NCT04605393|Cannabidiol|cannabidiol|mesh-list
1837769|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
1837770|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
1837771|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837772|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1837773|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1837774|NCT04605393|Analgesics|analgesics|mesh-ancestor
1837775|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
1837776|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837777|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1837778|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1837779|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1837780|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837781|NCT04605393|Hormones|hormones|mesh-ancestor
1837782|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1837783|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1837784|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1837785|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837786|NCT04605731|Durvalumab|durvalumab|mesh-list
1837787|NCT04605731|Ipilimumab|ipilimumab|mesh-list
1837788|NCT04605731|Tremelimumab|tremelimumab|mesh-list
1837789|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
1837790|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1837791|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
1837792|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1837793|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837794|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
1837795|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837796|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1837797|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837798|NCT04604938|Losartan|losartan|mesh-list
1837799|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1837800|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1837801|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1837802|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1837803|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837812|NCT04604756|Losartan|losartan|mesh-list
1837813|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1837814|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1837815|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1837816|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1837817|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837818|NCT04604886|Dobutamine|dobutamine|mesh-list
1837819|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1837820|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
1837821|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
1837822|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837823|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837824|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
1837825|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1837826|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1837827|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
1837828|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1837829|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837830|NCT04604886|Protective Agents|protective agents|mesh-ancestor
1837831|NCT04604678|Metformin|metformin|mesh-list
1837832|NCT04604678|Naltrexone|naltrexone|mesh-list
1837833|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1837834|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837835|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1837836|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1837837|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
1837838|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837839|NCT04604795|Itraconazole|itraconazole|mesh-list
1837840|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
1837841|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1837842|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1837843|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1837844|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837845|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837846|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1837847|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
1837848|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1837849|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837850|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1837851|NCT04604704|Niacinamide|niacinamide|mesh-list
1837852|NCT04604704|Naltrexone|naltrexone|mesh-list
1837853|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1837854|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1837855|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837856|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
1837857|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837858|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
1837859|NCT04604704|Vitamins|vitamins|mesh-ancestor
1837860|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
1837861|NCT04604691|Blinatumomab|blinatumomab|mesh-list
1837862|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837863|NCT04604509|Bupropion|bupropion|mesh-list
1837864|NCT04604509|Nicotine|nicotine|mesh-list
1837865|NCT04604509|Varenicline|varenicline|mesh-list
1837866|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1837867|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
1837868|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837869|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837870|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1837871|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1837872|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
1837873|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1837874|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837875|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1837876|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
1837877|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1837878|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1837879|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1837880|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1837881|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
1837882|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1837883|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1837884|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1837885|NCT04604366|Alprostadil|alprostadil|mesh-list
1837886|NCT04604366|Misoprostol|misoprostol|mesh-list
1837887|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1837888|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
1837889|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1837890|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837891|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1837892|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1837893|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
1837894|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1837895|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
1837896|NCT04604366|Urological Agents|urological agents|mesh-ancestor
1837897|NCT04604353|Calcium|calcium|mesh-list
1837898|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1837899|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837900|NCT04604327|Bemiparin|bemiparin|mesh-list
1837901|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
1837902|NCT04604223|Pioglitazone|pioglitazone|mesh-list
1837903|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1837904|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837905|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
1837906|NCT04604028|Lenalidomide|lenalidomide|mesh-list
1837907|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1837908|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
1837909|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837910|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1837911|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1837912|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
1837913|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837914|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837915|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1837916|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1837917|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1837918|NCT04604028|Growth Substances|growth substances|mesh-ancestor
1837919|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
1837920|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
1837921|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1837922|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837940|NCT04603729|Dexamethasone|dexamethasone|mesh-list
1837941|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
1837942|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1837943|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1837944|NCT04603729|Prednisolone|prednisolone|mesh-list
1837945|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
1837946|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1837947|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
1837948|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1837949|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
1837950|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
1837951|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837952|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837953|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1837954|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
1837955|NCT04603729|Hormones|hormones|mesh-ancestor
1837956|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1837957|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1837958|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837959|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1837960|NCT04603729|Protective Agents|protective agents|mesh-ancestor
1837961|NCT04603976|Erenumab|erenumab|mesh-list
1837962|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1837963|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1837964|NCT04603976|Analgesics|analgesics|mesh-ancestor
1837965|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
1837966|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1837967|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1837968|NCT04603833|Docetaxel|docetaxel|mesh-list
1837969|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1837970|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
1837971|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
1837972|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
1837973|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838009|NCT04603690|Colchicine|colchicine|mesh-list
1838010|NCT04603690|Gout Suppressants|gout suppressants|mesh-ancestor
1838011|NCT04603690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1838012|NCT04603690|Tubulin Modulators|tubulin modulators|mesh-ancestor
1838013|NCT04603690|Antimitotic Agents|antimitotic agents|mesh-ancestor
1838014|NCT04603690|Mitosis Modulators|mitosis modulators|mesh-ancestor
1838015|NCT04603690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838016|NCT04603690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838017|NCT04603872|Dasatinib|dasatinib|mesh-list
1838018|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838019|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1838020|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838021|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838022|NCT04603924|Niclosamide|niclosamide|mesh-list
1838023|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
1838024|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
1838025|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
1838026|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1838027|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838028|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
1838029|NCT04603937|Aflibercept|aflibercept|mesh-list
1838030|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1838031|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1838032|NCT04603937|Growth Substances|growth substances|mesh-ancestor
1838033|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838034|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
1838035|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838036|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
1838037|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
1838038|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
1838039|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
1838040|NCT04603794|Povidone|povidone|mesh-list
1838041|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1838042|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838043|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
1838044|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
1838045|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
1838046|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
1838047|NCT04603664|Cystatins|cystatins|mesh-list
1838048|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
1838049|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
1838050|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838051|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838063|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
1838064|NCT04603508|Empagliflozin|empagliflozin|mesh-list
1838065|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1838066|NCT04603508|Calcium|calcium|mesh-list
1838067|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1838068|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838069|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1838070|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1838071|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1838072|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
1838073|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838074|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1838075|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1838076|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838077|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1838078|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1838079|NCT04603573|Listerine|listerine|mesh-list
1838080|NCT04603573|Fluorides|fluorides|mesh-list
1838081|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
1838082|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
1838083|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
1838084|NCT04603573|Protective Agents|protective agents|mesh-ancestor
1838085|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838086|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1838087|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838088|NCT04603391|Cannabidiol|cannabidiol|mesh-list
1838089|NCT04603391|Methylphenidate|methylphenidate|mesh-list
1838090|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
1838091|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838092|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1838093|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1838094|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1838095|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838096|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
1838097|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838098|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
1838118|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
1838119|NCT04603456|Antacids|antacids|mesh-ancestor
1838120|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838121|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1838122|NCT04603248|Nivolumab|nivolumab|mesh-list
1838123|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1838124|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838125|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1838126|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838127|NCT04603131|Vaccines|vaccines|mesh-list
1838128|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
1838129|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838130|NCT04603066|Ondansetron|ondansetron|mesh-list
1838131|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
1838132|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
1838133|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838134|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838135|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1838136|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
1838137|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
1838138|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1838139|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
1838140|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838141|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838142|NCT04603066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1838143|NCT04603066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1838144|NCT04603066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1838145|NCT04603066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1838146|NCT04603066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1838147|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
1838148|NCT04602754|Empagliflozin|empagliflozin|mesh-list
1838149|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1838150|NCT04602754|Calcium|calcium|mesh-list
1838151|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1838152|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838153|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1838154|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1838155|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1838156|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
1838157|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838158|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1838159|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1838160|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838161|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1838162|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1838163|NCT04602767|Phenylephrine|phenylephrine|mesh-list
1838164|NCT04602767|Vasopressins|vasopressins|mesh-list
1838165|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
1838166|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
1838167|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1838168|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
1838169|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
1838170|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838171|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838172|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
1838173|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1838174|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
1838175|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
1838176|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1838177|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1838178|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1838179|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
1838180|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838181|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838182|NCT04602767|Protective Agents|protective agents|mesh-ancestor
1838183|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
1838184|NCT04602767|Coagulants|coagulants|mesh-ancestor
1838185|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1838186|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
1838192|NCT04602494|Varenicline|varenicline|mesh-list
1838193|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1838194|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1838195|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
1838196|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838197|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838198|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838199|NCT04602273|Azacitidine|azacitidine|mesh-list
1838200|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1838201|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
1838202|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838203|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838204|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838205|NCT04602247|Fesoterodine|fesoterodine|mesh-list
1838206|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1838207|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1838208|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
1838209|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838210|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838211|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838212|NCT04602247|Urological Agents|urological agents|mesh-ancestor
1838221|NCT04602026|Coal Tar|coal tar|mesh-list
1838222|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
1838223|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
1838224|NCT04602143|Testosterone|testosterone|mesh-list
1838225|NCT04602143|Androgens|androgens|mesh-ancestor
1838226|NCT04602143|Hormones|hormones|mesh-ancestor
1838227|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1838228|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838229|NCT04601961|Propofol|propofol|mesh-list
1838230|NCT04601961|Sevoflurane|sevoflurane|mesh-list
1838231|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1838232|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1838233|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838234|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1838235|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
1838236|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
1838237|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1838238|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1838239|NCT04602078|Gemcitabine|gemcitabine|mesh-list
1838240|NCT04602078|Atezolizumab|atezolizumab|mesh-list
1838241|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838242|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1838243|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
1838244|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838245|NCT04602078|Antiviral Agents|antiviral agents|mesh-ancestor
1838246|NCT04602078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838247|NCT04602078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838248|NCT04602078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1838249|NCT04602078|Immunologic Factors|immunologic factors|mesh-ancestor
1838250|NCT04602078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838251|NCT04602065|Antibodies|antibodies|mesh-list
1838252|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
1838253|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
1838254|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838255|NCT04602013|Paclitaxel|paclitaxel|mesh-list
1838256|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1838257|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1838258|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838259|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
1838260|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
1838261|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
1838262|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838267|NCT04601688|Dexamethasone|dexamethasone|mesh-list
1838268|NCT04601688|Bevacizumab|bevacizumab|mesh-list
1838269|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1838270|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838271|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1838272|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1838273|NCT04601688|Growth Substances|growth substances|mesh-ancestor
1838274|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838275|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
1838276|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1838277|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
1838278|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
1838279|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838280|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1838281|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
1838282|NCT04601688|Hormones|hormones|mesh-ancestor
1838283|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1838284|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1838285|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
1838286|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
1838287|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1838288|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838289|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1838290|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1838291|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
1838292|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1838293|NCT04601701|Dexamethasone|dexamethasone|mesh-list
1838294|NCT04601701|Bevacizumab|bevacizumab|mesh-list
1838295|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1838296|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838297|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1838298|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1838299|NCT04601701|Growth Substances|growth substances|mesh-ancestor
1838300|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838301|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
1838302|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1838303|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
1838304|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
1838305|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838306|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1838307|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
1838308|NCT04601701|Hormones|hormones|mesh-ancestor
1838309|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1838310|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1838311|NCT04601675|Dexamethasone|dexamethasone|mesh-list
1838312|NCT04601675|Ranibizumab|ranibizumab|mesh-list
1838313|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1838314|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
1838315|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
1838316|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838317|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838318|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1838319|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
1838320|NCT04601675|Hormones|hormones|mesh-ancestor
1838321|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1838322|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1838323|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838324|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1838325|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1838326|NCT04601675|Growth Substances|growth substances|mesh-ancestor
1838327|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
1838328|NCT04601402|Avelumab|avelumab|mesh-list
1838329|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1838330|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838331|NCT04601324|Fluticasone|fluticasone|mesh-list
1838332|NCT04601324|Xhance|xhance|mesh-list
1838333|NCT04601324|Azelastine|azelastine|mesh-list
1838334|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1838335|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1838336|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
1838337|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838338|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838339|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1838340|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
1838341|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
1838342|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1838343|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
1838344|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838345|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838346|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
1838347|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
1838348|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
1838349|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
1838350|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838351|NCT04600999|Favipiravir|favipiravir|mesh-list
1838352|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
1838353|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838357|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
1838358|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1838359|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1838360|NCT04601142|Prednisolone|prednisolone|mesh-list
1838361|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
1838362|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1838363|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
1838364|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1838365|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
1838366|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
1838367|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838368|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838369|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1838370|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
1838371|NCT04601142|Hormones|hormones|mesh-ancestor
1838372|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1838373|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1838374|NCT04601142|Protective Agents|protective agents|mesh-ancestor
1838375|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1838376|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838377|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
1838378|NCT04601259|Salicylates|salicylates|mesh-list
1838379|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838380|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
1838381|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
1838382|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
1838383|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1838384|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1838385|NCT04601259|Analgesics|analgesics|mesh-ancestor
1838386|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
1838387|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838388|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838389|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1838390|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1838391|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1838392|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838393|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838394|NCT04601389|Omalizumab|omalizumab|mesh-list
1838395|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1838396|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1838397|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1838398|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
1838399|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
1838400|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838401|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
1838402|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1838403|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
1838404|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838405|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838406|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1838407|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
1838408|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
1838409|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
1838410|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838411|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838412|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
1838413|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
1838414|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
1838415|NCT04601077|Protective Agents|protective agents|mesh-ancestor
1838419|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
1838420|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1838421|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838422|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
1838423|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838424|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838430|NCT04601116|Atorvastatin|atorvastatin|mesh-list
1838431|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1838432|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1838433|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
1838434|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838435|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1838436|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1838437|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838438|NCT04600648|Insulin|insulin|mesh-list
1838439|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1838440|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838441|NCT04600167|Isoniazid|isoniazid|mesh-list
1838442|NCT04600167|Rifapentine|rifapentine|mesh-list
1838443|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
1838444|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1838445|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838446|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
1838447|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1838448|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
1838449|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838450|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1838451|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1838452|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
1838453|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1838454|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
1838455|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838456|NCT04600427|Anesthetics|anesthetics|mesh-list
1838457|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1838458|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838459|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
1838460|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
1838461|NCT04600271|Norepinephrine|norepinephrine|mesh-list
1838462|NCT04600271|Analgesics|analgesics|mesh-list
1838463|NCT04600271|Diuretics|diuretics|mesh-list
1838464|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
1838465|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838466|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838467|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
1838468|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1838469|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1838470|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
1838471|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838472|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838473|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
1838474|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
1838475|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1838476|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1838477|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1838478|NCT04600141|Heparin|heparin|mesh-list
1838479|NCT04600141|Calcium heparin|calcium heparin|mesh-list
1838480|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
1838481|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1838482|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1838483|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838484|NCT04600089|Ketamine|ketamine|mesh-list
1838485|NCT04600089|Analgesics|analgesics|mesh-ancestor
1838486|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
1838487|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838488|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838489|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1838490|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1838491|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
1838492|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
1838493|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1838494|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1838495|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1838496|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838497|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838498|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
1838499|NCT04600414|Narcotics|narcotics|mesh-ancestor
1838500|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1838501|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838502|NCT04600414|Analgesics|analgesics|mesh-ancestor
1838503|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
1838504|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838505|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
1838506|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1838507|NCT04600115|Adenosine|adenosine|mesh-list
1838508|NCT04600115|Regadenoson|regadenoson|mesh-list
1838509|NCT04600115|Analgesics|analgesics|mesh-ancestor
1838510|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
1838511|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838512|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838513|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1838514|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
1838515|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1838516|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
1838517|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
1838518|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838519|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838520|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
1838521|NCT04600492|Riociguat|riociguat|mesh-list
1838522|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
1838523|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838524|NCT04600037|Pregabalin|pregabalin|mesh-list
1838525|NCT04600037|Analgesics|analgesics|mesh-ancestor
1838526|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
1838527|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838528|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838529|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
1838530|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1838531|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1838532|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838533|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1838534|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1838535|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1838536|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1838537|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1838538|NCT04599894|Pregabalin|pregabalin|mesh-list
1838539|NCT04599894|Analgesics|analgesics|mesh-ancestor
1838540|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
1838541|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838542|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838543|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
1838544|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1838545|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1838546|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838547|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1838548|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1838549|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1838550|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1838551|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1838552|NCT04599478|Naltrexone|naltrexone|mesh-list
1838553|NCT04599478|Bupropion|bupropion|mesh-list
1838554|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1838555|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1838556|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838557|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
1838558|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838559|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1838560|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
1838561|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1838562|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1838563|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1838564|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1838565|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838566|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
1838567|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838568|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1838569|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1838570|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838571|NCT04599465|Ivacaftor|ivacaftor|mesh-list
1838572|NCT04599465|Elexacaftor|elexacaftor|mesh-list
1838573|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1838574|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1838575|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838576|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
1838577|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1838578|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838579|NCT04599621|Uric Acid|uric acid|mesh-list
1838580|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
1838581|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838582|NCT04599621|Protective Agents|protective agents|mesh-ancestor
1838583|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838584|NCT04599816|Simendan|simendan|mesh-list
1838585|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
1838586|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
1838587|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
1838588|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
1838589|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838590|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838591|NCT04599816|Protective Agents|protective agents|mesh-ancestor
1838592|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838593|NCT04599790|Lenvatinib|lenvatinib|mesh-list
1838594|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838595|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1838596|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838597|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838598|NCT04599777|Sorafenib|sorafenib|mesh-list
1838599|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838600|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1838601|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838602|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838603|NCT04599699|Androgens|androgens|mesh-list
1838604|NCT04599699|Hormones|hormones|mesh-ancestor
1838605|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1838606|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838607|NCT04599075|Insulin|insulin|mesh-list
1838608|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1838609|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1838610|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838611|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
1838612|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
1838613|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1838614|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838615|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
1838616|NCT04599205|Coagulants|coagulants|mesh-ancestor
1838617|NCT04599140|Nivolumab|nivolumab|mesh-list
1838618|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1838619|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838620|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1838621|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838622|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
1838623|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
1838624|NCT04598880|Cathartics|cathartics|mesh-ancestor
1838625|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1838626|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
1838627|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
1838628|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1838629|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838630|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838631|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
1838632|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1838633|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1838634|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838635|NCT04598815|Sirolimus|sirolimus|mesh-list
1838636|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1838637|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838638|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1838639|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838640|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
1838641|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1838642|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
1838643|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838644|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
1838645|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1838646|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838647|NCT04598542|Triamcinolone|triamcinolone|mesh-list
1838648|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1838649|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1838650|NCT04598542|Lorecivivint|lorecivivint|mesh-list
1838651|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1838652|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1838653|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
1838654|NCT04598542|Hormones|hormones|mesh-ancestor
1838655|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1838656|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838657|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1838658|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
1838659|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838660|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838661|NCT04598594|Nicotine|nicotine|mesh-list
1838662|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1838663|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
1838664|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838665|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838666|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1838667|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1838668|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
1838669|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838670|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838671|NCT04598191|Iloprost|iloprost|mesh-list
1838672|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1838673|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
1838674|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
1838675|NCT04598074|Narcotics|narcotics|mesh-ancestor
1838676|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1838677|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838678|NCT04598074|Analgesics|analgesics|mesh-ancestor
1838679|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
1838680|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838681|NCT04598321|Talazoparib|talazoparib|mesh-list
1838682|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1838683|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838684|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838685|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838686|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
1838687|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1838688|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1838689|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838690|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1838691|NCT04598061|Analgesics|analgesics|mesh-ancestor
1838692|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
1838693|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838694|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1838695|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1838696|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1838697|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
1838698|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838699|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838705|NCT04597762|Cyclosporine|cyclosporine|mesh-list
1838706|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
1838707|NCT04597762|Cyclosporins|cyclosporins|mesh-list
1838708|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838709|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838710|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1838711|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
1838712|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838713|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
1838714|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838715|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
1838716|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1838717|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1838718|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1838719|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
1838720|NCT04597619|Analgesics|analgesics|mesh-ancestor
1838721|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
1838722|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838723|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838727|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
1838728|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1838729|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838730|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
1838731|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
1838732|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1838733|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1838734|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838735|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838736|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838737|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1838738|NCT04597437|Zanamivir|zanamivir|mesh-list
1838739|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
1838740|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838741|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838742|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838772|NCT04597424|Doxycycline|doxycycline|mesh-list
1838773|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1838774|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838775|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
1838776|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1838777|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1838778|NCT04597333|Dinoprostone|dinoprostone|mesh-list
1838779|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
1838780|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1838781|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838791|NCT04597320|Fentanyl|fentanyl|mesh-list
1838792|NCT04597320|Midazolam|midazolam|mesh-list
1838793|NCT04597320|Esketamine|esketamine|mesh-list
1838794|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1838795|NCT04597320|Narcotics|narcotics|mesh-ancestor
1838796|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1838797|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838798|NCT04597320|Analgesics|analgesics|mesh-ancestor
1838799|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
1838800|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838801|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1838802|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1838803|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
1838804|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
1838805|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1838806|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1838807|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1838808|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1838809|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
1838810|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
1838811|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838812|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838813|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
1838814|NCT04597476|Fucoidan|fucoidan|mesh-list
1838815|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1838816|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1838817|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
1838818|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838819|NCT04597203|Hydroquinone|hydroquinone|mesh-list
1838820|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
1838821|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838822|NCT04597203|Protective Agents|protective agents|mesh-ancestor
1838823|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838824|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
1838825|NCT04597190|Norepinephrine|norepinephrine|mesh-list
1838826|NCT04597190|Serotonin|serotonin|mesh-list
1838827|NCT04597190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
1838828|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1838829|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1838830|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
1838831|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838832|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838833|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838834|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
1838835|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
1838836|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838837|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1838838|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
1838839|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
1838840|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1838841|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1838842|NCT04596826|Dronabinol|dronabinol|mesh-list
1838843|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
1838844|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838845|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1838846|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1838847|NCT04596826|Analgesics|analgesics|mesh-ancestor
1838848|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
1838849|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838850|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
1838851|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
1838852|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838853|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838854|NCT04596826|Hormones|hormones|mesh-ancestor
1838855|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1838856|NCT04596839|Remdesivir|remdesivir|mesh-list
1838857|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
1838858|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838859|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
1838860|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838861|NCT04597099|Flutamide|flutamide|mesh-list
1838862|NCT04597099|Estradiol|estradiol|mesh-list
1838863|NCT04597099|Progesterone|progesterone|mesh-list
1838864|NCT04597099|Estrogens|estrogens|mesh-ancestor
1838865|NCT04597099|Hormones|hormones|mesh-ancestor
1838866|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1838867|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838868|NCT04597099|Progestins|progestins|mesh-ancestor
1838869|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
1838870|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
1838871|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1838872|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838873|NCT04596488|Efavirenz|efavirenz|mesh-list
1838874|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1838875|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1838876|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1838877|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838878|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
1838879|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1838880|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1838881|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1838882|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
1838883|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1838884|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1838885|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1838891|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
1838892|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1838893|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
1838894|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1838895|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
1838896|NCT04595942|Midodrine|midodrine|mesh-list
1838897|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
1838898|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
1838899|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838900|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838901|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1838902|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1838903|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1838904|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1838905|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
1838906|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838907|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838908|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1838909|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
1838910|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1838911|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
1838912|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838913|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1838914|NCT04595929|Leucovorin|leucovorin|mesh-list
1838915|NCT04595929|Docetaxel|docetaxel|mesh-list
1838916|NCT04595929|Fluorouracil|fluorouracil|mesh-list
1838917|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
1838918|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838919|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
1838920|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
1838921|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
1838922|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838923|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
1838924|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1838925|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1838926|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
1838927|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838928|NCT04595929|Antidotes|antidotes|mesh-ancestor
1838929|NCT04595929|Protective Agents|protective agents|mesh-ancestor
1838930|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
1838931|NCT04595929|Vitamins|vitamins|mesh-ancestor
1838932|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
1838933|NCT04595812|Misoprostol|misoprostol|mesh-list
1838934|NCT04595812|Hemostatics|hemostatics|mesh-list
1838935|NCT04595812|Oxytocin|oxytocin|mesh-list
1838936|NCT04595812|Carbetocin|carbetocin|mesh-list
1838937|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
1838938|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1838939|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838940|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1838941|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
1838942|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1838943|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1838944|NCT04595812|Coagulants|coagulants|mesh-ancestor
1838945|NCT04595981|Cisplatin|cisplatin|mesh-list
1838946|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1838947|NCT04595877|Dipyrone|dipyrone|mesh-list
1838948|NCT04595877|Endorphins|endorphins|mesh-list
1838949|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
1838950|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1838951|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1838952|NCT04595877|Analgesics|analgesics|mesh-ancestor
1838953|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
1838954|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838955|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838956|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1838957|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1838958|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
1838959|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838960|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838961|NCT04595617|Antibodies|antibodies|mesh-list
1838962|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
1838963|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838964|NCT04595318|Varenicline|varenicline|mesh-list
1838965|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1838966|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1838967|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
1838968|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1838969|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1838970|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838971|NCT04595591|Remifentanil|remifentanil|mesh-list
1838972|NCT04595591|Rocuronium|rocuronium|mesh-list
1838973|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1838974|NCT04595591|Narcotics|narcotics|mesh-ancestor
1838975|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1838976|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1838977|NCT04595591|Analgesics|analgesics|mesh-ancestor
1838978|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
1838979|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1838980|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
1838981|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
1838982|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1838983|NCT04595409|Ustekinumab|ustekinumab|mesh-list
1838984|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
1839030|NCT04594746|Amiodarone|amiodarone|mesh-list
1839031|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1839032|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
1839033|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
1839034|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1839035|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839036|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1839037|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1839038|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1839039|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839040|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
1839041|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1839042|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1839043|NCT04594733|Minocycline|minocycline|mesh-list
1839044|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1839045|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1839046|NCT04594759|Isotretinoin|isotretinoin|mesh-list
1839047|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
1839048|NCT04594915|Edoxaban|edoxaban|mesh-list
1839049|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1839050|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
1839051|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1839052|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
1839053|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839054|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839055|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
1839079|NCT04594772|Gemcitabine|gemcitabine|mesh-list
1839080|NCT04594772|Paclitaxel|paclitaxel|mesh-list
1839081|NCT04594772|Fluorouracil|fluorouracil|mesh-list
1839082|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
1839083|NCT04594772|Irinotecan|irinotecan|mesh-list
1839084|NCT04594772|Folfirinox|folfirinox|mesh-list
1839085|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1839086|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839087|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
1839088|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
1839089|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
1839090|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839091|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1839092|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
1839093|NCT04594772|Antiviral Agents|antiviral agents|mesh-ancestor
1839094|NCT04594772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1839095|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839096|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1839097|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
1839098|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839099|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1839100|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1839186|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1839111|NCT04594551|Vaccines|vaccines|mesh-list
1839112|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
1839113|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1839114|NCT04594551|Antibodies|antibodies|mesh-list
1839115|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
1839116|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839117|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
1839118|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
1839119|NCT04594018|Minoxidil|minoxidil|mesh-list
1839120|NCT04594018|Finasteride|finasteride|mesh-list
1839121|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
1839122|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1839123|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839124|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839125|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
1839126|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1839127|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839128|NCT04594018|Urological Agents|urological agents|mesh-ancestor
1839129|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1839130|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
1839131|NCT04594005|Paclitaxel|paclitaxel|mesh-list
1839132|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1839133|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839134|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
1839135|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
1839136|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
1839137|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839138|NCT04594343|Disulfiram|disulfiram|mesh-list
1839139|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1839140|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
1839141|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839142|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839143|NCT04593706|Dexamethasone|dexamethasone|mesh-list
1839144|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
1839145|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1839146|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1839147|NCT04593706|Prednisolone|prednisolone|mesh-list
1839148|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
1839149|NCT04593706|Triamcinolone|triamcinolone|mesh-list
1839150|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
1839151|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
1839152|NCT04593706|Betamethasone|betamethasone|mesh-list
1839153|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
1839154|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
1839155|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
1839156|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
1839157|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
1839158|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1839159|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
1839160|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
1839161|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
1839162|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
1839163|NCT04593706|BB 1101|bb 1101|mesh-list
1839164|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1839165|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
1839166|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
1839167|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839168|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839169|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1839170|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
1839171|NCT04593706|Hormones|hormones|mesh-ancestor
1839172|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1839173|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1839174|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839175|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1839176|NCT04593706|Protective Agents|protective agents|mesh-ancestor
1839177|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1839178|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
1839179|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839180|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839181|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1839182|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
1839183|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
1839184|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
1839185|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
1839187|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1839188|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1839189|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839190|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839191|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1839192|NCT04593836|Peppermint oil|peppermint oil|mesh-list
1839193|NCT04593836|Menthol|menthol|mesh-list
1839194|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
1839195|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
1839196|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
1839197|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
1839198|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839199|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839200|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1839201|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
1839202|NCT04593654|Dalteparin|dalteparin|mesh-list
1839203|NCT04593654|Tinzaparin|tinzaparin|mesh-list
1839204|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1839205|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
1839206|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1839207|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1839208|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839209|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1839210|NCT04593238|Calcium|calcium|mesh-list
1839211|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1839212|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839213|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1839214|NCT04593524|Vitamin D|vitamin d|mesh-list
1839215|NCT04593524|Vitamins|vitamins|mesh-ancestor
1839216|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
1839217|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839218|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1839219|NCT04593329|Dipyrone|dipyrone|mesh-list
1839220|NCT04593329|Tramadol|tramadol|mesh-list
1839221|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1839222|NCT04593329|Narcotics|narcotics|mesh-ancestor
1839223|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1839224|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839225|NCT04593329|Analgesics|analgesics|mesh-ancestor
1839226|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
1839227|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839228|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1839229|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1839230|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1839231|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1839232|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
1839233|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
1839234|NCT04593446|Cathartics|cathartics|mesh-ancestor
1839235|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1839236|NCT04593459|Metformin|metformin|mesh-list
1839237|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1839238|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839239|NCT04593160|Acetaminophen|acetaminophen|mesh-list
1839240|NCT04593160|Diclofenac|diclofenac|mesh-list
1839241|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1839242|NCT04593160|Analgesics|analgesics|mesh-ancestor
1839243|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
1839244|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839245|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839246|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
1839247|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1839248|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1839249|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1839250|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1839251|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839252|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839253|NCT04593108|Letrozole|letrozole|mesh-list
1839254|NCT04593108|Misoprostol|misoprostol|mesh-list
1839255|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839256|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1839257|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1839258|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839259|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839260|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1839261|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
1839262|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1839263|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839264|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
1839265|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
1839266|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1839267|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1839268|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1839269|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
1839270|NCT04592952|Calcitonin|calcitonin|mesh-list
1839271|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
1839272|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
1839273|NCT04592952|Erenumab|erenumab|mesh-list
1839274|NCT04592952|Katacalcin|katacalcin|mesh-list
1839275|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
1839276|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839277|NCT04592952|Analgesics|analgesics|mesh-ancestor
1839278|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
1839279|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839280|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839281|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1839282|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1839283|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
1839284|NCT04593030|Warfarin|warfarin|mesh-list
1839285|NCT04593030|Apixaban|apixaban|mesh-list
1839286|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
1839287|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1839288|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
1839289|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1839290|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
1839291|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839292|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839293|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
1839294|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
1839295|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
1839296|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839297|NCT04592822|Dabigatran|dabigatran|mesh-list
1839298|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
1839299|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1839300|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
1839301|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839302|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839303|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
1839304|NCT04592744|Vasopressins|vasopressins|mesh-list
1839305|NCT04592744|Epinephrine|epinephrine|mesh-list
1839306|NCT04592744|Norepinephrine|norepinephrine|mesh-list
1839307|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
1839308|NCT04592744|Giapreza|giapreza|mesh-list
1839309|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
1839310|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1839311|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1839312|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
1839313|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1839314|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839315|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839316|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1839317|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1839318|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
1839319|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839320|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1839321|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
1839322|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
1839323|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
1839324|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1839325|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
1839326|NCT04592744|Coagulants|coagulants|mesh-ancestor
1839327|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1839328|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
1839329|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1839330|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
1839331|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839332|NCT04592666|Carboplatin|carboplatin|mesh-list
1839333|NCT04592666|Pemetrexed|pemetrexed|mesh-list
1839334|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839335|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839336|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839337|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1839338|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1839339|NCT04593056|Warfarin|warfarin|mesh-list
1839340|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
1839341|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
1839342|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
1839343|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
1839344|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1839345|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
1839346|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839347|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839348|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
1839349|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1839350|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839351|NCT04593043|Warfarin|warfarin|mesh-list
1839352|NCT04593043|Dabigatran|dabigatran|mesh-list
1839353|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
1839354|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
1839355|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1839356|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
1839357|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839358|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839359|NCT04592211|Paclitaxel|paclitaxel|mesh-list
1839360|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
1839361|NCT04592211|Olaparib|olaparib|mesh-list
1839362|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1839363|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839364|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
1839365|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
1839366|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
1839367|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839368|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1839369|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1839370|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839371|NCT04592159|Nabiximols|nabiximols|mesh-list
1839372|NCT04592159|Analgesics|analgesics|mesh-ancestor
1839373|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
1839374|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839375|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839376|NCT04592237|Carboplatin|carboplatin|mesh-list
1839377|NCT04592237|Niraparib|niraparib|mesh-list
1839378|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839379|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1839380|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839381|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839382|NCT04592419|Aflibercept|aflibercept|mesh-list
1839383|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1839384|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1839385|NCT04592419|Growth Substances|growth substances|mesh-ancestor
1839386|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839387|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
1839388|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839389|NCT04592380|Clevidipine|clevidipine|mesh-list
1839390|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1839391|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1839392|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1839393|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1839394|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
1839395|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1839396|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839397|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1839398|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839399|NCT04592198|Palonosetron|palonosetron|mesh-list
1839400|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
1839401|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
1839402|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839403|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839404|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1839405|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1839406|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1839407|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
1839408|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1839409|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839410|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
1839411|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
1839412|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
1839413|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
1839414|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1839415|NCT04592081|Dexamethasone|dexamethasone|mesh-list
1839416|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
1839417|NCT04592081|BB 1101|bb 1101|mesh-list
1839418|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1839419|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
1839420|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
1839421|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839422|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839423|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1839424|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
1839425|NCT04592081|Hormones|hormones|mesh-ancestor
1839426|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1839427|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1839428|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839429|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
1839430|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839431|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839432|NCT04591795|Diclofenac|diclofenac|mesh-list
1839433|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1839434|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1839435|NCT04591795|Analgesics|analgesics|mesh-ancestor
1839436|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
1839437|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839438|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839439|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1839440|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1839441|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1839442|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839443|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839444|NCT04591743|Nicotine|nicotine|mesh-list
1839445|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1839446|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
1839447|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839448|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839449|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1839450|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1839451|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
1839452|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1839453|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839454|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
1839455|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1839456|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839457|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1839458|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839459|NCT04592016|Diclofenac|diclofenac|mesh-list
1839460|NCT04592016|Coal Tar|coal tar|mesh-list
1839461|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1839462|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1839463|NCT04592016|Analgesics|analgesics|mesh-ancestor
1839464|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
1839465|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839466|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839467|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1839468|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1839469|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1839470|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839471|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839472|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
1839473|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
1839474|NCT04592029|Bevacizumab|bevacizumab|mesh-list
1839475|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1839476|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839477|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1839478|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1839479|NCT04592029|Growth Substances|growth substances|mesh-ancestor
1839480|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839481|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
1839482|NCT04591847|Vitamin D|vitamin d|mesh-list
1839483|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
1839484|NCT04591847|Vitamins|vitamins|mesh-ancestor
1839485|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
1839486|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839487|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1839488|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1839489|NCT04591535|Levodopa|levodopa|mesh-list
1839490|NCT04591535|Carbidopa|carbidopa|mesh-list
1839491|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1839492|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1839493|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1839494|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
1839495|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1839496|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839497|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839498|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1839499|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839500|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1839501|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
1839502|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
1839503|NCT04591444|Fluorides|fluorides|mesh-list
1839504|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
1839505|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
1839506|NCT04591444|Protective Agents|protective agents|mesh-ancestor
1839507|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839508|NCT04591457|Insulin|insulin|mesh-list
1839509|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
1839510|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
1839511|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1839512|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839513|NCT04591327|Anesthetics|anesthetics|mesh-list
1839514|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1839515|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839516|NCT04591275|Denosumab|denosumab|mesh-list
1839517|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1839518|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839519|NCT04591600|Ivermectin|ivermectin|mesh-list
1839520|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1839521|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1839534|NCT04591405|Vaccines|vaccines|mesh-list
1839535|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
1839536|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839537|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
1839538|NCT04591210|Giapreza|giapreza|mesh-list
1839539|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
1839540|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
1839541|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
1839542|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
1839543|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839544|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1839545|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
1839546|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
1839552|NCT04590742|Melatonin|melatonin|mesh-list
1839553|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
1839554|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839555|NCT04590742|Protective Agents|protective agents|mesh-ancestor
1839556|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839557|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1839558|NCT04590638|Epinephrine|epinephrine|mesh-list
1839559|NCT04590638|Racepinephrine|racepinephrine|mesh-list
1839560|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
1839561|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1839562|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1839563|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
1839564|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1839565|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839566|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839567|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1839568|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1839569|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
1839570|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839571|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1839572|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
1839573|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
1839574|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
1839575|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1839579|NCT04590664|Verteporfin|verteporfin|mesh-list
1839580|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1839581|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
1839582|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
1839583|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1839584|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1839585|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
1839586|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839587|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1839588|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1839589|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839590|NCT04590820|Rituximab|rituximab|mesh-list
1839591|NCT04590820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1839592|NCT04590820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839593|NCT04590820|Immunologic Factors|immunologic factors|mesh-ancestor
1839594|NCT04590820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839595|NCT04590820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1839596|NCT04590612|Levodopa|levodopa|mesh-list
1839597|NCT04590612|Carbidopa|carbidopa|mesh-list
1839598|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
1839599|NCT04590612|Citalopram|citalopram|mesh-list
1839600|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
1839601|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1839602|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1839603|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
1839604|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1839605|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839606|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839607|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
1839608|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839609|NCT04590612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
1839610|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1839611|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1839612|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
1839613|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1839614|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
1839615|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1839616|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1839617|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
1839618|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
1839619|NCT04590625|Carboplatin|carboplatin|mesh-list
1839620|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1839621|NCT04590625|Apatinib|apatinib|mesh-list
1839622|NCT04590625|Cisplatin|cisplatin|mesh-list
1839623|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839624|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839625|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1839626|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839627|NCT04590326|Cemiplimab|cemiplimab|mesh-list
1839628|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1839629|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839866|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
1839641|NCT04590183|Prednisolone|prednisolone|mesh-list
1839642|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
1839643|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
1839644|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
1839645|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
1839646|NCT04590183|Tacrolimus|tacrolimus|mesh-list
1839647|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
1839648|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
1839649|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1839650|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
1839651|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839652|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
1839653|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839654|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839655|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1839656|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
1839657|NCT04590183|Hormones|hormones|mesh-ancestor
1839658|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1839659|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1839660|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839661|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
1839662|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
1839663|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839664|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1839665|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1839666|NCT04590183|Protective Agents|protective agents|mesh-ancestor
1839667|NCT04590495|Cannabidiol|cannabidiol|mesh-list
1839668|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
1839669|NCT04590508|Xanthohumol|xanthohumol|mesh-list
1839670|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839671|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1839672|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1839673|NCT04590508|Growth Substances|growth substances|mesh-ancestor
1839674|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839675|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
1839676|NCT04590482|Letrozole|letrozole|mesh-list
1839677|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839678|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
1839679|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1839680|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839681|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839682|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
1839683|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
1839684|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1839685|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839686|NCT04590196|Curcumin|curcumin|mesh-list
1839687|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1839688|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1839689|NCT04590196|Analgesics|analgesics|mesh-ancestor
1839690|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
1839691|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839692|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839693|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1839694|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1839695|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839696|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839697|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839708|NCT04589819|Teriparatide|teriparatide|mesh-list
1839709|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
1839710|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839711|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
1839716|NCT04589728|Venetoclax|venetoclax|mesh-list
1839717|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839722|NCT04589429|Morphine|morphine|mesh-list
1839723|NCT04589429|Nalbuphine|nalbuphine|mesh-list
1839724|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1839725|NCT04589429|Narcotics|narcotics|mesh-ancestor
1839726|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1839727|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839728|NCT04589429|Analgesics|analgesics|mesh-ancestor
1839729|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
1839730|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839731|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
1839732|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1839733|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
1839734|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1839735|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1839736|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839737|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
1839738|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1839739|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839740|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1839741|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839742|NCT04589390|Selexipag|selexipag|mesh-list
1839743|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1839744|NCT04589546|Niacinamide|niacinamide|mesh-list
1839745|NCT04589546|Niacin|niacin|mesh-list
1839746|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
1839747|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
1839748|NCT04589546|Vitamins|vitamins|mesh-ancestor
1839749|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
1839750|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839751|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1839752|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
1839753|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839754|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1839755|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
1839756|NCT04589611|Amobarbital|amobarbital|mesh-list
1839757|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
1839758|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1839759|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
1839760|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839761|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
1839762|NCT04589611|Protective Agents|protective agents|mesh-ancestor
1839763|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1839764|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1839765|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
1839766|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
1839767|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1839768|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839769|NCT04589494|Morphine|morphine|mesh-list
1839770|NCT04589494|Tramadol|tramadol|mesh-list
1839771|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1839772|NCT04589494|Narcotics|narcotics|mesh-ancestor
1839773|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1839774|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839775|NCT04589494|Analgesics|analgesics|mesh-ancestor
1839776|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
1839777|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839784|NCT04589325|Ixekizumab|ixekizumab|mesh-list
1839785|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
1839786|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
1839787|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
1839788|NCT04589299|Antibodies|antibodies|mesh-list
1839789|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
1839790|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839791|NCT04589143|S 20098|s 20098|mesh-list
1839792|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1839793|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1839794|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839795|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
1839796|NCT04589130|Naltrexone|naltrexone|mesh-list
1839797|NCT04589130|Bupropion|bupropion|mesh-list
1839798|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1839799|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1839800|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839801|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
1839802|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839803|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1839804|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
1839805|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1839806|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1839807|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1839808|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1839809|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839810|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
1839811|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1839812|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1839813|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1839814|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839815|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1839816|NCT04589234|Gemcitabine|gemcitabine|mesh-list
1839817|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1839818|NCT04589234|Folfirinox|folfirinox|mesh-list
1839819|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1839820|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
1839821|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839822|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839823|NCT04589234|Antiviral Agents|antiviral agents|mesh-ancestor
1839824|NCT04589234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1839825|NCT04589234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839826|NCT04589234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1839827|NCT04589234|Immunologic Factors|immunologic factors|mesh-ancestor
1839828|NCT04589234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839829|NCT04588935|Bisoprolol|bisoprolol|mesh-list
1839830|NCT04588935|Perindopril|perindopril|mesh-list
1839831|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1839832|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
1839833|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
1839834|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839835|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839836|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
1839837|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1839838|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1839839|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
1839840|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1839841|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839842|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1839843|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
1839844|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839845|NCT04588987|Apatinib|apatinib|mesh-list
1839846|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839847|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1839848|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1839849|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839864|NCT04588857|Dexamethasone|dexamethasone|mesh-list
1839865|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1839867|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
1839868|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839869|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839870|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1839871|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
1839872|NCT04588857|Hormones|hormones|mesh-ancestor
1839873|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1839874|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1839875|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839876|NCT04588948|Aflibercept|aflibercept|mesh-list
1839877|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1839878|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1839879|NCT04588948|Growth Substances|growth substances|mesh-ancestor
1839880|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839881|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
1839882|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839883|NCT04588532|Doxepin|doxepin|mesh-list
1839884|NCT04588532|Histamine|histamine|mesh-list
1839885|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
1839886|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
1839887|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1839888|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839889|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839890|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
1839891|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1839892|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1839893|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
1839894|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
1839895|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1839896|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
1839897|NCT04588545|Trastuzumab|trastuzumab|mesh-list
1839898|NCT04588545|Pertuzumab|pertuzumab|mesh-list
1839899|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1839900|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1839919|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
1839920|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1839921|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
1839922|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
1839923|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
1839924|NCT04588792|Furosemide|furosemide|mesh-list
1839925|NCT04588792|Diuretics|diuretics|mesh-ancestor
1839926|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
1839927|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839928|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
1839929|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1839930|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839931|NCT04588441|Adenosine|adenosine|mesh-list
1839932|NCT04588441|Analgesics|analgesics|mesh-ancestor
1839933|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
1839934|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839935|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839936|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1839937|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
1839938|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
1839939|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
1839940|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
1839941|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1839942|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839943|NCT04588688|Mifepristone|mifepristone|mesh-list
1839944|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
1839945|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
1839946|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1839947|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839948|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
1839949|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
1839950|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
1839951|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
1839952|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
1839953|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
1839954|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
1839955|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1839956|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
1839957|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
1839958|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
1839959|NCT04588389|Lidocaine|lidocaine|mesh-list
1839960|NCT04588389|Ropivacaine|ropivacaine|mesh-list
1839961|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
1839962|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
1839963|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1839964|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839965|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
1839966|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839967|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1839968|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1839969|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1839970|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1839971|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839972|NCT04588233|Melatonin|melatonin|mesh-list
1839973|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
1839974|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839975|NCT04588233|Protective Agents|protective agents|mesh-ancestor
1839976|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839977|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1839978|NCT04588220|Plasminogen|plasminogen|mesh-list
1839979|NCT04588220|Melatonin|melatonin|mesh-list
1839980|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
1839981|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1839982|NCT04588220|Protective Agents|protective agents|mesh-ancestor
1839983|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839984|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1839985|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1839986|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1839987|NCT04588194|Dexamethasone|dexamethasone|mesh-list
1839988|NCT04588194|Rituximab|rituximab|mesh-list
1839989|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1839990|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
1839991|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
1839992|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1839993|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1839994|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1839995|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
1839996|NCT04588194|Hormones|hormones|mesh-ancestor
1839997|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1839998|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1839999|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840000|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1840001|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
1840002|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1840003|NCT04588090|Cisplatin|cisplatin|mesh-list
1840004|NCT04588090|Paclitaxel|paclitaxel|mesh-list
1840005|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840006|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1840007|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
1840008|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
1840009|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
1840010|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840011|NCT04588285|Ambroxol|ambroxol|mesh-list
1840012|NCT04588285|Expectorants|expectorants|mesh-ancestor
1840013|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
1840014|NCT04587947|Valsartan|valsartan|mesh-list
1840015|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1840016|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
1840017|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
1840018|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840019|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
1840020|NCT04587973|Ropivacaine|ropivacaine|mesh-list
1840021|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1840022|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840023|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840024|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1840025|NCT04587973|Analgesics|analgesics|mesh-ancestor
1840026|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
1840027|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840028|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
1840029|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1840030|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1840031|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
1840032|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840033|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840034|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
1840035|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
1840036|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
1840037|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
1840038|NCT04587843|Naltrexone|naltrexone|mesh-list
1840039|NCT04587843|Bupropion|bupropion|mesh-list
1840040|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
1840041|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
1840042|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840043|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
1840044|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840045|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1840046|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
1840047|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1840048|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
1840049|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1840050|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1840051|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840052|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
1840053|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840054|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
1840055|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1840056|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840057|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
1840058|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
1840059|NCT04588311|Hematinics|hematinics|mesh-ancestor
1840060|NCT04587830|Temozolomide|temozolomide|mesh-list
1840061|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1840062|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
1840063|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840064|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840065|NCT04587791|Cannabidiol|cannabidiol|mesh-list
1840066|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
1840067|NCT04587778|Ketamine|ketamine|mesh-list
1840068|NCT04587778|Esketamine|esketamine|mesh-list
1840069|NCT04587778|Analgesics|analgesics|mesh-ancestor
1840070|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
1840071|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840072|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840073|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
1840074|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1840075|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
1840076|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
1840077|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840078|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
1840079|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
1840080|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840081|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840082|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
1840083|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1840084|NCT04587505|Morphine|morphine|mesh-list
1840085|NCT04587505|Tramadol|tramadol|mesh-list
1840086|NCT04587505|Anesthetics|anesthetics|mesh-list
1840087|NCT04587505|Ropivacaine|ropivacaine|mesh-list
1840088|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840089|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840090|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1840091|NCT04587505|Narcotics|narcotics|mesh-ancestor
1840092|NCT04587505|Analgesics|analgesics|mesh-ancestor
1840093|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
1840094|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840095|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
1840109|NCT04587089|Anti-Infective Agents|anti-infective agents|mesh-list
1840110|NCT04587089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
1840111|NCT04587128|Irinotecan|irinotecan|mesh-list
1840112|NCT04587128|Cetuximab|cetuximab|mesh-list
1840113|NCT04587128|Panitumumab|panitumumab|mesh-list
1840114|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
1840115|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1840116|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840117|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840118|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840119|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1840120|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
1840121|NCT04587141|Hematinics|hematinics|mesh-ancestor
1840122|NCT04587115|Oxycodone|oxycodone|mesh-list
1840123|NCT04587115|Risperidone|risperidone|mesh-list
1840124|NCT04587115|Ziprasidone|ziprasidone|mesh-list
1840125|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1840126|NCT04587115|Narcotics|narcotics|mesh-ancestor
1840127|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840128|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840129|NCT04587115|Analgesics|analgesics|mesh-ancestor
1840130|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
1840131|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840132|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1840133|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
1840134|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840135|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840136|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1840137|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1840138|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1840139|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1840140|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
1840166|NCT04586543|Docetaxel|docetaxel|mesh-list
1840167|NCT04586543|Selegiline|selegiline|mesh-list
1840168|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840169|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
1840170|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
1840171|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
1840172|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840173|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
1840174|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1840175|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
1840176|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
1840177|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
1840178|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840179|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
1840180|NCT04586543|Protective Agents|protective agents|mesh-ancestor
1840181|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840182|NCT04586504|Midazolam|midazolam|mesh-list
1840183|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
1840184|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
1840185|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840186|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840187|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
1840188|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1840189|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1840190|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
1840191|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
1840192|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
1840193|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
1840194|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
1840195|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840196|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840197|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
1840198|NCT04586790|Epinephrine|epinephrine|mesh-list
1840199|NCT04586790|Racepinephrine|racepinephrine|mesh-list
1840200|NCT04586790|Midodrine|midodrine|mesh-list
1840201|NCT04586790|Norepinephrine|norepinephrine|mesh-list
1840202|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
1840203|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
1840204|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1840205|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
1840206|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840207|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840208|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840209|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1840210|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
1840211|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
1840212|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840213|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1840214|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
1840215|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
1840216|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
1840217|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
1840218|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
1840219|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
1840220|NCT04586790|Coagulants|coagulants|mesh-ancestor
1840221|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
1840222|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
1840223|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
1840224|NCT04586465|Gemcitabine|gemcitabine|mesh-list
1840225|NCT04586465|Carboplatin|carboplatin|mesh-list
1840226|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
1840227|NCT04586465|Pemetrexed|pemetrexed|mesh-list
1840228|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840229|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1840230|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
1840231|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840232|NCT04586465|Antiviral Agents|antiviral agents|mesh-ancestor
1840233|NCT04586465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1840234|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840235|NCT04586465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1840236|NCT04586465|Immunologic Factors|immunologic factors|mesh-ancestor
1840237|NCT04586465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840238|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1840239|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1840240|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1840241|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
1840242|NCT04586335|Olaparib|olaparib|mesh-list
1840243|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
1840244|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840245|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840246|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840247|NCT04586088|Apatinib|apatinib|mesh-list
1840248|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840249|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1840250|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840251|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840252|NCT04586166|Imidacloprid|imidacloprid|mesh-list
1840253|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
1840254|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840255|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840256|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840257|NCT04586348|Iodine|iodine|mesh-list
1840258|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
1840259|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1840260|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1840261|NCT04586348|Trace Elements|trace elements|mesh-ancestor
1840262|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
1840263|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840264|NCT04586062|Plasminogen|plasminogen|mesh-list
1840265|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1840266|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1840267|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840268|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
1840269|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
1840270|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
1840271|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840272|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
1840273|NCT04586361|Protective Agents|protective agents|mesh-ancestor
1840274|NCT04585997|Omalizumab|omalizumab|mesh-list
1840275|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1840276|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1840277|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
1840292|NCT04585737|Tenofovir|tenofovir|mesh-list
1840293|NCT04585737|Lamivudine|lamivudine|mesh-list
1840294|NCT04585737|Emtricitabine|emtricitabine|mesh-list
1840295|NCT04585737|Dolutegravir|dolutegravir|mesh-list
1840296|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
1840297|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
1840298|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1840299|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1840300|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1840301|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840302|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840303|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1840304|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1840305|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
1840306|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
1840307|NCT04585867|Bupivacaine|bupivacaine|mesh-list
1840308|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
1840309|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
1840310|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840311|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840312|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
1840313|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840314|NCT04585841|Cannabidiol|cannabidiol|mesh-list
1840315|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
1840316|NCT04585932|Leuprolide|leuprolide|mesh-list
1840317|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
1840318|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
1840319|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1840320|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840321|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
1840322|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840323|NCT04585776|Insulin|insulin|mesh-list
1840324|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1840325|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840326|NCT04585711|Etanercept|etanercept|mesh-list
1840327|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1840328|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1840329|NCT04585711|Analgesics|analgesics|mesh-ancestor
1840330|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
1840331|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840332|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840333|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1840334|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1840335|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1840336|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1840337|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
1840338|NCT04585893|Rituximab|rituximab|mesh-list
1840339|NCT04585893|Etoposide|etoposide|mesh-list
1840340|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1840341|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840342|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
1840343|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840344|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1840345|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1840346|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1840347|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1840348|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840349|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840350|NCT04585490|Paclitaxel|paclitaxel|mesh-list
1840351|NCT04585490|Cisplatin|cisplatin|mesh-list
1840352|NCT04585490|Carboplatin|carboplatin|mesh-list
1840353|NCT04585490|Pemetrexed|pemetrexed|mesh-list
1840354|NCT04585490|Durvalumab|durvalumab|mesh-list
1840355|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
1840356|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1840357|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840358|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
1840359|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
1840360|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
1840361|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840362|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840363|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1840364|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1840365|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1840366|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
1840367|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840368|NCT04585334|Diclofenac|diclofenac|mesh-list
1840369|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1840370|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1840371|NCT04585334|Analgesics|analgesics|mesh-ancestor
1840372|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
1840373|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840374|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840375|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1840376|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1840377|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1840378|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840379|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840380|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
1840381|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
1840382|NCT04585542|Laxatives|laxatives|mesh-ancestor
1840383|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1840384|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
1840385|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
1840386|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840387|NCT04585477|Durvalumab|durvalumab|mesh-list
1840388|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1840389|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840390|NCT04585412|Palonosetron|palonosetron|mesh-list
1840391|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
1840392|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
1840393|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840394|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840395|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1840396|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
1840397|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
1840398|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
1840399|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840400|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840401|NCT04585438|Diclofenac|diclofenac|mesh-list
1840402|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1840403|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1840404|NCT04585438|Analgesics|analgesics|mesh-ancestor
1840405|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
1840406|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840407|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840408|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1840409|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1840410|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1840411|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840412|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840413|NCT04585321|Diclofenac|diclofenac|mesh-list
1840414|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
1840415|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1840416|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1840417|NCT04585321|Analgesics|analgesics|mesh-ancestor
1840418|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
1840419|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840420|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840421|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1840422|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1840423|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
1840424|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840425|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840426|NCT04585230|Mineral Oil|mineral oil|mesh-list
1840427|NCT04585230|Emollients|emollients|mesh-ancestor
1840428|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
1840429|NCT04585152|Rituximab|rituximab|mesh-list
1840430|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1840431|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840432|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
1840433|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840434|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1840435|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
1840436|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
1840437|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
1840438|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1840439|NCT04585022|Cimetidine|cimetidine|mesh-list
1840440|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
1840441|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1840442|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
1840443|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
1840444|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
1840445|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840446|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840447|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840448|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
1840449|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1840450|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840451|NCT04584515|Itraconazole|itraconazole|mesh-list
1840452|NCT04584515|Rifampin|rifampin|mesh-list
1840453|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
1840454|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1840455|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
1840456|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
1840457|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840458|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840459|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
1840460|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
1840461|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
1840462|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840463|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
1840464|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
1840465|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
1840466|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1840467|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
1840468|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1840469|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
1840470|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
1840471|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
1840472|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
1840473|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
1840474|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
1840475|NCT04584580|Heparin|heparin|mesh-list
1840476|NCT04584580|Enoxaparin|enoxaparin|mesh-list
1840477|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
1840478|NCT04584580|Tinzaparin|tinzaparin|mesh-list
1840479|NCT04584580|Dalteparin|dalteparin|mesh-list
1840480|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
1840481|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
1840482|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
1840483|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840484|NCT04584749|Lidocaine|lidocaine|mesh-list
1840485|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
1840486|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
1840487|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840488|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840489|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
1840490|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840491|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1840492|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1840493|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1840494|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1840495|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840510|NCT04584710|Dactolisib|dactolisib|mesh-list
1840511|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840512|NCT04584671|Xenon|xenon|mesh-list
1840513|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
1840514|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
1840515|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
1840516|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840517|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840518|NCT04584736|Ezetimibe|ezetimibe|mesh-list
1840519|NCT04584736|Pitavastatin|pitavastatin|mesh-list
1840520|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
1840521|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
1840522|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
1840523|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840524|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
1840525|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
1840526|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840527|NCT04584125|Riboflavin|riboflavin|mesh-list
1840528|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
1840529|NCT04584125|Dextrans|dextrans|mesh-list
1840530|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
1840531|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
1840532|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
1840533|NCT04584125|Vitamins|vitamins|mesh-ancestor
1840534|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
1840535|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840536|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
1840537|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
1840538|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
1840539|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
1840540|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
1840541|NCT04584307|Pomalidomide|pomalidomide|mesh-list
1840542|NCT04584307|Elotuzumab|elotuzumab|mesh-list
1840543|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
1840544|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840545|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
1840546|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
1840547|NCT04584307|Growth Substances|growth substances|mesh-ancestor
1840548|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
1840549|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840550|NCT04584034|Albuterol|albuterol|mesh-list
1840551|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
1840552|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
1840553|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840554|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840555|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1840556|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
1840557|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
1840558|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
1840559|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
1840560|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
1840561|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
1840562|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
1840563|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840564|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840565|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1840566|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840567|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840568|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840569|NCT04583813|Empagliflozin|empagliflozin|mesh-list
1840570|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
1840571|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840572|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1840573|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840582|NCT04583410|Nicotine|nicotine|mesh-list
1840583|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
1840584|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
1840585|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840586|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840587|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
1840588|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
1840589|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
1840590|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840591|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840592|NCT04583501|Omalizumab|omalizumab|mesh-list
1840593|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
1840594|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
1840595|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
1840596|NCT04583267|Tenofovir|tenofovir|mesh-list
1840597|NCT04583267|Emtricitabine|emtricitabine|mesh-list
1840598|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
1840599|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1840600|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
1840601|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
1840602|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840603|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840604|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
1840605|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
1840606|NCT04583111|Domperidone|domperidone|mesh-list
1840607|NCT04583111|Sulpiride|sulpiride|mesh-list
1840608|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
1840609|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
1840610|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840611|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840612|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1840613|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
1840614|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
1840615|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840616|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840617|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
1840618|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
1840619|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840620|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
1840621|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
1840622|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
1840623|NCT04582968|Capecitabine|capecitabine|mesh-list
1840624|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1840625|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
1840626|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840627|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840628|NCT04583046|Iloprost|iloprost|mesh-list
1840629|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
1840630|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
1840631|NCT04583137|Lidocaine|lidocaine|mesh-list
1840632|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
1840633|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
1840634|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840635|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840636|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
1840637|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840638|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1840639|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
1840640|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
1840641|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1840642|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840643|NCT04583020|Temozolomide|temozolomide|mesh-list
1840644|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1840645|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
1840646|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840647|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840648|NCT04582942|Lactulose|lactulose|mesh-list
1840649|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1840650|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
1840651|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
1840652|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840653|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840654|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
1840655|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1840656|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840657|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
1840658|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840659|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
1840660|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840661|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840662|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840676|NCT04582591|Cannabidiol|cannabidiol|mesh-list
1840677|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
1840678|NCT04582604|Decitabine|decitabine|mesh-list
1840679|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1840680|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
1840681|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840682|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840683|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840684|NCT04582786|Morphine|morphine|mesh-list
1840685|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
1840686|NCT04582786|Narcotics|narcotics|mesh-ancestor
1840687|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840688|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840689|NCT04582786|Analgesics|analgesics|mesh-ancestor
1840690|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
1840691|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840692|NCT04582084|Etanercept|etanercept|mesh-list
1840693|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1840694|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1840695|NCT04582084|Analgesics|analgesics|mesh-ancestor
1840696|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
1840697|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840698|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840699|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1840700|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1840701|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
1840702|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1840703|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
1840704|NCT04582305|Bleomycin|bleomycin|mesh-list
1840705|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1840706|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840707|NCT04582136|Sirolimus|sirolimus|mesh-list
1840708|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1840709|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1840710|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1840711|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840712|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
1840713|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1840714|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
1840715|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840716|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
1840717|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
1840718|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
1840719|NCT04582032|Analgesics|analgesics|mesh-ancestor
1840720|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
1840721|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840722|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840723|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
1840724|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1840725|NCT04582097|Ramipril|ramipril|mesh-list
1840726|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
1840727|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
1840728|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840729|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840730|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1840731|NCT04581876|Paclitaxel|paclitaxel|mesh-list
1840732|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1840733|NCT04581876|Raltitrexed|raltitrexed|mesh-list
1840734|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1840735|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840736|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
1840737|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
1840738|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
1840739|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840740|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
1840741|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
1840742|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
1840743|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840744|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
1840745|NCT04581967|Doxorubicin|doxorubicin|mesh-list
1840746|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
1840747|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
1840748|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840749|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
1840750|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1840751|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
1840752|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840753|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840754|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
1840755|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
1840756|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
1840757|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
1840758|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840759|NCT04581447|Metformin|metformin|mesh-list
1840760|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1840761|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840762|NCT04581603|Topiramate|topiramate|mesh-list
1840763|NCT04581603|Anticonvulsants|anticonvulsants|mesh-ancestor
1840764|NCT04581603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
1840765|NCT04581603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840766|NCT04581213|Anesthetics|anesthetics|mesh-list
1840767|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840768|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840777|NCT04581408|Ivacaftor|ivacaftor|mesh-list
1840778|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
1840779|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1840780|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840781|NCT04581265|Paclitaxel|paclitaxel|mesh-list
1840782|NCT04581265|Ifosfamide|ifosfamide|mesh-list
1840783|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
1840784|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
1840785|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840786|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
1840787|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
1840788|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
1840789|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840790|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
1840791|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
1840792|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
1840793|NCT04581382|Nivolumab|nivolumab|mesh-list
1840794|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
1840795|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840796|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
1840797|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840798|NCT04580797|PF-06700841|pf-06700841|mesh-list
1840799|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
1840800|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840801|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840808|NCT04580771|Cisplatin|cisplatin|mesh-list
1840809|NCT04580771|Vaccines|vaccines|mesh-list
1840810|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
1840811|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840812|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
1840813|NCT04580355|Amoxicillin|amoxicillin|mesh-list
1840814|NCT04580355|Metronidazole|metronidazole|mesh-list
1840815|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1840816|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1840817|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
1840818|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
1840819|NCT04580342|Propranolol|propranolol|mesh-list
1840820|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
1840821|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
1840822|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
1840823|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840824|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840825|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840826|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
1840827|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
1840828|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
1840829|NCT04580381|Natalizumab|natalizumab|mesh-list
1840830|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
1840831|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840832|NCT04580472|Clindamycin|clindamycin|mesh-list
1840833|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
1840834|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
1840835|NCT04580472|Cephalexin|cephalexin|mesh-list
1840836|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
1840837|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1840838|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
1840839|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
1840840|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840841|NCT04580394|Oxybutynin|oxybutynin|mesh-list
1840842|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
1840843|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
1840844|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
1840845|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
1840846|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
1840847|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
1840848|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
1840849|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
1840850|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
1840851|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
1840852|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
1840853|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
1840854|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
1840855|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
1840856|NCT04580394|Urological Agents|urological agents|mesh-ancestor
1840857|NCT04580199|Ethanol|ethanol|mesh-list
1840858|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
1840859|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
1840860|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
1840861|NCT04580199|Phy